number_chromosome,genomic_position_start,genomic_position_end,cyto_location,computed_cyto_location,mim_number,gene_symbols,gene_name,approved_symbol,entrez_gene_id,ensembl_gene_id,comments,phenotypes,mouse_gene_symbol_id
1,0,27600000,1p36,NA,607413,AD7CNTP,Alzheimer disease neuronal thread protein,NA,NA,NA,NA,NA,NA
1,0,27600000,1p36,NA,612367,ALPQTL2,"Alkaline phosphatase, plasma level of, QTL 2",NA,100196914,NA,linkage with rs1780324,"{Alkaline phosphatase, plasma level of, QTL 2}, 612367 (2)",NA
1,0,123400000,1p,NA,606788,ANON1,"Anorexia nervosa, susceptibility to, 1",NA,171514,NA,NA,"{Anorexia nervosa, susceptibility to, 1}, 606788 (2)",NA
1,0,27600000,1p36,NA,605462,BCC1,"Basal cell carcinoma, susceptibility to, 1",NA,100307118,NA,associated with rs7538876,"{Basal cell carcinoma, susceptibility to, 1}, 605462 (2)",NA
1,0,27600000,1p36,NA,606928,BMND3,Bone mineral density QTL 3,NA,246259,NA,?another locus at 3p21,"[Bone mineral density QTL 3], 606928 (2)",NA
1,0,27600000,1p36,NA,155600,"CMM, MLM, DNS",Cutaneous malignant melanoma/dysplastic nevus,CMM,1243,NA,some linkage studies negative; see 9p,"{Melanoma, cutaneous malignant, 1}, 155600 (2), Autosomal dominant",NA
1,0,20100000,1pter-p36.13,NA,115665,"CTRCT8, CCV","Cataract, congenital, Volkmann type",CCV,7792,NA,linked to Rh in Scottish family,"Cataract 8, multiple types, 115665 (2), Autosomal dominant",NA
1,0,27600000,1p36,NA,607872,"DEL1p36, C1DELp36",Chromosome 1p36 deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 1p36 deletion syndrome, 607872 (4), Isolated cases",NA
1,0,46300000,1p36-p34,NA,608995,DYX8,"Dyslexia, susceptibility to, 8",DYX8,406874,NA,between D1S552 and D1S1622,"{Dyslexia, susceptibility to, 8}, 608995 (2), Autosomal dominant, Multifactorial",NA
1,0,27600000,1pter-p36,NA,131190,"ERPL1, HLM2",Endogenous retroviral pol gene-like sequence 1 (oncogene HLM2),NA,NA,NA,NA,NA,NA
1,0,27600000,1p36,NA,605225,IBD7,Inflammatory bowel disease 7,IBD7,57042,NA,associated with rs6426833,"{Inflammatory bowel disease 7}, 605225 (2)",NA
1,0,27600000,1p36,NA,612596,MS4,"Multiple sclerosis, susceptibility to, 4",NA,100271696,NA,associated with rs10492972,"{Multiple sclerosis, susceptibility to, 4}, 612596 (2)",NA
1,0,27600000,1p36,NA,610320,MYP14,Myopia 14,MYP14,100359407,NA,between D1S552 and D1S1622,"Myopia 14, 610320 (2)",NA
1,0,123400000,1p,NA,605606,PSORS7,Psoriasis susceptibility 7,PSORS7,65245,NA,NA,"{Psoriasis susceptibility 7}, 605606 (2)",NA
1,0,7100000,1p36.3,NA,604008,PTPRZ2,"Protein-tyrosine phosphatase, receptor-type, zeta-2",PTPRZ2,5804,NA,NA,NA,NA
1,0,94300000,1pter-p22.1,NA,154280,"SAI1, MTS1, TFS1",Suppression of anchorage independence-1 (malignant transformation suppression-1),SAI1,6298,NA,NA,NA,NA
1,0,27600000,1p36,NA,618485,ZBTB40IT1,"ZBTB40 intronic transcript 1, noncoding",ZBTB40-IT1,100874345,NA,NA,NA,NA
1,925730,944573,1p36.33,1p36.33,616765,"SAMD11, MRS",Sterile alpha motif domain-containing protein 11,SAMD11,148398,ENSG00000187634,NA,NA,Samd11 (MGI:2446220)
1,944202,959255,1p36.33,1p36.33,610770,"NOC2L, NIR","Nucleolar complex-associated protein 2, S. cerevisiae, homolog of",NOC2L,26155,ENSG00000188976,NA,NA,Noc2l (MGI:1931051)
1,975197,982275,1p36.33,1p36.33,615921,"PERM1, C1orf170","PPARGC1-and ESRR-induced regulator, muscle, 1",PERM1,84808,ENSG00000187642,NA,NA,NA
1,998961,1001051,1p36.31,1p36.33,608060,HES4,"Hairy/enhancer of split, Drosophila, homolog of, 4",HES4,57801,ENSG00000188290,NA,NA,NA
1,1013496,1014539,1p36.33,1p36.33,147571,"ISG15, G1P2, IFI15, IMD38",ISG15 ubiquitin-like modifier,ISG15,9636,ENSG00000187608,NA,"Immunodeficiency 38, 616126 (3), Autosomal recessive",Isg15 (MGI:1855694)
1,1020101,1056118,1pter-p32,1p36.33,103320,"AGRN, CMS8",Agrin,AGRN,375790,ENSG00000188157,NA,"Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive",Agrn (MGI:87961)
1,1167103,1167197,1p36.33,1p36.33,612091,"MIR200B, MIRN200B",Micro RNA 200B,MIR200B,406984,ENSG00000207730,NA,NA,NA
1,1167862,1167951,1p36.33,1p36.33,612090,"MIR200A, MIRN200A",Micro RNA 200A,MIR200A,406983,ENSG00000207607,NA,NA,NA
1,1169004,1169086,1p36.33,1p36.33,612094,"MIR429, MIRN429",Micro RNA 429,MIR429,554210,ENSG00000198976,NA,NA,NA
1,1203507,1207900,1p36.3,1p36.33,603905,"TNFRSF18, AITR, GITR","Tumor necrosis factor receptor superfamily, member 18",TNFRSF18,8784,ENSG00000186891,NA,NA,Tnfrsf18 (MGI:894675)
1,1211325,1216811,1p36,1p36.33,600315,"TNFRSF4, TXGP1L, OX40, ACT35, IMD16","Tumor necrosis factor receptor superfamily, member 4",TNFRSF4,7293,ENSG00000186827,mutation identified in 1 IMD16 family,"?Immunodeficiency 16, 615593 (3), Autosomal recessive",Tnfrsf4 (MGI:104512)
1,1216907,1232066,1p36.33,1p36.33,614282,"SDF4, CAB45",Stromal cell-derived factor 4,SDF4,51150,ENSG00000078808,NA,NA,Sdf4 (MGI:108079)
1,1232236,1235040,1p36.3,1p36.33,615291,"B3GALT6, SEMDJL1, EDSSPD2","UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6",B3GALT6,126792,ENSG00000176022,NA,"Ehlers-Danlos syndrome, spondylodysplastic type, 2, 615349 (3), Autosomal recessive; Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3), Autosomal recessive",B3galt6 (MGI:2152819)
1,1242447,1247217,1p36.33,1p36.33,616593,"FAM132A, C1QDC2, C1QTNF12","Family with sequence similarity 132, member A",C1QTNF12,388581,ENSG00000184163,NA,NA,C1qtnf12 (MGI:1914639)
1,1280435,1292028,1p36.3-p36.2,1p36.33,601328,SCNN1D,"Sodium channel, voltage-gated, type I, delta polypeptide",SCNN1D,6339,ENSG00000162572,NA,NA,NA
1,1311584,1324686,1p36.33,1p36.33,611354,"CPSF3L, INTS11, RC68",Cleavage and polyadenylation-specific factor 3-like,INTS11,54973,ENSG00000127054,NA,NA,Ints11 (MGI:1919207)
1,1324756,1328895,1p36.33,1p36.33,615467,"GLTPD1, CPTP",Glycolipid transfer protein domain-containing protein 1,CPTP,80772,ENSG00000224051,NA,NA,Cptp (MGI:1933107)
1,1331279,1335319,1p36.33,1p36.33,605865,"TAS1R3, T1R3","Taste receptor type 1, member 3",TAS1R3,83756,ENSG00000169962,NA,NA,Tas1r3 (MGI:1933547)
1,1335277,1349417,1p36,1p36.33,601365,"DVL1, DRS2",Dishevelled 1 (homologous to Drosophila dsh),DVL1,1855,ENSG00000107404,NA,"Robinow syndrome, autosomal dominant 2, 616331 (3), Autosomal dominant",Dvl1 (MGI:94941)
1,1352688,1363540,1p36.33,1p36.33,617293,"MXRA8, ASP3",Matrix remodeling-associated protein 8,MXRA8,54587,ENSG00000162576,NA,NA,Mxra8 (MGI:1922011)
1,1373729,1375515,1p36.3,1p36.33,609183,"AURKAIP1, AKIP, AIP",Aurora kinase A-interacting protein 1,AURKAIP1,54998,ENSG00000175756,NA,NA,Aurkaip1 (MGI:1913327)
1,1385710,1399341,1p36.33,1p36.33,613482,CCNL2,Cyclin L2,CCNL2,81669,ENSG00000221978,NA,NA,Ccnl2 (MGI:1927119)
1,1401908,1407292,1p36.3-p35.2,1p36.33,611833,MRPL20,Mitochondrial ribosomal protein L20,MRPL20,55052,ENSG00000242485,NA,NA,Mrpl20 (MGI:2137221)
1,1435689,1442881,1p36.3,1p36.33,611901,"VWA1, WARP",von Willebrand factor A domain-containing protein 1,VWA1,64856,ENSG00000179403,NA,NA,Vwa1 (MGI:2179729)
1,1449688,1470162,1p36.33,1p36.33,617227,ATAD3C,"ATPase family, AAA domain-containing, member 3C",ATAD3C,219293,ENSG00000215915,NA,NA,NA
1,1471731,1509465,1p36.33,1p36.33,612317,"ATAD3B, TOB3, KIAA1273","ATPase family, AAA domain-containing, member 3B",ATAD3B,83858,ENSG00000160072,NA,NA,NA
1,1512142,1534686,1p36.33,1p36.33,612316,"ATAD3A, HAYOS","ATPase family, AAA domain-containing, member 3A",ATAD3A,55210,ENSG00000197785,one family with AR inheritance reported,"Harel-Yoon syndrome, 617183 (3), Autosomal recessive, Autosomal dominant",Atad3a (MGI:1919214)
1,1534777,1540623,1p36.33,1p36.33,616101,"TMEM240, C1orf70, SCA21",Transmembrane protein 240,TMEM240,339453,ENSG00000205090,NA,"Spinocerebellar ataxia 21, 607454 (3), Autosomal dominant",Tmem240 (MGI:3648074)
1,1541672,1574862,1p36.33,1p36.33,617680,SSU72,"Ssu72, S. cerevisiae, homolof of",SSU72,29101,ENSG00000160075,NA,NA,Ssu72 (MGI:1916241)
1,1613729,1630609,1p36.32,1p36.33,611141,MIB2,"Mindbomb, Drosophila, homolog of, 2",MIB2,142678,ENSG00000197530,NA,NA,Mib2 (MGI:2679684)
1,1631680,1635637,1p36.3,1p36.33,603321,"MMP23B, MMP22",Matrix metalloproteinase 23B,MMP23B,8510,ENSG00000189409,NA,NA,Mmp23 (MGI:1347361)
1,1635224,1659618,1p36.3,1p36.33,176873,"CDK11B, CDC2L1, P58, CDK11",Cyclin-dependent kinase 11B,CDK11B,984,ENSG00000248333,NA,NA,NA
1,1699938,1701807,1p36.3,1p36.33,603320,"MMP23A, MMP21, MIFR",Matrix metalloproteinase 23A,MMP23A,8511,ENSG00000215914,NA,NA,NA
1,1702378,1724564,1p36.3,1p36.33,116951,"CDK11A, CDC2L2",Cyclin-dependent kinase 11A,CDK11A,728642,ENSG00000008128,NA,NA,Cdk11b (MGI:88353)
1,1751231,1780508,1p36.33-p36.21,1p36.33,611616,NADK,NAD kinase,NADK,65220,ENSG00000008130,NA,NA,Nadk (MGI:2183149)
1,1785284,1891116,1pter-p31.2,1p36.33,139380,"GNB1, MRD42","Guanine nucleotide-binding protein, beta polypeptide-1",GNB1,2782,ENSG00000078369,NA,"Leukemia, acute lymphoblastic, somatic, 613065 (3); Mental retardation, autosomal dominant 42, 616973 (3), Autosomal dominant",Gnb1 (MGI:95781)
1,1913750,1917295,1p36.33,1p36.33,610171,"CALML6, CAGLP",Calmodulin-like 6,CALML6,163688,ENSG00000169885,NA,NA,NA
1,2019344,2030757,1p36.3,1p36.33,137163,"GABRD, GEFSP5, EIG10, EJM7","Gamma-aminobutyric acid (GABA) A receptor, delta",GABRD,2563,ENSG00000187730,NA,"{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant",Gabrd (MGI:95622)
1,2050410,2185398,1p36,1p36.33,176982,"PRKCZ, PKC2","Protein kinase C, zeta form",PRKCZ,5590,ENSG00000067606,NA,NA,Prkcz (MGI:97602)
1,2184456,2212719,1p36.33,1p36.33,615183,"C1orf86, FAAP20",Chromosome 1 open reading frame 86,FAAP20,199990,ENSG00000162585,NA,NA,Faap20 (MGI:1914763)
1,2228318,2310212,1p36.3,1p36.33-p36.32,164780,"SKI, SGS",Avian sarcoma viral (v-ski) oncogene homolog,SKI,6497,ENSG00000157933,formerly mapped to 1q22-q24,"Shprintzen-Goldberg syndrome, 182212 (3), Autosomal dominant",Ski (MGI:98310)
1,2300000,20100000,1p36.32-p36.13,NA,607671,DYT13,"Dystonia 13, torsion",DYT13,93983,NA,NA,"Dystonia 13, torsion, 607671 (2), Autosomal dominant",NA
1,2300000,29900000,1p36.32-p35.3,NA,606242,KONDS,"Kondoh syndrome (mental retardation, microcephaly, growth retardation, joint contractures, and facial dysmorphism)",NA,100653373,NA,linked to rs966321 and rs1441834,"Kondoh syndrome, 606242 (2), Autosomal recessive",NA
1,2404801,2412573,1p36.32,1p36.32,602859,"PEX10, NALD, PBD6A, PBD6B",Peroxisome biogenesis factor 10,PEX10,5192,ENSG00000157911,NA,"Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive",Pex10 (MGI:2684988)
1,2412480,2505531,1p36.32,1p36.32,612836,"PLCH2, PLCL4","Phospholipase C, eta-2",PLCH2,9651,ENSG00000149527,NA,NA,Plch2 (MGI:2443078)
1,2508536,2526621,1p36,1p36.32,606162,PANK4,Pantothenate kinase 4,PANK4,55229,ENSG00000157881,NA,NA,Pank4 (MGI:2387466)
1,2528744,2530553,1p36.31,1p36.32,607348,HES5,"Hairy/enhancer of split, Drosophila, homolog of, 5",HES5,388585,ENSG00000197921,NA,NA,Hes5 (MGI:104876)
1,2556364,2565621,1p36.3-p36.2,1p36.32,602746,"TNFRSF14, HVEM, TR2","Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)",TNFRSF14,8764,ENSG00000157873,NA,NA,Tnfrsf14 (MGI:2675303)
1,2590638,2633041,1p36.32,1p36.32,618104,"MMEL1, NEPII, NEP2, NL1, SEP",Membrane metalloendopeptidase-like 1,MMEL1,79258,ENSG00000142606,NA,NA,Mmel1 (MGI:1351603)
1,3021466,3022902,1p36.32,1p36.32,608535,"ACTRT2, ARPT2, ARPM2",Actin-related protein T2,ACTRT2,140625,ENSG00000169717,NA,NA,Actrt2 (MGI:1920603)
1,3069202,3438620,1p36.3,1p36.32,605557,"PRDM16, MEL1, LVNC8, CMD1LL",PR domain-containing protein 16,PRDM16,63976,ENSG00000142611,NA,"Cardiomyopathy, dilated, 1LL, 615373 (3), Autosomal dominant; Left ventricular noncompaction 8, 615373 (3), Autosomal dominant",Prdm16 (MGI:1917923)
1,3487950,3624769,1p36.3,1p36.32,604266,"MEGF6, EGFL3",Multiple epidermal growth factor-like domains 6,MEGF6,1953,ENSG00000162591,NA,NA,Megf6 (MGI:1919351)
1,3560694,3560789,1p36.32,1p36.32,615148,MIR551A,Micro RNA 551A,MIR551A,693135,ENSG00000207776,NA,NA,NA
1,3625014,3630126,1p36.32,1p36.32,611460,"TPRG1L, FAM79A",Tumor protein p63 regulated 1-like,TPRG1L,127262,ENSG00000158109,NA,NA,Tprgl (MGI:1915058)
1,3630766,3650102,1p36.3,1p36.32,606040,WDR8,WD repeat-containing protein 8,WRAP73,49856,ENSG00000116213,NA,NA,Wrap73 (MGI:1891749)
1,3652515,3736200,1p36,1p36.32,601990,TP73,p53-related protein,TP73,7161,ENSG00000078900,imprinted,NA,Trp73 (MGI:1336991)
1,3772760,3775981,1p36,1p36.32,615242,"SMIM1, VEL",Small integral membrane protein 1,SMIM1,388588,ENSG00000235169,NA,"[Blood group, Vel system], 615264 (3), Autosomal recessive",Smim1 (MGI:1916109)
1,3812085,3857232,1p36.32,1p36.32,616690,"CEP104, GLYBP, KIAA0562, JBTS25","Centrosomal protein, 104kD",CEP104,9731,ENSG00000116198,NA,"Joubert syndrome 25, 616781 (3), Autosomal recessive",Cep104 (MGI:2687282)
1,3857266,3885428,1p36.3,1p36.32,601883,"DFFB, CAD, DFF2","DNA fragmentation factor, 40kD, beta subunit",DFFB,1677,ENSG00000169598,NA,NA,Dffb (MGI:1196287)
1,4654608,4792533,1p36.32,1p36.32,610972,"AJAP1, SHREW1",Adherens junction-associated protein 1,AJAP1,55966,ENSG00000196581,NA,NA,Ajap1 (MGI:2685419)
1,5300000,20100000,1p36.31-p36.13,NA,614414,DFNB96,"Deafness, autosomal recessive 96",DFNB96,100861440,NA,between rs3817914 and rs477558,"Deafness, autosomal recessive 96, 614414 (2), Autosomal recessive",NA
1,5862807,5992472,1p36,1p36.31,607215,"NPHP4, SLSN4",Nephrocystin 4,NPHP4,261734,ENSG00000131697,NA,"Nephronophthisis 4, 606966 (3), Autosomal recessive; Senior-Loken syndrome 4, 606996 (3), Autosomal recessive",Nphp4 (MGI:2384210)
1,5992638,6101185,1p36.3,1p36.31,601142,"KCNAB2, KCNA2B","Potassium voltage-gated channel, shaker-related subfamily, beta member 2",KCNAB2,8514,ENSG00000069424,NA,NA,Kcnab2 (MGI:109239)
1,6101786,6180320,1p36,1p36.31,610771,CHD5,Chromodomain helicase DNA-binding protein 5,CHD5,26038,ENSG00000116254,NA,NA,Chd5 (MGI:3036258)
1,6185019,6199594,1p36.31,1p36.31,180474,"RPL22, EAP",Ribosomal protein L22,RPL22,6146,ENSG00000116251,fused with AML1 in t(3;21),NA,Rpl22 (MGI:99262)
1,6206003,6221298,1p36.31,1p36.31,616923,"RNF207, C1orf188",RING finger protein 207,RNF207,388591,ENSG00000158286,NA,NA,Rnf207 (MGI:2684989)
1,6221192,6235963,1p36,1p36.31,605851,ICMT,Isoprenylcysteine carboxylmethyltransferase,ICMT,23463,ENSG00000116237,NA,NA,Icmt (MGI:1888594)
1,6244178,6245577,1p36.31,1p36.31,609971,HES3,"Hairy/enhancer of split, Drosophila, homolog of, 3",HES3,390992,ENSG00000173673,NA,NA,Hes3 (MGI:104877)
1,6247352,6261097,1p36.31,1p36.31,614269,GPR153,G protein-coupled receptor 153,GPR153,387509,ENSG00000158292,NA,NA,Gpr153 (MGI:1916157)
1,6264271,6393765,1p36,1p36.31,602587,"ACOT7, BACH, LACH",Acyl-CoA thioesterase 7,ACOT7,11332,ENSG00000097021,NA,NA,Acot7 (MGI:1917275)
1,6415231,6419918,1p36.31,1p36.31,609970,HES2,"Hairy/enhancer of split, Drosophila, homolog of, 2",HES2,54626,ENSG00000069812,NA,NA,Hes2 (MGI:1098624)
1,6424775,6461366,1p36.3-p36.1,1p36.31,606351,ESPN,"Espin, mouse, homolog of",ESPN,83715,ENSG00000187017,NA,"Deafness, autosomal recessive 36, 609006 (3), Autosomal recessive; Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)",Espn (MGI:1861630)
1,6461150,6466194,1p36.3,1p36.31,603366,"TNFRSF25, TNFRSF12, DR3, LARD","Tumor necrosis factor receptor superfamily, member 25",TNFRSF25,8718,ENSG00000215788,NA,NA,Tnfrsf25 (MGI:1934667)
1,6466091,6520060,1p36,1p36.31,611101,"PLEKHG5, KIAA0720, DSMA4, CMTRIC",Pleckstrin homology domain- and RhoGEF domain-containing protein G5,PLEKHG5,57449,ENSG00000171680,NA,"Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive; Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive",Plekhg5 (MGI:2652860)
1,6555306,6579754,1p36,1p36.31,606225,"TAS1R1, T1R1","Taste receptor type 1, member 1",TAS1R1,80835,ENSG00000173662,NA,NA,Tas1r1 (MGI:1927505)
1,6579993,6589279,1p36.3,1p36.31,165270,"ZBTB48, HKR3",Zinc finger- and BTB domain-containing protein 48,ZBTB48,3104,ENSG00000204859,NA,NA,Zbtb48 (MGI:2140248)
1,6590723,6602868,1p36.31,1p36.31,616262,"KLHL21, KIAA0469",Kelch-like 21,KLHL21,9903,ENSG00000162413,NA,NA,Klhl21 (MGI:1919288)
1,6624615,6635585,1p36.31,1p36.31,612532,THAP3,THAP domain-containing protein 3,THAP3,90326,ENSG00000041988,NA,NA,Thap3 (MGI:1917126)
1,6634167,6701832,1p36.31-p36.23,1p36.31,614827,DNAJC11,"DNAJ/HSP40 homolog, subfamily C, member 11",DNAJC11,55735,ENSG00000007923,NA,NA,Dnajc11 (MGI:2443386)
1,6785323,7769705,1p36,1p36.31-p36.23,611501,"CAMTA1, KIAA0833, CANPMR",Calmodulin-binding transcription activator 1,CAMTA1,23261,ENSG00000171735,NA,"Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3), Autosomal dominant",Camta1 (MGI:2140230)
1,7100000,27600000,1p36.2-p36.1,NA,600975,GLC3B,"Glaucoma 3, primary infantile, B",GLC3B,2728,NA,NA,"Glaucoma 3, primary infantile, B, 600975 (2), Autosomal recessive",NA
1,7100000,15900000,1p36.2,NA,608543,SCZD12,Schizophrenia 12,NA,619488,NA,max lod at D1S1612,"{Schizophrenia 12}, 181500 (2), Autosomal dominant",NA
1,7771274,7781431,1p36,1p36.23,603657,VAMP3,Vesicle-associated membrane protein 3,VAMP3,9341,ENSG00000049245,NA,NA,Vamp3 (MGI:1321389)
1,7784186,7845180,1p36.33-p36.21,1p36.23,603427,"PER3, FASPS3","Period, Drosophila, homolog of, 3",PER3,8863,ENSG00000049246,mutation identified in 1 FASPS3 family,"?Advanced sleep phase syndrome, familial, 3, 616882 (3), Autosomal dominant",Per3 (MGI:1277134)
1,7846344,7913614,1p36.23,1p36.23,604097,UTS2,Urotensin II,UTS2,10911,ENSG00000049247,NA,NA,Uts2 (MGI:1346329)
1,7915870,7943164,1p36,1p36.23,602250,"TNFRSF9, ILA, CD137","Tumor necrosis factor receptor superfamily, member 9 (interleukin-activated receptor; Ly63, mouse, homolog of)",TNFRSF9,3604,ENSG00000049249,NA,NA,Tnfrsf9 (MGI:1101059)
1,7961653,7985504,1p36,1p36.23,602533,"DJ1, PARK7",Oncogene DJ-1,PARK7,11315,ENSG00000116288,NA,"Parkinson disease 7, autosomal recessive early-onset, 606324 (3), Autosomal recessive",Park7 (MGI:2135637)
1,8011724,8026308,1p36,1p36.23,608069,"MIG6, RALT",Mitogen-inducible gene 6,ERRFI1,54206,ENSG00000116285,NA,NA,Errfi1 (MGI:1921405)
1,8318084,8344166,1p36.2-p36.1,1p36.23,605763,"SLC45A1, DNB5, IDDNPF","Solute carrier family 45, member 1",SLC45A1,50651,ENSG00000162426,NA,"Intellectual developmental disorder with neuropsychiatric features, 617532 (3), Autosomal recessive",Slc45a1 (MGI:2653235)
1,8352403,8817639,1p36.2-p36.1,1p36.23,605226,"RERE, NEDBEH",RE repeats-encoding gene,RERE,473,ENSG00000142599,NA,"Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3), Autosomal dominant",Rere (MGI:2683486)
1,8860999,8878685,1pter-p36.13,1p36.23,172430,"ENO1, PPH, MPB1","Enolase-1, alpha",ENO1,2023,ENSG00000074800,NA,Enolase deficiency (1),"Eno1b,Eno1 (MGI:95393,MGI:3648653)"
1,8945867,8975091,1p36.33-p36.22,1p36.23,114780,CA6,Carbonic anhydrase VI,CA6,765,ENSG00000131686,NA,NA,Car6 (MGI:1333786)
1,8992533,9026383,1p36.2,1p36.23,610371,"SLC2A7, GLUT7","Solute carrier family 2 (facilitated glucose transporter), member 7",SLC2A7,155184,ENSG00000197241,NA,NA,Slc2a7 (MGI:3650865)
1,9035105,9072258,1p36.2,1p36.23,138230,"SLC2A5, GLUT5","Solute carrier family 2 (facilitated glucose transporter), member 5",SLC2A5,6518,ENSG00000142583,NA,NA,Slc2a5 (MGI:1928369)
1,9151667,9151776,1p36,1p36.22,611172,"MIR34A, MIRN34A",Micro RNA 34A,MIR34A,407040,ENSG00000284357,NA,NA,NA
1,9234766,9271336,1p36,1p36.22,138090,"H6PD, GDH, G6PDH, CORTRD1",Hexose-6-phosphate dehydrogenase,H6PD,9563,ENSG00000049239,digenic triallelic mutations with HSD11B1,"Cortisone reductase deficiency 1, 604931 (3), Autosomal recessive",H6pd (MGI:2140356)
1,9292893,9369531,1p36.22,1p36.22,611657,"SPSB, SSB1",SPRY domain- and SOCS box-containing 1,SPSB1,80176,ENSG00000171621,NA,NA,Spsb1 (MGI:1921896)
1,9539464,9585172,1p36.22,1p36.22,610816,SLC25A33,"Solute carrier family 25 (mitochondrial carrier), member 33",SLC25A33,84275,ENSG00000171612,NA,NA,Slc25a33 (MGI:1917806)
1,9629888,9729113,1p36.2,1p36.22,602839,"PIK3CD, APDS, IMD14","Phosphatidylinositol 3-kinase, catalytic, 110kD, delta",PIK3CD,5293,ENSG00000171608,NA,"Immunodeficiency 14, 615513 (3), Autosomal dominant",Pik3cd (MGI:1098211)
1,9729020,9824525,1p36,1p36.22,611321,"CLSTN1, KIAA0911",Calsyntenin 1,CLSTN1,22883,ENSG00000171603,NA,NA,Clstn1 (MGI:1929895)
1,9848275,9910321,1p36.22,1p36.22,607758,"CTNNBIP1, ICAT","Catenin, beta-interacting protein 1",CTNNBIP1,56998,ENSG00000178585,NA,NA,Ctnnbip1 (MGI:1915756)
1,9922117,9943401,1p36.22,1p36.22,610458,LZIC,Leucine zipper and CTNNBIP1 domains-containing protein,LZIC,84328,ENSG00000162441,NA,NA,Lzic (MGI:1916401)
1,9942922,9996883,1p36.22,1p36.22,608700,"NMNAT1, NMNAT, PNAT1, LCA9",Nicotinamide nucleotide adenylyltransferase 1,NMNAT1,64802,ENSG00000173614,NA,"Leber congenital amaurosis 9, 608553 (3), Autosomal recessive",Nmnat1 (MGI:1913704)
1,10032957,10181238,1p36.3,1p36.22,613565,"UBE4B, UFD2A, KIAA0684",Ubiquitination factor E4B,UBE4B,10277,ENSG00000130939,NA,NA,Ube4b (MGI:1927086)
1,10210569,10381602,1p36.2,1p36.22,605995,"KIF1B, CMT2A, CMT2A1, NBLST1",Kinesin family member 1B,KIF1B,23095,ENSG00000054523,mutation identified in 1 CMT2A1 family,"?Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Pheochromocytoma, 171300 (3), Autosomal dominant",Kif1b (MGI:108426)
1,10399063,10420510,1p36.2-p36.13,1p36.22,172200,PGD,6-phosphogluconate dehydrogenase,PGD,5226,ENSG00000142657,NA,NA,Pgd (MGI:97553)
1,10430432,10442814,1p36.22,1p36.22,609130,APITD1,"Apoptosis-inducing, TAF9-like domain 1",CENPS,378708,ENSG00000175279,NA,NA,Cenps (MGI:1917178)
1,10450030,10451997,1p36,1p36.22,602784,CORT,Cortistatin,CORT,1325,ENSG00000241563,NA,NA,Cort (MGI:109538)
1,10456521,10472528,1p36.3-p36.2,1p36.22,601882,"DFFA, DFF1","DNA fragmentation factor, 45kD, alpha subunit",DFFA,1676,ENSG00000160049,NA,NA,Dffa (MGI:1196227)
1,10474945,10630757,1p36.2,1p36.22,601791,"PEX14, PBD13A",Peroxisome biogenesis factor 14,PEX14,5195,ENSG00000142655,NA,"Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3), Autosomal recessive",Pex14 (MGI:1927868)
1,10636603,10796649,1p36.22,1p36.22,609895,"CASZ1, SRG",Castor zinc finger protein 1,CASZ1,54897,ENSG00000130940,NA,NA,Casz1 (MGI:1196251)
1,11012621,11030527,1p36.2,1p36.22,605078,"TARDBP, TDP43, ALS10",TAR DNA-binding protein,TARDBP,23435,ENSG00000120948,"pseudogenes on 2, 6, 8, 13, 20","Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant; Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant",Tardbp (MGI:2387629)
1,11026522,11047238,1p36.3-p36.2,1p36.22,605102,MASP2,Mannan-binding lectin serine protease 2,MASP2,10747,ENSG00000009724,NA,"MASP2 deficiency, 613791 (3), Autosomal recessive",Masp2 (MGI:1330832)
1,11054588,11060052,1p36-p22,1p36.22,182891,"SRM, SPS1",Spermidine synthase-1,SRM,6723,ENSG00000116649,?pseudogene on 3p14-q21,NA,Srm (MGI:102690)
1,11066612,11099868,1p36.22,1p36.22,605960,"EXOSC10, PMSCL2",Exosome component 10,EXOSC10,5394,ENSG00000171824,NA,NA,Exosc10 (MGI:1355322)
1,11106534,11273496,1p36.2,1p36.22,601231,"MTOR, FRAP1, SKS",Mechanistic target of rapamycin,MTOR,2475,ENSG00000198793,NA,"Focal cortical dysplasia, type II, somatic, 607341 (3); Smith-Kingsmore syndrome, 616638 (3), Autosomal dominant",Mtor (MGI:1928394)
1,11273197,11299571,1p36.3,1p36.22,611632,"UBIAD1, TERE1, SCCD",UbiA prenyltransferase domain-containing protein 1,UBIAD1,29914,ENSG00000120942,NA,"Corneal dystrophy, Schnyder type, 121800 (3), Autosomal dominant",Ubiad1 (MGI:1918957)
1,11479154,11537582,1p36.22,1p36.22,611251,"PTCHD2, DISP3, KIAA1337",Patched domain-containing protein 2,DISP3,57540,ENSG00000204624,NA,NA,Disp3 (MGI:2444403)
1,11648386,11654428,1p36,1p36.22,607112,"FBXO2, FBX2, FBG1, NFB42",F-box only protein 2,FBXO2,26232,ENSG00000116661,NA,NA,Fbxo2 (MGI:2446216)
1,11654374,11663326,1p36.21,1p36.22,609111,"FBXO44, FBX44, FBX6A, FBG3",F-box only protein 44,FBXO44,93611,ENSG00000132879,NA,NA,Fbxo44 (MGI:1354744)
1,11664199,11674353,1p36.23,1p36.22,605647,"FBXO6, FBX6, FBG2",F-box only protein 6,FBXO6,26270,ENSG00000116663,NA,NA,Fbxo6 (MGI:1354743)
1,11674479,11691620,1p36,1p36.22,604094,"MAD2L2, MAD2B, FANCV","Mitotic arrest-deficient 2, S. cerevisiae, homolog-like 2",MAD2L2,10459,ENSG00000116670,mutation identified in 1 FANCV patient; pseudogene on 14q21-q23,"?Fanconi anemia, complementation group V, 617243 (3), Autosomal recessive",Mad2l2 (MGI:1919140)
1,11686634,11725856,1p36.22,1p36.22,612682,"DRAXIN, C1orf187",Dorsal repulsive axon guidance protein,DRAXIN,374946,ENSG00000162490,NA,NA,Draxin (MGI:1917683)
1,11785729,11806102,1p36.3,1p36.22,607093,MTHFR,Methylenetetrahydrofolate reductase,MTHFR,4524,ENSG00000177000,NA,"Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Vascular disease, susceptibility to} (3)",Mthfr (MGI:106639)
1,11806095,11843143,1p36,1p36.22,602726,CLCN6,Chloride channel 6,CLCN6,1185,ENSG00000011021,NA,NA,Clcn6 (MGI:1347049)
1,11845708,11847782,1p36.2,1p36.22,108780,"NPPA, PND, ANP, ATFB6, ATRST2",Natriuretic peptide precursor A,NPPA,4878,ENSG00000175206,NA,"Atrial fibrillation, familial, 6, 612201 (3), Autosomal dominant; Atrial standstill 2, 615745 (3), Autosomal recessive",Nppa (MGI:97367)
1,11857463,11858944,1p36.2,1p36.22,600295,"NPPB, BNP",Natriuretic peptide precursor B,NPPB,4879,ENSG00000120937,NA,NA,NA
1,11934716,11975536,1p36.3-p36.2,1p36.22,153454,"PLOD1, LH1, LLH, EDSKCL1","Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase)",PLOD1,5351,ENSG00000083444,NA,"Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive",Plod1 (MGI:99907)
1,11980180,12013514,1p36.2,1p36.22,608507,"MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B",Mitofusin 2,MFN2,9927,ENSG00000116688,NA,"Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant",Mfn2 (MGI:2442230)
1,12019465,12032044,1p36.22,1p36.22,608772,"MIIP, IIP45",Migration and invasion inhibitory protein,MIIP,60672,ENSG00000116691,NA,NA,Miip (MGI:106506)
1,12063302,12144212,1p36,1p36.22,153243,"TNFRSF8, CD30, D1S166E","Tumor necrosis factor receptor superfamily, member 8 (CD30 antigen; Ki-1 antigen)",TNFRSF8,943,ENSG00000120949,NA,NA,Tnfrsf8 (MGI:99908)
1,12166947,12209221,1p36.3-p36.2,1p36.22,191191,"TNFRSF1B, TNFR2, TNFBR","Tumor necrosis factor receptor superfamily, member 1B",TNFRSF1B,7133,ENSG00000028137,NA,NA,Tnfrsf1b (MGI:1314883)
1,12230029,12512046,1p36.22-p36.21,1p36.22-p36.21,608877,"VPS13D, SCAR4","Vacuolar protein sorting 13, yeast, homolog of, D",VPS13D,55187,ENSG00000048707,NA,"Spinocerebellar ataxia, autosomal recessive 4, 607317 (3), Autosomal recessive",Vps13d (MGI:2448530)
1,12500000,15900000,1p36.21,NA,609918,GBD2,Gallbladder disease 2,GBD2,100048905,NA,between D1S1597 and D1S47,"Gallbladder disease 2, 609918 (2)",NA
1,12567909,12618209,1p36.1,1p36.21,612830,"DHRS3, RETSDR1","Short-chain dehydrogenase/reductase family, member 3",DHRS3,9249,ENSG00000162496,NA,NA,Dhrs3 (MGI:1315215)
1,13474972,13514002,1p36.21,1p36.21,615212,LRRC38,Leucine-rich repeat-containing protein 38,LRRC38,126755,ENSG00000162494,NA,NA,Lrrc38 (MGI:2442845)
1,13583756,13617956,1p36.21,1p36.21,608863,"PDPN, TI1A, T1A2, GP36, OTS8, AGGRUS",Podoplanin,PDPN,10630,ENSG00000162493,NA,NA,Pdpn (MGI:103098)
1,13698873,13825078,1p36,1p36.21,601196,"PRDM2, RIZ",PR domain-containing protein 2 (retinoblastoma protein-binding zinc-finger protein RIZ),PRDM2,7799,ENSG00000116731,NA,NA,Prdm2 (MGI:107628)
1,13893385,15118042,1p36.21,1p36.21,618301,KAZN,"Kazrin, periplakin-interacting protein",KAZN,23254,ENSG00000189337,NA,NA,Kazn (MGI:1918779)
1,15409887,15430338,1p36.21,1p36.21,616450,"EFHD2, SWS1","EF-hand domain family, member D2",EFHD2,79180,ENSG00000142634,NA,NA,Efhd2 (MGI:106504)
1,15438441,15449246,1p36.21,1p36.21,601405,"CTRC, CLCR",Chymotrypsin,CTRC,11330,ENSG00000162438,NA,"{Pancreatitis, chronic, susceptibility to}, 167800 (3), Autosomal dominant",Ctrc (MGI:1923951)
1,15456731,15472090,1p36.2,1p36.21,609443,"CELA2A, ELA2A","Chymotrypsin-like elastase family, member 2A",CELA2A,63036,ENSG00000142615,NA,NA,Cela2a (MGI:95316)
1,15476103,15491394,1p36.2,1p36.21,609444,"CELA2B, ELA2B","Chymotrypsin-like elastase family, member 2B",CELA2B,51032,ENSG00000215704,NA,NA,NA
1,15491400,15524911,1p36.3-p36.1,1p36.21,602234,"CASP9, APAF3","Caspase 9, apoptosis-related cysteine protease",CASP9,842,ENSG00000132906,NA,NA,Casp9 (MGI:1277950)
1,15571698,15585050,1p36.21,1p36.21,617887,"AGMAT, AUH",Agmatinase,AGMAT,79814,ENSG00000116771,NA,NA,Agmat (MGI:1923236)
1,15659712,15662029,1p36.1,1p36.21,601966,"RSC1A1, RS1","Regulatory solute carrier protein, family 1, member 1",RSC1A1,6248,ENSG00000215695,NA,NA,Rsc1a1 (MGI:3526447)
1,15681505,15734768,1p36.21,1p36.21,609613,"PLEKHM2, SKIP, KIAA0842","Pleckstrin homology domain-containing protein, family M, member 2",PLEKHM2,23207,ENSG00000116786,NA,NA,Plekhm2 (MGI:1916832)
1,15735087,15741391,1p36.21,1p36.21,610817,SLC25A34,"Solute carrier family 25, member 34",SLC25A34,284723,ENSG00000162461,NA,NA,Slc25a34 (MGI:2686215)
1,15756169,15786589,1p36.13,1p36.21,607747,"FBLP1, MIGFILIN",Filamin-binding LIM protein 1,FBLIM1,54751,ENSG00000162458,NA,NA,Fblim1 (MGI:1921452)
1,15847706,15940455,1p36.13,1p36.21-p36.13,613484,"SPEN, MINT, SHARP, HIAA0929","SPEN, Drosophila, homolog of",SPEN,23013,ENSG00000065526,NA,NA,Spen (MGI:1891706)
1,15900000,39600000,1p36.13-p34.3,NA,609122,ANIB3,"Aneurysm, intracranial berry, 3",ANIB3,497657,NA,NA,"Aneurysm, intracranial berry, 3, 609122 (2), Autosomal dominant",NA
1,15900000,39600000,1p36.13-p34.3,NA,616055,EA8,"Episodic ataxia, type 8",NA,104326187,NA,between rs2743201 and rs215791,"Episodic ataxia, type 8, 616055 (2), Autosomal dominant",NA
1,15900000,34300000,1p36.1-p35,NA,601201,MEMO1,Methylation modifier for class I HLA,NA,7795,NA,NA,NA,NA
1,15939932,15976131,1p36.2-p36.1,1p36.13,604084,"ZBTB17, ZNF151, MIZ1",Zinc finger- and BTB domain-containing protein 17,ZBTB17,7709,ENSG00000116809,NA,NA,Zbtb17 (MGI:107410)
1,16014027,16019593,1p36.23-p34.3,1p36.13,610692,"HSPB7, CVHSP",Heat-shock 27kD protein 7,HSPB7,27129,ENSG00000173641,NA,NA,Hspb7 (MGI:1352494)
1,16022035,16034049,1p36,1p36.13,602024,CLCNKA,"Chloride channel, kidney, A",CLCNKA,1187,ENSG00000186510,11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKB,"Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive",Clcnkb (MGI:1930643)
1,16043735,16057325,1p36,1p36.13,602023,CLCNKB,"Chloride channel, kidney, B",CLCNKB,1188,ENSG00000184908,unequal crossingover with CLCNKA,"Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive",Clcnka (MGI:1329026)
1,16124336,16156103,1p36.1,1p36.13,176946,"EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6",Ephrin receptor EphA2,EPHA2,1969,ENSG00000142627,NA,"Cataract 6, multiple types, 116600 (3), Autosomal dominant",Epha2 (MGI:95278)
1,16197853,16212699,1p36.13,1p36.13,612496,"ARHGEF19, WGEF",RHO guanine nucleotide exchange factor 19,ARHGEF19,128272,ENSG00000142632,NA,NA,Arhgef19 (MGI:1925912)
1,16246839,16352479,1p36.23-p36.11,1p36.13,609109,"FBXO42, FBX42, KIAA1332",F-box only protein 42,FBXO42,54455,ENSG00000037637,NA,NA,Fbxo42 (MGI:1924992)
1,16440671,16460089,1p36.13,1p36.13,611624,NECAP2,NECAP endocytosis-associated protein 2,NECAP2,55707,ENSG00000157191,NA,NA,Necap2 (MGI:1913397)
1,16545938,16546008,Chr.16,1p36.13,189911,"TRNAG1, TRG1",tRNA glycine-1,NA,7195,NA,NA,NA,NA
1,16562426,16613604,1p36.2,1p36.13,610501,"NBPF1, KIAA1693","Neuroblastoma breakpoint family, member 1",NBPF1,55672,ENSG00000219481,pseudogenes on 3 and 5,NA,NA
1,16740515,16740678,1p36.3,1p36.13,180680,"RNU1A, RNU1","RNA, U1A small nuclear",RNU1-4,6060,ENSG00000207389,?same as A12M2,NA,NA
1,16872582,16872653,1p36,1p36.13,180640,"TRNAE1, TRNE, TRE",tRNA glutamic acid,TRE-TTC3-1,7193,NA,NA,NA,NA
1,16914081,16972978,1p36.11,1p36.13,615776,"CROCC, ROOTLETIN, KIAA0445",Ciliary rootlet coiled-coil protein,CROCC,9696,ENSG00000058453,NA,NA,Crocc (MGI:3529431)
1,16974501,16981585,1p36.1-p35,1p36.13,156790,"MFAP2, MAGP, MAGP1",Microfibrillar-associated protein-2,MFAP2,4237,ENSG00000117122,NA,NA,Mfap2 (MGI:99559)
1,16985957,17011971,1p36,1p36.13,610513,"ATP13A2, PARK9, KRPPD, SPG78","ATPase, type 13A2",ATP13A2,23400,ENSG00000159363,mutation identified in 1 family with CLN12,"Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive; Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive",Atp13a2 (MGI:1922022)
1,17018721,17054169,1p36.1-p35,1p36.13,185470,"SDHB, SDH2, SDHIP, PGL4","Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",SDHB,6390,ENSG00000117118,1 of 2 polypeptides,"Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases; Paraganglioma and gastric stromal sarcoma, 606864 (3); Paragangliomas 4, 115310 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant",Sdhb (MGI:1914930)
1,17066760,17119452,1p36.13,1p36.13,607935,PADI2,"Peptidylarginine deiminase, type II",PADI2,11240,ENSG00000117115,NA,NA,Padi2 (MGI:1338892)
1,17205124,17246006,1p36.13,1p36.13,607934,PADI1,"Peptidylarginine deiminase, type I",PADI1,29943,ENSG00000142623,NA,NA,Padi1 (MGI:1338893)
1,17249078,17284232,1p36.13,1p36.13,606755,"PADI3, UHS1","Peptidylarginine deiminase, type III",PADI3,51702,ENSG00000142619,NA,"Uncombable hair syndrome, 191480 (3), Autosomal recessive",Padi3 (MGI:1338891)
1,17308194,17364003,1p36.13,1p36.13,605347,"PADI4, PADI5, PAD","Peptidylarginine deiminase, type IV",PADI4,23569,ENSG00000159339,NA,"{Rheumatoid arthritis, susceptibility to}, 180300 (3)",Padi4 (MGI:1338898)
1,17372195,17401698,1p36.13,1p36.13,610363,"PADI6, PREMBL2","Peptidylarginine deiminase, type VI",PADI6,353238,ENSG00000276747,NA,"Preimplantation embryonic lethality 2, 617234 (3), Autosomal recessive",Padi6 (MGI:2655198)
1,17513441,17697874,1p36.13,1p36.13,612494,"ARHGEF10L, GRINCHGEF, KIAA1626",RHO guanine nucleotide exchange factor 10-like protein,ARHGEF10L,55160,ENSG00000074964,NA,NA,Arhgef10l (MGI:1920004)
1,18630845,18748865,1p36.2-p36.12,1p36.13,167410,"PAX7, RMS2",Paired box homeotic gene-7,PAX7,5081,ENSG00000009709,fused with FKHR in rhabdomyosarcoma,"Rhabdomyosarcoma 2, alveolar, 268220 (3), Somatic mutation",Pax7 (MGI:97491)
1,18839598,18859660,1p36,1p36.13,606226,"TAS1R2, T1R2","Taste receptor type 1, member 2",TAS1R2,80834,ENSG00000179002,NA,NA,Tas1r2 (MGI:1933546)
1,18871429,18902798,1p36,1p36.13,606811,"ALDH4A1, ALDH4, P5CDH","Aldehyde dehydrogenase 4 family, member A1 (delta-1-pyrroline 5-carboxylate dehydrogenase)",ALDH4A1,8659,ENSG00000159423,NA,"Hyperprolinemia, type II, 239510 (3), Autosomal recessive",Aldh4a1 (MGI:2443883)
1,19074507,19214331,1p36.13,1p36.13,609890,"UBR4, ZUBR1, RBAF600, KIAA1307",Ubiquitin protein ligase E3 component n-recognin 4,UBR4,23352,ENSG00000127481,NA,NA,Ubr4 (MGI:1916366)
1,19215659,19251546,1p36.13,1p36.13,616846,"EMC1, KIAA0090, CAVIPMR","Endoplasmic reticulum membrane protein complex, subunit 1",EMC1,23065,ENSG00000127463,NA,"Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3), Autosomal recessive",Emc1 (MGI:2443696)
1,19265981,19274121,1p36.13,1p36.13,608478,"AKR7A4, AFAR3","Aldo-keto reductase family 7, member A4",AKR7L,246181,ENSG00000211454,NA,NA,NA
1,19274228,19289361,1p36.13,1p36.13,608477,"AKR7A3, AFAR2","Aldo-keto reductase family 7, member A3",AKR7A3,22977,ENSG00000162482,NA,NA,NA
1,19302707,19312145,1p36.13,1p36.13,603418,"AKR7A2, AKR7, AFAR","Aldo-keto reductase family 7, member A2",AKR7A2,8574,ENSG00000053371,pseudogenes on Xq25 and 1p12,NA,Akr7a5 (MGI:107796)
1,19312245,19332610,1p36.13,1p36.13,614760,PQLC2,PQ loop repeat-containing protein 2,SLC66A1,54896,ENSG00000040487,NA,NA,Pqlc2 (MGI:2384837)
1,19338774,19485538,1p36.1,1p36.13,601572,"CAPZB, CAPPB","Capping protein (actin filament) muscle Z-line, beta",CAPZB,832,ENSG00000077549,NA,NA,Capzb (MGI:104652)
1,19596976,19629820,1p36.13,1p36.13,616574,"MICOS10, MINOS1, MIO10, MIC10","Mitochondrial contact site and cristae organizing system, 10kD subunit",MICOS10,440574,ENSG00000173436,NA,NA,Micos10 (MGI:1913628)
1,19643228,19658455,1p36.13-p36.11,1p36.13,600613,"D1S1733E, DAN",Differential-screening-selected gene aberrant in neuroblastoma,NBL1,4681,ENSG00000158747,aberrant in some neuroblastomas,NA,Nbl1 (MGI:104591)
1,19664874,19680965,1p36-p35,1p36.13,601109,HTR6,5-hydroxytryptamine (serotonin) receptor-6,HTR6,3362,ENSG00000158748,NA,NA,Htr6 (MGI:1196627)
1,19814028,19815282,1p36.13,1p36.13,617163,RNF186,Ring finger protein 186,RNF186,54546,ENSG00000178828,NA,NA,Rnf186 (MGI:1914075)
1,19881707,19912944,1p36.13,1p36.13,611758,"OTUD3, KIAA0459",OTU domain-containing protein 3,OTUD3,23252,ENSG00000169914,NA,NA,Otud3 (MGI:1920412)
1,19920008,19923616,1p36,1p36.13,618320,PLA2G2E,"Secretory phospholipase A2, group IIE",PLA2G2E,30814,ENSG00000188784,NA,NA,Pla2g2e (MGI:1349660)
1,19975430,19980433,1p35,1p36.13,172411,"PLA2G2A, PLA2B, PLA2L, MOM1","Phospholipase A2, group IIA, platelets, synovial fluid",PLA2G2A,5320,ENSG00000188257,germline mutation identified in 1 CRC patient,"{?Colorectal cancer, susceptibility to}, 114500 (3), Autosomal dominant, Somatic mutation",NA
1,20028348,20091910,1p36-p34,1p36.13,601192,"PLA2G5, FRFB","Phospholipase A2, group V",PLA2G5,5322,ENSG00000127472,NA,"[Fleck retina, familial benign], 228980 (3), Autosomal recessive",Pla2g5 (MGI:101899)
1,20100000,23600000,1p36.12,NA,612957,B6QTL1,Vitamin B6 plasma level QTL 1,NA,100302718,NA,associated with rs4654748,"{Vitamin B6 plasma level QTL 1}, 612957 (2)",NA
1,20100000,34300000,1p36.12-p35.1,NA,612627,"BFIS4, BFIC4","Seizures, benign familial infantile, 4",NA,100271922,NA,between D1S2864 and D1S2830,"Seizures, benign familial infantile, 4, 612627 (2)",NA
1,20111938,20119565,1p36.12,1p36.12,605630,"PLA2G2D, SPLASH","Phospholipase A2, group IID",PLA2G2D,26279,ENSG00000117215,NA,NA,Pla2g2d (MGI:1341796)
1,20139322,20150385,1p35,1p36.12,616793,PLA2G2F,"Phospholipase A2, group IIf",PLA2G2F,64600,ENSG00000158786,NA,NA,Pla2g2f (MGI:1349661)
1,20183006,20196049,1p36.12,1p36.12,616783,UBXN10,UBX domain protein 10,UBXN10,127733,ENSG00000162543,NA,NA,Ubxn10 (MGI:2443123)
1,20482390,20486209,1p36.12,1p36.12,614986,CAMK2N1,Calcium/calmodulin-dependent protein kinase II inhibitor 1,CAMK2N1,55450,ENSG00000162545,NA,NA,Camk2n1 (MGI:1913509)
1,20499447,20508482,1p36.12,1p36.12,612037,"MUL1, MULAN, C1orf166",Mitochondrial ubiquitin ligase activator of NFKB1,MUL1,79594,ENSG00000090432,NA,NA,Mul1 (MGI:1915600)
1,20589096,20618902,1p36.2-p35,1p36.12,123920,CDA,Cytidine deaminase,CDA,978,ENSG00000158825,NA,NA,Cda (MGI:1919519)
1,20633457,20651510,1p36,1p36.12,608309,"PINK1, PARK6",PTEN-induced putative kinase 1,PINK1,65018,ENSG00000158828,NA,"Parkinson disease 6, early onset, 605909 (3), Autosomal recessive",Pink1 (MGI:1916193)
1,20651766,20661543,1p36.1,1p36.12,602202,"DDOST, OST, OST48, CDG1R",Dolichyl-diphosphooligosaccharide-protein glycosyltransferase,DDOST,1650,ENSG00000244038,mutation (cmpd het) identified in 1 CDG1R patient,"?Congenital disorder of glycosylation, type Ir, 614507 (3), Autosomal recessive",Ddost (MGI:1194508)
1,20664013,20718006,1p36.12,1p36.12,605037,"KIF17, KIAA1405",Kinesin family member 17,KIF17,57576,ENSG00000117245,NA,NA,Kif17 (MGI:1098229)
1,20742676,20787807,1p36.12,1p36.12,616072,"HP1BP3, HP1BP74",Heterochromatin protein 1-binding protein 3,HP1BP3,50809,ENSG00000127483,NA,NA,Hp1bp3 (MGI:109369)
1,20806291,21176896,1p36.12,1p36.12,603929,"EIF4G3, EIF4GII","Eukaryotic translation initiation factor 4-gamma, 3",EIF4G3,8672,ENSG00000075151,NA,NA,Eif4g3 (MGI:1923935)
1,21217249,21345503,1p36.1,1p36.12,600423,ECE1,Endothelin converting enzyme 1,ECE1,1889,ENSG00000117298,mutation identified in 1 HCAD patient,"?Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3), Autosomal dominant; {Hypertension, essential, susceptibility to}, 145500 (3), Multifactorial",Ece1 (MGI:1101357)
1,21436774,21485004,1p36.2,1p36.12,612992,NBPF3,"Neuroblastoma breakpoint family, member 3",NBPF3,84224,ENSG00000142794,NA,NA,NA
1,21508983,21578411,1p36.1-p34,1p36.12,171760,"ALPL, HOPS, TNSALP","Alkaline phosphatase, liver/bone/kidney",ALPL,249,ENSG00000162551,NA,"Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant",Alpl (MGI:87983)
1,21596220,21669443,1p36.1-p35,1p36.12,600278,RAP1GA1,"RAP1, GTPase activating protein 1",RAP1GAP,5909,ENSG00000076864,NA,NA,Rap1gap (MGI:109338)
1,21678297,21784145,1p36,1p36.12,617445,"USP48, USP31",Ubiquitin-specific peptidase 48,USP48,84196,ENSG00000090686,NA,NA,Usp48 (MGI:2158502)
1,21822243,21937309,1p36.1,1p36.12,142461,"HSPG2, PLC, SJS, SJA, SJS1",Heparan sulfate proteoglycan of basement membrane (perlecan),HSPG2,3339,ENSG00000142798,NA,"Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive",Hspg2 (MGI:96257)
1,22052708,22101359,1p36.1,1p36.12,116952,"CDC42, TKS","Cell division cycle 42 (GTP-binding protein, 25kD)",CDC42,998,ENSG00000070831,NA,"Takenouchi-Kosaki syndrome, 616737 (3), Autosomal dominant",NA
1,22117307,22143980,1p35,1p36.12,603490,"WNT4, SERKAL","Wingless-type MMTV integration site family, member 4",WNT4,54361,ENSG00000162552,mutation identified in 1 SERKAL family,"Mullerian aplasia and hyperandrogenism, 158330 (3), Autosomal dominant; ?SERKAL syndrome, 611812 (3), Autosomal recessive",Wnt4 (MGI:98957)
1,22428837,22531156,1p36,1p36.12,612106,"ZBTB40, KIAA0478",Zinc finger- and BTB domain-containing protein 40,ZBTB40,9923,ENSG00000184677,NA,NA,Zbtb40 (MGI:2682254)
1,22563488,22603594,1p36.12,1p36.12,176945,"EPHA8, EEK, HEK3",Ephrin receptor EphA8 (eph- and elk-related kinase),EPHA8,2046,ENSG00000070886,NA,NA,Epha8 (MGI:109378)
1,22636627,22639681,1p36.3-p34.1,1p36.12,120550,C1QA,"Complement component 1, q subcomponent, A chain",C1QA,712,ENSG00000173372,NA,"C1q deficiency, 613652 (3), Autosomal recessive",C1qa (MGI:88223)
1,22643632,22648107,1p36.3-p34.1,1p36.12,120575,"C1QC, C1QG","Complement component 1, q subcomponent, C chain",C1QC,714,ENSG00000159189,NA,"C1q deficiency, 613652 (3), Autosomal recessive",C1qc (MGI:88225)
1,22653190,22661636,1p36.3-p34.1,1p36.12,120570,C1QB,"Complement component 1, q subcomponent, B chain",C1QB,713,ENSG00000173369,NA,"C1q deficiency, 613652 (3), Autosomal recessive",C1qb (MGI:88224)
1,22710769,22921499,1p36.1-p35,1p36.12,600997,"EPHB2, EPHT3, DRT, ERK, PCBC, CAPB, BDPLT22",eph tyrosine kinase 3 (ephrin receptor EphB2),EPHB2,2048,ENSG00000133216,mutation identified in 1 BDPLT22 family,"?Bleeding disorder, platelet-type, 22, 618462 (3), Autosomal recessive; {Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)",Ephb2 (MGI:99611)
1,23019442,23083690,1p36.12,1p36.12,609132,"KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF",Lysine-specific demethylase 1A,KDM1A,23028,ENSG00000004487,NA,"Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3), Autosomal dominant",Kdm1a (MGI:1196256)
1,23084022,23177807,1p36,1p36.12,601422,LUZP1,Leucine zipper protein 1,LUZP1,7798,ENSG00000169641,NA,NA,Luzp1 (MGI:107629)
1,23191894,23194728,1p36.3-p34.3,1p36.12,182133,HTR1D,5-hydroxytryptamine (serotonin) receptor-1D,HTR1D,3352,ENSG00000179546,NA,NA,Htr1d (MGI:96276)
1,23304687,23344315,1p36.11,1p36.12,607201,"HNRPR, HNRNPR",Heterogeneous nuclear ribonucleoprotein R,HNRNPR,10236,ENSG00000125944,NA,NA,Hnrnpr (MGI:1891692)
1,23359447,23369835,1p36,1p36.12,611703,"ZNF436, KIAA1710",Zinc finger protein 436,ZNF436,80818,ENSG00000125945,NA,NA,Zfp46 (MGI:99192)
1,23380908,23424775,1p36.12,1p36.12,604128,TCEA3,"Transcription elongation factor A, 3",TCEA3,6920,ENSG00000204219,NA,NA,Tcea3 (MGI:1196908)
1,23428562,23484630,1p36.13,1p36.12,616594,"ASAP3, UPLC1, CENTB6, DDEFL1, ACAP4","ARF GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 3",ASAP3,55616,ENSG00000088280,NA,NA,Asap3 (MGI:2684986)
1,23505695,23531249,1p36,1p36.12,600426,E2F2,E2F transcription factor 2,E2F2,1870,ENSG00000007968,NA,NA,E2f2 (MGI:1096341)
1,23557925,23559500,1p36.13-p36.12,1p36.12,600277,ID3,"Inhibitor of DNA binding 3, dominant negative, helix-loop-helix protein",ID3,3399,ENSG00000117318,NA,NA,Id3 (MGI:96398)
1,23626952,23640567,1p36.1,1p36.11,607305,MDS2,Myelodysplasia syndrome gene 2,MDS2,259283,NA,fused with ETV6 in myelodysplastic syndrome,NA,NA
1,23691778,23696834,1p36.1-p35,1p36.11,604175,"RPL11, DBA7",Ribosomal protein L11,RPL11,6135,ENSG00000142676,NA,"Diamond-Blackfan anemia 7, 612562 (3), Autosomal dominant",Rpl11 (MGI:1914275)
1,23743365,23762058,1p36.1,1p36.11,600786,TCEB3,"Transcription elongation factor B (SIII), polypeptide 3 (110kD, elongin A)",ELOA,6924,ENSG00000011007,NA,NA,Eloa (MGI:1351315)
1,23790788,23795538,1p36.11,1p36.11,616143,"LYPLA2, APT2",Lysophospholipase II,LYPLA2,11313,ENSG00000011009,NA,NA,Lypla2 (MGI:1347000)
1,23795598,23800753,1p36-p35,1p36.11,606953,GALE,UDP galactose-4-epimerase,GALE,2582,ENSG00000117308,NA,"Galactose epimerase deficiency, 230350 (3), Autosomal recessive",Gale (MGI:1921496)
1,23801876,23825458,1pter-p33,1p36.11,613898,HMGCL,3-hydroxy-3-methylglutaryl-Coenzyme A lyase,HMGCL,3155,ENSG00000117305,NA,"HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive",Hmgcl (MGI:96158)
1,23845076,23868368,1p34,1p36.11,612280,FUCA1,"Fucosidase, alpha-L- 1, tissue",FUCA1,2517,ENSG00000179163,8cM distal to RH; pseudogene on 2q31-q32,"Fucosidosis, 230000 (3), Autosomal recessive",Fuca1 (MGI:95593)
1,23870514,23913361,1p36,1p36.11,605051,"CNR2, CB2, CX5",Cannabinoid receptor 2,CNR2,1269,ENSG00000188822,NA,NA,Cnr2 (MGI:104650)
1,23959163,23963461,1p36.11,1p36.11,611882,PNRC2,Proline-rich nuclear receptor coactivator 2,PNRC2,55629,ENSG00000189266,NA,NA,Pnrc2 (MGI:106512)
1,23964346,23980462,1p36.1,1p36.11,605221,"SRSF10, FUSIP1, TASR, TASR1, TASR2","Splicine factor, serine/arginine-rich, 10",SRSF10,10772,ENSG00000188529,"pseudogenes on chr. 9, 12, 20",NA,Srsf10 (MGI:1333805)
1,24056040,24112134,1p36.11,1p36.11,616832,MYOM3,Myomesin 3,MYOM3,127294,ENSG00000142661,NA,NA,Myom3 (MGI:2685280)
1,24154155,24187294,1p36.11,1p36.11,607404,"IFNLR1, IL28RA","Interferon, lambda receptor 1",IFNLR1,163702,ENSG00000185436,NA,NA,Ifnlr1 (MGI:2429859)
1,24319332,24364481,1p36.11,1p36.11,608317,"GRHL3, SOM, TFCP2L4, VWS2",Grainyhead-like 3,GRHL3,57822,ENSG00000158055,NA,"Van der Woude syndrome 2, 606713 (3), Autosomal dominant",Grhl3 (MGI:2655333)
1,24356998,24415532,1p36.11,1p36.11,615826,"STPG1, MAPO2, C1orf201",Sperm-tail PG-rich repeat-containing protein 1,STPG1,90529,ENSG00000001460,NA,NA,Stpg1 (MGI:1926056)
1,24502343,24541039,1p35.2-p33,1p36.11,605860,"RCAN3, DSCR1L2, MCIP3",Regulator of calcineurin 3,RCAN3,11123,ENSG00000117602,NA,NA,Rcan3 (MGI:1858220)
1,24643272,24673280,1p36.11,1p36.11,605975,"SRRM1, SRM160","Serine/arginine repetitive matrix 1 (ser/arg-related nuclear matrix protein, 160kD)",SRRM1,10250,ENSG00000133226,NA,NA,NA
1,24745446,24844320,1p36.11,1p36.11,606536,"CLIC4, MTCLIC",Chloride intracellular channel 4,CLIC4,25932,ENSG00000169504,NA,NA,Clic4 (MGI:1352754)
1,24899510,24965157,1p36,1p36.11,600210,"RUNX3, CBFA3, PEBP2A3, AML2",Runt-related transcription factor 3,RUNX3,864,ENSG00000020633,NA,NA,Runx3 (MGI:102672)
1,25222275,25232501,1p36.11,1p36.11,607090,"SYF2, P29","SYF2 RNA splicing factor, S. cerevisiae, homolog of",SYF2,25949,ENSG00000117614,NA,NA,Syf2 (MGI:1915842)
1,25272392,25330444,1p36.2-p34,1p36.11,111680,RHD,Rhesus system D polypeptide,RHD,6007,ENSG00000187010,NA,[Rh-negative blood type] (3),Rhd (MGI:1202882)
1,25338333,25362360,1p36.11,1p36.11,605348,"TMEM50A, SMP1",Transmembrane protein 50A,TMEM50A,23585,ENSG00000183726,between RHD and RHCE,NA,Tmem50a (MGI:1919067)
1,25360658,25430192,1p36.2-p34,1p36.11,111700,"RHCE, RHNA",Rhesus system C and E polypeptides,RHCE,6006,ENSG00000188672,?order: C-E-D,"[Blood group, Rhesus] (3); Rh-null disease, amorph type, 617970 (3)",Rhd (MGI:1202882)
1,25430857,25500208,1p36.11,1p36.11,610301,"TMEM57, FLJ10747",Transmembrane protein 57,MACO1,55219,ENSG00000204178,NA,NA,Maco1 (MGI:1913396)
1,25543584,25590399,1p36-p35,1p36.11,605747,"LDLRAP1, ARH, FHCB2, FHCB1, FHCL4",Low density lipoprotein receptor adaptor protein 1,LDLRAP1,26119,ENSG00000157978,NA,"Hypercholesterolemia, familial, 4, 603813 (3), Autosomal recessive",Ldlrap1 (MGI:2140175)
1,25616819,25786206,1p36.13-p35.1,1p36.11,616772,MAN1C1,"Mannosidase, alpha, class 1C, member 1",MAN1C1,57134,ENSG00000117643,NA,NA,Man1c1 (MGI:2446214)
1,25800192,25818220,1p36-p35,1p36.11,606210,"SELENON, SEPN1, SELN, RSMD1, CFTD",Selenoprotein N,SELENON,57190,ENSG00000162430,NA,"Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant",Selenon (MGI:2151208)
1,25861483,25876706,1p36.11,1p36.11,607779,"PAQR7, MPRA, PGLP","Progestin and ADIPOQ receptor family, member 7",PAQR7,164091,ENSG00000182749,NA,NA,Paqr7 (MGI:1919154)
1,25884178,25906876,1p36.1-p35,1p36.11,151442,"STMN1, LAP18, SMN",Stathmin,STMN1,3925,ENSG00000117632,NA,NA,Stmn1 (MGI:96739)
1,25959763,25998163,1p36.11,1p36.11,602344,PAFAH2,Platelet-activating factor acetylhydrolase 2,PAFAH2,5051,ENSG00000158006,NA,NA,Pafah2 (MGI:2140321)
1,26021774,26036463,1p36.1,1p36.11,601738,EXTL1,Exostosin-like 1,EXTL1,2134,ENSG00000158008,NA,NA,Extl1 (MGI:1888742)
1,26037251,26046117,1p36.11,1p36.11,609617,"SLC30A2, ZNT2, TNZD","Solute carrier family 30 (zinc transporter), member 2",SLC30A2,7780,ENSG00000158014,NA,"Zinc deficiency, transient neonatal, 608118 (3), Autosomal dominant",Slc30a2 (MGI:106637)
1,26051303,26067633,1p36.11,1p36.11,606131,"TRIM63, RNF28, SMRZ, MURF1",Tripartite motif containing 63,TRIM63,84676,ENSG00000158022,NA,NA,Trim63 (MGI:2447992)
1,26109130,26125554,1p35.3,1p36.11,610785,PDIK1L,PDLIM1-interacting kinase 1-like,PDIK1L,149420,ENSG00000175087,NA,NA,Pdik1l (MGI:2385213)
1,26169907,26170872,1p36.11,1p36.11,616698,"ZNF593, ZT86",Zinc finger protein 593,ZNF593,51042,ENSG00000142684,NA,NA,Zfp593 (MGI:1915290)
1,26177490,26189883,1p36.11,1p36.11,603272,"CNKSR1, CNK1",Connector enhancer of KSR 1,CNKSR1,10256,ENSG00000142675,NA,NA,Cnksr1 (MGI:2670958)
1,26189961,26202541,1p35.3,1p36.11,609121,CATSPER4,"Cation channel, sperm-associated, 4",CATSPER4,378807,ENSG00000188782,NA,NA,Catsper4 (MGI:3043288)
1,26280085,26281521,1p36.11,1p36.11,615679,SH3BGRL3,SH3 domain-binding glutamic acid-rich protein-like protein 3,SH3BGRL3,83442,ENSG00000142669,NA,NA,Sh3bgrl3 (MGI:1920973)
1,26282281,26318264,1p36.11,1p36.11,609151,"UBXN11, SOC",UBX domain protein 11,UBXN11,91544,ENSG00000158062,NA,NA,Ubxn11 (MGI:1914836)
1,26317957,26320522,1p36.11,1p36.11,114280,"CD52, CDW52",CD52 molecule,CD52,1043,ENSG00000169442,NA,NA,NA
1,26361631,26374535,1p36.11,1p36.11,616775,"ZNF683, HOBIT",Zinc finger protein 683,ZNF683,257101,ENSG00000176083,NA,NA,NA
1,26410777,26429727,1p36.11,1p36.11,611043,"LIN28, LIN28A","Lin28, C. elegans, homolog of",LIN28A,79727,ENSG00000131914,NA,NA,Lin28a (MGI:1890546)
1,26432281,26471305,1p36.11,1p36.11,608172,"DHDDS, HDS, RP59, DEDSM",Dehydrodolichyl diphosphate synthase,DHDDS,79947,ENSG00000117682,mutation identified in 1 CDG1BB patient,"?Congenital disorder of glycosylation, type 1bb, 613861 (3), Autosomal recessive; Developmental delay and seizures with or without movement abnormalities, 617836 (3), Autosomal dominant; Retinitis pigmentosa 59, 613861 (3), Autosomal recessive",Dhdds (MGI:1914672)
1,26472439,26476641,1p36.1,1p36.11,163910,"HMGN2, HMG17",High-mobility group nucleosomal binding protein 2,HMGN2,3151,ENSG00000198830,NA,NA,NA
1,26529760,26575027,1p36.1,1p36.11,601684,"RPS6KA1, RSK1","Ribosomal protein S6 kinase, 90kD, 1",RPS6KA1,6195,ENSG00000117676,NA,NA,Rps6ka1 (MGI:104558)
1,26696014,26782103,1p35.3,1p36.11,603024,"ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2","AT rich interactive domain 1A, SWI-like",ARID1A,8289,ENSG00000117713,NA,"Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant",Arid1a (MGI:1935147)
1,26787962,26798402,1p36.11,1p36.11,610274,"PIGV, HPMRS1","Phosphatidylinositol glycan, class V",PIGV,55650,ENSG00000060642,NA,"Hyperphosphatasia with mental retardation syndrome 1, 239300 (3), Autosomal recessive",Pigv (MGI:2442480)
1,26863148,26864455,1p36.11,1p36.11,601290,SFN,Stratifin,SFN,2810,ENSG00000175793,NA,NA,Sfn (MGI:1891831)
1,26890487,26900466,1p36.11,1p36.11,617486,GPATCH3,G-patch domain-containing protein 3,GPATCH3,63906,ENSG00000198746,NA,NA,Gpatch3 (MGI:2442492)
1,26900568,26946870,1p36.11,1p36.11,610325,NUDC,"Nuclear distribution gene C, A. nigulans, homolog of",NUDC,10726,ENSG00000090273,NA,NA,Nudc (MGI:106014)
1,26911488,26914109,1p36.1,1p36.11,604630,"NR0B2, SHP","Nuclear receptor subfamily 0, group B, member 2",NR0B2,8431,ENSG00000131910,NA,"Obesity, mild, early-onset, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Nr0b2 (MGI:1346344)
1,26949555,26960495,1p36,1p36.11,616758,"KDF1, C1orf172, ECTD12",Keratinocyte differentiation factor 1,KDF1,126695,ENSG00000175707,mutation identified in 1 ECTD12 family,"?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type, 617337 (3), Autosomal dominant",Kdf1 (MGI:1916323)
1,26993662,27000890,1p36.11,1p36.11,616824,TRNP1,TMF1-regulated nuclear protein 1,TRNP1,388610,ENSG00000253368,NA,NA,Trnp1 (MGI:1916789)
1,27098808,27155129,1p36.1-p35,1p36.11,107310,"SLC9A1, NHE1, APNH, LIKNS","Solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive)",SLC9A1,6548,ENSG00000090020,mutation identified in 1 LIKNS family,"?Lichtenstein-Knorr syndrome, 616291 (3), Autosomal recessive",Slc9a1 (MGI:102462)
1,27342021,27353931,1p36.11,1p36.11,608042,"SYTL1, SLP1, JFC1",Synaptotagmin-like protein 1,SYTL1,84958,ENSG00000142765,NA,NA,Sytl1 (MGI:1933365)
1,27355178,27368036,1p36.11,1p36.11,604468,"MAP3K6, MAPKKK6, ASK2",Mitogen-activated protein kinase kinase kinase 6,MAP3K6,9064,ENSG00000142733,NA,NA,Map3k6 (MGI:1855691)
1,27369109,27374851,1p36.11,1p36.11,604973,"FCN3, HAKA1",Ficolin 3,FCN3,8547,ENSG00000142748,NA,"Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive",NA
1,27392621,27395813,1p36.1-p34.3,1p36.11,600241,GPR3,G protein-coupled receptor-3,GPR3,2827,ENSG00000181773,NA,NA,Gpr3 (MGI:101908)
1,27404229,27490166,1p36.11-p34.3,1p36.11,605875,"WASF2, WAVE2, SCAR2",WAS protein family member 2,WASF2,10163,ENSG00000158195,?pseudogene on Xp11.21,NA,Wasf2 (MGI:1098641)
1,27534244,27604177,1p36.11,1p36.1-p35.3,615790,"AHDC1, MRD25",AT-hook DNA-binding motif-containing protein 1,AHDC1,27245,ENSG00000126705,NA,"Xia-Gibbs syndrome, 615829 (3), Autosomal dominant",Ahdc1 (MGI:2444218)
1,27600000,34300000,1p35,NA,617930,"C1DELp35, DEL1p35",Chromosome 1p35 deletion syndrome,NA,NA,NA,SRO 1.03 Mb containing 23 genes,"Chromosome 1p35 deletion syndrome, 617930 (4), Autosomal dominant",NA
1,27600000,34300000,1p35,NA,132850,EBVS1,Epstein-Barr virus integration site,EBVS1,1888,NA,NA,NA,NA
1,27612063,27635560,1p36.2-p36.1,1p35.3,164940,"FGR, SRC2",Oncogene FGR,FGR,2268,ENSG00000000938,same as SRC2,NA,Fgr (MGI:95527)
1,27666060,27672228,1p35,1p35.3,147572,"G1P3, IFI616","Interferon, alpha-inducible protein (clone IFI-6-16)",IFI6,2537,ENSG00000126709,NA,NA,NA
1,27773218,27824442,1p35.3,1p35.3,606892,"STX12, STX13",Syntaxin 12,STX12,23673,ENSG00000117758,NA,NA,Stx12 (MGI:1931027)
1,27830781,27851675,1p35,1p35.3,602636,"PPP1R8, NIPP1, ARD1","Protein phosphatase-1, regulatory subunit-8",PPP1R8,5511,ENSG00000117751,NA,NA,Ppp1r8 (MGI:2140494)
1,27872530,27886684,1p35.3,1p35.3,617856,"THEMIS2, C1orf38, ICB1","Thymocyte selection-associated protein family, member 2",THEMIS2,9473,ENSG00000130775,NA,NA,Themis2 (MGI:2446213)
1,27891523,27914796,1p35,1p35.3,179836,RPA2,"Replication protein A2, 32kD",RPA2,6118,ENSG00000117748,NA,NA,Rpa2 (MGI:1339939)
1,27934954,27959151,1p35.3,1p35.3,617737,"SMPDL3B, ASML3B","Sphingolyelin phosphodiesterase, acid-like, 3B",SMPDL3B,27293,ENSG00000130768,NA,NA,Smpdl3b (MGI:1916022)
1,27970343,28088670,1p36,1p35.3,601655,EYA3,"Eyes absent, Drosophila, homolog of, 3",EYA3,2140,ENSG00000158161,NA,NA,Eya3 (MGI:109339)
1,28147165,28193935,1p35-p34.3,1p35.3,173393,PTAFR,Platelet-activating factor receptor,PTAFR,5724,ENSG00000169403,NA,NA,Ptafr (MGI:106066)
1,28236090,28238104,1p35.3,1p35.3,614981,"ATP1F1, IF1",ATPase inhibitory factor 1,ATP5IF1,93974,ENSG00000130770,NA,NA,Atpif1 (MGI:1196457)
1,28259451,28282490,1p35.3,1p35.3,607767,"SEST2, HI95",Sestrin 2,SESN2,83667,ENSG00000130766,NA,NA,Sesn2 (MGI:2651874)
1,28329039,28335966,1p35.3,1p35.3,612384,MED18,Mediator complex subunit 18,MED18,54797,ENSG00000130772,NA,NA,Med18 (MGI:1914469)
1,28369739,28500363,1p35.3,1p35.3,608726,PHACTR4,Phosphatase and actin regulator 4,PHACTR4,65979,ENSG00000204138,NA,NA,Phactr4 (MGI:2140327)
1,28505942,28539299,1p36.1,1p35.3,179710,"CHC1, RCC1",Regulator of chromosome condensation,RCC1,1104,ENSG00000180198,NA,NA,Rcc1 (MGI:1913989)
1,28505942,28510891,1p36.1,1p35.3,603238,"RNU17D, U17HG","RNA, U17d small nucleolar",SNHG3,8420,ENSG00000242125,NA,NA,NA
1,28507364,28507570,1p36.1,1p35.3,180645,"RNU17A, RNE1","RNA, U17a small nucleolar",SNORA73A,6080,ENSG00000274266,in IVS1 of CHC1,NA,NA
1,28508557,28508761,1p36.1,1p35.3,603239,RNU17B,"RNA, U17b small nucleolar",SNORA73B,26768,ENSG00000200087,NA,NA,NA
1,28602849,28648706,1p35.3,1p35.3,600773,TAF12,"TAF12 RNA polymerase II, TATA box-binding protein-associated factor, 20kD",TAF12,6883,ENSG00000120656,NA,NA,Taf12 (MGI:1913714)
1,28668781,28719352,1p35.3,1p35.3,604409,GMEB1,Glucocorticoid modulatory element-binding protein 1,GMEB1,10691,ENSG00000162419,NA,NA,Gmeb1 (MGI:2135604)
1,28736620,28769774,1p35,1p35.3,610640,YTHDF2,YTH N6-methyladenosine RNA-binding protein 2,YTHDF2,51441,ENSG00000198492,fused with AML1 in t(1;21),NA,Ythdf2 (MGI:2444233)
1,28812169,28871266,1p36.1-p34.3,1p35.3,165195,OPRD1,"Opioid receptor, delta-1",OPRD1,4985,ENSG00000116329,NA,NA,Oprd1 (MGI:97438)
1,28887090,29120045,1p36.2-p34,1p35.3,130500,"EPB41, EL1",Erythrocyte surface protein band 4.1,EPB41,2035,ENSG00000159023,NA,"Elliptocytosis-1, 611804 (3), Autosomal recessive, Autosomal dominant",Epb41 (MGI:95401)
1,29147742,29181899,1p35.3,1p35.3,601940,"SRSF4, SFRS4, SRp75","Splicing factor, serine/arginine-rich, 4",SRSF4,6429,ENSG00000116350,NA,NA,Srsf4 (MGI:1890577)
1,29192656,29230957,1p35.3,1p35.3,608205,"MECR, NRBF1, DYTOABG",Mitochondrial trans-2-enoyl-CoA reductase,MECR,51102,ENSG00000116353,NA,"Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3), Autosomal recessive",Mecr (MGI:1349441)
1,29236521,29326801,1p35.3,1p35.3,602454,"PTPRU, GLEPP1, PTPU2","Protein tyrosine phosphatase, receptor type, U",PTPRU,10076,ENSG00000060656,NA,NA,Ptpru (MGI:1321151)
1,30711276,30723584,1p35,1p35.2,115437,"MATN1, CRTM, CMP","Matrilin 1, cartilage matrix protein",MATN1,4146,ENSG00000162510,NA,NA,Matn1 (MGI:106591)
1,30732468,30757839,1p34,1p35.2,601476,LAPTM5,Lysosomal-associated multispanning membrane protein-5,LAPTM5,7805,ENSG00000162511,NA,NA,Laptm5 (MGI:108046)
1,30869465,30909734,1pter-p22.3,1p35.2,186357,"SDC3, SYND3, SDCN",Syndecan 3,SDC3,9672,ENSG00000162512,NA,"{Obesity, association with}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Sdc3 (MGI:1349163)
1,30931505,31065716,1p35.2,1p35.2,607204,"PUM1, KIAA0099, SCA47","Pumilio, Drosophila, homolog of, 1",PUM1,9698,ENSG00000134644,NA,"Spinocerebellar ataxia 47, 617931 (3), Autosomal dominant",Pum1 (MGI:1931749)
1,31179269,31239886,1p35.2,1p35.2,612871,NKAIN1,Na+/K+ transporting ATPase-interacting 1,NKAIN1,79570,ENSG00000084628,NA,NA,Nkain1 (MGI:1914399)
1,31259567,31296787,1p35.2,1p35.2,607797,"SNRNP40, SPF38, PRPF8BP",Small nuclear ribonucleoprotein 40kDa (U5),SNRNP40,9410,ENSG00000060688,NA,NA,Snrnp40 (MGI:1913835)
1,31359594,31373617,1p33-p31,1p35.2,134651,FABP3,"Fatty acid-binding protein 3, muscle",FABP3,2170,ENSG00000121769,NA,NA,Fabp3 (MGI:95476)
1,31409776,31434679,1p35.2,1p35.2,614549,SERINC2,Serine incorporator 2,SERINC2,347735,ENSG00000168528,NA,NA,Serinc2 (MGI:1919132)
1,31576383,31587685,1p35.2,1p35.2,616064,"TINAGL1, TINAGRP",Tubulointerstitial nephritis antigen-like protein 1,TINAGL1,64129,ENSG00000142910,NA,NA,Tinagl1 (MGI:2137617)
1,31617699,31632517,1p35.2,1p35.2,602392,"HCRTR1, OX1R",Hypocretin receptor 1,HCRTR1,3061,ENSG00000121764,NA,NA,Hcrtr1 (MGI:2385650)
1,31629861,31645236,1p34,1p35.2,610033,PEF1,Peflin,PEF1,553115,ENSG00000162517,NA,NA,Pef1 (MGI:1915148)
1,31652262,31704161,1p34,1p35.2,120326,COL16A1,"Collagen XVI, alpha-1 polypeptide",COL16A1,1307,ENSG00000084636,NA,NA,Col16a1 (MGI:1095396)
1,31727104,31764339,1p35,1p35.2,602683,"ADGRB2, BAI2",Adhesion G protein-coupled receptor B2,ADGRB2,576,ENSG00000121753,NA,NA,Adgrb2 (MGI:2451244)
1,31906420,31938367,1p35,1p35.2,601584,"PTP4A2, PTP4A, PRL2, HH13","Protein tyrosine phosphatase, type 4A, 2",PTP4A2,8073,ENSG00000184007,NA,NA,Ptp4a2 (MGI:1277117)
1,32013693,32060858,1p32,1p35.2,602489,"KHDRBS1, SAM68","KH domain-containing, RNA-binding, signal transduction-associated protein 1",KHDRBS1,10657,ENSG00000121774,NA,NA,Khdrbs1 (MGI:893579)
1,32108042,32176562,1p35.1,1p35.2,610563,KPNA6,Karyopherin alpha-6,KPNA6,23633,ENSG00000025800,NA,NA,Kpna6 (MGI:1100836)
1,32200385,32205389,1p35.1,1p35.2,610162,"CCDC28B, MGC1203",Coiled-coil domain-containing protein 28B,CCDC28B,79140,ENSG00000160050,NA,"{Bardet-Biedl syndrome 1, modifier of}, 209900 (3), Autosomal recessive, Digenic recessive",Ccdc28b (MGI:1913514)
1,32221583,32231603,1p34.1,1p35.2,603911,"EIF3I, EIF3S2, TRIP1","Eukaryotic translation initiation factor 3, subunit I",EIF3I,8668,ENSG00000084623,pseudogene on 7q32,NA,Eif3i (MGI:1860763)
1,32251264,32286166,1p35-p34.3,1p35.2,153390,"LCK, IMD22",Lymphocyte-specific protein tyrosine kinase,LCK,3932,ENSG00000182866,LCK/TCRB fusion in leukemia; mutation identified in 1 IMD22 patient,"?Immunodeficiency 22, 615758 (3), Autosomal recessive",Lck (MGI:96756)
1,32292082,32333627,1p34.1,1p35.2-p35.1,601241,"HDAC1, RPD3L1",Histone deacetylase-1,HDAC1,3065,ENSG00000116478,NA,NA,Hdac1 (MGI:108086)
1,32333838,32336232,1p34,1p35.1,602940,"MARCKSL1, MLP, MRP",MARCKS-like protein 1,MARCKSL1,65108,ENSG00000175130,NA,NA,Marcksl1 (MGI:97143)
1,32352719,32365264,1p35-p34,1p35.1,607660,"TSSK3, STK22C, STK22D",Testis-specific serine/threonine kinase 3,TSSK3,81629,ENSG00000162526,NA,NA,Tssk3 (MGI:1929914)
1,32364632,32394460,1p35.1,1p35.1,617518,BSDC1,BSD domain-containing protein 1,BSDC1,55108,ENSG00000160058,NA,NA,Bsdc1 (MGI:1913466)
1,32620817,32651007,1p35.1,1p35.1,615891,"ZBTB8OS, ARCH","Zinc finger- and BTB domain-containing protein 8, opposite strand",ZBTB8OS,339487,ENSG00000176261,NA,NA,Zbtb8os (MGI:1914356)
1,32679905,32703595,1p34.3-p34.1,1p35.1,611750,SYNC1,Syncoilin 1,SYNC,81493,ENSG00000162520,NA,NA,Sync (MGI:1916078)
1,32775237,32818031,1p35,1p35.1,603623,"YARS, CMTDIC, TYRRS, YTS, YRS",Tyrosyl-tRNA synthetase,YARS1,8565,ENSG00000134684,NA,"Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant",Yars (MGI:2147627)
1,32816766,32858878,1p34.3,1p35.1,611889,"S100PBP, S100PBPR",S100P-binding protein,S100PBP,64766,ENSG00000116497,NA,NA,S100pbp (MGI:1921898)
1,32862267,32872483,1p35.1,1p35.1,611906,"FNDC5, FRCP2",Fibronectin type III domain-containing protein 5,FNDC5,252995,ENSG00000160097,NA,NA,Fndc5 (MGI:1917614)
1,32885964,32894645,1p35-p34.2,1p35.1,142622,"HPCA, DYT2","Hippocalcin, 23kD, Ca2+-binding protein",HPCA,3208,ENSG00000121905,NA,"Dystonia 2, torsion, autosomal recessive, 224500 (3), Autosomal recessive",Hpca (MGI:1336200)
1,32932497,32965265,1p35.1,1p35.1,610872,"IBRDC3, NKLAM",IBR domain-containing protein 3,RNF19B,127544,ENSG00000116514,NA,NA,Rnf19b (MGI:1922484)
1,33007939,33036910,1p34,1p35.1,103020,AK2,"Adenylate kinase-2, mitochondrial",AK2,204,ENSG00000004455,NA,"Reticular dysgenesis, 267500 (3), Autosomal recessive",Ak2 (MGI:87978)
1,33081109,33162287,1p34.3-p33,1p35.1,608353,"AZIN2, ODC1L, KIAA1945",Antizyme inhibitor 2,AZIN2,113451,ENSG00000142920,NA,NA,Azin2 (MGI:2442093)
1,33145398,33184773,1p35.1,1p35.1,616755,"TRIM62, DEAR1",Tripartite motif-containing protein 62,TRIM62,55223,ENSG00000116525,NA,NA,Trim62 (MGI:1914775)
1,33472590,33504252,1p35.1,1p35.1,611315,"ZSCAN20, ZNF31, KOX29",Zinc finger- and SCAN domain-containing protein 20,ZSCAN20,7579,ENSG00000121903,NA,NA,Zscan20 (MGI:2679268)
1,33513998,34165841,1p35.3,1p35.1,608398,"CSMD2, KIAA1884",Cub and Sushi multiple domains 2,CSMD2,114784,ENSG00000121904,NA,NA,Csmd2 (MGI:2386401)
1,33860474,33864790,1p35.1,1p35.1,617285,HMGB4,High mobility group box 4,HMGB4,127540,ENSG00000176256,NA,NA,Hmgb4 (MGI:1916567)
1,34300000,39600000,1p34.3,NA,609919,GBD3,Gallbladder disease 3,GBD3,100048906,NA,new D2S255,"Gallbladder disease 3, 609919 (2)",NA
1,34300000,60800000,1p34-p32,NA,613545,MACST,Macrostomia,NA,100529231,NA,max lod at D1S2797,"Macrostomia, 613545 (2)",NA
1,34754776,34758512,1p35.1,1p34.3,604493,"GJB5, CX31.1","Gap junction protein, beta-5",GJB5,2709,ENSG00000189280,NA,NA,Gjb5 (MGI:95723)
1,34759739,34762326,1p35.1,1p34.3,605425,"GJB4, CX30.3, EKVP2","Gap junction protein, beta-4",GJB4,127534,ENSG00000189433,NA,"Erythrokeratodermia variabilis et progressiva 2, 617524 (3), Autosomal dominant",Gjb4 (MGI:95722)
1,34781213,34786363,1p35.1,1p34.3,603324,"GJB3, CX31, DFNA2B, EKVP1","Gap junction protein, beta-3",GJB3,2707,ENSG00000188910,same YAC as GJA4,"Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Deafness, autosomal dominant, with peripheral neuropathy (3); Deafness, autosomal recessive (3); Deafness, digenic, GJB2/GJB3, 220290 (3), Autosomal recessive; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant",Gjb3 (MGI:95721)
1,34792957,34795746,1p35.1,1p34.3,121012,"GJA4, CX37","Gap junction protein, alpha-4, 37kD (connexin 37)",GJA4,2701,ENSG00000187513,NA,NA,Gja4 (MGI:95715)
1,34986164,35031944,14q12,1p34.3,613567,"ZMYM6, ZNF258","Zinc finger, MYM-type 6",ZMYM6,9204,ENSG00000163867,NA,NA,Zmym6 (MGI:106505)
1,35176377,35193173,1p34,1p34.3,605199,"SFPQ, PSF","Splicing factor, proline- and glutamine-rich",SFPQ,6421,ENSG00000116560,fusion gene with TFE3 in RCC,NA,Sfpq (MGI:1918764)
1,35268693,35422057,1p34.3,1p34.3,613568,"ZMYM4, ZNF262, KIAA0425","Zinc finger, MYM-type 4",ZMYM4,9202,ENSG00000146463,NA,NA,Zmym4 (MGI:1915035)
1,35433489,35557602,1p34.3,1p34.3,613535,"KIAA0319L, KIAA1837",KIAA0319-like,KIAA0319L,79932,ENSG00000142687,NA,NA,AU040320 (MGI:2140475)
1,35557791,35566778,1p34.3,1p34.3,608458,"NCDN, KIAA0607",Neurochondrin,NCDN,23154,ENSG00000020129,NA,NA,Ncdn (MGI:1347351)
1,35568738,35595590,1p34.3,1p34.3,614428,TFAP2E,Transcription factor AP2-epsilon,TFAP2E,339488,ENSG00000116819,NA,NA,Tfap2e (MGI:2679630)
1,35599540,35641525,1p34.2,1p34.3,602175,PSMB2,"Proteasome subunit, beta type, 2",PSMB2,5690,ENSG00000126067,NA,NA,Psmb2 (MGI:1347045)
1,35720212,35769984,1p34.3-p34.1,1p34.3,605434,CLASPIN,"Claspin, Xenopus, homolog of",CLSPN,63967,ENSG00000092853,NA,NA,Clspn (MGI:2445153)
1,35807629,35857889,1p35-p34,1p34.3,607356,"EIF2C4, AGO4, KIAA1567","Eukaryotic translation initiation factor 2C, 4 (argonaute 4)",AGO4,192670,ENSG00000134698,NA,NA,Ago4 (MGI:1924100)
1,35869807,35930531,1p35-p34,1p34.3,606228,"AGO1, EIF2C1, GERP95, EIF2C","Argonaute 1, RISC catalytic component",AGO1,26523,ENSG00000092847,NA,NA,Ago1 (MGI:2446630)
1,35925682,36072499,1p35-p34,1p34.3,607355,"EIF2C3, AGO3","Eukaryotic translation initiation factor 2C, subunit 3 (argonaute 3)",AGO3,192669,ENSG00000126070,NA,NA,Ago3 (MGI:2446634)
1,36084093,36088274,1p34.3,1p34.3,608953,"TEKT2, TEKTB1",Tektin 2,TEKT2,27285,ENSG00000092850,NA,NA,Tekt2 (MGI:1346335)
1,36088884,36093931,1p35.3-p34.1,1p34.3,610624,"ADPRHL2, ARH3, CONDSIAS",ADP-ribosylhydrolase-like 2,ADPRHL2,54936,ENSG00000116863,NA,"Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, 618170 (3), Autosomal recessive",Adprhl2 (MGI:2140364)
1,36095238,36126206,1p34.3-p32.3,1p34.3,120252,"COL8A2, FECD1, PPCD2","Collagen VIII, alpha-2 polypeptide",COL8A2,1296,ENSG00000171812,NA,"Corneal dystrophy, Fuchs endothelial, 1, 136800 (3), Autosomal dominant; Corneal dystrophy, posterior polymorphous 2, 609140 (3), Autosomal dominant",Col8a2 (MGI:88464)
1,36136568,36156052,1p34.3,1p34.3,610955,"TRAPPC3, BET3","Trafficking protein particle complex, subunit 3",TRAPPC3,27095,ENSG00000054116,NA,NA,Trappc3 (MGI:1351486)
1,36224428,36305356,1p34.3,1p34.3,603809,"THRAP3, TRAP150",Thyroid hormone receptor-associated protein 3,THRAP3,9967,ENSG00000054118,NA,NA,Thrap3 (MGI:2442637)
1,36339627,36385923,1p34.3,1p34.3,609437,"STK40, SHIK",Serine/threonine protein kinase 40,STK40,83931,ENSG00000196182,NA,NA,Stk40 (MGI:1921428)
1,36393435,36397907,1p34.3,1p34.3,617909,LSM10,"Lsm10, U7 small nuclear RNA-associated protein",LSM10,84967,ENSG00000181817,NA,NA,Lsm10 (MGI:2151045)
1,36417905,36450484,1p34.2,1p34.3,608854,NOR1,Oxidored-nitro domain-containing protein 1,OSCP1,127700,ENSG00000116885,NA,NA,Oscp1 (MGI:1916308)
1,36455717,36464383,1p35-p34.1,1p34.3,611979,MRPS15,Mitochondrial ribosomal protein S15,MRPS15,64960,ENSG00000116898,NA,NA,Mrps15 (MGI:1913657)
1,36466042,36483313,1p35-p34.3,1p34.3,138971,"CSF3R, GCSFR, SCN7",Colony-stimulating factor-3 receptor (granulocyte),CSF3R,1441,ENSG00000119535,NA,"Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3), Autosomal recessive",Csf3r (MGI:1339755)
1,36795526,37034514,1p34-p33,1p34.3,138243,"GRIK3, GLUR7","Glutamate receptor, ionotropic, kainate 3",GRIK3,2899,ENSG00000163873,NA,NA,Grik3 (MGI:95816)
1,37474517,37484376,1p35.3-p33,1p34.3,610562,"ZC3H12A, MCPIP, MCPIP1",Zinc finger CCCH domain-containing protein 12A,ZC3H12A,80149,ENSG00000163874,NA,NA,Zc3h12a (MGI:2385891)
1,37489959,37514818,1p35.3-p33,1p34.3,611001,"MEAF6, C1orf149, EAF6",MYST/ESA1-associated factor 6,MEAF6,64769,ENSG00000163875,NA,NA,Meaf6 (MGI:1917338)
1,37534448,37554292,1p34.3,1p34.3,608241,"SNIP1, PMRED",SMAD nuclear interacting protein 1,SNIP1,79753,ENSG00000163877,NA,"Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3), Autosomal recessive",Snip1 (MGI:2156003)
1,37556939,37566856,1p35.1,1p34.3,602135,"DNALI1, P28","Dynein, axonemal, light intermediate polypeptide 1",DNALI1,7802,ENSG00000163879,NA,NA,Dnali1 (MGI:1922813)
1,37566811,37595984,1p34.3,1p34.3,609365,"GNL2, NGP1",Guanine nucleotide-binding protein-like 2,GNL2,29889,ENSG00000134697,NA,NA,Gnl2 (MGI:2385207)
1,37611349,37634905,1p34.3,1p34.3,609595,"RSPO1, FLJ40906","Roof plate-specific spondin, mouse, homolog of, 1",RSPO1,284654,ENSG00000169218,NA,"Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3), Autosomal recessive; Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3), Autosomal recessive",Rspo1 (MGI:2183426)
1,37681569,37692335,1p34.3,1p34.3,614799,C1orf109,Chromosome 1 open reading frame 109,C1orf109,54955,ENSG00000116922,NA,NA,9930104L06Rik (MGI:3041172)
1,37692515,37709718,1p34.3,1p34.3,609977,CDCA8,Cell division cycle-associated protein 8,CDCA8,55143,ENSG00000134690,possible pseudogene on chr.7,NA,Cdca8 (MGI:1196274)
1,37713887,37765151,1p34.3,1p34.3,611123,EPHA10,Ephrin receptor EphA10,EPHA10,284656,ENSG00000183317,NA,NA,Epha10 (MGI:3586824)
1,37802944,37808207,1p34.2,1p34.3,612276,"YRDC, IRIP",YRDC domain-containing protein,YRDC,79693,ENSG00000196449,NA,NA,Yrdc (MGI:2387201)
1,37809569,37859613,1p33,1p34.3,600172,MTF1,Metal-regulatory transcription factor 1,MTF1,4520,ENSG00000188786,NA,NA,Mtf1 (MGI:101786)
1,37860696,37947094,1p34,1p34.3,147264,INPP5B,"Inositol polyphosphate-5-phosphatase, 75kD",INPP5B,3633,ENSG00000204084,NA,NA,Inpp5b (MGI:103257)
1,37956974,37990021,1p34.3,1p34.3,605596,"SF3A3, SF3A60, SAP61, PRP9","Splicing factor 3A, subunit 3",SF3A3,10946,ENSG00000183431,NA,NA,Sf3a3 (MGI:1922312)
1,37996764,38005690,1p34,1p34.3,602790,"FHL3, SLIM2",Four-and-a-half LIM domains-3,FHL3,2275,ENSG00000183386,NA,NA,Fhl3 (MGI:1341092)
1,38012715,38024819,1p34.3,1p34.3,609440,"UTP11L, CGI94",UTP11-like protein,UTP11,51118,ENSG00000183520,NA,NA,Utp11 (MGI:1914455)
1,38043828,38046792,1p34.1,1p34.3,602479,POU3F1,"POU domain, class 3, transcription factor-1",POU3F1,5453,ENSG00000185668,NA,NA,NA
1,38838197,38859771,1p34,1p34.3,608267,"RRAGC, RAGC",RAS-related GTP-binding protein C,RRAGC,64121,ENSG00000116954,NA,NA,Rragc (MGI:1858751)
1,38862489,38873377,1p33-p32.2,1p34.3,606535,MYCBP,MYC-binding protein,MYCBP,26292,ENSG00000214114,NA,NA,Mycbp (MGI:1891750)
1,38874068,38881586,1p34.3,1p34.3,611923,"GJA9, CX59","Gap junction protein, alpha-9",GJA9,81025,ENSG00000131233,NA,NA,NA
1,38991243,39006064,1p34.3,1p34.3,615164,AKIRIN1,Akirin 1,AKIRIN1,79647,ENSG00000174574,NA,NA,Akirin1 (MGI:1915300)
1,39026294,39034635,1p34.2-p33,1p34.3,603847,NDUFS5,NADH-ubiquinone oxidoreductase subunit S5,NDUFS5,4725,ENSG00000168653,NA,NA,NA
1,39084166,39487137,1p32-p31,1p34.3,608271,"MACF1, ACF7, KIAA1251, LIS9",Microtubule-actin cross-linking factor 1,MACF1,23499,ENSG00000127603,NA,"Lissencephaly 9 with complex brainstem malformation, 618325 (3), Autosomal dominant",NA
1,39560815,39576789,1p36-p32,1p34.3,603407,"PABPC4, PABP4, IPABP, APP1","Polyadenylate-binding protein, cytoplasmic, 4",PABPC4,8761,ENSG00000090621,NA,NA,Pabpc4 (MGI:2385206)
1,39623434,39639642,1p34.3,1p34.2,609034,HEYL,Hariy/enhancer of split-related with YRPW motif-like protein,HEYL,26508,ENSG00000163909,NA,NA,Heyl (MGI:1860511)
1,39659120,39672037,1p34.3-p33,1p34.2,610525,"NT5C1A, CN1A, CNI, CN1","5'-nucleotidase, cytosolic, IA",NT5C1A,84618,ENSG00000116981,NA,NA,Nt5c1a (MGI:2155700)
1,39738844,39765697,1p34.2,1p34.2,602435,"PPIE, CYP33",Peptidyl-prolyl isomerase E,PPIE,10450,ENSG00000084072,NA,NA,Ppie (MGI:1917118)
1,39757181,39788864,1p34.2,1p34.2,602284,"BMP8B, OP2",Bone morphogenetic protein-8b (osteogenic protein 2),BMP8B,656,ENSG00000116985,NA,NA,NA
1,39769522,39771347,1p34.2,1p34.2,610289,"OXCT2, FLJ0030",3-oxoacid CoA transferase 2,OXCT2,64064,ENSG00000198754,NA,NA,NA
1,39838109,39883510,1p34.2,1p34.2,617840,"TRIT1, IPT, COXPD35",tRNA isopentenyltransferase 1,TRIT1,54802,ENSG00000043514,NA,"Combined oxidative phosphorylation deficiency 35, 617873 (3), Autosomal recessive",Trit1 (MGI:1914216)
1,39895427,39901916,1p34.3,1p34.2,164850,"MYCL, LMYC","Oncogene MYC, lung carcinoma-derived",MYCL,4610,ENSG00000116990,NA,NA,Mycl (MGI:96799)
1,39955111,39969967,1p34.2,1p34.2,614397,"MFSD2A, MCPH15",Major facilitator superfamily domain-containing protein 2A,MFSD2A,84879,ENSG00000168389,NA,"Microcephaly 15, primary, autosomal recessive, 616486 (3), Autosomal recessive",Mfsd2a (MGI:1923824)
1,40040064,40072648,1p34.2,1p34.2,617801,CAP1,Cyclase-associated actin cytoskeleton regulatory protein 1,CAP1,10487,ENSG00000131236,NA,NA,Cap1 (MGI:88262)
1,40071460,40097469,1p32,1p34.2,600722,"PPT1, CLN1",Palmitoyl-protein thioesterase 1,PPT1,5538,ENSG00000131238,NA,"Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive",Ppt1 (MGI:1298204)
1,40161386,40240920,1p32,1p34.2,180610,RLF,Rearranged L-myc fusion sequence,RLF,6018,ENSG00000117000,<800kb from MYCL1,NA,Rlf (MGI:1924705)
1,40258077,40294179,1p34,1p34.2,606480,"ZMPSTE24, FACE1, STE24, MADB",Zinc metalloproteinase STE24,ZMPSTE24,10269,ENSG00000084073,NA,"Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive",Zmpste24 (MGI:1890508)
1,40300486,40317652,1p34.2,1p34.2,120260,"COL9A2, EDM2, STL5","Collagen IX, alpha-2 polypeptide",COL9A2,1298,ENSG00000049089,mutation identified in1 STL5 family,"Epiphyseal dysplasia, multiple, 2, 600204 (3), Autosomal dominant; ?Stickler syndrome, type V, 614284 (3), Autosomal recessive",Col9a2 (MGI:88466)
1,40373671,40423325,1p34.2,1p34.2,616916,"SMAP2, SMAP1L",Small ADP-ribosylation factor GTPase-activating protein 2,SMAP2,64744,ENSG00000084070,NA,NA,Smap2 (MGI:1917030)
1,40477219,40496342,1p34.2,1p34.2,617939,"ZFP69, ZNF642",Zinc finger protein 69,ZFP69,339559,ENSG00000187815,NA,NA,Zfp69 (MGI:107794)
1,40620679,40692103,1p34.1,1p34.2,611600,"RIMS3, NIM3, KIAA0137",Protein regulating synaptic membrane exocytosis 3,RIMS3,9783,ENSG00000117016,NA,NA,Rims3 (MGI:2443331)
1,40691698,40771602,1p32,1p34.2,605344,"NFYC, CBFC","Nuclear transcription factor Y, gamma",NFYC,4802,ENSG00000066136,NA,NA,Nfyc (MGI:107901)
1,40757283,40757371,1p34.2,1p34.2,615151,MIR30C1,Micro RNA 30C-1,MIR30C1,407031,ENSG00000207962,NA,NA,NA
1,40783786,40840456,1p34,1p34.2,603537,"KCNQ4, DFNA2A","Potassium voltage-gated channel, KQT-like subfamily, member 4",KCNQ4,9132,ENSG00000117013,NA,"Deafness, autosomal dominant 2A, 600101 (3), Autosomal dominant",Kcnq4 (MGI:1926803)
1,40861053,40862362,1p35-p34,1p34.2,606815,CITED4,"CBP/P300-interacting transactivator, with glu/asp-rich carboxy terminal domain, 4",CITED4,163732,ENSG00000179862,NA,NA,Cited4 (MGI:1861694)
1,40979298,41012564,1p34.1,1p34.2,123860,"CTPS1, CTPS, IMD24",Cytidine 5'-triphosphate synthetase 1,CTPS1,1503,ENSG00000171793,NA,"Immunodeficiency 24, 615897 (3), Autosomal recessive",Ctps (MGI:1858304)
1,41027198,41242305,1p34,1p34.2,616396,SCMH1,"Sex comb on midleg, Drosophila, homolog of, 1",SCMH1,22955,ENSG00000010803,NA,NA,Scmh1 (MGI:1352762)
1,41361433,41383589,1p34.1,1p34.2,611457,FOXO6,Forkhead box O6,FOXO6,100132074,NA,NA,NA,Foxo6 (MGI:2676586)
1,41478774,41484698,1p34,1p34.2,131241,EDN2,Endothelin-2,EDN2,1907,ENSG00000127129,vasoactive intestinal contractor (VIC) = mouse and rat equivalent,NA,Edn2 (MGI:95284)
1,41506364,42035933,1p34,1p34.2,606649,"HIVEP3, KRC",Human immunodeficiency virus type 1 enhancer-binding protein 3,HIVEP3,59269,ENSG00000127124,NA,NA,Hivep3 (MGI:106589)
1,42153409,42155819,1p34-p33,1p34.2,601271,"GUCA2B, UGN",Guanylate cyclase activator 2B (uroguanylin),GUCA2B,2981,ENSG00000044012,NA,NA,Guca2b (MGI:1270851)
1,42162689,42164744,1p35-p34,1p34.2,139392,"GUCA2A, GUCA2","Guanylate cyclase activator 2A (guanylin 2, intestinal, heat-stable)",GUCA2A,2980,ENSG00000197273,NA,NA,Guca2a (MGI:102738)
1,42176538,42336804,1p34.2,1p34.2,616035,"FOXJ3, KIAA1041",Forkhead box J3,FOXJ3,22887,ENSG00000198815,NA,NA,Foxj3 (MGI:2443432)
1,42456340,42473380,1p13.1-p12,1p34.2,609853,"PPCS, CMD2C",Phosphopantothenoylcysteine synthetase,PPCS,79717,ENSG00000127125,NA,"Cardiomyopathy, dilated, 2C, 618189 (3), Autosomal recessive",Ppcs (MGI:1915237)
1,42657769,42681653,1p34.1,1p34.2,606095,PPIH,Peptidyl-prolyl isomerase H,PPIH,10465,ENSG00000171960,NA,NA,Ppih (MGI:106499)
1,42682417,42703804,1p34,1p34.2,154030,"YBX1, NSEP1, YB1, DBPB","Y box binding protein 1 (major histocompatibility complex, class II, Y box-binding protein I)",YBX1,4904,ENSG00000065978,NA,NA,Ybx1 (MGI:99146)
1,42733092,42740253,1p34.2,1p34.2,610036,"CLDN19, HOMG5",Claudin 19,CLDN19,149461,ENSG00000164007,NA,"Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive",Cldn19 (MGI:3033992)
1,42746334,42767083,1p34,1p34.2,610339,"P3H1, LEPRE1, GROS1, OI8",Prolyl 3-hydroxylase 1,P3H1,64175,ENSG00000117385,NA,"Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive",P3h1 (MGI:1888921)
1,42807051,42817396,1p34.2,1p34.2,617853,"SVBP, CCDC23",Small vasohibin-binding protein,SVBP,374969,ENSG00000177868,NA,NA,Svbp (MGI:1916466)
1,42817121,42844990,1p34,1p34.2,609017,"ERMAP, SC, RD",Erythroblast membrane-associated protein,ERMAP,114625,ENSG00000164010,NA,"[Blood group, Radin], 111620 (3); [Blood group, Scianna system], 111750 (3)",Ermap (MGI:1349816)
1,42925374,42958867,1p34.2,1p34.2,138140,"SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN","Solute carrier family 2 (facilitated glucose transporter), member 1",SLC2A1,6513,ENSG00000117394,probably in 1p33,"Dystonia 9, 601042 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant",Slc2a1 (MGI:95755)
1,43164173,43172569,1p35-p33,1p34.2,614443,"EBNA1BP2, EBP2",EBNA1-binding protein 2,EBNA1BP2,10969,ENSG00000117395,NA,NA,Ebna1bp2 (MGI:1916322)
1,43172329,43254357,1p34.2,1p34.2,614259,WDR65,WD repeat-containing protein 65,CFAP57,149465,ENSG00000243710,NA,NA,Cfap57 (MGI:2686209)
1,43300953,43323107,1p34-p33,1p34.2,600222,"TIE, JTK14, TIE1",Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains,TIE1,7075,ENSG00000066056,NA,NA,Tie1 (MGI:99906)
1,43336874,43354463,1p34,1p34.2,159530,"MPL, TPOR, MPLV, THCYT2","Myeloproliferative leukemia virus, homolog of",MPL,4352,ENSG00000117400,NA,"Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Autosomal dominant, Somatic mutation; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive",Mpl (MGI:97076)
1,43358980,43363202,1p34.2-p33,1p34.2,603618,CDC20,"Cell division cycle 20, S. cerevisiae, homolog of",CDC20,991,ENSG00000117399,pseudogene on 9q13-q21,NA,Cdc20 (MGI:1859866)
1,43363396,43368073,1p34.2,1p34.2,611813,"ELOVL1, SSC1",Elongation of very long chain fatty acids-like 1,ELOVL1,64834,ENSG00000066322,NA,NA,Elovl1 (MGI:1858959)
1,43383916,43389799,1p34.2,1p34.2,607956,MED8,Mediator complex subunit 8,MED8,112950,ENSG00000159479,NA,NA,Med8 (MGI:1915269)
1,43389883,43454246,1p34.2,1p34.2,615463,"SZT2, KIAA0467, EIEE18","Seizure threshold 2, mouse, homolog of",SZT2,23334,ENSG00000198198,NA,"Epileptic encephalopathy, early infantile, 18, 615476 (3), Autosomal recessive",Szt2 (MGI:3033336)
1,43522237,43623671,1p32,1p34.2,179590,"PTPRF, LAR, BNAH2","Protein tyrosine phosphatase, receptor type, f polypeptide",PTPRF,5792,ENSG00000142949,mutation identified in 1 BNAH2 family,"?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3), Autosomal recessive",Ptprf (MGI:102695)
1,43650148,43705517,1p34.1,1p34.2-p34.1,609764,"KDM4A, JMJD2A, JHDM3A, KIAA0677",Lysine-specific demethylase 4A,KDM4A,9682,ENSG00000066135,NA,NA,Kdm4a (MGI:2446210)
1,43700000,60800000,1p34.1-p32,NA,178300,PTOS1,"Ptosis, congenital 1, autosomal dominant",PTOS1,5765,NA,NA,"Ptosis, hereditary congenital, 1, 178300 (2), Autosomal dominant",NA
1,43707464,43931164,1p34.1,1p34.1,606494,"ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15","ST3 beta-galactoside alpha-2,3-sialyltransferase 3",ST3GAL3,6487,ENSG00000126091,mutation identified in 1 EIEE15 family,"?Epileptic encephalopathy, early infantile, 15, 615006 (3), Autosomal recessive; Mental retardation, autosomal recessive 12, 611090 (3), Autosomal recessive",St3gal3 (MGI:1316659)
1,43933319,43937239,1p34.1,1p34.1,603886,ARTN,Artemin,ARTN,9048,ENSG00000117407,NA,NA,Artn (MGI:1333791)
1,43946851,43968021,1p34.1,1p34.1,610411,"IPO13, IMP13, KIAA0724, RANBP13",Importin 13,IPO13,9670,ENSG00000117408,NA,NA,Ipo13 (MGI:2385205)
1,43969996,43973368,1p34,1p34.1,603456,"DPH2, DPH2L2",Diphthamide biosynthesis protein 2,DPH2,1802,ENSG00000132768,NA,NA,Dph2 (MGI:1914978)
1,43974959,43978294,1p32.3,1p34.1,603717,"ATP6V0B, ATP6F","ATPase, H+ transporting, V0 subunit b",ATP6V0B,533,ENSG00000117410,NA,NA,Atp6v0b (MGI:1890510)
1,43979201,43991170,1p33-p32,1p34.1,604013,B4GALT2,"Beta-1,4-galactosyltransferase 2",B4GALT2,8704,ENSG00000117411,NA,NA,B4galt2 (MGI:1858493)
1,43996482,44031461,1p33,1p34.1,601019,"SLC6A9, GLYT1, GCENSG","Solute carrier family 6 (neurotransmitter transporter, glycine), member 9",SLC6A9,6536,ENSG00000196517,NA,"Glycine encephalopathy with normal serum glycine, 617301 (3), Autosomal recessive",Slc6a9 (MGI:95760)
1,44043926,44135139,1p34.1,1p34.1,609602,ZNF393,Zinc finger protein-393,KLF17,128209,ENSG00000171872,NA,NA,Klf17 (MGI:2181068)
1,44213470,44220672,1p34.1,1p34.1,605077,"DNMAP1, DMAP1",DNMT1-associated protein 1,DMAP1,55929,ENSG00000178028,NA,NA,Dmap1 (MGI:1913483)
1,44221069,44355297,1p32,1p34.1,609917,"PRNPIP, PINT1",Prion protein-interacting protein,ERI3,79033,ENSG00000117419,NA,NA,Eri3 (MGI:2153887)
1,44405159,44651723,1p34.1,1p34.1,616136,RNF220,RING finger protein 220,RNF220,55182,ENSG00000187147,NA,NA,Rnf220 (MGI:1913993)
1,44739703,44767766,1p34.1,1p34.1,604538,"KIF2C, KNSL6, MCAK","Kinesin family, member 2C",KIF2C,11004,ENSG00000142945,NA,NA,Kif2c (MGI:1921054)
1,44775539,44778778,1p34.1-p32,1p34.1,600357,RPS8,Ribosomal protein S8,RPS8,6202,ENSG00000142937,NA,NA,Rps8 (MGI:98166)
1,44782144,44792827,1p33-p32.3,1p34.1,607336,"BEST4, VMD2L2",Bestrophin 4,BEST4,266675,ENSG00000142959,NA,NA,NA
1,44799951,44805994,1p34.1,1p34.1,602913,"PLK3, CNK, PRK",Polo-like kinase 3,PLK3,1263,ENSG00000173846,previously assigned to 8p21 by FISH,NA,Plk3 (MGI:109604)
1,44805907,44809751,1p34.1,1p34.1,611713,TCTEX1D4,TCTEX1 domain-containing 4,TCTEX1D4,343521,ENSG00000188396,NA,NA,Tctex1d4 (MGI:3045358)
1,44819843,44843252,1p32,1p34.1,603673,PTCH2,"Patched, Drosophila, homolog of, 2",PTCH2,8643,ENSG00000117425,NA,"Basal cell carcinoma, somatic, 605462 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Medulloblastoma, somatic, 155255 (3)",Ptch2 (MGI:1095405)
1,44850521,44986721,1p34.1,1p34.1,606273,EIF2B3,"Eukaryotic translation initiation factor 2B, subunit 3",EIF2B3,8891,ENSG00000070785,NA,"Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive",Eif2b3 (MGI:1313286)
1,45012132,45015668,1p34,1p34.1,613521,UROD,Uroporphyrinogen decarboxylase,UROD,7389,ENSG00000126088,NA,"Porphyria cutanea tarda, 176100 (3), Autosomal recessive, Autosomal dominant; Porphyria, hepatoerythropoietic, 176100 (3), Autosomal recessive, Autosomal dominant",Urod (MGI:98916)
1,45329241,45340469,1p34.3-p32.1,1p34.1,604933,"MUTYH, MYH","MutY, E. coli, homolog of",MUTYH,4595,ENSG00000132781,NA,"Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3), Somatic mutation; Gastric cancer, somatic, 613659 (3)",Mutyh (MGI:1917853)
1,45339750,45343972,1p34.1,1p34.1,613931,"TOE1, PCH7",Target of EGR1,TOE1,114034,ENSG00000132773,NA,"Pontocerebellar hypoplasia, type 7, 614969 (3), Autosomal recessive",Toe1 (MGI:1915526)
1,45343882,45491162,1p32,1p34.1,604746,TESK2,Testis-specific protein kinase 2,TESK2,10420,ENSG00000070759,NA,NA,Tesk2 (MGI:2385204)
1,45500228,45513381,1p34.1,1p34.1,609831,MMACHC,MMACHC gene,MMACHC,25974,ENSG00000132763,NA,"Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive",Mmachc (MGI:1914346)
1,45511034,45522889,1p34.1,1p34.1,176763,"PRDX1, PRXI, PAGA, NKEFA",Peroxiredoxin 1,PRDX1,5052,ENSG00000117450,pseudogene PAGB on 9p22,"Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive",Prdx1 (MGI:99523)
1,45550778,45570050,1p33-p32,1p34.1,103830,"AKR1A1, ALR","Aldo-keto reductase family 1, member A1 (aldehyde reductase)",AKR1A1,10327,ENSG00000117448,NA,NA,Akr1a1 (MGI:1929955)
1,45583987,45618905,1p34.1,1p34.1,603185,NASP,Nuclear autoantigenic sperm protein,NASP,4678,ENSG00000132780,NA,NA,Nasp (MGI:1355328)
1,45694323,45750812,1p32-p22,1p34.1,147485,IPP,Intracisternal A particle-promoted polypeptide,IPP,3652,ENSG00000197429,NA,NA,Ipp (MGI:96581)
1,45786991,46036123,1p34.1,1p34.1,612257,"MAST2, MAST205, KIAA0807",Microtubule-associated serine/threonine kinase 2,MAST2,23139,ENSG00000086015,NA,NA,Mast2 (MGI:894676)
1,46040139,46174900,1p34.2,1p34.1,606076,PIK3R3,"Phosphatidylinositol 3-kinase, regulatory, 3",PIK3R3,8503,ENSG00000117461,NA,NA,Pik3r3 (MGI:109277)
1,46175086,46196488,1p34.1,1p34.1,613170,"TSPAN1, NET1",Tetraspanin 1,TSPAN1,10103,ENSG00000117472,NA,NA,Tspan1 (MGI:1914055)
1,46188680,46220304,1p34-p33,1p34.1,606822,"POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15","Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase",POMGNT1,55624,ENSG00000085998,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive",Pomgnt1 (MGI:1915523)
1,46203333,46221255,1p34.1,1p34.1,616129,"LURAP1, LRAP35A",Leucine-rich adaptor protein 1,LURAP1,541468,ENSG00000171357,NA,NA,Lurap1 (MGI:1915325)
1,46247687,46278476,1p32,1p34.1,603615,"RAD54L, HR54, HRAD54","RAD54, S. cerevisiae, homolog-like",RAD54L,8438,ENSG00000085999,NA,"Adenocarcinoma, colonic, somatic (3); {Breast cancer, invasive ductal}, 114480 (3), Autosomal dominant, Somatic mutation; Lymphoma, non-Hodgkin, somatic, 605027 (3)",Rad54l (MGI:894697)
1,46300000,60800000,1p33-p32,NA,612728,BMND14,Bone mineral density quantitative trait locus 14,NA,100294718,NA,associated with rs17131547,"[Bone mineral density QTL 14], 612728 (2)",NA
1,46300000,84400000,1p33-p31.1,NA,613606,FWS,Forsythe-Wakeling syndrome,NA,100529224,NA,between rs2354462 and rs718883,"Forsythe-Wakeling syndrome, 613606 (2), Autosomal recessive",NA
1,46300000,50200000,1p33,NA,613857,OFC13,Orofacial cleft 13,NA,100653367,NA,associated with rs3827730,"Orofacial cleft 13, 613857 (2), Autosomal dominant",NA
1,46300000,50200000,1p33,NA,618377,PAINQTL1,Pain sensitivity quantitative trait locus 1,NA,NA,NA,deletion identified in 1 PAINQTL1 family,"?Pain sensitivity QTL1, 618377 (4), Autosomal dominant",NA
1,46300000,50200000,1p33,NA,616392,"SKINTL, SKINTP",SKINT1-like pseudogene,SKINT1L,391037,NA,NA,NA,NA
1,46303697,46316775,1p34.1,1p33,613844,UQCRH,Ubiquinol-cytochrome c reductase hinge protein,UQCRH,7388,ENSG00000173660,pseudogene on 1p36,NA,Uqcrh-ps1 (MGI:3641869)
1,46340176,46365151,1p33,1p33,615394,NSUN4,"NOP2/SUN RNA methyltransferase family, member 4",NSUN4,387338,ENSG00000117481,NA,NA,Nsun4 (MGI:1919431)
1,46394316,46413844,1p33,1p33,602935,FAAH,Fatty acid amide hydrolase,FAAH,2166,ENSG00000117480,NA,"{Drug addiction, susceptibility to}, 606581 (3)",Faah (MGI:109609)
1,46433826,46445701,1p33,1p33,618375,"FAAHP1, FAAHOUT, LINC00505",Fatty acid amide hydrolase pseudogene 1,FAAHP1,729041,NA,NA,NA,NA
1,46489835,46516215,1p33,1p33,607410,"DMBX1, OTX3",Diencephalon/mesencephalon homeobox 1,DMBX1,127343,ENSG00000197587,NA,NA,Dmbx1 (MGI:2153518)
1,46545637,46551656,1p33,1p33,611455,"KNCN, KINO, L5",Kinocilin,KNCN,148930,ENSG00000162456,NA,NA,Kncn (MGI:3614952)
1,46557406,46604310,1p33,1p33,606724,"MKNK1, MNK1",Mitogen-activated protein kinase-interacting serine/threonine kinase 1,MKNK1,8569,ENSG00000079277,NA,NA,Mknk1 (MGI:894316)
1,46798997,46819412,1p34-p12,1p33,124075,CYP4B1,"Cytochrome P450, subfamily IVB, polypeptide 1",CYP4B1,1580,ENSG00000142973,NA,NA,Cyp4b1 (MGI:103225)
1,46929173,46941483,1p33,1p33,601310,CYP4A11,"Cytochrome P450, subfamily IVA, polypeptide 11",CYP4A11,1579,ENSG00000187048,NA,NA,"Cyp4a10,Cyp4a32,Cyp4a31 (MGI:88611,MGI:3717148,MGI:3028580)"
1,46961363,47055431,1p33,1p33,614999,"CYP4X1, CYPIVX1","Cytochrome P450, family 4, subfamily X, polypeptide 1",CYP4X1,260293,ENSG00000186377,NA,NA,Cyp4x1 (MGI:1932403)
1,47137424,47149737,1p33,1p33,615341,CYP4A22,"Cytochrome P450, family 4, subfamily A, polypeptide 22",CYP4A22,284541,ENSG00000162365,NA,NA,"Cyp4a12a,Cyp4a12b (MGI:3611747,MGI:88612)"
1,47183581,47190035,1p33,1p33,607178,"PDZK1IP1, MAP17",PDZK1-interacting protein 1,PDZK1IP1,10158,ENSG00000162366,"near SLC in human, mouse, chicken, zebrafish",NA,Pdzk1ip1 (MGI:1914432)
1,47216289,47232388,1p32,1p33,187040,"TAL1, TCL5, SCL",T-cell acute lymphocytic leukemia-1,TAL1,6886,ENSG00000162367,proximal to MYCL1,"Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)",Tal1 (MGI:98480)
1,47250138,47314786,1p33,1p33,181590,"STIL, SIL, MCPH7",SCL/TAL1-interrupting locus,STIL,6491,ENSG00000123473,within about 250kb of SCL,"Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive",Stil (MGI:107477)
1,47333789,47378838,1p32,1p33,191710,"CMPK1, CMPK, UMPK, UMK, CMK","Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic",CMPK1,51727,ENSG00000162368,NA,NA,Cmpk1 (MGI:1913838)
1,47416284,47418051,1p32,1p33,601094,"FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11",Forkhead box E3,FOXE3,2301,ENSG00000186790,NA,"Anterior segment dysgenesis 2, multiple subtypes, 610256 (3), Autosomal recessive; {Aortic aneurysm, familial thoracic 11, susceptibility to}, 617349 (3), Autosomal dominant; Cataract 34, multiple types, 612968 (3)",NA
1,47436016,47440690,1p34-p32,1p33,602211,"FOXD2, FKHL17, FREAC9",Forkhead box D2,FOXD2,2306,ENSG00000186564,NA,NA,Foxd2 (MGI:1347471)
1,47760527,47997384,1p33,1p33,614913,"TRABD2B, TIKI2",TRAB domain-containing protein 2B,TRABD2B,388630,ENSG00000269113,NA,NA,Trabd2b (MGI:3650152)
1,48258642,48472207,1p33,1p33,613947,"SPATA6, SRF1, HASH",Spermatogenesis-associated protein 6,SPATA6,54558,ENSG00000132122,NA,NA,Spata6 (MGI:1915196)
1,48520156,50023953,1p33,1p33,616476,"AGBL4, CCP6",ATP/GTP-binding protein-like 4,AGBL4,84871,ENSG00000186094,NA,NA,Agbl4 (MGI:1918244)
1,50048054,50203771,1p34,1p33-p32,168360,"ELAVL4, HUD, PNEM","Embryonic lethal, abnormal vision, Drosophila, homolog of, like-4 (Hu antigen D)",ELAVL4,1996,ENSG00000162374,NA,NA,Elavl4 (MGI:107427)
1,50200000,60800000,1p32,NA,606852,"PARK10, AAOPD",Parkinson disease 10,PARK10,170534,NA,max lod at D1S2652; ?associated with CDCP2,"{Parkinson disease 10}, 606852 (2)",NA
1,50200000,60800000,1p32,NA,613548,STQTL23,Stature quantitative trait locus 23,NA,100529222,NA,linked to rs628667,"{Stature QTL 23}, 613548 (2)",NA
1,50417549,50423442,1p33-p32.3,1p32.3,614804,DMRTA2,Doublesex- and MAB3-related transcription factor A2,DMRTA2,63950,ENSG00000142700,NA,NA,Dmrta2 (MGI:2653629)
1,50437027,50960266,1p33,1p32.3,604460,"FAF1, HFAF1",Fas-associated factor 1,FAF1,11124,ENSG00000185104,NA,NA,Faf1 (MGI:109419)
1,50968694,50974633,1p32,1p32.3,603369,"CDKN2C, INK4C",Cyclin-dependent kinase inhibitor 2C,CDKN2C,1031,ENSG00000123080,NA,NA,Cdkn2c (MGI:105388)
1,51236272,51273446,1p32-p31,1p32.3,612598,RNF11,Ring finger protein 11,RNF11,26994,ENSG00000123091,NA,NA,Rnf11 (MGI:1352759)
1,51354262,51519274,1p32,1p32.3,600051,EPS15,Epidermal growth factor receptor pathway substrate-15,EPS15,2060,ENSG00000085832,NA,NA,Eps15 (MGI:104583)
1,51616873,51789218,1p34.2-p32.2,1p32.3,606737,"OSBPL9, ORP9",Oxysterol-binding protein-like protein 9,OSBPL9,114883,ENSG00000117859,NA,NA,Osbpl9 (MGI:1923784)
1,51789191,51878936,1p32.2,1p32.3,602651,NRD1,Nardilysin (N-arginine dibasic convertase),NRDC,4898,ENSG00000078618,NA,NA,Nrd1 (MGI:1201386)
1,51907955,51990699,1p32-p31,1p32.3,179510,RAB3B,Brain antigen RAB3B,RAB3B,5865,ENSG00000169213,NA,NA,Rab3b (MGI:1917158)
1,52020130,52056170,1p32.3,1p32.3,609448,"TXNDC12, TLP19, ERP18",Thioredoxin domain-containing protein 12,TXNDC12,51060,ENSG00000117862,NA,NA,Txndc12 (MGI:1913323)
1,52142000,52348663,1p32.3,1p32.3,603755,"ZFYVE9, MADHIP, SARA","Zinc finger, FYVE domain containing 9",ZFYVE9,9372,ENSG00000157077,NA,NA,Zfyve9 (MGI:2652838)
1,52372828,52404470,1p32,1p32.3,601902,"ORC1, ORC1L","Origin recognition complex, subunit 1, S. cerevisiae, homolog",ORC1,4998,ENSG00000085840,NA,"Meier-Gorlin syndrome 1, 224690 (3), Autosomal recessive",Orc1 (MGI:1328337)
1,52404563,52420835,1p32.3,1p32.3,617031,"PRPF38A, PRP38A","Precursor mRNA-processing factor 38, S. cerevisiae, homolog of, A",PRPF38A,84950,ENSG00000134748,NA,NA,Prpf38a (MGI:1916962)
1,52423274,52553462,1q23.3,1p32.3,613692,"ZCCHC11, KIAA0191",Zinc finger CCHC domain-containing protein 11,TUT4,23318,ENSG00000134744,NA,NA,Tut4 (MGI:2445126)
1,52602370,52609050,1p32,1p32.3,615784,"GPX7, NPGPX",Glutathione peroxidase 7,GPX7,2882,ENSG00000116157,NA,NA,Gpx7 (MGI:1914555)
1,52684448,52698346,1p32.3,1p32.3,615623,"COA7, RESA1, SELRC1, C1orf163, SCAN3",Cytochrome C oxidase assembly factor,COA7,65260,ENSG00000162377,NA,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3, 618387 (3), Autosomal recessive",Coa7 (MGI:1917143)
1,52927228,53051697,1p32,1p32.3,184755,SCP2,Sterol carrier protein-2,SCP2,6342,ENSG00000116171,mutation identified in 1 LKDMN patient,"?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive",Scp2 (MGI:98254)
1,53062051,53085501,1p32.3,1p32.3,608661,PODN,Podocan,PODN,127435,ENSG00000174348,NA,NA,Podn (MGI:2674939)
1,53196823,53214196,1p32,1p32.3,600650,"CPT2, IIAE4",Carnitine palmitoyltransferase II,CPT2,1376,ENSG00000157184,formerly at 1p13,"CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant; {Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant",Cpt2 (MGI:109176)
1,53226899,53238517,1p34-p33,1p32.3,602603,MAGOH,"Mago nashi, Drosophila, homolog of, proliferation-associated",MAGOH,4116,ENSG00000162385,NA,NA,Magoh (MGI:1330312)
1,53242363,53328069,1p34,1p32.3,602600,"LRP8, APOER2, MCI1",Low density lipoprotein receptor-related protein 8 (Apolipoprotein E receptor 2),LRP8,7804,ENSG00000157193,NA,"{Myocardial infarction, susceptibility to}, 608446 (3)",Lrp8 (MGI:1340044)
1,53459398,53467487,1p32.2,1p32.3,614805,DMRTB1,Doublesex- and MAB3-related transcription factor B1,DMRTB1,63948,ENSG00000143006,NA,NA,Dmrtb1 (MGI:1927125)
1,53506232,53739170,1p32.3,1p32.3,610378,GLIS1,Glis family zinc finger protein 1,GLIS1,148979,ENSG00000174332,NA,NA,Glis1 (MGI:2386723)
1,53765459,53838551,1p32.3,1p32.3,610115,"TMEM48, NDC1",Transmembrane protein 48,NDC1,55706,ENSG00000058804,NA,NA,Ndc1 (MGI:1920037)
1,53851718,53889813,1p32.3,1p32.3,617521,YIPF1,"YIP1 domain family, member 1",YIPF1,54432,ENSG00000058799,NA,NA,Yipf1 (MGI:1915532)
1,53894186,53911085,1p33-p32,1p32.3,147892,"DIO1, TXDI1","Deiodinase, iodothyronine, type I",DIO1,1733,ENSG00000211452,NA,NA,Dio1 (MGI:94896)
1,54026680,54053572,1p32.3,1p32.3,617084,"TMEM59, DCF1",Transmembrane protein 59,TMEM59,9528,ENSG00000116209,NA,NA,Tmem59 (MGI:1929278)
1,54132719,54153180,1p32,1p32.3,612320,CDCP2,Cub domain-containing protein 2,CDCP2,200008,ENSG00000157211,?associated with PARK10,NA,Cdcp2 (MGI:3045328)
1,54200166,54225488,1p32.1,1p32.3,611843,MRPL37,Mitochondrial ribosomal protein L37,MRPL37,51253,ENSG00000116221,NA,NA,Mrpl37 (MGI:1926268)
1,54225431,54413478,1p31.3,1p32.3,607390,SSBP3,Single-stranded DNA-binding protein 3,SSBP3,23648,ENSG00000157216,NA,NA,Ssbp3 (MGI:1919725)
1,54548227,54639191,1p32.3,1p32.3,606803,"ACOT11, THEA, BFIT, BFIT1, BFIT2, KIAA0707",Acyl-CoA thioesterase 11,ACOT11,26027,ENSG00000162390,NA,NA,Acot11 (MGI:1913736)
1,54715821,54742656,1p31.3,1p32.3,606753,TTC4,Tetratricopeptide repeat domain 4,TTC4,7268,ENSG00000243725,pseudogene on 7p14-p13,NA,Ttc4 (MGI:1919604)
1,54756897,54764522,1p32.2,1p32.3,612036,"PARS2, EIEE75",Prolyl-tRNA synthetase 2,PARS2,25973,ENSG00000162396,NA,"Epileptic encephalopathy, early infantile, 75, 618437 (3), Autosomal recessive",Pars2 (MGI:2386296)
1,54806062,54842263,1p32.3,1p32.3,616446,"LEXM, C1orf177, LEM",Lymphocyte expansion molecule,LEXM,163747,ENSG00000162398,NA,NA,Lexm (MGI:2681853)
1,54849626,54887194,1p33-p31.1,1p32.3,606418,"DHCR24, KIAA0018",24-dehydrocholesterol reductase,DHCR24,1718,ENSG00000116133,NA,"Desmosterolosis, 602398 (3), Autosomal recessive",Dhcr24 (MGI:1922004)
1,54998932,55017171,1p31,1p32.3,606412,BSND,Barttin,BSND,7809,ENSG00000162399,NA,"Bartter syndrome, type 4a, 602522 (3), Autosomal recessive; Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive",Bsnd (MGI:2153465)
1,55039475,55064852,1p32.3,1p32.3,607786,"PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3","Proprotein convertase, subtilisin/kexin-type, 9",PCSK9,255738,ENSG00000169174,NA,"Hypercholesterolemia, familial, 3, 603776 (3), Autosomal dominant; {Low density lipoprotein cholesterol level QTL 1}, 603776 (3), Autosomal dominant",Pcsk9 (MGI:2140260)
1,55066358,55215373,1p32.3,1p32.3,610569,"USP24, KIAA1057",Ubiquitin-specific protease 24,USP24,23358,ENSG00000162402,NA,NA,Usp24 (MGI:1919936)
1,56494760,56579562,1p32.2,1p32.2,607125,"PLPP3, PPAP2B",Phospholipid phosphatase 3,PLPP3,8613,ENSG00000162407,NA,NA,Plpp3 (MGI:1915166)
1,56645313,56715334,1p31,1p32.2,600497,"PRKAA2, AMPK","Protein kinase, AMP-activated, alpha-2 catalytic subunit",PRKAA2,5563,ENSG00000162409,NA,NA,Prkaa2 (MGI:1336173)
1,56718788,56831985,1p32.2,1p32.2,618478,"FYB2, ARAP, C1orf168",FYN-binding protein 2,FYB2,199920,ENSG00000187889,NA,NA,Fyb2 (MGI:2685466)
1,56854769,56918220,1p32,1p32.2,120950,C8A,"Complement component-8, alpha polypeptide",C8A,731,ENSG00000157131,NA,"C8 deficiency, type I, 613790 (3), Autosomal recessive",C8a (MGI:2668347)
1,56929206,56974382,1p32,1p32.2,120960,C8B,"Complement component-8, beta polypeptide",C8B,732,ENSG00000021852,NA,"C8 deficiency, type II, 613789 (3), Autosomal recessive",C8b (MGI:88236)
1,56994777,58250546,1p32-p31,1p32.2,603448,"DAB1, SCA37","Disabled, Drosophila, homolog 1",DAB1,1600,ENSG00000173406,NA,"Spinocerebellar ataxia 37, 615945 (3), Autosomal dominant",Dab1 (MGI:108554)
1,58480718,58546725,1p32.3-p32.1,1p32.2-p32.1,617081,"OMA1, MPRP1",OMA1 zinc metallopeptidase,OMA1,115209,ENSG00000162600,NA,NA,Oma1 (MGI:1914263)
1,58575432,58577251,1p32,1p32.1,137290,"TACSTD2, TROP2, M1S1",Tumor-associated calcium signal transducer 2,TACSTD2,4070,ENSG00000184292,NA,"Corneal dystrophy, gelatinous drop-like, 204870 (3), Autosomal recessive",Tacstd2 (MGI:1861606)
1,58654738,58700090,1p32.1,1p32.1,612176,"MYSM1, 2ADUB, KIAA1915, BMFS4","MYB-like, SWIRM, and MPN domains-containing protein 1",MYSM1,114803,ENSG00000162601,NA,"Bone marrow failure syndrome 4, 618116 (3), Autosomal recessive",Mysm1 (MGI:2444584)
1,58780790,58784046,1p32-p31,1p32.1,165160,JUN,Avian sarcoma virus 17 (v-jun) oncogene homolog,JUN,3725,ENSG00000177606,NA,NA,Jun (MGI:96646)
1,59296404,59762729,1p32.1,1p32.1,611370,"FGGY, FLJ10986",FGGY carbohydrate kinase domain-containing protein,FGGY,55277,ENSG00000172456,NA,NA,Fggy (MGI:1922828)
1,59814921,59876369,1p32.1,1p32.1,607820,"HOOK1, HK1","Hook, Drosophila, homolog of, 1",HOOK1,51361,ENSG00000134709,NA,NA,Hook1 (MGI:1925213)
1,59893307,59926797,1p31.3-p31.2,1p32.1,601258,CYP2J2,"Cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase), polypeptide 2",CYP2J2,1573,ENSG00000134716,NA,NA,Cyp2j6 (MGI:1270148)
1,60800000,84400000,1p31,NA,601676,AIR,Acute insulin response,NA,7808,NA,NA,"Acute insulin response, 601676 (2)",NA
1,60800000,84400000,1p31,NA,610906,ASRT4,"Asthma-related traits, susceptibility to, 4",NA,100188823,NA,max lod at D1S2890,"{Asthma-related traits, susceptibility to, 4}, 610906 (2)",NA
1,60800000,106700000,1p31-p21,NA,606215,"AVSD1, AVCD","Atrioventricular septal defect, susceptibility to, 1",AVSD1,7446,NA,NA,"{Atrioventricular septal defect, susceptibility to, 1}, 606215 (2)",NA
1,60800000,84400000,1p31,NA,615892,OFC14,Orofacial cleft 14,NA,103581096,NA,NA,"Orofacial cleft 14, 615892 (2), Autosomal recessive",NA
1,60800000,68500000,1p31.3,NA,164750,"OPHLC, C1DUPp31.3, DUP1p31.3",Omphalocele due to duplication of 1p31.3,NA,NA,NA,duplication of 710kb at 1p31.3,"Omphalocele due to duplication of 1p31.3, 164750 (4), Isolated cases",NA
1,60800000,84400000,1p31,NA,606787,PAOD1,Peripheral arterial occlusive disease 1,NA,171513,NA,NA,"Peripheral arterial occlusive disease 1, 606787 (2)",NA
1,60800000,84400000,1p31.3-p31.1,NA,612293,"POROK5, DSAP3","Porokeratosis 5, disseminated superficial actinic",NA,100190982,NA,between D1S438 and D1S464,"Porokeratosis 5, disseminated superficial actinic, 612293 (2)",NA
1,61077226,61462787,1p31.3-p31.2,1p31.3,600727,"NFIA, BRMUTD",Nuclear factor I/A,NFIA,4774,ENSG00000162599,NA,"Brain malformations with or without urinary tract defects, 613735 (3), Autosomal dominant",Nfia (MGI:108056)
1,61681045,61725422,1p31.3,1p31.3,610080,"TM2D1, BBP",TM2 domain-containing protein 1,TM2D1,83941,ENSG00000162604,NA,NA,Tm2d1 (MGI:2137022)
1,61742476,62163948,1p31.3,1p31.3,603199,"PATJ, INADL",PALS1-associated tight junction protein,PATJ,10207,ENSG00000132849,NA,NA,Patj (MGI:1277960)
1,62236164,62319433,1p31.3,1p31.3,614612,KANK4,KN motif- and ankyrin repeat domain-containing protein 4,KANK4,163782,ENSG00000132854,NA,NA,Kank4 (MGI:3043381)
1,62436303,62451803,1p32.1-p31.3,1p31.3,603478,USP1,Ubiquitin-specific protease 1,USP1,7398,ENSG00000162607,NA,NA,Usp1 (MGI:2385198)
1,62454725,62688385,1p31.3,1p31.3,615730,"DOCK7, KIAA1771, EIEE23",Dedicator of cytokinesis 7,DOCK7,85440,ENSG00000116641,NA,"Epileptic encephalopathy, early infantile, 23, 615859 (3), Autosomal recessive",Dock7 (MGI:1914549)
1,62597519,62606312,1p31,1p31.3,604774,"ANGPTL3, ANGPT5, FHBL2",Angiopoietin-like 3,ANGPTL3,27329,ENSG00000132855,NA,"Hypobetalipoproteinemia, familial, 2, 605019 (3), Autosomal recessive",Angptl3 (MGI:1353627)
1,62783764,62865515,1p31.3,1p31.3,611339,"ATG4C, APG4C","Autophagy 4, S. cerevisiae, homolog of, C",ATG4C,84938,ENSG00000125703,NA,NA,Atg4c (MGI:2651854)
1,63322566,63325127,1p31,1p31.3,611539,"FOXD3, AIS1, VAMAS2",Forkhead box D3,FOXD3,27022,ENSG00000187140,NA,"{Autoimmune disease, susceptibility to, 1}, 607836 (3), Autosomal dominant",Foxd3 (MGI:1347473)
1,63367626,63438552,1p22.3,1p31.3,604566,"ALG6, CDG1C","Alg6, S. cerevisiae, homolog of",ALG6,29929,ENSG00000088035,NA,"Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive",Alg6 (MGI:2444031)
1,63440769,63529394,1p31.3,1p31.3,605494,"ITGB3BP, NRIF3","Integrin, beta-3, binding protein of",ITGB3BP,23421,ENSG00000142856,NA,NA,Itgb3bp (MGI:1914983)
1,63523320,63585400,1p31.3,1p31.3,617632,"EFCAB7, KIAA1799",EF-hand calcium-binding domain-containing protein 7,EFCAB7,84455,ENSG00000203965,NA,NA,Efcab7 (MGI:2385199)
1,63593410,63660244,1p31,1p31.3,171900,"PGM1, GSD14, CDG1T",Phosphoglucomutase-1,PGM1,5236,ENSG00000079739,distal to ACADM; formerly 1p22.1,"Congenital disorder of glycosylation, type It, 614921 (3), Autosomal recessive",Pgm1 (MGI:97565)
1,63774016,64181497,1p31.3,1p31.3,602336,"ROR1, NTRKR1",Receptor tyrosine kinase-like orphan receptor 1,ROR1,4919,ENSG00000185483,mutation identified in 1 DFNB108 family,"?Deafness, autosomal recessive 108, 617654 (3), Autosomal recessive",Ror1 (MGI:1347520)
1,64744972,64833410,1p31.3,1p31.3,609953,"RAVER2, KIAA1579","Raver2, mouse, homolog of",RAVER2,55225,ENSG00000162437,NA,NA,Raver2 (MGI:2443623)
1,64833222,65067745,1p31.3,1p31.3,147795,JAK1,Janus kinase 1 (a protein-tyrosine kinase),JAK1,3716,ENSG00000162434,related gene on 9p24,NA,Jak1 (MGI:96628)
1,65058433,65058507,1p31.3,1p31.3,612511,"MIR101-1, MIRN101-1",Micro RNA 101-1,MIR101-1,406893,ENSG00000199135,"another locus, MIRN101-2, on 9p24",NA,NA
1,65147341,65232144,1p31.3,1p31.3,103030,AK3,"Adenylate kinase-3, mitochondrial",AK4,205,ENSG00000162433,NA,NA,Ak4 (MGI:87979)
1,65264693,65415870,1p32.1-p31.3,1p31.3,608375,"DNAJC6, DJC6, KIAA0473, PARK19","DNAJ, E. coli, homolog of, subfamily C, member 6",DNAJC6,9829,ENSG00000116675,NA,"Parkinson disease 19a, juvenile-onset, 615528 (3), Autosomal recessive; Parkinson disease 19b, early-onset, 615528 (3), Autosomal recessive",Dnajc6 (MGI:1919935)
1,65420651,65637492,1p31,1p31.3,601007,"LEPR, OBR, LEPRD",Leptin receptor,LEPR,3953,ENSG00000116678,NA,"Obesity, morbid, due to leptin receptor deficiency, 614963 (3), Autosomal recessive",Lepr (MGI:104993)
1,65420667,65436006,1p31,1p31.3,613461,"LEPROT, OBRGRP",Leptin receptor overlapping transcript,LEPROT,54741,ENSG00000213625,transcribed in same direction as LEPR,NA,Leprot (MGI:2687005)
1,65792509,66374578,1p31,1p31.3,600127,"PDE4B, DPDE4","Phosphodiesterase-4B, cAMP-specific (dunce-like phosphodiesterase E4)",PDE4B,5142,ENSG00000184588,NA,NA,Pde4b (MGI:99557)
1,66533271,66751138,1p31.3,1p31.3,611540,SGIP1,SH3-domain GRB2-like (endophilin)-interacting protein 1,SGIP1,84251,ENSG00000118473,NA,NA,Sgip1 (MGI:1920344)
1,66797740,66801258,1p31.1-p22.3,1p31.3,606413,INSL5,Insulin-like 5,INSL5,10022,ENSG00000172410,NA,NA,Insl5 (MGI:1346085)
1,66924894,66988618,1p31.3,1p31.3,616848,"MEIR1, KIAA1610",Mesoderm induction-early response protein 1,MIER1,57708,ENSG00000198160,NA,NA,Mier1 (MGI:1918398)
1,66999349,67054422,1p32-p31,1p31.3,610804,"SLC35D1, UGTREL7, KIAA0260, SHNKND","Solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1",SLC35D1,23169,ENSG00000116704,NA,"Schneckenbecken dysplasia, 269250 (3), Autosomal recessive",Slc35d1 (MGI:2140361)
1,67138638,67259978,1p31.3,1p31.3,607562,"IL23R, IBD17",Interleukin 23 receptor,IL23R,149233,ENSG00000162594,NA,"{Inflammatory bowel disease 17, protection against}, 612261 (3); {Psoriasis, protection against}, 605606 (3)",Il23r (MGI:2181693)
1,67307350,67397729,1p31.2,1p31.3,601642,IL12RB2,"Interleukin 12 receptor, beta-2",IL12RB2,3595,ENSG00000081985,NA,NA,Il12rb2 (MGI:1270861)
1,67407809,67430401,1p31.3,1p31.3,607378,"SERBP1, PAIRBP1",Serpine1 mRNA-binding protein 1,SERBP1,26135,ENSG00000142864,NA,NA,Serbp1 (MGI:1914120)
1,67685200,67688333,1p34-p12,1p31.3,126335,"DDIT1, GADD45",DNA damage-inducible transcript-1,GADD45A,1647,ENSG00000116717,NA,NA,Gadd45a (MGI:107799)
1,67701474,67833466,1p31.3,1p31.3,615405,GNG12,"Guanine nucleotide-binding protein, gamma 12",GNG12,55970,ENSG00000172380,NA,NA,Gng12 (MGI:1336171)
1,67832287,68202986,1p31.3,1p31.3,615406,GNG12AS1,GNG12 antisense RNA 1,GNG12-AS1,100289178,ENSG00000232284,NA,NA,NA
1,68045885,68051630,1p31.3,1p31.3,605193,"DIRAS3, ARHI","DIRAS family, GTP-binding RAS-like protein 3",DIRAS3,9077,ENSG00000162595,NA,NA,NA
1,68098458,68233017,1p31.3,1p31.3,611514,"WLS, GPR177, EVI","WNTless, Drosophila, homolog of",WLS,79971,ENSG00000116729,NA,NA,Wls (MGI:1915401)
1,68428821,68450321,1p31,1p31.3,180069,"RPE65, RP20, LCA2",RPE65 retinoid isomerohydrolase,RPE65,6121,ENSG00000116745,NA,"Leber congenital amaurosis 2, 204100 (3), Autosomal recessive; Retinitis pigmentosa 20, 613794 (3), Autosomal recessive",Rpe65 (MGI:98001)
1,68474151,68497081,1p31.2,1p31.3,612002,DEPDC1,DEP domain-containing 1,DEPDC1,55635,ENSG00000024526,NA,NA,Depdc1a (MGI:1923381)
1,68500000,69300000,1p31.2,NA,613008,PBC3,"Biliary cirrhosis, primary, 3",NA,100303717,NA,associated with rs3790567,"{Biliary cirrhosis, primary, 3}, 613008 (2)",NA
1,69300000,106700000,1p31.1-p21.1,NA,609727,SPG29,"Spastic paraplegia 29, autosomal dominant",SPG29,619379,NA,max lod at D1S2865,"Spastic paraplegia 29, autosomal dominant, 609727 (2), Autosomal dominant",NA
1,69567333,70152425,1p31.1,1p31.1,614453,"LRRC7, DENSIN, KIAA1365",Leucine-rich repeat-containing protein 7,LRRC7,57554,ENSG00000033122,NA,NA,Lrrc7 (MGI:2676665)
1,69919321,69920316,1p31,1p31.1,602051,PIN1L,"Peptidyl-prolyl cis/trans isomerase, NIMA-interacting-like",PIN1P1,5301,ENSG00000229359,?transcribed pseudogene,NA,NA
1,70205695,70253051,1p31.1,1p31.1,602010,"SRSF11, SFRS11","Splicing factor, serine/arginine-rich, 11",SRSF11,9295,ENSG00000116754,NA,NA,Srsf11 (MGI:1916457)
1,70258998,70354976,1p31.1,1p31.1,615125,ANKRD13C,Ankyrin repeat domain-containing protein 13C,ANKRD13C,81573,ENSG00000118454,NA,NA,Ankrd13c (MGI:2139746)
1,70353838,70368022,1p31.1,1p31.1,604372,HHLA3,Human endogenous retrovirus-H long terminal repeat-associating 3,HHLA3,11147,ENSG00000197568,NA,NA,NA
1,70411217,70441948,1p31.1,1p31.1,607657,CTH,Cystathionine gamma-lyase,CTH,1491,ENSG00000116761,previously assigned to chr.16,"Cystathioninuria, 219500 (3), Autosomal recessive; Homocysteine, total plasma, elevated (3)",Cth (MGI:1339968)
1,70852352,71047815,1p31.2,1p31.1,176806,"PTGER3, EP3","Prostaglandin E receptor 3, EP3 subtype",PTGER3,5733,ENSG00000050628,NA,NA,Ptger3 (MGI:97795)
1,71063290,71081034,1p22.1-p21.3,1p31.1,604347,"ZRANB2, ZNF265, ZIS",Zinc finger RANBP2-type domain-containing protein 2,ZRANB2,9406,ENSG00000132485,NA,NA,NA
1,71395942,72282538,1p31.1,1p31.1,613173,"NEGR1, KILON",Neuronal growth regulator 1,NEGR1,257194,ENSG00000172260,NA,NA,Negr1 (MGI:2444846)
1,74026014,74198200,1p31.1,1p31.1,617957,"LRRIQ3, LRRC44",Leucine rich repeats- and IQ motif-containing protein 3,LRRIQ3,127255,ENSG00000162620,NA,NA,Lrriq3 (MGI:1921685)
1,74198211,74208701,1p31.1,1p31.1,603609,"FPGT, GFPP",Fucose-1-phosphate guanylyltransferase,FPGT,8790,ENSG00000254685,NA,NA,Fpgt (MGI:1922790)
1,74235386,74544427,1p31.1,1p31.1,613932,"TNNI3K, CCDD",TNNI3-interacting kinase,TNNI3K,51086,ENSG00000116783,NA,"Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3), Autosomal dominant",Tnni3k (MGI:2443276)
1,74705469,74733407,1p31-p22,1p31.1,123691,CRYZ,"Crystallin, zeta (quinone reductase)",CRYZ,1429,ENSG00000116791,NA,NA,Cryz (MGI:88527)
1,74733151,74766676,1p31.3,1p31.1,611245,TYW3,"tRNA-wybutosine-synthesizing protein 3, S. cerevisiae, homolog of",TYW3,127253,ENSG00000162623,NA,NA,Tyw3 (MGI:2445040)
1,75128433,75199453,1p31.1,1p31.1,604425,LHX8,LIM homeobox 8,LHX8,431707,ENSG00000162624,NA,NA,Lhx8 (MGI:1096343)
1,75724346,75763678,1p31,1p31.1,607008,"ACADM, MCAD","Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain",ACADM,34,ENSG00000117054,NA,"Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive",Acadm (MGI:87867)
1,75786193,75795089,1p31,1p31.1,179080,RABGGTB,"Rab geranylgeranyltransferase, beta subunit",RABGGTB,5876,ENSG00000137955,NA,NA,Rabggtb (MGI:99537)
1,75796881,75913241,1p31,1p31.1,602105,MSH4,"mutS, E. coli, homolog of, 4",MSH4,4438,ENSG00000057468,NA,NA,Msh4 (MGI:1860077)
1,76074683,76637315,1p31.1,1p31.1,610133,"ST6GALNAC3, SIAT7C","ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3",ST6GALNAC3,256435,ENSG00000184005,NA,NA,St6galnac3 (MGI:1341828)
1,76867448,77069166,1p31.1,1p31.1,610134,"ST6GALNAC5, SIAT7E","ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6 sialyltransferase 5",ST6GALNAC5,81849,ENSG00000117069,NA,NA,St6galnac5 (MGI:1349471)
1,77088988,77219429,1p31.1,1p31.1,605087,"PIGK, GPI8","Phosphatidylinositol glycan, class K",PIGK,10026,ENSG00000142892,NA,NA,Pigk (MGI:1913863)
1,77281907,77559965,1p31,1p31.1,608009,AK5,Adenylate kinase 5,AK5,26289,ENSG00000154027,NA,NA,Ak5 (MGI:2677491)
1,77695986,77759878,1p31.1,1p31.1,615146,"USP33, VDU1",Ubiquitin-specific protease 33,USP33,23032,ENSG00000077254,NA,NA,Usp33 (MGI:2159711)
1,77779623,77879539,1p31.1,1p31.1,616773,"FAM73A, MIGA1","Miga, Drosophila, homolog of, 1",MIGA1,374986,ENSG00000180488,NA,NA,Miga1 (MGI:1924567)
1,77881347,77889538,1p31.1,1p31.1,618370,NEXAS1,NEXN antisense RNA 1,NEXN-AS1,374987,ENSG00000235927,NA,NA,NA
1,77888514,77948642,1p32-p31,1p31.1,613121,"NEXN, NELIN, CMD1CC, CMH20","Nexilin, rat, homolog of",NEXN,91624,ENSG00000162614,NA,"Cardiomyopathy, dilated, 1CC, 613122 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 20, 613876 (3), Autosomal dominant",Nexn (MGI:1916060)
1,77944050,77979434,1p31.1,1p31.1,603444,"FUBP1, FUBP, FBP",Far upstream element-binding protein 1,FUBP1,8880,ENSG00000162613,NA,NA,Fubp1 (MGI:1196294)
1,77979157,78017963,1p31.1,1p31.1,611327,"DNAJB4, HLJ1","DNAJ/HSP40 homolog, subfamily B, member 4",DNAJB4,11080,ENSG00000162616,NA,NA,Dnajb4 (MGI:1914285)
1,78490973,78540700,1p31.1,1p31.1,600563,PTGFR,Prostaglandin F receptor (FP),PTGFR,5737,ENSG00000122420,NA,NA,Ptgfr (MGI:97796)
1,78620386,78646144,1p31.1,1p31.1,613975,IFI44L,Interferon-induced protein 44-like,IFI44L,10964,ENSG00000137959,NA,NA,Ifi44l (MGI:95975)
1,78648942,78664077,1p31.1,1p31.1,610468,"IFI44, P44",Interferon-induced protein 44,IFI44,10561,ENSG00000137965,NA,NA,Ifi44 (MGI:2443016)
1,78889763,79006729,1p31.1,1p31.1,616419,"ADGRL4, ETL, ELTD1",Adhesion G protein-coupled receptor L4,ADGRL4,64123,ENSG00000162618,NA,NA,Adgrl4 (MGI:2655562)
1,81306103,81993931,1p31.1,1p31.1,607018,"ADGRL2, LPHN2, LPHH1, CIRL2, CL2, KIAA0786",Adhesion G protein-coupled receptor L2,ADGRL2,23266,ENSG00000117114,NA,NA,Adgrl2 (MGI:2139714)
1,84077974,84238497,1p31.1,1p31.1,176892,PRKACB,"Protein kinase, cAMP-dependent, catalytic, beta",PRKACB,5567,ENSG00000142875,NA,NA,Prkacb (MGI:97594)
1,84398531,84415894,1p22.3,1p31.1-p22.3,608057,"DNASE2B, DLAD",Deoxyribonuclease II beta,DNASE2B,58511,ENSG00000137976,NA,NA,Dnase2b (MGI:1913283)
1,84400000,94300000,1p22,NA,608035,CMM4,"Melanoma, cutaneous malignant, 4",NA,474388,NA,between D1S430 and D1S2664,"{Melanoma, cutaneous malignant, 4}, 608035 (2)",NA
1,84400000,94300000,1p22,NA,611381,KAZA2,"Kala-azar, susceptibility to, 2",NA,101241898,NA,NA,"{Kala-azar, susceptibility to, 2}, 611381 (2)",NA
1,84400000,94300000,1p22,NA,191540,UOX,"Urate oxidase, pseudogene",UOX,391051,NA,nonsense mutations responsible for absence of enzyme in man and hominoid primates,[Urate oxidase deficiency] (1),NA
1,84498324,84506580,1p22,1p22.3,600874,GNG5,"Guanine nucleotide-binding protein (G protein), gamma 5",GNG5,2787,ENSG00000174021,NA,NA,"Gng5,Gng5-ps (MGI:3783217,MGI:109164)"
1,84549610,84574439,1p22,1p22.3,600873,"CTBS, CTB","Chitobiase, di-N-acetyl-",CTBS,1486,ENSG00000117151,NA,NA,Ctbs (MGI:1921495)
1,84811600,84893205,1p31.1-p22.3,1p22.3,605106,"LPAR3, EDG7, LPA3",Lysophosphatidic acid receptor 3,LPAR3,23566,ENSG00000171517,NA,NA,Lpar3 (MGI:1929469)
1,84925582,84997112,1p22,1p22.3,607399,MCOLN2,Mucolipin 2,MCOLN2,255231,ENSG00000153898,incorrectly assigned to chr.3,NA,Mcoln2 (MGI:1915529)
1,85018081,85048901,1p22.3,1p22.3,607400,MCOLN3,Mucolipin 3,MCOLN3,55283,ENSG00000055732,NA,NA,Mcoln3 (MGI:1890500)
1,85062297,85133137,1p22.3,1p22.3,617968,WDR63,WD repeat-containing protein 63,WDR63,126820,ENSG00000162643,NA,NA,Wdr63 (MGI:3045269)
1,85265775,85276631,1p22,1p22.3,603517,"BCL10, IMD37",B-cell leukemia/lymphoma 10,BCL10,8915,ENSG00000142867,mutation identified in 1 IMD37 patient,"?Immunodeficiency 37, 616098 (3), Autosomal recessive; Lymphoma, MALT, somatic, 137245 (3); {Lymphoma, follicular, somatic}, 605027 (3); {Male germ cell tumor, somatic}, 273300 (3); {Mesothelioma, somatic}, 156240 (3); {Sezary syndrome, somatic} (3)",Bcl10 (MGI:1337994)
1,85318484,85578273,1p22,1p22.3,604743,DDAH1,Dimethylarginine dimethylaminohydrolase-1,DDAH1,23576,ENSG00000153904,NA,NA,Ddah1 (MGI:1916469)
1,85580760,85583949,1p22.3,1p22.3,602369,"CYR61, IGFBP10","Cysteine-rich angiogenic inducer, 61 (insulin-like growth factor-binding protein-10)",CCN1,3491,ENSG00000142871,NA,NA,Ccn1 (MGI:88613)
1,85728506,86157035,1p22.3,1p22.3,610025,COL24A1,"Collagen, type XXIV, alpha-1",COL24A1,255631,ENSG00000171502,NA,NA,Col24a1 (MGI:1918605)
1,86424143,86456552,1p22.3,1p22.3,604003,CLCA2,Chloride channel accessory 2,CLCA2,9635,ENSG00000137975,NA,NA,Clca2 (MGI:2139758)
1,86468842,86500293,1p22.3,1p22.3,603906,"CLCA1, CACC1",Chloride channel accessory 1,CLCA1,1179,ENSG00000016490,NA,NA,Clca1 (MGI:1346342)
1,86547075,86580757,1p22.3,1p22.3,616857,"CLCA4, CACC2",Chloride channel accessory 4,CLCA4,22802,ENSG00000016602,NA,NA,"Clca4b,Clca4a (MGI:2139790,MGI:2139744)"
1,86634275,86655375,1p22.32,1p22.3,604337,CLCA3,Chloride channel accessory 3,CLCA3P,9629,ENSG00000153923,NA,NA,NA
1,86862444,86914576,1p31,1p22.3,606254,"SELENOF, SEP15",Selenoprotein F,SELENOF,9403,ENSG00000183291,NA,NA,Selenof (MGI:1927947)
1,86914634,87109981,1p22,1p22.3,604844,HS2ST1,Heparan sulfate 2-O-sulfotransferase 1,HS2ST1,9653,ENSG00000153936,NA,NA,Hs2st1 (MGI:1346049)
1,87328879,87348922,1p22.3,1p22.3,603129,LMO4,LIM domain only 4,LMO4,8543,ENSG00000143013,NA,NA,Lmo4 (MGI:109360)
1,88684143,88836254,1p22.2,1p22.2,602549,"PKN2, PRKCL2, PRK2, PAK2",Protein kinase N2,PKN2,5586,ENSG00000065243,NA,NA,Pkn2 (MGI:109211)
1,88852632,88891943,1p22.2,1p22.2,189963,"GTF2B, TFIIB, TF2B",General transcription factor IIb,GTF2B,2959,ENSG00000137947,NA,NA,Gtf2b (MGI:2385191)
1,88921043,88992959,1p22.2,1p22.2,610656,"CCBL2, KAT3",Cysteine conjugate beta-lyase 2,KYAT3,56267,ENSG00000137944,NA,NA,Kyat3 (MGI:2677849)
1,89006676,89022869,1p22.2,1p22.2,600413,GBP3,Guanylate-binding protein 3,GBP3,2635,ENSG00000117226,NA,NA,Gbp2b (MGI:95666)
1,89052318,89065207,1p22.2,1p22.2,600411,GBP1,"Guanylate binding protein 1, interferon-inducible, 67kD",GBP1,2633,ENSG00000117228,NA,NA,NA
1,89106131,89126113,1p22.2,1p22.2,600412,GBP2,"Guanylate-binding protein 2, interferon-inducible",GBP2,2634,ENSG00000162645,NA,NA,Gbp2 (MGI:102772)
1,89131741,89176002,1p22.2,1p22.2,612468,GBP7,Guanylate-binding protein 7,GBP7,388646,ENSG00000213512,NA,NA,Gbp7 (MGI:2444421)
1,89181143,89198941,1p22.2,1p22.2,612466,GBP4,Guanylate-binding protein 4,GBP4,115361,ENSG00000162654,NA,NA,Gbp3 (MGI:1926263)
1,89258949,89272859,1p22.2,1p22.2,611467,GBP5,Guanylate-binding protein 5,GBP5,115362,ENSG00000154451,NA,NA,Gbp5 (MGI:2429943)
1,89363876,89388159,1p22.2,1p22.2,612467,GBP6,Guanylate-binding protein 6,GBP6,163351,ENSG00000183347,NA,NA,"Gbp6,Gbp10,Gbp11,Gbp9,Gbp4 (MGI:3605620,MGI:3646307,MGI:97072,MGI:4359647,MGI:2140937)"
1,89522625,89597860,1p22.2,1p22.2,612888,"LRRC8B, TALRRP, KIAA0231",Leucine-rich repeat-containing protein 8B,LRRC8B,23507,ENSG00000197147,NA,NA,Lrrc8b (MGI:2141353)
1,89615809,89719532,1p22.2,1p22.2,612889,"LRRC8C, FAD158, AD158",Leucine-rich repeat-containing protein 8C,LRRC8C,84230,ENSG00000171488,NA,NA,Lrrc8c (MGI:2140839)
1,89821013,89936610,1p22.2,1p22.2,612890,"LRRC8D, LRRC5",Leucine-rich repeat-containing protein 8D,LRRC8D,55144,ENSG00000171492,NA,NA,Lrrc8d (MGI:1922368)
1,89995094,90035532,1p22.2,1p22.2,614601,"ZNF326, ZIRD",Zinc finger protein 326,ZNF326,284695,ENSG00000162664,NA,NA,Zfp326 (MGI:1927246)
1,90711538,90717301,1p22.3,1p22.2,605212,BARHL2,BARH-like 2,BARHL2,343472,ENSG00000143032,NA,NA,Barhl2 (MGI:1859314)
1,90915297,91022266,1p22.2,1p22.2,614159,"ZNF644, MYP21",Zinc finger protein 644,ZNF644,84146,ENSG00000122482,NA,"Myopia 21, autosomal dominant, 614167 (3), Autosomal dominant",Zfp644 (MGI:1277212)
1,91260765,91408007,1p22.2,1p22.2,615684,"HFM1, MER3, POF9","Hfm1, ATP-dependent DNA helicase, S. cerevisiae, homolog of",HFM1,164045,ENSG00000162669,NA,"Premature ovarian failure 9, 615724 (3), Autosomal recessive",Hfm1 (MGI:3036246)
1,91498967,91525763,1p22,1p22.2-p22.1,603311,"CDC7L1, CDC7","Cell division cycle 7, S. Cerevisiae, homolog-like 1",CDC7,8317,ENSG00000097046,NA,NA,Cdc7 (MGI:1309511)
1,91680342,91906001,1p33-p32,1p22.1,600742,TGFBR3,"Transforming growth factor, beta receptor III (betaglycan, 300kD)",TGFBR3,7049,ENSG00000069702,NA,NA,Tgfbr3 (MGI:104637)
1,91949370,92014427,1p22.1,1p22.1,602144,"BRDT, SPGF21","Bromodomain, testis-specific",BRDT,676,ENSG00000137948,mutation identified in 1 SPGF21 patient,"?Spermatogenic failure 21, 617644 (3), Autosomal recessive",Brdt (MGI:1891374)
1,92029984,92063537,1p22.1,1p22.1,617401,"EPHX4, ABHD7",Epoxide hydrolase 4,EPHX4,253152,ENSG00000172031,NA,NA,Ephx4 (MGI:2686228)
1,92168920,92188508,1p22.1,1p22.1,617945,"KIAA1107, APACHE",KIAA1107 gene,KIAA1107,23285,ENSG00000189195,NA,NA,A830010M20Rik (MGI:2445097)
1,92245785,92441935,1p22-p21,1p22.1,601749,"GLML, GVM, VMGLOM",Glomulin,GLMN,11146,ENSG00000174842,NA,"Glomuvenous malformations, 138000 (3), Autosomal dominant",Glmn (MGI:2141180)
1,92299049,92402055,1p22.1,1p22.1,611476,"RPAP2, C1orf82",RNA polymerase II-associated protein 2,RPAP2,79871,ENSG00000122484,NA,NA,Rpap2 (MGI:2141142)
1,92473042,92486924,1p22,1p22.1,600871,"GFI1, ZNF163, SCN2",Growth factor independent 1,GFI1,2672,ENSG00000162676,mutation identified in 1 SCN2 patient and 1 NICINA patient,"?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; ?Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant",Gfi1 (MGI:103170)
1,92508695,92792412,1p22,1p22.1,602942,"EVI5, NB4S",Ecotropic viral integration site 5,EVI5,7813,ENSG00000067208,NA,NA,Evi5 (MGI:104736)
1,92831985,92841923,1p22.1,1p22.1,603634,"RPL5, DBA6",Ribosomal protein L5,RPL5,6125,ENSG00000122406,NA,"Diamond-Blackfan anemia 6, 612561 (3), Autosomal dominant",Rpl5 (MGI:102854)
1,92832728,92961521,1p22.1,1p22.1,614542,FAM69A,"Family with sequence similarity 69, member A",DIPK1A,388650,ENSG00000154511,NA,NA,Dipk1a (MGI:1914516)
1,92837288,92837382,1p22.1,1p22.1,603635,"SNORD21, RNU21","Small nucleolar RNA, C/D box 21",SNORD21,6083,ENSG00000206680,NA,NA,NA
1,93079234,93139080,1p22.1,1p22.1,609882,"MTF2, PCL2, M96",Metal-regulatory transcription factor 2,MTF2,22823,ENSG00000143033,NA,NA,Mtf2 (MGI:105050)
1,93149741,93180688,1p22.1,1p22.1,616876,TMED5,Transmembrane p24 trafficking protein 5,TMED5,50999,ENSG00000117500,NA,NA,Tmed5 (MGI:1921586)
1,93345906,93369492,1p22.1,1p22.1,601482,DR1,"Down-regulator of transcription 1, TBP-binding (negative cofactor 2)",DR1,1810,ENSG00000117505,NA,NA,Dr1 (MGI:1100515)
1,93448066,93569670,1p22.1,1p22.1,608848,"FNBP1L, TOCA1, C1orf39",Formin binding protein 1-like,FNBP1L,54874,ENSG00000137942,NA,NA,NA
1,93561740,93847218,1p22.1,1p22.1,604704,"BCAR3, SH2D3B, NSP2",Breast cancer antiestrogen resistance 3,BCAR3,8412,ENSG00000137936,NA,NA,Bcar3 (MGI:1352501)
1,93866283,93879205,1p22.1,1p22.1,611199,"DNTTIP2, ERBP, FCF2",DNTT-interacting protein 2,DNTTIP2,30836,ENSG00000067334,NA,NA,Dnttip2 (MGI:1923173)
1,93885198,93910369,1p22.1,1p22.1,601176,"GCLM, GLCLR","Glutamate-cysteine ligase, modifier subunit",GCLM,2730,ENSG00000023909,NA,"{Myocardial infarction, susceptibility to}, 608446 (3)",Gclm (MGI:104995)
1,93992833,94121147,1p22.1,1p22.1,601691,"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2","ATP-binding transporter, retina-specific",ABCA4,24,ENSG00000198691,NA,"Cone-rod dystrophy 3, 604116 (3); Fundus flavimaculatus, 248200 (3), Autosomal recessive; {Macular degeneration, age-related, 2}, 153800 (3), Autosomal dominant; Retinal dystrophy, early-onset severe, 248200 (3), Autosomal recessive; Retinitis pigmentosa 19, 601718 (3), Autosomal recessive; Stargardt disease 1, 248200 (3), Autosomal recessive",Abca4 (MGI:109424)
1,94168904,94275067,1p22.1,1p22.1,610496,"ARHGAP29, PARG1",RHO GTPase-activating protein 29,ARHGAP29,9411,ENSG00000137962,NA,NA,Arhgap29 (MGI:2443818)
1,94300000,111200000,1p21.3-p13.3,NA,609913,RP32,Retinitis pigmentosa-32,RP32,641433,NA,max lod at D1S485,"Retinitis pigmentosa 32, 609913 (2)",NA
1,94300000,106700000,1p21,NA,609822,STQTL7,Stature quantitative trait locus 7,NA,100037265,NA,max lod at D1S1631,"{Stature QTL 7}, 609822 (2)",NA
1,94300000,111200000,1p21-p13.3,NA,600193,WS2B,"Waardenburg syndrome, type 2B",WS2B,7488,NA,NA,"Waardenburg syndrome, type 2B, 600193 (2), Autosomal dominant",NA
1,94418085,94518662,1p22-p21,1p21.3,170995,"ABCD3, PXMP1, PMP70, CBAS5","ATP-binding cassette, subfamily D, member 3 (peroxisomal membrane protein 1, 70kD)",ABCD3,5825,ENSG00000117528,mutation identified in 1 CBAS5 family,"?Bile acid synthesis defect, congenital, 5, 616278 (3), Autosomal recessive",Abcd3 (MGI:1349216)
1,94529172,94541856,1p22-p21,1p21.3,134390,"F3, TFA",Coagulation factor III,F3,2152,ENSG00000117525,NA,NA,F3 (MGI:88381)
1,94896948,94927222,1p22-p21,1p21.3,602374,CNN3,"Calponin 3, acidic",CNN3,1266,ENSG00000117519,NA,NA,Cnn3 (MGI:1919244)
1,94974404,95072973,1p21.3,1p21.3,612866,"ALG14, CMS15","Alg14, S. cerevisiae, homolog of",ALG14,199857,ENSG00000172339,mutation identified in 1 CMSWTA family,"?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3), Autosomal recessive",Alg14 (MGI:1914039)
1,95234154,95247224,1p21.3,1p21.3,615875,"RWDD3, RSUME",RWD domain-containing protein 3,RWDD3,25950,ENSG00000122481,NA,NA,Rwdd3 (MGI:1920420)
1,96721604,96823738,1p21,1p21.3,608449,"PTBP2, NPTB",Polypyrimidine tract-binding protein 2,PTBP2,58155,ENSG00000117569,NA,NA,Ptbp2 (MGI:1860489)
1,97077742,97921058,1p22,1p21.3,612779,"DPYD, DPD",Dihydropyrimidine dehydrogenase,DPYD,1806,ENSG00000188641,NA,"Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive",Dpyd (MGI:2139667)
1,98046069,98046170,1p22,1p21.3,614304,"MIR137, MIRN137",Micro RNA 137,MIR137,406928,ENSG00000284202,NA,NA,NA
1,98661283,98760499,1p21.3,1p21.3,614904,SNX7,Sorting nexin 7,SNX7,51375,ENSG00000162627,NA,NA,Snx7 (MGI:1923811)
1,98890244,99006129,1p21.3,1p21.3,617287,"PLPPR5, LPPR5, PAP2D, PAP2",Phospholipid phosphatase-related protein 5,PLPPR5,163404,ENSG00000117598,NA,NA,Plppr5 (MGI:1923019)
1,99262955,99309583,1p21.3,1p21.3-p21.2,607813,"PLPPR4, LPPR4, PRG1, KIAA0455",Phospholipid phosphatase-related protein 4,PLPPR4,9890,ENSG00000117600,NA,NA,Plppr4 (MGI:106530)
1,99646112,99694534,1p21.2,1p21.2,610182,"PALMD, PALML",Palmdelphin,PALMD,54873,ENSG00000099260,NA,NA,Palmd (MGI:2148896)
1,99703966,99766634,1p21.2,1p21.2,611578,"FRRS1, SDR2",Ferric chelate reductase 1,FRRS1,391059,ENSG00000156869,NA,NA,Frrs1 (MGI:108076)
1,99850076,99924022,1p21,1p21.2,610860,"AGL, GDE","Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme)",AGL,178,ENSG00000162688,NA,"Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive",Agl (MGI:1924809)
1,99968400,100035633,1p21,1p21.2,605632,"SLC35A3, AMRS","Solute carrier family 35 (UDP-GlcNAc transporter), member 3",SLC35A3,23443,ENSG00000117620,mutation identified in 1 family,"?Arthrogryposis, mental retardation, and seizures, 615553 (3), Autosomal recessive",Slc35a3 (MGI:1917648)
1,100082631,100132929,1p21.2,1p21.2,609321,"SASS6, SAS6, MCPH14",SAS-6 centriolar assembly protein,SASS6,163786,ENSG00000156876,mutation identified in 1 MCPH14 family,"?Microcephaly 14, primary, autosomal recessive, 616402 (3), Autosomal recessive",Sass6 (MGI:1920026)
1,100186918,100249863,1p31,1p21.2,248610,"DBT, BCATE2",Dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex),DBT,1629,ENSG00000137992,pseudogene on 3q24,"Maple syrup urine disease, type II, 248600 (3), Autosomal recessive",Dbt (MGI:105386)
1,100266157,100292768,1p21.2,1p21.2,611286,"RTCD1, RPC",RNA terminal phosphate cyclase domain-containing protein 1,RTCA,8634,ENSG00000137996,NA,NA,Rtca (MGI:1913618)
1,100345000,100520280,1p21,1p21.2,603504,"CDC14A, DFNB32","Cell division cycle 14, S. cerevisiae, homolog A",CDC14A,8556,ENSG00000079335,NA,"Deafness, autosomal recessive 32, with or without immotile sperm, 608653 (3), Autosomal recessive",Cdc14a (MGI:2442676)
1,100538138,100542020,1p21.2,1p21.2,607468,"GPR88, STRG, COCPMR",G protein-coupled receptor 88,GPR88,54112,ENSG00000181656,mutation identified in 1 COCPMR family,"?Chorea, childhood-onset, with psychomotor retardation, 616939 (3), Autosomal recessive",Gpr88 (MGI:1927653)
1,100719639,100739044,1p32-p31,1p21.2,192225,VCAM1,Vascular cell adhesion molecule-1,VCAM1,7412,ENSG00000162692,NA,NA,Vcam1 (MGI:98926)
1,100872371,100895410,1p12-p11,1p21.2,602411,EXTL2,Exostosin-like 2,EXTL2,2135,ENSG00000162694,NA,NA,Extl2 (MGI:1889574)
1,100896089,100996912,1p21.2,1p21.2,611149,"SLC30A7, ZNT7","Solute carrier family 30 (zinc transporter), member 7",SLC30A7,148867,ENSG00000162695,NA,NA,Slc30a7 (MGI:1913750)
1,100975217,101025805,1p21.2,1p21.2,611075,"DPH5, HSPC143",Diphthamide biosynthesis protein 5,DPH5,51611,ENSG00000117543,NA,NA,Dph5 (MGI:1916990)
1,101236748,101241519,1p21,1p21.2,601974,"S1PR1, EDG1, S1P1",Sphingosine-1-phosphate receptor 1,S1PR1,1901,ENSG00000170989,NA,NA,S1pr1 (MGI:1096355)
1,101800000,155100000,1p21.1-q21.3,NA,612841,"HYPT5, MUHH2",Hypotrichosis 5,NA,100302560,NA,max lod at D1S2881,"Hypotrichosis 5, 612841 (2), Autosomal dominant",NA
1,101800000,111200000,1p21.1-p13.3,NA,611107,MRT4,"Mental retardation, autosomal recessive, 4",MRT4,100009675,NA,between D2S429 and D1S187,"Mental retardation, autosomal recessive, 4, 611107 (2), Autosomal recessive",NA
1,101800027,101997233,1p21,1p21.1,607567,"OLFM3, NOE3",Olfactomedin 3,OLFM3,118427,ENSG00000118733,NA,NA,Olfm3 (MGI:2387329)
1,102876466,103108579,1p21,1p21.1,120280,"COL11A1, STL2","Collagen XI, alpha-1 polypeptide",COL11A1,1301,ENSG00000060718,NA,"Fibrochondrogenesis 1, 228520 (3), Autosomal recessive; {Lumbar disc herniation, susceptibility to}, 603932 (3); Marshall syndrome, 154780 (3), Autosomal dominant; Stickler syndrome, type II, 604841 (3), Autosomal dominant",Col11a1 (MGI:88446)
1,103525698,103555238,1p21.1,1p21.1,618016,"RNPC3, SNRNP65, KIAA1839, IGHD5",RNA-binding region-containing protein 3,RNPC3,55599,ENSG00000185946,mutation identified in 1 IGHD5 family,"?Growth hormone deficiency, isolated, type V, 618160 (3), Autosomal recessive",Rnpc3 (MGI:1914475)
1,103554643,103579533,1p21,1p21.1,104660,AMY2B,"Amylase, pancreatic, alpha-2B",AMY2B,280,ENSG00000240038,distal to NGFB,NA,"Amy2a2,Amy2a3,Amy2a4,Amy2a5 (MGI:3711220,MGI:3714985,MGI:3711258,MGI:88020)"
1,103617331,103625779,1p21,1p21.1,104650,AMY2A,"Amylase, pancreatic, alpha-2A",AMY2A,279,ENSG00000243480,NA,NA,Amy1 (MGI:88019)
1,103655518,103664550,1p21,1p21.1,104700,AMY1A,"Amylase, salivary, alpha-1A",AMY1A,276,ENSG00000237763,multiple amylase genes,NA,NA
1,103687414,103696451,1p21,1p21.1,104701,AMY1B,"Amylase, salivary, alpha-1B",AMY1B,277,ENSG00000174876,NA,NA,NA
1,103745429,103758691,1p21,1p21.1,104702,AMY1C,"Amylase, salivary, alpha-1C",AMY1C,278,ENSG00000187733,NA,NA,NA
1,106700000,111200000,1p13.3,NA,118943,CYMP,Chymosin pseudogene,CYMP,643160,ENSG00000240194,NA,NA,NA
1,106700000,117200000,1p13,NA,193000,VUR,Vesicoureteral reflux,NA,54113,NA,NA,"Vesicoureteral reflux, 193000 (2), Autosomal dominant",NA
1,107056673,107059293,1p13.3,1p13.3,608274,PRMT6,Protein arginine N-methyltransferase 6,PRMT6,55170,ENSG00000198890,NA,NA,Prmt6 (MGI:2139971)
1,107140016,107484922,1p13.3,1p13.3,608818,"NTNG1, LMNT1, KIAA0976",Netrin G1,NTNG1,22854,ENSG00000162631,NA,NA,Ntng1 (MGI:1934028)
1,107571160,107965179,1p13.3,1p13.3,605541,VAV3,Vav3 oncogene,VAV3,10451,ENSG00000134215,NA,NA,Vav3 (MGI:1888518)
1,108134042,108200342,1p36.13,1p13.3,608744,"SLC25A24, SCAMC1","Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24",SLC25A24,29957,ENSG00000085491,NA,"Fontaine progeroid syndrome, 612289 (3), Autosomal dominant",Slc25a24 (MGI:1917160)
1,108222463,108244080,1p12,1p13.3,613994,NBPF4,"Neuroblastoma breakpoint family, member 4",NBPF4,148545,ENSG00000196427,NA,NA,NA
1,108375970,108383613,1p12,1p13.3,613995,NBPF5,"Neuroblastoma breakpoint family, member 5",NBPF5P,100507044,NA,NA,NA,NA
1,108421495,108471902,1p12,1p13.3,613996,NBPF6,"Neuroblastoma breakpoint family, member 6",NBPF6,653149,ENSG00000186086,NA,NA,NA
1,108648287,108661525,1p13.3,1p13.3,612178,"HENMT1, C1orf59, HEN1","Hen1 methyltransferase, arabidopsis, homolog of",HENMT1,113802,ENSG00000162639,NA,NA,Henmt1 (MGI:1913965)
1,108875349,108934544,1p13.1,1p13.3,609245,"GPSM2, LGN, PINS, DFNB82, CMCS",G protein signaling modulator 2,GPSM2,29899,ENSG00000121957,NA,"Chudley-McCullough syndrome, 604213 (3), Autosomal recessive",Gpsm2 (MGI:1923373)
1,108929507,108963498,1p13.3,1p13.3,617539,"CLCC1, MCLC",Chloride channel CLIC-like 1,CLCC1,23155,ENSG00000121940,NA,NA,Clcc1 (MGI:2385186)
1,108970210,109042227,1p13.3,1p13.3,615734,"WDR47, NEMITIN, KIAA0893",WD repeat-containing protein 47,WDR47,22911,ENSG00000085433,NA,NA,Wdr47 (MGI:2139593)
1,109064139,109076002,1p13.3,1p13.3,600774,"TAF13, TAF2K, MRT60","TAF13 RNA polymerase II, TATA box-binding protein-associated factor, 18kD",TAF13,6884,ENSG00000197780,NA,"Mental retardation, autosomal recessive 60, 617432 (3), Autosomal recessive",Taf13 (MGI:1913500)
1,109114105,109206780,1p13.3,1p13.3,611298,"KIAA1324, EIG121",KIAA1324 gene,KIAA1324,57535,ENSG00000116299,NA,NA,5330417C22Rik (MGI:1923930)
1,109213892,109238181,1p13,1p13.3,607529,"SARS, SERS, NEDMAS",Seryl-tRNA synthetase,SARS1,6301,ENSG00000031698,mutation identified in 1 NEDMAS family,"?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive",Sars (MGI:102809)
1,109249538,109275750,1p21,1p13.3,604265,"CELSR2, EGFL2, MEGF3",Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 2),CELSR2,1952,ENSG00000143126,NA,NA,Celsr2 (MGI:1858235)
1,109279553,109283171,1p13.1,1p13.3,613126,"PSRC1, DDA3",Proline/serine-rich coiled-coil protein 1,PSRC1,84722,ENSG00000134222,NA,NA,Psrc1 (MGI:1913099)
1,109309564,109397939,1p13.3,1p13.3,602458,"SORT1, NT3, LDLCQ6",Sortilin,SORT1,6272,ENSG00000134243,NA,"[Low density lipoprotein cholesterol level QTL6], 613589 (3), Autosomal dominant",Sort1 (MGI:1338015)
1,109399041,109426447,1p13,1p13.3,176844,"PSMA5, PSC5",Proteasome component 5,PSMA5,5686,ENSG00000143106,NA,NA,Psma5 (MGI:1347009)
1,109504177,109509741,1p13.3,1p13.3,615689,"AMIGO1, ALI2, KIAA1163",Adhesion molecule with Ig-like domain 1,AMIGO1,57463,ENSG00000181754,NA,NA,Amigo1 (MGI:2653612)
1,109539871,109545847,1p13.3,1p13.3,606916,GPR61,G protein-coupled receptor 61,GPR61,83873,ENSG00000156097,NA,NA,Gpr61 (MGI:2441719)
1,109548614,109600194,1p13,1p13.3,139370,"GNAI3, ARCND1","Guanine nucleotide-binding protein (G-protein), alpha-inhibiting activity polypeptide-3",GNAI3,2773,ENSG00000065135,NA,"Auriculocondylar syndrome 1, 602483 (3), Autosomal dominant",Gnai3 (MGI:95773)
1,109598892,109598966,1p13.3,1p13.3,611189,MIR197,Micro rNA 197,MIR197,406974,ENSG00000284443,NA,NA,NA
1,109603090,109619732,1p13,1p13.3,139340,"GNAT2, ACHM4","Guanine nucleotide-binding protein (G-protein), alpha-transducing (transducin) activity polypeptide-2",GNAT2,2780,ENSG00000134183,NA,"Achromatopsia 4, 613856 (3)",Gnat2 (MGI:95779)
1,109619812,109632054,1p13.3,1p13.3,102771,"AMPD2, SPG63, PCH9","Adenosine monophosphate deaminase-2, isoform L",AMPD2,271,ENSG00000116337,mutation identified in 1 SPG63 family,"Pontocerebellar hypoplasia, type 9, 615809 (3), Autosomal recessive; ?Spastic paraplegia 63, 615686 (3), Autosomal recessive",Ampd2 (MGI:88016)
1,109656075,109665496,1p13.3,1p13.3,138333,GSTM4,Glutathione S-transferase M4,GSTM4,2948,ENSG00000168765,NA,NA,Gstm4 (MGI:95862)
1,109668021,109683996,1p13.3,1p13.3,138380,"GSTM2, GST4","Glutathione S-transferase M2, muscle",GSTM2,2946,ENSG00000213366,NA,NA,Gstm7 (MGI:1915562)
1,109687816,109693744,1p13.3,1p13.3,138350,GSTM1,Glutathione S-transferase M1,GSTM1,2944,ENSG00000134184,NA,NA,Gstm2 (MGI:95861)
1,109711750,109718267,1p13.3,1p13.3,138385,GSTM5,Glutathione S-transferase M5,GSTM5,2949,ENSG00000134201,pseudogene on chr.3,NA,Gstm1 (MGI:95860)
1,109733931,109741037,1p13.3,1p13.3,138390,"GSTM3, GST5","Glutathione S-transferase M3, brain",GSTM3,2947,ENSG00000134202,NA,NA,Gstm5 (MGI:1309466)
1,109750079,109763975,1p13.3,1p13.3,614989,"EPS8L3, EPS8R3",EPS8-like protein 3,EPS8L3,79574,ENSG00000198758,NA,NA,Eps8l3 (MGI:2139743)
1,109910505,109930991,1p21-p13,1p13.3,120420,"CSF1, MCSF",Colony-stimulating factor-1 (macrophage),CSF1,1435,ENSG00000184371,incorrectly assigned to chr.5,NA,Csf1 (MGI:1339753)
1,109984764,110023741,1p13.3,1p13.3,607826,"AHCYL1, DCAL, IRBIT",Adenosylhomocysteine-like 1,AHCYL1,10768,ENSG00000168710,NA,NA,Ahcyl1 (MGI:2385184)
1,110031576,110054640,1p13.3,1p13.3,617918,"STRIP1, FAR11A, FAM40A",Striatin-interacting protein 1,STRIP1,85369,ENSG00000143093,NA,NA,Strip1 (MGI:2443884)
1,110059869,110070671,1p21-p13,1p13.3,606014,"ALX3, FND1",Aristaless-like homeobox 3,ALX3,257,ENSG00000156150,NA,"Frontonasal dysplasia 1, 136760 (3), Autosomal recessive",Alx3 (MGI:1277097)
1,110112442,110113946,1p13.3,1p13.3,611127,UBL4B,Ubiquitin-like 4B,UBL4B,164153,ENSG00000186150,NA,NA,Ubl4b (MGI:1914841)
1,110150493,110202201,1p13.3,1p13.3,610299,"SLC6A17, NTT4, MRT48","Solute carrier family 6 (neurotransmitter transporter), member 17",SLC6A17,388662,ENSG00000197106,NA,"Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive",Slc6a17 (MGI:2442535)
1,110210313,110282648,1p13.3,1p13.3,176265,KCNC4,"Potassium voltage-gated channel, Shaw-related subfamily, member 4",KCNC4,3749,ENSG00000116396,NA,NA,Kcnc4 (MGI:96670)
1,110339322,110346680,1p13,1p13.3,606077,"RBM15, SPEN, OTT","One-twenty two protein (RNA binding motif protein 15; Spen, Drosophila, homolog of)",RBM15,64783,ENSG00000162775,NA,"Megakaryoblastic leukemia, acute, 606077 (2)",Rbm15 (MGI:2443205)
1,110362850,110391970,1p13.3,1p13.3,603878,"SLC16A4, MCT5",Solute carrier family 16 (monocarboxylic acid transporter) member 4,SLC16A4,9122,ENSG00000168679,NA,NA,Slc16a4 (MGI:2385183)
1,110401252,110407923,1p13.2,1p13.3,608521,"LAMTOR5, HBXIP, XIP","Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 5",LAMTOR5,10542,ENSG00000134248,NA,NA,Lamtor5 (MGI:1915826)
1,110451148,110457357,1p21,1p13.3,606233,"PROK1, PK1, PRK1, EGVEGF",Prokineticin 1,PROK1,84432,ENSG00000143125,NA,NA,Prok1 (MGI:2180370)
1,110517216,110519174,1p13.1,1p13.3,602420,KCNA10,"Potassium voltage-gated channel, shaker-related subfamily, member 10",KCNA10,3744,ENSG00000143105,NA,NA,Kcna10 (MGI:3037820)
1,110593579,110631535,1p13.3,1p13.3,176262,"KCNA2, EIEE32","Potassium channel, voltage-gated, Shaker-related subfamily, member 2",KCNA2,3737,ENSG00000177301,NA,"Epileptic encephalopathy, early infantile, 32, 616366 (3), Autosomal dominant",Kcna2 (MGI:96659)
1,110653559,110674939,1p21-p13.3,1p13.3,176263,KCNA3,"Potassium voltage-gated channel, shaker-related subfamily, member 3",KCNA3,3738,ENSG00000177272,mapped probably in error to chr.13,NA,Kcna3 (MGI:96660)
1,110871166,110899935,1p21-p13.3,1p13.3,151525,"CD53, MOX44",CD53 antigen,CD53,963,ENSG00000143119,NA,NA,Cd53 (MGI:88341)
1,110877251,110963961,1p12,1p13.3,615354,"LRIF1, RIF1",Ligand-dependent nuclear receptor-interacting factor 1,LRIF1,55791,ENSG00000121931,NA,NA,Lrif1 (MGI:2445214)
1,111117169,111140215,1p13.3,1p13.3,613360,"DRAM2, TMEM77, CORD21",Damage-regulated autophagy modulator 2,DRAM2,128338,ENSG00000156171,NA,"Cone-rod dystrophy 21, 616502 (3), Autosomal recessive",Dram2 (MGI:1914421)
1,111139382,111185103,1p13.3,1p13.3,616751,CEPT1,Choline/ethanolamine phosphotransferase 1,CEPT1,10390,ENSG00000134255,NA,NA,Cept1 (MGI:2139793)
1,111185968,111204790,1p13.3,1p13.3-p13.2,615111,DENND2D,DENN/MADD domain-containing protein 2D,DENND2D,79961,ENSG00000162777,NA,NA,Dennd2d (MGI:2181193)
1,111200000,115500000,1p13.2,NA,617386,"NR1H5P, FXRB","Nuclear receptor subfamily 1, group H, member 5, pseudogene",NR1H5P,643609,NA,NA,NA,NA
1,111227079,111243439,1p13.3,1p13.2,601526,"CHI3L2, YKL39",Chitinase 3-like 2,CHI3L2,1117,ENSG00000064886,NA,NA,NA
1,111290850,111320565,1p21.3-p13.1,1p13.2,606080,"CHIA, TSA1902, CHIT2","Chitinase, acidic",CHIA,27159,ENSG00000134216,NA,NA,Chia1 (MGI:1932052)
1,111324662,111353016,1p13.2,1p13.2,614234,"C1orf88, PIFO","Chromosome 1 open reading frame 88 (pitchfork, mouse, homolog of)",PIFO,128344,ENSG00000173947,NA,NA,Pifo (MGI:1923670)
1,111414318,111427734,1p13.2,1p13.2,603578,OVGP1,Oviductal glycoprotein 1,OVGP1,5016,ENSG00000085465,NA,NA,Ovgp1 (MGI:106661)
1,111439889,111449307,1p13.2,1p13.2,611734,"WDR77, MEP50",WD repeat-containing protein 77,WDR77,79084,ENSG00000116455,NA,NA,Wdr77 (MGI:1917715)
1,111449463,111462772,1p13.2,1p13.2,603270,ATP5F1,"ATP synthase, H+ transporting, mitochondrial FO complex, subunit B, isoform 1",ATP5PB,515,ENSG00000116459,NA,NA,Atp5f1 (MGI:1100495)
1,111499428,111504120,1p21-p13,1p13.2,600445,ADORA3,Adenosine A3 receptor,ADORA3,140,ENSG00000282608,NA,NA,Adora3 (MGI:104847)
1,111542008,111716694,1p13.3,1p13.2,179520,"RAP1A, KREV1",RAS-related protein RAP1A,RAP1A,5906,ENSG00000116473,pseudogene on 14q24.3,NA,Rap1a (MGI:97852)
1,111755900,111767999,1p21.1-p13.2,1p13.2,606168,DDX20,DEAD/H box 20,DDX20,11218,ENSG00000064703,NA,NA,Ddx20 (MGI:1858415)
1,111770661,111989576,1p13.3-p13.2,1p13.2,605411,"KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9","Potassium voltage-gated channel, Shal-related subfamily, member 3",KCND3,3752,ENSG00000171385,NA,"Brugada syndrome 9, 616399 (3), Autosomal dominant; Spinocerebellar ataxia 19, 607346 (3), Autosomal dominant",Kcnd3 (MGI:1928743)
1,112391084,112461163,1p13.2,1p13.2,615100,CTTNBP2NL,CTTNBP2 N terminus-like protein,CTTNBP2NL,55917,ENSG00000143079,NA,NA,Cttnbp2nl (MGI:1933137)
1,112466540,112530164,1p13,1p13.2,601968,"WNT2B, WNT13, XWNT2","Wingless-type MMTV integration site family, member 2B",WNT2B,7482,ENSG00000134245,NA,"Diarrhea 9, 618168 (3), Autosomal recessive",Wnt2b (MGI:1261834)
1,112517443,112619880,1p13,1p13.2,617640,"ST7L, ST7R",Suppressor of tumorigenicity 7-like protein,ST7L,54879,ENSG00000007341,NA,NA,St7l (MGI:2386964)
1,112619774,112671615,1p13.2,1p13.2,601580,"CAPZA1, CAPPA1","Capping protein, muscle Z-line, alpha-1",CAPZA1,829,ENSG00000116489,NA,NA,Capza1 (MGI:106227)
1,112674311,112702376,1p13.2,1p13.2,610742,"MOV10, KIAA1631","Moloney leukemia virus 10, mouse, homolog of",MOV10,4343,ENSG00000155363,NA,NA,Mov10 (MGI:97054)
1,112701126,112707402,1p13.2,1p13.2,165380,"RHOC, ARHC, ARH9, RHOH9","RAS homolog gene family, member C (oncogene RHO H9)",RHOC,389,ENSG00000155366,incorrectly assigned to chr.5,NA,Rhoc (MGI:106028)
1,112709993,112715327,1p13.2,1p13.2,609957,"PPM1J, PP2CZ, PPP2CZ","Protein phosphatase, magnesium-dependent, 1J",PPM1J,333926,ENSG00000155367,NA,NA,Ppm1j (MGI:1919137)
1,112718960,112727234,1p13.2,1p13.2,617497,"FAM19A3, TAFA3","Family with sequence similarity 19, member A3, CC motif chemokine-like",TAFA3,284467,ENSG00000184599,NA,NA,Tafa3 (MGI:3046463)
1,112911846,112956352,1p13.2-p12,1p13.2,600682,"SLC16A1, MCT1, HHF7, MCT1D","Solute carrier family 16 (monocarboxylic acid transporters), member 1",SLC16A1,6566,ENSG00000155380,NA,"Erythrocyte lactate transporter defect, 245340 (3), Autosomal dominant; Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3), Autosomal dominant; Monocarboxylate transporter 1 deficiency, 616095 (3), Autosomal recessive, Autosomal dominant",Slc16a1 (MGI:106013)
1,113073169,113132259,1p13,1p13.2,608869,"LRIG2, LIG2, KIAA0806, UFS2",Leucine-rich repeats- and immunoglobulin-like domains-containing protein 2,LRIG2,9860,ENSG00000198799,NA,"Urofacial syndrome 2, 615112 (3), Autosomal recessive",Lrig2 (MGI:2443718)
1,113390473,113685922,1p21,1p13.2,615943,"MAGI3, KIAA1634","Membrane-associated guanylate kinase, WW and PDZ domains-containing, 3",MAGI3,260425,ENSG00000081026,NA,NA,Magi3 (MGI:1923484)
1,113696830,113759887,1p13,1p13.2,604950,PHTF1,Putative homeodomain transcription factor 1,PHTF1,10745,ENSG00000116793,NA,NA,Phtf1 (MGI:1332671)
1,113761831,113812536,1p13.2,1p13.2,615858,"RSBN1, ROSBIN",Round spermatid basic protein 1,RSBN1,54665,ENSG00000081019,NA,NA,Rsbn1 (MGI:2444993)
1,113813810,113871760,1p13,1p13.2,600716,"PTPN22, PEP, PTPN8, LYP","Protein tyrosine phosphatase, nonreceptor-type 22",PTPN22,26191,ENSG00000134242,NA,"{Diabetes, type 1, susceptibility to}, 222100 (3), Autosomal recessive; {Rheumatoid arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3), Autosomal dominant",Ptpn22 (MGI:107170)
1,113894193,113905066,1p13.2,1p13.2,607245,"AP4B1, SPG47, CPSQ5","Adaptor-related protein complex 4, beta-1 subunit",AP4B1,10717,ENSG00000134262,NA,"Spastic paraplegia 47, autosomal recessive, 614066 (3), Autosomal recessive",Ap4b1 (MGI:1337130)
1,113904618,113914085,1p13.3-p13.1,1p13.2,609683,"DCLRE1B, SNM1B, APOLLO",DNA cross-link repair protein 1B,DCLRE1B,64858,ENSG00000118655,NA,NA,Dclre1b (MGI:2156057)
1,113979390,113982253,1p13.1,1p13.2,610088,"OLFML3, OLF44",Olfactomedin-like 3,OLFML3,56944,ENSG00000116774,NA,NA,Olfml3 (MGI:1914877)
1,114089291,114153868,1p13.2,1p13.2,607718,SYT6,Synaptotagmin 6,SYT6,148281,ENSG00000134207,NA,NA,Syt6 (MGI:1859544)
1,114392786,114511202,1p13,1p13.2,605769,"TRIM33, TIF1G, RFG7, PTC7",Tripartite motif-containing protein 33,TRIM33,51592,ENSG00000197323,fused with RET to form PTC7,NA,Trim33 (MGI:2137357)
1,114567556,114581614,1p21-p13.3,1p13.2,605783,"BCAS2, DAM1",Breast carcinoma amplified sequence 2,BCAS2,10286,ENSG00000116752,NA,NA,Bcas2 (MGI:1915433)
1,114673097,114695617,1p21-p13,1p13.2,102770,"AMPD1, MMDD","Adenosine monophosphate deaminase-1, muscle",AMPD1,270,ENSG00000116748,NA,"Myopathy due to myoadenylate deaminase deficiency, 615511 (3), Autosomal recessive",Ampd1 (MGI:88015)
1,114704468,114716770,1p13.2,1p13.2,164790,"NRAS, ALPS4, NS6, CMNS, NCMS",Neuroblastoma RAS viral (v-ras) oncogene homolog,NRAS,4893,ENSG00000213281,cen-CD2-NGFB-NRAS,"Colorectal cancer, somatic, 114500 (3); Epidermal nevus, somatic, 162900 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Neurocutaneous melanosis, somatic, 249400 (3); Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3)",Nras (MGI:97376)
1,114716912,114758049,1p22,1p13.2,191510,"CSDE1, D1S155E, UNR","Cold-shock domain-containing E1, RNA-binding",CSDE1,7812,ENSG00000009307,130bp 5' to NRAS,NA,Csde1 (MGI:92356)
1,114769478,114780686,1p13.2,1p13.2,611656,SIKE,Suppressor of IKK-epsilon,SIKE1,80143,ENSG00000052723,NA,NA,Sike1 (MGI:1913891)
1,114854267,114995369,1p13,1p13.2,602162,"SYCP1, SCP1",Synaptonemal complex protein-1,SYCP1,6847,ENSG00000198765,NA,NA,Sycp1 (MGI:105931)
1,115029823,115035934,1p13,1p13.2,188540,"TSHB, CHNG4","Thyroid-stimulating hormone, beta polypeptide",TSHB,7252,ENSG00000134200,centromeric to NGFB,"Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive",Tshb (MGI:98848)
1,115048010,115089502,1p13.2,1p13.2,613133,"TSPAN2, NET3",Tetraspanin 2,TSPAN2,10100,ENSG00000134198,NA,NA,Tspan2 (MGI:1917997)
1,115285914,115338252,1p13.1,1p13.2,162030,"NGF, NGFB, HSAN5","Nerve growth factor, beta",NGF,4803,ENSG00000134259,same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-tel,"Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive",Ngf (MGI:97321)
1,115641969,115698223,1p13,1p13.1,610132,"VANGL1, STBM2",Vang-like 1,VANGL1,81839,ENSG00000173218,NA,"Caudal regression syndrome, 600145 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 182940 (3), Autosomal dominant",Vangl1 (MGI:2159344)
1,115700002,115768804,1p13.3-p11,1p13.1,114251,CASQ2,"Calsequestrin, fast-twitch, skeletal muscle-2",CASQ2,845,ENSG00000118729,NA,"Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3), Autosomal recessive",Casq2 (MGI:1309469)
1,115830776,115841125,1p12-p11,1p13.1,162361,"NHLH2, HEN2",Nescient helix loop helix 2,NHLH2,4808,ENSG00000177551,NA,NA,Nhlh2 (MGI:97324)
1,115976512,116070053,1p13.1,1p13.1,608275,"SLC22A15, FLIPT1","Solute carrier family 22 (organic cation transporter), member 15",SLC22A15,55356,ENSG00000163393,NA,NA,Slc22a15 (MGI:3607704)
1,116372985,116410258,1p13.1,1p13.1,182310,"ATP1A1, CMT2DD, HOMGSMR2","ATPase, Na+K+ transporting, alpha-1 polypeptide",ATP1A1,476,ENSG00000163399,NA,"Charcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3), Autosomal dominant; Hypomagnesemia, seizures, and mental retardation 2, 618314 (3), Autosomal dominant",Atp1a1 (MGI:88105)
1,116392864,116418621,1p13.1,1p13.1,618305,ATP1A1AS1,ATP1A1 antisense RNA 1,ATP1A1-AS1,84852,ENSG00000203865,NA,NA,NA
1,116500389,116571092,1p13,1p13.1,153420,"CD58, LFA3",CD58 antigen (lymphocyte function-associated antigen 3),CD58,965,ENSG00000116815,?same as MSK1; gene cloned,NA,NA
1,116574397,116667754,1p13,1p13.1,603491,"IGSF3, LCDD","Immunoglobulin superfamily, member 3",IGSF3,3321,ENSG00000143061,mutation identified in 1 LCDD family,"?Lacrimal duct defect, 149700 (3), Autosomal recessive",Igsf3 (MGI:1926158)
1,116754429,116769228,1p13.1,1p13.1,186990,CD2,"CD2 antigen (p50), sheep red blood cell receptor",CD2,914,ENSG00000116824,NA,NA,Cd2 (MGI:88320)
1,116909915,116990357,1p13.1-q21.3,1p13.1,601204,"PTGFRN, FPRP",Prostaglandin F2 receptor negative regulator,PTGFRN,5738,ENSG00000134247,NA,NA,Ptgfrn (MGI:1277114)
1,117060302,117107452,1p13.1,1p13.1,604718,TTF2,"Transcription termination factor, RNA polymerase II",TTF2,8458,ENSG00000116830,NA,NA,Ttf2 (MGI:1921294)
1,117107710,117121788,1p22,1p13.1,609318,TRIM45,Tripartite motif-containing protein 45,TRIM45,80263,ENSG00000134253,NA,NA,Trim45 (MGI:1918187)
1,117143586,117210984,1p13.1,1p13-p12,608162,"VCTN1, B7H4, B7X, B7S1",V-set domain containing T cell activation inhibitor 1,VTCN1,79679,ENSG00000134258,NA,NA,Vtcn1 (MGI:3039619)
1,117200000,120400000,1p12,NA,618026,NOTCH2NLR,"NOTCH2 N-terminal-like-related, pseudogene",NOTCH2NLR,101929796,ENSG00000286106,NA,NA,NA
1,117367392,117528871,1p13,1p12,604345,MAN1A2,"Mannosidase, alpha, class 1A, member 2",MAN1A2,10905,ENSG00000198162,NA,NA,Man1a2 (MGI:104676)
1,117606047,117628388,1p12,1p12,613952,"TENT5C, FAM46C",Terminal nucleotidyltransferase 5C,TENT5C,54855,ENSG00000183508,NA,NA,Tent5c (MGI:1921895)
1,117863484,117929620,1p12,1p12,618128,"GDAP2, SCAR27",Ganglioside-induced differentiation-associated protein 2,GDAP2,54834,ENSG00000196505,NA,"Spinocerebellar ataxia, autosomal recessive 27, 618369 (3), Autosomal recessive",Gdap2 (MGI:1338001)
1,117929738,117966542,1p13-p12,1p12,604737,WDR3,WD repeat-containing protein 3,WDR3,10885,ENSG00000065183,NA,NA,Wdr3 (MGI:2443143)
1,117953589,118185227,1p12,1p12,616554,"SPAG17, PF6",Sperm-associated antigen 17,SPAG17,200162,ENSG00000155761,NA,NA,Spag17 (MGI:1921612)
1,118883045,118989509,1p13,1p12,604127,TBX15,T-box 15,TBX15,6913,ENSG00000092607,NA,"Cousin syndrome, 260660 (3), Autosomal recessive",Tbx15 (MGI:1277234)
1,119031215,119140787,1p13.3-p13.1,1p12,604733,"WARS2, NEMMLAS",Tryptophanyl-tRNA synthetase 2,WARS2,10352,ENSG00000116874,NA,"Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3), Autosomal recessive",Wars2 (MGI:1917810)
1,119361912,119394129,1p13,1p12,605176,"HAO2, HAOX2",Hydroxyacid oxidase 2,HAO2,51179,ENSG00000116882,NA,NA,Hao2 (MGI:96012)
1,119414930,119423038,1p13.1,1p12,613890,HSD3B2,"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 2 (adrenal, gonadal)",HSD3B2,3284,ENSG00000203859,NA,"Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive",Hsd3b1 (MGI:96233)
1,119507202,119515057,1p13.1,1p12,109715,HSD3B1,"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 1 (placental, peripheral)",HSD3B1,3283,ENSG00000203857,NA,NA,"Hsd3b6,Hsd3b3,Hsd3b2 (MGI:109598,MGI:96235,MGI:96234)"
1,119711933,119744217,1p12,1p12,606879,"PHGDH, NLS1, PHGDHD",Phosphoglycerate dehydrogenase,PHGDH,26227,ENSG00000092621,NA,"Neu-Laxova syndrome 1, 256520 (3), Autosomal recessive; Phosphoglycerate dehydrogenase deficiency, 601815 (3), Autosomal recessive",Phgdh (MGI:1355330)
1,119747995,119768931,1p13-p12,1p12,600234,HMGCS2,"3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2, mitochondrial",HMGCS2,3158,ENSG00000134240,NA,"HMG-CoA synthase-2 deficiency, 605911 (3), Autosomal recessive",Hmgcs2 (MGI:101939)
1,119794016,119811459,1p13.1-p12,1p12,609846,REG4,"Regenerating islet-derived family, member 4",REG4,83998,ENSG00000134193,NA,NA,Reg4 (MGI:1914959)
1,119833729,119844879,1p12,1p12,613997,NBPF7,"Neuroblastoma breakpoint family, member 7",NBPF7,343505,NA,NA,NA,NA
1,119893532,119896514,1p13-p11,1p12,604779,ADAM30,A disintegrin and metalloproteinase domain 30,ADAM30,11085,ENSG00000134249,NA,NA,Adam30 (MGI:1918328)
1,119911552,120069702,1p12,1p12,600275,"NOTCH2, AGS2, HJCYS","Notch, Drosophila, homolog  of, 2",NOTCH2,4853,ENSG00000134250,NA,"Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant",Notch2 (MGI:97364)
1,120150897,120176519,1q21.2-q21.3,1p12,604029,"SEC22L1, SEC22B","Secretion deficient 22, S. Cerevisiae, homolog-like 1",SEC22B,9554,ENSG00000265808,NA,NA,Sec22b (MGI:1338759)
1,120400000,123400000,1p11,NA,606190,MNRI,"Meningioma, radiation-induced",NA,117192,NA,NA,"Meningioma, radiation-induced, 606190 (2)",NA
1,120415026,120469669,1q21.1,1p11.2,613998,NBPF8,"Neuroblastoma breakpoint family, member 8",NBPF8,728841,NA,NA,NA,NA
1,120432203,120434108,1q21.1,1p11.2,608609,"C1orf152, COAS3",Chromosome 1 open reading frame 152,PFN1P2,767846,ENSG00000270392,NA,NA,NA
1,121087344,121097160,1p12,1p11.2,601502,FCGR1B,"Fc fragment of IgG, high affinity Ib, receptor for (CD64)",FCGR1B,2210,ENSG00000198019,NA,NA,NA
1,121167645,121184317,1p11,1p11.2,614711,FAM72B,"Family with sequence similarity 72, member B",FAM72B,653820,ENSG00000188610,NA,NA,NA
1,121184974,121392873,1p12,1p11.2,614704,SRGAP2C,SLIT-ROBO Rho GTPase-activating protein 2C,SRGAP2C,653464,ENSG00000171943,NA,NA,NA
1,123400000,248956422,1q,NA,151628,LRE2,LINE retrotransposable element-2,NA,NA,NA,inserted in DMD gene,NA,NA
1,125100000,173000000,1q12-q24,NA,605549,CORD8,Cone-rod dystrophy 8,CORD8,54109,NA,NA,"Cone-rod dystrophy 8, 605549 (2), Autosomal recessive",NA
1,125100000,155100000,1q12-q21.3,NA,612875,GNRHR2,Gonadotropin-releasing hormone receptor 2,GNRHR2,114814,ENSG00000211451,?processed pseudogene,NA,NA
1,125100000,156600000,1q12-q22,NA,189890,TRNL,tRNA asparagine-like,NA,NA,NA,NA,NA,NA
1,143200000,155100000,1q21,NA,611152,AD13,Alzheimer disease-13,NA,100188837,NA,max lod D1S498,"{Alzheimer disease-13}, 611152 (2)",NA
1,143200000,156600000,1q21-q22,NA,608781,ASPG3,"Asperger syndrome, susceptibility to, 3",NA,449015,NA,max lod at D1S484,"{Asperger syndrome susceptibility 3}, 608781 (2)",NA
1,143200000,165500000,1q21-q23,NA,605833,BMND2,Bone mineral density QTL 2,NA,338027,NA,NA,"[Bone mineral density QTL 2], 605833 (2)",NA
1,143200000,147500000,1q21.1,NA,612474,"DEL1q21, C1DELq21",Chromosome 1q21.1 deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 1q21.1 deletion syndrome, 612474 (4), Autosomal dominant, Isolated cases",NA
1,143200000,165500000,1q21-q23,NA,608372,DFNA49,"Deafness, autosomal dominant 49",DFNA49,317664,NA,max lod at D1S3784 and D1S3786,"Deafness, autosomal dominant 49, 608372 (2), Autosomal dominant",NA
1,143200000,165500000,1q21-q23,NA,601412,DFNA7,"Deafness, autosomal dominant 7",DFNA7,1689,NA,NA,"Deafness, autosomal dominant 7, 601412 (2), Autosomal dominant",NA
1,143200000,147500000,1q21.1,NA,612475,"DUP1q21, C1DUPq21",Chromosome 1q21.1 duplication syndrome,NA,NA,NA,contiguous gene duplication syndrome,"Chromosome 1q21.1 duplication syndrome, 612475 (4), Autosomal dominant, Isolated cases",NA
1,143200000,165500000,1q21-q23,NA,614013,"ERVK-7, HERV-KIII, HERV-K102","Endogenous retrovirus group K, member 7",ERVK-7,449619,NA,NA,NA,NA
1,143200000,147500000,1q21.1,NA,613017,NBLST6,"Neuroblastoma, susceptibility to, 6",NA,100306939,NA,?contiguous gene deletion or duplication disease,"{Neuroblastoma, susceptibility to, 6}, 613017 (2)",NA
1,143200000,147500000,1q21.1,NA,612970,"NBPF17P, NBPF23","Neuroblastoma breakpoint family, member 17, pseudogene",NBPF17P,401967,NA,NA,NA,NA
1,143200000,155100000,1q21,NA,603935,PSORS4,Psoriasis susceptibility 4,PSORS4,10547,NA,NA,"{Psoriasis susceptibility 4}, 603935 (2)",NA
1,143200000,155100000,1q21,NA,605642,"PTCPRN, PRN1",Papillary thyroid carcinoma with papillary renal neoplasia,NA,79052,NA,NA,"Thyroid carcinoma, papillary, with papillary renal neoplasia, 605642 (2)",NA
1,143200000,155100000,1q21,NA,161900,"RFH1, AORF","Renal failure, progressive, with hypertension",NA,59331,NA,NA,"Nephropathy-hypertension, 161900 (2), Autosomal dominant",NA
1,143200000,165500000,1q21-q23,NA,613145,SLEB14,"Systemic lupus erythematosus, susceptibility to, 14",NA,100322878,NA,associated with rs3093061,"{Systemic lupus erythematosus, susceptibility to, 14}, 613145 (2)",NA
1,143200000,156600000,1q21-q22,NA,182269,SPRR2C,Small proline-rich protein 2C,SPRR2C,6702,NA,prob. pseudogene,NA,NA
1,143200000,147500000,1q21.1,NA,614747,UAQTL6,"Uric acid concentration, serum, quantitative trait locus 6",NA,100996935,NA,associated with C/T variant at chr1_142697422,"[Uric acid concentration, serum, QTL6], 614747 (2)",NA
1,143874742,143883732,1q21,1q21.1,601503,FCGR1C,"Fc fragment of IgG, high affinity Ic, receptor for (CD64)",FCGR1CP,100132417,ENSG00000265531,NA,NA,NA
1,143955363,143973518,1q21.2,1q21.1,616853,FAM72C,"Family with sequence similarity 72, member C",FAM72C,554282,ENSG00000263513,NA,NA,NA
1,143972638,144069703,1q21.1,1q21.1,614705,SRGAP2D,SLIT-ROBO Rho GTPase-activating protein 2D,SRGAP2D,100996712,NA,NA,NA,NA
1,144372874,144373658,1q21.1,1q21.1,608608,"PPIAL4A, COAS2",Peptidylprolyl isomerase A (cyclophilin A)-like 4A,PPIAL4E,730262,ENSG00000271567,NA,NA,NA
1,144421385,144459463,1q21.1,1q21.1,610414,"NBPF15, MGC8902","Neuroblastoma breakpoint family, member 15",NBPF15,284565,ENSG00000266338,contains 6 copies of DUF1220 domain,NA,NA
1,144421385,144459463,1q21.1,1q21.1,614005,NBPF16,"Neuroblastoma breakpoint family, member 16",NBPF15,284565,ENSG00000266338,NA,NA,NA
1,144887190,145095320,1q21.1,1q21.1,614703,SRGAP2B,SLIT-ROBO Rho GTPase-activating protein 2B,SRGAP2B,647135,ENSG00000196369,NA,NA,NA
1,145093804,145112695,1p21,1q21.1,614712,FAM72D,"Family with sequence similarity 72, member D",FAM72D,728833,ENSG00000215784,NA,NA,NA
1,145287765,145287838,1p36.1,1q21.1,189880,"TRNAN1, TRN1, TRN",tRNA asparagine,TRN-GTT2-1,7214,NA,NA,NA,NA
1,145289899,145405777,1q21.1,1q21.1,614007,NBPF20,"Neuroblastoma breakpoint family, member 20",NBPF20,100288142,ENSG00000162825,NA,NA,NA
1,145607959,145670976,1q21.1,1q21.1,612821,GPR89A,G protein-coupled receptor 89A,GPR89A,653519,ENSG00000117262,NA,NA,Gpr89 (MGI:1914799)
1,145670851,145708200,1q21,1q21.1,603831,PDZK1,PDZ domain-containing 1,PDZK1,5174,ENSG00000174827,NA,NA,Pdzk1 (MGI:1928901)
1,145719311,145739287,1q21.1,1q21.1,604463,"CD160, BY55",CD160 antigen,CD160,11126,ENSG00000117281,NA,NA,Cd160 (MGI:1860383)
1,145823182,145844401,1q21.1,1q21.1,617454,"POLR3C, RPC62, RPC3","Polymerase III, RNA, subunit C",POLR3C,10623,ENSG00000186141,NA,NA,Polr3c (MGI:1921664)
1,145848521,145859080,1q21,1q21.1,605987,PIAS3,Protein inhibitor of activated STAT3,PIAS3,10401,ENSG00000131788,NA,NA,Pias3 (MGI:1913126)
1,145891207,145910188,1q21.1,1q21.1,604042,ITGA10,"Integrin, alpha-10",ITGA10,8515,ENSG00000143127,NA,NA,Itga10 (MGI:2153482)
1,145911347,145918923,1q21.1,1q21.1,603867,"PEX11B, PEX14B",Peroxisome biogenesis 11B,PEX11B,8799,ENSG00000131779,mutation identified in 1 PEX14B patient,"?Peroxisome biogenesis disorder 14B, 614920 (3), Autosomal recessive",Pex11b (MGI:1338882)
1,145921555,145927535,1q12,1q21.1,605313,"RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1",RNA-binding motif protein 8A,RBM8A,9939,ENSG00000265241,pseudogene on chr.14,"Thrombocytopenia-absent radius syndrome, 274000 (3), Autosomal recessive",Rbm8a (MGI:1913129)
1,145959036,145978847,1q21.1,1q21.1,617457,POLR3GL,"Polymerase III, RNA, subunit G-like",POLR3GL,84265,ENSG00000121851,NA,NA,Polr3gl (MGI:1917120)
1,145992434,145996578,1q21,1q21.1,606599,"TXNIP, VDUP1",Thioredoxin-interacting protein,TXNIP,10628,ENSG00000265972,NA,NA,Txnip (MGI:1889549)
1,146017467,146021821,1q21,1q21.1,608374,"HJV, HFE2A",Hemojuvelin,HJV,148738,ENSG00000168509,between D1S442 and D1S2347,"Hemochromatosis, type 2A, 602390 (3), Autosomal recessive",Hjv (MGI:1916835)
1,146064698,146144803,1q21.1,1q21.1,614000,NBPF10,"Neuroblastoma breakpoint family, member 10",NBPF10,100132406,ENSG00000271425,NA,NA,NA
1,146151907,146229031,1q21.1,1q21.1,618023,NOTCH2NLA,NOTCH2 N-terminal-like protein A,NOTCH2NLA,388677,ENSG00000264343,NA,NA,NA
1,146486331,146822033,1q21.1,1q21.1,610813,"HYDIN2, KIAA1864","Hydin, mouse, homolog of, 2",HYDIN2,100288805,NA,duplicated copy 16q22.2,NA,NA
1,146938544,146996092,1q21.1,1q21.1,608607,"NBPF12, COAS1, KIAA1245","Neuroblastoma breakpoint family, member 12",NBPF12,149013,ENSG00000268043,NA,NA,NA
1,147155105,147173365,1q21.1,1q21.1,602741,PRKAB2,"Protein kinase, AMP-activated, noncatalytic, beta-2",PRKAB2,5565,ENSG00000131791,NA,NA,Prkab2 (MGI:1336185)
1,147172746,147295765,1q21,1q21.1,613039,"CHD1L, ALC1",Chromodomain helicase DNA-binding protein 1-like,CHD1L,9557,ENSG00000131778,NA,NA,Chd1l (MGI:1915308)
1,147183962,147225797,1q21.1,1q21.1,603957,FMO5,Flavin-containing monooxygenase 5,FMO5,2330,ENSG00000131781,NA,NA,Fmo5 (MGI:1310004)
1,147541500,147626216,1q21,1q21.2,602597,BCL9,B-cell CLL/lymphoma-9,BCL9,607,ENSG00000116128,NA,NA,Bcl9 (MGI:1924828)
1,147626181,147670542,1q21,1q21.2,611471,"ACP6, LPAP, ACPL1","Acid phosphatase 6, lysophosphatide",ACP6,51205,ENSG00000162836,NA,NA,Acp6 (MGI:1931010)
1,147756198,147781126,1q21.2,1q21.2,121013,"GJA5, CX40, ATFB11","Gap junction protein, alpha-5, 40kD (connexin 40)",GJA5,2702,ENSG00000265107,NA,"Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant",Gja5 (MGI:95716)
1,147902794,147915286,1q21.1,1q21.2,600897,"GJA8, CX50, CTRCT1, CZP1, CAE1",Gap junction membrane channel protein alpha-8 (connexin 50),GJA8,2703,ENSG00000121634,NA,"Cataract 1, multiple types, 116200 (3), Autosomal dominant",Gja8 (MGI:99953)
1,147928373,147993591,1q21.1,1q21.2,612806,"GPR89B, GPHR",G protein-coupled receptor 89B,GPR89B,51463,ENSG00000188092,NA,NA,Gpr89 (MGI:1914799)
1,148102045,148152280,1q21.1,1q21.2,614001,NBPF11,"Neuroblastoma breakpoint family, member 11",NBPF11,200030,ENSG00000263956,NA,NA,NA
1,148531384,148595716,1q21.1,1q21.2,614003,NBPF14,"Neuroblastoma breakpoint, member 14",NBPF14,25832,ENSG00000270629,NA,NA,NA
1,148595665,148712498,1q21.1,1q21.2,618024,NOTCH2NLB,NOTCH2 N-terminal-like protein B,NOTCH2NLB,100996763,ENSG00000286019,NA,NA,NA
1,148808180,149051276,1q21.1,1q21.2,608117,"PDE4DIP, MMGL, KIAA0454, KIAA0477",Phosphodiesterase 4D-interacting protein,PDE4DIP,9659,ENSG00000178104,NA,NA,Pde4dip (MGI:1891434)
1,149054032,149082310,1q21.1,1q21.2,613999,NBPF9,"Neuroblastoma breakpoint family, member 9",NBPF9,400818,ENSG00000269713,NA,NA,NA
1,149390637,149465302,1q21.1,1q21.2,618025,NOTCH2NLC,NOTCH2 N-terminal-like protein C,NOTCH2NLC,100996717,ENSG00000286219,NA,NA,NA
1,149475897,149556360,1q21.1,1q21.2,614006,NBPF19,"Neuroblastoma breakpoint family, member 19",NBPF19,101060226,ENSG00000271383,NA,NA,NA
1,149782070,149792517,1q21.2-q21.3,1q21.2,146760,"FCGR1A, IGFR1, CD64","Fc fragment of IgG, high affinity Ia, receptor for (CD64)",FCGR1A,2209,ENSG00000150337,NA,"[IgG receptor I, phagocytic, familial deficiency of] (3)",Fcgr1 (MGI:95498)
1,149832656,149833051,1q21,1q21.2,142750,"H4FN, H4F2","H4 histone, family 2",HIST2H4A,8370,ENSG00000270882,"100-200 histone genes; some on chromosome 6 and 12, as well as perhaps 7",NA,Hist1h4b (MGI:2448420)
1,149840686,149841192,1q21,1q21.2,142780,"HIST2H3C, H3F2","Histone 2, H3c",HIST2H3C,126961,ENSG00000203811,NA,NA,H3f3c (MGI:3650546)
1,149842217,149842750,1q21,1q21.2,142720,"HIST2H2AA, H2AFO, H2A","Histone 2, H2aa",HIST2H2AA3,8337,ENSG00000203812,NA,NA,"Hist2h2aa1,Hist2h2aa2 (MGI:96097,MGI:2448283)"
1,149884459,149886681,1q21-q23,1q21.2,601831,"HIST2H2BE, H2B","Histone 2, H2be",HIST2H2BE,8349,ENSG00000184678,NA,NA,NA
1,149886974,149887410,1q21-q23,1q21.2,602797,"HIST2H2AC, H2AFQ","Histone 2, H2ac",HIST2H2AC,8338,ENSG00000184260,NA,NA,Hist2h2ac (MGI:2448316)
1,149887468,149887915,1q21,1q21.2,615014,"HIST2H2AB, H2AB","Histone gene cluster 2, H2A histone family, member B",HIST2H2AB,317772,ENSG00000184270,NA,NA,Hist2h2ab (MGI:2448314)
1,149899567,149900794,1q21.2,1q21.2,613181,BOLA1,"BolA, E. coli, homolog of, 1",BOLA1,51027,ENSG00000178096,NA,NA,Bola1 (MGI:1916418)
1,149903317,149917843,1q21.2,1q21.2,185860,"SV2A, SV2",Synaptic vesicle glycoprotein 2A,SV2A,9900,ENSG00000159164,NA,NA,Sv2a (MGI:1927139)
1,149923316,149927802,1q21.2,1q21.2,605593,"SF3B4, SF3B49, SAP49, AFD1","Splicing factor 3B, subunit 4",SF3B4,10262,ENSG00000143368,NA,"Acrofacial dysostosis 1, Nager type, 154400 (3), Autosomal dominant",Sf3b4 (MGI:109580)
1,149937811,150010775,1q21.2,1q21.2,611748,"OTUD7B, CEZANNE",OTU domain-containing protein 7B,OTUD7B,56957,ENSG00000264522,NA,NA,Otud7b (MGI:2654703)
1,150067278,150145328,1q21-q22,1q21.2,610035,"VPS45A, VPS45, SCN5","Vacuolar protein sorting 45, yeast, homolog of, A",VPS45,11311,ENSG00000136631,NA,"Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3), Autosomal recessive",Vps45 (MGI:891965)
1,150149433,150160064,1q21.2,1q21.2,608335,"PLEKHO1, CKIP1","Pleckstrin homology domain-containing protein, family O, member 1",PLEKHO1,51177,ENSG00000023902,NA,NA,Plekho1 (MGI:1914470)
1,150218416,150236132,1q22,1q21.2,609611,"ANP32E, LANPL","Acidic leucine-rich nuclear phosphoprotein 32 family, member E",ANP32E,81611,ENSG00000143401,NA,NA,NA
1,150257257,150265861,1q21,1q21.2,604832,CA14,Carbonic anhydrase XIV,CA14,23632,ENSG00000118298,NA,NA,Car14 (MGI:1344341)
1,150265398,150282178,1p36.13-q31.3,1q21.2,607629,APH1A,"Anterior pharynx defective 1, C. elegans, homolog of, A",APH1A,51107,ENSG00000117362,NA,NA,Aph1a (MGI:2385110)
1,150282553,150287092,1q21.2,1q21.2,615782,"CIART, CHRONO, GM129",Circadian-associated repressor of transcription,CIART,148523,ENSG00000159208,NA,NA,Ciart (MGI:2684975)
1,150293841,150308978,1q21,1q21.2,611984,MRPS21,Mitochondrial ribosomal protein S21,MRPS21,54460,ENSG00000266472,9 pseudogenes,NA,Mrps21 (MGI:1913542)
1,150321467,150353232,1q21.2,1q21.2,607301,"PRPF3, HPRP3, RP18","Precursor mRNA-processing factor 3, S. cerevisiae, homolog of",PRPF3,9129,ENSG00000117360,NA,"Retinitis pigmentosa 18, 601414 (3), Autosomal dominant",Prpf3 (MGI:1918017)
1,150364110,150476565,1q21.3,1q21.2,614695,RPRD2,Regulation of nuclear pre-mRNA domain-containing 2,RPRD2,23248,ENSG00000163125,NA,NA,Rprd2 (MGI:1922387)
1,150487363,150507608,1q21.2,1q21.2,612805,"TARS2, COXPD21",Threonyl-tRNA synthetase 2,TARS2,80222,ENSG00000143374,mutation identified in one COXPD21 family,"?Combined oxidative phosphorylation deficiency 21, 615918 (3), Autosomal recessive",Tars2 (MGI:1919057)
1,150508108,150513788,1q21,1q21.2,602201,"ECM1, URBWD",Extracellular matrix protein-1,ECM1,1893,ENSG00000143369,NA,"Urbach-Wiethe disease, 247100 (3), Autosomal recessive",Ecm1 (MGI:103060)
1,150515756,150518031,1q21.2,1q21.2,616092,"FALEC, FAL1",Focally amplified long noncoding RNA in epithelial cancer,FALEC,100874054,ENSG00000228126,NA,NA,NA
1,150549368,150560936,1q21,1q21.2,610113,"ADAMTSL4, TSRC1, ECTOL2",ADAMTS-like 4,ADAMTSL4,54507,ENSG00000143382,NA,"Ectopia lentis et pupillae, 225200 (3), Autosomal recessive; Ectopia lentis, isolated, autosomal recessive, 225100 (3), Autosomal recessive",Adamtsl4 (MGI:2389008)
1,150574550,150579737,1q21,1q21.2,159552,MCL1,Myeloid cell leukemia sequence 1 (BCL2-related),MCL1,4170,ENSG00000143384,NA,NA,Mcl1 (MGI:101769)
1,150600000,155100000,1q21.3,NA,139450,HRM2,Hair morphology 2 (curly hair),NA,100379199,NA,associated with rs11803731,"Hair, curly, 139450 (2), Autosomal dominant",NA
1,150621245,150629621,1q21.2,1q21.3,603061,ENSA,"Endosulfine, alpha",ENSA,2029,ENSG00000143420,NA,NA,Ensa (MGI:1891189)
1,150646229,150697153,1q21.2,1q21.3,612208,"GOLPH3L, GPP34R",Golgi phosphoprotein 3-like,GOLPH3L,55204,ENSG00000143457,NA,NA,Golph3l (MGI:1917129)
1,150698059,150720909,1q21.3,1q21.3,609824,"HORMAD1, NOHMA",HORMA domain-containing 1,HORMAD1,84072,ENSG00000143452,NA,NA,Hormad1 (MGI:1915231)
1,150730187,150765777,1q21,1q21.3,116845,CTSS,Cathepsin S,CTSS,1520,ENSG00000163131,NA,NA,Ctss (MGI:107341)
1,150796207,150808259,1q21,1q21.3,601105,CTSK,Cathepsin K,CTSK,1513,ENSG00000143387,NA,"Pycnodysostosis, 265800 (3), Autosomal recessive",Ctsk (MGI:107823)
1,150809712,150876736,1q21,1q21.3,126110,ARNT,Aryl hydrocarbon receptor nuclear translocator,ARNT,405,ENSG00000143437,NA,NA,Arnt (MGI:88071)
1,150926262,150964736,1q21,1q21.3,604396,SETDB1,"SET domain protein, bifurcated, 1",SETDB1,9869,ENSG00000143379,NA,NA,Setdb1 (MGI:1934229)
1,150965172,150975002,1q21.3,1q21.3,606920,"CERS2, LASS2",Ceramide synthase 2,CERS2,29956,ENSG00000143418,NA,NA,Cers2 (MGI:1924143)
1,150982285,150996062,1q21,1q21.3,603319,"ANXA9, ANX31",Annexin A9 (annexin XXXI),ANXA9,8416,ENSG00000143412,NA,NA,Anxa9 (MGI:1923711)
1,150996535,151008392,1q21.3,1q21.3,618407,"MINDY1, FAM63A",MINDY lysine-48 deubiquitinase 1,MINDY1,55793,ENSG00000143409,NA,NA,Mindy1 (MGI:1922257)
1,151008390,151035712,1q21.3,1q21.3,617413,"PRUNE1, DRES17, NMIHBA",Prune exopolyphosphatase 1,PRUNE1,58497,ENSG00000143363,NA,"Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3), Autosomal recessive",Prune1 (MGI:1925152)
1,151036320,151047719,1q21.3,1q21.3,611275,"BNIPL, BNIPS, BNIPL1, BNIPL2",BCL2/adenovirus E1B 19kD protein-interacting protein 2-like,BNIPL,149428,ENSG00000163141,NA,NA,Bnipl (MGI:2384749)
1,151059674,151068496,1q21,1q21.3,604684,"MLLT11, AF1Q","Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 11",MLLT11,10962,ENSG00000213190,NA,NA,Mllt11 (MGI:1929671)
1,151131684,151148407,1q21.3,1q21.3,609294,"SEMA6C, KIAA1869",Semaphorin 6C,SEMA6C,10500,ENSG00000143434,NA,NA,Sema6c (MGI:1338032)
1,151156648,151159748,1q21.2-q21.3,1q21.3,612112,"TNFAIP8L2, TIPE2",Tumor necrosis factor-alpha-induced protein 8-like 2,TNFAIP8L2,79626,ENSG00000163154,NA,NA,Tnfaip8l2 (MGI:1917019)
1,151166021,151170296,1q21.3,1q21.3,608095,"SCNM1, MGC3180",Sodium channel modifier 1,SCNM1,79005,ENSG00000163156,NA,NA,Scnm1 (MGI:1341284)
1,151169985,151175980,1q12,1q21.3,605834,TMOD4,"Tropomodulin 4, muscle",TMOD4,29765,ENSG00000163157,NA,NA,Tmod4 (MGI:1355285)
1,151176303,151190209,1q21,1q21.3,600607,"VPS72, CFL1, YL1","Vacuolar protein sorting 72, yeast, homolog of",VPS72,6944,ENSG00000163159,NA,NA,Vps72 (MGI:1202305)
1,151197953,151249535,1q22-q24,1q21.3,603275,PIP5K1A,"Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha",PIP5K1A,8394,ENSG00000143398,NA,NA,Pip5k1a (MGI:107929)
1,151254733,151267459,1q21.3,1q21.3,601648,"PSMD4, S5A, RPN10","Proteasome 26S subunit, non-ATPase, 4",PSMD4,5710,ENSG00000159352,NA,NA,Psmd4 (MGI:1201670)
1,151281521,151292175,1q21.2,1q21.3,610568,"ZNF687, KIAA1441, PDB6",Zinc finger protein 687,ZNF687,57592,ENSG00000143373,fused with AML1 in t(1;21),"Paget disease of bone 6, 616833 (3), Autosomal dominant",Zfp687 (MGI:1925516)
1,151291796,151327714,1q21.1-q21.3,1q21.3,602758,PIK4CB,"Phosphatidylinositol 4-kinase, catalytic, beta polypeptide",PI4KB,5298,ENSG00000143393,NA,NA,Pi4kb (MGI:1334433)
1,151340639,151347318,1q21.1-q21.3,1q21.3,601863,RFX5,"Regulatory factor X, 5 (influences HLA class II expression)",RFX5,5993,ENSG00000143390,NA,"Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive",NA
1,151364303,151372724,1q21-q22,1q21.3,604188,"SELENBP1, SP56, EHMTO",Selenium-binding protein 1,SELENBP1,8991,ENSG00000143416,NA,"Extraoral halitosis due to MTO deficiency, 618148 (3), Autosomal recessive","Selenbp2,Selenbp1 (MGI:96825,MGI:104859)"
1,151399572,151401936,1q21,1q21.3,602177,"PSMB4, PRAAS3","Proteasome subunit, beta type, 4",PSMB4,5692,ENSG00000159377,mutation identified in 1 PRAAS3 patient and 1 digenic family,"?Proteasome-associated autoinflammatory syndrome 3 and digenic forms, 617591 (3), Autosomal recessive",Psmb4 (MGI:1098257)
1,151402723,151459493,1q21.3,1q21.3,614787,"POGZ, KIAA0461, MRD37, WHSUS",POGO transposable element with ZNF domain,POGZ,23126,ENSG00000143442,NA,"White-Sutton syndrome, 616364 (3), Autosomal dominant",Pogz (MGI:2442117)
1,151540293,151583582,1q21,1q21.3,600087,TUFT1,Tuftelin 1,TUFT1,7286,ENSG00000143367,?mutant in amelogenesis imperfecta,NA,Tuft1 (MGI:109572)
1,151612026,151699079,1q21.3,1q21.3,611541,"SNX27, MRT1",Sorting nexin 27,SNX27,81609,ENSG00000143376,NA,NA,Snx27 (MGI:1923992)
1,151696651,151716820,1q21,1q21.3,612678,"CELF3, TNRC4, BRUNOL1","CUGbp- and ELAV-like family, member 3",CELF3,11189,ENSG00000159409,NA,NA,Celf3 (MGI:1926034)
1,151759642,151763915,1q21,1q21.3,611824,MRPL9,Mitochondrial ribosomal protein L9,MRPL9,65005,ENSG00000143436,NA,NA,Mrpl9 (MGI:2137211)
1,151762968,151771329,1q21.3,1q21.3,605138,"OAZ3, AZ3",Ornithine decarboxylase antizyme 3,OAZ3,51686,ENSG00000143450,NA,NA,Oaz3 (MGI:1858170)
1,151800263,151805441,1q21.3,1q21.3,609794,"LINGO4, LRRN6D",Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 4,LINGO4,339398,ENSG00000213171,NA,NA,Lingo4 (MGI:2444651)
1,151806070,151832450,1q21,1q21.3,602943,"RORC, RORG, RZRG, IMD42",RAR-related orphan receptor C,RORC,6097,ENSG00000143365,NA,"Immunodeficiency 42, 616622 (3), Autosomal recessive",Rorc (MGI:104856)
1,151847100,151853711,1q21.3,1q21.3,615653,"THEM5, ACOT15",Thioesterase superfamily member 5,THEM5,284486,ENSG00000196407,NA,NA,Them5 (MGI:1913448)
1,151870865,151909510,1q21,1q21.3,606388,CTMP,C-terminal modulator protein,THEM4,117145,ENSG00000159445,NA,NA,Them4 (MGI:1923028)
1,151982914,151993858,1q21,1q21.3,114085,"S100A10, CAL1L","S100 calcium-binding protein A10 (annexin II ligand, calpactin I, light polypeptide (p11))",S100A10,6281,ENSG00000197747,on chr.3 in mouse,NA,S100a10 (MGI:1339468)
1,152032505,152037003,1q21,1q21.3,603114,S100A11,S100 calcium-binding protein A11,S100A11,6282,ENSG00000163191,NA,NA,S100a11-ps (MGI:3645720)
1,152106316,152115453,1q21.3,1q21.3,190370,"TCHH, THH, THL, TRHY, UHS3",Trichohyalin,TCHH,7062,ENSG00000159450,mutation identified in 1 UHS3 patient,"?Uncombable hair syndrome 3, 617252 (3), Autosomal recessive",NA
1,152153594,152159227,1q21,1q21.3,613259,RPTN,Repetin,RPTN,126638,ENSG00000215853,NA,NA,Rptn (MGI:1099055)
1,152212075,152224195,1q21.3,1q21.3,616293,HRNR,Hornerin,HRNR,388697,ENSG00000197915,NA,NA,NA
1,152302174,152325202,1q21,1q21.3,135940,"FLG, ATOD2",Filaggrin,FLG,2312,ENSG00000143631,NA,"{Dermatitis, atopic, susceptibility to, 2}, 605803 (3); Ichthyosis vulgaris, 146700 (3), Autosomal dominant",NA
1,152348734,152360027,1q21.3,1q21.3,616284,"FLG2, IFPS, PSS6","Filaggrin family, member 2",FLG2,388698,ENSG00000143520,NA,"Peeling skin syndrome 6, 618084 (3), Autosomal recessive",NA
1,152510802,152512176,1q21,1q21.3,612619,"LCE5A, LEP18",Late cornified envelope protein 5A,LCE5A,254910,ENSG00000186207,NA,NA,NA
1,152514481,152516009,1q21.3,1q21.3,617426,"CRCT1, NICE1, C1orf42",Cysteine-rich c-terminal 1,CRCT1,54544,ENSG00000169509,NA,NA,NA
1,152565653,152566779,1q21,1q21.3,612617,"LCE3E, LEP17",Late cornified envelope protein 3E,LCE3E,353145,ENSG00000185966,NA,NA,NA
1,152579380,152580515,1q21,1q21.3,612616,"LCE3D, LEP16",Late cornified envelope protein 3D,LCE3D,84648,ENSG00000163202,within intron 2 of LCE3C,NA,NA
1,152600661,152601085,1q21,1q21.3,612615,"LCE3C, LEP15",Late cornified envelope protein 3C,LCE3C,353144,ENSG00000244057,NA,NA,NA
1,152613810,152614097,1q21,1q21.3,612614,"LCE3B, LEP14",Late cornified envelope protein 3B,LCE3B,353143,ENSG00000187238,NA,NA,NA
1,152622833,152623102,1q21,1q21.3,612613,"LCE3A, LEP13",Late cornified envelope protein 3A,LCE3A,353142,ENSG00000185962,NA,NA,NA
1,152663379,152664658,1q21,1q21.3,612612,"LCE2D, LEP12",Late cornified envelope protein 2D,LCE2D,353141,ENSG00000187223,NA,NA,NA
1,152675314,152676573,1q21,1q21.3,612611,"LCE2C, LEP11",Late cornified envelope protein 2C,LCE2C,353140,ENSG00000187180,NA,NA,NA
1,152686122,152687396,1q21,1q21.3,612610,"LCE2B, LEP10, XP5",Late cornified envelope protein 2B,LCE2B,26239,ENSG00000159455,NA,NA,NA
1,152698344,152699441,1q21,1q21.3,612609,"LCE2A, LEP9",Late cornified envelope protein 2A,LCE2A,353139,ENSG00000187173,NA,NA,NA
1,152709046,152709433,1q21,1q21.3,612618,"LCE4A, LEP8",Late cornified envelope protein 4A,LCE4A,199834,ENSG00000187170,NA,NA,NA
1,152758024,152762052,1q21,1q21.3,613260,KPRP,Keratinocyte proline-rich protein,KPRP,448834,ENSG00000203786,NA,NA,Kprp (MGI:1920981)
1,152776371,152776968,1q21,1q21.3,612608,"LCE1F, LEP6",Late cornified envelope protein 1F,LCE1F,353137,ENSG00000240386,NA,NA,NA
1,152786256,152788425,1q21,1q21.3,612607,LCE1E,Late cornified envelope protein 1E,LCE1E,353135,ENSG00000186226,NA,NA,NA
1,152796720,152798180,1q21,1q21.3,612606,"LCE1D, LEP4",Late cornified envelope protein 1D,LCE1D,353134,ENSG00000172155,NA,NA,NA
1,152804831,152806650,1q21,1q21.3,612605,"LCE1C, LEP3",Late cornified envelope 1C,LCE1C,353133,ENSG00000197084,NA,NA,NA
1,152811970,152813107,1q21,1q21.3,612604,"LCE1B, LEP2",Late cornified envelope protein 1B,LCE1B,353132,ENSG00000196734,NA,NA,NA
1,152827472,152828096,1q21,1q21.3,612603,"LCE1A, LEP1",Late cornified envelope protein 1A,LCE1A,353131,ENSG00000186844,NA,NA,NA
1,152878321,152885046,1q21,1q21.3,601148,"SMCP, MCSP, MCS",Sperm mitochondria-associated cysteine-rich protein,SMCP,4184,ENSG00000163206,NA,NA,NA
1,152908544,152911885,1q21,1q21.3,147360,IVL,Involucrin,IVL,3713,ENSG00000163207,NA,NA,NA
1,152968754,152972601,1q21,1q21.3,616363,SPRR4,Small proline-rich protein 4,SPRR4,163778,ENSG00000184148,NA,NA,NA
1,152984080,152985813,1q21-q22,1q21.3,182265,SPRR1A,Small proline-rich protein 1A,SPRR1A,6698,ENSG00000169474,NA,NA,Sprr1a (MGI:106660)
1,153001746,153003855,1q21-q22,1q21.3,182271,SPRR3,Small proline-rich protein 3,SPRR3,6707,ENSG00000163209,NA,NA,Sprr3 (MGI:1330237)
1,153031202,153032899,1q21-q22,1q21.3,182266,SPRR1B,Small proline-rich protein 1B,SPRR1B,6699,ENSG00000169469,NA,NA,NA
1,153039729,153041143,1q21.3,1q21.3,617587,SPRR2D,Small proline-rich protein 2D,SPRR2D,6703,ENSG00000163216,NA,NA,NA
1,153056119,153057511,1q21-q22,1q21.3,182267,SPRR2A,Small proline-rich protein 2A,SPRR2A,6700,ENSG00000241794,about 7 SPRR2 genes,NA,NA
1,153070225,153071610,1q21-q22,1q21.3,182268,SPRR2B,Small proline-rich protein 2B,SPRR2B,6701,ENSG00000196805,NA,NA,NA
1,153093134,153094525,1q21.3,1q21.3,617588,SPRR2E,Small proline-rich protein 2E,SPRR2E,6704,ENSG00000203785,NA,NA,NA
1,153112120,153119459,1q21.3,1q21.3,617589,SPRR2F,Small proline-rich protein 2F,SPRR2F,6705,ENSG00000244094,NA,NA,NA
1,153149581,153195376,1q21.3,1q21.3,617590,SPRR2G,Small proline-rich protein 2G,SPRR2G,6706,ENSG00000159516,NA,NA,NA
1,153203429,153205119,1q21,1q21.3,611042,LELP1,Late cornified envelope-like proline-rich 1,LELP1,149018,ENSG00000203784,NA,NA,NA
1,153259634,153262124,1q21,1q21.3,152445,LOR,Loricrin,LOR,4014,ENSG00000203782,NA,"Vohwinkel syndrome with ichthyosis, 604117 (3), Autosomal dominant",NA
1,153297588,153312974,1q21,1q21.3,608197,PGRPIA,"Peptidoglycan recognition protein, intermediate, alpha",PGLYRP3,114771,ENSG00000159527,NA,NA,Pglyrp3 (MGI:2685266)
1,153327409,153348843,1q21,1q21.3,608198,PGRPIB,"Peptidoglycan recognition protein, intermediate, beta",PGLYRP4,57115,ENSG00000163218,NA,NA,Pglyrp4 (MGI:2686324)
1,153357853,153361022,1q12-q22,1q21.3,123886,"S100A9, CAGB, CFAG",S100 calcium-binding protein A9 (calgranulin B),S100A9,6280,ENSG00000163220,NA,NA,S100a9 (MGI:1338947)
1,153373710,153375620,1q21,1q21.3,603112,"S100A12, CAAF1, CGRP",S100 calcium-binding protein A12,S100A12,6283,ENSG00000163221,between S100A8 and S100A9,NA,NA
1,153390031,153422582,1q21,1q21.3,123885,"S100A8, CAGA, CFAG",S100 calcium-binding protein A8 (calgranulin A),S100A8,6279,ENSG00000143546,over-expressed in 1q21-linked psoriasis,NA,S100a8 (MGI:88244)
1,153416519,153423221,1q21.3,1q21.3,617427,"S100A7A, S100A15, NICE2",S100 calcium-binding protein A7A,S100A7A,338324,ENSG00000184330,NA,NA,NA
1,153457743,153460650,1q21,1q21.3,600353,S100A7,S100 calcium-binding protein A7,S100A7,6278,ENSG00000143556,NA,NA,NA
1,153534598,153536048,1q21,1q21.3,114110,"S100A6, CACY",S100 calcium-binding protein A6 (calcyclin),S100A6,6277,ENSG00000197956,NA,NA,S100a6 (MGI:1339467)
1,153537113,153543513,1q21,1q21.3,176991,"S100A5, S100D",S100 calcium-binding protein A5,S100A5,6276,ENSG00000196420,NA,NA,S100a5 (MGI:1338915)
1,153543620,153545805,1q21,1q21.3,114210,"S100A4, CAPL","S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)",S100A4,6275,ENSG00000196154,NA,NA,S100a4 (MGI:1330282)
1,153547328,153549257,1q21,1q21.3,176992,"S100A3, S100E",S100 calcium-binding protein A3,S100A3,6274,ENSG00000188015,NA,NA,S100a3 (MGI:1338849)
1,153561107,153565843,1q21,1q21.3,176993,"S100A2, S100L",S100 calcium-binding protein A2,S100A2,6273,ENSG00000196754,NA,NA,NA
1,153606882,153613136,1p21.3,1q21.3,617437,"S100A16, AAG13",S100 calcium-binding protein A16,S100A16,140576,ENSG00000188643,NA,NA,S100a16 (MGI:1915110)
1,153614254,153616916,1q21,1q21.3,607986,"S100A14, BCMP84",S100 Calcium-binding protein A14,S100A14,57402,ENSG00000189334,NA,NA,S100a14 (MGI:1913416)
1,153618798,153634360,1q21,1q21.3,601989,S100A13,S100 calcium-binding protein A13,S100A13,6284,ENSG00000189171,NA,NA,S100a13 (MGI:109581)
1,153628433,153632038,1q21,1q21.3,176940,S100A1,"S100 protein, alpha polypeptide",S100A1,6271,ENSG00000160678,NA,NA,S100a1 (MGI:1338917)
1,153633981,153646305,1q21.3,1q21.3,614206,"CHTOP, C10orf77, SRAG, FOP",Chromatin target of PRMT1,CHTOP,26097,ENSG00000160679,NA,NA,NA
1,153658653,153661851,1q22,1q21.3,607007,"SNAPIN, SNAPAP, BLOC1S7, BLOS7",SNAP-associated protein,SNAPIN,23557,ENSG00000143553,NA,NA,Snapin (MGI:1333745)
1,153678648,153693991,1q21-q22,1q21.3,108960,"NPR1, ANPRA",Natriuretic peptide receptor A/guanylate cyclase A,NPR1,4881,ENSG00000169418,NA,NA,Npr1 (MGI:97371)
1,153728049,153774807,1q21.3,1q21.3,611347,"INTS3, INT3, SOSSA",Integrator complex subunit 3,INTS3,65123,ENSG00000143624,NA,NA,Ints3 (MGI:2140050)
1,153775406,153780159,1q21.3,1q21.3,604193,"SLC27A3, FATP3","Solute carrier family 27 (fatty acid transporter), member 3",SLC27A3,11000,ENSG00000143554,NA,NA,Slc27a3 (MGI:1347358)
1,153804724,153923952,1q23.1,1q21.3,614998,"GATAD2B, KIAA1150, p68, MRD18",GATA zinc finger domain-containing protein 2B,GATAD2B,57459,ENSG00000143614,NA,"Mental retardation, autosomal dominant 18, 615074 (3), Autosomal dominant",Gatad2b (MGI:2443225)
1,153947674,153958642,1q21.3,1q21.3,608972,"CRTC2, TORC2",CREB-regulated transcription coactivator 2,CRTC2,200186,ENSG00000160741,NA,NA,Crtc2 (MGI:1921593)
1,153959098,153968183,1q21,1q21.3,604740,"SLC39A1, ZIRTL","Solute carrier family 39 (zinc transporter), member 3 (zinc/iron-regulated transporter-like)",SLC39A1,27173,ENSG00000143570,REc,NA,Slc39a1 (MGI:1353474)
1,153967486,153974363,1q21.3,1q21.3,607138,"CREB3L4, CREB4, AIBZIP",cAMP responsive element binding protein 3-like 4,CREB3L4,148327,ENSG00000143578,NA,NA,Creb3l4 (MGI:1916603)
1,153974268,153977673,1q21,1q21.3,604671,"JTB, PAR",Jumping translocation breakpoint,JTB,10899,ENSG00000143543,NA,NA,Jtb (MGI:1346082)
1,153981604,153990643,1q21.3,1q21.3,602672,RAB13,"RAB13, member RAS oncogene family",RAB13,5872,ENSG00000143545,previously assigned to 12q13 by in situ hybridization,NA,Rab13 (MGI:1927232)
1,153990754,153992154,1q21,1q21.3,603702,"RPS27, MPS1, DBA17",Ribosomal protein S27,RPS27,6232,ENSG00000177954,mutation identified in 1 DBA17 patient,"?Diamond-Blackfan anemia 17, 617409 (3), Autosomal dominant",NA
1,154155303,154192099,1q22-q23,1q21.3,191030,"TPM3, NEM1, CFTD, CAPM1",Tropomyosin 3,TPM3,7170,ENSG00000143549,TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by Fd,"CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant",Tpm3 (MGI:1890149)
1,154206719,154220796,1q21.3,1q21.3,617428,"C1orf43, NS5ATP4, NICE3",Chromosome 1 open reading frame 43,C1orf43,25912,ENSG00000143612,NA,NA,4933434E20Rik (MGI:1914027)
1,154220171,154271509,1q21.3,1q21.3,616472,"UBAP2L, NICE4",Ubiquitin-associated protein 2-like,UBAP2L,9898,ENSG00000143569,NA,NA,NA
1,154272562,154275874,1q21.3,1q21.3,605998,"HAX1, SCN3",HCLS1-associated protein X1,HAX1,10456,ENSG00000143575,NA,"Neutropenia, severe congenital 3, autosomal recessive, 610738 (3), Autosomal recessive",Hax1 (MGI:1346319)
1,154321058,154325324,1q21.3,1q21.3,606578,AQP10,Aquaporin 10,AQP10,89872,ENSG00000143595,NA,NA,NA
1,154325524,154351303,1q21.3,1q21.3,605867,"ATP8B2, ATPID","ATPase, class I, type 8B, member 2",ATP8B2,57198,ENSG00000143515,NA,NA,Atp8b2 (MGI:1859660)
1,154405192,154469449,1q21.3,1q21.3,147880,"IL6R, IL6RQ, IL6Q",Interleukin-6 receptor,IL6R,3570,ENSG00000160712,IL6R-like gene on chr.9,"[Interleukin 6, serum level of, QTL], 614752 (3); [Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3)",Il6ra (MGI:105304)
1,154467194,154502559,1q21.3,1q21.3,610482,SHE,SH2 domain-containing protein E,SHE,126669,ENSG00000169291,NA,NA,She (MGI:1099462)
1,154548576,154558661,1q21.3,1q21.3,617429,"UBE2Q1, GTAP, NICE5",Ubiquitin-conjugating enzyme E2Q family member 1,UBE2Q1,55585,ENSG00000160714,NA,NA,Ube2q1 (MGI:1917343)
1,154567777,154584707,1q21,1q21.3,118507,"CHRNB2, EFNL3","Cholinergic receptor, nicotinic, beta polypeptide-2",CHRNB2,1141,ENSG00000160716,linked to AMY in mouse,"Epilepsy, nocturnal frontal lobe, 3, 605375 (3)",Chrnb2 (MGI:87891)
1,154582056,154631559,1q21.3,1q21.3,146920,"ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6","Adenosine deaminase, RNA-specific",ADAR,103,ENSG00000160710,NA,"Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive; Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant",Adar (MGI:1889575)
1,154697454,154870280,1q21.3,1q21.3,602983,"KCNN3, SK3, SKCA3","Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 3",KCNN3,3782,ENSG00000143603,NA,NA,Kcnn3 (MGI:2153183)
1,154924739,154942657,1q21.3,1q21.3,607622,"PMVK, PMK, POROK1",Phosphomevalonate kinase,PMVK,10654,ENSG00000163344,NA,"Porokeratosis 1, multiple types, 175800 (3), Autosomal dominant",Pmvk (MGI:1915853)
1,154957025,154961781,1q21.3,1q21.3,606903,PYGO2,"Pygopus, Drosophila, homolog of, 2",PYGO2,90780,ENSG00000163348,NA,NA,Pygo2 (MGI:1916161)
1,154962297,154974491,1q21,1q21.3,600560,SHC1,SHC (Src homology 2 domain-containing) transforming protein-1,SHC1,6464,ENSG00000160691,NA,NA,Shc1 (MGI:98296)
1,154974641,154979250,1q21.3,1q21.3,116900,"CKS1B, CKS1",CDC28 protein kinase 1B,CKS1B,1163,ENSG00000173207,previously to 8q21 by FISH,NA,Cks1b (MGI:1889208)
1,154983343,154993110,1q21.3,1q21.3,610595,"FLAD1, FADS, LSMFLAD","Flavin adenine dinucleotide synthetase, S. cerevisiae, homolog of",FLAD1,80308,ENSG00000160688,NA,"Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3), Autosomal recessive",Flad1 (MGI:2443030)
1,154993585,154994320,1q22,1q21.3,607377,"LENEP, LEP503",Lens epithelial protein,LENEP,55891,ENSG00000163352,NA,NA,Lenep (MGI:1930020)
1,155002627,155018524,1q21.3,1q21.3,607646,"ZBTB7B, ZFP67, CKROX, THPOK",Zinc finger- and BTB domain-containing protein 7B,ZBTB7B,51043,ENSG00000160685,NA,NA,Zbtb7b (MGI:102755)
1,155051271,155062775,1q21.3,1q21.3,605548,"ADAM15, MDC15",A disintegrin and metalloproteinase domain 15,ADAM15,8751,ENSG00000143537,NA,NA,Adam15 (MGI:1333882)
1,155063739,155069552,1q21-q22,1q21.3,601380,"EFNA4, EPLG4",eph-related receptor tyrosine kinase ligand 4 (ephrin-A4),EFNA4,1945,ENSG00000243364,NA,NA,Efna4 (MGI:106643)
1,155078836,155087537,1q21-q22,1q21.3,601381,"EFNA3, EPLG3",eph-related receptor tyrosine kinase ligand 3 (ephrin A3),EFNA3,1944,ENSG00000143590,NA,NA,Efna3 (MGI:106644)
1,155127875,155134898,1q21-q22,1q22,191164,"EFNA1, EPLG1, TNFAIP4","eph-related receptor tyrosine kinase ligand 1 (tumor necrosis factor, alpha-induced protein 4)",EFNA1,1942,ENSG00000169242,NA,NA,Efna1 (MGI:103236)
1,155135374,155138857,1q22,1q22,613683,"SLC50A1, RAG1AP1","Solute carrier family 50 (sugar transporter), member 1",SLC50A1,55974,ENSG00000169241,NA,NA,Slc50a1 (MGI:107417)
1,155139890,155140572,1q12-q21,1q22,605951,"DPM3, CDG1O",Dolichyl-phosphate mannosyltransferase 3,DPM3,54344,ENSG00000179085,NA,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15, 612937 (3), Autosomal recessive",Dpm3 (MGI:1915813)
1,155173380,155184970,1q21,1q22,600986,GENEY,Gene Y,TRIM46,80128,ENSG00000163462,NA,NA,Trim46 (MGI:2673000)
1,155185823,155192914,1q21,1q22,158340,"MUC1, PUM, MCKD1","Mucin 1, transmembrane",MUC1,4582,ENSG00000185499,5cM proximal to SPTA1,"Medullary cystic kidney disease 1, 174000 (3), Autosomal dominant",NA
1,155195587,155209179,1q21,1q22,188062,"THBS3, TSP3",Thrombospondin 3,THBS3,7059,ENSG00000169231,NA,NA,Thbs3 (MGI:98739)
1,155208698,155213838,1q21,1q22,600605,"MTX1, MTXN",Metaxin 1,MTX1,4580,ENSG00000173171,between GBA and TSP3,NA,Mtx1 (MGI:103025)
1,155234451,155244626,1q21,1q22,606463,GBA,"Glucosidase, acid beta",GBA,2629,ENSG00000177628,pseudogene GBAP ~16kb 3' to GBA,"Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; {Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial",Gba (MGI:95665)
1,155255980,155262359,1q21,1q22,606913,"SCAMP3, PROPIN1",Secretory carrier membrane protein 3,SCAMP3,10067,ENSG00000116521,NA,NA,Scamp3 (MGI:1346346)
1,155262867,155273503,1p31,1q22,602989,CLK2,CDC-like kinase 2,CLK2,1196,ENSG00000176444,near GDLD and PRKAA2; conflicting assignment 1q21,NA,Clk2 (MGI:1098669)
1,155277426,155289847,1q22,1q22,609973,"HCN3, KIAA1535",Hyperpolarization-activated cyclic nucleotide-gated potassium channel 3,HCN3,57657,ENSG00000143630,NA,NA,Hcn3 (MGI:1298211)
1,155289292,155301437,1q21,1q22,609712,"PKLR, PK1","Pyruvate kinase, liver and RBC type",PKLR,5313,ENSG00000143627,NA,"Adenosine triphosphate, elevated, of erythrocytes, 102900 (3), Autosomal dominant; Pyruvate kinase deficiency, 266200 (3), Autosomal recessive",Pklr (MGI:97604)
1,155308747,155320665,1q22,1q22,134629,"FDPS, FPS, POROK9",Farnesyl diphosphate synthase,FDPS,2224,ENSG00000160752,NA,"Porokeratosis 9, multiple types, 616631 (3), Autosomal dominant",Fdps (MGI:104888)
1,155320893,155331117,1q22,1q22,617318,"RUSC1, NESCA",RUN domain- and SH3 domain-containing protein 1,RUSC1,23623,ENSG00000160753,NA,NA,Rusc1 (MGI:1919546)
1,155335262,155563159,1q22,1q22,607999,"ASH1L, KIAA1420, ASH1, MRD52","ash1 (absent, small, or homeotic), Drosophila, homolog of",ASH1L,55870,ENSG00000116539,NA,"Mental retardation, autosomal dominant 52, 617796 (3), Autosomal dominant",Ash1l (MGI:2183158)
1,155610169,155614966,1q22,1q22,617619,"MSTO1, MMYAT","Misato 1, mitochondrial distribution and morphology regulator",MSTO1,55154,ENSG00000125459,NA,"Myopathy, mitochondrial, and ataxia, 617675 (3), Autosomal recessive, Autosomal dominant",Msto1 (MGI:2385175)
1,155659441,155689031,1q22,1q22,607860,"YY1AP1, YAP, HCCA2, GRNG",YY1 associated protein 1,YY1AP1,55249,ENSG00000163374,NA,"Grange syndrome, 602531 (3), Autosomal recessive",NA
1,155687901,155739009,1q21,1q22,602074,DAP3,Death associated protein 3,DAP3,7818,ENSG00000132676,NA,NA,Dap3 (MGI:1929538)
1,155749657,155859425,1q22,1q22,610393,"GON4L, KIAA1606",GON4-like protein,GON4L,54856,ENSG00000116580,NA,NA,Gon4l (MGI:1917579)
1,155897807,155911348,1q22,1q22,609591,"RIT1, RIT, ROC1, NS8",Ric-like protein without CAAX motif 1,RIT1,6016,ENSG00000143622,NA,"Noonan syndrome 8, 615355 (3), Autosomal dominant",Rit1 (MGI:108053)
1,155941688,155942833,1q22,1q22,609043,"RXFP4, RLN3R2, GPR100, GPCR142",Relaxin/insulin-like family peptide receptor 4,RXFP4,339403,ENSG00000173080,NA,NA,Rxfp4 (MGI:2182926)
1,155946838,155991261,1q21-q22,1q22,607560,"ARHGEF2, GEFH1, KIAA0651, NEDMHM",RHO guanine nucleotide exchange factor 2,ARHGEF2,9181,ENSG00000116584,mutation identified in 1 NEDMHM family,"?Neurodevelopmental disorder with midbrain and hindbrain malformations, 617523 (3), Autosomal recessive",Arhgef2 (MGI:103264)
1,156009047,156020950,1q21-q23,1q22,600867,SSR2,"Signal sequence receptor, beta",SSR2,6746,ENSG00000163479,NA,NA,Ssr2 (MGI:1913506)
1,156033128,156053797,1q21,1q22,605440,"UBQLN4, A1U, C1orf6",Ubiquitin 4,UBQLN4,56893,ENSG00000160803,NA,NA,Ubqln4 (MGI:2150152)
1,156054725,156058509,1q22,1q22,610389,"LAMTOR2, MAPBPIP, p14","Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2",LAMTOR2,28956,ENSG00000116586,NA,"Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive",Lamtor2 (MGI:1932697)
1,156061148,156070513,1q22,1q22,612942,"RAB25, RAB11C",Ras-associated protein RAB25,RAB25,57111,ENSG00000132698,NA,NA,Rab25 (MGI:1858203)
1,156072012,156082464,1q22,1q22,611007,MEX3A,"Mex-3, C. elegans, homolog of, A",MEX3A,92312,ENSG00000254726,NA,NA,Mex3a (MGI:1919890)
1,156082545,156140088,1q21.2,1q22,150330,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS",Lamin A/C,LMNA,4000,ENSG00000160789,NA,"Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal recessive, Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant; Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive",Lmna (MGI:96794)
1,156149671,156177750,1q22,1q22,607292,"SEMA4A, SEMB, RP35, CORD10",Semaphorin 4A,SEMA4A,64218,ENSG00000196189,NA,"Cone-rod dystrophy 10, 610283 (3), Autosomal recessive; Retinitis pigmentosa 35, 610282 (3), Autosomal recessive, Autosomal dominant",Sema4a (MGI:107560)
1,156193931,156212795,1q22,1q22,610824,SLC25A44,"Solute carrier family 25, member 44",SLC25A44,9673,ENSG00000160785,NA,NA,Slc25a44 (MGI:2444391)
1,156212987,156240076,1q12,1q22,609176,PMF1,Polyamine-modulated factor 1,PMF1,11243,ENSG00000160783,NA,NA,Pmf1 (MGI:1914287)
1,156242183,156243316,1q25-q31,1q22,112260,BGLAP,Bone gamma-carboxyglutamic acid protein,BGLAP,632,ENSG00000242252,NA,NA,"Bglap3,Bglap2,Bglap (MGI:88157,MGI:88155,MGI:88156)"
1,156243319,156248521,1q22,1q22,614579,PAQR6,"Progestin and ADIPOQ receptor family, member 6",PAQR6,79957,ENSG00000160781,NA,NA,Paqr6 (MGI:1916207)
1,156249223,156291497,1q21.2,1q22,610962,"SMG5, EST1B, KIAA1089","SMG5, C. elegans, homolog of",SMG5,23381,ENSG00000198952,NA,NA,Smg5 (MGI:2447364)
1,156282912,156292442,1q23.1,1q22,615531,"TMEM79, MATT",Transmembrane protein 79,TMEM79,84283,ENSG00000163472,NA,NA,Tmem79 (MGI:1919163)
1,156308960,156338414,1q23,1q22,600114,"CCT3, TRIC5","Chaperonin-containing TCP1, subunit 3, gamma (TCP1 (t-complex-1) ring complex, polypeptide 5)",CCT3,7203,ENSG00000163468,NA,NA,Cct3 (MGI:104708)
1,156366043,156385220,1q21.3,1q22,607079,RHBG,"Rhesus blood group, B glycoprotein",RHBG,57127,ENSG00000132677,NA,NA,Rhbg (MGI:1927379)
1,156420340,156420428,1q22,1q22,611186,"MIR9-1, MIRN9-1",Micro RNA 9-1,MIR9-1,407046,ENSG00000207933,NA,NA,NA
1,156463726,156500839,1q12-q23,1q22,600663,MEF2D,"MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D)",MEF2D,4209,ENSG00000116604,NA,NA,Mef2d (MGI:99533)
1,156591775,156599817,1q21,1q22,608862,"NAXE, APOA1BP, AIBP, PEBEL",NAD(P)HX epimerase,NAXE,128240,ENSG00000163382,NA,"Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3), Autosomal recessive",Naxe (MGI:2180167)
1,156600000,165500000,1q23,NA,605913,BDET,"Bleeding disorder, east Texas type",NA,85504,NA,NA,"Bleeding disorder, east Texas type, 605913 (2)",NA
1,156600000,165500000,1q23,NA,157560,"D1S61, D1S111, MS336",Minisatellite 33.6,NA,7824,NA,NA,NA,NA
1,156642116,156659527,1q23.1,1q23.1,600347,BCAN,Brevican,BCAN,63827,ENSG00000132692,NA,NA,Bcan (MGI:1096385)
1,156668762,156677406,1q23.1,1q23.1,600915,NES,Nestin,NES,10763,ENSG00000132688,NA,NA,NA
1,156699605,156705815,1q21.3,1q23.1,180231,"CRABP2, RBP6",Cellular retinoic acid-binding protein-2,CRABP2,1382,ENSG00000143320,NA,NA,Crabp2 (MGI:88491)
1,156721890,156728765,1q23.1,1q23.1,611930,ISG20L2,Interferon-stimulated exonuclease gene 20-kD-like 2,ISG20L2,81875,ENSG00000143319,NA,NA,Isg20l2 (MGI:2140076)
1,156737302,156741266,1q21-q22,1q23.1,611836,MRPL24,Mitochondrial ribosomal protein L24,MRPL24,79590,ENSG00000143314,NA,NA,Mrpl24 (MGI:1914957)
1,156742106,156752447,1q21,1q23.1,600339,HDGF,Hepatoma-derived growth factor,HDGF,3068,ENSG00000143321,previously assigned to Chr.X,NA,Hdgf (MGI:1194494)
1,156767534,156800818,1q21,1q23.1,179755,"PRCC, RCCP1","Papillary renal cell carcinoma, translocation-associated",PRCC,5546,ENSG00000143294,t(X;1)(p11;q21); fuses with TFE3 in RCCP,"Renal cell carcinoma, papillary, 605074 (3)",Prcc (MGI:2137738)
1,156806237,156816852,1q21,1q23.1,604514,"SH2D2A, TSAD",SH2 domain protein 2A,SH2D2A,9047,ENSG00000027869,NA,NA,Sh2d2a (MGI:1351596)
1,156815749,156881849,1q21-q22,1q23.1,191315,"NTRK1, TRKA, MTC","Neurotrophic tyrosine kinase, receptor, type 1",NTRK1,4914,ENSG00000198400,TRK = chimera of TPM3 and NTRK1,"Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive; Medullary thyroid carcinoma, familial, 155240 (3), Autosomal dominant",Ntrk1 (MGI:97383)
1,156840062,156859116,1q21-q23,1q23.1,147671,"INSRR, IRR",Insulin receptor-related receptor,INSRR,3645,ENSG00000027644,NA,NA,Insrr (MGI:1346037)
1,156893696,156916433,1q23.1,1q23.1,610278,PEAR1,Platelet endothelial aggregation receptor 1,PEAR1,375033,ENSG00000187800,NA,NA,Pear1 (MGI:1920432)
1,157121190,157138590,1q21-q23,1q23.1,164873,"ETV3, PE1",ets variant gene 3,ETV3,2117,ENSG00000117036,NA,NA,Etv3 (MGI:1350926)
1,157513376,157552532,1q21,1q23.1,605877,IRTA2,Immunoglobulin superfamily receptor translocation-associated gene 2,FCRL5,83416,ENSG00000143297,NA,NA,Fcrl5 (MGI:3053558)
1,157573746,157598084,1q21,1q23.1,605876,IRTA1,Immunoglobulin superfamily receptor translocation-associated gene 1,FCRL4,83417,ENSG00000163518,fused with IGHA1 in multiple myeloma,NA,NA
1,157676480,157700984,1q21.2-q22,1q23.1,606510,FCRH3,Fc receptor-like protein 3,FCRL3,115352,ENSG00000160856,NA,NA,NA
1,157745732,157777471,1q21.2-q22,1q23.1,606509,"SPAP1, SPAP1A, SPAP1B, SPAP1C",SH2 domain-containing phosphatase anchor protein 1,FCRL2,79368,ENSG00000132704,NA,NA,NA
1,157792248,157820133,1q21.2-q22,1q23.1,606508,"FCRL1, FCRH1",Fc receptor-like protein 1,FCRL1,115350,ENSG00000163534,NA,NA,Fcrl1 (MGI:2442862)
1,157827067,157841843,1q21-q23,1q23.1,602592,CD5L,CD5 antigen-like (scavenger receptor cysteine rich family),CD5L,922,ENSG00000073754,NA,NA,Cd5l (MGI:1334419)
1,157993272,158100261,1q23.1,1q23.1,607428,"KIRREL, NEPH1",Kin of IRRE-like,KIRREL1,55243,ENSG00000183853,NA,NA,Kirrel (MGI:1891396)
1,158178037,158186426,1q21-q23,1q23.1,188410,CD1D,Thymocyte antigen CD1D,CD1D,912,ENSG00000158473,NA,NA,Cd1d1 (MGI:107674)
1,158248335,158258268,1q21-q23,1q23.1,188370,CD1A,Thymocyte antigen CD1A,CD1A,909,ENSG00000158477,"genes A, B, C, D in cluster",NA,NA
1,158285405,158331530,1q21-q23,1q23.1,188360,CD1B,Thymocyte antigen CD1B,CD1B,910,ENSG00000158485,NA,NA,NA
1,158289886,158294773,1q21-q23,1q23.1,188340,CD1C,Thymocyte antigen CD1C,CD1C,911,ENSG00000158481,NA,NA,NA
1,158353122,158357553,1q21-q23,1q23.1,188411,CD1E,Thymocyte antigen CD1E,CD1E,913,ENSG00000158488,NA,NA,NA
1,158610497,158686714,1q21,1q23.1,182860,"SPTA1, EL2, SPH3, HS3, HPP","Spectrin, alpha, erythrocytic-1",SPTA1,6708,ENSG00000163554,17cM proximal to FY,"Elliptocytosis-2, 130600 (3), Autosomal dominant; Pyropoikilocytosis, 266140 (3), Autosomal recessive; Spherocytosis, type 3, 270970 (3), Autosomal recessive",Spta1 (MGI:98385)
1,158831350,158849501,1q22,1q23.1,159553,MNDA,Myeloid cell nuclear differentiation antigen,MNDA,4332,ENSG00000163563,NA,NA,NA
1,158931546,158990908,1q21-q23,1q23.1,612677,"PYHIN1, IFIX","Pyrin and Hin domain family, member 1",PYHIN1,149628,ENSG00000163564,NA,NA,NA
1,158999969,159055154,1q22,1q23.1,147586,IFI16,"Interferon, gamma-inducible protein 16",IFI16,3428,ENSG00000163565,NA,NA,"Ifi209,Ifi208,Ifi207,Ifi206,Ifi205,Ifi204,Ifi203,Ifi214,Ifi213,Ifi211,Mndal,Ifi203-ps (MGI:3041120,MGI:3584522,MGI:3780953,MGI:96429,MGI:96428,MGI:3695276,MGI:3646410,MGI:2442822,MGI:3840117,MGI:2138302,MGI:101847,MGI:2138243)"
1,159059225,159132350,1q22,1q23.1-q23.2,604578,AIM2,Absent in melanoma 2,AIM2,9447,ENSG00000163568,NA,NA,Aim2 (MGI:2686159)
1,159171591,159203312,1q21.2-q22,1q23.2,609743,"CADM3, IGSF4B, TSLL1, NECL1, SYNCAM3",Cell adhesion molecule 3,CADM3,57863,ENSG00000162706,NA,NA,Cadm3 (MGI:2137858)
1,159204874,159206499,1q23.2,1q23.2,613665,"ACKR1, DARC, FY, GPD, WBCQ1",Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines),ACKR1,2532,ENSG00000213088,"by A, 1q22-q23","[Blood group, Duffy system], 110700 (3), Autosomal recessive, Autosomal dominant; {Malaria, vivax, protection against}, 611162 (3); [White blood cell count QTL], 611862 (3), Autosomal recessive",Ackr1 (MGI:1097689)
1,159283887,159308223,1q23,1q23.2,147140,FCER1A,"Fc IgE receptor, alpha polypeptide",FCER1A,2205,ENSG00000179639,NA,NA,Fcer1a (MGI:95494)
1,159587825,159588864,1q21-q23,1q23.2,104770,"APCS, SAP","Amyloid P component, serum",APCS,325,ENSG00000132703,probably close to CRP,"{?Amyloidosis, secondary, susceptibility to} (1)",Apcs (MGI:98229)
1,159712288,159714588,1q21-q23,1q23.2,123260,CRP,C-reactive protein,CRP,1401,ENSG00000132693,NA,NA,Crp (MGI:88512)
1,159780961,159782542,1q23,1q23.2,618361,"DUSP23, DUSP25, LDP3, VHZ",Dual-specificity phosphatase 23,DUSP23,54935,ENSG00000158716,NA,NA,Dusp23 (MGI:1915690)
1,159826688,159837496,1q21,1q23.2,606620,"SLAMF8, BLAME","SLAM family, member 8",SLAMF8,56833,ENSG00000158714,NA,NA,Slamf8 (MGI:1921998)
1,159872363,159900164,1q22-q24,1q23.2,605152,"CCDC19, NESG1",Coiled-coil domain-containing 19,CFAP45,25790,ENSG00000213085,NA,NA,Cfap45 (MGI:1919120)
1,159918110,159925506,1q21-q25,1q23.2,604634,TAGLN2,Transgelin 2,TAGLN2,8407,ENSG00000158710,NA,NA,Tagln2 (MGI:1312985)
1,159927040,159945660,1q22-q23,1q23.2,609738,"IGSF9, KIAA1355","Immunoglobulin superfamily, member 9",IGSF9,57549,ENSG00000085552,NA,NA,Igsf9 (MGI:2135283)
1,160024952,160031989,1q23.2,1q23.2,610273,PIGM,"Phosphatidylinositol glycan, class M",PIGM,93183,ENSG00000143315,NA,"Glycosylphosphatidylinositol deficiency, 610293 (3), Autosomal recessive",Pigm (MGI:1914806)
1,160037466,160070159,1q23.2,1q23.2,602208,"KCNJ10, SESAME","Potassium inwardly-rectifying channel, subfamily J, member 10",KCNJ10,3766,ENSG00000177807,NA,"Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive",Kcnj10 (MGI:1194504)
1,160055000,160090562,1q23.2,1q23.2,600932,"KCNJ9, GIRK3","Potassium inwardly-rectifying channel, subfamily J, member 9",KCNJ9,3765,ENSG00000162728,NA,NA,Kcnj9 (MGI:108007)
1,160091338,160099441,1q23.1,1q23.2,606644,"IGSF8, PGRL, CD81P3","Immunoglobulin superfamily, member 8",IGSF8,93185,ENSG00000162729,NA,NA,Igsf8 (MGI:2154090)
1,160115758,160143590,1q21-q23,1q23.2,182340,"ATP1A2, FHM2, MHP2","ATPase, Na+K+ transporting, alpha-2 polypeptide",ATP1A2,477,ENSG00000018625,NA,"Alternating hemiplegia of childhood 1, 104290 (3), Autosomal dominant; Migraine, familial basilar, 602481 (3), Autosomal dominant; Migraine, familial hemiplegic, 2, 602481 (3), Autosomal dominant",Atp1a2 (MGI:88106)
1,160151561,160186976,1q21-q32,1q23.2,607321,"ATP1A4, ATP1AL2","ATPase, Na+/K+ transporting, alpha-4 polypeptide",ATP1A4,480,ENSG00000132681,NA,NA,Atp1a4 (MGI:1351335)
1,160190574,160201885,1q21,1q23.2,114250,"CASQ1, VMCQA","Calsequestrin, fast-twitch, skeletal muscle-1",CASQ1,844,ENSG00000143318,NA,"Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3), Autosomal dominant",Casq1 (MGI:1309468)
1,160205383,160215375,1q21.1,1q23.2,603434,"PEA15, HMAT1, PED","Phosphoprotein enriched in astrocytes, 15kD",PEA15,8682,ENSG00000162734,NA,NA,Pea15a (MGI:104799)
1,160215714,160262548,1q23.2,1q23.2,615820,"DCAF8, WDR42A, GAN2",DDB1- and CUL4-associated factor 8,DCAF8,50717,ENSG00000132716,mutation identified in 1 GAN2 family,"?Giant axonal neuropathy 2, autosomal dominant, 610100 (3), Autosomal dominant",Dcaf8 (MGI:91860)
1,160276808,160285150,1q22,1q23.2,600279,"PEX19, PXF, HK33, D1S2223E, PBD12A",Peroxisome biogenesis factor 19 (peroxisomal farnesylated protein),PEX19,5824,ENSG00000162735,NA,"Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive",Pex19 (MGI:1334458)
1,160288593,160343249,1q23-q25,1q23.2,601924,"COPA, AILJK","Coatomer protein complex, subunit alpha",COPA,1314,ENSG00000122218,NA,"{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3), Autosomal dominant",Copa (MGI:1334462)
1,160343327,160358948,1q22-q23,1q23.2,605254,NCSTN,Nicastrin,NCSTN,23385,ENSG00000162736,NA,"Acne inversa, familial, 1, 142690 (3), Autosomal dominant",Ncstn (MGI:1891700)
1,160367070,160372845,1q22,1q23.2,162360,"NHLH1, HEN1",Nescient helix loop helix 1,NHLH1,4807,ENSG00000171786,closely linked to Sap in mouse,NA,Nhlh1 (MGI:98481)
1,160400563,160428673,1q21-q23,1q23.2,600533,"VANGL2, LTAP","Vang-like 2 (loop-tail, mouse, homolog of)",VANGL2,57216,ENSG00000162738,NA,"Neural tube defects, 182940 (3), Autosomal dominant",Vangl2 (MGI:2135272)
1,160485029,160523262,1q23.1,1q23.2-q23.3,606446,"SLAMF6, NTBA","SLAM family, member 6",SLAMF6,114836,ENSG00000162739,NA,NA,Slamf6 (MGI:1353620)
1,160500000,165500000,1q23.3,NA,610141,QTV,"QT interval, variation in",NA,100379215,NA,associated with rs12143842,"[QT interval, variation in], 610141 (2)",NA
1,160541093,160579515,1q23.3,1q23.3,604513,"CD84, SLAMF5",CD84 antigen,CD84,8832,ENSG00000066294,NA,NA,Cd84 (MGI:1336885)
1,160608099,160647310,1q22-q23,1q23.3,603492,"SLAMF1, SLAM, CDW150, CD150","SLAM family, member 1",SLAMF1,6504,ENSG00000117090,NA,NA,Slamf1 (MGI:1351314)
1,160678745,160711850,1q21.3-q22,1q23.3,109530,"CD48, BCM1, BLAST1",CD48 antigen (B-cell membrane protein),CD48,962,ENSG00000117091,NA,NA,Cd48 (MGI:88339)
1,160739056,160754820,1q23-q24,1q23.3,606625,"SLAMF7, CRACC, CS1","SLAM family, member 7",SLAMF7,57823,ENSG00000026751,NA,NA,Slamf7 (MGI:1922595)
1,160796111,160828255,1q21.3-q22,1q23.3,600684,LY9,T-lymphocyte surface antigen Ly-9,LY9,4063,ENSG00000122224,within 410kb of CD48,NA,Ly9 (MGI:96885)
1,160830159,160862891,1q22,1q23.3,605554,"CD244, NAIL, NKR2B4, SLAMF4",CD244 antigen,CD244,51744,ENSG00000122223,NA,"{Rheumatoid arthritis, susceptibility to}, 180300 (3)",Cd244a (MGI:109294)
1,160876539,160885179,1q21.3-q22,1q23.3,609873,"ITLN1, INTL, LFR, HL1",Intelectin 1,ITLN1,55600,ENSG00000179914,NA,NA,Itln1 (MGI:1333831)
1,160945019,160957377,1q21.3-q22,1q23.3,609874,"ITLN2, HL2",Intelectin 2,ITLN2,142683,ENSG00000158764,NA,NA,NA
1,160995210,161021151,1q21.2-q21.3,1q23.3,605721,"F11R, JAM1",F11 receptor (junctional adhesion molecule 1),F11R,50848,ENSG00000158769,NA,NA,F11r (MGI:1321398)
1,161037630,161038963,1q23.3,1q23.3,616041,"TSTD1, KAT",Thiosulfate sulfurtransferase (rhodanese)-like domain-containing protein 1,TSTD1,100131187,ENSG00000215845,NA,NA,Tstd1 (MGI:3648482)
1,161039250,161045976,1q22-q23,1q23.3,191523,"USF1, HYPLIP1",Upstream transcription factor 1,USF1,7391,ENSG00000158773,NA,"{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)",Usf1 (MGI:99542)
1,161046941,161069970,1q23.3,1q23.3,614264,ARHGAP30,RHO GTPase-activating protein 30,ARHGAP30,257106,ENSG00000186517,NA,NA,Arhgap30 (MGI:2684948)
1,161070997,161089565,1q23.3,1q23.3,609607,"NECTIN 4, PVRL4, PRR4, EDSS1",Nectin 4,NECTIN4,81607,ENSG00000143217,NA,"Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3), Autosomal recessive",Nectin4 (MGI:1918990)
1,161098360,161100345,1q23.3,1q23.3,617375,"KLHDC9, KARCA1",Kelch domain-containing protein 9,KLHDC9,126823,ENSG00000162755,NA,NA,Klhdc9 (MGI:1916124)
1,161100555,161118042,1q23.3,1q23.3,613466,PFDN2,Prefoldin 2,PFDN2,5202,ENSG00000143256,NA,NA,Pfdn2 (MGI:1276111)
1,161118091,161125445,1q21-q22,1q23.3,604618,NIT1,Nitrilase 1,NIT1,4817,ENSG00000158793,NA,NA,Nit1 (MGI:1350916)
1,161120973,161132782,1q23.3,1q23.3,606841,"DEDD, DEFT",Death effector domain-containing protein,DEDD,9191,ENSG00000158796,NA,NA,Dedd (MGI:1333874)
1,161132702,161158855,1q23.3,1q23.3,610554,"UFC1, NEDSG",Ubiquitin-fold modifier-conjugating enzyme 1,UFC1,51506,ENSG00000143222,NA,"Neurodevelopmental disorder with spasticity and poor growth, 618076 (3), Autosomal recessive",Ufc1 (MGI:1913405)
1,161159486,161165751,1q22,1q23.3,604729,"USP21, USP23",Ubiquitin-specific protease 21,USP21,27005,ENSG00000143258,NA,NA,Usp21 (MGI:1353665)
1,161165823,161178276,1q22,1q23.3,600923,PPOX,Protoporphyrinogen oxidase,PPOX,5498,ENSG00000143224,NA,"Porphyria variegata, 176200 (3), Autosomal dominant",Ppox (MGI:104968)
1,161171309,161185006,1q23,1q23.3,604014,B4GALT3,"Beta-1,4-galactosyltransferase 3",B4GALT3,8703,ENSG00000158850,NA,NA,B4galt3 (MGI:1928767)
1,161184301,161202338,1q21-q23,1q23.3,603876,ADAMTS4,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 4 (aggrecanase 1)",ADAMTS4,9507,ENSG00000158859,NA,NA,Adamts4 (MGI:1339949)
1,161199314,161214394,1q23,1q23.3,602985,"NDUFS2, MC1DN6",NADH-ubiquinone oxidoreductase core subunit S2,NDUFS2,4720,ENSG00000158864,NA,"Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive",Ndufs2 (MGI:2385112)
1,161215294,161219244,1q23,1q23.3,147139,FCER1G,"Fc fragment of IgE, high affinity I, receptor for, gamma polypeptide",FCER1G,2207,ENSG00000158869,probably on 1q close to CD32,NA,Fcer1g (MGI:95496)
1,161222291,161223627,1q21-q23,1q23.3,107670,APOA2,Apolipoprotein A-II,APOA2,336,ENSG00000158874,NA,"Apolipoprotein A-II deficiency (3); {Hypercholesterolemia, familial, modifier of}, 143890 (3), Autosomal dominant",Apoa2 (MGI:88050)
1,161229665,161238622,1q23.1,1q23.3,603881,"NR1I3, CAR, MB67","Nuclear receptor subfamily 1, group I, member 3",NR1I3,9970,ENSG00000143257,NA,NA,Nr1i3 (MGI:1346307)
1,161303593,161309968,1q22,1q23.3,159440,"MPZ, CMT1B, CMTDID, DSS, CHN2",Myelin protein zero,MPZ,4359,ENSG00000158887,NA,"Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant",Mpz (MGI:103177)
1,161314375,161375339,1q21,1q23.3,602413,"SDHC, PGL3","Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD",SDHC,6391,ENSG00000143252,NA,"Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases; Paraganglioma and gastric stromal sarcoma, 606864 (3); Paragangliomas 3, 605373 (3), Autosomal dominant",Sdhc (MGI:1913302)
1,161364730,161367882,1q23.3,1q23.3,616119,"CFAP126, FLTP",Cilia- and flagella-associated protein 126,CFAP126,257177,ENSG00000188931,NA,NA,Cfap126 (MGI:1922722)
1,161505429,161524047,1q21-q23,1q23.3,146790,"FCGR2A, IGFR2, CD32","Fc fragment of IgG, low affinity IIa, receptor for (CD32)",FCGR2A,2212,ENSG00000143226,FCG2 and FCG3 within 250kb,"{Lupus nephritis, susceptibility to}, 152700 (3), Autosomal dominant; {Malaria, severe, susceptibility to}, 611162 (3); {Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3), Autosomal recessive",Fcgr3 (MGI:95500)
1,161524539,161526893,1q,1q23.3,140555,HSPA6,Heat-shock 70kD protein-6 (HSP70B'),HSPA6,3310,ENSG00000173110,NA,NA,NA
1,161541758,161550736,1q23,1q23.3,146740,"FCGR3A, CD16, IGFR3, IMD20","Fc fragment of IgG, low affinity III, receptor for (CD16)",FCGR3A,2214,ENSG00000203747,FCGR2A and FCGR3A within 250kb antigen,"Immunodeficiency 20, 615707 (3), Autosomal recessive",Fcgr4 (MGI:2179523)
1,161581338,161601219,1q23,1q23.3,612169,"FCGR2C, CD32C","Fc fragment of IgG, low affinity IIc, receptor for",FCGR2C,9103,NA,NA,"Thrombocytopenic purpura, autoimmune, 188030 (1), Autosomal dominant",NA
1,161606058,161608550,1q,1q23.3,140556,HSPA7,Heat-shock 70kD protein-7 (HSP70B),HSPA7,3311,NA,NA,NA,NA
1,161623195,161631962,1q23,1q23.3,610665,FCGR3B,"Fc fragment of IgG, low affinity IIIb, receptor for",FCGR3B,2215,ENSG00000162747,NA,"Neutropenia, alloimmune neonatal (3)",Fcgr4 (MGI:2179523)
1,161647242,161678653,1q22,1q23.3,604590,"FCGR2B, CD32","Fc fragment of IgG, low affinity IIb, receptor for",FCGR2B,2213,ENSG00000072694,NA,"{Malaria, resistance to}, 611162 (3); {Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant",Fcgr2b (MGI:95499)
1,161707021,161714351,1q23,1q23.3,606891,FREB,Fc receptor homolog expressed in B cells,FCRLA,84824,ENSG00000132185,NA,NA,Fcrla (MGI:2138647)
1,161721543,161728142,1q23.3,1q23.3,609251,"FCRLB, FCRL2, FREB2, FCRY",Fc receptor-like protein B,FCRLB,127943,ENSG00000162746,NA,NA,Fcrlb (MGI:3576487)
1,161749785,161757237,1q21-q22,1q23.3,604835,"DUSP1, YVH1",Dual-specificity phosphatase 12,DUSP12,11266,ENSG00000081721,NA,NA,Dusp12 (MGI:1890614)
1,161766319,161964069,1q22-q23,1q23.3,605537,"ATF6, ACHM7",Activating transcription factor-6,ATF6,22926,ENSG00000118217,NA,"Achromatopsia 7, 616517 (3), Autosomal recessive",Atf6 (MGI:1926157)
1,162069690,162370474,1q23.3,1q23.3,605551,"NOS1AP, CAPON, KIAA0464",Nitric oxide synthase 1 (neuronal) adaptor protein,NOS1AP,9722,ENSG00000198929,NA,NA,NA
1,162373202,162376961,1q23.3,1q23.3,617257,SPATA46,Spermatogenesis-associated protein 46,SPATA46,284680,ENSG00000171722,NA,NA,Spata46 (MGI:1924175)
1,162395267,162412135,1q22,1q23.3,608510,"SH2D1B, EAT2",SH2 domain-containing 1B,SH2D1B,117157,ENSG00000198574,NA,NA,Sh2d1b1 (MGI:1349420)
1,162497173,162529630,1q23.1,1q23.3,608849,KIS,Kinase-interacting stathmin,UHMK1,127933,ENSG00000152332,NA,NA,Uhmk1 (MGI:1341908)
1,162561439,162599842,1q23.3,1q23.3,602862,"UAP1, SPAG2",ADP-N-acetylglucosamine pyrophosphorylase 1,UAP1,6675,ENSG00000117143,NA,NA,Uap1 (MGI:1334459)
1,162630862,162787404,1q12-qter,1q23.3,191311,"DDR2, NTRKR3, TKT, WRCN","Discoidin domain receptor family, member 2",DDR2,4921,ENSG00000162733,NA,"Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3), Autosomal recessive; Warburg-Cinotti syndrome, 618175 (3), Autosomal dominant",Ddr2 (MGI:1345277)
1,162790701,162812817,1q23.3,1q23.3,606756,HSD17B7,17-beta-hydroxysteroid dehydrogenase VII,HSD17B7,51478,ENSG00000132196,NA,NA,Hsd17b7 (MGI:1330808)
1,163068605,163076801,1q23.3,1q23.3,602516,RGS4,Regulator of G protein signaling 4,RGS4,5999,ENSG00000117152,NA,NA,Rgs4 (MGI:108409)
1,163142298,163321790,1q23,1q23.3,603276,RGS5,Regulator of G protein signaling-5,RGS5,8490,ENSG00000143248,NA,"[Blood pressure regulation QTL], 145500 (2), Multifactorial",Rgs5 (MGI:1098434)
1,163321947,163355763,1q23,1q23.3,611772,"NUF2, NUF2R, CDCA1","NUF2, S. cerevisiae, homolog of",NUF2,83540,ENSG00000143228,NA,NA,Nuf2 (MGI:1914227)
1,164559359,164886046,1q23,1q23.3,176310,"PBX1, CAKUHED",Pre-B cell leukemia transcription factor-1,PBX1,5087,ENSG00000185630,pseudogene PBXP1 on chr.3,"Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3), Autosomal dominant",Pbx1 (MGI:97495)
1,165201866,165356714,1q22-q23,1q23.3,600298,"LMX1A, LMX1","LIM homeo box transcription factor-1, alpha",LMX1A,4009,ENSG00000162761,NA,NA,Lmx1a (MGI:1888519)
1,165400921,165445354,1q22-q23,1q23.3,180247,RXRG,"Retinoid X receptor, gamma",RXRG,6258,ENSG00000143171,NA,NA,Rxrg (MGI:98216)
1,165500000,173000000,1q24,NA,605429,DFNM1,"Deafness, nonsyndromic, modifier 1",NA,NA,NA,NA,"{Deafness, nonsyndromic, modifier 1}, 605429 (2), Autosomal dominant",NA
1,165544240,165563947,1q24.1,1q24.1,615218,LRRC52,Leucine-rich repeat-containing protein 52,LRRC52,440699,ENSG00000162763,NA,NA,Lrrc52 (MGI:1924118)
1,165631233,165656135,1q23,1q24.1,604564,MGST3,"Glutatione S-transferase, microsomal, 3",MGST3,4259,ENSG00000143198,NA,NA,Mgst3 (MGI:1913697)
1,165662211,165698662,1q22-q23,1q24.1,602733,"ALDH9A1, ALDH9, E3","Aldehyde dehydrogenase 9 family, member A1",ALDH9A1,223,ENSG00000143149,NA,NA,Aldh9a1 (MGI:1861622)
1,165724290,165768921,1q24.1,1q24.1,614123,"TMCO1, CFSMR",Transmembrane and coiled-coil domains protein 1,TMCO1,54499,ENSG00000143183,NA,"Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3), Autosomal recessive",Tmco1 (MGI:1921173)
1,165827613,165911617,1q22-q23.2,1q24.1,609329,"UCK2, TSA903",Uridine/cytidine kinase 2,UCK2,7371,ENSG00000143179,NA,NA,Uck2 (MGI:1931744)
1,166856509,166876263,1q24-q25,1q24.1,612763,"TADA1L, STAF42",Transcriptional adaptor 1-like,TADA1,117143,ENSG00000152382,NA,NA,Tada1 (MGI:1196415)
1,166908186,166975539,1q24.1,1q24.1,618081,ILDR2,Immunoglobulin-like domain-containing receptor 2,ILDR2,387597,ENSG00000143195,NA,NA,Ildr2 (MGI:1196370)
1,166921120,167022213,1q24.1,1q24.1,611368,MAEL,"Maelstrom, Drosophila, homolog of",MAEL,84944,ENSG00000143194,NA,NA,Mael (MGI:2138453)
1,167052835,167090391,1q24.1,1q24.1,602171,GPA33,Glycoprotein A33,GPA33,10223,ENSG00000143167,NA,NA,Gpa33 (MGI:1891703)
1,167220877,167427344,1q22-q23,1q24.2,164175,"OTF1, OCT1",Octamer-binding transcription factor-1,POU2F1,5451,ENSG00000143190,NA,NA,Pou2f1 (MGI:101898)
1,167430639,167518609,1q22-q23,1q24.2,186780,"CD247, CD3Z, TCRZ, IMD25",CD247 antigen,CD247,919,ENSG00000198821,mutation identified in one IMD25 patient,"?Immunodeficiency 25, 610163 (3), Autosomal recessive",Cd247 (MGI:88334)
1,167541012,167553761,1q24.2,1q24.2,618055,CREG1,Cellular repressor of E1A-stimulated genes 1,CREG1,8804,ENSG00000143162,NA,NA,Creg1 (MGI:1344382)
1,167630192,167708695,1q24,1q24.2,610579,"RCSD1, CAPZIP",RCSD domain-containing protein 1,RCSD1,92241,ENSG00000198771,NA,NA,Rcsd1 (MGI:2676394)
1,167721981,167791918,1q24,1q24.2,604376,"MPZL1, PZR",Myelin protein zero-like 1,MPZL1,9019,ENSG00000197965,NA,NA,Mpzl1 (MGI:1915731)
1,167809079,167916388,1q24,1q24.2,605205,"ADCY10, SAC, HCA2","Adenylyl cyclase 10, soluble",ADCY10,55811,ENSG00000143199,NA,"{Hypercalciuria, absorptive, susceptibility to}, 143870 (3), Autosomal dominant",Adcy10 (MGI:2660854)
1,167916674,167937071,1q24.2,1q24.2,614737,"BRP44, MPC2",Brain protein 44,MPC2,25874,ENSG00000143158,NA,NA,Mpc2 (MGI:1917706)
1,167936238,168075842,1q24.2,1q24.2,610494,"DCAF6, IQWD1, NRIP",DDB1 and CUL4 associated factor 6,DCAF6,55827,ENSG00000143164,NA,NA,Dcaf6 (MGI:1921356)
1,168079541,168137666,1q24.2,1q24.2,612250,GPR161,G protein-coupled receptor 161,GPR161,23432,ENSG00000143147,NA,NA,Gpr161 (MGI:2685054)
1,168178961,168202108,1q23.2,1q24.2,611807,"TIPRL, TIP41, TIP",TIP41-like protein,TIPRL,261726,ENSG00000143155,NA,NA,Tiprl (MGI:1915087)
1,168280876,168314425,1q23-q24,1q24.2,604614,TBX19,T-box 19,TBX19,9095,ENSG00000143178,NA,"Adrenocorticotropic hormone deficiency, 201400 (3), Autosomal recessive",Tbx19 (MGI:1891158)
1,168540767,168543996,1q23,1q24.2,604828,"XCL2, SCYC2, SCM1B","Chemokine, C motif, ligand 2",XCL2,6846,ENSG00000143185,NA,NA,NA
1,168574127,168582068,1q23,1q24.2,600250,"XCL1, SCYC1, SCM1, LTN, LPTN","Chemokine, C motif, ligand 1 (lymphotactin)",XCL1,6375,ENSG00000143184,NA,NA,Xcl1 (MGI:104593)
1,168695467,168729205,1q12-q23,1q24.2,125597,DPT,Dermatopontin,DPT,1805,ENSG00000143196,NA,NA,Dpt (MGI:1928392)
1,169106689,169132718,1q22-q25,1q24.2,182330,ATP1B1,"ATPase, Na+K+ transporting, beta-1 polypeptide",ATP1B1,481,ENSG00000143153,NA,"[Blood pressure regulation QTL], 145500 (2), Multifactorial",Atp1b1 (MGI:88108)
1,169132529,169367962,1q24,1q24.2,613465,"NME7, MN23H7","Nonmetastatic cells 7, protein expressed in",NME7,29922,ENSG00000143156,NA,NA,Nme7 (MGI:2449121)
1,169463908,169485969,1q23.3,1q24.2,603941,"SLC19A2, THTR1, TRMA, THMD1","Solute carrier family 19 (thiamine transporter), member 2",SLC19A2,10560,ENSG00000117479,NA,"Thiamine-responsive megaloblastic anemia syndrome, 249270 (3), Autosomal recessive",Slc19a2 (MGI:1928761)
1,169511953,169586629,1q23,1q24.2,612309,"F5, THPH2, RPRGL1","Coagulation factor V (proaccelerin, labile factor)",F5,2153,ENSG00000198734,Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment,"{Budd-Chiari syndrome}, 600880 (3), Autosomal recessive; Factor V deficiency, 227400 (3), Autosomal recessive; {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3), Autosomal dominant; {Stroke, ischemic, susceptibility to}, 601367 (3), Multifactorial; Thrombophilia due to activated protein C resistance, 188055 (3), Autosomal dominant; {Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3), Autosomal dominant",F5 (MGI:88382)
1,169588848,169630124,1q23-q25,1q24.2,173610,"SELP, GRMP","Selectin P (granulocyte membrane protein, 140kD; antigen CD62)",SELP,6403,ENSG00000174175,"in same 300kb segment as LYAM1, ELAM1",NA,Selp (MGI:98280)
1,169690666,169711619,1q23-q25,1q24.2,153240,"SELL, LYAM1, LAM1, LNHR",Selectin L (lymphocyte adhesion molecule 1),SELL,6402,ENSG00000188404,NA,NA,Sell (MGI:98279)
1,169722639,169734078,1q23-q25,1q24.2,131210,"SELE, ELAM1",Selectin E (endothelial leukocyte adhesion molecule-1),SELE,6401,ENSG00000007908,NA,NA,Sele (MGI:98278)
1,169792523,169794906,1q24.2,1q24.2,615255,"METTL18, C1orf156",Methyltransferase-like 18,METTL18,92342,ENSG00000171806,NA,NA,Mettl18 (MGI:1917212)
1,169849630,169894266,1q24.2,1q24.2,608192,"SCYL3, PACE1","SCY1-like 3, S. cerevisiae, homolog of",SCYL3,57147,ENSG00000000457,NA,NA,Scyl3 (MGI:1921385)
1,169921325,170085202,1q24.2,1q24.2,601836,"KIFAP3, SMAP",Kinesin-associated protein 3,KIFAP3,22920,ENSG00000075945,NA,NA,Kifap3 (MGI:107566)
1,170532121,170553833,1q24.2,1q24.2,607983,"GORAB, SCYL1BP1, NTKLBP1, GO","Golgin, RAB6-interacting",GORAB,92344,ENSG00000120370,NA,"Geroderma osteodysplasticum, 231070 (3), Autosomal recessive",Gorab (MGI:2138271)
1,170662727,170739420,1q24,1q24.2,167420,"PRRX1, PMX1, PHOX1, AGOTC",Paired-related homeobox gene 1,PRRX1,5396,ENSG00000116132,NA,"Agnathia-otocephaly complex, 202650 (3), Autosomal recessive, Autosomal dominant",Prrx1 (MGI:97712)
1,171090872,171117818,1q23-q25,1q24.3,136132,"FMO3, TMAU",Flavin-containing monooxygenase 3,FMO3,2328,ENSG00000007933,NA,"Trimethylaminuria, 602079 (3), Autosomal recessive",Fmo3 (MGI:1100496)
1,171185207,171212685,1q23-q25,1q24.3,603955,FMO2,"Flavin-containing monooxygenase 2, pulmonary",FMO2,2327,ENSG00000094963,probably cluster of FMO genes at 1q23-q25,NA,Fmo2 (MGI:1916776)
1,171248470,171285977,1q23-q25,1q24.3,136130,FMO1,"Flavin-containing monooxygenase 1, fetal liver",FMO1,2326,ENSG00000010932,NA,NA,Fmo1 (MGI:1310002)
1,171314130,171342083,1q23-q25,1q24.3,136131,FMO4,"Flavin-containing monooxygenase 2, adult liver",FMO4,2329,ENSG00000076258,NA,NA,Fmo4 (MGI:2429497)
1,171485495,171593510,1q24.3,1q24.3,617373,"PRRC2C, KIAA1096",Proline-rich coiled-coil protein 3C,PRRC2C,23215,ENSG00000117523,NA,NA,Prrc2c (MGI:1913754)
1,171635416,171652687,1q24.3-q25.2,1q24.3,601652,"MYOC, TIGR, GLC1A, JOAG, GPOA",Myocilin (trabecular meshwork-induced glucocorticoid response protein),MYOC,4653,ENSG00000034971,NA,"Glaucoma 1A, primary open angle, 137750 (3), Autosomal dominant",Myoc (MGI:1202864)
1,171700155,171742843,1q24-q25,1q24.3,606909,VAMP24,Vesicle-associated membrane protein 4,VAMP4,8674,ENSG00000117533,NA,NA,Vamp4 (MGI:1858730)
1,171781659,171797715,1q24.3,1q24.3,617987,"EEF1AKNMT, METTL13, FEAT, KIAA0859, DFNB26M",EEF1A lysine and N-terminal methyltransferase,EEF1AKNMT,51603,ENSG00000010165,mutation identified in 1 family,"?{Deafness, autosomal recessive 26, modifier of}, 605429 (3), Autosomal dominant",Eef1aknmt (MGI:1918699)
1,171841494,172418465,1q24.3,1q24.3,611445,"DNM3, KIAA0820",Dynamin 3,DNM3,26052,ENSG00000197959,NA,NA,Dnm3 (MGI:1341299)
1,172138797,172138906,1q24.3,1q24.3,610721,"MIR214, MIRN214",Micro RNA 214,MIR214,406996,ENSG00000283844,NA,NA,NA
1,172138807,172138887,1q24.3,1q24.3,614722,MIR3120,Micro RNA 3120,MIR3120,100422882,ENSG00000283152,in intron 13 of DNM3 in sense orientation,NA,NA
1,172144534,172144643,1q24.3,1q24.3,610720,"MIR199A2, MIRN199A2",Micro RNA 199A2,MIR199A2,406977,ENSG00000208024,NA,NA,NA
1,172441456,172444068,1q23-q25,1q24.3,601730,"PIGC, GPI2, GPIBD16, MRT62","Phosphatidylinositol glycan, class C",PIGC,5279,ENSG00000135845,NA,"Glycosylphosphatidylinositol biosynthesis defect 16, 617816 (3), Autosomal recessive",Pigc (MGI:1914542)
1,172659007,172666875,1q23,1q24.3,134638,"FASLG, TNFSF6, APT1LG1, FASL, ALPS1B","Fas ligand (TNF superfamily, member 6)",FASLG,356,ENSG00000117560,NA,"Autoimmune lymphoproliferative syndrome, type IB, 601859 (3), Autosomal dominant; {Lung cancer, susceptibility to}, 211980 (3), Autosomal dominant, Somatic mutation",Fasl (MGI:99255)
1,173000000,185800000,1q25,NA,611154,AD14,Alzheimer disease 14,NA,100188754,NA,max lod at D1S218,"{Alzheimer disease-14}, 611154 (2)",NA
1,173000000,185800000,1q25,NA,608526,PDON2,"Periodontitis, aggressive, 2",NA,406237,NA,between D1S196 and D1S533,"Periodontitis, aggressive, 2, 608526 (2)",NA
1,173000000,185800000,1q25,NA,611013,RGSL2,Regulator of G protein signaling-like 2,NA,NA,NA,related to AD linked to 1q25,NA,NA
1,173041219,173050962,1q23,1q25.1,603898,"TNFSF18, AITRL, GITRL","Tumor necrosis factor ligand superfamily, member 18",TNFSF18,8995,ENSG00000120337,NA,NA,Tnfsf18 (MGI:2673064)
1,173183728,173462207,1q25,1q25.1,603594,"TNFSF4, GP34, OX4OL","Tumor necrosis factor ligand superfamily, member 4",TNFSF4,7292,ENSG00000117586,NA,"{Myocardial infarction, susceptibility to}, 608446 (3)",Tnfsf4 (MGI:104511)
1,173477334,173488814,1q25.1,1q25.1,602316,PRDX6,Peroxiredoxin 6,PRDX6,9588,ENSG00000117592,NA,NA,Prdx6 (MGI:894320)
1,173714911,173786825,1q25.1,1q25.1,617679,"KLHL20, KLEIP, KLHLX",Kelch-like 20,KLHL20,27252,ENSG00000076321,NA,NA,Klhl20 (MGI:2444855)
1,173799549,173824638,1q25.1,1q25.1,611503,CENPL,Centromeric protein L,CENPL,91687,ENSG00000120334,NA,NA,Cenpl (MGI:1917704)
1,173824672,173858545,1q25.1,1q25.1,610956,"DARS2, ASPRS. LBSL",Aspartyl-tRNA synthetase 2,DARS2,55157,ENSG00000117593,NA,"Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive",Dars2 (MGI:2442510)
1,173863898,173868881,1q23.3,1q25.1,608280,GAS5,Growth arrest-specific 5,GAS5,60674,ENSG00000234741,NA,NA,NA
1,173903518,173917377,1q23-q25,1q25.1,107300,"SERPINC1, AT3, AT3D, THPH7",Antithrombin III,SERPINC1,462,ENSG00000117601,~17cM distal to FY,"Thrombophilia due to antithrombin III deficiency, 613118 (3), Autosomal recessive, Autosomal dominant",Serpinc1 (MGI:88095)
1,173931083,173993071,1q25.1,1q25.1,609424,"RC3H1, KIAA2025",Roquin,RC3H1,149041,ENSG00000135870,NA,NA,Rc3h1 (MGI:2685397)
1,174447963,174449544,1q24,1q25.1,604106,GPR52,G protein-coupled receptor 52,GPR52,9293,ENSG00000203737,NA,NA,Gpr52 (MGI:3643278)
1,174999434,175012026,1q24-q25,1q25.1,606186,SIP,SIAH1-interacting protein,CACYBP,27101,ENSG00000116161,NA,NA,Cacybp (MGI:1270839)
1,175012957,175023454,1q23-q25,1q25.1,611978,"MRPS14, COXPD38",Mitochondrial ribosomal protein S14,MRPS14,63931,ENSG00000120333,mutation identified in 1 COXPD38 patient,"?Combined oxidative phosphorylation deficiency 38, 618378 (3), Autosomal recessive",Mrps14 (MGI:1928141)
1,175067832,175148074,1q25.1,1q25.1,617472,TNN,Tenascin N,TNN,63923,ENSG00000120332,NA,NA,Tnn (MGI:2665790)
1,175156985,175193294,1q25.1,1q25.1,616696,KIAA0040,KIAA0040 gene,KIAA0040,9674,ENSG00000235750,NA,NA,4930523C07Rik (MGI:1914897)
1,175315193,175743701,1q24,1q25.1,601995,TNR,"Tenascin R (restrictin, janusin)",TNR,7143,ENSG00000116147,NA,NA,Tnr (MGI:99516)
1,175944825,176209086,1q24.1,1q25.1-q25.2,608067,"RFWD2, COP1",Ring finger- and WD repeat domain-containing protein 2,COP1,64326,ENSG00000143207,"pseudogenes on chr. 3, 9, 18",NA,Cop1 (MGI:1347046)
1,176100000,185800000,1q25.2-q25.3,NA,615492,LINC-COX2,Long intergenic noncoding RNA COX2,NA,NA,NA,NA,NA,NA
1,176855116,177164903,1q25,1q25.2,600904,"ASTN1, ASTN",Astrotactin 1,ASTN1,460,ENSG00000152092,NA,NA,Astn1 (MGI:1098567)
1,177928787,177984302,1q25.2,1q25.2,612855,"SEC16B, LZTR2, RGPR, SEC16S","Sec16, S. cerevisiae, homolog of, B",SEC16B,89866,ENSG00000120341,NA,NA,Sec16b (MGI:2148802)
1,178093728,178484148,1q25.2,1q25.2,606136,"RASAL2, NGAP",Ras protein activator-like 2,RASAL2,9462,ENSG00000075391,NA,NA,Rasal2 (MGI:2443881)
1,178725146,178921841,1q25.2,1q25.2,617819,"RALGPS2, FLJ10244",RAL guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 2,RALGPS2,55103,ENSG00000116191,NA,NA,Ralgps2 (MGI:1925505)
1,178849534,178871076,1q25.2,1q25.2,603874,ANGPTL1,Angiopoietin-like 1,ANGPTL1,9068,ENSG00000116194,NA,NA,Angptl1 (MGI:1919963)
1,179025803,179076573,1q25,1q25.2,611063,FAM20B,"Family with sequence similarity 20, member B",FAM20B,9917,ENSG00000116199,NA,NA,Fam20b (MGI:2443990)
1,179082069,179095995,1q25-q31,1q25.2,607555,"TOR3A, ADIR","Torsin family 3, member A (ATP-dependent interferon-responsive protein)",TOR3A,64222,ENSG00000186283,NA,NA,Tor3a (MGI:1353652)
1,179099329,179229692,1q24-q25,1q25.2,164690,"ABL2, ABLL, ARG","Abelson murine leukemia viral (v-abl) oncogene homolog 2 (arg, Abelson-related gene)",ABL2,27,ENSG00000143322,fused with ETV6 in AML,"Leukemia, acute myeloid, with eosinophilia (1)",Abl2 (MGI:87860)
1,179293713,179358679,1q25,1q25.2,102642,"SOAT1, STAT, ACAT",Sterol O-acyltransferase 1 (acyl-Coenzyme A: cholesterol acyltransferase 1),SOAT1,6646,ENSG00000057252,NA,NA,Soat1 (MGI:104665)
1,179550538,179575986,1q25-q31,1q25.2,604766,"PDCN, NPHS2, SRN1",Podocin,NPHS2,7827,ENSG00000116218,modifies phenotype of NPHS1 mutations to FSGS,"Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive",Nphs2 (MGI:2157018)
1,179591612,179691271,1q25.2,1q25.2,617748,"TDRD5, TUDOR3",Tudor domain-containing protein 5,TDRD5,163589,ENSG00000162782,NA,NA,Tdrd5 (MGI:2684949)
1,179727762,179816197,1q24.3,1q25.2,611727,"C1orf76, NDSP",Neuroblastoma-derived secretory protein,FAM163A,148753,ENSG00000143340,NA,NA,Fam163a (MGI:3618859)
1,179839975,179877802,1q24,1q25.2,614513,"TOR1AIP2, LULL1",Torsin A-interacting protein 2,TOR1AIP2,163590,ENSG00000169905,NA,NA,Tor1aip2 (MGI:3582695)
1,179882041,179920076,1q24,1q25.2,614512,"TOR1AIP1, LAP1, LAP1B, LGMD2Y",Torsin A-interacting protein 1,TOR1AIP1,26092,ENSG00000143337,mutation identified in 1 MRRSDC family,"?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures, 617072 (3), Autosomal recessive",Tor1aip1 (MGI:3582693)
1,179954772,180114874,1q25.2,1q25.2,617870,"CEP350, CAP350, KIAA0480",Centrosomal protein 350,CEP350,9857,ENSG00000135837,NA,NA,Cep350 (MGI:1921331)
1,180154832,180204029,1q24,1q25.2,603120,QSOX1,Quiescin Q6 sulfhydryl oxidase 1,QSOX1,5768,ENSG00000116260,NA,NA,Qsox1 (MGI:1330818)
1,180228371,180278983,1q25,1q25.2,602146,"LHX4, CPHD4",LIM homeo box gene 4,LHX4,89884,ENSG00000121454,fused to IGH in ALL,"Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant",Lhx4 (MGI:101776)
1,180269662,180502576,1q25.3-q25.3,1q25.2-q25.3,616352,ACBD6,Acyl-CoA-binding domain-containing protein 6,ACBD6,84320,ENSG00000230124,NA,NA,Acbd6 (MGI:1919732)
1,180434795,180436801,1q25.3,1q25.3,610030,VDAC4,Voltage-dependent anion channel 4,VDAC1P4,7418,NA,NA,NA,NA
1,180632009,180890278,1q25.1,1q25.3,605237,"XPR1, SYG1, IBGC6",Xenotropic and polytropic retrovirus receptor,XPR1,9213,ENSG00000143324,NA,"Basal ganglia calcification, idiopathic, 6, 616413 (3), Autosomal dominant",Xpr1 (MGI:97932)
1,180972711,181023120,1q25.3,1q25.3,603944,STX6,Syntaxin 6,STX6,10228,ENSG00000135823,NA,NA,Stx6 (MGI:1926235)
1,181033391,181061937,1q25.3,1q25.3,600764,"MR1, HLALS","Major histocompatibility complex, class I-related",MR1,3140,ENSG00000153029,NA,NA,Mr1 (MGI:1195463)
1,181088699,181092899,1q25.3,1q25.3,607177,IER5,Immediate-early response gene 5,IER5,51278,ENSG00000162783,NA,NA,Ier5 (MGI:1337072)
1,181317711,181808083,1q25-q31,1q25.3,601013,"CACNA1E, CACNL1A6, EIEE69","Calcium channel, voltage-dependent, alpha 1E subunit",CACNA1E,777,ENSG00000198216,NA,"Epileptic encephalopathy, early infantile, 69, 618285 (3), Autosomal dominant",Cacna1e (MGI:106217)
1,182378092,182392205,1q31,1q25.3,138290,"GLUL, GLNS",Glutamate-ammonia ligase (glutamine synthase),GLUL,2752,ENSG00000135821,pseudogene on chr.9,"Glutamine deficiency, congenital, 610015 (3), Autosomal recessive",Glul (MGI:95739)
1,182447875,182560596,1q25,1q25.3,611012,RGSL1,Regulator of G protein signaling-like 1,RGSL1,353299,ENSG00000121446,NA,NA,Rgsl1 (MGI:2685048)
1,182573633,182589284,1q25,1q25.3,180435,"RNASEL, RNS4, PRCA1, HPC1","Ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)",RNASEL,6041,ENSG00000135828,NA,"Prostate cancer 1, 601518 (3), Autosomal dominant",Rnasel (MGI:1098272)
1,182598622,182604388,1q25-q31,1q25.3,602514,RGS16,Regulator of G protein signaling-16,RGS16,6004,ENSG00000143333,NA,NA,Rgs16 (MGI:108407)
1,182789448,182830383,1q25,1q25.3,611412,"NPL, C1orf13, C112",N-acetylneuraminate pyruvate lyase,NPL,80896,ENSG00000135838,NA,NA,Npl (MGI:1921341)
1,182839303,182887981,1q25,1q25.3,603115,"DHX9, DDX9, NDHII",DEAH (Asp-Glu-Ala-His) box polypeptide 9,DHX9,1660,ENSG00000135829,NA,NA,Dhx9 (MGI:108177)
1,183023419,183145591,1q31,1q25.3,150290,"LAMC1, LAMB2","Laminin, gamma-1 (formerly LAMB2)",LAMC1,3915,ENSG00000135862,"at least 3 genes, ?linked",NA,Lamc1 (MGI:99914)
1,183186263,183245126,1q25-q31,1q25.3,150292,"LAMC2, LAMNB2, LAMB2T","Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD)",LAMC2,3918,ENSG00000058085,NA,"Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive",Lamc2 (MGI:99913)
1,183248236,183418379,1q25.3,1q25.3,608701,"NMNAT2, PNAT2, KIAA0479",Nicotinamide nucleotide adenylyltransferase 2,NMNAT2,23057,ENSG00000157064,NA,NA,Nmnat2 (MGI:2444155)
1,183471992,183554192,1q25,1q25.3,610964,"SMG7, EST1C, KIAA0250","SMG7, C. elegans, homolog of",SMG7,9887,ENSG00000116698,NA,NA,Smg7 (MGI:2682334)
1,183555561,183590913,1q25,1q25.3,608515,NCF2,"Neutrophil cytosolic factor-2, 65kD",NCF2,4688,ENSG00000116701,NA,"Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3), Autosomal recessive",Ncf2 (MGI:97284)
1,183620845,183635782,1q25.3,1q25.3,604227,"ARPC5, ARC16","Actin-related protein 2/3 complex, subunit 5",ARPC5,10092,ENSG00000162704,NA,NA,Arpc5 (MGI:1915021)
1,183636093,183928542,1q25.3,1q25.3,605667,"RGL1, RGL",Ral guanine nucleotide dissociation stimulator-like 1,RGL1,23179,ENSG00000143344,NA,NA,Rgl1 (MGI:107484)
1,183646274,183653315,1q25.3,1q25.3,609908,APOBEC4,"Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 4",APOBEC4,403314,ENSG00000173627,NA,NA,Apobec4 (MGI:1918531)
1,183929661,184037727,1q25.3,1q25.3,617533,"COLGALT2, GLT25D2, KIAA0584",Collagen beta(1-0)galactosyltransferase 2,COLGALT2,23127,ENSG00000198756,NA,NA,Colgalt2 (MGI:2138232)
1,184051650,184097484,1q25,1q25.3,608756,"TSEN15, SEN15, C1orf19, PCH2F","tRNA splicing endonuclease 15, S. cerevisiae, homolog of",TSEN15,116461,ENSG00000198860,NA,"Pontocerebellar hypoplasia, type 2F, 617026 (3), Autosomal recessive",Tsen15 (MGI:1913887)
1,184690236,184754906,1q25.3,1q25.3,610214,"EDEM3, C1orf22",Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 3,EDEM3,80267,ENSG00000116406,NA,NA,Edem3 (MGI:1914217)
1,185045429,185102602,1q25.3,1q25.3,608985,"RNF2, RING2, RING1B, HIPI3, DING, BAP1",RING finger protein 2,RNF2,6045,ENSG00000121481,NA,NA,Rnf2 (MGI:1101759)
1,185118084,185157097,1q25,1q25.3,611673,"TRMT1L, C1orf25, TRM1L",tRNA methyltransferase 1-like,TRMT1L,81627,ENSG00000121486,NA,NA,Trmt1l (MGI:1916185)
1,185292366,185317291,1q25.3,1q25.3,609209,"IVNS1ABP, NS1BP, ND1",Influenza virus NS1A protein-binding protein,IVNS1ABP,10625,ENSG00000116679,NA,NA,Ivns1abp (MGI:2152389)
1,185734390,186190948,1q24-q25,1q25.3-q31.1,608548,"HMCN1, FBLN6, FIBL6, ARMD1",Hemicentin (fibulin 6),HMCN1,83872,ENSG00000143341,NA,"{Macular degeneration, age-related, 1}, 603075 (3), Autosomal dominant",Hmcn1 (MGI:2685047)
1,185800000,198700000,1q31,NA,120502,BOS2,Branchiootic syndrome 2,NA,64585,NA,NA,"Branchiootic syndrome 2, 120502 (2), Autosomal dominant",NA
1,185800000,198700000,1q31,NA,612005,CELIAC7,"Celiac disease, susceptibility to, 7",NA,100301522,NA,associated with rs2816316,"{Celiac disease, susceptibility to, 7}, 612005 (2)",NA
1,185800000,198700000,1q31,NA,607516,"MGR6, FHM3","Migraine, several forms",NA,317773,NA,NA,"{Migraine with or without aura, susceptibility to, 6}, 607516 (2), Autosomal dominant; {Migraine, familial hemiplegic, 4}, 607516 (2), Autosomal dominant",NA
1,185800000,236400000,1q31-q42,NA,145260,"PHA2A, PHA2",Pseudohypoaldosteronism type IIA,NA,7830,NA,NA,"Pseudohypoaldosteronism, type IIA, 145260 (2), Autosomal dominant",NA
1,185800000,190800000,1q31.1,NA,609454,PSNP2,"Supranuclear palsy, progressive, 2",NA,619408,NA,between D1S238 and D1S2823,"Supranuclear palsy, progressive, 2, 609454 (2), Autosomal dominant",NA
1,185800000,198700000,1q31,NA,176780,PVOP1,"Pelvic organ prolapse, susceptibility to, 1",NA,100312952,NA,associated with rs10911193,"{Pelvic organ prolapse, susceptibility to, 1}, 176780 (2), Autosomal dominant",NA
1,186296272,186314566,1q24-q25,1q31.1,604283,"PRG4, CACP, MSF, SZP, HAPO",Proteoglycan 4 (megakaryocyte stimulating factor; hemangiopoietin),PRG4,10216,ENSG00000116690,NA,"Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3), Autosomal recessive",NA
1,186311651,186375252,1q25,1q31.1,189940,TPR,Tumor potentiating region (translocated promoter region),TPR,7175,ENSG00000047410,fused with MET in chemically induced tumor,NA,Tpr (MGI:1922066)
1,186375757,186421374,1q31.1,1q31.1,609335,"ODR4, C1orf27","Odorant response abnormal 4, C. elegans, homolog of",ODR4,54953,ENSG00000157181,NA,NA,Odr4 (MGI:2385108)
1,186400571,186401454,1q31.1,1q31.1,604301,"OCLM, TISR",Oculomedin,OCLM,10896,ENSG00000262180,NA,NA,NA
1,186443565,186461113,1q25-q31.1,1q31.1,171490,PDC,"Phosducin, pineal gland",PDC,5132,ENSG00000116703,NA,NA,Pdc (MGI:98090)
1,186671790,186680422,1q25.2-q25.3,1q31.1,600262,PTGS2,Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),PTGS2,5743,ENSG00000073756,NA,NA,Ptgs2 (MGI:97798)
1,186680653,186681445,1q31.1,1q31.1,617650,"PACERR, PTGS2AS1","PTGS2 antisense NFKB1 complex-mediated expression regulator RNA, noncoding",PACERR,103752588,ENSG00000273129,NA,NA,NA
1,186828899,186988980,1q25,1q31.1,600522,"PLA2G4A, PLA2G4, GURDP","Phospholipase A2, group IVA, cytosolic",PLA2G4A,5321,ENSG00000116711,NA,"Gastrointestinal ulceration, recurrent, with dysfunctional platelets, 618372 (3), Autosomal recessive",Pla2g4a (MGI:1195256)
1,190097657,190477996,1q31.1,1q31.1,618390,"BRINP3, FAM5C",Bone morphogenetic protein/retionoic acid-inducible neural-specific protein 3,BRINP3,339479,ENSG00000162670,NA,NA,Brinp3 (MGI:2443035)
1,192316991,192367284,1q31.2,1q31.2,612407,RGS21,Regulator of G protein signaling 21,RGS21,431704,ENSG00000253148,NA,NA,Rgs21 (MGI:3645243)
1,192575772,192580023,1q31,1q31.2,600323,"RGS1, IER1, IR20",Regulator of G-protein signaling 1,RGS1,5996,ENSG00000090104,NA,NA,Rgs1 (MGI:1354694)
1,192809038,192812274,1q31,1q31.2,600861,"RGS2, G0S8","G0 to G1 switch regulatory 8, 24kD",RGS2,5997,ENSG00000116741,NA,NA,Rgs2 (MGI:1098271)
1,193012252,193060139,1q32,1q31.2,610667,"UCHL5, UCH37",Ubiquitin carboxyl-terminal hydrolase L5,UCHL5,51377,ENSG00000116750,NA,NA,Uchl5 (MGI:1914848)
1,193059453,193091776,1q31,1q31.2,600063,"TROVE2, RO60, SSA2","TROVE domain family, member 2",RO60,6738,ENSG00000116747,NA,NA,Ro60 (MGI:106652)
1,193096464,193106113,1q31.2-q31.3,1q31.2,606820,"GLRX2, GRX2",Glutaredoxin 2,GLRX2,51022,ENSG00000023572,NA,NA,Glrx2 (MGI:1916617)
1,193121957,193254814,1q25-q31,1q31.2,607393,"CDC73, HRPT2, C1orf28","Cell division cycle protein 73, S. cerevisiae, homolog of",CDC73,79577,ENSG00000134371,NA,"Hyperparathyroidism, familial primary, 145000 (3), Autosomal dominant; Hyperparathyroidism-jaw tumor syndrome, 145001 (3), Autosomal dominant; Parathyroid adenoma with cystic changes, 145001 (3), Autosomal dominant; Parathyroid carcinoma, 608266 (3)",Cdc73 (MGI:2384876)
1,193178729,193186612,1q31,1q31.2,603018,"B3GALT2, GLCT2","UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 2",B3GALT2,8707,ENSG00000162630,NA,NA,B3galt2 (MGI:1349461)
1,193800000,207100000,1q31.3-q32.1,NA,614826,NYS7,"Nystagmus 7, congenital, autosomal dominant",NA,101055624,NA,between D1S218 and D1S2655,"Nystagmus 7, congenital, autosomal dominant, 614826 (2), Autosomal dominant",NA
1,196225778,196608575,1q31.3,1q31.3,610044,"KCNT2, SLICK, EIEE57","Potassium channel, subfamily T, member 2",KCNT2,343450,ENSG00000162687,mutation identified in 1 EIEE57 patient,"?Epileptic encephalopathy, early infantile, 57, 617771 (3), Autosomal dominant",Kcnt2 (MGI:3036273)
1,196651877,196747503,1q32,1q31.3,134370,"CFH, HF1, HUS, ARMD4, AHUS1",Complement factor H,CFH,3075,ENSG00000000971,NA,"Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant; {Macular degeneration, age-related, 4}, 610698 (3)",Cfh (MGI:88385)
1,196774799,196794072,1q31-q32.1,1q31.3,605336,"CFHR3, FHR3, HLF4, CFHL3",Complement factor H-related 3,CFHR3,10878,ENSG00000116785,NA,"{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3), Autosomal recessive, Autosomal dominant; {Macular degeneration, age-related, reduced risk of}, 603075 (3), Autosomal dominant",NA
1,196819729,196832188,1q31-q32.1,1q31.3,134371,"CFHR1, FHR1, HFL1, CFHL1",Complement factor H-related 1,CFHR1,3078,ENSG00000244414,NA,"{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3), Autosomal recessive, Autosomal dominant; {Macular degeneration, age-related, reduced risk of}, 603075 (3), Autosomal dominant",Cfhr1 (MGI:2138169)
1,196888050,196918910,1q31-q32.1,1q31.3,605337,"CFHR4, FHR4, CFHL4",Complement factor H-related 4,CFHR4,10877,ENSG00000134365,NA,NA,NA
1,196943737,196959621,1q31-q32.1,1q31.3,600889,"CFHR2, FHR2, HFL3, CFHL2",Complement factor H-related 2,CFHR2,3080,ENSG00000080910,in same 165kb YAC as F13B,NA,NA
1,196975021,197009724,1q32,1q31.3,608593,"CFHR5, CFHL5, FHR5, CFHR5D",Complement factor H-related 5,CFHR5,81494,ENSG00000134389,NA,"Nephropathy due to CFHR5 deficiency, 614809 (3), Autosomal dominant",NA
1,197038740,197067266,1q31-q32.1,1q31.3,134580,F13B,"Coagulation factor XIII, B polypeptide",F13B,2165,ENSG00000143278,NA,"Factor XIIIB deficiency, 613235 (3), Autosomal recessive",F13b (MGI:88379)
1,197084126,197146693,1q31,1q31.3,605481,"ASPM, MCPH5","Abnormal spindle-like, microcephaly-associated",ASPM,259266,ENSG00000066279,NA,"Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive",Aspm (MGI:1334448)
1,197201503,197478454,1q31-q32.1,1q31.3,604210,"CRB1, RP12, LCA8","Crumbs, Drosophila, homolog of, 1",CRB1,23418,ENSG00000134376,NA,"Leber congenital amaurosis 8, 613835 (3); Pigmented paravenous chorioretinal atrophy, 172870 (3), Autosomal dominant; Retinitis pigmentosa-12, 600105 (3), Autosomal recessive",Crb1 (MGI:2136343)
1,197504747,197782137,1q31.3,1q31.3,613292,"DENND1B, FAM31B, C1orf18",DENN/MADD domain-containing 1B,DENND1B,163486,ENSG00000213047,NA,NA,Dennd1b (MGI:2447812)
1,197912504,197935477,1q31-q32,1q31.3,606066,LHX9,LIM homeo box gene 9,LHX9,56956,ENSG00000143355,NA,NA,Lhx9 (MGI:1316721)
1,198156997,198322419,1q31.3,1q31.3,606848,NEK7,Never-in-mitosis gene A-related kinase 7,NEK7,140609,ENSG00000151414,NA,NA,Nek7 (MGI:1890645)
1,198523221,198540944,1q31.2-q31.3,1q31.3,618071,ATP6V1G3,"ATPase, H+ transporting, V1 subunit G3",ATP6V1G3,127124,ENSG00000151418,NA,NA,Atp6v1g3 (MGI:2450548)
1,198638967,198757475,1q31-q32,1q31.3-q32.1,151460,"PTPRC, CD45, LCA","Protein tyrosine phosphatase, receptor type, c polypeptide",PTPRC,5788,ENSG00000081237,NA,"{Hepatitis C virus, susceptibility to}, 609532 (3); Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive",Ptprc (MGI:97810)
1,198700000,214400000,1q32,NA,137950,GFND1,Glomerulopathy with fibronectin deposits 1,NA,100689213,NA,max lod at D1S2782,"Glomerulopathy with fibronectin deposits 1, 137950 (2), Autosomal dominant",NA
1,198700000,236400000,1q32.1-q42,NA,139280,GUK2,Guanylate kinase-2,GUK2,2988,NA,genetic independence of GUK1 and GUK2 unproved,NA,NA
1,198700000,207100000,1q32.1,NA,612381,IBD23,Inflammatory bowel disease 23,NA,100240733,NA,associated with rs3024505,"{Inflammatory bowel disease 23}, 612381 (2)",NA
1,198700000,214400000,1q32,NA,613164,PARK16,Parkinson disease 16,PARK16,100359403,NA,associated with rs823128,"{Parkinson disease 16}, 613164 (2)",NA
1,198700000,214400000,1q32,NA,140400,PFHB2,"Progressive familial heart block, type II",NA,105463127,NA,between D1S70 and D1S505,"Progressive familial heart block, type II, 140400 (2), Autosomal dominant",NA
1,198858872,198858981,1q31.3,1q32.1,612744,"MIR181B1, MIRN181B1",Micro RNA 181B1,MIR181B1,406955,ENSG00000207975,NA,NA,NA
1,198859043,198859152,1q31.3,1q32.1,612742,"MIR181A1, MIR213, MIRN181A1",Micro RNA 181A1,MIR181A1,406995,ENSG00000207759,NA,NA,NA
1,200027709,200177423,1q32.1,1q32.1,604453,"NR5A2, FTF, HB1F","Nuclear receptor subfamily 5, group A, member 2 (fetoprotein transcription factor)",NR5A2,2494,ENSG00000116833,NA,NA,Nr5a2 (MGI:1346834)
1,200551496,200620790,1q31,1q32.1,611279,"KIF14, KIAA0042, MKS12, MCPH20",Kinesin family member 14,KIF14,9928,ENSG00000118193,mutation identified in 1 MKS12 family,"?Meckel syndrome 12, 616258 (3), Autosomal recessive; Microcephaly 20, primary, autosomal recessive, 617914 (3), Autosomal recessive",Kif14 (MGI:1098226)
1,200640804,200669997,1q32.1,1q32.1,615464,"DDX59, OFD5",DEAD box polypeptide 59,DDX59,83479,ENSG00000118197,NA,"Orofaciodigital syndrome V, 174300 (3), Autosomal recessive",Ddx59 (MGI:1915247)
1,200738904,200860706,1q32.1,1q32.1,613775,"CAMSAP1L, CAMSAP2, KIAA1078",Calmodulin-regulated spectrin-associated protein 1-like 1,CAMSAP2,23271,ENSG00000118200,NA,NA,Camsap2 (MGI:1922434)
1,200872980,200874177,1q32.1,1q32.1,602174,GPR25,G protein-coupled receptor-25,GPR25,2848,ENSG00000170128,NA,NA,Gpr25 (MGI:2686146)
1,200891073,200915741,1q32.1,1q32.1,618051,"INAVA, C1orf106, IBD29",Innate immunity activator,INAVA,55765,ENSG00000163362,NA,"{Inflammatory bowel disease 29}, 618077 (3)",Inava (MGI:1921579)
1,200969389,201023713,1q31-q32,1q32.1,608322,"KIF21B, KIAA0449",Kinesin family member 21B,KIF21B,23046,ENSG00000116852,NA,NA,Kif21b (MGI:109234)
1,201039508,201112452,1q32,1q32.1,114208,"CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1","Calcium channel, voltage-dependent, L type, alpha 1S subunit",CACNA1S,779,ENSG00000081248,"in mouse, mutation causes muscular dysgenesis","Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant; {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant",Cacna1s (MGI:88294)
1,201134770,201171624,1q41,1q32.1,616877,"TMEM9, TMEM9A, DERM4",Transmembrane protein 9,TMEM9,252839,ENSG00000116857,NA,NA,Tmem9 (MGI:1913491)
1,201190779,201228951,1q32.1,1q32.1,617309,"IGFN1, EEF1A2BP1",Immunoglobulin-like and fibronectin type III domains-containing protein 1,IGFN1,91156,ENSG00000163395,NA,NA,Igfn1 (MGI:3045352)
1,201283451,201332992,1q32,1q32.1,601975,PKP1,Plakophilin-1,PKP1,5317,ENSG00000081277,NA,"Ectodermal dysplasia/skin fragility syndrome, 604536 (3)",Pkp1 (MGI:1328359)
1,201359013,201377827,1q32,1q32.1,191045,"TNNT2, CMH2, CMD1D, RCM3, LVNC6","Troponin-T2, cardiac",TNNT2,7139,ENSG00000118194,NA,"Cardiomyopathy, dilated, 1D, 601494 (3), Autosomal dominant; Cardiomyopathy, familial restrictive, 3, 612422 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 2, 115195 (3), Autosomal dominant; Left ventricular noncompaction 6, 601494 (3), Autosomal dominant",Tnnt2 (MGI:104597)
1,201380832,201399323,1q25.1-q32.3,1q32.1,602314,LAD1,Ladinin,LAD1,3898,ENSG00000159166,NA,NA,Lad1 (MGI:109343)
1,201403783,201421729,1q31.3,1q32.1,191042,TNNI1,"Troponin-I, skeletal, slow",TNNI1,7135,ENSG00000159173,NA,NA,Tnni1 (MGI:105073)
1,201464277,201469187,1q31,1q32.1,607054,"PHLDA3, TIH1","Pleckstrin homology-like domain, family A, member 3",PHLDA3,23612,ENSG00000174307,NA,NA,Phlda3 (MGI:1351485)
1,201483529,201507122,1q32,1q32.1,123876,"CSRP1, CSRP",Cysteine and glycine-rich protein-1,CSRP1,1465,ENSG00000159176,NA,NA,Csrp1 (MGI:88549)
1,201539126,201826973,1q31,1q32.1,611628,"NAV1, POMFIL3, KIAA1151",Neuron navigator 1,NAV1,89796,ENSG00000134369,NA,NA,Nav1 (MGI:2183683)
1,201808610,201808701,1q32.1,1q32.1,617040,MIR1231,Micro RNA 1231,MIR1231,100302158,ENSG00000221028,NA,NA,NA
1,201888668,201892586,1q32.1,1q32.1,617326,"SHISA4, C1orf40, TMEM58","Shisa family, member 4",SHISA4,149345,ENSG00000198892,NA,NA,Shisa4 (MGI:1924802)
1,201896455,201946547,1q32,1q32.1,602715,"LMOD1, SMLMOD, 1D",Leiomodin 1,LMOD1,25802,ENSG00000163431,NA,NA,Lmod1 (MGI:2135671)
1,201955502,201970663,1q32,1q32.1,605057,"TIMM17A, TIM17A","Translocase of inner mitochondrial membrane 17, yeast, homolog of, A",TIMM17A,10440,ENSG00000134375,NA,NA,Timm17a (MGI:1343131)
1,201982647,202006142,1q32.1-q32.2,1q32.1,602675,RNPEP,Arginyl aminopeptidase (aminopeptidase B),RNPEP,6051,ENSG00000176393,NA,NA,Rnpep (MGI:2384902)
1,202010582,202017182,1q32,1q32.1,602191,"ELF3, ESX","E74-like factor 3 (ETS domain transcription factor, serine box, epithelial-specific)",ELF3,1999,ENSG00000163435,NA,NA,Elf3 (MGI:1101781)
1,202118668,202133591,1q32.1,1q32.1,617630,"GPR37L1, ETBRLP2",G protein-coupled receptor 37-like 1,GPR37L1,9283,ENSG00000170075,NA,NA,Gpr37l1 (MGI:1928503)
1,202133403,202144742,1q32.1,1q32.1,616597,"ARL8A, GIE2",ADP-ribosylation factor-like 8A,ARL8A,127829,ENSG00000143862,NA,NA,Arl8a (MGI:1915974)
1,202147011,202161587,1q32.1,1q32.1,176889,PTPN7,"Protein tyrosine phosphatase, nonreceptor-type, 7",PTPN7,5778,ENSG00000143851,NA,NA,Ptpn7 (MGI:2156893)
1,202193989,202319760,1q32,1q32.1,606653,LGR6,Leucine-rich repeat-containing G protein-coupled receptor-6,LGR6,59352,ENSG00000133067,NA,NA,Lgr6 (MGI:2441805)
1,202331656,202341965,1q31,1q32.1,610538,"UBE2T, HSPC150, FANCT",Ubiquitin-conjugating enzyme E2T,UBE2T,29089,ENSG00000077152,NA,"Fanconi anemia, complementation group T, 616435 (3), Autosomal recessive",Ube2t (MGI:1914446)
1,202348698,202592701,1q32.1,1q32.1,603768,"PPP1R12B, MYPT2","Protein phosphatase 1, regulatory subunit 12B (myosin phosphatase target subunit 2)",PPP1R12B,4660,ENSG00000077157,NA,NA,NA
1,202590595,202710453,1q32.1,1q32.1,600104,"SYT2, CMS7, MYSPC",Synaptotagmin-2,SYT2,127833,ENSG00000143858,NA,"Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3), Autosomal dominant",Syt2 (MGI:99666)
1,202725184,202809469,1q32,1q32.1,605393,"KDM5B, JARID1B, PUT1, PLU1, RBBP2H1A, MRT65",Lysine-specific demethylase 5B,KDM5B,10765,ENSG00000117139,NA,"Mental retardation, autosomal recessive 65, 618109 (3), Autosomal recessive",Kdm5b (MGI:1922855)
1,202878281,202889148,1q32-q41,1q32.1,603417,"RABIF, RASGFR3, MSS4",Rab-interacting factor (Ras-specific guanine-releasing factor-3; mammalian suppressor of SEC4),RABIF,5877,ENSG00000183155,NA,NA,Rabif (MGI:2138605)
1,202891115,202928627,1q32.1,1q32.1,614522,"KLHL12, DKIR",Kelch-like 12,KLHL12,59349,ENSG00000117153,NA,NA,Klhl12 (MGI:2385619)
1,202940824,202958571,1q32.1,1q32.1,607945,"ADIPOR1, CGI45",Adiponectin receptor 1,ADIPOR1,51094,ENSG00000159346,NA,NA,Adipor1 (MGI:1919924)
1,202961872,202967256,1q32,1q32.1,608341,"CYB5BR1, NQO3A2, B5R.1",Cytochrome b5 reductase 1,CYB5R1,51706,ENSG00000159348,NA,NA,Cyb5r1 (MGI:1919267)
1,203026490,203078735,1q32.1,1q32.1,603145,PPFIA4,"Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha 4",PPFIA4,8497,ENSG00000143847,NA,NA,NA
1,203083128,203086011,1q31-q41,1q32.1,159980,"MYOG, MYF4",Myogenic factor-4; myogenin,MYOG,4656,ENSG00000122180,NA,NA,Myog (MGI:97276)
1,203127704,203167404,1q32.1,1q32.1,102775,"ADORA1, RDC7",Adenosine A1 receptor,ADORA1,134,ENSG00000163485,NA,NA,Adora1 (MGI:99401)
1,203167810,203175825,1q32.1,1q32.1,160795,MYBPH,Myosin-binding protein H,MYBPH,4608,ENSG00000133055,NA,NA,Mybph (MGI:1858196)
1,203178930,203186703,1q32.1,1q32.1,601525,"CHI3L1, GP39, YKL40, ASRT7",Chitinase 3-like 1 (cartilage glycoprotein-39),CHI3L1,1116,ENSG00000133048,NA,"{Asthma-related traits, susceptibility to, 7}, 611960 (3); {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant",Chil1 (MGI:1340899)
1,203216078,203229731,1q31-q32,1q32.1,600031,"CHIT, CHITD",Chitotriosidase,CHIT1,1118,ENSG00000133063,NA,"[Chitotriosidase deficiency], 614122 (3), Autosomal recessive",Chit1 (MGI:1919134)
1,203305518,203309601,1q32,1q32.1,601597,"BTG2, PC3",B-cell translocation gene 2 (pheochromocytoma cell-3),BTG2,7832,ENSG00000159388,NA,NA,Btg2 (MGI:108384)
1,203340627,203351121,1q32.1,1q32.1,600245,FMOD,Fibromodulin,FMOD,2331,ENSG00000122176,NA,NA,Fmod (MGI:1328364)
1,203475805,203491351,1q32,1q32.1,601914,PRELP,Proline arginine-rich end leucine-rich repeat protein,PRELP,5549,ENSG00000188783,NA,NA,Prelp (MGI:2151110)
1,203626786,203744080,1q25-q32,1q32.1,108732,"ATP2B4, ATP2B2, PMCA4","ATPase, Ca++ transporting, plasma membrane, 4",ATP2B4,493,ENSG00000058668,NA,NA,Atp2b4 (MGI:88111)
1,203795536,203854127,1q32.1,1q32.1,613513,"ZC3H11A, KIAA0663",Zinc finger CCCH domain-containing protein 11A,ZC3H11A,9877,ENSG00000058673,NA,NA,Zc3h11a (MGI:1917829)
1,203797522,203801073,1q32.1,1q32.1,613512,ZBED6,Zinc finger BED domain-containing protein 6,ZBED6,100381270,ENSG00000257315,in intron 1 of ZC3H11A,NA,Zbed6 (MGI:3828086)
1,203861584,203871151,1q32,1q32.1,128260,"SNRPE, HYPT11",Small nuclear ribonucleoprotein polypeptide E,SNRPE,6635,ENSG00000182004,NA,"Hypotrichosis 11, 615059 (3), Autosomal dominant",Snrpert (MGI:3650419)
1,204073095,204127742,1q32,1q32.1,604748,"SOX13, ICA12",SRY-box 13,SOX13,9580,ENSG00000143842,NA,NA,Sox13 (MGI:98361)
1,204131061,204152043,1q32.1,1q32.1,609859,"ETNK2, EKI2",Ethanolamine kinase 2,ETNK2,55224,ENSG00000143845,NA,NA,Etnk2 (MGI:2443760)
1,204154818,204166336,1q32,1q32.1,179820,"REN, HNFJ2",Renin,REN,5972,ENSG00000143839,~24cM distal to AT3,"[Hyperproreninemia] (3); Hyperuricemic nephropathy, familial juvenile 2, 613092 (3), Autosomal dominant; Renal tubular dysgenesis, 267430 (3), Autosomal recessive",Ren1 (MGI:97898)
1,204190340,204196490,1q32,1q32.1,603286,"KISS1, HH13",KISS1 metastasis suppressor,KISS1,3814,ENSG00000170498,mutation identified in 1 HH13 family,"?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3), Autosomal recessive",Kiss1 (MGI:2663985)
1,204218852,204378376,1q32.1,1q32.1,607771,"PEPP3, KIAA0969",Phosphatidylinositol 3-phosphate-binding PH domain protein 3,PLEKHA6,22874,ENSG00000143850,NA,NA,NA
1,204398683,204412453,1q32.1,1q32.1,613257,"PPP1R15B, CREP, MSSGM2","Protein phosphatase 1, regulatory subunit 15B",PPP1R15B,84919,ENSG00000158615,NA,"Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3), Autosomal recessive",Ppp1r15b (MGI:2444211)
1,204422629,204494814,1q32,1q32.1,602838,PIK3C2B,"Phosphatidylinositol 3-kinase, class 2, beta polypeptide",PIK3C2B,5287,ENSG00000133056,NA,NA,Pik3c2b (MGI:2685045)
1,204516376,204558119,1q32,1q32.1,602704,MDM4,"Mouse double minute 4, homolog of",MDM4,4194,ENSG00000198625,NA,NA,Mdm4 (MGI:107934)
1,204617169,204685835,1q32.1,1q32.1,605492,"LRRN2, GAC1, LRANK1","Leucine-rich repeat protein, neuronal, 2",LRRN2,10446,ENSG00000170382,NA,NA,Lrrn2 (MGI:106037)
1,204828651,205022821,1q32.1,1q32.1,609145,"NFASC, KIAA0756, NEDCPMD",Neurofascin,NFASC,23114,ENSG00000163531,NA,"Neurodevelopmental disorder with central and peripheral motor dysfunction, 618356 (3), Autosomal recessive",Nfasc (MGI:104753)
1,205042936,205078288,1q32.1,1q32.1,190197,"CNTN2, TAX, TAX1, FAME5",Contactin 2 (transiently-expressed axonal glycoprotein),CNTN2,6900,ENSG00000184144,1 family identified with mutation,"?Epilepsy, myoclonic, familial adult, 5, 615400 (3), Autosomal recessive",Cntn2 (MGI:104518)
1,205086141,205122014,1q32,1q32.1,600697,"RBBP5, RBQ3",Retinoblastoma-binding protein-5,RBBP5,5929,ENSG00000117222,NA,NA,Rbbp5 (MGI:1918367)
1,205142496,205211701,1q32.1,1q32.1,612666,"DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23",Dual serine/threonine and tyrosine protein kinase,DSTYK,25778,ENSG00000133059,NA,"Congenital anomalies of kidney and urinary tract 1, 610805 (3), Autosomal dominant; Spastic paraplegia 23, 270750 (3), Autosomal recessive",Dstyk (MGI:1925064)
1,205302058,205321744,1q32,1q32.1,608131,"NUAK2, SNARK","NUAK family, SNF1-like kinase, 2",NUAK2,81788,ENSG00000163545,NA,NA,Nuak2 (MGI:1921387)
1,205336060,205357089,1q32.1,1q32.1,614503,KLHDC8A,Kelch domain-containing protein 8A,KLHDC8A,55220,ENSG00000162873,NA,NA,Klhdc8a (MGI:2442630)
1,205381377,205449955,1q32.1,1q32.1,610480,LEMD1,LEM domain-containing protein 1,LEMD1,93273,ENSG00000186007,NA,NA,NA
1,205434885,205456085,1q32.1,1q32.1,615480,"BLACAT1, LINC00912","Bladder cancer-associated transcript 1, noncoding",BLACAT1,101669762,NA,NA,NA,NA
1,205504592,205532792,1q31-q32,1q32.1,169190,"CDK18, PCTK3",Cyclin-dependent kinase 18,CDK18,5129,ENSG00000117266,NA,NA,Cdk18 (MGI:97518)
1,205607942,205632871,1q32,1q32.1,600246,"ELK4, SAP1","ELK4, ETS-domain protein (SRF accessory protein 1)",ELK4,2005,ENSG00000158711,NA,NA,Elk4 (MGI:102853)
1,205657850,205680508,1q32.1,1q32.1,605097,"SLC45A3, PRST, PCANAP6, IPCA6","Solute carrier family 45, member 3 (prostein)",SLC45A3,85414,ENSG00000158715,NA,NA,Slc45a3 (MGI:1922082)
1,205712821,205750219,1q32.1,1q32.1,611912,"NUCKS1, NUCKS",Nuclear casein kinase and cyclin-dependent kinase substrate 1,NUCKS1,64710,ENSG00000069275,NA,NA,Nucks1 (MGI:1934811)
1,205767985,205775486,1q32,1q32.1,603949,RAB7L1,RAB7-like 1,RAB29,8934,ENSG00000117280,NA,NA,Rab29 (MGI:2385107)
1,205789094,205813758,1q31-q32,1q32.1,610801,SLC41A1,"Solute carrier family 41, member 1",SLC41A1,254428,ENSG00000133065,NA,NA,Slc41a1 (MGI:2444823)
1,205828021,205850147,1q32.1,1q32.1,617124,PM20D1,Peptidase M20 domain-containing protein 1,PM20D1,148811,ENSG00000162877,NA,NA,Pm20d1 (MGI:2442939)
1,205913047,205943471,1q32.1,1q32.1,608481,SLC26A9,"Solute carrier family 26 (sulfate transporter), member 9",SLC26A9,115019,ENSG00000174502,NA,NA,Slc26a9 (MGI:2444594)
1,206009263,206023898,1q31,1q32.1,116890,CTSE,Cathepsin E,CTSE,1510,ENSG00000196188,closely linked to REN,NA,Ctse (MGI:107361)
1,206053172,206102448,1q32.1,1q32.1,616088,"C1orf186, RHEX",Chromosome 1 open reading frame 186,RHEX,440712,ENSG00000263961,NA,NA,NA
1,206106935,206117387,1q32,1q32.1,600264,"AVPR1B, AVPR3",Arginine vasopressin receptor-1B,AVPR1B,553,ENSG00000198049,NA,NA,Avpr1b (MGI:1347010)
1,206186178,206205345,1q32,1q32.1,614710,"FAM72A, LMPIP, UGENE","Family with sequence similarity 72, member A",FAM72A,729533,ENSG00000196550,NA,NA,Fam72a (MGI:1919669)
1,206203555,206464442,1q32.1,1q32.1,606524,"SRGAP2, KIAA0456","Slit-robo GTPase-activating protein, rho, 2",SRGAP2,23380,ENSG00000266028,NA,NA,Srgap2 (MGI:109605)
1,206470242,206496889,1q32.1,1q32.1,605048,IKBKE,I-kappa-B kinase-epsilon,IKBKE,9641,ENSG00000263528,NA,NA,Ikbke (MGI:1929612)
1,206507530,206589447,1q32.1,1q32.1,607020,"RASSF5, NORE1","Ras association (RalGDS/AF-6) domain family 5 (Nore1, mouse, homolog of)",RASSF5,83593,ENSG00000266094,NA,NA,Rassf5 (MGI:1926375)
1,206572483,206612550,1q32.1,1q32.1,613709,"EIF2D, HCA56",Eukaryotic translation initiation factor 2D,EIF2D,1939,ENSG00000143486,NA,NA,Eif2d (MGI:109342)
1,206635535,206655174,1q32.2,1q32.1,603497,DYRK3,Dual-specificity tyrosine phosphorylation-regulated kinase 3,DYRK3,8444,ENSG00000143479,NA,NA,Dyrk3 (MGI:1330300)
1,206684904,206734282,1q32.1,1q32.1,602006,"MAPKAPK2, MK2",Mitogen-activated protein kinase-activated protein kinase 2,MAPKAPK2,9261,ENSG00000162889,NA,NA,Mapkapk2 (MGI:109298)
1,206767601,206772493,1q31-q32,1q32.1,124092,"IL10, CSIF, GVHDS",Interleukin-10,IL10,3586,ENSG00000136634,NA,"{Graft-versus-host disease, protection against}, 614395 (3); {HIV-1, susceptibility to}, 609423 (3); {Rheumatoid arthritis, progression of}, 180300 (3)",Il10 (MGI:96537)
1,206770772,206842980,1q32,1q32.1,605687,IL19,Interleukin 19,IL19,29949,ENSG00000142224,NA,NA,Il19 (MGI:1890472)
1,206865246,206869222,1q32,1q32.1,605619,IL20,Interleukin 20,IL20,50604,ENSG00000162891,NA,NA,Il20 (MGI:1890473)
1,206897403,206904138,1q32,1q32.1,604136,"IL24, ST16, MDA7",Interleukin 24 (suppression of tumorigenicity 16),IL24,11009,ENSG00000162892,NA,NA,Il24 (MGI:2135548)
1,206903281,206922000,1q32.2,1q32.1,606015,"FAIM3, TOSO, FCMR",Fas apoptotic inhibitory molecule 3,FCMR,9214,ENSG00000162894,NA,NA,Fcmr (MGI:1916419)
1,206928521,206946465,1q31-q42,1q32.1,173880,PIGR,Polymeric immunoglobulin receptor,PIGR,5284,ENSG00000162896,NA,NA,Pigr (MGI:103080)
1,206957954,206970656,1q32.3,1q32.1,605484,FCAMR,"Fc fragment of IgA and IgM, receptor for",FCAMR,83953,ENSG00000162897,NA,NA,Fcamr (MGI:1927803)
1,207018520,207032760,1q32.2,1q32.1,611680,"SARG, C1orf116",Specifically androgen-regulated gene,C1orf116,79098,ENSG00000182795,NA,NA,AA986860 (MGI:2138143)
1,207043848,207052979,1q32.1,1q32.1,612023,"YOD1, OTUD2, DUBA8","YOD1 OTU deubiquitinating enzyme 1, S. cerevisiae, homolog of",YOD1,55432,ENSG00000180667,NA,NA,Yod1 (MGI:2442596)
1,207053062,207081026,1q31,1q32.1,171835,PFKFB2,"Fructose-2,6-bisphosphatase, cardiac isozyme",PFKFB2,5208,ENSG00000123836,NA,NA,Pfkfb2 (MGI:107815)
1,207088794,207099992,1q32,1q32.1,120831,C4BPB,"Complement component 4-binding protein, beta polypeptide",C4BPB,725,ENSG00000123843,NA,NA,NA
1,207104231,207144971,1q32,1q32.2,120830,C4BPA,"Complement component 4-binding protein, alpha polypeptide",C4BPA,722,ENSG00000123838,same RE fragment as C4BPB,NA,NA
1,207321471,207360965,1q32,1q32.2,125240,"CD55, DAF, CROM, CHAPLE",CD55 antigen (blood group Cromer),CD55,1604,ENSG00000196352,NA,"[Blood group Cromer], 613793 (3), Autosomal recessive; Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy, 226300 (3), Autosomal recessive","Cd55,Cd55b (MGI:104850,MGI:104849)"
1,207454299,207489894,1q32,1q32.2,120650,"CR2, C3DR, SLEB9, CVID7",Complement component (3d/Epstein-Barr virus) receptor-2,CR2,1380,ENSG00000117322,NA,"Immunodeficiency, common variable, 7, 614699 (3), Autosomal recessive; {Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)",Cr2 (MGI:88489)
1,207496127,207641764,1q32,1q32.2,120620,"CR1, C3BR",Complement component (3b/4b) receptor-1,CR1,1378,ENSG00000203710,NA,"[Blood group, Knops system], 607486 (3); CR1 deficiency (1); {Malaria, severe, resistance to}, 611162 (3); {?SLE susceptibility} (1)",NA
1,207645132,207723702,1q32,1q32.2,605886,CR1L,Complement component receptor 1-like,CR1L,1379,ENSG00000197721,NA,NA,Cr1l (MGI:88513)
1,207752037,207795515,1q32,1q32.2,120920,"MCP, CD46, AHUS2","Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen)",CD46,4179,ENSG00000117335,NA,"{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3), Autosomal recessive, Autosomal dominant",Cd46 (MGI:1203290)
1,207801851,207801938,1q32.2,1q32.2,610784,"MIR29C, MIRN29C",Micro RNA 29C,MIR29C,407026,ENSG00000284214,NA,NA,NA
1,207880971,207911124,1q32,1q32.2,142230,CD34,CD34 antigen,CD34,947,ENSG00000174059,NA,NA,Cd34 (MGI:88329)
1,208022241,208244383,1q32.2,1q32.2,601054,"PLXNA2, OCT, PLXN2",Plexin A2 (OCT transmembrane protein),PLXNA2,5362,ENSG00000076356,NA,NA,Plxna2 (MGI:107684)
1,209432132,209432241,1q32.2,1q32.2,613147,"MIR205, MIRN205",Micro RNA 205,MIR205,406988,ENSG00000284485,NA,NA,NA
1,209583713,209613938,1q32-q41,1q32.2,614994,"CAMK1G, CLICK3",Calcium/calmodulin-dependent protein kinase IG,CAMK1G,57172,ENSG00000008118,NA,NA,Camk1g (MGI:2388073)
1,209614869,209652466,1q32,1q32.2,150310,"LAMB3, AI1A","Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)",LAMB3,3914,ENSG00000196878,NA,"Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive",Lamb3 (MGI:99915)
1,209675411,209676389,1q32-q41,1q32.2,614447,G0S2,G0/G1 switch gene 2,G0S2,50486,ENSG00000123689,NA,NA,G0s2 (MGI:1316737)
1,209686179,209734949,1q32-q41,1q32.2,600713,"HSD11B1, HSD11, HSD11L, CORTRD2","Hydroxysteroid, 11-beta, dehydrogenase 1",HSD11B1,3290,ENSG00000117594,digenic triallelic mutations with H6PD,"Cortisone reductase deficiency 2, 614662 (3), Autosomal dominant",Hsd11b1 (MGI:103562)
1,209756031,209782322,1q32.3-q41,1q32.2,608255,"TRAF3IP3, T3JAM",TRAF3-interacting protein 3,TRAF3IP3,80342,ENSG00000009790,NA,NA,Traf3ip3 (MGI:2441706)
1,209785616,209806174,1q32-q41,1q32.2,607199,"IRF6, VWS, LPS, PIT, PPS1, OFC6",Interferon regulatory factor 6,IRF6,3664,ENSG00000117595,OFC6 in enhancer 5' of IRF6,"{Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome, 119300 (3), Autosomal dominant",Irf6 (MGI:1859211)
1,209938164,210171388,1q32.2,1q32.2,610949,"SYT14, SCAR11",Synaptotagmin 14,SYT14,255928,ENSG00000143469,mutation identified in 1 SCAR11 family,"?Spinocerebellar ataxia, autosomal recessive 11, 614229 (3), Autosomal recessive",Syt14 (MGI:2444490)
1,210327872,210676297,1q32,1q32.2,605743,"HHAT, MART2, SKI1",Hedgehog acyltransferase,HHAT,55733,ENSG00000054392,NA,NA,Hhat (MGI:2444681)
1,210678313,211134147,1q32-q41,1q32.2,603305,"KCNH1, EAG, TMBTS, ZLS1","Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of)",KCNH1,3756,ENSG00000143473,NA,"Temple-Baraitser syndrome, 611816 (3), Autosomal dominant; Zimmermann-Laband syndrome 1, 135500 (3), Autosomal dominant",Kcnh1 (MGI:1341721)
1,211326593,211374945,1q32,1q32.3,602356,TRAF5,TNF receptor-associated factor 5,TRAF5,7188,ENSG00000082512,NA,NA,Traf5 (MGI:107548)
1,211476521,211492916,1q32.3,1q32.3,180040,"RD3, LCA12, C1orf36","Retinal degeneration 3, mouse, homolog of",RD3,343035,ENSG00000198570,NA,"Leber congenital amaurosis 12, 610612 (3), Autosomal recessive",Rd3 (MGI:1921273)
1,211571567,211579160,1q32.3,1q32.3,609521,"SLC30A1, ZNT1","Solute carrier family 30 (zinc transporter), member 1",SLC30A1,7779,ENSG00000170385,NA,NA,Slc30a1 (MGI:1345281)
1,211658255,211675629,1q32.2-q41,1q32.3,604043,"NEK2, RP67",Never in mitosis gene a-related kinase 2,NEK2,4751,ENSG00000117650,"pseudogenes on chr. 2, 14, and 22; mutation identified in 1 family","?Retinitis pigmentosa 67, 615565 (3), Autosomal recessive",Nek2 (MGI:109359)
1,211940327,212035659,1q32.3,1q32.3,611350,"INTS7, INT7",Integrator complex subunit 7,INTS7,25896,ENSG00000143493,NA,NA,Ints7 (MGI:1924315)
1,212035552,212105012,1q32.1-q32.2,1q32.3,610617,"DTL, RAMP, DCAF2, CDT2","Denticleless, Drosophila, homolog of",DTL,51514,ENSG00000143476,NA,NA,Dtl (MGI:1924093)
1,212285409,212361852,1q41,1q32.3,601643,PPP2R5A,"Protein phosphatase-2, regulatory subunit B (B56), alpha isoform",PPP2R5A,5525,ENSG00000066027,NA,NA,Ppp2r5a (MGI:2388479)
1,212363927,212415507,1q32.3,1q32.3,618427,"PACC1, TMEM206",Proton-activated chloride channel 1,PACC1,55248,ENSG00000065600,NA,NA,Pacc1 (MGI:1914200)
1,212432886,212446378,1q32.3,1q32.3,611874,"NENF, CIR2",Neuron-derived neurotrophic factor,NENF,29937,ENSG00000117691,NA,NA,Nenf (MGI:1913458)
1,212565333,212620776,1q32.3,1q32.3,603148,ATF3,Activating transcription factor 3,ATF3,467,ENSG00000162772,NA,NA,Atf3 (MGI:109384)
1,212686416,212699942,1p32.3,1q32.3,612470,BATF3,"Basic leucine zipper transcription factor, ATF-like, 3",BATF3,55509,ENSG00000123685,NA,NA,Batf3 (MGI:1925491)
1,212726152,212798899,1q41,1q32.3,609174,"NSL1, DC8, C1orf48","NSL1, MIS12 kinetochore complex component",NSL1,25936,ENSG00000117697,NA,NA,Nsl1 (MGI:2685830)
1,212856603,212858137,1q31,1q32.3,610864,LQK1,LQK1 protein,FLVCR1-DT,642946,ENSG00000198468,NA,NA,NA
1,212858274,212899362,1q31.3,1q32.3,609144,"FLVCR1, AXPC1, PCARP",Feline leukemia virus subgroup C receptor 1,FLVCR1,28982,ENSG00000162769,NA,"Ataxia, posterior column, with retinitis pigmentosa, 609033 (3), Autosomal recessive",Flvcr1 (MGI:2444881)
1,212950540,212991584,1q32.3,1q32.3,610471,VASH2,Vasohibin 2,VASH2,79805,ENSG00000143494,NA,NA,Vash2 (MGI:2444826)
1,213051232,213378752,1q32.3,1q32.3,617517,"RPS6KC1, RPK118",Ribosomal protein S6 kinase C1,RPS6KC1,26750,ENSG00000136643,NA,NA,Rps6kc1 (MGI:2443419)
1,213924748,213926653,1q41,1q32.3,614635,"LINC00538, YIYA",Long intergenic noncoding RNA 538,LINC00538,100861504,NA,NA,NA,NA
1,213983238,214041509,1q32.2-q32.3,1q32.3,601546,PROX1,Prospero-related homeo box 1,PROX1,5629,ENSG00000117707,NA,NA,Prox1 (MGI:97772)
1,214281158,214337135,1q41,1q32.3,610663,SMYD2,SET and MYND domain-containing protein 2,SMYD2,56950,ENSG00000143499,NA,NA,Smyd2 (MGI:1915889)
1,214348699,214551676,1q32,1q32-q41,603155,"PTPN14, PEZ, CATLPH","Protein tyrosine phosphatase, nonreceptor-type, 14",PTPN14,5784,ENSG00000152104,NA,"Choanal atresia and lymphedema, 613611 (3), Autosomal recessive",Ptpn14 (MGI:102467)
1,214400000,236400000,1q41-q42,NA,610836,AUTS11,"Autism, susceptibility to, 11",NA,100188820,NA,"associated with rs12740310, rs3737296, and rs12310279","{Autism susceptibility 11}, 610836 (2)",NA
1,214400000,236400000,1q41-q42,NA,612530,"DEL1q41q42, C1DELq41q42",Chromosome 1q41-q42 deletion syndrome,NA,NA,NA,contiguous gene deletion of 1.7Mb,"Chromosome 1q41-q42 deletion syndrome, 612530 (4), Isolated cases",NA
1,214400000,248956422,1q41-q44,NA,615589,OTSC10,Otosclerosis 10,OTSC10,102723100,NA,NA,"Otosclerosis 10, 615589 (2), Autosomal dominant",NA
1,214400000,223900000,1q41,NA,600332,RMD1,Rippling muscle disease 1,RMD1,6022,NA,NA,"Rippling muscle disease-1, 600332 (2), Autosomal dominant",NA
1,214603194,214664570,1q32-q41,1q41,600236,"CENPF, CILD31, STROMS","Centromere autoantigen F, 400kD",CENPF,1063,ENSG00000117724,NA,"Stromme syndrome, 243605 (3), Autosomal recessive",Cenpf (MGI:1313302)
1,215002919,215237092,1q41,1q41,603219,"KCNK2, TREK","Potassium channel, subfamily K, member 2",KCNK2,3776,ENSG00000082482,NA,NA,Kcnk2 (MGI:109366)
1,215567303,215621806,1q41,1q41,613272,KCTD3,Potassium channel tetramerization domain-containing protein 3,KCTD3,51133,ENSG00000136636,NA,NA,Kctd3 (MGI:2444629)
1,215622890,216423447,1q41,1q41,608400,"USH2A, RP39",Usherin,USH2A,7399,ENSG00000042781,NA,"Retinitis pigmentosa 39, 613809 (3); Usher syndrome, type 2A, 276901 (3), Autosomal recessive",Ush2a (MGI:1341292)
1,216503245,217137701,1q41,1q41,602969,ESRRG,"Estrogen-related receptor, gamma",ESRRG,2104,ENSG00000196482,NA,NA,Esrrg (MGI:1347056)
1,217426991,217631089,1q41,1q41,616836,"GPATCH2, GPATC2",G-patch domain-containing protein 2,GPATCH2,55105,ENSG00000092978,NA,NA,Gpatch2 (MGI:1915019)
1,217631332,217871695,1q41,1q41,611032,"SPATA17, MSRG11",Spermatogenesis-associated protein 17,SPATA17,128153,ENSG00000162814,NA,NA,Spata17 (MGI:1921967)
1,218285292,218337982,1q41,1q41,611193,RRP15,"Ribosomal RNA-processing 15, S. cerevisiae, homolog of",RRP15,51018,ENSG00000067533,NA,NA,Rrp15 (MGI:1914473)
1,218345283,218444618,1q41,1q41,190220,"TGFB2, LDS4","Transforming growth factor, beta-2",TGFB2,7042,ENSG00000092969,NA,"Loeys-Dietz syndrome 4, 614816 (3), Autosomal dominant",Tgfb2 (MGI:98726)
1,219173830,219445120,1q41,1q41,616548,LYPLAL1,Lysophospholipase-like 1,LYPLAL1,127018,ENSG00000143353,NA,NA,Lyplal1 (MGI:2385115)
1,219910394,219960103,1q41,1q41,611146,"SLC30A10, ZNT10, HMNDYT1","Solute carrier family 30 (zinc transporter), member 10",SLC30A10,55532,ENSG00000196660,NA,"Hypermanganesemia with dystonia 1, 613280 (3), Autosomal recessive",Slc30a10 (MGI:2685058)
1,219968599,220046504,1q41-q42,1q41,138295,"EPRS, PARS, HLD15",Glutamyl-prolyl-tRNA synthetase,EPRS,2058,ENSG00000136628,NA,"Leukodystrophy, hypomyelinating, 15, 617951 (3), Autosomal recessive",Eprs (MGI:97838)
1,220057481,220089915,1q41,1q41,604053,BPNT1,"3'(2'),5'-bisphosphate nucleotidase 1",BPNT1,10380,ENSG00000162813,NA,NA,Bpnt1 (MGI:1338800)
1,220094131,220148040,1q41,1q41,612801,"IARS2, CAGSSS",Isoleucyl-tRNA synthetase 2,IARS2,55699,ENSG00000067704,mutation identified in 1 CAGSSS family,"?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive",Iars2 (MGI:1919586)
1,220117852,220117961,1q41,1q41,610943,"MIR215, MIRN215",Micro RNA 215,MIR215,406997,ENSG00000207590,NA,NA,NA
1,220118156,220118240,1q41,1q41,610940,"MIR194-1, MIRN194-1",Micro RNA 194-1,MIR194-1,406969,ENSG00000207624,NA,NA,NA
1,220148292,220272452,1q41,1q41,609275,"RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2",RAB3 GTPase-activating protein (noncatalytic) subunit 2,RAB3GAP2,25782,ENSG00000118873,NA,"Martsolf syndrome, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive",Rab3gap2 (MGI:1916043)
1,220528135,220664460,1q41,1q41,606511,"MARK1, KIAA1477",MAP/microtubule affinity-regulating kinase 1,MARK1,4139,ENSG00000116141,NA,NA,Mark1 (MGI:2664902)
1,220747416,220784814,1q41,1q41,614127,"MOSC2, MARC2",Molybdenum cofactor sulfurase C-terminal domain-containing protein 2,MARC2,54996,ENSG00000117791,NA,NA,Marc2 (MGI:1914497)
1,220786696,220819658,1q41,1q41,614126,"MOSC1, MARC1",Molybdenum cofactor sulfurase C-terminal domain-containing protein 1,MARC1,64757,ENSG00000186205,NA,NA,Marc1 (MGI:1913362)
1,220879442,220885058,1q41-q42.1,1q41,142995,HLX1,H.20-like homeobox 1,HLX,3142,ENSG00000136630,NA,NA,Hlx (MGI:96109)
1,221701419,221742175,1q41,1q41,608867,"DUSP10, MKP5",Dual-specificity phosphatase 10,DUSP10,11221,ENSG00000143507,NA,NA,Dusp10 (MGI:1927070)
1,222557901,222590095,1q42,1q41,604903,"TAF1A, RAFI48, SL1",TATA box-binding protein-associated factor 1A,TAF1A,9015,ENSG00000143498,NA,NA,Taf1a (MGI:109578)
1,222618096,222668011,1q42,1q41,613455,"MIA3, TANGO1, TANGO, KIAA0268","Melanoma inhibitory activity family, member 3",MIA3,375056,ENSG00000154305,NA,NA,Mia3 (MGI:2443183)
1,222668012,222712894,1q41,1q41,612375,AIDA,"Axin interactor, dorsalization-associated",AIDA,64853,ENSG00000186063,NA,NA,Aida (MGI:1919737)
1,222814513,223005994,1q42,1q41,607502,DISPA,"Dispatched, Drosophila, homolog of, A",DISP1,84976,ENSG00000154309,NA,NA,Disp1 (MGI:1916147)
1,223108400,223143280,1q41,1q41,603031,"TLR5, TIL3, SLEB1, MELIOS",Toll-like receptor-5,TLR5,7100,ENSG00000187554,NA,"{Legionnaire disease, susceptibility to}, 608556 (3); {Melioidosis, susceptibility to}, 615557 (3); {Systemic lupus erythematosus, resistance to}, 601744 (3); {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3)",Tlr5 (MGI:1858171)
1,223220825,223365270,1q41,1q41,615827,SUSD4,Sushi domain-containing protein 4,SUSD4,55061,ENSG00000143502,NA,NA,Susd4 (MGI:2138351)
1,223701592,223776017,1q41-q42,1q41,114230,CAPN2,"Calpain, large polypeptide L2",CAPN2,824,ENSG00000162909,NA,NA,Capn2 (MGI:88264)
1,223779892,223845971,1q42.1,1q41,602143,"TP53BP2, ASPP2",Tumor protein p53-binding protein-2,TP53BP2,7159,ENSG00000143514,NA,NA,Trp53bp2 (MGI:2138319)
1,223900000,236400000,1q42,NA,613058,BCC2,"Basal cell carcinoma, susceptibility to, 2",NA,100307119,NA,associated with rs801114,"{Basal cell carcinoma, susceptibility to, 2}, 613058 (2)",NA
1,223900000,236400000,1q42,NA,606554,EA3,"Episodic ataxia, type 3",NA,780905,NA,max lod at D1S235,"Episodic ataxia, type 3, 606554 (2), Autosomal dominant",NA
1,223900000,236400000,1q42,NA,143025,HRES1,HTLV-1 related endogenous sequence,HRES1,3272,NA,NA,NA,NA
1,223900000,236400000,1q42,NA,604801,MDC1B,"Muscular dystrophy, congenital, 1B",NA,53368,NA,NA,"Muscular dystrophy, congenital, 1B, 604801 (2), Autosomal recessive",NA
1,223900000,236400000,1q42,NA,170000,PEPC,Peptidase C,PEPC,5183,NA,"1q25, 1q32 = conflicting localizations",NA,NA
1,223900000,230500000,1q42.11-q42.13,NA,180420,RN5S1@,"RNA, 5S cluster 1",NA,NA,NA,25-30% at 1q31 (RN5S3@),NA,NA
1,224114086,224162046,1q42.12,1q42.11,609100,"FBXO28, FBX28, KIAA0483",F-box only protein 28,FBXO28,23219,ENSG00000143756,NA,NA,Fbxo28 (MGI:1261890)
1,224183239,224193440,1q42.11,1q42.11,615843,"DEGS1, DES1, MLD, HLD18","Delta(4)-desaturase, sphingolipid, 1",DEGS1,8560,ENSG00000143753,NA,"Leukodystrophy, hypomyelinating, 18, 618404 (3), Autosomal recessive",Degs1 (MGI:1097711)
1,224227333,224330188,1q41-q42.2,1q42.11,602426,NVL,Nuclear valosin-containing protein-like,NVL,4931,ENSG00000143748,NA,NA,Nvl (MGI:1914709)
1,224356810,224379451,1q42.11,1q42.11,617483,"CNIH4, CNIH2",Cornichon family AMPA receptor auxiliary protein 4,CNIH4,29097,ENSG00000143771,NA,NA,Cnih4 (MGI:1925828)
1,224385142,224434796,1q42.13,1q42.11-q42.12,617424,"WDR26, SKDEAS",WD repeat-containing protein 26,WDR26,80232,ENSG00000162923,NA,"Skraban-Deardorff syndrome, 617616 (3), Autosomal dominant",Wdr26 (MGI:1923825)
1,224928421,225399291,1q42,1q42.12,603341,"DNAH14, HL18","Dynein, axonemal, heavy chain 14",DNAH14,127602,ENSG00000185842,NA,NA,Dnah14 (MGI:2444525)
1,225401501,225428854,1q42.1,1q42.12,600024,"LBR, PHA, PHASK",Lamin B receptor,LBR,3930,ENSG00000143815,NA,"Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive; Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant",Lbr (MGI:2138281)
1,225486828,225660045,1q42.13,1q42.12,609061,"ENAH, ENA, MENA, NDPP1","Enabled, Drosophila, homolog of",ENAH,55740,ENSG00000154380,NA,NA,Enah (MGI:108360)
1,225777812,225790465,1q42.12,1q42.12,600707,"SRP9, ALURBP","Signal recognition particle, 9-kD",SRP9,6726,ENSG00000143742,NA,NA,Srp9 (MGI:1350930)
1,225810073,225845562,1q42.1,1q42.12,132810,EPHX1,"Epoxide hydroxylase 1, microsomal xenobiotic",EPHX1,2052,ENSG00000143819,mutation identified in 1 FHCA patient,"?Hypercholanemia, familial, 607748 (3), Autosomal recessive",Ephx1 (MGI:95405)
1,225886281,225889145,1q42.1,1q42.12,603037,"LEFTB, LEFTY1","Left-right determination, factor B",LEFTY1,10637,ENSG00000243709,NA,NA,Lefty1 (MGI:107405)
1,225919876,225924339,1q42.13,1q42.12,616406,"PYCR2, HLD10",Pyrroline-5-carboxylate reductase 2,PYCR2,29920,ENSG00000143811,NA,"Leukodystrophy, hypomyelinating, 10, 616420 (3), Autosomal recessive",Pycr2 (MGI:1277956)
1,225936597,225941491,1q42.1,1q42.12,601877,"LEFTY2, EBAF, TGFB4, LEFTA, LEFTYA",Left-right determination factor 2,LEFTY2,7044,ENSG00000143768,NA,NA,Lefty2 (MGI:2443573)
1,226062715,226073211,1q41,1q42.12,601128,"H3F3A, H3F3","H3 histone, family 3A",H3F3A,3020,ENSG00000163041,NA,NA,"H3f3b,H3f3a (MGI:1101768,MGI:1097686)"
1,226144678,226186740,1q42.1,1q42.12,606809,"ACBD3, GOCAP1, GOLPH1, GCP60",Acyl-Coenzyme A binding domain containing 3,ACBD3,64746,ENSG00000182827,NA,NA,Acbd3 (MGI:2181074)
1,226223663,226227059,1q42.1,1q42.12,609852,"MIXL1, MIXL, MIX",MIX1 homeobox-like protein 1,MIXL1,83881,ENSG00000185155,NA,NA,Mixl1 (MGI:1351322)
1,226231148,226310081,1q42.12,1q42.12,609375,LIN9,"Lin9, C. elegans, homolog of",LIN9,286826,ENSG00000183814,NA,NA,Lin9 (MGI:1919818)
1,226360690,226408092,1q42,1q42.12,173870,"PARP1, ADPRT, PPOL, PARP",Poly(ADP-ribose) polymerase 1,PARP1,142,ENSG00000143799,?processed pseudogenes on chr.13 and 14,NA,Parp1 (MGI:1340806)
1,226631689,226739295,1q41-q43,1q42.12,147522,ITPKB,"Inositol 1,4,5-trisphosphate 3-kinase B",ITPKB,3707,ENSG00000143772,NA,NA,Itpkb (MGI:109235)
1,226870571,226903828,1q31-q42,1q42.13,600759,"PSEN2, AD4, STM2, CMD1V",Presenilin 2,PSEN2,5664,ENSG00000143801,NA,"Alzheimer disease-4, 606889 (3), Autosomal dominant; Cardiomyopathy, dilated, 1V, 613697 (3), Autosomal dominant",Psen2 (MGI:109284)
1,226939338,226987543,1q42.2,1q42.13,606980,"ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4",AARF domain-containing kinase 3,COQ8A,56997,ENSG00000163050,NA,"Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive",Coq8a (MGI:1914676)
1,226989857,227318501,1q41-q42,1q42.13,603412,"CDC42BPA, PK428, MRCKA",CDC42-binding protein kinase alpha,CDC42BPA,8476,ENSG00000143776,NA,NA,Cdc42bpa (MGI:2441841)
1,227918655,227947931,1q42,1q42.13,602863,WNT14,"Wingless-type MMTV integration site family, member 14",WNT9A,7483,ENSG00000143816,NA,NA,Wnt9a (MGI:2446084)
1,228006997,228067112,1q42,1q42.13,606359,WNT3A,"Wingless-type MMTV integration site family, member 3A",WNT3A,89780,ENSG00000154342,NA,NA,Wnt3a (MGI:98956)
1,228082659,228099211,1q42,1q42.13,103180,"ARF1, PVNH8",ADP-ribosylation factor-1,ARF1,375,ENSG00000143761,NA,"Periventricular nodular heterotopia 8, 618185 (3), Autosomal dominant",Arf1 (MGI:99431)
1,228106678,228111745,1q42.13,1q42.13,611859,MRPL55,Mitochondrial ribosomal protein L55,MRPL55,128308,ENSG00000162910,NA,NA,Mrpl55 (MGI:1914462)
1,228140083,228148983,1q32.1-q42,1q42.13,139270,GUK1,Guanylate kinase-1,GUK1,2987,ENSG00000143774,NA,NA,Guk1 (MGI:95871)
1,228149929,228159825,1q42.13,1q42.13,608803,"GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3","Gap junction protein, gamma-2 (47kD)",GJC2,57165,ENSG00000198835,NA,"Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive; Lymphatic malformation 3, 613480 (3), Autosomal dominant; Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive",Gjc2 (MGI:2153060)
1,228165803,228182256,1q42.13,1q42.13,615316,"IBA57, C1orf69, MMDS3, SPG74","IBA57, S. cerevisiae, homolog of",IBA57,200205,ENSG00000181873,NA,"Multiple mitochondrial dysfunctions syndrome 3, 615330 (3), Autosomal recessive; ?Spastic paraplegia 74, autosomal recessive, 616451 (3), Autosomal recessive",Iba57 (MGI:3041174)
1,228393671,228406834,1q42.13,1q42.13,607868,TRIM11,Tripartite motif-containing protein 11,TRIM11,81559,ENSG00000154370,NA,NA,Trim11 (MGI:2137355)
1,228406876,228416881,1q42,1q42.13,606123,RNF16,RING finger protein-16,TRIM17,51127,ENSG00000162931,NA,NA,Trim17 (MGI:1861440)
1,228424844,228425324,1q42,1q42.13,602820,"HIST3H3, H3FT, H3T","Histone 3, H3",HIST3H3,8290,ENSG00000168148,NA,NA,NA
1,228457363,228457858,1q42,1q42.13,615015,HIST3H2A,"Histone gene cluster 3, H2A histone",HIST3H2A,92815,ENSG00000181218,NA,NA,Hist3h2a (MGI:2448458)
1,228458106,228458557,1q42,1q42.13,615046,"HIST3H2BB, H2Bb","Histone gene cluster 3, H2B histone family, member B",HIST3H2BB,128312,ENSG00000196890,NA,NA,Hist3h2bb-ps (MGI:1922442)
1,228487381,228496187,1q42.13,1q42.13,613754,"RNF186, RACO1",Ring finger protein 187,RNF187,149603,ENSG00000168159,NA,NA,Rnf187 (MGI:1914224)
1,228644646,228746668,1q42,1q42.13,606366,"RHOU, WRCH1","Ras homolog gene family, member U",RHOU,58480,ENSG00000116574,NA,NA,Rhou (MGI:1916831)
1,229271061,229305893,1q42-q43,1q42.13,179511,"RAB4A, RAB4",Ras-associated protein RAB4A,RAB4A,5867,ENSG00000168118,NA,NA,Rab4a (MGI:105069)
1,229321014,229343794,1q42.13,1q42.13,616762,"CCSAP, CSAP, C1orf96","Centriole-, cilia-, and spindle-associated protein",CCSAP,126731,ENSG00000154429,NA,NA,Ccsap (MGI:1920670)
1,229431244,229434095,1q42.1,1q42.13,102610,"ACTA1, ASMA, NEM3, CFTD1, SHPM","Actin, alpha-1, skeletal muscle",ACTA1,58,ENSG00000143632,mutation identified in 1 SHPM family,"Myopathy, actin, congenital, with cores, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal recessive, Autosomal dominant; ?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal recessive, Autosomal dominant",Acta1 (MGI:87902)
1,229440258,229508341,1q42.13,1q42.13,607613,"NUP133, NPHS18, GAMOS8","Nucleoporin, 133kD",NUP133,55746,ENSG00000069248,mutation identified in 1 GAMOS8 family,"?Galloway-Mowat syndrome 8, 618349 (3), Autosomal recessive; Nephrotic syndrome, type 18, 618177 (3), Autosomal recessive",Nup133 (MGI:2442620)
1,229516581,229558987,1q42,1q42.13,605454,"ABCB10, MTABC2","ATP-binding cassette, subfamily B, member 10",ABCB10,23456,ENSG00000135776,pseudogene on 15q13-q14,NA,Abcb10 (MGI:1860508)
1,230057788,230282121,1q41-q42,1q42.13,602274,GALNT2,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2,GALNT2,2590,ENSG00000143641,NA,NA,Galnt2 (MGI:894694)
1,230314489,230426331,1q42.13,1q42.13,616791,PGBD5,Piggybac transposable element-derived 5,PGBD5,79605,ENSG00000177614,NA,NA,Pgbd5 (MGI:2429955)
1,230500000,243500000,1q42.2-q43,NA,602759,PCAP,Predisposing for prostate cancer,PCAP,7834,NA,NA,"{Prostate cancer, susceptibility to}, 602759 (2)",NA
1,230500000,243500000,1q42.2-q43,NA,119100,"SHFL1, SHFLD",Split-hand/foot malformation with long bone deficiency 1,NA,791121,NA,between rs1124110 and rs535043,"Split-hand/foot malformation with long bone deficiency 1, 119100 (2), Autosomal dominant",NA
1,230642480,230693981,1q42.2,1q42.2,606974,"COG2, LDLC, CDG2Q",Component of oligomeric golgi complex 2,COG2,22796,ENSG00000135775,mutation identified in 1 CDG2Q patient,"?Congenital disorder of glycosylation, type IIq, 617395 (3), Autosomal recessive",Cog2 (MGI:1923582)
1,230702522,230714121,1q42-q43,1q42.2,106150,"AGT, SERPINA8",Angiotensinogen,AGT,183,ENSG00000135744,NA,"{Hypertension, essential, susceptibility to}, 145500 (3), Multifactorial; {Preeclampsia, susceptibility to} (3); Renal tubular dysgenesis, 267430 (3), Autosomal recessive",Agt (MGI:87963)
1,230747288,230803355,1q42,1q42.2,606401,CAPN9,Calpain 9,CAPN9,10753,ENSG00000135773,NA,NA,Capn9 (MGI:1920897)
1,230979048,231000732,1q42.2,1q42.2,611647,"ARV1, EIEE38","ARV1, S. cerevisiae, homolog of",ARV1,64801,ENSG00000173409,NA,"Epileptic encephalopathy, early infantile, 38, 617020 (3), Autosomal recessive",Arv1 (MGI:1916115)
1,231162390,231221564,1q42,1q42.2,610584,TRIM67,Tripartite motif-containing protein 67,TRIM67,440730,ENSG00000119283,NA,NA,Trim67 (MGI:3045323)
1,231241209,231277972,1q42,1q42.2,602744,"GNPAT, DHAPAT, RCDP2",Glyceronephosphate O-acyltransferase,GNPAT,8443,ENSG00000116906,NA,"Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive",Gnpat (MGI:1343460)
1,231332752,231337851,1q42.2,1q42.2,615283,"EXOC8, EXO84, SEC84",Exocyst complex component 8,EXOC8,149371,ENSG00000116903,NA,NA,Exoc8 (MGI:2142527)
1,231337979,231355022,1q42.2,1q42.2,616086,"SPRTN, DVC1, C1orf124, RJALS",SprT-like N-terminal domain protein,SPRTN,83932,ENSG00000010072,NA,"Ruijs-Aalfs syndrome, 616200 (3), Autosomal recessive",Sprtn (MGI:2685351)
1,231363750,231425043,1q42-q43,1q42.2,606425,"EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH","Egl9, C. elegans, homolog of, 1",EGLN1,54583,ENSG00000135766,NA,"Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; [Hemoglobin, high altitude adaptation], 609070 (3), Autosomal dominant",Egln1 (MGI:1932286)
1,231528668,231566523,1q41,1q42.2,602964,"TSNAX, TRAX",Translin-associated factor X,TSNAX,7257,ENSG00000116918,NA,NA,Tsnax (MGI:1855672)
1,231626789,232041271,1q42.1,1q42.2,605210,"DISC1, SCZD9",Disrupted in schizophrenia 1,DISC1,27185,ENSG00000162946,NA,"{Schizophrenia 9, susceptibility to}, 604906 (3)",Disc1 (MGI:2447658)
1,231814625,231818516,1q42.1,1q42.2,606271,DISC2,Disrupted in schizophrenia 2,DISC2,27184,NA,noncoding antisense RAN,"Schizophrenia, 181500 (2), Autosomal dominant",NA
1,232397964,232630490,1q42.2,1q42.2,611609,"SIPA1L2, KIAA1389",SIPA1-like protein 2,SIPA1L2,57568,ENSG00000116991,NA,NA,Sipa1l2 (MGI:2676970)
1,232983434,233295729,1q42.2,1q42.2,617656,"PCNX2, KIAA0435","Pecanex, Drosophila, homolog of, 2",PCNX2,80003,ENSG00000135749,NA,NA,Pcnx2 (MGI:2445010)
1,233327723,233385147,1q42,1q42.2,614793,"MLK4, KIAA1804",Mixed-lineage kinase 4,MAP3K21,84451,ENSG00000143674,NA,NA,Map3k21 (MGI:2385307)
1,233614105,233672513,1q42-q43,1q42.2,601745,"KCNK1, TWIK1","Potassium channel, subfamily K, member 1",KCNK1,3775,ENSG00000135750,NA,NA,Kcnk1 (MGI:109322)
1,234373455,234385079,1q42.2,1q42.2,614772,"COA6, C1orf31, CEMCOX4",Cytochrome c oxidase assembly factor 6,COA6,388753,ENSG00000168275,NA,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3), Autosomal recessive",NA
1,234391312,234479178,1q42.3,1q42.2,605052,"TARBP1, TRP185",TAR RNA-binding protein 1,TARBP1,6894,ENSG00000059588,NA,NA,Tarbp1 (MGI:4936930)
1,234604268,234609524,1q42.3,1q42.3,615332,"IRF2BP2, CVID14",Interferon regulatory factor 2-binding protein 2,IRF2BP2,359948,ENSG00000168264,mutation identified in 1 CVID14 family,"?Immunodeficiency, common variable, 14, 617765 (3), Autosomal dominant",Irf2bp2 (MGI:2443921)
1,235109340,235128836,1q42.3,1q42.3,601848,"TOMM20, MAS20, KIAA0016","Translocase of outer mitochondrial membrane 20, S. cerevisiae, homolog of",TOMM20,9804,ENSG00000173726,NA,NA,Tomm20 (MGI:1915202)
1,235166894,235328223,1q42.1-q43,1q42.3,609696,"ARID4B, SAP180, RBP1L1, RBBP1L1, BRCAA1",AT-rich interactive domain-containing protein 4B,ARID4B,51742,ENSG00000054267,NA,NA,Arid4b (MGI:2137512)
1,235328437,235344531,1q43,1q42.3,606982,"GGPS1, GGPPS1",Geranylgeranyl diphosphate synthase 1,GGPS1,9453,ENSG00000152904,NA,NA,Ggps1 (MGI:1341724)
1,235367359,235452442,1q42-q43,1q42.3,604934,"TBCE, KCS, KCS1, HRD, PEAMO",Tubulin-specific chaperone E,TBCE,6905,ENSG00000284770,NA,"Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive",Tbce (MGI:1917680)
1,235440653,235504480,1q42.3,1q42.3,610194,"B3GALNT2, MGC39558, MDDGA11","Beta-1,3-N-acetylgalactosaminyltransferase 2",B3GALNT2,148789,ENSG00000162885,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3), Autosomal recessive",B3galnt2 (MGI:2145517)
1,235547684,235650753,1q42.3,1q42.3,604388,GNG4,"Guanine nucleotide-binding protein, gamma 4",GNG4,2786,ENSG00000168243,NA,NA,Gng4 (MGI:102703)
1,235661030,235883712,1q42.3,1q42.3,606897,"LYST, CHS1",Lysosomal trafficking regulator,LYST,1130,ENSG00000143669,NA,"Chediak-Higashi syndrome, 214500 (3), Autosomal recessive",Lyst (MGI:107448)
1,235975829,236065091,1q43,1q42.3,131390,NID,Nidogen,NID1,4811,ENSG00000116962,NA,NA,Nid1 (MGI:97342)
1,236142528,236213534,1q42-q43,1q42.3,604658,TM7SF1,"Transmembrane 7 superfamily, member 1",GPR137B,7107,ENSG00000077585,NA,NA,Gpr137b (MGI:1891463)
1,236213063,236281982,1q42.3,1q42.3,615437,ERO1LB,Endoplasmic reticulum oxidoreduction 1-like beta,ERO1B,56605,ENSG00000086619,NA,NA,Ero1lb (MGI:1914725)
1,236394285,236484908,1q42.2-q43,1q42-q43,606603,"EDARADD, ED3, EDA3, ECTD11B, ECTD11A",EDAR-associated death domain,EDARADD,128178,ENSG00000186197,NA,"Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant; Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive",Edaradd (MGI:1931001)
1,236400000,248956422,1q43-q44,NA,612433,DFNB45,"Deafness, autosomal recessive 45",DFNB45,449483,NA,between D1S547 and D1S2836,"Deafness, autosomal recessive 45, 612433 (2), Autosomal recessive",NA
1,236518213,236552980,1q42-q43,1q43,606099,"LGALS8, PCTA1","Lectin, galactoside-binding, soluble, 8",LGALS8,3964,ENSG00000116977,NA,NA,Lgals8 (MGI:1928481)
1,236686453,236764630,1q42-q43,1q43,102573,"ACTN2, CMD1AA, CMH23","Actinin, alpha-2",ACTN2,88,ENSG00000077522,NA,"Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3), Autosomal dominant",Actn2 (MGI:109192)
1,236794303,236903980,1q43,1q43,156570,"MTR, HMAG",5-methyltetrahydrofolate-homocysteine methyltransferase 1,MTR,4548,ENSG00000116984,NA,"Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive; {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive",Mtr (MGI:894292)
1,237042183,237833987,1q42.1-q43,1q43,180902,"RYR2, VTSIP, ARVD2, ARVC2",Ryanodine receptor-2 (cardiac),RYR2,6262,ENSG00000198626,NA,"Arrhythmogenic right ventricular dysplasia 2, 600996 (3), Autosomal dominant; Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3), Autosomal dominant",Ryr2 (MGI:99685)
1,237882376,237890921,1q43,1q43,613514,"ZP4, ZPB",Zona pellucida glycoprotein 4,ZP4,57829,ENSG00000116996,NA,NA,NA
1,239386564,239915449,1q41-q44,1q43,118494,"CHRM3, PBS, EGBRS","Cholinergic receptor, muscarinic, 3",CHRM3,1131,ENSG00000133019,mutation identified in 1 PBS family,"?Prune belly syndrome, 100100 (3), Autosomal recessive",Chrm3 (MGI:88398)
1,240091882,240475186,1q43,1q43,606373,"FMN2, MRT47",Formin 2,FMN2,56776,ENSG00000155816,NA,"Mental retardation, autosomal recessive 47, 616193 (3), Autosomal recessive",Fmn2 (MGI:1859252)
1,240489572,240612371,1q43,1q43,608832,"GREM2, PRDC, STHAG9","Gremlin 2 homolog, cystine knot superfamily",GREM2,64388,ENSG00000180875,NA,"Tooth agenesis, selective, 9, 617275 (3), Autosomal dominant",Grem2 (MGI:1344367)
1,240775192,241357273,1q43,1q43,602517,RGS7,Regulator of G protein signaling 7,RGS7,6000,ENSG00000182901,NA,NA,Rgs7 (MGI:1346089)
1,241497556,241519784,1q42.1,1q43,136850,"FH, HLRCC, MCUL1, FMRD",Fumarate hydratase,FH,2271,ENSG00000091483,NA,"Fumarase deficiency, 606812 (3), Autosomal recessive; Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant",Fh1 (MGI:95530)
1,241531882,241595641,1q43,1q43,603538,KMO,Kynurenine 3-monooxygenase,KMO,8564,ENSG00000117009,NA,NA,Kmo (MGI:2138151)
1,241593123,241640368,1q43,1q43,606695,"OPN3, ECPN",Opsin 3,OPN3,23596,ENSG00000054277,NA,NA,Opn3 (MGI:1338022)
1,241628863,241635929,1q43,1q43,118825,"CHML, REP2",Choroideremia-like,CHML,1122,ENSG00000203668,NA,NA,Chml (MGI:101913)
1,241847966,241889938,1q42-q43,1q43,606063,"EXO1, HEX1","Exonuclease 1, S. cerevisiae, homolog of",EXO1,9156,ENSG00000174371,NA,NA,Exo1 (MGI:1349427)
1,241957766,241959061,1q43,1q43,615687,"BECN2, BECN1L1",Beclin 2,BECN2,441925,ENSG00000196289,NA,NA,NA
1,243124427,243255795,1q44,1q43,613023,"CEP170, KIAA0470","Centrosomal protein, 170kD",CEP170,9859,ENSG00000143702,NA,NA,Cep170 (MGI:1918348)
1,243255417,243503682,1q43-q44,1q43-q44,613524,"SDCCAG8, CCCAP, SLSN7, BBS16",Serologically defined colon cancer antigen 8,SDCCAG8,10806,ENSG00000054282,NA,"Bardet-Biedl syndrome 16, 615993 (3), Autosomal recessive; Senior-Loken syndrome 7, 613615 (3)",Sdccag8 (MGI:1924066)
1,243488232,243851078,1q44,1q43-q44,611223,"AKT3, PKBG, MPPH2",v-Akt murine thymoma viral oncogene homolog 3,AKT3,10000,ENSG00000117020,NA,"Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3), Autosomal dominant",Akt3 (MGI:1345147)
1,244048938,244057475,1q44,1q44,608433,"ZBTB18, ZNF238, RP58, MRD22",Zinc finger and BTB domain containing 18,ZBTB18,10472,ENSG00000179456,NA,"Mental retardation, autosomal dominant 22, 612337 (3), Autosomal dominant",Zbtb18 (MGI:1353609)
1,244408491,244452059,1cen-q12,1q44,103060,ADSS,Adenylosuccinate synthetase (Ade(-)H-complementing),ADSS2,159,ENSG00000035687,NA,NA,Adss (MGI:87948)
1,244452012,244640503,1q44,1q44,617510,"CATSPERE, C10orf101","Cation channel, sprem-associated, auxiliary subunit epsilon",CATSPERE,257044,ENSG00000179397,NA,NA,Catspere1 (MGI:3647531)
1,244652759,244709033,1q44,1q44,614638,"DESI2, PPPDE1",Desumoylating isopeptidase 2,DESI2,51029,ENSG00000121644,NA,NA,Desi2 (MGI:1926075)
1,244835305,244845062,1q44,1q44,614698,"COX20, FAM36A","Cytochrome c oxidase 20, S. cerevisiae, homolog of",COX20,116228,ENSG00000203667,NA,"Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Cox20 (MGI:1913609)
1,244850296,244864542,1q44,1q44,602869,"HNRNPU, HNRPU, SAFA, EIEE54",Heterogeneous nuclear ribonucleoprotein U,HNRNPU,3192,ENSG00000153187,NA,"Epileptic encephalopathy, early infantile, 54, 617391 (3), Autosomal dominant",Hnrnpu (MGI:1858195)
1,245154984,245709431,1q44,1q44,614026,KIF26B,Kinesin family member 26B,KIF26B,55083,ENSG00000162849,NA,NA,Kif26b (MGI:2447076)
1,245749339,246507317,1q44,1q44,608783,SMYD3,SET and MYND domain-containing protein 3,SMYD3,64754,ENSG00000185420,NA,NA,Smyd3 (MGI:1916976)
1,246540560,246566260,1q44,1q44,607055,TFB2M,"Transcription factor B2, mitochondrial",TFB2M,64216,ENSG00000162851,NA,NA,Tfb2m (MGI:107937)
1,246566336,246668594,1q44,1q44,613439,CNST,Consortin,CNST,163882,ENSG00000162852,NA,NA,Cnst (MGI:2445141)
1,246839097,246931977,1q44,1q44,610853,"AHCTF1, ELYS",AT hook containing transcription factor 1,AHCTF1,25909,ENSG00000153207,NA,NA,Ahctf1 (MGI:1915033)
1,246945545,247008092,1q44,1q44,616348,"ZNF695, SBZF3",Zinc finger protein 695,ZNF695,57116,ENSG00000197472,NA,NA,NA
1,247121974,247172378,1q44,1q44,194631,ZNF124,Zinc finger protein-124 (HZF-16),ZNF124,7678,ENSG00000196418,NA,NA,Gm20541 (MGI:5142006)
1,247297414,247331866,1q44,1q44,613911,"ZNF496, NIZP1, ZFP496",Zinc finger protein 496,ZNF496,84838,ENSG00000162714,NA,NA,Zkscan17 (MGI:2679270)
1,247416155,247449107,1q44,1q44,606416,"NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH","NLR family, pyrin domain containing 3",NLRP3,114548,ENSG00000162711,NA,"CINCA syndrome, 607115 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant",Nlrp3 (MGI:2653833)
1,247672117,247673040,1q44,1q44,611677,OR13G1,"Olfactory receptor, family 13, subfamily G, member 1",OR13G1,441933,ENSG00000197437,NA,NA,Olfr309 (MGI:3030143)
1,247895586,247896530,1q44,1q44,616729,OR2W3,Olfactory receptor family 2 subfamily W member 3,OR2W3,343171,ENSG00000238243,NA,NA,Olfr322 (MGI:3030156)
1,248323629,248324567,1q44,1q44,618509,OR2M7,"Olfactory receptor, family 2, subfamily M, member 7",OR2M7,391196,ENSG00000177186,NA,NA,NA
1,248739414,248755786,1q44,1q44,617067,LYPD8,LY6/PLAUR domain-containing protein 8,LYPD8,646627,ENSG00000259823,NA,NA,Lypd8 (MGI:1917413)
1,248850003,248860760,1q44,1q44,617758,"ZNF692, AREBP",Zinc finger protein 692,ZNF692,55657,ENSG00000171163,NA,NA,Zfp692 (MGI:2144276)
1,0,248956422,Chr.1,NA,108420,"SPGF2, ASG",Spermatogenic failure 2,NA,100653377,NA,inversion of chromosome 1,"Spermatogenic failure 2, 108420 (2), Autosomal dominant",NA
2,0,12000000,2p25,NA,612396,ALLC,Allantoicase,ALLC,55821,ENSG00000151360,nonfunctional in humans,NA,NA
2,0,23800000,2pter-p24,NA,115800,CTRCT29,"Cataract 29, coralliform",NA,101867602,NA,between D2S297 and D2S2269,"Cataract 29, coralliform, 115800 (2), Autosomal dominant",NA
2,0,41500000,2p25-p22,NA,602134,"ETM2, ETM","Tremor, hereditary essential, 2",ETM2,2112,NA,max lod at D2S272,"Essential tremor, hereditary, 2, 602134 (2), Autosomal dominant",NA
2,0,23800000,2p25-p24,NA,607329,HYT3,"Hypertension, essential, susceptibility to, 3",NA,387575,NA,NA,"{Hypertension, essential, susceptibility to, 3}, 145500 (2), Multifactorial",NA
2,0,12000000,2p25,NA,609402,PEE2,Preeclampsia/eclampsia 2,NA,780908,NA,NA,"Preeclampsia/eclampsia 2, 609402 (2)",NA
2,0,83100000,2p25-p12,NA,101850,PPKP3,"Keratoderma, palmoplantar, punctate type III",NA,NA,NA,max lod at ACP1 and IGKC,"?Keratoderma, palmoplantar, punctate type 3, 101850 (2), Autosomal dominant",NA
2,38813,47076,2p25.3,2p25.3,611395,FAM110C,"Family with sequence similarity 110, member C",FAM110C,642273,ENSG00000184731,NA,NA,Fam110c (MGI:1918813)
2,218135,264865,2p25.3,2p25.3,617314,SH3YL1,SH3 domain- and SYLF domain-containing protein 1,SH3YL1,26751,ENSG00000035115,NA,NA,Sh3yl1 (MGI:1346118)
2,264868,278282,2p25,2p25.3,171500,ACP1,"Acid phosphatase 1, soluble",ACP1,52,ENSG00000143727,NA,NA,Acp1 (MGI:87881)
2,663876,677405,2p25.3,2p25.3,613220,TMEM18,Transmembrane protein 18,TMEM18,129787,ENSG00000151353,NA,NA,NA
2,950848,1367990,2p25,2p25.3,608715,"SNTG2, SYN5","Syntrophin, gamma-2",SNTG2,54221,ENSG00000172554,NA,NA,Sntg2 (MGI:1919541)
2,1413287,1542726,2p25,2p25.3,606765,"TPO, TPX, TDH2A",Thyroid peroxidase,TPO,7173,ENSG00000115705,NA,"Thyroid dyshormonogenesis 2A, 274500 (3), Autosomal recessive",Tpo (MGI:98813)
2,1631886,1744851,2p25.3,2p25.3,605158,"PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7","Peroxidasin, Drosophila, homolog of",PXDN,7837,ENSG00000130508,NA,"Anterior segment dysgenesis 7, with sclerocornea, 269400 (3), Autosomal recessive",Pxdn (MGI:1916925)
2,1789112,2331387,2p24,2p25.3,613084,"MYT1L, KIAA1106, MRD39",Myelin transcription factor 1-like,MYT1L,23040,ENSG00000186487,NA,"Mental retardation, autosomal dominant 39, 616521 (3), Autosomal dominant",Myt1l (MGI:1100511)
2,3188924,3377817,2p25.2,2p25.3,608998,"EIPR1, TSSC1",EARP complex and GARP complex interacting protein 1,EIPR1,7260,ENSG00000032389,NA,NA,Eipr1 (MGI:1289332)
2,3379244,3479570,2p25.3,2p25.3,614139,"TRAPPC12, TTC15, PEBAS","Trafficking protein particle complex, subunit 12",TRAPPC12,51112,ENSG00000171853,NA,"Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3), Autosomal recessive",Trappc12 (MGI:2445089)
2,3497365,3519530,2p25.3,2p25.3,613400,"ADI1, SIPL",Acireductone dioxygenase 1,ADI1,55256,ENSG00000182551,NA,NA,Adi1 (MGI:2144929)
2,3531812,3558370,2p25,2p25.3,604123,"RNASEH1, PEOB2",Ribonuclease H1,RNASEH1,246243,ENSG00000171865,pseudogenes on chr. 17 and chr.1,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3), Autosomal recessive",Rnaseh1 (MGI:1335073)
2,3575259,3580919,2p25,2p25.3,603658,"RPS7, DBA8",Ribosomal protein S7,RPS7,6201,ENSG00000171863,NA,"Diamond-Blackfan anemia 8, 612563 (3), Autosomal dominant",Rps7 (MGI:1333818)
2,3594831,3644643,2p25.3,2p25.3,612502,"COLEC11, CLK1, 3MC2",Collectin 11,COLEC11,78989,ENSG00000118004,NA,"3MC syndrome 2, 265050 (3), Autosomal recessive",Colec11 (MGI:1918943)
2,5692383,5701384,2p25,2p25.2,600898,"SOX11, MRD27, CSS9",SRY (sex-determining region Y)-box 11,SOX11,6664,ENSG00000176887,NA,"Coffin-Siris syndrome 9, 615866 (3), Autosomal dominant",Sox11 (MGI:98359)
2,6840416,6866634,2p25.2,2p25.2,611787,CMPK2,"Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial",CMPK2,129607,ENSG00000134326,NA,NA,Cmpk2 (MGI:99830)
2,6865732,6898238,2p25.2,2p25.2,607810,"RSAD2, VIPERIN",Radical S-adenosyl methionine domain containing 2,RSAD2,91543,ENSG00000134321,NA,NA,Rsad2 (MGI:1929628)
2,6900000,16500000,2p25.1-p24.3,NA,609946,DFNB47,"Deafness, neurosensory, autosomal recessive 47",DFNB47,449489,NA,max lod at D2S1400 and D2S262,"Deafness, neurosensory, autosomal recessive 47, 609946 (2), Autosomal recessive",NA
2,8682055,8684460,2p25,2p25.1,600386,ID2,"Inhibitor of DNA binding 2, dominant negative",ID2,3398,ENSG00000115738,NA,NA,Id2 (MGI:96397)
2,8721080,8837638,2p25.1,2p25.1,615759,"KIDINS220, ARMS, SINO","Kinase D-interacting substrate, 220kD",KIDINS220,57498,ENSG00000134313,NA,"Spastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3), Autosomal dominant",Kidins220 (MGI:1924730)
2,8852689,9003749,2p25.1,2p25.1,611949,"MBOAT2, LPCAT4",Membrane-bound O-acyltransferase domain-containing 2,MBOAT2,129642,ENSG00000143797,NA,NA,Mboat2 (MGI:1914466)
2,9206764,9405682,2p24,2p25.1,603817,"DDEF2, PAP",Development- and differentiation-enhancing factor 2,ASAP2,8853,ENSG00000151693,NA,NA,Asap2 (MGI:2685438)
2,9403474,9423568,2p25.2,2p25.1,607153,"ITGB1BP1, ICAP1, ICAP1A, ICAP1B",Integrin cytoplasmic domain-associated protein 1 beta,ITGB1BP1,9270,ENSG00000119185,NA,NA,Itgb1bp1 (MGI:1306802)
2,9488485,9555829,2p25,2p25.1,603639,"ADAM17, TACE, NISBD1",A disintegrin and metalloproteinase domain 17,ADAM17,6868,ENSG00000151694,mutation identified in 1 NISBD1 family,"?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3), Autosomal recessive",Adam17 (MGI:1096335)
2,9583966,9630996,2p25.1,2p25.1,609009,TYHAQ,"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta isoform",YWHAQ,10971,ENSG00000134308,pseudogene on chr.22,NA,"Ywhaq,Ywhaq-ps3 (MGI:3650241,MGI:891963)"
2,9843441,9934415,2p25,2p25.1,604904,"RAF1B, RAFI63, SL1",TATA box-binding protein-associated factor 1B,TAF1B,9014,ENSG00000115750,NA,NA,Taf1b (MGI:109577)
2,9951692,10002278,2p25.1,2p25.1,609786,"GRHL1, LBP32, MGR",Grainyhead-like 1,GRHL1,29841,ENSG00000134317,NA,NA,Grhl1 (MGI:2182540)
2,10043549,10054835,2p25,2p25.1,603301,"KLF11, TIEG2, FKLF1, FKLF, MODY7",Kruppel-like factor 11,KLF11,8462,ENSG00000172059,NA,"Maturity-onset diabetes of the young, type VII, 610508 (3)",Klf11 (MGI:2653368)
2,10122567,10131418,2p25-p24,2p25.1,180390,RRM2,"Ribonucleotide reductase, M2 polypeptide",RRM2,6241,ENSG00000171848,"pseudogenes on 1p, 1q, Xp",NA,Rrm2 (MGI:98181)
2,10302123,10427616,2p25.1,2p25.1,600207,HPCAL1,Hippocalcin-like 1,HPCAL1,3241,ENSG00000115756,NA,NA,Hpcal1 (MGI:1855689)
2,10439967,10448326,2p25,2p25.1,165640,ODC1,Ornithine decarboxylase-1,ODC1,4953,ENSG00000115758,pseudogene ODCP on 7q31-qter,"{Colonic adenoma recurrence, reduced risk of}, 114500 (3), Autosomal dominant, Somatic mutation",Odc1 (MGI:97402)
2,10570753,10689986,2p25.1,2p25.1,616197,"NOL10, PQBP5",Nucleolar protein 10,NOL10,79954,ENSG00000115761,NA,NA,Nol10 (MGI:2684913)
2,10720972,10785109,2p25.1,2p25.1,618070,ATP6V1C2,"ATPase, H+ transporting, V1 subunit C2",ATP6V1C2,245973,ENSG00000143882,NA,NA,Atp6v1c2 (MGI:1916025)
2,10783390,10837711,2p25-p24,2p25.1,611099,"PDIA6, ERP5","Protein disulfide isomerase, family A, member 6",PDIA6,10130,ENSG00000143870,NA,NA,Pdia6 (MGI:1919103)
2,10911933,10914224,2p25,2p25.1,603787,"KCNF1, KH1","Potassium voltage-gated channel, subfamily F, member 1",KCNF1,3754,ENSG00000162975,NA,NA,Kcnf1 (MGI:2687399)
2,11179758,11345436,2p24,2p25.1,604002,ROCK2,RHO-associated coiled-coil-containing protein kinase 2,ROCK2,9475,ENSG00000134318,NA,NA,Rock2 (MGI:107926)
2,11481674,11642787,2p25.1,2p25.1,611736,GREB1,GREB1 protein,GREB1,9687,ENSG00000196208,NA,NA,Greb1 (MGI:2149712)
2,11658118,11670205,2p25.1,2p25.1,605538,NTSR2,Neurotensin receptor 2,NTSR2,23620,ENSG00000169006,NA,NA,Ntsr2 (MGI:108018)
2,11677543,11827408,2p21,2p25.1,605518,LPIN1,Lipin 1,LPIN1,23175,ENSG00000134324,related to LSL,"Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3), Autosomal recessive",Lpin1 (MGI:1891340)
2,12000000,41500000,2p24-p22,NA,610760,CLQTL2,Cholesterol level quantitative trait locus 2,NA,100188817,NA,max lod at D2S1360,"[Cholesterol level QTL 2], 610760 (2)",NA
2,12000000,23800000,2p24,NA,609800,GEFSP4,"Generalized epilepsy with febrile seizures plus, type 4",NA,100188796,NA,max lod at D2S305,"Epilepsy, generalized, with febrile seizures plus, type 4, 609800 (2), Autosomal dominant",NA
2,12000000,23800000,2p24,NA,609271,KTCN4,Keratoconus 4,NA,550624,NA,between D2S305 and D2S2373,"Keratoconus 4, 609271 (2)",NA
2,14632682,14651915,2p24.3,2p24.3,611234,"FAM84A, NSE1","Family with sequence similarity 84, member A",LRATD1,151354,ENSG00000162981,NA,NA,Lratd1 (MGI:2145011)
2,14998066,15561347,2p24-p23,2p24.3,608025,"NBAS, NAG, SOPH, ILFS2",Neuroblastoma-amplified sequence,NBAS,51594,ENSG00000151779,NA,"Infantile liver failure syndrome 2, 616483 (3), Autosomal recessive; Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3), Autosomal recessive",Nbas (MGI:1918419)
2,15591867,15631100,2p24,2p24.3,601257,DDX1,DEAD/H box-1,DDX1,1653,ENSG00000079785,NA,NA,Ddx1 (MGI:2144727)
2,15920398,15936017,2p24.3,2p24.3,615968,MYCNUT,"MYCN upstream transcript, noncoding",MYCNUT,103752554,ENSG00000223850,NA,NA,NA
2,15936264,15942432,2p24.1,2p24.3,605374,"MYCNOS, NCYM","Oncogene NCYM, opposite strand",MYCNOS,10408,ENSG00000233718,NA,NA,NA
2,15940549,15947003,2p24.1,2p24.3,164840,"MYCN, NMYC, ODED, MODED",Oncogene NMYC,MYCN,4613,ENSG00000134323,proximal to APOB,"Feingold syndrome 1, 164280 (3), Autosomal dominant",Mycn (MGI:97357)
2,16050426,16085688,2p24.3,2p24.3,616132,"GACAT3, LINC01458","Gastric cancer-associated transcript 3, noncoding",GACAT3,104797537,ENSG00000236289,NA,NA,NA
2,17539971,17657017,2p,2p24.2,600817,VSNL1,Visinin-like 1,VSNL1,7447,ENSG00000163032,NA,NA,Vsnl1 (MGI:1349453)
2,17663811,17753832,2p24.2,2p24.2,609387,"SMC6L1, SMC6",Structural maintenance of chromosomes 6-like 1,SMC6,79677,ENSG00000163029,NA,NA,Smc6 (MGI:1914491)
2,17753686,17788945,2p24.2,2p24.2,612449,GEN1,"GEN1, Drosophila, homolog of",GEN1,348654,ENSG00000178295,NA,NA,Gen1 (MGI:2443149)
2,17816459,17817797,2p24.2,2p24.2,612209,MSGN1,Mesogenin 1,MSGN1,343930,ENSG00000151379,NA,NA,Msgn1 (MGI:1860483)
2,17877846,17932960,2p24,2p24.2,603888,"KCNS3, KV9.3","Potassium voltate-gated channel, delayed-rectifier, subfamily S, member 3",KCNS3,3790,ENSG00000170745,NA,NA,Kcns3 (MGI:1098804)
2,18554722,18560652,2p24.2,2p24.2,616796,"RDH14, SDR7C4, PAN2",Retinol dehydrogenase 14,RDH14,57665,ENSG00000240857,NA,NA,Rdh14 (MGI:1920402)
2,18562870,18589568,2p24.2,2p24.2,610526,"NT5C1B, CN1B, AIRP","5'-nucleotidase, cytosolic, Ib",NT5C1B,93034,ENSG00000185013,NA,NA,Nt5c1b (MGI:1918131)
2,19351484,19358622,2p24,2p24.1,608891,"ODD, OSR1","ODD-skipped, Drosophila, homolog of",OSR1,130497,ENSG00000143867,NA,NA,Osr1 (MGI:1344424)
2,19910259,19990104,2p24.1,2p24.1,613602,"WDR35, NAOFEN, KIAA1336, CED2, SRTD7",WD repeat-containing protein 35,WDR35,57539,ENSG00000118965,NA,"Cranioectodermal dysplasia 2, 613610 (3), Autosomal recessive; Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3), Autosomal recessive",Wdr35 (MGI:1921932)
2,19992051,20012667,2p24-p23,2p24.1,602109,"MATN3, EDM5, HOA, OS2",Matrilin 3,MATN3,4148,ENSG00000132031,mutation identified in 1 SEMDM family,"Epiphyseal dysplasia, multiple, 5, 607078 (3), Autosomal dominant; {Osteoarthritis susceptibility 2}, 140600 (3), Autosomal dominant; ?Spondyloepimetaphyseal dysplasia, 608728 (3), Autosomal recessive",Matn3 (MGI:1328350)
2,20200796,20225432,2p24.1,2p24.1,186355,SDC1,Syndecan 1,SDC1,6382,ENSG00000115884,close to NMYC in mouse,NA,Sdc1 (MGI:1349162)
2,20248690,20352252,2p22-p21,2p24.1,607205,"PUM2, KIAA0235","Pumilio, Drosophila, homolog of, 2",PUM2,23369,ENSG00000055917,NA,NA,Pum2 (MGI:1931751)
2,20447073,20449439,2p24.1,2p24.1,165370,"RHOB, ARHB, ARH6, RHOH6","RAS homolog gene family, member B (oncogene RHO H6)",RHOB,388,ENSG00000143878,NA,NA,Rhob (MGI:107949)
2,20552933,20651660,2p24.1,2p24.1,609359,"HS1BP3, FLJ14249, ETM2",HS1-binding protein 3,HS1BP3,64342,ENSG00000118960,NA,NA,Hs1bp3 (MGI:1913224)
2,20667143,20679242,2p24-p23,2p24.1,604651,GDF7,Growth/differentiation factor 7,GDF7,151449,ENSG00000143869,NA,NA,Gdf7 (MGI:95690)
2,20682488,20823138,2p24.1,2p24.1,613570,"LDAH, C2orf43",Lipid droplet associated hydrolase,LDAH,60526,ENSG00000118961,NA,NA,Ldah (MGI:1916082)
2,21001428,21044072,2p24,2p24.1,107730,"APOB, FLDB, LDLCQ4, FCHL2",Apolipoprotein B (including Ag(x) antigen),APOB,338,ENSG00000084674,1 gene for liver apo-B100 and gut apo-B48; Ag linked,"Hypercholesterolemia, familial, 2, 144010 (3), Autosomal dominant; Hypobetalipoproteinemia, 615558 (3), Autosomal recessive",Apob (MGI:88052)
2,23687623,23927122,2p24.1-p23.3,2p24.1-p23.3,615347,"ATAD2B, KIAA1240","ATPase family, AAA domain-containing, member 2B",ATAD2B,54454,ENSG00000119778,NA,NA,Atad2b (MGI:2444798)
2,23800000,36300000,2p23.3-p22.3,NA,609955,"GINGF3, HGF3, GGF3","Fibromatosis, gingival, 3",GINGF3,780916,NA,between D2S2221 and D2S1788,"Fibromatosis, gingival, 3, 609955 (2)",NA
2,24009021,24026774,2p23.3,2p23.3,617845,MFSD2B,Major facilitator superfamily domain-containing protein 2B,MFSD2B,388931,ENSG00000205639,NA,NA,Mfsd2b (MGI:3583946)
2,24029335,24047425,2p23.3,2p23.3,616234,"C2orf44, WDCP",WD repeat- and coiled-coil-containing protein,WDCP,80304,ENSG00000163026,NA,NA,Wdcp (MGI:3040699)
2,24033204,24067742,2p23.3,2p23.3,600620,"FKBP1B, PKBP1L",FK506-binding protein 1B,FKBP1B,2281,ENSG00000119782,NA,NA,Fkbp1b (MGI:1336205)
2,24067585,24076325,2p25,2p23.3,607835,"SAP14, SF3B14, P14","Spliceosome-associated protein, 14kD",SF3B6,51639,ENSG00000115128,NA,NA,Sf3b6 (MGI:1913305)
2,24077427,24085766,2p23.3,2p23.3,605171,"TP53I3, PIG3",Tumor protein p53-inducible protein 3,TP53I3,9540,ENSG00000115129,NA,NA,NA
2,24202863,24360537,2p25,2p23.3,604464,"ITSN2, SH3D1B, SWAP, KIAA1256",Intersectin 2,ITSN2,50618,ENSG00000198399,NA,NA,Itsn2 (MGI:1338049)
2,24491253,24770701,2p23,2p23.3,602691,"NCOA1, SRC1",Nuclear receptor coactivator 1,NCOA1,8648,ENSG00000084676,NA,NA,Ncoa1 (MGI:1276523)
2,24790266,24793381,2p23.3,2p23.3,617342,"PRTHD1, C2orf79",Peptidyl-tRNA hydrolase domain-containing 1,PTRHD1,391356,ENSG00000184924,NA,NA,Ptrhd1 (MGI:1916959)
2,24793114,24822375,2p23.3,2p23.3,611504,CENPO,Centromeric protein O,CENPO,79172,ENSG00000138092,NA,NA,Cenpo (MGI:1923800)
2,24819168,24920236,2p24-p22,2p23.3,600291,"ADCY3, BMIQ19",Adenylate cyclase-3,ADCY3,109,ENSG00000138031,NA,"{Obesity, susceptibility to, BMIQ19}, 617885 (3), Autosomal recessive",Adcy3 (MGI:99675)
2,24943635,24972093,2p23.3,2p23.3,613527,"DNAJC27, RBJ","DNAJ/HSP40 homolog, subfamily, C, member 27",DNAJC27,51277,ENSG00000115137,NA,NA,Dnajc27 (MGI:2443036)
2,25042075,25159136,2p23.3,2p23.3,616797,"EFR3B, KIAA0953","Efr3, S. cerevisiae, homolog of, B",EFR3B,22979,ENSG00000084710,NA,NA,Efr3b (MGI:2444851)
2,25160852,25168850,2p23.3,2p23.3,176830,"POMC, OBAIRH",Proopiomelanocortin (adrenocorticotropin/beta-lipotropin),POMC,5443,ENSG00000115138,NA,"Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3), Autosomal recessive; {Obesity, early-onset, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Pomc (MGI:97742)
2,25232960,25342589,2p23,2p23.3,602769,"DNMT3A, TBRS",DNA methyltransferase 3A,DNMT3A,1788,ENSG00000119772,NA,"Acute myeloid leukemia, somatic, 601626 (3); Tatton-Brown-Rahman syndrome, 615879 (3), Autosomal dominant",Dnmt3a (MGI:1261827)
2,25377242,25673673,2p23-p22,2p23.3,602415,DTNB,"Dystrobrevin, beta",DTNB,1838,ENSG00000138101,NA,NA,Dtnb (MGI:1203728)
2,25733752,25878486,2p23.3,2p23.3,612991,"ASXL2, KIAA1685, SHAPNS",Additional sex combs-like 2,ASXL2,55252,ENSG00000143970,NA,"Shashi-Pena syndrome, 617190 (3), Autosomal dominant",Asxl2 (MGI:1922552)
2,25926597,25982739,2p23,2p23.3,602845,KIF3C,Kinesin family member 3C,KIF3C,3797,ENSG00000084731,NA,NA,Kif3c (MGI:107979)
2,26034083,26137453,2p23.3,2p23.3,612672,RAB10,Ras-associated protein,RAB10,10890,ENSG00000084733,NA,NA,Rab10 (MGI:105066)
2,26173087,26202528,2p23.1,2p23.3,617999,GAREM2,"GRB2-associated regulator of MAPK1, subtype 2",GAREM2,150946,ENSG00000157833,NA,NA,Garem2 (MGI:2685290)
2,26190634,26244631,2p23,2p23.3,600890,"HADHA, MTPA","Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit",HADHA,3030,ENSG00000084754,NA,"Fatty liver, acute, of pregnancy, 609016 (3), Autosomal recessive; HELLP syndrome, maternal, of pregnancy, 609016 (3), Autosomal recessive; LCHAD deficiency, 609016 (3), Autosomal recessive; Trifunctional protein deficiency, 609015 (3), Autosomal recessive",Hadha (MGI:2135593)
2,26244747,26290464,2p23,2p23.3,143450,HADHB,"Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase /enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit",HADHB,3032,ENSG00000138029,NA,"Trifunctional protein deficiency, 609015 (3), Autosomal recessive",Hadhb (MGI:2136381)
2,26346142,26395884,2p23.3,2p23.3,607915,"SELENOI, SELI",Selenoprotein I,SELENOI,85465,ENSG00000138018,NA,NA,Selenoi (MGI:107898)
2,26401919,26456712,2p23.3,2p23.3,615288,"DRC1, CCDC164, C2orf39, CILD21","Dynein regulatory complex, subunit 1, Chlamydomonas, homolog of",DRC1,92749,ENSG00000157856,NA,"Ciliary dyskinesia, primary, 21, 615294 (3), Autosomal recessive",Drc1 (MGI:2685906)
2,26457202,26558755,2p23-p22,2p23.3,603681,"OTOF, DFNB9, NSRD9, AUNB1",Otoferlin,OTOF,9381,ENSG00000115155,symbolized DFNB6 by authors,"Auditory neuropathy, autosomal recessive, 1, 601071 (3), Autosomal recessive; Deafness, autosomal recessive 9, 601071 (3), Autosomal recessive",Otof (MGI:1891247)
2,26581204,26641797,2p23.3,2p23.3,610646,"CIB4, KIP4",Calcium- and integrin-binding protein 4,CIB4,130106,ENSG00000157884,NA,NA,Cib4 (MGI:1920509)
2,26692721,26733419,2p23,2p23.3,603220,"KCNK3, TASK, PPH4","Potassium channel, subfamily K, member 3",KCNK3,3777,ENSG00000171303,NA,"Pulmonary hypertension, primary, 4, 615344 (3), Autosomal dominant",Kcnk3 (MGI:1100509)
2,26786014,26794588,2p24-p21,2p23.3,117139,CENPA,"Centromere protein A, 17kD",CENPA,1058,ENSG00000115163,NA,NA,Cenpa (MGI:88375)
2,26848101,26950350,2p23.3,2p23.3,608383,"DPYSL5, CRMP5, CRAM",Dihydropyrimidinase-like 5,DPYSL5,56896,ENSG00000157851,NA,NA,Dpysl5 (MGI:1929772)
2,26970636,27027218,2p23.3-p23.1,2p23.3,605788,"MAPRE3, EB3, RP3, EBF3","Microtubule-associated protein, RP/EB family, member 3",MAPRE3,22924,ENSG00000084764,NA,NA,Mapre3 (MGI:2140967)
2,27032964,27041693,2p23.3,2p23.3,615301,TMEM214,Transmembrane protein 214,TMEM214,54867,ENSG00000119777,NA,NA,Tmem214 (MGI:1916046)
2,27051422,27070621,2p23.3,2p23.3,615900,"AGBL5, CCP5, RP75",AATP/GTP-binding protein-like 5,AGBL5,60509,ENSG00000084693,NA,"Retinitis pigmentosa 75, 617023 (3), Autosomal recessive",Agbl5 (MGI:2441745)
2,27078614,27086402,2p23.3-p23.2,2p23.3,130660,"EMILIN1, EMILIN",Elastin microfibril interfacer 1,EMILIN1,11117,ENSG00000138080,NA,NA,Emilin1 (MGI:1926189)
2,27086759,27100761,2p23.3-p23.2,2p23.3,614058,KHK,Ketohexokinase (fructokinase),KHK,3795,ENSG00000138030,NA,"[Fructosuria], 229800 (3), Autosomal recessive",Khk (MGI:1096353)
2,27099352,27119127,2p23.3,2p23.3,606137,"CGREF1, CGR11",Cell growth regulator with EF-hand domain 1,CGREF1,10669,ENSG00000138028,NA,NA,Cgref1 (MGI:1915817)
2,27123779,27131113,2p23.3,2p23.3,612195,"ABHD1, LABH1",Abhydrolase domain-containing 1,ABHD1,84696,ENSG00000143994,NA,NA,NA
2,27130755,27134674,2p23,2p23.3,606395,PREB,Prolactin regulatory element-binding protein,PREB,10113,ENSG00000138073,NA,NA,Preb (MGI:1355326)
2,27148891,27156973,2p24-p23,2p23.3,609635,TCF23,Transcription factor 23,TCF23,150921,ENSG00000163792,NA,NA,Tcf23 (MGI:1934960)
2,27199586,27212341,2p23.3,2p23.3,604024,"SLC5A6, SMVT","Solute carrier family 5 (sodium dependent vitamin transporter), member 6",SLC5A6,8884,ENSG00000138074,NA,NA,Slc5a6 (MGI:2660847)
2,27217368,27243942,2p21,2p23.3,114010,"CAD, CDG1Z, EIEE50",CAD trifunctional protein of pyrimidine biosynthesis,CAD,790,ENSG00000084774,NA,"Epileptic encephalopathy, early infantile, 50, 616457 (3), Autosomal recessive",Cad (MGI:1916969)
2,27253683,27275862,2p23.3,2p23.3,602878,"SLC30A3, ZNT3","Solute carrier family 30 (zinc transporter), member 3",SLC30A3,7781,ENSG00000115194,NA,NA,Slc30a3 (MGI:1345280)
2,27275426,27281498,2p23.3,2p23.3,613946,DNAJC5G,"DNAJ/HSP40 homolog, subfamily C, member 5, gamma",DNAJC5G,285126,ENSG00000163793,NA,NA,Dnajc5g (MGI:3045263)
2,27282428,27307438,2p23.3,2p23.3,606474,"TRIM54, RNF30, MURF3",Tripartite motif containing 54,TRIM54,57159,ENSG00000138100,NA,NA,Trim54 (MGI:1889623)
2,27307399,27308444,2p23-p21,2p23.3,600945,"UCN, UROC",Urocortin,UCN,7349,ENSG00000163794,NA,NA,Ucn (MGI:1276123)
2,27309491,27323096,2p23-p21,2p23.3,137960,"MPV17, MTDPS6, CMT2EE","Mpv17 transgene, mouse, glomerulosclerosis, homolog of",MPV17,4358,ENSG00000115204,NA,"Charcot-Marie-Tooth disease, axonal, type 2EE, 618400 (3), Autosomal recessive; Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3), Autosomal recessive",Mpv17 (MGI:97138)
2,27364351,27370456,2p23.3,2p23.3,606687,EIF2B4,"Eukaryotic translation initiation factor 2B, subunit 4",EIF2B4,8890,ENSG00000115211,NA,"Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive; Ovarioleukodystrophy, 603896 (3), Autosomal recessive",Eif2b4 (MGI:95300)
2,27370495,27377534,2p23-p22,2p23.3,605963,SNX17,Sorting nexin 17,SNX17,9784,ENSG00000115234,NA,NA,Snx17 (MGI:2387801)
2,27377230,27380865,2p24.1-p22.3,2p23.3,613598,"ZNF513, RP58",Zinc finger protein 513,ZNF513,130557,ENSG00000163795,mutation identified in 1 RP58 family,"?Retinitis pigmentosa 58, 613617 (3), Autosomal recessive",Zfp513 (MGI:2141255)
2,27381198,27409590,2p23.3,2p23.3,605119,"PPM1G, PP2CG","Protein phosphatase, magnesium/manganese-dependent, 1G",PPM1G,5496,ENSG00000115241,NA,NA,Ppm1g (MGI:106065)
2,27427789,27442258,2p23,2p23.3,606010,NRBP,Nuclear receptor-binding protein,NRBP1,29959,ENSG00000115216,NA,NA,Nrbp1 (MGI:2183436)
2,27444372,27489818,2p23.3,2p23.3,607386,"IFT172, SLB, KIAA1179, SRTD10, RP71","Intraflagellar transport 172, Chlamydomonas, homolog of",IFT172,26160,ENSG00000138002,NA,"Retinitis pigmentosa 71, 616394 (3), Autosomal recessive; Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3), Autosomal recessive",Ift172 (MGI:2682064)
2,27491882,27495501,2p23.3,2p23.3,611905,"FNDC4, FRCP1",Fibronectin type III domain-containing protein 4,FNDC4,64838,ENSG00000115226,NA,NA,Fndc4 (MGI:1917195)
2,27496838,27523688,2p23.3-p23.2,2p23.3,600842,"GCKR, GKRP, FGQTL5",Glucokinase (hexokinase 4) regulatory protein,GCKR,2646,ENSG00000084734,NA,"[Fasting plasma glucose level QTL 5], 613463 (3)",Gckr (MGI:1096345)
2,27628647,27651510,2p23.3,2p23.3,611479,"XAB1, MBDIN",XPA-binding protein,GPN1,11321,ENSG00000198522,NA,NA,Gpn1 (MGI:1921504)
2,27642567,27663839,2p25,2p23.3,612762,"SUPT7L, SUPT7H, SPT7l, KIAA0764, STAF65G",Suppressor of TY 7-like,SUPT7L,9913,ENSG00000119760,NA,NA,Supt7l (MGI:1919445)
2,27663470,27694979,2p23.3-p23.2,2p23.3,602655,SLC4A1AP,"Solute carrier family 4 (anion exchanger), member 1, adaptor protein",SLC4A1AP,22950,ENSG00000163798,NA,NA,Slc4a1ap (MGI:1196608)
2,27771716,27779740,2p22,2p23.2,610059,MRPL33,Mitochondrial ribosomal protein L33,MRPL33,9553,ENSG00000243147,NA,NA,Mrpl33 (MGI:2137225)
2,27781363,27890395,2p23.2,2p23.2,611132,RBKS,Ribokinase,RBKS,64080,ENSG00000171174,NA,NA,Rbks (MGI:1918586)
2,27888708,28338900,2p23.2,2p23.2,610497,"BRE, BRCC4, BRCC45",Brain and reproductive organ-expressed protein,BABAM2,9577,ENSG00000158019,NA,NA,Babam2 (MGI:1333875)
2,28392854,28417316,2p23.2,2p23.2,601575,FOSL2,FOS-like antigen-2,FOSL2,2355,ENSG00000075426,NA,NA,Fosl2 (MGI:102858)
2,28488577,28644141,2p23.2,2p23.2,610179,"PLB1, PLB, FLJ30866",Phospholipase B1,PLB1,151056,ENSG00000163803,NA,NA,Plb1 (MGI:1922406)
2,28751747,28802939,2p23,2p23.2,600590,"PPP1CB, NSLH2","Protein phosphatase-1, catalytic subunit, beta isoform",PPP1CB,5500,ENSG00000213639,NA,"Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3), Autosomal dominant",Ppp1cb (MGI:104871)
2,28810833,28850609,2p23.2,2p23.2,614029,"SPDYA, SPY1, RINGOA","Speedy, xenopus, homolog of, A",SPDYA,245711,ENSG00000163806,NA,NA,Spdya (MGI:1918141)
2,28894666,28948218,2p23.2,2p23.2,616195,"WDR43, UTP5, KIAA0007",WD repeat-containing protein 43,WDR43,23160,ENSG00000163811,NA,NA,Wdr43 (MGI:1919765)
2,29061694,29074522,2p23.2,2p23.2,613425,"PCARE, C2orf71, RP54",Photoreceptor cilium actin regulator,PCARE,388939,ENSG00000179270,NA,"Retinitis pigmentosa 54, 613428 (3)",Pcare (MGI:2385061)
2,29190991,29921588,2p23,2p23.2-p23.1,105590,"ALK, NBLST3",Anaplastic lymphoma kinase (Ki-1),ALK,238,ENSG00000171094,NA,"{Neuroblastoma, susceptibility to, 3}, 613014 (3)",Alk (MGI:103305)
2,30146567,30160532,2p23.1,2p23.1,609726,YPEL5,Yippee-like 5,YPEL5,51646,ENSG00000119801,NA,NA,Ypel5 (MGI:1916937)
2,30231533,30260027,2p23.1,2p23.1,611763,LBH,"Limb bud and heart development, mouse, homolog of",LBH,81606,ENSG00000213626,NA,NA,Lbh (MGI:1925139)
2,30447240,30644224,2p23.1,2p23.1,614241,"LCLAT1, ALCAT1, AGPAT8",Lysocardiolipin acyltransferase 1,LCLAT1,253558,ENSG00000172954,NA,NA,Lclat1 (MGI:2684937)
2,30722770,30809526,2p23.1,2p23.1,610228,"CAPN13, FLJ23523",Calpain 13,CAPN13,92291,ENSG00000162949,NA,NA,Capn13 (MGI:2685789)
2,30888517,31138439,2p23.2,2p23.1,608225,GALNT14,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14,GALNT14,79623,ENSG00000158089,NA,NA,Galnt14 (MGI:1918935)
2,31173055,31233969,2p23.1,2p23.1,610229,CAPN14,Calpain 14,CAPN14,440854,ENSG00000214711,NA,NA,NA
2,31234151,31269450,2p21,2p23.1,605891,EHD3,EH domain-containing 3,EHD3,30845,ENSG00000013016,NA,NA,Ehd3 (MGI:1928900)
2,31334319,31414776,2p23-p22,2p23.1,607633,"XDH, XAN1",Xanthine dehydrogenase (xanthine oxidase),XDH,7498,ENSG00000158125,NA,"Xanthinuria, type I, 278300 (3), Autosomal recessive",Xdh (MGI:98973)
2,31522479,31665650,2p23,2p23.1,607306,SRD5A2,"Steroid-5-alpha-reductase, alpha polypeptide-2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha-2)",SRD5A2,6716,ENSG00000277893,NA,"Pseudovaginal perineoscrotal hypospadias, 264600 (3), Autosomal recessive",Srd5a2 (MGI:2150380)
2,31800000,47500000,2p22.3-p21,NA,114580,"CANDF1, CMCT","Candidiasis, familial, 1",NA,117084,NA,between D2S367 and D2S2240,"Candidiasis, familial, 1, autosomal dominant, 114580 (2), Autosomal dominant",NA
2,31865059,32011051,2p22-p21,2p22.3,611786,"MEMO1, MEMO, C2orf4",Mediator of cell motility 1,MEMO1,51072,ENSG00000162959,NA,NA,Memo1 (MGI:1924140)
2,32011648,32039839,2p22.3,2p22.3,612032,DPY30,"DPY30, C. elegans, homolog of",DPY30,84661,ENSG00000162961,NA,NA,Dpy30 (MGI:1913560)
2,32063550,32157636,2p22-p21,2p22.3,604277,"SPAST, SPG4",Spastin,SPAST,6683,ENSG00000021574,NA,"Spastic paraplegia 4, autosomal dominant, 182601 (3), Autosomal dominant",Spast (MGI:1858896)
2,32165840,32224378,2p22-p21,2p22.3,611148,"SLC30A6, ZNT6","Solute carrier family 30 (zinc transporter), member 6",SLC30A6,55676,ENSG00000152683,NA,NA,Slc30a6 (MGI:2386741)
2,32224448,32265742,2p22.3,2p22.3,606831,"NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4","NLR family, caspase recruitment domain-containing 4",NLRC4,58484,ENSG00000091106,mutation identified in 1 FCAS4 family,"Autoinflammation with infantile enterocolitis, 616050 (3), Autosomal dominant; ?Familial cold autoinflammatory syndrome 4, 616115 (3), Autosomal dominant",Nlrc4 (MGI:3036243)
2,32277903,32316593,2p22.3,2p22.3,617534,YIPF4,"Yip1 domain family, member 4",YIPF4,84272,ENSG00000119820,NA,NA,Yipf4 (MGI:1915114)
2,32356906,32618898,2p22-p21,2p22.3,605638,"BIRC6, KIAA1289",Baculoviral IAP repeat-containing protein-6,BIRC6,57448,ENSG00000115760,NA,NA,Birc6 (MGI:1276108)
2,32532152,32532245,2p22.3,2p22.3,616473,MIR558,Micro RNA 558,MIR558,693143,ENSG00000207653,BIRC6 is host gene,NA,NA
2,32902128,33399508,2p12-q22,2p22.3,150390,LTBP1,Latent transforming growth factor beta binding protein 1,LTBP1,4052,ENSG00000049323,NA,NA,Ltbp1 (MGI:109151)
2,36300000,38300000,2p22.2,NA,602499,MACOM,"Macrophthalmia, colobomatous, with microcornea",NA,NA,NA,NA,"Macrophthalmia, colobomatous, with microcornea, 602499 (4), Autosomal dominant",NA
2,36355777,36551134,2p22-p21,2p22.2,606189,CRIM1,Cysteine-rich motor neuron protein 1,CRIM1,51232,ENSG00000150938,NA,NA,Crim1 (MGI:1354756)
2,36552238,36598189,2p22.2,2p22.2,604826,FEZ2,Fasciculation and elongation protein zeta 2,FEZ2,9637,ENSG00000171055,NA,NA,Fez2 (MGI:2675856)
2,36696689,36814793,2p22.2,2p22.2,617693,"VIT, VIT1",Vitrin,VIT,5212,ENSG00000205221,NA,NA,Vit (MGI:1921449)
2,36837697,36966606,2p22,2p22.2,614765,STRN,"Striatin, calmodulin-binding protein",STRN,6801,ENSG00000115808,NA,NA,Strn (MGI:1333757)
2,37099209,37157064,2p21,2p22.2,176871,PRKR,"Protein kinase, interferon-inducible double stranded RNA dependent",EIF2AK2,5610,ENSG00000055332,NA,NA,Eif2ak2 (MGI:1353449)
2,37167819,37196086,2p22.3,2p22.2,617152,SULT6B1,"Sulfotransferase family 6B, member 1",SULT6B1,391365,ENSG00000138068,NA,NA,Sult6b1 (MGI:1920921)
2,37201611,37231595,2p22.2,2p22.2,612828,"CEBPZ, CBF, NOC1","CCAAT/enhancer-binding protein, zeta",CEBPZ,10153,ENSG00000115816,NA,NA,Cebpz (MGI:109386)
2,37231630,37271364,2p22.2,2p22.2,615898,"NDUFAF7, MIDA",NADH-ubiquinone oxidoreductase complex assembly factor 7,NDUFAF7,55471,ENSG00000003509,NA,NA,Ndufaf7 (MGI:1920944)
2,37250501,37324784,2p21,2p22.2,607077,PRKCN,"Protein kinase C, nu",PRKD3,23683,ENSG00000115825,NA,NA,Prkd3 (MGI:1922542)
2,37344629,37373321,2p22.2,2p22.2,607065,"QPCT, QC",Glutaminyl-peptide cyclotransferase,QPCT,25797,ENSG00000115828,NA,NA,Qpct (MGI:1917786)
2,37641881,37672534,2p21,2p22.2,606133,"CDC42EP3, CEP3, BORG2",CDC42 effector protein 3,CDC42EP3,10602,ENSG00000163171,NA,NA,Cdc42ep3 (MGI:2384718)
2,37920788,38069245,2p22.2,2p22.2,611872,"FAM82A1, FAM82A, RMD2","Family with sequence similarity 82, member A1",RMDN2,151393,ENSG00000115841,NA,NA,Rmdn2 (MGI:2147043)
2,38067602,38076180,2p22-p21,2p22.2,601771,"CYP1B1, GLC3A, ASGD6","Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1",CYP1B1,1545,ENSG00000138061,NA,"Anterior segment dysgenesis 6, multiple subtypes, 617315 (3); Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3), Autosomal recessive",Cyp1b1 (MGI:88590)
2,38293953,38378583,2p22.3,2p22.2-p22.1,609368,"ARL3IP2, ATL2",ADP-ribosylation-like factor 6-interacting protein 2 (atlastin 2),ATL2,64225,ENSG00000119787,NA,NA,Atl2 (MGI:1929492)
2,38300000,47500000,2p22.1-p21,NA,614227,HNFJ3,"Hyperuricemic nephropathy, familial juvenile, 3",NA,100689490,NA,between rs372139 and rs896986,"Hyperuricemic nephropathy, familial juvenile, 3, 614227 (2), Autosomal dominant",NA
2,38561968,38603035,2p22,2p22.1,611208,"HNRNPLL, HNRPLL, SRRF",Heterogeneous nuclear ribonucleoprotein L-like,HNRNPLL,92906,ENSG00000143889,NA,NA,Hnrnpll (MGI:1919942)
2,38665921,38734764,2p22-p11,2p22.1,137030,"GALM, GLAT",Galactose mutarotase,GALM,130589,ENSG00000143891,NA,NA,Galm (MGI:2442420)
2,38743598,38751493,2p22-p21,2p22.1,600572,"SRSF7, SFRS7","Splicing factor, arginine/serine-rich 7, 35kD",SRSF7,6432,ENSG00000115875,NA,NA,Srsf7 (MGI:1926232)
2,38778209,38785001,2p22.1,2p22.1,607006,GEMIN6,GEM-associated protein 6,GEMIN6,79833,ENSG00000152147,NA,NA,"Gemin6-ps,Gemin6 (MGI:1914492,MGI:3645567)"
2,38981548,39124958,2p22-p21,2p22.1,182530,"SOS1, GINGF, GF1, HGF, NS4","Son of sevenless, Drosophila, homolog of, 1",SOS1,6654,ENSG00000115904,mutation identified in 1 GINGF1 family,"?Fibromatosis, gingival, 1, 135300 (3), Autosomal dominant; Noonan syndrome 4, 610733 (3), Autosomal dominant",Sos1 (MGI:98354)
2,39248940,39437311,2p22.1,2p22.1,604921,"MAP4K3, GLK",Mitogen-activated protein kinase kinase kinase kinase 3,MAP4K3,8491,ENSG00000011566,NA,NA,Map4k3 (MGI:2154405)
2,39736059,39779275,2p22-p21,2p22.1,611751,"THUMPD2, C2orf8",THUMP domain-containing 2,THUMPD2,80745,ENSG00000138050,NA,NA,Thumpd2 (MGI:1919417)
2,40097269,40512451,2p23-p22,2p22.1,182305,"SLC8A1, NCX1","Solute carrier family 8, member 1 (sodium-calcium exchanger-1)",SLC8A1,6546,ENSG00000183023,NA,NA,Slc8a1 (MGI:107956)
2,41500000,47500000,2p21,NA,606407,"DEL2p21, C2DELp21",Homozygous 2p21 deletion syndrome,NA,NA,NA,contiguous gene syndrome disrupting SLC3A1 and PREPL genes,"Hypotonia-cystinuria syndrome, 606407 (4), Autosomal recessive",NA
2,41500000,83100000,2p21-p12,NA,615654,DFNA58,"Deafness, autosomal dominant 58",DFNA58,100359395,NA,between D2S2259 and D2S2114,"Deafness, autosomal dominant 58, 615654 (2), Autosomal dominant",NA
2,41500000,47500000,2p21,NA,601694,"LEPQTL1, LSL",Leptin serum levels quantitative trait locus 1,NA,7839,NA,NA,"[Leptin serum levels QTL1], 601694 (2)",NA
2,41500000,74800000,2p21-p13,NA,608703,SCA25,Spinocerebellar ataxia 25,SCA25,338435,NA,NA,"Spinocerebellar ataxia 25, 608703 (2), Autosomal dominant",NA
2,42048020,42058516,2p21,2p21,614150,"PKDCC, VLK, SGK493","Protein kinase domain-containing protein, cytoplasmic, mouse, homolog of",PKDCC,91461,ENSG00000162878,NA,NA,Pkdcc (MGI:2147077)
2,42169352,42332547,2p22-p21,2p21,607442,"EML4, ROPP120",Echinoderm microtubule associated protein like-4,EML4,27436,ENSG00000143924,NA,NA,Eml4 (MGI:1926048)
2,42335558,42368956,2p21,2p21,605771,"COX7A2L, COX7RP, EB1","Cytochrome c oxidase subunit VIIA, polypeptide 2-like",COX7A2L,9167,ENSG00000115944,NA,NA,Cox7a2l (MGI:106015)
2,42442016,42493981,2p21,2p21,606767,"KCNG3, KV6.3","Potassium voltage-gated channel, subfamily G, member 3",KCNG3,170850,ENSG00000171126,NA,NA,Kcng3 (MGI:2663923)
2,42767086,42801001,2p21,2p21,604521,"HAAO, VCRL1","3-hydroxyanthranilate 3,4-dioxygenase",HAAO,23498,ENSG00000162882,NA,"Vertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3), Autosomal recessive",Haao (MGI:1349444)
2,43222401,43226605,2p21,2p21,612053,"ZFP36L2, ERF2, TIS11D",Zinc finger protein 36-like 2,ZFP36L2,678,ENSG00000152518,incorrectly mapped to 6p21.3,NA,Zfp36l2 (MGI:107945)
2,43230835,43596045,2p21,2p21,611800,"THADA, KIAA1767",Thyroid adenoma-associated gene,THADA,63892,ENSG00000115970,NA,NA,Thada (MGI:3039623)
2,43637259,43767986,2p21,2p21,612723,PLEKHH2,"Pleckstrin homology domain-containing protein, family H, member 2",PLEKHH2,130271,ENSG00000152527,NA,NA,Plekhh2 (MGI:2146813)
2,43774038,43828319,2p25.1-p24.1,2p21,617083,"DYNC2LI1, D2LIC, LIC3, SRTD15","Dynein, cytoplasmic 2, light intermediate chain 1",DYNC2LI1,51626,ENSG00000138036,NA,"Short-rib thoracic dysplasia 15 with polydactyly, 617088 (3), Autosomal recessive",Dync2li1 (MGI:1913996)
2,43806153,43838839,2p21,2p21,605459,ABCG5,"ATP-binding cassette, subfamily G, member 5",ABCG5,64240,ENSG00000138075,NA,"Sitosterolemia, 210250 (3), Autosomal recessive",Abcg5 (MGI:1351659)
2,43831941,43882987,2p21,2p21,605460,"ABCG8, GBD4","ATP-binding cassette, subfamily G, member 8",ABCG8,64241,ENSG00000143921,NA,"{Gallbladder disease 4}, 611465 (3); Sitosterolemia, 210250 (3), Autosomal recessive",Abcg8 (MGI:1914720)
2,43886223,43995988,2p21,2p21,607544,"LRPPRC, LRP130, LSFC",Leucine-rich PPR motif-containing protein,LRPPRC,10128,ENSG00000138095,NA,"Leigh syndrome, French-Canadian type, 220111 (3), Autosomal recessive",Lrpprc (MGI:1919666)
2,44168802,44247329,2p21,2p21,603770,PPM1B,"Protein phosphatase, magnesium-dependent, 1, beta isoform",PPM1B,5495,ENSG00000138032,formerly PP2CB,NA,Ppm1b (MGI:101841)
2,44275463,44321493,2p16.3,2p21,104614,"SLC3A1, ATR1, D2H, NBAT","Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1",SLC3A1,6519,ENSG00000138079,NA,"Cystinuria, 220100 (3), Autosomal recessive, Autosomal dominant",Slc3a1 (MGI:1195264)
2,44317606,44361861,2p21,2p21,609557,"PREPL, KIAA0436, CMS22",Prolyl endopeptidase-like,PREPL,9581,ENSG00000138078,NA,"Myasthenic syndrome, congenital, 22, 616224 (3), Autosomal recessive",Prepl (MGI:2441932)
2,44361713,44772591,2p21,2p21,609559,"CAMKMT, C2orf34",Calmodulin lysine N-methyltransferase,CAMKMT,79823,ENSG00000143919,NA,NA,Camkmt (MGI:1920832)
2,44941701,44946070,2p21,2p21,603714,"SIX3, HPE2","Sine oculis homeo box, Drosophila, homolog of, 3",SIX3,6496,ENSG00000138083,NA,"Holoprosencephaly 2, 157170 (3), Autosomal dominant; Schizencephaly, 269160 (3)",Six3 (MGI:102764)
2,45005181,45009644,2p16-p15,2p21,604994,SIX2,"Sine oculis homeo box, Drosophila, homolog of, 2",SIX2,10736,ENSG00000170577,NA,NA,Six2 (MGI:102778)
2,45651314,46187989,2p21,2p21,176975,"PRKCE, PKCE","Protein kinase C, epsilon",PRKCE,5581,ENSG00000171132,NA,NA,Prkce (MGI:97599)
2,46297406,46386696,2p21-p16,2p21,603349,"EPAS1, MOP2, HIF2A, ECYT4",Endothelial PAS domain protein 1,EPAS1,2034,ENSG00000116016,NA,"Erythrocytosis, familial, 4, 611783 (3)",Epas1 (MGI:109169)
2,46511846,46542576,2p21,2p21,617385,"ATP6V1E2, ATP6E1","ATPase, H+ transporting, V1 subunit E1",ATP6V1E2,90423,ENSG00000250565,NA,NA,Atp6v1e2 (MGI:1922165)
2,46542408,46584687,2p21,2p21,605857,"RHOQ, ARHQ, TC10","Ras-homolog gene family, member Q",RHOQ,23433,ENSG00000119729,NA,NA,Rhoq (MGI:1931553)
2,46580936,46617056,2p21-p16,2p21,600153,PIGF,"Phosphatidylinositol glycan, class F",PIGF,5281,ENSG00000151665,pseudogene on 5,NA,Pigf (MGI:99462)
2,46617214,46630175,2p21,2p21,604594,"CRIPT, SSMDF",Cystine-rich PDZ binding protein,CRIPT,9419,ENSG00000119878,NA,"Short stature with microcephaly and distinctive facies, 615789 (3), Autosomal recessive",Cript (MGI:1929655)
2,46698959,46763128,2p21,2p21,607094,"SOCS5, CIS6, KIAA0671",Suppressor of cytokine signaling 5,SOCS5,9655,ENSG00000171150,also signals at 3p22,NA,Socs5 (MGI:2385459)
2,46901869,46941854,2p21-p16.3,2p21,607788,"MCFD2, F5F8D2",Multiple coagulation factor deficiency protein 2,MCFD2,90411,ENSG00000180398,NA,"Factor V and factor VIII, combined deficiency of, 613625 (3)",Mcfd2 (MGI:2183439)
2,46915865,47076122,2p21,2p21,609332,"TTC7A, TTC7, KIAA1140, MINAT, GIDID",Tetratricopeptide repeat domain 7A,TTC7A,57217,ENSG00000068724,NA,"Gastrointestinal defects and immunodeficiency syndrome, 243150 (3), Autosomal recessive",Ttc7 (MGI:1920999)
2,47160081,47176935,2p21,2p21,114182,"CALM2, LQT15",Calmodulin-2,CALM2,805,ENSG00000143933,NA,"Long QT syndrome 15, 616249 (3), Autosomal dominant",NA
2,47369147,47387027,2p21,2p21,185535,"EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8",Epithelial cellular adhesion molecule,EPCAM,4072,ENSG00000119888,previously assigned to 4q,"Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3); Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive",Epcam (MGI:106653)
2,47403066,47634500,2p22-p21,2p21-p16,609309,"MSH2, COCA1, FCC1, HNPCC1","mutS, E. coli, homolog of, 2",MSH2,4436,ENSG00000095002,NA,"Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant; Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive; Muir-Torre syndrome, 158320 (3), Autosomal dominant",Msh2 (MGI:101816)
2,47500000,61000000,2p16,NA,609958,ASRT3,"Asthma-related traits, susceptibility to, 3",NA,100188801,NA,max lod at rs2063871,"{Asthma-related traits, susceptibility to, 3}, 609958 (2)",NA
2,47500000,61000000,2p16,NA,605244,CNC2,"Carney complex, type II",CNC2,1257,NA,NA,"Carney complex, type II, 605244 (2)",NA
2,47500000,63900000,2p16-p15,NA,604254,DYX3,"Dyslexia, susceptibility to, 3",DYX3,11192,NA,NA,"{Dyslexia, susceptibility to, 3}, 604254 (2)",NA
2,47500000,63900000,2p16-p15,NA,611276,GLC1H,"Glaucoma 1, open angle, H",GLC1H,399564,NA,between D2S123 AND D2S2165,"Glaucoma 1, open angle, H, 611276 (2)",NA
2,47500000,61000000,2p16,NA,613549,STQTL24,Stature quantitative trait locus 24,NA,100529223,NA,linked to rs1520446,"{Stature QTL 24}, 613549 (2)",NA
2,47520774,47570330,2p22-p21,2p16.3,607366,"KCNK12, THIK2","Potassium channel, subfamily K, member 12",KCNK12,56660,ENSG00000184261,NA,NA,Kcnk12 (MGI:2684043)
2,47783081,47806953,2p16,2p16.3,600678,"MSH6, GTBP, HNPCC5","MutS, E. coli, homolog of, 6",MSH6,2956,ENSG00000116062,0.5 Mb from MSH2,"Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant; {Endometrial cancer, familial}, 608089 (3); Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive",Msh6 (MGI:1343961)
2,47806919,47905792,2p21,2p16.3,607871,"FBXO11, FBX11, VIT1, PRMT9, IDDFBA",F-box only protein 11,FBXO11,80204,ENSG00000138081,?2p16,"Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant",Fbxo11 (MGI:2147134)
2,48314639,48379294,2p22-p16,2p16.3,143089,HTLF,Human T-cell leukemia virus enhancer factor,FOXN2,3344,ENSG00000170802,NA,NA,Foxn2 (MGI:1347478)
2,48440765,48515391,2p16.3,2p16.3,618159,"PPP1R21, CCDC128, KLRAQ1","Protein phosphatase 1, regulatory subunit 21",PPP1R21,129285,ENSG00000162869,NA,NA,Ppp1r21 (MGI:1921075)
2,48530168,48598514,2p16.3,2p16.3,605357,"STON1, STN1, SBLF, SALF",Stonin 1,STON1,11037,ENSG00000243244,NA,NA,Ston1 (MGI:1924307)
2,48617779,48679608,2p16.3,2p16.3,605358,"GTF2A1L, ALF","General transcription factor IIA, 1-like",GTF2A1L,11036,ENSG00000242441,NA,NA,Gtf2a1l (MGI:1919078)
2,48686773,48755723,2p21,2p16.3,152790,"LHCGR, LHR, LCGR",Luteinizing hormone/choriogonadotropin receptor,LHCGR,3973,ENSG00000138039,NA,"Leydig cell adenoma, somatic, with precocious puberty, 176410 (3); Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3), Autosomal recessive; Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3), Autosomal recessive; Luteinizing hormone resistance, female, 238320 (3), Autosomal recessive; Precocious puberty, male, 176410 (3), Autosomal dominant",Lhcgr (MGI:96783)
2,48953160,49154526,2p21-p16,2p16.3,136435,"FSHR, ODG1",Follicle stimulating hormone receptor,FSHR,2492,ENSG00000170820,NA,"Ovarian dysgenesis 1, 233300 (3), Autosomal recessive; Ovarian hyperstimulation syndrome, 608115 (3), Autosomal dominant; Ovarian response to FSH stimulation, 276400 (3), Autosomal recessive",Fshr (MGI:95583)
2,49918502,51032535,2p16.3,2p16.3,600565,"NRXN1, PTHSL2, SCZD17",Neurexin 1,NRXN1,9378,ENSG00000179915,NA,"Pitt-Hopkins-like syndrome 2, 614325 (3), Autosomal recessive; {Schizophrenia, susceptibility to, 17}, 614332 (3)",Nrxn1 (MGI:1096391)
2,53669979,53786952,2p16.2,2p16.2,605760,ASB3,Ankyrin repeat-containing SOCS box protein 3,ASB3,51130,ENSG00000115239,NA,NA,Asb3 (MGI:1929749)
2,53767782,53775195,2p16.2,2p16.2,617446,CHAC2,"ChaC, E. coli, homolog of, 2",CHAC2,494143,ENSG00000143942,NA,NA,Chac2 (MGI:1915294)
2,53786930,53834523,2p16.2,2p16.2,611229,"ERLEC1, C2orf30",Erlectin (endoplasmic reticulum lectin 1),ERLEC1,27248,ENSG00000068912,NA,NA,Erlec1 (MGI:1914003)
2,53852911,53859966,2p16,2p16.2,606704,GPR75,G protein-coupled receptor 75,GPR75,10936,ENSG00000119737,NA,NA,Gpr75 (MGI:2441843)
2,53864068,53970992,2p16.2,2p16.2,607705,"PSME4, PA200, KIAA0077",Proteasome activator subunit 4,PSME4,23198,ENSG00000068878,NA,NA,Psme4 (MGI:2143994)
2,53970837,54305299,2p16.2,2p16.2,102595,"ACYP2, ACYP","Acylphosphatase 2, muscle type",ACYP2,98,ENSG00000170634,NA,NA,Acyp2 (MGI:1922822)
2,54456326,54671445,2p21,2p16.2,182790,SPTBN1,"Spectrin, beta, nonerythrocytic-1 (beta-fodrin)",SPTBN1,6711,ENSG00000115306,NA,NA,Sptbn1 (MGI:98388)
2,54700000,63900000,2p16.1-p15,NA,612513,"DEL2p16.1-p15, C2DELp161-p15",Chromosome 2p16.1-p15 deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 2p16.1-p15 deletion syndrome, 612513 (4), Isolated cases",NA
2,54700000,61000000,2p16.1,NA,142335,HBFQTL5,Fetal hemoglobin quantitative trait locus 5,HPFH2,3247,NA,associated with rs11886868,"[Fetal hemoglobin QTL5], 142335 (2), Autosomal dominant",NA
2,54972188,55137830,2p14-p13,2p16.1,604475,"RTN4, NOGO",Neurite outgrowth inhibitor (reticulon 4),RTN4,57142,ENSG00000115310,NA,NA,Rtn4 (MGI:1915835)
2,55231902,55235852,2p16.1,2p16.1,191343,"RPS27A, UBA80, HUBCEP80, CEP80, UBCEP1",Ribosomal protein S27a,RPS27A,6233,ENSG00000143947,NA,NA,Rps27a (MGI:1925544)
2,55235582,55269313,2p16-p14,2p16.1,603766,MTIF2,Mitochondrial translational initiation factor 2,MTIF2,4528,ENSG00000085760,NA,NA,Mtif2 (MGI:1924034)
2,55287816,55419855,2p16.1,2p16.1,609736,"CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHOL",Coiled-coil domain-containing protein 88A,CCDC88A,55704,ENSG00000115355,mutation identified in 1 PEHOL family,"?PEHO syndrome-like, 617507 (3), Autosomal recessive",Ccdc88a (MGI:1925177)
2,55547291,55618131,2p16.1,2p16.1,610352,"PPP4R3B, PP4R3B, SMEK2, KIAA1387","Protein phosphatase 4, regulatory subunit 3, beta",PPP4R3B,57223,ENSG00000275052,NA,NA,Ppp4r3b (MGI:2144474)
2,55634060,55693852,2p16.1,2p16.1,610316,"PNPT1, OLD35, COXPD13, DFNB70",Polyribonucleotide nucleotidyltransferase 1,PNPT1,87178,ENSG00000138035,NA,"Combined oxidative phosphorylation deficiency 13, 614932 (3), Autosomal recessive; Deafness, autosomal recessive 70, 614934 (3), Autosomal recessive",Pnpt1 (MGI:1918951)
2,55865966,55924162,2p16,2p16.1,601548,"EFEMP1, FBNL, DHRD",EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like),EFEMP1,2202,ENSG00000115380,NA,"Doyne honeycomb degeneration of retina, 126600 (3), Autosomal dominant",Efemp1 (MGI:1339998)
2,55982966,55983075,2p16.1,2p16.1,615096,MIR217,Micro RNA 217,MIR217,406999,ENSG00000207548,NA,NA,NA
2,55988949,55989058,2p16.1,2p16.1,610944,"MIR216, MIRN216",Micro RNA 216,MIR216A,406998,ENSG00000207798,NA,NA,NA
2,57907650,58163992,2p16-p15,2p16.1,602169,VRK2,Vaccinia-related kinase-2,VRK2,7444,ENSG00000028116,NA,NA,Vrk2 (MGI:1917172)
2,58159242,58241680,2p16.1,2p16.1,608111,"PHF9, FANCL",PHD finger protein 9,FANCL,55120,ENSG00000115392,NA,"Fanconi anemia, complementation group L, 614083 (3), Autosomal recessive",Fancl (MGI:1914280)
2,60450519,60553653,2p16.1,2p16.1,606557,"BCL11A, CTIP1, EVI9, KIAA1809, DILOS",B-cell CLL/lymphoma 11A,BCL11A,53335,ENSG00000119866,NA,"Dias-Logan syndrome, 617101 (3), Autosomal dominant",Bcl11a (MGI:106190)
2,60756247,60802085,2p16.1,2p16.1,616865,PAPOLG,"Poly(A) polymerase, gamma",PAPOLG,64895,ENSG00000115421,NA,NA,Papolg (MGI:2442119)
2,60881520,60931611,2p13-p12,2p16.1,164910,REL,"Oncogene REL, avian reticuloendotheliosis",REL,5966,ENSG00000162924,NA,NA,Rel (MGI:97897)
2,60940217,61019692,2p16.1,2p16-p15,612787,"PUS10, DOBI",Pseudouridylate synthase 10,PUS10,150962,ENSG00000162927,NA,NA,Pus10 (MGI:1921717)
2,61017719,61051989,2p15,2p15,601789,"PEX13, ZWS, NALD, PBD11A, PBD11B",Peroxisome biogenesis factor 13 (peroxin 13),PEX13,5194,ENSG00000162928,NA,"Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3), Autosomal recessive; Peroxisome biogenesis disorder 11B, 614885 (3), Autosomal recessive",Pex13 (MGI:1919379)
2,61187462,61471086,2p15,2p15,615295,"USP34, KIAA0570",Ubiquitin-specific protease 34,USP34,9736,ENSG00000115464,NA,NA,Usp34 (MGI:109473)
2,61477848,61538521,2p16,2p15,602559,"XPO1, CRM1",Exportin-1 (required for chromosome region maintenance),XPO1,7514,ENSG00000082898,NA,NA,Xpo1 (MGI:2144013)
2,61800239,61854142,2p15,2p15,613596,"FAM161A, RP28","Family with sequence similarity 161, member A",FAM161A,84140,ENSG00000170264,NA,"Retinitis pigmentosa 28, 606068 (3)",Fam161a (MGI:1921123)
2,61868084,61888670,2p15,2p15,605142,"CCT4, CCTD, SRB","Chaperonin containing T-complex polypeptide 1, subunit 4",CCT4,10575,ENSG00000115484,NA,NA,Cct4 (MGI:104689)
2,61888722,62136069,2p16-p13,2p15,607238,"COMMD1, MURR1",Copper metabolism Murr1 domain-containing 1,COMMD1,150684,ENSG00000173163,NA,NA,Commd1 (MGI:109474)
2,62196114,62224730,2p15,2p15,605581,"B3GNT2, B3GNT1, B3GNT","Beta-1,3-N-acetylglucosyaminyltransferase 2",B3GNT2,10678,ENSG00000170340,NA,NA,B3gnt2 (MGI:1889505)
2,62452777,62511893,2p15,2p15,614950,TMEM17,Transmembrane protein 17,TMEM17,200728,ENSG00000186889,NA,NA,Tmem17 (MGI:2144205)
2,62673877,63046486,2p15,2p15,609922,"EHBP1, KIAA0903, HPC12",EH domain-binding protein 1,EHBP1,23301,ENSG00000115504,NA,"{Prostate cancer, hereditary, 12}, 611868 (3)",Ehbp1 (MGI:2667252)
2,63050056,63057830,2p13,2p15,600036,OTX1,"Orthodenticle, Drosophila, homolog of, 1",OTX1,5013,ENSG00000115507,NA,NA,Otx1 (MGI:97450)
2,63119558,63588798,2p15,2p15,613580,"WDPCP, C2orf86, BBS15, CHDTHP",WD repeat-containing planar cell polarity effector,WDPCP,51057,ENSG00000143951,mutation identified in 1 BBS15 family and 1 CHDTHP patient,"?Bardet-Biedl syndrome 15, 615992 (3), Autosomal recessive; ?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3), Autosomal recessive",Wdpcp (MGI:2144467)
2,63588962,63607196,2p16,2p15,154200,MDH1,"Malate dehydrogenase, soluble",MDH1,4190,ENSG00000014641,proximal to APOB,NA,Mdh1 (MGI:97051)
2,63840963,63891561,2p14-p13,2p15,191760,"UGP2, UGPP2",Uridyl diphosphate glucose pyrophosphorylase-2,UGP2,7360,ENSG00000169764,NA,NA,Ugp2 (MGI:2183447)
2,63892148,64019427,2p14,2p15-p14,614633,"VPS54, VPS54L, WR","Vacuolar protein sorting 54, S. Cerevisiae, homolog of",VPS54,51542,ENSG00000143952,NA,NA,Vps54 (MGI:2178798)
2,63900000,71300000,2p14-p13.3,NA,610071,HRPT3,Hyperparathyroidism 3,NA,780919,NA,between D2S2368 and D2S358,"Hyperparathyroidism 3, 610071 (2)",NA
2,63900000,74800000,2p14-p13,NA,612853,RLS7,"Restless legs syndrome, susceptibility to, 7",NA,100302561,NA,associated with rs2300478,"{Restless legs syndrome 7}, 612853 (2)",NA
2,64092651,64144420,2p13.3,2p14,614797,PELI1,"Pellino, Drosophila, homolog of, 1",PELI1,57162,ENSG00000197329,NA,NA,Peli1 (MGI:1914495)
2,64454161,64461380,2p14,2p14,617902,LGALSL,Galectin-like protein,LGALSL,29094,ENSG00000119862,NA,NA,Lgalsl (MGI:1916114)
2,64631620,64751085,2p14,2p14,617851,"SERTAD2, TRIPBR2, KIAA0127",SERTA domain-containing protein 2,SERTAD2,9792,ENSG00000179833,NA,NA,Sertad2 (MGI:1931026)
2,64988478,65023864,2p14,2p14,600229,"SLC1A4, SATT, ASCT1, SPATCCM","Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4",SLC1A4,6509,ENSG00000115902,NA,"Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3), Autosomal recessive",Slc1a4 (MGI:2135601)
2,65056360,65087007,2p14,2p14,616889,"CEP68, KIAA0582","Centrosomal protein, 68kD",CEP68,23177,ENSG00000011523,NA,NA,Cep68 (MGI:2667663)
2,65086853,65130300,2p14,2p14,179508,"RAB1, RAB1A","RAB1, member RAS oncogene family",RAB1A,5861,ENSG00000138069,NA,NA,Rab1a (MGI:97842)
2,65227694,65271252,2p14,2p14,604221,"ACTR2, ARP2",Actin-related protein 2,ACTR2,10097,ENSG00000138071,NA,NA,Actr2 (MGI:1913963)
2,65307424,65432598,2p14,2p14,609292,SPRED2,Sprouty-related EVH1 domain-containing protein 2,SPRED2,200734,ENSG00000198369,NA,NA,Spred2 (MGI:2150019)
2,66435124,66573868,2p14-p13,2p14,601739,MEIS1,"Meis1, mouse, homolog of",MEIS1,4211,ENSG00000143995,NA,NA,NA
2,67397316,67412088,2p15-p13,2p14,613196,"ETAA1, ETAA16",Ewing tumor-associated antigen 1,ETAA1,54465,ENSG00000143971,NA,NA,Etaa1 (MGI:1915395)
2,68041129,68063003,2p13-p12,2p14,606997,"C1D, SUNCOR",Nuclear DNA-binding protein C1D,C1D,10438,ENSG00000197223,pseudogene on chr.10,NA,C1d (MGI:1927354)
2,68129804,68157545,2q14,2p14,610729,"WDR92, LOC116143, MONAD",WD repeat-containing protein 92,WDR92,116143,ENSG00000243667,NA,NA,Wdr92 (MGI:2144224)
2,68178856,68252531,2p16-p15,2p14,601302,"PPP3R1, CALNB1","Protein phosphatase-3 (formerly 2B), regulatory subunit B (19kD), alpha isoform (calcineurin B, type I)",PPP3R1,5534,ENSG00000221823,NA,NA,Ppp3r1 (MGI:107172)
2,68365281,68397452,2p,2p14,173570,PLEK,Pleckstrin,PLEK,5341,ENSG00000115956,NA,NA,Plek (MGI:1860485)
2,68400000,74800000,2p13,NA,602966,OFC2,Orofacial cleft 2,OFC2,4964,NA,?relation to TGFA,"Orofacial cleft 2, 602966 (2)",NA
2,68400000,74800000,2p13,NA,602404,PARK3,Parkinson disease 3,PARK3,5072,NA,NA,"{Parkinson disease 3}, 602404 (2)",NA
2,68400000,74800000,2p13,NA,189800,"PEE1, PREG1",Preeclampsia/eclampsia 1,PEE1,5177,NA,?distinct loci at 2p25 and 9p13,"Preeclampsia/eclampsia 1, 189800 (2), Autosomal dominant",NA
2,68467584,68580161,2p14,2p13.3,611035,"AFPL, C2orf13",Aprataxin- and PNK-like factor,APLF,200558,ENSG00000169621,NA,NA,Aplf (MGI:1919353)
2,68643587,68655575,2p13.3,2p13.3,607122,"PROKR1, PKR1, GPR73",Prokineticin receptor 1,PROKR1,10887,ENSG00000169618,NA,NA,Prokr1 (MGI:1929676)
2,68710509,68826844,2p13,2p13.3,610587,"ARHGAP25, KAIA0053",RHO GTPase-activating protein 25,ARHGAP25,9938,ENSG00000163219,NA,NA,Arhgap25 (MGI:2443687)
2,68860908,68871396,2p13.3,2p13.3,608748,BMP10,Bone morphogenetic protein 10,BMP10,27302,ENSG00000163217,NA,NA,Bmp10 (MGI:1338820)
2,68974572,68980979,2p13.3,2p13.3,606402,"GKN1, CA11",Gastrokine 1,GKN1,56287,ENSG00000169605,NA,NA,Gkn1 (MGI:1913533)
2,69013143,69249326,2p13.1,2p13.3,606410,"ANTXR1, TEM8, ATR, GAPO",Anthrax toxin receptor 1,ANTXR1,84168,ENSG00000169604,mutation identified in 1 HCI patient,"GAPO syndrome, 230740 (3), Autosomal recessive; {?Hemangioma, capillary infantile, susceptibility to}, 602089 (3), Autosomal dominant",Antxr1 (MGI:1916788)
2,69319768,69387253,2p13,2p13.3,138292,"GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1",Glutamine-fructose-6-phosphate transaminase,GFPT1,2673,ENSG00000198380,NA,"Myasthenia, congenital, 12, with tubular aggregates, 610542 (3), Autosomal recessive",Gfpt1 (MGI:95698)
2,69395749,69439648,2p15-p13,2p13.3,608100,"NFU1, HIRIP, MMDS1","NFU1 iron-sulfur cluster scaffold, S. cerevisiae, homolog of",NFU1,27247,ENSG00000169599,NA,"Multiple mitochondrial dysfunctions syndrome 1, 605711 (3), Autosomal recessive",Nfu1 (MGI:1913290)
2,69457996,69643738,2p13.3,2p13.3,616405,"AAK1, KIAA1048",Adaptor protein 2-associated kinase 1,AAK1,22848,ENSG00000115977,NA,NA,Aak1 (MGI:1098687)
2,69643807,69827111,2p13,2p13.3,106491,"ANXA4, ANX4",Annexin A4 (placental anticoagulant protein II),ANXA4,307,ENSG00000196975,NA,NA,Anxa4 (MGI:88030)
2,69915040,69942944,2p13,2p13.3,600021,MAD,MAD protein (MAX-binding protein),MXD1,4084,ENSG00000059728,NA,NA,Mxd1 (MGI:96908)
2,69960088,69962264,2p13.1,2p13.3,611765,"ASPRV1, SASP, TAPS, MUNO","Aspartic peptidase, retroviral-like 1",ASPRV1,151516,ENSG00000244617,NA,NA,Asprv1 (MGI:1915105)
2,70087476,70089202,2p13-p12,2p13.3,601209,PCBP1,Poly(rC)-binding protein-1,PCBP1,5093,ENSG00000169564,NA,NA,Pcbp1 (MGI:1345635)
2,70209443,70248792,2p13,2p13.3,603518,"TIA1, WDM",TIA1 cytotoxic granule-associated RNA-binding protein,TIA1,7072,ENSG00000116001,NA,"Welander distal myopathy, 604454 (3), Autosomal recessive, Autosomal dominant",Tia1 (MGI:107914)
2,70258136,70281184,2p13.3,2p13.3,610995,"PCYOX1, PCL1, KIAA0908",Prenylcysteine oxidase 1,PCYOX1,51449,ENSG00000116005,NA,NA,Pcyox1 (MGI:1914131)
2,70281361,70293770,2p13.3,2p13.3,603542,SNRPG,Small nuclear ribonucleoprotein polypeptide G,SNRPG,6637,ENSG00000143977,NA,NA,NA
2,70295975,70302066,2p13.3,2p13.3,616275,FAM136A,"Family with sequence similarity 136, member A",FAM136A,84908,ENSG00000035141,NA,NA,Fam136a (MGI:1913738)
2,70447283,70553825,2p13,2p13.3,190170,TGFA,"Transforming growth factor, alpha",TGFA,7039,ENSG00000163235,NA,NA,Tgfa (MGI:98724)
2,70656783,70768199,2p14-p13,2p13.3,102681,ADD2,"Adducin-2, beta",ADD2,119,ENSG00000075340,NA,NA,Add2 (MGI:87919)
2,70777309,70790642,2p12,2p13.3,608697,"FIGLA, POF6","Factor in germline alpha, mouse, homolog of",FIGLA,344018,ENSG00000183733,NA,"Premature ovarian failure 6, 612310 (3), Autosomal dominant",Figla (MGI:1349421)
2,70825247,70860786,2p13,2p13.3,604862,"CD207, LANGERIN, CLEC4K",CD207 antigen,CD207,50489,ENSG00000116031,mutation identified in 1 patient,"[?Birbeck granule deficiency], 613393 (3)",Cd207 (MGI:2180021)
2,70900550,70933916,2p13,2p13.3,604295,VAX2,Ventral anterior homeo box 2,VAX2,25806,ENSG00000116035,NA,NA,Vax2 (MGI:1346018)
2,70935899,70965430,2cen-q13,2p13.3,192132,"ATP6B1, VPP3","ATPase, H+ transporting, lysosomal, beta polypeptide, 58kD (vacuolar proton pump, subunit 3)",ATP6V1B1,525,ENSG00000116039,NA,"Renal tubular acidosis with deafness, 267300 (3), Autosomal recessive",Atp6v1b1 (MGI:103285)
2,70978444,70986676,2p13.3,2p13.3,617009,ANKRD53,Ankyrin repeat domain-containing protein 53,ANKRD53,79998,ENSG00000144031,NA,NA,Ankrd53 (MGI:1922555)
2,71068277,71079807,2p13.3,2p13.3,606828,"NAGK, GNK",N-acetylglucosamine kinase,NAGK,55577,ENSG00000124357,NA,NA,Nagk (MGI:1860418)
2,71109683,71130287,2p13.3,2p13.3,608419,MCEE,Methylmalonyl-CoA epimerase,MCEE,84693,ENSG00000124370,NA,"Methylmalonyl-CoA epimerase deficiency, 251120 (3), Autosomal recessive",Mcee (MGI:1920974)
2,71182737,71227109,2p13.3,2p13.3,611018,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,PAIP2B,400961,ENSG00000124374,NA,NA,Paip2b (MGI:2386865)
2,71331754,71435060,2p13.2,2p13.2,614349,"ZNF638, NP220",Zinc finger protein 638,ZNF638,27332,ENSG00000075292,NA,NA,Zfp638 (MGI:1203484)
2,71453153,71686762,2p13.3-p13.1,2p13.2,603009,"DYSF, LGMDR2, MMD1",Dysferlin,DYSF,8291,ENSG00000135636,NA,"Miyoshi muscular dystrophy 1, 254130 (3), Autosomal recessive; Muscular dystrophy, limb-girdle, autosomal recessive 2, 253601 (3), Autosomal recessive; Myopathy, distal, with anterior tibial onset, 606768 (3), Autosomal recessive",Dysf (MGI:1349385)
2,72129237,72147861,2p13.2,2p13.2,605207,"CYP26B1, CYP26A2, P450RAI2, RHFCA","Cytochrome P450, subfamily XXVIB, polypeptide 1",CYP26B1,56603,ENSG00000003137,NA,"Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)",Cyp26b1 (MGI:2176159)
2,72175983,72826041,2p13.2,2p13.2,607880,"EXOC6B, SEC15B, KIAA0919, SEMDJL3",Exocyst complex component 6B,EXOC6B,23233,ENSG00000144036,NA,"Spondyloepimetaphyseal dysplasia with joint laxity, type 3, 618395 (3), Autosomal recessive",Exoc6b (MGI:1923164)
2,72887407,72892157,2p14-p12,2p13.2,182125,SPR,Sepiapterin reductase,SPR,6697,ENSG00000116096,NA,"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3), ?Autosomal dominant, Autosomal recessive",Spr (MGI:103078)
2,72910948,72936690,2p14-p13,2p13.2,600034,EMX1,"Empty spiracles, Drosophila, homolog of, 1",EMX1,2016,ENSG00000135638,close to VAX2,NA,Emx1 (MGI:95387)
2,72942035,73071835,2p13,2p13.2,615572,SFXN5,Sideroflexin 5,SFXN5,94097,ENSG00000144040,NA,NA,Sfxn5 (MGI:2137681)
2,73073381,73112947,2p13-p12,2p13.2,605536,"RAB11RIP5, RIP11, KIAA0857",Rab11 family-interacting protein 5,RAB11FIP5,26056,ENSG00000135631,NA,NA,Rab11fip5 (MGI:1098586)
2,73233424,73253021,2p13,2p13.2,605140,CCT7,"Chaperonin containing T-complex polypeptide 1, subunit 7",CCT7,10574,ENSG00000135624,NA,NA,Cct7 (MGI:107184)
2,73254681,73284448,2p13.2,2p13.2,609108,"FBXO41, FBX41, KIAA1940",F-box only protein 41,FBXO41,150726,ENSG00000163013,NA,NA,Fbxo41 (MGI:1261912)
2,73290928,73293547,2p13,2p13.2,128992,"EGR4, NGFIC",Early growth response-4,EGR4,1961,ENSG00000135625,NA,NA,Egr4 (MGI:99252)
2,73385757,73609918,2p13,2p13.1,606844,"ALMS1, ALSS, KIAA0328",Alstrom syndrome gene,ALMS1,7840,ENSG00000116127,NA,"Alstrom syndrome, 203800 (3), Autosomal recessive",Alms1 (MGI:1934606)
2,73640722,73642421,2p13.1-p12,2p13.1,606716,"NAT8, TSC510",N-acetyltransferase 8,NAT8,9027,ENSG00000144035,NA,NA,Nat8 (MGI:1915646)
2,73700508,73701339,2p13.1-p12,2p13.1,608190,"NAT8B, CML2",N-acetyltransferase 8B,NAT8B,51471,ENSG00000204872,NA,NA,Nat8f1 (MGI:1913366)
2,73729836,73737405,2p13.1,2p13.1,608680,"TPRKB, GAMOS5",TP53RK-binding protein,TPRKB,51002,ENSG00000144034,NA,"Galloway-Mowat syndrome 5, 617731 (3), Autosomal recessive",Tprkb (MGI:1917036)
2,73762197,73780156,2p13.1,2p13.1,603092,"DUSP11, PIR1","Dual specificity phosphatase-11, RNA/RNP complex-interacting",DUSP11,8446,ENSG00000144048,NA,NA,Dusp11 (MGI:1919352)
2,73828910,73873660,2p13.1,2p13.1,606247,"STAMBP, AMSH, MICCAP",STAM binding protein,STAMBP,10617,ENSG00000124356,NA,"Microcephaly-capillary malformation syndrome, 614261 (3), Autosomal recessive",Stambp (MGI:1917777)
2,73893007,73919864,2p13.1,2p13.1,102545,"ACTG2, ACTA3, VSCM","Actin, gamma-2, smooth muscle, enteric",ACTG2,72,ENSG00000163017,NA,"Visceral myopathy, 155310 (3), Autosomal dominant",Actg2 (MGI:104589)
2,73926825,73958960,2p13,2p13.1,601465,"DGUOK, DGK, MTDPS3, PEOB4, NCPH","Deoxyguanosine kinase, mitochondrial",DGUOK,1716,ENSG00000114956,NA,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3), Autosomal recessive; Portal hypertension, noncirrhotic, 617068 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, 617070 (3), Autosomal recessive",Dguok (MGI:1351602)
2,73982035,74135393,2p13.1,2p13.1,613555,"TET3, KIAA0401","TET oncogene family, member 3",TET3,200424,ENSG00000187605,NA,NA,Tet3 (MGI:2446229)
2,74135399,74147911,2p13.1,2p13.1,613183,"BOLA3, MMDS2","BolA, E. coli, homolog of, 3",BOLA3,388962,ENSG00000163170,NA,"Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3), Autosomal recessive",Bola3 (MGI:1925903)
2,74216241,74343415,2p13,2p13.1,606757,"SLC4A5, NBC4","Solute carrier family 4, sodium bicarbonate cotransporter, member 5",SLC4A5,57835,ENSG00000188687,NA,NA,Slc4a5 (MGI:2443220)
2,74361153,74392086,2p13,2p13.1,601143,"DCTN1, HMN7B","Dynactin 1 (p150, glued, Drosophila, homolog of)",DCTN1,1639,ENSG00000204843,NA,"{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominant; Neuropathy, distal hereditary motor, type VIIB, 607641 (3), Autosomal dominant; Perry syndrome, 168605 (3), Autosomal dominant",Dctn1 (MGI:107745)
2,74425834,74441936,2p13,2p13.1,602288,RTKN,Rhotekin,RTKN,6242,ENSG00000114993,NA,NA,Rtkn (MGI:107371)
2,74455086,74457943,2p13,2p13.1,616456,"INO80B, PAPA1, HMGA1L4","INO80 complex, subunit B",INO80B,83444,ENSG00000115274,NA,NA,Ino80b (MGI:1917270)
2,74458437,74460880,2p12,2p13.1,606961,WBP1,WW domain-binding protein 1,WBP1,23559,ENSG00000239779,NA,NA,Wbp1 (MGI:104710)
2,74461056,74465381,2p13.1,2p13.1,601336,"MOGS, GCS1, CDG2B",Mannosyl-oligosaccharide glucosidase,MOGS,7841,ENSG00000115275,NA,"Congenital disorder of glycosylation, type IIb, 606056 (3), Autosomal recessive",Mogs (MGI:1929872)
2,74471981,74472679,2p12,2p13.1,611857,MRPL53,Mitochondrial ribosomal protein L53,MRPL53,116540,ENSG00000204822,pseudogene on 1,NA,Mrpl53 (MGI:1915749)
2,74497516,74503315,2p13,2p13.1,607164,LBX2,Lady bird-like homeo box 2,LBX2,85474,ENSG00000179528,NA,NA,Lbx2 (MGI:1342288)
2,74505042,74507694,2p13.1,2p13.1,610231,"PCGF1, NSPC1",Polycomb group RING finger protein 1,PCGF1,84759,ENSG00000115289,NA,NA,Pcgf1 (MGI:1917087)
2,74514449,74517147,2p13.1-p12,2p13.1,604240,"TLX2, HOX11L1","T-cell leukemia, homeobox 2",TLX2,3196,ENSG00000115297,NA,NA,Tlx2 (MGI:1350935)
2,74526647,74529896,2p13,2p13.1,602434,AUP1,Ancient ubiquitous protein 1,AUP1,550,ENSG00000115307,NA,NA,Aup1 (MGI:107789)
2,74529404,74533555,2p12,2p13.1,606441,"HTRA2, OMI, PARK13, PRSS25, MGCA8",HTRA serine peptidase 2,HTRA2,27429,ENSG00000115317,NA,"3-methylglutaconic aciduria, type VIII, 617248 (3), Autosomal recessive; {Parkinson disease 13}, 610297 (3)",Htra2 (MGI:1928676)
2,74532257,74555718,2p13.3,2p13.1,607163,LOXL3,Lysyl oxidase-like 3,LOXL3,84695,ENSG00000115318,NA,NA,Loxl3 (MGI:1337004)
2,74549019,74557550,2p13,2p13.1,602919,DOK1,Downstream of tyrosine kinase 1,DOK1,1796,ENSG00000115325,NA,NA,Dok1 (MGI:893587)
2,74654227,74699012,2p13,2p13.1,603706,SEMAW,Semaphorin W,SEMA4F,10505,ENSG00000135622,NA,NA,Sema4f (MGI:1340055)
2,74800000,83100000,2p12,NA,607304,"CTRCT27, CCNP","Cataract 27, nuclear progressive",NA,266979,NA,near D2S2333,"Cataract 27, nuclear progressive, 607304 (2)",NA
2,74800000,91800000,2p12-p11.2,NA,613564,"DEL2p12p11.2, C2DELp12p11.2",Chromosome 2p12-p11.2 deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 2p12-p11.2 deletion syndrome, 613564 (4)",NA
2,74800000,83100000,2p12,NA,608394,DFNA43,"Deafness, autosomal dominant 43",DFNA43,192676,NA,max lod at D2S139,"Deafness, autosomal dominant 43, 608394 (2), Autosomal dominant",NA
2,74800000,147900000,2p12-q22,NA,139900,HSR,"Hand skill, relative",NA,338386,NA,NA,"[Handedness], 139900 (2), Autosomal dominant",NA
2,74800000,83100000,2p12,NA,146970,IGKJ@,Immunoglobulin kappa light chain joining gene cluster,NA,7842,NA,5 genes,NA,NA
2,74800000,83100000,2p12,NA,146980,IGKV@,Immunoglobulin kappa light chain variable gene cluster,NA,3519,NA,25+ genes in 4 classes; orphon gene 1.5Mb telomeric of IGKC,NA,NA
2,74832654,74893353,2p12,2p12,601125,HK2,"Hexokinase-2, muscle",HK2,3099,ENSG00000159399,no recombination with TGFA,NA,Hk2 (MGI:1315197)
2,74958642,74970127,2p12,2p12,607269,POLE4,"Polymerase, DNA, epsilon-4",POLE4,56655,ENSG00000115350,NA,NA,Pole4 (MGI:1914229)
2,75046462,75199519,2p11,2p12,162323,"TACR1, TAC1R, NK1R",Tachykinin receptor 1 (substance P receptor; neurokinin-1 receptor),TACR1,6869,ENSG00000115353,NA,NA,Tacr1 (MGI:98475)
2,75646782,75662205,2p11.2-q11.2,2p12,611832,"MRPL19, MRPL15, KIAA0104",Mitochondrial ribosomal protein L19,MRPL19,9801,ENSG00000115364,NA,NA,Mrpl19 (MGI:1926274)
2,75655605,75711641,2p11.2-p11.1,2p12,189901,"C2orf3, TCF9, GCF",GC factor,GCFC2,6936,ENSG00000005436,NA,NA,Gcfc2 (MGI:2141656)
2,76747722,77522432,2p12,2p12,610870,LRRTM4,Leucine-rich repeat transmembrane protein 4,LRRTM4,80059,ENSG00000176204,NA,NA,Lrrtm4 (MGI:2389180)
2,79025663,79028501,2p12,2p12,609933,"REG3G, PAP1B",Regenerating islet-derived 3-gamma,REG3G,130120,ENSG00000143954,NA,NA,Reg3g (MGI:109406)
2,79085022,79087992,2p12,2p12,167771,"REGL, PSPS2","Regenerating islet-derived, rat, homolog-like (pancreatic stone protein-like; pancreatic thread protein-like)",REG1B,5968,ENSG00000172023,NA,NA,Reg2 (MGI:97896)
2,79120487,79123408,2p12,2p12,167770,"REG1A, PSPS1, REG","Regenerating islet-derived 1 alpha (pancreatic stone protein, pancreatic thread protein)",REG1A,5967,ENSG00000115386,NA,NA,Reg1 (MGI:97895)
2,79157005,79159752,2p12,2p12,167805,PAP,Pancreatitis-associated protein,REG3A,5068,ENSG00000172016,NA,NA,Reg3b (MGI:97478)
2,79505053,80648867,2p12-p11.1,2p12,114025,"CTNNA2, CAPR, CTNR, CDCBM9","Catenin, alpha-2 (cadherin-associated protein, related)",CTNNA2,1496,ENSG00000066032,NA,"Cortical dysplasia, complex, with other brain malformations 9, 618174 (3), Autosomal recessive",Ctnna2 (MGI:88275)
2,80301877,80304751,2p12,2p12,610867,LRRTM1,Leucine-rich repeat transmembrane protein 1,LRRTM1,347730,ENSG00000162951,NA,NA,Lrrtm1 (MGI:2389173)
2,84423527,84459279,2p11.2,2p11.2,611224,"SUCLG1, SUCLA1, MTDPS9","Succinate-CoA ligase, alpha subunit",SUCLG1,8802,ENSG00000163541,NA,"Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3), Autosomal recessive",Suclg1 (MGI:1927234)
2,84459571,84819588,2p11.2,2p11.2,603336,"DNAH6, HL2","Dynein, axonemal, heavy chain 6",DNAH6,1768,ENSG00000115423,NA,NA,Dnah6 (MGI:107744)
2,84821649,84881974,2p11.2,2p11.2,614912,"TRABD2A, TIKI1",TRAB domain-containing protein 2A,TRABD2A,129293,ENSG00000186854,NA,NA,NA
2,84905655,84906670,2p11.2,2p11.2,188399,TMSB10,"Thymosin, beta-10",TMSB10,9168,ENSG00000034510,NA,NA,NA
2,84971160,85059471,2p11.2,2p11.2,614719,"KCMF1, DEBT91, FIGC",Potassium channel modulatory factor 1,KCMF1,56888,ENSG00000176407,NA,NA,Kcmf1 (MGI:1921537)
2,85133391,85310386,2p11.2,2p11.2,604652,TCF7L1,Transcription factor 7-like 1,TCF7L1,83439,ENSG00000152284,NA,NA,Tcf7l1 (MGI:1202876)
2,85318026,85327988,2p11.2,2p11.2,603062,"TGOLN2, TGN46, TGN38","Trans-golgi network protein 2, 46kD",TGOLN2,10618,ENSG00000152291,NA,NA,NA
2,85341954,85354527,2p11.2,2p11.2,617597,RETSAT,Retinol saturase,RETSAT,54884,ENSG00000042445,NA,NA,Retsat (MGI:1914692)
2,85354393,85391751,2p11.3,2p11.2,615427,"ELMOD3, RBED1, DFNB88",ELMO/CED12 domain-containing protein 3,ELMOD3,84173,ENSG00000115459,one family identified with mutation,"?Deafness, autosomal recessive 88, 615429 (3), Autosomal recessive",Elmod3 (MGI:2445168)
2,85394747,85418466,2cen-q24,2p11.2,153615,CAPG,"Capping protein (actin filament), gelsolin-like",CAPG,822,ENSG00000042493,NA,NA,Capg (MGI:1098259)
2,85537466,85538885,2p11.2,2p11.2,616350,PARTICL,Promoter of MAT2A antisense radiation-induced circulating long noncoding RNA,PARTICL,100630918,ENSG00000286532,overlaps promoter of MAT2A on opposite strand,NA,NA
2,85539167,85545280,2p11.2,2p11.2,601468,"MAT2A, MATA2, SAMS2","Methionine adenosyltransferase II, alpha",MAT2A,4144,ENSG00000168906,NA,NA,Mat2a (MGI:2443731)
2,85544719,85561526,2p12,2p11.2,137167,"GGCX, VKCFD1",Gamma-glutamyl carboxylase,GGCX,2677,ENSG00000115486,NA,"Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3); Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3), Autosomal recessive",Ggcx (MGI:1927655)
2,85577534,85582030,2p12-p11.2,2p11.2,603177,VAMP8,Vesicle-associated membrane protein 8,VAMP8,8673,ENSG00000118640,NA,NA,Vamp8 (MGI:1336882)
2,85584430,85593405,2p11.2,2p11.2,607029,VAMP5,Vesicle-associated membrane protein 5 (myobrevin),VAMP5,10791,ENSG00000168899,NA,NA,Vamp5 (MGI:1858622)
2,85593822,85597707,2p11.2,2p11.2,612490,RNF181,Ring finger protein 181,RNF181,51255,ENSG00000168894,NA,NA,Rnf181 (MGI:1913760)
2,85598546,85602698,2p11.2,2p11.2,616757,"TMEM150A, TMEM150",Transmembrane protein 150A,TMEM150A,129303,ENSG00000168890,NA,NA,Tmem150a (MGI:2385244)
2,85602842,85649283,2p11.2,2p11.2,611594,"USP39, SAD1",Ubiquitin-specific protease 39,USP39,10713,ENSG00000168883,NA,NA,Usp39 (MGI:107622)
2,85657306,85668740,2p12-p11.2,2p11.2,178640,"SFTPB, SFTB3, SMDP1","Pulmonary surfactant-associated protein B, 18kD",SFTPB,6439,ENSG00000168878,NA,"Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3), Autosomal recessive",Sftpb (MGI:109516)
2,85694293,85698853,2p12-q11,2p11.2,188855,"GNLY, D2S69E, TLA519",Granulysin (T-lymphocyte activation gene 519),GNLY,10578,ENSG00000115523,NA,NA,NA
2,85837119,85889033,2p11.2,2p11.2,604402,"SIAT9, ST3GALV, SPDRS",Sialyltransferase 9,ST3GAL5,8869,ENSG00000115525,NA,"Salt and pepper developmental regression syndrome, 609056 (3), Autosomal recessive",St3gal5 (MGI:1339963)
2,86020215,86105885,2p11.2,2p11.2,616404,"POLR1A, RPA194, AFDCIN","Polymerase I, RNA, subunit A",POLR1A,25885,ENSG00000068654,NA,"Acrofacial dysostosis, Cincinnati type, 616462 (3), Autosomal dominant",Polr1a (MGI:1096397)
2,86106234,86142156,2p11.2,2p11.2,614918,PTCD3,Pentatricopeptide repeat domain-containing protein 3,PTCD3,55037,ENSG00000132300,NA,NA,Ptcd3 (MGI:1917206)
2,86143931,86195769,2p11.2,2p11.2,600378,"IMMT, HMP","Inner membrane protein, mitochondrial (mitofilin)",IMMT,10989,ENSG00000132305,pseudogene on chr.21,NA,Immt (MGI:1923864)
2,86199432,86213793,2p11.2,2p11.2,611841,MRPL35,Mitochondrial ribosomal protein L35,MRPL35,51318,ENSG00000132313,"pseudogenes on 6, 10, and X",NA,Mrpl35 (MGI:1913473)
2,86213992,86338082,2p11.2,2p11.2,609139,"REEP1, C2orf23, SPG31, HMN5B",Receptor expression-enhancing protein 1,REEP1,65055,ENSG00000068615,mutation identified in 1 HMN5B family,"?Neuronopathy, distal hereditary motor, type VB, 614751 (3), Autosomal dominant; Spastic paraplegia 31, autosomal dominant, 610250 (3), Autosomal dominant",Reep1 (MGI:1098827)
2,86440646,86492715,2p11.2,2p11.2,611512,"KDM3A, JMJD1A, JHDM2A, TSGA, KIAA0742",Lysine-specific demethylase 3A,KDM3A,55818,ENSG00000115548,NA,NA,Kdm3a (MGI:98847)
2,86503429,86563496,2p24,2p11.2,610052,"VPS24, CHMP3, NEDF","Vacuolar protein sorting 24, yeast, homolog of",CHMP3,51652,ENSG00000115561,NA,NA,Chmp3 (MGI:1913950)
2,86603392,86623876,2p11.2,2p11.2,602507,"ZFP103, KF1","Zinc finger protein 103, mouse, homolog of",RNF103,7844,ENSG00000239305,NA,NA,Rnf103 (MGI:109483)
2,86784604,86808395,2p12,2p11.2,186910,CD8A,"CD8 antigen, alpha polypeptide  (p32)",CD8A,925,ENSG00000153563,distal to IGK,"CD8 deficiency, familial, 608957 (3), Autosomal recessive",Cd8a (MGI:88346)
2,86815336,86861923,2p12,2p11.2,186730,"CD8B1, CD8B","CD8 antigen, beta polypeptide 1 (p37)",CD8B,926,ENSG00000172116,"pseudogene, CD8B2, on 2q12",NA,Cd8b1 (MGI:88347)
2,86913576,87013975,2p11.2,2p11.2,612704,"RGPD1, RGP1",RANBP2-like and GRIP domain-containing protein 1,RGPD1,400966,ENSG00000187627,NA,NA,Ranbp2 (MGI:894323)
2,87010463,87021845,2p11-q11,2p11.2,173340,"PLGLB1, PLGL, PRGB",Plasminogen-like B1,PLGLB1,5343,ENSG00000183281,NA,NA,NA
2,87757197,87992818,2p11.2,2p11.2,612705,"RGPD2, RGP2",RANBP2-like and GRIP domain-containing protein 2,RGPD2,729857,ENSG00000185304,NA,NA,Ranbp2 (MGI:894323)
2,88067824,88113383,2p11.2,2p11.2,606846,"SMYD1, BOP, ZMYND18",SET and MYND domain-containing protein 1,SMYD1,150572,ENSG00000115593,NA,NA,Smyd1 (MGI:104790)
2,88122981,88128061,2p11,2p11.2,134650,FABP1,"Fatty acid-binding protein, liver",FABP1,2168,ENSG00000163586,NA,NA,Fabp1 (MGI:95479)
2,88170294,88186636,2p11.2,2p11.2,611261,"THNSL2, THS2",Threonine synthase-like 2,THNSL2,55258,ENSG00000144115,NA,NA,Thnsl2 (MGI:3041254)
2,88446786,88452692,2p11.2,2p11.2,612351,FOXI3,Forkhead box I3,FOXI3,344167,ENSG00000214336,NA,NA,Foxi3 (MGI:3511278)
2,88556739,88627463,2p12,2p11.2,604032,"EIF2AK3, PEK, PERK, WRS",Eukaryotic translation initiation factor 2-alpha kinase 3,EIF2AK3,9451,ENSG00000172071,NA,"Wolcott-Rallison syndrome, 226980 (3), Autosomal recessive",Eif2ak3 (MGI:1341830)
2,88691672,88750928,2p11.2,2p11.2,180430,"RPIA, RPI, RPIAD",Ribose 5-phosphate isomerase A,RPIA,22934,ENSG00000153574,NA,"Ribose 5-phosphate isomerase deficiency, 608611 (3), Autosomal recessive",Rpia (MGI:103254)
2,88832221,88833330,2p12,2p11.2,146780,IGKDEL,Immunoglobulin kappa polypeptide deleting element,IGKDEL,3515,NA,NA,NA,NA
2,88857360,88857682,2p12,2p11.2,147200,"IGKC, IGKCD",Immunoglobulin kappa constant region,IGKC,3514,NA,NA,"Kappa light chain deficiency, 614102 (3), Autosomal recessive",NA
2,93900000,108700000,2q11-q12,NA,612006,CELIAC8,"Celiac disease, susceptibility to, 8",NA,100188870,NA,associated with rs917997 and rs13015714,"{Celiac disease, susceptibility to, 8}, 612006 (2)",NA
2,93900000,242193529,2q,NA,606963,COPD,"Pulmonary disease, chronic obstructive, severe early-onset",NA,260431,NA,?SERPINE2,"Pulmonary disease, chronic obstructive, severe early-onset, 606963 (2)",NA
2,93900000,112200000,2cen-q13,NA,606689,GLC1B,"Glaucoma 1, open angle, B (adult-onset)",GLC1B,2722,NA,NA,"Glaucoma 1B, primary open angle, adult onset, 606689 (2)",NA
2,93900000,129100000,2q11-q14,NA,611897,NNO3,Nanophthalmos 3,NA,100187717,NA,max lod at D2S2265,"Nanophthalmos 3, 611897 (2)",NA
2,95025654,95053991,2cen-q13,2q11.1,188860,MAL,T-lymphocyte maturation-associated protein,MAL,4118,ENSG00000172005,NA,NA,Mal (MGI:892970)
2,95085368,95122026,2p11.2-q11.2,2q11.1,611972,MRPS5,Mitochondrial ribosomal protein S5,MRPS5,64969,ENSG00000144029,NA,NA,Mrps5 (MGI:1924971)
2,95165808,95184316,2q11.2,2q11.1,194500,ZNF2,Zinc finger protein-2,ZNF2,7549,ENSG00000275111,NA,NA,Zfp661 (MGI:1919430)
2,95274448,95291319,2q11.1,2q11.1,617160,"PROM2, PROML2",Prominin 2,PROM2,150696,ENSG00000155066,NA,NA,Prom2 (MGI:2138997)
2,95297324,95386076,2q11.1,2q11.1,604662,"KCNIP3, KCHIP3, CSEN, DREAM",Potassium channel-interacting protein 3,KCNIP3,30818,ENSG00000115041,NA,NA,Kcnip3 (MGI:1929258)
2,96021945,96035973,2q11.2,2q11.2,616431,GPAT2,"Glycerol-3-phosphate acyltransferase 2, mitochondrial",GPAT2,150763,ENSG00000186281,NA,NA,Gpat2 (MGI:2684962)
2,96112875,96116570,2q11.2,2q11.2,104260,"ADRA2B, ADRA2L1, FAME2","Adrenergic, alpha-2B-, receptor",ADRA2B,151,ENSG00000274286,NA,"Epilepsy, myoclonic, familial adult, 2, 607876 (3), Autosomal dominant",Adra2b (MGI:87935)
2,96143165,96145467,2q11,2q11.2,603068,"DUSP2, PAC1",Dual-specificity phosphatase-2,DUSP2,1844,ENSG00000158050,NA,NA,Dusp2 (MGI:101911)
2,96184858,96208845,2q11.2,2q11.2,616712,"STARD7, GTT1",START domain-containing protein 4,STARD7,56910,ENSG00000084090,NA,NA,Stard7 (MGI:2139090)
2,96248513,96266012,2q11,2q11.2,613403,TMEM127,Transmembrane protein 127,TMEM127,55654,ENSG00000135956,NA,"{Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant",Tmem127 (MGI:1916720)
2,96266158,96274172,2q11.2,2q11.2,604333,"CIAO1, WDR39",WD repeat-containing protein CIAO1,CIAO1,9391,ENSG00000144021,NA,NA,Ciao1 (MGI:1346998)
2,96274337,96305545,2q11.2,2q11.2,601664,"SNRNP200, ASCC3L1, KIAA0788, RP33",Small nuclear ribonucleoprotein 200kD (U5),SNRNP200,23020,ENSG00000144028,NA,"Retinitis pigmentosa 33, 610359 (3), Autosomal dominant",Snrnp200 (MGI:2444401)
2,96335765,96377090,2q11.2,2q11.2,602332,"NCAPH, CAPH, BRRN1, MCPH23",Non-SMC condensin I complex subunit H,NCAPH,23397,ENSG00000121152,mutation identified in 1 MCPH23 patient,"?Microcephaly 23, primary, autosomal recessive, 617985 (3), Autosomal recessive",Ncaph (MGI:2444777)
2,96497642,96508156,2p11,2q11.2,617206,"NEURL3, LINCR",Neuralized E3 ubiquitin protein ligase 3,NEURL3,93082,ENSG00000163121,NA,NA,Neurl3 (MGI:2429944)
2,96536751,96552637,2q11.2,2q11.2,611583,"ARID5A, MRF1",AT-rich interactive domain-containing protein 5A,ARID5A,10865,ENSG00000196843,NA,NA,Arid5a (MGI:2443039)
2,96593154,96638378,2q11.2,2q11.2,617742,"KANSL3, NSL3, KIAA1310","Kat8 regulatory NSL complex, subunit 3",KANSL3,55683,ENSG00000114982,NA,NA,Kansl3 (MGI:1918055)
2,96705928,96740091,2q11.2,2q11.2,609552,"LMAN2L, VIPL, MRT52",LMAN2-like protein,LMAN2L,81562,ENSG00000114988,mutation identified in 1 MRT52 family,"?Mental retardation, autosomal recessive, 52, 616887 (3), Autosomal recessive",Lman2l (MGI:2443010)
2,96760901,96811887,2q11.2,2q11.2,607805,"CNNM4, ACDP4",Cyclin M4,CNNM4,26504,ENSG00000158158,NA,"Jalili syndrome, 217080 (3), Autosomal recessive",Cnnm4 (MGI:2151060)
2,96814945,96837108,2q11.2,2q11.2,607804,"CNNM3, ACDP3",Cyclin M3,CNNM3,26505,ENSG00000168763,previously assigned to 2p12-p11.2,NA,Cnnm3 (MGI:2151055)
2,96837911,96844020,2p11.2-q11.1,2q11.2,610736,"ANKRD23, DARP",Ankyrin repeat domain-containing protein 23,ANKRD23,200539,ENSG00000163126,NA,NA,Ankrd23 (MGI:1925571)
2,96859717,96870942,5p15.3,2q11.2,604462,"SEMA4C, SEMAF, KIAA1739",Semaphorin 4C,SEMA4C,54910,ENSG00000168758,NA,NA,Sema4c (MGI:109252)
2,97646061,97648382,2cen-q13,2q11.2,123866,COX5B,"Cytochrome c oxidase, subunit Vb",COX5B,1329,ENSG00000135940,"7 pseudogenes on 4, 6, 7, 11, 12, 13, and 22",NA,NA
2,97655938,97664043,2q11.1-q11.2,2q11.2,605144,"ACTR1B, ARP1B, CTRN2",Actin-related protein 1B,ACTR1B,10120,ENSG00000115073,NA,NA,Actr1b (MGI:1917446)
2,97712029,97744326,2q12,2q11.2,176947,"ZAP70, SRK, ADMIO2, IMD48","Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase)",ZAP70,7535,ENSG00000115085,NA,"Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3), Autosomal recessive; Immunodeficiency 48, 269840 (3), Autosomal recessive",Zap70 (MGI:99613)
2,97756335,97996181,2q11.2,2q11.2,615659,"TMEM131, KIAA0257, CC28",Transmembrane protein 131,TMEM131,23505,ENSG00000075568,NA,NA,Tmem131 (MGI:1927110)
2,98087131,98330681,2q11.2,2q11.2,614884,"VWA3B, SCAR22",von Willebrand factor A domain-containing protein 3B,VWA3B,200403,ENSG00000168658,mutation identified in 1 SCAR22 family,"?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3), Autosomal recessive",Vwa3b (MGI:1918103)
2,98346154,98399153,2q11,2q11.2,600053,"CNGA3, CNG3, ACHM2","Cyclic nucleotide-gated channel, alpha-3",CNGA3,1261,ENSG00000144191,NA,"Achromatopsia 2, 216900 (3), Autosomal recessive",Cnga3 (MGI:1341818)
2,98444537,98594391,2q11.2,2q11.2,600916,"INPP4A, INPP4","Inositol polyphosphate-4-phosphatase, type I, 107kD",INPP4A,3631,ENSG00000040933,NA,NA,Inpp4a (MGI:1931123)
2,98599313,98608511,2q11.2,2q11.2,613920,"COA5, C2orf64, PET191, CEMCOX3",Cytochrome c oxidase assembly factor 5,COA5,493753,ENSG00000183513,mutation identified in 1 CEMCOX3 family,"?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3), Autosomal recessive",Coa5 (MGI:1923428)
2,98608547,98618514,2q11.2,2q11.2,617826,"UNC50, UNCL, GMH1","Unc50, inner nuclear membrane RNA-binding protein",UNC50,25972,ENSG00000115446,NA,NA,Unc50 (MGI:1914637)
2,98619105,98731131,2q12,2q11.2,604623,MGAT4A,"Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A",MGAT4A,11320,ENSG00000071073,NA,NA,Mgat4a (MGI:2662992)
2,98997260,99154965,2q11.2,2q11.2,607166,"TSGA10, SPGF26",Testis-specific protein 10,TSGA10,80705,ENSG00000135951,mutation identified in 1 SPGF26,"?Spermatogenic failure 26, 617961 (3), Autosomal recessive",Tsga10 (MGI:2685063)
2,99154954,99163156,2q11.2,2q11.2,610284,"LIPT1, LIPT1D",Lipoyltransferase 1,LIPT1,51601,ENSG00000144182,NA,"Lipoyltransferase 1 deficiency, 616299 (3), Autosomal recessive",Lipt1 (MGI:3645211)
2,99181078,99199560,2q11.2,2q11.2,611838,"MRPL30, MRPL28",Mitochondrial ribosomal protein L30,MRPL30,51263,ENSG00000185414,NA,NA,Mrpl30 (MGI:1333820)
2,99242245,99260014,2q11.2,2q11.2,616547,"LYG2, LYSG2",Lysozyme G-like 2,LYG2,254773,ENSG00000185674,NA,NA,Lyg2 (MGI:2685622)
2,99306183,99336384,2q11.2,2q11.2,612564,"TXNDC9, PHLP3",Thioredoxin domain-containing protein 9,TXNDC9,10190,ENSG00000115514,NA,NA,Txndc9 (MGI:2138153)
2,99400474,99490122,2q11.2,2q11.2,606134,"REV1L, REV1","Rev1, S. cerevisiae, homolog of",REV1,51455,ENSG00000135945,NA,NA,Rev1 (MGI:1929074)
2,99545860,100142582,2q11.2-q12,2q11.2,601464,LAF4,Lymphoid nuclear protein related to AF4,AFF3,3899,ENSG00000144218,NA,NA,Aff3 (MGI:106927)
2,100391859,100417667,2q11.2,2q11.2,606376,"CHST10, HNK1ST",Carbohydrate sulfotransferase 10,CHST10,9486,ENSG00000115526,NA,NA,Chst10 (MGI:2138283)
2,100562992,100577471,2q11.2,2q11.2,611678,"PDCL3, PHLP3, VIAF",Phosducin-like 3,PDCL3,79031,ENSG00000115539,NA,NA,Pdcl3 (MGI:1916083)
2,100820138,100996828,2q13,2q11.2,603347,"NPAS2, MOP4",Neuronal PAS domain protein 2,NPAS2,4862,ENSG00000170485,NA,NA,Npas2 (MGI:109232)
2,101002228,101019692,2q11.2,2q11.2,617415,RPL31,Ribosomal protein L31,RPL31,6160,ENSG00000071082,NA,NA,Rpl31 (MGI:2149632)
2,101697702,101894689,2q11.2,2q11.2,604666,"MAP4K4, HGK, NIK, KIAA0687",Mitogen-activated protein kinase kinase kinase kinase 4,MAP4K4,9448,ENSG00000071054,NA,NA,Map4k4 (MGI:1349394)
2,101991804,102028543,2q12-q22,2q11.2,147811,"IL1R2, IL1RB","Interleukin-1 receptor, type II",IL1R2,7850,ENSG00000115590,NA,NA,Il1r2 (MGI:96546)
2,102069637,102179873,2q12,2q11.2-q12.1,147810,"IL1R1, IL1RA","Interleukin-1 receptor, type I",IL1R1,3554,ENSG00000115594,NA,NA,Il1r1 (MGI:96545)
2,102100000,129100000,2q12-q14,NA,147185,"IGKV1OR2-108, IGO1",Immunoglobulin orphon (transposed element) 1,IGKV1OR2-108,28862,NA,NA,NA,NA
2,102100000,105300000,2q12.1,NA,617071,LNC13,Long noncoding RNA 13,NA,NA,NA,NA,NA,NA
2,102186972,102242909,2q12,2q12.1,604512,"IL1RL2, IL1RRP2",Interleukin 1 receptor-like 2,IL1RL2,8808,ENSG00000115598,NA,NA,Il1rl2 (MGI:1913107)
2,102311501,102352366,2q11.2,2q12.1,601203,IL1RL1,Interleukin 1 receptor-like 1,IL1RL1,9173,ENSG00000115602,NA,NA,Il1rl1 (MGI:98427)
2,102355800,102398776,2q12,2q12.1,604494,"IL18R1, IL1RRP",Interleukin 18 receptor 1,IL18R1,8809,ENSG00000115604,NA,NA,Il18r1 (MGI:105383)
2,102418549,102452567,2q12,2q12.1,604509,"IL18RAP, ACPL",Interleukin 18 receptor accessory protein,IL18RAP,8807,ENSG00000115607,NA,NA,Il18rap (MGI:1338888)
2,102473225,102533973,2q12.1,2q12.1,600531,"SLC9A4, NHE4","Solute carrier family 9 (sodium/hydrogen exchanger), member 4",SLC9A4,389015,ENSG00000180251,NA,NA,Slc9a4 (MGI:105074)
2,102619552,102711354,2q11.2,2q12.1,600530,SLC9A2,"Solute carrier family 9 (sodium/hydrogen exchanger), member 2",SLC9A2,6549,ENSG00000115616,NA,NA,Slc9a2 (MGI:105075)
2,104805424,104853182,2q12.1,2q12.1,618169,"PANTR1, LINC01158",POU3F3-adjacent noncoding transcript 1,PANTR1,100506421,ENSG00000233639,NA,NA,NA
2,104854114,104858573,2q12.1,2q12.1,602480,POU3F3,"POU domain, class 3, transcription factor-3",POU3F3,5455,ENSG00000198914,previously mapped to 3p14.2,NA,Pou3f3 (MGI:102564)
2,104865496,104872594,2q12.1,2q12.1,618208,"LINC01159, LINC-BRN1B",Long intergenic noncoding RNA 1159,LINC01159,102682016,ENSG00000229743,NA,NA,NA
2,105037468,105099959,2q12.1,2q12.1,611975,MRPS9,Mitochondrial ribosomal protein S9,MRPS9,64965,ENSG00000135972,NA,NA,Mrps9 (MGI:1916777)
2,105241742,105243466,2q11.2-q12,2q12.1,604838,GPR45,G protein-coupled receptor 45,GPR45,11250,ENSG00000135973,NA,NA,Gpr45 (MGI:2135882)
2,105249407,105329734,2q12.1,2q12.1-q12.2,606237,"TGFBRAP1, TRAP1",Transforming growth factor-beta receptor-associated protein 1,TGFBRAP1,9392,ENSG00000135966,NA,NA,Tgfbrap1 (MGI:2447427)
2,105357711,105438528,2q12-q14,2q12.2,602633,"FHL2, DRAL",Four and a half LIM domains-2 (Down-regulated in rhabdomyosarcoma LIM protein),FHL2,2274,ENSG00000115641,NA,NA,Fhl2 (MGI:1338762)
2,105744648,105894273,2q12,2q12.2,604930,NCK2,NCK adaptor protein 2,NCK2,8440,ENSG00000071051,NA,NA,Nck2 (MGI:1306821)
2,106063289,106078154,2q14.1-q14.3,2q12.2,611752,"C2orf40, ECRG4",Esophageal cancer-related gene 4,ECRG4,84417,ENSG00000119147,NA,NA,Ecrg4 (MGI:1926146)
2,106093302,106194338,2q12,2q12.2,609749,"UXS1, UGD",UDP-glucuronate decarboxylase 1,UXS1,80146,ENSG00000115652,NA,NA,Uxs1 (MGI:1915133)
2,106382113,106391394,2q12.2,2q12.2,612212,"PLGLA, PRGA",Plasminogen-like A,PLGLA,285189,ENSG00000240935,NA,NA,NA
2,106404679,106470934,2q12.3-q13,2q12.2,612706,"RGPD3, RGP3",RANBP2-like and GRIP domain-containing protein 3,RGPD3,653489,ENSG00000153165,NA,NA,Ranbp2 (MGI:894323)
2,106700000,112200000,2q12.3-q13,NA,612710,"RGPD7, RGP7",RANBP2-like and GRIP domain-containing protein 7,NA,NA,NA,NA,NA,NA
2,106801599,106887409,2q11.2-q12.1,2q12.3,608472,"ST6GALII, KIAA1877","Beta-galactoside alpha-2,6-sialyltransferase II",ST6GAL2,84620,ENSG00000144057,NA,NA,St6gal2 (MGI:2445190)
2,107826920,107892543,2q12.3-q13,2q12.3,612707,"RGPD4, RGP4",RANBP2-like and GRIP domain-containing protein 4,RGPD4,285190,ENSG00000196862,NA,NA,Ranbp2 (MGI:894323)
2,107986523,108014496,2q12.3,2q12.3,608761,"SLC5A7, CHT1, HMN7A, CMS20","Solute carrier family 5 (choline transporter), member 7",SLC5A7,60482,ENSG00000115665,NA,"Myasthenic syndrome, congenital, 20, presynaptic, 617143 (3), Autosomal recessive; Neuronopathy, distal hereditary motor, type VIIA, 158580 (3), Autosomal dominant",Slc5a7 (MGI:1927126)
2,108239967,108265607,2q12.2,2q12.3,617151,SULT1C3,"Sulfotransferase family 1C, member 3",SULT1C3,442038,ENSG00000196228,NA,NA,Sult1c1 (MGI:102928)
2,108288894,108309914,2q11.1-q11.2,2q12.3,602385,SULT1C1,Sulfotransferase 1C1,SULT1C2,6819,ENSG00000198203,NA,NA,Sult1c2 (MGI:1916333)
2,108377910,108388988,2q11.2,2q12.3,608357,SULT1C2,"Sulfotransferase family 1C, member 2",SULT1C4,27233,ENSG00000198075,NA,NA,NA
2,108448560,108509414,2q12.3,2q12.3,612711,"GCC2, GCC185, KIAA0336",GRIP and coiled-coil domains-containing protein 2,GCC2,9648,ENSG00000135968,NA,NA,Gcc2 (MGI:1917547)
2,108700000,112200000,2q13,NA,257550,COMA,Cogan-type congenital oculomotor apraxia,NA,266710,NA,independent gene or feature of nephronophthisis,"Oculomotor apraxia, congenital, Cogan-type, 257550 (2), Autosomal recessive",NA
2,108719445,109842300,2q11-q13,2q13,601181,"RANBP2, NUP358, ANE1, IIAE3",RAN-binding protein 2,RANBP2,5903,ENSG00000153201,NA,"{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3), Autosomal dominant",NA
2,108894470,108989255,2q11-q13,2q13,604095,"EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B","Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)",EDAR,10913,ENSG00000135960,NA,"Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3), Autosomal dominant; Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3), Autosomal recessive; [Hair morphology 1, hair thickness], 612630 (3)",Edar (MGI:1343498)
2,109542796,109614204,2q13,2q13,611737,SEPT10,Septin 10,SEPTIN10,151011,ENSG00000186522,pseudogene on 8q22.1-q12,NA,Sept10 (MGI:1918110)
2,109760593,109857704,2q12.3-q13,2q13,612708,"RGPD5, RGP5, BS63",RANBP2-like and GRIP domain-containing protein 5,RGPD5,84220,ENSG00000015568,NA,NA,Ranbp2 (MGI:894323)
2,110083869,110118138,2q13,2q13,602022,"MALL, BENE","mal, T-cell differentiation protein-like",MALL,7851,ENSG00000144063,NA,NA,Mall (MGI:2385152)
2,110122310,110205012,2q13,2q13,607100,"NPHP1, NPH1, SLSN1, JBTS4",Nephrocystin,NPHP1,4867,ENSG00000144061,NA,"Joubert syndrome 4, 609583 (3), Autosomal recessive; Nephronophthisis 1, juvenile, 256100 (3), Autosomal recessive; Senior-Loken syndrome-1, 266900 (3), Autosomal recessive",Nphp1 (MGI:1858233)
2,110513801,110610902,2q12.3-q13,2q13,612709,"RGPD6, RGP6",RANBP2-like and GRIP domain-containing protein 6,RGPD6,729540,ENSG00000183054,NA,NA,Ranbp2 (MGI:894323)
2,110637527,110678106,2q14,2q13,602452,BUB1,"Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of (mitotic checkpoint gene BUB1)",BUB1,699,ENSG00000169679,NA,"Colorectal cancer with chromosomal instability, somatic (3)",Bub1 (MGI:1100510)
2,111120913,111168444,2q13,2q13,603827,"BCL2L11, BIM",BCL2-like 11,BCL2L11,10018,ENSG00000153094,NA,NA,Bcl2l11 (MGI:1197519)
2,111195865,111495160,2q13,2q13,617144,"MIR4435-2HG, MORRBID",MIR4435-2 host gene (long noncoding RNA MORRBID),MIR4435-2HG,541471,ENSG00000172965,NA,NA,NA
2,111766149,111884195,2q13,2q13,608473,"ANAP1, APC1","Anaphase-promoting complex, subunit 1",ANAPC1,64682,ENSG00000153107,NA,NA,Anapc1 (MGI:103097)
2,111898606,112029560,2q14.1,2q13,604705,"MERTK, RP38",Mer tyrosine kinase protooncogene,MERTK,10461,ENSG00000153208,NA,"Retinitis pigmentosa 38, 613862 (3), Autosomal recessive",Mertk (MGI:96965)
2,112055265,112119313,2q13,2q13,617203,TMEM87B,Transmembrane protein 87B,TMEM87B,84910,ENSG00000153214,NA,NA,Tmem87b (MGI:1919727)
2,112138384,112254557,2q13,2q13-q14,611551,"FBLN7, TM14",Fibulin 7,FBLN7,129804,ENSG00000144152,NA,NA,Fbln7 (MGI:1917620)
2,112200000,118100000,2q14.1,NA,612459,BMIQ13,Body mass index quantitative trait locus 13,NA,100233157,NA,associated with rs7566605,"[Body mass index QTL13], 612459 (2)",NA
2,112200000,147900000,2q14-q22,NA,604288,CMD1H,"Cardiomyopathy, dilated, 1H",CMD1H,23459,NA,NA,"Cardiomyopathy, dilated, 1H, 604288 (2)",NA
2,112200000,136100000,2q14-q21,NA,165320,LCO,Liver cancer oncogene,NA,NA,NA,NA,?Hepatocellular carcinoma (1),NA
2,112200000,136100000,2q14-q21,NA,164755,"VIS1, HIS1",Viral integration site 1,VIS1,7435,NA,NA,NA,NA
2,112368368,112433644,2q12.3-q13,2q14.1,602752,"RGPD8, RGP8, RANBP2L1",RANBP2-like and GRIP domain-containing protein 8,RGPD8,727851,ENSG00000169629,NA,NA,Ranbp2 (MGI:894323)
2,112482126,112541738,2q13,2q14.1,608291,TTL,Tubulin-tyrosine ligase,TTL,150465,ENSG00000114999,NA,NA,Ttl (MGI:1916987)
2,112541914,112577152,2q14.1,2q14.1,602000,POLR1B,"Polymerase I, RNA, subunit B",POLR1B,84172,ENSG00000125630,NA,NA,Polr1b (MGI:108014)
2,112584436,112589039,2q14.1,2q14.1,616978,"CHCHD5, MIC14",Coiled coil-helix-coiled coil-helix domain-containing protein 5,CHCHD5,84269,ENSG00000125611,NA,NA,Chchd5 (MGI:1913420)
2,112645937,112663824,2q11-q14,2q14.1,137570,"SLC20A1, GLVR1","Solute carrier family 20, phosphate transporter, member 1 (Gibbon ape leukemia virus receptor-1)",SLC20A1,6574,ENSG00000144136,NA,NA,Slc20a1 (MGI:108392)
2,112736348,112764676,2q13,2q14.1,616174,"CKAP2L, RADMIS",Cytoskeleton-associated protein 2-like,CKAP2L,150468,ENSG00000169607,NA,"Filippi syndrome, 272440 (3), Autosomal recessive",Ckap2l (MGI:1917716)
2,112773914,112785397,2q14,2q14.1,147760,IL1A,"Interleukin-1, alpha",IL1A,3552,ENSG00000115008,"within 430kb of IL1B, IL1RN",NA,Il1a (MGI:96542)
2,112829750,112836842,2q14,2q14.1,147720,IL1B,"Interleukin-1, beta",IL1B,3553,ENSG00000125538,"within 430kb of IL1RN, IL1A","{Gastric cancer risk after H. pylori infection}, 137215 (3), Autosomal dominant",Il1b (MGI:96543)
2,112908884,112918881,2q12.1,2q14.1,605510,"IL37, IL1F7, FIL1Z, IL1H4, IL1RP1",Interleukin 37,IL37,27178,ENSG00000125571,NA,NA,NA
2,112978005,112985657,2q13,2q14.1,605542,"IL36G, IL1F9, IL1H1, IL1RP2","Interleukin 36, gamma",IL36G,56300,ENSG00000136688,NA,NA,Il1f9 (MGI:2449929)
2,113005458,113011070,2q13,2q14.1,605509,"IL36A, IL1F6, FIL1E","Interleukin 36, alpha",IL36A,27179,ENSG00000136694,NA,NA,Il1f6 (MGI:1859324)
2,113022088,113052866,2q13,2q14.1,605508,"IL36B, IL1F8, IL1H2, FIL1H","Interleukin 36, beta",IL36B,27177,ENSG00000136696,NA,NA,Il1f8 (MGI:1916927)
2,113058637,113064743,2q13,2q14.1,605507,"IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14",Interleukin 36 receptor antagonist,IL36RN,26525,ENSG00000136695,NA,"Psoriasis 14, pustular, 614204 (3), Autosomal recessive",Il1f5 (MGI:1859325)
2,113067969,113075842,2q14,2q14.1,615296,"IL1F10, IL1HY2","Interleukin 1 family, member 10",IL1F10,84639,ENSG00000136697,NA,NA,Il1f10 (MGI:2652548)
2,113099364,113134015,2q14.2,2q14.1,147679,"IL1RN, MVCD4, DIRA",Interleukin-1 receptor antagonist,IL1RN,3557,ENSG00000136689,NA,"{Gastric cancer risk after H. pylori infection}, 137215 (3), Autosomal dominant; Interleukin 1 receptor antagonist deficiency, 612852 (3), Autosomal recessive; {Microvascular complications of diabetes 4}, 612628 (3)",Il1rn (MGI:96547)
2,113157398,113209390,2q13,2q14.1,614442,"PSD4, EFA6B, TIC",Pleckstrin and Sec7 domains-containing protein 4,PSD4,23550,ENSG00000125637,NA,NA,Psd4 (MGI:2674093)
2,113215996,113278920,2q12-q14,2q14.1,167415,PAX8,Paired box homeotic gene-8,PAX8,7849,ENSG00000125618,NA,"Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3), Autosomal dominant",Pax8 (MGI:97492)
2,113437690,113496203,2q13-q14.1,2q14.1,611079,CBWD2,Cobalamin synthetase W domain-containing protein 2,CBWD2,150472,ENSG00000136682,NA,NA,NA
2,113499083,113501149,2q13-q14.1,2q14.1,611084,FOXD4L1,Forkhead box D4-like 1,FOXD4L1,200350,ENSG00000184492,NA,NA,NA
2,113627217,113643397,2q13,2q14.1,605412,RABL2A,RAB-like 2A,RABL2A,11159,ENSG00000144134,NA,NA,Rabl2 (MGI:1915958)
2,113889933,113962595,2q14.1,2q14.1,604222,"ACTR3, ARP3",Actin-related protein 3,ACTR3,10096,ENSG00000115091,NA,NA,Actr3 (MGI:1921367)
2,114442640,115845751,2q12.3-q14.2,2q14.1,608209,"DPP10, DPRP3, KIAA1492",Dipeptidyl peptidase X,DPP10,57628,ENSG00000175497,NA,NA,Dpp10 (MGI:2442409)
2,117814690,117832376,2q14.1,2q14.1,606355,DDX18,DEAD/H box 18,DDX18,8886,ENSG00000088205,NA,NA,Ddx18 (MGI:1914192)
2,118088417,118110996,2q14.1,2q14.1-q14.2,608660,INSIG2,Insulin-induced gene 2,INSIG2,51141,ENSG00000125629,NA,NA,Insig2 (MGI:1920249)
2,118842170,118848182,2q13-q21,2q14.2,131290,EN1,Engrailed-1,EN1,2019,ENSG00000163064,NA,NA,En1 (MGI:95389)
2,118942168,118994663,2q12-q13,2q14.2,604870,MARCO,Macrophage receptor with collagenous structure,MARCO,8685,ENSG00000019169,NA,NA,Marco (MGI:1309998)
2,119156242,119158750,2q14.2,2q14.2,614330,"C1QL2, CTRP10, C1QTNF10","Complement component 1, q subcomponent-like 2",C1QL2,165257,ENSG00000144119,NA,NA,C1ql2 (MGI:3032521)
2,119222475,119265651,2q14.2,2q14.2,609671,"STEAP3, TSAP6, AHMIO2",Six-transmembrane epithelial antigen of prostate 3,STEAP3,55240,ENSG00000115107,mutation identified in 1 AHMIO2 family,"?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3), Autosomal dominant",Steap3 (MGI:1915678)
2,119366923,119372550,2q12-q21,2q14.2,125950,DBI,Diazepam-binding inhibitor,DBI,1622,ENSG00000155368,?on 6q21-qter,NA,Dbi (MGI:94865)
2,119439842,119524451,2q14.1,2q14.2,182098,SCTR,Secretin receptor,SCTR,6344,ENSG00000080293,NA,NA,Sctr (MGI:2441720)
2,119759921,119984898,2q14.2,2q14.2,176878,"PTPN4, PTPMEG1","Protein-tyrosine phosphatase, nonreceptor-type, 4",PTPN4,5775,ENSG00000088179,NA,NA,Ptpn4 (MGI:1099792)
2,120013027,120179118,2q14,2q14.2,611730,"EPB41L5, KIAA1548",Erythrocyte membrane protein band 4.1-like 5,EPB41L5,57669,ENSG00000115109,NA,NA,Epb41l5 (MGI:103006)
2,120252849,120294710,2cen-q13,2q14.2,179551,RALB,RAS-like protein B,RALB,5899,ENSG00000144118,NA,NA,Ralb (MGI:1927244)
2,120346135,120351802,2cen-q13,2q14.2,147390,INHBB,"Inhibin, beta-2",INHBB,3625,ENSG00000163083,NA,NA,Inhbb (MGI:96571)
2,120735864,120992652,2q14,2q14.2,165230,"GLI2, HPE9, CJS",GLI-Kruppel family member GLI2 (oncogene GLI2),GLI2,2736,ENSG00000074047,NA,"Culler-Jones syndrome, 615849 (3), Autosomal dominant; Holoprosencephaly 9, 610829 (3), Autosomal dominant",Gli2 (MGI:95728)
2,121216586,121285209,2q14,2q14.2,609785,"TFCP2L1, CRTR1, LBP9",Transcription factor CP2-like 1,TFCP2L1,29842,ENSG00000115112,NA,NA,Tfcp2l1 (MGI:2444691)
2,121337775,121649461,2q14,2q14.2-q14.3,605852,"CLASP1, KIAA0622",CLIP-associated protein 1,CLASP1,23332,ENSG00000074054,NA,NA,Clasp1 (MGI:1923957)
2,121530879,121531008,2q14.2,2q14.2,601428,"RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN","RNA, U4, small nuclear, AT-AC form",RNU4ATAC,100151683,ENSG00000264229,NA,"Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3), Autosomal recessive; Roifman syndrome, 616651 (3), Autosomal recessive",NA
2,121600000,136100000,2q14.3-q21.3,NA,614588,DYT21,Dystonia 21,DYT21,100885773,NA,NA,"Dystonia 21, 614588 (2), Autosomal dominant",NA
2,121726944,121736874,2q14.3,2q14.3,611970,"NIFK, MKI67IP, NOPP34",Nucleolar protein interacting with the FHA domain of MKI67,NIFK,84365,ENSG00000155438,NA,NA,Nifk (MGI:1915199)
2,121755544,121767852,2q21.1,2q14.3,600575,TSN,Translin,TSN,7247,ENSG00000211460,NA,NA,Tsn (MGI:109263)
2,124025286,124921218,2q14,2q14.3,610519,"CNTNAP5, CASPR5",Contactin-associated protein-like 5,CNTNAP5,129684,ENSG00000155052,NA,NA,Cntnap5a (MGI:3643623)
2,126655934,126696674,2q14-q21,2q14.3,110750,"GYPC, GE, GPC",Glycophorin C,GYPC,2995,ENSG00000136732,NA,"[Blood group, Gerbich], 616089 (3); {Malaria, resistance to}, 611162 (3)",Gypc (MGI:1098566)
2,127048022,127107153,2q14,2q14.3,601248,"BIN1, AMPHL, CNM2",Box-dependent MYC-interacting protein-1 (amphiphysin-like),BIN1,274,ENSG00000136717,NA,"Centronuclear myopathy 2, 255200 (3), Autosomal recessive",Bin1 (MGI:108092)
2,127257289,127294175,2q21,2q14.3,133510,"ERCC3, XPB, TTD2","Excision-repair cross-complementing rodent repair deficiency, complementation group 3",ERCC3,2071,ENSG00000163161,NA,"Trichothiodystrophy 2, photosensitive, 616390 (3), Autosomal recessive; Xeroderma pigmentosum, group B, 610651 (3), Autosomal recessive",Ercc3 (MGI:95414)
2,127298668,127387532,2q14.3,2q14.3,609487,"MAP3K2, MEKK2",Mitogen-activated protein kinase kinase kinase 2,MAP3K2,10746,ENSG00000169967,NA,NA,Map3k2 (MGI:1346873)
2,127418142,127429245,2q13-q14,2q14.3,612283,"PROC, PC, THPH3, THPH4",Protein C (inactivator of coagulation factors Va and VIIIa),PROC,5624,ENSG00000115718,NA,"Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3), Autosomal dominant; Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3), Autosomal recessive",Proc (MGI:97771)
2,127535688,127637727,2q21.1,2q14.3,606541,MYO7B,Myosin VIIb,MYO7B,4648,ENSG00000169994,NA,NA,Myo7b (MGI:107709)
2,127638380,127681785,2q14.3,2q14.3,607908,"LIMS2, PINCH2, MDRCMTT",LIM and senescent cell antigen-like domains 2,LIMS2,55679,ENSG00000072163,mutation identified in 1 LGMD2W family,"?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue, 616827 (3), Autosomal recessive",Lims2 (MGI:2385067)
2,127645863,127652638,2q21,2q14.3,603071,GPR17,G protein-coupled receptor-17,GPR17,2840,ENSG00000144230,NA,NA,Gpr17 (MGI:3584514)
2,127701026,127811186,2q14.2,2q14.3,618082,"WDR33, WDC146",WD repeat-containing protein 33,WDR33,55339,ENSG00000136709,NA,NA,Wdr33 (MGI:1921570)
2,127843552,127858154,2q14.3,2q14.3,606017,POLR2D,"Polymerase II, RNA, subunit D",POLR2D,5433,ENSG00000144231,NA,NA,Polr2d (MGI:1916491)
2,127941216,128028058,2q14.3,2q14.3,609697,SAP130,"Sin3A-associated protein, 130kD",SAP130,79595,ENSG00000136715,NA,NA,Sap130 (MGI:1919782)
2,128091183,128195676,2q14.3,2q14.3,605897,"UGGT1, HUGT1",UDP-glucose glycoprotein glucosyltransferase 1,UGGT1,56886,ENSG00000136731,NA,NA,Uggt1 (MGI:2443162)
2,128265479,128318867,2q21,2q14.3,604846,"HS6ST1, HS6ST, HH15",Heparan sulfate 6-O-sulfotransferase 1,HS6ST1,9394,ENSG00000136720,NA,"{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3), Autosomal dominant",Hs6st1 (MGI:1354958)
2,129100000,131700000,2q21.1,NA,612311,ADHD5,"Attention deficit-hyperactivity disorder, susceptibility to, 5",NA,100190790,NA,max lod at rs985162,"{Attention deficit-hyperactivity disorder, susceptibility to, 5}, 612311 (2)",NA
2,129100000,147900000,2q21.1-q22,NA,608316,CHDS2,"Coronary heart disease, susceptibility to, 2",NA,387584,NA,NA,"{Coronary heart disease, susceptibility to, 2}, 608316 (2)",NA
2,129100000,136100000,2q21,NA,606240,NMTC3,Nonmedullary thyroid carcinoma 3,NA,114568,NA,NA,"{Thyroid carcinoma, nonmedullary, 3}, 606240 (2), Autosomal dominant",NA
2,129979665,129982737,2q21.1,2q21.1,612909,"RAB6C, WTH3",Ras-associated protein RAB6C,RAB6C,84084,ENSG00000222014,NA,NA,NA
2,130151391,130181756,2q21.1,2q21.1,610457,"SMPD4, NSMASE3, KIAA1418","Sphingomyelin phosphodiesterase 4, neutral membrane",SMPD4,55627,ENSG00000136699,NA,NA,Smpd4 (MGI:1924876)
2,130182261,130190726,2q21.1,2q21.1,613450,"FAM128B, MOZART2B","Family with sequence similarity 128, member B",MZT2B,80097,ENSG00000152082,NA,NA,NA
2,130337932,130342680,2q21.2,2q21.1,613734,"CCDC115, CCP1, CDG2O",Coiled-coil domain-containing protein 115,CCDC115,84317,ENSG00000136710,NA,"Congenital disorder of glycosylation, type IIo, 616828 (3), Autosomal recessive",Ccdc115 (MGI:1916918)
2,130342224,130347960,2q21.1,2q21.1,612981,"IMP4, BXDC4","Imp4, S. cerevisiae, homolog of",IMP4,92856,ENSG00000136718,NA,NA,Imp4 (MGI:106572)
2,130356011,130375404,2q21.1,2q21.1,606587,"PTPN18, BDP1","Protein-tyrosine phosphatase, nonreceptor-type, 18",PTPN18,26469,ENSG00000072135,NA,NA,Ptpn18 (MGI:108410)
2,130592164,130599574,2q21.1,2q21.1,605194,"CFC1, CRYPTIC, HTX2",Cryptic protein,CFC1,55997,ENSG00000136698,NA,"Heterotaxy, visceral, 2, autosomal, 605376 (3), Autosomal dominant",Cfc1 (MGI:109448)
2,130836913,131051513,2q22,2q21.1,605216,"ARHGEF4, ASEF",RHO guanine nucleotide exchange factor 4,ARHGEF4,50649,ENSG00000136002,NA,NA,Arhgef4 (MGI:2442507)
2,131104846,131149851,2q21.1,2q21.1,618452,"PLEKHB2, EVT2","Pleckstrin homology domain-containing protein, family B, member 2",PLEKHB2,55041,ENSG00000115762,NA,NA,Plekhb2 (MGI:2385825)
2,131209580,131265253,2q21.1,2q21.1,608914,"POTEE, POTE2","POTE ankyrin domain family, member E",POTEE,445582,ENSG00000188219,5 POTE2 genes within 2Mb segment,NA,NA
2,131469723,131493079,2q21.1,2q21.1,613449,"FAM128A, MOZART2A","Family with sequence similarity 128, member A",MZT2A,653784,ENSG00000173272,NA,NA,Mzt2 (MGI:1922845)
2,131476118,131482933,2q21.1,2q21.1,617878,"TUBA3D, KTCN9","Tubulin, alpha-3D",TUBA3D,113457,ENSG00000075886,NA,"Keratoconus 9, 617928 (3), Autosomal dominant",NA
2,131592041,131626428,2q21.1,2q21.1,611266,"POTEKP, ACT, ACTBL3, POTEK, FKSG30","POTE ankyrin domain family, member K, pseudogene",POTEKP,440915,NA,NA,NA,NA
2,132416804,132646581,2q21-q22,2q21.2,602886,GPR39,G protein-coupled receptor-39,GPR39,2863,ENSG00000183840,NA,NA,Gpr39 (MGI:1918361)
2,132643285,132671525,2q21.2,2q21.2,610450,"LYPD1, PHTS",LY6/PLAUR domain-containing protein 1,LYPD1,116372,ENSG00000150551,NA,NA,Lypd1 (MGI:1919835)
2,132671787,133675181,2q21.2,2q21.2,608789,"NCKAP5, NAP5",NCK-associated protein 5,NCKAP5,344148,ENSG00000176771,NA,NA,Nckap5 (MGI:2686394)
2,134119921,134454620,2q21,2q21.2-q21.3,601774,MGAT5,"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl- glucosaminyltransferase",MGAT5,4249,ENSG00000152127,NA,NA,Mgat5 (MGI:894701)
2,134918809,134959344,2p14-q21.3,2q21.3,603862,CCNT2,Cyclin T2,CCNT2,905,ENSG00000082258,NA,NA,Ccnt2 (MGI:1920199)
2,135052280,135176666,2q21.3,2q21.3,602536,"RAB3GAP1, WARBM1, P130","RAB3 GTPase-activating protein, catalytic subunit",RAB3GAP1,22930,ENSG00000115839,NA,"Warburg micro syndrome 1, 600118 (3), Autosomal recessive",Rab3gap1 (MGI:2445001)
2,135164217,135531217,2q21.3,2q21.3,615655,ZRANB3,Zinc finger RANBP2-type domain-containing protein 3,ZRANB3,84083,ENSG00000121988,NA,NA,Zranb3 (MGI:1918362)
2,135665396,135665477,2q21,2q21.3,611774,"MIR128-1, MIRN128-1, MIR128A",Micro RNA 128-1,MIR128-1,406915,ENSG00000207654,NA,NA,NA
2,135741854,135785055,2q21.3-q22.1,2q21.3,611216,"UBXN4, UBXD2, KIAA2042, ERASIN",UBX domain protein 4,UBXN4,23190,ENSG00000144224,NA,NA,Ubxn4 (MGI:1915062)
2,135787849,135837194,2q21,2q21.3,603202,"LCT, LAC, LPH",Lactase (lactase-phlorizin hydrolase),LCT,3938,ENSG00000115850,NA,"Lactase deficiency, congenital, 223000 (3), Autosomal recessive",Lct (MGI:104576)
2,135839625,135876442,2q21,2q21.3,601806,MCM6,"Minichromosome maintenance deficient (mis5, S. pombe) 6",MCM6,4175,ENSG00000076003,mutations in introns 9 and 13,"Lactase persistence/nonpersistence, 223100 (3), Autosomal dominant",Mcm6 (MGI:1298227)
2,135905880,135985683,2q21.3,2q21.3,603084,"DARS, HBSL, HBSL",Aspartyl tRNA synthetase,DARS1,1615,ENSG00000115866,NA,"Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3), Autosomal recessive",Dars (MGI:2442544)
2,136100000,168900000,2q22-q24,NA,611535,MAFD5,Major affective disorder 5,NA,100188843,NA,NA,"{Major affective disorder 5}, 611535 (2)",NA
2,136114348,136118154,2q21,2q22.1,162643,"CXCR4, D2S201E, NPY3R, WHIMS",Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3),CXCR4,7852,ENSG00000121966,NA,"Myelokathexis, isolated (3); WHIM syndrome, 193670 (3), Autosomal dominant",Cxcr4 (MGI:109563)
2,137964067,138016363,2q22,2q22.1,605238,"HNMT, MRT51",Histamine N-methyltransferase,HNMT,3176,ENSG00000150540,NA,"{Asthma, susceptibility to}, 600807 (3), Autosomal dominant; Mental retardation, autosomal recessive 51, 616739 (3), Autosomal recessive",Hnmt (MGI:2153181)
2,138669156,138780389,2q22.1,2q22.1,604635,"NXPH2, NPH2",Neuroxophilin 2,NXPH2,11249,ENSG00000144227,NA,NA,Nxph2 (MGI:107491)
2,142877663,143055832,2q22.2,2q22.2,605197,"KYNU, KYNUU, VCRL2",Kynureninase,KYNU,8942,ENSG00000115919,mutation identified in 1 KYNUU family,"?Hydroxykynureninuria, 236800 (3), Autosomal recessive; Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3), Autosomal recessive",Kynu (MGI:1918039)
2,143070972,143768351,2q22.2-q22.3,2q22.2-q22.3,610578,"ARHGAP15, BM046",Rho GTPase-activating protein 15,ARHGAP15,55843,ENSG00000075884,NA,NA,Arhgap15 (MGI:1923367)
2,143945044,144333068,2q22,2q22.3,610165,GTDC1,Glycosyltransferase-like domain containing 1,GTDC1,79712,ENSG00000121964,NA,NA,Gtdc1 (MGI:2444269)
2,144384080,144520118,2q22,2q22.3,605802,"ZEB2, ZFHX1B, SMADIP1, SIP1",Zinc finger E box-binding homeobox 2,ZEB2,9839,ENSG00000169554,NA,"Mowat-Wilson syndrome, 235730 (3), Autosomal dominant",Zeb2 (MGI:1344407)
2,147844516,147930826,2q22.2-q23.3,2q22.3-q23.1,102581,"ACVR2A, ACVR2","Activin A receptor, type IIA",ACVR2A,92,ENSG00000121989,NA,NA,Acvr2a (MGI:102806)
2,147900000,168900000,2q23-q24.3,NA,603964,DFNA16,"Deafness, autosomal dominant 16",DFNA16,1694,NA,NA,"Deafness, autosomal dominant 16, 603964 (2), Autosomal dominant",NA
2,147900000,182100000,2q23-q31,NA,605818,DFNB27,"Deafness, autosomal recessive 27",DFNB27,23713,NA,NA,"Deafness, autosomal recessive 27, 605818 (2), Autosomal recessive",NA
2,147930395,148021603,2q22-q23,2q23.1,603056,"ORC4, ORC4L","Origin recognition complex, subunit 4, S. cerevisiae, homolog of",ORC4,5000,ENSG00000115947,NA,"Meier-Gorlin syndrome 2, 613800 (3), Autosomal recessive",Orc4 (MGI:1347043)
2,148021010,148516922,2q23.1,2q23.1,611472,"MBD5, KIAA1461, MRD1",Methyl-CpG-binding domain protein 5,MBD5,55777,ENSG00000204406,NA,"Mental retardation, autosomal dominant 1, 156200 (3), Autosomal dominant",Mbd5 (MGI:2138934)
2,148644750,148788490,2q23.1,2q23.1,611000,EPC2,"Enhancer of polycomb, Drosophila, homolog of, 2",EPC2,26122,ENSG00000135999,NA,NA,Epc2 (MGI:1278321)
2,148875226,149026758,2q23.1,2q23.1-q23.2,604593,"KIF5C, NKHC2, CDCBM2",Kinesin family member 5C,KIF5C,3800,ENSG00000168280,NA,"Cortical dysplasia, complex, with other brain malformations 2, 615282 (3), Autosomal dominant",Kif5c (MGI:1098269)
2,149329984,149474147,2q23.1-q23.2,2q23.2,613359,LYPD6,LY6/PLAUR domain-containing protein 6,LYPD6,130574,ENSG00000187123,NA,NA,Lypd6 (MGI:2443848)
2,149569636,149587774,2q23.2,2q23.2,611935,"C2orf25, MMADHC",Chromosome 2 open reading frame 25,MMADHC,27249,ENSG00000168288,NA,"Homocystinuria, cblD type, variant 1, 277410 (3), Autosomal recessive; Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3), Autosomal recessive; Methylmalonic aciduria, cblD type, variant 2, 277410 (3), Autosomal recessive",Mmadhc (MGI:1923786)
2,150468192,150487694,2q23.3,2q23.3,602924,"RND3, RHOE, ARHE",RHO family GTPase 3,RND3,390,ENSG00000115963,NA,NA,Rnd3 (MGI:1921444)
2,151270464,151289667,2q23.3,2q23.3,603525,NMI,NMYC interactor,NMI,9111,ENSG00000123609,previously assigned to 22q13.3,NA,Nmi (MGI:1928368)
2,151357591,151380045,2q23.3,2q23.3,600410,TNFAIP6,"Tumor necrosis factor, alpha-induced protein-6",TNFAIP6,7130,ENSG00000123610,NA,NA,Tnfaip6 (MGI:1195266)
2,151485333,151734486,2q22,2q23.3,161650,"NEB, NEM2",Nebulin,NEB,4703,ENSG00000183091,NA,"Nemaline myopathy 2, autosomal recessive, 256030 (3), Autosomal recessive",Neb (MGI:97292)
2,151798796,151828420,2q23-q24.1,2q23.3,608960,ARL5,ADP-ribosylation factor-like 5,ARL5A,26225,ENSG00000162980,NA,NA,Arl5a (MGI:1922673)
2,151832770,152099166,2q22-q23,2q23.3,601949,"CACNB4, EJM6, EA5, EIG9","Calcium channel, voltage-dependent, beta 4 subunit",CACNB4,785,ENSG00000182389,NA,"{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3), Autosomal dominant; Episodic ataxia, type 5, 613855 (3), Autosomal dominant",Cacnb4 (MGI:103301)
2,152116800,152175776,2q23.3,2q23.3,606244,STAM2,Signal-transducing adaptor molecule 2,STAM2,10254,ENSG00000115145,NA,NA,Stam2 (MGI:1929100)
2,152335169,152649825,2q23.3,2q23.3,616285,"FMNL2, KIAA1902",Formin-like 2,FMNL2,114793,ENSG00000157827,NA,NA,Fmnl2 (MGI:1918659)
2,152651592,152718018,2q23.3,2q23.3,612941,"PRPF40A, HYPA, FNBP3, FBP11","Precursor mRNA-processing factor 40, S. cerevisiae, homolog of, A",PRPF40A,55660,ENSG00000196504,NA,NA,Prpf40a (MGI:1860512)
2,152717692,152761252,2q23.3,2q23.3,616495,"ARL6IP6, AIP6",ADP-ribosylation factor-like 6-interacting protein 6,ARL6IP6,151188,ENSG00000177917,NA,NA,Arl6ip6 (MGI:1929507)
2,153477337,153478761,2q23,2q23.3,612171,RPRM,Reprimo,RPRM,56475,ENSG00000177519,NA,NA,Rprm (MGI:1915124)
2,153871911,154454176,2q24.1,2q23.3-q24.1,608369,"GALNT13, KIAA1918",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13,GALNT13,114805,ENSG00000144278,NA,NA,Galnt13 (MGI:2139447)
2,154000000,196600000,2q24-q32,NA,612108,FGQTL1,Fasting plasma glucose level QTL 1,NA,100499165,NA,associated with rs560887,"[Fasting plasma glucose level QTL 1], 612108 (2)",NA
2,154000000,177100000,2q24.1-q31.1,NA,610295,INTLQ2,Intelligence quantitative trait locus 3,NA,100462723,NA,NA,"{Intelligence QTL3}, 610295 (2)",NA
2,154000000,196600000,2q24-q32,NA,156232,"MMDK, MDK","Mesomelic dysplasia, Kantaputra type",NA,10305,NA,NA,"Mesomelic dysplasia, Kantaputra type, 156232 (2), Autosomal dominant",NA
2,154000000,158900000,2q24.1,NA,612759,SYNSTH,Synesthesia,NA,100301527,NA,max lod at D2S142,"Synesthesia, 612759 (2)",NA
2,154698580,154858353,2q24.1,2q24.1,601534,"KCNJ3, GIRK1","Potassium inwardly-rectifying channel, subfamily J, member 3",KCNJ3,3760,ENSG00000162989,NA,NA,Kcnj3 (MGI:104742)
2,156324431,156332723,2q22-q23,2q24.1,601828,"NR4A2, NURR1, NOT, TINUR","Nuclear receptor subfamily 4, group A, member 2",NR4A2,4929,ENSG00000153234,NA,NA,Nr4a2 (MGI:1352456)
2,156435289,156586402,2q24.1,2q24.1,138430,GPD2,Glycerol-3-phosphate dehydrogenase 2 (mitochondrial),GPD2,2820,ENSG00000115159,pseudogene on 19,"{Diabetes, type 2, susceptibility to}, 125853 (3), Autosomal dominant",Gpd2 (MGI:99778)
2,157257655,157318490,2q24.2,2q24.1,615129,"GALNT5, GALNACT5",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5,GALNT5,11227,ENSG00000136542,NA,NA,Galnt5 (MGI:2179403)
2,157318612,157327711,2q24.1,2q24.1,610072,"ERMN, JN, KIAA1189",Ermin,ERMN,57471,ENSG00000136541,NA,NA,Ermn (MGI:1925017)
2,157412781,157444088,2q11.2,2q24.1,604448,"CYTIP, PSCDBP, HE",Cytohesin 1 interacting protein,CYTIP,9595,ENSG00000115165,NA,NA,Cytip (MGI:2183535)
2,157526766,157628863,2q24.1,2q24.1,608981,"ACVR1C, ALK7","Activin A receptor, type IC",ACVR1C,130399,ENSG00000123612,NA,NA,Acvr1c (MGI:2661081)
2,157736445,157875895,2q23-q24,2q24.1,102576,"ACVR1, ACVRLK2, ALK2, FOP","Activin A receptor, type I",ACVR1,90,ENSG00000115170,NA,"Fibrodysplasia ossificans progressiva, 135100 (3), Autosomal dominant",Acvr1 (MGI:87911)
2,157995178,158136153,2q24.1,2q24.1,617340,UPP2,Uridine phosphorylase 2,UPP2,151531,ENSG00000007001,NA,NA,Upp2 (MGI:1923904)
2,158456879,158682889,2q23-q31,2q24.1,604276,PKP4,Plakophilin-4,PKP4,8502,ENSG00000144283,NA,NA,Pkp4 (MGI:109281)
2,158968599,159232658,2q24.2,2q24.2,611397,"TANC1, KIAA1728","Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 1",TANC1,85461,ENSG00000115183,NA,NA,Tanc1 (MGI:1914110)
2,159315311,159712441,2q23-q24,2q24.2,605683,BAZ2B,"Bromodomain adjacent to zinc finger domain, 2B",BAZ2B,29994,ENSG00000123636,NA,NA,Baz2b (MGI:2442782)
2,159712456,159771026,2q24.2,2q24.2,613334,MARCH7,Membrane-associated RING-CH finger protein 7,MARCHF7,64844,ENSG00000136536,NA,NA,March7 (MGI:1931053)
2,159768627,159798254,2q24,2q24.2,612246,"CD302, DCL1, KIAA0022",CD302 antigen,CD302,9936,ENSG00000241399,NA,NA,Cd302 (MGI:1913455)
2,159932001,160062614,2q23-q24,2q24.2,604939,"PLA2R1, PLA2R",Phospholipase A2 receptor 1,PLA2R1,22925,ENSG00000153246,NA,NA,Pla2r1 (MGI:102468)
2,160099665,160200312,2q24.2,2q24.2,147558,"ITGB6, AI1H","Integrin, beta-6",ITGB6,3694,ENSG00000115221,NA,"Amelogenesis imperfecta, type IH, 616221 (3), Autosomal recessive",Itgb6 (MGI:96615)
2,160272150,160493982,2q24.2,2q24.2,602310,"RBMS1, MSSP, SCR2","RNA-binding motif protein, single strand-interacting, 1",RBMS1,5937,ENSG00000153250,NA,NA,Rbms1 (MGI:1861774)
2,161136954,161236229,2q24.2,2q24.2,603893,"TANK, ITRAF",TRAF family member-associated NF-Kappa-B activator,TANK,10010,ENSG00000136560,NA,NA,Tank (MGI:107676)
2,161308424,161411716,2q24.2,2q24.2,607173,"PSMD14, POH1, PAD1","Proteasome 26S subunit, non-ATPase, 14",PSMD14,10213,ENSG00000115233,NA,NA,Psmd14 (MGI:1913284)
2,161416296,161425869,2q24.2,2q24.2,604616,"TBR1, IDDAS","T-box, brain, 1",TBR1,10716,ENSG00000136535,NA,"Intellectual developmental disorder with autism and speech delay, 606053 (3), Autosomal dominant",Tbr1 (MGI:107404)
2,161620962,161985275,2q23-q24,2q24.2,605556,SLC4A10,"Solute carrier family 4 (sodium bicarbonate cotransporter-like), member 10",SLC4A10,57282,ENSG00000144290,NA,NA,Slc4a10 (MGI:2150150)
2,161992240,162074214,2q23,2q24.2,102720,"DPP4, CD26, ADCP2",Dipeptidylpeptidase IV (CD26; adenosine deaminase complexing protein-2),DPP4,1803,ENSG00000197635,NA,NA,Dpp4 (MGI:94919)
2,162142881,162152246,2q36-q37,2q24.2,138030,GCG,Glucagon,GCG,2641,ENSG00000115263,NA,[?Hyperproglucagonemia] (1),NA
2,162170683,162243471,2q23,2q24.2,600403,"FAP, FAPA","Fibroblast activation protein, alpha subunit",FAP,2191,ENSG00000078098,NA,NA,Fap (MGI:109608)
2,162267073,162318683,2q24,2q24.2,606951,"IFIH1, MDA5, AGS7, SGMRT1",Interferon induced with helicase C domain 1,IFIH1,64135,ENSG00000115267,NA,"Aicardi-Goutieres syndrome 7, 615846 (3), Autosomal dominant; Singleton-Merten syndrome 1, 182250 (3), Autosomal dominant",Ifih1 (MGI:1918836)
2,162318762,162377224,2q24.2,2q24.2,607030,GCA,Grancalcin,GCA,25801,ENSG00000115271,NA,NA,Gca (MGI:1918521)
2,162371406,162838816,2q24.2,2q24.2,608169,"KCNH7, ERG3, HERG3, Kv11.3","Potassium channel, voltage-gated, subfamily H, member 7",KCNH7,90134,ENSG00000184611,NA,NA,Kcnh7 (MGI:2159566)
2,162900000,168900000,2q24.3,NA,610155,IDDM19,"Diabetes mellitus, insulin-dependent, 19",NA,NA,NA,associated with rs1990760,"{Diabetes mellitus, insulin-dependent, 19}, 610155 (2)",NA
2,163602610,163736154,4q22.1,2q24.3,605295,FIGN,Fidgetin,FIGN,55137,ENSG00000182263,NA,NA,Fign (MGI:1890647)
2,164492416,164622958,2q22-q24,2q24.3,601524,GRB14,Growth factor receptor-bound protein 14,GRB14,2888,ENSG00000115290,NA,NA,Grb14 (MGI:1355324)
2,164657930,164842075,2q24,2q24.3,610318,"COBLL1, COBLR1, KIAA0977",COBL-like protein 1,COBLL1,22837,ENSG00000082438,NA,NA,Cobll1 (MGI:2442894)
2,164898198,164955720,2q24.3,2q24.3,616526,SLC38A11,"Solute carrier family 38 (amino acid transporter), member 11",SLC38A11,151258,ENSG00000169507,NA,NA,Slc38a11 (MGI:2443383)
2,165087525,165204294,2q24,2q24.3,182391,"SCN3A, FFEVF4, EIEE62","Sodium channel, voltage-gated, type III, alpha polypeptide",SCN3A,6328,ENSG00000153253,NA,"Epilepsy, familial focal, with variable foci 4, 617935 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 62, 617938 (3), Autosomal dominant",Scn3a (MGI:98249)
2,165208055,165392309,2q23-q24.3,2q24.3,182390,"SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS","Sodium channel, voltage-gated, type II, alpha subunit",SCN2A,6326,ENSG00000136531,4 related genes on chr.2,"Epileptic encephalopathy, early infantile, 11, 613721 (3), Autosomal dominant; Seizures, benign familial infantile, 3, 607745 (3), Autosomal dominant",Scn2a (MGI:98248)
2,165747587,165796351,2q24-q31,2q24.3,601756,"GALNT3, HHS, HFTC1",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3,GALNT3,2591,ENSG00000115339,NA,"Tumoral calcinosis, hyperphosphatemic, familial, 1, 211900 (3), Autosomal recessive",Galnt3 (MGI:894695)
2,165873361,165953780,2q24.3,2q24.3,612014,"TTC21B, THM1, NPHP12, SRTD4, ATD4",Tetratricopeptide repeat domain 21B,TTC21B,79809,ENSG00000123607,NA,"Nephronophthisis 12, 613820 (3), Autosomal recessive, Autosomal dominant; Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3), Autosomal recessive",Ttc21b (MGI:1920918)
2,165984640,166149160,2q24,2q24.3,182389,"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3","Sodium channel, voltage-gated, type I, alpha polypeptide",SCN1A,6323,ENSG00000144285,NA,"Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 6 (Dravet syndrome), 607208 (3), Autosomal dominant; Febrile seizures, familial, 3A, 604403 (3), Autosomal dominant; Migraine, familial hemiplegic, 3, 609634 (3), Autosomal dominant",Scn1a (MGI:98246)
2,166195184,166375986,2q24,2q24.3,603415,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D","Sodium channel, voltage-gated, type IX, alpha subunit",SCN9A,6335,ENSG00000169432,NA,"{Dravet syndrome, modifier of}, 607208 (3), Autosomal dominant; Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3), Autosomal dominant; Erythermalgia, primary, 133020 (3), Autosomal dominant; Febrile seizures, familial, 3B, 613863 (3), Autosomal dominant; HSAN2D, autosomal recessive, 243000 (3), Autosomal recessive; Insensitivity to pain, congenital, 243000 (3), Autosomal recessive; Paroxysmal extreme pain disorder, 167400 (3), Autosomal dominant; Small fiber neuropathy, 133020 (3), Autosomal dominant",Scn9a (MGI:107636)
2,166403572,166494263,2q21-q23,2q24.3,182392,"SCN7A, SCN6A","Sodium channel, voltage-gated, type VII, alpha polypeptide",SCN7A,6332,ENSG00000136546,NA,NA,Scn7a (MGI:102965)
2,166888486,167259752,2q24.3,2q24.3,609778,"CMYA3, XIRP2",Cardiomyopathy-associated protein 3,XIRP2,129446,ENSG00000163092,NA,NA,Xirp2 (MGI:2685198)
2,167293059,167870855,2q24.3,2q24.3,603093,B3GALT1,"UDP-GAL:beta-GlcNAc beta-1,3-galactosyltransferase, polypeptide 1",B3GALT1,8708,ENSG00000172318,NA,NA,B3galt1 (MGI:1349403)
2,167954019,168247594,2q24.3,2q24.3,607648,"STK39, SPAK",Serine/threonine protein kinase 39,STK39,27347,ENSG00000198648,NA,NA,Stk39 (MGI:1858416)
2,168455861,168775133,2q24.3,2q24.3,615336,"CERS6, LASS6",Ceramide synthase 6,CERS6,253782,ENSG00000172292,NA,NA,Cers6 (MGI:2442564)
2,168786538,168865338,2q31.1,2q24.3,607496,NOSTRIN,Nitric oxide synthase trafficker,NOSTRIN,115677,ENSG00000163072,NA,NA,Nostrin (MGI:3606242)
2,168865044,168890442,2q31.1,2q24.3,609395,"SPC25, SPBC25","SPC25, NDC80 kinetochore complex component",SPC25,57405,ENSG00000152253,NA,NA,Spc25 (MGI:1913692)
2,168900000,177100000,2q31.1,NA,613681,"DUP2q31.1, C2DUPq31.1",Chromosome 2q31.1 duplication syndrome,NA,NA,NA,duplication of 9 HOXD genes and MTX2,"Chromosome 2q31.1 duplication syndrome, 613681 (4), Autosomal dominant",NA
2,168900000,182100000,2q31,NA,600321,IDDM7,Insulin-dependent diabetes mellitus-7,IDDM7,3406,NA,NA,"{Diabetes mellitus, insulin-dependent, 7}, 600321 (2)",NA
2,168900000,182100000,2q31,NA,611147,PNKD2,Paroxysmal nonkinesigenic dyskinesia 2,NA,100188328,NA,between D2S2188 and D2S364,"Paroxysmal nonkinesigenic dyskinesia 2, 611147 (2), Autosomal dominant",NA
2,168900000,182100000,2q31,NA,606708,SHFM5,Split-hand/foot malformation 5,SHFM5,171157,NA,between EVX2 and D2S294,"Split-hand/foot malformation 5, 606708 (2)",NA
2,168901222,168909999,2q24-q32,2q31.1,608058,"G6PC2, IGRP","Glucose-6-phosphatase, catalytic, 2",G6PC2,57818,ENSG00000152254,NA,NA,G6pc2 (MGI:1277193)
2,168915467,169031395,2q24,2q31.1,603201,"ABCB11, BSEP, SPGP, PFIC2, BRIC2","ATP-binding cassette, subfamily B, member 11 (bile salt export pump)",ABCB11,8647,ENSG00000073734,NA,"Cholestasis, benign recurrent intrahepatic, 2, 605479 (3), Autosomal recessive; Cholestasis, progressive familial intrahepatic 2, 601847 (3), Autosomal recessive",Abcb11 (MGI:1351619)
2,169067034,169096166,2q31.1,2q31.1,612131,"DHRS9, RDHTBE","Short-chain dehydrogenase/reductase family, member 9",DHRS9,10170,ENSG00000073737,NA,NA,Dhrs9 (MGI:2442798)
2,169127108,169362596,2q24-q31,2q31.1,600073,"LRP2, DBS",Low density lipoprotein-related protein 2,LRP2,4036,ENSG00000081479,NA,"Donnai-Barrow syndrome, 222448 (3), Autosomal recessive",Lrp2 (MGI:95794)
2,169479493,169506654,2q31,2q31.1,603650,BBS5,BBS gene 5,BBS5,129880,ENSG00000163093,NA,"Bardet-Biedl syndrome 5, 615983 (3), Autosomal recessive",Bbs5 (MGI:1919819)
2,169509701,169526257,2q31.1,2q31.1,607701,"KLHL41, KBTBD10, SARCOSIN, NEM9",Kelch-like family member 41,KLHL41,10324,ENSG00000239474,NA,"Nemaline myopathy 9, 615731 (3), Autosomal recessive",Klhl41 (MGI:2683854)
2,169527879,169573920,2q31.3,2q31.1,617529,"FASTKD1, KIAA1800",Fast kinase domains 1,FASTKD1,79675,ENSG00000138399,NA,NA,Fastkd1 (MGI:2444596)
2,169584342,169641405,2q31.1,2q31.1,606093,PPIG,Peptidyl-prolyl isomerase G (cyclophilin G),PPIG,9360,ENSG00000138398,NA,NA,Ppig (MGI:2445173)
2,169798870,169812063,2q31.1,2q31.1,109090,"SSB, LARP3",Sjogren syndrome antigen B,SSB,6741,ENSG00000138385,NA,NA,Ssb (MGI:98423)
2,169827461,170084130,2q31.1,2q31.1,613831,UBR3,Ubiquitin protein ligase E3 component N-recognin 3,UBR3,130507,ENSG00000144357,NA,NA,Ubr3 (MGI:1861100)
2,170178144,170655166,2q31.1-q31.2,2q31.1,610040,MYO3B,Myosin IIIB,MYO3B,140469,ENSG00000071909,NA,NA,Myo3b (MGI:2448580)
2,170714724,170718077,2q31.1,2q31.1,609391,SP5,Transcription factor Sp5,SP5,389058,ENSG00000204335,NA,NA,Sp5 (MGI:1927715)
2,170813209,170861150,2q31,2q31.1,605363,"GAD1, SCP, CPSQ1","Glutamate decarboxylase-1, brain, 67kD",GAD1,2571,ENSG00000128683,mutation identified in 1 CPSQ1 family,"?Cerebral palsy, spastic quadriplegic, 1, 603513 (3), Autosomal recessive",Gad1 (MGI:95632)
2,171434165,171491028,2q22.3-q35,2q31.1,612515,"DCAF17, C20orf37",DDB1- and CUL4-associated factor 17,DCAF17,80067,ENSG00000115827,NA,"Woodhouse-Sakati syndrome, 241080 (3), Autosomal recessive",Dcaf17 (MGI:1923013)
2,171687464,171750157,2q31.1,2q31.1,603331,"DYNC1I2, DNCI2, IC2, NEDMIBA","Dynein, cytoplasmic-1, intermediate chain-2",DYNC1I2,1781,ENSG00000077380,NA,"Neurodevelopmental disorder with microcephaly and structural brain anomalies, 618492 (3)",NA
2,171783404,171894305,2q24,2q31.1,603667,"SLC25A12, ARALAR, EIEE39","Solute carrier family 25 (mitochondrial carrier, Aralar), member 12",SLC25A12,8604,ENSG00000115840,NA,"Epileptic encephalopathy, early infantile, 39, 612949 (3), Autosomal recessive",Slc25a12 (MGI:1926080)
2,171922424,171983685,2q31.2-q33.1,2q31.1,603053,HAT1,Histone acetyltransferase-1,HAT1,8520,ENSG00000128708,NA,NA,Hat1 (MGI:96013)
2,171999952,172082429,2q31.1,2q31.1,610267,"METAP1D, MAP1D",Methionyl aminopeptidase type 1D (mitochondrial),METAP1D,254042,ENSG00000172878,NA,NA,Metap1d (MGI:1913809)
2,172085506,172089673,2q32,2q31.1,600029,DLX1,Distal-less homeo box-1,DLX1,1745,ENSG00000144355,NA,NA,Dlx1 (MGI:94901)
2,172099437,172102899,2q32,2q31.1,126255,"DLX2, TES1",Distal-less homeo box-2,DLX2,1746,ENSG00000115844,NA,NA,Dlx2 (MGI:94902)
2,172427335,172506458,2q31.1,2q31.1,147556,ITGA6,"Integrin, alpha-6",ITGA6,3655,ENSG00000091409,NA,"Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3), Autosomal recessive",Itga6 (MGI:96605)
2,172555372,172672697,2q31.1,2q31.1,602524,PDK1,"Pyruvate dehydrogenase kinase, isoenzyme 1",PDK1,5163,ENSG00000152256,NA,NA,Pdk1 (MGI:1926119)
2,173075434,173268014,2q31.1,2q31.1,609479,"ZAK, MLTK, MRK, SFMMP, CNM6",Leucine zipper- and sterile alpha motif-containing kinase,MAP3K20,51776,ENSG00000091436,NA,"Centronuclear myopathy 6 with fiber-type disproportion, 617760 (3), Autosomal recessive; Split-foot malformation with mesoaxial polydactyly, 616890 (3), Autosomal recessive",Map3k20 (MGI:2443258)
2,173354860,173368996,2q31,2q31.1,609937,"CDCA7, JPO1, ICF3",Cell division cycle-associated 7,CDCA7,83879,ENSG00000144354,NA,"Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3), Autosomal recessive",Cdca7 (MGI:1914203)
2,173900774,173965701,2q31,2q31.1,601804,SP3,Sp3 transcription factor,SP3,6670,ENSG00000172845,NA,NA,Sp3 (MGI:1277166)
2,174072446,174248531,2q31.1,2q31.1,611175,"OLA1, GTBP9",OBG-like ATPase 1,OLA1,29789,ENSG00000138430,NA,NA,Ola1 (MGI:1914309)
2,174348021,174395711,2q31.1,2q31.1,605228,CIR1,CBF1-interacting corepressor,CIR1,9541,ENSG00000138433,NA,NA,Cir1 (MGI:1914185)
2,174395728,174430073,2q31.1,2q31.1,614967,"SCRN3, SES3",Secernin 3,SCRN3,79634,ENSG00000144306,NA,NA,Scrn3 (MGI:1921866)
2,174559573,174682898,2q31.1,2q31.1,602357,"WIPF1, WASPIP, WIP, WAS2","WAS/WASL-interacting protein family, member 1",WIPF1,7456,ENSG00000115935,mutation identified in 1 WAS2 patient,"?Wiskott-Aldrich syndrome 2, 614493 (3)",Wipf1 (MGI:2178801)
2,174747591,174764471,2q24-q32,2q31.1,100690,"CHRNA1, ACHRD, CMS1B, CMS1A","Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle",CHRNA1,1134,ENSG00000138435,NA,"Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive; Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3), Autosomal dominant; Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3), Autosomal recessive, Autosomal dominant",Chrna1 (MGI:87885)
2,174799313,175005378,2q31-q32.1,2q31.1,118423,"CHN1, CHN, ARHGAP2, RHOGAP2, DURS2","Chimerin 1 (GTPase-activating protein, rho, 2)",CHN1,1123,ENSG00000128656,NA,"Duane retraction syndrome 2, 604356 (3)",Chn1 (MGI:1915674)
2,175072249,175168205,2q32,2q31.1,123811,"ATF2, CREB2",Activating transcription factor 2,ATF2,1386,ENSG00000115966,NA,NA,Atf2 (MGI:109349)
2,175176257,175181709,2q31.1,2q31.1,602736,ATP5G3,"ATP synthase, mitochondrial, C subunit-3",ATP5MC3,518,ENSG00000154518,NA,NA,Atp5g3 (MGI:2442035)
2,175923861,176002900,2q31,2q31.1,610236,"LNPK, KIAA1715, NEDEHCC",Lunapark,LNPK,80856,ENSG00000144320,NA,"Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3), Autosomal recessive",Lnpk (MGI:1918115)
2,176080106,176083961,2q31-q32,2q31.1,142991,EVX2,Even-skipped homeo box-2,EVX2,344191,ENSG00000174279,13kb 5' to HOX4I,NA,Evx2 (MGI:95462)
2,176087486,176095943,2q31-q32,2q31.1,142989,"HOXD13, HOX4I, SPD1, BDSD",Homeo box-D13,HOXD13,3239,ENSG00000128714,mutation identified in 1 BDSD family,"Brachydactyly, type D, 113200 (3), Autosomal dominant; Brachydactyly, type E, 113300 (3), Autosomal dominant; ?Brachydactyly-syndactyly syndrome, 610713 (3); Syndactyly, type V, 186300 (3), Autosomal dominant; Synpolydactyly 1, 186000 (3), Autosomal dominant",Hoxd13 (MGI:96205)
2,176099801,176100759,2q31-q32,2q31.1,142988,"HOXD12, HOX4H",Homeo box-D12,HOXD12,3238,ENSG00000170178,upstream from HOX4A-G,NA,Hoxd12 (MGI:96204)
2,176107279,176109753,2q31-q32,2q31.1,142986,"HOXD11, HOX4F",Homeo box-D11,HOXD11,3237,ENSG00000128713,NA,NA,Hoxd11 (MGI:96203)
2,176116763,176119941,2q31-q32,2q31.1,142984,"HOXD10, HOX4D",Homeo box-D10,HOXD10,3236,ENSG00000128710,NA,"Charcot-Marie-Tooth disease, foot deformity of, 192950 (3), Autosomal dominant; Vertical talus, congenital, 192950 (3), Autosomal dominant",Hoxd10 (MGI:96202)
2,176122718,176124936,2q31-q32,2q31.1,142982,"HOXD9, HOX4C",Homeo box-D9,HOXD9,3235,ENSG00000128709,NA,NA,Hoxd9 (MGI:96210)
2,176129704,176132694,2q31-q32,2q31.1,142985,"HOXD8, HOX4E",Homeo box-D8,HOXD8,3234,ENSG00000175879,NA,NA,Hoxd8 (MGI:96209)
2,176150302,176150411,2q31,2q31.1,611576,"MIR10B, MIRN10B",Micro RNA 10B,MIR10B,406903,ENSG00000207744,NA,NA,NA
2,176150393,176156077,2q31-q32,2q31.1,142981,"HOXD4, HOX4B",Homeo box-D4,HOXD4,3233,ENSG00000170166,NA,NA,Hoxd4 (MGI:96208)
2,176157162,176173101,2q31-q32,2q31.1,142980,"HOXD3, HOX4A",Homeo box-D3,HOXD3,3232,ENSG00000128652,NA,NA,Hoxd3 (MGI:96207)
2,176173188,176188957,2q31.1,2q31.1,618209,"HAGLR, MDGT",HOXD antisense growth-associated long noncoding RNA,HAGLR,401022,ENSG00000224189,NA,NA,NA
2,176188667,176190906,2q31-q32,2q31.1,142987,"HOXD1, HOX4G",Homeo box-D1,HOXD1,3231,ENSG00000128645,NA,NA,Hoxd1 (MGI:96201)
2,176269422,176338024,2q31.1,2q31.1,608555,MTX2,Metaxin 2,MTX2,10651,ENSG00000128654,NA,NA,Mtx2 (MGI:1859652)
2,177100000,179700000,2q31.2,NA,612345,DEL2q31,Chromosome 2q31.2 deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 2q31.2 deletion syndrome, 612345 (4)",NA
2,177212693,177223958,2q31.2,2q31.2,605372,"HNRPA3, D10S102, FBRNP",Heterogeneous nuclear ribonucleoprotein A3,HNRNPA3,220988,ENSG00000170144,NA,NA,NA
2,177230302,177265130,2q31,2q31.2,600492,"NFE2L2, NRF2, IMDDHH","Nuclear factor, erythroid-derived 2-like 2",NFE2L2,4780,ENSG00000116044,NA,"Immunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3), Autosomal dominant",Nfe2l2 (MGI:108420)
2,177392772,177543833,2q31,2q31.2,603051,"AGPS, ADHAPS, RCDP3",Alkylglycerone-phosphate synthase,AGPS,8540,ENSG00000018510,NA,"Rhizomelic chondrodysplasia punctata, type 3, 600121 (3), Autosomal recessive",Agps (MGI:2443065)
2,177623243,178108338,2q31.2,2q31.2,604961,"PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2",Phosphodiesterase 11A,PDE11A,50940,ENSG00000128655,NA,"Pigmented nodular adrenocortical disease, primary, 2, 610475 (3), Autosomal dominant",Pde11a (MGI:3036251)
2,178112408,178129655,2q31.2,2q31.2,608888,RBM45,RNA binding motif protein 45,RBM45,129831,ENSG00000155636,NA,NA,Rbm45 (MGI:2387367)
2,178194464,178402892,2q32.1,2q31.2,606734,"OSBPL6, ORP6",Oxysterol-binding protein-like protein 6,OSBPL6,114880,ENSG00000079156,NA,NA,Osbpl6 (MGI:2139014)
2,178431413,178451174,2q31.3,2q31.2,603424,"PRKRA, PACT, RAX, DYT16","Protein kinase, interferon-inducible double-stranded RNA-dependent activator",PRKRA,8575,ENSG00000180228,NA,"Dystonia 16, 612067 (3), Autosomal recessive",Prkra (MGI:1344375)
2,178450591,178467548,2q31.1-q31.3,2q31.2,610219,"PJVK, DFNB59",Pejvakin,PJVK,494513,ENSG00000204311,NA,"Deafness, autosomal recessive 59, 610220 (3), Autosomal recessive",Pjvk (MGI:2685847)
2,178463663,178480816,2q31.2,2q31.2,607062,"FKBP7, FKBP23",FK506-binding protein 7,FKBP7,51661,ENSG00000079150,NA,NA,Fkbp7 (MGI:1336879)
2,178480453,178516462,2q31.2,2q31.2,607774,"PLEKHA3, FAPP1","Pleckstrin homology domain-containing protein, family A, member 3",PLEKHA3,65977,ENSG00000116095,NA,NA,Plekha3 (MGI:1932515)
2,178525988,178807422,2q31,2q31.2,188840,"TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY",Titin,TTN,7273,ENSG00000155657,NA,"Cardiomyopathy, dilated, 1G, 604145 (3); Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant; Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive; Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant; Salih myopathy, 611705 (3), Autosomal recessive; Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant",Ttn (MGI:98864)
2,178825307,179050136,2q31,2q31.2,616031,"CCDC141, CAMDI",Coiled-coil domain-containing protein 141,CCDC141,285025,ENSG00000163492,NA,NA,Ccdc141 (MGI:1919735)
2,179441981,179864549,2q31.2-q31.3,2q31.2-q31.3,612344,"ZNF385B, ZFN533",Zinc finger protein 385B,ZNF385B,151126,ENSG00000144331,NA,NA,Zfp385b (MGI:2444734)
2,179700000,188500000,2q31.3-q32.1,NA,187370,DA10,"Arthrogryposis, distal, type 10",NA,NA,NA,max lod at D2S364,"Arthrogryposis, distal, type 10, 187370 (2), Autosomal dominant",NA
2,179860835,179860907,2q31.3,2q31.3,614488,MIR1258,Micro RNA 1258,MIR1258,100302172,ENSG00000221240,on opposite strand from ZNF385B,NA,NA
2,179944875,180007296,2q31.3,2q31.3,615186,"CWC2, KIAA1604, NCM","CWC22 spliceosome-associated protein, X. cerevisiae, homolog of",CWC22,57703,ENSG00000163510,NA,NA,Cwc22 (MGI:2136773)
2,180692103,180916938,2q31.3,2q31.3,615568,"SCHLAP1, PCAT114, LINC00913","SWI/SNF complex antagonist associated with prostate cancer 1, noncoding",SCHLAP1,101669767,ENSG00000281131,NA,NA,NA
2,180980384,181063426,2q32.1,2q31.3,604151,"UBE2E3, UBCH9",Ubiquitin-conjugating enzyme E2E 3,UBE2E3,10477,ENSG00000170035,NA,NA,Ube2e3 (MGI:107412)
2,181456891,181538939,2q31-q32,2q31.3,192975,"ITGA4, CD49D","Integrin, alpha-4 (antigen CD49D, alpha-4 subunit of VLA-4 receptor)",ITGA4,3676,ENSG00000115232,NA,NA,Itga4 (MGI:96603)
2,181536671,181657106,2q31.3,2q31.3,608381,"CERKL, RP26",Ceramide kinase-like,CERKL,375298,ENSG00000188452,NA,"Retinitis pigmentosa 26, 608380 (3)",Cerkl (MGI:3037816)
2,181668294,181680664,2q32,2q31.3,601724,"NEUROD1, NIDDM",Neurogenic differentiation 1,NEUROD1,4760,ENSG00000162992,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant; Maturity-onset diabetes of the young 6, 606394 (3)",Neurod1 (MGI:1339708)
2,181891715,181930737,2q31.3,2q31.3,118990,"SSFA2, CS1",Sperm-specific antigen 2,ITPRID2,6744,ENSG00000138434,NA,NA,Itprid2 (MGI:1917849)
2,181954240,182131384,2q32.1,2q31.3-q32.1,613240,"PPP1R1C, IPP5","Protein phosphatase 1, regulatory subunit 1C",PPP1R1C,151242,ENSG00000150722,NA,NA,Ppp1r1c (MGI:1923185)
2,182100000,196600000,2q32.1-q32.3,NA,602087,ARVD4,Arrhythmogenic right ventricular dysplasia 4,ARVD4,425,NA,NA,"Arrhythmogenic right ventricular dysplasia 4, 602087 (2), Autosomal dominant",NA
2,182100000,188500000,2q32.1,NA,612361,SCZD14,Schizophrenia 14,NA,100196913,NA,associated with rs1344706,"{Schizophrenia, susceptibility to, 14}, 612361 (2)",NA
2,182140034,182523374,2q32.1,2q32.1,171890,PDE1A,Phosphodiesterase-1A,PDE1A,5136,ENSG00000115252,NA,NA,Pde1a (MGI:1201792)
2,182716256,182794463,2p23.1-p22.1,2q32.1,607987,"DNAJC10, ERDJ5, JPDI","DNAJ/HSP40 homolog, subfamily C, member 10",DNAJC10,54431,ENSG00000077232,NA,NA,Dnajc10 (MGI:1914111)
2,182833274,182866636,2q31-q33,2q32.1,605083,"FRZB, FRZB1, SRFP3, OS1",Frizzled-related protein,FRZB,2487,ENSG00000162998,NA,"{Osteoarthritis susceptibility 1}, 165720 (3), Multifactorial",Frzb (MGI:892032)
2,182909114,183038456,2q32.1-q32.2,2q32.1,604891,"NCKAP1, NAP1",NCK-associated protein 1,NCKAP1,10787,ENSG00000061676,NA,NA,Nckap1 (MGI:1355333)
2,183117479,183161683,2q32.1,2q32.1,608140,"NUP35, NP44","Nucleoporin, 35kD",NUP35,129401,ENSG00000163002,NA,NA,Nup35 (MGI:1916732)
2,184598528,184939491,2q32.1,2q32.1,612282,"ZNF804A, C2orf10",Zinc finger protein 804A,ZNF804A,91752,ENSG00000170396,NA,NA,Zfp804a (MGI:2442949)
2,185738803,185833289,2q32.1,2q32.1,615796,"FSIP2, SPGF34",Fibrous sheath-interacting protein 2,FSIP2,401024,ENSG00000188738,NA,"Spermatogenic failure 34, 618153 (3), Autosomal recessive",Fsip2 (MGI:2664111)
2,186590055,186680901,2q31,2q32.1,193210,"ITGAV, VNRA","Integrin, alpha-V (vitronectin receptor, alpha polypeptide)",ITGAV,3685,ENSG00000138448,NA,NA,Itgav (MGI:96608)
2,187341963,187448303,2q31-q32,2q32.1,114190,"CALCRL, CGRPR, CRLR",Calcitonin receptor-like,CALCRL,10203,ENSG00000064989,NA,NA,Calcrl (MGI:1926944)
2,187464229,187554504,2q31-q32.1,2q32.1,152310,"TFPI, LACI",Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor),TFPI,7035,ENSG00000003436,NA,NA,Tfpi (MGI:1095418)
2,188291668,188595925,2q32.2-q33,2q32.1-q32.2,608165,"GULP1, CED6",PTB domain-containing engulfment adaptor protein 1,GULP1,51454,ENSG00000144366,NA,NA,Gulp1 (MGI:1920407)
2,188733737,188790122,2q33,2q32.2,606423,DIRC1,Disrupted in renal cancer 1,DIRC1,116093,ENSG00000174325,NA,NA,NA
2,188974372,189012745,2q32.2,2q32.2,120180,"COL3A1, EDSVASC, PMGEDSV","Collagen III, alpha-1 polypeptide",COL3A1,1281,ENSG00000168542,in same 35kb segment as COL5A2,"Ehlers-Danlos syndrome, vascular type, 130050 (3), Autosomal dominant; Polymicrogyria with or without vascular-type EDS, 618343 (3), Autosomal recessive",Col3a1 (MGI:88453)
2,189031897,189225300,2q32.2,2q32.2,120190,"COL5A2, EDSCL2","Collagen V, alpha-2 polypeptide",COL5A2,1290,ENSG00000204262,very close to COL3A1,"Ehlers-Danlos syndrome, classic type, 2, 130010 (3), Autosomal dominant",Col5a2 (MGI:88458)
2,189560589,189580810,2q32,2q32.2,604653,"SLC40A1, SLC11A3, FPN1, IREG1, HFE4","Solute carrier family 40 (iron-regulated transporter), member 1",SLC40A1,30061,ENSG00000138449,NA,"Hemochromatosis, type 4, 606069 (3), Autosomal dominant",Slc40a1 (MGI:1315204)
2,189674291,189763058,2q32.2,2q32.2,609803,FLJ25415,FLJ25415 gene,ANKAR,150709,ENSG00000151687,NA,NA,Ankar (MGI:2442559)
2,189766266,189784370,2q32.2,2q32.2,610073,ORMDL1,ORM1-like protein 1,ORMDL1,94101,ENSG00000128699,pseudogene on 10p14,NA,Ormdl1 (MGI:2181669)
2,189784084,189877628,2q31-q33,2q32.2,600258,"PMS1, PMSL1, HNPCC3","Postmeiotic segregation increased, S. cerevisiae, like 1",PMS1,5378,ENSG00000064933,NA,NA,Pms1 (MGI:1202302)
2,189879478,190203483,2q32.2,2q32.2,615117,"C2orf88, SMAKAP",Small membrane protein kinase A-anchoring protein,C2orf88,84281,ENSG00000187699,NA,NA,1700019D03Rik (MGI:1914330)
2,190055699,190062728,2q32.2,2q32.2,601788,"GDF8, MSTN, MSLHP",Growth differentiation factor-8 (myostatin),MSTN,2660,ENSG00000138379,NA,"Muscle hypertrophy, 614160 (3)",Mstn (MGI:95691)
2,190203919,190319825,2q32.2,2q32.2,610690,HIBCH,3-hydroxyisobutyryl-CoA hydrolase,HIBCH,26275,ENSG00000198130,NA,"3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3), Autosomal recessive",Hibch (MGI:1923792)
2,190343588,190371664,2q32,2q32.2,147263,INPP1,Inositol polyphosphate-1-phosphatase,INPP1,3628,ENSG00000151689,NA,NA,Inpp1 (MGI:104848)
2,190408354,190502313,2q32.2,2q32.2,613476,"MFSD6, MMR2",Major facilitator superfamily domain-containing protein 6,MFSD6,54842,ENSG00000151690,NA,NA,Mfsd6 (MGI:1922925)
2,190454087,190607125,2q32.2,2q32.2,616497,"NEMP2, TMEM194B",Nuclear envelope integral membrane protein 2,NEMP2,100131211,ENSG00000189362,NA,NA,Nemp2 (MGI:2444113)
2,190648859,190692765,2q32.3-q33,2q32.2,600800,NAB1,"NGFI-A-binding protein, ERG1-binding protein",NAB1,4664,ENSG00000138386,NA,NA,Nab1 (MGI:107564)
2,190880820,190965551,2q32-q34,2q32.2,138280,"GLS, GLS1, EIEE71, CASGID, GDPAG",Glutaminase,GLS,2744,ENSG00000115419,mutation identified in 1 CASGID patient,"Epileptic encephalopathy, early infantile, 71, 618328 (3), Autosomal recessive; Global developmental delay, progressive ataxia, and elevated glutamine, 618312 (3); ?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development, 618339 (3), Autosomal dominant",Gls (MGI:95752)
2,190968988,191014249,2q32.2-q32.3,2q32.2,600555,"STAT1, CANDF7, IMD31A, IMD31B, IMD31C",Signal transducer and activator of transcription-1,STAT1,6772,ENSG00000115415,NA,"Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3), Autosomal dominant; Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3), Autosomal recessive; Immunodeficiency 31C, autosomal dominant, 614162 (3), Autosomal dominant",Stat1 (MGI:103063)
2,191029575,191172683,2q32.2-q32.3,2q32.2-q32.3,600558,"STAT4, SLEB11",Signal transducer and activator of transcription-4,STAT4,6775,ENSG00000138378,NA,"{Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3)",Stat4 (MGI:103062)
2,191245399,191425385,2q32,2q32.3,606537,MYO1B,Myosin IB,MYO1B,4430,ENSG00000128641,NA,NA,Myo1b (MGI:107752)
2,191678071,191690151,2q32.3,2q32.3,612103,"OBFC2A, SSB2",Oligonucleotide/oligosaccharide-binding fold-containing protein 2A,NABP1,64859,ENSG00000173559,NA,NA,Nabp1 (MGI:1923258)
2,191834309,191847087,2q32-q33,2q32.3,606728,"CAVIN2, SDPR, SDR",Caveolae-associated protein 2,CAVIN2,8436,ENSG00000168497,NA,NA,Cavin2 (MGI:99513)
2,191948299,192194932,2q32-q33,2q32.3,605734,"TMEFF2, HPP1, TR",Transmembrane protein with EGF-like and 2 follistatin-like domains 2,TMEFF2,23671,ENSG00000144339,NA,NA,Tmeff2 (MGI:1861735)
2,192749844,192776898,2q32,2q32.3,605443,PCGEM1,Prostate-specific gene PCGEM1,PCGEM1,64002,ENSG00000227418,NA,NA,NA
2,195737603,196068836,2q33.1,2q32.3,610061,"DNAH7, KIAA0944","Dynein, axonemal, heavy chain 7",DNAH7,56171,ENSG00000118997,NA,NA,"Dnah7c,Dnah7b,Dnah7a (MGI:3639762,MGI:2684953,MGI:2685838)"
2,196133582,196176502,2q32.3,2q32.3,604727,"STK17B, DRAK2",Serine/threonine protein kinase 17b,STK17B,9262,ENSG00000081320,NA,NA,Stk17b (MGI:2138162)
2,196194071,196593691,2q32.3,2q32.3,617245,"HECW2, NEDL2, KIAA1301, NDHSAL","HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 2",HECW2,57520,ENSG00000138411,NA,"Neurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3), Autosomal dominant",Hecw2 (MGI:2685817)
2,196600000,202500000,2q33.1,NA,612586,ANIB9,"Aneurysm, intracranial berry, 9",NA,100271688,NA,associated with rs700651,"{Aneurysm, intracranial berry, 9}, 612586 (2)",NA
2,196600000,230100000,2q33-q36,NA,614280,EJM9,"Epilepsy, juvenile myoclonic, susceptibility to, 9",NA,100750238,NA,max lod at D2S2248,"{Epilepsy, juvenile myoclonic, susceptibility to, 9}, 614280 (2), Autosomal dominant",NA
2,196600000,208200000,2q33,NA,610439,RLS4,"Restless legs syndrome, susceptibility to, 4",NA,100188813,NA,between D2S311 and D2S317,"{Restless legs syndrome 4}, 610439 (2)",NA
2,196763034,196799682,2q33.1,2q33.1,604888,"GTF3C3, TFIIIC102","General transcription factor 3C, polypeptide 3",GTF3C3,9330,ENSG00000119041,NA,NA,Gtf3c3 (MGI:2138383)
2,196833003,196926994,2q33.1,2q33.1,611655,"PGAP1, MRT42",Post-GPI attachment to proteins 1,PGAP1,80055,ENSG00000197121,NA,"Mental retardation, autosomal recessive 42, 615802 (3), Autosomal recessive",Pgap1 (MGI:2443342)
2,197391973,197435092,2q33.1,2q33.1,605590,"SF3B1, SF3B155, SAP155, MDS","Splicing factor 3B, subunit 1",SF3B1,23451,ENSG00000115524,NA,"Myelodysplastic syndrome, somatic, 614286 (3)",Sf3b1 (MGI:1932339)
2,197486583,197500273,2q33.1,2q33.1,118190,"HSPD1, SPG13, HSP60, HLD4",Heat-shock 60kD protein 1,HSPD1,3329,ENSG00000144381,NA,"Leukodystrophy, hypomyelinating, 4, 612233 (3), Autosomal recessive; Spastic paraplegia 13, autosomal dominant, 605280 (3), Autosomal dominant",Hspd1 (MGI:96242)
2,197500378,197503448,2q33.1,2q33.1,600141,"HSPE1, HSP10",Heat-shock 10kD protein,HSPE1,3336,ENSG00000115541,NA,NA,Hspe1 (MGI:104680)
2,197515553,197553698,2q33.1,2q33.1,609361,"MOB4, MOBKL3, PREI3, MOB1, MOB3","MOB family, member 4",MOB4,25843,ENSG00000115540,NA,NA,Mob4 (MGI:104899)
2,197568223,197675793,2q34,2q33.1,618215,RFTN2,Lipid raft linking protein 2,RFTN2,130132,ENSG00000162944,NA,NA,Rftn2 (MGI:1921263)
2,197705368,197708394,2q33.1,2q33.1,609728,"MARS2, SPAX3, COXPD25",Methionyl-tRNA synthetase 2,MARS2,92935,ENSG00000247626,mutation identified in 1 COXPD25 family,"?Combined oxidative phosphorylation deficiency 25, 616430 (3), Autosomal recessive; Spastic ataxia 3, autosomal recessive, 611390 (3), Autosomal recessive",Mars2 (MGI:2444136)
2,197726878,197786311,2q33,2q33.1,606165,"BOLL, BOULE","BOL-like (Boule, Drosophila, homolog of)",BOLL,66037,ENSG00000152430,NA,NA,Boll (MGI:1922638)
2,197804592,198149872,2q33,2q33.1,600597,"PLDL1, PLCE, PLCL",Phospholipase C-like 1,PLCL1,5334,ENSG00000115896,NA,NA,Plcl1 (MGI:3036262)
2,199269499,199471265,2q33,2q33.1,608148,"SATB2, KIAA1034, GLSS",Special AT-rich sequence-binding protein 2,SATB2,23314,ENSG00000119042,NA,"Glass syndrome, 612313 (3), Autosomal dominant",Satb2 (MGI:2679336)
2,199663331,199851179,2q33.1,2q33.1,614308,"FTCDNL1, FONG",Formiminotransferase cyclodeaminase N-terminal like,FTCDNL1,348751,ENSG00000226124,NA,NA,NA
2,199955316,199964116,2q33.1,2q33.1,617267,"MAIP1, C2orf47",Matrix AAA peptidase-interacting protein 1,MAIP1,79568,ENSG00000162972,NA,NA,Maip1 (MGI:1915365)
2,200305878,200482263,2q33.1,2q33.1,613817,"SPATS2L, SGNP",Spermatogenesis-associated serine-rich protein 2-like,SPATS2L,26010,ENSG00000196141,NA,NA,Spats2l (MGI:1914448)
2,200510197,200584095,2q33.1,2q33.1,612425,"SGOL2, SGO2, TRIPIN",Shugoshin-like 2,SGO2,151246,ENSG00000163535,NA,NA,"Sgo2a,Sgo2b (MGI:1098767,MGI:3644562)"
2,200585951,200677063,2q33,2q33.1,602841,AOX1,Aldehyde oxidase-1,AOX1,316,ENSG00000138356,NA,NA,Aox1 (MGI:88035)
2,200853008,200864743,2q33,2q33.1,601951,"CLK1, CLK, STY",CDC-like kinase 1,CLK1,1195,ENSG00000013441,NA,NA,Clk1 (MGI:107403)
2,200870906,200889332,2q33,2q33.1,615811,PPIL3,Peptidyl-prolyl isomerase-like 3,PPIL3,53938,ENSG00000240344,NA,NA,Ppil3 (MGI:1917475)
2,200889326,200903931,2q33,2q33.1,605778,NIF3L1,"Ngg1 interacting factor 3, S. pombe, homolog of, like 1",NIF3L1,60491,ENSG00000196290,NA,NA,Nif3l1 (MGI:1929485)
2,200908976,200963700,2q33,2q33.1,601182,"ORC2, ORC2L","Origin recognition complex, subunit 2, S. cerevisiae, homolog of",ORC2,4999,ENSG00000115942,NA,NA,Orc2 (MGI:1328306)
2,201071783,201085749,2q31.3,2q33.1,603839,"NDUFB3, MC1DN25",NADH-ubiquinone oxidoreductase subunit B3,NDUFB3,4709,ENSG00000119013,"pseudogenes on chr. 1, 9, and 14","Mitochondrial complex I deficiency, nuclear type 25, 618246 (3), Autosomal recessive",Ndufb3 (MGI:1913745)
2,201116103,201176686,2q33,2q33.1,603599,"CFLAR, FLIP, CASPER, FLAME1, CASH",CASP8- and FADD-like apoptosis regulator,CFLAR,8837,ENSG00000003402,NA,NA,Cflar (MGI:1336166)
2,201182884,201229405,2q33-q34,2q33.1,601762,"CASP10, MCH4, ALPS2","Caspase 10, apoptosis-related cysteine protease",CASP10,843,ENSG00000003400,NA,"Autoimmune lymphoproliferative syndrome, type II, 603909 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3)",NA
2,201233442,201287710,2q33,2q33.1,601763,"CASP8, MCH5, ALPS2B","Caspase 8, apoptosis-related cysteine protease",CASP8,841,ENSG00000064012,mutation identified in 1 ALPS2B family,"?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3), Autosomal recessive; {Breast cancer, protection against}, 114480 (3), Autosomal dominant, Somatic mutation; Hepatocellular carcinoma, somatic, 114550 (3); {Lung cancer, protection against}, 211980 (3), Autosomal dominant, Somatic mutation",Casp8 (MGI:1261423)
2,201377206,201451576,2q33-q34,2q33.1,607334,"TRAK2, GRIF1, ALS2CR3, KIAA0549, OIP98",Gamma-aminobutyric acid receptor-interacting factor 1,TRAK2,66008,ENSG00000115993,NA,NA,Trak2 (MGI:1918077)
2,201451733,201480845,2q33-q34,2q33.1,607333,"STRADB, ILPIP, ALS2CR2",STE20-related kinase adaptor beta,STRADB,55437,ENSG00000082146,pseudogenes on chromosomes 1 and 9,NA,Stradb (MGI:2144047)
2,201620185,201643502,2q33.2,2q33.1,614423,"TMEM237, ALS2CR4, JBTS14",Transmembrane protein 237,TMEM237,65062,ENSG00000155755,NA,"Joubert syndrome 14, 614424 (3), Autosomal recessive",Tmem237 (MGI:2138365)
2,201644873,201700262,2q31,2q33.1,606575,"MPP4, DLG6","Membrane protein, palmitoylated 4",MPP4,58538,ENSG00000082126,NA,NA,Mpp4 (MGI:2386681)
2,201700266,201781152,2q33,2q33.1,606352,"ALS2, ALSJ, PLSJ, IAHSP",Alsin,ALS2,57679,ENSG00000003393,NA,"Amyotrophic lateral sclerosis 2, juvenile, 205100 (3), Autosomal recessive; Primary lateral sclerosis, juvenile, 606353 (3), Autosomal recessive; Spastic paralysis, infantile onset ascending, 607225 (3), Autosomal recessive",Als2 (MGI:1921268)
2,201790323,201895549,2q33.1,2q33.1,616147,"CDK15, PFTAIRE2, ALS2CR7",Cyclin-dependent kinase 15,CDK15,65061,ENSG00000138395,NA,NA,Cdk15 (MGI:3583944)
2,202034586,202038436,2q33,2q33.1,603410,FZD7,"Frizzled, Drosophila, homolog of, 7",FZD7,8324,ENSG00000155760,NA,NA,Fzd7 (MGI:108570)
2,202206179,202238598,2q32.2-q33,2q33.1,601912,"SUMO1, UBL1, SMT3, OFC10",Small ubiquitin-like modifier 1,SUMO1,7341,ENSG00000116030,mutation identified in 1 OFC10 patient,"?Orofacial cleft 10, 613705 (3), Isolated cases",Sumo1 (MGI:1197010)
2,202265762,202303660,2p33.1,2q33.1,616742,"NOP58, NOP5","Nop58, S. cerevisiae, homolog of",NOP58,51602,ENSG00000055044,NA,NA,Nop58 (MGI:1933184)
2,202376309,202567750,2q33,2q33.1-q33.2,600799,"BMPR2, PPH1, POVD1","Bone morphogenetic receptor, type II",BMPR2,659,ENSG00000204217,NA,"Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3), Autosomal dominant; Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3), Autosomal dominant; Pulmonary venoocclusive disease 1, 265450 (3), Autosomal dominant",Bmpr2 (MGI:1095407)
2,202878918,202912225,2q33.2,2q33.2,616620,WDR12,WD repeat-containing protein 12,WDR12,55759,ENSG00000138442,NA,NA,Wdr12 (MGI:1927241)
2,202912217,202988262,2q33,2q33.2,607586,"ALS2CR8, CARF","Amyotrophic lateral sclerosis 2 chromosome region, candidate 8 (calcium response factor)",CARF,79800,ENSG00000138380,NA,NA,Carf (MGI:2182269)
2,203013783,203225193,2q33-q34,2q33.2,609816,"NBEAL1, ALS2CR17",Neurobeachin-like 1,NBEAL1,65065,ENSG00000144426,NA,NA,Nbeal1 (MGI:2444343)
2,203325012,203447727,2q33.2,2q33.2,606442,"ABI2, AIP1",ABL interactor 2,ABI2,10152,ENSG00000138443,NA,NA,Abi2 (MGI:106913)
2,203706474,203739755,2q33-q34,2q33.2,186760,CD28,CD28 antigen (Tp44),CD28,940,ENSG00000178562,NA,NA,Cd28 (MGI:88327)
2,203867770,203873964,2q33,2q33.2,123890,"CTLA4, IDDM12, CELIAC3, ALPS5",Cytotoxic T-lymphocyte-associated serine esterase-4,CTLA4,1493,ENSG00000163599,NA,"Autoimmune lymphoproliferative syndrome, type V, 616100 (3), Autosomal dominant; {Celiac disease, susceptibility to, 3}, 609755 (3); {Diabetes mellitus, insulin-dependent, 12}, 601388 (3); {Hashimoto thyroiditis}, 140300 (3), Autosomal dominant; {Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant",Ctla4 (MGI:88556)
2,203936747,203961576,2q33,2q33.2,604558,"ICOS, AILIM, CVID1",Inducible costimulator,ICOS,29851,ENSG00000163600,NA,"Immunodeficiency, common variable, 1, 607594 (3), Autosomal recessive",Icos (MGI:1858745)
2,204100000,208200000,2q33.3,NA,610839,"OS4, GOA1",Osteoarthritis susceptibility 4,NA,100188821,NA,max lod at D2S2358,"{Osteoarthritis susceptibility 4}, 610839 (2)",NA
2,205682499,205798130,2q34,2q33.3,602070,"NRP2, VEGF1265R2, NPN2",Neuropilin 2,NRP2,8828,ENSG00000118257,NA,NA,Nrp2 (MGI:1100492)
2,206114816,206159443,2q33-q34,2q33.3,157655,"NDUFS1, MC1DN5",NADH-ubiquinone oxidoreductase core subunit S1,NDUFS1,4719,ENSG00000023228,NA,"Mitochondrial complex I deficiency, nuclear type 5, 618226 (3), Autosomal recessive",Ndufs1 (MGI:2443241)
2,206159593,206162928,2q33-q34,2q33.3,600655,"EEF1B2, EEF1B1","Eukaryotic translation elongation factor-1, beta-2",EEF1B2,1933,ENSG00000114942,pseudogene on chr.15,NA,Eef1b2 (MGI:1929520)
2,206175315,206218046,2q33.3,2q33.3,600239,GPR1,G protein-coupled receptor-1,GPR1,2825,ENSG00000183671,conflicting assignment to 15q21.6,NA,Gpr1 (MGI:2385324)
2,206203375,206266242,2q33.3,2q33.3,617636,GPR1AS,GPR1 antisense RNA,GPR1-AS,101669764,NA,NA,NA,NA
2,206273571,206314426,2q33.3,2q33.3,617059,"ZDBF2, KIAA1571",Zinc finger DBF domain-containing protein 2,ZDBF2,57683,ENSG00000204186,NA,NA,Zdbf2 (MGI:1921134)
2,206443531,206621126,2q33,2q33.3,603710,"ADAM23, MDC3",A disintegrin and metalloproteinase domain 23,ADAM23,8745,ENSG00000114948,NA,NA,Adam23 (MGI:1345162)
2,206651620,206718395,2q33.3,2q33.3,618510,DYTN,Dystrotelin,DYTN,391475,ENSG00000232125,NA,NA,NA
2,206765387,206796188,2q33.3,2q33.3,612322,"FASTKD2, KIAA0971",FAST kinase domains 2,FASTKD2,22868,ENSG00000118246,mutation identified in 1 family,"?Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Fastkd2 (MGI:1922869)
2,207074136,207173850,2q32,2q33.3,604865,"KLF7, UKLF",Kruppel-like factor 7,KLF7,8609,ENSG00000118263,NA,NA,Klf7 (MGI:1935151)
2,207529891,207605988,2q32.3-q34,2q33.3,123810,CREB1,cAMP-response element-binding protein-1,CREB1,1385,ENSG00000118260,fusion gene with EWSR1,"Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)",Creb1 (MGI:88494)
2,207580630,207626052,2q33.3,2q33.3,615257,"METTL21A, FAM119A",Methyltransferase-like 21A,METTL21A,151194,ENSG00000144401,NA,NA,Mettl21a (MGI:1914349)
2,207753888,207769905,2q33-q34,2q33.3,601723,FZD5,"Polarity gene 'frizzled,' Drosophila, homolog of",FZD5,7855,ENSG00000163251,NA,NA,Fzd5 (MGI:108571)
2,208121606,208124523,2q33-q35,2q33.3,123690,"CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC","Crystallin, gamma D",CRYGD,1421,ENSG00000118231,NA,"Cataract 4, multiple types, 115700 (3), Autosomal dominant",Crygd (MGI:88524)
2,208128136,208139099,2q33-q35,2q33.3,123680,"CRYGC, CRYG3, CTRCT2, CCL","Crystallin, gamma C",CRYGC,1420,ENSG00000163254,NA,"Cataract 2, multiple types, 604307 (3), Autosomal dominant",Crygc (MGI:88523)
2,208142572,208146326,2q33-q35,2q33.3,123670,"CRYGB, CRYG2, CTRCT39","Crystallin, gamma B",CRYGB,1419,ENSG00000182187,NA,"Cataract 39, multiple types, autosomal dominant, 615188 (3), Autosomal dominant",Crygb (MGI:88522)
2,208160739,208163588,2q33-q35,2q33.3,123660,"CRYGA, CRYG1","Crystallin, gamma A",CRYGA,1418,ENSG00000168582,NA,NA,Cryga (MGI:88521)
2,208165346,208190257,2q34,2q33.3,615536,"C2orf80, GONDA1",Chromosome 2 open reading frame 80,C2orf80,389073,ENSG00000188674,NA,NA,D630023F18Rik (MGI:2138198)
2,208200000,230100000,2q34-q36,NA,185900,"DUP2q35, C2DUPq35, SDTY1, SD1","Chromosome 2q35 duplication syndrome (syndactyly, type I)",NA,NA,NA,NA,"Syndactyly, type 1, with or without craniosynostosis, 185900 (4), Autosomal dominant",NA
2,208200000,214500000,2q34,NA,601318,IDDM13,Insulin-dependent diabetes mellitus-13,IDDM13,3412,NA,NA,"{Diabetes mellitus, insulin-dependent, 13}, 601318 (2)",NA
2,208200000,220700000,2q34-q35,NA,607966,SLEN2,"Systemic lupus erythematosus with nephritis, susceptibility to, 2",SLEN2,192679,NA,NA,"{Systemic lupus erythematosus with nephritis, susceptibility to, 2}, 607966 (2)",NA
2,208200000,214500000,2q34,NA,186860,TCL4,T-cell leukemia/lymphoma-4,TCL4,6946,NA,NA,"Leukemia/lymphoma, T-cell, 186860 (2)",NA
2,208236226,208255142,2q33.3,2q34,147700,IDH1,"Isocitrate dehydrogenase, soluble",IDH1,3417,ENSG00000138413,NA,"{Glioma, susceptibility to, somatic}, 137800 (3)",Idh1 (MGI:96413)
2,208266177,208358746,2q35,2q34,609414,"PIKFYVE, PIP5K3","Phosphatidylinositol kinase, FYVE-finger containing",PIKFYVE,200576,ENSG00000115020,NA,"Corneal fleck dystrophy, 121850 (3), Autosomal dominant",Pikfyve (MGI:1335106)
2,208359691,208494505,2q33,2q34,601469,PTHR2,Parathyroid hormone receptor 2,PTH2R,5746,ENSG00000144407,NA,NA,Pth2r (MGI:2180917)
2,209424046,209734117,2q34-q35,2q34,157130,MAP2,Microtubule-associated protein-2,MAP2,4133,ENSG00000078018,NA,NA,Map2 (MGI:97175)
2,209771831,209999299,2q35,2q34,612636,"UNC80, C2orf21, KIAA1843","Unc-80 homolog, NALCN activator",UNC80,285175,ENSG00000144406,NA,"Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3), Autosomal recessive",Unc80 (MGI:2652882)
2,210002564,210023362,2q32-q33.3,2q34,180480,RPE,Ribulose 5-phosphate 3-epimerase,RPE,6120,ENSG00000197713,NA,NA,Rpe (MGI:1913896)
2,210021420,210171408,2q34,2q34,613833,"KANSL1L, C2orf67, MSL1V2",KAT8 regulatory NSL complex subunit 1-like,KANSL1L,151050,ENSG00000144445,NA,NA,Kansl1l (MGI:1915941)
2,210187922,210225446,2q34-q35,2q34,609576,"ACADL, LCAD","Acyl-Coenzyme A dehydrogenase, long chain",ACADL,33,ENSG00000115361,NA,NA,Acadl (MGI:87866)
2,210290149,210315173,2q32.1-qter,2q34,160780,"MYL1, MYOFTA","Myosin, light polypeptide-1, alkali, skeletal, fast",MYL1,4632,ENSG00000168530,NA,"Myopathy, congenital, with fast-twitch (type II) fiber atrophy, 618414 (3), Autosomal recessive",Myl1 (MGI:97269)
2,210431248,210477617,2q34,2q34,604155,"LANCL1, GPR69A",LanC-like 1 (G protein-coupled receptor 69A),LANCL1,10314,ENSG00000115365,NA,NA,Lancl1 (MGI:1336997)
2,210477684,210679106,2q35,2q34,608307,"CPS1, PHN","Carbamoyl-phosphate synthetase 1, mitochondrial",CPS1,1373,ENSG00000021826,urea cycle enzyme,"Carbamoylphosphate synthetase I deficiency, 237300 (3), Autosomal recessive; {Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3)",Cps1 (MGI:891996)
2,211375716,212538801,2q34,2q34,600543,"ERBB4, HER4, ALS19",Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4,ERBB4,2066,ENSG00000178568,NA,"Amyotrophic lateral sclerosis 19, 615515 (3), Autosomal dominant",Erbb4 (MGI:104771)
2,212999691,213155296,2q34,2q34,606234,"IKZF2, ANF1A2, HELIOS",Ikaros family zinc finger 2,IKZF2,22807,ENSG00000030419,NA,NA,Ikzf2 (MGI:1342541)
2,213284368,214410500,2q34,2q34,612173,"SPAG16, PF20",Sperm-associated antigen 16,SPAG16,79582,ENSG00000144451,NA,NA,Spag16 (MGI:1913972)
2,214500000,220700000,2q35,NA,607949,MTBS1,"Mycobacterium tuberculosis, susceptibility to infection by",NA,404716,NA,NA,"{Tuberculosis, susceptibility to}, 607949 (2)",NA
2,214500000,220700000,2q35,NA,613016,NBLST5,"Neuroblastoma, susceptibility to, 5",NA,100306938,NA,"associated with rs6435862, rs3768716","{Neuroblastoma, susceptibility to, 5}, 613016 (2)",NA
2,214500000,230100000,2q35-q36,NA,609153,PSHK2,"Pseudohyperkalemia, familial, 2, due to red cell leak",NA,NA,NA,max lod at D2S1338,"Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (2), Autosomal dominant",NA
2,214725644,214809710,2q34-q35,2q35,601593,BARD1,BRCA1-associated RING domain 1,BARD1,580,ENSG00000138376,NA,"{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation",Bard1 (MGI:1328361)
2,214931541,215138625,2q34,2q35,607800,"ABCA12, ARCI4A, ARCI4B, ICR2B, LI2","ATP-binding cassette, subfamily A, member 12",ABCA12,26154,ENSG00000144452,NA,"Ichthyosis, congenital, autosomal recessive 4A, 601277 (3), Autosomal recessive; Ichthyosis, congenital, autosomal recessive 4B (harlequin), 242500 (3), Autosomal recessive",Abca12 (MGI:2676312)
2,215311973,215359744,2q35,2q35,601731,"ATIC, PURH, AICAR",5-aminoimidazole-4-carboxyamide ribonucleotide formyltransferase/IMP cyclohydrolase,ATIC,471,ENSG00000138363,NA,"AICA-ribosiduria due to ATIC deficiency, 608688 (3), Autosomal recessive",Atic (MGI:1351352)
2,215360439,215436166,2q34,2q35,135600,"FN1, FN, LETS, FNZ, GFND2, SMDCF",Fibronectin-1,FN1,2335,ENSG00000115414,NA,"Glomerulopathy with fibronectin deposits 2, 601894 (3), Autosomal dominant; Plasma fibronectin deficiency, 614101 (1), Autosomal dominant; Spondylometaphyseal dysplasia, corner fracture type, 184255 (3), Autosomal dominant",Fn1 (MGI:95566)
2,215939096,216013550,2q35,2q35,609207,"MREG, DSU",Melanoregulin,MREG,55686,ENSG00000118242,NA,NA,Mreg (MGI:2151839)
2,216031655,216081842,2q35,2q35,605843,"PECR, TERP",Peroxisomal trans-2-enoyl-CoA reductase,PECR,55825,ENSG00000115425,NA,NA,Pecr (MGI:2148199)
2,216109347,216206292,2q35,2q35,194364,XRCC5,"X-ray repair, complementing defective, repair in Chinese hamster cells-5",XRCC5,7520,ENSG00000079246,included in YAC contig spanning 2q33-q34,NA,Xrcc5 (MGI:104517)
2,216257864,216372482,2q35,2q35,608208,"MARCH4, RNF174, KIAA1399",Membrane-associated RING-CH finger protein 4,MARCHF4,57574,ENSG00000144583,NA,NA,March4 (MGI:2683550)
2,216412413,216483052,2q34-q36,2q35,606622,"SMARCAL1, HARP, SIOD","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A-like",SMARCAL1,50485,ENSG00000138375,NA,"Schimke immunoosseous dysplasia, 242900 (3), Autosomal recessive",Smarcal1 (MGI:1859183)
2,216498843,216504085,2q35,2q35,613314,RPL37A,Ribosomal protein L37A,RPL37A,6168,ENSG00000197756,NA,NA,Rpl37a (MGI:98068)
2,216632827,216664435,2q33-q34,2q35,146731,IGFBP2,"Insulin-like growth factor-binding protein-2, 36kD",IGFBP2,3485,ENSG00000115457,NA,NA,Igfbp2 (MGI:96437)
2,216672104,216695548,2q33-q36,2q35,146734,"IGFBP5, IBP5",Insulin-like growth factor-binding protein 5,IGFBP5,3488,ENSG00000115461,NA,NA,Igfbp5 (MGI:96440)
2,216859457,216860063,2q35-q36,2q35,190231,TNP1,Transition protein-1,TNP1,7141,ENSG00000118245,NA,NA,NA
2,217799587,218002994,2q35-q36,2q35,600076,"TNS1, TNS",Tensin 1,TNS1,7145,ENSG00000079308,NA,NA,Tns1 (MGI:104552)
2,218125293,218137252,2q35,2q35,146928,"CXCR2, IL8RB, IL8R2","Chemokine, CXC motif, receptor 2",CXCR2,3579,ENSG00000180871,NA,NA,Cxcr2 (MGI:105303)
2,218162840,218166961,2q35,2q35,146929,"CXCR1, IL8RA","Chemokine, CXC motif, receptor 1",CXCR1,3577,ENSG00000163464,NA,"{AIDS, slow progression to}, 609423 (3)",Cxcr1 (MGI:2448715)
2,218217137,218254347,2q35,2q35,604224,"ARPC2, ARC34","Actin-related protein 2/3 complex, subunit 2",ARPC2,10109,ENSG00000163466,NA,NA,Arpc2 (MGI:1923959)
2,218259495,218263860,2q35,2q35,610147,"GPBAR1, BG37",G protein-coupled bile acid receptor 1,GPBAR1,151306,ENSG00000179921,NA,NA,Gpbar1 (MGI:2653863)
2,218264126,218270180,2q35,2q35,603488,AAMP,Angio-associated migratory cell protein,AAMP,14,ENSG00000127837,NA,NA,Aamp (MGI:107809)
2,218270484,218346792,2q35,2q35,609023,"MR1, TAHCCP2, KIPP1184, BRP17, PNKD1, FPD1, PDC, DYT8",Myofibrillogenesis regulator 1,PNKD,25953,ENSG00000127838,NA,"Paroxysmal nonkinesigenic dyskinesia 1, 118800 (3), Autosomal dominant",Pnkd (MGI:1930773)
2,218274191,218292576,2q35,2q35,610364,"TMBIM1, RECS1",Transmembrane BAX inhibitor motif-containing protein 1,TMBIM1,64114,ENSG00000135926,NA,NA,Tmbim1 (MGI:1916910)
2,218381765,218396893,2q35,2q35,600266,"NRAMP1, NRAMP, SLC11A1","Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",SLC11A1,6556,ENSG00000018280,within 220 kb of VIL1,"{Buruli ulcer, susceptibility to}, 610446 (3); {Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3)",Slc11a1 (MGI:1345275)
2,218398232,218405940,2q34,2q35,605323,"CTDSP1, NLIIF, SCP1","C-terminal domain of RNA polymerase II polypeptide A, small phosphatase of, 1",CTDSP1,58190,ENSG00000144579,NA,NA,Ctdsp1 (MGI:2654470)
2,218402645,218402721,2q35,2q35,612152,"MIR26B, MIRN26B",Micro RNA 26B,MIR26B,407017,ENSG00000199121,NA,NA,NA
2,218419122,218453294,2q35-q36,2q35,193040,VIL1,Villin-1,VIL1,7429,ENSG00000127831,NA,NA,Vil1 (MGI:98930)
2,218568577,218597079,2q35,2q35,612054,"RQCD1, RCD1, CNOT9","Required for cell differentiation 1, S. pombe, homolog of",CNOT9,9125,ENSG00000144580,NA,NA,Cnot9 (MGI:1928902)
2,218637915,218659622,2q35,2q35,604083,"ZNF142, NEDISHM",Zinc finger protein-142,ZNF142,7701,ENSG00000115568,NA,"Neurodevelopmental disorder with impaired speech and hyperkinetic movements, 618425 (3), Autosomal recessive",Zfp142 (MGI:1924514)
2,218659655,218663442,2q33,2q35,603647,"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1","bcs1, S. cerevisiae, homolog-like",BCS1L,617,ENSG00000074582,NA,"Bjornstad syndrome, 262000 (3), Autosomal recessive; GRACILE syndrome, 603358 (3); Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial; Mitochondrial complex III deficiency, nuclear type 1, 124000 (3), Autosomal recessive",Bcs1l (MGI:1914071)
2,218663873,218672001,2q35,2q35,616014,"RNF25, AO7",Ring finger protein 25,RNF25,64320,ENSG00000163481,NA,NA,Rnf25 (MGI:1890215)
2,218672048,218702716,2q35,2q35,607652,"STK36, FU, KIAA1278",Serine/threonine protein kinase 36,STK36,27148,ENSG00000163482,NA,NA,Stk36 (MGI:1920831)
2,218781732,218815292,2q33-qter,2q35,606530,"CYP27A1, CYP27, CTX","Cytochrome P450, subfamily XXVIIA, polypeptide 1 (sterol 27-hydroxylase)",CYP27A1,1593,ENSG00000135929,NA,"Cerebrotendinous xanthomatosis, 213700 (3), Autosomal recessive",Cyp27a1 (MGI:88594)
2,218819948,218831802,2q35,2q35,604976,PRKAG3,"Protein kinase, AMP-activated, noncatalytic, gamma 3",PRKAG3,53632,ENSG00000115592,NA,NA,Prkag3 (MGI:1891343)
2,218859804,218874232,2q35,2q35,604663,WNT6,"Wingless-type MMTV integration site family, member 6",WNT6,7475,ENSG00000115596,NA,NA,Wnt6 (MGI:98960)
2,218874115,218893930,2q35,2q35,606268,"WNT10A, SSPS, STHAG4, OODD","Wingless-type MMTV integration site family, member 10A",WNT10A,80326,ENSG00000135925,NA,"Odontoonychodermal dysplasia, 257980 (3), Autosomal recessive; Schopf-Schulz-Passarge syndrome, 224750 (3), Autosomal recessive; Tooth agenesis, selective, 4, 150400 (3), Autosomal recessive, Autosomal dominant",Wnt10a (MGI:108071)
2,218959665,218962154,2q35,2q35,603764,"CDK5R2, NCK5AI","Cyclin-dependent kinase 5, regulatory subunit 2",CDK5R2,8941,ENSG00000171450,NA,NA,Cdk5r2 (MGI:1330828)
2,218981086,218985656,2q36,2q35,607150,FEV,Fifth Ewing sarcoma variant,FEV,54738,ENSG00000163497,fused with EWS in tumors,NA,Fev (MGI:2449712)
2,218990189,218993421,2q34-q36,2q35,600836,"CRYBA2, CTRCT42","Crystallin, beta A2",CRYBA2,1412,ENSG00000163499,mutation identified in 1 CTRCT42 family,"?Cataract 42, 115900 (3), Autosomal dominant",Cryba2 (MGI:104336)
2,219001644,219001707,2q35,2q35,611173,"MIR375, MIRN375",Micro RNA 375,MIR375,494324,ENSG00000198973,NA,NA,NA
2,219002845,219043141,2q35,2q35,614270,"CFAP65, CCDC108",Cilia- and flagella-associated protein 65,CFAP65,255101,ENSG00000181378,NA,NA,Cfap65 (MGI:2444274)
2,219054423,219060920,2q33-q35,2q35,600726,"IHH, BDA1",Indian hedgehog,IHH,3549,ENSG00000163501,NA,"Acrocapitofemoral dysplasia, 607778 (3), Autosomal recessive; Brachydactyly, type A1, 112500 (3), Autosomal dominant",Ihh (MGI:96533)
2,219075323,219160864,2q35,2q35,611290,"NHEJ1, XLF",Nonhomologous end-joining factor 1,NHEJ1,79840,ENSG00000187736,NA,"Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)",Nhej1 (MGI:1922820)
2,219206781,219209650,2q35,2q35,613474,"ZFAND2B, AIRAPL",Zinc finger AN1 domain-containing protein 2B,ZFAND2B,130617,ENSG00000158552,NA,NA,Zfand2b (MGI:1916068)
2,219209771,219218957,2q36,2q35,605452,"ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2","ATP-binding cassette, subfamily B, member 6",ABCB6,10058,ENSG00000115657,NA,"[Blood group, Langereis system], 111600 (3); Dyschromatosis universalis hereditaria 3, 615402 (3), Autosomal dominant; Microphthalmia, isolated, with coloboma 7, 614497 (3), Autosomal dominant; Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3), Autosomal dominant",Abcb6 (MGI:1921354)
2,219219379,219229687,2q35,2q35,612204,"ATG9A, APG9L1","Autophagy 9, S. cerevisiae, homolog of, A",ATG9A,79065,ENSG00000198925,NA,NA,Atg9a (MGI:2138446)
2,219229805,219236678,2q35,2q35,617541,"ANKZF1, ZNF744",Ankyrin repeat- and zinc finger domain-containing 1,ANKZF1,55139,ENSG00000163516,NA,NA,Ankzf1 (MGI:1098746)
2,219249709,219254607,2q35,2q35,191110,"TUBA4A, TUBA1, ALS22","Tubulin, alpha-4A",TUBA4A,7277,ENSG00000127824,NA,"Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3), Autosomal dominant",Tuba4a (MGI:1095410)
2,219279365,219286894,2q35,2q35,604139,"DNAJB2, HSJ1, HSPF3, DSMA5","DnaJ, E. coli, homolog of, subfamily B, member 2 (heat-shock protein, DNAJ-like 1)",DNAJB2,3300,ENSG00000135924,NA,"Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3), Autosomal recessive",Dnajb2 (MGI:1928739)
2,219289622,219309403,2q35-q36.1,2q35,601773,"PTPRN, IA2","Protein tyrosine phosphatase, receptor type N (islet cell antigen 2)",PTPRN,5798,ENSG00000054356,NA,NA,Ptprn (MGI:102765)
2,219327406,219334534,2q35,2q35,612721,RESP18,Regulated endocrine-specific protein 18,RESP18,389075,ENSG00000182698,NA,NA,Resp18 (MGI:1098222)
2,219372028,219400006,2q35,2q35,611367,"DNPEP, ASPEP, DAP",Aspartyl aminopeptidase,DNPEP,23549,ENSG00000123992,NA,NA,Dnpep (MGI:1278328)
2,219418376,219426733,2q35,2q35,125660,"DES, CMD1I, MFM1, SCPNK",Desmin,DES,1674,ENSG00000175084,1 family with LGMD2R identified with mutation,"Cardiomyopathy, dilated, 1I, 604765 (3); Myopathy, myofibrillar, 1, 601419 (3), Autosomal recessive, Autosomal dominant; Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3), Autosomal dominant",Des (MGI:94885)
2,219434214,219493628,2q35,2q35,615950,"SPEG, APEG1, CNM5",SPEG complex locus,SPEG,10290,ENSG00000072195,NA,"Centronuclear myopathy 5, 615959 (3), Autosomal recessive",Speg (MGI:109282)
2,219498886,219506990,2q35,2q35,615495,"GMPPA, AAMR",GDP-mannose pyrophosphorylase A,GMPPA,29926,ENSG00000144591,NA,"Alacrima, achalasia, and mental retardation syndrome, 615510 (3), Autosomal recessive",Gmppa (MGI:1916330)
2,219514169,219538771,2q35-q36,2q35,606715,"ACCN4, ASIC4, BNAC4","Cation channel, amiloride-sensitive, neuronal, 4",ASIC4,55515,ENSG00000072182,NA,NA,Asic4 (MGI:2652846)
2,219538946,219543808,2q36.1,2q35,610405,"CHPF, CSS2",Chondroitin polymerizing factor,CHPF,79586,ENSG00000123989,NA,NA,Chpf (MGI:106576)
2,219549407,219571572,2q35,2q35,610991,"OBSL1, KIAA0657, 3M2",Obscurin-like 1,OBSL1,23363,ENSG00000124006,NA,"3-M syndrome 2, 612921 (3), Autosomal recessive",NA
2,219572309,219575710,2q33-q36,2q35,147380,INHA,"Inhibin, alpha",INHA,3623,ENSG00000123999,proximal to PAX3,NA,Inha (MGI:96569)
2,219597856,219616450,2q36,2q35,607172,"STK11IP, KIAA1898, LIP1",Serine/threonine kinase 11 interacting protein,STK11IP,114790,ENSG00000144589,NA,NA,Stk11ip (MGI:1918978)
2,219627569,219641979,2q36,2q35,106195,"SLC2C, AE3","Anion exchanger 3, neuronal",SLC4A3,6508,ENSG00000114923,NA,NA,Slc4a3 (MGI:109350)
2,220700000,230100000,2q36,NA,102510,ACRPV,Acropectorovertebral dysplasia (F syndrome),NA,414058,NA,NA,"Acropectorovertebral dysplasia, 102510 (2), Autosomal dominant",NA
2,220700000,230100000,2q36,NA,613944,IGAN2,"IgA nephropathy, susceptibility to, 2",NA,100653384,NA,between D2S1323 and D2S362,"{IgA nephropathy, susceptibility to, 2}, 613944 (2), ?Autosomal dominant",NA
2,220700000,230100000,2q36.1-q36.3,NA,613238,SPDA3,"Spondyloarthropathy, susceptibility to, 3",NA,100379218,NA,max lod at D2S2228,"{Spondyloarthropathy, susceptibility to, 3}, 613238 (2)",NA
2,221418026,221574201,2q36.1,2q36.1,602188,"EPHA4, HEK8, TYRO1",Ephrin receptor EphA4,EPHA4,2043,ENSG00000116106,NA,NA,Epha4 (MGI:98277)
2,222199886,222298997,2q36.1,2q36.1,606597,"PAX3, WS1, HUP2, CDHS, WS3",Paired box homeotic gene-3,PAX3,5077,ENSG00000135903,NA,"Craniofacial-deafness-hand syndrome, 122880 (3), Autosomal dominant; Rhabdomyosarcoma 2, alveolar, 268220 (3), Somatic mutation; Waardenburg syndrome, type 1, 193500 (3), Autosomal dominant; Waardenburg syndrome, type 3, 148820 (3), Autosomal recessive, Autosomal dominant",Pax3 (MGI:97487)
2,222423987,222562620,2q36.1,2q36.1,612827,"SGPP2, SPP2",Sphingosine-1-phosphate phosphatase 2,SGPP2,130367,ENSG00000163082,NA,NA,Sgpp2 (MGI:3589109)
2,222566898,222656354,2q36,2q36.1,609690,"FARSLB, FRSB, RILDBC","Phenylalanine-tRNA synthetase-like, beta subunit",FARSB,10056,ENSG00000116120,NA,"Rajab interstitial lung disease with brain calcifications, 613658 (3), Autosomal recessive",Farsb (MGI:1346035)
2,222671657,222709929,2q36.1,2q36.1,610268,"MOGAT1, MGAT1, DGAT2L1",Monoacylglycerol O-acyltransferase 1,MOGAT1,116255,ENSG00000124003,NA,NA,Mogat1 (MGI:1915643)
2,222861035,222944638,2q34-q35,2q36.1,602371,"ACSL3, FACL3, ACS3",Acyl-CoA synthetase long-chain family member 3,ACSL3,2181,ENSG00000123983,NA,NA,Acsl3 (MGI:1921455)
2,223051929,223055636,2q35-q36,2q36.1,607775,"KCNE4, MIRP3","Potassium channel, voltage-gated, ISK-related subfamily, member 4",KCNE4,23704,ENSG00000152049,NA,NA,Kcne4 (MGI:1891125)
2,223596939,223602360,2q35-q36,2q36.1,118930,"SCG2, CHGC",Secretogranin II (chromogranin C),SCG2,7857,ENSG00000171951,NA,NA,Scg2 (MGI:103033)
2,223755325,223837601,2q36.1,2q36.1,615781,"AP1S3, PSORS15","Adaptor-related protein complex 1, sigma-3 subunit",AP1S3,130340,ENSG00000152056,NA,"{Psoriasis 15, pustular, susceptibility to}, 616106 (3), Autosomal dominant",Ap1s3 (MGI:1891304)
2,223875347,223945334,2q36.1,2q36.1,618080,"WDFY1, FENS1",WD repeat-and FYVE domain-containing protein 1,WDFY1,57590,ENSG00000085449,NA,NA,Wdfy1 (MGI:1916618)
2,223950845,223967713,2q36,2q36.1,611849,"MRPL44, COXPD16",Mitochondrial ribosomal protein L44,MRPL44,65080,ENSG00000135900,Mutation identified in 1 family,"?Combined oxidative phosphorylation deficiency 16, 615395 (3), Autosomal recessive",Mrpl44 (MGI:1916413)
2,223975047,224039318,2q33-q35,2q36.1,177010,"PI7, PN1, SERPINE2",Protease inhibitor 7 (protease nexin I),SERPINE2,5270,ENSG00000135919,near MYL1; ?COPD susceptibility,NA,Serpine2 (MGI:101780)
2,224300000,225200000,2q36.2,NA,613658,RJBS,Rajab syndrome,NA,NA,NA,between D2S351 and D2S2390,"Rajab syndrome, 613658 (2), Autosomal recessive",NA
2,224378697,224402106,2q36.2,2q36.2,618403,FAM124B,"Family with sequence similarity 124, member B",FAM124B,79843,ENSG00000124019,NA,NA,Fam124b (MGI:3026880)
2,224470149,224585396,2q36,2q36.2,603136,"CUL3, PHA2E",Cullin 3,CUL3,8452,ENSG00000036257,NA,"Pseudohypoaldosteronism, type IIE, 614496 (3), Autosomal dominant",Cul3 (MGI:1347360)
2,224765089,225042688,2q36.2,2q36.2,611518,"DOCK10, KIAA0694, ZIZ3",Dedicator of cytokinesis 10,DOCK10,55619,ENSG00000135905,NA,NA,Dock10 (MGI:2146320)
2,225399709,225703652,2q36.3,2q36.3,615478,"NYPA2, KIAA1486",Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 2,NYAP2,57624,ENSG00000144460,NA,NA,Nyap2 (MGI:2443135)
2,226731316,226798789,2q36,2q36.3,147545,IRS1,Insulin receptor substrate-1,IRS1,3667,ENSG00000169047,NA,"{Coronary artery disease, susceptibility to} (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant",Irs1 (MGI:99454)
2,226800158,226999209,2q36.3,2q36.3,617515,"RHBDD1, RRP4, RHBDL4",Rhomboid domain-containing 1,RHBDD1,84236,ENSG00000144468,NA,NA,Rhbdd1 (MGI:1924117)
2,226970292,227164558,2q36-q37,2q36.3,120131,"COL4A4, ATS2, BFH","Collagen IV, alpha-4 polypeptide",COL4A4,1286,ENSG00000081052,head-to-head with COL4A4 in same YAC,"Alport syndrome 2, autosomal recessive, 203780 (3), Autosomal recessive; Hematuria, familial benign, 141200 (3), Autosomal dominant",Col4a4 (MGI:104687)
2,227164564,227314791,2q36-q37,2q36.3,120070,"COL4A3, ATS2, ATS3","Collagen IV, alpha-3 polypeptide (Goodpasture antigen)",COL4A3,1285,ENSG00000169031,noncollagenous domain = Goodpasture antigen,"Alport syndrome 2, autosomal recessive, 203780 (3), Autosomal recessive; Alport syndrome 3, autosomal dominant, 104200 (3), Autosomal dominant; Hematuria, benign familial, 141200 (3), Autosomal dominant",Col4a3 (MGI:104688)
2,227325232,227357835,2q36.3,2q36.3,614785,"MFF, C2orf33, EMPF2",Mitochondrial fission factor,MFF,56947,ENSG00000168958,NA,"Encephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3), Autosomal recessive",NA
2,227362037,227379305,2q36.3,2q36.3,615404,"TM4SF20, SLI5","Transmembrane 4 L6 family, member 20",TM4SF20,79853,ENSG00000168955,NA,"{Specific language impairment 5}, 615432 (3), Autosomal dominant",Tm4sf20 (MGI:1913511)
2,227472168,227561221,2q36,2q36.3,600862,"AGFG1, HRB, RIP, RAB",ADP-ribosylation factor GTPase-activating protein with FG repeats 1,AGFG1,3267,ENSG00000173744,NA,NA,Agfg1 (MGI:1333754)
2,227683762,227718029,2q36.3,2q36.3,606152,"SLC19A3, THMD2, BBGD","Solute carrier family 19 (folate transporter), member 3",SLC19A3,80704,ENSG00000135917,NA,"Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3), Autosomal recessive",Slc19a3 (MGI:1931307)
2,227813841,227817555,2q33-q37,2q36.3,601960,"CCL20, SCYA20, MIP3A, LARC","Chemokine, C-C motif, ligand 20",CCL20,6364,ENSG00000115009,NA,NA,Ccl20 (MGI:1329031)
2,227979953,228181998,2q36,2q36.3,611646,"SPHKAP, SKIP, KIAA1678","SPHK1 interactor, AKAP domain containing",SPHKAP,80309,ENSG00000153820,NA,NA,Sphkap (MGI:1924879)
2,229023972,229271286,2q36.3,2q36.3,612930,"PID1, NYGGF4",Phosphotyrosine interaction domain-containing 1,PID1,55022,ENSG00000153823,NA,NA,Pid1 (MGI:2138391)
2,229357628,229714554,2q37,2q36.3,607299,DNER,Delta-and notch-like egf-related receptor,DNER,92737,ENSG00000187957,NA,NA,Dner (MGI:2152889)
2,229763836,229923233,2q36.3,2q36.3,604506,"TRIP12, MRD49",Thyroid hormone receptor interactor 12,TRIP12,9320,ENSG00000153827,NA,"Mental retardation, autosomal dominant 49, 617752 (3), Autosomal dominant",Trip12 (MGI:1309481)
2,229922502,230013912,2q37.1,2q36.3,609105,"FBXO36, FBX36",F-box only protein 36,FBXO36,130888,ENSG00000153832,NA,NA,Fbxo36 (MGI:1289192)
2,230100000,242193529,2q37,NA,600430,"BDMR, C2DELq37, DEL2q37",Chromosome 2q37 deletion syndrome,NA,NA,NA,NA,"Chromosome 2q37 deletion syndrome, 600430 (4), Autosomal dominant",NA
2,230100000,242193529,2q37.1-q37.3,NA,605934,HPE6,Holoprosencephaly 6,NA,117190,NA,NA,"Holoprosencephaly 6, 605934 (2)",NA
2,230100000,242193529,2q37,NA,606656,IBGC2,"Basal ganglia calcification, idiopathic, 2",NA,100874532,NA,NA,"Basal ganglia calcification, idiopathic, 2, 606656 (2)",NA
2,230100000,234700000,2q37.1,NA,609995,MYP12,Myopia 12,MYP12,664780,NA,max lod at D2S2344,"Myopia 12, 609995 (2)",NA
2,230100000,234700000,2q37.1,NA,613440,STQTL21,Stature quantitative trait locus 21,NA,100502568,NA,associated with rs6717918,"{Stature QTL 21}, 613440 (2)",NA
2,230165472,230225728,2q37.1,2q37.1,604457,"SP110, IFI41, IFI75, VODI","SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD)",SP110,3431,ENSG00000135899,NA,"Hepatic venoocclusive disease with immunodeficiency, 235550 (3), Autosomal recessive; {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)","Sp110,Gm15753,Gm16026 (MGI:3783243,MGI:1923364,MGI:3783195)"
2,230327151,230407505,2q37.1,2q37.1,617747,SP140L,Nuclear body protein SP140-like,SP140L,93349,ENSG00000185404,NA,NA,NA
2,230416155,230545605,2q37.1,2q37.1,604585,SP100,Nuclear antigen SP100,SP100,6672,ENSG00000067066,NA,NA,NA
2,230712841,230821074,2q37.1,2q37.1,612174,CAB39,Calcium-binding protein 39,CAB39,51719,ENSG00000135932,NA,NA,Cab39 (MGI:107438)
2,230864184,230879253,2q37,2q37.1,609554,"ITM2C, BRI3",Integral membrane protein 2C,ITM2C,81618,ENSG00000135916,NA,NA,Itm2c (MGI:1927594)
2,230907317,230961269,2q37,2q37.1,604107,GPR55,G protein-coupled receptor 55,GPR55,9290,ENSG00000135898,NA,NA,Gpr55 (MGI:2685064)
2,231056863,231172826,2q37.1,2q37.1,617842,PSMD1,"Proteasome 26S subunit, non-ATPase, 1",PSMD1,5707,ENSG00000173692,NA,NA,Psmd1 (MGI:1917497)
2,231108229,231126171,2q36.3-q37.1,2q37.1,601122,HTR2B,5-hydroxytryptamine (serotonin) receptor-2B,HTR2B,3357,ENSG00000135914,NA,NA,Htr2b (MGI:109323)
2,231198545,231394990,2q37.1,2q37.1,617612,"ARMC9, KIAA1868, JBTS30",Armadillo repeat-containing protein 9,ARMC9,80210,ENSG00000135931,NA,"Joubert syndrome 30, 617622 (3), Autosomal recessive",Armc9 (MGI:1926045)
2,231395709,231401163,2q37.1,2q37.1,615313,B3GNT7,"Beta-1,3-N-acetylglucosaminyltransferase 7",B3GNT7,93010,ENSG00000156966,NA,NA,B3gnt7 (MGI:2384394)
2,231453530,231464483,2q12-qter,2q37.1,164035,NCL,Nucleolin,NCL,4691,ENSG00000115053,NA,NA,Ncl (MGI:97286)
2,231456443,231456522,2q37.1,2q37.1,604012,RNU20,"RNA, U20 small nucleolar",SNORD20,6082,ENSG00000207280,NA,NA,NA
2,231460367,231460441,2q12-qter,2q37.1,611133,"SNORD82, RNU82","Small nucleolar RNA, C/D box, 82",SNORD82,25826,ENSG00000202400,NA,NA,NA
2,231519902,231530455,2q37.1,2q37.1,604153,"NMUR1, GPR66, FM3",Neuromedin U receptor 1,NMUR1,10316,ENSG00000171596,NA,NA,Nmur1 (MGI:1341898)
2,231708524,231713540,2q36-q37,2q37.1,188390,"PTMA, TMSA","Prothymosin, alpha (gene sequence 28)",PTMA,5757,ENSG00000187514,NA,NA,NA
2,231732424,231781326,2q36-q37,2q37.1,602676,"PDE6D, JBTS22","Phosphodiesterase 6D, cGMP-specific, rod, delta",PDE6D,5147,ENSG00000156973,mutation identified in 1 JBTS22 family,"?Joubert syndrome 22, 615665 (3), Autosomal recessive",Pde6d (MGI:1270843)
2,231781670,231809252,2q37.1,2q37.1,616010,COPS7B,"COP9 signalosome, subunit 7B",COPS7B,64708,ENSG00000144524,NA,NA,Cops7b (MGI:1349388)
2,231921808,231926404,2q24-qter,2q37.1,600296,NPPC,Natriuretic peptide precursor C,NPPC,4880,ENSG00000163273,NA,NA,Nppc (MGI:97369)
2,231961582,232344349,2q37.2,2q37.1,614184,"DIS3L2, PRLMNS","Dis3 mitotic control, S. cerevisiae, homolog-like 2",DIS3L2,129563,ENSG00000144535,NA,"Perlman syndrome, 267000 (3), Autosomal recessive",Dis3l2 (MGI:2442555)
2,232378750,232382888,2q37,2q37.1,171800,ALPP,"Alkaline phosphatase, placental (Regan isozyme)",ALPP,250,ENSG00000163283,NA,NA,Alpi (MGI:1924018)
2,232406843,232410713,2q37,2q37.1,171810,ALPPL2,"Alkaline phosphatase, placental-like 2",ALPG,251,ENSG00000163286,NA,NA,Alppl2 (MGI:108009)
2,232456152,232460752,2q37.1,2q37.1,171740,ALPI,"Alkaline phosphatase, intestinal",ALPI,248,ENSG00000163295,close to ALPP; proximal to PAX3,NA,Akp3 (MGI:87984)
2,232479826,232487833,2q36-q37,2q37.1,605896,"ECEL1, XCE, DA5D",Endothelin-converting enzyme-like 1,ECEL1,9427,ENSG00000171551,NA,"Arthrogryposis, distal, type 5D, 615065 (3), Autosomal recessive",Ecel1 (MGI:1343461)
2,232520462,232525715,2q37.1,2q37.1,613858,"PRSS56, MCOP6","Protease, serine, 56",PRSS56,646960,ENSG00000237412,NA,"Microphthalmia, isolated 6, 613517 (3), Autosomal recessive",Prss56 (MGI:1916703)
2,232526159,232537906,2q33-q34,2q37.1,100720,"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C","Cholinergic receptor, nicotinic, delta polypeptide",CHRND,1144,ENSG00000135902,mutation identified in 1 CMS3A patient and 1 CMS3C family,"Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive; ?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3), Autosomal dominant; Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3), Autosomal recessive; ?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3), Autosomal recessive",Chrnd (MGI:87893)
2,232539691,232548114,2q33-q34,2q37.1,100730,"CHRNG, ACHRG","Cholinergic receptor, nicotinic, gamma polypeptide",CHRNG,1146,ENSG00000196811,tightly linked to CHRND by RE,"Escobar syndrome, 265000 (3), Autosomal recessive; Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive",Chrng (MGI:87895)
2,232547969,232550556,2q37.1,2q37.1,612972,TIGD1,TIGGER transposable element-derived gene 1,TIGD1,200765,ENSG00000221944,NA,NA,NA
2,232550586,232583644,2q37.1,2q37.1,605895,"EIF4E2, EIF4EL3, 4EHP","Eukaryotic translation initiation factor 4E family, member 2",EIF4E2,9470,ENSG00000135930,NA,NA,Eif4e2 (MGI:1914440)
2,232606056,232682780,2q37.1,2q37.1,611617,EFHD1,"EF-hand domain family, member D1",EFHD1,80303,ENSG00000115468,NA,NA,Efhd1 (MGI:1921607)
2,232697330,232860576,2q37.1,2q37.1,612003,"GIGYF2, KIAA0642, PARK11",GRB10-interacting GYF protein 2,GIGYF2,26058,ENSG00000204120,NA,"{Parkinson disease 11}, 607688 (3)",Gigyf2 (MGI:2138584)
2,232765801,232776564,2q37,2q37.1,603208,"KCNJ13, SVD, LCA16","Potassium inwardly-rectifying channel, subfamily J, member 13",KCNJ13,3769,ENSG00000115474,NA,"Leber congenital amaurosis 16, 614186 (3), Autosomal recessive; Snowflake vitreoretinal degeneration, 193230 (3), Autosomal dominant",Kcnj13 (MGI:3781032)
2,232878685,233013255,2q37,2q37.1,605991,NGEF,Neuronal guanine nucleotide exchange factor,NGEF,25791,ENSG00000066248,NA,NA,Ngef (MGI:1858414)
2,233032671,233035056,2q37,2q37.1,605528,"NEU2, SIAL2",Neuraminidase 2,NEU2,4759,ENSG00000115488,NA,NA,Neu2 (MGI:1344417)
2,233060341,233207902,2q36-q37,2q37.1,601582,"INPP5D, SHIP","Inositol polyphosphate-5-phosphatase, 145kD",INPP5D,3635,ENSG00000168918,NA,NA,Inpp5d (MGI:107357)
2,233251570,233295673,2q37.1,2q37.1,610767,"ATG16L1, APG16L, IBD10",Autophagy 16-like 1,ATG16L1,55054,ENSG00000085978,NA,"{Inflammatory bowel disease (Crohn disease) 10}, 611081 (3)",Atg16l1 (MGI:1924290)
2,233275725,233276002,2q37.1,2q37.1,615640,SCARNA5,Small Cajal body-specific RNA 5,SCARNA5,677775,ENSG00000252010,within intron 9 of ATG16L1,NA,NA
2,233288675,233288940,2q37.1,2q37.1,615641,SCARNA6,Small Cajal body-specific RNA 6,SCARNA6,677772,ENSG00000251791,within intron 12 of ATG16L1,NA,NA
2,233307815,233347065,2q37.1,2q37.1,181031,"SAG, RP47",S-antigen; retina and pineal gland (arrestin),SAG,6295,ENSG00000130561,NA,"Oguchi disease-1, 258100 (3), Autosomal recessive; Retinitis pigmentosa 47, 613758 (3)",Sag (MGI:98227)
2,233354493,233472097,2q37.1,2q37.1,601826,DGKD,"Diacylglycerol kinase, delta, 130kD",DGKD,8527,ENSG00000077044,NA,NA,Dgkd (MGI:2138334)
2,233475090,233566788,2q37.1,2q37.1,610570,USP40,Ubiquitin-specific protease 40,USP40,55230,ENSG00000085982,NA,NA,Usp40 (MGI:2443184)
2,233617644,233773298,2q37,2q37.1,606433,UGT1A8,"UDP-glycosyltransferase 1 family, polypeptide A8",UGT1A8,54576,ENSG00000242366,NA,NA,"Ugt1a9,Ugt1a10 (MGI:3576092,MGI:3580642)"
2,233636476,233773304,2q37,2q37.1,606435,UGT1A10,"UDP-glycosyltransferase 1 family, polypeptide A10",UGT1A10,54575,ENSG00000242515,NA,NA,"Ugt1a9,Ugt1a10 (MGI:3576092,MGI:3580642)"
2,233671897,233773299,2q37,2q37.1,606434,UGT1A9,"UDP-glycosyltransferase 1 family, polypeptide A9",UGT1A9,54600,ENSG00000241119,NA,NA,"Ugt1a9,Ugt1a10 (MGI:3576092,MGI:3580642)"
2,233681937,233773298,2q37,2q37.1,606432,UGT1A7,"UDP-glycosyltransferase 1 family, polypeptide A7",UGT1A7,54577,ENSG00000244122,NA,NA,"Ugt1a9,Ugt1a10 (MGI:3576092,MGI:3580642)"
2,233691669,233773299,2q37,2q37.1,606431,UGT1A6,"UDP-glycosyltransferase 1 family, polypeptide A6",UGT1A6,54578,ENSG00000167165,NA,NA,"Ugt1a6b,Ugt1a6a (MGI:3580629,MGI:2137698)"
2,233712991,233773298,2q37,2q37.1,606430,UGT1A5,"UDP-glycosyltransferase 1 family, polypeptide A5",UGT1A5,54579,ENSG00000240224,NA,NA,NA
2,233718735,233773299,2q37,2q37.1,606429,"UGT1A4, UGT1D","UDP-glycosyltransferase 1 family, polypeptide A4",UGT1A4,54657,ENSG00000244474,NA,NA,Ugt1a5 (MGI:3032634)
2,233729126,233773298,2q37,2q37.1,606428,"UGT1A3, UGT1C","UDP-glycosyltransferase 1 family, polypeptide A3",UGT1A3,54659,ENSG00000243135,NA,NA,Ugt1a2 (MGI:3576049)
2,233760272,233773298,2q37,2q37.1,191740,"UGT1A1, UGT1, GNT1, BILIQTL1","UDP glycosyltransferase 1 family, polypeptide A1",UGT1A1,54658,ENSG00000241635,NA,"[Bilirubin, serum level of, QTL1], 601816 (3); Crigler-Najjar syndrome, type I, 218800 (3), Autosomal recessive; Crigler-Najjar syndrome, type II, 606785 (3), Autosomal recessive; [Gilbert syndrome], 143500 (3), Autosomal recessive; Hyperbilirubinemia, familial transient neonatal, 237900 (3), Autosomal recessive",Ugt1a1 (MGI:98898)
2,233836700,233854565,2q37.1,2q37.1,612667,HJURP,Holliday junction recognition protein,HJURP,55355,ENSG00000123485,NA,NA,Hjurp (MGI:2685821)
2,233917341,234019521,2q37,2q37.1,606678,"TRPM8, TRPP8","Transient receptor potential cation channel, subfamily M, member 8",TRPM8,79054,ENSG00000144481,NA,NA,Trpm8 (MGI:2181435)
2,234050666,234077133,2q37-qter,2q37.1,602637,SPP2,"Secreted phosphoprotein-2, 24kD",SPP2,6694,ENSG00000072080,NA,NA,Spp2 (MGI:1922646)
2,234493040,234497080,2q37.1,2q37.1,604787,"ARL4C, ARL7",ADP-ribosylation factor-like 4C,ARL4C,10123,ENSG00000188042,NA,NA,Arl4c (MGI:2445172)
2,234952016,235055713,2q37.1-q37.2,2q37.2,605611,"SH3BP4, BOG25",SH3 domain-binding protein 4,SH3BP4,23677,ENSG00000130147,NA,NA,Sh3bp4 (MGI:2138297)
2,235494042,236131794,2q37.2,2q37.2,608651,"AGAP1, CENTG2, KIAA1099","Arf GTPase-activating protein with GTPase domain, ankyrin repeat, and pleckstrin homology domain 1",AGAP1,116987,ENSG00000157985,NA,NA,Agap1 (MGI:2653690)
2,236165235,236168385,2q36-q37,2q37.2,601135,GBX2,Gastrulation brain homeobox 2,GBX2,2637,ENSG00000168505,NA,NA,Gbx2 (MGI:95668)
2,236537130,236582357,2q37,2q37.3,610376,"ACKR3, CXCR7, CMKOR1, GPR159, RDC1",Atypical chemokine receptor 3,ACKR3,57007,ENSG00000144476,NA,NA,Ackr3 (MGI:109562)
2,237085440,237100473,2q37.3,2q37.3,616011,"COPS8, CSN8","COP9 signalosome, subunit 8",COPS8,10920,ENSG00000198612,NA,NA,Cops8 (MGI:1915363)
2,237324011,237434821,2q37,2q37.3,120250,"COL6A3, DYT27, BTHLM1, UCMD1","Collagen VI, alpha-3 polypeptide",COL6A3,1293,ENSG00000163359,close to CRBP1,"Bethlem myopathy 1, 158810 (3), Autosomal recessive, Autosomal dominant; Dystonia 27, 616411 (3), Autosomal recessive; Ullrich congenital muscular dystrophy 1, 254090 (3), Autosomal recessive, Autosomal dominant",Col6a3 (MGI:88461)
2,237486409,237555321,2q37,2q37.3,606526,MLPH,Melanophilin,MLPH,79083,ENSG00000115648,NA,"Griscelli syndrome, type 3, 609227 (3), Autosomal recessive",Mlph (MGI:2176380)
2,237566573,237567174,2q37.3,2q37.3,602663,"PRLH, PRRP",Prolactin-releasing hormone,PRLH,51052,ENSG00000071677,NA,NA,Prlh (MGI:3644668)
2,237574321,237591125,2q37.3,2q37.3,602206,RAB17,Ras-associated protein,RAB17,64284,ENSG00000124839,NA,NA,Rab17 (MGI:104640)
2,237627575,237781646,2q37.3,2q37.3,603256,"LRRFIP1, GCF2, TRIP, FLAP1",Leucine-rich repeat in FLII-interacting protein 1,LRRFIP1,9208,ENSG00000124831,NA,NA,Lrrfip1 (MGI:1342770)
2,237858554,237912113,2q36-q37.1,2q37.3,605153,RAMP1,Receptor activity-modifying protein 1,RAMP1,10267,ENSG00000132329,NA,NA,Ramp1 (MGI:1858418)
2,237966944,238042781,2q37.3,2q37.3,617700,"UBE2F, NCE2",Ubiquitin-conjugating enzyme E2F,UBE2F,140739,ENSG00000184182,NA,NA,Ube2f (MGI:1915171)
2,238061000,238099412,2q37.3,2q37.3,611056,"SCLY, SCL",Selenocysteine lyase,SCLY,51540,ENSG00000132330,NA,NA,Scly (MGI:1355310)
2,238158969,238168889,2q37.3,2q37.3,615099,"ERFE, FAM132B, CTRP15",Erythroferrone,ERFE,151176,ENSG00000178752,NA,NA,Erfe (MGI:3606476)
2,238238266,238240037,2q37.3,2q37.3,610331,HES6,"Hairy/enhancer of split, Drosophila, homolog of, 6",HES6,55502,ENSG00000144485,NA,NA,Hes6 (MGI:1859852)
2,238244037,238290101,2q37.3,2q37.3,603426,"PER2, FASPS1, KIAA0347","Period, Drosophila, homolog of, 2",PER2,8864,ENSG00000132326,NA,"Advanced sleep phase syndrome, familial, 1, 604348 (3), Autosomal dominant",Per2 (MGI:1195265)
2,238320488,238400899,2q37.3,2q37.3,607380,"TRAF3IP1, MIPT3, SLSN9",TNF receptor-associated factor 3-interacting protein 1,TRAF3IP1,26146,ENSG00000204104,NA,"Senior-Loken syndrome 9, 616629 (3), Autosomal recessive",Traf3ip1 (MGI:1921269)
2,238426926,238452249,2q37,2q37.3,605758,ASB1,Ankyrin repeat-containing SOCS box protein 1,ASB1,51665,ENSG00000065802,NA,NA,Asb1 (MGI:1929735)
2,238848084,238910533,2q37.3,2q37.3,607556,"TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS","Twist, Drosophila, homolog of, 2 (dermis-expressed protein 1, mouse, homolog of)",TWIST2,117581,ENSG00000233608,NA,"Ablepharon-macrostomia syndrome, 200110 (3), Autosomal dominant; Barber-Say syndrome, 209885 (3), Autosomal dominant; Focal facial dermal dysplasia 3, Setleis type, 227260 (3), Autosomal recessive",Twist2 (MGI:104685)
2,239048167,239401646,2q37.2,2q37.3,605314,"HDAC4, HDACA",Histone deacetylase 4,HDAC4,9759,ENSG00000068024,NA,NA,Hdac4 (MGI:3036234)
2,239892449,240025401,2q37.3,2q37.3,603835,"NDUFA10, MC1DN22",NADH-ubiquinone oxidoreductase subunit A10,NDUFA10,4705,ENSG00000130414,NA,"Mitochondrial complex I deficiency, nuclear type 22, 618243 (3), Autosomal recessive",Ndufa10 (MGI:1914523)
2,240138941,240141372,2q37.3,2q37.3,607877,OTOSP,Otospiralin,OTOS,150677,ENSG00000178602,NA,NA,Otos (MGI:2672814)
2,240435662,240468075,2q35-q37,2q37.3,600395,GPC1,Glypican 1,GPC1,2817,ENSG00000063660,NA,NA,Gpc1 (MGI:1194891)
2,240456000,240456088,2q37.3,2q37.3,615209,MIR149,Micro RNA 149,MIR149,406941,ENSG00000207611,NA,NA,NA
2,240568483,240581371,2q37.3,2q37.3,605287,RNPEPL1,Arginyl aminopeptidase-like 1 (aminopeptidase B-like),RNPEPL1,57140,ENSG00000142327,NA,NA,Rnpepl1 (MGI:1914170)
2,240586733,240599103,2q37.3,2q37.3,605286,"CAPN10, NIDDM1",Calpain-10,CAPN10,11132,ENSG00000142330,NA,"{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)",Capn10 (MGI:1344392)
2,240605429,240631258,2q37.3,2q37.3,602646,GPR35,G protein-coupled receptor-35,GPR35,2859,ENSG00000178623,NA,NA,Gpr35 (MGI:1929509)
2,240691865,240698482,2q34-q37,2q37.3,609789,"AQP12A, AQPX2, AQP12",Aquaporin 12A,AQP12A,375318,ENSG00000184945,NA,NA,Aqp12 (MGI:2664636)
2,240713763,240820307,2q37,2q37.3,601255,"KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9",Kinesin family member 1A,KIF1A,547,ENSG00000130294,incorrectly assigned to chr.9,"Mental retardation, autosomal dominant 9, 614255 (3), Autosomal dominant; Neuropathy, hereditary sensory, type IIC, 614213 (3), Autosomal recessive; Spastic paraplegia 30, autosomal recessive, 610357 (3), Autosomal recessive",Kif1a (MGI:108391)
2,240868823,240880499,2q36-q37,2q37.3,604285,"AGXT, SPAT","Alanine-glyoxylate aminotransferase, liver-specific peroxisomal",AGXT,189,ENSG00000172482,NA,"Hyperoxaluria, primary, type 1, 259900 (3), Autosomal recessive",Agxt (MGI:1329033)
2,240997409,241095567,2q37.3,2q37.3,616634,"SNED1, SNEP","SUSHI, NIDOGEN, and EGF-like domains protein 1",SNED1,25992,ENSG00000162804,NA,NA,Sned1 (MGI:3045960)
2,241074393,241102331,2q37.3,2q37.3,615393,"MTERF4, MTERFD2",Mitochondrial transcription termination factor 4,MTERF4,130916,ENSG00000122085,NA,NA,Mterf4 (MGI:1918355)
2,241106098,241150263,2q37.3,2q37.3,607505,"PASK, KIAA0135",Pas domain-containing serine-threonine kinase,PASK,23178,ENSG00000115687,NA,NA,Pask (MGI:2155936)
2,241149572,241183651,2q37.3,2q37.3,602877,"PPP1R7, SDS22","Protein phosphatase 1, regulatory subunit 7",PPP1R7,5510,ENSG00000115685,NA,NA,Ppp1r7 (MGI:1913635)
2,241188513,241239601,2q37.3,2q37.3,605096,"TMEM16G, PCANAP5, IPCA5, DTMPP, NGEP",Transmembrane protein 16G,ANO7,50636,ENSG00000146205,NA,NA,Ano7 (MGI:3052714)
2,241227263,241315841,2q37,2q37.3,142695,"HDLBP, VGL",High-density lipoprotein-binding protein,HDLBP,3069,ENSG00000115677,NA,NA,Hdlbp (MGI:99256)
2,241315186,241354026,2q37,2q37.3,601506,"SEPT2, NEDD5, DIFF6",Septin 2,SEPTIN2,4735,ENSG00000168385,NA,NA,Sept2 (MGI:97298)
2,241356284,241494840,2q37.3,2q37.3,617586,"FARP2, FRG, FIR","FERM, ARHGEF, and pleckstrin domain-containing protein 2",FARP2,9855,ENSG00000006607,NA,NA,Farp2 (MGI:2385126)
2,241492669,241509729,2q37.3,2q37.3,602255,"STK25, SOK1, YSK1",Serine/threonine protein kinase 25,STK25,10494,ENSG00000115694,NA,NA,Stk25 (MGI:1891699)
2,241558744,241574130,2q37.3,2q37.3,605404,"BOK, BCL2L9",BCL2-related ovarian killer,BOK,666,ENSG00000176720,NA,NA,Bok (MGI:1858494)
2,241584404,241637542,2q37.3,2q37.3,612533,THAP4,THAP domain-containing protein 4,THAP4,51078,ENSG00000176946,NA,NA,Thap4 (MGI:1914276)
2,241637658,241673856,2q37.3,2q37.3,611338,"ATG4B, APG4B, KIAA0943","Autophagy 4, S. cerevisiae, homolog of, B",ATG4B,23192,ENSG00000168397,NA,NA,Atg4b (MGI:1913865)
2,241675741,241686967,2q37.3,2q37.3,188345,"DTYMK, TYMK, CDC8",Deoxythymidylate kinase,DTYMK,1841,ENSG00000168393,NA,NA,Dtymk (MGI:108396)
2,241687016,241729480,2q37.3,2q37.3,608525,ING5,Inhibitor of growth-5,ING5,84289,ENSG00000168395,NA,NA,Ing5 (MGI:1922816)
2,241734578,241768815,2q37.3,2q37.3,609186,"D2HGDH, D2HGD",D-2-hydroxyglutarate dehydrogenase,D2HGDH,728294,ENSG00000180902,NA,"D-2-hydroxyglutaric aciduria, 600721 (3), Autosomal recessive",D2hgdh (MGI:2138209)
2,241776821,241804286,2q37.3,2q37.3,608237,"GAL3ST2, GP3ST",Galactose-3-O-sulfotransferase 2,GAL3ST2,64090,ENSG00000154252,NA,NA,"Gal3st2,Gal3st2c,Gal3st2b (MGI:2685834,MGI:3646771,MGI:3711964)"
2,241809192,241817412,2q37.3,2q37.3,608527,NEU4,Neuraminidase 4,NEU4,129807,ENSG00000204099,NA,NA,Neu4 (MGI:2661364)
2,241849880,241858907,2q37.3,2q37.3,600244,"PDCD1, SLEB2",Programmed cell death 1,PDCD1,5133,ENSG00000188389,NA,"{Multiple sclerosis, disease progression, modifier of}, 126200 (3), Multifactorial; {Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3)",Pdcd1 (MGI:104879)
2,0,242193529,Chr.2,NA,601136,TSE2,Transsuppressor of expression 2,NA,57324,NA,NA,NA,NA
3,0,90900000,3p,NA,607135,CRCL,Creatinine clearance QTL,NA,261727,NA,in African Americans,"Creatinine clearance QTL, 607135 (2)",NA
3,0,16300000,3pter-p25,NA,613792,"DEL3pterp25, C3DELpterp25",3p- syndrome (chromosome 3pter-p25 deletion syndrome),NA,NA,NA,contiguous gene deletion syndrome,"3p- syndrome, 613792 (4), Autosomal dominant",NA
3,0,8100000,3p26,NA,609299,HPC5,"Prostate cancer, hereditary, 5",NA,619402,NA,between D3S1270 and D3S4559,"{Prostate cancer, hereditary, 5}, 609299 (2)",NA
3,0,8100000,3p26,NA,608448,IBD9,Inflammatory bowel disease 9,IBD9,317669,NA,NA,"{Inflammatory bowel disease 9}, 608448 (2)",NA
3,0,26300000,3p26-p24.2,NA,252350,"MYMY1, MYMY",Moyamoya disease,MYMY1,50960,NA,max lod at D3S3050,"Moyamoya disease, 252350 (2), Autosomal recessive",NA
3,0,8100000,3p26,NA,608982,STQTL5,Stature quantitative trait locus 5,NA,619479,NA,max lod between D3S1297 and D3S1304,"{Stature QTL 5}, 608982 (2)",NA
3,196587,409416,3p26.1,3p26.3,607416,"CHL1, CALL, L1CAM2","CHL1, mouse, homolog of (L1 cell adhesion molecule 2)",CHL1,10752,ENSG00000134121,NA,NA,Chl1 (MGI:1098266)
3,978020,1404216,3p26-p25,3p26.3,607220,"CNTN6, NB3",Contactin 6,CNTN6,27255,ENSG00000134115,NA,NA,Cntn6 (MGI:1858223)
3,2098802,3059079,3p26-p25,3p26.3-p26.2,607280,CNTN4,Contactin 4,CNTN4,152330,ENSG00000144619,NA,NA,Cntn4 (MGI:1095737)
3,3066323,3110413,3p26-p24,3p26.2,147851,IL5RA,"Interleukin-5 receptor, alpha",IL5RA,3568,ENSG00000091181,NA,NA,Il5ra (MGI:96558)
3,3126936,3153434,3p25.1,3p26.2,612907,"TRNT1, SIFD, RPEM","tRNA nucleotidyltransferase, CCA-adding, 1",TRNT1,51095,ENSG00000072756,pseudogenes on chromosomes 1 and 22,"Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3), Autosomal recessive; Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3), Autosomal recessive",Trnt1 (MGI:1917297)
3,3148489,3179716,3p26.2,3p26.2,609262,"CRBN, MRT2",Cereblon,CRBN,51185,ENSG00000113851,between D3S3525 and D3S1560,"Mental retardation, autosomal recessive 2, 607417 (3), Autosomal recessive",Crbn (MGI:1913277)
3,4000000,16300000,3p26.1-p25.1,NA,612976,ARHI2,Age-related hearing impairment 2,NA,100302721,NA,"associated with rs11928865, rs779701, and rs779706","{Age-related hearing impairment 2}, 612976 (2)",NA
3,4034713,4467281,3p26,3p26.1,607939,"SUMF1, FGE",Sulfatase-modifying factor-1,SUMF1,285362,ENSG00000144455,NA,"Multiple sulfatase deficiency, 272200 (3), Autosomal recessive",Sumf1 (MGI:1889844)
3,4303303,4320648,3p26,3p26.1,609834,"SETMAR, METNASE",SET and Mariner transposase domains-containing protein,SETMAR,6419,ENSG00000170364,NA,NA,NA
3,4493347,4847839,3p26.1,3p26.1,147265,"ITPR1, SCA15, SCA16, SCA29","Inositol 1,4,5-triphosphate receptor, type 1",ITPR1,3708,ENSG00000150995,NA,"Gillespie syndrome, 206700 (3), Autosomal recessive, Autosomal dominant; Spinocerebellar ataxia 15, 606658 (3), Autosomal dominant; Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3), Autosomal dominant",Itpr1 (MGI:96623)
3,4749191,4751589,3p26.2,3p26.1,611662,EGO,Eosinophil granule ontogeny,EGOT,100126791,ENSG00000235947,NA,NA,NA
3,4979419,4985322,3p26,3p26.1,604256,"BHLHE40, HLHB2, STRA13, DEC1","Basic helix-loop-helix family, member E40",BHLHE40,8553,ENSG00000134107,NA,NA,Bhlhe40 (MGI:1097714)
3,5122291,5180910,3p26.1,3p26.1,616596,"ARL8B, GIE1",ADP-ribosylation factor-like 8B,ARL8B,55207,ENSG00000134108,NA,NA,Arl8b (MGI:1914416)
3,5187706,5219962,3p26.1,3p26.1,607673,"EDEM, KIAA0212",ER degradation-enhancing alpha-mannosidase-like protein,EDEM1,9695,ENSG00000134109,NA,NA,Edem1 (MGI:2180139)
3,6861114,7743037,3p26.1,3p26.1,604101,"GRM7, MGLUR7","Glutamate receptor, metabotropic, 7",GRM7,2917,ENSG00000196277,NA,NA,Grm7 (MGI:1351344)
3,8100000,43600000,3p25-p22,NA,607893,OVCAS1,"Ovarian cancer, susceptibility to, 1",NA,574048,NA,between D3S1597 and D3S3611,"{Ovarian cancer, susceptibility to}, 607893 (2)",NA
3,8100000,16300000,3p25,NA,602011,"ST11, PETS1","Suppression of tumorigenicity 11, pancreas",ST11,8466,NA,NA,?Pancreatic endocrine tumors (1),NA
3,8501806,8574667,3p26-p24,3p25.3,604859,LMCD1,LIM and cysteine-rich domains 1,LMCD1,29995,ENSG00000071282,NA,NA,Lmcd1 (MGI:1353635)
3,8619399,8745034,3p26.1-p25.3,3p25.3,617479,"SSUH2, C3orf32, FLS485","Ssu2, C. elegans, homolog of",SSUH2,51066,ENSG00000125046,NA,NA,Ssu2 (MGI:2443733)
3,8733799,8746764,3p25,3p25.3,601253,"CAV3, LQT9, MPDT, RMD2",Caveolin-3,CAV3,859,ENSG00000182533,within 7-10kb of OXTR,"Cardiomyopathy, familial hypertrophic, 192600 (3), Autosomal dominant; Creatine phosphokinase, elevated serum, 123320 (3), Autosomal dominant; Long QT syndrome 9, 611818 (3), Autosomal dominant; Myopathy, distal, Tateyama type, 614321 (3), Autosomal dominant; Rippling muscle disease 2, 606072 (3), Autosomal dominant",Cav3 (MGI:107570)
3,8750402,8769613,3p26.2,3p25.3,167055,OXTR,Oxytocin receptor,OXTR,5021,ENSG00000180914,3p25 by others; within 7-10kb of CAV3,NA,Oxtr (MGI:109147)
3,8877074,8969248,3p25-p24,3p25.3,605256,RAD18,"Rad18, S. cerevisiae, homolog of",RAD18,56852,ENSG00000070950,NA,NA,Rad18 (MGI:1890476)
3,8980590,9363445,3p25,3p25.3,606525,"SRGAP3, KIAA0411, MEGAP","Slit-robo GTPase-activating protein, rho, 3",SRGAP3,9901,ENSG00000196220,NA,NA,Srgap3 (MGI:2152938)
3,9397614,9478153,3p25.3,3p25.3,615743,"SETD5, KIAA1757",SET domain-containing protein 5,SETD5,55209,ENSG00000168137,NA,"Mental retardation, autosomal dominant 23, 615761 (3), Autosomal dominant",Setd5 (MGI:1920145)
3,9498360,9553821,3p25,3p25.3,610240,LHFPL4,LHFP-like protein 4,LHFPL4,375323,ENSG00000156959,NA,NA,Lhfpl4 (MGI:3057108)
3,9649464,9702392,3p25.3,3p25.3,611089,"MTMR14, C3orf29, HJUMPY",Myotubularin-related protein 14,MTMR14,64419,ENSG00000163719,NA,"{Centronuclear myopathy, autosomal, modifier of}, 160150 (3), Autosomal dominant",Mtmr14 (MGI:1916075)
3,9731728,9748014,3p26-p25,3p25.3,602410,"BRPF1, BR140, IDDDFP","Bromodomain- and PHD finger-containing protein 1, 140kD",BRPF1,7862,ENSG00000156983,NA,"Intellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3), Autosomal dominant",Brpf1 (MGI:1926033)
3,9749943,9788245,3p26.2,3p25.3,601982,OGG1,8-hydroxyguanine DNA glycosylase,OGG1,4968,ENSG00000114026,NA,"Renal cell carcinoma, clear cell, somatic, 144700 (3)",Ogg1 (MGI:1097693)
3,9757344,9769986,3p25.3,3p25.3,604998,"CAMK1, CAMKI",Calcium/calmodulin-dependent protein kinase I,CAMK1,8536,ENSG00000134072,NA,NA,Camk1 (MGI:1098535)
3,9779963,9793010,3p25.3,3p25.3,602945,"TADA3, TADA3L, ADA3",Transcriptional adaptor 3,TADA3,10474,ENSG00000171148,NA,NA,Tada3 (MGI:1915724)
3,9792494,9807723,3p25.3,3p25.3,604226,"ARPC4, ARC20","Actin-related protein 2/3 complex, subunit 4",ARPC4,10093,ENSG00000241553,NA,NA,Arpc4 (MGI:1915339)
3,9836252,9844058,3p25.3,3p25.3,617759,RPUSD3,RNA pseudouridylate synthase domain-containing protein 3,RPUSD3,285367,ENSG00000156990,NA,NA,Rpusd3 (MGI:2141440)
3,9866709,9880253,3p25,3p25.3,612120,"CIDEC, FSP27, CIDE3, FPLD5",Cell death-inducing DFFA-like effector C,CIDEC,63924,ENSG00000187288,1 patient identified with mutation,"?Lipodystrophy, familial partial, type 5, 615238 (3), Autosomal recessive",Cidec (MGI:95585)
3,9890609,9894348,3p25.3,3p25.3,616012,"JAGN1, SCN6","Jagunal, Drosophila, homolog of, 1",JAGN1,84522,ENSG00000171135,NA,"Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3), Autosomal recessive",Jagn1 (MGI:1915017)
3,9902086,9916401,3p25.3,3p25.3,614995,IL17RE,Interleukin 17 receptor E,IL17RE,132014,ENSG00000163701,NA,NA,Il17re (MGI:1889371)
3,9917073,9933626,3p25.3-p24.1,3p25.3,610925,"IL17RC, IL17RL, CANDF9",Interleukin 17 receptor C,IL17RC,84818,ENSG00000163702,NA,"Candidiasis, familial, 9, 616445 (3), Autosomal recessive",Il17rc (MGI:2159336)
3,9933787,9945405,3p25.3,3p25.3,607170,"CRELD1, AVSD2",Cysteine-rich protein with EGF-like domains 1,CRELD1,78987,ENSG00000163703,NA,"Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3), Autosomal dominant; {Atrioventricular septal defect, susceptibility to, 2}, 606217 (3), Autosomal dominant",Creld1 (MGI:2152539)
3,10026386,10101936,3p25.3,3p25.3,613984,"FANCD2, FANCD, FACD, FAD","Fanconi anemia, complementation group D2",FANCD2,2177,ENSG00000144554,NA,"Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive",Fancd2 (MGI:2448480)
3,10115674,10127189,3p25.3,3p25.3,611183,"BRK1, C3orf10, HSPC300","BRICK1, SCAR/WAVE actin-nucleating complex subunit",BRK1,55845,ENSG00000254999,NA,NA,Brk1 (MGI:1915406)
3,10141634,10153669,3p26-p25,3p25.3,608537,VHL,VHL gene,VHL,7428,ENSG00000134086,NA,"Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive; Hemangioblastoma, cerebellar, somatic (3); Pheochromocytoma, 171300 (3), Autosomal dominant; Renal cell carcinoma, somatic, 144700 (3); von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant",Vhl (MGI:103223)
3,10164918,10243744,3p25.3,3p25.3,603304,IRAK2,Interleukin 1 receptor-associated kinase 2,IRAK2,3656,ENSG00000134070,NA,NA,Irak2 (MGI:2429603)
3,10280951,10293448,3p25.3,3p25.3,618445,GHRLOS,"Ghrelin opposite strand, noncoding",GHRLOS,100126793,ENSG00000240288,NA,NA,NA
3,10285665,10292946,3p26-p25,3p25.3,605353,GHRL,Ghrelin,GHRL,51738,ENSG00000157017,NA,"{Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Ghrl (MGI:1930008)
3,10300928,10321187,3p25-p24,3p25.3,600152,"SEC13L1, D3S1231E, SEC13R","SEC13, S. cerevisiae, like 1",SEC13,6396,ENSG00000157020,NA,NA,Sec13 (MGI:99832)
3,10324022,10707961,3p26-p25,3p25.3,108733,"ATP2B2, PMCA2","ATPase, Ca++ transporting, plasma membrane, 2",ATP2B2,491,ENSG00000157087,NA,"{Deafness, autosomal recessive 12, modifier of}, 601386 (3), Autosomal recessive",Atp2b2 (MGI:105368)
3,10816199,10940713,3p25.3,3p25.3,607952,"SLC6A11, GAT3, GAT4","Solute carrier family 6 (neurotransmitter transporter, GABA), member 11",SLC6A11,6538,ENSG00000132164,NA,NA,Slc6a11 (MGI:95630)
3,10992733,11039248,3p25-p24,3p25.3,137165,"SLC6A1, GABATR, MAE","Solute carrier family 6 (neurotransmitter transporter, GABA), member 1",SLC6A1,6529,ENSG00000157103,NA,"Myoclonic-atonic epilepsy, 616421 (3), Autosomal dominant",Slc6a1 (MGI:95627)
3,11137237,11263556,3p21-p14,3p25.3,600167,HRH1,"Histamine receptor, subclass H1",HRH1,3269,ENSG00000196639,NA,NA,Hrh1 (MGI:107619)
3,11272347,11564651,3p25.3,3p25.3,608760,"ATG7, APG7L, GSA7","Autophagy 7, S. cerevisiae, homolog of",ATG7,10533,ENSG00000197548,NA,NA,Atg7 (MGI:1921494)
3,11600000,16300000,3p25.2-p25.1,NA,606661,UVM2,"Melanoma, uveal, susceptibility to, 2",NA,170593,NA,NA,"{Melanoma, uveal, susceptibility to, 2}, 606661 (2)",NA
3,11721895,11846918,3p25.2,3p25.2,614948,"TAMM41, RAM41, C3orf31","Translocator assembly and maintenance, mitochondrial, S. cerevisiae, homolog of",TAMM41,132001,ENSG00000144559,NA,NA,Tamm41 (MGI:1916221)
3,12004359,12192031,3p25,3p25.2,600755,SYN2,Synapsin II,SYN2,6854,ENSG00000157152,NA,"{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant",Syn2 (MGI:103020)
3,12153067,12158911,3p25,3p25.2,601915,TIMP4,Tissue inhibitor of metalloproteinase 4,TIMP4,7079,ENSG00000157150,NA,NA,Timp4 (MGI:109125)
3,12287484,12434355,3p25,3p25.2,601487,"PPARG, PPARG1, PPARG2, CIMT1, GLM1","Peroxisome proliferator activated receptor, gamma",PPARG,5468,ENSG00000132170,"PPARG1, PPARG2 from same gene","Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3), Autosomal dominant; Insulin resistance, severe, digenic, 604367 (3), Autosomal dominant; Lipodystrophy, familial partial, type 3, 604367 (3), Autosomal dominant; [Obesity, resistance to] (3); Obesity, severe, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Pparg (MGI:97747)
3,12484431,12539623,3p25.1,3p25.2,608753,"TSEN2, SEN2, PCH2B","tRNA splicing endonuclease 2, S. cerevisiae, homolog of",TSEN2,80746,ENSG00000154743,NA,"Pontocerebellar hypoplasia type 2B, 612389 (3), Autosomal recessive",Tsen2 (MGI:2141599)
3,12557013,12583712,3p25,3p25.2,608426,MKRN2,Makorin 2,MKRN2,23609,ENSG00000075975,NA,NA,Mkrn2 (MGI:1914277)
3,12583600,12664200,3p25,3p25.2,164760,"RAF1, CRAF, NS5, CMD1NN",Oncogene RAF1,RAF1,5894,ENSG00000132155,NA,"Cardiomyopathy, dilated, 1NN, 615916 (3), Autosomal dominant; LEOPARD syndrome 2, 611554 (3); Noonan syndrome 5, 611553 (3), Autosomal dominant",Raf1 (MGI:97847)
3,12796653,12834817,3p25.2,3p25.2,610403,"CAND2, TIP120B, KIAA0667",Cullin-associated neddylation -dissociated 2,CAND2,23066,ENSG00000144712,NA,NA,Cand2 (MGI:1914338)
3,12897042,13073428,3p25.2,3p25.2,610166,"IQSEC1, KIAA0763",IQ motif- and Sec7 domain-containing protein 1,IQSEC1,9922,ENSG00000144711,NA,NA,Iqsec1 (MGI:1196356)
3,13200000,32000000,3p25.1-p23,NA,613530,LGMD1H,"Muscular dystrophy, limb-girdle, type 1H",LGMD1H,100529230,NA,between D3S1263 and D3S1277,"Muscular dystrophy, limb-girdle, type 1H, 613530 (2), Autosomal dominant",NA
3,13316234,13420321,3p25.1,3p25.1,607703,"NUP210, GP210, KIAA0906","Nucleoporin, 210kD",NUP210,23225,ENSG00000132182,NA,NA,Nup210 (MGI:1859555)
3,13549124,13638407,3p25-p24,3p25.1,135821,FBLN2,Fibulin-2,FBLN2,2199,ENSG00000163520,NA,NA,Fbln2 (MGI:95488)
3,13816257,13880070,3p25,3p25.1,601570,WNT7A,"Wingless-type MMTV integration site family, member 7A",WNT7A,7476,ENSG00000154764,NA,"Fuhrmann syndrome, 228930 (3), Autosomal recessive; Ulna and fibula, absence of, with severe limb deficiency, 276820 (3), Autosomal recessive",Wnt7a (MGI:98961)
3,13937306,14065983,3p25.1,3p25.1,611167,TPRXL,Tetrapeptide repeat homeobox-like,TPRXL,348825,ENSG00000180438,NA,NA,NA
3,14112076,14124869,3p25.1,3p25.1,611077,"CHDH4, MIA40",Coiled-coil-helix-coiled-coil-helix domain-containing protein 4,CHCHD4,131474,ENSG00000163528,NA,NA,Chchd4 (MGI:1919420)
3,14124939,14143679,3p25,3p25.1,612048,"TMEM43, ARVD5, ARVC5, EDMD7",Transmembrane protein 43,TMEM43,79188,ENSG00000170876,NA,"Arrhythmogenic right ventricular dysplasia 5, 604400 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3), Autosomal dominant",Tmem43 (MGI:1921372)
3,14145144,14178671,3p25,3p25.1,613208,"XPC, XPCC",XPC gene,XPC,7508,ENSG00000154767,NA,"Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive",Xpc (MGI:103557)
3,14178816,14201121,3p25.1,3p25.1,607283,LSM3,LSM3 protein,LSM3,27258,ENSG00000170860,NA,NA,Lsm3 (MGI:1914928)
3,14402575,14489348,3p25-q24,3p25.1,186854,"SLC6A6, TAUT","Solute carrier family 6 (neurotransmitter transporter, taurine), member 6",SLC6A6,6533,ENSG00000131389,NA,NA,Slc6a6 (MGI:98488)
3,14651745,14672658,3p25.1,3p25.1,616735,"CCDC174, HSPC212, IHPM",Coiled-coil domain-containing protein 174,CCDC174,51244,ENSG00000154781,NA,"Hypotonia, infantile, with psychomotor retardation, 616816 (3), Autosomal recessive",Ccdc174 (MGI:2444652)
3,14818961,14934570,3p25.1,3p25.1,614788,FGD5,"FYVE, RhoGEF, and PH domain-containing protein 5",FGD5,152273,ENSG00000154783,NA,NA,Fgd5 (MGI:2443369)
3,14947582,15049272,3p25,3p25.1,601426,"NR2C2, TR4, TAK1","Nuclear receptor subfamily 2, group C, member 2",NR2C2,7182,ENSG00000177463,NA,NA,Nr2c2 (MGI:1352466)
3,15042250,15065336,3p25,3p25.1,611987,MRPS25,Mitochondrial ribosomal protein S25,MRPS25,64432,ENSG00000131368,NA,NA,Mrps25 (MGI:1928140)
3,15070068,15099162,3p25.1,3p25.1,609511,"RBSN,  ZFYVE20",Rabenosyn 5,RBSN,64145,ENSG00000131381,NA,NA,Rbsn (MGI:1925537)
3,15165361,15205958,3p24.3,3p25.1,612397,"COL6A4P1, DVWA, DIVA, LOC344875","Collagen, type VI, alpha 4, pseudogene 1",COL6A4P1,344875,ENSG00000230524,NA,NA,NA
3,15206245,15252915,3p24,3p25.1,606400,"CAPN7, PALBH",Calpain 7,CAPN7,23473,ENSG00000131375,NA,NA,Capn7 (MGI:1338030)
3,15254352,15341379,3p25.1,3p25.1,605612,"SH3BP5, SAB",SH3 domain-binding protein 5,SH3BP5,9467,ENSG00000131370,previously mapped to 1q431,NA,Sh3bp5 (MGI:1344391)
3,15427597,15442612,3p25.1,3p25.1,608315,EAF1,ELL-associated factor 1,EAF1,85403,ENSG00000144597,NA,NA,Eaf1 (MGI:1921677)
3,15450132,15521705,3p25,3p25.1,603033,"COLQ, EAD, CMS5",Collagenic tail of endplate acetylcholinesterase,COLQ,8292,ENSG00000206561,NA,"Myasthenic syndrome, congenital, 5, 603034 (3), Autosomal recessive",NA
3,15560698,15601851,3p25.1,3p25.1,604300,"HACL1, HPCL2",2-hydroxyacyl-CoA lyase 1,HACL1,26061,ENSG00000131373,NA,NA,Hacl1 (MGI:1929657)
3,15601351,15722515,3p25,3p25.1,609019,BTD,Biotinidase,BTD,686,ENSG00000169814,NA,"Biotinidase deficiency, 253260 (3), Autosomal recessive",Btd (MGI:1347001)
3,15667235,15859813,3p25.1,3p25.1,611122,"ANKRD28, PITK, KIAA0379",Ankyrin repeat domain-containing protein 28,ANKRD28,23243,ENSG00000206560,NA,NA,Ankrd28 (MGI:2145661)
3,16174578,16248223,3p25.1,3p25.1,615131,"GALNT15, GALNACT15",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15,GALNT15,117248,ENSG00000131386,NA,NA,Galnt15 (MGI:1926004)
3,16257060,16264942,3p24.3,3p25.1,608959,"DPH3, KTI11, ZCSL2, DELGIP1",Diphthamide biosynthesis protein 3,DPH3,285381,ENSG00000154813,NA,NA,Dph3 (MGI:1922658)
3,16300000,54400000,3p24-p21,NA,609954,ASPG4,"Asperger syndrome, susceptibility to, 4",NA,100188800,NA,max lod at D3S2432,"{Asperger syndrome susceptibility 4}, 609954 (2)",NA
3,16300000,30800000,3p24,NA,613519,ATOD9,"Dermatitis, atopic, 9",NA,105463126,NA,max lod at D3S1768,"{Dermatitis, atopic, susceptibility to, 9}, 613519 (2)",NA
3,16300000,43600000,3p24-p22,NA,608088,HSN1B,"Hereditary sensory neuropathy, type IB",NA,378888,NA,max lod at D3S2338,"Neuropathy, hereditary sensory, type IB, 608088 (2), Autosomal dominant",NA
3,16300000,23800000,3p24.3,NA,612401,OS6,Osteoarthritis susceptibility 6,NA,100286836,NA,associated with rs11718863 and rs7639618,"{Osteoarthritis susceptibility 6}, 612401 (2)",NA
3,16300000,52300000,3p24-p21.2,NA,609649,TRICY1,Trichilemmal cyst 1,TRICY1,94014,NA,max lod at D3S1277,"Trichilemmal cyst 1, 609649 (2), Autosomal dominant",NA
3,16315844,16513698,3p24.3,3p24.3,618210,"RFTN1, KIAA0084",Lipid raft linking protein 1,RFTN1,23180,ENSG00000131378,NA,NA,Rftn1 (MGI:1923688)
3,16586791,16605422,3p24,3p24.3,601486,"DAZL, DAZH, SPGYLA",Deleted in azoospermia-like,DAZL,1618,ENSG00000092345,?founding member of DAZ gene family,"{Spermatogenic failure, susceptibility to} (3)",NA
3,16802690,17090605,3p25-p24,3p24.3,614276,"PLCL2, KIAA1092",Phospholipase C-like 2,PLCL2,23228,ENSG00000154822,NA,NA,Plcl2 (MGI:1352756)
3,17157161,17742738,3p24.3,3p24.3,615740,"TBC1D5, KIAA0210","TBC1 domain family, member 5",TBC1D5,9779,ENSG00000131374,NA,NA,Tbc1d5 (MGI:1919488)
3,18345376,18445591,3p23,3p24.3,602075,SATB1,Special AT-rich sequence binding protein-1,SATB1,6304,ENSG00000182568,NA,NA,Satb1 (MGI:105084)
3,19947079,19985174,3p24-p22,3p24.3,179512,"RAB5A, RAB5",RAS-associated protein RAB5A,RAB5A,5868,ENSG00000144566,NA,NA,Rab5a (MGI:105926)
3,20040406,20154403,3p24,3p24.3,602303,CAF,CREBBP-associated factor,KAT2B,8850,ENSG00000114166,NA,NA,Kat2b (MGI:1343094)
3,20160592,20188142,3p24.3,3p24.3,609168,"SGOL1, SGO, SGO1, CAID",Shugoshin-like 1,SGO1,151648,ENSG00000129810,NA,"Chronic atrial and intestinal dysrhythmia, 616201 (3), Autosomal recessive",Sgo1 (MGI:1919665)
3,23203006,23591924,3p24.2,3p24.3,602163,UBE2E2,Ubiquitin-conjugating enzyme E2E 2 (homologous to yeast UBC4/5),UBE2E2,7325,ENSG00000182247,NA,NA,Ube2e2 (MGI:2384997)
3,23800000,32000000,3p24.2-p23,NA,611634,FEB9,"Febrile seizures, familial, 9",NA,100188849,NA,between D3S3727 and D3S3567,"Febrile seizures, familial, 9, 611634 (2), Autosomal dominant",NA
3,23805954,23891639,3p24.3-p24.2,3p24.2,602916,"UBE2E1, UBCH6",Ubiquitin-conjugating enzyme E2E 1,UBE2E1,7324,ENSG00000170142,NA,NA,Ube2e1 (MGI:107411)
3,23916544,23924630,3p24.2,3p24.2,604174,"RPL15, DBA12",Ribosomal protein L15,RPL15,6138,ENSG00000174748,mutation identified in 1 family,"?Diamond-Blackfan anemia 12, 615550 (3), Autosomal dominant",Rpl15 (MGI:1913730)
3,23945259,23980617,3p24.3,3p24.2,602304,"NR1D2, RVR, BD73","Nuclear receptor subfamily 1, group D, member 2",NR1D2,9975,ENSG00000174738,NA,NA,Nr1d2 (MGI:2449205)
3,24117152,24495707,3p24.3,3p24.2,190160,"THRB, ERBA2, THR1, PRTH","Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)",THRB,7068,ENSG00000151090,NA,"Thyroid hormone resistance, 188570 (3), Autosomal dominant; Thyroid hormone resistance, autosomal recessive, 274300 (3), Autosomal recessive; Thyroid hormone resistance, selective pituitary, 145650 (3), Autosomal dominant",Thrb (MGI:98743)
3,24829322,25597931,3p24,3p24.2,180220,"RARB, HAP, MCOPS12","Retinoic acid receptor, beta polypeptide",RARB,5915,ENSG00000077092,= HAP = HBV-activated protein,"Microphthalmia, syndromic 12, 615524 (3), Autosomal recessive, Autosomal dominant",Rarb (MGI:97857)
3,25597904,25664890,3p24,3p24.2,126431,TOP2B,"Topoisomerase (DNA) II, beta, 180kD",TOP2B,7155,ENSG00000077097,NA,NA,Top2b (MGI:98791)
3,25718943,25790038,3p24,3p24.2,610661,"NGLY1, PNG1, CDDG, CDG1V",N-glycanase 1,NGLY1,55768,ENSG00000151092,NA,"Congenital disorder of deglycosylation, 615273 (3), Autosomal recessive",Ngly1 (MGI:1913276)
3,25788282,25794533,3p24.2,3p24.2,610324,"OXSM, KS","3-oxoacyl-ACP synthase, mitochondrial",OXSM,54995,ENSG00000151093,NA,NA,Oxsm (MGI:1918397)
3,27372720,27484419,3p22,3p24.1,603353,"SLC4A7, NBC2, NBC3","Solute carrier family 4, sodium bicarbonate cotransporter, member 7",SLC4A7,9497,ENSG00000033867,NA,NA,Slc4a7 (MGI:2443878)
3,27715948,27722714,3p21.3-p21.2,3p24.1,604615,"EOMES, TBR2","Eomesodermin, Xenopus laevis, homolog of",EOMES,8320,ENSG00000163508,?translocation separating regulatory element from promoter,NA,Eomes (MGI:1201683)
3,28241592,28325141,3p24,3p24.1,615166,"CMC1, C3orf68","Cytochrome C oxidase assembly mitochondrial protein 1, S. cerevisiae, homolog of",CMC1,152100,ENSG00000187118,NA,NA,Cmc1 (MGI:1915149)
3,28321046,28349277,3p24.1,3p24.1,609916,"AZI2, AZ2, NAP1, TILP","5-azacytidine-induced gene 2, mouse, homolog of",AZI2,64343,ENSG00000163512,NA,NA,Azi2 (MGI:1351332)
3,29280859,30010394,3p24-p23,3p24.1,605786,RBMS3,"RNA-binding motif protein, single strand-interacting, 3",RBMS3,27303,ENSG00000144642,NA,NA,Rbms3 (MGI:2444477)
3,30606471,30694141,3p24.1,3p24.1,190182,"TGFBR2, HNPCC6, AAT3, MFS2, LDS2","Transforming growth factor, beta receptor II, 70-80kD",TGFBR2,7048,ENSG00000163513,NA,"Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3); Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome 2, 610168 (3), Autosomal dominant",Tgfbr2 (MGI:98729)
3,30726008,30894660,3p24.1,3p24-p23,615601,GADL1,Glutamate decarboxylase-like 1,GADL1,339896,ENSG00000144644,NA,NA,Gadl1 (MGI:1920998)
3,30800000,54400000,3p23-p21,NA,182280,SCLC1,Small-cell cancer of lung,NA,7864,NA,centromeric to ERBA2,"Small-cell cancer of lung, 182280 (2), Autosomal dominant",NA
3,31532637,31637620,3p23,3p23,608605,"STT3B, SIMP, CDG1X","STT3B, subunit of the oligosaccharyltransferase complex (catalytic)",STT3B,201595,ENSG00000163527,mutation identified in 1 family,"?Congenital disorder of glycosylation, type Ix, 615597 (3), Autosomal recessive",Stt3b (MGI:1915542)
3,31660824,31981849,3p25.3-p22,3p23,606738,"OSBPL10, ORP10",Oxysterol-binding protein-like protein 10,OSBPL10,114884,ENSG00000144645,NA,NA,Osbpl10 (MGI:1921736)
3,32000000,43600000,3p22,NA,614836,HHV8S,"Human herpesvirus 8, susceptibility to",NA,101056702,NA,NA,"{Human herpesvirus 8, susceptibility to}, 614836 (2)",NA
3,32106510,32168714,3p22.3,3p22.3,611778,"GPD1L, KIAA0089",Glycerol-3-phosphate dehydrogenase 1-like,GPD1L,23171,ENSG00000152642,NA,"Brugada syndrome 2, 611777 (3)",Gpd1l (MGI:1289257)
3,32238678,32370324,3p22.3,3p22.3,607891,"CMTM8, CKLFSF8",CKLF-like marvel transmembrane domain-containing 8,CMTM8,152189,ENSG00000170293,NA,NA,Cmtm8 (MGI:2447167)
3,32391824,32455527,3p22.3,3p22.3,607890,"CMTM7, CKLFSF7",CKLF-like marvel transmembrane domain-containing 7,CMTM7,112616,ENSG00000153551,NA,NA,Cmtm7 (MGI:2447166)
3,32481311,32502851,3p22.3,3p22.3,607889,"CMTM6, CKLFSF6",CKLF-like marvel transmembrane domain-containing 6,CMTM6,54918,ENSG00000091317,NA,NA,Cmtm6 (MGI:2447165)
3,32525970,32570923,3p22.3,3p22.3,615890,"DYNC1LI1, LIC1","Dynein, cytoplasmic 1, light intermediate chain 1",DYNC1LI1,51143,ENSG00000144635,NA,NA,Dync1li1 (MGI:2135610)
3,32951554,32956348,3p24,3p22.3,604836,"CCR4, CKR4, CMKBR4",Chemokine (C-C) receptor-4,CCR4,1233,ENSG00000183813,NA,NA,Ccr4 (MGI:107824)
3,32996607,33097229,3p21.33,3p22.3,611458,"GLB1, MPS4B","Galactosidase, beta-1",GLB1,2720,ENSG00000170266,3p14.2-p11 excluded,"GM1-gangliosidosis, type I, 230500 (3), Autosomal recessive; GM1-gangliosidosis, type II, 230600 (3), Autosomal recessive; GM1-gangliosidosis, type III, 230650 (3), Autosomal recessive; Mucopolysaccharidosis type IVB (Morquio), 253010 (3), Autosomal recessive",Glb1 (MGI:88151)
3,33113957,33147772,3p22,3p22.3,605497,"CRTAP, CASP, OI7",Cartilage-associated protein,CRTAP,10491,ENSG00000170275,NA,"Osteogenesis imperfecta, type VII, 610682 (3), Autosomal recessive",Crtap (MGI:1891221)
3,33277024,33422697,3p22.3,3p22.3,605652,"FBXL2, FBL2",F-box and leucine-rich repeat protein 2,FBXL2,25827,ENSG00000153558,NA,NA,Fbxl2 (MGI:1919429)
3,33388335,33440404,3p23,3p22.3,609784,"UBP1, LBP1A, LBP1B",Upstream binding protein 1,UBP1,7342,ENSG00000153560,NA,NA,Ubp1 (MGI:104889)
3,33496244,33718355,3p22.3,3p22.3,605853,CLASP2,CLIP-associated protein 2,CLASP2,23122,ENSG00000163539,NA,NA,Clasp2 (MGI:1923749)
3,33798570,33869706,3p22.3,3p22.3,608074,"PDCD6IP, AIP1, ALIX, KIAA1375",Programmed cell death 6-interacting protein,PDCD6IP,10015,ENSG00000170248,NA,NA,Pdcd6ip (MGI:1333753)
3,35639524,35798932,3p22.3,3p22.3,605488,"ARPP21, RCS","Cyclic AMP-regulated phosphoprotein, 21kD",ARPP21,10777,ENSG00000172995,NA,NA,Arpp21 (MGI:107562)
3,35744475,35744558,3p22,3p22.3,611769,"MIR128-2, MIR128B, MIRN128-2",Micro RNA 128-2,MIR128-2,406916,ENSG00000207625,NA,NA,NA
3,36380342,36548006,3p24-p22,3p22.3-p22.2,602317,STAC,SRC homology three (SH3) and cysteine-rich domain,STAC,6769,ENSG00000144681,NA,NA,Stac (MGI:1201400)
3,36400000,39300000,3p22.2,NA,615612,DDH2,Developmental dysplasia of the hip 2,NA,102775567,NA,between rs4481097 and rs4626072,"Developmental dysplasia of the hip 2, 615612 (2), Autosomal dominant",NA
3,36712421,36764205,3p22.3,3p22.2,613167,"DCLK3, DCK3, CLR",Doublecortin-like kinase 3,DCLK3,85443,ENSG00000163673,NA,NA,Dclk3 (MGI:3039580)
3,36985042,36993130,3p22.1,3p22.2,607911,"EPM2AIP1, KIAA0766",EPM2A-interacting protein 1,EPM2AIP1,9852,ENSG00000178567,NA,NA,Epm2aip1 (MGI:1925031)
3,36993349,37050845,3p21.3,3p22.2,120436,"MLH1, COCA2, HNPCC2","mutL, E. coli, homolog of, 1",MLH1,4292,ENSG00000076242,NA,"Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive; Muir-Torre syndrome, 158320 (3), Autosomal dominant",Mlh1 (MGI:101938)
3,37052625,37176816,3p22.2,3p22.2,614043,LRRFIP2,Leucine-rich repeat in FLII-interacting protein 2,LRRFIP2,9209,ENSG00000093167,NA,NA,NA
3,37243268,37366878,3p22-p21.3,3p22.2,602509,GOLGA4,"Golgi autoantigen, golgin subfamily a, 4",GOLGA4,2803,ENSG00000144674,NA,NA,Golga4 (MGI:1859646)
3,37452140,37823506,3p21.3,3p22.2,603963,ITGA9,"Integrin, alpha-9",ITGA9,3680,ENSG00000144668,NA,NA,Itga9 (MGI:104756)
3,37969403,37969479,3p22.2,3p22.2,612151,"MIR26A, MIRN26A1",Micro RNA 26A1,MIR26A1,407015,ENSG00000199075,NA,NA,NA
3,38007495,38029641,3p22-p21.3,3p22.2,602142,"PLCD1, NDNC3","Phospholipase C, delta-1",PLCD1,5333,ENSG00000187091,NA,"Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3), Autosomal recessive, Autosomal dominant",Plcd1 (MGI:97614)
3,38038594,38124024,3p22-p21.3,3p22.2,604050,"DLEC1, DLC1",Deleted in lung and esophageal cancer 1,DLEC1,9940,ENSG00000008226,NA,NA,Dlec1 (MGI:2443671)
3,38122709,38137241,3p23-p22,3p22.2,604054,ACAA1,Acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase),ACAA1,30,ENSG00000060971,NA,NA,Acaa1a (MGI:2148491)
3,38138660,38143021,3p22-p21.3,3p22.2,602170,"MYD88, MYD88D",Myeloid differentiation primary response gene 88,MYD88,4615,ENSG00000172936,NA,"Macroglobulinemia, Waldenstrom, somatic, 153600 (3); Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3)",Myd88 (MGI:108005)
3,38165050,38255485,3p22-p21.3,3p22.2,604046,OSR1,Oxidative stress-responsive 1,OXSR1,9943,ENSG00000172939,NA,NA,Oxsr1 (MGI:1917378)
3,38265811,38278756,3p22.2,3p22.2,604047,"SLC22A13, ORCTL3, OCTL1","Solute carrier family 22 (organic anion/urate transporter), member 13",SLC22A13,9390,ENSG00000172940,NA,NA,Slc22a13 (MGI:2143107)
3,38281661,38318574,3p22.2,3p22.2,604048,"SLC22A14, ORCTL4, OCTL2","Solute carrier family 22, member 14",SLC22A14,9389,ENSG00000144671,NA,NA,Slc22a14 (MGI:2685974)
3,38346759,38453040,3p22-p21.3,3p22.2,604049,XYLB,"Xylulokinase, H. influenzae, homolog of",XYLB,9942,ENSG00000093217,NA,NA,Xylb (MGI:2142985)
3,38453889,38493141,3p22-p21.3,3p22.2,602730,"ACVR2B, ACTRIIB, HTX4","Activin A receptor, type IIB",ACVR2B,93,ENSG00000114739,NA,"Heterotaxy, visceral, 4, autosomal, 613751 (3)",Acvr2b (MGI:87912)
3,38496126,38526304,3p22-p21.3,3p22.2,604051,"EXOG, ENDOGL1, ENGL","Endo/exonuclease, ENDOG-like",EXOG,9941,ENSG00000157036,NA,NA,Exog (MGI:2143333)
3,38548060,38649686,3p21,3p22.2,600163,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2","Sodium channel, voltage-gated, type V, alpha polypeptide",SCN5A,6331,ENSG00000183873,NA,"Atrial fibrillation, familial, 10, 614022 (3), Autosomal dominant; Brugada syndrome 1, 601144 (3), Autosomal dominant; Cardiomyopathy, dilated, 1E, 601154 (3), Autosomal dominant; Heart block, nonprogressive, 113900 (3), Autosomal dominant; Heart block, progressive, type IA, 113900 (3), Autosomal dominant; Long QT syndrome-3, 603830 (3), Autosomal dominant; Sick sinus syndrome 1, 608567 (3), Autosomal recessive; {Sudden infant death syndrome, susceptibility to}, 272120 (3), Autosomal recessive; Ventricular fibrillation, familial, 1, 603829 (3)",Scn5a (MGI:98251)
3,38697109,38794009,3p22.2,3p22.2,604427,"SCN10A, FEPS2","Sodium channel, voltage-gated, type X, alpha subunit",SCN10A,6336,ENSG00000185313,NA,"Episodic pain syndrome, familial, 2, 615551 (3), Autosomal dominant",Scn10a (MGI:108029)
3,38845763,39051943,3p22.2,3p22.2,604385,"SCN11A, HSAN7, FEPS3","Sodium channel, voltage-gated, type XI, alpha subunit",SCN11A,11280,ENSG00000168356,NA,"Episodic pain syndrome, familial, 3, 615552 (3), Autosomal dominant; Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3), Autosomal dominant",Scn11a (MGI:1345149)
3,39051985,39096670,3p21.33,3p22.2,612167,"WDR48, KIAA1449",WD repeat-containing protein 48,WDR48,57599,ENSG00000114742,NA,NA,Wdr48 (MGI:1914811)
3,39096598,39108362,3p21.3,3p22.2,606867,"GORASP1, GOLPH5, GRASP65, P65","Golgi reassembly stacking protein 1, 65kD",GORASP1,64689,ENSG00000114745,NA,NA,Gorasp1 (MGI:1921748)
3,39107660,39139008,3p21.3,3p22.2,611430,"TTC21A, STI2, SPGF37",Tetratricopeptide repeat domain-containing protein 21A,TTC21A,199223,ENSG00000168026,NA,"Spermatogenic failure 37, 618429 (3), Autosomal recessive",Ttc21a (MGI:1921302)
3,39141850,39154640,3p22,3p22.2,606458,AXUD1,Axin1 upregulated,CSRNP1,64651,ENSG00000144655,NA,NA,Csrnp1 (MGI:2387989)
3,39183213,39192620,3p22.2,3p22.2,609777,"CMYA1, XIN",Cardiomyopathy-associated protein 1,XIRP1,165904,ENSG00000168334,NA,NA,Xirp1 (MGI:1333878)
3,39263493,39281734,3pter-p21,3p22.2,601470,"CX3CR1, GPR13, V28",Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13),CX3CR1,1524,ENSG00000168329,NA,"{Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, 12}, 613784 (3); {Rapid progression to AIDS from HIV1 infection}, 609423 (3)",Cx3cr1 (MGI:1333815)
3,39329708,39333679,3p22,3p22.1,601834,"CCR8, CMKBR8, CMKBRL2, CKRL1",Chemokine (C-C) receptor 8,CCR8,1237,ENSG00000179934,NA,NA,Ccr8 (MGI:1201402)
3,39383352,39397350,3p22.1,3p22.1,610819,"SLC25A38, SIDBA2","Solute carrier family 25, member 38",SLC25A38,54977,ENSG00000144659,NA,"Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3), Autosomal recessive",Slc25a38 (MGI:2384782)
3,39406719,39412541,3p21.3,3p22.1,150370,"RPSA, LAMR1, LAMBR, ICAS",Ribosomal protein SA,RPSA,3921,ENSG00000168028,NA,"Asplenia, isolated congenital, 271400 (3), Autosomal dominant",Rpsa (MGI:105381)
3,39411053,39411206,3p22.1,3p22.1,180646,"SNORA62, RNU108, RNE2","Small nucleolar RNA, H/ACA box, 62",SNORA62,6044,ENSG00000202363,NA,NA,NA
3,39467572,39529496,3p22-p21,3p22.1,600948,MOBP,Myelin-associated oligodendrocyte basic protein,MOBP,4336,ENSG00000168314,NA,NA,Mobp (MGI:108511)
3,39808913,40260320,3p21.33-p21.32,3p22.1,611790,"MYRIP, SLAC2C",Myosin VIIA- and RAB-interacting protein,MYRIP,25924,ENSG00000170011,NA,NA,Myrip (MGI:2384407)
3,40387181,40428743,3p21.3,3p22.1,603161,"ENTPD3, CD39L3",Ectonucleoside triphosphate diphosphohydrolase 3,ENTPD3,956,ENSG00000168032,NA,NA,Entpd3 (MGI:1321386)
3,40457338,40468586,3p22.1,3p22.1,617414,RPL14,Ribosomal protein L14,RPL14,9045,ENSG00000188846,NA,NA,Rpl14 (MGI:1914365)
3,41199421,41240444,3p22.1,3p22.1,116806,"CTNNB1, NEDSDV, EVR7","Catenin (cadherin-associated protein), beta 1, 88kD",CTNNB1,1499,ENSG00000168036,NA,"Colorectal cancer, somatic, 114500 (3); Exudative vitreoretinopathy 7, 617572 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Medulloblastoma, somatic, 155255 (3); Neurodevelopmental disorder with spastic diplegia and visual defects, 615075 (3), Autosomal dominant; Ovarian cancer, somatic, 167000 (3); Pilomatricoma, somatic, 132600 (3)",Ctnnb1 (MGI:88276)
3,41246598,41962439,3p22.1,3p22.1,617010,"ULK4, FAM7C1",Unc51-like kinase 4,ULK4,54986,ENSG00000168038,NA,NA,Ulk4 (MGI:1921622)
3,42013801,42225889,3p25.3-p24.1,3p22.1,608112,"TRAK1, OIP106, KIAA1042, EIEE68","Trafficking protein, kinesin-binding 1",TRAK1,22906,ENSG00000182606,NA,"Epileptic encephalopathy, early infantile, 68, 618201 (3), Autosomal recessive",Trak1 (MGI:1914345)
3,42257823,42266184,3pter-p21,3p22.1,118440,CCK,Cholecystokinin,CCK,885,ENSG00000187094,NA,NA,Cck (MGI:88297)
3,42360765,42411793,3p21.33,3p22.1,612750,LYZL4,Lysozyme-like 4,LYZL4,131375,ENSG00000157093,NA,NA,Lyzl4 (MGI:1916282)
3,42489298,42537572,3p22,3p22.1,192321,VIPR1,Vasoactive intestinal peptide receptor 1,VIPR1,7433,ENSG00000114812,incorrectly assigned to 2q37,NA,Vipr1 (MGI:109272)
3,42547968,42603126,3p22.1,3p22.1,604028,SEC22C,"Secretion deficient 22, S. cerevisiae, homolog of, C",SEC22C,9117,ENSG00000093183,NA,NA,Sec22c (MGI:2447871)
3,42581839,42596933,3p21,3p22.1,606473,SS18L2,SS18-like gene 2,SS18L2,51188,ENSG00000008324,NA,NA,Ss18l2 (MGI:1349474)
3,42600006,42648734,3p22.1,3p22.1,161565,NKTR,Natural tumor-killer recognition sequence,NKTR,4820,ENSG00000114857,mouse gene close to Cck,NA,Nktr (MGI:97346)
3,42685536,42692543,3p22.1,3p22.1,615340,"KLHL40, SYRP, KBTBD5, NEM8",Kelch-like 40,KLHL40,131377,ENSG00000157119,NA,"Nemaline myopathy 8, autosomal recessive, 615348 (3)",Klhl40 (MGI:1919580)
3,42692662,42702848,3p22.1,3p22.1,608116,"HHATL, MBOAT3, C3orf3, KIAA1173",Hedgehog acyltransferase-like protein,HHATL,57467,ENSG00000010282,NA,NA,Hhatl (MGI:1922020)
3,42809444,42867285,3p21.3,3p22.1,602648,"ACKR2, CCBP2, CMKBR9, D6, CCR9, CCR10",Atypical chemokine receptor 2,ACKR2,1238,ENSG00000144648,NA,NA,Ackr2 (MGI:1891697)
3,42872191,42875878,3p22-p21.3,3p22.1,602172,"CYP8B1, CYP12","Cytochrome P450, subfamily VIIIB, polypeptide 1",CYP8B1,1582,ENSG00000180432,NA,NA,Cyp8b1 (MGI:1338044)
3,43079228,43106084,3p22.1,3p22.1,614828,"POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8","Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2",POMGNT2,84892,ENSG00000144647,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8, 618135 (3), Autosomal recessive",Pomgnt2 (MGI:2143424)
3,43286511,43351142,3p21,3p22.1,612760,"SNRK, KIAA0096",SNF-related kinase,SNRK,54861,ENSG00000163788,NA,NA,Snrk (MGI:108104)
3,43365847,43691593,3p22.1,3p22.1-p21.3,613726,"ANO10, TMEM16K, SCAR10",Anoctamin 10,ANO10,55129,ENSG00000160746,NA,"Spinocerebellar ataxia, autosomal recessive 10, 613728 (3), Autosomal recessive",Ano10 (MGI:2143103)
3,43600000,54400000,3p21,NA,612007,CELIAC9,"Celiac disease, susceptibility to, 9",NA,100188871,NA,associated with rs6441961,"{Celiac disease, susceptibility to, 9}, 612007 (2)",NA
3,43600000,54400000,3p21,NA,606874,HSCR6,"Hirschsprung disease, susceptibility to, 6",NA,246321,NA,NA,"{Hirschsprung disease, susceptibility to, 6}, 606874 (2)",NA
3,43600000,50600000,3p21.3,NA,612241,IBD12,Inflammatory bowel disease 12,NA,100188952,NA,NA,"{Inflammatory bowel disease 12}, 612241 (2)",NA
3,43600000,74100000,3p21-p13,NA,612574,MPVQTL2,Mean platelet volume quantitative trait locus 2,NA,100271868,NA,associated with rs12485738,"[Mean platelet volume QTL2], 612574 (2)",NA
3,43600000,54400000,3p21,NA,613806,PSC,"Cholangitis, primary sclerosing",NA,100653366,NA,NA,"Cholangitis, primary sclerosing, 613806 (2)",NA
3,43600000,50600000,3p21.3,NA,601994,TRR,Transfer RNA arginine,NA,7870,NA,NA,NA,NA
3,43690869,43734370,3p21,3p21.33,604780,"ABHD5, CGI58, IECN2, NCIE2",Abhydrolase domain containing 5,ABHD5,51099,ENSG00000011198,NA,"Chanarin-Dorfman syndrome, 275630 (3), Autosomal recessive",Abhd5 (MGI:1914719)
3,44114211,44114309,3p21.32,3p21.32,613394,"MIR138-1, MIRN138-1",Micro RNA 138-1,MIR138-1,406929,ENSG00000207954,NA,NA,NA
3,44200000,50600000,3p21.31,NA,609815,ZD1,Zygodactyly 1,NA,780914,NA,max lod at D3S2409,"Zygodactyly 1, 609815 (2)",NA
3,44241885,44337070,3p21.33,3p21.31,614412,"TOPAZ1, C3orf77",Testis- and ovary-specific PAZ domain protein 1,TOPAZ1,375337,ENSG00000173769,NA,NA,Topaz1 (MGI:3779933)
3,44625018,44648470,3p21,3p21.31,618359,"ZNF197, ZNF20, VHLAK",Zinc finger protein 197,ZNF197,10168,ENSG00000186448,NA,NA,NA
3,44648731,44660790,3p22-p21,3p21.31,194533,"ZNF35, HF10",Zinc finger protein-35 (HF.10),ZNF35,7584,ENSG00000169981,NA,NA,Zfp105 (MGI:1277119)
3,44761739,44853273,3p21.31,3p21.31,617569,"KIF15, KLP2, KNSL7","Kinesin family, member 15",KIF15,56992,ENSG00000163808,NA,NA,Kif15 (MGI:1098258)
3,44874607,44914989,3p22-p21.33,3p21.31,600585,TGM4,"Transglutaminase-4, prostate",TGM4,7047,ENSG00000163810,NA,NA,Tgm4 (MGI:3027002)
3,44915260,44976184,3p21.31,3p21.31,617150,"ZDHHC3, DHHC3, GODZ",Zinc finger DHHC domain-containing protein 3,ZDHHC3,51304,ENSG00000163812,NA,NA,Zdhhc3 (MGI:1926134)
3,44975290,45012667,3p21.31,3p21.31,606488,"EXOSC7, RRP42",Exosome component 7,EXOSC7,23016,ENSG00000075914,NA,NA,Exosc7 (MGI:1913696)
3,45026206,45036070,3p22-p21.3,3p21.31,187520,TNA,Tetranectin (plasminogen-binding protein),CLEC3B,7123,ENSG00000163815,NA,NA,Clec3b (MGI:104540)
3,45082276,45146421,3p23-p21,3p21.31,611735,"CDCP1, SIMA135",CUB domain-containing protein 1,CDCP1,64866,ENSG00000163814,NA,NA,Cdcp1 (MGI:2442010)
3,45388563,45549406,3p21.3,3p21.31,604544,"LARS2, PRLTS4, HLASA","Leucyl-tRNA synthetase, mitochondrial",LARS2,23395,ENSG00000011376,mutation identified in 1 HLASA patient,"?Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3), Autosomal recessive; Perrault syndrome 4, 615300 (3), Autosomal recessive",Lars2 (MGI:2142973)
3,45594104,45686340,3p21.3,3p21.31,604543,LIMD1,LIM domain-containing protein 1,LIMD1,8994,ENSG00000144791,NA,NA,Limd1 (MGI:1352502)
3,45689361,45745408,3p21.3,3p21.31,606569,"SACM1L, SAC1, KIAA0851",SAC1 suppressor of actin mutations 1-like,SACM1L,22908,ENSG00000211456,NA,NA,Sacm1l (MGI:1933169)
3,45755448,45796552,3p21.3,3p21.31,605616,"SLC6A20, XT3",X transporter protein 3,SLC6A20,54716,ENSG00000163817,NA,"Hyperglycinuria, 138500 (3), Autosomal dominant; Iminoglycinuria, digenic, 242600 (3), Autosomal recessive, Digenic recessive",Slc6a20a (MGI:2143217)
3,45823315,45916036,3p21.3,3p21.31,606568,"LZTFL1, BBS17",Leucine zipper transcription factor-like 1,LZTFL1,54585,ENSG00000163818,NA,"Bardet-Biedl syndrome 17, 615994 (3), Autosomal recessive",Lztfl1 (MGI:1934860)
3,45886503,45903176,3p21.3,3p21.31,604738,CCR9,"Chemokine, CC motif, receptor 9",CCR9,10803,ENSG00000173585,NA,NA,Ccr9 (MGI:1341902)
3,45917902,45995823,3p21.3,3p21.31,607182,"FYCO1, CATC2, CTRCT18",FYVE and coiled-coil domain containing 1,FYCO1,79443,ENSG00000163820,NA,"Cataract 18, autosomal recessive, 610019 (3), Autosomal recessive",Fyco1 (MGI:107277)
3,45940687,45948353,3p21,3p21.31,605163,"CXCR6, STRL33, BONZO","Chemokine, CXC motif, receptor 6",CXCR6,10663,ENSG00000172215,NA,NA,Cxcr6 (MGI:1934582)
3,46016989,46086802,3p21.3-p21.1,3p21.31,600552,"XCR1, CCXCR1, GPR5","Chemokine, C motif, receptor 1 (G protein-coupled receptor-5)",XCR1,2829,ENSG00000173578,NA,NA,Xcr1 (MGI:1346338)
3,46201710,46208312,3p21,3p21.31,601159,"CCR1, CMKBR1, CKR1, HM145",Chemokine (C-C) receptor 1,CCR1,1230,ENSG00000163823,NA,NA,Ccr1 (MGI:104618)
3,46210698,46266705,3p21.3,3p21.31,601268,"CCR3, CKR3, CMKBR3",Chemokine (C-C) receptor 3,CCR3,1232,ENSG00000183625,NA,NA,Ccr3 (MGI:104616)
3,46353743,46360939,3p21,3p21.31,601267,"CCR2, CMKBR2",Chemokine (C-C) receptor 2,CCR2,729230,ENSG00000121807,NA,"{HIV infection, susceptibility/resistance to} (3)",Ccr2 (MGI:106185)
3,46370141,46376205,3p21,3p21.31,601373,"CCR5, CMKBR5, CCCKR5, IDDM22",Chemokine (C-C) receptor 5,CCR5,1234,ENSG00000160791,NA,"{Diabetes mellitus, insulin-dependent, 22}, 612522 (3); {HIV infection, susceptibility/resistance to} (3); {Hepatitis C virus, resistance to}, 609532 (3); {West nile virus, susceptibility to}, 610379 (3)",Ccr5 (MGI:107182)
3,46407165,46409522,3p21,3p21.31,608379,CCRL2,"Chemokine, CC motif, receptor-like protein 2",CCRL2,9034,ENSG00000121797,NA,NA,Ccrl2 (MGI:1920904)
3,46435644,46485233,3p21.31,3p21.31,150210,LTF,Lactotransferrin,LTF,4057,ENSG00000012223,NA,NA,Ltf (MGI:96837)
3,46497975,46500949,3p21.3,3p21.31,607181,"RTP3, TMEM7",Receptor-transporting protein 3,RTP3,83597,ENSG00000163825,NA,NA,NA
3,46515384,46580098,3p21.3,3p21.31,607180,LRRC2,Leucine-rich repeat-containing 2,LRRC2,79442,ENSG00000163827,NA,NA,Lrrc2 (MGI:1921499)
3,46574534,46582456,3p23-p21,3p21.31,187395,TDGF1,Teratocarcinoma-derived growth factor-1,TDGF1,6997,ENSG00000241186,NA,Forebrain defects (3),Tdgf1 (MGI:98658)
3,46668994,46693712,3p21.31,3p21.31,612402,ALS2CL,ALS2 C-terminal-like protein,ALS2CL,259173,ENSG00000178038,NA,NA,Als2cl (MGI:2447532)
3,46693777,46710922,3p21,3p21.31,607237,"TMIE, DFNB6",Transmembrane inner ear-expressed gene,TMIE,259236,ENSG00000181585,NA,"Deafness, autosomal recessive 6, 600971 (3), Autosomal recessive",Tmie (MGI:2159400)
3,46712116,46717868,3p21.31,3p21.31,607950,PRSS50,"Protease, serine, 50",PRSS50,29122,ENSG00000283706,NA,NA,Prss50 (MGI:2447303)
3,46857866,46863482,3p,3p21.31,160790,"MYL3, CMH8","Myosin, light polypeptide-3, alkali; ventricular, skeletal, slow",MYL3,4634,ENSG00000160808,NA,"Cardiomyopathy, hypertrophic, 8, 608751 (3), Autosomal recessive, Autosomal dominant",Myl3 (MGI:97268)
3,46877688,46903798,3p22-p21.1,3p21.31,168468,"PTH1R, PTHR1, PTHR, PFE, EKNS",Parathyroid hormone 1 receptor,PTH1R,5745,ENSG00000160801,NA,"Chondrodysplasia, Blomstrand type, 215045 (3), Autosomal recessive; Eiken syndrome, 600002 (3), Autosomal recessive; Failure of tooth eruption, primary, 125350 (3), Autosomal dominant; Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3), Autosomal dominant",Pth1r (MGI:97801)
3,46979682,47009703,3p22.1-p21.1,3p21.31,614169,"NBEAL2, KIAA0540, GPS, BDPLT4",Neurobeachin-like 2,NBEAL2,23218,ENSG00000160796,NA,"Gray platelet syndrome, 139090 (3), Autosomal recessive",Nbeal2 (MGI:2448554)
3,47016407,47164112,3p21.3-p21.2,3p21.31,612778,"SETD2, SET2, HYPB, HBP231, KIAA1732, LLS",SET domain-containing protein 2,SETD2,29072,ENSG00000181555,NA,"Luscan-Lumish syndrome, 616831 (3), Autosomal dominant",Setd2 (MGI:1918177)
3,47228025,47282846,3p21.31,3p21.31,607910,KIF9,Kinesin family member 9,KIF9,64147,ENSG00000088727,NA,NA,Kif9 (MGI:1098237)
3,47381000,47413434,3p21.3,3p21.31,606584,"PTPN23, KIAA1471, HDPTP","Protein-tyrosine phosphatase, nonreceptor-type, 23",PTPN23,25930,ENSG00000076201,NA,NA,Ptpn23 (MGI:2144837)
3,47413680,47477125,3p21.31,3p21.31,601510,SCAP,SREBP cleavage-activating protein,SCAP,22937,ENSG00000114650,NA,NA,Scap (MGI:2135958)
3,47495639,47513724,3p21.31,3p21.31,615020,"ELP6, TMEM103, C3orf75","Elongator acetyltransferase complex, subunit 6",ELP6,54859,ENSG00000163832,NA,NA,Elp6 (MGI:1919349)
3,47562237,47580239,3p21.31,3p21.31,606775,"CSPG5, NGC",Chondroitin sulfate proteoglycan 5,CSPG5,10675,ENSG00000114646,NA,NA,Cspg5 (MGI:1352747)
3,47585268,47781892,3p23-p21,3p21.31,601732,"SMARCC1, BAF155","SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily C, member 1",SMARCC1,6599,ENSG00000173473,NA,NA,Smarcc1 (MGI:1203524)
3,47802908,47850195,3p21.31,3p21.31,616423,"DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL",DEAH box polypeptide 30,DHX30,22907,ENSG00000132153,NA,"Neurodevelopmental disorder with severe motor impairment and absent language, 617804 (3), Autosomal dominant",Dhx30 (MGI:1920081)
3,47850694,48089271,3p21,3p21.31,157132,MAP4,Microtubule-associated protein 4,MAP4,4134,ENSG00000047849,NA,NA,Map4 (MGI:97178)
3,48157145,48188416,3p21,3p21.31,116947,CDC25A,Cell division cycle 25A,CDC25A,993,ENSG00000164045,NA,NA,Cdc25a (MGI:103198)
3,48223494,48225484,3p21.3,3p21.31,600474,"CAMP, FALL39",Cathelicidin antimicrobial peptide,CAMP,820,ENSG00000164047,NA,NA,Camp (MGI:108443)
3,48241103,48270989,3p21,3p21.31,616702,"ZNF589, SZF1",Zinc finger protein 589,ZNF589,51385,ENSG00000164048,NA,NA,NA
3,48288401,48302903,3p21.3,3p21.31,608294,NME6,"Nonmetastatic cells 6, protein expressed in",NME6,10201,ENSG00000172113,NA,NA,Nme6 (MGI:1861676)
3,48372218,48394829,3p21,3p21.31,609075,"FBXW12, FBW12, FBXO35, FBXO12",F-box and WD40 domain protein 12,FBXW12,285231,ENSG00000164049,NA,NA,NA
3,48403853,48430323,3p21.31,3p21.31,601053,"PLXNB1, SEP",Plexin B1,PLXNB1,5364,ENSG00000164050,NA,NA,Plxnb1 (MGI:2154238)
3,48440256,48444207,3p21.31,3p21.31,615808,"TMA7, HSPC016","Translation machinery-associated 7, S. cerevisiae, homolog of",TMA7,51372,ENSG00000232112,NA,NA,Tma7 (MGI:1913417)
3,48446709,48467644,3p21.3-p21.2,3p21.31,606605,ATRIP,ATR-interacting protein,ATRIP,84126,ENSG00000164053,NA,NA,Atrip (MGI:1925349)
3,48465829,48467644,3p21.3-p21.2,3p21.31,606609,"TREX1, AGS1, CRV, HERNS",3' repair exonuclease 1,TREX1,11277,ENSG00000213689,NA,"Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3), Autosomal recessive, Autosomal dominant; Chilblain lupus, 610448 (3), Autosomal dominant; {Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant; Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3), Autosomal dominant",Trex1 (MGI:1328317)
3,48467797,48504825,3p21.3,3p21.31,607290,"SHISA5, SCOTIN","Shisa family, member 5",SHISA5,51246,ENSG00000164054,pseudogene on Xq13.1-q13.3,NA,Shisa5 (MGI:1915044)
3,48517683,48562382,3p22-p21,3p21.31,605320,PFKFB4,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",PFKFB4,5210,ENSG00000114268,NA,NA,Pfkfb4 (MGI:2687284)
3,48561717,48563780,3p21.3,3p21.31,605902,"UCN2, SRP, UR",Urocortin II,UCN2,90226,ENSG00000145040,NA,NA,Ucn2 (MGI:2176375)
3,48564072,48595301,3p21.3,3p21.31,120120,"COL7A1, NDNC8","Collagen VII, alpha-1 polypeptide",COL7A1,1294,ENSG00000114270,NA,"EBD inversa, 226600 (3), Autosomal recessive; EBD, Bart type, 132000 (3), Autosomal dominant; EBD, localisata variant (3); Epidermolysis bullosa dystrophica, AD, 131750 (3), Autosomal dominant; Epidermolysis bullosa dystrophica, AR, 226600 (3), Autosomal recessive; Epidermolysis bullosa pruriginosa, 604129 (3), Autosomal recessive, Autosomal dominant; Epidermolysis bullosa, pretibial, 131850 (3), Autosomal recessive, Autosomal dominant; Toenail dystrophy, isolated, 607523 (3), Autosomal dominant; Transient bullous of the newborn, 131705 (3), Autosomal recessive, Autosomal dominant",Col7a1 (MGI:88462)
3,48599001,48609663,3p21.3,3p21.31,191328,UQCRC1,Ubiquinol-cytochrome c reductase core protein I,UQCRC1,7384,ENSG00000010256,close upstream of COL7A1,NA,Uqcrc1 (MGI:107876)
3,48625722,48635460,3p21.3,3p21.31,610068,SLC26A6,"Solute carrier family 26 (anion transporter), member 6",SLC26A6,65010,ENSG00000225697,NA,NA,Slc26a6 (MGI:2159728)
3,48636462,48662885,3p24.1-p21.2,3p21.31,604264,"CELSR3, EGFL1, MEGF2",Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 1),CELSR3,1951,ENSG00000008300,NA,NA,Celsr3 (MGI:1858236)
3,48663813,48685940,3p21,3p21.31,606671,"NCKIPSD, AF3P21, SPIN90",NCK-interacting protein with SH3 domain,NCKIPSD,51517,ENSG00000213672,NA,NA,Nckipsd (MGI:1931834)
3,48688002,48717277,3p21,3p21.31,606992,"IHPK2, IP6K2",Inositol hexaphosphate kinase 2,IP6K2,51447,ENSG00000068745,NA,NA,Ip6k2 (MGI:1923750)
3,48744600,48847873,3p21.3-p21.2,3p21.31,176910,PRKAR2A,"Protein kinase, cAMP-dependent, regulatory, type II, alpha",PRKAR2A,5576,ENSG00000114302,NA,NA,Prkar2a (MGI:108025)
3,48856925,48898881,3p21.31,3p21.31,613698,"SLC25A20, CACT, CAC","Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (carnitine-acylcarnitine translocase)",SLC25A20,788,ENSG00000178537,pseudogene on 6p12,"Carnitine-acylcarnitine translocase deficiency, 212138 (3), Autosomal recessive",Slc25a20 (MGI:1928738)
3,48918819,48986381,3p21,3p21.31,605615,"ARIH2, ARI2, TRIAD1","Ariadne, Drosophila, homolog of, 2",ARIH2,10425,ENSG00000177479,NA,NA,Arih2 (MGI:1344361)
3,48989907,49007152,3p21.31,3p21.31,614584,"P4HTM, PH4, HIDEA","Prolyl 4-hydroxylase, transmembrane",P4HTM,54681,ENSG00000178467,NA,"Hypotonia, hyperventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities, 618493 (3)",P4htm (MGI:1921693)
3,49007390,49015952,3p21.31,3p21.31,606031,WDR6,WD repeat-containing protein 6,WDR6,11180,ENSG00000178252,previously assigned to 15q21 by FISH,NA,Wdr6 (MGI:1930140)
3,49020474,49023494,3p21.31,3p21.31,612911,"NDUFAF3, MC1DN18",NADH-ubiquinone oxidoreductase complex assembly factor 3,NDUFAF3,25915,ENSG00000178057,NA,"Mitochondrial complex I deficiency, nuclear type 18, 618240 (3), Autosomal recessive",Ndufaf3 (MGI:1913956)
3,49020617,49020708,3p21.31,3p21.31,615150,MIR191,Micro RNA 191,MIR191,406966,ENSG00000207605,NA,NA,NA
3,49024324,49029749,3p21.2,3p21.31,146691,"IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase, type II",IMPDH2,3615,ENSG00000178035,NA,"[IMPDH2 enzyme activity, variation in], 617995 (3)","Impdh2,Impdh2-ps (MGI:3705743,MGI:109367)"
3,49029706,49094372,3p21.31,3p21.31,617387,"QRICH1, VERBRAS",Glutamine-rich protein 1,QRICH1,54870,ENSG00000198218,NA,"Ververi-Brady syndrome, 617982 (3), Autosomal dominant",Qrich1 (MGI:1916482)
3,49095931,49105128,3p21,3p21.31,603727,"QARS, GLNRS, MSCCA",Glutaminyl-tRNA synthetase,QARS1,5859,ENSG00000172053,NA,"Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3), Autosomal recessive",NA
3,49108045,49120937,3p21.31,3p21.31,614471,"USP19, KIAA0891",Ubiquitin-specific protease 19,USP19,10869,ENSG00000172046,NA,NA,Usp19 (MGI:1918722)
3,49121113,49133065,3p21,3p21.31,150325,"LAMB2, LAMS, NPHS5","Laminin, beta-2 (laminin S)",LAMB2,3913,ENSG00000172037,NA,"Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3); Pierson syndrome, 609049 (3), Autosomal recessive",Lamb2 (MGI:99916)
3,49171119,49176486,3p21.31,3p21.31,613169,"KLHDC8B, CHL",Kelch domain-containing protein 8B,KLHDC8B,200942,ENSG00000185909,NA,"{Hodgkin lymphoma, susceptibility to}, 236000 (3), Autosomal recessive",Klhdc8b (MGI:1925517)
3,49274119,49274185,3p21.31,3p21.31,617176,MIR4271,Micro RNA 4271,MIR4271,100422952,ENSG00000264633,NA,NA,NA
3,49277143,49340052,3p21.31,3p21.31,603486,"USP4, UNP",Ubiquitin-specific protease-4,USP4,7375,ENSG00000114316,NA,NA,Usp4 (MGI:98905)
3,49357170,49358599,3p21.3,3p21.31,138320,"GPX1, GPXD",Glutathione peroxidase-1,GPX1,2876,ENSG00000233276,?pseudogene on 3p11-p12,"Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1), Autosomal recessive",Gpx1 (MGI:104887)
3,49359144,49411975,3p21.3,3p21.31,165390,"RHOA, ARHA, ARH12, RHOH12","Ras homolog gene family, member A (oncogene RHO H12)",RHOA,387,ENSG00000067560,NA,NA,Rhoa (MGI:1096342)
3,49412205,49416475,3p21,3p21.31,600690,TCTA,T-cell leukemia translocation altered gene,TCTA,6988,ENSG00000145022,NA,NA,Tcta (MGI:1918829)
3,49416777,49422677,3p21.2-p21.1,3p21.31,238310,"AMT, NKH, GCE",Aminomethyltransferase (glycine cleavage system protein T),AMT,275,ENSG00000145020,NA,"Glycine encephalopathy, 605899 (3), Autosomal recessive",Amt (MGI:3646700)
3,49422332,49429323,3p21,3p21.31,611516,NICN1,Nicolin 1,NICN1,84276,ENSG00000145029,processed pseudogene on X,NA,Nicn1 (MGI:1913507)
3,49468702,49535617,3p21,3p21.31,128239,"DAG1, DAG, MDDGC9, MDDGA9, LGMDR16",Dystrophin-associated glycoprotein-1,DAG1,1605,ENSG00000173402,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3), Autosomal recessive",Dag1 (MGI:101864)
3,49554476,49671548,3p21.31,3p21.31,604020,"BSN, ZNF231","Bassoon, mouse, homolog of",BSN,8927,ENSG00000164061,NA,NA,Bsn (MGI:1277955)
3,49673101,49683970,3p21,3p21.31,102645,"APEH, D3S48E",N-acylaminoacyl-peptide hydrolase,APEH,327,ENSG00000164062,NA,NA,Apeh (MGI:88041)
3,49683946,49689522,3p21,3p21.31,142408,"MST1, HGFL",Macrophage-stimulating-1 (hepatocyte growth factor-like),MST1,4485,ENSG00000173531,NA,NA,Mst1 (MGI:96080)
3,49688752,49721528,3p21.31,3p21.31,614472,"RNF123, KPC1",Ring finger protein 123,RNF123,63891,ENSG00000164068,NA,NA,Rnf123 (MGI:2148796)
3,49716828,49719683,3p21.31,3p21.31,615691,"AMIGO3, ALI3",Adhesion molecule with Ig-like domain 3,AMIGO3,386724,ENSG00000176020,NA,NA,Amigo3 (MGI:2444854)
3,49716828,49723973,3p21.31,3p21.31,615320,"GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19",GDP-mannose pyrophosphorylase B,GMPPB,29925,ENSG00000173540,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3), Autosomal recessive",Gmppb (MGI:2660880)
3,49724293,49786541,3p21.31,3p21.31,606991,"IHPK1, IP6K1, KIAA0263",Inositol hexaphosphate kinase 1,IP6K1,9807,ENSG00000176095,NA,NA,Ip6k1 (MGI:1351633)
3,49805204,49813952,3p21,3p21.31,191325,"UBE7, UBE1L",Ubiquitin-activating enzyme-7,UBA7,7318,ENSG00000182179,NA,NA,Uba7 (MGI:1349462)
3,49828594,49856583,3p21.31,3p21.31,605958,"TRAIP, TRIP, RNF206, SCKL9",TRAF-interacting protein,TRAIP,10293,ENSG00000183763,NA,"Seckel syndrome 9, 616777 (3), Autosomal recessive",Traip (MGI:1096377)
3,49857988,49869905,3p21.31,3p21.31,614993,"CAMKV, 1G5",CAM kinase-like vesicle-associated,CAMKV,79012,ENSG00000164076,NA,NA,Camkv (MGI:2384296)
3,49886470,49903872,3p21.3,3p21.31,600168,"MST1R, RON, NPCA3",Macrophage stimulating 1 receptor (c-met-related tyrosine kinase),MST1R,4486,ENSG00000164078,NA,"{Nasopharyngeal carcinoma, susceptibility to, 3}, 617075 (3), Autosomal dominant",Mst1r (MGI:99614)
3,49908868,49930011,3p21.31,3p21.31,611464,"MON1A, SAND1","Mon1, S. cerevisiae, homolog of, A",MON1A,84315,ENSG00000164077,NA,NA,Mon1a (MGI:1920075)
3,49940040,50077248,3p21.3,3p21.31,606886,"RBM6, DEF3",RNA-binding motif protein 6,RBM6,10180,ENSG00000004534,NA,NA,Rbm6 (MGI:1338037)
3,50088907,50119020,3p21.3,3p21.31,606884,"RMB5, LUCA15",RNA-binding motif protein 5,RBM5,10181,ENSG00000003756,NA,NA,Rbm5 (MGI:1933204)
3,50155057,50189074,3p21.3,3p21.31,601124,"SEMA3F, SEMA4",Semaphorin III/F,SEMA3F,6405,ENSG00000001617,NA,NA,Sema3f (MGI:1096347)
3,50191609,50197695,3p21,3p21.31,139330,"GNAT1, CSNBAD3, CSNB1G","Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1",GNAT1,2779,ENSG00000114349,NA,"Night blindness, congenital stationary, autosomal dominant 3, 610444 (3), Autosomal dominant; Night blindness, congenital stationary, type 1G, 616389 (3), Autosomal recessive",Gnat1 (MGI:95778)
3,50205267,50221485,3p21.3,3p21.31,604437,"SLC38A3, SN1, G17","Solute carrier family 38, member 3",SLC38A3,10991,ENSG00000188338,NA,NA,Slc38a3 (MGI:1923507)
3,50227067,50259361,3p21,3p21.31,139360,"GNAI2, GNAI2B, GIP","Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2",GNAI2,2771,ENSG00000114353,"on 12p13-p12, GNAI2L","Pituitary ACTH-secreting adenoma (3); Ventricular tachycardia, idiopathic, 192605 (3), Autosomal dominant",Gnai2 (MGI:95772)
3,50267557,50277545,3p21.3,3p21.31,601281,SEMA5,Semaphorin A(V),SEMA3B,7869,ENSG00000012171,NA,NA,Sema3b (MGI:107561)
3,50287731,50292594,3p21.3,3p21.31,602725,IFRD2,Interferon-related developmental regulator-2,IFRD2,7866,ENSG00000214706,NA,NA,Ifrd2 (MGI:1316708)
3,50292831,50299404,3p21.3,3p21.31,604038,"HYAL3, LUCA3",Hyaluronoglucosaminidase 3,HYAL3,8372,ENSG00000186792,NA,NA,Hyal3 (MGI:1330288)
3,50296401,50299404,3p21.3,3p21.31,607073,FUS2,FUS2 gene,NAA80,24142,ENSG00000243477,NA,NA,Naa80 (MGI:1888902)
3,50299888,50312950,3p21.3-p21.2,3p21.31,607071,"HYAL1, MPS9",Hyaluronoglucosaminidase 1,HYAL1,3373,ENSG00000114378,mutation identified in 1 MPS9 patient,"?Mucopolysaccharidosis type IX, 601492 (3), Autosomal recessive",Hyal1 (MGI:96298)
3,50317789,50322849,3p21.3,3p21.31,603551,"HYAL2, LUCA2",Hyaluronoglucosaminidase 2,HYAL2,8692,ENSG00000068001,NA,NA,Hyal2 (MGI:1196334)
3,50324908,50328237,3p21.3,3p21.31,607052,FUS1,FUS1 gene,TUSC2,11334,ENSG00000114383,NA,NA,Tusc2 (MGI:1931086)
3,50329785,50340935,3p21.3,3p21.31,605082,RASSF1,RAS association domain family protein 1,RASSF1,11186,ENSG00000068028,epigenetically inactivated,NA,Rassf1 (MGI:1928386)
3,50341109,50345731,3p21.3,3p21.31,607070,"ZMYND10, BLU",Zinc finger MYND domain-containing protein 10,ZMYND10,51364,ENSG00000004838,NA,"Ciliary dyskinesia, primary, 22, 615444 (3), Autosomal recessive",Zmynd10 (MGI:2387863)
3,50347329,50350820,3p21.3,3p21.31,607072,"NPR2L, NPRL2, FFEVF2","Npr2, S. cerevisiae, homolog of",NPRL2,10641,ENSG00000114388,NA,"Epilepsy, familial focal, with variable foci 2, 617116 (3), Autosomal dominant",Nprl2 (MGI:1914482)
3,50350694,50368196,3p21.3,3p21.31,607068,"CYB561D2, 101F6",Cytochrome b-561 domain containing 2,CYB561D2,11068,ENSG00000114395,NA,NA,Cyb561d2 (MGI:1929280)
3,50354749,50359520,3p21.3,3p21.31,607069,"TMEM115, PL6",Transmembrane protein 115,TMEM115,11070,ENSG00000126062,NA,NA,NA
3,50362612,50504243,3p21.3,3p21.31,607082,"CACNA2D2, KIAA0558","Calcium channel, voltage-dependent, alpha-2/delta subunit 2",CACNA2D2,9254,ENSG00000007402,NA,NA,Cacna2d2 (MGI:1929813)
3,50606453,50611773,3p21.3,3p21.2,602441,"CISH, BACTS2",Cytokine inducible SH2-containing protein,CISH,1154,ENSG00000114737,NA,"{Bacteremia, susceptibility to}, 614383 (3); {Malaria, susceptibility to}, 611162 (3); {Tuberculosis, susceptibility to}, 607948 (3)",Cish (MGI:103159)
3,50611861,50649296,3p21.3,3p21.2,602130,"MAPKAP3, 3PK, MDPT3",Mitogen-activated protein kinase-activated protein kinase-3,MAPKAPK3,7867,ENSG00000114738,mutation identified in 1 MDPT3 family,"?Macular dystrophy, patterned, 3, 617111 (3), Autosomal dominant",Mapkapk3 (MGI:2143163)
3,50674926,51384197,3p14,3p21.2,603123,"DOCK3, NEDIDHA",Dedicator of cytokinesis 3,DOCK3,1795,ENSG00000088538,NA,"Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia, 618292 (3), Autosomal recessive",Dock3 (MGI:2429763)
3,51385290,51389396,3p21.1,3p21.2,601916,"ARMET, ARP","Arginine-rich protein, mutated in early stage tumors",MANF,7873,ENSG00000145050,NA,NA,Manf (MGI:1922090)
3,51391284,51397907,3p21.1,3p21.2,612602,"RBM15B, OTT3, HUMAGCGB",RNA-binding motif protein 15B,RBM15B,29890,ENSG00000259956,NA,NA,Rbm15b (MGI:1923598)
3,51394260,51505619,3p21.2,3p21.2,617259,"DCAF1, RIP, VPRBP, KIAA0800",DDB1- and CUL4-associated factor 1,DCAF1,9730,ENSG00000145041,NA,NA,Dcaf1 (MGI:2445220)
3,51707067,51718615,3p21.2-p21.1,3p21.2,604099,"GRM2, MGLUR2","Glutamate receptor, metabotropic, 2",GRM2,2912,ENSG00000164082,NA,NA,Grm2 (MGI:1351339)
3,51942289,51948866,3p21.3-p21.1,3p21.2,607726,"PARP3, ADPRTL3",Poly(ADP-ribose) polymerase 3,PARP3,10039,ENSG00000041880,NA,NA,Parp3 (MGI:1891258)
3,51955380,51957498,3p21.1,3p21.2,606917,GPR62,G protein-coupled receptor 62,GPR62,118442,ENSG00000180929,NA,NA,Gpr62 (MGI:3525078)
3,51957453,51967465,3p21.2,3p21.2,608503,"PCBP4, MGC10",Poly(rC)-binding protein 4,PCBP4,57060,ENSG00000090097,NA,NA,Pcbp4 (MGI:1890471)
3,51983534,51989196,3p21.1,3p21.2,104620,"ACY1, ACY1D",Aminoacylase-1,ACY1,95,ENSG00000243989,NA,"Aminoacylase 1 deficiency, 609924 (3), Autosomal recessive",Acy1 (MGI:87913)
3,51993521,51995894,3q29-qter,3p21.2,601832,"RPL29, HIP",Ribosomal protein L29,RPL29,6159,ENSG00000162244,NA,NA,NA
3,52048918,52056570,3p21,3p21.2,602749,"DUSP7, MKPX, PYST2",Dual-specificity phosphatase-7,DUSP7,1849,ENSG00000164086,NA,NA,Dusp7 (MGI:2387100)
3,52075225,52154422,3p21.2,3p21.2,614783,"POC1A, PIX2, SOFT","POC1 centriolar protein, Chlamydomonas, homolog of, A",POC1A,25886,ENSG00000164087,NA,"Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3), Autosomal recessive",Poc1a (MGI:1917485)
3,52198082,52214326,3p21.1,3p21.2,125290,ALAS1,"Aminolevulinate, delta-, synthase-1",ALAS1,211,ENSG00000023330,NA,NA,Alas1 (MGI:87989)
3,52221079,52226162,3p21.3,3p21.2,605474,TLR9,Toll-like receptor 9,TLR9,54106,ENSG00000239732,NA,NA,Tlr9 (MGI:1932389)
3,52228611,52239157,3p21.1,3p21.2,607433,"TWF2, PTK9L, A6RP","Twinfilin, actin-binding protein, Drosophila, homolog of, 2",TWF2,11344,ENSG00000247596,NA,NA,Twf2 (MGI:1346078)
3,52245724,52250598,3p21.2,3p21.2,608979,"PPM1M, PP2CE","Protein phosphatase 1M (protein phosphatase 2C, eta isoform)",PPM1M,132160,ENSG00000164088,NA,NA,Ppm1m (MGI:1915155)
3,52254423,52278648,3p21.1,3p21.2,611059,"WDR82, TMEM113",WD repeat-containing protein 82,WDR82,80335,ENSG00000164091,NA,NA,Wdr82 (MGI:1924555)
3,52268277,52268360,3p21.1,3p21.2,612102,"MIRLET7G, LET7G, MIRNLET7G",Micro RNA Let7G,MIRLET7G,406890,ENSG00000199150,NA,NA,NA
3,52287557,52295256,3p21,3p21.2,610516,"GLYCTK, GLYCTK1",Glycerate kinase,GLYCTK,132158,ENSG00000168237,NA,"D-glyceric aciduria, 220120 (3), Autosomal recessive",Glyctk (MGI:2444085)
3,52313009,52400496,3p21.3,3p21.1,603332,"DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37","Dynein, axonemal, heavy chain-1",DNAH1,25981,ENSG00000114841,mutation identified in 1 CILD37 family,"?Ciliary dyskinesia, primary, 37, 617577 (3), Autosomal recessive; Spermatogenic failure 18, 617576 (3), Autosomal recessive",Dnah1 (MGI:107721)
3,52401003,52410029,3p21.3,3p21.1,603089,"BAP1, TPDS",BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),BAP1,8314,ENSG00000163930,NA,"Tumor predisposition syndrome, 614327 (3), Autosomal dominant",Bap1 (MGI:1206586)
3,52451099,52454040,3p21.3-p14.3,3p21.1,191040,"TNNC1, CMD1Z, CMH13","Troponin-C1, slow",TNNC1,7134,ENSG00000114854,NA,"Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, hypertrophic, 13, 613243 (3), Autosomal dominant",Tnnc1 (MGI:98779)
3,52455602,52493067,3p21.1,3p21.1,615507,"NISCH, IRAS, KIAA0975",Nischarin,NISCH,11188,ENSG00000010322,NA,NA,NA
3,52545366,52685912,3p21,3p21.1,606083,"PBRM1, PB1, BAF180","Polybromo 1, chicken, homolog of",PBRM1,55193,ENSG00000163939,NA,NA,Pbrm1 (MGI:1923998)
3,52685919,52694496,3p21.1,3p21.1,608011,"GNL3, NS, E2IG3",Guanine nucleotide-binding protein-like 3,GNL3,26354,ENSG00000163938,NA,NA,Gnl3 (MGI:1353651)
3,52694483,52706082,3p21.1,3p21.1,618399,GLT8D1,Glycosyltransferase 8 domain-containing protein 1,GLT8D1,55830,ENSG00000016864,NA,NA,Glt8d1 (MGI:1923735)
3,52706105,52711147,3p21.1,3p21.1,610358,"SPCS1, SPC12","Signal peptidase complex, subunit 1, S. cerevisiae, homolog of",SPCS1,28972,ENSG00000114902,NA,NA,Spcs1 (MGI:1916269)
3,52708443,52770948,3p21.1,3p21.1,601959,"NEK4, STK2, NRK2",NIMA (never in mitosis gene a)-related kinase 4 (serine/threonine protein kinase-2),NEK4,6787,ENSG00000114904,NA,NA,Nek4 (MGI:1344404)
3,52777598,52792067,3p21.2-p21.1,3p21.1,147270,ITIH1,"Inter-alpha (globulin) inhibitor, H1 polypeptide",ITIH1,3697,ENSG00000055957,NA,NA,Itih1 (MGI:96618)
3,52794767,52809008,3p21.2-p21.1,3p21.1,146650,ITIH3,"Inter-alpha (globulin) inhibitor, H3 polypeptide",ITIH3,3699,ENSG00000162267,NA,NA,Itih3 (MGI:96620)
3,52812961,52830700,3p21.2-p14.1,3p21.1,600564,"ITIH4, PK120, ITIHL1","Inter-alpha (globulin) inhibitor, H4 polypeptide",ITIH4,3700,ENSG00000055955,NA,NA,Itih4 (MGI:109536)
3,52833120,52835018,3p21.1,3p21.1,617195,"MUSTN1, MUSTANG",Musculoskeletal embryonic nuclear protein 1,MUSTN1,389125,ENSG00000272573,NA,NA,Mustn1 (MGI:1913425)
3,52836755,52897547,3p21.1,3p21.1,617189,"TMEM110, STIMATE",Transmembrane protein 110,STIMATE,375346,ENSG00000213533,NA,NA,NA
3,52899208,53046654,3p21.1,3p21.1,607319,"SFMBT1, RU1",SCM-like protein with 4 MBT domains 1,SFMBT1,51460,ENSG00000163935,NA,NA,Sfmbt1 (MGI:1859609)
3,53071150,53130468,3p21.1,3p21.1,611908,"RFT1, CDG1N","RFT1, S. cerevisiae, homolog of",RFT1,91869,ENSG00000163933,NA,"Congenital disorder of glycosylation, type In, 612015 (3), Autosomal recessive",Rft1 (MGI:3607791)
3,53161208,53192716,3p,3p21.1,176977,"PRKCD, CVID9, ALPS3","Protein kinase C, delta",PRKCD,5580,ENSG00000163932,mutation identified in 1 family,"Autoimmune lymphoproliferative syndrome, type III, 615559 (3), Autosomal recessive",Prkcd (MGI:97598)
3,53224706,53256113,3p14.3,3p21.1,606781,"TKT, SDDHD",Transketolase,TKT,7086,ENSG00000163931,NA,"Short stature, developmental delay, and congenital heart defects, 617044 (3), Autosomal recessive",Tkt (MGI:105992)
3,53283428,53347542,3p21.1,3p21.1,607010,"DCP1A, SMIF","Decapping enzyme 1, X. cerevisiae, homolog of, A",DCP1A,55802,ENSG00000272886,NA,NA,Dcp1a (MGI:1923151)
3,53494610,53813732,3p21.1,3p21.1,114206,"CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA","Calcium channel, voltage-dependent, L type, alpha 1D subunit",CACNA1D,776,ENSG00000157388,NA,"Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3), Autosomal dominant; Sinoatrial node dysfunction and deafness, 614896 (3), Autosomal recessive",Cacna1d (MGI:88293)
3,53846549,53867387,3p21.1,3p21.1,605458,"IL17RB, IL17BR, IL17RH1","Interleukin 17, receptor B",IL17RB,55540,ENSG00000056736,NA,NA,Il17rb (MGI:1355292)
3,53884416,53891858,3p21.31,3p21.1,607916,"SELENOK, SELK, HSPC030",Selenoprotein K,SELENOK,58515,ENSG00000113811,NA,NA,Selenok (MGI:1931466)
3,54122551,55074556,3p21.1,3p21.1-p14.3,606399,CACNA2D3,"Calcium channel, voltage-dependent, alpha-2/delta subunit 3",CACNA2D3,55799,ENSG00000157445,NA,NA,Cacna2d3 (MGI:1338890)
3,54400000,122200000,3p14-q13,NA,608586,KTCN3,Keratoconus 3,NA,406215,NA,NA,"Keratoconus 3, 608586 (2)",NA
3,54632123,54639856,3p14.3,3p14.3,611473,HESRG,Embryonic stem cell-related protein,ESRG,790952,ENSG00000265992,NA,NA,NA
3,55465714,55505260,3p21-p14,3p14.3,164975,WNT5A,"Wingless-type MMTV integration site family, member 5A",WNT5A,7474,ENSG00000114251,NA,"Robinow syndrome, autosomal dominant 1, 180700 (3), Autosomal dominant",Wnt5a (MGI:98958)
3,55508310,56468472,3p14.3,3p14.3,617250,"ERC2, CAST, KIAA0378","ELKS/RAB6-interacting/CAST family, member 2",ERC2,26059,ENSG00000187672,NA,NA,Erc2 (MGI:1098749)
3,56620131,56683264,3p14.3,3p14.3,616493,"FAM208A, RAP140, C3orf63, KIAA1105","Family with sequence similarity 208, member A",TASOR,23272,ENSG00000163946,NA,NA,Tasor (MGI:1921694)
3,56727418,57079307,3p21-p13,3p14.3,612115,"ARHGEF3, XPLN",RHO guanine nucleotide exchange factor 3,ARHGEF3,50650,ENSG00000163947,NA,NA,Arhgef3 (MGI:1918954)
3,57060663,57075431,3p21.2-p21.1,3p14.3,609869,"SPATA12, SRG5",Spermatogenesis-associated protein 12,SPATA12,353324,ENSG00000186451,NA,NA,NA
3,57089981,57170316,3p14.3-p14.2,3p14.3,606807,"IL17RD, SEF, HH18","Interleukin 17, receptor D (Sef, zebrafish, homolog of)",IL17RD,54756,ENSG00000144730,NA,"Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3), Autosomal recessive, Autosomal dominant",Il17rd (MGI:2159727)
3,57197837,57227642,3p21.2-p21.1,3p14.3,601802,"HESX1, RPX, CPHD5",Homeo box gene expressed in ES cells,HESX1,8820,ENSG00000163666,NA,"Growth hormone deficiency with pituitary anomalies, 182230 (3), Autosomal recessive, Autosomal dominant; Pituitary hormone deficiency, combined, 5, 182230 (3), Autosomal recessive, Autosomal dominant; Septooptic dysplasia, 182230 (3), Autosomal recessive, Autosomal dominant",Hesx1 (MGI:96071)
3,57227728,57273470,3p21.1-p14.3,3p14.3,604299,"APPL1, APPL, MODY14","Adaptor protein containing PH domain, PTB domain, and leucine zipper motif 1",APPL1,26060,ENSG00000157500,NA,"{Maturity-onset diabetes of the young, type 14}, 616511 (3), Autosomal dominant",Appl1 (MGI:1920243)
3,57293698,57545202,3p21.1,3p14.3,603340,"DNAH12, DNAHC3, HL19","Dynein, heavy chain-5",DNAH12,201625,ENSG00000174844,NA,NA,Dnah12 (MGI:107720)
3,57556273,57656494,3q21.2,3p14.3,616519,PDE12,Phosphodiesterase 12,PDE12,201626,ENSG00000174840,NA,NA,Pde12 (MGI:2443226)
3,57571362,57597343,3p14.1,3p14.3,601177,"ARF4, ARF2",ADP-ribosylation factor 4,ARF4,378,ENSG00000168374,NA,NA,Arf4 (MGI:99433)
3,57756228,57930012,3p21.2-p14.3,3p14.3,602701,SLAP,Sarcolemmal-associated protein,SLMAP,7871,ENSG00000163681,NA,NA,Slmap (MGI:1933549)
3,58008421,58172250,3p14.3,3p14.3,603381,"FLNB, SCT, AOI, LRS1",Filamin B,FLNB,2317,ENSG00000136068,NA,"Atelosteogenesis, type I, 108720 (3), Autosomal dominant; Atelosteogenesis, type III, 108721 (3), Autosomal dominant; Boomerang dysplasia, 112310 (3), Autosomal dominant; Larsen syndrome, 150250 (3), Autosomal dominant; Spondylocarpotarsal synostosis syndrome, 272460 (3), Autosomal recessive",Flnb (MGI:2446089)
3,58192256,58211002,3p21.1-p14.3,3p14.3,602244,"DNASE1L3, SLEB16",Deoxyribonuclease I-like 3,DNASE1L3,1776,ENSG00000163687,NA,"Systemic lupus erythematosus 16, 614420 (3), Autosomal recessive",Dnase1l3 (MGI:1314633)
3,58237501,58294735,3p14.3,3p14.3,616966,ADHB6,Abhydrolase domain-containing protein 6,ABHD6,57406,ENSG00000163686,NA,NA,Abhd6 (MGI:1913332)
3,58306244,58324696,3p14.3,3p14.3,606112,RPP14,"Ribonuclease P, 14kD subunit",RPP14,11102,ENSG00000163684,NA,NA,Rpp14 (MGI:1914303)
3,58332889,58426126,3p14.3,3p14.3,611450,"PXK, MONAKA",PXK domain-containing serine/threonine kinase,PXK,54899,ENSG00000168297,NA,NA,Pxk (MGI:1289230)
3,58427629,58433851,3p13-q23,3p14.3,179060,"PDHB, PDHBD","Pyruvate dehydrogenase, E1 beta polypeptide",PDHB,5162,ENSG00000168291,NA,"Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)",Pdhb (MGI:1915513)
3,58505135,58537195,3p14.3,3p14.3,601641,"ACOX2, BRCACOX, CBAS6","Acyl-Coenzyme A oxidase 2, branched chain",ACOX2,8309,ENSG00000168306,NA,"Bile acid synthesis defect, congenital, 6, 617308 (3), Autosomal recessive",Acox2 (MGI:1934852)
3,58564116,58627609,3p21.1,3p14.3-p14.2,608295,"FAM107A, DRR1, TU3A","Family with sequence similarity 107, member A (downregulated in renal cell carcinoma 1)",FAM107A,11170,ENSG00000168309,NA,NA,Fam107a (MGI:3041256)
3,58633942,58666842,3p14.2,3p14.2,608619,FAM3D,"Family with sequence similarity 3, member D",FAM3D,131177,ENSG00000198643,NA,NA,Oit1 (MGI:1201784)
3,59747276,61251460,3p14.2,3p14.2,601153,"FRA3B, FHIT",Fragile histidine triad gene,FHIT,2272,ENSG00000189283,deleted in RCC,NA,Fhit (MGI:1277947)
3,61561570,62297608,3p14.2,3p14.2,176886,"PTPRG, PTPG","Protein tyrosine phosphatase, receptor type, gamma polypeptide",PTPRG,5793,ENSG00000144724,NA,NA,Ptprg (MGI:97814)
3,62369680,62373549,3p14.2,3p14.2,607414,"FEZF2, ZNF312, FEZL, TOF",FEZ family zinc finger 2,FEZF2,55079,ENSG00000153266,NA,NA,Fezf2 (MGI:1859823)
3,62398347,62875864,3p21.1,3p14.2,604667,"CADPS, CAPS",Ca(2+)-dependent activator protein for secretion,CADPS,8618,ENSG00000163618,NA,NA,Cadps (MGI:1350922)
3,63652674,63665211,3p14.2,3p14.2,617832,"SNTN, S100AL, S100A1L","Sentan, cilia apical structural protein",SNTN,132203,ENSG00000188817,NA,NA,Sntn (MGI:3045373)
3,63800000,103100000,3p14.1-q12.3,NA,610948,HYT7,"Hypertension, essential, susceptibility to, 7",NA,100188825,NA,NA,"{Hypertension, essential, susceptibility to, 7}, 610948 (2)",NA
3,63833869,63864477,3p14.1,3p14.1,611965,"THOC7, NIF3L1BP1","THO complex, subunit 7",THOC7,80145,ENSG00000163634,NA,NA,Thoc7 (MGI:1913481)
3,63864556,64003461,3p14.1,3p14.1,607640,"ATXN7, SCA7, OPCA3",Ataxin 7,ATXN7,6314,ENSG00000163635,NA,"Spinocerebellar ataxia 7, 164500 (3), Autosomal dominant",Atxn7 (MGI:2179277)
3,63911517,63911771,3p14.1,3p14.1,614481,"ATXN7AS1, SCAANT1",ATXN7 antisense noncoding transcript 1,SCAANT1,100861563,ENSG00000280620,NA,NA,NA
3,64010548,64024009,3p14.1,3p14.1,617857,"PSMD6, KIAA0107","Proteasome 26S subunit, non-ATPase, 6",PSMD6,9861,ENSG00000163636,NA,NA,Psmd6 (MGI:1913663)
3,64092235,64445475,3p14,3p14.1,608501,PRICKLE2,Prickle-like 2,PRICKLE2,166336,ENSG00000163637,NA,NA,Prickle2 (MGI:1925144)
3,64515653,64687999,3p14.3-p14.2,3p14.1,605421,ADAMTS9,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 9",ADAMTS9,56999,ENSG00000163638,NA,NA,Adamts9 (MGI:1916320)
3,65353525,66038917,3p14.1,3p14.1,602625,"MAGI1, BAIAP1, WWP3, TNRC19","Membrane-associated guanylate kinase, WW and PDZ domains-containing, 1",MAGI1,9223,ENSG00000151276,NA,NA,Magi1 (MGI:1203522)
3,66133609,66380020,3p14.3,3p14.1,611037,"SLC25A26, SAMC, COXPD28","Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26",SLC25A26,115286,ENSG00000144741,NA,"Combined oxidative phosphorylation deficiency 28, 616794 (3), Autosomal recessive",Slc25a26 (MGI:1914832)
3,66378796,66501262,3p14,3p14.1,608868,"LRIG1, LIG1",Leucine-rich repeats- and immunoglobulin-like domains-containing protein 1,LRIG1,26018,ENSG00000144749,NA,NA,Lrig1 (MGI:107935)
3,66998306,67011209,3p14.1,3p14.1,616607,"KBTBD8, TAKRP, KIAA1842",KELCH repeat- and BTB/POZ domain-containing protein 8,KBTBD8,84541,ENSG00000163376,NA,NA,Kbtbd8 (MGI:2661430)
3,67360459,67654613,3p14.1,3p14.1,603922,SUCLG2,"Succinate-CoA ligase, GDP-forming, beta subunit",SUCLG2,8801,ENSG00000172340,NA,NA,Suclg2 (MGI:1306824)
3,67991591,68546055,3p14.1,3p14.1,617495,"FAM19A1, TAFA1","Family with sequence similarity 19, member A1, CC motif chemokine-like",TAFA1,407738,ENSG00000183662,NA,NA,Tafa1 (MGI:2443695)
3,68731763,68932609,3p14.1,3p14.1,617498,"FAM19A4, TAFA4","Family with sequence similarity 19, member A4, CC motif chemokine-like",TAFA4,151647,ENSG00000163377,NA,NA,Tafa4 (MGI:2444563)
3,68975211,69013960,3p14.1,3p14.1,614789,"EOGT, EOGT1, C3orf64, AOS4",EGF domain-specific O-linked N-acetylglucosamine transferase,EOGT,285203,ENSG00000163378,NA,"Adams-Oliver syndrome 4, 615297 (3), Autosomal recessive",Eogt (MGI:2141669)
3,69019826,69052332,3p21-p12,3p14.1,601126,TMF1,TATA element modulatory factor 1,TMF1,7110,ENSG00000144747,NA,NA,Tmf1 (MGI:2684999)
3,69054729,69080372,3p14.1,3p14.1,603172,"UBE1C, UBA3",Ubiquitin-activating enzyme E1C,UBA3,9039,ENSG00000144744,NA,NA,Uba3 (MGI:1341217)
3,69084936,69106091,3p14,3p14.1,605709,ARL6IP5,ADP-ribosylation-like factor 6-interacting protein 5,ARL6IP5,10550,ENSG00000144746,NA,NA,Arl6ip5 (MGI:1929501)
3,69106871,69122594,3p14.1,3p14.1,616112,"LMOD3, NEM10",Leiomodin 3,LMOD3,56203,ENSG00000163380,NA,"Nemaline myopathy 10, 616165 (3), Autosomal recessive",Lmod3 (MGI:2444169)
3,69168781,69541339,3p14.1,3p14.1,617467,"FRMD4B, GRSP1, KIAA1013",FERM domain-containing protein 4B,FRMD4B,23150,ENSG00000114541,NA,NA,Frmd4b (MGI:2141794)
3,69739463,69968336,3p14.1-p12.3,3p13,156845,"MITF, WS2A, CMM8, COMMAD",Microphthalmia-associated transcription factor,MITF,4286,ENSG00000187098,NA,"COMMAD syndrome, 617306 (3), Autosomal recessive; {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3); Tietz albinism-deafness syndrome, 103500 (3), Autosomal dominant; Waardenburg syndrome, type 2A, 193510 (3), Autosomal dominant; Waardenburg syndrome/ocular albinism, digenic, 103470 (3), Autosomal dominant",Mitf (MGI:104554)
3,69999743,70015300,3p13,3p13,616895,"SAMMSON, LINC01212",Survival-associated mitochondrial melanoma-specific oncogenic noncoding RNA,SAMMSON,101927152,ENSG00000240405,NA,NA,NA
3,70952816,71583988,3p14.1,3p13,605515,"FOXP1, QRF1",Forkhead box P1,FOXP1,27086,ENSG00000114861,NA,"Mental retardation with language impairment and with or without autistic features, 613670 (3), Autosomal dominant",NA
3,71675413,71754772,3p14,3p13,609896,EIF4E3,"Eukaryotic translation initiation factor 4E family, member 3",EIF4E3,317649,ENSG00000163412,NA,NA,Eif4e3 (MGI:1914142)
3,71753854,71756495,3p21-p14,3p13,605187,"GPR27, SREB1",G protein-coupled receptor 27,GPR27,2850,ENSG00000170837,NA,NA,Gpr27 (MGI:1202299)
3,71771654,71785147,3p21.1,3p13,607002,"PROK2, PK2, BV8, HH4",Prokineticin 2,PROK2,60675,ENSG00000163421,NA,"Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3), Autosomal dominant",Prok2 (MGI:1354178)
3,72374592,72446622,3p13,3p13,607535,"RYBP, YEAF1",Ring1- and YY1-binding protein,RYBP,23429,ENSG00000163602,NA,NA,"Rybp,Rybp-ps (MGI:3648043,MGI:1929059)"
3,72725701,72848474,3p13,3p13,613663,SHQ1,"Shq1, S. cerevisiae, homolog of",SHQ1,55164,ENSG00000144736,NA,NA,Shq1 (MGI:1919421)
3,72848521,72976916,3p13,3p13,613322,"GXYLT2, GLT8D4",Glucoside xylosyltransferase 2,GXYLT2,727936,ENSG00000172986,NA,NA,Gxylt2 (MGI:2682940)
3,72996742,73069200,3p13,3p13,613822,"PPP4R2, PP4R2","Protein phosphatase 4, regulatory subunit 2",PPP4R2,151987,ENSG00000163605,NA,NA,Ppp4r2 (MGI:3027896)
3,73061658,73063336,3p14-p13,3p13,613250,EBLN2,Endogenous Borna-like N element-containing protein 2,EBLN2,55096,ENSG00000255423,NA,NA,NA
3,73382429,73624996,3p13,3p13,609729,"PDZRN3, KIAA1095",PDZ domain-containing ring finger protein 3,PDZRN3,23024,ENSG00000121440,NA,NA,Pdzrn3 (MGI:1933157)
3,74100000,122200000,3p12-q13,NA,606896,DYX5,"Dyslexia, susceptibility to, 5",DYX5,171089,NA,?same locus as SSD,"{Dyslexia, susceptibility to, 5}, 606896 (2)",NA
3,74100000,113700000,3p12-q13.2,NA,109720,PBC1,"Biliary cirrhosis, primary, 1",NA,NA,NA,associated with rs6441286,"Biliary cirrhosis, primary, 1, 109720 (2), Autosomal dominant",NA
3,74100000,122200000,3p12-q13,NA,608445,SSD,Speech-sound disorder,NA,404713,NA,?same locus as DYX5,"{Speech-sound disorder}, 608445 (2)",NA
3,74262567,74614447,3p26,3p12.3,601325,"CNTN3, PANG",Contactin 3 (plasmocytoma-associated neuronal glycoprotein),CNTN3,5067,ENSG00000113805,NA,NA,Cntn3 (MGI:99534)
3,75729960,75785577,3p12.3,3p12.3,618405,"ZNF717, OB1",Zinc finger protein 717,ZNF717,100131827,ENSG00000227124,NA,NA,Zfp39 (MGI:99183)
3,75906674,77649963,3p12.3,3p12.3,602431,"ROBO2, SAX3, KIAA1568","Roundabout, Drosophila, homolog of, 2",ROBO2,6092,ENSG00000185008,NA,"Vesicoureteral reflux 2, 610878 (3)",Robo2 (MGI:1890110)
3,78597237,79767997,3p12,3p12.3,602430,"ROBO1, DUTT1, SAX3","Roundabout, Drosophila, homolog of, 1",ROBO1,6091,ENSG00000169855,NA,NA,Robo1 (MGI:1274781)
3,81489702,81761644,3p12,3p12.2,607839,"GBE1, GSD4, APBD",Glycogen branching enzyme,GBE1,2632,ENSG00000114480,NA,"Glycogen storage disease IV, 232500 (3), Autosomal recessive; Polyglucosan body disease, adult form, 263570 (3), Autosomal recessive",Gbe1 (MGI:1921435)
3,84958988,86074428,3p12,3p12.1,609938,"CADM2, IGSF4D, SYNCAM2, NECL3",Cell adhesion molecule 2,CADM2,253559,ENSG00000175161,NA,NA,Cadm2 (MGI:2442722)
3,86937972,86991148,3p12.1,3p12.1,609980,"VGLL3, VGL3",Vestigial-like 3,VGLL3,389136,ENSG00000206538,NA,NA,Vgll3 (MGI:1920819)
3,87227308,87255555,3p11.2,3p11.2,609512,"CHMP2B, DMT1, VPS2B, ALS17","CHMP family, member 2B",CHMP2B,25978,ENSG00000083937,NA,"Amyotrophic lateral sclerosis 17, 614696 (3), Autosomal dominant; Dementia, familial, nonspecific, 600795 (3), Autosomal dominant",Chmp2b (MGI:1916192)
3,87259403,87276583,3p11,3p11.2,173110,"POU1F1, PIT1, CPHD1","POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1)",POU1F1,5449,ENSG00000064835,NA,"Pituitary hormone deficiency, combined, 1, 613038 (3), Autosomal recessive, Autosomal dominant",Pou1f1 (MGI:97588)
3,87792705,87994855,3p12,3p11.2-p11.1,182134,"HTR1F, HTR1EL, MR77",5-hydroxytryptamine receptor 1F,HTR1F,3355,ENSG00000179097,NA,NA,Htr1f (MGI:99842)
3,88051949,88149865,3p12-p11.1,3p11.1,603363,CGGBP1,CGG triplet repeat binding protein 1,CGGBP1,8545,ENSG00000163320,NA,NA,Cggbp1 (MGI:2146370)
3,89107620,89482133,3p11.2,3p11.1,179611,"EPHA3, ETK1, HEK",Ephrin receptor EphA3 (human embryo kinase 1),EPHA3,2042,ENSG00000044524,NA,NA,Epha3 (MGI:99612)
3,90900000,122200000,3cen-q13,NA,614012,"ERVK-5, HERV-KII","Endogenous retrovirus group K, member 5",ERVK-5,60358,NA,NA,NA,NA
3,93873036,93974089,3q11.2,3q11.1,176880,"PROS1, THPH5, THPH6","Protein S, alpha",PROS1,5627,ENSG00000184500,pseudogene PROSP contiguous on chr.3,"Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3), Autosomal dominant; Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3), Autosomal recessive",Pros1 (MGI:1095733)
3,93980138,94055677,3q11.2,3q11.1-q11.2,608922,"ARL13B, ARL2L1, JBTS8",ADP-ribosylation factor-like 13B,ARL13B,200894,ENSG00000169379,NA,"Joubert syndrome 8, 612291 (3), Autosomal recessive",Arl13b (MGI:1915396)
3,94000000,108200000,3q11.2-q13.12,NA,114200,CAMPD1,Camptodactyly 1,NA,100381210,NA,between D3S2465 and D3S3044,"Camptodactyly 1, 114200 (2), Autosomal dominant",NA
3,94057921,94063388,3q11.2,3q11.2,616588,DHFRL1,Dihydrofolate reductase-like 1,DHFR2,200895,ENSG00000178700,NA,NA,NA
3,94063060,94131831,3q11.2,3q11.2,617491,NSUN3,"NOP2/SUN RNA methyltransferase family, member 3",NSUN3,63899,ENSG00000178694,NA,NA,Nsun3 (MGI:2146565)
3,96814580,97761531,3q11.2,3q11.2,600066,"EPHA6, HEK12, EHK2",Ephrin receptor EphA6,EPHA6,285220,ENSG00000080224,NA,NA,Epha6 (MGI:108034)
3,97762580,97812584,3p12-q13,3q11.2,608845,"ARL6, BBS3, RP55",ADP-ribosylation factor-like 6,ARL6,84100,ENSG00000113966,mutation identified in 1 RPS55 family,"{Bardet-Biedl syndrome 1, modifier of}, 209900 (3), Autosomal recessive, Digenic recessive; Bardet-Biedl syndrome 3, 600151 (3), Autosomal recessive; ?Retinitis pigmentosa 55, 613575 (3)",Arl6 (MGI:1927136)
3,97941816,97972450,3q12.1,3q11.2,612049,"MINA, MINA53, MDIG",MYC-induced nuclear antigen,RIOX2,84864,ENSG00000170854,NA,NA,Riox2 (MGI:1914264)
3,98531977,98534680,3q11.2-q13.1,3q11.2,601166,GPR15,G protein-coupled receptor-15,GPR15,2838,ENSG00000154165,NA,NA,Gpr15 (MGI:1918473)
3,98569836,98593683,3q12,3q11.2,612732,CPOX,Coproporphyrinogen oxidase,CPOX,1371,ENSG00000080819,NA,"Coproporphyria, 121300 (3), Autosomal dominant; Harderoporphyria, 121300 (3), Autosomal dominant",Cpox (MGI:104841)
3,98732235,98795844,3q12.1,3q12.1,607156,"ST3GAL6, ST3GALVI","ST3 beta-galactoside alpha-2,3-sialyltransferase 6",ST3GAL6,10402,ENSG00000064225,NA,NA,St3gal6 (MGI:1888707)
3,98795940,98901694,3q12.1,3q12.1,608698,"DCBLD2, ESDN","Discoidin, CUB, and LCCL domain-containing protein 2",DCBLD2,131566,ENSG00000057019,NA,NA,Dcbld2 (MGI:1920629)
3,99638593,99799216,3q12-q13.1,3q12.1,120251,COL8A1,"Collagen VIII, alpha-1 polypeptide",COL8A1,1295,ENSG00000144810,NA,NA,Col8a1 (MGI:88463)
3,99833143,100114512,3q12.1,3q12.1,612993,FILIP1L,Filamin A-interacting protein 1-like,FILIP1L,11259,ENSG00000168386,NA,NA,Filip1l (MGI:1925999)
3,100185823,100194185,3q12,3q12.1,611030,"TMEM30C, CDC50C",Transmembrane protein 30C,TMEM30CP,644444,ENSG00000235156,NA,NA,NA
3,100260991,100325237,3q12.1-q12.2,3q12.1-q12.2,617687,"TBC1D23, PCH11","TBC1 domain family, member 23",TBC1D23,55773,ENSG00000036054,NA,"Pontocerebellar hypoplasia, type 11, 617695 (3), Autosomal recessive",Tbc1d23 (MGI:1914831)
3,100334756,100361634,3q12.2,3q12.2,616769,NIT2,Nitrilase family member 2,NIT2,56954,ENSG00000114021,NA,NA,Nit2 (MGI:1261838)
3,100363430,100401088,3q12.2,3q12.2,606081,TOMM70A,"Translocase of outer mitochondrial membrane 70, yeast, homolog of, A",TOMM70,9868,ENSG00000154174,NA,NA,Tomm70a (MGI:106295)
3,100492618,100577445,3q12.2,3q12.2,616928,"TMEM45A, DERP7, DNAPTP4",Transmembrane protein 45A,TMEM45A,55076,ENSG00000181458,NA,NA,Tmem45a (MGI:1913122)
3,100609600,100696173,3q12.2,3q12.2,612307,"ADGRG7, GPR128",Adhesion G protein-coupled receptor G7,ADGRG7,84873,ENSG00000144820,NA,NA,Adgrg7 (MGI:2441732)
3,100709289,100748966,3q11-q12,3q12.2,602498,"TFG, HMSNP, SPG57",TRK-fused gene,TFG,10342,ENSG00000114354,fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family,"Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3), Autosomal dominant; ?Spastic paraplegia 57, autosomal recessive, 615658 (3), Autosomal recessive",Tfg (MGI:1338041)
3,100749328,100993507,3q12,3q12.2,606279,TARSH,Target of Nesh-SH3,ABI3BP,25890,ENSG00000154175,NA,NA,NA
3,101222545,101320574,3q11.2,3q12.3,607056,"IMPG2, IPM200, RP56, VMD5",Interphotoreceptor matrix proteoglycan 2,IMPG2,50939,ENSG00000081148,NA,"Macular dystrophy, vitelliform, 5, 616152 (3), Autosomal dominant; Retinitis pigmentosa 56, 613581 (3), Autosomal recessive",Impg2 (MGI:3044955)
3,101324204,101513882,3q12.3,3q12.3,612846,"SENP7, KIAA1707","Sentrin-specific protease family, member 7",SENP7,57337,ENSG00000138468,NA,NA,Senp7 (MGI:1913565)
3,101561867,101566445,3q12.3,3q12.3,615423,"TRMT10C, RG9MTD1, MRPP1, COXPD30","tRNA methyltransferase 10, S. cerevisiae, homolog of, C",TRMT10C,54931,ENSG00000174173,NA,"Combined oxidative phosphorylation deficiency 30, 616974 (3), Autosomal recessive",Trmt10c (MGI:1196261)
3,101574093,101594464,3q12.3,3q12.3,615210,PCNP,PEST-containing nuclear protein,PCNP,57092,ENSG00000081154,NA,NA,Pcnp (MGI:1923552)
3,101648888,101677131,3q12.3,3q12.3,618181,"ZBTB11, MRT69",Zinc finger- and BTB domain-containing protein 11,ZBTB11,27107,ENSG00000066422,NA,"Intellectual developmental disorder, autosomal recessive 69, 618383 (3), Autosomal recessive",Zbtb11 (MGI:2443876)
3,101681090,101686717,3q,3q12.3,604180,RPL24,Ribosomal protein L24,RPL24,6152,ENSG00000114391,NA,NA,Rpl24 (MGI:1915443)
3,101723930,101770561,3q12.2,3q12.3,615864,CEP97,"Centrosomal protein, 97kD",CEP97,79598,ENSG00000182504,NA,NA,Cep97 (MGI:1921451)
3,101827989,101861021,3q13.11,3q12.3,608004,"NFKBIZ, INAP, MAIL, IKBZ","Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, zeta",NFKBIZ,64332,ENSG00000144802,NA,NA,Nfkbiz (MGI:1931595)
3,102385143,102479840,3q12.3,3q12.3,615915,ZPLD1,Zona pellucida-like domain-containing protein 1,ZPLD1,131368,ENSG00000170044,NA,NA,Zpld1 (MGI:2443415)
3,103100000,111600000,3q13.1,NA,600467,MHS4,Malignant hyperthermia susceptibility 4,MHS4,4265,NA,NA,"{Malignant hyperthermia susceptibility 4}, 600467 (2), Autosomal dominant",NA
3,105366712,105576899,3q13.1-q13.2,3q13.11,601662,ALCAM,Activated leukocyte cell adhesion molecule,ALCAM,214,ENSG00000170017,NA,NA,Alcam (MGI:1313266)
3,105655460,105869551,3q13.11,3q13.11,604491,CBLB,CAS-BR-M murine ecotropic retroviral transforming sequence B,CBLB,868,ENSG00000114423,NA,NA,Cblb (MGI:2146430)
3,107240691,107326963,3q13.12,3q13.12,616619,"DUBR, DUM, LINC0883","DPPA2 upstream-binding RNA, noncoding",DUBR,344595,ENSG00000243701,NA,NA,NA
3,108043093,108094199,3q13.1-q13.2,3q13.12,601028,"CD47, MER6, IAP",CD47 antigen (Rh-related antigen; integrin-associated protein),CD47,961,ENSG00000196776,NA,NA,Cd47 (MGI:96617)
3,108160811,108222423,3p12-q13,3q13.12-q13.13,606621,"IFT57, ESRRBL1, HIPPI, OFD18","Intraflagellar transport 57, chlamydomonas, homolog of (HIP1 protein interactor)",IFT57,55081,ENSG00000114446,mutation identified in 1 OFD18 family,"?Orofaciodigital syndrome XVIII, 617927 (3), Autosomal recessive",Ift57 (MGI:1921166)
3,108296489,108378284,3q13.13,3q13.13,604371,HHLA2,Human endogenous retrovirus-H long terminal repeat-associating 2,HHLA2,11148,ENSG00000114455,NA,NA,NA
3,108380367,108549461,3q13.13,3q13.13,609929,MYH15,"Myosin, heavy chain 15",MYH15,22989,ENSG00000144821,NA,NA,Myh15 (MGI:3643515)
3,108545751,108589455,3q13.13,3q13.13,610643,"CIP2A, KIAA1524, p90",Cell proliferation-regulating inhibitor of protein phosphatase 2A,CIP2A,57650,ENSG00000163507,NA,NA,Cip2a (MGI:2146335)
3,108589489,108694839,3q13.13,3q13.13,608672,"DZIP3, KIAA0675",DAZ-interacting zinc finger protein 3,DZIP3,9666,ENSG00000198919,NA,NA,Dzip3 (MGI:1917433)
3,108755638,108757282,3q13.13,3q13.13,605645,"RETNLB, RELMB, FIZZ2","Resistin-like protein, beta",RETNLB,84666,ENSG00000163515,NA,NA,Retnlb (MGI:1888505)
3,108822785,108855004,3q13,3q13.13,604962,"TRAT1, TRIM",T-cell receptor-associated transmembrane adaptor 1,TRAT1,50852,ENSG00000163519,NA,NA,Trat1 (MGI:1924897)
3,108907643,108955194,3q13.1,3q13.13,605128,"GUCA1C, GCAP3",Guanylate cyclase activator 1C,GUCA1C,9626,ENSG00000138472,NA,NA,NA
3,108958247,109118133,3q13,3q13.13,603205,MORC1,"MORC family CW-type zinc finger 1 (microrchidia, mouse, homolog of)",MORC1,27136,ENSG00000114487,NA,NA,Morc1 (MGI:1316740)
3,109293787,109316588,3q13.13,3q13.13,614445,"DPPA2, PESCRG1, ECAT15-2",Developmental pluripotency-associated gene 2,DPPA2,151871,ENSG00000163530,NA,NA,Dppa2 (MGI:2157523)
3,109326140,109339634,3q13.13,3q13.13,614125,DPPA4,Developmental pluripotency-associated gene 4,DPPA4,55211,ENSG00000121570,NA,NA,Dppa4 (MGI:2157525)
3,111071763,111201443,3q13,3q13.13,607147,"NECTIN3, PVRL3, PRR3",Nectin 3,NECTIN3,25945,ENSG00000177707,NA,NA,Nectin3 (MGI:1930171)
3,111542078,111665995,3q13.13,3q13.1-q13.2,606037,"CD96, TACTILE",CD96 antigen,CD96,10225,ENSG00000153283,NA,"C syndrome, 211750 (3), Autosomal dominant",Cd96 (MGI:1934368)
3,111592899,111595345,3q13.2,3q13.13,615246,ZBED2,Zinc finger BED domain-containing protein 2,ZBED2,79413,ENSG00000177494,NA,NA,NA
3,111600000,122200000,3q13.2-q13.33,NA,614655,STUT3,"Stuttering, familial persistent, 3",NA,100909386,NA,max lod at D3S1310,"Stuttering, familial persistent, 3, 614655 (2)",NA
3,111674675,111846446,3q13.2,3q13.2,617015,PLCXD1,"Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 2",PLCXD2,257068,ENSG00000240891,NA,NA,Plcxd2 (MGI:3647874)
3,111732495,111976516,3q13.2,3q13.2,610298,PHLDB2,"Pleckstrin homology-like domain, family B, member 2",PHLDB2,90102,ENSG00000144824,NA,NA,Phldb2 (MGI:2444981)
3,111998738,112013887,3q13.2,3q13.2,607953,"TAGLN3, NP24, NP22",Transgelin 3,TAGLN3,29114,ENSG00000144834,NA,NA,Tagln3 (MGI:1926784)
3,112086334,112136378,3q13.2,3q13.2,611956,"C3orf52, TTMP",Chromosome 3 open reading frame 52,C3orf52,79669,ENSG00000114529,NA,NA,BC016579 (MGI:2384848)
3,112120838,112133955,3q13,3q13.2,607792,"GCET2, HGAL",Germinal center-expressed transcript 2,GCSAM,257144,ENSG00000174500,NA,NA,Gcsam (MGI:102969)
3,112140897,112294257,3q13.2,3q13.2,612738,SLC9A10,"Solute carrier family 9, member 10",SLC9C1,285335,ENSG00000172139,NA,NA,Slc9c1 (MGI:2685456)
3,112332572,112362811,3q12-q13,3q13.2,155970,MOX2,MRC OX-2 antigen,CD200,4345,ENSG00000091972,NA,NA,Cd200 (MGI:1196990)
3,112463029,112499756,3q13.2,3q13.2,607925,BTLA,B- and T-lymphocyte attenuator,BTLA,151888,ENSG00000186265,NA,NA,Btla (MGI:2658978)
3,112604385,112641142,3q13.2,3q13.2,608298,"URB, SSG1","Urb, mouse, homolog of",CCDC80,151887,ENSG00000091986,NA,NA,Ccdc80 (MGI:1915146)
3,112921204,112975102,3q13.1,3q13.2,607546,"CD200R1, MOX2R, OX2R",CD200 receptor 1,CD200R1,131450,ENSG00000163606,NA,NA,Cd200r1 (MGI:1889024)
3,113002443,113019732,3q13.2,3q13.2,617089,"NEPRO, C3orf17",Nucleolus and neural progenitor protein,NEPRO,25871,ENSG00000163608,NA,NA,Nepro (MGI:2384836)
3,113211002,113287462,3q13.2,3q13.2,608708,BOC,Brother of CDON,BOC,91653,ENSG00000144857,NA,NA,Boc (MGI:2151153)
3,113286929,113441513,3q13.2,3q13.2,617559,"CFAP44, WDR52, SPGF20",Cilia- and flagella-associated protein 44,CFAP44,55779,ENSG00000206530,mutation identified in 1 SPGF20 patient,"?Spermatogenic failure 20, 617593 (3), Autosomal recessive",Cfap44 (MGI:1277238)
3,113442717,113515155,3q13.2,3q13.2,613447,"SPICE1, CCDC52",Spindle- and centriole-associated protein 1,SPICE1,152185,ENSG00000163611,NA,NA,Spice1 (MGI:1196252)
3,113532295,113629578,3q13.2,3q13.2,606816,SIDT1,"SID1 transmembrane family, member 1",SIDT1,54847,ENSG00000072858,NA,NA,Sidt1 (MGI:2443155)
3,113648384,113696656,3q13.2,3q13.2,617568,USF3,"Upstream transcription factor family, member 3",USF3,205717,ENSG00000176542,NA,NA,Usf3 (MGI:2685454)
3,113700000,117600000,3q13.31,NA,615433,"DEL3q13.31, C13DELq13.31",Chromosome 3q13.31 deletion syndrome,NA,NA,NA,NA,"Chromosome 3q13.31 deletion syndrome, 615433 (4), Autosomal dominant",NA
3,113716457,113746248,3q13.2,3q13.31,610834,"NAT13, NAT5, SAN",N-acetyltransferase 13,NAA50,80218,ENSG00000121579,NA,NA,Naa50 (MGI:1919367)
3,113747034,113812055,3p13,3q13.31,607027,"ATP6V1A, HO68, ARCL2D, IECEE3","ATPase, H+ transporting, V1 subunit A",ATP6V1A,523,ENSG00000114573,NA,"Cutis laxa, autosomal recessive, type IID, 617403 (3), Autosomal recessive; Epileptic encephalopathy, infantile or early childhood, 3, 618012 (3), Autosomal dominant",Atp6v1a (MGI:1201780)
3,113947900,113998001,3q13.31,3q13.31,617334,"ZDHHC23, NIDD",Zinc finger DHHC-type containing 23,ZDHHC23,254887,ENSG00000184307,NA,NA,Zdhhc23 (MGI:2685625)
3,114127622,114199406,3q13.3,3q13.31,126451,"DRD3, ETM1, FET1",Dopamine receptor D3,DRD3,1814,ENSG00000151577,NA,"{Essential tremor, hereditary, 1}, 190300 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant",Drd3 (MGI:94925)
3,114234630,114237577,3p12-qter,3q13.31,194553,ZNF80,Zinc finger protein-80 (pT17),ZNF80,7634,ENSG00000174255,NA,NA,NA
3,114291101,114329746,3q13.3,3q13.31,612859,TIGIT,T-cell immunoreceptor with immunoglobulin and ITIM domains,TIGIT,201633,ENSG00000181847,NA,NA,Tigit (MGI:3642260)
3,114314499,115147287,3q13.2,3q13.31,606025,"ZBTB20, ZNF288, DPZF, PRIMS",Zinc finger and BTB-domain containing 20,ZBTB20,26137,ENSG00000181722,NA,"Primrose syndrome, 259050 (3), Autosomal dominant",Zbtb20 (MGI:1929213)
3,115623509,115721484,3q13,3q13.31,162060,GAP43,Neuron growth-associated protein 43,GAP43,2596,ENSG00000172020,NA,NA,Gap43 (MGI:95639)
3,115802373,116445486,3q13.2-q21,3q13.31,603241,"LSAMP, LAMP",Limbic system-associated membrane protein,LSAMP,4045,ENSG00000185565,NA,NA,Lsamp (MGI:1261760)
3,116709787,116717039,3q13.31,3q13.31,616057,"TUSC7, LSAMPAS3, LOC285194","Tumor suppressor candidate 7, noncoding",TUSC7,285194,ENSG00000243197,NA,NA,NA
3,119173597,119205142,3q13.3-q21,3q13.32,602380,UPK1B,Uroplakin 1B,UPK1B,7348,ENSG00000114638,NA,NA,Upk1b (MGI:98912)
3,119211741,119240906,3q13.3,3q13.32,604015,B4GALT4,"Beta-1,4-galactosyltransferase 4",B4GALT4,8702,ENSG00000121578,NA,NA,B4galt4 (MGI:1928387)
3,119294288,119420713,3q13.3,3q13.32-q13.33,610911,"ARHGAP31, CDGAP, KIAA1204, AOS1",Rho GTPase-activating protein 31,ARHGAP31,57514,ENSG00000031081,NA,"Adams-Oliver syndrome 1, 100300 (3), Autosomal dominant",Arhgap31 (MGI:1333857)
3,119468937,119494707,3q13.33,3q13.33,615618,"POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21",Protein O-glucosyltransferase 1,POGLUT1,56983,ENSG00000163389,mutation identified in 1 LGMDR21 family,"Dowling-Degos disease 4, 615696 (3), Autosomal dominant; ?Muscular dystrophy, limb-girdle, autosomal recessive 21, 617232 (3), Autosomal recessive",Poglut1 (MGI:2444232)
3,119498524,119525089,3q13.33,3q13.33,615534,"TIMMDC1, C3orf1, MC1DN31",Translocase of inner mitochondrial membrane domain-containing protein 1,TIMMDC1,51300,ENSG00000113845,NA,"Mitochondrial complex I deficiency, nuclear type 31, 618251 (3), Autosomal recessive",Timmdc1 (MGI:1922139)
3,119524292,119559613,3q21,3q13.33,112203,"CD80, CD28LG, LAB7","CD80 antigen (CD28 antigen ligand 1, B7-1 antigen)",CD80,941,ENSG00000121594,NA,NA,Cd80 (MGI:101775)
3,119579432,119589953,3q13.33,3q13.33,603081,ADPRH,ADP-ribosylarginine hydrolase,ADPRH,141,ENSG00000144843,NA,NA,Adprh (MGI:1098234)
3,119597847,119629810,3q13.2-q13.3,3q13.33,607460,"PLA1A, PSPLA1",Phosphatidylserine-specific phospholipase A1-alpha,PLA1A,51365,ENSG00000144837,NA,NA,Pla1a (MGI:1934677)
3,119642051,119660589,3q13.3,3q13.33,605823,"POPDC2, POP2",Popeye domain-containing protein 2,POPDC2,64091,ENSG00000121577,NA,NA,Popdc2 (MGI:1930150)
3,119669524,119677395,3q,3q13.33,604813,COX17,Cytochrome c oxidase assembly protein COX17,COX17,10063,ENSG00000138495,pseudogene on chr. 13?,NA,Cox17 (MGI:1333806)
3,119703021,119767101,3q13.3-q21.1,3q13.33,609910,"MAATS1, AAT1, C3orf15",MYCBP-associated testis-expressed protein 1,MAATS1,89876,ENSG00000183833,NA,NA,Maats1 (MGI:2443598)
3,119780483,119818484,3q13-q21,3q13.33,603065,"NR1I2, PXR, SXR, PARq","Nuclear receptor subfamily 1, group I, member 2",NR1I2,8856,ENSG00000144852,NA,NA,Nr1i2 (MGI:1337040)
3,119821320,120095822,3q13.3,3q13.33,605004,GSK3B,Glycogen synthase kinase 3-beta,GSK3B,2932,ENSG00000082701,NA,NA,Gsk3b (MGI:1861437)
3,120165480,120285073,3q13.33,3q13.33,610464,"GPR156, GABABL",G protein-coupled receptor 156,GPR156,165829,ENSG00000175697,NA,NA,Gpr156 (MGI:2653880)
3,120392292,120450992,3q13.3,3q13.33,605547,"FSTL1, FRP, MIR198",Follistatin-like 1,FSTL1,11167,ENSG00000163430,FSTL1 mRNA can encode a protein or produce an micoRNA,NA,Fstl1 (MGI:102793)
3,120596335,120602506,3q13.33,3q13.33,603840,NDUFB4,NADH-ubiquinone oxidoreductase subunit B4,NDUFB4,4710,ENSG00000065518,NA,NA,"Ndufb4c,Ndufb4b,Ndufb4 (MGI:3781422,MGI:1915444,MGI:3782046)"
3,120628167,120682554,3q13.33,3q13.33,607474,"HGD, AKU","Homogentisate 1,2-dioxygenase (homogentisate oxidase)",HGD,3081,ENSG00000113924,NA,"Alkaptonuria, 203500 (3), Autosomal recessive",Hgd (MGI:96078)
3,120742743,120783068,3q13.33,3q13.33,189962,"GTF2E1, TF2E1","General transcription factor IIE, polypeptide 1",GTF2E1,2960,ENSG00000153767,NA,NA,Gtf2e1 (MGI:1921447)
3,120908202,121424760,3q13.3,3q13.33,609381,"STXBP5L, LLGL4",Syntaxin-binding protein 5-like,STXBP5L,9515,ENSG00000145087,NA,NA,Stxbp5l (MGI:2443815)
3,121431430,121545987,3q13.3,3q13.33,604419,POLQ,"Polymerase, DNA, theta",POLQ,10721,ENSG00000051341,NA,NA,Polq (MGI:2155399)
3,121567948,121590621,3q13.3,3q13.33,611164,ARGFX,Arginine-fifty homeobox,ARGFX,503582,ENSG00000186103,pseudogenes on 5q23.2 and 17q11.2,NA,NA
3,121593378,121630294,3q21.1,3q13.33,609107,"FBXO40, FBX40, KIAA1195",F-box only protein 40,FBXO40,51725,ENSG00000163833,NA,NA,Fbxo40 (MGI:2443753)
3,121631398,121660902,3q13,3q13.33,601306,HCLS1,Hematopoietic cell-specific Lyn substrate 1,HCLS1,3059,ENSG00000180353,NA,NA,Hcls1 (MGI:104568)
3,121663198,121751168,3q13,3q13.33,602500,"GOLGB1, GCP372","Golgi autoantigen, golgin subfamily B, 1",GOLGB1,2804,ENSG00000173230,NA,NA,Golgb1 (MGI:1099447)
3,121769760,121835078,3q13.33,3q13.33,609237,"IQCB1, NPHP5, KIAA0036",IQ motif-containing protein B1,IQCB1,9657,ENSG00000173226,NA,"Senior-Loken syndrome 5, 609254 (3), Autosomal recessive",Iqcb1 (MGI:2443764)
3,121835179,121886525,3q13.33,3q13.33,607659,EAF2,ELL-associated factor 2,EAF2,55840,ENSG00000145088,NA,NA,Eaf2 (MGI:2146616)
3,121894400,121944187,3q13.33,3q13.33,602339,"SLC15A2, PEPT2","Solute carrier family 15 (H+/peptide transporter), member 2",SLC15A2,6565,ENSG00000163406,NA,NA,Slc15a2 (MGI:1890457)
3,121987322,122060553,3q21.1,3q13.33,609739,"ILDR1, DFNB42",Immunoglobulin-like domain-containing receptor 1,ILDR1,286676,ENSG00000145103,NA,"Deafness, autosomal recessive 42, 609646 (3), Autosomal recessive",Ildr1 (MGI:2146574)
3,122055361,122121142,3q21,3q13.33,601020,"CD86, CD28LG2, LAB72","CD86 antigen (CD28 antigen ligand 2, B7-2 antigen)",CD86,942,ENSG00000114013,NA,NA,Cd86 (MGI:101773)
3,122183667,122291628,3q21.1,3q13.3-q21.1,601199,"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",Calcium-sensing receptor,CASR,846,ENSG00000036828,15cM from RHO,"{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3); Hyperparathyroidism, neonatal, 239200 (3), Autosomal recessive, Autosomal dominant; Hypocalcemia, autosomal dominant, 601198 (3), Autosomal dominant; Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3), Autosomal dominant; Hypocalciuric hypercalcemia, type I, 145980 (3), Autosomal dominant",Casr (MGI:1351351)
3,122200000,129500000,3q21,NA,603165,ATOD1,"Dermatitis, atopic, 1",NA,64069,NA,max lod at D3S3606,"{Dermatitis, atopic, susceptibility to, 1}, 603165 (2), Autosomal dominant",NA
3,122200000,155300000,3q21-q25.2,NA,614011,"ERVK-4, HERV-KI","Endogenous retrovirus group K, member 4",ERVK-4,60359,NA,NA,NA,NA
3,122200000,129500000,3q21,NA,613460,"FGQTL6, BWQTL3, PGQTL1","Fasting plasma glucose level QTL 6; Birth weight QTL 3; Plasma glucose, 2-hour, QTL 1",NA,100499168,NA,associated with rs11708067 and rs11708067,"[Birth weight QTL 3], 613460 (2); [Fasting plasma glucose level QTL 6], 613460 (2); [Plasma glucose, 2-hour, QTL 1], 613460 (2)",NA
3,122200000,149200000,3q21-q24,NA,601682,GLC1C,"Glaucoma 1, open angle, C",GLC1C,2723,NA,NA,"Glaucoma 1C, primary open angle, 601682 (2), Autosomal dominant",NA
3,122200000,139000000,3q21-q22,NA,601471,"HCFP1, MBS2","Facial paresis, hereditary congenital, 1",MBS2,7880,NA,NA,"Facial paresis, hereditary congenital, 1, 601471 (2), Autosomal dominant",NA
3,122200000,129500000,3q21,NA,604316,PSORS5,Psoriasis susceptibility 5,PSORS5,63870,NA,NA,"{Psoriasis susceptibility 5}, 604316 (2)",NA
3,122325247,122341968,3q21,3q21.1,184600,"CSTA, STFA, STF1, AREI, PSS4",Cystatin A (stefin A),CSTA,1475,ENSG00000121552,NA,"Peeling skin syndrome 4, 607936 (3), Autosomal recessive","Csta1,Csta2,Cstdc4 (MGI:3524930,MGI:1924020,MGI:3645124)"
3,122384181,122412333,3q21.1,3q21.1,608017,"FAM162A, ,C3orf28, E2IG5","Family with sequence similiarity 162, member A",FAM162A,26355,ENSG00000114023,NA,NA,Fam162a (MGI:1917436)
3,122421900,122514938,3q21,3q21.1,600686,"KPNA1, RCH2, SRP1","Karyopherin, alpha-1",KPNA1,3836,ENSG00000114030,NA,NA,Kpna1 (MGI:103560)
3,122527923,122564783,3q21,3q21.1,612065,"PARP9, BAL1, BAL",Poly(ADP-ribose) polymerase 9,PARP9,83666,ENSG00000138496,NA,NA,Parp9 (MGI:1933117)
3,122564337,122575202,3q21,3q21.1,613143,"DTX3L, BBAP",DTX3-like,DTX3L,151636,ENSG00000163840,head-to-head with PARP9,NA,Dtx3l (MGI:2656973)
3,122575925,122639046,3q21,3q21.1,612066,"PARP15, BAL3",Poly(ADP-ribose) polymerase 15,PARP15,165631,ENSG00000173200,NA,NA,NA
3,122680725,122730839,3q21.1,3q21.1,610028,"PARP14, KIAA1268",Poly(ADP-ribose) polymerase 14,PARP14,54625,ENSG00000173193,NA,NA,Parp14 (MGI:1919489)
3,122795057,122892156,3q21,3q21.1,602773,"DIRC2, RCC4",Disrupted in renal carcinoma 2,SLC49A4,84925,ENSG00000138463,t(2;3)(q35;q21) in renal cell carcinoma,"Renal cell carcinoma, 144700 (1)",Slc49a4 (MGI:2387188)
3,123067008,123162105,3q21.1,3q21.1,616942,"PDIA5, PDIR","Protein disulfide isomerase, family A, member 5",PDIA5,10954,ENSG00000065485,NA,NA,Pdia5 (MGI:1919849)
3,123201942,123274135,3q21.1,3q21.1,612442,"SEC22A, SEC22L2","Secretion deficient 22, S. cerevisiae, homolog of, A",SEC22A,26984,ENSG00000121542,NA,NA,Sec22a (MGI:2447876)
3,123282295,123448987,3q13.2-q21,3q21.1,600293,"ADCY5, FDFM",Adenylate cyclase-5,ADCY5,111,ENSG00000173175,NA,"Dyskinesia, familial, with facial myokymia, 606703 (3), Autosomal dominant",Adcy5 (MGI:99673)
3,123491547,123585098,3q21.1,3q21.1,615939,"PTPLB, HACD2","Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member B",HACD2,201562,ENSG00000206527,NA,NA,Hacd2 (MGI:1918007)
3,123610048,123884331,3q21,3q21.1,600922,"MYLK, MLCK, AAT7",Myosin-light-polypeptide kinase,MYLK,4638,ENSG00000065534,pseudogene on 3p13,"Aortic aneurysm, familial thoracic 7, 613780 (3), Autosomal dominant",Mylk (MGI:894806)
3,123887382,123961411,3q21.1,3q21.1,617147,CCDC14,Coiled-coil domain-containing protein 14,CCDC14,64770,ENSG00000175455,NA,NA,Ccdc14 (MGI:2443448)
3,123968520,123992169,3q21.1,3q21.1,611757,"ROPN1, ODF6",Rhophilin-associated tail protein 1,ROPN1,54763,ENSG00000065371,NA,NA,Ropn1 (MGI:1923628)
3,124033340,124726324,3q13,3q21.1-q21.2,604605,"KALRN, HAPIP, DUO, CHDS5",Kalirin,KALRN,8997,ENSG00000160145,NA,"{Coronary heart disease, susceptibility to, 5}, 608901 (3)",Kalrn (MGI:2685385)
3,124730365,124749272,3q13,3q21.2,613891,"UMPS, OPRT",Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase),UMPS,7372,ENSG00000114491,NA,"Orotic aciduria, 258900 (3), Autosomal recessive",Umps (MGI:1298388)
3,124761947,124901410,3q21.2,3q21.2,147561,ITGB5,"Integrin, beta-5",ITGB5,3693,ENSG00000082781,NA,NA,Itgb5 (MGI:96614)
3,124905441,124934750,3q13.3,3q21.2,612181,MUC13,"Mucin 13, cell surface-associated",MUC13,56667,ENSG00000173702,NA,NA,Muc13 (MGI:103190)
3,124965709,125055996,3q21.2,3q21.2,614182,"HEG1, KIAA1237","Heart of glass, zebrafish, homolog of, 1",HEG1,57493,ENSG00000173706,NA,NA,Heg1 (MGI:1924696)
3,125225668,125375353,3q21,3q21.2,601897,"ZNF148, ZFP148, GDACCF",Zinc finger protein-148,ZNF148,7707,ENSG00000163848,NA,"Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3), Autosomal dominant",Zfp148 (MGI:1332234)
3,125446643,125520213,3q21.2,3q21.2,605931,SNX4,Sorting nexin 4,SNX4,8723,ENSG00000114520,NA,NA,Snx4 (MGI:1916400)
3,125528857,125595496,3q21.1,3q21.2,606739,"OSBPL11, ORP11",Oxysterol-binding protein-like protein 11,OSBPL11,114885,ENSG00000144909,previously assigned to chr.8,NA,Osbpl11 (MGI:2146553)
3,126006356,126101549,3q21.2,3q21.2-q21.3,610803,SLC41A3,"Solute carrier family 41, member 3",SLC41A3,54946,ENSG00000114544,NA,NA,Slc41a3 (MGI:1918949)
3,126103560,126197757,3q21.3,3q21.3,600249,"ALDH1L1, FTHFD","Aldehyde dehydrogenase 1 family, member L1",ALDH1L1,10840,ENSG00000144908,NA,NA,Aldh1l1 (MGI:1340024)
3,126288120,126357407,3q21-q22,3q21.3,606465,"KLF15, KKLF",Kruppel-like factor 15,KLF15,28999,ENSG00000163884,NA,NA,Klf15 (MGI:1929988)
3,126437347,126475937,3q21.3,3q21.3,615746,ZXDC,ZCD family zinc finger protein C,ZXDC,79364,ENSG00000070476,NA,NA,Zxdc (MGI:1933108)
3,126481165,126517772,3q21.3,3q21.3,613012,"UROC1, UROCD",Urocanase domain-containing protein 1,UROC1,131669,ENSG00000159650,mutation identified in 1 UROCD patient,"?Urocanase deficiency, 276880 (3), Autosomal recessive",Uroc1 (MGI:2385332)
3,126524154,126543290,3p21.3,3q21.3,610124,"CHST13, C4ST3",Carbohydrate sulfotransferase 13,CHST13,166012,ENSG00000180767,NA,NA,Chst13 (MGI:1919047)
3,126607058,126655123,3q21,3q21.3,606235,"TXNRD3, TRXR3, TR2",Thioredoxin reductase 3,TXNRD3,114112,ENSG00000197763,NA,NA,Txnrd3 (MGI:2386711)
3,126704239,126960419,3q21.3,3q21.3,615634,"CHCHD6, CHCM1",Coiled-coil-helix-coiled-coil-helix domain-containing protein 6,CHCHD6,84303,ENSG00000159685,NA,NA,Chchd6 (MGI:1913348)
3,126983258,127037391,3q21-qter,3q21.3,601055,"PLXNA1, NOVP, NOV, PLXN1",Plexin A1 (NOV transmembrane protein),PLXNA1,5361,ENSG00000114554,NA,NA,Plxna1 (MGI:107685)
3,127598356,127622435,3q21,3q21.3,116945,"MCM2, CDCL1, DFNA70","Minichromosome maintenance deficient, S. cerevisiae, 2, homolog of (mitotin)",MCM2,4171,ENSG00000073111,mutation identified in 1 DFNA70 family,"?Deafness, autosomal dominant 70, 616968 (3), Autosomal dominant",Mcm2 (MGI:105380)
3,127629184,127672801,3q21.3,3q21.3,616627,"PODXL2, EG",Podocalyxin-like 2,PODXL2,50512,ENSG00000114631,NA,NA,Podxl2 (MGI:2442488)
3,127672927,127680925,3q21,3q21.3,608308,"ABTB1, BPOZ",Ankyrin repeat and BTB/POZ domain containing 1,ABTB1,80325,ENSG00000114626,NA,NA,Abtb1 (MGI:1933148)
3,127689061,127823249,3p21.3,3q21.3,609699,"MGLL, MGL, HUK5",Monoglyceride lipase,MGLL,11343,ENSG00000074416,NA,NA,Mgll (MGI:1346042)
3,128052436,128071682,3q21.3,3q21.3,609213,"SEC61A1, SEC61, HNFJ4","Sec61 translocon, alpha-1 subunit",SEC61A1,29927,ENSG00000058262,NA,"Hyperuricemic nephropathy, familial juvenile, 4, 617056 (3), Autosomal dominant",Sec61a1 (MGI:1858417)
3,128064610,128153913,3q21,3q21.3,603449,"RUVBL1, NMP238, TIP49","RUVB, E. coli, homolog-like 1",RUVBL1,8607,ENSG00000175792,NA,NA,Ruvbl1 (MGI:1928760)
3,128153452,128426192,3q21.3,3q21.3,607695,"EEFSEC, SELB, EFSEC","Eukaryotic elongation factor, selenocysteine-tRNA-specific",EEFSEC,60678,ENSG00000132394,NA,NA,Eefsec (MGI:2137092)
3,128462433,128467247,3q21.3,3q21.3,611337,"DNAJB8, DJ6","DNAJ/HSP40 homolog, subfamily B, member 8",DNAJB8,165721,ENSG00000179407,NA,NA,Dnajb8 (MGI:1922801)
3,128479421,128493186,3q21,3q21.3,137295,"GATA2, DCML, MONOMAC, IMD21",GATA-binding protein-2,GATA2,2624,ENSG00000179348,NA,"Emberger syndrome, 614038 (3), Autosomal dominant; Immunodeficiency 21, 614172 (3), Autosomal dominant; {Leukemia, acute myeloid, susceptibility to}, 601626 (3), Autosomal dominant, Somatic mutation; {Myelodysplastic syndrome, susceptibility to}, 614286 (3)",Gata2 (MGI:95662)
3,128571999,128576085,3q21,3q21.3,618259,LINC01565,Long intergenic noncoding RNA 1565,LINC01565,23434,ENSG00000198685,NA,NA,NA
3,128619968,128650817,3q,3q21.3,180470,RPN1,Ribophorin I,RPN1,6184,ENSG00000163902,NA,NA,Rpn1 (MGI:98084)
3,128726135,128814797,3q21,3q21.3,602298,"RAB7, CMT2B, PSN",Ras-associated protein RAB7,RAB7A,7879,ENSG00000075785,NA,"Charcot-Marie-Tooth disease, type 2B, 600882 (3), Autosomal dominant",Rab7 (MGI:105068)
3,128879489,128913113,3q26,3q21.3,611103,"ACAD9, MC1DN20","Acyl-CoA dehydrogenase family, member 9",ACAD9,28976,ENSG00000177646,NA,"Mitochondrial complex I deficiency, nuclear type 20, 611126 (3), Autosomal recessive",Acad9 (MGI:1914272)
3,129055448,129062410,3q21,3q21.3,173515,GP9,"Glycoprotein IX, platelet",GP9,2815,ENSG00000169704,NA,"Bernard-Soulier syndrome, type C, 231200 (3), Autosomal recessive",Gp9 (MGI:1860137)
3,129127414,129161062,3q21.3,3q21.3,612764,"ISY1, KIAA1160","ISY1 splicing factor, S. cerevisiae, homolog of",ISY1,57461,ENSG00000240682,NA,NA,NA
3,129167826,129183895,3q21.3,3q21.3,116955,"CNBP, ZNF9, CNBP1, DM2, PROMM",CCHC-type zinc finger nucleic acid-binding protein,CNBP,7555,ENSG00000169714,NA,"Myotonic dystrophy 2, 602668 (3), Autosomal dominant",Cnbp (MGI:88431)
3,129249574,129277772,3q21.3,3q21.3,615525,COPG1,"Coatomer protein complex, subunit gamma-1",COPG1,22820,ENSG00000181789,NA,NA,Copg1 (MGI:1858696)
3,129314770,129316285,3q21.3,3q21.3,602785,"H1FX, H1X","H1 histone family, member X",H1FX,8971,ENSG00000184897,NA,NA,H1fx (MGI:2685307)
3,129430943,129440178,3q21-q22,3q21.3,603574,"MBD4, MED1",Methyl-CpG-binding domain protein 4,MBD4,8930,ENSG00000129071,NA,NA,Mbd4 (MGI:1333850)
3,129440035,129520506,3q21,3q21.3-q22.1,606045,"IFT122, WDR10, CED1","Intraflagellar transport 122, homolog of",IFT122,55764,ENSG00000163913,NA,"Cranioectodermal dysplasia 1, 218330 (3), Autosomal recessive",Ift122 (MGI:1932386)
3,129500000,149200000,3q22-q24,NA,611155,AD15,Alzheimer disease 15,NA,100188838,NA,max lod at D3S1579,"{Alzheimer disease-15}, 611155 (2)",NA
3,129500000,139000000,3q22,NA,606012,DFNA18,"Deafness, autosomal dominant 18",DFNA18,85507,NA,NA,"Deafness, autosomal dominant 18, 606012 (2), Autosomal dominant",NA
3,129500000,149200000,3q22-q24,NA,220200,"DWS, C3DELq22q24, DEL3q22q24",Dandy-Walker syndrome,DWS,1858,NA,ZIC1 and ZIC4 good candidate genes,"Dandy-Walker syndrome, 220200 (4), Isolated cases",NA
3,129500000,149200000,3q22-q24,NA,608787,OTSC5,Otosclerosis 5,OTSC5,317682,NA,max lod at D3S1569,"Otosclerosis 5, 608787 (2)",NA
3,129500000,161000000,3q22-q25,NA,173865,PABPL1,Polyadenylate-binding protein-like 1,NA,NA,NA,NA,NA,NA
3,129500000,139000000,3q22,NA,616361,PARK21,Parkinson disease 21,NA,108353827,NA,conflicting mapping on 20pter-p12,"Parkinson disease 21, 616361 (2), Autosomal dominant",NA
3,129500000,139000000,3q22,NA,606995,SLSN3,Senior-Loken syndrome 3,NA,260432,NA,?allelic with NPHP3,"Senior-Loken syndrome 3, 606995 (2), Autosomal recessive",NA
3,129528638,129535343,3q21-q24,3q22.1,180380,"RHO, RP4, OPN2, CSNBAD1",Rhodopsin (opsin 2),RHO,6010,ENSG00000163914,NA,"Night blindness, congenital stationary, autosomal dominant 1, 610445 (3); Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3), Autosomal recessive, Autosomal dominant; Retinitis punctata albescens, 136880 (3), Autosomal recessive, Autosomal dominant",Rho (MGI:97914)
3,129555212,129606738,3q22,3q22.1,604282,PLXND1,Plexin D1,PLXND1,23129,ENSG00000004399,NA,NA,Plxnd1 (MGI:2154244)
3,129647791,129893710,3q22.1,3q22.1,616242,"TMCC1, KIAA0779",Transmembrane and coiled-coil domain family 1,TMCC1,23023,ENSG00000172765,NA,NA,Tmcc1 (MGI:2442368)
3,129974719,129977934,3q13.3-q21,3q22.1,613879,TRH,Thyrotropin-releasing hormone,TRH,7200,ENSG00000170893,NA,"Thyrotropin-releasing hormone deficiency, 275120 (1), Autosomal recessive",Trh (MGI:98823)
3,130212819,130273805,3q21,3q22.1,616612,COL6A4P2,"Collagen, type VI, alpha-4, pseudogene 2",COL6A4P2,646300,NA,NA,NA,NA
3,130345515,130484845,3q21,3q22.1,611916,"COL6A5, COL29A1","Collagen, type VI, alpha-5",COL6A5,256076,ENSG00000172752,NA,NA,Col6a5 (MGI:3648134)
3,130516708,130678136,3q21,3q22.1,616613,COL6A6,"Collagen, type VI, alpha-6",COL6A6,131873,ENSG00000206384,NA,NA,Col6a6 (MGI:2444259)
3,130678933,130746828,3q22.1,3q22.1,602610,PIK3R4,"Phosphatidylinositol 3-kinase, regulatory subunit 4",PIK3R4,30849,ENSG00000196455,NA,NA,Pik3r4 (MGI:1922919)
3,130850499,131016711,3q21-q24,3q22.1,604384,"ATP2C1, BCPM, HHD","ATPase, Ca(2+)-sequestering",ATP2C1,27032,ENSG00000017260,NA,"Hailey-Hailey disease, 169600 (3), Autosomal dominant",Atp2c1 (MGI:1889008)
3,131026850,131350464,3q21-q22,3q22.1,609779,NEK11,Never in mitosis gene A-related kinase 11,NEK11,79858,ENSG00000114670,NA,NA,Nek11 (MGI:2442276)
3,131381670,131388829,3q22.1,3q22.1,617381,NUDT16,Nudix hydrolase 16,NUDT16,131870,ENSG00000198585,NA,NA,Nudt16 (MGI:1922936)
3,131462211,131502970,3q22.1,3q22.1,607118,"MRPL3, MRL3, COXPD9",Mitochondrial ribosomal protein L3,MRPL3,11222,ENSG00000114686,NA,"Combined oxidative phosphorylation deficiency 9, 614582 (3), Autosomal recessive",Mrpl3 (MGI:2137204)
3,131533559,132285695,3q22.1,3q22.1,604208,"CPNE4, CPN4",Copine IV,CPNE4,131034,ENSG00000196353,NA,NA,Cpne4 (MGI:1921270)
3,132317402,132368764,3q21-q23,3q22.1,171790,ACPP,"Acid phosphatase, prostate",ACPP,55,ENSG00000014257,NA,NA,Acpp (MGI:1928480)
3,132417501,132539031,3q22.1,3q22.1,614334,"DNAJC13, RME8, KIAA0678","DNAJ/HSP40 homolog, subfamily C, member 13",DNAJC13,23317,ENSG00000138246,NA,NA,Dnajc13 (MGI:2676368)
3,132558137,132660130,3q22.1,3q22.1,614288,ACAD11,"Acyl-CoA dehydrogenase family, member 11",ACAD11,84129,ENSG00000240303,NA,NA,Acad11 (MGI:2143169)
3,132597269,132602643,3q22,3q22.1,606065,"ACKR4, CCRL1, PPR1",Atypical chemokine receptor 4,ACKR4,51554,ENSG00000129048,NA,NA,Ackr4 (MGI:2181676)
3,132654445,132679785,3q22,3q22.1,610552,"UBA5, UBE1DC1, EIEE44, SCAR24",Ubiquitin-like modifier activating enzyme 5,UBA5,79876,ENSG00000081307,mutation identified in 1 SCAR24 family,"Epileptic encephalopathy, early infantile, 44, 617132 (3), Autosomal recessive; ?Spinocerebellar ataxia, autosomal recessive 24, 617133 (3), Autosomal recessive",Uba5 (MGI:1913913)
3,132680608,132722408,3q22,3q22.1,608002,"NPHP3, NPH3, RHPD1, MKS7",Nephrocystin 3,NPHP3,27031,ENSG00000113971,NA,"Meckel syndrome 7, 267010 (3), Autosomal recessive; Nephronophthisis 3, 604387 (3), Autosomal recessive; Renal-hepatic-pancreatic dysplasia 1, 208540 (3), Autosomal recessive",Nphp3 (MGI:1921275)
3,133038287,133397774,3q22.1,3q22.1,617361,"TMEM108, RTLN, KIAA1690",Transmembrane protein 108,TMEM108,66000,ENSG00000144868,NA,NA,Tmem108 (MGI:1932411)
3,133397881,133475207,3q21-q25,3q22.1,603212,"BFSP2, CP49, CP47, CTRCT12","Beaded filament structural protein 2 (cytoskeletal protein, 49 kD)",BFSP2,8419,ENSG00000170819,NA,"Cataract 12, multiple types, 611597 (3), Autosomal dominant",Bfsp2 (MGI:1333828)
3,133600237,133661967,3q22.1,3q22.1,607760,"TOPBP1, KIAA0259",DNA topoisomerase II-binding protein 1,TOPBP1,11073,ENSG00000163781,NA,NA,Topbp1 (MGI:1920018)
3,133661997,133796640,3q21,3q22.1,190000,"TF, TFQTL1",Transferrin,TF,7018,ENSG00000091513,NA,"Atransferrinemia, 209300 (3), Autosomal recessive",Trf (MGI:98821)
3,133784022,133828573,3q22.1,3q22.1,616883,"SRPRB, APMCF1","Signal recognition particle receptor, beta subunit",SRPRB,58477,ENSG00000144867,NA,NA,Srprb (MGI:102964)
3,133824234,133895881,3q22.1,3q22.1,615852,RAB6B,Ras-associated protein RAB6B,RAB6B,51560,ENSG00000154917,NA,NA,Rab6b (MGI:107283)
3,133932700,134029954,3q21,3q22.1-q22.2,601460,"SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2","Solute carrier organic anion transporter family, member 2A1",SLCO2A1,6578,ENSG00000174640,NA,"Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3), Autosomal recessive",Slco2a1 (MGI:1346021)
3,134157132,134250833,3q22.2,3q22.2,600524,"RYK, RYK1",RYK receptor-like tyrosine kinase,RYK,6259,ENSG00000163785,NA,NA,Ryk (MGI:101766)
3,134355344,134375416,3q22.2,3q22.2,614658,"AMOTL2, KIAA0989",Angiomotin-like 2,AMOTL2,51421,ENSG00000114019,NA,NA,Amotl2 (MGI:1929286)
3,134477703,134486022,3q22.2,3q22.2,614484,"ANAPC13, APC13, SWM1","Anaphase-promoting complex, subunit 13",ANAPC13,25847,ENSG00000129055,NA,NA,Anapc13 (MGI:1916260)
3,134485723,134783168,3q22.2,3q22.2,614724,"CEP63, SCKL6","Centrosomal protein, 63kD",CEP63,80254,ENSG00000182923,mutation identified in 1 family,"?Seckel syndrome 6, 614728 (3), Autosomal recessive",Cep63 (MGI:2158560)
3,134595263,135260466,3q21-q23,3q22.2,600600,"EPHB1, EPHT2, NET",eph tyrosine kinase 2 (ephrin receptor EphB1),EPHB1,2047,ENSG00000154928,NA,NA,Ephb1 (MGI:1096337)
3,134599922,134656052,3q21,3q22.2,605739,"KY, MFM7",Kyphoscoliosis peptidase,KY,339855,ENSG00000174611,NA,"Myopathy, myofibrillar, 7, 617114 (3), Autosomal recessive",Ky (MGI:96709)
3,135965672,136149614,3q22,3q22.2-q22.3,604944,"PP2R3A, PR72, PR130","Protein phosphatase 2, regulatory subunit B'', alpha",PPP2R3A,5523,ENSG00000073711,NA,NA,Ppp2r3a (MGI:2442104)
3,136148916,136197299,3q22.3,3q22.3,614802,"MSL2, KIAA1585","Male-specific lethal 2, Drosophila, homolog of",MSL2,55167,ENSG00000174579,NA,NA,Msl2 (MGI:1925103)
3,136250324,136330170,3q21-q22,3q22.3,232050,PCCB,"Propionyl Coenzyme A carboxylase, beta polypeptide",PCCB,5096,ENSG00000114054,pccB complementation group,"Propionicacidemia, 606054 (3), Autosomal recessive",Pccb (MGI:1914154)
3,136336234,136752411,3q22.3,3q22.3,604358,"STAG1, MRD47",Stromal antigen 1,STAG1,10274,ENSG00000118007,NA,"Mental retardation, autosomal dominant 47, 617635 (3), Autosomal dominant",Stag1 (MGI:1098658)
3,136819018,136855891,3q22.3,3q22.3,617812,"SLC35G2, TMEM22","Solute carrier family 35, member G2",SLC35G2,80723,ENSG00000168917,NA,NA,Slc35g2 (MGI:2685365)
3,136862207,136951605,3q21,3q22.3,600508,NCK,Non-catalytic region of tyrosine kinase,NCK1,4690,ENSG00000158092,NA,NA,Nck1 (MGI:109601)
3,137764314,137766333,3q23,3q22.3,604747,SOX14,SRY-box 14,SOX14,8403,ENSG00000168875,NA,NA,Sox14 (MGI:98362)
3,138061989,138115861,3q22.3,3q22.3,617570,"DZIP1L, DZIP2, PKD5",DAZ-interacting zinc finger protein 1-like,DZIP1L,199221,ENSG00000158163,NA,"Polycystic kidney disease 5, 617610 (3), Autosomal recessive",Dzip1l (MGI:1919757)
3,138123712,138133309,3p14.3,3q22.3,616709,A4GNT,"Alpha-1,4-N-acetylglucosaminyltransferase",A4GNT,51146,ENSG00000118017,NA,NA,A4gnt (MGI:2143261)
3,138160987,138174920,3q22.3,3q22.3,607024,DBR1,"Debranching enzyme 1, S. cerevisiae, homolog of",DBR1,51163,ENSG00000138231,NA,NA,Dbr1 (MGI:1931520)
3,138347647,138405534,3q22.3,3q22.3,608435,"MRAS, RRAS3, NS11",Muscle Ras viral oncogene homolog,MRAS,22808,ENSG00000158186,NA,"Noonan syndrome 11, 618499 (3)",Mras (MGI:1100856)
3,138434572,138481685,3q22.3,3q22.3,616692,"ESYT3, FAM62C",Extended synaptotagmin-like protein 3,ESYT3,83850,ENSG00000158220,NA,NA,Esyt3 (MGI:1098699)
3,138494338,138594382,3q22.3,3q22.3,614310,CEP70,"Centrosomal protein, 70kD",CEP70,80321,ENSG00000114107,NA,NA,Cep70 (MGI:1915371)
3,138608098,138633375,3q22,3q22.3,617535,FAIM,Fax apoptotic inhibitory molecule,FAIM,55179,ENSG00000158234,NA,NA,Faim (MGI:1344387)
3,138652697,138834937,3q22.3,3q22.3,602925,"PIK3CB, PI3KCB","Phosphatidylinositol 3-kinase, catalytic, beta",PIK3CB,5291,ENSG00000051382,NA,NA,Pik3cb (MGI:1922019)
3,138944223,138947136,3q23,3q22.3,605597,"FOXL2, BPES, BPES1, PFRK, POF3",Forkhead transcription factor FOXL2,FOXL2,668,ENSG00000183770,NA,"Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3), Autosomal dominant; Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3), Autosomal dominant; Premature ovarian failure 3, 608996 (3), Autosomal dominant",Foxl2 (MGI:1349428)
3,139000000,143100000,3q23,NA,612221,STQTL10,Stature quantitative trait locus 10,NA,100270794,NA,associated with rs6440003,"{Stature QTL 10}, 612221 (2)",NA
3,139343993,139357139,3q23,3q23,605810,"MRPS22, C3orf5, COXPD5, ODG7",Mitochondrial ribosomal protein S22,MRPS22,56945,ENSG00000175110,NA,"Combined oxidative phosphorylation deficiency 5, 611719 (3), Autosomal recessive; Ovarian dysgenesis 7, 618117 (3), Autosomal recessive",Mrps22 (MGI:1928137)
3,139355594,139389679,3q23,3q23,606990,"COPB2, MCPH19","Coatomer protein complex, subunit beta-2",COPB2,9276,ENSG00000184432,mutation identified in 1 MCPH19 family,"?Microcephaly 19, primary, autosomal recessive, 617800 (3), Autosomal recessive",Copb2 (MGI:1354962)
3,139452883,139476515,3q21-qter,3q23,180280,"RBP2, CRBP2","Retinol-binding protein-2, cellular",RBP2,5948,ENSG00000114113,close to CRBP1,NA,Rbp2 (MGI:97877)
3,139517437,139539741,3q21-q22,3q23,180260,"RBP1, CRBP1","Retinol-binding protein-1, cellular",RBP1,5947,ENSG00000114115,close to CRBP2,NA,Rbp1 (MGI:97876)
3,139560179,139678049,3q23,3q23,608702,"NMNAT3, PNAT3",Nicotinamide nucleotide adenylyltransferase 3,NMNAT3,349565,ENSG00000163864,NA,NA,NA
3,139935184,140577396,3q23,3q23,611323,CLSTN2,Calsyntenin 2,CLSTN2,64084,ENSG00000158258,NA,NA,Clstn2 (MGI:1929897)
3,140941835,140980977,3q23,3q23,616149,"SLC25A36, PNC2","Solute carrier family 25 (mitochondrial carrier, pyrimidine nucleotide transporter), member 36",SLC25A36,55186,ENSG00000114120,NA,NA,Slc25a36 (MGI:1924909)
3,141051346,141148610,3q23,3q23,611660,"SPSB4, SSB4",SPRY domain- and SOCS box-containing 4,SPSB4,92369,ENSG00000175093,NA,NA,Spsb4 (MGI:2183445)
3,141324185,141449791,3q23,3q23,612218,ZBTB38,Zinc finger- and BTB domain-containing protein 38,ZBTB38,253461,ENSG00000177311,NA,NA,Zbtb38 (MGI:2442866)
3,141487026,141615355,3q22-q23,3q23,601589,"RASA2, GAP1M",RAS p21 protein activator 2,RASA2,5922,ENSG00000155903,NA,NA,Rasa2 (MGI:2149960)
3,141738208,141747559,3q22-q24,3q23,603863,"RNF7, ROC2, SAG",RING finger protein-7 (regulator of cullins 2; sensitive to apoptosis gene),RNF7,9616,ENSG00000114125,NA,NA,Rnf7 (MGI:1337096)
3,141763123,141818489,3q21-q23,3q23,606987,"GRK7, GPRK7",G protein-coupled receptor kinase 7,GRK7,131890,ENSG00000114124,NA,NA,NA
3,141876642,141926548,3q22-q23,3q23,601867,ATP1B3,"ATPase, Na+/K+ transporting, beta 3 polypeptide",ATP1B3,483,ENSG00000069849,NA,NA,Atp1b3 (MGI:107788)
3,141944427,142149543,3q23,3q23,602160,"TFDP2, DP2",Transcription factor Dp-2 (E2F dimerization partner 2),TFDP2,7029,ENSG00000114126,NA,NA,Tfdp2 (MGI:107167)
3,142306609,142448061,3q25-q26.1,3q23,607994,"XRN1, SEP1",Exoribonuclease 1,XRN1,54464,ENSG00000114127,NA,NA,Xrn1 (MGI:891964)
3,142449234,142578792,3q22-q24,3q23,601215,"ATR, FRP1, SCKL1, FCTCS",Ataxia-telangiectasia and Rad3-related (FRAP-related protein-1),ATR,545,ENSG00000175054,mutation identified in 1 FCTCS family,"?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant; Seckel syndrome 1, 210600 (3), Autosomal recessive",Atr (MGI:108028)
3,142596392,142713663,3q23,3q23,602734,PLS1,Plastin-1,PLS1,5357,ENSG00000120756,NA,NA,Pls1 (MGI:104809)
3,142724033,142807887,3q22-q24,3q23,602343,"TRPC1, TRP1",Transient receptor potential channel 1,TRPC1,7220,ENSG00000144935,also called Htrp-1,NA,Trpc1 (MGI:109528)
3,142817873,142889082,3q21-q24,3q23,607064,PCOLCE2,Procollagen C-endopeptidase enhancer-2,PCOLCE2,26577,ENSG00000163710,NA,NA,Pcolce2 (MGI:1923727)
3,142961237,142963673,3q23,3q23,614580,PAQR9,"Progestin and ADIPOQ receptor family, member 9",PAQR9,344838,ENSG00000188582,NA,NA,Paqr9 (MGI:1922802)
3,143001569,143060724,3q23,3q23,617849,"U2SURP, SR140, KIAA0332",U2 small nuclear ribonucleoprotein-associated SURP domain-containing protein,U2SURP,23350,ENSG00000163714,NA,NA,U2surp (MGI:1915208)
3,143100000,183000000,3q24-q26,NA,610761,HDLCQ5,High density lipoprotein cholesterol level QTL 5,NA,100188818,NA,max lod at D3S3053,"[High density lipoprotein cholesterol level QTL 5], 610761 (2)",NA
3,143100000,183000000,3q24-q26,NA,606660,UVM1,"Melanoma, uveal, susceptibility to, 1",NA,170592,NA,NA,"{Melanoma, uveal, susceptibility to, 1}, 606660 (2)",NA
3,143119770,143124013,3q24,3q24,603798,CHST2,Carbohydrate sulfotransferase-2 (GlcNAc-6-O-sulfotransferase; N-acetylglucosamine-6-O-sulfotransferase),CHST2,9435,ENSG00000175040,mapped by FISH to 7q31,NA,Chst2 (MGI:1891160)
3,143265221,143848491,3q24,3q24,608396,"SLC9A9, AUTS16","Solute carrier family 9 (sodium/hydrogen exchanger), member A9",SLC9A9,285195,ENSG00000181804,mutation identified in 1 family,"{?Autism susceptibility 16}, 613410 (3)",Slc9a9 (MGI:2679732)
3,143971797,143992367,3q24,3q24,612200,"C3orf58, DIA1",Chromosome 3 open reading frame 58,DIPK2A,205428,ENSG00000181744,NA,NA,Dipk2a (MGI:1916111)
3,146069436,146161494,3q23-q24,3q24,601865,"PLOD2, LH2, TLH, BRKS2","Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2",PLOD2,5352,ENSG00000152952,NA,"Bruck syndrome 2, 609220 (3), Autosomal recessive",Plod2 (MGI:1347007)
3,146192334,146251178,3q23,3q24,607612,PLSCR4,Phospholipid scramblase 4,PLSCR4,57088,ENSG00000114698,NA,NA,Plscr4 (MGI:2143267)
3,146391362,146497162,3q23,3q24,607610,PLSCR2,Phospholipid scramblase 2,PLSCR2,57047,ENSG00000163746,NA,NA,NA
3,146515177,146544804,3q23,3q24,604170,"PLSCR1, MMTRA1B",Phospholipid scramblase 1,PLSCR1,5359,ENSG00000188313,NA,NA,Plscr1 (MGI:893575)
3,147386047,147407475,3q24,3q24,608948,ZIC4,"Zic family, member 4",ZIC4,84107,ENSG00000174963,NA,NA,Zic4 (MGI:107201)
3,147409364,147416718,3q24,3q24,600470,"ZIC1, CRS6","Zic family, member 1",ZIC1,7545,ENSG00000152977,NA,"Craniosynostosis 6, 616602 (3), Autosomal dominant",Zic1 (MGI:106683)
3,148697870,148743002,3q21-q25,3q24,106165,"AGTR1, AGTR1A, AT2R1",Angiotensin receptor 1,AGTR1,185,ENSG00000144891,NA,"{Hypertension, essential}, 145500 (3), Multifactorial; Renal tubular dysgenesis, 267430 (3), Autosomal recessive",Agtr1a (MGI:87964)
3,148827810,148860186,3q24,3q24,114852,"CPB1, PCPB, PASP","Carboxypeptidase B1, tissue",CPB1,1360,ENSG00000153002,NA,NA,Cpb1 (MGI:1923953)
3,148865295,148897202,3q24,3q24,114851,CPA3,"Carboxypeptidase A3, mast cell",CPA3,1359,ENSG00000163751,NA,NA,Cpa3 (MGI:88479)
3,148991407,149027668,3q24-q25.1,3q24,603942,"GYG1, GSD15",Glycogenin 1,GYG1,2992,ENSG00000163754,mutation identified in 1 GSD15 patient,"?Glycogen storage disease XV, 613507 (3), Autosomal recessive; Polyglucosan body myopathy 2, 616199 (3), Autosomal recessive",Gyg (MGI:1351614)
3,149030062,149086553,3q25.1-q26.1,3q24,603257,"SMARCA3, SNF2L3, HIP116","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3",HLTF,6596,ENSG00000071794,NA,NA,Hltf (MGI:1196437)
3,149129623,149173731,3q24,3q24,606118,HPS3,HPS gene 3,HPS3,84343,ENSG00000163755,NA,"Hermansky-Pudlak syndrome 3, 614072 (3), Autosomal recessive",Hps3 (MGI:2153839)
3,149162409,149222044,3q23-q24,3q24-q25,117700,CP,Ceruloplasmin,CP,1356,ENSG00000047457,~15cM from TF,"Cerebellar ataxia, 604290 (3), Autosomal recessive; Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3), Autosomal recessive; [Hypoceruloplasminemia, hereditary], 604290 (3), Autosomal recessive",Cp (MGI:88476)
3,149200000,188200000,3q25-q27,NA,608638,ASPG1,"Asperger syndrome, susceptibility to, 1",NA,431710,NA,max lod with D3S3037,"{Asperger syndrome susceptibility 1}, 608638 (2), Isolated cases, Multifactorial",NA
3,149200000,188200000,3q25-q27,NA,607373,AUTS8,"Autism, susceptibility to, 8",NA,282553,NA,NA,"{Autism susceptibility 8}, 607373 (2), Isolated cases, Multifactorial",NA
3,149200000,183000000,3q25-q26,NA,612008,CELIAC10,"Celiac disease, susceptibility to, 10",NA,100188872,NA,associated with rs17810546,"{Celiac disease, susceptibility to, 10}, 612008 (2)",NA
3,149200000,183000000,3q25-q26,NA,615697,ETL6,"Epilepsy, familial temporal lobe, 6",NA,103106902,NA,between D3S1584 and D3S3520,"Epilepsy, familial temporal lobe, 6, 615697 (2), Autosomal dominant",NA
3,149369021,149377780,3q21-q25,3q25.1,191155,"TM4SF1, M3S1, TAAL6","Transmembrane-4 superfamily, member 1",TM4SF1,4071,ENSG00000169908,NA,NA,Tm4sf1 (MGI:104678)
3,149474696,149503393,3q25,3q25.1,606567,"TM4SF4, ILTMP","Transmembrane 4 superfamily, member 4",TM4SF4,7104,ENSG00000169903,NA,NA,Tm4sf4 (MGI:2385173)
3,149517228,149724787,3q24,3q25.1,607392,"WWTR1, TAZ",WW domain-containing transcription regulator 1,WWTR1,25937,ENSG00000018408,NA,NA,Wwtr1 (MGI:1917649)
3,149738469,149752498,3q25.1,3q25.1,616699,COMMD2,COMM domain-containing protein 2,COMMD2,51122,ENSG00000114744,NA,NA,Commd2 (MGI:1098806)
3,149812687,149962138,3q25.1,3q25.1,609247,"RNF13, EIEE73",RING finger protein 13,RNF13,11342,ENSG00000082996,NA,"Epileptic encephalopathy, early infantile, 73, 618379 (3), Autosomal dominant",Rnf13 (MGI:1346341)
3,149964903,149970894,3q25.1-q25.2,3q25.1,176590,"PFN2, PFL, D3S1319E",Profilin-2,PFN2,5217,ENSG00000070087,mapped previously to chr.1,NA,Pfn2 (MGI:97550)
3,149981660,149983365,3q25.1,3q25.1,611365,"TMEM183B, C1orf37DUP",Transmembrane protein 183B,TMEM183B,653659,NA,NA,NA,NA
3,150408297,150466421,3q25.1,3q25.1,617724,"TSC22D2, KIAA0669","TSC22 domain family, member 2",TSC22D2,9819,ENSG00000196428,NA,NA,Tsc22d2 (MGI:1919283)
3,150541997,150546495,3q25.1,3q25.1,617674,"SERP1, RAMP4",Stress-associated endoplasmic reticulum protein 1,SERP1,27230,ENSG00000120742,NA,NA,Serp1 (MGI:92638)
3,150546677,150586015,3q25.1,3q25.1,609234,EIF2A,Eukaryotic translation initiation factor 2A,EIF2A,83939,ENSG00000144895,NA,NA,Eif2a (MGI:1098684)
3,150603320,150630435,3q24,3q25.1,607912,"SELENOT, SELT",Selenoprotein T,SELENOT,51714,ENSG00000198843,NA,NA,Selenot (MGI:1916477)
3,150741124,150763168,3q25,3q25.1,602213,SIAH2,"Seven in absentia, Drosophila, homolog of, 2",SIAH2,6478,ENSG00000181788,NA,NA,Siah2 (MGI:108062)
3,150926162,150972998,3q21-q25,3q25.1,606397,"CLRN1, USH3A, USH3, RP61",Clarin 1,CLRN1,7401,ENSG00000163646,frequent in Finland; ?digenic interaction with MYO7A,"Retinitis pigmentosa 61, 614180 (3); Usher syndrome, type 3A, 276902 (3), Autosomal recessive",Clrn1 (MGI:2388124)
3,151085664,151436676,3q21-q25,3q25.1,611318,"MED12L, NOPAR, KIAA1635",Mediator complex subunit 12-like,MED12L,116931,ENSG00000144893,NA,NA,Med12l (MGI:2139916)
3,151212114,151279166,3q25.1,3q25.1,610116,"P2RY14, BPR105, KIAA0001","Purinergic receptor P2Y, G protein-coupled, 14",P2RY14,9934,ENSG00000174944,NA,NA,P2ry14 (MGI:2155705)
3,151294085,151316819,3q24,3q25.1,606379,GPR87,G protein-coupled receptor 87,GPR87,53836,ENSG00000138271,NA,NA,Gpr87 (MGI:1934133)
3,151326311,151329548,3q24,3q25.1,606380,GPR86,G protein-coupled receptor 86,P2RY13,53829,ENSG00000181631,NA,NA,P2ry13 (MGI:1921441)
3,151336842,151384811,3q24-q25,3q25.1,600515,"P2RY12, P2Y12, BDPLT8","Purinergic receptor P2Y, G protein-coupled, 12",P2RY12,64805,ENSG00000169313,NA,"Bleeding disorder, platelet-type, 8, 609821 (3), Autosomal recessive",P2ry12 (MGI:1918089)
3,151433493,151619925,3q25.1,3q25.1,617351,IGSF10,"Immunoglobulin superfamily, member 10",IGSF10,285313,ENSG00000152580,NA,NA,Igsf10 (MGI:1923481)
3,151814007,151828487,3q21.3-q25.2,3q25.1,600338,"AADAC, DAC",Arylacetamide deacetylase (esterase),AADAC,13,ENSG00000114771,NA,NA,Aadac (MGI:1915008)
3,151873642,151884618,3q24-q25.1,3q25.1,606381,"SUCNR1, GPR91",Succinate receptor 1,SUCNR1,56670,ENSG00000198829,NA,NA,Sucnr1 (MGI:1934135)
3,152243655,152465779,3q25,3q25.1-q25.2,606516,"MBNL1, KIAA0428, EXP",Muscleblind-like protein,MBNL1,4154,ENSG00000152601,NA,NA,Mbnl1 (MGI:1928482)
3,152835130,152841438,3q25,3q25.2,601167,"P2RY1, P2Y1","Purinergic receptor P2Y, G-protein coupled, 1",P2RY1,5028,ENSG00000169860,NA,NA,P2ry1 (MGI:105049)
3,153162225,153170626,3q25.2,3q25.2,179541,RAP2B,Ras-related protein 2B,RAP2B,5912,ENSG00000181467,NA,NA,Rap2b (MGI:1921262)
3,154121002,154257826,3q25.2,3q25.2,617552,"ARHGEF26, SGEF",Rho guanine nucleotide exchange factor 26,ARHGEF26,26084,ENSG00000114790,NA,NA,Arhgef26 (MGI:1918053)
3,154272545,154324496,3q25.2,3q25.2,612767,"DHX36, G4R1, RHAU, KIAA1488",DEAH (Asp-Glu-Ala-His) box polypeptide 36,DHX36,170506,ENSG00000174953,NA,NA,Dhx36 (MGI:1919412)
3,155024123,155183728,3q21-q27,3q25.2,120520,"MME, CD10, CALLA, NEP, CMT2T, SCA43",Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen),MME,4311,ENSG00000196549,mutation identified in 1 SCA43 family,"Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3), Autosomal recessive, Autosomal dominant; ?Spinocerebellar ataxia 43, 617018 (3), Autosomal dominant",Mme (MGI:97004)
3,155290226,155293682,3q25.2,3q25.2,616891,"DWORF, LOC100507537",Dwarf open reading frame,STRIT1,100507537,ENSG00000240045,NA,NA,NA
3,155300000,161000000,3q25.3,NA,613459,BWQTL2,Birth weight quantitative trait locus 2,NA,100502569,NA,associated with rs900400,"[Birth weight QTL 2], 613459 (2)",NA
3,155458602,155745723,3q25.31,3q25.31,612835,"PLCH1, PLCL3, KIAA1069","Phospholipase C, eta-1",PLCH1,23007,ENSG00000114805,NA,NA,Plch1 (MGI:2683547)
3,155821023,155855357,3q25.31,3q25.31,603690,"SLC33A1, ACATN, AT1, SPG42, CCHLND","Solute carrier family 33 (acetyl-CoA transporter), member 1",SLC33A1,9197,ENSG00000169359,NA,"Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3), Autosomal recessive; Spastic paraplegia 42, autosomal dominant, 612539 (3), Autosomal dominant",Slc33a1 (MGI:1332247)
3,155869429,155944019,3q24,3q25.31,600358,GMPS,Guanine monophosphate synthetase,GMPS,8833,ENSG00000163655,fusion gene with MLL in AML,NA,Gmps (MGI:2448526)
3,156118215,156542647,3q26.1,3q25.31,601141,"KCNAB1, KCNA1B","Potassium voltage-gated channel, shaker-related subfamily, beta member 1",KCNAB1,7881,ENSG00000169282,NA,NA,Kcnab1 (MGI:109155)
3,156539552,156555199,3q25.31,3q25.31,606213,"SSR3, TRAPG","Signal sequence receptor, gamma",SSR3,6747,ENSG00000114850,NA,NA,Ssr3 (MGI:1914687)
3,156674589,156706769,3q25.31,3q25.31,612480,TIPARP,TCDD-inducible poly(ADP-ribose) polymerase,TIPARP,25976,ENSG00000163659,NA,NA,Tiparp (MGI:2159210)
3,156826286,157047658,3q25.31,3q25.31,613536,LEKR1,"Leucine-, glutamate-, and lysine-rich protein 1",LEKR1,389170,ENSG00000197980,NA,NA,Lekr1 (MGI:3645902)
3,157146501,157160759,3q25.31,3q25.31,613384,"CCNL1, ANIA6A",Cyclin L1,CCNL1,57018,ENSG00000163660,NA,NA,Ccnl1 (MGI:1922664)
3,157259741,157503776,3q24-q25,3q25.31-q25.32,609594,"VEPH1, MELT, KIAA1692","Ventricular zone-expressed PH domain-containing protein, zebrafish, homolog of, 1",VEPH1,79674,ENSG00000197415,NA,NA,Veph1 (MGI:1920039)
3,157436849,157443632,3q25,3q25.32,602492,PTX3,Pentraxin-3,PTX3,5806,ENSG00000163661,NA,NA,Ptx3 (MGI:104641)
3,158096010,158106211,3q25-q26,3q25.32,602504,"SHOX2, SHOT, OG12",Short stature homeo box 2,SHOX2,6474,ENSG00000168779,NA,NA,Shox2 (MGI:1201673)
3,158110051,158545729,3q25.32,3q25.32,613352,"RSRC1, SRRP53, MRT70",Arginine/serine-rich coiled-coil protein 1,RSRC1,51319,ENSG00000174891,NA,"Intellectual developmental disorder, autosomal recessive 70, 618402 (3), Autosomal recessive",Rsrc1 (MGI:1914130)
3,158571162,158606455,3q25.1,3q25.32,601402,MLF1,Myeloid leukemia factor-1,MLF1,4291,ENSG00000178053,NA,"Leukemia, acute myeloid, 601626 (1), Autosomal dominant, Somatic mutation",Mlf1 (MGI:1341819)
3,158644523,158692571,3q25.32,3q25.32,606639,"GFM1, EFG1, GFM, COXPD1",Mitochondrial elongation factor G1,GFM1,85476,ENSG00000168827,NA,"Combined oxidative phosphorylation deficiency 1, 609060 (3), Autosomal recessive",Gfm1 (MGI:107339)
3,158666413,158672721,3q25.3,3q25.32,609305,"LXN, ECI, TCI",Latexin,LXN,56925,ENSG00000079257,NA,NA,Lxn (MGI:107633)
3,158696891,158732943,3q25.3,3q25.32,605090,"RARRES1, TIG1",Retinoic acid receptor responder 1,RARRES1,5918,ENSG00000118849,NA,NA,Rarres1 (MGI:1924461)
3,159069251,159266306,3q25,3q25.32,611622,IQCJ,IQ motif-containing protein J,IQCJ,654502,ENSG00000214216,NA,NA,Iqcj (MGI:3644166)
3,159988834,159996018,3p12-q13.2,3q25.33,161560,IL12A,"Interleukin-12A (natural killer cell stimulatory factor-1, cytotoxic lymphocyte maturation factor-1, p35)",IL12A,3592,ENSG00000168811,NA,NA,Il12a (MGI:96539)
3,160256985,160399224,3q25.33,3q25.33,611177,"IFT80, KIAA1374, WDR56, SRTD2, ATD2","Intraflagellar transport 80, Chlamydomonas, homolog of",IFT80,57560,ENSG00000068885,NA,"Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3), Autosomal recessive",Ift80 (MGI:1915509)
3,160399637,160434952,3q26.1,3q25.33,605575,CAPC,Chromosome-associated protein C,SMC4,10051,ENSG00000113810,NA,NA,Smc4 (MGI:1917349)
3,160435502,160449785,3q26.1,3q25.33,616148,"TRIM59, RNF104, MRF1, IFT80L",Tripartite motif-containing protein 59,TRIM59,286827,ENSG00000213186,NA,NA,Trim59 (MGI:1914199)
3,160495006,160565570,3q26.1,3q25.33,602970,"KPNA4, QIP1",Karyopherin alpha-4,KPNA4,3840,ENSG00000186432,NA,NA,Kpna4 (MGI:1100848)
3,160514906,160515235,3q25.33,3q25.33,615644,SCARNA7,Small Cajal body-specific RNA 7,SCARNA7,677767,ENSG00000238741,NA,NA,NA
3,160677159,160678447,3q25.33,3q25.33,614439,"ARL14, ARF7",ADP-ribosylation factor-like 14,ARL14,80117,ENSG00000179674,NA,NA,Arl14 (MGI:1918869)
3,160755531,161078906,3q26.1,3q25.3-q26.1,611931,"PPM1L, PP2CE",Protein phosphatase 1-like,PPM1L,151742,ENSG00000163590,NA,NA,Ppm1l (MGI:2139740)
3,161000000,183000000,3q26,NA,109200,"AGA1, MPB","Alopecia, androgenetic, 1",NA,100188784,NA,NA,"Alopecia, androgenetic, 1, 109200 (2), Autosomal dominant",NA
3,161000000,183000000,3q26,NA,600049,MDS1,Myelodysplasia syndrome-1,NA,NA,NA,cen--EVI1--MDS1--EAP--tel,Myelodysplasia syndrome-1 (3),NA
3,161000000,183000000,3q26.1-q26.3,NA,606082,MNG3,Multinodular goiter-3,NA,94337,NA,NA,"Goiter, multinodular, 3, 606082 (2)",NA
3,161000000,183000000,3q26,NA,609257,MYP8,Myopia 8,MYP8,553192,NA,NA,"Myopia 8, 609257 (2), Multifactorial",NA
3,161083882,161105468,3q25,3q26.1,603094,"B3GALT3, GLCT3, GLOB","UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3",B3GALNT1,8706,ENSG00000169255,NA,"[Blood group, P1PK system, P(k) phenotype], 111400 (3); [Blood group, globoside system], 615021 (3)",B3galnt1 (MGI:1349405)
3,161221289,161253531,3q26.1,3q26.1,611021,NMD3,"NMD3, S. cerevisiae, homolog of",NMD3,51068,ENSG00000169251,NA,NA,Nmd3 (MGI:2140103)
3,161344783,161373227,3q26.1,3q26.1,610412,"SPTSSB, C3orf57, SSSPTB, ADMP","Serine palmitoyltransferase, small subunit B",SPTSSB,165679,ENSG00000196542,NA,NA,Sptssb (MGI:1913433)
3,164978897,165078495,3q25-q26,3q26.1,609845,SI,Sucrase-isomaltase,SI,6476,ENSG00000090402,NA,"Sucrase-isomaltase deficiency, congenital, 222900 (3), Autosomal recessive",Sis (MGI:1917233)
3,165186719,165197108,3q26,3q26.1,609679,"SLITRK3, KIAA0848","SLIT- and NTRK-like family, member 3",SLITRK3,22865,ENSG00000121871,NA,NA,Slitrk3 (MGI:2679447)
3,165772902,165837471,3q26.1-q26.2,3q26.1,177400,"BCHE, CHE1, BCHED",Butyrylcholinesterase,BCHE,590,ENSG00000114200,"distal to CP, TF","{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}, 617936 (3); Butyrylcholinesterase deficiency, 617936 (3)",Bche (MGI:894278)
3,167441788,167474131,3q26.1-q26.2,3q26.1,605587,"SERPIN12, PI14, MEPI",Protease inhibitor 14,SERPINI2,5276,ENSG00000114204,NA,NA,Serpini2 (MGI:1915181)
3,167683297,167735809,3q26.1,3q26.1,609118,"PDCD10, TFAR15, CCM3",Programmed cell death 10,PDCD10,11235,ENSG00000114209,NA,"Cerebral cavernous malformations 3, 603285 (3)",Pdcd10 (MGI:1928396)
3,167735643,167825568,3q26,3q26.1,602445,"SERPINI1, PI12",Protease inhibitor 12,SERPINI1,5274,ENSG00000163536,NA,"Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3), Autosomal dominant",Serpini1 (MGI:1194506)
3,167900000,176000000,3q26.2-q26.31,NA,610422,APMR2,Alopecia-mental retardation syndrome 2,NA,100049544,NA,between D3S1564 and D3S2427,"Alopecia-mental retardation syndrome 2, 610422 (2), Autosomal recessive",NA
3,167900000,183000000,3q26.2-q26.33,NA,612637,FEB10,"Febrile seizures, familial, 10",NA,100271923,NA,between D3S3656 and D3S1232,"Febrile seizures, familial, 10, 612637 (2)",NA
3,168008671,168095923,3q26.2,3q26.2,606805,"GOLIM4, GOLPH4, GPP130",Golgi integral membrane protein 4,GOLIM4,27333,ENSG00000173905,NA,NA,Golim4 (MGI:1920374)
3,169083498,169663780,3q26,3q26.2,165215,"MECOM, EVI1, RUSAT2",MDS1 and EVS1 complex locus,MECOM,2122,ENSG00000085276,NA,"Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3), Autosomal dominant",Mecom (MGI:95457)
3,169764609,169765059,3q21-q28,3q26.2,602322,"TERC, TRC3, TR, DKCA1, PFBMFT2",Telomerase RNA component,TERC,7012,ENSG00000277925,NA,"{Aplastic anemia}, 614743 (3), Autosomal dominant; Dyskeratosis congenita, autosomal dominant 1, 127550 (3), Autosomal dominant; {Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3), Autosomal dominant",NA
3,169766920,169769560,3q26.2,3q26.2,608534,ARPM1,Actin-related protein M1,ACTRT3,84517,ENSG00000184378,NA,NA,Actrt3 (MGI:1923902)
3,169772229,169772301,3q26.2,3q26.2,615310,"TRV-AAC1-1, TRNAV24",Transfer RNA valine (AAC) 1-1,TRV-AAC1-1,100189318,NA,NA,NA,NA
3,169773064,169789715,3q26.2,3q26.2,606042,MYNN,Myoneurin,MYNN,55892,ENSG00000085274,NA,NA,Mynn (MGI:1931415)
3,169966135,169998372,3q26.2,3q26.2,602173,"SEC62, TLOC1, HTP1","Sec62, S. cerevisiae, homolog of",SEC62,7095,ENSG00000008952,NA,NA,Sec62 (MGI:1916526)
3,170222423,170305980,3p25-q27,3q26.2,600539,PRKCI,"Protein kinase C, iota",PRKCI,5584,ENSG00000163558,pseudogene on X,NA,Prkci (MGI:99260)
3,170357677,170396848,3q26.2,3q26.2,165340,"SKIL, SNO",SKI-like,SKIL,6498,ENSG00000136603,NA,NA,Skil (MGI:106203)
3,170418867,170434690,3q26.2-q26.3,3q26.2,601326,"CLDN11, OTM, OSP",Claudin 11 (oligodendrocyte transmembrane protein),CLDN11,5010,ENSG00000013297,NA,NA,Cldn11 (MGI:106925)
3,170459547,170586074,3q26.2,3q26.2,615720,"SLC7A14, KIAA1613, RP68","Solute carrier family 7, member 14",SLC7A14,57709,ENSG00000013293,NA,"Retinitis pigmentosa 68, 615725 (3), Autosomal recessive",Slc7a14 (MGI:3040688)
3,170888417,170908636,3q25-q27,3q26.2,605782,EIF5A2,Eukaryotic translation initiation factor 5A2,EIF5A2,56648,ENSG00000163577,NA,NA,Eif5a2 (MGI:1933735)
3,170996340,171026720,3q26.1-q26.3,3q26.2,138160,"SLC2A2, GLUT2","Solute carrier family 2 (facilitated glucose transporter), member 2",SLC2A2,6514,ENSG00000163581,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant; Fanconi-Bickel syndrome, 227810 (3), Autosomal recessive",Slc2a2 (MGI:1095438)
3,171058413,171460407,3q26.2-q26.3,3q26.2-q26.3,610005,"TNIK, KIAA0551, MRT54",TRAF2-and NCK-interacting kinase,TNIK,23043,ENSG00000154310,NA,"Mental retardation, autosomal recessive 54, 617028 (3), Autosomal recessive",Tnik (MGI:1916264)
3,171200000,188200000,3q26.3-q27.3,NA,203650,APMR1,Alopecia-mental retardation syndrome 1,NA,NA,NA,max lod at D3S3583,"Alopecia-mental retardation syndrome 1, 203650 (2), Autosomal recessive",NA
3,171600403,171810482,3q26,3q26.31,602382,"PLD1, CVDD","Phospholipase D1, phosphatidylcholine-specific",PLD1,5337,ENSG00000075651,NA,"Cardiac valvular defect, developmental, 212093 (3), Autosomal recessive",Pld1 (MGI:109585)
3,172039577,172401668,3q26,3q26.31,611909,"FNDC3B, FAD104",Fibronectin domain III-containing protein 3B,FNDC3B,64778,ENSG00000075420,NA,NA,Fndc3b (MGI:1919257)
3,172443290,172448455,3q26.3,3q26.31,601898,"GHSR, GHDP",Growth hormone secretagogue receptor,GHSR,2693,ENSG00000121853,NA,"Growth hormone deficiency, isolated partial, 615925 (3), Autosomal recessive, Autosomal dominant",Ghsr (MGI:2441906)
3,172505507,172523506,3q26,3q26.31,603598,"TNFSF10, TRAIL, APO2L","Tumor necrosis factor ligand superfamily, member 10",TNFSF10,8743,ENSG00000121858,NA,NA,Tnfsf10 (MGI:107414)
3,172630248,172711066,3q26.3,3q26.31,613234,"NCEH1, NCEH, KIAA1363",Neutral cholesterol ester hydrolase 1,NCEH1,57552,ENSG00000144959,NA,NA,Nceh1 (MGI:2443191)
3,172750684,172829272,3q26.1-q26.2,3q26.31,600586,ECT2,Epithelial cell transforming sequence 2 oncogene,ECT2,1894,ENSG00000114346,NA,NA,Ect2 (MGI:95281)
3,172889356,173141234,3q26.3,3q26.31,609856,"SPATA16, SPGF6",Spermatogenesis-associated protein 16,SPATA16,83893,ENSG00000144962,mutation identified in 1 SPGF6 family,"?Spermatogenic failure 6, 102530 (3), Autosomal recessive",Spata16 (MGI:1918112)
3,173395928,174294371,3q26.3,3q26.31,600568,NLGN1,Neuroligin 1,NLGN1,22871,ENSG00000169760,NA,NA,Nlgn1 (MGI:2179435)
3,174438533,175810547,3q26.3,3q26.31,608806,NAALADL2,N-acetylated alpha-linked acidic dipeptidase-like 2,NAALADL2,254827,ENSG00000177694,?involved in Cornelia de Lange syndrome,NA,Naaladl2 (MGI:2685867)
3,176000000,192600000,3q26.32-q28,NA,615127,"FAME4, FCMTE4","Epilepsy, familial adult myoclonic, 4",NA,101409188,NA,between D3S3730 and D3S1580,"Epilepsy, myoclonic, familial adult, 4, 615127 (2), Autosomal dominant",NA
3,177019356,177197481,3q26.32,3q26.32,608628,"TBL1XR1, TBLR1, IRA1, C21, MRD41",Transducin-beta-like 1 receptor 1,TBL1XR1,79718,ENSG00000177565,NA,"Mental retardation, autosomal dominant 41, 616944 (3), Autosomal dominant; Pierpont syndrome, 602342 (3), Autosomal dominant",Tbl1xr1 (MGI:2441730)
3,178536393,178844428,3q26.32,3q26.32,605214,KCNMB2,"Potassium channel, calcium-activated, large conductance, subfamily M, beta member 2",KCNMB2,10242,ENSG00000197584,NA,NA,Kcnmb2 (MGI:1919663)
3,179017222,179071867,3q26.3-q27,3q26.32,606452,WIG1,Wildtype p53-induced gene,ZMAT3,64393,ENSG00000172667,NA,NA,Zmat3 (MGI:1195270)
3,179148113,179240092,3q26.3,3q26.32,171834,"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO","Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide",PIK3CA,5290,ENSG00000121879,NA,"Breast cancer, somatic, 114480 (3); CLAPO syndrome, somatic, 613089 (3); CLOVE syndrome, somatic, 612918 (3); Colorectal cancer, somatic, 114500 (3); Cowden syndrome 5, 615108 (3); Gastric cancer, somatic, 613659 (3); Hepatocellular carcinoma, somatic, 114550 (3); Keratosis, seborrheic, somatic, 182000 (3); Macrodactyly, somatic, 155500 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Nevus, epidermal, somatic, 162900 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Ovarian cancer, somatic, 167000 (3)",Pik3ca (MGI:1206581)
3,179239748,179267049,3q26.3-q27.1,3q26.32,605222,KCNMB3,"Potassium large conductance calcium-activated channel, subfamily M, beta member 3",KCNMB3,27094,ENSG00000171121,NA,NA,Kcnmb3 (MGI:3612244)
3,179396087,179451469,3q26.3,3q26.33,610863,"GNB4, CMTD1F","Guanine nucleotide-binding protein, beta-4",GNB4,59345,ENSG00000114450,NA,"Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3), Autosomal dominant",Gnb4 (MGI:104581)
3,179562879,179588406,3q26.3,3q26.33,604958,"ACTL6A, BAF53, BAF53A",Actin-like 6A,ACTL6A,86,ENSG00000136518,NA,NA,Actl6a (MGI:1861453)
3,179588284,179604645,3q26.3,3q26.33,611852,MRPL47,Mitochondrial ribosomal protein L47,MRPL47,57129,ENSG00000136522,NA,NA,Mrpl47 (MGI:1921850)
3,179604786,179627646,3q26.33,3q26.33,603841,NDUFB5,NADH-ubiquinone oxidoreductase subunit B5,NDUFB5,4711,ENSG00000136521,NA,NA,Ndufb5 (MGI:1913296)
3,179653039,179789400,3q26.2-q26.3,3q26.33,603591,"USP13, ISOT3",Ubiquitin-specific protease-13,USP13,8975,ENSG00000058056,NA,NA,Usp13 (MGI:1919857)
3,179794957,180037008,3q26.2-q27,3q26.33,611058,"PEX5L, PEX5R, PXR2B",Peroxisome biogenesis factor 5-like,PEX5L,51555,ENSG00000114757,NA,NA,Pex5l (MGI:1916672)
3,180614007,180679488,3q26.33,3q26.33,613798,CCDC39,Coiled-coil domain-containing protein 39,CCDC39,339829,ENSG00000284862,NA,"Ciliary dyskinesia, primary, 14, 613807 (3)",Ccdc39 (MGI:1289263)
3,180912669,180982752,3q28,3q26.33,600819,FXR1,"Fragile X mental retardation, autosomal homolog",FXR1,8087,ENSG00000114416,pseudogene on 12q12,NA,Fxr1 (MGI:104860)
3,180983708,180989773,3q26.3,3q26.33,608977,"DNAJC19, TIM14","DnaJ (Hsp40) homolog, subfamily C, member 19 (translocase of inner mitochondrial membrane 14, yeast, homolog of)",DNAJC19,131118,ENSG00000205981,NA,"3-methylglutaconic aciduria, type V, 610198 (3), Autosomal recessive","Dnajc19-ps,Dnajc19 (MGI:1914963,MGI:3709029)"
3,181056679,181742227,3q26.33,3q26.33,616338,"SOX2OT, NCRNA00043","SOX2 overlapping transcript, noncoding",SOX2-OT,347689,ENSG00000242808,NA,NA,NA
3,181711924,181714435,3q26.3-q27,3q26.33,184429,"SOX2, MCOPS3",SRY (sex determining region Y)-box 2,SOX2,6657,ENSG00000181449,NA,"Microphthalmia, syndromic 3, 206900 (3), Autosomal dominant; Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3), Autosomal dominant",Sox2 (MGI:98364)
3,182793503,182923009,3q27,3q26.33,605869,"ATP11B, ATPIR","ATPase, class VI, type 11B",ATP11B,23200,ENSG00000058063,NA,NA,Atp11b (MGI:1923545)
3,182938073,182986363,3q26.3,3q26.33,605905,"DCUN1D1, RP42",DCN1 domain-containing protein 1,DCUN1D1,54165,ENSG00000043093,previously mapped to 6q16,NA,Dcun1d1 (MGI:2150386)
3,183000000,188200000,3q27,NA,605552,"AOMS1, SYNX",Abdominal obesity-metabolic syndrome QTL1,NA,65076,NA,epistatic gene on 17p12,"Abdominal obesity-metabolic syndrome 1, 605552 (2), Autosomal dominant",NA
3,183000000,192600000,3q27-q28,NA,605229,SPG14,"Spastic paraplegia 14, autosomal recessive",SPG14,57309,NA,NA,"Spastic paraplegia 14, autosomal recessive, 605229 (2), Autosomal recessive",NA
3,183015217,183099586,3q25-q27,3q27.1,609010,"MCCC1, MCCA",3-Methylcrotonyl-CoA carboxylase 1,MCCC1,56922,ENSG00000078070,NA,"3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3), Autosomal recessive",Mccc1 (MGI:1919289)
3,183122214,183162760,3q26.3-q27,3q27.1,605883,DCLAMP,"Lysosome-associated membrane glycoprotein, dendritic cell-specific",LAMP3,27074,ENSG00000078081,NA,NA,Lamp3 (MGI:2441659)
3,183253206,183273390,3q27.1,3q27.1,615333,B3GNT5,"Beta-1,3-N-acetylglucosaminyltransferase 5",B3GNT5,84002,ENSG00000176597,NA,NA,B3gnt5 (MGI:2137302)
3,183487550,183555710,3q27.3,3q27.1,614214,"KLHL6, FLJ00029",Kelch-like 6,KLHL6,89857,ENSG00000172578,NA,NA,Klhl6 (MGI:2686922)
3,183635618,183684518,3q27.1,3q27.1,611295,"KLHL24, KRIP6, EBSSH",Kelch-like 24,KLHL24,54800,ENSG00000114796,NA,"Epidermolysis bullosa simplex, generalized, with scarring and hair loss, 617294 (3), Autosomal dominant",Klhl24 (MGI:1923035)
3,183697796,183812624,3q27.1,3q27.1,613373,"YEATS2, KIAA1197",YEATS domain-containing protein 2,YEATS2,55689,ENSG00000163872,NA,NA,Yeats2 (MGI:2447762)
3,183815880,183825601,3q27,3q27.1,610593,"MAPO6D1, SL21",MAP6 domain-containing protein 1,MAP6D1,79929,ENSG00000180834,NA,NA,Map6d1 (MGI:3607784)
3,183826487,183884907,3q27,3q27.1,607858,PARL,Presenilin-associated rhomboid-like protein,PARL,55486,ENSG00000175193,NA,NA,Parl (MGI:1277152)
3,183919933,184018009,3q27,3q27.1,605251,"ABCC5, MRP5, MOATC","ATP-binding cassette, subfamily C, member 5",ABCC5,10057,ENSG00000114770,NA,NA,Abcc5 (MGI:1351644)
3,184031543,184039368,3q27,3q27.1,610122,HTR3D,"5-hydroxytryptamine receptor 3, subunit D",HTR3D,200909,ENSG00000186090,NA,NA,NA
3,184053046,184060672,3q27,3q27.1,610121,HTR3C,5-hydroxytryptamine receptor 3C,HTR3C,170572,ENSG00000178084,NA,NA,NA
3,184097063,184106994,3q27,3q27.1,610123,HTR3E,"5-hydroxytryptamine receptor 3, subunit E",HTR3E,285242,ENSG00000186038,NA,NA,NA
3,184135022,184145310,3q27,3q27.1,603945,"EIF2B5, LVWM, CACH, CLE","Eukaryotic translation initiation factor 2B, subunit 5",EIF2B5,8893,ENSG00000145191,NA,"Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive; Ovarioleukodystrophy, 603896 (3), Autosomal recessive",Eif2b5 (MGI:2446176)
3,184155310,184173613,3q27,3q27.1,601368,"DVL3, DRS3",Dishevelled 3 (homologous to Drosophila dsh),DVL3,1857,ENSG00000161202,NA,"Robinow syndrome, autosomal dominant 3, 616894 (3), Autosomal dominant",Dvl3 (MGI:108100)
3,184174845,184184090,3q28,3q27.1,601024,"AP2M1, CLAPM1","Adaptor-related protein complex 2, mu 1 subunit",AP2M1,1173,ENSG00000161203,NA,NA,Ap2m1 (MGI:1298405)
3,184241404,184241488,3q27.1,3q27.1,611620,"MIR1224, MIRN1224",Micro RNA 1224,MIR1224,100187716,ENSG00000221120,NA,NA,NA
3,184242300,184258300,3q27,3q27.1,608750,"ALG3, NOT56L, CDGS4, CDG1D","Alg3, S. cerevisiae, homolog of",ALG3,10195,ENSG00000214160,NA,"Congenital disorder of glycosylation, type Id, 601110 (3), Autosomal recessive",Alg3 (MGI:1098592)
3,184259212,184261552,3q27.1,3q27.1,608721,"CAMK2N2, CAMKIIN",Calcium/calmodulin-dependent protein kinase II inhibitor 2,CAMK2N2,94032,ENSG00000163888,NA,NA,Camk2n2 (MGI:1920297)
3,184276021,184293030,3q27.1,3q27.1,610145,"ECE2, KIAA0604",Endothelin-converting enzyme 2,ECE2,9718,ENSG00000145194,NA,NA,Ece2 (MGI:1101356)
3,184299240,184309049,3q27.1,3q27.1,606223,"PSMD2, S2, TRAP2","Proteasome 26S subunit, non-APTase, 2",PSMD2,5708,ENSG00000175166,NA,NA,Psmd2 (MGI:1096584)
3,184314494,184335357,3q27,3q27.1,600495,"EIF4G1, EIF4G, PARK18","Eukaryotic translation initiation factor 4 gamma, 1",EIF4G1,1981,ENSG00000114867,amplified in squamous cell lung cancer,"{Parkinson disease 18}, 614251 (3), Autosomal dominant",Eif4g1 (MGI:2384784)
3,184346184,184361604,3q26,3q27.1,600570,"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2",Chloride channel-2,CLCN2,1181,ENSG00000114859,NA,"{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3), Autosomal dominant; {Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3), Autosomal dominant; Hyperaldosteronism, familial, type II, 605635 (3), Autosomal dominant; Leukoencephalopathy with ataxia, 615651 (3), Autosomal recessive",Clcn2 (MGI:105061)
3,184361709,184368594,3q28,3q27.1,606023,"POLR2H, RPB8","Polymerase II, RNA, subunit H",POLR2H,5437,ENSG00000163882,NA,NA,Polr2h (MGI:2384309)
3,184371934,184379687,3q26.3-q27,3q27.1,600044,"THPO, MGDF, MPLLG, TPO, THCYT1",Thrombopoietin (megakaryocyte growth and development factor),THPO,7066,ENSG00000090534,NA,"Thrombocythemia 1, 187950 (3), Autosomal dominant",Thpo (MGI:101875)
3,184380072,184390738,3q27,3q27.1,603475,CHRD,Chordin,CHRD,8646,ENSG00000090539,"near THPO, CLCN2, EIF4G1",NA,Chrd (MGI:1313268)
3,184561784,184582407,3q21-qter,3q27.1,601839,"EPHB3, ETK2",EPH-like tyrosine kinase-2,EPHB3,2049,ENSG00000182580,NA,NA,Ephb3 (MGI:104770)
3,184710363,184712063,3q13,3q27.1,609267,MAGEF1,"Melanoma antigen, family F, 1",MAGEF1,64110,ENSG00000177383,NA,NA,NA
3,184812142,185052613,3q27.2,3q27.2,618366,VPS8,"VPS8, corvet complex subunit",VPS8,23355,ENSG00000156931,NA,NA,Vps8 (MGI:2146407)
3,185190623,185254048,3q27,3q27.2,607037,"EHHADH, PBFE, LBFP, FRTS3","Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase",EHHADH,1962,ENSG00000113790,mutation identified in 1 family,"?Fanconi renotubular syndrome 3, 615605 (3), Autosomal dominant",Ehhadh (MGI:1277964)
3,185282937,185489093,3q27,3q27.2,604915,"MAP3K13, LZK",Mitogen-activated protein kinase kinase kinase 13 (leucine zipper-bearing kinase),MAP3K13,9175,ENSG00000073803,NA,NA,Map3k13 (MGI:2444243)
3,185506261,185552660,3q27-q28,3q27.2,607365,"LIPH, LAH2, ARWH2, HYPT7",Lipase H,LIPH,200879,ENSG00000163898,NA,"Hypotrichosis 7, 604379 (3), Autosomal recessive; Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3), Autosomal recessive",Liph (MGI:2388029)
3,185586294,185633550,3q27,3q27.2,608261,"SENP2, SMT3IP2, AXAM2, KIAA1331","Sentrin-specific protease family, member 2",SENP2,59343,ENSG00000163904,NA,NA,Senp2 (MGI:1923076)
3,185643129,185825055,3q28,3q27.2,608289,"IGF2BP2, IMP2",Insulin-like growth factor 2 mRNA-binding protein 2,IGF2BP2,10644,ENSG00000073792,NA,"{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant",Igf2bp2 (MGI:1890358)
3,185914557,185938026,3q26.2-q27,3q27.2,602719,"TRA2B, SFRS10","Splicing factor, arginine/serine-rich, 10 (transformer 2, drosophila, homolog of, beta)",TRA2B,6434,ENSG00000136527,NA,NA,Tra2b (MGI:106016)
3,186046313,186109088,3q28,3q27.2,601600,"ETV5, ERM",ets variant gene 5 (ets-related molecule),ETV5,2119,ENSG00000244405,NA,NA,Etv5 (MGI:1096867)
3,186147200,186362233,3q27-q28,3q27.2-q27.3,601854,"DGKG, DAGK3","Diacylglycerol kinase, gamma, 90-kD",DGKG,1608,ENSG00000058866,NA,NA,Dgkg (MGI:105060)
3,186538442,186544379,3q27,3q27.3,123730,"CRYGS, CRYG8, CTRCT20","Crystallin, gamma S",CRYGS,1427,ENSG00000213139,NA,"Cataract 20, multiple types, 116100 (3), Autosomal dominant",Crygs (MGI:1298216)
3,186570675,186585799,3q27.3,3q27.3,611341,"DNAJB11, HEDJ, DJ9, ABBP2, PKD6","DNAJ/HSP40 homolog, subfamily B, member 11",DNAJB11,51726,ENSG00000090520,NA,"Polycystic kidney disease 6 with or without polycystic liver disease, 618061 (3), Autosomal dominant",Dnajb11 (MGI:1915088)
3,186613059,186621317,3q27,3q27.3,138680,"AHSG, APMR1",Alpha-2HS-glycoprotein,AHSG,197,ENSG00000145192,mutation identified in 1 APMR1 family,"?Alopecia-mental retardation syndrome 1, 203650 (3), Autosomal recessive",Ahsg (MGI:107189)
3,186635827,186653140,3q27,3q27.3,605954,FETUB,Fetuin B,FETUB,26998,ENSG00000090512,NA,NA,Fetub (MGI:1890221)
3,186665951,186678239,3q27,3q27.3,142640,"HRG, THPH11",Histidine-rich glycoprotein,HRG,3273,ENSG00000113905,NA,"Thrombophilia due to HRG deficiency, 613116 (3), Autosomal dominant; Thrombophilia due to elevated HRG, 613116 (1), Autosomal dominant",NA
3,186717358,186744409,3q27,3q27.3,612358,"KNG1, KNG",Kininogen 1,KNG1,3827,ENSG00000113889,NA,"[High molecular weight kininogen deficiency], 228960 (3), Autosomal recessive; [Kininogen deficiency], 228960 (3), Autosomal recessive","Kng2,Kng1 (MGI:1097705,MGI:3027157)"
3,186783576,186789896,3q28,3q27.3,601102,EIF4A2,"Eukaryotic translation initiation factor-4A, isoform 2",EIF4A2,1974,ENSG00000156976,previously 18p11.2 by FISH,NA,Eif4a2 (MGI:106906)
3,186786674,186786851,3q27.3,3q27.3,611334,SNORA81,"Small nucleolar RNA, H/ACA box, 81",SNORA81,677847,ENSG00000221420,in intron 3 of EIF2A,NA,NA
3,186787298,186787432,3q27.3,3q27.3,180647,"SNORA63, RNU107, RNE3","Small nucleolar RNA, H/ACA box, 63",SNORA63,6043,ENSG00000200320,NA,NA,NA
3,186789891,186806694,3q27,3q27.3,102577,RFC4,"Replication factor C4, 37kD (activator 1, 37kD)",RFC4,5984,ENSG00000163918,NA,NA,Rfc4 (MGI:2146571)
3,186842709,186858462,3q27,3q27.3,605441,"ADIPOQ, APM1, GBP28, ADIPQTL1","Adipocyte-, C1q-, and collagen domain-containing",ADIPOQ,9370,ENSG00000181092,NA,"Adiponectin deficiency, 612556 (3)",Adipoq (MGI:106675)
3,186930525,187078552,3q21-q28,3q27.3,109675,SIAT1,"Sialyltransferase-1 (beta-galactoside alpha-2,6-sialyltransferase)",ST6GAL1,6480,ENSG00000073849,NA,NA,St6gal1 (MGI:108470)
3,187120947,187139495,3q27,3q27.3,607547,RPL39L,Ribosomal protein L39-like,RPL39L,116832,ENSG00000163923,NA,NA,NA
3,187197485,187201461,3q27.3,3q27.3,609137,RTP1,Receptor-transporting protein 1,RTP1,132112,ENSG00000175077,NA,NA,Rtp1 (MGI:2685450)
3,187216084,187293528,3q27-q28,3q27.3,600521,"MASP1, CRARF, 3MC1",Mannan-binding lectin serine protease-1 (C4/C2 activating component of Ra-reactive factor),MASP1,5648,ENSG00000127241,NA,"3MC syndrome 1, 257920 (3), Autosomal recessive",NA
3,187368384,187372075,3q27,3q27.3,609350,RTP4,Receptor-transporting protein 4,RTP4,64108,ENSG00000136514,NA,NA,Rtp4 (MGI:1915025)
3,187668911,187670393,3q28,3q27.3,182450,SST,Somatostatin,SST,6750,ENSG00000157005,NA,NA,Sst (MGI:98326)
3,187698258,187715624,3q27.3,3q27.3,609138,RTP2,Receptor-transporting protein 2,RTP2,344892,ENSG00000198471,NA,NA,Rtp2 (MGI:2685451)
3,187721376,187745471,3q27,3q27.3,109565,BCL6,B-cell CLL/lymphoma-6,BCL6,604,ENSG00000113916,NA,"Lymphoma, B-cell, 109565 (2)",Bcl6 (MGI:107187)
3,188152151,188890670,3q28,3q27-q28,600700,LPP,Lipoma-preferred-partner gene,LPP,4026,ENSG00000145012,fused with HMGIC in lipoma; fused with MLL in leukemia,"Leukemia, acute myeloid, 601626 (3), Autosomal dominant, Somatic mutation; Lipoma (3)",Lpp (MGI:2441849)
3,188200000,192600000,3q28,NA,612009,CELIAC11,"Celiac disease, susceptibility to, 11",NA,100188873,NA,associated with rs1464510,"{Celiac disease, susceptibility to, 11}, 612009 (2)",NA
3,188200000,192600000,3q28,NA,614210,LNCR5,Lung cancer susceptibility 5,NA,100682395,NA,associated with rs4488809,"{Lung cancer susceptibility 5}, 614210 (2)",NA
3,188688780,188688865,3q28,3q28,612154,"MIR28, MIRN28",Micro RNA 28,MIR28,407020,ENSG00000207651,NA,NA,NA
3,189596745,189897278,3q27,3q28,603273,"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",Tumor protein p63 (tumor protein p73-like),TP63,8626,ENSG00000073282,NA,"ADULT syndrome, 103285 (3), Autosomal dominant; Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3), Autosomal dominant; Hay-Wells syndrome, 106260 (3), Autosomal dominant; Limb-mammary syndrome, 603543 (3), Autosomal dominant; Orofacial cleft 8, 618149 (3); Rapp-Hodgkin syndrome, 129400 (3), Autosomal dominant; Split-hand/foot malformation 4, 605289 (3), Autosomal dominant",Trp63 (MGI:1330810)
3,189956727,190122436,3q29,3q28,610341,"P3H2, LEPREL1, MCVD",Prolyl 3-hydroxylase 2,P3H2,55214,ENSG00000090530,NA,"Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3), Autosomal recessive",P3h2 (MGI:2146663)
3,190305706,190322445,3q28-q29,3q28,603718,"CLDN1, SEMP1, ILVASC",Claudin 1,CLDN1,9076,ENSG00000163347,NA,"Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3), Autosomal recessive",Cldn1 (MGI:1276109)
3,190387871,190412142,3q27,3q28,603959,"CLDN16, PCLN1, HOMG3",Claudin 16 (paracellin 1),CLDN16,10686,ENSG00000113946,NA,"Hypomagnesemia 3, renal, 248250 (3), Autosomal recessive",Cldn16 (MGI:2148742)
3,190428654,190449875,3q28,3q28,614786,TMEM207,Transmembrane protein 207,TMEM207,131920,ENSG00000198398,NA,NA,Tmem207 (MGI:2685386)
3,190514084,190659749,3q28,3q28,602626,IL1RAP,Interleukin 1 receptor accessory protein,IL1RAP,3556,ENSG00000196083,NA,NA,Il1rap (MGI:104975)
3,190843270,190864199,3q28,3q28,614448,"GMNC, GEMC1",Geminin coiled-coil domain-containing protein,GMNC,647309,ENSG00000205835,NA,NA,Gmnc (MGI:2685452)
3,191199240,191265614,3q26,3q28,610280,OSTN,Osteocrin,OSTN,344901,ENSG00000188729,NA,NA,Ostn (MGI:2677164)
3,191266464,191330535,3q28,3q28,618134,"UTS2B, URP",Urotensin 2B,UTS2B,257313,ENSG00000188958,NA,NA,Uts2b (MGI:2677064)
3,191329081,191398658,3q28,3q28,611051,"CCDC50, C3orf6, DFNA44",Coiled-coil domain-containing protein 50,CCDC50,152137,ENSG00000152492,mutation identified in 1 DFNA44 family,"?Deafness, autosomal dominant 44, 607453 (3), Autosomal dominant",NA
3,191461162,191461455,3q28,3q28,615701,"PYDC2, POP2",Pyrin domain-containing protein 2,PYDC2,152138,ENSG00000253548,NA,NA,NA
3,192139389,192727540,3q28,3q28-q29,601513,"FGF12, FHF1, EIEE47",Fibroblast growth factor-12,FGF12,2257,ENSG00000114279,NA,"Epileptic encephalopathy, early infantile, 47, 617166 (3), Autosomal dominant",Fgf12 (MGI:109183)
3,192600000,198295559,3q29,NA,609425,"DEL3q29, MICRODEL3q29",Chromosome 3q29 microdeletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 3q29 microdeletion syndrome, 609425 (4), Isolated cases",NA
3,192600000,198295559,3q29,NA,611936,"DUP3q29, MICRODUP3q29",Chromosome 3q29 microduplication syndrome,NA,NA,NA,contiguous gene duplication syndrome,"Chromosome 3q29 microduplication syndrome, 611936 (4), Autosomal dominant",NA
3,193241127,193281638,3q28-q29,3q29,606487,HRASLS,HRAS-like suppressor,PLAAT1,57110,ENSG00000127252,NA,NA,Plaat1 (MGI:1351473)
3,193398966,193593113,3q29,3q29,609556,ATP13A4,"ATPase, type 13A4",ATP13A4,84239,ENSG00000127249,NA,NA,Atp13a4 (MGI:1924456)
3,193593143,193697810,3q28-q29,3q29,605290,"OPA1, NTG, NPG, BERHS, MTDPS14",Optic atrophy 1 gene,OPA1,4976,ENSG00000198836,mutation identified in 1 MTDPS14 family,"Behr syndrome, 210000 (3), Autosomal recessive; {Glaucoma, normal tension, susceptibility to}, 606657 (3); ?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3); Optic atrophy 1, 165500 (3), Autosomal dominant; Optic atrophy plus syndrome, 125250 (3), Autosomal dominant",Opa1 (MGI:1921393)
3,194136147,194138731,3q28-q29,3q29,139605,"HES1, HRY","Hairy and enhancer of split, Drosophila, homolog of",HES1,3280,ENSG00000114315,NA,NA,Hes1 (MGI:104853)
3,194339764,194351386,3q29,3q29,603104,CPN2,"Carboxypeptidase N, polypeptide 2, 83-KD",CPN2,1370,ENSG00000178772,conflicting assignment to chr.8,NA,Cpn2 (MGI:1919006)
3,194394820,194399265,3q29,3q29,173511,GP5,"Glycoprotein V, platelet",GP5,2814,ENSG00000178732,NA,NA,Gp5 (MGI:1096363)
3,194402673,194487005,3q26.32,3q29,610232,"ATP13A3, AFURS1","ATPase, type 13A3",ATP13A3,79572,ENSG00000133657,NA,NA,Atp13a3 (MGI:2685387)
3,194640787,194672190,3q29,3q29,610780,LSG1,"Large subunit GTPase 1, S. cerevisiae, homolog of",LSG1,55341,ENSG00000041802,NA,NA,Lsg1 (MGI:107236)
3,195066969,195271158,3q29,3q29,614552,"XXYLT1, C3orf21",Xyloside xylosyltransferase 1,XXYLT1,152002,ENSG00000173950,NA,NA,Xxylt1 (MGI:2146443)
3,195274741,195443175,3q29,3q29,607766,"CENTB2, KIAA0041, ACAP2","Centaurin, beta-2",ACAP2,23527,ENSG00000114331,NA,NA,Acap2 (MGI:1925868)
3,195514421,195543400,3q29,3q29,601792,"PPP1R2, IPP2","Protein phosphatase-1, regulatory (inhibitor) subunit 2",PPP1R2,5504,ENSG00000184203,pseudogenes on chr. 5 and 6,NA,Ppp1r2 (MGI:1914099)
3,195568704,195583939,3q26.2-qter,3q29,107740,APOD,Apolipoprotein D,APOD,347,ENSG00000189058,NA,NA,Apod (MGI:88056)
3,195699400,195699496,3q29,3q29,614538,MIR570,Micro RNA 570,MIR570,693155,ENSG00000207650,NA,NA,NA
3,195720977,195733550,3q29,3q29,610360,MUC20,"Mucin 20, cell surface-associated",MUC20,200958,ENSG00000176945,NA,NA,Muc20 (MGI:2385039)
3,195746770,195811928,3q29,3q29,158372,MUC4,"Mucin 4, tracheobronchial",MUC4,4585,ENSG00000145113,NA,NA,NA
3,195863363,195909008,3q29,3q29,606994,"TNK2, ACK, ACK1","Tyrosine kinase, non-receptor, 2",TNK2,10188,ENSG00000061938,NA,NA,Tnk2 (MGI:1858308)
3,196018693,196082122,3q29,3q29,190010,"TFRC, TFR, CD71, IMD46",Transferrin receptor,TFRC,7037,ENSG00000072274,NA,"Immunodeficiency 46, 616740 (3), Autosomal recessive",Tfrc (MGI:98822)
3,196216533,196233426,3q29,3q29,612084,OSTA,"Organic solute transporter, alpha",SLC51A,200931,ENSG00000163959,NA,NA,Slc51a (MGI:2146634)
3,196234367,196287725,3q29,3q29,123695,"PCYT1A, CTPCT, PCYT1, SMDCRD","Phosphate cytidylyltransferase 1, choline, alpha isoform",PCYT1A,5130,ENSG00000161217,NA,"Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3), Autosomal recessive",Pcyt1a (MGI:88557)
3,196291218,196318239,3q29,3q29,617353,"TCTEX1D2, SRTD17",TCTEX1 domain-containing protein 2,TCTEX1D2,255758,ENSG00000213123,NA,"Short-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3), Autosomal recessive",Tctex1d2 (MGI:1913311)
3,196347658,196454322,3q29,3q29,616379,"UBXN7, KIAA0794",UBX domain protein 7,UBXN7,26043,ENSG00000163960,NA,NA,Ubxn7 (MGI:2146388)
3,196468782,196503767,3q29,3q29,612688,RNF168,RING finger protein 168,RNF168,165918,ENSG00000163961,NA,"RIDDLE syndrome, 611943 (3), Autosomal recessive",Rnf168 (MGI:1917488)
3,196554176,196568673,3q29,3q29,615110,WDR53,WD repeat-containing protein 53,WDR53,348793,ENSG00000185798,NA,NA,Wdr53 (MGI:1916230)
3,196568659,196589058,3q29,3q29,609112,"FBXO45, FBX45",F-box only protein 45,FBXO45,200933,ENSG00000174013,NA,NA,Fbxo45 (MGI:2447775)
3,196639693,196662003,3q29,3q29,615322,"NRROS, LRRC33",Negative regulator of oxygen species,NRROS,375387,ENSG00000174004,NA,NA,Nrros (MGI:2445095)
3,196706272,196712289,3q29,3q29,615586,"CEP19, C3orf34, MOSPGF","Centrosomal protein, 19kD",CEP19,84984,ENSG00000174007,mutation identified in 1 family,"Morbid obesity and spermatogenic failure, 615703 (3), Autosomal recessive",Cep19 (MGI:1914244)
3,196712376,196736006,3q29,3q29,610276,PIGX,"Phosphatidylinositol glycan, class X",PIGX,54965,ENSG00000163964,NA,NA,Pigx (MGI:1919334)
3,196739856,196832646,3q29,3q29,605022,"PAK2, PAK65",p21-activated kinase 2,PAK2,5062,ENSG00000180370,deleted in 3q29 microdeletion syndrome,NA,Pak2 (MGI:1339984)
3,196867855,196934713,3q29,3q29,612845,SENP5,"Sentrin-specific protease family, member 5",SENP5,205564,ENSG00000119231,NA,NA,Senp5 (MGI:2443596)
3,196932728,196942592,3q29,3q29,605133,"NCBP2, CBP20, NIP1",Nuclear CAP-binding protein 2,NCBP2,22916,ENSG00000114503,NA,NA,Ncbp2 (MGI:1915342)
3,196946355,196969410,3q29,3q29,611671,"PIGZ, SMP3","Phosphatidylinositol glycan, class Z",PIGZ,80235,ENSG00000119227,NA,NA,Pigz (MGI:2443822)
3,197001739,197029816,3q29,3q29,155750,"MFI2, MAP97",Melanoma-associated antigen p97,MELTF,4241,ENSG00000163975,NA,NA,Meltf (MGI:1353421)
3,197042559,197299320,3q29,3q29,601014,DLG1,"Discs, large, Drosophila, homolog of, 1",DLG1,1739,ENSG00000075711,deleted in 3q29 microdeletion syndrome,NA,Dlg1 (MGI:107231)
3,197509782,197573322,3q29,3q29,603063,"BDH1, BDH",3-hydroxybutyrate dehydrogenase 1,BDH1,622,ENSG00000161267,NA,NA,Bdh1 (MGI:1919161)
3,197668866,197749726,3q29,3q29,613516,"RUBCN, RUBICON, KIAA0226, SCAR15","RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein",RUBCN,9711,ENSG00000145016,mutation identified in 1 family,"?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3), Autosomal recessive",Rubcn (MGI:1915160)
3,197749552,197787595,3q29,3q29,616933,"FYTTD1, UIF",Forty-two-three domain-containing protein 1,FYTTD1,84248,ENSG00000122068,NA,NA,Fyttd1 (MGI:1917955)
3,197889074,197960110,3q29,3q29,612477,IQCG,IQ motif-containing protein G,IQCG,84223,ENSG00000114473,NA,NA,Iqcg (MGI:1916957)
3,197950189,197956609,3q29-qter,3q29,180468,"RPL35A, DBA5",Ribosomal protein L35A,RPL35A,6165,ENSG00000182899,previous assignment to chr.18 in error,"Diamond-Blackfan anemia 5, 612528 (3), Autosomal dominant",Rpl35a (MGI:1928894)
3,197960199,198043719,3q29,3q29,609380,LMLN,Leishmanolysin-like,LMLN,89782,ENSG00000185621,NA,NA,Lmln (MGI:2444736)
4,0,4500000,4p16.3,NA,610203,"CRIPAK, FLJ3443",Cysteine-rich inhibitor of PAK1,NA,NA,NA,NA,NA,NA
4,0,11300000,4p16,NA,600593,"CRSA, CRS3","Craniosynostosis, Adelaide type",NA,7885,NA,NA,"Craniosynostosis, Adelaide type, 600593 (2), ?Autosomal dominant",NA
4,0,182300000,4p16-q34,NA,603783,INTLQ1,Intelligence quantitative trait locus 1,NA,100462721,NA,"associated with D4S2943, MSX1, and D4S1607","{Intelligence QTL1}, 603783 (2)",NA
4,0,4500000,4p16.3,NA,609456,MDCMP,"Muscular dystrophy, congenital, merosin-positive",NA,619409,NA,max lod at D4S432,"Muscular dystrophy, congenital, merosin-positive, 609456 (2), Autosomal recessive",NA
4,0,50000000,4p,NA,603663,MHW1,Mental health wellness 1,NA,10386,NA,at D4S2949,"{Mental health wellness-1}, 603663 (2)",NA
4,0,35800000,4p16-p15,NA,611863,MNDEC,Microtia with nasolacrimal duct imperforation and eye coloboma,NA,100188855,NA,copy number variant (CNV) association,"Microtia with nasolacrimal duct imperforation and eye coloboma, 611863 (4)",NA
4,0,11300000,4p16,NA,611637,"PLSA1, PLSA","Primary lateral sclerosis, adult, 1",NA,100240702,NA,max lod at D4S2936,"Primary lateral sclerosis, adult, 1, 611637 (2), Autosomal dominant",NA
4,0,27700000,4p16-p15.2,NA,605480,SLEB3,"Systemic lupus erythematosus, susceptibility to, 3",SLEB3,64695,NA,NA,"{Systemic lupus erythematosus, susceptibility to, 3}, 605480 (2)",NA
4,0,35800000,4p16-p15,NA,612335,SPG38,"Spastic paraplegia 38, autosomal dominant",SPG38,100049707,NA,between D4S432 and D4S1599,"Spastic paraplegia 38, autosomal dominant, 612335 (2), Autosomal dominant",NA
4,0,4500000,4p16.3,NA,194190,WHS,Wolf-Hirschhorn syndrome,NA,NA,NA,contiguous gene syndrome; critical region 200kb region 1.9Mb from telomere,"Wolf-Hirschhorn syndrome, 194190 (4), Isolated cases",NA
4,337813,384867,4p16.3,4p16.3,194648,"ZNF141, D4S90, PAPA6",Zinc finger protein-141 (clone pHZ-44),ZNF141,7700,ENSG00000131127,1 family identified with mutation,"?Polydactyly, postaxial, type A6, 615226 (3), Autosomal recessive",NA
4,499199,540199,4p16.3,4p16.3,616918,"PIGG, GPI7, MRT53",Phosphatidylinositol glycan anchor biosynthesis class G protein,PIGG,54872,ENSG00000174227,NA,"Mental retardation, autosomal recessive 53, 616917 (3), Autosomal recessive",Pigg (MGI:3576484)
4,587324,670891,4p16.3,4p16.3,180072,"PDE6B, PDEB, RP40, CSNBAD2","Phosphodiesterase-6B, cGMP-specific, rod, beta",PDE6B,5158,ENSG00000133256,NA,"Night blindness, congenital stationary, autosomal dominant 2, 163500 (3), Autosomal dominant; Retinitis pigmentosa-40, 613801 (3), Autosomal recessive",Pde6b (MGI:97525)
4,672435,674337,4p16.3,4p16.3,601519,"ATP5I, ATP5K","ATP synthase, H+ transporting, mitochondrial FO complex, subunit E",ATP5ME,521,ENSG00000169020,NA,NA,NA
4,674198,682032,4p16.3,4p16.3,160782,MYL5,"Myosin, light polypeptide-5, regulatory",MYL5,4636,ENSG00000215375,NA,NA,NA
4,705831,770979,4p16.3,4p16.3,617543,"PCGF3, RNF3, RNF3A",Polycomb group RING finger protein 3,PCGF3,10336,ENSG00000185619,NA,NA,Pcgf3 (MGI:1916837)
4,784956,826128,4p16.3,4p16.3,605032,"CPLX1, CPX1, EIEE63",Complexin 1,CPLX1,10815,ENSG00000168993,NA,"Epileptic encephalopathy, early infantile, 63, 617976 (3), Autosomal recessive",Cplx1 (MGI:104727)
4,849275,932329,4p16,4p16.3,602052,GAK,Cyclin G associated kinase,GAK,2580,ENSG00000178950,NA,NA,Gak (MGI:2442153)
4,932386,958655,4p16.3,4p16.3,616660,TMEM175,Transmembrane protein 175,TMEM175,84286,ENSG00000127419,NA,NA,Tmem175 (MGI:1919642)
4,958886,973568,4p16.3,4p16.3,601207,"DGKQ, DAGK4","Diacylglycerol kinase, theta, 110kD",DGKQ,1609,ENSG00000145214,NA,NA,Dgkq (MGI:102918)
4,979072,993403,4p16.3,4p16.3,610130,"SLC26A1, SAT1, CAON","Solute carrier family 26 (sulfate transporter), member 1",SLC26A1,10861,ENSG00000145217,mutation identified in 1 CAON patient,"?Nephrolithiasis, calcium oxalate, 167030 (3), Autosomal recessive",Slc26a1 (MGI:2385894)
4,986996,1004563,4p16.3,4p16.3,252800,"IDUA, IDA","Iduronidase, alpha-L-",IDUA,3425,ENSG00000127415,NA,"Mucopolysaccharidosis Ih, 607014 (3), Autosomal recessive; Mucopolysaccharidosis Ih/s, 607015 (3), Autosomal recessive; Mucopolysaccharidosis Is, 607016 (3), Autosomal recessive",Idua (MGI:96418)
4,1009929,1026897,4p16,4p16.3,605830,FGFRL1,Fibroblast growth factor receptor-like 1,FGFRL1,53834,ENSG00000127418,NA,NA,Fgfrl1 (MGI:2150920)
4,1056247,1113793,4p16.3,4p16.3,612041,"RNF212, ZHP3",Ring finger protein 212,RNF212,285498,ENSG00000178222,NA,"Recombination rate QTL 1, 612042 (3)",Rnf212 (MGI:3645767)
4,1166931,1208961,4p16.3,4p16.3,605918,SPON2,Spondin 2,SPON2,10417,ENSG00000159674,NA,NA,Spon2 (MGI:1923724)
4,1211443,1253918,4p16,4p16.3,602618,"CTBP1, HADDTS",C-terminal binding protein 1,CTBP1,1487,ENSG00000159692,NA,"Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3), Autosomal dominant",Ctbp1 (MGI:1201685)
4,1289850,1340147,4p16.3,4p16.3,606801,"MAEA, EMP",Macrophage erythroblast attacher,MAEA,10296,ENSG00000090316,NA,NA,Maea (MGI:1891748)
4,1341997,1388048,4p16.3,4p16.3,614632,"UVSSA, KIAA1530, UVSS3",UV-stimulated scaffold protein A,UVSSA,57654,ENSG00000163945,NA,"UV-sensitive syndrome 3, 614640 (3), Autosomal recessive",Uvssa (MGI:1918351)
4,1402931,1406441,4p16.3,4p16.3,617869,"NKX1-1, SAX2",NK1 homeobox 1,NKX1-1,54729,ENSG00000235608,NA,NA,NA
4,1574054,1684312,4p16.3,4p16.3,617229,"FAM53A, DNTNP","Family with sequence similarity 53, member A",FAM53A,152877,ENSG00000174137,NA,NA,Fam53a (MGI:1919225)
4,1692730,1715875,4p16.3,4p16.3,602422,"SLBP, HBP",Histone stem-loop binding protein,SLBP,7884,ENSG00000163950,NA,NA,Slbp (MGI:108402)
4,1715951,1721372,4p16.3,4p16.3,615975,TMEM129,Transmembrane protein 129,TMEM129,92305,ENSG00000168936,NA,NA,Tmem129 (MGI:1915616)
4,1721496,1745170,4p16.3,4p16.3,605303,TACC3,"Transforming, acidic, coiled-coil-containing protein 3",TACC3,10460,ENSG00000013810,NA,NA,Tacc3 (MGI:1341163)
4,1793292,1808871,4p16.3,4p16.3,134934,"FGFR3, ACH",Fibroblast growth factor receptor-3,FGFR3,2261,ENSG00000068078,NA,"Achondroplasia, 100800 (3), Autosomal dominant; Bladder cancer, somatic, 109800 (3); CATSHL syndrome, 610474 (3), Autosomal recessive, Autosomal dominant; Cervical cancer, somatic, 603956 (3); Colorectal cancer, somatic, 114500 (3); Crouzon syndrome with acanthosis nigricans, 612247 (3), Autosomal dominant; Hypochondroplasia, 146000 (3), Autosomal dominant; LADD syndrome, 149730 (3), Autosomal dominant; Muenke syndrome, 602849 (3), Autosomal dominant; Nevus, epidermal, somatic, 162900 (3); SADDAN, 616482 (3), Autosomal dominant; Spermatocytic seminoma, somatic, 273300 (3); Thanatophoric dysplasia, type I, 187600 (3), Autosomal dominant; Thanatophoric dysplasia, type II, 187601 (3), Autosomal dominant",Fgfr3 (MGI:95524)
4,1811478,1856155,4p16.3,4p16.3,604407,LETM1,Leucine zipper/EF-hand-containing transmembrane protein 1,LETM1,3954,ENSG00000168924,NA,NA,Letm1 (MGI:1932557)
4,1871392,1982206,4p16.3,4p16.3,602952,"NSD2, WHSC1, MMSET",Nuclear receptor-binding SET domain protein 2,NSD2,7468,ENSG00000109685,NA,NA,Nsd2 (MGI:1276574)
4,1982716,2041913,4p16.3,4p16.3,606026,WHSC2,WHS candidate 2 gene,NELFA,7469,ENSG00000185049,NA,NA,Nelfa (MGI:1346098)
4,2035609,2043969,4p16.3,4p16.3,614690,C4orf48,chromosome 4 open reading frame 48,C4orf48,401115,ENSG00000243449,NA,NA,NA
4,2059326,2069088,4p16.3,4p16.3,610647,"NAT8L, CML3, NACED",N-acetyltransferase 8-like,NAT8L,339983,ENSG00000185818,mutation identified in 1 patient,"?N-acetylaspartate deficiency, 614063 (3), Autosomal recessive",Nat8l (MGI:2447776)
4,2071917,2242120,4p16.2,4p16.3,610887,POLN,"Polymerase, DNA, nu",POLN,353497,ENSG00000130997,NA,NA,NA
4,2228348,2242120,4p16.3,4p16.3,613430,"HAUS3, DGT3, C4orf15","HAUS augmin-like complex, subunit 3",HAUS3,79441,ENSG00000214367,NA,NA,Haus3 (MGI:2387633)
4,2269584,2418697,4p16,4p16.3,614176,"ZFYVE28, LST2, KIAA1643",Zinc finger FYVE domain-containing protein 28,ZFYVE28,57732,ENSG00000159733,NA,NA,Zfyve28 (MGI:2684992)
4,2469105,2515858,4p16.3,4p16.3,602850,RNF4,RING finger protein-4,RNF4,6047,ENSG00000063978,NA,NA,Rnf4 (MGI:1201691)
4,2741647,2756335,4p16.3,4p16.3,610669,"TNIP2, ABIN2, FLIP1",TNFAIP3-interacting protein 2,TNIP2,79155,ENSG00000168884,NA,NA,Tnip2 (MGI:2386643)
4,2793084,2841095,4p16.3,4p16.3,602104,"SH3BP2, CRPM",SH3-domain binding protein 2,SH3BP2,6452,ENSG00000087266,NA,"Cherubism, 118400 (3), Autosomal dominant",Sh3bp2 (MGI:1346349)
4,2843843,2930075,4p16.3,4p16.3,102680,ADD1,"Adducin-1, alpha",ADD1,118,ENSG00000087274,NA,"{Hypertension, essential, salt-sensitive}, 145500 (3), Multifactorial",Add1 (MGI:87918)
4,2930555,2934858,4p16.3,4p16.3,610977,"TETRAN, TPO1",Tetracycline transporter-like protein,MFSD10,10227,ENSG00000109736,NA,NA,Mfsd10 (MGI:1915544)
4,2937935,2963505,4p16.3,4p16.3,611526,"NOP14, NOL14, RES425","Nop14, S. cerevisiae, homolog of",NOP14,8602,ENSG00000087269,NA,NA,Nop14 (MGI:1922666)
4,2963503,3040759,4p16.3,4p16.3,137026,"GRK4, GPRK2L, GPRK4",G protein-coupled receptor kinase 4,GRK4,2868,ENSG00000125388,NA,NA,Grk4 (MGI:95801)
4,3074680,3243959,4p16.3,4p16.3,613004,"HTT, HD, IT15, LOMARS",Huntingtin,HTT,3064,ENSG00000197386,distal to D4S10,"Huntington disease, 143100 (3), Autosomal dominant; Lopes-Maciel-Rodan syndrome, 617435 (3), Autosomal recessive",Htt (MGI:96067)
4,3292977,3439912,4p16.2,4p16.3,602512,RGS12,Regulator of G protein signaling 12,RGS12,6002,ENSG00000159788,NA,NA,Rgs12 (MGI:1918979)
4,3441967,3449485,4p16,4p16.3,604552,"HGFAC, HGFA",Hepatocyte growth factor activator,HGFAC,3083,ENSG00000109758,NA,NA,Hgfac (MGI:1859281)
4,3463305,3501481,4p16.2,4p16.3,610285,"DOK7, C4orf25, CMS10, FADS3",Downstream of tyrosine kinase 7,DOK7,285489,ENSG00000175920,mutation identified in 1 FADS3 family,"?Fetal akinesia deformation sequence 3, 618389 (3); Myasthenic syndrome, congenital, 10, 254300 (3), Autosomal recessive",Dok7 (MGI:3584043)
4,3503596,3532496,4p16.3,4p16.3,104225,"LRPAP1, A2MRAP, MYP23",Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1),LRPAP1,4043,ENSG00000163956,NA,"Myopia 23, autosomal recessive, 615431 (3), Autosomal recessive",Lrpap1 (MGI:96829)
4,3766384,3768525,4p16.1,4p16.3,104250,"ADRA2C, ADRA2L2","Adrenergic, alpha-2C-, receptor",ADRA2C,152,ENSG00000184160,linked to D4S10,"{Congestive heart failure and beta-blocker response, modifier of} (3)",Adra2c (MGI:87936)
4,4188725,4226893,4p16.2,4p16.3,607806,OTOP1,Otopetrin 1,OTOP1,133060,ENSG00000163982,NA,NA,Otop1 (MGI:2388363)
4,4267700,4290194,4p16.3,4p16.3,617684,LYAR,"Ly1 antibody-reactive protein, mouse, homolog of",LYAR,55646,ENSG00000145220,NA,NA,Lyar (MGI:107470)
4,4290196,4321785,4p16.3,4p16.3,616238,"ZBTB49, ZNF509",Zinc finger- and BTB domain-containing protein 49,ZBTB49,166793,ENSG00000168826,NA,NA,Zbtb49 (MGI:1922329)
4,4386255,4419057,4p16.3,4p16.3,607645,"D4S234E, D4S234",D4S234E gene,NSG1,27065,ENSG00000168824,NA,NA,Nsg1 (MGI:109149)
4,4859664,4863935,4p16.1,4p16.2,142983,"MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3","Muscle segment homeo box, Drosophila, homolog of, 1 (homeo box 7)",MSX1,4487,ENSG00000163132,NA,"Ectodermal dysplasia 3, Witkop type, 189500 (3), Autosomal dominant; Orofacial cleft 5, 608874 (3); Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3), Autosomal dominant",Msx1 (MGI:97168)
4,5014585,5019469,4p16.2,4p16.2,607930,"CYTL1, C17",Cytokine-like protein 1,CYTL1,54360,ENSG00000170891,NA,NA,Cytl1 (MGI:2684993)
4,5562407,5709547,4p16,4p16.2,607261,"EVC2, LBN, WAD",EVC2 (limbin) gene,EVC2,132884,ENSG00000173040,NA,"Ellis-van Creveld syndrome, 225500 (3), Autosomal recessive; Weyers acrofacial dysostosis, 193530 (3), Autosomal dominant",Evc2 (MGI:1915775)
4,5711198,5829042,4p16,4p16.2,604831,EVC,EVC gene,EVC,2121,ENSG00000072840,mutation identified in 1 WAD patient,"Ellis-van Creveld syndrome, 225500 (3), Autosomal recessive; ?Weyers acrofacial dysostosis, 193530 (3), Autosomal dominant",Evc (MGI:1890596)
4,5820763,5893085,4p16.1-p15,4p16.2,602462,"CRMP1, DPYSL1, DRP1",Collapsin response mediator protein-1,CRMP1,1400,ENSG00000072832,NA,NA,Crmp1 (MGI:107793)
4,6024924,6200554,4p16.2,4p16.1,611195,"JAKMIP1, JAMIP1, MARLIN1",Janus kinase and microtubule-interacting protein 1,JAKMIP1,152789,ENSG00000152969,NA,NA,Jakmip1 (MGI:1923321)
4,6260367,6303264,4p16.1,4p16.1,606201,"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",Wolframin,WFS1,7466,ENSG00000109501,mutation identified in 1 CTRCT41 family,"?Cataract 41, 116400 (3), Autosomal dominant; Deafness, autosomal dominant 6/14/38, 600965 (3), Autosomal dominant; {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3), Autosomal dominant; Wolfram syndrome 1, 222300 (3), Autosomal recessive; Wolfram-like syndrome, autosomal dominant, 614296 (3), Autosomal dominant",Wfs1 (MGI:1328355)
4,6320577,6563798,4p16,4p16.1,605997,"PPP2R2C, PR52","Protein phosphatase 2A, regulatory subunit B, gamma isoform",PPP2R2C,5522,ENSG00000074211,NA,NA,Ppp2r2c (MGI:2442660)
4,6640090,6642744,4p16.1,4p16.1,616905,"MRFAP1, PAM14, PGR1`",MORF4 family- associated protein 1,MRFAP1,93621,ENSG00000179010,NA,NA,Mrfap1 (MGI:1914818)
4,6693877,6697169,4p16,4p16.1,600614,S100P,S100 calcium-binding protein P,S100P,6286,ENSG00000163993,NA,NA,NA
4,6716173,6717663,4p16.1,4p16.1,605695,"BLOC1S4, BLOS4, CNO","Biogenesis of lysosome-related organelles complex 1, subunit 4",BLOC1S4,55330,ENSG00000186222,NA,NA,Bloc1s4 (MGI:1929230)
4,6909443,7033117,4p16.1,4p16.1,614855,"TBC1D14, KIAA1322","TBC1 domain family, member 14",TBC1D14,57533,ENSG00000132405,NA,NA,Tbc1d14 (MGI:1098708)
4,7043371,7057951,4p16.1,4p16.1,608790,"TADA2B, ADA2B",Transcriptional adaptor 2B,TADA2B,93624,ENSG00000173011,NA,NA,Tada2b (MGI:3035274)
4,7058894,7068063,4p16,4p16.1,606173,"GRPEL1, HMGE","GrpE, E. coli, homolog of",GRPEL1,80273,ENSG00000109519,NA,NA,Grpel1 (MGI:1334417)
4,7192537,7742827,4p16.1,4p16.1,606284,"SORCS2, KIAA1329",SORCS receptor 2,SORCS2,57537,ENSG00000184985,NA,NA,Sorcs2 (MGI:1932289)
4,7758712,7939925,4p16.1,4p16.1,608252,"AFAP1, AFAP, AFAP110",Actin filament-associated protein 1,AFAP1,60312,ENSG00000196526,NA,NA,Afap1 (MGI:1917542)
4,7965311,8158812,4p16,4p16.1,612544,"ABLIM2, KIAA1808","Actin-binding LIM protein family, member 2",ABLIM2,84448,ENSG00000163995,NA,NA,Ablim2 (MGI:2385758)
4,8005300,8005380,Chr.4,4p16.1,613185,"MIR95, MIRN95",Micro RNA 95,MIR95,407052,ENSG00000207807,NA,NA,NA
4,8269711,8307097,4p16.1,4p16.1,608785,"HTRA3, PRSP",HTRA serine peptidase 3,HTRA3,94031,ENSG00000170801,NA,NA,Htra3 (MGI:1925808)
4,8366262,8440724,4p15.3,4p16.1,603402,ACOX3,"Acyl-coenzyme A oxidase 3, pristanoyl",ACOX3,8310,ENSG00000087008,NA,NA,Acox3 (MGI:1933156)
4,8440773,8512530,4p16.3,4p16.1,614309,"TRMT44, METTL19","tRNA methyltransferase 44, S. cerevisiae, homolog of",TRMT44,152992,ENSG00000155275,NA,NA,Trmt44 (MGI:1926140)
4,8580236,8590022,4p16.1,4p16.1,606921,GPR78,G protein-coupled receptor 78,GPR78,27201,ENSG00000155269,NA,NA,NA
4,8592659,8619760,4p16.1,4p16.1,603105,CPZ,Carboxypeptidase Z,CPZ,8532,ENSG00000109625,NA,NA,Cpz (MGI:88487)
4,8846075,8871838,4p16.1,4p16.1,142992,"HMX1, H6",Homeo box (H6 family) 1,HMX1,3166,ENSG00000215612,NA,"Oculoauricular syndrome, 612109 (3), Autosomal recessive",Hmx1 (MGI:107178)
4,9358381,9359973,4p16.1,4p16.1,607011,"USP17L9P, USP17","Ubiquitin-specific protease 17-like family member 9, pseudogene",USP17L9P,391627,ENSG00000251694,NA,NA,NA
4,9771124,10040247,4p16-p15.3,4p16.1,606142,"SLC2A9, GLUT9, UAQTL2","Solute carrier family 2 (facilitated glucose transporter), member 9",SLC2A9,56606,ENSG00000109667,NA,"Hypouricemia, renal, 2, 612076 (3), Autosomal recessive, Autosomal dominant; {Uric acid concentration, serum, QTL 2}, 612076 (3), Autosomal recessive, Autosomal dominant",Slc2a9 (MGI:2152844)
4,9781633,9784008,4p16.1-p15.3,4p16.1,126453,"DRD5, DRD1B, DRD1L2",Dopamine receptor D5,DRD5,1816,ENSG00000169676,pseudogenes on 2p11 and 1q21,"{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3), Autosomal dominant; {Blepharospasm, primary benign}, 606798 (3), Autosomal dominant",Drd5 (MGI:94927)
4,10074338,10116859,4p,4p16.1,604734,WDR1,WD repeat-containing protein 1,WDR1,9948,ENSG00000071127,NA,NA,Wdr1 (MGI:1337100)
4,10439879,10457425,4p16.1,4p16.1,617734,"ZNF518B, KIAA1729",Zinc finger protein 518B,ZNF518B,85460,ENSG00000178163,NA,NA,Zfp518b (MGI:2140750)
4,10486394,10734852,4p16.1,4p16.1,611434,"CLNK, MIST",Cytokine-dependent hematopoietic cell linker,CLNK,116449,ENSG00000109684,NA,NA,Clnk (MGI:1351468)
4,11300000,41200000,4p15-p14,NA,608410,BMIQ7,Body mass index quantitative trait locus 7,NA,404683,NA,NA,"{Obesity, susceptibility to, BMIQ7}, 608410 (2)",NA
4,11300000,35800000,4p15,NA,607221,EPPS,"Epilepsy, partial, with pericentral spikes",NA,266789,NA,NA,"Epilepsy, partial, with pericentral spikes, 607221 (2)",NA
4,11300000,21300000,4p15.3,NA,604802,"HDL3, HLN2",Huntington disease-like 3,NA,53369,NA,NA,"Huntington disease-like 3, 604802 (2), Autosomal recessive",NA
4,11300000,21300000,4p15.3,NA,612226,STQTL13,Stature quantitative trait locus 13,NA,100270796,NA,associated with rs16896068,"{Stature QTL 13}, 612226 (2)",NA
4,11393149,11434397,4p15.33,4p15.33,603244,"HS3ST1, 3OST, 3OST1",Heparan sulfate (glucosamine)3-O-sulfotransferase 1,HS3ST1,9957,ENSG00000002587,NA,NA,Hs3st1 (MGI:1201606)
4,13367722,13484364,4p15.33,4p15.33,612994,"RAB28, CORD18",Ras-associated protein 28,RAB28,9364,ENSG00000157869,NA,"Cone-rod dystrophy 18, 615374 (3), Autosomal recessive",Rab28 (MGI:1917285)
4,13540829,13544507,4p16.1,4p15.33,602183,"NKX3-2, BAPX1, SMMD","Bagpipe homeo box, Drosophila, homolog of",NKX3-2,579,ENSG00000109705,NA,"Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3), Autosomal recessive",Nkx3-2 (MGI:108015)
4,13568737,13627724,4p16.1,4p15.33,616746,"BOD1L1, FAM44A",BOD1-like protein 1,BOD1L1,259282,ENSG00000038219,NA,NA,Bod1l (MGI:2444804)
4,15002425,15070152,4q32-q33,4p15.32,610605,CPEB2,Cytoplasmic polyadenylation element-binding protein 2,CPEB2,132864,ENSG00000137449,NA,NA,Cpeb2 (MGI:2442640)
4,15468659,15601970,4p15.3,4p15.32,612013,"CC2D2A, KIAA1345, MKS6",Coiled-coil and C2 domains-containing protein 2A,CC2D2A,57545,ENSG00000048342,NA,"COACH syndrome, 216360 (3), Autosomal recessive; Joubert syndrome 9, 612285 (3), Autosomal recessive; Meckel syndrome 6, 612284 (3), Autosomal recessive",Cc2d2a (MGI:1924487)
4,15604380,15681543,4p15.33,4p15.32,605655,"FBXL5, FBL5",F-box and leucine-rich repeat protein 5,FBXL5,26234,ENSG00000118564,NA,NA,Fbxl5 (MGI:2152883)
4,15701865,15774177,4p15.32,4p15.32,600387,BST1,Bone marrow stromal cell antigen 1,BST1,683,ENSG00000109743,previously assigned to 14q32.3,NA,Bst1 (MGI:105370)
4,15778264,15853242,4p15,4p15.32,107270,CD38,CD38 antigen (p45); ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase,CD38,952,ENSG00000004468,NA,NA,Cd38 (MGI:107474)
4,15935576,15938739,4p15.3,4p15.32,607737,"FGFBP1, FGFBP, HBP17",Fibroblast growth factor-binding protein 1,FGFBP1,9982,ENSG00000137440,NA,NA,Fgfbp1 (MGI:1096350)
4,15960244,15963174,4p16,4p15.32,607713,KSP37,"Killer-specific secretory protein, 37kD",FGFBP2,83888,ENSG00000137441,NA,NA,NA
4,15968225,16084058,4p15.3,4p15.32,604365,"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",Prominin 1,PROM1,8842,ENSG00000007062,NA,"Cone-rod dystrophy 12, 612657 (3); Macular dystrophy, retinal, 2, 608051 (3), Autosomal dominant; Retinitis pigmentosa 41, 612095 (3), Autosomal recessive; Stargardt disease 4, 603786 (3)",Prom1 (MGI:1100886)
4,16160504,16226476,4p15.32,4p15.32,612758,"TAPT1, CMVFR, OCLSBG",Transmembrane anterior posterior transformation 1,TAPT1,202018,ENSG00000169762,NA,"Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3), Autosomal recessive",Tapt1 (MGI:2683537)
4,16501533,16898808,4p15,4p15.32,603450,"LDB2, CLIM1",LIM domain-binding factor-2,LDB2,9079,ENSG00000169744,NA,NA,Ldb2 (MGI:894670)
4,17486392,17512233,4p15.31,4p15.32,612676,"QDPR, DHPR",Quinoid dihydropteridine reductase,QDPR,5860,ENSG00000151552,NA,"Hyperphenylalaninemia, BH4-deficient, C, 261630 (3), Autosomal recessive",Qdpr (MGI:97836)
4,17577303,17607966,4p11-q12,4p15.32,170250,PEPS,Peptidase S,LAP3,51056,ENSG00000002549,NA,NA,Lap3 (MGI:1914238)
4,17614640,17634104,4p15.32,4p15.32,610311,"MED28, EG1, MAGICIN",Mediator complex subunit 28,MED28,80306,ENSG00000118579,NA,NA,Med28 (MGI:1914249)
4,17810812,17844864,4p15.3,4p15.31,606280,"NCAPG, CAPG",Non-SMC condensin I complex subunit G,NCAPG,64151,ENSG00000109805,NA,NA,Ncapg (MGI:1930197)
4,17841198,18023286,4p15.3,4p15.31,611799,"LCORL, MLR1",Ligand-dependent nuclear receptor corepressor-like protein,LCORL,254251,ENSG00000178177,NA,NA,Lcorl (MGI:2651932)
4,20251904,20620560,4p15.2,4p15.31,603746,SLIT2,"Slit, Drosophila, homolog of, 2",SLIT2,9353,ENSG00000145147,NA,NA,Slit2 (MGI:1315205)
4,20528274,20528383,4p15.31,4p15.31,616770,MIR218-1,Micro RNA 218-1,MIR218-1,407000,ENSG00000207732,within intron of SLIT2,NA,NA
4,20728519,21948771,4p15.3,4p15.3-p15.2,608182,"KCNIP4, KCHIP4",Kv channel-interacting protein 4,KCNIP4,80333,ENSG00000185774,NA,NA,Kcnip4 (MGI:1933131)
4,22387375,22516065,4p15.2,4p15.2,612303,"ADGRA3, GPR125",Adhesion G protein-coupled receptor A3,ADGRA3,166647,ENSG00000152990,NA,NA,Adgra3 (MGI:1917943)
4,22692936,22819574,4p15.31,4p15.2,606619,"GBA3, CBGL1","Glucosidase, beta, acid 3",GBA3,57733,ENSG00000249948,NA,NA,NA
4,23792020,24472904,4p15.1,4p15.2,604517,"PPARGC1A, PPARGC1","Peroxisome proliferator-activated receptor-gamma, coactivator 1, alpha",PPARGC1A,10891,ENSG00000109819,NA,NA,Ppargc1a (MGI:1342774)
4,24527474,24584553,4p15.3,4p15.2,603403,"DHX15, DDX15, DBP1, HRH2",DEAH (Asp-Glu-Ala-His) box polypeptide 15,DHX15,1665,ENSG00000109606,NA,NA,Dhx15 (MGI:1099786)
4,24795477,24800844,4p15.3-p15.1,4p15.2,185490,SOD3,"Superoxide dismutase-3, extracellular",SOD3,6649,ENSG00000109610,NA,"[Superoxide dismutase, elevated extracellular] (3)",Sod3 (MGI:103181)
4,24991959,25030945,4p15.2,4p15.2,608301,"LGI2, KIAA1916","Leucine-rich gene, glioma-inactivated, 2",LGI2,55203,ENSG00000153012,NA,NA,Lgi2 (MGI:2180196)
4,25120013,25160545,4p15.2,4p15.2,613009,"SEPSECS, SLA, LP, PCH2D",O-phosphoserine tRNA-selenocysteine tRNA synthase,SEPSECS,51091,ENSG00000109618,NA,"Pontocerebellar hypoplasia type 2D, 613811 (3), Autosomal recessive",Sepsecs (MGI:1098791)
4,25234030,25279208,4p15.2,4p15.2,612101,PI4K2B,"Phosphatidylinositol 4-kinase, type 2, beta",PI4K2B,55300,ENSG00000038210,NA,NA,Pi4k2b (MGI:1914323)
4,25312773,25373175,4p15.2,4p15.2,611792,ZCCHC4,Zinc finger CCHC domain-containing protein 4,ZCCHC4,29063,ENSG00000168228,NA,NA,Zcchc4 (MGI:1926046)
4,25377262,25418497,4p15.2,4p15.2,606947,"ANAPC4, APC4","Anaphase-promoting complex, subunit 4",ANAPC4,29945,ENSG00000053900,NA,NA,Anapc4 (MGI:1098673)
4,25655850,25678747,4p15.31-p15.2,4p15.2,604217,SLC34A2,"Solute carrier family 34 (sodium/phosphate cotransporter), member 2",SLC34A2,10568,ENSG00000157765,NA,"Pulmonary alveolar microlithiasis, 265100 (3), Autosomal recessive",Slc34a2 (MGI:1342284)
4,25914191,25929878,4p15.2,4p15.2,617465,"SMIM20, MITRAC7, C4orf52",Small integral membrane protein 20,SMIM20,389203,ENSG00000250317,NA,NA,Smim20 (MGI:1913528)
4,26163488,26435130,4p15.2,4p15.2,147183,"RBPJ, RBPSUH, IGKJRB1, AOS3",Recombination signal-binding protein 1 for kappa J region,RBPJ,3516,ENSG00000168214,"pseudogenes at 9q13, 9p13, and 3q25","Adams-Oliver syndrome 3, 614814 (3), Autosomal dominant",Rbpj (MGI:96522)
4,26481395,26490483,4p15.2-p15.1,4p15.2,118444,CCKAR,Cholecystokinin A receptor,CCKAR,886,ENSG00000163394,NA,NA,Cckar (MGI:99478)
4,26860840,27025380,4p15.1,4p15.2,610841,"STIM2, KIAA1482",Stromal interaction molecule 2,STIM2,57620,ENSG00000109689,NA,NA,Stim2 (MGI:2151156)
4,27700000,58500000,4p15.1-q12,NA,607107,"NPC1, NPCA1",Nasopharyngeal carcinoma 1,NA,257641,NA,?associated with acyl-CoA thioesterase 7-like,"{Nasopharyngeal carcinoma 1}, 607107 (2)",NA
4,30719860,31146799,4p15,4p15.1,602988,"PCDH7, BHPCDH",Protocadherin-7,PCDH7,5099,ENSG00000169851,NA,NA,Pcdh7 (MGI:1860487)
4,35800000,41200000,4p14,NA,614991,UCH1LAS,"Ubiquitin carboxyl-terminal esterase L1, antisense",NA,101180899,NA,NA,NA,NA
4,36005185,36244832,4p14,4p14,606645,"ARAP2, CENTD1, KIAA0580","ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2",ARAP2,116984,ENSG00000047365,NA,NA,Arap2 (MGI:2684416)
4,36281593,36347510,4p14,4p14,616979,DTHD1,Death domain-containing protein 1,DTHD1,401124,ENSG00000197057,NA,NA,Dthd1 (MGI:4937018)
4,37590803,37686402,4p14,4p14,611212,RELL1,Relt-like 1,RELL1,768211,ENSG00000181826,NA,NA,Rell1 (MGI:2140767)
4,37826685,37862936,4p14-q12,4p14,172000,PGM2,Phosphoglucomutase-2,PGM2,55276,ENSG00000169299,NA,NA,Pgm2 (MGI:97564)
4,37891083,38139174,4p15.1-q21,4p14,609850,"TBC1D1, KIAA1108","TBC1 domain family, member 1",TBC1D1,23216,ENSG00000065882,NA,NA,Tbc1d1 (MGI:1889508)
4,37960397,37961127,4p12,4p14,604231,PTTG2,Pituitary tumor-transforming gene 2,PTTG2,10744,ENSG00000250254,NA,NA,NA
4,38664078,38701516,4p14,4p14,609392,"KLF3, BKLF",Kruppel-like factor 3,KLF3,51274,ENSG00000109787,NA,NA,Klf3 (MGI:1342773)
4,38772237,38782989,4p14,4p14,606270,TLR10,Toll-like receptor 10,TLR10,81793,ENSG00000174123,NA,NA,NA
4,38791054,38806261,4p14,4p14,601194,"TLR1, TIL. LPRS5",Toll-like receptor-1,TLR1,7096,ENSG00000174125,NA,"{Leprosy, protection against}, 613223 (3); {Leprosy, susceptibility to, 5}, 613223 (3)",Tlr1 (MGI:1341295)
4,38823679,38857766,4p14,4p14,605403,TLR6,Toll-like receptor 6,TLR6,10333,ENSG00000174130,NA,NA,Tlr6 (MGI:1341296)
4,38868031,38868126,4p14,4p14,615469,"MIR574, MIR574-3p",Micro RNA 574,MIR574,693159,ENSG00000207944,NA,NA,NA
4,39044673,39143100,4p15.1-p13,4p14,608064,KLHL5,Kelch-like 5,KLHL5,51088,ENSG00000109790,NA,NA,Klhl5 (MGI:1919028)
4,39182472,39285809,4p14-p11,4p14,608151,"WDR19, SRTD5, ATD5, NPHP13, CED4",WD repeat-containing protein 19,WDR19,57728,ENSG00000157796,mutation identified in 1 CED4 family and 1 SRTD5 family,"?Cranioectodermal dysplasia 4, 614378 (3), Autosomal recessive; Nephronophthisis 13, 614377 (3), Autosomal recessive; Senior-Loken syndrome 8, 616307 (3), Autosomal recessive; ?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3), Autosomal recessive",Wdr19 (MGI:2443231)
4,39287455,39366380,4p14-p13,4p14,102579,"RFC1, RECC1, CANVAS","Replication factor C1, 145kD (activator 1, 145kD)",RFC1,5981,ENSG00000035928,NA,"Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome, 614575 (3), Autosomal recessive",Rfc1 (MGI:97891)
4,39406929,39451532,4p14,4p14,611135,"KLB, BKL","Klotho, beta",KLB,152831,ENSG00000134962,NA,NA,Klb (MGI:1932466)
4,39454123,39458947,4p13,4p14,603686,RPL9,Ribosomal protein L9,RPL9,6133,ENSG00000163682,pseudogene on Xpter-p21,NA,Rpl9 (MGI:1298373)
4,39459023,39479505,4p14,4p14,607031,"LIAS, PDHLD, HGCLAS",Lipoic acid synthase,LIAS,11019,ENSG00000121897,NA,"Hyperglycinemia, lactic acidosis, and seizures, 614462 (3), Autosomal recessive",Lias (MGI:1934604)
4,39498754,39527438,4p15.1,4p14,603370,"UGDH, UDPGDH",UDP-glucose dehydrogenase,UGDH,7358,ENSG00000109814,NA,NA,Ugdh (MGI:1306785)
4,39698135,39782791,4p14,4p14,602846,HIP2,Huntingtin-interacting protein-2,UBE2K,3093,ENSG00000078140,NA,NA,Ube2k (MGI:1858216)
4,39822862,39977955,4p14,4p14,613200,"PDS5A, KIAA0648, SCC112","PDS5, regulator of cohesion maintenance, S. Cerevisiae, homolog of, A",PDS5A,23244,ENSG00000121892,NA,NA,Pds5a (MGI:1918771)
4,40042916,40057198,4p14-p11,4p14,611963,LOC344967,Acyl-CoA thioesterase 7-like,NA,344967,ENSG00000205794,?associated with nasopharyngeal carcinoma,NA,NA
4,40191079,40246966,4p13,4p14,602037,"RHOH, ARHH, TTF","Ras homolog gene family, member H",RHOH,399,ENSG00000168421,mutation identified in 1 EV4 family,"{?Epidermodysplasia verruciformis, susceptibility to, 4}, 618307 (3), Autosomal recessive",Rhoh (MGI:1921984)
4,40335332,40355216,4p15.1-p14,4p14,605116,CHRNA9,"Cholinergic receptor, neuronal nicotinic, alpha polypeptide 9",CHRNA9,55584,ENSG00000174343,NA,NA,Chrna9 (MGI:1202403)
4,40749873,40815728,4p14,4p14,617185,NSUN7,"NOP2/SUN RNA methyltransferase family, member 7",NSUN7,79730,ENSG00000179299,NA,NA,Nsun7 (MGI:1918168)
4,40810026,41216713,4p14,4p14-p13,602710,"APBB2, FE65L1","Amyloid beta A4 precursor protein-binding, family B, member 2 (Fe65-like 1)",APBB2,323,ENSG00000163697,NA,NA,Apbb2 (MGI:108405)
4,41200000,87100000,4p13-q21,NA,605841,NRCLP2,Narcolepsy 2,NA,100918,NA,max lod at D4S2987,"Narcolepsy 2, 605841 (2)",NA
4,41256927,41268454,4p14,4p13,191342,"UCHL1, PARK5, SPG79, NDGOA",Ubiquitin C-terminal esterase L1,UCHL1,7345,ENSG00000154277,mutation identified in 1 PARK5 family,"{?Parkinson disease 5, susceptibility to}, 613643 (3); Spastic paraplegia 79, autosomal recessive, 615491 (3), Autosomal recessive",Uchl1 (MGI:103149)
4,41359606,41700043,4p13,4p13,617750,"LIMCH1, LMO7B",LIM and calponin homology domains-containing protein 1,LIMCH1,22998,ENSG00000064042,NA,NA,Limch1 (MGI:1924819)
4,41744081,41748969,4p12,4p13,603851,"PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS",Paired mesoderm homeo box 2B,PHOX2B,8929,ENSG00000109132,NA,"Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3), Autosomal dominant; Neuroblastoma with Hirschsprung disease, 613013 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3)",Phox2b (MGI:1100882)
4,41990501,42090460,4p13,4p13,604604,"SLC30A9, C4orf1, HUEL, BILAPES","Solute carrier family 30 (zinc transporter), member 9",SLC30A9,10463,ENSG00000014824,mutation identified in 1 BILAPES family,"?Birk-Landau-Perez syndrome, 617595 (3), Autosomal recessive",Slc30a9 (MGI:1923690)
4,42397487,42402486,4p13,4p13,617325,SHISA3,"Shisa family, member 3",SHISA3,152573,ENSG00000178343,NA,NA,Shisa3 (MGI:3041225)
4,42893265,43030657,4p13,4p13,613283,GRXCR1,"Glutaredoxin, cysteine-rich, 1",GRXCR1,389207,ENSG00000215203,NA,"Deafness, autosomal recessive 25, 613285 (3), Autosomal recessive",Grxcr1 (MGI:3577767)
4,44173902,44449791,4p13,4p13,618442,KCTD8,Potassium channel tetramerization domain-containing protein 8,KCTD8,386617,ENSG00000183783,NA,NA,Kctd8 (MGI:2443804)
4,44678394,44700927,4p12,4p12,617064,"GUF1, EF4, EIEE40","GTPase, S. cerevisiae, homolog of",GUF1,60558,ENSG00000151806,mutation identified in 1 EIEE40 family,"?Epileptic encephalopathy, early infantile, 40, 617065 (3), Autosomal recessive",Guf1 (MGI:2140726)
4,44701794,44726633,4p13,4p12,613222,"GNPDA2, GNP2",Glucosamine-6-phosphate deaminase 2,GNPDA2,132789,ENSG00000163281,NA,NA,Gnpda2 (MGI:1915230)
4,46035768,46124053,4p14-q21.1,4p12,137166,GABRG1,"Gamma-aminobutyric acid (GABA) A receptor, gamma-1",GABRG1,2565,ENSG00000163285,NA,NA,Gabrg1 (MGI:103156)
4,46243547,46390348,4p13-p12,4p12,137140,GABRA2,"Gamma-aminobutyric acid (GABA) A receptor, alpha-2",GABRA2,2555,ENSG00000151834,NA,"{Alcohol dependence, susceptibility to}, 103780 (3), Multifactorial",Gabra2 (MGI:95614)
4,46734826,46909265,4p12,4p12,609811,COX7B2,Cytochrome C oxidase subunit VIIb2,COX7B2,170712,ENSG00000170516,NA,NA,NA
4,46918899,46993580,4p14-q12,4p12,137141,GABRA4,"Gamma-aminobutyric acid (GABA) A receptor, alpha-4",GABRA4,2557,ENSG00000109158,"cluster with GABRA2, B1, G1; ?involved in autism",NA,Gabra4 (MGI:95616)
4,46993559,47438408,4p13-p12,4p12,137190,"GABRB1, EIEE45","Gamma-aminobutyric acid (GABA) A receptor, beta-1",GABRB1,2560,ENSG00000163288,NA,"Epileptic encephalopathy, early infantile, 45, 617153 (3), Autosomal dominant",Gabrb1 (MGI:95619)
4,47450786,47463729,4p12,4p12,616656,COMMD8,COMM domain-containing protein 8,COMMD8,54951,ENSG00000169019,NA,NA,Commd8 (MGI:1343485)
4,47593997,47838105,4p12,4p12,605236,"CORIN, CRN, TMPRSS10, ATC2, PEE5","Corin, serine peptidase",CORIN,10699,ENSG00000145244,NA,"Preeclampsia/eclampsia 5, 614595 (3)",Corin (MGI:1349451)
4,47935014,48016717,4p12-cen,4p12,123825,"CNGA1, CNCG1, RP49","Cyclic nucleotide gated channel, alpha 1",CNGA1,1259,ENSG00000198515,NA,"Retinitis pigmentosa 49, 613756 (3)",Cnga1 (MGI:88436)
4,48063503,48135321,4p12,4p12,600058,"TXK, BTKL",TXK tyrosine kinase,TXK,7294,ENSG00000074966,NA,NA,Txk (MGI:102960)
4,48135782,48269863,4p12,4p12-p11,600583,TEC,tec protein tyrosine kinase,TEC,7006,ENSG00000135605,NA,NA,Tec (MGI:98662)
4,48341474,48426200,4p11,4p11,610492,"SLAIN2, KIAA1458","SLAIN motif family, member 2",SLAIN2,57606,ENSG00000109171,NA,NA,Slain2 (MGI:1923241)
4,48490251,48499350,4p11,4p11,607520,ZAR1,Zygote arrest 1,ZAR1,326340,ENSG00000182223,NA,NA,Zar1 (MGI:2180337)
4,50000000,190214555,4q,NA,603664,MHW2,Mental health wellness 2,NA,50979,NA,at D4S397,"{Mental health wellness-2}, 603664 (2)",NA
4,50000000,190214555,4q,NA,601454,PSORS3,Psoriasis susceptibility 3,PSORS3,7889,NA,NA,"{Psoriasis susceptibility 3}, 601454 (2)",NA
4,50000000,190214555,4q,NA,610430,WM2,"Macroglobulinemia, Waldenstrom, susceptibility to, 2",NA,100188811,NA,between D4S2910 and D4S1539,"{Macroglobulinemia, Waldenstrom, susceptibility to, 2}, 610430 (2)",NA
4,51800000,65500000,4q12-q13.1,NA,612431,DFNA27,"Deafness, autosomal dominant 27",NA,NA,NA,max lod at D4S398,"Deafness, autosomal dominant 27, 612431 (2), Autosomal dominant",NA
4,51800000,69400000,4q12-q13.2,NA,609952,DFNB55,"Deafness, autosomal recessive 55",DFNB55,494148,NA,max lod at D4S2638,"Deafness, autosomal recessive 55, 609952 (2), Autosomal recessive",NA
4,51800000,65500000,4q12-q13.1,NA,614329,MRT31,"Mental retardation, autosomal recessive 31",NA,100852399,NA,between rs11944876 and rs6551838,"Mental retardation, autosomal recessive 31, 614329 (2), Autosomal recessive",NA
4,51800000,58500000,4q12,NA,609258,MYP9,Myopia 9,MYP9,553194,NA,NA,"Myopia 9, 609258 (2), Multifactorial",NA
4,51800000,58500000,4q12,NA,106700,TAPVR1,Total anomalous pulmonary venous return 1,TAPVR1,6893,NA,between D4S1630 and D4S3019; ?mutation in KDR,"Total anomalous pulmonary venous return, 106700 (2), Autosomal dominant",NA
4,51842999,51916836,4q12,4q12,612977,"DCUN1D4, KIAA0276",DCN1 domain-containing protein 4,DCUN1D4,23142,ENSG00000109184,NA,NA,Dcun1d4 (MGI:2140972)
4,52020694,52038318,4q12,4q12,600900,"SGCB, LGMDR4","Sarcoglycan, beta (43kD dystrophin-associated glycoprotein)",SGCB,6443,ENSG00000163069,NA,"Muscular dystrophy, limb-girdle, autosomal recessive 4, 604286 (3), Autosomal recessive",Sgcb (MGI:1346523)
4,52051303,52097304,4q11-q12,4q12,612814,"SPATA18, SPETEX1",Spermatogenesis-associated protein 18,SPATA18,132671,ENSG00000163071,NA,NA,Spata18 (MGI:1920722)
4,52590959,52659300,4q12,4q12,612849,USP46,Ubiquitin-specific peptidase 46,USP46,64854,ENSG00000109189,NA,NA,Usp46 (MGI:1916977)
4,52712393,52720696,4q12,4q12,614625,"DANCR, ANCR, KIAA0114",Differentiation-antagonizing noncoding RNA,DANCR,57291,ENSG00000226950,NA,NA,NA
4,52712681,52712746,4q12,4q12,614627,MIR4449,Micro RNA 4449,MIR4449,100616436,ENSG00000264585,NA,NA,NA
4,52713248,52713369,4q12,4q12,614626,SNORA26,"Small nucleolar RNA, H/ACA box, 26",SNORA26,677810,ENSG00000212588,NA,NA,NA
4,52862316,52866834,4q12,4q12,612404,RASL11B,"RAS-like, family 11, member B",RASL11B,65997,ENSG00000128045,NA,NA,Rasl11b (MGI:1916189)
4,53377571,53462610,4q12,4q12,607686,FIP1L1,Fip1-like 1,FIP1L1,81608,ENSG00000145216,fused to PDGFRA in hypereosinophilic syndrome,NA,NA
4,53458263,53652524,4q12,4q12,609732,"LNX1, LNX, PDZRN2",Ligand of numb protein X1,LNX1,84708,ENSG00000072201,NA,NA,Lnx1 (MGI:1278335)
4,53996334,54064689,4q11-q12,4q12,604332,"CHIC2, BTL",Cysteine-rich hydrophobic domain 2 (Brx-like gene translocated in leukemia),CHIC2,26511,ENSG00000109220,NA,"{Leukemia, acute myeloid}, 601626 (3), Autosomal dominant, Somatic mutation",Chic2 (MGI:1921527)
4,54100162,54102497,4q12,4q12,616253,"GSX2, GSH2",GS homeobox 2,GSX2,170825,ENSG00000180613,NA,NA,Gsx2 (MGI:95843)
4,54229126,54298246,4q12,4q12,173490,PDGFRA,"Platelet-derived growth factor receptor, alpha polypeptide",PDGFRA,5156,ENSG00000134853,same 700bp segment as KIT; fused to BCR or FIP1L1,"Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial, 175510 (3); Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation",Pdgfra (MGI:97530)
4,54657927,54740714,4q12,4q12,164920,"KIT, PBT, MASTC",Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene,KIT,3815,ENSG00000157404,same 700bp segment as PDGFRA,"Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases; Germ cell tumors, somatic, 273300 (3); Leukemia, acute myeloid, somatic, 601626 (3); Mastocytosis, cutaneous, 154800 (3), Autosomal dominant; Mastocytosis, systemic, somatic, 154800 (3); Piebaldism, 172800 (3), Autosomal dominant",Kit (MGI:96677)
4,55078480,55125594,4q12,4q12,191306,KDR,Kinase insert domain receptor,KDR,3791,ENSG00000128052,?mutant in TAPVR1,"Hemangioma, capillary infantile, somatic, 602089 (3); {Hemangioma, capillary infantile, susceptibility to}, 602089 (3), Autosomal dominant",Kdr (MGI:96683)
4,55346227,55373099,4q12,4q12,611715,"SRD5A3, SRD5A2L, CDG1Q, KRIZI",Steroid 5-alpha-reductase 3,SRD5A3,79644,ENSG00000128039,NA,"Congenital disorder of glycosylation, type Iq, 612379 (3), Autosomal recessive; Kahrizi syndrome, 612713 (3), Autosomal recessive",Srd5a3 (MGI:1930252)
4,55395652,55453396,4q12,4q12,614726,"TMEM165, FT27, CDG2K",Transmembrane protein 165,TMEM165,55858,ENSG00000134851,NA,"Congenital disorder of glycosylation, type IIk, 614727 (3), Autosomal recessive",Tmem165 (MGI:894407)
4,55427900,55547137,4q12,4q12,601851,CLOCK,Circadian locomotor output cycles kaput,CLOCK,9575,ENSG00000134852,NA,NA,Clock (MGI:99698)
4,55556518,55592273,4q11,4q12,611676,PDCL2,Phosducin-like 2,PDCL2,132954,ENSG00000163440,NA,NA,Pdcl2 (MGI:1890655)
4,55853647,55905085,4q12,4q12,607879,"EXOC1, SEC3",Exocyst complex component 1,EXOC1,55763,ENSG00000090989,NA,NA,Exoc1 (MGI:2445020)
4,55948807,56033360,4q12,4q12,611423,"CEP135, KIAA0635, MCPH8","Centrosomal protein, 135kD",CEP135,9662,ENSG00000174799,NA,"Microcephaly 8, primary, autosomal recessive, 614673 (3), Autosomal recessive",Cep135 (MGI:2681869)
4,56337686,56389417,4q12,4q12,614365,"AASDH, ACSF4",Aminoadipate-semialdehyde dehydrogenase,AASDH,132949,ENSG00000157426,NA,NA,Aasdh (MGI:2442517)
4,56393361,56435635,4q12,4q12,172450,"PPAT, GPAT",Phosphoribosylpyrophosphate amidotransferase,PPAT,5471,ENSG00000128059,NA,NA,Ppat (MGI:2387203)
4,56435748,56464577,4q12,4q12,172439,"PAICS, AIRC",Phosphoribosylaminoimidazole carboxylase,PAICS,10606,ENSG00000128050,bifunctional enzyme; ade-D; 625bp from PPAT,NA,Paics (MGI:1914304)
4,56467595,56503680,4q12,4q12,602122,"SRP72, BMFS1","Signal recognition particle, 72kD",SRP72,6731,ENSG00000174780,NA,"Bone marrow failure syndrome 1, 614675 (3), Autosomal dominant",Srp72 (MGI:1333795)
4,56505208,56524455,4q12,4q12,612405,ARL9,ADP-ribosylation factor-like 9,ARL9,132946,ENSG00000196503,NA,NA,Arl9 (MGI:1915496)
4,56647987,56681865,4q11-q12,4q12,607275,"HOPX, HOP",HOP homeobox,HOPX,84525,ENSG00000171476,NA,NA,Hopx (MGI:1916782)
4,56809859,56822209,4q12,4q12,605753,"SPINK2, SPGF29","Serine protease inhibitor, Kazal-type, 2",SPINK2,6691,ENSG00000128040,mutation identified in 1 SPGF29 family,"?Spermatogenic failure 29, 618091 (3), Autosomal recessive",NA
4,56907899,56935846,4q12,4q12,600571,"REST, NRSF, WT6, GINGF5, HGF5",RE1-silencing transcription factor,REST,5978,ENSG00000084093,NA,"Fibromatosis, gingival, 5, 617626 (3), Autosomal dominant; {Wilms tumor 6, susceptibility to}, 616806 (3)",Rest (MGI:104897)
4,56963349,56977605,4q12,4q12,614919,"NOA1, C4orf14",Nitric oxide-associated protein 1,NOA1,84273,ENSG00000084092,NA,NA,Noa1 (MGI:1914306)
4,56978639,57031161,4q12,4q12,180661,POL2RB,"Polymerase (RNA) II (DNA directed) polypeptide B, 140kD",POLR2B,5431,ENSG00000047315,NA,NA,Polr2b (MGI:2388280)
4,57030772,57110384,4q12,4q12,602867,"IGFBP7, MAC25, RAMSVPS",Insulin-like growth factor-binding protein-7,IGFBP7,3490,ENSG00000163453,NA,"Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3), Autosomal recessive",Igfbp7 (MGI:1352480)
4,58500000,87100000,4q13-q21,NA,609400,"AIS4, VAMAS5","Autoimmune disease, susceptibility to, 4",NA,619405,NA,between D4S392 and D4S3042,"{Autoimmune disease, susceptibility to, 4}, 609400 (2)",NA
4,61201229,62078334,4q13.1,4q13.1,616417,"ADGRL3, LPHN3, CIRL3, CL3, LEC3, KIAA0768",Adhesion G protein-coupled receptor L3,ADGRL3,23284,ENSG00000150471,NA,NA,Adgrl3 (MGI:2441950)
4,64276297,64409509,4q13.1,4q13.1,617242,"TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3","Trans-2,3-enoyl-CoA reductase-like protein",TECRL,253017,ENSG00000205678,NA,"Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3), Autosomal recessive",Tecrl (MGI:2444966)
4,65319562,65670494,4q13,4q13.1-q13.2,600004,"EPHA5, TYRO4, HEK7",Ephrin receptor EphA5,EPHA5,2044,ENSG00000145242,NA,NA,Epha5 (MGI:99654)
4,65500000,87100000,4q13.2-q21.3,NA,611630,"ETL3, FMTLE","Epilepsy, familial temporal lobe, 3",NA,100188848,NA,max lod at D4S1517,"Epilepsy, familial temporal lobe, 3, 611630 (2), Autosomal dominant",NA
4,67468761,67545605,4q12-q13.3,4q13.2,117141,"CENPC1, CENPC",Centromere autoantigen C1,CENPC,1060,ENSG00000145241,?pseudogene on chr.12,NA,Cenpc1 (MGI:99700)
4,67558726,67607336,4q13.2,4q13.2,604298,"STAP1, BRDG1",Signal transducing adaptor family member 1,STAP1,26228,ENSG00000035720,NA,NA,Stap1 (MGI:1926193)
4,67612651,67701154,4q13.2,4q13.2,611361,"UBA6, UBE1L2",Ubiquitin activating enzyme 6,UBA6,55236,ENSG00000033178,NA,NA,Uba6 (MGI:1913894)
4,67737374,67756085,4q21.2,4q13.2,138850,"GNRHR, LHRHR, HH7",Gonadotropin-releasing hormone receptor,GNRHR,2798,ENSG00000109163,placed at 4q12 or 4q13 by some,"Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3), Autosomal recessive",Gnrhr (MGI:95790)
4,67909394,67963492,4q13.2,4q13.2,611704,"TMPRSS11A, ECRG1","Transmembrane protease, serine 11A",TMPRSS11A,339967,ENSG00000187054,NA,NA,Tmprss11a (MGI:2684853)
4,68038415,68042510,4q12,4q13.2,608311,GRINL1B,"Glutamate receptor, ionotropic, N-methyl D-aspartate-like 1B",GCOM2,339970,NA,NA,NA,NA
4,68060609,68063296,4q13.2,4q13.2,610892,"SYT14L, SYTDEP, CHR415SYT",Synaptotagmin 14-like protein,SYT14P1,401135,NA,NA,NA,NA
4,68310386,68350092,4q13.2,4q13.2,617283,"YTHDC1, KIAA1966",TYH domain-containing protein 1,YTHDC1,91746,ENSG00000083896,NA,NA,Ythdc1 (MGI:2443713)
4,68447462,68497603,4q13.2,4q13.2,610399,"TMPRSS11E, DESC1","Transmembrane protease, serine 11E",TMPRSS11E,28983,ENSG00000087128,NA,NA,Tmprss11e (MGI:3513175)
4,68537183,68576353,4q13,4q13.2,601903,"UGT2B17, BMND12","UDP-glucuronyltransferase, family 2, beta-17",UGT2B17,7367,ENSG00000197888,NA,"{Bone mineral density QTL 12, osteoporosis}, 612560 (3)",Ugt2b1 (MGI:1919023)
4,68646596,68670651,4q13,4q13.2,600069,"UGT2B15, UGT2B8","UDP-glucuronyltransferase, family 2, beta-15",UGT2B15,7366,ENSG00000196620,NA,NA,NA
4,68815993,68832037,4q13.2,4q13.2,600070,UGT2B10,"Uridine diphosphate glycosyltransferase 2 family, member B10",UGT2B10,7365,ENSG00000109181,NA,NA,Ugt2b34 (MGI:2140962)
4,68928458,68951803,4q13,4q13.2,616382,UGT2A3,"Uridine diphosphate glucuronosyltransferase 2 family, member A3",UGT2A3,79799,ENSG00000135220,NA,NA,Ugt2a3 (MGI:1919344)
4,69051263,69112986,4q13,4q13.2,600068,"UGT2B7, UGT2B9","UDP-glucuronyltransferase, family 2, beta-7",UGT2B7,7364,ENSG00000171234,NA,NA,"Ugt2b36,Ugt2b35 (MGI:3576103,MGI:3576100)"
4,69199950,69224979,4q13.2,4q13.2,603064,UGT2B11,"Uridine diphosphate glycosyltransferase 2 family, member B11",UGT2B11,10720,ENSG00000213759,NA,NA,NA
4,69280428,69295049,4q13.2,4q13.2,606497,UGT2B28,"Uridine diphosphate glycosyltransferase 2 family, member B28",UGT2B28,54490,ENSG00000135226,NA,NA,"Ugt2b38,Ugt2b37,Ugt2b5 (MGI:2148239,MGI:2140794,MGI:98900)"
4,69480164,69526013,4q13,4q13.3,600067,"UGT2B4, UGT2B11","UDP-glucuronyltransferase, family 2, beta-4",UGT2B4,7363,ENSG00000156096,cluster in order B7--B4--B15 in 195kb,NA,NA
4,69588416,69653246,4q13,4q13.3,604716,UGT2A1,"Uridine diphosphate glycosyltransferase 2 family, member A1",UGT2A1,10941,ENSG00000173610,NA,NA,Ugt2a1 (MGI:2149905)
4,69721166,69760643,4q13.3,4q13.3,608436,"SULT1B1, ST1B2","Sulfotransferase family 1B, member 1",SULT1B1,27284,ENSG00000173597,NA,NA,Sult1b1 (MGI:2136282)
4,69841211,69860150,4q13.1,4q13.3,600043,"STE, EST","Sulfotransferase, estrogen-preferring",SULT1E1,6783,ENSG00000109193,NA,NA,Sult1e1 (MGI:98431)
4,69931061,69946573,4q21.1,4q13.3,115450,CSN1,"Casein, alpha",CSN1S1,1446,ENSG00000126545,NA,NA,NA
4,69955255,69965761,4q21.1,4q13.3,115460,CSN2,"Casein, beta",CSN2,1447,ENSG00000135222,NA,NA,Csn2 (MGI:88541)
4,69995965,70002569,4q11-q13,4q13.3,184470,STATH,Statherin,STATH,6779,ENSG00000126549,NA,NA,NA
4,70028458,70036537,4q13,4q13.3,142702,"HTN3, HTN2, HIS2",Histatin-3,HTN3,3347,ENSG00000205649,NA,NA,NA
4,70050437,70058847,4q13,4q13.3,142701,HTN1,Histatin-1,HTN1,3346,ENSG00000126550,3 genes in a 15kb segment,NA,NA
4,70195727,70204575,4q13.3,4q13.3,614843,"ODAM, APIN",Odontogenic ameloblast-associated protein,ODAM,54959,ENSG00000109205,NA,NA,Odam (MGI:1916842)
4,70238369,70251431,4q13-q21,4q13.3,601695,"CSN3, CNS10, CSNK","Casein, kappa",CSN3,1448,ENSG00000171209,NA,NA,Csn3 (MGI:107461)
4,70360759,70367157,4q13.3,4q13.3,618340,"SMR3A, PBI",Submaxillary gland androgen-regulated protein 3A,SMR3A,26952,ENSG00000109208,NA,NA,NA
4,70383130,70390243,4q13.3,4q13.3,611593,"SMR3B, SMR1B, PRL3, PBII","Submaxillary gland androgen-regulated protein 3, mouse, homolog of, B",SMR3B,10879,ENSG00000171201,NA,NA,NA
4,70397881,70410196,4q13.3,4q13.3,608936,"PROL1, PRL1, BPLP",Proline-rich lacrimal protein 1,OPRPN,58503,ENSG00000171199,NA,NA,NA
4,70430491,70482996,4q13-q21,4q13.3,158375,MUC7,"Mucin 7, salivary",MUC7,4589,ENSG00000171195,NA,"{Asthma, protection against}, 600807 (3), Autosomal dominant",NA
4,70518568,70532742,4q13.3,4q13.3,610912,"AMTN, AI3B",Amelotin,AMTN,401138,ENSG00000187689,mutation identified in 1 AI3B family,"?Amelogenesis imperfecta, type IIIB, 617607 (3), Autosomal dominant",Amtn (MGI:1918671)
4,70592255,70607287,4q21,4q13.3,601259,"AMBN, AI1F",Ameloblastin,AMBN,258,ENSG00000178522,mutation identified in 1 AI1F family,"Amelogenesis imperfecta, type IF, 616270 (3), Autosomal recessive",Ambn (MGI:104655)
4,70627470,70646823,4q21,4q13.3,606585,"ENAM, AIH2, AI1C",Enamelin,ENAM,10117,ENSG00000132464,NA,"Amelogenesis imperfecta, type IB, 104500 (3), Autosomal dominant; Amelogenesis imperfecta, type IC, 204650 (3), Autosomal recessive",Enam (MGI:1333772)
4,70655540,70666507,4q21,4q13.3,147790,IGJ,"Immunoglobulin J polypeptide, linker protein for",JCHAIN,3512,ENSG00000132465,NA,NA,Jchain (MGI:96493)
4,70688531,70690550,4q21,4q13.3,611614,"UTP3, CRL1, CRLZ1","UTP3, S. crevisiae, homolog of",UTP3,57050,ENSG00000132467,NA,NA,Utp3 (MGI:1919230)
4,70704203,70808618,4q13.3,4q13.3,611194,"RUFY3, SINGAR1, RIPX",FUN and FYVE domains-containing protein 3,RUFY3,22902,ENSG00000018189,NA,NA,Rufy3 (MGI:106484)
4,70815781,70843273,4q13,4q13.3,604851,GRSF1,G-rich RNA sequence-binding factor 1,GRSF1,2926,ENSG00000132463,NA,NA,Grsf1 (MGI:106479)
4,70993648,71030913,4q13.3-q21.1,4q13.3,125450,DCK,Deoxycytidine kinase,DCK,1633,ENSG00000156136,NA,NA,Dck (MGI:102726)
4,71062645,71572086,4q21,4q13.3,603345,"SLC4A4, NBC1, KNBC","Solute carrier family 4, sodium bicarbonate cotransporter, member 4",SLC4A4,8671,ENSG00000080493,NA,"Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3), Autosomal recessive",Slc4a4 (MGI:1927555)
4,71741692,71805519,4q12,4q13.3,139200,"GC, DBP",Group-specific component (vitamin D-binding protein),GC,2638,ENSG00000145321,4q13-q21.1 by in situ hybridization,NA,Gc (MGI:95669)
4,72031803,72148200,4q13.3,4q13.3,607449,"NPFFR2, GPR74, NPFF2, NPGPR",Neuropeptide FF receptor 2,NPFFR2,10886,ENSG00000056291,NA,NA,Npffr2 (MGI:1860130)
4,72280968,72569220,4q21,4q13.3,605011,"ADAMTS3, HKLLS3","A Disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 3",ADAMTS3,9508,ENSG00000156140,NA,"Hennekam lymphangiectasia-lymphedema syndrome 3, 618154 (3), Autosomal recessive",Adamts3 (MGI:3045353)
4,73052361,73069776,4q21.1,4q13.3,610428,COX18,Cytochrome c oxidase assembly protein COX18,COX18,285521,ENSG00000163626,NA,NA,Cox18 (MGI:2448532)
4,73073375,73259765,4q13.3,4q13.3,615929,"ANKRD17, GTAR",Ankyrin repeat domain-containing protein 17,ANKRD17,26057,ENSG00000132466,NA,NA,Ankrd17 (MGI:1932101)
4,73404286,73421481,4q11-q13,4q13.3,103600,"ALB, ANALBA, FDAH",Albumin,ALB,213,ENSG00000163631,linked to GC,"Analbuminemia, 616000 (3); [Dysalbuminemic hyperthyroxinemia], 615999 (3)",Alb (MGI:87991)
4,73436220,73456173,4q11-q13,4q13.3,104150,"AFP, HPAFP, AFPD",Alpha-fetoprotein,AFP,174,ENSG00000081051,order: 5'-ALB-3'--5'-AFP-3',"Alpha-fetoprotein deficiency, 615969 (3), Autosomal recessive; [Hereditary persistence of alpha-fetoprotein], 615970 (3), Autosomal dominant",Afp (MGI:87951)
4,73481744,73504000,4q11-q13,4q13.3,104145,"AFM, ALBA, ALB2",Afamin,AFM,173,ENSG00000079557,10kb 3' of AFP,NA,Afm (MGI:2429409)
4,73571549,73620630,4q13.3,4q13.3,612620,RASSF6,"Ras association domain family, member 6",RASSF6,166824,ENSG00000169435,NA,NA,Rassf6 (MGI:1920496)
4,73740568,73743715,4q12-q13,4q13.3,146930,IL8,Interleukin-8,CXCL8,3576,ENSG00000169429,NA,NA,NA
4,73836677,73838759,4q12-q13,4q13.3,138965,"CXCL6, SCYB6, GCP2","Chemokine, C-X-C motif, ligand 6 (granulocyte chemotactic protein-2)",CXCL6,6372,ENSG00000124875,NA,NA,Cxcl5 (MGI:1096868)
4,73848735,73849252,4q12-q13,4q13.3,188035,"PPBPL1, TGB2","Pro-platelet basic protein-like 1 (thromboglobulin, beta-2)",PPBPP1,728045,NA,"in cluster with PPBP, PF4, and PF4V1",NA,NA
4,73853295,73854482,4q12-q13,4q13.3,173461,PF4V1,"Platelet factor 4, variant 1 (PF4-like)",PF4V1,5197,ENSG00000109272,same region as PF4 and IP10,NA,NA
4,73869391,73871307,4q12-q13,4q13.3,155730,"CXCL1, GRO1, MGSA","Chemokine, C-X-C, ligand 1 (GRO1 oncogene; melanoma growth stimulating activity, alpha)",CXCL1,2919,ENSG00000163739,apparently cluster of 3 GRO genes,NA,NA
4,73980810,73982123,4q12-q13,4q13.3,173460,PF4,Platelet factor 4,PF4,5196,ENSG00000163737,6kb from PF4V1,NA,Pf4 (MGI:1888711)
4,73986438,73988189,4q12-q13,4q13.3,121010,"PPBP, CXCL7, SCYB7, CTAP3, TGB",Pro-platelet basic protein,PPBP,5473,ENSG00000163736,less than 7kb from PF4,NA,NA
4,73995641,73998676,4q12-q13,4q13.3,600324,"CXCL5, SCYB5, ENA78","Chemokine, C-X-C motif, ligand 5 (epithelial-derived neutrophil-activating peptide 78)",CXCL5,6374,ENSG00000163735,NA,NA,NA
4,74036588,74038688,4q12-q13,4q13.3,139111,"CXCL3, GRO3, MIP2B","Chemokine, C-X-C motif, ligand 3 (GRO3 oncogene)",CXCL3,2921,ENSG00000163734,NA,NA,Cxcl2 (MGI:1340094)
4,74054037,74055398,4q13.3,4q13.3,611591,"PPBPP2, PPBPL2",Pro-platelet basic protein pseudogene 2,PPBPP2,10895,ENSG00000248848,NA,NA,NA
4,74097039,74099194,4q12-q13,4q13.3,139110,"CXCL2, GRO2, MIP2A","Chemokine, C-X-C motif, ligand 2 (GRO2 oncogene)",CXCL2,2920,ENSG00000081041,NA,NA,Cxcl1 (MGI:108068)
4,74123272,74303098,4q13.3,4q13.3,614047,MTHFD2L,"Methylenetetrahydrofolate dehydrogenase 2-like, NADP(+)-dependent",MTHFD2L,441024,ENSG00000163738,NA,NA,Mthfd2l (MGI:1915871)
4,74365144,74388748,4q13.3,4q13.3,602061,EREG,Epiregulin,EREG,2069,ENSG00000124882,NA,NA,Ereg (MGI:107508)
4,74445135,74455004,4q13-q21,4q13.3,104640,AREG,Amphiregulin,AREG,374,ENSG00000109321,NA,NA,Areg (MGI:88068)
4,74744758,74794717,4q13-q21,4q13.3,600345,BTC,Betacellulin,BTC,685,ENSG00000174808,tightly linked to Areg in mouse,NA,Btc (MGI:99439)
4,74933115,75050112,4q13.3,4q13.3,617688,"PARM1, CIPAR1",Prostate androgen-regulated mucin-like protein 1,PARM1,25849,ENSG00000169116,NA,NA,Parm1 (MGI:2443349)
4,75300000,87100000,4q21,NA,613509,"DEL4q21, C4DELq21",Chromosome 4q21 deletion syndrome,NA,NA,NA,contiguous gene deletion if at least 30 genes,"Chromosome 4q21 deletion syndrome, 613509 (4), Isolated cases",NA
4,75300000,113200000,4q21-q25,NA,134720,FECB,"Fecundity gene, Boorla, of sheep, homolog of",NA,7892,NA,sheep chr.6,NA,NA
4,75300000,154600000,4q21-q31,NA,608371,OFC4,Orofacial cleft 4,NA,474387,NA,NA,"Orofacial cleft 4, 608371 (2)",NA
4,75300000,100100000,4q21-q23,NA,609566,PFM3,Parietal foramina 3,PFM3,619475,NA,maximum lod between D4S2986 and D4S421,"Parietal foramina 3, 609566 (2), Autosomal dominant",NA
4,75479036,75515056,4q21.1,4q21.1,607680,"RCHY1, ZNF363, PIRH2, ARNIP","Ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase",RCHY1,25898,ENSG00000163743,NA,NA,Rchy1 (MGI:1915348)
4,75513943,75547333,4q21.1,4q21.1,612535,THAP6,THAP domain-containing protein 6,THAP6,152815,ENSG00000174796,NA,NA,NA
4,75554996,75565892,4q21.1,4q21.1,614829,"ODAPH, C4orf26",Odontogenesis-associated phosphoprotein,ODAPH,152816,ENSG00000174792,NA,"Amelogenesis imperfecta, type IIA4, 614832 (3), Autosomal recessive",Odaph (MGI:2685891)
4,75576493,75630527,4q21.1,4q21.1,603442,"CDKL2, KKIAMRE, P56",Cyclin-dependent kinase-like 2,CDKL2,8999,ENSG00000138769,NA,NA,Cdkl2 (MGI:1858227)
4,75724521,75814288,4q21.1,4q21.1,603344,"USO1, TAP, p115","USO1 vesicle docking protein, S. cerevisiae, homolog of",USO1,8615,ENSG00000138768,NA,NA,Uso1 (MGI:1929095)
4,75859866,75902451,4q21.1,4q21.1,602256,PPEF2,"Protein phosphatase, EF hand calcium-binding domain-2",PPEF2,5470,ENSG00000156194,NA,NA,Ppef2 (MGI:1342304)
4,75910654,75941012,4q21.1,4q21.1,607469,"NAAA, ASAHL",N-acylethanolamine acid amidase,NAAA,27163,ENSG00000138744,NA,NA,Naaa (MGI:1914361)
4,76001274,76007508,4q21,4q21.1,601704,"CXCL9, MIG, SCYB9","Chemokine, C-X-C motif, ligand 9",CXCL9,4283,ENSG00000138755,close to INP10,NA,NA
4,76011167,76112801,4q21.1,4q21.1,603086,ART3,ADP-ribosyltransferase 3,ART3,419,ENSG00000156219,NA,NA,Art3 (MGI:1202729)
4,76021117,76023496,4q21,4q21.1,147310,"CXCL10, INP10","Chemokine, C-X-C motif, ligand 10 (interferon-inducible cytokine IP-10)",CXCL10,3627,ENSG00000169245,?involved in monocytic leukemia with t(4;11)(q21;q23),NA,Cxcl10 (MGI:1352450)
4,76033681,76036069,4q21.2,4q21.1,604852,"CXCL11, SCYB11, IP9, SCYB9B","Chemokine, C-X-C motif, ligand 11",CXCL11,6373,ENSG00000169248,NA,NA,NA
4,76114658,76148514,4q21.1,4q21.1,607607,NUP54,"Nucleoporin, 54kD",NUP54,53371,ENSG00000138750,NA,NA,Nup54 (MGI:1920460)
4,76158736,76213823,4q13-q21,4q21.1,602257,"SCARB2, CD36L2, LIMPII, AMRF, EPM4","Scavenger receptor class B, member 2",SCARB2,950,ENSG00000138760,NA,"Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3), Autosomal recessive",Scarb2 (MGI:1196458)
4,76306025,76311129,4q25-q34,4q21.1,607406,GENEX3414,Genethonin 1,STBD1,8987,ENSG00000118804,NA,NA,Stbd1 (MGI:1261768)
4,76435228,76783252,4q21.1,4q21.1,604570,"SHROOM3, SHRM, KIAA1481",Shroom family member 3,SHROOM3,57619,ENSG00000138771,NA,NA,Shroom3 (MGI:1351655)
4,76949751,77040153,4q21.1,4q21.1,612887,SEPT11,Septin 11,SEPTIN11,55752,ENSG00000138758,NA,NA,Sept11 (MGI:1277214)
4,77157206,77170059,4q21.1,4q21.1,603203,CCNG2,Cyclin G2,CCNG2,901,ENSG00000138764,NA,NA,Ccng2 (MGI:1095734)
4,77511752,77611833,4q21,4q21.1,605149,"CXCL13, SCYB13, BCA1, BLC","Chemokine, C-X-C motif, ligand 13",CXCL13,10563,ENSG00000156234,NA,NA,Cxcl13 (MGI:1888499)
4,77713386,77820268,4q21.1,4q21.1,618069,"CNOT6L, CCR4B","CCR4-NOT transcription complex, subunit 6-like",CNOT6L,246175,ENSG00000138767,NA,NA,Cnot6l (MGI:2443154)
4,77862679,77952789,4q21.1,4q21.1,611821,MRPL1,Mitochondrial ribosomal protein L1,MRPL1,65008,ENSG00000169288,NA,NA,Mrpl1 (MGI:2137202)
4,78057322,78544268,4q21,4q21.21,607830,"FRAS1, FRASRS1",FRAS1 gene,FRAS1,80144,ENSG00000138759,NA,"Fraser syndrome 1, 219000 (3), Autosomal recessive",Fras1 (MGI:2385368)
4,78551760,78610446,4q21,4q21.21,106490,"ANXA3, ANX3",Annexin A3 (lipocortin III),ANXA3,306,ENSG00000138772,NA,NA,Anxa3 (MGI:1201378)
4,78776349,78916364,4q21.21,4q21.21,617648,"BMP2K, BIKE",BMP2-inducible kinase,BMP2K,55589,ENSG00000138756,NA,NA,Bmp2k (MGI:2155456)
4,78887224,78939437,4q21.21,4q21.21,614577,"PAQR3, RKTG","Progestin and ADIPOQ receptor family, member 3",PAQR3,152559,ENSG00000163291,NA,NA,Paqr3 (MGI:2679683)
4,79827470,79863246,4q21.1,4q21.21,609717,"PCAT4, GDEP",Prostate cancer-associated transcript 4,PCAT4,118425,ENSG00000251321,NA,NA,NA
4,79901145,80073471,4q21,4q21.21,608041,"ANTXR2, CMG2, HFS",Anthrax toxin receptor 2,ANTXR2,118429,ENSG00000163297,NA,"Hyaline fibromatosis syndrome, 228600 (3), Autosomal recessive",Antxr2 (MGI:1919164)
4,80183417,80204328,4q21.21,4q21.21,616639,"PRDM8, EPM10",PR domain-containing protein 8,PRDM8,56978,ENSG00000152784,mutation identified in 1 EPM10 family,"?Epilepsy, progressive myoclonic, 10, 616640 (3), Autosomal recessive",Prdm8 (MGI:1924880)
4,80266587,80291016,4q21,4q21.21,165190,"FGF5, TCMGLY",Fibroblast growth factor-5,FGF5,2250,ENSG00000138675,NA,"Trichomegaly, 190330 (3), Autosomal recessive",Fgf5 (MGI:95519)
4,81030707,81057631,4p14-q21,4q21.21,112263,BMP3,Bone morphogenetic protein-3,BMP3,651,ENSG00000152785,NA,NA,Bmp3 (MGI:88179)
4,81087369,81217836,4q13.1-q21.1,4q21.21,601591,"PRKG2, PRKGR2","Protein kinase, cGMP-dependent, type II",PRKG2,5593,ENSG00000138669,NA,NA,Prkg2 (MGI:108173)
4,81426392,81471906,4q12-q21,4q21.21,614532,"RASGEF1B, GPIG4","RASGEF domain family, member 1B",RASGEF1B,153020,ENSG00000138670,NA,NA,Rasgef1b (MGI:2443755)
4,82352497,82373995,4q21.1-q21.2,4q21.22,601324,"HNRPD, AUF1, AUF1A",Heterogeneous nuclear ribonucleoprotein D,HNRNPD,3184,ENSG00000138668,NA,NA,Hnrnpd (MGI:101947)
4,82422563,82430224,4q21.33,4q21.22,607137,"HNRNPDL, HNRPDL, JKTBP, LGMDD3",Heterogeneous nuclear ribonucleoprotein D-like protein,HNRNPDL,9987,ENSG00000152795,NA,"Muscular dystrophy, limb-girdle, autosomal dominant 3, 609115 (3), Autosomal dominant",Hnrnpdl (MGI:1355299)
4,82483175,82562252,4q21.22,4q21.22,617292,"TMEM150C, TTN3",Transmembrane protein 150C,TMEM150C,441027,ENSG00000249242,NA,NA,Tmem150c (MGI:3041258)
4,82629538,82798856,4q21.1,4q21.22,608370,"SCD4, ACOD4",Stearoyl-CoA desaturase 4,SCD5,79966,ENSG00000145284,NA,NA,NA
4,82818508,82900570,4q21.22,4q21.22,610257,"SEC31A, SEC31L1, KIAA0905","Sec31, yeast, homolog of, A",SEC31A,22872,ENSG00000138674,NA,NA,Sec31a (MGI:1916412)
4,82900649,82920282,4q21.22,4q21.22,612537,THAP9,THAP domain-containing protein 9,THAP9,79725,ENSG00000168152,NA,NA,NA
4,82924602,83012950,4q21.22,4q21.22,613367,LIN54,"Lin54, C. elegans, homolog of",LIN54,132660,ENSG00000189308,NA,NA,Lin54 (MGI:2140902)
4,83035182,83075817,4q21.22,4q21.22,616008,"COPS4, CSN4","COP9 signalosome, subunit 4",COPS4,51138,ENSG00000138663,NA,NA,Cops4 (MGI:1349414)
4,83090047,83114728,4q21,4q21.22,607515,PLAC8,Placenta-specific gene 8,PLAC8,51316,ENSG00000145287,NA,NA,Plac8 (MGI:2445289)
4,83263823,83285133,4q21-q22,4q21.23,609825,"COQ2, COQ10D1, MSA1","CoQ2, S. cerevisiae, homolog of (parahydroxybenzoate-polyprenyltransferase, mitochondrial)",COQ2,27235,ENSG00000173085,NA,"Coenzyme Q10 deficiency, primary, 1, 607426 (3), Autosomal recessive; {Multiple system atrophy, susceptibility to}, 146500 (3), Autosomal recessive, Autosomal dominant",Coq2 (MGI:1919133)
4,83292460,83335152,4q21.3,4q21.23,604724,"HPSE, HSE1, HPA",Heparanase,HPSE,10855,ENSG00000173083,NA,NA,Hpse (MGI:1343124)
4,83407342,83455882,4q21.23,4q21.23,606769,"HELQ, HEL308","Helicase, POLQ-like",HELQ,113510,ENSG00000163312,NA,NA,Helq (MGI:2176740)
4,83455931,83462297,4q21.23,4q21.23,611983,"MRPS18C, MRPS18-1",Mitochondrial ribosomal protein S18C,MRPS18C,51023,ENSG00000163319,6 pseudogenes,NA,Mrps18c (MGI:1915985)
4,83459516,83485136,4q21.2,4q21.23,611143,"FAM175A, CCDC98, ABRAXAS, ABRA1","Family with sequence similarity 175, member A",ABRAXAS1,84142,ENSG00000163322,NA,NA,Abraxas1 (MGI:1917931)
4,83535633,83605874,4q21.23,4q21.23,610958,"AGPAT9, GPAT3, MAG1",1-acylglycerol-3-phosphate O-acyltransferase 9,GPAT3,84803,ENSG00000138678,NA,NA,Gpat3 (MGI:3603816)
4,84493282,84498233,4q21.2-q22,4q21.23,602563,"NKX6-1, NKX6A","NK6, Drosophila, homolog of, 1",NKX6-1,4825,ENSG00000163623,NA,NA,Nkx6-1 (MGI:1206039)
4,84582930,84651333,4q21,4q21.23,603548,CDS1,CDP-diacylglycerol synthase 1,CDS1,1040,ENSG00000163624,NA,NA,Cds1 (MGI:1921846)
4,84669546,84966689,4q21,4q21.23,617485,"WDFY3, ALFY, BCHS, MCPH18",WD repeat- and FYVE domain-containing protein 3,WDFY3,23001,ENSG00000163625,mutation identified in 1 MCPH18 family,"?Microcephaly 18, primary, autosomal dominant, 617520 (3), Autosomal dominant",Wdfy3 (MGI:1096875)
4,85475149,86002665,4q21,4q21.2-q21.3,610586,"ARHGAP24, RCGAP72, FILGAP",RHO GTPase-activating protein 24,ARHGAP24,83478,ENSG00000138639,NA,NA,Arhgap24 (MGI:1922647)
4,86010404,86594624,4q21.3,4q21.3,602897,"MAPK10, PRKM10, JNK3",Mitogen-activated protein kinase 10,MAPK10,5602,ENSG00000109339,NA,NA,Mapk10 (MGI:1346863)
4,86594306,86815175,4q21.3,4q21.3,600267,PTPN13,"Protein tyrosine phosphatase, nonreceptor-type, 13 (APO-1/CD95 (Fas)-associated phosphatase)",PTPN13,5783,ENSG00000163629,633bp upstream of JNK3,NA,Ptpn13 (MGI:103293)
4,86823467,86849383,4q21.3,4q21.3,613366,"SLC10A6, SOAT","Solute carrier family 10 (sodium/bile acid cotransporter family), member 6",SLC10A6,345274,ENSG00000145283,NA,NA,Slc10a6 (MGI:1923000)
4,86934605,87141053,4q21,4q21.3-q22.1,159557,"AFF1, MLLT2, AF4","AF4/FMR2 family, member 1",AFF1,4299,ENSG00000172493,fuses with ALL1,NA,Aff1 (MGI:1100819)
4,87100000,92800000,4q22.1,NA,613518,ATOD8,"Dermatitis, atopic, 8",NA,105463125,NA,NA,"{Dermatitis, atopic, susceptibility to, 8}, 613518 (2)",NA
4,87100000,97900000,4q22,NA,612343,MUSQTL1,Musical aptitude quantitative trait locus 1,NA,100192307,NA,near D4S423 and D4S2460,"[Musical aptitude QTL 1], 612343 (2)",NA
4,87100000,122800000,4q22-q27,NA,609994,MYP11,Myopia 11,MYP11,594832,NA,max lod at D4S1564,"Myopia 11, 609994 (2)",NA
4,87160102,87220617,4q22.1,4q22.1,611967,"KLHL8, KIAA1378",Kelch-like 8,KLHL8,57563,ENSG00000145332,NA,NA,Klhl8 (MGI:2179430)
4,87303793,87322881,4q22.1,4q22.1,612127,"HSD17B13, SCDR9",17-beta-hydroxysteroid dehydrogenase XIII,HSD17B13,345275,ENSG00000170509,NA,NA,Hsd17b13 (MGI:2140804)
4,87336514,87391251,4q21,4q22.1,612831,"HSD17B11, RETSDR2, PAN1B",17-beta-hydroxysteroid dehydrogenase XI,HSD17B11,51170,ENSG00000198189,NA,NA,Hsd17b11 (MGI:2149821)
4,87608528,87616872,4q21.3,4q22.1,125485,"DSPP, DPP, DGI1, DFNA39, DTDP2",Dentin sialophosphoprotein,DSPP,1834,ENSG00000152591,NA,"Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3), Autosomal dominant; Dentin dysplasia, type II, 125420 (3), Autosomal dominant; Dentinogenesis imperfecta, Shields type II, 125490 (3), Autosomal dominant; Dentinogenesis imperfecta, Shields type III, 125500 (3), Autosomal dominant",NA
4,87650279,87664356,4q21,4q22.1,600980,"DMP1, ARHR, ARHP",Dentin matrix acidic phosphoprotein,DMP1,1758,ENSG00000152592,NA,"Hypophosphatemic rickets, AR, 241520 (3), Autosomal recessive",Dmp1 (MGI:94910)
4,87799553,87812434,4q21-q25,4q22.1,147563,IBSP,Integrin-binding sialoprotein (bone sialoprotein II),IBSP,3381,ENSG00000029559,NA,NA,Ibsp (MGI:96389)
4,87821397,87846816,4q21.1,4q22.1,605912,MEPE,"Matrix, extracellular, phosphoglycoprotein",MEPE,56955,ENSG00000152595,NA,NA,Mepe (MGI:2137384)
4,87975649,87983410,4q21-q25,4q22.1,166490,"SPP1, OPN","Secreted phosphoprotein-1 (osteopontin, bone sialoprotein)",SPP1,6696,ENSG00000118785,NA,NA,Spp1 (MGI:98389)
4,88007634,88077778,4q21-q23,4q22.1,173910,PKD2,Polycystin-2,PKD2,5311,ENSG00000118762,NA,"Polycystic kidney disease 2, 613095 (3), Autosomal dominant",Pkd2 (MGI:1099818)
4,88090263,88231625,4q22,4q22.1,603756,"ABCG2, BCRP, ABCP, UAQTL1, GOUT1","ATP-binding cassette, subfamily G, member 2",ABCG2,9429,ENSG00000118777,NA,"[Junior blood group system], 614490 (3); [Uric acid concentration, serum, QTL1], 138900 (3), ?Autosomal dominant",Abcg2 (MGI:1347061)
4,88257616,88284669,4q22.1,4q22.1,611065,"PPM1K, PP2CM, PTMP, MSUDMV","Protein phosphatase, PP2C domain-containing, 1K",PPM1K,152926,ENSG00000163644,mutation identified in 1 MSUDMV family,"?Maple syrup urine disease, mild variant, 615135 (3)",Ppm1k (MGI:2442111)
4,88456603,88506169,4q22.2-q22.3,4q22.1,608242,"HERC5, CEB1",HECT domain and RCC1-like domain 5,HERC5,51191,ENSG00000138646,NA,NA,NA
4,88520977,88523800,4q22.1,4q22.1,610662,"PIGY, HPMRS6","Phosphatidylinositol glycan, class Y",PIGY,84992,ENSG00000255072,NA,"Hyperphosphatasia with mental retardation syndrome 6, 616809 (3), Autosomal recessive",Pigyl (MGI:1913518)
4,88592422,88709302,4q22.1,4q22.1,605200,HERC3,HECT domain and RCC1-like domain 3,HERC3,8916,ENSG00000138641,NA,NA,Herc3 (MGI:1921248)
4,88695912,88697828,4q21-q22,4q22.1,612203,"NAP1L5, DRLM",Nucleosome assembly protein 1-like 5,NAP1L5,266812,ENSG00000177432,NA,NA,Nap1l5 (MGI:1923555)
4,88709788,88730102,4q22.1,4q22.1,613300,"FAM13AOS, FAM13A1OS",FAM13A opposite strand,FAM13A-AS1,285512,ENSG00000248019,overlaps with FAM13A,NA,NA
4,88725953,89111397,4q22.1,4q22.1,613299,"FAM13A, FAM13A1, KIAA0914","Family with sequence similarity 13, member A",FAM13A,10144,ENSG00000138640,overlaps with FAM13AOS,NA,NA
4,89112816,89114900,4q22.1,4q22.1,612973,TIGD2,TIGGER transposable element-derived gene 2,TIGD2,166815,ENSG00000180346,NA,NA,Tigd2 (MGI:1915390)
4,89236382,89307799,4q22.1,4q22.1,611241,"GPRIN3, GRIN3",G protein-regulated inducer of neurite outgrowth 3,GPRIN3,285513,ENSG00000185477,NA,NA,Gprin3 (MGI:1924785)
4,89724098,89838323,4q21,4q22.1,163890,"SNCA, NACP, PARK1, PARK4","Synuclein, alpha (non A4 component of amyloid precursor)",SNCA,6622,ENSG00000145335,NA,"Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant",Snca (MGI:1277151)
4,89879538,89954628,4q22.1,4q22.1,601456,"MMRN1, ECM",Multimerin 1,MMRN1,22915,ENSG00000138722,NA,NA,Mmrn1 (MGI:1918195)
4,92303621,93810414,4q22,4q22.1-q22.2,602368,"GRID2, SCAR18","Glutamate receptor, ionotropic, delta-2",GRID2,2895,ENSG00000152208,NA,"Spinocerebellar ataxia, autosomal recessive 18, 616204 (3), Autosomal recessive",Grid2 (MGI:95813)
4,93828752,93830963,4q22,4q22.2,601461,"ATOH1, ATH1","Atonal, Drosophila, homolog of, 1",ATOH1,474,ENSG00000172238,NA,NA,Atoh1 (MGI:104654)
4,94207607,94291291,4q22-q23,4q22.3,612761,"SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ","SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1",SMARCAD1,56916,ENSG00000163104,NA,"Adermatoglyphia, 136000 (3), Autosomal dominant; Basan syndrome, 129200 (3), Autosomal dominant; Huriez syndrome, 181600 (3), Autosomal dominant",Smarcad1 (MGI:95453)
4,94298534,94342875,4q21-q22,4q22.3,602598,"HPGDS, PGDS","Prostaglandin D2 synthase, hematopoietic",HPGDS,27306,ENSG00000163106,NA,NA,Hpgds (MGI:1859384)
4,94451856,94668226,4q22,4q22.3,605904,ENH,Enigma-like LIM domain protein,PDLIM5,10611,ENSG00000163110,NA,NA,Pdlim5 (MGI:1927489)
4,94757954,95158452,4q23-q24,4q22.3,603248,"BMPR1B, ALK6, AMDD, BDA2, BDA1D","Bone morphogenetic protein receptor, type IB",BMPR1B,658,ENSG00000138696,NA,"Acromesomelic dysplasia, Demirhan type, 609441 (3), Autosomal recessive; Brachydactyly, type A1, D, 616849 (3), Autosomal dominant; Brachydactyly, type A2, 112600 (3), Autosomal dominant",Bmpr1b (MGI:107191)
4,95162503,95549209,4q21-q23,4q22.3,603610,"UNC5C, UNC5H3","UNC5, C. elegans, homolog of, C",UNC5C,8633,ENSG00000182168,NA,NA,Unc5c (MGI:1095412)
4,95840092,95841463,4q22-q23,4q22.3,179061,PDHA2,"Pyruvate dehydrogenase, E1-alpha polypeptide, testis specific form",PDHA2,5161,ENSG00000163114,NA,NA,NA
4,98261380,98443857,4q21-q25,4q23,179502,RAP1GDS1,"RAP1, GTP-GDP dissociation stimulator 1",RAP1GDS1,5910,ENSG00000138698,fusion partner with NUP98 in ALL,"Lymphocytic leukemia, acute T-cell (3)",Rap1gds1 (MGI:2385189)
4,98470366,98658660,4q23,4q23,613136,"TSPAN5, NET4",Tetraspanin 5,TSPAN5,10098,ENSG00000168785,NA,NA,Tspan5 (MGI:1928096)
4,98871683,98930636,4q21-q25,4q23,133440,"EIF4E, EIF4EL1, AUTS19",Eukaryotic translation initiation factor 4E,EIF4E,1977,ENSG00000151247,pseudogene on 20,"{Autism, susceptibility to, 19}, 615091 (3)",Eif4e (MGI:95305)
4,98995692,99063108,4q23,4q23,610151,"METAP1, KIAA0094",Methionyl aminopeptidase 1,METAP1,23173,ENSG00000164024,NA,NA,Metap1 (MGI:1922874)
4,99070977,99088787,4q21-q25,4q23,103710,"ADH5, FDH","Alcohol dehydrogenase (class III), chi polypeptide",ADH5,128,ENSG00000197894,NA,NA,Adh5 (MGI:87929)
4,99123656,99144297,4q22,4q23,103740,ADH4,"Alcohol dehydrogenase (class II), pi polypeptide",ADH4,127,ENSG00000198099,NA,NA,Adh4 (MGI:1349472)
4,99202637,99219245,4q23-q24,4q23,103735,ADH6,Alcohol dehydrogenase 6 (aldehyde reductase),ADH6,130,ENSG00000172955,NA,NA,NA
4,99276368,99290984,4q22,4q23,103700,"ADH1A, ADH1","Alcohol dehydrogenase IA (class I), alpha polypeptide",ADH1A,124,ENSG00000187758,NA,NA,NA
4,99304970,99321400,4q22,4q23,103720,"ADH1B, ADH2","Alcohol dehydrogenase IB (class I), beta polypeptide",ADH1B,125,ENSG00000196616,NA,"{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}, 103780 (3), Multifactorial; {Alcohol dependence, protection against}, 103780 (3), Multifactorial",NA
4,99336491,99353044,4q22,4q23,103730,"ADH1C, ADH3","Alcohol dehydrogenase IC (class I), gamma polypeptide",ADH1C,126,ENSG00000248144,NA,"{Alcohol dependence, protection against}, 103780 (3), Multifactorial; {Parkinson disease, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial",Adh1 (MGI:87921)
4,99412260,99435509,4q23-q24,4q23,600086,ADH7,Alcohol dehydrogenase-7,ADH7,131,ENSG00000196344,NA,NA,Adh7 (MGI:87926)
4,99546708,99564038,4q23,4q23,616013,"TRMT10A, RG9MTD2, MSSGM1","tRNA methyltransferase 10, S. cerevisiae, homolog of, A",TRMT10A,93587,ENSG00000145331,NA,"Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3), Autosomal recessive",Trmt10a (MGI:1920421)
4,99564077,99623996,4q22-q24,4q23,157147,MTTP,"Microsomal triglyceride transfer protein, 88kD",MTTP,4547,ENSG00000138823,NA,"Abetalipoproteinemia, 200100 (3), Autosomal recessive; {Metabolic syndrome, protection against}, 605552 (3), Autosomal dominant",Mttp (MGI:106926)
4,99636528,99657805,4q23,4q23,617881,"C4orf54, LOC285556, FOPV",Chromosome 4 open reading frame 54,C4orf54,285556,ENSG00000248713,NA,NA,1110002E22Rik (MGI:1915066)
4,99816826,99872289,4q25-q27,4q23,605768,"DAPP1, BAM32",Dual adaptor of phosphotyrosine and 3-phosphoinositides 1,DAPP1,27071,ENSG00000070190,NA,NA,Dapp1 (MGI:1347063)
4,99878335,99894545,4q23,4q23,603296,"LAMTOR3, MP1, MAPBP","Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 3",LAMTOR3,8649,ENSG00000109270,NA,NA,Lamtor3 (MGI:1929467)
4,99896247,99946712,4q23,4q23,617487,DNAJB14,"DNAJ/HSP40 homolog, subfamily B, member 14",DNAJB14,79982,ENSG00000164031,NA,NA,Dnajb14 (MGI:1917854)
4,99948087,99950274,4q24,4q23,142763,H2AZ,H2AZ histone,H2AFZ,3015,ENSG00000164032,NA,NA,H2afz (MGI:1888388)
4,100100000,138500000,4q24-q28,NA,613340,HWE2,"Epilepsy, hot water, 2",NA,100415904,NA,between D4S1572 and D4S2277,"Epilepsy, hot water, 2, 613340 (2)",NA
4,100100000,106700000,4q24,NA,157300,"MGR1, MA","Migraine with or without aura, susceptibility to, 1",NA,192115,NA,NA,"{Migraine with or without aura, susceptibility to, 1}, 157300 (2), Autosomal dominant",NA
4,100100000,106700000,4q24,NA,615312,OCA5,"Albinism, oculocutaneous, type V",OCA5,101926885,NA,max lod at D4S961,"Albinism, oculocutaneous, type V, 615312 (2), Autosomal recessive",NA
4,100185869,100190467,4q24-q25,4q24,607730,"DDIT4L, REDD2",DNA damage-inducible transcript 4-like,DDIT4L,115265,ENSG00000145358,NA,NA,Ddit4l (MGI:1920534)
4,101023417,101348294,4q24-q25,4q24,114105,"PPP3CA, PPP2B, CALNA, CNA1, IECEE1, ACCIID","Protein phosphatase 3, catalytic subunit, alpha isoform (calcineurin A alpha)",PPP3CA,5530,ENSG00000138814,NA,"Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, 618265 (3), Autosomal dominant; Epileptic encephalopathy, infantile or early childhood, 1, 617711 (3), Autosomal dominant",Ppp3ca (MGI:107164)
4,101790481,102074811,4q22-q24,4q24,610292,"BANK1, FLJ20706, BANK",B-cell scaffold protein with ankyrin repeats 1,BANK1,55024,ENSG00000153064,NA,NA,Bank1 (MGI:2442120)
4,102251040,102345481,4q22-q24,4q24,608732,"SLC39A8, BIGM103, CDG2N","Solute carrier family 39 (zinc transporter), member 8",SLC39A8,64116,ENSG00000138821,NA,"Congenital disorder of glycosylation, type IIn, 616721 (3), Autosomal recessive",Slc39a8 (MGI:1914797)
4,102501265,102617301,4q23-q24,4q24,164011,"NFKB1, CVID12",Nuclear factor of kappa light chain gene enhancer in B-cells 1 (p105),NFKB1,4790,ENSG00000109320,NA,"Immunodeficiency, common variable, 12, 616576 (3), Autosomal dominant",Nfkb1 (MGI:97312)
4,102630769,102760967,4q22-q25,4q24,609489,"MANBA, MANB1","Mannosidase, beta A, lysosomal",MANBA,4126,ENSG00000109323,linked in mouse to Adl-3,"Mannosidosis, beta, 248510 (3), Autosomal recessive",Manba (MGI:88175)
4,102794382,102868892,4q24,4q24,602963,"UBE2D3, UBCH5C",Ubiquitin-conjugating enzyme E2D 3,UBE2D3,7323,ENSG00000109332,NA,NA,Ube2d3 (MGI:1913355)
4,102868991,102892806,4q22-q24,4q24,611507,"CISD2, WFS2, ZCD2, ERIS",CDGSH iron sulfur domain protein 2,CISD2,493856,ENSG00000145354,NA,"Wolfram syndrome 2, 604928 (3), Autosomal recessive",Cisd2 (MGI:1914256)
4,102885047,103019738,4q24,4q24,611527,NHEDC1,Na+/H+ exchanger domain-containing protein 1,SLC9B1,150159,ENSG00000164037,NA,NA,Slc9b1 (MGI:1921696)
4,103018028,103077318,4q24,4q24,611789,"NHEDC2, NHA2",NA+/H+ exchanger domain-containing protein 2,SLC9B2,133308,ENSG00000164038,NA,NA,Slc9b2 (MGI:2140077)
4,103105805,103198408,4q24-q25,4q24,117143,"CENPE, MCPH13","Centromere autoantigen E, 312kD",CENPE,1062,ENSG00000138778,mutation identified in 1 MCPH13 family,"?Microcephaly 13, primary, autosomal recessive, 616051 (3), Autosomal recessive",Cenpe (MGI:1098230)
4,103586030,103719984,4q25,4q24,162332,"TACR3, NK3R, HH11",Tachykinin receptor 3,TACR3,6870,ENSG00000169836,NA,"Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3), Autosomal recessive",Tacr3 (MGI:892968)
4,104468307,104494966,4q22-q24,4q24,611645,"CXXC4, IDAX",CXXC finger protein 4,CXXC4,80319,ENSG00000168772,NA,NA,Cxxc4 (MGI:2442112)
4,105145874,105279802,4q24,4q24,612839,"TET2, KIAA1546, MDS","TET oncogene family, member 2",TET2,54790,ENSG00000168769,NA,"Myelodysplastic syndrome, somatic, 614286 (3)",Tet2 (MGI:2443298)
4,105369076,105474069,4q25,4q24,609988,"PPA2, SCFI, SCFAI","Pyrophosphatase, inorganic, 2",PPA2,27068,ENSG00000138777,mutation identified in 1 SCFAI family,"?Sudden cardiac failure, alcohol-induced, 617223 (3), Autosomal recessive; Sudden cardiac failure, infantile, 617222 (3), Autosomal recessive",Ppa2 (MGI:1922026)
4,105682626,105708724,4q24,4q24,611355,"INTS12, INT12",Integrator complex subunit 12,INTS12,57117,ENSG00000138785,NA,NA,Ints12 (MGI:1919043)
4,105708777,105847725,4q24,4q24,615912,GSTCD,Glutathione S-transferase C-terminal domain-containing protein,GSTCD,79807,ENSG00000138780,NA,NA,Gstcd (MGI:1914803)
4,105895452,105971670,4q24,4q24,610306,"NPNT, POEM",Nephronectin,NPNT,255743,ENSG00000168743,NA,NA,Npnt (MGI:2148811)
4,106041598,106316703,4q24,4q24,616899,"TBCK, IHPRF3",TBC1 domain-containing kinase,TBCK,93627,ENSG00000145348,NA,"Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3), Autosomal recessive",Tbck (MGI:2445052)
4,106315609,106349455,4q24,4q24,603605,"AIMP1, SCYE1, EMAP2, EMAPII, HLD3",ARS-interacting multifunctional protein 1,AIMP1,9255,ENSG00000164022,NA,"Leukodystrophy, hypomyelinating, 3, 260600 (3), Autosomal recessive",Aimp1 (MGI:102774)
4,106700000,113200000,4q25,NA,611494,ATFB5,"Atrial fibrillation, familial, 5",NA,100188842,NA,association with rs2200733 and rs10033464,"{Atrial fibrillation, familial, 5}, 611494 (2)",NA
4,106700000,113200000,4q25,NA,152430,LGV1,"Longevity 1, QTL",NA,140802,NA,maximum lod at D4S1564,"[Longevity 1], 152430 (2)",NA
4,107613665,107720233,4q24,4q25,603262,"PAPSS1, ATPSK1",3'-phosphoadenosine 5'-phosphosulfate synthase 1 (ATP sulfurylase/APS kinase-1),PAPSS1,9061,ENSG00000138801,NA,NA,Papss1 (MGI:1330587)
4,107823644,107915046,4q25,4q25,611574,"SGMS2, SMS2, CDL",Sphingomyelin synthase 2,SGMS2,166929,ENSG00000164023,NA,"Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia, 126550 (3), Autosomal dominant",Sgms2 (MGI:1921692)
4,107931548,107953460,4q25,4q25,610670,"CYP2U1, SPG56","Cytochrome P450, family 2, subfamily U, polypeptide 1",CYP2U1,113612,ENSG00000155016,NA,"Spastic paraplegia 56, autosomal recessive, 615030 (3), Autosomal recessive",Cyp2u1 (MGI:1918769)
4,107989713,108035174,4q22-q26,4q25,601609,"HADHSC, SCHAD, HHF4","L-3-hydroxyacyl-CoA dehydrogenase, short chain",HADH,3033,ENSG00000138796,NA,"3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3), Autosomal recessive; Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3), Autosomal recessive",Hadh (MGI:96009)
4,108047544,108168955,4q23-q25,4q25,153245,LEF1,Lymphoid enhancer-binding factor-1,LEF1,51176,ENSG00000138795,NA,"Sebaceous tumors, somatic (3)",Lef1 (MGI:96770)
4,108620557,108630483,4q25,4q25,616862,RPL34,Ribosomal protein L34,RPL34,6164,ENSG00000109475,NA,NA,Rpl34-ps2 (MGI:3648994)
4,108742052,108763052,4q25,4q25,614682,AGXT2L1,Alanine-glyoxylate aminotransferase 2-like 1,ETNPPL,64850,ENSG00000164089,NA,NA,Etnppl (MGI:1919010)
4,108808724,109302736,4q25,4q25,610004,"COL25A1, CLAC, CFEOM5","Collagen, type XXV, alpha-1 polypeptide",COL25A1,84570,ENSG00000188517,NA,"Fibrosis of extraocular muscles, congenital, 5, 616219 (3), Autosomal recessive",Col25a1 (MGI:1924268)
4,109433714,109540895,4q25,4q25,607184,SEC24B,"Sec24-related gene family, member B",SEC24B,10427,ENSG00000138802,NA,NA,Sec24b (MGI:2139764)
4,109688627,109703472,4q25-q25,4q25,601532,"CASP6, MCH2","Caspase 6, apoptosis-related cysteine protease",CASP6,839,ENSG00000138794,NA,NA,Casp6 (MGI:1312921)
4,109709988,109730069,4q25,4q25,611652,"PLA2G12A, GXII, ROSSY","Phospholipase A2, Group XIIA",PLA2G12A,81579,ENSG00000123739,NA,NA,Pla2g12a (MGI:1913600)
4,109731220,109802224,4q25,4q25,217030,"CFI, FI, AHUS3, ARMD13",Complement factor I,CFI,3426,ENSG00000205403,40kb distal to EGF,"Complement factor I deficiency, 610984 (3), Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3), Autosomal dominant; {Macular degeneration, age-related, 13, susceptibility to}, 615439 (3), Autosomal dominant",Cfi (MGI:105937)
4,109815509,109824736,4q25,4q25,606468,"NOLA1, GAR1","Nucleolar protein family A, member 1",GAR1,54433,ENSG00000109534,NA,NA,NA
4,109827971,109849122,4q,4q25,605224,RRH,"Rhodopsin homolog, retinal pigment epithelium-derived (peropsin)",RRH,10692,ENSG00000180245,NA,NA,Rrh (MGI:1097709)
4,109848106,109872314,4q25,4q25,615004,"LRIT3, FIGLER4, CSNB1F","Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 3",LRIT3,345193,ENSG00000183423,NA,"Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3), Autosomal recessive",Lrit3 (MGI:2685267)
4,109912882,110013765,4q25,4q25,131530,"EGF, URG, HOMG4",Epidermal growth factor (urogastrone),EGF,1950,ENSG00000138798,linked to ADH3; cen-ADH3-EGF-IL2-qter,"Hypomagnesemia 4, renal, 611718 (3)",Egf (MGI:95290)
4,110045845,110199198,4q25,4q25,611546,"ELOVL6, LCE, FACE",Elongation of very long chain fatty acids-like 6,ELOVL6,79071,ENSG00000170522,NA,NA,Elovl6 (MGI:2156528)
4,110476154,110565284,4q25,4q25,138297,ENPEP,Glutamyl aminopeptidase (aminopeptidase A),ENPEP,2028,ENSG00000138792,NA,NA,Enpep (MGI:106645)
4,110595512,110615457,4q25,4q25,617286,PANCR,PITX2 adjacent noncoding RNA,PANCR,110231149,ENSG00000250103,NA,NA,NA
4,110617422,110642122,4q25-q26,4q25,601542,"PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4",Paired-like homeodomain transcription factor-2,PITX2,5308,ENSG00000164093,NA,"Anterior segment dysgenesis 4, 137600 (3), Autosomal dominant; Axenfeld-Rieger syndrome, type 1, 180500 (3), Autosomal dominant; Ring dermoid of cornea, 180550 (3), Autosomal dominant",Pitx2 (MGI:109340)
4,110860581,110860646,4q25,4q25,615520,MIR297,Micro RNA 297,MIR297,100126354,ENSG00000215961,NA,NA,NA
4,112231786,112273109,4q25,4q25,610851,"C4orf16, GBAR, 2C18",Gamma-1 adaptin brefeldin-A resistance protein,AP1AR,55435,ENSG00000138660,NA,NA,Ap1ar (MGI:2384822)
4,112274536,112285903,4q25,4q25,609028,"TIFA, T2BP",TRAF-interacting protein with forkhead-associated domain,TIFA,92610,ENSG00000145365,NA,NA,Tifa (MGI:2182965)
4,112297342,112442620,4q25,4q25,607347,"ALPK1, LAK, KIAA1527",Alpha-kinase 1,ALPK1,80216,ENSG00000073331,NA,NA,Alpk1 (MGI:1918731)
4,112513515,112516179,4q25,4q25,606624,"NEUROG2, NGN2, ATOH4",Neurogenin 2,NEUROG2,63973,ENSG00000178403,NA,NA,Neurog2 (MGI:109619)
4,112636963,112657591,4q25,4q25,612026,"LARP7, PIP7S, ALAZS","La ribonucleoprotein domain family, member 7",LARP7,51574,ENSG00000174720,NA,"Alazami syndrome, 615071 (3), Autosomal recessive",Larp7 (MGI:107634)
4,112647873,112647940,4q25,4q25,614600,MIR367,Micro RNA 367,MIR367,442912,ENSG00000199169,NA,NA,NA
4,112648003,112648070,4q25,4q25,614599,MIR302D,Micro RNA 302D,MIR302D,442896,ENSG00000199145,NA,NA,NA
4,112648182,112648250,4q25,4q25,614596,MIR302A,Micro RNA 302A,MIR302A,407028,ENSG00000207927,NA,NA,NA
4,112648362,112648429,4q25,4q25,614598,MIR302C,Micro RNA 302C,MIR302C,442895,ENSG00000199102,NA,NA,NA
4,112648484,112648556,4q25,4q25,614597,MIR302B,Micro RNA 302B,MIR302B,442894,ENSG00000284463,NA,NA,NA
4,112706017,113383739,4q25-q27,4q25-q26,106410,"ANK2, LQT4","Ankyrin-2, nonerythrocytic",ANK2,287,ENSG00000145362,NA,"Cardiac arrhythmia, ankyrin-B-related, 600919 (3), Autosomal dominant; Long QT syndrome 4, 600919 (3), Autosomal dominant",NA
4,113451031,113762176,4q26,4q26,607708,CAMK2D,Calcium/calmodulin-dependent protein kinase II-delta,CAMK2D,817,ENSG00000145349,NA,NA,Camk2d (MGI:1341265)
4,113899928,113980463,4q26,4q26,610010,ARSJ,Arylsulfatase J,ARSJ,79642,ENSG00000180801,NA,NA,Arsj (MGI:2443513)
4,114598401,114687913,4q26,4q26,601291,"UGT8, CGT",UDP glycosyltransferase 8 (cerebroside synthase),UGT8,7368,ENSG00000174607,NA,NA,Ugt8a (MGI:109522)
4,114824121,115114132,4q25-q26,4q26,615039,NDST4,N-deacetylase/N-sulfotransferase 4,NDST4,64579,ENSG00000138653,NA,NA,Ndst4 (MGI:1932545)
4,117083553,117085575,4q26,4q26,617505,TRAM1L1,Translocation-associated membrane protein 1-like 1,TRAM1L1,133022,ENSG00000174599,NA,NA,Tram1l1 (MGI:2443503)
4,118033607,118258944,4q26,4q26,603950,NDST3,N-deacetylase/N-sulfotransferase 3,NDST3,9348,ENSG00000164100,NA,NA,Ndst3 (MGI:1932544)
4,118280037,118353041,4q25-q26,4q26,606709,"PRSS12, BSSP3, MRT1","Protease, serine, 12",PRSS12,8492,ENSG00000164099,NA,"Mental retardation, autosomal recessive 1, 249500 (3), Autosomal recessive",Prss12 (MGI:1100881)
4,118685374,118715429,4q26,4q26,616504,"METTL14, KIAA1627",Methyltransferase-like 14,METTL14,57721,ENSG00000145388,NA,NA,Mettl14 (MGI:2442926)
4,118722822,118838682,4q26,4q26,607186,"SEC24D, KIAA0755, CLCRP2","Sec24-related gene family, member D",SEC24D,9871,ENSG00000150961,NA,"Cole-Carpenter syndrome 2, 616294 (3), Autosomal recessive",Sec24d (MGI:1916858)
4,119135783,119187788,4q26-q27,4q26,605602,"MYOZ2, CMH16",Myozenin 2,MYOZ2,51778,ENSG00000172399,NA,"Cardiomyopathy, hypertrophic, 16, 613838 (3), Autosomal dominant",Myoz2 (MGI:1913063)
4,119212582,119295517,4q26,4q26,617431,"USP53, KIAA1350",Ubiquitin-specific peptidase 53,USP53,54532,ENSG00000145390,NA,NA,Usp53 (MGI:2139607)
4,119317249,119322137,4q28-q31,4q26,134640,FABP2,"Fatty acid-binding protein, intestinal",FABP2,2169,ENSG00000145384,NA,NA,Fabp2 (MGI:95478)
4,119494394,119628803,4q26,4q26,603310,PDE5A,Phosphodiesterase 5A,PDE5A,8654,ENSG00000138735,NA,NA,Pde5a (MGI:2651499)
4,119900000,122800000,4q27,NA,611598,"CELIAC6, AIS5","Celiac disease, susceptibility to, 6",NA,100188846,NA,NA,"{Autoimmune disease, susceptibility to, 5}, 611598 (2); {Celiac disease, susceptibility to, 6}, 611598 (2)",NA
4,119900000,122800000,4q27,NA,612622,IDDM23,"Diabetes mellitus, insulin-dependent, 23",NA,100271697,NA,associated with rs6534347,"{Diabetes mellitus, insulin-dependent, 23}, 612622 (2)",NA
4,119900000,130100000,4q27-q28.2,NA,614333,MRT29,"Mental retardation, autosomal recessive 29",NA,100852393,NA,between rs10518325 and rs10518608,"Mental retardation, autosomal recessive 29, 614333 (2), Autosomal recessive",NA
4,120055622,120066847,4q27,4q27,601467,MAD2L1,"Mitotic arrest deficient, yeast, homolog-like 1",MAD2L1,4085,ENSG00000164109,previously mapped to 5q23-q31,NA,Mad2l1 (MGI:1860374)
4,120684905,120922865,4q27,4q27,614161,"PRDM5, BCS2",PR domain-containing protein 5,PRDM5,11107,ENSG00000138738,NA,"Brittle cornea syndrome 2, 614170 (3), Autosomal recessive",Prdm5 (MGI:1918029)
4,121029292,121072534,4q27,4q27,616506,"NDNF, C4orf31, NORD",Neuron-derived neurotrophic factor,NDNF,79625,ENSG00000173376,NA,NA,Ndnf (MGI:1915419)
4,121328641,121381053,4q27,4q27,606925,"QRFPR, GPR103",Pyroglutamylated RFamide peptide receptor,QRFPR,84109,ENSG00000186867,NA,NA,Qrfpr (MGI:2677633)
4,121667945,121696993,4q26-q28,4q27,131230,"ANXA5, ENX2, RPRGL3",Annexin A5 (endonexin II),ANXA5,308,ENSG00000164111,NA,"{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3), Autosomal dominant",Anxa5 (MGI:106008)
4,121801322,121817020,4q27,4q27,606180,"EXOSC9, PMSCL1, PCH1D",Exosome component 9,EXOSC9,5393,ENSG00000123737,NA,"Pontocerebellar hypoplasia, type 1D, 618065 (3), Autosomal recessive",Exosc9 (MGI:1355319)
4,121816443,121823882,4q27,4q27,123835,"CCNA, CCN1",Cyclin A,CCNA2,890,ENSG00000145386,NA,NA,Ccna2 (MGI:108069)
4,121824328,121870496,4q27,4q27,607590,BBS7,BBS7 gene,BBS7,55212,ENSG00000138686,NA,"Bardet-Biedl syndrome 7, 615984 (3), Autosomal recessive",Bbs7 (MGI:1918742)
4,121874480,121952059,4q27,4q27,602345,"TRPC3, TRP3, SCA41","Transient receptor potential cation channel, subfamily C, member 3",TRPC3,7222,ENSG00000138741,mutation identified in one SCA41 patient,"?Spinocerebellar ataxia 41, 616410 (3), Autosomal dominant",Trpc3 (MGI:109526)
4,122152332,122362758,4q27,4q27,611565,"KIAA1109, ALKKUCS",KIAA1109 gene,KIAA1109,84162,ENSG00000138688,NA,"Alkuraya-Kucinskas syndrome, 617822 (3), Autosomal recessive",4932438A13Rik (MGI:2444631)
4,122378970,122429814,4q27,4q27,614130,"ADAD1, TENR","Adenosine deaminase domain-containing protein 1, testis-specific",ADAD1,132612,ENSG00000164113,NA,NA,Adad1 (MGI:103258)
4,122449478,122456494,4q26-q27,4q27,147680,IL2,Interleukin-2,IL2,3558,ENSG00000109471,NA,NA,Il2 (MGI:96548)
4,122610107,122621065,4q26-q27,4q27,605384,"IL21, CVID11",Interleukin 21,IL21,59067,ENSG00000138684,mutation identified in 1 CVID11 patient,"?Immunodeficiency, common variable, 11, 615767 (3), Autosomal recessive",Il21 (MGI:1890474)
4,122700436,122744942,4q27,4q27,610683,"BBS12, FLJ35630, C4orf24",BBS12 gene,BBS12,166379,ENSG00000181004,1Mb centromeric to BBS,"Bardet-Biedl syndrome 12, 615989 (3), Autosomal recessive",Bbs12 (MGI:2686651)
4,122800000,154600000,4q28-q31,NA,111800,SF,Stoltzfus blood group,NA,6420,NA,~25cM from MNSs,"[Blood group, Stoltzfus system], 111800 (2)",NA
4,122826707,122898235,4q25-q27,4q28.1,134920,"FGF2, FGFB",Fibroblast growth factor-2 (basic),FGF2,2247,ENSG00000138685,many alternate names,NA,Fgf2 (MGI:95516)
4,122892576,122922967,4q28.1,4q28.1,606261,"NUDT6, ASFGF2",Nudix hydrolase 6,NUDT6,11162,ENSG00000170917,NA,NA,Nudt6 (MGI:2387618)
4,122923069,123319432,4q28.1,4q28.1,613940,"SPATA5, SPAF, EHLMRS",Spermatogenesis-associated protein 5,SPATA5,166378,ENSG00000145375,NA,"Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3), Autosomal recessive",Spata5 (MGI:1927170)
4,123396790,123403759,4q28.1,4q28.1,602465,SPRY1,"Sprouty, Drosophila, homolog of",SPRY1,10252,ENSG00000164056,NA,NA,Spry1 (MGI:1345139)
4,125314912,125492931,4q28.1,4q28.1,612411,"FAT4, VMLDS2, HKLLS2","FAT tumor suppressor, Drosophila, homolog of, 4",FAT4,79633,ENSG00000196159,NA,"Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3), Autosomal recessive; Van Maldergem syndrome 2, 615546 (3), Autosomal recessive",Fat4 (MGI:3045256)
4,127623270,127726736,4q28,4q28.1,610621,"INTU, KIAA1284, PDZK6, SRTD20, OFD17","Inturned, Drosophila, homolog of",INTU,27152,ENSG00000164066,mutation identified in 1 SRTD20 patient and 1 OFD17 patient,"?Orofaciodigital syndrome XVII, 617926 (3), Autosomal recessive; ?Short-rib thoracic dysplasia 20 with polydactyly, 617925 (3), Autosomal recessive",Intu (MGI:2443752)
4,127730371,127774298,4q28.1,4q28.1,610796,"SLC25A31, ANT4, AAC4","Solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 31",SLC25A31,83447,ENSG00000151475,NA,NA,Slc25a31 (MGI:1920583)
4,127880892,127899223,4q27-q28,4q28.1,605031,"PLK4, STK18, SAK, MCCRP2",Polo-like kinase 4 (serine/threonine protein kinase-18),PLK4,10733,ENSG00000142731,NA,"Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3), Autosomal recessive",Plk4 (MGI:101783)
4,127917731,127966031,4q28.1-q28.2,4q28.2,611124,"MFSD8, MGC33302, CLN7, CCMD",Major facilitator superfamily domain-containing protein 8,MFSD8,256471,ENSG00000164073,NA,"Ceroid lipofuscinosis, neuronal, 7, 610951 (3), Autosomal recessive; Macular dystrophy with central cone involvement, 616170 (3), Autosomal recessive",Mfsd8 (MGI:1919425)
4,128269241,128288204,4q26,4q28.2,607735,PGRMC2,Progesterone receptor membrane component 2,PGRMC2,10424,ENSG00000164040,NA,NA,Pgrmc2 (MGI:1918054)
4,128809686,128875223,4q28.2,4q28.2,610514,"PHF17, JADE1",PHD finger protein 17,JADE1,79960,ENSG00000077684,NA,NA,Jade1 (MGI:1925835)
4,128874389,129093579,4q28.2,4q28.2,611399,"SCLT1, CAP1A",Sodium channel and clathrin linker 1,SCLT1,132320,ENSG00000151466,NA,NA,Sclt1 (MGI:1914411)
4,133149293,133208605,4q28.3,4q28.3,608286,"PCDH10, KIAA1400",Protocadherin 10,PCDH10,57575,ENSG00000138650,NA,NA,Pcdh10 (MGI:1338042)
4,137518917,137532529,4q31,4q28.3,608287,"PCDH18, KIAA1562",Protocadherin 18,PCDH18,54510,ENSG00000189184,NA,NA,Pcdh18 (MGI:1920423)
4,138164096,138242348,4q28.3,4q28.3,607933,"SLC7A11, XCT","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 11",SLC7A11,23657,ENSG00000151012,NA,NA,Slc7a11 (MGI:1347355)
4,138500000,154600000,4q31,NA,609782,AAA2,"Aortic aneurysm, familial abdominal 2",NA,100505390,NA,max lod at D4S1644,"Aortic aneurysm, familial abdominal 2, 609782 (2)",NA
4,138500000,182300000,4q31-q34,NA,609985,PAND3,Panic disorder 3,NA,677663,NA,max lod at D4S413,"Panic disorder 3, 609985 (2)",NA
4,138500000,182300000,4q31-q34,NA,607857,PSORS9,Psoriasis susceptibility 9,PSORS9,359825,NA,max lod at D4S1597,"{Psoriasis susceptibility 9}, 607857 (2)",NA
4,138500000,154600000,4q31,NA,612224,STQTL12,Stature quantitative trait locus 12,NA,100301523,NA,associated with rs6854783,"{Stature QTL 12}, 612224 (2)",NA
4,139015780,139045938,4q31.1,4q31.1,608468,"CCRN4L, CCR4L, CCR4",Carbon catabolite repression 4-like,NOCT,25819,ENSG00000151014,NA,NA,Noct (MGI:109382)
4,139289916,139302550,4q28.2-q31.1,4q31.1,603844,NDUFC1,NADH-ubiquinone oxidoreductase subunit C1,NDUFC1,4717,ENSG00000109390,NA,NA,Ndufc1 (MGI:1913627)
4,139301498,139391383,4q31.1,4q31.1,608000,"NAA15, NARG1, NATH, MRD50","N-alpha-acetyltransferase 15, NatA auxiliary subunit",NAA15,80155,ENSG00000164134,NA,"Mental retardation, autosomal dominant 50, 617787 (3), Autosomal dominant",Naa15 (MGI:1922088)
4,139453231,139476608,4q31.1,4q31.1,605950,"RAB33B, SMC2",Ras-associated protein RAB33B,RAB33B,83452,ENSG00000172007,NA,"Smith-McCort dysplasia 2, 615222 (3), Autosomal recessive",Rab33b (MGI:1330805)
4,139495933,139556768,4q31.1,4q31.1,606594,"SETD7, SET7, KIAA1717",SET domain-containing protein 7,SETD7,80854,ENSG00000145391,NA,NA,Setd7 (MGI:1920501)
4,139665724,139754607,4q28-q31,4q31.1,601733,"MGST2, GST2",Microsomal glutathione S-transferase 2,MGST2,4258,ENSG00000085871,NA,NA,Mgst2 (MGI:2448481)
4,139716752,140154183,4q28.3,4q31.1,608991,"MAML3, MAM2, KIAA1816",Mastermind-like 3,MAML3,55534,ENSG00000196782,NA,NA,Maml3 (MGI:2389461)
4,140388452,140427660,4q31.1,4q31.1,601858,CLGN,Calmegin,CLGN,1047,ENSG00000153132,NA,NA,Clgn (MGI:107472)
4,140442256,140499045,4q31.1,4q31.1,610310,LOC152586,LOC152586 gene,MGAT4D,152586,ENSG00000205301,NA,NA,Mgat4d (MGI:1914805)
4,140524145,140553769,4q31.1,4q31.1,610196,ELMOD2,ELMO domain-containing protein 2,ELMOD2,255520,ENSG00000179387,NA,NA,Elmod2 (MGI:2445165)
4,140555769,140568960,4q31,4q31.1,113730,UCP1,"Uncoupling protein 1 (mitochondrial, proton carrier)",UCP1,7350,ENSG00000109424,NA,NA,Ucp1 (MGI:98894)
4,140620781,140756384,4q31.21,4q31.21,618035,"TBC1D9, KIAA0882",TBC1 domain family member 9,TBC1D9,23158,ENSG00000109436,NA,NA,Tbc1d9 (MGI:1918560)
4,141220293,141234696,4q31.1-q31.2,4q31.21,609550,"ZNF330, NOA36",Zinc finger protein 330,ZNF330,27309,ENSG00000109445,NA,NA,Zfp330 (MGI:1353574)
4,141636582,141733986,4q31,4q31.21,600554,IL15,Interleukin-15,IL15,3600,ENSG00000164136,NA,NA,Il15 (MGI:103014)
4,143184916,143224428,4q31.21,4q31.21,618322,USP38,Ubiquitin-specific protease 38,USP38,84640,ENSG00000170185,NA,NA,Usp38 (MGI:1922091)
4,143336875,143474564,4q13.1,4q31.21,604439,"GAB1, DFNB26",Grb2-associated binding protein 1,GAB1,2549,ENSG00000109458,mutation identified in 1 family,"?Deafness, autosomal recessive 26, 605428 (3), Autosomal recessive",Gab1 (MGI:108088)
4,143513500,143557485,4q31.1-q31.2,4q31.21,603375,"SMARCA5, SNF2H","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 5",SMARCA5,8467,ENSG00000153147,NA,NA,Smarca5 (MGI:1935129)
4,143577301,143700674,4q31.2,4q31.21,608946,FREM3,FRAS1-related extracellular matrix protein 3,FREM3,166752,ENSG00000183090,NA,NA,Frem3 (MGI:2685641)
4,143870863,143912130,4q28-q31,4q31.21,138590,"GYPE, GPE",Glycophorin E,GYPE,2996,ENSG00000197465,tandem: 5'-GYPA-GYPB-GYPE-3'; ?4q31.1,NA,NA
4,143995171,144021860,4q28-q31,4q31.21,617923,"GYPB, SS",Glycophorin B,GYPB,2994,ENSG00000250361,NA,"[Blood group, Ss], 111740 (3); {Malaria, resistance to}, 611162 (3)",NA
4,144109302,144140853,4q28.2-q31.1,4q31.21,617922,"GYPA, MN, GPA",Glycophorin A,GYPA,2993,ENSG00000170180,NA,"[Blood group, MNSs system], 111300 (3); {Malaria, resistance to}, 611162 (3)",NA
4,144646153,144745270,4q28-q32,4q31.21,606178,"HHIP, HIP",Hedgehog-interacting protein,HHIP,64399,ENSG00000164161,NA,NA,Hhip (MGI:1341847)
4,144967116,145098540,4q31.21,4q31.21,613745,"ANAPC10, DOC1, APC10","Anaphase-promoting complex, subunit 10",ANAPC10,10393,ENSG00000164162,NA,NA,Anapc10 (MGI:1916249)
4,145098310,145129523,4q31,4q31.21,601213,"ABCE1, RNASELI, RNS4I","ATP-binding cassette, subfamily E, member 1 (ribonuclease L inhibitor)",ABCE1,6059,ENSG00000164163,NA,NA,Abce1 (MGI:1195458)
4,145133649,145180588,4q31.2,4q31.21,611744,"OTUD4, KIAA1046, HIN1",OTD domain-containing protein 4,OTUD4,54726,ENSG00000164164,NA,NA,Otud4 (MGI:1098801)
4,145481305,145559175,4q28,4q31.21,601595,"SMAD1, MADH1, MADR1, BSP1","Mothers against decapentaplegic, Drosophila, homolog of, 1",SMAD1,4086,ENSG00000170365,NA,NA,Smad1 (MGI:109452)
4,145619384,145660032,4q31.1-q31.2,4q31.21,607481,MMAA,MMAA gene,MMAA,166785,ENSG00000151611,NA,"Methylmalonic aciduria, vitamin B12-responsive, 251100 (3), Autosomal recessive",Mmaa (MGI:1923805)
4,145757626,145938822,4q31.21-q31.22,4q31.21-q31.22,617962,ZNF827,Zinc finger protein 827,ZNF827,152485,ENSG00000151612,NA,NA,Zfp827 (MGI:2444807)
4,146175702,146204435,4q31.2,4q31.22,607286,LSM6,LSM6 protein,LSM6,11157,ENSG00000164167,NA,NA,Lsm6 (MGI:1925901)
4,146253980,146522350,4q31.2,4q31.22,611459,"SLC10A7, SSASKS","Solute carrier family 10 (sodium/bile acid cotransporter family), member 7",SLC10A7,84068,ENSG00000120519,NA,"Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis, 618363 (3), Autosomal recessive",Slc10a7 (MGI:1924025)
4,146638892,146642473,4q31.2,4q31.22,113725,BRN3B,Brn3b POU domain transcription factor,POU4F2,5458,ENSG00000151615,NA,NA,Pou4f2 (MGI:102524)
4,147480916,147544953,4q31.2,4q31.22-q31.23,131243,"EDNRA, MFDA",Endothelin receptor type A,EDNRA,1909,ENSG00000151617,NA,"Mandibulofacial dysostosis with alopecia, 616367 (3), Autosomal dominant; {Migraine, resistance to}, 157300 (3), Autosomal dominant",Ednra (MGI:105923)
4,147617370,147637272,4q31.21,4q31.23,613937,"TMEM184C, TMEM34",Transmembrane protein 184C,TMEM184C,55751,ENSG00000164168,NA,NA,Tmem184c (MGI:2384562)
4,147635649,147684229,4q31.23,4q31.23,616125,"PRMT9, PRMT10",Protein arginine methyltransferase 9,PRMT9,90826,ENSG00000164169,NA,NA,Prmt9 (MGI:2142651)
4,147732062,148072780,4q31.2,4q31.23,609746,"ARHGAP10, GRAF2, PSGAP",RHO GTPase-activating protein 10,ARHGAP10,79658,ENSG00000071205,NA,NA,Arhgap10 (MGI:1925764)
4,148078763,148444697,4q31.1,4q31.23,600983,"NR3C2, MLR, MCR","Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)",NR3C2,4306,ENSG00000151623,NA,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3); Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3), Autosomal dominant",Nr3c2 (MGI:99459)
4,150078273,150257456,4q31.23,4q31.2-q31.3,613166,"DCLK2, DCK2, CLIK2, CL2",Doublecortin-like kinase 2,DCLK2,166614,ENSG00000170390,NA,NA,Dclk2 (MGI:1918012)
4,150200000,169200000,4q31.3-q32.3,NA,611644,HSCR9,"Hirschsprung disease, susceptibility to, 9",NA,100188850,NA,between D4S3049 and D4S1566,"{Hirschsprung disease, susceptibility to, 9}, 611644 (2)",NA
4,150264434,151015726,4q31.3,4q31.3,606453,"LRBA, LBA, CDC4L, CVID8","Lipopolysaccharide-responsive, beige-like anchor protein",LRBA,987,ENSG00000198589,NA,"Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3), Autosomal recessive",Lrba (MGI:1933162)
4,150582150,150584692,4q31.3,4q31.3,604357,"MAB21L2, MCSKS14","MAB21, C. elegans, homolog-like 2",MAB21L2,10586,ENSG00000181541,NA,"Microphthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3), Autosomal recessive, Autosomal dominant",Mab21l2 (MGI:1346022)
4,151099572,151104641,4q31.2-q31.3,4q31.3,180478,RPS3A,Ribosomal protein S3a,RPS3A,6189,ENSG00000145425,NA,NA,NA
4,151103826,151103890,4q31.3,4q31.3,603568,"SNORD73A, RNU73","Small nucleolar RNA, C/D box 73A",SNORD73A,8944,ENSG00000208797,NA,NA,NA
4,151120280,151325664,4q31.3,4q31.3,608674,"SH3D19, EBP",SH3 domain protein 19,SH3D19,152503,ENSG00000109686,fused with AML1 in t(4;21),NA,Sh3d19 (MGI:1350923)
4,151670503,151761022,4q31.328,4q31.3,603645,"GATB, PET112","Glutamyl-tRNA amidotransferase, subunit B",GATB,5188,ENSG00000059691,NA,NA,Gatb (MGI:2442496)
4,152320543,152536872,4q31.3,4q31.3,606278,"FBXW7, AGO, CDC4",F-box and WD40 domain protein 7,FBXW7,55294,ENSG00000109670,NA,NA,Fbxw7 (MGI:1354695)
4,153152280,153339316,4q31.3,4q31.3,614141,"TRIM2, KIAA0517, CMT2R",Tripartite motif-containing protein 2,TRIM2,23321,ENSG00000109654,NA,"Charcot-Marie-Tooth disease, type 2R, 615490 (3), Autosomal recessive",Trim2 (MGI:1933163)
4,153344648,153415117,4q31.3,4q31.3,611422,MND1,"Meiotic nuclear division 1, S. cerevisiae, homolog of",MND1,84057,ENSG00000121211,NA,NA,Mnd1 (MGI:1924165)
4,153466345,153637607,4q31.3,4q31.3,616243,"KIAA0922, TMEM131L",KIAA0922 gene,TMEM131L,23240,ENSG00000121210,NA,NA,Tmem131l (MGI:2443399)
4,153684079,153710642,4q32,4q31.3,603028,"TLR2, TIL4",Toll-like receptor-2,TLR2,7097,ENSG00000137462,NA,"{Colorectal cancer, susceptibility to}, 114500 (3), Autosomal dominant, Somatic mutation; {Leprosy, susceptibility to}, 246300 (3), Autosomal dominant; {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)",Tlr2 (MGI:1346060)
4,153780590,153789082,4q31.3,4q31.3,604157,"SFRP2, SARP1",Secreted frizzled-related protein 2,SFRP2,6423,ENSG00000145423,NA,NA,Sfrp2 (MGI:108078)
4,154231741,154491798,4q31.3,4q31.3,612486,"DCHS2, CDHJ, PCDHJ","Dachsous, Drosophila, homolog of, 2",DCHS2,54798,ENSG00000197410,NA,NA,NA
4,154534996,154550432,4q31.2-q32.1,4q31.3,605961,"PLRG1, PRL1",Pleiotropic regulator 1,PLRG1,5356,ENSG00000171566,NA,NA,Plrg1 (MGI:1858197)
4,154562979,154572762,4q28,4q31.3,134830,FGB,"Fibrinogen, beta polypeptide",FGB,2244,ENSG00000171564,4q31 by A; proximal to GYPB/GYPA,"Afibrinogenemia, congenital, 202400 (3), Autosomal recessive; Dysfibrinogenemia, congenital, 616004 (3); Hypofibrinogenemia, congenital, 202400 (3), Autosomal recessive",Fgb (MGI:99501)
4,154583125,154590741,4q28,4q31.3,134820,FGA,"Fibrinogen, alpha polypeptide",FGA,2243,ENSG00000171560,NA,"Afibrinogenemia, congenital, 202400 (3), Autosomal recessive; Amyloidosis, familial visceral, 105200 (3), Autosomal dominant; Dysfibrinogenemia, congenital, 616004 (3); Hypodysfibrinogenemia, congenital, 616004 (3)",Fga (MGI:1316726)
4,154600000,182300000,4q32-q34,NA,612165,RP29,Retinitis pigmentosa 29,RP29,54110,NA,maximum lod at D4S415,"Retinitis pigmentosa 29, 612165 (2), Autosomal recessive",NA
4,154600000,163600000,4q32.1-q32.2,NA,613603,"TRIP4q32.1q32.2, C4TRIPq32.1q32.2",Chromosome 4q32.1-q32.2 triplication syndrome,NA,NA,NA,NA,"Chromosome 4q32.1-q32.2 triplication syndrome, 613603 (4), Autosomal dominant",NA
4,154604133,154612807,4q28,4q32.1,134850,FGG,"Fibrinogen, gamma polypeptide",FGG,2266,ENSG00000171557,linked to MN,"Afibrinogenemia, congenital, 202400 (3), Autosomal recessive; Dysfibrinogenemia, congenital, 616004 (3); Hypodysfibrinogenemia, 616004 (3); Hypofibrinogenemia, congenital, 202400 (3), Autosomal recessive",Fgg (MGI:95526)
4,154740840,154753119,4q31,4q32.1,604863,"LRAT, LCA14",Lecithin retinol acyltransferase,LRAT,9227,ENSG00000121207,NA,"Leber congenital amaurosis 14, 613341 (3), Autosomal recessive; Retinal dystrophy, early-onset severe, 613341 (3), Autosomal recessive; Retinitis pigmentosa, juvenile, 613341 (3), Autosomal recessive",Lrat (MGI:1891259)
4,155173513,155217075,4q31,4q32.1,162642,NPY2R,Neuropeptide Y receptor Y2,NPY2R,4887,ENSG00000185149,NA,NA,Npy2r (MGI:108418)
4,155342657,155376969,4q32,4q32.1,610070,ASAP,Aster-associated protein,MAP9,79884,ENSG00000164114,NA,NA,Map9 (MGI:2442208)
4,155666709,155737058,4q32,4q32.1,139396,"GUCY1A3, GUC1A3, GUCSA3, MYMY6","Guanylate cyclase 1, soluble, alpha 3",GUCY1A1,2982,ENSG00000164116,NA,"Moyamoya 6 with achalasia, 615750 (3), Autosomal recessive",Gucy1a1 (MGI:1926562)
4,155759020,155807773,4q32,4q32.1,139397,"GUCY1B3, GUC1B3, GUCSB3","Guanylate cyclase 1, soluble, beta 3",GUCY1B1,2983,ENSG00000061918,NA,NA,Gucy1b1 (MGI:1860604)
4,155829698,155867302,4q31.3-q32,4q32.1,616693,"ASIC5, HINAC",Acid-sensing ion channel family member 5,ASIC5,51802,ENSG00000256394,NA,NA,Asic5 (MGI:1929259)
4,155903695,155920405,4q31-q32,4q32.1,191070,"TDO2, TPH2, TRPO, HYPTRP",Tryptophan oxygenase,TDO2,6999,ENSG00000151790,mutation identified in 1 HYPTRP patient,"[?Hypertryptophanemia], 600627 (3), Autosomal recessive",Tdo2 (MGI:1928486)
4,155924117,155953865,4q32.1,4q32.1,600550,CTSO,Cathepsin O,CTSO,1519,ENSG00000256043,NA,NA,Ctso (MGI:2139628)
4,156760453,156971798,4q32,4q32.1,608452,PDGFC,Platelet-derived growth factor C,PDGFC,56034,ENSG00000145431,NA,NA,Pdgfc (MGI:1859631)
4,157076124,157172089,4q31.3,4q32.1,138492,"GLRB, HKPX2","Glycine receptor, beta subunit",GLRB,2743,ENSG00000109738,NA,"Hyperekplexia 2, 614619 (3), Autosomal recessive",Glrb (MGI:95751)
4,157220583,157370582,4q32-q33,4q32.1,138247,"GRIA2, GLUR2","Glutamate receptor, ionotropic, AMPA 2",GRIA2,2891,ENSG00000120251,NA,NA,Gria2 (MGI:95809)
4,158521710,158653371,4q32,4q32.1,606654,"RXFP1, LGR7",Relaxin/insulin-like family peptide receptor 1,RXFP1,59350,ENSG00000171509,NA,NA,Rxfp1 (MGI:2682211)
4,158666674,158672055,4q32.1,4q32.1,616210,"C4orf46, RCDG1",Chromosome 4 open reading frame 46,C4orf46,201725,ENSG00000205208,NA,NA,4930579G24Rik (MGI:1923189)
4,158672100,158709622,4q32-qter,4q32.1,231675,"ETFDH, MADD",Electron transfer flavoprotein:ubiquinone oxidoreductase,ETFDH,2110,ENSG00000171503,NA,"Glutaric acidemia IIC, 231680 (3), Autosomal recessive",Etfdh (MGI:106100)
4,158709126,158723395,4q31.3,4q32.1,601753,PPID,Peptidylprolyl isomerase D (cyclophilin D),PPID,5481,ENSG00000171497,NA,NA,Ppid (MGI:1914988)
4,158769025,158908049,4q32.1,4q32.1,612768,"FNIP2, FNIPL, KIAA1450",Folliculin-interacting protein 2,FNIP2,57600,ENSG00000052795,NA,NA,Fnip2 (MGI:2683054)
4,159104050,159360172,4q32.1,4q32.1,609530,"RAPGEF2, NRAPGEP, RAGEF, KIAA0313",Rap guanine nucleotide exchange factor 2,RAPGEF2,9693,ENSG00000109756,mutation identified in 1 FAME7 patient,"?Epilepsy, familial adult myoclonic, 7, 618075 (3)",Rapgef2 (MGI:2659071)
4,163109132,163166909,4q32.2,4q32.2,617868,NAF1,Nuclear assembly factor 1 ribonucleoprotein,NAF1,92345,ENSG00000145414,NA,NA,Naf1 (MGI:2682306)
4,163323961,163344831,4q31.3-q32,4q32.2,162641,NPY1R,Neuropeptide Y receptor,NPY1R,4886,ENSG00000164128,NA,NA,Npy1r (MGI:104963)
4,163336967,163352276,4q31-q32,4q32.2,602001,NPY5R,Neuropeptide Y receptor Y5,NPY5R,4889,ENSG00000164129,NA,NA,Npy5r (MGI:108082)
4,163524297,164384049,4q32.2-q32.3,4q32.2-q32.3,613331,MARCH1,Membrane-associated RING-CH finger protein 1,MARCHF1,55016,ENSG00000145416,NA,NA,March1 (MGI:1920175)
4,163600000,169200000,4q32.3,NA,611109,CINN,"Cinnamon odor, pleasantness of",NA,100188835,NA,max lod at AFM295YES,"[Cinnamon odor, pleasantness of], 611109 (2)",NA
4,163600000,169200000,4q32.3,NA,610239,HDLCQ4,High density lipoprotein cholesterol level QTL 4,NA,100188806,NA,between D4S1597 and D4S1539,"[High density lipoprotein cholesterol level QTL 4], 610239 (2)",NA
4,164197006,164197710,4q32.3,4q32.3,606877,"ANP32C, PP32R1","Acidic leucine-rich nuclear phosphoprotein 32 family, member C",ANP32C,23520,NA,NA,NA,NA
4,164877022,164899062,4q32.3,4q32.3,615594,"ELA, LOC100506013",Elabela,APELA,100506013,ENSG00000248329,NA,NA,NA
4,165207560,165323155,4q21.2,4q32.3,605774,"KLHL2, MAYVEN",Kelch-like 2,KLHL2,11275,ENSG00000109466,NA,NA,Klhl2 (MGI:1924363)
4,165327665,165343163,4q32-q34,4q32.3,607545,"MSMO1, SC4MOL, ERG25, MCCPD",Methylsterol monooxygenase 1,MSMO1,6307,ENSG00000052802,NA,"Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3), Autosomal recessive",Msmo1 (MGI:1913484)
4,165379007,165498546,4q32.3,4q32.3,114855,CPE,Carboxypeptidase E,CPE,1363,ENSG00000109472,NA,NA,Cpe (MGI:101932)
4,165873123,166105177,4q32-q33,4q32.3,606742,"TLL1, TLL, ASD6",Tolloid-like 1,TLL1,7092,ENSG00000038295,NA,"Atrial septal defect 6, 613087 (3), Autosomal dominant",Tll1 (MGI:106923)
4,166733383,167234868,4q32.3,4q32.3,607989,SPOCK3,"SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 3",SPOCK3,50859,ENSG00000196104,NA,NA,Spock3 (MGI:1920152)
4,168092524,168187735,4q33,4q32.3,608008,ANXA10,Annexin A10,ANXA10,11199,ENSG00000109511,NA,NA,Anxa10 (MGI:1347090)
4,168216292,168325980,4q32.3,4q32.3,613974,DDX60,DEAD box polypeptide 60,DDX60,55601,ENSG00000137628,NA,NA,Ddx60 (MGI:2384570)
4,168356734,168480513,4q32.3,4q32.3,616725,DDX60L,DEAD box polypeptide 60-like,DDX60L,91351,ENSG00000181381,NA,NA,NA
4,168497038,168928440,4q32.3,4q32.3,608092,"PALLD, KIAA0992, PNCA1","Palladin, mouse, homolog of",PALLD,23022,ENSG00000129116,NA,"{Pancreatic cancer, susceptibility to, 1}, 606856 (3)",Palld (MGI:1919583)
4,169200000,190214555,4q33-qter,NA,607258,HCA1,"Hypercalciuria, absorptive, 1",NA,266790,NA,NA,"Hypercalciuria, absorptive, 607258 (2)",NA
4,169392856,169612628,4q33,4q33,604588,"NEK1, SRTD6, SRPS2A, ALS24",Never in mitosis gene A-related kinase 1,NEK1,4750,ENSG00000137601,1 patient showed heterozygous NEK2 and DYNC2H1 mutations,"{Amyotrophic lateral sclerosis, susceptibility to, 24}, 617892 (3), Autosomal dominant; Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3), Autosomal recessive, Digenic recessive",Nek1 (MGI:97303)
4,169620577,169723672,4q33,4q33,600580,CLCN3,Chloride channel-3,CLCN3,1182,ENSG00000109572,NA,NA,Clcn3 (MGI:103555)
4,169729469,169757943,4q33,4q33,616614,"HPF1, C4orf27",Histone parylation factor 1,HPF1,54969,ENSG00000056050,NA,NA,Hpf1 (MGI:1919862)
4,169986601,170033002,4q32.3,4q33,616523,"MFAP3L, KIAA0626",Microfibrillar-associated protein 3-like,MFAP3L,9848,ENSG00000198948,NA,NA,Mfap3l (MGI:1918556)
4,170060221,170091698,4q32.2,4q33,611754,"AADAT, KAT2",Alpha-aminoadipate aminotransferase,AADAT,51166,ENSG00000109576,NA,NA,Aadat (MGI:1345167)
4,171812655,173041558,4q34.1,4q34.1,615138,"GALNTL6, GALNACT20",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6,GALNTL6,442117,ENSG00000174473,NA,NA,Galntl6 (MGI:1913581)
4,173168768,173323966,4q31.1,4q34.1,605005,GALNT7,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7,GALNT7,51809,ENSG00000109586,NA,NA,Galnt7 (MGI:1349449)
4,173331375,173334357,4q31,4q34.1,163906,"HMGB2, HMG2",High-mobility group box 2 (high-mobility group (nonhistone chromosomal) protein 2),HMGB2,3148,ENSG00000164104,NA,NA,Hmgb2 (MGI:96157)
4,173370953,173377531,4q34.1,4q34.1,603378,SAP30,"SIN3-associated polypeptide, 30kD",SAP30,8819,ENSG00000164105,NA,NA,Sap30 (MGI:1929129)
4,173384700,173519237,4q34.1,4q34.1,603163,SCRG1,Scraptie-responsive gene 1,SCRG1,11341,ENSG00000164106,NA,NA,Scrg1 (MGI:1328308)
4,173526090,173530228,4q33,4q34.1,602407,"HAND2, DHAND2, DHAND",Heart- and neural crest derivative-expressed 2,HAND2,9464,ENSG00000164107,NA,NA,Hand2 (MGI:103580)
4,173528599,173591254,4q34.1,4q34.1,617240,"HAND2AS1, UPH, DEIN","HAND2 antisense RNA 1, noncoding (Upperhand)",HAND2-AS1,79804,ENSG00000237125,NA,NA,NA
4,173615735,173616841,4q33-q34.1,4q34.1,116960,"MORF4, SEN1, CSRB","Mortality factor 4 (senescence-related, cellular, 1)",MORF4,10934,NA,NA,NA,NA
4,174236657,174284250,4q34.1,4q34.1,605649,"FBXO8, FBX8, FBS",F-box only protein 8,FBXO8,26269,ENSG00000164117,NA,NA,Fbxo8 (MGI:1354696)
4,174423794,174423863,4q34.1,4q34.1,616274,MIR4276,Micro RNA 4276,MIR4276,100423042,ENSG00000265846,NA,NA,NA
4,174490174,174522897,4q34-q35,4q34.1,601688,"HPGD, PGDH1, PHOAR1",Hydroxyprostaglandin dehydrogenase 15-(NAD),HPGD,3248,ENSG00000164120,NA,"Cranioosteoarthropathy, 259100 (3), Autosomal recessive; Digital clubbing, isolated congenital, 119900 (3), Autosomal recessive; Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3), Autosomal recessive",Hpgd (MGI:108085)
4,174636919,174829567,4q33-q34,4q34.1,600421,GLRA3,"Glycine receptor, alpha-3 polypeptide",GLRA3,8001,ENSG00000145451,NA,NA,Glra3 (MGI:95749)
4,174918357,174978179,4q34,4q34.1,604778,ADAM29,A disintegrin and metalloproteinase domain 29,ADAM29,11086,ENSG00000168594,NA,NA,Adam29 (MGI:2676326)
4,175632936,176002690,4q34,4q34.2,601275,"GPM6A, M6A",Glycoprotein M6A,GPM6A,2823,ENSG00000150625,NA,NA,Gpm6a (MGI:107671)
4,176065840,176182823,4q34,4q34.2,609005,WDR17,WD repeat-containing protein 17,WDR17,116966,ENSG00000150627,NA,NA,Wdr17 (MGI:1924662)
4,176184578,176195584,4q34.1-q34.2,4q34.2,609879,"SPATA4, TSARG2",Spermatogenesis-associated protein 4,SPATA4,132851,ENSG00000150628,NA,NA,Spata4 (MGI:1916531)
4,176213672,176277570,4q34.2,4q34.2,615050,ASB5,Ankyrin repeat- and SOCS box-containing protein 5,ASB5,140458,ENSG00000164122,NA,NA,Asb5 (MGI:1923544)
4,176600000,190214555,4q34.3-q35.2,NA,600361,HMSN5,Hereditary motor and sensory neuropathy V,NA,101059903,NA,D4S1552 and D4S2930,"Hereditary motor and sensory neuropathy V, 600361 (2), Autosomal dominant",NA
4,176600000,186200000,4q34.3-q35.1,NA,613371,SCA30,Spinocerebellar ataxia 30,SCA30,100359393,NA,between rs1397413 and rs2175476; max lod 3.0,"?Spinocerebellar ataxia 30, 613371 (2), Autosomal dominant",NA
4,176683537,176792921,4q34.3,4q34.3,601528,"VEGFC, VRP, LMPHM4",Vascular endothelial growth factor C,VEGFC,7424,ENSG00000150630,NA,"Lymphatic malformation 4, 615907 (3), Autosomal dominant",Vegfc (MGI:109124)
4,177430773,177442502,4q32-q33,4q34.3,613228,AGA,Aspartylglucosaminidase,AGA,175,ENSG00000038002,NA,"Aspartylglucosaminuria, 208400 (3), Autosomal recessive",Aga (MGI:104873)
4,181447612,182803023,4q35.1,4q34.3-q35.1,610083,"TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9",Teneurin transmembrane protein 3,TENM3,55714,ENSG00000218336,NA,"Microphthalmia, isolated, with coloboma 9, 615145 (3), Autosomal recessive",Tenm3 (MGI:1345183)
4,182300000,190214555,4q35-qter,NA,606282,DFNA24,"Deafness, autosomal dominant 24",DFNA24,23723,NA,NA,"Deafness, autosomal dominant 24, 606282 (2), Autosomal dominant",NA
4,182300000,190214555,4q35,NA,127600,DKBI,"Dyskeratosis, hereditary benign intraepithelial",NA,80870,NA,NA,"Dyskeratosis, hereditary benign intraepithelial, 127600 (2), Autosomal dominant",NA
4,182300000,190214555,4q35,NA,158900,"FSHD1, FSHD1A",Facioscapulohumeral muscular dystrophy 1,NA,NA,NA,due to D4Z4 macrosatellite repeat on 4q35,"Facioscapulohumeral muscular dystrophy 1, 158900 (4), Autosomal dominant",NA
4,182890090,182917476,4q35,4q35.1,607638,DCTD,Deoxycytidylate deaminase,DCTD,1635,ENSG00000129187,NA,NA,Dctd (MGI:2444529)
4,183444635,183449063,4q35.1,4q35.1,615914,"CDKN2AIP, CARF",Cyclin-dependent kinase inhibitor 2A-interacting protein,CDKN2AIP,55602,ENSG00000168564,NA,NA,Cdkn2aip (MGI:1918175)
4,183505057,183512428,4q35.1,4q35.1,604215,"ING2, ING1L",Inhibitor of growth 2,ING2,3622,ENSG00000168556,NA,NA,Ing2 (MGI:1916510)
4,183659266,183713593,4q35.1,4q35.1,614138,"TRAPPC11, C4orf41, LGMDR18","Trafficking protein particle complex, subunit 11",TRAPPC11,60684,ENSG00000168538,NA,"Muscular dystrophy, limb-girdle, autosomal recessive 18, 615356 (3), Autosomal recessive",Trappc11 (MGI:2444585)
4,183796330,184023529,4q35,4q35.1,617359,"STOX2, KIAA1392",Storkhead box 2,STOX2,56977,ENSG00000173320,NA,NA,Stox2 (MGI:1918319)
4,184088705,184217872,4q35.1,4q35.1,616983,ENPP6,Ectonucleotide pyrophosphatase/phosphodiesterase 6,ENPP6,133121,ENSG00000164303,NA,NA,Enpp6 (MGI:2445171)
4,184382740,184474579,4q35.1,4q35.1,147576,IRF2,Interferon regulatory factor-2,IRF2,3660,ENSG00000168310,NA,NA,Irf2 (MGI:96591)
4,184627695,184649474,4q35,4q35.1,600636,"CASP3, CPP32","Caspase 3, apoptosis-related cysteine protease",CASP3,836,ENSG00000164305,NA,NA,Casp3 (MGI:107739)
4,184649612,184694958,4q35.1,4q35.1,615421,"CCDC111, MYP22",Coiled-coil domain containing 111,PRIMPOL,201973,ENSG00000164306,NA,"Myopia 22, autosomal dominant, 615420 (3), Autosomal dominant",Primpol (MGI:3603756)
4,184694064,184734131,4q35.1,4q35.1,611511,"MLF1IP, CENPU, CENP50",MLF1-interacting protein (centromere protein U),CENPU,79682,ENSG00000151725,NA,NA,Cenpu (MGI:1919126)
4,184755594,184826592,4q34-q35,4q35.1,152425,"ACSL1, FACL2, FACL1, LACS, ACS1",Acyl-CoA synthetase long-chain family member 1,ACSL1,2180,ENSG00000151726,NA,NA,Acsl1 (MGI:102797)
4,185018840,185021264,4q35.1,4q35.1,617546,"HELT, HESL, MGN",HELT basic helix-loop-helix transcription factor,HELT,391723,ENSG00000187821,NA,NA,Helt (MGI:3040955)
4,185143265,185150381,4q35,4q35.1,103220,"SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2","Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)",SLC25A4,291,ENSG00000151729,NA,"Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD, 617184 (3), Autosomal dominant; Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR, 615418 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3), Autosomal dominant",Slc25a4 (MGI:1353495)
4,185151722,185205442,4q35.1,4q35.1,616047,"CFAP97, HMW, KIAA1430",Cilia- and flagella-associated protein 97,CFAP97,57587,ENSG00000164323,NA,NA,Cfap97 (MGI:1914006)
4,185399536,185425984,4q35.1,4q35.1,611482,"UFSP2, C4orf20, BHD, SEMDDR",UFM1-specific peptidase 2,UFSP2,55325,ENSG00000109775,mutation identified in 1 BHD family,"?Hip dysplasia, Beukes type, 142669 (3), Autosomal dominant; ?Spondyloepimetaphyseal dysplasia, Di Rocco type, 617974 (3), Autosomal dominant",Ufsp2 (MGI:1913679)
4,185445181,185471751,4q35.1,4q35.1,609488,KMHN1,Cancer/testis antigen KM-HN-1,CCDC110,256309,ENSG00000168491,NA,NA,Ccdc110 (MGI:2685018)
4,185500659,185535557,4q35,4q35.1,605889,ALP,Actinin-associated LIM protein,PDLIM3,27295,ENSG00000154553,NA,NA,NA
4,185585443,185956371,4q35.1,4q35.1,616349,"SORBS2, ARGBP2, KIAA0777",Sorbin and SH3 domains-containing protein 2,SORBS2,8470,ENSG00000154556,NA,NA,Sorbs2 (MGI:1924574)
4,186069154,186085097,4q35,4q35.1,603029,"TLR3, IIAE2",Toll-like receptor-3,TLR3,7098,ENSG00000164342,NA,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}, 613002 (3), Autosomal recessive, Autosomal dominant; {HIV1 infection, resistance to}, 609423 (3)",Tlr3 (MGI:2156367)
4,186191566,186213462,4q35.1,4q35.1-q35.2,608614,"CYP4V2, BCD","Cytochrome P450, family 4, subfamily V, polypeptide 2",CYP4V2,285440,ENSG00000145476,NA,"Bietti crystalline corneoretinal dystrophy, 210370 (3), Autosomal recessive",Cyp4v3 (MGI:2142763)
4,186215713,186258476,4q35,4q35.2,229000,"KLKB1, KLK3, PKKD",Kallikrein B plasma 1 (Fletcher factor),KLKB1,3818,ENSG00000164344,similar to F11,"Fletcher factor (prekallikrein) deficiency, 612423 (3), Autosomal recessive",Klkb1 (MGI:102849)
4,186265963,186290726,4q35,4q35.2,264900,F11,Coagulation factor XI (plasma thromboplastin antecedent),F11,2160,ENSG00000088926,not closely linked to MNS,"Factor XI deficiency, autosomal dominant, 612416 (3); Factor XI deficiency, autosomal recessive, 612416 (3)",F11 (MGI:99481)
4,186532768,186555566,4q35.1,4q35.2,600665,MTNR1A,Melatonin receptor 1A,MTNR1A,4543,ENSG00000168412,NA,NA,Mtnr1a (MGI:102967)
4,186587788,186726695,4q34-q35,4q35.2,600976,"FAT1, FAT","FAT tumor suppressor, Drosophila, homolog of, 1",FAT1,2195,ENSG00000083857,NA,NA,Fat1 (MGI:109168)
4,187994043,188005045,4q35.2,4q35.2,614572,"ZFP42, REX1",Zinc finger protein 42,ZFP42,132625,ENSG00000179059,NA,NA,Zfp42 (MGI:99187)
4,189940845,189963203,4q35,4q35.2,601278,"FRG1, FSG1",Facioscapulohumeral muscular dystrophy region gene-1,FRG1,2483,ENSG00000109536,NA,NA,Frg1 (MGI:893597)
4,190021168,190022664,4q35,4q35.2,615581,"DUX4L9, DUX4C",Double homeobox 4-like 9,DUX4L9,100288711,NA,NA,NA,NA
4,190024350,190027256,4q35,4q35.2,609032,FRG2,Facioscapulohumeral muscular dystrophy region gene 2,FRG2,448831,ENSG00000205097,NA,NA,"Frg2f8,Frg2f7,Frg2f9,Frg2f2,Frg2f1,Frg2f4,Frg2f3,Frg2f10,Frg2f6,Frg2f11,Frg2f5,Frg2f12,Frg2f13 (MGI:3643940,MGI:3782846,MGI:3782845,MGI:3779576,MGI:3647970,MGI:3779574,MGI:3647962,MGI:3648470,MGI:3644083,MGI:3648177,MGI:3035485,MGI:3643939,MGI:3805017)"
4,190064501,190067863,4q35,4q35.2,614865,DBET,"D4A4 binding element transcript, noncoding",DBET,100419743,ENSG00000281591,NA,NA,NA
4,190067934,190069218,4q35.2,4q35.2,611442,DUX2,Double homeobox protein 2,DUX4L8,26583,NA,?10q26.3,NA,NA
4,190173773,190185910,4q35,4q35.2,606009,DUX4,Double homeo box protein 4,DUX4,100288687,ENSG00000260596,NA,NA,NA
4,0,190214555,Chr.4,NA,187320,TS13,"Temperature sensitivity complementation, ts13",NA,7896,NA,NA,NA,NA
5,0,48800000,5p,NA,108800,ASD1,Atrial septal defect 1,ASD1,431,NA,max lod at D5S406,"Atrial septal defect 1, 108800 (2), Autosomal dominant",NA
5,0,4400000,5p15.33,NA,613059,BCC3,"Basal cell carcinoma, susceptibility to, 3",NA,100307120,NA,NA,"{Basal cell carcinoma, susceptibility to, 3}, 613059 (2)",NA
5,0,4400000,5p15.33,NA,613033,GLM8,Glioma susceptibility 8,NA,100316847,NA,associated with rs2736100,"{Glioma susceptibility 8}, 613033 (2)",NA
5,0,4400000,5p15.33,NA,612571,LNCR3,Lung cancer susceptibility 3,NA,100271687,NA,associated with rs402710 and rs2736100,"{Lung cancer susceptibility 3}, 612571 (2)",NA
5,0,42500000,5p15.33-p13.1,NA,608850,MCDR3,"Macular dystrophy, retinal, 3",MCDR3,317668,NA,maximum lod at D5S630,"Macular dystrophy, retinal, 3, 608850 (2), Autosomal dominant",NA
5,0,48800000,5p,NA,601888,MHS6,Malignant hyperthermia susceptibility 6,MHS6,4266,NA,NA,"{Malignant hyperthermia susceptibility 6}, 601888 (2)",NA
5,0,15000000,5p15.33-p15.2,NA,612554,MYP16,Myopia 16,MYP16,100270641,NA,max lod at D5S2505,"Myopia 16, 612554 (2)",NA
5,0,18400000,5p15,NA,613637,TST2,Tuberculin skin test reactivity quantitative trait locus,NA,100526823,NA,max lod at 16:2.70Mb,"[Tuberculin skin test reactivity QTL], 613637 (2)",NA
5,218222,264815,5p15,5p15.33,600857,"SDHA, SDH1, SDHF, CMD1GG, PGL5","Succinate dehydrogenase complex, subunit A, flavoprotein",SDHA,6389,ENSG00000073578,copy on 3q29,"Cardiomyopathy, dilated, 1GG, 613642 (3); Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial; Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive; Paragangliomas 5, 614165 (3), Autosomal dominant",Sdha (MGI:1914195)
5,271620,314973,5p15.33,5p15.33,601057,"PDCD6, ALG2",Programmed cell death 6,PDCD6,10016,ENSG00000249915,NA,NA,Pdcd6 (MGI:109283)
5,304175,438290,5p15.3,5p15.33,606517,"AHRR, KIAA1234",Arylhydrocarbon receptor repressor,AHRR,57491,ENSG00000286169,NA,NA,Ahrr (MGI:1333776)
5,443175,467289,5p15.33,5p15.33,608186,"EXOC3, SEC6",Exocyst complex component 3,EXOC3,11336,ENSG00000180104,NA,NA,Exoc3 (MGI:2443972)
5,470455,524448,5p15.3,5p15.33,182307,"SLC9A3, NHE3, DIAR8","Solute carrier family 9 (sodium/hydrogen exchanger), member 3",SLC9A3,6550,ENSG00000066230,pseudogene on chr.10,"Diarrhea 8, secretory sodium, congenital, 616868 (3), Autosomal recessive",Slc9a3 (MGI:105064)
5,612339,663499,5p15.33,5p15.33,616475,"CEP72, KIAA1519","Centrosomal protein, 72kD",CEP72,55722,ENSG00000112877,NA,NA,Cep72 (MGI:1921720)
5,659861,700726,5p15.3,5p15.33,608773,"TPPP, P25, P24",Tubulin polymerization-promoting protein,TPPP,11076,ENSG00000171368,NA,NA,Tppp (MGI:1920198)
5,863734,892802,5p15.33,5p15.33,618465,BRD9,Bromodomain-containing protein 9,BRD9,65980,ENSG00000028310,NA,NA,Brd9 (MGI:2145317)
5,892883,919347,5p15.33,5p15.33,604507,"TRIP13, 16E1BP, MVA3",Thyroid hormone receptor interactor 13,TRIP13,9319,ENSG00000071539,NA,"Mosaic variegated aneuploidy syndrome 3, 617598 (3), Autosomal recessive",Trip13 (MGI:1916966)
5,1008801,1038942,5p15.3,5p15.33,607852,NKD2,"Naked cuticle, Drosophila, homolog of, 2",NKD2,85409,ENSG00000145506,NA,NA,Nkd2 (MGI:1919543)
5,1050383,1155886,5p15.3,5p15.33,604879,"SLC12A7, KCC4","Solute carrier family 12 (potassium/chloride transporters), member 7",SLC12A7,10723,ENSG00000113504,NA,NA,Slc12a7 (MGI:1342283)
5,1201594,1225110,5p15.33,5p15.33,608893,"SLC6A19, HND","Solute carrier family 6 (neurotransmitter transporter), member 19",SLC6A19,340024,ENSG00000174358,NA,"Hartnup disorder, 234500 (3), Autosomal recessive; Hyperglycinuria, 138500 (3), Autosomal dominant; Iminoglycinuria, digenic, 242600 (3), Autosomal recessive, Digenic recessive",Slc6a19 (MGI:1921588)
5,1225380,1246188,5p15.33,5p15.33,610300,"SLC6A18, XTRP2","Solute carrier family 6 (neurotransmitter transporter), member 18",SLC6A18,348932,ENSG00000164363,NA,NA,Slc6a18 (MGI:1336892)
5,1253147,1295067,5p15.33,5p15.33,187270,"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",Telomerase reverse transcriptase,TERT,7015,ENSG00000164362,deleted in cri du chat,"{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3), Autosomal recessive, Autosomal dominant; {Dyskeratosis congenita, autosomal recessive 4}, 613989 (3), Autosomal recessive, Autosomal dominant; {Leukemia, acute myeloid}, 601626 (3), Autosomal dominant, Somatic mutation; {Melanoma, cutaneous malignant, 9}, 615134 (3); {Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3), Autosomal dominant",Tert (MGI:1202709)
5,1317751,1345098,5p15.33,5p15.33,612585,"CLPTM1L, CRR9",CLPTM1-like protein,CLPTM1L,81037,ENSG00000049656,NA,NA,Clptm1l (MGI:2442892)
5,1392793,1445439,5p15.3,5p15.33,126455,"SLC6A3, DAT1, PKDYS1","Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3",SLC6A3,6531,ENSG00000142319,NA,"{Nicotine dependence, protection against}, 188890 (3); Parkinsonism-dystonia, infantile, 1, 613135 (3), Autosomal recessive",Slc6a3 (MGI:94862)
5,1461426,1523959,5p15.33,5p15.33,610472,"AYTL2, LPCAT, LPCAT1",Acyltransferase-like 2,LPCAT1,79888,ENSG00000153395,NA,NA,Lpcat1 (MGI:2384812)
5,1798384,1801431,5p15.3,5p15.33,611842,MRPL36,Mitochondrial ribosomal protein L36,MRPL36,64979,ENSG00000171421,NA,NA,Mrpl36 (MGI:2137228)
5,1801406,1816604,5pter-p15.33,5p15.33,603848,"NDUFS6, MC1DN9",NADH-ubiquinone oxidoreductase subunit S6,NDUFS6,4726,ENSG00000145494,NA,"Mitochondrial complex I deficiency, nuclear type 9, 618232 (3), Autosomal recessive","Ndufs6b,Ndufs6 (MGI:107932,MGI:3648526)"
5,1877412,1887178,5p15.3,5p15.33,606199,IRX4,Iroquois homeobox protein 4,IRX4,50805,ENSG00000113430,NA,NA,Irx4 (MGI:1355275)
5,2707929,2751676,5p15.3,5p15.33,606198,IRX2,Iroquois homeo box protein 2,IRX2,153572,ENSG00000170561,NA,NA,Irx2 (MGI:1197526)
5,2712590,2715236,5p15.33,5p15.33,615764,LSINCT5,Long stress-induced noncoding transcript 5,LSINCT5,101234261,ENSG00000281560,NA,NA,NA
5,2751892,2758577,5p15.33,5p15.33,610522,CEI,Coordinated expression to IRXA2,C5orf38,153571,ENSG00000186493,NA,NA,NA
5,3595831,3601402,5p15.3,5p15.33,606197,IRX1,Iroquois homeo box protein 1,IRX1,79192,ENSG00000170549,NA,NA,Irx1 (MGI:1197515)
5,5140329,5320303,5p15,5p15.32,607510,ADAMTS16,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 16",ADAMTS16,170690,ENSG00000145536,NA,NA,Adamts16 (MGI:2429637)
5,5422672,5490219,5p15.32,5p15.32,617958,"ICE1, KIAA0947",Interactor of little elongation complex ELL subunit 1,ICE1,23379,ENSG00000164151,NA,NA,Ice1 (MGI:2385865)
5,6300000,18400000,5p15.31-p15.1,NA,613608,"FAME3, FCMTE3","Epilepsy, myoclonic, familial adult, 3",NA,100529229,NA,between D5S580 and D5S2096,"Epilepsy, myoclonic, familial adult, 3, 613608 (2), Autosomal dominant",NA
5,6371873,6378546,5p15.31,5p15.31,612382,"MED10, NUT2",Mediator complex subunit 10,MED10,84246,ENSG00000133398,NA,NA,Med10 (MGI:106331)
5,6437346,6496722,5p15.3,5p15.31,615832,UBE2QL1,Ubiquitin-conjugating enzyme E2Q family-like protein 1,UBE2QL1,134111,ENSG00000215218,NA,NA,Ube2ql1 (MGI:1924230)
5,6582135,6588499,5p15.31,5p15.31,616385,"LINC01018, SRHC",Long intergenic noncoding RNA 1018,LINC01018,255167,ENSG00000250056,NA,NA,NA
5,6599238,6633359,5p15.31,5p15.31,610916,"NSUN2, TRM4, SAKI, MISU, MRT5","NOP2/SUN RNA methyltransferase family, member 2",NSUN2,54888,ENSG00000037474,NA,"Mental retardation, autosomal recessive 5, 611091 (3), Autosomal recessive",Nsun2 (MGI:107252)
5,6633439,6674385,5p15,5p15.31,184753,SRD5A1,"Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",SRD5A1,6715,ENSG00000145545,pseudogene on X,NA,Srd5a1 (MGI:98400)
5,6713431,6757044,5p15,5p15.31,605198,"TENT4A, POLS, TRF4, POLK",Terminal nucleotidyltransferase 4A,TENT4A,11044,ENSG00000112941,NA,NA,Tent4a (MGI:2682295)
5,7396137,7830080,5p15.3,5p15.31,103071,ADCY2,"Adenylyl cyclase-2, brain",ADCY2,108,ENSG00000078295,NA,NA,Adcy2 (MGI:99676)
5,7851185,7901130,5p15.3-p15.2,5p15.31,602568,MTRR,Methionine synthase reductase,MTRR,4552,ENSG00000124275,NA,"Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3), Autosomal recessive; {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive",Mtrr (MGI:1891037)
5,7859158,7869036,5p15.31,5p15.31,617530,FASTKD3,Fast kinase domains 3,FASTKD3,79072,ENSG00000124279,NA,NA,Fastkd3 (MGI:1916827)
5,9035029,9546120,5p15.2,5p15.31,609297,"SEMA5A, SEMF",Semaphorin 5a,SEMA5A,9037,ENSG00000112902,NA,NA,Sema5a (MGI:107556)
5,9628996,9630350,5p15,5p15.31,604796,"TRB7, T2R1","Taste receptor, family B, member 7",TAS2R1,50834,ENSG00000169777,NA,NA,Tas2r119 (MGI:2681253)
5,9900000,28900000,5p15.2-p14,NA,606770,"ADIPQTL2, CAQ5","Adiponectin, serum level of, QTL 2",NA,171511,NA,near D5S817,"{Adiponectin, serum level of, QTL2}, 606770 (2)",NA
5,9900000,23300000,5p15.2-p14.3,NA,610213,ANIB4,"Aneurysm, intracranial berry, 4",ANIB4,724058,NA,max lod at D5S1954,"Aneurysm, intracranial berry, 4, 610213 (2)",NA
5,10249920,10266411,5p15.2,5p15.2,610150,"CCT5, KIAA0098, CCTE","chaperonin containing TCP1, subunit 5 (epsilon)",CCT5,22948,ENSG00000150753,NA,"Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3), Autosomal recessive",Cct5 (MGI:107185)
5,10277594,10307901,5p15.2,5p15.2,613379,CMBL,Carboxymethylenebutenolidase-like protein,CMBL,134147,ENSG00000164237,NA,NA,Cmbl (MGI:1916824)
5,10353692,10440387,5p15.2,5p15.2,613297,"MARCH6, TEB4, DOA10, KIAA0597",Membrane-associated RING-CH finger protein 6,MARCHF6,10299,ENSG00000145495,NA,NA,March6 (MGI:2442773)
5,10441878,10482806,5p15.2,5p15.2,611756,"ROPN1L, ASP",ROPN1-like protein,ROPN1L,83853,ENSG00000145491,NA,NA,Ropn1l (MGI:2182357)
5,10679229,10761233,5p15.2,5p15.2,600954,DAP,Death-associated protein,DAP,1611,ENSG00000112977,NA,NA,Dap (MGI:1918190)
5,10971835,11904445,5p15.2,5p15.2,604275,"CTNND2, NPRAP","Catenin, delta-2",CTNND2,1501,ENSG00000169862,NA,NA,Ctnnd2 (MGI:1195966)
5,12574856,12805182,5p15.2,5p15.2,617097,"LINC01194, TAG",Long intergenic noncoding RNA 1194,LINC01194,404663,NA,NA,NA,NA
5,13690327,14011828,5p15-p14,5p15.2,603335,"DNAH5, HL1, PCD, CILD3","Dynein, axonemal, heavy chain 5",DNAH5,1767,ENSG00000039139,NA,"Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)",Dnah5 (MGI:107718)
5,14143341,14510203,5p15.1-p14,5p15.2,601893,"TRIO, MRD44",Triple functional domain,TRIO,7204,ENSG00000038382,NA,"Mental retardation, autosomal dominant 44, 617061 (3), Autosomal dominant",Trio (MGI:1927230)
5,14660793,14716551,5p15.2,5p15.2,615712,"OTULIN, FAM105B, GUM, AIPDS",OTU deubiquitinase with linear linkage specificity,OTULIN,90268,ENSG00000154124,NA,"Autoinflammation, panniculitis, and dermatosis syndrome, 617099 (3), Autosomal recessive",Otulin (MGI:3577015)
5,14704799,14871777,5p15.2-p14.1,5p15.2,605145,"ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD","Ank, mouse, homolog of",ANKH,56172,ENSG00000154122,NA,"Chondrocalcinosis 2, 118600 (3), Autosomal dominant; Craniometaphyseal dysplasia, 123000 (3), Autosomal dominant",Ank (MGI:3045421)
5,15000000,33800000,5p15.1-p13.3,NA,613969,MYP19,"Myopia 19, autosomal dominant",NA,100653370,NA,highest lod at D5S419,"Myopia 19, 613969 (2), Autosomal dominant",NA
5,15000000,18400000,5p15.1,NA,608098,PVNH3,Periventricular nodular heterotopia 3,NA,100302681,NA,NA,"Periventricular nodular heterotopia 3, 608098 (2)",NA
5,15500179,15939795,5p15.1,5p15.1,605656,"FBXL7, FBL7",F-box and leucine-rich repeat protein 7,FBXL7,23194,ENSG00000183580,NA,NA,Fbxl7 (MGI:3052506)
5,16067138,16179790,5p15.1,5p15.1,613338,MARCH11,Membrane-associated RING-CH finger protein 11,MARCHF11,441061,ENSG00000183654,NA,NA,March11 (MGI:3608327)
5,16451518,16465799,5p15.1,5p15.1,608694,"ZNF622, ZPR9",Zinc finger protein 622,ZNF622,90441,ENSG00000173545,NA,NA,Zfp622 (MGI:1289282)
5,16473037,16617095,5p15.1,5p15.1,613114,"FAM134B, HSAN2B","Family with sequence similarity 134, member B",RETREG1,54463,ENSG00000154153,NA,"Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3), Autosomal recessive",Retreg1 (MGI:1913520)
5,16661906,16936287,5p15.1-p14.3,5p15.1,601481,MYO10,Myosin X,MYO10,4651,ENSG00000145555,NA,NA,Myo10 (MGI:107716)
5,17216822,17276844,5p15.1-p14,5p15.1,605940,"BASP1, CAP23, NAP22","Brain-abundant signal protein, membrane-attached, 1",BASP1,10409,ENSG00000176788,NA,NA,Basp1 (MGI:1917600)
5,18400000,28900000,5p14,NA,157960,MLVI2,Moloney leukemia virus integration site-2,NA,4309,NA,NA,NA,NA
5,19471295,20575885,5p15.2-p15.1,5p14.3,603019,"CDH18, CDH14",Cadherin 18,CDH18,1016,ENSG00000145526,NA,NA,Cdh18 (MGI:1344366)
5,21750672,22853343,5p14-p13,5p14.3,600562,"CDH12, CDHB",Cadherin-12 (N-cadherin 2),CDH12,1010,ENSG00000154162,pseudogene on 5q13 in SMA region,NA,Cdh12 (MGI:109503)
5,22142351,22152271,5p14,5p14.3,176793,PMCHL1,Pro-melanin-concentrating hormone-like 1,PMCHL1,5369,ENSG00000168967,NA,NA,NA
5,23507608,23528596,5p14.2,5p14.2,609760,PRDM9,PR domain-containing protein 9,PRDM9,56979,ENSG00000164256,NA,NA,Prdm9 (MGI:2384854)
5,24487099,24644977,5p14-p13,5p14.2-p14.1,604555,CDH10,Cadherin 10,CDH10,1008,ENSG00000040731,NA,NA,Cdh10 (MGI:107436)
5,26880596,27038585,5p14,5p14.1,609974,CDH9,Cadherin 9,CDH9,1007,ENSG00000113100,NA,NA,Cdh9 (MGI:107433)
5,28900000,42500000,5p13,NA,608906,ADHD4,"Attention deficit-hyperactivity disorder, susceptibility to, 4",NA,450090,NA,NA,"{Attention deficit-hyperactivity disorder}, 143465 (2), Autosomal dominant",NA
5,28900000,38400000,5p13.3-p13.2,NA,607004,BDA1B,"Brachydactyly, type A1, locus B",NA,246260,NA,NA,"Brachydactyly, type A1, B, 607004 (2), Autosomal dominant",NA
5,28900000,42500000,5p13,NA,613174,"DUP5p13, C5DUPp13",Chromosome 5p13 duplication syndrome,NA,NA,NA,NA,"Chromosome 5p13 duplication syndrome, 613174 (4), Isolated cases",NA
5,28900000,67400000,5p13-q12,NA,610262,HYT6,"Hypertension, essential, susceptibility to, 6",NA,100188808,NA,NA,"{Hypertension, essential, susceptibility to, 6}, 145500 (2), Multifactorial",NA
5,28900000,42500000,5p13,NA,610170,KYPSC1,Kyphoscoliosis 1,NA,780921,NA,NA,"Kyphoscoliosis 1, 610170 (2)",NA
5,31193685,31329145,5p15.1-p14,5p13.3,603007,CDH6,Cadherin 6,CDH6,1004,ENSG00000113361,NA,NA,Cdh6 (MGI:107435)
5,31400493,31532141,5p14-p13,5p13.3,608828,"RNASEN, DROSHA, RANSE3L, RN3","Ribonuclease III, nuclear",DROSHA,29102,ENSG00000113360,NA,NA,Drosha (MGI:1261425)
5,31639130,32110931,5p13.2,5p13.3,610697,"PDZD2, PAPIN, PIN1, AIPC",PDZ domain containing 2,PDZD2,23037,ENSG00000133401,NA,NA,Pdzd2 (MGI:1922394)
5,32124710,32174318,5p13.3,5p13.3,612207,"GOLPH3, GPP34, MIDAS",Golgi phosphoprotein 3,GOLPH3,64083,ENSG00000113384,NA,NA,Golph3 (MGI:1913879)
5,32227006,32312938,5p13.3,5p13.3,606501,"MTMR12, 3PAP, KIAA1682",Myotubularin-related protein 12,MTMR12,54545,ENSG00000150712,NA,NA,Mtmr12 (MGI:2443034)
5,32354345,32444760,5p13.3,5p13.3,615635,ZFR,Zinc finger RNA-binding protein,ZFR,51663,ENSG00000056097,NA,NA,Zfr (MGI:1341890)
5,32531777,32604078,5p13.3,5p13.3,600503,"SUB1, PC4, p15","Sub1, S. cerevisiae, homolog of",SUB1,10923,ENSG00000113387,NA,NA,Sub1 (MGI:104811)
5,32689075,32791723,5p14-p12,5p13.3,108962,"NPR3, ANPRC",Natriuretic peptide receptor C,NPR3,4883,ENSG00000113389,NA,"?Hypertension, salt-resistant (1)",Npr3 (MGI:97373)
5,33440695,33468090,5p13-cen,5p13.3,187790,TARS,Threonyl-tRNA synthetase,TARS1,6897,ENSG00000113407,linked to LARS,NA,Tars (MGI:106314)
5,33523534,33892179,5q35,5p13.3-p13.2,606184,ADAMTS12,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 12",ADAMTS12,81792,ENSG00000151388,NA,NA,Adamts12 (MGI:2146046)
5,33800000,38400000,5p13.2,NA,612595,MS3,"Multiple sclerosis, susceptibility to, 3",NA,100271695,NA,associated with rs6897932,"{Multiple sclerosis, susceptibility to, 3}, 612595 (2)",NA
5,33936385,33938917,5p15.1-p14,5p13.2,609445,"RXFP3, RLN3R1, SALPR, GPCR135",Relaxin/insulin-like family peptide receptor 3,RXFP3,51289,ENSG00000182631,NA,NA,Rxfp3 (MGI:2441827)
5,33944622,33984692,5p13.3,5p13.2,606202,"SLC45A2, MATP, AIM1, SHEP5, OCA4","Solute carrier family 45, member 2",SLC45A2,51151,ENSG00000164175,NA,"Albinism, oculocutaneous, type IV, 606574 (3); [Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3), Autosomal recessive; [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3), Autosomal recessive; [Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3), Autosomal recessive",Slc45a2 (MGI:2153040)
5,33986164,34008049,5p13.2-q11.1,5p13.2,604489,"AMACR, CBAS4, AMACRD",Alpha-methylacyl-CoA racemase,AMACR,23600,ENSG00000242110,NA,"Alpha-methylacyl-CoA racemase deficiency, 614307 (3), Autosomal recessive; Bile acid synthesis defect, congenital, 4, 214950 (3), Autosomal recessive",Amacr (MGI:1098273)
5,34017857,34244723,5p13,5p13.2,612045,"C1ATNF3, CTRP3, CORS26",C1q- and tumor necrosis factor-related protein 3,C1QTNF3,114899,ENSG00000082196,NA,NA,C1qtnf3 (MGI:1932136)
5,34656302,34832611,5p13.3-p13.2,5p13.2,606586,"RAI14, KIAA1334",Retinoic acid-induced 14,RAI14,26064,ENSG00000039560,NA,NA,Rai14 (MGI:1922896)
5,34839163,34900510,5p13.2,5p13.2,616344,TTC23L,Tetratricopeptide repeat domain-containing protein 23-like,TTC23L,153657,ENSG00000205838,NA,NA,Ttc23l (MGI:1923027)
5,34905259,34915625,5p13.3-p13.2,5p13.2,603153,RAD1,"RAD1, S. pombe, homolog of",RAD1,5810,ENSG00000113456,NA,NA,Rad1 (MGI:1316678)
5,34915710,34925995,5p13.2,5p13.2,618466,BRIX1,"Biogenesis of ribosomes, Xenopus, homolog of, 1",BRIX1,55299,ENSG00000113460,NA,NA,Brix1 (MGI:1915082)
5,34929539,34958963,5p13.2,5p13.2,617048,"DNAJC21, DNAJA5, BMFS3","DNAJ/HSP40 homolog, subfamily C, member 21",DNAJC21,134218,ENSG00000168724,NA,"Bone marrow failure syndrome 3, 617052 (3), Autosomal recessive",Dnajc21 (MGI:1925371)
5,34998098,35048187,5p13,5p13.2,612471,"AGXT2, AGT2, BAIBA",Alanine-glyoxylate aminotransferase 2,AGXT2,64902,ENSG00000113492,NA,"[Beta-aminoisobutyric acid, urinary excretion of], 210100 (3), Autosomal recessive",Agxt2 (MGI:2146052)
5,35048755,35230723,5p13.2,5p13.2,176761,"PRLR, MFAB, HPRL",Prolactin receptor,PRLR,5618,ENSG00000113494,NA,"Hyperprolactinemia, 615555 (3), Autosomal recessive, Autosomal dominant; Multiple fibroadenomas of the breast, 615554 (3), Autosomal dominant",Prlr (MGI:97763)
5,35617366,35814610,5p13.2,5p13.2,610172,"SPEF2, KPL2, KIAA1770",Sperm flagellar 2,SPEF2,79925,ENSG00000152582,NA,NA,Spef2 (MGI:2443727)
5,35856848,35879602,5p13,5p13.2,146661,"IL7R, IL7RA, CD127",Interleukin-7 receptor,IL7R,3575,ENSG00000168685,NA,"Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3), Autosomal recessive",Il7r (MGI:96562)
5,35951005,36001054,5p13.2,5p13.2,616383,UGT3A1,"Uridine diphosphate glucuronosyltransferase 3 family, member A1",UGT3A1,133688,ENSG00000145626,NA,NA,"Ugt3a1,Ugt3a2 (MGI:2145969,MGI:2146055)"
5,36035016,36071357,5p13.2,5p13.2,616384,UGT3A2,"Uridine diphosphate glucuronosyltransferase 3 family, member A2",UGT3A2,167127,ENSG00000168671,NA,NA,NA
5,36152042,36184318,5p13,5p13.2,601436,SKP2,S-phase kinase-associated protein 2 (p45),SKP2,6502,ENSG00000145604,NA,NA,Skp2 (MGI:1351663)
5,36192588,36242278,5p13.2,5p13.2,615787,"NADK2, C5orf33, DECRD","NAD kinase 2, mitochondrial",NADK2,133686,ENSG00000152620,mutation identified in 1 DECRD family,"?2,4-dienoyl-CoA reductase deficiency, 616034 (3), Autosomal recessive",Nadk2 (MGI:1915896)
5,36246912,36301901,6p13.2,5p13.2,616391,RANBP3L,RAN-binding protein 3-like,RANBP3L,202151,ENSG00000164188,NA,NA,Ranbp3l (MGI:2444654)
5,36606354,36688333,5p13,5p13.2,600111,"SLC1A3, EAAT1, EA6","Solute carrier family 1 (glial high affinity glutamate transporter), member 3",SLC1A3,6507,ENSG00000079215,NA,"Episodic ataxia, type 6, 612656 (3), Autosomal dominant",Slc1a3 (MGI:99917)
5,36876768,37066412,5p13.1,5p13.2,608667,"NIPBL, CDLS1",Nipped-B-like (delangin),NIPBL,25836,ENSG00000164190,NA,"Cornelia de Lange syndrome 1, 122470 (3), Autosomal dominant",Nipbl (MGI:1913976)
5,37063927,37249498,5p13.2,5p13.2,614571,"CPLANE1, C5orf42, JBTS17, OFD6",Ciliogenesis and planar polarity effector 1,CPLANE1,65250,ENSG00000197603,NA,"Joubert syndrome 17, 614615 (3), Autosomal recessive; Orofaciodigital syndrome VI, 277170 (3), Autosomal recessive",Cplane1 (MGI:1920942)
5,37288136,37371105,5p13,5p13.2,606694,"NUP155, KIAA0791, ATFB15","Nucleoporin, 155kD",NUP155,9631,ENSG00000113569,mutation identified in 1 ATFB15 family,"?Atrial fibrillation 15, 615770 (3), Autosomal recessive",Nup155 (MGI:2181182)
5,37379317,37753434,5p13.2,5p13.2,617233,WDR70,WD repeat-containing protein 70,WDR70,55100,ENSG00000082068,NA,NA,Wdr70 (MGI:1921020)
5,37812676,37840043,5p13.1-p12,5p13.2,600837,"GDNF, HSCR3",Glial cell line derived neurotrophic factor,GDNF,2668,ENSG00000168621,NA,"Central hypoventilation syndrome, 209880 (3), Autosomal dominant; {Hirschsprung disease, susceptibility to, 3}, 613711 (3), Autosomal dominant; {Pheochromocytoma, modifier of}, 171300 (3), Autosomal dominant",Gdnf (MGI:107430)
5,38258558,38465479,5p13.2-p13.1,5p13.2-p13.1,617683,"EGFLAM, PIKA, AGRINL","EGF-like, fibronectin type III, and laminin G domains-containing protein",EGFLAM,133584,ENSG00000164318,NA,NA,Egflam (MGI:2146149)
5,38400000,42500000,5p13.1,NA,612262,IBD18,Inflammatory bowel disease 18,NA,100190931,NA,associated with rs1373692,"{Inflammatory bowel disease 18}, 612262 (2)",NA
5,38474667,38606289,5p13.1,5p13.1,151443,"LIFR, STWS, SWS, SJS2",Leukemia inhibitory factor receptor,LIFR,3977,ENSG00000113594,NA,"Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3), Autosomal recessive",Lifr (MGI:96788)
5,38845857,38945578,5p13.1,5p13.1,601743,"OSMR, OSMRB, PLCA1",Oncostatin M receptor,OSMR,9180,ENSG00000145623,NA,"Amyloidosis, primary localized cutaneous, 1, 105250 (3), Autosomal dominant",Osmr (MGI:1330819)
5,38937919,39074420,5p13.1,5p13.1,609022,"RICTOR, AVO3, KIAA1999",Rapamycin-insensitive campion of mTOR,RICTOR,253260,ENSG00000164327,NA,NA,Rictor (MGI:1926007)
5,39105251,39274499,5p13.1,5p13.1,602731,"FYB1, SLAP130, ADAP, THC3",FYN-binding protein 1,FYB1,2533,ENSG00000082074,NA,"Thrombocytopenia 3, 273900 (3), Autosomal recessive",Fyb (MGI:1346327)
5,39284139,39364494,5p13,5p13.1,120940,"C9, C9D, ARMD15",Complement component-9,C9,735,ENSG00000113600,NA,"C9 deficiency, 613825 (3); {Macular degeneration, age-related, 15, susceptibility to}, 615591 (3)",C9 (MGI:1098282)
5,39371673,39425232,5p13,5p13.1,601236,"DAB2, DOC2","Disabled, Drosophila, homolog of, 2 (differentially expressed in ovarian cancer-2)",DAB2,1601,ENSG00000153071,NA,NA,Dab2 (MGI:109175)
5,40679914,40740935,5p13.1,5p13.1,601586,PTGER4,"Prostaglandin E receptor 4, EP4 subtype",PTGER4,5734,ENSG00000171522,NA,NA,Ptger4 (MGI:104311)
5,40759378,40798194,5p12,5p13.1,602739,PRKAA1,"Protein kinase, AMP-activated, catalytic, alpha-1",PRKAA1,5562,ENSG00000132356,NA,NA,Prkaa1 (MGI:2145955)
5,40825261,40835221,5p,5p13.1,604181,RPL37,Ribosomal protein L37,RPL37,6167,ENSG00000145592,NA,NA,Rpl37 (MGI:1914531)
5,40841196,40855353,5p13.1-p12,5p13.1,609986,"CARD6, CINCIN1",Caspase recruitment domain-containing protein 6,CARD6,84674,ENSG00000132357,NA,NA,Card6 (MGI:3032959)
5,40909496,40984642,5p13,5p13.1,217070,C7,Complement component-7,C7,730,ENSG00000112936,NA,"C7 deficiency, 610102 (3)",C7 (MGI:88235)
5,41142145,41261485,5p13,5p13.1,217050,C6,Complement component-6,C6,729,ENSG00000039537,NA,"C6 deficiency, 612446 (3); Combined C6/C7 deficiency (3)",C6 (MGI:88233)
5,41306951,41510600,5p13.1,5p13.1,617016,PLCXD3,"Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 3",PLCXD3,345557,ENSG00000182836,NA,NA,Plcxd3 (MGI:2442605)
5,41730064,41870534,5p13,5p13.1,601424,"OXCT1, OXCT, SCOT",3-oxoacid CoA transferase 1,OXCT1,5019,ENSG00000083720,NA,"Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)",Oxct1 (MGI:1914291)
5,41918060,42040229,5p12,5p13.1,609090,"FBXO4, FBX4",F-box only protein 4,FBXO4,26272,ENSG00000151876,NA,NA,Fbxo4 (MGI:2146220)
5,42423438,42721877,5p13-p12,5p13-p12,600946,"GHR, GHIP",Growth hormone receptor,GHR,2690,ENSG00000112964,NA,"Growth hormone insensitivity, partial, 604271 (3), Autosomal dominant; {Hypercholesterolemia, familial, modifier of}, 143890 (3), Autosomal dominant; Increased responsiveness to growth hormone, 604271 (3), Autosomal dominant; Laron dwarfism, 262500 (3), Autosomal recessive",Ghr (MGI:95708)
5,42799879,42812075,5p11,5p12,601484,"SELENOP, SEPP1",Selenoprotein P,SELENOP,6414,ENSG00000250722,NA,NA,Selenop (MGI:894288)
5,43039079,43040344,5p12,5p12,611296,"ANXA2R, C5orf39, AX2R, AXIIR",Annexin A2 receptor,ANXA2R,389289,ENSG00000177721,NA,NA,NA
5,43120913,43176323,5p12-p11,5p12,604073,ZNF131,Zinc finger protein -31,ZNF131,7690,ENSG00000172262,NA,NA,Zfp131 (MGI:1919715)
5,43287469,43313476,5p14-p13,5p12,142940,HMGCS1,3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1,HMGCS1,3157,ENSG00000112972,"like HMGCR, regulated transcriptionally by steroid",NA,Hmgcs1 (MGI:107592)
5,43356971,43412390,5p12,5p12,605240,CCL28,"Chemokine, C-C motif, ligand 28",CCL28,56477,ENSG00000151882,NA,NA,Ccl28 (MGI:1861731)
5,43526266,43557418,5p12,5p12,605184,PAIP1,Polyadenylate-binding protein-interacting protein 1,PAIP1,10605,ENSG00000172239,NA,NA,Paip1 (MGI:2384993)
5,43601091,43707395,5p12,5p12,607878,"NNT, GCCD4",Nicotinamide nucleotide transhydrogenase,NNT,23530,ENSG00000112992,NA,"Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3), Autosomal recessive",NA
5,44301654,44389705,5p13-p12,5p12,602115,FGF10,Fibroblast growth factor-10,FGF10,2255,ENSG00000070193,NA,"Aplasia of lacrimal and salivary glands, 180920 (3), Autosomal dominant; LADD syndrome, 149730 (3), Autosomal dominant",Fgf10 (MGI:1099809)
5,44808946,44815513,5p12-q11,5p12,611991,MRPS30,Mitochondrial ribosomal protein S30,MRPS30,10884,ENSG00000112996,NA,NA,Mrps30 (MGI:1926237)
5,45254947,45696379,5p12,5p12,602780,"HCN1, BCNG1, EIEE24, GEFSP10",Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1,HCN1,348980,ENSG00000164588,NA,"Epileptic encephalopathy, early infantile, 24, 615871 (3), Autosomal dominant; Generalized epilepsy with febrile seizures plus, type 10, 618482 (3)",Hcn1 (MGI:1096392)
5,48800000,181538259,5q,NA,609657,BSZQTL2,Bone size quantitative trait locus 2,NA,100188794,NA,NA,"{Bone size QTL}, 609657 (2)",NA
5,50396191,50443298,5q11.1,5q11.1,615669,"EMB, GP70",Embigin,EMB,133418,ENSG00000170571,NA,NA,Emb (MGI:95321)
5,51383447,51394729,5q,5q11.1,600366,ISL1,"ISL1 transcription factor, LIM/homeodomain (islet-1)",ISL1,3670,ENSG00000016082,between D5S395 and D5S407; proximal 5q,NA,Isl1 (MGI:101791)
5,52787915,52959208,5q11.2,5q11.2,192968,"ITGA1, VLA1","Integrin, alpha-1",ITGA1,3672,ENSG00000213949,NA,NA,Itga1 (MGI:96599)
5,52787915,52804043,5q11.2,5q11.2,605757,PELO,"Pelota, Drosophila, homolog of",PELO,53918,ENSG00000152684,NA,NA,Pelo (MGI:2145154)
5,52989325,53094778,5q23-q31,5q11.2,192974,"ITGA2, CD49B, BR, BDPLT9","Integrin, alpha-2 (CD49B; alpha-2 subunit of VLA-2 receptor; platelet antigen Br)",ITGA2,3673,ENSG00000164171,NA,"?Glycoprotein Ia deficiency, 614200 (1), Autosomal dominant",Itga2 (MGI:96600)
5,53095678,53109756,5q11,5q11.2,603708,"MOCS2, MPTS, MOCODB",Molybdenum cofactor synthesis-2,MOCS2,4338,ENSG00000164172,NA,"Molybdenum cofactor deficiency B, 252160 (3), Autosomal recessive",Mocs2 (MGI:1336894)
5,53480337,53487133,5q11.2,5q11.2,136470,"FST, FS",Follistatin,FST,10468,ENSG00000134363,NA,NA,Fst (MGI:95586)
5,53560609,53683340,5q11.1,5q11.2,602694,"NDUFS4, AQDQ, MC1DN1",NADH-ubiquinone oxidoreductase subunit S4,NDUFS4,4724,ENSG00000164258,NA,"Mitochondrial complex I deficiency, nuclear type 1, 252010 (3), Autosomal recessive",Ndufs4 (MGI:1343135)
5,54455698,54456376,5q11.2,5q11.2,604624,"HSPB3, HSPL27, HMN2C, DHMN2C",Heat-shock 27kD protein 3,HSPB3,8988,ENSG00000169271,mutation identified in 1 HMN2C family,"?Neuronopathy, distal hereditary motor, type IIC, 613376 (3), Autosomal dominant",Hspb3 (MGI:1928479)
5,54977866,54985592,5q11.2,5q11.2,601521,ESM1,Endothelial cell-specific molecule 1,ESM1,11082,ENSG00000164283,NA,NA,Esm1 (MGI:1918940)
5,55024255,55034569,5q11.2,5q11.2,600784,"GZMK, TRYP2",Granzyme K,GZMK,3003,ENSG00000113088,NA,NA,Gzmk (MGI:1298232)
5,55102645,55110251,5q11-q12,5q11.2,140050,"GZMA, CTLA3, HFSP",Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factor serine protease),GZMA,3001,ENSG00000145649,NA,NA,Gzma (MGI:109266)
5,55160117,55167300,5q11.2,5q11.2,617172,GPX8,Glutathione peroxidase 8,GPX8,493869,ENSG00000164294,NA,NA,Gpx8 (MGI:1916840)
5,55170531,55170621,5q11.2,5q11.2,613131,"MIR449A, MIRN449A",Micro RNA 449A,MIR449A,554213,ENSG00000198983,NA,NA,NA
5,55170645,55170741,5q11.2,5q11.2,613132,"MIR449B, MIRN449B",Micro RNA 449B,MIR449B,693123,ENSG00000207728,NA,NA,NA
5,55218790,55227314,5q11.2,5q11.2,614086,IDAS,IDAS,MCIDAS,345643,ENSG00000234602,NA,NA,Mcidas (MGI:3648807)
5,55231151,55233716,5q11.2,5q11.2,607752,"CCNO, UNG2, CILD29",Cyclin O,CCNO,10309,ENSG00000152669,NA,"Ciliary dyskinesia, primary, 29, 615872 (3), Autosomal recessive",Ccno (MGI:2145534)
5,55256054,55307721,5q11.2,5q11.2,612720,DHX29,DEAH (Asp-Glu-Ala-His) box polypeptide 29,DHX29,54505,ENSG00000067248,NA,NA,Dhx29 (MGI:2145374)
5,55307988,55425578,5q11.2,5q11.2,618122,"MTREX, MTR4, SKIV2L2",MTR4 exosome RNA helicase,MTREX,23517,ENSG00000039123,NA,NA,Mtrex (MGI:1919448)
5,55424841,55535077,5q11.2,5q11.2,607124,"PLPP1, PPAP2A",Phopshplipid phosphatase 1,PLPP1,8611,ENSG00000067113,NA,NA,NA
5,55625844,55712342,5q11.2,5q11.2,616203,"SLC38A9, URLC11","Solute carrier family 38, member 9",SLC38A9,153129,ENSG00000177058,NA,NA,Slc38a9 (MGI:1918839)
5,55737993,55817156,5q11.2-q12,5q11.2,605281,"DDX4, VASA","DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 4 (vasa, Drosophila, homolog of)",DDX4,54514,ENSG00000152670,NA,NA,Ddx4 (MGI:102670)
5,55840333,55922853,5q11.2,5q11.2,609510,"IL31RA, GLMR, GPL, PLCA2",Interleukin 31 receptor A,IL31RA,133396,ENSG00000164509,mutation identified in 1 PLCA2 patient,"?Amyloidosis, primary localized cutaneous, 2, 613955 (3), Autosomal dominant",Il31ra (MGI:2180511)
5,55935094,55994992,5q11,5q11.2,600694,IL6ST,"Interleukin-6 signal transducer (gp130, oncostatin M receptor)",IL6ST,3572,ENSG00000134352,NA,NA,Il6st (MGI:96560)
5,56099679,56233329,5q11,5q11.2,615189,ANKRD55,Ankyrin repeat domain-containing protein 55,ANKRD55,79722,ENSG00000164512,NA,NA,Ankrd55 (MGI:1924568)
5,56815542,56896151,5q11.2,5q11.2,600982,"MAP3K1, MEKK1, MEKK, SRXY6",Mitogen-activated protein kinase kinase kinase 1,MAP3K1,4214,ENSG00000095015,NA,"46XY sex reversal 6, 613762 (3), Autosomal dominant",Map3k1 (MGI:1346872)
5,57173947,57264678,5q11.2,5q11.2,608412,"GPBP1, GPBP",GC-rich promoter-binding protein 1,GPBP1,65056,ENSG00000062194,NA,NA,Gpbp1 (MGI:1920524)
5,57480017,57482810,5q11.2,5q11.2,614835,ACTBL2,"Actin, beta-like, 2",ACTBL2,345651,ENSG00000169067,NA,NA,Actbl2 (MGI:2444552)
5,58453981,58460138,5q12-q13,5q11.2,607023,"PLK2, SNK",Polo-like kinase 2,PLK2,10769,ENSG00000145632,NA,NA,Plk2 (MGI:1099790)
5,58582151,58859393,5q13,5q11.2,612829,RAB3C,Ras-associated protein RAB3C,RAB3C,115827,ENSG00000152932,NA,NA,Rab3c (MGI:1914545)
5,58969037,60524328,5q12,5q11.2-q12.1,600129,"PDE4D, DPDE3, ACRDYS2","Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3)",PDE4D,5144,ENSG00000113448,NA,"Acrodysostosis 2, with or without hormone resistance, 614613 (3), Autosomal dominant",NA
5,59600000,67400000,5q12,NA,615668,"DEL5q12, C5DELq12",Chromosome 5q12 deletion syndrome,NA,NA,NA,NA,"Chromosome 5q12 deletion syndrome, 615668 (4), Autosomal dominant",NA
5,59600000,93000000,5q12-q14,NA,611364,EJM4,"Myoclonic epilepsy, juvenile, 4",NA,100126594,NA,max lod at D5S459,"Myoclonic epilepsy, juvenile, 4, 611364 (2), Autosomal dominant",NA
5,59600000,67400000,5q12,NA,606799,STRK1,"Stroke, susceptibility to, 1",NA,NA,NA,association with PDE4D,"{Stroke, susceptibility to, 1}, 606799 (2)",NA
5,60487712,60547656,5q12,5q12.1,604991,PART1,Prostate androgen-regulated transcript 1,PART1,25859,ENSG00000152931,NA,NA,NA
5,60596911,60700165,5q12.1,5q12.1,616073,DEPDC1B,DEP domain-containing protein 1B,DEPDC1B,55789,ENSG00000035499,NA,NA,Depdc1b (MGI:2145425)
5,60751788,60844291,5q12.1,5q12.1,614451,ELOVL7,Elongation of very long chain fatty acids-like 6,ELOVL7,79993,ENSG00000164181,NA,NA,Elovl7 (MGI:1921809)
5,60873831,60945077,5q12,5q12.1,609412,"ERCC8, CKN1, CSA, UVSS2","Excision repair cross-complementing rodent repair deficiency, complementation group 8",ERCC8,1161,ENSG00000049167,NA,"Cockayne syndrome, type A, 216400 (3), Autosomal recessive; UV-sensitive syndrome 2, 614621 (3), Autosomal recessive",Ercc8 (MGI:1919241)
5,60945204,61153025,5q12.1,5q12.1,609653,"NDUFAF2, NDUFA12L, MMTN, B17.2L, MC1DN10",NADH-ubiquinone oxidoreductase complex assembly factor 2,NDUFAF2,91942,ENSG00000164182,pseudogene on chr.2,"Mitochondrial complex I deficiency, nuclear type 10, 618233 (3), Autosomal recessive",Ndufaf2 (MGI:1922847)
5,61332257,61546171,5q12.1,5q12.1,615951,"ZSWIM6, KIAA1577, AFND, NEDMAGA",Zinc finger SWIM domain-containing protein 6,ZSWIM6,57688,ENSG00000130449,NA,"Acromelic frontonasal dysostosis, 603671 (3), Autosomal dominant; Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features, 617865 (3), Autosomal dominant",Zswim6 (MGI:1914513)
5,62306161,62387183,5q12.1,5q12.1,602591,"KIF2A, CDCBM3","Kinesin, heavy chain, 2",KIF2A,3796,ENSG00000068796,NA,"Cortical dysplasia, complex, with other brain malformations 3, 615411 (3), Autosomal dominant",Kif2a (MGI:108390)
5,62387253,62403904,5q12.1,5q12.1,612499,"DIMT1L, DIM1, HUSSY5",Dimethyladenosine transferase 1-like,DIMT1,27292,ENSG00000086189,previously assigned to 8p12,NA,Dimt1 (MGI:1913504)
5,62412745,62628588,5q12.1,5q12.1,610889,"IPO11, RANBP11, SLRN",Importin 11,IPO11,51194,ENSG00000086200,NA,NA,Ipo11 (MGI:2442377)
5,63960047,63962291,5q11.2-q13,5q12.3,109760,"HTR1A, ADRB2RL1, PFMCD",5-hydroxytryptamine (serotonin) receptor-1A,HTR1A,3350,ENSG00000178394,NA,"Periodic fever, menstrual cycle dependent, 614674 (3), Autosomal dominant",Htr1a (MGI:96273)
5,64165310,64372878,5q12.3,5q12.3,616015,"RNF180, RINES",RING finger protein 180,RNF180,285671,ENSG00000164197,NA,NA,Rnf180 (MGI:1919066)
5,64505946,64612329,5q12.3,5q12.3,610890,"RGS7BP, R7BP",Regulator of G protein signaling 7-binding protein,RGS7BP,401190,ENSG00000186479,NA,NA,Rgs7bp (MGI:106334)
5,64768917,65018762,5q12.3,5q12.3,617170,"CWC27, SDCCAG10, RPSKA","CWC27 spliceosome-associated protein, X. cerevisiae, homolog of",CWC27,10283,ENSG00000153015,NA,"Retinitis pigmentosa with or without skeletal anomalies, 250410 (3), Autosomal recessive",Cwc27 (MGI:1914535)
5,65148735,65482662,5q12,5q12.3,605008,ADAMTS6,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 6",ADAMTS6,11174,ENSG00000049192,NA,NA,Adamts6 (MGI:1347348)
5,65488918,65563193,5p15.2-q12.3,5q12.3,611502,"CEMPK, SOLT",Centromeric protein K,CENPK,64105,ENSG00000123219,NA,NA,Cenpk (MGI:1926210)
5,65563238,65587548,5q12.3,5q12.3,618274,PPWD1,Peptidylprolyl isomerase domain- and WD40 repeat-containing protein 1,PPWD1,23398,ENSG00000113593,NA,NA,Ppwd1 (MGI:2443069)
5,65589689,65624332,5q12.3,5q12.3,601747,"TRIM23, ARD1",Tripartite motif-containing protein 23,TRIM23,373,ENSG00000113595,NA,NA,Trim23 (MGI:1933161)
5,65625026,65630704,5q12.3,5q12.3,618030,"SHLD3, RINN1","Shield complex, subunit 3",SHLD3,112441434,ENSG00000253251,NA,NA,NA
5,65722204,65829282,5q12.3,5q12.3,611530,"NLN, KIAA1226, AGTBP",Neurolysin,NLN,57486,ENSG00000123213,NA,NA,Nln (MGI:1923055)
5,65926553,66082545,5q12,5q12.3,606944,"ERBB2IP, ERBIN",ERBB2 interacting protein,ERBIN,55914,ENSG00000112851,NA,NA,Erbin (MGI:1890169)
5,66144299,66183615,5q11.2-q12.1,5q12.3,609268,"SREK1, SFRS12, SRRp508",Splicing regulatory glutamine/lysine-rich protein 1,SREK1,140890,ENSG00000153914,NA,NA,Srek1 (MGI:2145245)
5,66596353,67169594,5q13,5q12.3,618002,MAST4,Microtubule-associated serine-threonine kinase 4,MAST4,375449,ENSG00000069020,NA,NA,Mast4 (MGI:1918885)
5,67179612,67196798,5q12,5q12.3,602226,"CD180, LY64, RP105",CD180 antigen,CD180,4064,ENSG00000134061,NA,NA,Cd180 (MGI:1194924)
5,67400000,93000000,5q13-q14,NA,607087,"AAT2, FAA2","Aortic aneurysm, familial thoracic 2",NA,252843,NA,NA,"Aortic aneurysm, familial thoracic 2, 607087 (2)",NA
5,67400000,115900000,5q13-q22,NA,605544,"GINGF2, GGF2, HGF2","Fibromatosis, gingival, 2",GINGF2,64644,NA,formerly GINGF2 used for a locus on 2p16-p13,"Fibromatosis, gingival, 2, 605544 (2)",NA
5,67400000,77600000,5q13,NA,612306,TSHQTL1,Thyroid-stimulating hormone level QTL 1,NA,100190789,NA,associated with rs4704397,"[Thyroid-stimulating hormone level QTL 1], 612306 (2)",NA
5,68215736,68301820,5q13,5q13.1,171833,"PIK3R1, GRB1, AGM7, SHORT, IMD36","Phosphatidylinositol 3-kinase, regulatory, 1",PIK3R1,5295,ENSG00000145675,mutation identified in 1 AGM7 family,"?Agammaglobulinemia 7, autosomal recessive, 615214 (3), Autosomal recessive; Immunodeficiency 36, 616005 (3), Autosomal dominant; SHORT syndrome, 269880 (3), Autosomal dominant",Pik3r1 (MGI:97583)
5,69093992,69131068,5q11.2,5q13.1-q13.2,607819,"SLC30A5, ZNT5, ZTL1","Solute carrier family 30 (zinc transporter), member 5",SLC30A5,64924,ENSG00000145740,NA,NA,Slc30a5 (MGI:1916298)
5,69167009,69178244,5q12,5q13.2,123836,CCNB1,Cyclin B1,CCNB1,891,ENSG00000134057,NA,NA,"Ccnb1,Ccnb1-ps (MGI:88302,MGI:3648694)"
5,69189582,69210356,5q13.2,5q13.2,605607,CENPH,Centromeric protein H,CENPH,64946,ENSG00000153044,NA,NA,Cenph (MGI:1349448)
5,69217759,69230157,5q12.1,5q13.2,611996,MRPS36,Mitochondrial ribosomal protein S36,MRPS36,92259,ENSG00000134056,6 pseudogenes,NA,Mrps36 (MGI:1913378)
5,69234794,69277429,5q13.2,5q13.2,601955,"CDK7, STK1, CAK1",Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase),CDK7,1022,ENSG00000134058,previously mapped to 2p15-cen,NA,Cdk7 (MGI:102956)
5,69273086,69333069,5q13.2,5q13.2,613781,"CCDC125, KENAE",Coiled-coil domain-containing protein 125,CCDC125,202243,ENSG00000183323,NA,NA,Ccdc125 (MGI:1923291)
5,69364742,69370012,5q11.2-q13.1,5q13.2,600822,"TAF9, TAF2G, TAFII32","TAF9 RNA polymerase II, TATA box-binding protein-associated factor, 32kD",TAF9,6880,ENSG00000273841,NA,NA,Taf9 (MGI:1888697)
5,69369296,69414800,5q13,5q13.2,603139,RAD17,"RAD17, S. pombe, homolog of",RAD17,5884,ENSG00000152942,NA,NA,Rad17 (MGI:1333807)
5,69415115,69444329,5q13.1,5q13.2,610572,"MARVELD2, MARVD2, TRIC, DFNB49",Marvel domain-containing protein 2 (tricellulin),MARVELD2,153562,ENSG00000152939,NA,"Deafness, autosomal recessive 49, 610153 (3), Autosomal recessive",Marveld2 (MGI:2446166)
5,69492546,69558103,5q13.1,5q13.2,602876,"OCLN, BLCPMG, PTORCH1",Occludin,OCLN,100506658,ENSG00000197822,NA,"Pseudo-TORCH syndrome 1, 251290 (3), Autosomal recessive",Ocln (MGI:106183)
5,70049522,70077594,5q12.2-q13.3,5q13.2,601627,SMN2,"Survival of motor neuron 2, centromeric",SMN2,6607,ENSG00000205571,NA,"{Spinal muscular atrophy, type III, modifier of}, 253400 (3), Autosomal recessive",Smn1 (MGI:109257)
5,70900662,70918529,5q12.2-q13.3,5q13.2,603011,"SERF1A, H4F5, SMAM1",Small EDRK-rich factor 1A,SERF1A,8293,ENSG00000172058,NA,NA,Serf1 (MGI:1337114)
5,70924940,70953014,5q12.2-q13.3,5q13.2,600354,"SMN1, SMA1, SMA2, SMA3, SMA4","Survival of motor neuron 1, telomeric",SMN1,6606,ENSG00000172062,NA,"Spinal muscular atrophy-1, 253300 (3), Autosomal recessive; Spinal muscular atrophy-2, 253550 (3), Autosomal recessive; Spinal muscular atrophy-3, 253400 (3), Autosomal recessive; Spinal muscular atrophy-4, 271150 (3), Autosomal recessive",Smn1 (MGI:109257)
5,70968482,71025113,5q12.2-q13.3,5q13.2,600355,"BIRC1, NAIP",Baculoviral IAP repeat-containing 1 (neuronal apoptosis inhibitory protein),NAIP,4671,ENSG00000249437,?involved in SMA,NA,Naip2 (MGI:1298226)
5,71035123,71109112,5q12.2-q13.3,5q13.2,601748,GTF2H2,"General transcription factor IIH, polypeptide 2 (44kD subunit)",GTF2H2,2966,ENSG00000145736,2 copies,NA,Gtf2h2 (MGI:1345669)
5,71375784,71385992,5q12-q13,5q13.2,176794,PMCHL2,Pro-melanin-concentrating hormone-like 2,PMCHL2,5370,ENSG00000169040,NA,NA,NA
5,71455635,71578287,5q13,5q13.2,607012,"BDP1, TFNR, DFNB112","B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB",BDP1,55814,ENSG00000145734,mutation identified in 1 DFNB112 family,"?Deafness, autosomal recessive 112, 618257 (3), Autosomal recessive",Bdp1 (MGI:1347077)
5,71587339,71658705,5q12-q13,5q13.2,609014,"MCCC2, MCCB",3-Methylcrotonyl-CoA carboxylase 2,MCCC2,64087,ENSG00000131844,NA,"3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3), Autosomal recessive",Mccc2 (MGI:1925288)
5,71719274,71721044,5q13.2,5q13.2,602606,"CARTPT, CART",Cocaine- and amphetamine-regulated transcript prepropeptide,CARTPT,9607,ENSG00000164326,mutation identified in 1 family,"{?Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Cartpt (MGI:1351330)
5,72107474,72209564,5q13,5q13.2,157129,MAP1B,Microtubule-associated protein-1B,MAP1B,4131,ENSG00000131711,NA,NA,Map1b (MGI:1306778)
5,72219402,72320239,5q13.2,5q13.2,611989,"MRPS27, KIAA0264",Mitochondrial ribosomal protein S27,MRPS27,23107,ENSG00000113048,NA,NA,Mrps27 (MGI:1919064)
5,72320366,72368394,5q13.2,5q13.2,615484,PTCD2,Pentatricopeptide repeat domain-containing protein 2,PTCD2,79810,ENSG00000049883,NA,NA,Ptcd2 (MGI:1916177)
5,72439902,72507409,5q13.2,5q13.2,610159,"ZNF366, DCSCRIPT",Zinc finger protein 366,ZNF366,167465,ENSG00000178175,NA,NA,Zfp366 (MGI:2178429)
5,72816590,72916740,5q13.2,5q13.2,602901,"TNPO1, KPNB2, MIP1",Transportin 1,TNPO1,3842,ENSG00000083312,NA,NA,Tnpo1 (MGI:2681523)
5,72956040,73090521,5q13.2,5q13.2,613438,FCHO2,FCH domain-only protein 2,FCHO2,115548,ENSG00000157107,NA,NA,Fcho2 (MGI:3505790)
5,73173192,73175142,5q13.2,5q13.2,614909,TMEM174,Transmembrane protein 174,TMEM174,134288,ENSG00000164325,NA,NA,Tmem174 (MGI:1915594)
5,73446265,73448776,5q12-q13,5q13.2,601091,"FOXD1, FKHL8",Forkhead box D1,FOXD1,2297,ENSG00000251493,NA,NA,Foxd1 (MGI:1347463)
5,73552189,73565638,5q12-q13,5q13.2,605787,"ANKRA2, ANKRA","Ankyrin repeat-containing protein, family A, member 2",ANKRA2,57763,ENSG00000164331,NA,NA,Ankra2 (MGI:1915808)
5,73565740,73583379,5q13.2,5q13.2,616194,UTP15,"UTP15, U3 small nucleolar ribonucleoprotein, S. cerevisiae, homolog of",UTP15,84135,ENSG00000164338,NA,NA,Utp15 (MGI:2145443)
5,73626157,73941992,5q13.2,5q13.2,612790,"RGNEF, p190RHOGEF","Rgnef, mouse, homolog of",ARHGEF28,64283,ENSG00000214944,NA,NA,Arhgef28 (MGI:1346016)
5,74000000,77600000,5q13.3,NA,618214,LINC01157,Long intergenic noncoding RNA 1157,LINC01157,105379037,NA,NA,NA,NA
5,74627405,74641423,5q13,5q13.3,605173,"ENC1, PIG10",Ectodermal-neural cortex 1,ENC1,8507,ENSG00000171617,NA,NA,Enc1 (MGI:109610)
5,74640022,74721287,5q13,5q13.3,606873,HEXB,"Hexosaminidase B, beta polypeptide",HEXB,3074,ENSG00000049860,NA,"Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3), Autosomal recessive",Hexb (MGI:96074)
5,74721203,74767370,5q13,5q13.3,606544,"GFM2, EFG2, RRF",Mitochondrial elongation factor G2,GFM2,84340,ENSG00000164347,NA,"Combined oxidative phosphorylation deficiency 39, 618397 (3), Autosomal recessive",Gfm2 (MGI:2444783)
5,74767248,74780112,5q13.3,5q13.3,612497,"TINP1, NSA2, HUSSY29",Transforming growth factor-beta-inducible nuclear protein 1,NSA2,10412,ENSG00000164346,NA,NA,Nsa2 (MGI:1913883)
5,74777573,74867993,5q13.3,5q13.3,615769,"FAM169A, SLAP75, KIAA0888","Family with sequence similarity 169, member A",FAM169A,26049,ENSG00000198780,NA,NA,Fam169a (MGI:2444268)
5,75016978,75055412,5q12,5q13.3,616782,GCNT4,"Glucosaminyl (N-acetyl) transferase 4, core 2",GCNT4,51301,ENSG00000176928,NA,NA,Gcnt4 (MGI:2684919)
5,75068296,75236921,5q13.3,5q13.3,618423,ANKRD31,Ankyrin repeat domain-containing protein 31,ANKRD31,256006,ENSG00000145700,NA,NA,Ankrd31 (MGI:5006716)
5,75336333,75362115,5q13.3-q14,5q13.3,142910,"HMGCR, LDLCQ3",3-hydroxy-3-methylglutaryl-Coenzyme A reductase; HMG CoA reductase,HMGCR,3156,ENSG00000113161,NA,"[Low density lipoprotein cholesterol level QTL 3] (3); [Statins, attenuated cholesterol lowering by] (3)",Hmgcr (MGI:96159)
5,75368485,75511980,5q13.3,5q13.3,604677,"COL4A3BP, GPBP, CERT, MRD34",COL4A3-binding protein (ceramide transporter),CERT1,10087,ENSG00000113163,NA,"Mental retardation, autosomal dominant 34, 616351 (3), Autosomal dominant",Col4a3bp (MGI:1915268)
5,75511307,75605819,5q13.1,5q13.3,605650,"POLK, POLQ, DINB1","Polymerase, DNA, kappa",POLK,51426,ENSG00000122008,NA,NA,Polk (MGI:1349767)
5,75674123,75717487,5q13.3,5q13.3,617880,"POC5, C5orf37",POC5 centriolar protein,POC5,134359,ENSG00000152359,NA,NA,Poc5 (MGI:1914713)
5,75847462,76353938,5q13.3,5q13.3,610291,SV2C,Synaptic vesicle glycoprotein 2C,SV2C,22987,ENSG00000122012,NA,NA,Sv2c (MGI:1922459)
5,76403284,76708131,5q11-q13,5q13.3,605401,IQGAP2,IQ motif-containing GTPase-activating protein-2,IQGAP2,10788,ENSG00000145703,NA,NA,Iqgap2 (MGI:2449975)
5,76615481,76623402,5q13,5q13.3,601919,"F2RL2, PAR3",Coagulation factor II receptor-like 2 (protease-activated receptor 3),F2RL2,2151,ENSG00000164220,order: PAR2-PAR1-PAR3,NA,F2rl2 (MGI:1298208)
5,76716125,76735769,5q13,5q13.3,187930,"F2R, CF2R, PAR1",Coagulation factor II (thrombin) receptor,F2R,2149,ENSG00000181104,within 900kb of GPR11,NA,F2r (MGI:101802)
5,76819029,76835314,5q13,5q13.3,600933,"F2RL1, GPR11, PAR2","Coagulation factor II, thrombin, receptor-like 1 (G protein-coupled receptor-11)",F2RL1,2150,ENSG00000164251,within 900kb of F2R,NA,F2rl1 (MGI:101910)
5,76849952,76952881,5q13.3,5q13.3,610103,S100Z,"S100 calcium-binding protein, zeta",S100Z,170591,ENSG00000171643,NA,NA,S100z (MGI:2685471)
5,76952854,76981142,5q11.2-q13.3,5q13.3,122559,CRHBP,Corticotropin releasing hormone-binding protein,CRHBP,1393,ENSG00000145708,NA,NA,Crhbp (MGI:88497)
5,77030403,77065233,5q13.3,5q13.3,608464,"AGGF1, VG5Q, HUS84971, FLJ10283",Angiogenic factor with G patch and FHA domains 1,AGGF1,55109,ENSG00000164252,NA,NA,Aggf1 (MGI:1913799)
5,77072071,77087284,5q13.3,5q13.3,615250,ZBED3,Zinc finger BED domain-containing protein 3,ZBED3,84327,ENSG00000132846,NA,NA,Zbed3 (MGI:1919364)
5,77180251,77429806,5q13,5q13.3,603390,"PDE8B, PPNAD3, ADSD",Phosphodiesterase 8B,PDE8B,8622,ENSG00000113231,NA,"Pigmented nodular adrenocortical disease, primary, 3, 614190 (3); Striatal degeneration, autosomal dominant, 609161 (3), Autosomal dominant",Pde8b (MGI:2443999)
5,77426651,77620610,5q13.3,5q13.3-q14.1,617502,WDR41,WD repeat-containing protein 41,WDR41,55255,ENSG00000164253,NA,NA,Wdr41 (MGI:2445123)
5,77600000,93000000,5q14,NA,187260,HBT,"Telangiectasia, hereditary benign",TELAB1,338411,NA,max lod at D5S641,"Telangiectasia, hereditary benign, 187260 (2), Autosomal dominant",NA
5,77600000,110200000,5q14.1-q21.3,NA,614622,KTCN5,Keratoconus 5,NA,100885801,NA,between D5S2499 and D5S495,"Keratoconus 5, 614622 (2), Autosomal dominant",NA
5,77628711,77638696,5q13.3,5q14.1,604529,OTP,"Orthopedia, Drosophila, homolog of",OTP,23440,ENSG00000171540,NA,NA,Otp (MGI:99835)
5,77691165,77776360,5q14.1,5q14.1,610058,TBCA,Tubulin-specific chaperone A,TBCA,6902,ENSG00000171530,NA,NA,Tbca (MGI:107549)
5,78000521,78294754,5q14.1,5q14.1,603401,"AP3B1, ADTB3A, HPS2","Adaptor-related protein complex 3, beta 1 subunit (adaptin, beta-3a)",AP3B1,8546,ENSG00000132842,NA,"Hermansky-Pudlak syndrome 2, 608233 (3), Autosomal recessive",Ap3b1 (MGI:1333879)
5,78360502,78480738,5q13.3-q14.1,5q14.1,606911,"SCAMP1, SCAMP37",Secretory carrier membrane protein 1,SCAMP1,9522,ENSG00000085365,NA,NA,Scamp1 (MGI:1349480)
5,78485223,78770255,5q14.1,5q14.1,609718,"LHFPL2, KIAA0206",LHFP-like protein 2,LHFPL2,10184,ENSG00000145685,NA,NA,Lhfpl2 (MGI:2145236)
5,78777208,78986086,5q11-q13,5q14.1,611542,"ARSB, MPS6",Arylsulfatase B,ARSB,411,ENSG00000113273,NA,"Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3), Autosomal recessive",Arsb (MGI:88075)
5,78997563,79069673,5q12.2-q12.3,5q14.1,605849,"DMGDH, DMGDHD",Dimethylglycine dehydrogenase,DMGDH,29958,ENSG00000132837,NA,"Dimethylglycine dehydrogenase deficiency, 605850 (3), Autosomal recessive",Dmgdh (MGI:1921379)
5,79069766,79090068,5q13.1-q13.2,5q14.1,605932,BHMT2,Betaine-homocysteine methyltransferase 2,BHMT2,23743,ENSG00000132840,NA,NA,Bhmt2 (MGI:1891379)
5,79111808,79132287,5q13.1-q13.2,5q14.1,602888,BHMT,Betaine-homocysteine methyltransferase,BHMT,635,ENSG00000145692,NA,NA,Bhmt (MGI:1339972)
5,79236130,79327214,5q13.2,5q14.1,604279,JMY,Junction-mediating and regulatory protein,JMY,133746,ENSG00000152409,NA,NA,Jmy (MGI:1913096)
5,79372635,79514133,5q14.2,5q14.1,604798,"HOMER1, HOMER1B, HOMER1C, HOMER1A","Homer, homlog 1 (Drosophila)",HOMER1,9456,ENSG00000152413,NA,NA,Homer1 (MGI:1347345)
5,79612416,79688245,5q14.1,5q14.1,614121,"TENT2, APD4, GLD2",Terminal nucleotidyltransferase 1,TENT2,167153,ENSG00000164329,NA,NA,Tent2 (MGI:2140950)
5,79689338,79800225,5q12-q13,5q14.1,612193,"CMYA5, MYOSPRYN, TRIM76",Cardiomyopathy-associated protein 5,CMYA5,202333,ENSG00000164309,NA,NA,NA
5,79991295,80083752,5q14.1,5q14.1,600715,THBS4,Thrombospondin IV,THBS4,7060,ENSG00000113296,NA,NA,Thbs4 (MGI:1101779)
5,80111224,80256081,5q14.1,5q14.1,614551,"SERINC5, C5orf12, TPO1",Serine incorporator 5,SERINC5,256987,ENSG00000164300,NA,NA,Serinc5 (MGI:2444223)
5,80320001,80321841,5q14.1,5q14.1,618068,"SPZ1, PPP1R148",Spermatogenic leucine zipper protein 1,SPZ1,84654,ENSG00000164299,NA,NA,Spz1 (MGI:1930801)
5,80407614,80483378,5q14.1,5q14.1,608880,"ZFYVE16, ENDOFIN, KIAA0305",Zinc finger FYVE domain-containing protein 16,ZFYVE16,9765,ENSG00000039319,NA,NA,Zfyve16 (MGI:2145181)
5,80626225,80654982,5q11.2-q13.2,5q14.1,126060,DHFR,Dihydrofolate reductase,DHFR,1719,ENSG00000228716,NA,"Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive",Dhfr (MGI:94890)
5,80654651,80876814,5q11-q12,5q14.1,600887,"MSH3, FAP4","mutS, E. coli, homolog of, 3",MSH3,4437,ENSG00000113318,5' to DHFR,"Endometrial carcinoma, somatic, 608089 (3); Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive",Msh3 (MGI:109519)
5,80960362,81230161,5q13,5q14.1,606614,RASGRF2,Ras protein-specific guanine nucleotide-releasing factor 2,RASGRF2,5924,ENSG00000113319,NA,NA,Rasgrf2 (MGI:109137)
5,81227594,81266397,5q13.3,5q14.1,123295,CKMT2,"Creatine kinase, mitochondrial-2 (sarcomeric)",CKMT2,1160,ENSG00000131730,NA,NA,Ckmt2 (MGI:1923972)
5,81309044,81394173,5q14.1,5q14.1,614315,"ACOT12, CACH",Acyl-CoA thioesterase 12,ACOT12,134526,ENSG00000172497,NA,NA,Acot12 (MGI:1921406)
5,81412806,81751252,5q13.3,5q14.1,607389,SSBP2,Single-stranded DNA-binding protein 2,SSBP2,23635,ENSG00000145687,NA,NA,Ssbp2 (MGI:1914220)
5,81972020,82258501,5q14.2,5q14.1-q14.2,610800,"ATG10, APG10","Autophagy 10, S. cerevisiae, homolog of",ATG10,83734,ENSG00000152348,NA,NA,Atg10 (MGI:1914045)
5,82100000,83500000,5q14.2,NA,614317,VUR4,Vesicoureteral reflux 4,NA,100820757,NA,closest marker rs1501656,"Vesicoureteral reflux 4, 614317 (2)",NA
5,82273319,82278353,5q14.2,5q14.2,603683,"RPS23, BTDD, MCINS",Ribosomal protein S23,RPS23,6228,ENSG00000186468,NA,"Brachycephaly, trichomegaly, and developmental delay, 617412 (3), Autosomal dominant",Rps23 (MGI:1913725)
5,83064203,83064336,5q14.2,5q14.2,611329,SCARNA18,Small cajal body-specific RNA 18,SCARNA18,677765,ENSG00000238835,in intron 1 of TMEM167,NA,NA
5,83077408,83370332,5q13-q14,5q14.2,194363,"XRCC4, SSMED","X-ray repair, complementing defective, repair in Chinese hamster cells-4",XRCC4,7518,ENSG00000152422,between D5S427 and D5S401,"Short stature, microcephaly, and endocrine dysfunction, 616541 (3), Autosomal recessive",Xrcc4 (MGI:1333799)
5,83471673,83582302,5q12-q14,5q14.2-q14.3,118661,"VCAN, CSPG2, WGN, WGN1, ERVR",Versican (chondroitin sulfate proteoglycan-2),VCAN,1462,ENSG00000038427,NA,"Wagner syndrome 1, 143200 (3), Autosomal dominant",Vcan (MGI:102889)
5,83500000,98900000,5q14.3-q15,NA,612881,PVNH5,Periventricular nodular heterotopia 5,NA,NA,NA,"deletion range 6.3-17Mb, common range 5.8Mb","Periventricular nodular heterotopia 5, 612881 (4)",NA
5,83637804,83721209,5q13-q14.1,5q14.3,115435,"HAPLN1, CRTL1",Hyaluronan and proteoglycan link protein 1,HAPLN1,1404,ENSG00000145681,NA,NA,Hapln1 (MGI:1337006)
5,86617940,86620961,5q14,5q14.3,603774,COX7C,"Cytochrome C oxidase, subunit VII C",COX7C,1350,ENSG00000127184,pseudogene on 13q14-q21,NA,NA
5,87267844,87391925,5q13.3,5q14.3,139150,"RASA1, GAP, CMAVM1, PKWS",RAS p21 protein activator 1 (GTPase activating protein),RASA1,5921,ENSG00000145715,NA,"Basal cell carcinoma, somatic, 605462 (3); Capillary malformation-arteriovenous malformation 1, 608354 (3), Autosomal dominant",Rasa1 (MGI:97860)
5,87311470,87413032,5q13.3-q14,5q14.3,601953,"CCNH, CAK",Cyclin H,CCNH,902,ENSG00000134480,NA,NA,Ccnh (MGI:1913921)
5,88538265,88691040,5q14.3,5q14.3,616611,"LINC00461, VISC",Long intergenic noncoding RNA 461,LINC00461,645323,ENSG00000245526,NA,NA,NA
5,88666852,88666938,5q14.3,5q14.3,611187,"MIR9-2, MIRN9-2",Micro RNA 9-2,MIR9-2,407047,ENSG00000284447,NA,NA,NA
5,88717116,88904104,5q14,5q14.3,600662,"MEF2C, C5DELq14.3, DEL5q14.3","MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)",MEF2C,4208,ENSG00000081189,NA,"Chromosome 5q14.3 deletion syndrome, 613443 (4), Autosomal dominant; Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3), Autosomal dominant",Mef2c (MGI:99458)
5,90393334,90409785,5q14.3,5q14.3,602907,"CETN3, CDC31",Centrin 3,CETN3,1070,ENSG00000153140,NA,NA,Cetn3 (MGI:1097706)
5,90473928,90514556,5p14.3,5q14.3,617456,"POLR3G, RPC32, RPC7","Polymerase III, RNA, subunit G",POLR3G,10622,ENSG00000113356,NA,NA,Polr3g (MGI:1914736)
5,90558795,91164436,5q14.3,5q14.3,602851,"ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C",Adhesion G protein-coupled receptor V1,ADGRV1,84059,ENSG00000164199,mutation identified in 1 FEB4 family,"?Febrile seizures, familial, 4, 604352 (3), Autosomal dominant; Usher syndrome, type 2C, 605472 (3), Autosomal recessive; Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3), Autosomal recessive",Adgrv1 (MGI:1274784)
5,91302985,91314401,5q14.3,5q14.3,618190,"LUCAT1, SCAL1","Lung cancer-associated transcript 1, noncoding",LUCAT1,100505994,ENSG00000248323,NA,NA,NA
5,91368630,91383372,5q14.3,5q14.3,612464,"ARRDC3, TLIMP, KIAA1376",Arrestin domain-containing 3,ARRDC3,57561,ENSG00000113369,NA,NA,Arrdc3 (MGI:2145242)
5,93583221,93594612,5q14,5q15,132890,"NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS","Nuclear receptor subfamily 2, group F, member 1 (transcription factor COUP 1)",NR2F1,7025,ENSG00000175745,NA,"Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3), Autosomal dominant",Nr2f1 (MGI:1352451)
5,94150855,94618603,5q15,5q15,617266,"KIAA0825, PAPA10",KIAA0825 gene,KIAA0825,285600,ENSG00000185261,NA,"Polydactyly, postaxial, type A10, 618498 (3)",2210408I21Rik (MGI:1919621)
5,94613475,94714917,5q15,5q15,618467,"SLF1, BRCTX",SMC5-SMC6 complex localization factor 1,SLF1,84250,ENSG00000133302,NA,NA,Slf1 (MGI:2145448)
5,94703689,95284574,5q15,5q15,616296,MCTP1,Multiple C2 domains-containing transmembrane protein 1,MCTP1,79772,ENSG00000175471,NA,NA,Mctp1 (MGI:1926021)
5,95463894,95555004,5q15,5q15,614589,"TTC37, KIAA0372",Tetratricopeptide repeat domain 37,TTC37,9652,ENSG00000198677,NA,"Trichohepatoenteric syndrome 1, 222470 (3), Autosomal recessive",Ttc37 (MGI:2679923)
5,95555100,95605101,5q15,5q15,610011,ARSK,Arylsulfatase K,ARSK,153642,ENSG00000164291,NA,NA,Arsk (MGI:1924291)
5,95713521,95796360,5q14.3,5q15,607353,"RHOBTB3, KIAA0878",Rho-related BTB domain-containing protein 3,RHOBTB3,22836,ENSG00000164292,NA,NA,Rhobtb3 (MGI:1920546)
5,95813848,95822872,5q14,5q15,600443,"GLRX, GRX",Glutaredoxin (thioltransferase),GLRX,2745,ENSG00000173221,NA,NA,Glrx (MGI:2135625)
5,95885097,95961961,5q15,5q15,601874,ELL2,"Elongation factor, RNA polymerase II, 2",ELL2,22936,ENSG00000118985,NA,NA,Ell2 (MGI:2183438)
5,96390332,96433247,5q15-q21,5q15,162150,"PCSK1, NEC1, PC1, PC3, BMIQ12",Proprotein convertase subtilisin/kexin type 1,PCSK1,5122,ENSG00000175426,NA,"Obesity with impaired prohormone processing, 600955 (3), Autosomal recessive; {Obesity, susceptibility to, BMIQ12}, 612362 (3)",Pcsk1 (MGI:97511)
5,96662036,96774682,5q15-q21,5q15,114090,"CAST, PLACK",Calpastatin,CAST,831,ENSG00000153113,NA,"Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3), Autosomal recessive",Cast (MGI:1098236)
5,96760272,96935982,5q15,5q15,606832,"ERAP1, ALAP, ARTS1, PILSAP, KIAA0525",Endoplasmic reticulum aminopeptidase 1,ERAP1,51752,ENSG00000164307,NA,NA,Erap1 (MGI:1933403)
5,96875938,96919715,5q15,5q15,609497,"ERAP2, LRAP",Endoplasmic reticulum aminopeptidase 2,ERAP2,64167,ENSG00000164308,NA,NA,NA
5,96934858,97037512,5q14.2-q15,5q15,151300,LNPEP,Leucyl-cystinyl aminopeptidase,LNPEP,4012,ENSG00000113441,NA,NA,Lnpep (MGI:2387123)
5,97091866,97142610,5q15,5q15,610466,LIX1,"Limb expression 1, mouse, homolog of",LIX1,167410,ENSG00000145721,NA,NA,Lix1 (MGI:1913893)
5,97160866,97183246,5q15,5q15,617754,"RIOK2, RIO2",RIO kianse 2,RIOK2,55781,ENSG00000058729,NA,NA,Riok2 (MGI:1914295)
5,98768631,98796493,5q21.1,5q15,612687,"RGMB, DRAGON","RGM domain family, member B",RGMB,285704,ENSG00000174136,NA,NA,Rgmb (MGI:1916049)
5,98855203,98929771,5q15-q21,5q15-q21,602118,"CHD1, PILBOS",Chromodomain helicase DNA binding protein-1,CHD1,1105,ENSG00000153922,NA,"Pilarowski-Bjornsson syndrome, 617682 (3), Autosomal dominant",Chd1 (MGI:88393)
5,98900000,110200000,5q21,NA,609570,MGR8,"Migraine, susceptibility to, 8",NA,100188790,NA,NA,"{Migraine, susceptibility to, 8}, 609570 (2)",NA
5,100806932,100903281,5q21,5q21.1,602547,"PST, PST1",Polysialyltransferase,ST8SIA4,7903,ENSG00000113532,NA,NA,St8sia4 (MGI:106018)
5,102233985,102296515,5q21.1,5q21.1,609013,"SLCO4C1, OATP4C1","Solute carrier organic anion transporter family, member 4C1",SLCO4C1,353189,ENSG00000173930,NA,NA,Slco4c1 (MGI:2442784)
5,102371773,102502212,5q21.1,5q21.1,613365,"SLCO6A1, GST","Solute carrier organic anion transporter family, member 6A1",SLCO6A1,133482,ENSG00000205359,NA,NA,Slco6b1 (MGI:1915104)
5,102754782,103031104,5q14-q21,5q21.1,170270,PAM,Peptidylglycine alpha-amidating monooxygenase,PAM,5066,ENSG00000145730,NA,NA,Pam (MGI:97475)
5,103120272,103212798,5q21.1,5q21.1,611648,"PPIP5K2, HISPPD1, VIP2, KIAA0433, DFNB100",Histidine acid phosphatase domain-containing protein 1,PPIP5K2,23262,ENSG00000145725,NA,"Deafness, autosomal recessive 100, 618422 (3), Autosomal recessive",Ppip5k2 (MGI:2142810)
5,103258762,103278659,5q21.1,5q21.1,616608,C5orf30,Chromosome 5 open reading frame 30,C5orf30,90355,ENSG00000181751,NA,NA,D1Ertd622e (MGI:1277184)
5,105100000,156300000,5q21.3-q33.2,NA,608970,MDBS2,"Macular dystrophy, butterfly-shaped pigmentary, 2",NA,NA,NA,between D5S433 and D5S410,"Macular dystrophy, butterfly-shaped pigmentary, 2, 608970 (2), Autosomal dominant",NA
5,107376888,107670936,5q21.3,5q21.3,601535,"EFNA5, EPLG7, LERK7",Ephrin A5,EFNA5,1946,ENSG00000184349,NA,NA,Efna5 (MGI:107444)
5,107859032,108382097,5q21.3,5q21.3,609083,"FBXL17, FBL17, FBX13, FBXO13",F-box and leucine-rich repeat protein 17,FBXL17,64839,ENSG00000145743,NA,NA,Fbxl17 (MGI:1354704)
5,108593483,108594002,5q13-q23,5q21.3,180463,RPS20A,Ribosomal protein S20A,RPS20P3,6225,NA,?pseudogene,NA,NA
5,108746084,109196840,5q21-q22,5q21.3,176942,"FER, TYK3",fer (fps/fes related) tyrosine kinase,FER,2241,ENSG00000151422,NA,NA,Fer (MGI:105917)
5,109689365,109869624,5q21-q22,5q21.3,154582,"MAN2A1, MANA2","Mannosidase, alpha, class 2A, member 1",MAN2A1,4124,ENSG00000112893,NA,NA,Man2a1 (MGI:104669)
5,110200000,115900000,5q22,NA,613412,EOE2,"Esophagitis, eosinophilic, 2",NA,100499167,NA,association with rs3806932,"{Esophagitis, eosinophilic, 2}, 613412 (2), Multifactorial",NA
5,110200000,150400000,5q22.1-q32,NA,610535,GLC1M,"Glaucoma 1, open angle, M",GLC1M,777643,NA,between D5S2051 and D5S2090,"Glaucoma 1, open angle, M, 610535 (2), Autosomal dominant",NA
5,110738144,110765173,5q22.1,5q22.1,610826,"SLC25A46, HMSN6B","Solute carrier family 25, member 46",SLC25A46,91137,ENSG00000164209,NA,"Neuropathy, hereditary motor and sensory, type VIB, 616505 (3), Autosomal recessive",Slc25a46 (MGI:1914703)
5,111070079,111078025,5q22.1,5q22.1,607003,TSLP,Thymic stromal lymphopoietin,TSLP,85480,ENSG00000145777,NA,NA,Tslp (MGI:1855696)
5,111092171,111130501,5q21.3-q22.1,5q22.1,609669,"WDR36, TAWDRP, GLC1G",WD repeat-containing protein 36,WDR36,134430,ENSG00000134987,NA,"Glaucoma 1, open angle, G, 609887 (3)",Wdr36 (MGI:1917819)
5,111223582,111498502,5q21-q23,5q22.1,114080,CAMK4,Ca(2+)-calmodulin-dependent protein kinase type IV of brain,CAMK4,814,ENSG00000152495,NA,NA,Camk4 (MGI:88258)
5,111491421,111512596,5q22,5q22.1,607049,STARD4,Start domain-containing protein 4,STARD4,134429,ENSG00000164211,NA,NA,Stard4 (MGI:2156764)
5,111728801,111976931,5q22.1,5q22.1,607332,"C5orf13, P311, PTZ17",P311 protein,NREP,9315,ENSG00000134986,NA,NA,Nrep (MGI:99444)
5,112141828,112419315,5q22,5q22.1-q22.2,612141,"EPB41L4A, EPB41L4, NBL4",Erythrocyte membrane protein band 4.1-like 4A,EPB41L4A,64097,ENSG00000129595,NA,NA,Epb41l4a (MGI:103007)
5,112707497,112846238,5q22.2,5q22.2,611731,"APC, GS, FPC, BTPS2",Adenomatous polyposis coli,APC,324,ENSG00000134982,150kb distal to MCC,"Adenoma, periampullary, somatic (3); Adenomatous polyposis coli, 175100 (3), Autosomal dominant; Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3); Hepatoblastoma, somatic, 114550 (3)",Apc (MGI:88039)
5,112861187,112898370,5q21-q22,5q22.2,182175,SRP19,Signal recognition particle 19kD,SRP19,6728,ENSG00000153037,within 100kb of APC,NA,Srp19 (MGI:1913634)
5,112876384,112922288,5q22-q23,5q22.2,125265,"REEP5, D5S346, DP1, C5orf18",Receptor expression-enhancing protein 5,REEP5,7905,ENSG00000129625,NA,NA,Reep5 (MGI:1270152)
5,112891615,112893096,5q22,5q22.2,601079,"ZRSR1, U2AF1RS1","Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 1",ZRSR2P1,7310,NA,NA,NA,NA
5,112976701,113022194,5q21-q22,5q22.2,609844,DCP2,"Decapping enzyme 2, S. cerevisiae, homolog of",DCP2,167227,ENSG00000172795,NA,NA,Dcp2 (MGI:1917890)
5,113022100,113488452,5q21,5q22.2,159350,MCC,Mutated in colorectal cancers,MCC,4163,ENSG00000171444,NA,"Colorectal cancer, somatic, 114500 (3)",Mcc (MGI:96930)
5,113432552,113434988,5q22.2,5q22.2,610709,"TSSK1, STK22D",Testis-specific serine/threonine kinase 1,TSSK1B,83942,ENSG00000212122,pseudogene on chr22,NA,Tssk1 (MGI:1347557)
5,113513682,113595283,5q22.2,5q22.2,616530,"YTHDC2, CAHL",YTH domain-containing protein 2,YTHDC2,64848,ENSG00000047188,NA,NA,Ythdc2 (MGI:2448561)
5,114056005,114496499,5q21.2-q22.1,5q22.3,605879,"KCNN2, SK2","Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 2",KCNN2,3781,ENSG00000080709,NA,NA,NA
5,115124771,115180545,5q22.3,5q22.3,609317,"TRIM36, RBCC728, ANPH",Tripartite motif-containing protein 36,TRIM36,55521,ENSG00000152503,mutation identified in 1 ANPH patient,"?Anencephaly, 206500 (3), Autosomal recessive",Trim36 (MGI:106264)
5,115200246,115262886,5q22.3,5q22.3,602031,PGGT1B,"Protein geranylgeranyltransferase type I, beta subunit",PGGT1B,5229,ENSG00000164219,NA,NA,Pggt1b (MGI:1917514)
5,115578495,115602478,5q23.1,5q22.3,608321,"TIRP, TRAM",Toll/interleukin-1 receptor domain-containing protein,TICAM2,353376,ENSG00000243414,NA,NA,Ticam2 (MGI:3040056)
5,115804732,115816707,5q22-q23,5q22.3,603943,CDO1,"Cysteine dioxygenase, type 1",CDO1,1036,ENSG00000129596,NA,NA,Cdo1 (MGI:105925)
5,115841605,115914080,5q23.1,5q22.3-q23.1,601507,"AP3S1, CLAPS3","Adaptor-related protein complex 3, sigma 1 subunit",AP3S1,1176,ENSG00000177879,previously assigned to chr. 12 by FISH,NA,Ap3s1 (MGI:1337062)
5,115900000,181538259,5q23-q35,NA,181510,SCZD1,"Schizophrenia susceptibility locus, chromosome 5-related",SCZD1,6377,NA,max lod at D5S820,"{Schizophrenia}, 181500 (2), Autosomal dominant",NA
5,115962474,116027605,5q23.1,5q23.1,610046,LVRN,Laeverin,LVRN,206338,ENSG00000172901,NA,NA,Lvrn (MGI:1921824)
5,116085024,116293289,5q23.1,5q23.1,616704,COMMD10,COMM domain-containing protein 10,COMMD10,51397,ENSG00000145781,NA,NA,Commd10 (MGI:1916706)
5,116443554,116574822,5q23.1,5q23.1,605885,SEMA6A,Semaphorin 6A,SEMA6A,57556,ENSG00000092421,NA,NA,Sema6a (MGI:1203727)
5,119071001,119249431,5q21-q22,5q23.1,605671,DMXL1,DMX-like 1,DMXL1,1657,ENSG00000172869,NA,NA,Dmxl1 (MGI:2443926)
5,119268758,119399687,5q23.1,5q23.1,612111,"TNFAIP8, SCCS2",Tumor necrosis factor-alpha-induced protein 8,TNFAIP8,25816,ENSG00000145779,NA,NA,Tnfaip8 (MGI:2147191)
5,119452496,119542331,5q23.1,5q23.1,601860,"HSD17B4, PRLTS1",Hydroxysteroid (17-beta) dehydrogenase 4,HSD17B4,3295,ENSG00000133835,NA,"D-bifunctional protein deficiency, 261515 (3), Autosomal recessive; Perrault syndrome 1, 233400 (3), Autosomal recessive",Hsd17b4 (MGI:105089)
5,119629557,119635821,5q23.1,5q23.1,618401,"FAM170A, ZNFD","Family with sequence similarity 170, member A",FAM170A,340069,ENSG00000164334,NA,NA,Fam170a (MGI:2684939)
5,120464221,120794586,5q23.1,5q23.1,615931,"PRR16, LARGEN",Proline-rich protein 16,PRR16,51334,ENSG00000184838,NA,NA,Prr16 (MGI:1918623)
5,121851881,121852832,5q21.3,5q23.1,608847,FTMT,"Ferritin, mitochondrial",FTMT,94033,ENSG00000181867,NA,NA,Ftmt (MGI:1914884)
5,121961974,122075623,5q23.1,5q23.1,610479,"SRFBP1, P49",Serum response factor binding protein 1,SRFBP1,153443,ENSG00000151304,NA,NA,Srfbp1 (MGI:1914472)
5,122063194,122078258,5q23.3-q31.2,5q23.1,153455,"LOX, AAT10",Lysyl oxidase,LOX,4015,ENSG00000113083,NA,"Aortic aneurysm, familial thoracic 10, 617168 (3), Autosomal dominant",Lox (MGI:96817)
5,122311353,122464218,5q23.1-q23.3,5q23.2,603779,SNCAIP,Synuclein-alpha-interacting protein (synphilin 1),SNCAIP,9627,ENSG00000064692,NA,NA,Sncaip (MGI:1915097)
5,122774995,122834542,5q23,5q23.2,605929,SNX2,Sorting nexin 2,SNX2,6643,ENSG00000205302,NA,NA,Snx2 (MGI:1915054)
5,123023249,123036724,5q23.2,5q23.2,123842,PPIC,Peptidyl-prolyl isomerase C,PPIC,5480,ENSG00000168938,NA,NA,Ppic (MGI:97751)
5,123089147,123194265,5q23.2,5q23.2,616982,"PRDM6, PRISM, PDA3",PR domain-containing protein 6,PRDM6,93166,ENSG00000061455,NA,"Patent ductus arteriosus 3, 617039 (3), Autosomal dominant",Prdm6 (MGI:2684938)
5,123344884,123423591,5q23.2,5q23.2,613446,"CEP120, CCDC100, SRTD13, JBTS31","Centrosomal protein, 120kD",CEP120,153241,ENSG00000168944,NA,"Joubert syndrome 31, 617761 (3), Autosomal recessive; Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3), Autosomal recessive",Cep120 (MGI:2147298)
5,123512098,123617048,5q23,5q23.2,604253,CSNK1G3,"Casein kinase I, gamma-3",CSNK1G3,1456,ENSG00000151292,NA,NA,Csnk1g3 (MGI:1917675)
5,126541840,126595218,5q31,5q23.2,107323,"ALDH7A1, ATQ1, EPD, PDE","Aldehyde dehydrogenase 7 family, member A1 (antiquitin 1)",ALDH7A1,501,ENSG00000164904,NA,"Epilepsy, pyridoxine-dependent, 266100 (3), Autosomal recessive",Aldh7a1 (MGI:108186)
5,126600946,126627251,5q23.2,5q23.2,604924,"RNUXA, PHAX","RNA, U small nuclear, export adaptor",PHAX,51808,ENSG00000164902,NA,NA,Phax (MGI:1891839)
5,126776622,126837019,5q23.2,5q23.2,150340,"LMNB1, ADLD",Lamin B1,LMNB1,4001,ENSG00000113368,NA,"Leukodystrophy, adult-onset, autosomal dominant, 169500 (3), Autosomal dominant",Lmnb1 (MGI:96795)
5,126867713,127032401,5q23.2,5q23.2,613333,MARCH3,Membrane-associated RING-CH finger protein 3,MARCHF3,115123,ENSG00000173926,NA,NA,March3 (MGI:2443667)
5,127229518,127461221,5q23.2,5q23.2,612453,"MEGF10, KIAA1780, EMARDD",Multiple epidermal growth factor-like domains 10,MEGF10,84466,ENSG00000145794,NA,"Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3), Autosomal recessive; Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3), Autosomal recessive",Megf10 (MGI:2685177)
5,128083765,128189687,5q23.3,5q23.3,600840,"SLC12A2, NKCC1","Solute carrier family 12 (sodium/potassium/chloride transporters), member 2",SLC12A2,6558,ENSG00000064651,NA,NA,Slc12a2 (MGI:101924)
5,128257908,128538244,5q23-q31,5q23.3,612570,"FBN2, CCA, EOMD",Fibrillin-2,FBN2,2201,ENSG00000138829,NA,"Contractural arachnodactyly, congenital, 121050 (3), Autosomal dominant; Macular degeneration, early-onset, 616118 (3), Autosomal dominant",Fbn2 (MGI:95490)
5,129460280,129738680,5q31,5q23.3,607513,ADAMTS19,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 19",ADAMTS19,171019,ENSG00000145808,NA,NA,Adamts19 (MGI:2442875)
5,129903383,130186636,5q31,5q23.3,609963,"CHSY3, CSS3",Chondroitin sulfate synthase 3,CHSY3,337876,ENSG00000198108,NA,NA,Chsy3 (MGI:1926173)
5,131159026,131165347,5q31.2,5q23.3,601314,"HINT1, PRKCNH1, NMAN",Histidine triad nucleotide-binding protein 1 (protein kinase C inhibitor 1),HINT1,3094,ENSG00000169567,NA,"Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3), Autosomal recessive",Hint1 (MGI:1321133)
5,131170943,131205427,5q23.3,5q23.3-q31.1,615831,"LYRM7, MZM1L, MC3DN8",LYR motif-containing protein 7,LYRM7,90624,ENSG00000186687,NA,"Mitochondrial complex III deficiency, nuclear type 8, 615838 (3), Autosomal recessive",Lyrm7 (MGI:1922780)
5,131200000,160500000,5q31-q33,NA,608174,AITD2,"Autoimmune thyroid disease, susceptibility to, 2",NA,387579,NA,NA,"{Autoimmune thyroid disease, susceptibility to, 2}, 608174 (2)",NA
5,131200000,160500000,5q31-q33,NA,605845,ATOD6,"Dermatitis, atopic, 6",NA,114477,NA,between D5S436 and D5S643,"{Dermatitis, atopic, susceptibility to, 6}, 605845 (2)",NA
5,131200000,160500000,5q31-q33,NA,609754,CELIAC2,"Celiac disease, susceptibility to, 2",CELIAC2,317782,NA,NA,"{Celiac disease, susceptibility to, 2}, 609754 (2)",NA
5,131200000,150400000,5q31.1-q32,NA,607683,"DFNA52, DFNA42","Deafness, autosomal dominant 52",NA,NA,NA,max lod at D5S2017,"Deafness, autosomal dominant 52, 607683 (2), Autosomal dominant",NA
5,131200000,145100000,5q31,NA,615649,DFNA54,"Deafness, autosomal dominant 54",DFNA54,448962,NA,between D5S1972 and D5S410,"Deafness, autosomal dominant 54, 615649 (2), Autosomal dominant",NA
5,131200000,160500000,5q31-q33,NA,131400,EOS,"Eosinophilia, familial",NA,7908,NA,NA,"Eosinophilia, familial, 131400 (2), Autosomal dominant",NA
5,131200000,145100000,5q31,NA,606348,IBD5,Inflammatory bowel disease 5,IBD5,50941,NA,NA,"{Inflammatory bowel disease 5}, 606348 (2)",NA
5,131200000,153300000,5q31.1-q33.1,NA,605598,IDDM18,Insulin-dependent diabetes mellitus-18,IDDM18,57044,NA,close to IL12B,"{Diabetes mellitus, insulin-dependent, 18}, 605598 (2)",NA
5,131200000,136900000,5q31.1,NA,147061,IGES,"Immunoglobulin E concentration, serum",IGES,3478,NA,NA,"{?Allergy and asthma susceptibility}, 147061 (2)",NA
5,131200000,145100000,5q31,NA,604966,PCDHA@,Protocadherin-alpha gene cluster,NA,NA,NA,NA,NA,NA
5,131200000,145100000,5q31,NA,604967,PCDHB@,Protocadherin-beta gene cluster,NA,NA,NA,NA,NA,NA
5,131200000,145100000,5q31,NA,604968,PCDHG,Protocadherin-gamma gene cluster,NA,NA,NA,NA,NA,NA
5,131200000,145100000,5q31,NA,606263,PDB4,Paget disease of bone 4,PDB4,94003,NA,NA,"Paget disease of bone 4, 606263 (2), Autosomal dominant",NA
5,131200000,160500000,5q31-q33,NA,248310,PFBI,Plasmodium falciparum blood infection levels,NA,7910,NA,NA,"{Malaria, intensity of infection}, 248310 (2), Autosomal recessive",NA
5,131200000,153300000,5q31.1-q33.1,NA,612599,PSORS11,Psoriasis susceptibility 11,NA,100271719,NA,associated with rs10045431,"{Psoriasis susceptibility 11}, 612599 (2)",NA
5,131200000,145100000,5q31,NA,615197,RLS8,"Restless legs syndrome, susceptibility to, 8",NA,101448072,NA,NA,"{Restless legs syndrome 8}, 615197 (2)",NA
5,131200000,160500000,5q31-q33,NA,181460,SM1,"Schistosoma mansoni infection, susceptibility/resistance to",NA,7911,NA,NA,"{Schistosoma mansoni infection, susceptibility/resistance to}, 181460 (2), Autosomal dominant",NA
5,131423920,131635228,5q31.1,5q31.1,610499,"RAPGEF6, RAGEF2, PDZGEF2",RAP guanine nucleotide exchange factor 6,RAPGEF6,51735,ENSG00000158987,NA,NA,Rapgef6 (MGI:2384761)
5,131641713,131797016,5q23.3,5q31.1,610594,"FNIP1, KIAA1961",Folliculin-interacting protein 1,FNIP1,96459,ENSG00000217128,NA,NA,Fnip1 (MGI:2444668)
5,131806989,131945662,5q31.1,5q31.1,616232,MEIKIN,Meiotic kinetochore factor,MEIKIN,728637,ENSG00000239642,NA,NA,Meikin (MGI:1922097)
5,131949972,132012067,5q31,5q31.1,604443,"ACSL6, FACL6, ACS2",Acyl-CoA synthetase long-chain family member 6,ACSL6,23305,ENSG00000164398,NA,"Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)",Acsl6 (MGI:894291)
5,132060654,132063203,5q31.1,5q31.1,147740,IL3,Interleukin-3,IL3,3562,ENSG00000164399,9kb from CSF2; order: cen-5'IL3-5'CF2-qter,NA,NA
5,132073788,132076169,5q31.1,5q31.1,138960,"CSF2, GMCSF",Colony-stimulating factor-2 (granulocyte-macrophage),CSF2,1437,ENSG00000164400,order: cen-CSF2-CSF1-FMS-qter,NA,Csf2 (MGI:1339752)
5,132190146,132227862,5q31,5q31.1,600608,"P4HA2, MYP25","Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 2",P4HA2,8974,ENSG00000072682,NA,"Myopia 25, autosomal dominant, 617238 (3), Autosomal dominant",P4ha2 (MGI:894286)
5,132257657,132273453,5q31.1,5q31.1,603422,RIL,LIM domain protein ril,PDLIM4,8572,ENSG00000131435,NA,"{Osteoporosis, susceptibility to}, 166710 (3), Autosomal dominant",Pdlim4 (MGI:1353470)
5,132294383,132344198,5q31,5q31.1,604190,"SLC22A4, OCTN1","Solute carrier family 22 (organic cation transporter), member 4",SLC22A4,6583,ENSG00000197208,NA,"{Rheumatoid arthritis, susceptibility to}, 180300 (3)",Slc22a4 (MGI:1353479)
5,132369703,132395613,5q31.1,5q31.1,603377,"SLC22A5, OCTN2, CDSP, SCD","Solute carrier, family 22 (organic cation transporter), member 5",SLC22A5,6584,ENSG00000197375,NA,"Carnitine deficiency, systemic primary, 212140 (3), Autosomal recessive",Slc22a5 (MGI:1329012)
5,132481608,132490788,5q31.1,5q31.1,147575,"IRF1, MAR",Interferon regulatory factor-1,IRF1,3659,ENSG00000125347,NA,"Gastric cancer, somatic, 613659 (3); Myelodysplastic syndrome, preleukemic (3); Myelogenous leukemia, acute (3); Nonsmall cell lung cancer, somatic, 211980 (3)",Irf1 (MGI:96590)
5,132539193,132556863,5q31.1,5q31.1,147850,IL5,Interleukin-5,IL5,3567,ENSG00000113525,< 310kb from IL4,NA,Il5 (MGI:96557)
5,132556976,132646348,5q31,5q31.1,604040,"RAD50, NBSLD","RAD50, S. cerevisiae, homolog of",RAD50,10111,ENSG00000113522,NA,"Nijmegen breakage syndrome-like disorder, 613078 (3)",Rad50 (MGI:109292)
5,132656521,132661109,5q31,5q31.1,147683,"IL13, ALRH, BHR1",Interleukin-13,IL13,3596,ENSG00000169194,NA,"{Allergic rhinitis, susceptibility to}, 607154 (3); {Asthma, susceptibility to}, 600807 (3), Autosomal dominant",Il13 (MGI:96541)
5,132673985,132682677,5q31.1,5q31.1,147780,IL4,Interleukin-4,IL4,3565,ENSG00000113520,NA,NA,Il4 (MGI:96556)
5,132688807,132737562,5q31,5q31.1,604683,KIF3A,Kinesin family member 3A,KIF3A,11127,ENSG00000131437,NA,NA,Kif3a (MGI:107689)
5,132750818,132778215,5q31-q33,5q31.1,608418,"SEPT8, KIAA0202",Septin 8,SEPTIN8,23176,ENSG00000164402,NA,NA,Sept8 (MGI:894310)
5,132822140,132831626,5q31.1,5q31.1,611179,"SHROOM1, APXL2, KIAA1960",SHROOM family member 1,SHROOM1,134549,ENSG00000164403,NA,NA,Shroom1 (MGI:1919024)
5,132861180,132866883,5q31.1,5q31.1,601918,"GDF9, POF14",Growth/differentiation factor 9,GDF9,2661,ENSG00000164404,mutation identified in 1 patient,"?Premature ovarian failure 14, 618014 (3), Autosomal recessive",Gdf9 (MGI:95692)
5,132866641,132868846,5q31.1,5q31.1,612080,"UQCRQ, QPC, MC3DN4","Ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kD",UQCRQ,27089,ENSG00000164405,NA,"Mitochondrial complex III deficiency, nuclear type 4, 615159 (3), Autosomal recessive",Uqcrq (MGI:107807)
5,132873667,132875045,5q31.1,5q31.1,611373,LEAP2,Liver-expressed antimicrobial peptide 2,LEAP2,116842,ENSG00000164406,NA,NA,Leap2 (MGI:2672795)
5,132875380,132963654,5q31,5q31.1,604417,"AFF4, AF5Q31, CHOPS","AF4/FMR2 family, member 4",AFF4,27125,ENSG00000072364,NA,"CHOPS syndrome, 616368 (3), Autosomal dominant",Aff4 (MGI:2136171)
5,133052012,133106448,5q31.1-q31.2,5q31.1,601113,HSPA4,Heat-shock 70kD protein-4,HSPA4,3308,ENSG00000170606,NA,NA,Hspa4 (MGI:1342292)
5,133913676,133917268,5q31.1,5q31.1,616333,"WSPAR, lncTCF7",WNT signaling pathway activating noncoding RNA,WSPAR,105664404,ENSG00000249073,NA,NA,NA
5,133971870,134070986,5q31,5q31.1,604492,VDAC1,Voltage-dependent anion channel 1,VDAC1,7416,ENSG00000213585,NA,NA,Vdac1 (MGI:106919)
5,134114680,134148228,5q31.1,5q31.1,189908,TCF7,"Transcription factor-7, T-cell specific",TCF7,6932,ENSG00000081059,originally called TCF-1,NA,NA
5,134148934,134177032,5q31,5q31.1,601434,"SKP1, SKP1A, TCEB1L, OCP2",S-phase kinase-associated protein 1 (p19A),SKP1,6500,ENSG00000113558,pseudogene on chr.7,NA,Skp1a (MGI:103575)
5,134194331,134226072,5q23-q31,5q31.1,176915,"PPP2CA, NEDLBA","Protein phosphatase-2 (formerly 2A), catalytic subunit, alpha isoform",PPP2CA,5515,ENSG00000113575,NA,"Neurodevelopmental disorder and language delay with or without structural brain abnormalities, 618354 (3), Autosomal dominant",Ppp2ca (MGI:1321159)
5,134236119,134372379,5q31,5q31.1,608459,"CDKL3, NKIAMRE",Cyclin-dependent kinase-like 3,CDKL3,51265,ENSG00000006837,NA,NA,Cdkl3 (MGI:2388268)
5,134371568,134392107,5q23-q31,5q31.1,179095,"UBE2B, RAD6B",Ubiquitin-conjugating enzyme E2B (RAD6 homolog),UBE2B,7320,ENSG00000119048,NA,?Male infertility (1),Ube2b (MGI:102944)
5,134524152,134583227,5q31.1,5q31.1,610515,"PHF15, JADE2, KIAA0239",PHD finger protein 15,JADE2,23338,ENSG00000043143,NA,NA,Jade2 (MGI:1924151)
5,134601148,134632827,5q31.1,5q31.1,607690,"SAR1B, CMRD, SARA2, ANDD","Sar1a, S. cerevisiae, homolog 2",SAR1B,51128,ENSG00000152700,NA,"Chylomicron retention disease, 246700 (3), Autosomal recessive",Sar1b (MGI:1913647)
5,134647756,134727908,5q31.1,5q31.1,607183,SEC24A,"Sec24-related gene family, member A",SEC24A,10802,ENSG00000113615,NA,NA,Sec24a (MGI:1924621)
5,134738547,134752156,5q23,5q31.1,601118,CAMLG,Calcium-modulating cyclophilin ligand,CAMLG,819,ENSG00000164615,NA,NA,Caml (MGI:104728)
5,134758733,134831137,5q31.1,5q31.1,617848,"DDX46, PRP5, KIAA0801",DEAD box helicase 46,DDX46,9879,ENSG00000145833,NA,NA,Ddx46 (MGI:1920895)
5,134873769,134901632,5q31.1,5q31.1,617778,"TXNDC15, C5orf14, BUG",Thioredoxin domain-containing protein 15,TXNDC15,79770,ENSG00000113621,NA,NA,Txndc15 (MGI:1916922)
5,134905119,134962645,5q31.2,5q31.1,609836,"PCBD2, DCOH2, DCOHM",Pterin-4-alpha-carbinolamine dehydratase 2,PCBD2,84105,ENSG00000132570,NA,NA,Pcbd2 (MGI:1919812)
5,134967906,135011695,5q31.1,5q31.1,609120,"CATSPER3, CACRC","Cation channel, sperm-associated, 3",CATSPER3,347732,ENSG00000152705,NA,NA,Catsper3 (MGI:1924106)
5,135027733,135034227,5q31,5q31.1,602149,"PITX1, PTX1, BFT, POTX, CCF, LBNBG",Paired-like homeodomain transcription factor-1,PITX1,5307,ENSG00000069011,NA,"Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3), Autosomal dominant; Liebenberg syndrome, 186550 (4), Autosomal dominant",Pitx1 (MGI:107374)
5,135334380,135401997,5q31.3-q32,5q31.1,610054,"H2AFY, MH2A1","H2A histone family, member Y",H2AFY,9555,ENSG00000113648,NA,NA,H2afy (MGI:1349392)
5,135444213,135447347,5q31.1,5q31.1,609710,"C5orf20, DCNP1",Dendritic cell nuclear protein 1,DCANP1,140947,ENSG00000251380,NA,NA,NA
5,135444225,135452350,5q31.2,5q31.1,612663,TIFAB,"TRAF-interacting protein with forkhead-associated domain, family member B",TIFAB,497189,ENSG00000255833,NA,NA,Tifab (MGI:2385852)
5,135534281,135535963,5q23-q31,5q31.1,601726,"NEUROG1, NEUROD3",Neurogenin 1,NEUROG1,4762,ENSG00000181965,NA,NA,Neurog1 (MGI:107754)
5,135570678,135579278,5q31,5q31.1,604186,"CXCL14, SCYB14, BRAK","Chemokine, C-X-C motif, ligand 14",CXCL14,9547,ENSG00000145824,NA,NA,Cxcl14 (MGI:1888514)
5,135579164,135888636,5q31.1,5q31.1,616150,SLC25A48,"Solute carrier family 25, member 48",SLC25A48,153328,ENSG00000145832,NA,NA,NA
5,135892245,135895840,5q31.1,5q31.1,146931,IL9,Interleukin-9,IL9,3578,ENSG00000145839,NA,NA,Il9 (MGI:96563)
5,135930296,135941995,5q31.1,5q31.1,609087,"FBXL21, FBL21, FBXL3B, FBL3B",F-box and leucine-rich repeat protein 21,FBXL21P,26223,NA,NA,NA,NA
5,135946903,135954982,5q31.1-q32,5q31.1,602882,LECT2,Leukocyte cell-derived chemotaxin 2,LECT2,3950,ENSG00000145826,NA,NA,Lect2 (MGI:1278342)
5,136028987,136063817,5q31,5q31.1,601692,"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD","Transforming growth factor, beta-induced, 68kD",TGFBI,7045,ENSG00000120708,NA,"Corneal dystrophy, Avellino type, 607541 (3), Autosomal dominant; Corneal dystrophy, Groenouw type I, 121900 (3), Autosomal dominant; Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3), Autosomal dominant; Corneal dystrophy, epithelial basement membrane, 121820 (3), Autosomal dominant; Corneal dystrophy, lattice type I, 122200 (3), Autosomal dominant; Corneal dystrophy, lattice type IIIA, 608471 (3), Autosomal dominant",Tgfbi (MGI:99959)
5,136080490,136080597,5q31,5q31.1,614938,"VTRNA2-1, NC886, CBL3, VTRNA2",Vault RNA 2-1,VTRNA2-1,100126299,ENSG00000278815,NA,NA,NA
5,136132844,136182733,5q31,5q31.1,603110,"MADH5, SMAD5","Mothers against decapentaplegic, Drosophila, homolog of, 5",SMAD5,4090,ENSG00000113658,NA,NA,Smad5 (MGI:1328787)
5,136975297,137499325,5q31,5q31.2,602264,SPOCK,Testican,SPOCK1,6695,ENSG00000152377,previously mapped to chr.21,NA,Spock1 (MGI:105371)
5,137617499,137736088,5q31,5q31.2,605775,"KLHL3, PHA2D",Kelch-like 3,KLHL3,26249,ENSG00000146021,NA,"Pseudohypoaldosteronism, type IID, 614495 (3), Autosomal recessive, Autosomal dominant",Klhl3 (MGI:2445185)
5,137745650,137754362,5q31,5q31.2,609409,HNRPA0,Heterogeneous nuclear ribonucleoprotein A0,HNRNPA0,10949,ENSG00000177733,NA,NA,Hnrnpa0 (MGI:1924384)
5,137801192,137810750,5q31,5q31.2,601770,"NPY6R, PP2",Neuropeptide Y receptor Y6,NPY6R,4888,ENSG00000226306,?nonfunctional pseudogene,NA,NA
5,137867281,137887850,5q31,5q31.2,604103,"MYOT, TTOD, MFM3",Myotilin (titin immunoglobulin domain protein),MYOT,9499,ENSG00000120729,NA,"Myopathy, myofibrillar, 3, 609200 (3), Autosomal dominant; Myopathy, spheroid body, 182920 (3), Autosomal dominant",Myot (MGI:1889800)
5,137889410,137942746,5q31,5q31.2,604669,PKD2L2,Polycystin 2-like 2,PKD2L2,27039,ENSG00000078795,NA,NA,Pkd2l2 (MGI:1858231)
5,137937908,138051960,5q31.2,5q31.2,609371,"FAM13B, C5orf5","Family with sequence similarity 13, member B",FAM13B,51306,ENSG00000031003,NA,NA,Fam13b (MGI:2447834)
5,138077366,138092899,5q31.2,5q31.2,606360,WNT8A,"Wingless-type MMTV integration site family, member 8A",WNT8A,7478,ENSG00000061492,NA,NA,Wnt8a (MGI:107924)
5,138115174,138139470,5q23-q31,5q31.2,603575,"NME5, NM23H5","Nonmetastatic cells 5, protein expressed in (nonmetastatic protein 23, homolog 5)",NME5,8382,ENSG00000112981,NA,NA,Nme5 (MGI:1922783)
5,138139769,138178668,5q31.2,5q31.2,602848,"BRD8, SMAP",Bromodomain-containing protein 8,BRD8,10902,ENSG00000112983,NA,NA,Brd8 (MGI:1925906)
5,138179111,138187722,5q31,5q31.2,605664,"KIF20A, RAB6KIFL",Kinesin family member 20A,KIF20A,10112,ENSG00000112984,NA,NA,Kif20a (MGI:1201682)
5,138187649,138213322,5q31.1,5q31.2,603462,"CDC23, APC8",Cell division cycle 23 (anaphase-promoting complex 8),CDC23,8697,ENSG00000094880,NA,NA,Cdc23 (MGI:1098815)
5,138252379,138274620,5q31,5q31.2,605710,GFRA3,GDNF family receptor alpha-3,GFRA3,2676,ENSG00000146013,NA,NA,Gfra3 (MGI:1201403)
5,138285264,138338354,5q31,5q31.2,157680,CDC25C,Cell division cycle 25C,CDC25C,995,ENSG00000158402,NA,NA,Cdc25c (MGI:88350)
5,138337556,138349728,5q31.2,5q31.2,609372,"FAM53C, C5orf6","Family with sequence similarity 53, member C",FAM53C,51307,ENSG00000120709,NA,NA,Fam53c (MGI:1913556)
5,138352684,138437026,5q31,5q31.2,609373,"KDM3B, C5orf7, KIAA1082, JMJD1B",Lysine-specific demethylase 3B,KDM3B,51780,ENSG00000120733,NA,NA,Kdm3b (MGI:1923356)
5,138439000,138446968,5q31,5q31.2,609347,"REEP2, C5orf19, SPG72",Receptor expression-enhancing protein 2,REEP2,51308,ENSG00000132563,mutation identified in 1 family each SPG72 AR and AD,"?Spastic paraplegia 72, autosomal dominant, 615625 (3), Autosomal recessive, Autosomal dominant; ?Spastic paraplegia 72, autosomal recessive, 615625 (3), Autosomal recessive, Autosomal dominant",Reep2 (MGI:2385070)
5,138465478,138469302,5q31.1,5q31.2,128990,EGR1,Early growth response-1,EGR1,1958,ENSG00000120738,NA,NA,Egr1 (MGI:95295)
5,138506092,138543235,5q31.1,5q31.2,600285,"ETF1, RF1, ERF1",Eukaryotic translation termination factor-1,ETF1,2107,ENSG00000120705,NA,NA,Etf1 (MGI:2385071)
5,138553755,138575400,5q31.2,5q31.2,600548,"HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4",Heat-shock 70kD protein-9 (mortalin),HSPA9,3313,ENSG00000113013,NA,"Anemia, sideroblastic, 4, 182170 (3), Autosomal dominant; Even-plus syndrome, 616854 (3), Autosomal recessive",Hspa9 (MGI:96245)
5,138753385,138935033,5q31,5q31.2,116805,"CTNNA1, MDPT2","Catenin (cadherin-associated protein), alpha 1, 102kD",CTNNA1,1495,ENSG00000044115,NA,"Macular dystrophy, patterned, 2, 608970 (3), Autosomal dominant",Ctnna1 (MGI:88274)
5,138868920,138875334,5q31.2,5q31.2,610868,"LRRTM2, KIAA0416",Leucine-rich repeat transmembrane protein 2,LRRTM2,26045,ENSG00000146006,NA,NA,Lrrtm2 (MGI:2389174)
5,138946723,139198367,5q31,5q31.2,608005,"SIL1, BAP, MSS","Sil1, S. cerevisiae, homolog of",SIL1,64374,ENSG00000120725,NA,"Marinesco-Sjogren syndrome, 248800 (3), Autosomal recessive",Sil1 (MGI:1932040)
5,139273751,139331676,5q31.2,5q31.2,164015,"MATR3, MPD2, ALS21",Matrin 3,MATR3,9782,ENSG00000015479,NA,"Amyotrophic lateral sclerosis 21, 606070 (3), Autosomal dominant",Matr3 (MGI:1298379)
5,139341831,139369719,5q31.2,5q31.2,605604,"PAIP2, PAIP2A",Polyadenylate-binding protein-interacting protein 2,PAIP2,51247,ENSG00000120727,NA,NA,Paip2 (MGI:1915119)
5,139367195,139384552,5q31.2-q31.3,5q31.2,603790,"SLC23A1, SVCT1","Solute carrier family 23 (nucleobase transporter), member 1 (sodium-dependent vitamin C transporter 1)",SLC23A1,9963,ENSG00000170482,opposite orientation to MATR3,NA,Slc23a1 (MGI:1341903)
5,139387466,139389912,5q31.2,5q31.2,609447,"MZB1, PACAP, MGC29506",Marginal zone B and B1 cell-specific protein,MZB1,51237,ENSG00000170476,NA,NA,Mzb1 (MGI:1917066)
5,139448553,139462742,5q31,5q31.2,615736,"ECSCR, ECSM2, ARIA",Endothelial cell surface-expressed chemotaxis and apoptosis regulator,ECSCR,641700,ENSG00000249751,NA,NA,Ecscr (MGI:1915795)
5,139475532,139482757,5q31.2,5q31.2,612374,"TMEM173, STING, MPYS, SAVI",Transmembrane protein 173,TMEM173,340061,ENSG00000184584,NA,"STING-associated vasculopathy, infantile-onset, 615934 (3), Autosomal dominant",Tmem173 (MGI:1919762)
5,139561165,139628433,5q31.2,5q31.2,602962,"UBE2D2, UBCH5B, UBC4",Ubiquitin-conjugating enzyme E2D 2,UBE2D2,7322,ENSG00000131508,NA,NA,Ube2d2a (MGI:1930715)
5,139647298,139683884,5q31.3,5q31.2,612752,CXXC5,CXXC finger protein 5,CXXC5,51523,ENSG00000171604,NA,NA,Cxxc5 (MGI:1914643)
5,139846778,140043674,5q23-q33,5q31.2,603818,NRG2,Neuregulin 2,NRG2,9542,ENSG00000158458,NA,NA,Nrg2 (MGI:1098246)
5,140100000,150400000,5q31.3-q32,NA,601101,"HHT3, ORW3","Hereditary hemorrhagic telangiectasia, type 3",NA,780903,NA,NA,"Telangiectasia, hereditary hemorrhagic, type 3, 601101 (2)",NA
5,140114108,140125618,5q31,5q31.3,600473,"PURA, PUR1, MRD31",Purine-rich element binding protein A,PURA,5813,ENSG00000185129,NA,"Mental retardation, autosomal dominant 31, 616158 (3), Autosomal dominant",Pura (MGI:103079)
5,140245034,140303100,5q31,5q31.3,604897,PFDN1,Prefoldin 1,PFDN1,5201,ENSG00000113068,NA,NA,Pfdn1 (MGI:1914449)
5,140332842,140346602,5q23,5q31.3,126150,"HBEGF, DTR, DTSF, HEGFL",Heparin-binding EGF-like growth factor (diphtheria toxin receptor),HBEGF,1839,ENSG00000113070,NA,"{Diphtheria, susceptibility to} (1)",Hbegf (MGI:96070)
5,140359644,140375176,5q31.3,5q31.3,610207,"SLC4A9, AE4","Solute carrier family 4 (anion exchanger), member 9",SLC4A9,83697,ENSG00000113073,NA,NA,Slc4a9 (MGI:2443384)
5,140401813,140539848,5q31.3,5q31.3,610500,"ANKHD1, MASK, KIAA1085, VBARP",Ankyrin repeat and KH domain-containing protein 1,ANKHD1,54882,ENSG00000131503,NA,NA,Ankhd1 (MGI:1921733)
5,140547661,140549575,5q31.3,5q31.3,603483,EIF4EBP3,Eukaryotic translation initiation factor 4E-binding protein 3,EIF4EBP3,8637,ENSG00000243056,NA,NA,Eif4ebp3 (MGI:1270847)
5,140550066,140558092,5q31.3,5q31.3,603819,SRA1,Steroid receptor RNA activator 1,SRA1,10011,ENSG00000213523,NA,NA,Sra1 (MGI:1344414)
5,140558267,140564603,5q31,5q31.3,602711,"APBB3, FE65L2","Amyloid beta (A4) precursor protein-binding, family B, member 3",APBB3,10307,ENSG00000113108,NA,NA,Apbb3 (MGI:108404)
5,140631727,140633700,5q31.1,5q31.3,158120,CD14,CD14 antigen,CD14,929,ENSG00000170458,NA,NA,Cd14 (MGI:88318)
5,140645362,140647784,5q31.2,5q31.3,602137,"NDUFA2, MC1DN13",NADH-ubiquinone oxidoreductase subunit A2,NDUFA2,4695,ENSG00000131495,mutation identified in 1 MC1DN13 patient,"?Mitochondrial complex I deficiency, nuclear type 13, 618235 (3), Autosomal recessive",Ndufa2 (MGI:1343103)
5,140647817,140662479,5q31.3,5q31.3,600549,"IK, RED","IK cytokine, downregulator of HLA II",IK,3550,ENSG00000113141,NA,NA,Ik (MGI:1345142)
5,140670793,140673575,5q31.3,5q31.3,609385,DND1,"Dead end, zebrafish, homolog of, 1",DND1,373863,ENSG00000256453,NA,NA,Dnd1 (MGI:2447763)
5,140673903,140691726,5q31.3,5q31.3,142810,"HARS, USH3B, CMT2W",Histidyl-tRNA synthetase,HARS1,3035,ENSG00000170445,NA,"Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3), Autosomal dominant; Usher syndrome type 3B, 614504 (3), Autosomal recessive",Hars (MGI:108087)
5,140691443,140699307,5q31.3,5q31.3,600783,"HARS2, HARSL, HARSR, HO3, PRLTS2",Histidyl-tRNA synthetase 2,HARS2,23438,ENSG00000112855,mutation identified in 1 PRLTS2 family,"?Perrault syndrome 2, 614926 (3), Autosomal recessive",Hars2 (MGI:1918041)
5,140711275,140711372,5q31,5q31.3,612695,"VTRNA1-1, HVG1, VAULTRC1",Vault RNA 1-1,VTRNA1-1,56664,ENSG00000199990,NA,NA,NA
5,140718925,140719012,5q31,5q31.3,612696,"VTRNA1-2, HVG2, VAULTRC2",Vault RNA 1-2,VTRNA1-2,56663,ENSG00000202111,NA,NA,NA
5,140726158,140726245,5q31,5q31.3,612697,"VTRNA1-3, HVG3, VAULTRC3",Vault RNA 1-3,VTRNA1-3,56662,ENSG00000202515,NA,NA,NA
5,140786135,141012343,5q31,5q31.3,606307,PCDHA1,Protocadherin-alpha 1,PCDHA1,56147,ENSG00000204970,NA,NA,Pcdha1 (MGI:2150982)
5,140794851,141012346,5q31,5q31.3,606308,PCDHA2,Protocadherin-alpha 2,PCDHA2,56146,ENSG00000204969,NA,NA,Pcdha2 (MGI:2681880)
5,140801056,141012346,5q31,5q31.3,606309,PCDHA3,Protocadherin-alpha 3,PCDHA3,56145,ENSG00000255408,NA,NA,Pcdha3 (MGI:2447313)
5,140807067,141012346,5q31,5q31.3,606310,PCDHA4,Protocadherin-alpha 4,PCDHA4,56144,ENSG00000204967,NA,NA,Pcdha4 (MGI:1298406)
5,140821612,141012346,5q31,5q31.3,606311,PCDHA5,Protocadherin-alpha 5,PCDHA5,56143,ENSG00000204965,NA,NA,Pcdha5 (MGI:1298371)
5,140827959,141012346,5q31,5q31.3,606312,PCDHA6,Protocadherin-alpha 6,PCDHA6,56142,ENSG00000081842,NA,NA,Pcdha6 (MGI:1298367)
5,140834268,141012346,5q31,5q31.3,606313,PCDHA7,Protocadherin-alpha 7,PCDHA7,56141,ENSG00000204963,NA,NA,Pcdha7 (MGI:1298369)
5,140841186,141012346,5q31,5q31.3,606314,PCDHA8,Protocadherin-alpha 8,PCDHA8,56140,ENSG00000204962,NA,NA,NA
5,140847771,141012343,5q31,5q31.3,606315,PCDHA9,Protocadherin-alpha 9,PCDHA9,9752,ENSG00000204961,NA,NA,Pcdha8 (MGI:2681879)
5,140855896,141012346,5q31,5q31.3,606316,PCDHA10,Protocadherin-alpha 10,PCDHA10,56139,ENSG00000250120,NA,NA,Pcdha9 (MGI:2447322)
5,140867512,141012343,5q31,5q31.3,606317,PCDHA11,Protocadherin-alpha 11,PCDHA11,56138,ENSG00000249158,NA,NA,Pcdha11 (MGI:1298372)
5,140875307,141012346,5q31,5q31.3,606318,PCDHA12,Protocadherin-alpha 12,PCDHA12,56137,ENSG00000251664,NA,NA,Pcdha10 (MGI:1298408)
5,140882123,141012346,5q31,5q31.3,606319,PCDHA13,Protocadherin-alpha 13,PCDHA13,56136,ENSG00000239389,NA,NA,Pcdha12 (MGI:1298370)
5,140926716,141012343,5q31,5q31.3,606320,PCDHAC1,"Protocadherin-alpha, subfamily C, member 1",PCDHAC1,56135,ENSG00000248383,NA,NA,Pcdhac1 (MGI:1891442)
5,140966475,141012346,5q31,5q31.3,606321,PCDHAC2,"Protocadherin-alpha, subfamily C, member 2",PCDHAC2,56134,ENSG00000243232,NA,NA,Pcdhac2 (MGI:1891443)
5,141051375,141053961,5q31,5q31.3,606327,PCDHB1,Protocadherin-beta 1,PCDHB1,29930,ENSG00000171815,NA,NA,Pcdhb1 (MGI:2136730)
5,141094614,141098702,5q31,5q31.3,606328,PCDHB2,Protocadherin-beta 2,PCDHB2,56133,ENSG00000112852,NA,NA,Pcdhb2 (MGI:2136735)
5,141100241,141103826,5q31,5q31.3,606329,PCDHB3,Protocadherin-beta 3,PCDHB3,56132,ENSG00000113205,NA,NA,Pcdhb3 (MGI:2136737)
5,141121817,141125622,5q31,5q31.3,606330,PCDHB4,Protocadherin-beta 4,PCDHB4,56131,ENSG00000081818,NA,NA,Pcdhb5 (MGI:2136739)
5,141135205,141138614,5q31,5q31.3,606331,PCDHB5,Protocadherin-beta 5,PCDHB5,26167,ENSG00000113209,NA,NA,Pcdhb10 (MGI:2136745)
5,141150021,141153286,5q31,5q31.3,606332,PCDHB6,Protocadherin-beta 6,PCDHB6,56130,ENSG00000113211,NA,NA,Pcdhb13 (MGI:2136748)
5,141172643,141176382,5q31,5q31.3,606333,PCDHB7,Protocadherin-beta 7,PCDHB7,56129,ENSG00000113212,NA,NA,Pcdhb15 (MGI:2136750)
5,141177789,141180538,5q31,5q31.3,606334,PCDHB8,Protocadherin-beta 8,PCDHB8,56128,ENSG00000120322,NA,NA,Pcdhb16 (MGI:2136752)
5,141181689,141186220,5q31,5q31.3,606345,PCDHB16,Protocadherin-beta 16,PCDHB16,57717,ENSG00000272674,NA,NA,Pcdhb17 (MGI:2136754)
5,141187160,141191540,5q31,5q31.3,606335,PCDHB9,Protocadherin-beta 9,PCDHB9,56127,ENSG00000177839,NA,NA,NA
5,141192352,141195646,5q31,5q31.3,606336,PCHB10,Protocadherin-beta 10,PCDHB10,56126,ENSG00000120324,NA,NA,NA
5,141199626,141203778,5q31,5q31.3,606337,PCDHB11,Protocadherin-beta 11,PCDHB11,56125,ENSG00000197479,NA,NA,Pcdhb21 (MGI:2136759)
5,141208718,141212570,5q31,5q31.3,606338,PCDHB12,Protocadherin-beta 12,PCDHB12,56124,ENSG00000120328,NA,NA,Pcdhb19 (MGI:2136757)
5,141213918,141218978,5q31,5q31.3,606339,PCDHB13,Protocadherin-beta 13,PCDHB13,56123,ENSG00000187372,NA,NA,NA
5,141222325,141226287,5q31,5q31.3,606340,PCDHB14,Protocadherin-beta 14,PCDHB14,56122,ENSG00000120327,NA,NA,Pcdhb20 (MGI:2136758)
5,141245394,141249364,5q31,5q31.3,606341,PCDHB15,Protocadherin-beta 15,PCDHB15,56121,ENSG00000113248,NA,NA,Pcdhb22 (MGI:2136760)
5,141302634,141304048,5q31,5q31.3,608157,"SLC25A2, ORNT2","Solute carrier family 25 (mitochondrial carrier, ornithine transporter), member 2",SLC25A2,83884,ENSG00000120329,NA,NA,NA
5,141318489,141320783,5q31,5q31.3,600573,"TAF7, TAF2F, TAFII55","TAF7 RNA polymerase II, TATA box-binding protein-associated factor, 55kD",TAF7,6879,ENSG00000178913,NA,NA,Taf7 (MGI:1346348)
5,141330684,141512978,5q31,5q31.3,606288,PCDHGA1,"Protocadherin-gamma, subfamily A, member 1",PCDHGA1,56114,ENSG00000204956,NA,NA,Pcdhga1 (MGI:1935212)
5,141338759,141512974,5q31,5q31.3,606289,PCDHGA2,"Protocadherin-gamma, subfamily A, member 2",PCDHGA2,56113,ENSG00000081853,NA,NA,Pcdhga2 (MGI:1935214)
5,141343828,141512974,5q31,5q31.3,606290,PCDHGA3,"Protocadherin-gamma, subfamily A, member 3",PCDHGA3,56112,ENSG00000254245,NA,NA,Pcdhga3 (MGI:1935215)
5,141350260,141512978,5q31,5q31.3,606299,PCDHGB1,"Protocadherin-gamma, subfamily B, member 1",PCDHGB1,56104,ENSG00000254221,NA,NA,Pcdhgb1 (MGI:1935169)
5,141355020,141512974,5q31,5q31.3,606291,PCDHGA4,"Protocadherin-gamma, subfamily A, member 4",PCDHGA4,56111,ENSG00000262576,NA,NA,Pcdhga4 (MGI:1935216)
5,141360135,141512978,5q31,5q31.3,606300,PCDHGB2,"Protocadherin-gamma, subfamily B, member 2",PCDHGB2,56103,ENSG00000253910,NA,NA,Pcdhgb2 (MGI:1935170)
5,141364330,141512978,5q31,5q31.3,606292,PCDHGA5,"Protocadherin-gamma, subfamily A, member 5",PCDHGA5,56110,ENSG00000253485,NA,NA,Pcdhga5 (MGI:1935217)
5,141370241,141512974,5q31,5q31.3,606301,PCDHGB3,"Protocadherin-gamma, subfamily B, member 3",PCDHGB3,56102,ENSG00000262209,NA,NA,Pcdhgb8 (MGI:1935200)
5,141373890,141512974,5q31,5q31.3,606293,PCDHGA6,"Protocadherin-gamma, subfamily A, member 6",PCDHGA6,56109,ENSG00000253731,NA,NA,Pcdhga6 (MGI:1935218)
5,141382741,141512974,5q31,5q31.3,606294,PCDHGA7,"Protocadherin-gamma, subfamily A, member 7",PCDHGA7,56108,ENSG00000253537,NA,NA,Pcdhga7 (MGI:1935219)
5,141387884,141512974,5q31,5q31.3,603058,PCDHGB4,"Protocadherin-gamma, subfamily B, member 4",PCDHGB4,8641,ENSG00000253953,NA,NA,Pcdhgb4 (MGI:1935173)
5,141391915,141512978,5q31,5q31.3,606295,PCDHGA8,"Protocadherin-gamma, subfamily A, member 8",PCDHGA8,9708,ENSG00000253767,NA,NA,Pcdhga8 (MGI:1935221)
5,141398127,141512978,5q31,5q31.3,606302,PCDHGB5,"Protocadherin-gamma, subfamily B, member 5",PCDHGB5,56101,ENSG00000276547,NA,NA,Pcdhgb5 (MGI:1935196)
5,141402952,141512978,5q31,5q31.3,606296,PCDHGA9,"Protocadherin-gamma, subfamily A, member 9",PCDHGA9,56107,ENSG00000261934,NA,NA,Pcdhga9 (MGI:1935226)
5,141408202,141512978,5q31,5q31.3,606303,PCDHGB6,"Protocadherin-gamma, subfamily B, member 6",PCDHGB6,56100,ENSG00000253305,NA,NA,Pcdhgb6 (MGI:1935197)
5,141413175,141512978,5q31,5q31.3,606297,PCDHGA10,"Protocadherin-gamma, subfamily A, member 10",PCDHGA10,56106,ENSG00000253846,NA,NA,Pcdhga10 (MGI:1935227)
5,141417676,141512974,5q31,5q31.3,606304,PCDHGB7,"Protocadherin-gamma, subfamily B, member 7",PCDHGB7,56099,ENSG00000254122,NA,NA,Pcdhgb7 (MGI:1935199)
5,141421050,141512974,5q31,5q31.3,606298,PCDHGA11,"Protocadherin-gamma, subfamily A, member 11",PCDHGA11,56105,ENSG00000253873,NA,NA,Pcdhga11 (MGI:1935228)
5,141430506,141512974,5q31,5q31.3,603059,PCDHGA12,"Protocadherin-gamma, subfamily A, member 12",PCDHGA12,26025,ENSG00000253159,NA,NA,Pcdhga12 (MGI:1935229)
5,141475965,141512974,5q31,5q31.3,603627,PCDHGC3,"Protocadherin-gamma, subfamily C, member 3",PCDHGC3,5098,ENSG00000240184,NA,NA,Pcdhgc3 (MGI:1935201)
5,141485173,141512978,5q31,5q31.3,606305,PCDHGC4,"Protocadherin-gamma, subfamily C, member 4",PCDHGC4,56098,ENSG00000242419,NA,NA,Pcdhgc4 (MGI:1935203)
5,141489080,141512974,5q31,5q31.3,606306,PCDHGC5,"Protocadherin-gamma, subfamily C, member 5",PCDHGC5,56097,ENSG00000240764,NA,NA,Pcdhgc5 (MGI:1935205)
5,141515015,141619054,5q31,5q31.3,602121,"DIAPH1, DFNA1, LFHL1, SCBMS","Diaphanous, Drosophila, homolog of, 1",DIAPH1,1729,ENSG00000131504,NA,"Deafness, autosomal dominant 1, 124900 (3), Autosomal dominant; Seizures, cortical blindness, microcephaly syndrome, 616632 (3), Autosomal recessive",Diaph1 (MGI:1194490)
5,141620875,141636855,5q31,5q31.3,605166,HDAC3,Histone deacetylase 3,HDAC3,8841,ENSG00000171720,NA,NA,Hdac3 (MGI:1343091)
5,141636949,141641076,5q31.3,5q31.3,611213,RELL2,Relt-like 2,RELL2,285613,ENSG00000164620,NA,NA,Rell2 (MGI:1918044)
5,141639301,141651442,5q31.3,5q31.3,617555,"FCHSD1, NWK2",FCH and double SH3 domains protein 1,FCHSD1,89848,ENSG00000197948,NA,NA,Fchsd1 (MGI:2441771)
5,141653400,141682229,5q31.3,5q31.3,606647,"ARAP3, CENTD3","ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3",ARAP3,64411,ENSG00000120318,NA,NA,Arap3 (MGI:2147274)
5,141850392,141878409,5q32-q33,5q31.3,603626,"PCDH1, PC42",Protocadherin 1 (cadherin-like 1),PCDH1,5097,ENSG00000156453,NA,NA,Pcdh1 (MGI:104692)
5,141923870,141952030,5q31.3,5q31.3,615741,"KIAA0141, DELE",KIAA0141 gene,DELE1,9812,ENSG00000081791,NA,NA,Dele1 (MGI:1914089)
5,141943584,141959061,5q31,5q31.3,605622,"PCDH12, VECAD2, PCDH12","Protocadherin 12 (cadherin, vascular endothelial, 2)",PCDH12,51294,ENSG00000113555,NA,"Microcephaly, seizures, spasticity, and brain calcification, 251280 (3), Autosomal recessive",Pcdh12 (MGI:1855700)
5,141966806,141990291,5q23.3-q31.1,5q31.3,605675,"RNF14, ARA54",RING finger protein-14,RNF14,9604,ENSG00000013561,NA,NA,Rnf14 (MGI:1929668)
5,142000670,142013026,5q31,5q31.3,601798,"GNPDA1, GNP1, GNPI, KIAA0060",Glucosamine 6-phosphate deaminase 1,GNPDA1,10007,ENSG00000113552,NA,NA,Gnpda1 (MGI:1347054)
5,142108778,142154439,5q31.3,5q31.3,612050,"NDFIP1, N4WBP5",NEDD4 family-interacting protein 1,NDFIP1,80762,ENSG00000131507,NA,NA,Ndfip1 (MGI:1929601)
5,142310434,142325020,5q31.3,5q31.3,607984,"SPRY4, HH17","Sprouty, Drosophila, homolog of",SPRY4,81848,ENSG00000187678,NA,"Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3), Autosomal dominant",Spry4 (MGI:1345144)
5,142317619,142318321,5q31.3,5q31.3,617617,SPRY4IT1,"SPRY4 intronic transcript 1, noncoding",SPRY4-IT1,100642175,NA,in intron 2 of SPRY4,NA,NA
5,142592177,142698069,5q31,5q31.3,131220,"FGF1, FGFA",Fibroblast growth factor-1 (acidic),FGF1,2246,ENSG00000113578,NA,NA,Fgf1 (MGI:95515)
5,142770369,143229010,5q31,5q31.3,605370,"ARHGAP26, GRAF",RHO GTPase-activating protein 26,ARHGAP26,23092,ENSG00000145819,NA,"Leukemia, juvenile myelomonocytic, somatic, 607785 (3)",Arhgap26 (MGI:1918552)
5,143277930,143435511,5q31,5q31.3,138040,"NR3C1, GCR, GRL, GCRST","Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",NR3C1,2908,ENSG00000113580,NA,"Glucocorticoid resistance, 615962 (3), Autosomal dominant",Nr3c1 (MGI:95824)
5,143812160,143820715,5q32,5q31.3,609961,HLA-HB1,Minor histocompatibility antigen HB-1,HMHB1,57824,ENSG00000158497,NA,NA,NA
5,144158161,144170658,5q32,5q31.3,611483,"YIPF5, SMAP5, YIP1A","Yip1 domain family, member 5",YIPF5,81555,ENSG00000145817,NA,NA,Yipf5 (MGI:1914430)
5,144170722,144485685,5q31.3,5q31.3,613423,"KCTD16, KIAA1317",Potassium channel tetramerization domain-containing 16,KCTD16,57528,ENSG00000183775,NA,NA,NA
5,145858537,145931672,5q32,5q32,615762,"GRXCR2, DFNB101","Glutaredoxin, cysteine-rich, 2",GRXCR2,643226,ENSG00000204928,mutation identified in 1 DFNB101 family,"?Deafness, autosomal recessive 101, 615837 (3), Autosomal recessive",Grxcr2 (MGI:2685697)
5,145936569,146081772,5q32,5q32,613377,"SH3RF2, HEPP1",SH3 domain-containing RING finger protein 2,SH3RF2,153769,ENSG00000156463,NA,NA,Sh3rf2 (MGI:2444628)
5,146113025,146182786,5q32,5q32,151350,"LARS, LFIS, ILFS1",Leucyl-tRNA synthetase,LARS1,51520,ENSG00000133706,mutation identified in 1 family,"?Infantile liver failure syndrome 1, 615438 (3), Autosomal recessive",Lars (MGI:1913808)
5,146338838,146341727,5q31,5q32,602460,"POU4F3, BRN3C","POU domain, class 4, transcription factor-3",POU4F3,5459,ENSG00000091010,NA,"Deafness, autosomal dominant 15, 602459 (3), Autosomal dominant",Pou4f3 (MGI:102523)
5,146447329,146511960,5q31,5q32,605409,"TCERG1, TAF2S, CA150",Transcription elongation regulator 1 (transcription factor CA150),TCERG1,10915,ENSG00000113649,NA,NA,Tcerg1 (MGI:1926421)
5,146589503,147081519,5q31-q33,5q32,604325,PPP2R2B,"Protein phosphatase 2, regulatory subunit B, beta",PPP2R2B,5521,ENSG00000156475,NA,"Spinocerebellar ataxia 12, 604326 (3), Autosomal dominant",Ppp2r2b (MGI:1920180)
5,147390807,147510067,5q32,5q32,601168,"DPYSL3, ULIP, DRP3",Dihydropyrimidinase-like 3,DPYSL3,1809,ENSG00000113657,NA,NA,Dpysl3 (MGI:1349762)
5,147585437,147782795,5q32,5q32,611197,"JAKMIP2, JAMIP2, NECC1, KIAA0555",Janus kinase and microtubule-interacting protein 2,JAKMIP2,9832,ENSG00000176049,NA,NA,Jakmip2 (MGI:1923467)
5,147824579,147839230,5q32,5q32,167790,"SPINK1, PSTI, PCTT, TATI, TCP","Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)",SPINK1,6690,ENSG00000164266,NA,"{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3), Autosomal recessive, Autosomal dominant; Pancreatitis, hereditary, 167800 (3), Autosomal dominant; Tropical calcific pancreatitis, 608189 (3), Autosomal recessive, Autosomal dominant",Spink1 (MGI:106202)
5,147878710,147882190,5q31-q34,5q32,606531,"SCGB3A2, UGRP1","Secretoglobin, family 3A, member 2 (uteroglobin-related protein 1)",SCGB3A2,117156,ENSG00000164265,NA,"{Asthma, susceptibility to}, 600807 (3), Autosomal dominant",Scgb3a2 (MGI:2153470)
5,148063971,148137381,5q32,5q32,605010,"SPINK5, LEKTI","Serine protease inhibitor, Kazal type, 5",SPINK5,11005,ENSG00000133710,NA,"Netherton syndrome, 256500 (3), Autosomal recessive",Spink5 (MGI:1919682)
5,148202793,148215136,5q32,5q32,615868,SPINK6,"Serine peptidase inhibitor, KAZAL-type, 6",SPINK6,404203,ENSG00000178172,NA,NA,NA
5,148268793,148286254,5q32,5q32,615205,SPINK13,"Serine protease inhibitor, Kazal-type, 13",SPINK13,153218,ENSG00000214510,NA,NA,Spink13 (MGI:3642511)
5,148312422,148315918,5q32,5q32,617288,"SPINK7, ECRG2","Serine peptidase inhibitor, Kazal-type, 7",SPINK7,84651,ENSG00000145879,NA,NA,Spink7 (MGI:3644691)
5,148323218,148341973,5q33.1,5q32,613511,"SPINK9, LEKTI2","Serine protease inhibitor, Kazal-type, 9",SPINK9,643394,ENSG00000204909,NA,NA,NA
5,148383934,148442835,5q33.1,5q32,608533,"FBXO38, FBX38, MOKA, HMN2D",F-box only protein 38,FBXO38,81545,ENSG00000145868,NA,"Neuronopathy, distal hereditary motor, type IID, 615575 (3), Autosomal dominant",NA
5,148451031,148654526,5q31-q33,5q32,602164,HTR4,5-hydroxytryptamine (serotonin) receptor-4,HTR4,3360,ENSG00000164270,NA,NA,Htr4 (MGI:109246)
5,148826592,148828633,5q32-q34,5q32,109690,ADRB2,"Adrenergic, beta-2-, receptor, surface",ADRB2,154,ENSG00000169252,NA,"{Asthma, nocturnal, susceptibility to}, 600807 (3), Autosomal dominant; Beta-2-adrenoreceptor agonist, reduced response to (3); {Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Adrb2 (MGI:87938)
5,148982149,149063173,5q32,5q32,608206,"SH3TC2, KIAA1985, MNMN",SH3 domain and tetratricopeptide repeat domain 2,SH3TC2,79628,ENSG00000169247,NA,"Charcot-Marie-Tooth disease, type 4C, 601596 (3), Autosomal recessive; Mononeuropathy of the median nerve, mild, 613353 (3), Autosomal dominant",Sh3tc2 (MGI:2444417)
5,149141446,149260438,5q32,5q32,611305,"ABLIM3, KIAA0843","Actin-binding LIM protein family, member 3",ABLIM3,22885,ENSG00000173210,NA,NA,Ablim3 (MGI:2442582)
5,149271837,149343636,5q33.1,5q32,614410,AFAP1L1,Actin filament-associated protein 1-like 1,AFAP1L1,134265,ENSG00000157510,NA,NA,Afap1l1 (MGI:2147199)
5,149374266,149404201,5q32-q34,5q32,604627,IL17B,Interleukin 17B,IL17B,27190,ENSG00000127743,NA,NA,Il17b (MGI:1928397)
5,149428917,149429022,5q33.1,5q32,612117,"MIR143, MIRN143",Micro RNA 143,MIR143,406935,ENSG00000284182,NA,NA,NA
5,149430645,149430732,5q33.1,5q32,611795,"MIR145, MIRN145",Micro RNA 145,MIR145,406937,ENSG00000276365,NA,NA,NA
5,149492981,149551438,5q32,5q32,600505,CSNK1A1,"Casein kinase-1, alpha-1 polypeptide",CSNK1A1,1452,ENSG00000113712,previously assigned to 13q13,NA,Csnk1a1 (MGI:1934950)
5,149730301,149857860,5q33,5q32,608886,"PPARGC1B, PGC1B, PERC","Peroxisome proliferator-activated receptor-gamma, coactivator 1, beta",PPARGC1B,133522,ENSG00000155846,NA,NA,Ppargc1b (MGI:2444934)
5,149732824,149732889,5q33.1,5q32,611957,"MIR378, MIRN378",Micro RNA 378,MIR378A,494327,ENSG00000199047,NA,NA,NA
5,149857952,149944792,5q31.2-q34,5q32,180071,"PDE6A, PDEA, RP43","Phosphodiesterase-6A, cGMP-specific, rod, alpha",PDE6A,5145,ENSG00000132915,NA,"Retinitis pigmentosa 43, 613810 (3)",Pde6a (MGI:97524)
5,149960736,149987399,5q32-q33.1,5q32,606718,"SLC26A2, DTD, DTDST, D5S1708, EDM4","Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)",SLC26A2,1836,ENSG00000155850,distal to APC,"Achondrogenesis Ib, 600972 (3), Autosomal recessive; Atelosteogenesis, type II, 256050 (3), Autosomal recessive; De la Chapelle dysplasia, 256050 (3), Autosomal recessive; Diastrophic dysplasia, 222600 (3), Autosomal recessive; Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3), Autosomal recessive; Epiphyseal dysplasia, multiple, 4, 226900 (3), Autosomal recessive",Slc26a2 (MGI:892977)
5,150021530,150022052,5q33-qter,5q32,180464,RPS20B,Ribosomal protein S20B,RPS20P4,6226,NA,?pseudogene,NA,NA
5,150053290,150113371,5q32,5q32,164770,"CSF1R, FMS, HDLS, BANDDOS",Colony-stimulating factor-1 receptor; oncogene FMS (McDonough feline sarcoma),CSF1R,1436,ENSG00000182578,FMS2 is 5' end,"Brain abnormalities, neurodegeneration, and dysosteosclerosis, 618476 (3), Autosomal recessive; Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3), Autosomal dominant",Csf1r (MGI:1339758)
5,150113838,150155844,5q32,5q32,173410,"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS","Platelet-derived growth factor receptor, beta polypeptide",PDGFRB,5159,ENSG00000113721,"fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders","Basal ganglia calcification, idiopathic, 4, 615007 (3), Autosomal dominant; Kosaki overgrowth syndrome, 616592 (3), Autosomal dominant; Myeloproliferative disorder with eosinophilia, 131440 (4), Autosomal dominant; Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant; Premature aging syndrome, Penttinen type, 601812 (3), Autosomal dominant",Pdgfrb (MGI:97531)
5,150166777,150184557,5q31-q33,5q32,600746,CDX1,Caudal type homeo box transcription factor 1,CDX1,1044,ENSG00000113722,100kb distal to CSF1R,NA,Cdx1 (MGI:88360)
5,150190061,150211071,5q31-q32,5q32,606205,"SLC6A7, PROT","Solute carrier family 6 (neurotransmitter transporter, L-proline), member 7",SLC6A7,6534,ENSG00000011083,NA,NA,Slc6a7 (MGI:2147363)
5,150219383,150290129,5q32,5q32,114078,"CAMK2A, KIAA0968, CAMKA, MRD53, MRT63",Calcium/calmodulin-dependent protein kinase II-alpha,CAMK2A,815,ENSG00000070808,mutation identified in 1 MRT63 family,"Mental retardation, autosomal dominant 53, 617798 (3), Autosomal dominant; ?Mental retardation, autosomal recessive 63, 618095 (3), Autosomal recessive",Camk2a (MGI:88256)
5,150296342,150302904,5q32,5q32,610009,ARSI,Arylsulfatase I,ARSI,340075,ENSG00000183876,NA,NA,Arsi (MGI:2670959)
5,150357638,150400307,5q32-q33.1,5q32-q33,606847,"TCOF1, MFD1, TCS1",Treacle,TCOF1,6949,ENSG00000070814,prox. to SPARC,"Treacher Collins syndrome 1, 154500 (3), Autosomal dominant",Tcof1 (MGI:892003)
5,150400000,177100000,5q33.1-q35.2,NA,613269,"FECD5, FCD3","Corneal dystrophy, Fuchs endothelial, 5",NA,100380874,NA,flanked by D5S470 and D5S2108,"Corneal dystrophy, Fuchs endothelial, 5, 613269 (2)",NA
5,150400040,150412935,5q32,5q33.1,142790,"CD74, DHLAG",CD74 antigen (invariant polypeptide of major histocompatibility class II antigen-associated),CD74,972,ENSG00000019582,NA,NA,Cd74 (MGI:96534)
5,150442634,150449738,5q32,5q33.1,130620,"RPS14, EMTB",Ribosomal protein S14,RPS14,6208,ENSG00000164587,NA,"Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)",Rps14 (MGI:98107)
5,150497778,150558210,5q32-q33.3,5q33.1,600853,"NDST1, HSST, MRT46",N-deacetylase/N-sulfotransferase (heparan sulfate-N-deacetylase/N-sulfotransferase),NDST1,3340,ENSG00000070614,NA,"Mental retardation, autosomal recessive 46, 616116 (3), Autosomal recessive",Ndst1 (MGI:104719)
5,150586025,150659213,5q33.1,5q33.1,608155,SYNPO,Synaptopodin,SYNPO,11346,ENSG00000171992,NA,NA,Synpo (MGI:1099446)
5,150660840,150679367,5q31,5q33.1,610735,"MYOZ3, FRP3",Myozenin 3,MYOZ3,91977,ENSG00000164591,NA,NA,Myoz3 (MGI:2179296)
5,150690791,150701088,5q33.1,5q33.1,612430,RBM22,RNA-binding motif protein 22,RBM22,55696,ENSG00000086589,NA,NA,Rbm22 (MGI:1914060)
5,150708746,150759094,5q33.1,5q33.1,614758,"DCTN4, P62, DYN4",Dynactin 4,DCTN4,51164,ENSG00000132912,NA,NA,Dctn4 (MGI:1914915)
5,150777945,150796735,5q32,5q33.1,608324,"SMIM3, NID67",Small integral membrane protein 3,SMIM3,85027,ENSG00000256235,NA,NA,Smim3 (MGI:1917088)
5,150846520,150902401,5q33.1,5q33.1,608212,"IRGM, LRG47, IFI1, IBD19","Immunity-related GTPase family, M",IRGM,345611,ENSG00000237693,NA,"{Inflammatory bowel disease (Crohn disease) 19}, 612278 (3); {Mycobacterium tuberculosis, protection against}, 607948 (3)",Irgm2 (MGI:1926262)
5,150892957,150904982,5q33.1,5q33.1,612429,ZNF300,Zinc finger protein 300,ZNF300,91975,ENSG00000145908,NA,NA,NA
5,151020590,151028987,5q32-q33.1,5q33.1,138321,GPX3,"Glutathione peroxidase-3, plasma",GPX3,2878,ENSG00000211445,NA,NA,Gpx3 (MGI:105102)
5,151029942,151087684,5q32-q33.1,5q33.1,607714,"TNIP1, NAF1, KIAA0113",TNFAIP3-interacting protein 1,TNIP1,10318,ENSG00000145901,NA,NA,Tnip1 (MGI:1926194)
5,151100705,151157778,5q32-q34,5q33.1,114070,"ANXA6, CBP68",Annexin A6 (calcium-binding protein p68),ANXA6,309,ENSG00000197043,NA,NA,Anxa6 (MGI:88255)
5,151253184,151270439,5q31.3-q33.1,5q33.1,613109,GM2A,GM2 ganglioside activator protein,GM2A,2760,ENSG00000196743,pseudogene on chr.3,"GM2-gangliosidosis, AB variant, 272750 (3), Autosomal recessive",Gm2a (MGI:95762)
5,151314971,151347582,5q33.1,5q33.1,608331,"SLC36A2, PAT2","Solute carrier family 36 (proton/amino acid symporter), member 2",SLC36A2,153201,ENSG00000186335,NA,"Hyperglycinuria, 138500 (3), Autosomal dominant; Iminoglycinuria, digenic, 242600 (3), Autosomal recessive, Digenic recessive",Slc36a2 (MGI:1891430)
5,151411343,151556317,5q31-q33,5q33.1,606561,"SLC36A1, LYAAT1, PAT1","Solute carrier family 36 (proton/amino acid symporter), member 1 (lysosomal amino acid transporter 1)",SLC36A1,206358,ENSG00000123643,NA,NA,Slc36a1 (MGI:2445299)
5,151504091,151594821,5q32-q33,5q33.1,604269,"FAT2, MEGF1, SCA45","Fat tumor suppressor, Drosophila, homolog of, 2",FAT2,2196,ENSG00000086570,NA,"Spinocerebellar ataxia 45, 617769 (3), Autosomal dominant",Fat2 (MGI:2685369)
5,151661095,151686914,5q31.3-q32,5q33.1,182120,"SPARC, ON, OI17","Osteonectin (secreted protein, acidic, cysteine-rich)",SPARC,6678,ENSG00000113140,NA,"Osteogenesis imperfecta, type XVII, 616507 (3), Autosomal recessive",Sparc (MGI:98373)
5,151742821,151758630,5q32,5q33.1,602270,"ATOX1, HAH1","Antioxidant protein 1 (ATX, yeast, homolog of)",ATOX1,475,ENSG00000177556,NA,NA,Atox1 (MGI:1333855)
5,151771953,151812784,5q33.1,5q33.1,608431,"G3BP1, G3BP",GTPase-activating protein SH3 domain-binding protein 1,G3BP1,10146,ENSG00000145907,NA,NA,G3bp1 (MGI:1351465)
5,151822512,151924850,5q32,5q33.1,138491,"GLRA1, STHE, HKPX1","Glycine receptor, alpha-1 polypeptide",GLRA1,2741,ENSG00000145888,NA,"Hyperekplexia 1, 149400 (3), Autosomal recessive, Autosomal dominant",Glra1 (MGI:95747)
5,152391540,152405278,5q33.1,5q33.1,605108,"NMUR2, NMU2R, FM4",Neuromedin U receptor 2,NMUR2,56923,ENSG00000132911,NA,NA,Nmur2 (MGI:2441765)
5,153490523,153813872,5q33,5q33.2,138248,"GRIA1, GLUR1","Glutamate receptor, ionotropic, AMPA 1",GRIA1,2890,ENSG00000155511,NA,NA,Gria1 (MGI:95808)
5,154038966,154057449,5q32-q33.3,5q33.2,600491,MFAP3,Microfibrillar-associated protein-3,MFAP3,4238,ENSG00000037749,NA,NA,Mfap3 (MGI:1924068)
5,154190732,154420983,5q33.2,5q33.2,608043,"GALNT10, GalNAcT10",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10,GALNT10,55568,ENSG00000164574,NA,NA,Galnt10 (MGI:1890480)
5,154445956,154461052,5q33.2,5q33.2,610398,SAP30L,SAP30-like protein,SAP30L,79685,ENSG00000164576,NA,NA,Sap30l (MGI:1354709)
5,154474971,154478226,5q33.2,5q33.2,602406,"HAND1, EHAND",Heart- and neural crest derivatives-expressed 1,HAND1,9421,ENSG00000113196,NA,NA,Hand1 (MGI:103577)
5,154682978,154817604,5q33.2,5q33.2,612059,"LARP1, LARP, KIAA0731","La ribonucleoprotein domain family, member 1",LARP1,23367,ENSG00000155506,incorrectly mapped to chromosome 10,NA,Larp1 (MGI:1890165)
5,154857951,154876791,5q31-q33,5q33.2,603731,"CNOT8, CALIF, POP2","CCR4-NOT transcription complex, subunit 8",CNOT8,9337,ENSG00000155508,NA,NA,Cnot8 (MGI:1916375)
5,154887410,154938215,5q33.2,5q33.2,607005,GEMIN5,GEM-associated protein 5,GEMIN5,25929,ENSG00000082516,NA,NA,Gemin5 (MGI:2449311)
5,154941072,154969410,5q33,5q33.2,611835,MRPL22,Mitochondrial ribosomal protein L22,MRPL22,29093,ENSG00000082515,NA,NA,Mrpl22 (MGI:1333794)
5,155013754,155018140,5q33.1,5q33.2,609184,KIF4B,Kinesin family member 4B,KIF4B,285643,ENSG00000226650,NA,NA,NA
5,155728635,156767787,5q33,5q33.2-q33.3,601411,"SGCD, SGD, LGMDR6, CMD1L","Sarcoglycan, delta (35kD dystrophin-associated glycoprotein)",SGCD,6444,ENSG00000170624,mutant in Syrian hamster cardiomyopathy,"Cardiomyopathy, dilated, 1L, 606685 (3); Muscular dystrophy, limb-girdle, autosomal recessive 6, 601287 (3), Autosomal recessive",Sgcd (MGI:1346525)
5,156919291,156963225,5q33.2,5q33.3,610096,"TIMED4, TIM4, SMUCKLER",T-cell immunoglobulin and mucin domains-containing protein 4,TIMD4,91937,ENSG00000145850,NA,NA,Timd4 (MGI:2445125)
5,157028382,157069632,5q33.2,5q33.3,606518,"HAVCR1, HAVCR",Hepatitis A virus cellular receptor 1,HAVCR1,26762,ENSG00000113249,NA,NA,NA
5,157085831,157109043,5q33.2,5q33.3,606652,"HAVCR2, TIM3, SPTCL",Hepatitis A virus cellular receptor 2,HAVCR2,84868,ENSG00000135077,NA,"T-cell lymphoma, subcutaneous panniculitis-like, 618398 (3), Autosomal recessive",Havcr2 (MGI:2159682)
5,157137423,157142864,5q33.3,5q33.3,605045,"MED7, CRSP9, CRSP33",Mediator complex subunit 7,MED7,9443,ENSG00000155868,NA,NA,Med7 (MGI:1913463)
5,157180895,157255184,5q32,5q33.3,186973,"ITK, EMT, LPFS1",T-cell-specific tyrosine kinase; homolog of mouse T-cell itk/tsk tyrosine kinase,ITK,3702,ENSG00000113263,NA,"Lymphoproliferative syndrome 1, 613011 (3), Autosomal recessive",Itk (MGI:96621)
5,157266090,157395593,5q33.3,5q33.3,606323,"CYFIP2, EIEE65",Cytoplasmic FMRP interacting protein 2,CYFIP2,26999,ENSG00000055163,NA,"Epileptic encephalopathy, early infantile, 65, 618008 (3), Autosomal dominant",Cyfip2 (MGI:1924134)
5,157460018,157474721,5q33,5q33.3,609383,"NIPAL4, ICHYN, ARCI6",NIPA-like domain-containing 4,NIPAL4,348938,ENSG00000172548,NA,"Ichthyosis, congenital, autosomal recessive 6, 612281 (3), Autosomal recessive",Nipal4 (MGI:2444671)
5,157477303,157575774,5q32-q33,5q33.3,603640,"ADAM19, MLTNB","A disintegrin and metalloproteinase domain-19 (meltrin-beta, mouse, homolog of)",ADAM19,8728,ENSG00000135074,NA,NA,Adam19 (MGI:105377)
5,157625678,157671479,5q33.3,5q33.3,606698,SOX30,SRY-box 30,SOX30,11063,ENSG00000039600,NA,NA,Sox30 (MGI:1341157)
5,157743711,157760708,5q33.3,5q33.3,617910,LSM11,"Lsm11, U7 small nuclear RNA-associated protein",LSM11,134353,ENSG00000155858,NA,NA,Lsm11 (MGI:1919540)
5,157785746,157859144,5q33.3,5q33.3,607265,"CLINT1, EPN4, EPNR, KIAA0171",Clathrin interactor 1 (epsin 4),CLINT1,9685,ENSG00000113282,NA,NA,Clint1 (MGI:2144243)
5,158695917,159099915,5q34,5q33.3,164343,"EBF, OLF1",Early B-cell factor (olfactory neuronal transcription factor 1),EBF1,1879,ENSG00000164330,NA,NA,Ebf1 (MGI:95275)
5,159263289,159286035,5q33.3,5q33.3,609867,UBLCP1,Ubiquitin-like domain-containing CTD phosphatase 1,UBLCP1,134510,ENSG00000164332,NA,NA,Ublcp1 (MGI:1933105)
5,159314782,159330472,5q33.3,5q33.3,161561,"IL12B, NKSF2, IMD29","Interleukin-12B (natural killer cell stimulatory factor-2, cytotoxic lymphocyte maturation factor-2, p40)",IL12B,3593,ENSG00000113302,between GLR1 and GABRA1,"Immunodeficiency 29, mycobacteriosis, 614890 (3), Autosomal recessive",Il12b (MGI:96540)
5,159916481,159989204,5q33,5q33.3,104220,ADRA1B,"Adrenergic, alpha-1B-, receptor",ADRA1B,147,ENSG00000170214,NA,NA,Adra1b (MGI:104774)
5,160009099,160065544,5q32-q33.2,5q33.3,601963,"TTC1, TPR1",Tetratricopeptide repeat domain-1,TTC1,7265,ENSG00000113312,NA,NA,Ttc1 (MGI:1914077)
5,160043537,160120700,5q33.3,5q33.3,617823,PWWP2A,PWWP domain-containing protein 2A,PWWP2A,114825,ENSG00000170234,NA,NA,Pwwp2a (MGI:1918052)
5,160187380,160238721,5q23-q35,5q33.3,600422,"FABP6, ILLBP","Fatty acid-binding protein 6, ileal (gastrotropin)",FABP6,2172,ENSG00000170231,NA,NA,Fabp6 (MGI:96565)
5,160393147,160400096,5q33.3,5q33.3,615253,"C5orf54, ZBED8, BUSTER3",Chromosome 5 open reading frame 54,ZBED8,63920,ENSG00000221886,NA,NA,NA
5,160421854,160428743,5q33,5q33.3,604147,"PTTG1, EAP1, TUTR1",Pituitary tumor-transforming gene 1,PTTG1,9232,ENSG00000164611,NA,NA,Pttg1 (MGI:1353578)
5,160485351,160485449,5q33.3,5q33.3,610566,"MIR146A, MIRN146A",Micro RNA 146A,MIR146A,406938,ENSG00000283733,NA,NA,NA
5,160500000,177100000,5q34-q35.2,NA,608036,NIDDM4,"Diabetes mellitus, noninsulin-dependent, 4",NA,100188782,NA,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (2), Autosomal dominant",NA
5,161288428,161548403,5q34-q35,5q34,600232,"GABRB2, ICEE2","Gamma-aminobutyric acid (GABA) A receptor, beta-2",GABRB2,2561,ENSG00000145864,NA,"Epileptic encephalopathy, infantile or early childhood, 2, 617829 (3), Autosomal dominant",Gabrb2 (MGI:95620)
5,161685720,161702591,5q31.1-q35,5q34,137143,GABRA6,"Gamma-aminobutyric acid (GABA) A receptor, alpha-6",GABRA6,2559,ENSG00000145863,NA,NA,Gabra6 (MGI:95618)
5,161847190,161899970,5q34-q35,5q34,137160,"GABRA1, EJM5, ECA4, EIEE19","Gamma-aminobutyric acid (GABA) A receptor, alpha-1",GABRA1,2554,ENSG00000022355,in same 200kb as GABRG2,"{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3); {Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3); Epileptic encephalopathy, early infantile, 19, 615744 (3), Autosomal dominant",Gabra1 (MGI:95613)
5,162067641,162155538,5q34,5q34,137164,"GABRG2, EIEE74, FEB8, ECA2, GEFSP3","Gamma-aminobutyric acid (GABA) A receptor, gamma-2",GABRG2,2566,ENSG00000113327,in alpha/beta/gamma cluster,"Epilepsy, generalized, with febrile seizures plus, type 3, 607681 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 74, 618396 (3), Autosomal dominant; Febrile seizures, familial, 8, 607681 (3), Autosomal dominant",Gabrg2 (MGI:95623)
5,163437570,163448198,5q32-q34,5q34,601578,CCNG1,Cyclin G1,CCNG1,900,ENSG00000113328,NA,NA,Ccng1 (MGI:102890)
5,163460631,163491940,5q33.2,5q34,600936,HMMR,Hyaluronan-mediated motility receptor (RHAMM),HMMR,3161,ENSG00000072571,NA,"{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation",Hmmr (MGI:104667)
5,166979065,168264158,5q34,5q34,610119,"TENM2, ODZ2, TNM2, KIAA1127",Teneurin transmembrane protein 2,TENM2,57451,ENSG00000145934,NA,NA,Tenm2 (MGI:1345184)
5,168291644,168472302,5q34-q35.2,5q34,610533,"WWC1, KIBRA, KIAA0869, MEMRYQTL","WW, C2, and coiled-coil domain-containing 1",WWC1,23286,ENSG00000113645,NA,"[Memory, enhanced, QTL], 615602 (3)",Wwc1 (MGI:2388637)
5,168486470,168519300,5q34,5q34,107820,"RARS, HLD9",Arginyl-tRNA synthetase,RARS1,5917,ENSG00000113643,NA,"Leukodystrophy, hypomyelinating, 9, 616140 (3), Autosomal recessive",Rars (MGI:1914297)
5,168548494,168579367,5q35,5q34,606161,PANK3,Pantothenate kinase 3,PANK3,79646,ENSG00000120137,NA,NA,Pank3 (MGI:2387464)
5,168560895,168560972,5q34,5q34,613187,"MIR103-1, MIRN103-1",Micro RNA 103-1,MIR103A1,406895,ENSG00000199035,NA,NA,NA
5,168661739,169301138,5q35,5q34-q35,603745,"SLIT3, SLIL2, MEGF5","Slit, Drosophila, homolog of, 3",SLIT3,6586,ENSG00000184347,NA,NA,Slit3 (MGI:1315202)
5,168768145,168768254,5q34,5q34,616771,MIR218-2,Micro RNA 218-2,MIR218-2,407001,ENSG00000207739,in intron of SLIT3,NA,NA
5,169000000,181538259,5q35,NA,118840,CHR,Chromate resistance (sulfate transport),NA,NA,NA,NA,NA,NA
5,169583660,169604777,5q35.1,5q35.1,616401,"SPDL1, CCDC99, SPINDLY",Spindly apparatus coiled-coil protein 1,SPDL1,54908,ENSG00000040275,NA,NA,Spdl1 (MGI:1917635)
5,169637246,170083381,5q35.1,5q35.1,603122,"DOCK2, IMD40",Dedicator of cytokinesis 2,DOCK2,1794,ENSG00000134516,NA,"Immunodeficiency 40, 616433 (3), Autosomal recessive",Dock2 (MGI:2149010)
5,170105896,170109733,5q34,5q35.1,601093,"FOXI1, FKHL10, FREAC6",Forkhead box I1,FOXI1,2299,ENSG00000168269,some patients have digenic mutations with SLC26A4,"Enlarged vestibular aqueduct, 600791 (3), Autosomal recessive",Foxi1 (MGI:1096329)
5,170246232,170297776,5q33.1-qter,5q35.1,601603,"LCP2, SLP76",Lymphocyte cytosolic protein-2 (SH2 domain-containing leukocyte protein of 76kD),LCP2,3937,ENSG00000043462,NA,NA,Lcp2 (MGI:1321402)
5,170374670,170389366,5q34,5q35.1,603951,KCNMB1,"Potassium large conductance calcium-activated channel, subfamily M, beta member 1",KCNMB1,3779,ENSG00000145936,NA,"{Hypertension, diastolic, resistance to}, 608622 (3), Autosomal dominant",Kcnmb1 (MGI:1334203)
5,170782840,170814046,5q32-q33,5q35.1,602729,GABRP,"Gamma-aminobutyric acid receptor, pi",GABRP,2568,ENSG00000094755,NA,NA,Gabrp (MGI:2387597)
5,170862017,171300014,5q34,5q35.1,606141,RANBP17,RAN-binding protein 17,RANBP17,64901,ENSG00000204764,NA,NA,Ranbp17 (MGI:1929706)
5,171309247,171312138,5q35.1,5q35.1,604640,"TLX3, HOX11L2, RNX","T-cell leukemia, homeobox 3",TLX3,30012,ENSG00000164438,activated in T-cell ALL,NA,Tlx3 (MGI:1351209)
5,171387115,171410883,5q35,5q35.1,164040,NPM1,"Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin)",NPM1,4869,ENSG00000181163,fused with RARA in APL,"Leukemia, acute myeloid, somatic, 601626 (3)",Npm1 (MGI:106184)
5,171419646,171457625,5q34,5q35.1,603726,FGF18,Fibroblast growth factor-18,FGF18,8817,ENSG00000156427,NA,NA,Fgf18 (MGI:1277980)
5,171861548,172009603,5q35.1,5q35.1,605651,"FBXW11, FBXW1B, BTRC2, BTRCP2",F-box and WD40 domain protein 11,FBXW11,23291,ENSG00000072803,NA,NA,Fbxw11 (MGI:2144023)
5,172042073,172188223,5q35.1,5q35.1,603919,"STK10, LOK",Serine/threonine protein kinase-10,STK10,6793,ENSG00000072786,NA,NA,Stk10 (MGI:1099439)
5,172209644,172283796,5q35,5q35.1,610174,"UBTD2, DCUBP, MGC30022",Ubiquitin domain-containing protein 2,UBTD2,92181,ENSG00000168246,NA,NA,Ubtd2 (MGI:2444752)
5,172325180,172454524,5q35.1,5q35.1,613293,"SH3PXD2B, TKS4, KIAA1295, FTHS",SH3 and PX domains-containing protein 2B,SH3PXD2B,285590,ENSG00000174705,NA,"Frank-ter Haar syndrome, 249420 (3), Autosomal recessive",Sh3pxd2b (MGI:2442062)
5,172641262,172691539,5q31,5q35.1,615893,"NEURL1B, NEUR2",Neuralized E3 ubiquitin protein ligase 1B,NEURL1B,54492,ENSG00000214357,NA,NA,Neurl1b (MGI:3643092)
5,172768095,172771194,5q34,5q35.1,600714,"DUSP1, CL100, PTPN10",Dual specificity phosphatase-1,DUSP1,1843,ENSG00000120129,NA,NA,Dusp1 (MGI:105120)
5,172834250,172952682,5q35.2,5q35.1,617946,"ERGIC1, ERGIC32, KIAA1181, AMCN",Endoplasmic reticulum-golgi intermediate compartment protein 1,ERGIC1,57222,ENSG00000113719,mutation identified in 1 AMCN family,"?Arthrogryposis multiplex congenita, neurogenic type, 208100 (3), Autosomal recessive",Ergic1 (MGI:1914708)
5,172983770,173035444,5q35.1,5q35.1,603931,"ATP6V0E1, ATP6H","ATPase, H+ transporting, V0 subunit e1",ATP6V0E1,8992,ENSG00000113732,previously mapped to Chr.2,NA,Atp6v0e (MGI:1328318)
5,173020725,173020928,5q35.1,5q35.1,611331,SNORA74B,"Small nucleolar RNA, H/ACA box, 74B",SNORA74B,677841,ENSG00000212402,in intron 3 of ATP6V0E1,NA,NA
5,173056348,173139283,5q35.1,5q35.1,617109,"CREBRF, LRF, C5orf41",CREB3 recruitment factor,CREBRF,153222,ENSG00000164463,NA,NA,Crebrf (MGI:1924378)
5,173144446,173164386,5q35.1,5q35.1,603291,"BNIP1, NIP1",BCL2/adenovirus E1B 19kD protein-interacting protein 1,BNIP1,662,ENSG00000113734,NA,NA,Bnip1 (MGI:109328)
5,173232108,173235320,5q34,5q35.1,600584,"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",NK2 homeobox-5 gene,NKX2-5,1482,ENSG00000183072,near border with 5q35,"Atrial septal defect 7, with or without AV conduction defects, 108900 (3), Autosomal dominant; Conotruncal heart malformations, variable, 217095 (3); Hypoplastic left heart syndrome 2, 614435 (3), Autosomal dominant; Hypothyroidism, congenital nongoitrous, 5, 225250 (3), Autosomal dominant; Tetralogy of Fallot, 187500 (3), Autosomal dominant; Ventricular septal defect 3, 614432 (3), Autosomal dominant",Nkx2-5 (MGI:97350)
5,173300000,177100000,5q35.2,NA,612886,MENOQ4,"Menopause, natural, age at, QTL4",NA,100302519,NA,"associated with rs365132, rs7718874, rs402511, rs691141, rs2278493","{Menopause, natural, age at, QTL4}, 612886 (2)",NA
5,173314722,173329502,5q35.1,5q35.2,603665,"STC2, STCRP",Stanniocalcin 2,STC2,8614,ENSG00000113739,NA,NA,Stc2 (MGI:1316731)
5,173607144,173617071,5q35.2,5q35.2,616745,"BOD1, FAM44B",Biorientation of chromosomes in cell division 1,BOD1,91272,ENSG00000145919,NA,NA,Bod1 (MGI:1916806)
5,173888327,173961979,5q21,5q35.2,610607,"CPEB4, KIAA1673",Cytoplasmic polyadenylation element-binding protein 4,CPEB4,80315,ENSG00000113742,NA,NA,Cpeb4 (MGI:1914829)
5,174045705,174109178,5q35.2,5q35.2,616752,"HMP19, NSG2","Hypothalamus golgi apparatus-expressed protein, 19kD",NSG2,51617,ENSG00000170091,NA,NA,Nsg2 (MGI:1202070)
5,174724581,174730895,5q34-q35,5q35.2,123101,"MSX2, CRS2, HOX8","msh, Drosophila, homeo box homolog of, 2",MSX2,4488,ENSG00000120149,NA,"Craniosynostosis 2, 604757 (3), Autosomal dominant; Parietal foramina 1, 168500 (3), Autosomal dominant; Parietal foramina with cleidocranial dysplasia, 168550 (3), Autosomal dominant",Msx2 (MGI:97169)
5,175440035,175444181,5q35.1,5q35.2,126449,DRD1,Dopamine receptor D1,DRD1,1812,ENSG00000184845,same 300kb fragment as GRL,NA,Drd1 (MGI:99578)
5,175478559,175529741,5q35.2,5q35.2,615569,SFXN1,Sideroflexin 1,SFXN1,94081,ENSG00000164466,NA,NA,Sfxn1 (MGI:2137677)
5,175657761,175710755,5q35.2,5q35.2,142703,HRH2,Histamine receptor H2,HRH2,3274,ENSG00000113749,NA,NA,Hrh2 (MGI:108482)
5,175796532,175884020,5q35.2,5q35.2,605033,"CPLX2, CPX2",Complexin 2,CPLX2,10814,ENSG00000145920,NA,NA,Cplx2 (MGI:104726)
5,175959530,176034904,5q35.2,5q35.2,606929,"THOC3, TEX1","THO complex 3 (Tex1, yeast, homolog of)",THOC3,84321,ENSG00000051596,NA,NA,Thoc3 (MGI:1920916)
5,176238358,176345990,5q35.2,5q35.2,618102,"SIMC1, PLEIAD",SUMO-interacting motifs-containing protein 1,SIMC1,375484,ENSG00000170085,NA,NA,Simc1 (MGI:2442599)
5,176383936,176388926,5q35.2,5q35.2,612861,"NOP15, HSPC111","Nop16, S. cerevisiae, homolog of",NOP16,51491,ENSG00000048162,NA,NA,Nop16 (MGI:107862)
5,176392451,176416568,5q35.2,5q35.2,118970,CLTB,"Clathrin, light polypeptide (Lcb)",CLTB,1212,ENSG00000175416,previously mapped to chr. 4,NA,Cltb (MGI:1921575)
5,176448327,176510073,5q35.2,5q35.2,616935,"FAF2, ETEA, UBXD8, KIAA0887","Fas-associated factor family, member 2",FAF2,23197,ENSG00000113194,NA,NA,Faf2 (MGI:1923827)
5,176595801,176610155,5q35.2,5q35.2,611239,"GPRIN1, GRIN1, KIAA1893",G protein-regulated inducer of neurite outgrowth 1,GPRIN1,114787,ENSG00000169258,NA,NA,Gprin1 (MGI:1349455)
5,176620081,176630560,5q35,5q35.2,602569,SNCB,"Synuclein, beta",SNCB,6620,ENSG00000074317,NA,"Dementia, Lewy body, 127750 (3), Autosomal dominant",Sncb (MGI:1889011)
5,176810558,176880897,5q35.2,5q35.2,607869,"UNC5A, UNC5H1","UNC5, C. elegans, homolog of, A",UNC5A,90249,ENSG00000113763,NA,NA,Unc5a (MGI:894682)
5,176880868,176899372,5q35.2,5q35.2,142570,HK3,"Hexokinase-3, white cell",HK3,3101,ENSG00000160883,NA,NA,Hk3 (MGI:2670962)
5,176905004,177022639,5q35,5q35.2,609433,"UIMC1, RAP80",Ubiquitin interaction motif containing 1,UIMC1,51720,ENSG00000087206,NA,NA,Uimc1 (MGI:103185)
5,177022679,177081188,5q35.2,5q35.2,605308,"ZNF346, JAZ",Zinc finger protein 346,ZNF346,23567,ENSG00000113761,NA,NA,Zfp346 (MGI:1349417)
5,177086914,177098143,5q35.1-qter,5q35.2,134935,FGFR4,Fibroblast growth factor receptor-4,FGFR4,2264,ENSG00000160867,distal to DRD1,{Cancer progression/metastasis} (3),Fgfr4 (MGI:95525)
5,177131834,177300212,5q35,5q35.3,606681,"NSD1, ARA267, STO, SOTOS1",Nuclear receptor binding SET domain protein 1,NSD1,64324,ENSG00000165671,fusion gene with NUP98 in AML,"Leukemia, acute myeloid, 601626 (1), Autosomal dominant, Somatic mutation; Sotos syndrome 1, 117550 (3), Autosomal dominant",Nsd1 (MGI:1276545)
5,177301189,177303743,5q35.3,5q35.3,612415,RAB24,Ras-associated protein 24,RAB24,53917,ENSG00000169228,NA,NA,Rab24 (MGI:105065)
5,177303798,177306948,5q35.3,5q35.3,605733,"PRELID1, PRELI, PX19",PRELI domain-containing protein 1,PRELID1,27166,ENSG00000169230,NA,NA,Prelid1 (MGI:1913744)
5,177305498,177311897,5q35.3,5q35.3,609450,"MXD3, MAD3",MAX dimerization protein 3,MXD3,83463,ENSG00000213347,NA,NA,Mxd3 (MGI:104987)
5,177357671,177372600,5q35.3,5q35.3,602513,RGS14,Regulator of G protein signaling 14,RGS14,10636,ENSG00000169220,NA,NA,Rgs14 (MGI:1859709)
5,177384433,177412020,5q35,5q35.3,182309,"SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2","Solute carrier family 34 (sodium phosphate cotransporter), member 1",SLC34A1,6569,ENSG00000131183,mutation identified in 1 FRTS2 family,"?Fanconi renotubular syndrome 2, 613388 (3), Autosomal recessive; Hypercalcemia, infantile, 2, 616963 (3), Autosomal recessive; Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3), Autosomal dominant",Slc34a1 (MGI:1345284)
5,177400108,177400660,5q35.2,5q35.3,612812,PFN3,Profilin 3,PFN3,345456,ENSG00000196570,NA,NA,Pfn3 (MGI:2178800)
5,177402137,177409575,5q33-qter,5q35.3,610619,"F12, HAF, HAE3",Coagulation factor XII (Hageman factor),F12,2161,ENSG00000131187,NA,"Angioedema, hereditary, type III, 610618 (3), Autosomal dominant; Factor XII deficiency, 234000 (3), Autosomal recessive",F12 (MGI:1891012)
5,177426495,177442890,5q35,5q35.3,600869,"GRK6, GPRK6",G protein-coupled receptor kinase 6,GRK6,2870,ENSG00000198055,NA,NA,Grk6 (MGI:1347078)
5,177445935,177456700,5q35.3,5q35.3,618306,PRR7,Proline-rich protein 7,PRR7,80758,ENSG00000131188,NA,NA,Prr7 (MGI:3487246)
5,177456591,177480367,5q35.3,5q35.3,126660,DBN1,Drebrin-1,DBN1,1627,ENSG00000113758,NA,NA,Dbn1 (MGI:1931838)
5,177483393,177497604,5q35.3,5q35.3,605903,"PDLIM7, ENIGMA",PDZ and LIM domain 7 (enigma),PDLIM7,9260,ENSG00000196923,NA,NA,Pdlim7 (MGI:1914649)
5,177501903,177510507,5q35.3,5q35.3,611435,"DOK3, DOKL",Docking protein 3,DOK3,79930,ENSG00000146094,NA,NA,Dok3 (MGI:1351490)
5,177511576,177516960,5q35.3,5q35.3,608170,"DDX41, ABS, MPLPF",DEAD/H box 41,DDX41,51428,ENSG00000183258,NA,"{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3), Autosomal dominant",Ddx41 (MGI:1920185)
5,177519787,177554562,5q35.3,5q35.3,615813,"FAM193B, IRIZIO, KIAA1931","Family with sequence similarity 193, member B",FAM193B,54540,ENSG00000146067,NA,NA,NA
5,177600101,177610329,5q35.2-q35.3,5q35.3,604327,"B4GALT7, XGALT1, XGPT1, EDSSPD1","Beta-1,4-galactosyltransferase 7",B4GALT7,11285,ENSG00000027847,NA,"Ehlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3), Autosomal recessive",B4galt7 (MGI:2384987)
5,177992234,177996241,5q,5q35.3,601538,"PROP1, CPHD2","Prophet of Pit1, paired-like homeodomain transcription factor",PROP1,5626,ENSG00000175325,NA,"Pituitary hormone deficiency, combined, 2, 262600 (3), Autosomal recessive",Prop1 (MGI:109330)
5,178149462,178153959,5q35.3,5q35.3,606470,"NOLA2, NHP2, DKCB2","Nucleolar protein family A, member 2",NHP2,55651,ENSG00000145912,NA,"Dyskeratosis congenita, autosomal recessive 2, 613987 (3), Autosomal recessive",Nhp2 (MGI:1098547)
5,178207143,178232821,5q35.3,5q35.3,614683,"PHYKPL, AGXT2L2, PHLU",5-phosphohydroxy-L-lysine phospho-lyase,PHYKPL,85007,ENSG00000175309,mutation identified in 1 PHLU patient,"[?Phosphohydroxylysinuria], 615011 (3)",Phykpl (MGI:1920197)
5,178237615,178590392,5q35,5q35.3,610043,COL23A1,"Collagen, type XXIII, alpha-1",COL23A1,91522,ENSG00000050767,NA,NA,Col23a1 (MGI:2653243)
5,178602663,178627049,5q35,5q35.3,607969,CLK4,CDC-like kinase 4,CLK4,57396,ENSG00000113240,NA,NA,Clk4 (MGI:1098551)
5,178711511,178730658,5q35.3,5q35.3,602444,"TCF17, KID1",Transcription factor-17,ZNF354A,6940,ENSG00000169131,NA,NA,Zfp354a (MGI:103172)
5,178978326,178995319,5q35,5q35.3,604096,"GRM6, MGLUR6, CSNB1B","Glutamate receptor, metabotropic, 6",GRM6,2916,ENSG00000113262,NA,"Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3), Autosomal recessive",Grm6 (MGI:1351343)
5,179110852,179345460,5q23,5q35.3,604539,"ADAMTS2, NPI, EDSDERMS","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 2 (procollagen I N-proteinase)",ADAMTS2,9509,ENSG00000087116,NA,"Ehlers-Danlos syndrome, dermatosparaxis type, 225410 (3), Autosomal recessive",Adamts2 (MGI:1347356)
5,179550550,179610011,5q35.3,5q35.3,610327,RUFY1,RUN and FYVE domains-containing protein 1,RUFY1,80230,ENSG00000176783,NA,NA,Rufy1 (MGI:2429762)
5,179614177,179634783,5q35.3,5q35.3,601035,HNRPH1,Heterogeneous nuclear ribonucleoprotein H,HNRNPH1,3187,ENSG00000169045,NA,NA,Hnrnph1 (MGI:1891925)
5,179678645,179731640,5q35,5q35.3,114217,CANX,Calnexin,CANX,821,ENSG00000127022,NA,NA,Canx (MGI:88261)
5,179732821,179777282,5q35,5q35.3,605424,MAML1,"Mastermind, Drosophila, homolog of, 1",MAML1,9794,ENSG00000161021,NA,NA,Maml1 (MGI:1890504)
5,179793985,179796646,5q35,5q35.3,246530,LTC4S,Leukotriene C4 synthase,LTC4S,4056,ENSG00000213316,NA,"Leukotriene C4 synthase deficiency, 614037 (1), Autosomal recessive",Ltc4s (MGI:107498)
5,179797596,179806976,5q35,5q35.3,604561,MGAT4B,"Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B",MGAT4B,11282,ENSG00000161013,NA,NA,Mgat4b (MGI:2143974)
5,179806392,179838077,5q35,5q35.3,601530,"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",Sequestosome 1,SQSTM1,8878,ENSG00000161011,NA,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3), Autosomal dominant; Myopathy, distal, with rimmed vacuoles, 617158 (3), Autosomal dominant; Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, 617145 (3), Autosomal recessive; Paget disease of bone 3, 167250 (3), Autosomal dominant",Sqstm1 (MGI:107931)
5,179837275,179858816,5q35.3,5q35.3,617154,"MRNIP, C5orf45",MRN complex-interacting protein,MRNIP,51149,ENSG00000161010,NA,NA,Mrnip (MGI:1915317)
5,179862070,179907896,5q35.3,5q35.3,618039,"TBC1D9B, KIAA0676","TBC domain family, member 9B",TBC1D9B,23061,ENSG00000197226,NA,NA,Tbc1d9b (MGI:1924045)
5,180233142,180292082,5q35,5q35.3,602896,"MAPK9, PRKM9, JNK2",Mitogen-activated protein kinase 9,MAPK9,5601,ENSG00000050748,NA,NA,Mapk9 (MGI:1346862)
5,180300697,180353335,5q34-q35,5q35.3,603865,"GFPT2, GFAT2",Glutamine: fructose-6-phosphate amidotransferase 2,GFPT2,9945,ENSG00000131459,NA,NA,Gfpt2 (MGI:1338883)
5,180494372,180578357,5q35.3,5q35.3,608951,"CNOT6, CCR4, KIAA1194","CCR4-NOT transcription complex, subunit 6",CNOT6,57472,ENSG00000113300,NA,NA,Cnot6 (MGI:2144529)
5,180590104,180591498,5q35,5q35.3,606500,"SCGB3A1, HIN1","Secretoglobin, family 3A, member 1",SCGB3A1,92304,ENSG00000161055,NA,NA,Scgb3a1 (MGI:1915912)
5,180601505,180650297,5q35.3,5q35.3,136352,"FLT4, VEGFR3, PCL, LMPHM1",fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3),FLT4,2324,ENSG00000037280,NA,"Hemangioma, capillary infantile, somatic, 602089 (3); Lymphatic malformation 1, 153100 (3), Autosomal dominant",Flt4 (MGI:95561)
5,180784779,180815615,5q35,5q35.3,160995,"MGAT1, GLYT1","Mannosyl (alpha-1,3-)-glycoprotein beta-1,2, N-acetylglucosaminyltransferase",MGAT1,4245,ENSG00000131446,NA,NA,Mgat1 (MGI:96973)
5,180843579,180861326,5q35.3,5q35.3,610281,ZFP62,Zinc finger protein 62,ZFP62,643836,ENSG00000196670,NA,NA,Zfp62 (MGI:99662)
5,180899076,180952165,5q35.3,5q35.3,615606,"BTNL8, BTN9.2",Butyrophilin-like protein 8,BTNL8,79908,ENSG00000113303,NA,NA,NA
5,180988845,181006726,5q35,5q35.3,606192,BTNL3,Butyrophilin-like protein 3,BTNL3,10917,ENSG00000168903,NA,NA,NA
5,181097069,181097141,5q35.3,5q35.3,612995,"TRV-CAC1-2, TRNAV2, TRV2",Transfer RNA valine (CAC) 1-2,TRV-CAC1-2,7240,NA,NA,NA,NA
5,181188853,181188924,5q35.3,5q35.3,189912,"TRP-TGG3-5, TRNAP3, TRP3",Transfer RNA-Pro (TGG) 3-5,TRP-TGG3-1,7219,NA,NA,NA,NA
5,181191686,181191757,5q35.3,5q35.3,189913,"TRT-TGT6-1, TRNAT1, TRT1",Transfer RNA-Thr (TGT) 6-1,TRT-TGT6-1,7236,NA,NA,NA,NA
5,181193923,181218331,5q35.3,5q35.3,609315,"TRIM7, GNIP",Tripartite motif-containing protein 7,TRIM7,81786,ENSG00000146054,NA,NA,Trim7 (MGI:2137353)
5,181218269,181218341,5q35.3,5q35.3,189921,"TRV-AAC1-4, TRNAV1, TRV1",Transfer RNA valine (AAC) 1-4,TRV-AAC1-4,7239,NA,NA,NA,NA
5,181221978,181222050,5q35.3,5q35.3,612996,"TRK-CTT2-4, TRNAK2, TRK2",Transfer RNA lysine (CTT) 2-4,TRK-CTT2-3,790966,NA,NA,NA,NA
5,181223262,181235807,5q35.3,5q35.3,610530,TRIM41,Tripartite motif-containing 41,TRIM41,90933,ENSG00000146063,NA,NA,Trim41 (MGI:2384814)
5,181236896,181243905,5q35.3,5q35.3,176981,"GNB2L1, RACK1","Guanine nucleotide-binding protein, beta-2-like 1",RACK1,10399,ENSG00000204628,NA,NA,Rack1 (MGI:101849)
6,0,7100000,6p25,NA,612558,CLLS4,"Leukemia, chronic lymphocytic susceptibility to, 4",NA,100270643,NA,associated with rs872071,"{Leukemia, chronic lymphocytic susceptibility to, 4}, 612558 (2)",NA
6,0,59800000,6p,NA,122550,CSCI,Corticosterone side-chain isomerase,NA,NA,NA,?linked to MHC,NA,NA
6,0,13400000,6pter-p24,NA,612582,"DEL6pter, C6DELpter",Chromosome 6pter-p24 deletion syndrome,NA,NA,NA,NA,"Chromosome 6pter-p24 deletion syndrome, 612582 (4), Isolated cases",NA
6,0,25200000,6p25.3-p22.3,NA,610294,INTLQ3,Intelligence quantitative trait locus 3,NA,100462722,NA,NA,"{Intelligence QTL3}, 610294 (2)",NA
6,0,7100000,6p25,NA,608545,LRSL,Larsen-like syndrome,NA,406214,NA,NA,"Larsen-like syndrome, 608545 (2), Isolated cases",NA
6,292056,351354,6p25.3,6p25.3,616778,"DUSP22, LMWDSP2, MKPX, VHX, JKAP, JSP1",Dual-specificity phosphatase 22,DUSP22,56940,ENSG00000112679,NA,NA,Dusp22 (MGI:1915926)
6,391738,411442,6p25-p23,6p25.3,601900,"IRF4, LSIRF, SHEP8",Interferon regulatory factor-4,IRF4,3662,ENSG00000137265,dysregulated in t(6;14),"[Skin/hair/eye pigmentation, variation in, 8], 611724 (3)",Irf4 (MGI:1096873)
6,485137,693140,6p25.3,6p25.3,615329,"EXOC2, SEC5L1, SEC5",Exocyst complex component 2,EXOC2,55770,ENSG00000112685,NA,NA,Exoc2 (MGI:1913732)
6,655938,656963,6p25.3-p25.1,6p25.3,609713,HUS1B,"Hydroxyurea-sensitive 1, S. pombe, homolog of, B",HUS1B,135458,ENSG00000188996,NA,NA,Hus1b (MGI:2671003)
6,1312097,1314757,6p25,6p25.3,612788,"FOXQ1, HFH1",Forkhead box Q1,FOXQ1,94234,ENSG00000164379,NA,NA,Foxq1 (MGI:1298228)
6,1389575,1395602,6p25.3,6p25.3,603250,"FOXF2, FKHL6, FREAC2",Forkhead box F2,FOXF2,2295,ENSG00000137273,NA,NA,Foxf2 (MGI:1347479)
6,1605530,1607357,6p25,6p25.3,615976,"FOXCUT, LINC01379","FOXC1 upstream transcript, noncoding",FOXCUT,101927703,NA,NA,NA,NA
6,1609914,1613896,6p25,6p25.3,601090,"FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3","Forkhead, Drosophila, homolog-like 7",FOXC1,2296,ENSG00000054598,NA,"Anterior segment dysgenesis 3, multiple subtypes, 601631 (3), Autosomal dominant; Axenfeld-Rieger syndrome, type 3, 602482 (3), Autosomal dominant",Foxc1 (MGI:1347466)
6,1623799,2245604,6p25,6p25.3,602884,GMDS,"GDP-mannose 4,6-dehydratase",GMDS,2762,ENSG00000112699,NA,NA,Gmds (MGI:1891112)
6,2765340,2786951,6p25.2,6p25.2,608196,"WRNIP1, WHIP",Werner helicase-interacting protein 1,WRNIP1,56897,ENSG00000124535,NA,NA,Wrnip1 (MGI:1926153)
6,2832331,2842048,6pter-p24,6p25.2,130135,"ELANH2, EI","Protease inhibitor 2 (anti-elastase), monocyte/neutrophil derived",SERPINB1,1992,ENSG00000021355,NA,NA,Serpinb1a (MGI:1913472)
6,2887269,2903317,6p25,6p25.2,601799,"PI9, CAP3, SERPINB9","Protease inhibitor 9, ovalbumin type",SERPINB9,5272,ENSG00000170542,NA,NA,Serpinb9 (MGI:106603)
6,2948158,2972164,6p25,6p25.2,173321,"SERPINB6, PI6, PTI, SPI3, DFNB91",Protease inhibitor 6 (placental thrombin inhibitor),SERPINB6,5269,ENSG00000124570,mutation identified in 1 DFNB91 family,"?Deafness, autosomal recessive 91, 613453 (3), Autosomal recessive",Serpinb6a (MGI:103123)
6,2999815,3022745,6p25,6p25.2,160998,"NQO2, NMOR2","NAD(P)H dehydrogenase, quinone 2 (NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2)",NQO2,4835,ENSG00000124588,NA,"{?Breast cancer susceptibility}, 114480 (1), Autosomal dominant, Somatic mutation",Nqo2 (MGI:104513)
6,3063966,3115186,6p25.2,6p25.2,603453,"RIPK1, RIP1, RIP, IMD57",Receptor-interacting serine/threonine kinase 1,RIPK1,8737,ENSG00000137275,NA,"Immunodeficiency 57, 618108 (3), Autosomal recessive",Ripk1 (MGI:108212)
6,3118375,3153598,6p25,6p25.2,603156,BPHL,Biphenyl hydrolase-like,BPHL,670,ENSG00000137274,NA,NA,Bphl (MGI:1915271)
6,3153665,3157543,6p25.2,6p25.2,615101,"TUBB2A, CDCBM5","Tubulin, beta-2A",TUBB2A,7280,ENSG00000137267,NA,"Cortical dysplasia, complex, with other brain malformations 5, 615763 (3), Autosomal dominant",Tubb2a (MGI:107861)
6,3224276,3227652,6p25.2,6p25.2,612850,"TUBB2B, CDCBM7","Tubulin, beta-2B",TUBB2B,347733,ENSG00000137285,TUBB2A is 70kb telomeric to TUBB2B,"Cortical dysplasia, complex, with other brain malformations 7, 610031 (3), Autosomal dominant",Tubb2b (MGI:1920960)
6,3254324,3308223,6p25.2,6p25.2,617550,"PSMG4, PAC4, C6orf86",Proteasome assembly chaperone 4,PSMG4,389362,ENSG00000180822,NA,NA,Psmg4 (MGI:1916916)
6,3268972,3456573,6p25.2,6p25.2,611697,"SLC22A23, C6orf85","Solute carrier family 22, member 23",SLC22A23,63027,ENSG00000137266,NA,NA,Slc22a23 (MGI:1920352)
6,3831900,3851319,6p25.2,6p25.2,614686,"FAM60B, X5L","Family with sequence similarity 50, member B",FAM50B,26240,ENSG00000145945,NA,NA,Fam50b (MGI:1351640)
6,4021299,4064982,6p25.2,6p25.2,602338,"PRPF4B, PRP4","Pre-mRNA processing factor 4, yeast, homolog of, B",PRPF4B,8899,ENSG00000112739,NA,NA,Prpf4b (MGI:109584)
6,4115692,4135596,6p25.2,6p25.2,608024,"ECI2, PECI, DRS1",Enoyl-CoA delta isomerase 2,ECI2,10455,ENSG00000198721,NA,NA,Eci2 (MGI:1346064)
6,4706137,4955543,6p25.1,6p25.1,603778,CDYL,Chromodomain protein on Y chromosome-like,CDYL,9425,ENSG00000153046,NA,NA,Cdyl (MGI:1339956)
6,4992404,5004062,6p25.1,6p25.1,606117,RPP40,"Ribonuclease P, 40kD subunit",RPP40,10799,ENSG00000124787,NA,NA,Rpp40 (MGI:1346084)
6,5031028,5260949,6p25.1,6p25.1,613311,"LYRM4, ISD11, C6orf149, COXPD19",LYR motif-containing protein 4,LYRM4,57128,ENSG00000214113,mutation identified in 1 family,"?Combined oxidative phosphorylation deficiency 19, 615595 (3), Autosomal recessive",Lyrm4 (MGI:2683538)
6,5261000,5771591,6p25.1,6p25.1,611592,"FARS2, FARS1, COXPD14, SPG77","Phenylalanyl-tRNA synthetase 2, mitochondrial",FARS2,10667,ENSG00000145982,NA,"Combined oxidative phosphorylation deficiency 14, 614946 (3), Autosomal recessive; Spastic paraplegia 77, autosomal recessive, 617046 (3), Autosomal recessive",Fars2 (MGI:1917205)
6,5997998,6007604,6p25.1,6p25.1,607409,"NRN1, NRN",Neuritin 1,NRN1,51299,ENSG00000124785,NA,NA,Nrn1 (MGI:1915654)
6,6144077,6320690,6p25-p24,6p25.1,134570,"F13A1, F13A","Coagulation factor XIII, A polypeptide",F13A1,2162,ENSG00000124491,NA,"Factor XIIIA deficiency, 613225 (3), Autosomal recessive; {Myocardial infarction, protection against}, 608446 (3); {Venous thrombosis, protection against}, 188050 (3), Autosomal dominant",F13a1 (MGI:1921395)
6,6588638,6654981,6p25.1,6p25.1,605241,"LY86, MD1",Lymphocyte antigen 86,LY86,9450,ENSG00000112799,NA,NA,Ly86 (MGI:1321404)
6,7100000,10600000,6p24.3,NA,119530,"OFC1, CL",Orofacial cleft-1 (cleft lip with or without cleft palate; isolated cleft palate),OFC1,4963,NA,probable heterogeneity,"Orofacial cleft-1, 119530 (2), Autosomal dominant",NA
6,7107742,7251979,6p25,6p24.3,602209,RREB1,RAS-responsive element binding protein-1,RREB1,6239,ENSG00000124782,NA,NA,Rreb1 (MGI:2443664)
6,7281142,7313313,6p24.3,6p24.3,600868,SSR1,"Signal sequence receptor, alpha",SSR1,6745,ENSG00000124783,NA,NA,Ssr1 (MGI:105082)
6,7326658,7389741,6p25.3-p24.1,6p24.3,608304,"CTAG3, CAGE1",Cancer/testis antigen 3,CAGE1,285782,ENSG00000164304,NA,NA,Cage1 (MGI:1918463)
6,7389807,7418036,6p24.3,6p24.3,617753,"RIOK1, RIO1",RIO kinase 1,RIOK1,83732,ENSG00000124784,NA,NA,Riok1 (MGI:1918590)
6,7541670,7586713,6p24,6p24.3,125647,"DSP, KPPS2, PPKS2, DCWHKTA",Desmoplakin,DSP,1832,ENSG00000096696,splice variants result in DP I and DP II,"Arrhythmogenic right ventricular dysplasia 8, 607450 (3), Autosomal dominant; Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3), Autosomal recessive; Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3), Autosomal dominant; Epidermolysis bullosa, lethal acantholytic, 609638 (3), Autosomal recessive; Keratosis palmoplantaris striata II, 612908 (3), Autosomal dominant; Skin fragility-woolly hair syndrome, 607655 (3), Autosomal recessive",Dsp (MGI:109611)
6,7726098,7881727,6p24-p23,6p24.3,112266,BMP6,Bone morphogenetic protein-6,BMP6,654,ENSG00000153162,NA,NA,Bmp6 (MGI:88182)
6,7881513,7910787,6p25.2,6p24.3,616412,"TXNDC5, ERP46, ENDOPDI, HCC2",Thioredoxin domain-containing protein 5,TXNDC5,81567,ENSG00000239264,NA,NA,Txndc5 (MGI:2145316)
6,8013566,8064413,6p24.3,6p24.3,607289,"BLOC1S5, BLOS5, MUTED","Biogenesis of lysosome-related organelles complex 1, subunit 5",BLOC1S5,63915,ENSG00000188428,NA,NA,Bloc1s5 (MGI:2178598)
6,8073359,8102547,6p25.1-p23,6p24.3,609206,EEF1E1,"Eukaryotic translation elongation factor 1, epsilon-1",EEF1E1,9521,ENSG00000124802,NA,NA,Eef1e1 (MGI:1913393)
6,8413065,8435566,6p24.3,6p24.3,610845,"SLC35B3, PAPST2","Solute carrier family 25 (3'-phosphoadenosine 5'-phosphosulfate transporter), member B3",SLC35B3,51000,ENSG00000124786,NA,NA,Slc35b3 (MGI:1913978)
6,8652208,8653845,6p24.3,6p24.3,612210,HULC,Highly upregulated in liver cancer,HULC,728655,NA,NA,NA,NA
6,9850415,10211607,6p24,6p24.3,614287,"OFCC1, MRDS1",OFC1 candidate gene 1,OFCC1,266553,NA,NA,NA,Ofcc1 (MGI:2658851)
6,10396676,10420059,6p24,6p24.3,107580,"TFAP2A, AP2TF, BOFS",Transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha),TFAP2A,7020,ENSG00000137203,NA,"Branchiooculofacial syndrome, 113620 (3), Autosomal dominant",Tfap2a (MGI:104671)
6,10404501,10407926,6p24.3,6p24.3,617136,"TFAP2AAS2, HIPSTR",TFAP2A antisense RNA 2,TFAP2A-AS2,109729173,ENSG00000285278,overlaps TFAP2A,NA,NA
6,10521282,10629367,6p24-p23,6p24.3-p24.2,600429,"GCNT2, Ii, CTRCT13","Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",GCNT2,2651,ENSG00000111846,previously assigned to 9q21,"Adult i phenotype without cataract, 110800 (3), Autosomal dominant; [Blood group, Ii], 110800 (3), Autosomal dominant; Cataract 13 with adult i phenotype, 116700 (3), Autosomal recessive",Gcnt2 (MGI:1100870)
6,10690864,10709781,6p24.2,6p24.2,607811,"PAK1IP1, PIP1",PAK1-interacting protein,PAK1IP1,55003,ENSG00000111845,NA,NA,Pak1ip1 (MGI:1915333)
6,10722914,10731128,6p24.3,6p24.2,615318,TMEM14C,Transmembrane protein 14C,TMEM14C,51522,ENSG00000111843,NA,NA,Tmem14c (MGI:1913404)
6,10762722,10838953,6p24.2,6p24.2,154235,"MAK, RP62",Male germ cell-associated kinase,MAK,4117,ENSG00000111837,NA,"Retinitis pigmentosa 62, 614181 (3), Autosomal recessive",Mak (MGI:96913)
6,10873222,10881864,6p24.2,6p24.2,603716,"GCM2, GCMB, HRPT4","Glial cells missing, Drosophila, homolog of, 2",GCM2,9247,ENSG00000124827,NA,"Hyperparathyroidism 4, 617343 (3), Autosomal dominant; Hypoparathyroidism, familial isolated, 146200 (3), Autosomal recessive, Autosomal dominant",Gcm2 (MGI:1861438)
6,10887051,10974308,6p24.2,6p24.2,616799,"SYCP2L, C6orf177",Synaptonemal complex protein 2-like,SYCP2L,221711,ENSG00000153157,NA,NA,Sycp2l (MGI:2685114)
6,10980758,11044304,6p24.2,6p24.2,611814,"ELOVL2, SSC2",Elongation of very long chain fatty acids-like 2,ELOVL2,54898,ENSG00000197977,NA,NA,Elovl2 (MGI:1858960)
6,11102488,11111724,6p24.1,6p24.2,610524,ERVFRD-1,"Endogenous retrovirus group FRD, member 1",ERVFRD-1,405754,ENSG00000244476,NA,NA,Synb (MGI:3045308)
6,11183297,11382347,6p24.2,6p24.2,602265,"NEDD9, HEF1, CASL","Neural precursor cell expressed, developmentally downregulated 9",NEDD9,4739,ENSG00000111859,NA,NA,Nedd9 (MGI:97302)
6,11600000,25200000,6p24.1-p22.3,NA,607017,DFNA21,"Deafness, autosomal dominant 21",DFNA21,192644,NA,previously mapped to 6p21.3,"Deafness, autosomal dominant 21, 607017 (2), Autosomal dominant",NA
6,11713522,11779627,6p24.1,6p24.1,614348,"C6orf105, ADTRP",Chromosome 6 open reading frame 105 (androgen-dependent TFPI-regulating protein),ADTRP,84830,ENSG00000111863,NA,NA,Adtrp (MGI:1924596)
6,12002095,12212033,6p24-p22.3,6p24.1,194540,"HIVEP1, ZNF40",Human immunodeficiency virus type I enhancer-binding protein-1,HIVEP1,3096,ENSG00000095951,NA,NA,Hivep1 (MGI:96100)
6,12256462,12297193,6p24-p23,6p24.1,131240,"EDN1, ARCND3, QME, HDLCQ7",Endothelin-1,EDN1,1906,ENSG00000078401,NA,"Auriculocondylar syndrome 3, 615706 (3), Autosomal recessive; {High density lipoprotein cholesterol level QTL 7} (3); Question mark ears, isolated, 612798 (3), Autosomal dominant",Edn1 (MGI:95283)
6,12716634,13290483,6p24.1,6p24.1,608723,"PHACTR1, KIAA1733, EIEE70",Phosphatase and actin regulator 1,PHACTR1,221692,ENSG00000112137,NA,"Epileptic encephalopathy, early infantile, 70, 618298 (3), Autosomal dominant",Phactr1 (MGI:2659021)
6,13304950,13328582,6p24.1,6p24.1,612655,"TBC1D7, PIG51, TBC7, MGCPH","TBC1 domain family, member 7",TBC1D7,51256,ENSG00000145979,NA,"Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3), Autosomal recessive",Tbc1d7 (MGI:1914296)
6,13400000,15200000,6p23,NA,611456,ETM3,"Tremor, hereditary essential, 3",NA,101027378,NA,max lod at D6S1630 and D6S1605,"Essential tremor, hereditary, 3, 611456 (2)",NA
6,13400000,46200000,6p23-p21,NA,271250,"SCAR3, SCABD","Spinocerebellar ataxia, autosomal recessive 3",SCAR3,85502,NA,NA,"Spinocerebellar ataxia, autosomal recessive 3, 271250 (2), Autosomal recessive",NA
6,13400000,15200000,6p23,NA,600511,SCZD3,"Schizophrenia susceptibility locus, chromosome 6-related",SCZD3,6365,NA,?same as DTNBP1; cognitive deficit type,"{Schizophrenia}, 181500 (2), Autosomal dominant",NA
6,13574216,13615157,6p23,6p23,604483,SIRT5,"Sirtuin, S. cerevisiae, homolog 5",SIRT5,23408,ENSG00000124523,NA,NA,Sirt5 (MGI:1915596)
6,13615326,13632469,6p23,6p23,611533,NOL7,Nucleolar protein 7,NOL7,51406,ENSG00000225921,NA,NA,Nol7 (MGI:1917328)
6,13621497,13711834,6p23,6p23,603854,"RANBP9, RANBPM",RAN-binding protein 9,RANBP9,10048,ENSG00000010017,NA,NA,Ranbp9 (MGI:1928741)
6,13786548,13814993,6p23,6p23,616952,"MCUR1, CCDC90A, FMP32",Mitochondrial calcium uniporter regulator 1,MCUR1,63933,ENSG00000050393,NA,NA,Mcur1 (MGI:1923387)
6,14117255,14136917,6p23,6p23,604534,"CD83, HB15, BL11",CD83 antigen,CD83,9308,ENSG00000112149,NA,NA,Cd83 (MGI:1328316)
6,15200000,30500000,6p22,NA,612368,ALPQTL3,"Alkaline phosphatase, plasma level of, QTL 3",NA,100196915,NA,linkage with rs9467160,"{Alkaline phosphatase, plasma level of, QTL3}, 612368 (2)",NA
6,15200000,25200000,6p22.3,NA,615192,BWQTL4,Birth weight quantitative trait locus 4,NA,101448071,NA,associated with rs7756992,"[Birth weight QTL4], 615192 (2)",NA
6,15200000,25200000,6p22.3,NA,613290,CIHL,"Hearing loss, cisplatin-induced, susceptibility to",NA,100381207,NA,associated with rs12201199,"{?Hearing loss, cisplatin-induced, susceptibility to}, 613290 (2)",NA
6,15200000,27100000,6p22.3-p22.2,NA,603209,"CMAHP, CMAH",Cytidine monophospho-N-acetylneuraminic acid hydroxylase pseudogene,CMAHP,8418,ENSG00000168405,mutation inactivates gene in humans,NA,NA
6,15200000,46200000,6p22-p21,NA,600202,DYX2,"Dyslexia, susceptibility to, 2",NA,NA,NA,?between D6S105 and TNFB,"{Dyslexia, susceptibility to, 2}, 600202 (2), Autosomal dominant",NA
6,15200000,30500000,6p22,NA,613015,NBLST4,"Neuroblastoma, susceptibility to, 4",NA,100306937,NA,"associated with rs6939340, rs4712653, rs9295536","{Neuroblastoma, susceptibility to, 4}, 613015 (2)",NA
6,15200000,36600000,6p22.3-p21.3,NA,608244,OTSC3,Otosclerosis 3,OTSC3,170532,NA,NA,"Otosclerosis 3, 608244 (2), Autosomal dominant",NA
6,15200000,46200000,6p22.3-p21.1,NA,601431,TRNAA1,tRNA alanine-1,TRA-TGC7-1,7154,NA,NA,NA,NA
6,15245974,15522041,6p24-p23,6p22.3,601594,JMJ,Jumonji,JARID2,3720,ENSG00000008083,NA,NA,Jarid2 (MGI:104813)
6,15522800,15663057,6p22.3,6p22.3,607145,"DTNBP1, HPS7",Dystrobrevin-binding protein 1 (dysbindin),DTNBP1,84062,ENSG00000047579,NA,"Hermansky-Pudlak syndrome 7, 614076 (3), Autosomal recessive",Dtnbp1 (MGI:2137586)
6,16129085,16151014,6p23-p22.3,6p22.3,610082,"MYLIP, MIR",Myosin regulatory light chain-interacting protein,MYLIP,29116,ENSG00000007944,NA,NA,Mylip (MGI:2388271)
6,16238586,16295548,6p23,6p22.3,139265,"GMPR, GMPR1",Guanosine monophosphate reductase,GMPR,2766,ENSG00000137198,NA,NA,Gmpr (MGI:1913605)
6,16299111,16761489,6p23,6p22.3,601556,"ATXN1, ATX1, SCA1",Ataxin-1,ATXN1,6310,ENSG00000124788,NA,"Spinocerebellar ataxia 1, 164400 (3), Autosomal dominant",Atxn1 (MGI:104783)
6,17281360,17293874,6p22.3,6p22.3,617603,"RBM24, RNPC6",RNA-binding motif protein 24,RBM24,221662,ENSG00000112183,NA,NA,Rbm24 (MGI:3610364)
6,17393504,17557791,6p22.3,6p22.3,618385,CAP2,Cyclase-associated actin cytoskeleton regulatory protein 2,CAP2,10486,ENSG00000112186,NA,NA,Cap2 (MGI:1914502)
6,17600301,17611714,6p23,6p22.3,618409,FAM8A1,"Family with sequence similarity 8, member A1",FAM8A1,51439,ENSG00000137414,NA,NA,Fam8a1 (MGI:2145496)
6,17615034,17706924,6p22.3,6p22.3,603948,NUP153,"Nucleoporin, 153kD",NUP153,9972,ENSG00000124789,NA,NA,Nup153 (MGI:2385621)
6,17759182,17987634,6p22.3,6p22.3,605433,KIF13A,Kinesin family member 13A,KIF13A,63971,ENSG00000137177,NA,NA,Kif13a (MGI:1098264)
6,18120439,18122676,6p22.3,6p22.3,608072,"NHLRC1, EPM2A, EPM2B",NHL repeat-containing 1 gene (malin),NHLRC1,378884,ENSG00000187566,NA,"Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3), Autosomal recessive",Nhlrc1 (MGI:2145264)
6,18128310,18155168,6p22.3,6p22.3,187680,"TPMT, TPMTD",Thiopurine S-methyltransferase,TPMT,7172,ENSG00000137364,NA,"{Thiopurines, poor metabolism of, 1}, 610460 (3), Autosomal recessive",Tpmt (MGI:98812)
6,18155387,18223853,6p22.3,6p22.3,613081,"KDM1B, LSD2, AOF1",Lysine-specific demethylase 1B,KDM1B,221656,ENSG00000165097,NA,NA,NA
6,18223859,18264540,6p23,6p22.3,125264,"DEK, D6S231E",DEK oncogene,DEK,7913,ENSG00000124795,fused with CAN in t(6;9),"Leukemia, acute nonlymphocytic, 125264 (2)",Dek (MGI:1926209)
6,19837369,19842196,6p22-p21.3,6p22.3,600581,ID4,"Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein",ID4,3400,ENSG00000172201,NA,NA,Id4 (MGI:99414)
6,20099683,20212468,6p23,6p22.3,611732,MBOAT1,Membrane-bound O-acetyltransferase domain-containing 1,MBOAT1,154141,ENSG00000172197,NA,NA,Mboat1 (MGI:2387184)
6,20401878,20493713,6p22,6p22.3,600427,E2F3,E2F transcription factor 3,E2F3,1871,ENSG00000112242,NA,NA,E2f3 (MGI:1096340)
6,20534456,21232403,6p22.3,6p22.3,611259,CDKAL1,CDK5 regulatory subunit-associated protein 1-like 1,CDKAL1,54901,ENSG00000145996,NA,NA,Cdkal1 (MGI:1921765)
6,21593750,21598618,6p22.3,6p22.3,184430,"SOX4, CSS10",SRY (sex determining region Y)-box 4,SOX4,6659,ENSG00000124766,NA,"Coffin-Siris syndrome 10, 618506 (3), Autosomal dominant",Sox4 (MGI:98366)
6,21666412,22195819,6p22.3,6p22.3,616610,"CASC15, LINC00340","Cancer susceptibility candidate 15, noncoding",CASC15,401237,NA,NA,NA,NA
6,22134601,22147192,6p22,6p22.3,616206,NBAT1,"Neuroblastoma-associated transcript 1, noncoding",NBAT1,729177,NA,NA,NA,NA
6,22287245,22302896,6p22.2-p21.3,6p22.3,176760,PRL,Prolactin,PRL,5617,ENSG00000172179,?between 6cen and GLO1,NA,Prl (MGI:97762)
6,24126214,24147529,6p22,6p22.3,616630,"NRSN1, VMP",Neurensin 1,NRSN1,140767,ENSG00000152954,NA,NA,Nrsn1 (MGI:894662)
6,24171754,24383291,6p22.1,6p22.3,605755,"DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC",Doublecortin domain-containing protein 2,DCDC2,51473,ENSG00000146038,mutation identified in 1 DFNB66 family,"?Deafness, autosomal recessive 66, 610212 (3), Autosomal recessive; Nephronophthisis 19, 616217 (3), Autosomal recessive; Sclerosing cholangitis, neonatal, 617394 (3), Autosomal recessive",Dcdc2a (MGI:2652818)
6,24356902,24358284,6p22.1,6p22.3,608211,"KAAG1, RU2AS",Kidney-associated antigen 1,KAAG1,353219,ENSG00000146049,NA,NA,NA
6,24423968,24495231,6p22.1,6p22.3,602515,"GPLD1, PIGPLD, GPIPLD","Phospholipase D1, glycosylphosphatidylinositol-specific",GPLD1,2822,ENSG00000112293,NA,NA,Gpld1 (MGI:106604)
6,24494968,24537206,6p22,6p22.3,610045,"ALDH5A1, SSADH",Succinic semialdehyde dehydrogenase,ALDH5A1,7915,ENSG00000112294,NA,"Succinic semialdehyde dehydrogenase deficiency, 271980 (3), Autosomal recessive",Aldh5a1 (MGI:2441982)
6,24540127,24646190,6p22.2,6p22.3,609269,KIAA0319,KIAA0319 gene,KIAA0319,9856,ENSG00000137261,NA,NA,D130043K22Rik (MGI:3036268)
6,24649978,24666898,6p22.3-p22.1,6p22.3,605764,"TDP2, TTRAP",Tyrosyl-DNA phosphodiesterase 2,TDP2,51567,ENSG00000111802,NA,"Spinocerebellar ataxia, autosomal recessive 23, 616949 (3), Autosomal recessive",Tdp2 (MGI:1860486)
6,24667034,24705068,6p22.3,6p22.3,615652,"ACOT13, THEM2",Acyl-CoA thioesterase 13,ACOT13,55856,ENSG00000112304,NA,NA,Acot13 (MGI:1914084)
6,24774936,24786098,6p22.3,6p22.3,602842,"GMNN, MGORS6",Geminin,GMNN,51053,ENSG00000112312,NA,"Meier-Gorlin syndrome 6, 616835 (3), Autosomal dominant",Gmnn (MGI:1927344)
6,24804283,25042287,6p22.3-p21.32,6p22.3,611410,"RIPOR2, FAM65B, C6orf32, KIAA0386, PL48, DFNB104",RHO family interacting cell polarization regulator 2,RIPOR2,9750,ENSG00000111913,mutation identified in 1 DFNB104 family,"?Deafness, autosomal recessive 104, 616515 (3), Autosomal recessive",Ripor2 (MGI:2444879)
6,25279373,25620529,6p22.2,6p22.2,609593,"CARMIL1, LRRC16A, LRRC16",Capping protein regulator and myosin 1 linker 1,CARMIL1,55604,ENSG00000079691,NA,NA,Carmil1 (MGI:1915982)
6,25723742,25832107,6p23-p21.3,6p22.2,182308,"SLC17A1, NPT1","Solute carrier family 17, sodium phosphate, member-1 (Sodium phosphate transport 1, kidney)",SLC17A1,6568,ENSG00000124568,NA,NA,Slc17a1 (MGI:103209)
6,25726062,25726561,6p22.2,6p22.2,613499,"HISTH2AA, H2AFR, H2AA","Histone gene cluster 1, H2A histone family, member A",HIST1H2AA,221613,ENSG00000164508,NA,NA,Hist1h2ak (MGI:2448297)
6,25726908,25727344,6p22.2,6p22.2,609904,"HIST1H2BA, TSH2B","Histone 1, H2BA",HIST1H2BA,255626,ENSG00000146047,NA,NA,Hist1h2ba (MGI:2448375)
6,25754672,25781198,6p22-p21.3,6p22.2,604216,SLC17A4,"Solute carrier family 17 (sodium phosphate), member 4",SLC17A4,10050,ENSG00000146039,NA,NA,Slc17a4 (MGI:2442850)
6,25844855,25874242,6p21.3,6p22.2,611034,"SLC17A3, NPT4, UAQTL4, GOUT4","Solute carrier family 17 (sodium phosphate cotransporter), member 3",SLC17A3,10786,ENSG00000124564,NA,"{Gout susceptibility 4}, 612671 (3), Autosomal dominant; [Uric acid concentration, serum, QTL4], 612671 (3), Autosomal dominant",Slc17a3 (MGI:2389216)
6,25912753,25930726,6p21.3,6p22.2,611049,"SLC17A2, NPT3","Solute carrier family 17 (sodium phosphate cotransporter), member 2",SLC17A2,10246,ENSG00000112337,NA,NA,Slc17a2 (MGI:2443098)
6,26017031,26017811,6p21.3,6p22.2,142709,"HIST1H1A, H1F1","Histone 1, H1a",HIST1H1A,3024,ENSG00000124610,NA,NA,NA
6,26020489,26020957,6p21.3,6p22.2,602810,"HIST1H3A, H3FA","Histone 1, H3a",HIST1H3A,8350,ENSG00000275714,NA,NA,Hist1h3d (MGI:2448322)
6,26021678,26022049,6p21.3,6p22.2,602822,"HIST1H4A, H4FA","Histone 1, H4a",HIST1H4A,8359,ENSG00000278637,NA,NA,Hist1h4d (MGI:2448423)
6,26026895,26027251,6p21.3,6p22.2,602829,"HIST1H4B, H4FI","Histone 1, H4b",HIST1H4B,8366,ENSG00000278705,NA,NA,Hist4h4 (MGI:2448443)
6,26031588,26032059,6p21.3,6p22.2,602819,"HIST1H3B, H3FL","Histone 1, H3fl",HIST1H3B,8358,ENSG00000286522,in major cluster on 6p,NA,Hist2h3b (MGI:2448351)
6,26033091,26033567,6p21.3,6p22.2,602795,"HIST1H2AB, H2AFM","Histone 1, H2ab",HIST1H2AB,8335,ENSG00000278463,NA,NA,Hist1h2ag (MGI:2448293)
6,26043226,26043656,6p21.3,6p22.2,602803,"HIST1H2BB, H2BFF","Histone 1, H2bb",HIST1H2BB,3018,ENSG00000276410,NA,NA,Hist1h2bb (MGI:2448377)
6,26045410,26045868,6p21.3,6p22.2,602812,"HIST1H3C, H3FC","Histone 1, H3c",HIST1H3C,8352,ENSG00000287080,NA,NA,Hist2h3c1 (MGI:2448355)
6,26055739,26056470,6p21.3,6p22.2,142710,"HIST1H1C, H1F2","Histone 1, H1c",HIST1H1C,3006,ENSG00000187837,NA,NA,Hist1h1c (MGI:1931526)
6,26087280,26098342,6p21.3,6p22.2,613609,"HFE, HLA-H, HFE1, MVCD7, TFQTL2",Hemochromatosis gene,HFE,3077,ENSG00000010704,NA,"{Alzheimer disease, susceptibility to}, 104300 (3), Autosomal dominant; Hemochromatosis, 235200 (3), Autosomal recessive; {Microvascular complications of diabetes 7}, 612635 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3), Autosomal recessive, Autosomal dominant; {Porphyria variegata, susceptibility to}, 176200 (3), Autosomal dominant; [Transferrin serum level QTL2], 614193 (3)",Hfe (MGI:109191)
6,26103947,26104336,6p21.3,6p22.2,602827,"HIST1H4C, H4FG","Histone 1, H4c",HIST1H4C,8364,ENSG00000197061,NA,NA,Hist2h4 (MGI:2140113)
6,26107411,26108135,6p21.3,6p22.2,142712,"HIST1H1T, H1FT","Histone 1, H1t",HIST1H1T,3010,ENSG00000187475,NA,NA,Hist1h1t (MGI:1888530)
6,26123466,26123903,6p21.3,6p22.2,602847,"HIST1H2BC, H2BFL","Histone 1, H2bc",HIST1H2BC,8347,ENSG00000180596,NA,NA,Hist1h2bg (MGI:2448386)
6,26124144,26124689,6p21.3,6p22.2,602794,"HIST1H2AC, H2AFL","Histone 1, H2ac",HIST1H2AC,8334,ENSG00000180573,NA,NA,Hist1h2ao (MGI:2448302)
6,26156330,26157114,6p21.3,6p22.2,142220,"HIST1H1E, H1F4, RMNS","Histone 1, H1e",HIST1H1E,3008,ENSG00000168298,NA,"Rahman syndrome, 617537 (3), Autosomal dominant",NA
6,26158007,26171348,6p21.3,6p22.2,602799,"HIST1H2BD, H2BFB","Histone 1, H2bd",HIST1H2BD,3017,ENSG00000158373,NA,NA,Hist3h2ba (MGI:1925553)
6,26183795,26184229,6p21.3,6p22.2,602805,"HIST1H2BE, H2BFH","Histone 1, H2be",HIST1H2BE,8344,ENSG00000274290,NA,NA,Hist1h2bl (MGI:2448403)
6,26188709,26189075,6p21.3,6p22.2,602823,"HIST1H4D, H4FB","Histone 1, H4d",HIST1H4D,8360,ENSG00000277157,NA,NA,Hist1h4m (MGI:2448441)
6,26196783,26199292,6p21.3,6p22.2,602811,"HIST1H3D, H3FB","Histone 1, H3d",HIST1H3D,8351,ENSG00000197409,NA,NA,Hist1h3a (MGI:2668828)
6,26198783,26199292,6p21.3,6p22.2,602792,"HIST1H2AD, H2AFG","Histone 1, H2ad",HIST1H2AD,3013,ENSG00000196866,NA,NA,Hist1h2ab (MGI:2448306)
6,26199558,26199987,6p21.3,6p22.2,602804,"HIST1H2BF, H2BFG","Histone 1, H2bf",HIST1H2BF,8343,ENSG00000277224,NA,NA,Hist1h2be (MGI:2448380)
6,26204644,26205020,6p21.3,6p22.2,602830,"HIST1H4E, H4FJ","Histone 1, H4e",HIST1H4E,8367,ENSG00000276966,NA,NA,NA
6,26216199,26216643,6p21.3,6p22.2,602798,"HIST1H2BG, H2BFA","Histone 1, H2bg",HIST1H2BG,8339,ENSG00000273802,NA,NA,Hist1h2bf (MGI:2448383)
6,26216919,26217482,6p21.3,6p22.2,602786,"HIST1H2AE, H2AFA","Histone 1, H2ae",HIST1H2AE,3012,ENSG00000277075,NA,NA,Hist1h2ai (MGI:2448457)
6,26225154,26225615,6p21.3,6p22.2,602813,"HIST1H3E, H3FD, H3.1","Histone 1, H3e",HIST1H3E,8353,ENSG00000274750,in cluster of 35 histone genes,NA,Hist1h3h (MGI:2448349)
6,26234211,26234987,6p21.3,6p22.2,142210,"HIST1H1D, H1F3","Histone 1, H1d",HIST1H1D,3007,ENSG00000124575,NA,NA,Hist1h1d (MGI:107502)
6,26240425,26240792,6p21.3,6p22.2,602824,"HIST1H4F, H4FC","Histone 1, H4f",HIST1H4F,8361,ENSG00000274618,NA,NA,Hist1h4c (MGI:2448421)
6,26246610,26246976,6p21.3,6p22.2,602832,"HIST1H4G, H4FL","Histone 1, H4g",HIST1H4G,8369,ENSG00000275663,NA,NA,NA
6,26250141,26250606,6p21.3,6p22.2,602816,HIST1H3F,"Histone 1, H3f",HIST1H3F,8968,ENSG00000277775,NA,NA,Hist1h3i (MGI:2448350)
6,26251650,26252074,6p21.3,6p22.2,602806,"HIST1H2BH, H2BFJ","Histone 1, H2bh",HIST1H2BH,8345,ENSG00000275713,NA,NA,"Hist1h2br,Hist1h2bq (MGI:3710645,MGI:3702051)"
6,26270917,26271383,6p21.3,6p22.2,602815,"HIST1H3G, H3FH","Histone 1, H3g",HIST1H3G,8355,ENSG00000273983,NA,NA,Hist2h3c2 (MGI:2448357)
6,26272975,26273411,6p21.3,6p22.2,602807,"HIST1H2BI, H2BFK","Histone 1, H2bi",HIST1H2BI,8346,ENSG00000278588,NA,NA,Hist1h2bc (MGI:1915274)
6,26285125,26285498,6p21.3,6p22.2,602828,"HIST1H4H, H4FH","Histone 1, H4h",HIST1H4H,8365,ENSG00000158406,NA,NA,Hist1h4k (MGI:2448439)
6,26286525,26286596,6p23-q12,6p22.2,180621,"TRNAM1, TRMI2, TRM2, RNTMT1",tRNA methionine-1,TRX-CAT1-2,7210,NA,NA,NA,NA
6,26299676,26299748,6p22.3-p21.1,6p22.2,601432,"TRNAR3, TRR3",tRNA arginine-3,TRR-TCG4-1,7232,NA,NA,NA,NA
6,26365158,26378319,6p22.1,6p22.2,613594,"BTN3A2, BTF4","Butyrophilin, subfamily 3, member A2",BTN3A2,11118,ENSG00000186470,NA,NA,NA
6,26382892,26394873,6p22.1,6p22.2,613591,"BTN2A2, BTF2","Butyrophilin, subfamily 2, member A2",BTN2A2,10385,ENSG00000124508,NA,NA,Btn2a2 (MGI:3606486)
6,26402268,26415215,6p22.1,6p22.2,613593,"BTN3A1, BTF5, CD277","Butyrophilin, subfamily 3, member A1",BTN3A1,11119,ENSG00000026950,NA,NA,NA
6,26421390,26430587,6p22.1,6p22.2,613592,BTN2A3,"Butyrophilin, subfamily 2, member A3",BTN2A3P,54718,ENSG00000124549,NA,NA,NA
6,26440503,26453414,6p22.1,6p22.2,613595,"BTN3A3, BTF3","Butyrophilin, subfamily 3, member A3",BTN3A3,10384,ENSG00000111801,NA,NA,NA
6,26457903,26476621,6p22.1,6p22.2,613590,"BTN2A1, BTF1","Butyrophilin, subfamily 2, member A1",BTN2A1,11120,ENSG00000112763,NA,NA,NA
6,26499289,26510424,6p22.1,6p22.2,601610,"BTN1A1, BTN",Butyrophilin,BTN1A1,696,ENSG00000124557,NA,NA,Btn1a1 (MGI:103118)
6,26537497,26537569,6p22.2,6p22.2,615305,TRNAR2,Transfer RNA arginine 2,TRR-ACG1-2,7231,NA,NA,NA,NA
6,26538053,26538125,6p22.2,6p22.2,615306,TRNAV21,Transfer RNA valine 21,TRV-CAC1-6,100189227,NA,NA,NA,NA
6,26634382,26659751,6p22.1,6p22.2,610847,"ZNF322A, ZNF489, ZNF322",Zinc finger protein 322A,ZNF322,79692,ENSG00000181315,NA,NA,Zfp322a (MGI:2442566)
6,27100000,30500000,6p22.1,NA,612892,STQTL18,Stature quantitative trait locus 18,NA,100302683,NA,associated with rs10946808,"{Stature QTL 18}, 612892 (2)",NA
6,27132315,27132795,6p22-p21.3,6p22.1,615044,"HIST1H2BJ, H2BJ","Histone gene cluster 1, H2B histone family, member J",HIST1H2BJ,8970,ENSG00000124635,NA,NA,Hist2h2be (MGI:2448415)
6,27133037,27133534,6p22-p21.3,6p22.1,615012,"HIST1H2AG, H2AG, H2AFP","Histone gene cluster 1, H2A histone family, member 6",HIST1H2AG,8969,ENSG00000196787,NA,NA,Hist1h2an (MGI:2448300)
6,27138292,27146857,6p22-p21.3,6p22.1,615045,"HIST1H2BK, H2BK","Histone gene cluster 1, H2B histone family, member K",HIST1H2BK,85236,ENSG00000197903,NA,NA,Hist1h2bk (MGI:2448399)
6,27139308,27139677,6p21.3,6p22.1,602833,"HIST1H4I, H4FM, H4M","Histone 1, H4i",HIST1H4I,8294,ENSG00000276180,NA,NA,Hist1h4h (MGI:2448427)
6,27147081,27147561,6p22-p21.3,6p22.1,615013,"HIST1H2AH, H2AH","Histone gene cluster 1, H2A histone family, member H",HIST1H2AH,85235,ENSG00000274997,NA,NA,Hist1h2ah (MGI:2448295)
6,27235508,27235580,6p22.1,6p22.1,615307,TRNAV12,Transfer RNA valine 12,TRV-AAC5-1,100189014,NA,NA,NA,NA
6,27247700,27256619,6p22-p21.3,6p22.1,607169,"PRSS16, TSSP","Protease, serine, 16",PRSS16,10279,ENSG00000112812,NA,NA,Prss16 (MGI:1859181)
6,27404009,27473117,6p21.3,6p22.1,602277,ZNF184,Zinc finger protein-184,ZNF184,7738,ENSG00000096654,NA,NA,Zfp184 (MGI:1922244)
6,27495813,27495894,6p22.1,6p22.1,189910,"TRS-AGA2-4, TRNAS2, TRS2, TRNS",Transfer RNA serine (AGA) 2-4,TRS-AGA2-3,23437,NA,NA,NA,NA
6,27505827,27505908,6p22.1,6p22.1,606172,"TRS-TGA4-1, TRNAS3, TRS3",Transfer RNA serine (TGA) 4-1,TRS-TGA4-1,23540,NA,NA,NA,NA
6,27681105,27681177,6p22.1,6p22.1,615308,TRNAV17,Transfer RNA valine 17,TRV-AAC4-1,100189161,NA,NA,NA,NA
6,27684694,27684767,6p22.1,6p22.1,615309,TRNAT15,Transfer RNA threonine 15,TRT-AGT2-2,100189340,NA,NA,NA,NA
6,27777884,27777955,6p23-q12,6p22.1,180620,"TRNAM2, TRNAMI2, RNTMI2",tRNA methionine-2,TRX-CAT2-1,7212,NA,2 of 12+ RNTMI genes are on chr. 6,NA,NA
6,27807478,27807930,6p22-p21.3,6p22.1,602800,"HIST1H2BL, H2BFC","Histone 1, H2bl",HIST1H2BL,8340,ENSG00000185130,NA,NA,Hist1h2bj (MGI:2448388)
6,27808198,27808666,6p22-p21.3,6p22.1,602787,"HIST1H2AI, H2AFC","Histone 1, H2ai",HIST1H2AI,8329,ENSG00000196747,NA,NA,NA
6,27810063,27810535,6p22-p21.3,6p22.1,602818,"HIST1H3H, H3FK","Histone 1, H3h",HIST1H3H,8357,ENSG00000278828,in minor cluster on 6p,NA,Hist1h3b (MGI:2448319)
6,27814301,27814739,6p22-p21.3,6p22.1,602791,"HIST1H2AJ, HIST1H2AK, H2AFE","Histone 1, H2aj",HIST1H2AJ,8331,ENSG00000276368,NA,NA,Hist1h2af (MGI:2448309)
6,27815043,27815488,6p22-p21.3,6p22.1,602802,"HIST1H2BM, H2BFE","Histone 1, H2bm",HIST1H2BM,8342,ENSG00000273703,NA,NA,Hist1h2bn (MGI:2448407)
6,27824124,27824479,6p22-p21.3,6p22.1,602826,"HIST1H4J, H4FE","Histone 1, H4j",HIST1H4J,8363,ENSG00000197238,NA,NA,Hist1h4f (MGI:2448425)
6,27831173,27831526,6p22-p21.3,6p22.1,602825,"HIST1H4K, H4FD","Histone 1, H4k",HIST1H4K,8362,ENSG00000273542,NA,NA,Hist1h4j (MGI:2448436)
6,27837879,27838338,6p22-p21.3,6p22.1,602788,"HIST1H2AK, HIST1H2AI, H2AFD","Histone 1, H2ak",HIST1H2AK,8330,ENSG00000275221,NA,NA,Hist1h2ac (MGI:2448287)
6,27838661,27839109,6p22-p21.3,6p22.1,602801,"HIST1H2BN, H2BFD","Histone 1, H2bn",HIST1H2BN,8341,ENSG00000233822,NA,NA,Hist1h2bm (MGI:2448404)
6,27865328,27865797,6p22-p21.3,6p22.1,602793,"HIST1H2AL, H2AFI","Histone 1, H2al",HIST1H2AL,8332,ENSG00000276903,NA,NA,Hist1h2ae (MGI:2448290)
6,27866791,27867580,6p22-p21.3,6p22.1,142711,"HIST1H1B, H1F5","Histone 1, H1b",HIST1H1B,3009,ENSG00000184357,~2Mb centromeric of H1F1 cluster,NA,NA
6,27871844,27872320,6p22-p21.3,6p22.1,602814,"HIST1H3I, H3FF","Histone 1, H3i",HIST1H3I,8354,ENSG00000275379,in cluster of 16 histone genes centromeric of major cluster,NA,Hist1h3e (MGI:2448326)
6,27873147,27873510,6p22-p21.3,6p22.1,602831,"HIST1H4L, H4FK","Histone 1, H4l",HIST1H4L,8368,ENSG00000275126,NA,NA,Hist1h4n (MGI:4843992)
6,27890314,27890791,6p22-p21.3,6p22.1,602817,"HIST1H3J, H3FJ","Histone 1, H3j",HIST1H3J,8356,ENSG00000197153,in 2nd cluster on 6p,NA,Hist1h3g (MGI:2145541)
6,27892698,27893184,6p22-p21.3,6p22.1,602796,"HIST1H2AM, H2AFN","Histone 1, H2am",HIST1H2AM,8336,ENSG00000278677,NA,NA,Hist1h2ad (MGI:2448289)
6,27893424,27893890,6p22-p21.3,6p22.1,602808,"HIST1H2BO, H2BFN","Histone 1, H2bo",HIST1H2BO,8348,ENSG00000274641,NA,NA,Hist1h2bp (MGI:2448409)
6,28080567,28104243,6p21.3,6p22.1,600834,"ZNF165, LD65",Zinc finger protein-165,ZNF165,7718,ENSG00000197279,NA,NA,NA
6,28141642,28159471,6p21.3,6p22.1,602240,ZNF192,Zinc finger protein-192,ZKSCAN8,7745,ENSG00000198315,NA,NA,Zkscan8 (MGI:1913815)
6,28224701,28233486,6p21.3,6p22.1,602246,ZNF193,Zinc finger protein-193,ZSCAN9,7746,ENSG00000137185,NA,NA,NA
6,28241696,28259257,6p21.33-p21.31,6p22.1,611643,"ZKSCAN4, ZNF307",Zinc finger with KRAB and SCAN domains 4,ZKSCAN4,387032,ENSG00000187626,NA,NA,NA
6,28267009,28278223,6p22.1,6p22.1,616474,"ZSCAN26, SREZBP",Zinc finger- and SCAN domain-containing protein 26,ZSCAN26,7741,ENSG00000197062,NA,NA,Zscan26 (MGI:3531417)
6,28324736,28359156,6p22.3-p22.1,6p22.1,610794,ZNF323,Zinc finger protein 323,ZSCAN31,64288,ENSG00000235109,NA,NA,NA
6,28349912,28369173,6p22.1,6p22.1,612791,"ZKSCAN3, ZNF306",Zinc finger protein with KRAB and SCAN domains 3,ZKSCAN3,80317,ENSG00000189298,NA,NA,Zkscan3 (MGI:1919989)
6,28378820,28399767,6p22.2-p21.3,6p22.1,603978,"ZSCAN12, ZNF96, KIAA0426",Zinc finger- and SCAN domain-containing protein 12,ZSCAN12,9753,ENSG00000158691,NA,NA,Zscan12 (MGI:1099444)
6,28503295,28515792,6p22.1,6p22.1,607913,GPX6,Glutathione peroxidase 6,GPX6,257202,ENSG00000198704,NA,NA,Gpx6 (MGI:1922762)
6,28526011,28534950,6p22.1,6p22.1,603435,GPX5,Glutathione peroxidase 5 (epididymal),GPX5,2880,ENSG00000224586,NA,NA,Gpx5 (MGI:104886)
6,28568287,28616176,6p22.1,6p22.1,615254,"SCAND3, ZBED9, BUSTER4, KIAA1925",SCAN domain-containing protein 3,ZBED9,114821,ENSG00000232040,NA,NA,NA
6,28903001,28923984,6p22,6p22.1,602165,"TRIM27, RFP",Tripartite motif-containing 27,TRIM27,5987,ENSG00000204713,NA,NA,Trim27 (MGI:97904)
6,29111809,29112883,6p22.1,6p22.1,615016,"OR2J3, C3HEXS","Olfactory receptor, family 2, subfamily J, member 3",OR2J3,442186,ENSG00000204701,NA,"[C3HEX, ability to smell], 615082 (3), Autosomal dominant",NA
6,29486696,29487955,6p21,6p22.1,607235,"MAS1L, MRG",MAS1 oncogene-like,MAS1L,116511,ENSG00000204687,NA,NA,NA
6,29555514,29559731,6p21.3,6p22.1,606050,"UBD, FAT10",Ubiquitin D,UBD,10537,ENSG00000213886,NA,NA,Ubd (MGI:1344410)
6,29586523,29592505,6p21.3,6p22.1,600578,"OR2H3, OLFR2","Olfactory receptor, family 2, subfamily H, member 3 (olfactory receptor 2)",OR2H2,7932,ENSG00000204657,in class I MHC region,NA,Olfr90 (MGI:2177473)
6,29602227,29633182,6p21.3,6p22.1,603540,"GABBR1, GABABR1",Gamma-aminobutyric acid B receptor 1,GABBR1,2550,ENSG00000204681,NA,NA,Gabbr1 (MGI:1860139)
6,29657091,29672364,6p21.3,6p22.1,159465,"MOG, NRCLP7",Myelin-oligodendrocyte glycoprotein,MOG,4340,ENSG00000204655,60kb telomeric to HLA-F; mutation identified in 1 NRCLP7 family,"?Narcolepsy 7, 614250 (3), Autosomal dominant",Mog (MGI:97435)
6,29672391,29681151,6p22.1,6p22.1,612192,"ZFP57, TNDM1","Zinc finger protein 57, mouse, homolog of",ZFP57,346171,ENSG00000204644,NA,"Diabetes mellitus, transient neonatal, 1, 601410 (3), Autosomal dominant",Zfp57 (MGI:99204)
6,29723339,29740354,6p21.3,6p22.1,143110,"HLA-F, HLA-CDA12, HLAF","Major histocompatibility complex, class I, F",HLA-F,3134,ENSG00000204642,NA,NA,"Gm11127,Gm7030 (MGI:3779381,MGI:3647514)"
6,29826978,29831129,6p21.3,6p22.1,142871,HLA-G,"HLA-G histocompatibility antigen, class I",HLA-G,3135,ENSG00000204632,NA,"{Asthma, susceptibility to}, 600807 (2), Autosomal dominant",H2-M3 (MGI:95915)
6,29942531,29945869,6p21.3,6p22.1,142800,HLA-A,"Major histocompatibility complex, class I, A",HLA-A,3105,ENSG00000206503,NA,"{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)","Gm8909,H2-Bl,H2-Q6,H2-K1,H2-Q7,H2-Q4,H2-Q2,Gm10499,H2-Q1,H2-D1,H2-Q10 (MGI:95935,MGI:95936,MGI:95904,MGI:3702919,MGI:95931,MGI:892004,MGI:95933,MGI:3704134,MGI:95896,MGI:95928,MGI:95929)"
6,29975114,29978402,6p21.3,6p22.1,615797,"HCG9, HCGIX, HCGIX4","HLA complex group 9, noncoding",HCG9,10255,ENSG00000204625,NA,NA,NA
6,30001010,30061188,6p22.1,6p22.1,615714,"ZNRD1AS1, TCTEX4, HTEX4",ZNRD1 antisense RNA 1,ZNRD1ASP,80862,ENSG00000204623,NA,NA,NA
6,30061239,30064908,6p22.1,6p22.1,607525,"ZNRD1, TCTEX6, HTEX6",Zinc ribbon domain-containing protein 1,ZNRD1,30834,ENSG00000066379,NA,NA,Znrd1 (MGI:1913386)
6,30066863,30070332,6p21.3,6p22.1,606670,"PPP1R11, TCTEX5","Protein phosphatase 1, regulatory subunit 11",PPP1R11,6992,ENSG00000204619,NA,NA,Ppp1r11 (MGI:1923747)
6,30070265,30080624,6p21.3,6p22.1,607524,"RNF39, HZFW, HZF, LIRF",Ring finger protein 39,RNF39,80352,ENSG00000204618,NA,NA,Rnf39 (MGI:2156378)
6,30102891,30113105,6p23-p21,6p22.1,609316,"TRIM31, HCGI",Tripartite motif-containing protein 31,TRIM31,11074,ENSG00000204616,NA,NA,Trim31 (MGI:2385051)
6,30135997,30148772,6p22.1,6p22.1,616976,"TRIM40, RNF35",Tripartite motif-containing protein 40,TRIM40,135644,ENSG00000204614,NA,NA,Trim40 (MGI:2684881)
6,30151938,30163215,6p21.3,6p22.1,605701,"RNF9, RFB30, HERF1",RING finger protein-9,TRIM10,10107,ENSG00000204613,NA,NA,Trim10 (MGI:1338757)
6,30184452,30213434,6p21.3,6p22.1,600830,ZNF173,Zinc finger protein-173,TRIM26,7726,ENSG00000234127,NA,NA,Trim26 (MGI:1337056)
6,30326468,30343728,6p22.1-p21.3,6p22.1,605700,"TRIM39, RNF23, TFP",Tripartite motif-containing 39,TRIM39,56658,ENSG00000204599,NA,NA,Trim39 (MGI:1890659)
6,30345155,30346893,6p21,6p22.1,612524,RPP21,"Ribonuclease P/MRP, 21kD subunit",RPP21,79897,ENSG00000241370,NA,NA,Rpp21 (MGI:1914926)
6,30489507,30494193,6p21.3,6p22.1,143010,HLA-E,"Major histocompatibility complex, class I, E",HLA-E,3133,ENSG00000204592,NA,NA,"H2-T23,H2-T-ps (MGI:95957,MGI:2442805)"
6,30500000,36600000,6p21.3,NA,107320,ATPLS,"Antiphospholipid syndrome, familial",NA,100499532,NA,possible linkage with HLA-DRB1*14,"?Antiphospholipid syndrome, familial, 107320 (2), Autosomal dominant",NA
6,30500000,40500000,6p21.3-p21.2,NA,153380,CP20,"Lymphocyte cytosolic protein, molecular weight 20kD",NA,7938,NA,NA,NA,NA
6,30500000,36600000,6p21.3,NA,612862,CTEPH1,"Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to",NA,100302516,NA,associated with DPB1*0202,"{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}, 612862 (2)",NA
6,30500000,36600000,6p21.3,NA,608645,DFNA31,"Deafness, autosomal dominant 31",DFNA31,347737,NA,between D6S276 and D6S273,"Deafness, autosomal dominant 31, 608645 (2), Autosomal dominant",NA
6,30500000,46200000,6p21,NA,608816,EJM3,"Epilepsy, juvenile myoclonic 3",NA,449018,NA,NA,"Epilepsy, juvenile myoclonic 3, 608816 (2)",NA
6,30500000,32100000,6p21.33,NA,613024,FL1,"Follicular lymphoma, susceptibility to, 1",NA,100306940,NA,associated with rs6457327,"{Follicular lymphoma, susceptibility to, 1}, 613024 (2)",NA
6,30500000,36600000,6p21.3,NA,608710,"GPA, WG",Granulomatosis with polyangiitis,NA,474168,NA,NA,"Granulomatosis with polyangiitis, 608710 (2)",NA
6,30500000,36600000,6p21.3,NA,615801,"HCG8, HCGVIII",HLA complex group 8,NA,NA,NA,NA,NA,NA
6,30500000,36600000,6p21.3,NA,612735,"HLA-DRB3, HLA-DR52","Major histocompatibility complex, class II, DR beta-3",HLA-DRB3,3125,NA,NA,NA,NA
6,30500000,36600000,6p21.3,NA,604519,IBD3,Inflammatory bowel disease 3,IBD3,30829,NA,NA,"{Inflammatory bowel disease 3}, 604519 (2), Autosomal dominant",NA
6,30500000,36600000,6p21.3,NA,222100,IDDM1,Insulin-dependent diabetes mellitus-1,NA,NA,NA,"linkage or association, with HLA","{Diabetes mellitus, insulin-dependent-1}, 222100 (2), Autosomal recessive",NA
6,30500000,36600000,6p21.3,NA,137100,IGAD1,Immunoglobulin A deficiency,IGAD1,10986,NA,NA,"Immunoglobulin A deficiency, 137100 (2), Autosomal recessive, Autosomal dominant, Isolated cases",NA
6,30500000,36600000,6p21.3,NA,146820,IGAT,Immune response to synthetic polypeptide--IRGAT,NA,7927,NA,in B/D segment,NA,NA
6,30500000,36600000,6p21.3,NA,147080,IGLP1,Immune response to synthetic polypeptides-1,IGLP1,7925,NA,NA,NA,NA
6,30500000,36600000,6p21.3,NA,147090,IGLP2,Immune response to synthetic polypeptides-2,IGLP2,7926,NA,NA,NA,NA
6,30500000,36600000,6p21.3,NA,146850,ISCW,Immune suppression to streptococcal antigen,NA,7928,NA,HLA-linked,NA,NA
6,30500000,40500000,6p21.3-p21.2,NA,150270,LAP,Laryngeal adductor paralysis,NA,7939,NA,?linkage to HLA and GLO1,"?Laryngeal adductor paralysis, 150270 (2), Autosomal dominant",NA
6,30500000,46200000,6p21,NA,601086,LATD,"Laterality defects, autosomal dominant",NA,207115,NA,max lod 2.95 at theta = 0,NA,NA
6,30500000,32100000,6p21.33,NA,612593,LNCR4,Lung cancer susceptibility 4,NA,100271693,NA,associated with rs3117582 and rs3131379,"{Lung cancer susceptibility 4}, 612593 (2)",NA
6,30500000,36600000,6p21.3,NA,614692,MBNP,"Membranous nephropathy, susceptibility to",NA,101154649,NA,NA,"{?Membranous nephropathy, susceptibility to}, 614692 (2)",NA
6,30500000,40500000,6p21.3-p21.2,NA,614644,MPVQTL4,Mean platelet volume quantitative trait locus 4,NA,100887753,NA,associated with rs210134,"Mean platelet volume QTL4, 614644 (2)",NA
6,30500000,36600000,6p21.3,NA,607085,MYAS1,Myasthenia gravis with thymus hyperplasia,NA,246750,NA,NA,"Myasthenia gravis with thymus hyperplasia, 607085 (2)",NA
6,30500000,36600000,6p21.3,NA,272370,"NKS1, EC1",Susceptibility to lysis by alloreactive natural killer cells,NKS1,4819,NA,NA,NA,NA
6,30500000,36600000,6p21.3,NA,161550,NPCA2,"Nasopharyngeal carcinoma, susceptibility to, 2",NA,100312951,NA,associated with rs2517713 and rs2975042,"{Nasopharyngeal carcinoma, susceptibility to, 2}, 161550 (2)",NA
6,30500000,36600000,6p21.3,NA,613007,PBC2,"Biliary cirrhosis, primary, 2",NA,100303716,NA,associated with rs2856683,"{Biliary cirrhosis, primary, 2}, 613007 (2)",NA
6,30500000,36600000,6p21.3,NA,600089,PBCA,"Pancreatic beta cell, agenesis of",NA,7962,NA,uniparental disomy,"?Diabetes mellitus, insulin-dependent, neonatal, 600089 (2), Autosomal recessive",NA
6,30500000,36600000,6p21.3,NA,604809,PBLT,"Panbronchiolitis, diffuse",NA,NA,NA,NA,"Panbronchiolitis, diffuse, 604809 (2), Multifactorial",NA
6,30500000,36600000,6p21.3,NA,614590,PDCOS,"Podoconiosis, susceptibility to",NA,100885774,NA,NA,"{Podoconiosis, susceptibility to}, 614590 (2)",NA
6,30500000,46200000,6p21,NA,611185,RLS6,"Restless legs syndrome, susceptibility to, 6",NA,100302512,NA,associated with rs9296249 and rs9357271,"{Restless legs syndrome 6}, 611185 (2)",NA
6,30500000,36600000,6p21.3,NA,179450,RWS,Ragweed sensitivity,NA,7937,NA,"?linkage or association, with HLA","?Ragweed sensitivity, 179450 (2), Autosomal dominant",NA
6,30500000,36600000,6p21.3,NA,193200,VAMAS6,Vitiligo-associated multiple autoimmune disease susceptibility 6,NA,246319,NA,possible second locus on 1p31.3-p32.2,"{Vitiligo-associated multiple autoimmune disease susceptibility 6}, 193200 (2), Autosomal recessive",NA
6,30500000,36600000,6p21.3,NA,153600,WM1,"Macroglobulinemia, Waldenstrom, susceptibility to, 1",NA,100188787,NA,linked to HLA,"{Macroglobulinemia, Waldenstrom, susceptibility to, 1}, 153600 (2), Autosomal dominant",NA
6,30500000,36600000,6p21.3,NA,603282,ZNF204,Zinc finger protein-204,ZNF204P,7754,NA,?pseudogene,NA,NA
6,30541376,30557593,6p21.3,6p21.33,143024,"GNL1, HSR1",Guanine nucleotide-binding protein-like 1,GNL1,2794,ENSG00000204590,NA,NA,Gnl1 (MGI:95764)
6,30571441,30591521,6p21.33,6p21.33,603429,"ABCF1, ABC50","ATP-binding cassette 50, TNF-alpha stimulated",ABCF1,23,ENSG00000204574,NA,NA,Abcf1 (MGI:1351658)
6,30584331,30584416,6p21.33,6p21.33,611619,"MIR877, MIRN877",Micro RNA 877,MIR877,100126314,ENSG00000216101,NA,NA,NA
6,30600399,30618606,6p21.3,6p21.33,603771,"PPP1R10, PNUTS","Protein phosphatase 1, regulatory subunit 10",PPP1R10,5514,ENSG00000204569,NA,NA,Ppp1r10 (MGI:1289273)
6,30617319,30626392,6p21.3,6p21.33,611982,"MRPS18B, MRPS18-2",Mitochondrial ribosomal protein S18B,MRPS18B,28973,ENSG00000204568,pseudogenes on chromosomes 1 and 2,NA,Mrps18b (MGI:1914223)
6,30626841,30646822,6p21.33,6p21.33,615556,"ATAT1, MEC17, C6orf134",Alpha-tubulin acetyltransferase 1,ATAT1,79969,ENSG00000137343,NA,NA,Atat1 (MGI:1913869)
6,30653118,30673052,6p21.3,6p21.33,603405,"DHX16, DDX16, DBP2, PRP8",DEAH (Asp-Glu-Ala-His) box polypeptide 16,DHX16,8449,ENSG00000204560,NA,NA,Dhx16 (MGI:1916442)
6,30676388,30687206,6p21.3,6p21.33,610990,"PPP1R18, KIAA1949",Protein phosphatase 1 regulatory subunit 18,PPP1R18,170954,ENSG00000146112,NA,NA,Ppp1r18 (MGI:1923698)
6,30699806,30717987,6pter-p21.3,6p21.33,607593,"MDC1, NFBD1, KIAA0170",Mediator of DNA damage checkpoint protein 1,MDC1,9656,ENSG00000137337,NA,NA,Mdc1 (MGI:3525201)
6,30720200,30725425,6p21.3,6p21.33,191130,"TUBB, TUBB5, M40, CDCBM6, CSCSC1","Tubulin, beta polypeptide",TUBB,203068,ENSG00000196230,NA,"Cortical dysplasia, complex, with other brain malformations 6, 615771 (3), Autosomal dominant; Symmetric circumferential skin creases, congenital, 1, 156610 (3), Autosomal dominant",Tubb5 (MGI:107812)
6,30727708,30742850,6p21.3,6p21.33,606998,FLOT1,Flotillin 1,FLOT1,10211,ENSG00000137312,NA,NA,Flot1 (MGI:1100500)
6,30743198,30744546,6p21.3,6p21.33,602996,"IER3, DIF2, IEX1, PRG1, GLY96",Immediate early response-3,IER3,8870,ENSG00000137331,NA,NA,Ier3 (MGI:104814)
6,30880957,30900155,6p21.3,6p21.33,600408,"NEP, EDDR1, NTRK4, TRKE",Neuroepithelial tyrosine kinase,DDR1,780,ENSG00000204580,NA,NA,Ddr1 (MGI:99216)
6,30908206,30914105,6p21.3,6p21.33,601760,GTF2H4,"General transcription factor IIH, polypeptide 4",GTF2H4,2968,ENSG00000213780,NA,NA,Gtf2h4 (MGI:1338799)
6,30914207,30926458,6p21.3,6p21.33,612802,"VARS2, KIAA1885, COXPD20",Valyl-tRNA synthetase 2,VARS2,57176,ENSG00000137411,NA,"Combined oxidative phosphorylation deficiency 20, 615917 (3), Autosomal recessive",Vars2 (MGI:1916165)
6,30940972,30954220,6p21.3,6p21.33,613928,"DPCR1, C6orf37",Diffuse panbronchiolitis critical region gene 1,MUCL3,135656,ENSG00000168631,NA,NA,Mucl3 (MGI:2685476)
6,30983707,30989902,6p21.33,6p21.33,616991,"MUC21, C6orf205","Mucin 21, cell surface-associated",MUC21,394263,ENSG00000204544,NA,NA,NA
6,31005951,31035401,6p21.3,6p21.33,613917,"MUC22, PBMUCL1",Mucin 22,MUC22,100507679,ENSG00000261272,NA,NA,NA
6,31053449,31059889,6p21.3,6p21.33,613918,"HCG22, PBMUCL2",HLA complex group 22,HCG22,285834,ENSG00000228789,NA,NA,NA
6,31114799,31140091,6p21.3,6p21.33,613525,"SEEK1, C6orf16, PSORS1C1",SEEK1 gene,PSORS1C1,170679,ENSG00000204540,NA,NA,NA
6,31115086,31120445,6p21.3,6p21.33,602593,"CDSN, HTSS1, HYPT2, PSS1",Corneodesmosin,CDSN,1041,ENSG00000204539,NA,"Hypotrichosis 2, 146520 (3), Autosomal dominant; Peeling skin syndrome 1, 270300 (3), Autosomal recessive",NA
6,31142438,31158230,6p21.3,6p21.33,605310,"CCHCR1, HCR, C6orf18",Coiled-coil alpha-helical rod protein 1,CCHCR1,54535,ENSG00000204536,?role in psoriasis,NA,Cchcr1 (MGI:2385321)
6,31158588,31164214,6p21.3,6p21.33,600912,"TCF19, SC1",Transcription factor-19 (SC1),TCF19,6941,ENSG00000137310,NA,NA,Tcf19 (MGI:103180)
6,31164336,31170681,6p21.3,6p21.33,164177,"POU5F1, OTF3, OCT3","Pou domain, class 5, transcription factor 1 (octamer-binding transcription factor 3)",POU5F1,5460,ENSG00000204531,OTF3L on 12; ?related pseudogene on chr.8,NA,Pou5f1 (MGI:101893)
6,31268748,31272091,6p21.3,6p21.33,142840,"HLA-C, PSORS1","Major histocompatibility complex, class I, C",HLA-C,3107,ENSG00000204525,NA,"{HIV-1 viremia, susceptibility to}, 609423 (3); {Psoriasis susceptibility 1}, 177900 (3), Multifactorial",NA
6,31353874,31357178,6p21.3,6p21.33,142830,"HLA-B, SPDA1","Major histocompatibility complex, class I, B",HLA-B,3106,ENSG00000234745,NA,"{Abacavir hypersensitivity, susceptibility to} (3); {Drug-induced liver injury due to flucloxacillin} (3); {Spondyloarthropathy, susceptibility to, 1}, 106300 (3), Multifactorial; {Stevens-Johnson syndrome, susceptibility to}, 608579 (3); {Synovitis, chronic, susceptibility to} (3); {Toxic epidermal necrolysis, susceptibility to}, 608579 (3)",NA
6,31400710,31415314,6p21.3,6p21.33,600169,MICA,MHC class I polypeptide-related sequence A,MICA,100507436,ENSG00000204520,NA,NA,NA
6,31463179,31465808,6p21.3,6p21.33,604676,"HCP5, 6S2650E","Major histocompatibility complex, class I, gene P5-1",HCP5,10866,ENSG00000206337,NA,NA,NA
6,31494880,31511123,6p21.3,6p21.33,602436,MICB,MHC class I polypeptide-related sequence B,MICB,4277,ENSG00000204516,NA,NA,Mill2 (MGI:2179989)
6,31528961,31530231,6p21.3,6p21.33,609624,MCCD1,Mitochondrial coiled-coil domain 1,MCCD1,401250,ENSG00000204511,NA,NA,NA
6,31530218,31542474,6p21.3,6p21.33,142560,"DDX39B, BAT1, D6S81E",DEAD box polypeptide 39Bipt-1,DDX39B,7919,ENSG00000198563,"5 BATs in 160kb segment including also TNFA, TNFB",NA,Ddx39b (MGI:99240)
6,31544443,31546741,6p21.3,6p21.33,606853,"ATP6V1G2, ATP6G","ATPase, H+ transporting, V1 subunit G2",ATP6V1G2,534,ENSG00000213760,NA,NA,Atp6v1g2 (MGI:1913487)
6,31546850,31558828,6p21.3,6p21.33,601022,NFKBIL1,Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1,NFKBIL1,4795,ENSG00000204498,NA,"{Rheumatoid arthritis, susceptibility to}, 180300 (3)",Nfkbil1 (MGI:1340031)
6,31560549,31574323,6p21.3,6p21.33,153440,"LTA, TNFB",Lymphotoxin alpha (formerly tumor necrosis factor beta),LTA,4049,ENSG00000226979,cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B,"{Leprosy, susceptibility to, 4}, 610988 (3); {Myocardial infarction, susceptibility to}, 608446 (3); {Psoriatic arthritis, susceptibility to}, 607507 (3)",Lta (MGI:104797)
6,31575564,31578335,6p21.3,6p21.33,191160,"TNF, TNFA",Tumor necrosis factor (cachectin),TNF,7124,ENSG00000232810,5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B,"{Asthma, susceptibility to}, 600807 (3), Autosomal dominant; {Dementia, vascular, susceptibility to} (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Migraine without aura, susceptibility to}, 157300 (3), Autosomal dominant; {Septic shock, susceptibility to} (3)",Tnf (MGI:104798)
6,31580557,31582424,6p21.3,6p21.33,600978,"LTB, TNFC",Lymphotoxin B,LTB,4050,ENSG00000227507,NA,NA,Ltb (MGI:104796)
6,31586184,31588908,6p21.3-p21.1,6p21.33,109170,"LST1, D6S49E, B144",Leukocyte-specific transcript 1 (B144 protein),LST1,7940,ENSG00000204482,10kb 3' from TNFA,NA,NA
6,31588894,31593023,6p21.3,6p21.33,611550,"NCR3, 1C7, NKP30, CD337, MALS",Natural cytotoxicity triggering receptor 3,NCR3,259197,ENSG00000204475,NA,"{Malaria, mild, susceptibility to}, 609148 (3)",NA
6,31615211,31617014,6p21.3,6p21.33,601833,"AIF1, IRT1",Allograft inflammatory factor 1,AIF1,199,ENSG00000204472,part of TNF block,NA,Aif1 (MGI:1343098)
6,31620714,31637779,6p21.3,6p21.33,142580,"PRRC2A, BAT2, D6S51E",Proline-rich coiled-coil protein 2A,PRRC2A,7916,ENSG00000204469,NA,NA,Prrc2a (MGI:1915467)
6,31639027,31660899,6p21.3,6p21.33,142590,"BAG6, BAT3, D6S52E",BCL2-associated athanogene 6,BAG6,7917,ENSG00000204463,NA,NA,Bag6 (MGI:1919439)
6,31652403,31658209,6p21.3,6p21.33,606907,"APOM, NG20",Apolipoprotein M,APOM,55937,ENSG00000204444,NA,NA,Apom (MGI:1930124)
6,31661227,31666282,6p21.3,6p21.33,142610,"GPANK1, BAT4, D6S54E",G patch domain- and ankyrin repeats-containing protein 1,GPANK1,7918,ENSG00000204438,NA,NA,Gpank1 (MGI:2148975)
6,31665879,31670069,6p21.3,6p21.33,115441,CSNK2B,"Casein kinase-2, beta polypeptide",CSNK2B,1460,ENSG00000204435,NA,NA,Csnk2b (MGI:88548)
6,31670950,31672449,6p21.3,6p21.33,610433,"LY6G5B, G5B","Lymphocyte antigen 6 complex, locus G5B",LY6G5B,58496,ENSG00000240053,NA,NA,Ly6g5b (MGI:2385809)
6,31676683,31680372,6p21.3,6p21.33,610434,"LY6G5C, G5C","Lymphocyte antigen 6 complex, locus G5C",LY6G5C,80741,ENSG00000204428,NA,NA,Ly6g5c (MGI:2148974)
6,31686948,31703359,6p21.3,6p21.33,142620,"ABHD16A, BAT5, D6S82E",Abhydrolase domain-containing 16A,ABHD16A,7920,ENSG00000204427,NA,NA,Abhd16a (MGI:99476)
6,31711975,31714064,6p21.3,6p21.33,610437,"LY6G6E, G6E","Lymphocyte antigen 6 complex, locus G6E",LY6G6E,79136,NA,NA,NA,NA
6,31715355,31717803,6p21.3,6p21.33,606038,"LY6G6D, MEGT1, G6D, C6orf23","Lymphocyte antigen 6 complex, locus G6D",LY6G6D,58530,ENSG00000244355,NA,NA,Ly6g6d (MGI:2148931)
6,31718647,31721745,6p21.3,6p21.33,610435,"LY6G6C, G6C","Lymphocyte antigen 6 complex, locus G6C",LY6G6C,80740,ENSG00000204421,NA,NA,Ly6g6c (MGI:2148930)
6,31720556,31726709,6p21.33,6p21.33,606520,"G6B, C6orf25, THAMY",G6B protein,MPIG6B,80739,ENSG00000204420,mutation identified in 1 THAMY family,"?Thrombocytopenia, anemia, and myelofibrosis, 617441 (3), Autosomal recessive",Mpig6b (MGI:2146995)
6,31727039,31730262,6p21.3,6p21.33,604744,DDAH2,Dimethylarginine dimethylaminohydrolase-2,DDAH2,23564,ENSG00000213722,NA,NA,Ddah2 (MGI:1859016)
6,31739947,31762677,6p21.33,6p21.33,603382,"MSH5, POF13","MutS, E. coli, homolog of, 5",MSH5,4439,ENSG00000204410,mutation identified in POF13 family,"?Premature ovarian failure 13, 617442 (3), Autosomal recessive",Msh5 (MGI:1329021)
6,31764134,31777330,6p21.33,6p21.33,609693,"VWA7, C6orf27, G7C",von Willebrand factor A domain-containing protein 7,VWA7,80737,ENSG00000204396,NA,NA,Vwa7 (MGI:1306798)
6,31777517,31795927,6p21.3,6p21.33,192150,"VARS, VARS1, G7A, VARS2, NDMSCA",Valyl-tRNA synthetase,VARS,7407,ENSG00000204394,NA,"Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3), Autosomal recessive",Vars (MGI:90675)
6,31797395,31806965,6p21.3,6p21.33,607282,"LSM2, C6orf28",LSM2 protein,LSM2,57819,ENSG00000204392,NA,NA,Lsm2 (MGI:90676)
6,31809618,31815282,6p21.3,6p21.33,140559,HSPA1L,Heat-shock 70kD protein-like-1,HSPA1L,3305,ENSG00000204390,NA,NA,Hspa1l (MGI:96231)
6,31815542,31817941,6p21.3,6p21.33,140550,HSPA1A,Heat-shock 70kD protein-1A,HSPA1A,3303,ENSG00000204389,"also 14q22-q24, chr.21, and at least 1 other chromosome",NA,Hspa1a (MGI:96244)
6,31827737,31830253,6p21.3,6p21.33,603012,HSPA1B,Heat-shock 70kD protein-1B,HSPA1B,3304,ENSG00000204388,NA,NA,Hspa1a (MGI:96244)
6,31834915,31839760,6p21.3,6p21.33,605447,G8,G8 protein,SNHG32,50854,ENSG00000204387,NA,NA,NA
6,31857658,31862820,6p21.3,6p21.33,608272,"NEU1, NEU, SIAL1",Neuraminidase 1 (lysosomal sialidase; sialidase 1),NEU1,4758,ENSG00000204386,NA,"Sialidosis, type I, 256550 (3), Autosomal recessive; Sialidosis, type II, 256550 (3), Autosomal recessive",Neu1 (MGI:97305)
6,31863191,31879045,6p21.3,6p21.33,606107,"SLC44A4, CTL4, C6orf29, DFNA72","Solute carrier family 44, member 4",SLC44A4,80736,ENSG00000204385,mutation identified in 1 DFNA72 family,"?Deafness, autosomal dominant 72, 617606 (3), Autosomal dominant",Slc44a4 (MGI:1917379)
6,31879758,31897697,6p21.3,6p21.33,604599,"EHMT2, GAT8, G9A, NG36",Euchromatic histone-lysine N-methyltransferase 2,EHMT2,10919,ENSG00000204371,NA,NA,Ehmt2 (MGI:2148922)
6,31897782,31945673,6p21.3,6p21.33,613927,"C2, ARMD14",Complement component-2,C2,717,ENSG00000166278,no crossover with BF,"C2 deficiency, 217000 (3), Autosomal recessive; {Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)",C2 (MGI:88226)
6,31945943,31952083,6p21.3,6p21.33,138470,"CFB, BF, GBG, AHUS4, ARMD14, CFBD",Complement factor B,CFB,629,ENSG00000243649,mutation identified in 1 CFBD family,"?Complement factor B deficiency, 615561 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3), Autosomal dominant; {Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)",Cfb (MGI:105975)
6,31952086,31959042,6p21.3,6p21.33,154040,RDBP,RD RNA-binding protein,NELFE,7936,ENSG00000204356,between C4 and BF,NA,Nelfe (MGI:102744)
6,31959156,31969851,6p21,6p21.33,600478,"SKIV2L, SKI2, SKI2W, THES2","Superkiller viralicidic activity 2, S. cerevisiae, homolog, like",SKIV2L,6499,ENSG00000204351,NA,"Trichohepatoenteric syndrome 2, 614602 (3), Autosomal recessive",Skiv2l (MGI:1099835)
6,31969810,31972289,6p21.3,6p21.33,605996,DOM3Z,"DOM3, C. elegans, homolog of, Z",DXO,1797,ENSG00000204348,NA,NA,Dxo (MGI:1890444)
6,31971174,31981445,6p21.3,6p21.33,604977,STK19,Serine/threonine protein kinase 19,STK19,8859,ENSG00000204344,NA,NA,Stk19 (MGI:1860085)
6,31982056,32002679,6p21.3,6p21.33,120810,"C4A, C4S, C4AD",Complement component-4A,C4A,720,ENSG00000244731,"order:  HLA-B, C2, BF, C4A, C4B, CYP21, DR","[Blood group, Rodgers], 614374 (3); C4a deficiency, 614380 (3), Autosomal recessive","C4b,C4a (MGI:98320,MGI:88228)"
6,32014794,32035417,6p21.3,6p21.33,120820,"C4B, C4F, C4BD",Complement component-4B,C4B,721,ENSG00000224389,10kb from C4S,"C4B deficiency, 614379 (3)","C4b,C4a (MGI:98320,MGI:88228)"
6,32038305,32041669,6p21.3,6p21.33,613815,"CYP21A2, CYP21, CA21H","Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase)",CYP21A2,1589,ENSG00000231852,"linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p","Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3), Autosomal recessive; Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3), Autosomal recessive",Cyp21a1 (MGI:88591)
6,32041152,32109337,6p21.3,6p21.33-p21.32,600985,"TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8",Tenascin XB,TNXB,7148,ENSG00000168477,NA,"Ehlers-Danlos syndrome, classic-like, 1, 606408 (3), Autosomal recessive; Vesicoureteral reflux 8, 615963 (3), Autosomal dominant",Tnxb (MGI:1932137)
6,32115263,32128245,6p21.3,6p21.32,600984,"ATF6B, CREBL1",Activating transcription factor 6 beta,ATF6B,1388,ENSG00000213676,NA,NA,Atf6b (MGI:105121)
6,32128706,32130287,6p21.3,6p21.32,617076,"FKBPL, DIR1, WISP39",FK506-binding protein-like,FKBPL,63943,ENSG00000204315,NA,NA,Fkbpl (MGI:1932127)
6,32148327,32153625,6p21.32,6p21.32,618297,"PRRT1, DSPD1",Proline-rich transmembrane protein 1,PRRT1,80863,ENSG00000204314,NA,NA,NA
6,32153527,32163674,6p21.3,6p21.32,603298,PPT2,Palmitoyl-protein thioesterase-2,PPT2,9374,ENSG00000221988,NA,NA,Ppt2 (MGI:1860075)
6,32164594,32168284,6p21.32,6p21.32,609897,EGFL8,Epidermal growth factor-like 8,EGFL8,80864,ENSG00000241404,NA,NA,Egfl8 (MGI:1932094)
6,32168211,32178107,6p21.3,6p21.32,603099,"AGPAT1, LPAATA",1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase-alpha),AGPAT1,10554,ENSG00000204310,NA,NA,Agpat1 (MGI:1932075)
6,32178404,32180792,6p21.3,6p21.32,602677,"RNF5, RING5",RING finger protein-5,RNF5,6048,ENSG00000204308,NA,NA,Rnf5 (MGI:1860076)
6,32180967,32184379,6p21.3,6p21.32,600214,"AGER, RAGE",Advanced glycosylation end product-specific receptor,AGER,177,ENSG00000204305,"at junction of classes II, III MHC",NA,Ager (MGI:893592)
6,32184732,32190201,6p21.3,6p21.32,176311,"PBX2, HOX12, G17",Pre-B-cell leukemia transcription factor-2,PBX2,5089,ENSG00000204304,NA,NA,Pbx2 (MGI:1341793)
6,32194842,32224066,6p21.3,6p21.32,164951,"NOTCH4, INT3","Notch, Drosophila, homolog of, 4",NOTCH4,4855,ENSG00000204301,NA,NA,Notch4 (MGI:107471)
6,32290522,32371903,6p21.32,6p21.32,618151,"TSBP1, TSBP, C6orf10",Testis-expressed basic protein 1,TSBP1,10665,ENSG00000204296,NA,NA,NA
6,32393338,32408878,6p21.3,6p21.32,606000,"BTNL2, SS2",Butyrophilin-like protein 2,BTNL2,56244,ENSG00000204290,NA,"{Sarcoidosis, susceptibility to, 2}, 612387 (3), Autosomal dominant",Btnl2 (MGI:1859549)
6,32439886,32445045,6p21.3,6p21.32,142860,HLA-DRA,"Major histocompatibility complex, class II, DR alpha",HLA-DRA,3122,ENSG00000204287,"1 alpha, 3 different beta chains",NA,H2-Ea-ps (MGI:95900)
6,32517342,32530315,6p21.3,6p21.32,604776,HLA-DRB5,"Major histocompatibility complex, class II, DR beta-5",HLA-DRB5,3127,ENSG00000198502,NA,NA,H2-Eb1 (MGI:95901)
6,32578768,32589835,6p21.3,6p21.32,142857,"HLA-DRB1, SS1","Major histocompatibility complex, class II, DR beta-1",HLA-DRB1,3123,ENSG00000196126,NA,"{Multiple sclerosis, susceptibility to, 1}, 126200 (3), Multifactorial; {Sarcoidosis, susceptibility to, 1}, 181000 (3), Autosomal dominant",NA
6,32637405,32654845,6p21.3,6p21.32,146880,"HLA-DQA1, CELIAC1","Major histocompatibility complex, class II, DQ alpha-1",HLA-DQA1,3117,ENSG00000196735,NA,"{Celiac disease, susceptibility to}, 212750 (3), Autosomal recessive, Multifactorial",H2-Aa (MGI:95895)
6,32659466,32666656,6p21.3,6p21.32,604305,"HLA-DQB1, CELIAC1","Major histocompatibility complex, class II, DQ beta-1",HLA-DQB1,3119,ENSG00000179344,NA,"{Celiac disease, susceptibility to}, 212750 (3), Autosomal recessive, Multifactorial; {Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3), Autosomal dominant; {Multiple sclerosis, susceptibility to, 1}, 126200 (3), Multifactorial",H2-Ab1 (MGI:103070)
6,32741390,32747197,6p21.32,6p21.32,613503,"HLA-DQA2, HLA-DXA","Major histocompatibility complex, class II, DQ alpha-2",HLA-DQA2,3118,ENSG00000237541,NA,NA,NA
6,32756093,32763552,6p21.32,6p21.32,615161,"HLA-DQB2, HLA-DXB","Major histocompatibility complex, class II, DQ beta-2",HLA-DQB2,3120,ENSG00000232629,NA,NA,NA
6,32812762,32817001,6p21.3,6p21.32,600629,HLA-DOB,"Major histocompatibility complex, class II, DO beta",HLA-DOB,3112,ENSG00000241106,NA,NA,H2-Ob (MGI:95925)
6,32821832,32838822,6p21.3,6p21.32,170261,"TAP2, ABCB3, PSF2, RING11","Transporter 2, ATP-binding cassette, subfamily B",TAP2,6891,ENSG00000204267,tel-TAP1-LMP2-LMP1-TAP2-cen,"Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3), Autosomal recessive",Tap2 (MGI:98484)
6,32840716,32844678,6p21.3,6p21.32,177046,"PSMB8, LMP7, RING10, JMP, NKJO, ALDD, PRAAS1","Proteasome subunit, beta type, 8 (large multifunctional protease-7)",PSMB8,5696,ENSG00000204264,between TAP1 and TAP2,"Proteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3), Autosomal recessive",Psmb8 (MGI:1346527)
6,32845208,32853970,6p21.3,6p21.32,170260,"TAP1, ABCB2, RING4, PSF1","Transporter 1, ATP-binding cassette, subfamily B",TAP1,6890,ENSG00000168394,~7kb telomeric to TAP2,"Bare lymphocyte syndrome, type I, 604571 (3), Autosomal recessive",Tap1 (MGI:98483)
6,32854191,32859850,6p21.3,6p21.32,177045,"PSMB9, LMP2, RING12, PRAAS3","Proteasome subunit, beta type, 9",PSMB9,5698,ENSG00000240065,mutation identified in 1 digenic family,"?Proteasome-associated autoinflammatory syndrome 3, digenic, 617591 (3), Autosomal recessive",Psmb9 (MGI:1346526)
6,32934635,32941027,6p21.3,6p21.32,142856,"HLA-DMB, RING7","Major histocompatibility complex, class II, DM beta",HLA-DMB,3109,ENSG00000242574,NA,NA,"H2-DMb2,H2-DMb1 (MGI:95922,MGI:95923)"
6,32948617,32953096,6p21.3,6p21.32,142855,"HLA-DMA, RING6","Major histocompatibility complex, class II, DM alpha",HLA-DMA,3108,ENSG00000204257,NA,NA,H2-DMa (MGI:95921)
6,32968593,32981504,6p21.3,6p21.32,601540,"BRD2, RING3, FSRG1",Bromodomain-containing protein 2,BRD2,6046,ENSG00000204256,between HLA-DNA and HLA-DMA,NA,Brd2 (MGI:99495)
6,33004181,33009590,6p21.3,6p21.32,142930,HLA-DNA,"Major histocompatibility complex, class II, DN alpha",HLA-DOA,3111,ENSG00000204252,NA,NA,H2-Oa (MGI:95924)
6,33064568,33080747,6p21.3,6p21.32,142880,"HLA-DPA1, HLADP","Major histocompatibility complex, class II, DP alpha-1",HLA-DPA1,3113,ENSG00000231389,"2 different alpha, 2 different beta chains",NA,NA
6,33075989,33089695,6p21.3,6p21.32,142858,HLA-DPB1,"Major histocompatibility complex, class II, DP beta-1",HLA-DPB1,3115,ENSG00000223865,NA,"{Beryllium disease, chronic, susceptibility to} (3)",NA
6,33162691,33193008,6p21.3,6p21.32,120290,"COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB","Collagen XI, alpha-2 polypeptide",COL11A2,1302,ENSG00000204248,45kb centromeric of HLA-DPB2; 3'--5'-cen,"Deafness, autosomal dominant 13, 601868 (3), Autosomal dominant; Deafness, autosomal recessive 53, 609706 (3), Autosomal recessive; Fibrochondrogenesis 2, 614524 (3), Autosomal recessive, Autosomal dominant; Otospondylomegaepiphyseal dysplasia, autosomal dominant, 184840 (3), Autosomal dominant; Otospondylomegaepiphyseal dysplasia, autosomal recessive, 215150 (3), Autosomal recessive",Col11a2 (MGI:88447)
6,33193584,33200990,6p21.3,6p21.32,180246,RXRB,"Retinoid X receptor, beta",RXRB,6257,ENSG00000204231,NA,NA,Rxrb (MGI:98215)
6,33200866,33204436,6p21.3,6p21.32,601416,"SLC39A7, D6S2244E, HKE4","Solute carrier family 39 (zinc transporter), member 7 (Ke4 gene, mouse, homolog of)",SLC39A7,7922,ENSG00000112473,NA,NA,Slc39a7 (MGI:95909)
6,33204654,33206830,6p21.3,6p21.32,601417,"HSD17B8, FABGL, D6S2245E, HKE6","Hydroxysteroid (17-beta) dehydrogenase 8 (Ke6 gene, mouse, homolog of)",HSD17B8,7923,ENSG00000204228,NA,NA,H2-Ke6 (MGI:95911)
6,33207834,33207943,6p21.32,6p21.32,611500,"MRI219-1, MIRN219-1",Micro RNA 219-1,MIR219A1,407002,ENSG00000199036,NA,NA,NA
6,33208499,33212715,6p21.3,6p21.32,602045,"RING1, RNF1",RING finger protein-1,RING1,6015,ENSG00000204227,NA,NA,Ring1 (MGI:1101770)
6,33250271,33271964,6p21.3,6p21.32,603443,"VPS52, SACM2L",Vacuolar protein sorting 52 homolog (S. cerevisiae),VPS52,6293,ENSG00000223501,NA,NA,Vps52 (MGI:1330304)
6,33272074,33276510,6p21.3,6p21.32,180473,RPS18,Ribosomal protein S18,RPS18,6222,ENSG00000231500,NA,NA,Rps18 (MGI:98146)
6,33277122,33278824,6p21.3,6p21.32,603095,B3GALT4,"UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 4",B3GALT4,8705,ENSG00000235863,NA,NA,B3galt4 (MGI:1859517)
6,33278206,33289238,6p21.3,6p21.32,611440,"WDR46, BING4",WD repeat-containing protein 46,WDR46,9277,ENSG00000227057,NA,NA,Wdr46 (MGI:1931871)
6,33291653,33299387,6p21.3,6p21.32,602306,RAB2L,"RAB2, member RAS oncogene family-like",RGL2,5863,ENSG00000237441,NA,NA,Rgl2 (MGI:107483)
6,33299693,33314386,6p21.3,6p21.32,601962,"TAPBP, TPSN",TAP-binding protein (tapasin),TAPBP,6892,ENSG00000231925,NA,"Bare lymphocyte syndrome, type I, 604571 (3), Autosomal recessive",Tapbp (MGI:1201689)
6,33314404,33317941,6p21.3,6p21.32,611439,"ZBTB22, BING1",Zinc finger- and BTB domain-containing protein 22,ZBTB22,9278,ENSG00000236104,NA,NA,Zbtb22 (MGI:1931870)
6,33318557,33323015,6p21.3,6p21.32,603186,DAXX,Death-associated protein 6,DAXX,1616,ENSG00000204209,NA,NA,Daxx (MGI:1197015)
6,33391523,33410225,6p21.3,6p21.32,603763,"KIFC1, KNSL2, HSET",Kinesin family member C1,KIFC1,3833,ENSG00000237649,NA,NA,"Kifc1,Kifc5b (MGI:2137414,MGI:109596)"
6,33410750,33416452,6p21.3,6p21.32,602881,PHF1,PHD finger protein-1,PHF1,5252,ENSG00000112511,NA,NA,Phf1 (MGI:98647)
6,33416441,33418287,6p21.32,6p21.32,616953,"CUTA, ACHAP, C6orf82","CutA, E. coli, homolog of",CUTA,51596,ENSG00000112514,NA,NA,Cuta (MGI:1914925)
6,33418293,33453688,6p21.3,6p21.32,603384,"SYNGAP1, MRD5",Synaptic Ras GTPase activating protein 1,SYNGAP1,8831,ENSG00000197283,NA,"Mental retardation, autosomal dominant 5, 612621 (3), Autosomal dominant",Syngap1 (MGI:3039785)
6,33500000,36600000,6p21.31,NA,612893,STQTL19,Stature quantitative trait locus 19,NA,100302684,NA,associated with rs1776897,"{Stature QTL 19}, 612893 (2)",NA
6,33572551,33580295,6p21.3-p21.2,6p21.31,600516,BAK1,BCL2-antagonist/killer 1,BAK1,578,ENSG00000030110,centromeric to MHC region,NA,Bak1 (MGI:1097161)
6,33621321,33696561,6pter-p21,6p21.31,147267,ITPR3,"Inositol 1,4,5-triphosphate receptor, type 3",ITPR3,3710,ENSG00000096433,NA,"{Diabetes, type 1, susceptibility to}, 222100 (2), Autosomal recessive",Itpr3 (MGI:96624)
6,33696763,33711699,6p21.31,6p21.31,614461,"UQCC2, C6orf126, M19, MC3DN7",Ubiquinol-cytochrome c reductase complex assembly factor 2,UQCC2,84300,ENSG00000137288,NA,"Mitochondrial complex III deficiency, nuclear type 7, 615824 (3), Autosomal recessive",Uqcc2 (MGI:1914517)
6,33721475,33755670,6p21,6p21.31,606993,"IHPK3, INSP6K3, IP6K3",Inositol hexaphosphate kinase 3,IP6K3,117283,ENSG00000161896,pseudogene on 6p24.1,NA,Ip6k3 (MGI:3045325)
6,33771212,33794273,6p21.31,6p21.31,616312,"LEMD2, NET25, CTRCT42",LEM domain-containing protein 2,LEMD2,221496,ENSG00000161904,NA,"Cataract 46, juvenile-onset, 212500 (3), Autosomal recessive",Lemd2 (MGI:2385045)
6,33794672,33804002,6p21.3,6p21.31,158270,MLN,Motilin,MLN,4295,ENSG00000096395,NA,NA,NA
6,34018642,34155621,6p21.3,6p21.31,604100,"GRM4, MGLUR4","Glutamate receptor, metabotropic, 4",GRM4,2914,ENSG00000124493,NA,NA,Grm4 (MGI:1351341)
6,34236872,34246230,6p21,6p21.31,600701,"HMGA1, HMGIY",High-mobility group AT-hook 1,HMGA1,3159,ENSG00000137309,NA,"{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant","Hmga1,Hmga1b (MGI:96161,MGI:96160)"
6,34246379,34249107,6p21.3,6p21.31,611419,"C6orf1, LBH","Chromosome 6, open reading frame 1",SMIM29,221491,ENSG00000186577,"opposite strand, tail-to-tail with HMGA1",NA,NA
6,34417453,34426068,6p,6p21.31,603632,"RPS10, DBA9",Ribosomal protein S10,RPS10,6204,ENSG00000124614,NA,"Diamond-Blackfan anemia 9, 613308 (3), Autosomal dominant",Rps10 (MGI:1914347)
6,34466075,34536261,6p21,6p21.31,606512,"PACSIN1, KIAA1379",Protein kinase C and casein kinase substrate in neurons 1,PACSIN1,29993,ENSG00000124507,NA,NA,Pacsin1 (MGI:1345181)
6,34537799,34556332,6p21.3,6p21.31,608144,"SPDEF, PDEF",SAM pointed domain-containing ETS transcription factor,SPDEF,25803,ENSG00000124664,NA,NA,Spdef (MGI:1353422)
6,34587287,34696766,6p21.31,6p21.31,612217,C6orf106,Chromosome 6 open reading frame 106,ILRUN,64771,ENSG00000196821,NA,NA,Ilrun (MGI:106281)
6,34757093,34773856,6p21.31,6p21.31,603522,SNRPC,Small nuclear ribonucleoprotein polypeptide C,SNRPC,6631,ENSG00000124562,NA,NA,NA
6,34877461,34888070,6p21.31,6p21.31,600772,"TAF11, TAF2I, TAFII28","TAF11 RNA polymerase II, TATA box-binding protein-associated factor, 28kD",TAF11,6882,ENSG00000064995,NA,NA,Taf11 (MGI:1916026)
6,34889254,35097991,6p21.3,6p21.31,608994,"ANKS1, ODIN, KIAA0229",Ankyrin repeat and sterile alpha motif domains-containing protein 1,ANKS1A,23294,ENSG00000064999,NA,NA,Anks1 (MGI:2446180)
6,35118063,35141641,6p21.3-p21.2,6p21.31,186982,"TCP11, D6S230E",T-complex homolog tcp-11,TCP11,6954,ENSG00000124678,expressed only in testis at same time as ZNF76 (day 20 after birth),NA,Tcp11 (MGI:98544)
6,35213955,35253078,6p21.3,6p21.31,614708,SCUBE3,"Signal peptide-, CUB domain-,  and EGF-like domains-containing protein 3",SCUBE3,222663,ENSG00000146197,NA,NA,Scube3 (MGI:3045253)
6,35259472,35295984,6p21.3-p21.2,6p21.31,194549,"ZNF76, D6S229E",Zinc finger protein-76 (expressed in testis),ZNF76,7629,ENSG00000065029,same 300kb fragment as TCP11,NA,Zfp523 (MGI:2687278)
6,35297817,35321770,6p21.31,6p21.31,610094,"DEF6, IBP, SLAT","Def6, mouse, homolog of",DEF6,50619,ENSG00000023892,NA,NA,Def6 (MGI:1346328)
6,35342557,35428190,6p21.2-p21.1,6p21.31,600409,"PPARD, NUC1","Peroxisome proliferative activated receptor, delta",PPARD,5467,ENSG00000112033,NA,NA,Ppard (MGI:101884)
6,35452338,35467105,6p22-p21,6p21.31,613976,"FANCE, FACE","Fanconi anemia, complementation group E gene",FANCE,2178,ENSG00000112039,NA,"Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive",Fance (MGI:1920025)
6,35468400,35470780,6p21.31,6p21.31,615660,"RPL10A, CSA19",Ribosomal protein L10A,RPL10A,4736,ENSG00000198755,NA,NA,Rpl10a (MGI:1343877)
6,35473596,35497078,6p21.3,6p21.31,603170,"TEAD3, TEF5, TEAD5",TEA domain family member 3 (transcriptional enhancer factor 5),TEAD3,7005,ENSG00000007866,NA,NA,Tead3 (MGI:109241)
6,35497873,35512895,6p21.3,6p21.31,602280,"TULP1, RP14, LCA15",Tubby-like protein-1,TULP1,7287,ENSG00000112041,NA,"Leber congenital amaurosis 15, 613843 (3), Autosomal recessive; Retinitis pigmentosa 14, 600132 (3), Autosomal recessive",Tulp1 (MGI:109571)
6,35573584,35728582,6p21.3-p21.2,6p21.31,602623,"FKBP5, FKBP51",FK506-binding protein 5,FKBP5,2289,ENSG00000096060,NA,"{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)",Fkbp5 (MGI:104670)
6,35794981,35797343,6pter-p21.1,6p21.31,120105,CLPS,"Colipase, pancreatic",CLPS,1208,ENSG00000137392,NA,NA,Clps (MGI:88421)
6,35805351,35824069,6p21.3,6p21.31,609427,"LHFPL5, TMHS, DFNB67",LHFP-like protein 5,LHFPL5,222662,ENSG00000197753,NA,"Deafness, autosomal recessive 67, 610265 (3), Autosomal recessive",Lhfpl5 (MGI:1915382)
6,35832965,35921179,6p21.31,6p21.31,601939,SRPK1,"Protein kinase, serine/arginine-specific, 1",SRPK1,6732,ENSG00000096063,NA,NA,Srpk1 (MGI:106908)
6,35943513,36024640,6p21.31,6p21.31,608480,"SLC26A8, TAT1, SPGF3","Solute carrier family 26 (sulfate transporter), member 8",SLC26A8,116369,ENSG00000112053,NA,"Spermatogenic failure 3, 606766 (3), Autosomal dominant",Slc26a8 (MGI:2385046)
6,36027676,36122963,6p21.3-p21.2,6p21.31,600289,"MAPK14, CSBP1",Mitogen-activated protein kinase 14 (cytokine suppressive anti-inflammatory drug binding protein 1),MAPK14,1432,ENSG00000112062,NA,NA,Mapk14 (MGI:1346865)
6,36196743,36232789,6p21.31,6p21.31,616856,"BRPF3, KIAA1286",Bromodomain- and PHD finger-containing protein 3,BRPF3,27154,ENSG00000096070,NA,NA,Brpf3 (MGI:2146836)
6,36242522,36313954,6p21.31,6p21.31,612121,"PNPLA1, ARCI10",Patatin-like phospholipase domain-containing protein 1,PNPLA1,285848,ENSG00000180316,NA,"Ichthyosis, congenital, autosomal recessive 10, 615024 (3), Autosomal recessive",Pnpla1 (MGI:3617850)
6,36354087,36387799,6p21,6p21.31,605255,"ETV7, TEL2, TELB",ETS variant gene 7,ETV7,51513,ENSG00000010030,NA,NA,NA
6,36442766,36491142,6p21.31,6p21.31,615932,KCTD20,Potassium channel tetramerization domain-containing protein 20,KCTD20,222658,ENSG00000112078,NA,NA,Kctd20 (MGI:1914239)
6,36493888,36547478,6p21,6p21.31,606964,"STK38, NDR",Serine/threonine protein kinase 38,STK38,11329,ENSG00000112079,NA,NA,Stk38 (MGI:2442572)
6,36594312,36605599,6p21,6p21.3-p21.2,603364,"SRSF3, SFRS3, SRP20","Splicing factor, arginine/serine-rich, 3",SRSF3,6428,ENSG00000112081,NA,NA,Srsf3 (MGI:98285)
6,36600000,40500000,6p21.2,NA,615080,AD17,Alzheimer disease 17,NA,101290498,NA,associated with rs75932628T,"Alzheimer disease 17, 615080 (2)",NA
6,36600000,40500000,6p21.2,NA,616343,TP53COR1,"Tumor protein p53 pathway corepressor 1, noncoding",TP53COR1,102800311,NA,NA,NA,NA
6,36673620,36675125,6p21.2,6p21.2,617179,PANDAR,Promoter of CDKN1A antisense DNA damage-activated RNA,PANDAR,101154753,ENSG00000281450,NA,NA,NA
6,36676249,36687338,6p21.2,6p21.2,116899,"CDKN1A, WAF1, CIP1, CDKN1","Cyclin-dependent kinase inhibitor 1A (p21, Cip1)",CDKN1A,1026,ENSG00000124762,NA,NA,Cdkn1a (MGI:104556)
6,36740772,36839443,6p21,6p21.2,604209,"CPNE5, CPN5",Copine V,CPNE5,57699,ENSG00000124772,NA,NA,Cpne5 (MGI:2385908)
6,36834885,36928963,6p21.2,6p21.2,616642,"C6orf89, BRAP, AMFION",Bombesin receptor-activated protein,C6orf89,221477,ENSG00000198663,NA,NA,BC004004 (MGI:2136782)
6,36854828,36874802,6p21.1,6p21.2,601301,"PPIL1, CYPL1",Peptidylprolyl isomerase (cyclophilin)-like 1,PPIL1,51645,ENSG00000137168,previously assigned to chr.2,NA,Ppil1 (MGI:1916066)
6,36968134,36987170,6p21.2,6p21.2,610449,"MTCH1, PSAP",Mitochondrial carrier homolog 1,MTCH1,23787,ENSG00000137409,NA,NA,Mtch1 (MGI:1929261)
6,37005654,37029071,6p21.2,6p21.2,605091,FGD2,"FYVE, RhoGEF, and PH domain-containing protein 2",FGD2,221472,ENSG00000146192,NA,NA,Fgd2 (MGI:1347084)
6,37170151,37175427,6p21.2,6p21.2,164960,PIM1,Oncogene PIM1,PIM1,5292,ENSG00000137193,NA,NA,Pim1 (MGI:97584)
6,37257703,37332969,6p21.2,6p21.2,616880,"TBC1D22B, C6orf197","TBC1 domain family, member 22B",TBC1D22B,55633,ENSG00000065491,NA,NA,Tbc1d22b (MGI:2681867)
6,37353971,37394737,6p21.3,6p21.2,611685,"RNF8, KIAA0646",Ring finger protein 8,RNF8,9025,ENSG00000112130,NA,NA,Rnf8 (MGI:1929069)
6,37433213,37482843,6p21.2,6p21.2,616189,"CMTR1, MTR1, ISG95, FTSJD2, KIAA0082",CAP methyltransferase 1,CMTR1,23070,ENSG00000137200,NA,NA,Cmtr1 (MGI:1921407)
6,37630678,37697882,6p21,6p21.2,609626,"MDGA1, GPIM",MAM domain-containing glycosylphosphatidylinositol anchor 1,MDGA1,266727,ENSG00000112139,NA,NA,Mdga1 (MGI:1922012)
6,37819726,38154623,6pter-p22.3,6p21.2,607455,"ZFAND3, TEX27",Zinc finger AN1 domain-containing protein 3,ZFAND3,60685,ENSG00000156639,NA,NA,Zfand3 (MGI:1096572)
6,38168450,38640540,6p21,6p21.2,611237,"BTBD9, KIAA1880",BTB/POZ domain-containing protein 9,BTBD9,114781,ENSG00000183826,NA,NA,Btbd9 (MGI:1916625)
6,38675924,38703144,6p21.3-p21.2,6p21.2,138750,GLO1,Glyoxalase I,GLO1,2739,ENSG00000124767,~3cM proximal to HLA,NA,Glo1 (MGI:95742)
6,38715310,39030797,6p21,6p21.2,603337,"DNAH8, HDHC9","Dynein, axonemal, heavy chain 8",DNAH8,1769,ENSG00000124721,NA,NA,Dnah8 (MGI:107714)
6,39048780,39091302,6p21,6p21.2,138032,GLP1R,Glucagon-like peptide 1 receptor,GLP1R,2740,ENSG00000112164,NA,NA,Glp1r (MGI:99571)
6,39188970,39229474,6p21,6p21.2,603493,"KCNK5, TASK2","Potassium channel, subfamily K, member 5",KCNK5,8645,ENSG00000164626,NA,NA,Kcnk5 (MGI:1336175)
6,39299000,39314418,6p21.2-p21.1,6p21.2,607370,"KCNK17, TASK4, TALK2","Potassium channel, subfamily K, member 17",KCNK17,89822,ENSG00000124780,NA,NA,NA
6,39314565,39322967,6p21.2-p21.1,6p21.2,607369,"KCNK16, TALK1","Potassium channel, subfamily K, member 16",KCNK16,83795,ENSG00000095981,NA,NA,Kcnk16 (MGI:1921821)
6,39329989,39725422,6p21,6p21.2,613919,KIF6,Kinesin family member 6,KIF6,221458,ENSG00000164627,NA,NA,Kif6 (MGI:1098238)
6,39792365,39904876,6p21.2,6p21.2,606627,"DAAM2, KIAA0381",Dishevelled-associated activator of morphogenesis 2,DAAM2,23500,ENSG00000146122,NA,NA,Daam2 (MGI:1923691)
6,39904169,39934550,6p21.3,6p21.2,603707,"MOCS1, MOCODA",Molybdenum cofactor synthesis-1,MOCS1,4337,ENSG00000124615,NA,"Molybdenum cofactor deficiency A, 252150 (3), Autosomal recessive",NA
6,40378336,40379892,6p21.2-p21.1,6p21.2,615676,"TDRG1, LINC00532","Testis development-related gene 1, noncoding",TDRG1,732253,ENSG00000204091,NA,NA,NA
6,40391588,40587363,6p21.2,6p21.2-p21.1,612808,"LRFN2, SALM1, KIAA1246",Leucine-rich repeat and fibronectin type III domain-containing protein 2,LRFN2,57497,ENSG00000156564,NA,NA,Lrfn2 (MGI:1917780)
6,40500000,53000000,6p21.1-p12.2,NA,607498,MGR3,"Migraine with or without aura, susceptibility to, 3",NA,337892,NA,lod 5.78 at D6S452,"{Migraine with or without aura, susceptibility to, 3}, 607498 (2), Autosomal dominant",NA
6,40500000,46200000,6p21.1,NA,132100,PPR1,Photoparoxysmal response 1,NA,100528023,NA,max lod at D6S2427,"Photoparoxysmal response 1, 132100 (2), Autosomal dominant",NA
6,41026894,41039220,6p21.1,6p21.1,617464,"UNC5CL, ZUD",Unc5 family C-terminal-like protein,UNC5CL,222643,ENSG00000124602,NA,NA,Unc5cl (MGI:1923839)
6,41053200,41064890,6p21,6p21.1,604797,APOBEC2,"Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2",APOBEC2,10930,ENSG00000124701,NA,NA,Apobec2 (MGI:1343178)
6,41064771,41097786,6p21.2,6p21.1,614393,"OARD1, C6orf130",O-acyl-ADP-ribose deacylase 1,OARD1,221443,ENSG00000124596,NA,NA,Oard1 (MGI:2146818)
6,41072973,41102402,6p21.3,6p21.1,189903,NFYA,"Transcription factor NF-Y, A subunit",NFYA,4800,ENSG00000001167,NA,NA,Nfya (MGI:97316)
6,41149096,41158449,6p21.1,6p21.1,609714,"TREML1, TLT1",Triggering receptor expressed on myeloid cells-like protein 1,TREML1,340205,ENSG00000161911,NA,NA,Treml1 (MGI:1918576)
6,41158505,41163185,6p21.2,6p21.1,605086,"TREM2, PLOSL2",Triggering receptor expressed on myeloid cells 2,TREM2,54209,ENSG00000095970,NA,"Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, 618193 (3)",Trem2 (MGI:1913150)
6,41189748,41201232,6p21.1,6p21.1,609715,"TREML2, TLT2",Triggering receptor expressed on myeloid cells-like protein 2,TREML2,79865,ENSG00000112195,NA,NA,Treml2 (MGI:2147038)
6,41208553,41217946,6p21.1,6p21.1,609716,"TREML3, TLT3",Triggering receptor expressed on myeloid cells-like protein 3,TREML3P,340206,ENSG00000184106,NA,NA,NA
6,41228286,41239385,6p21,6p21.1,614664,"TREML4, TLT4",Triggering receptor expressed on myeloid cells-like protein 4,TREML4,285852,ENSG00000188056,NA,NA,NA
6,41267384,41286744,6p21.1,6p21.1,605085,TREM1,Triggering receptor expressed on myeloid cells 1,TREM1,54210,ENSG00000124731,NA,NA,Trem1 (MGI:1930005)
6,41335607,41350888,6p21.1,6p21.1,604531,"NCR2, LY95, NKP44","Natural cytotoxicity triggering receptor 2 (lymphocyte antigen 95, mouse, homolog of)",NCR2,9436,ENSG00000096264,NA,NA,NA
6,41546380,41602383,6p21.1,6p21.1,608924,FOXP4,Forkhead box P4,FOXP4,116113,ENSG00000137166,NA,NA,Foxp4 (MGI:1921373)
6,41637017,41654245,6p21,6p21.1,604971,MDFI,MYOD family inhibitor,MDFI,4188,ENSG00000112559,NA,NA,Mdfi (MGI:107687)
6,41683977,41736222,6p21,6p21.1,600744,"TFEB, TCFEB",Transcription factor EB,TFEB,7942,ENSG00000112561,NA,NA,Tfeb (MGI:103270)
6,41736710,41747400,6p21.3-p21.1,6p21.1,169740,PGC,Preprogastricsin,PGC,5225,ENSG00000096088,cen-PGG-GLO1-HLA,NA,Pgc (MGI:98909)
6,41780761,41787371,6p21.31,6p21.1,611389,"PRICKLE4, C6orf49, OBTP","Prickle, Drosophila, homolog of, 4",PRICKLE4,29964,ENSG00000278224,NA,NA,Prickle4 (MGI:2685785)
6,41787442,41789895,6p21.1,6p21.1,616168,"TOMM6, TOM6","Translocase of outer mitochondrial membrane 6, yeast, homolog of",TOMM6,100188893,ENSG00000214736,NA,NA,Tomm6 (MGI:1913369)
6,41905352,41921138,6p21.1,6p21.1,612915,"MED20, TRFP",Mediator complex subunit 20,MED20,9477,ENSG00000124641,NA,NA,Med20 (MGI:1929648)
6,41921498,41933045,6p21.1,6p21.1,603871,BYSL,"By the ribosomal protein S6 gene, Drosophila, homolog-like (bystin)",BYSL,705,ENSG00000112578,NA,NA,Bysl (MGI:1858419)
6,41934932,42048893,6p21,6p21.1,123834,CCND3,Cyclin D3,CCND3,896,ENSG00000112576,pseudogene also on 6p21,NA,Ccnd3 (MGI:88315)
6,42155376,42180082,6p21.1,6p21.1,600364,"GUCA1A, GCAP, COD3, CORD14","Guanylate cyclase activator 1A, retina",GUCA1A,2978,ENSG00000048545,NA,"Cone dystrophy-3, 602093 (3), Autosomal dominant; Cone-rod dystrophy 14, 602093 (3), Autosomal dominant",Guca1a (MGI:102770)
6,42183283,42194955,6p21.1,6p21.1,602275,"GUCA1B, GCAP2, GUCA2, RP48","Guanylate cyclase activator 1B, retina",GUCA1B,2979,ENSG00000112599,NA,"Retinitis pigmentosa 48, 613827 (3)",Guca1b (MGI:1194489)
6,42206800,42217869,6p21.1-p12.1,6p21.1,611976,MRPS10,Mitochondrial ribosomal protein S10,MRPS10,55173,ENSG00000048544,"5 pseudogenes on chromosomes 1, 3, and 9",NA,Mrps10 (MGI:1928139)
6,42224930,42452223,6p21.1,6p21.1,610322,"TRERF1, TREP132",Transcriptional regulating factor 1,TRERF1,55809,ENSG00000124496,NA,NA,Trerf1 (MGI:2442086)
6,42563953,42693504,6p21.1,6p21.1,609134,"UBR2, C6orf133, KIAA0349",Ubiquitin-protein ligase E3 component N-recognin 2,UBR2,23304,ENSG00000024048,NA,NA,Ubr2 (MGI:1861099)
6,42694508,42723038,6p21.1-cen,6p21.1,179605,"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1","Peripherin 2, mouse, homolog of",PRPH2,5961,ENSG00000112619,digenic RP with ROM1,"Choroidal dystrophy, central areolar 2, 613105 (3), Autosomal dominant; Leber congenital amaurosis 18, 608133 (3), Autosomal recessive, Autosomal dominant; Macular dystrophy, patterned, 1, 169150 (3), Autosomal dominant; Macular dystrophy, vitelliform, 3, 608161 (3), Autosomal dominant; Retinitis pigmentosa 7 and digenic form, 608133 (3), Autosomal recessive, Autosomal dominant; Retinitis punctata albescens, 136880 (3), Autosomal recessive, Autosomal dominant",Prph2 (MGI:102791)
6,42744497,42746102,6p21.1,6p21.1,602971,"TBCC, CFC",Tubulin-specific chaperone C,TBCC,6903,ENSG00000124659,NA,NA,Tbcc (MGI:1919976)
6,42746986,42868559,6p21.1,6p21.1,618502,"BICRAL, GLTSCR1L, KIAA0240",BRD4-interacting chromatin remodeling complex-associated protein-like,BICRAL,23506,ENSG00000112624,NA,NA,NA
6,42879615,42889933,6p21.1,6p21.1,617417,RPL7L1,Ribosomal protein L7-like 1,RPL7L1,285855,ENSG00000146223,NA,NA,Rpl7l1 (MGI:1913479)
6,42915596,42925837,6p21.3,6p21.1,606817,PTCRA,"Pre-T-cell receptor, alpha-chain precursor",PTCRA,171558,ENSG00000171611,NA,NA,Ptcra (MGI:104857)
6,42928001,42939293,6pter-p12,6p21.1,610774,"CNPY3, TNRC5, PRAT4A, ERDA5, EIEE60","Canopy 3, zebrafish, homolog of",CNPY3,10695,ENSG00000137161,NA,"Epileptic encephalopathy, early infantile, 60, 617929 (3), Autosomal recessive",Cnpy3 (MGI:1919279)
6,42960753,42963879,6p12,6p21.1,606628,GNMT,Glycine N-methyltransferase,GNMT,27232,ENSG00000124713,NA,"Glycine N-methyltransferase deficiency, 606664 (3), Autosomal recessive",Gnmt (MGI:1202304)
6,42963864,42980223,6p21.1,6p21.1,601498,"PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2",Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1),PEX6,5190,ENSG00000124587,NA,"Heimler syndrome 2, 616617 (3), Autosomal recessive; Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3), Autosomal recessive; Peroxisome biogenesis disorder 4B, 614863 (3), Autosomal recessive, Autosomal dominant",Pex6 (MGI:2385054)
6,42980343,43017085,6p23-q12,6p21.1,143170,"MEA1, MEA",Male-enhanced antigen 1,MEA1,4201,ENSG00000124733,NA,NA,Mea1 (MGI:96957)
6,42984569,43012341,6p21.1,6p21.1,601646,"PPP2R5D, MRD35","Protein phosphatase-2, regulatory subunit B (B56), delta isoform",PPP2R5D,5528,ENSG00000112640,NA,"Mental retardation, autosomal dominant 35, 616355 (3), Autosomal dominant",Ppp2r5d (MGI:2388481)
6,43014102,43021297,6p21.1,6p21.1,611248,"KLHDC3, PEAS",KELCH domain-containing protein 3,KLHDC3,116138,ENSG00000124702,NA,NA,Klhdc3 (MGI:2651568)
6,43021601,43029598,6p21.1,6p21.1,613475,"RRP36, C6orf153","Ribosomal RNA-processing factor, 36",RRP36,88745,ENSG00000124541,NA,NA,Rrp36 (MGI:2385053)
6,43037616,43053944,6p21.1,6p21.1,609577,"CUL7, 3M1",Cullin 7,CUL7,9820,ENSG00000044090,NA,"3-M syndrome 1, 273750 (3), Autosomal recessive",Cul7 (MGI:1913765)
6,43054028,43060179,6p21.3,6p21.1,611822,MRPL2,Mitochondrial ribosomal protein L2,MRPL2,51069,ENSG00000112651,NA,NA,Mrpl2 (MGI:1351622)
6,43076267,43161719,6p21.1-p12.2,6p21.1,601890,PTK7,PTK7 protein tyrosine kinase 7,PTK7,5754,ENSG00000112655,NA,NA,Ptk7 (MGI:1918711)
6,43171268,43181505,6p21.1,6p21.1,600589,SRF,Serum response factor,SRF,6722,ENSG00000112658,NA,NA,Srf (MGI:106658)
6,43182169,43224586,6p21.1,6p21.1,607489,"CUL9, PARC, KIAA0708",Cullin 9,CUL9,23113,ENSG00000112659,NA,NA,Cul9 (MGI:1925559)
6,43295709,43305537,6p21.2-p21.1,6p21.1,604995,"SLC22A7, OAT2","Solute carrier family 22 (organic anion transporter), member 7",SLC22A7,10864,ENSG00000137204,NA,NA,Slc22a7 (MGI:1859559)
6,43336069,43369646,6p21.1,6p21.1,617512,"ZNF318, TZF, ZFP318",Zinc finger protein 318,ZNF318,24149,ENSG00000171467,NA,NA,Zfp318 (MGI:1889348)
6,43427537,43451993,6p21.1,6p21.1,612509,"ABCC10, MRP7","ATP-binding cassette, subfamily C, member 10",ABCC10,89845,ENSG00000124574,NA,NA,Abcc10 (MGI:2386976)
6,43477522,43506555,6p21.1,6p21.1,612658,"TJAP1, PILT, TJP4",Tight junction-associated protein 1,TJAP1,93643,ENSG00000137221,NA,NA,Tjap1 (MGI:1921344)
6,43511831,43516925,6p21.2-p21.1,6p21.1,609775,"YIPF3, KLIP1","YIP1 domain family, member 3",YIPF3,25844,ENSG00000137207,NA,NA,Yipf3 (MGI:106280)
6,43517023,43562406,6p22.3,6p21.1,610060,"POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11","Polymerase I, RNA, subunit C",POLR1C,9533,ENSG00000171453,NA,"Leukodystrophy, hypomyelinating, 11, 616494 (3), Autosomal recessive; Treacher Collins syndrome 3, 248390 (3), Autosomal recessive",Polr1c (MGI:103288)
6,43522329,43576074,6p21.1,6p21.1,607845,"XPO5, KIAA1291",Exportin 5,XPO5,57510,ENSG00000124571,NA,NA,Xpo5 (MGI:1913789)
6,43576140,43620522,6p21.1-p12,6p21.1,603968,"POLH, XPV","Polymerase, DNA, eta",POLH,5429,ENSG00000170734,NA,"Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive",Polh (MGI:1891457)
6,43620480,43631308,6p21.2-p21.1,6p21.1,607434,"GTPBP2, JABELS",GTP-binding protein 2,GTPBP2,54676,ENSG00000172432,NA,"Jaberi-Elahi syndrome, 617988 (3), Autosomal recessive",Gtpbp2 (MGI:1860138)
6,43629541,43640951,6p21.1,6p21.1,618136,MAD2L1BP,MAD2L1-binding protein,MAD2L1BP,9587,ENSG00000124688,NA,NA,Mad2l1bp (MGI:1913841)
6,43645029,43672599,6p21.1,6p21.1,612648,"RSPH9, CILD12","Radial spoke head 9, Chlamydomonas, homolog of",RSPH9,221421,ENSG00000172426,NA,"Ciliary dyskinesia, primary, 12, 612650 (3)",Rsph9 (MGI:1922814)
6,43671196,43687811,6p21.3,6p21.1,611981,"MRPS18A, MRPS18-3",Mitochondrial ribosomal protein S18A,MRPS18A,55168,ENSG00000096080,NA,NA,Mrps18a (MGI:1915815)
6,43770208,43786486,6p12,6p21.1,192240,"VEGF, MVCD1",Vascular endothelial growth factor,VEGFA,7422,ENSG00000112715,NA,"{Microvascular complications of diabetes 1}, 603933 (3)",Vegfa (MGI:103178)
6,44113450,44127490,6p21.3,6p21.1,611827,"MRPL14, MRPL32",Mitochondrial ribosomal protein L14,MRPL14,64928,ENSG00000180992,NA,NA,Mrpl14 (MGI:1333864)
6,44158810,44184400,6p12,6p21.1,604822,CAPN11,Calpain 11,CAPN11,11131,ENSG00000137225,NA,NA,Capn11 (MGI:1352490)
6,44219586,44234150,6p21.2-p21.1,6p21.1,602193,"SLC29A1, ENT1","Solute carrier family 29 (nucleoside transporters), member 1 (equilibrative nucleoside transporter-1)",SLC29A1,2030,ENSG00000112759,NA,NA,Slc29a1 (MGI:1927073)
6,44246165,44253887,6p21.1,6p21.1,140572,"HSP90AB1, HSPCB, HSPC2, HSP90B","Heas-shock protein, 90kD, alpha, class B, member 1",HSP90AB1,3326,ENSG00000096384,NA,NA,Hsp90ab1 (MGI:96247)
6,44254100,44257889,6p12.1-p11.2,6p21.1,610788,"SLC35B2, PAPST1, SLL","Solute carrier family 35 (3'-phosphoadenosine 5')-phosphosulfate transporter), member B2",SLC35B2,347734,ENSG00000157593,NA,NA,Slc35b2 (MGI:1921086)
6,44258165,44265787,6p21.1,6p21.1,604548,"NFKBIE, IKBE","Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, epsilon",NFKBIE,4794,ENSG00000146232,NA,NA,Nfkbie (MGI:1194908)
6,44278733,44297804,6p21.3-cen,6p21.1,186975,TCTE1,T-complex-associated-testis-expressed-1,TCTE1,202500,ENSG00000146221,NA,NA,Tcte1 (MGI:98640)
6,44297849,44313357,6p21.1,6p21.1,612035,"AARS2, KIAA1270, MTALARS, COXPD8, LKENP",Alanyl-tRNA synthetase 2,AARS2,57505,ENSG00000124608,NA,"Combined oxidative phosphorylation deficiency 8, 614096 (3), Autosomal recessive; Leukoencephalopathy, progressive, with ovarian failure, 615889 (3), Autosomal recessive",Aars2 (MGI:2681839)
6,44387705,44450424,6p21,6p21.1,602868,CDC5L,"Cell division cycle 5, S. pombe, homolog-like",CDC5L,988,ENSG00000096401,NA,NA,Cdc5l (MGI:1918952)
6,44809056,45378050,6p21.1,6p21.1,602947,"SUPT3H, SPT3","Suppressor of Ty 3, S. cerevisiae, homolog of",SUPT3H,8464,ENSG00000196284,NA,NA,Supt3 (MGI:1923723)
6,45328316,45551081,6p21,6p21.1,600211,"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",Runt-related transcription factor 2,RUNX2,860,ENSG00000124813,NA,"Cleidocranial dysplasia, 119600 (3), Autosomal dominant; Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3), Autosomal dominant; Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3), Autosomal dominant; Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3), Autosomal dominant",Runx2 (MGI:99829)
6,45898450,46129818,6p21.1-p12.1,6p21.1,607293,"CLIC5, DFNB103",Chloride intracellular channel 5,CLIC5,53405,ENSG00000112782,mutation identified in 1 DFNB103 family,"?Deafness, autosomal recessive 103, 616042 (3), Autosomal recessive",Clic5 (MGI:1917912)
6,46129988,46146687,6p21.1,6p21.1,617000,"ENPP4, NPP4, KIAA0879",Ectonucleotide pyrophosphatase/phosphodiesterase 4,ENPP4,22875,ENSG00000001561,NA,NA,Enpp4 (MGI:2682634)
6,46159181,46171009,6p21.1,6p21.1,617001,"ENPP5, NPP5",Ectonucleotide pyrophosphatase/phosphodiesterase 5,ENPP5,59084,ENSG00000112796,NA,NA,Enpp5 (MGI:1933830)
6,46200000,69200000,6p12-q12,NA,609026,"CTRCT28, ARCC1",Cataract 28,NA,493862,NA,NA,"{Cataract 28, age-related cortical, susceptibility to}, 609026 (2)",NA
6,46200000,57200000,6p12,NA,164100,"NYS2, NYSA","Nystagmus 2, congenital, autosomal dominant",NYS2,4933,NA,NA,"Nystagmus 2, congenital, autosomal dominant, 164100 (2), Autosomal dominant",NA
6,46220729,46492066,6p12.3,6p12.3,604876,"RCAN2, ZAKI4, DSCR1L1, MCIP2, CSP2",Regulator of calcineurin 2,RCAN2,10231,ENSG00000172348,NA,NA,Rcan2 (MGI:1858219)
6,46549579,46652848,6p21.1-p11.2,6p12.3,605994,CYP39A1,"Cytochrome P450, subfamily XXXIXA (oxysterol 7-alpha-hydroxylase), polypeptide 1",CYP39A1,51302,ENSG00000146233,NA,NA,Cyp39a1 (MGI:1927096)
6,46652914,46678189,6p12.3,6p12.3,613725,"SLC25A27, UCP4","Solute carrier family 25, member 17",SLC25A27,9481,ENSG00000153291,NA,NA,Slc25a27 (MGI:1921261)
6,46680267,46704318,6p12.3,6p12.3,611200,TDRD6,TUDOR domain-containing protein 6,TDRD6,221400,ENSG00000180113,NA,NA,Tdrd6 (MGI:2679727)
6,46700557,46735835,6p21.2-p12,6p12.3,601690,"PLA2G7, PAFAH, PAFAD","Phospholipase A2, group VII (platelet-activating factor acetylhydrolase)",PLA2G7,7941,ENSG00000146070,NA,"{Asthma, susceptibility to}, 600807 (3), Autosomal dominant; {Atopy, susceptibility to}, 147050 (3), Autosomal dominant; Platelet-activating factor acetylhydrolase deficiency, 614278 (3), Autosomal recessive",Pla2g7 (MGI:1351327)
6,46793383,46845986,6p21.2-p21.1,6p12.3,600388,MEP1A,"Meprin A, alpha",MEP1A,4224,ENSG00000112818,NA,NA,Mep1a (MGI:96963)
6,46997707,47042349,6p12.3,6p12.3,617430,"ADGRF1, GPR110",Adhesion G protein-coupled receptor F1,ADGRF1,266977,ENSG00000153292,NA,NA,Adgrf1 (MGI:1924846)
6,47477745,47627262,6p12,6p12.3,604241,"CD2AP, CMS",CD2-associated protein,CD2AP,23607,ENSG00000198087,NA,"Glomerulosclerosis, focal segmental, 3, 607832 (3)",Cd2ap (MGI:1330281)
6,47698544,47722020,6p12.3,6p12.3,614268,"ADGRF4, GPR115",Adhesion G protein-coupled receptor F4,ADGRF4,221393,ENSG00000153294,NA,NA,Adgrf4 (MGI:1925499)
6,47782036,47831087,6p12.3,6p12.3,609042,"OPN5, GRP136, PGR12",Opsin 5,OPN5,221391,ENSG00000124818,NA,NA,Opn5 (MGI:2662912)
6,47858597,48111131,6p21.3,6p12.3,616908,"PTCHD4, PTCH53, C6orf138",Patched domain-containing protein 4,PTCHD4,442213,ENSG00000244694,NA,NA,Ptchd4 (MGI:1920485)
6,49430359,49463297,6p21,6p12.3,609058,"MUT, MCM",Methylmalonyl Coenzyme A mutase,MMUT,4594,ENSG00000146085,NA,"Methylmalonic aciduria, mut(0) type, 251000 (3), Autosomal recessive",Mmut (MGI:97239)
6,49463326,49493106,6p12.3,6p12.3,611506,CENPQ,Centromeric protein Q,CENPQ,55166,ENSG00000031691,NA,NA,Cenpq (MGI:1933744)
6,49499922,49528077,6p12.3,6p12.3,614763,GLYATL3,Glycine N-acyltransferase-like 3,GLYATL3,389396,ENSG00000203972,NA,NA,Glyatl3 (MGI:3647683)
6,49605174,49636873,6p21.1-p11,6p12.3,180297,"RHAG, RH50A, OHST, RHNR",Rhesus blood group-associated glycoprotein,RHAG,6005,ENSG00000112077,NA,"Anemia, hemolytic, Rh-null, regulator type, 268150 (3), Autosomal dominant; Overhydrated hereditary stomatocytosis, 185000 (3), Autosomal dominant",Rhag (MGI:1202713)
6,49676664,49714197,6p12,6p12.3,187430,"CRISP2, TPX1, TSP1",Cysteine-rich secretory protein 2,CRISP2,7180,ENSG00000124490,NA,NA,Crisp2 (MGI:98815)
6,49727375,49744454,6p12.3,6p12.3,618062,"CRISP3, SGP28",Cysteine-rich secretory protein 3,CRISP3,10321,ENSG00000096006,NA,NA,NA
6,49785659,49787284,6p21.1-p12,6p12.3,172270,PGK2,Phosphoglycerate kinase-2 (testicular PGK),PGK2,5232,ENSG00000170950,pseudogene on chr.12,NA,Pgk2 (MGI:97563)
6,49833938,49877095,6p21.2-p21.1,6p12.3,601193,"CRISP1, AEGL1",Cysteine-rich secretory protein 1,CRISP1,167,ENSG00000124812,NA,NA,Crisp4 (MGI:1925331)
6,49960248,49964163,6p12,6p12.3,615243,"DEFB114, DEFB14","Defensin, beta, 114",DEFB114,245928,ENSG00000177684,NA,NA,NA
6,50713543,50773032,6p21.1-p12.1,6p12.3,610161,"TFAP2D, TFAP2BL1",Transcription factor AP2-delta,TFAP2D,83741,ENSG00000008197,NA,NA,Tfap2d (MGI:2153466)
6,50817691,50847618,6p12,6p12.3,601601,"TFAP2B, CHAR, PDA2",Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta),TFAP2B,7021,ENSG00000008196,NA,"Char syndrome, 169100 (3), Autosomal dominant; Patent ductus arteriosus 2, 617035 (3), Autosomal dominant",Tfap2b (MGI:104672)
6,51614684,52087624,6p12.3-p12.2,6p12.3-p12.2,606702,"FCYT, PKHD1, ARPKD, PKD4",Fibrocystin,PKHD1,5314,ENSG00000170927,NA,"Polycystic kidney disease 4, with or without hepatic disease, 263200 (3), Autosomal recessive",Pkhd1 (MGI:2155808)
6,51800000,69200000,6p12.2-q12,NA,614345,MRT24,"Mental retardation, autosomal recessive 24",MRT24,100852402,NA,between rs651733 and rs1508668,"Mental retardation, autosomal recessive 24, 614345 (2), Autosomal recessive",NA
6,52144348,52144433,6p12.2,6p12.2,611599,"MIR206, MIRN206",Micro RNA 206,MIR206,406989,ENSG00000207604,NA,NA,NA
6,52146813,52151022,6p12.2,6p12.2,614933,LINCMD1,"Long intergenic noncoding RNA, muscle differentiation 1",LINCMD1,101154644,NA,NA,NA,NA
6,52148922,52149040,6p12.2,6p12.2,610946,"MIR133B, MIRN133B",Micro RNA 133B,MIR133B,442890,ENSG00000199080,NA,NA,NA
6,52186374,52190637,6p12.2,6p12.2,603149,"IL17A, IL17, CTLA8",Interleukin-17a,IL17A,3605,ENSG00000112115,previously mapped to 2q31,NA,Il17a (MGI:107364)
6,52236680,52245688,6p12,6p12.2,606496,"IL17F, ML1, CANDF6",Interleukin 17F,IL17F,112744,ENSG00000112116,mutation identified in 1 CANDF6 family,"?Candidiasis, familial, 6, autosomal dominant, 613956 (3)",Il17f (MGI:2676631)
6,52264014,52284741,6p12,6p12.2,602693,MCM3,"Minichromosome maintenance, S. cerevisiae, homolog of, 3",MCM3,4172,ENSG00000112118,NA,NA,Mcm3 (MGI:101845)
6,52362150,52407776,6p12,6p12.2,607780,"PAQR8, C6orf33, LMPB1, MPRB","Progestin and ADIPOQ receptor family, member 8",PAQR8,85315,ENSG00000170915,NA,NA,Paqr8 (MGI:1921479)
6,52420195,52497197,6p12-p11,6p12.2,608815,"EFHC1, FLJ10466, EJM1, JAE, EJA1",EF hand domain (C-terminal)-containing 1,EFHC1,114327,ENSG00000096093,NA,"{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3), Autosomal dominant; {Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3), Autosomal dominant",Efhc1 (MGI:1919127)
6,52497404,52577059,6p12.2,6p12.2,608485,"TRAM2, KIAA0057",Translocation-associated membrane protein 2,TRAM2,9697,ENSG00000065308,NA,NA,Tram2 (MGI:1924817)
6,52671098,52686587,6p12.2,6p12.2,616870,TMEM14A,Transmembrane protein 14A,TMEM14A,28978,ENSG00000096092,NA,NA,Tmem14a (MGI:1922962)
6,52750086,52763474,6p12.2,6p12.2,138360,"GSTA2, GST2",Glutathione S-transferase A2,GSTA2,2939,ENSG00000244067,NA,NA,NA
6,52791370,52803826,6p12.2,6p12.2,138359,GSTA1,Glutathione S-transferase A1,GSTA1,2938,ENSG00000243955,NA,NA,NA
6,52831741,52846094,6p12.2,6p12.2,607605,GSTA5,"Glutathione S-transferase, alpha-5",GSTA5,221357,ENSG00000182793,NA,NA,"Gm10639,Gsta1,Gsta2,Gm3776 (MGI:1095417,MGI:3704339,MGI:95863,MGI:3826440)"
6,52896645,52909798,6p12.2,6p12.2,605449,GSTA3,"Glutathione S-transferase, alpha-3",GSTA3,2940,ENSG00000174156,NA,NA,Gsta3 (MGI:95856)
6,52977951,52995331,6p12.2,6p12.2,605450,GSTA4,"Glutathione S-transferase, alpha-4",GSTA4,2941,ENSG00000170899,NA,NA,NA
6,52995619,52995950,6p12.1,6p12.2,606515,"RN7SK, 7SK","RNA, 7SK small nuclear",RN7SK,125050,ENSG00000202198,NA,NA,NA
6,53001278,53061863,6p12.3,6p12.1,612325,"ICK, MRK, KIAA0936, ECO, EJM10",Intestinal cell kinase,ICK,22858,ENSG00000112144,NA,"Endocrine-cerebroosteodysplasia, 612651 (3), Autosomal recessive; {Epilepsy, juvenile myoclonic, susceptibility to, 10}, 617924 (3), Autosomal dominant",Ick (MGI:1934157)
6,53057806,53100872,6p12.3-p11.2,6p12.1,609091,"FBXO9, FBX9",F-box only protein 9,FBXO9,26268,ENSG00000112146,NA,NA,Fbxo9 (MGI:1918788)
6,53126960,53262802,6p12.1,6p12.1,603715,"GCM1, GCMA","Glial cells missing, Drosophila, homolog of, 1",GCM1,8521,ENSG00000137270,NA,NA,Gcm1 (MGI:108045)
6,53267397,53349178,6p12,6p12.1,611805,"ELOVL5, HELO1, SCA38",Elongation of very long chain fatty acids-like 5,ELOVL5,60481,ENSG00000012660,NA,"Spinocerebellar ataxia 38, 615957 (3), Autosomal dominant",Elovl5 (MGI:1916051)
6,53497340,53545100,6p12,6p12.1,606857,"GCLC, GLCLC","Glutamate-cysteine ligase, catalytic subunit",GCLC,2729,ENSG00000001084,NA,"Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3), Autosomal recessive; {Myocardial infarction, susceptibility to}, 608446 (3)",Gclc (MGI:104990)
6,53647915,53665853,6p12,6p12.1,610749,"KLHL31, KLHL",Kelch-like 31,KLHL31,401265,ENSG00000124743,NA,NA,Klhl31 (MGI:3045305)
6,53794496,53924124,6p12.3-p12.2,6p12.1,608195,"LRRC1, LANO",Leucine-rich repeat-containing protein 1,LRRC1,55227,ENSG00000137269,NA,NA,Lrrc1 (MGI:2442313)
6,54018915,54266324,6p12.1,6p12.1,614106,"MLIP, C6orf142",Muscular LMNA-interating protein,MLIP,90523,ENSG00000146147,NA,NA,Mlip (MGI:1916892)
6,54307791,54390150,6p12-p11.2,6p12.1,606749,"TINAG, TIN1, TIN2",Tubulointerstitial nephritis antigen,TINAG,27283,ENSG00000137251,NA,NA,Tinag (MGI:1349477)
6,55106459,55284697,6p12.1,6p12.1,602393,"HCRTR2, OX2R",Hypocretin receptor 2,HCRTR2,3062,ENSG00000137252,NA,NA,Hcrtr2 (MGI:2680765)
6,55327468,55402492,6p12.1,6p12.1,617837,"GFRAL, GRAL",GDNF family receptor alpha-like protein,GFRAL,389400,ENSG00000187871,NA,NA,Gfral (MGI:3607786)
6,55753652,55875589,6p12.1,6p12.1,112265,BMP5,Bone morphogenetic protein-5,BMP5,653,ENSG00000112175,NA,NA,Bmp5 (MGI:88181)
6,56056589,56394127,6p12.3-p11.2,6p12.1,610002,COL21A1,"Collagen, type XXI, alpha-1 polypeptide",COL21A1,81578,ENSG00000124749,NA,NA,NA
6,56457986,56954829,6p12-p11,6p12.1,113810,"DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2",Dystonin (bullous pemphigoid antigen 1),DST,667,ENSG00000151914,?mutation identified in 1 HSAN6 family,"Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3), Autosomal recessive; ?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3), Autosomal recessive",NA
6,57088969,57170304,6p12.1,6p12.1,615708,"ZNF451, COASTER",Zinc finger protein 451,ZNF451,26036,ENSG00000112200,NA,NA,Zfp451 (MGI:2137896)
6,57172325,57189832,6p11.2,6p12.1,603882,BAG2,BCL2-associated athanogene 2,BAG2,9532,ENSG00000112208,NA,NA,Bag2 (MGI:1891254)
6,57186991,57222313,6p11,6p12.1-p11.2,606144,RAB23,Ras-associated protein RAB23,RAB23,51715,ENSG00000112210,NA,"Carpenter syndrome, 201000 (3), Autosomal recessive",Rab23 (MGI:99833)
6,57200000,59800000,6p11,NA,608173,AITD1,"Autoimmune thyroid disease, susceptibility to, 1",NA,387578,NA,NA,"{Autoimmune thyroid disease, susceptibility to, 1}, 608173 (2)",NA
6,57314804,57646851,6p12-p11.1,6p11.2,176636,PRIM2A,"Primase polypeptide 2A, 58kD",PRIM2,5558,ENSG00000146143,NA,NA,Prim2 (MGI:97758)
6,59800000,170805979,6q,NA,193007,BPPV,"Vertigo, benign paroxysmal positional",NA,619536,NA,max lod at D6S1556,"Vestibulopathy, familial, 193007 (2), Autosomal dominant",NA
6,59800000,87300000,6q11-q14,NA,613544,"DEL6q11q14, C6DELq11q14",Chromosome 6q11-q14 deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 6q11-q14 deletion syndrome, 613544 (4), Isolated cases",NA
6,61542696,62286226,6q11.1,6q11.1,610487,"KHDRBS2, SLM1","KH domain-containing, RNA-binding, signal transduction-associated protein 2",KHDRBS2,202559,ENSG00000112232,NA,NA,Khdrbs2 (MGI:2159649)
6,62700000,69200000,6q12,NA,608905,ADHD3,"Attention deficit-hyperactivity disorder, susceptibility to, 2",NA,450089,NA,NA,"{Attention deficit-hyperactivity disorder}, 143465 (2), Autosomal dominant",NA
6,62700000,105000000,6q12-q16,NA,605582,CMD1K,"Cardiomyopathy, dilated, 1K",CMD1K,65014,NA,NA,"Cardiomyopathy, dilated, 1K, 605582 (2)",NA
6,62700000,92500000,6q12-q15,NA,614342,MRT30,"Mental retardation, autosomal recessive 30",NA,100852401,NA,between rs4612125 and rs285651,"Mental retardation, autosomal recessive 30, 614342 (2), Autosomal recessive",NA
6,63275950,63567920,6q12,6q12,611470,"GLULD1, LGS",Glutamate-ammonia ligase (glutamine synthetase) domain-containing 1,LGSN,51557,ENSG00000146166,NA,NA,Lgsn (MGI:2672844)
6,63528020,63583587,6q12,6q12,601585,"PTP4A1, HH72, PRL1","Protein tyrosine phosphatase, type 4A, 1",PTP4A1,7803,ENSG00000112245,NA,NA,Ptp4a1 (MGI:1277096)
6,63635801,63715521,6q12,6q12,607789,"PHF3, KIAA0244",PHD finger protein 3,PHF3,23469,ENSG00000118482,NA,NA,Phf3 (MGI:2446126)
6,63719979,65707225,6q12,6q12,612424,"EYS, RP25","Eyes shut, Drosophila, homolog of",EYS,346007,ENSG00000188107,NA,"Retinitis pigmentosa 25, 602772 (3), Autosomal recessive",NA
6,68635281,69389505,6q12,6q12-q13,602684,"ADGRB3, BAI3",Adhesion G protein-coupled receptor B3,ADGRB3,577,ENSG00000135298,NA,NA,Adgrb3 (MGI:2441837)
6,69200000,98900000,6q13-q16.1,NA,611572,OTSC7,Otosclerosis 7,OTSC7,399516,NA,between D6S1036 and D6S300,"Otosclerosis 7, 611572 (2), Autosomal dominant",NA
6,69200000,164100000,6q13-q26,NA,603175,SCZD5,"Schizophrenia susceptibility locus, chromosome 6q-related",NA,NA,NA,max lod at D6S1626 and D6S292,"{Schizophrenia}, 181500 (2), Autosomal dominant",NA
6,69674009,69797009,6q13,6q13,612625,"LMBRD1, LMBD1, NESI, MAHCF",LMBR1 domain-containing protein 1,LMBRD1,55788,ENSG00000168216,NA,"Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3), Autosomal recessive",Lmbrd1 (MGI:1915671)
6,69866555,70215062,6q12-q14,6q13,120165,"COL19A1, D6S228E, COL9A1L","Collagen XIX, alpha-1 polypeptide",COL19A1,1310,ENSG00000082293,NA,NA,Col19a1 (MGI:1095415)
6,70215060,70303083,6q13,6q13,120210,"COL9A1, EDM6, STL4","Collagen IX, alpha-1 polypeptide",COL9A1,1297,ENSG00000112280,mutation identified in 1 EDM6 family,"?Epiphyseal dysplasia, multiple, 6, 614135 (3), Autosomal dominant; Stickler syndrome, type IV, 614134 (3)",Col9a1 (MGI:88465)
6,70667882,70862014,6q13,6q13,611372,SMAP1,Small ADP-ribosylation factor GTPase-activating protein 1,SMAP1,60682,ENSG00000112305,NA,NA,Smap1 (MGI:2138261)
6,70856678,70957059,6q13,6q13,607497,"GLCATS, KIAA1963",UDP-glucuronyltransferase S,B3GAT2,135152,ENSG00000112309,NA,NA,B3gat2 (MGI:2389490)
6,71403550,71403620,6q13,6q13,612329,"MIR30A, MIRN30A",Micro RNA 30A,MIR30A,407029,ENSG00000207827,NA,NA,NA
6,71886702,72403144,6q12-q13,6q13,606629,"RIMS1, RIM1, RIM, KIAA0340, CORD7",Regulating synaptic membrane exocytosis 1,RIMS1,22999,ENSG00000079841,NA,"Cone-rod dystrophy 7, 603649 (3)",Rims1 (MGI:2152971)
6,72621842,73198850,6q14,6q13,607357,"KCNQ5, MRD46","Potassium channel, voltage-gated, KQT-like subfamily, member 5",KCNQ5,56479,ENSG00000185760,NA,"Mental retardation, autosomal dominant 46, 617601 (3), Autosomal dominant",Kcnq5 (MGI:1924937)
6,73241313,73310364,6q13,6q13,611688,KHDC1,KH homology domain-containing protein 1,KHDC1,80759,ENSG00000135314,NA,NA,NA
6,73353062,73354275,6q13,6q13,611111,"DPPA5, ESG1",Developmental pluripotency-associated gene 5,DPPA5,340168,ENSG00000203909,NA,NA,Dppa5a (MGI:101800)
6,73362657,73364170,6q13,6q13,611687,"KHDC3L, C6orf221, ECAT1, HYDM2","KH domain containing 3-like, subcortical maternal complex member",KHDC3L,154288,ENSG00000203908,NA,"Hydatidiform mole, recurrent, 2, 614293 (3), Autosomal recessive",Khdc3 (MGI:1914241)
6,73368554,73369791,6q13,6q13,611689,"OOEP, KHDC2","Oocyte-expressed protein, Dog, homolog of",OOEP,441161,ENSG00000203907,NA,NA,Ooep (MGI:1915218)
6,73394827,73417565,6q12-q13,6q13,606286,"DDX43, HAGE",DEAD/H box 43,DDX43,55510,ENSG00000080007,NA,NA,Ddx43 (MGI:3642857)
6,73423710,73452296,6q13,6q13,613973,"CGAS, MB21D1, C6orf150",Cyclic GMP-AMP synthase,CGAS,115004,ENSG00000164430,NA,NA,Cgas (MGI:2442261)
6,73461736,73509235,6q13,6q13,614667,"MTO1, COXPD10","Mitochondrial translation optimization 1, S. cerevisiae, homolog of",MTO1,25821,ENSG00000135297,NA,"Combined oxidative phosphorylation deficiency 10, 614702 (3), Autosomal recessive",Mto1 (MGI:1915541)
6,73515749,73521031,6q14,6q13,130590,"EEF1A1, EF1A","Eukaryotic translation elongation factor-1, alpha-1",EEF1A1,1915,ENSG00000156508,NA,NA,Eef1a1 (MGI:1096881)
6,73593378,73653991,6q14-q15,6q13,604322,"SLC17A5, SIASD, SLD","Solute carrier family 17 (sodium phosphate), member 5",SLC17A5,26503,ENSG00000119899,NA,"Salla disease, 604369 (3), Autosomal recessive; Sialic acid storage disorder, infantile, 269920 (3), Autosomal recessive",Slc17a5 (MGI:1924105)
6,73696084,73828316,6q13,6q13,608859,CD109,CD109 antigen,CD109,135228,ENSG00000156535,NA,NA,Cd109 (MGI:2445221)
6,75084325,75206261,6q13-q14.1,6q13-q14,120320,"COL12A1, UCMD2, BTHLM2, EDSMYP","Collagen, type XII, alpha-1",COL12A1,1303,ENSG00000111799,mutation identified in 1 UCMD2 family,"Bethlem myopathy 2, 616471 (3), Autosomal dominant; ?Ullrich congenital muscular dystrophy 2, 616470 (3)",Col12a1 (MGI:88448)
6,75200000,105000000,6q14-q16,NA,608988,ATFB2,"Atrial fibrillation, familial, 2",NA,619478,NA,max lod between  D6S286 and D6S1021,"Atrial fibrillation, familial, 2, 608988 (2)",NA
6,75200000,100000000,6q14-q16.2,NA,600790,"PBCRA, CRAPB",Progressive bifocal chorioretinal atrophy,PBCRA1,7948,NA,NA,"Chorioretinal atrophy, progressive bifocal, 600790 (2), Autosomal dominant",NA
6,75200000,83200000,6q14.1,NA,610685,SHFLD2,Split-hand/foot malformation with long bone deficiency 2,NA,791123,NA,between rs623155 and rs1547251,"Split-hand/foot malformation with long bone deficiency 2, 610685 (2)",NA
6,75237674,75250297,6q12,6q14.1,123996,COX7A2,"Cytochrome c oxidase, subunit VIIa, polypeptide-2, liver",COX7A2,1347,ENSG00000112695,previously thought to be on chr.4,NA,Cox7a2 (MGI:1316715)
6,75252923,75284791,6q14.1,6q14.1,611028,"TMEM30A, CDC50A",Transmembrane protein 30A,TMEM30A,55754,ENSG00000112697,NA,NA,Tmem30a (MGI:106402)
6,75291857,75493799,6q14.1,6q14.1,607307,"FILIP, KIAA1275",Filamin A-interacting protein,FILIP1,27145,ENSG00000118407,NA,NA,Filip1 (MGI:1917848)
6,75601508,75718280,6q13,6q14.1,605003,"SENP6, SSP1, SUSP1","Sentrin-specific protease family, member 6",SENP6,26054,ENSG00000112701,NA,NA,Senp6 (MGI:1922075)
6,75749202,75919536,6q13,6q14.1,600970,"MYO6, DFNA22, DFNB37",Myosin VI,MYO6,4646,ENSG00000196586,NA,"Deafness, autosomal dominant 22, 606346 (3), Autosomal dominant; Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3), Autosomal dominant; Deafness, autosomal recessive 37, 607821 (3), Autosomal recessive",Myo6 (MGI:104785)
6,75921113,76072677,6q13-q15,6q14.1,602870,"IMPG1, IPM150, VMD4",Interphotoreceptor matrix proteoglycan-1,IMPG1,3617,ENSG00000112706,NA,"Macular dystrophy, vitelliform, 4, 616151 (3), Autosomal dominant",Impg1 (MGI:1926876)
6,77460847,77464021,6q13,6q14.1,182131,HTR1B,5-hydroxytryptamine (serotonin) receptor-1B,HTR1B,3351,ENSG00000135312,NA,NA,Htr1b (MGI:96274)
6,77650273,77927044,6q14.1,6q14.1,618417,MEI4,Meiotic double-stranded break formation protein 4,MEI4,101928601,ENSG00000269964,NA,NA,Mei4 (MGI:1922283)
6,78867485,78979410,6q14.1,6q14.1,615375,"IRAK1BP1, SIMPL",Interleukin 1 receptor-associated kinase 1-binding protein 1,IRAK1BP1,134728,ENSG00000146243,NA,NA,Irak1bp1 (MGI:1929475)
6,78934418,79078293,6q14,6q14.1,612870,"PHIP, DIDOD",Pleckstrin homology domain-interacting protein,PHIP,55023,ENSG00000146247,NA,"Developmental delay, intellectual disability, obesity, and dysmorphic features, 617991 (3), Autosomal dominant",Phip (MGI:1932404)
6,79201244,79234681,6q14.1,6q14.1,604502,"HMGN3, TRIP7",High-mobility group nucleosomal binding protein 3 (thyroid hormone receptor interactor 7),HMGN3,9324,ENSG00000118418,NA,NA,NA
6,79484990,79537429,6q14.1,6q14.1,611408,"LCA5, C6orf152",Lebercilin,LCA5,167691,ENSG00000135338,NA,"Leber congenital amaurosis 5, 604537 (3)",Lca5 (MGI:1923032)
6,79631328,79703658,6q14.1,6q14.1,615678,SH3BGRL2,SH3 domain-binding glutamic acid-rich protein-like protein 2,SH3BGRL2,83699,ENSG00000198478,NA,NA,Sh3bgrl2 (MGI:1915350)
6,79914813,79947552,6q14,6q14.1,605512,"ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34",Elongation of very long chain fatty acids 4,ELOVL4,6785,ENSG00000118402,NA,"Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3), Autosomal recessive; Spinocerebellar ataxia 34, 133190 (3), Autosomal dominant; Stargardt disease 3, 600110 (3), Autosomal dominant",Elovl4 (MGI:1933331)
6,80004146,80042650,6q13-q21,6q14.1,604092,"TTK, MPS1L1, PYT",TTK protein kinase,TTK,7272,ENSG00000112742,NA,NA,Ttk (MGI:1194921)
6,80106609,80469087,6q14,6q14.1,248611,"BCKDHB, E1B","Branched chain keto acid dehydrogenase E1, beta polypeptide",BCKDHB,594,ENSG00000083123,NA,"Maple syrup urine disease, type Ib, 248600 (3), Autosomal recessive",Bckdhb (MGI:88137)
6,81745729,81752680,6q14,6q14.1,611357,"TENT5A, FAM46A, C6orf37, OI18",Terminal nucleotidyltransferase 5A,TENT5A,55603,ENSG00000112773,NA,"Osteogenesis imperfecta, type XVIII, 617952 (3), Autosomal recessive",Tent5a (MGI:2670964)
6,82169986,82247746,6q13-q14,6q14.1,606457,IBTK,Inhibitor of Bruton agammaglobulinemia tyrosine kinase,IBTK,25998,ENSG00000005700,NA,NA,Ibtk (MGI:1918677)
6,82363205,82367416,6q14-q15,6q14.1,190920,TPBG,Trophoblast glycoprotein,TPBG,7162,ENSG00000146242,NA,NA,Tpbg (MGI:1341264)
6,82880833,83065840,6q14.1,6q14.1,612495,"UBE2CBP, H10BH",Ubiquitin-conjugating enzyme E2C-binding protein,UBE3D,90025,ENSG00000118420,NA,NA,Ube2cbp (MGI:1917598)
6,83067665,83171350,6q14.1,6q14.1,616823,"DOPEY1, DOP1, KIAA1117",DOPEY family member 1,DOP1A,23033,ENSG00000083097,NA,NA,Dop1a (MGI:1289294)
6,83150727,83193899,6q12,6q14.1,172100,"PGM3, AGM1, IMD23",Phosphoglucomutase-3 (N-acetylglucosamine-phosphate mutase 1),PGM3,5238,ENSG00000013375,NA,"Immunodeficiency 23, 615816 (3), Autosomal recessive",Pgm3 (MGI:97566)
6,83210401,83431077,6q12,6q14.2,154250,ME1,"Malic enzyme, cytoplasmic",ME1,4199,ENSG00000065833,NA,NA,Me1 (MGI:97043)
6,83552884,83709407,6q14.2,6q14.2,607923,"SNAP91, AP180, KIAA0656","Synaptosomal-associated protein, 91kD",SNAP91,9892,ENSG00000065609,NA,NA,Snap91 (MGI:109132)
6,83853265,83857514,6q14.2,6q14.2,609891,"RIPPLY2, C6orf59, SCDO6","Ripply2, zebrafish, homolog of",RIPPLY2,134701,ENSG00000203877,mutation identified in 1 SCDO6 family,"?Spondylocostal dysostosis 6, 616566 (3), Autosomal recessive",Ripply2 (MGI:2685968)
6,83859688,83967422,6q14-q15,6q14.2,608343,"CYB5R4, NCB5OR",Cytochrome b5 reductase 4,CYB5R4,51167,ENSG00000065615,NA,NA,Cyb5r4 (MGI:2386848)
6,84032620,84146277,6q14.2,6q14.2,615410,"MRAP2, C6orf117, BMIQ18",Melanocortin 2 receptor accessory protein 2,MRAP2,112609,ENSG00000135324,mutation identified in 1 BMIQ18 individual,"{?Obesity, susceptibility to, BMIQ18}, 615457 (3), Autosomal dominant",Mrap2 (MGI:3609239)
6,84124249,84227888,6q14.2-q14.3,6q14.2-q14.3,610201,"CEP162, KIAA1009","Centrosomal protein, 162kD",CEP162,22832,ENSG00000135315,NA,NA,Cep162 (MGI:1925343)
6,84666809,84764597,6q14.3,6q14.3,604613,"TBX18, CAKUT2",T-box 18,TBX18,9096,ENSG00000112837,NA,"Congenital anomalies of kidney and urinary tract 2, 143400 (3), Autosomal dominant",Tbx18 (MGI:1923615)
6,85449583,85495790,6q14-q21,6q14.3,129190,"NT5E, NT5","5' nucleotidase, ecto (CD73)",NT5E,4907,ENSG00000135318,NA,"Calcification of joints and arteries, 211800 (3), Autosomal recessive",Nt5e (MGI:99782)
6,85505495,85594155,6q14.3,6q14.3,616105,"SNX14, SCAR20",Sorting nexin 14,SNX14,57231,ENSG00000135317,NA,"Spinocerebellar ataxia, autosomal recessive 20, 616354 (3), Autosomal recessive",Snx14 (MGI:2155664)
6,85607783,85643861,6q14.3,6q14.3,616686,"SYNCRIP, NSAP1, GRYRBP, HNRNPQ",Synaptotagmin-binding cytoplasmic RNA-interacting protein,SYNCRIP,10492,ENSG00000135316,NA,NA,Syncrip (MGI:1891690)
6,85677006,85678732,6q15,6q14.3,613263,"SNHG5, U50HG",Small nucleolar RNA host gene 5,SNHG5,387066,ENSG00000203875,NA,NA,NA
6,85677293,85677367,6q15,6q14.3,613117,"SNORD50A, RNU50","Small nucleolar RNA, C/D box, 50A",SNORD50A,26799,NA,NA,NA,NA
6,85677588,85677658,6q15,6q14.3,613264,SNORD50B,"Small nucleolar RNA, C/D box",SNORD50B,692088,ENSG00000275072,NA,NA,NA
6,86936918,87020067,6q14-q15,6q14.3,182132,HTR1E,5-hydroxytryptamine (serotonin) receptor-1E,HTR1E,3354,ENSG00000168830,NA,NA,NA
6,87085497,87095105,6q12-q21,6q14.3,118850,CGA,"Chorionic gonadotropin, alpha polypeptide",CGA,1081,ENSG00000135346,"shared with LH, FSH, TSH",NA,Cga (MGI:88390)
6,87155564,87265942,6q14.3,6q14.3,616213,"ZNF292, ZFP292, KIAA0530",Zinc finger protein 292,ZNF292,23036,ENSG00000188994,NA,NA,Zfp292 (MGI:1353423)
6,87282977,87329277,6q15,6q14-q15,611921,"GJB7, CX25","Gap junction protein, beta-7",GJB7,375519,ENSG00000164411,NA,NA,NA
6,87472924,87512338,6q15,6q15,605634,"SLC35A1, CST, CDG2F","Solute carrier family 35 (CMP-sialic acid transporter), member 1",SLC35A1,10559,ENSG00000164414,NA,"Congenital disorder of glycosylation, type IIf, 603585 (3), Autosomal recessive",Slc35a1 (MGI:1345622)
6,87513934,87590031,6q16.1,6q15,611524,"RARS2, RARSL, PCH6",Arginyl-tRNA synthetase 2,RARS2,57038,ENSG00000146282,NA,"Pontocerebellar hypoplasia, type 6, 611523 (3), Autosomal recessive",Rars2 (MGI:1923596)
6,87590066,87677823,6q15,6q15,604972,"ORC3, ORC3L, LAT","Origin recognition complex, subunit 3, S. cerevisiae, homolog of",ORC3,23595,ENSG00000135336,NA,NA,Orc3 (MGI:1354944)
6,87674859,87702232,6q15,6q15,615165,AKIRIN2,Akirin 2,AKIRIN2,55122,ENSG00000135334,NA,NA,Akirin2 (MGI:1889364)
6,88046906,88066837,6q15-q16.2,6q15,612739,"SPACA1, SAMP32",Sperm acrosome-associated 1,SPACA1,81833,ENSG00000118434,NA,NA,Spaca1 (MGI:1914902)
6,88139863,88167348,6q14-q15,6q15,114610,CNR1,"Cannabinoid receptor-1, brain",CNR1,1268,ENSG00000118432,NA,NA,Cnr1 (MGI:104615)
6,88609896,88963617,6q16,6q15,603512,"RNGTT, HCE1, CAP1A",RNA guanylyltransferase and 5'-phosphatase,RNGTT,8732,ENSG00000111880,NA,NA,Rngtt (MGI:1329041)
6,89080748,89085159,6q15,6q15,606714,"PNRC1, PROL2",Proline-rich nuclear receptor coactivator 1,PNRC1,10957,ENSG00000146278,NA,NA,Pnrc1 (MGI:1917838)
6,89094817,89165564,6q15,6q15,615913,"PM20D2, ACY1L2",Peptidase M20 domain-containing 2,PM20D2,135293,ENSG00000146281,NA,NA,Pm20d2 (MGI:2685270)
6,89177503,89231287,6q14-q21,6q15,137161,GABRR1,"Gamma-aminobutyric acid (GABA) A receptor, rho-1",GABRR1,2569,ENSG00000146276,NA,NA,Gabrr1 (MGI:95625)
6,89254463,89315298,6q14-q21,6q15,137162,GABRR2,"Gamma-aminobutyric acid (GABA) A receptor, rho-2",GABRR2,2570,ENSG00000111886,NA,NA,Gabrr2 (MGI:95626)
6,89326624,89353154,6q15,6q15,616175,"UBE2J1, UBC6E",Ubiquitin-conjugating enzyme E2J 1,UBE2J1,51465,ENSG00000198833,NA,NA,Ube2j1 (MGI:1926245)
6,89363508,89412272,6q15-q16,6q15,608268,"RRAGD, RAGD",RAS-related GTP-binding protein D,RRAGD,58528,ENSG00000025039,NA,NA,Rragd (MGI:1098604)
6,89433151,89633833,6q14-q16,6q15,610583,"ANKRD6, KIAA0957",Ankyrin repeat domain-containing protein 6,ANKRD6,22881,ENSG00000135299,NA,NA,Ankrd6 (MGI:2154278)
6,89642497,89828020,6q15,6q15,618200,MDN1,Midasin AAA Atpase 1,MDN1,23195,ENSG00000112159,NA,NA,Mdn1 (MGI:1926159)
6,89829899,89874435,6q15,6q15,606880,"CASP8AP2, FLASH",Caspase 8-associated protein 2,CASP8AP2,9994,ENSG00000118412,NA,NA,Casp8ap2 (MGI:1349399)
6,89894468,89896119,6q15,6q15,611924,"GJA10, CX62","Gap junction protein, alpha-10",GJA10,84694,ENSG00000135355,NA,NA,Gja10 (MGI:1339969)
6,89926527,90296907,6q15,6q15,605394,"BACH2, IMD60",BTB and CNC homology 2,BACH2,60468,ENSG00000112182,NA,"Immunodeficiency 60, 618394 (3), Autosomal dominant",Bach2 (MGI:894679)
6,90513578,90587071,6q14-q21,6q15,602614,"MAP3K7, TAK1, CSCF, FMD2",Mitogen-activated protein kinase kinase kinase 7,MAP3K7,6885,ENSG00000135341,NA,"Cardiospondylocarpofacial syndrome, 157800 (3), Autosomal dominant; Frontometaphyseal dysplasia 2, 617137 (3), Autosomal dominant",NA
6,93240019,93419583,6q16.1,6q16.1,602190,"EPHA7, HEK11",Ephrin receptor EphA7,EPHA7,2045,ENSG00000135333,NA,NA,Epha7 (MGI:95276)
6,95577534,95609451,6q16,6q16.1,612327,"MANEA, ENDO","Mannosidase, endo-alpha",MANEA,79694,ENSG00000172469,NA,NA,Manea (MGI:2444484)
6,96015973,96215611,6q16,6q16.1,606865,FUT9,Fucosyltransferase 9,FUT9,10690,ENSG00000172461,NA,NA,Fut9 (MGI:1330859)
6,96521805,96555275,6q16.1,6q16.1,613372,"UFL1, KIAA0776, NLBP",UFM1-specific ligase 1,UFL1,23376,ENSG00000014123,NA,NA,Ufl1 (MGI:1914740)
6,96562524,96618625,6q16.1-q16.3,6q16.1,605126,"FHL5, ACT",Four-and-a-half LIM domains 5,FHL5,9457,ENSG00000112214,NA,NA,Fhl5 (MGI:1913192)
6,96794124,96837476,6q16.1-q16.3,6q16.1,606915,GPR63,G protein-coupled receptor 63,GPR63,81491,ENSG00000112218,NA,NA,Gpr63 (MGI:2135884)
6,96889314,96897890,6q16.1,6q16.1,611776,"NDUFAF4, HRPAP20, C6orf66, MC1DN15",NADH-ubiquinone oxidoreductase complex assembly factor 4,NDUFAF4,29078,ENSG00000123545,NA,"Mitochondrial complex I deficiency, nuclear type 15, 618237 (3), Autosomal recessive",Ndufaf4 (MGI:1915743)
6,97142160,97283436,6q16.1,6q16.1,615614,"MMS22L, C6orf167",MMS22-like protein,MMS22L,253714,ENSG00000146263,NA,NA,Mms22l (MGI:2684980)
6,98830140,98831699,6q16.1,6q16.1,616328,PNKY,Long intergenic noncoding RNA Pinky,NA,105447646,NA,NA,NA,NA
6,98834573,98839457,6q16,6q16.1,600494,"POU3F2, OCT7","POU domain, class 3, transcription factor 2",POU3F2,5454,ENSG00000184486,NA,NA,Pou3f2 (MGI:101895)
6,98868534,98948005,6q16.1-q16.3,6q16.1-q16.2,605654,"FBXL4, FBL4, MTDPS13",F-box and leucine-rich repeat protein 4,FBXL4,26235,ENSG00000112234,NA,"Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3), Autosomal recessive",Fbxl4 (MGI:2140367)
6,98900000,100000000,6q16.2,NA,616842,"DHS6S1, MCDR1","DNase1 hypersensitivity, chromosome 6, site 1",NA,107305681,NA,upstream of PRDM13 and CCNC,"Macular dystrophy, North Carolina type, 136550 (3), Autosomal dominant",NA
6,98900000,117900000,6q16.2-q22.1,NA,611944,LMPHM2,Lymphatic malformation 2,NA,100188865,NA,max lod at D6S1671,"Lymphatic malformation 2, 611944 (2), Autosomal dominant",NA
6,99398049,99426305,6q16.2,6q16.2,616653,"PNISR, SRRP130, SFRS18",PNN-interacting serine/arginine-rich protein,PNISR,25957,ENSG00000132424,NA,NA,Pnisr (MGI:1913875)
6,99432305,99515769,6q16.2,6q16.2,618439,USP45,Ubiquitin-specific protease 45,USP45,85015,ENSG00000123552,NA,NA,Usp45 (MGI:101850)
6,99542386,99568813,6q21,6q16.2,123838,CCNC,Cyclin C,CCNC,892,ENSG00000112237,NA,NA,Ccnc (MGI:1858199)
6,99606773,99615577,6q16.2,6q16.2,616741,PRDM13,PR domain-containing protein 13,PRDM13,59336,ENSG00000112238,NA,NA,Prdm13 (MGI:2448528)
6,99919909,99994237,6q16.2-q21,6q16.2,606111,"MCHR2, MCH2R, SLT, MCH2",Melanin-concentrating hormone receptor 2,MCHR2,84539,ENSG00000152034,NA,NA,NA
6,100000000,125800000,6q16.3-q22.31,NA,613828,GEFSP8,"Generalized epilepsy with febrile seizures plus, type 8",NA,100653381,NA,between D6S962 and D6S287,"Epilepsy, generalized, with febrile seizures plus, type 8, 613828 (2)",NA
6,100385008,100464928,6q16.3-q21,6q16.3,603128,SIM1,"Single-minded, Drosophila, homolog of, 1",SIM1,6492,ENSG00000112246,NA,NA,Sim1 (MGI:98306)
6,100508193,100884454,6q16.3,6q16.3,614217,"ASCC3, p200","Activating signal cointegrator 1 complex, subunit 3",ASCC3,10973,ENSG00000112249,NA,NA,Ascc3 (MGI:1925237)
6,101393707,102070082,6q21,6q16.3,138244,"GRIK2, GLUR6, MRT6","Glutamate receptor, ionotropic, kainate 2",GRIK2,2898,ENSG00000164418,NA,"Mental retardation, autosomal recessive, 6, 611092 (3), Autosomal recessive",Grik2 (MGI:95815)
6,104728092,104859918,6q21,6q16.3,610876,"HACE1, KIAA1320, SPPRS",HECT domain- and ankyrin repeat-containing E3 ubiquitin protein ligase 1,HACE1,57531,ENSG00000085382,NA,"Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3), Autosomal recessive",Hace1 (MGI:2446110)
6,104936998,105083331,6q21,6q16-q21,611044,LIN28B,"Lin28, C. elegans, homolog of, B",LIN28B,389421,ENSG00000187772,NA,NA,Lin28b (MGI:3584032)
6,105000000,114200000,6q21,NA,109780,BKMA1,Banded krait minor satellite DNA-1,NA,NA,NA,related to heterogametic sex,NA,NA
6,105000000,114200000,6q21,NA,606325,HTX3,"Heterotaxy, visceral, 3, autosomal",NA,116629,NA,NA,"?Heterotaxy, visceral, 3, autosomal, 606325 (2)",NA
6,105000000,114200000,6q21,NA,601666,IDDM15,Insulin-dependent diabetes mellitus-15,IDDM15,3414,NA,NA,"{Diabetes mellitus, insulin-dependent, 15}, 601666 (2)",NA
6,105000000,114200000,6q21,NA,606460,LGV2,Longevity 2,NA,100329168,NA,associated with rs2802292,"[Longevity 2], 606460 (2)",NA
6,105000000,114200000,6q21,NA,601349,"MCOPS8, MMEP","Microphthalmia, syndromic 8",NA,NA,NA,translocation with 13q12,"Microphthalmia, syndromic 8, 601349 (2), ?Autosomal dominant",NA
6,105000000,114200000,6q21,NA,612882,MENAQ2,"Menarche, age at, QTL2",NA,100302562,NA,associated with rs7759938,"{Menarche, age at, QTL2}, 612882 (2)",NA
6,105000000,130000000,6q21-q22,NA,608852,PLF,Pulmonary function,NA,450095,NA,close to D6S281,"{Pulmonary function}, 608852 (2)",NA
6,105096821,105137156,6q21,6q21,604577,"BVES, HBVES, POPDC1, LGMDR25",Blood vessel epicardial substance,BVES,11149,ENSG00000112276,NA,"Muscular dystrophy, limb-girdle, autosomal recessive 25, 616812 (3), Autosomal recessive",Bves (MGI:1346013)
6,105157899,105180013,6q21,6q21,605824,"POPDC3, POP3",Popeye domain-containing protein 3,POPDC3,64208,ENSG00000132429,NA,NA,Popdc3 (MGI:1930153)
6,105273217,105403101,6q22,6q21,600400,PREP,Prolyl endopeptidase,PREP,5550,ENSG00000085377,NA,NA,Prep (MGI:1270863)
6,106046728,106109937,6q21-q22.1,6q21,603423,"PRDM1, BLIMP1",PR domain-containing protein 1 (B-lymphocyte-induced maturation protein 1),PRDM1,639,ENSG00000057657,NA,NA,Prdm1 (MGI:99655)
6,106184475,106325819,6q21,6q21,604261,"ATG5, APG5, APG5L, ASP, SCAR25","Autophagy 5, S. cerevisiae, homolog of",ATG5,9474,ENSG00000057663,mutation identified in one SCAR25 family,"?Spinocerebellar ataxia, autosomal recessive 25, 617584 (3), Autosomal recessive",Atg5 (MGI:1277186)
6,106360807,106570448,6q21,6q21,601797,"AIM1, ST4",Absent in melanoma 1,CRYBG1,202,ENSG00000112297,NA,NA,Crybg1 (MGI:109544)
6,106559236,106630920,6q21,6q21,610502,"RTN4IP1, NIMP, OPA10",Reticulon 4-interacting protein 1,RTN4IP1,84816,ENSG00000130347,NA,"Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3), Autosomal recessive",Rtn4ip1 (MGI:2178759)
6,106629577,106668416,6q21,6q21,617209,"QRSL1, GATA",Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like protein 1,QRSL1,55278,ENSG00000130348,NA,NA,Qrsl1 (MGI:1923813)
6,106969830,106976854,6q21,6q21,600074,CD24,CD24 antigen,CD24,100133941,ENSG00000272398,pseudogenes at 15q21-q22; Yq11,NA,NA
6,107065180,107115514,6q21,6q21,616374,"BEND3, KIAA1553",BEN domain-containing protein 3,BEND3,57673,ENSG00000178409,NA,NA,Bend3 (MGI:2677212)
6,107152556,107459680,6q21,6q21,610564,"PDSS2, DLP1, C6orf210, COQ10D3","Prenyl diphosphate synthase, subunit 2",PDSS2,57107,ENSG00000164494,NA,"Coenzyme Q10 deficiency, primary, 3, 614652 (3), Autosomal recessive",Pdss2 (MGI:1918615)
6,107490103,107661305,6q21,6q21,613667,"SOBP, JXC1, MRAMS","Sine oculis-binding protein, Drosophila, homolog of",SOBP,55084,ENSG00000112320,NA,"Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3), Autosomal recessive",Sobp (MGI:1924427)
6,107867755,107958207,6q21,6q21,608648,"SEC63, PCLD2","Sec63, S. cerevisiae, homolog of",SEC63,11231,ENSG00000025796,NA,"Polycystic liver disease 2, 617004 (3), Autosomal dominant",Sec63 (MGI:2155302)
6,108041408,108074740,6q21,6q21,607649,"OSTM1, GL, OPTB5","Osteopetrosis associated transmembrane protein 1 (grey-lethal, mouse, homolog of)",OSTM1,28962,ENSG00000081087,NA,"Osteopetrosis, autosomal recessive 5, 259720 (3), Autosomal recessive",Ostm1 (MGI:2655574)
6,108166021,108188808,6q21,6q21,603849,"NR2E1, TLX","Nuclear receptor subfamily 2, group E, member 1 (tailless, Drosophila, homolog of)",NR2E1,7101,ENSG00000112333,NA,NA,Nr2e1 (MGI:1100526)
6,108211221,108261039,6q21,6q21,605930,SNX3,Sorting nexin 3,SNX3,8724,ENSG00000112335,t(6;13)(q21;q12),NA,Snx3 (MGI:1860188)
6,108294873,108526000,6q21,6q21,617469,"AFG1L, AFG1, LACE1",AFG1-like ATPase,AFG1L,246269,ENSG00000135537,NA,NA,Afg1l (MGI:2148801)
6,108559824,108684773,6q21,6q21,602681,"FOXO3A, FOXO3, FKHRL1",Forkhead box O3A,FOXO3,2309,ENSG00000118689,NA,NA,Foxo3 (MGI:1890081)
6,108848409,108989089,6q21,6q21,618424,"ARMC2, SPGF38",Armadillo repeat containing 2,ARMC2,84071,ENSG00000118690,NA,"Spermatogenic failure 38, 618433 (3), Autosomal recessive",Armc2 (MGI:1916449)
6,108986436,109094504,6q21,6q21,606103,"SESN1, SEST1, PA26",Sestrin 1,SESN1,27244,ENSG00000080546,NA,NA,Sesn1 (MGI:2155278)
6,109366513,109382811,6q21,6q21,603356,"CD164, DFNA66",CD164 antigen,CD164,8763,ENSG00000135535,mutation identified in 1 DFNA66 family,"?Deafness, autosomal dominant 66, 616969 (3), Autosomal dominant",Cd164 (MGI:1859568)
6,109440720,109443921,6q21,6q21,603498,"SMPD2, NSMASE1",Sphingomyelin phosphodiesterase 2,SMPD2,6610,ENSG00000135587,NA,NA,Smpd2 (MGI:1278330)
6,109444061,109465967,6q16.1,6q21,607129,"MICAL1, NICAL, MICAL","Microtubule-associated monooxygenase, calponin and LIM domains-containing 1",MICAL1,64780,ENSG00000135596,NA,NA,Mical1 (MGI:2385847)
6,109462515,109483236,6q21,6q21,614064,"ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2",Zinc finger- and BTB domain-containing protein 24,ZBTB24,9841,ENSG00000112365,NA,"Immunodeficiency-centromeric instability-facial anomalies syndrome 2, 614069 (3), Autosomal recessive",Zbtb24 (MGI:3039618)
6,109492854,109691211,6q21,6q21,615358,AK9,Adenylate kinase 9,AK9,221264,ENSG00000155085,NA,NA,Ak9 (MGI:2685080)
6,109691220,109825430,6q21,6q21,609390,"FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP","Fig4, S. cerevisiae, homolog of",FIG4,9896,ENSG00000112367,mutation identified in 1 BTOP family,"Amyotrophic lateral sclerosis 11, 612577 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 4J, 611228 (3), Autosomal recessive; ?Polymicrogyria, bilateral temporooccipital, 612691 (3), Autosomal recessive; Yunis-Varon syndrome, 216340 (3), Autosomal recessive",Fig4 (MGI:2143585)
6,109978255,109980719,6q21-q22.1,6q21,600553,GPR6,G protein-coupled receptor-6,GPR6,2830,ENSG00000146360,NA,NA,Gpr6 (MGI:2155249)
6,110099818,110180003,6q21-q22,6q21,605035,"WASF1, WAVE, WAVE1, SCAR1",WAS protein family member 1,WASF1,8936,ENSG00000112290,NA,NA,Wasf1 (MGI:1890563)
6,110180426,110232231,6q22.1,6q21,605585,"CDC40, PRP17","Cell division cycle 40, S. cerevisiae, homolog of",CDC40,51362,ENSG00000168438,NA,NA,Cdc40 (MGI:1918963)
6,110388320,110415574,6q21,6q21,124450,"DDO, DASOX",D-aspartate oxidase,DDO,8528,ENSG00000203797,NA,NA,Ddo (MGI:1925528)
6,110424586,110476673,6q21,6q21,608276,"SLC22A16, FLIPT2, CT2","Solute carrier family 22 (organic cation transporter), member 16",SLC22A16,85413,ENSG00000004809,NA,NA,Slc22a16 (MGI:1918090)
6,110609977,110816530,6q21,6q21,614720,"CDK19, KIAA1028",Cyclin-dependent kinase 19,CDK19,23097,ENSG00000155111,NA,NA,Cdk19 (MGI:1925584)
6,110814620,110895712,6q21-q22,6q21,180980,AMD1,S-adenosylmethionine decarboxylase-1,AMD1,262,ENSG00000123505,pseudogene AMD2 on Xq28,NA,"Amd2,Amd1 (MGI:88004,MGI:1333111)"
6,110958705,110967871,6q21,6q21,611784,"GTF3C6, C6orf51","General transcription factor 3C, polypeptide 6",GTF3C6,112495,ENSG00000155115,NA,NA,Gtf3c6 (MGI:1914621)
6,110982016,111028262,6q21,6q21,618471,"RPF2, BXDC1","Ribosome production factor 2, S. cerevisiae, homolog of",RPF2,84154,ENSG00000197498,NA,NA,Rpf2 (MGI:1914489)
6,111087502,111231193,6q21-q22,6q21,607550,"SLC16A10, TAT1","Solute carrier family 16 (monocarboxylic acid transporter), member 10",SLC16A10,117247,ENSG00000112394,NA,NA,Slc16a10 (MGI:1919722)
6,111259278,111280004,6q21,6q21,617331,"MFSD4B, NAGLT1, Kiaa1919",Major facilitator superfamily domain-containing protein 4B,MFSD4B,91749,ENSG00000173214,NA,NA,Mfsd4b1 (MGI:2143575)
6,111299030,111483714,6q21,6q21,602776,"REV3L, POLZ, REV3","Rev-3, yeast, homolog-like (polymerase, DNA, zeta)",REV3L,5980,ENSG00000009413,NA,NA,Rev3l (MGI:1337131)
6,111555377,111606273,6q21,6q21,607043,"TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8",TRAF3-interacting protein 2,TRAF3IP2,10758,ENSG00000056972,mutation identified in 1 family with CANDF8,"?Candidiasis, familial, 8, 615527 (3), Autosomal recessive; {Psoriasis susceptibility 13}, 614070 (3)",Traf3ip2 (MGI:2143599)
6,111660331,111873451,6q21,6q21,137025,FYN,"FYN oncogene related to SRC, FGR, YES",FYN,2534,ENSG00000010810,proximal 6q21,NA,Fyn (MGI:95602)
6,112052812,112069685,6q22-q23,6q21,603400,"WISP3, PPAC, PPD",Wnt-1 inducible signaling pathway protein 3,CCN6,8838,ENSG00000112761,NA,"Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3), Autosomal recessive; Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3), Autosomal recessive",Ccn6 (MGI:2685581)
6,112070662,112087528,6q21,6q21,607345,"TUBE1, TUBE","Tubulin, epsilon-1",TUBE1,51175,ENSG00000074935,NA,NA,Tube1 (MGI:1919174)
6,112107930,112254721,6q21,6q21,600133,"LAMA4, LAMA3, CMD1JJ","Laminin, alpha-4",LAMA4,3910,ENSG00000112769,NA,"Cardiomyopathy, dilated, 1JJ, 615235 (3), Autosomal dominant",Lama4 (MGI:109321)
6,113857344,113863474,6q22.2,6q21,177061,"MRACKS, MACS, PKCSL","Myristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L)",MARCKS,4082,ENSG00000277443,monomorphic,NA,NA
6,113933027,113971194,6q21,6q21,605164,HDAC2,Histone deacetylase 2,HDAC2,3066,ENSG00000196591,NA,NA,Hdac2 (MGI:1097691)
6,114055585,114342394,6q22.31,6q21-q22,609407,"HS3ST5, 3OST5",Heparan sulfate 3-O-sulfotransferase 5,HS3ST5,222537,ENSG00000249853,NA,NA,Hs3st5 (MGI:2441996)
6,114200000,148500000,6q22-q24,NA,609255,FEB5,"Febrile seizures, familial, 5",FEB5,619398,NA,between D6S1572 and D6S472,"Febrile seizures, familial, 5, 609255 (2), Autosomal dominant",NA
6,114200000,148500000,6q22-q24,NA,606035,FIQTL1,Fasting insulin level quantitative trait locus 1,NA,619503,NA,max lod at D6S1569,"[Fasting insulin level quantitative trait locus 1], 606035 (2)",NA
6,114200000,138300000,6q22-q23,NA,161950,IGAN1,"IgA nephropathy, susceptibility to, 1",NA,60498,NA,NA,"{IgA nephropathy, susceptibility to, 1}, 161950 (2), ?Autosomal dominant",NA
6,114200000,138300000,6q22-q23,NA,604201,SM2,Hepatic fibrosis susceptibility due to Schistosoma mansoni infection,NA,53366,NA,?polymorphism of INFGR1,"{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}, 604201 (2)",NA
6,115931148,116100738,6q21-q22.3,6q22.1,606573,"FRK, RAK, GTK",FYN-related kinase,FRK,2444,ENSG00000111816,NA,NA,Frk (MGI:103265)
6,116118908,116219936,6q21-q22.3,6q22.1,120110,COL10A1,"Collagen X, alpha-1 polypeptide",COL10A1,1300,ENSG00000123500,NA,"Metaphyseal chondrodysplasia, Schmid type, 156500 (3), Autosomal dominant",Col10a1 (MGI:88445)
6,116254170,116444860,6q22,6q22.1,605942,"DSE, SART2, EDSMC2",Dermatan sulfate epimerase,DSE,29940,ENSG00000111817,NA,"Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3), Autosomal recessive",Dse (MGI:2443455)
6,116274858,116280116,6q22-q23,6q22.1,604714,"TSPYL1, TSPYL, SIDDT",Y-encoded testis-specific protein-like,TSPYL1,7259,ENSG00000189241,NA,"Sudden infant death with dysgenesis of the testes syndrome, 608800 (3), Autosomal recessive",Tspyl1 (MGI:1298395)
6,116461374,116463781,6q22.1,6q22.1,617305,"FAM26F, INAM","Family with sequence similarity 26, member F",CALHM6,441168,ENSG00000188820,NA,NA,Calhm6 (MGI:2443082)
6,116494988,116545683,6q22.1,6q22.1,614137,"BET3L, TRAPPC3L","Bet3, S. cerevisiae, homolog-like",TRAPPC3L,100128327,ENSG00000173626,NA,NA,Trappc3l (MGI:3642034)
6,116598183,116633050,6q22.1,6q22.1,612647,"RSPH4A, CILD11","Radial spoke head 4, Chlamydomonas, homolog of, A",RSPH4A,345895,ENSG00000111834,NA,"Ciliary dyskinesia, primary, 11, 612649 (3)",Rsph4a (MGI:3027894)
6,116677642,116741866,6q22.1,6q22.1,604545,KPNA5,Karyopherin alpha-5,KPNA5,3841,ENSG00000196911,NA,NA,NA
6,116877217,116932162,6q22.2,6q22.1,612659,"RFX6, RFXDC1, MTCHRS","Regulatory factor X, 6",RFX6,222546,ENSG00000185002,NA,"Mitchell-Riley syndrome, 615710 (3), Autosomal recessive",Rfx6 (MGI:2445208)
6,117265557,117273564,6q21,6q22.1,609979,"VGLL2, VGL2, VITO1",Vestigial-like 2,VGLL2,245806,ENSG00000170162,NA,NA,Vgll2 (MGI:2447460)
6,117287917,117426064,6q22,6q22.1,165020,"ROS1, MCF3",Avian UR2 sarcoma virus oncogene (v-ros) homolog 1,ROS1,6098,ENSG00000047936,NA,NA,Ros1 (MGI:97999)
6,117560268,117602519,6q21,6q22.1,606845,"GOPC, PIST, FIG, CAL",Golgi-associated PDZ and coiled-coil domains-containing protein,GOPC,57120,ENSG00000047932,NA,NA,Gopc (MGI:2149946)
6,117675468,117710726,6q22.31,6q22.1,610463,"NUS1, NGBR, C6orf68, CDG1AA, MRD55","Nuclear undecaprenyl pyrophosphate synthase 1, S. cerevisiae, homolog of",NUS1,116150,ENSG00000153989,mutation identified in 1 CDG1AA family,"?Congenital disorder of glycosylation, type 1aa, 617082 (3), Autosomal recessive; Mental retardation, autosomal dominant 55, with seizures, 617831 (3), Autosomal dominant",Nus1 (MGI:1196365)
6,118100000,130900000,6q22.3-q23.1,NA,142470,"HBFQTL2, FCP",Fetal hemoglobin quantitative trait locus 2,NA,7954,NA,NA,"Fetal hemoglobin quantitative trait locus 2, 142470 (2), Autosomal dominant",NA
6,118548295,118561715,6q22.1,6q22.31,172405,"PLN, PLB, CMD1P, CMH18",Phospholamban,PLN,5350,ENSG00000198523,NA,"Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, hypertrophic, 18, 613874 (3), Autosomal dominant",NA
6,118813448,118935161,6q22.1-q22.33,6q22.31,610098,"MCM9, MCMDC1, ODG4",Minichromosome maintenance complex component 9,MCM9,254394,ENSG00000111877,NA,"Ovarian dysgenesis 4, 616185 (3), Autosomal recessive",Mcm9 (MGI:1918817)
6,118894151,118909170,6q22.31,6q22.31,609189,"ASF1A, CIA","Anti-silencing function 1, S. cerevisiae, homolog of, A",ASF1A,25842,ENSG00000111875,NA,NA,Asf1a (MGI:1913653)
6,119177203,119350618,6q22,6q22.31,604344,MAN1A1,"Mannosidase, alpha, class 1A, member 1",MAN1A1,4121,ENSG00000111885,NA,NA,Man1a (MGI:104677)
6,121079493,121335383,6q22.31,6q22.31,615867,"TBC1D32, BROMI","TBC1 domain family, member 32",TBC1D32,221322,ENSG00000146350,NA,NA,Tbc1d32 (MGI:2442827)
6,121435645,121449726,5q22.31,6q22.31,121014,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3","Gap junction protein, alpha-1, 43kD (connexin 43)",GJA1,2697,ENSG00000152661,pseudogene on chr.5,"Atrioventricular septal defect 3, 600309 (3), Autosomal dominant; Craniometaphyseal dysplasia, autosomal recessive, 218400 (3), Autosomal recessive; Erythrokeratodermia variabilis et progressiva 3, 617525 (3), Autosomal dominant; Hypoplastic left heart syndrome 1, 241550 (3), Autosomal recessive; Oculodentodigital dysplasia, 164200 (3), Autosomal dominant; Oculodentodigital dysplasia, autosomal recessive, 257850 (3), Autosomal recessive; Palmoplantar keratoderma with congenital alopecia, 104100 (3), Autosomal dominant; Syndactyly, type III, 186100 (3), Autosomal dominant",Gja1 (MGI:95713)
6,122399550,122433118,6q22.3,6q22.31,140581,HSF2,Heat-shock transcription factor 2,HSF2,3298,ENSG00000025156,NA,NA,Hsf2 (MGI:96239)
6,122443350,122471806,6q22.31,6q22.31,614548,"SERINC1, TMS2, KIAA1253",Serine incorporator 1,SERINC1,57515,ENSG00000111897,NA,NA,Serinc1 (MGI:1926228)
6,122471916,122726372,6q22.31,6q22.31,606914,PKIB,"Protein kinase, cAMP-dependent catalytic, inhibitor beta",PKIB,5570,ENSG00000135549,NA,NA,Pkib (MGI:101937)
6,122749200,122784076,6q22-q23,6q22.31,602965,"FABP7, FABPB, BLBP",Fatty acid-binding protein 7,FABP7,2173,ENSG00000164434,NA,NA,Fabp7 (MGI:101916)
6,122788455,122809719,6q22.31,6q22.31,610728,"SMPDL3A, ASML3A","Sphingomyelin phosphodiesterase, acid-like, 3A",SMPDL3A,10924,ENSG00000172594,NA,NA,Smpdl3a (MGI:1931437)
6,122996234,123072924,6q22.31,6q22.31,616945,CLVS2,Clavesin 2,CLVS2,134829,ENSG00000146352,NA,NA,Clvs2 (MGI:2443223)
6,123216338,123637092,6q22-q23,6q22.31,603283,"TRDN, TDN, CPVT5",Triadin,TRDN,10345,ENSG00000186439,NA,"Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3), Autosomal recessive",Trdn (MGI:1924007)
6,123803841,124825651,6q21,6q22.31,609758,"NKAIN2, TCBA",Na+/K+ transporting ATPase interacting 2,NKAIN2,154215,ENSG00000188580,fused with SUSP1 in T-cell lymphoma/leukemia,NA,Nkain2 (MGI:1923447)
6,124908242,124963026,6q23,6q22.31,602532,STL,Six-twelve leukemia gene,RNF217-AS1,7955,ENSG00000236548,NA,NA,NA
6,125153729,125264406,6q22.31,6q22.31,604069,"TPD52L1, D53",Tumor protein D52-like 1,TPD52L1,7164,ENSG00000111907,NA,NA,Tpd52l1 (MGI:1298386)
6,125747638,125762242,6q21,6q22.31,604674,"HEY2, HERP1, GRL",Hairy/enhancer of split-related with YRPW motif 2,HEY2,23493,ENSG00000135547,NA,NA,Hey2 (MGI:1341884)
6,125780942,125932033,6q22.33,6q22.31-q22.32,609752,"NCOA7, ERAP140",Nuclear receptor coactivator 7,NCOA7,135112,ENSG00000111912,NA,NA,Ncoa7 (MGI:2444847)
6,125956769,125980243,6q22.33,6q22.32,609998,HINT3,Histidine triad nucleotide-binding protein 3,HINT3,135114,ENSG00000111911,NA,NA,Hint3 (MGI:1914097)
6,126339695,126483319,6q22.32,6q22.32,611264,"CEMPW, C6orf173, CUG2",Centromeric protein W,CENPW,387103,ENSG00000203760,NA,NA,Cenpw (MGI:1913561)
6,127118670,127199480,6q22.2,6q22.33,610574,"RSPO3, PWTSR, CRISTIN1",R-spondin family member 3,RSPO3,84870,ENSG00000146374,NA,NA,Rspo3 (MGI:1920030)
6,127263414,127289892,6q22.1-q22.33,6q22.33,612137,RNF146,Ring finger protein 146,RNF146,81847,ENSG00000118518,NA,NA,Rnf146 (MGI:1915281)
6,127288711,127344178,6q22.33,6q22.33,612136,ECHDC1,Enoyl coenzyme A hydratase domain-containing protein 1,ECHDC1,55862,ENSG00000093144,NA,NA,Echdc1 (MGI:1277169)
6,127708193,127918630,6q22.33,6q22.33,613607,"THEMIS, GASP, SPOT, C6orf190",Thymocyte-expressed molecule involved in selection,THEMIS,387357,ENSG00000172673,NA,NA,Themis (MGI:2443552)
6,127968784,128520602,6q22.2-q22.3,6q22.33,602545,PTPRK,"Protein-tyrosine phosphatase, receptor type, kappa",PTPRK,5796,ENSG00000152894,NA,NA,Ptprk (MGI:103310)
6,128883137,129516565,6q22-q23,6q22.33,156225,"LAMA2, LAMM, MDC1A","Laminin, alpha-2 (merosin)",LAMA2,3908,ENSG00000196569,NA,"Muscular dystrophy, congenital, merosin deficient or partially deficient, 607855 (3), Autosomal recessive; Muscular dystrophy, limb-girdle, autosomal recessive 23, 618138 (3), Autosomal recessive",Lama2 (MGI:99912)
6,129576131,129710224,6q22-q24,6q22.33,613351,ARHGAP18,RHO GTPase-activating protein 18,ARHGAP18,93663,ENSG00000146376,NA,NA,Arhgap18 (MGI:1921160)
6,130000000,160600000,6q23-q25,NA,607446,BMIQ3,Body mass index quantitative trait locus 3,BMIQ3,337895,NA,max lod at D6S305,"[Body mass index QTL3], 607446 (2)",NA
6,130000000,138300000,6q23,NA,602067,"CMD1F, CDCD3, LGMD1D","Cardiomyopathy, dilated-1F, autosomal dominant",NA,NA,NA,NA,"Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D, 602067 (2)",NA
6,130000000,138300000,6q23,NA,609319,HCHGQ1,Hematocrit/hemoglobin quantitative trait locus 1,NA,100381204,NA,NA,"[Hematocrit/hemoglobin quantitative trait locus 1], 609319 (2)",NA
6,130000000,160600000,6q23-q25,NA,608935,LNCR1,Lung cancer 1,NA,450093,NA,max hlod at D6S2436,"{Lung cancer susceptibility}, 608935 (2)",NA
6,130000000,148500000,6q23-q24,NA,611536,"MAFD6, BPAD",Major affective disorder 6,NA,100188844,NA,NA,"{Major affective disorder 6}, 611536 (2)",NA
6,130000000,148500000,6q23-q24,NA,602154,NTT,Noncoding transcript in T cells,NA,7956,NA,NA,NA,NA
6,130000000,138300000,6q23,NA,180300,RA,"Rheumatoid arthritis, susceptibility to",NA,NA,NA,associated with SNP rs10499194 and rs6920220,"{Rheumatoid arthritis, susceptibility to}, 180300 (2)",NA
6,130000000,138300000,6q23,NA,614494,RP63,Retinitis pigmentosa 63,RP63,100862681,NA,between D6S457 and D6S1656,"Retinitis pigmentosa 63, 614494 (2), Autosomal dominant",NA
6,130000000,138300000,6q23,NA,612378,SLEB13,"Systemic lupus erythematosus, susceptibility to, 13",NA,100196918,NA,associated with rs5029939,"{Systemic lupus erythematosus, susceptibility to, 13}, 612378 (2)",NA
6,130000000,142200000,6q23-q24.1,NA,608220,SPG25,"Spastic paraplegia 25, autosomal recessive, with disc herniation",SPG25,387583,NA,NA,"Spastic paraplegia 25, autosomal recessive, 608220 (2), Autosomal recessive",NA
6,130827954,131063321,6q22-q23,6q23.1-q23.2,603237,EPB41L2,Erythrocyte membrane protein band 4.1-like 2,EPB41L2,2037,ENSG00000079819,NA,NA,Epb41l2 (MGI:103009)
6,131573225,131584328,6q23,6q23.2,608313,ARG1,"Arginase, liver",ARG1,383,ENSG00000118520,NA,"Argininemia, 207800 (3), Autosomal recessive",Arg1 (MGI:88070)
6,131573965,131628241,6q23.2,6q23.2,605042,"MED23, MRT18",Mediator complex subunit 23,MED23,9439,ENSG00000112282,NA,"Mental retardation, autosomal recessive 18, 614249 (3), Autosomal recessive",Med23 (MGI:1917458)
6,131637234,131747412,6q22,6q23.2,602182,"ENPP3, PDNP3",Ectonucleotide pyrophosphatase/phosphodiesterase 3,ENPP3,5169,ENSG00000154269,NA,NA,Enpp3 (MGI:2143702)
6,131808019,131895154,6q22-q23,6q23.2,173335,"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED","Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)",ENPP1,5167,ENSG00000197594,NA,"Arterial calcification, generalized, of infancy, 1, 208000 (3), Autosomal recessive; Cole disease, 615522 (3), Autosomal dominant; {Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant; Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3), Autosomal recessive; {Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Enpp1 (MGI:97370)
6,131948175,131951371,6q23.1,6q23.2,121009,"CTGF, NOV2",Connective tissue growth factor,CCN2,1490,ENSG00000118523,proximal to MYB,NA,Ccn2 (MGI:95537)
6,132296054,132401519,6q23.1-q23.3,6q23.2,609000,"MOXD1, MOX","Monooxygenase, DBH-like, 1",MOXD1,26002,ENSG00000079931,NA,NA,Moxd1 (MGI:1921582)
6,132445866,132513471,6q23.2,6q23.2,603217,STX7,Syntaxin 7,STX7,8417,ENSG00000079950,NA,NA,Stx7 (MGI:1858210)
6,132538287,132539335,6q23.2,6q23.2,608282,"TAR3, TA3",Trace amine receptor 3,TAAR9,134860,ENSG00000237110,NA,NA,Taar9 (MGI:3527454)
6,132552683,132553730,6q23.2,6q23.2,606927,"GPR102, TA5",G protein-coupled receptor 102,TAAR8,83551,ENSG00000146385,NA,NA,"Taar8c,Taar8b,Taar8a (MGI:2685995,MGI:3527452,MGI:2685076)"
6,132570321,132571358,6q23.2,6q23.2,608923,"TAAR6, TRAR4",Trace amine-associated receptor 6,TAAR6,319100,ENSG00000146383,NA,NA,Taar6 (MGI:2685074)
6,132588591,132589737,6q23.2,6q23.2,607405,PNR,Putative neurotransmitter receptor,TAAR5,9038,ENSG00000135569,NA,NA,Taar5 (MGI:2685073)
6,132617149,132624274,6q24,6q23.2,604849,"TAAR2, GPR58",Trace amine-associated receptor 2,TAAR2,9287,ENSG00000146378,NA,NA,Taar2 (MGI:2685071)
6,132644897,132646025,6q23.1,6q23.2,609333,"TAAR1, TA1",Trace amine-associated receptor 1,TAAR1,134864,ENSG00000146399,NA,NA,Taar1 (MGI:2148258)
6,132680848,132714054,6q23-q24,6q23.2,603570,"VNN1, HDLCQ8",Vanin 1,VNN1,8876,ENSG00000112299,NA,[High density lipoprotein cholesterol level QTL 8] (3),Vnn1 (MGI:108395)
6,132722786,132734764,6q23-q24,6q23.2,606592,VNN3,Vanin 3,VNN3,55350,NA,NA,NA,NA
6,132743502,132763488,6q23-q24,6q23.2,603571,VNN2,Vanin 2,VNN2,8875,ENSG00000112303,NA,NA,NA
6,132769369,132798655,6q22.3,6q23.2,613361,C6orf192,Chromosome 6 open reading frame 192,SLC18B1,116843,ENSG00000146409,NA,NA,Slc18b1 (MGI:1923556)
6,132814568,132817563,6q,6q23.2,603660,RPS12,Ribosomal protein S12,RPS12,6206,ENSG00000112306,NA,NA,Rps12 (MGI:98105)
6,133240339,133532127,6q23,6q23.2,603550,"EYA4, DFNA10, CMD1J","Eyes absent, Drosophila, homolog of, 4",EYA4,2070,ENSG00000112319,mutation identified in 1 CMD1J family,"?Cardiomyopathy, dilated, 1J, 605362 (3), Autosomal dominant; Deafness, autosomal dominant 10, 601316 (3), Autosomal dominant",Eya4 (MGI:1337104)
6,133502251,133889005,6q23.2,6q23.2,616058,TARID,TCF21 antisense RNA inducing promoter demethylation,TARID,100507308,ENSG00000227954,NA,NA,NA
6,133889112,133895536,6q23-q24,6q23.2,603306,"TCF21, POD1",Transcription factor-21 (epicardin; podocyte-expressed 1),TCF21,6943,ENSG00000118526,NA,NA,Tcf21 (MGI:1202715)
6,133987580,134052650,6q23.2,6q23.2,610372,"SLC2A12, GLUT12","Solute carrier family 2 (facilitated glucose transporter), member 12",SLC2A12,154091,ENSG00000146411,NA,NA,Slc2a12 (MGI:3052471)
6,134169245,134318111,6q23,6q23.2,602958,SGK1,Serum/glucocorticoid-regulated kinase 1,SGK1,6446,ENSG00000118515,NA,NA,Sgk1 (MGI:1340062)
6,134700000,138300000,6q23.3,NA,614645,MPVQTL5,Mean platelet volume quantitative trait locus 5,NA,100887752,NA,associated with rs9399137,"Mean platelet volume QTL5, 614645 (2)",NA
6,134917392,134950100,6q23.2,6q23.3,606467,"ALDH8A1, ALDH12","Aldehyde dehydrogenase 8 family, member A1",ALDH8A1,64577,ENSG00000118514,NA,NA,Aldh8a1 (MGI:2653900)
6,134960377,135054825,6q24,6q23.3,612450,"HBS1L, KIAA1038, ERFS",HBS1-like protein,HBS1L,10767,ENSG00000112339,NA,NA,Hbs1l (MGI:1891704)
6,135181307,135219172,6q22,6q23.3,189990,MYB,Avian myeloblastosis viral (v-myb) oncogene homolog,MYB,4602,ENSG00000118513,NA,{T-cell acute lymphoblastic leukemia} (3),Myb (MGI:97249)
6,135283531,135497770,6q23.3,6q23.3,608894,AHI1,Abelson helper integration site 1,AHI1,54806,ENSG00000135541,NA,"Joubert syndrome 3, 608629 (3), Autosomal recessive",Ahi1 (MGI:87971)
6,135851700,136195573,6q23.3,6q23.3,604645,PDE7B,"Phosphodiesterase 7B, cAMP-specific, high-affinity",PDE7B,27115,ENSG00000171408,NA,NA,Pde7b (MGI:1352752)
6,136256626,136289850,6q22-q23,6q23.3,612588,"BCLAF1, BTF, KIAA0164",BCL2-associated transcription factor 1,BCLAF1,9774,ENSG00000029363,NA,NA,Bclaf1 (MGI:1917580)
6,136342280,136550818,6q22-q25,6q23.3,604108,"MAP7, EMAP115",Microtubule-associated protein-7,MAP7,9053,ENSG00000135525,NA,NA,Map7 (MGI:1328328)
6,136557045,136793097,6q22.33,6q23.3,602448,"MAP3K5, MEKK5, MAPKKK5, ASK1",Mitogen-activated protein kinase kinase kinase 5,MAP3K5,4217,ENSG00000197442,NA,NA,Map3k5 (MGI:1346876)
6,136821682,136913933,6q23.3,6q23.3,601757,"PEX7, RCDP1, PBD9B",Peroxisomal biogenesis factor-7,PEX7,5191,ENSG00000112357,NA,"Peroxisome biogenesis disorder 9B, 614879 (3), Autosomal recessive; Rhizomelic chondrodysplasia punctata, type 1, 215100 (3), Autosomal recessive",Pex7 (MGI:1321392)
6,136922300,136925659,6q23.3,6q23.3,612519,SLC35D3,"Solute carrier family 35, member D3",SLC35D3,340146,ENSG00000182747,NA,NA,Slc35d3 (MGI:1923407)
6,136999970,137045179,6q23,6q23.3,605620,IL20RA,"Interleukin 20 receptor, alpha",IL20RA,53832,ENSG00000016402,NA,NA,Il20ra (MGI:3605069)
6,137143819,137173643,6q24.1-q24.2,6q23.3,606648,"IL22BP, IL22RA2",Interleukin 22-binding protein,IL22RA2,116379,ENSG00000164485,NA,NA,Il22ra2 (MGI:2665114)
6,137197483,137220350,6q23.3,6q23.3,107470,"IFNGR1, IMD27A, IMD27B","Immune interferon, receptor for",IFNGR1,3459,ENSG00000027697,NA,"{H. pylori infection, susceptibility to}, 600263 (3); {Hepatitis B virus infection, susceptibility to}, 610424 (3); Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3), Autosomal recessive; Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3), Autosomal dominant; {Tuberculosis infection, protection against}, 607948 (3); {Tuberculosis, susceptibility to}, 607948 (3)",Ifngr1 (MGI:107655)
6,137492198,137494393,6q23.3,6q23.3,609323,"OLIG3, BHLHB7",Oligodendrocyte lineage transcription factor 3,OLIG3,167826,ENSG00000177468,NA,NA,Olig3 (MGI:2149955)
6,137823668,137868232,6q23.3,6q23.3,618508,WAKMAR2,Wound- and keratinocyte migration-associated long noncoding RNA 2,WAKMAR2,100130476,ENSG00000237499,partially overlaps TNFAIP on opposite strand,NA,NA
6,137866316,137883311,6q23,6q23.3,191163,"TNFAIP3, A20, OTUD7C, AISBL",Tumor necrosis factor-alpha-induced protein 3,TNFAIP3,7128,ENSG00000118503,NA,"Autoinflammatory syndrome, familial, Behcet-like, 616744 (3), Autosomal dominant",Tnfaip3 (MGI:1196377)
6,138088504,138107418,6q23.3,6q23.3,609301,PERP,p53 effector related to PMP22,PERP,64065,ENSG00000112378,NA,NA,Perp (MGI:1929938)
6,138161689,138344662,6q23.3-q24.1,6q23.3-q24.1,617411,"ARFGEF3, BIG3, KIAA1244",ADP-ribosylation factor guanine nucleotide exchange factor 3,ARFGEF3,57221,ENSG00000112379,NA,NA,Arfgef3 (MGI:106387)
6,138215985,138218489,6q23-q24,6q23.3,605669,"PBOV1, UROC28, UC28",Prostate and breast cancer overexpressed 1,PBOV1,59351,ENSG00000254440,NA,NA,NA
6,138300000,160600000,6q24-q25,NA,612863,"DEL6q24q25, C6DELq25q25",Chromosome 6q24-q25 deletion syndrome,NA,NA,NA,NA,"Chromosome 6q25-q25 deletion syndrome, 612863 (4)",NA
6,138300000,160600000,6q24-q25,NA,606255,STQTL1,Stature quantitative trait locus 1,NA,NA,NA,associated with rs4896582 and rs3748069,"{Stature QTL 1}, 606255 (2)",NA
6,138300000,148500000,6q24,NA,601410,TNDM1,Transient neonatal diabetes mellitus 1,NA,NA,NA,disordered imprinting of PLAGL1 and HYMAI,"{Diabetes mellitus, transient neonatal, 1}, 601410 (4), Autosomal dominant",NA
6,138403530,138422196,6q24,6q24.1,605825,"C6orf34, SOUL","Soul, chicken, homolog of",HEBP2,23593,ENSG00000051620,NA,NA,Hebp2 (MGI:1860084)
6,138773516,138793318,6q24.1,6q24.1,615353,"CCDC28A, C6orf80",Coiled-coil domain-containing 28A,CCDC28A,25901,ENSG00000024862,NA,NA,Ccdc28a (MGI:2443508)
6,138904014,138988260,6q23.1-q24.1,6q24.1,614825,"REPS1, NBIA7",RALBP1-associated EPS domain-containing protein 1,REPS1,85021,ENSG00000135597,mutation identified in 1 NBIA7 family,"?Neurodegeneration with brain iron accumulation 7, 617916 (3), Autosomal recessive",Reps1 (MGI:1196373)
6,139135079,139180801,6q24.1,6q24.1,607977,"HECA, HDC","Headcase, Drosophila, homolog of",HECA,51696,ENSG00000112406,NA,NA,Heca (MGI:2685715)
6,139371806,139374647,6q23.3,6q24.1,602937,"CITED2, MRG1, P35SRJ, VSD2, ASD8","CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2",CITED2,10370,ENSG00000164442,?pseudogene on 1q22,"Atrial septal defect 8, 614433 (3), Autosomal dominant; Ventricular septal defect 2, 614431 (3), Autosomal dominant",Cited2 (MGI:1306784)
6,142074483,142147121,6q21-qter,6q24.1,162341,NMBR,Neuromedin B receptor,NMBR,4829,ENSG00000135577,NA,NA,Nmbr (MGI:1100525)
6,142147161,142224684,6q24.1,6q24.1-q24.2,610902,"C6orf55, SBP1, LIP5, VTA1, DRG1",SKD1-binding protein 1,VTA1,51534,ENSG00000009844,NA,NA,Vta1 (MGI:1913451)
6,142200000,155200000,6q24.2-q25.2,NA,127500,"DUH1, DUH",Dyschromatosis universalis hereditaria 1,NA,NA,NA,max lod at D6S1553,"Dyschromatosis universalis hereditaria 1, 127500 (2), Autosomal dominant",NA
6,142301918,142446265,6q24.1,6q24.2,612243,"ADGRG6, PR126, VIGR, LCCS9",Adhesion G protein-coupled receptor G6,ADGRG6,57211,ENSG00000112414,NA,"Lethal congenital contracture syndrome 9, 616503 (3), Autosomal recessive",Adgrg6 (MGI:1916151)
6,142751468,142945755,6q23-q24,6q24.2,143054,"HIVEP2, MRD43",Human immunodeficiency virus type I enhancer-binding protein-2,HIVEP2,3097,ENSG00000010818,NA,"Mental retardation, autosomal dominant 43, 616977 (3), Autosomal dominant",Hivep2 (MGI:1338076)
6,143422831,143450749,6q24.2,6q24.2,615388,"ADAT2, TAD2","Adenosine deaminase, tRNA-specific, 2",ADAT2,134637,ENSG00000189007,NA,NA,Adat2 (MGI:1914007)
6,143450804,143490615,6q24.2,6q24.2,603164,"PEX3, PBD10A, PBD10B",Peroxisomal biogenesis factor-3,PEX3,8504,ENSG00000034693,mutation identified in 1 PBD10B patient,"Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3), Autosomal recessive; ?Peroxisome biogenesis disorder 10B, 617370 (3), Autosomal recessive",Pex3 (MGI:1929646)
6,143494811,143511719,6q24.2,6q24.2,136820,FUCA2,"Fucosidase, alpha-L- 2, plasma",FUCA2,2519,ENSG00000001036,linked to PLG,NA,Fuca2 (MGI:1914098)
6,143608179,143831184,6q24.2,6q24.2,608724,"PHACTR2, KIAA0680",Phosphatase and actin regulator 2,PHACTR2,9749,ENSG00000112419,NA,NA,Phactr2 (MGI:2446138)
6,143940299,144064598,6q24,6q24.2,603044,"PLAGL1, ZAC, LOT1",Pleomorphic adenoma gene-like 1 (ZAC tumor suppressor),PLAGL1,5325,ENSG00000118495,relaxed imprinting in TNDM,NA,Plagl1 (MGI:1100874)
6,144004915,144008729,6q24,6q24.2,606546,HYMAI,Hydatidiform mole-associated and imprinted transcript,HYMAI,57061,ENSG00000283122,relaxed imprinting in TNDM,NA,NA
6,144094883,144095572,6q24.2,6q24.2,617847,"SF3B5, SF3B10","Splicing factor 3B, subunit 5",SF3B5,83443,ENSG00000169976,NA,NA,Sf3b5 (MGI:1913375)
6,144140043,144191938,6q24,6q24.2,605014,"STX11, FHL4, HPLH4, HLH4",Syntaxin-11,STX11,8676,ENSG00000135604,NA,"Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3), Autosomal recessive",Stx11 (MGI:1921982)
6,144284954,144853033,6q24,6q24.2,128240,"UTRN, DMDL, DRP1",Utrophin (homologous to dystrophin),UTRN,7402,ENSG00000152818,near dy in mouse,NA,Utrn (MGI:104631)
6,145382539,145736022,6q24,6q24.3,607566,"EPM2A, MELF, EPM2",Laforin,EPM2A,7957,ENSG00000112425,NA,"Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3), Autosomal recessive",Epm2a (MGI:1341085)
6,145793501,145864408,6q24,6q24.3,609101,"FBXO30, FBX30",F-box only protein 30,FBXO30,84085,ENSG00000118496,NA,NA,Fbxo30 (MGI:1919115)
6,146027633,146437600,6q24,6q24.3,604473,"GRM1, MGLUR1, GRM1A, SCAR13, SCA44","Glutamate receptor, metabotropic, 1",GRM1,2911,ENSG00000152822,NA,"Spinocerebellar ataxia 44, 617691 (3), Autosomal dominant; Spinocerebellar ataxia, autosomal recessive 13, 614831 (3), Autosomal recessive",Grm1 (MGI:1351338)
6,146543832,146554952,6q24.3,6q24.3,612906,RAB32,Ras-associated protein RAB32,RAB32,10981,ENSG00000118508,NA,NA,Rab32 (MGI:1915094)
6,146598971,146815461,6q24.3,6q24.3,614630,ADGB,Androglobin,ADGB,79747,ENSG00000118492,NA,NA,Adgb (MGI:3605549)
6,147204183,147390475,6q24.3,6q24.3,604586,STXBP5,Syntaxin-binding protein 5 (tomosyn),STXBP5,134957,ENSG00000164506,NA,NA,Stxbp5 (MGI:1926058)
6,148193439,148552049,6q24.3,6q24.3-q25.1,607955,"SASH1, KIAA0790, CAPOK, DUH1",Sterile alpha motifs- and SH3 domain-containing protein 1,SASH1,23328,ENSG00000111961,mutation identified in 1 CAPOK family,"?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma, 618373 (3), Autosomal recessive; Dyschromatosis universalis hereditaria 1, 127500 (3), Autosomal dominant",Sash1 (MGI:1917347)
6,148500000,160600000,6q25,NA,612114,BMND11,Bone mineral density quantitative trait locus 11,NA,100188884,NA,"associated with rs4870044, rs1038304, and rs1999805","[Bone mineral density QTL 11], 612114 (2)",NA
6,148500000,160600000,6q25,NA,612521,IDDM21,"Diabetes mellitus, insulin-dependent, 21",NA,NA,NA,associated with rs1738074,"{Diabetes mellitus, insulin-dependent, 21}, 612521 (2)",NA
6,148500000,170805979,6q25-q27,NA,600883,IDDM8,Insulin-dependent diabetes mellitus-8,IDDM8,3407,NA,NA,"{Diabetes mellitus, insulin-dependent, 8}, 600883 (2)",NA
6,148500000,160600000,6q25,NA,607572,LPRS2,"Leprosy, susceptibility to, 2",NA,NA,NA,association with PARK2,"{Leprosy, susceptibility to, 2}, 607572 (2)",NA
6,148500000,164100000,6q25-q26,NA,180020,RCD1,Retinal cone dystrophy-1,RCD1,5953,NA,NA,"?Retinal cone dystrophy-1, 180020 (2), Autosomal dominant",NA
6,148745890,149076989,6q25.1,6q25.1,610752,UST,Uronyl 2-sulfotransferase,UST,10090,ENSG00000111962,NA,NA,Ust (MGI:2442406)
6,149217923,149411612,6q25,6q25.1,605101,"TAB2, MAP3K7IP2, KIAA0733, CHTD2",Tak1 (MAP3K7) binding protein 2,TAB2,23118,ENSG00000055208,NA,"Congenital heart defects, nonsyndromic, 2, 614980 (3), Autosomal dominant",Tab2 (MGI:1915902)
6,149400261,149401277,6q25,6q25.1,608829,"SUMO4, IDDM5",Small ubiquitin-like modifier 4,SUMO4,387082,ENSG00000177688,NA,"{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)",NA
6,149446794,149485013,6q25.1,6q25.1,611106,"ZC3H12D, p34, C6orf95",Zinc finger CCCH domain-containing protein 12D,ZC3H12D,340152,ENSG00000178199,NA,NA,Zc3h12d (MGI:3045313)
6,149504494,149546042,6q24-q25,6q25.1,607609,PPIL4,Peptidyl-prolyl isomerase-like 4,PPIL4,85313,ENSG00000131013,NA,NA,Ppil4 (MGI:1914668)
6,149594872,149649017,6q25.1,6q25.1,606696,KATNA1,"Katanin, p60 subunit, A1",KATNA1,11104,ENSG00000186625,NA,NA,Katna1 (MGI:1344353)
6,149658152,149718255,6q25.1,6q25.1,603473,LATS1,"Large tumor suppressor, Drosophila, homolog of, 1",LATS1,9113,ENSG00000131023,NA,NA,Lats1 (MGI:1333883)
6,149724314,149746571,6q24.3,6q25.1,608141,NUP43,"Nucleoporin, 43kD",NUP43,348995,ENSG00000120253,NA,NA,Nup43 (MGI:1917162)
6,149749694,149811420,6q22.3-q24,6q25.1,176851,PCMT1,Protein-L-isoaspartate (D-aspartate) O-methyltransferase,PCMT1,5110,ENSG00000120265,NA,NA,NA
6,149941946,149949234,6q25,6q25.1,605698,ULBP2,UL16-binding protein 2,ULBP2,80328,ENSG00000131015,NA,NA,NA
6,149963942,149973714,6q25,6q25.1,605697,ULBP1,UL16-binding protein 1,ULBP1,80329,ENSG00000111981,NA,NA,Ulbp1 (MGI:1925027)
6,150018333,150025531,6q24.2-q25.3,6q25.1,611047,RAET1L,Retinoic acid early transcript 1L,RAET1L,154064,ENSG00000155918,NA,NA,NA
6,150061052,150069120,6q25,6q25.1,605699,ULBP3,UL16-binding protein 3,ULBP3,79465,ENSG00000131019,NA,NA,NA
6,150143043,150250391,6q24.3-q25.3,6q25.1,613242,"PPP1R14C, KEPI","Protein phosphatase 1, regulatory subunit 14C",PPP1R14C,81706,ENSG00000198729,NA,NA,Ppp1r14c (MGI:1923392)
6,150368853,150405968,6q24-q25,6q25.1,612025,"IYD, DEHAL1, TDH4",Iodotyrosine deiodinase,IYD,389434,ENSG00000009765,NA,"Thyroid dyshormonogenesis 4, 274800 (3), Autosomal recessive",Iyd (MGI:1917587)
6,150865678,151101886,6q25.2,6q25.1,611427,"MTHFD1L, MTC1THFS","Methylenetetrahydrofolate dehydrogenase 1-like, NADP(+)-dependent",MTHFD1L,25902,ENSG00000120254,NA,NA,Mthfd1l (MGI:1924836)
6,151364114,151391704,6q25.1,6q25.1,616595,"ZBTB2, ZNF437, KIAA1483",Zinc finger- and BTB domain-containing protein 2,ZBTB2,57621,ENSG00000181472,NA,NA,Zbtb2 (MGI:2685949)
6,151404547,151452180,6q25,6q25.1,614917,"RMND1, COXPD11","Required for meiotic nuclear division 1, S. cerevisiae, homolog of",RMND1,55005,ENSG00000155906,NA,"Combined oxidative phosphorylation deficiency 11, 614922 (3), Autosomal recessive",Rmnd1 (MGI:1913334)
6,151452257,151470100,6q25.1,6q25.1,616332,"ARMT1, C6orf211",Acidic residue methyltransferase 1,ARMT1,79624,ENSG00000146476,NA,NA,Armt1 (MGI:1920669)
6,151654147,152129618,6q25.1,6q25.1-q25.2,133430,"ESR1, ESR, ESTRR",Estrogen receptor 1,ESR1,2099,ENSG00000091831,NA,"{Atherosclerosis, susceptibility to} (3); Breast cancer, somatic, 114480 (3); Estrogen resistance, 615363 (3), Autosomal recessive; {HDL response to hormone replacement, augmented} (3); {Migraine, susceptibility to}, 157300 (3), Autosomal dominant; {Myocardial infarction, susceptibility to}, 608446 (3)",Esr1 (MGI:1352467)
6,152121683,152637394,6q25,6q25.2,608441,"SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMCM",Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1),SYNE1,23345,ENSG00000131018,NA,"Arthrogryposis multiplex congenita, myogenic type, 618484 (3); Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3), Autosomal dominant; Spinocerebellar ataxia, autosomal recessive 8, 610743 (3), Autosomal recessive",Syne1 (MGI:1927152)
6,152697894,152747174,6q25,6q25.2,616805,"MYCT1, MTLC",MYC target in myeloid cells 1,MYCT1,80177,ENSG00000120279,NA,NA,Myct1 (MGI:1915882)
6,152750796,152759764,6q26-q27,6q25.2,192320,VIP,Vasoactive intestinal peptide,VIP,7432,ENSG00000146469,NA,NA,Vip (MGI:98933)
6,152970534,152983578,6q25-q26,6q25.2,606013,"FBXO5, FBX5, EMI1",F-box only protein 5,FBXO5,26271,ENSG00000112029,NA,NA,Fbxo5 (MGI:1914391)
6,154010495,154246866,6q24-q25,6q25.2,600018,OPRM1,"Opioid receptor, mu-1",OPRM1,4988,ENSG00000112038,NA,NA,Oprm1 (MGI:97441)
6,154387514,154510684,6q25.2,6q25.2,617476,"CNKSR3, CNK3","CNKSR family, member 3",CNKSR3,154043,ENSG00000153721,NA,NA,Cnksr3 (MGI:2674130)
6,154733377,154834243,6q25.2,6q25.2,616024,"SCAF8, KIAA1116",SR-related C-terminal domain-associated factor 8,SCAF8,22828,ENSG00000213079,NA,NA,Scaf8 (MGI:1925212)
6,155090288,155257722,6q25.2-q25.3,6q25.2-q25.3,604709,TIAM2,T-cell lymphoma invasion and metastasis 2,TIAM2,26230,ENSG00000146426,NA,NA,Tiam2 (MGI:1344338)
6,155200000,160600000,6q25.3,NA,612010,CELIAC12,"Celiac disease, susceptibility to, 12",NA,100188874,NA,in LD block containing TAGAP,"{Celiac disease, susceptibility to, 12}, 612010 (2)",NA
6,155229870,155314496,6q25,6q25.3,607033,"TFB1M, CGI75","Transcription factor B1, mitochondrial",TFB1M,51106,ENSG00000029639,NA,NA,Tfb1m (MGI:2146851)
6,155395367,155455838,6q25.1,6q25.3,607105,NOX3,NADPH oxidase 3,NOX3,50508,ENSG00000074771,NA,NA,Nox3 (MGI:2681162)
6,156777846,157210778,6q25.1,6q25.3,614556,"ARID1B, BAF250B, KIAA1235, MRD12, CSS1",AT-rich interaction domain-containing protein 1B,ARID1B,57492,ENSG00000049618,NA,"Coffin-Siris syndrome 1, 135900 (3), Autosomal dominant",Arid1b (MGI:1926129)
6,157716045,157945076,6q26.3,6q25.3,605952,"SNX9, SH3PX1",Sorting nexin 9,SNX9,51429,ENSG00000130340,NA,NA,Snx9 (MGI:1913866)
6,157981855,158099175,6q25.3,6q25.3,609410,"SYNJ2, KIAA0348",Synaptojanin 2,SYNJ2,8871,ENSG00000078269,NA,NA,Synj2 (MGI:1201671)
6,158109514,158168279,6q25.3,6q25.3,614725,"SERAC1, MEGDEL",Serine active site-containing protein 1,SERAC1,84947,ENSG00000122335,NA,"3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3), Autosomal recessive",Serac1 (MGI:2447813)
6,158168315,158199343,6q25.3,6q25.3,608780,"GTF2H5, TTD3, TFB5, C6orf175, TTDA","General transcription factor IIH, polypeptide 5",GTF2H5,404672,ENSG00000272047,NA,"Trichothiodystrophy 3, photosensitive, 616395 (3)",Gtf2h5 (MGI:107227)
6,158536431,158635434,6q25.3,6q25.3,613209,"TMEM181, GPR178, KIAA1423",Transmembrane protein 181,TMEM181,57583,ENSG00000146433,NA,NA,Tmem181a (MGI:1924356)
6,158636473,158644742,6q25.2-q25.3,6q25.3,601554,TCTEL1,T-complex-associated-testis-expressed 1-like 1,DYNLT1,6993,ENSG00000146425,NA,NA,"Dynlt1c,Dynlt1b,Dynlt1a,Dynlt1f (MGI:3807476,MGI:3780996,MGI:98643,MGI:3807506)"
6,158765743,158819367,6q25.3,6q25.3,123900,"EZR, VIL2, CVL",Ezrin,EZR,7430,ENSG00000092820,coamplified with MYB,NA,Ezr (MGI:98931)
6,158947011,159000425,6q25.3,6q25.3,615876,"RSPH3, RSHL2, RSP3, CILD32","Radial spoke head 3, Chlamydomonas, homolog of",RSPH3,83861,ENSG00000130363,NA,"Ciliary dyskinesia, primary, 32, 616481 (3), Autosomal recessive","Rsph3a,Rsph3b (MGI:1914082,MGI:3630308)"
6,159034467,159045151,6q25.3,6q25.3,609667,TAGAP,T-cell activation GTPase-activating protein,TAGAP,117289,ENSG00000164691,NA,NA,Tagap (MGI:3615484)
6,159169399,159272107,6q25,6q25.3,609991,"FNDC1, AGS8, KIAA1866",Fibronectin type III domain-containing protein 1,FNDC1,84624,ENSG00000164694,NA,NA,NA
6,159669068,159762280,6q25.3,6q25.3,147460,"SOD2, MNSOD, MVCD6","Superoxide dismutase-2, mitochondrial",SOD2,6648,ENSG00000112096,NA,"{Microvascular complications of diabetes 6}, 612634 (3)",Sod2 (MGI:98352)
6,159726695,159756318,6q25.3,6q25.3,605442,WTAP,Wilms tumor 1-associating protein,WTAP,9589,ENSG00000146457,NA,NA,Wtap (MGI:1926395)
6,159762044,159779111,6q25.3-q26,6q25.3,100678,ACAT2,Acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase),ACAT2,39,ENSG00000120437,encoded on strand opposite TCP1,"?ACAT2 deficiency, 614055 (1), Isolated cases","Acat3,Acat2 (MGI:109182,MGI:87871)"
6,159778497,159789702,6q25.3-q26,6q25.3,186980,TCP1,T-complex locus TCP-1,TCP1,6950,ENSG00000120438,tightly linked to PLG; ~15cM proximal to TCP10; overlap with ACAT2,NA,Tcp1 (MGI:98535)
6,159789811,159798428,6q25.3,6q25.3,611831,MRPL18,Mitochondrial ribosomal protein L18,MRPL18,29074,ENSG00000112110,NA,NA,Mrpl18 (MGI:1914931)
6,159890987,159909001,6q24-q27,6q25.3,165180,MAS1,Oncogene MAS1,MAS1,4142,ENSG00000130368,NA,NA,Mas1 (MGI:96918)
6,159969098,160111503,6q26,6q25.3,147280,"IGF2R, MPRI","Insulin-like growth factor-2 receptor (mannose-6-phosphate receptor, cation-independent)",IGF2R,3482,ENSG00000197081,behaves as a tumor suppressor,"Hepatocellular carcinoma, somatic, 114550 (3)",Igf2r (MGI:96435)
6,160003290,160007663,6q26,6q25.3,604893,"AIRN, AIR","Antisense IGF2R RNA, noncoding",AIRN,100271873,ENSG00000268257,NA,NA,NA
6,160121807,160160589,6q26,6q25.3,602607,"SLC22A1, OCT1","Solute carrier family 22 (organic cation transporter), member 1",SLC22A1,6580,ENSG00000175003,NA,NA,Slc22a1 (MGI:108111)
6,160216754,160258820,6q26,6q25.3,602608,"SLC22A2, OCT2","Solute carrier family 22 (organic cation transporter), member 2",SLC22A2,6582,ENSG00000112499,NA,NA,Slc22a2 (MGI:1335072)
6,160348377,160454981,6q27,6q25.3,604842,"SLC22A3, EMT","Solute carrier family 22 (extraneuronal monoamine transporter), member 3",SLC22A3,6581,ENSG00000146477,NA,NA,Slc22a3 (MGI:1333817)
6,160466554,160511123,6q26-q27,6q25.3,611682,"LPAL2, APOARGC",Lipoprotein(a)-like 2,LPAL2,80350,ENSG00000213071,NA,NA,NA
6,160531482,160664258,6q27,6q25-q26,152200,LPA,Apolipoprotein Lp(a),LPA,4018,ENSG00000198670,absent in mice,"{Coronary artery disease, susceptibility to} (1); [LPA deficiency, congenital] (3)",NA
6,160600000,170805979,6q26-q27,NA,608219,DFNB38,"Deafness, autosomal recessive 38",DFNB38,337991,NA,NA,"Deafness, autosomal recessive 38, 608219 (2), Autosomal recessive",NA
6,160600000,170805979,6q26-q27,NA,614347,MRT28,"Mental retardation, autosomal recessive 28",MRT28,100852396,NA,between rs6935718 and rs3886091,"Mental retardation, autosomal recessive 28, 614347 (2), Autosomal recessive",NA
6,160702192,160754053,6q26,6q26,173350,PLG,Plasminogen,PLG,5340,ENSG00000122194,20cM from TCP10A,"Dysplasminogenemia, 217090 (3), Autosomal recessive; Plasminogen deficiency, type I, 217090 (3), Autosomal recessive",Plg (MGI:97620)
6,160991520,161117384,6q26,6q26,602425,"MAP3K4, MEKK4, MTK1, MAPKKK4",Mitogen-activated protein kinase kinase kinase 4,MAP3K4,4216,ENSG00000085511,NA,NA,Map3k4 (MGI:1346875)
6,161129966,161274107,6q26,6q26,614795,AGPAT4,1-acylglycerol-3-phosphate O-acyltransferase 4,AGPAT4,56895,ENSG00000026652,NA,NA,Agpat4 (MGI:1915512)
6,161347416,162727801,6q25.2-q27,6q26,602544,"PRKN, PARK2, PDJ",Parkin,PRKN,5071,ENSG00000185345,shares 5' regulatory region and both 3' UTRs with PACRG,"Adenocarcinoma of lung, somatic, 211980 (3); Ovarian cancer, somatic, 167000 (3); Parkinson disease, juvenile, type 2, 600116 (3), Autosomal recessive",Prkn (MGI:1355296)
6,162726869,163315491,6q25-q27,6q26,608427,PACRG,Parkin coregulated gene,PACRG,135138,ENSG00000112530,shares 5' regulatory region and both 3' UTRs with PARK2,NA,Pacrg (MGI:1916560)
6,163413064,163413949,6q26,6q26,615930,"CAHM, LINC00468","Colorectal adenocarcinoma hypermethylated gene, noncoding",CAHM,100526820,ENSG00000270419,NA,NA,NA
6,163414485,163578591,6q26,6q26,609590,"QKI, QK1","Quaking, mouse, homolog of",QKI,9444,ENSG00000112531,NA,NA,Qk (MGI:97837)
6,164100000,170805979,6q27,NA,215400,CHDM,Chordoma,NA,NA,NA,associated with duplication of the T gene,"{Chordoma, susceptibility to}, 215400 (4), Autosomal dominant",NA
6,164100000,170805979,6q27,NA,616837,HPAT5,"Human pluripotency-associated transcript 5, noncoding",NA,NA,NA,NA,NA,NA
6,164100000,170805979,6q27,NA,611382,KAZA3,"Kala-azar, susceptibility to, 3",NA,101241899,NA,NA,"{Kala-azar, susceptibility to, 3}, 611382 (2)",NA
6,165327286,165988114,6q27,6q27,610652,"PDE10A, IOLOD, ADSD2",Phosphodiesterase 10A,PDE10A,10846,ENSG00000112541,NA,"Dyskinesia, limb and orofacial, infantile-onset, 616921 (3), Autosomal recessive; Striatal degeneration, autosomal dominant, 616922 (3), Autosomal dominant",Pde10a (MGI:1345143)
6,166157641,166168668,6q27,6q27,601397,"TBXT, T, TFT, SAVA",T-box transcription factor T,TBXT,6862,ENSG00000164458,NA,"{Neural tube defects, susceptibility to}, 182940 (3), Autosomal dominant; Sacral agenesis with vertebral anomalies, 615709 (3), Autosomal recessive",T (MGI:98472)
6,166364918,166383012,6q27,6q27,614738,"BRP44L, MPC1, MPYCD",Brain protein 44-like,MPC1,51660,ENSG00000060762,NA,"Mitochondrial pyruvate carrier deficiency, 614741 (3), Autosomal recessive",Mpc1 (MGI:1915240)
6,166409363,166862524,6q27,6q27,601685,"RPS6KA2, RSK3","Ribosomal protein S6 kinase, 90kD, 2",RPS6KA2,6196,ENSG00000071242,NA,NA,Rps6ka2 (MGI:1342290)
6,166922112,166956579,6q27,6q27,612944,"RNASET2, RNASE6PL",Ribonuclease T2,RNASET2,8635,ENSG00000026297,NA,"Leukoencephalopathy, cystic, without megalencephaly, 612951 (3), Autosomal recessive","Rnaset2a,Rnaset2b (MGI:3702087,MGI:1915445)"
6,166999316,167052717,6q27,6q27,605392,"FGFR1OP, FOP",Fibroblast growth factor receptor-1 oncogene partner,FGFR1OP,11116,ENSG00000213066,"fusion gene with ZNF198, CEP1, and FGFR1","Myeloproliferative disorder, 605392 (2)",Fgfr1op (MGI:1922546)
6,167111806,167139140,6q27,6q27,601835,"CCR6, CMKBR6, CKRL3, GPR29, GPRCY4",Chemokine (C-C) receptor 6,CCR6,1235,ENSG00000112486,NA,NA,Ccr6 (MGI:1333797)
6,167156871,167157830,6q27,6q27,602043,GPR31,G protein-coupled receptor-31,GPR31,2853,ENSG00000120436,NA,NA,Gpr31b (MGI:1354372)
6,167269031,167316013,6q27,6q27,607995,UNC93A,"UNC93, C. elegans, homolog of, A",UNC93A,54346,ENSG00000112494,NA,NA,"Unc93a2,Unc93a (MGI:1933250,MGI:3712668)"
6,167373089,167384509,6q27,6q27,187020,TCP10,T-complex 10 (a murine tcp homolog),TCP10,6953,NA,NA,NA,NA
6,167826563,167972022,6q27,6q27,159559,"AFDN, MLLT4, AF6",Afadin,AFDN,4301,ENSG00000130396,NA,NA,Afdn (MGI:1314653)
6,167999091,168045106,6q27,6q27,603815,"KIF25, KNSL3",Kinesin family member 25,KIF25,3834,ENSG00000125337,NA,NA,NA
6,168292829,168319776,6q27,6q27,608966,"DACT2, DPR2, DAPPER2","Dapper, antagonist of beta-catenin, 2",DACT2,168002,ENSG00000164488,NA,NA,Dact2 (MGI:1920347)
6,168441152,168667991,6q27,6q27,607223,"SMOC2, SMAP2, DTDP1",Secreted modular calcium-binding protein 2,SMOC2,64094,ENSG00000112562,NA,"Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3), Autosomal recessive",Smoc2 (MGI:1929881)
6,169215779,169254113,6q27,6q27,188061,THBS2,Thrombospondin 2,THBS2,7058,ENSG00000186340,NA,"{Lumbar disc herniation, susceptibility to}, 603932 (3)",Thbs2 (MGI:98738)
6,169702111,169706359,6q27,6q27,616987,C6orf120,Chromosome 6 open reading frame 120,C6orf120,387263,ENSG00000185127,NA,NA,1600012H06Rik (MGI:1915162)
6,169703901,169724499,6q26,6q27,613069,"PHF10, BAF45A",PHD finger protein 10,PHF10,55274,ENSG00000130024,NA,NA,Phf10 (MGI:1919307)
6,169725487,169751580,6q27,6q27,186977,TCTE3,T-complex-associated-testis-expressed-3,TCTE3,6991,ENSG00000184786,NA,NA,"Gm3448,Gm3417,Tcte3 (MGI:3809205,MGI:98642,MGI:3781595)"
6,169751621,169781599,6q27,6q27,615532,"ERMARD, C6orf70, PVNH6",Endoplasmic reticulum membrane-associated RNA degradation protein,ERMARD,55780,ENSG00000130023,NA,"?Periventricular nodular heterotopia 6, 615544 (3), Autosomal dominant",Ermard (MGI:1917317)
6,170282199,170291077,6q27,6q27,606582,"DLL1, DELTA1",Delta-like 1,DLL1,28514,ENSG00000198719,NA,NA,Dll1 (MGI:104659)
6,170290702,170407747,6q26-q27,6q27,612266,"FAM120B, PGCC1, CCPG, KIAA1838","Family with sequence similarity 120, member B",FAM120B,84498,ENSG00000112584,NA,NA,Fam120b (MGI:1914794)
6,170535119,170553306,6q27,6q27,602017,PSMB1,"Proteasome subunit, beta type, 1",PSMB1,5689,ENSG00000008018,incorrectly assigned to 7p,NA,Psmb1 (MGI:104884)
6,170554332,170572869,6q27,6q27,600075,"TBP, SCA17, HDL4",TATA box binding protein,TBP,6908,ENSG00000112592,NA,"{Parkinson disease, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial; Spinocerebellar ataxia 17, 607136 (3), Autosomal dominant",Tbp (MGI:101838)
6,170575294,170584691,6q27,6q27,600866,PDCD2,Programmed cell death 2,PDCD2,5134,ENSG00000071994,NA,NA,Pdcd2 (MGI:104643)
6,0,170805979,Chr.6,NA,109180,BEVI,Baboon M7 virus replication,NA,628,NA,NA,NA,NA
6,0,170805979,Chr.6,NA,137010,FEA,F9 embryonic antigen,NA,7959,NA,NA,NA,NA
6,0,170805979,Chr.6,NA,153435,"LAKLG, LAKL",Lymphokine-activated killer cell ligand,LAKLG,3905,NA,NA,NA,NA
6,0,170805979,Chr.6,NA,158050,MRBC,Monkey RBC receptor,NA,7960,NA,NA,NA,NA
6,0,170805979,Chr.6,NA,187330,TS546,"Temperature sensitivity complementation, cell cycle specific, ts546 cells",NA,7963,NA,NA,NA,NA
7,0,43300000,7p22-p14,NA,614021,CPVT3,"Ventricular tachycardia, catecholaminergic polymorphic, 3",NA,NA,NA,between D7S526 and D7S481,"Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (2), Autosomal recessive",NA
7,0,7200000,7p22,NA,605626,ERVK-6,"Endogenous retroviral group K, member 6",ERVK-6,64006,NA,NA,NA,NA
7,0,13700000,7p22.3-p21.3,NA,614238,HYPT10,Hypotrichosis 10,NA,100736251,NA,between D7S1532 and D7S3047,"Hypotrichosis 10, 614238 (2), Autosomal recessive",NA
7,192570,260771,7p22,7p22.3,611061,"FAM20C, DMP4","Family with sequence similarity 20, member C",FAM20C,56975,ENSG00000177706,NA,"Raine syndrome, 259775 (3), Autosomal recessive",Fam20c (MGI:2136853)
7,497244,520667,7p22,7p22.3,173430,PDGFA,"Platelet-derived growth factor, alpha polypeptide",PDGFA,5154,ENSG00000197461,NA,NA,Pdgfa (MGI:97527)
7,549184,727675,7pter-p22,7p22.3,176911,PRKAR1B,"Protein kinase, cAMP-dependent, regulatory, type I, beta",PRKAR1B,5575,ENSG00000188191,NA,NA,Prkar1b (MGI:97759)
7,726691,786478,7p22.3,7p22.3,614864,"DNAAF5, HEATR2, CILD18",Dynein axonemal assembly factor 5,DNAAF5,54919,ENSG00000164818,NA,"Ciliary dyskinesia, primary, 18, 614874 (3), Autosomal recessive",Dnaaf5 (MGI:3616079)
7,815556,874933,7p22.3,7p22.3,607723,"UNC84A, KIAA0810, SUN1","UNC84, C. elegans, homolog of, A",SUN1,23353,ENSG00000164828,NA,NA,Sun1 (MGI:1924303)
7,876553,896435,7p22.3,7p22.3,612056,"GET4, C7orf20, CEE","Golgi to ER traffic protein 4, S. cerevisiae, homolog of",GET4,51608,ENSG00000239857,NA,NA,Get4 (MGI:1914854)
7,897899,955406,7p22.3,7p22.3,608114,CENTA1,"Centaurin, alpha-1",ADAP1,11033,ENSG00000105963,NA,NA,Adap1 (MGI:2442201)
7,964851,975548,7p22.3,7p22.3,610429,COX19,Cytochrome c oxidase assembly protein Cox19,COX19,90639,ENSG00000240230,NA,NA,Cox19 (MGI:1915283)
7,983154,989639,7p22.3,7p22.3,615967,CYP2W1,"Cytochrome P450, family 2, subfamily W, polypeptide 1",CYP2W1,54905,ENSG00000073067,NA,NA,Cyp2w1 (MGI:3616076)
7,1022932,1023025,7p22.3,7p22.3,615977,MIR339,Micro RNA 339,MIR339,442907,ENSG00000199023,NA,NA,NA
7,1086806,1093814,7p22,7p22.3,601805,"GPER, CMKRL2, GPR30",G protein-coupled estrogen receptor 1,GPER1,2852,ENSG00000164850,NA,NA,Gper1 (MGI:1924104)
7,1148849,1160195,7p22.3,7p22.3,610699,"ZFAND2A, AIRAP",Zinc finger AN1 domain-containing protein 2A,ZFAND2A,90637,ENSG00000178381,NA,NA,Zfand2a (MGI:2140729)
7,1470276,1504388,7p22.3,7p22.3,611345,"INTS1, INT1, KIAA1440",Integrator complex subunit 1,INTS1,26173,ENSG00000164880,NA,NA,Ints1 (MGI:1915760)
7,1530701,1543042,7p22,7p22.3,600197,"MAFK, NFE2U","V-maf avian musculoaponeurotic fibrosarcoma oncogene family, protein K (nuclear factor erythroid 2, ubiquitous subunit)",MAFK,7975,ENSG00000198517,NA,NA,Mafk (MGI:99951)
7,1567331,1570489,7p22.3,7p22.3,617528,"PSMG3, PAC3",Proteasome assembly chaperone 3,PSMG3,84262,ENSG00000157778,NA,NA,Psmg3 (MGI:1913756)
7,1666074,1747953,7p22.3,7p22.3,614964,"ELFN1, PPP1R28",Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1,ELFN1,392617,ENSG00000225968,NA,NA,Elfn1 (MGI:2442479)
7,1815794,2232944,7p22,7p22.3,602686,"MAD1L1, TXBP181","Mitotic arrest-deficient 1, yeast, homolog-like 1",MAD1L1,8379,ENSG00000002822,NA,"Lymphoma, somatic (3); Prostate cancer, somatic, 176807 (3)",Mad1l1 (MGI:1341857)
7,2234221,2242204,7p22,7p22.3,606906,"MRM2, FTSJ2, FJH1",Mitochondrial ribosomal RNA methyltransferase 2,MRM2,29960,ENSG00000122687,NA,NA,Mrm2 (MGI:1915267)
7,2242221,2251144,7p22,7p22.3,600312,"NUDT1, MTH1",Nudix-type motif 1,NUDT1,4521,ENSG00000106268,NA,NA,Nudt1 (MGI:109280)
7,2251769,2354476,7p22.3,7p22.3,614905,SNX8,Sorting nexin 8,SNX8,29886,ENSG00000106266,NA,NA,Snx8 (MGI:2443816)
7,2354085,2380744,7p22.2,7p22.3,603917,"EIF3B, EIF3S9, PRT1","Eukaryotic translation initiation factor 3, subunit B",EIF3B,8662,ENSG00000106263,NA,NA,Eif3b (MGI:106478)
7,2403488,2448483,7p22,7p22.3,610129,"CHST12, C4ST2",Carbohydrate sulfotransferase 12,CHST12,55501,ENSG00000136213,NA,NA,Chst12 (MGI:1929064)
7,2512528,2529176,7p22,7p22.3,602576,"LFNG, SCDO3",Lunatic fringe,LFNG,3955,ENSG00000106003,NA,"Spondylocostal dysostosis 3, autosomal recessive, 609813 (3), Autosomal recessive",Lfng (MGI:1095413)
7,2537809,2555757,7p22.3,7p22.3,614506,"BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS",BRCA1-associated ATM activator 1,BRAT1,221927,ENSG00000106009,NA,"Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, 618056 (3), Autosomal recessive; Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3), Autosomal recessive",Brat1 (MGI:1891679)
7,2558971,2614733,7p22.3,7p22.3,617631,"IQCE, KIAA1023, PAPA7",IQ domain-containing protein E,IQCE,23288,ENSG00000106012,mutation identified in 1 PAPA7 family,"?Polydactyly, postaxial, type A7, 617642 (3), Autosomal recessive",Iqce (MGI:1921489)
7,2679521,2765186,7p22.3,7p22.3,615168,"AMZ1, KIAA1950",Archaelysin family metallopeptidase 1,AMZ1,155185,ENSG00000174945,NA,NA,Amz1 (MGI:2442258)
7,2728104,2844307,7p22.2,7p22.3-p22.2,604394,GNA12,"Guanine nucleotide-binding protein, alpha-12",GNA12,2768,ENSG00000146535,NA,NA,Gna12 (MGI:95767)
7,2906074,3043866,7p22,7p22.2,607210,"CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A",Caspase recruitment domain-containing protein 11,CARD11,84433,ENSG00000198286,NA,"B-cell expansion with NFKB and T-cell anergy, 616452 (3), Autosomal dominant; Immunodeficiency 11A, 615206 (3), Autosomal recessive; Immunodeficiency 11B with atopic dermatitis, 617638 (3), Autosomal dominant",Card11 (MGI:1916978)
7,3301251,4268999,7p22.2,7p22.2,607216,SDK1,"Sidekick, Drosophila, homolog of, 1",SDK1,221935,ENSG00000146555,NA,NA,Sdk1 (MGI:2444413)
7,4500000,7200000,7p22.1,NA,185100,STBMS1,"Strabismus, susceptibility to, 1",NA,100188805,NA,max lod at marker 1911/1912,"{Strabismus, susceptibility to, 1}, 185100 (2)",NA
7,4682294,4771441,7p22.1,7p22.1,616302,"FOXK1, MNF",Forkhead box K1,FOXK1,221937,ENSG00000164916,NA,NA,Foxk1 (MGI:1347488)
7,4775622,4794396,7p22.1,7p22.1,613653,"AP5Z1, KIAA0415, SPG48","Adaptor-related protein complex 5, zeta-1 subunit",AP5Z1,9907,ENSG00000242802,NA,"Spastic paraplegia 48, autosomal recessive, 613647 (3), Autosomal recessive",Ap5z1 (MGI:1924908)
7,4797054,4883715,7p22.1,7p22.1,611491,"RADIL, KIAA1849",RAP GTPase interactor,RADIL,55698,ENSG00000157927,NA,NA,Radil (MGI:2443088)
7,4857737,4862029,7p22.1,7p22.1,607436,"PAPOLB, TPAP","Poly(A) polymerase, beta",PAPOLB,56903,ENSG00000218823,NA,NA,Papolb (MGI:1932115)
7,4892244,4959212,7p22.1,7p22.1,614581,"MMD2, PAQR10",Monocyte-to-macrophage differentiation-associated protein 2,MMD2,221938,ENSG00000136297,NA,NA,Mmd2 (MGI:1922354)
7,5045859,5069486,7p22.1,7p22.1,608191,RBAK,RB-associated KRAB repressor,RBAK,57786,ENSG00000146587,NA,NA,Rbak (MGI:1927369)
7,5190232,5233854,7p22.2,7p22.1,609225,"WIPI2, IDDSSA",WD40 repeat protein interacting with phosphoinositides 2,WIPI2,26100,ENSG00000157954,mutation identified in 1 IDDSSA family,"?Intellectual developmental disorder with short stature and variable skeletal anomalies, 618453 (3), Autosomal recessive",Wipi2 (MGI:1923831)
7,5274310,5306861,7p22.1,7p22.1,609149,"SLC29A4, PMAT, ENT4","Solute carrier family 29 (monoamine transporter), member 4",SLC29A4,222962,ENSG00000164638,NA,NA,Slc29a4 (MGI:2385330)
7,5454424,5513808,7p22.1,7p22.1,609084,"FBXL18, FBL18",F-box and leucine-rich repeat protein 18,FBXL18,80028,ENSG00000155034,NA,NA,Fbxl18 (MGI:2444450)
7,5527147,5530600,7p22-p12,7p22.1,102630,"ACTB, BRWS1","Actin, beta",ACTB,60,ENSG00000075624,~20 pseudogenes also; mutation identified in twin DJO patients,"Baraitser-Winter syndrome 1, 243310 (3), Autosomal dominant; ?Dystonia, juvenile-onset, 607371 (3), Autosomal dominant",Actb (MGI:87904)
7,5592815,5606654,7p22,7p22.1,602689,"FSCN1, SNL","Fascin homolog 1, actin-bundling protein (singed, Drosophila, homolog-like)",FSCN1,6624,ENSG00000075618,NA,NA,Fscn1 (MGI:1352745)
7,5620046,5781720,7p22,7p22.1,609948,"RNF216, TRIAD3, ZIN, CAHH",RING finger protein 216,RNF216,54476,ENSG00000011275,NA,"Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3), Autosomal recessive",Rnf216 (MGI:1344349)
7,5859788,5886362,7p13-p11,7p22.1,164795,OCM,Oncomodulin,OCM,654231,ENSG00000122543,NA,NA,Ocm (MGI:97401)
7,5970924,6009105,7p22,7p22.1,600259,"PMS2, PMSL2, HNPCC4","Postmeiotic segregation increased, S. cerevisiae, 2, homolog of",PMS2,5395,ENSG00000122512,NA,"Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive",Pms2 (MGI:104288)
7,6009244,6023833,7p22,7p22.1,600859,"AIMP2, JTV1, HLD17",Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2,AIMP2,7965,ENSG00000106305,NA,"Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive",Aimp2 (MGI:2385237)
7,6022246,6059228,7p22.1,7p22.1,613635,"EIF2AK1, HRI",Eukaryotic translation initiation factor 2-alpha kinase 1,EIF2AK1,27102,ENSG00000086232,NA,NA,Eif2ak1 (MGI:1353448)
7,6161778,6272623,7p22.1,7p22.1,605081,"CYTH3, PSCD3, ARNO3, GRP1",Cytohesin 3,CYTH3,9265,ENSG00000008256,NA,NA,Cyth3 (MGI:1335107)
7,6329410,6348966,7p22.1,7p22.1,616628,"FAM220A, SIPAR, ACPIN1, C7orf70","Family with sequence similarity 220, member A",FAM220A,84792,ENSG00000178397,NA,NA,Fam220a (MGI:1914488)
7,6374526,6403966,7p22.1,7p22.1,602048,"RAC1, MRD48",Ras-related C3 botulinum toxin substrate 1,RAC1,5879,ENSG00000136238,NA,"Mental retardation, autosomal dominant 48, 617751 (3), Autosomal dominant",Rac1 (MGI:97845)
7,6409115,6448011,7p22.1,7p22.1,614016,DAGLB,"Diacylglycerol lipase, beta",DAGLB,221955,ENSG00000164535,NA,NA,Daglb (MGI:2442032)
7,6688432,6706946,7p22-p21,7p22.1,194536,ZNF12,Zinc finger protein-12 (KOX3),ZNF12,7559,ENSG00000164631,NA,NA,Zfp12 (MGI:99157)
7,7182546,7248650,7p14-p13,7p22.1-p21.3,610555,C1GALT1,"Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1",C1GALT1,56913,ENSG00000106392,NA,NA,C1galt1 (MGI:2151071)
7,7200000,16500000,7p21.3-p21.2,NA,616986,LOC105375159,Long intergenic noncoding RNA AC011288.2,NA,NA,NA,NA,NA,NA
7,7200000,28800000,7p21-p15,NA,153880,MDDC,"Macular dystrophy, dominant cystoid",CYMD,1541,NA,?allelic to RP9,"Macular dystrophy, dominant cystoid, 153880 (2), Autosomal dominant",NA
7,7338541,7542093,7p21.3,7p21.3,609996,COL28A1,"Collagen, type XXVIII, alpha-1 polypeptide",COL28A1,340267,ENSG00000215018,NA,NA,Col28a1 (MGI:2685312)
7,7566874,7609143,7p21.3,7p21.3,615359,MIOS,"Missing oocyte/meiosis regulator, Drosophila, homolog of",MIOS,54468,ENSG00000164654,NA,NA,Mios (MGI:2182066)
7,7636517,7718606,7p22,7p21.3,179837,RPA3,"Replication protein A3, 14kD",RPA3,6119,ENSG00000106399,NA,NA,Rpa3 (MGI:1915490)
7,7968795,8089079,7p22,7p21.3,614283,"GLCCI1, TSSN1, GCTR",Glucocorticoid-induced transcript 1,GLCCI1,113263,ENSG00000106415,NA,"{Glucocorticoid therapy, response to}, 614400 (3)",Glcci1 (MGI:2179717)
7,8113183,8262686,7p22,7p21.3,147625,ICA1,"Islet cell autoantigen 1, 69kD",ICA1,3382,ENSG00000003147,NA,NA,Ica1 (MGI:96391)
7,8433608,8752960,7p21.3,7p21.3,604639,"NXPH1, NPH1",Neurexophilin 1,NXPH1,30010,ENSG00000122584,NA,NA,Nxph1 (MGI:107492)
7,10931942,10940152,7p21.3,7p21.3,603833,NDUFA4,NADH-ubiquinone oxidoreductase subunit A4,NDUFA4,4697,ENSG00000189043,NA,NA,Ndufa4 (MGI:107686)
7,11370364,11832197,7p21.3,7p21.3,612249,"THSD7A, KIAA0960",Thrombospondin type-1 domain-containing protein 7A,THSD7A,221981,ENSG00000005108,NA,NA,Thsd7a (MGI:2685683)
7,12211293,12243366,7p21.3,7p21.3,613413,"TMEM106B, HLD16",Transmembrane protein 106B,TMEM106B,54664,ENSG00000106460,NA,"Leukodystrophy, hypomyelinating, 16, 617964 (3), Autosomal dominant",Tmem106b (MGI:1919150)
7,12570671,12660181,7p21.3,7p21.3,613416,"SCIN, KIAA1905",Scinderin,SCIN,85477,ENSG00000006747,NA,NA,Scin (MGI:1306794)
7,12686826,12690957,7q,7p21.3,604786,ARL4,ADP-ribosylation factor-like 4,ARL4A,10124,ENSG00000122644,NA,NA,Arl4a (MGI:99437)
7,13700000,34900000,7p21.2-p14.3,NA,613576,EDSS2,Ectodermal dysplasia-syndactyly syndrome 2,NA,100505394,NA,between D7S488 and D7S817,"Ectodermal dysplasia-syndactyly syndrome 2, 613576 (2), Autosomal recessive",NA
7,13700000,16500000,7p21.2,NA,613462,FGQTL4,Fasting plasma glucose level QTL 4,NA,100499169,NA,associated with rs2191349,"[Fasting plasma glucose level QTL 4], 613462 (2)",NA
7,13891228,13991424,7p22,7p21.2,600541,ETV1,ETS variant gene-1,ETV1,2115,ENSG00000006468,fused with EWS in some Ewing sarcoma,NA,Etv1 (MGI:99254)
7,14145048,14974857,7p21.2,7p21.2,604070,"DGKB, DGK, KIAA0718","Diacylglycerol kinase, beta, 90kD",DGKB,1607,ENSG00000136267,NA,NA,Dgkb (MGI:2442474)
7,15117222,15562014,7p21.2,7p21.2,613738,"AGMO, TMEM195",Alkylglycerol monooxygenase,AGMO,392636,ENSG00000187546,NA,NA,Agmo (MGI:2442495)
7,15611211,15686682,7p22.1-p21.3,7p21.2,600535,MEOX2,Mesenchyme homeo box 2,MEOX2,4223,ENSG00000106511,NA,NA,Meox2 (MGI:103219)
7,16087524,16421537,7p21.2,7p21.2,614631,"ISPD, MDDGA7, MDDGC7, LGMDR20",Isoprenoid synthase domain-containing protein,CRPPA,729920,ENSG00000214960,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3), Autosomal recessive",Crppa (MGI:1923097)
7,16461480,16465737,7p21.2,7p21.2,609675,"SOSTDC1, ECTODIN, USAG1",Sclerostin domain-containing protein 1,SOSTDC1,25928,ENSG00000171243,NA,NA,Sostdc1 (MGI:1913292)
7,16753754,16784535,7p21.1,7p21.1,613139,"TSPAN13, NET6",Tetraspanin 13,TSPAN13,27075,ENSG00000106537,NA,NA,Tspan13 (MGI:1913359)
7,16791810,16804998,7p21.3,7p21.1,606358,"AGR2, AG2","Anterior gradient 2, Xenopus, homolog of",AGR2,10551,ENSG00000106541,NA,NA,Agr2 (MGI:1344405)
7,16854710,16881982,7p21.3,7p21.1,609482,"AGR3, BCMP11","Anterior gradient 3, Xenopus, homolog of",AGR3,155465,ENSG00000173467,NA,NA,Agr3 (MGI:2685734)
7,17298651,17346146,7p15,7p21.1,600253,"AHR, RP85",Aryl hydrocarbon receptor,AHR,196,ENSG00000106546,mutation identified in 1 RP85 family,"?Retinitis pigmentosa 85, 618345 (3), Autosomal recessive",Ahr (MGI:105043)
7,17790760,17940507,7p21.1,7p21.1,606589,"SNX13, KIAA0713",Sorting nexin 13,SNX13,23161,ENSG00000071189,NA,NA,Snx13 (MGI:2661416)
7,18026769,18027845,7p21.2,7p21.1,611566,"PRPS1L1, PRPS3",Phosphoribosylpyrophosphate synthetase 1-like 1,PRPS1L1,221823,ENSG00000229937,NA,NA,Prps1l1 (MGI:1922706)
7,18086824,19002415,7p21-p15,7p21.1,606543,"HDAC9, MITR, HDAC7B, KIAA0744",Histone deacetylase 9,HDAC9,9734,ENSG00000048052,NA,NA,Hdac9 (MGI:1931221)
7,19113046,19117671,7p21,7p21.1,601622,"TWIST1, ACS3, SCS, CRS1, SWCOS","TWIST, Drosophila, homolog of, 1",TWIST1,7291,ENSG00000122691,NA,"Craniosynostosis 1, 123100 (3), Autosomal dominant; Robinow-Sorauf syndrome, 180750 (3), Autosomal dominant; Saethre-Chotzen syndrome with or without eyelid anomalies, 101400 (3), Autosomal dominant; Sweeney-Cox syndrome, 617746 (3), Autosomal dominant",Twist1 (MGI:98872)
7,19144781,19145420,7p21.1,7p21.1,617578,"FERD3L, NTWIST, NATO3, PTFB","Fer3, Drosophila, homolog of",FERD3L,222894,ENSG00000146618,NA,NA,Ferd3l (MGI:2150010)
7,19695460,19709036,7p21,7p21.1,608312,TWISTNB,TWIST neighbor,TWISTNB,221830,ENSG00000105849,pseudogene on 6q14.3,NA,Twistnb (MGI:106292)
7,20134654,20217383,7p21.1,7p21.1,612646,MACC1,Metastasis-associated gene in colon cancer 1,MACC1,346389,ENSG00000183742,NA,NA,Macc1 (MGI:2685113)
7,20329818,20415753,7p21.1,7p21.1,604160,ITGB8,"Integrin, beta-8",ITGB8,3696,ENSG00000105855,NA,NA,Itgb8 (MGI:1338035)
7,20615666,20757007,7p15.3,7p21.1,611785,ABCB5,"ATP-binding cassette, subfamily B, member 5",ABCB5,340273,ENSG00000004846,NA,NA,Abcb5 (MGI:1924956)
7,20782278,20786885,7p21,7p21.1,608306,"SP8, BTD",Transcription factor Sp8,SP8,221833,ENSG00000164651,NA,NA,Sp8 (MGI:2443471)
7,20900000,45400000,7p15-p13,NA,613219,"FGQTL2, BWQTL1",Fasting plasma glucose level QTL 2; Birth weight QTL 1,NA,100379216,NA,associated with rs4607517,"[Birth weight QTL 1], 613219 (2); [Fasting plasma glucose level QTL 2], 613219 (2)",NA
7,20900000,28800000,7p15,NA,164865,MYCLK1,Avian myelocytomatosis viral (v-myc) oncogene homolog like 1,NA,NA,NA,NA,NA,NA
7,20900000,28800000,7p15,NA,608367,"MYP17, MYP4",Myopia 17,MYP17,100359401,NA,previously assigned to 7q36 (MYP4),"Myopia 17, 608367 (2), Autosomal dominant",NA
7,20900000,28800000,7p15,NA,612737,STQTL17,Stature quantitative trait locus 17,NA,100301526,NA,associated with rs1635852 and rs849140,"{Stature QTL 17}, 612737 (2)",NA
7,21428082,21514821,7p15,7p15.3,600540,SP4,Sp4 transcription factor,SP4,6671,ENSG00000105866,NA,NA,Sp4 (MGI:107595)
7,21543038,21901838,7p21,7p15.3,603339,"DNAH11, DNAHC11, CILD7, DNAHBL","Dynein, axonemal, heavy chain-11",DNAH11,8701,ENSG00000105877,NA,"Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3), Autosomal recessive",Dnah11 (MGI:1100864)
7,21900898,21945898,7p15,7p15.3,609685,"CDCA7L, R1, JPO2",Cell division cycle-associated protein 7-like,CDCA7L,55536,ENSG00000164649,NA,NA,Cdca7l (MGI:2384982)
7,22725888,22732001,7p21,7p15.3,147620,"IL6, IFNB2, BSF2, HSF, HGF","Interleukin-6 (interferon, beta-2)",IL6,3569,ENSG00000136244,NA,"{Crohn disease-associated growth failure}, 266600 (3), Multifactorial; {Diabetes, susceptibility to},, 222100 (3), Autosomal recessive; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3), Autosomal dominant; {Kaposi sarcoma, susceptibility to}, 148000 (3), Autosomal dominant; {Rheumatoid arthritis, systemic juvenile}, 604302 (3)",Il6 (MGI:96559)
7,22812631,22822848,7p15.3,7p15.3,607980,TOMM7,"Translocase of outer mitochondrial membrane 7, yeast, homolog of",TOMM7,54543,ENSG00000196683,NA,NA,Tomm7 (MGI:1913419)
7,22895847,23014132,7p15.3,7p15.3,610531,"FAM126A, DRCTNNB1A, HLD5",Hyccin,FAM126A,84668,ENSG00000122591,NA,"Leukodystrophy, hypomyelinating, 5, 610532 (3), Autosomal recessive",Fam126a (MGI:2149839)
7,23105733,23177913,7p15.3,7p15.3,611119,"KLHL7, RP42, CISS3",Kelch-like 7,KLHL7,55975,ENSG00000122550,NA,"Cold-induced sweating syndrome 3, 617055 (3), Autosomal recessive; Retinitis pigmentosa 42, 612943 (3), Autosomal dominant",Klhl7 (MGI:1196453)
7,23246765,23275109,7p15.3,7p15.3,604368,"GPNMB, PLCA3",Glycoprotein NMB,GPNMB,10457,ENSG00000136235,NA,"Amyloidosis, primary localized cutaneous, 3, 617920 (3), Autosomal recessive",Gpnmb (MGI:1934765)
7,23298743,23311728,7p15.3,7p15.3,614624,"MALSU1, C7orf30",Mitochondrial assembly of ribosomal large subunit 1,MALSU1,115416,ENSG00000156928,NA,NA,Malsu1 (MGI:1922843)
7,23310208,23470673,7p15,7p15.3,608259,"IGF2BP3, IMP3, KOC1, VICKZ3",Insulin-like growth factor 2 mRNA-binding protein 3,IGF2BP3,10643,ENSG00000136231,NA,NA,Igf2bp3 (MGI:1890359)
7,23504779,23532040,7p15.3,7p15.3,602718,TRA2A,"Transformer 2, Drosophila, homolog of",TRA2A,29896,ENSG00000164548,NA,NA,Tra2a (MGI:1933972)
7,23710139,23832514,7p15.3,7p15.3,605790,STK31,Serine/threonine kinase 31,STK31,56164,ENSG00000196335,NA,NA,Stk31 (MGI:1924735)
7,24284189,24291861,7p15.1,7p15.3,162640,NPY,Neuropeptide Y,NPY,4852,ENSG00000122585,NA,NA,Npy (MGI:97374)
7,24573352,24694192,7p21-p15,7p15.3,606959,"MPP6, VAM1, PALS2","Membrane protein, palmitoylated 6",MPP6,51678,ENSG00000105926,NA,NA,Mpp6 (MGI:1927340)
7,24698354,24762234,7p15,7p15.3,608798,"GSDME, DFNA5",Gasdermin E,GSDME,1687,ENSG00000105928,NA,"Deafness, autosomal dominant 5, 600994 (3), Autosomal dominant",Gsdme (MGI:1889850)
7,24796536,24980217,7p15,7p15.3,606732,"OSBPL3, ORP3, KIAA0704",Oxysterol-binding protein-like protein 3,OSBPL3,26031,ENSG00000070882,NA,NA,Osbpl3 (MGI:1918970)
7,25118650,25125360,7p15.2,7p15.3,123970,"CYCS, CYC, THC4","Cytochrome C, somatic",CYCS,54205,ENSG00000172115,NA,"Thrombocytopenia 4, 612004 (3), Autosomal dominant",Cycs (MGI:88578)
7,25134691,25180741,7p15.3,7p15.3,616071,C7orf31,Chromosome 7 open reading frame 31,C7orf31,136895,ENSG00000153790,NA,NA,4921507P07Rik (MGI:1918071)
7,25224569,25228485,7p15.3,7p15.3,616984,"NPVF, RFRP, C7orf9",Neuropeptide VF precursor,NPVF,64111,ENSG00000105954,NA,NA,Npvf (MGI:1926488)
7,25949918,25949985,7p15.2,7p15.2,613786,"MIR148A, MIRN148A",Micro RNA 148A,MIR148A,406940,ENSG00000199085,NA,NA,NA
7,26152197,26187136,7p15-p14,7p15.2,604135,"NFE2L3, NRF3",Nuclear factor erythroid 2-like 3,NFE2L3,9603,ENSG00000050344,NA,NA,Nfe2l3 (MGI:1339958)
7,26189919,26200774,7p15,7p15.2,600124,"HNRPA2B1, IBMPFD2",Heterogeneous nuclear ribonucleoprotein A2/B1,HNRNPA2B1,3181,ENSG00000122566,mutation identified in 1 family,"?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3)",Hnrnpa2b1 (MGI:104819)
7,26201442,26213606,7p15.2,7p15.2,604477,CBX3,Chromobox homolog 3,CBX3,11335,ENSG00000122565,NA,NA,Cbx3 (MGI:108515)
7,26291877,26374328,7p15.2,7p15.2,614780,"SNX10, OPTB8",Sorting nexin 10,SNX10,29887,ENSG00000086300,NA,"Osteopetrosis, autosomal recessive 8, 615085 (3), Autosomal recessive",Snx10 (MGI:1919232)
7,26654771,26864622,7p15.2,7p15.2,605215,"SKAP2, SCAP2, SKAP55R",src kinase associated phosphoprotein 2,SKAP2,8935,ENSG00000005020,NA,NA,Skap2 (MGI:1889206)
7,27092992,27096005,7p15.3,7p15.2,142955,"HOXA1, HOX1F, BSAS",Homeo box-A1,HOXA1,3198,ENSG00000105991,NA,"Athabaskan brainstem dysgenesis syndrome, 601536 (3); Bosley-Salih-Alorainy syndrome, 601536 (3)",Hoxa1 (MGI:96170)
7,27100353,27102682,7p15-p14,7p15.2,604685,"HOXA2, MCOHI",Homeobox A2,HOXA2,3199,ENSG00000105996,mutation identified in 1 MCOHICP family,"Microtia with or without hearing impairment (AD), 612290 (3), Autosomal recessive, Autosomal dominant; ?Microtia, hearing impairment, and cleft palate (AR), 612290 (3), Autosomal recessive, Autosomal dominant",Hoxa2 (MGI:96174)
7,27106189,27153237,7p15-p14.2,7p15.2,142954,"HOXA3, HOX1E",Homeo box-A3,HOXA3,3200,ENSG00000105997,"homolog of Drosophila zen1, zen2",NA,Hoxa3 (MGI:96175)
7,27121918,27128759,7p15.2,7p15.2,616068,HOXAAS2,HOXA cluster antisense RNA 2,HOXA-AS2,285943,NA,NA,NA,NA
7,27128524,27130756,7p15-p14.2,7p15.2,142953,"HOXA4, HOX1D",Homeo box-A4,HOXA4,3201,ENSG00000197576,homolog of Drosophila Dfd,NA,Hoxa4 (MGI:96176)
7,27141051,27143680,7p15-p14.2,7p15.2,142952,"HOXA5, HOX1C",Homeo box-A5,HOXA5,3202,ENSG00000106004,NA,NA,Hoxa5 (MGI:96177)
7,27145395,27147773,7p15-p14.2,7p15.2,142951,"HOXA6, HOX1B",Homeo box-A6,HOXA6,3203,ENSG00000106006,NA,NA,Hoxa6 (MGI:96178)
7,27153715,27156674,7p15-p14.2,7p15.2,142950,"HOXA7, HOX1A",Homeo box-A7,HOXA7,3204,ENSG00000122592,homolog of Drosophila Antp,NA,Hoxa7 (MGI:96179)
7,27162437,27165536,7p15-p14.2,7p15.2,142956,"HOXA9, HOX1G",Homeo box-A9,HOXA9,3205,ENSG00000078399,homolog of Drosophila Abd-B; fused to NUP98 in myeloid leukemia,NA,Hoxa9 (MGI:96180)
7,27169479,27169562,7p15-p14.2,7p15.2,609688,"MIR196B, MIRN196B",Micro RNA 196B,MIR196B,442920,ENSG00000283745,NA,NA,NA
7,27170604,27179860,7p15-p14.2,7p15.2,142957,"HOXA10, HOX1H",Homeo box-A10,HOXA10,3206,ENSG00000253293,NA,NA,Hoxa10 (MGI:96171)
7,27181156,27185215,7p15-p14.2,7p15.2,142958,"HOXA11, HOX1I, RUSAT1",Homeo box-A11,HOXA11,3207,ENSG00000005073,NA,"Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3), Autosomal dominant",Hoxa11 (MGI:96172)
7,27185407,27189292,7p15.2,7p15.2,607530,HOXA11AS,"Homeo box A11, antisense",HOXA11-AS,221883,ENSG00000240990,NA,NA,NA
7,27194363,27200090,7p15-p14.2,7p15.2,142959,"HOXA13, HOX1J",Homeo box-A13,HOXA13,3209,ENSG00000106031,mutation identified in 1 GTMS family,"?Guttmacher syndrome, 176305 (3), Autosomal dominant; Hand-foot-uterus syndrome, 140000 (3), Autosomal dominant",Hoxa13 (MGI:96173)
7,27200420,27207258,7p15.2,7p15.2,614060,"HOTTIP, NCRNA00213",HOXA distal transcript antisense RNA,HOTTIP,100316868,NA,NA,NA,NA
7,27242801,27247829,7p15-p14,7p15.2,142996,EVX1,Even-skipped homeo box-1 (homolog of Drosophila),EVX1,2128,ENSG00000106038,at 5' end of HOX1 cluster,NA,Evx1 (MGI:95461)
7,27525439,27662902,7p15.2,7p15.2,608475,HIBADH,3-hydroxyisobutyrate dehydrogenase,HIBADH,11112,ENSG00000106049,NA,NA,Hibadh (MGI:1889802)
7,27739372,27829766,7p15,7p15.2,605326,"TAX1BP1, TXBP151",TAX1-binding protein 1,TAX1BP1,8887,ENSG00000106052,NA,NA,Tax1bp1 (MGI:1289308)
7,27830572,28180794,7p15,7p15.2-p15.1,606246,"JAZF1, TIP27",JAZF1 gene,JAZF1,221895,ENSG00000153814,fused with JJAZ1,NA,Jazf1 (MGI:2141450)
7,28299320,28825893,7p15.1-p14.3,7p15.1-p14.3,618262,"CREB5, CREBPA",cAMP response element-binding protein 5,CREB5,9586,ENSG00000146592,NA,NA,Creb5 (MGI:2443973)
7,28800000,43300000,7p14,NA,610655,HHT4,"Telangiectasia, hereditary hemorrhagic, type 4",NA,791087,NA,between D7S2252 and D7S510,"Telangiectasia, hereditary hemorrhagic, type 4, 610655 (2), Autosomal dominant",NA
7,28800000,45400000,7p14-p13,NA,600762,"HPVC1, PE5L",Human papillomavirus E5 central sequence-like 1,NA,NA,NA,NA,NA,NA
7,28953357,28958329,7p14.3,7p14.3,613356,"TRIL, KIAA0644",TLR4 interactor with leucine-rich repeats,TRIL,9865,ENSG00000255690,NA,NA,Tril (MGI:1914123)
7,28995230,29195450,7p15-p14,7p14.3,609780,"CPVL, HVLP","Carboxypeptidase, vitellogenic-like",CPVL,54504,ENSG00000106066,NA,NA,Cpvl (MGI:1918537)
7,29146546,29514334,7p15.3,7p14.3,602857,"CHN2, ARHGAP3, RHOGAP3","Chimerin 2 (GTPase-activating protein, rho, 3)",CHN2,1124,ENSG00000106069,NA,NA,Chn2 (MGI:1917243)
7,29563834,29567299,7p14.3,7p14.3,618344,PRR15,Proline-rich protein 15,PRR15,222171,ENSG00000176532,NA,NA,Prr15 (MGI:1925254)
7,29806553,29917065,7p15.1,7p14.3,612432,"WIPF3, CR16","WAS/WASL-interacting protein family, member 3",WIPF3,644150,ENSG00000122574,NA,NA,Wipf3 (MGI:3044681)
7,29920102,29990288,7p14.3-p14.1,7p14.3,614965,"SCRN1, SES1, KIAA0193",Secernin 1,SCRN1,9805,ENSG00000136193,NA,NA,Scrn1 (MGI:1917188)
7,30010582,30026800,7p15.1,7p14.3,614505,"FKBP14, EDSKSCL2",FK506-binding protein 14,FKBP14,55033,ENSG00000106080,NA,"Ehlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3), Autosomal recessive",Fkbp14 (MGI:2387639)
7,30028360,30130482,7p21-p11.2,7p14.3,608639,FAPP2,Phosphatidylinositol 4-phosphate adaptor protein 2,PLEKHA8,84725,ENSG00000106086,NA,NA,Plekha8 (MGI:2681164)
7,30284596,30367688,7p15.1,7p14.3,612061,ZNRF2,Zinc finger and ring finger protein 2,ZNRF2,223082,ENSG00000180233,NA,NA,Znrf2 (MGI:1196246)
7,30424526,30478865,7p15-p14,7p14.3,605980,"NOD1, CARD4",Nucleotide-binding oligomerization domain protein 1,NOD1,10392,ENSG00000106100,NA,NA,Nod1 (MGI:1341839)
7,30496620,30504840,7p15-p14,7p14.3,137170,"GGCT, GCTG, C7orf24",Gamma-glutamylcyclotransferase,GGCT,79017,ENSG00000006625,NA,NA,Ggct (MGI:95700)
7,30594734,30634032,7p15,7p14.3,600287,"GARS, SMAD1, CMT2D, HMN5",Glycyl-tRNA synthetase,GARS1,2617,ENSG00000106105,NA,"Charcot-Marie-Tooth disease, type 2D, 601472 (3), Autosomal dominant; Neuropathy, distal hereditary motor, type VA, 600794 (3), Autosomal dominant",Gars (MGI:2449057)
7,30649405,30700102,7p21-p15,7p14.3,602034,"CRHR2, CRFR2",Corticotropin releasing hormone receptor-2,CRHR2,1395,ENSG00000106113,NA,NA,Crhr2 (MGI:894312)
7,30752134,30757601,7p15.3-p15.2,7p14.3,604854,INMT,Indolethylamine N-methyltransferase,INMT,11185,ENSG00000241644,NA,NA,Inmt (MGI:102963)
7,30911693,30925516,7p14,7p14.3,107776,"AQP1, CHIP28, CO","Aquaporin-1 (channel-forming integral protein, 28kD)",AQP1,358,ENSG00000240583,NA,"[Aquaporin-1 deficiency], 110450 (3); [Blood group, Colton], 110450 (3)",Aqp1 (MGI:103201)
7,30963952,30979527,7p15-p14,7p14.3,139191,"GHRHR, GHRFR, IGHD4",Growth hormone releasing hormone receptor,GHRHR,2692,ENSG00000106128,NA,"Growth hormone deficiency, isolated, type IV, 618157 (3)",Ghrhr (MGI:95710)
7,31052307,31111478,7p14,7p14.3,102981,"ADCYAP1R1, PACAPR",Adenylate cyclase activating polypeptide-1 (pituitary) receptor type 1,ADCYAP1R1,117,ENSG00000078549,NA,NA,Adcyap1r1 (MGI:108449)
7,31337464,31340725,7p15-p14,7p14.3,611513,"NEUROD6, ATOH2, MATH2",Neurogenic differentiation 6,NEUROD6,63974,ENSG00000164600,NA,NA,Neurod6 (MGI:106593)
7,31616776,32428223,7p14.3,7p14.3,602987,"PDE1C, HCAM3, DFNA74",Phosphodiesterase 1C,PDE1C,5137,ENSG00000154678,mutation identified in 1 DFNA74 family,"?Deafness, autosomal dominant 74, 618140 (3), Autosomal dominant",Pde1c (MGI:108413)
7,31687016,31710157,7p15,7p14.3,604088,GSBS,G-substrate,PPP1R17,10842,ENSG00000106341,NA,"{Hypercholesterolemia, susceptibility to}, 143890 (3), Autosomal dominant",Ppp1r17 (MGI:1333876)
7,32485332,32495282,7p14.3,7p14.3,607285,LSM5,LSM5 protein,LSM5,23658,ENSG00000106355,NA,NA,Lsm5 (MGI:1913623)
7,32495488,32588725,7p14.3,7p14.3,612927,"AVL9, KIAA0241","AVL9, S. cerevisiae, homolog of",AVL9,23080,ENSG00000105778,NA,NA,Avl9 (MGI:1926187)
7,32957403,33006930,7p12,7p14.3,616257,"FKBP9, FKBP60, FKBP63",FK506-binding protein 9,FKBP9,11328,ENSG00000122642,NA,NA,Fkbp9 (MGI:1350921)
7,33014112,33062796,7p15-p14,7p14.3,606224,"NT5C3A, NT5C3, UMPH1, PSN1","5' nucleotidase, cytosolic IIIA (uridine 5' monophosphate hydrolase 1)",NT5C3A,51251,ENSG00000122643,pseudogenes on chr.4 and chr.7,"Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3), Autosomal recessive",Nt5c3 (MGI:1927186)
7,33094796,33109403,7p14.2,7p14.3,607331,"RP9, PAP1","RP9 gene (pim1-associated protein, mouse, homolog of)",RP9,6100,ENSG00000164610,mutation identified in 1 patient,"?Retinitis pigmentosa 9, 180104 (3), Autosomal dominant",Rp9 (MGI:2157166)
7,33129243,33637237,7p14,7p14.3,607968,"PTHB1, BBS9",Parathyroid hormone-responsive B1 gene,BBS9,27241,ENSG00000122507,NA,"Bardet-Biedl syndrome 9, 615986 (3), Autosomal recessive",Bbs9 (MGI:2442833)
7,33904914,34156426,7p14.3,7p14.3,608699,"BMPER, CV2",BMP binding endothelial regulator,BMPER,168667,ENSG00000164619,NA,"Diaphanospondylodysostosis, 608022 (3), Autosomal recessive",Bmper (MGI:1920480)
7,34346511,34834330,7p15-p14,7p14.3,608596,AAA1,Asthma-associated alternatively spliced gene 1,NPSR1-AS1,404744,ENSG00000197085,NA,NA,NA
7,34658217,34878331,7p15-p14,7p14.3,608595,"NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2",Neuropeptide S receptor 1,NPSR1,387129,ENSG00000187258,NA,"{Asthma, susceptibility to, 2}, 608584 (3)",Npsr1 (MGI:2441738)
7,34928880,35038040,7p14.3,7p14.2,613892,"DPY19L1, KIAA0877",DPY19-like 1,DPY19L1,23333,ENSG00000173852,NA,NA,Dpy19l1 (MGI:1915685)
7,35199935,35254099,7p15-p14,7p14.2,606061,"TBX20, ASD4",T-box 20,TBX20,57057,ENSG00000164532,NA,"Atrial septal defect 4, 611363 (3)",Tbx20 (MGI:1888496)
7,35800985,35915762,7p14,7p14.2,603151,"SEPT7, CDC10",Septin 7,SEPTIN7,989,ENSG00000122545,NA,NA,Sept7 (MGI:1335094)
7,36153251,36301537,7p14.2,7p14.2,617192,"EEPD1, KIAA1706",Endonuclease/exonuclease/phosphatase family domain-containing protein 1,EEPD1,80820,ENSG00000122547,NA,NA,Eepd1 (MGI:1914734)
7,36389808,36453790,7p14.2,7p14.2,616027,"ANLN, FSFS8",Actin-binding protein anillin,ANLN,54443,ENSG00000011426,NA,"Focal segmental glomerulosclerosis 8, 616032 (3), Autosomal dominant",Anln (MGI:1920174)
7,36509312,36724548,7p14-p12,7p14.2,102593,AOAH,Acyloxyacyl hydrolase (neutrophil),AOAH,313,ENSG00000136250,NA,NA,Aoah (MGI:1350928)
7,36852905,37449325,7p14,7p14.2-p14.1,606420,"ELMO1, CED12",Engulfment and cell motility gene 1,ELMO1,9844,ENSG00000155849,NA,NA,Elmo1 (MGI:2153044)
7,37100000,43300000,7p14.1,NA,615455,TRGJ@,T-cell receptor gamma chain joining gene cluster,NA,NA,NA,NA,NA,NA
7,37100000,43300000,7p14.1,NA,615454,TRGV@,T-cell receptor gamma chain variable gene cluster,NA,NA,NA,NA,NA,NA
7,37683559,37743834,7p14.1,7p14.1,609045,"GPR141, PGR13",G protein -coupled receptor 141,GPR141,353345,ENSG00000187037,NA,NA,Gpr141 (MGI:2672983)
7,37848596,37900396,7p14.1,7p14.1,607421,"NME8, TXNDC3, SPTRX2, CILD6",NME/NM23 family member 8,NME8,51314,ENSG00000086288,NA,"Ciliary dyskinesia, primary, 6, 610852 (3), Autosomal recessive",Nme8 (MGI:1920662)
7,37905931,37916816,7p14.1,7p14.1,606570,"SFRP4, FRPHE, PYL",Secreted frizzled-related protein 4,SFRP4,6424,ENSG00000106483,NA,"Pyle disease, 265900 (3), Autosomal recessive",Sfrp4 (MGI:892010)
7,38178244,38230670,7p14-p13,7p14.1,611759,"STARD3NL, MENTHO",STARD3 N-terminal like,STARD3NL,83930,ENSG00000010270,NA,NA,Stard3nl (MGI:1923455)
7,38239576,38276740,7p15-p14,7p14.1,609642,TARP,"T-cell antigen receptor, gamma subunit, alternate reading frame protein",NA,445347,NA,NA,NA,NA
7,38240023,38249571,7p14.1,7p14.1,615450,TRGC2,T-cell receptor gamma chain constant region 2,TRGC2,6967,NA,NA,NA,NA
7,38260087,38265677,7p14.1,7p14.1,186970,TRGC1,T-cell receptor gamma chain constant region 1,TRGC1,6966,NA,NA,NA,NA
7,38383693,38631566,7p14-p13,7p14.1,600418,AMPH,Amphiphysin,AMPH,273,ENSG00000078053,NA,NA,Amph (MGI:103574)
7,38722973,38909199,7p14.1,7p14.1,605485,VPS41,"Vacuolar protein sorting 41, Yeast, homolog of",VPS41,27072,ENSG00000006715,NA,NA,Vps41 (MGI:1929215)
7,38977877,39468600,7p14-p13,7p14.1,609062,"POU6F2, WTSL, WT5","POU domain, class 6, transcription factor 2",POU6F2,11281,ENSG00000106536,NA,"{Wilms tumor susceptibility-5}, 601583 (3), Autosomal dominant, Somatic mutation",NA
7,39622954,39708123,7p22-p15,7p14.1,179550,RALA,"RAS-like protein A (Simian leukemia viral (v-ral) oncogene homolog A, ras-related)",RALA,5898,ENSG00000006451,NA,NA,Rala (MGI:1927243)
7,39949663,40099579,7p14.1,7p14.1,603309,"CDK13, CDC2L5, CHED, CHDFIDD",Cyclin-dependent kinase 13,CDK13,8621,ENSG00000065883,NA,"Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3), Autosomal dominant",Cdk13 (MGI:1916812)
7,40126026,40134621,7p14,7p14.1,609188,"MPLKIP, C7orf11, ABHS, TTDN1, TTD4",M-phase specific PLK1 interacting protein,MPLKIP,136647,ENSG00000168303,NA,"Trichothiodystrophy 4, nonphotosensitive, 234050 (3), Autosomal recessive",Mplkip (MGI:1913558)
7,40134886,40860766,7p14,7p14.1,609187,"C7orf10, GA3",Chromosome 7 open reading frame 10,SUGCT,79783,ENSG00000175600,NA,"Glutaric aciduria III, 231690 (3), Autosomal recessive",Sugct (MGI:1923221)
7,41685100,41710531,7p15-p13,7p14.1,147290,INHBA,"Inhibin, beta-1",INHBA,3624,ENSG00000122641,NA,NA,Inhba (MGI:96570)
7,41960948,42237208,7p13,7p14.1,165240,"GLI3, PAPA, PAPB",GLI-Kruppel family member GLI3 (oncogene GLI3),GLI3,2737,ENSG00000106571,amplified in glioblastoma,"Greig cephalopolysyndactyly syndrome, 175700 (3), Autosomal dominant; {Hypothalamic hamartomas, somatic}, 241800 (3); Pallister-Hall syndrome, 146510 (3), Autosomal dominant; Polydactyly, postaxial, types A1 and B, 174200 (3), Autosomal dominant; Polydactyly, preaxial, type IV, 174700 (3), Autosomal dominant",Gli3 (MGI:95729)
7,42916860,42932173,7p13,7p14.1,176842,"PSMA2, PSC2, HC3","Proteasome (prosome, macropain) subunit, alpha type, 2",PSMA2,5683,ENSG00000106588,incorrectly assigned to 6q,NA,Psma2 (MGI:104885)
7,42932375,42937856,7p14,7p14.1,611839,MRPL32,Mitochondrial ribosomal protein L32,MRPL32,64983,ENSG00000106591,NA,NA,Mrpl32 (MGI:2137226)
7,43112579,43566000,7p13,7p14-p13,610384,"HECW1, NEDL1, KIAA0322","HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 1",HECW1,23072,ENSG00000002746,NA,NA,Hecw1 (MGI:2444115)
7,43508727,43522541,7p13,7p13,618172,"LUARIS, lncRNA32",Long noncoding RNA upregulator of antiviral response interferon signaling,LUARIS,100506895,ENSG00000231638,overlaps in antisense orientation with HECW1 gene,NA,NA
7,43583107,43627378,7p13,7p13,604726,"STK17A, DRAK1",Serine/threonine protein kinase 17A,STK17A,9263,ENSG00000164543,NA,NA,NA
7,43608451,43729540,7p13,7p13,614769,"COA1, C7orf44","Cytochrome c oxidase assembly factor 1, S. cerevisiae, homolog of",COA1,55744,ENSG00000106603,NA,NA,NA
7,43758121,43807341,7p13,7p13,109750,BLVRA,Biliverdin reductase A,BLVRA,644,ENSG00000106605,NA,"Hyperbiliverdinemia, 614156 (3), Autosomal recessive, Autosomal dominant",Blvra (MGI:88170)
7,43866557,43869516,7p14,7p13,611986,MRPS24,Mitochondrial ribosomal protein S24,MRPS24,64951,ENSG00000062582,NA,NA,Mrps24 (MGI:1928142)
7,43875893,43926410,7p13,7p13,610337,"URGCP, URG4",Upregulator of cell proliferation,URGCP,55665,ENSG00000106608,NA,NA,Urgcp (MGI:1919296)
7,43997854,44011039,7p13,7p13,617623,"SPDYE1, SPDYB2L2, RINGO1","SPEEDY/RINGO cell cycle regulator family, member E1",SPDYE1,285955,ENSG00000136206,NA,NA,NA
7,44044639,44069455,7p13,7p13,610106,"DBNL, HIP55",Drebrin-like,DBNL,28988,ENSG00000136279,NA,NA,Dbnl (MGI:700006)
7,44062726,44065566,7p13-p12.3,7p13,612931,"PGAM2, PGAMM, GSD10","Phosphoglycerate mutase, muscle form",PGAM2,5224,ENSG00000164708,NA,"Glycogen storage disease X, 261670 (3), Autosomal recessive",Pgam2 (MGI:1933118)
7,44072061,44082539,7p13,7p13,606344,POLM,"Polymerase, DNA, mu",POLM,27434,ENSG00000122678,NA,NA,Polm (MGI:1860191)
7,44104319,44114563,7p13,7p13,602981,"AEBP1, ACLP",AE-binding protein 1,AEBP1,165,ENSG00000106624,NA,"Ehlers-Danlos syndrome, classic-like, 2, 618000 (3), Autosomal recessive",Aebp1 (MGI:1197012)
7,44114679,44123667,7p13,7p13,600815,POLD2,"Polymerase (DNA directed), delta 2, regulatory subunit, 50kD",POLD2,5425,ENSG00000106628,NA,NA,Pold2 (MGI:1097163)
7,44138863,44141391,7p13,7p13,613993,"MYL7, MYL2A, MLC2A, MYLC2A","Myosin, light chain 7, regulatory",MYL7,58498,ENSG00000106631,NA,NA,Myl7 (MGI:107495)
7,44143212,44189438,7p15-p13,7p13,138079,"GCK, HHF3",Glucokinase (hexokinase-4),GCK,2645,ENSG00000106633,proximal to TCRB,"Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3), Autosomal dominant; Diabetes mellitus, permanent neonatal, 606176 (3), Autosomal recessive, Autosomal dominant; Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3), Autosomal dominant; MODY, type II, 125851 (3), Autosomal dominant",Gck (MGI:1270854)
7,44200977,44214293,7p13,7p13,606209,YKT6,"Ykt6, S. cerevisiae, homolog of",YKT6,10652,ENSG00000106636,NA,NA,Ykt6 (MGI:1927550)
7,44217149,44326166,7p14,7p13,607707,"CAMK2B, MRD54",Calcium/calmodulin-dependent protein kinase II-beta,CAMK2B,816,ENSG00000058404,NA,"Mental retardation, autosomal dominant 54, 617799 (3), Autosomal dominant",Camk2b (MGI:88257)
7,44379118,44490874,7p13,7p13,610296,"NUDCD3, KIAA1068, NUDCL",NUDC domain-containing protein 3,NUDCD3,23386,ENSG00000015676,NA,NA,Nudcd3 (MGI:2144158)
7,44512439,44541650,7p13,7p13,608010,"NPC1L1, LDLCQ7",NPC1-like 1,NPC1L1,29881,ENSG00000015520,NA,"[Ezetimibe, nonresponse to], 617966 (3); [Low density lipoprotein cholesterol level QTL 7], 617966 (3)",Npc1l1 (MGI:2685089)
7,44565416,44574537,7p13,7p13,608023,"DDX56, NOH61",DEAD/H box 56,DDX56,54606,ENSG00000136271,NA,NA,Ddx56 (MGI:1277172)
7,44577893,44582294,7p22.2,7p13,612038,TMED4,Transmembrane p24 trafficking protein 4,TMED4,222068,ENSG00000158604,NA,NA,Tmed4 (MGI:1915070)
7,44606571,44709065,7p14-p13,7p13,613022,OGDH,"Oxoglutarate dehydrogenase, lipoamide (alpha-ketoglutarate dehydrogenase)",OGDH,4967,ENSG00000105953,NA,"Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1), Autosomal recessive",Ogdh (MGI:1098267)
7,44748546,44769880,7p13,7p13,611196,"ZMIZ2, KIAA1886, ZIMP7",Zinc finger MIZ-domain containing 2,ZMIZ2,83637,ENSG00000122515,NA,NA,Zmiz2 (MGI:106374)
7,44795959,44803116,7p13,7p13,123840,PPIA,Peptidylprolyl isomerase A (cyclophilin A),PPIA,5478,ENSG00000196262,NA,NA,Ppia (MGI:97749)
7,44876298,44885529,7p13,7p13,608887,PURB,Purine-rich element-binding protein B,PURB,5814,ENSG00000146676,NA,NA,Purb (MGI:1338779)
7,44962661,44979104,7p13,7p13,600642,"MYO1G, HA2, HLA-HA2",Myosin IG,MYO1G,64005,ENSG00000136286,NA,NA,Myo1g (MGI:1927091)
7,44999745,45076469,7p13,7p13,607929,"C7orf22, CCM2, MGC4067",Malcavernin,CCM2,83605,ENSG00000136280,NA,"Cerebral cavernous malformations-2, 603284 (3), Autosomal dominant",Ccm2 (MGI:2384924)
7,45100099,45111746,7p13,7p13,611325,"TBRG4, KIAA0948, CPR2",Transforming growth factor-beta regulator 4,TBRG4,9238,ENSG00000136270,NA,NA,Tbrg4 (MGI:1100868)
7,45104905,45105041,7p13,7p13,611335,SNORA5C,"Small nucleolar RNA, H/ACA box, 5C",SNORA5C,677796,ENSG00000201772,in intron 3 of TBRG4,NA,NA
7,45157777,45184249,7p13-p12,7p13,605155,RAMP3,Receptor activity-modifying protein 3,RAMP3,10268,ENSG00000122679,NA,NA,Ramp3 (MGI:1860292)
7,45400000,60100000,7p12-cen,NA,147830,TTIM1,"T-cell tumor invasion and metastasis-1 (invasion-metastasis of neoplasms, chromosome 7 determined)",NA,NA,NA,NA,NA,NA
7,45574139,45723115,7p13-p12,7p12.3,103072,"ADCY1, DFNB44","Adenylate cyclase-1, brain",ADCY1,107,ENSG00000164742,mutation identified in 1 DFNB44 family,"?Deafness, autosomal recessive 44, 610154 (3), Autosomal recessive",Adcy1 (MGI:99677)
7,45723786,45769017,7p13,7p12.3,611563,SEPT13,Septin 13,SEPTIN7P2,641977,ENSG00000214765,NA,NA,NA
7,45888487,45893659,7p14-p12,7p12.3,146730,IGFBP1,Insulin-like growth factor-binding protein-1,IGFBP1,3484,ENSG00000146678,NA,NA,Igfbp1 (MGI:96436)
7,45912244,45921271,7p14-p12,7p12.3,146732,IGFBP3,Insulin-like growth factor-binding protein-3,IGFBP3,3486,ENSG00000146674,tail-to-tail 20kb from IGFBP1,NA,Igfbp3 (MGI:96438)
7,47275153,47582552,7p12.3,7p12.3,606825,"TNS3, TEM6",Tensin 3,TNS3,64759,ENSG00000136205,NA,NA,Tns3 (MGI:2443012)
7,47774602,47958912,7p13-p12,7p12.3,609721,"PKD1L1, HTX8",Polycystin 1L1,PKD1L1,168507,ENSG00000158683,NA,"Heterotaxy, visceral, 8, autosomal, 617205 (3), Autosomal recessive",Pkd1l1 (MGI:2156538)
7,47962979,47979618,7p13-p12,7p12.3,603760,HUS1,"Hydroxyurea-sensitive 1, S. pombe, homolog of",HUS1,3364,ENSG00000136273,NA,NA,Hus1 (MGI:1277962)
7,48088307,48108745,7p12.3,7p12.3,191730,"UPP1, UP",Uridine phosphorylase 1,UPP1,7378,ENSG00000183696,NA,NA,Upp1 (MGI:1097668)
7,48171423,48647496,7p12.3,7p12.3,607807,ABCA13,"ATP-binding cassette, subfamily A, member 13",ABCA13,154664,ENSG00000179869,NA,NA,Abca13 (MGI:2388707)
7,49000000,50500000,7p12.2,NA,613067,ALL2,"Leukemia, acute lymphoblastic, susceptibility to, 2",NA,100310786,NA,associated with rs11978267,"{Leukemia, acute lymphoblastic, susceptibility to, 2}, 613067 (2)",NA
7,49773637,49923776,7p12.2,7p12.2,611108,"VWC2, BRORIN",von Willebrand factor C domain-containing protein 2,VWC2,375567,ENSG00000188730,NA,NA,Vwc2 (MGI:2442987)
7,49846354,50093257,7p12.2,7p12.2,608498,"ZPBP, SP38",Zona pellucida-binding protein,ZPBP,11055,ENSG00000042813,NA,NA,Zpbp (MGI:1855701)
7,50303452,50405100,7p12,7p12.2,603023,"IKZF1, ZNFN1A1, IK1, LYF1, CVID13",Ikaros family zinc finger 1,IKZF1,10320,ENSG00000185811,fused with BCL6 in DLBL,"Immunodeficiency, common variable, 13, 616873 (3), Autosomal dominant",Ikzf1 (MGI:1342540)
7,50437319,50450405,7p12.1,7p12.2,615383,FIGNL1,Fidgetin-like protein 1,FIGNL1,63979,ENSG00000132436,NA,NA,Fignl1 (MGI:1890648)
7,50458435,50565459,7p11,7p12.2-p12.1,107930,DDC,DOPA decarboxylase (aromatic L-amino acid decarboxylase),DDC,1644,ENSG00000132437,NA,"Aromatic L-amino acid decarboxylase deficiency, 608643 (3), Autosomal recessive",Ddc (MGI:94876)
7,50500000,98400000,7p12.1-q21,NA,614676,CMH21,"Cardiomyopathy, familial hypertrophic, 21",NA,100909387,NA,max lod at D7S669,"Cardiomyopathy, hypertrophic, 21, 614676 (2), Autosomal dominant",NA
7,50590062,50793461,7p12-p11.2,7p12.1,601523,"GRB10, RSS",Growth factor receptor-bound protein-10,GRB10,2887,ENSG00000106070,NA,NA,Grb10 (MGI:103232)
7,51016211,51316860,7p12,7p12.1,610317,"COBL, KIAA0633","Cordon-bleu, mouse, homolog of",COBL,23242,ENSG00000106078,NA,NA,Cobl (MGI:105056)
7,53900000,98400000,7p11-q21,NA,608658,HPC4,"Prostate cancer, hereditary, 4",NA,408260,NA,NA,"{Prostate cancer, susceptibility to, 4}, 608658 (2)",NA
7,53900000,58100000,7p11.2,NA,608345,NYS3,"Nystagmus 3, congenital, autosomal dominant",NYS3,4934,NA,translocation t(7;15)(p11.2;q11.2),"Nystagmus 3, congenital, autosomal dominant, 608345 (2), Autosomal dominant",NA
7,53900000,58100000,7p11.2,NA,180860,"SRS, RSS",Silver-Russell syndrome,NA,NA,NA,maternal uniparental disomy of chromosome 7,"Silver-Russell syndrome, 180860 (4), Autosomal dominant",NA
7,54752246,54759245,7p11.2,7p11.2,609215,SEC61G,"Sec61 translocon, gamma subunit",SEC61G,23480,ENSG00000132432,NA,NA,"Gm16261,Sec61g,Gm11575,Gm12881,Gm4184 (MGI:3782360,MGI:3649592,MGI:3651892,MGI:3826544,MGI:1202066)"
7,55019016,55211627,7p12.3-p12.1,7p11.2,131550,"EGFR, NISBD2",Epidermal growth factor receptor,EGFR,1956,ENSG00000146648,same as oncogene ERBB; mutation identified in 1 NISBD2 family,"Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal dominant, Somatic mutation; ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive; Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal dominant, Somatic mutation; {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal dominant, Somatic mutation",Egfr (MGI:95294)
7,55238435,55255634,7p11.2,7p11.2,618217,"ELDR, LINC01156, FABL",EGFR long noncoding downstream RNA,ELDR,102725541,NA,NA,NA,NA
7,55365447,55433741,7p11.2,7p11.2,612919,"LANCL2, TASP",LanC-like 2,LANCL2,55915,ENSG00000132434,NA,NA,Lancl2 (MGI:1919085)
7,55434405,55572501,7p11.2,7p11.2,611915,"VOPP1, ECOP, GASP","Vesicular, overexpressed in cancer, prosurvival protein 1",VOPP1,81552,ENSG00000154978,NA,NA,Vopp1 (MGI:2141658)
7,55764796,55773682,7q11.2,7p11.2,604239,"PSPHP1, PSPHL, CO9",Phosphoserine phosphatase-like (pseudogene),PSPHP1,8781,NA,NA,NA,NA
7,55793539,55862751,7p11.2,7p11.2,612140,SEPT14,Septin 14,SEPTIN14,346288,ENSG00000154997,NA,NA,Sept14 (MGI:1921472)
7,55887455,55942224,7p11.2,7p11.2,616181,ZNF713,Zinc finger protein 713,ZNF713,349075,ENSG00000178665,NA,NA,NA
7,55951876,55956499,7p11-q11.21,7p11.2,611980,MRPS17,Mitochondrial ribosomal protein S17,MRPS17,51373,ENSG00000239789,9 pseudogenes,NA,Mrps17 (MGI:1913508)
7,55964584,56000178,7p12,7p11.2,603004,"GBAS, NIPSNAP2",Glioblastoma amplified sequence,NIPSNAP2,2631,ENSG00000146729,NA,NA,Nipsnap2 (MGI:1278343)
7,56010486,56051603,7p11.2,7p11.2,172480,"PSPH, PSP, PSPHD",Phosphoserine phosphatase,PSPH,5723,ENSG00000146733,NA,"Phosphoserine phosphatase deficiency, 614023 (3), Autosomal recessive",Psph (MGI:97788)
7,56051764,56063988,7p11.2,7p11.2,104613,"CCT6A, CCT6, HTR3, TCP20","Chaperonin containing T-complex polypeptide 1, subunit 6A",CCT6A,908,ENSG00000146731,NA,NA,Cct6a (MGI:107943)
7,56064006,56080671,7p11.2,7p11.2,607940,SUMF2,Sulfatase-modifying factor 2,SUMF2,25870,ENSG00000129103,NA,NA,Sumf2 (MGI:1915152)
7,56079926,56093449,7p12-q21,7p11.2,172470,PHKG1,"Phosphorylase kinase, gamma 1, muscle",PHKG1,5260,ENSG00000164776,presumed pseudogene on 11,NA,Phkg1 (MGI:97579)
7,56101561,56106629,7p11.2,7p11.2,616244,"CHCHD2, PARK22",Coiled-coil-helix-coiled-coil-helix domain-containing protein 2,CHCHD2,51142,ENSG00000106153,NA,"Parkinson disease 22, autosomal dominant, 616710 (3), Autosomal dominant","Chchd2,Chchd2-ps (MGI:1261428,MGI:3649942)"
7,57119573,57139898,7p11.2,7p11.2,617444,"ZNF479, KR19",Zinc finger protein 479,ZNF479,90827,ENSG00000185177,NA,NA,NA
7,60100000,159345973,7q,NA,145290,HRX,Hyperreflexia,NA,7974,NA,linked to KEL,NA,NA
7,60100000,159345973,7q,NA,252270,"MLSM7, DEL7q, C7DELq",Monosomy 7 of bone marrow,NA,NA,NA,NA,"Myelodysplasia and leukemia syndrome with monosomy 7, 252270 (4), Autosomal recessive",NA
7,62100000,77900000,7q11.2,NA,105800,ANIB1,"Aneurysm, intracranial berry, 1",ANIB1,116833,NA,in or near ELN,"Aneurysm, intracranial berry, 1, 105800 (2), Autosomal dominant",NA
7,62100000,98400000,7q11.2-q21.3,NA,129900,EEC1,"Ectrodactyly, ectodermal dysplasia, cleft lip/palate, 1",EEC1,1913,NA,NA,"?EEC syndrome-1, 129900 (2), Autosomal dominant",NA
7,62100000,77900000,7q11.2,NA,610247,"EOE1, EE","Esophagitis, eosinophilic, 1",NA,100302511,NA,associated with rs2302009,"{Esophagitis, eosinophilic, 1}, 610247 (2), Multifactorial",NA
7,64665009,64711581,7q11.2,7q11.21,603989,ZNF107,Zinc finger protein-107,ZNF107,51427,ENSG00000196247,NA,NA,NA
7,64794427,64860822,7q11.21-q11.23,7q11.21,604080,ZNF138,Zinc finger protein-138,ZNF138,7697,ENSG00000197008,NA,NA,NA
7,64882492,64932238,7q11.21,7q11.21,604756,"ZNF273, HZF9",Zinc finger protein 273,ZNF273,10793,ENSG00000198039,NA,NA,NA
7,64971775,64991035,7q11.2,7q11.21,194624,ZNF117,Zinc finger protein-117,ZNF117,51351,ENSG00000152926,NA,NA,NA
7,64990355,65006686,7q11.2,7q11.21,131170,ERV3,Endogenous retroviral sequence-3 (includes zinc finger protein H-plk),ERV3-1,2086,ENSG00000213462,NA,NA,NA
7,65373798,65401135,7q11.21,7q11.21,603974,ZNF92,Zinc finger protein-92,ZNF92,168374,ENSG00000146757,sequence aligns with sequence on 19p13.1-p12,NA,NA
7,65865771,65959557,7q11.21,7q11.21,608838,VKORC1L1,"Vitamin K epoxide reductase complex, subunit 1-like 1",VKORC1L1,154807,ENSG00000196715,NA,NA,Vkorc1l1 (MGI:1916818)
7,65960683,65982313,7q21.11,7q11.21,611499,"GUSB, MPS7","Glucuronidase, beta-",GUSB,2990,ENSG00000169919,NA,"Mucopolysaccharidosis VII, 253220 (3), Autosomal recessive",Gusb (MGI:95872)
7,66075818,66093575,7cen-q11.2,7q11.21,608310,ASL,Argininosuccinate lyase,ASL,435,ENSG00000126522,NA,"Argininosuccinic aciduria, 207900 (3), Autosomal recessive",Asl (MGI:88084)
7,66114817,66154567,7q21.3-q22,7q11.21,606121,RCP,Calcitonin gene-related peptide receptor component protein,CRCP,27297,ENSG00000241258,NA,NA,Crcp (MGI:1100818)
7,66205313,66360442,7q11.21,7q11.21,603125,TPST1,Tyrosylprotein sulfotransferase 1,TPST1,8460,ENSG00000169902,NA,NA,Tpst1 (MGI:1298231)
7,66628880,66643228,7q11.21,7q11.21,611725,"KCTD7, EPM3, CLN14",Potassium channel tetramerization domain containing 7,KCTD7,154881,ENSG00000243335,NA,"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3), Autosomal recessive",Kctd7 (MGI:2442265)
7,66654566,66811463,7q11.21,7q11.21,609700,"RABGEF1, RABEX5",RAB guanine nucleotide exchange factor 1,RABGEF1,27342,ENSG00000154710,NA,NA,Rabgef1 (MGI:1929459)
7,66987679,66995585,7q11,7q11.21,607444,"SBDS, SDS",SBDS gene,SBDS,51119,ENSG00000126524,NA,"{Aplastic anemia, susceptibility to}, 609135 (3); Shwachman-Diamond syndrome, 260400 (3), Autosomal recessive",Sbds (MGI:1913961)
7,66996804,67239514,7q11.21,7q11.21,611243,TYW1,"tRNA-wybutosine-synthesizing protein 1, S. cerevisiae, homolog of",TYW1,55253,ENSG00000198874,NA,NA,Tyw1 (MGI:2141161)
7,69598474,70793505,7q11.2,7q11.22,607270,"KIAA0442, MRD26",KIAA0442 gene,AUTS2,26053,ENSG00000158321,translocation break at 7q11.2,"Mental retardation, autosomal dominant 26, 615834 (3), Autosomal dominant",Auts2 (MGI:1919847)
7,71132143,71713598,7q11.22,7q11.22,615137,"WBSCR17, GALNTL3, GALNACT17",Williams-Beuren syndrome chromosome region 17,GALNT17,64409,ENSG00000185274,NA,NA,Galnt17 (MGI:2137594)
7,72700000,77900000,7q11.23,NA,613729,"DEL7q11.23, C7DELq11.23","Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb",NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb, 613729 (4)",NA
7,72700000,77900000,7q11.23,NA,609757,"DUP7q11.23, C7DUPq11.23",Chromosome 7q11.23 duplication syndrome,NA,NA,NA,NA,"Chromosome 7q11.23 duplication syndrome, 609757 (4), Autosomal dominant",NA
7,72700000,77900000,7q11.23,NA,194050,"WBS, WMS, WS, DEL7q11, C7DELq11",Williams-Beuren syndrome (chromosome 7q11.23 deletion syndrome),NA,NA,NA,contiguous gene syndrome,"Williams-Beuren syndrome, 194050 (4), Autosomal dominant",NA
7,72879334,72951458,7q11.23,7q11.23,615753,"POM121, POM121A, KIAA0618",POM121 transmembrane nucleoporin,POM121,9883,ENSG00000196313,NA,NA,Pom121 (MGI:2137624)
7,72954844,73005931,7q11.23,7q11.23,612550,"TRIM74, TRIM50C",Tripartite motif-containing protein 74,TRIM74,378108,ENSG00000155428,NA,NA,NA
7,73302515,73308866,7q11.23,7q11.23,615732,"NSUN5, WBSCR20, WBSCR20A","NOP2/SUN RNA methyltransferase family, member 5",NSUN5,55695,ENSG00000130305,NA,NA,Nsun5 (MGI:2140844)
7,73312535,73328081,7q11.23,7q11.23,612548,"TRIM50, TRIM50A",Tripartite motif-containing protein 50,TRIM50,135892,ENSG00000146755,NA,NA,Trim50 (MGI:2664992)
7,73328153,73358624,7q11.23,7q11.23,604839,FKBP6,FK506-binding protein 6,FKBP6,8468,ENSG00000077800,NA,NA,Fkbp6 (MGI:2137612)
7,73433777,73436119,7q11.23,7q11.23,601766,"FZD9, FZD3","Frizzled, Drosophila, homolog of, 9",FZD9,8326,ENSG00000188763,NA,NA,Fzd9 (MGI:1313278)
7,73440405,73522292,7q11-q21,7q11.23,605681,"BAZ1B, WSTF, WBSCR9","Bromodomain adjacent to zinc finger domain, 1B",BAZ1B,9031,ENSG00000009954,NA,NA,Baz1b (MGI:1353499)
7,73536355,73557689,7q11.23,7q11.23,605846,BCL7B,B-cell CLL/lymphoma 7B,BCL7B,9275,ENSG00000106635,NA,NA,Bcl7b (MGI:1332238)
7,73567536,73578604,7q11.23,7q11.23,605842,TBL2,Transducin-beta-like 2,TBL2,26608,ENSG00000106638,NA,NA,Tbl2 (MGI:1351652)
7,73593193,73624542,7q11.23,7q11.23,605678,"MLXIPL, WBSCR14, MONDOB, CHREBP",MLX interacting protein-like,MLXIPL,51085,ENSG00000009950,NA,NA,Mlxipl (MGI:1927999)
7,73665345,73672109,7q11.23,7q11.23,610039,"VPS37D, WBSCR24","Vacuolar protein sorting 37, yeast, homolog of, D",VPS37D,155382,ENSG00000176428,NA,NA,Vps37d (MGI:2159402)
7,73680917,73683452,7q11.23,7q11.23,618202,"DNAJC30, WBSCR18","DNAJ/HSP40 homolog, subfamily C, member 30",DNAJC30,84277,ENSG00000176410,NA,NA,Dnajc30 (MGI:1913364)
7,73683567,73698220,7q11.23,7q11.23,615733,"BUD23, WBSCR22, MERM1",rRNA methyltransferase and ribosome maturation factor Bud23,BUD23,114049,ENSG00000071462,NA,NA,Bud23 (MGI:1913388)
7,73699209,73719672,7q11.2,7q11.23,186590,"STX1A, STX1","Syntaxin 1A, brain",STX1A,6804,ENSG00000106089,NA,NA,Stx1a (MGI:109355)
7,73735068,73735999,7q11.23,7q11.23,612545,WBSCR26,Williams-Beuren syndrome chromosome region 26,ABHD11-AS1,171022,NA,NA,NA,NA
7,73768996,73770269,7q11,7q11.23,602910,"CLDN3, CPETR2",Claudin-3 (Clostridium perfringens enterotoxin receptor 2),CLDN3,1365,ENSG00000165215,NA,NA,Cldn3 (MGI:1329044)
7,73830862,73832692,7q11.23,7q11.23,602909,"CLDN4, CPETR1, CPER",Claudin 4,CLDN4,1364,ENSG00000189143,NA,NA,Cldn4 (MGI:1313314)
7,73834589,73842526,7q11.23,7q11.23,612546,WBSCR27,Williams-Beuren syndrome chromosome region 27,METTL27,155368,ENSG00000165171,NA,NA,Mettl27 (MGI:1933146)
7,73860847,73865891,7q11.23,7q11.23,612547,WBSCR28,Williams-Beuren syndrome chromosome region 28,TMEM270,135886,ENSG00000175877,NA,NA,Tmem270 (MGI:1923879)
7,74027771,74069906,7q11.2,7q11.23,130160,"ELN, SVAS, ADCL1",Elastin,ELN,2006,ENSG00000049540,NA,"Cutis laxa, autosomal dominant, 123700 (3), Autosomal dominant; Supravalvar aortic stenosis, 185500 (3), Autosomal dominant",NA
7,74083803,74122524,7q11.23,7q11.23,601329,LIMK1,LIM domain kinase 1,LIMK1,3984,ENSG00000106683,NA,NA,Limk1 (MGI:104572)
7,74174355,74197095,7q11.23,7q11.23,603431,"EIF4H, WBSCR1, WSCR1",Eukaryotic translation initiation factor 4H,EIF4H,7458,ENSG00000106682,NA,NA,Eif4h (MGI:1341822)
7,74191197,74191293,7q11.23,7q11.23,615070,MIR590,Micro RNA 590,MIR590,693175,ENSG00000207741,NA,NA,NA
7,74210005,74229833,7q11.23,7q11.23,605719,"LAT2, WBSCR5, LAB, NTAL","Linker for activation of T cells family, member 2",LAT2,7462,ENSG00000086730,NA,NA,Lat2 (MGI:1926479)
7,74231501,74254457,7q11.23,7q11.23,600404,RFC2,"Replication factor C2, 40kD (activator 1, 40kD)",RFC2,5982,ENSG00000049541,NA,NA,Rfc2 (MGI:1341868)
7,74289406,74405942,7q11.23,7q11.23,603432,"CLIP2, CYLN2, WBSCR4, WSCR4",CAP-GLY domain-containing linker protein 2,CLIP2,7461,ENSG00000106665,?neurodevelopmental defect of Williams syndrome,NA,Clip2 (MGI:1313136)
7,74453905,74603069,7q11.23,7q11.23,604318,"GTF2IRD1, GTF3, MUSTRD1, WBS",GTF21 repeat domain-containing protein 1,GTF2IRD1,9569,ENSG00000006704,NA,NA,Gtf2ird1 (MGI:1861942)
7,74657664,74760691,7q11.23,7q11.23,601679,"GTF2I, BAP135, WBS","General transcription factor II-I (BTK-associated protein, 135kD)",GTF2I,2969,ENSG00000263001,NA,NA,Gtf2i (MGI:1202722)
7,74773961,74789375,7q11.23,7q11.23,608512,NCF1,"Neutrophil cytosolic factor-1, 47kD",NCF1,653361,ENSG00000158517,NA,"Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3), Autosomal recessive",Ncf1 (MGI:97283)
7,74964692,75031530,7q11.23,7q11.23,617033,"GATSL2, CASTOR2",GATS protein-like 2,CASTOR2,729438,ENSG00000274070,NA,NA,Castor2 (MGI:1933384)
7,75395628,75405612,7q11.23,7q11.23,612549,"TRIM73, TRIM50B",Tripartite motif-containing protein 73,TRIM73,375593,ENSG00000178809,NA,NA,NA
7,75416785,75486298,7q11.23,7q11.23,615754,"POM121C, POM121-2",POM121 Transmembrane nucleoporin C,POM121C,100101267,ENSG00000272391,NA,NA,Pom121 (MGI:2137624)
7,75533297,75738975,7q11.23,7q11.23,601767,HIP1,Huntingtin interacting protein-1,HIP1,3092,ENSG00000127946,NA,NA,Hip1 (MGI:1099804)
7,75769523,75791582,7q11.2,7q11.23,604697,"CCL26, SCYA26","Chemokine, C-C motif, ligand 26",CCL26,10344,ENSG00000006606,NA,NA,NA
7,75810824,75823355,7q11.23,7q11.23,602495,"CCL24, SCYA24, MPIF2","Chemokine, C-C motif, ligand 24",CCL24,6369,ENSG00000106178,NA,NA,Ccl24 (MGI:1928953)
7,75878991,75888925,7q11.23,7q11.23,615203,RHBDD2,Rhomboid domain-containing protein 2,RHBDD2,57414,ENSG00000005486,NA,NA,Rhbdd2 (MGI:1915612)
7,75915154,75986854,7q11.2,7q11.23,124015,POR,Cytochrome P450 oxidoreductase,POR,5447,ENSG00000127948,NA,"Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3), Autosomal recessive; Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)",Por (MGI:97744)
7,75986830,75994668,7q11.23,7q11.23,616550,"TMEM120A, TMPIT, NET29",Transmembrane protein 120A,TMEM120A,83862,ENSG00000189077,NA,NA,Tmem120a (MGI:2686991)
7,75995819,76049343,7q11.23,7q11.23,616695,"STYXL1, MKSTYX, DUSP24",Serine/threonine/tyrosine-interacting protein-like 1,STYXL1,51657,ENSG00000127952,NA,NA,Styxl1 (MGI:1923821)
7,76048105,76067507,7q11.23,7q11.23,154100,"MDH2, EIEE51","Malate dehydrogenase, mitochondrial",MDH2,4191,ENSG00000146701,NA,"Epileptic encephalopathy, early infantile, 51, 617339 (3), Autosomal recessive",Mdh2 (MGI:97050)
7,76302672,76304291,7q11.23,7q11.23,602195,"HSPB1, HSP27, CMT2F, HMN2B",Heat-shock 27kD protein-1,HSPB1,3315,ENSG00000106211,NA,"Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3), Autosomal dominant; Neuropathy, distal hereditary motor, type IIB, 608634 (3), Autosomal dominant",Hspb1 (MGI:96240)
7,76326798,76358990,7q11.23,7q11.23,605356,"YWHAG, EIEE56","Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma isoform",YWHAG,7532,ENSG00000170027,NA,"Epileptic encephalopathy, early infantile, 56, 617665 (3), Autosomal dominant",Ywhag (MGI:108109)
7,76389336,76410024,7q11.23,7q11.23,607639,"SSC4D, SRCRB4D",Scavenger receptor cysteine-rich family member with 4 domains,SSC4D,136853,ENSG00000146700,NA,NA,Ssc4d (MGI:1924709)
7,76397521,76442068,7q11.23,7q11.23,182889,"ZP3, ZP3A, ZP3B, OOMD3",Zona pellucida glycoprotein-3 (sperm receptor),ZP3,7784,ENSG00000188372,NA,"Oocyte maturation defect 3, 617712 (3), Autosomal dominant",Zp3 (MGI:99215)
7,76461654,76505994,7q11.23,7q11.23,613141,"DTX2, KIAA1528","Deltex, Drosophila, homolog of, 2",DTX2,113878,ENSG00000091073,NA,NA,Dtx2 (MGI:1921448)
7,76510551,76516521,7q11.23,7q11.23,611887,"UPK3B, UPIIIB, P35",Uroplakin 3B,UPK3B,105375355,ENSG00000243566,NA,NA,NA
7,76609985,76627302,7q11.2,7q11.23,600587,POMZP3,POM121/ZP3 fusion protein,POMZP3,22932,ENSG00000146707,NA,NA,NA
7,77193368,77199818,7q11.2,7q11.23,605351,FGL2,Fibrinogen-like 2,FGL2,10875,ENSG00000127951,NA,NA,Fgl2 (MGI:103266)
7,77310750,77416418,7q11.23,7q11.23,613552,"GSAP, PION",Gamma-secretase-activating protein,GSAP,54103,ENSG00000186088,NA,NA,Gsap (MGI:2442259)
7,77537189,77640068,7q11.23,7q11.23,600079,"PTPN12, PTPG1","Protein tyrosine phosphatase, nonreceptor-type, 12",PTPN12,5782,ENSG00000127947,NA,"Colon cancer, somatic, 114500 (3)",Ptpn12 (MGI:104673)
7,77657659,77697344,7q21,7q11.23,616048,APTR,"Alu-mediated CDKN1A/p21 transcriptional regulator, noncoding",APTR,100505854,ENSG00000214293,NA,NA,NA
7,77798772,77957503,7q11.23-q21,7q11.23-q21.11,616785,PHTF2,Putative homeodomain transcription factor 2,PHTF2,57157,ENSG00000006576,NA,NA,Phtf2 (MGI:1916020)
7,77900000,98400000,7q21,NA,608950,"MAGI2IT, PR47",MAGI2 intronic transcript,NA,NA,NA,NA,NA,NA
7,77900000,107800000,7q21-q22,NA,154276,MHS3,Malignant hyperthermia susceptibility 3,NA,7977,NA,?mutation in CACNA2,"{Malignant hyperthermia susceptibility 3}, 154276 (2), Autosomal dominant",NA
7,77900000,98400000,7q21,NA,612223,STQTL11,Stature quantitative trait locus 11,NA,100270795,NA,associated with rs2282978,"{Stature QTL 11}, 612223 (2)",NA
7,78017054,79453666,7q21,7q21.11,606382,"MAGI2, AIP1, KIAA0705, NPHS15","Membrane-associated guanylate kinase, WW and PDZ domains-containing, 2",MAGI2,9863,ENSG00000187391,NA,"Nephrotic syndrome, type 15, 617609 (3), Autosomal recessive",Magi2 (MGI:1354953)
7,80134830,80226180,7q21,7q21.11,139310,GNAI1,"Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-1",GNAI1,2770,ENSG00000127955,NA,NA,Gnai1 (MGI:95771)
7,80457290,80512502,7q21.11,7q21.11,139395,"GNAT3, GDCA","Guanine nucleotide-binding protein, alpha-transducing activity polypeptide 3",GNAT3,346562,ENSG00000214415,NA,NA,Gnat3 (MGI:3588268)
7,80602206,80679276,7q21.11,7q21.11,173510,"CD36, CHDS7, BDPLT10",CD36 antigen (collagen type I),CD36,948,ENSG00000135218,NA,"{Coronary heart disease, susceptibility to, 7}, 610938 (3); [Macrothrombocytopenia] (1); {Malaria, cerebral, reduced risk of}, 611162 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); Platelet glycoprotein IV deficiency, 608404 (3), Autosomal recessive",Cd36 (MGI:107899)
7,80742535,80922388,7q21.11,7q21.11,602645,SEMA3C,Semaphorin 3C,SEMA3C,10512,ENSG00000075223,NA,NA,Sema3c (MGI:107557)
7,81699005,81770437,7q21.1,7q21.11,142409,"HGF, DFNB39",Hepatic growth factor,HGF,3082,ENSG00000019991,NA,"Deafness, autosomal recessive 39, 608265 (3), Autosomal recessive",Hgf (MGI:96079)
7,81946443,82443955,7q21-q22,7q21.11,114204,"CACNA2, CACNL2A","Calcium channel, voltage-dependent, L type, alpha 2/delta subunit",CACNA2D1,781,ENSG00000153956,NA,NA,Cacna2d1 (MGI:88295)
7,82754011,83164160,7q11.23-q21.1,7q21.11,604918,"PCLO, PCH3","Piccolo, mouse, homolog of",PCLO,27445,ENSG00000186472,mutation identified in 1 PCHD3 family,"?Pontocerebellar hypoplasia, type 3, 608027 (3), Autosomal recessive",Pclo (MGI:1349390)
7,83363237,83649138,7q21.11,7q21.11,608166,"SEMA3E, SEMAH, KIAA0331",Semaphorin 3E,SEMA3E,9723,ENSG00000170381,mutation identified in 1 CHARGE patient,"?CHARGE syndrome, 214800 (3), Autosomal dominant",Sema3e (MGI:1340034)
7,83955776,84515188,7q21.11,7q21.11,603961,"SEMA3A, SEMAD, COLL1, HH16",Semaphorin 3A,SEMA3A,10371,ENSG00000075213,NA,"{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3), Autosomal dominant",Sema3a (MGI:107558)
7,84995191,85187175,7q21.11,7q21.11,609907,SEMA3D,Semaphorin 3D,SEMA3D,223117,ENSG00000153993,NA,NA,Sema3d (MGI:1860118)
7,86643908,86864875,7q21.1-q21.2,7q21.11-q21.12,601115,GRM3,"Glutamate receptor, metabotropic-3",GRM3,2913,ENSG00000198822,NA,NA,Grm3 (MGI:1351340)
7,86876905,87059713,7q21.12,7q21.12,614048,"KIAA1324L, EIG121L",KIAA1324-like gene,KIAA1324L,222223,ENSG00000164659,NA,NA,9330182L06Rik (MGI:2443264)
7,87152360,87196331,7q21.12,7q21.12,608491,"DMTF1, DMP1",Cyclin D-binding MYB-like transcription factor 1,DMTF1,9988,ENSG00000135164,NA,NA,Dmtf1 (MGI:1344415)
7,87196159,87220586,7q21.12,7q21.12,616993,"TMEM243, C7orf23, MMTRAG",Transmembrane protein 243,TMEM243,79161,ENSG00000135185,NA,NA,Tmem243 (MGI:3606159)
7,87325346,87345491,7q21.12,7q21.12,616403,TP53TG1,TP53 target gene 1,TP53TG1,11257,NA,NA,NA,NA
7,87345645,87399793,7q21.1,7q21.12,606090,"CROT, COT",Carnitine octanoyltransferase,CROT,54677,ENSG00000005469,NA,NA,Crot (MGI:1921364)
7,87398987,87476721,7q21.1,7q21.12,171060,"ABCB4, PGY3, MDR3, ICP3","ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)",ABCB4,5244,ENSG00000005471,within 500kb of MDR1,"Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3), Autosomal recessive, Autosomal dominant; Cholestasis, progressive familial intrahepatic 3, 602347 (3), Autosomal recessive; Gallbladder disease 1, 600803 (3), Autosomal recessive, Autosomal dominant",Abcb4 (MGI:97569)
7,87503862,87713322,7q21.1,7q21.12,171050,"ABCB1, PGY1, MDR1, IBD13, CLCs","ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)",ABCB1,5243,ENSG00000085563,NA,"{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13}, 612244 (3)",Abcb1a (MGI:97570)
7,87627655,87832295,7q21.12,7q21.12,617295,"RUNDC3B, RPIP9",RUN domain-containing protein 3B,RUNDC3B,154661,ENSG00000105784,NA,NA,Rundc3b (MGI:2685286)
7,87833567,87876359,7q21.12,7q21.12,610821,SLC25A40,"Solute carrier family 25, member 40",SLC25A40,55972,ENSG00000075303,NA,NA,Slc25a40 (MGI:2442486)
7,87876492,87909552,7q21.3,7q21.12,604281,"ASK, DBF4",Activator of S-phase kinase,DBF4,10926,ENSG00000006634,NA,NA,Dbf4 (MGI:1351328)
7,87934142,88202888,7q21,7q21.12,603709,"ADAM22, EIEE61",A disintegrin and metalloproteinase domain 22,ADAM22,53616,ENSG00000008277,mutation identified in 1 EIEE61 patient,"?Epileptic encephalopathy, early infantile, 61, 617933 (3), Autosomal recessive",Adam22 (MGI:1340046)
7,88205114,88226992,7q21.1,7q21.12,182520,"SRI, SCN",Sorcin (class 4 gene),SRI,6717,ENSG00000075142,NA,NA,Sri (MGI:98419)
7,88270891,88306893,7q21,7q21.12,611098,"STEAP4, STAMP2, TIARP",Six-transmembrane epithelial antigen of prostate 4,STEAP4,79689,ENSG00000127954,NA,NA,Steap4 (MGI:1923560)
7,90154468,90164826,7q21,7q21.13,604415,STEAP,Six-transmembrane epithelial antigen of the prostate,STEAP1,26872,ENSG00000164647,NA,NA,Steap1 (MGI:1917608)
7,90211739,90243407,7q21,7q21.13,605094,"STEAP2, STAMP1, IPCA1, PCANAP1",Six-transmembrane epithelial antigen of prostate 2,STEAP2,261729,ENSG00000157214,NA,NA,Steap2 (MGI:1921301)
7,90245173,90320963,7q21.13,7q21.13,617949,"CFAP69, C7orf63, SPGF24",Cilia- and flagella-associated protein 69,CFAP69,79846,ENSG00000105792,NA,"Spermatogenic failure 24, 617959 (3), Autosomal recessive",Cfap69 (MGI:2443778)
7,90346715,90391452,7q21.13,7q21.13,610920,"GTPBP10, OBGH2",GTP-binding protein 10,GTPBP10,85865,ENSG00000105793,NA,NA,Gtpbp10 (MGI:2385599)
7,90403460,90415953,7q21,7q21.13,611232,CLKDN12,Claudin 12,CLDN12,9069,ENSG00000157224,NA,NA,Cldn12 (MGI:1929288)
7,90596320,91210589,7q21.13,7q21.13,610679,"CDK14, PFTK1, PFTAIRE1, KIAA0834",Cyclin-dependent kinase 14,CDK14,5218,ENSG00000058091,NA,NA,Cdk14 (MGI:894318)
7,91264432,91271325,7q21,7q21.13,603408,FZD1,"Frizzled, Drosophila, homolog of, 1",FZD1,8321,ENSG00000157240,NA,NA,Fzd1 (MGI:1196625)
7,91500000,98400000,7q21.2-q21.3,NA,183600,"SHFM1, SHFD1, SHSF1",Split hand/foot malformation (ectrodactyly) type 1,NA,NA,NA,contiguous gene deletion syndrome,"Split hand/foot malformation 1, 183600 (4), Autosomal dominant",NA
7,91870928,91880732,7q21.2,7q21.2,602318,MTERF,"Transcription termination factor, mitochondrial",MTERF1,7978,ENSG00000127989,NA,NA,"Mterf1a,Mterf1b (MGI:1918240,MGI:3704243)"
7,91940861,92112907,7q21-q22,7q21.2,604001,"AKAP9, YOTIAO, AKAP450",A-kinase anchor protein 9,AKAP9,10142,ENSG00000127914,mutation identified in 1 LQT11 family,"?Long QT syndrome-11, 611820 (3), Autosomal dominant",NA
7,92112148,92134744,7q21.2-q21.3,7q21.2,601637,"CYP51A1, CYP51","Cytochrome P450, family 51, subfamily A, polypeptide 1 (lanosterol 14-alpha-demethylase)",CYP51A1,1595,ENSG00000001630,NA,NA,Cyp51 (MGI:106040)
7,92198968,92246099,7q11.2-q21,7q21.2,604214,"CCM1, CAM, KRIT1",KREV interaction trapped 1,KRIT1,889,ENSG00000001631,NA,"Cavernous malformations of CNS and retina, 116860 (3), Autosomal dominant; Cerebral cavernous malformations-1, 116860 (3), Autosomal dominant; Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3), Autosomal dominant",Krit1 (MGI:1930618)
7,92447447,92494630,7q21.2,7q21.2,614518,"GATAD1, ODAG, CMD2B",GATA zinc finger domain-containing protein 1,GATAD1,57798,ENSG00000157259,mutation identified in 1 GATAD1 family,"?Cardiomyopathy, dilated, 2B, 614672 (3), Autosomal recessive",Gatad1 (MGI:1914460)
7,92468379,92477945,7q21-q22,7q21.2,604659,"ERVW1, ERVWE1, HERVW","Endogenous retroviral family W, member 1 (syncytin)",ERVW-1,30816,ENSG00000242950,NA,NA,NA
7,92487022,92528519,7q21-q22,7q21.2,602136,"PEX1, ZWS1, PBD1A, PBD1B, HMLR1",Peroxisome biogenesis factor-1,PEX1,5189,ENSG00000127980,NA,"Heimler syndrome 1, 234580 (3), Autosomal recessive; Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3), Autosomal recessive; Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3), Autosomal recessive",Pex1 (MGI:1918632)
7,92604920,92836626,7q21-q22,7q21.2,603368,"CDK6, PLSTIRE, MCPH12",Cyclin-dependent kinase 6,CDK6,1021,ENSG00000105810,mutation identified in 1 MCPH12 family,"?Microcephaly 12, primary, autosomal recessive, 616080 (3), Autosomal recessive",Cdk6 (MGI:1277162)
7,93099512,93118022,7q21,7q21.2,610456,"SAMD9, NFTC, MIRAGE",Sterile alpha motif domain-containing protein 9,SAMD9,54809,ENSG00000205413,NA,"MIRAGE syndrome, 617053 (3), Autosomal dominant; Tumoral calcinosis, familial, normophosphatemic, 610455 (3), Autosomal recessive",NA
7,93130055,93148384,7q21.2,7q21.2,611170,"SAMD9L, ATXPC",Sterile alpha motif domain-containing 9-like,SAMD9L,219285,ENSG00000177409,NA,"Ataxia-pancytopenia syndrome, 159550 (3), Autosomal dominant",Samd9l (MGI:1343184)
7,93188533,93232292,7q21.2-q21.3,7q21.2,614133,"HEPACAM2, MIKI",Hepacam family member 2,HEPACAM2,253012,ENSG00000188175,NA,NA,Hepacam2 (MGI:2141520)
7,93232339,93361122,7q21.2-q21.3,7q21.2-q21.3,616465,"VPS50, CCDC132, KIAA1861","VPS50, EARP/GARPII complex subunit",VPS50,55610,ENSG00000004766,NA,NA,Vps50 (MGI:1920538)
7,93424485,93574729,7q21.3,7q21.3,114131,"CALCR, CRT",Calcitonin receptor,CALCR,799,ENSG00000004948,not deleted in Williams syndrome,"{Osteoporosis, postmenopausal, susceptibility}, 166710 (3), Autosomal dominant",Calcr (MGI:101950)
7,93483935,93484018,7q21.3,7q21.3,614523,MIR489,Micro RNA 489,MIR489,574442,ENSG00000207656,in intron 4 of CALCR,NA,NA
7,93885395,93890752,7q22,7q21.3,600033,TFPI2,Tissue factor pathway inhibitor-2,TFPI2,7980,ENSG00000105825,NA,NA,Tfpi2 (MGI:108543)
7,93906566,93911264,7q21.3,7q21.3,189970,GNGT1,"Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 1",GNGT1,2792,ENSG00000127928,NA,NA,Gngt1 (MGI:109165)
7,93921734,93928609,7q21.3,7q21.3,604390,GNG11,"Guanine nucleotide-binding protein, gamma 11",GNG11,2791,ENSG00000127920,NA,NA,Gng11 (MGI:1913316)
7,93962769,94004381,7q21.3,7q21.3,605456,BET1,Bet1 golgi vesicular membrane-trafficking protein,BET1,10282,ENSG00000105829,NA,NA,Bet1 (MGI:1343104)
7,94394560,94431231,7q22.1,7q21.3,120160,"COL1A2, EDSCV, EDSARTH2","Collagen I, alpha-2 polypeptide",COL1A2,1278,ENSG00000164692,~17cM from CF,"Ehlers-Danlos syndrome, arthrochalasia type, 2, 617821 (3), Autosomal dominant; Ehlers-Danlos syndrome, cardiac valvular type, 225320 (3), Autosomal recessive; Osteogenesis imperfecta, type II, 166210 (3), Autosomal dominant; Osteogenesis imperfecta, type III, 259420 (3), Autosomal dominant; Osteogenesis imperfecta, type IV, 166220 (3), Autosomal dominant; {Osteoporosis, postmenopausal}, 166710 (3), Autosomal dominant",Col1a2 (MGI:88468)
7,94509808,94633464,7q21,7q21.3,611686,"CASD1, C7orf12",CAS1 domain-containing protein 1,CASD1,64921,ENSG00000127995,NA,NA,Casd1 (MGI:2384865)
7,94584979,94656204,7q21,7q21.3,604149,"SGCE, DYT11","Sarcoglycan, epsilon",SGCE,8910,ENSG00000127990,pseudogene on 2q21; maternally imprinted,"Dystonia-11, myoclonic, 159900 (3), Autosomal dominant",Sgce (MGI:1329042)
7,94656324,94669694,7q21,7q21.3,609810,"PEG10, KIAA1051",Paternally expressed gene 10,PEG10,23089,ENSG00000242265,NA,NA,Peg10 (MGI:2157785)
7,94907201,95296414,7q21.3,7q21.3,602468,"PPP1R9A, NRBI, NRB1, KIAA1222","Protein phosphatase 1, regulatory subunit 9A (neurabin I)",PPP1R9A,55607,ENSG00000158528,NA,NA,Ppp1r9a (MGI:2442401)
7,95297675,95324531,7q21.3,7q21.3,168820,"PON1, PON, ESA, MVCD5",Paraoxonase-1,PON1,5444,ENSG00000005421,NA,"{Coronary artery disease, susceptibility to} (3); {Coronary artery spasm 2, susceptibility to (3); {Microvascular complications of diabetes 5}, 612633 (3); {Organophosphate poisoning, sensitivity to} (3)",Pon1 (MGI:103295)
7,95359871,95396374,7q21.3,7q21.3,602720,PON3,Paraoxonase-3,PON3,5446,ENSG00000105852,NA,NA,Pon3 (MGI:106686)
7,95404861,95435071,7q21.3,7q21.3,602447,PON2,Paraoxonase-2,PON2,5445,ENSG00000105854,NA,"{Coronary artery disease, susceptibility to} (3)",Pon2 (MGI:106687)
7,95485438,95544737,7q21-q22,7q21.3,605761,ASB4,Ankyrin repeat-containing SOCS box protein 4,ASB4,51666,ENSG00000005981,NA,NA,Asb4 (MGI:1929751)
7,95583498,95596515,7q21.3-q22.1,7q21.3,602527,PDK4,"Pyruvate dehydrogenase kinase, isoenzyme 4",PDK4,5166,ENSG00000004799,NA,NA,Pdk4 (MGI:1351481)
7,95772505,96110321,7q21.3-q22.1,7q21.3,603772,DNCI1,"Dynein, cytoplasmic, intermediate chain 1",DYNC1I1,1780,ENSG00000158560,NA,NA,Dync1i1 (MGI:107743)
7,96120219,96322146,7q21.3,7q21.3,603859,"SLC25A13, CTLN2","Solute carrier family 25 (mitochondrial carrier, citrin), member 13",SLC25A13,10165,ENSG00000004864,NA,"Citrullinemia, adult-onset type II, 603471 (3), Autosomal recessive; Citrullinemia, type II, neonatal-onset, 605814 (3), Autosomal recessive",Slc25a13 (MGI:1354721)
7,96481625,96709890,7q21.3-q22.1,7q21.3,601285,"SEM!, DSS1",Proteasome 26S subunit SEM1,SEM1,7979,ENSG00000127922,?gene mutant in SHFM1,NA,Sem1 (MGI:109238)
7,97005552,97011039,7q22,7q21.3,600030,DLX6,Distal-less homeo box-6,DLX6,1750,ENSG00000006377,NA,NA,Dlx6 (MGI:101927)
7,97020395,97024830,7q22,7q21.3,600028,"DLX5, SHFM1D",Distal-less homeo box-5,DLX5,1749,ENSG00000105880,mutation identified in 1 family,"?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3), Autosomal recessive",Dlx5 (MGI:101926)
7,97116592,97181762,7q21.3,7q21.3,615773,ACN9,"Acn9, S. cerevisiae, homolog of",SDHAF3,57001,ENSG00000196636,NA,NA,Sdhaf3 (MGI:1913288)
7,97732085,97740471,7q21-q22,7q21.3,162320,"TAC1, TAC2, NKNA",Tachykinin 1 (substance K; neurokinin A; neurokinin 2; neuromedin L; neuropeptide gamma; tachykinin 2),TAC1,6863,ENSG00000006128,NA,NA,Tac1 (MGI:98474)
7,97851676,97928440,7q21-q31,7q21.3,108370,"ASNS, ASNSD",Asparagine synthetase,ASNS,440,ENSG00000070669,temperature sensitive G1 mutant,"Asparagine synthetase deficiency, 615574 (3), Autosomal recessive",Asns (MGI:1350929)
7,98106861,98209637,7q21.3-q22.1,7q21.3,610989,"LMTK2, KPI2, BREK, KIAA1079",Lemur tyrosine kinase 2,LMTK2,22853,ENSG00000164715,NA,NA,Lmtk2 (MGI:3036247)
7,98212253,98212958,7q21,7q21.3,608606,"BHLHA15, MIST1","Basic helix-loop-helix family, member A15",BHLHA15,168620,ENSG00000180535,NA,NA,Bhlha15 (MGI:891976)
7,98214623,98252234,7q21.3,7q21.3,614781,"TECPR1, KIAA1358",Tectonin beta-propeller repeat-containing 1,TECPR1,25851,ENSG00000205356,NA,NA,Tecpr1 (MGI:1917631)
7,98281672,98322397,7q21.3,7q21.3,615628,BRI3,Brain protein I3,BRI3,25798,ENSG00000164713,NA,NA,Bri3 (MGI:1933174)
7,98291649,98401089,7q21.3-q22.1,7q21.3-q22.1,611877,"BAIAP2L1, IRTKS",BAI1-associated protein 2-like 1,BAIAP2L1,55971,ENSG00000006453,NA,NA,Baiap2l1 (MGI:1914148)
7,98400000,107800000,7q22,NA,209850,AUTS1,"Autism, susceptibility to, 1",NA,100188832,NA,NA,"{Autism susceptibility 1}, 209850 (2), Isolated cases, Multifactorial",NA
7,98400000,132900000,7q22-q32,NA,148750,G7P1,Kinase-like protein,NA,NA,NA,NA,NA,NA
7,98400000,104200000,7q22.1,NA,612130,GAEC1,Gene amplified in esophageal cancer 1,NA,100126794,NA,NA,NA,NA
7,98400000,107800000,7q22,NA,191390,IBD11,Inflammatory bowel disease 11,NA,100529151,NA,associated with MUC3A,"{Inflammatory bowel disease 11}, 191390 (2), Multifactorial",NA
7,98400000,107800000,7q22,NA,605633,MUC3B,"Mucin 3B, intestinal",MUC3B,57876,NA,NA,NA,NA
7,98400000,107800000,7q22,NA,608580,MYH16,"Myosin, heavy chain 16, skeletal muscle",MYH16,84176,NA,inactivated in humans; expressed in masticatory muscles in nonhuman primates,NA,NA
7,98400000,159345973,7q22-qter,NA,162820,"NM, NCR","Neutrophil migration, abnormal",NM,4827,NA,NA,"?Neutrophil chemotactic response, abnormal, 162820 (2), Autosomal dominant",NA
7,98400000,107800000,7q22,NA,608562,PAPA4,"Polydactyly, postaxial, type A4",NA,450096,NA,highest lod with D7S1799,"Polydactyly, postaxial, type A4, 608562 (2)",NA
7,98400000,132900000,7q22-q32,NA,607458,"SCA18, SMNA",Spinal cerebellar ataxia 18,SCA18,94008,NA,between D7S2418 and D7S1804,"Spinocerebellar ataxia 18, 607458 (2), Autosomal dominant",NA
7,98617284,98629868,7q21.3-q22.1,7q22.1,600750,NPTX2,Pentraxin II,NPTX2,4885,ENSG00000106236,NA,NA,Nptx2 (MGI:1858209)
7,98878489,99013242,7q21.2-q22.1,7q22.1,603015,"TRRAP, DEDDFA",Transformation/transcription domain-associated protein,TRRAP,8295,ENSG00000196367,NA,"Developmental delay with or without dysmorphic facies and autism, 618454 (3), Autosomal dominant",Trrap (MGI:2153272)
7,99027434,99144117,7q21.1-q31.1,7q22.1,605568,SMURF1,SMAD ubiquitination regulatory factor 1,SMURF1,57154,ENSG00000198742,NA,NA,Smurf1 (MGI:1923038)
7,99145466,99219416,7q22.1,7q22.1,614107,KPNA7,Karyopherin alpha 7,KPNA7,402569,ENSG00000185467,NA,NA,Kpna7 (MGI:2141165)
7,99325872,99366261,7q21-q22,7q22.1,604220,"ARPC1A, SOP2L","Actin-related protein 2/3 complex, subunit 1A",ARPC1A,10552,ENSG00000241685,NA,NA,Arpc1a (MGI:1928896)
7,99374253,99394815,7q21-q22,7q22.1,604223,"ARPC1B, ARC41, PLTEID","Actin-related protein 2/3 complex, subunit 1B",ARPC1B,10095,ENSG00000130429,NA,"Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, 617718 (3), Autosomal recessive",Arpc1b (MGI:1343142)
7,99394672,99408596,7q22.1,7q22.1,607075,"PDAP1, PAP1, PAP",PDGFA-associated protein 1,PDAP1,11333,ENSG00000106244,NA,NA,Pdap1 (MGI:2448536)
7,99408640,99419615,7q22.1,7q22.1,603477,"BUD31, G10","Bud31, S. cerevisiae, homolog of",BUD31,8896,ENSG00000106245,NA,NA,NA
7,99416738,99438797,7q22.1,7q22.1,614774,"PTCD1, KIAA0632",Pentatricopeptide repeat domain 1,PTCD1,26024,ENSG00000106246,NA,NA,NA
7,99438911,99457376,7q21-q22,7q22.1,603052,"CPSF4, CPSF30, NEB1","Cleavage-polyadenylation specificity factor 4, 30kD",CPSF4,10898,ENSG00000160917,NA,NA,Cpsf4 (MGI:1861602)
7,99504649,99534699,7q22.1,7q22.1,611272,"ZKSCAN5, ZFP95, KIAA1015",Zinc finger protein with KRAB and SCAN domains 5,ZKSCAN5,23660,ENSG00000196652,NA,NA,Zkscan5 (MGI:107533)
7,99558421,99576452,7q22.1,7q22.1,617891,"ZNF655, VIK",Zinc finger protein 655,ZNF655,79027,ENSG00000197343,NA,NA,Zfp655 (MGI:1919861)
7,99648188,99680025,7q22.1,7q22.1,605325,"CYP3A5, P450PCN3","Cytochrome P450, subfamily IIIA, polypeptide 5",CYP3A5,1577,ENSG00000106258,NA,"{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3), Multifactorial","Cyp3a16,Cyp3a11,Cyp3a41b,Cyp3a44,Cyp3a41a (MGI:2449818,MGI:106099,MGI:3714859,MGI:88609,MGI:1858451)"
7,99705035,99735195,7q22.1,7q22.1,605340,CYP3A7,"Cytochrome P450, subfamily IIIA, polypeptide 7",CYP3A7,1551,ENSG00000160870,NA,NA,Cyp3a13 (MGI:88610)
7,99756966,99784183,7q22.1,7q22.1,124010,CYP3A4,"Cytochrome P450, subfamily IIIA (nifedipine oxidase) polypeptide 4",CYP3A4,1576,ENSG00000160868,NA,NA,NA
7,99827625,99867137,7q22.1,7q22.1,606534,CYP3A43,"Cytochrome P450, subfamily IIIa, polypeptide 43",CYP3A43,64816,ENSG00000021461,NA,NA,NA
7,99923265,99929619,7q22.1,7q22.1,611925,"GJC3, CX30.2, CX31.3","Gap junction protein, gamma-3",GJC3,349149,ENSG00000176402,NA,NA,Gjc3 (MGI:2153041)
7,99966729,99976030,7q22.1,7q22.1,194460,"AZGP1, ZAG","Alpha-2-glycoprotein, zinc",AZGP1,563,ENSG00000160862,NA,NA,Azgp1 (MGI:103163)
7,100015551,100045373,7q21-q22,7q22.1,601260,"ZNF36, KOX18",Zinc finger protein-36 (KOX 18),ZKSCAN1,7586,ENSG00000106261,NA,NA,Zkscan1 (MGI:1921820)
7,100049773,100065040,7q21-q22,7q22.1,601261,"ZNF38, KOX25",Zinc finger protein-38 (KOX 25),ZSCAN21,7589,ENSG00000166529,NA,NA,Zscan21 (MGI:99182)
7,100063836,100082576,7q22.1,7q22.1,194510,ZNF3,Zinc finger protein-3,ZNF3,7551,ENSG00000166526,"?relation to ZNF4, ZNF5; previous assignment to Chr.5",NA,Zfp113 (MGI:1929116)
7,100088968,100092186,7q22.1,7q22.1,614729,"COPS6, CSN6","COP9 signalosome, subunit 6",COPS6,10980,ENSG00000168090,NA,NA,Cops6 (MGI:1349439)
7,100092727,100101939,7q21.3-q22.1,7q22.1,600592,"MCM7, MCM2","Minichromosome maintenance deficient, S. cerevisiae, homolog of, 7",MCM7,4176,ENSG00000166508,NA,NA,Mcm7 (MGI:1298398)
7,100093559,100093642,7q22.1,7q22.1,612150,"MIR25, MIRN25",Micro RNA 25,MIR25,407014,ENSG00000207547,NA,NA,NA
7,100093767,100093846,7q22,7q22.1,612984,"MIR93, MIRN9",Micro RNA 93,MIR93,407050,ENSG00000207757,NA,NA,NA
7,100093992,100094073,7q22,7q22.1,612983,"MIR106B, MIRN106B",Micro RNA 106B,MIR106B,406900,ENSG00000208036,NA,NA,NA
7,100101412,100109038,7q22.1,7q22.1,602296,"AP4M1, SPG50, CPSQ3","Adaptor-related protein complex 4, mu-1 subunit",AP4M1,9179,ENSG00000221838,NA,"Spastic paraplegia 50, autosomal recessive, 612936 (3), Autosomal recessive",Ap4m1 (MGI:1337063)
7,100107069,100127207,7q22.1,7q22.1,602955,"TAF6, TAF2E, TAFII80, ALYUS","TAF6 RNA polymerase II, TATA box-binding protein-associated factor, 80kD",TAF6,6878,ENSG00000106290,NA,"Alazami-Yuan syndrome, 617126 (3), Autosomal recessive",Taf6 (MGI:109129)
7,100119633,100125507,7q22.1,7q22.1,610047,"CNPY4, PRAT4B, MGC40499","Canopy 4, zebrafish, homolog of",CNPY4,245812,ENSG00000166997,NA,NA,Cnpy4 (MGI:1913705)
7,100154422,100158722,7q22.1,7q22.1,618350,"MAP11, C7orf43, MCPH25",Microtubule-associated protein 11,MAP11,55262,ENSG00000146826,mutation identified in 1 MCHP25 family,"?Microcephaly 25, primary, autosomal recessive, 618351 (3), Autosomal recessive",Map11 (MGI:2385896)
7,100159243,100168616,7q22,7q22.1,608235,GAL3ST4,Galactose-3-O-sulfotransferase 4,GAL3ST4,79690,ENSG00000197093,NA,NA,Gal3st4 (MGI:1916254)
7,100169605,100177380,7q22.1,7q22.1,618446,GPC2,Glypican 2,GPC2,221914,ENSG00000213420,NA,NA,Gpc2 (MGI:1919201)
7,100177562,100219333,7q22,7q22.1,608489,"STAG3, POF8",Stromalin 3,STAG3,10734,ENSG00000066923,NA,"Premature ovarian failure 8, 615723 (3), Autosomal recessive",Stag3 (MGI:1355311)
7,100218624,100221488,7q22.1,7q22.1,617012,"PVRIG, CD112R, C7orf15",Poliovirus receptor-related immunoglobulin domain-containing protein,PVRIG,79037,ENSG00000213413,NA,NA,Pvrig (MGI:5596028)
7,100306797,100322195,7q22.1,7q22.1,617625,"SPDYE3, SPDYB2","SPEEDY/RINGO cell cycle regulator family, member E3",SPDYE3,441272,ENSG00000214300,NA,NA,NA
7,100320639,100336306,7q22.1,7q22.1,605038,"PMS2P1, PMS2L1, PMS3",Postmeiotic segregation increased 2 pseudogene 1,PMS2P1,5379,NA,NA,NA,NA
7,100358002,100367830,7q22,7q22.1,605342,PILRB,"Paired immunoglobulin-like receptor, beta",PILRB,29990,ENSG00000121716,NA,NA,"Pilrb1,Pilrb2 (MGI:2450532,MGI:2450535)"
7,100372658,100400097,7q22,7q22.1,605341,PILRA,"Paired immunoglobulin-like receptor, alpha",PILRA,29992,ENSG00000085514,NA,NA,Pilra (MGI:2450529)
7,100428789,100434117,7q22,7q22.1,611478,"MEPCE, BCDIN3",Methylphosphate capping enzyme,MEPCE,56257,ENSG00000146834,NA,NA,Mepce (MGI:106477)
7,100466518,100479278,7p21-p15,7q22.1,611914,"TSC22D4, THG1","TSC22 domain family, member 4",TSC22D4,81628,ENSG00000166925,NA,NA,Tsc22d4 (MGI:1926079)
7,100483926,100494801,7q22.1,7q22.1,615477,NYPA1,Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1,NYAP1,222950,ENSG00000166924,NA,NA,Nyap1 (MGI:2443880)
7,100539202,100568219,7q22.1,7q22.1,604019,"AGFG2, HRBL, RABR",ADP-ribosylation factor GTPase-activating protein with FG repeats 2,AGFG2,3268,ENSG00000106351,NA,NA,Agfg2 (MGI:2443267)
7,100574010,100575218,7q22,7q22.1,617677,ZASP,ZO2-associated speckle protein,NA,101927655,NA,NA,NA,NA
7,100582489,100601116,7q22,7q22.1,609097,"FBXO24, FBX24",F-box only protein 24,FBXO24,26261,ENSG00000106336,NA,NA,Fbxo24 (MGI:1918426)
7,100602362,100608174,7q21.3-q22,7q22.1,600270,PCOLCE,Procollagen C-endopeptidase enhancer,PCOLCE,5118,ENSG00000106333,NA,NA,Pcolce (MGI:105099)
7,100620415,100641551,7q22,7q22.1,604720,"TFR2, HFE3",Transferrin receptor 2,TFR2,7036,ENSG00000106327,NA,"Hemochromatosis, type 3, 604250 (3), Autosomal recessive",Tfr2 (MGI:1354956)
7,100643096,100656460,7q22,7q22.1,612458,"ACTL6B, BAF53B, IDDSSAD, EIEE76",Actin-like 6B,ACTL6B,51412,ENSG00000077080,NA,"Epileptic encephalopathy, early infantile, 76, 618468 (3); Intellectual developmental disorder with severe speech and ambulation defects, 618470 (3), Autosomal dominant",Actl6b (MGI:1933548)
7,100673739,100679168,7q21,7q22.1,139390,GNB2,"Guanine nucleotide-binding protein, beta polypeptide-2",GNB2,2783,ENSG00000172354,30-70kb from EPO,NA,Gnb2 (MGI:95784)
7,100679505,100694279,7q22.1,7q22.1,612064,GIGYF1,GRB10-interacting GYF protein 1,GIGYF1,64599,ENSG00000146830,NA,NA,Gigyf1 (MGI:1888677)
7,100706120,100707485,7q22,7q22.1,606113,"POP7, RPP20","Processing of precursor 7, S. cerevisiae, homolog of",POP7,10248,ENSG00000172336,NA,NA,Pop7 (MGI:1921347)
7,100720467,100723699,7q21,7q22.1,133170,"EPO, MVCD2, ECYT5, DBAL",Erythropoietin,EPO,2056,ENSG00000130427,mutation identified in 1 DBAL family,"?Diamond-Blackfan anemia-like, 617911 (3), Autosomal recessive; Erythrocytosis, familial, 5, 617907 (3), Autosomal dominant; {Microvascular complications of diabetes 2}, 612623 (3)",Epo (MGI:95407)
7,100733594,100797796,7q22,7q22.1,602372,ZAN,Zonadhesin,ZAN,7455,ENSG00000146839,NA,NA,Zan (MGI:106656)
7,100802564,100827522,7q22,7q22.1,600011,"EPHB4, HTK, MYK1, HFASD, CMAVM2, LMPHM7",Ephrin receptor EphB4 (hepatoma transmembrane kinase),EPHB4,2050,ENSG00000196411,NA,"Capillary malformation-arteriovenous malformation 2, 618196 (3), Autosomal dominant; Lymphatic malformation 7, 617300 (3), Autosomal dominant",Ephb4 (MGI:104757)
7,100826868,100867011,7q22,7q22.1,616861,"SLC12A9, CIP1, CCC6","Solute carrier family 12 (potassium/chloride transporter), member 9",SLC12A9,56996,ENSG00000146828,NA,NA,Slc12a9 (MGI:1933532)
7,100867386,100873453,7q22,7q22.1,602933,"TRIP6, OIP1",Thyroid hormone receptor interactor-6,TRIP6,7205,ENSG00000087077,NA,NA,Trip6 (MGI:1343458)
7,100874970,100888663,7q22,7q22.1,614469,"SRRT, ARS2","Serrate RNA effector molecule, arabidopsis, homolog of",SRRT,51593,ENSG00000087087,NA,NA,Srrt (MGI:1933527)
7,100888720,100889714,7q22.1,7q22.1,611481,UFSP1,UFM1-specific peptidase 1,UFSP1,402682,ENSG00000176125,NA,NA,Ufsp1 (MGI:1917490)
7,100889993,100896993,7q22,7q22.1,100740,"ACHE, YT",Acetylcholinesterase (YT blood group),ACHE,43,ENSG00000087085,blood group YT (112100) = epitope of ACHE,"[Blood group, Yt system], 112100 (3)",Ache (MGI:87876)
7,100949053,100968346,7q22,7q22.1,158371,MUC3A,"Mucin 3A, intestinal",MUC3A,4584,ENSG00000169894,NA,NA,Muc3a (MGI:3588263)
7,100969622,101018948,7q22,7q22.1,604609,"MUC12, MUC11",Mucin 12,MUC12,10071,ENSG00000205277,NA,NA,NA
7,101020080,101058858,7q22,7q22.1,608424,MUC17,Mucin 17,MUC17,140453,ENSG00000169876,NA,NA,NA
7,101085423,101097966,7q22.1,7q22.1,616996,TRIM56,Tripartite motif-containing protein 56,TRIM56,81844,ENSG00000169871,NA,NA,Trim56 (MGI:2685298)
7,101127088,101139265,7q21.3-q22,7q22.1,173360,"PAI1, PLANH1, SERPINE1","Plasminogen activator inhibitor, type I",SERPINE1,5054,ENSG00000106366,NA,"Plasminogen activator inhibitor-1 deficiency, 613329 (3), Autosomal recessive, Autosomal dominant; {Transcription of plasminogen activator inhibitor, modulator of} (3)",Serpine1 (MGI:97608)
7,101154475,101161275,7q22.1,7q22.1,603531,"AP1S1, CLAPS1, AP19, MEDNIK","Adaptor-related protein complex 1, sigma 1 subunit",AP1S1,1174,ENSG00000106367,NA,"MEDNIK syndrome, 609313 (3), Autosomal recessive",Ap1s1 (MGI:1098244)
7,101162508,101169955,7q22,7q22.1,602186,VGF,VGF nerve growth factor inducible,VGF,7425,ENSG00000128564,NA,NA,Vgf (MGI:1343180)
7,101170495,101180292,7q22.1,7q22.1,615783,NAT16,N-acetyltransferase 16,NAT16,375607,ENSG00000167011,NA,NA,NA
7,101192885,101201130,7q22.1,7q22.1,610184,"MOGAT3, MGAT3",Monoacylglycerol O-acyltransferase 3,MOGAT3,346606,ENSG00000106384,NA,NA,NA
7,101205983,101217580,7q22,7q22.1,603066,"PLOD3, LH3","Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3)",PLOD3,8985,ENSG00000106397,previously assigned to 7q36,"Lysyl hydroxylase 3 deficiency, 612394 (3), Autosomal recessive",Plod3 (MGI:1347008)
7,101232091,101238819,7q22.1,7q22.1,615778,CLDN15,Claudin 15,CLDN15,24146,ENSG00000106404,NA,NA,Cldn15 (MGI:1913103)
7,101239471,101245080,7q22.1,7q22.1,609003,"TTC11, FIS1",Tetratricopeptide repeat domain 11,FIS1,51024,ENSG00000214253,NA,NA,Fis1 (MGI:1913687)
7,101613329,101629295,7q22.1,7q22.1,617177,"MYL10, PLRLC",Myosin light chain 10,MYL10,93408,ENSG00000106436,NA,NA,Myl10 (MGI:1891705)
7,101815990,102283957,7q22,7q22.1,116896,"CUX1, CUTL1, CDP, GDDI",Cut-like homeobox 1,CUX1,1523,ENSG00000257923,NA,"Global developmental delay with or without impaired intellectual development, 618330 (3), Autosomal dominant",NA
7,102284524,102321710,7q22,7q22.1,605300,APS,Adaptor protein containing PH and SH2 domains,SH2B2,10603,ENSG00000160999,NA,NA,Sh2b2 (MGI:1345171)
7,102396362,102426665,7q22.1,7q22.1,617458,"PRKRIP1, C114","PRKR-interacting protein 1, IL11-inducible",PRKRIP1,79706,ENSG00000128563,NA,NA,Prkrip1 (MGI:1914051)
7,102433529,102456824,7q22.1,7q22.1,610929,"ORAI2, MEM142B, C7orf19",ORAI calcium release-activated calcium modulator 2,ORAI2,80228,ENSG00000160991,NA,NA,Orai2 (MGI:2443195)
7,102456219,102464862,7q22.1,7q22.1,613302,"ALKBH4, ABH4","AlkB, E. coli, homolog of, 4",ALKBH4,54784,ENSG00000160993,NA,NA,Alkbh4 (MGI:1919291)
7,102464882,102473167,7q22.1,7q22.1,615167,"LRWD1, ORCA",Leucine-rich repeats- and WD repeat domain-containing protein 1,LRWD1,222229,ENSG00000161036,NA,NA,Lrwd1 (MGI:1918985)
7,102473093,102478933,7q22-q31.1,7q22.1,604150,POLR2J,"Polymerase II, RNA, subunit J",POLR2J,5439,ENSG00000005075,NA,NA,Polr2j (MGI:109582)
7,102551231,102565226,7q22.1,7q22.1,617624,"SPDYE2, SPDYB2L1","SPEEDY/RINGO cell cycle regulator family, member E2",SPDYE2,441273,ENSG00000205238,NA,NA,NA
7,102579645,102616757,7q22,7q22.1,607943,"RASA4, CAPRI, GAPL, KIAA0538",Ras p21 protein activator 4,RASA4,10156,ENSG00000105808,NA,NA,Rasa4 (MGI:1858600)
7,102636747,102671734,7q11.2,7q22.1,609881,"POLR2J2, RPB11",RNA polymerase II polypeptide J-related gene,POLR2J2,246721,ENSG00000267645,NA,NA,NA
7,102810965,103075215,7q22.1,7q22.1,609080,"EBXL13, FBL13",F-box and leucine-rich repeat protein 13,FBXL13,222235,ENSG00000161040,NA,NA,Fbxl13 (MGI:2443416)
7,102973429,102978666,7q22.1,7q22.1,612133,NFE4,Transcription factor NFE4,NFE4,58160,ENSG00000230257,NA,NA,NA
7,103074880,103099772,7q11.2,7q22.1,611864,"ARMC10, SVH",Armadillo repeat-containing 10,ARMC10,83787,ENSG00000170632,NA,NA,Armc10 (MGI:1914461)
7,103099575,103149559,7q22.1,7q22.1,612334,NAPEPLD,N-acyl phosphatidylethanolamine-hydrolyzing phospholipase D,NAPEPLD,222236,ENSG00000161048,NA,NA,Napepld (MGI:2140885)
7,103297434,103329901,7q22.1,7q22.1,603131,"PMPCB, MPPB","Peptidase, mitochondrial processing, beta",PMPCB,9512,ENSG00000105819,NA,"Multiple mitochondrial dysfunctions syndrome 6, 617954 (3), Autosomal recessive",Pmpcb (MGI:1920328)
7,103312288,103344872,7q22,7q22.1,605502,"DNAJC2, ZRF1, MPP11","DnaJ (Hsp40) homolog, subfamily C, member 2",DNAJC2,27000,ENSG00000105821,NA,NA,Dnajc2 (MGI:99470)
7,103344404,103369394,7q22.1-q22.3,7q22.1,154365,"PSMC2, MSS1, S7","Proteasome 26S subunit, ATPase, 2",PSMC2,5701,ENSG00000161057,NA,NA,Psmc2 (MGI:109555)
7,103352597,103446206,7q22.1,7q22.1,604943,"SLC26A5, PRES, DFNB61","Solute carrier family 26, member 5",SLC26A5,375611,ENSG00000170615,mutation identified in 1 DFNB61 family,"?Deafness, autosomal recessive 61, 613865 (3), Autosomal recessive",Slc26a5 (MGI:1933154)
7,103471783,103989657,7q22,7q22.1,600514,"RELN, RL, LIS2, ETL7",Reelin,RELN,5649,ENSG00000189056,NA,"{Epilepsy, familial temporal lobe, 7}, 616436 (3), Autosomal dominant; Lissencephaly 2 (Norman-Roberts type), 257320 (3), Autosomal recessive",Reln (MGI:103022)
7,104126340,104208046,7q22.1,7q22.1-q22.2,602331,"ORC5, ORC5L","Origin recognition complex, subunit 5, S. cerevisiae, homolog of",ORC5,5001,ENSG00000164815,NA,NA,Orc5 (MGI:1347044)
7,104328655,104908557,7q22.1,7q22.2-q22.3,609719,LHFPL3,LHFP-like protein 3,LHFPL3,375612,ENSG00000187416,NA,NA,Lhfpl3 (MGI:1925076)
7,104900000,115000000,7q22.3-q31.1,NA,609915,CMD1Q,"Cardiomyopathy, dilated, 1Q",CMD1Q,664728,NA,between D7S2545 and D7S2554,"Cardiomyopathy, dilated, 1Q, 609915 (2)",NA
7,104900000,107800000,7q22.3,NA,614646,MPVQTL6,Mean platelet volume quantitative trait locus 6,NA,100887751,NA,associated with rs342293,"Mean platelet volume QTL6, 614646 (2)",NA
7,104940948,105115018,7q22,7q22.3,608444,"KMT2E, MLL5",Lysine (K)-specific methyltransferase 2E,KMT2E,55904,ENSG00000005483,NA,NA,Kmt2e (MGI:1924825)
7,105456500,105522270,7q22.3,7q22.3,616261,"PUS7, KIAA1897, IDDABS","Pseudouridylate synthase 7, putative",PUS7,54517,ENSG00000091127,NA,"Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature, 618342 (3), Autosomal recessive",Pus7 (MGI:1925947)
7,105532080,105567683,7q22.3,7q22.3,610089,RINT1,RAD50-interacting protein 1,RINT1,60561,ENSG00000135249,NA,NA,Rint1 (MGI:1916233)
7,105876749,106036431,7q22.3,7q22.3,615610,CDHR3,"Cadherin-related family, member 3",CDHR3,222256,ENSG00000128536,NA,NA,Cdhr3 (MGI:1916014)
7,106090361,106112575,7q22.3,7q22.3,616665,"SYPL1, SYPL",Synaptophysin-like 1,SYPL1,6856,ENSG00000008282,NA,NA,Sypl (MGI:108081)
7,106248297,106284982,7q22.2,7q22.3,608764,"NAMPT, PBEF1, VF, PBEF",Nicotinamide phosphoribosyltransferase,NAMPT,10135,ENSG00000105835,NA,NA,Nampt (MGI:1929865)
7,106865281,106908979,7q22,7q22.3,601232,PIK3CG,"Phosphatidylinositol 3-kinase, catalytic, gamma",PIK3CG,5294,ENSG00000105851,NA,NA,Pik3cg (MGI:1353576)
7,107044704,107161810,7q22,7q22.3,176912,PRKAR2B,"Protein kinase, cAMP-dependent, regulatory, type II, beta",PRKAR2B,5577,ENSG00000005249,NA,NA,Prkar2b (MGI:97760)
7,107168960,107202528,7q22.3,7q22.3,616714,HBP1,HMG-box transcription factor 1,HBP1,26959,ENSG00000105856,NA,NA,Hbp1 (MGI:894659)
7,107201743,107564513,7q31,7q22.3,606821,"COG5, GOLTC1, GTC90, CDG2I",Component of oligomeric golgi complex 5,COG5,10466,ENSG00000164597,NA,"Congenital disorder of glycosylation, type IIi, 613612 (3)",Cog5 (MGI:2145130)
7,107470056,107476206,7q22-q31.1,7q22.3,601910,GPR22,G protein-coupled receptor-22,GPR22,2845,ENSG00000172209,NA,NA,Gpr22 (MGI:1920260)
7,107660827,107717808,7q31,7q22.3,605646,"SLC26A4, PDS, DFNB4, EVA, TDH2B","Solute carrier family 26 (sulfate transporter), member 4",SLC26A4,5172,ENSG00000091137,some patients have digenic mutations with FOXI1,"Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3), Autosomal recessive; Pendred syndrome, 274600 (3), Autosomal recessive",Slc26a4 (MGI:1346029)
7,107743696,107764996,7q22.3,7q22.3,606872,"CBLL1, HAKAI, RNF188",Cas-Br-M murine ectopic retroviral transforming sequence like-1,CBLL1,79872,ENSG00000105879,NA,NA,Cbll1 (MGI:2144842)
7,107765466,107803232,7q22-q31.1,7q22.3-q31.1,126650,"SLC26A3, DRA, CLD","Solute carrier family 26 (sulfate transporter), member 3",SLC26A3,1811,ENSG00000091138,5' and close to PDS,"Diarrhea 1, secretory chloride, congenital, 214700 (3), Autosomal recessive",Slc26a3 (MGI:107181)
7,107800000,127500000,7q31,NA,611015,AUTS9,"Autism, susceptibility to, 9",NA,NA,NA,max lod near D7S530,"{Autism, susceptibility to, 9}, 611015 (2)",NA
7,107800000,127500000,7q31,NA,603678,DFNB14,"Deafness, autosomal recessive 14",DFNB14,1706,NA,?same as DFNB17,"Deafness, autosomal recessive 14, 603678 (2), Autosomal recessive",NA
7,107800000,127500000,7q31,NA,603010,DFNB17,"Deafness, autosomal recessive 17",DFNB17,1709,NA,NA,"Deafness, autosomal recessive 17, 603010 (2), Autosomal recessive",NA
7,107891106,107921197,7q31-q32,7q31.1,238331,"DLD, LAD, PHE3, DLDD","Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex)",DLD,1738,ENSG00000091140,NA,"Dihydrolipoamide dehydrogenase deficiency, 246900 (3), Autosomal recessive",Dld (MGI:107450)
7,107923798,108003175,7q31.1-q31.3,7q31.1,150240,"LAMB1, LIS5","Laminin, beta-1",LAMB1,3912,ENSG00000091136,NA,"Lissencephaly 5, 615191 (3), Autosomal recessive",Lamb1 (MGI:96743)
7,108011661,108130360,7q31.1,7q31.1,616380,LAMB4,"Laminin, beta-4",LAMB4,22798,ENSG00000091128,NA,NA,NA
7,108147625,108456441,7q31.1-q31.2,7q31.1,601581,NRCAM,Neuronal cell adhesion molecule,NRCAM,4897,ENSG00000091129,NA,NA,Nrcam (MGI:104750)
7,108470416,108528177,7q31,7q31.1,612123,"PNPLA8, MMLA",Patatin-like phospholipase domain-containing protein 8,PNPLA8,50640,ENSG00000135241,mutation identified in 1 MMLA family,"?Mitochondrial myopathy with lactic acidosis, 251950 (3), Autosomal recessive",Pnpla8 (MGI:1914702)
7,108562131,108569767,7q31.1,7q31.1,612534,THAP5,THAP domain-containing protein 5,THAP5,168451,ENSG00000177683,NA,NA,NA
7,108569873,108574849,7q31.1,7q31.1,602634,"DNAJB9, MDG1","DnaJ, E. coli, homolog of, subfamily B, member 9 (microvascular endothelial differentiation gene-1)",DNAJB9,4189,ENSG00000128590,previously assigned to chr.14 by FISH,NA,Dnajb9 (MGI:1351618)
7,110662644,111562530,7q31,7q31.1,605977,"IMMP2L, IMP2","Inner mitochondrial membrane peptidase, subunit 2, S. cerevisiae, homolog of",IMMP2L,83943,ENSG00000184903,NA,NA,Immp2l (MGI:2135611)
7,111726109,112206398,7q31,7q31.1,607679,"DOCK4, KIAA0716",Dedicator of cytokinesis 4,DOCK4,9732,ENSG00000128512,NA,NA,Dock4 (MGI:1918006)
7,112206611,112343933,7q31.1,7q31.1,605465,ZNF277,Zinc finger protein-277,ZNF277,11179,ENSG00000198839,NA,NA,Zfp277 (MGI:1890393)
7,112423143,112477202,7q22-q31,7q31.1,603502,IFRD1,Interferon-related developmental regulator 1,IFRD1,3475,ENSG00000006652,NA,NA,Ifrd1 (MGI:1316717)
7,112819146,112939874,7q31.1,7q31.1,617855,"BMT2, SAMTOR, C7orf60","Base methyltransferase of 25S rRNA 2, S. cerevisiae, homolog of",BMT2,154743,ENSG00000164603,NA,NA,Bmt2 (MGI:2141466)
7,113080412,113087777,7q31,7q31.1,605188,"GPR85, SREB2",G protein-coupled receptor-85,GPR85,54329,ENSG00000164604,NA,NA,Gpr85 (MGI:1927851)
7,113876776,113919093,7q11.23-q21.11,7q31.1,600917,"PPP1R3A, PPP1R3","Protein phosphatase 1, regulatory subunit 3A",PPP1R3A,5506,ENSG00000154415,NA,"Insulin resistance, severe, digenic, 125853 (3), Autosomal dominant",Ppp1r3a (MGI:2153588)
7,114086309,114693771,7q31,7q31.1,605317,"FOXP2, SPCH1, TNRC10, CAGH44",Forkhead box P2,FOXP2,93986,ENSG00000128573,NA,"Speech-language disorder-1, 602081 (3), Autosomal dominant",NA
7,114922153,115019915,7q31.1,7q31.1-q31.2,614511,"MDFIC, HIC",MYOD family inhibitor domain-containing protein,MDFIC,29969,ENSG00000135272,NA,NA,Mdfic (MGI:104611)
7,115935147,116159890,7q31.2,7q31.2,604732,"TFEC, TFECL",Transcription factor EC,TFEC,22797,ENSG00000105967,NA,NA,Tfec (MGI:1333760)
7,116210538,116258785,7q31.2,7q31.2,606085,TES,Testin,TES,26136,ENSG00000135269,NA,NA,Tes (MGI:105081)
7,116499737,116508540,7q31.1,7q31.2,601048,CAV2,Caveolin-2,CAV2,858,ENSG00000105971,NA,NA,Cav2 (MGI:107571)
7,116525008,116561184,7q31.1,7q31.2,601047,"CAV1, BSCL3, CGL3, PPH3, LCCNS",Caveolin-1,CAV1,857,ENSG00000105974,mutation identified in 1 CGL3 family,"?Lipodystrophy, congenital generalized, type 3, 612526 (3), Autosomal recessive; Lipodystrophy, familial partial, type 7, 606721 (3), Autosomal dominant; Pulmonary hypertension, primary, 3, 615343 (3), Autosomal dominant",Cav1 (MGI:102709)
7,116672195,116798385,7q31,7q31.2,164860,"MET, DFNB97, OSFD",Oncogene MET,MET,4233,ENSG00000105976,mutation identified in 1 DFNB97 family,"?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive; Hepatocellular carcinoma, childhood type, somatic, 114550 (3); {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant; Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3)",Met (MGI:96969)
7,116862586,116922048,7q31.2-q31.3,7q31.2,601571,"CAPZA2, CAPPA2","Capping protein (actin filament) muscle Z-line, alpha 2",CAPZA2,830,ENSG00000198898,NA,NA,Capza2 (MGI:106222)
7,116953500,117230175,7q31.1,7q31.2,600833,"ST7, TSG7, RAY1, FAM4A1",Suppressor of tumorigenicity 7 (breast),ST7,7982,ENSG00000004866,NA,NA,St7 (MGI:1927450)
7,117275450,117323288,7q31,7q31.2,147870,"WNT2, INT1L1","Wingless-type MMTV integration site family, member 2",WNT2,7472,ENSG00000105989,isolated by CMGT with MET,NA,Wnt2 (MGI:98954)
7,117363221,117427492,7q31.3,7q31.2,605797,"ASZ1, ALP1, ANKL1, GASZ","Ankyrin repeat, SAM, and basic leucine zipper domain-containing 1",ASZ1,136991,ENSG00000154438,NA,NA,Asz1 (MGI:1921318)
7,117479962,117668664,7q31.2,7q31.2,602421,"CFTR, ABCC7, CF, MRP7","Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)",CFTR,1080,ENSG00000001626,distal and 5' to MET,"{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3), Autosomal dominant; Congenital bilateral absence of vas deferens, 277180 (3), Autosomal recessive; Cystic fibrosis, 219700 (3), Autosomal recessive; {Hypertrypsinemia, neonatal} (3); {Pancreatitis, hereditary}, 167800 (3), Autosomal dominant; Sweat chloride elevation without CF (3)",Cftr (MGI:88388)
7,117700000,127500000,7q31.3,NA,606256,STQTL2,Stature quantitative trait locus 2,NA,192143,NA,max lod at D7S195,"{Stature QTL 2}, 606256 (2)",NA
7,117710647,117873817,7q31,7q31.31,609772,"CTTNBP2, CORTBP2, KIAA1758",Cortactin-binding protein 2,CTTNBP2,83992,ENSG00000077063,NA,NA,Cttnbp2 (MGI:1353467)
7,118184163,118204034,7q31.31,7q31.31,607288,LSM8,"LSM8, S. cerevisiae, homolog of, U6 small nuclear RNA associated",LSM8,51691,ENSG00000128534,NA,NA,Lsm8 (MGI:1923772)
7,118224703,118242731,7q31.3,7q31.31,610731,ANKRD7,Ankyrin repeat domain-containing protein 7,ANKRD7,56311,ENSG00000106013,NA,NA,Ankrd7 (MGI:1922446)
7,120273174,120750336,7q31,7q31.31,605410,"KCND2, KIAA1044","Potassium voltage-gated channel, Shal-related subfamily, member 2",KCND2,3751,ENSG00000184408,NA,NA,Kcnd2 (MGI:102663)
7,120787319,120858336,7q31,7q31.31,613138,"TSPAN12, NET2, EVR5",Tetraspanin 12,TSPAN12,23554,ENSG00000106025,NA,"Exudative vitreoretinopathy 5, 613310 (3), Autosomal dominant",Tspan12 (MGI:1889818)
7,120950748,120977215,7q31,7q31.31,607493,"ING3, P47ING3","Inhibitor of growth family, member 3",ING3,54556,ENSG00000071243,NA,NA,Ing3 (MGI:1919027)
7,121325366,121341103,7q31.3,7q31.31,606267,WNT16,"Wingless-type MMTV integration site family, member 16",WNT16,51384,ENSG00000002745,NA,NA,Wnt16 (MGI:2136018)
7,121348850,121396368,7q31.3,7q31.31,608618,FAM3C,"Family with sequence similarity 3, member C",FAM3C,10447,ENSG00000196937,NA,NA,Fam3c (MGI:107892)
7,121873160,122062035,7q31.3,7q31.32,176891,"PTPRZ1, PTP18","Protein-tyrosine phosphatase, receptor-type, zeta-1, polypeptide",PTPRZ1,5803,ENSG00000106278,NA,NA,Ptprz1 (MGI:97816)
7,122073543,122144268,7q31.3,7q31.32,605113,AASS,Alpha-aminoadipic semialdehyde synthase,AASS,10157,ENSG00000008311,NA,"Hyperlysinemia, 238700 (3), Autosomal recessive; Saccharopinuria, 268700 (1), Autosomal recessive",Aass (MGI:1353573)
7,122300938,122311854,7q31.32,7q31.32,613301,"FEZF1, FEZ, ZNF312B, HH22",FEZ family zinc finger protein 1,FEZF1,389549,ENSG00000128610,NA,"Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3), Autosomal recessive",Fezf1 (MGI:1920441)
7,122318410,122886758,7q31.3,7q31.32,609978,"CADPS2, KIAA1591",Calcium-dependent activator protein for secretion 2,CADPS2,93664,ENSG00000081803,NA,NA,Cadps2 (MGI:2443963)
7,122994703,122995699,7q31,7q31.32,604867,"TAS2R16, T2R16, BGLPT","Taste receptor type 2, member 16",TAS2R16,50833,ENSG00000128519,NA,"[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}, 617956 (3)",Tas2r118 (MGI:2681247)
7,123113489,123201835,7q31-q32,7q31.32,606193,"SLC13A1, NAS1","Solute carrier family 13 (sodium/sulfate symporters), member 1",SLC13A1,6561,ENSG00000081800,NA,NA,Slc13a1 (MGI:1859937)
7,123536996,123601650,7q32,7q31.32,601677,"NDUFA5, UQOR13",NADH-ubiquinone oxidoreductase subunit A5,NDUFA5,4698,ENSG00000128609,NA,NA,Ndufa5 (MGI:1915452)
7,123655865,123664289,7q31.32,7q31.32,608006,"LMOD2, CLMOD",Leiomodin 2,LMOD2,442721,ENSG00000170807,NA,NA,Lmod2 (MGI:2135672)
7,123681942,123749002,7q31.3,7q31.32,605056,"WASL, NWASP",Wiskott-Aldrich syndrome gene-like,WASL,8976,ENSG00000106299,NA,NA,NA
7,123763707,123877480,7q31,7q31.32,604510,HYAL4,Hyaluronoglucosaminidase 4,HYAL4,23553,ENSG00000106302,NA,NA,Hyal4 (MGI:1924292)
7,123925240,123971413,7q31,7q31.32,600930,SPAM1,"Sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)",SPAM1,6677,ENSG00000106304,NA,NA,Hyal5 (MGI:1921718)
7,124743884,124765791,7q31,7q31.33,602583,GPR37,G protein-coupled receptor-37,GPR37,2861,ENSG00000170775,NA,NA,Gpr37 (MGI:1313297)
7,124822385,124929982,7q31.33,7q31.33,606478,"POT1, CMM10, GLM9",Protection of telomeres 1,POT1,25913,ENSG00000128513,NA,"{Glioma susceptibility 9}, 616568 (3), Autosomal dominant; {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant",Pot1a (MGI:2141503)
7,126438597,127253292,7q31.3-q32.1,7q31.33,601116,GRM8,"Glutamate receptor, metabotropic-8",GRM8,2918,ENSG00000179603,NA,NA,Grm8 (MGI:1351345)
7,127500000,132900000,7q32,NA,613063,BCC6,"Basal cell carcinoma, susceptibility to, 6",NA,100307123,NA,associated with rs157935,"{Basal cell carcinoma, susceptibility to, 6}, 613063 (2)",NA
7,127500000,132900000,7q32,NA,600676,CATR1,CATR tumorigenic conversion 1,CATR1,856,NA,NA,NA,NA
7,127500000,132900000,7q32,NA,614220,PBC4,"Biliary cirrhosis, primary, 4",NA,100689215,NA,associated with rs10488631,"Biliary cirrhosis, primary, 4, 614220 (2)",NA
7,127500000,132900000,7q32,NA,609573,PPR3,Photoparoxysmal response 3,NA,619471,NA,max lod at D7S1804,"Photoparoxysmal response 3, 609573 (2)",NA
7,127500000,138500000,7q32-q33,NA,613909,SCA32,Spinocerebellar ataxia 32,NA,NA,NA,between rs3847110 and rs2241728,"Spinocerebellar ataxia 32, 613909 (2), Autosomal dominant",NA
7,127580627,127585595,7q32.1,7q32.1,607418,"GCC1, GCC88",GRIP and coiled-coil domains-containing protein 1,GCC1,79571,ENSG00000179562,NA,NA,Gcc1 (MGI:1921625)
7,127588410,127591699,7q31.3,7q32.1,103188,ARF5,ADP-ribosylation factor 5,ARF5,381,ENSG00000004059,NA,NA,Arf5 (MGI:99434)
7,127593735,127602143,7q31.3,7q32.1,615800,FSCN3,"Fascin actin-bundling protein 3, testicular",FSCN3,29999,ENSG00000106328,NA,NA,Fscn3 (MGI:1890386)
7,127610291,127618141,7q32,7q32.1,167413,"PAX4, MODY9, KPD",Paired box homeotic gene-4,PAX4,5078,ENSG00000106331,NA,"{Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3), Autosomal recessive, Autosomal dominant; Diabetes mellitus, type 2, 125853 (3), Autosomal dominant; Maturity-onset diabetes of the young, type IX, 612225 (3)",Pax4 (MGI:97488)
7,127652144,128092592,7q31.3,7q32.1,602181,"P100, SND1",EBNA-2 coactivator p100,SND1,27044,ENSG00000197157,NA,NA,Snd1 (MGI:1929266)
7,128027070,128032106,7q32.1,7q32.1,610486,LRRC4,Leucine-rich repeat-containing protein 4,LRRC4,64101,ENSG00000128594,NA,NA,Lrrc4 (MGI:2182081)
7,128241200,128257628,7q31.3,7q32.1,164160,"LEP, OB, LEPD",Leptin (murine obesity homolog),LEP,3952,ENSG00000174697,in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel,"Obesity, morbid, due to leptin deficiency, 614962 (3), Autosomal recessive",Lep (MGI:104663)
7,128297684,128343914,7q32.1,7q32.1,612074,"RBM28, ANES",RNA-binding motif protein 28,RBM28,55131,ENSG00000106344,mutation identified in 1 ANES family,"?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3), Autosomal recessive",Rbm28 (MGI:2655711)
7,128392276,128409988,7q31.3-q32,7q32.1,146690,"IMPDH1, RP10, LCA11","Inosine-5'-monophosphate dehydrogenase, type I",IMPDH1,3614,ENSG00000106348,pseudogene on 16p13.13,"Leber congenital amaurosis 11, 613837 (3), Autosomal dominant; Retinitis pigmentosa 10, 180105 (3), Autosomal dominant",Impdh1 (MGI:96567)
7,128455829,128458417,7q32.1,7q32.1,617905,"HILPDA, HIG2",Hypoxia-inducible lipid droplet-associated protein,HILPDA,29923,ENSG00000135245,NA,NA,Hilpda (MGI:1916823)
7,128739291,128773422,7q32,7q32.1,603420,CALU,Calumenin,CALU,813,ENSG00000128595,NA,NA,Calu (MGI:1097158)
7,128772488,128775789,7q31.3-q32,7q32.1,613522,"OPN1SW, BCP, CBT","Blue cone pigment (opsin 1, short-wave-sensitive)",OPN1SW,611,ENSG00000128617,NA,"Colorblindness, tritan, 190900 (3), Autosomal dominant",Opn1sw (MGI:99438)
7,128790761,128822129,7q31-q32,7q32.1,611902,"CCDC136, NAG6, KIAA1793",Coiled-coil domain-containing protein 136,CCDC136,64753,ENSG00000128596,NA,NA,Ccdc136 (MGI:1918128)
7,128830405,128859273,7q32,7q32.1,102565,"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",Filamin C (actin-binding protein-280),FLNC,2318,ENSG00000128591,NA,"Cardiomyopathy, familial hypertrophic, 26 (3); Cardiomyopathy, familial restrictive 5, 617047 (3), Autosomal dominant; Myopathy, distal, 4, 614065 (3), Autosomal dominant; Myopathy, myofibrillar, 5, 609524 (3), Autosomal dominant",Flnc (MGI:95557)
7,128870644,128910718,7q32.3,7q32.1,609344,KCP,Kielin/chordin-like protein,KCP,375616,ENSG00000135253,NA,NA,Kcp (MGI:2141640)
7,128937031,128950041,7q32,7q32.1,607218,"IRF5, IBD14, SLEB10",Interferon regulatory factor 5,IRF5,3663,ENSG00000128604,NA,"{Inflammatory bowel disease 14}, 612245 (3); {Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)",Irf5 (MGI:1350924)
7,128954179,129055172,7q32.1,7q32.1,610032,"TNPO3, TRNSR, LGMDD2",Transportin 3,TNPO3,23534,ENSG00000064419,NA,"Muscular dystrophy, limb-girdle, autosomal dominant 2, 608423 (3), Autosomal dominant",Tnpo3 (MGI:1196412)
7,129144706,129169698,7q32.1,7q32.1,610120,"TSPAN33, PEN",Tetraspanin 33,TSPAN33,340348,ENSG00000158457,NA,NA,Tspan33 (MGI:1919012)
7,129188632,129213547,7q31-q32,7q32.1,601500,"SMOH, SMO, CRJS","Smoothened, Drosophila, homolog of",SMO,6608,ENSG00000128602,NA,"Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)",Smo (MGI:108075)
7,129225029,129430210,7q32.1,7q32.1,616520,AHCYL2,Adenosylhomocysteinase-like 2,AHCYL2,23382,ENSG00000158467,NA,NA,Ahcyl2 (MGI:1921590)
7,129434431,129488398,7q32.1,7q32.1,617919,"STRIP2, FAR11B, FAM40B",Striatin-interacting protein 2,STRIP2,57464,ENSG00000128578,NA,NA,Strip2 (MGI:2444363)
7,129600000,152800000,7q32.2-q36.1,NA,146450,HYSP3,"Hypospadias 3, autosomal",NA,100689211,NA,between D7S2519 and D7S2442.,"Hypospadias 3, autosomal, 146450 (2), Autosomal dominant, Multifactorial",NA
7,129611719,129757081,7q32,7q32.2,600879,NRF1,Nuclear respiratory factor 1,NRF1,4899,ENSG00000106459,earlier location = 7q31,NA,Nrf1 (MGI:1332235)
7,129770382,129770491,7q32.2,7q32.2,611607,"MIR182, MIRN182",Micro RNA 182,MIR182,406958,ENSG00000207990,NA,NA,NA
7,129774691,129774768,7q32.2,7q32.2,611606,"MIR96, MIRN96, DFNA50",Micro RNA 96,MIR96,407053,ENSG00000199158,NA,"Deafness, autosomal dominant 50, 613074 (3), Autosomal dominant",NA
7,129774904,129775013,7q32.2,7q32.2,611608,"MIR183, MIRN183",Micro RNA 183,MIR183,406959,ENSG00000207691,NA,NA,NA
7,129830731,129952959,7q32,7q32.2,601082,"UBE2H, UBCH2, UBC8",Ubiquitin-conjugating enzyme E2H (homologous to yeast UBC8),UBE2H,7328,ENSG00000186591,NA,NA,Ube2h (MGI:104632)
7,130070531,130135704,7q32.2,7q32.2,615152,"KLHDC10, SLIM",KELCH domain-containing protein 10,KLHDC10,23008,ENSG00000128607,NA,NA,Klhdc10 (MGI:1924038)
7,130266862,130289797,7q32,7q32.2,600688,CPA2,"Carboxypeptidase A2, pancreatic",CPA2,1358,ENSG00000158516,NA,NA,Cpa2 (MGI:3617840)
7,130293133,130324179,7q32,7q32.2,607635,"CPA4, CPA3",Carboxypeptidase A4,CPA4,51200,ENSG00000128510,NA,NA,Cpa4 (MGI:1919041)
7,130380493,130388107,7q32-qter,7q32.2,114850,CPA1,Carboxypeptidase A,CPA1,1357,ENSG00000091704,both CPA and TRY1 = serine proteases,NA,Cpa1 (MGI:88478)
7,130393770,130441209,7q32,7q32.2,610523,"CEP41, TSGA14, JBTS15","Centrosomal protein, 41kD",CEP41,95681,ENSG00000106477,NA,"Joubert syndrome 15, 614464 (3), Autosomal recessive",Cep41 (MGI:1891414)
7,130486174,130506464,7q32,7q32.2,601029,"MEST, PEG1","Mesoderm specific transcript, mouse, homolog of",MEST,4232,ENSG00000106484,imprinted maternally,NA,Mest (MGI:96968)
7,130506237,130668757,7q32,7q32.2,604355,COPG2,"Coatomer protein complex, subunit gamma-2",COPG2,26958,ENSG00000158623,NA,NA,Copg2 (MGI:1858683)
7,130543452,130546899,7q32,7q32.2,610581,"COPG2IT1, CIT1","Coatomer protein complex, subunit gamma-2, intronic transcript 1",COPG2IT1,53844,NA,NA,NA,NA
7,130732553,130734032,7q32.2,7q32.2,609393,"LKF14, BTEB5",Kruppel-like factor 14,KLF14,136259,ENSG00000266265,NA,NA,Klf14 (MGI:3577024)
7,130800000,132900000,7q32.3,NA,606641,BMIQ1,Body mass index quantitative trait locus 1,BMIQ1,170815,NA,max lod at D7S1804,"[Body mass index QTL1], 606641 (2)",NA
7,130876746,130876809,7q32.3,7q32.3,610782,"MIR29A, MIRN29A",Micro RNA 29A,MIR29A,407021,ENSG00000284032,NA,NA,NA
7,130877458,130877538,7q32.3,7q32.3,610783,"MIR29B1, MIRN29B1",Micro RNA 29B1,MIR29B1,407024,ENSG00000283797,NA,NA,NA
7,130877561,131109915,7q32.3,7q32.3,618212,"LINC-PINT, PINT","Long intergenic noncoding RNA, p53-induced transcript",LINC-PINT,378805,ENSG00000231721,NA,NA,NA
7,131110093,131496636,7q32,7q32.3,605623,MKLN1,Muskelin 1,MKLN1,4289,ENSG00000128585,NA,NA,Mkln1 (MGI:1351638)
7,131500270,131556627,7q32-q33,7q32.3,602632,"PODXL, PCLP",Podocalyxin-like,PODXL,5420,ENSG00000128567,NA,NA,NA
7,132123331,132648687,7q32.3,7q32.3,604280,PLXNA4,Plexin A4,PLXNA4,91584,ENSG00000221866,NA,NA,Plxna4 (MGI:2179061)
7,132784861,133082157,7q32.3-q33,7q32-q33,613748,CHCHD3,Coiled-coil-helix-coiled-coil-helix domain-containing protein 3,CHCHD3,54927,ENSG00000106554,NA,NA,Chchd3 (MGI:1913325)
7,133253066,134067136,7q31,7q33,608185,"EXOC4, SEC8, KIAA1699",Exocyst complex component 4,EXOC4,60412,ENSG00000131558,NA,NA,Exoc4 (MGI:1096376)
7,134127339,134282474,7q33,7q33,616478,LRGUK,Leucine-rich repeats- and guanylate kinase domain-containing protein,LRGUK,136332,ENSG00000155530,NA,NA,Lrguk (MGI:1921604)
7,134289331,134320306,7q33,7q33,610923,SLC35B4,"Solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4",SLC35B4,84912,ENSG00000205060,NA,NA,Slc35b4 (MGI:1931249)
7,134442349,134459238,7q35,7q33,103880,"AKR1B1, ALDR1","Aldo-keto reductase family 1, member B1",AKR1B1,231,ENSG00000085662,NA,NA,Akr1b3 (MGI:1353494)
7,134527566,134541411,7q33,7q33,604707,"AKR1B10, ARL1","Aldo-keto reductase family 1, member B10",AKR1B10,57016,ENSG00000198074,NA,NA,Akr1b8 (MGI:107673)
7,134549109,134579868,7q33,7q33,616336,"AKR1B15, AKR1B10L, AKR1R1B7","Aldo-keto reductase family 1, member B15",AKR1B15,441282,ENSG00000227471,NA,NA,NA
7,134646778,134679815,7q31-q34,7q33,613896,"BPGM, ECYT8","2,3-bisphosphoglycerate mutase",BPGM,669,ENSG00000172331,NA,"Erythrocytosis, familial, 8, 222800 (3), Autosomal recessive",Bpgm (MGI:1098242)
7,134779628,134970728,7q33,7q33,114213,"CALD1, CDM",Caldesmon-1,CALD1,800,ENSG00000122786,NA,NA,NA
7,134986138,135135781,7q33,7q33,617346,"AGBL3, CCP3",ATP/GTP-binding protein-like 3,AGBL3,340351,ENSG00000146856,NA,NA,Agbl3 (MGI:1923473)
7,135092302,135170825,7q33,7q33,616980,"CYREN, C7orf49, MRI",Cell cycle regulator of nonhomologous end joining,CYREN,78996,ENSG00000122783,NA,NA,Cyren (MGI:1925662)
7,135183838,135211555,7q33,7q33,616303,"WDR91, SORF1",WD repeat-containing protein 91,WDR91,29062,ENSG00000105875,NA,NA,Wdr91 (MGI:2141558)
7,135231407,135258662,7q31,7q33,609987,STRA8,"Stimulated by retinoic acid 8, mouse, homolog of",STRA8,346673,ENSG00000146857,NA,NA,Stra8 (MGI:107917)
7,135361794,135510126,7q22-qter,7q33,604911,"CNOT4, NOT4","CCR4-NOT transcription complex, subunit 4",CNOT4,4850,ENSG00000080802,NA,NA,Cnot4 (MGI:1859026)
7,135557916,135648752,7q33,7q33,614352,"NUP205, C7orf14, KIAA0225, NPHS13","Nucleoporin, 205kD",NUP205,23165,ENSG00000155561,mutation identified in 1 NPHS13 family,"?Nephrotic syndrome, type 13, 616893 (3)",Nup205 (MGI:2141625)
7,135681230,135728185,7q33,7q33,604309,"SLC13A4, SUT1","Solute carrier family 13 (sodium/sulfate symporters), member 4 (sulfate transporter 1)",SLC13A4,26266,ENSG00000164707,NA,NA,Slc13a4 (MGI:2442367)
7,135926759,135977358,7q33,7q33,611050,"LUZP6, MPD6",Leucine zipper protein 6,LUZP6,767558,ENSG00000267697,NA,NA,NA
7,135926759,135977358,7q33-q35,7q33,606484,MTPN,Myotrophin,MTPN,136319,ENSG00000105887,NA,NA,Mtpn (MGI:99445)
7,136868636,137020254,7q35-q36,7q33,118493,CHRM2,"Cholinergic receptor, muscarinic, 2",CHRM2,1129,ENSG00000181072,NA,NA,Chrm2 (MGI:88397)
7,136903166,136903293,7q33,7q33,616972,MIR490,Micro RNA 490,MIR490,574443,ENSG00000207597,NA,NA,NA
7,137227340,137343732,7q33,7q33,162095,"PTN, NEGF1","Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)",PTN,5764,ENSG00000105894,NA,NA,Ptn (MGI:97804)
7,137381036,137846863,7q32.3-q33,7q33,604072,DGKI,"Diacylglycerol kinase, iota, 130-kD",DGKI,9162,ENSG00000157680,NA,NA,Dgki (MGI:2443430)
7,137874978,138002085,7q33,7q33,608834,"CREB3L2, BBF2H7",cAMP response element-binding protein 3-like 2,CREB3L2,64764,ENSG00000182158,NA,NA,Creb3l2 (MGI:2442695)
7,138076458,138118304,7q32-q33,7q33,604741,"AKR1D1, SRD5B1, CBAS2","Bile acid synthesis defect, congenital, 2",AKR1D1,6718,ENSG00000122787,NA,"Bile acid synthesis defect, congenital, 2, 235555 (3), Autosomal recessive",Akr1d1 (MGI:2384785)
7,138460258,138589995,7q32-q34,7q33-q34,603406,"TRIM24, TIF1, TIF1A, PTC6",Tripartite motif-containing protein 24 (Transcriptional intermediary factor 1),TRIM24,8805,ENSG00000122779,fused with RET to form PTC6,NA,Trim24 (MGI:109275)
7,138500000,159345973,7q34-q36,NA,603098,DFNB13,"Deafness, autosomal recessive 13",DFNB13,1705,NA,NA,"Deafness, autosomal recessive 13, 603098 (2), Autosomal recessive",NA
7,138500000,159345973,7q34-q36,NA,182960,DHMN1,"Neuronopathy, distal hereditary motor, type I",NA,NA,NA,between D7S2513 and D7S637,"Neuronopathy, distal hereditary motor, type I, 182960 (2), Autosomal dominant",NA
7,138500000,159345973,7q34-q36,NA,605727,OTSC2,Otosclerosis 2,OTSC2,93999,NA,NA,"Otosclerosis 2, 605727 (2)",NA
7,138500000,143400000,7q34,NA,615449,TRBJ@,T-cell receptor beta chain joining gene cluster,NA,NA,NA,NA,NA,NA
7,138500000,143400000,7q34,NA,615446,TRBV@,T-cell receptor beta chain variable gene cluster,NA,NA,NA,NA,NA,NA
7,138591688,138701546,7q34,7q34,611700,SVOPL,SV2-related protein-like,SVOPL,136306,ENSG00000157703,NA,NA,Svopl (MGI:2444335)
7,138706293,138799838,7q33-q34,7q34,605239,"ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR","ATPase, H+ transporting, V0 subunit a4",ATP6V0A4,50617,ENSG00000105929,NA,"Renal tubular acidosis, distal, autosomal recessive, 602722 (3)",Atp6v0a4 (MGI:2153480)
7,138831376,138981625,7q34,7q34,613344,KIAA1549,KIAA1549 gene,KIAA1549,57670,ENSG00000122778,NA,NA,D630045J12Rik (MGI:2669829)
7,139043514,139109719,7q34,7q34,607312,"ZC3HAV1, ZAP, FLJ13288, FLB6421",Zinc finger CCCH domain-containing antiviral protein 1,ZC3HAV1,56829,ENSG00000105939,NA,NA,Zc3hav1 (MGI:1926031)
7,139133743,139191985,7q34,7q34,617453,"TTC26, IFT56",Tetratricopeptide repeat domain-containing protein 26,TTC26,79989,ENSG00000105948,NA,NA,Ttc26 (MGI:2444853)
7,139228407,139329420,7q34,7q34,613841,UBN2,Ubinuclein 2,UBN2,254048,ENSG00000157741,NA,NA,Ubn2 (MGI:2444236)
7,139340358,139423456,7q34,7q34,613056,LUC7L2,"Luc7, S. cerevisiae, homolog of, 2",LUC7L2,51631,ENSG00000146963,NA,NA,Luc7l2 (MGI:2183260)
7,139561569,139777997,7q33-q34,7q34,606868,HIPK2,Homeodomain-interacting protein kinase 2,HIPK2,28996,ENSG00000064393,NA,NA,Hipk2 (MGI:1314872)
7,139778241,140020320,7q34,7q34,274180,"TBXAS1, GHOSAL, CYP5, BDPLT14","Thromboxane A synthase 1, platelet",TBXAS1,6916,ENSG00000059377,NA,"Ghosal hematodiaphyseal syndrome, 231095 (3), Autosomal recessive; ?Thromboxane synthase deficiency, 614158 (1), Autosomal dominant",Tbxas1 (MGI:98497)
7,140023743,140063720,7q34,7q34,612481,"PARP12, ZC3HDC1, FLJ22693","Poly(ADP-ribose) polymerase family, member 12",PARP12,64761,ENSG00000059378,NA,NA,Parp12 (MGI:2143990)
7,140696707,140706642,7q34,7q34,603838,NDUFB2,NADH-ubiquinone oxidoreductase subunit B2,NDUFB2,4708,ENSG00000090266,NA,NA,Ndufb2 (MGI:1915448)
7,140719330,140924928,7q34,7q34,164757,"BRAF, NS7",Murine sarcoma viral (v-raf) oncogene homolog B1,BRAF,673,ENSG00000157764,pseudogene BRAF2 on Xq13 or 7q,"Adenocarcinoma of lung, somatic, 211980 (3); Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant; Colorectal cancer, somatic (3); LEOPARD syndrome 3, 613707 (3), Autosomal dominant; Melanoma, malignant, somatic (3); Nonsmall cell lung cancer, somatic (3); Noonan syndrome 7, 613706 (3), Autosomal dominant",Braf (MGI:88190)
7,141002609,141014951,7q32-q34,7q34,611993,MRPS33,Mitochondrial ribosomal protein S33,MRPS33,51650,ENSG00000090263,4 pseudogenes,NA,Mrps33 (MGI:1338046)
7,141551409,141662152,7q34,7q34,610345,"AGK, MULK, MTDPS10, CATC5, CTRCT38",Acylglycerol kinase,AGK,55750,ENSG00000006530,NA,"Cataract 38, autosomal recessive, 614691 (3), Autosomal recessive; Sengers syndrome, 212350 (3), Autosomal recessive",Agk (MGI:1917173)
7,141708352,141731270,7q34,7q34,614084,"WEE2, WEE1B, OOMD5","Wee1, S. pombe, homolog of, 2",WEE2,494551,ENSG00000214102,NA,"Oocyte maturation defect 5, 617996 (3), Autosomal recessive",Wee2 (MGI:3027899)
7,141738320,141750487,7q34,7q34,600439,"SSBP1, SSBP",Single-stranded DNA-binding protein 1,SSBP1,6742,ENSG00000106028,NA,NA,Ssbp1 (MGI:1920040)
7,141764096,141765196,7q31.3-q32,7q34,604868,"TAS2R3, T2R3","Taste receptor type 2, member 3",TAS2R3,50831,ENSG00000127362,NA,NA,Tas2r137 (MGI:3606604)
7,141778488,141779387,7q31.3-q32,7q34,604869,"TAS2R4, T2R4","Taste receptor type 2, member 4",TAS2R4,50832,ENSG00000127364,NA,NA,Tas2r108 (MGI:2681210)
7,141790216,141791366,7q31.3-q32,7q34,605062,"TAS2R5, T2R5","Taste receptor type 2, member 5",TAS2R5,54429,ENSG00000127366,NA,NA,NA
7,141927355,141947008,7q33,7q34,604987,"CLEC5A, CLECSF5, MDL1","C-type lectin domain family 5, member A",CLEC5A,23601,ENSG00000258227,NA,NA,Clec5a (MGI:1345151)
7,141972630,141973772,7q34,7q34,607751,"TAS2R38, T2R61, PTC, THIOT","Taste receptor, type 2, member 38",TAS2R38,5726,ENSG00000257138,NA,"[Phenylthiocarbamide tasting], 171200 (3), Autosomal dominant",Tas2r138 (MGI:2681306)
7,141986516,142106746,7q34,7q34,154360,"MGAM, MGA",Maltase-glucoamylase,MGAM,8972,ENSG00000257335,similar to EST GS1365,NA,Mgam (MGI:1203495)
7,142740234,142753075,7q35,7q34,276000,"PRSS1, TRY1","Protease, serine, 1 (trypsin 1)",PRSS1,5644,ENSG00000204983,8 trypsinogen genes embedded in TCRB locus,"Pancreatitis, hereditary, 167800 (3), Autosomal dominant; Trypsinogen deficiency, 614044 (1), Autosomal recessive",Try10 (MGI:3687012)
7,142770942,142774563,7q35,7q34,601564,"PRSS2, TRY2","Protease, serine, 2 (trypsin 2)",PRSS2,5645,ENSG00000275896,NA,"{Pancreatitis, chronic, protection against}, 167800 (3), Autosomal dominant",Prss2 (MGI:102759)
7,142786212,142786223,7q34,7q34,615447,TRBD1,T-cell receptor beta chain diversity gene 1,TRBD1,28637,NA,NA,NA,NA
7,142791693,142793140,7q34,7q34,186930,TRBC1,T-cell receptor beta chain constant region 1,TRBC1,28639,NA,NA,NA,NA
7,142795704,142795719,7q34,7q34,615448,TRBD2,T-cell receptor beta chain diversity gene 2,TRBD2,28636,NA,NA,NA,NA
7,142801040,142802528,7q34,7q34,615445,TRBC2,T-cell receptor beta chain constant region 2,TRBC2,28638,NA,NA,NA,NA
7,142854638,142871092,7q33-q35,7q34,602757,"EPHB6, HEP",Ephrin receptor EPHB6,EPHB6,2051,ENSG00000106123,NA,NA,Ephb6 (MGI:1096338)
7,142871207,142885744,7q33-q34,7q34,606680,"TRPV6, ECAC2, CAT1, CATL, HRPTTN","Transient receptor potential cation channel, subfamily V, member 6",TRPV6,55503,ENSG00000165125,NA,"Hyperparathyroidism, transient neonatal, 618188 (3), Autosomal recessive",Trpv6 (MGI:1927259)
7,142908100,142933745,7q35,7q34,606679,"TRPV5, ECAC1, CAT2","Transient receptor potential cation channel, subfamily V, member 5",TRPV5,56302,ENSG00000127412,NA,NA,Trpv5 (MGI:2429764)
7,142941113,142962362,7q33,7q34,613883,KEL,Kell blood group,KEL,3792,ENSG00000197993,NA,"[Blood group, Kell], 110900 (3)",Kel (MGI:1346053)
7,143132076,143139738,7q32-q36,7q34,176720,PIP,Prolactin-inducible protein,PIP,5304,ENSG00000159763,NA,NA,Pip (MGI:102696)
7,143222036,143223078,7q34,7q34,613964,"TAS2R40, T2R40","Taste receptor, type 2, member 40",TAS2R40,259286,ENSG00000221937,NA,NA,Tas2r144 (MGI:2681312)
7,143263428,143269128,7q34,7q34,602321,GSTK1,"Glutathione S-transferase, kappa-1",GSTK1,373156,ENSG00000197448,NA,NA,Gstk1 (MGI:1923513)
7,143284898,143288048,7q34,7q34,616524,TMEM139,Transmembrane protein 139,TMEM139,135932,ENSG00000178826,NA,NA,Tmem139 (MGI:1924444)
7,143288350,143307695,7q35,7q34,600639,"CASP2, NEDD2, ICH1","Caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2)",CASP2,835,ENSG00000106144,NA,NA,Casp2 (MGI:97295)
7,143316110,143352082,7q35,7q34,118425,CLCN1,"Chloride channel-1, skeletal muscle",CLCN1,1180,ENSG00000188037,NA,"Myotonia congenita, dominant, 160800 (3), Autosomal dominant; Myotonia congenita, recessive, 255700 (3), Autosomal recessive; Myotonia levior, recessive (3)",Clcn1 (MGI:88417)
7,143381226,143391110,7q34-q35,7q34,602002,ZYX,Zyxin,ZYX,7791,ENSG00000159840,NA,NA,Zyx (MGI:103072)
7,143390812,143408864,7q32-q36,7q34-q35,179610,"EPHA1, EPHT1",eph tyrosine kinase 1 (erythropoietin-producing hepatoma amplified sequence; oncogene EPH; ephrin receptor EphA1),EPHA1,2041,ENSG00000146904,NA,NA,Epha1 (MGI:107381)
7,143400000,159345973,7q35-q36,NA,157570,"D7S437, MS3315",Minisatellite 33.15,NA,NA,NA,NA,NA,NA
7,143400000,159345973,7q35-q36,NA,600510,"GPDS1, PDS1",Glaucoma-related pigment dispersion syndrome-1,GPDS1,7986,NA,NA,"Pigment dispersion syndrome, 600510 (2), Autosomal dominant",NA
7,143400000,159345973,7q35-q36,NA,612514,SLI4,Specific language impairment 4,NA,100233227,NA,associated with rs1723629,"{Specific language impairment 4}, 612514 (2)",NA
7,143443452,143444408,7q35,7q35,613968,"TAS2R60, T2R60","Taste receptor, type 2, member 60",TAS2R60,338398,ENSG00000185899,NA,NA,Tas2r135 (MGI:2681302)
7,143477872,143478795,7q35,7q35,613965,"TAS2R41, T2R59","Taste receptor, type 2, member 41",TAS2R41,259287,ENSG00000221855,NA,NA,Tas2r126 (MGI:2681273)
7,143620973,143730409,7q35,7q35,616252,"TCAF2, FAM115C, FAM139A",TRPM8 channel-associated factor 2,TCAF2,285966,ENSG00000170379,NA,NA,Tcaf2 (MGI:2385258)
7,143851374,143902197,7q35,7q35,616251,"TCAF1, FAM115A, KIAA0738",TRPM8 channel-associated factor 1,TCAF1,9747,ENSG00000198420,NA,NA,Tcaf1 (MGI:1914665)
7,143907151,143988539,7q35,7q35,608497,"OR2F1, OLF3","Olfactory receptor, family 2, subfamily F, member 1",OR2F1,26211,ENSG00000213215,NA,NA,Olfr453 (MGI:3030287)
7,144355395,144380631,7q33-q35,7q35,600888,"ARHGEF5, TIM",Rho guanine nucleotide exchange factor-5 (oncogene TIM),ARHGEF5,7984,ENSG00000050327,NA,NA,Arhgef5 (MGI:1858952)
7,144396804,144410421,7q35,7q35,610934,"NOBOX, POF5","Newborn ovary homeobox, mouse, homolog of",NOBOX,135935,ENSG00000106410,NA,"Premature ovarian failure 5, 611548 (3), Autosomal dominant",Nobox (MGI:108011)
7,144451940,144836423,7q34,7q35,606370,"TPK1, THMD5",Thiamine pyrophosphokinase,TPK1,27010,ENSG00000196511,NA,"Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3), Autosomal recessive",Tpk1 (MGI:1352500)
7,146116206,148420997,7q35-q36,7q35-q36,604569,"CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1",Contactin-associated protein-like 2,CNTNAP2,26047,ENSG00000174469,NA,"{Autism susceptibility 15}, 612100 (3); Cortical dysplasia-focal epilepsy syndrome, 610042 (3), Autosomal recessive; Pitt-Hopkins like syndrome 1, 610042 (3), Autosomal recessive",Cntnap2 (MGI:1914047)
7,148200000,159345973,7q36,NA,605967,ACRPS,Acropectoral syndrome,NA,85505,NA,NA,"Acropectoral syndrome, 605967 (2), Autosomal dominant",NA
7,148200000,159345973,7q36,NA,609636,AD10,Alzheimer disease-10,NA,780912,NA,max lod with D7S798,"Alzheimer disease-10, 609636 (2), Autosomal dominant",NA
7,148200000,159345973,7q36,NA,611016,AUTS10,"Autism, susceptibility to, 10",NA,NA,NA,max lod at D7S483,"{Autism, susceptibility to, 10}, 611016 (2)",NA
7,148697755,148801109,7q36.1,7q36.1,603134,CUL1,Cullin 1,CUL1,8454,ENSG00000055130,NA,NA,Cul1 (MGI:1349658)
7,148807371,148884348,7q35,7q36.1,601573,"EZH2, EZH1, WVS","Enhancer of zeste, Drosophila, homolog of, 2",EZH2,2146,ENSG00000106462,pseudogene on 21q22,"Weaver syndrome, 277590 (3), Autosomal dominant",Ezh2 (MGI:107940)
7,148941487,148941570,7q36,7q36.1,601824,"RNY5, Y5","RNA, Y5 small cytoplasmic",RNY5,6090,NA,NA,NA,NA
7,148963314,148963409,7q36,7q36.1,601823,"RNY4, Y4","RNA, Y4 small cytoplasmic",RNY4,6086,ENSG00000252316,NA,NA,NA
7,148983754,148983855,7q36,7q36.1,601822,"RNY3, Y3","RNA, Y3 small cytoplasmic",RNY3,6085,ENSG00000202354,NA,NA,NA
7,148987135,148987247,7q36,7q36.1,601821,"RNY1, Y1","RNA, Y1 small cytoplasmic",RNY1,6084,ENSG00000201098,NA,NA,NA
7,149195494,149226242,7q36.1,7q36.1,603397,"ZNF282, HUB1",Zinc finger protein 282,ZNF282,8427,ENSG00000170265,NA,NA,Zfp282 (MGI:2141413)
7,149239650,149255605,7q36.1,7q36.1,602386,"ZNF212, ZNFC150, ZNF182",Zinc finger protein 212,ZNF212,7988,ENSG00000170260,NA,NA,Zfp212 (MGI:2682609)
7,149472695,149497831,7q36.1,7q36.1,613914,"ZNF746, PARIS",Zinc finger protein 746,ZNF746,155061,ENSG00000181220,NA,NA,Zfp746 (MGI:1916478)
7,149764181,149776322,7q36.1,7q36.1,614040,"ZNF467, EZI, ZFP467",Zinc finger protein 467,ZNF467,168544,ENSG00000181444,NA,NA,Zfp467 (MGI:1916160)
7,149776041,149833964,7q36.1,7q36.1,617356,SSPO,Subcommissural organ spondin,SSPO,23145,ENSG00000197558,NA,NA,Sspo (MGI:2674311)
7,149872963,149880712,7q36,7q36.1,611019,ATP6V0E2,"ATPase, H+ transporting, V0 subunit e2",ATP6V0E2,155066,ENSG00000171130,NA,NA,Atp6v0e2 (MGI:1923502)
7,150041354,150045371,7q36.1,7q36.1,615171,LOC100134040,LOC100134040 gene,NA,100134040,NA,NA,NA,NA
7,150329848,150332720,7q36.1,7q36.1,615252,"ZBED6CL, C7orf29",ZBED6 C terminus-like protein,ZBED6CL,113763,ENSG00000188707,NA,NA,NA
7,150338328,150341684,7q36.1,7q36.1,601973,"RARRES2, TIG2",Retinoic acid receptor responder 2,RARRES2,5919,ENSG00000106538,NA,NA,Rarres2 (MGI:1918910)
7,150450629,150479394,7q36.1,7q36.1,616962,GIMAP8,"GTPase, IMAP family, member 8",GIMAP8,155038,ENSG00000171115,NA,NA,Gimap8 (MGI:2685303)
7,150514871,150521072,7q36.1,7q36.1,616961,GIMAP7,"GTPase IMAP family, member 7",GIMAP7,168537,ENSG00000179144,NA,NA,Gimap7 (MGI:1349657)
7,150567369,150573952,7q36.1,7q36.1,608087,"GIMAP4, IMAP4, IAN1","GTPase, IMAP family, member 4",GIMAP4,55303,ENSG00000133574,NA,NA,Gimap4 (MGI:1349656)
7,150625374,150632647,7q36.1,7q36.1,616960,GIMAP6,"GTPase, IMAP family, member 6",GIMAP6,474344,ENSG00000133561,NA,NA,Gimap6 (MGI:1918876)
7,150685705,150693640,7q36.1,7q36.1,608085,"GIMAP2, IMAP2","GTPase, IMAP family, member 2",GIMAP2,26157,ENSG00000106560,NA,NA,NA
7,150716612,150724283,7q36.1,7q36.1,608084,"GIMAP1, IMAP1","GTPase, IMAP family, member 1",GIMAP1,170575,ENSG00000213203,NA,NA,Gimap1 (MGI:109368)
7,150737347,150743648,7q36.1,7q36.1,608086,"GIMAP5, IAN4L1, IMAP3","GTPase, IMAP family, member 5",GIMAP5,55340,ENSG00000196329,NA,NA,NA
7,150791286,150801359,7q36.1,7q36.1,610385,LR8,LR8 protein,TMEM176B,28959,ENSG00000106565,NA,NA,Tmem176b (MGI:1916348)
7,150800542,150805118,7q36.1,7q36.1,610334,"TEM176A, HCA112, GS188",Transmembrane protein 176A,TMEM176A,55365,ENSG00000002933,NA,NA,Tmem176a (MGI:1913308)
7,150824874,150861503,7q31-q32,7q36.1,104610,ABP1,Amiloride-binding protein-1,AOC1,26,ENSG00000002726,NA,NA,Aoc1 (MGI:1923757)
7,150944955,150978313,7q35-q36,7q36.1,152427,"KCNH2, LQT2, HERG, SQT1","Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)",KCNH2,3757,ENSG00000055118,NA,"Long QT syndrome 2, 613688 (3), Autosomal dominant; {Long QT syndrome 2, acquired, susceptibility to}, 613688 (3), Autosomal dominant; Short QT syndrome 1, 609620 (3)",Kcnh2 (MGI:1341722)
7,150991016,151014587,7q36,7q36.1,163729,NOS3,"Nitric oxide synthase 3, endothelial cell",NOS3,4846,ENSG00000164867,NA,"{Alzheimer disease, late-onset, susceptibility to}, 104300 (3), Autosomal dominant; {Coronary artery spasm 1, susceptibility to} (3); {Hypertension, pregnancy-induced}, 189800 (3), Autosomal dominant; {Hypertension, susceptibility to}, 145500 (3), Multifactorial; {Ischemic stroke, susceptibility to}, 601367 (3), Multifactorial; {Placental abruption} (3)",Nos3 (MGI:97362)
7,151012208,151028266,7q36.1,7q36.1,612205,"ATG9B, NOS3AS, APG9L2, SONE","Autophagy 9, S. cerevisiae, homolog of, B",ATG9B,285973,ENSG00000181652,NA,NA,Atg9b (MGI:2685420)
7,151028421,151047781,7q35-q36,7q36.1,605464,"ABCB8, MABC1","ATP-binding cassette, subfamily B, member 8",ABCB8,11194,ENSG00000197150,NA,NA,Abcb8 (MGI:1351667)
7,151048291,151052755,7q35,7q36.1,611741,"ACCN3, ASIC3, TNAC1, DRASIC","Cation channel, amiloride-sensitive, neuronal 3",ASIC3,9311,ENSG00000213199,NA,NA,Asic3 (MGI:2159339)
7,151053814,151057896,7q36,7q36.1,123831,"CDK5, LIS7",Cyclin-dependent kinase 5,CDK5,1020,ENSG00000164885,mutation identified in 1 LIS7 family,"?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3), Autosomal recessive",Cdk5 (MGI:101765)
7,151058199,151076526,7q35-q36,7q36.1,109280,"SLC4A2, AE2, EPB3L1","Solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1)",SLC4A2,6522,ENSG00000164889,NA,NA,Slc4a2 (MGI:109351)
7,151076620,151080882,7q35,7q36.1,606965,"FASTK, FAST",Fas-activated serine/threonine kinase,FASTK,10922,ENSG00000164896,NA,NA,Fastk (MGI:1913837)
7,151081084,151083492,7q36.1,7q36.1,614792,"TMUB1, DULP, SB144, C7orf21",Transmembrane and ubiquitin-like domain-containing protein 1,TMUB1,83590,ENSG00000164897,NA,NA,Tmub1 (MGI:1923764)
7,151085866,151144434,7q36.1,7q36.1,616813,"AGAP3, CENTG3, CRAG","ARF GTPase-activating protein with GTPase domain, ankyrin repeat, and pleckstrin homology domain 3",AGAP3,116988,ENSG00000133612,NA,NA,Agap3 (MGI:2183446)
7,151148588,151167547,7q36,7q36.1,603354,GBX1,Gastrulation brain homeobox 1,GBX1,2636,ENSG00000164900,NA,NA,Gbx1 (MGI:95667)
7,151175697,151187791,7q36.1,7q36.1,615054,"ASB10, GLC1F",Ankyrin repeat- and SOCS box-containing protein 10,ASB10,136371,ENSG00000146926,NA,"Glaucoma 1, open angle, F, 603383 (3)",Asb10 (MGI:2152836)
7,151211483,151227204,7q36,7q36.1,612510,"ABCF2, HUSSY18","ATP-binding cassette, subfamily F, member 2",ABCF2,10061,ENSG00000033050,NA,NA,Abcf2 (MGI:1351657)
7,151232482,151238826,7q36.1,7q36.1,608037,"CHPF2, KIAA1402, CSGlcAT",Chondroitin polymerizing factor 2,CHPF2,54480,ENSG00000033100,NA,NA,Chpf2 (MGI:1917522)
7,151238420,151238537,7q36.1,7q36.1,615245,MIR671,Micro RNA 671,MIR671,768213,ENSG00000284191,NA,NA,NA
7,151238779,151277451,7q35-q36,7q36.1,601737,"SMARCD3, BAF60C","SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 3",SMARCD3,6604,ENSG00000082014,NA,NA,Smarcd3 (MGI:1914243)
7,151341698,151378460,7q36.1,7q36.1,607981,NUB1,Negative regulator of ubiquitin-like proteins 1,NUB1,51667,ENSG00000013374,NA,NA,Nub1 (MGI:1889001)
7,151466011,151519894,7q36,7q36.1,601293,"RHEB, RHEB2",Ras homolog enriched in brain,RHEB,6009,ENSG00000106615,NA,NA,Rheb (MGI:97912)
7,151556113,151877114,7q36,7q36.1,602743,"PRKAG2, WPWS, CMH6","Protein kinase, AMP-activated, noncatalytic, gamma-2",PRKAG2,51422,ENSG00000106617,NA,"Cardiomyopathy, hypertrophic 6, 600858 (3), Autosomal dominant; Glycogen storage disease of heart, lethal congenital, 261740 (3), Autosomal dominant; Wolff-Parkinson-White syndrome, 194200 (3), ?Autosomal dominant",Prkag2 (MGI:1336153)
7,151956378,152019933,7q36.1,7q36.1,615133,"GALNTL5, GALNACT19",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5,GALNTL5,168391,ENSG00000106648,NA,NA,Galntl5 (MGI:1915159)
7,152025654,152122344,7q36.1,7q36.1,615130,"GALNT11, GALNACT11",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11,GALNT11,63917,ENSG00000178234,NA,NA,Galnt11 (MGI:2444392)
7,152134924,152436641,7q36,7q36.1,606833,"KMT2C, MLL3, KIAA1506, KLEFS2",Lysine (K)-specific methyltransferase 2C,KMT2C,58508,ENSG00000055609,NA,"Kleefstra syndrome 2, 617768 (3), Autosomal dominant",Kmt2c (MGI:2444959)
7,152644775,152676140,7q36.1,7q36.1,600375,"XRCC2, FANCU","X-ray repair, complementing defective, repair in Chinese hamster cells-2",XRCC2,7516,ENSG00000196584,mutation identified in 1 FANCU patient,"?Fanconi anemia, complementation group U, 617247 (3), Autosomal recessive",Xrcc2 (MGI:1927345)
7,153748132,154894284,7q36.2,7q36.2,126141,"DPP6, VF2, MRD33",Dipeptidylpeptidase VI,DPP6,1804,ENSG00000130226,NA,"Mental retardation, autosomal dominant 33, 616311 (3); {Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3), Autosomal dominant",Dpp6 (MGI:94921)
7,154943689,155003418,7q36,7q36.2,608254,"PAXIP1, PAXIP1L, PTIP",PAX transcription activation domain-interacting protein 1,PAXIP1,22976,ENSG00000157212,NA,NA,NA
7,155070323,155087391,7q36.1,7q36.2,601305,HTR5A,5-hydroxytryptamine (serotonin) receptor-5A,HTR5A,3361,ENSG00000157219,NA,NA,Htr5a (MGI:96283)
7,155200000,159345973,7q36.3,NA,613959,"SCZD16, C16DUPq36.3, DUP7q36.3","Chromosome 7q36.3 duplication syndrome, 362kb",NA,NA,NA,362kb duplication that includes VIPR2,"Schizophrenia 16, 613959 (4)",NA
7,155297771,155310234,7q36,7q36.3,602055,INSIG1,Insulin-induced gene 1,INSIG1,3638,ENSG00000186480,NA,NA,Insig1 (MGI:1916289)
7,155356987,155367932,7q36,7q36.3,608450,BLACE,B-cell acute lymphoblastic leukemia-expressed gene,BLACE,338436,ENSG00000204960,NA,NA,NA
7,155458128,155464830,7q36,7q36.3,131310,EN2,Engrailed-2,EN2,2020,ENSG00000164778,NA,NA,En2 (MGI:95390)
7,155501128,155570745,7q36.3,7q36.3,612493,CNPY1,"Canopy 1, zebrafish, homolog of",CNPY1,285888,ENSG00000146910,NA,NA,Cnpy1 (MGI:2442451)
7,155799979,155812462,7q36,7q36.3,600725,"SHH, HPE3, HLP3, SMMCI, MCOPCB5",Sonic hedgehog,SHH,6469,ENSG00000164690,separate from TPT1,"Holoprosencephaly 3, 142945 (3), Autosomal dominant; Microphthalmia with coloboma 5, 611638 (3), Autosomal dominant; Schizencephaly, 269160 (3); Single median maxillary central incisor, 147250 (3), Autosomal dominant",Shh (MGI:98297)
7,156472098,156640534,7q36,7q36.3,610242,C7orf13,Chromosome 7 open reading frame 13,LINC01006,100506380,ENSG00000182648,overlaps RNF32 on the opposite strand,NA,NA
7,156640201,156678332,7q36,7q36.3,610241,RNF32,RING finger protein 32,RNF32,140545,ENSG00000105982,NA,NA,Rnf32 (MGI:1861747)
7,156669011,156893207,7q36,7q36.3,605522,"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS","Limb region 1, mouse, homolog of",LMBR1,64327,ENSG00000105983,NA,"Acheiropody, 200500 (3), Autosomal recessive; Hypoplastic or aplastic tibia with polydactyly, 188740 (3), Autosomal dominant; Laurin-Sandrow syndrome, 135750 (3), Autosomal dominant; Polydactyly, preaxial type II, 174500 (3), Autosomal dominant; Syndactyly, type IV, 186200 (3), Autosomal dominant; Triphalangeal thumb, type I, 174500 (3), Autosomal dominant; Triphalangeal thumb-polysyndactyly syndrome, 174500 (3), Autosomal dominant",Lmbr1 (MGI:1861746)
7,156949711,156973175,7q36,7q36.3,611269,"NOM1, C7orf3",Nucleolar protein with MIF4G domain 1,NOM1,64434,ENSG00000146909,NA,NA,Nom1 (MGI:1861749)
7,157004852,157010662,7q36,7q36.3,142994,"MNX1, HLXB9, HOXHB9, SCRA1",Motor neuron and pancreas homeobox 1,MNX1,3110,ENSG00000130675,NA,"Currarino syndrome, 176450 (3), Autosomal dominant",Mnx1 (MGI:109160)
7,157138925,157269369,7q36.3,7q36.3,614454,"UBE3C, HECTH2, KIAA0010, KIAA10",Ubiquitin protein ligase E3C,UBE3C,9690,ENSG00000009335,NA,NA,Ube3c (MGI:2140998)
7,157337003,157417438,7q36.3,7q36.3,611332,"DNAJB6, MRJ, DJ4, LGMDD1","DNAJ/HSP40 homolog, subfamily B, member 6",DNAJB6,10049,ENSG00000105993,NA,"Muscular dystrophy, limb-girdle, autosomal dominant 1, 603511 (3), Autosomal dominant",Dnajb6 (MGI:1344381)
7,157539051,158587822,7q36,7q36.3,601698,"PTPRN2, IAR, ICAAR","Protein-tyrosine phosphatase, receptor-type, N, polypeptide 2",PTPRN2,5799,ENSG00000155093,NA,NA,Ptprn2 (MGI:107418)
7,158631168,158704830,7q36.3,7q36.3,608532,"NCAPG2, CAPG2, MTB, 3KS",Non-SMC condensin II complex subunit G2,NCAPG2,54892,ENSG00000146918,NA,"Khan-Khan-Katsanis syndrome, 618460 (3), Autosomal recessive",Ncapg2 (MGI:1923294)
7,158730996,158829576,7q36.3,7q36.3,616691,"ESYT2, FAM62B",Extended synaptotagmin-like protein 2,ESYT2,57488,ENSG00000117868,NA,NA,Esyt2 (MGI:1261845)
7,158839244,158958694,7q36.3,7q36.3,615462,"WDR60, SRTD8, SRPS6",WD repeat containing protein 60,WDR60,55112,ENSG00000126870,NA,"Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3), Autosomal recessive",Wdr60 (MGI:2445085)
7,159028174,159144956,7q36.3,7q36.3,601970,VIPR2,Vasoactive intestinal peptide receptor 2,VIPR2,7434,ENSG00000106018,NA,NA,Vipr2 (MGI:107166)
7,0,159345973,Chr.7,NA,608391,"AIS2, VAMAS3","Autoimmune disease, susceptibility to, 2",AIS2,378426,NA,NA,"{Autoimmune disease, susceptibility to, 2}, 608391 (2)",NA
7,0,159345973,Chr.7,NA,118880,NHCP2,Nonhistone chromosomal protein-2,NA,NA,NA,NA,NA,NA
8,0,19200000,8p23.3-p22,NA,606129,DBA2,Diamond-Blackfan anemia 2,NA,114086,NA,NA,"Diamond-Blackfan anemia 2, 606129 (2)",NA
8,0,29000000,8p23-p21,NA,612279,GEFSP6,"Generalized epilepsy with febrile seizures plus, type 6",NA,100190787,NA,between D8S1706 and D8S549,"Epilepsy, generalized, with febrile seizures plus, type 6, 612279 (2)",NA
8,0,19200000,8p23-p22,NA,148370,KWE,Keratolytic winter erythema,NA,NA,NA,NA,"Keratolytic winter erythema, 148370 (2), Autosomal dominant",NA
8,0,12800000,8p23,NA,609259,MYP10,Myopia 10,MYP10,553195,NA,NA,"Myopia 10, 609259 (2), Multifactorial",NA
8,0,19200000,8p23-p22,NA,615174,TDH,"L-threonine dehydrogenase, pseudogene",TDH,157739,ENSG00000154316,NA,NA,NA
8,0,12800000,8p23,NA,606662,WS2C,"Waardenburg syndrome, type 2C",NA,170594,NA,NA,"Waardenburg syndrome, type 2C, 606662 (2)",NA
8,406807,477966,8p23.3,8p23.3,609098,"FBXO25, FBX25",F-box only protein 25,FBXO25,26260,ENSG00000147364,NA,NA,Fbxo25 (MGI:1914072)
8,737604,1708475,8p,8p23.3,605438,"DLGAP2, DAP2",Discs large associated protein 2,DLGAP2,9228,ENSG00000198010,NA,NA,Dlgap2 (MGI:2443181)
8,1755777,1786569,8p23,8p23.3,607837,"CLN8, EPMR",CLN8 gene,CLN8,2055,ENSG00000182372,NA,"Ceroid lipofuscinosis, neuronal, 8, 600143 (3), Autosomal recessive; Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3), Autosomal recessive",Cln8 (MGI:1349447)
8,1823925,1958640,8p23,8p23.3,608136,"ARHGEF10, KIAA0294, SNCV",Rho guanine nucleotide exchange factor 10,ARHGEF10,9639,ENSG00000104728,mutation identified in 1 SNCV family,"?Slowed nerve conduction velocity, AD, 608236 (3), Autosomal dominant",Arhgef10 (MGI:2444453)
8,2045045,2145455,8p23.3,8p23.3,603509,MYOM2,Myomesin 2,MYOM2,9172,ENSG00000036448,NA,NA,Myom2 (MGI:1328358)
8,2935352,4995034,8p23,8p23.2,608397,"CSMD1, KIAA1890",Cub and Sushi multiple domains 1,CSMD1,64478,ENSG00000183117,NA,NA,Csmd1 (MGI:2137383)
8,6300000,12800000,8p23.1,NA,222400,DIH2,"Hernia, congenital diaphragmatic 2",NA,780899,NA,NA,"Hernia, congenital diaphragmatic 2, 222400 (2), Autosomal recessive",NA
8,6300000,12800000,8p23.1,NA,612254,SLEB12,"Systemic lupus erythematosus, susceptibility to, 12",NA,100190928,NA,associated with rs13277113,"{Systemic lupus erythematosus, susceptibility to, 12}, 612254 (2)",NA
8,6406591,6648507,8p23,8p23.1,607117,MCPH1,Microcephalin,MCPH1,79648,ENSG00000147316,genetic heterogeneity,"Microcephaly 1, primary, autosomal recessive, 251200 (3), Autosomal recessive",Mcph1 (MGI:2443308)
8,6499631,6563419,8p23,8p23.1,601922,"ANGPT2, ANG2",Angiopoietin 2,ANGPT2,285,ENSG00000091879,close to MCPH1,NA,Angpt2 (MGI:1202890)
8,6708586,6761502,8p23.1,8p23.1,614796,AGPAT5,1-acylglycerol-3-phosphate O-acyltransferase 5,AGPAT5,55326,ENSG00000155189,NA,NA,Agpat5 (MGI:1196345)
8,6870591,6877935,8p23.1,8p23.1,602056,DEFB1,"Defensin, beta-1",DEFB1,1672,ENSG00000164825,NA,NA,NA
8,6924696,6926075,8p23.1,8p23.1,600471,"DEFA6, DEF6","Defensin, alpha-6, Paneth cell-specific",DEFA6,1671,ENSG00000164822,NA,NA,NA
8,6935819,6938305,8p23,8p23.1,601157,"DEFA4, DEF4, HP4","Defensin, alpha-4, corticostatin",DEFA4,1669,ENSG00000164821,NA,NA,NA
8,6977648,6980119,8p23.1,8p23.1,125220,"DEFA1, DEF1, MRS","Defensin, alpha-1, myeloid-related sequence",DEFA1,1667,ENSG00000206047,NA,NA,NA
8,7055303,7056738,8p23.1,8p23.1,600472,"DEFA5, DEF5","Defensin, alpha-5, Paneth cell-specific",DEFA5,1670,ENSG00000164816,NA,NA,NA
8,7255242,7260475,8p23.1,8p23.1,613051,FAM90A15,"Family with sequence similarity 90, member A15",FAM90A15P,389630,NA,copy 1,NA,NA
8,7262865,7268097,8p23.1,8p23.1,613042,FAM90A3,"Family with sequence similarity 90, member A3",FAM90A3P,389611,NA,copy 2,NA,NA
8,7278109,7283341,8p23.1,8p23.1,613049,FAM90A13,"Family with sequence similarity 90, member A13",FAM90A13P,441314,NA,copy 4,NA,NA
8,7285731,7290963,8p23.1,8p23.1,613043,FAM90A5,"Family with sequence similarity 90, member A5",FAM90A5P,441315,NA,copy 5,NA,NA
8,7293353,7298583,8p23.1,8p23.1,613054,FAM90A20,"Family with sequence similarity 90, member A20",FAM90A20P,728430,NA,copy 6,NA,NA
8,7428887,7430347,8p23.1,8p23.1,606611,"DEFB103A, DEFB3, HBD3, HBP3","Defensin, beta 103A",DEFB103B,55894,ENSG00000177243,NA,NA,NA
8,7447753,7463669,8p23-p22,8p23.1,606560,"SPAG11, HE2, EP2",Sperm-associated antigen 11,SPAG11B,10407,ENSG00000164871,NA,NA,Spag11b (MGI:3647173)
8,7556137,7559103,8p23.1,8p23.1,613044,FAM90A7,"Family with sequence similarity 90, member A7",FAM90A7P,441317,NA,copy 8,NA,NA
8,7713782,7719014,8p23.1,8p23.1,613050,FAM90A14,"Family with sequence similarity 90, member A14",FAM90A14P,645651,NA,copy 12,NA,NA
8,7721428,7726662,8p23.1,8p23.1,613052,FAM90A18,"Family with sequence similarity 90, member A18",FAM90A18P,441326,NA,copy 13,NA,NA
8,7736724,7741957,8p23.1,8p23.1,613045,FAM90A8,"Family with sequence similarity 90, member A8",FAM90A8P,441324,NA,copy 15,NA,NA
8,7752019,7757253,8p23.1,8p23.1,613053,FAM90A19,"Family with sequence similarity 90, member A19",FAM90A19P,728753,NA,copy 17,NA,NA
8,7759667,7764901,8p23.1,8p23.1,613046,FAM90A9,"Family with sequence similarity 90, member A9",FAM90A9P,441327,NA,copy 18,NA,NA
8,7769583,7771312,8p23.1,8p23.1,613047,FAM90A10,"Family with sequence similarity 90, member A10",FAM90A10P,441328,NA,copy 19,NA,NA
8,7894564,7896715,8p23.1,8p23.1,602215,"DEFB4A, DEFB4, DEFB2","Defensin, beta-4a (formerly defensin, beta-2)",DEFB4A,1673,ENSG00000171711,NA,NA,NA
8,8027073,8032304,8p23.1,8p23.1,613048,FAM90A12,"Family with sequence similarity 90, member A12",FAM90A12P,645879,NA,copy 22,NA,NA
8,8317735,8386438,8p23.1,8p23.1,617344,"PRAG1, PRAGMIN, NACK",PEAK1-related kinase-activating pseudokinase 1,PRAG1,157285,ENSG00000275342,NA,NA,Prag1 (MGI:1196223)
8,8701936,8704095,8p23.1,8p23.1,609203,CLDN23,Claudin 23,CLDN23,137075,ENSG00000253958,NA,NA,Cldn23 (MGI:1919158)
8,8783353,8893629,8p23.1,8p23.1,605352,"MFHAS1, MASL1",Malignant fibrous histiocytoma-amplified sequences with leucine-rich tandem repeats-1,MFHAS1,9258,ENSG00000147324,NA,"Malignant fibrous histiocytoma, 605352 (2)",Mfhas1 (MGI:1098644)
8,9136254,9151585,8p23,8p23.1,610541,"PPP1R3B, GL","Protein phosphatase 1, regulatory subunit 3B",PPP1R3B,79660,ENSG00000173281,NA,NA,Ppp1r3b (MGI:2177268)
8,9555229,9782345,Chr.8,8p23.1,603303,TNKS,"TRF1-interacting, ankyrin-related ADP-ribose polymerase (tankyrase)",TNKS,8658,ENSG00000173273,NA,NA,Tnks (MGI:1341087)
8,9903387,9903471,8p23.1,8p23.1,609327,"MIR124-1, MIR124A",Micro RNA 124-1,MIR124-1,406907,ENSG00000284321,NA,NA,NA
8,10054223,10428890,8p23.1,8p23.1,601250,MSRA,Peptide methionine sulfoxide reductase,MSRA,4482,ENSG00000175806,NA,NA,Msra (MGI:106916)
8,10525483,10554165,8p23.1,8p23.1,615144,"PRSS55, TSP1","Protease, serine, 55",PRSS55,203074,ENSG00000184647,NA,NA,Prss55 (MGI:1918287)
8,10606348,10655142,8p23,8p23.1,608581,RP1L1,RP1-like protein 1,RP1L1,94137,ENSG00000183638,NA,"Occult macular dystrophy, 613587 (3), Autosomal dominant",Rp1l1 (MGI:2384303)
8,10723767,10730510,8p22,8p23.1,612202,SOX7,SRY-box 7,SOX7,83595,ENSG00000171056,NA,NA,Sox7 (MGI:98369)
8,10764960,10839898,8p23,8p23.1,606505,PINX1,PIN2-interacting protein 1,PINX1,54984,ENSG00000254093,NA,NA,Pinx1 (MGI:1919650)
8,11284415,11328145,8p23-p22,8p23.1,606260,"MTMR9, MTMR8",Myotubularin-related protein 9,MTMR9,66036,ENSG00000104643,NA,NA,Mtmr9 (MGI:2442842)
8,11330985,11332185,8p21.3,8p23.1,615199,"SLC35G5, AMAC, AMAC1L2","Solute carrier family 35, member G5",SLC35G5,83650,ENSG00000177710,NA,NA,NA
8,11421464,11475908,8p23-p22,8p23.1,610085,"FAM167A, C8orf13","Family with sequence similarity 167, member A",FAM167A,83648,ENSG00000154319,NA,NA,Fam167a (MGI:3606565)
8,11493990,11564598,8p23-p22,8p23.1,191305,"BLK, MODY11",BLK nonreceptor tyrosine kinase,BLK,640,ENSG00000136573,NA,"Maturity-onset diabetes of the young, type 11, 613375 (3), Autosomal dominant",Blk (MGI:88169)
8,11676930,11760001,8p23.1-p22,8p23.1,600576,"GATA4, ASD2, VSD1, TACHD, TOF",GATA-binding protein-4,GATA4,2626,ENSG00000136574,mutations identified in 1 TACHD family,"Atrial septal defect 2, 607941 (3), Autosomal dominant; Atrioventricular septal defect 4, 614430 (3), Autosomal dominant; ?Testicular anomalies with or without congenital heart disease, 615542 (3), Autosomal dominant; Tetralogy of Fallot, 187500 (3), Autosomal dominant; Ventricular septal defect 1, 614429 (3), Autosomal dominant",Gata4 (MGI:95664)
8,11769624,11787354,8p23.1,8p23.1,608933,"NEIL2, NEI2",Endonuclease VIII-like 2,NEIL2,252969,ENSG00000154328,NA,NA,Neil2 (MGI:2686058)
8,11795572,11839308,8p23.1-p22,8p23.1,184420,"FDFT1, DGPT, SQSD",Farnesyl-diphosphate farnesyltransferase 1 (squalene synthase),FDFT1,2222,ENSG00000079459,NA,"Squalene synthase deficiency, 618156 (3)",Fdft1 (MGI:102706)
8,11842523,11868117,8p22,8p23.1,116810,"CTSB, CPSB, RECEUP","Cathepsin B (regulatory element, cis-acting, enhancer upstream of CTSB, included)",CTSB,1508,ENSG00000164733,KWE due to duplication upstream of CTSB that disrupts a cis-acting regulatory element,"Keratolytic winter erythema, 148370 (4), Autosomal dominant",Ctsb (MGI:88561)
8,12137167,12138759,8p23.1,8p23.1,610186,"USP17L2, DUB3",Ubiquitin specific peptidase 17-like family member 2,USP17L2,377630,ENSG00000223443,NA,NA,NA
8,12182105,12195435,8p23.1,8p23.1,616122,FAM86B1,"Family with sequence similarity 86, member B1",FAM86B1,85002,ENSG00000186523,NA,NA,NA
8,12425400,12436405,8p23.1,8p23.1,616123,FAM86B2,"Family with sequence similarity 86, member B2",FAM86B2,653333,ENSG00000145002,NA,NA,NA
8,12800000,19200000,8p22,NA,614252,ANIB11,"Aneurysm, intracranial berry, 11",NA,100750328,NA,max lod at D8S552,"Aneurysm, intracranial berry, 11, 614252 (2)",NA
8,12800000,19200000,8p22,NA,612030,CHDS9,"Coronary heart disease, susceptibility to, 9",NA,100188877,NA,max lod at D8S1106,"{Coronary heart disease, susceptibility to, 9}, 612030 (2)",NA
8,12800000,23500000,8p22-p21.3,NA,612789,DFNB71,"Deafness, autosomal recessive 71",DFNB71,100302513,NA,max lod at D8S261,"Deafness, autosomal recessive 71, 612789 (2), Autosomal recessive",NA
8,12800000,54600000,8p22-q11,NA,610099,MPD3,"Myopathy, distal 3",NA,780920,NA,possible locus on 12q13-q22,"Myopathy, distal 3, 610099 (2), Autosomal dominant",NA
8,12945672,13029776,8p22,8p22,615666,"KIAA1456, TRM9L",KIAA1456 gene,TRMT9B,57604,ENSG00000250305,NA,NA,Trmt9b (MGI:2442328)
8,13083360,13604619,8p22-p21.3,8p22,604258,DLC1,Deleted in liver cancer 1,DLC1,10395,ENSG00000164741,NA,"Colorectal cancer, somatic, 114500 (3)",Dlc1 (MGI:1354949)
8,14084844,15238430,8p22,8p22,608113,"SGCZ, ZSG1","Sarcoglycan, zeta",SGCZ,137868,ENSG00000185053,NA,NA,Sgcz (MGI:2388820)
8,15540086,15766648,8p22,8p22,601385,"TUSC3, M33, D8S1992, MRT7, MRT22",Tumor suppressor candidate 3,TUSC3,7991,ENSG00000104723,NA,"Mental retardation, autosomal recessive 7, 611093 (3), Autosomal recessive",Tusc3 (MGI:1933134)
8,16107877,16192790,8p22,8p22,153622,"MSR1, SCARA1, SRA",Macrophage scavenger receptor,MSR1,4481,ENSG00000038945,~11cM distal to LPL,"Barrett esophagus/esophageal adenocarcinoma, 614266 (3)",Msr1 (MGI:98257)
8,16992180,17002344,8p22-p21.3,8p22,605558,"FGF20, RHDA2",Fibroblast growth factor-20,FGF20,26281,ENSG00000078579,mutation identified in 1 RHDA2 family,"?Renal hypodysplasia/aplasia 2, 615721 (3), Autosomal recessive",Fgf20 (MGI:1891346)
8,17027237,17133068,8p22,8p22,610633,"MICU3, EFHA2",Mitochondrial calcium uptake protein 3,MICU3,286097,ENSG00000155970,NA,NA,Micu3 (MGI:1925756)
8,17221980,17246908,8p22-p21.3,8p22,604913,"CNOT7, CAF1","CCR4-NOT transcription complex, subunit 7",CNOT7,29883,ENSG00000198791,NA,NA,Cnot7 (MGI:1298230)
8,17246891,17333454,8p23-p21,8p22,609927,"VPS37A, HCRP1, SPG53",Vacuolar protein sorting 37A,VPS37A,137492,ENSG00000155975,NA,"Spastic paraplegia 53, autosomal recessive, 614898 (3), Autosomal recessive",Vps37a (MGI:1261835)
8,17296127,17413352,8p22,8p22,603562,MTMR7,Myotubularin-related protein 7,MTMR7,9108,ENSG00000003987,NA,NA,Mtmr7 (MGI:1891693)
8,17494348,17570565,8p22,8p22,601872,"SLC7A2, ATRC2, HCAT2","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2",SLC7A2,6542,ENSG00000003989,NA,NA,Slc7a2 (MGI:99828)
8,17576432,17643132,8p22-p21.3,8p22,604584,"PDGFRL, PDGRL, PRLTS",Platelet-derived growth factor receptor-like,PDGFRL,5157,ENSG00000104213,NA,"Colorectal cancer, somatic, 114500 (3); Hepatocellular cancer, somatic, 114550 (3)",Pdgfrl (MGI:1916047)
8,17864379,17909982,8p22,8p22,605776,"FGL1, HFREP1",Fibrinogen-like 1,FGL1,2267,ENSG00000104760,NA,NA,Fgl1 (MGI:102795)
8,17922783,18029947,8p22-p21.3,8p22,600299,"PCM1, PTC4",Pericentriolar material 1,PCM1,5108,ENSG00000078674,fused with RET to form PTC4,NA,Pcm1 (MGI:1277958)
8,18055991,18084960,8p22-p21.3,8p22,613468,"ASAH1, AC, SMAPME",N-acylsphingosine amidohydrolase (acid ceramidase) 1,ASAH1,427,ENSG00000104763,NA,"Farber lipogranulomatosis, 228000 (3), Autosomal recessive; Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3), Autosomal recessive",Asah1 (MGI:1277124)
8,18170418,18223688,8p23.1-p21.3,8p22,108345,"NAT1, AAC1",Arylamine N-acetyltransferase-1,NAT1,9,ENSG00000171428,NA,NA,Nat2 (MGI:109201)
8,18386584,18401218,8p23.1-p21.3,8p22,612182,"NAT2, AAC2",Arylamine N-acetyltransferase-2,NAT2,10,ENSG00000156006,acetylation polymorphism,"[Acetylation, slow], 243400 (3), Autosomal recessive",Nat1 (MGI:97279)
8,18527302,19086908,8p22,8p22,614440,"PSD3, HCA67, EFA6R",Pleckstrin and Sec7 domains-containing protein 3,PSD3,23362,ENSG00000156011,NA,NA,Psd3 (MGI:1918215)
8,19200000,29000000,8p21,NA,603013,SCZD6,"Schizophrenia susceptibility locus, chromosome 8p-related",SCZD6,8400,NA,?neuregulin 1,"{Schizophrenia}, 181500 (2), Autosomal dominant",NA
8,19313569,19396217,8p22,8p21.3,614968,"SH2D4A, SH2A, PPP1R38",SH2 domain-containing protein 4A,SH2D4A,63898,ENSG00000104611,NA,NA,Sh2d4a (MGI:1919531)
8,19404160,19758028,8p21.3,8p21.3,616615,CSGALNACT1,Chondroitin sulfate N-acetylgalactosaminyltransferase 1,CSGALNACT1,55790,ENSG00000147408,NA,NA,Csgalnact1 (MGI:2442354)
8,19817148,19852082,8p21.3,8p21.3,611353,"INTS10, INT10",Integrator complex subunit 10,INTS10,55174,ENSG00000104613,NA,NA,Ints10 (MGI:1918135)
8,19939252,19967258,8p22,8p21.3,609708,"LPL, LIPD, HDLCQ11",Lipoprotein lipase,LPL,4023,ENSG00000175445,NA,"Combined hyperlipidemia, familial, 144250 (3), Autosomal dominant; [High density lipoprotein cholesterol level QTL 11], 238600 (3), Autosomal recessive; Lipoprotein lipase deficiency, 238600 (3), Autosomal recessive",Lpl (MGI:96820)
8,20144854,20183205,8p21.3,8p21.3,193002,"SLC18A1, VMAT1, VAT1, CGAT","Solute carrier family 18 (vesicular monoamine), member 1",SLC18A1,6570,ENSG00000036565,NA,NA,Slc18a1 (MGI:106684)
8,20197374,20226851,8p21.3,8p21.3,606939,"ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2","ATPase, H+ transporting, V1 subunit B2",ATP6V1B2,526,ENSG00000147416,NA,"Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3), Autosomal dominant; Zimmermann-Laband syndrome 2, 616455 (3), Autosomal dominant",Atp6v1b2 (MGI:109618)
8,20246164,20303962,8p22,8p21.3,606551,"LZTS1, F37, FEZ1","Leucine zipper, putative tumor suppressor 1",LZTS1,11178,ENSG00000061337,NA,"Esophageal squamous cell carcinoma, somatic, 133239 (3)",Lzts1 (MGI:2684762)
8,21690397,21789295,8p21,8p21.3,601956,"GFRA2, GDNFRB",GDNF family receptor alpha-2,GFRA2,2675,ENSG00000168546,NA,NA,Gfra2 (MGI:1195462)
8,21908872,21913716,8p21.3,8p21.3,604997,"DOK2, P56DOK",Docking protein 2,DOK2,9046,ENSG00000147443,NA,NA,Dok2 (MGI:1332623)
8,21919661,22006584,8p21.3,8p21.3,606140,"XPO7, RANBP16, KIAA0745",Exportin 7,XPO7,23039,ENSG00000130227,NA,NA,Xpo7 (MGI:1929705)
8,22023307,22036907,8p21.3,8p21.3,608073,NPM2,"Nucleophosmin/nucleoplasmin family, member 2",NPM2,10361,ENSG00000158806,NA,NA,Npm2 (MGI:1890811)
8,22039707,22048808,8p21.3,8p21.3,603725,"FGF17, HH20",Fibroblast growth factor 17,FGF17,8822,ENSG00000158815,NA,"Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3), Autosomal dominant",Fgf17 (MGI:1202401)
8,22048930,22082526,8p21.1,8p21.3,125305,"EPB49, DMT",Erythrocyte membrane protein band 49 (dematin),DMTN,2039,ENSG00000158856,NA,NA,Dmtn (MGI:99670)
8,22106871,22110354,8p21.3,8p21.3,615791,"NUDT18, MTH3",Nucleoside diphosphate-linked moiety X motif 18,NUDT18,79873,ENSG00000275074,NA,NA,Nudt18 (MGI:2385853)
8,22114418,22133383,8p21.2,8p21.3,602302,"HR, AU, MUHH1, HYPT4","Hairless, mouse, homolog of",HR,55806,ENSG00000168453,NA,"Alopecia universalis, 203655 (3), Autosomal recessive; Atrichia with papular lesions, 209500 (3), Autosomal recessive; Hypotrichosis 4, 146550 (3), Autosomal dominant",Hr (MGI:96223)
8,22138019,22141906,8p21.3,8p21.3,609349,"REEP4, C8orf20",Receptor expression-enhancing protein 4,REEP4,80346,ENSG00000168476,NA,NA,Reep4 (MGI:1919799)
8,22146829,22156805,8p21.3,8p21.3,608302,LGI3,"Leucine-rich gene, glioma-inactivated, 3",LGI3,203190,ENSG00000168481,NA,NA,Lgi3 (MGI:2182619)
8,22161732,22164478,8p21,8p21.3,178620,"SFTPC, SFTP2, SMDP2","Surfactant, pulmonary-associated protein C (pulmonary surfactant apoprotein-2, SP-C)",SFTPC,6440,ENSG00000168484,NA,"Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3), Autosomal dominant",Sftpc (MGI:109517)
8,22165139,22212325,8p21,8p21.3,112264,"BMP1, OI13",Bone morphogenetic protein-1,BMP1,649,ENSG00000168487,1kb 3' to SFTP2,"Osteogenesis imperfecta, type XIII, 614856 (3), Autosomal recessive",Bmp1 (MGI:88176)
8,22244965,22245036,8p21.3,8p21.3,614112,"MIR320A, MIRN320A",Micro RNA 320A,MIR320A,407037,ENSG00000208037,NA,NA,NA
8,22245103,22254600,8q21,8p21.3,187280,"POLR3D, BN51T, TSBN51","Polymerase III, RNA, subunit D",POLR3D,661,ENSG00000168495,NA,NA,Polr3d (MGI:1914315)
8,22275313,22357567,8p21.3,8p21.3,610312,"PIWIL2, MILI",PIWI-like 2,PIWIL2,55124,ENSG00000197181,NA,NA,Piwil2 (MGI:1930036)
8,22367277,22434128,8p21.3,8p21.3,608736,"SLC39A14, ZIP14, KIAA0062, HMNDYT2, HCIN","Solute carrier family 39 (zinc transporter), member 14",SLC39A14,23516,ENSG00000104635,mutation identified in 1 HCTN family,"Hypermanganesemia with dystonia 2, 617013 (3), Autosomal recessive; ?Hyperostosis cranalis interna, 144755 (3), Autosomal dominant",Slc39a14 (MGI:2384851)
8,22440969,22541465,Chr.8,8p21.3,114107,"PPP3CC, CALNA3","Protein phosphatase-3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma)",PPP3CC,5533,ENSG00000120910,NA,NA,Ppp3cc (MGI:107162)
8,22544989,22575787,8p21.3,8p21.3,610795,"SORBS3, SCAM1, SH3D4",Sorbin and SH3 domains-containing 3,SORBS3,10174,ENSG00000120896,NA,NA,Sorbs3 (MGI:700013)
8,22578740,22598025,8p21.2,8p21.3,609722,"PDLIM2, MYSTIQUE",PDZ and LIM domain protein 2,PDLIM2,64236,ENSG00000120913,NA,NA,Pdlim2 (MGI:2384850)
8,22604739,22621513,8p21,8p21.3,607359,"CCAR2, DBC1, KIAA1967",Cell division cycle and apoptosis regulator 2,CCAR2,57805,ENSG00000158941,NA,NA,Ccar2 (MGI:2444228)
8,22620417,22669147,8p21.3,8p21.3,606396,BIN3,Bridging integrator 3,BIN3,55909,ENSG00000147439,NA,NA,Bin3 (MGI:1929883)
8,22687658,22693479,8p23-p21,8p21.3,602419,EGR3,Early growth response 3,EGR3,1960,ENSG00000179388,NA,NA,Egr3 (MGI:1306780)
8,22713250,22941076,8p21.2,8p21.3,612473,"PEPB4, CORK1",Phosphatidylethanolamine-binding protein 4,PEBP4,157310,ENSG00000134020,NA,NA,Pebp4 (MGI:1920773)
8,22987250,23020198,8p21.2,8p21.3,607352,"RHOBTB2, DBC2, KIAA0717, EIEE64",Rho-related BTB domain-containing protein 2,RHOBTB2,23221,ENSG00000008853,NA,"Epileptic encephalopathy, early infantile, 64, 618004 (3), Autosomal dominant",Rhobtb2 (MGI:2180557)
8,23020132,23069186,8p22-p21,8p21.3,603612,"TNFRSF10B, DR5, TRAILR2","Tumor necrosis factor receptor superfamily, member 10B",TNFRSF10B,8795,ENSG00000120889,NA,"Squamous cell carcinoma, head and neck, 275355 (3), Autosomal recessive",NA
8,23102813,23117436,8p22-p21,8p21.3,603613,"TNFRSF10C, DCR1, TRAILR3, TRID","Tumor necrosis factor receptor superfamily, member 10C",TNFRSF10C,8794,ENSG00000173535,NA,NA,NA
8,23135587,23164026,8p21,8p21.3,603614,"TNFRSF10D, DCR2, TRAILR4","Tumor necrosis factor receptor superfamily, member 10D",TNFRSF10D,8793,ENSG00000173530,NA,NA,NA
8,23190451,23225101,8p21,8p21.3,603611,"TNFRSF10A, DR4, TRAILR1, APO2","Tumor necrosis factor receptor superfamily, member 10A",TNFRSF10A,8797,ENSG00000104689,NA,NA,Tnfrsf10b (MGI:1341090)
8,23243636,23261999,8p21.3,8p21.3,611130,CHMP7,"CHMP family, member 7",CHMP7,91782,ENSG00000147457,NA,NA,Chmp7 (MGI:1913922)
8,23296896,23404119,8p21.3-p21.2,8p21.3,606663,LOXL2,Lysyl oxidase-like 2,LOXL2,4017,ENSG00000134013,NA,NA,Loxl2 (MGI:2137913)
8,23429151,23457730,8p21.3,8p21.3,607577,"ENTPD4, LYSAL1, LAP70, KIAA0392",Ectonucleoside triphosphate diphosphohydrolase 4,ENTPD4,9583,ENSG00000197217,NA,NA,"Entpd4,Entpd4b (MGI:1914714,MGI:5435040)"
8,23528955,23575462,8p21,8p21.2,610387,"SLC25A37, MFRN, MFRN1","Solute carrier family 25 (mitochondrial iron carrier), member 37",SLC25A37,51312,ENSG00000147454,NA,NA,Slc25a37 (MGI:1914962)
8,23678692,23682937,8p21,8p21.2,602041,"NKX3-1, NKX3A, BAPX2",NK3 homeo box 1,NKX3-1,4824,ENSG00000167034,NA,NA,Nkx3-1 (MGI:97352)
8,23702450,23706597,8p21,8p21.2,611770,"NKX2-6, CSX2, CTHM","NK2, Drosophila, homolog of, 6",NKX2-6,137814,ENSG00000180053,NA,"Conotruncal heart malformations, 217095 (3); Persistent truncus arteriosus, 217095 (3)",Nkx2-6 (MGI:97351)
8,23841928,23854805,8p21-p11.2,8p21.2,601185,"STC1, STC",Stanniocalcin 1,STC1,6781,ENSG00000159167,NA,NA,Stc1 (MGI:109131)
8,24294039,24359017,8p12,8p21.2,606188,"ADAM28, MDCL",A disintegrin and metalloproteinase domain 28,ADAM28,10863,ENSG00000042980,NA,NA,Adam28 (MGI:105988)
8,24384284,24406012,8p12,8p21.2,606393,"ADAMDEC1, DECYSIN",A disintegrin and metalloproteinase domain-like protein decysin 1,ADAMDEC1,27299,ENSG00000134028,NA,NA,Adamdec1 (MGI:1917650)
8,24441025,24509564,8p12,8p21.2,607310,ADAM7,A disintegrin and metalloproteinase domain 7,ADAM7,8756,ENSG00000069206,NA,NA,Adam7 (MGI:107247)
8,24913760,24919092,8p21,8p21.2,162250,"NEFM, NEF3, NFM","Neurofilament protein, medium polypeptide",NEFM,4741,ENSG00000104722,NA,NA,NA
8,24950954,24956868,8p21,8p21.2,162280,"NEFL, CMT2E, CMT1F, CMTDIG","Neurofilament, light polypeptide",NEFL,4747,ENSG00000277586,NA,"Charcot-Marie-Tooth disease, dominant intermediate G, 617882 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 1F, 607734 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 2E, 607684 (3), Autosomal dominant",Nefl (MGI:97313)
8,25184688,25415710,8p21.2,8p21.2,616904,DOCK5,Dedicator of cytokinesis 5,DOCK5,80005,ENSG00000147459,NA,NA,Dock5 (MGI:2652871)
8,25419257,25425039,8p21-p11.2,8p21.2,152760,"GNRH1, LNRH, HH12",Gonadotropin-releasing hormone-1 (luteinizing-releasing hormone),GNRH1,2796,ENSG00000147437,mutation identified in 1 HH12 family,"?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3), Autosomal recessive",Gnrh1 (MGI:95789)
8,25424356,25458467,8p21.2,8p21.2,617265,"KCTD9, BTBD27",Potassium channel tetramerization domain-containing protein 9,KCTD9,54793,ENSG00000104756,NA,NA,Kctd9 (MGI:2145579)
8,25841724,26045412,8p21.2,8p21.2,609934,EBF2,Early B-cell factor 2,EBF2,64641,ENSG00000221818,NA,NA,Ebf2 (MGI:894332)
8,26383053,26413126,8p21,8p21.2,605368,"BNIP3L, NIX",BCL2/adenovirus E1B 19-kD protein-interacting protein 3-like,BNIP3L,665,ENSG00000104765,NA,NA,"Bnip3l,Bnip3l-ps (MGI:1332659,MGI:3642435)"
8,26504694,26513871,8p21.2,8p21.2,603970,"PNMA2, MA2, MM2",Paraneoplastic MA antigen 2,PNMA2,10687,ENSG00000240694,NA,NA,Pnma2 (MGI:2444129)
8,26514030,26658174,8p21,8p21.2,602463,"DPYSL2, DRP2, CRMP2",Dihydropyrimidinase-like 2,DPYSL2,1808,ENSG00000092964,NA,NA,Dpysl2 (MGI:1349763)
8,26738112,26870993,8p21,8p21.2,104221,ADRA1C,"Adrenergic, alpha-1C-, receptor",ADRA1A,148,ENSG00000120907,.03cM from NEFL,NA,Adra1a (MGI:104773)
8,27284885,27311271,8p21.1,8p21.2,617007,"TRIM35, MAIR, HLS5, KIAA1098",Tripartite motif-containing protein 35,TRIM35,23087,ENSG00000104228,NA,NA,Trim35 (MGI:1914104)
8,27311477,27459390,8p22-p11.2,8p21.2,601212,"PTK2B, FAK2, PYK2","Protein tyrosine kinase-2, beta (focal adhesion kinase 2)",PTK2B,2185,ENSG00000120899,NA,NA,Ptk2b (MGI:104908)
8,27459755,27479284,8p21,8p21.2,118502,CHRNA2,"Cholinergic receptor, nicotinic, alpha polypeptide-2",CHRNA2,1135,ENSG00000120903,NA,"Epilepsy, nocturnal frontal lobe, type 4, 610353 (3), Autosomal dominant",Chrna2 (MGI:87886)
8,27491142,27597558,8p21-p12,8p21.2-p21.1,132811,EPHX2,"Epoxide hydrolase 2, cytoplasmic",EPHX2,2053,ENSG00000120915,NA,"{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3), Autosomal dominant",Ephx2 (MGI:99500)
8,27500000,29000000,8p21.1,NA,240400,"GULOP, GULO",Gulonolactone (L-) oxidase pseudogene,GULOP,2989,NA,NA,Scurvy (3),NA
8,27500000,72000000,8p21.1-q13.3,NA,611945,SPG37,Spastic paraplegia 37,SPG37,100049159,NA,max lod at D8S601,"Spastic paraplegia 37, autosomal dominant, 611945 (2), Autosomal dominant",NA
8,27596916,27615030,8p21-p12,8p21.1,185430,"CLU, CLI, SGP2, TRPM2","Clusterin (complement lysis inhibitor, SP-40,40; sulfated glycoprotein 2; testosterone-repressed prostate message-2; apolipoprotein J)",CLU,1191,ENSG00000120885,NA,NA,Clu (MGI:88423)
8,27633664,27736593,8p21,8p21.1,602728,"SCARA3, MSLR1, CSR","Scavenger receptor class A, member 3",SCARA3,51435,ENSG00000168077,NA,NA,Scara3 (MGI:2444418)
8,27771948,27812429,8p21.1,8p21.1,609353,ESCO2,"Establishment of cohesion 1, S. cerevisiae, homolog of, 2",ESCO2,157570,ENSG00000171320,NA,"Roberts syndrome, 268300 (3), Autosomal recessive; SC phocomelia syndrome, 269000 (3), Autosomal recessive",Esco2 (MGI:1919238)
8,27809623,27837816,8p21.1,8p21.1,611210,"PBK, TOPK",PDZ-binding kinase,PBK,55872,ENSG00000168078,NA,NA,Pbk (MGI:1289156)
8,27869882,27992672,8p21.1,8p21.1,611306,SCARA5,"Scavenger receptor class A, member 5",SCARA5,286133,ENSG00000168079,NA,NA,Scara5 (MGI:1918395)
8,28090231,28191152,8p21.1,8p21.1,612722,"ELP3, KAT9","Elongation protein 3, S. cerevisiae, homolog of",ELP3,55140,ENSG00000134014,NA,NA,Elp3 (MGI:1921445)
8,28316978,28343354,8p21,8p21.1,601459,"PNOC, PPNOC",Prepronociceptin,PNOC,5368,ENSG00000168081,NA,NA,Pnoc (MGI:105308)
8,28345589,28386459,8p21.1,8p21.1,609494,"ZNF395, PBF, HDBP2",Zinc finger protein 395,ZNF395,55893,ENSG00000186918,NA,NA,Zfp395 (MGI:2682318)
8,28428407,28490317,8p21.1,8p21.1,608519,"FBXO16, FBX16",F-box only protein 16,FBXO16,157574,ENSG00000214050,?8p12,NA,Fbxo16 (MGI:1354706)
8,28494204,28574267,8p21,8p21.1,606143,FZD3,"Frizzled, Drosophila, homolog of, 3",FZD3,7976,ENSG00000104290,NA,NA,Fzd3 (MGI:108476)
8,28607735,28755598,8p21,8p21.1,605744,"EXTL3, EXTR1, ISDNA",Exostosin-like 3,EXTL3,2137,ENSG00000012232,NA,"Immunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3), Autosomal recessive",Extl3 (MGI:1860765)
8,28767657,28890225,8p21.1,8p21.1,611352,"INTS9, INT9, RC74",Integrator complex subunit 9,INTS9,55756,ENSG00000104299,NA,NA,Ints9 (MGI:1098533)
8,29000000,105100000,8p12-q22,NA,611073,AD12,Alzheimer disease 12,NA,100188830,NA,max lod at D8S1119,"{Alzheimer disease 12}, 611073 (2)",NA
8,29000000,36700000,8p12,NA,612348,THPH9,Thrombophilia due to decreased release of tissue plasminogen activator,NA,NA,NA,NA,?Thrombophilia due to decreased release of tissue plasminogen (1),NA
8,29067277,29263384,8p12,8p12,607350,"KIF13B, GAKIN, KIAA0639",Kinesin family member 13B,KIF13B,23303,ENSG00000197892,NA,NA,Kif13b (MGI:1098265)
8,29333061,29350683,8p12-p11,8p12,602747,"DUSP4, MKP2, HVH2",Dual-specificity phosphatase-4 (MAP kinase phosphatase-2),DUSP4,1846,ENSG00000120875,NA,NA,Dusp4 (MGI:2442191)
8,30063002,30083207,8p12,8p12,614768,"TMEM66, SARAF",Transmembrane protein 66,SARAF,51669,ENSG00000133872,NA,NA,Saraf (MGI:1915137)
8,30095407,30138347,8p21.2-p21.1,8p12,607338,LEPROTL1,Leptin receptor overlapping transcript-like 1,LEPROTL1,23484,ENSG00000104660,NA,NA,Leprotl1 (MGI:1915442)
8,30131453,30148767,8p12,8p12,611940,"MBOAT4, GOAT",Membrane-bound O-acetyltransferase domain-containing 4,MBOAT4,619373,ENSG00000177669,NA,NA,Mboat4 (MGI:2685017)
8,30156368,30183638,8p12-p11,8p12,612963,"DCTN6, WS3, P27",Dynactin 6,DCTN6,10671,ENSG00000104671,NA,NA,Dctn6 (MGI:1343154)
8,30384500,30572260,8p12-p11,8p12,601558,RBPMS,RNA-binding protein gene with multiple splicing,RBPMS,11030,ENSG00000157110,NA,NA,Rbpms (MGI:1334446)
8,30578317,30658240,8p21-p12,8p12,189964,"GTF2E2, TTD6","General transcription factor IIE, polypeptide 2, beta subunit, 34kD",GTF2E2,2961,ENSG00000197265,NA,"Trichothiodystrophy 6, nonphotosensitive, 616943 (3), Autosomal recessive",Gtf2e2 (MGI:1915403)
8,30678060,30727998,8p21.1,8p12,138300,GSR,Glutathione reductase,GSR,2936,ENSG00000104687,NA,Hemolytic anemia due to glutathione reductase deficiency (1),Gsr (MGI:95804)
8,30729130,30767005,8p12-p11.2,8p12,602155,"UBXN8, D8S2298E, REP8",UBX domain protein 8,UBXN8,7993,ENSG00000104691,NA,NA,Ubxn8 (MGI:1337129)
8,30785615,30812817,8p12-p11.2,8p12,176916,PPP2CB,"Protein phosphatase-2 (formerly 2A), catalytic subunit, beta isoform",PPP2CB,5516,ENSG00000104695,pseudogene on 16,NA,Ppp2cb (MGI:1321161)
8,30831543,30913011,8p12,8p12,605795,"TEX15, SPGF25",Testis-expressed gene 15,TEX15,56154,ENSG00000133863,NA,"Spermatogenic failure 25, 617960 (3), Autosomal recessive",Tex15 (MGI:1934816)
8,30995801,31033355,8p12,8p12,618041,"PURG, PURGA, PURGB",Purine-rich element-binding protein G,PURG,29942,ENSG00000172733,NA,NA,Purg (MGI:1922279)
8,31033261,31175870,8p12-p11.2,8p12,604611,"RECQL2, RECQ3, WRN","DNA helicase, RecQ-like 2",WRN,7486,ENSG00000165392,NA,"Werner syndrome, 277700 (3), Autosomal recessive",Wrn (MGI:109635)
8,31639244,32774045,8p22-p11,8p12,142445,"NRG1, HGL, HRGA, ARIA","Neuregulin 1 (heregulin, alpha, 45kD; ERBB2 p185-activator)",NRG1,3084,ENSG00000157168,NA,"{?Schizophrenia, susceptibility to}, 603013 (1)",NA
8,33308101,33473145,8p12,8p12,616931,"FUT10, FUCTX",Fucosyltransferase 10,FUT10,84750,ENSG00000172728,NA,NA,Fut10 (MGI:2384748)
8,33498464,33513184,8p12,8p12,614426,"TTI2, C8orf41, MRT39",TELO2-interacting protein 2,TTI2,80185,ENSG00000129696,NA,"Mental retardation, autosomal recessive 39, 615541 (3), Autosomal recessive",Tti2 (MGI:2384576)
8,33513474,33513577,8p12,8p12,616664,SNORD13,"Small nucleolar RNA, C/D box, 13",SNORD13,692084,ENSG00000239039,NA,NA,NA
8,33591329,33600105,8p12,8p12,618368,"DUSP26, MKP8, LDP4, NEAP",Dual-specificity phosphatase 26,DUSP26,78986,ENSG00000133878,NA,NA,Dusp26 (MGI:1914209)
8,35235474,35796549,8p12,8p12,616466,"UNC5D, UNC5H4","Unc5. C. elegans, homolog of, D",UNC5D,137970,ENSG00000156687,NA,NA,Unc5d (MGI:2389364)
8,36700000,45200000,8p11,NA,613523,SCLL,Chromosome 8p11 myeloproliferative syndrome (stem cell leukemia/lymphoma),NA,NA,NA,translocation of FGFR1 (8p11) and various partners,"Chromosome 8p11 myeloproliferative syndrome, 613523 (4)",NA
8,36784323,36936124,8p11.23,8p11.23,615215,"KCNU1, SLO3","Potassium channel, subfamily U, member 1",KCNU1,157855,ENSG00000215262,NA,NA,Kcnu1 (MGI:1202300)
8,37695781,37700018,8p11.23,8p11.23,617045,"ZNF703, ZEPPO1, NLZ1",Zinc finger protein 703,ZNF703,80139,ENSG00000183779,NA,NA,Zfp703 (MGI:2662729)
8,37736626,37758421,8p11.2,8p11.23,611605,"ERLIN2, SPFH2, C8orf2, SPG18",Endoplasmic reticulum lipid raft-associated protein 2,ERLIN2,11160,ENSG00000147475,NA,"Spastic paraplegia 18, autosomal recessive, 611225 (3), Autosomal recessive",Erlin2 (MGI:2387215)
8,37762545,37779767,8p11.2,8p11.23,604436,"PLPBP, PROSC, EPVB6D",Pyridoxal phosphate-binding protein,PLPBP,11212,ENSG00000147471,NA,"Epilepsy, early-onset, vitamin B6-dependent, 617290 (3), Autosomal recessive",Plpbp (MGI:1891207)
8,37796882,37844895,8p12,8p11.23,606823,"ADGRA2, GPR124, TEM5, KIAA1531",Adhesion G protein-coupled receptor A2,ADGRA2,25960,ENSG00000020181,NA,NA,Adgra2 (MGI:1925810)
8,37843267,37849860,8p11.23,8p11.23,607013,"BRF2, BRFU, TFIIIB50",BRF2 subunit of RNA polymerase III transcription initiation factor,BRF2,55290,ENSG00000104221,NA,NA,Brf2 (MGI:1913903)
8,37858617,37899496,8p11.22,8p11.23,608737,"RAB11FIP1, RCP",RAB11 family-interacting protein 1,RAB11FIP1,80223,ENSG00000156675,NA,NA,Rab11fip1 (MGI:1923017)
8,37962989,37966598,8p12-p11.2,8p11.23,109691,ADRB3,"Adrenergic, beta-3-, receptor",ADRB3,155,ENSG00000188778,NA,"{Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Adrb3 (MGI:87939)
8,38030533,38060364,8p12,8p11.23,602223,"EIF4EBP1, 4EBP1",Eukaryotic translation initiation factor-4E binding protein-1,EIF4EBP1,1978,ENSG00000187840,NA,NA,Eif4ebp1 (MGI:103267)
8,38104964,38140079,8p11.2,8p11.23,604782,"ASH2L, ASH2L2, ASH2L1","ASH2, Drosophila, homolog of",ASH2L,9070,ENSG00000129691,NA,NA,Ash2l (MGI:1344416)
8,38142699,38150951,8p11.2,8p11.23,600617,STAR,Steroidogenic acute regulatory protein,STAR,6770,ENSG00000147465,NA,"Lipoid adrenal hyperplasia, 201710 (3), Autosomal recessive",Star (MGI:102760)
8,38163320,38176729,8p11.23,8p11.23,607281,LSM1,LSM1 protein,LSM1,27257,ENSG00000175324,NA,NA,Lsm1 (MGI:1914457)
8,38176854,38213300,8p11.23,8p11.23,603884,"BAG4, SODD",Bcl2-associated athanogene 4,BAG4,9530,ENSG00000156735,NA,NA,Bag4 (MGI:1914634)
8,38231490,38273921,8p11.23,8p11.23,615003,"DDHD2, KIAA0725, SPG54",DDHD domain-containing protein 2,DDHD2,23259,ENSG00000085788,NA,"Spastic paraplegia 54, autosomal recessive, 615033 (3), Autosomal recessive",Ddhd2 (MGI:1919358)
8,38261789,38269434,8p11.23,8p11.23,610626,"PLPP5, PPAPDC1B, HTPAP",Phospholipid phosphatase 5,PLPP5,84513,ENSG00000147535,NA,NA,Plpp5 (MGI:1919160)
8,38269703,38382271,8p12,8p11.23,607083,"NSD3, WHSC1L1",Nuclear receptor-binding SET domain protein 3,NSD3,54904,ENSG00000147548,pseudogene on 17q21; fusion partner with NUP98 in AML,NA,Nsd3 (MGI:2142581)
8,38411137,38468833,8p11.2-p11.1,8p11.23,136350,"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2),FGFR1,2260,ENSG00000077782,"fused with BCR, CEP1, FOP, FIM in hematologic malignancies","Encephalocraniocutaneous lipomatosis, 613001 (3), Somatic mosaicism; Hartsfield syndrome, 615465 (3), Autosomal dominant; Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3), Autosomal dominant; Jackson-Weiss syndrome, 123150 (3), Autosomal dominant; Osteoglophonic dysplasia, 166250 (3), Autosomal dominant; Pfeiffer syndrome, 101600 (3), Autosomal dominant; Trigonocephaly 1, 190440 (3), Autosomal dominant",Fgfr1 (MGI:95522)
8,38728185,38853027,8p11,8p11.22,605301,TACC1,"Transforming, acidic, coiled-coil-containing protein-1",TACC1,6867,ENSG00000147526,NA,NA,Tacc1 (MGI:2443510)
8,38901345,38973911,Chr.8,8p11.22,607773,"PLEKHA2, TAPP2","Pleckstrin homology domain-containing protein, family A, member 2",PLEKHA2,59339,ENSG00000169499,NA,NA,Plekha2 (MGI:1928144)
8,38974148,38988662,8p11.23,8p11.22,610700,HTRA4,HTRA serine peptidase 4,HTRA4,203100,ENSG00000169495,NA,NA,Htra4 (MGI:3036260)
8,38988807,38997138,8p11.22,8p11.22,610081,"TM2D2, BLP1",TM2 domain-containing protein 2,TM2D2,83877,ENSG00000169490,NA,NA,Tm2d2 (MGI:1916992)
8,38996766,39105260,8p11.23,8p11.22,602713,"ADAM9, MDC9, MCMP, CORD9",A disintegrin and metalloproteinase domain 9,ADAM9,8754,ENSG00000168615,NA,"Cone-rod dystrophy 9, 612775 (3)",Adam9 (MGI:105376)
8,39743734,39838226,8p11.2,8p11.22,601533,"ADAM2, FTNB, PH30, CRYN1, CRYN2","A disintegrin and metalloproteinase domain 2 (fertilin, beta)",ADAM2,2515,ENSG00000104755,NA,NA,Adam2 (MGI:1340894)
8,39913890,39928789,8p12-p11,8p11.21,147435,"IDO1, INDO, IDO","Indoleamine 2,3-dioxygenase",IDO1,3620,ENSG00000131203,NA,NA,Ido1 (MGI:96416)
8,39934954,40016390,8p12,8p11.21,612129,"IDO2, INDOL1","Indoleamine 2,3-dioxygenase 2",IDO2,169355,ENSG00000188676,NA,NA,Ido2 (MGI:2142489)
8,40153481,40155309,8p11.2,8p11.21,607702,"TCIM, C8orf4",Transcriptional and immune response regulator,TCIM,56892,ENSG00000176907,NA,NA,Tcim (MGI:1916318)
8,41261961,41309472,8p12-p11.1,8p11.21,604156,"SFRP1, FRP, SARP2",Secreted frizzled-related protein 1,SFRP1,6422,ENSG00000104332,NA,NA,Sfrp1 (MGI:892014)
8,41529204,41545029,8p11.21,8p11.21,610611,"GINS4, SLD5",GINS complex subunit 4,GINS4,84296,ENSG00000147536,NA,NA,Gins4 (MGI:1923847)
8,41578189,41625000,8p11.21,8p11.21,608143,"AGPAT6, LPAATZ",1-acylglycerol-3-phosphate O-acyltransferase 6,GPAT4,137964,ENSG00000158669,NA,NA,Gpat4 (MGI:2142716)
8,41645176,41650816,8p11.2,8p11.21,610772,"NKX6-3, NKX6.3","NK6, Drosophila, homolog of",NKX6-3,157848,ENSG00000165066,NA,NA,NA
8,41653224,41896740,8p11.2,8p11.21,612641,"ANK1, SPH1","Ankyrin-1, erythrocytic",ANK1,286,ENSG00000029534,NA,"Spherocytosis, type 1, 182900 (3), Autosomal recessive, Autosomal dominant",Ank1 (MGI:88024)
8,41929478,42051987,8p11,8p11.21,601408,"KAT6A, MYST3, MOZ, ZNF220, MRD32",K(lysine) acetyltransferase 6A,KAT6A,7994,ENSG00000083168,NA,"Mental retardation, autosomal dominant 32, 616268 (3), Autosomal dominant",Kat6a (MGI:2442415)
8,42152945,42171182,8p11.2,8p11.21,610469,"AP3M2, CLA20","Adaptor-related protein complex 3, mu-2 subunit",AP3M2,10947,ENSG00000070718,NA,NA,Ap3m2 (MGI:1929214)
8,42174717,42207564,8p12,8p11.21,173370,"PLAT, TPA","Plasminogen activator, tissue type",PLAT,5327,ENSG00000104368,NA,"Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1); Thrombophilia, familial, due to decreased release of PLAT, 612348 (1)",Plat (MGI:97610)
8,42270726,42332652,8p11.2,8p11.21,603258,"IKBKB, NFKBIKB, IMD15B, IMD15A","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, beta",IKBKB,3551,ENSG00000104365,NA,"Immunodeficiency 15A, 618204 (3), Autosomal dominant; Immunodeficiency 15B, 615592 (3), Autosomal recessive",Ikbkb (MGI:1338071)
8,42338451,42371809,8p11.2,8p11.21,174760,POLB,"Polymerase (DNA directed), beta",POLB,5423,ENSG00000070501,NA,NA,Polb (MGI:97740)
8,42373193,42391321,8p11.2-p11.1,8p11.21,605417,DKK4,"Dickkopf, Xenopus, homolog of, 4",DKK4,27121,ENSG00000104371,NA,NA,Dkk4 (MGI:2385299)
8,42391623,42405936,8p11.2,8p11.21,610029,VDAC3,Voltage-dependent anion channel 3,VDAC3,7419,ENSG00000078668,NA,NA,Vdac3 (MGI:106922)
8,42416461,42542142,8p11.21,8p11.21,158378,"SLC20A2, MLVAR, GLVR2, IBGC1","Solute carrier family 20, phosphate transporter, member 2 (murine leukemia virus, amphotropic, receptor for)",SLC20A2,6575,ENSG00000168575,NA,"Basal ganglia calcification, idiopathic, 1, 213600 (3), Autosomal dominant",Slc20a2 (MGI:97851)
8,42697365,42737406,8p11.2,8p11.21,118508,CHRNB3,"Cholinergic receptor, nicotinic, beta polypeptide-3",CHRNB3,1142,ENSG00000147432,NA,NA,Chrnb3 (MGI:106212)
8,42752619,42768785,8p11.21,8p11.21,606888,CHRNA6,"Cholinergic receptor, neuronal nicotinic, alpha polypeptide 6",CHRNA6,8973,ENSG00000147434,NA,NA,Chrna6 (MGI:106213)
8,42836673,42843330,8p11.21,8p11.21,609520,"THAP1, DYT6",THAP domain-containing protein 1,THAP1,55145,ENSG00000131931,NA,"Dystonia 6, torsion, 602629 (3), Autosomal dominant",Thap1 (MGI:1921004)
8,42849636,42897293,8p11.2,8p11.21,614649,"RNF170, SNAX1",RING finger protein 170,RNF170,81790,ENSG00000120925,NA,"Ataxia, sensory, 1, autosomal dominant, 608984 (3), Autosomal dominant",Rnf170 (MGI:1924983)
8,42896977,43030534,8p11.21,8p11.21,607825,"HOOK3, HK3","Hook, Drosophila, homolog of, 3",HOOK3,84376,ENSG00000168172,NA,NA,Hook3 (MGI:2443554)
8,43056298,43085787,8p22-q11,8p11.21,134635,FNTA,"Farnesyltransferase, CAAX box, alpha",FNTA,2339,ENSG00000168522,"related FNTAL1 on 11, FNTAL2 on 13",NA,Fnta (MGI:104683)
8,43093505,43123433,8p11,8p11.21,615247,"POMK, SGK196, MDDGA12, MDDGC12",Protein-O-mannose kinase,POMK,84197,ENSG00000185900,mutation in 1 MDDGC12 family has been reported,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3), Autosomal recessive; ?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3), Autosomal recessive",Pomk (MGI:1921903)
8,43140448,43202854,8p11.1,8p11.2-p11.1,610453,"HGSNAT, TMEM76, MPS3C, RP73",Heparan-alpha-glucosaminide N-acetyltransferase,HGSNAT,138050,ENSG00000165102,NA,"Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3), Autosomal recessive; Retinitis pigmentosa 73, 616544 (3), Autosomal recessive",Hgsnat (MGI:1196297)
8,45200000,145138636,8q,NA,600668,CCAL1,Chondrocalcinosis 1,CCAL1,882,NA,NA,"Chondrocalcinosis with early-onset osteoarthritis, 600668 (2), Autosomal dominant",NA
8,45200000,145138636,8q,NA,109640,GPB,"Glycerol phosphatase, beta-",NA,NA,NA,NA,NA,NA
8,45200000,145138636,8q,NA,606789,HBFQTL4,Fetal hemoglobin quantitative trait locus 4,NA,171515,NA,NA,"Fetal hemoglobin quantitative trait locus 4, 606789 (2)",NA
8,45200000,72000000,8q11.1-q13.3,NA,128700,PAFC,"Preauricular fistulae, congenital",NA,404715,NA,between D8S532 and D8S279,"?Preauricular fistulae, congenital, 128700 (2), Autosomal dominant",NA
8,46840885,46855784,8q11.2,8q11.1,609543,BEYLA,BEYLA gene,LINC00293,497634,ENSG00000253314,NA,NA,NA
8,47200000,69600000,8q11.2-q13.2,NA,609197,"GCCD3, FGD3, GCCD2",Glucocorticoid deficiency 3,NA,619477,NA,between D8S285 and D8S1718,"Glucocorticoid deficiency 3, 609197 (2), Autosomal recessive",NA
8,47260877,47736305,8q11.21,8q11.21,615384,"SPIDR, KIAA0146",Scaffolding protein involved in DNA repair,SPIDR,23514,ENSG00000164808,NA,NA,Spidr (MGI:1924834)
8,47736912,47738163,8p11.2-p11.1,8q11.21,116898,CEBPD,"CCAAT/enhancer-binding protein (C/EBP), delta",CEBPD,1052,ENSG00000221869,earlier mapped to 8q11,NA,Cebpd (MGI:103573)
8,47773107,47960182,8q11,8q11.21,600899,"PRKDC, HYRC1, DNPK1, IMD26","Protein kinase, DNA-activated, catalytic polypeptide (hyperradiosensitivity of murine SCID mutation, complementing-1)",PRKDC,5591,ENSG00000253729,NA,"Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive",Prkdc (MGI:104779)
8,47960940,47978159,8q11.2,8q11.21,602638,"MCM4, NKGCD, NKCD, IMD54","Minichromosome maintenance deficient, S. cerevisiae, homolog of, 4",MCM4,4173,ENSG00000104738,NA,"Immunodeficiency 54, 609981 (3), Autosomal recessive",Mcm4 (MGI:103199)
8,47997526,48064707,8q11.21,8q11.21,603001,"UBE2V2, UEV2, DDVIT1, EDPF1, MMS2",Ubiquitin-conjugating enzyme E2 variant 2,UBE2V2,7336,ENSG00000169139,NA,NA,Ube2v2 (MGI:1917870)
8,48917597,48921428,8q11,8q11.21,602150,"SNAI2, SLUG, WS2D","snail, Drosophila, homolog of, 2 (Neural crest transcription factor SLUG)",SNAI2,6591,ENSG00000019549,NA,"Piebaldism, 172800 (3), Autosomal dominant; Waardenburg syndrome, type 2D, 608890 (3), Autosomal recessive",Snai2 (MGI:1096393)
8,49909795,50796691,8q11,8q11.21,608714,"SNTG1, SYN4","Syntrophin, gamma-1",SNTG1,54212,ENSG00000147481,implicated in idiopathic scoliosis,NA,Sntg1 (MGI:1918346)
8,51319574,51809444,8q11,8q11.22-q11.23,615904,"PXDNL, PMR1, VPO2","Peroxidasin, Drosophila, homolog-like",PXDNL,137902,ENSG00000147485,NA,NA,NA
8,52110831,52409878,8q11.2,8q11.23,617155,"ST18, ZNF387, KIAA0535",Suppression of tumorigenicity 18,ST18,9705,ENSG00000147488,NA,NA,St18 (MGI:2446700)
8,52622457,52714465,8q11,8q11.23,606837,"RB1CC1, CC1, KIAA0203",RB1-inducible coiled-coil 1,RB1CC1,9821,ENSG00000023287,NA,"Breast cancer, somatic, 114480 (3)",Rb1cc1 (MGI:1341850)
8,52939907,52940893,8q11.23,8q11.23,600730,"NPBWR1, GPR7",Neuropeptides B and W receptor 1,NPBWR1,2831,ENSG00000183729,previously assigned to 10q11.2-q21.1 by FISH,NA,Npbwr1 (MGI:891989)
8,53225715,53251696,8q11.2,8q11.23,165196,OPRK1,"Opiate receptor, kappa-1",OPRK1,4986,ENSG00000082556,NA,NA,Oprk1 (MGI:97439)
8,53966553,54022455,8q11.23,8q11.23,601425,"TCEA1, TF2S, GTF2S","Transcription elongation factor A, SII, 1",TCEA1,6917,ENSG00000187735,previously mapped to 3p22-p21.3,NA,Tcea1 (MGI:1196624)
8,54046366,54102016,Chr.8,8q11.23,605599,LYPLA1,Lysophospholipase I,LYPLA1,10434,ENSG00000120992,NA,NA,Lypla1 (MGI:1344588)
8,54135223,54148513,8q11.2-q13,8q11.23,611828,MRPL15,Mitochondrial ribosomal protein L15,MRPL15,29088,ENSG00000137547,NA,NA,Mrpl15 (MGI:1351639)
8,54457934,54460891,8q12-q13,8q11.23,610928,"SOX17, VUR3",SRY-box 17,SOX17,64321,ENSG00000164736,NA,"Vesicoureteral reflux 3, 613674 (3), Autosomal dominant",Sox17 (MGI:107543)
8,54509447,54630833,8q11-q13,8q11.2-q12.1,603937,"RP1, ORP1",Oxygen-regulated photoreceptor protein-1 (retinitis pigmentosa-1),RP1,6101,ENSG00000104237,NA,"Retinitis pigmentosa 1, 180100 (3), Autosomal recessive, Autosomal dominant",Rp1 (MGI:1341105)
8,54600000,60600000,8q12.1,NA,612587,ANIB10,"Aneurysm, intracranial berry, 10",NA,100271689,NA,associated with rs10958409,"{Aneurysm, intracranial berry, 10}, 612587 (2)",NA
8,54600000,65100000,8q12,NA,608765,IS3,"Scoliosis, isolated, susceptibility to, 3",NA,NA,NA,NA,"{Scoliosis, isolated, susceptibility to, 3}, 608765 (2)",NA
8,54600000,72000000,8q12-q13,NA,611046,MTBS2,"Mycobacterium tuberculosis, susceptibility to, 2",NA,100188829,NA,max lod at D8S1723,"{Mycobacterium tuberculosis, susceptibility to, 2}, 611046 (2)",NA
8,55773445,55826444,8q11,8q12.1,606461,"TGS1, NCOA6IP, PIMT","Trimethylguanosine synthase, S. cerevisiae, homolog of",TGS1,96764,ENSG00000137574,NA,NA,Tgs1 (MGI:2151797)
8,55876040,56014168,8q13-qter,8q12.1,165120,LYN,Yamaguchi sarcoma viral (v-yes-1) related oncogene homolog,LYN,4067,ENSG00000254087,NA,NA,Lyn (MGI:96892)
8,56067294,56074580,8q12.1,8q12.1,603682,RPS20,Ribosomal protein S20,RPS20,6224,ENSG00000008988,NA,NA,Rps20 (MGI:1914677)
8,56112941,56113981,8q11,8q12.1,190060,MOS,"Oncogene MOS, Moloney murine sarcoma virus",MOS,4342,ENSG00000172680,NA,NA,Mos (MGI:97052)
8,56160908,56211326,8q12,8q12.1,603026,"PLAG1, SGPA, PSA",Pleomorphic adenoma gene 1,PLAG1,5324,ENSG00000181690,fused with CTNNB1 in SGPA,"Adenomas, salivary gland pleomorphic, somatic, 181030 (3)",Plag1 (MGI:1891916)
8,56211637,56218808,8q12,8q12.1,611238,CHCHD7,Coiled-coil-helix-coiled-coil-helix domain-containing protein 7,CHCHD7,79145,ENSG00000170791,NA,NA,Chchd7 (MGI:1913683)
8,56299647,56320775,8q12.1,8q12.1,608989,RDHE2,"Retinal dehydrogenase, epidermal, 2",SDR16C5,195814,ENSG00000170786,NA,NA,Sdr16c5 (MGI:2668443)
8,56440956,56446640,8q23-q24,8q12.1,131330,PENK,Proenkephalin,PENK,5179,ENSG00000181195,NA,NA,Penk (MGI:104629)
8,56957930,56993873,8q12.1,8q12.1,614010,"IMPAD1, GPAPP, IMPA3",Inositol monophosphatase domain-containing protein 1,IMPAD1,54928,ENSG00000104331,NA,"Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3), Autosomal recessive",Impad1 (MGI:1915720)
8,57994508,58149707,8q12.1,8q12.1,611394,"FAM110B, C8orf72","Family with sequence similarity 110, member B",FAM110B,90362,ENSG00000169122,NA,NA,Fam110b (MGI:1916593)
8,58411263,58451500,8q12.1,8q12.1,610686,"UBXN2B, LOC137886, p37",UBX domain protein 2B,UBXN2B,137886,ENSG00000215114,NA,NA,Ubxn2b (MGI:1915303)
8,58490177,58500162,8q11-q12,8q12.1,118455,"CYP7A1, CYP7","Cytochrome P450, subfamily VII (cholesterol 7-alpha-monooxygenase), polypeptide 1",CYP7A1,1581,ENSG00000167910,NA,NA,Cyp7a1 (MGI:106091)
8,58552923,58582859,8q12.1,8q12.1,602217,"SDCBP, TACIP18, MDA9",Syndecan-binding protein,SDCBP,6386,ENSG00000137575,NA,NA,Sdcbp (MGI:1337026)
8,58583503,58659852,8q12-q13,8q12.1,603043,"NSMAF, FAN",Neutral sphingomyelinase activation-associated factor,NSMAF,8439,ENSG00000035681,NA,NA,Nsmaf (MGI:1341864)
8,58805411,59119292,8q12.1,8q12.1,606863,"TOX, KIAA0808","Thymus high mobility group box protein, mouse, homolog of",TOX,9760,ENSG00000198846,NA,NA,Tox (MGI:2181659)
8,60185411,60281422,8q11-q12,8q12.1,114815,"CA8, CALS, CARP, CAMRQ3",Carbonic anhydrase VIII,CA8,767,ENSG00000178538,NA,"Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3), Autosomal recessive",Car8 (MGI:88253)
8,60516909,60623643,8q12.1,8q12.1-q12.2,179509,"RAB2, RAB2A",Ras-associated protein RAB2,RAB2A,5862,ENSG00000104388,NA,NA,Rab2a (MGI:1928750)
8,60600000,85900000,8q12.2-q21.2,NA,600257,"DEL8q12q21, C8DELq12q21",Bor-Duane hydrocephalus contiguous gene syndrome (chromosome 8q12.1-q21.2 deletion syndrome),NA,NA,NA,NA,"Bor-Duane hydrocephalus contiguous gene syndrome, 600257 (4), Autosomal dominant",NA
8,60600000,85900000,8q12.2-q21.2,NA,123155,HDCPH1,"Hydrocephalus, autosomal dominant",NA,NA,NA,NA,"?Hydrocephalus, autosomal dominant, 123155 (2), Autosomal dominant",NA
8,60678739,60868027,8q12.1,8q12.2,608892,"CHD7, HH5",Chromodomain helicase DNA binding protein 7,CHD7,55636,ENSG00000171316,NA,"CHARGE syndrome, 214800 (3), Autosomal dominant; Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3), Autosomal dominant",Chd7 (MGI:2444748)
8,60964832,61501628,8q12.2,8q12.2-q12.3,611292,"CLVS1, RLBP1L1, CRALBPL",Clavesin 1,CLVS1,157807,ENSG00000177182,NA,NA,Clvs1 (MGI:1921688)
8,61500555,61714639,8q12.1,8q12.3,600582,"ASPH, HAAH, FDLAB",Aspartate beta-hydroxylase (junctin; junctate),ASPH,444,ENSG00000198363,NA,"Traboulsi syndrome, 601552 (3), Autosomal recessive",Asph (MGI:1914186)
8,62248853,62999651,8q12.13,8q12.3,612872,NKAIN3,Na+/K+ transporting ATPase-interacting 3,NKAIN3,286183,ENSG00000185942,NA,NA,Nkain3 (MGI:2444830)
8,63015078,63038805,8q12.3,8q12.3,601509,GGH,Gamma-glutamyl hydrolase,GGH,8836,ENSG00000137563,NA,NA,Ggh (MGI:1329035)
8,63059487,63086522,8q13.1-q13.3,8q12.3,600415,"TTPA, TTP1, AVED","Tocopherol, alpha, transfer protein",TTPA,7274,ENSG00000137561,NA,"Ataxia with isolated vitamin E deficiency, 277460 (3), Autosomal recessive",Ttpa (MGI:1354168)
8,64580364,64583626,8q13,8q12.3,613483,"BHLHE22, BHLHB5, BETA3","Basic helix-loop-helix family, member E22",BHLHE22,27319,ENSG00000180828,NA,NA,Bhlhe22 (MGI:1930001)
8,64586574,64798736,8q21.3,8q12.3,603711,"CYP7B1, CBAS3, SPG5A","Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1",CYP7B1,9420,ENSG00000172817,NA,"Bile acid synthesis defect, congenital, 3, 613812 (3), Autosomal recessive; Spastic paraplegia 5A, autosomal recessive, 270800 (3), Autosomal recessive",Cyp7b1 (MGI:104978)
8,65100000,116700000,8q13-q23,NA,607731,CMT2H,"Charcot-Marie-Tooth disease, axonal, type 2H",NA,619496,NA,between D8S1807 and D8S548,"Charcot-Marie-Tooth disease, axonal, type 2H, 607731 (2), Autosomal recessive",NA
8,65100000,72000000,8q13,NA,600383,"DEL8q13, C8DELq13",Mesomelia-synostoses syndrome (Chromosome 8q13 deletion syndrome),NA,NA,NA,contiguous gene deletion of SULF1 and SLCO5A1,"Mesomelia-synostoses syndrome, 600383 (4), Autosomal dominant",NA
8,65100000,72000000,8q13,NA,126800,"DURS1, DUS",Duane retraction syndrome 1,DURS1,10674,NA,NA,"Duane retraction syndrome 1, 126800 (2), Autosomal dominant",NA
8,65100000,92300000,8q13-q21,NA,121210,FEB1,"Febrile seizures, familial, 1",FEB1,2233,NA,NA,"Febrile seizures, familial, 1, 121210 (2), Autosomal dominant",NA
8,65714333,65842063,8q13-q22,8q13.1,171885,"PDE7A, HCP1",Phosphodiesterase-7A,PDE7A,5150,ENSG00000205268,NA,NA,Pde7a (MGI:1202402)
8,66014977,66101244,8q13.1,8q13.1,613945,DNAJC5B,"DNAJ/HSP40 homolog, subfamily C, member 5, beta",DNAJC5B,85479,ENSG00000147570,NA,NA,Dnajc5b (MGI:1913576)
8,66112666,66175484,8q13.1,8q13.1,606469,"TRIM55, RNF29, MURF2",Tripartite motif containing 55,TRIM55,84675,ENSG00000147573,NA,NA,Trim55 (MGI:3036269)
8,66176375,66178463,8q13,8q13.1,122560,CRH,Corticotropin releasing hormone,CRH,1392,ENSG00000147571,NA,NA,Crh (MGI:88496)
8,66429013,66430732,8q13.1,8q13.1,618311,RRS1,"Ribosome biogenesis regulator 1, S. cerevisiae, homolog of",RRS1,23212,ENSG00000179041,NA,NA,Rrs1 (MGI:1929721)
8,66432503,66468906,8q13.1,8q13.1,611083,"ADHFE1, HOT, ADH8","Alcohol dehydrogenase, iron-containing, 1",ADHFE1,137872,ENSG00000147576,NA,NA,Adhfe1 (MGI:1923437)
8,66562174,66613217,8q22,8q13.1,159405,MYBL1,Avian myeloblastosis viral (v-myb) oncogene homolog like-1,MYBL1,4603,ENSG00000185697,NA,NA,Mybl1 (MGI:99925)
8,66628486,66667230,8q13,8q13.1,611745,"VCPIP1 VCIP135, KIAA1850",VCP/p47 complex-interacting protein 1,VCPIP1,80124,ENSG00000175073,NA,NA,Vcpip1 (MGI:1917925)
8,66712780,66862021,8q12.3-q13.1,8q13.1,607591,"SGK3, SGKL, CISK",Serum/glucocorticoid-regulated kinase 3,SGK3,23678,ENSG00000104205,NA,NA,Sgk3 (MGI:2182368)
8,66870756,66926435,8q13.1,8q13.1,617545,"MCMDC2, C8orf45",Minichromosome maintenance domain-containing protein 2,MCMDC2,157777,ENSG00000178460,NA,NA,Mcmdc2 (MGI:3045334)
8,66921689,66925540,8q13,8q13.1,612215,"SNHG6, U87HG",Small nucleolar RNA host gene 6,SNHG6,641638,ENSG00000245910,NA,NA,NA
8,66922473,66922548,8q13,8q13.1,612216,"SNORD87, U87","Small nucleolar RNA, C/D box, 87",SNORD87,641648,ENSG00000254341,within intron 2 of SNHG6,NA,NA
8,66964102,67028553,8q13.1,8q13.1,617720,"PPP1R42, TLRR, LRRC67","Protein phosphatase 1, rebulatory subunit 42",PPP1R42,286187,ENSG00000178125,NA,NA,Ppp1r42 (MGI:1921138)
8,67043078,67062132,8q13.2,8q13.1,604850,"COPS5, JAB1, SGN5","COP9, subunit 5",COPS5,10987,ENSG00000121022,NA,NA,Cops5 (MGI:1349415)
8,67062416,67198002,8q13.2,8q13.1-q13.2,611654,"CSPP1, CSPP, JBTS21",Centrosome spindle pole-associated protein 1,CSPP1,79848,ENSG00000104218,NA,"Joubert syndrome 21, 615636 (3), Autosomal recessive",Cspp1 (MGI:2681832)
8,67174297,67343823,8q13,8q13.2,604141,"ARFGEF1, ARFGEP1, BIG1, P200",ADP-ribosylation factor guanine nucleotide exchange factor 1,ARFGEF1,10565,ENSG00000066777,NA,NA,Arfgef1 (MGI:2442988)
8,67422037,67747113,8q13,8q13.2,609562,"CPA6, CPAH, ETL5, FEB11",Carboxypeptidase A6,CPA6,57094,ENSG00000165078,NA,"Epilepsy, familial temporal lobe, 5, 614417 (3), Autosomal recessive, Autosomal dominant; Febrile seizures, familial, 11, 614418 (3), Autosomal recessive",Cpa6 (MGI:3045348)
8,67951917,68237031,8q13.1-q13.2,8q13.2,612139,"PREX2, DEPDC2","Phosphatidylinositol 3,4,5-trisphosphate-dependent RAC exchanger 2",PREX2,80243,ENSG00000046889,NA,NA,Prex2 (MGI:1923385)
8,69466623,69660911,8q13.3,8q13.2-q13.3,610012,"SULF1, KIAA1077",Sulfatase 1,SULF1,23213,ENSG00000137573,NA,NA,Sulf1 (MGI:2138563)
8,69667045,69835063,8q13.3,8q13.3,613543,"SLCO5A1, OATPRP4, SLC21A15, OATPJ, OATP5A1","Solute carrier organic anion transporter family, member 5A1",SLCO5A1,81796,ENSG00000137571,NA,NA,Slco5a1 (MGI:2443431)
8,70051612,70071251,8q13.3,8q13.3,611781,"PRDM14, PFM11",PR domain-containing protein 14,PRDM14,63978,ENSG00000147596,NA,NA,Prdm14 (MGI:3588194)
8,70109769,70405389,8q13.2-q13.3,8q13.3,601993,"NCOA2, GRIP1, TIF2, SRC2",Nuclear receptor coactivator 2,NCOA2,10499,ENSG00000140396,NA,NA,Ncoa2 (MGI:1276533)
8,70573217,70608452,Chr.8,8q13.3,605190,TRAM,Translocating chain-associating membrane protein,TRAM1,23471,ENSG00000067167,NA,NA,Tram1 (MGI:1919515)
8,71197432,71548103,8q13.3,8q13.3,601653,"EYA1, BOR, BOS1, OFC1","Eyes absent, Drosophila, homolog of, 1",EYA1,2138,ENSG00000104313,mutation identified in 1 OFC1 family,"Anterior segment anomalies with or without cataract, 602588 (3), Autosomal dominant; Branchiootic syndrome 1, 602588 (3), Autosomal dominant; Branchiootorenal syndrome 1, with or without cataracts, 113650 (3), Autosomal dominant; ?Otofaciocervical syndrome, 166780 (3), Autosomal dominant",Eya1 (MGI:109344)
8,71841541,71844495,8q13.3,8q13.3,603628,"MSC, ABF1, MYOR",Musculin,MSC,9242,ENSG00000178860,NA,NA,Msc (MGI:1333884)
8,72000000,74600000,8q21.11,NA,614230,"DEL8q21.11, C8DELq21.11",Chromosome 8q21.11 deletion syndrome,NA,NA,NA,"contiguous gene deletion; minimal region (GRCh37, 8:77226464-77766239","Chromosome 8q21.11 deletion syndrome, 614230 (4), Autosomal dominant, Isolated cases",NA
8,72000000,145138636,8q21.1-qter,NA,138480,GLYB,"Glycine auxotroph B, complementation of hamster",GLYB,2757,NA,gly(-)B,NA,NA
8,72000000,105100000,8q21-q22,NA,258500,OPA6,Optic atrophy 6,OPA6,777778,NA,between D8S1702 and D8S1794,"Optic atrophy 6, 258500 (2), Autosomal recessive",NA
8,72021249,72094884,8q13,8q21.11,604775,"TRPA1, ANKTM1, FEPS1","Transient receptor potential cation channel, subfamily A, member 1 (ankyrin-like protein with transmembrane domains 1)",TRPA1,8989,ENSG00000104321,mutation identified in 1 FEPS1 family,"?Episodic pain syndrome, familial, 1, 615040 (3), Autosomal dominant",Trpa1 (MGI:3522699)
8,72537224,72945889,Chr.8,8q21.11,607738,"KCNB2, KV2.2","Potassium channel, voltage-gated, shab-related subfamily, member 2",KCNB2,9312,ENSG00000182674,NA,NA,Kcnb2 (MGI:99632)
8,73008855,73048122,8q13,8q21.11,600951,"TERF1, TRF1",Telomeric repeat binding factor 1,TERF1,7013,ENSG00000147601,NA,NA,Terf1 (MGI:109634)
8,73290241,73294465,8q,8q21.11,604166,RPL7,Ribosomal protein L7,RPL7,6129,ENSG00000147604,pseudogene on chr.5,NA,Rpl7 (MGI:98073)
8,73294601,73325280,Chr.8,8q21.11,607599,RDH10,Retinol dehydrogenase 10,RDH10,157506,ENSG00000121039,NA,NA,Rdh10 (MGI:1924238)
8,73420368,73747707,8q13-q21.1,8q21.11,605920,STAU2,"Staufen, Drosophila, homolog of, 2",STAU2,27067,ENSG00000040341,NA,NA,Stau2 (MGI:1352508)
8,73780095,73878861,8q13-q21.1,8q21.11,614277,"UBE2W, UBC16",Ubiquitin-conjugating enzyme 2W,UBE2W,55284,ENSG00000104343,NA,NA,Ube2w (MGI:1914049)
8,73945118,73972286,Chr.8,8q21.11,600788,TCEB1,"Transcription elongation factor B, polypeptide 1, 15kD (elongin C)",ELOC,6921,ENSG00000154582,NA,NA,Eloc (MGI:1915173)
8,73976141,73982782,8q21.11,8q21.11,612418,"TMEM70, MC5DN2",Transmembrane protein 70,TMEM70,54968,ENSG00000175606,NA,"Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3), Autosomal recessive",Tmem70 (MGI:1915068)
8,73991274,74099806,8q21.11,8q21.11,605243,"LY96, MD2",Lymphocyte antigen 96,LY96,23643,ENSG00000154589,NA,NA,Ly96 (MGI:1341909)
8,74234699,74321539,8q21,8q21.11,605266,"JPH1, JP1, CMT2K",Junctophilin 1,JPH1,56704,ENSG00000104369,mutation identified in 1 CMT2K family,"?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3), Autosomal recessive, Autosomal dominant",Jph1 (MGI:1891495)
8,74350382,74488871,8q21.11,8q21.11,606598,"GDAP1, CMT4A, CMT2K, CMTRIA",Ganglioside-induced differentiation-associated protein 1,GDAP1,54332,ENSG00000104381,NA,"Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3), Autosomal recessive; Charcot-Marie-Tooth disease, type 4A, 214400 (3), Autosomal recessive",Gdap1 (MGI:1338002)
8,74700000,83500000,8q21.13,NA,612578,STQTL15,Stature quantitative trait locus 15,NA,100270801,NA,associated with rs2220456,"{Stature QTL 15}, 612578 (2)",NA
8,74824533,74855028,8q21.13,8q21.13,607076,"PI15, P25TI",Protease inhibitor 15,PI15,51050,ENSG00000137558,NA,NA,Pi15 (MGI:1934659)
8,75407566,75566833,8q21,8q21.13,605966,HNF4G,Hepatocyte nuclear factor 4-gamma,HNF4G,3174,ENSG00000164749,NA,NA,Hnf4g (MGI:1353604)
8,76681218,76867284,8q21.12,8q21.13,606940,"ZFHX4, ZFH4",Zinc finger homeobox 4,ZFHX4,79776,ENSG00000091656,NA,"?Ptosis, congenital, 178300 (2), Autosomal dominant",Zfhx4 (MGI:2137668)
8,76980257,77001043,8q21.1,8q21.13,170993,"PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3",Peroxisome biogenesis factor 2,PEX2,5828,ENSG00000164751,NA,"Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3), Autosomal recessive; Peroxisome biogenesis disorder 5B, 614867 (3), Autosomal recessive",Pex2 (MGI:107486)
8,78516339,78605266,Chr.8,8q21.13,606059,PKIA,"Protein kinase, cAMP-dependent catalytic, inhibitor alpha",PKIA,5569,ENSG00000171033,NA,NA,Pkia (MGI:104747)
8,78675869,78806829,8q21.13,8q21.13,146660,IL7,Interleukin-7,IL7,3574,ENSG00000104432,mutation identified in 1 EV5 family,"{?Epidermodysplasia verruciformis, susceptibility to, 5}, 618309 (3), Autosomal recessive",Il7 (MGI:96561)
8,79611116,79666161,8q21.13,8q21.13,600621,"STMN2, SCGN10, SCG10",Stathmin-like 2,STMN2,11075,ENSG00000104435,NA,NA,Stmn2 (MGI:98241)
8,79764009,79767862,8q21.13,8q21.13,602953,"HEY1, NERP2, HESR1",Hairy/enhancer of split-related with YRPW motif 1,HEY1,23462,ENSG00000164683,NA,NA,Hey1 (MGI:1341800)
8,79918716,80030258,8q21.1-q21.3,8q21.13,611990,"MRPS28, MRPS35",Mitochondrial ribosomal protein S28,MRPS28,28957,ENSG00000147586,NA,NA,Mrps28 (MGI:1913480)
8,80034744,80171563,8q21,8q21.13,604068,"TPD52, D52",Tumor protein D52,TPD52,7163,ENSG00000076554,NA,NA,Tpd52 (MGI:107749)
8,80967809,81112067,Chr.8,8q21.13,605767,PAG,Phosphoprotein associated with glycosphingolipid-enriched microdomains,PAG1,55824,ENSG00000076641,NA,NA,Pag1 (MGI:2443160)
8,81280535,81284774,8q21.13,8q21.13,605168,"FABP5, PAFABP, EFABP",Fatty acid-binding protein 5,FABP5,2171,ENSG00000164687,NA,NA,Fabp5 (MGI:101790)
8,81440325,81447438,8q21.3-q22.1,8q21.13,170715,"PMP2, CMT1G",Peripheral myelin protein-2,PMP2,5375,ENSG00000147588,NA,"Charcot-Marie-Tooth disease, demyelinating, type 1G, 618279 (3), Autosomal dominant",Pmp2 (MGI:102667)
8,81478418,81483232,8q21,8q21.13,600434,FABP4,"Fatty acid-binding protein-4, adipocyte",FABP4,2167,ENSG00000170323,NA,NA,Fabp4 (MGI:88038)
8,81656913,81686353,8q21.13-q21.3,8q21.13,602064,"IMPA1, MRT59",Inositol(myo)-1(or 4)-monophosphatase-1,IMPA1,3612,ENSG00000133731,NA,"Mental retardation, autosomal recessive 59, 617323 (3), Autosomal recessive",Impa1 (MGI:1933158)
8,81732447,81759514,8q21.12,8q21.13,610899,"CHMP4C, SNF7-3","CHMP family, member 4C",CHMP4C,92421,ENSG00000164695,NA,NA,Chmp4c (MGI:1913621)
8,81799582,81842325,8q21.13,8q21.13,614903,SNX16,Sorting nexin 16,SNX16,64089,ENSG00000104497,NA,NA,Snx16 (MGI:1921968)
8,84182764,84921843,8q21.2,8q21.2,614648,RALYL,RALY-like protein,RALYL,138046,ENSG00000184672,NA,NA,Ralyl (MGI:1924147)
8,85107148,85146079,8q21.2,8q21.2,617791,"LRRCC1, CLERK, KIAA1764",Leucine-rich repeat- and coiled-coil domain-containing centrosomal protein 1,LRRCC1,85444,ENSG00000133739,NA,NA,Lrrcc1 (MGI:1918960)
8,85177153,85214517,8q21.2,8q21.2,600967,E2F5,E2F transcription factor 5,E2F5,1875,ENSG00000133740,NA,NA,E2f5 (MGI:105091)
8,85327607,85378112,8q22,8q21.2,114800,CA1,Carbonic anhydrase I,CA1,759,ENSG00000133742,NA,NA,Car1 (MGI:88268)
8,85438858,85449039,8q22,8q21.2,114750,CA3,Carbonic anhydrase III,CA3,761,ENSG00000164879,NA,NA,Car3 (MGI:88270)
8,85463901,85481492,8q22,8q21.2,611492,CA2,Carbonic anhydrase II,CA2,760,ENSG00000104267,"CA1, CA2 linked in monkey and mouse","Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3), Autosomal recessive",Car2 (MGI:88269)
8,86098909,86154224,8q21.3,8q21.3,618072,ATP6V0D2,"ATPase, H+ transporting, V0 subunit D2",ATP6V0D2,245972,ENSG00000147614,NA,NA,Atp6v0d2 (MGI:1924415)
8,86213908,86230380,8q21.3,8q21.3,617256,"SLC7A13, AGT1, XAT2","Solute carrier family 7, member 13",SLC7A13,157724,ENSG00000164893,NA,NA,Slc7a13 (MGI:1921337)
8,86342546,86468502,8q21,8q21.3,602307,"WWP1, TIUL1",WW domain-containing protein 1,WWP1,11059,ENSG00000123124,NA,NA,Wwp1 (MGI:1861728)
8,86467054,86514356,8q21.3,8q21.3,611871,"FAM82B, RMD1","Family with sequence similarity 82, member B",RMDN1,51115,ENSG00000176623,NA,NA,Rmdn1 (MGI:1913552)
8,86514421,86561497,8q21.3,8q21.3,604207,"CPNE3, CPN3",Copine III,CPNE3,8895,ENSG00000085719,NA,NA,Cpne3 (MGI:1917818)
8,86573607,86743674,8q21-q22,8q21.3,605080,"CNGB3, ACHM3, ACHM1","Cyclic nucleotide-gated channel, beta-3",CNGB3,54714,ENSG00000170289,NA,"Achromatopsia 3, 262300 (3), Autosomal recessive; Macular degeneration, juvenile, 248200 (3), Autosomal recessive",Cngb3 (MGI:1353562)
8,88032008,88327482,8q21,8q21.3,602262,MMP16,Matrix metalloproteinase 16 (membrane-inserted),MMP16,4325,ENSG00000156103,NA,NA,Mmp16 (MGI:1276107)
8,89757782,89791063,8q21.3,8q21.3,603455,"RIPK2, CARDIAK, RIP2, RICK",Receptor-interacting serine/threonine kinase 2,RIPK2,8767,ENSG00000104312,NA,NA,Ripk2 (MGI:1891456)
8,89901867,89935613,8q21.3,8q21.3,604598,"OSGIN2, C8orf1",Oxidative stress-induced growth inhibitor family member 2,OSGIN2,734,ENSG00000164823,NA,NA,Osgin2 (MGI:2384798)
8,89933335,89984723,8q21,8q21.3,602667,"NBN, NBS1",Nibrin,NBN,4683,ENSG00000104320,NA,"Aplastic anemia, 609135 (3); Leukemia, acute lymphoblastic, 613065 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive",Nbn (MGI:1351625)
8,90001351,90053632,8q21.3,8q21.3,222745,DECR1,"2,4-dienoyl CoA reductase",DECR1,1666,ENSG00000104325,NA,NA,Decr1 (MGI:1914710)
8,90058607,90082878,8q21.3-q22.1,8q21.3,114050,CALB1,"Calbindin 1, 28kD",CALB1,793,ENSG00000104327,NA,NA,Calb1 (MGI:88248)
8,90993801,91040895,8q21.2,8q21.3,609864,TMEM55A,Transmembrane protein 55A,PIP4P2,55529,ENSG00000155099,NA,NA,Pip4p2 (MGI:1919769)
8,91070304,91087094,8q21.3,8q21.3,612021,"OTUD6B, DUBA5, IDDFSDA",OTU domain-containing protein 6B,OTUD6B,51633,ENSG00000155100,NA,"Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3), Autosomal recessive",Otud6b (MGI:1919451)
8,91954966,92103450,8q22,8q21.3,133435,"RUNX1T1, CBFA2T1, AML1T1, ETO","unt-related transcription factor 1, translocated to, 1, cyclin D-related",RUNX1T1,862,ENSG00000079102,fused with AML1 in t(8;21),NA,Runx1t1 (MGI:104793)
8,92300000,97900000,8q22.1,NA,151200,"DUP8q22.1, C8DUPq22.1",Chromosome 8q22.1 duplication syndrome (Leri pleonosteosis),NA,NA,NA,duplication of 0.9-1.2 Mb on 8q22.1,"Leri pleonosteosis chromosome duplication syndrome, 151200 (4), Autosomal dominant",NA
8,92300000,105100000,8q22,NA,145701,HTC1,"Hypertrichosis universalis congenita, Ambras type",HTC1,3341,NA,NA,"?Hypertrichosis universalis congenita, Ambras type, 145701 (2), Autosomal dominant",NA
8,92300000,97900000,8q22.1,NA,608156,"NMLFS, DEL8q22.1, C8DELq22.1",Nablus mask-like facial syndrome (chromosome 8q22.1 deletion syndrome),NA,NA,NA,NA,"Nablus mask-like facial syndrome, 608156 (4), Autosomal dominant",NA
8,93700506,93731526,8q22.1,8q22.1,617273,"FAM92A, FAM92A1, PAPA9","Family with sequence similarity 92, member A",FAM92A,137392,ENSG00000188343,mutation identified in 1 PAPA9 family,"?Polydactyly, postaxial, type A9, 618219 (3), Autosomal recessive",Fam92a (MGI:1915349)
8,93754843,93832652,8q21.13-q22.1,8q22.1,609884,"TMEM67, MKS3, JBTS6, NPHP11",Transmembrane protein 67 (meckelin),TMEM67,91147,ENSG00000164953,mutation identified in 1 RHYNS patient,"{Bardet-Biedl syndrome 14, modifier of}, 615991 (3), Autosomal recessive; COACH syndrome, 216360 (3), Autosomal recessive; Joubert syndrome 6, 610688 (3), Autosomal recessive; Meckel syndrome 3, 607361 (3), Autosomal recessive; Nephronophthisis 11, 613550 (3), Autosomal recessive; ?RHYNS syndrome, 602152 (3), Autosomal recessive",Tmem67 (MGI:1923928)
8,93916922,93926067,8q22.1,8q22.1,605993,"PDP1, PPM2C, PDPC",Pyruvate dehydrogenase phosphatase catalytic subunit 1,PDP1,54704,ENSG00000164951,NA,"Pyruvate dehydrogenase phosphatase deficiency, 608782 (3), Autosomal recessive",Pdp1 (MGI:2685870)
8,94127161,94217277,8q22.1,8q22.1,603017,"CDH17, CDH16, HPT1","Cadherin-17, liver-intestine",CDH17,1015,ENSG00000079112,NA,NA,Cdh17 (MGI:1095414)
8,94249248,94262344,8q13-q21,8q22.1,600164,GEM,GTP-binding protein overexpressed in skeletal muscle,GEM,2669,ENSG00000164949,NA,NA,Gem (MGI:99844)
8,94371959,94475114,8q21.3-q22,8q22.1,604289,RAD54B,"RAD54, S. cerevisiae, homolog of, B",RAD54B,25788,ENSG00000197275,NA,"Colon cancer, somatic, 114500 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3)",Rad54b (MGI:3605986)
8,94427715,94436943,8q22.1,8q22.1,616306,FSBP,Fibrinogen silencer-binding protein,FSBP,100861412,ENSG00000265817,NA,NA,Fsbp (MGI:5301008)
8,94487688,94553517,8q22.1,8q22.1,616447,KIAA1429,KIAA1429 gene,VIRMA,25962,ENSG00000164944,NA,NA,Virma (MGI:1913435)
8,94640998,94707465,8q22.1,8q22.1,612959,"ESRP1, RMB35A, DFNB109",Epithelial splicing regulatory protein 1,ESRP1,54845,ENSG00000104413,mutation identified in 1 DFNB109 family,"?Deafness, autosomal recessive 109, 618013 (3), Autosomal recessive",Esrp1 (MGI:1917326)
8,94719707,94793835,8q22.1,8q22.1,613895,DPY19L4,DPY19-like 4,DPY19L4,286148,ENSG00000156162,NA,NA,Dpy19l4 (MGI:2685869)
8,94823286,94894663,8q22.1,8q22.1,611351,"INTS8, INT8",Integrator complex subunit 8,INTS8,55656,ENSG00000164941,NA,NA,Ints8 (MGI:1919906)
8,94880223,94896670,8q22.1,8q22.1,603775,CCNE2,Cyclin E2,CCNE2,9134,ENSG00000175305,NA,NA,Ccne2 (MGI:1329034)
8,94895767,95118495,8q22.1,8q22.1,612392,"NDUFAF6, C8orf38, MC1DN17",NADH-ubiquinone oxidoreductase complex assembly factor 6,NDUFAF6,137682,ENSG00000156170,NA,"Mitochondrial complex I deficiency, nuclear type 17, 618239 (3), Autosomal recessive",Ndufaf6 (MGI:1924197)
8,94925971,94949377,8q22,8q22.1,606185,"TP53DINP1, P53DINP1",Tumor protein p53 inducible nuclear protein 1,TP53INP1,94241,ENSG00000164938,NA,NA,Trp53inp1 (MGI:1926609)
8,95133784,95156684,8q22.1,8q22.1,615208,"PLEKHF2, EAPF, PHAFIN2","Pleckstrin homology domain-containing protein, family F, member 2",PLEKHF2,79666,ENSG00000175895,NA,NA,Plekhf2 (MGI:1919051)
8,95244912,95269200,8q22.1,8q22.1,614477,"C8orf37, CORD16, RP64, BBS21",Chromosome 8 open reading frame 37,C8orf37,157657,ENSG00000156172,NA,"Bardet-Biedl syndrome 21, 617406 (3), Autosomal recessive; Cone-rod dystrophy 16, 614500 (3), Autosomal recessive; Retinitis pigmentosa 64, 614500 (3), Autosomal recessive",2610301B20Rik (MGI:1914407)
8,96142332,96160805,8q22.1,8q22.1,601147,"GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4",Growth/differentiation factor 6,GDF6,392255,ENSG00000156466,NA,"Klippel-Feil syndrome 1, autosomal dominant, 118100 (3), Autosomal dominant; Leber congenital amaurosis 17, 615360 (3), Autosomal recessive; Microphthalmia with coloboma 6, digenic, 613703 (3), Autosomal dominant; Microphthalmia, isolated 4, 613094 (3); Multiple synostoses syndrome 4, 617898 (3), Autosomal dominant",Gdf6 (MGI:95689)
8,96226675,96235633,8q22,8q22.1,191330,"UQCRB, UQBP, QPC, MC3DN3",Ubiquinol-cytochrome c reductase binding protein,UQCRB,7381,ENSG00000156467,NA,"Mitochondrial complex III deficiency, nuclear type 3, 615158 (3), Autosomal recessive",Uqcrb (MGI:1914780)
8,96239397,96261612,8q22.1,8q22.1,616930,"MTERF3, MTERFD1","Transcription termination factor 3, mitochondrial",MTERF3,51001,ENSG00000156469,NA,NA,Mterf3 (MGI:1913660)
8,96261901,96336994,8q22,8q22.1,612792,"PTDSS1, PSS1, KIAA0024, LMHD",Phosphatidylserine synthase 1,PTDSS1,9791,ENSG00000156471,NA,"Lenz-Majewski hyperostotic dwarfism, 151050 (3), Autosomal dominant",Ptdss1 (MGI:1276575)
8,96493600,96611789,8q22-q24,8q22.1,142460,"SDC2, HSPG1","Syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated; fibroglycan)",SDC2,6383,ENSG00000169439,NA,NA,Sdc2 (MGI:1349165)
8,97273487,97277927,8q22,8q22.1,614721,"TSPYL5, KIAA1750",TSPY-like 5,TSPYL5,85453,ENSG00000180543,NA,NA,Tspyl5 (MGI:2442458)
8,97643971,97730259,8q22-q23,8q22.1,610323,"MTDH, AEG1, LYRIC",Metadherin,MTDH,92140,ENSG00000147649,NA,NA,Mtdh (MGI:1914404)
8,97775787,97853012,8q22.1,8q22.1,613296,LAPTM4B,"Lysosome-associated protein, transmembrane 4, beta",LAPTM4B,55353,ENSG00000104341,"pseudogenes on 1q, 3q,3p, 4q, and 7q33-q35",NA,Laptm4b (MGI:1890494)
8,97869063,98036723,8q22,8q22.1-q22.2,602108,MATN2,Matrilin 2,MATN2,4147,ENSG00000132561,NA,NA,Matn2 (MGI:109613)
8,98041720,98045544,Chr.8,8q22.2,180467,RPL30,Ribosomal protein L30,RPL30,6156,ENSG00000156482,NA,NA,Rpl30 (MGI:98037)
8,98102343,98117170,8q22,8q22.2,602487,"HRSP12, PSP, UK114",Heat-responsive protein 12,RIDA,10247,ENSG00000132541,NA,NA,Rida (MGI:1095401)
8,98117292,98159840,8q22,8q22.2,602486,"POP1, ANXD2","Processing of precursor 1, S. cerevisiae, homolog of",POP1,10940,ENSG00000104356,NA,"Anauxetic dysplasia 2, 617396 (3), Autosomal recessive",Pop1 (MGI:1914974)
8,98426957,98432852,8q22,8q22.2,602906,KCNS2,"Potassium voltage-gated channel, delayed-rectifier, subfamily S, member-2",KCNS2,3788,ENSG00000156486,NA,NA,Kcns2 (MGI:1197011)
8,98433047,98944328,8q22.2,8q22.2,605030,"STK3, MST2, KRS1",Serine/threonine protein kinase 3,STK3,6788,ENSG00000104375,NA,NA,Stk3 (MGI:1928487)
8,98944402,98952103,8q23,8q22.2,611297,OSR2,Odd-skipped-related 2,OSR2,116039,ENSG00000164920,NA,NA,Osr2 (MGI:1930813)
8,99013265,99877585,8q22-q23,8q22.2,607817,"VPS13B, KIAA0532, COH1","Vacuolar protein sorting 13, yeast, homolog of, B",VPS13B,157680,ENSG00000132549,NA,"Cohen syndrome, 216550 (3), Autosomal recessive",Vps13b (MGI:1916380)
8,99877864,99893706,8q22-q23,8q22.2,124090,COX6C,"Cytochrome c oxidase, subunit VIc",COX6C,1345,ENSG00000164919,pseudogene on 16p12,NA,Cox6c2 (MGI:3649160)
8,99960935,100106945,8q22.2,8q22.2,615650,RGS22,Regulator of G protein signaling 22,RGS22,26166,ENSG00000132554,NA,NA,Rgs22 (MGI:3613651)
8,100133350,100150568,8q22.3,8q22.2,609110,"FBXO43, EMI2, ERP1, FBX43",F-box only protein 43,FBXO43,286151,ENSG00000156509,NA,NA,Fbxo43 (MGI:1926053)
8,100150635,100154002,8p22,8q22.2,606033,"POLR2K, RPB12","Polymerase II, RNA, subunit K",POLR2K,5440,ENSG00000147669,NA,NA,Polr2k (MGI:102725)
8,100157868,100241903,8q22,8q22.2,603395,"SPAG1, CILD28",Sperm-associated antigen-1,SPAG1,6674,ENSG00000104450,NA,"Ciliary dyskinesia, primary, 28, 615505 (3), Autosomal recessive",Spag1 (MGI:1349387)
8,100500000,105100000,8q22.3,NA,149000,"KTWS, KTS",Klippel-Trenaunay-Weber syndrome,NA,791122,NA,translocation with 14q13,"Klippel-Trenaunay-Weber syndrome, 149000 (2), Isolated cases",NA
8,100500000,105100000,8q22.3,NA,613318,MMD2,Miyoshi muscular dystrophy 2,NA,100505381,NA,max lod at D10S2325,"Miyoshi muscular dystrophy 2, 613318 (2)",NA
8,100702915,100722087,8q22,8q22.3,604679,"PABPC1, PAB1, PABP1, PABP","Polyadenylate-binding protein, cytoplasmic, 1",PABPC1,26986,ENSG00000070756,NA,NA,Pabpc1 (MGI:1349722)
8,100916522,100954067,8q22.3,8q22.3,601288,"YWHAZ, POPCHAS","Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide",YWHAZ,7534,ENSG00000164924,pseudogene on 2p25,"Popov-Chang syndrome, 618428 (3), Autosomal dominant",Ywhaz (MGI:109484)
8,101492438,101678103,8q22,8q22.3,608576,"GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4",Grainyhead-like 2,GRHL2,79977,ENSG00000083307,NA,"Corneal dystrophy, posterior polymorphous, 4, 618031 (3), Autosomal dominant; Deafness, autosomal dominant 28, 608641 (3), Autosomal dominant; Ectodermal dysplasia/short stature syndrome, 616029 (3), Autosomal recessive",Grhl2 (MGI:2182543)
8,101686541,102125080,8q22.2,8q22.3,606722,NCALD,"Neurocalcin, delta",NCALD,83988,ENSG00000104490,NA,NA,Ncald (MGI:1196326)
8,102204500,102239117,8q23.1,8q22.3,604712,"RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B","Ribonucleotide reductase M2 B, TP53 inducible",RRM2B,50484,ENSG00000048392,NA,"Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3), Autosomal recessive; Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3), Autosomal dominant",Rrm2b (MGI:2155865)
8,102252272,102412699,8q22.3,8q22.3,608413,"UBR5, EDD1, HYD, KIAA0896",Ubiquitin protein ligase E3 component n-recognin 5,UBR5,51366,ENSG00000104517,NA,NA,Ubr5 (MGI:1918040)
8,102551588,102561017,8q22,8q22.3,182878,ODF1,Outer dense fiber of sperm tails 1,ODF1,4956,ENSG00000155087,NA,NA,Odf1 (MGI:97424)
8,102648776,102655724,8q22.2,8q22.3,601878,"KLF10, TIEG",Kruppel-like factor 10,KLF10,7071,ENSG00000155090,NA,NA,Klf10 (MGI:1101353)
8,102826301,102864199,8q22.3,8q22.3,607909,"AZIN1, OAZIN",Antizyme inhibitor 1,AZIN1,51582,ENSG00000155096,NA,NA,Azin1 (MGI:1859169)
8,103021082,103073050,8q22.3,8q22.3,603097,"ATP6V1C1, ATP6C, ATP6D","ATPase, H+ transporting, V1 subunit C1",ATP6V1C1,528,ENSG00000155097,NA,NA,Atp6v1c1 (MGI:1913585)
8,103140724,103230304,8q22.3,8q22.3,606602,BAALC,"Brain and acute leukemia gene, cytoplasmic",BAALC,79870,ENSG00000164929,NA,NA,Baalc (MGI:1928704)
8,103298493,103332865,8q22.3-q23.1,8q22.3,603409,"FZD6, NDNC10","Frizzled, Drosophila, homolog of, 6",FZD6,8323,ENSG00000164930,NA,"Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3), Autosomal recessive",Fzd6 (MGI:108474)
8,103371537,103382988,8q22.3,8q22.3,610635,CTHRC1,Collagen triple-helix repeat-containing protein 1,CTHRC1,115908,ENSG00000164932,NA,"Barrett esophagus/esophageal adenocarcinoma, 614266 (3)",Cthrc1 (MGI:1915838)
8,103398637,103415334,8q21.2,8q22.3,610815,"SLC25A32, MFT, RREI","Solute carrier family 25 (mitochondrial carrier, folate), member 32",SLC25A32,81034,ENSG00000164933,mutation identified in 1 RREI patient,"?Exercise intolerance, riboflavin-responsive, 616839 (3), Autosomal recessive",Slc25a32 (MGI:1917156)
8,103415385,103443452,8q22.3,8q22.3,616196,"DCAF13, WDSOF1",DDB1- and CUL4-associated factor 13,DCAF13,25879,ENSG00000164934,NA,NA,Dcaf13 (MGI:2684929)
8,103499933,104256093,8q23,8q22.3,606630,"RIMS2, KIAA0751, RIM2, OBOE",Regulating synaptic membrane exocytosis-2,RIMS2,9699,ENSG00000176406,NA,NA,Rims2 (MGI:2152972)
8,104339086,104356873,8q22,8q22.3,605933,"TM7SF4, DCSTAMP, FIND","Transmembrane 7 superfamily, member 4",DCSTAMP,81501,ENSG00000164935,NA,NA,Dcstamp (MGI:1923016)
8,104379428,104467073,8q22,8q22.3,613326,"DPYS, DHP",Dihydropyrimidinase,DPYS,1807,ENSG00000147647,NA,"Dihydropyrimidinuria, 222748 (3), Autosomal recessive",Dpys (MGI:1928679)
8,104489230,104589023,8q22.3,8q22.3,618299,"LRP12, MIG13A",Low density lipoprotein receptor-related protein 12,LRP12,29967,ENSG00000147650,NA,NA,Lrp12 (MGI:2443132)
8,105100000,116700000,8q23,NA,612231,CRCS6,"Colorectal cancer, susceptibility to, 6",NA,100187710,NA,associated with rs16892766,"{Colorectal cancer, susceptibility to, 6}, 612231 (2)",NA
8,105100000,116700000,8q23,NA,602429,GLC1D,"Glaucoma 1, open angle, D",GLC1D,2724,NA,NA,"Glaucoma 1D, primary open angle, 602429 (2)",NA
8,105100000,116700000,8q23,NA,607053,HDLCQ2,High density lipoprotein cholesterol level QTL 2,NA,353127,NA,NA,"[High density lipoprotein cholesterol level QTL 2], 607053 (2)",NA
8,105100000,145138636,8q23-q24,NA,140300,HT,Hashimoto thyroiditis,NA,140805,NA,?chr.12,"Hashimoto thyroiditis, 140300 (2), Autosomal dominant",NA
8,105100000,116700000,8q23,NA,612729,LBMQTL1,Lean body mass quantitative trait locus 1,NA,100294719,NA,associated with rs16892496 and rs7832552,"[Lean body mass QTL 1], 612729 (2)",NA
8,105100000,145138636,8q23-q24,NA,611376,MGS,Mungan syndrome,NA,NA,NA,between D8S1830 and D8S1799,"Mungan syndrome, 611376 (2), Autosomal recessive",NA
8,105100000,116700000,8q23,NA,608796,MYMY3,Moyamoya disease 3,MYMY3,493818,NA,max lod at D8S546,"Moyamoya disease 3, 608796 (2)",NA
8,105318437,105804538,8q23,8q23.1,603693,"ZFPM2, FOG2, DIH3, SRXY9","Zinc finger protein, multitype 2 (friend of GATA2)",ZFPM2,23414,ENSG00000169946,NA,"Diaphragmatic hernia 3, 610187 (3); Tetralogy of Fallot, 187500 (3), Autosomal dominant; 46XY sex reversal 9, 616067 (3), Autosomal dominant",Zfpm2 (MGI:1334444)
8,106270177,106752693,8q23,8q23.1,605609,OXR1,Oxidation resistance 1,OXR1,55074,ENSG00000164830,?pseudogene on chr.15,NA,Oxr1 (MGI:2179326)
8,106759482,106809072,8q23,8q23.1,609747,"ABRA, STARS",Actin-binding RHO-activating protein,ABRA,137735,ENSG00000174429,NA,NA,Abra (MGI:2444891)
8,107249481,107497917,8q22,8q23.1,601667,"ANGPT1, ANG1",Angiopoietin-1,ANGPT1,284,ENSG00000154188,NA,NA,Angpt1 (MGI:108448)
8,107899315,108083679,8q23.1,8q23.1,610575,"RSPO2, CRISTIN2, TETAMS2, HHRRD","R-spondin family, member 2",RSPO2,340419,ENSG00000147655,mutation identified in 1 HHRRD family,"?Humerofemoral hypoplasia with radiotibial ray deficiency, 618022 (3), Autosomal recessive; Tetraamelia syndrome 2, 618021 (3), Autosomal recessive",Rspo2 (MGI:1922667)
8,108201215,108248733,8q22-q23,8q23.1,602210,"EIF3E, EIF3S6, INT6","Eukaryotic translation initiation factor 3, subunit E (oncogene INT6)",EIF3E,3646,ENSG00000104408,NA,NA,Eif3e (MGI:99257)
8,108443582,108489195,8q23.1,8q23.1,607722,"EMC2, KIAA0103",ER membrane protein complex subunit 2,EMC2,9694,ENSG00000104412,NA,NA,Emc2 (MGI:1913986)
8,108606849,108787593,8q23.2,8q23.1,613935,TMEM74,Transmembrane protein 74,TMEM74,157753,ENSG00000164841,NA,NA,Tmem74 (MGI:2443417)
8,109086627,109121564,8q23,8q23.1,188545,TRHR,Thyrotropin-releasing hormone receptor,TRHR,7201,ENSG00000174417,NA,"Thyrotropin-releasing hormone resistance, generalized (3)",Trhr (MGI:98824)
8,109240918,109334086,8q23,8q23.1,606109,CML66,Immunogenic tumor antigen CML66,NUDCD1,84955,ENSG00000120526,NA,NA,Nudcd1 (MGI:1914679)
8,109362460,109537206,8q23,8q23.1-q23.2,607843,PKHD1L1,PKHD1-like 1,PKHD1L1,93035,ENSG00000205038,NA,NA,Pkhd1l1 (MGI:2183153)
8,109539699,109565995,8q23,8q23.2,605772,"EBAG9, RCAS1, EB9",Estrogen receptor-binding site-associated antigen 9,EBAG9,9166,ENSG00000147654,NA,NA,Ebag9 (MGI:1859920)
8,109573977,109691790,8q23,8q23.2,611568,"GOLSYN, SYBU, KIAA1472",Golgi-localized syntaphilin-related protein,SYBU,55638,ENSG00000147642,NA,NA,Sybu (MGI:2442392)
8,109963635,109975770,8q22.3-q24.1,8q23.2,608164,"KCNV1, KV8.1","Potassium channel, voltage-gated, subfamily V, member 1",KCNV1,27012,ENSG00000164794,NA,NA,Kcnv1 (MGI:1914748)
8,112222927,113437498,8q23.3,8q23.3,608399,"CSMD3, KIAA1894",Cub and Sushi multiple domains 3,CSMD3,114788,ENSG00000164796,NA,NA,Csmd3 (MGI:2386403)
8,115408495,115669636,8q24.12,8q23.3,604386,TRPS1,Zinc finger transcription factor TRPS1,TRPS1,7227,ENSG00000104447,NA,"Trichorhinophalangeal syndrome, type I, 190350 (3), Autosomal dominant; Trichorhinophalangeal syndrome, type III, 190351 (3), Autosomal dominant",Trps1 (MGI:1927616)
8,116642129,116755822,8q24.11,8q23.3-q24.1,603912,"EIF3H, EIF3S3","Eukaryotic translation initiation factor 3, subunit H",EIF3H,8667,ENSG00000147677,NA,NA,Eif3h (MGI:1915385)
8,116700000,145138636,8q24,NA,612113,BMND10,Bone mineral density quantitative trait locus 10,NA,100188883,NA,associated with rs6469804 and rs6993813,"[Bone mineral density QTL 10], 612113 (2)",NA
8,116700000,145138636,8q24,NA,610649,BSZQTL3,Bone size quantitative trait locus 3,NA,100188815,NA,NA,"[Bone size quantitative trait locus 3], 610649 (2)",NA
8,116700000,145138636,8q24,NA,611469,CRCS2,"Colorectal cancer, susceptibility to, 2",NA,100188841,NA,associated with rs7014346,"{Colorectal cancer, susceptibility to, 2}, 611469 (2)",NA
8,116700000,145138636,8q24,NA,600131,ECA1,"Epilepsy, childhood absence, 1",ECA1,50966,NA,NA,"Epilepsy, childhood absence, 1, 600131 (2), Autosomal dominant",NA
8,116700000,145138636,8q24,NA,600669,EIG1,"Epilepsy, idiopathic generalized, susceptibility to 1",EGI,1957,NA,?same as EBN2,"{Epilepsy, idiopathic generalized, susceptibility to, 1}, 600669 (2), Autosomal dominant",NA
8,116700000,145138636,8q24,NA,611100,HPC10,"Prostate cancer, hereditary, 10",NA,100188834,NA,strongest assoc. with rs1447295,"{Prostate cancer, hereditary, 10}, 611100 (2)",NA
8,116700000,145138636,8q24,NA,167959,HPV18I1,Human papillomavirus type 18 integration site-1,HPV18I1,3260,NA,NA,NA,NA
8,116700000,126300000,8q24.1,NA,275220,THM,Tibial hemimelia,NA,117193,NA,NA,"?Tibial hemimelia, 275220 (2), Autosomal recessive",NA
8,116700000,126300000,8q24.11-q24.13,NA,150230,"TRPS2, LGCR, LGS","Trichorhinophalangeal syndrome, type II (Langer-Giedion syndrome)",NA,NA,NA,contiguous gene syndrome involving TRPS1 and EXT1,"Trichorhinophalangeal syndrome, type II, 150230 (4), Autosomal dominant",NA
8,116845933,116874865,8q24,8q24.11,606462,"RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS","Rad21, S. pombe, homolog of",RAD21,5885,ENSG00000164754,mutation identified in 1 MGS family,"Cornelia de Lange syndrome 4, 614701 (3), Autosomal dominant; ?Mungan syndrome, 611376 (3), Autosomal recessive",Rad21 (MGI:108016)
8,116950216,117176713,8q24.11,8q24.11,611145,"SLC30A8, ZNT8","Solute carrier family 30 (zinc transporter), member 8",SLC30A8,169026,ENSG00000164756,NA,"{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant",Slc30a8 (MGI:2442682)
8,117520712,117540261,8q24.11,8q24.11,610237,"MED30, TRAP25, THRAP6",Mediator complex subunit 30,MED30,90390,ENSG00000164758,NA,NA,Med30 (MGI:1917040)
8,117799362,118111818,8q24.11-q24.13,8q24.11,608177,EXT1,Exostosin 1,EXT1,2131,ENSG00000182197,distal to TRPS1,"Chondrosarcoma, 215300 (3), Autosomal recessive; Exostoses, multiple, type 1, 133700 (3), Autosomal dominant",Ext1 (MGI:894663)
8,118131827,118621962,8q24.1,8q24.11-q24.12,618073,SAMD12,Sterile alpha motif domain containing 12,SAMD12,401474,ENSG00000177570,NA,"Epilepsy, familial adult myoclonic, 1, 601068 (3), Autosomal dominant",Samd12 (MGI:2444518)
8,118923556,118951884,8q24,8q24.12,602643,"TNFRSF11B, OPG, OCIF, PDB5","Tumor necrosis factor receptor superfamily, member 11B (osteoprotegerin)",TNFRSF11B,4982,ENSG00000164761,NA,"Paget disease of bone 5, juvenile-onset, 239000 (3), Autosomal recessive",Tnfrsf11b (MGI:109587)
8,118952232,119108454,8q23-q24.1,8q24.12,607620,"COLEC10, CLL1, 3MC3",Collectin 10,COLEC10,10584,ENSG00000184374,NA,"3MC syndrome 3, 248340 (3), Autosomal recessive",Colec10 (MGI:3606482)
8,119416445,119424433,8q24.1,8q24.12,164958,NOV,Nephroblastoma overexpressed gene,CCN3,4856,ENSG00000136999,proximal to MYC,NA,Ccn3 (MGI:109185)
8,119557076,119673403,8q24.1,8q24.12,601060,"ENPP2, PDNP2",Ectonucleotide pyrophosphatase/phosphodiesterase 2,ENPP2,5168,ENSG00000136960,NA,NA,Enpp2 (MGI:1321390)
8,119730772,119832857,8q24.12,8q24.12,604912,"TAF2, TAF2B, TAFII150, CIF150, MRT40","TAF2 RAN polymerase II, TATA box-binding protein-associated factor, 150kD",TAF2,6873,ENSG00000064313,NA,"Mental retardation, autosomal recessive 40, 615599 (3), Autosomal recessive",Taf2 (MGI:2443028)
8,119833959,119855919,8q24.12,8q24.12,613203,"DSCC1, DCC1","Defective in sister chromatid cohesion 1, S. cerevisiae, homolog of",DSCC1,79075,ENSG00000136982,NA,NA,Dscc1 (MGI:1919357)
8,119873654,120050917,8q24.12,8q24.12,612974,"DEPDC6, DEPTOR",DEP domain-containing protein 6,DEPTOR,64798,ENSG00000155792,NA,NA,Deptor (MGI:2146322)
8,120124466,120373572,8q23,8q24.12,120324,"COL14A1, UND","Collagen, type XIV, alpha-1 (undulin)",COL14A1,7373,ENSG00000187955,NA,NA,Col14a1 (MGI:1341272)
8,120395436,120445149,8q24.12,8q24.12,610200,"MRPL13, RPML13, L13A",Mitochondrial ribosomal protein L13,MRPL13,28998,ENSG00000172172,NA,NA,Mrpl13 (MGI:2137218)
8,120445400,120523635,8q24.1-q24.3,8q24.12,605927,MTBP,"Mouse double minute 2 homolog, binding protein of",MTBP,27085,ENSG00000172167,NA,NA,Mtbp (MGI:2146005)
8,120535755,120812045,8q23-q24,8q24.12,600026,"SNT2B1, A1B, SNTB1","Syntrophin, beta 1 (dystrophin-associated protein A1, 59kD, basic basic component 1)",SNTB1,6641,ENSG00000172164,NA,NA,Sntb1 (MGI:101781)
8,121500000,135400000,8q24.13-q24.22,NA,612448,ARHI1,Age-related hearing impairment 1,NA,100233147,NA,between rs3765212 and rs4601326,"{Age-related hearing impairment 1}, 612448 (2)",NA
8,121500000,130400000,8q24.13-q24.21,NA,614936,PPKP1B,"Keratoderma, palmoplantar, punctate type IB",NA,101154752,NA,between D8S1804 and D8S1720,"Keratoderma, palmoplantar, punctate type IB, 614936 (2), Autosomal dominant",NA
8,121612115,121641439,8q24.12,8q24.13,601636,HAS2,Hyaluronan synthase-2,HAS2,3037,ENSG00000170961,NA,NA,Has2 (MGI:107821)
8,121639345,121645324,8q24.13,8q24.13,614353,"HAS2AS1, HASNT",HAS2 antisense RNA 1,HAS2-AS1,594842,NA,NA,NA,NA
8,123013163,123042422,8q24.13,8q24.13,608813,"DERL1, DER1","DER1-like domain family, member 1",DERL1,79139,ENSG00000136986,NA,NA,Derl1 (MGI:1915069)
8,123248449,123275540,8q,8q24.13,604764,ZHX1,Zinc finger and homeodomain protein 1,ZHX1,11244,ENSG00000165156,NA,NA,Zhx1 (MGI:109271)
8,123319849,123396446,8q24.13,8q24.13,611941,"ATAD2, ANCCA","ATPase family, AAA domain-containing, member 2",ATAD2,29028,ENSG00000156802,NA,NA,Atad2 (MGI:1917722)
8,123497886,123541205,8q24.13,8q24.13,606604,"FBXO32, MAFBX, FLJ32424, ATROGIN1",F-box only protein 32,FBXO32,114907,ENSG00000156804,NA,NA,Fbxo32 (MGI:1914981)
8,123680793,123737392,8q24.1-q24.2,8q24.13,602573,"ANX13, ISA",Annexin XIII,ANXA13,312,ENSG00000104537,NA,NA,Anxa13 (MGI:1917037)
8,124310917,124372698,8q24.13,8q24.13,616609,TMEM65,Transmembrane protein 65,TMEM65,157378,ENSG00000164983,NA,NA,Tmem65 (MGI:1922118)
8,124450819,124453025,8q24.13,8q24.13,611244,"TRMT12, TRM12","tRNA methyltransferase 12, S. cerevisiae, homolog of",TRMT12,55039,ENSG00000183665,NA,NA,Trmt12 (MGI:1915510)
8,124474766,124488617,8q24.1,8q24.13,603046,"RNF139, TRC8, RCA1",RING finger protein 139,RNF139,11236,ENSG00000170881,NA,"Renal cell carcinoma, 144700 (3)",Rnf139 (MGI:1923091)
8,124539101,124549985,8q13.3,8q24.13,601445,"NDUFB9, UQOR22, MC1DN24",NADH-ubiquinone oxidoreductase subunit B9,NDUFB9,4715,ENSG00000147684,mutation identified in 1 MC1DN24 family,"?Mitochondrial complex I deficiency, nuclear type 24, 618245 (3), Autosomal recessive",Ndufb9 (MGI:1913468)
8,124550769,124728506,8q24.1,8q24.13,608486,"MTSS1, MIM, KIAA0429",Metastasis suppressor 1,MTSS1,9788,ENSG00000170873,NA,NA,Mtss1 (MGI:2384818)
8,124998504,125022282,8q24.1,8q24.13,602019,SQLE,Squalene epoxidase,SQLE,6713,ENSG00000104549,NA,NA,Sqle (MGI:109296)
8,125024259,125091818,8q24.13,8q24.13,610657,"WSHC5, KIAA0196, SPG8, RTSC1","WASH complex, subunit 5",WASHC5,9897,ENSG00000164961,NA,"Ritscher-Schinzel syndrome 1, 220210 (3), Autosomal recessive; Spastic paraplegia 8, autosomal dominant, 603563 (3), Autosomal dominant",Washc5 (MGI:2146110)
8,125091778,125367124,8q24.13,8q24.13,617246,"NSMCE2, NSE2, MMS21","Non-SMC element 2, S. cerevisiae, homolog of",NSMCE2,286053,ENSG00000156831,NA,"Seckel syndrome 10, 617253 (3), Autosomal recessive",Nsmce2 (MGI:1915751)
8,125430289,125438404,8q24.13,8q24.13,609461,"TRIB1, TRB1, SKIP1, C8FW","Tribbles, Drosophila, homolog of, 1",TRIB1,10221,ENSG00000173334,NA,NA,Trib1 (MGI:2443397)
8,126300000,130400000,8q24.21,NA,613032,GLM7,Glioma susceptibility 7,NA,101409265,NA,associated with rs55705857,"{Glioma susceptibility 7}, 613032 (2)",NA
8,126552437,126558497,8q24.21,8q24.21,609483,"FAM84B, BCMP101","Family with sequence similarity 84, member B",LRATD2,157638,ENSG00000168672,NA,NA,Lratd2 (MGI:3026924)
8,127013153,127021013,8q24,8q24.21,616043,PCAT1,"Prostate cancer-associated transcript 1, noncoding",PCAT1,100750225,ENSG00000253438,NA,NA,NA
8,127072693,127082220,8q24.21,8q24.21,617678,"PCAT2, PCA2, CARLO4","Prostate cancer-associated transcript 2, noncoding",PCAT2,103164619,ENSG00000254166,NA,NA,NA
8,127079873,127092594,8q24,8q24.21,615452,"PRNCR1, PCAT8",Prostate cancer-associated noncoding RNA 1,PRNCR1,101867536,ENSG00000282961,NA,NA,NA
8,127187784,127197626,8q24.21,8q24.21,617703,"CASC19, LINC01245, CARLO6","Cancer susceptibility candidate 19, noncoding",CASC19,103021165,NA,NA,NA,NA
8,127207381,127219267,8q24.21,8q24.21,617705,"CCAT1, CARLO5","Colon cancer-associated transcript 1, noncoding",CCAT1,100507056,NA,NA,NA,NA
8,127244636,127392630,8q24.21,8q24.21,617702,"CASC21, LINC01244, CARLO2","Cancer susceptibility candidate 21, noncoding",CASC21,103021164,NA,NA,NA,NA
8,127289675,127482138,8q24.21,8q24.21,617701,"CASC8, LINC00860, CARLO1","Cancer susceptibility candidate 8, noncoding",CASC8,727677,ENSG00000246228,NA,NA,NA
8,127415824,127417209,8q24.21,8q24.21,615739,"POU5F1B, POU5F1P1, OCT4PG1","POU domain, class 5, transcription factor 1B",POU5F1B,5462,ENSG00000212993,NA,NA,NA
8,127700607,127733966,8q24.21,8q24.21,617704,"CASC11, LINC00990, CARLO7","Cancer susceptibility candidate 11, noncoding",CASC11,100270680,ENSG00000249375,NA,NA,NA
8,127735433,127742950,8q24.12-q24.13,8q24.21,190080,MYC,Avian myelocytomatosis viral (v-myc) oncogene homolog,MYC,4609,ENSG00000136997,cen-5'-3'-ter,"Burkitt lymphoma, somatic, 113970 (3)",Myc (MGI:97250)
8,127794532,128101252,8q24,8q24.21,165140,PVT1,Oncogene PVT-1 (MYC activator),PVT1,5820,ENSG00000249859,NA,NA,NA
8,129351693,129680238,8q24.21,8q24.21,613040,"CCD26, RAM",Coiled-coil domain-containing protein 26,CCDC26,137196,ENSG00000229140,NA,NA,NA
8,129705902,129786623,8q24.1-q24.2,8q24.21,608384,"GSDMC, MLZE",Gasdermin C,GSDMC,56169,ENSG00000147697,NA,NA,"Gsdmc,Gsdmc4,Gsdmc3,Gsdmc2 (MGI:1933176,MGI:3580656,MGI:1921798,MGI:2146102)"
8,129839592,130017128,8q24,8q24.21,617978,FAM149B,"Family with sequence similarity 49, member B",FAM49B,51571,ENSG00000153310,NA,NA,Fam49b (MGI:1923520)
8,130052103,130443847,8q24.1-q24.2,8q24.21-q24.22,605953,"ASAP1, DDEF1","Arf GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 1",ASAP1,50807,ENSG00000153317,NA,NA,Asap1 (MGI:1342335)
8,130780299,131041603,8q24.2,8q24.22,103070,"ADCY8, ADCY3","Adenylyl cyclase-8, brain",ADCY8,114,ENSG00000155897,NA,NA,Adcy8 (MGI:1341110)
8,131904087,132013641,8q24.2,8q24.22,611798,"EFR3A, KIAA0143","EFR3, S. cerevisiae, homolog of, A",EFR3A,23167,ENSG00000132294,NA,NA,Efr3a (MGI:1923990)
8,132024215,132059381,8q24,8q24.22,601658,"OC90, PLA2L",Otoconin 90 (phospholipase A2-like),OC90,729330,ENSG00000253117,PLA2L = fusion between HHLA1 and OC90,NA,Oc90 (MGI:1313269)
8,132061485,132105264,8q24,8q24.22,604109,HHLA1,Human endogenous retrovirus-H long terminal repeat-associating 1,HHLA1,10086,ENSG00000132297,NA,NA,Hhla1 (MGI:3615329)
8,132120857,132481094,8q24,8q24.22,602232,"KCNQ3, EBN2, BFNC2","Potassium voltage-gated channel, KQT-like subfamily, member 3",KCNQ3,3786,ENSG00000184156,NA,"Seizures, benign neonatal, 2, 121201 (3), Autosomal dominant",Kcnq3 (MGI:1336181)
8,132570415,132685038,8q24.22,8q24.22,614930,"LRRC6, LRTP, CILD19",Leucine-rich repeat-containing protein 6,LRRC6,23639,ENSG00000129295,NA,"Ciliary dyskinesia, primary, 19, 614935 (3), Autosomal recessive",Lrrc6 (MGI:1859553)
8,132866942,133134901,8q24.2-q24.3,8q24.22,188450,"TG, AITD3, TDH3",Thyroglobulin,TG,7038,ENSG00000042832,distal to MYC,"{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3); Thyroid dyshormonogenesis 3, 274700 (3), Autosomal recessive",Tg (MGI:98733)
8,133036727,133103052,8q24.2-q24.3,8q24.22,601099,SLA,Src-like-adaptor,SLA,6503,ENSG00000155926,in intron of TG,NA,Sla (MGI:104295)
8,133054958,133057766,8q24,8q24.22,617440,"PTCSC1, NCRNA00197",Papillary thyroid carcinoma susceptibility candidate 1 gene,PTCSC1,100302522,ENSG00000287736,NA,NA,NA
8,133190906,133231689,8q24.1-q24.3,8q24.22,603398,WISP1,Wnt-1 inducible signaling pathway protein 1,CCN4,8840,ENSG00000104415,NA,NA,Ccn4 (MGI:1197008)
8,133237170,133297586,8q24.3,8q24.22,605262,"NDRG1, HMSNL, CMT4D",N-myc downstream-regulated gene 1,NDRG1,10397,ENSG00000104419,NA,"Charcot-Marie-Tooth disease, type 4D, 601455 (3), Autosomal recessive",Ndrg1 (MGI:1341799)
8,134477787,134713048,8q23-q24,8q24.22,610931,"ZFAT1, ZNF406, AITD3",Zinc finger gene in autoimmune thyroid disease 1,ZFAT,57623,ENSG00000066827,NA,"{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)",Zfat (MGI:2681865)
8,135457455,135656515,8q24.2,8q24.23,610421,"KHDRBS3, TSTAR, SALP, SLM2, ETOILE","KH domain-containing, RNA-binding, signal transduction-associated protein 3",KHDRBS3,10656,ENSG00000131773,NA,NA,Khdrbs3 (MGI:1313312)
8,138588234,138914086,8q24.2,8q24.2-q24.3,610026,COL22A1,"Collagen, type XXII, alpha-1 polypeptide",COL22A1,169044,ENSG00000169436,NA,NA,Col22a1 (MGI:1916950)
8,138900000,145138636,8q24.3,NA,616992,"C8orf17, MOST1",Chromosome 8 open reading frame 17,C8orf17,100507249,NA,NA,NA,NA
8,138900000,145138636,8q24.3,NA,612858,OFC12,Orofacial cleft 12,NA,100302515,NA,associated with rs987525,"Orofacial cleft 12, 612858 (2)",NA
8,139600837,139703134,8q24.1-q24.3,8q24.3,605874,"KCNK9, TASK3","Potassium channel, subfamily K, member 9",KCNK9,51305,ENSG00000169427,NA,"Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)",Kcnk9 (MGI:3521816)
8,139727724,140458578,8q24.3,8q24.3,611966,"TRAPPC9, NIBP, KIAA1882, MRT13",Trafficking protein particle complex 9,TRAPPC9,83696,ENSG00000167632,NA,"Mental retardation, autosomal recessive 13, 613192 (3), Autosomal recessive",Trappc9 (MGI:1923760)
8,140511297,140517153,8q11-q12,8q24.3,607268,"CHARC1, CHARC15, YCL1","Chromatin accessibility complex, subunit 1",CHRAC1,54108,ENSG00000104472,NA,NA,Chrac1 (MGI:2135796)
8,140520155,140642405,8q24,8q24.3,606229,"AGO2, EIF2C2","Argonaute 2, RISC catalytic component",AGO2,27161,ENSG00000123908,NA,NA,Ago2 (MGI:2446632)
8,140657899,141002078,8q24-qter,8q24.3,600758,"PTK2, FADK",PTK2 protein tyrosine kinase,PTK2,5747,ENSG00000169398,NA,NA,Ptk2 (MGI:95481)
8,141128561,141195803,8q24.3,8q24.3,617503,"DENND3, KIAA0870",DENN domain-containing protein 3,DENND3,22898,ENSG00000105339,NA,NA,Dennd3 (MGI:2146009)
8,141356469,141367285,8q24.2-q24.3,8q24.3,601908,GPR20,G protein-coupled receptor-20,GPR20,2843,ENSG00000204882,NA,NA,Gpr20 (MGI:2441803)
8,141391994,141432453,8q24.3,8q24.3,606449,"PTP4A3, PRL3","Protein-tyrosine phosphatase, type 4A, 3",PTP4A3,11156,ENSG00000184489,NA,NA,Ptp4a3 (MGI:1277098)
8,142449648,142545008,8q24,8q24.3,602682,"ADGRB1, BAI1, GDAIF",Adhesion G protein-coupled receptor B1,ADGRB1,575,ENSG00000181790,NA,NA,Adgrb1 (MGI:1933736)
8,142611048,142614478,8q24,8q24.3,612461,"ARC, KIAA0278",Activity-regulated cytoskeleton-associated protein,ARC,23237,ENSG00000198576,NA,NA,Arc (MGI:88067)
8,142651500,142669993,8q24,8q24.3,603210,"JRK, JH8","Jerky, mouse, homolog of",JRK,8629,ENSG00000234616,NA,NA,Jrk (MGI:106214)
8,142670296,142682724,8q24.2,8q24.3,602470,PSCA,Prostate stem cell antigen,PSCA,8000,ENSG00000167653,NA,NA,Psca (MGI:1919623)
8,142700080,142705126,8q24.3,8q24.3,615093,LY6K,"Lymphocyte antigen 6 complex, locus K",LY6K,54742,ENSG00000160886,NA,NA,NA
8,142740948,142742405,8qter,8q24.3,606119,"SLURP1, MDM",Secreted LY6/uPAR-related protein 1,SLURP1,57152,ENSG00000126233,NA,"Meleda disease, 248300 (3), Autosomal recessive",Slurp1 (MGI:1930923)
8,142771196,142777871,Chr.8,8q24.3,606110,LYNX1,"Lynx1, mouse, homolog of",LYNX1,66004,ENSG00000180155,NA,NA,Lynx1 (MGI:1345180)
8,142784881,142786538,8q24-qter,8q24.3,606204,"LY6D, E48","Lymphocyte antigen 6 complex, locus D",LY6D,8581,ENSG00000167656,?pseudogene ono 15q22,NA,Ly6d (MGI:96881)
8,142834800,142846850,8q24.3,8q24.3,602370,GML,Glycosylphosphatidylinositol-anchored molecule-like protein,GML,2765,ENSG00000104499,NA,NA,"Gml,Gml2 (MGI:1341831,MGI:3644767)"
8,142872356,142879819,8q21,8q24.3,610613,"CYP11B1, P450C11, FHI","Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II))",CYP11B1,1584,ENSG00000160882,chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like,"Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3), Autosomal recessive; Aldosteronism, glucocorticoid-remediable, 103900 (3), Autosomal dominant",Cyp11b2 (MGI:88584)
8,142910558,142917842,8q21,8q24.3,124080,CYP11B2,"Cytochrome P450, subfamily XIB, polypeptide 2",CYP11B2,1585,ENSG00000179142,NA,"Aldosterone to renin ratio raised (3); Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3), Autosomal recessive; Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3), Autosomal recessive; {Low renin hypertension, susceptibility to} (3)",Cyp11b1 (MGI:88583)
8,143018484,143022409,8q24.3,8q24.3,601384,"LY6E, RIGE, SCA2","Lymphocyte antigen 6 complex, locus E (retinoic acid induced gene E)",LY6E,4061,ENSG00000160932,NA,NA,Ly6e (MGI:106651)
8,143157915,143160653,8q24.3,8q24.3,603625,LY6H,"Lymphocyte antigen 6 complex, locus H",LY6H,4062,ENSG00000176956,NA,NA,Ly6h (MGI:1346030)
8,143213217,143217169,8q24.3,8q24.3,612757,"GPIHBP1, HYPL1D",Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,GPIHBP1,338328,ENSG00000277494,NA,"Hyperlipoproteinemia, type 1D, 615947 (3), Autosomal recessive",NA
8,143267444,143276930,8q24.3,8q24.3,165280,"GLI4, HKR4",GLI-Kruppel family member GLI4 (oncogene HKR4),GLI4,2738,ENSG00000250571,NA,NA,NA
8,143309323,143359976,8q24.3,8q24.3,606387,TOP1MT,"Topoisomerase I, mitochondrial",TOP1MT,116447,ENSG00000184428,NA,NA,Top1mt (MGI:1920210)
8,143368826,143384220,8q24.3,8q24.3,601031,"RHPN1, ODF5",Rhophilin 1,RHPN1,114822,ENSG00000158106,NA,NA,Rhpn1 (MGI:1098783)
8,143428063,143430731,8q24,8q24.3,610303,"MAFA, RIPE3B1, INSDM",v-MAF avian musculoaponeurotic fibrosarcoma oncogene homolog A,MAFA,389692,ENSG00000182759,NA,"Insulinomatosis and diabetes mellitus, 147630 (3), Autosomal dominant",Mafa (MGI:2673307)
8,143553386,143563061,8q24.3,8q24.3,617042,"GSDMD, GSDMDC1, DFNA5L",Gasdermin D,GSDMD,79792,ENSG00000104518,NA,NA,Gsdmd (MGI:1916396)
8,143574584,143578348,8q24.3,8q24.3,611552,NAPRT1,Nicotinate phosphoribosyltransferase domain-containing 1,NAPRT,93100,ENSG00000147813,NA,NA,Naprt (MGI:2442664)
8,143579693,143597674,8q24.3,8q24.3,130592,"EEF1D, EF1D","Eukaryotic translation elongation factor 1, delta",EEF1D,1936,ENSG00000104529,NA,NA,Eef1d (MGI:1913906)
8,143603209,143609574,8q24.3,8q24.3,616408,"PYCRL, PYCR3",Pyrroline-5-carboxylate reductase-like,PYCR3,65263,ENSG00000104524,NA,NA,Pycrl (MGI:1913444)
8,143612617,143618042,8q24.3,8q24.3,137020,TSTA3,Tissue-specific transplantation antigen-3,TSTA3,7264,ENSG00000104522,NA,NA,Tsta3 (MGI:98857)
8,143723932,143733778,8q24.3,8q24.3,611927,"FAM83H, AI3A","Family with sequence similarity 83, member H",FAM83H,286077,ENSG00000180921,NA,"Amelogenesis imperfecta, type IIIA, 130900 (3), Autosomal dominant",Fam83h (MGI:2145900)
8,143790924,143815772,8q24.3,8q24.3,607733,"SCRIB, SCRB1, KIAA0147","Scribble, Drosophila, homolog of",SCRIB,23513,ENSG00000180900,NA,NA,Scrib (MGI:2145950)
8,143816343,143830040,8q24.3,8q24.3,604819,"PUF60, FIR, SIAHBP1, VRJS","Poly-U-binding splicing factor, 60kD",PUF60,22827,ENSG00000179950,NA,"Verheij syndrome, 615583 (3), Autosomal dominant",Puf60 (MGI:1915209)
8,143829775,143840973,8q24.3,8q24.3,615563,NRBP2,Nuclear receptor-binding protein 2,NRBP2,340371,ENSG00000185189,NA,NA,NA
8,143857318,143879042,8q24.3,8q24.3,607553,EPPK1,Epiplakin 1,EPPK1,83481,ENSG00000261150,NA,NA,Eppk1 (MGI:2386306)
8,143915152,143976799,8q24,8q24.3,601282,"PLEC1, PLEC, PLTN, EBS1, LGMDR17, EBSOG, EBSPA, EBSMD, EBSND",Plectin 1,PLEC,5339,ENSG00000178209,mutation identified in 1 EBSND family,"Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3), Autosomal recessive; ?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3), Autosomal recessive; Epidermolysis bullosa simplex with pyloric atresia, 612138 (3), Autosomal recessive; Epidermolysis bullosa simplex, Ogna type, 131950 (3), Autosomal dominant; Muscular dystrophy, limb-girdle, autosomal recessive 17, 613723 (3), Autosomal recessive",Plec (MGI:1277961)
8,143945190,143945278,8q24.3,8q24.3,613716,"MIR661, MIRN661",Micro RNA 661,MIR661,724031,ENSG00000207574,NA,NA,NA
8,143990055,143993414,8q24.3,8q24.3,138251,"GRINA, NMDARA1","Glutamate receptor, ionotropic, N-methyl",GRINA,2907,ENSG00000178719,NA,NA,Grina (MGI:1913418)
8,144010991,144047113,8q24,8q24.3,610874,SPATC1,Spermatogenesis- and centriole-associated 1 (speriolin),SPATC1,375686,ENSG00000186583,NA,NA,Spatc1 (MGI:1921531)
8,144051265,144064025,8q24.3,8q24.3,614243,"OPLAH, OPLAHD",5-oxoprolinase (ATP-hydrolyzing),OPLAH,26873,ENSG00000178814,NA,"5-oxoprolinase deficiency, 260005 (3), Autosomal recessive, Autosomal dominant",Oplah (MGI:1922725)
8,144064060,144080647,8q24.3,8q24.3,606491,"EXOSC4, RRP41",Exosome component 4,EXOSC4,54512,ENSG00000178896,NA,NA,Exosc4 (MGI:1923576)
8,144082633,144086215,8q24,8q24.3,603048,"GPAA1, GAA1, GPIBD15",Glycophosphatidylinositol anchor attachment protein 1,GPAA1,8733,ENSG00000197858,NA,"Glycosylphosphatidylinositol biosynthesis defect 15, 617810 (3), Autosomal recessive",Gpaa1 (MGI:1202392)
8,144095075,144097524,8q24.3,8q24.3,123980,"CYC1, MC3DN6",Cytochrome c1,CYC1,1537,ENSG00000179091,NA,"Mitochondrial complex III deficiency, nuclear type 6, 615453 (3), Autosomal recessive",Cyc1 (MGI:1913695)
8,144098636,144104247,8q24.3,8q24.3,611885,"SHARPIN, SIPL1",SHANK-associated RH domain interactor,SHARPIN,81858,ENSG00000179526,NA,NA,Sharpin (MGI:1913331)
8,144104460,144107610,8q24.3,8q24.3,610210,MAF1,"Maf1, S. cerevisiae, homolog of",MAF1,84232,ENSG00000179632,NA,NA,Maf1 (MGI:1916127)
8,144262044,144291437,8q24,8q24.3,610596,"BOP1, KIAA0124",Block of proliferation 1,BOP1,23246,ENSG00000261236,NA,NA,Bop1 (MGI:1334460)
8,144265059,144268482,8q24.3,8q24.3,609067,"SCXA, SCX","Scleraxis, mouse, homolog of, A",SCX,642658,ENSG00000260428,NA,NA,Scx (MGI:102934)
8,144291602,144314719,8q24.3,8q24.3,140580,HSF1,Heat-shock transcription factor 1,HSF1,3297,ENSG00000185122,NA,NA,Hsf1 (MGI:96238)
8,144314583,144326851,8q24.3,8q24.3,604900,"DGAT1, ARGP1, DIAR7",Diacylglycerol O-acyltransferase 1,DGAT1,8694,ENSG00000185000,mutation identified in 1 DIAR7 family,"?Diarrhea 7, protein-losing enteropathy type, 615863 (3), Autosomal recessive",Dgat1 (MGI:1333825)
8,144330564,144336481,Chr.8,8q24.3,605858,SCRT1,"Scratch, mouse, homolog of",SCRT1,83482,ENSG00000261678,NA,NA,Scrt1 (MGI:2176606)
8,144355430,144358471,8q24.3,8q24.3,609076,"FBXL6, FBL6, FBL6A",F-box and leucine-rich repeat protein 6,FBXL6,26233,ENSG00000182325,NA,NA,Fbxl6 (MGI:1354705)
8,144358546,144361285,8q24.3,8q24.3,607882,"SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2","Solute carrier family 52, riboflavin transporter, member 2",SLC52A2,79581,ENSG00000185803,NA,"Brown-Vialetto-Van Laere syndrome 2, 614707 (3), Autosomal recessive",Slc52a2 (MGI:1289288)
8,144412413,144417145,8q24.3,8q24.3,607059,"SLC39A4, ZIP4","Solute carrier family 36 (zinc transporter), member 4",SLC39A4,55630,ENSG00000147804,NA,"Acrodermatitis enteropathica, 201100 (3), Autosomal recessive",Slc39a4 (MGI:1919277)
8,144423600,144428562,8q24.3,8q24.3,611952,VPS28,"Vacuolar protein sorting 28, yeast, homolog of",VPS28,51160,ENSG00000160948,NA,NA,Vps28 (MGI:1914164)
8,144428774,144444487,8q24.3,8q24.3,604546,"NFKBIL2, IKBR",Nuclear factor of kappa light chain gene enhancer in B cells inhibitor-like 2,TONSL,4796,ENSG00000160949,NA,NA,Tonsl (MGI:1919999)
8,144449581,144465700,8q24.3,8q24.3,616635,"CYHR1, KIAA0496",Cysteine- and histidine-rich protein 1,CYHR1,50626,ENSG00000187954,NA,NA,Cyhr1 (MGI:1859320)
8,144466245,144474201,8q24.3,8q24.3,615216,KIFC2,Kinesin family member C2,KIFC2,90990,ENSG00000167702,NA,NA,Kifc2 (MGI:109187)
8,144473411,144475848,8q24.3,8q24.3,603621,FAST1,"Forkhead activin signal transducer 1, Xenopus, homolog of",FOXH1,8928,ENSG00000160973,NA,NA,Foxh1 (MGI:1347465)
8,144502216,144507173,8q24.3,8q24.3,138200,"GPT, GPT1, AAT1",Glutamic-pyruvate transaminase (alanine aminotransferase),GPT,2875,ENSG00000167701,NA,NA,Gpt (MGI:95802)
8,144511283,144517827,8q24.3,8q24.3,603780,"RECQL4, RTS, RECQ4","DNA helicase, RecQ-like 4",RECQL4,9401,ENSG00000160957,NA,"Baller-Gerold syndrome, 218600 (3), Autosomal recessive; RAPADILINO syndrome, 266280 (3), Autosomal recessive; Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive",Recql4 (MGI:1931028)
8,144529178,144700519,8q24.3,8q24.3,615880,"ARHGAP39, VILSE, KIAA1688",RHO GTPase-activating protein 39,ARHGAP39,80728,ENSG00000147799,NA,NA,Arhgap39 (MGI:107858)
8,144772223,144787370,8q24.12-q24.13,8q24.3,194526,"ZNF34, KOX32",Zinc finger protein-34 (KOX32),ZNF34,80778,ENSG00000196378,NA,NA,NA
8,144789768,144792389,8q,8q24.3,604177,RPL8,Ribosomal protein L8,RPL8,6132,ENSG00000161016,NA,NA,Rpl8 (MGI:1350927)
8,144827508,144848069,8q24,8q24.3,194531,"ZNF7, KOX4",Zinc finger protein-7 (KOX4),ZNF7,7553,ENSG00000147789,NA,NA,Zfp7 (MGI:99208)
8,144837977,144853555,8q24.3,8q24.3,608216,"COMMD5, HCARG",COMM domain-containing protein 5,COMMD5,28991,ENSG00000170619,NA,NA,Commd5 (MGI:1913648)
8,144930357,144950879,8q24,8q24.3,601262,"ZNF16, KOX9",Zinc finger protein-16 (KOX 9),ZNF16,7564,ENSG00000170631,NA,NA,NA
8,0,145138636,Chr.8,NA,608392,"AIS3, VAMAS4","Autoimmune disease, susceptibility to, 3",AIS3,378427,NA,NA,"{Autoimmune disease, susceptibility to, 3}, 608392 (2)",NA
8,0,145138636,Chr.8,NA,147860,IFNB3,"Interferon, beta-3, fibroblast",NA,NA,NA,previously assigned to 2p23-qter,NA,NA
8,0,145138636,Chr.8,NA,194490,ZNF1,Zinc finger protein-1,NA,NA,NA,NA,NA,NA
9,0,43000000,9p,NA,158170,"DEL9p, C9DELp",Chromosome 9p deletion syndrome,NA,NA,NA,NA,"Chromosome 9p deletion syndrome, 158170 (4), Autosomal dominant",NA
9,0,2200000,9p24.3,NA,154230,"DEL9p24.3, C9DELp24.3, SRXY4",Chromosome 9p24.3 deletion syndrome,NA,NA,NA,NA,"46XY sex reversal 4, 154230 (4)",NA
9,0,43000000,9p,NA,606613,HDLCQ1,High density lipoprotein cholesterol level QTL 1,HDLCQ1,192144,NA,NA,"[High density lipoprotein cholesterol level QTL 1], 606613 (2)",NA
9,0,9000000,9p24,NA,614113,MRD2,"Mental retardation, autosomal dominant 2",NA,NA,NA,2 patients reported with genomic deletion or rearrangement including disruption of DOCK8,"Mental retardation, autosomal dominant 2, 614113 (4), Autosomal dominant",NA
9,0,19900000,9p24-p22,NA,610438,RLS3,"Restless legs syndrome, susceptibility to, 3",NA,100188812,NA,associated with rs4626664 and rs1975197,"{Restless legs syndrome 3}, 610438 (2)",NA
9,14474,30486,9p24.3,9p24.3,613632,"WASHC1, WASH1","WASH complex, subunit 1",WASHC1,100287171,ENSG00000181404,"pseudogenes on 1p, 15q, 16p, Xq/Yq",NA,Washc1 (MGI:1916017)
9,116230,118416,9q21.11,9p24.3,601092,"FOXD4, FKHL9",Forkhead box D4,FOXD4,2298,ENSG00000170122,NA,NA,Foxd4 (MGI:1347467)
9,121037,179082,9p24.3,9p24.3,611078,CBWD1,Cobalamin synthetase W domain-containing protein 1,CBWD1,55871,ENSG00000172785,NA,NA,Cbwd1 (MGI:2385089)
9,211295,465259,9p24,9p24.3,611432,DOCK8,Dedicator of cytokinesis 8,DOCK8,81704,ENSG00000107099,NA,"Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3), Autosomal recessive",Dock8 (MGI:1921396)
9,470290,746105,9p24.3,9p24.3,607704,"KANK1, KANK, ANKRD15, KIAA0172, CPSQ2",KN motif- and ankyrin repeat domain-containing protein 1,KANK1,23189,ENSG00000107104,NA,"Cerebral palsy, spastic quadriplegic, 2, 612900 (3)",Kank1 (MGI:2147707)
9,841646,969089,9p24.3,9p24.3,602424,"DMRT1, DMT1",Double sex and mab-3-related transcription factor-1,DMRT1,1761,ENSG00000137090,NA,NA,Dmrt1 (MGI:1354733)
9,976654,991731,9p24.3,9p24.3,614754,"DMRT3, DMRTA3",Doublesex-and mab3-related transcription factor 3,DMRT3,58524,ENSG00000064218,NA,NA,Dmrt3 (MGI:2449470)
9,1003236,1057553,9p24.3,9p24.3,604935,DMRT2,Double sex and mab-3-related transcription factor-2,DMRT2,10655,ENSG00000173253,NA,NA,Dmrt2 (MGI:1330307)
9,2015346,2193623,9p24-p23,9p24.3,600014,"SMARCA2, SNF2L2, NCBRS","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",SMARCA2,6595,ENSG00000080503,NA,"Nicolaides-Baraitser syndrome, 601358 (3), Autosomal dominant",Smarca2 (MGI:99603)
9,2621785,2660055,9p24,9p24.2,192977,"VLDLR, CAMRQ1",Very low density lipoprotein receptor,VLDLR,7436,ENSG00000147852,NA,"Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3), Autosomal recessive",Vldlr (MGI:98935)
9,2717509,2730036,9p24.2,9p24.2,607604,"KCNV2, KV11.1, RCD3B","Potassium channel, voltage-gated, subfamily V, member 2",KCNV2,169522,ENSG00000168263,NA,"Retinal cone dystrophy 3B, 610356 (3), Autosomal recessive",Kcnv2 (MGI:2670981)
9,2804151,2844094,9p24.2,9p24.2,609960,"KIAA0020, HLA-HA8",Minor histocompatibility antigen HA-8,PUM3,9933,ENSG00000080608,NA,NA,Pum3 (MGI:106253)
9,3218296,3526528,9p24.2,9p24.2,601337,RFX3,"Regulatory factor X, 3",RFX3,5991,ENSG00000080298,NA,NA,Rfx3 (MGI:106582)
9,3824126,4310693,9p24.3-p23,9p24.2,610192,"GLIS3, ZNF515, NDH",GLIS family zinc finger protein 3,GLIS3,169792,ENSG00000107249,NA,"Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3), Autosomal recessive",Glis3 (MGI:2444289)
9,4490465,4587468,9p24,9p24.2,133550,"SLC1A1, EAAC1, SCZD18, DCBXA","Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1)",SLC1A1,6505,ENSG00000106688,mutation identified in 1 SCZD18 family,"Dicarboxylic aminoaciduria, 222730 (3), Autosomal recessive; {?Schizophrenia susceptibility 18}, 615232 (3)",Slc1a1 (MGI:105083)
9,4600000,19900000,9p24.1-p22.1,NA,613271,"FECD7, FCD4","Corneal dystrophy, Fuchs endothelial, 7",NA,100380875,NA,max lod at D9S256,"Corneal dystrophy, Fuchs endothelial, 7, 613271 (2)",NA
9,4662293,4665261,9p24.1,9p24.1,611666,"PLPP6, PPAPDC2",PPAP2 domain-containing protein 2,PLPP6,403313,ENSG00000205808,NA,"Phospholipid phosphatase 6, 611666 (3)",Plpp6 (MGI:1921661)
9,4679568,4708398,9p24.1,9p24.1,610346,"CDC37L1, HARC, FLJ20639",CDC37-like 1,CDC37L1,55664,ENSG00000106993,NA,NA,Cdc37l1 (MGI:1914322)
9,4709555,4742042,9p24.1,9p24.1,609290,"AK3, AK3L1",Adenylate kinase 3,AK3,50808,ENSG00000147853,NA,NA,Ak3 (MGI:1860835)
9,4792833,4861076,9p24.1,9p24.1,611405,"RCL1, RPCL1, RNAC",RNA terminal phosphate cyclase-like 1,RCL1,10171,ENSG00000120158,NA,NA,Rcl1 (MGI:1913275)
9,4850296,4850374,9p24.1,9p24.1,612512,"MIR101-2, MIRN101-2",Micro RNA 101-2,MIR101-2,406894,ENSG00000199065,"another locus, MIRN101-1, on 1p31",NA,NA
9,4985085,5128182,9p24,9p24.1,147796,"JAK2, THCYT3",Janus kinase 2 (a protein-tyrosine kinase),JAK2,3717,ENSG00000096968,NA,"{Budd-Chiari syndrome, somatic}, 600880 (3); Erythrocytosis, somatic, 133100 (3); Leukemia, acute myeloid, somatic, 601626 (3); Myelofibrosis, somatic, 254450 (3); Polycythemia vera, somatic, 263300 (3); Thrombocythemia 3, 614521 (3), Autosomal dominant, Somatic mutation",Jak2 (MGI:96629)
9,4992408,5185706,9p24,9p24.1,606414,INSL6,Insulin-like 6,INSL6,11172,ENSG00000120210,NA,NA,Insl6 (MGI:1351595)
9,5231418,5235303,9p24,9p24.1,600910,INSL4,"Insulin-like 4, placenta",INSL4,3641,ENSG00000120211,NA,NA,NA
9,5299863,5340914,9pter-q12,9p24.1,179730,RLN1,"Relaxin, H1",RLN1,6013,ENSG00000107018,NA,NA,Rln1 (MGI:97931)
9,5299863,5339437,9pter-q12,9p24.1,179740,RLN2,"Relaxin, H2",RLN2,6019,ENSG00000107014,NA,NA,NA
9,5357965,5438538,9p24.1,9p24.1,618444,PLGRKT,Plasminogen receptor with C-terminal lysine,PLGRKT,55848,ENSG00000107020,NA,NA,Plgrkt (MGI:1915009)
9,5450502,5470566,9p24,9p24.1,605402,"CD274, PDCD1LG1, B7H1",CD274 molecule,CD274,29126,ENSG00000120217,NA,NA,Cd274 (MGI:1926446)
9,5510437,5571281,9p24.2,9p24.1,605723,"PDCD1L2, PDL2",Programmed cell death 1 ligand 2,PDCD1LG2,80380,ENSG00000197646,NA,NA,Pdcd1lg2 (MGI:1930125)
9,5629029,5778632,9p24.1,9p24.1,610354,"CIP150, KIAA1432","Connexin 43-interacting protein, 150kD",RIC1,57589,ENSG00000107036,NA,NA,Ric1 (MGI:1924893)
9,5764060,5867090,9p24,9p24.1,611156,"ERMP1, KIAA1815, FXNA",Endoplasmic reticulum metallopeptidase 1,ERMP1,79956,ENSG00000099219,NA,NA,Ermp1 (MGI:106250)
9,5890888,5910605,9p24.1,9p24.1,605513,"MLANA, MART1",Melan A,MLANA,2315,ENSG00000120215,NA,NA,Mlana (MGI:108454)
9,6214590,6257982,9p24.1,9p24.1,608678,"IL33, C9orf26, NFEHEV",Interleukin 33,IL33,90865,ENSG00000137033,NA,NA,Il33 (MGI:1924375)
9,6328369,6331890,9p24.1,9p24.1,617567,TPD52L3,Tumor protein D52-like 3,TPD52L3,89882,ENSG00000170777,NA,NA,Trpd52l3 (MGI:1913995)
9,6413147,6507055,9p24.1-p23,9p24.1,615211,"UHRF2, NIRF","Ubiquitin-like protein containing PDH and RING finger domains 2, E3 ubiquitin protein ligase",UHRF2,115426,ENSG00000147854,NA,NA,Uhrf2 (MGI:1923718)
9,6532463,6645691,9p22,9p24.1,238300,"GLDC, HYGN1, GCSP, GCE, NKH","Glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)",GLDC,2731,ENSG00000178445,NA,"Glycine encephalopathy, 605899 (3), Autosomal recessive",Gldc (MGI:1341155)
9,6720862,7175647,9p24.1,9p24.1,605469,"KDM4C, JMJD2C, GASC1, KIAA0780",Lysine-specific demethylase 4C,KDM4C,23081,ENSG00000107077,NA,NA,Kdm4c (MGI:1924054)
9,7796499,7799777,9p24.1,9p24.1,617261,"TMEM261, DMAC1, C9orf123",Transmembrane protein 261,DMAC1,90871,ENSG00000137038,NA,NA,Dmac1 (MGI:1914178)
9,8314245,10613001,9p24.3-p23,9p24-p23,601598,"PTPRD, PTPD, HPTP","Protein tyrosine phosphatase, receptor type, delta polypeptide",PTPRD,5789,ENSG00000153707,NA,NA,NA
9,9000000,28000000,9p23-p21.2,NA,613685,DFNB83,"Deafness, autosomal recessive 83",DFNB83,100359400,NA,between rs4742645 and rs1471364,"Deafness, autosomal recessive 83, 613685 (2), Autosomal recessive",NA
9,9000000,43000000,9p23-p11,NA,601992,FRDA2,Friedreich ataxia 2,FRDA2,2420,NA,NA,"Friedreich ataxia 2, 601992 (2), Autosomal recessive",NA
9,9000000,36300000,9p23-p13.3,NA,614208,MRT16,"Mental retardation, autosomal recessive 16",NA,100689014,NA,between rs10738277 and rs12376565,"Mental retardation, autosomal recessive 16, 614208 (2), Autosomal recessive",NA
9,12693374,12710284,9p23,9p23,115501,"TYRP1, CAS2, GP75, SHEP11",Tyrosinase-related protein 1,TYRP1,7306,ENSG00000107165,NA,"Albinism, oculocutaneous, type III, 203290 (3), Autosomal recessive; [Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)",Tyrp1 (MGI:98881)
9,12774993,12823059,9p23,9p23,616130,"LURAP1L, LRAP35B",Leucine-rich adaptor protein 1-like,LURAP1L,286343,ENSG00000153714,NA,NA,Lurap1l (MGI:106510)
9,13105295,13279712,9p23,9p23,603785,"MPDZ, MUPP1, HYC2",Multiple PDZ domain protein,MPDZ,8777,ENSG00000107186,NA,"Hydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3), Autosomal recessive",Mpdz (MGI:1343489)
9,14081842,14532076,9p24.1,9p23-p22,600728,"NFIB, MACID",Nuclear factor I/B,NFIB,4781,ENSG00000147862,NA,"Macrocephaly, acquired, with impaired intellectual development, 618286 (3), Autosomal dominant",Nfib (MGI:103188)
9,14200000,33200000,9p22-p21,NA,608652,"DFNA47, DFNB83","Deafness, autosomal dominant 47",DFNA47,246289,NA,between D9S268 and D9S942; possibly allelic to DFNB83,"Deafness, autosomal dominant 47, 608652 (2), Autosomal dominant",NA
9,14200000,33200000,9p22-p21,NA,247640,LALL,Lymphomatous acute lymphoblastic leukemia,NA,8009,NA,NA,"Leukemia, acute lymphoblastic, 247640 (2), Autosomal recessive",NA
9,14588796,14693545,9p22.3,9p22.3,614605,"ZDHHC21, DHHC21",Zinc finger DHHC domain-containing protein 21,ZDHHC21,340481,ENSG00000175893,NA,NA,Zdhhc21 (MGI:1915518)
9,14715081,14724307,9p22,9p22.3,603777,CER1,"Cerebrus 1, Xenopus, homolog of",CER1,9350,ENSG00000147869,NA,NA,Cer1 (MGI:1201414)
9,14733485,14911652,9p22.3,9p22.3,608944,"FREM1, C9orf154, BNAR, MOTA, TRIGNO2",FRAS1-related extracellular matrix protein 1,FREM1,158326,ENSG00000164946,NA,"Bifid nose with or without anorectal and renal anomalies, 608980 (3); Manitoba oculotrichoanal syndrome, 248450 (3), Autosomal recessive; Trigonocephaly 2, 614485 (3), Autosomal dominant",Frem1 (MGI:2670972)
9,15163621,15307359,9p22.3,9p22.3,613574,TTC39B,Tetratricopeptide repeat domain 39B,TTC39B,158219,ENSG00000155158,NA,NA,Ttc39b (MGI:1917113)
9,15422783,15466750,9p22.3,9p22.3,602348,"SNAPC3, SNAP50","Small nuclear RNA-activating protein complex, polypeptide 3",SNAPC3,6619,ENSG00000164975,NA,NA,Snapc3 (MGI:1916338)
9,15464065,15511018,9p22.2,9p22.3,603620,"PSIP1, LEDGF",PC4- and SFRS1-interacting protein 1,PSIP1,11168,ENSG00000164985,NA,NA,Psip1 (MGI:2142116)
9,16409502,16832349,9p22.1,9p22.3-p22.2,608669,BNC2,Basonuclin 2,BNC2,54796,ENSG00000173068,NA,NA,Bnc2 (MGI:2443805)
9,17134990,17510019,9p22.2,9p22.2,611870,"CNTLN, C9orf101, C9orf39",Centlein,CNTLN,54875,ENSG00000044459,NA,NA,Cntln (MGI:2443104)
9,17579065,17797123,9p22,9p22.2,604465,"SH3GL2, SH3P4","SH3 domain, GRB2-like, 2",SH3GL2,6456,ENSG00000107295,NA,NA,Sh3gl2 (MGI:700009)
9,17906514,18910949,9p22.1-p21.2,9p22.2-p22.1,609198,ADAMTSL1,ADAMTS-like protein 1,ADAMTSL1,92949,ENSG00000178031,NA,NA,Adamtsl1 (MGI:1924989)
9,18500000,19900000,9p22.1,NA,609790,AD11,Alzheimer disease 11,NA,100188795,NA,between D9S157 and D9S259,"Alzheimer disease-11, 609790 (2)",NA
9,18927649,19049505,9p22.1,9p22.1,616292,"SAXO1, FAM154A",Stabilizer of axonemal microtubules 1,SAXO1,158297,ENSG00000155875,NA,NA,Saxo1 (MGI:1923061)
9,19049426,19051024,9p22.1,9p22.1,612194,"RRAGA, RAGA, FIP1",Ras-related GTP-binding protein A,RRAGA,10670,ENSG00000155876,NA,NA,Rraga (MGI:1915691)
9,19053140,19102903,9p22.1,9p22.1,613433,"HAUS6, DGT6, FAM29A","HAUS, augmin-like complex, subunit 6",HAUS6,54801,ENSG00000147874,NA,NA,Haus6 (MGI:1923389)
9,19063655,19063785,9p22.1,9p22.1,615646,SCARNA8,Small Cajal body-specific RNA 8,SCARNA8,677776,ENSG00000251733,NA,NA,NA
9,19108390,19127605,9p22.1,9p22.1,103195,PLIN2,Perilipin 2,PLIN2,123,ENSG00000147872,NA,NA,Plin2 (MGI:87920)
9,19375714,19380235,9p21,9p22.1,180460,RPS6,Ribosomal protein S6,RPS6,6194,ENSG00000137154,NA,NA,Rps6 (MGI:98159)
9,19408926,19455172,9p22.1,9p22.1,613492,ACER2,Alkaline ceramidase 2,ACER2,340485,ENSG00000177076,NA,NA,Acer2 (MGI:1920932)
9,19507451,20307887,9p22,9p22.1-p21.3,609838,"SLC24A2, NCKX2","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2",SLC24A2,25769,ENSG00000155886,NA,NA,Slc24a2 (MGI:1923626)
9,19900000,33200000,9p21,NA,611891,AAA3,"Aneurysm, familial abdominal 3",NA,100188857,NA,associated with rs10757278,"{Aneurysm, familial abdominal 3}, 611891 (2)",NA
9,19900000,33200000,9p21,NA,611892,ANIB6,"Aneurysm, intracranial berry, 6",NA,100188858,NA,associated with rs10757278,"{Aneurysm, intracranial berry, 6}, 611892 (2)",NA
9,19900000,33200000,9p21,NA,613062,BCC5,"Basal cell carcinoma, susceptibility to, 5",NA,100307122,NA,associated with rs2151280,"{Basal cell carcinoma, susceptibility to, 5}, 613062 (2)",NA
9,19900000,33200000,9p21,NA,611139,CHDS8,"Coronary heart disease, susceptibility to, 8",NA,100188836,NA,strongest linkage with dbSNP rs1333049,"{Coronary heart disease, susceptibility to, 8}, 611139 (2)",NA
9,19900000,25600000,9p21.3,NA,613030,GLM5,Glioma susceptibility 5,NA,100415894,NA,associated with rs4977756,"{Glioma susceptibility 5}, 613030 (2)",NA
9,19900000,33200000,9p21,NA,612099,"MFT2, TEM","Trichoepithelioma, multiple familial, 2",NA,100188881,NA,max lod at D9S171,"Trichoepithelioma, multiple familial, 2, 612099 (2)",NA
9,20341668,20622498,9p22,9p21.3,159558,"MLLT3, AF9","Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 3",MLLT3,4300,ENSG00000171843,fuses with ALL1,NA,Mllt3 (MGI:1917372)
9,20658308,20995954,9p21.3,9p21.3,614606,"FOCAD, KIAA1797",Focadhesin,FOCAD,54914,ENSG00000188352,NA,NA,Focad (MGI:2676921)
9,20999508,21031711,9p21.3,9p21.3,615941,"PTPLAD2, HACD4",Protein tyrosine phosphatase-like A domain-containing protein 2,HACD4,401494,ENSG00000188921,NA,NA,Hacd4 (MGI:1914025)
9,21077103,21077941,9p21,9p21.3,147640,IFNB1,"Interferon, beta-1, fibroblast",IFNB1,3456,ENSG00000171855,distal to IFL; ?9p23-p22; IFF duplicate in some,NA,Ifnb1 (MGI:107657)
9,21140631,21141900,9p21,9p21.3,147553,IFNW1,"Interferon, omega-1",IFNW1,3467,ENSG00000177047,pseudogene IFNWP2; interspersed with IFNA,NA,NA
9,21165636,21166659,9p22,9p21.3,147584,IFNA21,"Interferon, alpha-21",IFNA21,3452,ENSG00000137080,NA,NA,NA
9,21186617,21187598,9p22,9p21.3,147564,IFNA4,"Interferon, alpha-4",IFNA4,3441,ENSG00000236637,NA,NA,"Ifnab,Ifna13,Ifna14,Ifna5,Ifna11,Ifna6,Ifna12,Ifna7,Ifna1,Ifna15,Ifna2,Ifna16,Ifna9 (MGI:107659,MGI:3649418,MGI:107666,MGI:107668,MGI:107661,MGI:107662,MGI:2676324,MGI:107663,MGI:3641425,MGI:109210,MGI:1097683,MGI:3649260,MGI:2667155)"
9,21201468,21202204,9p22,9p21.3,147567,IFNA7,"Interferon, alpha-7",IFNA7,3444,ENSG00000214042,NA,NA,NA
9,21206180,21207142,9p22,9p21.3,147577,IFNA10,"Interferon, alpha-10",IFNA10,3446,ENSG00000186803,NA,NA,NA
9,21216372,21217310,9p22,9p21.3,147580,IFNA16,"Interferon, alpha-16",IFNA16,3449,ENSG00000147885,NA,NA,NA
9,21227242,21228221,9p22,9p21.3,147583,IFNA17,"Interferon, alpha-17",IFNA17,3451,ENSG00000234829,NA,NA,NA
9,21239001,21240004,9p22,9p21.3,147579,IFNA14,"Interferon, alpha-14",IFNA14,3448,ENSG00000228083,NA,NA,NA
9,21304613,21305312,9p22,9p21.3,147565,IFNA5,"Interferon, alpha-5",IFNA5,3442,ENSG00000147873,NA,NA,NA
9,21329664,21335403,9p21.3,9p21.3,611201,"KLHL9, KIAA1354",Kelch-like 9,KLHL9,55958,ENSG00000198642,NA,NA,Klhl9 (MGI:2180122)
9,21350317,21350886,9p22,9p21.3,147566,IFNA6,"Interferon, alpha-6",IFNA6,3443,ENSG00000120235,NA,NA,NA
9,21367371,21368075,9p22,9p21.3,147578,IFNA13,"Interferon, alpha-13",IFNA13,3447,ENSG00000233816,NA,NA,NA
9,21384254,21385397,9p22,9p21.3,147562,IFNA2,"Interferon, alpha-2",IFNA2,3440,ENSG00000188379,NA,NA,NA
9,21409116,21410184,9p22,9p21.3,147568,IFNA8,"Interferon, alpha-8",IFNA8,3445,ENSG00000120242,NA,NA,NA
9,21440438,21441315,9p22,9p21.3,147660,"IFNA1, IFNA@","Interferon, alpha-1",IFNA1,3439,ENSG00000197919,"very close to IFF by Fd, LD; 15-30 genes","Interferon, alpha, deficiency (1)",NA
9,21454267,21559797,9p21.3,9p21.3,616356,"MIR31HG, LOC554202","Micro RNA 31 host gene, noncoding",MIR31HG,554202,ENSG00000171889,NA,NA,NA
9,21480838,21482312,9p21,9p21.3,615223,"IFNE, INFE1, IFNT1","Interferon, epsilon",IFNE,338376,ENSG00000184995,NA,NA,Ifne (MGI:2667156)
9,21512114,21512184,9p21.3,9p21.3,612155,"MIR31, MIRN31",Micro RNA 31,MIR31,407035,ENSG00000199177,NA,NA,NA
9,21802635,21867080,9p21,9p21.3,156540,"MTAP, DMSMFH",Methylthioadenosine phosphorylase,MTAP,4507,ENSG00000099810,NA,"Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3), Autosomal dominant",Mtap (MGI:1914152)
9,21967751,21995323,9p21,9p21.3,600160,"CDKN2A, MTS1, P16, MLM, CMM2","Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)",CDKN2A,1029,ENSG00000147889,NA,"Melanoma and neural system tumor syndrome, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; Orolaryngeal cancer, multiple (3); Pancreatic cancer/melanoma syndrome, 606719 (3), Autosomal dominant",Cdkn2a (MGI:104738)
9,21994790,22121096,9p21,9p21.3,613149,"CDKN2BAS, ANRIL",CDKN2B antisense RNA,CDKN2B-AS1,100048912,ENSG00000240498,NA,NA,NA
9,22002902,22009312,9p21,9p21.3,600431,"CDKN2B, MTS2, P15, INK4B","Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)",CDKN2B,1030,ENSG00000147883,tandem with MTS1,NA,Cdkn2b (MGI:104737)
9,22446823,22455739,9p21.3,9p21.3,614803,"DMRTA1, DMRT4",Doublesex- and MAB3-related transcription factor A1,DMRTA1,63951,ENSG00000176399,NA,NA,Dmrta1 (MGI:2653627)
9,23690098,23850707,9p21,9p21.3,601673,"ELAVL2, HELN1, HUB","Embryonic lethal, abnormal vision, Drosophila, homolog of, like-2 (Hu antigen B)",ELAVL2,1993,ENSG00000107105,NA,NA,Elavl2 (MGI:1100887)
9,25600000,28000000,9p21.2,NA,617651,EMICER1,"EQTN, MOB3B, IFNK, and C9orf72 enhancer RNA I, noncoding",NA,NA,NA,NA,NA,NA
9,25676388,25678857,9p21,9p21.2,610529,"TUSC1, TSG9",Tumor suppressor candidate 1,TUSC1,286319,ENSG00000198680,NA,NA,Tusc1 (MGI:2684283)
9,26903371,26947472,9p21.2,9p21.2,603873,"PLAA, PLAP, NDMSBA",Phospholipase A2-activating protein,PLAA,9373,ENSG00000137055,NA,"Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3), Autosomal recessive",Plaa (MGI:104810)
9,26946989,27066133,9p21.2,9p21.2,608040,"IFT74, CCDC2, CMG1, BBS20","Intraflagellar transport 74, Chlamydomonas, homolog of",IFT74,80173,ENSG00000096872,mutation identified in 1 BBS20 patient,"?Bardet-Biedl syndrome 20, 617119 (3), Autosomal recessive",Ift74 (MGI:1914944)
9,27109140,27230177,9p21,9p21.2,600221,"TEK, TIE2, VMCM, GLC3E","TEK tyrosine kinase, endothelial",TEK,7010,ENSG00000120156,NA,"Glaucoma 3, primary congenital, E, 617272 (3), Autosomal dominant; Venous malformations, multiple cutaneous and mucosal, 600195 (3), Autosomal dominant",Tek (MGI:98664)
9,27284653,27297149,9p21.2,9p21.2,617653,"EQTN, AFAF, SPACA8, C9orf11",Equatorin,EQTN,54586,ENSG00000120160,NA,NA,Eqtn (MGI:1915003)
9,27325208,27529813,9p21.2,9p21.2,617652,"MOB3B, MOB1D, MOBKL2B, C9orf35",MOB kinase activator 3B,MOB3B,79817,ENSG00000120162,NA,NA,Mob3b (MGI:2664539)
9,27524313,27526497,9p21.2,9p21.2,615326,IFNK,"Interferon, kappa",IFNK,56832,ENSG00000147896,NA,NA,Ifnk (MGI:2683287)
9,27546545,27573865,9p21,9p21.2,614260,"C9orf72, FTDALS1, FTDALS, ALSFTD",Chromosome 9 open reading frame 72,C9orf72,203228,ENSG00000147894,NA,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3), Autosomal dominant",C9orf72 (MGI:1920455)
9,27937616,29215242,9p21.2-p21.1,9p21.2-p21.1,609793,"LRRN6C, LINGO2, LERN3","Leucine-rich repeat protein, neuronal, 6C",LINGO2,158038,ENSG00000174482,NA,NA,Lingo2 (MGI:2442298)
9,28888878,28888954,9p21.1,9p21.1,616137,MIR873,Micro RNA 873,MIR873,100126316,ENSG00000215939,NA,NA,NA
9,32384602,32454768,9p21.2,9p21.1,100880,"ACO1, IREB1","Aconitase, soluble (iron-responsive element-binding protein-1)",ACO1,48,ENSG00000122729,NA,NA,Aco1 (MGI:87879)
9,32455301,32526195,9p21.1,9p21.1,609631,"DDX58, RIGI, SGMRT2",DEAD box polypeptide 58,DDX58,23586,ENSG00000107201,NA,"Singleton-Merten syndrome 2, 616298 (3), Autosomal dominant",Ddx58 (MGI:2442858)
9,32540543,32552627,9p21,9p21.1,609507,"TOPORS, P53BP3, LUN, RP31",Topoisomerase I-binding arginine/serine-rich protein,TOPORS,10210,ENSG00000197579,NA,"Retinitis pigmentosa 31, 609923 (3)",Topors (MGI:2146189)
9,32553000,32573183,9p21.1,9p21.1,603322,NDUFB6,NADH-ubiquinone oxidoreductase subunit B6,NDUFB6,4712,ENSG00000165264,NA,NA,Ndufb6 (MGI:2684983)
9,32883871,33025119,9p13.3,9p21.1,606350,"APTX, AOA, AOA1",Aprataxin,APTX,54840,ENSG00000137074,NA,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3), Autosomal recessive",Aptx (MGI:1913658)
9,33041764,33076704,9p21.1,9p21.1,617811,SMU1,DNA replication regulator and spliceosomal factor SMU1,SMU1,55234,ENSG00000122692,NA,NA,Smu1 (MGI:1915546)
9,33110640,33167357,9p13,9p21.1,137060,"B4GALT1, GGTB2, GT1, GTB, CDG2D",Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22),B4GALT1,2683,ENSG00000086062,NA,"Congenital disorder of glycosylation, type IId, 607091 (3), Autosomal recessive",B4galt1 (MGI:95705)
9,33200000,39000000,9p13,NA,609403,PEE3,Preeclampsia/eclampsia 3,NA,780909,NA,NA,"Preeclampsia/eclampsia 3, 609403 (2)",NA
9,33240166,33248566,9p13.3,9p13.3,613929,"SPINK4, PEC60","Serine protease inhibitor, Kazal-type, 4",SPINK4,27290,ENSG00000122711,NA,NA,Spink4 (MGI:1341848)
9,33252470,33264707,9p12,9p13.3,601497,BAG1,BCL2-associated athanogene,BAG1,573,ENSG00000107262,NA,NA,Bag1 (MGI:108047)
9,33264878,33282069,9p13.3,9p13.3,610900,CHMP5,"CHMP family, member 5",CHMP5,51510,ENSG00000086065,NA,NA,Chmp5 (MGI:1924209)
9,33290474,33371156,9p13.3,9p13.3,603255,NFX1,"Nuclear transcription factor, X box-binding, protein 1",NFX1,4799,ENSG00000086102,NA,NA,Nfx1 (MGI:1921414)
9,33383134,33402681,9p13,9p13.3,602974,"AQP7, GLYCQTL",Aquaporin-7,AQP7,364,ENSG00000165269,NA,"[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive",Aqp7 (MGI:1314647)
9,33441153,33447595,9p13,9p13.3,600170,AQP3,Aquaporin-3,AQP3,360,ENSG00000165272,incorrectly mapped to chr.7,"[Blood group GIL], 607457 (3)",Aqp3 (MGI:1333777)
9,33460810,33473942,9p13,9p13.3,611532,"NOL6, NRAP",Nucleolar protein 6,NOL6,65083,ENSG00000165271,NA,NA,Nol6 (MGI:2140151)
9,33673503,33677419,9p13.3,9p13.3,613531,PTENP1,Phosphatase and tensin homolog pseudogene 1 (functional),PTENP1,11191,ENSG00000237984,NA,NA,NA
9,33750465,33799230,9p13,9p13.3,613578,"PRSS3, TRY3, T9","Protease, serine, 3",PRSS3,5646,ENSG00000010438,NA,NA,"Try5,Try4 (MGI:102756,MGI:102757)"
9,33817159,33920398,9p22.1,9p13.3,612506,"UBE2R2, UBC3B",Ubiquitin-conjugating enzyme E2R 2,UBE2R2,54926,ENSG00000107341,NA,NA,Ube2r2 (MGI:1914865)
9,34179004,34252522,9p22-p21,9p13.3,609787,"UBAP1, UBAP, SPG80",Ubiquitin-associated protein 1,UBAP1,51271,ENSG00000165006,NA,"Spastic paraplegia 80, autosomal dominant, 618418 (3), Autosomal dominant",Ubap1 (MGI:2149543)
9,34252032,34333519,9p13.3,9p13.3,613747,KIF24,Kinesin family member 24,KIF24,347240,ENSG00000186638,NA,NA,Kif24 (MGI:1918345)
9,34329505,34343712,9p13,9p13.3,602852,"NUDT2, APAH1",Nudix-type motif 1 (AP4A hydrolase-1),NUDT2,318,ENSG00000164978,NA,NA,Nudt2 (MGI:1913651)
9,34366148,34376951,9p13.3,9p13.3,618255,"MYORG, NET37, KIAA1161, IBGC7",Myogenesis-regulating glycosidase,MYORG,57462,ENSG00000164976,NA,"Basal ganglia calcification, idiopathic, 7, autosomal recessive, 618317 (3), Autosomal recessive",Myorg (MGI:2140300)
9,34458751,34520988,9p13.3,9p13.3,604366,"DNAI1, CILD1, ICS, PCD","Dynein, axonemal, intermediate chain 1",DNAI1,27019,ENSG00000122735,NA,"Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3), Autosomal recessive",Dnaic1 (MGI:1916172)
9,34551431,34590385,9p13,9p13.3,118946,CNTFR,Ciliary neurotrophic factor receptor,CNTFR,1271,ENSG00000122756,NA,NA,Cntfr (MGI:99605)
9,34613544,34620522,9p13,9p13.3,607387,"DCTN3, DCTN22",Dynactin 3,DCTN3,11258,ENSG00000137100,NA,NA,Dctn3 (MGI:1859251)
9,34634721,34637825,9p13,9p13.3,601978,"SIGMAR1, SRBP, ALS16, DSMA2",Sigma nonopioid intracellular receptor 1,SIGMAR1,10280,ENSG00000147955,mutation identified in 1 ALS16 family and 1 DSMA2 family,"?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3), Autosomal recessive; ?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3), Autosomal recessive",Sigmar1 (MGI:1195268)
9,34646588,34651034,9p13,9p13.3,606999,GALT,Galactose-1-phosphate uridyltransferase,GALT,2592,ENSG00000213930,NA,"Galactosemia, 230400 (3), Autosomal recessive",Galt (MGI:95638)
9,34652184,34661901,9p13,9p13.3,600939,"IL11RA, CRSDA","Interleukin-11 receptor, alpha",IL11RA,3590,ENSG00000137070,NA,"Craniosynostosis and dental anomalies, 614188 (3), Autosomal recessive","Il11ra1,Gm13305,Gm2002,Il11ra2 (MGI:3780172,MGI:107426,MGI:3801997,MGI:109123)"
9,34661889,34662656,9p13,9p13.3,604833,"CCL27, SCYA27, ILC, CTACK","Chemokine, C-C motif, ligand 27",CCL27,10850,ENSG00000213927,NA,NA,"Gm2506,Gm13306,Ccl27b (MGI:1891389,MGI:3713752,MGI:3780673)"
9,34689569,34691275,9p13,9p13.3,602227,"CCL19, SCYA19, ELC, MIP3B","Chemokine, C-C motif, ligand 19",CCL19,6363,ENSG00000172724,NA,NA,"Ccl19-ps1,Gm12407,Gm13309,Gm21104,Gm2457,Gm2564,Ccl19,Gm2023 (MGI:5434459,MGI:3708691,MGI:1891387,MGI:3780624,MGI:1346316,MGI:3780192,MGI:3693096,MGI:3702000)"
9,34709004,34710135,9p13,9p13.3,602737,"CCL21, SCYA21, SLC","Chemokine, C-C motif, ligand 21",CCL21,6366,ENSG00000137077,NA,NA,"Ccl21c,Gm1987,Gm13304,Gm10591,Ccl21b,Ccl21a,Gm21541 (MGI:1349183,MGI:3711256,MGI:1349182,MGI:5434896,MGI:3710514,MGI:1891386,MGI:3780156)"
9,34989640,34998899,9p13.3,9p13.3,611328,"DNAJB5, KIAA1045, HSC40","DNAJ/HSP40 homolog, subfamily B, member 5",DNAJB5,25822,ENSG00000137094,NA,NA,Dnajb5 (MGI:1930018)
9,35056063,35072667,9p13-p12,9p13.3,601023,"VCP, IBMPFD1, ALS14, CMT2Y",Valosin-containing protein,VCP,7415,ENSG00000165280,NA,"Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3); Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant",Vcp (MGI:99919)
9,35073837,35080015,9p13,9p13.3,602956,"XRCC9, FANCG","X-ray repair, complementing defective, in Chinese hamster, 9",FANCG,2189,ENSG00000221829,NA,"Fanconi anemia, complementation group G, 614082 (3)",Fancg (MGI:1926471)
9,35085495,35096600,9p13,9p13.3,614730,"PIGO, HPMRS2","Phosphatidylinositol glycan, class O",PIGO,84720,ENSG00000165282,NA,"Hyperphosphatasia with mental retardation syndrome 2, 614749 (3), Autosomal recessive",Pigo (MGI:1861452)
9,35099775,35103194,9p13.1,9p13.3,608292,STOML2,Stomatin-like protein 2,STOML2,30968,ENSG00000165283,NA,NA,Stoml2 (MGI:1913842)
9,35161968,35405337,Chr.9,9p13.3,605836,"UNC13, MUNC13","UNC13, C. elegans, homolog of",UNC13B,10497,ENSG00000198722,NA,NA,Unc13b (MGI:1342278)
9,35489832,35561897,9p13.1,9p13.3,611053,"RUSC2, KIAA0375, IPORIN, MRT61",RUN and SH3 domain-containing 2,RUSC2,9853,ENSG00000198853,NA,"Mental retardation, autosomal recessive 61, 617773 (3), Autosomal recessive",Rusc2 (MGI:2140371)
9,35605261,35610032,9p13,9p13.3,601782,TESK1,Testis-specific protein kinase-1,TESK1,7016,ENSG00000107140,NA,NA,Tesk1 (MGI:1201675)
9,35609978,35618426,9p,9p13.3,107272,"CD72, LYB2",CD72 antigen,CD72,971,ENSG00000137101,NA,NA,Cd72 (MGI:88345)
9,35649294,35650930,9p13-p12,9p13.3,604964,SIT,SHP2-interacting transmembrane adaptor protein,SIT1,27240,ENSG00000137078,NA,NA,Sit1 (MGI:1889342)
9,35657750,35658017,9p21-p12,9p13.3,157660,"RMRP, RMRPR, CHH",Mitochondrial RNA-processing endoribonuclease,RMRP,6023,ENSG00000269900,NA,"Anauxetic dysplasia 1, 607095 (3), Autosomal recessive; Cartilage-hair hypoplasia, 250250 (3), Autosomal recessive; Metaphyseal dysplasia without hypotrichosis, 250460 (3), Autosomal recessive",NA
9,35673808,35681158,9p13.3,9p13.3,603179,"CA9, MN",Carbonic anhydrase IX,CA9,768,ENSG00000107159,previously assigned to 17q21.2,NA,Car9 (MGI:2447188)
9,35681992,35690055,9p13.2-p13.1,9p13.3,190990,"TPM2, TMSB, AMCD1, DA1, DA2B4, NEM4","Tropomyosin-2, beta",TPM2,7169,ENSG00000198467,NA,"Arthrogryposis, distal, type 1A, 108120 (3), Autosomal dominant; Arthrogryposis, distal, type 2B4, 108120 (3), Autosomal dominant; CAP myopathy 2, 609285 (3), Autosomal dominant; Nemaline myopathy 4, autosomal dominant, 609285 (3), Autosomal dominant",NA
9,35696947,35732194,9p,9p13.3,186745,TLN1,Talin 1,TLN1,7094,ENSG00000137076,NA,NA,Tln1 (MGI:1099832)
9,35732665,35736998,9p13.3,9p13.3,606443,"CREB3, LZIP",cAMP response element-binding protein 3,CREB3,10488,ENSG00000107175,NA,NA,Creb3 (MGI:99946)
9,35736861,35749227,9p13.3,9p13.3,609471,"GBA2, KIAA1605, SPG46","Glucosidase, beta, acid 2",GBA2,57704,ENSG00000070610,NA,"Spastic paraplegia 46, autosomal recessive, 614409 (3), Autosomal recessive",Gba2 (MGI:2654325)
9,35749286,35758584,9p13.3,9p13.3,615742,"RGP1, KIAA0258","RGP1 retrograde golgi transport, S. cerevisiae, homolog of",RGP1,9827,ENSG00000107185,NA,NA,Rgp1 (MGI:1915956)
9,35752989,35754275,9p13.3,9p13.3,612191,"MSMP, PSMP","Microseminoprotein, prostate-associated",MSMP,692094,ENSG00000215183,NA,NA,Msmp (MGI:3652339)
9,35782085,35809730,9p21-p12,9p13.3,108961,"NPR2, ANPRB, AMDM, ECDM, SNSK",Natiuretic peptide receptor 2,NPR2,4882,ENSG00000159899,NA,"Acromesomelic dysplasia, Maroteaux type, 602875 (3), Autosomal recessive; Epiphyseal chondrodysplasia, Miura type, 615923 (3), Autosomal dominant; Short stature with nonspecific skeletal abnormalities, 616255 (3), Autosomal dominant",Npr2 (MGI:97372)
9,35807784,35812271,9p13-p12,9p13.3,605731,"SPAG8, SMP1",Sperm-associated antigen 8,SPAG8,26206,ENSG00000137098,NA,NA,Spag8 (MGI:3056295)
9,35812959,35815478,9p11.2,9p13.3,609997,HINT2,Histidine triad nucleotide-binding protein 2,HINT2,84681,ENSG00000137133,NA,NA,Hint2 (MGI:1916167)
9,35825816,35865514,9p13.3,9p13.3,616888,"TMEM8B, NGX6, NAG5",Transmembrane protein 8B,TMEM8B,51754,ENSG00000137103,NA,NA,Tmem8b (MGI:2441680)
9,35909489,35911685,9p13.3,9p13.3,617627,"SPAAR, LINC00961",Small regulatory polypeptide of amino acid response,SPAAR,158376,ENSG00000235387,NA,NA,NA
9,36036904,36124454,9p13-p12,9p13.3,605227,"RECK, ST15",Reversion-inducing cysteine-rich protein with kazal motifs (suppressor of tumorigenicity 15),RECK,8434,ENSG00000122707,NA,NA,Reck (MGI:1855698)
9,36136535,36163912,9p13.3,9p13.3,607141,"GLIPR2, GAPR1, C9orf19",GLI pathogenesis-related 2,GLIPR2,152007,ENSG00000122694,NA,NA,Glipr2 (MGI:1917770)
9,36169387,36171333,9p13.3,9p13.3,603960,CCIN,Calicin,CCIN,881,ENSG00000185972,NA,NA,Ccin (MGI:3045316)
9,36190854,36212061,9p13.3,9p13.3,118960,CLTA,"Clathrin, light polypeptide (Lca)",CLTA,1211,ENSG00000122705,previously mapped to 12q23-q24,NA,Clta (MGI:894297)
9,36214440,36277055,9p13.3,9p13.3,603824,"GNE, GLCNE, IBM2, DMRV, NM",UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,GNE,10020,ENSG00000159921,NA,"Nonaka myopathy, 605820 (3), Autosomal recessive; Sialuria, 269921 (3), Autosomal dominant",Gne (MGI:1354951)
9,36336397,36487383,9p13,9p13.2,612488,RNF38,Ring finger protein 38,RNF38,152006,ENSG00000137075,NA,NA,Rnf38 (MGI:1920719)
9,36572861,36677682,Chr.9,9p13.2,607025,"MELK, KIAA0175",Maternal embryonic leucine zipper kinase,MELK,9833,ENSG00000165304,NA,NA,Melk (MGI:106924)
9,36833268,37034478,9p13,9p13.2,167414,"PAX5, BSAP, ALL3",Paired box homeotic gene-5 (B-cell lineage specific activator protein),PAX5,5079,ENSG00000196092,NA,"{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)",Pax5 (MGI:97489)
9,37422434,37438951,9cen,9p13.2,604296,"GRHPR, GLXR",Glyoxylate reductase/hydroxypyruvate reductase,GRHPR,9380,ENSG00000137106,NA,"Hyperoxaluria, primary, type II, 260000 (3), Autosomal recessive",Grhpr (MGI:1923488)
9,37438101,37465449,9p13.2,9p13.2,616590,"ZBTB5, KIAA0354",Zinc finger- and BTB domain-containing protein 5,ZBTB5,9925,ENSG00000168795,NA,NA,Zbtb5 (MGI:1924601)
9,37510891,37576458,9p13.1,9p13.2,609092,"FBXO10, FBX10",F-box only protein 10,FBXO10,26267,ENSG00000147912,NA,NA,Fbxo10 (MGI:2686937)
9,37588412,37592638,9p13.2,9p13.2,616169,"TOMM5, TOM5","Translocase of outer mitochondrial membrane 5, yeast, homolog of",TOMM5,401505,ENSG00000175768,NA,NA,NA
9,37602976,37746903,9p13.2,9p13.2,616919,"FRMPD1, FRMD2, KIAA0967",FERM and PDZ domains-containing protein 1,FRMPD1,22844,ENSG00000070601,NA,NA,Frmpd1 (MGI:2446274)
9,37779713,37785091,9p13.2,9p13.2,606489,"EXOSC3, RRP40, PCH1B",Exosome component 3,EXOSC3,51010,ENSG00000107371,NA,"Pontocerebellar hypoplasia, type 1B, 614678 (3), Autosomal recessive",Exosc3 (MGI:1913612)
9,37900000,69300000,9p13.1-q21.11,NA,612096,OTSC8,Otosclerosis 8,OTSC8,100151644,NA,between D9S970 and D9S1799,"Otosclerosis 8, 612096 (2), Autosomal dominant",NA
9,37915897,38069226,9p12-p11,9p13.1,600314,SHB,SHB adaptor protein (a Src homology 2 protein),SHB,6461,ENSG00000107338,NA,NA,Shb (MGI:98294)
9,38392701,38398664,9p13,9p13.1,100670,"ALDH1B1, ALDH5","Aldehyde dehydrogenase 1 family, member B1",ALDH1B1,219,ENSG00000137124,NA,NA,Aldh1b1 (MGI:1919785)
9,38406527,38424453,9p13.1,9p13.1,610413,"IGFBPL1, IGFBPRP4",Insulin-like growth factor binding protein-like 1,IGFBPL1,347252,ENSG00000137142,NA,NA,Igfbpl1 (MGI:1933198)
9,39000000,61500000,9p12-q12,NA,605388,ACP,"Cerebral palsy, ataxic, autosomal recessive",CPAT1,60502,NA,NA,"Cerebral palsy, ataxic, autosomal recessive, 605388 (2), Autosomal recessive",NA
9,39072766,39288302,9p13.1,9p12,610517,"CNTNAP3, KIAA1714",Contactin-associated protein-like 3,CNTNAP3,79937,ENSG00000106714,NA,NA,Cntnap3 (MGI:3588199)
9,40000000,43000000,9p11,NA,155900,MROS,Melkersson-Rosenthal syndrome,MROS,8011,NA,NA,"?Melkersson-Rosenthal syndrome, 155900 (2), Autosomal dominant",NA
9,43000000,138394717,9q,NA,609320,HCHGQ2,Hematocrit/hemoglobin quantitative trait locus 2,NA,100381205,NA,NA,"[Hematocrit/hemoglobin quantitative trait locus 2], 609320 (2)",NA
9,43000000,138394717,9q,NA,607152,SPG19,Spastic paraplegia-19,SPG19,140907,NA,NA,"Spastic paraplegia 19, autosomal dominant, 607152 (2), Autosomal dominant",NA
9,45500000,61500000,9q12,NA,126330,DNCM,Cytoplasmic membrane DNA,NA,1784,NA,in 9qh,NA,NA
9,61190035,61196279,9q12,9q12,616584,"SPATA31A7, AEP1, FAM75A7, C9orf36","Spermatogenesis-associated protein 31, subfamily A, member 7",SPATA31A7,26165,ENSG00000276040,NA,NA,Spata31 (MGI:1925374)
9,61500000,65000000,9q13,NA,600884,"CMD1B, CMPD1, FDC","Cardiomyopathy, dilated-1B, autosomal dominant",CMD1B,1218,NA,NA,"Cardiomyopathy, dilated 1B, 600884 (2), Autosomal dominant",NA
9,61500000,99800000,9q13-q22,NA,605749,"CTRCT26, CAAR","Cataract 26, multiple types",CTPL1,81863,NA,NA,"Cataract 26, multiple types, 605749 (2)",NA
9,61500000,87800000,9q13-q21,NA,190100,"GSM1, GSP",Geniospasm 1,GSM1,2933,NA,NA,"Geniospasm, 190100 (2), Autosomal dominant",NA
9,65000000,69300000,9q21.11,NA,613558,"DFNA51, C9DUPq21.11, DUP9q21.11","Deafness, autosomal dominant 51 (chromosome 9q21.11 duplication syndrome)",NA,NA,NA,259kb duplication involving TJP2 and FAM189A2,"Deafness, autosomal dominant 51, 613558 (4), Autosomal dominant",NA
9,65000000,99800000,9q21-q22,NA,611631,"ETL4, ETOLM","Epilepsy, familial temporal lobe, 4",NA,100144434,NA,between GATA152H04 and D9S253,"Epilepsy, familial temporal lobe, 4, 611631 (2), Autosomal dominant",NA
9,65000000,87800000,9q21,NA,613088,PVOP2,"Pelvic organ prolapse, susceptibility to, 2",NA,100312955,NA,between rs4077632 and rs10868525,"{Pelvic organ prolapse, susceptibility to, 2}, 613088 (2)",NA
9,65737145,65738395,9p11.2,9q21.11,611085,"FOXD4L4, FOXD4L2",Forkhead box D4-like 4,FOXD4L4,349334,ENSG00000184659,NA,NA,NA
9,66900724,66932140,9q21.11,9q21.11,616290,ZNF658,Zinc finger protein 658,ZNF658,26149,ENSG00000274349,NA,NA,"Gm7145,Zfp735,Zfp616 (MGI:3648947,MGI:1923640,MGI:3650906)"
9,68241865,68300034,9q13,9q21.11,611080,CBWD3,Cobalamin synthetase W domain-containing protein 3,CBWD3,445571,ENSG00000196873,NA,NA,NA
9,68302866,68305083,9q13,9q21.11,611086,FOXD4L3,Forkhead box D4-like 3,FOXD4L3,286380,ENSG00000187559,NA,NA,NA
9,68356583,68531060,9p12-q12,9q21.11,600981,PGM5,Phosphoglucomutase-5,PGM5,5239,ENSG00000154330,NA,NA,Pgm5 (MGI:1925668)
9,68705216,69009175,9q13,9q21.11,602745,"PIP5K1B, STM7, MSS4","Phosphatidylinositol-4-phosphate 5-kinase, type I, beta",PIP5K1B,8395,ENSG00000107242,NA,NA,Pip5k1b (MGI:107930)
9,68780064,68785565,9q21.1,9q21.11,617249,"FAM122A, C9orf42","Family with sequence similarity 122, member A",FAM122A,116224,ENSG00000187866,NA,NA,Fam122a (MGI:1915284)
9,69012528,69014122,9q21.11,9q21.11,176893,"PRKACG, BDPLT19","Protein kinase, cAMP-dependent, catalytic, gamma",PRKACG,5568,ENSG00000165059,mutation identified in 1 BDPLT19 family,"?Bleeding disorder, platelet-type, 19, 616176 (3), Autosomal recessive",NA
9,69035751,69079075,9q13,9q21.11,606829,"FXN, FRDA, FARR, X25",Frataxin,FXN,2395,ENSG00000165060,NA,"Friedreich ataxia, 229300 (3), Autosomal recessive; Friedreich ataxia with retained reflexes, 229300 (3), Autosomal recessive",Fxn (MGI:1096879)
9,69121005,69255207,9q12-q13,9q21.11,607709,"TJP2, ZO2, PFIC4",Tight junction protein 2,TJP2,9414,ENSG00000119139,NA,"Cholestasis, progressive familial intrahepatic 4, 615878 (3), Autosomal recessive; Hypercholanemia, familial, 607748 (3), Autosomal recessive",Tjp2 (MGI:1341872)
9,69324571,69392472,9q13-q21,9q21.12,607710,X123,X123 gene,FAM189A2,9413,ENSG00000135063,NA,NA,Fam189a2 (MGI:2685813)
9,69427531,69673011,9q21.11-q21.12,9q21.12,602414,"APBA1, X11, D9S411E, MINT1, LIN10","Amyloid beta A4 precursor protein-binding, family A, member 1",APBA1,320,ENSG00000107282,NA,NA,Apba1 (MGI:1860297)
9,70043580,70226971,9q21.11,9q21.12,612879,MAMDC2,MAM domain-containing 2,MAMDC2,256691,ENSG00000165072,NA,NA,Mamdc2 (MGI:1918988)
9,70258961,70354872,9q21.11,9q21.12,609386,"SMC5L1, SMC5, KIAA0594",Structural maintenance of chromosomes 5-like 1,SMC5,23137,ENSG00000198887,NA,NA,Smc5 (MGI:2385088)
9,70384596,70414656,9q13,9q21.12,602902,"BTEB1, BTEB",Basic transcription element-binding protein 1,KLF9,687,ENSG00000119138,NA,NA,Klf9 (MGI:1333856)
9,70529059,71446970,9q21.12,9q21.12-q21.13,608961,"TRPM3, MLSN2, LTRPC3, KIAA1616","Transient receptor potential cation channel, subfamily M, member 3",TRPM3,80036,ENSG00000083067,NA,NA,Trpm3 (MGI:2443101)
9,70809974,70810083,9q21.11,9q21.12,610942,"MIR204, MIRN204, RDICC",Micro RNA 204,MIR204,406987,ENSG00000207935,mutation identified in 1 RDICC family,"?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3), Autosomal dominant",NA
9,71683365,71769531,9q13-q21,9q21.13,605835,TMEM2,Transmembrane protein 2,CEMIP2,23670,ENSG00000135048,NA,NA,Cemip2 (MGI:1890373)
9,71862451,71911535,9q21.13,9q21.13,617943,"ABHD17B, FAM108B1",Abhydrolase domain-containing protein 17B,ABHD17B,51104,ENSG00000107362,NA,NA,Abhd17b (MGI:1917816)
9,72114594,72256044,9q21.13,9q21.13,139260,"GDA, CYPIN",Guanine deaminase,GDA,9615,ENSG00000119125,NA,NA,Gda (MGI:95678)
9,72351412,72365207,9q13-q21,9q21.13,604761,"ZFAND5, ZNF216",Zinc finger AN1 domain-containing protein 5,ZFAND5,7763,ENSG00000107372,NA,NA,Zfand5 (MGI:1278334)
9,72521800,72836350,9q13-q21,9q21.13,606706,"TMC1, DFNB7, DFNB11, DFNA36",Transmembrane channel-like protein 1,TMC1,117531,ENSG00000165091,NA,"Deafness, autosomal dominant 36, 606705 (3), Autosomal dominant; Deafness, autosomal recessive 7, 600974 (3), Autosomal recessive",Tmc1 (MGI:2151016)
9,72900670,72953052,9q21,9q21.13,100640,ALDH1A1,"Aldehyde dehydrogenase-1 family, member A1, soluble",ALDH1A1,216,ENSG00000165092,NA,NA,Aldh1a1 (MGI:1353450)
9,73151864,73170392,9q11-q22,9q21.13,151690,"ANXA1, LPC1",Annexin A1 (lipocortin I),ANXA1,301,ENSG00000135046,NA,NA,Anxa1 (MGI:96819)
9,74497334,74693176,9q22,9q21.13,601972,"RORB, RZRB, EIG15",RAR-related orphan receptor B,RORB,6096,ENSG00000198963,NA,"{Epilepsy, idiopathic generalized, susceptibility to, 15}, 618357 (3), Autosomal dominant",Rorb (MGI:1343464)
9,74722494,74887920,9q22,9q21.13,607009,"TRPM6, CHAK2, HOMG1","Transient receptor potential cation channel, subfamily M, member 6",TRPM6,140803,ENSG00000119121,NA,"Hypomagnesemia 1, intestinal, 602014 (3), Autosomal recessive",Trpm6 (MGI:2675603)
9,74980789,75028455,9q21.13,9q21.13,616552,"CARNMT1, C9orf41, UPF0586",Carnosine N-methyltransferase 1,CARNMT1,138199,ENSG00000156017,NA,NA,Carnmt1 (MGI:1914633)
9,75060576,75088318,9q21.13,9q21.13,608704,"NMRK1, C9orf95",Nicotinamide riboside kinase 1,NMRK1,54981,ENSG00000106733,NA,NA,Nmrk1 (MGI:2147434)
9,75088479,75147264,9q21.13,9q21.13,610180,"OSTF1, OSF, SH3P2",Osteoclast-stimulating factor 1,OSTF1,26578,ENSG00000134996,NA,NA,Ostf1 (MGI:700012)
9,75890643,76362338,9q21.3,9q21.13,600488,PCSK5,Proprotein convertase subtilisin/kexin type 5,PCSK5,5125,ENSG00000099139,?close to LPC1 on 9q,NA,Pcsk5 (MGI:97515)
9,76385525,76394425,9q21.1,9q21.13,613010,RFK,Riboflavin kinase,RFK,55312,ENSG00000135002,NA,NA,Rfk (MGI:1914688)
9,76441665,76507415,9q13,9q21.13,600391,GCNT1,"Glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase)",GCNT1,2650,ENSG00000187210,NA,NA,Gcnt1 (MGI:95676)
9,76611375,76906219,9p13,9q21.2,610691,"PRUNE2, BMCC1, KIAA0367","PRUNE, Drosophila, homolog of, 2",PRUNE2,158471,ENSG00000106772,NA,NA,Prune2 (MGI:1925004)
9,76764435,76787568,9q21-q22,9q21.2,604845,"PCA3, DD3",Prostate cancer antigen 3,PCA3,50652,ENSG00000225937,NA,NA,NA
9,77177352,77421536,9q21,9q21.2,605978,"VPS13A, CHAC",Vacuolar protein sorting 13A (chorein),VPS13A,23230,ENSG00000197969,NA,"Choreoacanthocytosis, 200150 (3), Autosomal recessive",Vps13a (MGI:2444304)
9,77423078,77648321,9q21,9q21.2,604397,GNA14,"Guanine nucleotide-binding protein, alpha-14",GNA14,9630,ENSG00000156049,NA,NA,Gna14 (MGI:95769)
9,77716096,78031810,9q21,9q21.2,600998,"GNAQ, SWS, CMC1","Guanine nucleotide-binding protein (G protein), q",GNAQ,2776,ENSG00000156052,pseudogene on 2q,"Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3); Sturge-Weber syndrome, somatic, mosaic, 185300 (3)",Gnaq (MGI:95776)
9,78236074,78279689,9q21.2,9q21.2,617110,"CEP78, CRDHL","Centrosomal protein, 78kD",CEP78,84131,ENSG00000148019,NA,"Cone-rod dystrophy and hearing loss, 617236 (3), Autosomal recessive",Cep78 (MGI:1924386)
9,78297124,78330092,9q21.31,9q21.2,610936,"PSAT1, PSAT, EPIP, PSATD, NLS2",Phosphoserine aminotransferase 1,PSAT1,29968,ENSG00000135069,mutation identified in 1 PSATD family,"Neu-Laxova syndrome 2, 616038 (3), Autosomal recessive; ?Phosphoserine aminotransferase deficiency, 610992 (3), Autosomal recessive",Psat1 (MGI:2183441)
9,78500000,99800000,9q21.3-q22,NA,267700,"FHL1, HPLH1, HLH1","Hemophagocytic lymphohistiocytosis, familial, 1",HPLH1,27259,NA,NA,"Hemophagocytic lymphohistiocytosis, familial, 1, 267700 (2), Autosomal recessive",NA
9,81583682,81689546,9q21.3,9q21.32,600189,"TLE1, ESG1",Transducin-like enhancer of split 1 (homolog of Drosophila E(spl)),TLE1,7088,ENSG00000196781,conflicting assignment to chr.19,NA,Tle1 (MGI:104636)
9,82979588,83063171,9q21.32,9q21.32,611344,RASEF,RAS and EF-hand domains-containing protein,RASEF,158158,ENSG00000165105,NA,NA,Rasef (MGI:2448565)
9,83242989,83585796,9q21-q22,9q21.32,607619,"FRMD3, EPB41LO",FERM domain-containing 3,FRMD3,257019,ENSG00000172159,NA,NA,Frmd3 (MGI:2442466)
9,83622323,83644129,9q21.32,9q21.32,611343,C9orf103,Chromosome 9 open reading frame 103,IDNK,414328,ENSG00000148057,NA,NA,Idnk (MGI:1922981)
9,83659967,83707978,9q21.2-q21.3,9q21.32,605046,"UBQLN1, DA41","Ubiquilin 1 (Da41, rat, homolog of)",UBQLN1,29979,ENSG00000135018,NA,NA,Ubqln1 (MGI:1860276)
9,83739420,83817836,9q21.32,9q21.32,611356,"GKAP1, GKAP42",G kinase-anchoring protein 1,GKAP1,80318,ENSG00000165113,NA,NA,Gkap1 (MGI:1891694)
9,83832794,83921543,9q21.32,9q21.32,611253,KIF27,Kinesin family member 27,KIF27,55582,ENSG00000165115,NA,NA,Kif27 (MGI:1922300)
9,83938310,83956985,9q21.32,9q21.32,611342,C9orf64,Chromosome 9 open reading frame 64,C9orf64,84267,ENSG00000165118,NA,NA,2210016F16Rik (MGI:1917403)
9,83968082,83980781,9q21.32-q21.33,9q21.32,600712,"HNRNPK, HNRPK, AUKS",Heterogeneous nuclear ribonucleoprotein K,HNRNPK,3190,ENSG00000165119,NA,"Au-Kline syndrome, 616580 (3), Autosomal dominant",Hnrnpk (MGI:99894)
9,83969747,83969856,9q21.32,9q21.32,615239,MIR7-1,Micro RNA 7-1,MIR7-1,407043,ENSG00000284179,NA,NA,NA
9,83980358,84004073,9q21.32,9q21.32,610404,"RMI1, BLAP75, C9orf76","RecQ-mediated genome instability 1, S. cerevisiae, homolog of",RMI1,80010,ENSG00000178966,NA,NA,Rmi1 (MGI:1921636)
9,84273122,84368726,9q22.2,9q21.32-q21.33,608269,"SLC28A3, CNT3","Solute carrier family (sodium-coupled nucleoside transporter), member 3",SLC28A3,64078,ENSG00000197506,NA,NA,Slc28a3 (MGI:2137361)
9,84668457,85027069,9q21.33,9q21.33,600456,"NTRK2, TRKB, OBHD, EIEE58","Neurotrophic tyrosine kinase, receptor, type 2",NTRK2,4915,ENSG00000148053,NA,"Epileptic encephalopathy, early infantile, 58, 617830 (3), Autosomal dominant; Obesity, hyperphagia, and developmental delay, 613886 (3), Autosomal dominant",Ntrk2 (MGI:97384)
9,85546538,85742028,9q21.33,9q21.33,606830,"AGTPBP1, NNA1, KIAA1035, CCP1, CONDCA",ATP/GTP-binding protein 1,AGTPBP1,23287,ENSG00000135049,NA,"Neurodegeneration, childhood-onset, with cerebellar atrophy, 618276 (3), Autosomal recessive",Agtpbp1 (MGI:2159437)
9,86026140,86100200,9q21.33,9q21.33,606804,"GOLM1, GOLPH2, GP73, C9orf155",Golgi membrane protein 1,GOLM1,51280,ENSG00000135052,NA,NA,Golm1 (MGI:1917329)
9,86264545,86282537,9q21.2-q22.1,9q21.33,611006,"ISCA1, HBLD2, HISCA, MMDS5","Iron-sulfur cluster assembly 1, S. cerevisiae, homolog of",ISCA1,81689,ENSG00000135070,NA,"Multiple mitochondrial dysfunctions syndrome 5, 617613 (3), Autosomal recessive",Isca1 (MGI:1916296)
9,86287732,86354496,9q21.33,9q21.33,613467,"ZCCHC6, TUT7, KIAA1711",Zinc finger CCHC domain-containing protein 6,TUT7,79670,ENSG00000083223,NA,NA,Tut7 (MGI:2387179)
9,86944361,86947505,9q21.3-q22.1,9q21.33,139185,GAS1,Growth arrest-specific gene-1,GAS1,2619,ENSG00000180447,NA,NA,Gas1 (MGI:95655)
9,87497227,87708633,9q34.1,9q21.33,600831,DAPK1,Death-associated protein kinase-1,DAPK1,1612,ENSG00000196730,NA,NA,Dapk1 (MGI:1916885)
9,87725436,87731468,9q21-q22,9q21.33,116880,CTSL,Cathepsin L,CTSL,1514,ENSG00000135047,\'like\' sequence on 10q23-q24,NA,NA
9,87800000,99800000,9q22,NA,608695,JOAG2,"Glaucoma, primary open angle, juvenile-onset, 2",GLC1J,574078,NA,between D9S1803 and D9S196,"Glaucoma, primary open angle, juvenile-onset, 2, 608695 (2)",NA
9,87800000,99800000,9q22,NA,610114,STQTL8,Stature quantitative trait locus 8,NA,100037266,NA,between GATA81C04M and ATA18A07M,"{Stature QTL 8}, 610114 (2)",NA
9,87966440,87974779,9q22.1,9q22.1,610076,"CDK20, CCRK, CDCH, P42",Cyclin-dependent kinase 20,CDK20,23552,ENSG00000156345,NA,NA,Cdk20 (MGI:2145349)
9,88388443,88478693,9q22.1-q22.3,9q22.1,609936,"SPIN, SPIN1",Spindlin,SPIN1,10927,ENSG00000106723,NA,NA,Spin1 (MGI:109242)
9,88535087,88584509,9q22.1,9q22.1,615299,"NXNL2, RDCVF2",Nucleoredoxin-like protein 2,NXNL2,158046,ENSG00000130045,NA,NA,Nxnl2 (MGI:1922374)
9,88991467,89005154,9q22.1-q22.2,9q22.1,601965,"S1PR3, EDG3",Sphingosine-1-phosphate receptor 3,S1PR3,1903,ENSG00000213694,NA,NA,S1pr3 (MGI:1339365)
9,89005770,89182401,9q22.1,9q22.1,605263,"SHC3, NSHC, RAI, SHCC",SHC transforming protein 3,SHC3,53358,ENSG00000148082,NA,NA,Shc3 (MGI:106179)
9,89311194,89316702,9q22.2,9q22.2,116901,CKS2,CDC2-associated protein CKS2,CKS2,1164,ENSG00000123975,NA,NA,Cks2 (MGI:1913447)
9,89318499,89367116,9q22.2,9q22.2,607693,"SECISBP2, SBP2",Selenocysteine insertion sequence-binding protein 2,SECISBP2,79048,ENSG00000187742,NA,"Thyroid hormone metabolism, abnormal, 609698 (3)",Secisbp2 (MGI:1922670)
9,89360790,89498064,9q22.2,9q22.2,601866,"SEMA4D, SEMAJ, CD100, COLL4",Semaphorin 4D,SEMA4D,10507,ENSG00000187764,NA,NA,Sema4d (MGI:109244)
9,89605008,89606554,9q22.1-q22.2,9q22.2,604949,"GADD45G, GRP17","Growth arrest- and DNA damage-inducible gene 45, gamma",GADD45G,10912,ENSG00000130222,NA,NA,Gadd45g (MGI:1346325)
9,90609831,90642823,9q22.2,9q22.2,607863,DIRAS2,"DIRAS family, GTP-binding Ras-like protein 2",DIRAS2,54769,ENSG00000165023,NA,NA,Diras2 (MGI:1915453)
9,90801599,90898548,9q22,9q22.2,600085,SYK,Spleen tyrosine kinase,SYK,6850,ENSG00000165025,NA,NA,Syk (MGI:99515)
9,91213814,91361968,9q22.31,9q22.31,600529,AUH,AU-specific RNA-binding protein (3-methylglutaconyl-CoA hydratase),AUH,549,ENSG00000148090,NA,"3-methylglutaconic aciduria, type I, 250950 (3), Autosomal recessive",Auh (MGI:1338011)
9,91409044,91425062,9q22.1-q22.3,9q22.31,605327,"NFIL3, NFIL3A, E4BP4","Nuclear factor, interleukin 3-regulated",NFIL3,4783,ENSG00000165030,NA,NA,Nfil3 (MGI:109495)
9,91722597,91950227,9q22,9q22.31,602337,"ROR2, BDB1, BDB, NTRKR2",Receptor tyrosine kinase-like orphan receptor 2,ROR2,4920,ENSG00000169071,NA,"Brachydactyly, type B1, 113000 (3), Autosomal dominant; Robinow syndrome, autosomal recessive, 268310 (3), Autosomal recessive",Ror2 (MGI:1347521)
9,92031140,92115412,9q22.1-q22.3,9q22.31,605712,"SPTLC1, LBC1, SPT1, HSN1, HSAN","Serine palmitoyltransferase, long-chain base subunit 1",SPTLC1,10558,ENSG00000090054,NA,"Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3), Autosomal dominant",Sptlc1 (MGI:1099431)
9,92210206,92293755,9q21,9q22.31,600709,"IARS, GRIDHH",Isoleucine-tRNA synthetase,IARS1,3376,ENSG00000196305,NA,"Growth retardation, impaired intellectual development, hypotonia, and hepatopathy, 617093 (3), Autosomal recessive",Iars (MGI:2145219)
9,92297357,92325993,9q22.32,9q22.31,611534,"NOL8, NOP132",Nucleolar protein 8,NOL8,55035,ENSG00000198000,NA,NA,Nol8 (MGI:1918180)
9,92325456,92620528,9q22.31,9q22.31,611505,CENPP,Centromeric protein P,CENPP,401541,ENSG00000188312,NA,NA,Cenpp (MGI:1913586)
9,92383267,92404698,9q22.3,9q22.31,602383,"OGN, OIF",Osteoglycin,OGN,4969,ENSG00000106809,NA,NA,Ogn (MGI:109278)
9,92456204,92482505,9q21.3-q22,9q22.31,608135,"ASPN, PLAP1, OS3",Asporin,ASPN,54829,ENSG00000106819,NA,"{Lumbar disc degeneration}, 603932 (3); {Osteoarthritis susceptibility 3}, 607850 (3), Autosomal dominant",Aspn (MGI:1913945)
9,92493546,92536840,9q22.3,9q22.31,603479,ECM2,Extracellular matrix protein-2,ECM2,1842,ENSG00000106823,NA,NA,Ecm2 (MGI:3039578)
9,92711362,92764840,9q22.3,9q22.31,609797,"BICD2, KIAA0699, SMALED2A, SMALED2B","Bicaudal D, Drosophila, homolog of, 2",BICD2,23299,ENSG00000185963,NA,"Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant, 615290 (3), Autosomal dominant; Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant, 618291 (3), Autosomal dominant",Bicd2 (MGI:1924145)
9,92947522,93036235,9q22.31,9q22.31,617554,"FGD3, ZFYVE5","FYVE, RhoGEF, and Ph domain-containing protein 3",FGD3,89846,ENSG00000127084,NA,NA,Fgd3 (MGI:1353657)
9,93058687,93085137,9q22.31,9q22.31,616429,SUSD3,SUSHI domain-containing protein 3,SUSD3,203328,ENSG00000157303,NA,NA,Susd3 (MGI:1913579)
9,93096122,93113294,9q22.32,9q22.31,617726,"CARD19, BINCARD, C9orf89",Caspase recruitment domain-containing protein 19,CARD19,84270,ENSG00000165233,NA,NA,Card19 (MGI:1915730)
9,93121495,93134303,9q22,9q22.31,602062,NINJ1,Ninjurin,NINJ1,4814,ENSG00000131669,NA,NA,Ninj1 (MGI:1196617)
9,93184155,93327580,9q22.3,9q22.31,606249,"WNK2, PRKWNK2",WNK lysine deficient protein kinase 2,WNK2,65268,ENSG00000165238,NA,NA,Wnk2 (MGI:1922857)
9,93451684,93566111,9q22.31,9q22.31,612265,"FAM120A, C9orf10, KIAA0183","Family with sequence similarity 120, member A",FAM120A,23196,ENSG00000048828,NA,NA,Fam120a (MGI:2446163)
9,93576583,93679586,9q22,9q22.31,604351,PHF2,PHD finger protein-2,PHF2,5253,ENSG00000197724,NA,NA,Phf2 (MGI:1338034)
9,93951626,93955354,9q12,9q22.32,603260,BARX1,BarH-like homeo box gene 1,BARX1,56033,ENSG00000131668,NA,NA,Barx1 (MGI:103124)
9,94175956,94176035,9q22.32,9q22.32,605386,"MIRLET7A1, LET7A1, MIRNLET7A1",Micro RNA Let7a1,MIRLET7A1,406881,ENSG00000199165,NA,NA,NA
9,94176346,94176432,9q22.32,9q22.32,612146,"MIRLET7F1, LET7F1, MIRNLET7F1",Micro RNA Let7f1,MIRLET7F1,406888,ENSG00000199072,NA,NA,NA
9,94178833,94178919,9q22.32,9q22.32,612145,"MIRLET7D, LET7D, MIRNLET7D",Micro RNA Let7d,MIRLET7D,406886,ENSG00000199133,NA,NA,NA
9,94259265,94303966,9q22.3,9q22.32,603404,ZNF169,Zinc finger protein-169,ZNF169,169841,ENSG00000175787,NA,NA,Zfp169 (MGI:1915161)
9,94558719,94593823,Chr.9,9q22.32,603027,FBP2,"Fructose-1,6-bisphosphatase 2",FBP2,8789,ENSG00000130957,NA,NA,Fbp2 (MGI:95491)
9,94603132,94640257,9q22.2-q22.3,9q22.32,611570,FBP1,Fructose-bisphosphatase 1,FBP1,2203,ENSG00000165140,NA,"Fructose-1,6-bisphosphatase deficiency, 229700 (3), Autosomal recessive",Fbp1 (MGI:95492)
9,95085207,95085303,9q22.32,9q22.32,610723,"MIR23B, MIRN23B",Micro RNA 23B,MIR23B,407011,ENSG00000207563,NA,NA,NA
9,95085444,95085540,9q22.32,9q22.32,610636,"MIR27B, MIRN27B",Micro RNA 27B,MIR27B,407019,ENSG00000207864,NA,NA,NA
9,95086020,95086087,9q22.32,9q22.32,609705,"MIR189, MIRN24-1",Micro RNA 24-1,MIR24-1,407012,ENSG00000284459,NA,NA,NA
9,95099053,95317729,9q22.3,9q22.32,613899,"FANCC, FACC","Fanconi anemia, complementation group C",FANCC,2176,ENSG00000158169,NA,"Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive",Fancc (MGI:95480)
9,95442979,95517056,9q22.3,9q22.32,601309,"PTCH1, NBCCS, BCNS, HPE7","Patched, Drosophila, homolog of",PTCH1,5727,ENSG00000185920,NA,"Basal cell carcinoma, somatic, 605462 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Holoprosencephaly 7, 610828 (3), Autosomal dominant",Ptch1 (MGI:105373)
9,95875631,96041091,9q22.32,9q22.32,615667,"ERCC6L2, RAD26L, BMFS2",ERCC6-like 2,ERCC6L2,375748,ENSG00000182150,NA,"Bone marrow failure syndrome 2, 615715 (3), Autosomal recessive",Ercc6l2 (MGI:1923501)
9,96235305,96313986,9q22,9q22.32,605573,"HSD17B3, EDH17B3",Hydroxysteroid (17-beta) dehydrogenase 3,HSD17B3,3293,ENSG00000130948,NA,"Pseudohermaphroditism, male, with gynecomastia, 264300 (3), Autosomal recessive",Hsd17b3 (MGI:107177)
9,96313436,96383710,9q22.3,9q22.32,609182,"SLC35D2, HFRC1, SQV7L","Solute carrier family 35, member D2",SLC35D2,11046,ENSG00000130958,NA,NA,Slc35d2 (MGI:1917734)
9,96385940,96418638,9q22.32,9q22.32,610160,"ZNF367, AFF29",Zinc finger protein 367,ZNF367,195828,ENSG00000165244,NA,NA,Zfp367 (MGI:2442266)
9,96450161,96491335,9q22.32,9q22.32,617369,"HABP4, IHABP4",Hyaluronan-binding protein 4,HABP4,22927,ENSG00000130956,NA,NA,Habp4 (MGI:1891713)
9,96492742,96619842,9q22.32-q22.33,9q22.32-q22.33,603505,CDC14B,"Cell division cycle 14, S. cerevisiae, homolog B",CDC14B,8555,ENSG00000081377,NA,NA,Cdc14b (MGI:2441808)
9,97029676,97039642,9q22.2,9q22.33,603308,"CTSL2, CTSV",Cathepsin L2,CTSV,1515,ENSG00000136943,NA,NA,Ctsl (MGI:88564)
9,97412095,97496124,9q22.33,9q22.33,611258,"TDRD7, KIAA1529, TRAP, CATC4, CTRCT36",Tudor domain-containing protein 7,TDRD7,23424,ENSG00000196116,NA,"Cataract 36, 613887 (3), Autosomal recessive",Tdrd7 (MGI:2140279)
9,97501179,97601742,9q22.3,9q22.33,190930,TMOD,Tropomodulin,TMOD1,7111,ENSG00000136842,NA,NA,Tmod1 (MGI:98775)
9,97633422,97673747,9q22.3-q31,9q22.33,600469,NCBP1,"Nuclear cap binding protein 1, 80kD",NCBP1,4686,ENSG00000136937,in 500kb of XPA,NA,Ncbp1 (MGI:1891840)
9,97654397,97697408,9q22.3,9q22.33,611153,"XPA, XPAC",XPA complementing gene,XPA,7507,ENSG00000136936,NA,"Xeroderma pigmentosum, group A, 278700 (3), Autosomal recessive",Xpa (MGI:99135)
9,97853225,97856716,9q22,9q22.33,602617,"FOXE1, FKHL15, TITF2, TTF2, NMTC4",Forkhead box E1 (thyroid transcription factor-2),FOXE1,2304,ENSG00000178919,NA,"Bamforth-Lazarus syndrome, 241850 (3), Autosomal recessive; {Thyroid cancer, nonmedullary, 4}, 616534 (3), Autosomal dominant",Foxe1 (MGI:1353500)
9,97926790,97944851,9q22,9q22.33,610715,"HEMGN, EDAG",Hemogen,HEMGN,55363,ENSG00000136929,NA,NA,Hemgn (MGI:2136910)
9,98056727,98083082,9q22.33,9q22.33,605202,"NANS, SAS, SEMDCG",N-acetylneuraminic acid synthase (sialic acid synthase),NANS,54187,ENSG00000095380,NA,"Spondyloepimetaphyseal dysplasia, Camera-Genevieve type, 610442 (3), Autosomal recessive",Nans (MGI:2149820)
9,98072013,98119419,9q22-q31,9q22.33,606556,"TRIM14, KIAA0129",Tripartite motif-containing protein 14,TRIM14,9830,ENSG00000106785,NA,NA,Trim14 (MGI:1921985)
9,98120974,98192636,9q22.3,9q22.33,602159,"CORO2A, WDR2, IR10",Coronin 2A,CORO2A,7464,ENSG00000106789,NA,NA,Coro2a (MGI:1345966)
9,98198997,98255720,9q22.3,9q22.33,609871,"TBC1D2, PARIS1","TBC1 domain family, member 2",TBC1D2,55357,ENSG00000095383,NA,NA,Tbc1d2 (MGI:2652885)
9,98288103,98708934,9q22.1,9q22.33,607340,"GABBR2, GPR51, EIEE59, NDPLHS",Gamma-aminobutyric acid B receptor 2,GABBR2,9568,ENSG00000136928,NA,"Epileptic encephalopathy, early infantile, 59, 617904 (3), Autosomal dominant; Neurodevelopmental disorder with poor language and loss of hand skills, 617903 (3), Autosomal dominant; {Nicotine dependence, protection against}, 188890 (3); {Nicotine dependence, susceptibility to}, 188890 (3)",Gabbr2 (MGI:2386030)
9,98732008,98796554,9q22.33,9q22.33,615370,"ANKS6, PKDR1, NPHP16",Ankyrin repeat and sterile alpha motif domains-containing protein 6,ANKS6,203286,ENSG00000165138,NA,"Nephronophthisis 16, 615382 (3), Autosomal recessive",Anks6 (MGI:1922941)
9,98807669,98850080,9q22,9q22.33,610290,"GALNT12, CRCS1",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12,GALNT12,79695,ENSG00000119514,NA,"{Colorectal cancer, susceptibility to, 1}, 608812 (3)",Galnt12 (MGI:2444664)
9,98943391,99070786,9q21-q22,9q22.33,120325,COL15A1,"Collagen XV, alpha-1 polypeptide",COL15A1,1306,ENSG00000204291,NA,NA,Col15a1 (MGI:88449)
9,99104037,99154191,9q22,9q22.33,190181,"TGFBR1, ALK5, AAT5, LDS1, MSSE","Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)",TGFBR1,7046,ENSG00000106799,NA,"Loeys-Dietz syndrome 1, 609192 (3), Autosomal dominant; {Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3), Autosomal dominant",Tgfbr1 (MGI:98728)
9,99216424,99221963,9q22,9q22.33,607905,"ALG2, CDGII, CMSTA3, CMS14","Alg2, S. cerevisiae, homolog of",ALG2,85365,ENSG00000119523,mutation identified in 1 CDGII patient,"?Congenital disorder of glycosylation, type Ii, 607906 (3), Autosomal recessive; Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3), Autosomal recessive",Alg2 (MGI:1914731)
9,99222281,99230614,9q22.33,9q22.33,609214,SEC61B,"Sec61 translocon, beta subunit",SEC61B,10952,ENSG00000106803,NA,NA,Sec61b (MGI:1913462)
9,99800000,105400000,9q31.1,NA,614954,CHDT3,"Congenital heart defects, multiple types, 3",NA,101154642,NA,max lod at D9S1690,"Congenital heart defects, multiple types, 3, 614954 (2), Autosomal dominant",NA
9,99800000,114900000,9q31-q32,NA,608026,HNP1,Hypertensive nephropathy,NA,574045,NA,NA,"Hypertensive nephropathy, 608026 (2)",NA
9,99800000,112100000,9q31,NA,600156,HSCR5,"Hirschsprung disease, susceptibility to, 5",NA,404720,NA,NA,"{Hirschsprung disease, susceptibility to, 5}, 600156 (2), Autosomal dominant",NA
9,99800000,112100000,9q31,NA,607853,PAND2,Panic disorder 2,NA,619493,NA,max lod at D9S271,"Panic disorder 2, 607853 (2)",NA
9,99800000,138394717,9q31-q34,NA,183840,SPDA2,"Spondyloarthropathy, susceptibility to, 2",NA,791255,NA,max lod at D9S1776,"{Spondyloarthropathy, susceptibility to, 2}, 183840 (2), Autosomal dominant",NA
9,99821854,99866892,9q22,9q31.1,600542,CSMF,"Chondrosarcoma, extraskeletal myxoid, fused to EWS in",NR4A3,8013,ENSG00000119508,t(9;17)(q22;q11); t(9;22)(q22;q11-q12),"Chondrosarcoma, extraskeletal myxoid, 612237 (3)",Nr4a3 (MGI:1352457)
9,99906653,99974540,9q31,9q31.1,604204,STX17,Syntaxin 17,STX17,55014,ENSG00000136874,NA,NA,Stx17 (MGI:1914977)
9,99979184,100098999,9q31.1,9q31.1,609170,"TXNDC4, KIAA0573",Thioredoxin domain-containing protein 4,ERP44,23071,ENSG00000023318,NA,NA,Erp44 (MGI:1923549)
9,100099184,100302174,9q31,9q31.1,243305,"INVS, INV, NPHP2, NPH2",Inversin,INVS,27130,ENSG00000119509,NA,"Nephronophthisis 2, infantile, 602088 (3), Autosomal recessive",Invs (MGI:1335082)
9,100302074,100352941,9q31.1,9q31.1,616717,TEX10,Testis-expressed gene 10,TEX10,54881,ENSG00000136891,NA,NA,Tex10 (MGI:1344413)
9,100473148,100577635,9q31,9q31.1,603421,"TMEFF1, C9orf2",Transmembrane protein with EGF-like and 2 follistatin-like domains 1,TMEFF1,8577,ENSG00000241697,NA,NA,Tmeff1 (MGI:1926810)
9,100578078,100588388,9q31,9q31.1,617714,"CAVIN4, MURC",Caveolae-associated protein 4,CAVIN4,347273,ENSG00000170681,NA,NA,Cavin4 (MGI:1915266)
9,101360416,101385005,9q22.3,9q31.1,602938,BAAT,Bile acid coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase),BAAT,570,ENSG00000136881,NA,"Hypercholanemia, familial, 607748 (3), Autosomal recessive",Baat (MGI:106642)
9,101387632,101398617,9q31.1,9q31.1,611854,MRPL50,Mitochondrial ribosomal protein L50,MRPL50,54534,ENSG00000136897,"pseudogenes on 2, 5, and 10",NA,Mrpl50 (MGI:107329)
9,101398829,101410659,9q22-q31,9q31.1,603132,ZNF189,Zinc finger protein-189,ZNF189,7743,ENSG00000136870,NA,NA,Zfp189 (MGI:2444707)
9,101420559,101435773,9q22.3,9q31.1,612724,ALDOB,"Aldolase B, fructose-bisphosphatase",ALDOB,229,ENSG00000136872,NA,"Fructose intolerance, hereditary, 229600 (3), Autosomal recessive",Aldob (MGI:87995)
9,101533852,101563343,9q31.1,9q31.1,607699,"RNF20, BRE1A",Ring finger protein 20,RNF20,56254,ENSG00000155827,NA,NA,Rnf20 (MGI:1925927)
9,101569351,101738579,9q31.1,9q31.1,606650,"GRIN3A, NR3A","Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A",GRIN3A,116443,ENSG00000198785,NA,NA,Grin3a (MGI:1933206)
9,101591603,101594968,9q31.1,9q31.1,613821,"PPP3R2, PPP3RL, CBLP","Protein phosphatase 3, regulatory subunit B, beta",PPP3R2,5535,ENSG00000188386,NA,NA,Ppp3r2 (MGI:107171)
9,102995332,103018487,9q31.1,9q31.1,604035,CYLC2,Cylicin 2,CYLC2,1539,ENSG00000155833,NA,NA,NA
9,104093759,104141418,Chr.9,9q31.1,605576,CAPE,Chromosome-associated protein E,SMC2,10592,ENSG00000136824,NA,NA,Smc2 (MGI:106067)
9,104747682,104760119,9q31.1,9q31.1,608871,"NIPSNAP3A, TASSC","NIPSNAP, C. elegans, homolog of, 3A",NIPSNAP3A,25934,ENSG00000136783,NA,NA,Nipsnap3b (MGI:1913786)
9,104781005,104928231,9q22-q31,9q31.1,600046,"ABCA1, ABC1, HDLDT1, TGD, HDLCQTL13",ATP-binding cassette 1,ABCA1,19,ENSG00000165029,NA,"HDL deficiency, type 2, 604091 (3); Tangier disease, 205400 (3), Autosomal recessive",Abca1 (MGI:99607)
9,105244604,105439774,9q31.2,9q31.1-q31.2,606105,"SLC44A1, CTL1, CDW92","Solute carrier family 44, member 1",SLC44A1,23446,ENSG00000070214,NA,NA,Slc44a1 (MGI:2140592)
9,105400000,134500000,9q31.2-q34.2,NA,612238,IS4,"Scoliosis, idiopathic, susceptibility to, 4",NA,100190785,NA,max lod at D9S2157,"{Scoliosis, idiopathic, susceptibility to, 4}, 612238 (2)",NA
9,105400000,108500000,9q31.2,NA,612883,MENAQ3,"Menarche, age at, QTL3",NA,100302563,NA,associated with rs2090409,"{Menarche, age at, QTL3}, 612883 (2)",NA
9,105442182,105552432,9q31,9q31.2,609829,"FSD1NL, FSD1L, MIR1, CCDC10",FSD1 N-terminus-like protein,FSD1L,83856,ENSG00000106701,NA,NA,Fsd1l (MGI:2442443)
9,105558116,105655949,9q31,9q31.2,607440,"FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4",Fukutin,FKTN,2218,ENSG00000106692,NA,"Cardiomyopathy, dilated, 1X, 611615 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3), Autosomal recessive",Fktn (MGI:2179507)
9,105662456,105663123,9q31,9q31.2,186855,TAL2,T-cell acute lymphocytic leukemia-2,TAL2,6887,ENSG00000186051,33kb from breakpoint in t(7;9),"Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)",Tal2 (MGI:99540)
9,105694540,105776628,9q31.2,9q31.2,611236,"TMEM38B, TRICB, OI14",Transmembrane protein 38B,TMEM38B,55151,ENSG00000095209,NA,"Osteogenesis imperfecta, type XIV, 615066 (3)",Tmem38b (MGI:1098718)
9,106860153,107013633,9q31.2,9q31.2,617371,"ZNF462, KIAA1803",Zinc finger protein 462,ZNF462,58499,ENSG00000148143,NA,NA,Zfp462 (MGI:107690)
9,107283278,107332193,9q31.2,9q31.2,600062,RAD23B,"RAD23 (Saccharomyces cerevisiae) homolog of, B",RAD23B,5887,ENSG00000119318,previously 3p25.1,NA,Rad23b (MGI:105128)
9,107484851,107489768,9q31,9q31.2,602253,"KLF4, EZF, GKLF",Kruppel-like factor 4,KLF4,9314,ENSG00000136826,NA,NA,Klf4 (MGI:1342287)
9,108854587,108855985,9q31,9q31.3,604304,ACTL7B,Actin-like 7B,ACTL7B,10880,ENSG00000148156,NA,NA,Actl7b (MGI:1343053)
9,108862265,108863755,9q31,9q31.3,604303,ACTL7A,Actin-like 7A,ACTL7A,10881,ENSG00000187003,NA,NA,Actl7a (MGI:1343051)
9,108867516,108934134,9q31,9q31.3,603722,"IKBKAP, IKAP","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase complex-associated protein",ELP1,8518,ENSG00000070061,NA,"Dysautonomia, familial, 223900 (3), Autosomal recessive",Elp1 (MGI:1914544)
9,108942568,109013534,9q31.2,9q31.3,604785,CTNNAL1,"Catenin, alpha-like, 1",CTNNAL1,8727,ENSG00000119326,NA,NA,Ctnnal1 (MGI:1859649)
9,109046228,109046297,9q31.3,9q31.3,609355,"MIR32, MIRN32",Micro RNA 32,MIR32,407036,ENSG00000207698,NA,NA,NA
9,109130292,109167290,9q31.3,9q31.3,604574,"FRRS1L, C9orf4, CG6, EIEE37",Ferric-chelate reductase 1-like,FRRS1L,23732,ENSG00000260230,NA,"Epileptic encephalopathy, early infantile, 37, 616981 (3), Autosomal recessive",Frrs1l (MGI:2442704)
9,109171973,109320963,9q31-q32,9q31.3,610340,"EPB41L4B, EHM2",Erythrocyte membrane protein band 4.1-like 4B,EPB41L4B,54566,ENSG00000095203,NA,NA,Epb41l4b (MGI:1859149)
9,109375693,109538394,9q31.3,9q31.3,176877,"PTPN3, PTPH1","Protein-tyrosine phosphatase, nonreceptor-type, 3",PTPN3,5774,ENSG00000070159,NA,NA,Ptpn3 (MGI:105307)
9,109640787,110172511,9q31-q33,9q31.3,604582,"AKAP2, AKAPKL, KIAA0920, PALM2",A-kinase anchor protein 2,PALM2-AKAP2,445815,ENSG00000157654,multiple splice variants,NA,NA
9,110243809,110256506,9q31,9q31.3,187700,TXN,Thioredoxin,TXN,7295,ENSG00000136810,incorrectly assigned to 3,NA,Txn1 (MGI:98874)
9,110300899,110337886,9q32,9q31.3,617789,"TXNDC8, SPTRX3",Thioredoxin domain-containing protein 8,TXNDC8,255220,ENSG00000204193,NA,NA,Txndc8 (MGI:1914652)
9,110365247,110579740,9q32,9q31.3,611691,"SVEP1, POLYDOM, SELOB","Sushi, von willebrand factor type A, EGF, and pentraxin domain-containing 1",SVEP1,79987,ENSG00000165124,NA,NA,Svep1 (MGI:1928849)
9,110668188,110806632,9q31.3-q32,9q31.3,601296,"MUSK, CMS9, FADS1",Receptor tyrosine kinase MuSK,MUSK,4593,ENSG00000030304,NA,"Fetal akinesia deformation sequence 1, 208150 (3), Autosomal recessive; Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3), Autosomal recessive",Musk (MGI:103581)
9,110873251,111038997,9q31.3,9q31.3,602282,"LPAR1, EDG2, LPA1, VZG1",Lysophosphatidic acid receptor 1,LPAR1,1902,ENSG00000198121,NA,NA,Lpar1 (MGI:108429)
9,111360684,111484382,9q31.3,9q31.3,616694,"KIAA0368, ECM29",KIAA0368 gene,ECPAS,23392,ENSG00000136813,NA,NA,Ecpas (MGI:2140220)
9,111549721,111599854,9q31.3,9q31.3,601274,"PTGR1, LTB4DH",Prostaglandin reductase 1,PTGR1,22949,ENSG00000106853,NA,NA,Ptgr1 (MGI:1914353)
9,111661604,111670225,9q31.3,9q31.3,604389,GNG10,"Guanine nucleotide-binding protein, gamma 10",GNG10,2790,ENSG00000242616,NA,NA,Gng10 (MGI:1336169)
9,111686170,111795948,9q31.3,9q31.3,618038,"C9orf84, SHOC1, ZIP2",Chromosome 9 open reading frame 84,SHOC1,158401,ENSG00000165181,NA,NA,Shoc1 (MGI:2140313)
9,111896765,111935368,9q31,9q31.3,602874,"UGCG, GCS",UDP-glucose ceramide glucosyltransferase,UGCG,7357,ENSG00000148154,NA,NA,Ugcg (MGI:1332243)
9,112100000,127500000,9q32-q33,NA,611488,ARMD10,"Macular degeneration, age-related, 10",NA,107880065,NA,NA,"Macular degeneration, age-related, 10, 611488 (2)",NA
9,112100000,127500000,9q32-q33,NA,608762,EIG3,"Epilepsy, idiopathic generalized, susceptibility to 3",NA,432400,NA,NA,"{Epilepsy, idiopathic generalized, susceptibility to, 3}, 608762 (2), Autosomal recessive",NA
9,112100000,114900000,9q32,NA,612259,IBD16,"Inflammatory bowel disease 16, susceptibility to",NA,100190930,NA,NA,"{Inflammatory bowel disease 16}, 612259 (2)",NA
9,112217714,112333668,Chr.9,9q32,607527,ROD1,Regulator of differentiation 1,PTBP3,9991,ENSG00000119314,NA,NA,Ptbp3 (MGI:1923334)
9,112486826,112669396,3q32,9q32,617390,KIAA1958,KIAA1958 gene,KIAA1958,158405,ENSG00000165185,NA,NA,NA
9,112683925,112718116,9q32,9q32,613273,"INIP, C9orf80, SOSSC",INST3- and NABP-interacting protein,INIP,58493,ENSG00000148153,NA,NA,Inip (MGI:1913459)
9,112878919,112895537,9q31-q34,9q32,608956,"SLC46A2, TSCOT","Solute carrier family 46, member 2",SLC46A2,57864,ENSG00000119457,NA,NA,Slc46a2 (MGI:1353616)
9,113038376,113056723,9q32,9q32,602951,ZFP37,"Zinc finger protein-37, mouse, homolog of",ZFP37,7539,ENSG00000136866,?candidate for Nager syndrome,NA,Zfp37 (MGI:99181)
9,113150975,113164139,9q31-q32,9q32,603088,"SLC13A2, COPT2, CTR2","Solute carrier family 31 (copper transporter), member 2",SLC31A2,1318,ENSG00000136867,NA,NA,Slc31a2 (MGI:1333844)
9,113161005,113221324,9q32,9q32,617398,"FKBP15, FKBP133, KIAA0674, WAFL",FK506-binding protein 15,FKBP15,23307,ENSG00000119321,NA,NA,Fkbp15 (MGI:2444782)
9,113221543,113264491,9q31-q32,9q32,603085,"SLC31A1, COPT1, CTR1","Solute carrier family 31 (copper transporter), member 1",SLC31A1,1317,ENSG00000136868,NA,NA,Slc31a1 (MGI:1333843)
9,113266991,113275578,9q32,9q32,614533,"CDC26, APC12","Cell division cycle 26, S. cerevisiae, homolog of",CDC26,246184,ENSG00000176386,pseudogene on 7q32.1,NA,Cdc26 (MGI:1913690)
9,113275633,113292904,9q31-q33,9q32,607795,"PRPF4, PRP4, HPRP4, RP70","Precursor mRNA-processing factor 4, S. cerevisiae, homolog of",PRPF4,9128,ENSG00000136875,NA,"Retinitis pigmentosa 70, 615922 (3), Autosomal dominant",Prpf4 (MGI:1917302)
9,113386311,113401337,9q34,9q32,125270,"ALAD, ALADH, PBGS","Aminolevulinate, delta-, dehydratase",ALAD,210,ENSG00000148218,linked to ABO; ORM-ALAD-AK-ABO,"{Lead poisoning, susceptibility to}, 612740 (3), Autosomal recessive; Porphyria, acute hepatic, 612740 (3), Autosomal recessive",Alad (MGI:96853)
9,113407234,113410748,9q33,9q32,607267,"POLE3, CHARAC17, YBL1","Polymerase, DNA, epsilon-3",POLE3,54107,ENSG00000148229,NA,NA,Pole3 (MGI:1933378)
9,113444729,113597742,9q31-q33,9q32,602189,RGS3,Regulator of G-protein signaling-3,RGS3,5998,ENSG00000138835,NA,NA,Rgs3 (MGI:1354734)
9,113876281,114056594,9q32,9q32,617077,"ZNF618, NEDD10, KIAA1952",Zinc finger protein 618,ZNF618,114991,ENSG00000157657,NA,NA,Zfp618 (MGI:1919950)
9,114060126,114078299,9q32-q33,9q32,176870,"AMBP, ITIL, ITI, HCP","Alpha-1-microglobulin/bikunin precursor (inter-alpha-trypsin inhibitor, light chain; protein HC)",AMBP,259,ENSG00000106927,NA,NA,Ambp (MGI:88002)
9,114091622,114100089,9q32,9q32,611278,KIF12,Kinesin family member 12,KIF12,113220,ENSG00000136883,NA,NA,Kif12 (MGI:1098232)
9,114154270,114312510,9q32,9q32,608461,"COL27A1, KIAA1870, STLS","Collagen, type XXVII, alpha-1",COL27A1,85301,ENSG00000196739,NA,"Steel syndrome, 615155 (3), Autosomal recessive",Col27a1 (MGI:2672118)
9,114323022,114326478,9q34.1-q34.3,9q32,138600,"ORM1, AGP1",Orosomucoid-1 (alpha-1-acid glycoprotein-1),ORM1,5004,ENSG00000229314,"linked to ABO, AK1, ALAD",NA,NA
9,114329788,114333255,9q34.1-q34.3,9q32,138610,ORM2,Orosomucoid-2,ORM2,5005,ENSG00000228278,NA,NA,NA
9,114402077,114505499,9q32-q34,9q32,607928,"WHRN, CIP98, KIAA1526, DFNB31, USH2D",Whirlin,WHRN,25861,ENSG00000095397,NA,"Deafness, autosomal recessive 31, 607084 (3), Autosomal recessive; Usher syndrome, type 2D, 611383 (3), Autosomal recessive",Whrn (MGI:2682003)
9,114587768,114598878,9q32,9q32,607296,"ATP6V1G1, ATP6G1","ATPase, H+ transporting, V1 subunit G1",ATP6V1G1,9550,ENSG00000136888,NA,NA,Atp6v1g1 (MGI:1913540)
9,114784634,114806038,9q32,9q32,604052,"TNFSF15, TL1, VEGI","Tumor necrosis factor ligand superfamily, member 15 (vascular endothelial growth inhibitor)",TNFSF15,9966,ENSG00000181634,NA,NA,Tnfsf15 (MGI:2180140)
9,114893342,114930673,9q33,9q32-q33,603875,"TNFSF8, CD30L, CD30LG","Tumor necrosis factor ligand superfamily, member 8 (CD30 ligand)",TNFSF8,944,ENSG00000106952,NA,NA,Tnfsf8 (MGI:88328)
9,114900000,127500000,9q33,NA,613207,ASRT8,"Asthma-related traits, susceptibility to, 8",NA,100415896,NA,associated with rs3789873,"{Asthma-related traits, susceptibility to, 8}, 613207 (2)",NA
9,115019574,115118243,9q33,9q33.1,187380,"TNC, HXB, DFNA56",Tenascin C (hexabrachion),TNC,3371,ENSG00000041982,proximal to ABL,"Deafness, autosomal dominant 56, 615629 (3), Autosomal dominant",Tnc (MGI:101922)
9,115141817,115402643,9q32,9q33.1,604767,DEC1,Deleted in esophageal cancer 1,DEC1,50514,ENSG00000173077,NA,NA,NA
9,116153751,116402320,9q33.1,9q33.1,176385,PAPPA,Pregnancy-associated plasma protein A,PAPPA,5069,ENSG00000182752,NA,NA,Pappa (MGI:97479)
9,116398156,116400605,9q33.1,9q33.1,610689,DIPAS,"DIPLA1, antisense",PAPPA-AS1,493913,ENSG00000256040,NA,NA,NA
9,116423111,117415056,9q33.1,9q33.1,612856,"ASTN2, KIAA0634",Astrotactin 2,ASTN2,23245,ENSG00000148219,NA,NA,Astn2 (MGI:1889277)
9,116687301,116701299,9q31-q34.1,9q33.1,602290,"TRIM32, HT2A, LGMDR8, BBS11",Tripartite-motif-containing protein 32,TRIM32,22954,ENSG00000119401,mutation identified in 1 BBS11 family,"?Bardet-Biedl syndrome 11, 615988 (3), Autosomal recessive; Muscular dystrophy, limb-girdle, autosomal recessive 8, 254110 (3), Autosomal recessive",Trim32 (MGI:1917057)
9,117704402,117724734,9q32-q33,9q33.1,603030,TLR4,Toll-like receptor-4,TLR4,7099,ENSG00000136869,NA,NA,Tlr4 (MGI:96824)
9,119166628,119369434,9q33.1,9q33.1,602865,"BRINP1, DBC1, DBCCR1",Bone morphogenetic protein/retinoic acid-inducible neural-specific protein 1,BRINP1,1620,ENSG00000078725,NA,NA,Brinp1 (MGI:1928478)
9,120388868,120580169,9q33.3,9q33.2,608201,"CDK5RAP2, KIAA1633, MCPH3",CDK5 regulatory subunit-associated protein 2,CDK5RAP2,55755,ENSG00000136861,NA,"Microcephaly 3, primary, autosomal recessive, 604804 (3), Autosomal recessive",Cdk5rap2 (MGI:2384875)
9,120600810,120714469,9q32-q33.3,9q33.2,604268,"MEGF9, EGFL5",Multiple epidermal growth factor-like domains 9,MEGF9,1955,ENSG00000106780,NA,NA,Megf9 (MGI:1918264)
9,120756973,120793461,9q34,9q33.2,609071,"FBXW2, FBW2, FWD2",F-box and WD40 domain protein 2,FBXW2,26190,ENSG00000119402,NA,NA,Fbxw2 (MGI:1353435)
9,120816052,120842921,9q33.2,9q33.2,604452,"PSMD5, S5B","Proteasome 26S subunit, non-ATPase, 5",PSMD5,5711,ENSG00000095261,NA,NA,Psmd5 (MGI:1914248)
9,120855650,120902159,9q33.3,9q33.2,609740,PHF19,PHD finger protein 19,PHF19,26147,ENSG00000119403,NA,NA,Phf19 (MGI:1921266)
9,120902392,120929172,9q33-q34,9q33.2,601711,TRAF1,TNF receptor-associated factor 2,TRAF1,7185,ENSG00000056558,NA,NA,Traf1 (MGI:101836)
9,120952334,121074864,9q34.1,9q33.2,120900,"C5, C5D, ECLZB",Complement component-5,C5,727,ENSG00000106804,NA,"C5 deficiency, 609536 (3); [Eculizumab, poor response to], 615749 (3), Autosomal dominant",Hc (MGI:96031)
9,121074891,121177609,9q33,9q33.2,605496,"CEP1, CEP110, FAN",Centrosomal protein 1,CNTRL,11064,ENSG00000119397,NA,NA,Cntrl (MGI:1889576)
9,121178132,121201868,9q33.2,9q33.2,612673,RAB14,Ras-associated protein,RAB14,51552,ENSG00000119396,NA,NA,Rab14 (MGI:1915615)
9,121201482,121332843,9q34,9q33.2,137350,GSN,Gelsolin,GSN,2934,ENSG00000148180,40kb proximal to ABL,"Amyloidosis, Finnish type, 105120 (3), Autosomal dominant",Gsn (MGI:95851)
9,121338986,121370303,9q34.1,9q33.2,133090,"STOM, EPB72, BND7",Stomatin (erythrocyte membrane protein band 7.2),STOM,2040,ENSG00000148175,proximal to ABL,NA,Stom (MGI:95403)
9,121455040,121500026,9q33-q34,9q33.2,104175,"GGTA1P, GGTA1","Glycoprotein, alpha-galactosyltransferase-1 pseudogene",GGTA1P,2681,ENSG00000204136,processed pseudogene GGTA1P on 12q14-q15,NA,NA
9,121566882,121785529,9q33,9q33.2,609205,"DAB2IP, AIP1, KIAA1743",DAB2-interacting protein,DAB2IP,153090,ENSG00000136848,NA,NA,Dab2ip (MGI:1916851)
9,122132465,122159778,9q33.2-q34.11,9q33.2,603359,NDUFA8,NADH-ubiquinone oxidoreductase subunit A8,NDUFA8,4702,ENSG00000119421,NA,NA,Ndufa8 (MGI:1915625)
9,122185625,122228956,9q33.2,9q33.2,608215,LHX6,LIM homeobox gene 6,LHX6,26468,ENSG00000106852,NA,NA,Lhx6 (MGI:1306803)
9,122264602,122331336,9q32-q34.1,9q33.2,604602,"MRFF, RRF","Ribosome-recycling factor, mitochondrial",MRRF,92399,ENSG00000148187,NA,NA,Mrrf (MGI:1915121)
9,122369905,122395702,9q32-q33.3,9q33.2,176805,"PTGS1, COX1, PGHS1, COX3, PCOX1",Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),PTGS1,5742,ENSG00000095303,NA,NA,Ptgs1 (MGI:97797)
9,122818096,122828587,Chr.9,9q33.2,604421,PDCL,Phosducin-like,PDCL,5082,ENSG00000136940,NA,NA,Pdcl (MGI:1914716)
9,122844555,122905358,9q34,9q33.2,615231,"RC3H2, MNAB",RING finger and CCCH-type zinc finger domains-containing protein 2,RC3H2,54542,ENSG00000056586,NA,NA,Rc3h2 (MGI:2442789)
9,122931639,123104868,9q33.2-q33.3,9q33.2-q33.3,615882,"RABGAP1, GAPCENA, TBC1D11",RAB GTPase-activating protein 1,RABGAP1,23637,ENSG00000011454,NA,NA,Rabgap1 (MGI:2385139)
9,123033634,123042750,9q33,9q33.2,601909,GPR21,G protein-coupled receptor-21,GPR21,2844,ENSG00000011454,NA,NA,Gpr21 (MGI:2441890)
9,123109493,123268585,9q34,9q33.3,611138,"STRBP, SPNR, p74",Spermatid perinuclear RNA-binding protein,STRBP,55342,ENSG00000165209,NA,NA,Strbp (MGI:104626)
9,123354064,123380325,9q33.3,9q33.3,609720,"CRB2, FSGS9, VMCKD","Crumbs, Drosophila, homolog of",CRB2,286204,ENSG00000148204,NA,"Focal segmental glomerulosclerosis 9, 616220 (3), Autosomal recessive; Ventriculomegaly with cystic kidney disease, 219730 (3), Autosomal recessive",Crb2 (MGI:2679260)
9,123379653,123930157,9q33.2,9q33.3,613633,"DENND1A, KIAA1608",DENN/MADD domain-containing protein 1A,DENND1A,57706,ENSG00000119522,NA,NA,Dennd1a (MGI:2442794)
9,124011758,124033300,9q33-q34.1,9q33.3,603759,"LHX2, LH2",LIM/homeodomain protein LHX2,LHX2,9355,ENSG00000106689,NA,NA,Lhx2 (MGI:96785)
9,124257605,124352441,9q33.3-q34.11,9q33.3,604884,NEK6,Never-in-mitosis gene A-related kinase 6,NEK6,10783,ENSG00000119408,NA,NA,Nek6 (MGI:1891638)
9,124353464,124415441,9q34.11-q34.12,9q33.3,604030,PSMB7,"Proteasome subunit, beta-type, 7",PSMB7,5695,ENSG00000136930,NA,NA,Psmb7 (MGI:107637)
9,124481235,124507398,9q33,9q33.3,184757,"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4","Nuclear receptor subfamily 5, group A, member 1",NR5A1,2516,ENSG00000136931,NA,"Adrenocortical insufficiency, 612964 (3), Autosomal dominant; Premature ovarian failure 7, 612964 (3), Autosomal dominant; Spermatogenic failure 8, 613957 (3), Autosomal dominant; 46, XX sex reversal 4, 617480 (3), Autosomal dominant; 46XY sex reversal 3, 612965 (3), Autosomal dominant",Nr5a1 (MGI:1346833)
9,124517274,124771310,9q33-q34.1,9q33.3,602778,GCNF,Germ cell nuclear factor,NR6A1,2649,ENSG00000148200,NA,NA,Nr6a1 (MGI:1352459)
9,124692441,124692550,9q33.3,9q33.3,612743,"MIR181A2, MIRN181A2",Micro RNA 181A2,MIR181A2,406954,ENSG00000207595,NA,NA,NA
9,124693709,124693797,9q33.3,9q33.3,612745,"MIR181B2, MIRN181B2",Micro RNA 181B2,MIR181B2,406956,ENSG00000207737,NA,NA,NA
9,124777132,124814890,9q33.3,9q33.3,615899,OLFML2A,Olfactomedin-like 2A,OLFML2A,169611,ENSG00000185585,NA,NA,Olfml2a (MGI:2444741)
9,124857882,124861956,9q33.3,9q33.3,618315,"RPL35, DBA19",Ribosomal protein L35,RPL35,11224,ENSG00000136942,mutation identified in 1 DBA19 family,"?Diamond-Blackfan anemia 19, 618312 (3)",Rpl35 (MGI:1913739)
9,124878274,124941406,9q33.3,9q33.3,602502,GOLGA1,"Golgi autoantigen, golgin subfamily A, 1",GOLGA1,2800,ENSG00000136935,NA,NA,Golga1 (MGI:1924149)
9,125146572,125189938,9q33.3,9q33.3,612725,PPP6C,"Protein phosphatase 6, catalytic subunit",PPP6C,5537,ENSG00000119414,highly related sequence on Xq22.3,NA,Ppp6c (MGI:1915107)
9,125234852,125241342,9q34,9q33.3,138120,"HSPA5, GRP78","Heat-shock 70kD protein-5 (glucose-regulated protein, 78kD)",HSPA5,3309,ENSG00000044574,NA,NA,Hspa5 (MGI:95835)
9,125261793,125367206,9q33.3,9q33.3,611714,"GAPVD1, RAP6, GAPEX5, KIAA1521",GTPase-activating protein and VPS9 domains 1,GAPVD1,26130,ENSG00000165219,NA,NA,Gapvd1 (MGI:1913941)
9,125437393,125707233,9q33.3,9q33.3,610558,"MAPKAP1, SIN1, MIP1, JC310",Mitogen-activated protein kinase-associated protein 1,MAPKAP1,79109,ENSG00000119487,NA,NA,Mapkap1 (MGI:2444554)
9,125747337,125967376,9q33-q34,9q33.3,176312,PBX3,Pre-B-cell leukemia transcription factor-3,PBX3,5090,ENSG00000167081,NA,NA,Pbx3 (MGI:97496)
9,126614442,126701031,9q34.1,9q33.3,602575,"LMX1B, NPS1","LIM homeo box transcription factor 1, beta",LMX1B,4010,ENSG00000136944,NA,"Nail-patella syndrome, 161200 (3), Autosomal dominant",Lmx1b (MGI:1100513)
9,126860638,126885877,9q33.3,9q33.3,611692,"ZBTB34, KIAA1993",Zinc finger- and BTB domain-containing protein 34,ZBTB34,403341,ENSG00000177125,NA,NA,Zbtb34 (MGI:2685195)
9,126914773,127223165,9q33.3,9q33.3,614444,"RALGPS1, RALGEF2, KIAA0351",Ral guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 1,RALGPS1,9649,ENSG00000136828,NA,NA,Ralgps1 (MGI:1922008)
9,127087347,127122683,9q33.3,9q33.3,605001,"ANGPTL2, ARP2",Angiopoietin-like 2,ANGPTL2,23452,ENSG00000136859,NA,NA,Angptl2 (MGI:1347002)
9,127397137,127407897,Chr.9,9q33.3,605245,"SLC2A8, GLUT8","Solute carrier family 2, (facilitated glucose transporter) member 8",SLC2A8,29988,ENSG00000136856,NA,NA,Slc2a8 (MGI:1860103)
9,127424373,127446288,9q34,9q33.3,194552,ZNF79,Zinc finger protein-79 (pT7),ZNF79,7633,ENSG00000196152,NA,NA,NA
9,127447673,127451405,9q33.3,9q33.3,180475,RPL12,Ribosomal protein L12,RPL12,6136,ENSG00000197958,NA,NA,Rpl12 (MGI:98002)
9,127451485,127503500,9q33.3-q34.11,9q33.3-q34.1,610933,"LRSAM1, TAL, RIFLE, CMT2P",Leucine-rich repeat- and sterile alpha motif-containing 1,LRSAM1,90678,ENSG00000148356,NA,"Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3), Autosomal recessive, Autosomal dominant",Lrsam1 (MGI:2684789)
9,127500000,133100000,9q34.1,NA,612557,CLLS3,"Leukemia, chronic lymphocytic, susceptibility to, 3",NA,100270642,NA,associated with SNP -6531 upstream of DAPK1 promoter,"{Leukemia, chronic lymphocytic, susceptibility to, 3}, 612557 (2)",NA
9,127500000,138394717,9q34,NA,614860,DYT23,Dystonia 23,NA,115029024,NA,linkage to D9S159 and D9S1818,"Dystonia 23, 614860 (2), Autosomal dominant",NA
9,127500000,138394717,9q34,NA,614623,KTCN6,Keratoconus 6,NA,100885802,NA,max lod at 159cM,"Keratoconus 6, 614623 (2), Autosomal dominant",NA
9,127505338,127579030,9q34.13,9q34.11,614045,"FAM129B, MINERVA","Family with sequence similarity 129, member B",NIBAN2,64855,ENSG00000136830,NA,NA,Fam129b (MGI:2442910)
9,127612276,127692935,9q34.1,9q34.11,602926,"STXBP1, UNC18, EIEE4",Syntaxin-binding protein 1,STXBP1,6812,ENSG00000136854,NA,"Epileptic encephalopathy, early infantile, 4, 612164 (3), Autosomal dominant",Stxbp1 (MGI:107363)
9,127731523,127735327,9q34.11,9q34.11,608052,"TOR2A, TORP1",Torsin 2A,TOR2A,27433,ENSG00000160404,NA,NA,Tor2a (MGI:1353596)
9,127738316,127778665,9q34.11,9q34.11,604722,"SH2D3C, NSP3",SH2 domain-containing protein 3C,SH2D3C,10044,ENSG00000095370,NA,NA,Sh2d3c (MGI:1351631)
9,127785917,127786006,9q34.11,9q34.11,613405,"MIR2861, MIRN2861, BMND15",Micro RNA 2861,MIR2861,100422910,ENSG00000284547,NA,"[Bone mineral density QTL 15], 613418 (3), Autosomal recessive, Autosomal dominant",NA
9,127786033,127790791,9q34.1,9q34.11,603251,"CDK9, CDC2L4",Cyclin-dependent kinase-9,CDK9,1025,ENSG00000136807,NA,NA,Cdk9 (MGI:1328368)
9,127802857,127814519,9cen-q34,9q34.11,136510,FPGS,Folylpolyglutamate synthetase,FPGS,2356,ENSG00000136877,NA,NA,Fpgs (MGI:95576)
9,127815011,127854772,9q34.1,9q34.11,131195,"ENG, END, HHT1, ORW",Endoglin,ENG,2022,ENSG00000106991,NA,"Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3), Autosomal dominant",Eng (MGI:95392)
9,127866479,127885541,9q34.1,9q34.11,103000,AK1,Adenylate kinase-1,AK1,203,ENSG00000106992,"proximal to Ph1 break, 9q34.1; AK1 to ORM = 17cM","Hemolytic anemia due to adenylate kinase deficiency, 612631 (3), Autosomal recessive",Ak1 (MGI:87977)
9,127885320,127906763,9q34.11,9q34.11,610135,"ST6GALNAC6, SIAT7F","ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6",ST6GALNAC6,30815,ENSG00000160408,NA,NA,St6galnac6 (MGI:1355316)
9,127907885,127917051,9q31,9q34.11,606378,"SIAT7D, SIAT3C",Sialyltransferase 7D,ST6GALNAC4,27090,ENSG00000136840,NA,NA,St6galnac4 (MGI:1341894)
9,127920880,127931957,9q34.11,9q34.11,612865,"PIP5KL1, PIPKH",Phosphatidylinositol-4-phosphate-5-kinase-like 1,PIP5KL1,138429,ENSG00000167103,NA,NA,Pip5kl1 (MGI:2448520)
9,127935094,127938483,9q34.11,9q34.11,603564,"DPM2, CDG1U","Dolichyl-phosphate mannosyltransferase 2, regulatory subunit",DPM2,8818,ENSG00000136908,NA,"Congenital disorder of glycosylation, type Iu, 615042 (3), Autosomal recessive",Dpm2 (MGI:1330238)
9,127940581,127980988,9q34.13,9q34.11,610891,"FAM102A, EEIG1","Family with sequence similarity 102, member A",FAM102A,399665,ENSG00000167106,NA,NA,Fam102a (MGI:2138935)
9,128061232,128067866,9q34.11,9q34.11,610673,"C9orf90, NAIF1",Nuclear apoptosis-inducing factor 1,NAIF1,203245,ENSG00000171169,NA,NA,Naif1 (MGI:1918504)
9,128120692,128128461,9q34.13,9q34.11,608152,"PTGES2, PGES2, GBF1",Prostaglandin E synthase 2,PTGES2,80142,ENSG00000148334,NA,NA,Ptges2 (MGI:1917592)
9,128149452,128153452,9q34,9q34.11,600181,"LCN2, NGAL",Lipocalin 2 (oncogene 24p3),LCN2,3934,ENSG00000148346,NA,NA,Lcn2 (MGI:96757)
9,128166064,128204221,9q34,9q34.11,611420,"CIZ1, ZNF356, LSFR1, NP94",CDKN1A-interacting zinc finger protein 1,CIZ1,25792,ENSG00000148337,NA,NA,Ciz1 (MGI:1920234)
9,128203378,128255243,9q34,9q34.11,602377,"DNM1, EIEE31",Dynamin-1,DNM1,1759,ENSG00000106976,NA,"Epileptic encephalopathy, early infantile, 31, 616346 (3), Autosomal dominant",Dnm1 (MGI:107384)
9,128244720,128244829,9q34.11,9q34.11,614791,MIR199B,Micro RNA 199B,MIR199B,406978,ENSG00000207581,NA,NA,NA
9,128255828,128275999,9q34.11,9q34.11,602580,"GOLGA2, GM130","Golgi autoantigen, golgin subfamily A, 2",GOLGA2,2801,ENSG00000167110,NA,NA,Golga2 (MGI:2139395)
9,128275363,128288989,9q34.11,9q34.11,616528,"SWI5, SAE3, C9orf119",SWi5 homologous recombination repair protein,SWI5,375757,ENSG00000175854,NA,NA,Swi5 (MGI:1920181)
9,128305158,128322779,9q34.11,9q34.11,610727,TRUB2,"TRUB pseudouridine synthase, E. coli, homolog of, 2",TRUB2,26995,ENSG00000167112,NA,NA,Trub2 (MGI:2442186)
9,128322485,128334071,9q34.13,9q34.11,612898,"COQ4, COQ10D7","Coenzyme Q4, S. cerevisiae, homolog of",COQ4,51117,ENSG00000167113,NA,"Coenzyme Q10 deficiency, primary, 7, 616276 (3), Autosomal recessive",Coq4 (MGI:1098826)
9,128340515,128361469,9q34,9q34.11,604194,"SLC27A4, FATP4, IPS","Solute carrier family 27 (fatty acid transporter), member 4",SLC27A4,10999,ENSG00000167114,NA,"Ichthyosis prematurity syndrome, 608649 (3)",Slc27a4 (MGI:1347347)
9,128371318,128392015,9q34.11,9q34.11,612693,URM1,"Ubiquitin-related modifier 1, S. cerevisiae, homolog of",URM1,81605,ENSG00000167118,NA,NA,Urm1 (MGI:1915455)
9,128405993,128437350,9q34.11,9q34.11,616626,CERCAM,Cerebral endothelial cell adhesion molecule,CERCAM,51148,ENSG00000167123,NA,NA,Cercam (MGI:2139134)
9,128455154,128501291,9q34,9q34.11,602015,"ODF2, ODF84",Outer dense fiber of sperm tails 2,ODF2,4957,ENSG00000136811,NA,NA,Odf2 (MGI:1098824)
9,128504691,128542300,9q34,9q34.11,603371,"GLE1, GLE1L, LCCS, LCCS1, CAAHD","Gle1, RNA export mediator, S. cerevisiae, homolog of",GLE1,2733,ENSG00000119392,NA,"Congenital arthrogryposis with anterior horn cell disease, 611890 (3), Autosomal recessive; Lethal congenital contracture syndrome 1, 253310 (3), Autosomal recessive",Gle1 (MGI:1921662)
9,128552563,128633661,9q33-q34,9q34.11,182810,"SPTAN1, NEAS, EIEE5","Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)",SPTAN1,6709,ENSG00000197694,NA,"Epileptic encephalopathy, early infantile, 5, 613477 (3), Autosomal dominant",Sptan1 (MGI:98386)
9,128633652,128656849,9q34.11,9q34.11,613363,"WDR34, SRTD11",WD repeat-containing protein 34,WDR34,89891,ENSG00000119333,NA,"Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3), Autosomal recessive",Wdr34 (MGI:1919070)
9,128683431,128696395,9q34,9q34.11,600960,"SET, MRD58",SET gene,SET,6418,ENSG00000119335,fused with CAIN in acute undifferentiated leukemia,"Mental retardation, autosomal dominant 58, 618106 (3), Autosomal dominant",Set (MGI:1860267)
9,128702496,128720917,9q34.11,9q34.11,610714,PKN3,Protein kinase N3,PKN3,29941,ENSG00000160447,NA,NA,Pkn3 (MGI:2388285)
9,128729785,128772506,9q34.11,9q34.11,617764,"ZER1, ZYG11BL, C9orf60",Zyg11-related cell cycle regulator,ZER1,10444,ENSG00000160445,NA,NA,Zer1 (MGI:2442511)
9,128787206,128810431,9q34.11,9q34.11,616218,TBC1D13,"TBC1 domain family, member 13",TBC1D13,54662,ENSG00000107021,NA,NA,Tbc1d13 (MGI:2385326)
9,128818401,128822675,9q34.1,9q34.11,600440,ENDOG,Endonuclease G,ENDOG,2021,ENSG00000167136,NA,NA,Endog (MGI:1261433)
9,128819650,128833308,9q34.11,9q34.11,617614,"SPOUT1, CENP32, C9orf114",SPOUT domain-containing methyltransferase 1,SPOUT1,51490,ENSG00000198917,NA,NA,Spout1 (MGI:106544)
9,128832941,128882557,9q34.11,9q34.11,600547,CCBL1,Cysteine conjugate beta-lyase 1,KYAT1,883,ENSG00000171097,NA,NA,Kyat1 (MGI:1917516)
9,128882111,128918041,9q34.13,9q34.11,608360,"LRRC8A, KIAA1437, AGM5",Leucine-rich repeat-containing 8A,LRRC8A,56262,ENSG00000136802,mutation identified in 1 AGM5 patient,"?Agammaglobulinemia 5, 613506 (3), Autosomal dominant",Lrrc8a (MGI:2652847)
9,128945529,128947732,9q34.11,9q34.11,610746,"DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M",Dolichol kinase,DOLK,22845,ENSG00000175283,NA,"Congenital disorder of glycosylation, type Im, 610768 (3), Autosomal recessive",Dolk (MGI:2677836)
9,128947698,129007095,9q34.11,9q34.11,615587,"NUP188, KIAA1069","Nucleoporin, 188kD",NUP188,23511,ENSG00000095319,NA,NA,Nup188 (MGI:2446190)
9,129080987,129090437,9q34.1,9q34.11,614516,"DOLPP1, LSFR2",Dolichyl pyrophosphate phosphatase 1,DOLPP1,57171,ENSG00000167130,NA,NA,Dolpp1 (MGI:1914093)
9,129094793,129110792,9q34.1,9q34.11,600184,"CRAT, CAT1, NBIA8",Carnitine acetyltransferase,CRAT,1384,ENSG00000095321,mutation identified in 1 NBIA8 patient,"?Neurodegeneration with brain iron accumulation 8, 617917 (3), Autosomal recessive",Crat (MGI:109501)
9,129110948,129148945,9q34,9q34.11,600756,"PPP2R4, PTPA","Protein phosphatase-2A, regulatory subunit B' (PR 53)",PTPA,5524,ENSG00000119383,proximal to ABL,NA,Ptpa (MGI:1346006)
9,129608883,129636741,9q34.11,9q34.11,613560,"NTMT1, METTL11A, NRMT, C9orf32",N-terminal X-Pro-Lys N-methyltransferase 1,NTMT1,28989,ENSG00000148335,NA,NA,Ntmt1 (MGI:1913867)
9,129634603,129642168,9q34.11,9q34.11,615051,ASB6,Ankyrin repeat- and SOCS box-containing protein 6,ASB6,140459,ENSG00000148331,NA,NA,Asb6 (MGI:1919573)
9,129665646,129722673,9q34.1,9q34.11,604675,"PRRX2, PRX2",Paired-related homeo box gene 2,PRRX2,51450,ENSG00000167157,NA,NA,Prrx2 (MGI:98218)
9,129738348,129753041,9q34.3,9q34.11,605172,"PTGES, PGES, PIG12, MGST1L1",Prostaglandin E synthase,PTGES,9536,ENSG00000148344,NA,NA,Ptges (MGI:1927593)
9,129803142,129811423,9q34,9q34.11,608050,"TOR1B, DQ1",Torsin 1B,TOR1B,27348,ENSG00000136816,centromeric to TOR1A; pseudogene on chr.2,NA,Tor1b (MGI:1353605)
9,129812941,129824135,9q34,9q34.11,605204,"DYT1, TOR1A",Torsin A,TOR1A,1861,ENSG00000136827,NA,"{Dystonia-1, modifier of} (3); Dystonia-1, torsion, 128100 (3), Autosomal dominant",Tor1a (MGI:1353568)
9,129835416,129881837,9q34.11,9q34.11,615143,"USP20, VDU2",Ubiquitin-specific protease 20,USP20,10868,ENSG00000136878,NA,NA,Usp20 (MGI:1921520)
9,129887186,130053845,9q34,9q34.11,606191,"FNBP1, FBP17",Formin-binding protein 17,FNBP1,23048,ENSG00000187239,fused with MLL in chronic myeloid leukemia,NA,Fnbp1 (MGI:109606)
9,130172403,130237302,9q34,9q34.11,603315,"FREQ, NCS1","Frequenin, Drosophila, homolog of",NCS1,23413,ENSG00000107130,NA,NA,Ncs1 (MGI:109166)
9,130444706,130501273,9q34.1,9q34.11,603470,"ASS1, ASS",Argininosuccinate synthetase 1,ASS1,445,ENSG00000130707,"14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12","Citrullinemia, 215700 (3), Autosomal recessive",Ass1 (MGI:88090)
9,130579576,130638351,9q34.11-q34.12,9q34.11-q34.12,603536,"FUBP3, FBP3",FAR upstream element-binding protein 3,FUBP3,8939,ENSG00000107164,NA,NA,Fubp3 (MGI:2443699)
9,130664593,130682982,9q34.1,9q34.12,616458,"PRDM12, HSAN8",PR domain-containing protein 12,PRDM12,59335,ENSG00000130711,NA,"Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3), Autosomal recessive",Prdm12 (MGI:2685844)
9,130693759,130704893,9q34.12,9q34.12,602238,"EXOSC2, RRP4, SHRF",Exosome component 2,EXOSC2,23404,ENSG00000130713,NA,"Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3), Autosomal recessive",Exosc2 (MGI:2385133)
9,130713880,130887674,9q34.1,9q34.12,189980,"ABL1, CHDSKM",Abelson murine leukemia viral (v-abl) oncogene homolog 1,ABL1,25,ENSG00000097007,fusion hybrid gene with BCR1 in CML,"Congenital heart defects and skeletal malformations syndrome, 617602 (3), Autosomal dominant; Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)",Abl1 (MGI:87859)
9,130892706,130896811,9q34.12,9q34.12,609795,"QRFP, P518, 26RFA",Pyroglutamylated FR-amide peptide precursor protein,QRFP,347148,ENSG00000188710,NA,NA,Qrfp (MGI:3630329)
9,130902437,130939246,9q34.1,9q34.12,613357,FIBCD1,Fibrinogene C domain-containing protein 1,FIBCD1,84929,ENSG00000130720,NA,NA,Fibcd1 (MGI:2138953)
9,131009173,131094472,9q33-q34,9q34.12,604349,"LAMC3, OCCM","Laminin, gamma-3",LAMC3,10319,ENSG00000050555,NA,"Cortical malformations, occipital, 614115 (3), Autosomal recessive",Lamc3 (MGI:1344394)
9,131100000,133100000,9q34.13,NA,171720,ALPQTL1,"Alkaline phosphatase, plasma level of, QTL 1",NA,100196909,NA,linkage with rs657152,"{Alkaline phosphatase, plasma level of, QTL1}, 171720 (2), ?Autosomal dominant",NA
9,131125585,131234662,9q34.1,9q34.13,114350,"NUP214, D9S46E, CAN, CAIN, IIAE9","Nucleoporin, 214kD",NUP214,8021,ENSG00000126883,fused with DEK in AML; fused with ABL1 in T-ALL,"{Encephalopathy, acute, infection-induced, suseptibility to, 9}, 618426 (3), Autosomal recessive; Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3); Leukemia, acute myeloid, somatic, 601626 (3)",Nup214 (MGI:1095411)
9,131502901,131523805,9q34.1,9q34.13,607423,"POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11",Protein O-mannosyltransferase 1,POMT1,10585,ENSG00000130714,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3), Autosomal recessive",Pomt1 (MGI:2138994)
9,131523795,131531274,9q34.2,9q34.13,609328,UCK1,Uridine/cytidine kinase 1,UCK1,83549,ENSG00000130717,NA,NA,Uck1 (MGI:98904)
9,131576769,131740067,9q34.3,9q34.13,600303,"RAPGEF1, GRF2, C3G",RAP guanine nucleotide exchange factor 1,RAPGEF1,2889,ENSG00000107263,NA,NA,Rapgef1 (MGI:104580)
9,131860109,132079866,9q34,9q34.13,605044,"MED27, CRSP8, CRAP34",Mediator complex subunit 27,MED27,9442,ENSG00000160563,NA,NA,Med27 (MGI:1916225)
9,132261355,132356725,9q34,9q34.13,608465,"SETX, SCAN2, AOA2, ALS4",Senataxin,SETX,23064,ENSG00000107290,NA,"Amyotrophic lateral sclerosis 4, juvenile, 602433 (3), Autosomal dominant; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, 606002 (3), Autosomal recessive",Setx (MGI:2443480)
9,132375547,132406850,9q34.13,9q34.13,600777,TTF1,"Transcription termination factor, RNA polymerase I",TTF1,7270,ENSG00000125482,NA,NA,NA
9,132582605,132590251,9q34,9q34.13,605211,BARHL1,BARH-like 1,BARHL1,56751,ENSG00000125492,NA,NA,Barhl1 (MGI:1859288)
9,132592996,132670400,9q34.13,9q34.13,616533,"DDX31, PPP1R25",DEAD box polypeptide 31,DDX31,64794,ENSG00000125485,NA,NA,Ddx31 (MGI:2682639)
9,132725573,132878810,9q34.13,9q34.13,615365,AK8,Adenylate kinase 8,AK8,158067,ENSG00000165695,NA,NA,Ak8 (MGI:1916120)
9,132891347,132945268,9q34,9q34.13,605284,"TSC1, LAM",Hamartin (tuberous sclerosis 1 gene),TSC1,7248,ENSG00000165699,"linked to ABO, ABL","Focal cortical dysplasia, type II, somatic, 607341 (3); Lymphangioleiomyomatosis, 606690 (3); Tuberous sclerosis-1, 191100 (3), Autosomal dominant",Tsc1 (MGI:1929183)
9,132945544,132991696,9q34.13,9q34.13,604383,"GFI1B, BDPLT17",Growth factor-independent 1B,GFI1B,8328,ENSG00000165702,NA,"Bleeding disorder, platelet-type, 17, 187900 (3), Autosomal recessive, Autosomal dominant",Gfi1b (MGI:1276578)
9,133030674,133058502,9q34.2,9q34.13,604890,"GTF3C5, TFIIIC63","General transcription factor 3C, polypeptide 5",GTF3C5,9328,ENSG00000148308,NA,NA,Gtf3c5 (MGI:1917489)
9,133061981,133071860,9q34.3,9q34.13,114840,"CEL, BSSL, CELL, MODY8",Carboxyl-ester lipase (bile-salt stimulated lipase),CEL,1056,ENSG00000170835,NA,"Maturity-onset diabetes of the young, type VIII, 609812 (3), Autosomal dominant",Cel (MGI:88374)
9,133097721,133149209,9q34,9q34.1-q34.2,601619,RALGDS,ral guanine nucleotide dissociation stimulator,RALGDS,5900,ENSG00000160271,NA,NA,Ralgds (MGI:107485)
9,133152947,133163913,9q34,9q34.2,606074,"GBGT1, FS","Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (Forssman synthetase)",GBGT1,26301,ENSG00000148288,NA,NA,Gbgt1 (MGI:2449143)
9,133205278,133223254,9q34,9q34.2,604606,OBP2B,Odorant-binding protein 2B,OBP2B,29989,ENSG00000171102,NA,NA,Obp2a (MGI:2387617)
9,133250400,133275200,9q34,9q34.2,110300,ABO,ABO glycosyltransferase,ABO,28,ENSG00000175164,linked to AK1,"[Blood group, ABO system], 616093 (3)",Abo (MGI:2135738)
9,133328775,133336209,9q34,9q34.2,185642,SURF6,Surfeit-6,SURF6,6838,ENSG00000148296,NA,NA,Surf6 (MGI:98447)
9,133338311,133348155,9q34,9q34.2,185641,SURF5,Surfeit-5,MED22,6837,ENSG00000148297,NA,NA,Med22 (MGI:98446)
9,133348217,133351425,9q34,9q34.2,185640,"RPL7A, SURF3",Ribosomal protein L7a (surfeit-3),RPL7A,6130,ENSG00000148303,in cluster with SURF1,NA,Rpl7a (MGI:1353472)
9,133351757,133356486,9q34,9q34.2,185620,"SURF1, CMT4K",Surfeit-1,SURF1,6834,ENSG00000148290,"distal to ABL, CAN","Charcot-Marie-Tooth disease, type 4K, 616684 (3), Autosomal recessive; Leigh syndrome, due to COX IV deficiency, 256000 (3), Autosomal recessive, Mitochondrial",Surf1 (MGI:98443)
9,133356549,133361157,9q34,9q34.2,185630,SURF2,Surfeit-2,SURF2,6835,ENSG00000148291,NA,NA,Surf2 (MGI:98444)
9,133361448,133377948,9q34,9q34.2,185660,SURF4,Surfeit-4,SURF4,6836,ENSG00000148248,NA,NA,Surf4 (MGI:98445)
9,133406057,133418171,9q34,9q34.2,602930,"REXO4, XPMC2H","RNA exonuclease 4, S. cerevisiae, homolog of",REXO4,57109,ENSG00000148300,NA,NA,Rexo4 (MGI:2684957)
9,133414338,133459402,9q34,9q34.2,604134,"ADAMTS13, VWFCP, TTP","A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 13",ADAMTS13,11093,ENSG00000160323,NA,"Thrombotic thrombocytopenic purpura, familial, 274150 (3), Autosomal recessive",Adamts13 (MGI:2685556)
9,133459964,133470843,9q34.2,9q34.2,613104,"CACFD1, FLOWER, C9orf7",Calcium channel FLOWER-domain containing protein 1,CACFD1,11094,ENSG00000160325,NA,NA,Cacfd1 (MGI:1924317)
9,133471093,133479126,9q34,9q34.2,606813,SLC2A6,"Solute carrier family 2, member 6",SLC2A6,11182,ENSG00000160326,NA,NA,Slc2a6 (MGI:2443286)
9,133514585,133524958,9q34.2,9q34.2,615345,"MYMK, TMEM8C",Myomaker,MYMK,389827,ENSG00000187616,NA,"Carey-Fineman-Ziter syndrome, 254940 (3), Autosomal recessive",Mymk (MGI:1913389)
9,133532163,133575518,9q34.2,9q34.2,612277,"ADAMTSL2, KIAA0605, GPHYSD1",ADAMTS-like protein 2,ADAMTSL2,9719,ENSG00000197859,NA,"Geleophysic dysplasia 1, 231050 (3), Autosomal recessive",Adamtsl2 (MGI:1925044)
9,133636362,133659328,9q34,9q34.2,609312,"DBH, ORTHYP1",Dopamine-beta-hydroxylase,DBH,1621,ENSG00000123454,tightly linked to ABO,"Orthostatic hypotension 1, due to DBH deficiency, 223360 (3), Autosomal recessive",Dbh (MGI:94864)
9,133663073,133739957,9q34.2,9q34.2,604455,"SARDH, SARD, SAR",Sarcosine dehydrogenase,SARDH,1757,ENSG00000123453,NA,"[Sarcosinemia], 268900 (3), Autosomal recessive",Sardh (MGI:2183102)
9,133761893,133992373,9q34,9q34.2,600428,VAV2,Oncogene VAV2,VAV2,7410,ENSG00000160293,NA,NA,Vav2 (MGI:102718)
9,134030304,134068532,9q34,9q34.2,601541,"RING3L, ORFX",RING3-like gene (open reading frame X),BRD3,8019,ENSG00000169925,NA,NA,Brd3 (MGI:1914632)
9,134164439,134164563,9q34.2,9q34.2,601429,"RNU6ATAC, U6ATAC","RNA, U6ATAC small nuclear",RNU6ATAC,100151684,ENSG00000221676,NA,NA,NA
9,134326454,134440585,9q34.3,9q34.2,180245,RXRA,"Retinoid X receptor, alpha",RXRA,6256,ENSG00000186350,distal to DBH,NA,Rxra (MGI:98214)
9,134641788,134844842,9q34.2-q34.3,9q34.3,120215,"COL5A1, EDSCL1","Collagen V, alpha-1 polypeptide",COL5A1,1289,ENSG00000130635,NA,"Ehlers-Danlos syndrome, classic type, 1, 130000 (3), Autosomal dominant",Col5a1 (MGI:88457)
9,134864061,134890505,9q34,9q34.3,601624,FCN2,Ficolin (collagen/fibrinogen domain-containing lectin) 2,FCN2,2220,ENSG00000160339,NA,NA,NA
9,134903231,134917911,9q34,9q34.3,601252,FCN1,Ficolin (collagen/fibrinogen domain-containing) 1,FCN1,2219,ENSG00000085265,NA,NA,Fcnb (MGI:1341158)
9,135075504,135121183,Chr.9,9q34.3,605366,"OLFM1, AMY",Olfactomedin 1,OLFM1,10439,ENSG00000130558,NA,NA,Olfm1 (MGI:1860437)
9,135477649,135488893,9q34.3,9q34.3,614056,"PPP1R26, KIAA0649","Protein phosphatase 1, regulatory subunit 26",PPP1R26,9858,ENSG00000196422,NA,NA,Ppp1r26 (MGI:2685193)
9,135495180,135499868,9q34.3,9q34.3,614502,"C9orf116, PIERCE1",p53-induced expression in RB-null cells 1,C9orf116,138162,ENSG00000160345,NA,NA,1700007K13Rik (MGI:1916577)
9,135499988,135504672,9q34,9q34.3,611971,"MRPS2, COXPD36",Mitochondrial ribosomal protein S2,MRPS2,51116,ENSG00000122140,NA,"Combined oxidative phosphorylation deficiency 36, 617950 (3), Autosomal recessive",Mrps2 (MGI:2153089)
9,135521295,135526539,9q34,9q34.3,151675,LCN1,"Lipocalin 1 (protein migrating faster than albumin, tear prealbumin)",LCN1,3933,ENSG00000160349,NA,NA,NA
9,135544811,135549968,9q34,9q34.3,164320,OBP2A,Odorant-binding protein 2A,OBP2A,29991,ENSG00000122136,NA,NA,Obp2b (MGI:3651927)
9,135561626,135566954,9q34,9q34.3,173310,"PAEP, PP14",Progestagen-associated endometrial protein (placental protein 14),PAEP,5047,ENSG00000122133,NA,NA,NA
9,135623647,135641223,9q34.3,9q34.3,613699,"GLT6D1, GT6M7, GLTDC1",Glycosyltransferase 6 domain-containing 1,GLT6D1,360203,ENSG00000204007,NA,NA,Glt6d1 (MGI:1918353)
9,135663321,135670730,9q34,9q34.3,612903,LCN9,Lipocalin 9,LCN9,392399,ENSG00000148386,NA,NA,Lcn9 (MGI:1924954)
9,135691861,135702111,9q34.3,9q34.3,610224,"SOHLH1, NOHLH, TEB2, ODG5, SPGF32",Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 1,SOHLH1,402381,ENSG00000165643,NA,"Ovarian dysgenesis 5, 617690 (3), Autosomal recessive; Spermatogenic failure 32, 618115 (3), Autosomal dominant",Sohlh1 (MGI:2684956)
9,135702184,135795501,9q34.3,9q34.3,608167,"KCNT1, KIAA1422, EIEE14, ENFL5","Potassium channel, subfamily T, member 1",KCNT1,57582,ENSG00000107147,NA,"Epilepsy, nocturnal frontal lobe, 5, 615005 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 14, 614959 (3), Autosomal dominant",Kcnt1 (MGI:1924627)
9,135808486,135907550,9q34.3,9q34.3,613774,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,CAMSAP1,157922,ENSG00000130559,NA,NA,Camsap1 (MGI:3036242)
9,135932968,135961372,9q34.3,9q34.3,608129,"UBAC1, GBDR1",Ubiquitin-associated domain-containing protein 1,UBAC1,10422,ENSG00000130560,NA,NA,Ubac1 (MGI:1920995)
9,136006536,136095288,9q34.3,9q34.3,615786,"NACC2, RBB","NACC family, member 2, BEN and BTB/POZ domains-containing",NACC2,138151,ENSG00000148411,NA,NA,Nacc2 (MGI:1915241)
9,136196249,136205127,9q34.3,9q34.3,600577,"LHX3, CPHD3",LIM/homeodomain protein LHX3,LHX3,8022,ENSG00000107187,"in mouse, close to Notch1; centromeric to ABL","Pituitary hormone deficiency, combined, 3, 221750 (3), Autosomal recessive",Lhx3 (MGI:102673)
9,136206332,136245840,9q34.3,9q34.3,612860,"QSOX2, SOXN",Quiescin Q6 sulfhydryl oxidase 2,QSOX2,169714,ENSG00000165661,NA,NA,Qsox2 (MGI:2387194)
9,136363955,136373680,9q34.3,9q34.3,607212,"CARD9, CANDF2",Caspase recruitment domain-containing protein 9,CARD9,64170,ENSG00000187796,NA,"Candidiasis, familial, 2, autosomal recessive, 212050 (3), Autosomal recessive",Card9 (MGI:2685628)
9,136375568,136400219,9q34.3,9q34.3,602777,"SNAPC4, SNAP190","Small nuclear RNA-activating protein complex, polypeptide 4",SNAPC4,6621,ENSG00000165684,NA,NA,Snapc4 (MGI:2443935)
9,136410572,136423760,9q34.3,9q34.3,613036,"PMPCA, KIAA0123, SCAR2","Peptidase, mitochondrial processing, alpha",PMPCA,23203,ENSG00000165688,NA,"Spinocerebellar ataxia, autosomal recessive 2, 213200 (3), Autosomal recessive",Pmpca (MGI:1918568)
9,136428618,136439860,9q34.3,9q34.3,613037,"INPP5E, MORMS, JBTS1, CORS1","Inositol polyphosphate-5-phosphatase, 72kD",INPP5E,56623,ENSG00000148384,NA,"Joubert syndrome 1, 213300 (3), Autosomal recessive; Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3), Autosomal recessive",Inpp5e (MGI:1927753)
9,136440095,136484551,9q34.3,9q34.3,612854,"SEC16A, SEC16L, KIAA0310, p250","Sec16, S. Cerevisiae, homolog of, A",SEC16A,9919,ENSG00000148396,NA,NA,Sec16a (MGI:2139207)
9,136494432,136546047,9q34.3,9q34.3,190198,"NOTCH1, TAN1, AOS5, AOVD1","Notch, Drosophila, homolog of, 1, translocation-associated",NOTCH1,4851,ENSG00000148400,NA,"Adams-Oliver syndrome 5, 616028 (3), Autosomal dominant; Aortic valve disease 1, 109730 (3), Autosomal dominant",Notch1 (MGI:97363)
9,136654752,136672677,9q34.3,9q34.3,608582,EGFL7,Epidermal growth factor-like 7,EGFL7,51162,ENSG00000172889,NA,NA,Egfl7 (MGI:2449923)
9,136670601,136670685,9q34.3,9q34.3,611767,"MIR126, MIRN126",Micro RNA 126,MIR126,406913,ENSG00000199161,NA,NA,NA
9,136673142,136687456,9q34.3,9q34.3,603100,"AGPAT2, LPAAB, BSCL, BSCL1",1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase-beta),AGPAT2,10555,ENSG00000169692,NA,"Lipodystrophy, congenital generalized, type 1, 608594 (3), Autosomal recessive",Agpat2 (MGI:1914762)
9,136712571,136724741,9q34.3,9q34.3,614543,FAM69B,"Family with sequence similarity 69, member B",DIPK1B,138311,ENSG00000165716,NA,NA,Dipk1b (MGI:1927576)
9,136738169,136742939,9q34,9q34.3,612904,LCN10,Lipocalin 10,LCN10,414332,ENSG00000187922,NA,NA,Lcn10 (MGI:1925000)
9,136744016,136748524,9q34,9q34.3,609379,LCN6,Lipocalin 6,LCN6,158062,ENSG00000267206,NA,NA,Lcn6 (MGI:3045364)
9,136754387,136758550,9q34,9q34.3,612902,LCN8,Lipocalin 8,LCN8,138307,ENSG00000204001,NA,NA,Lcn8 (MGI:2135945)
9,136796337,136807740,9q34.3,9q34.3,615955,"CCDC183, KIAA1984",Coiled-coil domain-containing protein 183,CCDC183,84960,ENSG00000213213,NA,NA,Ccdc183 (MGI:1924308)
9,136807947,136841186,9q34.3,9q34.3,610615,"RABL6, PARF, C9orf86",RAB-like protein 6,RABL6,55684,ENSG00000196642,NA,NA,Rabl6 (MGI:2442633)
9,136848815,136851042,9q34.3,9q34.3,610167,PHPT1,Phosphohistidine phosphatase 1,PHPT1,29085,ENSG00000054148,NA,NA,Phpt1 (MGI:1922704)
9,136852345,136860798,9q34.3,9q34.3,617208,MAMDC4,MAM domain-containing protein 4,MAMDC4,158056,ENSG00000177943,NA,NA,Mamdc4 (MGI:2685841)
9,136881932,136926614,9q34.3,9q34.3,601895,"TRAF2, TRAP",TNF receptor-associated factor 2,TRAF2,7186,ENSG00000127191,NA,NA,Traf2 (MGI:101835)
9,136940434,136944773,9q34.3,9q34.3,609072,"FBXW5, FBW5",F-box and WD40 domain protein 5,FBXW5,54461,ENSG00000159069,NA,NA,Fbxw5 (MGI:1354731)
9,136944869,136946980,9q34.3,9q34.3,120930,C8G,"Complement component-8, gamma polypeptide",C8G,733,ENSG00000176919,NA,NA,C8g (MGI:88237)
9,136949179,136955504,9q34,9q34.3,612905,LCN12,Lipocalin 12,LCN12,286256,ENSG00000184925,NA,NA,Lcn12 (MGI:1924951)
9,136977503,136981741,9q34.2-q34.3,9q34.3,176803,PTGDS,"Prostaglandin D2 synthase (21kD, brain)",PTGDS,5730,ENSG00000107317,distal to ABL,NA,Ptgds (MGI:99261)
9,136992417,136993987,9q34.3,9q34.3,616315,"PAXX, C9orf142",Paralog of XRCC4 and XLF,PAXX,286257,ENSG00000148362,NA,NA,Paxx (MGI:2442831)
9,136994607,136997928,Chr.9,9q34.3,606533,CLIC3,Chloride intracellular channel 3,CLIC3,9022,ENSG00000169583,NA,NA,Clic3 (MGI:1916704)
9,137007233,137028921,9q34,9q34.3,600047,"ABCA2, ABC2",ATP-binding cassette 2,ABCA2,20,ENSG00000107331,NA,NA,Abca2 (MGI:99606)
9,137030173,137032839,Chr.9,9q34.3,602030,FUT7,"Fucosyltransferase 7 (alpha (1,3) fucosyltransferase)",FUT7,2529,ENSG00000180549,NA,NA,Fut7 (MGI:107692)
9,137039462,137046176,Chr.9,9q34.3,605798,"NPDC1, CAB1","Neural proliferation, differentiation, and control protein 1",NPDC1,56654,ENSG00000107281,NA,NA,Npdc1 (MGI:1099802)
9,137048106,137054060,9q34,9q34.3,602012,"ENTPD2, CD39L1",Ectonucleoside triphosphate diphosphohydrolase 2,ENTPD2,954,ENSG00000054179,same cosmid as ABC2,NA,Entpd2 (MGI:1096863)
9,137062126,137070558,9q34.3,9q34.3,612057,"SAPCD2, C9orf140, P42.3",Suppressor APC domain-containing protein 2,SAPCD2,89958,ENSG00000186193,NA,NA,Sapcd2 (MGI:1919330)
9,137086926,137109186,9q34.3,9q34.3,604346,"MAN1B1, MRT15","Mannosidase, alpha, class 1B member 1",MAN1B1,11253,ENSG00000177239,NA,"Mental retardation, autosomal recessive 15, 614202 (3), Autosomal recessive",Man1b1 (MGI:2684954)
9,137110539,137117979,9q34.3,9q34.3,610537,"DPP7, QPP",Dipeptidyl peptidase VII,DPP7,29952,ENSG00000176978,NA,NA,Dpp7 (MGI:1933213)
9,137139091,137168758,9q34.3,9q34.3,138249,"GRIN1, NMDAR1, NDHMSR, NDHMSD","Glutamate receptor, ionotropic, N-methyl D-aspartate 1",GRIN1,2902,ENSG00000176884,NA,"Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant, 614254 (3), Autosomal dominant; Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive, 617820 (3), Autosomal recessive",Grin1 (MGI:95819)
9,137168757,137170038,9q34.3,9q34.3,613505,"LRRC26, CAPC",Leucine-rich repeat-containing protein 26,LRRC26,389816,ENSG00000184709,NA,NA,Lrrc26 (MGI:2385129)
9,137174783,137188584,Chr.9,9q34.3,606946,"ANAPC2, APC2, KIAA1406","Anaphase-promoting complex, subunit 2",ANAPC2,29882,ENSG00000176248,NA,NA,Anapc2 (MGI:2139135)
9,137188675,137190365,9q34.3,9q34.3,610882,"SSNA1, NA14",Sjogren syndrome nuclear autoantigen 1,SSNA1,8636,ENSG00000176101,NA,NA,Ssna1 (MGI:1915725)
9,137191618,137200740,9q34.3,9q34.3,613354,"TPRN, C9orf75, DFNB79",Taperin,TPRN,286262,ENSG00000176058,NA,"Deafness, autosomal recessive 79, 613307 (3), Autosomal recessive",Tprn (MGI:2139535)
9,137204081,137205647,9q34.3,9q34.3,616499,TMEM203,Transmembrane protein 203,TMEM203,94107,ENSG00000187713,NA,NA,Tmem203 (MGI:2443597)
9,137205666,137219360,9q34.3,9q34.3,606073,NR1,NADPH-dependent FMN- and FAD-containing oxidoreductase,NDOR1,27158,ENSG00000188566,NA,NA,Ndor1 (MGI:1926047)
9,137230756,137236553,9q34,9q34.3,609826,"SLC34A3, NPTIIC, HHRH","Solute carrier family 34 (sodium/phosphate cotransporter), member 3",SLC34A3,142680,ENSG00000198569,NA,"Hypophosphatemic rickets with hypercalciuria, 241530 (3), Autosomal recessive",Slc34a3 (MGI:2159410)
9,137241286,137243706,9q34.3,9q34.3,602660,"TUBB4B, TUBB2C, LCAEOD","Tubulin, beta-4B",TUBB4B,10383,ENSG00000188229,NA,"Leber congenital amaurosis with early-onset deafness, 617879 (3), Autosomal dominant",Tubb4b (MGI:1915472)
9,137255326,137273541,9q34,9q34.3,611180,"COBRA1, NELFB, KIAA1182",Cofactor of BRCA1,NELFB,25920,ENSG00000188986,NA,NA,Nelfb (MGI:1931035)
9,137423371,137434405,9q34.3,9q34.3,611255,NOXA1,NADPH oxidase activator 1,NOXA1,10811,ENSG00000188747,NA,NA,Noxa1 (MGI:2449980)
9,137434363,137441709,9q34,9q34.3,616748,ENTPD8,Ectonucleoside triphosphate diphosphohydrolase 8,ENTPD8,377841,ENSG00000188833,NA,NA,Entpd8 (MGI:1919340)
9,137447569,137459333,9q34.3,9q34.3,608137,"NSMF, NELF, HH9",NMDA receptor synaptonuclear signaling and neuronal migration factor,NSMF,26012,ENSG00000165802,NA,"Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3), Autosomal dominant",Nsmf (MGI:1861755)
9,137459398,137550665,9q34.3,9q34.3,612122,PNPLA7,Patatin-like phospholipase domain containing 7,PNPLA7,375775,ENSG00000130653,NA,NA,Pnpla7 (MGI:2385325)
9,137551878,137552554,9q34.3,9q34.3,611846,"MRPL41, MRPL27",Mitochondrial ribosomal protein L41,MRPL41,64975,ENSG00000182154,NA,NA,Mrpl41 (MGI:1333816)
9,137554443,137578924,9q34.3,9q34.3,613210,"DPH7, WDR85",Diphthamide biosynthesis 7,DPH7,92715,ENSG00000148399,NA,NA,Dph7 (MGI:1914478)
9,137582078,137590511,9q34.3,9q34.3,611424,"ZMYND19, MIZIP",Zinc finger MYND domain-containing protein 19,ZMYND19,116225,ENSG00000165724,NA,NA,Zmynd19 (MGI:1914437)
9,137619000,137836126,9q34.3,9q34.3,607001,"EHMT1, EUHMTASE1, KMT1D, DEL9q34, KLEFS1",Euchromatic histone methyltransferase 1,EHMT1,79813,ENSG00000181090,NA,"Kleefstra syndrome 1, 610253 (3), Autosomal dominant",Ehmt1 (MGI:1924933)
9,137877781,138124618,9q34,9q34.3,601012,"CACNA1B, CACNL1A5, NEDNEH","Calcium channel, voltage-dependent, L type, alpha 1B subunit",CACNA1B,774,ENSG00000148408,NA,"Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, 618497 (3)",Cacna1b (MGI:88296)
9,0,138394717,Chr.9,NA,187290,H142T,"Temperature sensitivity complementation, H142",NA,8023,NA,NA,NA,NA
10,0,39800000,10p,NA,603188,BMIQ8,Body mass index quantitative trait locus 8,NA,56694,NA,NA,"{Obesity, susceptibility to, BMIQ8}, 603188 (2)",NA
10,0,39800000,10p,NA,607499,BULN,"Bulimia nervosa, susceptibility to",NA,337893,NA,between D10S1430 and D10S1423,"{Bulimia nervosa, susceptibility to}, 607499 (2), Multifactorial",NA
10,0,6600000,10p15,NA,611384,PFFE1,Plasmodium falciparum fever episodes QTL1,NA,101910199,NA,NA,"{Plasmodium falciparum fever episodes QTL1}, 611384 (2)",NA
10,0,51100000,10pter-q11,NA,601188,"ST12, PAC1","Suppression of tumorigenicity 12, prostate",NA,NA,NA,NA,"Prostate adenocarcinoma, 601188 (2)",NA
10,46436,49503,10p15.3,10p15.3,616768,"TUBB8, OOMD2","Tubulin, beta 8",TUBB8,347688,ENSG00000261456,NA,"Oocyte maturation defect 2, 616780 (3), Autosomal recessive, Autosomal dominant",NA
10,130087,254636,10p14,10p15.3,608668,"ZMYND11, BS69, BRAM1, MRD30",Zinc finger MYND domain-containing protein 11,ZMYND11,10771,ENSG00000015171,NA,"Mental retardation, autosomal dominant 30, 616083 (3), Autosomal dominant",Zmynd11 (MGI:1913755)
10,274200,689709,10p15.3,10p15.3,611380,"DIP2C, KIAA0934","Disco-interacting protein 2, Drosophila, homolog of, C",DIP2C,22982,ENSG00000151240,NA,NA,Dip2c (MGI:1920179)
10,806913,931899,10p15.3,10p15.3,616513,"LARP4B, LARP5, KIAA0217","La ribonucleoprotein domain family, member 4B",LARP4B,23185,ENSG00000107929,NA,NA,Larp4b (MGI:106330)
10,1018909,1025858,10p15,10p15.3,615389,"IDI2, IPPI2",Isopentenyl-diphosphate delta isomerase 2,IDI2,91734,ENSG00000148377,NA,NA,NA
10,1022636,1044200,10p15,10p15.3,615391,IDI2AS1,"IDI2 antisense RNA 1, noncoding",IDI2-AS1,55853,ENSG00000232656,NA,NA,NA
10,1039151,1056703,10p15,10p15.3,604055,IDI1,Isopentenyl-diphosphate delta isomerase 1,IDI1,3422,ENSG00000067064,NA,NA,Idi1 (MGI:2442264)
10,1177312,1737524,10p15,10p15.3,602065,"ADARB2, RED2","Adenosine deaminase, RNA-specific, B2 (homolog of rat BLUE)",ADARB2,105,ENSG00000185736,NA,NA,Adarb2 (MGI:2151118)
10,3067474,3136804,10p15.3-p15.2,10p15.2,171840,PFKP,"Phosphofructokinase, platelet type",PFKP,5214,ENSG00000067057,NA,NA,Pfkp (MGI:1891833)
10,3137726,3172840,10p15.2,10p15.2,618211,"PITRM1, MP1, PREP",Pitrilysin metallopeptidase 1,PITRM1,10531,ENSG00000107959,NA,NA,Pitrm1 (MGI:1916867)
10,3775995,3785280,10p15,10p15.2,602053,"KLF6, COPEB, BCD1, ZF9",Kruppel-like factor-6,KLF6,1316,ENSG00000067082,NA,"Gastric cancer, somatic, 613659 (3); Prostate cancer, somatic, 176807 (3)",Klf6 (MGI:1346318)
10,3800000,6600000,10p15.1,NA,612594,MS2,"Multiple sclerosis, susceptibility to, 2",NA,100271694,NA,associated with rs12722489 and rs2104286,"{Multiple sclerosis, susceptibility to, 2}, 612594 (2)",NA
10,4824553,4908420,10p15.1,10p15.1,617451,"AKR1E2, HTSP, TAKR","Aldo-keto reductase family 1, member E2",AKR1E2,83592,ENSG00000165568,NA,NA,Akr1e1 (MGI:1914758)
10,4963414,4983282,10p15-p14,10p15.1,600449,"AKR1C1, DDH1, DD1, HAKRC","Aldo-keto reductase family 1, member 1 (dihydrodiol dehydrogenase, type 1)",AKR1C1,1645,ENSG00000187134,NA,NA,Akr1c21 (MGI:1924587)
10,4987774,5018032,10p15-p14,10p15.1,600450,"AKR1C2, DDH2, DD2, HAKRD, SRXY8","Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II)",AKR1C2,1646,ENSG00000151632,NA,"46XY sex reversal 8, 614279 (3), Autosomal recessive",Akr1c21 (MGI:1924587)
10,5048765,5107685,10p15-p14,10p15.1,603966,"AKR1C3, HAKRB, DD3","Aldo-keto reductase family 1, member C3",AKR1C3,8644,ENSG00000196139,NA,NA,Akr1c18 (MGI:2145420)
10,5196836,5218948,10p15-p14,10p15.1,600451,"AKR1C4, CHDR, CDR, HAKRA, DD4","Aldo-keto reductase family 1, member C4 (chlordecone reductase)",AKR1C4,1109,ENSG00000198610,NA,"{46XY sex reversal 8, modifier of}, 614279 (3), Autosomal recessive",Akr1c6 (MGI:1933427)
10,5412556,5459055,10p15.1,10p15.1,606450,NET1,Neuroepithelial cell transforming gene 1,NET1,10276,ENSG00000173848,NA,NA,Net1 (MGI:1927138)
10,5524960,5526770,10pter-p13,10p15.1,114184,CALML3,Calmodulin-like 3,CALML3,810,ENSG00000178363,NA,NA,Calml3 (MGI:1917655)
10,5638856,5666594,10p15.1,10p15.1,615055,ASB13,Ankyrin repeat- and SOCS box-containing protein 13,ASB13,79754,ENSG00000196372,NA,NA,Asb13 (MGI:2145525)
10,5765221,5813548,10p15,10p15.1,600767,"GDI2, RABGDIB",GDP dissociation inhibitor 2,GDI2,2665,ENSG00000057608,pseudogene on chr.7,NA,Gdi2 (MGI:99845)
10,5861615,5889896,10p15.1,10p15.1,618017,ANKRD16,Ankyrin repeat domain-containing protein 16,ANKRD16,54522,ENSG00000134461,NA,NA,Ankrd16 (MGI:2444796)
10,5889571,5937594,10p15.1,10p15.1,607222,"FBXO18, FBH1, FBX18",F-box only protein 18,FBH1,84893,ENSG00000134452,NA,NA,Fbh1 (MGI:1354699)
10,5948896,5978740,10p15-p14,10p15.1,601070,IL15RA,"Interleukin-15 receptor, alpha",IL15RA,3601,ENSG00000134470,NA,NA,Il15ra (MGI:104644)
10,6010688,6062369,10p15.1,10p15.1,147730,"IL2RA, CD25, IL2R, IDDM10, IMD41","Interleukin-2 receptor, alpha",IL2RA,3559,ENSG00000134460,NA,"{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3); Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3), Autosomal recessive",Il2ra (MGI:96549)
10,6089033,6117458,10p15.1,10p15.1,606935,"RBM17, SPF45",RNA binding motif protein 17,RBM17,84991,ENSG00000134453,NA,NA,Rbm17 (MGI:1924188)
10,6144917,6254647,10p15-p14,10p15.1,605319,"PFKFB3, IPFK2","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3",PFKFB3,5209,ENSG00000170525,NA,NA,Pfkfb3 (MGI:2181202)
10,6393037,6580645,10p15,10p15.1,600448,PRKCQ,"Protein kinase C, theta",PRKCQ,5588,ENSG00000065675,NA,NA,Prkcq (MGI:97601)
10,6600000,29300000,10p14-p12,NA,604401,ARVD6,Arrhythmogenic right ventricular dysplasia 6,NA,27038,NA,NA,"Arrhythmogenic right ventricular dysplasia 6, 604401 (2)",NA
10,6600000,12200000,10p14,NA,612230,CRCS5,"Colorectal cancer, susceptibility to, 5",NA,100188887,NA,associated with rs10795668,"{Colorectal cancer, susceptibility to, 5}, 612230 (2)",NA
10,6600000,17300000,10p14-p13,NA,601362,"DGCR2, DGS2",DiGeorge syndrome chromosome region-2,NA,8026,NA,NA,"DiGeorge syndrome/velocardiofacial syndrome complex-2, 601362 (2)",NA
10,7158623,7411485,10p14,10p14,615392,"SFMBT2, KIAA1617",SCM-like protein with 4 MBT domains 2,SFMBT2,57713,ENSG00000198879,NA,NA,Sfmbt2 (MGI:2447794)
10,7559269,7666997,10p15,10p14,609783,ITIH5,"Inter-alpha-trypsin inhibitor, heavy chain 5",ITIH5,80760,ENSG00000123243,NA,NA,Itih5 (MGI:1925751)
10,7703315,7749519,10p15,10p14,146640,ITIH2,"Inter-alpha (globulin) inhibitor, H2 polypeptide",ITIH2,3698,ENSG00000151655,NA,NA,Itih2 (MGI:96619)
10,7750961,7788026,10p15-p14,10p14,601720,"KIN, KIN17, BTCD","Antigenic determinant of recombination protein A, mouse, homolog of",KIN,22944,ENSG00000151657,NA,NA,Kin (MGI:96676)
10,7788103,7807800,10p15.1,10p14,108729,"ATP5C1, ATP5CL1, ATP5C","ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide-1",ATP5F1C,509,ENSG00000165629,NA,NA,Atp5c1 (MGI:1261437)
10,7818504,8016630,10p14,10p14,606576,"TAF3, TAFII140","TAF3 RNA polymerase II, TATA box-binding protein-associated factor, 140kD",TAF3,83860,ENSG00000165632,NA,NA,Taf3 (MGI:2388097)
10,8045419,8075197,10p15,10p14,131320,"GATA3, HDR, HDRS",GATA-binding protein-3,GATA3,2625,ENSG00000107485,NA,"Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3), Autosomal dominant",Gata3 (MGI:95663)
10,10462514,11336674,10p13,10p14,602538,"CELF2, CUGBP2, ETR3, BRUNOL3","CUGbp- and ELAV-like family, member 2",CELF2,10659,ENSG00000048740,NA,NA,Celf2 (MGI:1338822)
10,11453945,11611788,10p13,10p14,605405,"USP6NL, RNTRE",USP6 N-terminal-like,USP6NL,9712,ENSG00000148429,NA,NA,Usp6nl (MGI:2138893)
10,11920021,12043169,10p15-p13,10p14,605529,"UPF2, RENT2","UPF2 regulator of nonsense transcripts, yeast, homolog of",UPF2,26019,ENSG00000151461,NA,NA,Upf2 (MGI:2449307)
10,12068953,12123220,10p14,10p14,614984,"DHTKD1, KIAA1630, AMOXAD, CMT2Q",Dehydrogenase E1 and transketolase domains-containing protein 1,DHTKD1,55526,ENSG00000181192,mutation identified in 1 CMT2Q family,"2-aminoadipic 2-oxoadipic aciduria, 204750 (3), Autosomal recessive; ?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3), Autosomal dominant",Dhtkd1 (MGI:2445096)
10,12129640,12169957,10p14,10p14,618271,SEC61A2,"Sec61 translocon, alpha-2 subunit",SEC61A2,55176,ENSG00000065665,NA,NA,Sec61a2 (MGI:1931071)
10,12196187,12250588,10p14-p13,10p14-p13,617708,CDC123,Cell division cycle 123,CDC123,8872,ENSG00000151465,NA,NA,Cdc123 (MGI:2138811)
10,12200000,17300000,10p13,NA,606187,AD7,Alzheimer disease 7,NA,114475,NA,max LOD at D10S1423,"Alzheimer disease-7, 606187 (2)",NA
10,12200000,17300000,10p13,NA,609888,LPRS,"Leprosy, paucibacillary type, susceptibility to",NA,81861,NA,NA,"{Leprosy, paucibacillary type, susceptibility to}, 609888 (2)",NA
10,12349513,12835544,10p13,10p13,607957,"CAMK1D, CKLIK",Calcium/calmodulin-dependent protein kinase I-delta,CAMK1D,57118,ENSG00000183049,NA,NA,Camk1d (MGI:2442190)
10,13100081,13138307,10p15-p14,10p13,602432,"OPTN, GLC1E, FIP2, HYPL, NRP, ALS12",Optineurin,OPTN,10133,ENSG00000123240,NA,"Amyotrophic lateral sclerosis 12, 613435 (3); Glaucoma 1, open angle, E, 137760 (3), Autosomal dominant; {Glaucoma, normal tension, susceptibility to}, 606657 (3)",Optn (MGI:1918898)
10,13161557,13211109,10p13,10p13,609357,"MCM10, CNA43","Minichromosome maintenance 10, S. cerevisiae, homolog of",MCM10,55388,ENSG00000065328,NA,NA,Mcm10 (MGI:1917274)
10,13277795,13300129,10pter-p11.2,10p13,602026,"PHYH, PAHX",Phytanoyl-CoA hydroxylase,PHYH,5264,ENSG00000107537,NA,"Refsum disease, 266500 (3), Autosomal recessive",Phyh (MGI:891978)
10,13317427,13348297,10p13,10p13,600902,"SEPHS1, SPS1",Selenophosphate synthetase 1,SEPHS1,22929,ENSG00000086475,NA,NA,Sephs1 (MGI:1923580)
10,13586810,13645343,10p13,10p13,604993,"PRPF18, PRP18","Prp18, S. cerevisiae, homolog of",PRPF18,8559,ENSG00000165630,NA,NA,Prpf18 (MGI:1914479)
10,13638299,14330923,10p13,10p13,616305,"FRMD4A, KIAA1294, CCAFCA",FERM domain-containing protein 4A,FRMD4A,55691,ENSG00000151474,mutation identified in 1 CCAFCA family,"?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3), Autosomal recessive",Frmd4a (MGI:1919850)
10,14819244,14838072,10p13,10p13,611233,"ARMETL1, CDNF",Arginine-rich protein mutated in early stage tumors-like 1,CDNF,441549,ENSG00000185267,NA,NA,Cdnf (MGI:3606576)
10,14838159,14871740,10p12.3,10p13,610369,"HSPA14, HSP70L1",Heat-shock 70kD protein 14,HSPA14,51182,ENSG00000187522,NA,NA,Hspa14 (MGI:1354164)
10,14878782,14904314,10p13,10p13,606503,"SUV39H2, FLJ23414","Suppressor of variegation 3-9, Drosophila, homolog of, 2",SUV39H2,79723,ENSG00000152455,NA,NA,Suv39h2 (MGI:1890396)
10,14897358,14954431,10p,10p13,605988,"DCLRE1C, ARTEMIS, SCIDA",DNA cross-link repair protein 1C,DCLRE1C,64421,ENSG00000152457,NA,"Omenn syndrome, 603554 (3), Autosomal recessive; Severe combined immunodeficiency, Athabascan type, 602450 (3), Autosomal recessive",Dclre1c (MGI:2441769)
10,14954227,14988049,10p13,10p13,614174,MEIG1,"Meiosis-expressed gene 1, mouse, homolog of",MEIG1,644890,ENSG00000197889,NA,NA,Meig1 (MGI:1202878)
10,15097179,15104256,10p13,10p13,606116,RPP38,"Ribonuclease P, 38-kD subunit",RPP38,10557,ENSG00000152464,NA,NA,Rpp38 (MGI:2443607)
10,15104587,15168692,10p13,10p13,603801,NMT2,N-myristoyltransferase 2,NMT2,9397,ENSG00000152465,NA,NA,Nmt2 (MGI:1202298)
10,15513948,15720334,10p13,10p13,604063,"ITGA8, RHDA1","Integrin, alpha-8",ITGA8,8516,ENSG00000077943,NA,"Renal hypodysplasia/aplasia 1, 191830 (3), Autosomal recessive",Itga8 (MGI:109442)
10,15778168,15860532,10p13,10p13,611649,"MINDY3, C10orf97, CARP",MINDY lysine-48 deubiquitinase 3,MINDY3,80013,ENSG00000148481,NA,NA,Mindy3 (MGI:1914210)
10,16436942,16517961,10p12,10p13,604446,PTER,Phosphotriesterase-related protein,PTER,9317,ENSG00000165983,NA,NA,Pter (MGI:107372)
10,16513733,16521878,10p13,10p13,615227,"C1QL3, CTRP13, K100","Complement component 1, q subcomponent-like 3",C1QL3,389941,ENSG00000165985,NA,NA,C1ql3 (MGI:2387350)
10,16590610,16817453,10p13,10p13,179555,RSU1,Ras suppressor protein 1,RSU1,6251,ENSG00000148484,NA,NA,Rsu1 (MGI:103040)
10,16823965,17130491,10p12.1,10p13,602997,"CUBN, IFCR, MGA1",Cubilin (intrinsic factor-cobalamin receptor),CUBN,8029,ENSG00000107611,NA,"Megaloblastic anemia-1, Finnish type, 261100 (3), Autosomal recessive",Cubn (MGI:1931256)
10,17137335,17202070,10p15.1,10p13,602478,"TRDMT1, DMNT2",tRNA aspartic acid methyltransferase 1 (DNA methyltransferase 2),TRDMT1,1787,ENSG00000107614,NA,NA,Trdmt1 (MGI:1274787)
10,17228240,17237592,10p13,10p13,193060,"VIM, CTRCT30",Vimentin,VIM,7431,ENSG00000026025,NA,"Cataract 30, pulverulent, 116300 (3), Autosomal dominant",Vim (MGI:98932)
10,17315413,17455965,10p12.31,10p12.33,610139,"ST8SIA6, SIAT8F","ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6",ST8SIA6,338596,ENSG00000148488,NA,NA,St8sia6 (MGI:2386797)
10,17589031,17617373,10p12.33,10p12.33,610467,"HACD1, PTPLA",3-hydroxyacyl-CoA dehydratase 1,HACD1,9200,ENSG00000165996,NA,NA,Hacd1 (MGI:1353592)
10,17644149,17716823,10p14-p13,10p12.33,601899,STAM,Signal transducing adaptor molecule,STAM,8027,ENSG00000136738,NA,NA,Stam (MGI:1329014)
10,17809347,17911163,10p13,10p12.33,153618,"MRC1, MMR","Mannose receptor, C type 1",MRC1,4360,ENSG00000260314,NA,NA,Mrc1 (MGI:97142)
10,18140423,18545880,10p12,10p12.33-p12.31,600003,CACNB2,"Calcium channel, voltage-dependent, beta 2 subunit",CACNB2,783,ENSG00000165995,NA,"Brugada syndrome 4, 611876 (3)",Cacnb2 (MGI:894644)
10,18512581,18659263,10p12.31,10p12.31,617199,NSUN6,"NOP2/SUN RNA methyltransferase family, member 6",NSUN6,221078,ENSG00000241058,NA,NA,Nsun6 (MGI:1921705)
10,18659334,18681638,10p12.31,10p12.31,608909,"ARL5B, ARL8",ADP-ribosylation factor-like 5B,ARL5B,221079,ENSG00000165997,NA,NA,Arl5b (MGI:1923119)
10,19046930,19734477,10p12.31,10p12.31,617715,"MALRD1, C10orf112, DIET1",MAM and LDL receptor class A domain-containing protein 1,MALRD1,340895,ENSG00000204740,NA,NA,Malrd1 (MGI:1928271)
10,19816214,20289855,10p12.3,10p12.31,606827,"PLXDC2, TEM7R",Plexin domain containing 2,PLXDC2,84898,ENSG00000120594,NA,NA,Plxdc2 (MGI:1914698)
10,20779972,21174186,10p13-p12,10p12.31,605491,NEBL,Nebulette,NEBL,10529,ENSG00000078114,NA,NA,NA
10,21496561,21496640,10p12.31,10p12.31,615202,MIR1915,Micro RNA 1915,MIR1915,100302129,ENSG00000222071,NA,NA,NA
10,21524615,21743629,10p12,10p12.31,602409,AF10,ALL1 fused gene from chromosome 10,MLLT10,8028,ENSG00000078403,fuses with MLL and HEAB,"Leukemia, acute myeloid, 601626 (3), Autosomal dominant, Somatic mutation",Mllt10 (MGI:1329038)
10,21756547,22003762,10p12.31,10p12.31,611207,"DNAJC1, HTJ1","DNAJ/HSP40 homolog, subfamily C, member 1",DNAJC1,64215,ENSG00000136770,NA,NA,Dnajc1 (MGI:103268)
10,22208813,22209982,10p12.3,10p12.31,613249,EBLN1,Endogenous Borna-like N element-containing protein 1,EBLN1,340900,ENSG00000223601,NA,NA,NA
10,22316387,22320305,10p12.2,10p12.2,616700,COMMD3,COMM domain-containing protein 3,COMMD3,23412,ENSG00000148444,NA,NA,Commd3 (MGI:88218)
10,22321098,22331483,10p13,10p12.2,164831,BMI1,Oncogene BMI-1,BMI1,648,ENSG00000168283,NA,NA,NA
10,22345444,22417609,10p12-p11.2,10p12.2,605730,SPAG6,Sperm-associated antigen 6,SPAG6,9576,ENSG00000077327,NA,NA,Spag6l (MGI:1354388)
10,22534836,22714577,10p12.2,10p12.2,603140,"PIP4K2A, PI5P4KA, PIP5K2A","Phosphatidylinositol 5-phosphate 4-kinase, type II, alpha",PIP4K2A,5305,ENSG00000150867,NA,NA,Pip4k2a (MGI:1298206)
10,22928023,23038526,10p12.23,10p12.2,611226,ARMC3,Armadillo repeat-containing protein 3,ARMC3,219681,ENSG00000165309,NA,NA,Armc3 (MGI:1918132)
10,23095563,23122012,10p12,10p12.2,613782,"MSRB2, CBS1",Methionine sulfoxide reductase B2,MSRB2,22921,ENSG00000148450,NA,NA,Msrb2 (MGI:1923717)
10,23192311,23194244,10p12.3,10p12.2,607194,"PTF1A, PACA, PAGEN2","Pancreas transcription factor 1, alpha subunit",PTF1A,256297,ENSG00000168267,NA,"Pancreatic agenesis 2, 615935 (3), Autosomal recessive; Pancreatic and cerebellar agenesis, 609069 (3), Autosomal recessive",Ptf1a (MGI:1328312)
10,23439268,23442380,10p12.2,10p12.2,612022,"OTUD1, DUBA7",OTU domain-containing protein 1,OTUD1,220213,ENSG00000165312,NA,NA,Otud1 (MGI:1918448)
10,23694726,24547847,10p12.2,10p12.2-p12.1,617367,"KIAA1217, SKT",KIAA1217 gene,KIAA1217,56243,ENSG00000120549,NA,NA,Etl4 (MGI:95454)
10,24583609,24725420,10p12.3,10p12.1,609870,"ARHGAP21, KIAA1424","GTPase-activating protein, Rho, 21",ARHGAP21,57584,ENSG00000107863,pseudogene on chr.6,NA,Arhgap21 (MGI:1918685)
10,24848613,24952605,10p12.1,10p12.1,610751,PRTFDC1,Phosphoribosyl transferase domain-containing protein 1,PRTFDC1,56952,ENSG00000099256,NA,NA,NA
10,24952318,25026663,10p12.1,10p12.1,611260,"THNSL1, TSH1",Threonine synthase-like 1,THNSL1,79896,ENSG00000185875,NA,NA,Thnsl1 (MGI:2139347)
10,24981978,25062278,10p12.1,10p12.1,611025,"ENKUR, C10orf63","Enkurin, TRPC channel-interacting protein",ENKUR,219670,ENSG00000151023,NA,NA,Enkur (MGI:1918483)
10,25174736,25602228,10p12.1,10p12.1,614573,"GPR158, KIAA1136",G protein-coupled receptor 158,GPR158,57512,ENSG00000151025,NA,NA,Gpr158 (MGI:2441697)
10,25934228,26212535,10p11.1,10p12.1,606808,"MYO3A, DFNB30",Myosin IIIA,MYO3A,53904,ENSG00000095777,NA,"Deafness, autosomal recessive 30, 607101 (3), Autosomal recessive",Myo3a (MGI:2183924)
10,26216306,26304561,10p11.23,10p12.1,138275,GAD2,"Glutamate decarboxylase-2, pancreas",GAD2,2572,ENSG00000136750,NA,NA,Gad2 (MGI:95634)
10,26697423,26747245,10p12.1,10p12.1,607429,"PDSS1, TPT, COQ1, COQ10D2","Prenyl diphosphate synthase, subunit 1",PDSS1,23590,ENSG00000148459,NA,"Coenzyme Q10 deficiency, primary, 2, 614651 (3), Autosomal recessive",Pdss1 (MGI:1889278)
10,26746595,26861086,10p11.2,10p12.1,603050,ABI1,ABL-interactor 1,ABI1,10006,ENSG00000136754,NA,NA,Abi1 (MGI:104913)
10,26938194,27100497,10p12.1,10p12.1,610855,"ANKRD26, KIAA1074, THC2",Ankyrin repeat domain-containing protein 26,ANKRD26,22852,ENSG00000107890,NA,"Thrombocytopenia 2, 188000 (3), Autosomal dominant",Ankrd26 (MGI:1917887)
10,27110110,27155050,10p14,10p12.1,607472,"YME1L1, YME1L, PAMP, OPA11",Mitochondrial escape 1-like 1,YME1L1,10730,ENSG00000136758,mutation identified in1 OPA11 family,"?Optic atrophy 11, 617302 (3), Autosomal recessive",Yme1l1 (MGI:1351651)
10,27154478,27187952,10p12.1,10p12.1,608221,"MASTL, FLJ14813, GWL",Microtubule-associated serine/threonine kinase-like,MASTL,84930,ENSG00000120539,NA,NA,Mastl (MGI:1914371)
10,27182837,27243541,10p12.1,10p12.1,616618,"ACBD5, KIAA1996",Acyl-CoA-binding domain-containing protein 5,ACBD5,91452,ENSG00000107897,NA,NA,Acbd5 (MGI:1921409)
10,27398187,27414367,10p12.1,10p12.1,611791,PTCHD3,Patched domain-containing protein 3,PTCHD3,374308,ENSG00000182077,NA,NA,Ptchd3 (MGI:1921925)
10,27504173,27542238,10p12.1,10p12.1,602207,"RAB18, WARBM3",Ras-associated protein RAB18,RAB18,22931,ENSG00000099246,NA,"Warburg micro syndrome 3, 614222 (3), Autosomal recessive",Rab18 (MGI:102790)
10,27672873,27745818,10p12.1,10p12.1,601332,"MKX, IFRX, IRXL1",Mohawk homeobox,MKX,283078,ENSG00000150051,NA,NA,Mkx (MGI:2687286)
10,27812165,27999499,10p12.1,10p12.1,615408,"ARMC4, CILD23",Armadillo repeat-containing protein 4,ARMC4,55130,ENSG00000169126,NA,"Ciliary dyskinesia, primary, 23, 615451 (3), Autosomal recessive",Armc4 (MGI:1922184)
10,28050992,28303065,10p12.1,10p12.1,610973,MPP7,"Membrane protein, palmitoylated 7",MPP7,143098,ENSG00000150054,NA,NA,Mpp7 (MGI:1922989)
10,28532771,28623111,10p12.1-p11.2,10p12.1,615049,"WAC, KIAA1844, DESSH",WW domain-containing adaptor with coiled-coil region,WAC,51322,ENSG00000095787,NA,"Desanto-Shinawi syndrome, 616708 (3), Autosomal dominant",Wac (MGI:2387357)
10,28677520,28682931,10p12.3-p11.2,10p12.1,604444,"BAMBI, NMA","BMP and activin membrane-bound inhibitor, xenopus, homolog of",BAMBI,25805,ENSG00000095739,NA,NA,Bambi (MGI:1915260)
10,29300000,59400000,10p11.23-q21.1,NA,607239,DFNB33,"Deafness, autosomal recessive 33",DFNB33,170508,NA,prev. assignment to chr. 9 an error,"Deafness, autosomal recessive 33, 607239 (2), Autosomal recessive",NA
10,29457337,29736935,10p11.2,10p11.23,604126,SVIL,Supervillin,SVIL,6840,ENSG00000197321,NA,NA,Svil (MGI:2147319)
10,30012802,30115493,10p11,10p11.23,614398,"KIAA1462, JCAD",KIAA1462 gene,JCAD,57608,ENSG00000165757,NA,NA,Jcad (MGI:2685174)
10,30309800,30349337,10p11.23,10p11.23,613669,"MTPAP, PAPD1, SPAX4",Mitochondrial poly(A) polymerase,MTPAP,55149,ENSG00000107951,mutation identified in 1 SPAX4 family,"?Spastic ataxia 4, autosomal recessive, 613672 (3), Autosomal recessive",Mtpap (MGI:1914690)
10,30434020,30461832,10p11.2,10p11.23,191195,"MAP3K8, COT, EST, TPL2",Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene),MAP3K8,1326,ENSG00000107968,NA,"Lung cancer, somatic, 211980 (3)",Map3k8 (MGI:1346878)
10,30606221,30629760,10p11.23,10p11.23,612748,LYZL2,Lysozyme-like 2,LYZL2,119180,ENSG00000151033,NA,NA,NA
10,31100000,34200000,10p11.22,NA,611934,EIG5,"Epilepsy, idiopathic generalized, susceptibility to, 5",NA,100188861,NA,max lod at D10S1426,"{Epilepsy, idiopathic generalized, susceptibility to, 5}, 611934 (2)",NA
10,31307716,31320446,10p11.22,10p11.22,616915,ZEB1AS1,"ZEB1 antisense RNA 1, noncoding",ZEB1-AS1,220930,ENSG00000237036,NA,NA,NA
10,31318416,31529813,10p11.2,10p11.22,189909,"ZEB1, TCF8, NIL2A, PPCD3, FECD6",Zinc finger E box-binding homeobox 1,ZEB1,6935,ENSG00000148516,NA,"Corneal dystrophy, Fuchs endothelial, 6, 613270 (3); Corneal dystrophy, posterior polymorphous, 3, 609141 (3)",Zeb1 (MGI:1344313)
10,31805397,31928875,10p12,10p11.22,610577,ARHGAP12,Rho GTPase-activating protein 12,ARHGAP12,94134,ENSG00000165322,NA,NA,Arhgap12 (MGI:1922665)
10,32009014,32056424,10p11.22,10p11.22,602809,"KIF5B, KNS1, UKHC",Kinesin 1,KIF5B,3799,ENSG00000170759,NA,NA,Kif5b (MGI:1098268)
10,32267715,32378794,10p11,10p11.22,610999,EPC1,"Enhancer of polycomb, Drosophila, homolog of, 1",EPC1,80314,ENSG00000120616,NA,NA,Epc1 (MGI:1278322)
10,32900317,32958229,10p11.2,10p11.22,135630,"ITGB1, FNRB","Integrin, beta-1 (fibronectin receptor, beta polypeptide; antigen CD29 includes MDF2, MSK12)",ITGB1,3688,ENSG00000150093,pseudogene FNRBL on 19p,NA,Itgb1 (MGI:96610)
10,33177490,33334904,10p12,10p11.22,602069,"NRP1, NRP, VEGF165R",Neuropilin 1,NRP1,8829,ENSG00000099250,NA,NA,Nrp1 (MGI:106206)
10,34109559,34815324,10p11.21,10p11.22-p11.21,606745,"PARD3, PAR3","Partitioning-defective protein 3, C. elegans, homolog of",PARD3,56288,ENSG00000148498,NA,NA,Pard3 (MGI:2135608)
10,34200000,59400000,10p11.21-q21.1,NA,614990,USH1K,"Usher syndrome, type IK",USH1K,101180907,NA,max lod at D10S539,"Usher syndrome, type IK, 614990 (2), Autosomal recessive",NA
10,35008550,35126898,10p11.2-p11.1,10p11.21,603135,CUL2,Cullin 2,CUL2,8453,ENSG00000108094,NA,NA,Cul2 (MGI:1918995)
10,35126829,35212957,10p12.1-p11.2,10p11.21,123812,CREM,cAMP-responsive element modulator,CREM,1390,ENSG00000095794,NA,NA,Crem (MGI:88495)
10,35247024,35572669,10p11.2,10p11.21,612786,"CCNY, CFP1, CCNX, C10orf9",Cyclin Y,CCNY,219771,ENSG00000108100,NA,NA,Ccny (MGI:1915224)
10,35605340,35608934,10p11.21,10p11.21,611922,"GJD4, CX40.1","Gap junction protein, delta-4",GJD4,219770,ENSG00000177291,NA,NA,Gjd4 (MGI:2444990)
10,35638248,35641433,10p11.2,10p11.21,606146,FZD8,"Frizzled, Drosophila, homolog of, 8",FZD8,8325,ENSG00000177283,NA,NA,Fzd8 (MGI:108460)
10,37125753,37309297,10p11.21,10p11.21,610856,ANKRD30A,Ankyrin repeat domain-containing protein 30A,ANKRD30A,91074,ENSG00000148513,NA,NA,NA
10,37949571,37976654,10p11.2-q11.2,10p11.21,194528,"ZNF25, KOX19",Zinc finger protein-25 (KOX 19),ZNF25,219749,ENSG00000175395,NA,NA,Zfp9 (MGI:99210)
10,38010482,38067833,10q11.2,10p11.1,194521,"ZNF33A, NF11A, KOX2",Zinc finger protein-33a,ZNF33A,7581,ENSG00000189180,NA,NA,NA
10,38094326,38150292,10p11.1,10p11.1,616085,"ZNF37A, KOX21, ZNF37",Zinc finger protein 37A,ZNF37A,7587,ENSG00000075407,NA,NA,NA
10,39800000,133797422,10q,NA,608176,AITD4,"Autoimmune thyroid disease, susceptibility to, 4",NA,387581,NA,NA,"{Autoimmune thyroid disease, susceptibility to, 4}, 608176 (2)",NA
10,41600000,68800000,10q11.2-q21,NA,610926,STHAG5,"Tooth agenesis, selective, 5",NA,100188748,NA,D10S604 and D10S568,"Tooth agenesis, selective, 5, 610926 (2)",NA
10,42574168,42638836,10q11.2,10q11.21,194522,"ZNF33B, ZNF11B, KOX2",Zinc finger protein-33b,ZNF33B,7582,ENSG00000196693,NA,NA,NA
10,42782774,42834936,10q11.21,10q11.21,611448,"BMS1, BMS1L, KIAA0187, ACC","Bms1, ribosome assembly protein, S. cerevisiae, homolog of",BMS1,9790,ENSG00000165733,mutation identified in one ACC family,"?Aplasia cutis congenita, nonsyndromic, 107600 (3), Autosomal dominant",Bms1 (MGI:2446132)
10,43077026,43130350,10q11.2,10q11.21,164761,"RET, MEN2A, HSCR1",RET transforming sequence; oncogene RET,RET,5979,ENSG00000165731,NA,"Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant",Ret (MGI:97902)
10,43138444,43185307,10q11.22,10q11.21,616616,CSGALNACT2,Chondroitin sulfate N-acetylgalactosaminyltransferase 2,CSGALNACT2,55454,ENSG00000169826,NA,NA,Csgalnact2 (MGI:1926002)
10,43194532,43267064,10q11.21,10q11.21,614531,RASFEF1A,"RASGEF domain family, member 1A",RASGEF1A,221002,ENSG00000198915,NA,NA,Rasgef1a (MGI:1917977)
10,43371635,43376334,10q11.21,10q11.21,616926,"FXYD4, CHIF",FXYD domain-containing ion transport regulator 4,FXYD4,53828,ENSG00000150201,NA,NA,Fxyd4 (MGI:1889005)
10,43385616,43409247,10q11.21-q11.22,10q11.21,601037,HNRPF,Heterogeneous nuclear ribonucleoprotein F,HNRNPF,3185,ENSG00000169813,NA,NA,Hnrnpf (MGI:2138741)
10,43554515,43574618,10q11.2,10q11.21,601069,"ZNF239, MOK2",Zinc finger protein-239,ZNF239,8187,ENSG00000196793,previously 19q13.2-q13.3,NA,Zfp239 (MGI:1306812)
10,43643858,43648880,10q23-q24,10q11.21,194539,"ZNF32, KOX30",Zinc finger protein-32 (KOX30),ZNF32,7580,ENSG00000169740,NA,NA,Zfp637 (MGI:2448537)
10,44292087,44385096,10q11.1,10q11.21,600835,"CXCL12, SDF1","Chemokine, C-X-C motif, ligand 12 (stromal cell-derived factor 1)",CXCL12,6387,ENSG00000107562,NA,"{AIDS, resistance to}, 609423 (3)",Cxcl12 (MGI:103556)
10,44959752,44995890,10q11.21,10q11.21,610559,"RASSF4, AD037","Ras association domain family, member 4",RASSF4,83937,ENSG00000107551,NA,NA,Rassf4 (MGI:2386853)
10,44976127,44978808,10q11.21,10q11.21,611309,"C10orf10, DEPP, FIG",Chromosome 10 open reading frame 10,DEPP1,11067,ENSG00000165507,NA,NA,Depp1 (MGI:1918730)
10,45000922,45005325,10q11.2,10q11.21,194529,"ZNF22, KOX15",Zinc finger protein-22 (KOX15),ZNF22,7570,ENSG00000165512,NA,NA,Zfp422 (MGI:1914505)
10,45374165,45446120,10q11.2,10q11.21,152390,ALOX5,Arachidonate 5-lipoxygenase,ALOX5,240,ENSG00000012779,NA,"{Asthma, diminished response to antileukotriene treatment in}, 600807 (3), Autosomal dominant; {Atherosclerosis, susceptibility to} (3)",Alox5 (MGI:87999)
10,45454584,45594905,10q11.21,10q11.21-q11.22,613335,MARCH8,Membrane-associated RING-CH finger protein 8,MARCHF8,220972,ENSG00000165406,NA,NA,March8 (MGI:1919029)
10,45727042,45792963,10q11.22,10q11.22,613631,"WASHC2C, FAM21C, VPEF, KIAA0592","WASH complex, subunit 2C",WASHC2C,253725,ENSG00000172661,NA,NA,Washc2 (MGI:106463)
10,45972452,46003741,10q11.21-q11.23,10q11.22,605034,TIMM23,"Translocase of inner mitochondrial membrane 23, Yeast, homolog of",TIMM23,100287932,ENSG00000265354,NA,NA,Timm23 (MGI:1858317)
10,46005087,46030713,10q11.2,10q11.22,601984,"NCOA4, ELE1, PTC3",Nuclear receptor coactivator 4,NCOA4,8031,ENSG00000266412,fused with RET to form PTC3,NA,Ncoa4 (MGI:1350932)
10,46033304,46046268,10q11.2,10q11.22,157145,"MSMB, HPC13","Microseminoprotein, beta",MSMB,4477,ENSG00000263639,NA,"{Prostate cancer, hereditary, 13}, 611928 (3)",Msmb (MGI:97166)
10,46458547,46470693,10q11.2-q21.2,10q11.22,601790,"PPYR1, NPY4R, PP1",Pancreatic polypeptide receptor-1,NPY4R,5540,ENSG00000204174,NA,NA,NA
10,46543973,46557417,10q11.22,10q11.22,611240,"GPRIN2, GRIN2",G protein-regulated inducer of neurite outgrowth 2,GPRIN2,9721,ENSG00000204175,NA,NA,Gprin2 (MGI:2444560)
10,46578017,46595169,10q11.1,10q11.22,608081,SYT15,Synaptotagmin 15,SYT15,83849,ENSG00000204176,NA,NA,Syt15 (MGI:2442166)
10,46911371,47003828,10q11.2,10q11.22,610630,PTPN20A,"Protein tyrosine phosphatase, nonreceptor-type, 20A",PTPN20,26095,ENSG00000204179,NA,NA,NA
10,46911371,47003828,10q11.2,10q11.22,610631,PTPN20B,"Protein tyrosine phosphatase, nonreceptor-type, 20B",PTPN20,26095,ENSG00000204179,NA,NA,Ptpn20 (MGI:1196295)
10,47300196,47313576,10q11.22,10q11.22,601361,"GDF10, BMP3B",Growth/differentiation factor 10,GDF10,2662,ENSG00000266524,NA,NA,Gdf10 (MGI:95684)
10,47322453,47327587,10q11.22,10q11.22,605120,"GDF2, BMP9, HHT5",Growth differentiation factor 2 (bone morphogenetic protein 9),GDF2,2658,ENSG00000263761,NA,"Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3), Autosomal dominant",Gdf2 (MGI:1321394)
10,47348362,47357880,10q11.2,10q11.22,180290,"RBP3, RP66","Retinol-binding protein-3, interstitial",RBP3,5949,ENSG00000265203,1 family identified with mutation,"?Retinitis pigmentosa 66, 615233 (3), Autosomal recessive",Rbp3 (MGI:97878)
10,47467992,47991878,10q11.2,10q11.22,602396,ANXA8,Annexin A8,ANXA8,653145,ENSG00000265190,NA,NA,Anxa8 (MGI:1201374)
10,48156558,48274695,10q11.22,10q11.22,613323,FRMPD2,FERM and PDZ domains-containing protein 2,FRMPD2,143162,ENSG00000170324,NA,NA,Frmpd2 (MGI:2685472)
10,48306638,48439359,10q11.2,10q11.22,601158,"MAPK8, PRKM8, JNK1, SAPK1",Mitogen-activated protein kinase 8,MAPK8,5599,ENSG00000107643,NA,NA,Mapk8 (MGI:1346861)
10,48429830,48656264,10q11,10q11.22-q11.23,610585,ARHGAP22,Rho GTPase-activating protein 22,ARHGAP22,58504,ENSG00000128805,NA,NA,Arhgap22 (MGI:2443418)
10,48600000,51100000,10q11.23,NA,610987,"ASAH2C, ASAH2L",N-acylsphingosine amidohydrolase 2C,NA,NA,NA,NA,NA,NA
10,48600000,80300000,10q11.23-q22.3,NA,614237,HYPT9,Hypotrichosis 9,NA,100736250,NA,between D10S538 and D10S2327,"Hypotrichosis 9, 614237 (2), Autosomal recessive",NA
10,48684826,48982955,10q11.22-q11.23,10q11.23,613316,"WDFY4, KIAA1607",WD repeat- and FYVE domain-containing protein 4,WDFY4,57705,ENSG00000128815,NA,NA,Wdfy4 (MGI:3584510)
10,49364065,49396088,10q11.23,10q11.23,606701,"DRGX, DRG11",Dorsal root ganglia homeobox,DRGX,644168,ENSG00000165606,NA,NA,NA
10,49454469,49539537,10q11,10q11.23,609413,"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11","Excision repair cross complementing rodent repair deficiency, complementation group 6",ERCC6,2074,ENSG00000225830,NA,"Cerebrooculofacioskeletal syndrome 1, 214150 (3), Autosomal recessive; Cockayne syndrome, type B, 133540 (3), Autosomal recessive; De Sanctis-Cacchione syndrome, 278800 (3), Autosomal recessive; {Lung cancer, susceptibility to}, 211980 (3), Autosomal dominant, Somatic mutation; {Macular degeneration, age-related, susceptibility to, 5}, 613761 (3); Premature ovarian failure 11, 616946 (3), Autosomal dominant; UV-sensitive syndrome 1, 600630 (3), Autosomal recessive",Ercc6 (MGI:1100494)
10,49609094,49665103,10q11.2,10q11.23,118490,"CHAT, CMS6",Choline acetyltransferase,CHAT,1103,ENSG00000070748,NA,"Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3), Autosomal recessive",Chat (MGI:88392)
10,49610309,49612719,10q11.2,10q11.23,600336,"SLC18A3, VACHT, CMS21","Solute carrier family 18 (vesicular acetylcholine), member 3",SLC18A3,6572,ENSG00000187714,NA,"Myasthenic syndrome, congenital, 21, presynaptic, 617239 (3), Autosomal recessive",Slc18a3 (MGI:1101061)
10,49734640,49762378,10q11.23,10q11.23,617513,"OGDHL, KIAA1290",Oxoglutarate dehydrogenase-like protein,OGDHL,55753,ENSG00000197444,NA,NA,Ogdhl (MGI:3616088)
10,49818273,49942026,10q11.23,10q11.23,603501,PARG,Poly(ADP-ribose) glycohydrolase,PARG,8505,ENSG00000227345,NA,NA,Parg (MGI:1347094)
10,50184860,50251563,10q11.23,10q11.23,611202,ASAH2,N-acylsphingosine amidohydrolase 2,ASAH2,56624,ENSG00000188611,NA,NA,Asah2 (MGI:1859310)
10,50305599,50623955,10q11.2,10q11.23,611573,"SGMS1, SMS1, TMEM23, MOB",Sphingomyelin synthase 1,SGMS1,259230,ENSG00000198964,NA,NA,Sgms1 (MGI:2444110)
10,50799408,50885674,10q11.21,10q11.23,618199,"A1CF, ASP",APOBEC1 complementation factor,A1CF,29974,ENSG00000148584,NA,NA,A1cf (MGI:1917115)
10,50990887,52298349,10q11.2,10q11.2-q21.1,176894,"PRKG1, PRKG1B, PRKGR1B, AAT8","Protein kinase, cGMP-dependent, regulatory, type I",PRKG1,5592,ENSG00000185532,NA,"Aortic aneurysm, familial thoracic 8, 615436 (3), Autosomal dominant",Prkg1 (MGI:108174)
10,51100000,68800000,10q21,NA,613065,ALL1,"Leukemia, acute lymphocytic, susceptibility to, 1",NA,100310785,NA,associated with rs10821936,"{Leukemia, acute lymphocytic, susceptibility to, 1}, 613065 (2)",NA
10,51100000,68800000,10q21,NA,612369,ALPQTL4,"Alkaline phosphatase, plasma level of, QTL 4",NA,100196916,NA,linkage with rs12355784,"{Alkaline phosphatase, plasma level of, QTL4}, 612369 (2)",NA
10,51100000,68800000,10q21,NA,612255,IBD15,Inflammatory bowel disease 15,NA,100190929,NA,association with rs10761659,"{Inflammatory bowel disease 15}, 612255 (2)",NA
10,51100000,68800000,10q21,NA,612357,MAFD8,Major affective disorder 8,NA,100196912,NA,associated with rs20994336,"{Major affective disorder-8, susceptibility to}, 612357 (2)",NA
10,51100000,59400000,10q21.1,NA,612717,MYP15,Myopia 15,MYP15,100294716,NA,max lod at D10S1643,"Myopia 15, 612717 (2), Autosomal dominant",NA
10,51695485,51699594,10q22-q23,10q21.1,611968,"CSTF2T, KIAA0689","Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD, tau variant",CSTF2T,23283,ENSG00000177613,NA,NA,Cstf2t (MGI:1932622)
10,52314280,52317656,10q11.2,10q21.1,605189,DKK1,"Dickkopf, Xenopus, homolog of, 1",DKK1,22943,ENSG00000107984,NA,NA,Dkk1 (MGI:1329040)
10,52764976,52772846,10q11.2-q21,10q21.1,154545,"MBL2, MBL, MBP1, MBL2D, MBPD","Mannose-binding lectin 2, soluble (opsonic defect)",MBL2,4153,ENSG00000165471,near MEN2A,"{Chronic infections, due to MBL deficiency}, 614372 (3), Autosomal dominant",Mbl2 (MGI:96924)
10,53802770,55629181,10q21-q22,10q21.1,605514,"PCDH15, DFNB23, USH1F",Protocadherin 15,PCDH15,65217,ENSG00000150275,NA,"Deafness, autosomal recessive 23, 609533 (3), Autosomal recessive; Usher syndrome, type 1D/F digenic, 601067 (3), Autosomal recessive, Digenic recessive; Usher syndrome, type 1F, 602083 (3), Autosomal recessive",Pcdh15 (MGI:1891428)
10,56357226,56361272,10q21-q22,10q21.1,609177,"ZWINT, SIP30",ZW10 interacting kinetochore protein,ZWINT,11130,ENSG00000122952,NA,NA,Zwint (MGI:1289227)
10,58191516,58269960,10q21,10q21.1,609851,IPMK,Inositol polyphosphate multikinase,IPMK,253430,ENSG00000151151,NA,NA,Ipmk (MGI:1916968)
10,58269161,58289585,10q21.1,10q21.1,611932,"CISD1, MITONEET",CDGSH iron sulfur domain protein 1,CISD1,55847,ENSG00000122873,NA,NA,Cisd1 (MGI:1261855)
10,58334978,58370752,10q11.2-q21,10q21.1,602961,"UBE2D1, UBCH5A, UBCH5",Ubiquitin-conjugating enzyme E2D 1,UBE2D1,7321,ENSG00000072401,NA,NA,Ube2d1 (MGI:2384911)
10,58385142,58399229,10q21,10q21.1,600438,"TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6, MTDPS15","Transcription factor A, mitochondrial",TFAM,7019,ENSG00000108064,mutation identified in 1 MTDPS15 family,"?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type), 617156 (3), Autosomal recessive",Tfam (MGI:107810)
10,58512871,58831434,10q21.2,10q21.1,614295,"BICC1, BICC, CYSRD","Bicaudal C, Drosophila, homolog of, 1",BICC1,80114,ENSG00000122870,NA,"{Renal dysplasia, cystic, susceptibility to}, 601331 (3), Autosomal dominant",Bicc1 (MGI:1933388)
10,59650763,59710078,10q21.2,10q21.2,614242,"SLC16A9, MCT9","Solute carrier family 16 (monocarboxylic acid transporter), member 9",SLC16A9,220963,ENSG00000165449,NA,NA,Slc16a9 (MGI:1914109)
10,59736691,59753454,10q21.2,10q21.2,616246,"MRLN, LINC00948",Myoregulin,MRLN,100507027,ENSG00000227877,NA,NA,NA
10,59788746,59906555,10q21,10q21.2,601985,"CCDC6, D10S170, H4, TST1",Coiled-coil domain-containing 6,CCDC6,8030,ENSG00000108091,fused with RET to form PTC1,NA,Ccdc6 (MGI:1923801)
10,60026297,60733527,10q21,10q21.2,600465,"ANK3, MRT37","Ankyrin-3, node of Ranvier",ANK3,288,ENSG00000151150,mutation identified in 1 family,"?Mental retardation, autosomal recessive, 37, 615493 (3), Autosomal recessive",Ank3 (MGI:88026)
10,60778330,60794851,10q21.1,10q21.2,116940,"CDK1, CDC2",Cyclin-dependent kinase 1,CDK1,983,ENSG00000170312,NA,NA,Cdk1 (MGI:88351)
10,60869437,61001485,10q21.1,10q21.2,607351,"RHOBTB1, KIAA0740",Rho-related BTB domain-containing protein 1,RHOBTB1,9886,ENSG00000072422,NA,NA,Rhobtb1 (MGI:1916538)
10,61406641,61453449,10q21.2,10q21.2,617803,TMEM26,Transmembrane protein 26,TMEM26,219623,ENSG00000196932,NA,NA,Tmem26 (MGI:2143537)
10,61901253,62096943,10q21.2,10q21.2,608538,"ARID5B, MRF2, DESRT",AT-rich interaction domain-containing protein 5B,ARID5B,84159,ENSG00000150347,NA,NA,Arid5b (MGI:2175912)
10,62159130,62268878,10q21.3,10q21.2,618450,RTKN2,Rhotekin 2,RTKN2,219790,ENSG00000182010,NA,NA,Rtkn2 (MGI:2158417)
10,62374156,62672010,10q21.2,10q21.2,607818,"ZNF365, UAN",Zinc finger protein 365,ZNF365,22891,ENSG00000138311,NA,"{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)",Zfp365 (MGI:2143676)
10,62800000,73100000,10q21.3-q22.1,NA,604185,HCFP2,"Facial paresis, hereditary congenital, 2",MBS3,22811,NA,NA,"Facial paresis, hereditary congenital, 2, 604185 (2), Autosomal dominant",NA
10,62800000,80300000,10q21.3-q22.3,NA,613339,HWE1,"Epilepsy, hot water, 1",NA,100415903,NA,max lod at D10S412,"Epilepsy, hot water, 1, 613339 (2), Autosomal dominant",NA
10,62800000,68800000,10q21.3,NA,614996,MSE,Myelinating Schwann cell element,NA,101180900,NA,NA,NA,NA
10,62804719,62808478,10q21.3,10q21.3,611392,"ADO, C10orf22",2-aminoethanethiol dioxygenase,ADO,84890,ENSG00000181915,NA,NA,Ado (MGI:2685083)
10,62811995,62819166,10q21.1-q22.1,10q21.3,129010,"EGR2, KROX20, CHN1","KROX-20, Drosophila, homolog of (early growth response-2)",EGR2,1959,ENSG00000122877,NA,"Charcot-Marie-Tooth disease, type 1D, 607678 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Hypomyelinating neuropathy, congenital, 1, 605253 (3), Autosomal recessive, Autosomal dominant",Egr2 (MGI:95296)
10,63133246,63155030,10q21.3,10q21.3,616477,"NRBF2, COPR",Nuclear receptor-binding factor 2,NRBF2,29982,ENSG00000148572,NA,NA,Nrbf2 (MGI:1354950)
10,63167220,63521889,10q21.3,10q21.3,604503,"JMJD1C, TRIP8, KIAA1380",Jumonji domain-containing protein 1C,JMJD1C,221037,ENSG00000171988,NA,NA,Jmjd1c (MGI:1918614)
10,63521352,63625127,10q21.3,10q21.3,609348,"REEP3, C10orf74",Receptor expression-enhancing protein 3,REEP3,221035,ENSG00000165476,NA,NA,Reep3 (MGI:88930)
10,65912517,67696216,10q21,10q21.3,607667,"CTNNA3, ARVD13","Catenin, alpha-3",CTNNA3,29119,ENSG00000183230,NA,"Arrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3), Autosomal dominant",Ctnna3 (MGI:2661445)
10,66926035,67101550,10q21.3,10q21.3,610869,LRRTM3,Leucine-rich repeat transmembrane protein 3,LRRTM3,347731,ENSG00000198739,NA,NA,Lrrtm3 (MGI:2389177)
10,67796664,67838187,10q21.1,10q21.3,606060,"DNAJC12, JDP1, HPANBH4","DNAJ/HSP40 homolog, subfamily C, member 12",DNAJC12,56521,ENSG00000108176,NA,"Hyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3), Autosomal recessive",Dnajc12 (MGI:1353428)
10,67884655,67918389,10q21.3,10q21.3,604479,"SIRT1, SIR2L1","Sirtuin, S. cerevisiae, homolog 1",SIRT1,23411,ENSG00000096717,NA,NA,Sirt1 (MGI:2135607)
10,68087906,68212016,10q21.1,10q21.3,608517,"MYPN, CMD1DD, CMH22, RCM4, NEM11",Myopalladin,MYPN,84665,ENSG00000138347,NA,"Cardiomyopathy, dilated, 1KK, 615248 (3), Autosomal dominant; Cardiomyopathy, familial restrictive, 4, 615248 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 22, 615248 (3), Autosomal dominant; Nemaline myopathy 11, autosomal recessive, 617336 (3), Autosomal recessive",Mypn (MGI:1916052)
10,68230594,68232112,10q21.3-q22.1,10q21.3,609875,"ATOH7, PHPVAR, NCRNA","Atonal, Drosophila, homolog of, 7",ATOH7,220202,ENSG00000179774,NA,"Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3), Autosomal recessive",Atoh7 (MGI:1355553)
10,68282659,68332957,10q21.1,10q21.3,612189,"PBLD, MAWBP, MAWDBP",Phenazine biosynthesis-like protein domain-containing protein,PBLD,64081,ENSG00000108187,NA,NA,Pbld1 (MGI:1915621)
10,68331692,68343195,10q22,10q21.3,602324,"HNRPH3, 2H9",Heterogeneous nuclear ribonucleoprotein H3,HNRNPH3,3189,ENSG00000096746,NA,NA,Hnrnph3 (MGI:1926462)
10,68341106,68407301,10q21.1,10q21.3,610328,"RUFY2, KIAA1537",RUN and FYVE domains-containing protein 2,RUFY2,55680,ENSG00000204130,NA,NA,Rufy2 (MGI:1917682)
10,68414063,68472520,10q21.3-q22.1,10q21.3,601810,"DNA2, DNA2L, KIAA0083, PEOA6, SCKL8","DNA replication helicase 2, yeast, homolog of",DNA2,1763,ENSG00000138346,mutation identified in 1 SCKL8 family,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3), Autosomal dominant; ?Seckel syndrome 8, 615807 (3), Autosomal recessive",Dna2 (MGI:2443732)
10,68477997,68527522,10q21.3-q22.1,10q21.3,139080,"SLC25A16, D10S105E, GDA","Solute carrier family 25 (mitochondrial carrier), member 16 (Graves disease autoantigen)",SLC25A16,8034,ENSG00000122912,NA,NA,Slc25a16 (MGI:1920382)
10,68560336,68700793,10q22,10q21.3,607790,"TET1, CXXC6, LCX, KIAA1676",tet oncogene 1,TET1,80312,ENSG00000138336,NA,NA,Tet1 (MGI:1098693)
10,68721143,68792376,10q21.3,10q21.3,612569,"CCAR1, CARP1",Cell division cycle and apoptosis regulator 1,CCAR1,55749,ENSG00000060339,NA,NA,Ccar1 (MGI:1914750)
10,68800000,104000000,10q22-q24,NA,608583,ATFB1,"Atrial fibrillation, familial, 1",NA,406216,NA,NA,"Atrial fibrillation, familial, 1, 608583 (2), Autosomal dominant",NA
10,68800000,95300000,10q22-q23,NA,611706,MGR12,"Migraine, with or without aura, susceptibility to, 12",NA,100188851,NA,max lod at 100cM,"{Migraine, with or without aura, susceptibility to, 12}, 611706 (2), Autosomal dominant",NA
10,68800000,97500000,10q22.1-q24.1,NA,609041,SPG27,"Spastic paraplegia-27, autosomal recessive",SPG27,414886,NA,between  D10S606 and D10S1758,"Spastic paraplegia 27, autosomal recessive, 609041 (2), Autosomal recessive",NA
10,68800000,80300000,10q22,NA,611003,SQTL1,Smoking as a quantitative trait locus 1,NA,100188827,NA,near D10S1432,"{Smoking as a quantitative trait locus 1}, 611003 (2)",NA
10,68827530,68895941,10q22.1,10q22.1,609397,"STOX1, PEE4",Storkhead box 1,STOX1,219736,ENSG00000165730,NA,"Preeclampsia/eclampsia 4, 609404 (3)",Stox1 (MGI:2684909)
10,68898816,68956311,10q22.1,10q22.1,610373,"DDX50, GUB",DEAD/H box 50,DDX50,79009,ENSG00000107625,NA,NA,Ddx50 (MGI:2182303)
10,68956130,68985068,10q21,10q22.1,606357,DDX21,DEAD/H box 21,DDX21,9188,ENSG00000165732,NA,NA,Ddx21 (MGI:1860494)
10,68988802,69016981,10q22.1,10q22.1,609367,KIAA1279,KIAA1279 gene,KIFBP,26128,ENSG00000198954,NA,"Goldberg-Shprintzen megacolon syndrome, 609460 (3), Autosomal recessive",Kif1bp (MGI:1919570)
10,69057532,69104810,10q22.1,10q22.1,177040,"SRGN, PRG1, PRG",Serglycin,SRGN,5552,ENSG00000122862,NA,NA,NA
10,69124152,69174415,10q21.1,10q22.1,605506,"VPS26A, VPS26, HB58","Vacuolar protein sorting 26, yeast, homolog of, A",VPS26A,9559,ENSG00000122958,NA,NA,Vps26a (MGI:1353654)
10,69180233,69209092,10q22.1,10q22.1,605122,SUPV3L1,Suv3-like 1,SUPV3L1,6832,ENSG00000156502,NA,NA,Supv3l1 (MGI:2441711)
10,69220302,69267551,10q22.1,10q22.1,617221,HKDC1,Hexokinase domain-containing protein 1,HKDC1,80201,ENSG00000156510,NA,NA,Hkdc1 (MGI:2384910)
10,69269990,69401881,10q22,10q22.1,142600,"HK1, HKD, HMSNR, RP79",Hexokinase-1,HK1,3098,ENSG00000156515,10p11.2 conflicting assignment; ?2 loci on chr.10,"Hemolytic anemia due to hexokinase deficiency, 235700 (3), Autosomal recessive; Neuropathy, hereditary motor and sensory, Russe type, 605285 (3), Autosomal recessive; Retinitis pigmentosa 79, 617460 (3), Autosomal dominant",Hk1 (MGI:96103)
10,69403902,69416917,10q11-q21,10q22.1,162321,"TACR2, TAC2R, NKNAR",Tachykinin receptor 2 (substance K receptor; neurokinin 2 receptor),TACR2,6865,ENSG00000075073,NA,NA,Tacr2 (MGI:98477)
10,69451463,69549507,10q22.1,10q22.1,613140,"TSPAN15, NET7",Tetraspanin 15,TSPAN15,23555,ENSG00000099282,NA,NA,Tspan15 (MGI:1917673)
10,69571439,69573424,10q21.3,10q22.1,604882,"NEUROG3, NGN3, ATOH5",Neurogenin 3,NEUROG3,50674,ENSG00000122859,NA,"Diarrhea 4, malabsorptive, congenital, 610370 (3), Autosomal recessive",Neurog3 (MGI:893591)
10,69801834,69959143,10q22,10q22.1,120350,"COL13A1, CMS19","Collagen XIII, alpha-1 polypeptide",COL13A1,1305,ENSG00000197467,~550kb proximal to P4HA,"Myasthenic syndrome, congenital, 19, 616720 (3), Autosomal recessive",Col13a1 (MGI:1277201)
10,70052845,70112281,10q22.3,10q22.1,616141,H2AFY2,"H2A histone family, member Y2",H2AFY2,55506,ENSG00000099284,NA,NA,H2afy2 (MGI:3037658)
10,70137980,70146739,10q22.1,10q22.1,611017,TYSND1,Trypsin domain-containing protein 1,TYSND1,219743,ENSG00000156521,NA,NA,Tysnd1 (MGI:1919017)
10,70147288,70170513,10q22.1,10q22.1,607691,"SARA1, SAR1A","Sar1a, S. cerevisiae, homolog 1",SAR1A,56681,ENSG00000079332,NA,NA,Sar1a (MGI:98230)
10,70202830,70233428,10q21.3,10q22.1,179030,PP,Inorganic pyrophosphatase,PPA1,5464,ENSG00000180817,NA,NA,Ppa1 (MGI:97831)
10,70247328,70284003,10q21,10q22.1,607448,"NPFFR1, NPFF1, GPR147",Neuropeptide FF receptor 1,NPFFR1,64106,ENSG00000148734,NA,NA,Npffr1 (MGI:2685082)
10,70404144,70428617,10q21-q22,10q22.1,602224,"EIF4EBP2, 4EBP2",Eukaryotic translation initiation factor-4E binding protein-1,EIF4EBP2,1979,ENSG00000148730,NA,NA,Eif4ebp2 (MGI:109198)
10,70431935,70447947,10q22.1,10q22.1,601265,"NODAL, HTX5","Nodal, mouse, homolog of",NODAL,4838,ENSG00000156574,NA,"Heterotaxy, visceral, 5, 270100 (3), Autosomal dominant",Nodal (MGI:97359)
10,70458541,70568449,10q22.1,10q22.1,614656,"KIAA1274, PALD","Paladin, mouse, homolog of",PALD1,27143,ENSG00000107719,NA,NA,Pald1 (MGI:1351623)
10,70597347,70602787,10q22,10q22.1,170280,"PRF1, HPLH2, FLH2",Perforin,PRF1,5551,ENSG00000180644,mistakenly assigned to chr.17,"Aplastic anemia, 609135 (3); Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3), Autosomal recessive; Lymphoma, non-Hodgkin, 605027 (3)",Prf1 (MGI:97551)
10,70672505,70762440,10q22.1,10q22.1,607506,ADAMTS14,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 14",ADAMTS14,140766,ENSG00000138316,NA,NA,Adamts14 (MGI:2179942)
10,70771236,70785418,10q22.1,10q22.1,612640,C10orf27,chromosome 10 open reading frame 27,TBATA,219793,ENSG00000166220,NA,NA,Tbata (MGI:1923820)
10,70815919,70881183,10q22.1,10q22.1,603729,"SGPL1, SPL, NPHS14",Sphingosine-1-phosphate lyase 1,SGPL1,8879,ENSG00000166224,NA,"Nephrotic syndrome, type 14, 617575 (3), Autosomal recessive",Sgpl1 (MGI:1261415)
10,70882279,70888564,10q22,10q22.1,126090,"PCBD1, DCOH",Pterin-4a-carbinolamine dehydratase 1,PCBD1,5092,ENSG00000166228,NA,"Hyperphenylalaninemia, BH4-deficient, D, 264070 (3), Autosomal recessive",Pcbd1 (MGI:94873)
10,71212534,71302878,10q21-q22,10q22.1,607870,"UNC5B, UNC5H2","Unc5, C. elegans, homolog of, B",UNC5B,219699,ENSG00000107731,NA,NA,Unc5b (MGI:894703)
10,71319252,71363389,10q22.1,10q22.1,612373,"SLC29A3, ENT3, PHID, HCLAP","Solute carrier family 29 (nucleoside transporter), member 3",SLC29A3,55315,ENSG00000198246,NA,"Histiocytosis-lymphadenopathy plus syndrome, 602782 (3), Autosomal recessive",Slc29a3 (MGI:1918529)
10,71396919,71815946,10q21-q22,10q22.1,605516,"CDH23, USH1D, DFNB12, PITA5",Cadherin-23 (otocadherin),CDH23,64072,ENSG00000107736,between D10S529 and D10S573,"Deafness, autosomal recessive 12, 601386 (3), Autosomal recessive; {Pituitary adenoma 5, multiple types}, 617540 (3), Autosomal dominant; Usher syndrome, type 1D, 601067 (3), Autosomal recessive, Digenic recessive; Usher syndrome, type 1D/F digenic, 601067 (3), Autosomal recessive, Digenic recessive",Cdh23 (MGI:1890219)
10,71747555,71773519,10q22.1,10q22.1,615608,"VSIR, C10orf54, B7H5",V-set immunoregulatory receptor,VSIR,64115,ENSG00000107738,NA,NA,Vsir (MGI:1921298)
10,71816297,71851250,10q22.1,10q22.1,176801,"PSAP, SAP1",Prosaposin (sphingolipid activator protein-1),PSAP,5660,ENSG00000197746,NA,"Combined SAP deficiency, 611721 (3), Autosomal recessive; Gaucher disease, atypical, 610539 (3); Krabbe disease, atypical, 611722 (3), Autosomal recessive; Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3), Autosomal recessive",Psap (MGI:97783)
10,71964394,72013561,10q22.1,10q22.1,603799,"CHST3, C6ST, C6ST1, HSD",Carbohydrate sulfotransferase 3,CHST3,9469,ENSG00000122863,NA,"Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3), Autosomal recessive",Chst3 (MGI:1858224)
10,72059033,72095312,10q21-q23,10q22.1,607988,"SPOCK2, KIAA0275","SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 2",SPOCK2,9806,ENSG00000107742,NA,NA,Spock2 (MGI:1891351)
10,72096031,72218776,10q22.1,10q22.1,614215,"ASCC1, p50, SMABF2","Activating signal cointegrator 1 complex, subunit 1",ASCC1,51008,ENSG00000138303,mutation identified in 1 SMABF2 family,"Barrett esophagus/esophageal adenocarcinoma, 614266 (3); ?Spinal muscular atrophy with congenital bone fractures 2, 616867 (3), Autosomal recessive",Ascc1 (MGI:1916340)
10,72215999,72235859,10q22.1,10q22.1,613427,"ANAPC16, MSAG, C10orf104","Anaphase-promoting complex, subunit 16",ANAPC16,119504,ENSG00000166295,NA,NA,Anapc16 (MGI:1289325)
10,72273923,72276035,10q24.33,10q22.1,607729,"DDIT4, REDD1, RTP801",DNA damage-inducible transcript 4,DDIT4,54541,ENSG00000168209,NA,NA,Ddit4 (MGI:1921997)
10,72332834,72354918,10q22.2,10q22.1,608376,"DNAJB12, DJ10, FLJ0027","DNAJ, E. coli, homolog of, subfamily B, member 12",DNAJB12,54788,ENSG00000148719,NA,NA,Dnajb12 (MGI:1931881)
10,72367325,72626190,10q22.1,10q22.1,605084,"MICU1, CBARA1, MPXPS",Mitochondrial calcium uptake protein 1,MICU1,10367,ENSG00000107745,NA,"Myopathy with extrapyramidal signs, 615673 (3), Autosomal recessive",Micu1 (MGI:2384909)
10,72692130,72887693,10q22.1,10q22.1,614197,"MCU, CCDC109A",Mitochondrial calcium uniporter,MCU,90550,ENSG00000156026,NA,NA,Mcu (MGI:3026965)
10,72893555,72933035,10q21.3,10q22.1,609330,"OIT3, LZP","Oncoprotein-induced transcript 3, mouse, homolog of",OIT3,170392,ENSG00000138315,NA,NA,Oit3 (MGI:1201782)
10,72934761,72955043,10q22.1,10q22.1,611653,"PLA2G12B, GXIIB","Phospholipase A2, group XIIB",PLA2G12B,84647,ENSG00000138308,NA,NA,Pla2g12b (MGI:1917086)
10,73007216,73096973,10q21.3-q23.1,10q22.1,176710,"P4HA1, P4HA","Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide 1",P4HA1,5033,ENSG00000122884,NA,NA,P4ha1 (MGI:97463)
10,73133667,73168094,10q22.2,10q22.2,616464,"ECD, SGT1","Ecdysoneless, Drosophila, homolog of",ECD,11319,ENSG00000122882,NA,NA,Ecd (MGI:1917851)
10,73168089,73244503,10q22.2,10q22.2,618413,"FAM149B1, KIAA0974","Family with sequence similarity 149, member B1",FAM149B1,317662,ENSG00000138286,NA,NA,Fam149b (MGI:2145567)
10,73241953,73247254,10q22.2,10q22.2,611206,"DNAJC9, JDD1, KIAA0974","DNAJ/HSP40 homolog, subfamily C, member 9",DNAJC9,23234,ENSG00000213551,NA,NA,Dnajc9 (MGI:1915326)
10,73248848,73252643,10q22.1,10q22.2,609204,"MRPS16, COXPD2",Mitochondrial ribosomal protein S16,MRPS16,51021,ENSG00000182180,NA,"Combined oxidative phosphorylation deficiency 2, 610498 (3), Autosomal recessive",Mrps16 (MGI:1913492)
10,73375100,73414057,10q21.1-q21.2,10q22.2,186360,"ANXA7, SNX",Annexin A7 (synexin),ANXA7,310,ENSG00000138279,NA,NA,Anxa7 (MGI:88031)
10,73423578,73433560,10q22.2,10q22.2,614773,"MSS51, ZMYND17","MSS51 mitochondrial translational activator, S. cerevisiae, homolog of",MSS51,118490,ENSG00000166343,NA,NA,Mss51 (MGI:1922093)
10,73436427,73496023,10q21-q22,10q22.2,114106,"PPP3CB, CALNB","Protein phosphatase-3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta)",PPP3CB,5532,ENSG00000107758,NA,NA,Ppp3cb (MGI:107163)
10,73631611,73641473,10q22.1,10q22.2,605603,MYOZ1,Myozenin 1 (calsarcin 2),MYOZ1,58529,ENSG00000177791,NA,NA,Myoz1 (MGI:1929471)
10,73744163,73772166,10q22.2,10q22.2,607185,"SEC24C, KIAA0079","Sec24-related gene family, member C",SEC24C,9632,ENSG00000176986,NA,NA,Sec24c (MGI:1919746)
10,73772275,73779103,10q22.2,10q22.2,616932,"FUT11, FUCTXI",Fucosyltransferase 11,FUT11,170384,ENSG00000196968,NA,NA,Fut11 (MGI:1920318)
10,73801915,73811819,10q22,10q22.2,603268,NDST2,N-deacetylase/N-sulfotransferase 2,NDST2,8509,ENSG00000166507,in intron of PCDH15,NA,Ndst2 (MGI:97040)
10,73812500,73874590,10q22,10q22.2,602123,"CAMK2G, CAMKG",Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma,CAMK2G,818,ENSG00000148660,in intron of PCDH15,NA,Camk2g (MGI:88259)
10,73909181,73917500,10q24,10q22.2,191840,"PLAU, URK, QPD, BDPLT5","Plasminogen activator, urokinase",PLAU,5328,ENSG00000122861,proximal to HOX11,"{Alzheimer disease, late-onset, susceptibility to}, 104300 (3), Autosomal dominant; Quebec platelet disorder, 601709 (3), Autosomal dominant",Plau (MGI:97611)
10,73998113,74121362,10q22.1-q23,10q22.2,193065,"VCL, CMD1W, CMH15",Vinculin,VCL,7414,ENSG00000035403,NA,"Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, hypertrophic, 15, 613255 (3), Autosomal dominant",Vcl (MGI:98927)
10,74120011,74151084,10q22.2,10q22.2,610366,AP3M1,"Adaptor-related protein complex 3, mu-1 subunit",AP3M1,26985,ENSG00000185009,NA,NA,Ap3m1 (MGI:1929212)
10,74151184,74709302,10q11-q24,10q22.2,102750,ADK,Adenosine kinase,ADK,132,ENSG00000156110,NA,"Hypermethioninemia due to adenosine kinase deficiency, 614300 (3), Autosomal recessive",Adk (MGI:87930)
10,74824926,75032623,10q22,10q22.2,605880,"KAT6B, MYST4, MORF, GTPTS",Lysine acetyltransferase 6B,KAT6B,23522,ENSG00000156650,NA,"Genitopatellar syndrome, 606170 (3), Autosomal dominant; SBBYSS syndrome, 603736 (3), Autosomal dominant",NA
10,75094431,75109220,10q22.2,10q22.2,613191,"DUSP13, TMDP, MDSP",Dual-specificity phosphatase 13,DUSP13,51207,ENSG00000079393,NA,NA,Dusp13 (MGI:1351599)
10,75099574,75182122,10q22.2,10q22.2,611575,"SAMD8, SMSR",Sterile alpha motif domain-containing 8,SAMD8,142891,ENSG00000156671,NA,NA,Samd8 (MGI:1914880)
10,75210153,75231447,10q22,10q22.2,193245,VDAC2,Voltage-dependent anion channel 2,VDAC2,7417,ENSG00000165637,NA,NA,Vdac2 (MGI:106915)
10,75279725,75401893,10q22.2,10q22.2,613902,"ZNF503, NOLZ1",Zinc finger protein 503,ZNF503,84858,ENSG00000165655,NA,NA,Zfp503 (MGI:1353644)
10,75431623,76560167,10q22.3,10q22.2-q22.3,614537,"LRMDA, C10orf11, OCA7",Leucine-rich melanocyte differentiation-associated protein,LRMDA,83938,ENSG00000148655,NA,"Albinism, oculocutaneous, type VII, 615179 (3), Autosomal recessive",Lrmda (MGI:1923883)
10,75900000,80300000,10q22.3,NA,608078,SCZD11,"Schizophrenia susceptibility locus, chromosome 10q-related",NA,404686,NA,between D10S1677 and D10S1753,"{Schizophrenia}, 181500 (2), Autosomal dominant",NA
10,75900000,80300000,10q22.3,NA,607965,SLEN1,"Systemic lupus erythematosus with nephritis, susceptibility to, 1",SLEN1,192677,NA,NA,"{Systemic lupus erythematosus with nephritis, susceptibility to, 1}, 607965 (2)",NA
10,75900000,80300000,10q22.3,NA,612388,SS3,"Sarcoidosis, susceptibility to, 3",NA,100196919,NA,associated with rs2789679 and rs1049550,"{Sarcoidosis, susceptibility to, 3}, 612388 (2)",NA
10,76869600,77637968,10q22.3,10q22.3,600150,"KCNMA1, SLO, PNKD3, CADEDS","Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)",KCNMA1,3778,ENSG00000156113,mutation identified in 1 CADEDS family,"?Cerebellar atrophy, developmental delay, and seizures, 617643 (3), Autosomal recessive; Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy, 609446 (3), Autosomal dominant",Kcnma1 (MGI:99923)
10,77790786,77926754,10q23,10q22.3,604090,"DLG5, PDLG, KIAA0583","Discs large, Drosophila, homolog of, 5",DLG5,9231,ENSG00000151208,NA,NA,Dlg5 (MGI:1918478)
10,77975148,78029514,10q22.3,10q22.3,614258,"POLR3A, RPC1, RPC155, ADDH, HLD7, WDRTS","Polymerase III, RNA, subunit A",POLR3A,11128,ENSG00000148606,NA,"Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3), Autosomal recessive; Wiedemann-Rautenstrauch syndrome, 264090 (3), Autosomal recessive",Polr3a (MGI:2681836)
10,78033759,78056805,10q22-q23,10q22.3,602412,"RPS24, DBA3",Ribosomal protein S24,RPS24,6229,ENSG00000138326,NA,"Diamond-blackfan anemia 3, 610629 (3), Autosomal dominant",Rps24 (MGI:98147)
10,79068965,79316518,10q22.1-q22.3,10q22.3,607159,"RAI17, KIAA1224, ZIMP10",Retinoic acid-induced gene 17,ZMIZ1,57178,ENSG00000108175,NA,NA,Zmiz1 (MGI:3040693)
10,79347468,79355333,10q22-q23,10q22.3,604486,"PPIF, CYP3","Peptidylprolyl-cis-trans-isomerase, mitochondrial",PPIF,10105,ENSG00000108179,NA,NA,Ppif (MGI:2145814)
10,79555851,79560458,10q22-q23,10q22.3,178642,"SFTPA2, SPA2, COLEC5","Surfactant, pulmonary-associated protein A2",SFTPA2,729238,ENSG00000185303,contiguous with SFTPA1,"Pulmonary fibrosis, idiopathic, 178500 (3), Autosomal dominant",NA
10,79610938,79615454,10q22.2-q23.1,10q22.3,178630,"SFTPA1, SFTP1","Surfactant, pulmonary-associated protein A1",SFTPA1,653509,ENSG00000122852,contiguous with SFTPA2,NA,Sftpa1 (MGI:109518)
10,79937739,79982235,10q23.3,10q22.3,178635,"SFTPD, SFTP4","Surfactant, pulmonary-associated protein D",SFTPD,6441,ENSG00000133661,NA,NA,Sftpd (MGI:109515)
10,80131660,80145358,10q22.3,10q22.3,612857,PLAC9,Placenta-specific gene 9,PLAC9,219348,ENSG00000189129,NA,NA,NA
10,80150888,80205807,10q22.3-q23.1,10q22.3,602572,"ANXA11, ANX11, ALS23",Annexin A11 (annexin XI),ANXA11,311,ENSG00000122359,NA,"Amytrophic lateral sclerosis 23, 617839 (3), Autosomal dominant",Anxa11 (MGI:108481)
10,80271819,80289657,10q22,10q22.3,610550,"MAT1A, MATA1, SAMS1","Methionine adenosyltransferase I, alpha",MAT1A,4143,ENSG00000151224,NA,"Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3), Autosomal recessive, Autosomal dominant; Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3), Autosomal recessive, Autosomal dominant",Mat1a (MGI:88017)
10,80300000,104000000,10q23-q24,NA,611920,CPROTQ,C-reactive protein QTL,NA,100188860,NA,max lod at D10S1239,"[C-reactive protein QTL], 611920 (2)",NA
10,80300000,95300000,10q23,NA,612242,"DEL10q23, C10DELq23",Chromosome 10q22.3-q23.2 deletion syndrome,NA,NA,NA,NA,"Chromosome 10q22.3-q23.2 deletion syndrome, 612242 (4)",NA
10,80300000,104000000,10q23-q24,NA,612288,IBD20,Inflammatory bowel disease 20,NA,100190788,NA,associated with rs11190140,"{Inflammatory bowel disease 20}, 612288 (2)",NA
10,80336012,80356786,10q23.1,10q23.1,615154,DYDC1,DPY30 domain-containing protein 1,DYDC1,143241,ENSG00000170788,NA,NA,Dydc1 (MGI:1916746)
10,80407828,80437114,10q23.1,10q23.1,617165,"FAM213A, PAMM","Family with sequence similarity 213, member A",PRXL2A,84293,ENSG00000122378,NA,NA,Prxl2a (MGI:1917814)
10,81875189,82989978,10q22,10q23.1,605533,NRG3,Neuregulin 3,NRG3,10718,ENSG00000185737,NA,NA,Nrg3 (MGI:1097165)
10,84167227,84172075,10q23.1,10q23.1,617434,HOST2,Long noncoding RNA HOST2,CERNA2,642934,ENSG00000285972,NA,NA,NA
10,84173763,84185293,10q23.1,10q23.1,617775,"C10orf99, CSBF, AP57",Chromosome 10 open reading frame 99,C10orf99,387695,ENSG00000188373,NA,NA,NA
10,84194536,84219620,10q23.1,10q23.1,609502,"CDHR1, PCDH21, PRCAD, CORD15, RP65","Cadherin-related family, member 1",CDHR1,92211,ENSG00000148600,NA,"Cone-rod dystrophy 15, 613660 (3), Autosomal recessive; Retinitis pigmentosa 65, 613660 (3), Autosomal recessive",Cdhr1 (MGI:2157782)
10,84231519,84241545,10q23.1,10q23.1,616103,"LRIT1, PAL","Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 1",LRIT1,26103,ENSG00000148602,"REc, A",NA,Lrit1 (MGI:2385320)
10,84243740,84259959,10q23,10q23.1,600342,"RGR, RP44",Retinal G protein coupled receptor,RGR,5995,ENSG00000148604,NA,"Retinitis pigmentosa 44, 613769 (3)",Rgr (MGI:1929473)
10,85599551,86366794,10q22,10q23.1-q23.2,610659,"GRID1, KIAA1220","Glutamate receptor, inotropic, delta 1",GRID1,2894,ENSG00000182771,NA,NA,Grid1 (MGI:95812)
10,86264693,86264787,10q23.2,10q23.2,611190,MIR346,Micro RNA 346,MIR346,442911,ENSG00000199104,NA,NA,NA
10,86435255,86521815,10q23.2,10q23.2,610754,"WAPAL, KIAA0261, FOE, WAPL","Wings apart-like protein, Drosophila, homolog of",WAPL,23063,ENSG00000062650,NA,NA,Wapl (MGI:2675859)
10,86653494,86666459,10q23.2,10q23.2,606665,OPN4,Opsin 4,OPN4,94233,ENSG00000122375,NA,NA,Opn4 (MGI:1353425)
10,86666787,86736071,10q22.2-q23.3,10q23.2,605906,"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",LIM domain binding 3,LDB3,11155,ENSG00000122367,NA,"Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 24, 601493 (3), Autosomal dominant; Left ventricular noncompaction 3, 601493 (3), Autosomal dominant; Myopathy, myofibrillar, 4, 609452 (3), Autosomal dominant",Ldb3 (MGI:1344412)
10,86755785,86927968,10q22.3,10q23.2,601299,"BMPR1A, ACVRLK3, ALK3","Bone morphogenetic protein receptor, type IA",BMPR1A,657,ENSG00000107779,NA,"Juvenile polyposis syndrome, infantile form, 174900 (3), Autosomal dominant; Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant",Bmpr1a (MGI:1338938)
10,86955758,86963259,10q23.2-q23.3,10q23.2,602998,"SNCG, BCSG1","Synuclein, gamma (breast cancer-specific gene 1)",SNCG,6623,ENSG00000173267,NA,NA,Sncg (MGI:1298397)
10,87050201,87094842,10q23.3,10q23.2,138130,GLUD1,Glutamate dehydrogenase-1,GLUD1,2746,ENSG00000148672,pseudogene on Xq26-q28,"Hyperinsulinism-hyperammonemia syndrome, 606762 (3), Autosomal dominant",Glud1 (MGI:95753)
10,87094477,87191468,10q23.2,10q23.2,618029,"SHLD2, RINN2, FAM35A","Shield complex, subunit 2",SHLD2,54537,ENSG00000122376,NA,NA,Shld2 (MGI:1922948)
10,87504465,87553460,10q23,10q23.2,605391,"MINPP1, HIPER1",Multiple inositol polyphosphate phosphatase 1,MINPP1,9562,ENSG00000107789,NA,"{Thyroid carcinoma, follicular}, 188470 (3), Autosomal dominant, Somatic mutation",Minpp1 (MGI:1336159)
10,87659877,87747704,10q22-q24,10q23.2-q23.3,603005,"PAPSS2, ATPSK2, BCYM4",3'-phosphoadenosine 5'-phosphosulfate synthase 2,PAPSS2,9060,ENSG00000198682,NA,"Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3), Autosomal recessive",Papss2 (MGI:1330223)
10,87700000,91100000,10q23.31,NA,613006,IDDM24,"Diabetes mellitus, insulin-dependent, 24",NA,100303715,NA,associated with rs10509540,"{Diabetes mellitus, insulin-dependent, 24}, 613006 (2)",NA
10,87700000,95300000,10q23.3,NA,609578,RCM2,"Cardiomyopathy, familial restrictive, 2",NA,619468,NA,max lod at D10S1242,"Cardiomyopathy, familial restrictive, 2, 609578 (2)",NA
10,87751511,87841358,10q23.31,10q23.31,614452,"ATAD1, THORASE, HKPX4","ATPase family, AAA domain-containing, member 1",ATAD1,84896,ENSG00000138138,NA,"Hyperekplexia 4, 618011 (3), Autosomal recessive",Atad1 (MGI:1915229)
10,87859160,87863436,10q23,10q23.31,612105,"KLLN, CWS4",Killin,KLLN,100144748,ENSG00000227268,NA,"Cowden syndrome 4, 615107 (3)",NA
10,87863624,87971929,10q23.31,10q23.31,601728,"PTEN, MMAC1, GLM2, CWS1",Phosphatase and tensin homolog (mutated in multiple advanced cancers 1),PTEN,5728,ENSG00000171862,NA,"Cowden syndrome 1, 158350 (3), Autosomal dominant; {Glioma susceptibility 2}, 613028 (3); Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant; Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant; {Meningioma}, 607174 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3)",Pten (MGI:109583)
10,88176051,88584479,10q23.33,10q23.31,609360,"RNLS, C10orf59",Renalase,RNLS,55328,ENSG00000184719,NA,NA,Rnls (MGI:1915045)
10,88583276,88623160,10q23.31,10q23.31,613921,"LIPJ, LIPL1",Lipase J,LIPJ,142910,ENSG00000204022,NA,NA,NA
10,88664441,88678814,10q23.31,10q23.31,601980,LIPF,"Lipase F, gastric type",LIPF,8513,ENSG00000182333,NA,NA,Lipf (MGI:1914967)
10,88706224,88753091,10q23.31,10q23.31,613922,"LIPK, LIPL2","Lipase family, member K",LIPK,643414,ENSG00000204021,NA,NA,Lipk (MGI:2679259)
10,88757225,88783661,10q23.31,10q23.31,613924,"LIPN, LIPL4, ARCI8, LI4","Lipase family, member N",LIPN,643418,ENSG00000204020,NA,"Ichthyosis, congenital, autosomal recessive 8, 613943 (3), Autosomal recessive",Lipn (MGI:1917416)
10,88802729,88822021,10q23.31,10q23.31,613923,"LIPM, LIPL3","Lipase family, member M",LIPM,340654,ENSG00000173239,NA,NA,Lipm (MGI:1926003)
10,88879367,88923501,10q23,10q23.31,612352,"STAMBPL1, KIAA1373",STAM-binding protein-like 1,STAMBPL1,57559,ENSG00000138134,NA,NA,Stambpl1 (MGI:1923880)
10,88935073,88991396,10q22-q24,10q23.31,102620,"ACTA2, ACTSA, AAT6, MYMY5","Actin, alpha-2, smooth muscle, aorta",ACTA2,59,ENSG00000107796,NA,"Aortic aneurysm, familial thoracic 6, 611788 (3), Autosomal dominant; Moyamoya disease 5, 614042 (3); Multisystemic smooth muscle dysfunction syndrome, 613834 (3), Autosomal dominant",Acta2 (MGI:87909)
10,88968428,89017060,10q24.1,10q23.31,134637,"FAS, TNFRSF6, APT1, CD95, ALPS1A",Fas cell surface death receptor,FAS,355,ENSG00000026103,NA,"Autoimmune lymphoproliferative syndrome, type IA, 601859 (3), Autosomal dominant; {Autoimmune lymphoproliferative syndrome}, 601859 (3), Autosomal dominant; Squamous cell carcinoma, burn scar-related, somatic (3)",Fas (MGI:95484)
10,89205628,89207316,10q23,10q23.31,604551,CH25H,Cholesterol 25-hydroxylase,CH25H,9023,ENSG00000138135,NA,NA,Ch25h (MGI:1333869)
10,89213568,89252038,10q23.31,10q23.31,613497,"LIPA, CESD","Lipase A, lysosomal acid, cholesterol esterase",LIPA,3988,ENSG00000107798,?close to GOT,"Cholesteryl ester storage disease, 278000 (3), Autosomal recessive; Wolman disease, 278000 (3), Autosomal recessive",Lipa (MGI:96789)
10,89302045,89309270,10q23.3,10q23.31,147040,"IFIT2, IFI54, G10P2",Interferon-induced protein with tetratricopeptide repeats 2,IFIT2,3433,ENSG00000119922,NA,NA,Ifit2 (MGI:99449)
10,89327996,89340967,10q23.3,10q23.31,604650,IFIT4,Interferon-induced protein with tetratricopeptide repeats 4,IFIT3,3437,ENSG00000119917,NA,NA,"Ifit3b,Ifit3 (MGI:1101055,MGI:3698419)"
10,89392545,89406486,10q23.3,10q23.31,147690,"IFIT1, IFI56, G10P1, IFNAI1",Interferon-induced protein with tetratricopeptide repeats 1,IFIT1,3434,ENSG00000185745,10q25-q26 = conflicting site,NA,"Ifit1bl1,Ifit1bl2 (MGI:2148249,MGI:3650685)"
10,89414567,89420996,10q23.31,10q23.31,616135,"IFIT5, RI58, ISG58",Interferon-induced protein with tetratricopeptide repeats 5,IFIT5,24138,ENSG00000152778,NA,NA,NA
10,89430298,89536028,10q23.3,10q23.31,611910,"SLC16A12, MCT12, CTRCT47","Solute carrier family 16 (monocarboxylic acid transporter), member 12",SLC16A12,387700,ENSG00000152779,mutation identified in 1 CTRCT47 family,"Cataract 47, juvenile, with microcornea, 612018 (3), Autosomal dominant",Slc16a12 (MGI:2147716)
10,89579494,89645571,10q23,10q23.31,606160,PANK1,Pantothenate kinase 1,PANK1,53354,ENSG00000152782,NA,NA,Pank1 (MGI:1922985)
10,89592746,89592826,10q23.31,10q23.31,613189,"MIR107, MIRN107",Micro RNA 107,MIR107,406901,ENSG00000198997,NA,NA,NA
10,89701589,89774942,10q22-q24,10q23.31,605498,"MPHOSPH1, MPP1",M-phase phosphoprotein 1,KIF20B,9585,ENSG00000138182,NA,NA,Kif20b (MGI:2444576)
10,90738692,90858038,10q21-q24,10q23.31,182137,HTR7,"5-hydroxytryptamine (serotonin) receptor-7, adenylate cyclase-coupled",HTR7,3363,ENSG00000148680,NA,NA,Htr7 (MGI:99841)
10,90871951,90908555,10q23.31,10q23.31,606115,RPP30,"Ribonuclease P, 30kD subunit",RPP30,10556,ENSG00000148688,NA,NA,Rpp30 (MGI:1859683)
10,90912099,90921274,10q23.31,10q23.31,609599,"ANKRD1, CARP",Ankyrin repeat domain-containing protein 1,ANKRD1,27063,ENSG00000148677,NA,NA,Ankrd1 (MGI:1097717)
10,91162401,91284336,10q23.32,10q23.32,617407,PCGF5,Polycomb group ring finger protein 5,PCGF5,84333,ENSG00000180628,NA,NA,Pcgf5 (MGI:1923505)
10,91628441,91633070,10q23-q24,10q23.32,602999,"PPP1R3C, PPP1R5","Phosphatase 1, regulatory subunit 3C",PPP1R3C,5507,ENSG00000119938,NA,NA,Ppp1r3c (MGI:1858229)
10,91923769,92031436,10q22-q23,10q23.32,605191,"BTAF1, TAFII170, TAF172, MOT1","BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kD (Mot1, S. cerevisiae, homolog of)",BTAF1,9044,ENSG00000095564,NA,NA,Btaf1 (MGI:2147538)
10,92046691,92291498,10q23.3,10q23.32,610606,"CPEB3, KIAA0940",Cytoplasmic polyadenylation element-binding protein 3,CPEB3,22849,ENSG00000107864,NA,NA,Cpeb3 (MGI:2443075)
10,92291163,92353963,10q23.3,10q23.32-q23.33,610637,MARCH5,Membrane-associated RING-CH finger protein 5,MARCHF5,54708,ENSG00000198060,NA,NA,March5 (MGI:1915207)
10,92451683,92574094,10q23-q25,10q23.33,146680,IDE,Insulin-degrading enzyme,IDE,3416,ENSG00000119912,NA,NA,Ide (MGI:96412)
10,92593129,92655394,10q23.33,10q23.33,148760,"KIF11, KNSL1, MCLMR",Kinesin family member 11,KIF11,3832,ENSG00000138160,NA,"Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3), Autosomal dominant",Kif11 (MGI:1098231)
10,92689954,92695646,10q24,10q23.33,604420,"HHEX, PRHX, PRH",Hematopoietically expressed homeo box,HHEX,3087,ENSG00000152804,NA,NA,Hhex (MGI:96086)
10,92826830,93059493,10q23.33,10q23.33,609672,"EXOC6, SEC15L1, SEC15L, SEC15",Exocyst complex component 6,EXOC6,54536,ENSG00000138190,NA,NA,Exoc6 (MGI:1351611)
10,93060797,93069539,10q23.3,10q23.33,608428,"CYP26C1, FFDD4","Cytochrome P450, subfamily XXVIC, polypeptide 1",CYP26C1,340665,ENSG00000187553,NA,"Focal facial dermal dysplasia 4, 614974 (3), Autosomal recessive",Cyp26c1 (MGI:2679699)
10,93073474,93077884,10q23-q24,10q23.33,602239,CYP26A1,"Cytochrome p450, subfamily XXVIA, polypeptide 1",CYP26A1,1592,ENSG00000095596,NA,NA,Cyp26a1 (MGI:1096359)
10,93306428,93482504,10q24,10q23.33,604603,"MYOF, FER1L3",Myoferlin,MYOF,26509,ENSG00000138119,NA,NA,Myof (MGI:1919192)
10,93496611,93529093,10q23.33,10q23.33,610000,"CEP55, MARCH","Centrosomal protein, 55kD",CEP55,55165,ENSG00000138180,NA,"Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3), Autosomal recessive",Cep55 (MGI:1921357)
10,93566177,93590071,10q23.33,10q23.33,609044,"FFAR4, O3FAR1, GPR120, PGR4, BMIQ10",Free fatty acid receptor 4,FFAR4,338557,ENSG00000186188,NA,"{Obesity, susceptibility to}, 607514 (3)",Ffar4 (MGI:2147577)
10,93591693,93601743,10q24,10q23.33,180250,"RBP4, RDCCAS, MCOPCB10","Retinol-binding protein-4, interstitial",RBP4,5950,ENSG00000138207,just centromeric of CYP2C cluster,"Microphthalmia, isolated, with coloboma 10, 616428 (3), Autosomal dominant; Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3), Autosomal recessive",Rbp4 (MGI:97879)
10,93612536,93666009,10q24,10q23.33,600827,"PDE6C, PDEA2, COD4","Phosphodiesterase-6C, cGMP-specific, cone, alpha prime",PDE6C,5146,ENSG00000095464,NA,"Cone dystrophy 4, 613093 (3), Autosomal recessive",Pde6c (MGI:105956)
10,93667882,93702958,10q23.33,10q23.33,608866,"C10orf4, FRA10AC1, FRA10A",Chromosome 10 open reading frame 4,FRA10AC1,118924,ENSG00000148690,NA,NA,Fra10ac1 (MGI:1917817)
10,93757808,93798173,10q24,10q23.33,604619,"LGI1, EPT, ETL1, ADLTE, ADPEAF","Leucine-rich gene, glioma-inactivated, 1",LGI1,9211,ENSG00000108231,NA,"Epilepsy, familial temporal lobe, 1, 600512 (3), Autosomal dominant",Lgi1 (MGI:1861691)
10,93893950,93914270,10q23.33,10q23.33,617167,"SLC35G1, POST, TMEM20, C10orf60","Solute carrier family 35, member G1",SLC35G1,159371,ENSG00000176273,NA,NA,Slc35g1 (MGI:2444789)
10,93993930,94332822,10q23,10q23.33,608414,"PLCE1, KIAA1516, NPHS3","Phospholipase C, epsilon-1",PLCE1,51196,ENSG00000138193,NA,"Nephrotic syndrome, type 3, 610725 (3), Autosomal recessive",Plce1 (MGI:1921305)
10,94314906,94362958,10q24,10q23.33,610769,"NOC3L, FAD24","Nucleolar complex-associated 3, S. cerevisiae, homolog of",NOC3L,64318,ENSG00000173145,NA,NA,Noc3l (MGI:1932610)
10,94545766,94613904,10q23.3-q24.2,10q23.33,603946,"HELLS, LSH, ICF4","Helicase, lymphoid-specific",HELLS,3070,ENSG00000119969,NA,"Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3), Autosomal recessive",Hells (MGI:106209)
10,94683728,94736189,10q23.33,10q23.33,601131,CYP2C18,"Cytochrome P450, subfamily IIC, polypeptide 18",CYP2C18,1562,ENSG00000108242,NA,NA,Cyp2c55 (MGI:1919332)
10,94762680,94855546,10q24.1-q24.3,10q23.33,124020,"CYP2C, CYP2C19","Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)",CYP2C19,1557,ENSG00000165841,4 genes in order: cen-C18-C19-C9-C8-tel,"Clopidogrel, impaired responsiveness to, 609535 (3), Autosomal recessive; Mephenytoin poor metabolizer, 609535 (3), Autosomal recessive; Omeprazole poor metabolizer, 609535 (3), Autosomal recessive; Proguanil poor metabolizer, 609535 (3), Autosomal recessive",NA
10,94938657,94990090,10q24,10q23.33,601130,CYP2C9,"Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9",CYP2C9,1559,ENSG00000138109,NA,"Tolbutamide poor metabolizer (3); Warfarin sensitivity, 122700 (3), Autosomal dominant","Cyp2c65,Cyp2c66 (MGI:1919553,MGI:1917138)"
10,95036771,95069496,10q23.3,10q23.33,601129,"CYP2C8, CYP2C8DM","Cytochrome P450, subfamily IIc, polypeptide 8",CYP2C8,1558,ENSG00000138115,NA,"{Drug metabolism, altered, CYP2C8-related}, 618018 (3)","Cyp2c29,Cyp2c38,Cyp2c39 (MGI:103238,MGI:1306818,MGI:1306819)"
10,95237568,95291005,10q26,10q23.33,605900,"PDLIM1, CLP36, CLIM1",PDZ and LIM domain protein 1,PDLIM1,9124,ENSG00000107438,NA,NA,Pdlim1 (MGI:1860611)
10,95300000,104000000,10q24,NA,605526,AD6,Alzheimer disease 6,NA,64851,NA,NA,"Alzheimer disease 6, 605526 (2)",NA
10,95300000,110100000,10q24.1-q25.1,NA,606483,CMTDIA,"Charcot-Marie-Tooth disease, dominant intermediate A",NA,387574,NA,NA,"Charcot-Marie-Tooth disease, dominant intermediate A, 606483 (2), Autosomal dominant",NA
10,95300000,104000000,10q24,NA,246560,"SHFM3, SHSF3, DUP10q24, C10DUPq24",Split-hand/foot malformation 3 (Chromosome 10q24 duplication syndrome),NA,NA,NA,contiguous gene duplication syndrome,"Split-hand/foot malformation 3, gene duplication syndrome, 246560 (4), Autosomal dominant",NA
10,95311772,95561438,10q23.3-q24.1,10q24.1,605264,"SORBS1, SH3D5, SH3P12, KIAA1296",Sorbin and SH3 domain containing 1,SORBS1,10580,ENSG00000095637,NA,NA,Sorbs1 (MGI:700014)
10,95605937,95656900,10q24.3,10q24.1,138250,"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3","Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)",ALDH18A1,5832,ENSG00000059573,GOT1 and GSAS in same pathway,"Cutis laxa, autosomal dominant 3, 616603 (3), Autosomal dominant; Cutis laxa, autosomal recessive, type IIIA, 219150 (3), Autosomal recessive; Spastic paraplegia 9A, autosomal dominant, 601162 (3), Autosomal dominant; Spastic paraplegia 9B, autosomal recessive, 616586 (3), Autosomal recessive",Aldh18a1 (MGI:1888908)
10,95663395,95694142,10q24.1,10q24.1,613847,"TCTN3, TECT3, C10orf61, OFD4, JBTS18","Tectonic family, member 3",TCTN3,26123,ENSG00000119977,NA,"Joubert syndrome 18, 614815 (3), Autosomal recessive; Orofaciodigital syndrome IV, 258860 (3), Autosomal recessive",Tctn3 (MGI:1914840)
10,95710900,95877265,10q24,10q24.1,601752,"ENTPD1, CD39, SPG64",Ectonucleoside triphosphate diphosphohydrolase 1 (CD39 antigen),ENTPD1,953,ENSG00000138185,NA,"Spastic paraplegia 64, autosomal recessive, 615683 (3), Autosomal recessive",Entpd1 (MGI:102805)
10,96128905,96205290,10q24.1,10q24.1,617733,"ZNF518A, KIAA0335",Zinc finger protein 518A,ZNF518A,9849,ENSG00000177853,NA,NA,Zfp518a (MGI:1919922)
10,96189170,96271575,10q23.2,10q24.1,604515,"BLNK, SLP65, AGM4","B-cell linker protein (SH2 domain-containing leukocyte protein, 65kD)",BLNK,29760,ENSG00000095585,mutation identified in 1 AGM4 family,"?Agammaglobulinemia 4, 613502 (3), Autosomal recessive",Blnk (MGI:96878)
10,96304433,96338563,10q23-q24,10q24.1,187410,"DNTT, TDT",Terminal deoxynucleotidyltransferase,DNTT,1791,ENSG00000107447,NA,NA,Dntt (MGI:98659)
10,96343215,96359364,10q24,10q24.1,617200,"OPALIN, TMEM10, TMP10",Oligodendrocytic myelin paranodal and inner loop protein,OPALIN,93377,ENSG00000197430,NA,NA,Opalin (MGI:2657025)
10,96364607,96513925,10q23-q24,10q24.1,606743,"TLL2, KIAA0932",Tolloid-like 2,TLL2,7093,ENSG00000095587,NA,NA,Tll2 (MGI:1346044)
10,96518109,96587011,10q24.1,10q24.1,616872,"TM9SF3, SMBP","Transmembrane 9 superfamily, member 3",TM9SF3,56889,ENSG00000077147,NA,NA,Tm9sf3 (MGI:1914262)
10,96593311,96720513,10q24.1,10q24.1,607942,"PIK3AP1, BCAP, FLJ35564",Phosphoinositide 3-kinase adaptor protein 1,PIK3AP1,118788,ENSG00000155629,NA,NA,Pik3ap1 (MGI:1933177)
10,96832297,96995955,10q24.1,10q24.1,607698,"LCOR, MLR2, KIAA1795",Ligand-dependent nuclear receptor corepressor,LCOR,84458,ENSG00000196233,NA,NA,Lcor (MGI:2443930)
10,96998037,97185958,10q24.1,10q24.1,603742,"SLIT1, SLIL1, MEGF4","Slit, Drosophila, homolog of, 1",SLIT1,6585,ENSG00000187122,NA,NA,Slit1 (MGI:1315203)
10,97222172,97292672,10q24.1,10q24.1,611587,ARHGAP19,RHO GTPase-activating protein 19,ARHGAP19,84986,ENSG00000213390,NA,NA,Arhgap19 (MGI:1918335)
10,97319270,97321914,10q24.1,10q24.1,602503,FRAT1,Frequently rearranged in advanced T-cell lymphomas 1,FRAT1,10023,ENSG00000165879,NA,NA,Frat1 (MGI:109450)
10,97332496,97334728,10q24.1,10q24.1,605006,FRAT2,Frequently rearranged in advanced T-cell lymphomas 2,FRAT2,23401,ENSG00000181274,NA,NA,Frat2 (MGI:2673967)
10,97356356,97401369,10q24.1,10q24.1,617723,"RRP12, KIAA0690","Ribosomal RNA-processing protein 12, S. cerevisiae, homolog of",RRP12,23223,ENSG00000052749,NA,NA,Rrp12 (MGI:2147437)
10,97426190,97433443,10q25.3,10q24.1,172250,PGAM1,"Phosphoglycerate mutase A, nonmuscle form",PGAM1,5223,ENSG00000171314,NA,NA,Pgam1 (MGI:97552)
10,97435908,97446016,10q24.1,10q24.1,606493,"EXOSC1, CSL4",Exosome component 1,EXOSC1,51013,ENSG00000171311,NA,NA,Exosc1 (MGI:1913833)
10,97446130,97457369,10q24,10q24.1,616750,"ZDHHC16, APH2",Zinc finger DHHC domain-containing protein 16,ZDHHC16,84287,ENSG00000171307,NA,NA,Zdhhc16 (MGI:1921418)
10,97458323,97498793,10q24.1,10q24.1,614777,"MMS19, MMS19L","MMS19 nucleotide excision repair, S. Cerevisiae, homolog of",MMS19,64210,ENSG00000155229,NA,NA,Mms19 (MGI:1919449)
10,97498923,97571205,10q24.1-q24.2,10q24.1-q24.2,616388,UBTD1,Ubiquitin domain-containing protein 1,UBTD1,80019,ENSG00000165886,NA,NA,Ubtd1 (MGI:2385092)
10,97572440,97583883,10q23.31-q23.32,10q24.2,610734,"ANKRD2, ARPP",Ankyrin repeat domain-containing protein 2,ANKRD2,26287,ENSG00000165887,NA,NA,Ankrd2 (MGI:1861447)
10,97584344,97612801,10q24.2,10q24.2,613597,"HOGA1, DHDPSL, HP3",4-hydroxy-2-oxoglutarate aldolase 1,HOGA1,112817,ENSG00000241935,NA,"Hyperoxaluria, primary, type III, 613616 (3)",Hoga1 (MGI:1914682)
10,97614552,97634155,10q24.2,10q24.2,617736,"MORN4, RTP, UTA",MORN repeat-containing protein 4,MORN4,118812,ENSG00000171160,NA,NA,Morn4 (MGI:2449568)
10,97640685,97676433,10q24,10q24.2,609763,PI4K2A,Phosphatidylinositol 4-kinase type 2 alpha,PI4K2A,55361,ENSG00000155252,NA,NA,Pi4k2a (MGI:1934031)
10,97713729,97718149,10q24.2,10q24.2,616970,"MARVELD1, MARVD1",Marvel domain-containing protein 1,MARVELD1,83742,ENSG00000155254,NA,NA,Marveld1 (MGI:2147570)
10,97737120,97760906,10q24.2,10q24.2,610243,"ZFYVE27, SPG33",Zinc finger FYVE domain-containing protein 27,ZFYVE27,118813,ENSG00000155256,NA,"Spastic paraplegia 33, autosomal dominant, 610244 (3), Autosomal dominant",Zfyve27 (MGI:1919602)
10,97766750,97771998,10q24.1,10q24.2,604158,"SFRP5, SARP3",Secreted frizzled-related protein 5,SFRP5,6425,ENSG00000120057,NA,NA,Sfrp5 (MGI:1860298)
10,97849842,97871577,10q22,10q24.2,614189,"GOLGA7B, C10orf132","Golgin A7 family, member B",GOLGA7B,401647,ENSG00000155265,NA,NA,Golga7b (MGI:1918396)
10,97854710,98030827,10q24.2,10q24.2,606276,"CRTAC1, CEP68, LOTUS",Cartilage acidic protein 1,CRTAC1,55118,ENSG00000095713,NA,NA,Crtac1 (MGI:1920082)
10,98247689,98268220,10q24,10q24.2,607318,LOXL4,Lysyl oxidate-like 4,LOXL4,84171,ENSG00000138131,NA,NA,Loxl4 (MGI:1914823)
10,98383564,98415181,10q24.2,10q24.2,617889,"PYROXD2, C10orf33, YUEF",Pyridine nucleotide-disulphide oxidoreductase domain-containing protein 2,PYROXD2,84795,ENSG00000119943,NA,NA,Pyroxd2 (MGI:1921830)
10,98416192,98446962,10q23.1,10q24.2,604982,HPS1,HPS gene 1,HPS1,3257,ENSG00000107521,NA,"Hermansky-Pudlak syndrome 1, 203300 (3), Autosomal recessive",Hps1 (MGI:2177763)
10,98457076,99235874,10q23-q24,10q24.2,613469,"HPSE2, HPA2, UFS1",Heparanase 2,HPSE2,60495,ENSG00000172987,NA,"Urofacial syndrome 1, 236730 (3), Autosomal recessive",Hpse2 (MGI:2685814)
10,99329098,99394329,10q23-q24,10q24.2,607802,"CNNM1, ACDP1",Cyclin M1 (ancient conserved domain protein 1),CNNM1,26507,ENSG00000119946,NA,NA,Cnnm1 (MGI:1891366)
10,99396869,99430623,10q24.1-q25.1,10q24.2,138180,"GOT1, ASTQTL1","Glutamic-oxaloacetic transaminase-1, soluble (EC 2.6.1.1)",GOT1,2805,ENSG00000120053,10q26.1 = conflicting localization,"Aspartate aminotransferase, serum level of, QTL1, 614419 (3)",Got1 (MGI:95791)
10,99532941,99536523,10q24.2,10q24.2,606727,"NKX2C, NK2.3, CSX3","NK2, Drosophila, homolog of, C",NKX2-3,159296,ENSG00000119919,NA,NA,Nkx2-3 (MGI:97348)
10,99610521,99659506,10q24,10q24.2,609767,"SLC25A28, MRS4L, NPD016","Solute carrier family 25 (mitochondrial carrier), member 28",SLC25A28,81894,ENSG00000155287,NA,NA,Slc25a28 (MGI:2180509)
10,99659508,99711244,10q23-q24,10q24.2,616753,"ENTPD7, LALP1",Ectonucleoside triphosphate diphosphohydrolase 7,ENTPD7,57089,ENSG00000198018,NA,NA,Entpd7 (MGI:2135885)
10,99694792,99732665,10q24,10q24.2,603646,"COX15, CEMCOX2","Cytochrome c oxidase, subunit 15",COX15,1355,ENSG00000014919,NA,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2, 615119 (3), Autosomal recessive; Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3), Autosomal recessive, Mitochondrial",Cox15 (MGI:1920112)
10,99732233,99756133,10q24,10q24.2,610101,CUTC,"CutC copper transporter, E. coli, homolog of",CUTC,51076,ENSG00000119929,NA,NA,Cutc (MGI:1913638)
10,99782601,99853740,10q24,10q24.2,601107,"ABCC2, CMOAT","ATP-binding cassette, subfamily C, member 2 (canalicular multispecific organic anion transporter)",ABCC2,1244,ENSG00000023839,NA,"Dubin-Johnson syndrome, 237500 (3), Autosomal recessive",Abcc2 (MGI:1352447)
10,99875570,100009947,10q24.2,10q24.2,611282,"DNMBP, TUBA, KIAA1010, CTRCT48",Dynamin-binding protein,DNMBP,23268,ENSG00000107554,NA,"Cataract 48, 618415 (3), Autosomal recessive",Dnmbp (MGI:1917352)
10,100042192,100081868,10q24.2,10q24.2,603103,"CPN1, SCPN, CPN","Carboxypeptidase N, polypeptide 1, 50-kD",CPN1,1369,ENSG00000120054,NA,"Carboxypeptidase N deficiency, 212070 (3), Autosomal recessive",Cpn1 (MGI:2135874)
10,100150089,100186056,10q24.31,10q24.31,611604,"ERLIN1, SPG62",Endoplasmic reticulum lipid raft-associated protein 1,ERLIN1,10613,ENSG00000107566,NA,"Spastic paraplegia 62, 615681 (3), Autosomal recessive",Erlin1 (MGI:2387613)
10,100188297,100229609,10q24,10q24.31,600664,"CHUK, IKBKA, NFKBIKA, IKKA, IKK1",Conserved helix-loop-helix ubiquitous kinase,CHUK,1147,ENSG00000213341,NA,"Cocoon syndrome, 613630 (3)",Chuk (MGI:99484)
10,100232297,100267637,10q24.31,10q24.31,616120,"CWF19L1, C19L1, SCAR17",CWF19-like protein 1,CWF19L1,55280,ENSG00000095485,NA,"Spinocerebellar ataxia, autosomal recessive 17, 616127 (3), Autosomal recessive",Cwf19l1 (MGI:1919752)
10,100237155,100237301,10q24.31,10q24.31,611330,SNORA12,"Small nucleolar RNA, H/ACA box, 12",SNORA12,677800,ENSG00000212464,in intron 11 of CWF19L1,NA,NA
10,100273277,100286711,10q24.31,10q24.31,609768,"BLOC1S2, BLOS2","Biogenesis of lysosome-related organelles complex 1, subunit 2",BLOC1S2,282991,ENSG00000196072,NA,NA,Bloc1s2 (MGI:1920939)
10,100288144,100347029,10q24-q25,10q24.31,604532,"PKD2L1, PKDL, PKD2L",Polycystin L,PKD2L1,9033,ENSG00000107593,NA,NA,Pkd2l1 (MGI:1352448)
10,100347232,100364825,10q24.31,10q24.31,604031,SCD,Stearoyl-CoA desaturase,SCD,6319,ENSG00000099194,pseudogene on chr.17,NA,Scd1 (MGI:98239)
10,100373575,100388353,10q24.31,10q24.31,616240,"OLMALINC, LINC00263, OLMALINCAS",Oligodendrocyte maturation-associated long intergenic noncoding RNA,OLMALINC,90271,ENSG00000235823,OLMALINCAS is on opposite strand overlapping exon 1 of OLMALINC,NA,NA
10,100463008,100483743,10q24,10q24.31,601396,WNT8B,"Wingless-type MMTV integration site family, member 8B",WNT8B,7479,ENSG00000075290,NA,NA,Wnt8b (MGI:109485)
10,100486646,100519860,10q24.3,10q24.31,610258,"SEC31B, SEC31L2","Sec31, yeast, homolog of, B",SEC31B,25956,ENSG00000075826,NA,NA,Sec31b (MGI:2685187)
10,100523728,100529922,10q23.2-q23.33,10q24.31,602140,"NDUFB8, MC1DN32",NADH-ubiquinone oxidoreductase subunit B8,NDUFB8,4714,ENSG00000166136,previously assigned to 12q21,"Mitochondrial complex I deficiency, nuclear type 32, 618252 (3), Autosomal recessive",Ndufb8 (MGI:1914514)
10,100535920,100559997,10q24,10q24.31,606615,"HIF1AN, FIH1",Hypoxia-inducible factor 1-alpha inhibitor,HIF1AN,55662,ENSG00000166135,NA,NA,Hif1an (MGI:2442345)
10,100735395,100829943,10q24.3-q25.1,10q24.31,167409,"PAX2, PAPRS, FSGS7",Paired box homeotic gene-2,PAX2,5076,ENSG00000075891,NA,"Glomerulosclerosis, focal segmental, 7, 616002 (3), Autosomal dominant; Papillorenal syndrome, 120330 (3), Autosomal dominant",Pax2 (MGI:97486)
10,100909415,100965133,10q24,10q24.31,610348,"FAM178A, C10orf6","Family with sequence similarity 178, member A",SLF2,55719,ENSG00000119906,NA,NA,Slf2 (MGI:1924968)
10,100977819,100987514,10q24,10q24.31,611848,MRPL43,Mitochondrial ribosomal protein L43,MRPL43,84545,ENSG00000055950,NA,NA,Mrpl43 (MGI:2137229)
10,100987542,100994402,10q24,10q24.31,606075,"TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5",Twinkle mtDNA helicase,TWNK,56652,ENSG00000107815,PEO digenic with POLG,"Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3), Autosomal recessive; Perrault syndrome 5, 616138 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3), Autosomal dominant",Twnk (MGI:2137410)
10,100997064,101007835,10q24.3,10q24.31,610454,"LZTS2, KIAA1813, LAPSER1","Leucine zipper, putative tumor suppressor 2",LZTS2,84445,ENSG00000107816,NA,NA,Lzts2 (MGI:2385095)
10,101007678,101031156,10q24.3,10q24.31,612971,"PDZD7, DFNB57",PDZ domain-containing 7,PDZD7,79955,ENSG00000186862,NA,"Deafness, autosomal recessive 57, 618003 (3), Autosomal recessive; {Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3), Autosomal recessive; Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3), Autosomal recessive",Pdzd7 (MGI:3608325)
10,101031233,101041242,10q24.31,10q24.31,615571,SFXN3,Sideroflexin 3,SFXN3,81855,ENSG00000107819,NA,NA,Sfxn3 (MGI:2137679)
10,101089320,101141265,10q24,10q24.31,612734,TD1,TLX1 divergent gene,TLX1NB,100038246,ENSG00000236311,NA,NA,NA
10,101130772,101137788,10q24,10q24.31,186770,"TLX1, HOX11, TCL3","T-cell leukemia, homeobox 1",TLX1,3195,ENSG00000107807,t(7;10) or t(10;4) in T-ALL,NA,Tlx1 (MGI:98769)
10,101200000,110100000,10q24.32-q25.1,NA,614927,ECTD5,"Ectodermal dysplasia 5, hair/nail type",NA,101101769,NA,between D10S1239 and D10S1264,"Ectodermal dysplasia 5, hair/nail type, 614927 (2), Autosomal recessive",NA
10,101226975,101228959,10q24,10q24.32,604255,"LBX1, LBX1H","Lady bird late, Drosophila, homolog of, 1",LBX1,10660,ENSG00000138136,NA,NA,Lbx1 (MGI:104867)
10,101353807,101557320,10q24-q25,10q24.32,603482,"BTRC, BTRCP",Beta-transducin repeat-containing protein,BTRC,8945,ENSG00000166167,NA,NA,Btrc (MGI:1338871)
10,101578881,101588318,10q23,10q24.32,606343,POLL,"Polymerase, DNA, lambda",POLL,27343,ENSG00000166169,NA,NA,Poll (MGI:1889000)
10,101588320,101609661,10q24.32,10q24.32,616467,DPCD,"Deleted in primary ciliary dyskinesia, mouse, homolog of",DPCD,25911,ENSG00000166171,NA,NA,Dpcd (MGI:1924407)
10,101610663,101695294,10q24,10q24.32,608071,"FBXW4, DAC, FBW4, FBWD4",F-box and WD repeat domain containing 4,FBXW4,6468,ENSG00000107829,NA,NA,Fbxw4 (MGI:1354698)
10,101770129,101780368,10q24,10q24.32,600483,"FGF8, HH6",Fibroblast growth factor-8,FGF8,2253,ENSG00000107831,NA,"Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3), Autosomal dominant",Fgf8 (MGI:99604)
10,101781324,101783412,10q24-q26,10q24.32,606456,NPM3,"Nucleophosmin/nucleoplasmin family, member 3",NPM3,10360,ENSG00000107833,NA,NA,Npm3 (MGI:894653)
10,101784442,101818708,10q24.1-q24.3,10q24.32,604039,MGEA5,Meningioma-expressed antigen 5,OGA,10724,ENSG00000198408,NA,NA,Oga (MGI:1932139)
10,102065366,102068037,10q24.32,10q24.32,607522,"HPS6, RU",HPS gene 6,HPS6,79803,ENSG00000166189,NA,"Hermansky-Pudlak syndrome 6, 614075 (3), Autosomal recessive",Hps6 (MGI:2181763)
10,102102099,102120472,10q24-q25,10q24.32,603451,"LDB1, CLIM2, NLI",LIM domain-binding factor-1,LDB1,8861,ENSG00000198728,NA,NA,Ldb1 (MGI:894762)
10,102120633,102150332,10q24.2-q24.3,10q24.32,617462,"PPRC1, PRC, KIAA0595","Peroxisome proliferator-activated receptor-gamma, coactivator-related protein 1",PPRC1,23082,ENSG00000148840,NA,NA,Pprc1 (MGI:2385096)
10,102152175,102163870,10q24.32,10q24.32,602394,"NOLC1, p130, NOPP140",Nucleolar and coiled-body phosphoprotein 1,NOLC1,9221,ENSG00000166197,NA,NA,NA
10,102224766,102229588,10q24.32,10q24.32,611815,"ELOVL3, CIG30",Elongation of very long chain fatty acids-like 3,ELOVL3,83401,ENSG00000119915,NA,NA,Elovl3 (MGI:1195976)
10,102230188,102241511,10q25,10q24.32,602669,"PITX3, CTPP4, CTRCT11, ASGD1",Paired-like homeodomain transcription factor-3,PITX3,5309,ENSG00000107859,NA,"Anterior segment dysgenesis 1, multiple subtypes, 107250 (3), Autosomal dominant; Cataract 11, multiple types, 610623 (3), Autosomal recessive, Autosomal dominant; Cataract 11, syndromic, autosomal recessive, 610623 (3), Autosomal recessive, Autosomal dominant",Pitx3 (MGI:1100498)
10,102245530,102382898,10q24,10q24.32,603698,GBF1,Golgi-specific brefeldin-A resistance factor 1,GBF1,8729,ENSG00000107862,NA,NA,Gbf1 (MGI:1861607)
10,102394109,102402528,10q24,10q24.32,164012,"NFKB2, LYT10, CVID10",Nuclear factor of kappa light chain gene enhancer in B-cells 2 (p49/p100); oncogene Lyt-10,NFKB2,4791,ENSG00000077150,NA,"Immunodeficiency, common variable, 10, 615577 (3), Autosomal dominant",Nfkb2 (MGI:1099800)
10,102402616,102420163,10q24,10q24.32,602327,PSD,Pleckstrin and Sec7 domain protein,PSD,5662,ENSG00000059915,NA,NA,Psd (MGI:1920978)
10,102419221,102423137,10q24.32,10q24.32,610287,"FBXL15, JET",F-box and leucine-rich repeat protein 15,FBXL15,79176,ENSG00000107872,NA,NA,Fbxl15 (MGI:1915681)
10,102423248,102432573,10q24.32,10q24.32,614142,CUEDC2,Cue domain-containing protein 2,CUEDC2,79004,ENSG00000107874,NA,NA,Cuedc2 (MGI:1914366)
10,102436511,102436583,10q24.32,10q24.32,610567,MIR146B,Micro RNA 146B,MIR146B,574447,ENSG00000202569,NA,NA,NA
10,102479228,102502711,10q24.32,10q24.32,605143,"ACTR1A, ARP1",Actin-related protein 1A,ACTR1A,10121,ENSG00000138107,NA,NA,Actr1a (MGI:1858964)
10,102502800,102633457,10q24-q25,10q24.32,607035,"SUFU, SUFUXL, SUFUH, JBTS32",Suppressor of fused,SUFU,51684,ENSG00000107882,NA,"Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Autosomal dominant; {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant",Sufu (MGI:1345643)
10,102644494,102658318,10q24.3,10q24.32,606125,"TRIM8, RNF27, GERP",Tripartite motif-containing 8,TRIM8,81603,ENSG00000171206,NA,NA,Trim8 (MGI:1933302)
10,102673730,102714396,10q23.3,10q24.32,604695,"ARL3, ARFL3, JBTS35, RP83",ADP-ribosylation factor-like 3,ARL3,403,ENSG00000138175,NA,"Joubert syndrome 35, 618161 (3), Autosomal recessive; Retinitis pigmentosa 83, 618173 (3), Autosomal dominant",Arl3 (MGI:1929699)
10,102714517,102743491,10q24.32,10q24.32,615570,SFXN2,Sideroflexin 2,SFXN2,118980,ENSG00000156398,NA,NA,Sfxn2 (MGI:2137678)
10,102742707,102816266,10q24.32,10q24.32,611129,"C10orf26, OPAL1",Chromosome 10 open reading frame 26,WBP1L,54838,ENSG00000166272,NA,NA,Wbp1l (MGI:107577)
10,102830530,102837412,10q24.3,10q24.32,609300,"CYP17A1, CYP17, P450C17","Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase)",CYP17A1,1586,ENSG00000148795,at least 2 genes; distal to GOT1,"17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3), Autosomal recessive; 17,20-lyase deficiency, isolated, 202110 (3), Autosomal recessive",Cyp17a1 (MGI:88586)
10,102854258,102864960,10q24.32,10q24.32,616600,"BORCS7, C10orf32","BLOC1-related complex, subunit 7",BORCS7,119032,ENSG00000166275,NA,NA,Borcs7 (MGI:1913689)
10,102869469,102901898,10q24,10q24.32,611806,"AS3MT, CYT19",Arsenic (+3 oxidation state) methyltransferase,AS3MT,57412,ENSG00000214435,NA,NA,As3mt (MGI:1929882)
10,102918292,103090221,10q24.33,10q24.32,607803,"CNNM2, ACDP2, HOMG6, HOMGSMR",Cyclin M2,CNNM2,54805,ENSG00000148842,NA,"Hypomagnesemia 6, renal, 613882 (3), Autosomal dominant; Hypomagnesemia, seizures, and mental retardation, 616418 (3), Autosomal recessive, Autosomal dominant",Cnnm2 (MGI:2151054)
10,103088016,103193305,10q24.3,10q24.32-q24.33,600417,"NT5C2, NT5B, PNT5, SPG45","5' nucleotidase, cytosolic II",NT5C2,22978,ENSG00000076685,NA,"Spastic paraplegia 45, autosomal recessive, 613162 (3), Autosomal recessive",Nt5c2 (MGI:2178563)
10,103302795,103351139,10q24.33,10q24.33,607816,"PCGF6, RNF134, MBLR",Polycomb group ring finger 6,PCGF6,84108,ENSG00000156374,NA,NA,Pcgf6 (MGI:1918291)
10,103367975,103389064,10q24-q25.2,10q24.33,601787,"TAF5, TAF2D, TAFII100","TAF5 RNA polymerase II, TATA box binding protein-associated factor, 100kD",TAF5,6877,ENSG00000148835,NA,NA,Taf5 (MGI:2442144)
10,103389049,103396504,10q24,10q24.33,615204,"USMG5, DAPIT","Upregulated during skeletal muscle growth 5, mouse, homolog of",ATP5MD,84833,ENSG00000173915,NA,NA,Atp5md (MGI:1891435)
10,103396614,103446294,10q24.2-q25.1,10q24.33,612333,"PDCD11, ALG4, NFBP, KIAA0185",Programmed cell death 11,PDCD11,22984,ENSG00000148843,NA,NA,Pdcd11 (MGI:1341788)
10,103446782,103452404,10q24.33,10q24.33,612235,"CALHM2, FAM26B",Calcium homeostasis modulator 2,CALHM2,51063,ENSG00000138172,NA,NA,Calhm2 (MGI:1919941)
10,103453386,103458890,10q24.33,10q24.33,612234,"CALHM1, FAM26C",Calcium homeostasis modulator 1,CALHM1,255022,ENSG00000185933,"?Alzheimer disease, 605526",NA,Calhm1 (MGI:3643383)
10,103472803,103479239,10q24.33,10q24.33,618263,CALHM3,Calcium homeostasis modulator 3,CALHM3,119395,ENSG00000183128,NA,NA,NA
10,103493704,103592545,10q25.1,10q24.33,603804,"NEURL1, NEURL, NEUR1",Neuralized E3 ubiquitin protein ligase 1,NEURL1,9148,ENSG00000107954,NA,NA,Neurl1a (MGI:1334263)
10,103877568,103918183,10q24.33,10q24.33,613128,"STN1, OBFC1, AAF44","STN1, CST complex subunit",STN1,79991,ENSG00000107960,NA,"Cerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3), Autosomal recessive",Stn1 (MGI:1915581)
10,103967099,104029232,10q24.33-q25.1,10q24.3-q25.1,616563,"SLK, LOSK, KIAA0204",STE20-like protein kinase,SLK,9748,ENSG00000065613,NA,NA,Slk (MGI:103241)
10,104000000,133797422,10q25-q26,NA,609750,EIG4,"Epilepsy, idiopathic generalized, susceptibility to 4",NA,780913,NA,between D16S397 and D16S3095,"{Epilepsy, idiopathic generalized, susceptibility to 4}, 609750 (2)",NA
10,104000000,117300000,10q25,NA,603266,IDDM17,Insulin-dependent diabetes mellitus-17,IDDM17,8691,NA,NA,"{Diabetes mellitus, insulin-dependent, 17}, 603266 (2)",NA
10,104031285,104085879,10q24.3,10q25.1,113811,"COL17A1, BPAG2, ERED","Collagen XVII, alpha-1 polypeptide",COL17A1,1308,ENSG00000065618,NA,"Epidermolysis bullosa, junctional, localisata variant, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epithelial recurrent erosion dystrophy, 122400 (3), Autosomal dominant",NA
10,104122057,104126384,10q25.1,10q25.1,616527,"SFR1, MEI5, C10orf78",SWI5-dependent homologous recombination repair protein 1,SFR1,119392,ENSG00000156384,NA,NA,Sfr1 (MGI:1915038)
10,104129887,104232382,10q25.1,10q25.1,617558,"CFAP43, WDR96, C10orf79, SPGF19",Cilia- and flagella-associated protein 43,CFAP43,80217,ENSG00000197748,NA,"Spermatogenic failure 19, 617592 (3), Autosomal recessive",Cfap43 (MGI:1289258)
10,104254193,104267463,10q24-q25,10q25.1,605482,GSTO1,"Glutathione S-transferase, omega-1",GSTO1,9446,ENSG00000148834,NA,NA,Gsto1 (MGI:1342273)
10,104267625,104304949,10q24-q25,10q25.1,612314,GSTO2,"Glutathione S-transferase, omega-2",GSTO2,119391,ENSG00000065621,NA,NA,Gsto2 (MGI:1915464)
10,104641289,105265241,10q23.3,10q25.1,606285,"SORCS3, KIAA1059",SORCS receptor 3,SORCS3,22986,ENSG00000156395,NA,NA,Sorcs3 (MGI:1913923)
10,106573662,107181137,10q23.3,10q25.1,606283,SORCS1,SORCS receptor 1,SORCS1,114815,ENSG00000108018,NA,NA,Sorcs1 (MGI:1929666)
10,109864765,109923552,10q25.3,10q25.1,602443,"XPNPEP1, SAMP, XPNPEPL",X-prolyl aminopeptidase P1,XPNPEP1,7511,ENSG00000108039,NA,NA,Xpnpep1 (MGI:2180003)
10,109996364,110135564,10q24.2-q24.3,10q25.1-q25.2,601568,"ADD3, ADDL, CPSQ3","Adducin-3, gamma",ADD3,120,ENSG00000148700,fusion with NUP98 in T-ALL,"Cerebral palsy, spastic quadriplegic, 3, 617008 (3), Autosomal recessive",Add3 (MGI:1351615)
10,110207604,110287364,10q25,10q25.2,600020,MXI1,MAX-interacting protein 1,MXI1,4601,ENSG00000119950,NA,"Neurofibrosarcoma, somatic (3); Prostate cancer, somatic, 176807 (3)",Mxi1 (MGI:97245)
10,110290729,110304968,10q23,10q25.2,603519,"SMNR, SPF30",Survival motor neuron-related protein,SMNDC1,10285,ENSG00000119953,NA,NA,Smndc1 (MGI:1923729)
10,110497906,110511532,10q25,10q25.2,603069,"DUSP5, HVH3",Dual-specificity phosphatase-5,DUSP5,1847,ENSG00000138166,NA,NA,Dusp5 (MGI:2685183)
10,110567690,110604633,10q25,10q25.2,606062,"SMC3, CSPG6, HCAP, BAM, CDLS3",Structural maintenance of chromosomes 3,SMC3,9126,ENSG00000108055,NA,"Cornelia de Lange syndrome 3, 610759 (3), Autosomal dominant",Smc3 (MGI:1339795)
10,110641932,110839470,10q25.2,10q25.2,613171,RBM20,RNA-binding motif protein 20,RBM20,282996,ENSG00000203867,NA,"Cardiomyopathy, dilated, 1DD, 613172 (3), Autosomal dominant",Rbm20 (MGI:1920963)
10,110871794,110900005,10q24,10q25.2,608610,PDCD4,Programmed cell death 4,PDCD4,27250,ENSG00000150593,NA,NA,Pdcd4 (MGI:107490)
10,110898729,110919365,10q25.2,10q25.2,613605,"BBIP1, NCRNA00081, BBIP10, BBS18",BBSome interacting protein 1,BBIP1,92482,ENSG00000214413,mutation identified in 1 BBS18 family,"?Bardet-Biedl syndrome 18, 615995 (3), Autosomal recessive",Bbip1 (MGI:1913610)
10,110919369,111013666,10q25,10q25.2,602775,"SHOC2, SIAA0862, SOC2, SUR8","Suppressor of clear, C. elegans, homolog of",SHOC2,8036,ENSG00000108061,NA,"Noonan-like syndrome with loose anagen hair, 607721 (3), Autosomal dominant",Shoc2 (MGI:1927197)
10,111077028,111080906,10q24-q26,10q25.2,104210,"ADRA2A, ADRA2R","Adrenergic, alpha-2A-, receptor",ADRA2A,150,ENSG00000150594,NA,NA,Adra2a (MGI:87934)
10,112149864,112216305,10q24-q26,10q25.2,602395,GPAM,Glycerol-3-phosphate acyltransferase,GPAM,57678,ENSG00000119927,NA,NA,Gpam (MGI:109162)
10,112283399,112305037,10q25.2,10q25.2,602653,TECTB,"Tectorin, beta",TECTB,6975,ENSG00000119913,NA,NA,Tectb (MGI:109574)
10,112374115,112428379,10q25.1-q25.2,10q25.2,605677,"ACSL5, FACL5, ACS5",Acyl-CoA synthetase long-chain family member 5,ACSL5,51703,ENSG00000197142,NA,NA,Acsl5 (MGI:1919129)
10,112446987,112855367,10q25.2,10q25.2,614316,"VTI1A, VTI1RP2, MMDS3","VTI1, S. cerevisiae, homolog of, A",VTI1A,143187,ENSG00000151532,NA,NA,Vti1a (MGI:1855699)
10,112950246,113167677,10q25.3,10q25.2-q25.3,602228,"TCF7L2, TCF4",Transcription factor 7-like 2,TCF7L2,6934,ENSG00000148737,NA,"{Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant",Tcf7l2 (MGI:1202879)
10,113100000,133797422,10q25.3-q26.3,NA,102777,"ADORA2L1, ADORA2L",Adenosine A2 receptor-like 1,NA,NA,NA,NA,NA,NA
10,113550830,113589601,10q25-q26,10q25.3,603924,"HABP2, PHBP, HGFAL, FSAP, NMTC5",Hyaluronan-binding protein 2,HABP2,3026,ENSG00000148702,mutation identified in 1 NMTC5 family,"{?Thyroid cancer, nonmedullary, 5}, 616535 (3), Autosomal dominant; {Venous thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant",Habp2 (MGI:1196378)
10,113588713,113664069,10q24-q26,10q25.3,602873,NRAP,Nebulin-related anchoring protein,NRAP,4892,ENSG00000197893,NA,NA,Nrap (MGI:1098765)
10,113679161,113730908,10q25.1-q25.2,10q25.3,601761,"CASP7, MCH3","Caspase 7, apoptosis-related cysteine protease",CASP7,840,ENSG00000165806,NA,NA,Casp7 (MGI:109383)
10,113834724,113854393,10q25.1,10q25.3,609682,"DCLRE1A, SNM1, SNM1A, KIAA0086",DNA cross-link repair protein 1A,DCLRE1A,9937,ENSG00000198924,NA,NA,Dclre1a (MGI:1930042)
10,113854633,113917193,10q25,10q25.3,618277,"NHLRC2, FINCA",NHL repeat-containing protein 2,NHLRC2,374354,ENSG00000196865,NA,"FINCA syndrome, 618278 (3), Autosomal recessive",Nhlrc2 (MGI:1914116)
10,114043865,114046903,10q24-q26,10q25.3,109630,"ADRB1, ADRB1R, RHR","Adrenergic, beta-1-, receptor",ADRB1,153,ENSG00000043591,close linkage to ADRA2R,"{Congestive heart failure and beta-blocker response, modifier of} (3); [Resting heart rate], 607276 (3)",Adrb1 (MGI:87937)
10,114174441,114232668,10q25.3,10q25.3,605796,TDRD1,Tudor domain protein 1,TDRD1,56165,ENSG00000095627,NA,NA,Tdrd1 (MGI:1933218)
10,114239253,114294499,10q25.3,10q25.3,618281,"VWA2, CCSP2, AMACO",von Willibrand factor A domain-containing protein 2,VWA2,340706,ENSG00000165816,NA,NA,Vwa2 (MGI:2684334)
10,114280759,114404777,10q25.3,10q25.3,612420,"AFAP1L2, XB130, KIAA1914",Actin filament-associated protein 1-like protein 2,AFAP1L2,84632,ENSG00000169129,NA,NA,Afap1l2 (MGI:2147658)
10,114431109,114821642,10q25,10q25.3,602330,LIMAB1,LIM actin-binding protein-1,ABLIM1,3983,ENSG00000099204,NA,NA,Ablim1 (MGI:1194500)
10,114821779,114899831,10q25.3,10q25.3,617312,"FAM160B1, KIAA1600","Family with sequence similarity 160, member B1",FAM160B1,57700,ENSG00000151553,NA,NA,Fam160b1 (MGI:2147545)
10,114938194,114977675,10q25.3,10q25.3,610726,"TRUB1, PUS4","TRUB pseudouridine synthase, E. coli, homolog of, 1",TRUB1,142940,ENSG00000165832,NA,NA,Trub1 (MGI:1919383)
10,115093364,115948998,10q26,10q25.3,612869,"ATRNL1, KIAA0534, ALP",Attractin-like 1,ATRNL1,26033,ENSG00000107518,NA,NA,Atrnl1 (MGI:2147749)
10,116056924,116273644,10q26,10q25.3,601496,"GFRA1, GDNFRA, GDNFR","GDNF family receptor, alpha-1",GFRA1,2674,ENSG00000151892,NA,NA,Gfra1 (MGI:1100842)
10,116545930,116567854,10q26.1,10q25.3,246600,"PNLIP, PNLIPD",Pancreatic lipase,PNLIP,5406,ENSG00000175535,mutation identified in 1 family,"?Pancreatic lipase deficiency, 614338 (3), Autosomal recessive",Pnlip (MGI:97722)
10,116590958,116609174,10q25.3,10q25.3,604422,"PNLIPRP1, PLRP1",Pancreatic lipase-related protein 1,PNLIPRP1,5407,ENSG00000187021,NA,NA,Pnliprp1 (MGI:97723)
10,116620952,116645142,10q25.3,10q25.3,604423,"PNLIPRP2, PLRP2",Pancreatic lipase-related protein 2,PNLIPRP2,5408,ENSG00000266200,NA,NA,Pnliprp2 (MGI:1336202)
10,116671191,116853271,10q26.12,10q25.3,610701,"HSPA12A, KIAA0417",Heat-shock 70kD protein 12A,HSPA12A,259217,ENSG00000165868,NA,NA,Hspa12a (MGI:1920692)
10,116881476,117126585,10q25.3,10q25.3,611171,"SHTN1, KIAA1598, SHOOTIN1",Shootin1,SHTN1,57698,ENSG00000187164,NA,NA,Shtn1 (MGI:1918903)
10,117128519,117138269,10q26.1,10q25.3,604294,"VAX1, MCOPS11",Ventral anterior homeo box 1,VAX1,11023,ENSG00000148704,mutation identified in one MCOPS11 family,"?Microphthalmia, syndromic 11, 614402 (3), Autosomal recessive",Vax1 (MGI:1277163)
10,117197488,117210298,10q25.3,10q25.3,613655,"KCNK18, TRESK, TRIK, MGR13","Potassium channel, subfamily K, member 18",KCNK18,338567,ENSG00000186795,NA,"{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)",Kcnk18 (MGI:2685627)
10,117241113,117279429,10q25,10q25.3,193001,"SLC18A2, VAT2, SVMT, PKDYS2","Solute carrier family 18 (vesicular monoamine), member 2",SLC18A2,6571,ENSG00000165646,mutation identified in 1 PKDYS2 family,"?Parkinsonism-dystonia, infantile, 2, 618049 (3), Autosomal recessive",Slc18a2 (MGI:106677)
10,117277273,117375491,10q25.3-q26.11,10q25.3-q26.1,614235,PDZD8,PDZ domain-containing protein 8,PDZD8,118987,ENSG00000165650,NA,NA,Pdzd8 (MGI:2677270)
10,117300000,133797422,10q26,NA,615163,CORD17,Cone-rod dystrophy 17,CORD17,101409267,NA,between D10S1757 and D10S1782,"Cone-rod dystrophy 17, 615163 (2), Autosomal dominant",NA
10,117300000,133797422,10q26,NA,609625,"DEL10q26, C10q26DEL",Chromosome 10q26 deletion syndrome,NA,NA,NA,NA,"Chromosome 10q26 deletion syndrome, 609625 (4), Autosomal dominant",NA
10,117300000,133797422,10q26,NA,131200,ENDO1,"Endometriosis, susceptibility to, 1",NA,100188863,NA,max lod at D10S587,"{Endometriosis, susceptibility to, 1}, 131200 (2), Autosomal recessive, Multifactorial",NA
10,117300000,133797422,10q26,NA,609116,RRIS,Respiratory rhythmicity in sleep,NA,497662,NA,NA,"[Respiratory rhythmicity in sleep], 609116 (2)",NA
10,117484292,117545067,10q26,10q26.11,607637,EMX2OS,EMX2 opposite strand,EMX2OS,196047,ENSG00000229847,non-coding RNA,NA,NA
10,117542444,117549545,10q26.1,10q26.11,600035,EMX2,"Empty spiracles, Drosophila, homolog of, 2",EMX2,2018,ENSG00000170370,close to VAX1,"Schizencephaly, 269160 (3)",Emx2 (MGI:95388)
10,118004915,118046940,10q26,10q26.11,608599,"RAB11FIP2, KIAA0941",RAB11 family-interacting protein 2,RAB11FIP2,22841,ENSG00000107560,NA,NA,Rab11fip2 (MGI:1922248)
10,118046820,118210152,10q26,10q26.11,608598,CASC2,Cancer susceptibility candidate 2,CASC2,255082,ENSG00000177640,head-to-head orientation with RAB11FIP2,NA,NA
10,118589996,118595647,10q25.3-q26,10q26.11,600895,GPR10,G protein-coupled receptor-10,PRLHR,2834,ENSG00000119973,NA,NA,Prlhr (MGI:2135956)
10,119029713,119033729,10q26.11,10q26.11,608226,"NANOS1, NOS1, SPGF12","NANOS, Drosophila, homolog of, 1",NANOS1,340719,ENSG00000188613,NA,"Spermatogenic failure 12, 615413 (3), Autosomal dominant",Nanos1 (MGI:2669254)
10,119033669,119080816,10q26,10q26.11,602039,"EIF3A, EIF3S10, P167","Eukaryotic translation initiation factor 3, subunit A",EIF3A,8661,ENSG00000107581,NA,NA,Eif3a (MGI:95301)
10,119140766,119165727,10q26.11,10q26.11,615564,"SFXN4, COXPD18",Sideroflexin 4,SFXN4,119559,ENSG00000183605,NA,"Combined oxidative phosphorylation deficiency 18, 615578 (3), Autosomal recessive",Sfxn4 (MGI:2137680)
10,119167698,119178864,10q25-q26,10q26.11,604769,"PRDX3, AOP1",Peroxiredoxin 3 (antioxidant protein 1),PRDX3,10935,ENSG00000165672,NA,NA,Prdx3 (MGI:88034)
10,119207570,119459744,10q24-qter,10q26.11,600870,"GRK5, GPRK5",G protein-coupled receptor kinase 5,GRK5,2869,ENSG00000198873,NA,NA,Grk5 (MGI:109161)
10,119573464,119598840,10q,10q26.11,603413,"TIAL1, TIAR, TCBP",Tia1 cytotoxic granule-associated RNA-binding protein-like 1,TIAL1,7073,ENSG00000151923,NA,NA,Tial1 (MGI:107913)
10,119651369,119677818,10q25.2-q26.2,10q26.11,603883,"BAG3, MFM6",BCL2-associated athanogene 3,BAG3,9531,ENSG00000151929,NA,"Cardiomyopathy, dilated, 1HH, 613881 (3), Autosomal dominant; Myopathy, myofibrillar, 6, 612954 (3), Autosomal dominant",Bag3 (MGI:1352493)
10,119704394,119830481,10q26.11,10q26.11,609389,"INPP5F, SAC2, KIAA0966",Inositol polyphosphate 5-phosphatase F,INPP5F,22876,ENSG00000198825,NA,NA,Inpp5f (MGI:2141867)
10,119829403,119873627,10q26.11,10q26.11,610909,"MCMBP, C10orf119",Minichromosome maintenance complex-binding protein,MCMBP,79892,ENSG00000197771,NA,NA,Mcmbp (MGI:1920977)
10,119892572,119944657,10q26.11-q26.12,10q26.11-q26.12,617852,SEC23IP,Sec23-interacting protein,SEC23IP,11196,ENSG00000107651,NA,NA,Sec23ip (MGI:2450915)
10,120851312,120909524,10q26,10q26.12,606417,"WDR11, DR11, KIAA1351, BRWD2, HH14",WD repeat-containing protein 11,WDR11,55717,ENSG00000120008,NA,"Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3), Autosomal dominant",Wdr11 (MGI:1920230)
10,121478329,121598457,10q26,10q26.13,176943,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",Fibroblast growth factor receptor-2 (bacteria-expressed kinase),FGFR2,2263,ENSG00000066468,NA,"Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3), Autosomal dominant; Apert syndrome, 101200 (3), Autosomal dominant; Beare-Stevenson cutis gyrata syndrome, 123790 (3), Autosomal dominant; Bent bone dysplasia syndrome, 614592 (3), Autosomal dominant; Craniofacial-skeletal-dermatologic dysplasia, 101600 (3), Autosomal dominant; Craniosynostosis, nonspecific (3); Crouzon syndrome, 123500 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3); Jackson-Weiss syndrome, 123150 (3), Autosomal dominant; LADD syndrome, 149730 (3), Autosomal dominant; Pfeiffer syndrome, 101600 (3), Autosomal dominant; Saethre-Chotzen syndrome, 101400 (3), Autosomal dominant; Scaphocephaly and Axenfeld-Rieger anomaly (3); Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)",Fgfr2 (MGI:95523)
10,121957087,121975227,10q26.13,10q26.13,612987,"NSMCE4A, NSE4A","Non-SMC element 4, S. cerevisiae, homolog of, A",NSMCE4A,54780,ENSG00000107672,NA,NA,Nsmce4a (MGI:1915122)
10,121989162,122254541,10q26,10q26.13,605302,TACC2,"Transforming, acidic, coiled-coil-containing protein 2",TACC2,10579,ENSG00000138162,NA,NA,Tacc2 (MGI:1928899)
10,122374674,122442599,10q25.3-q26.2,10q26.13,607772,"PLEKHA1, TAPP1","Pleckstrin homology domain-containing protein, family A, member 1",PLEKHA1,59338,ENSG00000107679,NA,NA,Plekha1 (MGI:2442213)
10,122454652,122457351,10q26.13,10q26.13,611313,"LOC387715, ARMD8",LOC387715 gene,ARMS2,387715,ENSG00000254636,NA,"{Macular degeneration, age-related, 8}, 613778 (3)",NA
10,122461552,122514906,10q25.3-q26.2,10q26.13,602194,"HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2",HTRA serine peptidase 1,HTRA1,5654,ENSG00000166033,NA,"CARASIL syndrome, 600142 (3), Autosomal recessive; Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3), Autosomal dominant; {Macular degeneration, age-related, 7}, 610149 (3); {Macular degeneration, age-related, neovascular type}, 610149 (3)",Htra1 (MGI:1929076)
10,122560664,122643735,10q25.3-q26.1,10q26.13,601969,DMBT1,Deleted in malignant brain tumors 1,DMBT1,1755,ENSG00000187908,NA,NA,Dmbt1 (MGI:106210)
10,122832154,122846174,10q26.13,10q26.13,616644,"CUZD1, ERG1, ITMAP1",Cub and zona pellucida-like domains 1,CUZD1,50624,ENSG00000138161,NA,NA,Cuzd1 (MGI:1202881)
10,122980400,122990389,10q26.13,10q26.13,611310,"PSTK, C10orf89",Phosphoseryl-tRNA kinase,PSTK,118672,ENSG00000179988,NA,NA,Pstk (MGI:2685945)
10,122990805,123008849,10q26.13,10q26.13,606238,"IFZF5, ZNFN1A5, PEGASUS",Ikaros family zinc finger 5,IKZF5,64376,ENSG00000095574,NA,NA,Ikzf5 (MGI:1914393)
10,123008912,123058316,10q25-q26,10q26.13,600301,"ACADSB, SBCAD","Acyl-Coenzyme A dehydrogenase, short/branched chain",ACADSB,36,ENSG00000196177,NA,"2-methylbutyrylglycinuria, 610006 (3), Autosomal recessive",Acadsb (MGI:1914135)
10,123135969,123139422,10q26.13,10q26.13,613380,"HMX3, NKX5.1",H6 family homeobox 3,HMX3,340784,ENSG00000188620,NA,NA,Hmx3 (MGI:107160)
10,123142420,123150672,10q25.2-q26.3,10q26.13,600647,HMX2,Homeo box (H6 family) 2,HMX2,3167,ENSG00000188816,NA,NA,Hmx2 (MGI:107159)
10,123154243,123170466,10q24-q26,10q26.13,603719,BUB3,"Budding uninhibited by benzimidazoles 3, S. cerevisiae, homolog of",BUB3,9184,ENSG00000154473,NA,NA,Bub3 (MGI:1343463)
10,123666354,123697398,10q26.2-q26.3,10q26.13,604847,GPR26,G protein-coupled receptor 26,GPR26,2849,ENSG00000154478,NA,NA,Gpr26 (MGI:2441758)
10,123745635,123944093,10q26.13,10q26.13,617348,"CPXM2, CPX2","Carboxypeptidase X, M14 family, member 2",CPXM2,119587,ENSG00000121898,NA,NA,Cpxm2 (MGI:1926006)
10,124006058,124093683,10q26,10q26.13,608277,"CHST15, BRAG, KIAA0598",Carbohydrate sulfotransferase 15,CHST15,51363,ENSG00000182022,NA,NA,Chst15 (MGI:1924840)
10,124397302,124418975,10q26,10q26.13,613349,"OAT, GACR",Ornithine aminotransferase,OAT,4942,ENSG00000065154,pseudogene at Xp11.2,"Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3), Autosomal recessive",Oat (MGI:97394)
10,124461822,124614140,10q26.13,10q26.13,617231,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,LHPP,64077,ENSG00000107902,NA,NA,Lhpp (MGI:1923679)
10,124619291,124744377,10q26.13,10q26.13,617289,"FAM53B, KIAA0140","Family with sequence similarity 53, member B",FAM53B,9679,ENSG00000189319,NA,NA,Fam53b (MGI:1925188)
10,124757833,124791886,10q26.13,10q26.13,617794,"EEF1AKMT2, METTL10",EEF1A lysine methyltransferase 2,EEF1AKMT2,399818,ENSG00000203791,NA,NA,Eef1akmt2 (MGI:1919346)
10,124801802,124836669,10q26.13,10q26.13,611144,"FAM175B, ABRO1, KIAA0157","Family with sequence similarity 175, member B",ABRAXAS2,23172,ENSG00000165660,NA,NA,Abraxas2 (MGI:1926116)
10,124939488,124988188,10q26.13,10q26.13,611749,"ZRANB1, TRABID",Zinc finger- and RAN-binding domain-containing protein 1,ZRANB1,54764,ENSG00000019995,NA,NA,Zranb1 (MGI:106441)
10,124984316,125161038,10q26.13,10q26.13,602619,CTBP2,C-terminal-binding protein 2,CTBP2,1488,ENSG00000175029,NA,NA,Ctbp2 (MGI:1201686)
10,125766452,125775820,10q26.13,10q26.2,608416,"MMP21, HTX7",Matrix metalloproteinase 21,MMP21,118856,ENSG00000154485,NA,"Heterotaxy, visceral, 7, autosomal, 616749 (3), Autosomal recessive",Mmp21 (MGI:2664387)
10,125784979,125823279,10q25.2-q26.3,10q26.2,606938,UROS,Uroporphyrinogen III synthase,UROS,7390,ENSG00000188690,NA,"Porphyria, congenital erythropoietic, 263700 (3), Autosomal recessive",Uros (MGI:98917)
10,125823545,125853694,10q25.3-q26.2,10q26.2,611883,"BCCIP, TOK1",BRCA2- and CDKN1A-interacting protein,BCCIP,56647,ENSG00000107949,NA,NA,Bccip (MGI:1913415)
10,125836336,125881291,10q26,10q26.2,607960,"DHX32, DDX32",DEAH (Asp-Glu-Ala-His) box polypeptide 32,DHX32,55760,ENSG00000089876,NA,NA,Dhx32 (MGI:2141813)
10,125896222,126009598,10q26.2,10q26.2,611640,FANK1,Fibronectin type III and ankyrin repeat domains 1,FANK1,92565,ENSG00000203780,NA,NA,Fank1 (MGI:1914180)
10,126012390,126388476,10q26.3,10q26.2,602714,"ADAM12, MLTN","A disintegrin and metalloproteinase domain 12 (Meltrin-alpha, mouse, homolog of)",ADAM12,8038,ENSG00000148848,NA,NA,Adam12 (MGI:105378)
10,126424996,126670509,10q26.2,10q26.2,617735,"C10orf90, FATS",Chromosome 10 open reading frame 90,C10orf90,118611,ENSG00000154493,NA,NA,D7Ertd443e (MGI:1196431)
10,126905408,127452516,10q26.13-q26.3,10q26.2,601403,"DOCK1, DOCK180",Dedicator of cytokinesis-1,DOCK1,1793,ENSG00000150760,NA,NA,Dock1 (MGI:2429765)
10,127135429,127196590,10q26.2,10q26.2,617129,"FAM196A, C10orf141, INSYN2","Family with sequence similarity 196, member A",INSYN2A,642938,ENSG00000188916,NA,NA,Insyn2a (MGI:3605068)
10,127549348,127552670,10q26.2,10q26.2,609513,NPS,Neuropeptide S,NPS,594857,ENSG00000214285,NA,NA,Nps (MGI:3642232)
10,127737184,127741182,10q26.2,10q26.2,617202,FOXI2,Forkhead box I2,FOXI2,399823,ENSG00000186766,NA,NA,Foxi2 (MGI:3028075)
10,127907052,128085854,10q26,10q26.2,600926,PTPRE,"Protein tyrosine phosphatase, receptor type, epsilon",PTPRE,5791,ENSG00000132334,NA,NA,Ptpre (MGI:97813)
10,128096658,128126422,10q25-qter,10q26.2,176741,MKI67,Proliferation-related Ki-67 antigen,MKI67,4288,ENSG00000148773,NA,NA,Mki67 (MGI:106035)
10,129467213,129770982,10q26,10q26.3,156569,MGMT,Methylguanine-DNA methyltransferase,MGMT,4255,ENSG00000170430,NA,NA,Mgmt (MGI:96977)
10,129835232,129964273,10q26.3,10q26.3,607407,"EBF3, COE3, HADDS",Early B-cell factor 3,EBF3,253738,ENSG00000108001,NA,"Hypotonia, ataxia, and delayed development syndrome, 617330 (3), Autosomal dominant",Ebf3 (MGI:894289)
10,130136374,130182876,10q26.3,10q26.3,612754,"GLRX3, PICOT",Glutaredoxin 3,GLRX3,10539,ENSG00000108010,NA,NA,Glrx3 (MGI:1353653)
10,131900643,131971534,10q26.3,10q26.3,613992,PPP2R2D,"Protein phosphatase 2, regulatory subunit B, delta",PPP2R2D,55844,ENSG00000175470,NA,NA,Ppp2r2d (MGI:1289252)
10,131967682,131982012,10q26.3,10q26.3,603293,"BNIP3, NIP3",BCL2/adenovirus E1B 19-kD protein-interacting protein 3,BNIP3,664,ENSG00000176171,NA,NA,Bnip3 (MGI:109326)
10,132036067,132184857,10q26.1,10q26.3,611198,"JAKMIP3, C10orf39, NECC2, JAMIP3",Janus kinase and microtubule interacting protein 3,JAKMIP3,282973,ENSG00000188385,NA,NA,Jakmip3 (MGI:1921254)
10,132184982,132205758,10q25.2-q26,10q26.3,608407,"DPYSL4, CRMP3, ULIP4",Dihydropyrimidinase-like 4,DPYSL4,10570,ENSG00000151640,NA,NA,Dpysl4 (MGI:1349764)
10,132537783,132783479,10q26.3,10q26.3,600106,INPP5A,"Inositol polyphosphate-5-phosphatase, 40kD",INPP5A,3632,ENSG00000068383,NA,NA,Inpp5a (MGI:2686961)
10,132782228,132786146,10q26,10q26.3,605955,"NKX6-2, NKX6B, NKX6.2, SPAX8","NK6 transcription factor related, locus 2 (Drosophila)",NKX6-2,84504,ENSG00000148826,NA,"Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3), Autosomal recessive",Nkx6-2 (MGI:1352738)
10,133070928,133131674,10q26.3,10q26.3,612302,"ADGRA1, GPR123, KIAA1828",Adhesion G protein-coupled receptor A1,ADGRA1,84435,ENSG00000197177,NA,NA,Adgra1 (MGI:1277167)
10,133160218,133226411,10q26.3,10q26.3,616237,"KNDC1, RASGEF2, KIAA1768",Kinase noncatalytic C-lobe domain-containing protein 1,KNDC1,85442,ENSG00000171798,NA,NA,Kndc1 (MGI:1923734)
10,133230216,133231557,10q26,10q26.3,604130,UTF1,Undifferentiated embryonic cell transcription factor 1,UTF1,8433,ENSG00000171794,NA,NA,Utf1 (MGI:1276125)
10,133237854,133241927,10q26.3,10q26.3,607158,"VENTX, VENTX2, HPX42B",VENT homeobox,VENTX,27287,ENSG00000151650,NA,NA,NA
10,133262421,133276890,10q26.3,10q26.3,602267,"ADAM8, CD156",A disintegrin and metalloprotease domain 8,ADAM8,101,ENSG00000151651,NA,NA,Adam8 (MGI:107825)
10,133278629,133312336,10q26.3,10q26.3,617817,"TUBGCP2, GCP2, GRIP103, SPC97, ALP4",Tubulin-gamma complex-associated protein 2,TUBGCP2,10844,ENSG00000130640,NA,NA,Tubgcp2 (MGI:1921487)
10,133324071,133336895,10q26.3,10q26.3,604647,"CALY, DRD1IP",Calcyon neuron-specific vesicular protein,CALY,50632,ENSG00000130643,NA,NA,Caly (MGI:1915816)
10,133347372,133352682,10q26.3,10q26.3,609776,PRAP1,Proline-rich acidic protein 1,PRAP1,118471,ENSG00000165828,NA,NA,Prap1 (MGI:893573)
10,133352772,133358030,10q26.3,10q26.3,617725,"FUOM, FUCU",Fucose mutarotase,FUOM,282969,ENSG00000148803,NA,NA,Fuom (MGI:1916314)
10,133362479,133373395,10q26.2-q26.3,10q26.3,602292,"ECHS1, SCEH, ECHS1D","Enoyl-CoA hydratase, short-chain, 1, mitochondrial",ECHS1,1892,ENSG00000127884,NA,"Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3), Autosomal recessive",Echs1 (MGI:2136460)
10,133379236,133391695,10q26.3,10q26.3,615853,"PAOX, PAO",Polyamine oxidase,PAOX,196743,ENSG00000148832,NA,NA,Paox (MGI:1916983)
10,133420665,133424616,10q26.3,10q26.3,610447,"SPRN, SHADOO, SHO",Shadow of prion protein,SPRN,503542,ENSG00000203772,NA,NA,Sprn (MGI:3582583)
10,133527362,133539122,10q24.3-qter,10q26.3,124040,"CYP2E, CYP2E1, P450C2E","Cytochrome P450, subfamily IIE, ethanol-inducible",CYP2E1,1571,ENSG00000130649,NA,NA,Cyp2e1 (MGI:88607)
10,133553899,133568274,10q26.3,10q26.3,611486,"SYCE1, POF12, SPGF15",Synaptonemal complex central element protein 1,SYCE1,93426,ENSG00000171772,mutation identified in 1 POF12 and 1 SPGF15 family,"?Premature ovarian failure 12, 616947 (3), Autosomal recessive; ?Spermatogenic failure 15, 616950 (3), Autosomal recessive",Syce1 (MGI:1921325)
11,0,31000000,11p15-p14,NA,606528,"DEL11p15p14, C11DELp15p14",Chromosome 11p15-p14 deletion syndrome (homozygous),NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 11p15-p14 deletion syndrome, 606528 (4), Autosomal recessive",NA
11,0,22000000,11p15,NA,611010,"GINGF4, HGF4, GGF4","Fibromatosis, gingival, 4",GINGF4,100124414,NA,between D11S1984 and D11S1338,"Fibromatosis, gingival, 4, 611010 (2)",NA
11,0,53400000,11p,NA,604499,HYPLIP2,"Hyperlipidemia, combined, 2",NA,28515,NA,NA,"Hyperlipidemia, combined, 2, 604499 (2)",NA
11,0,22000000,11p15,NA,235000,"IH, HHP","Hemihyperplasia, isolated",NA,100188864,NA,epigenetic or uniparental disomy,"Hemihypertrophy, 235000 (2), Autosomal dominant",NA
11,0,2800000,11p15.5,NA,147510,"IRDN, ILPR",Insulin-related DNA polymorphism (insulin-related VNTR),NA,NA,NA,NA,NA,NA
11,0,22000000,11p15,NA,609470,LVNC2,Left ventricular noncompaction 2,NA,619411,NA,max lod at D11S902,"Left ventricular noncompaction 2, 609470 (2)",NA
11,0,22000000,11p15,NA,616792,NBLST7,"Neuroblastoma, susceptibility to, 7",NA,107181289,NA,associated with rs2168101,"{Neuroblastoma, susceptibility to, 7}, 616792 (2)",NA
11,0,53400000,11p,NA,600165,NNO1,Nanophthalmos 1,NNO1,23691,NA,NA,"Nanophthalmos-1, 600165 (2), Autosomal dominant",NA
11,0,2800000,11p15.5,NA,607967,SLEN3,"Systemic lupus erythematosus with nephritis, susceptibility to, 3",SLEN3,282849,NA,NA,"{Systemic lupus erythematosus with nephritis, susceptibility to, 3}, 607967 (2)",NA
11,0,48800000,11pter-p11.2,NA,186710,TP250,T-cell activation antigen p250,NA,NA,NA,NA,NA,NA
11,187880,194574,11p15.5,11p15.5,610176,"SCGB1C1, RYD5","Secretoglobin, family 1C, member 1",SCGB1C1,147199,ENSG00000188076,NA,NA,NA
11,196760,200257,11p15.5,11p15.5,608356,"ODF3, SHIPPO1",Outer dense fiber of sperm tails 3,ODF3,113746,ENSG00000177947,NA,NA,Odf3 (MGI:1916537)
11,202923,207421,11p15.5,11p15.5,615417,"BET1L, GS15",BET1-like protein,BET1L,51272,ENSG00000177951,NA,NA,Bet1l (MGI:1913128)
11,207510,215174,11p15.5,11p15.5,609146,RIC8A,"Ric8, C. elegans, homolog of, A",RIC8A,60626,ENSG00000177963,NA,NA,Ric8a (MGI:2141866)
11,215029,236930,11p15.5,11p15.5,604481,"SIRT3, SIR2L3","Sirtuin, S. cerevisiae, homolog 3",SIRT3,23410,ENSG00000142082,NA,NA,Sirt3 (MGI:1927665)
11,236971,252983,11p15.5,11p15.5,603481,"PSMD13, S11","Proteasome 26S subunit, non-ATPase, 13",PSMD13,5719,ENSG00000185627,NA,NA,Psmd13 (MGI:1345192)
11,278364,285941,11p15.5,11p15.5,609650,"NALP6, PYPAF5","NACHT domain-, leucine-rich repeat-, and PYD-containing protein 6",NLRP6,171389,ENSG00000174885,NA,NA,Nlrp6 (MGI:2141990)
11,287759,296106,11p15.5,11p15.5,617032,"PGGHG, ATHL1",Protein-glucosylgalactosylhydroxylysine glucosidase,PGGHG,80162,ENSG00000142102,NA,NA,Pgghg (MGI:2444047)
11,298199,299525,11p15.5,11p15.5,614757,"IFITM5, OI5",Interferon-induced transmembrane protein 5,IFITM5,387733,ENSG00000206013,NA,"Osteogenesis imperfecta, type V, 610967 (3), Autosomal dominant",Ifitm5 (MGI:1934923)
11,308106,309409,11p15.5,11p15.5,605578,IFITM2,Interferon-induced transmembrane protein 1,IFITM2,10581,ENSG00000185201,NA,NA,Ifitm2 (MGI:1933382)
11,314039,315271,11p15.5,11p15.5,604456,"IFITM1, IFI17, LEU13",Interferon-induced transmembrane protein 1,IFITM1,8519,ENSG00000185885,NA,NA,NA
11,319675,320859,11p15.5,11p15.5,605579,IFITM3,Interferon-induced transmembrane protein 3,IFITM3,10410,ENSG00000142089,NA,"{Influenza, severe, susceptibility to}, 614680 (3)",Ifitm3 (MGI:1913391)
11,392595,404907,11p15,11p15.5,605561,PKP3,Plakophilin-3,PKP3,11187,ENSG00000184363,NA,NA,Pkp3 (MGI:1891830)
11,405715,417453,11p15.5,11p15.5,605478,SIGIRR,Single immunoglobulin domain-containing IL1R-related protein,SIGIRR,59307,ENSG00000185187,NA,NA,Sigirr (MGI:1344402)
11,448214,491399,11p15.5,11p15.5,612793,"PTDSS2, PSS2",Phosphatidylserine synthase 2,PTDSS2,81490,ENSG00000174915,NA,NA,Ptdss2 (MGI:1351664)
11,494511,507254,11p15.5,11p15.5,173320,"RNH1, RNH",Ribonuclease/angiogenin inhibitor 1,RNH1,6050,ENSG00000023191,NA,NA,Rnh1 (MGI:1195456)
11,518966,554915,11p15.5,11p15.5,618227,"LRRC56, CILD39",Leucine-rich repeat-containing protein 56,LRRC56,115399,ENSG00000161328,NA,"Ciliary dyskinesia, primary, 39, 618254 (3), Autosomal recessive",Lrrc56 (MGI:1917802)
11,532241,535575,11p15.5,11p15.5,190020,HRAS,Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog,HRAS,3265,ENSG00000174775,pseudogene HRASP on X,"Bladder cancer, somatic, 109800 (3); Congenital myopathy with excess of muscle spindles, 218040 (3), Autosomal dominant; Costello syndrome, 218040 (3), Autosomal dominant; Nevus sebaceous or woolly hair nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Spitz nevus or nevus spilus, somatic, 137550 (3); Thyroid carcinoma, follicular, somatic, 188470 (3)",Hras (MGI:96224)
11,560969,564024,11p15.5,11p15.5,143023,"RASSF7, C11orf13, HRC1","RAS association domain family, member 7",RASSF7,8045,ENSG00000099849,29kb 5' to HRAS1; divergently transcribed,NA,Rassf7 (MGI:1914235)
11,568088,568197,11p15.5,11p15.5,612982,"MIR210, MIRN210",Micro RNA 210,MIR210,406992,ENSG00000199038,NA,NA,NA
11,576445,612221,11p15.5,11p15.5,611780,"PHRF1, KIAA1542",PHD and RING finger domain-containing protein 1,PHRF1,57661,ENSG00000070047,NA,NA,Phrf1 (MGI:2141847)
11,612554,615998,11p15.5,11p15.5,605047,"IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39",Interferon regulatory factor 7,IRF7,3665,ENSG00000185507,mutation identified in 1 family,"?Immunodeficiency 39, 616345 (3), Autosomal recessive",Irf7 (MGI:1859212)
11,616564,625066,11p15.5,11p15.5,606839,"CDHR5, MUCDHL","Cadherin-related family, member 5",CDHR5,53841,ENSG00000099834,NA,NA,Cdhr5 (MGI:1919290)
11,626094,627691,11p15.5,11p15.5,182099,SCT,Secretin,SCT,6343,ENSG00000070031,NA,NA,NA
11,637268,640705,11p15.5,11p15.5,126452,DRD4,Dopamine receptor D4,DRD4,1815,ENSG00000069696,proximal to HRAS,"{Attention deficit-hyperactivity disorder}, 143465 (3), Autosomal dominant; Autonomic nervous system dysfunction (3); [Novelty seeking personality], 601696 (1), ?Autosomal dominant",Drd4 (MGI:94926)
11,644219,707082,11p15.5,11p15.5,602635,"DEAF1, SPN, ZMYND5, MRD24","Deaf1, Drosophila, homolog of",DEAF1,10522,ENSG00000177030,mutation identified in 1 DYSEIDD family,"?Dyskinesia, seizures, and intellectual developmental disorder, 617171 (3), Autosomal recessive; Mental retardation, autosomal dominant 24, 615828 (3), Autosomal dominant",Deaf1 (MGI:1858496)
11,706201,727726,11p15,11p15.5,614988,"EPS8L2, EPS8R2, DFNB106",EPS8-like protein 2,EPS8L2,64787,ENSG00000177106,NA,"Deafness autosomal recessive 106, 617637 (3), Autosomal recessive",Eps8l2 (MGI:2138828)
11,747463,765011,11p15.5-p15.4,11p15.5,602063,TALDO1,Transaldolase-1,TALDO1,6888,ENSG00000177156,pseudogene on chr.1,"Transaldolase deficiency, 606003 (3), Autosomal recessive",Taldo1 (MGI:1274789)
11,787114,790089,11p15.5,11p15.5,608213,"CEND1, BM88",Cell cycle exit and neuronal differentiation 1,CEND1,51286,ENSG00000184524,NA,NA,Cend1 (MGI:1929898)
11,790474,798280,11p15.5,11p15.5,609302,"SLC25A22, GC1, EIEE3","Solute carrier family 25 (mitochondrial carrier, glutamate), member 22",SLC25A22,79751,ENSG00000177542,NA,"Epileptic encephalopathy, early infantile, 3, 609304 (3), Autosomal recessive",Slc25a22 (MGI:1915517)
11,799178,809866,11p15.5,11p15.5,605247,"PIDD1, LRDD",p53-induced death domain protein 1,PIDD1,55367,ENSG00000177595,NA,NA,Pidd1 (MGI:1889507)
11,809966,812875,11p15.5,11p15.5,180530,RPLP2,"Ribosomal phosphoprotein, large, P2",RPLP2,6181,ENSG00000177600,NA,NA,Rplp2 (MGI:1914436)
11,818889,825572,11p15.5,11p15.5,609059,"PNPLA2, TTS2, ATGL",Patatin-like phospholipase domain-containing protein 2,PNPLA2,57104,ENSG00000177666,NA,"Neutral lipid storage disease with myopathy, 610717 (3), Autosomal recessive",Pnpla2 (MGI:1914103)
11,825557,831990,11p15.5,11p15.5,614177,"EFCAB4A, CRACR2B",EF-hand calcium-binding domain-containing protein 4A,CRACR2B,283229,ENSG00000177685,NA,NA,Cracr2b (MGI:2446129)
11,832951,838834,11p15.5,11p15.5,602243,"CD151, PETA3, SFA1, MER2",CD151 antigen,CD151,977,ENSG00000177697,NA,"[Blood group, Raph], 179620 (3); Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)",Cd151 (MGI:1096360)
11,839720,842528,11p15,11p15.5,601189,"POLR2L, RPB10","Polymerase II, RNA, subunit L",POLR2L,5441,ENSG00000177700,NA,NA,Polr2l (MGI:1913741)
11,842823,867115,11p15.5,11p15.5,602644,"TSPAN4, TM4SF7, NAG2",Tetraspanin 4,TSPAN4,7106,ENSG00000214063,NA,NA,Tspan4 (MGI:1928097)
11,867858,915057,11p15.5,11p15.5,615692,"CHID1, SICLP",Chitinase domain-containing protein 1,CHID1,66005,ENSG00000177830,NA,NA,Chid1 (MGI:1915288)
11,925808,1012244,11p15.5,11p15.5,607242,"AP2A2, KIAA0899","Adaptor-related protein complex 2, alpha-2 subunit",AP2A2,161,ENSG00000183020,NA,NA,Ap2a2 (MGI:101920)
11,1012822,1036717,11p15.5-p15.4,11p15.5,158374,MUC6,"Mucin 6, gastric",MUC6,4588,ENSG00000184956,order: tel-HRAS-MUC6-MUC2-MUC5AC-MUC5B-IGF2-cen,NA,Muc6 (MGI:2663233)
11,1074874,1110507,11p15.5,11p15.5,158370,MUC2,"Mucin 2, intestinal/tracheal",MUC2,4583,NA,NA,NA,Muc2 (MGI:1339364)
11,1157952,1201137,11p15.5,11p15.5,158373,"MUC5AC, MUC5","Mucin 5, subtypes A and C, tracheobronchial/gastric",MUC5AC,4586,ENSG00000215182,NA,NA,Muc5ac (MGI:104697)
11,1223065,1262171,11p15,11p15.5,600770,MUC5B,"Mucin 5, subtype B, tracheobronchial",MUC5B,727897,ENSG00000117983,NA,"{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant",Muc5b (MGI:1921430)
11,1274367,1309631,11p15.5,11p15.5,606277,TOLLIP,Toll-interacting protein,TOLLIP,54472,ENSG00000078902,NA,NA,Tollip (MGI:1891808)
11,1389898,1462688,11p15.5,11p15.5,609236,"BRSK2, SAD1, PEN11B",BR serine/threonine kinase 2,BRSK2,9024,ENSG00000174672,NA,NA,Brsk2 (MGI:1923020)
11,1469447,1486778,11p15.5,11p15.5,611969,HCCA2,HCCA2 gene,MOB2,81532,ENSG00000182208,NA,NA,Mob2 (MGI:1919891)
11,1554050,1572838,11p15.5,11p15.5,602038,"DUSP8, HVH8",Dual specificity phosphatase-8,DUSP8,1850,ENSG00000184545,pseudogene on 10q11.2,NA,Dusp8 (MGI:106626)
11,1584341,1585282,11p15.5,11p15.5,148022,"KRTAP5-1, KRN1L",Keratin associated protein 5-1,KRTAP5-1,387264,ENSG00000205869,NA,NA,NA
11,1732405,1750594,11p15.5,11p15.5,618293,"IFITM10, DSPA3",Interferon-induced transmembrane protein 10,IFITM10,402778,ENSG00000244242,NA,NA,NA
11,1752754,1763926,11p15.5,11p15.5,116840,"CTSD, CPSD, CLN10",Cathepsin D (lysosomal aspartyl protease),CTSD,1509,ENSG00000117984,NA,"Ceroid lipofuscinosis, neuronal, 10, 610127 (3), Autosomal recessive",Ctsd (MGI:88562)
11,1827483,1837520,11p15.5,11p15.5,607719,SYT8,Synaptotagmin 8,SYT8,90019,ENSG00000149043,NA,NA,Syt8 (MGI:1859867)
11,1838980,1841677,11p15.5,11p15.5,191043,"TNNI2, AMCD2B, DA2B1, FSSV","Troponin I, fast-twitch skeletal muscle isoform",TNNI2,7136,ENSG00000130598,NA,"Arthrogryposis, distal, type 2B1, 601680 (3), Autosomal dominant",Tnni2 (MGI:105070)
11,1853083,1892262,11p15.5,11p15.5,153432,LSP1,Lymphocyte-specific protein pp52,LSP1,4046,ENSG00000130592,NA,NA,Lsp1 (MGI:96832)
11,1919550,1938703,11p15.5,11p15.5,600692,"TNNT3, AMCD2B, DA2B2, FSSV","Troponin-T3, skeletal, fast",TNNT3,7140,ENSG00000130595,NA,"Arthrogryposis, distal, type 2B2, 618435 (3), Autosomal dominant",Tnnt3 (MGI:109550)
11,1947271,2013175,11p15.5,11p15.5,600789,"RPL23L, L23MRP, MRPL23",Ribosomal protein L23-like (L23 mitochondrial-related protein),MRPL23,6150,ENSG00000214026,NA,NA,Mrpl23 (MGI:1196612)
11,1995175,2001465,11p15.5,11p15.5,103280,"H19, D11S813E, ASM1, BWS, WT2",H19 gene,H19,283120,ENSG00000130600,same 200kb fragment as IGF2,"Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant; Silver-Russell syndrome, 180860 (3), Autosomal dominant; Wilms tumor 2, 194071 (3), Autosomal dominant, Somatic mutation",NA
11,1996758,1996830,11p15.5,11p15.5,615509,MIR675,Micro RNA 675,MIR675,100033819,ENSG00000284010,NA,NA,NA
11,1998744,2003508,11p15.5,11p15.5,616186,ICR1,H19-IGF2-imprinting control region,NA,105259599,NA,NA,"Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant",NA
11,2129111,2149602,11p15.5,11p15.5,147470,"IGF2, GRDF","Insulin-like growth factor-2, or somatomedin A",IGF2,3481,ENSG00000167244,mutation identified in 1 GRDF family,"?Growth restriction, severe, with distinctive facies, 616489 (3), Autosomal dominant",Igf2 (MGI:96434)
11,2140511,2148665,11p15.5,11p15.5,610146,"IGF2AS, PEG8","Insulin-like growth factor II, antisense",IGF2-AS,51214,ENSG00000099869,NA,NA,NA
11,2159778,2161208,11p15.5,11p15.5,176730,"INS, MODY10, IDDM2",Insulin,INS,3630,ENSG00000254647,5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH,"Diabetes mellitus, insulin-dependent, 2, 125852 (3), Autosomal dominant; Diabetes mellitus, permanent neonatal, 606176 (3), Autosomal recessive, Autosomal dominant; Hyperproinsulinemia, 616214 (3), Autosomal dominant; Maturity-onset diabetes of the young, type 10, 613370 (3), Autosomal dominant",Ins2 (MGI:96573)
11,2163928,2174080,11p15.5,11p15.5,191290,"TH, TYH",Tyrosine hydroxylase,TH,7054,ENSG00000180176,distal to HRAS1,"Segawa syndrome, recessive, 605407 (3), Autosomal recessive",Th (MGI:98735)
11,2268497,2270951,11p15.5,11p15.5,601886,ASCL2,"Achaete-scute complex, Drosophila, homolog-like 2",ASCL2,430,ENSG00000183734,NA,NA,Ascl2 (MGI:96920)
11,2295627,2303139,11p15.5,11p15.5,611033,C11orf21,Chromosome 11 open reading frame 21,C11orf21,29125,ENSG00000110665,NA,NA,NA
11,2299479,2318200,11p15.5,11p15.5,603853,"TSPAN32, PHEMX, TSSC6",Tetraspanin 32,TSPAN32,10077,ENSG00000064201,not imprinted,NA,Tspan32 (MGI:1350360)
11,2376176,2397418,11p,11p15.5,186845,"CD81, TAPA1, CVID6",CD81 antigen (target of antiproliferative antibody-1),CD81,975,ENSG00000110651,NA,"Immunodeficiency, common variable, 6, 613496 (3), Autosomal recessive",Cd81 (MGI:1096398)
11,2398411,2403877,11p15.5,11p15.5,603852,TSSC4,Tumor-suppressing subchromosomal transferable fragment cDNA 4,TSSC4,10078,ENSG00000184281,not imprinted,NA,Tssc4 (MGI:1861712)
11,2403961,2423423,11p15.5,11p15.5,604600,"TRPM5, MTR1","Transient receptor potential cation channel, subfamily M, member 5 (MLSN1- and TRP-related gene 1)",TRPM5,29850,ENSG00000070985,maternal allele imprinted,NA,Trpm5 (MGI:1861718)
11,2444990,2849109,11p15.5,11p15.5-p15.4,607542,"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2","Potassium voltage-gated channel, KQT-like subfamily, member 1",KCNQ1,3784,ENSG00000053918,NA,"Atrial fibrillation, familial, 3, 607554 (3), Autosomal dominant; Jervell and Lange-Nielsen syndrome, 220400 (3), Autosomal recessive; Long QT syndrome 1, 192500 (3), Autosomal dominant; {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3), Autosomal dominant; Short QT syndrome 2, 609621 (3), Autosomal dominant",Kcnq1 (MGI:108083)
11,2608327,2699997,11p15.5,11p15.5,604115,"KCNQ1OT1, LIT1",KCNQ1-overlapping transcript 1,KCNQ1OT1,10984,ENSG00000269821,NA,"Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant",NA
11,2800000,11700000,11p15.4,NA,616121,"GVINP1, VLIG1","GTPase, very large interferon-inducible, pseudogene 1",GVINP1,387751,ENSG00000254838,NA,NA,NA
11,2870032,2872104,11p15.5,11p15.4,610980,KCNQ1DN,KCNQ1 downstream neighbor,KCNQ1DN,55539,ENSG00000237941,NA,NA,NA
11,2883217,2885774,11p15.5,11p15.4,600856,"CDKN1C, KIP2, BWS, IMAGE","Cyclin-dependent kinase inhibitor 1C (p57, Kip2)",CDKN1C,1028,ENSG00000129757,rare cause of BWS,"Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant; IMAGE syndrome, 614732 (3), Autosomal dominant",NA
11,2887343,2905503,11p15.5,11p15.4,603240,"SLC22A1LS, ORCTL2S, BWSCR1B","Solute carrier family 22, member 1-like-antisense",SLC22A18AS,5003,ENSG00000254827,NA,NA,NA
11,2899690,2925245,11p15.5,11p15.4,602631,"SLC22A1L, BWSCR1A, IMPT1","Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)",SLC22A18,5002,ENSG00000110628,NA,"Breast cancer, somatic, 114480 (3); Lung cancer, somatic, 211980 (3); Rhabdomyosarcoma, somatic, 268210 (3)",Slc22a18 (MGI:1336884)
11,2928272,2929419,11p15.5,11p15.4,602131,"PHLDA2, TSSC3, IPL, BRW1C","Pleckstrin homology-like domain, family A, member 2",PHLDA2,7262,ENSG00000181649,NA,NA,Phlda2 (MGI:1202307)
11,2944436,2992328,11p15.5,11p15.4,601651,"NAP1L4, NAP2L, NAP2",Nucleosome assembly protein 1-like 4,NAP1L4,4676,ENSG00000205531,NA,NA,Nap1l4 (MGI:1316687)
11,3000921,3057450,11p15.5,11p15.4,123859,CARS,Cysteinyl-tRNA synthetase,CARS1,833,ENSG00000110619,NA,NA,Cars (MGI:1351477)
11,3087106,3165309,11p15.4,11p15.4,606733,"OSBPL5, ORP5, KIAA1534",Oxysterol-binding protein-like protein 5,OSBPL5,114879,ENSG00000021762,NA,NA,Osbpl5 (MGI:1930265)
11,3217943,3218812,11p15.5,11p15.4,607234,"MRGPRG, MRGG","MAS-related G protein-coupled receptor family, member G",MRGPRG,386746,ENSG00000182170,NA,NA,Mrgprg (MGI:3033145)
11,3225029,3232416,11p15.4,11p15.4,607232,"MRGPRE, MRGE","Mas-related G protein-coupled receptor family, member E",MRGPRE,116534,ENSG00000184350,NA,NA,Mrgpre (MGI:2441884)
11,3357926,3379221,11p15.5,11p15.4,602187,ZNF195,Zinc finger protein-195,ZNF195,7748,ENSG00000005801,NA,NA,NA
11,3380960,3409147,11p15.5,11p15.4,608999,TSSC2,Tumor-suppressing subtransferable fragment candidate gene 2,TSSC2,650368,ENSG00000223756,NA,NA,NA
11,3638502,3642391,11p15,11p15.4,610625,ART5,ADP-ribosyltransferase 5,ART5,116969,ENSG00000167311,NA,NA,Art5 (MGI:107948)
11,3645109,3665515,11p15,11p15.4,601625,ART1,ADP-ribosyltransferase 1,ART1,417,ENSG00000129744,NA,NA,Art1 (MGI:107511)
11,3665586,3673628,11p15.5,11p15.4,606372,CHRNA10,"Cholinergic receptor, neuronal nicotinic, alpha polypeptide 10",CHRNA10,57053,ENSG00000129749,NA,NA,Chrna10 (MGI:3609260)
11,3675009,3797553,11p15,11p15.4,601021,NUP98,"Nucleoporin, 98kD",NUP98,4928,ENSG00000110713,"fused with HOXA9, NSD1, NSD3, PMX1, HOXC13, DDX10, TOP1, HOXD11 in myeloid leukemia",NA,Nup98 (MGI:109404)
11,3797723,3826370,11p15.5,11p15.4,615187,"PGAP2, FRAG1, HPMRS3, MRT17, MRT21",Post-GPI attachment to proteins 2,PGAP2,27315,ENSG00000148985,NA,"Hyperphosphatasia with mental retardation syndrome 3, 614207 (3), Autosomal recessive",NA
11,3826977,3840958,11p15.5-p15.4,11p15.4,179505,ARHG,"ras homolog gene family, member G (rho G)",RHOG,391,ENSG00000177105,NA,NA,Rhog (MGI:1928370)
11,3855663,4093209,11p15.5,11p15.4,605921,"STIM1, TAM1, IMD10, STRMK",Stromal interaction molecule 1,STIM1,6786,ENSG00000167323,NA,"Immunodeficiency 10, 612783 (3), Autosomal recessive; Myopathy, tubular aggregate, 1, 160565 (3), Autosomal dominant; Stormorken syndrome, 185070 (3), Autosomal dominant",Stim1 (MGI:107476)
11,4094684,4138931,11p15.5,11p15.4,180410,RRM1,"Ribonucleotide reductase, M1 polypeptide",RRM1,6240,ENSG00000167325,NA,NA,Rrm1 (MGI:98180)
11,4384896,4393701,11p15.5,11p15.4,109092,"TRIM21, SSA1, RO52",Tripartite motif-containing protein 21,TRIM21,6737,ENSG00000132109,NA,NA,Trim21 (MGI:106657)
11,4598671,4608230,11p15.4,11p15.4,613184,"TRIM68, SS56, GC109",Tripartite motif-containing protein 68,TRIM68,55128,ENSG00000167333,incorrectly assigned to 2p24 by FISH,NA,Trim68 (MGI:2142077)
11,4643981,4655487,11p15.4,11p15.4,611267,"OR51E1, DGPCR, PSGR2","Olfactory receptor, family 51, subfamily E, member 1",OR51E1,143503,ENSG00000180785,NA,NA,Olfr558 (MGI:3030392)
11,4680170,4697852,11p15.4,11p15.4,611268,"OR51E2, PSGR","Olfactory receptor, family 51, subfamily E, member 2",OR51E2,81285,ENSG00000167332,NA,NA,Olfr78 (MGI:2157548)
11,4988190,4992428,11p15,11p15.4,605470,MMP26,Matrix metalloproteinase 26 (matrilysin 2),MMP26,56547,ENSG00000167346,NA,NA,NA
11,5225463,5227070,11p15.5,11p15.4,141900,"HBB, ECYT6",Hemoglobin beta,HBB,3043,ENSG00000244734,pseudogene HBBP1 between HBG and HBD loci,"Delta-beta thalassemia, 141749 (3), Autosomal dominant; Erythrocytosis 6, 617980 (3); Heinz body anemia, 140700 (3), Autosomal dominant; Hereditary persistence of fetal hemoglobin, 141749 (3), Autosomal dominant; {Malaria, resistance to}, 611162 (3); Methmoglobinemia, beta type, 617971 (3); Sickle cell anemia, 603903 (3), Autosomal recessive; Thalassemia, beta, 613985 (3); Thalassemia-beta, dominant inclusion-body, 603902 (3)","Hbb-bt,Hbb-bs (MGI:5474850,MGI:5474852)"
11,5232837,5234482,11p15.5,11p15.4,142000,HBD,Hemoglobin delta,HBD,3045,ENSG00000223609,NA,"Thalassemia due to Hb Lepore (3); Thalassemia, delta- (3)",NA
11,5244553,5245545,11p15.4,11p15.4,616308,"BGLT3, LINC01083","Beta-globin locus transcript 3, noncoding",BGLT3,103344929,ENSG00000260629,NA,NA,NA
11,5248271,5249856,11p15.5,11p15.4,142200,HBG1,"Hemoglobin, gamma A",HBG1,3047,ENSG00000213934,NA,"Fetal hemoglobin quantitative trait locus 1, 141749 (3), Autosomal dominant",NA
11,5253187,5254780,11p15.5,11p15.4,142250,"HBG2, TNCY","Hemoglobin, gamma G",HBG2,3048,ENSG00000196565,NA,"Cyanosis, transient neonatal, 613977 (3), Autosomal dominant; Fetal hemoglobin quantitative trait locus 1, 141749 (3), Autosomal dominant",Hbb-y (MGI:96027)
11,5268344,5269944,11p15.5,11p15.4,142100,HBE1,Hemoglobin epsilon,HBE1,3046,ENSG00000213931,NA,NA,Hbb-bh1 (MGI:96024)
11,5269924,5304185,11p15.5,11p15.4,152424,LCRB,Locus control region beta,NA,109580095,NA,NA,"Thalassemia, Hispanic gamma-delta-beta, 613985 (3)",NA
11,5507299,5509956,11p15,11p15.4,605473,UBQLN3,Ubiquilin 3,UBQLN3,50613,ENSG00000175520,NA,NA,Ubqln3 (MGI:3045291)
11,5590905,5685107,11p15,11p15.4,608487,"TRIM5, RNF88",Tripartite motif-containing protein 5,TRIM5,85363,ENSG00000132256,NA,NA,"Trim5,Trim12c (MGI:4821183,MGI:3646853)"
11,5596110,5612951,11p15,11p15.4,607564,TRIM6,Tripartite motif-containing protein 6,TRIM6,117854,ENSG00000121236,NA,NA,Trim6 (MGI:2137352)
11,5619943,5644397,11p15.4-p15.3,11p15.4,605684,"TRIM34, RNF21, IFP1",Tripartite motif-containing 34 (RING finger protein-21),TRIM34,53840,ENSG00000258659,NA,NA,NA
11,5689789,5710862,11p15,11p15.4,606559,"TRIM22, STAF50",Tripartite motif-containing protein 22,TRIM22,10346,ENSG00000132274,NA,NA,NA
11,6259837,6272126,11p15.5-p15.4,11p15.4,118445,"CCKBR, GASR",Cholecystokinin B receptor,CCKBR,887,ENSG00000110148,NA,NA,Cckbr (MGI:99479)
11,6318945,6320500,11p15.4,11p15.4,618303,"CAVIN3, SRBC",Caveolae-associated protein 3,CAVIN3,112464,ENSG00000170955,NA,NA,Cavin3 (MGI:1923422)
11,6390413,6394997,11p15.4-p15.1,11p15.4,607608,"SMPD1, NPD","Sphingomyelin phosphodiesterase-1, acid lysosomal",SMPD1,6609,ENSG00000166311,NA,"Niemann-Pick disease, type A, 257200 (3), Autosomal recessive; Niemann-Pick disease, type B, 607616 (3), Autosomal recessive",Smpd1 (MGI:98325)
11,6395123,6419452,11p15,11p15.4,602709,"APBB1, FE65","Amyloid beta A4 precursor protein-binding, family B, member-1",APBB1,322,ENSG00000166313,NA,NA,Apbb1 (MGI:107765)
11,6431048,6440986,11p15.5-p15.4,11p15.4,142290,HPX,Hemopexin,HPX,3263,ENSG00000110169,NA,NA,Hpx (MGI:105112)
11,6448612,6474458,11p15.4,11p15.4,605493,"TRIM3, RNF22, BERP",Tripartite motif-containing 3,TRIM3,10612,ENSG00000110171,NA,NA,Trim3 (MGI:1860040)
11,6474680,6481478,11p15.4,11p15.4,601638,"ARFIP2, POR1",ADP-ribosylation factor-interacting protein 2,ARFIP2,23647,ENSG00000132254,NA,NA,Arfip2 (MGI:1924182)
11,6481500,6484680,11p15.5-p15.2,11p15.4,607388,"FXC1, TIMM10B","Fracture callus 1, rat, homolog of",TIMM10B,26515,ENSG00000132286,NA,NA,Timm10b (MGI:1315196)
11,6497279,6572024,11p15.4,11p15.4,617277,"DHND1, FLJ00251",Dynein heavy chain domain 1,DNHD1,144132,ENSG00000179532,NA,NA,Dnhd1 (MGI:1924755)
11,6514829,6603677,11p15.4,11p15.4,615818,"RRP8, NML, KIAA0409","Ribosomal RNA processing protein 8, homolog of",RRP8,23378,ENSG00000132275,NA,NA,Rrp8 (MGI:1914251)
11,6603707,6610873,11p15.5-p15.4,11p15.4,602366,"ILK, P59",Integrin-linked kinase,ILK,3611,ENSG00000166333,NA,NA,Ilk (MGI:1195267)
11,6606293,6612215,11p15.3,11p15.4,600475,"TAF10, TAF2H, TAF2A","TAF10 RNA polymerase II, TATA box-binding protein-associated factor, 30kD",TAF10,6881,ENSG00000166337,NA,NA,Taf10 (MGI:1346320)
11,6612767,6619421,11p15.5,11p15.4,607998,"TPP1, CLN2, SCAR7",Tripeptidyl peptidase 1,TPP1,1200,ENSG00000166340,NA,"Ceroid lipofuscinosis, neuronal, 2, 204500 (3), Autosomal recessive; Spinocerebellar ataxia, autosomal recessive 7, 609270 (3), Autosomal recessive",Tpp1 (MGI:1336194)
11,6621329,6655808,11p15.4,11p15.4,603057,"DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2","Dachsous, Drosophila, homolog of, 1",DCHS1,8642,ENSG00000166341,NA,"Mitral valve prolapse 2, 607829 (3), Autosomal dominant; Van Maldergem syndrome 1, 601390 (3), Autosomal recessive",Dchs1 (MGI:2685011)
11,6680384,6683339,11p15.5-p15.4,11p15.4,611830,MRPL17,Mitochondrial ribosomal protein L17,MRPL17,63875,ENSG00000158042,NA,NA,Mrpl17 (MGI:1351608)
11,6794524,6795907,11p15,11p15.4,608495,"OR6A2, OR6A1","Olfactory receptor, family 6, subfamily A, member 2",OR6A2,8590,ENSG00000184933,NA,NA,Olfr2 (MGI:97432)
11,6845682,6846635,11p15.4,11p15.4,608493,OR10A1,"Olfactory receptor, family 10, subfamily A, member 1",OR10A5,144124,ENSG00000166363,NA,NA,Olfr713 (MGI:3030547)
11,6891573,6892499,11p15.4,11p15.4,608494,OR2D2,"Olfactory receptor, family 2, subfamily D, member 2",OR2D2,120776,ENSG00000166368,NA,NA,"Olfr715,Olfr715b (MGI:3647188,MGI:3030549)"
11,6926360,6991143,11p15.4,11p15.4,605016,ZNF215,Zinc finger protein-215,ZNF215,7762,ENSG00000149054,NA,NA,NA
11,6993481,7020366,11p15.4,11p15.4,605015,ZNF214,Zinc finger protein-214,ZNF214,7761,ENSG00000149050,NA,NA,NA
11,7020445,7089024,11p15.4,11p15.4,609665,"NLRP1, NALP14, NOD5","NLR family, pyrin domain containing 1",NLRP14,338323,ENSG00000158077,NA,NA,Nlrp14 (MGI:1924108)
11,7088997,7091147,11p15,11p15.4,605444,"RBMXL2, HNRNPGT, HNRPGT","RNA-binding motif protein, X chromosome, like 2",RBMXL2,27288,ENSG00000170748,NA,NA,Rbmxl2 (MGI:1923822)
11,7238783,7470031,11p15.4,11p15.4,613528,SYT9,Synaptotagmin 9,SYT9,143425,ENSG00000170743,NA,NA,Syt9 (MGI:1926373)
11,7513764,7666641,11p15.4,11p15.4,603142,PPFIB2,"Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein-binding protein 2",PPFIBP2,8495,ENSG00000166387,NA,NA,Ppfibp2 (MGI:894649)
11,7665094,7678568,11p15.4,11p15.4,608342,CYB5R2,Cytochrome b5 reductase 2,CYB5R2,51700,ENSG00000166394,NA,NA,Cyb5r2 (MGI:2444415)
11,7957536,7965426,11p15,11p15.4,609662,"NLRP10, NALP10, PYNOD, NOD8","NLR family, pyrin domain containing 10",NLRP10,338322,ENSG00000182261,NA,NA,Nlrp10 (MGI:2444084)
11,7987336,8001851,11p15.4,11p15.4,603914,"EIF3F, EIF3S5, MRT67","Eukaryotic translation initiation factor 3, subunit F",EIF3F,8665,ENSG00000175390,NA,"Mental retardation, autosomal recessive 67, 618295 (3), Autosomal recessive",Eif3f (MGI:1913335)
11,8019179,8106106,11p15.4,11p15.4,601197,"TUB, RDOB","Tubby, mouse, homolog of",TUB,7275,ENSG00000166402,mutation identified in 1 RDOB family,"?Retinal dystrophy and obesity, 616188 (3), Autosomal recessive",Tub (MGI:2651573)
11,8092964,8169093,11p15.4,11p15.4,610509,RIC3,"Resistance to inhibitors of cholinesterase 3, C. elegans, homolog of",RIC3,79608,ENSG00000166405,NA,NA,Ric3 (MGI:2443887)
11,8224303,8268786,11p15,11p15.4,186921,"LMO1, RBTN1, RHOM1",LIM domain only 1 (rhombotin 1),LMO1,4004,ENSG00000166407,NA,"Leukemia, T-cell acute lymphoblastic, 186921 (2)",Lmo1 (MGI:102812)
11,8335028,8594227,11p15.3,11p15.4,607670,STK33,Serine/threonine protein kinase 33,STK33,65975,ENSG00000130413,NA,NA,Stk33 (MGI:2152419)
11,8612036,8683216,11p15.4,11p15.4,612000,"TRIM66, TIF1D, KIAA0298",Tripartite motif-containing protein 66,TRIM66,9866,ENSG00000166436,NA,NA,Trim66 (MGI:2152406)
11,8682791,8689871,11p15,11p15.4,603637,RPL27A,Ribosomal protein L27a,RPL27A,6157,ENSG00000166441,NA,NA,Rpl27a (MGI:1347076)
11,8685438,8685568,11p15.4,11p15.4,611333,"SNORA3B, SNORA45","Small nucleolar RNA, H/ACA box 3B",SNORA3B,677826,ENSG00000212607,NA,NA,NA
11,8693351,8910950,11p15,11p15.4,140750,"ST5, HTS1",Suppression of tumorigenicity-5,ST5,6764,ENSG00000166444,NA,NA,St5 (MGI:108517)
11,8911116,8920078,11p15.3,11p15.4,609191,"AKIP1, BCA3, C11orf17",Protein kinase A-interacting protein 1,AKIP1,56672,ENSG00000166452,NA,NA,Akip1 (MGI:3041226)
11,8980575,9004650,11p15.3,11p15.4,613125,NRIP3,Nuclear receptor-interacting protein 3,NRIP3,56675,ENSG00000175352,NA,NA,Nrip3 (MGI:1925843)
11,9019499,9091598,11p15.4,11p15.4,611747,SCUBE2,"Signal peptide-, CUB domain-, and EGF-like domains-containing protein 2",SCUBE2,57758,ENSG00000175356,NA,NA,Scube2 (MGI:1928765)
11,9138824,9265349,11p15.4,11p15.4,617278,"DENND5A, RAB6IP1, KIAA1091, EIEE49",DENN domain-containing protein 5A,DENND5A,23258,ENSG00000184014,NA,"Epileptic encephalopathy, early infantile, 49, 617281 (3), Autosomal recessive",Dennd5a (MGI:1201681)
11,9384651,9448126,Chr.11,11p15.4,605586,"IPO7, RANBP7",Importin 7,IPO7,10527,ENSG00000205339,NA,NA,Ipo7 (MGI:2152414)
11,9460964,9528523,11p15.4-p15.3,11p15.4,603433,"ZNF143, SBF",Zinc finger protein-143,ZNF143,7702,ENSG00000166478,NA,NA,Zfp143 (MGI:1277969)
11,9573669,9589984,11p15.3-p15.1,11p15.4,193525,WEE1,"wee1+, S. pombe, homolog of",WEE1,7465,ENSG00000166483,NA,NA,Wee1 (MGI:103075)
11,9664076,9752992,11p15,11p15.4,604762,SWAP70,Switch-associated protein 70,SWAP70,23075,ENSG00000133789,NA,NA,Swap70 (MGI:1298390)
11,9778666,10294206,11p15,11p15.4,607697,"SBF2, MTMR13, CMT4B2",SET binding factor 2 (myotubularin-related 13),SBF2,81846,ENSG00000133812,NA,"Charcot-Marie-Tooth disease, type 4B2, 604563 (3), Autosomal recessive",Sbf2 (MGI:1921831)
11,10305072,10307396,11p15.4,11p15.4,103275,ADM,Adrenomedullin,ADM,133,ENSG00000148926,NA,NA,Adm (MGI:108058)
11,10450320,10507578,11pter-p13,11p15.4,102772,AMPD3,"Adenosine monophosphate deaminase-3, isoform E",AMPD3,272,ENSG00000133805,NA,"[AMP deaminase deficiency, erythrocytic], 612874 (3), Autosomal recessive",Ampd3 (MGI:1096344)
11,10511672,10541186,11p15,11p15.4,616641,"RNF141, ZNF230",RING finger protein 141,RNF141,50862,ENSG00000110315,NA,NA,Rnf141 (MGI:1914400)
11,10556965,10568664,Chr.11,11p15.4,605702,LYVE1,Lymphatic vessel endothelial hyaluronan receptor 1,LYVE1,10894,ENSG00000133800,NA,NA,Lyve1 (MGI:2136348)
11,10573090,10693987,11p15.4-p15.3,11p15.4,604673,"MRVI1, IRAG","Murine retrovirus integration site 1, homolog of",MRVI1,10335,ENSG00000072952,NA,NA,Mrvi1 (MGI:1338023)
11,10751245,10779745,11p15.3,11p15.4,609366,"SH2BP1, KIAA0155, p150",SH2 domain-binding protein 1,CTR9,9646,ENSG00000198730,NA,NA,Ctr9 (MGI:109345)
11,10797045,10809034,11p15,11p15.4,602325,"EIF4G2, DAP5",Eukaryotic translation initiation factor 4G-like 1,EIF4G2,1982,ENSG00000110321,NA,NA,Eif4g2 (MGI:109207)
11,10852705,10858052,11p15.3,11p15.4,615251,"ZBED5, BUSTER1",Zinc finger BED domain-containing protein 5,ZBED5,58486,ENSG00000236287,NA,NA,Zbed5 (MGI:1919220)
11,11270876,11622004,11p15.3,11p15.4,615136,"GALNT18, GALNACT18, GALNTL4",UPD-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 18,GALNT18,374378,ENSG00000110328,NA,NA,Galnt18 (MGI:2446239)
11,11841422,11959324,11p15.3,11p15.3,614460,USP47,Ubiquitin-specific protease 47,USP47,55031,ENSG00000170242,NA,NA,Usp47 (MGI:1922246)
11,11962978,12009826,11p15.1,11p15.3,605416,"DKK3, RIG","Dickkopf, Xenopus, homolog of, 3",DKK3,27122,ENSG00000050165,NA,NA,Dkk3 (MGI:1354952)
11,12110575,12263789,11p15.3,11p15.3,608881,"MICAL2, KIAA0750","Microtubule-associated monooxygenase, calponin and LIM domains-containing 2",MICAL2,9645,ENSG00000133816,NA,NA,Mical2 (MGI:2444947)
11,12286899,12362139,11p15.3,11p15.3,612355,"MICALCL, EBITEIN1",MICAL C terminus-like protein,MICALCL,84953,ENSG00000133816,NA,NA,Micalcl (MGI:1918127)
11,12376440,12535355,11p15,11p15.3,608120,PARVA,"Parvin, alpha",PARVA,55742,ENSG00000197702,NA,NA,Parva (MGI:1931144)
11,12674420,12944736,11p15.2,11p15.3,189967,"TEAD1, TCF13, REF1",TEA domain family member 1,TEAD1,7003,ENSG00000187079,NA,"Sveinsson chorioretinal atrophy, 108985 (3), Autosomal dominant",Tead1 (MGI:101876)
11,12979533,12989547,11p15.3,11p15.3,618335,"LINC00958, BLACAT2",Long intergenic noncoding RNA 958,LINC00958,100506305,ENSG00000251381,NA,NA,NA
11,13009315,13012118,11p15.2,11p15.3,614713,RASSF10,"Ras association domain family, member 10",RASSF10,644943,ENSG00000189431,NA,NA,Rassf10 (MGI:1925998)
11,13276551,13387267,11p15,11p15.3,602550,"ARNTL, BMAL1, TIC",Aryl hydrocarbon receptor nuclear translocator-like,ARNTL,406,ENSG00000133794,NA,NA,Arntl (MGI:1096381)
11,13387995,13463296,11p15.2,11p15.3,615933,BTBD10,BTB/POZ domain-containing protein 10,BTBD10,84280,ENSG00000148925,NA,NA,Btbd10 (MGI:1916065)
11,13492044,13496174,11p15.3-p15.1,11p15.3,168450,PTH,Parathyroid hormone,PTH,5741,ENSG00000152266,~9cM distal to CALC1; distal to MYOD,"Hypoparathyroidism, autosomal dominant, 146200 (3), Autosomal recessive, Autosomal dominant; Hypoparathyroidism, autosomal recessive, 146200 (3), Autosomal recessive, Autosomal dominant",Pth (MGI:97799)
11,13668665,13732345,11p15.2,11p15.3,616107,"FAR1, MLSTD2, PFCRD",Fatty acyl CoA reductase 1,FAR1,84188,ENSG00000197601,NA,"Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3), Autosomal recessive",Far1 (MGI:1914670)
11,13962722,14268132,Chr.11,11p15.2,604989,SPON1,"F-spondin, Rat, homolog of",SPON1,10418,ENSG00000262655,NA,NA,Spon1 (MGI:2385287)
11,14277919,14364505,11pter-p15.5,11p15.2,600098,"RRAS2, TC21",Related Ras viral oncogene homolog 2,RRAS2,22800,ENSG00000133818,NA,Ovarian carcinoma (3),Rras2 (MGI:1914172)
11,14457502,14499894,11p15.2,11p15.2,600959,"COPB1, COPB","Coatomer protein complex, subunit beta 1",COPB1,1315,ENSG00000129083,NA,NA,Copb1 (MGI:1917599)
11,14504875,14643633,11p15.1,11p15.2,602854,"PSMA1, PROS30","Proteasome subunit, alpha-type, 1",PSMA1,5682,ENSG00000129084,NA,NA,Psma1 (MGI:1347005)
11,14643690,14874138,11p15,11p15.2,602047,PDE3B,"Phosphodiesterase-3B, cGMP-inhibited",PDE3B,5140,ENSG00000152270,NA,NA,Pde3b (MGI:1333863)
11,14878004,14898914,11p15.2,11p15.2,608713,CYP2R1,"Cytochrome P450, subfamily IIR, polypeptide 1 (vitamin D 25-hydroxylase)",CYP2R1,120227,ENSG00000186104,NA,"Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3), Autosomal recessive",Cyp2r1 (MGI:2449771)
11,14966667,14972360,11p15.2-p15.1,11p15.2,114130,"CALCA, CALC1","Calcitonin/calcitonin-related polypeptide, alpha",CALCA,796,ENSG00000110680,same 220kb fragment as CALCB,NA,NA
11,15073592,15078636,11p15.2-p15.1,11p15.2,114160,"CALCB, CALC2","Calcitonin-related polypeptide, beta",CALCB,797,ENSG00000175868,NA,NA,Calca (MGI:2151253)
11,15111415,15269674,11p15.2,11p15.2,610668,INSC,"Inscuteable, Drosophila, homolog of",INSC,387755,ENSG00000188487,NA,NA,Insc (MGI:1917942)
11,15966448,16738476,11p15.3-p15.2,11p15.2,607257,SOX6,SRY-box 6,SOX6,55553,ENSG00000110693,NA,NA,Sox6 (MGI:98368)
11,16777296,17014422,11p15.1,11p15.2-p15.1,612686,PLEKHA7,"Pleckstrin homology domain-containing protein, family A, member 7",PLEKHA7,144100,ENSG00000166689,NA,NA,Plekha7 (MGI:2445094)
11,17074387,17077666,11p,11p15.1,180476,RPS13,Ribosomal protein S13,RPS13,6207,ENSG00000110700,NA,NA,Rps13 (MGI:1915302)
11,17086574,17207985,11p15.1,11p15.1,603601,"PIK3C2A, CPK, OCSKD","Phosphatidylinositol 3-kinase, class 2, alpha",PIK3C2A,5286,ENSG00000011405,NA,"Oculoskeletodental syndrome, 618440 (3), Autosomal recessive",Pik3c2a (MGI:1203729)
11,17260336,17349979,11p15-p14,11p15.1,608020,"NUCB2, NEFA",Nucleobindin 2,NUCB2,4925,ENSG00000070081,NA,NA,Nucb2 (MGI:1858179)
11,17351799,17377340,11p15.1,11p15.1,613714,B7H6,B7 homolog 6,NCR3LG1,374383,ENSG00000188211,NA,NA,NA
11,17385245,17389345,11p15.1,11p15.1,600937,"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13","Potassium inwardly-rectifying channel, subfamily J, member 11",KCNJ11,3767,ENSG00000187486,4.5kb 3' of SUR,"Diabetes mellitus, transient neonatal, 3, 610582 (3), Autosomal dominant; {Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant; Diabetes, permanent neonatal, with or without neurologic features, 606176 (3), Autosomal recessive, Autosomal dominant; Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3), Autosomal recessive; Maturity-onset diabetes of the young, type 13, 616329 (3), Autosomal dominant",Kcnj11 (MGI:107501)
11,17392497,17476848,11p15.1,11p15.1,600509,"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2","ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)",ABCC8,6833,ENSG00000006071,NA,"Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant; Diabetes mellitus, permanent neonatal, 606176 (3), Autosomal recessive, Autosomal dominant; Diabetes mellitus, transient neonatal 2, 610374 (3); Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3), Autosomal recessive, Autosomal dominant; Hypoglycemia of infancy, leucine-sensitive, 240800 (3), Autosomal dominant",Abcc8 (MGI:1352629)
11,17493894,17544415,11p15.1,11p15.1,605242,"USH1C, DFNB18A",Harmonin (Usher syndrome 1C gene),USH1C,10083,ENSG00000006611,Acadian and Samaritan variety,"Deafness, autosomal recessive 18A, 602092 (3), Autosomal recessive; Usher syndrome, type 1C, 276904 (3), Autosomal recessive",Ush1c (MGI:1919338)
11,17547372,17645943,11p14.3,11p15.1,604487,"OTOG, OTGN, DFNB18B",Otogelin,OTOG,340990,ENSG00000188162,NA,"Deafness, autosomal recessive 18B, 614945 (3), Autosomal recessive",Otog (MGI:1202064)
11,17719570,17722135,11p15.4,11p15.1,159970,"MYOD1, MYF3",Myogenic factor-3,MYOD1,4654,ENSG00000129152,"proximal to CALCA, HBB, BWS, PTH; ?11p14.3",NA,Myod1 (MGI:97275)
11,17734809,17783054,11p15,11p15.1,176258,"KCNC1, EPM7","Potassium voltage-gated channel, Shaw-related subfamily, member 1",KCNC1,3746,ENSG00000129159,NA,"Epilepsy, progressive myoclonic 7, 616187 (3), Autosomal dominant",Kcnc1 (MGI:96667)
11,17788047,18013161,11p14,11p15.1,606051,"SERGEF, DELGEF",Secretion-regulating guanine nucleotide exchange factor,SERGEF,26297,ENSG00000129158,NA,NA,Sergef (MGI:1351630)
11,18020536,18040787,11p15.3-p14,11p15.1,191060,"TPH1, TPH",Tryptophan hydroxylase 1 (tryptophan-5-monooxygenase),TPH1,7166,ENSG00000129167,NA,NA,Tph1 (MGI:98796)
11,18120954,18138487,11p15.1,11p15.1,607229,"MRGPRX3, MRGX3","Mas-related G protein-coupled receptor family, member X3",MRGPRX3,117195,ENSG00000179826,NA,NA,"Mrgpra9,Mrgpra1,Mrgpra2b,Mrgpra2a (MGI:3033148,MGI:3033095,MGI:3033098,MGI:3821888)"
11,18172836,18174279,11p15.1,11p15.1,607230,"MRGPRX4, MRGX4","Mas-related G protein-coupled receptor family, member X4",MRGPRX4,117196,ENSG00000179817,NA,NA,Mrgprx1 (MGI:3033139)
11,18231354,18236801,11p15.1,11p15.1,104752,SAA4,"Serum amyloid A4, constitutive",SAA4,6291,ENSG00000148965,NA,NA,NA
11,18238235,18248667,11p15.1,11p15.1,104751,SAA2,Serum amyloid A2,SAA2,6289,ENSG00000134339,pseudogene = SAA3,NA,NA
11,18266224,18269976,11p15.1,11p15.1,104750,SAA1,Serum amyloid A1,SAA1,6288,ENSG00000173432,NA,NA,"Saa2,Saa1 (MGI:98221,MGI:98222)"
11,18278669,18322497,11p15-p13,11p15.1,607521,"HPS5, RU2, KIAA1017","HPS gene 5 (ruby-eye 2, mouse, homolog of)",HPS5,11234,ENSG00000110756,NA,"Hermansky-Pudlak syndrome 5, 614074 (3), Autosomal recessive",Hps5 (MGI:2180307)
11,18322268,18367044,11p15.1-p14,11p15.1,189972,GTF2H1,"General transcription factor IIH, polypeptide 1 (62kD subunit)",GTF2H1,2965,ENSG00000110768,within 50kb of LDHA,NA,Gtf2h1 (MGI:1277216)
11,18394388,18408424,11p15.4,11p15.1,150000,"LDHA, LDH1, GSD11",Lactate dehydrogenase A,LDHA,3939,ENSG00000134333,NA,"Glycogen storage disease XI, 612933 (3), Autosomal recessive",Ldha (MGI:96759)
11,18412297,18452062,11p15.5-p15.3,11p15.1,150150,"LDHC, LDH3",Lactate dehydrogenase C,LDHC,3948,ENSG00000166796,closely linked to LDHB in other species; in man syntenic with LDHA; ?close to LDHA,NA,Ldhc (MGI:96764)
11,18480310,18526941,11p15.2-p15.1,11p15.1,601387,TSG101,Tumor susceptibility gene 101,TSG101,7251,ENSG00000074319,NA,NA,Tsg101 (MGI:106581)
11,18529605,18588733,11p15.2-p15.1,11p15.1,610985,"UEVLD, UEV3, ATTP",Ubiquitin E2 variant and lactate/malate dehydrogenase domains-containing protein,UEVLD,55293,ENSG00000151116,NA,NA,Uevld (MGI:1860490)
11,18727927,18792720,11p15.2-p15.1,11p15.1,176879,"PTPN5, STEP, STEP61","Protein tyrosine phosphatase, nonreceptor-type, 5 (striatum-enriched)",PTPN5,84867,ENSG00000110786,NA,NA,Ptpn5 (MGI:97807)
11,18933812,18935001,11p15.1,11p15.1,607227,"MRGPRX1, MRGX1","Mas-related G protein-coupled receptor family, member X1",MRGPRX1,259249,ENSG00000170255,NA,NA,Mrgprb2 (MGI:2441674)
11,19054454,19060716,11p15.1,11p15.1,607228,"MRGPRX2, MRGX2","Mas-related G protein-coupled receptor family, member X2",MRGPRX2,117194,ENSG00000183695,NA,NA,"Mrgprx2,Mrgprb1 (MGI:3033115,MGI:3588270)"
11,19117098,19176419,11p15.1,11p15.1,612815,"ZDHHC13, HIP14L",Zinc finger DHHC domain-containing protein 13,ZDHHC13,54503,ENSG00000177054,NA,NA,Zdhhc13 (MGI:1919227)
11,19182029,19201982,11p15.1,11p15.1,600824,"CSRP3, CRP3, CLP, CMD1M, CMH12",Cysteine- and glycine-rich protein 3,CSRP3,8048,ENSG00000129170,mutation identified in 1 CMD1M family,"?Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy, hypertrophic, 12, 612124 (3), Autosomal dominant",Csrp3 (MGI:1330824)
11,19224062,19241654,11p15.1,11p15.1,612047,E2F8,E2F transcription factor 8,E2F8,79733,ENSG00000129173,NA,NA,E2f8 (MGI:1922038)
11,19345199,20121600,11p15.1,11p15.1,607026,"NAV2, RAINB1, KIAA1419",Neuron navigator 2,NAV2,89797,ENSG00000166833,NA,NA,Nav2 (MGI:2183691)
11,20363684,20383782,11p15.1,11p15.1,605628,"HTATIP2, TIP30, CC3","HIV-1 TAT-interacting protein 2, 30kD",HTATIP2,10553,ENSG00000109854,NA,NA,Htatip2 (MGI:1859271)
11,20599399,20655063,11p15.2-p15.1,11p15.1,604159,"SLC6A5, GLYT2, HKPX3","Solute carrier family 6 (neurotransmitter transporter, glycine), member 5",SLC6A5,9152,ENSG00000165970,NA,"Hyperekplexia 3, 614618 (3), Autosomal recessive, Autosomal dominant",Slc6a5 (MGI:105090)
11,20669550,21575685,11p15.2-p15.1,11p15.1,602319,NELL1,Nel-like 1,NELL1,4745,ENSG00000165973,NA,NA,Nell1 (MGI:2443902)
11,22000000,43400000,11p14.3-p12,NA,185440,ST2,Suppression of tumorigenicity-2,ST2,6761,NA,NA,NA,NA
11,22000000,31000000,11p14,NA,613636,TST1,"Tuberculin skin test reactivity, absence of",NA,100526790,NA,at chr11:26.37M,"[Tuberculin skin test reactivity, absence of], 613636 (2)",NA
11,22192484,22283366,11p14.3,11p14.3,608662,"ANO5, TMEM16E, GDD1, LGMDR12",Anoctamin 5,ANO5,203859,ENSG00000171714,NA,"Gnathodiaphyseal dysplasia, 166260 (3), Autosomal dominant; Miyoshi muscular dystrophy 3, 613319 (3), Autosomal recessive; Muscular dystrophy, limb-girdle, autosomal recessive 12, 611307 (3), Autosomal recessive",Ano5 (MGI:3576659)
11,22338380,22379502,11p14.3,11p14.3,607563,"SLC17A6, VGLUT2, DNPI","Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6",SLC17A6,57084,ENSG00000091664,NA,NA,Slc17a6 (MGI:2156052)
11,22622532,22625840,11p15,11p14.3,613897,FANCF,"Fanconi anemia, complementation group F",FANCF,2188,ENSG00000183161,NA,"Fanconi anemia, complementation group F, 603467 (3)",Fancf (MGI:3689889)
11,22627757,22885929,11p15.2-p14.3,11p14.3,602835,GAS2,Growth arrest-specific 2,GAS2,2620,ENSG00000148935,NA,NA,Gas2 (MGI:95657)
11,24496487,25082639,11p14-p13,11p14.3,608178,LUZP2,Leucine zipper protein 2,LUZP2,338645,ENSG00000187398,NA,NA,Luzp2 (MGI:1889615)
11,26189122,26667906,11p14,11p14.3-p14.2,610110,"ANO3, TMEM16C, C11orf25, DYT24",Anoctamin 3,ANO3,63982,ENSG00000134343,NA,"Dystonia 24, 615034 (3), Autosomal dominant",Ano3 (MGI:3613666)
11,26200000,63600000,11p14.2-q12.3,NA,612642,DFNA59,"Deafness, autosomal dominant 59",DFNA59,100271924,NA,between D22S929 and D11S480,"Deafness, autosomal dominant 59, 612642 (2), Autosomal dominant",NA
11,26667019,26723355,11p14.2,11p14.2,612455,"SLC5A12, SMCT2","Solute carrier family 5 (sodium/glucose cotransporter), member 12",SLC5A12,159963,ENSG00000148942,NA,NA,Slc5a12 (MGI:2138890)
11,26994111,26997086,11p14.2,11p14.2,617085,FIBIN,"Fin bud initiation factor, zebrafish, homolog of",FIBIN,387758,ENSG00000176971,NA,NA,Fibin (MGI:1914856)
11,27040704,27127808,11p14.2,11p14.2,603312,"BBOX1, BBOX","Butyrobetaine-gamma, 2-oxoglutarate dioxygenase 1",BBOX1,8424,ENSG00000129151,NA,NA,Bbox1 (MGI:1891372)
11,27200000,31000000,11p14.1,NA,612321,"DCDC5, KIAA1493",Doublecortin domain-containing protein 5,NA,NA,NA,NA,NA,NA
11,27200000,48800000,11p14.1-p11.2,NA,613364,SPG41,Spastic paraplegia 41,SPG41,100359402,NA,max lod 2.36; between D11S1324 and D11S1993,"?Spastic paraplegia 41, autosomal dominant, 613364 (2), Autosomal dominant",NA
11,27338511,27363247,11p14.1,11p14.1,612324,CCDC34,Coiled-coil domain-containing protein 34,CCDC34,91057,ENSG00000109881,NA,NA,Ccdc34 (MGI:1915451)
11,27365960,27472789,11p14.1,11p14.1,606666,"LGR4, GPR48, BNMD17",Leucine-rich repeat-containing G protein-coupled receptor 4,LGR4,55366,ENSG00000205213,previously mapped to 5q34-q35.1,"{Bone mineral density, low, susceptibility to}, 615311 (3)",Lgr4 (MGI:1891468)
11,27494417,27506768,11p14.1,11p14.1,612332,"LIN7C, VELI3, MALS3","Lin7, C. elegans, homolog of, C",LIN7C,55327,ENSG00000148943,NA,NA,Lin7c (MGI:1330839)
11,27506851,27698170,11p14,11p14.1,611468,"BDNFAS, BDNFOS",BDNF antisense RNA,BDNF-AS,497258,ENSG00000245573,NA,NA,NA
11,27654892,27722029,11p13,11p14.1,113505,BDNF,Brain-derived neurotrophic factor,BDNF,627,ENSG00000176697,homeology with NRF3 on 12p; at p14 boundary,NA,Bdnf (MGI:88145)
11,27888170,27891091,11p14.1,11p14.1,140575,"HSP90AA2, HSPCAL3","Heat-shock protein, 90kD, alpha, class A, member 2",HSP90AA2P,3324,NA,NA,NA,NA
11,28020618,28108179,11p14,11p14.1,611271,KIF18A,Kinesin family member 18A,KIF18A,81930,ENSG00000121621,NA,NA,Kif18a (MGI:2446977)
11,28056814,28056909,11p14.1,11p14.1,612330,"MIR610, MIRN610",Micro RNA 610,MIR610,693195,ENSG00000207874,NA,NA,NA
11,30009729,30017029,11q13.4-q14.1,11p14.1,176266,"KCNA4, KCNA8, MCIDDS","Potassium voltage-gated channel, shaker-related subfamily, member 4",KCNA4,3739,ENSG00000182255,other map to 11p,"Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum, 618284 (3), Autosomal recessive",Kcna4 (MGI:96661)
11,30231013,30235276,11p13,11p14.1,136530,"FSHB, HH24","Follicle-stimulating hormone, beta polypeptide",FSHB,2488,ENSG00000131808,distal to AN2,"Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3), Autosomal recessive",Fshb (MGI:95582)
11,30323103,30338457,11p14.1-p13,11p14.1,612295,C11orf46,Chromosome 11 open reading frame 46,ARL14EP,120534,ENSG00000152219,NA,NA,Arl14ep (MGI:1926020)
11,30384492,30586994,11p14-p13,11p14.1,600911,"MPPED2, C11orf8, D11S302E, 239FB",Metallophosphoesterase domain-containing protein 2,MPPED2,744,ENSG00000066382,NA,NA,Mpped2 (MGI:1924265)
11,30863602,31369809,11p13,11p14-p13,608062,DCDC1,Doublecortin domain-containing protein 1,DCDC1,341019,ENSG00000170959,NA,NA,NA
11,31000000,63600000,11p13-q12,NA,607644,"CANDF3, CANDN1, FCNC","Candidiasis, familial, 3",CANDN1,338434,NA,between D11S1312 and D11S4191,"Candidiasis, familial, 3, 607644 (2), Autosomal dominant",NA
11,31000000,36400000,11p13,NA,616902,"DEL11p13, C11DELp13","Chromosome 11p13 deletion syndrome, distal",NA,NA,NA,NA,"Chromosome 11p13 deletion syndrome, distal, 616902 (4), Autosomal dominant",NA
11,31000000,36400000,11p13,NA,194072,"DEL11p13, C11DELp13, WAGR","Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (chromosome 11p13 deletion syndrome)",NA,NA,NA,deletion of WT1 and PAX6 genes,"Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome, 194072 (4), Autosomal dominant, Somatic mutation",NA
11,31000000,43400000,11p13-p12,NA,609941,DFNB51,"Deafness, autosomal recessive 51",DFNB51,448963,NA,max lod at D11S4102,"Deafness, autosomal recessive 51, 609941 (2), Autosomal recessive",NA
11,31000000,36400000,11p13,NA,117100,"ECT, BECTS",Centrotemporal epilepsy,NA,100379198,NA,previously assigned to 15q14,"Centrotemporal epilepsy, 117100 (2), Isolated cases",NA
11,31000000,43400000,11p13-p12,NA,605750,EVR3,Exudative vitreoretinopathy 3,EVR3,81864,NA,NA,"Exudative vitreoretinopathy 3, 605750 (2), Autosomal dominant",NA
11,31000000,85900000,11p13-q14.1,NA,614344,MRT23,"Mental retardation, autosomal recessive 23",MRT23,100852398,NA,between rs604518 and rs10899421,"Mental retardation, autosomal recessive 23, 614344 (2), Autosomal recessive",NA
11,31000000,36400000,11p13,NA,609256,MYP7,Myopia 7,MYP7,553190,NA,NA,"Myopia 7, 609256 (2), Multifactorial",NA
11,31000000,43400000,11p13-p12,NA,612469,"WAGRO, DEL11p14p12","Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome",NA,NA,NA,contiguous gene deletion syndrome,"WAGRO syndrome, 612469 (4)",NA
11,31369839,31432834,11p13,11p13,611072,"DNAJC24, DPH4","DNAJ/HSP40 homolog, subfamily C, member 24",DNAJC24,120526,ENSG00000170946,NA,NA,Dnajc24 (MGI:1919522)
11,31432400,31509643,11p13,11p13,612323,"IMMP1L, IMP1","Inner mitochondrial membrane peptidase, subunit 1, S. cerevisiae, homolog of",IMMP1L,196294,ENSG00000148950,NA,NA,Immp1l (MGI:1913791)
11,31509766,31790323,11p13,11p13,606985,"ELP4, PAX6NEB, AN2","Elongation protein 4, S. cerevisiae, homolog of",ELP4,26610,ENSG00000109911,mutation identified in 1 AN2 patient,"?Aniridia 2, 617141 (3), Autosomal dominant",Elp4 (MGI:1925016)
11,31784791,31817960,11p13,11p13,607108,"PAX6, AN2, MGDA, FVH1, ASGD5",Paired box homeotic gene-6,PAX6,5080,ENSG00000007372,"mutation identified in 1 patient each with MDGA, COLBN, or COLB","Aniridia, 106210 (3), Autosomal dominant; Anterior segment dysgenesis 5, multiple subtypes, 604229 (3); Cataract with late-onset corneal dystrophy, 106210 (3), Autosomal dominant; ?Coloboma of optic nerve, 120430 (3), Autosomal dominant; ?Coloboma, ocular, 120200 (3), Autosomal dominant; Foveal hypoplasia 1, 136520 (3), Autosomal dominant; Keratitis, 148190 (3), Autosomal dominant; ?Morning glory disc anomaly, 120430 (3), Autosomal dominant; Optic nerve hypoplasia, 165550 (3), Autosomal dominant",Pax6 (MGI:97490)
11,32091073,32105769,11p13,11p13,602735,RCN1,Reticulocalbin 1,RCN1,5954,ENSG00000049449,NA,NA,Rcn1 (MGI:104559)
11,32387774,32435538,11p13,11p13,607102,"WT1, NPHS4",Wilms tumor-1,WT1,7490,ENSG00000184937,clumped: pter-FSHB-AN2-WT1-CAT,"Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation; Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation; Meacham syndrome, 608978 (3); Mesothelioma, somatic, 156240 (3); Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant; Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation",Wt1 (MGI:98968)
11,32435517,32458768,11p13,11p13,607899,"WT1AS, WIT1",WT1 antisense RNA,WT1-AS,51352,ENSG00000183242,NA,NA,NA
11,32583815,32606263,11p13,11p13,609641,"EIF3M, PCID1, B5, GA17","Eukaryotic translation initiation factor 3, subunit M",EIF3M,10480,ENSG00000149100,NA,NA,Eif3m (MGI:1351744)
11,32602079,32794657,11p13,11p13,612328,CCDC73,Coiled-coil domain-containing protein 73,CCDC73,493860,ENSG00000186714,NA,NA,Ccdc73 (MGI:3606488)
11,32829755,32858122,11p13,11p13,611690,"PRRG4, PRGP4, TMG4",Proline-rich gamma-carboxyglutamic acid protein 4,PRRG4,79056,ENSG00000135378,NA,NA,Prrg4 (MGI:2442211)
11,33015877,33033581,11p13,11p13,612294,"DEPDC7, TR2",DEP domain-containing protein 7,DEPDC7,91614,ENSG00000121690,NA,NA,Depdc7 (MGI:2139258)
11,33076149,33079453,11p14.1-p13,11p13,612296,LOC283267,LOC283267 gene,LINC00294,283267,ENSG00000280798,NA,NA,NA
11,33084583,33161490,11p13,11p13,600367,CSTF3,"Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kD",CSTF3,1479,ENSG00000176102,NA,NA,Cstf3 (MGI:1351825)
11,33256671,33357022,11p13,11p13,604424,"HIPK3, PKY, DYRK6",Homeodomain-interacting protein kinase-3,HIPK3,10114,ENSG00000110422,NA,NA,Hipk3 (MGI:1314882)
11,33376107,33674101,11p13,11p13,612297,"C11orf41, G2",Chromosome 11 open reading frame 41,KIAA1549L,25758,ENSG00000110427,NA,NA,D430041D05Rik (MGI:2181743)
11,33703009,33736478,11p13,11p13,107271,"CD59, MIC11",CD59 antigen (p18-20),CD59,966,ENSG00000085063,in mouse Ly-6 = multigene complex,"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3), Autosomal recessive",Cd59b (MGI:1888996)
11,33740943,33774519,11p13,11p13,609089,"FBXO3, FBX3, FBA",F-box only protein 3,FBXO3,26273,ENSG00000110429,NA,NA,Fbxo3 (MGI:1929084)
11,33858575,33892075,11p13,11p13,180385,"LMO2, RBTNL1, RHOM2, TTG2",LIM domain only 2 (rhombotin-like 1),LMO2,4005,ENSG00000135363,3rd rhombotin gene not on 11,"Leukemia, acute T-cell, 180385 (2)",Lmo2 (MGI:102811)
11,34051662,34102609,11p13,11p13,601178,"CAPRIN1, M11S1, GPIAP1, GRIP137",Cell cycle associated protein 1,CAPRIN1,4076,ENSG00000135387,NA,NA,Caprin1 (MGI:1858234)
11,34105628,34146907,11p13,11p13,609221,"NAT10, ALP, KIAA1709",N-acetyltransferase 10,NAT10,55226,ENSG00000135372,NA,NA,Nat10 (MGI:2138939)
11,34438933,34472059,11p13,11p13,115500,CAT,Catalase,CAT,847,ENSG00000121691,cen-CAT-WT1-AN2-pter,"Acatalasemia, 614097 (3)",Cat (MGI:88271)
11,34478790,34513793,11p15-p13,11p13,605169,"ELF5, ESE2",E74-like factor 5 (epithelium-specific ETS factor 2),ELF5,2001,ENSG00000135374,NA,NA,NA
11,34621092,34663287,11p12,11p13,605439,"EHF, ESE3",ETS homologous factor,EHF,26298,ENSG00000135373,NA,NA,Ehf (MGI:1270840)
11,34882294,34916410,11p13,11p13,612491,"APIP, CGI29, MMRP19",APAF1-interacting protein,APIP,51074,ENSG00000149089,NA,NA,Apip (MGI:1926788)
11,34915828,34996127,11p13,11p13,608769,"PDHX, PDX1, E3BP, PDHXD","Pyruvate dehydrogenase complex, lipoyl-containing component X",PDHX,8050,ENSG00000110435,NA,"Lacticacidemia due to PDX1 deficiency, 245349 (3), Autosomal recessive",Pdhx (MGI:1351627)
11,35139167,35232401,11pter-p13,11p13,107269,"CD44, MDU2, MDU3, MIC4, IN",CD44 antigen (homing function),CD44,960,ENSG00000026508,NA,"[Blood group, Indian system], 609027 (3)",Cd44 (MGI:88338)
11,35251204,35420057,11p13-p12,11p13,600300,"SLC1A2, EAAT2, EIEE41","Solute carrier family 1 (glial high affinity glutamate transporter), member 2",SLC1A2,6506,ENSG00000110436,NA,"Epileptic encephalopathy, early infantile, 41, 617105 (3), Autosomal dominant",Slc1a2 (MGI:101931)
11,35618459,35620864,11p13,11p13,612206,FJX1,"Four-jointed box, Drosophila, homolog of, 1",FJX1,24147,ENSG00000179431,NA,NA,Fjx1 (MGI:1341907)
11,35662691,35818006,11p13,11p13,612298,"TRIM44, AN3",Tripartite motif-containing protein 44,TRIM44,54765,ENSG00000166326,mutation identified in 1 AN3 family,"?Aniridia 3, 617142 (3), Autosomal dominant",Trim44 (MGI:1931835)
11,35943980,36232135,11p13,11p13,617986,"LDLRAD3, LRAD3",Low density lipoprotein receptor class A domain-containing protein 3,LDLRAD3,143458,ENSG00000179241,NA,NA,Ldlrad3 (MGI:2138856)
11,36272291,36289427,11p13,11p13,612299,COMM9,COMM domain-containing protein 9,COMMD9,29099,ENSG00000110442,NA,NA,Commd9 (MGI:1923751)
11,36296287,36465203,11p13-p12,11p13-p12,611728,"PRR5L, PROTOR2, FLJ14213",Proline-rich protein 5-like,PRR5L,79899,ENSG00000135362,NA,NA,Prr5l (MGI:1919696)
11,36400000,43400000,11p12,NA,611739,BMND8,Bone mineral density QTL 8,NA,100188854,NA,between D11S1392 and D11S4102,"{Osteoporosis}, 166710 (2), Autosomal dominant",NA
11,36400000,53400000,11p12-p11,NA,610898,PSNP3,"Supranuclear palsy, progressive, 3",NA,100038248,NA,NA,"Supranuclear palsy, progressive, 3, 610898 (2)",NA
11,36483768,36510312,11p12,11p12,602355,TRAF6,TNF receptor-associated factor 6,TRAF6,7189,ENSG00000175104,NA,NA,Traf6 (MGI:108072)
11,36510365,36579761,11p13,11p12,179615,RAG1,Recombination activating gene-1,RAG1,5896,ENSG00000166349,assignment to 14 in error,"Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3), Autosomal recessive; Omenn syndrome, 603554 (3), Autosomal recessive; Severe combined immunodeficiency, B cell-negative, 601457 (3), Autosomal recessive",Rag1 (MGI:97848)
11,36591942,36598278,11p13,11p12,179616,RAG2,Recombination activating gene-2,RAG2,5897,ENSG00000175097,assignment to 14 in error,"Combined cellular and humoral immune defects with granulomas, 233650 (3), Autosomal recessive; Omenn syndrome, 603554 (3), Autosomal recessive; Severe combined immunodeficiency, B cell-negative, 601457 (3), Autosomal recessive",Rag2 (MGI:97849)
11,40107065,41460418,11p12,11p12,608817,"LRRC4C, NGL1, KIAA1580",Leucine rich repeat containing 4C (netrin-G1 ligand),LRRC4C,57689,ENSG00000148948,NA,NA,Lrrc4c (MGI:2442636)
11,43311954,43344529,11p12,11p12,609774,"API5, AAC11",Apoptosis inhibitor 5,API5,8539,ENSG00000166181,NA,NA,Api5 (MGI:1888993)
11,43400000,53400000,11p11,NA,609630,CLLS1,"Leukemia, chronic lymphocytic, susceptibility to, 1",NA,100188791,NA,NA,"{Leukemia, chronic lymphocytic, susceptibility to, 1}, 609630 (2)",NA
11,43400000,48800000,11p11.2,NA,601224,PSS,Potocki-Shaffer syndrome,NA,NA,NA,contiguous gene syndrome caused by deletion of 11p11.2,"Potocki-Shaffer syndrome, 601224 (4)",NA
11,43400000,48800000,11p11.2,NA,191270,TYRL,Tyrosinase-like,TYRL,7300,NA,NA,NA,NA
11,43880830,43920273,11p11.12,11p11.2,610603,"ALKBH3, PCA1, DEPC1, ABH3","AlkB, E. coli, homolog of, 3",ALKBH3,221120,ENSG00000166199,NA,NA,Alkbh3 (MGI:1916363)
11,44066117,44084236,11p11,11p11.2,608405,"ACCS, ACS, PHACS",1-aminocyclopropane-1-carboxylate synthase,ACCS,84680,ENSG00000110455,NA,NA,Accs (MGI:1919717)
11,44095548,44251980,11p12-p11,11p11.2,608210,"EXT2, SSMS",Exostosin 2,EXT2,2132,ENSG00000151348,mutation identified in 1 SSMS family,"Exostoses, multiple, type 2, 133701 (3), Autosomal dominant; ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive",Ext2 (MGI:108050)
11,44260439,44310138,11p11.2,11p11.2,605420,"ALX4, PFM2, FPP, FND2, CRS5","Aristaless-like 4, mouse, homolog of",ALX4,60529,ENSG00000052850,NA,"{Craniosynostosis 5, susceptibility to}, 615529 (3), Autosomal dominant; Frontonasal dysplasia 2, 613451 (3), Autosomal recessive; Parietal foramina 2, 609597 (3), Autosomal dominant",Alx4 (MGI:108359)
11,44565609,44620362,11p11.2,11p11.2,600623,"CD82, SAR2, KAI1, ST6",CD82 antigen,CD82,3732,ENSG00000085117,NA,NA,Cd82 (MGI:104651)
11,44932347,44951305,11p11.2,11p11.2,617867,"TP53I11, PIG11",Tumor protein p53-inducible protein 11,TP53I11,9537,ENSG00000175274,NA,NA,Trp53i11 (MGI:2670995)
11,45094012,45235123,11p11.2,11p11.2,616347,"PRDM11, PFM8",PR domain-containing protein 11,PRDM11,56981,ENSG00000019485,NA,NA,Prdm11 (MGI:2685553)
11,45240301,45286340,Chr.11,11p11.2,607716,"SYT13, KIAA1427",Synaptotagmin 13,SYT13,57586,ENSG00000019505,NA,NA,Syt13 (MGI:1933945)
11,45647688,45665650,11p11.2-p11.1,11p11.2,603797,"CHST1, KSGAL6ST",Carbohydrate sulfotransferase-1,CHST1,8534,ENSG00000175264,NA,NA,Chst1 (MGI:1924219)
11,45804071,45813015,11p11.2,11p11.2,605881,"SLC35C1, FUCT1, CDG2C","Solute carrier family 35, member C1 (GDP-Fucose transporter 1)",SLC35C1,55343,ENSG00000181830,NA,"Congenital disorder of glycosylation, type IIc, 266265 (3), Autosomal recessive",Slc35c1 (MGI:2443301)
11,45847117,45883247,Chr.11,11p11.2,603732,CRY2,Cryptochrome 2,CRY2,1408,ENSG00000121671,NA,NA,Cry2 (MGI:1270859)
11,45885650,45906464,11p12-p11.2,11p11.2,604641,"MAPK8IP1, IB1",Mitogen-activated protein kinase 8-interacting protein 1,MAPK8IP1,9479,ENSG00000121653,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant",Mapk8ip1 (MGI:1309464)
11,45909662,45918122,11p12-p11.2,11p11.2,603360,"PEX16, PBD8A, PBD8B",Peroxisome biogenesis factor 16,PEX16,9409,ENSG00000121680,NA,"Peroxisome biogenesis disorder 8A (Zellweger), 614876 (3), Autosomal recessive; Peroxisome biogenesis disorder 8B, 614877 (3), Autosomal recessive",Pex16 (MGI:1338829)
11,45921620,45929095,11p11.2,11p11.2,609709,"GYLTL1B, LARGE2",Glycosyltransferase-like 1B,LARGE2,120071,ENSG00000165905,NA,NA,Large2 (MGI:2443769)
11,45929318,46121433,11p11.2,11p11.2,608325,"PHF21A, BHC80, KIAA1696",PHD finger protein 21A,PHF21A,51317,ENSG00000135365,NA,NA,Phf21a (MGI:2384756)
11,46277660,46321408,11p11.2,11p11.2,616215,"CREB3L1, OASIS, OI16",cAMP response element-binding protein 3-like 1,CREB3L1,90993,ENSG00000157613,NA,"Osteogenesis imperfecta, type XVI, 616229 (3), Autosomal recessive",Creb3l1 (MGI:1347062)
11,46332904,46380553,11p11.2,11p11.2,601441,DGKZ,"Diacylglycerol kinase, zeta, 104kD",DGKZ,8525,ENSG00000149091,NA,NA,Dgkz (MGI:1278339)
11,46380783,46383836,11p11.2,11p11.2,162096,"MDK, NEGF2",Midkine (neurite growth-promoting factor 2),MDK,4192,ENSG00000110492,NA,NA,Mdk (MGI:96949)
11,46383788,46391667,11p12-p11.2,11p11.2,118495,CHRM4,"Cholinergic receptor, muscarinic, 4",CHRM4,1132,ENSG00000180720,NA,NA,Chrm4 (MGI:88399)
11,46396411,46594054,11p11.2,11p11.2,611359,"AMBRA1, KIAA1736",Activating molecule in beclin 1-regulated autophagy,AMBRA1,55626,ENSG00000110497,NA,NA,Ambra1 (MGI:2443564)
11,46602860,46617893,11p11.2,11p11.2,615086,HARBI1,Harbinger transposase-derived gene 1,HARBI1,283254,ENSG00000180423,NA,NA,Harbi1 (MGI:2443194)
11,46617275,46676018,11p11.2,11p11.2,615088,"ATG13, KIAA0652, PARATARG8","Autophagy 13, S. cerevisiae, homolog of",ATG13,9776,ENSG00000175224,NA,NA,Atg13 (MGI:1196429)
11,46677076,46700659,11p12-q12,11p11.2,602732,"ARHGAP1, RHOGAP1, CDC42GAP",RHO GTPase-activating protein 1,ARHGAP1,392,ENSG00000175220,NA,NA,Arhgap1 (MGI:2445003)
11,46701030,46705911,11p11.2,11p11.2,616454,"ZNF408, EVR6, RP72",Zinc finger protein 408,ZNF408,79797,ENSG00000175213,mutation identified in 1 EVR6 family,"?Exudative vitreoretinopathy 6, 616468 (3), Autosomal dominant; Retinitis pigmentosa 72, 616469 (3), Autosomal recessive",Zfp408 (MGI:2685857)
11,46719165,46739507,11p11-q12,11p11.2,176930,"F2, THPH1, RPRGL2",Coagulation factor II (thrombin),F2,2147,ENSG00000180210,NA,"Dysprothrombinemia, 613679 (3), Autosomal recessive; Hypoprothrombinemia, 613679 (3), Autosomal recessive; {Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3), Autosomal dominant; {Stroke, ischemic, susceptibility to}, 601367 (3), Multifactorial; Thrombophilia due to thrombin defect, 188050 (3), Autosomal dominant",F2 (MGI:88380)
11,46743047,46846307,11p11.2,11p11.2,611142,"CKAP5, CHTOG, MSPS, KIAA0097",Cytoskeleton-associated protein 5,CKAP5,9793,ENSG00000175216,NA,NA,Ckap5 (MGI:1923036)
11,46854714,46918549,11p12-p11.2,11p11.2,604270,"LRP4, MEGF7, CLSS, SOST2, CMS17",Low density lipoprotein receptor-related protein 4,LRP4,4038,ENSG00000134569,mutation identified in 1 CMS17 family,"Cenani-Lenz syndactyly syndrome, 212780 (3), Autosomal recessive; ?Myasthenic syndrome, congenital, 17, 616304 (3), Autosomal recessive; Sclerosteosis 2, 614305 (3), Autosomal recessive, Autosomal dominant",Lrp4 (MGI:2442252)
11,47164297,47177124,11p11.2-p11.12,11p11.2,606908,"ARFGAP2, ZNF289",ADP-ribosylation factor GTPase-activating protein 2,ARFGAP2,84364,ENSG00000149182,NA,NA,Arfgap2 (MGI:1924288)
11,47177520,47186445,11p11,11p11.2,606513,PACSIN3,Protein kinase C and casein kinase substrate in neurons 3,PACSIN3,29763,ENSG00000165912,NA,NA,Pacsin3 (MGI:1891410)
11,47214941,47239217,11p12-p11,11p11.2,600811,DDB2,"Damage-specific DNA binding protein 2, 48kD",DDB2,1643,ENSG00000134574,NA,"Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3), Autosomal recessive",Ddb2 (MGI:1355314)
11,47239301,47248846,11p11.2,11p11.2,171650,ACP2,"Acid phosphatase 2, lysosomal",ACP2,53,ENSG00000134575,NA,"?Lysosomal acid phosphatase deficiency, 200950 (1), Autosomal recessive",Acp2 (MGI:87882)
11,47248299,47269032,11p11.2,11p11.2,602423,"NR1H3, LXRA","Nuclear receptor subfamily 1, group H, member 3",NR1H3,10062,ENSG00000025434,NA,NA,Nr1h3 (MGI:1352462)
11,47269374,47330030,11p11.2,11p11.2,603584,"MADD, DENN",MAP kinase-activating death domain (differentially expressed in normal and neoplastic cells),MADD,8567,ENSG00000110514,NA,NA,Madd (MGI:2444672)
11,47331405,47352701,11p11.2,11p11.2,600958,"MYBPC3, CMH4, CMD1MM, LVNC10","Myosin-binding protein C, cardiac",MYBPC3,4607,ENSG00000134571,NA,"Cardiomyopathy, dilated, 1MM, 615396 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 4, 115197 (3), Autosomal dominant; Left ventricular noncompaction 10, 615396 (3), Autosomal dominant",Mybpc3 (MGI:102844)
11,47354858,47395639,11p11.2,11p11.2,165170,"SPI1, SFPI1",Oncogene SPI1,SPI1,6688,ENSG00000066336,NA,NA,Spi1 (MGI:98282)
11,47407131,47416500,11p11.2,11p11.2,608735,"SLC39A13, ZIP13, EDSSPD3","Solute carrier family 39 (zinc transporter), member 13",SLC39A13,91252,ENSG00000165915,NA,"Ehlers-Danlos syndrome, spondylodysplastic type, 3, 612350 (3), Autosomal recessive",Slc39a13 (MGI:1915677)
11,47418768,47426472,11p13-p12,11p11.2,186852,"PSMC3, TBP1","Proteasome (prosome, macropain) 26S subunit, ATPase, 3",PSMC3,5702,ENSG00000165916,NA,NA,Psmc3 (MGI:1098754)
11,47437763,47449135,11p11.2-p11.1,11p11.2,601592,"RAPSN, CMS1D, CMS11, FADS2","Receptor-associated protein of the synapse, 43kD",RAPSN,5913,ENSG00000165917,NA,"Fetal akinesia deformation sequence 2, 618388 (3); Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3), Autosomal recessive",Rapsn (MGI:99422)
11,47465936,47565568,11p11,11p11.2,601074,"CELF1, CUGBP1, NAB50, BRUNOL2, CUGBP","CUGbp and ELAV-like family, member 1",CELF1,10658,ENSG00000149187,NA,NA,NA
11,47572196,47579014,11p11.2,11p11.2,617645,"KBTBD4, HSPC252, BKLHD4",KELCH repeat- and BTB/POZ domain-containing protein 4,KBTBD4,55709,ENSG00000123444,NA,NA,Kbtbd4 (MGI:1914386)
11,47579073,47584561,11p11.11,11p11.2,603846,"NDUFS3, MC1DN8",NADH-ubiquinone oxidoreductase core subunit S3,NDUFS3,4722,ENSG00000213619,NA,"Mitochondrial complex I deficiency, nuclear type 8, 618230 (3), Autosomal recessive",Ndufs3 (MGI:1915599)
11,47589663,47596335,11p11.2,11p11.2,614911,"C1QTNF4, CTRP4",C1q- and tumor necrosis factor-related protein 4,C1QTNF4,114900,ENSG00000172247,NA,NA,C1qtnf4 (MGI:1914695)
11,47604308,47642653,11q12.1,11p11.2,613221,MTCH2,Mitochondrial carrier homolog 2,MTCH2,23788,ENSG00000109919,NA,NA,Mtch2 (MGI:1929260)
11,47659167,47715381,11p11.2,11p11.2,617345,"AGBL2, CCP2",ATP/GTP-binding protein-like 2,AGBL2,79841,ENSG00000165923,NA,NA,Agbl2 (MGI:2443254)
11,47716493,47767459,11p11.2,11p11.2,615265,"FNBP4, FBP30, KIAA1014",Formin-binding protein 4,FNBP4,23360,ENSG00000109920,NA,NA,Fnbp4 (MGI:1860513)
11,47778082,47848543,11p11.2,11p11.2,607614,"NUP160, KIAA0197, NPHS19","Nucleoporin, 160kD",NUP160,23279,ENSG00000030066,mutation identified in 1 NPHS19 family,"?Nephrotic syndrome, type 19, 618178 (3), Autosomal recessive",Nup160 (MGI:1926227)
11,47980503,48170838,11p11.2,11p11.2,600925,"PTPRJ, DEP1","Protein tyrosine phosphatase, receptor type, J polypeptide",PTPRJ,5795,ENSG00000149177,NA,"Colon cancer, somatic, 114500 (3)",Ptprj (MGI:104574)
11,49145091,49208641,11p11.2,11p11.12,600934,"FOLH1, FOLH, PSM, PSMA",Folate hydrolase 1 (prostate-specific membrane antigen),FOLH1,2346,ENSG00000086205,?pseudogene on 11q14,NA,NA
11,54603068,54603997,11p11.12,11q11,614273,OR4C46,"Olfactory receptor, family 4, subfamily C, member 46",OR4C46,119749,ENSG00000185926,NA,NA,Olfr1258 (MGI:3031092)
11,55800000,77400000,11q12.1-q13.5,NA,135610,FNL2,Fibronectin-like-2,NA,NA,NA,NA,NA,NA
11,55800000,66100000,11q12-q13.1,NA,612795,PURAQTL1,Polyunsaturated fatty acids plasma level QTL1,NA,100302559,NA,associated with rs174537,"[Polyunsaturated fatty acids plasma level QTL1], 612795 (2)",NA
11,55800000,63600000,11q12,NA,608687,"SCA20, DUP11q12, C11DUPq12","Spinocerebellar ataxia 20 (chromosome 11q12 duplication syndrome, 260kb)",NA,NA,NA,contiguous gene duplication syndrome,"Spinocerebellar ataxia 20, 608687 (4), Autosomal dominant",NA
11,55935455,55936399,11q12.1,11q12.1,608496,"OR5I1, OLF1","Olfactory receptor, family 5, subfamily I, member 1",OR5I1,10798,ENSG00000167825,NA,NA,Olfr152 (MGI:1313139)
11,55993680,55994624,11q12.1,11q12.1,608492,OR5F1,"Olfactory receptor, family 5, subfamily F, member 1",OR5F1,338674,ENSG00000149133,NA,NA,NA
11,57181952,57191716,11q12.1,11q12.1,615213,LRRC55,Leucine-rich repeat-containing protein 55,LRRC55,219527,ENSG00000183908,NA,NA,Lrrc55 (MGI:2685197)
11,57233576,57237452,11q12,11q12.1,600052,"APLNR, AGTRL1, APJ",Apelin receptor,APLNR,187,ENSG00000134817,NA,NA,Aplnr (MGI:1346086)
11,57299630,57324951,11q12,11q12.1,607104,"TNKS1BP1, TAB182, KIAA1741","Tankyrase 1-binding protein 1, 182kD",TNKS1BP1,85456,ENSG00000149115,NA,NA,Tnks1bp1 (MGI:2446193)
11,57325985,57335891,11q12,11q12.1,604328,"SSRP1, FACT",Structure-specific recognition protein 1,SSRP1,6749,ENSG00000149136,NA,NA,Ssrp1 (MGI:107912)
11,57335942,57372398,11q12,11q12.1,600843,"P2RX3, P2X3","Purinergic receptor P2X, ligand-gated ion channel, 3",P2RX3,5024,ENSG00000109991,NA,NA,P2rx3 (MGI:1097160)
11,57376768,57381149,11cen-q12,11q12.1,606814,"PRG3, MBPH",Proteoglycan 3,PRG3,10394,ENSG00000156575,NA,NA,Prg3 (MGI:1858200)
11,57386779,57390649,11cen-q12,11q12.1,605601,"PRG2, MBP",Proteoglycan 2,PRG2,5553,ENSG00000186652,NA,NA,Prg2 (MGI:103294)
11,57406953,57427579,11q12.1,11q12.1,618034,"SLC43A3, EEG1, ENBT1","Solute carrier family 43, member 3",SLC43A3,29015,ENSG00000134802,NA,NA,Slc43a3 (MGI:1931054)
11,57460527,57477533,11q12.1,11q12.1,610462,"RTN4RL2, NGRH1, NGR2",Reticulon 4 receptor-like 2,RTN4RL2,349667,ENSG00000186907,NA,NA,Rtn4rl2 (MGI:2669796)
11,57484530,57516560,11p11.2-p11.1,11q12.1,603733,"SLC43A1, LAT3, POV1","Solute carrier family 43 (L-type amino acid transporter), member 1",SLC43A1,8501,ENSG00000149150,NA,NA,Slc43a1 (MGI:1931352)
11,57528463,57542504,11q12.1-q12.3,11q12.1,602251,"TIMM10, TIM10A, TIM10","Translocase of inner mitochondrial membrane 10, yeast, homolog of",TIMM10,26519,ENSG00000134809,NA,NA,Timm10 (MGI:1353429)
11,57536840,57550273,11q12.1,11q12.1,613664,"SMTNL1, CHASM",Smoothelin-like 1,SMTNL1,219537,ENSG00000214872,NA,NA,Smtnl1 (MGI:1915928)
11,57551654,57568329,11q12,11q12.1,603890,"UBE2L6, UBCH8",Ubiquitin-conjugating enzyme E2L 6,UBE2L6,9246,ENSG00000156587,NA,NA,Ube2l6 (MGI:1914500)
11,57597553,57614852,11q11-q13.1,11q12.1,606860,"C1NH, HAE1, HAE2, SERPING1",Complement component-1 inhibitor,SERPING1,710,ENSG00000149131,NA,"Angioedema, hereditary, types I and II, 106100 (3), Autosomal recessive, Autosomal dominant; Complement component 4, partial deficiency of, 120790 (3), Autosomal dominant",Serping1 (MGI:894696)
11,57641197,57641285,11q12,11q12.1,610175,"MIR130A, MIRN130A",Micro RNA 130A,MIR130A,406919,ENSG00000208009,NA,NA,NA
11,57645086,57649943,11q12.1,11q12.1,609725,YPEL4,Yippee-like 4,YPEL4,219539,ENSG00000166793,NA,NA,Ypel4 (MGI:3605071)
11,57657743,57661864,11q12.1,11q12.1,608757,"CLP1, HEAB, PCH10","Cleavage and polyadenylation factor I subunit 1, yeast, homolog of",CLP1,10978,ENSG00000172409,NA,"Pontocerebellar hypoplasia, type 10, 615803 (3), Autosomal recessive",Clp1 (MGI:2138968)
11,57668039,57701186,11q12.1,11q12.1,614586,"ZDHHC5, DHHC5, ZNF375, KIAA1748",Zinc finger DHHC domain-containing protein 5,ZDHHC5,25921,ENSG00000156599,NA,NA,Zdhhc5 (MGI:1923573)
11,57703708,57712322,11q12.1,11q12.1,612385,MED19,Mediator complex subunit 19,MED19,219541,ENSG00000156603,NA,NA,Med19 (MGI:1914234)
11,57712522,57740972,11cen-q22.3,11q12.1,616715,TMX2,Thioredoxin-related transmembrane protein 2,TMX2,51075,ENSG00000213593,NA,NA,Tmx2 (MGI:1914208)
11,57741249,57743553,11q12.1,11q12.1,607914,"SELENOH, SELH",Selenoprotein H,SELENOH,280636,ENSG00000211450,NA,NA,Selenoh (MGI:1919907)
11,57761801,57819539,11q11,11q12.1,601045,"CTNND1, CTNND, BCDS2","Catenin (cadherin-associated protein), delta 1",CTNND1,1500,ENSG00000198561,NA,"Blepharocheilodontic syndrome 2, 617681 (3), Autosomal dominant",Ctnnd1 (MGI:105100)
11,58526870,58578238,11q12.1,11q12.1,605390,LPXN,Leupaxin,LPXN,9404,ENSG00000110031,NA,NA,Lpxn (MGI:2147677)
11,58622664,58625732,11q12.2,11q12.1,118945,CNTF,Ciliary neurotrophic factor,CNTF,1270,ENSG00000242689,NA,NA,Cntf (MGI:88439)
11,58708756,58731973,11q12.1,11q12.1,607424,"GLYAT, ACGNAT, CAT",Glycine-N-acyltransferase,GLYAT,10249,ENSG00000149124,NA,NA,Glyat (MGI:2147502)
11,58834064,58905839,11q12.1,11q12.1,614762,GLYATL2,Glycine N-acyltransferase-like 2,GLYATL2,219970,ENSG00000156689,NA,NA,NA
11,58905397,58957073,11q12.1,11q12.1,614761,GLYATL1,Glycine-N-acyltransferase-like 1,GLYATL1,92292,ENSG00000166840,NA,NA,NA
11,59107184,59127414,11q12.1,11q12.1,615584,"FAM111B, POIKTMP","Family with sequence similarity 111, member B",FAM111B,374393,ENSG00000189057,NA,"Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3), Autosomal dominant",NA
11,59142745,59155038,11q12.1,11q12.1,615292,"FAM111A, KIAA1895, KCS2, GCLEB","Family with sequence similarity 111, member A",FAM111A,63901,ENSG00000166801,NA,"Gracile bone dysplasia, 602361 (3), Autosomal dominant; Kenny-Caffey syndrome, type 2, 127000 (3), Autosomal dominant",Fam111a (MGI:1915508)
11,59171429,59208587,11q12.1,11q12.1,616110,"DTX4, RNF155, KIAA0937","Deltex, Drosoophila, homolog of, 4",DTX4,23220,ENSG00000110042,NA,NA,Dtx4 (MGI:2672905)
11,59208509,59212926,11q12.1,11q12.1,610390,"MPEG1, MPG1",Macrophage expressed gene 1,MPEG1,219972,ENSG00000197629,NA,NA,Mpeg1 (MGI:1333743)
11,59364458,59365393,11q12.1,11q12.1,615702,OR5AN1,"Olfactory receptor, family 5, subfamily AN, member 1",OR5AN1,390195,ENSG00000176495,NA,NA,Olfr1434 (MGI:3031268)
11,59574397,59615773,11q12.1,11q12.1,167040,OSBP,Oxysterol-binding protein,OSBP,5007,ENSG00000110048,NA,NA,Osbp (MGI:97447)
11,59636715,59669036,11q12.1,11q12.1,614660,"PATL1, PAT1B","Protein associated with topoisomerase II, S. cerevisiae, homolog of, 1",PATL1,219988,ENSG00000166889,NA,NA,Patl1 (MGI:2147679)
11,59755373,59805878,11q12.1,11q12.1,600876,"STX3, STX3A",Syntaxin 3,STX3,6809,ENSG00000166900,NA,NA,Stx3 (MGI:103077)
11,59806139,59810777,11q12-q13.1,11q12.1,611829,MRPL16,Mitochondrial ribosomal protein L16,MRPL16,54948,ENSG00000166902,NA,NA,Mrpl16 (MGI:2137219)
11,59829267,59845500,11q13,11q12.1,609342,"GIF, IF",Gastric intrinsic factor,CBLIF,2694,ENSG00000134812,NA,"Intrinsic factor deficiency, 261000 (3), Autosomal recessive",Cblif (MGI:1202394)
11,59852807,59866486,11q11-q12,11q12.1,189905,"TCN1, TC1",Transcobalamin I,TCN1,6947,ENSG00000134827,NA,NA,NA
11,60056627,60071115,11q12-q13,11q12.1,606498,"MS4A3, HTM4, CD20L","Membrane-spanning 4-domains, subfamily A, member 3",MS4A3,932,ENSG00000149516,NA,NA,Ms4a3 (MGI:2158468)
11,60088260,60098466,11q13,11q12.1,147138,"MS4A2, FCER1B","Membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for, beta polypeptide)",MS4A2,2206,ENSG00000149534,NA,"{Atopy, susceptibility to}, 147050 (3), Autosomal dominant",Ms4a2 (MGI:95495)
11,60171606,60184665,11q12-q13,11q12.2,606548,"MS4A6A, MS4A6","Membrane-spanning 4-domains, subfamily A, member 6A",MS4A6A,64231,ENSG00000110077,NA,NA,Ms4a6d (MGI:1916024)
11,60201252,60243136,11q12-q13.1,11q12.2,608401,MS4A4E,"Membrane-spanning 4-domains, subfamily A, member 4E",MS4A4E,643680,NA,NA,NA,NA
11,60280665,60308969,11q12-q13,11q12.2,606547,"MS4A4A, MS4A4","Membrane-spanning 4-domains, subfamily A, member 4A",MS4A4A,51338,ENSG00000110079,NA,NA,Ms4a4a (MGI:3643932)
11,60334881,60340967,11q12-q13.1,11q12.2,608402,MS4A6E,"Membrane-spanning 4-domains, subfamily A, member 6E",MS4A6E,245802,ENSG00000166926,NA,NA,NA
11,60378484,60395953,11q12-q13,11q12.2,606502,"MS4A7, CFFM4","Membrane-spanning 4-domains, subfamily A, member 7",MS4A7,58475,ENSG00000166927,NA,NA,Ms4a7 (MGI:1918846)
11,60429571,60447791,11q12-q13,11q12.2,606499,"MS4A5, TETM4, CD20L2","Membrane-spanning 4-domains, subfamily A, member 5",MS4A5,64232,ENSG00000166930,NA,NA,Ms4a5 (MGI:2670985)
11,60455808,60470751,11q13,11q12.2,112210,"MS4A1, CD20, CVID5","Membrane-spanning 4-domains, subfamily A, member 1",MS4A1,931,ENSG00000156738,NA,"Immunodeficiency, common variable, 5, 613495 (3), Autosomal recessive",Ms4a1 (MGI:88321)
11,60492742,60507429,11q12-q13,11q12.2,606550,MS4A12,"Membrane-spanning 4-domains, subfamily A, member 12",MS4A12,54860,ENSG00000071203,NA,NA,Ms4a12 (MGI:2685812)
11,60699611,60715806,11q12-q13,11q12.2,606549,MS4A8B,"Membrane-spanning 4-domains, subfamily A, member 8B",MS4A8,83661,ENSG00000166959,NA,NA,Ms4a8a (MGI:1927657)
11,60785331,60801304,11q12-q13.1,11q12.2,608403,MS4A10,"Membrane-spanning 4-domains, subfamily A, member 10",MS4A10,341116,ENSG00000172689,NA,NA,Ms4a10 (MGI:1917076)
11,60842112,60851080,11q12,11q12.2,611293,"CCDC86, CYCLON",Coiled-coil domain-containing protein 86,CCDC86,79080,ENSG00000110104,NA,NA,Ccdc86 (MGI:1277220)
11,60850932,60855949,11q12.2,11q12.2,604837,"PTGDR2, GPR44",Prostaglandin D2 receptor 2,PTGDR2,11251,ENSG00000183134,NA,NA,Ptgdr2 (MGI:1330275)
11,60867541,60875692,11q12.2,11q12.2,195000,"ZP1, OOMD1",Zona pellucida glycoprotein 1,ZP1,22917,ENSG00000149506,NA,"Oocyte maturation defect 1, 615774 (3), Autosomal recessive",Zp1 (MGI:103073)
11,60890546,60906584,11q12.2,11q12.2,608330,"PRPF19, PRP19, PSO4, NMP200","Precursor mRNA-processing factor 19, S. cerevisiae, homolog of",PRPF19,27339,ENSG00000110107,NA,NA,Prpf19 (MGI:106247)
11,60924459,60937158,11q12.2,11q12.2,617363,"TMEM132A, KIAA1583",Transmembrane protein 132A,TMEM132A,54972,ENSG00000006118,NA,NA,Tmem132a (MGI:2147810)
11,60937082,60952175,11q12,11q12.2,610408,"SLC15A3, PHT2","Solute carrier family 15 (oligopeptide transporter), member 3",SLC15A3,51296,ENSG00000110446,NA,NA,Slc15a3 (MGI:1929691)
11,60971640,61020376,Chr.11,11q12.2,186720,"CD6, TP120",CD6 antigen,CD6,923,ENSG00000013725,NA,NA,Cd6 (MGI:103566)
11,61093962,61127851,11q13,11q12.2,153340,"CD5, LEU1",CD5 antigen (p56-62),CD5,921,ENSG00000110448,NA,NA,Cd5 (MGI:88340)
11,61130256,61161425,11q12.2,11q12.2,610038,VPS37C,"Vacuolar protein sorting 37, yeast, homolog of, C",VPS37C,55048,ENSG00000167987,NA,NA,Vps37c (MGI:2147661)
11,61222348,61231694,11q13,11q12.2,169720,PGA4,Pepsinogen A4,PGA4,643847,ENSG00000229183,NA,NA,NA
11,61241175,61251443,11q13,11q12.2,169730,PGA5,Pepsinogen A5,PGA5,5222,ENSG00000256713,pter-5'HRAS--5'INS--cen,NA,NA
11,61258285,61295315,11q11,11q12.2,611115,"VWC1, URG11",von Willebrand factor C and EGF domain-containing protein,VWCE,220001,ENSG00000167992,NA,NA,Vwce (MGI:1919018)
11,61299446,61333211,11q12-q13,11q12.2,600045,DDB1,"Damage-specific DNA binding protein 1, 127kD",DDB1,1642,ENSG00000167986,NA,NA,Ddb1 (MGI:1202384)
11,61333181,61353425,11q12.2,11q12.2,615844,DAK,"Dihydroxyacetone kinase 2, S. cerevisiae, homolog of",TKFC,26007,ENSG00000149476,NA,NA,Tkfc (MGI:2385084)
11,61362360,61378223,11q12.2,11q12.2,614459,"TMEM138, JBTS16",Transmembrane protein 138,TMEM138,51524,ENSG00000149483,NA,"Joubert syndrome 16, 614465 (3), Autosomal recessive",Tmem138 (MGI:1920232)
11,61391981,61398862,11q12.2,11q12.2,613277,"TMEM216, JBTS2, CORS2, MKS2",Transmembrane protein 216,TMEM216,51259,ENSG00000187049,NA,"Joubert syndrome 2, 608091 (3), Autosomal recessive; Meckel syndrome 2, 603194 (3), Autosomal recessive",Tmem216 (MGI:1920020)
11,61430124,61446766,11q13.1,11q12.2,613019,"SDHAF2, SDH5, PGL2",Succinate dehydrogenase complex assembly factor 2,SDHAF2,54949,ENSG00000167985,NA,"Paragangliomas 2, 601650 (3), Autosomal dominant",Sdhaf2 (MGI:1913322)
11,61513715,61588403,11q13,11q12.2,604146,SYT7,Synaptotagmin 7,SYT7,9066,ENSG00000011347,NA,NA,Syt7 (MGI:1859545)
11,61680183,61747001,11q12.2,11q12.2,614015,"DAGLA, KIAA0659","Diacylglycerol lipase, alpha",DAGLA,747,ENSG00000134780,NA,NA,Dagla (MGI:2677061)
11,61752616,61788517,11q12.2,11q12.2,608329,"MYRF, C11orf9, KIAA0954, MMERV, CUGS",Myelin regulatory factor,MYRF,745,ENSG00000124920,NA,"Cardiac-urogenital syndrome, 618280 (3), Autosomal dominant; Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, 618113 (3), Autosomal dominant",Myrf (MGI:2684944)
11,61788948,61792598,11q12,11q12.2,617615,"TMEM258, C11orf10",Transmembrane protein 258,TMEM258,746,ENSG00000134825,NA,NA,Tmem258 (MGI:1916288)
11,61792910,61797237,11q12,11q12.2,600393,FEN1,Flap structure-specific endonuclease 1,FEN1,2237,ENSG00000168496,NA,NA,Fen1 (MGI:102779)
11,61799626,61817002,11q12-q13.1,11q12.2,606148,FADS1,Fatty acid desaturase 1,FADS1,3992,ENSG00000149485,NA,NA,Fads1 (MGI:1923517)
11,61816202,61867353,11q12-q13.1,11q12.2,606149,FADS2,Fatty acid desaturase 2,FADS2,9415,ENSG00000134824,NA,NA,Fads2 (MGI:1930079)
11,61873525,61892223,11q12-q13.1,11q12.2,606150,FADS3,Fatty acid desaturase 3,FADS3,3995,ENSG00000221968,NA,NA,Fads3 (MGI:1928740)
11,61946721,61965514,11q13,11q12.3,607854,"BEST1, VMD2, ARB, RP50",Bestrophin 1,BEST1,7439,ENSG00000167995,NA,"Bestrophinopathy, autosomal recessive, 611809 (3); Macular dystrophy, vitelliform, 2, 153700 (3), Autosomal dominant; Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3), Autosomal dominant; Retinitis pigmentosa, concentric, 613194 (3); Retinitis pigmentosa-50, 613194 (3); Vitreoretinochoroidopathy, 193220 (3), Autosomal dominant",Best1 (MGI:1346332)
11,61964284,61967633,11q12-q13,11q12.3,134770,"FTH1, FTHL6, HFE5","Ferritin, heavy polypeptide 1",FTH1,2495,ENSG00000167996,mutation identified in 1 family,"?Hemochromatosis, type 5, 615517 (3), Autosomal dominant",Fth1 (MGI:95588)
11,62123997,62155473,11q12.3,11q12.3,604411,INCENP,Inner centromere protein,INCENP,3619,ENSG00000149503,NA,NA,Incenp (MGI:1313288)
11,62190215,62193538,11q12.3,11q12.3,615060,"SCGB1D1, LPNA","Secretoglobin, family 1D, member 1",SCGB1D1,10648,ENSG00000168515,previously mapped to 15q12-q13,NA,NA
11,62208672,62213942,11q12.3,11q12.3,604398,"SCGB2A1, MGB2, LPNC","Secretoglobin, family 2A, member 1 (mammaglobin 2)",SCGB2A1,4246,ENSG00000124939,NA,NA,NA
11,62242238,62244811,11q12.3,11q12.3,615061,"SCGB1D2, LPNB","Secretoglobin, family 1D, member 2",SCGB1D2,10647,ENSG00000124935,previously mapped to 10q23,NA,NA
11,62270129,62273159,11q12.3-q13.1,11q12.3,605562,"MGB1, SCGB2A2","Mammaglobin 1 (secretoglobin, family 2A, member 2)",SCGB2A2,4250,ENSG00000110484,NA,NA,NA
11,62296280,62299074,11q12.3,11q12.3,615062,"SCGB1D4, IIS","Secretoglobin, family 1D, member 4",SCGB1D4,404552,ENSG00000197745,NA,NA,NA
11,62419032,62423194,11q12.3-q13.1,11q12.3,192020,"SCGB1A1, UGB, CC10, CCSP","Secretoglobin, family 1A, member 1 (uteroglobin)",SCGB1A1,7356,ENSG00000149021,NA,NA,Scgb1a1 (MGI:98919)
11,62433543,62546805,11q12-q13,11q12.3,103390,AHNAK,AHNAK nucleoprotein (desmoyokin),AHNAK,79026,ENSG00000124942,NA,NA,Ahnak (MGI:1316648)
11,62559595,62573890,11q12.3,11q12.3,130593,"EEF1G, EF1G","Eukaryotic translation elongation factor 1, gamma",EEF1G,1937,ENSG00000254772,NA,NA,Eef1g (MGI:1914410)
11,62593213,62601864,11q12-q13.1,11q12.3,603947,"MTA2, MTA1L1",Metastasis-associated protein 2,MTA2,9219,ENSG00000149480,NA,NA,Mta2 (MGI:1346340)
11,62602217,62612774,11q12.3,11q12.3,618118,"EML3, EMAP3, EMAP95",Echinoderm microtubule-associated protein-like 3,EML3,256364,ENSG00000149499,NA,NA,Eml3 (MGI:2387612)
11,62612740,62615119,11q13,11q12.3,180721,"ROM1, ROSP1, RP7",Rod outer segment membrane protein-1,ROM1,6094,ENSG00000149489,digenic RP with RDS,"Retinitis pigmentosa 7, digenic form, 608133 (3), Autosomal recessive, Autosomal dominant",Rom1 (MGI:97998)
11,62615295,62622174,11q12-q13,11q12.3,606374,"B3GAT3, GLCATI, JDSCD","Beta-1,3-glucuronyltransferase 3",B3GAT3,26229,ENSG00000149541,pseudogene on chr.3,"Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3), Autosomal recessive",B3gat3 (MGI:1919977)
11,62624825,62646725,11q13-qter,11q12.3,104160,"GANAB, PKD3",Neutral alpha-glucosidase AB,GANAB,23193,ENSG00000089597,NA,"Polycystic kidney disease 3, 600666 (3), Autosomal dominant",Ganab (MGI:1097667)
11,62646847,62653301,11q12.3,11q12.3,611349,"INTS5, INT5, KIAA1698",Integrator complex subunit 5,INTS5,80789,ENSG00000185085,NA,NA,Ints5 (MGI:1923578)
11,62665252,62668107,11q12.3,11q12.3,617897,"CSKMT, METTL12",Citrate synthase lysine methyltransferase,CSKMT,751071,ENSG00000214756,NA,NA,NA
11,62671672,62673685,11q12.3,11q12.3,616097,"UQCC3, C11orf83, MC3DN9",Ubiquinol-cytochrome C reductase complex assembly factor 3,UQCC3,790955,ENSG00000204922,mutation identified in 1 MC3DN9 patient,"?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3), Autosomal recessive",Uqcc3 (MGI:2147553)
11,62676497,62679116,11q12.3,11q12.3,616378,"UBXN1, SAKS1",UBX domain protein 1,UBXN1,51035,ENSG00000162191,NA,NA,Ubxn1 (MGI:1289301)
11,62690261,62709618,11q13,11q12.3,606158,"BSCL2, SPG17, HMN5, PELD",Seipin,BSCL2,26580,ENSG00000168000,NA,"Encephalopathy, progressive, with or without lipodystrophy, 615924 (3), Autosomal recessive; Lipodystrophy, congenital generalized, type 2, 269700 (3), Autosomal recessive; Neuropathy, distal hereditary motor, type VA, 600794 (3), Autosomal dominant; Silver spastic paraplegia syndrome, 270685 (3), Autosomal dominant",Bscl2 (MGI:1298392)
11,62761579,62766709,11q13.1,11q12.3,602013,POLR2G,Polymerase (RNA) II (DNA directed) polypeptide G,POLR2G,5436,ENSG00000168002,NA,NA,Polr2g (MGI:1914960)
11,62792124,62805442,11q12-q13,11q12.3,602647,"NXF1, TAP, MEX67",Nuclear RNA export factor 1,NXF1,10482,ENSG00000162231,NA,NA,Nxf1 (MGI:1858330)
11,62806859,62832052,11q12.3,11q12.3,603189,"STX5, STX5A",Syntaxin 5,STX5,6811,ENSG00000162236,NA,NA,Stx5a (MGI:1928483)
11,62832904,62841808,11q12.3,11q12.3,617947,WDR74,WD repeat-containing protein 74,WDR74,54663,ENSG00000133316,NA,NA,Wdr74 (MGI:2147427)
11,62851977,62855884,11q13,11q12.3,603222,"UHG, U22HG",U22 host gene,SNHG1,23642,ENSG00000255717,NA,NA,NA
11,62852909,62853034,11q13,11q12.3,603223,RNU22,"RNA, U22 small nucleolar",SNORD22,9304,ENSG00000277194,NA,NA,NA
11,62853325,62853392,11q13,11q12.3,603230,RNU31,"RNA, U31 small nucleolar",SNORD31,9298,NA,NA,NA,NA
11,62853662,62853731,11q13,11q12.3,603229,RNU30,"RNA, U30 small nucleolar",SNORD30,9299,ENSG00000277846,NA,NA,NA
11,62853903,62853967,11q13,11q12.3,603228,RNU29,"RNA, U29 small nucleolar",SNORD29,9297,NA,NA,NA,NA
11,62854620,62854694,11q13,11q12.3,603227,RNU28,"RNA, U28 small nucleolar",SNORD28,9300,ENSG00000274544,NA,NA,NA
11,62855011,62855082,11q13,11q12.3,603226,RNU27,"RNA, U27 small nucleolar",SNORD27,9301,ENSG00000275996,NA,NA,NA
11,62855291,62855365,11q13,11q12.3,603225,RNU26,"RNA, U26 small nucleolar",SNORD26,9302,ENSG00000276788,NA,NA,NA
11,62855564,62855630,11q13,11q12.3,603224,RNU25,"RNA, U25 small nucleolar",SNORD25,9303,ENSG00000275043,NA,NA,NA
11,62856108,62888882,11q13,11q12.3,158070,"SLC3A2, MDU1, NACAE","Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2",SLC3A2,6520,ENSG00000168003,prob. 11q13,NA,Slc3a2 (MGI:96955)
11,62908674,62921860,11q13,11q12.3,118510,CHRM1,"Cholinergic receptor, muscarinic, 1",CHRM1,1128,ENSG00000168539,NA,NA,Chrm1 (MGI:88396)
11,62976596,62984966,11q13.1-q13.2,11q12.3,607582,"SLC22A6, OAT1, PAHT","Solute carrier family 22 (organic anion transporter), member 6",SLC22A6,9356,ENSG00000197901,NA,NA,Slc22a6 (MGI:892001)
11,62992823,63015844,Chr.11,11q12.3,607581,"SLC22A8, OAT3","Solute carrier family 22 (organic anion transporter), member 8",SLC22A8,9376,ENSG00000149452,NA,NA,Slc22a8 (MGI:1336187)
11,63079939,63144220,11q12.3,11q12.3,611698,SLC22A24,"Solute carrier family 22, member 24",SLC22A24,283238,ENSG00000197658,NA,NA,Slc22a19 (MGI:2442751)
11,63162263,63243522,11q12.3,11q12.3,610792,UST6,Organic anion transporter UST6,SLC22A25,387601,ENSG00000196600,NA,NA,"Slc22a29,Slc22a28,Slc22a27,Slc22a30 (MGI:2442750,MGI:3645714,MGI:3605624,MGI:3042283)"
11,63268256,63311982,11q12.3,11q12.3,607580,"SLC22A10, OAT5","Solute carrier family 22 (organic anion/cation transporter), member 10",SLC22A10,387775,ENSG00000184999,NA,NA,NA
11,63368870,63410877,11q12.3,11q12.3,607579,"SLC22A9, OAT4, UST3","Solute carrier family 22 (organic anion/cation transporter), member 9",SLC22A9,114571,ENSG00000149742,NA,NA,NA
11,63506051,63516771,11q13,11q12.3,606096,LGALS12,"Lectin, galactoside-binding, soluble, 12",LGALS12,85329,ENSG00000133317,NA,NA,Lgals12 (MGI:1929094)
11,63536807,63546457,11q23,11q12.3,605092,"RARRES3, TIG3",Retinoic acid receptor responder 3,PLAAT4,5920,ENSG00000133321,NA,NA,NA
11,63552758,63565071,11q12.3,11q12.3,613866,HRASLS2,HRAS-like suppressor 2,PLAAT2,54979,ENSG00000133328,NA,NA,NA
11,63574461,63616925,11q12.3-q13.1,11q12.3-q13.1,613867,"PLA2G16, HRASLS3, HRSL3, HREV107","Phospholipase A2, group XVI",PLAAT3,11145,ENSG00000176485,NA,NA,Plaat3 (MGI:2179715)
11,63600000,77400000,11q13,NA,617697,CUPID2,"CCND1 upstream intergenic DNA repair 2, noncoding",NA,NA,NA,NA,NA,NA
11,63600000,110600000,11q13-q22,NA,133220,ESA4,Esterase-A4,ESA4,2090,NA,NA,NA,NA
11,63600000,77400000,11q13,NA,611958,HPC14,"Prostate cancer, hereditary, 14",NA,100188867,NA,associated with rs7931342,"{Prostate cancer, hereditary, 14}, 611958 (2)",NA
11,63600000,77400000,11q13,NA,600319,IDDM4,Insulin-dependent diabetes mellitus-4,IDDM4,3403,NA,NA,"{Diabetes mellitus, insulin-dependent, 4}, 600319 (2)",NA
11,63600000,77400000,11q13,NA,166750,"OTDD, DEL11q13, C11DELq13",Otodental dysplasia (chromosome 11q13 deletion syndrome),NA,NA,NA,between rs9666584 and rs41408348,"Otodental dysplasia chromosome deletion syndrome, 166750 (4), Autosomal dominant",NA
11,63600000,77400000,11q13,NA,169710,PGA3,Pepsinogen A3,PGA3,643834,ENSG00000229859,NA,NA,NA
11,63600000,77400000,11q13,NA,165110,SEA,Oncogene SEA (S13 avian erythroblastosis),SEA,6395,NA,NA,NA,NA
11,63600000,77400000,11q13,NA,607088,SMAR,"Spinal muscular atrophy, chronic distal, autosomal recessive",NA,246751,NA,no mutations found in IGHMBP2,"Spinal muscular atrophy, chronic distal, autosomal recessive, 607088 (2), Autosomal recessive",NA
11,63600000,77400000,11q13,NA,191181,ST3,"Suppression of tumorigenicity-3 (tumor-suppressor gene, HELA cell type)",ST3,6762,NA,NA,"Cervical carcinoma, 191181 (2)",NA
11,63624081,63671973,11q13.1,11q13.1,609369,"ATL3, HSN1F",Atlastin 3,ATL3,25923,ENSG00000184743,NA,"Neuropathy, hereditary sensory, type IF, 615632 (3), Autosomal dominant",Atl3 (MGI:1924270)
11,63681314,63759890,11q13,11q13.1,604249,"RTN3, NSPL2",Reticulon 3,RTN3,10313,ENSG00000133318,pseudogene on chr.4,NA,Rtn3 (MGI:1339970)
11,63759891,63768774,11q13,11q13.1,615699,C11orf95,Chromosome 11 open reading frame 95,C11orf95,65998,ENSG00000188070,NA,NA,2700081O15Rik (MGI:1919667)
11,63838927,63911019,11q12-q13,11q13.1,600526,"MARK2, EMK1",MAP/microtubule affinity-regulating kinase 2,MARK2,2011,ENSG00000072518,NA,NA,Mark2 (MGI:99638)
11,63911229,63917163,11q13.1,11q13.1,616019,RCOR2,Rest corepressor 2,RCOR2,283248,ENSG00000167771,NA,NA,Rcor2 (MGI:1859854)
11,63974619,63976542,11q13,11q13.1,123870,COX8A,"Cytochrome c oxidase, subunit VIIIA",COX8A,1351,ENSG00000176340,mutation identified in 1 COX4D patient,"?Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Cox8a (MGI:105959)
11,63985852,63998419,11q13.1,11q13.1,608337,"OTUB1, OTU1, OTB1",OTU domain-containing ubiquitin aldehyde-binding protein 1,OTUB1,55611,ENSG00000167770,NA,NA,NA
11,63998553,64166651,11q13.1,11q13.1,610400,"MACROD1, LRP16",Macro domain-containing 1,MACROD1,28992,ENSG00000133315,NA,NA,Macrod1 (MGI:2147583)
11,64035969,64127288,11q12-q13,11q13.1,604806,FLRT1,Fibronectin-like domain-containing leucine-rich transmembrane protein-1,FLRT1,23769,ENSG00000126500,NA,NA,Flrt1 (MGI:3026647)
11,64185271,64204547,11q13,11q13.1,605063,"STIP1, HOP",Stress-induced phosphoprotein 1,STIP1,10963,ENSG00000168439,NA,NA,Stip1 (MGI:109130)
11,64206661,64223890,11q12,11q13.1,607901,"FERMT3, KIND3, URP2, MIG2B","Fermitin family, member 3",FERMT3,83706,ENSG00000149781,NA,"Leukocyte adhesion deficiency, type III, 612840 (3), Autosomal recessive",Fermt3 (MGI:2147790)
11,64223798,64226253,11q13,11q13.1,610470,TRPT1,Transfer RNA phosphotransferase 1,TRPT1,83707,ENSG00000149743,NA,NA,Trpt1 (MGI:1333115)
11,64230280,64234280,11q13,11q13.1,604189,"DANJC4, HSPF2","DnaJ, E. coli, homolog of, subfamily C, member 4 (heat-shock 40kD protein 2)",DNAJC4,3338,ENSG00000110011,NA,NA,Dnajc4 (MGI:1927346)
11,64234583,64239263,11q13,11q13.1,601398,"VEGFB, VRF",Vascular endothelial growth factor B,VEGFB,7423,ENSG00000173511,NA,NA,Vegfb (MGI:106199)
11,64241094,64244134,11q13.1-q13.3,11q13.1,186946,FKBP2,"FK506-binding protein-2, 13kD",FKBP2,2286,ENSG00000173486,NA,NA,Fkbp2 (MGI:95542)
11,64244478,64246942,11q13,11q13.1,601140,"PPP1R14B, PLCB3N, PNG","Protein phosphatase 1, regulatory subunit 14B",PPP1R14B,26472,ENSG00000173457,NA,NA,Ppp1r14b (MGI:107682)
11,64251529,64269451,11q13,11q13.1,600230,PLCB3,"Phospholipase C, beta 3 (phosphatidylinositol-specific)",PLCB3,5331,ENSG00000149782,within 900kb of MEN1,NA,Plcb3 (MGI:104778)
11,64269827,64284703,11q13.1,11q13.1,603167,"BAD, BCL2L8",BCL1 antagonist of cell death,BAD,572,ENSG00000002330,NA,NA,Bad (MGI:1096330)
11,64291301,64300030,11q13,11q13.1,605720,"KCNK4, TRAAK, FHEIG","Potassium channel, subfamily K, member 4",KCNK4,50801,ENSG00000182450,NA,"Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome, 618381 (3), Autosomal dominant",Kcnk4 (MGI:1298234)
11,64300357,64304769,11q13.1,11q13.1,617511,"CATSPERZ, TEX40","Cation channel, sperm-associated, auxiliary subunit zeta",CATSPERZ,25858,ENSG00000219435,NA,NA,Catsperz (MGI:1914327)
11,64305523,64316742,11q12,11q13.1,601998,"ESRRA, ESRL1","Estrogen-related receptor, alpha",ESRRA,2101,ENSG00000173153,NA,NA,NA
11,64318120,64321822,11q13,11q13.1,606583,"PRDX5, AOEB166",Peroxiredoxin 5,PRDX5,25824,ENSG00000126432,NA,NA,Prdx5 (MGI:1859821)
11,64340202,64357533,11q13.1,11q13.1,611205,"CCDC88B, GIPIE",Coiled-coil domain-containing protein 88B,CCDC88B,283234,ENSG00000168071,NA,NA,Ccdc88b (MGI:1925567)
11,64359161,64372214,11q13.1,11q13.1,603606,"RPS6KA4, RSKB, MSK2","Ribosomal protein S6 kinase, 90kD, 4",RPS6KA4,8986,ENSG00000162302,NA,NA,Rps6ka4 (MGI:1930076)
11,64555846,64572874,11q13,11q13.1,607097,"SLC22A11, OAT4","Solute carrier family 22 (organic anion/cation transporter), member 11",SLC22A11,55867,ENSG00000168065,NA,NA,NA
11,64590809,64603249,11q13,11q13.1,607096,"SLC22A12, OAT4L, URAT1","Solute carrier family 22 (urate transporter), member 12",SLC22A12,116085,ENSG00000197891,NA,"Hypouricemia, renal, 220150 (3), Autosomal recessive",Slc22a12 (MGI:1195269)
11,64606173,64723196,11q13,11q13.1,600566,NRXN2,Neurexin 2,NRXN2,9379,ENSG00000110076,NA,NA,Nrxn2 (MGI:1096362)
11,64726910,64745480,11q13,11q13.1,605577,"RASGRP2, CDC25L",Ras guanyl nucleotide-releasing protein 2,RASGRP2,10235,ENSG00000068831,mutation identified in 1 BDPLT18 family,"?Bleeding disorder, platelet-type, 18, 615888 (3), Autosomal recessive",Rasgrp2 (MGI:1333849)
11,64746388,64760714,11q13,11q13.1,608455,PYGM,"Phosphorylase, glycogen, muscle",PYGM,5837,ENSG00000068976,NA,"McArdle disease, 232600 (3), Autosomal recessive",Pygm (MGI:97830)
11,64764603,64778843,11q13,11q13.1,601516,"SF1, ZNF162, D11S636, ZFM1",Splicing factor 1 (zinc finger protein-162),SF1,7536,ENSG00000168066,NA,NA,NA
11,64784917,64803247,11q13,11q13.1,603166,"MAP4K2, RAB8IP, GCK",Mitogen-activating protein kinase kinase kinase kinase 2 (RAB8-interacting protein; germinal center kinase),MAP4K2,5871,ENSG00000168067,NA,NA,Map4k2 (MGI:1346883)
11,64803513,64811293,11q13,11q13.1,613733,MEN1,Menin,MEN1,4221,ENSG00000133895,linked distal to PYGM,"Adrenal adenoma, somatic (3); Angiofibroma, somatic (3); Carcinoid tumor of lung (3); Lipoma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Parathyroid adenoma, somatic (3)",Men1 (MGI:1316736)
11,64823051,64844685,11q13,11q13.1,613991,"CDC42BPG, MRCKG","CDC42-binding protein kinase, gamma",CDC42BPG,55561,ENSG00000171219,NA,NA,Cdc42bpg (MGI:2652845)
11,64851641,64879712,11q13,11q13.1,605888,EHD1,EH domain-containing 1 protein,EHD1,10938,ENSG00000110047,NA,NA,Ehd1 (MGI:1341878)
11,64891136,64891245,11q13.1,11q13.1,610939,"MIR192, MIRN192",Micro RNA 192,MIR192,406967,ENSG00000283926,NA,NA,NA
11,64891354,64891438,11q13.1,11q13.1,610941,"MIR194-2, MIRN194-2",Micro RNA 194-2,MIR194-2,406970,ENSG00000284155,NA,NA,NA
11,64894545,64917240,11q13.1,11q13.1,616225,"ATG2A, KIAA0404","Autophagy 2, S. cerevisiae, homolog of, A",ATG2A,23130,ENSG00000110046,NA,NA,Atg2a (MGI:1916291)
11,64917552,64934477,11q13,11q13.1,601644,PPP2R5B,"Protein phosphatase-2, regulatory subunit B (B56), beta isoform",PPP2R5B,5526,ENSG00000068971,NA,NA,Ppp2r5b (MGI:2388480)
11,64934470,64938130,11q13.1,11q13.1,609651,"GPHA2, GPA2","Glycoprotein hormone, alpha-2",GPHA2,170589,ENSG00000149735,NA,NA,Gpha2 (MGI:2156541)
11,64938229,64972107,11q13.1,11q13.1,617130,"MAJIN, C11orf85",Membrane-anchored junction protein,MAJIN,283129,ENSG00000168070,NA,NA,Majin (MGI:1923913)
11,64987944,64996970,11q13.1,11q13.1,614983,"BATF2, SARI","Basic leucine zipper transcription factor, ATF-like 2",BATF2,116071,ENSG00000168062,NA,NA,Batf2 (MGI:1921731)
11,65014159,65022183,11q13,11q13.1,601175,ARL2,ADP=ribosylation factor-like 2,ARL2,402,ENSG00000213465,NA,NA,Arl2 (MGI:1928393)
11,65027438,65040571,11q13,11q13.1,605964,SNX15,Sorting nexin 15,SNX15,29907,ENSG00000110025,NA,NA,Snx15 (MGI:1916274)
11,65044817,65059019,11q12,11q13.1,602640,"NAALADL1, I100",N-acetylated alpha-linked acidic dipeptidase-like 1,NAALADL1,10004,ENSG00000168060,NA,NA,Naaladl1 (MGI:2685810)
11,65061008,65084128,11q13.1,11q13.1,609374,"CDCA5, SORORIN",Cell division cycle-associated protein 5 (sororin),CDCA5,113130,ENSG00000146670,NA,NA,Cdca5 (MGI:1915099)
11,65096114,65111861,11q13.1,11q13.1,615738,"VPS51, ANG2","Vacuolar protein sorting 51, S. cerevisiae, homolog of",VPS51,738,ENSG00000149823,NA,NA,Vps51 (MGI:1915755)
11,65111853,65116395,11q13,11q13.1,603414,"TM7SF2, ANG1","Transmembrane 7 superfamily, member 2",TM7SF2,7108,ENSG00000149809,NA,NA,Tm7sf2 (MGI:1920416)
11,65116402,65117700,11q13,11q13.1,604575,"ZNHIT2, C11orf5, FON",Zinc finger HIT domain containing protein 2,ZNHIT2,741,ENSG00000174276,NA,NA,Znhit2 (MGI:1352481)
11,65120629,65122133,11q13,11q13.1,134690,FAU,Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived),FAU,2197,ENSG00000149806,NA,NA,Fau (MGI:102547)
11,65122182,65127370,11q13,11q13.1,606866,"MRPL49, NOF1",Mitochondrial ribosomal protein L49,MRPL49,740,ENSG00000149792,NA,NA,Mrpl49 (MGI:108180)
11,65127278,65135177,11q13,11q13.1,608046,"SYVN1, HRD1, KIAA1810",Synovial apoptosis inhibitor 1,SYVN1,84447,ENSG00000162298,NA,NA,Syvn1 (MGI:1921376)
11,65170153,65173665,11q13.1,11q13.1,614030,"SPDYC, RINGOC","Speedy, xenopus, homolog of, C",SPDYC,387778,ENSG00000204710,NA,NA,NA
11,65181372,65212005,11q13,11q13.1,114220,"CAPN1, SPG76","Calpain, large polypeptide L1",CAPN1,823,ENSG00000014216,NA,"Spastic paraplegia 76, autosomal recessive, 616907 (3), Autosomal recessive",Capn1 (MGI:88263)
11,65213839,65242756,11q13.1,11q13.1,611696,"SLC22A20, OAT6","Solute carrier family 22, member 20",SLC22A20P,440044,ENSG00000197847,NA,NA,NA
11,65314865,65322416,11q12-q13,11q13.1,606132,"CDC42EP2, CEP2, BORG1",CDC42 effector protein 2,CDC42EP2,10435,ENSG00000149798,NA,NA,Cdc42ep2 (MGI:1929744)
11,65333839,65354261,11q13,11q13.1,601671,"DPF2, REQ, UBID4, CSS7","D4, zinc, and double PHD fingers family, member 2",DPF2,5977,ENSG00000133884,NA,"Coffin-Siris syndrome 7, 618027 (3), Autosomal dominant",Dpf2 (MGI:109529)
11,65375191,65383700,11q13.1,11q13.1,610825,SLC25A45,"Solute carrier family 25, member 45",SLC25A45,283130,ENSG00000162241,NA,NA,Slc25a45 (MGI:2147731)
11,65386636,65413524,11q13.1,11q13.1,618337,"FRMD8, ITAP",FERM domain-containing protein 8,FRMD8,83786,ENSG00000126391,NA,NA,Frmd8 (MGI:1914707)
11,65422797,65445539,11q13.1,11q13.1,612769,"NEAT1, TNCRNA",Noncoding nuclear-enriched abundant transcript 1,NEAT1,283131,ENSG00000245532,NA,NA,NA
11,65497737,65506515,11q13.1,11q13.1,607924,"MALAT1, PRO1073",Metastasis-associated lung adenocarcinoma transcript 1,MALAT1,378938,ENSG00000251562,fused with TFEB in renal tumors,NA,NA
11,65525080,65538709,11q13,11q13.1,607982,"SCYL1, NTKL, SCAR21",SCY1-like 1,SCYL1,57410,ENSG00000142186,NA,"Spinocerebellar ataxia, autosomal recessive 21, 616719 (3), Autosomal recessive",Scyl1 (MGI:1931787)
11,65538558,65558388,11q12,11q13.1,602090,"LTBP3, LTBP2, DASS, GPHYSD3",Latent transforming growth factor beta binding protein-3,LTBP3,4054,ENSG00000168056,NA,"Dental anomalies and short stature, 601216 (3), Autosomal recessive; Geleophysic dysplasia 3, 617809 (3), Autosomal dominant",Ltbp3 (MGI:1101355)
11,65572537,65574189,11q13.1,11q13.1,616128,"FAM89B, MTVR, LRAP25","Family with sequence similarity 89, member B",FAM89B,23625,ENSG00000176973,NA,NA,Fam89b (MGI:106595)
11,65592854,65595995,11q13,11q13.1,603940,KCNK7,"Potassium channel, subfamily K, member 7",KCNK7,10089,ENSG00000173338,NA,NA,Kcnk7 (MGI:1341841)
11,65597754,65614220,11q13.1-q13.3,11q13.1,600050,"MAP3K11, MLK3, PTK1, SPRK",Mitogen-activated protein kinase kinase kinase 11,MAP3K11,4296,ENSG00000173327,NA,NA,Map3k11 (MGI:1346880)
11,65614310,65637438,11q13.1,11q13.1,617657,PCNX3,"Pecanex, Drosophila, homolog of, 3",PCNX3,399909,ENSG00000197136,NA,NA,Pcnx3 (MGI:1861733)
11,65638100,65650929,11q13.3,11q13.1,602180,"SIPA1, SPA1",Signal-induced proliferation-associated gene-1,SIPA1,6494,ENSG00000213445,NA,NA,Sipa1 (MGI:107576)
11,65653595,65662971,11q12-q13,11q13.1,164014,"RELA, NFKB3, CMCU","RELA proto-oncogene, NF-kB subunit",RELA,5970,ENSG00000173039,mutation identified in 1 CMCU family,"?Mucocutaneous ulceration, chronic, 618287 (3), Autosomal dominant",Rela (MGI:103290)
11,65712017,65719603,11q13,11q13.1,601409,"KAT5, HTATIP, TIP60, ESA1, PLIP",K(lysine) acetyltransferase 5,KAT5,10524,ENSG00000172977,NA,NA,Kat5 (MGI:1932051)
11,65717672,65720937,11q13.2,11q13.1,610330,"RNASEH2C, AYP1, FLJ20974, AGS3","Ribonuclease H2, subunit C",RNASEH2C,84153,ENSG00000172922,NA,"Aicardi-Goutieres syndrome 3, 610329 (3), Autosomal recessive",Rnaseh2c (MGI:1915459)
11,65773897,65780975,11q13.1,11q13.1,614367,"AP5B1, DKFZp761E198","Adaptor-related protein complex 5, beta-1 subunit",AP5B1,91056,ENSG00000254470,NA,NA,Ap5b1 (MGI:2685808)
11,65787062,65797218,11q13,11q13.1,602313,OVOL1,"Ovo, Drosophila, homolog-like, 1",OVOL1,5017,ENSG00000172818,NA,NA,Ovol1 (MGI:1330290)
11,65854672,65858179,11q13,11q13.1,601442,CFL1,Cofilin 1 (non-muscle),CFL1,1072,ENSG00000172757,NA,NA,Cfl1 (MGI:101757)
11,65860243,65867652,11q13,11q13.1,606591,MUS81,"Mus81, S. cerevisiae, homolog of",MUS81,80198,ENSG00000172732,NA,NA,Mus81 (MGI:1918961)
11,65866440,65872933,11q13,11q13.1,604633,"EFEMP2, FBLN4, UPH1, ARCL1B",EGF-containing fibulin-like extracellular matrix protein 2 (fibulin 4),EFEMP2,30008,ENSG00000172638,NA,"Cutis laxa, autosomal recessive, type IB, 614437 (3), Autosomal recessive",Efemp2 (MGI:1891209)
11,65879836,65883740,11q13.1,11q13.1,602364,CTSW,Cathepsin W,CTSW,1521,ENSG00000172543,NA,NA,Ctsw (MGI:1338045)
11,65883739,65888509,11q13.1,11q13.1,608296,"FIBP, TROFAS","Fibroblast growth factor, acidic, intracellular binding protein",FIBP,9158,ENSG00000172500,NA,"Thauvin-Robinet-Faivre syndrome, 617107 (3), Autosomal recessive",Fibp (MGI:1926233)
11,65890672,65891634,11q13.1,11q13.1,605360,DIPA,Delta antigen-interacting protein A,CCDC85B,11007,ENSG00000175602,NA,NA,Ccdc85b (MGI:2147607)
11,65892048,65900525,11q13,11q13.1,136515,FOSL1,FOS-like antigen-1,FOSL1,8061,ENSG00000175592,NA,NA,Fosl1 (MGI:107179)
11,65919425,65921562,11q13.1,11q13.1,602289,DRAP1,DR1-associated protein 1,DRAP1,10589,ENSG00000175550,NA,NA,Drap1 (MGI:1913806)
11,65961726,65980136,Chr.11,11q13.1,605941,"SART1, HOMS1",Squamous cell carcinoma antigen recognized by T cells 1,SART1,9092,ENSG00000175467,NA,NA,Sart1 (MGI:1309453)
11,65996544,66002216,11q13.1,11q13.1,618473,"EIF1AD, OBELIX",Eukaryotic translation initiation factor 1A domain-containing protein,EIF1AD,84285,ENSG00000175376,NA,NA,Eif1ad (MGI:1917110)
11,66002078,66004148,11q13.1,11q13.1,603811,"BANF1, BAF, NGPS",Barrier to autointegration factor 1,BANF1,8815,ENSG00000175334,NA,"Nestor-Guillermo progeria syndrome, 614008 (3), Autosomal recessive",Banf1 (MGI:1346330)
11,66012007,66013504,11q13,11q13.1,601891,CST6,Cystatin-M,CST6,1474,ENSG00000175315,NA,NA,Cst6 (MGI:1920970)
11,66016751,66026517,11q13.1,11q13.1,606389,"CATSPER1, CATSPER, SPGF7","Cation channel, sperm-associated, 1",CATSPER1,117144,ENSG00000175294,NA,"Spermatogenic failure 7, 612997 (3), Autosomal recessive",Catsper1 (MGI:2179947)
11,66040764,66049160,11q13,11q13.1,608234,"GAL3ST3, GAL3ST2",Galactose-3-O-sulfotransferase 3,GAL3ST3,89792,ENSG00000175229,NA,NA,Gal3st3 (MGI:3617843)
11,66052360,66069307,Chr.11,11q13.1,605591,"SF3B2, SF3B145, SAP145","Splicing factor 3B, subunit 2",SF3B2,10992,ENSG00000087365,NA,NA,Sf3b2 (MGI:2441856)
11,66070271,66244743,11q13.1,11q13.1-q13.2,607492,"PACS1, SHMS, MRD17",Phosphofurin acidic cluster sorting protein 1,PACS1,55690,ENSG00000175115,NA,"Schuurs-Hoeijmakers syndrome, 615009 (3), Autosomal dominant",Pacs1 (MGI:1277113)
11,66257293,66267860,11q12-q13,11q13.2,611729,"KLC2, SPOAN","Kinesin, light chain 2",KLC2,64837,ENSG00000174996,NA,"Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3), Autosomal recessive",Klc2 (MGI:107953)
11,66268525,66277491,11q13.1,11q13.2,612565,RAB1B,Ras-associated protein RAB1B,RAB1B,81876,ENSG00000174903,NA,NA,Rab1b (MGI:1923558)
11,66278174,66284213,11q13.2,11q13.2,611288,"CNIH2, CNIL","Cornichon, Drosophila, homolog of, 2",CNIH2,254263,ENSG00000174871,NA,NA,Cnih2 (MGI:1277225)
11,66284579,66289142,11q13,11q13.2,611484,"YIF1A, YIF1","Yip1-interacting factor, S. cerevisiae, homolog of, A",YIF1A,10897,ENSG00000174851,NA,NA,Yif1a (MGI:1915340)
11,66314493,66317043,11q13,11q13.2,606064,"CD248, TEM1",CD248 antigen,CD248,57124,ENSG00000174807,NA,NA,Cd248 (MGI:1917695)
11,66337332,66345124,11q13.1-q13.2,11q13.2,606259,BRMS1,Breast cancer metastasis suppressor 1,BRMS1,25855,ENSG00000174744,NA,NA,Brms1 (MGI:2388804)
11,66345373,66347628,11q13.2,11q13.2,605517,"B4GAT1, B3GNT1, IGNT, IGAT, MDDGA13","Beta-1,4glucuronyltransferase 1",B4GAT1,11041,ENSG00000174684,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3), Autosomal recessive",B4gat1 (MGI:1919680)
11,66362520,66372475,11q13,11q13.2,602110,"SLC29A2, HNP36, DER12","Solute carrier family 29 (nucleoside transporters), member 2 (hydrophobic nucleolar protein, 36kD)",SLC29A2,3177,ENSG00000174669,NA,NA,Slc29a2 (MGI:1345278)
11,66408921,66426706,11q13,11q13.2,608554,"NPAS4, NXF",Neuronal PAS domain protein 4,NPAS4,266743,ENSG00000174576,NA,NA,Npas4 (MGI:2664186)
11,66435074,66438859,11q13.3,11q13.2,611826,MRPL11,Mitochondrial ribosomal protein L11,MRPL11,65003,ENSG00000174547,NA,NA,Mrpl11 (MGI:2137215)
11,66466326,66477336,11q13.2,11q13.2,609827,PELI3,"Pellino, Drosophila, homolog of, 3",PELI3,246330,ENSG00000174516,NA,NA,Peli3 (MGI:1924963)
11,66480433,66509656,11q12-q13.1,11q13.2,606818,DPP3,Dipeptidyl peptidase III,DPP3,10072,ENSG00000254986,NA,NA,Dpp3 (MGI:1922471)
11,66510634,66533597,11q13,11q13.2,209901,BBS1,BBS1 gene,BBS1,582,ENSG00000174483,NA,"Bardet-Biedl syndrome 1, 209900 (3), Autosomal recessive, Digenic recessive",Bbs1 (MGI:1277215)
11,66546394,66563333,11q13-q14,11q13.2,102574,"ACTN3, ACTN3D","Actinin, alpha-3",ACTN3,89,ENSG00000248746,NA,"[Alpha-actinin-3 deficiency], 617749 (3); [Sprinting performance], 617749 (3)",NA
11,66563462,66568605,11q13.1,11q13.2,603539,"CTSF, CLN13",Cathepsin F,CTSF,8722,ENSG00000174080,NA,"Ceroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3), Autosomal recessive",Ctsf (MGI:1861434)
11,66593161,66606018,11q13,11q13.2,603864,CCS,Copper chaperone for superoxide dismutase,CCS,9973,ENSG00000173992,NA,NA,Ccs (MGI:1333783)
11,66616629,66629933,11q13,11q13.2,612409,"RBM14, PSP2, COAA, SIP",RNA-binding motif protein 14,RBM14,10432,ENSG00000239306,NA,NA,Rbm14 (MGI:1929092)
11,66638616,66668379,11q13,11q13.2,602571,RBM4. LARK,"RNA-binding motif protein-4 (lark, Drosophila, homolog of)",RBM4,5936,ENSG00000173933,NA,NA,Rbm4 (MGI:1100865)
11,66682495,66729360,11q13,11q13.2,604985,"SPTBN2, SCA5, SCAR14","Spectrin, beta, nonerythrocytic, 2",SPTBN2,6712,ENSG00000173898,NA,"Spinocerebellar ataxia 5, 600224 (3), Autosomal dominant; Spinocerebellar ataxia, autosomal recessive 14, 615386 (3), Autosomal recessive",Sptbn2 (MGI:1313261)
11,66744735,66843515,11q13.2,11q13.2,616109,"C11orf80, HYDM4",Chromosome 11 open reading frame 80,C11orf80,79703,ENSG00000173715,NA,"Hydatidiform mole, recurrent, 4, 618432 (3)",Gm960 (MGI:2685806)
11,66843440,66846551,11q13,11q13.2,605385,RCE1,Ras converting CAAX endopeptidase 1,RCE1,9986,ENSG00000173653,NA,NA,Rce1 (MGI:1336895)
11,66848419,66958417,11q13.4-q13.5,11q13.2,608786,PC,Pyruvate carboxylase,PC,5091,ENSG00000173599,NA,"Pyruvate carboxylase deficiency, 266150 (3), Autosomal recessive",Pcx (MGI:97520)
11,66857063,66860474,11q13.1,11q13.2,612810,"LRFN4, SALM3",Leucine-rich repeat and fibronectin type III domain-containing protein 4,LRFN4,78999,ENSG00000173621,NA,NA,Lrfn4 (MGI:2385612)
11,67006772,67050862,11q13.2,11q13.2,606436,"SYT12, SRG1",Synaptotagmin 12,SYT12,91683,ENSG00000173227,NA,NA,Syt12 (MGI:2159601)
11,67056846,67072016,11q14.3,11q13.2,605781,"RHOD, ARHD, RHOHP1","Ras homolog gene family, member D",RHOD,29984,ENSG00000173156,NA,NA,Rhod (MGI:108446)
11,67119262,67258081,Chr.11,11q13.2,605657,"FBXL11, FBL11",F-box and leucine-rich repeat protein-11,KDM2A,22992,ENSG00000173120,NA,NA,Kdm2a (MGI:1354736)
11,67266419,67286555,11q13.2,11q13.2,109635,"GRK2, ADRBK1",G protein-coupled receptor kinase 2,GRK2,156,ENSG00000173020,NA,NA,Grk2 (MGI:87940)
11,67289290,67302483,11q13.2,11q13.2,615126,ANKRD13D,Ankyrin repeat domain-containing protein 13D,ANKRD13D,338692,ENSG00000172932,NA,NA,Ankrd13d (MGI:1915673)
11,67303477,67312606,11q13.2,11q13.2,606780,SSH3,"Slingshot, Drosophila, homolog of, 3",SSH3,54961,ENSG00000172830,NA,NA,Ssh3 (MGI:2683546)
11,67350764,67353595,11q13,11q13.2,611525,"POLD4, POLDS, P12","Polymerase, DNA-directed, delta 4",POLD4,57804,ENSG00000175482,NA,NA,Pold4 (MGI:1916995)
11,67364167,67374176,11q13.3,11q13.2,607672,"CLCF1, BSF3, CLC, CISS2",Cardiotrophin-like cytokine,CLCF1,23529,ENSG00000175505,NA,"Cold-induced sweating syndrome 2, 610313 (3), Autosomal recessive",Clcf1 (MGI:1930088)
11,67391975,67398411,11q13.1-q13.2,11q13.2,603761,"RAD9A, RAD9","RAD9, S. pombe, homolog of",RAD9A,5883,ENSG00000172613,NA,NA,Rad9a (MGI:1328356)
11,67398182,67401857,11q13,11q13.2,176875,"PPP1CA, PPP1A","Protein phosphatase-1, catalytic subunit, alpha isoform",PPP1CA,5499,ENSG00000172531,NA,NA,Ppp1ca (MGI:103016)
11,67403717,67410089,11q13.1,11q13.2,610831,"TBC1D10C, CARABIN","TBC1 domain family, member 10C",TBC1D10C,374403,ENSG00000175463,NA,NA,Tbc1d10c (MGI:1922072)
11,67415677,67425606,11q13,11q13.2,613368,"CARNS1, ATPGD1, KIAA1394",Carnosine synthase 1,CARNS1,57571,ENSG00000172508,NA,NA,Carns1 (MGI:2147595)
11,67435509,67443820,11q13.2,11q13.2,609849,CORO1B,Coronin 1B,CORO1B,57175,ENSG00000172725,NA,NA,Coro1b (MGI:1345963)
11,67435509,67437681,11q13.3,11q13.2,601577,"PTPRCAP, LPAP","Protein tyrosine phosphatase, receptor type, c polypeptide-associated protein",PTPRCAP,5790,ENSG00000213402,NA,NA,Ptprcap (MGI:97811)
11,67452402,67461773,11q13.1,11q13.2,608965,"CABP4, CRSD, CSNB2B",Calcium-binding protein 4,CABP4,57010,ENSG00000175544,NA,"Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3), Autosomal recessive",Cabp4 (MGI:1920910)
11,67468178,67491107,11q13.3,11q13.2,605555,"AIP, XAP2, ARA9, PITA1",Aryl hydrocarbon receptor-interacting protein,AIP,9049,ENSG00000110711,NA,"Pituitary adenoma 1, multiple types, 102200 (3), Autosomal dominant, Somatic mutation; Pituitary adenoma predisposition, 102200 (3), Autosomal dominant, Somatic mutation",Aip (MGI:109622)
11,67518911,67523445,11q13.1,11q13.2,607314,"CABP2, DFNB93",Calcium-binding protein 2,CABP2,51475,ENSG00000167791,NA,"Deafness, autosomal recessive 93, 614899 (3), Autosomal recessive",Cabp2 (MGI:1352749)
11,67583594,67586652,11q13,11q13.2,134660,"GSTP1, GST3",Glutathione S-transferase pi,GSTP1,2950,ENSG00000084207,formerly called GST1,NA,"Gstp2,Gstp-ps,Gstp1 (MGI:95865,MGI:3782108,MGI:95864)"
11,67606935,67612553,11q13,11q13.2,161015,"NDUFV1, UQOR1, MC1DN4",NADH-ubiquinone oxidoreductase core subunit V1,NDUFV1,4723,ENSG00000167792,NA,"Mitochondrial complex I deficiency, nuclear type 4, 618225 (3), Autosomal recessive",Ndufv1 (MGI:107851)
11,67631302,67639559,11q13.1-q13.2,11q13.2,604648,TBX10,T-box 10,TBX10,347853,ENSG00000167800,NA,NA,Tbx10 (MGI:1261436)
11,67642550,67650828,11q13.2,11q13.2,614413,"ACY3, HCBP1",Aminoacylase 3,ACY3,91703,ENSG00000132744,NA,NA,Acy3 (MGI:1918920)
11,67662161,67681223,Chr.11,11q13.2,601917,"ALDH3B2, ALDH8","Aldehyde dehydrogenase 3 family, member B2",ALDH3B2,222,ENSG00000132746,NA,NA,NA
11,67991099,68004096,11q13,11q13.2,608204,"UNC93B1, IIAE1","UNC93, C. elegans, homolog of, B1",UNC93B1,81622,ENSG00000110057,NA,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, 610551 (3)",Unc93b1 (MGI:1859307)
11,68008546,68029275,Chr.11,11q13.2,600466,"ALDH3B1, ALDH7","Aldehyde dehydrogenase 3 family, member B1",ALDH3B1,221,ENSG00000006534,NA,NA,Aldh3b1 (MGI:1914939)
11,68030680,68036643,11q13,11q13.2,602141,"NDUFS8, MC1DN2",NADH-ubiquinone oxidoreductase core subunit S8,NDUFS8,4728,ENSG00000110717,previously assigned to 3q28,"Mitochondrial complex I deficiency, nuclear type 2, 618222 (3), Autosomal recessive",Ndufs8 (MGI:2385079)
11,68038999,68053845,11q13.4-q13.5,11q13.2,604592,"TCIRG1, TIRC7, OC116, OPTB1",T-cell immune regulator 1,TCIRG1,10312,ENSG00000110719,NA,"Osteopetrosis, autosomal recessive 1, 259700 (3), Autosomal recessive",Tcirg1 (MGI:1350931)
11,68052858,68121390,11q13.2,11q13.2,118491,"CHKA, CHK","Choline kinase, alpha",CHKA,1119,ENSG00000110721,NA,NA,Chka (MGI:107760)
11,68154862,68213898,11q13,11q13.2,610881,"KMT5B, SUV420H1, CGI85, MRD51",Lysine methyltransferase 5B,KMT5B,51111,ENSG00000110066,NA,"Mental retardation, autosomal dominant 51, 617788 (3), Autosomal dominant",Kmt5b (MGI:2444557)
11,68261337,68271972,11q13,11q13.2,610880,C11orf24,Chromosome 11 open reading frame 24,C11orf24,53838,ENSG00000171067,NA,NA,1810055G02Rik (MGI:1919306)
11,68298865,68449274,11q13.4,11q13.2,603506,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4",Low density lipoprotein receptor-related protein-5,LRP5,4041,ENSG00000162337,NA,"[Bone mineral density variability 1], 601884 (3), Autosomal dominant; Exudative vitreoretinopathy 4, 601813 (3), Autosomal recessive, Autosomal dominant; Hyperostosis, endosteal, 144750 (3), Autosomal dominant; Osteopetrosis, autosomal dominant 1, 607634 (3), Autosomal dominant; Osteoporosis-pseudoglioma syndrome, 259770 (3), Autosomal recessive; {Osteoporosis}, 166710 (3), Autosomal dominant; Osteosclerosis, 144750 (3), Autosomal dominant; Polycystic liver disease 4 with or without kidney cysts, 617875 (3), Autosomal dominant; van Buchem disease, type 2, 607636 (3), Autosomal dominant",Lrp5 (MGI:1278315)
11,68460717,68615333,11q13,11q13.2,610879,"SAPS3, PP6R3, C11orf23, KIAA1558","SAPS domain family, member 3",PPP6R3,55291,ENSG00000110075,NA,NA,Ppp6r3 (MGI:1921807)
11,68684543,68691174,11q13.3-q13.5,11q13.2,137035,"GAL, GALN, GLNN, ETL8",Galanin,GAL,51083,ENSG00000069482,mutation identified in 1 ETL8 family,"?Epilepsy, familial temporal lobe, 8, 616461 (3), Autosomal dominant",Gal (MGI:95637)
11,68700000,75500000,11q13.3-q13.4,NA,194633,ZNF126,Zinc finger protein-126 (HZF-2),NA,NA,NA,NA,NA,NA
11,68706673,68751563,11q13.2-q13.3,11q13.3,604374,"MTL5, TESMIN","Metallothionein-like 5, testis-specific",TESMIN,9633,ENSG00000132749,NA,NA,Tesmin (MGI:1340029)
11,68754619,68844409,11q13,11q13.3,600528,CPT1A,"Carnitine palmitoyltransferase I, liver",CPT1A,1374,ENSG00000110090,NA,"CPT deficiency, hepatic, type IA, 255120 (3), Autosomal recessive",Cpt1a (MGI:1098296)
11,68891275,68903831,11q13.2,11q13.3,611834,MRPL21,Mitochondrial ribosomal protein L21,MRPL21,219927,ENSG00000197345,NA,NA,Mrpl21 (MGI:2660674)
11,68903850,68940600,11q13.2-q13.4,11q13.3,600502,"IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S",Immunoglobulin mu binding protein 2,IGHMBP2,3508,ENSG00000132740,NA,"Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3), Autosomal recessive; Neuronopathy, distal hereditary motor, type VI, 604320 (3), Autosomal recessive",Ighmbp2 (MGI:99954)
11,68980020,68980985,11q13.2,11q13.3,607231,"MRGPRD, MRGD","Mas-related G protein-coupled receptor family, member D",MRGPRD,116512,ENSG00000172938,NA,NA,Mrgprd (MGI:3033142)
11,69004374,69013670,11q13.2,11q13.3,607233,"MRGPRF, MRGF, RTA","Mas-related G protein-coupled receptor family, member F",MRGPRF,116535,ENSG00000172935,NA,NA,Mrgprf (MGI:2384823)
11,69048931,69090596,11q13.2,11q13.3,612163,"TPCN2, TPC2, SHEP10",Two-pore segment channel 2,TPCN2,219931,ENSG00000162341,NA,"[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)",Tpcn2 (MGI:2385297)
11,69294154,69297286,11q13.1,11q13.3,605625,MYEOV,Myeloma overexpressed gene,MYEOV,26579,ENSG00000172927,NA,NA,NA
11,69485560,69493542,11q13,11q13.3,617696,"CUPID1, LINC01488, BRCAT8","CCND1 upstream intergenic DNA repair 1, noncoding",LINC01488,101928292,NA,NA,NA,NA
11,69641104,69654473,11q13,11q13.3,168461,"CCND1, PRAD1, BCL1",Cyclin D1,CCND1,595,ENSG00000110092,pseudogene on 11q13,"{Colorectal cancer, susceptibility to}, 114500 (3), Autosomal dominant, Somatic mutation; {Multiple myeloma, susceptibility to}, 254500 (3), Somatic mutation; {von Hippel-Lindau syndrome, modifier of}, 193300 (3), Autosomal dominant",Ccnd1 (MGI:88313)
11,69665562,69675353,11q13,11q13.3,607224,"ORAOV1, TAOS1",Oral cancer overexpressed gene 1,LTO1,220064,ENSG00000149716,NA,NA,LTO1 (MGI:1919534)
11,69698237,69704021,11q13.1,11q13.3,603891,FGF19,Fibroblast growth factor 19,FGF19,9965,ENSG00000162344,NA,NA,Fgf15 (MGI:1096383)
11,69771021,69775340,11q13,11q13.3,164980,"FGF4, HSTF1",Fibroblast growth factor-4 (heparin secretory transforming protein-1; Kaposi sarcoma oncogene),FGF4,2249,ENSG00000075388,coamplified with FGF3 in melanoma,NA,Fgf4 (MGI:95518)
11,69809967,69819415,11q13,11q13.3,164950,"FGF3, INT2",Fibroblast growth factor-3 (oncogene INT2),FGF3,2248,ENSG00000186895,35kb 5' to HST1,"Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3), Autosomal recessive",Fgf3 (MGI:95517)
11,70078539,70189544,11q13,11q13.3,610108,"ANO1, TMEM16A, FLJ10261","Anoctamin 1, calcium activated chloride channel",ANO1,55107,ENSG00000131620,NA,NA,Ano1 (MGI:2142149)
11,70203162,70207401,11q13.3,11q13.3,602457,FADD,FAS-associating protein with death domain,FADD,8772,ENSG00000168040,NA,"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations, 613759 (3), Autosomal recessive",Fadd (MGI:109324)
11,70270686,70385311,11q13.3,11q13.3,611054,"PPFIA1, LIP1","Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha-1",PPFIA1,8500,ENSG00000131626,NA,NA,Ppfia1 (MGI:1924750)
11,70398505,70436583,11q13,11q13.3,164765,"CTTN, EMS1",Cortactin,CTTN,2017,ENSG00000085733,amplified in breast cancer and squamous cell cancer,NA,Cttn (MGI:99695)
11,70467853,71252723,11q13.3-q13.4,11q13.3-q13.4,603290,"SHANK2, CORTBP1, AUTS17",SH3 and multiple ankyrin repeat domains 2,SHANK2,22941,ENSG00000162105,NA,"{Autism susceptibility 17}, 613436 (3)",Shank2 (MGI:2671987)
11,71434410,71448430,11q12-q13,11q13.4,602858,"DHCR7, SLOS",Delta-7-dehydrocholesterol reductase,DHCR7,1717,ENSG00000172893,NA,"Smith-Lemli-Opitz syndrome, 270400 (3), Autosomal recessive",Dhcr7 (MGI:1298378)
11,71453202,71501815,11q13.2,11q13.4,608285,NADSYN1,NAD synthetase 1,NADSYN1,55191,ENSG00000172890,NA,NA,Nadsyn1 (MGI:1926164)
11,71548419,71549606,11q13.5,11q13.4,148021,"KRTAP5-9, KRN1",Keratin associated protein 5-9,KRTAP5-9,3846,ENSG00000254997,NA,NA,NA
11,71787510,71801236,11q13.4,11q13.4,616124,FAM86C1,"Family with sequence similarity 86, member C1",FAM86C1,55199,ENSG00000158483,NA,NA,NA
11,71997943,72002918,11q13.4,11q13.4,604113,IL18BP,Interleukin 18-binding protein,IL18BP,10068,ENSG00000137496,NA,NA,Il18bp (MGI:1333800)
11,72002863,72080692,11q13,11q13.4,164009,NUMA1,Nuclear mitotic apparatus protein-1,NUMA1,4926,ENSG00000137497,fused with RARA in APL,"Leukemia, acute promyelocytic, somatic, 612376 (3)",Numa1 (MGI:2443665)
11,72080330,72110781,11q13.3-q13.4,11q13.4,612414,"LRTOMT, LRTOMT1, LRTOMT2, DFNB63",Leucine-rich transmembrane O-methyltransferase,LRTOMT,220074,ENSG00000184154,NA,"Deafness, autosomal recessive 63, 611451 (3), Autosomal recessive",Tomt (MGI:3769724)
11,72097291,72103296,11q13.4,11q13.4,613510,"LAMTOR1, C11orf59, PDRO","Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 1",LAMTOR1,55004,ENSG00000149357,NA,NA,Lamtor1 (MGI:1913758)
11,72106371,72112775,11q13.4,11q13.4,614717,"ANAPC15, APC15","Anaphase-promoting complex, subunit 15",ANAPC15,25906,ENSG00000110200,NA,NA,NA
11,72135724,72139891,11q13.4,11q13.4,602469,FOLR3,Folate receptor 3,FOLR3,2352,ENSG00000110203,NA,NA,NA
11,72189708,72196322,11q13.3-q13.5,11q13.4,136430,FOLR1,"Folate receptor-1, adult",FOLR1,2348,ENSG00000110195,telomeric of FGF3,"Neurodegeneration due to cerebral folate transport deficiency, 613068 (3), Autosomal recessive",Folr1 (MGI:95568)
11,72216772,72221949,11q13.3-q13.5,11q13.4,136425,FOLR2,Folate receptor-2 (fetal),FOLR2,2350,ENSG00000165457,23kb from FOLR1,NA,Folr2 (MGI:95569)
11,72223860,72239146,11q23,11q13.4,600829,"INPPL1, OPSMD",Inositol polyphosphate phosphatase-like 1,INPPL1,3636,ENSG00000165458,NA,"Opsismodysplasia, 258480 (3), Autosomal recessive",Inppl1 (MGI:1333787)
11,72239076,72244175,11q13.3-q13.4,11q13.4,602753,"PHOX2A, ARIX, CFEOM2",Paired-like (astraless) homeobox 2a,PHOX2A,401,ENSG00000165462,NA,"Fibrosis of extraocular muscles, congenital, 2, 602078 (3), Autosomal recessive",Phox2a (MGI:106633)
11,72285494,72434683,11q13.4,11q13.4,616254,"CLPB, SKD3, MEGCANN, MGCA7",Caseinolytic peptidase B,CLPB,81570,ENSG00000162129,NA,"3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3), Autosomal recessive",Clpb (MGI:1100517)
11,72576139,72674421,11q13.4,11q13.4,602658,PDE2A,Phosphodiesterase 2A,PDE2A,5138,ENSG00000186642,NA,NA,Pde2a (MGI:2446107)
11,72615062,72615129,11q13.4,11q13.4,615017,"MIR139, MIR139-3p",Micro RNA 139,MIR139,406931,ENSG00000272036,NA,NA,NA
11,72685068,72752388,11q13.4,11q13.4,606646,"ARAP1, CENTD2, KIAA0782","ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1",ARAP1,116985,ENSG00000186635,NA,NA,Arap1 (MGI:1916960)
11,72754728,72793704,11q13,11q13.4,617382,STARD10,START domain-containing protein 10,STARD10,10809,ENSG00000214530,NA,NA,Stard10 (MGI:1860093)
11,72836742,73142681,11q13.4,11q13.4,617556,"FCHSD2, KIAA0769, NWK",FCH and double SH3 domains protein 2,FCHSD2,9873,ENSG00000137478,NA,NA,Fchsd2 (MGI:2448475)
11,73200415,73246742,11q13.5,11q13.4,600041,"P2RY2, P2Y2, P2U","Purinergic receptor P2Y, G-protein coupled, 2",P2RY2,5029,ENSG00000175591,NA,NA,P2ry2 (MGI:105107)
11,73264502,73298624,11q13.5,11q13.4,602451,"P2RY6, P2Y6","Pyrimidinergic receptor P2Y, G protein-coupled, 6",P2RY6,5031,ENSG00000171631,NA,NA,P2ry6 (MGI:2673874)
11,73305960,73369387,11q13.4,11q13.4,617043,"ARHGEF17, RHOGEF17, TEM4, KIAA0337",Rho guanine nucleotide exchange factor 17,ARHGEF17,9828,ENSG00000110237,NA,NA,Arhgef17 (MGI:2673002)
11,73376394,73397473,11q13.4,11q13.4,611211,"RELT, TNFRSF19L, AI3C",Receptor expressed in lymphoid tissues,RELT,84957,ENSG00000054967,NA,"Amelogenesis imperfecta, type IIIC, 618386 (3), Autosomal recessive",Relt (MGI:2443373)
11,73400486,73598111,11q13.4,11q13.4,616316,"RAM168A, TCRP1, KIAA0280","Family with sequence similarity 168, member A",FAM168A,23201,ENSG00000054965,NA,NA,Fam168a (MGI:2442372)
11,73646580,73662818,11q13-q14.1,11q13.4,607651,"PLEKHB1, PHR1, KPL1","Pleckstrin homology domain-containing protein, family B, member 1",PLEKHB1,58473,ENSG00000021300,NA,NA,Plekhb1 (MGI:1351469)
11,73675637,73761073,11q13.4,11q13.4,179513,"RAB6A, RAB6",Oncogene RAB6,RAB6A,5870,ENSG00000175582,previously assigned to 2q14-q21,NA,Rab6a (MGI:894313)
11,73787871,73865132,11q13.2,11q13.4,611853,MRPL48,Mitochondrial ribosomal protein L48,MRPL48,51642,ENSG00000175581,pseudogene on 6,NA,Mrpl48 (MGI:1289321)
11,73870257,73876900,11q13.4,11q13.4,608016,"CHCHD8, E2IG2",Coiled-coil-helix-coiled-coil-helix domain containing 8,COA4,51287,ENSG00000181924,NA,NA,Coa4 (MGI:1915435)
11,73950318,73970286,11q13.3,11q13.4,610263,"DNAJB13, TSARG6, CILD34","DNAJ/HSP40 homolog, subfamily B, member 13",DNAJB13,374407,ENSG00000187726,NA,"Ciliary dyskinesia, primary, 34, 617091 (3), Autosomal recessive",Dnajb13 (MGI:1916637)
11,73974670,73982871,11q13,11q13.4,601693,"UCP2, BMIQ4",Uncoupling protein-2,UCP2,7351,ENSG00000175567,NA,"{Obesity, susceptibility to, BMIQ4}, 607447 (3)",Ucp2 (MGI:109354)
11,74000276,74009236,11q13,11q13.4,602044,UCP3,Uncoupling protein-3,UCP3,7352,ENSG00000175564,NA,"{Obesity, severe, and type II diabetes}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Ucp3 (MGI:1099787)
11,74012577,74171209,11q13.4,11q13.4,615944,"C2CD3, OFD14",C2 calcium-dependent domain-containing protein 3,C2CD3,26005,ENSG00000168014,NA,"Orofaciodigital syndrome XIV, 615948 (3), Autosomal recessive",C2cd3 (MGI:2142166)
11,74171089,74254702,11q13.4,11q13.4,611117,PPME1,Protein phosphatase methylesterase 1,PPME1,51400,ENSG00000214517,NA,NA,Ppme1 (MGI:1919840)
11,74259922,74311675,11q12,11q13.4,608987,P4HA3,"Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 3",P4HA3,283208,ENSG00000149380,NA,NA,P4ha3 (MGI:2444049)
11,74330315,74398750,11q13.4,11q13.4,611610,PGM2L1,Phosphoglucomutase 2-like 1,PGM2L1,283209,ENSG00000165434,NA,NA,Pgm2l1 (MGI:1918224)
11,74454840,74467728,11q13-q14,11q13.4,604433,"KCNE3, HOKPP, HYPP","Potassium voltage-gated channel, ISK-related subfamily, member 3",KCNE3,10008,ENSG00000175538,mutation identified in 1 BRGDA6 family,"?Brugada syndrome 6, 613119 (3)",Kcne3 (MGI:1891124)
11,74490518,74493723,11q13.4,11q13.4,617659,LIPT2,Lipoyl(octanoyl) transferase 2,LIPT2,387787,ENSG00000175536,NA,"Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3), Autosomal recessive",Lipt2 (MGI:1914414)
11,74696427,74731425,11q13.4,11q13.4,613127,"CHRDL2, CHL2, BNF1",Chordin-like 2,CHRDL2,25884,ENSG00000054938,NA,NA,Chrdl2 (MGI:1916371)
11,74840229,74949186,11q13.3,11q13.4,609788,XRRA1,X-ray radiation resistance-associated 1,XRRA1,143570,ENSG00000166435,NA,NA,Xrra1 (MGI:2181647)
11,74988643,75010906,11q13.5,11q13.4,604617,"NEU3, SIAL3",Neuraminidase 3 (membrane sialidase; sialidase 3),NEU3,10825,ENSG00000162139,NA,NA,Neu3 (MGI:1355305)
11,75151106,75206548,Chr.11,11q13.4,604988,"SLC21A9, OATPB","Solute carrier family 21 (organic anion transporter), member 9",SLCO2B1,11309,ENSG00000137491,NA,NA,Slco2b1 (MGI:1351872)
11,75260121,75351661,11q13,11q13.4,107940,ARRB1,"Arrestin, beta 1",ARRB1,408,ENSG00000137486,NA,NA,Arrb1 (MGI:99473)
11,75335091,75335185,11q13,11q13.4,613755,"MIR326, MIRN326",Micro RNA 326,MIR326,442900,ENSG00000199090,NA,NA,NA
11,75399490,75422301,11q13.3-q13.5,11q13.4,600454,RPS3,Ribosomal protein S3,RPS3,6188,ENSG00000149273,NA,NA,Rps3 (MGI:1350917)
11,75400390,75400537,11q13.3-q13.5,11q13.4,600455,RNU15A,"RNA, U15a small nucleolar",SNORD15A,6079,ENSG00000206941,processed from intron of RPS3,NA,NA
11,75434639,75525940,11q13.4-q13.5,11q13.4-q13.5,609632,"GDPD5, GDE2, PP1665",Glycerophosphodiester phosphodiesterase domain-containing protein 3,GDPD5,81544,ENSG00000158555,NA,NA,Gdpd5 (MGI:2686926)
11,75500000,77400000,11q13.5,NA,613064,ATOD7,"Dermatitis, atopic, 7",NA,100310755,NA,associated with rs7927894,"{Dermatitis, atopic, susceptibility to, 7}, 613064 (2)",NA
11,75562252,75572810,11q13.5,11q13.5,600943,"SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10","Serpin peptidase inhibitor, clade H, member 1",SERPINH1,871,ENSG00000149257,NA,"Osteogenesis imperfecta, type X, 613848 (3), Autosomal recessive; {Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)",Serpinh1 (MGI:88283)
11,75586913,75668723,11q13.5,11q13.5,601783,"MAP6, MTAP6, STOP, KIAA1878",Microtubule-associated protein 6,MAP6,4135,ENSG00000171533,NA,NA,Map6 (MGI:1201690)
11,75717818,75732952,11q13.5,11q13.5,610270,"MOGAT2, MGAT2",Monoacylglycerol O-acyltransferase 2,MOGAT2,80168,ENSG00000166391,NA,NA,Mogat2 (MGI:2663253)
11,75768732,75801535,11q13.5,11q13.5,606983,DGAT2,Diacylglycerol O-acyltransferase 2,DGAT2,84649,ENSG00000062282,NA,NA,Dgat2 (MGI:1915050)
11,75815188,76144231,11q13,11q13.5,602493,UVRAG,UV radiation resistance-associated gene,UVRAG,7405,ENSG00000198382,NA,NA,Uvrag (MGI:1925860)
11,76186324,76210841,11q13.5,11q13.5,603699,WNT11,"Wingless-type MMTV integration site family, member 11",WNT11,7481,ENSG00000085741,NA,NA,Wnt11 (MGI:101948)
11,76349955,76381131,11q13.5,11q13.5,607374,PRKRIR,"PRKR inhibitor, repressor of",THAP12,5612,ENSG00000137492,NA,NA,Thap12 (MGI:1920231)
11,76444927,76553030,11q13.4-q13.5,11q13.5,608574,"EMSY, C11orf30",EMSY gene,EMSY,56946,ENSG00000158636,100kb from GARP,NA,Emsy (MGI:1924203)
11,76657523,76670746,11q13.5,11q13.5,137207,"LRRC32, GARP, D11S833E",Leucine rich repeat containing 32,LRRC32,2615,ENSG00000137507,NA,NA,Lrrc32 (MGI:93882)
11,76782312,76798153,11q13.5,11q13.5,608015,"TSKU, E2IG4, TSK",Tsukushin,TSKU,25987,ENSG00000182704,NA,NA,Tsku (MGI:2443855)
11,76860887,77026796,11q13.5,11q13.5,617036,"ACER3, APHC, PHCA, PLDECO",Alkaline ceramidase 3,ACER3,55331,ENSG00000078124,mutation identified in 1 PLDECO family,"?Leukodystrophy, progressive, early childhood-onset, 617762 (3), Autosomal recessive",Acer3 (MGI:1913440)
11,77034397,77041972,11q14,11q13.5,615315,B3GNT6,"Beta-1,3-N-acetylglucosaminyltransferase 6",B3GNT6,192134,ENSG00000198488,NA,NA,B3gnt6 (MGI:3039603)
11,77066970,77126154,11q14,11q13.5,602537,"CAPN5, HTRA3, VRNI",Calpain 5,CAPN5,726,ENSG00000149260,NA,"Vitreoretinopathy, neovascular inflammatory, 193235 (3), Autosomal dominant",Capn5 (MGI:1100859)
11,77102839,77103330,11q13.4-q14.1,11q13.5,164340,OMP,Olfactory marker protein,OMP,4975,ENSG00000254550,NA,NA,Omp (MGI:97436)
11,77128191,77215240,11q13.5,11q13.5,276903,"MYO7A, USH1B, DFNB2, DFNA11",Myosin VIIA,MYO7A,4647,ENSG00000137474,NA,"Deafness, autosomal dominant 11, 601317 (3), Autosomal dominant; Deafness, autosomal recessive 2, 600060 (3), Autosomal recessive; Usher syndrome, type 1B, 276900 (3), Autosomal recessive",Myo7a (MGI:104510)
11,77322014,77514956,11q13-q14,11q13.5-q14.1,602590,"PAK1, IDDMSSD",p21/CDC42/RAC1-activated kinase 1,PAK1,5058,ENSG00000149269,NA,"Intellectual developmental disorder with macrocephaly, seizures, and speech delay, 618158 (3), Autosomal dominant",Pak1 (MGI:1339975)
11,77400000,93000000,11q14,NA,610888,GCRG224,Gastric cancer-related gene 224,NA,360219,NA,NA,NA,NA
11,77400000,110600000,11q14-q22,NA,612017,IHPS3,"Pyloric stenosis, infantile hypertrophic, 3",NA,100188876,NA,max lod at rs541821,"Pyloric stenosis, infantile hypertrophic, 3, 612017 (2)",NA
11,77400000,97400000,11q14-q21,NA,603342,SCZD2,"Schizophrenia susceptibility locus, chromosome 11-related",SCZD2,6378,NA,NA,"{?Schizophrenia}, 181500 (2), Autosomal dominant",NA
11,77400000,93000000,11q14,NA,607279,SLEH1,"Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1",SLEH1,170682,NA,NA,"{Systemic lupus erythematosus with hemolytic anemia}, 607279 (2)",NA
11,77589634,77610355,11q14,11q14.1,609914,"AQP11, AQPX1",Aquaporin 11,AQP11,282679,ENSG00000178301,NA,NA,Aqp11 (MGI:1913583)
11,77614529,77637805,11q13.5-q14.1,11q14.1,602158,"CLNS1A, CLNS1B","Chloride channel, nucleotide-sensitive, 1A",CLNS1A,1207,ENSG00000074201,CLNS1B on 6p12.1-q13 = pseudogene?,NA,Clns1a (MGI:109638)
11,77660008,77872231,11q13,11q14.1,608522,"HBXAP, RSF1",Hepatitis B virus X-associated protein,RSF1,51773,ENSG00000048649,NA,NA,Rsf1 (MGI:2682305)
11,77874417,77994669,11q14.1,11q14.1,611348,"INTS4, INT4",Integrator complex subunit 4,INTS4,92105,ENSG00000149262,NA,NA,Ints4 (MGI:1917164)
11,78063860,78068350,11q13.5,11q14.1,601926,THRSP,"Thyroid hormone responsive SPOT14, rat, homolog of",THRSP,7069,ENSG00000151365,NA,NA,Thrsp (MGI:109126)
11,78068296,78079861,11q14.1,11q14.1,603845,NDUFC2,NADH-ubiquinone oxidoreductase subunit C2,NDUFC2,4718,ENSG00000151366,NA,NA,Ndufc2 (MGI:1344370)
11,78100941,78139652,11pter-p15.5,11q14.1,608103,"ALG8, CDG1H, PCLD3","Alg8, S. cerevisiae, homolog of",ALG8,79053,ENSG00000159063,NA,"Congenital disorder of glycosylation, type Ih, 608104 (3), Autosomal recessive; Polycystic liver disease 3 with or without kidney cysts, 617874 (3), Autosomal dominant",Alg8 (MGI:2141959)
11,78215289,78417819,11q13.4-q13.5,11q14.1,606203,GAB2,GRB2-associated binding protein 2,GAB2,9846,ENSG00000033327,NA,NA,Gab2 (MGI:1333854)
11,78435960,78574863,11q14.1,11q14.1,612803,"NARS2, COXPD24, DFNB94",Asparaginyl-tRNA synthetase 2,NARS2,79731,ENSG00000137513,mutation identified in 1 DFNB94 family,"Combined oxidative phosphorylation deficiency 24, 616239 (3), Autosomal recessive; ?Deafness, autosomal recessive 94, 618434 (3), Autosomal recessive",Nars2 (MGI:2142075)
11,78652828,79441029,11q14.1,11q14.1,610084,"TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5",Teneurin transmembrane protein 4,TENM4,26011,ENSG00000149256,NA,"Essential tremor, hereditary, 5, 616736 (3), Autosomal dominant",Tenm4 (MGI:2447063)
11,82822935,82901739,11q14,11q14.1,176785,"PRCP, PCP",Prolylcarboxypeptidase (angiotensinase C),PRCP,5547,ENSG00000137509,NA,NA,Prcp (MGI:1919711)
11,82901734,82934658,11q14.1,11q14.1,618045,"DDIAS, NOXIN, C11orf82",DNA damage-induced apoptosis suppressor,DDIAS,220042,ENSG00000165490,NA,NA,Ddias (MGI:1921291)
11,82973132,83071896,11q12-q14,11q14.1,605693,RAB30,Ras-associated protein RAB30,RAB30,27314,ENSG00000137502,NA,NA,Rab30 (MGI:1923235)
11,83157094,83187450,11q14.1,11q14.1,608876,"PCF11, KIAA0824","PCF11, yeast, homolog of",PCF11,51585,ENSG00000165494,NA,NA,Pcf11 (MGI:1919579)
11,83455008,85628534,11q21,11q14.1,603583,DLG2,"Discs large, Drosophila, homolog of, 2 (channel-associated protein of synapses, 110kD)",DLG2,1740,ENSG00000150672,NA,NA,Dlg2 (MGI:1344351)
11,85628572,85636539,11q14.1,11q14.1,615533,"TMEM126B, MC1DN29",Transmembrane protein 126B,TMEM126B,55863,ENSG00000171204,NA,"Mitochondrial complex I deficiency, nuclear type 29, 618250 (3), Autosomal recessive",Tmem126b (MGI:1915722)
11,85647918,85656552,11q14.1-q21,11q14.1,612988,"TMEM126A, OPA7",Transmembrane protein 126A,TMEM126A,84233,ENSG00000171202,NA,"Optic atrophy 7, 612989 (3), Autosomal recessive",Tmem126a (MGI:1913521)
11,85657563,85665147,11q14.1,11q14.1,606444,"CREBZF, ZF",CREB/ATF bZIP transcription factor,CREBZF,58487,ENSG00000137504,NA,NA,Crebzf (MGI:2675296)
11,85694220,85811181,11q14,11q14.1,612880,"SYTL2, SLP2, SLP2A, EXO4, KIAA1597",Synaptotagmin-like 2,SYTL2,54843,ENSG00000137501,NA,NA,Sytl2 (MGI:1933366)
11,85957174,86069859,11q14,11q14.2,603025,"PICALM, CALM, CLTH, LAP",Phosphatidylinositol-binding clathrin assembly protein,PICALM,8301,ENSG00000073921,fuses with AF10 in t(10;11),"Leukemia, acute myeloid, somatic, 601626 (3)",Picalm (MGI:2385902)
11,86244383,86285419,11q14.2-q22.3,11q14.2,605984,"EED, WAIT1, COGIS","Embryonic ectoderm development protein, mouse, homolog of",EED,8726,ENSG00000074266,NA,"Cohen-Gibson syndrome, 617561 (3), Autosomal dominant",Eed (MGI:95286)
11,86302226,86345942,11q14.2,11q14.2,614908,"HIKESHI, C11orf73, HLD13",Hikeshi,HIKESHI,51501,ENSG00000149196,NA,"Leukodystrophy, hypomyelinating, 13, 616881 (3), Autosomal recessive",Hikeshi (MGI:96738)
11,86441107,86674745,11cen-q22.3,11q14.2,604626,ME3,Malic enzyme 3,ME3,10873,ENSG00000151376,NA,NA,Me3 (MGI:1916679)
11,86791070,86952909,11q14.1,11q14.2,618376,PRSS23,"Protease, serine, 23",PRSS23,11098,ENSG00000150687,NA,NA,Prss23 (MGI:1923703)
11,86945678,86955394,11q14-q21,11q14.2,604579,"FZD4, EVR1","Frizzled, Drosophila, homolog of, 4",FZD4,8322,ENSG00000174804,NA,"Exudative vitreoretinopathy 1, 133780 (3), Autosomal dominant; Retinopathy of prematurity, 133780 (3), Autosomal dominant",Fzd4 (MGI:108520)
11,87037843,87328833,11q14.2,11q14.2,616360,"TMEM135, PMP52",Transmembrane protein 135,TMEM135,65084,ENSG00000166575,NA,NA,Tmem135 (MGI:1920009)
11,87809489,88175503,11q13.5-q22.3,11q14.2,606281,RAB38,"Ras-family, member RAB38",RAB38,23682,ENSG00000123892,NA,NA,Rab38 (MGI:1919683)
11,88293591,88337735,11q14.1-q14.3,11q14.2,602365,"CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD",Cathepsin C,CTSC,1075,ENSG00000109861,NA,"Haim-Munk syndrome, 245010 (3), Autosomal recessive; Papillon-Lefevre syndrome, 245000 (3), Autosomal recessive; Periodontitis 1, juvenile, 170650 (3), Autosomal recessive",Ctsc (MGI:109553)
11,88504575,89065962,11q14.2-q14.3,11q14.2-q14.3,604102,"GRM5, MGLUR5","Glutamate receptor, metabotropic, 5",GRM5,2915,ENSG00000168959,NA,NA,Grm5 (MGI:1351342)
11,89177564,89295758,11q14-q21,11q14.3,606933,"TYR, SHEP3, CMM8, OCA1A, ATN",Tyrosinase,TYR,7299,ENSG00000077498,NA,"Albinism, oculocutaneous, type IA, 203100 (3), Autosomal recessive; Albinism, oculocutaneous, type IB, 606952 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3), Autosomal dominant; [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3), Autosomal dominant; [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3), Autosomal dominant; Waardenburg syndrome/albinism, digenic, 103470 (3), Autosomal dominant",Tyr (MGI:98880)
11,89324352,89589556,11q14.2-q21,11q14.3,605261,"NOX4, RENOX",NADPH oxidase 4,NOX4,50507,ENSG00000086991,NA,NA,Nox4 (MGI:1354184)
11,89637579,89698717,11p13-p11.1,11q14.3,609020,"FOLH1B, PSMAL, GCP3",Folate hydrolase 1B,FOLH1B,219595,NA,NA,NA,NA
11,89766435,89808574,11p11.12-q12,11q14.3,606124,RNF18,RING finger protein-18,TRIM49,57093,ENSG00000168930,NA,NA,NA
11,90085949,90087130,11q14.3,11q14.3,613696,"UBTFL1, HMGPI",Upstream binding transcription factor (RNA polymerase I)-like 1,UBTFL1,642623,ENSG00000255009,NA,NA,NA
11,90131692,90193576,11q14.3-q21,11q14.3,611636,NAALAD2,N-acetylated alpha-linked acidic dipeptidase 2,NAALAD2,10003,ENSG00000077616,NA,NA,Naalad2 (MGI:1919810)
11,90200428,90223363,11q14.3,11q14.3,604353,"CHRODC1, CHP1",Cysteine- and histidine-rich domain-containing protein 1,CHORDC1,26973,ENSG00000110172,NA,NA,Chordc1 (MGI:1914167)
11,92224635,92896472,11q14.3-q21,11q14.3,612483,FAT3,"FAT tumor suppressor, Drosophila, homolog of, 3",FAT3,120114,ENSG00000165323,NA,NA,Fat3 (MGI:2444314)
11,92969622,92986240,11q21-q22,11q14.3,600804,MTNR1B,Melatonin receptor 1B,MTNR1B,4544,ENSG00000134640,NA,"{Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant",Mtnr1b (MGI:2181726)
11,93000000,110600000,11q21-q22,NA,613233,FGQTL3,Fasting plasma glucose level QTL 3,NA,100379217,NA,associated with rs10830963,"[Fasting plasma glucose level QTL 3], 613233 (2)",NA
11,93144173,93386037,11q14.3,11q21,613760,"SLC36A4, PAT4","Solute carrier family 36, member 4",SLC36A4,120103,ENSG00000180773,NA,NA,Slc36a4 (MGI:2442595)
11,93329078,93438469,11q21,11q21,617148,"DEUP1, CCDC67",Deuterosome assembly protein 1,DEUP1,159989,ENSG00000165325,NA,NA,Deup1 (MGI:2443026)
11,93478471,93553978,11q21,11q21,609477,"C11orf75, FN5","FN5, pufferfish, homolog of",SMCO4,56935,ENSG00000166002,NA,NA,NA
11,93661681,93730380,11q21,11q21,617728,"CEP295, KIAA1731","Centrosomal protein, 295kD",CEP295,85459,ENSG00000166004,NA,NA,Cep295 (MGI:2442521)
11,93730193,93741536,11q21,11q21,612823,"TAF1D, RAFI41, JOSD3",TATA box-binding protein-associated factor 1D,TAF1D,79101,ENSG00000166012,NA,NA,Taf1d (MGI:1922566)
11,93741593,93764748,11q21,11q21,615810,"C11orf54, PTOD012",Chromosome 11 open reading frame 54,C11orf54,28970,ENSG00000182919,NA,NA,4931406C07Rik (MGI:1918234)
11,93784281,93814962,11q21,11q21,603810,"MED17, CRSP6, CRSP77, TRAP80, DRIP80",Mediator complex subunit 17,MED17,9440,ENSG00000042429,NA,"Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3), Autosomal recessive",Med17 (MGI:2182585)
11,94021353,94114207,11q21,11q21,618455,"HEPHL1, ZP, HJDD",Hephaestin-like protein 1,HEPHL1,341208,ENSG00000181333,mutation identified in 1 HJDD patient,"?Abnormal hair, joint laxity, and developmental delay, 261990 (3)",Hephl1 (MGI:2685355)
11,94128840,94185595,11q21,11q21,608420,"PANX1, PX1",Pannexin 1,PANX1,24145,ENSG00000110218,NA,NA,Panx1 (MGI:1860055)
11,94305636,94307691,11q21,11q21,615737,FOLR4,Folate receptor 4,IZUMO1R,390243,ENSG00000183560,NA,NA,Izumo1r (MGI:1929185)
11,94377315,94401418,11q21,11q21,605569,"GPR83, GIR, GPR72",G protein-coupled receptor 83,GPR83,10888,ENSG00000123901,NA,NA,Gpr83 (MGI:95712)
11,94415569,94512700,11q21,11q21,600814,"MRE11A, MRE11, ATLD","Meiotic recombination 11, S. cerevisiae, homolog A of",MRE11,4361,ENSG00000020922,NA,"Ataxia-telangiectasia-like disorder 1, 604391 (3), Autosomal recessive",Mre11a (MGI:1100512)
11,94543850,94549897,11q21,11q21,104230,"FUT4, FCT3A, CD15","Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)",FUT4,2526,ENSG00000196371,NA,NA,Fut4 (MGI:95594)
11,94567367,94621420,11q12,11q21,610315,"PIWIL4, HIWI2, MIWI2",PIWI-like 4,PIWIL4,143689,ENSG00000134627,NA,NA,Piwil4 (MGI:3041167)
11,94706417,94876747,11q21,11q21,614657,"AMOTL1, JEAP",Angiomotin-like 1,AMOTL1,154810,ENSG00000166025,NA,NA,Amotl1 (MGI:1922973)
11,94973708,94999518,11q21,11q21,609766,"KDM4D, JMJD2D",Lysine demethylase 4D,KDM4D,55693,ENSG00000186280,NA,NA,Kdm4d (MGI:3606484)
11,95025257,95027595,11q21,11q21,616581,"KDM4E, JMJD2E",Lysine-specific demethylase 4E,KDM4E,390245,ENSG00000235268,NA,NA,NA
11,95066876,95071226,11q22,11q21,603269,"SRSF8, SFRS2B, SRp46","Splicing factor, arginine/serine-rich, 8",SRSF8,10929,ENSG00000263465,NA,NA,NA
11,95165512,95232535,11q21,11q21,607768,SEST3,Sestrin 3,SESN3,143686,ENSG00000149212,NA,NA,Sesn3 (MGI:1922997)
11,95790460,95832692,11q21,11q21,607951,"CEP57, PIG8, TSP57, KIAA0092, MVA2",Centrosomal protein 57kD,CEP57,9702,ENSG00000166037,NA,"Mosaic variegated aneuploidy syndrome 2, 614114 (3), Autosomal recessive",Cep57 (MGI:1915551)
11,95832879,95924206,11q22,11q21,603557,"MTMR2, CMT4B1",Myotubularin-related protein 2,MTMR2,8898,ENSG00000087053,NA,"Charcot-Marie-Tooth disease, type 4B1, 601382 (3), Autosomal recessive",Mtmr2 (MGI:1924366)
11,95976597,96343307,11q21,11q21,607537,"MAML2, MAM3",Mastermind-like 2,MAML2,84441,ENSG00000184384,t(11;19),Mucoepidermoid salivary gland carcinoma (3),NA
11,96341437,96341525,11q21,11q21,615372,MIR1260B,Micro RNA 1260B,MIR1260B,100422991,ENSG00000266192,NA,NA,NA
11,96390012,96393560,11q21,11q21,603211,"JRKL, HHMJG","Jerky, mouse, homolog-like",JRKL,8690,ENSG00000183340,NA,NA,Jrkl (MGI:1924782)
11,97400000,135086622,11q22-qter,NA,105580,ANC,Anal canal carcinoma,NA,8066,NA,3p22 also deleted,"?Anal canal carcinoma, 105580 (2), Autosomal dominant",NA
11,99020903,100358884,11q21-q22.2,11q22.1,607219,"CNTN5, NB2",Contactin 5,CNTN5,53942,ENSG00000149972,NA,NA,Cntn5 (MGI:3042287)
11,100687287,100993940,11q22.1,11q22.1,615936,"ARHGAP42, GRAF3",Rho GTPase-activating protein 42,ARHGAP42,143872,ENSG00000165895,NA,NA,Arhgap42 (MGI:1918794)
11,101029623,101130680,11q22,11q22.1,607311,PGR,Progesterone receptor,PGR,5241,ENSG00000082175,11q13 = earlier regionalization,"?Progesterone resistance, 264080 (2), Autosomal recessive",Pgr (MGI:97567)
11,101451469,101584006,11q21-q22,11q22.1,603652,"TRPC6, TRP6, FSGS2",Transient receptor potential channel-6,TRPC6,7225,ENSG00000137672,NA,"Glomerulosclerosis, focal segmental, 2, 603965 (3), Autosomal dominant",Trpc6 (MGI:109523)
11,101890673,101917049,11q22,11q22.1,607666,ANGPTL5,Angiopoietin-like 5,ANGPTL5,253935,ENSG00000187151,NA,NA,NA
11,101915009,102001061,11q22.1,11q22.1,614634,KIAA1377,KIAA1377 gene,CEP126,57562,ENSG00000110318,NA,NA,Cep126 (MGI:2680221)
11,102047408,102084559,11q22.11,11q22.1,618058,"CFAP300, C11orf70, CILD38",Cilia- and flagella-associated protein 300,CFAP300,85016,ENSG00000137691,NA,"Ciliary dyskinesia, primary, 38, 618063 (3), Autosomal recessive",Cfap300 (MGI:3045346)
11,102109956,102233423,11q13,11q22.1,606608,"YAP1, COB1","Yes-associated protein 1, 65kD",YAP1,10413,ENSG00000137693,NA,"Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3), Autosomal dominant",Yap1 (MGI:103262)
11,102317372,102339402,11q22-q23,11q22.2,601721,"API2, HAIP1",Apoptosis inhibitor-2,BIRC3,330,ENSG00000023445,fused with MALT1 in MALT lymphoma,NA,Birc3 (MGI:1197007)
11,102347181,102378669,11q22-q23,11q22.2,601712,"API1, HIAP2",Apoptosis inhibitor-1,BIRC2,329,ENSG00000110330,NA,NA,Birc2 (MGI:1197009)
11,102396331,102452764,11q22.1,11q22.2,606356,"TMEM123, PORIMIN",Transmembrane protein 123,TMEM123,114908,ENSG00000152558,NA,NA,Tmem123 (MGI:1919179)
11,102520507,102530746,11q21-q22,11q22.2,178990,MMP7,"Matrix metalloproteinase 7 (matrilysin, uterine)",MMP7,4316,ENSG00000137673,NA,NA,Mmp7 (MGI:103189)
11,102576831,102625331,11q22.3-q23,11q22.2,604629,"MMP20, AI2A2",Matrix metalloproteinase-20 (enamelysin),MMP20,9313,ENSG00000137674,NA,"Amelogenesis imperfecta, type IIA2, 612529 (3), Autosomal recessive",Mmp20 (MGI:1353466)
11,102690942,102705784,11q22.2,11q22.2,618101,MMP27,Matrix metalloproteinase 27,MMP27,64066,ENSG00000137675,NA,NA,Mmp27 (MGI:3039232)
11,102711795,102724966,11q21-q22,11q22.2,120355,"MMP8, CLG1",Matrix metalloproteinase 8 (neutrophil collagenase),MMP8,4317,ENSG00000118113,NA,NA,Mmp8 (MGI:1202395)
11,102770501,102780627,11q22.3-q23,11q22.2,185260,"MMP10, STMY2",Matrix metalloproteinase 10 (stromelysin 2),MMP10,4319,ENSG00000166670,NA,NA,Mmp10 (MGI:97007)
11,102789918,102798159,11q22-q23,11q22.2,120353,"MMP1, CLG",Matrix metalloproteinase 1 (interstitial collagenase),MMP1,4312,ENSG00000196611,NA,"COPD, rate of decline of lung function in, 606963 (3); {Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3), Autosomal recessive",Mmp1a (MGI:1933846)
11,102835800,102843608,11q23,11q22.2,185250,"MMP3, STMY1, CHDS6","Matrix metalloproteinase 3 (stromelysin 1, progelatinase)",MMP3,4314,ENSG00000149968,NA,"{Coronary heart disease, susceptibility to, 6}, 614466 (3)",Mmp3 (MGI:97010)
11,102862735,102874981,11q22.2-q22.3,11q22.2,601046,MMP12,Matrix metalloproteinase 12 (macrophage elastase),MMP12,4321,ENSG00000262406,NA,NA,Mmp12 (MGI:97005)
11,102942994,102955731,11q22.3,11q22.2,600108,"MMP13, CLG3, MANDP1, MDST",Matrix metalloproteinase 13 (collagenase 3),MMP13,4322,ENSG00000137745,NA,"Metaphyseal anadysplasia 1, 602111 (3), Autosomal dominant; Metaphyseal dysplasia, Spahr type, 250400 (3), Autosomal recessive; Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3), Autosomal dominant",Mmp13 (MGI:1340026)
11,103050685,103092214,11q22.3,11q22.3,616522,"DCUN1D5, SCCRO5",DCN1 domain-containing protein 5,DCUN1D5,84259,ENSG00000137692,NA,NA,Dcun1d5 (MGI:1924113)
11,103109425,103479862,11q22.3,11q22.3,603297,"DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3","Dynein, cytoplasmic-2, heavy chain-1",DYNC2H1,79659,ENSG00000187240,1 patient showed heterozygous NEK2 and DYNC2H1 mutations,"Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3), Autosomal recessive, Digenic recessive",Dync2h1 (MGI:107736)
11,103907188,104164146,11q22.3,11q22.3,609673,"PDGFD, SCDGFB, IEGF",Platelet-derived growth factor D,PDGFD,80310,ENSG00000170962,NA,NA,Pdgfd (MGI:1919035)
11,104885717,104898669,11q22.3,11q22.3,608633,"CASP12, CASP12P1","Caspase 12, apoptosis-related cysteine protease",CASP12,100506742,ENSG00000204403,NA,"{Sepsis, susceptibility to} (3)",NA
11,104942865,104968595,11q22.2-q22.3,11q22.3,602664,CASP4,"Caspase 4, apoptosis-related cysteine protease",CASP4,837,ENSG00000196954,NA,NA,Casp4 (MGI:107700)
11,104994234,105023901,11q22.2-q22.3,11q22.3,602665,CASP5,"Caspase 5, apoptosis-related cysteine protease",CASP5,838,ENSG00000137757,NA,NA,NA
11,105025442,105035590,11q22.2-q22.3,11q22.3,147678,"CASP1, IL1BC","Caspase 1, apoptosis-related cysteine protease (interleukin-1, beta convertase)",CASP1,834,ENSG00000137752,NA,NA,Casp1 (MGI:96544)
11,105040217,105045415,11q22,11q22.3,615680,"CARD16, COP1",Caspase recruitment domain-containing protein 16,CARD16,114769,ENSG00000204397,NA,NA,NA
11,105080452,105101491,11q22,11q22.3,609490,INCA,Inhibitory caspase recruitment domain protein,CARD17,440068,ENSG00000255221,NA,NA,NA
11,105137713,105139768,11q22.3,11q22.3,605354,"CARD18, ICEBERG",Caspase recruitment domain-containing protein 18,CARD18,59082,ENSG00000255501,NA,NA,NA
11,105609539,105982091,11q22-q23,11q22.3,138246,"GRIA4, GLUR4, NEDSGA","Glutamate receptor, ionotropic, AMPA 4",GRIA4,2893,ENSG00000152578,NA,"Neurodevelopmental disorder with or without seizures and gait abnormalities, 617864 (3), Autosomal dominant",Gria4 (MGI:95811)
11,106077604,106098694,11q22.3,11q22.3,607756,AASDHPPT,Alpha-aminoadipate semialdehyde dehydrogenase-phosphopantetheinyl transferase,AASDHPPT,60496,ENSG00000149313,NA,NA,Aasdhppt (MGI:1914868)
11,106674018,107018475,11q21-q22,11q22.3,601244,"GUCY1A2, GUC1A2","Guanylate cyclase 1, soluble, alpha 2",GUCY1A2,2977,ENSG00000152402,NA,NA,Gucy1a2 (MGI:2660877)
11,107502725,107565739,11q22.3,11q22.3,613306,"ALKBH8, ABH8","AlkB, E. coli, homolog of, 8",ALKBH8,91801,ENSG00000137760,NA,NA,Alkbh8 (MGI:1914917)
11,107591008,107666778,11q22.3,11q22.3,615456,ELMOD1,ELMO/CED12 domain-containing protein 1,ELMOD1,55531,ENSG00000110675,NA,NA,Elmod1 (MGI:3583900)
11,107707377,107712055,11q22-q23,11q22.3,602203,SLN,Sarcolipin,SLN,6588,ENSG00000170290,NA,NA,NA
11,108008732,108107765,11q22-q23,11q22.3,601741,"CUL5, VACM1",Cullin-5 (vasopressin-activated calcium-mobilizing receptor-1),CUL5,8065,ENSG00000166266,NA,NA,Cul5 (MGI:1922967)
11,108116704,108148821,11q22.3-q23.1,11q22.3,607809,ACAT1,Acetyl-Coenzyme A acetyltransferase-1 (acetoacetyl Coenzyme A thiolase),ACAT1,38,ENSG00000075239,cluster: cen-STMY2-CLG-STMY1-ter,"Alpha-methylacetoacetic aciduria, 203750 (3), Autosomal recessive",Acat1 (MGI:87870)
11,108155279,108222637,11q22.3,11q22.3,601448,"NPAT, E14","Nuclear protein, ataxia-telangiectasia locus",NPAT,4863,ENSG00000149308,NA,NA,Npat (MGI:107605)
11,108222483,108369101,11q22.3,11q22.3,607585,"ATM, ATA, AT1","Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)",ATM,472,ENSG00000149311,NA,"Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; Lymphoma, B-cell non-Hodgkin, somatic (3); Lymphoma, mantle cell, somatic (3); T-cell prolymphocytic leukemia, somatic (3)",Atm (MGI:107202)
11,108472115,108498383,11q22.3,11q22.3,618503,"POGLUT3, KDELC2",Protein O-glucosyltransferase 3,POGLUT3,143888,ENSG00000178202,NA,NA,NA
11,108505430,108607513,11q22.3,11q22.3,612878,"EXPH5, SLAC2B, KIAA0624",Exophilin 5,EXPH5,23086,ENSG00000110723,NA,"Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3), Autosomal recessive",Exph5 (MGI:2443248)
11,108665068,108940926,11q22-q23,11q22.3,601235,DDX10,DEAD/H box-10 (RNA helicase),DDX10,1662,ENSG00000178105,400kb telomeric to ATM; pseudogene on 9q21-q22; fused with NUP98 in AML,NA,Ddx10 (MGI:1924841)
11,110092424,110171840,11q22.3,11q22.3,615001,"ZC3H12C, MCPIP3",Zinc finger CCCH domain-containing protein 12C,ZC3H12C,85463,ENSG00000149289,NA,NA,Zc3h12c (MGI:3026959)
11,110174879,110296711,11q23,11q22.3,179410,"RDX, DFNB24",Radixin,RDX,5962,ENSG00000137710,NA,"Deafness, autosomal recessive 24, 611022 (3), Autosomal recessive",Rdx (MGI:97887)
11,110429947,110464883,11q22,11q22.3,103260,"FDX1, ADX",Ferredoxin-1 (adrenodoxin),FDX1,2230,ENSG00000137714,pseudogene on 20q11-q12,NA,Fdx1 (MGI:103224)
11,110600000,130900000,11q23-q24,NA,612629,ADIPQTL4,"Adiponectin, serum level of, quantitative trait locus locus 4",NA,100271698,NA,between D11S925 and D11S968,"{Adiponectin, serum level of, QTL4}, 612629 (2)",NA
11,110600000,121300000,11q23,NA,609354,BMND5,Bone mineral density QTL 5,NA,554315,NA,between D11S901 and D11S925,"[Bone mineral density QTL 5], 609354 (2)",NA
11,110600000,121300000,11q23,NA,612232,CRCS7,"Colorectal cancer, susceptibility to, 7",NA,100187711,NA,associated with rs3802842,"{Colorectal cancer, susceptibility to, 7}, 612232 (2)",NA
11,110600000,112700000,11q23.1,NA,132860,EBVM1,Epstein-Barr virus modification site-1,NA,NA,NA,NA,NA,NA
11,110600000,121300000,11q23,NA,137580,GTS,Gilles de la Tourette syndrome,NA,NA,NA,"several loci suspected (e.g., 17q25)","Tourette syndrome, 137580 (2), Autosomal dominant",NA
11,110600000,121300000,11q23,NA,147791,JBS,Jacobsen syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Jacobsen syndrome, 147791 (4), Isolated cases",NA
11,110600000,121300000,11q23,NA,613387,NAFLD2,"Fatty liver disease, nonalcoholic, susceptibility to, 2",NA,100462725,NA,"associated with rs2854116, rs2854117","{Fatty liver disease, nonalcoholic, susceptibility to, 2}, 613387 (2), Multifactorial",NA
11,110600000,121300000,11q23,NA,188025,TCPT,"Thrombocytopenia, Paris-Trousseau type (deletion 11q23 syndrome)",NA,NA,NA,contiguous gene deletion of 11q23,"?Thrombocytopenia, Paris-Trousseau type, 188025 (4), Isolated cases",NA
11,110600000,121300000,11q23,NA,603040,TSG11,Tumor suppressor gene on chromosome 11,NA,50970,NA,NA,"{Nonsmall cell lung cancer}, 603040 (2)",NA
11,110600000,114600000,11q23.1-q23.2,NA,194632,ZNF125,Zinc finger protein-125 (HZF-3),NA,NA,NA,NA,NA,NA
11,111293388,111305047,11q23,11q23.1,615693,COLCA1,Colorectal cancer-associated gene 1,COLCA1,399948,NA,NA,NA,NA
11,111298348,111308734,11q23,11q23.1,615694,COLCA2,Colorectal cancer-associated gene 2,COLCA2,120376,ENSG00000214290,opposite strand from COLCA1,NA,Colca2 (MGI:2685530)
11,111352250,111379670,11q23.1,11q23.1,601206,"POU2AF1, OBF1","POU domain, class 2, associating factor 1",POU2AF1,5450,ENSG00000110777,NA,NA,Pou2af1 (MGI:105086)
11,111383827,111514733,11q23,11q23.1,605673,"BTG4, PC3B",B-cell translocation gene 4,BTG4,54766,ENSG00000137707,NA,NA,Btg4 (MGI:1860140)
11,111512937,111513020,11q23.1,11q23.1,611374,MIR34B,Micro RNA 34B,MIR34B,407041,ENSG00000207811,NA,NA,NA
11,111513438,111513514,11q23.1,11q23.1,611375,MIR34C,Micro RNA 34C,MIR34C,407042,ENSG00000207562,NA,NA,NA
11,111602448,111730854,11q23.1,11q23.1,608973,"SIK2, KIAA0781",Salt-inducible kinase 2,SIK2,23235,ENSG00000170145,NA,NA,Sik2 (MGI:2445031)
11,111690272,111766388,11q22-q24,11q23.1,603113,PPP2R1B,"Protein phosphatase 2, structural/regulatory subunit A, beta",PPP2R1B,5519,ENSG00000137713,NA,"Lung cancer, somatic, 211980 (3)",Ppp2r1b (MGI:1920949)
11,111776095,111871580,11q23,11q23.1,606941,"ALG9, DIBD1, CDG1L, GIKANIS","Alg9, yeast, homolog of",ALG9,79796,ENSG00000086848,NA,"Congenital disorder of glycosylation, type Il, 608776 (3), Autosomal recessive; Gillessen-Kaesbach-Nishimura syndrome, 263210 (3), Autosomal recessive",Alg9 (MGI:1924753)
11,111908563,111923739,11q22.3-q23.1,11q23.1,123590,"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2","Crystallin, alpha B",CRYAB,1410,ENSG00000109846,NA,"Cardiomyopathy, dilated, 1II, 615184 (3), Autosomal dominant; Cataract 16, multiple types, 613763 (3), Autosomal recessive, Autosomal dominant; Myopathy, myofibrillar, 2, 608810 (3), Autosomal dominant; Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related, 613869 (3), Autosomal recessive",Cryab (MGI:88516)
11,111912733,111914092,11q22-q23,11q23.1,602179,HSPB2,Heat-shock 27kD protein-2,HSPB2,3316,ENSG00000170276,NA,NA,Hspb2 (MGI:1916503)
11,111927143,112022652,11q23.1,11q23.1,610493,"DIXDC1, CCD1, KIAA1735",DIX domain-containing protein 1,DIXDC1,85458,ENSG00000150764,NA,NA,Dixdc1 (MGI:2679721)
11,112024813,112064277,11q23.1,11q23.1,608770,"DLAT, PDCE2",Dihydrolipoamide S-acetyltransferase,DLAT,1737,ENSG00000150768,NA,"Pyruvate dehydrogenase E2 deficiency, 245348 (3), Autosomal recessive",Dlat (MGI:2385311)
11,112084799,112086755,11q23.1,11q23.1,606659,"TIMM8B, DDP2","Translocase of inner mitochondrial membrane 8, yeast, homolog of, B",TIMM8B,26521,ENSG00000150779,NA,NA,Timm8b (MGI:1353424)
11,112086823,112095800,11q23,11q23.1,602690,"SDHD, PGL1","Succinate dehydrogenase complex, subunit D, integral membrane protein",SDHD,6392,ENSG00000204370,NA,"Mitochondrial complex II deficiency, 252011 (3), Autosomal recessive; Paraganglioma and gastric stromal sarcoma, 606864 (3); Paragangliomas 1, with or without deafness, 168000 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant",Sdhd (MGI:1914175)
11,112143250,112164103,11q22.2-q22.3,11q23.1,600953,"IL18, IGIF",Interleukin-18,IL18,3606,ENSG00000150782,NA,NA,Il18 (MGI:107936)
11,112167371,112172555,Chr.11,11q23.1,605791,TEX12,Testis-expressed gene 12,TEX12,56158,ENSG00000150783,NA,NA,Tex12 (MGI:1913904)
11,112175511,112218932,11q22.3-q23.1,11q23.1,611740,"BCO2, BCDO2",Beta-carotene oxygenase 2,BCO2,83875,ENSG00000197580,NA,NA,Bco2 (MGI:2177469)
11,112226427,112233972,11q22.3-q23.3,11q23.1,612719,PTS,6-pyruvoyltetrahydropterin synthase,PTS,5805,ENSG00000150787,NA,"Hyperphenylalaninemia, BH4-deficient, A, 261640 (3), Autosomal recessive",Pts (MGI:1338783)
11,112248152,112260859,11q23.2,11q23.1,611904,"C11orf34, PLET1",Chromosome 11 open reading frame 34,PLET1,349633,ENSG00000188771,NA,NA,Plet1 (MGI:1923759)
11,112961419,113278435,11q23.1,11q23.2,116930,"NCAM1, MSK39",Neural cell adhesion molecule 1,NCAM1,4684,ENSG00000149294,"defective in ""staggerer"" in mice",NA,Ncam1 (MGI:97281)
11,113314568,113385951,11q23.2,11q23.2,610732,"TTC12, TPARM",Tetratricopeptide repeat domain 12,TTC12,54970,ENSG00000149292,NA,NA,Ttc12 (MGI:2444588)
11,113386013,113400415,11q23.2,11q23.2,608774,ANKK1,Ankyrin repeat and kinase domain containing 1,ANKK1,255239,ENSG00000170209,NA,NA,Ankk1 (MGI:3045301)
11,113409594,113475397,11q23.1,11q23.2,126450,DRD2,Dopamine receptor D2,DRD2,1813,ENSG00000149295,11q22-q23 junction; 150kb 5' to NCAM; centromeric to APOA1; telomeric to STMY1,NA,Drd2 (MGI:94924)
11,113687545,113709810,11q23.3,11q23.2,606751,TMPRSS5,"Transmembrane protease, serine 5",TMPRSS5,80975,ENSG00000166682,NA,NA,Tmprss5 (MGI:1933407)
11,113733182,113773698,11q23.2,11q23.2,603954,ZW10,"Zeste-white 10, Drosophila, homolog of",ZW10,9183,ENSG00000086827,NA,NA,Zw10 (MGI:1349478)
11,113797874,113875571,11q23,11q23.2,610748,"USP28, KIAA1515",Ubiquitin-specific protease 28,USP28,57646,ENSG00000048028,NA,NA,Usp28 (MGI:2442293)
11,113898922,113949118,11q23.1,11q23.2,604654,HTR3B,5-hydroxytryptamine receptor 3B,HTR3B,9177,ENSG00000149305,NA,NA,Htr3b (MGI:1861899)
11,113975074,113990312,11q23.1-q23.2,11q23.2,182139,HTR3,5-hydroxytryptamine (serotonin) receptor-3,HTR3A,3359,ENSG00000166736,NA,NA,Htr3a (MGI:96282)
11,114059575,114256769,11q23.1,11q23.2,176797,"ZBTB16, ZNF145, PLZF",Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger),ZBTB16,7704,ENSG00000109906,fused with RARA in APL of t(11;17) type,"Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3), Autosomal recessive",Zbtb16 (MGI:103222)
11,114295812,114312515,11q23.1,11q23.2,600008,NNMT,Nicotinamide N-methyltransferase,NNMT,4837,ENSG00000166741,NA,"Homocysteine plasma level, 600008 (2)",Nnmt (MGI:1099443)
11,114400528,114410609,11q23.1-q23.2,11q23.2,612413,RBM7,RNA-binding motif protein 7,RBM7,10179,ENSG00000076053,NA,NA,Rbm7 (MGI:1914260)
11,114439466,114450278,11q23.1-q23.2,11q23.2,607149,"REXO2, RFN","RNA exonuclease 2, S. cerevisiae, homolog of",REXO2,25996,ENSG00000076043,NA,NA,Rexo2 (MGI:1888981)
11,114570590,114596214,11q23.2,11q23.2,618133,"NXPE4, C11orf33","Neurexophilin and PC-esterase domain family, member 4",NXPE4,54827,ENSG00000137634,NA,NA,Nxpe4 (MGI:1924792)
11,114600000,130900000,11q23.3-q24,NA,607086,"AAT1, FAA1","Aortic aneurysm, familial thoracic 1",NA,252842,NA,NA,"Aortic aneurysm, familial thoracic 1, 607086 (2)",NA
11,114600000,121300000,11q23.3,NA,605201,"HDLCQ14, HYLAP",High density lipoprotein cholesterol level quantitative trait locus 14,NA,56801,NA,NA,"High density lipoprotein cholesterol level QTL14, 605201 (2)",NA
11,115169235,115504427,11q23.2,11q23.3,605686,"CADM1, IGSF4, TSLC1",Cell adhesion molecule 1,CADM1,23705,ENSG00000182985,NA,NA,Cadm1 (MGI:1889272)
11,116773798,116789271,11q23.3,11q23.3,603901,"ZPR1, ZNF259",ZPR1 zinc finger protein,ZPR1,8882,ENSG00000109917,NA,NA,Zpr1 (MGI:1330262)
11,116789366,116792419,11q23,11q23.3,606368,APOA5,Apolipoprotein A-V,APOA5,116519,ENSG00000110243,"proximal to APOA1, APOC3, APOA4","Hyperchylomicronemia, late-onset, 144650 (3), Autosomal dominant; {Hypertriglyceridemia, susceptibility to}, 145750 (3), Autosomal dominant",Apoa5 (MGI:1913363)
11,116820699,116823303,11q23,11q23.3,107690,APOA4,Apolipoprotein A-IV,APOA4,337,ENSG00000110244,12 kb 3' to APOA1,NA,Apoa4 (MGI:88051)
11,116829906,116833071,11q23,11q23.3,107720,"APOC3, HALP2",Apolipoprotein C-III,APOC3,345,ENSG00000110245,2.6kb 3' to APOA1,"Apolipoprotein C-III deficiency, 614028 (3)",NA
11,116835750,116837949,11q23,11q23.3,107680,APOA1,Apolipoprotein A-I,APOA1,335,ENSG00000118137,NA,"Amyloidosis, 3 or more types, 105200 (3), Autosomal dominant; ApoA-I and apoC-III deficiency, combined (3); Corneal clouding, autosomal recessive (3); Hypoalphalipoproteinemia, 604091 (3)",Apoa1 (MGI:88049)
11,116843409,117098452,11q23.3,11q23.3,614776,"SIK3, KIAA0999, SEMDK",Salt-inducible kinase 3,SIK3,23387,ENSG00000160584,mutation identified in 1 SEMDK family,"?Spondyloepimetaphyseal dysplasia, Krakow type, 618162 (3), Autosomal recessive",Sik3 (MGI:2446296)
11,117144283,117178172,11q23,11q23.3,602508,PAFAH1B2,"Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit",PAFAH1B2,5049,ENSG00000168092,NA,NA,Pafah1b2 (MGI:108415)
11,117178742,117197441,11q23.3,11q23.3,617551,SIDT2,"SID1 transmembrane family, member 2",SIDT2,51092,ENSG00000149577,NA,NA,Sidt2 (MGI:2446134)
11,117199293,117207464,11q23.2,11q23.3,600818,"TAGLN, SMCC, SM22",Transgelin,TAGLN,6876,ENSG00000149591,NA,NA,Tagln (MGI:106012)
11,117201155,117232524,11q23.3,11q23.3,604872,"PCSK7, PC8, PC7, LPC","Proprotein convertase, subtilisin/kexin-type, 7",PCSK7,9159,ENSG00000160613,NA,NA,Pcsk7 (MGI:107421)
11,117285206,117316255,11q23.3,11q23.3,604252,"BACE1, BACE","Beta-site amyloid beta A4 precursor protein-cleaving enzyme (secretase, beta; memapsin 2)",BACE1,23621,ENSG00000186318,NA,NA,Bace1 (MGI:1346542)
11,117291345,117292169,11q23.3,11q23.3,614263,BACE1AS,BACE1 antisense RNA,BACE1-AS,100379571,NA,NA,NA,NA
11,117316345,117413265,11q23.3,11q23.3,614848,"CEP164, KIAA1052","Centrosomal protein, 164kD",CEP164,22897,ENSG00000110274,NA,"Nephronophthisis 15, 614845 (3), Autosomal recessive",Cep164 (MGI:2384878)
11,117427771,117817513,11q23,11q23.3,611782,"DSCAML1, KIAA1132",Down syndrome cell adhesion molecule-like 1,DSCAML1,57453,ENSG00000177103,NA,NA,Dscaml1 (MGI:2150309)
11,117820056,117828088,11q23,11q23.3,601814,"FXYD2, ATP1G1, HOMG2","FXYD domain-containing ion transport regulator 2 (sodium-potassium-ATPase, gamma polypeptide)",FXYD2,486,ENSG00000137731,NA,"Hypomagnesemia 2, renal, 154020 (3), Autosomal dominant",NA
11,117836975,117877429,Chr.11,11q23.3,606683,FXYD6,FXYD domain-containing ion transport regulator 6,FXYD6,53826,ENSG00000137726,NA,NA,Fxyd6 (MGI:1890226)
11,117900640,117929452,11q23,11q23.3,610050,"TMPRSS13, MSPL, MSPS","Transmembrane protease, serine 13",TMPRSS13,84000,ENSG00000137747,NA,NA,Tmprss13 (MGI:2682935)
11,117986390,118001482,11q23.3,11q23.3,146933,"IL10RA, IL10R, IBD28","Interleukin-10 receptor, alpha",IL10RA,3587,ENSG00000110324,NA,"Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3), Autosomal recessive",Il10ra (MGI:96538)
11,118077011,118125504,11q23.3,11q23.3,606565,TMPRSS4,"Transmembrane protease, serine 4",TMPRSS4,56649,ENSG00000137648,NA,NA,Tmprss4 (MGI:2384877)
11,118133376,118152914,11q23,11q23.3,608256,"SCN4B, LQT10, ATFB17","Sodium channel, voltage-gated, type IV, beta subunit",SCN4B,6330,ENSG00000177098,NA,"Atrial fibrillation, familial, 17, 611819 (3), Autosomal dominant; Long QT syndrome-10, 611819 (3), Autosomal dominant",Scn4b (MGI:2687406)
11,118162805,118176638,11q23,11q23.3,601327,"SCN2B, ATFB14","Sodium channel, voltage-gated, type II, beta polypeptide",SCN2B,6327,ENSG00000149575,NA,"Atrial fibrillation, familial, 14, 615378 (3), Autosomal dominant",Scn2b (MGI:106921)
11,118193724,118225088,11q23,11q23.3,609770,"AMICA1, JAML","Adhesion molecule, interacts with CXADR antigen 1",JAML,120425,ENSG00000160593,NA,NA,Jaml (MGI:2685484)
11,118226689,118252367,11q23.3,11q23.3,611707,MPZL3,Myelin protein zero-like 3,MPZL3,196264,ENSG00000160588,NA,NA,Mpzl3 (MGI:2442647)
11,118253415,118264535,11q24,11q23.3,604873,"MPZL2, EVA1, EVA, DFNB111",Myelin protein zero-like 2,MPZL2,10205,ENSG00000149573,NA,"Deafness, autosomal recessive 111, 618145 (3), Autosomal recessive",Mpzl2 (MGI:1289160)
11,118304579,118316174,11q23,11q23.3,186830,"CD3E, IMD18","CD3E antigen, epsilon polypeptide (TiT3 complex)",CD3E,916,ENSG00000198851,NA,"Immunodeficiency 18, 615615 (3), Autosomal recessive; Immunodeficiency 18, SCID variant, 615615 (3), Autosomal recessive",Cd3e (MGI:88332)
11,118338953,118342743,11q23,11q23.3,186790,"CD3D, T3D, IMD19","CD3D antigen, delta polypeptide (TiT3 complex)",CD3D,915,ENSG00000167286,3 CD3 genes in 50kb,"Immunodeficiency 19, 615617 (3), Autosomal recessive",Cd3d (MGI:88331)
11,118344343,118353781,11q23,11q23.3,186740,"CD3G, IMD17","CD3G antigen, gamma polypeptide (TiT3 complex)",CD3G,917,ENSG00000160654,NA,"Immunodeficiency 17, CD3 gamma deficient, 615607 (3), Autosomal recessive",Cd3g (MGI:88333)
11,118359599,118399210,Chr.11,11q23.3,603753,"UBE4A, UFD2, E4",Ubiquitination factor E4A,UBE4A,9354,ENSG00000110344,NA,NA,Ube4a (MGI:2154580)
11,118401388,118409846,11q22.3,11q23.3,617473,ATP5JG,"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G",ATP5MG,10632,ENSG00000167283,NA,NA,Atp5l (MGI:1351597)
11,118436489,118526831,11q23,11q23.3,159555,"KMT2A, MLL, HRX, HTRX1, WDSTS",Lysine (K)-specific methyltransferase 2E,KMT2A,4297,ENSG00000118058,"fuses with ENL, AF4, AF9, GMPS","Leukemia, myeloid/lymphoid or mixed-lineage, 159555 (2), Autosomal dominant; Wiedemann-Steiner syndrome, 605130 (3), Autosomal dominant",Kmt2a (MGI:96995)
11,118531087,118546597,11q23.3,11q23.3,613934,TMEM25,Transmembrane protein 25,TMEM25,84866,ENSG00000149582,NA,NA,Tmem25 (MGI:1918937)
11,118572386,118603032,11q23.3,11q23.3,600820,"ARCN1, SRMMD",Archain 1,ARCN1,372,ENSG00000095139,60kb telomeric to MLL,"Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay, 617164 (3), Autosomal dominant",Arcn1 (MGI:2387591)
11,118606295,118658027,11q23.3,11q23.3,612834,"PHLDB1, LL5A, KIAA0638","Pleckstrin homology-like domain, family B, member 1",PHLDB1,23187,ENSG00000019144,NA,NA,Phldb1 (MGI:2143230)
11,118657315,118679649,11q23,11q23.3,275360,"TREH, TREHD",Trehalase,TREH,11181,ENSG00000118094,NA,"Trehalase deficiency, 612119 (3), Autosomal recessive",Treh (MGI:1926230)
11,118747762,118791695,11q23.3,11q23.3,600326,"DDX6, HLR2","DEAD/H box-6 (RNA helicase, 54kD)",DDX6,1656,ENSG00000110367,NA,NA,Ddx6 (MGI:104976)
11,118883891,118897786,11q23.3,11q23.3,601613,"CXCR5, BLR1","Chemokine, CXC motif, receptor 5",CXCR5,643,ENSG00000160683,NA,NA,Cxcr5 (MGI:103567)
11,118893874,118926071,11q23.3,11q23.3,609004,BCL9L,B-cell CLL/lymphoma 9-like,BCL9L,283149,ENSG00000186174,NA,NA,Bcl9l (MGI:1933114)
11,118956297,118958558,11q23.3,11q23.3,611558,"UPK2, UP2, UPII",Uroplakin 2,UPK2,7379,ENSG00000110375,NA,NA,Upk2 (MGI:98913)
11,118971397,118981600,11q23.3,11q23.3,615755,"FOXR1, FOXN5",Forkhead box R1,FOXR1,283150,ENSG00000176302,NA,NA,Foxr1 (MGI:2685961)
11,119015716,119018342,11q23.3,11q23.3,180465,RPS25,Ribosomal protein S25,RPS25,6230,ENSG00000118181,NA,NA,Rps25 (MGI:1922867)
11,119018765,119024133,11q23.3,11q23.3,610971,TRAPPC4,"Trafficking protein particle complex, subunit 4 (synbindin)",TRAPPC4,51399,ENSG00000196655,NA,NA,Trappc4 (MGI:1926211)
11,119024111,119030905,11q23,11q23.3,602671,"SLC37A4, G6PT1","Solute carrier family 37 (glucose-6-phosphate transporter), member 4",SLC37A4,2542,ENSG00000137700,NA,"Glycogen storage disease Ib, 232220 (3), Autosomal recessive; Glycogen storage disease Ic, 232240 (3), Autosomal recessive",Slc37a4 (MGI:1316650)
11,119044186,119057204,11q23.3,11q23.3,601746,"HYOU1, IMD59",Hypoxia-upregulated 1,HYOU1,10525,ENSG00000149428,mutation identified in 1 IMD59 patient,"?Immunodeficiency 59 and hypoglycemia, 233600 (3), Autosomal recessive",Hyou1 (MGI:108030)
11,119067751,119081977,11q23.3,11q23.3,608549,"VPS11, HLD12","Vacuolar protein sorting 11, yeast, homolog of",VPS11,55823,ENSG00000160695,NA,"Leukodystrophy, hypomyelinating, 12, 616683 (3), Autosomal recessive",Vps11 (MGI:1918982)
11,119084863,119093548,11q23.3,11q23.3,609806,"HMBS, PBGD, UPS",Hydroxymethylbilane synthase,HMBS,3145,ENSG00000256269,NA,"Porphyria, acute intermittent, 176000 (3), Autosomal dominant; Porphyria, acute intermittent, nonerythroid variant, 176000 (3), Autosomal dominant",Hmbs (MGI:96112)
11,119093873,119095466,11q23.2-q23.3,11q23.3,601772,H2AX,H2AX histone,H2AFX,3014,ENSG00000188486,NA,NA,H2afx (MGI:102688)
11,119096504,119101883,11q23.3,11q23.3,191350,"DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13",Dolichyl-phosphate N-acetylglucosamine phosphotransferase,DPAGT1,1798,ENSG00000172269,NA,"Congenital disorder of glycosylation, type Ij, 608093 (3), Autosomal recessive; Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3), Autosomal recessive",Dpagt1 (MGI:1196396)
11,119106751,119118543,11q23.3,11q23.3,617582,"C2CD2L, TMEM24",C2 calcium-dependent domain-containing protein 2-like,C2CD2L,9854,ENSG00000172375,NA,NA,C2cd2l (MGI:1919014)
11,119121522,119136058,Chr.11,11q23.3,607099,MIZF,MBD2-interaction zinc finger protein,HINFP,25988,ENSG00000172273,NA,NA,Hinfp (MGI:2429620)
11,119149051,119162665,11q23.3,11q23.3,607784,"ABCG4, WHITE2","ATP-binding cassette, subfamily G, member 4",ABCG4,64137,ENSG00000172350,NA,NA,Abcg4 (MGI:1890594)
11,119168333,119184015,11q23.3,11q23.3,611947,"NLRX1, NOD9, CLR11.3",NLR family member X1,NLRX1,79671,ENSG00000160703,NA,NA,Nlrx1 (MGI:2429611)
11,119185456,119190222,11q23,11q23.3,607146,"PDZD3, IKEPP",PDZ domain-containing 3,PDZD3,79849,ENSG00000172367,NA,NA,Pdzd3 (MGI:2429554)
11,119206275,119308148,11q23.3,11q23.3,165360,"CBL, CBL2, NSLL",Cas-Br-M ecotropic retroviral transforming sequence (Oncogene CBL2),CBL,867,ENSG00000110395,mutation identified in 1 JMML family,"?Juvenile myelomonocytic leukemia, 607785 (3), Autosomal dominant, Somatic mutation; Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3), Autosomal dominant",Cbl (MGI:88279)
11,119305758,119317129,11q23.3,11q23.3,155735,"MCAM, MUC18, CD146",Melanoma adhesion molecule,MCAM,4162,ENSG00000076706,NA,NA,Mcam (MGI:1933966)
11,119334526,119337308,11q23,11q23.3,606130,RNF26,RING finger protein-26,RNF26,79102,ENSG00000173456,NA,NA,Rnf26 (MGI:2388131)
11,119338941,119346704,11q23.3,11q23.3,608752,"C1QTNF5, CTRP5, LORD",C1q- and tumor necrosis factor-related protein 5,C1QTNF5,114902,ENSG00000223953,NA,"Retinal degeneration, late-onset, autosomal dominant, 605670 (3), Autosomal dominant",C1qtnf5 (MGI:2385958)
11,119338941,119346704,11q23,11q23.3,606227,"MFRP, MCOP5, NNO2",Membrane-type frizzled-related protein,MFRP,83552,ENSG00000235718,NA,"Microphthalmia, isolated 5, 611040 (3), Autosomal recessive; Nanophthalmos 2, 609549 (3)",Mfrp (MGI:2385957)
11,119417940,119424984,11q23.3,11q23.3,188230,THY1,Thy-1 T-cell antigen,THY1,7070,ENSG00000154096,NA,NA,Thy1 (MGI:98747)
11,119638097,119729199,11q23-q24,11q23.3,600644,"NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1",Nectin 1,NECTIN1,5818,ENSG00000110400,NA,"Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3), Autosomal recessive; Orofacial cleft 7, 225060 (3), Autosomal recessive",Nectin1 (MGI:1926483)
11,120111285,120138112,11q23.3,11q23.3,610658,"TRIM29, ATDC",Tripartite motif-containing protein 29,TRIM29,23650,ENSG00000137699,NA,NA,Trim29 (MGI:1919419)
11,120236637,120319944,11q23.3,11q23.3,607394,"POU2F3, OCT11","POU domain, class 2, transcription factor 3",POU2F3,25833,ENSG00000137709,NA,NA,Pou2f3 (MGI:102565)
11,120336275,120489936,11q23.3,11q23.3,604763,"ARHGEF12, LARG, KIAA0382","Rho guanine nucleotide exchange factor 12, leukemia-associated",ARHGEF12,23365,ENSG00000196914,fused with MLL in AML,NA,Arhgef12 (MGI:1916882)
11,120511745,120988804,11q22.3,11q23.3,600282,GRIK4,"Glutamate receptor, ionotropic, kainate 4",GRIK4,2900,ENSG00000149403,NA,NA,Grik4 (MGI:95817)
11,121024071,121090775,11q23.3,11q23.3,610451,"LRRC35, EL",Leucine-rich repeat-containing protein 35,TBCEL,219899,ENSG00000154114,NA,NA,Tbcel (MGI:1925543)
11,121102665,121190805,11q22-q24,11q23.3,602574,"TECTA, DFNA8, DFNA12, DFNB21","Tectorin, alpha",TECTA,7007,ENSG00000109927,NA,"Deafness, autosomal dominant 8/12, 601543 (3), Autosomal dominant; Deafness, autosomal recessive 21, 603629 (3), Autosomal recessive",Tecta (MGI:109575)
11,121292770,121313409,11q23.3,11q23.3-q24.1,602286,"SC5DL, ERG3",Sterol C5-desaturase-like,SC5D,6309,ENSG00000109929,NA,"Lathosterolosis, 607330 (3), Autosomal recessive",Sc5d (MGI:1353611)
11,121300000,135086622,11q24-q25,NA,612161,ANIB7,"Aneurysm, intracranial berry, 7",NA,100188885,NA,between rs618176 and rs1940033,"Aneurysm, intracranial berry, 7, 612161 (2)",NA
11,121300000,124000000,11q24.1,NA,612559,CLLS5,"Leukemia, chronic lymphocytic susceptibility to, 5",NA,100270644,NA,associated with rs735665,"{Leukemia, chronic lymphocytic susceptibility to, 5}, 612559 (2)",NA
11,121300000,130900000,11q24,NA,609670,MGR9,"Migraine with aura, susceptibility to, 9",NA,100415943,NA,max lod at GATA64D03,"{Migraine with aura, susceptibility to, 9}, 609670 (2)",NA
11,121300000,130900000,11q24,NA,609469,NEDE,"Nephropathy, progressive, with deafness",NA,619410,NA,max lod at D11S4464,"Nephropathy, progressive, with deafness, 609469 (2)",NA
11,121452313,121633762,11q23.2-q24.2,11q24.1,602005,"SORL1, LR11, SORLA","Sortilin-related receptor, L(DLR class) A repeats-containing",SORL1,6653,ENSG00000137642,NA,NA,Sorl1 (MGI:1202296)
11,122028328,122422870,11q24.1,11q24.1,615965,"MIR100HG, AGD1","MIR100-LET7A2 cluster host gene, noncoding",MIR100HG,399959,ENSG00000255248,NA,NA,NA
11,122099756,122099843,11q24.1,11q24.1,610104,"MIR125B1, MIRN125B1",Micro RNA 125B-1,MIR125B1,406911,ENSG00000207971,NA,NA,NA
11,122115339,122116214,11q24.1,11q24.1,608853,"BLID, BRCC@",BH3-like motif-containing cell death inducer,BLID,414899,ENSG00000259571,distal to SORL1,NA,NA
11,122146521,122146592,11q24.1,11q24.1,612142,"MIRLET7A2, LET7A2, MIRNLET7A2",Micro RNA let7a2,MIRLET7A2,406882,ENSG00000198975,NA,NA,NA
11,122152228,122152307,11q24.1,11q24.1,613186,"MIR100, MIRN100",Micro RNA 100,MIR100,406892,ENSG00000207994,NA,NA,NA
11,122655721,122814472,11q24.1,11q24.1,609201,"UBASH3B, STS1, KIAA1959, P70",Ubiquitin-associated and SH3 domain-containing protein B,UBASH3B,84959,ENSG00000154127,NA,NA,Ubash3b (MGI:1920078)
11,122838418,122872642,11q22-q23,11q24.1,612597,CRTAM,Cytotoxic and regulatory T-cell molecule,CRTAM,56253,ENSG00000109943,NA,NA,Crtam (MGI:1859822)
11,122881639,122963861,11q24.1,11q24.1,617594,"JHY, C11orf63","Jhy, mouse, homology of",JHY,79864,ENSG00000109944,NA,NA,Jhy (MGI:1918239)
11,122977569,122981833,11q24.1,11q24.1,611074,BSX1,"Brain-specific homeobox, mouse, homolog of",BSX,390259,ENSG00000188909,NA,NA,Bsx (MGI:2669849)
11,123057488,123062365,11q23.3-q25,11q24.1,600816,"HSPA8, HSP73",Heat-shock 70kD protein-8 (HSP73),HSPA8,3312,ENSG00000109971,NA,NA,Hspa8 (MGI:105384)
11,123069871,123195247,11q24.1,11q24.1,611693,"CLMP, ASAM, ACAM, CSBS",Coxsackievirus- and adenovirus receptor-like membrane protein,CLMP,79827,ENSG00000166250,NA,"Congenital short bowel syndrome, 615237 (3), Autosomal recessive",Clmp (MGI:1918816)
11,123629186,123654606,11q23.3,11q24.1,608214,"SCN3B, SCNB3, BRGDA7, ATFB16","Sodium channel, voltage-gated, type III, beta subunit",SCN3B,55800,ENSG00000166257,NA,"Atrial fibrillation, familial, 16, 613120 (3), Autosomal dominant; Brugada syndrome 7, 613120 (3), Autosomal dominant",Scn3b (MGI:1918882)
11,123723913,123741674,11q23.3,11q24.1,603430,ZNF202,Zinc finger protein-202,ZNF202,7753,ENSG00000166261,NA,NA,Zfp202 (MGI:1933401)
11,124000000,127900000,11q24.2,NA,612581,MRD4,"Mental retardation, autosomal dominant 4",NA,112441440,NA,translocation t(11;16)(q24.2;q24),"Mental retardation, autosomal dominant 4, 612581 (2), Autosomal dominant",NA
11,124115403,124147720,11q23,11q24.2,602929,"VWA5A, LOH11CR2A, BCSC1",von Willebrand factor A domain-containing protein 5A,VWA5A,4013,ENSG00000110002,NA,NA,Vwa5a (MGI:1915026)
11,124611427,124620355,11q24.2,11q24.2,608422,"PANX3, PX3",Pannexin 3,PANX3,116337,ENSG00000154143,NA,NA,Panx3 (MGI:1918881)
11,124622845,124635925,11q24.2,11q24.2,610614,"TBRG1, NIAM",Transforming growth factor-beta regulator 1,TBRG1,84897,ENSG00000154144,NA,NA,Tbrg1 (MGI:1100877)
11,124633112,124676302,11q24,11q24.2,610079,"SIAE, AIS6",Sialic acid acetylesterase,SIAE,54414,ENSG00000110013,NA,"{Autoimmune disease, susceptibility to, 6}, 613551 (3)",Siae (MGI:104803)
11,124739941,124747209,11q24,11q24.2,602350,NRGN,Neurogranin,NRGN,4900,ENSG00000154146,NA,NA,NA
11,124747473,124752254,11q24,11q24.2,606011,"VSIG2, CTXL",V-set and immunoglobulin domains-containing protein 2,VSIG2,23584,ENSG00000019102,NA,NA,Vsig2 (MGI:1928009)
11,124753125,124762289,11q24.2,11q24.2,614281,ESAM,Endothelial cell adhesion molecule,ESAM,90952,ENSG00000149564,NA,NA,Esam (MGI:1916774)
11,124865431,124881470,11q23-q25,11q24.2,608630,"ROBO3, RBIG1, RIG1, HGPPS1","Roundabout, Drosophila, homolog of, 3",ROBO3,64221,ENSG00000154134,NA,"Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3), Autosomal recessive",Robo3 (MGI:1343102)
11,124883690,124897864,11q24.2,11q24.2,607528,"ROBO4, AOVD3","Roundabout, Drosophila, homolog of, 4",ROBO4,54538,ENSG00000154133,NA,"Aortic valve disease 8, 618496 (3)",Robo4 (MGI:1921394)
11,124919204,124936411,11q24,11q24.2,611642,"HEPACAM, MLC2A, MLC2B",Hepatocyte cell adhesion molecule,HEPACAM,220296,ENSG00000165478,NA,"Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3), Autosomal recessive; Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3), Autosomal dominant",Hepacam (MGI:1920177)
11,124919249,124920676,11q24.2,11q24.2,611641,HEPN1,Cancer susceptibility gene HEPN1,HEPN1,641654,ENSG00000221932,NA,NA,NA
11,125235036,125433388,11q24-q25,11q24.2,613066,"PKNOX2, PREP2",PBX/Knotted 1 homeobox 2,PKNOX2,63876,ENSG00000165495,NA,NA,Pknox2 (MGI:2445415)
11,125442880,125496309,11q24.2,11q24.2,604825,FEZ1,Fasciculation and elongation protein zeta 1,FEZ1,9638,ENSG00000149557,NA,NA,Fez1 (MGI:2670976)
11,125569215,125584688,11q23,11q24.2,605170,"EI24, PIG8, EPG4",Etoposide-induced 1.4 mRNA,EI24,9538,ENSG00000149547,NA,NA,Ei24 (MGI:108090)
11,125592846,125623090,11q23.3,11q24.2,601134,"STT3A, ITM1, TMC","STT3A, subunit of the oligosaccharyltransferase complex (catalytic)",STT3A,3703,ENSG00000134910,mutation identified in 1 family,"?Congenital disorder of glycosylation, type Iw, 615596 (3), Autosomal recessive",Stt3a (MGI:105124)
11,125624909,125676255,11q22-q23,11q24.2,603078,"CHEK1, CHK1","Checkpoint kinase 1, S. pombe, homolog of",CHEK1,1111,ENSG00000149554,NA,NA,Chek1 (MGI:1202065)
11,125671521,125680846,11p12-q13,11q24.2,102525,ACRV1,Acrosomal vesicle protein-1,ACRV1,56,ENSG00000134940,NA,NA,Acrv1 (MGI:104590)
11,125746278,125749866,11q24,11q24.2,606861,PATE,Prostate- and testis-expressed gene,PATE1,160065,ENSG00000171053,NA,NA,Pate1 (MGI:4936886)
11,125883613,125900645,11q24.2,11q24.2,610693,"HYLS1, FLJ32915",HYLS1 gene,HYLS1,219844,ENSG00000198331,NA,"Hydrolethalus syndrome, 236680 (3), Autosomal recessive",Hyls1 (MGI:1924082)
11,125893484,125903277,11q24.2,11q24.2,616283,"PUS3, MRT55",Pseudouridylate synthase 3,PUS3,83480,ENSG00000110060,NA,"Mental retardation, autosomal recessive 55, 617051 (3), Autosomal recessive",Pus3 (MGI:1914299)
11,125903327,125928842,11q24,11q24.2,607663,GRTH,Gonadotropin-regulated testicular RNA helicase,DDX25,29118,ENSG00000109832,NA,NA,Ddx25 (MGI:1353582)
11,125956812,126063334,11q24.2,11q24.2,608707,"CDON, CDO, HPE11",Cell adhesion molecule-related/downregulated by oncogenes,CDON,50937,ENSG00000064309,NA,"Holoprosencephaly 11, 614226 (3), Autosomal dominant",Cdon (MGI:1926387)
11,126202093,126211691,11q24.2,11q24.2,617488,RPUSD4,RNA pseudouridylate synthase domain-containing protein 4,RPUSD4,84881,ENSG00000165526,NA,NA,Rpusd4 (MGI:1919239)
11,126211413,126264539,11q24.2,11q24.2,616587,FAM118B,"Family with sequence similarity 118, member B",FAM118B,79607,ENSG00000197798,NA,NA,Fam118b (MGI:1924483)
11,126255150,126268981,11q23-q24,11q24.2,182180,"SRPRA, SRPR, DP","Signal recognition particle receptor, alpha subunit",SRPRA,6734,ENSG00000182934,NA,NA,Srpr (MGI:1914648)
11,126269039,126278131,11q24.2,11q24.2,613622,"FOXRED1, MC1DN19",FAD-dependent oxidoreductase domain-containing protein 1,FOXRED1,55572,ENSG00000110074,NA,"Mitochondrial complex I deficiency, nuclear type 19, 618241 (3), Autosomal recessive",Foxred1 (MGI:2446262)
11,126283086,126294932,11q23-q24,11q24.2,606252,"TIRAP, BACTS1",TIR domain-containing adaptor protein,TIRAP,114609,ENSG00000150455,NA,"{Bacteremia, protection against}, 614382 (3); {Malaria, protection against}, 611162 (3); {Pneumococcal disease, invasive, protection against}, 610799 (3); {Tuberculosis, protection against}, 607948 (3)",Tirap (MGI:2152213)
11,126304059,126350004,11q24.2,11q24.2,610534,"DCPS, HINT5, DCS1, ARS","Decapping enzyme, scavenger",DCPS,28960,ENSG00000110063,NA,"Al-Raqad syndrome, 616459 (3), Autosomal recessive",Dcps (MGI:1916555)
11,126355644,126414640,11q24.2,11q24.2,104240,"ST3GAL4, SIAT4C, SIAT4, CGS23, NANTA3","ST3 beta-galactoside alpha-2,3-sialyltransferase 4",ST3GAL4,6484,ENSG00000110080,NA,NA,St3gal4 (MGI:1316743)
11,126423357,127003459,11q24.2,11q24.2,607761,"KIRREL3, NEPH2, KIAA1867, KIRRE",Kin of IRRE-like 3,KIRREL3,84623,ENSG00000149571,NA,NA,Kirrel3 (MGI:1914953)
11,128458760,128587592,11q23.3,11q24.3,164720,ETS1,Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1,ETS1,2113,ENSG00000134954,shown by HSR; 19cM distal to THY1; Ewing sarcoma breakpoint region-2 splices to EWSR1,NA,Ets1 (MGI:95455)
11,128685262,128813266,11q24,11q24.3,193067,"FLI1, BDPLT21",Friend leukemia virus integration 1,FLI1,2313,ENSG00000151702,fused with EWS in Ewing sarcoma,"Bleeding disorder, platelet-type, 21, 617443 (3), Autosomal recessive, Autosomal dominant",Fli1 (MGI:95554)
11,128691671,128696022,11q24.1,11q24.3,615815,"SENCR, lncRNA9",Smooth muscle- and endothelial cell-enriched migration/differentiation-associated long noncoding RNA,SENCR,100507392,ENSG00000254703,NA,NA,NA
11,128836314,128867372,11q24,11q24.3,600359,"KCNJ1, ROMK1","Potassium inwardly-rectifying channel, subfamily J, member 1",KCNJ1,3758,ENSG00000151704,NA,"Bartter syndrome, type 2, 241200 (3), Autosomal recessive",Kcnj1 (MGI:1927248)
11,128891355,128921162,11q24,11q24.3,600734,"KCNJ5, GIRK4, KATP1, LQT13","Potassium inwardly-rectifying channel, subfamily J, member 5",KCNJ5,3762,ENSG00000120457,NA,"Hyperaldosteronism, familial, type III, 613677 (3), Autosomal dominant; Long QT syndrome 13, 613485 (3), Autosomal dominant",Kcnj5 (MGI:104755)
11,128934731,128944232,11q24,11q24.3,605426,"TP53AIP1, P53AIP1",Tumor protein p53-regulated apoptosis-inducing protein 1,TP53AIP1,63970,ENSG00000120471,NA,NA,NA
11,128965059,129279166,11q24.3,11q24.3,608541,"ARHGAP32, RICS, GRIT, p200RHOGAP, p250GAP",Rho GTPase activating protein 32,ARHGAP32,9743,ENSG00000134909,NA,NA,Arhgap32 (MGI:2450166)
11,129295202,129296614,11q23.1-q23.2,11q24.3,194630,ZNF123,Zinc finger protein-123 (HZF-1),ZNF123P,100188891,NA,NA,NA,NA
11,129375236,129452278,11q25,11q24.3,604823,BARX2,BarH-like homeo box gene 2,BARX2,8538,ENSG00000043039,NA,NA,Barx2 (MGI:109617)
11,129863635,129895595,11q24-q25,11q24.3,164013,NFRKB,Nuclear factor related to kappa B-binding protein,NFRKB,4798,ENSG00000170322,most telomeric 11q marker,NA,Nfrkb (MGI:2442410)
11,129899710,130003096,11q24.3,11q24.3,618319,"PRDM10, TRIS, KIAA1231",PR domain-containing protein 10,PRDM10,56980,ENSG00000170325,NA,NA,Prdm10 (MGI:2682952)
11,130069820,130144810,11q24,11q24.3,104776,APLP2,Amyloid beta (A4) precursor-like protein-2,APLP2,334,ENSG00000084234,NA,NA,Aplp2 (MGI:88047)
11,130159781,130210361,11q24-q25,11q24.3,606797,"ST14, MTSP1, ARCI11",Suppression of tumorigenicity 14,ST14,6768,ENSG00000149418,NA,"Ichthyosis, congenital, autosomal recessive 11, 602400 (3), Autosomal recessive",St14 (MGI:1338881)
11,130404922,130428608,11q25,11q24.3,605175,"ADAMTS8, METH2","A disintegrin-like and metalloproteinase with thrombospondin type-1 motif, 8",ADAMTS8,11095,ENSG00000134917,NA,NA,Adamts8 (MGI:1353468)
11,130448875,130478214,11q24.3,11q24.3,607509,ADAMTS15,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 15",ADAMTS15,170689,ENSG00000166106,NA,NA,Adamts15 (MGI:2449569)
11,130900000,135086622,11q25-qter,NA,604060,DFNB20,"Deafness, autosomal recessive 20",DFNB20,1713,NA,NA,"Deafness, autosomal recessive 20, 604060 (2), Autosomal recessive",NA
11,131370307,132336821,11q25,11q25,607938,"NTM, HNT",Neurotrimin,NTM,50863,ENSG00000182667,NA,NA,Ntm (MGI:2446259)
11,132403360,133532533,11q25,11q25,600632,OPCML,Opioid-binding protein/cell adhesion molecule-like,OPCML,4978,ENSG00000183715,NA,"Ovarian cancer, somatic, 167000 (3)",Opcml (MGI:97397)
11,133835929,133845532,11q25,11q25,609805,SPATA19,Spermatogenesis-associated protein 19,SPATA19,219938,ENSG00000166118,NA,NA,Spata19 (MGI:1922719)
11,133908409,133956959,11q25,11q25,613773,"IGSF9B, KIAA1030","Immunoglobulin superfamily, member 9B",IGSF9B,22997,ENSG00000080854,NA,NA,Igsf9b (MGI:2685354)
11,134068924,134152000,11q25,11q25,606871,JAM3,Junctional adhesion molecule 3,JAM3,83700,ENSG00000166086,NA,"Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3), Autosomal recessive",Jam3 (MGI:1933825)
11,134152441,134225453,11q25,11q25,609276,"NCAPD3, CAPD3, KIAA0056, MCPH22",Non-SMC condensin II complex subunit D3,NCAPD3,23310,ENSG00000151503,NA,"Microcephaly 22, primary, autosomal recessive, 617984 (3), Autosomal recessive",Ncapd3 (MGI:2142989)
11,134224663,134247787,11q25,11q25,610027,VPS26B,"Vacuolar protein sorting 26, yeast, homolog of, B",VPS26B,112936,ENSG00000151502,NA,NA,Vps26b (MGI:1917656)
11,134248264,134253406,11q25,11q25,613739,"THYN1, HSPC144, THY28",Thymocyte nuclear protein 1,THYN1,29087,ENSG00000151500,NA,NA,Thyn1 (MGI:1925112)
11,134253537,134265857,11q25,11q25,604773,ACAD8,"Acyl-CoA dehydrogenase family, member 8",ACAD8,27034,ENSG00000151498,NA,"Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)",Acad8 (MGI:1914198)
11,134378503,134412241,11q25,11q25,151290,"B3GAT1, GLCATP, CD57, HNK1","Beta-1,3-glucuronyltransferase 1",B3GAT1,27087,ENSG00000109956,NA,NA,B3gat1 (MGI:1924148)
11,0,135086622,Chr.11,NA,606049,AOCH,"Acromegaloid features, overgrowth, cleft palate, and hernia",NA,93956,NA,"pericentric inversion (46,XY,inv(11)(p15.3;q23.3))","Acromegaloid features, overgrowth, cleft palate, and hernia, 606049 (2)",NA
12,0,35500000,12p,NA,107920,KAR,Aromatic alpha-keto acid reductase,NA,NA,NA,?same as MDH1,NA,NA
12,0,10000000,12p13.3,NA,612372,MAFD9,Major affective disorder 9,NA,100196917,NA,associated with rs1006737,"{Major affective disorder-9, susceptibility to}, 612372 (2)",NA
12,0,35500000,12p,NA,601803,PKS,Pallister-Killian syndrome,NA,NA,NA,NA,"Pallister-Killian syndrome, 601803 (4), Somatic mosaicism",NA
12,66766,178454,12p13.33,12p13.33,612118,"IQSEC3, KIAA1110",IQ motif- and SEC7 domain-containing protein 3,IQSEC3,440073,ENSG00000120645,NA,NA,Iqsec3 (MGI:2677208)
12,190080,214156,12p13,12p13.33,603080,SLC6A12,"Solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12",SLC6A12,6539,ENSG00000111181,NA,NA,Slc6a12 (MGI:95628)
12,220620,262929,12p13.3,12p13.33,615097,"SLC6A13, GAT2, GAT3","Solute carrier family 6 (neurotransmitter transporter, GABA), member 13",SLC6A13,6540,ENSG00000010379,NA,NA,Slc6a13 (MGI:95629)
12,280056,389319,12p11,12p13.33,180202,"KDM5A, JARID1A, RBP2, RBBP2",Lysine(K)-specific demethylase 5A,KDM5A,5927,ENSG00000073614,NA,NA,Kdm5a (MGI:2136980)
12,459938,563508,12p13.3,12p13.33,612220,B4GALNT3,"Beta-1,4-N-acetylgalactosaminyltransferase 3",B4GALNT3,283358,ENSG00000139044,NA,NA,B4galnt3 (MGI:3041155)
12,564295,663444,12p13,12p13.33,607297,NINJ2,Nerve injury-induced protein 2,NINJ2,4815,ENSG00000171840,NA,NA,Ninj2 (MGI:1352751)
12,752578,911451,12p13,12p13.33,605232,"WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2",WNK lysine deficient protein kinase 1,WNK1,65125,ENSG00000060237,NA,"Neuropathy, hereditary sensory and autonomic, type II, 201300 (3), Autosomal recessive; Pseudohypoaldosteronism, type IIC, 614492 (3), Autosomal dominant",Wnk1 (MGI:2442092)
12,911027,991194,12p13-p12.2,12p13.33,600392,RAD52,"RAD52, yeast, homolog of",RAD52,5893,ENSG00000002016,NA,NA,Rad52 (MGI:101949)
12,1529855,1647212,12p13.3,12p13.33,606361,WNT5B,"Wingless-type MMTV integration site family, member 5B",WNT5B,81029,ENSG00000111186,NA,NA,Wnt5b (MGI:98959)
12,1559640,1594580,12p13.33,12p13.33,609081,"FBXL14, FBL14",F-box and leucine-rich repeat protein 14,FBXL14,144699,ENSG00000171823,NA,NA,Fbxl14 (MGI:2141676)
12,1691026,1788673,12p13.31,12p13.33,607946,"ADIPOR2, FLJ21432",Adiponectin receptor 2,ADIPOR2,79602,ENSG00000006831,NA,NA,Adipor2 (MGI:93830)
12,1791962,1922605,12p13.3,12p13.33,608171,"CACNA2D4, RCD4","Calcium channel, voltage-dependent, alpha-2/delta subunit 4",CACNA2D4,93589,ENSG00000151062,NA,"Retinal cone dystrophy 4, 610478 (3), Autosomal recessive",Cacna2d4 (MGI:2442632)
12,1941590,2004534,12p13.33,12p13.33,609843,"DCP1B, DCP1","Decapping enzyme 1, S. cerevisiae, homolog of",DCP1B,196513,ENSG00000151065,NA,NA,Dcp1b (MGI:2442404)
12,1969551,2697949,12p13.3,12p13.33,114205,"CACNA1C, CACNL1A1, CCHL1A1, TS. LQT8","Calcium channel, voltage-dependent, L type, alpha 1C subunit",CACNA1C,775,ENSG00000151067,NA,"Brugada syndrome 3, 611875 (3); Long QT syndrome 8, 618447 (3); Timothy syndrome, 601005 (3), Autosomal dominant",Cacna1c (MGI:103013)
12,2794969,2805422,12p13.33,12p13.33,600611,"FKBP4, FKBP52",FK506-binding protein 4,FKBP4,2288,ENSG00000004478,NA,NA,Fkbp4 (MGI:95543)
12,2812621,2859906,12p13.33,12p13.33,617421,"ITFG2, FGGAP1",Integrin-alpha FG-GAP repeat-containing protein 2,ITFG2,55846,ENSG00000111203,NA,NA,Itfg2 (MGI:1915450)
12,2857679,2877173,12p13,12p13.33,602341,"FOXM1, FKHL16, HFH11",Forkhead box M1,FOXM1,2305,ENSG00000111206,NA,NA,Foxm1 (MGI:1347487)
12,2876264,2889524,12p13.33,12p13.33,614085,"RHNO1, RHINO, C12orf32","Rad9-, Rad1-, and Hus1-interacting nuclear orphan 1",RHNO1,83695,ENSG00000171792,NA,NA,NA
12,2890890,2941137,12p13,12p13.33,604730,TULP3,Tubby-like protein 3,TULP3,7289,ENSG00000078246,NA,NA,Tulp3 (MGI:1329045)
12,2959396,3040675,12p13.3-p13.2,12p13.33,601714,"TEAD4, TCF13L1, RTEF1","TEA domain family, member 4",TEAD4,7004,ENSG00000197905,NA,NA,Tead4 (MGI:106907)
12,3077354,3286563,12p13.32,12p13.33-p13.32,613137,"TSPAN9, NET5",Tetraspanin 9,TSPAN9,10867,ENSG00000011105,NA,NA,Tspan9 (MGI:1924558)
12,3381348,3593972,12p13.3,12p13.32,610086,"PRMT8, HRMT1L3, HRMT1L4",Protein arginine methyltransferase 8,PRMT8,56341,ENSG00000111218,NA,NA,Prmt8 (MGI:3043083)
12,3613365,3753217,12p13.32,12p13.32,614178,"EFCAB4B, CRACR2A",EF-hand calcium-binding domain-containing protein 4B,CRACR2A,84766,ENSG00000130038,NA,NA,Cracr2a (MGI:2685919)
12,3808860,3873470,12p13.3,12p13.32,616706,"PARP11, ARTD11","Poly(ADP-ribose) polymerase family, member 11",PARP11,57097,ENSG00000111224,NA,NA,Parp11 (MGI:2141505)
12,4273761,4305352,12p13,12p13.32,123833,"CCND2, MPPH3",Cyclin D2,CCND2,894,ENSG00000118971,NA,"Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3), Autosomal dominant",Ccnd2 (MGI:88314)
12,4321212,4360027,12p13.3,12p13.32,610775,"TIGAR, C12orf5",TP53-induced glycolysis and apoptosis regulator,TIGAR,57103,ENSG00000078237,NA,NA,Tigar (MGI:2442752)
12,4368226,4379711,12p13.3,12p13.32,605380,"FGF23, ADHR, HPDR2, PHPTC, HFTC2",Fibroblast growth factor 23,FGF23,8074,ENSG00000118972,NA,"Hypophosphatemic rickets, autosomal dominant, 193100 (3), Autosomal dominant; Osteomalacia, tumor-induced (1); Tumoral calcinosis, hyperphosphatemic, familial, 2, 617993 (3)",Fgf23 (MGI:1891427)
12,4434141,4445798,12p13,12p13.32,134921,FGF6,Fibroblast growth factor-6,FGF6,2251,ENSG00000111241,NA,NA,Fgf6 (MGI:95520)
12,4487729,4538507,12p13.3,12p13.32,616082,C12orf4,Chromosome 12 open reading frame 4,C12orf4,57102,ENSG00000047621,NA,"Mental retardation, autosomal recessive 66, 618221 (3), Autosomal recessive",D6Wsu163e (MGI:107893)
12,4538889,4560046,12p13.2-p13.1,12p13.32,603070,"RAD51AP1, PIR51",Rad51-associated protein 1,RAD51AP1,10635,ENSG00000111247,NA,NA,Rad51ap1 (MGI:1098224)
12,4590071,4613887,12p13.32,12p13.32,609181,DYRK4,Dual-specificity tyrosine phosphorylation-regulated kinase 4,DYRK4,8798,ENSG00000010219,NA,NA,Dyrk4 (MGI:1330292)
12,4649113,4694316,12p,12p13.32,603834,"NDUFA9, MC1DN26",NADH-ubiquinone oxidoreductase subunit A9,NDUFA9,4704,ENSG00000139180,NA,"Mitochondrial complex I deficiency, nuclear type 26, 618247 (3), Autosomal recessive",Ndufa9 (MGI:1913358)
12,4720399,4772725,12p13.3,12p13.32,606250,GALNT8,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8,GALNT8,26290,ENSG00000130035,NA,NA,NA
12,4806876,4851926,12p13,12p13.32,176257,KCNA6,"Potassium voltage-gated channel, shaker-related subfamily, member 6",KCNA6,3742,ENSG00000130035,NA,NA,Kcna6 (MGI:96663)
12,4909904,4918255,12p13,12p13.32,176260,"KCNA1, AEMK, EA1","Potassium voltage-gated channel, shaker-related subfamily, member 1",KCNA1,3736,ENSG00000111262,close to VWF,"Episodic ataxia/myokymia syndrome, 160120 (3), Autosomal dominant",Kcna1 (MGI:96654)
12,5043878,5046787,12p13,12p13.32,176267,"KCNA5, ATFB7","Potassium voltage-gated channel, shaker-related subfamily, member 5",KCNA5,3741,ENSG00000130037,NA,"Atrial fibrillation, familial, 7, 612240 (3), Autosomal dominant",Kcna5 (MGI:96662)
12,5432107,5495298,12p13,12p13.31,162660,NTF3,Neurotrophin-3,NTF3,4908,ENSG00000185652,NA,NA,Ntf3 (MGI:97380)
12,5560240,5948789,12p13,12p13.31,610109,"ANO2, TMEM16B, C12orf3",Anoctamin 2,ANO2,57101,ENSG00000047617,NA,NA,Ano2 (MGI:2387214)
12,5948873,6124674,12p13.3,12p13.31,613160,"VWF, F8VWF",Coagulation factor VIII VWF (von Willebrand factor),VWF,7450,ENSG00000110799,pseudogene on chr. 22,"von Willebrand disease, type 1, 193400 (3), Autosomal dominant; von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3), Autosomal recessive, Autosomal dominant; von Willibrand disease, type 3, 277480 (3), Autosomal recessive",Vwf (MGI:98941)
12,6199945,6238265,12p13,12p13.31,143030,"CD9, MIC3",CD9 antigen (p24),CD9,928,ENSG00000010278,NA,NA,Cd9 (MGI:88348)
12,6310435,6328505,12p13.31,12p13.31,611743,"PLEKHG6, MYOGEF",Pleckstrin homology domain- and RhoGEF domain-containing protein G6,PLEKHG6,55200,ENSG00000008323,NA,NA,Plekhg6 (MGI:2682298)
12,6328756,6342116,12p13.2,12p13.31,191190,"TNFRSF1A, TNFR1, TNFAR, FPF, MS5","Tumor necrosis factor receptor superfamily, member 1A",TNFRSF1A,7132,ENSG00000067182,NA,"{Multiple sclerosis, susceptibility to, 5}, 614810 (3); Periodic fever, familial, 142680 (3), Autosomal dominant",Tnfrsf1a (MGI:1314884)
12,6346842,6377356,12p13,12p13.31,600228,"SCNN1A, BESC2, LIDLS3","Sodium channel, nonvoltage-gated 1, alpha",SCNN1A,6337,ENSG00000111319,mutation identified in 1 LIDLS3 patient,"Bronchiectasis with or without elevated sweat chloride 2, 613021 (3), Autosomal dominant; ?Liddle syndrome 3, 618126 (3), Autosomal dominant; Pseudohypoaldosteronism, type I, 264350 (3), Autosomal recessive",Scnn1a (MGI:101782)
12,6375159,6391570,12p13,12p13.31,600979,"LTBR, TNFCR",Lymphotoxin-beta receptor (tumor necrosis factor C receptor),LTBR,4055,ENSG00000111321,tightly linked to TNFR1 in mouse,NA,Ltbr (MGI:104875)
12,6444866,6451717,12p13,12p13.31,186711,"CD27, TNFRSF7, S152. LPFS2",CD27 antigen,CD27,939,ENSG00000139193,NA,"Lymphoproliferative syndrome 2, 615122 (3), Autosomal recessive",Cd27 (MGI:88326)
12,6451655,6472005,12p13.3,12p13.31,607081,TAPBPR,TAP-binding protein-related protein,TAPBPL,55080,ENSG00000139192,NA,NA,Tapbpl (MGI:2384853)
12,6462236,6470898,12p13.31,12p13.31,185880,"VAMP1, SYB1, SPAX1, CMS25",Vesicle-associated membrane protein-1 (synaptobrevin-1),VAMP1,6843,ENSG00000139190,NA,"Myasthenic syndrome, congenital, 25, 618323 (3), Autosomal recessive; Spastic ataxia 1, autosomal dominant, 108600 (3), Autosomal dominant",Vamp1 (MGI:1313276)
12,6491885,6493261,12p13.3-p13.1,12p13.31,611855,"MRPL51, MRP64",Mitochondrial ribosomal protein L51,MRPL51,51258,ENSG00000111639,NA,NA,Mrpl51 (MGI:1913743)
12,6494101,6531954,12p13.31,12p13.31,615638,"NCAPD2, CNAP1, KIAA0159, MCPH21",Non-SMC condensin I complex subunit D2,NCAPD2,9918,ENSG00000010292,mutation identified in 1 MCPH21 patient,"?Microcephaly 21, primary, autosomal recessive, 617983 (3), Autosomal recessive",Ncapd2 (MGI:1915548)
12,6510221,6510550,12p13.31,12p13.31,615639,SCARNA10,Small cajal body-specific RNA 10,SCARNA10,692148,ENSG00000239002,in intron 4 of NCAPD2,NA,NA
12,6534516,6538370,12p13.31-p13.1,12p13.31,138400,"GAPDH, GAPD",Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,2597,ENSG00000111640,pseudogene on Xp21-q11,NA,"Gapdh,Gapdh-ps15 (MGI:5434255,MGI:95640)"
12,6538960,6556096,12p13.31,12p13.31,610495,IFFO1,Intermediate filament family orphan 1,IFFO1,25900,ENSG00000010295,NA,NA,Iffo1 (MGI:2444516)
12,6556870,6568290,12p13,12p13.31,164031,NOL1,"Nucleolar protein 1, 120kD",NOP2,4839,ENSG00000111641,NA,NA,Nop2 (MGI:107891)
12,6570081,6607378,12p13,12p13.31,603277,"CHD4, SIHIWES",Chromodomain helicase DNA-binding protein-4,CHD4,1108,ENSG00000111642,NA,"Sifrim-Hitz-Weiss syndrome, 617159 (3), Autosomal dominant",Chd4 (MGI:1344380)
12,6618834,6635958,12p13,12p13.31,606926,"LPAR5, GPR92, GPR93, LPA5",Lysophosphatidic acid receptor 5,LPAR5,57121,ENSG00000184574,NA,NA,Lpar5 (MGI:2685918)
12,6650300,6663142,12p13.31,12p13.31,608524,ING4,Inhibitor of growth-4,ING4,51147,ENSG00000111653,NA,NA,Ing4 (MGI:107307)
12,6666476,6689571,12p12,12p13.31,609951,"ZNF384, CIZ, CAGH1, NMP4",Zinc finger protein 384,ZNF384,171017,ENSG00000126746,NA,NA,Zfp384 (MGI:2443203)
12,6689704,6700814,12p13.31,12p13.31,616065,"PIANP, PANP, LEDA1",PILR-alpha-associated neural protein,PIANP,196500,ENSG00000139200,NA,NA,Pianp (MGI:2441908)
12,6724045,6731867,12p13.31,12p13.31,616009,"COPS7A, CSN7","COP9 signalosome, subunit 7A",COPS7A,50813,ENSG00000111652,NA,NA,Cops7a (MGI:1349400)
12,6747991,6753140,12p13,12p13.31,601401,MLF2,Myeloid leukemia factor-2,MLF2,8079,ENSG00000089693,NA,NA,Mlf2 (MGI:1353554)
12,6766362,6770951,12p13.31,12p13.31,168440,PTMS,Parathymosin,PTMS,5763,ENSG00000159335,previously assigned to 17q12-q22,NA,NA
12,6772482,6778454,12p13.32,12p13.31,153337,LAG3,Lymphocyte activation gene-3,LAG3,3902,ENSG00000089692,NA,NA,Lag3 (MGI:106588)
12,6789527,6820809,12p13.31,12p13.31,186940,CD4,CD4 antigen (p55),CD4,920,ENSG00000010610,CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens,"OKT4 epitope deficiency, 613949 (3)",Cd4 (MGI:88335)
12,6828406,6839846,12p13,12p13.31,610342,"P3H3, LEPREL2",Prolyl 3-hydroxylase 3,P3H3,10536,ENSG00000110811,NA,NA,P3h3 (MGI:1315208)
12,6840921,6847392,12p13,12p13.31,139130,"GNB3, CSNB1H","Guanine nucleotide-binding protein, beta polypeptide-3",GNB3,2784,ENSG00000111664,NA,"{Hypertension, essential, susceptibility to}, 145500 (3), Multifactorial; Night blindness, congenital stationary, type 1H, 617024 (3), Autosomal recessive",Gnb3 (MGI:95785)
12,6852137,6866631,12p13,12p13.31,601447,"USP5, ISOT",Ubiquitin-specific protease-5 (ubiquitin isopeptidase T),USP5,8078,ENSG00000111667,NA,NA,Usp5 (MGI:1347343)
12,6866833,6870945,12p13,12p13.31,190450,"TPI1, TPID",Triosephosphate isomerase-1,TPI1,7167,ENSG00000111669,NA,"Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3), Autosomal recessive",Tpi1 (MGI:98797)
12,6870934,6873302,12p13.31,12p13.31,611658,"SPSB2, SSB2",SPRY domain- and SOCS box-containing 2,SPSB2,84727,ENSG00000111671,NA,NA,Spsb2 (MGI:1315199)
12,6914579,6923696,12p13,12p13.31,131360,ENO2,"Enolase-2, gamma, neuronal",ENO2,2026,ENSG00000111674,NA,NA,Eno2 (MGI:95394)
12,6924458,6942320,12p13.31,12p13.31,607462,"ATN1, DRPLA, HRS, NOD, CHEDDA",Atrophin 1,ATN1,1822,ENSG00000111676,NA,"Congenital hypotonia, epilepsy, developmental delay, and digital anomalies, 618494 (3); Dentatorubral-pallidoluysian atrophy, 125370 (3), Autosomal dominant",Atn1 (MGI:104725)
12,6943437,6946002,12p13,12p13.31,615140,"C12orf57, C10, TEMTYS",Chromosome 12 open reading frame 57,C12orf57,113246,ENSG00000111678,NA,"Temtamy syndrome, 218340 (3), Autosomal recessive",Grcc10 (MGI:1315201)
12,6943815,6943877,12p13.31,12p13.31,617876,"RNU7-1, RNU7","RNA, U7 small nuclear, 1",RNU7-1,100147744,ENSG00000238923,NA,NA,NA
12,6946576,6961315,12p13,12p13.31,176883,PTPN6,"Protein tyrosine phosphatase, nonreceptor-type, 6",PTPN6,5777,ENSG00000111679,NA,NA,Ptpn6 (MGI:96055)
12,6963698,6963765,12p13.31,12p13.31,612092,"MIR200C, MIRN200C",Micro RNA 200C,MIR200C,406985,ENSG00000207713,NA,NA,NA
12,6964096,6964190,12p13.31,12p13.31,612093,"MIR141, MIRN141",Micro RNA 141,MIR141,406933,ENSG00000207708,NA,NA,NA
12,6965326,6970752,12p13,12p13.31,610704,"PHB2, REA",Prohibitin 2,PHB2,11331,ENSG00000215021,NA,NA,Phb2 (MGI:102520)
12,6967336,6967605,12p13.31,12p13.31,615642,SCARNA12,Small Cajal body-specific RNA 12,SCARNA12,677777,ENSG00000238795,NA,NA,NA
12,6970780,6997427,12p13,12p13.31,611531,"EMG1, NEP1, C2F, BWCNS","Essential for mitotic growth 1, S. cerevisiae, homolog of",EMG1,10436,ENSG00000126749,NA,"Bowen-Conradi syndrome, 211180 (3), Autosomal recessive",Emg1 (MGI:1315195)
12,6976184,7018507,12p13.31,12p13.31,611950,"LPCAT3, MBOAT5, NESSY",Lysophosphatidylcholine acyltransferase 3,LPCAT3,10162,ENSG00000111684,NA,NA,Lpcat3 (MGI:1315211)
12,7060717,7071031,12p13,12p13.31,120580,"C1S, EDSPD2","Complement component-1, s subcomponent",C1S,716,ENSG00000182326,NA,"C1s deficiency, 613783 (3); Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3), Autosomal dominant","C1s2,C1s1 (MGI:1355312,MGI:3644269)"
12,7080218,7092444,12p13,12p13.31,613785,"C1R, EDSPD1","Complement component-1, r subcomponent",C1R,715,ENSG00000159403,NA,"Ehlers-Danlos syndrome, periodontal type, 1, 130080 (3), Autosomal dominant","C1rb,C1ra (MGI:3779804,MGI:1355313)"
12,7094553,7109213,12p13.31,12p13.31,608974,"C1RL, CLSPA, C1RLP",Complement component C1r-like protein,C1RL,51279,ENSG00000139178,NA,NA,C1rl (MGI:2660692)
12,7119105,7130271,12p13.31,12p13.31,611866,"RBP5, CRBP3",Retinol-binding protein 5,RBP5,83758,ENSG00000139194,NA,NA,NA
12,7130370,7158944,12p13,12p13.31,611324,"CLSTN3, KIAA0726",Calsyntenin 3,CLSTN3,9746,ENSG00000139182,NA,NA,Clstn3 (MGI:2178323)
12,7188684,7218573,12p13.3,12p13.31,600414,"PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5",Peroxisome biogenesis factor 5,PEX5,5830,ENSG00000139197,NA,"Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3), Autosomal recessive; Peroxisome biogenesis disorder 2B, 202370 (3), Autosomal recessive; Rhizomelic chondrodysplasia punctata, type 5, 616716 (3), Autosomal recessive",Pex5 (MGI:1098808)
12,7304331,7328372,12p13.31,12p13.31,614360,ACSM4,"Acyl-CoA synthetase medium-chain family, member 4",ACSM4,341392,ENSG00000215009,NA,NA,Acsm4 (MGI:2681844)
12,7320509,7444184,12p13.3,12p13.31,606079,"CD164L1, CD163B, M160",CD164 antigen-like 1,CD163L1,283316,ENSG00000177675,NA,NA,NA
12,7470810,7503817,12p13.3,12p13.31,605545,CD163,CD163 antigen (hemoglobin scavenger receptor),CD163,9332,ENSG00000177575,NA,NA,Cd163 (MGI:2135946)
12,7649399,7670598,12p13.1,12p13.31,600130,"APOBEC1, BEDP","Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1",APOBEC1,339,ENSG00000111701,NA,NA,Apobec1 (MGI:103298)
12,7689783,7695774,12p13.1,12p13.31,606522,"GDF3, KFS3, MCOPCB6, MCOP7",Growth differentiation factor 3,GDF3,9573,ENSG00000184344,NA,"Klippel-Feil syndrome 3, autosomal dominant, 613702 (3); Microphthalmia with coloboma 6, 613703 (3), Autosomal dominant; Microphthalmia, isolated 7, 613704 (3), Autosomal dominant",Gdf3 (MGI:95686)
12,7711432,7717558,12p13.31,12p13.31,608408,DPPA3,Developmental pluripotency-associated gene 3,DPPA3,359787,ENSG00000187569,NA,NA,NA
12,7729244,7751599,12p13.2-p12.3,12p13.31,606677,"CLEC4C, CLECSF11, DLEC, BDCA2","C-type lectin domain family 4, member C",CLEC4C,170482,ENSG00000198178,NA,NA,Clec4b1 (MGI:1917060)
12,7789401,7799145,12p13.31,12p13.31,607937,NANOG,Homeobox transcription factor NANOG,NANOG,79923,ENSG00000111704,NA,NA,Nanog (MGI:1919200)
12,7812513,7891195,12p13.3,12p13.31,611039,"SLC2A14, GLUT14","Solute carrier family 2 (facilitated glucose transporter), member 14",SLC2A14,144195,ENSG00000173262,NA,NA,NA
12,7919229,7936186,12p13.3,12p13.31,138170,"SLC2A3, GLUT3","Solute carrier family 2 (facilitated glucose transporter), member 3",SLC2A3,6515,ENSG00000059804,pseudogene SLC2A3P on 5q34,NA,Slc2a3 (MGI:95757)
12,8056843,8066358,12p13.31,12p13.31,605246,"C3AR1, C3AR",Complement component 3a receptor 1,C3AR1,719,ENSG00000171860,NA,NA,C3ar1 (MGI:1097680)
12,8082210,8097880,12p13.31,12p13.31,611623,"NECAP1, EIEE21",NECAP endocytosis-associated protein 1,NECAP1,25977,ENSG00000089818,mutation identified in 1 EIEE21 family,"?Epileptic encephalopathy, early infantile, 21, 615833 (3), Autosomal recessive",Necap1 (MGI:1914852)
12,8102901,8138606,12p13,12p13.31,605306,"CLEC4A, CLECSF6, DCIR, DDB27","C-type lectin domain family 4, member A",CLEC4A,50856,ENSG00000111729,NA,NA,Clec4a2 (MGI:1349412)
12,8221259,8227617,12p13.31,12p13.31,613041,FAM90A1,"Family with sequence similarity 90, member A1",FAM90A1,55138,ENSG00000171847,other family members on chr. 8,NA,Fam90a1b (MGI:1921682)
12,8455961,8478329,12p13.31-p31.2,12p13.31,613579,"CLEC6A, CLEC4N","C-type lectin domain family 6, member A",CLEC6A,93978,ENSG00000205846,NA,NA,Clec4n (MGI:1861231)
12,8513491,8522365,12p13,12p13.31,609964,"CLEC4D, CLECSF8, CLEC6","C-type lectin domain family 4, member D",CLEC4D,338339,ENSG00000166527,NA,NA,Clec4d (MGI:1298389)
12,8533304,8541326,12p13,12p13.31,609962,"CLEC4E, MINCLE","C-type lectin domain family 4, member E",CLEC4E,26253,ENSG00000166523,NA,NA,Clec4e (MGI:1861232)
12,8602169,8612969,12p13,12p13.31,605257,"AICDA, AID, HIGM2",Activation-induced cytidine deaminase,AICDA,57379,ENSG00000111732,NA,"Immunodeficiency with hyper-IgM, type 2, 605258 (3), Autosomal recessive",Aicda (MGI:1342279)
12,8645942,8662887,12p13.1-p12.3,12p13.31,601103,"MFAP5, MAGP2, AAT9",Microfibril-associated protein 5,MFAP5,8076,ENSG00000197614,NA,"Aortic aneurysm, familial thoracic 9, 616166 (3), Autosomal dominant",Mfap5 (MGI:1354387)
12,8681676,8783097,12p13.31,12p13.31,614054,"RIMKLB, NAAGS","Ribosomal modification protein RimK-like family, member B",RIMKLB,57494,ENSG00000166532,NA,NA,Rimklb (MGI:1918325)
12,8822553,8887201,12p13.31,12p13.31,610627,"A2ML1, OMS",Alpha-2-macroglobulin-like 1,A2ML1,144568,ENSG00000166535,NA,"{Otitis media, susceptibility to}, 166760 (3), Autosomal dominant",NA
12,8914508,8941466,12p13.31,12p13.31,602978,"PHC1, EDR1, HPH1, RAE28, MCPH11",Polyhomeotic-like 1,PHC1,1911,ENSG00000111752,mutations identified in 1 family,"?Microcephaly 11, primary, autosomal recessive, 615414 (3), Autosomal recessive",Phc1 (MGI:103248)
12,8940360,8949760,12p13,12p13.31,154540,M6PR,"Mannose-6-phosphate receptor, cation-dependent",M6PR,4074,ENSG00000003056,NA,NA,M6pr (MGI:96904)
12,8950043,9215656,12p13.31,12p13.31,604874,"KLRG1, MAFA, MAFAL","Killer cell lectin-like receptor, subfamily G, member 1",KLRG1,10219,ENSG00000139187,NA,NA,Klrg1 (MGI:1355294)
12,9067707,9116228,12p13.3-p12.3,12p13.31,103950,"A2M , A2MD",Alpha-2-macroglobulin,A2M,2,ENSG00000175899,cluster of genes,"Alpha-2-macroglobulin deficiency, 614036 (1), Autosomal dominant; {Alzheimer disease, susceptibility to}, 104300 (3), Autosomal dominant",A2m (MGI:2449119)
12,9140729,9208394,12p13-p12.2,12p13.31,176420,PZP,Pregnancy zone protein,PZP,5858,ENSG00000126838,NA,NA,NA
12,9417690,9448171,12p13,12p13.31,601151,"DDX12, CHLR2",DEAD/H box-12,DDX12P,440081,NA,NA,NA,NA
12,9594550,9607915,12p13-p12,12p13.31,602890,"KLRB1, NKRP1A","Killer cell lectin-like receptor, subfamily B, member 1",KLRB1,3820,ENSG00000111796,NA,NA,"Klrb1b,Klrb1c,Klrb1a (MGI:107538,MGI:107539,MGI:107540)"
12,9669707,9699554,12p13,12p13.31,605659,"CLEC2D, LLT1","C-type lectin domain family 2, member D",CLEC2D,29121,ENSG00000069493,NA,NA,NA
12,9715859,9733434,12p13.31,12p13.31,607467,"CLECL1, DCAL1",C-type lectin-like 1,CLECL1,160365,ENSG00000184293,NA,NA,NA
12,9752485,9760900,12p13-p12,12p13.31,107273,CD69,"CD69 antigen (p60, early T-cell activation antigen)",CD69,969,ENSG00000110848,NA,NA,Cd69 (MGI:88343)
12,9800051,9845004,12p13.2-p12.3,12p13.31,605029,KLRF1,"Killer cell lectin-like receptor, subfamily F, member 1",KLRF1,51348,ENSG00000150045,NA,NA,NA
12,9852368,9869858,12p13-p12,12p13.31,603242,"CLEC2B, CLECSF2, AICL","C-type lectin domain family 2, member B",CLEC2B,9976,ENSG00000110852,NA,NA,NA
12,9882732,9932429,12p13.31,12p13.31,612087,CLEC2A,"C-type lectin domain family 2, member A",CLEC2A,387836,ENSG00000188393,NA,NA,Clec2f (MGI:3522133)
12,9951267,9995208,12p13,12p13.31,612088,"CLEC12A, MICL","C-type lectin domain family 12, member A",CLEC12A,160364,ENSG00000172322,NA,NA,Clec12a (MGI:3040968)
12,9986118,10001893,12p13,12p13.3-p13.2,606783,"CLEC2B, CLEC2","C-type lectin domain family 1, member B",CLEC1B,51266,ENSG00000165682,NA,NA,Clec1b (MGI:1913287)
12,10000000,27600000,12p13.2-p11.23,NA,610143,DFNB62,"Deafness, autosomal recessive 62",DFNB62,692220,NA,between D12S358 and D12S1042,"Deafness, autosomal recessive 62, 610143 (2), Autosomal recessive",NA
12,10000000,113900000,12p13.2-q24.1,NA,601458,IBD2,Inflammatory bowel disease 2,IBD2,3378,NA,mainly ulcerative colitis,"{Inflammatory bowel disease 2}, 601458 (2)",NA
12,10000000,12600000,12p13.2,NA,168710,PCS,Parotid proline-rich salivary protein Pc,NA,NA,NA,linked to PRB2,NA,NA
12,10000000,12600000,12p13.2,NA,613967,"TAS2R45, T2R45","Taste receptor, type 2, member 45",TAS2R45,259291,NA,NA,NA,NA
12,10006137,10018799,12p13.2,12p13.2,617573,CLEC12B,"C-type lectin domain family 12, member B",CLEC12B,387837,ENSG00000256660,NA,NA,Clec12b (MGI:1918433)
12,10030681,10066030,12p13.31,12p13.2,612252,"CLEC9A, DNGR1","C-type lectin domain family 9, member A",CLEC9A,283420,ENSG00000197992,NA,NA,Clec9a (MGI:2444608)
12,10069503,10099064,12p13,12p13.2,606782,"CLEC1A, CLEC1","C-type lectin domain family 1, member A",CLEC1A,51267,ENSG00000150048,NA,"{Aspergillosis, susceptibility to}, 614079 (3)",Clec1a (MGI:2444151)
12,10116776,10130268,12p13.2-p12.3,12p13.2,606264,"CLEC7A, CLECSF12, DECTIN1, CANDF4","C-type lectin domain family 7, member A",CLEC7A,64581,ENSG00000172243,in natural killer gene complex,"{Aspergillosis, susceptibility to}, 614079 (3); Candidiasis, familial, 4, autosomal recessive, 613108 (3), Autosomal recessive",Clec7a (MGI:1861431)
12,10158299,10172190,12p13-p12,12p13.2,602601,"OLR1, LOX1","Low density lipoprotein, oxidized, receptor 1",OLR1,4973,ENSG00000173391,NA,"{Myocardial infarction, susceptibility to}, 608446 (3)",Olr1 (MGI:1261434)
12,10212876,10223127,12p12.3,12p13.2,607420,"GABARAPL1, GEC1",GABA-A receptor-associated protein-like protein 1,GABARAPL1,23710,ENSG00000139112,NA,NA,Gabarapl1 (MGI:1914980)
12,10238382,10329607,12p13.2-p12.3,12p13.2,602894,"KLRD1, CD94","Killer cell lectin-like receptor, subfamily D, member 1",KLRD1,3824,ENSG00000134539,NA,NA,Klrd1 (MGI:1196275)
12,10372352,10390040,12p13.2-p12.3,12p13.2,611817,"KLRK1, NKG2D","Kill cell lectin-like receptor, subfamily K, member 1",KLRK1,22914,ENSG00000213809,NA,NA,NA
12,10407383,10409756,12p13.2-p12.3,12p13.2,602893,"KLRC4, NKG2F, D12S2489E","Killer cell lectin-like receptor, subfamily C, member 4",KLRC4,8302,ENSG00000183542,NA,NA,NA
12,10412314,10420594,12p13.2-p12.3,12p13.2,602892,"KLRC3, NKG2E","Killer cell lectin-like receptor, subfamily C, member 3",KLRC3,3823,ENSG00000205810,NA,NA,NA
12,10430598,10435992,12p13.2-p12.3,12p13.2,602891,"KLRC2, NKG2C","Killer cell lectin-like receptor, subfamily C, member 2",KLRC2,3822,ENSG00000205809,NA,NA,NA
12,10441672,10454684,12p13.2-p12.3,12p13.2,161555,"KLRC1, NKG2, NKG2A","Killer cell lectin-like receptor, subfamily C, member 1",KLRC1,3821,ENSG00000134545,family of at least 3 genes on 12,NA,Klrc1 (MGI:1336161)
12,10588477,10599834,12p13-p12,12p13.2,604274,"KLRA1, LY49L","Killer cell lectin-like receptor, subfamily A, member 1",KLRA1P,10748,NA,?functional,NA,NA
12,10618922,10674317,12p13.2,12p13.2,611433,"STYK1, NOK",Serine/threonine/tyrosine kinase 1,STYK1,55359,ENSG00000060140,NA,NA,Styk1 (MGI:2141396)
12,10699083,10723441,12p13.1,12p13.2,603437,"CSDA, DBPA",Cold-shock domain protein A,YBX3,8531,ENSG00000060138,NA,NA,Ybx3 (MGI:2137670)
12,10801531,10802626,12p13,12p13.2,604793,"TRB4, T2R7","Taste receptor, family B, member 4",TAS2R7,50837,ENSG00000121377,NA,NA,Tas2r130 (MGI:2681278)
12,10806050,10806979,12p13,12p13.2,604794,"TRB5, T2R8","Taste receptor, family B, member 5",TAS2R8,50836,ENSG00000121314,NA,NA,NA
12,10809093,10810167,12p13,12p13.2,604795,"TRB6, T2R9","Taste receptor, family B, member 6",TAS2R9,50835,ENSG00000121381,NA,NA,NA
12,10825345,10826268,12p13,12p13.2,604791,"TRB2, T2R10","Taste receptor, family B, member 2",TAS2R10,50839,ENSG00000121318,NA,NA,Tas2r114 (MGI:2681218)
12,10845848,10849474,Chr.12,12p13.2,605359,"PROL4, LPRP","Proline rich 4, lacrimal",PRR4,11272,ENSG00000111215,NA,NA,NA
12,10880964,11171622,12p13.2,12p13.2,168730,PRH1,"Proline-rich protein HaeIII, subfamily-1",PRH1,5554,ENSG00000231887,"Pa, Db, PIF alleles",NA,NA
12,10907925,10909561,12p13,12p13.2,604792,"TRB3, T2R13","Taste receptor, family B, member 3",TAS2R13,50838,ENSG00000212128,NA,NA,Tas2r121 (MGI:2681259)
12,10929235,10934844,12p13.2,12p13.2,168790,PRH2,"Proline-rich protein HaeIII, subfamily-2",PRH2,5555,ENSG00000134551,Pr allele,NA,NA
12,10938253,10939206,12p13,12p13.2,604790,"TRB1, T2R14","Taste receptor, family B, member 1",TAS2R14,50840,ENSG00000212127,NA,NA,Tas2r140 (MGI:2681298)
12,10985912,10986911,12p13.2,12p13.2,609627,"TAS2R50, T2R50, TAS2R51, T2R51","Taste receptor, type 2, member 50",TAS2R50,259296,ENSG00000212126,NA,NA,NA
12,10995961,10998303,12p13.2,12p13.2,613962,"TAS2R20, T2R56","Taste receptor, type 2, member 20",TAS2R20,259295,ENSG00000255837,NA,NA,NA
12,11021618,11022619,12p13,12p13.2,613961,"TAS2R19, T2R19, T2R48","Taste receptor, type 2, member 19",TAS2R19,259294,ENSG00000212124,NA,NA,NA
12,11030386,11031406,12p13.2,12p13.2,612669,"TAS2R31, TAS2R44, T2R53","Taste receptor, type 2, member 31",TAS2R31,259290,ENSG00000256436,NA,NA,Tas2r136 (MGI:2681304)
12,11061364,11062293,12p13.2,12p13.2,612774,"TAS2R46, T2R46, T2R54","Taste receptor, type 2, member 46",TAS2R46,259292,ENSG00000226761,NA,NA,Tas2r120 (MGI:2681256)
12,11091286,11092312,12p13.2,12p13.2,612668,"TAS2R43, T2R52","Taste receptor, type 2, member 43",TAS2R43,259289,ENSG00000255374,NA,NA,NA
12,11133284,11134243,12p13.2,12p13.2,613963,"TAS2R30, T2R30, T2R47","Taste receptor, type 2, member 30",TAS2R30,259293,ENSG00000256188,previously assigned to chr.1,NA,NA
12,11185992,11186936,12p13,12p13.2,613966,"TAS2R42, T2R42, T2R55","Taste receptor, type 2, member 42",TAS2R42,353164,ENSG00000186136,NA,NA,Tas2r131 (MGI:2681280)
12,11265913,11269706,12p13.2,12p13.2,168840,PRB3,"Proline-rich protein BstNI, subfamily-3 (parotid salivary glycoprotein)",PRB3,5544,ENSG00000197870,G1 allele,NA,NA
12,11307080,11310434,12p13.2,12p13.2,180990,PRB4,"Proline-rich protein BstNI, subfamily-4",PRB4,5545,ENSG00000230657,"Po, CON1, CON2 alleles",NA,NA
12,11351820,11355589,12p13.2,12p13.2,180989,PRB1,"Proline-rich protein BstNI, subfamily-1",PRB1,5542,ENSG00000251655,NA,NA,NA
12,11391539,11395566,12p13.2,12p13.2,168810,PRB2,"Proline-rich protein BstNI, subfamily-2 (parotid size variant)",PRB2,653247,ENSG00000121335,Ps allele,NA,NA
12,11649600,11895401,12p13,12p13.2,600618,"ETV6, TEL, THC5",ETS variant gene-6 (TEL oncogene),ETV6,2120,ENSG00000139083,fused to PDGFRB or AML1 in leukemia,"Leukemia, acute myeloid, somatic, 601626 (3); Thrombocytopenia 5, 616216 (3), Autosomal dominant",Etv6 (MGI:109336)
12,12049848,12099694,12p12,12p13.2,606126,BCLG,Apoptosis regulator BCLG,BCL2L14,79370,ENSG00000121380,NA,NA,Bcl2l14 (MGI:1914063)
12,12116024,12267043,12p13.3-p11.2,12p13.2,603507,"LRP6, ADCAD2, STHAG7",Low density lipoprotein receptor-related protein 6,LRP6,4040,ENSG00000070018,NA,"{Coronary artery disease, autosomal dominant, 2}, 610947 (3), Autosomal dominant; Tooth agenesis, selective, 7, 616724 (3), Autosomal dominant",Lrp6 (MGI:1298218)
12,12357077,12471232,12p13.2,12p13.2,616598,"BORCS5, LOH12CR1, MYRLYSIN","BLOC1-related complex, subunit 5",BORCS5,118426,ENSG00000165714,NA,NA,Borcs5 (MGI:1915024)
12,12473281,12562862,12p12,12p13.2,607175,"DUSP16, MKP7, KIAA1700",Dual-specificity phosphatase 16,DUSP16,80824,ENSG00000111266,NA,NA,Dusp16 (MGI:1917936)
12,12611875,12645107,12p13,12p13.1,603476,CREBL2,Cyclic AMP response element-binding protein-like 2,CREBL2,1389,ENSG00000111269,NA,NA,Crebl2 (MGI:1889385)
12,12659690,12717785,12p13.2-p12.3,12p13.1,602927,GPR19,G protein-coupled receptor-19,GPR19,2842,ENSG00000183150,NA,NA,Gpr19 (MGI:892973)
12,12717269,12722382,12p13,12p13.1,600778,"CDKN1B, KIP1, CDKN4, MEN4","Cyclin-dependent kinase inhibitor 1B (p27, Kip1)",CDKN1B,1027,ENSG00000111276,NA,"Multiple endocrine neoplasia, type IV, 610755 (3), Autosomal dominant",Cdkn1b (MGI:104565)
12,12725916,12791465,12p13.2,12p13.1,612456,"APOLD1, VERGE",Apolipoprotein L domain-containing 1,APOLD1,81575,ENSG00000178878,NA,NA,Apold1 (MGI:2685921)
12,12813345,12829980,12p13.1,12p13.1,615428,DDX47,DEAD box polypeptide 47,DDX47,51202,ENSG00000213782,NA,NA,Ddx47 (MGI:1915005)
12,12891021,12913665,12p13.1,12p13.1,604138,"GPRC5A, RAI3, RAIG1","G protein-coupled receptor, family C, group 5, member A",GPRC5A,9052,ENSG00000013588,NA,NA,Gprc5a (MGI:1891250)
12,12940517,12955907,12p13.3,12p13.1,607437,GPRC5D,"G protein-coupled receptor, family C, group 5, member D",GPRC5D,55507,ENSG00000111291,NA,NA,Gprc5d (MGI:1935037)
12,12974869,13000264,Chr.12,12p13.1,605826,"HEBP1, HBP",Heme-binding protein 1,HEBP1,50865,ENSG00000013583,NA,NA,Hebp1 (MGI:1333880)
12,13044380,13083448,12p13.1,12p13.1,617838,"FAM234B, KIAA1467","Family with sequence similarity 234, member B",FAM234B,57613,ENSG00000084444,NA,NA,Fam234b (MGI:1921775)
12,13196725,13219940,12p12.3,12p13.1,602333,"EMP1, TMP",Epithelial membrane protein-1,EMP1,2012,ENSG00000134531,NA,NA,Emp1 (MGI:107941)
12,13537336,13982011,12p12,12p13.1,138252,"GRIN2B, NMDAR2B, MRD6, EIEE27","Glutamate receptor, ionotropic, N-methyl D-aspartate 2B",GRIN2B,2904,ENSG00000273079,NA,"Epileptic encephalopathy, early infantile, 27, 616139 (3), Autosomal dominant; Mental retardation, autosomal dominant 6, 613970 (3), Autosomal dominant",Grin2b (MGI:95821)
12,14254913,14255485,12p13.1,12p13.1,139180,"GNAI2P1, GNAI2L, GNAI2A","Guanine nucleotide-binding protein (G protein), alpha-inhibiting, polypeptide 2 pseudogene 1",GNAI2P1,2772,NA,NA,NA,NA
12,14365631,14502934,12p13.1,12p13.1,613644,"ATF7IP, AM, MCAF, MCAF1",Activating transcription factor 7-interacting protein,ATF7IP,55729,ENSG00000171681,NA,NA,Atf7ip (MGI:1858965)
12,14612631,14696624,12p12,12p12.3,601330,"GUCY2C, GUC2C, DIAR6, MECIL",Guanylate cyclase 2C (heat stable enterotoxin receptor),GUCY2C,2984,ENSG00000070019,NA,"Diarrhea 6, 614616 (3), Autosomal dominant; Meconium ileus, 614665 (3), Autosomal recessive",Gucy2c (MGI:106903)
12,14770719,14771130,12p13.1,12p12.3,615069,HIST4H4,"Histone gene cluster 4, H4 histone",HIST4H4,121504,ENSG00000197837,NA,NA,Hist1h4i (MGI:2448432)
12,14784581,14803477,12p12.3,12p12.3,618083,"WBP11, NPWBP, SIPP1",WW-binding protein 11,WBP11,51729,ENSG00000084463,NA,NA,Wbp11 (MGI:1891823)
12,14825568,14843525,12p13-p12,12p12.3,110600,"ART4, DO, DOK1",ADP-ribosyltransferase-4 (Dombrock blood group),ART4,420,ENSG00000111339,NA,"[Blood group, Dombrock], 616060 (3)",Art4 (MGI:1202710)
12,14880863,14885853,12p13.1-p12.3,12p12.3,154870,MGP,Matrix Gla protein,MGP,4256,ENSG00000111341,NA,"Keutel syndrome, 245150 (3), Autosomal recessive",Mgp (MGI:96976)
12,14942014,14961600,12p12.3,12p12.3,602843,"ARHGDIB, GDID4, D4",Rho GDP dissociation inhibitor (GDI) beta,ARHGDIB,397,ENSG00000111348,NA,NA,Arhgdib (MGI:101940)
12,14973041,14981864,12p13,12p12.3,601190,"PDE6H, RCD3, ACHM6","Phosphodiesterase 6H, cGMP-specific, cone, gamma",PDE6H,5149,ENSG00000139053,NA,"Achromatopsia 6, 610024 (3), Autosomal recessive, Autosomal dominant; Retinal cone dystrophy 3, 610024 (3), Autosomal recessive, Autosomal dominant",Pde6h (MGI:1925850)
12,15107782,15221416,12p12,12p12.3,612664,RERG,Ras-like and estrogen-regulated growth inhibitor,RERG,85004,ENSG00000134533,NA,NA,Rerg (MGI:2665139)
12,15322333,15598330,12p13-p12,12p12.3,600579,"PTPRO, GLEPP1, NPHS6","Protein tyrosine phosphatase, receptor type, O",PTPRO,5800,ENSG00000151490,NA,"Nephrotic syndrome, type 6, 614196 (3), Autosomal recessive",Ptpro (MGI:1097152)
12,15620133,15789387,12p12.3,12p12.3,600206,"EPS8, DFNB102",Epidermal growth factor receptor pathway substrate-8,EPS8,2059,ENSG00000151491,mutation identified in 1 DFNB102 family,"?Deafness, autosomal recessive 102, 615974 (3), Autosomal recessive",Eps8 (MGI:104684)
12,15882381,15903477,12p12.3,12p12.3,605986,"STRAP, UNRIP, MAWD",Serine/threonine kinase receptor-associated protein,STRAP,11171,ENSG00000023734,previously assigned to 12q,NA,Strap (MGI:1329037)
12,16347141,16377191,Chr.12,12p12.3,138330,"MGST1, GST12",Microsomal glutathione S-transferase 1,MGST1,4257,ENSG00000008394,pseudogene at 12q13-q14,NA,Mgst1 (MGI:1913850)
12,16548371,16610232,12p13,12p12.3,180386,"LMO3, RBTNL2, RHOM3",LIM domain only 3 (rhombotin-like 2),LMO3,55885,ENSG00000048540,expressed mainly in brain,NA,NA
12,16988746,16990627,12p12,12p12.3,601435,"SKP1P2, SKP1B",S-phase kinase-associated protein 1 pseudogene 2 (p19B),SKP1P2,728622,NA,NA,NA,NA
12,18242945,18716860,12p12,12p12.3,609001,PIK3C2G,"Phosphatidylinositol 3-kinase, class 2, gamma",PIK3C2G,5288,ENSG00000139144,NA,NA,Pik3c2g (MGI:1203730)
12,18645528,18738051,12p12.3,12p12.3,608075,"PLCZ1, SPGF17","Phospholipase C, zeta-1",PLCZ1,89869,ENSG00000139151,mutation identified in 1 SPGF17 family,"?Spermatogenic failure 17, 617214 (3), Autosomal recessive",Plcz1 (MGI:2150308)
12,18738118,18739187,12p12,12p12.3,608722,"CAPZA3, CAPPA3","Capping protein, actin, alpha-3",CAPZA3,93661,ENSG00000177938,NA,NA,Capza3 (MGI:106221)
12,19129679,19376399,12p12,12p12.3,607770,"PEPP2, KIAA1686",Phosphatidylinositol 3-phosphate-binding PH domain protein 2,PLEKHA5,54477,ENSG00000052126,NA,NA,Plekha5 (MGI:1923802)
12,19404100,19522226,12p12.3,12p12.3,617934,AEBP2,AE-binding protein 2,AEBP2,121536,ENSG00000139154,NA,NA,Aebp2 (MGI:1338038)
12,19800000,26300000,12p12.2-p12.1,NA,608742,HYT4,"Hypertension, essential, susceptibility to, 4",NA,444980,NA,NA,"{Hypertension, essential, susceptibility to, 4}, 145500 (2), Multifactorial",NA
12,20369244,20688578,12p12.2,12p12.2,123805,"PDE3A, HTNB","Phosphodiesterase 3A, cGMP-inhibited",PDE3A,5139,ENSG00000172572,NA,"Hypertension and brachydactyly syndrome, 112410 (3), Autosomal dominant",Pde3a (MGI:1860764)
12,20681799,20753385,12p12,12p12.2,613389,"SLCO1C1, OATPF, OATP14, SLC21A14","Solute carrier organic anion transporter family, member 1C1",SLCO1C1,53919,ENSG00000139155,NA,NA,Slco1c1 (MGI:1889679)
12,20810704,20916910,12p12.2,12p12.2,605495,"SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR","Solute carrier organic anion transporter family, member 1B3",SLCO1B3,28234,ENSG00000111700,HBLRR digenic with SLCO1B1,"Hyperbilirubinemia, Rotor type, digenic, 237450 (3), Digenic recessive",Slco1b2 (MGI:1351899)
12,21131193,21239795,12p12,12p12.1,604843,"SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR","Solute carrier organic anion transporter family, member 1B1",SLCO1B1,10599,ENSG00000134538,HBLRR digenic with SLCO1B3,"Hyperbilirubinemia, Rotor type, digenic, 237450 (3), Digenic recessive",NA
12,21264599,21403662,12p12,12p12.1,602883,"SLC21A3, OATP","Solute carrier family 21 (organic anion transporter), member 3",SLCO1A2,6579,ENSG00000084453,NA,NA,Slco1a5 (MGI:1351865)
12,21354959,21379979,12p12.3-p12.1,12p12.1,147940,IAPP,Islet amyloid polypeptide (diabetes-associated peptide; amylin),IAPP,3375,ENSG00000121351,NA,NA,Iapp (MGI:96382)
12,21437629,21471251,12p12.1,12p12.1,617220,"PYROXD1, MFM8",Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1,PYROXD1,79912,ENSG00000121350,NA,"Myopathy, myofibrillar, 8, 617258 (3), Autosomal recessive",Pyroxd1 (MGI:2676395)
12,21468909,21501668,12p12-p11,12p12.1,600537,"RECQL, RECQL1","RecQ helicase-like (DNA helicase, RecQ-like 1)",RECQL,5965,ENSG00000004700,NA,NA,Recql (MGI:103021)
12,21501175,21518407,12p12.1,12p12.1,615078,"GOLT1B, GOT1B, GCT2",Golgi transport 1B,GOLT1B,51026,ENSG00000111711,NA,NA,Golt1b (MGI:1914214)
12,21531526,21604857,12p12.2,12p12.1,138571,GYS2,"Glycogen synthase-2, liver",GYS2,2998,ENSG00000111713,NA,"Glycogen storage disease 0, liver, 240600 (3), Autosomal recessive",Gys2 (MGI:2385254)
12,21635341,21657970,12p12.2-p12.1,12p12.1,150100,"LDHB, LDHBD",Lactate dehydrogenase B,LDHB,3945,ENSG00000111716,NA,"[Lactate dehydrogenase-B deficiency], 614128 (3)",Ldhb (MGI:96763)
12,21764954,21775592,12p11.23,12p12.1,600935,KCNJ8,"Potassium inwardly-rectifying channel, subfamily J, member 8",KCNJ8,3764,ENSG00000121361,NA,NA,Kcnj8 (MGI:1100508)
12,21797388,21941862,12p12.1,12p12.1,601439,"ABCC9, SUR2, CMD1O, ATFB12, CANTU","ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)",ABCC9,10060,ENSG00000069431,NA,"Atrial fibrillation, familial, 12, 614050 (3), Autosomal dominant; Cardiomyopathy, dilated, 1O, 608569 (3); Hypertrichotic osteochondrodysplasia, 239850 (3), Autosomal dominant",Abcc9 (MGI:1352630)
12,22046173,22065673,12p12.1,12p12.1,603316,CMAS,Cytidine monophosphate N-acetylneuraminic acid synthetase,CMAS,55907,ENSG00000111726,NA,NA,Cmas (MGI:1337124)
12,22193390,22334713,12p12.1-p11.2,12p12.1,601123,SIAT8,"Sialyltransferase-8 (alpha-N-acetylneuraminate: alpha-2,8-sialyltransferase, GD3 synthase)",ST8SIA1,6489,ENSG00000111728,NA,NA,St8sia1 (MGI:106011)
12,22448545,22544545,12p12.1,12p12.1,618044,"C2CD5, CDP138, KIAA0528",C2 calcium-dependent domain-containing protein 5,C2CD5,9847,ENSG00000111731,NA,NA,C2cd5 (MGI:1921991)
12,22625144,22690664,12p12.1-p11.2,12p12.1,609858,"ETNK1, EKI1",Ethanolamine kinase 1,ETNK1,55500,ENSG00000139163,NA,NA,Etnk1 (MGI:1922570)
12,23529498,24562700,12p12.1,12p12.1,604975,"SOX5, LAMSHF",SRY-box 5,SOX5,6660,ENSG00000134532,some LAMSHF patients have 12p12 deletions,"Lamb-Shaffer syndrome, 616803 (3), Autosomal dominant",Sox5 (MGI:98367)
12,24810023,24949100,12p12,12p12.1,113520,"BCAT1, BCT1","Branched chain aminotransferase-1, cytosolic",BCAT1,586,ENSG00000060982,NA,?Hyperleucinemia-isoleucinemia or hypervalinemia (1),Bcat1 (MGI:104861)
12,24917701,24918383,12p12.1-p11.2,12p12.1,609860,DADR,DAD1-related gene,DAD1P1,56286,NA,NA,NA,NA
12,25052227,25108334,12p12.1,12p12.1,602003,"LRMP, JAW1",Lymphoid-restricted membrane protein,LRMP,4033,ENSG00000118308,NA,NA,Lrmp (MGI:108424)
12,25107056,25195161,12p12.1,12p12.1,616906,"CASC1, LAS1, PPP1R54",Cancer susceptibility candidate 1,CASC1,55259,ENSG00000118307,NA,NA,Casc1 (MGI:2444480)
12,25205245,25250928,12p12.1,12p12.1,190070,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog,KRAS,3845,ENSG00000133703,pseudogene KRAS1P on 6p12-p11,"Arteriovenous malformation of the brain, somatic, 108010 (3); Bladder cancer, somatic, 109800 (3); Breast cancer, somatic, 114480 (3); Cardiofaciocutaneous syndrome 2, 615278 (3); Gastric cancer, somatic, 137215 (3); Leukemia, acute myeloid, 601626 (3), Autosomal dominant, Somatic mutation; Lung cancer, somatic, 211980 (3); Noonan syndrome 3, 609942 (3), Autosomal dominant; Pancreatic carcinoma, somatic, 260350 (3); RAS-associated autoimmune leukoproliferative disorder, 614470 (3), Autosomal dominant; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)",Kras (MGI:96680)
12,25476081,25648603,12p12.1,12p12.1,617254,"LMNTD1, IFLTD1, LMNARS1, PAS1C1",Lamin tail domain-containing protein 1,LMNTD1,160492,ENSG00000152936,NA,NA,Lmntd1 (MGI:1921321)
12,25958231,26079888,12p12.1,12p12.1,608231,"RASSF8, C12orf2","RAS association domain family, member 8",RASSF8,11228,ENSG00000123094,NA,NA,Rassf8 (MGI:1918573)
12,26120029,26125036,12p12.1-p11.23,12p12.1,606200,"BHLHE41, BHLHB3, DEC2, SHARP1","Basic helix-loop-helix domain-containing protein, member E41",BHLHE41,79365,ENSG00000123095,NA,"[Short sleeper], 612975 (3), Autosomal dominant",NA
12,26121950,26234776,12p11.2,12p12.1,601599,"SSPN, KRAG",Sarcospan (Kirsten-ras associated gene),SSPN,8082,ENSG00000123096,NA,NA,Sspn (MGI:1353511)
12,26300000,51100000,12p11.23-q13.12,NA,602096,AD5,"Alzheimer disease, familial, type 5",AD5,8081,NA,NA,"Alzheimer disease-5, 602096 (2), Autosomal dominant",NA
12,26300000,54500000,12p11.2-q13.1,NA,615022,ARCI7,"Ichthyosis, congenital, autosomal recessive 7",NA,101202686,NA,between D12S345 and D12S390,"Ichthyosis, congenital, autosomal recessive 7, 615022 (2), Autosomal recessive",NA
12,26300000,67300000,12p11.2-q14,NA,606257,STQTL3,Stature quantitative trait locus 3,NA,282549,NA,max lod at D12S398 and D12S10990,"{Stature QTL 3}, 606257 (2)",NA
12,26300000,57700000,12p11-q13,NA,615390,VUR7,Vesicoureteral reflux 7,NA,102095631,NA,max lod at D12S1048,"Vesicoureteral reflux 7, 615390 (2)",NA
12,26335351,26833196,12p11,12p11.23,600144,"ITPR2, ANHD","Inositol 1,4,5-triphosphate receptor, type 2",ITPR2,3709,ENSG00000123104,mutation has been identified in 1 ANHD family,"?Anhidrosis, isolated, with normal sweat glands, 106190 (3), Autosomal recessive",Itpr2 (MGI:99418)
12,26905170,26938337,12p11.23,12p11.23,615079,"ASUN, MAT89BB, GCT1","Asunder, spermatogenesis regulator",INTS13,55726,ENSG00000064102,NA,NA,Ints13 (MGI:1918427)
12,26966523,27014426,12q11-q12,12p11.23,605181,TM7SF3,"Transmembrane 7 superfamily, member 3",TM7SF3,51768,ENSG00000064115,NA,NA,Tm7sf3 (MGI:1914873)
12,27022521,27030672,12p11.23,12p11.23,603800,"MED21, SURB7, SRB7",Mediator complex subunit 21,MED21,9412,ENSG00000152944,NA,NA,Med21 (MGI:1347064)
12,27244232,27325958,12p12.3,12p11.23,615836,"STK38L, NDR2, KIAA0965",Serine/threonine protein kinase 38-like protein,STK38L,23012,ENSG00000211455,NA,NA,Stk38l (MGI:1922250)
12,27332835,27425812,12p11.23,12p11.23,614517,"ARNTL2, BMAL2, CLIF",Aryl hydrocarbon receptor nuclear translocator-like protein 2,ARNTL2,56938,ENSG00000029153,NA,NA,Arntl2 (MGI:2684845)
12,27524125,27695563,12p11.2,12p11.23-p11.22,603141,PPFIBP1,"Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein-binding protein 1",PPFIBP1,8496,ENSG00000110841,NA,NA,Ppfibp1 (MGI:1914783)
12,27696446,27697595,12p11.22,12p11.22,610848,REP15,Rab15 effector protein,REP15,387849,ENSG00000174236,NA,NA,Rep15 (MGI:1913782)
12,27710772,27756303,12q21.1-q21.3,12p11.22,611995,"MRPS35, MRPS28",Mitochondrial ribosomal protein S35,MRPS35,60488,ENSG00000061794,3 pseudogenes,NA,Mrps35 (MGI:2385255)
12,27958083,27972863,12p12.1-p11.2,12p11.22,168470,"PTHLH, BDE2",Parathyroid hormone-like hormone,PTHLH,5744,ENSG00000087494,NA,"Brachydactyly, type E2, 613382 (3), Autosomal dominant",Pthlh (MGI:97800)
12,28190445,28550165,12p11.22,12p11.22,617366,CCDC91,Coiled-coil domain-containing protein 91,CCDC91,55297,ENSG00000123106,NA,NA,Ccdc91 (MGI:1914265)
12,29149100,29335616,12p11.23,12p11.22,616156,"FAR2, MLSTD1",Fatty acyl CoA reductase 2,FAR2,55711,ENSG00000064763,NA,NA,Far2 (MGI:2687035)
12,29336543,29381171,12p11.22,12p11.22,612236,"ERGIC2, CDA14, PTX1",Endoplasmic reticulum-golgi intermediate compartment protein 2,ERGIC2,51290,ENSG00000087502,NA,NA,Ergic2 (MGI:1914706)
12,29500812,29784758,12p11.22,12p11.22,615855,TMTC1,Transmembrane and tetratricopeptide repeat domains-containing protein 1,TMTC1,83857,ENSG00000133687,NA,NA,Tmtc1 (MGI:3039590)
12,30628980,30695985,12p11.2,12p11.21,605600,"IPO8, RANBP8",Importin 8,IPO8,10526,ENSG00000133704,NA,NA,Ipo8 (MGI:2444611)
12,30709551,30754992,12p11.21,12p11.21,610375,"CAPRIN2, C1QDC1, EEG1, KIAA1873","Caprin family, member 2",CAPRIN2,65981,ENSG00000110888,NA,NA,Caprin2 (MGI:2448541)
12,31073859,31104798,12p11,12p11.21,601150,"DDX11, CHLR1, KRG2",DEAD/H box-11 (CHL1-related helicase gene-1),DDX11,1663,ENSG00000013573,NA,"Warsaw breakage syndrome, 613398 (3), Autosomal recessive",Ddx11 (MGI:2443590)
12,31280583,31326217,12p11,12p11.21,615027,"SINHCAF, FAM60A",SIN3-HDAC complex associated factor,SINHCAF,58516,ENSG00000139146,NA,NA,Sinhcaf (MGI:1929091)
12,31382222,31591135,12p11.21,12p11.21,617279,DENND5B,DENN domain-containing protein 5B,DENND5B,160518,ENSG00000170456,NA,NA,Dennd5b (MGI:2444273)
12,31647159,31673113,12p11.21,12p11.21,615256,"ETFBKMT, METTL20, C12orf72",Electron transfer flavoprotein beta-subunit lysine methyltransferase,ETFBKMT,254013,ENSG00000139160,NA,NA,Etfbkmt (MGI:2443575)
12,31791184,31792297,12p11.21,12p11.21,616134,H3F3C,"H3 histone, family 3C",H3F3C,440093,ENSG00000188375,NA,NA,Gm12657 (MGI:3651714)
12,32106772,32383636,12p11.2-p11.1,12p11.21,602204,BICD1,"Bicaudal-D, Drosophila, homolog of, 1",BICD1,636,ENSG00000151746,second homolog on 9q,NA,Bicd1 (MGI:1101760)
12,32399522,32646049,12p11.2,12p11.21,611104,"FGD4, FRABIN, CMT4H","FYVE, RhoGEF, and PH domain-containing protein 4",FGD4,121512,ENSG00000139132,NA,"Charcot-Marie-Tooth disease, type 4H, 609311 (3), Autosomal recessive",Fgd4 (MGI:2183747)
12,32679199,32745649,12p11.21,12p11.21,603850,"DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5",Dynamin 1-like,DNM1L,10059,ENSG00000087470,NA,"Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3), Autosomal recessive, Autosomal dominant; Optic atrophy 5, 610708 (3), Autosomal dominant",Dnm1l (MGI:1921256)
12,32725246,32756457,12p11.21,12p11.21,610957,"YARS2, TYRRS, MLASA2",Tyrosyl-tRNA synthetase 2,YARS2,51067,ENSG00000139131,NA,"Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3), Autosomal recessive",Yars2 (MGI:1917370)
12,32790745,32896845,12p11,12p11.21,602861,"PKP2, ARVD9",Plakophilin-2,PKP2,5318,ENSG00000057294,pseudogene on 12p13,"Arrhythmogenic right ventricular dysplasia 9, 609040 (3), Autosomal dominant",Pkp2 (MGI:1914701)
12,34022314,34035295,12p11.1,12p11.1,618355,"ALG10A, ALG10","Alg10, S. cerevisiae, homolog of, A",ALG10,84920,ENSG00000139133,NA,NA,Alg10b (MGI:2146159)
12,35500000,133275309,12q,NA,179010,"IHPS1, IHPS","Pyloric stenosis, infantile hypertrophic 1",NA,NA,NA,NA,"Pyloric stenosis, infantile hypertrophic 1, 179010 (2), Autosomal dominant, Multifactorial",NA
12,37800000,92200000,12q12-q21,NA,102300,RLS1,"Restless legs syndrome, susceptibility to, 1",NA,192142,NA,between D12S1044 and D12S78,"{Restless legs syndrome 1}, 102300 (2), Autosomal dominant",NA
12,38316678,38329724,12q12,12q12,603313,"ALG10B, KCR1, ALG10","Alg10, S. cerevisiae, homolog of, B",ALG10B,144245,ENSG00000175548,NA,"{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3), Autosomal dominant",NA
12,39293227,39443146,12q12,12q12,608283,"KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B",Kinesin family member 21A,KIF21A,55605,ENSG00000139116,NA,"Fibrosis of extraocular muscles, congenital, 1, 135700 (3), Autosomal dominant; Fibrosis of extraocular muscles, congenital, 3B, 135700 (3), Autosomal dominant",Kif21a (MGI:109188)
12,39530964,39651332,12q11-q12,12q12,601081,"ABCD2, ALDR, ALDL1","ATP-binding cassette, subfamily D, member 2",ABCD2,225,ENSG00000173208,NA,NA,Abcd2 (MGI:1349467)
12,39755020,40106084,12q12,12q12,611036,"SLC2A13, HMIT","Solute carrier family 2 (facilitated glucose transporter), member 13",SLC2A13,114134,ENSG00000151229,NA,NA,Slc2a13 (MGI:2146030)
12,40224889,40369284,12q12,12q12,609007,"LRRK2, PARK8",Leucine-rich repeat kinase 2 (dardarin),LRRK2,120892,ENSG00000188906,NA,"{Parkinson disease 8}, 607060 (3), Autosomal dominant",Lrrk2 (MGI:1913975)
12,40393393,40570756,12q12,12q12,612170,MUC19,"Mucin 19, oligomeric",MUC19,283463,NA,NA,NA,NA
12,40692428,41072414,12q11-q12,12q12,600016,"CNTN1, MYPCN",Contactin 1,CNTN1,1272,ENSG00000018236,mutation identified in 1 MYPCN family,"?Myopathy, congenital, Compton-North, 612540 (3), Autosomal recessive",Cntn1 (MGI:105980)
12,41188319,41574744,12q12,12q12,609730,PDZRN4,PDZ domain-containing ring finger protein 4,PDZRN4,29951,ENSG00000165966,NA,NA,Pdzrn4 (MGI:3056996)
12,42081844,42144873,12q12,12q12,613321,"GXYLT1, GLT8D3",Glucoside xylosyltransferase 1,GXYLT1,283464,ENSG00000151233,NA,NA,Gxylt1 (MGI:2684933)
12,42157103,42238372,12q12,12q12,607534,YAF2,YY1-associated factor 2,YAF2,10138,ENSG00000015153,NA,NA,NA
12,42312085,42326106,12q12,12q12,610750,"ZCRB1, MADP1",Zinc finger CCHC domain- and RNA-binding motif-containing protein 1,ZCRB1,85437,ENSG00000139168,"possible pseudogenes on chr16, X, and 6",NA,Zcrb1 (MGI:1914447)
12,42326125,42448620,12q12,12q12,608150,PPHLN1,Periphilin 1,PPHLN1,51535,ENSG00000134283,NA,NA,Pphln1 (MGI:1917029)
12,42456756,42589754,12q12,12q12,608500,"PRICKLE1, RILP, EPM1B",Prickle-like 1,PRICKLE1,144165,ENSG00000139174,NA,"Epilepsy, progressive myoclonic 1B, 612437 (3), Autosomal recessive",Prickle1 (MGI:1916034)
12,43352842,43552202,12q11,12q12,611681,ADAMTS20,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 20",ADAMTS20,80070,ENSG00000173157,NA,NA,Adamts20 (MGI:2660628)
12,43758908,43789542,12q12,12q12,606883,"IRAK4, REN64, IPD1",Interleukin 1 receptor-associated kinase 4,IRAK4,51135,ENSG00000198001,NA,"IRAK4 deficiency, 607676 (3); Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)",Irak4 (MGI:2182474)
12,43793722,43806374,12q12,12q12,610932,"TWF1, PTK9","Twinfilin, Drosophila, homolog of, 1",TWF1,5756,ENSG00000151239,NA,NA,Twf1 (MGI:1100520)
12,44508274,44921847,12q13.11-q13.12,12q12,602320,NELL2,Nel-like 2,NELL2,4753,ENSG00000184613,NA,NA,Nell2 (MGI:1858510)
12,45216032,45440403,12q12,12q12,608663,"ANO6, TMEM16F, SCTS, BDPLT7",Anoctamin 6,ANO6,196527,ENSG00000177119,NA,"Scott syndrome, 262890 (3), Autosomal recessive",Ano6 (MGI:2145890)
12,45729705,45908036,12q12,12q12,609539,"ARID2, BAF200, KIAA1557, CSS6",AT-rich interaction domain-containing protein 2,ARID2,196528,ENSG00000189079,NA,"Coffin-Siris syndrome 6, 617808 (3), Autosomal dominant",Arid2 (MGI:1924294)
12,45919130,45992039,12q12-q13.11,12q12,603668,"SCAF11, SFRS2IP, SIP1, CASP11, SRRP129",SR-related C-terminal domain-associated factor 11,SCAF11,9169,ENSG00000139218,previously assigned to 21q22.3,NA,Scaf11 (MGI:1919443)
12,46000000,57700000,12q13,NA,613061,BCC4,"Basal cell carcinoma, susceptibility to, 4",NA,100307121,NA,associated with rs11170164,"{Basal cell carcinoma, susceptibility to, 4}, 613061 (2)",NA
12,46000000,57700000,12q13,NA,616182,CMTS,"Chronic mountain sickness, susceptibility to",NA,105180377,NA,NA,"{Chronic mountain sickness, susceptibility to}, 616182 (2)",NA
12,46000000,67300000,12q13-q14,NA,607841,DFNA48,"Deafness, autosomal dominant 48",NA,NA,NA,NA,"Deafness, autosomal dominant 48, 607841 (2), Autosomal dominant",NA
12,46000000,92200000,12q13-q21,NA,600808,ENUR2,"Enuresis, nocturnal, 2",ENUR2,2032,NA,NA,"Enuresis, nocturnal, 2, 600808 (2), Autosomal dominant",NA
12,46000000,57700000,12q13,NA,167960,HPV18I2,Human papillomavirus type 18 integration site-2,HPV18I2,3261,NA,on 8 near MYC in HeLa,NA,NA
12,46000000,71100000,12q13.11-q15,NA,614346,MRT25,"Mental retardation, autosomal recessive 25",MRT25,100852403,NA,between rs4760658 and rs1882033,"Mental retardation, autosomal recessive 25, 614346 (2), Autosomal recessive",NA
12,46000000,54500000,12q13.1,NA,613488,MXLPO,Myxoid liposarcoma,NA,NA,NA,fusion of DDIT3 and FUS,"Myxoid liposarcoma, 613488 (4)",NA
12,46000000,67300000,12q13-q14,NA,604681,PABPL2,Poly(A)-binding protein-like 2,NA,NA,NA,?pseudogenes on 3q and 13q,NA,NA
12,46000000,57700000,12q13,NA,184100,SPDT,"Spondyloepiphyseal dysplasia tarda, autosomal dominant",NA,103875461,NA,NA,"Spondyloepiphyseal dysplasia tarda, autosomal dominant, 184100 (2), Autosomal dominant",NA
12,46183062,46269148,12q13.11,12q13.11,608490,SLC38A1,"Solute carrier family 38 (amino acid transporter), member 1",SLC38A1,81539,ENSG00000111371,NA,NA,Slc38a1 (MGI:2145895)
12,46358187,46372773,12q13.11,12q13.11,605180,"SLC38A2, ATA2, KIAA1382","Solute carrier family 38, member 2",SLC38A2,54407,ENSG00000134294,NA,NA,Slc38a2 (MGI:1915010)
12,46764760,46832421,12q13,12q13.11,608065,"SLC38A4, NAT3, ATA3","Solute carrier family 38 (amino acid transporter), member 4",SLC38A4,55089,ENSG00000139209,NA,NA,Slc38a4 (MGI:1916604)
12,47075706,47079958,12q13.11,12q13.11,615690,"AMIGO2, ALI1",Adhesion molecule with Ig-like domain 2,AMIGO2,347902,ENSG00000139211,NA,NA,Amigo2 (MGI:2145995)
12,47661248,47706060,12q13.11,12q13.11,611477,RPAP3,RNA polymerase II-associated protein 3,RPAP3,79657,ENSG00000005175,NA,NA,Rpap3 (MGI:1277218)
12,47709733,47725489,12q13.1,12q13.11,606720,"ENDOU, PP11",Endonuclease polyU-specific,ENDOU,8909,ENSG00000111405,NA,NA,Endou (MGI:97746)
12,47753618,47782752,12q13,12q13.11,612187,HRG1,Heme-responsive gene 1,SLC48A1,55652,ENSG00000211584,NA,NA,Slc48a1 (MGI:1914989)
12,47734362,47758879,Chr.12,12q13.11,606057,EPAC,cAMP-regulated guanine nucleotide exchange factor I,RAPGEF3,10411,ENSG00000079337,NA,NA,Rapgef3 (MGI:2441741)
12,47782721,47820611,Chr.12,12q13.11,606542,"HDAC7A, HDAC7",Histone deacetylase 7A,HDAC7,51564,ENSG00000061273,NA,NA,Hdac7 (MGI:1891835)
12,47841536,47905030,12q12-q14,12q13.11,601769,VDR,"Vitamin D (1,25-dihydroxyvitamin D3) receptor",VDR,7421,ENSG00000111424,NA,"?Osteoporosis, involutional, 166710 (1), Autosomal dominant; Rickets, vitamin D-resistant, type IIA, 277440 (3), Autosomal recessive",Vdr (MGI:103076)
12,47972966,48006211,12q13.11-q13.2,12q13.11,120140,COL2A1,"Collagen II, alpha-1 polypeptide",COL2A1,1280,ENSG00000139219,NA,"Achondrogenesis, type II or hypochondrogenesis, 200610 (3), Autosomal dominant; Avascular necrosis of the femoral head, 608805 (3), Autosomal dominant; Czech dysplasia, 609162 (3), Autosomal dominant; Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3), Autosomal dominant; Kniest dysplasia, 156550 (3), Autosomal dominant; Legg-Calve-Perthes disease, 150600 (3), Autosomal dominant; Osteoarthritis with mild chondrodysplasia, 604864 (3), Autosomal dominant; Platyspondylic skeletal dysplasia, Torrance type, 151210 (3), Autosomal dominant; SED congenita, 183900 (3), Autosomal dominant; SMED Strudwick type, 184250 (3), Autosomal dominant; Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3), Autosomal dominant; Spondyloperipheral dysplasia, 271700 (3), Autosomal dominant; Stickler sydrome, type I, nonsyndromic ocular, 609508 (3), Autosomal dominant; Stickler syndrome, type I, 108300 (3), Autosomal dominant; Vitreoretinopathy with phalangeal epiphyseal dysplasia (3)",Col2a1 (MGI:88452)
12,48042892,48106307,12q13.1,12q13.11,612157,SENP1,"Sentrin-specific protease family, member 1",SENP1,29843,ENSG00000079387,NA,NA,Senp1 (MGI:2445054)
12,48105252,48146403,12q13.3,12q13.11,610681,"PFKM, GSD7","Phosphofructokinase, muscle type",PFKM,5213,ENSG00000152556,incorrectly assigned to chr.1,"Glycogen storage disease VII, 232800 (3), Autosomal recessive",Pfkm (MGI:97548)
12,48147788,48157514,12q13,12q13.11,615053,ASB8,Ankyrin repeat- and SOCS box-containing protein 8,ASB8,140461,ENSG00000177981,NA,NA,Asb8 (MGI:1925791)
12,48334379,48351413,12q13.11,12q13.11,613906,ZNF641,Zinc finger protein 641,ZNF641,121274,ENSG00000167528,NA,NA,Zfp641 (MGI:2442788)
12,48472664,48473059,12q13.11,12q13.11,606878,"ANP32D, PP32R2","Acidic leucine-rich nuclear phosphoprotein 32 family, member D",ANP32D,23519,ENSG00000139223,NA,NA,NA
12,48567683,48571882,12q13,12q13.11,149750,LALBA,"Lactalbumin, alpha",LALBA,3906,ENSG00000167531,NA,NA,Lalba (MGI:96742)
12,48653210,48682237,12q13.11,12q13.11,615488,"KANSL2, NSL2, C12orf41","KAT8 regulatory NSL complex, subunit 2",KANSL2,54934,ENSG00000139620,NA,NA,Kansl2 (MGI:1916862)
12,48654381,48654517,12q13.11,12q13.11,615487,"SNORA2C, SNORA34, ACA34, MIR1291","Small nucleolar RNA, H/ACA box, 34",SNORA2C,677815,ENSG00000221491,MIR1291 in intron of SNORA34,NA,NA
12,48688457,48716706,12q11-q13.3,12q13.11-q13.12,143055,"CCNT1, CCNT",Cyclin T1,CCNT1,904,ENSG00000129315,NA,NA,Ccnt1 (MGI:1328363)
12,48766193,48789088,12q12-q13,12q13.12,600294,"ADCY6, LCCS8",Adenylate cyclase-6,ADCY6,112,ENSG00000174233,mutation identified in 1 LCCS8 family,"?Lethal congenital contracture syndrome 8, 616287 (3), Autosomal recessive",Adcy6 (MGI:87917)
12,48814431,48828940,12q13,12q13.12,601958,CACNB3,"Calcium channel, voltage-dependent, beta 3 subunit",CACNB3,784,ENSG00000167535,NA,NA,Cacnb3 (MGI:103307)
12,48829755,48852162,12q13.12,12q13.12,612172,"DDX23, PRP28",Dead box polypeptide 23,DDX23,9416,ENSG00000174243,NA,NA,Ddx23 (MGI:1921601)
12,48857144,48865869,12q13.12,12q13.12,609038,"RND1, RHO6",Rho family GTPase 1,RND1,27289,ENSG00000172602,NA,NA,Rnd1 (MGI:2444878)
12,48904132,48921575,12q13.12,12q13.12,611088,"CCDC65, CILD27",Coiled-coil domain-containing protein 65,CCDC65,85478,ENSG00000139537,NA,"Ciliary dyskinesia, primary, 27, 615504 (3), Autosomal recessive",Ccdc65 (MGI:2146001)
12,48921962,48925546,12q13,12q13.12,610571,"FKBP11, FKBP19",FK506-binding protein 11,FKBP11,51303,ENSG00000134285,NA,NA,Fkbp11 (MGI:1913370)
12,48930251,48957525,12q13,12q13.12,103190,ARF3,ADP-ribosylation factor-3,ARF3,377,ENSG00000134287,NA,NA,Arf3 (MGI:99432)
12,48965339,48979586,12q13,12q13.12,601906,"WNT10B, SHFM6, STHAG8","Wingless-type MMTV integration site family, member 10B",WNT10B,7480,ENSG00000169884,NA,"Split-hand/foot malformation 6, 225300 (3), Autosomal recessive; Tooth agenesis, selective, 8, 617073 (3), Autosomal dominant",Wnt10b (MGI:108061)
12,48978321,48982619,12q12-q13,12q13.12,164820,"WNT1, INT1, OI15, BMND16","Wingless-type MMTV integration site family, member 1 (oncogene INT1)",WNT1,7471,ENSG00000125084,NA,"Osteogenesis imperfecta, type XV, 615220 (3), Autosomal recessive; {Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)",Wnt1 (MGI:98953)
12,48995148,49001772,12q13.1,12q13.12,610588,"DDN, KIAA0749",Dendrin,DDN,23109,ENSG00000181418,NA,NA,Ddn (MGI:108101)
12,49002271,49018974,12q13.1,12q13.12,602742,PRKAG1,"Protein kinase, AMP-activated, noncatalytic, gamma-1",PRKAG1,5571,ENSG00000181929,NA,NA,Prkag1 (MGI:108411)
12,49018974,49060883,12q13.12,12q13.12,602113,"KMT2D, MLL2, ALR, KABUK1",Lysine (K)-specific methyltransferase 2D,KMT2D,8085,ENSG00000167548,NA,"Kabuki syndrome 1, 147920 (3), Autosomal dominant",Kmt2d (MGI:2682319)
12,49086655,49094800,12q13.1,12q13.12,605423,"DHH, SRXY7, GDXYM",Desert hedgehog,DHH,50846,ENSG00000139549,NA,"46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3); 46XY sex reversal 7, 233420 (3), Autosomal recessive",Dhh (MGI:94891)
12,49096550,49110899,12q13.12,12q13.12,610007,"LMBR1L, LIMR, KIAA1174",Limb region 1 homolog-like,LMBR1L,55716,ENSG00000139636,NA,NA,Lmbr1l (MGI:1289247)
12,49127781,49131394,12q13.12,12q13.12,602530,TUBA1B,"Tubulin, alpha-1B",TUBA1B,10376,ENSG00000123416,NA,NA,Tuba1b (MGI:107804)
12,49184794,49189323,12q12-q14,12q13.12,602529,"TUBA1A, TUBA3, LIS3","Tubulin, alpha-1A",TUBA1A,7846,ENSG00000167552,NA,"Lissencephaly 3, 611603 (3), Autosomal dominant",Tuba1a (MGI:98869)
12,49295143,49298697,12q12-q13,12q13.12,170710,PRPH,Peripherin,PRPH,5630,ENSG00000135406,NA,"{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominant",Prph (MGI:97774)
12,49323254,49331732,12q13.2,12q13.12,603872,"TROAP, TASTIN",Trophinin-associated protein,TROAP,10024,ENSG00000135451,NA,NA,Troap (MGI:1925983)
12,49332408,49337194,12q13,12q13.12,615229,"C1QL4, CTRP11","Complement component 1, q subcomponent-like 4",C1QL4,338761,ENSG00000186897,NA,NA,C1ql4 (MGI:3579909)
12,49366904,49527440,12q13.2,12q13.12,611667,"SPATS2, SPATA10, P59SCR, SCR59",Spermatogenesis-associated serine-rich protein 2,SPATS2,65244,ENSG00000123352,NA,NA,Spats2 (MGI:1919822)
12,49538540,49558336,12q13,12q13.12,604527,"KCNH3, BEC1","Potassium voltage-gated channel, subfamily H (eag-related), member 3",KCNH3,23416,ENSG00000135519,NA,NA,Kcnh3 (MGI:1341723)
12,49558293,49568232,12q13.12,12q13.12,609504,"MCRS1, MSP58, MCRS2","Microspherule protein 1 (microspherule protein 2, included)",MCRS1,10445,ENSG00000187778,NA,NA,Mcrs1 (MGI:1858420)
12,49636498,49707404,12q13,12q13.12,616288,"FMNL3, FRL2",Formin-like 3,FMNL3,91010,ENSG00000161791,NA,NA,Fmnl3 (MGI:109569)
12,49741556,49764933,12q13.12,12q13.12,600748,"TMBIM6, TEGT",Transmembrane BAX inhibitor motif-containing protein 6,TMBIM6,7009,ENSG00000139644,NA,NA,Tmbim6 (MGI:99682)
12,49791138,49828749,12q13.12,12q13.12,615104,"NCKAP5L, KIAA1602",NCK-associated protein 5-like,NCKAP5L,57701,ENSG00000167566,NA,NA,Nckap5l (MGI:3609653)
12,49866895,49903899,12q13,12q13.12,604306,"FAIM2, LFG, NMP35",FAS apoptotic inhibitory molecule 2,FAIM2,23017,ENSG00000135472,NA,NA,Faim2 (MGI:1919643)
12,49950740,49958880,12q13,12q13.12,107777,AQP2,Aquaporin-2 (collecting duct),AQP2,359,ENSG00000167580,NA,"Diabetes insipidus, nephrogenic, 125800 (3), Autosomal recessive, Autosomal dominant",Aqp2 (MGI:1096865)
12,49961854,49965681,12q13,12q13.12,600442,"AQP5, PPKB",Aquaporin-5,AQP5,362,ENSG00000161798,NA,"Palmoplantar keratoderma, Bothnian type, 600231 (3), Autosomal dominant",Aqp5 (MGI:106215)
12,49972946,49977138,12q13,12q13.12,601383,"AQP6, AQP2L","Aquaporin-6, kidney specific",AQP6,363,ENSG00000086159,NA,NA,Aqp6 (MGI:1341204)
12,49989161,50033205,12q13.12,12q13.12,604980,"RCGAP1, MGCRACGAP, CYK4","GTPase-activating protein, Rac, 1",RACGAP1,29127,ENSG00000161800,NA,NA,Racgap1 (MGI:1349423)
12,50057595,50083621,12q12,12q13.12,602866,ACCN2,"Cation channel, amiloride-sensitive, neuronal, 2",ASIC1,41,ENSG00000110881,NA,NA,Asic1 (MGI:1194915)
12,50085235,50100706,12q13-q14,12q13.12,601735,"SMARCD1, BAF60A","SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1",SMARCD1,6602,ENSG00000066117,NA,NA,Smarcd1 (MGI:1933623)
12,50104007,50111312,12q12-q13,12q13.12,138420,"GPD1, HTGTI","Glycerol-3-phosphate dehydrogenase, soluble",GPD1,2819,ENSG00000167588,NA,"Hypertriglyceridemia, transient infantile, 614480 (3), Autosomal recessive",Gpd1 (MGI:95679)
12,50112235,50120452,12q13.12,12q13.12,614478,"COX14, C12orf62",Cytochrome c oxidase assembly protein COX14,COX14,84987,ENSG00000178449,mutation identified in 1 Cox4 deficient family,"?Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Cox14 (MGI:1913629)
12,50129298,50167532,12q13.12,12q13.12,615335,"CERS5, LASS5, TRH4",Ceramide synthase 5,CERS5,91012,ENSG00000139624,NA,NA,Cers5 (MGI:1919199)
12,50175779,50283519,12q13,12q13.12,608364,"LIMA1, EPLIN, SREBP3, LDLCQ8",LIM domain and actin-binding protein 1,LIMA1,51474,ENSG00000050405,NA,"[Low density lipoprotein cholesterol level QTL 8], 618079 (3)",Lima1 (MGI:1920992)
12,50504984,50748656,12q13.12,12q13.12,611379,"DIP2B, KIAA1463","Disco-interacting protein 2, Drosophila, homolog of, B",DIP2B,57609,ENSG00000066084,NA,"Mental retardation, FRA12A type, 136630 (3), Autosomal dominant",Dip2b (MGI:2145977)
12,50763681,50821161,12q13,12q13.12,123803,"ATF1, TREB36",Activating transcription factor 1,ATF1,466,ENSG00000123268,"fused with EWS in soft tissue clear cell sarcoma, with FUS in angiomatoid fibrous histiocytoma",NA,"Atf1,Atf1-ps (MGI:3037720,MGI:1298366)"
12,50925014,50932507,12q13.12,12q13.12,618338,"METTL7A, AAMB",Methyltransferase-like protein 7A,METTL7A,25840,ENSG00000185432,NA,NA,Mettl7a1 (MGI:1916523)
12,50952262,51028334,12q13,12q13.12,600523,"SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1",Solute carrier family 11 (proton-coupled divalent metal ion transporter) member 2,SLC11A2,4891,ENSG00000110911,NA,"Anemia, hypochromic microcytic, with iron overload 1, 206100 (3), Autosomal recessive",Slc11a2 (MGI:1345279)
12,51093655,51173134,12q13,12q13.12-q13.13,189889,TFCP2,"Transcription factor CP2, alpha globin",TFCP2,7024,ENSG00000135457,NA,NA,Tfcp2 (MGI:98509)
12,51186935,51219874,12q13.13,12q13.13,618043,"POU6F1, BRN5, MPOU","POU domain, class 6, transcription factor 1",POU6F1,5463,ENSG00000184271,NA,NA,Pou6f1 (MGI:102935)
12,51281037,51324667,12q13.13,12q13.13,605936,BIN2,Bridging integrator 2,BIN2,51411,ENSG00000110934,previously mapped to 4q22.1,NA,Bin2 (MGI:3611448)
12,51328441,51346678,12q13,12q13.13,130120,"CELA1, ELA1","Chymotrypsin-like elastase family, member 1",CELA1,1990,ENSG00000139610,on proximal 12p,NA,Cela1 (MGI:95314)
12,51351251,51391954,12q13,12q13.13,605148,"GALNT6, GalNAcT6",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6,GALNT6,11226,ENSG00000139629,NA,NA,Galnt6 (MGI:1891640)
12,51391316,51515762,Chr.12,12q13.13,605024,"SLC4A8, NBC3","Solute carrier family 4 (sodium bicarbonate cotransporter), member 8",SLC4A8,9498,ENSG00000050438,NA,NA,Slc4a8 (MGI:1928745)
12,51591232,51812863,12q13,12q13.13,600702,"SCN8A, CIAT, EIEE13, BFIS5, MYOCL2","Sodium channel, voltage gated, type VIII, alpha polypeptide",SCN8A,6334,ENSG00000196876,mutation identified in 1 MYOCL2 family,"Cognitive impairment with or without cerebellar ataxia, 614306 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 13, 614558 (3), Autosomal dominant; ?Myoclonus, familial, 2, 618364 (3), Autosomal dominant; Seizures, benign familial infantile, 5, 617080 (3), Autosomal dominant",Scn8a (MGI:103169)
12,51906912,51923360,12q11-q14,12q13.13,601284,"ACVRL1, ACVRLK1, ALK1, HHT2","Activin A receptor, type II-like kinase 1",ACVRL1,94,ENSG00000139567,NA,"Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3), Autosomal dominant",Acvrl1 (MGI:1338946)
12,51951695,51997078,12q13,12q13.13,601300,"ACVR1B, ACVRLK4, ALK4","Activin A receptor, type IB",ACVR1B,91,ENSG00000135503,NA,"Pancreatic cancer, somatic (3)",Acvr1b (MGI:1338944)
12,52006945,52015888,12q13.13,12q13.13,612027,"GRASP, TAMALIN",GRP1-associated scaffold protein,GRASP,160622,ENSG00000161835,NA,NA,Grasp (MGI:1860303)
12,52022831,52059506,12q13,12q13.13,139139,"NR4A1, HMR, NP10, GFRP1","Nuclear receptor subfamily 4, group A, member 1",NR4A1,3164,ENSG00000123358,NA,NA,Nr4a1 (MGI:1352454)
12,52069922,52077494,12q13.13,12q13.13,615089,"ATG101, C12orf44",Autophagy-related protein 101,ATG101,60673,ENSG00000123395,NA,NA,Atg101 (MGI:1915368)
12,52168995,52192013,12q13.13,12q13.13,611161,"KRT80, KB20",Keratin 80,KRT80,144501,ENSG00000167767,NA,NA,Krt80 (MGI:1921377)
12,52233242,52252666,12q12-q14,12q13.13,148059,KRT7,Keratin 7,KRT7,3855,ENSG00000135480,NA,NA,Krt7 (MGI:96704)
12,52270506,52309162,12q13,12q13.13,601928,"KRT86, KRTHB6, HB6",Keratin 86,KRT86,3892,ENSG00000170442,NA,"Monilethrix, 158000 (3), Autosomal dominant",Krt86 (MGI:109362)
12,52285912,52291533,12q13,12q13.13,602153,"KRT81, KRTHB1, HB1",Keratin 81,KRT81,3887,ENSG00000205426,NA,"Monilethrix, 158000 (3), Autosomal dominant",Krt81 (MGI:1928858)
12,52314300,52321397,12q13,12q13.13,602765,"KRT83, KRTHB3, HB3, MNLIX, EKVP5",Keratin 83,KRT83,3889,ENSG00000170523,NA,"Erythrokeratodermia variabilis et progressiva 5, 617756 (3), Autosomal recessive; Monilethrix, 158000 (3), Autosomal dominant",Krt83 (MGI:3690448)
12,52360005,52367480,12q13,12q13.13,602767,"KRT85, KRTHB5, HB5, ECTD4",Keratin 85,KRT85,3891,ENSG00000135443,NA,"Ectodermal dysplasia 4, hair/nail type, 602032 (3), Autosomal recessive",NA
12,52377664,52386976,12q13.13,12q13.13,602766,"KRT84, KRTHB4, HB4",Keratin 84,KRT84,3890,ENSG00000161849,NA,NA,Krt84 (MGI:96700)
12,52393950,52406391,12q13.13,12q13.13,601078,"KRT82, KRTHB2, HB2",Keratin 82,KRT82,3888,ENSG00000161850,NA,NA,Krt82 (MGI:2149248)
12,52424069,52434370,12q13,12q13.13,609025,"KRT75, K6HF, PFB",Keratin 75,KRT75,9119,ENSG00000170454,NA,"{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)",Krt75 (MGI:1923500)
12,52446650,52452145,12q13,12q13.13,148042,"KRT6B, PC4",Keratin 6B,KRT6B,3854,ENSG00000185479,NA,"Pachyonychia congenita 4, 615728 (3)","Krt6a,Krt6b (MGI:1333768,MGI:1100845)"
12,52468515,52473804,12q13.13,12q13.13,612315,"KRT6C, PPKNEFD",Keratin 6C,KRT6C,286887,ENSG00000170465,NA,"Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3), Autosomal dominant",NA
12,52487175,52493256,12q13,12q13.13,148041,"KRT6A, PC3",Keratin 6A,KRT6A,3853,ENSG00000205420,NA,"Pachyonychia congenita 3, 615726 (3)",NA
12,52514574,52520393,12q13,12q13.13,148040,"KRT5, DDD1",Keratin 5,KRT5,3852,ENSG00000186081,NA,"Dowling-Degos disease 1, 179850 (3), Autosomal dominant; Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3), Autosomal dominant; Epidermolysis bullosa simplex, Koebner type, 131900 (3), Autosomal dominant; Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3), Autosomal dominant; Epidermolysis bullosa simplex, recessive 1, 601001 (3), Autosomal recessive; Epidermolysis bullosa simplex-MCR, 609352 (3); Epidermolysis bullosa simplex-MP, 131960 (3), Autosomal dominant",Krt5 (MGI:96702)
12,52543908,52553144,12q13,12q13.13,608245,"KRT71, K6IRS1, KRT6IRS1, HYPT13",Keratin 71,KRT71,112802,ENSG00000139648,mutation identified in 1 HYPT13 family,"?Hypotrichosis 13, 615896 (3), Autosomal dominant",Krt71 (MGI:1861586)
12,52565781,52573842,12q13,12q13.13,608248,"KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH",Keratin 74,KRT74,121391,ENSG00000170484,mutation identified in 1 HYPT3 family and ECTD7 family,"?Ectodermal dysplasia 7, hair/nail type, 614929 (3), Autosomal recessive; ?Hypotrichosis 3, 613981 (3), Autosomal dominant; Woolly hair, autosomal dominant, 194300 (3), Autosomal dominant",NA
12,52585588,52602899,12q13,12q13.13,608246,"KRT72, K6IRS2, KRT6IRS2",Keratin 72,KRT72,140807,ENSG00000170486,NA,NA,Krt72 (MGI:2146034)
12,52601812,52620132,12q13,12q13.13,608247,"KRT73, K6IRS3, KRT6IRS3",Keratin 73,KRT73,319101,ENSG00000186049,NA,NA,Krt73 (MGI:3607712)
12,52644557,52652210,12q11-q13,12q13.13,600194,"KRT2, KRT2A, KRT2E",Keratin 2,KRT2,3849,ENSG00000172867,NA,"Ichthyosis bullosa of Siemens, 146800 (3), Autosomal dominant",NA
12,52674735,52680406,12q13,12q13.13,139350,"KRT1, EPPK, NEPPK, EHK",Keratin 1,KRT1,3848,ENSG00000167768,close to Hox-3 in mouse; class II keratin,"Epidermolytic hyperkeratosis, 113800 (3), Autosomal recessive, Autosomal dominant; Ichthyosis histrix, Curth-Macklin type, 146590 (3), Autosomal dominant; Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3), Autosomal dominant; Keratosis palmoplantaris striata III, 607654 (3); Palmoplantar keratoderma, epidermolytic, 144200 (3), Autosomal dominant; Palmoplantar keratoderma, nonepidermolytic, 600962 (3), Autosomal dominant",Krt1 (MGI:96698)
12,52689611,52703523,12q13.13,12q13.13,611158,"KRT77, K1B",Keratin 77,KRT77,374454,ENSG00000189182,NA,NA,Krt77 (MGI:3588209)
12,52768154,52777344,12q13.13,12q13.13,616671,"KRT76, K76, KRT2P","Keratin 76, type II",KRT76,51350,ENSG00000185069,NA,NA,Krt76 (MGI:1924305)
12,52789684,52805734,12q13,12q13.13,148043,KRT3,Keratin 3,KRT3,3850,ENSG00000186442,NA,"Meesmann corneal dystrophy, 122100 (3), Autosomal dominant",NA
12,52806548,52814115,12q13,12q13.13,123940,"KRT4, CYK4, WSN1",Keratin 4,KRT4,3851,ENSG00000170477,class II keratin,"White sponge nevus 1, 193900 (3), Autosomal dominant",Krt4 (MGI:96701)
12,52821407,52834310,12q13.13,12q13.13,611160,"KRT79,  KRT6L, K6L",Keratin 79,KRT79,338785,ENSG00000185640,NA,NA,Krt79 (MGI:2385030)
12,52837803,52848993,12q13.13,12q13.13,611159,"KRT78, K5B",Keratin 78,KRT78,196374,ENSG00000170423,NA,NA,Krt78 (MGI:1917529)
12,52897186,52949865,12q13,12q13.13,148060,KRT8,Keratin 8,KRT8,3856,ENSG00000170421,NA,"Cirrhosis, cryptogenic, 215600 (3), Autosomal recessive; {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3), Autosomal recessive",Krt8 (MGI:96705)
12,52948870,52952905,12q13,12q13.13,148070,KRT18,Keratin 18,KRT18,3875,ENSG00000111057,"contiguous to KRT8, type II heteromer partner","Cirrhosis, cryptogenic, 215600 (3), Autosomal recessive; {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3), Autosomal recessive",Krt18 (MGI:96692)
12,53006455,53042214,12q13.13,12q13.13,603928,EIF4B,Eukaryotic translation initiation factor 4B,EIF4B,1975,ENSG00000063046,NA,NA,Eif4b (MGI:95304)
12,53046979,53064378,12q13.13,12q13.13,607717,"TNS2, TENC1, C1TEN, KIAA1075",Tensin 2,TNS2,23371,ENSG00000111077,NA,NA,Tns2 (MGI:2387586)
12,53097666,53102339,Chr.12,12q13.13,146735,IGFBP6,Insulin-like growth factor-binding protein-6,IGFBP6,3489,ENSG00000167779,NA,NA,Igfbp6 (MGI:96441)
12,53103485,53124534,12q13,12q13.13,601311,"SOAT2, ACACT2",Sterol O-acyltransferase 2,SOAT2,8435,ENSG00000167780,NA,NA,Soat2 (MGI:1332226)
12,53157662,53181662,12q13.13,12q13.13,616569,"CSAD, CSD, PCAP",Cysteine sulfinic acid decarboxylase,CSAD,51380,ENSG00000139631,NA,NA,Csad (MGI:2180098)
12,53191317,53207374,12q13.13,12q13.13,147559,ITGB7,"Integrin, beta-7",ITGB7,3695,ENSG00000139626,NA,NA,Itgb7 (MGI:96616)
12,53210565,53232255,12q13,12q13.13,180190,RARG,"Retinoic acid receptor, gamma polypeptide",RARG,5916,ENSG00000172819,NA,NA,Rarg (MGI:97858)
12,53268256,53293642,12q13,12q13.13,604143,"ESPL1, ESP1",Extra spindle poles-like 1,ESPL1,9700,ENSG00000135476,prev. mapping to chr.8,NA,Espl1 (MGI:2146156)
12,53295450,53299449,12q12,12q13.13,604899,"PFDN5, MM1",Prefoldin 5,PFDN5,5204,ENSG00000123349,NA,NA,Pfdn5 (MGI:1928753)
12,53299694,53307176,12q13,12q13.13,611366,"C12orf10, MYG1",Chromosome 12 open reading frame 10,C12orf10,60314,ENSG00000139637,NA,NA,Myg1 (MGI:1929864)
12,53307455,53321609,12q13,12q13.13,605378,"AAAS, AAA",Aladin,AAAS,8086,ENSG00000094914,NA,"Achalasia-addisonianism-alacrimia syndrome, 231550 (3), Autosomal recessive",Aaas (MGI:2443767)
12,53326574,53344792,12q13.13,12q13.13,606633,"SP7, OSX, OI12",Transcription factor Sp7,SP7,121340,ENSG00000170374,NA,"Osteogenesis imperfecta, type XII, 613849 (3), Autosomal recessive",Sp7 (MGI:2153568)
12,53380175,53416445,12q13.1,12q13.13,189906,SP1,Sp1 transcription factor,SP1,6667,ENSG00000185591,NA,NA,Sp1 (MGI:98372)
12,53423854,53431671,12q13,12q13.13,600956,"AMHR2, AMHR","Anti-Mullerian hormone receptor, type II",AMHR2,269,ENSG00000135409,NA,"Persistent Mullerian duct syndrome, type II, 261550 (3), Autosomal recessive",Amhr2 (MGI:105062)
12,53441648,53446642,12q13.13,12q13.13,610459,"PRR13, TXR1",Proline-rich protein 13,PRR13,54458,ENSG00000205352,NA,NA,NA
12,53452101,53481161,12q13.12-q13.13,12q13.13,601210,PCBP2,Poly(rC)-binding protein-2,PCBP2,5094,ENSG00000197111,NA,NA,Pcbp2 (MGI:108202)
12,53479668,53501204,12q13,12q13.13,600447,"MAP3K12, ZPK",Mitogen-activated protein kinase kinase kinase 12,MAP3K12,7786,ENSG00000139625,NA,NA,Map3k12 (MGI:1346881)
12,53500920,53506430,12p12.1-q13.1,12q13.13,605053,TARBP2,TAR RNA-binding protein 2,TARBP2,6895,ENSG00000139546,pseudogene on 8q22-qter,NA,Tarbp2 (MGI:103027)
12,53507855,53626414,Chr.12,12q13.13,606371,ATF7,Activating transcription factor 7,ATF7,11016,ENSG00000170653,NA,NA,Atf7 (MGI:2443472)
12,53665159,53677545,Chr.12,12q13.13,603193,ATP5G2,"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 2",ATP5MC2,517,ENSG00000135390,NA,NA,Atp5g2 (MGI:1915192)
12,53938830,53946543,12q13,12q13.13,142976,"HOXC13, HOX3G, ECTD9",Homeo box-C13,HOXC13,3229,ENSG00000123364,fused with NUP98 in AML,"Ectodermal dysplasia 9, hair/nail type, 614931 (3), Autosomal recessive",Hoxc13 (MGI:99560)
12,53954902,53958955,12q13,12q13.13,142975,"HOXC12, HOX3F",Homeo box-C12,HOXC12,3228,ENSG00000123407,NA,NA,Hoxc12 (MGI:96194)
12,53962307,53974955,12q13.13,12q13.13,611400,HOTAIR,Hox transcript antisense RNA,HOTAIR,100124700,ENSG00000228630,NA,NA,NA
12,53973125,53977642,Chr.12,12q13.13,605559,HOXC11,Homeo box-C11,HOXC11,3227,ENSG00000123388,NA,NA,Hoxc11 (MGI:96193)
12,53985145,53990278,Chr.12,12q13.13,605560,HOXC10,Homeo box-C10,HOXC10,3226,ENSG00000180818,NA,NA,Hoxc10 (MGI:96192)
12,53991737,53991846,12q13,12q13.13,609687,"MIR196A2, MIRN196A2",Micro RNA 196A2,MIR196A2,406973,ENSG00000207924,NA,NA,NA
12,54000160,54003336,12q13,12q13.13,142971,"HOXC9, HOX3B",Homeo box-C9,HOXC9,3225,ENSG00000180806,NA,NA,Hoxc9 (MGI:96199)
12,54008984,54012768,12q13,12q13.13,142970,"HOXC8, HOX3A",Homeo box-C8,HOXC8,3224,ENSG00000037965,NA,NA,Hoxc8 (MGI:96198)
12,54016887,54056029,12q13,12q13.13,142974,"HOXC4, HOX3E",Homeo box-C4,HOXC4,3221,ENSG00000198353,NA,NA,Hoxc4 (MGI:96195)
12,54016887,54035360,12q13,12q13.13,142973,"HOXC5, HOX3D",Homeo box-C5,HOXC5,3222,ENSG00000172789,NA,NA,Hoxc5 (MGI:96196)
12,54016887,54030822,12q13,12q13.13,142972,"HOXC6, HOX3C",Homeo box-C6,HOXC6,3223,ENSG00000197757,NA,NA,Hoxc6 (MGI:96197)
12,54121273,54188993,12q,12q13.13,607753,SMUG1,Single-strand-selective monofunctional uracil-DNA glycosylase 1,SMUG1,23583,ENSG00000123415,NA,NA,Smug1 (MGI:1918976)
12,54230941,54280121,12q13.13,12q13.13,604478,"CBX5, HP1",Chromobox homolog 5,CBX5,23468,ENSG00000094916,NA,NA,Cbx5 (MGI:109372)
12,54280689,54287087,12q13.1,12q13.13,164017,"HNRNPA1, IBMPFD3, ALS20",Heterogeneous nuclear ribonucleoprotein A1,HNRNPA1,3178,ENSG00000135486,mutation identified in 1 family with IBMPFD3,"Amyotrophic lateral sclerosis 20, 615426 (3), Autosomal dominant; ?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3), Autosomal dominant",NA
12,54292106,54301036,12q13,12q13.13,601490,NFE2,"Nuclear factor, erythroid-derived 2, 45kD",NFE2,4778,ENSG00000123405,NA,NA,Nfe2 (MGI:97308)
12,54325089,54351850,12q13.13,12q13.13,615472,"COPZ1, COPZ","Coatomer protein complex, subunit zeta-1",COPZ1,22818,ENSG00000111481,NA,NA,Copz1 (MGI:1929063)
12,54337215,54337313,12q13.13,12q13.13,613787,"MIR148B, MIRN148B",Micro RNA 148B,MIR148B,442892,ENSG00000199122,NA,NA,NA
12,54362444,54365223,12q13.13,12q13.13,606383,GPR84,G protein-coupled receptor 84,GPR84,53831,ENSG00000139572,NA,NA,Gpr84 (MGI:1934129)
12,54369133,54391609,12q13.13,12q13.13,609124,"ZNF385A, ZNF385, RZF, HZF",Zinc finger protein 385A,ZNF385A,25946,ENSG00000161642,NA,NA,Zfp385a (MGI:1352495)
12,54395260,54419265,12q11-q13,12q13.13,135620,"ITGA5, FNRA, VLA5A","Integrin, alpha-5 (fibronectin receptor, alpha subunit; very late activation protein-5, alpha subunit)",ITGA5,3678,ENSG00000161638,NA,NA,Itga5 (MGI:96604)
12,54455951,54473601,12q13.2,12q13.13,617484,"GTSF1, FAM112B",Gametocyte-specific factor 1,GTSF1,121355,ENSG00000170627,NA,NA,Gtsf1 (MGI:1921424)
12,54497751,54548242,12q13.1,12q13.1-q13.2,141180,HEM1,Hematopoietic protein-1,NCKAP1L,3071,ENSG00000123338,NA,NA,Nckap1l (MGI:1926063)
12,54549392,54579238,12q13,12q13.2,171891,"PDE1B1, PDES1B, PDE1B",Phosphodiesterase-1B,PDE1B,5153,ENSG00000123360,NA,NA,Pde1b (MGI:97523)
12,54579245,54588658,12q13.2,12q13.2,613246,"PPP1R1A, IPP1, I1","Protein phosphatase 1, regulatory subunit 1A",PPP1R1A,5502,ENSG00000135447,NA,NA,Ppp1r1a (MGI:1889595)
12,54630810,54634894,12q13,12q13.2,607360,LACRT,Lacritin,LACRT,90070,ENSG00000135413,NA,NA,NA
12,54644588,54648364,12q13.1,12q13.2,606634,DCD,Dermcidin,DCD,117159,ENSG00000161634,NA,NA,NA
12,54854515,54858386,12q13.2,12q13.2,610857,SBEM,Small breast epithelial mucin,MUCL1,118430,ENSG00000172551,NA,NA,NA
12,54948014,54984761,12q13.2,12q13.2,615664,"TESPA1, KIAA0748",Thymocyte-expressed positive selection-associated protein 1,TESPA1,9840,ENSG00000135426,NA,NA,Tespa1 (MGI:1914846)
12,55019973,55030016,12q13,12q13.2,611635,"NEUROD4, MATH3",Neurogenic differentiation 4,NEUROD4,58158,ENSG00000123307,NA,NA,Neurod4 (MGI:108055)
12,55684567,55716036,12q13,12q13.2,600536,ITGA7,"Integrin, alpha-7",ITGA7,3679,ENSG00000135424,NA,"Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3), Autosomal recessive",Itga7 (MGI:102700)
12,55716033,55719706,12q13-q14,12q13.2,601444,GCN5L1,"GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 1",BLOC1S1,2647,ENSG00000135441,NA,NA,Bloc1s1 (MGI:1195276)
12,55720392,55724741,12q13-q14,12q13.2,601617,RDH5,Retinol dehydrogenase-5,RDH5,5959,ENSG00000135437,NA,"Fundus albipunctatus, 136880 (3), Autosomal recessive, Autosomal dominant",Rdh5 (MGI:1201412)
12,55725442,55729672,12q12-q13,12q13.2,155740,"CD63, MLA1",CD63 antigen (melanoma 1 antigen),CD63,967,ENSG00000135404,NA,NA,Cd63 (MGI:99529)
12,55743121,55757263,12q13.13,12q13.2,603936,"GDF11, BMP11",Growth/differentiation factor 11,GDF11,10220,ENSG00000135414,NA,NA,Gdf11 (MGI:1338027)
12,55752462,55817755,12q13,12q13.2,610049,"SARNP, CIP29, HCC1, HSPC316",SAP domain-containing ribonucleoprotein,SARNP,84324,ENSG00000205323,fused with MLL in AML,NA,Sarnp (MGI:1913368)
12,55818040,55821878,12q13.2,12q13.2,610074,ORMDL2,ORM1-like protein 2,ORMDL2,29095,ENSG00000123353,pseudogene on 8q22.1,NA,Ormdl2 (MGI:1914094)
12,55820959,55829635,12q13.1-q13.2,12q13.2,606092,"DRIP78, HDJ3","Dopamine receptor-interacting protein, 78kD",DNAJC14,85406,ENSG00000135392,NA,NA,Dnajc14 (MGI:1921580)
12,55835429,55842982,12q14,12q13.2,601807,"MMP19, MMP18, CODA",Matrix metalloproteinase-19,MMP19,4327,ENSG00000123342,triplication in upstream regulatory region,"Cavitary optic disc anomalies, 611543 (3), Autosomal dominant",Mmp19 (MGI:1927899)
12,55931090,55954022,12q13.3,12q13.2,125855,"DGKA, DAGK1","Diacylglycerol kinase, alpha, 80kD",DGKA,1606,ENSG00000065357,NA,NA,Dgka (MGI:102952)
12,55954104,55966711,12q13-q14,12q13.2,155550,"SILV, D12S53E, PMEL17","Silver, mouse, homolog of",PMEL,6490,ENSG00000185664,NA,NA,Pmel (MGI:98301)
12,55966829,55972788,12q13,12q13.2,116953,CDK2,Cyclin-dependent kinase 2,CDK2,1017,ENSG00000123374,NA,NA,Cdk2 (MGI:104772)
12,55973912,55996682,12q13,12q13.2,179514,RAB5B,Ras-associated protein RAB5B,RAB5B,5869,ENSG00000111540,NA,NA,Rab5b (MGI:105938)
12,55992546,56005524,Chr.12,12q13.2,606887,SUOX,Sulfite oxidase,SUOX,6821,ENSG00000139531,NA,"Sulfite oxidase deficiency, 272300 (3), Autosomal recessive",Suox (MGI:2446117)
12,56007503,56038434,12q13,12q13.2,606239,"IKZF4, ZNFN1A4, EOS, KIAA1782",Ikaros family zinc finger 4,IKZF4,64375,ENSG00000123411,NA,NA,Ikzf4 (MGI:1343139)
12,56041917,56044696,12q,12q13.2,603701,"RPS26, DBA10",Ribosomal protein S26,RPS26,6231,ENSG00000197728,NA,"Diamond-Blackfan anemia 10, 613309 (3), Autosomal dominant",Rps26 (MGI:1351628)
12,56080024,56103506,12q13,12q13.2,190151,"ERBB3, LCCS2, FERLK",Transformation gene ERBB-3,ERBB3,2065,ENSG00000065361,mutations identified in 1 LCCS2 family and 1 FERLK family,"{?Erythroleukemia, familial, susceptibility to}, 133180 (3), Autosomal dominant; ?Lethal congenital contractural syndrome 2, 607598 (3), Autosomal recessive",Erbb3 (MGI:95411)
12,56104558,56113909,12q13,12q13.2,602145,PA2G4,"Proliferation-associated 2G4, 38kD",PA2G4,5036,ENSG00000170515,family of genes on 7 chromosomes,NA,Pa2g4 (MGI:894684)
12,56116632,56117966,12q13.2,12q13.2,613315,"RPL41, HG12",Ribosomal protein L41,RPL41,6171,ENSG00000229117,NA,NA,NA
12,56128201,56144675,12q13.2,12q13.2,616670,"ESYT1, MBC2, FAM62A",Extended synaptotagmin-like protein 1,ESYT1,23344,ENSG00000139641,NA,NA,Esyt1 (MGI:1344426)
12,56152586,56157981,12q13.13,12q13.2,609930,"MYL6B, MLC1SA","Myosin, light chain 6B, alkali, smooth muscle and nonmuscle, slow",MYL6B,140465,ENSG00000196465,NA,NA,Myl6b (MGI:1917789)
12,56158358,56161578,12q13.2,12q13.2,609931,MYL6,"Myosin light chain 6, alkali, smooth muscle and nonmuscle",MYL6,4637,ENSG00000092841,NA,NA,Myl6 (MGI:109318)
12,56162358,56189503,12q13-q14,12q13.2,601734,"SMARCC2, BAF170, CSS8","SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2",SMARCC2,6601,ENSG00000139613,NA,"Coffin-Siris syndrome 8, 618362 (3), Autosomal dominant",Smarcc2 (MGI:1915344)
12,56200000,57700000,12q13.3,NA,614375,AAA4,"Aortic aneurysm, familial abdominal, 4",NA,100859927,NA,associated with rs1466535,"Aortic aneurysm, familial abdominal, 4, 614375 (2)",NA
12,56222011,56229857,12q13.3,12q13.3,612104,"OBFC2B, SSB1",Oligonucleotide/oligosaccharide-binding fold-containing protein 2B,NABP2,79035,ENSG00000139579,NA,NA,Nabp2 (MGI:1917167)
12,56230035,56237849,12q13.3,12q13.3,608730,"SLC39A5, MYP24","Solute carrier family 39 (zinc transporter), member 5",SLC39A5,283375,ENSG00000139540,NA,"Myopia 24, autosomal dominant, 615946 (3), Autosomal dominant",Slc39a5 (MGI:1919336)
12,56271698,56300329,12q13.2-q13.3,12q13.3,118950,CS,"Citrate synthase, mitochondrial",CS,1431,ENSG00000062485,NA,NA,Cs (MGI:88529)
12,56309843,56316347,12q15,12q13.3,605861,"CNPY4, TMEM4, MSAP","Canopy 2, zebrafish, homolog of",CNPY2,10330,ENSG00000257727,NA,NA,Cnpy2 (MGI:1928477)
12,56316222,56333999,12q13.3,12q13.3,617447,"PAN2, USP52, KIAA0710",PABP-dependent poly(A) nuclease 2,PAN2,9924,ENSG00000135473,NA,NA,Pan2 (MGI:1918984)
12,56334158,56340409,12q13.2,12q13.3,605580,"IL23A, SGRF, P19, IL23P19","Interleukin 23, p19 subunit",IL23A,51561,ENSG00000110944,NA,NA,Il23a (MGI:1932410)
12,56341596,56360160,12q13.2,12q13.3,600556,"STAT2, IMD44",Signal transducer and activator of transcription 2,STAT2,6773,ENSG00000170581,NA,"Immunodeficiency 44, 616636 (3), Autosomal recessive",Stat2 (MGI:103039)
12,56360567,56362856,12q13.3,12q13.3,107760,"APOF, LTIP",Apolipoprotein F,APOF,319,ENSG00000175336,NA,NA,Apof (MGI:104539)
12,56416362,56449464,12q12-q13,12q13.3,603887,"TIMELESS, TIM, TIM1","Timeless, Drosophila, homolog of",TIMELESS,8914,ENSG00000111602,NA,NA,Timeless (MGI:1321393)
12,56449501,56456552,12q13,12q13.3,154050,"MIP, AQP0, CTRCT15",Major intrinsic protein of lens fiber,MIP,4284,ENSG00000135517,slightly distal to AQP2,"Cataract 15, multiple types, 615274 (3), Autosomal dominant",Mip (MGI:96990)
12,56470943,56488413,12q13,12q13.3,606365,"GLS2, GA","Glutaminase, liver",GLS2,27165,ENSG00000135423,NA,NA,Gls2 (MGI:2143539)
12,56520405,56596192,12q13.3,12q13.3,602387,"RBMS2, SCR3","RNA-binding motif protein, single strand interacting, 2",RBMS2,5939,ENSG00000076067,NA,NA,Rbms2 (MGI:1861776)
12,56595595,56636815,12q24.3-qter,12q13.3,605682,BAZ2A,"Bromodomain adjacent to zinc finger domain, 2A",BAZ2A,11176,ENSG00000076108,NA,NA,Baz2a (MGI:2151152)
12,56638174,56645983,12p13-qter,12q13.3,102910,"ATP5B, ATPSB","ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide",ATP5F1B,506,ENSG00000110955,NA,NA,Atp5b (MGI:107801)
12,56663340,56689574,12q13.3,12q13.3,607061,"PTGES3, P23, CPGES",Prostaglandin E synthase 3,PTGES3,10728,ENSG00000110958,NA,NA,"Ptges3,Ptges3-ps (MGI:1929282,MGI:3704271)"
12,56712426,56725298,12q23-q24.1,12q13.3,601234,NACA,Nascent-polypeptide-associated complex alpha polypeptide,NACA,4666,ENSG00000196531,NA,NA,Naca (MGI:106095)
12,56731579,56752322,12q13,12q13.3,176635,PRIM1,"Primase, polypeptide-1, 49kD",PRIM1,5557,ENSG00000198056,NA,NA,Prim1 (MGI:97757)
12,56752448,56787789,12q13,12q13.3,606623,HSE,3-alpha-hydroxysteroid epimerase,HSD17B6,8630,ENSG00000025423,NA,NA,Hsd17b6 (MGI:1351670)
12,56923132,56934407,12q13.3,12q13.3,609769,"SDR9C7, SDRO, ARCI13",Short chain dehydrogenase/reductase family 9C member 7,SDR9C7,121214,ENSG00000170426,NA,"Ichthyosis, congenital, autosomal recessive 13, 617574 (3), Autosomal recessive",Sdr9c7 (MGI:1917311)
12,57009996,57016559,12q13-q21,12q13.3,162330,"TAC3, NKNB, HH10","Tachykinin 3 (neuromedin K, neurokinin B)",TAC3,6866,ENSG00000166863,NA,"Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3), Autosomal recessive",Tac2 (MGI:98476)
12,57028516,57051197,12q13-q15,12q13.3,601478,MYO1A,Myosin IA,MYO1A,4640,ENSG00000166866,NA,NA,Myo1a (MGI:107732)
12,57055642,57088702,12q13.3,12q13.3,616496,"NEMP1, TMEM194A",Nuclear envelope integral membrane protein 1,NEMP1,23306,ENSG00000166881,NA,NA,Nemp1 (MGI:2446113)
12,57089113,57095475,12q13.3-q14.1,12q13.3,602381,NAB2,NGFIA-binding protein-2,NAB2,4665,ENSG00000166886,NA,NA,Nab2 (MGI:107563)
12,57095403,57111412,12q13,12q13.3,601512,STAT6,"Signal transducer and activator of transcription-6, interleukin-4 induced",STAT6,6778,ENSG00000166888,NA,NA,Stat6 (MGI:103034)
12,57128400,57213376,12q13.1-q13.3,12q13.3,107770,"LRP1, A2MR, KPA",Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor),LRP1,4035,ENSG00000123384,mutation identified in 1 KPA family,"?Keratosis pilaris atrophicans, 604093 (3), Autosomal recessive",Lrp1 (MGI:96828)
12,57216793,57226448,12q13.3,12q13.3,604637,"NXPH4, NPH4",Neuroexophilin 4,NXPH4,11247,ENSG00000182379,NA,NA,Nxph4 (MGI:1336197)
12,57229572,57234934,12q13,12q13.3,138450,"SHMT2, GLYA",Serine hydroxymethyltransferase,SHMT2,6472,ENSG00000182199,glycine A auxotroph,NA,Shmt2 (MGI:1277989)
12,57243452,57251192,12q13.3,12q13.3,615521,"STAC3, NAM, MYPBB",SH3 and cystein-rich domains 3,STAC3,246329,ENSG00000185482,NA,"Myopathy, congenital, Baily-Bloch, 255995 (3), Autosomal recessive",Stac3 (MGI:3606571)
12,57434783,57452061,12q13.1,12q13.3,601233,INHBC,"Inhibin, beta C",INHBC,3626,ENSG00000175189,NA,NA,Inhbc (MGI:105932)
12,57455306,57458024,12q13.3,12q13.3,612031,INHBE,"Inhibin, beta E",INHBE,83729,ENSG00000139269,NA,NA,Inhbe (MGI:109269)
12,57459784,57472450,12q13.2-q13.3,12q13.3,165220,"GLI1, PAPA8, PPD1",GLI family zinc finger 1,GLI1,2735,ENSG00000111087,mutation identified in 1 PPD1 family,"Polydactyly, postaxial, type A8, 618123 (3), Autosomal recessive; Polydactyly, preaxial I, 174400 (3), Autosomal recessive",Gli1 (MGI:95727)
12,57472261,57488823,12q14,12q13.3,610576,ARHGAP9,Rho GTPase-activating protein 9,ARHGAP9,64333,ENSG00000123329,NA,NA,Arhgap9 (MGI:2143764)
12,57488067,57516654,12q13.3,12q13.3,156560,"MARS, MTRNS, METRS, ILLD, CMT2U",Methioninyl-tRNA synthetase,MARS1,4141,ENSG00000166986,NA,"Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3), Autosomal dominant; Interstitial lung and liver disease, 615486 (3), Autosomal recessive",Mars (MGI:1345633)
12,57516587,57520516,12q13.1-q13.2,12q13.3,126337,"DDIT3, GADD153, CHOP10",DNA-damage-inducible transcript-3,DDIT3,1649,ENSG00000175197,fused with FUS in myxoid liposarcoma,NA,Ddit3 (MGI:109247)
12,57519162,57519258,12q13.3,12q13.3,614489,MIR616,Micro RNA 616,MIR616,693201,ENSG00000208028,NA,NA,NA
12,57530049,57547330,12q13.3,12q13.3,607376,"DCTN2, DCTN50",Dynactin 2,DCTN2,10540,ENSG00000175203,NA,NA,Dctn2 (MGI:107733)
12,57550038,57586632,12q13,12q13.3,602821,"KIF5A, NKHC, SPG10, NEIMY, ALS25",Kinesin family member 5A,KIF5A,3798,ENSG00000155980,NA,"{Amyotrophic lateral sclerosis, susceptibility to, 25}, 617921 (3), Autosomal dominant; Myoclonus, intractable, neonatal, 617235 (3), Autosomal dominant; Spastic paraplegia 10, autosomal dominant, 604187 (3), Autosomal dominant",Kif5a (MGI:109564)
12,57591187,57603417,12q13.3,12q13.3,617104,"PIP4K2C, PIP5K2C","Phosphatidylinositol 5-phosphate 4-kinase, type II, gamma",PIP4K2C,79837,ENSG00000166908,NA,NA,Pip4k2c (MGI:2152214)
12,57604326,57609801,12q13.3,12q13.3,613142,DTX3,"Deltex, Drosophila, homolog of, 3",DTX3,196403,ENSG00000178498,NA,NA,Dtx3 (MGI:2135752)
12,57610115,57617244,12q13.11,12q13.3,610215,"ARHGEF25, GEFT",Rho guanine nucleotide exchange factor 25,ARHGEF25,115557,ENSG00000240771,NA,NA,Arhgef25 (MGI:1277173)
12,57623408,57633238,12q13.3,12q13.3,601873,"B4GALNT1, GALGT, GALNACT, SPG26","Beta-1,4-N-acetylgalactosaminyltransferase 1",B4GALNT1,2583,ENSG00000135454,NA,"Spastic paraplegia 26, autosomal recessive, 609195 (3), Autosomal recessive",B4galnt1 (MGI:1342057)
12,57693954,57721556,12q13,12q13.3-q14.1,609677,OS9,Amplified in osteosarcoma 9,OS9,10956,ENSG00000135506,NA,NA,Os9 (MGI:1924301)
12,57700000,67300000,12q14,NA,177700,GLC1P,"Glaucoma 1, open angle, P",NA,NA,NA,caused by 300kb duplication,"Glaucoma 1, open angle, P, 177700 (4), Autosomal dominant",NA
12,57700000,67300000,12q14,NA,614354,PRO2268,PRO2268 gene,NA,55390,NA,NA,NA,NA
12,57723760,57742200,12q14.1,12q14.1,605476,"AGAP2, CENTG1, PIKE","ARF-GAP with GTP-binding protein-like, ankyrin repeat, and pleckstrin homology domains 2",AGAP2,116986,ENSG00000135439,NA,NA,Agap2 (MGI:3580016)
12,57745038,57750218,12q13-q14,12q14.1,181035,"TSPAN31, SAS",Tetraspanin 31,TSPAN31,6302,ENSG00000135452,NA,NA,Tspan31 (MGI:1914375)
12,57747726,57752309,12q14,12q14.1,123829,"CDK4, CMM3",Cyclin-dependent kinase 4,CDK4,1019,ENSG00000135446,NA,"{Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant",Cdk4 (MGI:88357)
12,57755102,57760410,12q14.1,12q14.1,613336,MARCH9,Membrane-associated RING-CH finger protein 9,MARCHF9,92979,ENSG00000139266,NA,NA,March9 (MGI:2446144)
12,57762333,57767077,12q13.1-q13.3,12q14.1,609506,"CYP27B1, VDD1, PDDR","Cytochrome P450, subfamily XXVIIB, polypeptide 1",CYP27B1,1594,ENSG00000111012,NA,"Vitamin D-dependent rickets, type I, 264700 (3), Autosomal recessive",Cyp27b1 (MGI:1098274)
12,57768470,57772104,12q13,12q14.1,604466,METTL1,Methyltransferase-like 1,METTL1,4234,ENSG00000037897,NA,NA,Mettl1 (MGI:1339986)
12,57772613,57782540,12q14.1,12q14.1,615258,"EEF1AKMT3, METTL21B, FAM119B",EEF1A lysine methyltransferase 3,EEF1AKMT3,25895,ENSG00000123427,NA,NA,Eef1akmt3 (MGI:3645330)
12,57782744,57802855,12q13-q14,12q14.1,604723,"TSFM, COXPD3","Ts translation elongation factor, mitochondrial",TSFM,10102,ENSG00000123297,NA,"Combined oxidative phosphorylation deficiency 3, 610505 (3), Autosomal recessive",Tsfm (MGI:1913649)
12,57797375,57818703,12q14,12q14.1,613397,AVIL,Advillin,AVIL,10677,ENSG00000135407,NA,NA,Avil (MGI:1333798)
12,57816701,57846728,12q14.1,12q14.1,608711,"CTDSP2, SCP2, OS4",CTD small phosphatase 2,CTDSP2,10106,ENSG00000175215,NA,NA,Ctdsp2 (MGI:1098748)
12,57824608,57824691,12q14.1,12q14.1,613057,"MIR26A2, MIRN26A2",Micro RNA 26A2,MIR26A2,407016,ENSG00000207789,NA,NA,NA
12,58872154,58920537,12q13.2,12q14.1,608870,"LIRG3, LIG3",Leucine-rich repeats- and immunoglobulin-like domains-containing protein 3,LRIG3,121227,ENSG00000139263,NA,NA,Lrig3 (MGI:2443955)
12,59595933,59789854,12q13,12q14.1,603654,"SLC16A7, MCT2","Solute carrier family 16 (monocarboxylic acid transporters), member 7",SLC16A7,9194,ENSG00000118596,NA,NA,Slc16a7 (MGI:1330284)
12,61708247,62260103,12q14.1,12q14.1,617496,"FAM19A2, TAFA2","Family with sequence similarity 19, member A2, CC motif chemokine-like",TAFA2,338811,ENSG00000198673,NA,NA,Tafa2 (MGI:2143691)
12,62260339,62416388,12q14.1,12q14.1,604731,USP15,Ubiquitin-specific protease 15,USP15,9958,ENSG00000135655,NA,NA,Usp15 (MGI:101857)
12,62466816,62600475,12q14.1,12q14.1,616822,"MON2, KIAA1040","Mon2, S. cerevisiae, homolog of",MON2,23041,ENSG00000061987,NA,NA,Mon2 (MGI:1914324)
12,62603685,62603768,12q14.1,12q14.1,612148,"MIRLET7I, LET7I, MIRNLET7I",Micro RNA Let7i,MIRLET7I,406891,ENSG00000199179,NA,NA,NA
12,62643991,62935149,12q14.1-q14.2,12q14.1-q14.2,616016,"PPM1H, KIAA1157","Protein phosphatase, magnesium/manganese-dependent, 1H",PPM1H,57460,ENSG00000111110,NA,NA,Ppm1h (MGI:2442087)
12,62700000,64700000,12q14.2,NA,610908,AUTS13,"Autism, susceptibility to, 13",NA,100188317,NA,linkage with rs1445442,"{Autism susceptibility 13}, 610908 (2)",NA
12,63142758,63152809,12q14-q15,12q14.2,600821,AVPR1A,Arginine vasopressin receptor-1A,AVPR1A,552,ENSG00000166148,NA,NA,Avpr1a (MGI:1859216)
12,63558912,63669200,12q14.2,12q14.2,613893,"DPY19L2, SPGF9",DPY19-like 2,DPY19L2,283417,ENSG00000177990,pseudogene on 7p14.3,"Spermatogenic failure 9, 613958 (3), Autosomal recessive",Dpy19l2 (MGI:2444662)
12,63779830,63809561,12q14.2,12q14.2,605862,"RXYLT1, TMEM5, MDDGA10",Ribitol xylosyltransferase 1,RXYLT1,10329,ENSG00000118600,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3), Autosomal recessive",Rxylt1 (MGI:2384919)
12,63843910,64162216,12q14.2,12q14.2,606523,"SRGAP1, KIAA1304, NMTC2","Slit-robo GTPase-activating protein, rho, 1",SRGAP1,57522,ENSG00000196935,NA,"{Thyroid cancer, nonmedullary, 2}, 188470 (3), Autosomal dominant, Somatic mutation",Srgap1 (MGI:2152936)
12,64186311,64222295,12q14.2,12q14.2,617420,C12orf66,Chromosome 12 open reading frame 66,C12orf66,144577,ENSG00000174206,NA,NA,BC048403 (MGI:2670984)
12,64452104,64502113,12q14.2,12q14.2,604834,"TBK1, NAK, FTDALS4, IIAE8",TANK-binding kinase 1,TBK1,29110,ENSG00000183735,NA,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}, 617900 (3), Autosomal dominant; Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3), Autosomal dominant",Tbk1 (MGI:1929658)
12,64610494,64697566,12q14.1,12q14.2,607019,RASSF3,Ras association domain family protein 3,RASSF3,283349,ENSG00000153179,NA,NA,Rassf3 (MGI:2179722)
12,64700000,67300000,12q14.3,NA,611547,STQTL9,Stature quantitative trait locus 9,NA,NA,NA,associated with rs1042725,"{Stature QTL 9}, 611547 (2)",NA
12,64713448,64759405,12q14,12q14.3,607664,"GNS, G6S",N-acetylglucosamine-6-sulfatase,GNS,2799,ENSG00000135677,NA,"Mucopolysaccharidosis type IIID, 252940 (3), Autosomal recessive",Gns (MGI:1922862)
12,64759496,64881032,12q14.3,12q14.3,615077,"TBC1D30, KIAA0984","TBC1 domain family, member 30",TBC1D30,23329,ENSG00000111490,NA,NA,Tbc1d30 (MGI:1921944)
12,65050625,65121304,Chr.12,12q14.3,605186,WIF1,WNT inhibitory factor 1,WIF1,11197,ENSG00000156076,NA,NA,Wif1 (MGI:1344332)
12,65169582,65248354,12q14,12q14.3,607844,"LEMD3, MAN1",LEM domain-containing 3,LEMD3,23592,ENSG00000174106,NA,"Buschke-Ollendorff syndrome, 166700 (3), Autosomal dominant; Osteopoikilosis with or without melorheostosis, 166700 (3), Autosomal dominant",Lemd3 (MGI:3580376)
12,65278592,65466906,12q14.3,12q14.3,613719,"MSRB3, DFNB74",Methionine sulfoxide reductase B3,MSRB3,253827,ENSG00000174099,NA,"Deafness, autosomal recessive 74, 613718 (3), Autosomal recessive",Msrb3 (MGI:2443538)
12,65824459,65966290,12q14.3,12q14.3,600698,"HMGA2, HMGIC, BABL",High-mobility group AT-hook 2,HMGA2,8091,ENSG00000149948,"fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas","Leiomyoma, uterine, somatic, 150699 (1)",NA
12,66116554,66130749,12q14.3,12q14.3,616998,LLPH,"LLP, Aplysia, homolog of",LLPH,84298,ENSG00000139233,NA,NA,"Llph-ps1,Llph-ps2,Llph (MGI:3649506,MGI:1913475,MGI:3642864)"
12,66136935,66170071,12q14.3,12q14.3,616874,"TMBIM4, GAAP",Transmembrane BAX inhibitor motif-containing protein 4,TMBIM4,51643,ENSG00000155957,NA,NA,Tmbim4 (MGI:1915462)
12,66189213,66254621,12q14.3,12q14.3,604459,"IRAK3, IRAKM, ASRT5",Interleukin 1 receptor-associated kinase 3,IRAK3,11213,ENSG00000090376,NA,"{Asthma susceptibility 5}, 611064 (3)",Irak3 (MGI:1921164)
12,66302492,66343642,12q13,12q14.3,614539,"HELB, HDHB","Helicase, DNA, B",HELB,92797,ENSG00000127311,NA,NA,Helb (MGI:2152895)
12,66347430,67069264,12q14.3,12q14.3,604597,"GRIP1, FRASRS3",Glutamate receptor-interacting protein 1,GRIP1,23426,ENSG00000155974,NA,"Fraser syndrome 3, 617667 (3), Autosomal recessive",Grip1 (MGI:1921303)
12,67269357,67319952,12q14.3-q15,12q14-q15,607727,"CAND1, TIP120A, TIP120, KIAA0829",Cullin-associated neddylation-dissociated protein 1,CAND1,55832,ENSG00000111530,NA,NA,Cand1 (MGI:1261820)
12,67300000,71100000,12q15,NA,612639,IBD26,Inflammatory bowel disease 26,NA,100271838,NA,associated with rs1558744,"{Inflammatory bowel disease 26}, 612639 (2)",NA
12,67648744,67665405,12q14,12q15,603496,DYRK2,Dual-specificity tyrosine phosphorylation-regulated kinase 2,DYRK2,8445,ENSG00000127334,NA,NA,Dyrk2 (MGI:1330301)
12,68154767,68159739,12q14,12q15,147570,"IFNG, IFG, IFI","Interferon, gamma",IFNG,3458,ENSG00000111537,"3 introns; none in IFF, IFL","{AIDS, rapid progression to}, 609423 (3); {Aplastic anemia}, 609135 (3); {Hepatitis C virus, response to therapy of}, 609532 (3); {TSC2 angiomyolipomas, renal, modifier of}, 613254 (3), Autosomal dominant; {Tuberculosis, protection against}, 607948 (3)",Ifng (MGI:107656)
12,68201348,68225809,12q15,12q15,605679,"IL26, AK155",Interleukin 26,IL26,55801,ENSG00000111536,NA,NA,NA
12,68248241,68253603,12q15,12q15,605330,"IL22, IL21, ILTIF",Interleukin 22,IL22,50616,ENSG00000127318,NA,NA,"Il22,Iltifb (MGI:1355307,MGI:2151139)"
12,68294565,68332413,12q15,12q15,613813,MDM1,Mouse double minute 1 homolog,MDM1,56890,ENSG00000111554,NA,NA,Mdm1 (MGI:96951)
12,68610898,68671900,12q14,12q15,179530,RAP1B,RAS-related protein RAP1B,RAP1B,5908,ENSG00000127314,NA,NA,Rap1b (MGI:894315)
12,68686970,68745808,12q15,12q15,607617,"NUP107, NUP84, NPHS11, ODG6; GAMOS7","Nucleoporin, 107kD",NUP107,57122,ENSG00000111581,mutation identified in 1 ODG6 family,"Galloway-Mowat syndrome 7, 618348 (3), Autosomal recessive; Nephrotic syndrome, type 11, 616730 (3), Autosomal recessive; ?Ovarian dysgenesis 6, 618078 (3), Autosomal recessive",Nup107 (MGI:2143854)
12,68808148,68850685,12q14.3-q15,12q15,164785,"MDM2, ACTFS","Mouse double minute 2, homolog of (p53-binding protein)",MDM2,4193,ENSG00000135679,NA,"{Accelerated tumor formation, susceptibility to}, 614401 (3)",Mdm2 (MGI:96952)
12,68842192,68963239,12q15,12q15,114860,CPM,Carboxypeptidase M,CPM,1368,ENSG00000135678,NA,NA,Cpm (MGI:1917824)
12,69239567,69274357,Chr.12,12q15,604979,"CPSF6, CFIM","Cleavage and polyadenylation specific factor 6, 68kD subunit",CPSF6,11052,ENSG00000111605,NA,NA,Cpsf6 (MGI:1913948)
12,69348353,69354232,12q15,12q15,153450,LYZ,Lysozyme,LYZ,4069,ENSG00000090382,NA,"Amyloidosis, renal, 105200 (3), Autosomal dominant","Lyz1,Lyz2 (MGI:96902,MGI:96897)"
12,69359704,69427076,12q13-q15,12q15,602116,"YEATS4, GAS41",YEATS domain-containing protein 4,YEATS4,8089,ENSG00000127337,NA,NA,Yeats4 (MGI:1927224)
12,69470370,69579792,12q15,12q15,607743,"FRS2, FRS1A, SNT1",Fibroblast growth factor receptor substrate 2,FRS2,10818,ENSG00000166225,NA,NA,Frs2 (MGI:1100860)
12,69585458,69601569,Chr.12,12q15,605139,"CCT2, CCTB","Chaperonin containing T-complex polypeptide 1, subunit 2",CCT2,10576,ENSG00000166226,NA,NA,Cct2 (MGI:107186)
12,69608563,69610906,12q15,12q15,610846,"LRRC10, HRLRRP",Leucine-rich repeat-containing protein 10,LRRC10,376132,ENSG00000198812,NA,NA,Lrrc10 (MGI:2448063)
12,69643507,69699415,12q14.2-q15,12q15,607337,"BEST3, VMD2L3",Bestrophin 3,BEST3,144453,ENSG00000127325,NA,NA,Best3 (MGI:3580298)
12,70242992,70354992,12q15,12q15,604909,"CNOT2, NOT2","CCR4-NOT transcription complex, subunit 2",CNOT2,4848,ENSG00000111596,NA,NA,Cnot2 (MGI:1919318)
12,70366219,70434291,12q14.1-q15,12q15,605223,KCNMB4,"Potassium large conductance calcium-activated channel, subfamily M, beta member 4",KCNMB4,27345,ENSG00000135643,NA,NA,Kcnmb4 (MGI:1913272)
12,70515869,70637439,12q15-q21,12q15,176882,PTPRB,"Protein tyrosine phosphatase, receptor type, beta polypeptide",PTPRB,5787,ENSG00000127329,NA,NA,Ptprb (MGI:97809)
12,70638072,70920737,12q15,12q15,602853,"PTPRR, PCPTP1","Protein-tyrosine phosphatase, receptor type, R",PTPRR,5801,ENSG00000153233,NA,NA,Ptprr (MGI:109559)
12,71100000,108600000,12q21-q23,NA,612715,DUH2,Dyschromatosis universalis hereditaria 2,NA,100301525,NA,between rs1921045 and rs2373584,"Dyschromatosis universalis hereditaria 2, 612715 (2)",NA
12,71100000,108600000,12q21-q23,NA,603221,MYP3,"Myopia, high grade, 3, autosomal dominant",MYP3,8782,NA,NA,"Myopia-3, 603221 (2), Autosomal dominant",NA
12,71100000,92200000,12q21,NA,169900,PEPB,Peptidase B,PEPB,5182,NA,NA,NA,NA
12,71125092,71157998,12q14.1-q21.1,12q21.1,600769,"TSPAN8, TM4SF3",Tetraspanin 8,TSPAN8,7103,ENSG00000127324,NA,NA,Tspan8 (MGI:2384918)
12,71439769,71586309,12q21.1,12q21.1,606667,"LGR5, GPR49",Leucine-rich repeat-containing G protein-coupled receptor 5,LGR5,8549,ENSG00000139292,NA,NA,Lgr5 (MGI:1341817)
12,71664300,71680643,12q21.1,12q21.1,612531,THAP2,THAP domain-containing protein 2,THAP2,83591,ENSG00000173451,NA,NA,Thap2 (MGI:1914066)
12,71754862,71800285,12q21.1,12q21.1,612398,"RAB21, KIAA0118",RAB-associated protein RAB21,RAB21,23011,ENSG00000080371,NA,NA,Rab21 (MGI:894308)
12,71839706,71927250,12q21.1,12q21.1,612662,TBC1D15,"TBC1 domain family, member 15",TBC1D15,64786,ENSG00000121749,NA,NA,Tbc1d15 (MGI:1913937)
12,71938844,72032439,12q21.1,12q21.1,607478,"TPH2, NTPH, ADHD7",Tryptophan hydroxylase 2,TPH2,121278,ENSG00000139287,NA,"{Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3); {Unipolar depression, susceptibility to}, 608516 (3)",Tph2 (MGI:2651811)
12,72087287,72666661,12q15-q21,12q21.1,606950,TRHDE,Thyrotropin-releasing hormone-degrading ectoenzyme,TRHDE,29953,ENSG00000072657,NA,NA,Trhde (MGI:2384311)
12,74537834,74545429,12q21,12q21.1,615579,ATXN7L3B,Ataxin 7-like 3B,ATXN7L3B,552889,ENSG00000253719,NA,NA,Atxn7l3b (MGI:1914971)
12,75040077,75209838,12q21.1,12q21.1,176256,KCNC2,"Potassium voltage-gated channel, Shaw-related subfamily, member 2",KCNC2,3747,ENSG00000166006,previously on 19q13.3-q13.4,NA,Kcnc2 (MGI:96668)
12,75275978,75390936,12q15,12q21.1-q21.2,607724,CAPS2,Calcyphosine 2,CAPS2,84698,ENSG00000180881,NA,NA,Caps2 (MGI:2441980)
12,75331833,75370559,12q21,12q21.2,610395,GLIPR1L1,GLIPR1-like protein 1,GLIPR1L1,256710,ENSG00000173401,NA,NA,"Glipr1l1,Glipr1l3 (MGI:1916536,MGI:3620621)"
12,75391069,75432687,12q21,12q21.2,610394,GLIPR1L2,GLIPR1-like protein 2,GLIPR1L2,144321,ENSG00000180481,NA,NA,Glipr1l2 (MGI:1914787)
12,75480753,75503862,12q21,12q21.2,602692,"GLIPR1, GLIPR, RTVP1",Glioma pathogenesis-related protein 1,GLIPR1,11010,ENSG00000139278,NA,NA,Glipr1 (MGI:1920940)
12,75490862,75511608,12q21.2,12q21.2,612817,KRR1,"KRR1, yeast, homolog of",KRR1,11103,ENSG00000111615,NA,NA,Krr1 (MGI:1289274)
12,76025446,76031775,12q15-q21.2,12q21.2,605335,"PHLDA1, TDAG51","Pleckstrin homology-like domain, family A, member 1",PHLDA1,22822,ENSG00000139289,NA,NA,Phlda1 (MGI:1096880)
12,76036584,76084686,12q21.2,12q21.2,164060,"NAP1L1, NAP1L",Nucleosome assembly protein 1-like 1,NAP1L1,4673,ENSG00000187109,NA,NA,Nap1l1 (MGI:1855693)
12,76344473,76348414,12q21.2,12q21.2,610148,"BBS10, C12orf58, FLJ23560",BBS10 gene,BBS10,79738,ENSG00000179941,NA,"Bardet-Biedl syndrome 10, 615987 (3), Autosomal recessive",Bbs10 (MGI:1919019)
12,76351796,76559804,12p,12q21.2,606736,"OSBPL8, ORP8, KIAA1451",Oxysterol-binding protein-like protein 8,OSBPL8,114882,ENSG00000091039,NA,NA,Osbpl8 (MGI:2443807)
12,76764073,76853700,12q14-q15,12q21.2,607799,"ZDHHC17, HIP14",Zinc finger DHHC domain-containing protein 17,ZDHHC17,23390,ENSG00000186908,NA,NA,Zdhhc17 (MGI:2445110)
12,76858708,76879018,12q21.1,12q21.2,601871,"CSRP2, LMO5","Cysteine and glycine-rich protein-2 (LIM domain only 5, smooth muscle)",CSRP2,1466,ENSG00000175183,pseudogene on 3q21.1,NA,Csrp2 (MGI:1202907)
12,77021250,77065579,12q21.3,12q21.2,612046,E2F7,E2F transcription factor 7,E2F7,144455,ENSG00000165891,NA,NA,E2f7 (MGI:1289147)
12,77571855,78213009,12q21.1,12q21.2,611629,"NAV3, POMFIl1, KIAA0938",Neuron navigator 3,NAV3,89795,ENSG00000067798,NA,NA,Nav3 (MGI:2183703)
12,78863981,79452007,12cen-q21,12q21.2,185605,"SYT1, BAGOS",Synaptotagmin-1,SYT1,6857,ENSG00000067715,NA,"Baker-Gordon syndrome, 618218 (3), Autosomal dominant",Syt1 (MGI:99667)
12,79584873,79691096,12q21,12q21.2,601936,"PAWR, PAR4","PRKC, apoptosis, WT1, regulator",PAWR,5074,ENSG00000177425,NA,NA,Pawr (MGI:2149961)
12,79773562,79935454,12q15-q21.2,12q21.2-q21.3,602021,"PPP1R12A, MYPT1","Protein phosphatase 1, regulatory subunit 12A (myosin phosphatase target subunit 1)",PPP1R12A,4659,ENSG00000058272,NA,NA,Ppp1r12a (MGI:1309528)
12,80099536,80380879,12q21.31,12q21.31,614925,"OTOGL, C12orf64, DFNB84B",Otogelin-like protein,OTOGL,283310,ENSG00000165899,NA,"Deafness, autosomal recessive 84B, 614944 (3), Autosomal recessive",Otogl (MGI:3647600)
12,80424260,80680272,12q21.2,12q21.31,603317,"PTPRQ, PTPGMC1, DFNB84A, DFNA73","Protein-tyrosine phosphatase, receptor-type, Q",PTPRQ,374462,ENSG00000139304,mutation identified in 1 DFNA73 family,"Deafness, autosomal dominant 73, 617663 (3), Autosomal dominant; Deafness, autosomal recessive 84A, 613391 (3), Autosomal recessive",Ptprq (MGI:1096349)
12,80707633,80709473,12q21,12q21.31,159991,"MYF6, CNM3",Myogenic factor-6,MYF6,4618,ENSG00000111046,NA,NA,Myf6 (MGI:97253)
12,80716911,80719670,12q21,12q21.31,159990,"MYF5, EORVA",Myogenic factor-5,MYF5,4617,ENSG00000111049,NA,"Ophthalmoplegia, external, with rib and vertebral anomalies, 618155 (3), Autosomal recessive",Myf5 (MGI:97252)
12,80792519,80937914,12q21.31,12q21.31,603380,"LIN7A, VELI1, MALS1","Lin7, C. elegans, homolog of, A",LIN7A,8825,ENSG00000111052,NA,NA,Lin7a (MGI:2135609)
12,81078036,81261209,12q21.31,12q21.31,614356,ACSS3,"Acyl-CoA synthetase short-chain family, member 3",ACSS3,79611,ENSG00000111058,NA,NA,Acss3 (MGI:2685720)
12,81257974,81759748,12q21.31,12q21.31,603143,PPFIA2,"Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha 2",PPFIA2,8499,ENSG00000139220,NA,NA,Ppfia2 (MGI:2443834)
12,82686905,83134867,12q21.31,12q21.31,615856,TMTC2,Transmembrane and tetratricopeptide repeat domains-containing protein 2,TMTC2,160335,ENSG00000179104,NA,NA,Tmtc2 (MGI:1914057)
12,84859490,84912828,12q21.3-q21.4,12q21.31,607971,"SLC6A15, SBAT1","Solute carrier family 6 (neurotransmitter transporter), member 15",SLC6A15,55117,ENSG00000072041,NA,NA,Slc6a15 (MGI:2143484)
12,85280219,85301783,12q21.3-q22,12q21.31,601527,"ALX1, CART1, FND3",Aristaless-like homeobox 1 (cartilage homeoprotein 1),ALX1,8092,ENSG00000180318,mutation identified in 1 FND3 patient,"?Frontonasal dysplasia 3, 613456 (3)",Alx1 (MGI:104621)
12,85800702,85836408,12q21.31,12q21.31,610383,"RASSF9, PAMCI, PCIP1","Ras association domain family, member 9",RASSF9,9182,ENSG00000198774,NA,NA,Rassf9 (MGI:2384307)
12,85874294,85882991,12q21,12q21.31,162650,NTS,Neurotensin,NTS,4922,ENSG00000133636,NA,NA,Nts (MGI:1328351)
12,85955666,86838999,12q21,12q21.31-q21.32,607385,GNTIVH,"UDP-N-acetylglucosamine:alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV",MGAT4C,25834,ENSG00000182050,NA,NA,Mgat4c (MGI:1914819)
12,88049012,88142215,12q21.3,12q21.32,610142,"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14","Centrosomal protein, 290kD",CEP290,80184,ENSG00000198707,mutation identified in 1 BBS14 family,"?Bardet-Biedl syndrome 14, 615991 (3), Autosomal recessive; Joubert syndrome 5, 610188 (3), Autosomal recessive; Leber congenital amaurosis 10, 611755 (3); Meckel syndrome 4, 611134 (3), Autosomal recessive; Senior-Loken syndrome 6, 610189 (3), Autosomal recessive",Cep290 (MGI:2384917)
12,88142306,88199886,12q21.32,12q21.32,617218,"TMTC3, SMILE, LIS8",Transmembrane and tetratricopeptide repeat domains-containing protein 3,TMTC3,160418,ENSG00000139324,NA,"Lissencephaly 8, 617255 (3), Autosomal recessive",Tmtc3 (MGI:3036255)
12,88492792,88580472,12q22,12q21.32,184745,"KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69","KIT ligand (mast cell growth factor; steel, mouse, homolog of)",KITLG,4254,ENSG00000049130,associated with dbSNP rs12821256,"Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3), Autosomal dominant; Hyperpigmentation with or without hypopigmentation, 145250 (3), Autosomal dominant; [Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)",Kitl (MGI:96974)
12,88600000,92200000,12q21.33,NA,121400,CNA1,"Cornea plana 1, autosomal dominant",CNA1,1255,NA,between D12S82 and D12S351,"Cornea plana 1, autosomal dominant, 121400 (2), Autosomal dominant",NA
12,88600000,92200000,12q21.33,NA,612868,PACD,"Corneal dystrophy, posterior amorphous",NA,NA,NA,contiguous gene deletion syndrome,"Corneal dystrophy, posterior amorphous, 612868 (4), Autosomal dominant",NA
12,89347234,89352500,12q21.33,12q21.33,602748,"DUSP6, MKP3, PYST1, HH19",Dual-specificity phosphatase-6,DUSP6,1848,ENSG00000139318,NA,"Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3), Autosomal dominant",Dusp6 (MGI:1914853)
12,89419717,89526261,12q21.33,12q21.33,614784,"POC1B, PIX1, CORD20","POC1 centriolar protein, Chlamydomonas, homolog of, B",POC1B,282809,ENSG00000139323,NA,"Cone-rod dystrophy 20, 615973 (3), Autosomal recessive",Poc1b (MGI:1918511)
12,89519411,89524795,12q21.3-q22,12q21.33,603565,"GALNT4, GalNAcT4",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4,GALNT4,8693,ENSG00000257594,NA,NA,Galnt4 (MGI:894692)
12,89588048,89709365,12q21-q23,12q21.33,108731,"ATP2B1, PMCA1","ATPase, Ca++ transporting, plasma membrane, 1",ATP2B1,490,ENSG00000070961,NA,NA,Atp2b1 (MGI:104653)
12,90963678,91004971,12q21,12q21.33,601657,"EPYC, DSPG3",Epiphycan,EPYC,1833,ENSG00000083782,NA,NA,Epyc (MGI:107942)
12,91050490,91058353,12q22,12q21.33,603288,"KERA, CNA2",Keratocan,KERA,11081,ENSG00000139330,NA,"Cornea plana 2, autosomal recessive, 217300 (3), Autosomal recessive",Kera (MGI:1202398)
12,91102628,91111493,12q21.3-q22,12q21.33,600616,"LUM, LDC",Lumican,LUM,4060,ENSG00000139329,NA,NA,Lum (MGI:109347)
12,91140483,91182816,12q21.3,12q21.33,125255,"DCN, CSCD",Decorin,DCN,1634,ENSG00000011465,conflicting assignments to 12q23 and 12q13.2,"Corneal dystrophy, congenital stromal, 610048 (3), Autosomal dominant",Dcn (MGI:94872)
12,92140277,92145845,12q22,12q21.33,109580,BTG1,"B-cell translocation gene 1, anti-proliferative",BTG1,694,ENSG00000133639,NA,NA,Btg1 (MGI:88215)
12,92200000,108600000,12q22-q23.3,NA,608096,"ETL2, FTLE","Epilepsy, familial temporal lobe",NA,619399,NA,max lod at D12S1706,"Epilepsy, familial temporal lobe, 2, 608096 (2), Autosomal dominant",NA
12,92200000,103500000,12q22-q23.2,NA,608520,MDD1,Major depressive disorder,NA,431708,NA,max lod with D12S1706,"Major depressive disorder 1, 608516 (2)",NA
12,92420085,92432998,12q22,12q22,616989,CLLU1OS,"Chronic lymphocytic leukemia upregulated 1, opposite strand",CLLU1OS,574016,ENSG00000205057,NA,NA,NA
12,92421530,92431001,12q22,12q22,616988,CLLU1,Chronic lymphocytic leukemia upregulated gene 1,CLLU1,574028,ENSG00000257127,NA,NA,NA
12,92770636,92975227,12q22,12q22,605070,EEA1,Early endosome antigen 1,EEA1,8411,ENSG00000102189,NA,NA,Eea1 (MGI:2442192)
12,93405683,93442335,12q22,12q22,603679,"UBE2N, UBCHBEN; UBC13",Ubiquitin-conjugating enzyme E2N,UBE2N,7334,ENSG00000177889,NA,NA,Ube2n (MGI:1934835)
12,93467513,93516213,12q22,12q22,611847,"MRPL42, MRPL31, MRPS32",Mitochondrial ribosomal protein L42,MRPL42,28977,ENSG00000198015,NA,NA,Mrpl42 (MGI:1333774)
12,93565627,93571397,12q22,12q22,617269,SOCS2AS1,SOCS2 antisense RNA 1,SOCS2-AS1,144481,ENSG00000246985,NA,NA,NA
12,93677341,93894839,12q21.33-q23.1,12q22,603454,"CRADD, RAIDD, MRT34",Caspase and RIP adaptor with death domain,CRADD,8738,ENSG00000169372,NA,"Mental retardation, autosomal recessive 34, with variant lissencephaly, 614499 (3), Autosomal recessive",Cradd (MGI:1336168)
12,94265651,94460615,12q22,12q22,615847,"CEP83, CCDC41, NPHP18","Centrosomal protein, 83kD",CEP83,51134,ENSG00000173588,NA,"Nephronophthisis 18, 615862 (3), Autosomal recessive",Cep83 (MGI:1924298)
12,94148576,94307674,Chr.12,12q22,604259,VESPR,Virus-encoded semaphorin protein receptor,PLXNC1,10154,ENSG00000136040,NA,NA,Plxnc1 (MGI:1890127)
12,94567121,94650556,12q22,12q22,617459,TMCC3,"Transmembrane and coiled-coil domain family, member 3",TMCC3,57458,ENSG00000057704,NA,NA,Tmcc3 (MGI:2442900)
12,94834397,94834512,12q22,12q22,614384,MIR492,Micro RNA 492,MIR492,574449,ENSG00000283998,within KRT19,NA,NA
12,94971327,95003712,12q22,12q22,614530,"NDUFA12, MC1DN23",NADH-ubiquinone oxidoreductase subunit A12,NDUFA12,55967,ENSG00000184752,mutation identified in 1 MC1DN23 patient,"?Mitochondrial complex I deficiency, nuclear type 23, 618244 (3), Autosomal recessive",Ndufa12 (MGI:1913664)
12,95020228,95073617,12q22,12q22,601529,"NR2C1, TR2","Nuclear receptor subfamily 2, group C, member 1",NR2C1,7181,ENSG00000120798,NA,NA,Nr2c1 (MGI:1352465)
12,95076748,95217466,12q22,12q22,613520,"FGD6, ZFYVE24","FYVE, RhoGEF, and ph domain-containing protein 6",FGD6,55785,ENSG00000180263,NA,NA,Fgd6 (MGI:1261419)
12,95474045,95515838,12q22,12q22,601870,"METAP2, p67",Methionine aminopeptidase 2,METAP2,10988,ENSG00000111142,NA,NA,Metap2 (MGI:1929701)
12,95516559,95551528,12q22,12q22,610993,USP44,Ubiquitin-specific protease 44,USP44,84101,ENSG00000136014,NA,NA,Usp44 (MGI:3045318)
12,95657806,95791154,12q22-q23,12q22,610401,NTN4,Netrin 4,NTN4,59277,ENSG00000074527,NA,NA,Ntn4 (MGI:1888978)
12,95800000,133275309,12q23-q24,NA,613096,SPG36,Spastic paraplegia-36,SPG36,791228,NA,between D12S360 and D12S354,"Spastic paraplegia 36, autosomal dominant, 613096 (2), Autosomal dominant",NA
12,95858951,95867052,12q23.1,12q23.1,603541,SNRPF,Small nuclear ribonucleoprotein polypeptide F,SNRPF,6636,ENSG00000139343,NA,NA,Snrpf (MGI:1917128)
12,95972661,95996364,12q22-q23,12q23.1,609457,"HAL, HSTD",Histidine ammonia-lyase (histidase),HAL,3034,ENSG00000084110,NA,"[Histidinemia], 235800 (3), Autosomal recessive, Autosomal dominant",Hal (MGI:96010)
12,96000752,96043519,12q22,12q23.1,151570,LTA4H,Leukotriene A4 hydrolase,LTA4H,4048,ENSG00000111144,NA,NA,Lta4h (MGI:96836)
12,96194374,96269823,12q23,12q23.1,600247,"ELK3, SAP2, ERP","ELK3, ETS-domain protein (SRF accessory protein 2)",ELK3,2004,ENSG00000111145,NA,NA,Elk3 (MGI:101762)
12,96278260,96400438,12q23.1,12q23.1,603440,"CDK17, PCTK2, PCTAIRE2",Cyclin-dependent kinase 17,CDK17,5128,ENSG00000059758,NA,NA,Cdk17 (MGI:97517)
12,96907221,96953779,12q22,12q23.1,600372,NEDD1,"Neural precursor cell expressed, developmentally down-regulated 1",NEDD1,121441,ENSG00000139350,NA,NA,Nedd1 (MGI:97293)
12,97462775,97565014,12q21,12q23.1,607045,"RMST, NCRMS, NCRNA00054",Rhabdomyosarcoma 2-associated transcript,RMST,196475,ENSG00000255794,NA,NA,NA
12,98515572,98550378,12q22,12q23.1,188380,"TMPO, LAP2",Thymopoietin,TMPO,7112,ENSG00000120802,NA,NA,Tmpo (MGI:106920)
12,98593624,98606366,12q23,12q23.1,600370,"SLC25A3, PHC","Solute carrier family 25 (mitochondrial carrier), member 3",SLC25A3,5250,ENSG00000075415,NA,"Mitochondrial phosphate carrier deficiency, 610773 (3)",Slc25a3 (MGI:1353498)
12,98613421,98644787,12q23,12q23.1,609861,IKIP,I-kappa-B kinase-interacting protein,IKBIP,121457,ENSG00000166130,NA,NA,Ikbip (MGI:1914704)
12,98645140,98735432,12q23,12q23.1,602233,APAF1,Apoptotic protease activating factor 1,APAF1,317,ENSG00000120868,NA,NA,Apaf1 (MGI:1306796)
12,98729903,99984772,12q23.1,12q23.1,607815,"ANKS1B, EB1",Ankyrin repeat and sterile alpha motif domain-containing protein 1B,ANKS1B,56899,ENSG00000185046,NA,NA,Anks1b (MGI:1924781)
12,100267139,100341723,12q23.1,12q23.1,616365,"SCYL2, CVAK104, KIAA1360",SCY1-like protein 2,SCYL2,55681,ENSG00000136021,NA,NA,Scyl2 (MGI:1289172)
12,100357073,100422054,12q23,12q23.1,607557,"SLC17A8, VGLUT3, DFNA25","Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (vesicular glutamate transporter 3)",SLC17A8,246213,ENSG00000179520,NA,"Deafness, autosomal dominant 25, 605583 (3), Autosomal dominant",Slc17a8 (MGI:3039629)
12,100473772,100564413,12q23.1,12q23.1,603826,"NR1H4, FXR, RIP14, PFIC5",Nuclear receptor subfamily 1 group H member 4,NR1H4,9971,ENSG00000012504,NA,"Cholestasis, progressive familial intrahepatic, 5, 617049 (3), Autosomal recessive",Nr1h4 (MGI:1352464)
12,100573667,100628287,12q23.1,12q23.1,617224,"GAS2L3, G2L3",Growth arrest-specific 2-like 3,GAS2L3,283431,ENSG00000139354,NA,NA,Gas2l3 (MGI:1918780)
12,100717456,101128640,12q23,12q23.1,610111,"TMEM16D, FLJ34272",Transmembrane protein 16D,ANO4,121601,ENSG00000151572,NA,NA,Ano4 (MGI:2443344)
12,101155492,101210237,12q22-q23,12q23.1-q23.2,608044,"SLC5A8, AIT, SMCT","Solute carrier family (iodide transporter), member 8",SLC5A8,160728,ENSG00000256870,NA,NA,Slc5a8 (MGI:2384916)
12,101200000,103500000,12q23.2,NA,614985,"HELLPAR, lncHELLP",HELLP syndrome-associated long noncoding RNA,HELLPAR,101101692,NA,NA,NA,NA
12,101280104,101386617,12q23.2-q23.3,12q23.2,612822,"UTP20, DRIM","UTP20, S. cerevisiae, homolog of",UTP20,27340,ENSG00000120800,NA,NA,Utp20 (MGI:1917933)
12,101393115,101407819,12q23.2,12q23.2,603425,ARL1,ADP-ribosylation factor-like 1,ARL1,400,ENSG00000120805,NA,NA,Arl1 (MGI:99436)
12,101475275,101486996,12q22,12q23.2,612568,SPIC,SPIC transcription factor,SPIC,121599,ENSG00000166211,NA,NA,Spic (MGI:1341168)
12,101594848,101695840,12q23.2,12q23.2,160794,"MYBPC1, LCCS4","Myosin-binding protein C, slow type",MYBPC1,4604,ENSG00000196091,NA,"Arthrogryposis, distal, type 1B, 614335 (3), Autosomal dominant; Lethal congenital contracture syndrome 4, 614915 (3), Autosomal recessive",Mybpc1 (MGI:1336213)
12,101697639,101752037,12q23.2,12q23.2,616747,"CHPT1, CPT, CPT1",Choline phosphotransferase 1,CHPT1,56994,ENSG00000111666,NA,NA,Chpt1 (MGI:2384841)
12,101728647,101739720,12q23,12q23.2,604759,"SYCP3, SCP3, COR1, SPGF4, RPRGL4",Synaptonemal complex protein 3,SYCP3,50511,ENSG00000139351,NA,"Pregnancy loss, recurrent, 4, 270960 (3), Autosomal dominant; Spermatogenic failure 4, 270960 (3), Autosomal dominant",Sycp3 (MGI:109542)
12,101745498,101830958,12q23.3,12q23.2,607840,"GNPTAB, GNPTA","N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits",GNPTAB,79158,ENSG00000111670,conflicting assignment to 4q,"Mucolipidosis II alpha/beta, 252500 (3), Autosomal recessive; Mucolipidosis III alpha/beta, 252600 (3), Autosomal recessive",Gnptab (MGI:3643902)
12,101877326,101923622,12q23.2,12q23.2,610776,DRAM1,Damage-regulated autophagy modulator 1,DRAM1,55332,ENSG00000136048,NA,NA,Dram1 (MGI:1918962)
12,102073102,102120130,12q23.2,12q23.2,609264,"NUP37, p37, MCPH24","Nucleoporin, 37kD",NUP37,79023,ENSG00000075188,mutation identified in 1 MCPH24 family,"?Microcephaly 24, primary, autosomal recessive, 618179 (3), Autosomal recessive",Nup37 (MGI:1919964)
12,102120170,102197519,12q23,12q23.2,613687,"C12orf48, AROM, PARPBP",Chromosome 12 open reading frame 48,PARPBP,55010,ENSG00000185480,NA,NA,Parpbp (MGI:1922567)
12,102196458,102199539,12q23-q24,12q23.2,176795,PMCH,Pro-melanin-concentrating hormone,PMCH,5367,ENSG00000183395,NA,NA,Pmch (MGI:97629)
12,102395859,102481838,12q22-q24.1,12q23.2,147440,IGF1,"Insulin-like growth factor-1, or somatomedin C",IGF1,3479,ENSG00000017427,NA,"Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3), Autosomal recessive",Igf1 (MGI:96432)
12,102836888,102958440,12q24.1,12q23.2,612349,"PAH, PKU1",Phenylalanine hydroxylase,PAH,5053,ENSG00000171759,close to IGF1,"[Hyperphenylalaninemia, non-PKU mild], 261600 (3), Autosomal recessive; Phenylketonuria, 261600 (3), Autosomal recessive",Pah (MGI:97473)
12,102957673,102960512,12q22-q23,12q23.2,100790,"ASCL1, ASH1","Achaete-scute complex, Drosophila, homolog-like 1",ASCL1,429,ENSG00000139352,distal to PAH and proximal to TRA1,"Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant; Haddad syndrome, 209880 (3), Autosomal dominant",Ascl1 (MGI:96919)
12,103746314,103841238,12q22-q23.1,12q23.3,611076,"NT5DC3, TU12B1TY, GNN",5' nucleotidase domain-containing protein 3,NT5DC3,51559,ENSG00000111696,NA,NA,Nt5dc3 (MGI:3513266)
12,103930409,103947925,12q23.3,12q23.3,191175,"HSP90B1, TRA1, GRP94, GP96","Heat-shock protein, 90kD, beta, 1",HSP90B1,7184,ENSG00000166598,NA,NA,Hsp90b1 (MGI:98817)
12,103965803,103988877,12q24.1,12q23.3,601423,TDG,Thymine-DNA glycosylase,TDG,6996,ENSG00000139372,NA,NA,"Tdg,Tdg-ps (MGI:108247,MGI:3645587)"
12,104064525,104108953,12q23.3,12q23.3,607926,"HCFC2, HCF2",Host cell factor C2,HCFC2,29915,ENSG00000111727,NA,NA,Hcfc2 (MGI:1915183)
12,104117085,104138240,12q23.3,12q23.3,189904,NFYB,"Transcription factor NF-Y, B subunit",NFYB,4801,ENSG00000120837,NA,NA,Nfyb (MGI:97317)
12,104215778,104350306,12q23-q24.1,12q23.3,601112,"TXNRD1, TXNR",Thioredoxin reductase-1,TXNRD1,7296,ENSG00000198431,NA,NA,Txnrd1 (MGI:1354175)
12,104303738,104305204,12q23-q24.1,12q23.3,612986,"EID3, NSMCE4B, NSE4B",E1A-like inhibitor of differentiation 3,EID3,493861,ENSG00000255150,NA,NA,Eid3 (MGI:1913591)
12,104456947,104762013,12q23,12q23.3,610128,"CHST11, C4ST1, OCBMD",Carbohydrate sulfotransferase 11,CHST11,50515,ENSG00000171310,mutation identified in 1 OCBMD family,"?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits, 618167 (3), Autosomal recessive",Chst11 (MGI:1927166)
12,104802552,104958743,12q23.3,12q23.3,610802,SLC41A2,"Solute carrier family 41, member 2",SLC41A2,84102,ENSG00000136052,NA,NA,Slc41a2 (MGI:2442940)
12,105019783,105084608,12q23.3,12q23.3,613584,ALDH1L2,"Aldehyde dehydrogenase 1 family, member L2",ALDH1L2,160428,ENSG00000136010,NA,NA,Aldh1l2 (MGI:2444680)
12,105107725,105169133,12q23.3,12q23.3,615748,"WASHC4, KIAA1033, SWIP, MRT43","WASH complex, subunit 4",WASHC4,23325,ENSG00000136051,mutation identified in 1 MRT43 family,"?Mental retardation, autosomal recessive 43, 615817 (3), Autosomal recessive",Washc4 (MGI:2441787)
12,105173296,105236229,12q24.1,12q23.3,606231,"APPL2, FLJ10659","Adaptor protein, phosphotyrosine interaction, PH domain, and leucine zipper-containing protein 2",APPL2,55198,ENSG00000136044,NA,NA,Appl2 (MGI:2384914)
12,106063346,106140032,12q23.3,12q23.3,608130,"NUAK1, ARK5,  KIAA0537","NUAK family, SNF1-like kinase, 1",NUAK1,9891,ENSG00000074590,NA,NA,Nuak1 (MGI:1925226)
12,106357711,106510197,12q23.3,12q23.3,614366,"POLR3B, RPC2, C128, HLD8","Polymerase III, RNA, subunit B",POLR3B,55703,ENSG00000013503,NA,"Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3), Autosomal recessive",Polr3b (MGI:1917678)
12,106582906,106762803,12q23.3,12q23.3,603958,RFX4,"Regulatory factor X, 4",RFX4,5992,ENSG00000111783,NA,NA,Rfx4 (MGI:1918387)
12,106774620,106889315,12q23.3,12q23.3,609147,RIC8B,"Ric8, C. elegans, homolog of, B",RIC8B,55188,ENSG00000111785,NA,NA,Ric8b (MGI:2682307)
12,106972855,106987165,12q23.3,12q23.3,616929,"MTERF2, MTERFD3","Transcription termination factor 2, mitochondrial",MTERF2,80298,ENSG00000120832,NA,NA,Mterf2 (MGI:1921488)
12,106991363,107093871,12q23-q24.1,12q23.3,601933,"CRY1, PHLL1, DSPD",Cryptochrome 1 (photolyase-like),CRY1,1407,ENSG00000008405,NA,"{Delayed sleep phase disorder, susceptibility to}, 614163 (3), Autosomal dominant",Cry1 (MGI:1270841)
12,107732865,107761271,12q23-q24.1,12q23.3,605780,"PRDM4, PFM1",PR domain-containing protein 4,PRDM4,11108,ENSG00000110851,NA,NA,Prdm4 (MGI:1920093)
12,108288043,108339346,12q24.1,12q23.3,602351,CMKLR1,Chemokine-like receptor 1,CMKLR1,1240,ENSG00000174600,NA,NA,Cmklr1 (MGI:109603)
12,108522213,108561172,12q24.1,12q23.3,611684,"SART3, P100, KIAA0156, TIP110",Squamous cell carcinoma antigen recognized by T cells 3,SART3,9733,ENSG00000075856,NA,NA,Sart3 (MGI:1858230)
12,108561462,108569383,12q24.1,12q23.3,611911,"ISCU, HML","Iron-sulfur cluster scaffold, E. coli, homolog of",ISCU,23479,ENSG00000136003,NA,"Myopathy with lactic acidosis, hereditary, 255125 (3), Autosomal recessive",Iscu (MGI:1913633)
12,108600000,133275309,12q24,NA,612011,CELIAC13,"Celiac disease, susceptibility to, 13",NA,100188875,NA,associated with rs3184504,"{Celiac disease, susceptibility to, 13}, 612011 (2)",NA
12,108600000,133275309,12q24,NA,608447,CIMT,Carotid intimal medial thickness,NA,404677,NA,161cM from pter; near SCARB1,"Carotid intimal medial thickness, 608447 (2)",NA
12,108600000,133275309,12q24,NA,607411,PDA1,Patent ductus arteriosus,NA,100996949,NA,NA,"{Patent ductus arteriosus, susceptibility to}, 607411 (2), Autosomal recessive",NA
12,108600000,120300000,12q24.1-q24.2,NA,175850,"POROK2, PPPD1","Porokeratosis 2, palmar, plantar, and disseminated",NA,100196910,NA,between D12S1613 and D12S1341,"Porokeratosis 2, palmar, plantar, and disseminated, 175850 (2), Autosomal dominant",NA
12,108600000,133275309,12q24,NA,608437,SLEB4,"Systemic lupus erythematosus, susceptibility to, 4",NA,404714,NA,NA,"{Systemic lupus erythematosus, susceptibility to, 4}, 608437 (2)",NA
12,108600000,113900000,12q24.1,NA,609261,STUT2,"Stuttering, familial persistent, 2",NA,100049543,NA,max lod with PAH,"Stuttering, familial persistent, 2, 609261 (2)",NA
12,108621894,108633893,12q24,12q24.11,600738,"SELPLG, PSGL1",Selectin P ligand,SELPLG,6404,ENSG00000110876,NA,NA,Selplg (MGI:106689)
12,108645108,108759954,12q24.1,12q24.11,605269,CORO1C,Coronin 1C,CORO1C,23603,ENSG00000110880,NA,NA,Coro1c (MGI:1345964)
12,108778190,108857605,12q24.11,12q24.11,606778,"SSH1, KIAA1298","Slingshot, Drosophila, homolog of, 1",SSH1,54434,ENSG00000084112,NA,NA,Ssh1 (MGI:2686240)
12,108880029,108901042,12q24,12q24.11,124050,"DAO, DAMOX",D-amino-acid oxidase,DAO,1610,ENSG00000110887,NA,NA,Dao (MGI:94859)
12,108907740,109021067,12q24.1,12q24.11,611699,SVOP,SV2-related protein,SVOP,55530,ENSG00000166111,NA,NA,Svop (MGI:1915916)
12,109023088,109088025,12q23-q24,12q24.11,612492,USP30,Ubiquitin-specific protease 30,USP30,84749,ENSG00000135093,NA,NA,Usp30 (MGI:2140991)
12,109088187,109093630,12q23.3,12q24.11,610602,"ALKBH2, ABH2","AlkB, E. coli, homolog of, 2",ALKBH2,121642,ENSG00000189046,NA,NA,Alkbh2 (MGI:2141032)
12,109097596,109110991,12q23-q24.1,12q24.11,191525,"UNG, DGU, HIGM5",Uracil-DNA glycosylase,UNG,7374,ENSG00000076248,NA,"Immunodeficiency with hyper IgM, type 5, 608106 (3), Autosomal recessive",Ung (MGI:109352)
12,109112665,109268225,12q24.1,12q24.11,601557,"ACACB, ACCB, ACC2","Acetyl-Coenzyme A carboxylase, beta",ACACB,32,ENSG00000076555,NA,NA,Acacb (MGI:2140940)
12,109277977,109309405,12q24.1,12q24.11,609429,FOXN4,Forkhead box N4,FOXN4,121643,ENSG00000139445,NA,NA,Foxn4 (MGI:2151057)
12,109388276,109448370,12q24.11,12q24.11,614636,MYO1H,Myosin IH,MYO1H,283446,ENSG00000174527,NA,NA,Myo1h (MGI:1914674)
12,109448654,109477543,12q24.11,12q24.11,613421,KCTD10,Potassium channel tetramerization domain-containing 10,KCTD10,83892,ENSG00000110906,NA,NA,Kctd10 (MGI:2141207)
12,109477409,109543627,12q24.11,12q24.11,608047,"UBE3B, BPIDS, KOS",Ubiquitin-protein ligase E3B,UBE3B,89910,ENSG00000151148,NA,"Kaufman oculocerebrofacial syndrome, 244450 (3), Autosomal recessive",Ube3b (MGI:1891295)
12,109553714,109573579,12q24,12q24.11,607568,MMAB,MMAB gene,MMAB,326625,ENSG00000139428,NA,"Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3), Autosomal recessive",Mmab (MGI:1924947)
12,109573460,109598124,12q24,12q24.11,251170,"MVK, MVLK, POROK3",Mevalonate kinase,MVK,4598,ENSG00000110921,NA,"Hyper-IgD syndrome, 260920 (3), Autosomal recessive; Mevalonic aciduria, 610377 (3), Autosomal recessive; Porokeratosis 3, multiple types, 175900 (3), Autosomal dominant",Mvk (MGI:107624)
12,109783086,109833406,12q24.1,12q24.11,605427,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3","Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)",TRPV4,59341,ENSG00000111199,mutation identified in 1 ANFH2 family,"?Avascular necrosis of femoral head, primary, 2, 617383 (3), Autosomal dominant; Brachyolmia type 3, 113500 (3), Autosomal dominant; Digital arthropathy-brachydactyly, familial, 606835 (3), Autosomal dominant; Hereditary motor and sensory neuropathy, type IIc, 606071 (3), Autosomal dominant; Metatropic dysplasia, 156530 (3), Autosomal dominant; Parastremmatic dwarfism, 168400 (3), Autosomal dominant; SED, Maroteaux type, 184095 (3), Autosomal dominant; Scapuloperoneal spinal muscular atrophy, 181405 (3), Autosomal dominant; [Sodium serum level QTL 1], 613508 (3); Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3), Autosomal dominant; Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3), Autosomal dominant",Trpv4 (MGI:1926945)
12,109850944,109880540,12q24.11,12q24.11,608949,GLTP,Glycolipid transfer protein,GLTP,51228,ENSG00000139433,NA,NA,Gltp (MGI:1929253)
12,109880666,109918068,12q24.1,12q24.11,612654,TCHP,Trichoplein,TCHP,84260,ENSG00000139437,NA,NA,Tchp (MGI:1925082)
12,109999168,110039762,12q24.11,12q24.11,615123,ANKRD13A,Ankyrin repeat domain-containing protein 13A,ANKRD13A,88455,ENSG00000076513,NA,NA,Ankrd13a (MGI:1915670)
12,110124334,110218794,12q24.13,12q24.11,605489,"IFT81, DV1, CDV1R, SRTD19","Intraflagellar transport 81, Chlamydomonas, homolog of",IFT81,28981,ENSG00000122970,NA,"Short-rib thoracic dysplasia 19 with or without polydactyly, 617895 (3), Autosomal recessive",Ift81 (MGI:1098597)
12,110281246,110351092,12q23-q24.1,12q24.11,108740,"ATP2A2, ATP2B, DAR","ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2",ATP2A2,488,ENSG00000174437,NA,"Acrokeratosis verruciformis, 101900 (3), Autosomal dominant; Darier disease, 124200 (3), Autosomal dominant",Atp2a2 (MGI:88110)
12,110372899,110403729,12q24.11,12q24.11,606949,"ANAPC7, APC7","Anaphase-promoting complex, subunit 7",ANAPC7,51434,ENSG00000196510,NA,NA,Anapc7 (MGI:1929711)
12,110434822,110450410,12q24.11,12q24.11,604225,"ARPC3, ARC21","Actin-related protein 2/3 complex, subunit 3",ARPC3,10094,ENSG00000111229,NA,NA,Arpc3 (MGI:1928375)
12,110501650,110534631,12q24,12q24.11,608368,RAD9B,"RAD9, S. pombe, homolog of, A",RAD9B,144715,ENSG00000151164,NA,NA,Rad9b (MGI:2385231)
12,110533244,110583317,12q24.1,12q24.11,609668,"PPTC7, TAPP2C","PTC7 protein phosphatase, S. cerevisiae, homolog of",PPTC7,160760,ENSG00000196850,NA,NA,Pptc7 (MGI:2444593)
12,110614026,110649429,12q24.1,12q24.11,609863,"TECT1, JBTS13","Tectonic family, member 1",TCTN1,79600,ENSG00000204852,NA,"Joubert syndrome 13, 614173 (3), Autosomal recessive",Tctn1 (MGI:3603820)
12,110648685,110704944,12q24.11,12q24.11,611227,"HVCN1, HV1, VSOP",Hydrogen voltage-gated channel 1,HVCN1,84329,ENSG00000122986,NA,NA,Hvcn1 (MGI:1921346)
12,110708368,110742913,12q24.1-q24.2,12q24.11,176914,PPP1CC,"Protein phosphatase-1, catalytic subunit, gamma isoform",PPP1CC,5501,ENSG00000186298,NA,NA,Ppp1ccb (MGI:3647492)
12,110844488,110907534,12q24.11,12q24.11,617969,"CCDC63, ODA5",Coiled-coil domain-containing protein 63,CCDC63,160762,ENSG00000173093,NA,NA,Ccdc63 (MGI:3607777)
12,110910818,110920599,12q23-q24.3,12q24.11,160781,"MYL2, CMH10","Myosin, light polypeptide-2, regulatory, cardiac, slow",MYL2,4633,ENSG00000111245,NA,"Cardiomyopathy, hypertrophic, 10, 608758 (3), Autosomal dominant",Myl2 (MGI:97272)
12,111034164,111350555,12q24.1,12q24.11-q24.12,610648,"CUX2, CDP2, CUTL2, EIEE67",Cut-like homeobox 2,CUX2,23316,ENSG00000111249,NA,"Epileptic encephalopathy, early infantile, 67, 618141 (3), Autosomal dominant",Cux2 (MGI:107321)
12,111360650,111369094,12q24.12,12q24.12,614239,"FAM109A, SES1, IPIP27A","Family with sequence similarity 109, member A",PHETA1,144717,ENSG00000198324,NA,NA,Pheta1 (MGI:2442708)
12,111405106,111451622,12q24,12q24.12,605093,"SH2B3, LNK",SH2B adaptor protein 3,SH2B3,10019,ENSG00000111252,NA,"Erythrocytosis, somatic, 133100 (3); Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3)",Sh2b3 (MGI:893598)
12,111452213,111599675,12q24,12q24.12,601517,"ATXN2, ATX2, SCA2, ASL13",Ataxin-2,ATXN2,6311,ENSG00000204842,NA,"{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3), Autosomal dominant; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial; Spinocerebellar ataxia 2, 183090 (3), Autosomal dominant",Atxn2 (MGI:1277223)
12,111642145,111686022,12q24,12q24.12,604986,"BRAP, BRAP2, IMP",BRCA1-associated protein,BRAP,8315,ENSG00000089234,NA,NA,Brap (MGI:1919649)
12,111686052,111757098,12q24.1,12q24.12,611181,ACAD10,"Acyl-CoA dehydrogenase family, member 10",ACAD10,80724,ENSG00000111271,NA,NA,Acad10 (MGI:1919235)
12,111766932,111817531,12q24.2,12q24.12,100650,ALDH2,"Aldehyde dehydrogenase 2 family, mitochondrial",ALDH2,217,ENSG00000111275,NA,"Alcohol sensitivity, acute, 610251 (3), Autosomal dominant; {Esophageal cancer, alcohol-related, susceptibility to} (3); {Hangover, susceptibility to}, 610251 (3), Autosomal dominant; {Sublingual nitroglycerin, susceptibility to poor response to} (3)",Aldh2 (MGI:99600)
12,111841977,111902224,12q24.12-q24.13,12q24.12-q24.13,606723,"MAPKAPK5, PRAK",Mitogen-activated protein kinase-activated protein kinase 5,MAPKAPK5,8550,ENSG00000089022,NA,NA,Mapkapk5 (MGI:1333110)
12,112013339,112023448,Chr.12,12q24.13,602287,"C12orf8, ERP28, ERP29",Endoplasmic reticulum lumenal protein 28,ERP29,10961,ENSG00000089248,NA,NA,Erp29 (MGI:1914647)
12,112026688,112108803,12q24.13,12q24.13,612755,"MDM20, C12orf30","Mitochondrial distribution and morphology 20, yeast, homolog of",NAA25,80018,ENSG00000111300,NA,NA,Naa25 (MGI:2442563)
12,112125544,112153603,12q24.13,12q24.13,613197,"TRAFD1, FLN29",TRAF-type zinc finger domain-containing 1,TRAFD1,10906,ENSG00000135148,NA,NA,Trafd1 (MGI:1923551)
12,112405180,112418849,12q,12q24.13,603703,RPL6,Ribosomal protein L6,RPL6,6128,ENSG00000089009,NA,NA,"Rpl6l,Rpl6 (MGI:108057,MGI:3647789)"
12,112418897,112509917,12q24.1,12q24.13,176876,"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS","Protein tyrosine phosphatase, nonreceptor-type, 11",PTPN11,5781,ENSG00000179295,NA,"LEOPARD syndrome 1, 151100 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, somatic, 607785 (3); Metachondromatosis, 156250 (3), Autosomal dominant; Noonan syndrome 1, 163950 (3), Autosomal dominant",Ptpn11 (MGI:99511)
12,112575235,112898880,12q24.1,12q24.13,612159,"RPH3A, KIAA0985",Rabphilin 3A,RPH3A,22895,ENSG00000089169,NA,NA,Rph3a (MGI:102788)
12,112906776,112933218,12q24.2,12q24.13,164350,"OAS1, OIAS","2',5'-oligoadenylate synthetase-1",OAS1,4938,ENSG00000089127,NA,NA,"Oas1g,Oas1a (MGI:2180860,MGI:97429)"
12,112938462,112973250,12q24.2,12q24.13,603351,OAS3,"2',5'-oligoadenylate synthetase-3",OAS3,4940,ENSG00000111331,NA,NA,Oas3 (MGI:2180850)
12,112978465,113011722,12q24.2,12q24.13,603350,OAS2,"2',5'-oligoadenylate synthetase-2",OAS2,4939,ENSG00000111335,NA,NA,Oas2 (MGI:2180852)
12,113056710,113098027,12q24,12q24.13,602582,DTX1,"Deltex, Drosophila, homolog of, 1",DTX1,1840,ENSG00000135144,NA,NA,Dtx1 (MGI:1352744)
12,113096514,113136247,12q23-q24,12q24.13,604118,"RASAL1, RASAL",Ras protein activator-like 1,RASAL1,8437,ENSG00000111344,NA,NA,Rasal1 (MGI:1330842)
12,113157172,113185477,12q22-q23,12q24.13,611665,"DDX54, DP97",Dead/H Box 54,DDX54,79039,ENSG00000123064,NA,NA,Ddx54 (MGI:1919240)
12,113221428,113298588,12q24.1,12q24.13,609666,"TPCN1, TPC1, KIAA1169",Two-pore segment channel 1,TPCN1,53373,ENSG00000186815,NA,NA,Tpcn1 (MGI:2182472)
12,113298765,113335167,12q24,12q24.13,609841,"SLC8B1, SLC24A6, NCKX6",Solute carrier family 8 member B1,SLC8B1,80024,ENSG00000089060,NA,NA,Slc8b1 (MGI:2180781)
12,113392444,113403886,12q24.13,12q24.13,182128,"SDS, SDH",Serine dehydratase,SDS,10993,ENSG00000135094,NA,NA,Sds (MGI:98270)
12,113462032,113471870,12q24.31-q24.32,12q24.13,605992,LHX5,LIM homeo box protein 5,LHX5,64211,ENSG00000089116,NA,NA,Lhx5 (MGI:107792)
12,113816739,113966370,12q24.13-q24.21,12q24.13-q24.21,616444,"RBM19, KIAA0682",RNA-binding motif protein 19,RBM19,9904,ENSG00000122965,NA,NA,Rbm19 (MGI:1921361)
12,113900000,133275309,12q24.2-q24.3,NA,614422,"CTRCT37, CCA5",Cataract 37,NA,100861439,NA,between D12S1718 and D12S1723,"Cataract 37, autosomal dominant, 614422 (2), Autosomal dominant",NA
12,113900000,120300000,12q24.2,NA,601407,NIDDM2,"Diabetes mellitus, noninsulin-dependent, 2",NIDDM2,4813,NA,no mutations found in HNF1A,"Diabetes mellitus, noninsulin-dependent, 2, 601407 (2)",NA
12,113900000,133275309,12q24.2-q24.3,NA,603416,"RPL21P1, ALFN1, HALF1",Ribosomal protein L21 pseudogene 1,RPL21P1,6145,NA,NA,NA,NA
12,114353910,114408707,12q24.1,12q24.21,601620,TBX5,T-box 5,TBX5,6910,ENSG00000089225,NA,"Holt-Oram syndrome, 142900 (3), Autosomal dominant",Tbx5 (MGI:102541)
12,114670254,114684174,12q24.1,12q24.21,601621,TBX3,T-box 3,TBX3,6926,ENSG00000135111,NA,"Ulnar-mammary syndrome, 181450 (3), Autosomal dominant",Tbx3 (MGI:98495)
12,115958575,116277218,12q24,12q24.21,608771,"MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD",Mediator complex subunit 13-like,MED13L,23389,ENSG00000123066,NA,"Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3), Autosomal dominant; Transposition of the great arteries, dextro-looped 1, 608808 (3), Autosomal dominant",Med13l (MGI:2670178)
12,116856143,116881440,12q24.2,12q24.22,603447,"HRK, DP5",Harakiri,HRK,8739,ENSG00000135116,NA,NA,NA
12,116910948,117032497,12q24.23,12q24.22,609073,"FBXW8, FBW8, FBXW6, FBW6, FBXO29, FBX29",F-box and WD40 domain protein 8,FBXW8,26259,ENSG00000174989,NA,NA,Fbxw8 (MGI:1923041)
12,117038922,117099489,12q24.2,12q24.22,611585,"TESC, TSC","Tescalcin, mouse, homolog of",TESC,54997,ENSG00000088992,NA,NA,Tesc (MGI:1930803)
12,117141990,117190470,12q24.23,12q24.22,609095,"FBXO21, FBX21, KIAA0875",F-box only protein 21,FBXO21,23014,ENSG00000135108,NA,NA,Fbxo21 (MGI:1924223)
12,117208141,117361801,12q24.2-q24.31,12q24.22,163731,NOS1,"Nitric oxide synthase 1, neuronal",NOS1,4842,ENSG00000089250,NA,NA,Nos1 (MGI:97360)
12,117453011,117968989,12q24.2,12q24.22-q24.23,610737,KSR2,Kinase suppressor of RAS 2,KSR2,283455,ENSG00000171435,NA,NA,Ksr2 (MGI:3610315)
12,118016660,118033563,12q24.2-q24.3,12q24.23,600407,RFC5,"Replication factor C5, 36.5kD (activator 1, 36.5kD)",RFC5,5985,ENSG00000111445,NA,NA,Rfc5 (MGI:1919401)
12,118136123,118145583,12q24.23,12q24.23,604591,"PEBP1, PBP, RKIP",Phosphatidylethanolamine-binding protein 1,PEBP1,5037,ENSG00000089220,NA,NA,Pebp1 (MGI:1344408)
12,118149800,118372949,12q24.23,12q24.23,616711,"TAOK3, JIK, DPK",TAO kinase 3,TAOK3,51347,ENSG00000135090,NA,NA,Taok3 (MGI:3041177)
12,118981540,119163050,12q24.23,12q24.23,613103,"SRRM4, KIAA1853, NSR100",Serine/arginine repetitive matrix protein 4,SRRM4,84530,ENSG00000139767,NA,NA,Srrm4 (MGI:1916205)
12,119178789,119194745,12q24,12q24.23,608014,"HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A",Heat-shock 22-kD protein 8,HSPB8,26353,ENSG00000152137,NA,"Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3), Autosomal dominant; Neuropathy, distal hereditary motor, type IIA, 158590 (3), Autosomal dominant",Hspb8 (MGI:2135756)
12,119592122,119654454,12q24.23,12q24.23,618296,"TMEM233, DSPB2",Transmembrane protein 233,TMEM233,387890,ENSG00000224982,NA,NA,Tmem233 (MGI:3651514)
12,119667863,119681623,12q24.1,12q24.23,602740,PRKAB1,"Protein kinase, AMP-activated, noncatalytic, beta-1",PRKAB1,5564,ENSG00000111725,NA,NA,Prkab1 (MGI:1336167)
12,119685790,119877319,12q24.1-q24.3,12q24.23,605629,"CIT, STK21, CRIK, MCPH17",Citron rho-interacting serine/threonine kinase,CIT,11113,ENSG00000122966,NA,"Microcephaly 17, primary, autosomal recessive, 617090 (3), Autosomal recessive",Cit (MGI:105313)
12,119989235,120094494,12q24.23,12q24.23,617002,"BICDL1, BICDR1, CCDC64",BICD family-like cargo adaptor 1,BICDL1,92558,ENSG00000135127,NA,NA,Bicdl1 (MGI:1922915)
12,120095093,120117468,12q24.23,12q24.23,604199,RAB35,Ras-associated protein Rab35,RAB35,11021,ENSG00000111737,NA,NA,Rab35 (MGI:1924657)
12,120127201,120194714,12q24.2,12q24.23,605614,GCN1L1,"General control of amino acid synthesis 1, yeast, homolog-like 1",GCN1,10985,ENSG00000089154,NA,NA,Gcn1 (MGI:2444248)
12,120196698,120201210,Chr.12,12q24.23,180510,RPLP0,"Ribosomal phosphoprotein, large, P0",RPLP0,6175,ENSG00000089157,NA,NA,Rplp0 (MGI:1927636)
12,120210438,120265770,12q24,12q24.23,602505,PXN,Paxillin,PXN,5829,ENSG00000089159,NA,NA,Pxn (MGI:108295)
12,120290638,120313241,12q24.31,12q24.23-q24.31,604482,"SIRT4, SIR2L4","Sirtuin, S. cerevisiae, homolog 4",SIRT4,23409,ENSG00000089163,NA,NA,Sirt4 (MGI:1922637)
12,120300000,125400000,12q24.31,NA,612573,MPVQTL1,Mean platelet volume quantitative trait locus 1,NA,100271867,NA,associated with rs7961894,"[Mean platelet volume QTL1], 612573 (2)",NA
12,120322114,120327778,12q23-q24.1,12q24.31,172410,"PLA2G1B, PLA2A, PLA2, PPLA2","Phospholipase A2, group IB, pancreas",PLA2G1B,5319,ENSG00000170890,NA,NA,Pla2g1b (MGI:101842)
12,120339661,120369173,12q24.1-q24.31,12q24.31,603328,MSI1,"Musashi, Drosophila, homolog of, 1",MSI1,4440,ENSG00000135097,NA,NA,Msi1 (MGI:107376)
12,120438112,120440729,12q24.2,12q24.31,602072,"COX6A1, CMTRID","Cytochrome c oxidase, subunit VIa, polypeptide-1",COX6A1,1337,ENSG00000111775,pseudogenes on chr.7 and chr.6,"Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3), Autosomal recessive",Cox6a1 (MGI:103099)
12,120443963,120446383,12q24.31,12q24.31,614943,"TRIAP1, HSPC132",TP53-regulated inhibitor of apoptosis 1,TRIAP1,51499,ENSG00000170855,NA,NA,Triap1 (MGI:1916326)
12,120446437,120463752,12q24.31,12q24.31,617210,GATC,"Glutamyl-tRNA amidotransferase, subunit C",GATC,283459,ENSG00000257218,NA,NA,Gatc (MGI:1923776)
12,120461671,120469747,12q24.31,12q24.31,601943,"SRSF9, SFRS9, SRp30c","Splicing factor, serine/arginine-rich, 9",SRSF9,8683,ENSG00000111786,NA,NA,Srsf9 (MGI:104896)
12,120469841,120498492,12q24.2,12q24.31,601562,"DYNLL1, DNCL1, DLC1, PIN","Dynein, light chain, LC8-type 1",DYNLL1,8655,ENSG00000088986,possible pseudogene on 14q24,NA,Dynll1 (MGI:1861457)
12,120490337,120495945,12q24.31,12q24.31,616207,"NRAV, DYNLL1AS1","Negative regulator of antiviral response, noncoding",NRAV,100506668,ENSG00000248008,overlaps intron 1 of DYNLL1 in antisense orientation,NA,NA
12,120503278,120534612,12q24.31,12q24.31,616359,COQ5,"Coq5, S. cerevisiae, homolog of",COQ5,84274,ENSG00000110871,NA,NA,Coq5 (MGI:1098643)
12,120534352,120577587,12q24.31,12q24.31,615998,"RNF10, KIAA0262",RING finger protein 10,RNF10,9921,ENSG00000022840,NA,NA,Rnf10 (MGI:1859162)
12,120578763,120581451,12q24.31,12q24.31,609992,"POP5, HSPC004","Processing of precursor 5, S. cerevisiae, homolog of",POP5,51367,ENSG00000167272,NA,NA,Pop5 (MGI:2151221)
12,120687148,120701863,12q24.31,12q24.31,613802,"MLEC, KIAA0152",Malectin,MLEC,9761,ENSG00000110917,NA,NA,Mlec (MGI:1924015)
12,120725825,120740007,12q22-qter,12q24.31,606885,"ACADS, SCAD","Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain",ACADS,35,ENSG00000122971,NA,"Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3), Autosomal recessive",Acads (MGI:87868)
12,120762509,120904357,12q24.31,12q24.31,608240,"SPPL3, IMP2",Signal peptide peptidase-like 3,SPPL3,121665,ENSG00000157837,NA,NA,Sppl3 (MGI:1891433)
12,120977682,121002511,12q24.2,12q24.31,142410,"HNF1A, TCF1, MODY3, IDDM20",HNF1 homeobox B,HNF1A,6927,ENSG00000135100,NA,"Diabetes mellitus, insulin-dependent, 20, 612520 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive; {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant; Hepatic adenoma, somatic, 142330 (3); MODY, type III, 600496 (3), Autosomal dominant; Renal cell carcinoma, 144700 (3)",Hnf1a (MGI:98504)
12,121018881,121039241,12q24.2,12q24.31,603281,"OASL, TRIP14","2',5'-oligoadenylate synthetase-like",OASL,8638,ENSG00000135114,NA,NA,Oasl1 (MGI:2180849)
12,121132818,121188031,12q24,12q24.31,602566,"P2RX7, P2X7","Purinergic receptor P2X, ligand-gated ion channel, 7",P2RX7,5027,ENSG00000089041,NA,NA,P2rx7 (MGI:1339957)
12,121209860,121234105,12q24.32,12q24.31,600846,"P2RX4, P2X4","Purinergic receptor P2X, ligand-gated ion channel, 4",P2RX4,5025,ENSG00000135124,NA,NA,P2rx4 (MGI:1338859)
12,121237691,121298307,12q24.2,12q24.31,615002,"CAMKK2, KIAA0787, CAMKKB","Calcium/calmodulin-dependent protein kinase kinase 2, beta",CAMKK2,10645,ENSG00000110931,NA,NA,Camkk2 (MGI:2444812)
12,121308244,121354208,Chr.12,12q24.31,606948,"ANAPC5, APC5","Anaphase-promoting complex, subunit 5",ANAPC5,51433,ENSG00000089053,NA,NA,Anapc5 (MGI:1929722)
12,121400082,121424351,12q23-q24.1,12q24.31,608299,"RNF34, RFI",Ring finger protein 34,RNF34,80196,ENSG00000170633,NA,NA,Rnf34 (MGI:2153340)
12,121402287,121582267,12q24.31,12q24.31,609078,"KDM2B, FBXL10, FBL10, CXXC2, JHDM1B",Lysine-specific demethylase 2B,KDM2B,84678,ENSG00000089094,NA,NA,Kdm2b (MGI:1354737)
12,121626549,121642039,12q24,12q24.31,610277,"ORAI1, TMEM142A, CRACM1, IMD9, TAM2",ORAI calcium release-activated calcium modulator 1,ORAI1,84876,NA,NA,"Immunodeficiency 9, 612782 (3), Autosomal recessive; Myopathy, tubular aggregate, 2, 615883 (3), Autosomal dominant",Orai1 (MGI:1925542)
12,121712751,121782067,12q24.31,12q24.31,616551,TMEM120B,Transmembrane protein 120B,TMEM120B,144404,ENSG00000188735,NA,NA,Tmem120b (MGI:3603158)
12,121803664,121832655,12q24.31,12q24.31,611055,"SETD1B, SET1B, KIAA1076",SET domain-containing protein 1B,SETD1B,23067,ENSG00000139718,NA,NA,NA
12,121839526,121888610,12q24-qter,12q24.31,609695,HPD,4-hydroxyphenylpyruvate dioxygenase,HPD,3242,ENSG00000158104,NA,"Hawkinsinuria, 140350 (3), Autosomal dominant; Tyrosinemia, type III, 276710 (3), Autosomal recessive",Hpd (MGI:96213)
12,121888730,121918296,12q24.2-q24.3,12q24.31,603146,PSMD9,"Proteasome 26S subunit, non-ATPase, 9",PSMD9,5715,ENSG00000110801,NA,NA,Psmd9 (MGI:1914401)
12,121918591,122003918,12q24.31,12q24.31,618146,"WDR66, CFAP251, SPGF33",WD repeat-containing protein 66,WDR66,144406,ENSG00000158023,NA,"Spermatogenic failure 33, 618152 (3), Autosomal recessive",Wdr66 (MGI:1918495)
12,122021883,122062043,12q24.1,12q24.31,601406,"BCL7A, BCL7",B-cell CLL/lymphoma-7A,BCL7A,605,ENSG00000110987,NA,"B-cell non-Hodgkin lymphoma, high-grade (3)",Bcl7a (MGI:1924295)
12,122078743,122147343,12q21.31,12q24.31,608090,"MLXIP, MONDOA, KIAA0867",MLX-interacting protein,MLXIP,22877,ENSG00000175727,NA,NA,Mlxip (MGI:2141183)
12,122172028,122174220,12q24.31,12q24.31,609509,IL31,Interleukin 31,IL31,386653,ENSG00000204671,NA,NA,NA
12,122203680,122208951,12q24.31,12q24.31,605864,B3GNT4,"Beta-1,3-N-acetylglucosaminyltransferase 4",B3GNT4,79369,ENSG00000176383,NA,NA,B3gnt4 (MGI:2680208)
12,122207661,122227455,12q24.31,12q24.31,605219,"SMAC, DIABLO, DFNA64",Second mitochondria-derived activator of caspase,DIABLO,56616,ENSG00000184047,NA,"Deafness, autosomal dominant 64, 614152 (3), Autosomal dominant",Diablo (MGI:1913843)
12,122229563,122266493,12q24.31,12q24.31,610034,"VPS33A, MPSPS","Vacuolar protein sorting 33, yeast, homolog of, A",VPS33A,65082,ENSG00000139719,NA,"Mucopolysaccharidosis-plus syndrome, 617303 (3), Autosomal recessive",Vps33a (MGI:1924823)
12,122271430,122422955,12q24.3,12q24.31,179838,"CLIP1, RSN, CYLN1, CLIP170",CAP-GLY domain containing linker protein 1,CLIP1,6249,ENSG00000130779,NA,NA,Clip1 (MGI:1928401)
12,122471599,122501183,12q24.31,12q24.31,616381,ZCCHC8,Zinc finger CCHC domain-containing protein 8,ZCCHC8,55596,ENSG00000033030,NA,NA,Zcchc8 (MGI:1917900)
12,122527105,122626408,12q24.31,12q24.31,607363,"KNTC1, ROD, KIAA0166",Kinetochore-associated protein 1,KNTC1,9735,ENSG00000184445,previously assigned to chr.17,NA,Kntc1 (MGI:2673709)
12,122701292,122703356,12q24.31,12q24.31,609163,"HCAR2, GPR109A, HM74A",Hydroxycarboxylic acid receptor 2,HCAR2,338442,ENSG00000182782,NA,NA,Hcar2 (MGI:1933383)
12,122714755,122716810,12q24.31,12q24.31,606039,"HCAR3, GPR109B, HM74, PUMAG",Hydroxycarboxylic acid receptor 3,HCAR3,8843,ENSG00000255398,NA,NA,NA
12,122726075,122730843,12q24.31,12q24.31,606923,"HCAR1, GPR81, TAGPCR",Hydroxycarboxylic acid receptor 1,HCAR1,27198,ENSG00000196917,NA,NA,Hcar1 (MGI:2441671)
12,122752823,122771063,12q24.31,12q24.31,604550,"DENR, DRP",Density-regulated protein,DENR,8562,ENSG00000139726,NA,NA,Denr (MGI:1915434)
12,122773620,122827527,12q24.31,12q24.31,613481,"CCDC62, ERAP75",Coiled-coil domain-containing protein 62,CCDC62,84660,ENSG00000130783,NA,NA,Ccdc62 (MGI:2684996)
12,122834497,122862960,12q24.2-q24.3,12q24.31,605613,"HIP1R, HIP12",Huntingtin-interacting protein 1-related protein,HIP1R,9026,ENSG00000130787,NA,NA,Hip1r (MGI:1352504)
12,122865329,122896142,12q24.31,12q24.31,610037,VPS37B,"Vacuolar protein sorting 37, yeast, homolog of, B",VPS37B,79720,ENSG00000139722,NA,NA,Vps37b (MGI:1916724)
12,122917323,122975159,12q24,12q24.31,605453,ABCB9,"ATP-binding cassette, subfamily B, member 9",ABCB9,23457,ENSG00000150967,NA,NA,Abcb9 (MGI:1861729)
12,122980059,122982912,12q24.31,12q24.31,607668,ARL6IP4,ADP-ribosylation-like factor 6 interacting protein 4,ARL6IP4,51329,ENSG00000182196,NA,NA,Arl6ip4 (MGI:1929500)
12,123233435,123257959,12q24.31,12q24.31,613541,"C12orf65, COXPD7, SPG55",Chromosome 12 open reading frame 65,C12orf65,91574,ENSG00000130921,NA,"Combined oxidative phosphorylation deficiency 7, 613559 (3), Autosomal recessive; Spastic paraplegia 55, autosomal recessive, 615035 (3), Autosomal recessive",2810006K23Rik (MGI:1919900)
12,123152323,123244013,Chr.12,12q24.31,605501,"MPHOSPH9, MPP9",M-phase phosphoprotein 9,MPHOSPH9,10198,ENSG00000051825,NA,NA,Mphosph9 (MGI:2443138)
12,123260969,123272239,12q24.31,12q24.31,602198,"CDK2AP1, DOC1",CDK-associated protein 1 (deleted in oral cancer-1),CDK2AP1,8099,ENSG00000111328,NA,NA,Cdk2ap1 (MGI:1202069)
12,123289108,123364846,12q24.31,12q24.31,614274,SBNO1,"Strawberry notch, Drosophila, homolog of, 1",SBNO1,55206,ENSG00000139697,NA,NA,Sbno1 (MGI:2384298)
12,123409889,123436732,12q24.31,12q24.31,614093,"RILPL2, RLP2",RAB-interacting lysosomal protein-like 2,RILPL2,196383,ENSG00000150977,NA,NA,Rilpl2 (MGI:1933112)
12,123470053,123533718,12q24.31,12q24.31,614092,"RILPL1, RLP1, GOSPEL",RAB-interacting lysosomal protein-like 1,RILPL1,353116,ENSG00000188026,NA,NA,Rilpl1 (MGI:1922945)
12,123620405,123633685,12q24.31,12q24.31,606686,"EIF2B1, EIF2BA","Eukaryotic translation initiation factor 2B, subunit 1",EIF2B1,1967,ENSG00000111361,NA,"Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive",Eif2b1 (MGI:2384802)
12,123633738,123662603,12q24.31,12q24.31,601750,"GTF2H3, TFB4","General transcription factor IIH, polypeptide 3",GTF2H3,2967,ENSG00000111358,NA,NA,Gtf2h3 (MGI:1277143)
12,123671107,123708404,12q24.31,12q24.31,613846,"TCTN2, TECT2, MKS8, JBTS24","Tectonic family, member 2",TCTN2,79867,ENSG00000168778,mutation identified in 1 MKS8 family,"Joubert syndrome 24, 616654 (3), Autosomal recessive; ?Meckel syndrome 8, 613885 (3), Autosomal recessive",Tctn2 (MGI:1915228)
12,123712352,123761754,12q24.3,12q24.31,611716,"ATP6V0A2, WSS, ARCL2A","ATPase, H+ transporting, V0 subunit A2",ATP6V0A2,23545,ENSG00000185344,NA,"Cutis laxa, autosomal recessive, type IIA, 219200 (3), Autosomal recessive; Wrinkly skin syndrome, 278250 (3), Autosomal recessive",Atp6v0a2 (MGI:104855)
12,123761994,123935719,12q24.31,12q24.31,605884,DNAH10,"Dynein, axonemal, heavy chain 10",DNAH10,196385,ENSG00000197653,previously assigned to 13q14,NA,Dnah10 (MGI:1860299)
12,123973214,124015426,12q24.2,12q24.31,617890,"ZNF664, ZFOC1",Zinc finger protein 664,ZNF664,144348,ENSG00000179195,NA,NA,Zfp664 (MGI:2442505)
12,124289163,124316023,12q24.31,12q24.31,615927,"FAM101A, CFM2","Family with sequence similarity 101, member A",RFLNA,144347,ENSG00000178882,NA,NA,Rflna (MGI:1920371)
12,124324414,124567611,12q24,12q24.31,600848,"NCOR2, SMRT",Nuclear receptor corepressor 2,NCOR2,9612,ENSG00000196498,NA,NA,Ncor2 (MGI:1337080)
12,124776855,124863863,12q24.31,12q24.31,601040,"SCARB1, CD36L1, CLA1, HDLQTL6","Scavenger receptor class B, member 1 (CD36 antigen-like 1)",SCARB1,949,ENSG00000073060,NA,"[High density lipoprotein cholesterol level QTL6], 610762 (3)",Scarb1 (MGI:893578)
12,124911645,124914649,12q24.3,12q24.31,191340,UBC,Ubiquitin C,UBC,7316,ENSG00000150991,NA,NA,Ubc (MGI:98889)
12,124946823,124989130,12q24.31,12q24.31,617362,"DHX37, KIAA1517",DEAH box polypeptide 37,DHX37,57647,ENSG00000150990,NA,NA,Dhx37 (MGI:3028576)
12,124993644,125051844,12q24.31,12q24.31,615627,BRI3BP,BRI3-binding protein,BRI3BP,140707,ENSG00000184992,NA,NA,Bri3bp (MGI:1924059)
12,125025442,125027422,12q24.31,12q24.31,615622,"THRIL, LINC1992, BRI3BPAS1",TNF- and HNRNPL-related immunoregulatory long noncoding RNA,THRIL,102659353,ENSG00000280634,NA,NA,NA
12,125065434,125143326,12q24.31,12q24.31,614364,"AACS, ACSF1",Acetoacetyl-CoA synthetase,AACS,65985,ENSG00000081760,NA,NA,Aacs (MGI:1926144)
12,128793193,128823965,12q24.32,12q24.33,615806,"SLC15A4, PHT1, PTR4","Solute carrier family 15 (oligopeptide transporter), member 4",SLC15A4,121260,ENSG00000139370,NA,NA,Slc15a4 (MGI:2140796)
12,129071725,129904024,12q24.3,12q24.33,611257,"TMEM132D, KIAA1944, MOLT",Transmembrane protein 132D,TMEM132D,121256,ENSG00000151952,NA,NA,Tmem132d (MGI:3044963)
12,130162458,130165739,12q24.33,12q24.33,606147,FZD10,"Frizzled, Drosophila, homolog of, 10",FZD10,11211,ENSG00000111432,NA,NA,Fzd10 (MGI:2136761)
12,130396132,130716360,12q24.33,12q24.33,611602,"RIMBP2, KIAA0318",RIMS-binding protein 2,RIMBP2,23504,ENSG00000060709,NA,NA,Rimbp2 (MGI:2443235)
12,130337886,130412707,Chr.12,12q24.33,605571,PIWIL1,"Piwi, Drosophila, homolog of",PIWIL1,9271,ENSG00000125207,NA,NA,Piwil1 (MGI:1928897)
12,130789599,130839273,12q24.33,12q24.33,132350,"STX2, EPIM, STX2C, STX2B, STX2A",Epimorphin (syntaxin 2),STX2,2054,ENSG00000111450,NA,NA,Stx2 (MGI:108059)
12,130871878,130877677,12q24.3,12q24.33,601179,"RAN, ARA24",Ras-related nuclear protein,RAN,5901,ENSG00000132341,NA,NA,Ran (MGI:1333112)
12,130953906,131141468,12q24.33,12q24.33,613639,"ADGRD1, GPR133, PGR25",Adhesion G protein-coupled receptor D1,ADGRD1,283383,ENSG00000111452,NA,NA,Adgrd1 (MGI:3041203)
12,131711087,131799737,12q24.33,12q24.33,601945,"SFSWAP, SFRS8, SWAP","Splicing factor, suppressor-of-white-apricot family",SFSWAP,6433,ENSG00000061936,NA,NA,Sfswap (MGI:101760)
12,131828392,131851770,12q24.33,12q24.33,602285,MMP17,Matrix metalloproteinase 17,MMP17,4326,ENSG00000198598,NA,NA,Mmp17 (MGI:1346076)
12,131894621,131923149,12q24.3,12q24.33,603168,"ULK1, UNC51",UNC51-like kinase 1,ULK1,8408,ENSG00000177169,NA,NA,Ulk1 (MGI:1270126)
12,131929267,131945895,12q24.33,12q24.33,608109,"PUS1, MLASA1",Pseudourine synthase 1,PUS1,80324,ENSG00000177192,NA,"Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3), Autosomal recessive",Pus1 (MGI:1929237)
12,131949941,132080459,12q24.33,12q24.33,606265,"EP400, TNRC12, KIAA1498",p400 SWI2/SNF2-related protein,EP400,57634,ENSG00000183495,NA,NA,Ep400 (MGI:1276124)
12,132144420,132152467,12q24.33,12q24.33,612819,"NOC4L, NOC4","Nucleolar complex-associated protein 4, S. cerevisiae, homolog of",NOC4L,79050,ENSG00000184967,NA,NA,Noc4l (MGI:2140843)
12,132196371,132329588,12q24.33,12q24.33,606251,"GALNT9, GALNACT9",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9,GALNT9,50614,ENSG00000182870,REc,NA,Galnt9 (MGI:2677965)
12,132471570,132476637,12q24.3,12q24.33,601932,MUC8,"Mucin 8, tracheobronchial",MUC8,100129528,NA,NA,NA,NA
12,132618775,132623735,12q24.33,12q24.33,600844,"P2RX2, P2X2, DFNA41","Purinergic receptor P2X, ligand-gated ion channel, 2",P2RX2,22953,ENSG00000187848,NA,"Deafness, autosomal dominant 41, 608224 (3), Autosomal dominant",P2rx2 (MGI:2665170)
12,132623757,132687523,12q24.3,12q24.33,174762,"POLE, CRCS12, FILS, IMAGEI","Polymerase, DNA, epsilon",POLE,5426,ENSG00000177084,NA,"{Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant; FILS syndrome, 615139 (3), Autosomal recessive; IMAGE-I syndrome, 618336 (3), Autosomal recessive",Pole (MGI:1196391)
12,132687586,132704984,12q24.33,12q24.33,617399,PXMP2,Peroxisomal membrane protein 2,PXMP2,5827,ENSG00000176894,NA,NA,Pxmp2 (MGI:107487)
12,132710841,132722733,12q24.33,12q24.33,614939,PGAM5,"Phosphogycerate mutase family, member 5",PGAM5,192111,ENSG00000247077,NA,NA,Pgam5 (MGI:1919792)
12,132725502,132761831,12q24.33,12q24.33,616062,"ANKLE2, LEM4, KIAA0692, MCPH16",Ankyrin repeat- and LEM domain-containing protein 2,ANKLE2,23141,ENSG00000176915,NA,"Microcephaly 16, primary, autosomal recessive, 616681 (3), Autosomal recessive",Ankle2 (MGI:1261856)
12,132768912,132829130,Chr.12,12q24.33,602581,GOLGA3,"Golgi autoantigen, golgin subfamily A, 3",GOLGA3,2802,ENSG00000090615,NA,NA,Golga3 (MGI:96958)
12,132840351,132887617,12q24.33,12q24.33,605209,CHFR,Checkpoint protein with FHA and ring-finger domains,CHFR,55743,ENSG00000072609,NA,NA,Chfr (MGI:2444898)
12,132986364,133027101,12q24.33,12q24.33,194537,ZNF26,Zinc finger protein-26 (KOX20),ZNF26,7574,ENSG00000198393,NA,NA,NA
12,133079469,133107673,12q24.32-q24.33,12q24.33,604082,ZNF140,Zinc finger protein-140,ZNF140,7699,ENSG00000196387,NA,NA,NA
12,133130626,133159464,12q13-qter,12q24.33,194538,"ZNF10, KOX1",Zinc finger protein-10 (KOX 1),ZNF10,7556,ENSG00000256223,same 300kb fragment as ZNF26,NA,NA
12,133181494,133214831,12q24.3,12q24.33,604753,ZNF268,Zinc finger protein 268,ZNF268,10795,ENSG00000090612,NA,NA,NA
12,0,133275309,Chr.12,NA,191120,TUBAL1,"Tubulin, alpha-like-1",NA,NA,NA,NA,NA,NA
13,0,27200000,13pter-q12.13,NA,610158,"FECD2, FCD1","Corneal dystrophy, Fuchs endothelial, 2",NA,100188278,NA,max lod at D13S1304,"Corneal dystrophy, Fuchs endothelial, 2, 610158 (2), Autosomal dominant",NA
13,4600000,10100000,13p12,NA,180450,RNR1,Ribosomal RNA-1,RNR1,6052,NA,NA,NA,NA
13,17700000,114364328,13q,NA,604595,"CLQTL1, CLF",Cholesterol level quantitative trait locus 1,NA,54501,NA,NA,"[Cholesterol level QTL 1], 604595 (2)",NA
13,18900000,22600000,13q12.11,NA,612312,ADHD6,"Attention deficit-hyperactivity disorder, susceptibility to, 6",NA,100190791,NA,max lod at rs1974047,"{Attention deficit-hyperactivity disorder, susceptibility to, 6}, 612312 (2)",NA
13,18900000,54700000,13q12-q14,NA,605844,ATOD5,"Dermatitis, atopic, 5",NA,117188,NA,max lod at D13S218,"{Dermatitis, atopic, susceptibility to, 5}, 605844 (2)",NA
13,18900000,22600000,13q12.11,NA,609384,"CFEOM3C, FEOM4","Fibrosis of extraocular muscles, congenital, 3C",NA,NA,NA,NA,"Fibrosis of extraocular muscles, congenital, 3C, 609384 (2), Autosomal dominant",NA
13,18900000,31600000,13q12,NA,608557,MCI2,"Myocardial infarction, susceptibility to, 2",NA,100233226,NA,defined by 4-SNP haplotype HapA,"{Myocardial infarction, susceptibility to, 2}, 608557 (2)",NA
13,19173771,19181823,13q11,13q12.11,602528,TUBA2,"Tubulin, alpha 2",TUBA3C,7278,ENSG00000198033,NA,NA,NA
13,19422876,19561573,13q12.11,13q12.11,606791,"TPTE2, TPIP",Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2,TPTE2,93492,ENSG00000132958,NA,NA,Tpte (MGI:2446460)
13,19633647,19673440,13q12.11,13q12.11,611626,"MPHOSPH8, TWA3",M-phase phosphoprotein 8,MPHOSPH8,54737,ENSG00000196199,NA,NA,Mphosph8 (MGI:1922589)
13,19674751,19783035,13q12.11,13q12.11,612408,"PSPC1, PSP1",Paraspeckle component 1,PSPC1,55269,ENSG00000121390,NA,NA,Pspc1 (MGI:1913895)
13,19823481,19863648,13q12.11,13q12.11,616443,"ZMYM5, ZNF237, ZNF198L1","Zinc finger, MYM-type 5",ZMYM5,9205,ENSG00000132950,NA,NA,Zmym5 (MGI:3041170)
13,19957405,20091847,13q12.11,13q12.11,602221,"ZMYM2, ZNF198, RAMP, FIM","Zinc finger, MYM-type 2",ZMYM2,7750,ENSG00000121741,NA,NA,Zmym2 (MGI:1923257)
13,20138251,20161326,13q11,13q12.11,121015,"GJA3, CX46, CZP3, CAE3, CTRCT14","Gap junction protein, alpha-3, 46kD (connexin 46)",GJA3,2700,ENSG00000121743,NA,"Cataract 14, multiple types, 601885 (3), Autosomal dominant",Gja3 (MGI:95714)
13,20187469,20192937,13q11-q12,13q12.11,121011,"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID","Gap junction protein, beta-2, 26kD (connexin 26)",GJB2,2706,ENSG00000165474,NA,"Bart-Pumphrey syndrome, 149200 (3), Autosomal dominant; Deafness, autosomal dominant 3A, 601544 (3), Autosomal dominant; Deafness, autosomal recessive 1A, 220290 (3), Autosomal recessive; Hystrix-like ichthyosis with deafness, 602540 (3), Autosomal dominant; Keratitis-ichthyosis-deafness syndrome, 148210 (3), Autosomal dominant; Keratoderma, palmoplantar, with deafness, 148350 (3), Autosomal dominant; Vohwinkel syndrome, 124500 (3), Autosomal dominant",Gjb2 (MGI:95720)
13,20221961,20232394,13q12,13q12.11,604418,"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2","Gap junction protein, beta-6 (connexin-30)",GJB6,10804,ENSG00000121742,NA,"Deafness, autosomal dominant 3B, 612643 (3), Autosomal dominant; Deafness, autosomal recessive 1B, 612645 (3), Autosomal recessive; Deafness, digenic GJB2/GJB6, 220290 (3), Autosomal recessive; Ectodermal dysplasia 2, Clouston type, 129500 (3), Autosomal dominant",Gjb6 (MGI:107588)
13,20403666,20525872,13q12.11,13q12.11,609877,CRYL1,"Crystallin, lambda-1",CRYL1,51084,ENSG00000165475,NA,NA,Cryl1 (MGI:1915881)
13,20566445,20691443,13q12.1,13q12.11,600595,"IFT88, D13S1056E, TG737","Intraflagellar transport 88, Chlamydomonas, homolog of",IFT88,8100,ENSG00000032742,NA,NA,Ift88 (MGI:98715)
13,20701104,20723099,13p11,13q12.11,607587,IL17D,Interleukin 17D,IL17D,53342,ENSG00000172458,?associated with Hodgkin lymphoma,NA,Il17d (MGI:2446510)
13,20728730,20773960,13q12.11,13q12.11,617793,"EEF1AKMT1, N6AMT2",EEF1A lysine methyltransferase 1,EEF1AKMT1,221143,ENSG00000150456,NA,NA,Eef1akmt1 (MGI:1915293)
13,20973035,21061585,13q11-q12,13q12.11,604861,LATS2,"Large tumor suppressor, Drosophila, homolog of, 2",LATS2,26524,ENSG00000150457,NA,NA,Lats2 (MGI:1354386)
13,21140513,21149096,13q12.11,13q12.11,602949,SAP18,"Sin3-associated polypeptide, 18kD",SAP18,10284,ENSG00000150459,NA,NA,"Sap18b,Sap18 (MGI:3704317,MGI:1277978)"
13,21176648,21179083,13q12.11,13q12.11,611997,MRP63,Mitochondrial ribosomal protein 63,MRPL57,78988,ENSG00000173141,10 pseudogenes,NA,Mrpl57 (MGI:1915090)
13,21372570,21459369,13q12.11,13q12.11,617972,"ZDHHC20, DHHC20",Zinc finger DHHC domain-containing protein 20,ZDHHC20,253832,ENSG00000180776,NA,NA,Zdhhc20 (MGI:1923215)
13,21492690,21604204,13q12.11,13q12.11,610632,"MICU2, EFHA1",Mitochondrial calcium uptake protein 2,MICU2,221154,ENSG00000165487,NA,NA,Micu2 (MGI:1915764)
13,21671072,21704500,13q11-q12,13q12.11,600921,"FGF9, SYNS3",Fibroblast growth factor-9 (glia-activating factor),FGF9,2254,ENSG00000102678,NA,"Multiple synostoses syndrome 3, 612961 (3), Autosomal dominant",Fgf9 (MGI:104723)
13,22600000,24900000,13q12.12,NA,614166,MYP20,"Myopia 20, autosomal dominant",NA,100682326,NA,associated with rs9318086,"Myopia 20, autosomal dominant, 614166 (2)",NA
13,23160307,23325164,13q12,13q12.12,608896,"SGCG, LGMDR5, DMDA1, SCG3","Sarcoglycan, gamma (35kD dystrophin-associated glycoprotein)",SGCG,6445,ENSG00000102683,NA,"Muscular dystrophy, limb-girdle, autosomal recessive 5, 253700 (3), Autosomal recessive",Sgcg (MGI:1346524)
13,23328826,23433727,13q12,13q12.12,604490,"SACS, ARSACS",Sacsin,SACS,26278,ENSG00000151835,NA,"Spastic ataxia, Charlevoix-Saguenay type, 270550 (3), Autosomal recessive",NA
13,23570247,23676104,13q12.11-q12.3,13q12.12,606122,"TAJ, TROY",Toxicity and JNK inducer,TNFRSF19,55504,ENSG00000127863,NA,NA,Tnfrsf19 (MGI:1352474)
13,23730188,23889447,13q12,13q12.12,602241,"MIPEP, COXPD31",Mitochondrial intermediate peptidase,MIPEP,4285,ENSG00000027001,NA,"Combined oxidative phosphorylation deficiency 31, 617228 (3), Autosomal recessive",Mipep (MGI:1917728)
13,23888867,23892103,13q12.12,13q12.12,617122,"C1QTNF9BAS1, PCOTH",C1QTNF9B antisense RNA 1,PCOTH,542767,NA,NA,NA,NA
13,23891098,23897501,13q12.12,13q12.12,614148,"C1QTNF9B, CTRP9B",C1q- and tumor necrosis factor-related protein 9B,C1QTNF9B,387911,ENSG00000205863,NA,NA,C1qtnf9 (MGI:3045252)
13,23979801,24307073,13q12.12,13q12.12,613324,"SPATA13, ASEF2",Spermatogenesis-associated protein 13,SPATA13,221178,ENSG00000182957,NA,NA,Spata13 (MGI:104838)
13,24307165,24322530,13q12.12,13q12.12,614285,"C1QTNF9A, CTRP9, C1QTNF9",C1q- and tumor necrosis factor-related protein 9A,C1QTNF9,338872,ENSG00000240654,NA,NA,NA
13,24420929,24512992,13q11,13q12.12,607519,"PARP4, ADPRTL1, VPARP, KIAA0177",Poly(ADP-ribose) polymerase 4,PARP4,143,ENSG00000102699,NA,NA,Parp4 (MGI:2685589)
13,24680407,24712492,13q12.1-q12.3,13q12.12,182360,"ATP12A, ATP1AL1","ATPase, H+/K+ transporting, nongastric, alpha polypeptide",ATP12A,479,ENSG00000075673,NA,NA,Atp12a (MGI:1926943)
13,24747640,24888815,13q12.1,13q12.12,605793,RNF17,RING finger protein-17,RNF17,56163,ENSG00000132972,NA,NA,Rnf17 (MGI:1353419)
13,24882273,24922888,13q12.2,13q12.12-q12.13,609279,"CENPJ, CPAP, MCPH6, SCKL4",Centromeric protein J,CENPJ,55835,ENSG00000151849,mutation identified in 1 SCKL4 family,"Microcephaly 6, primary, autosomal recessive, 608393 (3), Autosomal recessive; ?Seckel syndrome 4, 613676 (3), Autosomal recessive",Cenpj (MGI:2684927)
13,25161678,25172450,13q12.13,13q12.13,614659,"FAM123A, AMER2","Family with sequence similarity 123, member A (APC membrane recruitment protein 2)",AMER2,219287,ENSG00000165566,NA,NA,Amer2 (MGI:1919375)
13,25246200,25287511,13q12,13q12.13,603561,MTMR6,Myotubularin-related protein 6,MTMR6,9107,ENSG00000139505,NA,NA,Mtmr6 (MGI:2145637)
13,25301083,25349794,13q12.1,13q12.13,607615,"NUP58, NUPL1, KIAA0410",Nucleoporin 58kDa,NUP58,9818,ENSG00000139496,NA,NA,Nupl1 (MGI:1919094)
13,25371973,26025850,13q12,13q12.13,605870,"ATP8A2, ATPIB, CAMRQ4","ATPase, class I, type 8A, member 2",ATP8A2,51761,ENSG00000132932,NA,"?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3), Autosomal recessive",Atp8a2 (MGI:1354710)
13,26044596,26051059,13q12.13,13q12.13,617324,"SHISA2, C13orf13, TMEM46","Shisa family, member 2",SHISA2,387914,ENSG00000180730,NA,NA,Shisa2 (MGI:2444716)
13,26132114,26223084,13q12.11,13q12.13,604242,RNF6,RING finger protein-6,RNF6,6049,ENSG00000127870,NA,"Esophageal carcinoma, somatic, 133239 (3)",Rnf6 (MGI:1921382)
13,26254124,26405237,13q12,13q12.13,603184,CDK8,Cyclin-dependent kinase 8,CDK8,1024,ENSG00000132964,NA,NA,Cdk8 (MGI:1196224)
13,26539138,26688947,13q12,13q12.13,605068,"WASF3, WAVE3, SCAR3",WAS protein family member 3,WASF3,10810,ENSG00000132970,NA,NA,Wasf3 (MGI:2658986)
13,26755199,26760785,13q12,13q12.13,600752,GPR12,G protein-coupled receptor-12,GPR12,2835,ENSG00000132975,NA,NA,Gpr12 (MGI:101909)
13,27066153,27171810,13q12.13,13q12.13,603091,"USP12, UBH1",Ubiquitin-specific protease 12,USP12,219333,ENSG00000152484,NA,NA,Usp12 (MGI:1270128)
13,27200000,39500000,13q12.2-q13,NA,157900,"MBS, MBS1",Moebius syndrome,MBS1,4156,NA,NA,"?Moebius syndrome, 157900 (2), Autosomal dominant, Isolated cases",NA
13,27251554,27256567,13q12.2,13q12.2,603636,"RPL21, HYPT12",Ribosomal protein L21,RPL21,6144,ENSG00000122026,NA,"Hypotrichosis 12, 615885 (3), Autosomal dominant",Rpl21 (MGI:1278340)
13,27270326,27273766,13q12.2,13q12.2,612403,RASL11A,"RAS-like, family 11, member A",RASL11A,387496,ENSG00000122035,NA,NA,Rasl11a (MGI:1916145)
13,27424618,27435822,13q12.3-q13.1,13q12.2,600860,"GTF3A, TFIIIA",General transcription factor IIIA,GTF3A,2971,ENSG00000122034,NA,NA,Gtf3a (MGI:1913846)
13,27545912,27621105,13q12.2,13q12.2,609733,"LNX2, PDZRN1",Ligand of numb protein X2,LNX2,222484,ENSG00000139517,NA,NA,Lnx2 (MGI:2155959)
13,27620742,27667414,13q12.2,13q12.2,613715,"POLR1D, RPA16, RPAC2, TCS2","Polymerase I, RNA, subunit D",POLR1D,51082,ENSG00000186184,NA,"Treacher Collins syndrome 2, 613717 (3), Autosomal recessive, Autosomal dominant",Polr1d (MGI:108403)
13,27792482,27794767,13q12.2,13q12.2,616542,"GSX1, GSH1",GS homeobox 1,GSX1,219409,ENSG00000169840,NA,NA,Gsx1 (MGI:95842)
13,27919981,27926312,13q12.1,13q12.2,600733,"PDX1, IPF1, MODY4, PAGEN1",Pancreas/duodenum homeobox protein 1,PDX1,3651,ENSG00000139515,NA,"{Diabetes mellitus, type II, susceptibility to}, 125853 (3), Autosomal dominant; MODY, type IV, 606392 (3); Pancreatic agenesis 1, 260370 (3), Autosomal recessive",Pdx1 (MGI:102851)
13,27960917,27969367,13q12.3,13q12.2,600297,"CDX2, CDX3",Caudal type homeo box transcription factor 2,CDX2,1045,ENSG00000165556,NA,NA,Cdx2 (MGI:88361)
13,27978105,27988636,13q12.2,13q12.2,615804,URAD,Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase,URAD,646625,ENSG00000183463,NA,NA,Urad (MGI:3647519)
13,28003273,28100591,13q12,13q12.2,136351,FLT3,fms-related tyrosine kinase-3,FLT3,2322,ENSG00000122025,NA,"Leukemia, acute lymphoblastic, somatic, 613065 (3); Leukemia, acute myeloid, reduced survival in, somatic, 601626 (3); Leukemia, acute myeloid, somatic, 601626 (3)",Flt3 (MGI:95559)
13,28135020,28295334,13q12.2,13q12.2,617448,PAN3,PABP-dependent poly(A) nuclease 3,PAN3,255967,ENSG00000152520,NA,NA,Pan3 (MGI:1919837)
13,28300345,28495127,13q12,13q12.3,165070,FLT1,fms-related tyrosine kinase-1 (vascular endothelial growth factor/vascular permeability factor receptor),FLT1,2321,ENSG00000102755,150kb from FLT3,NA,Flt1 (MGI:95558)
13,28659129,28678958,13q12.3,13q12.3,613386,"POMP, UMP1, PRAAS2",Proteasome maturation protein,POMP,51371,ENSG00000132963,NA,"Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3), Autosomal recessive; Proteasome-associated autoinflammatory syndrome 2, 618048 (3), Autosomal dominant",Pomp (MGI:1913787)
13,28700079,28719012,13q12.3,13q12.3,616764,SLC46A3,"Solute carrier family 46, member 3",SLC46A3,283537,ENSG00000139508,NA,NA,Slc46a3 (MGI:1918956)
13,29509409,29595687,13q12.3,13q12.3,104615,"SLC7A1, ATRC1","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1",SLC7A1,6541,ENSG00000139514,distal to ATP1AL1,NA,Slc7a1 (MGI:88117)
13,29764370,29850616,13q12-q13,13q12.3,604711,UBL3,Ubiquitin-like 3,UBL3,5412,ENSG00000122042,NA,NA,Ubl3 (MGI:1344373)
13,30200025,30307550,13q12.3,13q12.3,614764,KATNAL1,Katanin p60 subunit A-like 1,KATNAL1,84056,ENSG00000102781,NA,NA,Katnal1 (MGI:2387638)
13,30456703,30617596,13q12,13q12.3,163905,"HMGB1, HMG1",High-mobility group box 1 (high-mobility group (nonhistone chromosomal) protein 1),HMGB1,3146,ENSG00000189403,NA,NA,NA
13,30617858,30660765,13q12.3,13q12.3,617470,USPL1,Ubiquitin-specific peptidase-like 1,USPL1,10208,ENSG00000132952,NA,NA,Uspl1 (MGI:2442342)
13,30713477,30764427,13q12,13q12.3,603700,"ALOX5AP, FLAP",Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,241,ENSG00000132965,NA,"{Stroke, susceptibility to}, 601367 (3), Multifactorial",Alox5ap (MGI:107505)
13,31134972,31162387,13q12.3,13q12.3,610703,"HSPH1, HSP105, KIAA0201",Heat-shock 105/110kD protein 1,HSPH1,10808,ENSG00000120694,NA,NA,Hsph1 (MGI:105053)
13,31199974,31332275,13q12.3,13q12.3,610308,"B3GLCT, B3GALTL, B3GTL",Beta 3-glucosyltransferase,B3GLCT,145173,ENSG00000187676,NA,"Peters-plus syndrome, 261540 (3), Autosomal recessive",B3glct (MGI:2685903)
13,31600000,54700000,13q13-q14.3,NA,600631,ENUR1,"Enuresis, nocturnal, 1",ENUR1,2031,NA,NA,"Enuresis, nocturnal, 1, 600631 (2), Autosomal dominant",NA
13,31600000,33400000,13q13.1,NA,612089,HPRHP,Hypophosphatemic rickets and hyperparathyroidism,NA,100188880,NA,?due to altered KLOTHO expression,"Hypophosphatemic rickets and hyperparathyroidism, 612089 (2), Autosomal dominant",NA
13,31739525,31803388,13q13.1,13q13.1,606655,"LGR8, GREAT",Leucine-rich repeat-containing G protein-coupled receptor 8,RXFP2,122042,ENSG00000133105,NA,NA,Rxfp2 (MGI:2153463)
13,32031773,32299124,13q13.1,13q13.1,614818,"FRY, C13orf14","Furry, Drosophila, homolog of",FRY,10129,ENSG00000073910,NA,NA,Fry (MGI:2443895)
13,32315479,32399671,13q12.3,13q13.1,600185,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",BRCA2 gene,BRCA2,675,ENSG00000139618,NA,"{Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation",Brca2 (MGI:109337)
13,32432416,32542709,13q13.1,13q13.1,615788,"N4BP2L2, PFAAP5",NEDD4-binding protein 2-like 2,N4BP2L2,10443,ENSG00000244754,NA,NA,N4bp2l2 (MGI:2687207)
13,32586431,32778018,13q12.3,13q13.1,605333,AS3,Androgen-induced prostate proliferative shutoff-associated protein,PDS5B,23047,ENSG00000083642,NA,NA,Pds5b (MGI:2140945)
13,33016062,33066142,13q12,13q13.1,604824,"KL, KLOTHO, HFTC3",Klotho,KL,9365,ENSG00000133116,mutation identified in 1 HFTC3 patient,"?Tumoral calcinosis, hyperphosphatemic, familial, 3, 617994 (3)",Kl (MGI:1101771)
13,33103136,33676828,13q12.3,13q13.1-q13.2,609866,"STARD13, DLC2",Start domain-containing protein 13,STARD13,90627,ENSG00000133121,NA,NA,Stard13 (MGI:2385331)
13,33818068,33973945,13q12.3-q13,13q13.2,600405,RFC3,"Replication factor C3, 38kD (activator 1, 38kD)",RFC3,5983,ENSG00000133119,NA,NA,Rfc3 (MGI:1916513)
13,34900000,39500000,13q13.3,NA,612796,IBD27,Inflammatory bowel disease 27,NA,100302059,NA,NA,"{Inflammatory bowel disease 27}, 612796 (2)",NA
13,34900000,72800000,13q13.3-q21,NA,263450,PAPA5,"Polydactyly, postaxial, type A5",NA,101241897,NA,between D13S1288 and D13S632,"Polydactyly, postaxial, type A5, 263450 (2), Autosomal recessive",NA
13,34942286,35672736,13q13.2,13q13.3,604889,NBEA,Neurobeachin,NBEA,26960,ENSG00000172915,site of FRA13A,NA,Nbea (MGI:1347075)
13,35473788,35476688,13q13,13q13.3,601280,"MAB21L1, COFG",mab-21 (C. elegans)-like 1,MAB21L1,4081,ENSG00000180660,NA,"Cerebellar, ocular, craniofacial, and genital syndrome, 618479 (3), Autosomal recessive",Mab21l1 (MGI:1333773)
13,35768651,36131938,13q13,13q13.3,604742,"DCLK1, DCAMKL1, CLICK1, CL1, KIAA0369",Doublecortin-like kinase 1,DCLK1,9201,ENSG00000133083,NA,NA,Dclk1 (MGI:1330861)
13,36168216,36214614,13q13.3,13q13.3,616066,SOHLH2,Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 2,SOHLH2,54937,ENSG00000120669,NA,NA,NA
13,36301637,36370179,13q12.3,13q13.3,607111,SPG20,Spartin,SPART,23111,ENSG00000133104,NA,"Troyer syndrome, 275900 (3), Autosomal recessive",NA
13,36430487,36442881,13q12.3-q13,13q13.3,604036,CCNA1,Cyclin A1,CCNA1,8900,ENSG00000133101,NA,NA,Ccna1 (MGI:108042)
13,36819201,36829602,13q14,13q13.3,601861,RFXAP,Regulatory factor X-associated protein,RFXAP,5994,ENSG00000133111,NA,"Bare lymphocyte syndrome, type II, complementation group D, 209920 (3), Autosomal recessive",Rfxap (MGI:2180854)
13,36844830,36920720,13q12-q14,13q13.3,603295,"MADH9, SMAD9, MADH6, PPH2","Mothers against decapentaplegic, Drosophila, homolog of, 9",SMAD9,4093,ENSG00000120693,NA,"Pulmonary hypertension, primary, 2, 615342 (3), Autosomal dominant",Smad9 (MGI:1859993)
13,36949737,36999366,13q13.3,13q13.3,604565,ALG5,"Alg5, S. cerevisiae, homolog of",ALG5,29880,ENSG00000120697,NA,NA,Alg5 (MGI:1913498)
13,37000372,37009613,13q13.1,13q13.3,606019,"EXOSC8, OIP2, RRP43, PCH1C",Exosome component 8,EXOSC8,11340,ENSG00000120699,NA,"Pontocerebellar hypoplasia, type 1C, 616081 (3), Autosomal recessive",Exosc8 (MGI:1916889)
13,37009311,37059713,13q13.3,13q13.3,613417,"FAM48A, P38IP, C13orf19","Family with sequence similarity 48, member A",SUPT20H,55578,ENSG00000102710,NA,NA,NA
13,37562581,37598843,13q13.3,13q13.3,608777,"POSTN, OSF2, PN",Periostin,POSTN,10631,ENSG00000133110,NA,NA,Postn (MGI:1926321)
13,37632062,37870424,13q13.1-q13.2,13q13.3,603651,"TRPC4, TRP4","Transient receptor potential cation channel, subfamily C, member 4",TRPC4,7223,ENSG00000133107,NA,NA,Trpc4 (MGI:109525)
13,38349770,38363618,13q13.3,13q13.3,610553,"UFM1, HLD14",Ubiquitin-fold modifier 1,UFM1,51569,ENSG00000120686,NA,"Leukodystrophy, hypomyelinating, 14, 617899 (3), Autosomal recessive",Ufm1 (MGI:1915140)
13,38687040,38887130,13q13.3,13q13.3,608945,"FREM2, FRASRS2, CRYPTOP",FRAS1-related extracellular matrix protein 2,FREM2,341640,ENSG00000150893,NA,"Cryptophthalmos, unilateral or bilateral, isolated, 123570 (3), Autosomal recessive; Fraser syndrome 2, 617666 (3), Autosomal recessive",Frem2 (MGI:2444465)
13,38965924,38990858,13q13,13q13.3,608327,"STOML3, SRO",Stomatin-like protein 3,STOML3,161003,ENSG00000133115,NA,NA,Stoml3 (MGI:2388072)
13,39342891,39603192,13q12,13q13.3-q14.1,606710,LHFP,Lipoma HMGIC fusion partner,LHFPL6,10186,ENSG00000183722,NA,NA,Lhfp (MGI:1920048)
13,39500000,54700000,13q14,NA,606643,BMIQ2,Body mass index quantitative trait locus 2,BMIQ2,192149,NA,max lod at D13S257,"[Body mass index QTL2], 606643 (2)",NA
13,39500000,54700000,13q14,NA,612110,BMND9,Bone mineral density quantitative trait locus 9,NA,100188882,NA,associated with rs9594759,"[Bone mineral density QTL 9], 612110 (2)",NA
13,39500000,54700000,13q14,NA,109543,"CLLS2, D13S25, DBM","Leukemia, chronic lymphocytic, susceptibility to, 2",NA,8101,NA,>530kb telomeric to RB1,"{Leukemia, chronic lymphocytic, susceptibility to, 2}, 109543 (2), Autosomal dominant",NA
13,39500000,54700000,13q14,NA,613884,"DEL13q14, C13DELq14",Chromosome 13q14 deletion syndrome,NA,NA,NA,NA,"Chromosome 13q14 deletion syndrome, 613884 (4), Autosomal dominant, Isolated cases",NA
13,39500000,54700000,13q14,NA,109350,GER,Gastroesophageal reflux,NA,59330,NA,NA,"Gastroesophageal reflux, 109350 (2), Autosomal dominant",NA
13,39500000,44600000,13q14.11,NA,613407,LPRS6,"Leprosy, susceptibility to, 6",NA,100499166,NA,associated with rs9533634 and rs3764147,"{Leprosy, susceptibility to, 6}, 613407 (2)",NA
13,39500000,54700000,13q14,NA,601499,"RIEG2, RGS2","Rieger syndrome, type 2",RIEG2,6012,NA,NA,"Rieger syndrome, type 2, 601499 (2), Autosomal dominant",NA
13,39500000,54700000,13q14,NA,607584,SPG24,"Spastic paraplegia 24, autosomal recessive",SPG24,338090,NA,NA,"Spastic paraplegia 24, autosomal recessive, 607584 (2), Autosomal recessive",NA
13,39500000,54700000,13q14,NA,194370,XRS,X-ray sensitivity,NA,8102,NA,NA,NA,NA
13,39655626,39791665,13q13.3,13q14.11,606977,"COG6, COD2, KIAA1134, CDG2L, SHNS",Component of oligomeric golgi complex 6,COG6,57511,ENSG00000133103,NA,"Congenital disorder of glycosylation, type IIl, 614576 (3), Autosomal recessive; Shaheen syndrome, 615328 (3), Autosomal recessive",Cog6 (MGI:1914792)
13,40555666,40666640,13q14.1,13q14.11,136533,"FOXO1A, FKHR",Forkhead box O1A (forkhead in rhabdomyosarcoma),FOXO1,2308,ENSG00000150907,chimeric with PAX3 in t(2;13); fuses with PAX3,"Rhabdomyosarcoma, alveolar, 268220 (3), Somatic mutation",Foxo1 (MGI:1890077)
13,40729127,40771206,13q13.3,13q14.11,611992,MRPS31,Mitochondrial ribosomal protein S31,MRPS31,10240,ENSG00000102738,4 pseudogenes,NA,Mrps31 (MGI:1913153)
13,40789610,40812459,13q14,13q14.11,603861,"SLC25A15, ORNT1, HHH","Solute carrier family 25 (mitochondrial carrier), member 15 (ornithine transporter 1)",SLC25A15,10166,ENSG00000102743,with deficiency of factors VII and X in 3 unrelated cases,"Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3), Autosomal recessive",Slc25a15 (MGI:1342274)
13,40931918,41061385,13q14.11,13q14.11,189973,"ELF1, RIA1, EFTUD1",E74-like factor 1,ELF1,1997,ENSG00000120690,NA,NA,Elf1 (MGI:107180)
13,41061508,41084005,13q14.11,13q14.11,604981,"WBP4, FBP21",WW domain-containing binding protein 4,WBP4,11193,ENSG00000120688,NA,NA,Wbp4 (MGI:109568)
13,41127568,41132801,13q14.11,13q14.11,617738,KBTBD6,Kelch repeat- and BTB domain-containing protein 6,KBTBD6,89890,ENSG00000165572,NA,NA,Kbtbd6 (MGI:3643058)
13,41189833,41194568,13q14.11,13q14.11,617739,KBTBD7,Kelch repeat- and BTB domain-containing protein 7,KBTBD7,84078,ENSG00000120696,NA,NA,Kbtbd7 (MGI:2685141)
13,41216368,41312037,13q14.1-q14.3,13q14.11,604601,MTRF1,"Translational release factor, mitochondrial, 1",MTRF1,9617,ENSG00000120662,NA,NA,Mtrf1 (MGI:2384815)
13,41457410,41470875,13q12-q14,13q14.11,610077,RGC32,Response gene to complement 32,RGCC,28984,ENSG00000102760,NA,NA,Rgcc (MGI:1913464)
13,41566834,41961108,13q14.11,13q14.11,617509,"VWA8, KIAA0564",von Willebrand factor A domain-containing protein 8,VWA8,23078,ENSG00000102763,NA,NA,Vwa8 (MGI:1919008)
13,42040035,42256583,13q14.11,13q14.11,604071,DGKH,"Diacylglycerol kinase, eta, 130kD",DGKH,160851,ENSG00000102780,NA,NA,Dgkh (MGI:2444188)
13,42271469,42323265,13q14.11,13q14.11,604696,"AKAP11, AKAP220",A-kinase anchor protein 11,AKAP11,11215,ENSG00000023516,NA,NA,Akap11 (MGI:2684060)
13,42562735,42608012,13q14,13q14.11,602642,"TNFSF11, OPGL, TRANCE, OPTB2","Tumor necrosis factor ligand superfamily, member 11 (osteoprotegerin ligand)",TNFSF11,8600,ENSG00000120659,NA,"Osteopetrosis, autosomal recessive 2, 259710 (3), Autosomal recessive",Tnfsf11 (MGI:1100089)
13,42886387,42992270,13q13.3,13q14.11,607441,EPSTI1,Epithelial stromal interaction 1,EPSTI1,94240,ENSG00000133106,NA,NA,Epsti1 (MGI:1915168)
13,43023585,43114212,13q14.1,13q14.11,615339,"DNAJC15, MCJ","DNAJ/HSP40 homolog, subfamily C, member 15",DNAJC15,29103,ENSG00000120675,NA,NA,Dnajc15 (MGI:1913398)
13,43213129,43786975,13q14.11,13q14.11,610914,"ENOX1, CNOX",ECTO-NOX disulfide-thiol exchanger 1,ENOX1,55068,ENSG00000120658,NA,NA,Enox1 (MGI:2444896)
13,43821958,43880022,13q14.11,13q14.11,613408,CCDC122,Coiled-coil domain-containing protein 122,CCDC122,160857,ENSG00000151773,NA,NA,Ccdc122 (MGI:1918358)
13,43879177,43893931,13q14.11,13q14.11,613409,"LACC1, C13orf31",Laccase (multicopper reductase) domain-containing protein 1,LACC1,144811,ENSG00000179630,NA,NA,Lacc1 (MGI:2445077)
13,44432142,44576824,13q14,13q14.11,607715,"TSC22D1, TSC22","TSC22 domain family, member 1",TSC22D1,8848,ENSG00000102804,NA,NA,Tsc22d1 (MGI:109127)
13,44939248,44989482,13q14,13q14.12,604354,"NUFIP1, NUFIP",Nuclear fragile X mental retardation protein-interacting protein 1,NUFIP1,26747,ENSG00000083635,pseudogene on 6q12,NA,Nufip1 (MGI:1351474)
13,45119829,45284892,13q14.12-q14.13,13q14.12-q14.13,189969,"GTF2F2, TF2F2, RAP30","General transcription factor IIF, polypeptide 2, 30kD",GTF2F2,2963,ENSG00000188342,NA,NA,Gtf2f2 (MGI:1915955)
13,45333470,45341283,13q12-q14,13q14.13,600763,"TPT1, HRF","Tumor protein, translationally-controlled 1",TPT1,7178,ENSG00000133112,NA,NA,Tpt1 (MGI:104890)
13,45393315,45434015,13q14.11,13q14.13,610793,"SLC25A30, KMCP1","Solute carrier family 25 (mitochondrial carrier, kidney), member 30",SLC25A30,253512,ENSG00000174032,NA,NA,Slc25a30 (MGI:1914804)
13,45464915,45536700,13q14.12,13q14.13,606975,"COG3, SEC34",Component of oligomeric golgi complex 3,COG3,83548,ENSG00000136152,NA,NA,Cog3 (MGI:2450151)
13,45777241,45851752,13q14.12,13q14.13,615609,SIAH3,"SIAH E3 ubiquitin protein ligase family, member 3",SIAH3,283514,ENSG00000215475,NA,NA,Siah3 (MGI:2685758)
13,45954464,46052793,13q14.13,13q14.13,616453,"ZC3H13, KIAA0853",Zinc finger CCCH domain-containing protein 13,ZC3H13,23091,ENSG00000123200,NA,NA,NA
13,46053065,46105075,13q14.11,13q14.13,603101,"CPB2, CPU, TAFI","Carboxypeptidase B2, plasma (carboxypeptidase U)",CPB2,1361,ENSG00000080618,NA,NA,Cpb2 (MGI:1891837)
13,46125922,46182176,13q14.1-q14.3,13q14.13,153430,LCP1,Lymphocyte cytosolic protein-1 (plasmin),LCP1,3936,ENSG00000136167,NA,NA,Lcp1 (MGI:104808)
13,46553169,46753040,13q14,13q14.1-q14.2,610368,"LRCH1, KIAA1016",Leucine-rich repeats and calponin homology domain-containing 1,LRCH1,23143,ENSG00000136141,NA,NA,Lrch1 (MGI:2443390)
13,46700000,46700000,13q14.2-q14.1,NA,608049,AUTS3,"Autism, susceptibility to, 3",NA,387577,NA,NA,"{Autism susceptibility 3}, 608049 (2), Isolated cases, Multifactorial",NA
13,46771255,46797699,13q14.11,13q14.2,133280,ESD,Esterase D; S-formylglutathione hydrolase,ESD,2098,ENSG00000139684,"proximal to RB1, WND",NA,"Esd,Esd-ps (MGI:3781082,MGI:95421)"
13,46831541,46897075,13q14-q21,13q14.2,182135,HTR2A,5-hydroxytryptamine (serotonin) receptor-2A,HTR2A,3356,ENSG00000102468,NA,"{Alcohol dependence, susceptibility to}, 103780 (3), Multifactorial; {Anorexia nervosa, susceptibility to}, 606788 (3); {Major depressive disorder, response to citalopram therapy in}, 608516 (3); {Obsessive-compulsive disorder, susceptibility to}, 164230 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Seasonal affective disorder, susceptibility to}, 608516 (3)",Htr2a (MGI:109521)
13,47942655,48001325,13q14.2,13q14.2,603921,"SUCLA2, MTDPS5","Succinate-CoA ligase, ADP-forming, beta subunit",SUCLA2,8803,ENSG00000136143,NA,"Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3), Autosomal recessive",Sucla2 (MGI:1306775)
13,48037566,48052741,13q14.2,13q14.2,615792,"NUDT15, MTH2, NUDT15D",Nucleoside diphosphate-linked moiety X motif 15,NUDT15,55270,ENSG00000136159,NA,"{Thiopurines, poor metabolism of, 2}, 616903 (3), Autosomal dominant",Nudt15 (MGI:2443366)
13,48075723,48095140,13q14.2,13q14.2,605718,"MED4, DRIP36, HSPC126","Mediator of RNA polymerase II transcription, subunit 4, S. cerevisiae, homolog of",MED4,29079,ENSG00000136146,NA,NA,Med4 (MGI:1914631)
13,48233205,48270356,13q14,13q14.2,603904,"ITM2B, BRI, ABRI, FBD, RDGCA",Integral membrane protein 2B (BRI gene),ITM2B,9445,ENSG00000136156,mutation identified in 1 RDGCA family,"Dementia, familial British, 176500 (3), Autosomal dominant; Dementia, familial Danish, 117300 (3), Autosomal dominant; ?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3), Autosomal dominant",Itm2b (MGI:1309517)
13,48303746,48481889,13q14.1-q14.2,13q14.2,614041,RB1,Retinoblastoma-1,RB1,5925,ENSG00000139687,NA,"Bladder cancer, somatic, 109800 (3); Osteosarcoma, somatic, 259500 (3); Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation; Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation; Small cell cancer of the lung, somatic, 182280 (3)",Rb1 (MGI:97874)
13,48400896,48444668,13q14.12-q14.2,13q14.2,609239,"LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8",Lysophosphatidic acid receptor 6,LPAR6,10161,ENSG00000139679,in intron 17 of RB gene,"Hypotrichosis 8, 278150 (3), Autosomal recessive; Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3), Autosomal recessive",Lpar6 (MGI:1914418)
13,48488962,48535996,13q14.3,13q14.2,603524,"RCBTB2, CHC1L",RCC1 domain- and BTB domain-containing protein 2,RCBTB2,1102,ENSG00000136161,NA,NA,Rcbtb2 (MGI:1917200)
13,48653928,48711225,13q14,13q14.2,605666,"CYSLTR2, CYSLT2",Cysteinyl leukotriene receptor 2,CYSLTR2,57105,ENSG00000152207,NA,NA,Cysltr2 (MGI:1917336)
13,48975240,49209778,13q14.2,13q14.2,615794,"FNDC3A, KIAA0970, HUGO",Fibronectin type III domain-containing protein 3A,FNDC3A,22862,ENSG00000102531,NA,NA,Fndc3a (MGI:1196463)
13,49220337,49222376,13q14-q21,13q14.2,602885,"MLNR, GPR38",Motilin receptor,MLNR,2862,ENSG00000102539,NA,NA,NA
13,49308649,49444850,13q14.2,13q14.2,612175,CAB39L,Calcium-binding protein 39-like protein,CAB39L,81617,ENSG00000102547,NA,NA,Cab39l (MGI:1914081)
13,49444273,49495002,13q14,13q14.2,607865,"SETDB2, CLLD8","SET domain protein, bifurcated, 2",SETDB2,83852,ENSG00000136169,NA,NA,Setdb2 (MGI:2685139)
13,49495609,49528991,13q14.1,13q14.2,607796,"PHF11, NYREN34",PHD finger protein 11,PHF11,51131,ENSG00000136147,NA,NA,"Phf11b,Phf11c,Phf11d,Phf11a (MGI:3645789,MGI:1277133,MGI:1918441,MGI:3648476)"
13,49531943,49585586,13q14,13q14.2,607867,"RCBTB1, CLLD7, GLP, RDEOA",RCC1 domain- and BTB domain-containing protein 1,RCBTB1,55213,ENSG00000136144,NA,"Retinal dystrophy with or without extraocular anomalies, 617175 (3), Autosomal recessive",Rcbtb1 (MGI:1918580)
13,49628455,49633871,13q14.3,13q14.2,609351,"ARL11, ARLTS1",ADP-ribosylation factor-like 11,ARL11,115761,ENSG00000152213,NA,NA,Arl11 (MGI:2444054)
13,49660673,49691486,13q14.2,13q14.2,617335,EBPL,Emopamil-binding protein-like,EBPL,84650,ENSG00000123179,NA,NA,Ebpl (MGI:1915427)
13,49699306,49792681,13q14.3,13q14.2,601892,KPNA3,Karyopherin (importin) alpha-3,KPNA3,3839,ENSG00000102753,NA,NA,Kpna3 (MGI:1100863)
13,49912701,49936500,13q14,13q14.2,607866,"CLLD6, C13orf1",Chronic lymphocytic leukemia deletion region gene 6,SPRYD7,57213,ENSG00000123178,NA,NA,Spryd7 (MGI:1913924)
13,49982548,50125540,13q14,13q14.2,605766,"DLEU2, LEU2, BCMSUN",Deleted in lymphocytic leukemia 2,DLEU2,8847,ENSG00000231607,NA,NA,NA
13,49997041,50018466,13q14.3,13q14.2,605661,"TRIM13, RFP2, LEU5",Tripartite motif-containing protein 13,TRIM13,10206,ENSG00000204977,NA,NA,Trim13 (MGI:1913847)
13,50015443,50020921,13q14.3,13q14.2,607947,"KCNRG, DLTET",Potassium channel regulator,KCNRG,283518,ENSG00000198553,NA,NA,Kcnrg (MGI:2685591)
13,50048972,50049060,13q14.3,13q14.2,609704,"MIR16-1, MIRN16-1",Micro RNA 16-1,MIR16-1,406950,ENSG00000208006,NA,NA,NA
13,50049118,50049200,13q14.3,13q14.2,609703,"MIR15A, MIRN15A",Micro RNA 15A,MIR15A,406948,ENSG00000283785,NA,NA,NA
13,50082168,50528642,13q14,13q14.2-q14.3,605765,"DLEU1, LEU1",Deleted in lymphocytic leukemia 1,DLEU1,10301,ENSG00000176124,NA,NA,NA
13,50300000,54700000,13q14.3,NA,612894,STQTL20,Stature quantitative trait locus 20,NA,100302685,NA,associated with rs3118914,"{Stature QTL 20}, 612894 (2)",NA
13,50909677,50970461,13q14.1,13q14.3,610326,"RNASEH2B, DLEU8, FLJ11712, AGS2","Ribonuclease H2, subunit B",RNASEH2B,79621,ENSG00000136104,NA,"Aicardi-Goutieres syndrome 2, 610181 (3), Autosomal recessive",Rnaseh2b (MGI:1914403)
13,50994510,51066156,13q14.3,13q14.3,603695,GUCY1B2,"Guanylate cyclase 1, soluble, beta-2",GUCY1B2,2974,ENSG00000123201,NA,NA,NA
13,51353170,51453332,13q14.3,13q14.3,604331,"INTS6, DDX26, DICE1",Integrator complex subunit 6,INTS6,26512,ENSG00000102786,NA,NA,Ints6 (MGI:1202397)
13,51584193,51767708,13q14.3,13q14.3,610418,WDFY2,WD repeat- and FYVE domain-containing protein 2,WDFY2,115825,ENSG00000139668,NA,NA,Wdfy2 (MGI:2442811)
13,51767992,51804162,13q14.3,13q14.3,616163,"DHRS12, SDR40C1","Short-chain dehydrogenase reductase family, member 12",DHRS12,79758,ENSG00000102796,NA,NA,NA
13,51907819,51910695,13q14-q21,13q14.3,608857,CTAGE3,Cutaneous T-cell lymphoma-associated antigen 3,CTAGE3P,220112,NA,NA,NA,NA
13,51932668,52012129,13q14.3-q21.1,13q14.3,606882,"ATP7B, WND","ATPase, Cu++ transporting, beta polypeptide",ATP7B,540,ENSG00000123191,NA,"Wilson disease, 277900 (3), Autosomal recessive",Atp7b (MGI:103297)
13,52012397,52033599,13q14.3,13q14.3,613666,"ALG11, KIAA1266, CDG1P","Alg11, S. cerevisiae, homolog of",ALG11,440138,ENSG00000253710,NA,"Congenital disorder of glycosylation, type Ip, 613661 (3), Autosomal recessive",Alg11 (MGI:2142632)
13,52033610,52129072,13q14.3,13q14.3,616731,NEK5,Never in mitosis gene A-related kinase 5,NEK5,341676,ENSG00000197168,NA,NA,Nek5 (MGI:2142824)
13,52132642,52159596,13q14.2,13q14.3,604044,NEK3,Never in mitosis gene A-related kinase 3,NEK3,4752,ENSG00000136098,NA,NA,Nek3 (MGI:1344371)
13,52377166,52406171,13q14.3,13q14.3,616821,"THSD1, TMTSP",Thrombospondin type 1 domain-containing protein 1,THSD1,55901,ENSG00000136114,NA,NA,Thsd1 (MGI:1929096)
13,52412601,52450633,13q14.3,13q14.3,610903,"VPS36, EAP45","Vacuolar protein sorting 36, S. cerevisiae, homolog of",VPS36,51028,ENSG00000136100,NA,NA,Vps36 (MGI:1917410)
13,52455359,52476630,13q14,13q14.3,611569,"CKAP2, TMAP, LB1",Cytoskeleton-associated protein 2,CKAP2,26586,ENSG00000136108,NA,NA,Ckap2 (MGI:1931797)
13,52652702,52700908,13q14.3,13q14.3,604098,"SUGT1, SGT1","Suppressor of G2 allele of Skp1, S. Cerevisiae, homolog of",SUGT1,10910,ENSG00000165416,NA,NA,Sugt1 (MGI:1915205)
13,52703263,52739819,13q14-q21,13q14.3,605147,"LECT1, CHM1",Leukocyte cell derived chemotaxin 1 (chondromodulin),CNMD,11061,ENSG00000136110,NA,NA,Cnmd (MGI:1341171)
13,52842888,52848639,13q14.3,13q14.3,603580,PCDH8,Protocadherin 8,PCDH8,5100,ENSG00000136099,NA,NA,Pcdh8 (MGI:1306800)
13,53028812,53052056,13q14.3,13q14.3,614061,"OLFM4, GC1, GW112",Olfactomedin 4,OLFM4,10562,ENSG00000102837,NA,NA,Olfm4 (MGI:2685142)
13,54700000,72800000,13q21,NA,613289,ATXN8,Ataxin 8,ATXN8,724066,NA,CAG repeat results in polyglutamine expansion protein,"Spinocerebellar ataxia 8, 608768 (3), Autosomal dominant",NA
13,54700000,101100000,13q21-q32,NA,602085,PAPA2,"Postaxial polydactyly, type A2",NA,8103,NA,NA,"Postaxial polydactyly, type A2, 602085 (2), Autosomal dominant",NA
13,54700000,72800000,13q21,NA,607134,SLI3,"Specific language impairment QTL, 3",NA,780906,NA,max with D13S1317,"Specific language impairment QTL, 3, 607134 (2)",NA
13,57630103,57729310,13q21.1,13q21.1,611760,"PCDH17, PCDH68",Protocadherin 17,PCDH17,27253,ENSG00000118946,NA,NA,Pcdh17 (MGI:2684924)
13,59665582,60163984,13q21.2,13q21.2,614567,"DIAPH3, DIA2, DRF3, AUNA1, NSDAN","Diaphanous, Drosophila, homolog of, 3",DIAPH3,81624,ENSG00000139734,NA,"Auditory neuropathy, autosomal dominant, 1, 609129 (3), Autosomal dominant",Diaph3 (MGI:1927222)
13,60396456,60573878,13q21.2,13q21.2,614392,TDRD3,Tudor domain-containing protein 3,TDRD3,81550,ENSG00000083544,NA,NA,Tdrd3 (MGI:2444023)
13,61409684,61415521,13q21.2,13q21.2,614449,"PCDH20, PCDH13",Protocadherin 20,PCDH20,64881,ENSG00000280165,NA,NA,Pcdh20 (MGI:2443376)
13,66302833,67230335,13q21.1,13q21.32,603581,PCDH9,Protocadherin 9,PCDH9,5101,ENSG00000184226,NA,NA,Pcdh9 (MGI:1306801)
13,69700592,70108492,13q21,13q21.33,605332,KLHL1,Kelch-like 1,KLHL1,57626,ENSG00000150361,NA,NA,Klhl1 (MGI:2136335)
13,70107212,70139752,13q21,13q21.33,603680,"ATXN8OS, SCA8, KLHL1AS",Ataxin 8 opposite strand,ATXN8OS,6315,NA,due to CTG repeat in untranslated DNA,"{Parkinson disease, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial; Spinocerebellar ataxia 8, 608768 (3), Autosomal dominant",NA
13,71437965,71868067,13q22,13q21.33,603803,DACH,"Dachshund, Drosophila, homolog of",DACH1,1602,ENSG00000276644,NA,NA,Dach1 (MGI:1277991)
13,72708366,72727628,13q21.33-q22.1,13q21.33,613448,"C13orf37, MOZART1",Mitotic spindle-organizing protein associated with a ring of gamma-tubulin,MZT1,440145,ENSG00000204899,NA,NA,Mzt1 (MGI:1924039)
13,72727738,72756197,13q22.1,13q21.33,610510,"BORA, C13orf34",Aurora borealis,BORA,79866,ENSG00000136122,NA,NA,Bora (MGI:1924994)
13,72752168,72781899,13q21-q22,13q21.33,607533,"DIS3, KIAA1008","Dis3, S. pombe, homolog of",DIS3,22894,ENSG00000083520,NA,NA,Dis3 (MGI:1919912)
13,72782022,73016460,13q21-q22,13q21.3-q22.1,607532,"PIBF1, JBTS33",Progesterone-induced blocking factor 1,PIBF1,10464,ENSG00000083535,NA,"Joubert syndrome 33, 617767 (3), Autosomal recessive",Pibf1 (MGI:1261910)
13,72800000,78500000,13q22,NA,142700,DDH1,Developmental dysplasia of the hip 1,NA,780896,NA,NA,"Developmental dysplasia of the hip 1, 142700 (2), Multifactorial",NA
13,72800000,101100000,13q22-q32,NA,167870,PAND1,Panic disorder syndrome 1,NA,387572,NA,NA,"Panic disorder syndrome 1, 167870 (2), ?Autosomal dominant",NA
13,73686011,74168294,13q22,13q22.1,607531,"KLF12, AP2REP",Kruppel-like factor 12,KLF12,11278,ENSG00000118922,NA,NA,Klf12 (MGI:1333796)
13,75283502,75483143,13q22.2,13q22.2,612465,"TBC1D4, AS160, KIAA0603, NIDDM5","TPC1 domain family, member 4",TBC1D4,9882,ENSG00000136111,NA,"{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)",Tbc1d4 (MGI:2429660)
13,75525213,75549438,13q22,13q22.2,612377,COMMD6,COMM domain-containing protein 6,COMMD6,170622,ENSG00000188243,NA,NA,NA
13,75549479,75606019,13q22,13q22.2,603090,UCHL3,Ubiquitin carboxyl-terminal esterase L3,UCHL3,7347,ENSG00000118939,NA,NA,Uchl3 (MGI:1355274)
13,75620433,75859869,13q21-q22,13q22.2,604362,"LMO7, FBXO20, FBX20, KIAA0858",LIM domain only 7,LMO7,4008,ENSG00000136153,NA,NA,Lmo7 (MGI:1353586)
13,76700000,78500000,13q22.3,NA,617979,"lncRNA-ACOD1, LOC105370268",Long noncoding RNA near ACOD1,NA,NA,NA,NA,NA,NA
13,76880174,76886404,13q21,13q22.3,610521,"KCTD12, PFET1, KIAA1778, C13orf2",Potassium channel tetramerization domain-containing protein 12,KCTD12,115207,ENSG00000178695,NA,NA,Kctd12 (MGI:2145823)
13,76928450,76929089,13q22,13q22.3,602543,"TNFRSF11B, OPG, OCIF","Tumor necrosis factor receptor superfamily, member 11B",BTF3P11,690,NA,NA,NA,NA
13,76948510,76958637,13q22.3,13q22.3,615275,"ACOD1, IRG1",Aconitate decarboxylase 1,ACOD1,730249,ENSG00000102794,NA,NA,Acod1 (MGI:103206)
13,76992080,77005116,13q22.3,13q22.3,608102,CLN5,CLN5 gene,CLN5,1203,ENSG00000102805,NA,"Ceroid lipofuscinosis, neuronal, 5, 256731 (3), Autosomal recessive",Cln5 (MGI:2442253)
13,76992596,77027163,13q22,13q22.3,605653,"FBXL3, FBXL3A, FBL3, IDDSFAS",F-box and leucine-rich repeat protein 3,FBXL3,26224,ENSG00000005812,NA,"Intellectual developmental disorder with short stature, facial anomalies, and speech defects, 606220 (3), Autosomal recessive",Fbxl3 (MGI:1354702)
13,77044656,77327097,13q22,13q22.3,610392,"MYCBP2, PAM, KIAA0916",Myc-binding protein 2,MYCBP2,23077,ENSG00000005810,NA,NA,Mycbp2 (MGI:2179432)
13,77535673,77645262,13q22,13q22.3,604112,SCEL,Sciellin,SCEL,8796,ENSG00000136155,NA,NA,Scel (MGI:1891228)
13,77697673,77764241,13q22.3,13q22.3,610491,SLAIN1,"SLAIN motif family, member 1",SLAIN1,122060,ENSG00000139737,NA,NA,Slain1 (MGI:2145578)
13,77895480,77975526,13q22,13q22.3,131244,"EDNRB, HSCR2, ABCDS, WS4A",Endothelin receptor type B,EDNRB,1910,ENSG00000136160,?piebald lethal in mouse,"ABCD syndrome, 600501 (3), Autosomal recessive; {Hirschsprung disease, susceptibility to, 2}, 600155 (3), Autosomal dominant; Waardenburg syndrome, type 4A, 277580 (3), Autosomal recessive, Autosomal dominant",Ednrb (MGI:102720)
13,78500000,109600000,13q31-q33,NA,193003,NYS4,"Nystagmus 4, congenital, autosomal dominant",NYS4,317685,NA,NA,"Nystagmus 4, congenital, autosomal dominant, 193003 (2), Autosomal dominant",NA
13,78598361,78603551,13q21.1-q22,13q31.1,601632,"POU4F1, BRN3A","POU domain, class 4, transcription factor 1",POU4F1,5457,ENSG00000152192,NA,NA,Pou4f1 (MGI:102525)
13,78614285,78659164,13q31.1,13q31.1,615906,"RNF219, C13orf7",Ring finger protein 219,OBI1,79596,ENSG00000152193,NA,NA,Rnf219 (MGI:1919736)
13,79480721,79556076,13q22.2,13q31.1,610041,"NDFIP2, N4WBP5A, KIAA1165",NEDD4 family-interacting protein 2,NDFIP2,54602,ENSG00000102471,NA,NA,Ndfip2 (MGI:1923523)
13,80011076,80026662,13q31.1,13q31.1,615230,LNCR13Q1,Long noncoding RNA on 13q (TCONS_00021856),LINC01080,101515984,NA,NA,NA,NA
13,80335975,80341125,13q31.1,13q31.1,602466,"SPRY2, IGAN3","Sprouty, Drosophila, homolog of, 2",SPRY2,10253,ENSG00000136158,mutation identified in 1 IGAN3 family,"{?IgA nephropathy, susceptibility to, 3}, 616818 (3), Autosomal dominant",Spry2 (MGI:1345138)
13,83877204,83882473,13q31,13q31.1,609678,"SLITRK1, KIAA1910, TTM","SLIT- and NTRK-like family, member 1",SLITRK1,114798,ENSG00000178235,mutation identified in 1 TTM patient,"Tourette syndrome, 137580 (3), Autosomal dominant; ?Trichotillomania, 613229 (3), Autosomal dominant, Multifactorial",Slitrk1 (MGI:2679446)
13,85792789,85799418,13q31,13q31.1,609681,"SLITRK6, DFNMYP","SLIT- and NTRK-like family, member 6",SLITRK6,84189,ENSG00000184564,NA,"Deafness and myopia, 221200 (3), Autosomal recessive",Slitrk6 (MGI:2443198)
13,87671231,87679618,13q31,13q31.2,609680,"SLITRK5, KIAA0918","SLIT- and NTRK-like family, member 5",SLITRK5,26050,ENSG00000165300,NA,NA,Slitrk5 (MGI:2679448)
13,89400000,97500000,13q31.3-q32.1,NA,610840,MMVP3,"Mitral valve prolapse, myxomatous 3",NA,100034705,NA,max lod at D13S132,"Mitral valve prolapse, myxomatous 3, 610840 (2), Autosomal dominant",NA
13,89400000,94400000,13q31.3,NA,609572,PPR2,Photoparoxysmal response 2,NA,780910,NA,max lod at D13S1230,"Photoparoxysmal response 2, 609572 (2)",NA
13,91347819,91354574,13q31.3,13q31.3,609415,"MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2",Micro RNA 17 host gene,MIR17HG,407975,ENSG00000215417,NA,"Feingold syndrome 2, 614326 (3), Autosomal dominant",NA
13,91350604,91350687,13q31.3,13q31.3,609416,"MIR17, MIR91, MIRN17",Micro RNA 17,MIR17,406952,ENSG00000284536,within C13orf25; sequence encodes 2 micro RNAs,NA,NA
13,91350750,91350820,13q31.3,13q31.3,609417,"MIR18A, MIRN18A",Micro RNA 18A,MIR18A,406953,ENSG00000283815,within C13orf25,NA,NA
13,91350890,91350971,13q31.3,13q31.3,609418,"MIR19A, MIRN19A",Micro RNA 19A,MIR19A,406979,ENSG00000284204,within C13orf25,NA,NA
13,91351064,91351134,13q31.3,13q31.3,609420,"MIR20A, MIRN20A",Micro RNA 20A,MIR20A,406982,ENSG00000283762,within C13orf25,NA,NA
13,91351191,91351277,13q31.3,13q31.3,609419,"MIR19B1, MIRN19B1",Micro RNA 19B1,MIR19B1,406980,ENSG00000284375,within C13orf25,NA,NA
13,91351313,91351390,13q31.3,13q31.3,609422,"MIR92A1, MIR92-1, MIRN92-1",Micro RNA 92A1,MIR92A1,407048,ENSG00000283705,within C13orf25,NA,NA
13,91398620,92867236,13q32,13q31.3,602446,GPC5,Glypican 5,GPC5,2262,ENSG00000179399,NA,NA,Gpc5 (MGI:1194894)
13,93226806,94408019,13q32,13q31.3-q32.1,604404,"GPC6, OMIMD1",Glypican 6,GPC6,10082,ENSG00000183098,NA,"Omodysplasia 1, 258315 (3), Autosomal recessive",Gpc6 (MGI:1346322)
13,94400000,101100000,13q32,NA,614629,KTCN7,Keratoconus 7,NA,100887822,NA,max lod at D13S159,"Keratoconus 7, 614629 (2), Autosomal dominant",NA
13,94400000,101100000,13q32,NA,156600,"MCOR, C13DELq32, DEL13q32","Microcoria, congenital (chromosome 13q32 deletion syndrome)",NA,NA,NA,35-80kb deletion encompassing TGDS and GPR180,"Microcoria, congenital, 156600 (4), Autosomal dominant",NA
13,94400000,101100000,13q32,NA,603176,SCZD7,"Schizophrenia susceptibility locus, chromosome 13q-related",SCZD7,8401,NA,NA,"{Schizophrenia}, 181500 (2), Autosomal dominant",NA
13,94400000,101100000,13q32,NA,609903,SLEB5,"Systemic lupus erythematosus, susceptibility to, 5",NA,100188798,NA,max lod at D13S892,"{Systemic lupus erythematosus, susceptibility to, 5}, 609903 (2)",NA
13,94400000,109600000,13q32-q33,NA,606258,STQTL4,Stature quantitative trait locus 4,NA,282550,NA,max lod at D13S779 and D13S797,"{Stature QTL 4}, 606258 (2)",NA
13,94436810,94549405,13q31-q32,13q32.1,191275,"DCT, TYRP2",Dopachrome tautomerase (dopachrome delta-isomerase; tyrosinase-related protein 2),DCT,1638,ENSG00000080166,NA,NA,Dct (MGI:102563)
13,94574053,94596274,13q32.1,13q32.1,616146,"TGDS, SDR2E1, CATMANS","TDP-glucose 4,6-dehydratase",TGDS,23483,ENSG00000088451,NA,"Catel-Manzke syndrome, 616145 (3), Autosomal recessive",Tgds (MGI:1923605)
13,94601856,94634660,13q31,13q32.1,607787,"GPR180, ITR",G protein-coupled receptor 180,GPR180,160897,ENSG00000152749,NA,NA,Gpr180 (MGI:1930949)
13,94709621,94712544,13q31-q32,13q32.1,604974,SOX21,SRY-box 21,SOX21,11166,ENSG00000125285,NA,NA,Sox21 (MGI:2654070)
13,95019828,95301450,13q32,13q32.1,605250,"ABCC4, MRP4, MOATB","ATP-binding cassette, subfamily C, member 4",ABCC4,10257,ENSG00000125257,NA,NA,Abcc4 (MGI:2443111)
13,95433587,95579758,13q32.1,13q32.1,617579,"CLDN10, OSPL, CPETRL3, HELIX",Claudin 10,CLDN10,9071,ENSG00000134873,NA,"HELIX syndrome, 617671 (3), Autosomal recessive",Cldn10 (MGI:1913101)
13,95578201,95644705,13q31,13q32.1,608671,"DZIP1, KIAA0996",DAZ-interacting zinc finger protein 1,DZIP1,22873,ENSG00000134874,NA,NA,Dzip1 (MGI:1914311)
13,95677138,95794987,13q32,13q32.1,601184,"DNAJC3, PRKRI, P58, ACPHD","DnaJ, E. coli, homolog of, subfamily C, member 3 (protein kinase inhibitor p58)",DNAJC3,5611,ENSG00000102580,mutation identified in 1 ACPHD family,"?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3), Autosomal recessive",Dnajc3 (MGI:107373)
13,95801579,96053436,13q32.1,13q32.1,605898,"UGGT2, HUGT2",UDP-glucose glycoprotein glucosyltransferase 2,UGGT2,55757,ENSG00000102595,NA,NA,Uggt2 (MGI:1913685)
13,96090633,96839561,13q32-q33,13q32.1,609401,HS6ST3,Heparan sulfate 6-O-sulfotransferase 3,HS6ST3,266722,ENSG00000185352,NA,NA,Hs6st3 (MGI:1354960)
13,96985718,96994729,13q32.1,13q32.1,606922,GPR80,G protein-coupled receptor 80,OXGR1,27199,ENSG00000165621,NA,NA,Oxgr1 (MGI:2685145)
13,97434168,97469127,13q34,13q32.1,179540,RAP2A,"RAP2, member of RAS oncogene family (K-rev)",RAP2A,5911,ENSG00000125249,NA,NA,Rap2a (MGI:97855)
13,97953640,98024295,13q32.2,13q32.2,602008,"IPO5, RANBP5, KPNB3",Importin 5,IPO5,3843,ENSG00000065150,NA,NA,Ipo5 (MGI:1917822)
13,98142588,98455175,13q32.2,13q32.2,602654,"FARP1, CDEP","FERM, ARHGEF, and pleckstrin domain-containing protein 1",FARP1,10160,ENSG00000152767,NA,NA,Farp1 (MGI:2446173)
13,98450198,98577150,13q31.2-q32.3,13q32.2,604984,"STK24, MST3, MST3B",Serine/threonine protein kinase 24,STK24,8428,ENSG00000102572,NA,NA,Stk24 (MGI:2385007)
13,98683800,98752671,13q33-q34,13q32.2-q32.3,600544,"SLC15A1, HPECT1","Solute carrier family 15 (oligopeptide transporter), member 1",SLC15A1,6564,ENSG00000088386,NA,NA,Slc15a1 (MGI:1861376)
13,98793428,99086693,13q32.3,13q32.3,607325,"ZIZ1, KIAA1058",Zizimin 1,DOCK9,23348,ENSG00000088387,NA,NA,Dock9 (MGI:106321)
13,99254712,99262497,13q32,13q32.3,602042,GPR18,G protein-coupled receptor-18,GPR18,2841,ENSG00000125245,NA,NA,Gpr18 (MGI:107859)
13,99294272,99307398,13q32.3,13q32.3,605741,"GPR183, EBI2",G protein-coupled receptor 183,GPR183,1880,ENSG00000169508,NA,NA,Gpr183 (MGI:2442034)
13,99501471,99564047,13q32.3,13q32.3,604678,TM9SF2,"Transmembrane 9 superfamily, member 2",TM9SF2,9375,ENSG00000125304,NA,NA,Tm9sf2 (MGI:1915309)
13,99606663,99909458,13q32,13q32.3,609686,"CLYBL, CLB",Citrate lyase beta-like,CLYBL,171425,ENSG00000125246,NA,NA,Clybl (MGI:1916884)
13,99962963,99971908,13q32.3,13q32.3,617896,"ZIC5, OPR","Zic family, member 5",ZIC5,85416,ENSG00000139800,NA,NA,Zic5 (MGI:1929518)
13,99981783,99986764,13q32,13q32.3,603073,"ZIC2, HPE5","ZIC family, member 2",ZIC2,7546,ENSG00000043355,NA,"Holoprosencephaly 5, 609637 (3), Autosomal dominant",Zic2 (MGI:106679)
13,100089014,100530436,13q32,13q32.3,232000,PCCA,"Propionyl Coenzyme A carboxylase, alpha polypeptide",PCCA,5095,ENSG00000175198,NA,"Propionicacidemia, 606054 (3), Autosomal recessive",Pcca (MGI:97499)
13,100530163,100588791,13q32.3,13q32.3,613378,"A2LD1, GGACT",AIG1-like domain-containing protein 1,GGACT,87769,ENSG00000134864,NA,NA,Ggact (MGI:2385008)
13,100603624,100675630,13q32.3,13q32.3,618203,TMTC4,Transmembrane and tetratricopeptide repeat domains-containing protein 4,TMTC4,84899,ENSG00000125247,NA,NA,Tmtc4 (MGI:1921050)
13,101053773,101417205,13q33.11,13q32.3-q33.1,611549,"NALCN, IHPRF1, CLIFAHDD","Sodium leak channel, nonselective",NALCN,259232,ENSG00000102452,NA,"Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3), Autosomal dominant; Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3), Autosomal recessive",Nalcn (MGI:2444306)
13,101100000,114364328,13q33.1-q34,NA,610361,OFC9,Orofacial cleft 9,NA,100462724,NA,associated with rs1830756,"Orofacial cleft 9, 610361 (2)",NA
13,101452592,101720855,13q33,13q33.1,604234,"ITGBL1, TIED","Integrin, beta-like 1",ITGBL1,9358,ENSG00000198542,NA,NA,Itgbl1 (MGI:2443439)
13,101710803,102402442,13q34,13q33.1,601515,"FGF14, FHF4, SCA27",Fibroblast growth factor-14,FGF14,2259,ENSG00000102466,NA,"Spinocerebellar ataxia 27, 609307 (3), Autosomal dominant",Fgf14 (MGI:109189)
13,102596984,102679957,13q32-q33,13q33.1,190470,TPP2,Tripeptidyl peptidase II,TPP2,7174,ENSG00000134900,NA,NA,Tpp2 (MGI:102724)
13,102678781,102704310,13q33.1,13q33.1,615259,"METTL21C, C13orf39",Methyltransferase-like 21C,METTL21C,196541,ENSG00000139780,NA,NA,Mettl21c (MGI:3611450)
13,102784280,102799008,13q33,13q33.1,611613,"POGLUT2, KDELC1, EP58",Protein O-glucosyltransferase 2,POGLUT2,79070,ENSG00000134901,NA,NA,Poglut2 (MGI:1919300)
13,102845840,102876000,13q33,13q33.1,133530,"ERCC5, XPG, COFS3","Excision-repair, complementing defective, in Chinese hamster, number 5",ERCC5,2073,ENSG00000134899,NA,"Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive; Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive; Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive",Ercc5 (MGI:103582)
13,103043997,103066416,13q33,13q33.1,601295,"SLC10A2, NTCP2, PBAM","Solute carrier family 10 (sodium/bile acid cotransporter family), member 2",SLC10A2,6555,ENSG00000125255,NA,"Bile acid malabsorption, primary, 613291 (3), Autosomal recessive",Slc10a2 (MGI:1201406)
13,104200000,106400000,13q33.2,NA,614318,VUR5,Vesicoureteral reflux 5,NA,100820760,NA,nearest marker rs4476030,"Vesicoureteral reflux 5, 614318 (2)",NA
13,105459054,105505680,13q34,13q33.2,607415,"DAOAAS, G30",DAOA antisense RAN,DAOA-AS1,282706,ENSG00000232307,NA,NA,NA
13,105465866,105491033,13q34,13q33.2,607408,"DAOA, G72",D-amino acid oxidase activator,DAOA,267012,ENSG00000182346,NA,"{Schizophrenia}, 181500 (2), Autosomal dominant",NA
13,106489730,106535039,13q33,13q33.3,600527,"EFNB2, EPLG5, LERK5, HTKL",eph-related receptor tyrosine kinase ligand 5 (ephrin-B2),EFNB2,1948,ENSG00000125266,NA,NA,Efnb2 (MGI:105097)
13,106541672,106568163,13q33.3,13q33.3,614046,ARGLU1,Arginine- and glutamate-rich protein 1,ARGLU1,55082,ENSG00000134884,NA,NA,Arglu1 (MGI:2442985)
13,108207441,108218348,13q22-q34,13q33.3,601837,"LIG4, LIG4S","Ligase IV, DNA, ATP-dependent",LIG4,3981,ENSG00000174405,NA,"LIG4 syndrome, 606593 (3), Autosomal recessive; {Multiple myeloma, resistance to}, 254500 (3), Somatic mutation",Lig4 (MGI:1335098)
13,108268239,108308483,13q32-q34,13q33.3,603969,"TNFSF13B, BLYS, BAFF","Tumor necrosis factor ligand superfamily, member 13B",TNFSF13B,10673,ENSG00000102524,NA,NA,Tnfsf13b (MGI:1344376)
13,108495728,109208004,13q33.3,13q33.3,615479,"MYO16, MYAP3, KIAA0865",Myosin XVI,MYO16,23026,ENSG00000041515,NA,NA,Myo16 (MGI:2685951)
13,109600000,114364328,13q34,NA,614211,DFNA33,"Deafness, autosomal dominant 33",DFNA33,29779,NA,maximum lod at D13S285,"Deafness, autosomal dominant 33, 614211 (2), Autosomal dominant",NA
13,109752694,109786582,13q34,13q34,600797,IRS2,Insulin receptor substrate 2,IRS2,8660,ENSG00000185950,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant",Irs2 (MGI:109334)
13,110148962,110307156,13q34,13q34,120130,"COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR","Collagen IV, alpha-1 polypeptide",COL4A1,1282,ENSG00000187498,mutation identified in 1 RATOR family,"Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3), Autosomal dominant; Brain small vessel disease with or without ocular anomalies, 175780 (3), Autosomal dominant; {Hemorrhage, intracerebral, susceptibility to}, 614519 (3); ?Retinal arteries, tortuosity of, 180000 (3), Autosomal dominant; Schizencephaly, 269160 (3)",Col4a1 (MGI:88454)
13,110307283,110513208,13q34,13q34,120090,"COL4A2, BSVD2, ICH","Collagen IV, alpha-2 polypeptide",COL4A2,1284,ENSG00000134871,NA,"Brain small vessel disease 2, 614483 (3), Autosomal dominant; {Hemorrhage, intracerebral, susceptibility to}, 614519 (3)",Col4a2 (MGI:88455)
13,110615459,110639995,13q34,13q34,615910,"NAXD, CARKD, PEBEL2",NAD(P)HX dehydratase,NAXD,55739,ENSG00000213995,NA,"Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2, 618321 (3), Autosomal recessive",Naxd (MGI:1913353)
13,110641409,110713600,13q34,13q34,612800,"CARS2, COXPD27",Cysteinyl-tRNA synthetase 2,CARS2,79587,ENSG00000134905,NA,"Combined oxidative phosphorylation deficiency 27, 616672 (3), Autosomal recessive",Cars2 (MGI:1919191)
13,110712622,110723338,13q34,13q34,601566,ING1,Inhibitor of growth 1,ING1,3621,ENSG00000153487,NA,"Squamous cell carcinoma, head and neck, somatic, 275355 (3)",Ing1 (MGI:1349481)
13,111114618,111305733,13q34,13q34,605477,"ARHGEF7, PIXB, COOL1","Rho guanine nucleotide exchange factor 7 (PAK-interacting exchange factor, beta)",ARHGEF7,8874,ENSG00000102606,NA,NA,Arhgef7 (MGI:1860493)
13,112067148,112071705,13q34,13q34,602148,SOX1,SRY (sex determining region Y)-box 1,SOX1,6656,ENSG00000182968,NA,NA,Sox1 (MGI:98357)
13,112485004,112606468,13q34,13q34,617818,"TUBGCP3, GCP3, GRIP104, SPC98, ALP6",Tubulin-gamma complex-associated protein 3,TUBGCP3,10426,ENSG00000126216,NA,NA,Tubgcp3 (MGI:2183752)
13,112690033,112887167,13q34,13q34,605868,"ATP11A, ATPIS, ATPIH","ATPase, class VI, type 11A",ATP11A,23250,ENSG00000068650,NA,NA,Atp11a (MGI:1354735)
13,112894377,113099741,13q34,13q34,609499,"MCF2L, OST, KIAA0362",MCF2-like protein,MCF2L,23263,ENSG00000126217,NA,NA,Mcf2l (MGI:103263)
13,113105772,113120680,13q34,13q34,613878,F7,Coagulation factor VII,F7,2155,ENSG00000057593,NA,"Factor VII deficiency, 227500 (3), Autosomal recessive; {Myocardial infarction, decreased susceptibility to}, 608446 (3)",F7 (MGI:109325)
13,113122798,113149528,13q34,13q34,613872,F10,Coagulation factor X,F10,2159,ENSG00000126218,NA,"Factor X deficiency, 227600 (3), Autosomal recessive",F10 (MGI:103107)
13,113155863,113172385,13q34,13q34,176895,"PROZ, PZ",Protein Z,PROZ,8858,ENSG00000126231,NA,"[Protein Z deficiency], 614024 (3)",Proz (MGI:1860488)
13,113165001,113209466,13q34,13q34,613713,PCID2,PCI domain-containing protein 2,PCID2,55795,ENSG00000126226,NA,NA,Pcid2 (MGI:2443003)
13,113208192,113267107,13q34,13q34,603137,CUL4A,Cullin 4A,CUL4A,8451,ENSG00000139842,NA,NA,Cul4a (MGI:1914487)
13,113297238,113323671,13q34,13q34,153330,LAMP1,Lysosome-associated membrane protein-1,LAMP1,3916,ENSG00000185896,NA,NA,Lamp1 (MGI:96745)
13,113421944,113453487,13q31,13q34,610620,"ADPRHL1, ARH2",ADP-ribosylhydrolase-like 1,ADPRHL1,113622,ENSG00000153531,NA,NA,Adprhl1 (MGI:2442168)
13,113490737,113550228,13q34,13q34,617134,"TMCO3, C13orf11",Transmembrane and coiled-coil domains protein 3,TMCO3,55002,ENSG00000150403,NA,NA,Tmco3 (MGI:2444946)
13,113584687,113641472,13q34,13q34,189902,"TFDP1, DP1, DRTF1",Transcription factor Dp-1,TFDP1,7027,ENSG00000198176,pseudogene on 1q32.3,NA,Tfdp1 (MGI:101934)
13,113645770,113737735,13q34,13q34,180381,"GRK1, RHOK, RK",G protein-dependent receptor kinase 1 (rhodopsin kinase),GRK1,6011,ENSG00000185974,NA,"Oguchi disease-2, 613411 (3)",Grk1 (MGI:1345146)
13,113648803,113658197,13q34,13q34,137217,ATP4B,"ATPase, H+, K+ transporting, beta",ATP4B,496,ENSG00000186009,NA,NA,Atp4b (MGI:88114)
13,113820548,113864075,13q34,13q34,600441,"GAS6, AXLLG, AXSF",Growth arrest-specific 6,GAS6,2621,ENSG00000183087,NA,NA,Gas6 (MGI:95660)
13,113977782,114132622,13q34,13q34,605182,RASA3,Ras p21 protein activator 3,RASA3,22821,ENSG00000185989,NA,NA,Rasa3 (MGI:1197013)
13,114234844,114272722,13q34,13q34,603461,"CDC16, APC6","Cell division cycle 16, S. cerevisiae, homolog of",CDC16,8881,ENSG00000130177,NA,NA,Cdc16 (MGI:1917207)
13,114281583,114305816,13q34,13q34,605530,"UPF3A, RENT3A","UPF3 regulator of nonsense transcripts, yeast, homolog of, A",UPF3A,65110,ENSG00000169062,NA,NA,Upf3a (MGI:1914281)
13,114314502,114327321,13q34,13q34,616327,"CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40",Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,283489,ENSG00000198824,NA,"Mental retardation, autosomal dominant 40, 616579 (3), Autosomal dominant",Champ1 (MGI:1196398)
14,3600000,8000000,14p12,NA,180451,RNR2,Ribosomal RNA-2,RNR2,6053,NA,NA,NA,NA
14,8000000,37400000,14p11.2-q13,NA,606771,"ADIPQTL3, CAQ14","Adiponectin, serum level of, quantitative trait locus 3",NA,171512,NA,between D14S608 and D14S599,"{Adiponectin, serum level of, QTL3}, 606771 (2)",NA
14,17200000,57600000,14q11-q22,NA,613457,"DEL14q11q22, C14DELq11q22",Chromosome 14q11-q22 deletion syndrome,NA,NA,NA,contiguous gene syndrome,"Chromosome 14q11-q22 deletion syndrome, 613457 (4), Isolated cases",NA
14,17200000,32900000,14q11-q12,NA,606675,IBD4,Inflammatory bowel disease 4,IBD4,50608,NA,NA,"{Inflammatory bowel disease 4}, 606675 (2)",NA
14,17200000,24100000,14q11,NA,617833,ZFHX2AS1,ZFHX2 antisense RNA 1,ZFHX2-AS1,109729160,NA,NA,NA,NA
14,18200000,32900000,14q11.2-q12,NA,609965,DFNA53,"Deafness, autosomal dominant 53",DFNA53,353347,NA,max lod at D14S1280,"Deafness, autosomal dominant 53, 609965 (2), Autosomal dominant",NA
14,18200000,37400000,14q11.2-q13,NA,144110,HHPP,Hyperhidrosis palmaris et plantaris,NA,100861529,NA,between D14S283 and D14S264,"Hyperhidrosis palmaris et plantaris, 144110 (2), Autosomal dominant",NA
14,18200000,32900000,14q11.2-q12,NA,611095,"MRT9, MRT26","Mental retardation, autosomal recessive, 9/26",MRT9,100101424,NA,between rs1998463 and rs243286,"Mental retardation, autosomal recessive, 9/26, 611095 (2), Autosomal recessive",NA
14,18200000,24100000,14q11.2,NA,612851,NRCLP5,Narcolepsy 5,NA,100302514,NA,"associated with rs1154155, rs12587781, rs1263646","{Narcolepsy 5}, 612851 (2)",NA
14,18200000,32900000,14q11.2-q12,NA,610420,PAURT1,"Preauricular tag, isolated, autosomal dominant, 1",NA,101669760,NA,between D14S990 and D14S264,"Preauricular tag, isolated, autosomal dominant, 1, 610420 (2), Autosomal dominant",NA
14,18200000,24100000,14q11.2,NA,605463,RSCIS,"Radiation sensitivity/chromosome instability syndrome, autosomal dominant",NA,64239,NA,NA,"Radiation sensitivity/chromosome instability syndrome, autosomal dominant (1)",NA
14,18200000,32900000,14q11.2-q12,NA,610234,SPD3,Synpolydactyly 3,NA,780922,NA,max lod at D14S264,"Synpolydactyly 3, 610234 (2)",NA
14,18200000,24100000,14q11.2,NA,615443,TRAJ@,T-cell receptor alpha chain joining gene cluster,NA,NA,NA,NA,NA,NA
14,18200000,24100000,14q11.2,NA,615442,TRAV@,T-cell receptor alpha chain variable gene cluster,NA,NA,NA,NA,NA,NA
14,18200000,24100000,14q11.2,NA,615460,TRDD@,T-cell receptor delta chain diversity gene cluster,NA,NA,NA,NA,NA,NA
14,18200000,24100000,14q11.2,NA,615461,TRDJ@,T-cell receptor delta chain joining gene cluster,NA,NA,NA,NA,NA,NA
14,18200000,24100000,14q11.2,NA,615459,TRDV@,T-cell receptor delta chain variable gene cluster,NA,NA,NA,NA,NA,NA
14,20311367,20333311,14q11.1,14q11.2,608249,"C14orf18, HEI10",Human enhancer of invasion 10,CCNB1IP1,57820,ENSG00000100814,NA,NA,Ccnb1ip1 (MGI:2685134)
14,20343040,20357903,14q11.2,14q11.2,607725,"PARP2, ADPRTL2, ADPRT2",Poly(ADP-ribose) polymerase 2,PARP2,10038,ENSG00000129484,NA,NA,Parp2 (MGI:1341112)
14,20343070,20343410,14q11.2,14q11.2,608513,"RPPH1, H1RNA","Ribonuclease P, RNA component H1",RPPH1,85495,ENSG00000277209,NA,NA,NA
14,20365666,20413539,14q11.2,14q11.2,601686,"TEP1, TP1",Telomerase-associated protein-1,TEP1,7011,ENSG00000129566,NA,NA,Tep1 (MGI:109573)
14,20446400,20454811,14q11.2-q12,14q11.2,610107,"OSGEP, FLJ20411, GAMOS3",O-sialoglycoprotein endopeptidase,OSGEP,55644,ENSG00000092094,NA,"Galloway-Mowat syndrome 3, 617729 (3), Autosomal recessive",Osgep (MGI:1913496)
14,20455225,20457766,14q12,14q11.2,107748,"APEX, APE",APEX nuclease (multifunctional DNA repair enzyme),APEX1,328,ENSG00000100823,NA,NA,Apex1 (MGI:88042)
14,20469378,20478005,14q13.1,14q11.2,164050,"PNP, NP",Purine nucleoside phosphorylase,PNP,4860,ENSG00000198805,centromeric to TCRA,"Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3), Autosomal recessive","Pnp,Pnp2 (MGI:3712328,MGI:97365)"
14,20556092,20560930,14q11.2,14q11.2,614014,RNAE9,"Ribonuclease A family, 9",RNASE9,390443,ENSG00000188655,NA,NA,Rnase9 (MGI:3057273)
14,20609335,20609406,14q11,14q11.2,189930,"TRNAP1, TRP1",tRNA proline-1,TRP-AGG2-5,7217,NA,NA,NA,NA
14,20610131,20610212,14q11-q12,14q11.2,189932,"TRL-AAG2-1, TRNAL1, TRL1",tRNA leucine (AAG) 2-1,TRL-AAG2-3,7207,NA,NA,NA,NA
14,20613400,20613471,14q11-q12,14q11.2,189931,"TRNAP2, TRP2",tRNA proline-2,TRP-AGG2-6,7218,NA,NA,NA,NA
14,20613789,20613861,14q11-q12,14q11.2,189933,"TRNAT2, TRT2",tRNA threonine-2,TRT-TGT3-1,7237,NA,NA,NA,NA
14,20684176,20694185,14q11.2,14q11.2,105850,"ANG, RNASE5, ALS9",Angiogenin,ANG,283,ENSG00000214274,proximal to TCRA/TCRD,"Amyotrophic lateral sclerosis 9, 611895 (3)",Ang (MGI:88022)
14,20684559,20701215,14q11.2,14q11.2,601030,"RNASE4, RNS4","Ribonuclease, RNase A family, 4",RNASE4,6038,ENSG00000258818,NA,NA,Rnase4 (MGI:1926217)
14,20722390,20748379,14q11.2,14q11.2,611580,"EDDM3A, FAM12A, HE3A",Epididymal protein 3A,EDDM3A,10876,ENSG00000181562,NA,NA,NA
14,20768403,20770947,14q11.2,14q11.2,611582,"FAM12B, HE3B","Family with sequence similarity 12, member B",EDDM3B,64184,ENSG00000181552,NA,NA,Eddm3b (MGI:2684921)
14,20780955,20782466,14q11.2,14q11.2,601981,RNASE6,"Ribonuclease, RNase A family, k6",RNASE6,6039,ENSG00000169413,NA,NA,Rnase6 (MGI:1925666)
14,20801227,20802843,14q11.2,14q11.2,180440,"RNASE1, RNS1","Ribonuclease, RNase A family, 1 (pancreatic)",RNASE1,6035,ENSG00000129538,NA,NA,Rnase1 (MGI:97919)
14,20891402,20892347,14q11.2,14q11.2,131398,"RNASE3, RNS3, ECP","Ribonuclease, RNase A family, 3 (eosinophil cationic protein)",RNASE3,6037,ENSG00000169397,NA,NA,NA
14,20955486,20956435,14q11.2,14q11.2,131410,"RNASE2, RNS2, EDN","Ribonuclease, RNase A family, 2, liver (eosinophil-derived neurotoxin)",RNASE2,6036,ENSG00000169385,NA,NA,"Rnase2a,Rnase2b (MGI:1890465,MGI:1858598)"
14,20989979,20997034,14q11.2,14q11.2,616091,"METTL17, METT11D1",Methyltransferase-like 17,METTL17,64745,ENSG00000165792,NA,NA,Mettl17 (MGI:1098577)
14,20999292,21001870,14q11.2,14q11.2,612166,"SLC39A2, ZIP2","Solute carrier family 39 (zinc transporter), member 2",SLC39A2,29986,ENSG00000165794,NA,NA,Slc39a2 (MGI:2684326)
14,21016762,21070871,14q11.2,14q11.2,605272,NDRG2,N-myc downstream-regulated gene 2,NDRG2,57447,ENSG00000165795,NA,NA,Ndrg2 (MGI:1352498)
14,21024261,21036351,14q11.2,14q11.2,616956,"TPPP2, p18","Tubulin polymerization-promoting protein family, member 2",TPPP2,122664,ENSG00000179636,NA,NA,Tppp2 (MGI:2684923)
14,21042361,21044232,14q11.2,14q11.2,612484,RNASE7,Ribonuclease A family 7,RNASE7,84659,ENSG00000165799,NA,NA,NA
14,21057821,21058454,14q11.2,14q11.2,612485,RNASE8,"Ribonuclease A family, 8",RNASE8,122665,ENSG00000173431,NA,NA,NA
14,21061275,21090247,14q11.2,14q11.2,610018,"SOLO, FLJ10357",SOLO gene,ARHGEF40,55701,ENSG00000165801,NA,NA,Arhgef40 (MGI:2685515)
14,21090045,21104720,14q11,14q11.2,605036,ZNF219,Zinc finger protein-219,ZNF219,51222,ENSG00000165804,NA,NA,Zfp219 (MGI:1917140)
14,21209135,21269478,14q11.2,14q11.2,164020,"HNRNPC, HNRPC",Heterogeneous nuclear ribonucleoprotein C,HNRNPC,3183,ENSG00000092199,NA,NA,Hnrnpc (MGI:107795)
14,21287976,21351315,14q11,14q11.2,605446,"RPGRIP1, LCA6, CORD13",Retinitis pigmentosa GTPase regulator-interacting protein,RPGRIP1,57096,ENSG00000092200,NA,"Cone-rod dystrophy 13, 608194 (3); Leber congenital amaurosis 6, 613826 (3)",Rpgrip1 (MGI:1932134)
14,21351471,21384018,14q11.2,14q11.2,605012,"SUPT16H, SPT16","Suppressor of ty 16, S. cerevisiae, homolog of",SUPT16H,11198,ENSG00000092201,NA,NA,Supt16 (MGI:1890948)
14,21385193,21437274,14q11.2,14q11.2,610528,"CHD8, DUPLIN, KIAA1564, AUTS18",Chromodomain helicase DNA-binding protein 8,CHD8,57680,ENSG00000100888,NA,"{Autism, susceptibility to, 18}, 615032 (3), Autosomal dominant",Chd8 (MGI:1915022)
14,21459019,21476972,14q11.1-q11.2,14q11.2,607466,RAB2B,Ras-associated protein RAB2B,RAB2B,84932,ENSG00000129472,NA,NA,Rab2b (MGI:1923588)
14,21477194,21499169,14q11.2,14q11.2,614032,"TOX4, LCP1, KIAA0737",TOX high mobility group box family member 4,TOX4,9878,ENSG00000092203,NA,NA,Tox4 (MGI:1915389)
14,21498137,21511339,14q11.1,14q11.2,612472,"METTL3, IME4",Methyltransferase-like 3,METTL3,56339,ENSG00000165819,NA,NA,Mettl3 (MGI:1927165)
14,21521079,21537215,14q11.1-q12,14q11.2,602219,"SALL2, HSAL2, COLB",Sal-like 2,SALL2,6297,ENSG00000165821,mutation identified in 1 COLB family,"?Coloboma, ocular, autosomal recessive, 216820 (3), Autosomal recessive",Sall2 (MGI:1354373)
14,22462931,22466576,14q11.2,14q11.2,186810,TRDC,T-cell receptor delta chain constant region,TRDC,28526,NA,in midst of TCRA,NA,NA
14,22547505,22552131,14q11.2,14q11.2,186880,"TRAC, TRCA, TRA, IMD7",T-cell receptor alpha,TRAC,28755,NA,cen--V-C--ter,"Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3), Autosomal recessive",NA
14,22564906,22589223,14q11-q12,14q11.2,600243,DAD1,Defender against cell death 1,DAD1,1603,ENSG00000129562,NA,NA,Dad1 (MGI:101912)
14,22766687,22773041,14q11.2,14q11.2,601066,OXA1L,Oxidase (cytochrome c) assembly 1-like,OXA1L,5018,ENSG00000155463,NA,NA,Oxa1l (MGI:1916339)
14,22773221,22819810,14q11.2,14q11.2,603593,"SLC7A7, LPI","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7",SLC7A7,9056,ENSG00000155465,NA,"Lysinuric protein intolerance, 222700 (3), Autosomal recessive",Slc7a7 (MGI:1337120)
14,22829861,22835036,14q11.2,14q11.2,611856,MRPL52,Mitochondrial ribosomal protein L52,MRPL52,122704,ENSG00000172590,NA,NA,Mrpl52 (MGI:1916086)
14,22836584,22847757,14q11-q12,14q11.2,600754,"MMP14, WNCHRS",Matrix metalloproteinase 14 (membrane-inserted),MMP14,4323,ENSG00000157227,mutation identified in 1 family,"?Winchester syndrome, 277950 (3)",Mmp14 (MGI:101900)
14,22871612,22881712,14q11.2,14q11.2,609921,"LRP10, LRP9",Low density lipoprotein receptor-related protein 10,LRP10,26020,ENSG00000197324,NA,NA,Lrp10 (MGI:1929480)
14,22883164,22887677,14q11.2,14q11.2,616955,REM2,RRAD- and GEM-like GTPase 2,REM2,161253,ENSG00000139890,NA,NA,Rem2 (MGI:2155260)
14,22920525,22929391,14q11.2,14q11.2,604045,"PRMT5, SKB1, IBP72, JBP1, HSL7",Protein arginine methyltransferase 5,PRMT5,10419,ENSG00000100462,NA,NA,Prmt5 (MGI:1351645)
14,22946227,22957141,14q11.2,14q11.2,613431,"HAUS4, C14orf94","HAUS augmin-like complex, subunit 4",HAUS4,54930,ENSG00000092036,NA,NA,Haus4 (MGI:1261794)
14,23025850,23035219,14q11.2,14q11.2,600306,"PSMB5, LMPX","Proteasome subunit, beta type, 5",PSMB5,5693,ENSG00000100804,NA,NA,Psmb5 (MGI:1194513)
14,23042211,23044059,14q11.2,14q11.2,611137,PSMB11,"Proteasome subunit, beta-type, 11",PSMB11,122706,ENSG00000222028,NA,NA,Psmb11 (MGI:1921152)
14,23058563,23095613,14q11.2,14q11.2,604562,"ACIN1, KIAA0670",Acinus,ACIN1,22985,ENSG00000100813,NA,NA,Acin1 (MGI:1891824)
14,23117305,23119610,14q11.2,14q11.2,600749,"CEBPE, CRP1","CCAAT/enhancer-binding protein (C/EBP), epsilon",CEBPE,1053,ENSG00000092067,NA,"Specific granule deficiency, 245480 (3), Autosomal recessive",Cebpe (MGI:103572)
14,23125294,23183659,14q11.2,14q11.2,604235,"SLC7A8, LAT2","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8",SLC7A8,23428,ENSG00000092068,NA,NA,Slc7a8 (MGI:1355323)
14,23272421,23286131,11q11.2,14q11.2,608119,"HOMEZ, KIAA1443",Homeodomain leucine zipper-containing factor,HOMEZ,57594,ENSG00000215271,NA,NA,Homez (MGI:2678023)
14,23306761,23311758,14q11.2-q12,14q11.2,601931,"BCL2L2, BCLW",BCL2-like 2,BCL2L2,599,ENSG00000129473,NA,NA,Bcl2l2 (MGI:108052)
14,23320187,23326184,14q11.2-q13,14q11.2,602279,"PABPN1, PABP2, PAB2","Poly(A)-binding protein, nuclear 1",PABPN1,8106,ENSG00000100836,NA,"Oculopharyngeal muscular dystrophy, 164300 (3), Autosomal dominant",Pabpn1 (MGI:1859158)
14,23346303,23354990,14q11.2,14q11.2,611461,"SLC22A17, NGALR, BOIT, BOCT, NGALR2, NGALR3","Solute carrier family 22, organic cation transporter, member 17",SLC22A17,51310,ENSG00000092096,NA,NA,Slc22a17 (MGI:1926225)
14,23356399,23365632,14q11.2-q12,14q11.2,609906,EFS,Embryonal FYN-associated substrate,EFS,10278,ENSG00000100842,NA,NA,Efs (MGI:105311)
14,23372808,23376402,14q11.2,14q11.2,605658,"IL25, IL17E",Interleukin 25,IL25,64806,ENSG00000166090,NA,NA,Il25 (MGI:2155888)
14,23376431,23379771,14q11.2,14q11.2,607888,"CMTM5, CKLFSF5",CKLF-like marvel transmembrane domain-containing 5,CMTM5,116173,ENSG00000166091,NA,NA,Cmtm5 (MGI:2447164)
14,23381989,23408276,14q12,14q11.2,160710,"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3","Myosin, heavy polypeptide-6, cardiac muscle, alpha",MYH6,4624,ENSG00000197616,NA,"Atrial septal defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); Cardiomyopathy, hypertrophic, 14, 613251 (3), Autosomal dominant; {Sick sinus syndrome 3}, 614090 (3)",Myh6 (MGI:97255)
14,23388595,23388665,14q12,14q11.2,611116,"MIR208A, MIRN208A, MIR208, MIRN208",Micro RNA 208A,MIR208A,406990,ENSG00000199157,NA,NA,NA
14,23412739,23435676,14q12,14q11.2,160760,"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD","Myosin, heavy polypeptide-7, cardiac muscle, beta",MYH7,4625,ENSG00000092054,5'-B-4.5kb-A-3',"Cardiomyopathy, dilated, 1S, 613426 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 1, 192600 (3), Autosomal dominant; Laing distal myopathy, 160500 (3), Autosomal dominant; Left ventricular noncompaction 5, 613426 (3), Autosomal dominant; Myopathy, myosin storage, autosomal dominant, 608358 (3), Autosomal dominant; Myopathy, myosin storage, autosomal recessive, 255160 (3), Autosomal recessive; Scapuloperoneal syndrome, myopathic type, 181430 (3), Autosomal dominant",Myh7 (MGI:2155600)
14,23415449,23417594,14q11.2,14q11.2,616096,MHRT,"Myosin heavy chain-associated RNA transcript, noncoding",MHRT,104564225,NA,NA,NA,NA
14,23417986,23418062,14q11.2,14q11.2,613613,"MIR208B, MIRN208B",Micro RNA 208B,MIR208B,100126336,ENSG00000215991,NA,NA,NA
14,23469702,23478825,14q11.2,14q11.2,610777,"NGDN, NGD",Neuroguidin,NGDN,25983,ENSG00000129460,NA,NA,Ngdn (MGI:1916216)
14,23511759,23560270,14q11.2,14q11.2,611612,THTPA,Thiamine triphosphatase,THTPA,79178,ENSG00000259431,NA,NA,Thtpa (MGI:2446078)
14,23520856,23556314,14q11.2,14q11.2,617828,"ZFHX2, ZFH5, ZNF409, KIAA1056, KIAA1762, MARSIS",Zinc finger homeobox 2,ZFHX2,85446,ENSG00000136367,mutation identified in 1 MARSIS family,"?Marsili syndrome, 147430 (3), Autosomal dominant",Zfhx2 (MGI:2686934)
14,23559564,23567938,14q11.2,14q11.2,603534,AP1G2,"Adaptor-related protein complex 1, gamma-2 subunit",AP1G2,8906,ENSG00000213983,NA,NA,Ap1g2 (MGI:1328307)
14,23630114,23645638,14q11.2,14q11.2,615194,"DHRS2, HEP27","Short-chain dehydrogenase/reductase family, member 2",DHRS2,10202,ENSG00000100867,NA,NA,NA
14,23938730,23955111,14q11.2,14q11.2,616925,"DHRS4AS1, AS1DHRS4, C14orf67","DDHRS4 antisense RNA 1, noncoding",DHRS4-AS1,55449,ENSG00000215256,NA,NA,NA
14,23953734,23969278,14q11.2,14q11.2,611596,"DHRS4, NRDR","Short-chain dehydrogenase/reductase family, member 4",DHRS4,10901,ENSG00000157326,NA,NA,Dhrs4 (MGI:90169)
14,23969873,24006407,14q11.2,14q11.2,615196,DHRS4L2,"Short-chain dehydrogenase/reductase family, member 4-like 2",DHRS4L2,317749,ENSG00000187630,NA,NA,NA
14,24007083,24051376,14q11.2,14q11.2,615195,DHRS4L1,"Short-chain dehydrogenase/reductase family, member 4-like 1",DHRS4L1,728635,NA,NA,NA,NA
14,24052008,24069728,14q11.2,14q11.2,614716,LRRC16B,Leucine-rich repeat-containing protein 16B,CARMIL3,90668,ENSG00000186648,NA,NA,Carmil3 (MGI:2448573)
14,24069832,24078099,14q11.2,14q11.2,605688,CPNE6,Copine VI,CPNE6,9362,ENSG00000100884,NA,NA,Cpne6 (MGI:1334445)
14,24078685,24114948,14q11.1-q11.2,14q11-q12,162080,"NRL, D14S46E, RP27",Neural retina leucine zipper,NRL,4901,ENSG00000129535,NA,"Retinal degeneration, autosomal recessive, clumped pigment type (3); Retinitis pigmentosa 27, 613750 (3), Autosomal dominant",Nrl (MGI:102567)
14,24094310,24104124,14q11.2-q12,14q11-q12,614095,"PCK2, PEPCK2","Phosphoenolpyruvate carboxykinase 2, mitochondrial",PCK2,5106,ENSG00000100889,NA,"PEPCK deficiency, mitochondrial, 261650 (1), Autosomal recessive",Pck2 (MGI:1860456)
14,24100000,57600000,14q12-q22,NA,602086,ARVD3,Arrhythmogenic right ventricular dysplasia 3,ARVD3,424,NA,?distinct from ARVD1,"Arrhythmogenic right ventricular dysplasia 3, 602086 (2), Autosomal dominant",NA
14,24100000,32900000,14q12,NA,600792,DFNB5,"Deafness, autosomal recessive 5",DFNB5,1697,NA,NA,"Deafness, autosomal recessive 5, 600792 (2), Autosomal recessive",NA
14,24100000,50400000,14q12-q21,NA,611252,SPG32,Spastic paraplegia-32,SPG32,724107,NA,between D14S264 and D14S978,"Spastic paraplegia 32, autosomal recessive, 611252 (2), Autosomal recessive",NA
14,24114696,24125241,14q11.2,14q12,613317,"DCAF11, WDR23",DDB1- and CUL4-associated factor 11,DCAF11,80344,ENSG00000100897,NA,NA,Dcaf11 (MGI:90168)
14,24131465,24132848,14q12,14q12,612028,"FITM1, FIT1",Fat storage-inducing transmembrane protein 1,FITM1,161247,ENSG00000139914,NA,NA,Fitm1 (MGI:1915930)
14,24136157,24138966,14q11.2,14q12,600654,"PSME1, IFI5111",Proteasome activator subunit-1,PSME1,5720,ENSG00000092010,NA,NA,Psme1 (MGI:1096367)
14,24143364,24146645,14q11.2,14q12,602161,PSME2,Proteasome activator subunit-2,PSME2,5721,ENSG00000100911,NA,NA,Psme2 (MGI:1096365)
14,24146874,24160660,14q11.2,14q12,612487,"RNF31, ZIBRA",Ring finger protein 31,RNF31,55072,ENSG00000092098,NA,NA,Rnf31 (MGI:1934704)
14,24161264,24166564,14q11.2,14q12,147574,"ISGF3, ISGF3G","Interferon-stimulated gene transcription factor 3, gamma, 48kD",IRF9,10379,ENSG00000213928,NA,NA,Irf9 (MGI:107587)
14,24171930,24180407,14q11.2-q12,14q12,608193,"REC8L1, REC8","Rec8, S. pombe, homolog of",REC8,9985,ENSG00000100918,NA,NA,Rec8 (MGI:1929645)
14,24205523,24208361,14q11.2,14q12,610711,"TSSK4, TSSK5",Testis-specific serine/threonine kinase 4,TSSK4,283629,ENSG00000139908,NA,NA,Tssk4 (MGI:1918349)
14,24209580,24213487,14q12,14q12,610051,"CHMP4A, SNF7","CHMP family, member 4A",CHMP4A,29082,ENSG00000254505,NA,NA,NA
14,24216856,24232366,14q12,14q12,603171,NEDD8,"Neural precursor cel expressed, developmentally downregulated 8",NEDD8,4738,ENSG00000129559,NA,NA,Nedd8 (MGI:97301)
14,24232421,24239241,14q11-q21,14q12,610781,GMPR2,Guanosine monophosphate reductase 2,GMPR2,51292,ENSG00000100938,NA,NA,Gmpr2 (MGI:1917903)
14,24239639,24242673,14q12,14q12,604319,"TINF2, TIN2, DKCA3",TRF1-interacting nuclear factor 2,TINF2,26277,ENSG00000092330,NA,"Dyskeratosis congenita, autosomal dominant 3, 613990 (3), Autosomal dominant; Revesz syndrome, 268130 (3), Autosomal dominant",Tinf2 (MGI:107246)
14,24249113,24263176,14q11.2,14q12,190195,"TGM1, ICR2, ARCI1","Transglutaminase-1 (K polypeptide epidermal type I, protein-glutamine gamma-glutamyltransferase)",TGM1,7051,ENSG00000092295,NA,"Ichthyosis, congenital, autosomal recessive 1, 242300 (3), Autosomal recessive",Tgm1 (MGI:98730)
14,24265537,24271626,14q11.2,14q12,601905,RABGGTA,"Rab geranylgeranyltransferase, alpha subunit",RABGGTA,5875,ENSG00000100949,NA,NA,Rabggta (MGI:1860443)
14,24290597,24299779,14q21.3,14q12,610410,DHRS1,"Short-chain dehydrogenase/reductase family, member 1",DHRS1,115817,ENSG00000157379,NA,NA,Dhrs1 (MGI:1196314)
14,24299849,24309123,14q12,14q12,618308,NOP9,"NOP9, S. cerevisiae, homolog of",NOP9,161424,ENSG00000196943,NA,NA,Nop9 (MGI:1915092)
14,24305095,24311434,14q12,14q12,604441,CIDEB,Cell death-inducing DFFA-like effector B,CIDEB,27141,ENSG00000136305,NA,NA,Cideb (MGI:1270844)
14,24310139,24312052,14q11.2-q12,14q12,605773,"LTB4R2, BLTR2, BLT2",Leukotriene B4 receptor 2,LTB4R2,56413,ENSG00000213906,NA,NA,Ltb4r2 (MGI:1888501)
14,24311501,24318035,14q11.2-q12,14q12,601531,"LTB4R, CMKRL1, P2RY7, BLTR","Leukotriene b4 receptor (purinergic receptor P2Y, G protein-coupled, 7; chemokine receptor-like 1)",LTB4R,1241,ENSG00000213903,NA,NA,Ltb4r1 (MGI:1309472)
14,24318358,24335070,14q11.2,14q12,600292,ADCY4,Adenylate cyclase-4,ADCY4,196883,ENSG00000129467,NA,NA,Adcy4 (MGI:99674)
14,24336024,24339990,14q11.2,14q12,605817,"RIPK3, RIP3",Receptor-interacting serine/threonine kinase 3,RIPK3,11035,ENSG00000129465,NA,NA,Ripk3 (MGI:2154952)
14,24366910,24379603,Chr.14,14q12,602699,NFATC4,"Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4",NFATC4,4776,ENSG00000100968,NA,NA,Nfatc4 (MGI:1920431)
14,24426544,24429667,14q12,14q12,612978,CBLN3,Precerebellin 3,CBLN3,643866,ENSG00000139899,NA,NA,Cbln3 (MGI:1889286)
14,24439764,24442904,14q12,14q12,616162,SDR39U1,"Short-chain dehydrogenase/reductase family 39U, member 1",SDR39U1,56948,ENSG00000100445,NA,NA,Sdr39u1 (MGI:1916876)
14,24505352,24508264,14q11.2,14q12,118938,CMA1,"Chymase-1, mast cell",CMA1,1215,ENSG00000092009,NA,NA,Cma1 (MGI:96941)
14,24573517,24576249,14q11.2,14q12,116830,CTSG,Cathepsin G,CTSG,1511,ENSG00000100448,NA,NA,Ctsg (MGI:88563)
14,24606479,24609762,14q11.2,14q12,116831,"GZMH, CTSGL2",Granzyme H (cathepsin G-like 2),GZMH,2999,ENSG00000100450,NA,NA,"Gzmd,Gzme,Gzmf,Gzmg (MGI:109253,MGI:109255,MGI:109265,MGI:109254)"
14,24630953,24634268,14q11.2,14q12,123910,"GZMB, CTLA1, CSPB",Granzyme B (cytotoxic T-lymphocyte-associated serine esterase-1; cathepsin G-like 1),GZMB,3002,ENSG00000100453,NA,NA,NA
14,24809653,25050296,14q12,14q12,607958,"STXBP6, AMISYN, HSPC156",Syntaxin-binding protein 6,STXBP6,29091,ENSG00000168952,NA,NA,Stxbp6 (MGI:2384963)
14,26443089,26598032,14q12,14q12,602157,NOVA1,NOVA alternative splicing regulator 1,NOVA1,4857,ENSG00000139910,NA,NA,Nova1 (MGI:104297)
14,28766786,28770276,14q13,14q12,164874,"FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1",Forkhead box G1B,FOXG1,2290,ENSG00000176165,NA,"Rett syndrome, congenital variant, 613454 (3), Autosomal dominant",Foxg1 (MGI:1347464)
14,29576478,29927846,14q12,14q12,605435,"PRKD1, PRKCM, PKD, CHDED",Protein kinase D1,PRKD1,5587,ENSG00000184304,NA,"Congenital heart defects and ectodermal dysplasia, 617364 (3), Autosomal dominant",Prkd1 (MGI:99879)
14,30559122,30620063,14q12,14q12,611299,"G2E3, KIAA1333",G2/M phase-specific E3 ubiquitin ligase,G2E3,55632,ENSG00000092140,NA,NA,G2e3 (MGI:2444298)
14,30622253,30735849,14q12,14q12,618207,"SCFD1, SLY1, RA410",Sec1 family domain-containing protein 1,SCFD1,23256,ENSG00000092108,NA,NA,Scfd1 (MGI:1924233)
14,30874495,30890617,14q12-q13,14q12,603196,"COCH, DFNA9, DFNB110",Cochlin,COCH,1690,ENSG00000100473,mutation identified in 1 DFNB110 family,"Deafness, autosomal dominant 9, 601369 (3), Autosomal dominant; ?Deafness, autosomal recessive 110, 618094 (3), Autosomal recessive",Coch (MGI:1278313)
14,30893803,31026400,14q12,14q12,614766,"STRN3, SG2NA","Striatin, calmodulin-binding protein 3",STRN3,29966,ENSG00000196792,NA,NA,Strn3 (MGI:2151064)
14,31025105,31096449,14q12,14q12,607243,"AP4S1, CPSQ6, SPG52","Adaptor-related protein complex 4, sigma-1 subunit",AP4S1,11154,ENSG00000100478,NA,"Spastic paraplegia 52, autosomal recessive, 614067 (3), Autosomal recessive",Ap4s1 (MGI:1337065)
14,31482874,31488038,14q12,14q12,610118,GPR33,G protein-coupled receptor 33,GPR33,2856,ENSG00000214943,NA,NA,Gpr33 (MGI:1277106)
14,31561384,31861292,14q12,14q12,613621,"NUBPL, IND1, MC1DN21",Nucleotide-binding protein-like protein,NUBPL,80224,ENSG00000151413,NA,"Mitochondrial complex I deficiency, nuclear type 21, 618242 (3), Autosomal recessive",Nubpl (MGI:1924076)
14,32072587,32159727,14q12,14q12,602680,"ARHGAP5, RHOGAP5",RHO GTPase-activating protein 5,ARHGAP5,394,ENSG00000100852,NA,NA,Arhgap5 (MGI:1332637)
14,32203609,32837683,14q,14q12,604691,"ADAP6, ADAP100",A-kinase anchor protein 6,AKAP6,9472,ENSG00000151320,NA,NA,Akap6 (MGI:3050566)
14,32900000,37400000,14q13,NA,609408,HPE8,Holoprosencephaly 8,NA,619406,NA,between D14S49 and D14S1014,"Holoprosencephaly 8, 609408 (2)",NA
14,32900000,50400000,14q13-q21,NA,608831,RLS2,"Restless legs syndrome, susceptibility to, 2",NA,450097,NA,max lod at D14S288,"{Restless legs syndrome 2}, 608831 (2)",NA
14,32934784,33804175,14q13,14q13.1,609430,"NPAS3, MOP6",Neuronal PAS domain protein 3,NPAS3,64067,ENSG00000151322,NA,NA,Npas3 (MGI:1351610)
14,33924226,33951073,14q13.1,14q13.1,606426,"EGLN3, PHD3, HIFP4H3","Egl9, C. elegans, homolog of, 3",EGLN3,112399,ENSG00000129521,NA,NA,Egln3 (MGI:1932288)
14,34432787,34462239,14q13.1,14q13.1,613540,"SPTSSA, C14orf147, SSSPTA","Serine palmitoyltransferase, small subunit, A",SPTSSA,171546,ENSG00000165389,NA,NA,Sptssa (MGI:1913399)
14,34561092,34630147,14q13.1,14q13.1,606098,SNX6,Sorting nexin 6,SNX6,58533,ENSG00000129515,NA,NA,Snx6 (MGI:1919433)
14,34709112,34714822,14q12,14q13.1,601443,"CFL2, NEM7","Cofilin 2, muscle",CFL2,1073,ENSG00000165410,NA,"Nemaline myopathy 7, autosomal recessive, 610687 (3), Autosomal recessive",Cfl2 (MGI:101763)
14,34752730,34875359,14q12-q13,14q13.1-q13.2,605680,BAZ1A,"Bromodomain adjacent to zinc finger domain, 1A",BAZ1A,11177,ENSG00000198604,NA,NA,Baz1a (MGI:1309478)
14,34982897,35029566,14q13.2,14q13.2,604857,SRP54,"Signal recognition particle, 54kD",SRP54,6729,ENSG00000100883,NA,NA,"Srp54a,Srp54b (MGI:3714357,MGI:1346087)"
14,35085466,35122661,14q13.2,14q13.2,615902,"PPP2R3C, G5PR, GDRM, SPGF36","Protein phosphatase 2, regulatory subunit B-double prime, gamma",PPP2R3C,55012,ENSG00000092020,NA,"Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy, 618419 (3), Autosomal recessive; Spermatogenic failure 36, 618420 (3), Autosomal dominant",Ppp2r3c (MGI:1930009)
14,35122302,35277621,14q13,14q13.2,609947,KIAA0391,KIAA0391 gene,PRORP,9692,ENSG00000100890,NA,NA,Prorp (MGI:1913382)
14,35278557,35317492,14q13,14q13.2,602855,"PSMA6, PROS27, P27K","Proteasome subunit, alpha-type, 6",PSMA6,5687,ENSG00000100902,NA,"{Myocardial infarction, susceptibility to}, 608446 (3)",Psma6 (MGI:1347006)
14,35401509,35404753,14q13,14q13.2,164008,"NFKBIA, IKBA, EDAID2","Nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha",NFKBIA,4792,ENSG00000100906,NA,"Ectodermal dysplasia and immunodeficiency 2, 612132 (3), Autosomal dominant",Nfkbia (MGI:104741)
14,35534163,35537053,14q13.2,14q13.2,614027,"INSM2, IA6",Insulinoma-associated 2,INSM2,84684,ENSG00000168348,NA,NA,Insm2 (MGI:1930787)
14,35538355,35809294,14q13.2,14q13.2,608884,"RALGAPA1, GARNL1, TULIP1, GRIPE, KIAA0884","Ral GTPase activating protein, alpha subunit 1 (catalytic)",RALGAPA1,253959,ENSG00000174373,pseudogene on 9q31.1,NA,Ralgapa1 (MGI:1931050)
14,36100000,43000000,14q13.3-q21.1,NA,604461,HPV6AI1,Human papillomavirus type 6A integration site 1,HPV6AI1,3259,NA,previously assigned to 10q24,NA,NA
14,36135709,36176650,14q13.3,14q13.3,614821,PTCSC3,PTCSC3 gene,PTCSC3,100886964,NA,NA,NA,NA
14,36298557,36320675,14q13.3,14q13.3,609431,MBIP,MAP3K12-binding inhibitory protein,MBIP,51562,ENSG00000151332,NA,NA,Mbip (MGI:1918320)
14,36473287,36519555,14q13.3,14q13.3,617860,"SFTA3, SPH",Surfactant-associated protein 3,SFTA3,253970,ENSG00000229415,NA,NA,NA
14,36516396,36520231,14q13,14q13.3,600635,"NKX2-1, TITF1, NKX2A, TTF1, NMTC1",NK2 homeobox 1,NKX2-1,7080,ENSG00000136352,NA,"Chorea, hereditary benign, 118700 (3), Autosomal dominant; Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3), Autosomal dominant; {Thyroid cancer, nonmedullary, 1}, 188550 (3), Autosomal dominant",Nkx2-1 (MGI:108067)
14,36580003,36582613,14q12-q13,14q13.3,603245,"NKX2-8, NKX2H, NKX2.8",NK2 homeobox 8,NKX2-8,26257,ENSG00000136327,NA,NA,Nkx2-9 (MGI:1270158)
14,36657567,36677806,14q12-q13,14q13.3,167416,"PAX9, STHAG3",Paired box gene 9,PAX9,5083,ENSG00000198807,NA,"Tooth agenesis, selective, 3, 604625 (3), Autosomal dominant",Pax9 (MGI:97493)
14,36677317,37172605,14q11.2,14q13.3,607571,"SLC25A21, ODC","Solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21",SLC25A21,89874,ENSG00000183032,NA,NA,Slc25a21 (MGI:2445059)
14,37197887,37579206,14q13,14q13.3-q21.1,606850,MIPOL1,MIPOL1 gene,MIPOL1,145282,ENSG00000151338,NA,NA,Mipol1 (MGI:1920740)
14,37589551,37595248,14q13,14q21.1,602294,"FOXA1, HNF3A","Forkhead box A1 (hepatocyte nuclear factor-3, alpha)",FOXA1,3169,ENSG00000129514,NA,NA,Foxa1 (MGI:1347472)
14,38207903,38213066,14q13,14q21.1,182451,SSTR1,Somatostatin receptor-1,SSTR1,6751,ENSG00000139874,NA,NA,Sstr1 (MGI:98327)
14,38253999,38256092,14q21.1,14q21.1,616845,CLEC14A,"C-type lectin domain family 14, member A",CLEC14A,161198,ENSG00000176435,NA,NA,Clec14a (MGI:1914114)
14,39031918,39103234,14q21.1,14q21.1,610511,"SEC23A, CLSD","Sec23, S. cerevisiae, homolog of, A",SEC23A,10484,ENSG00000100934,NA,"Craniolenticulosutural dysplasia, 607812 (3), Autosomal recessive",Sec23a (MGI:1349635)
14,39114260,39136972,14q21.1,14q21.1,602595,"GEMIN2, SIP1",GEM-associated protein 2,GEMIN2,8487,ENSG00000092208,NA,NA,Gemin2 (MGI:1913853)
14,39147810,39170399,14q21.1,14q21.1,610397,"TRAPPC6B, TPC6, NEDMEBA","Trafficking protein particle complex, subunit 6B",TRAPPC6B,122553,ENSG00000182400,NA,"Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, 617862 (3), Autosomal recessive",Trappc6b (MGI:1925482)
14,39175253,39183219,Chr.14,14q21.1,603154,"PNN, DRS",Pinin,PNN,5411,ENSG00000100941,NA,NA,Pnn (MGI:1100514)
14,39233914,39388521,14q,14q21.1,602132,"MGEA, MEA6",Meningioma-expressed antigen 6,MIA2,4253,ENSG00000150527,?pseudogenes on other chromosomes,NA,NA
14,39396372,39432499,14q13.3,14q21.1,609103,"FBXO33, FBX33, BMND12",F-box only protein 33,FBXO33,254170,ENSG00000165355,NA,NA,Fbxo33 (MGI:1917861)
14,41606855,41904548,14q21.2,14q21.1,612811,"LRFN5, SALM5",Leucine-rich repeat and fibronectin type III domain-containing protein 5,LRFN5,145581,ENSG00000165379,NA,NA,Lrfn5 (MGI:2144814)
14,43000000,57600000,14q21.2-q22.3,NA,607501,"MGR4, MGOA","Migraine without aura, susceptibility to, 4",NA,338342,NA,between D14S976 and D14S978,"{Migraine without aura, susceptibility to, 4}, 607501 (2), Autosomal dominant",NA
14,44504148,44507282,14q21.3,14q21.2,611779,"FSCB, C14orf155",Fibrous sheath cabyr-binding protein,FSCB,84075,ENSG00000189139,NA,NA,NA
14,44962189,45074430,14q21.2,14q21.2,617618,"TOGARAM1, FAM179B, KIAA0423",TOG array regulator of axonemal microtubules 1,TOGARAM1,23116,ENSG00000198718,NA,NA,Togaram1 (MGI:2684313)
14,45084115,45116281,14q21.2,14q21.2,614907,PRPF39,"Precursor mRNA-processing factor 39, S. cerevisiae, homolog of",PRPF39,55015,ENSG00000185246,NA,NA,Prpf39 (MGI:104602)
14,45115291,45134480,14q21.2,14q21.2,186947,"FKBP3, FKBP25",FK506-binding protein 3,FKBP3,2287,ENSG00000100442,NA,NA,Fkbp3 (MGI:1353460)
14,45135929,45200889,14q21.3,14q21.2,609644,"FANCM, KIAA1596, SPGF28, POF15",FANCM gene,FANCM,57697,ENSG00000187790,mutation identified in 1 POF15 family,"?Premature ovarian failure 15, 618096 (3), Autosomal recessive; Spermatogenic failure 28, 618086 (3), Autosomal recessive",Fancm (MGI:2442306)
14,45203189,45257189,14q21.2,14q21.2,618139,"MIS18BP, C14orf106",Mis18-binding protein 1,MIS18BP1,55320,ENSG00000129534,NA,NA,Mis18bp1 (MGI:2145099)
14,46836517,47675315,14q21,14q21.3,611128,MDGA2,MAM domain-containing glycosylphosphatidylinositol anchor 2,MDGA2,161357,ENSG00000139915,NA,NA,Mdga2 (MGI:2444706)
14,49570987,49598709,14q,14q21.3,603633,"RPS29, DBA13",Ribosomal protein S29,RPS29,6235,ENSG00000213741,NA,"Diamond-Blackfan anemia 13, 615909 (3), Autosomal dominant",Rps29 (MGI:107681)
14,49586579,49586877,14q22.1,14q21.3,612177,"RN7SL1, 7SL, 7L1A","RNA, 7SL, cytoplasmic 1",RN7SL1,6029,ENSG00000276168,NA,NA,NA
14,49618529,49620625,Chr.14,14q21.3,180469,"RPL36AL, RPL36A",Ribosomal protein L36a-like,RPL36AL,6166,ENSG00000165502,NA,NA,Rpl36al (MGI:1913733)
14,49620798,49623480,14q21,14q21.3,602616,"MGAT2, CDGS2, CDG2A","Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyl- transferase",MGAT2,4247,ENSG00000168282,NA,"Congenital disorder of glycosylation, type IIa, 212066 (3), Autosomal recessive",Mgat2 (MGI:2384966)
14,49625173,49635229,14q21.3,14q21.3,612517,"KTU, C14orf104, CILD10","Kintoun, Medaka, homolog of",DNAAF2,55172,ENSG00000165506,NA,"Ciliary dyskinesia, primary, 10, 612518 (3)",Dnaaf2 (MGI:1923566)
14,49643551,49688416,14q13-q21,14q21.3,602670,"POLE2, DPE2","Polymerase, DNA, epsilon-2",POLE2,5427,ENSG00000100479,NA,NA,Pole2 (MGI:1197514)
14,49690461,49753151,14q21.3,14q21.3,611281,KLHDC1,KELCH domain-containing protein 1,KLHDC1,122773,ENSG00000197776,NA,NA,Klhdc1 (MGI:2672853)
14,49767607,49786384,14q21.3,14q21.3,611280,"KLHDC2, HCLP1",KELCH domain-containing protein 2,KLHDC2,23588,ENSG00000165516,NA,NA,Klhdc2 (MGI:1916804)
14,49782082,49853202,14q22,14q21.3,608378,"NEMF, SDCCAG1",Nuclear export mediator factor,NEMF,9147,ENSG00000165525,NA,NA,Nemf (MGI:1918305)
14,49853615,49853913,14q22.1,14q21.3,612180,RN7SL3,"RNA, 7SL, cytoplasmic 3",RN7SL3,378707,ENSG00000278771,NA,NA,NA
14,49862550,49862848,14q22.1,14q21.3,612179,"RN7SL2, 7L1C","RNA, 7SL, cytoplasmic 2",RN7SL2,378706,ENSG00000274012,NA,NA,NA
14,49893081,49897053,14q21.3,14q21.3,600464,ARF6,ADP-ribosylation factor 6,ARF6,382,ENSG00000165527,NA,NA,Arf6 (MGI:99435)
14,50100455,50116578,14q21.3,14q21.3,615260,"VCPKMT, METTL21D, C14orf138",Valosin-containing protein lysine methyltransferase,VCPKMT,79609,ENSG00000100483,NA,NA,Vcpkmt (MGI:2684917)
14,50117129,50231577,14q21,14q21.3,601247,"SOS2, NS9","Son of sevenless, Drosophila, homolog of, 2",SOS2,6655,ENSG00000100485,NA,"Noonan syndrome 9, 616559 (3), Autosomal dominant",Sos2 (MGI:98355)
14,50242433,50312228,14q22.1,14q21.3,609584,"L2HGDH, C14orf160, L2HGA",L-2-hydroxyglutarate dehydrogenase,L2HGDH,79944,ENSG00000087299,NA,"L-2-hydroxyglutaric aciduria, 236792 (3), Autosomal recessive",L2hgdh (MGI:2384968)
14,50326264,50397398,14q21.3,14q21.3,603441,"CDKL1, KKIALRE, p42",Cyclin-dependent kinase-like 1,CDKL1,8814,ENSG00000100490,NA,NA,Cdkl1 (MGI:1918341)
14,50400000,67400000,14q22-q23,NA,115650,"CTRCT32, CTAA1, CAP, CTPP5","Cataract 32, multiple types",CTAA1,1483,NA,between D14S980 and D14S1069,"Cataract 32, multiple types, 115650 (2), Autosomal dominant",NA
14,50400000,57600000,14q22.1-q22.3,NA,609640,"FRIASS, DEL14q22, C14DELq22",Frias syndrome,NA,NA,NA,deletion spans 4.1 Mb on 14q22.1-q22.3,"Frias syndrome, 609640 (4), Autosomal dominant",NA
14,50400000,73300000,14q22.1-q24.2,NA,255500,MYP18,Myopia 18,MYP18,100359406,NA,between D14S984 and D14S999,"Myopia 18, 255500 (2), Autosomal recessive",NA
14,50533081,50633067,14q11-q21,14q22.1,606439,"ATL1, SPG3A, HSN1D",Atlastin GTPase 1,ATL1,51062,ENSG00000198513,NA,"Neuropathy, hereditary sensory, type ID, 613708 (3), Autosomal dominant; Spastic paraplegia 3A, autosomal dominant, 182600 (3), Autosomal dominant",Atl1 (MGI:1921241)
14,50418474,50561125,Chr.14,14q22.1,604923,"MAP4K5, MAPKKKK5",Mitogen-activated protein kinase kinase kinase kinase-5,MAP4K5,11183,ENSG00000012983,NA,NA,Map4k5 (MGI:1925503)
14,50633103,50668305,14q13-q23,14q22.1,607203,"WW45, SAV","WW domain-containing protein, 45kD",SAV1,60485,ENSG00000151748,NA,NA,Sav1 (MGI:1927144)
14,50719762,50831139,14q22.1,14q22.1,608684,"NIN, KIAA1565, SCKL7",Ninein,NIN,51199,ENSG00000100503,mutation identified in 1 SCKL7 family,"?Seckel syndrome 7, 614851 (3), Autosomal recessive",Nin (MGI:105108)
14,50905216,50944482,14q22.1,14q22.1,613741,PYGL,"Phosphorylase, glycogen, liver",PYGL,5836,ENSG00000100504,NA,"Glycogen storage disease VI, 232700 (3), Autosomal recessive",Pygl (MGI:97829)
14,50975260,51105172,14q21-q24,14q22.1,606555,"TRIM9, SPRING, KIAA0282",Tripartite motif-containing protein 9,TRIM9,114088,ENSG00000100505,NA,NA,Trim9 (MGI:2137354)
14,51240246,51257654,14q22.1,14q22.1,610527,"TXNDC1, TMX",Thioredoxin domain-containing 1,TMX1,81542,ENSG00000139921,NA,NA,Tmx1 (MGI:1919986)
14,51489099,51730726,14q22.1,14q22.1,614555,"FRMD6, WILLIN, C14orf31",FERM domain-containing protein 6,FRMD6,122786,ENSG00000139926,NA,NA,Frmd6 (MGI:2442579)
14,51847130,51969799,14q21,14q22.1,606981,GNG2,"Guanine nucleotide-binding protein, gamma-2",GNG2,54331,ENSG00000186469,NA,NA,Gng2 (MGI:102705)
14,51989545,52010693,14q22.1,14q22.1,610858,"C14orf166, CGI99",Chromosome 14 open reading frame 166,RTRAF,51637,ENSG00000087302,NA,NA,Rtraf (MGI:1915295)
14,52004808,52069058,Chr.14,14q22.1,605399,NID2,Nidogen 2,NID2,22795,ENSG00000087303,NA,NA,Nid2 (MGI:1298229)
14,52267255,52276723,14q22.1,14q22.1,604687,"PTGDR, AS1, ASRT1",Prostaglandin D2 receptor,PTGDR,5729,ENSG00000168229,NA,"{Asthma, susceptibility to, 1}, 607277 (3)",Ptgdr (MGI:102966)
14,52314311,52328597,14q22,14q22.1,176804,PTGER2,"Prostaglandin E receptor 2, EP2 subtype, 53kD",PTGER2,5732,ENSG00000125384,NA,"{Asthma, aspirin-induced, susceptibility to}, 208550 (3), Autosomal recessive",Ptger2 (MGI:97794)
14,52430589,52552582,14q22.1,14q22.1,616179,"TXNDC16, KIAA1344",Thioredoxin domain-containing protein 16,TXNDC16,57544,ENSG00000087301,NA,NA,Txndc16 (MGI:1917811)
14,52639914,52695749,14q22.1,14q22.1,615435,"ERO1L, ERO1LA",Endoplasmic reticulum oxidoreduction 1-like,ERO1A,30001,ENSG00000197930,NA,NA,Ero1l (MGI:1354385)
14,52707162,52728589,14q22.1,14q22.1,602708,PSMC6,"Proteasome 26S subunit, ATPase, 6",PSMC6,5706,ENSG00000100519,previously assigned to 12q15 by FISH,NA,Psmc6 (MGI:1914339)
14,52730158,52774988,14q22.1,14q22.1,615814,STYX,Serine/threonine/tyrosine-interacting protein,STYX,6815,ENSG00000198252,NA,NA,Styx (MGI:1891150)
14,52775192,52791606,14q22.1,14q22.1,616510,"GNPNAT1, GNA1",Glucosamine-phosphate N-acetyltransferase 1,GNPNAT1,64841,ENSG00000100522,NA,NA,Gnpnat1 (MGI:1858963)
14,52857270,52951096,14q22.1,14q22.1,607746,"FERMT2, PLEKHC1, MIG2, UNC112, KIND2","Fermitin family, member 2",FERMT2,10979,ENSG00000073712,NA,NA,Fermt2 (MGI:2385001)
14,53036754,53153322,14q22.1,14q22.1,614603,"DDHD1, PAPLA1, KIAA1705, SPG28",DDHD domain-containing protein 1,DDHD1,80821,ENSG00000100523,NA,"Spastic paraplegia 28, autosomal recessive, 609340 (3), Autosomal recessive",Ddhd1 (MGI:2150302)
14,53600000,55000000,14q22.2,NA,612589,CRCS8,"Colorectal cancer, susceptibility to, 8",NA,100271690,NA,associated with rs4444235,"{Colorectal cancer, susceptibility to, 8}, 612589 (2)",NA
14,53949735,53956890,14q22.2,14q22.2,112262,"BMP4, BMP2B1, BMP2B, MCOPS6, OFC11",Bone morphogenetic protein-4,BMP4,652,ENSG00000125378,NA,"Microphthalmia, syndromic 6, 607932 (3), Autosomal dominant; Orofacial cleft 11, 600625 (3)",Bmp4 (MGI:88180)
14,54396867,54420217,14q22,14q22.2,123832,CDKN3,Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase),CDKN3,1033,ENSG00000100526,NA,NA,Cdkn3 (MGI:1919641)
14,54423560,54441373,14q22.2,14q22.2,611287,"CNIH, TGAM77","Cornichon, Drosophila, homolog of",CNIH1,10175,ENSG00000100528,NA,NA,Cnih1 (MGI:1277202)
14,54474484,54488979,14q22.2,14q22.2,601713,"GMFB, GMF","Glia maturation factor, beta",GMFB,2764,ENSG00000197045,NA,NA,Gmfb (MGI:1927133)
14,54509895,54539309,14q22.1,14q22.2,606138,"GCRRF1, CGR19",Cell growth regulator with ring finger domain 1,CGRRF1,10668,ENSG00000100532,NA,NA,Cgrrf1 (MGI:1916368)
14,54567096,54793314,14q22.2,14q22.2,610747,"SAMD4A, SMAUG1, KIAA1053",Sterile alpha motif domain-containing 4A,SAMD4A,23034,ENSG00000020577,NA,NA,Samd4 (MGI:1921730)
14,54842004,54902825,14q22.1-q22.2,14q22.2,600225,"GCH1, DYT5, HPABH4B",GTP cyclohydrolase 1,GCH1,2643,ENSG00000131979,NA,"Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3), Autosomal recessive, Autosomal dominant; Hyperphenylalaninemia, BH4-deficient, B, 233910 (3), Autosomal recessive",Gch1 (MGI:95675)
14,54938948,55027105,14q22.2,14q22.2-q22.3,608126,"WDHD1, AND1",WD repeat and HMG-box DNA binding protein 1,WDHD1,11169,ENSG00000198554,NA,NA,Wdhd1 (MGI:2443514)
14,55027130,55049488,14q22.3,14q22.3,616337,"SOCS4, SOCS7",Suppressor of cytokine signaling 4,SOCS4,122809,ENSG00000180008,NA,NA,Socs4 (MGI:1914546)
14,55051646,55070193,14q22.3,14q22.3,617226,"MAP1IP1L, MISS",Mitogen-activated protein kinase 1-interacting protein 1-like protein,MAPK1IP1L,93487,ENSG00000168175,NA,NA,Mapk1ip1l (MGI:2444022)
14,55129251,55145429,14q21-q22,14q22.3,153619,"LGALS3, MAC2, GALBP","Lectin, galactose-binding, soluble, 3",LGALS3,3958,ENSG00000131981,assigned earlier to 1p13,NA,Lgals3 (MGI:96778)
14,55148129,55191584,14q22.3,14q22.3,617859,"DLGAP5, DLG7, HURP, KIAA0008",Discs large-associated protein 5,DLGAP5,9787,ENSG00000126787,NA,NA,Dlgap5 (MGI:2183453)
14,55229192,55229935,14q24.3,14q22.3,600012,"UBE2L1, UBCL, UBC4",Ubiquitin-conjugating enzyme E2L 1,UBE2L1,283556,NA,NA,NA,NA
14,55271420,55353610,14q22.2,14q22.3,609104,"FBXO34, FBX34",F-box only protein 34,FBXO34,55030,ENSG00000178974,NA,NA,Fbxo34 (MGI:1926188)
14,55366390,55411857,14q22.3,14q22.3,613515,"ATG14, ATG14L, KIAA0831, BARKOR","Autophagy 14, S. cerevisiae, homolog of",ATG14,22863,ENSG00000126775,NA,NA,Atg14 (MGI:1261775)
14,55580206,55684583,14q22,14q22.3,600381,"KTN1, CG1",Kinectin,KTN1,3895,ENSG00000126777,NA,NA,NA
14,56118328,56301585,14q21,14q22.3,614798,PELI2,"Pellino, Drosophila, homolog of, 2",PELI2,57161,ENSG00000139946,NA,NA,Peli2 (MGI:1891445)
14,56579791,56660628,14q22.3,14q22.3,617449,"TMEM260, C14orf101, SHDRA",Transmembrane protein 260,TMEM260,54916,ENSG00000070269,NA,"Structural heart defects and renal anomalies syndrome, 617478 (3), Autosomal recessive",Tmem260 (MGI:2443219)
14,56799904,56810478,14q22.3,14q22.3,600037,"OTX2, MCOPS5, CPHD6","Orthodenticle, Drosophila, homolog of, 2",OTX2,5015,ENSG00000165588,NA,"Microphthalmia, syndromic 5, 610125 (3), Autosomal dominant; Pituitary hormone deficiency, combined, 6, 613986 (3), Autosomal dominant; Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3), Autosomal dominant",Otx2 (MGI:97451)
14,57200506,57268904,14q22.3,14q22.3,604469,"EXOC5, SEC10L1",Exocyst complex component 5,EXOC5,10640,ENSG00000070367,NA,NA,Exoc5 (MGI:2145645)
14,57268887,57298741,14q22.3,14q22.3,614368,"AP5M1, MUDENG, MUD, C14orf108","Adaptor-related protein complex 5, mu-1 subunit",AP5M1,55745,ENSG00000053770,NA,NA,Ap5m1 (MGI:1921635)
14,57390585,57415905,14q22.3,14q22.3,617989,"NAA30, NAT12, MAK3, C14orf35","N-alpha-acetyltransferase 30, NatC catalytic subunit",NAA30,122830,ENSG00000139977,NA,NA,Naa30 (MGI:1922259)
14,57600000,67400000,14q23,NA,612162,ANIB8,"Aneurysm, intracranial berry, 8",NA,100188886,NA,associated with rs767603,"Aneurysm, intracranial berry, 8, 612162 (2)",NA
14,57600000,67400000,14q23,NA,606972,EIG2,"Epilepsy, idiopathic generalized, susceptibility to, 2",NA,353124,NA,NA,"{Epilepsy, idiopathic generalized, susceptibility to, 2}, 606972 (2)",NA
14,58244804,58272008,14q23,14q23.1,176843,PSMA3,"Proteasome (prosome, macropain) subunit, alpha type, 3",PSMA3,5684,ENSG00000100567,NA,NA,Psma3 (MGI:104883)
14,58298384,58373875,14q23.1,14q23.1,180201,"ARID4A, RBP1, RBBP1",AT-rich interactive domain-containing protein 4A,ARID4A,5926,ENSG00000032219,NA,NA,Arid4a (MGI:2444354)
14,58408493,58427613,14q21,14q23.1,607384,"TIMM9, TIM9","Translocase of inner mitochondrial membrane 9, yeast, homolog of",TIMM9,26520,ENSG00000100575,NA,NA,Timm9 (MGI:1353436)
14,58427384,58551296,14q23.1,14q23.1,610178,"KIAA0586, TALPID3, JBTS23, SRTD14",KIAA0586 gene,KIAA0586,9786,ENSG00000100578,NA,"Joubert syndrome 23, 616490 (3), Autosomal recessive; Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3), Autosomal recessive",2700049A03Rik (MGI:1924217)
14,58634067,58648320,14q22.3,14q23.1,607861,"DACT1, DPR1, DAPPER1, FRODO, TBS2","Dapper, antagonist of beta-catenin, 1",DACT1,51339,ENSG00000165617,mutation identified in 1 TBS2 family,"?Townes-Brocks syndrome 2, 617466 (3), Autosomal dominant",Dact1 (MGI:1891740)
14,59188656,59371404,14q23.1,14q23.1,606626,"DAAM1, KIAA0666",Dishevelled-associated activator of morphogenesis 1,DAAM1,23002,ENSG00000100592,NA,NA,Daam1 (MGI:1914596)
14,59452772,59465635,14q23.1,14q23.1,607970,GPR135,G protein-coupled receptor 135,GPR135,64582,ENSG00000181619,NA,NA,Gpr135 (MGI:2676315)
14,59472605,59505265,14q23.1,14q23.1,614811,"L3HYPDH, C14orf149","L-3-hydroxyproline dehydratase, trans",L3HYPDH,112849,ENSG00000126790,NA,NA,L3hypdh (MGI:1914467)
14,59484442,59505409,14q23.1,14q23.1,611176,"JKAMP, C24orf100, JAMP",JNK1/MAPK8-associated membrane protein,JKAMP,51528,ENSG00000050130,NA,NA,Jkamp (MGI:1915057)
14,59595975,59871287,14q21-q22,14q23.1,600865,"RTN1, NSP",Reticulon 1 (neuroendocrine-specific protein),RTN1,6252,ENSG00000139970,NA,NA,Rtn1 (MGI:1933947)
14,60144118,60169863,14q23.1,14q23.1,612833,"DHRS7, RETSDR4","Short-chain dehydrogenase/reductase family, member 7",DHRS7,51635,ENSG00000100612,NA,NA,Dhrs7 (MGI:1913625)
14,60245749,60299086,14q23.1,14q23.1,606108,"PPM1A, PP2CA","Protein phosphatase, magnesium/manganese-dependent, 1A",PPM1A,5494,ENSG00000100614,NA,NA,Ppm1a (MGI:99878)
14,60435953,60499773,14q23.1,14q23.1,617307,"C14orf39, SIX6OS1",Chromosome 14 open reading frame 39,C14orf39,317761,ENSG00000179008,NA,NA,4930447C04Rik (MGI:1923051)
14,60509145,60512849,14q23,14q23.1,606326,"SIX6, ODRMD","Sine oculis homeo box, Drosophila, homolog of, 6",SIX6,4990,ENSG00000184302,NA,"Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3), Autosomal recessive",Six6 (MGI:1341840)
14,60643420,60649488,14q23,14q23.1,601205,"SIX1, BOS3, DFNA23","Sine oculis homeo box, Drosophila, homolog of, 1",SIX1,6495,ENSG00000126778,NA,"Branchiootic syndrome 3, 608389 (3), Autosomal dominant; Deafness, autosomal dominant 23, 605192 (3), Autosomal dominant",Six1 (MGI:102780)
14,60709538,60724350,14q23,14q23.1,606342,SIX4,"Sine oculis homeo box, Drosophila, homolog of, 4",SIX4,51804,ENSG00000100625,NA,NA,Six4 (MGI:106034)
14,60734734,60969964,14q23,14q23.1,602659,"MNAT1, MAT1",Menage a trois 1,MNAT1,4331,ENSG00000020426,NA,NA,Mnat1 (MGI:106207)
14,60971440,60981689,14q23.1,14q23.1,611023,"TRMT5, TRM5, KIAA1393, COXPD26","tRNA methyltransferase 5, S. cerevisiae, homolog of",TRMT5,57570,ENSG00000126814,NA,"Combined oxidative phosphorylation deficiency 26, 616539 (3), Autosomal recessive",Trmt5 (MGI:1923607)
14,60981113,61083732,14q23.1,14q23.1,616518,"SLC38A6, SNAT6","Solute carrier family 38 (amino acid transporter), member 6",SLC38A6,145389,ENSG00000139974,NA,NA,Slc38a6 (MGI:3648156)
14,61187304,61550979,14q22-q23,14q23.1,605437,"PRKCH, PKCL, PRKCL","Protein kinase C, eta",PRKCH,5583,ENSG00000027075,NA,"{Cerebral infarction, susceptibility to}, 601367 (3), Multifactorial",Prkch (MGI:97600)
14,61277369,61281337,14q23.1,14q23.1,611029,"TMEM30B, CDC50B",Transmembrane protein 30B,TMEM30B,161291,ENSG00000182107,NA,NA,Tmem30b (MGI:2442082)
14,61600000,64300000,14q23.2,NA,609113,TELM,"Telomere length, mean leukocyte",NA,550641,NA,"suggestive QTL on 12, 10q, 3p","[Telomere length, mean leukocyte], 609113 (2)",NA
14,61681040,61695822,14q23.2,14q23.2,614528,HIF1AAS1,HIF1A antisense RNA 1,HIF1A-AS1,100750246,ENSG00000258777,NA,NA,NA
14,61695512,61748258,14q21-q24,14q23.2,603348,"HIF1A, MOP1","Hypoxia-inducible factor 1, alpha subunit",HIF1A,3091,ENSG00000100644,NA,NA,Hif1a (MGI:106918)
14,61747038,61749088,14q23.2,14q23.2,614529,HIF1AAS2,HIF1A antisense RNA 2,HIF1A-AS2,100750247,NA,NA,NA,NA
14,61762419,61796427,14q23.2,14q23.2,600591,"SNAPC1, SNAP43","Small nuclear RNA-activating protein complex, polypeptide 1",SNAPC1,6617,ENSG00000023608,NA,NA,Snapc1 (MGI:1922877)
14,61812161,62112824,14q23.1,14q23.2,610950,"SYT16, STREP14",Synaptotagmin 16,SYT16,83851,ENSG00000139973,NA,NA,Syt16 (MGI:2673872)
14,62699463,63045457,14q23.2,14q23.2,605716,KCNH5,"Potassium voltage-gated channel, subfamily H, member 5",KCNH5,27133,ENSG00000140015,NA,NA,Kcnh5 (MGI:3584508)
14,63204411,63293507,14q23.2,14q23.2,607653,"RHOJ, ARHJ, TCL","Ras homolog gene family, member J",RHOJ,57381,ENSG00000126785,NA,NA,Rhoj (MGI:1931551)
14,63312834,63318934,14q23.2,14q23.2,609652,"GPHB5, GPB5","Glycoprotein hormone, beta-5",GPHB5,122876,ENSG00000179600,NA,NA,Gphb5 (MGI:2156540)
14,63371355,63543394,14q23.1,14q23.2,601647,PPP2R5E,"Protein phosphatase-2, regulatory subunit B (B56), epsilon isoform",PPP2R5E,5529,ENSG00000154001,incorrectly assigned to 7p12-p11.2 by FISH,NA,Ppp2r5e (MGI:1349473)
14,63684215,63728107,14q22.1,14q23.2,612826,"SGPP1, SPPASE1",Sphingosine-1-phosphate phosphatase 1,SGPP1,81537,ENSG00000126821,NA,NA,Sgpp1 (MGI:2135760)
14,63761903,64226448,14q23,14q23.2,608442,"SYNE2, NUANCE, KIAA1011, EDMD5",Spectrin repeat-containing nuclear envelope protein 2 (nesprin 2),SYNE2,23224,ENSG00000054654,NA,"Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3), Autosomal dominant",Syne2 (MGI:2449316)
14,64226706,64338630,14q,14q23.2-q23.3,601663,"ESR2, ODG8",Estrogen receptor-2 (ER beta),ESR2,2100,ENSG00000140009,mutation identified in 1 ODG8 patient,"?Ovarian dysgenesis 8, 618187 (3), Autosomal dominant",Esr2 (MGI:109392)
14,64388352,64460024,14q24,14q23.3,172460,"MTHFD1, MTHFC, CIMAH",Methylenetetrahydrofolate dehydrogenase 1,MTHFD1,4522,ENSG00000100714,trifunctional protein,"Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, 617780 (3), Autosomal recessive; {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive",Mthfd1 (MGI:1342005)
14,64449105,64505212,14q23-q24,14q23.3,194541,"ZBTB25, ZNF46, KUP",Zinc finger and BTB domain containing 25,ZBTB25,7597,ENSG00000089775,NA,NA,Zbtb25 (MGI:99197)
14,64465498,64474502,14q23.3,14q23.3,604688,"AKAP5, AKAP79",A-kinase anchor protein 5,AKAP5,9495,ENSG00000179841,NA,NA,Akap5 (MGI:2685104)
14,64504573,64533692,14q23.3,14q23.3,616578,ZBTB1,Zinc finger- and BTB domain-containing protein 1,ZBTB1,22890,ENSG00000126804,NA,NA,Zbtb1 (MGI:2442326)
14,64540467,64543236,14q24.1,14q23.3,140560,HSPA2,Heat-shock 70kD protein-2,HSPA2,3306,ENSG00000126803,NA,NA,Hspa2 (MGI:96243)
14,64704127,64750248,14q23.3,14q23.3,617940,"PLEKHG2, ARHGEF43, KIAA0599",Pleckstrin homology domain- and RhoGEF domain-containing protein G3,PLEKHG3,26030,ENSG00000126822,NA,NA,Plekhg3 (MGI:2388284)
14,64744105,64879906,14q23.3,14q23.3,182870,"SPTB, SPH2, EL3, HS2","Spectrin, beta, erythrocytic",SPTB,6710,ENSG00000070182,NA,"Anemia, neonatal hemolytic, fatal or near-fatal, 617948 (3); Elliptocytosis-3, 617948 (3); Spherocytosis, type 2, 616649 (3), Autosomal dominant",Sptb (MGI:98387)
14,64914360,64935367,14q23.3,14q23.3,608577,"CHURC1, CHCH, C14orf52",Churchill domain-containing 1,CHURC1,91612,ENSG00000258289,NA,NA,Churc1 (MGI:1923684)
14,64939151,64942904,14q24.1,14q23.3,138319,GPX2,"Glutathione peroxidase-2, gastrointestinal",GPX2,2877,ENSG00000176153,NA,NA,Gpx2 (MGI:106609)
14,64986894,65062649,14q23-q24,14q23.3,134636,FNTB,"Farnesyltransferase, CAAX box, beta",FNTB,2342,ENSG00000257365,related FNTBL1 on 9,NA,Fntb (MGI:1861305)
14,65006100,65102694,14q23,14q23.3,154950,MAX,MAX protein,MAX,4149,ENSG00000125952,interacts with MYC,"{Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant",Max (MGI:96921)
14,65410591,65744121,14q23,14q23.3,602589,"FUT8, CDGF1",Fucosyltransferase 8,FUT8,2530,ENSG00000033170,NA,"Congenital disorder of glycosylation with defective fucosylation 1, 618005 (3), Autosomal recessive",Fut8 (MGI:1858901)
14,66507406,67735830,14q24,14q23.3-q24.1,603930,"GPHN, GPH, KIAA1385, GEPH, MOCODC",Gephyrin,GPHN,10243,ENSG00000171723,NA,"Molybdenum cofactor deficiency C, 615501 (3), Autosomal recessive",Gphn (MGI:109602)
14,67241394,67336060,14q23.3,14q23.3,606958,"MPP5, PALS1","Membrane protein, palmitoylated 5",MPP5,64398,ENSG00000072415,NA,NA,Mpp5 (MGI:1927339)
14,67337871,67359803,14q24,14q23.3,609398,"ATP6V1D, ATP6M","ATPase, H+ transporting, V1 subunit D",ATP6V1D,51382,ENSG00000100554,NA,NA,Atp6v1d (MGI:1921084)
14,67360327,67386515,14q23.3,14q23.3,603907,EIF2S1,"Eukaryotic translation initiation factor 2, subunit 1",EIF2S1,1965,ENSG00000134001,NA,NA,Eif2s1 (MGI:95299)
14,67386983,67412164,14q23.3,14q23.3-q24.1,608007,PLEK2,Pleckstrin 2,PLEK2,26499,ENSG00000100558,NA,NA,Plek2 (MGI:1351466)
14,67589305,67600301,14q24.1,14q24.1,600154,PIGH,"Phosphatidylinositol glycan, class H",PIGH,5283,ENSG00000100564,NA,"Glycosylphosphatidylinositol biosynthesis defect 17, 618010 (3), Autosomal recessive",Pigh (MGI:99463)
14,67619919,67651707,14q24.1-q24.3,14q24.1,107830,ARG2,Arginase II,ARG2,384,ENSG00000081181,NA,NA,Arg2 (MGI:1330806)
14,67647084,67674631,14q24.1,14q24.1,603207,"VTI1B, VTI1, VTI1L","Vti1, S. cerevisiae, homolog of, B",VTI1B,10490,ENSG00000100568,NA,NA,Vti1b (MGI:1855688)
14,67676799,67695763,14q23.3,14q24.1,607849,"RDH11, PSDR1, RALR1, RDJCSS",Retinol dehydrogenase 11,RDH11,51109,ENSG00000072042,mutation identified in 1 RDJCSS family,"?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3), Autosomal recessive",Rdh11 (MGI:102581)
14,67701885,67734450,14q23.3,14q24.1,608830,"RDH12, LCA13",Retinol dehydrogenase 12,RDH12,145226,ENSG00000139988,near RDH11,"Leber congenital amaurosis 13, 612712 (3), Autosomal recessive, Autosomal dominant",Rdh12 (MGI:1925224)
14,67728891,67817292,14q24.1,14q24.1,612012,"ZFYVE26, KIAA0321, SPG15",Zinc finger FYVE domain-containing protein 26,ZFYVE26,23503,ENSG00000072121,NA,"Spastic paraplegia 15, autosomal recessive, 270700 (3), Autosomal recessive",Zfyve26 (MGI:1924767)
14,67819778,68683117,14q23.3-q24,14q24.1,602948,RAD51L1,"RAD51. S. cerevisiae, homolog of, like 1",RAD51B,5890,ENSG00000182185,fused with HMGA2 in uterine leiomyoma,NA,Rad51b (MGI:1099436)
14,68787654,68796242,14q22-q24,14q24.1,601064,"ZFP36L1, BRF1, ERF1","Zinc finger protein 36, C3H type-like 1 (butyrate response factor 1; EGF-response factor 1)",ZFP36L1,677,ENSG00000185650,NA,NA,Zfp36l1 (MGI:107946)
14,68874122,68979365,14q24.1,14q24.1,102575,"ACTN1, BDPLT15","Actinin, alpha-1",ACTN1,87,ENSG00000072110,NA,"Bleeding disorder, platelet-type, 15, 615193 (3), Autosomal dominant",Actn1 (MGI:2137706)
14,69050880,69153392,14q24.1-q24.2,14q24.1,603812,"DCAF5, WDR22, BCRP2, D14S1461E",DDB1- and CUL4-associated factor 5,DCAF5,8816,ENSG00000139990,NA,NA,Dcaf5 (MGI:2444785)
14,69191476,69244019,14q24.1,14q24.1,616940,"EXD2, EXDL2",Exonuclease 3'-to-5' domain-containing protein 2,EXD2,55218,ENSG00000081177,NA,NA,Exd2 (MGI:1922485)
14,69259545,69379903,14q24.1,14q24.1,615132,"GALNT16, GALNACT16, GALNTL1, KIAA1130",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16,GALNT16,57452,ENSG00000100626,NA,NA,Galnt16 (MGI:1917754)
14,69380127,69398298,14q24.1,14q24.1,601191,ERH,"Enhancer of rudimentary, Drosophila, homolog of",ERH,2079,ENSG00000100632,possible pseudogene on 7q34,NA,Erh (MGI:108089)
14,69611595,69715143,14q24.1,14q24.1,616761,"SUSD6, DRAGO, KIAA0247",SUSHI domain-containing protein 6,SUSD6,9766,ENSG00000100647,NA,NA,Susd6 (MGI:2444661)
14,69767111,69772004,14q24.2,14q24.1,600914,"SRSF5, SFRS5, SRp40","Splicing factor, serine/arginine-rich, 5",SRSF5,6430,ENSG00000100650,NA,NA,NA
14,69775415,69797240,14q24.1,14q24.1,182396,"SLC10A1, NTCP1","Solute carrier family 10 (sodium/bile acid cotransporter family), member 1",SLC10A1,6554,ENSG00000100652,NA,NA,Slc10a1 (MGI:97379)
14,69879387,70032365,14q24.1,14q24.2,608488,"SMOC1, OAS",SPARC-related modular calcium-binding 1,SMOC1,64093,ENSG00000198732,NA,"Microphthalmia with limb anomalies, 206920 (3), Autosomal recessive",Smoc1 (MGI:1929878)
14,70325080,70359682,14q24.1,14q24.2,618064,COX16,Cytochrome c oxidase assembly factor 16,COX16,51241,ENSG00000133983,NA,NA,Cox16 (MGI:1913522)
14,70366498,70417089,14q24.2,14q24.2,609411,"SYNJ2BP, OMP25, ARIP2",Synaptojanin 2-binding protein,SYNJ2BP,55333,ENSG00000213463,NA,NA,Synj2bp (MGI:1344347)
14,70452173,70459904,14q24.1,14q24.2,603713,ADAM21,A disintegrin and metalloproteinase domain 21,ADAM21,8747,ENSG00000139985,NA,NA,Adam21 (MGI:1861229)
14,70520816,70564741,14q24.1,14q24.2,603712,ADAM20,A disintegrin and metalloproteinase domain 20,ADAM20,8748,ENSG00000134007,NA,NA,"Adam20,Adam25,Adam39 (MGI:3045694,MGI:1345157,MGI:2152342)"
14,70641915,70675365,14q24.2,14q24.2,610488,"TTC9, KIAA0227",Tetratricopeptide repeat domain-containing protein 9,TTC9,23508,ENSG00000133985,NA,NA,Ttc9 (MGI:1916730)
14,70722525,70809512,14q24.3-q31,14q24.2,600136,"MAP3K9, MLK1",Mitogen-activated protein kinase kinase kinase 9,MAP3K9,4293,ENSG00000006432,NA,NA,Map3k9 (MGI:2449952)
14,70907442,71115381,14q24.2,14q24.2,617655,"PCNX1, KIAA0995","Pecanex, Drosophila, homolog of, 1",PCNX1,22990,ENSG00000100731,NA,NA,Pcnx (MGI:1891924)
14,71320417,71741208,14q24.2,14q24.2,617504,"SIPA1L1, E6TP1, KIAA0440",SIPA1-like protein 1,SIPA1L1,26037,ENSG00000197555,NA,NA,Sipa1l1 (MGI:2443679)
14,71867396,72632477,14q24.3,14q24.2,603894,RGS6,Regulator of G protein signaling 6,RGS6,9628,ENSG00000182732,NA,NA,Rgs6 (MGI:1354730)
14,72619295,72894115,14q24.3-q31.1,14q24.2,601672,"DPF3, CERD4","D4, zinc and double PHD fingers, family 3",DPF3,8110,ENSG00000205683,NA,NA,Dpf3 (MGI:1917377)
14,72926331,72962097,14q24.2,14q24.2,616372,"DCAF4, WDR21, WDR21A",DDB1- and CUL4-associated factor 4,DCAF4,26094,ENSG00000119599,NA,NA,Dcaf4 (MGI:1921078)
14,72969444,73027135,14q22-q24,14q24.2,605471,"ZFYVE1, ZNFN2A1, DFCP1, TAFF1",Zinc finger FYVE type-containing protein 1,ZFYVE1,53349,ENSG00000165861,NA,NA,Zfyve1 (MGI:3026685)
14,73058531,73123898,14q24.2,14q24.2,612427,"RBM25, RED120",RNA-binding motif protein 25,RBM25,58517,ENSG00000119707,NA,NA,NA
14,73136435,73223690,14q24.3,14q24.2,104311,"PSEN1, AD3, ACNINV3",Presenilin 1,PSEN1,5663,ENSG00000080815,mutation identified in 1 ACNINV3 family,"?Acne inversa, familial, 3, 613737 (3), Autosomal dominant; Alzheimer disease, type 3, 607822 (3), Autosomal dominant; Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3), Autosomal dominant; Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3), Autosomal dominant; Cardiomyopathy, dilated, 1U, 613694 (3), Autosomal dominant; Dementia, frontotemporal, 600274 (3), Autosomal dominant; Pick disease, 172700 (3), Autosomal dominant",Psen1 (MGI:1202717)
14,73235840,73274622,14q24.2,14q24.2,617785,"PAPLN, PPN","Papilin, proteoglycan-like sulfated glycoprotein",PAPLN,89932,ENSG00000100767,NA,NA,Papln (MGI:2386139)
14,73275209,73458579,14q24.3,14q24.2-q24.3,603728,"NUMB, S171","Numb, Drosophila, homolog of",NUMB,8650,ENSG00000133961,NA,NA,Numb (MGI:107423)
14,73300000,78800000,14q24.3,NA,613085,GLC3C,"Glaucoma 3, primary congenital, C",GLC3C,399565,NA,between D14S61 and D14S1000,"Glaucoma 3, primary congenital, C, 613085 (2)",NA
14,73300000,89300000,14q24.3-q31,NA,601208,IDDM11,Insulin-dependent diabetes mellitus-11,IDDM11,3410,NA,NA,"{Diabetes mellitus, insulin-dependent, 11}, 601208 (2)",NA
14,73300000,78800000,14q24.3,NA,614628,KTCN8,Keratoconus 8,NA,100885803,NA,between rs1074501 and rs755212,"Keratoconus 8, 614628 (2), Autosomal dominant",NA
14,73300000,78800000,14q24.3,NA,612083,MUSTQTL1,Muscle strength quantitative trait locus 1,NA,100192311,NA,NA,"Muscle strength quantitative trait locus 1, 612083 (2)",NA
14,73490932,73493393,14q24.3,14q24.3,611919,"RIOX1, C14orf169, NO66, MAPJD",Ribosomal oxygenase 1,RIOX1,79697,ENSG00000170468,NA,NA,Riox1 (MGI:1919202)
14,73493020,73543798,14q24.3,14q24.3,614313,ACOT1,Acyl-CoA thioesterase 1,ACOT1,641371,ENSG00000184227,NA,NA,Acot3 (MGI:2159619)
14,73567619,73575657,14q24.3,14q24.3,609972,"ACOT2, PTE2, MTE1",Acyl-CoA thioesterase 2,ACOT2,10965,ENSG00000119673,NA,NA,Acot2 (MGI:2159605)
14,73591705,73595765,14q24.3,14q24.3,614314,ACOT4,Acyl-CoA thioesterase 4,ACOT4,122970,ENSG00000177465,?pseudogene on 19q13.12,NA,Acot4 (MGI:2159621)
14,73610944,73619887,14q24.3,14q24.3,614267,ACOT6,Acyl-CoA thioesterase 6,ACOT6,641372,ENSG00000205669,NA,NA,NA
14,73644985,73703731,14q24.3,14q24.3,610062,"DNAL1, C14orf168, CILD16","Dynein, axonemal, light chain 1",DNAL1,83544,ENSG00000119661,NA,"Ciliary dyskinesia, primary, 16, 614017 (3), Autosomal recessive",Dnal1 (MGI:1921462)
14,73711782,73714383,14q24.3,14q24.3,604010,"PNMA1, MA1",Paraneoplastic MA antigen 1,PNMA1,9240,ENSG00000176903,NA,NA,Pnma1 (MGI:2180564)
14,73851830,73886826,14q24,14q24.3,608642,ZADH1,Zinc-binding alcohol dehydrogenase domain-containing protein 1,PTGR2,145482,ENSG00000140043,NA,NA,Ptgr2 (MGI:1916372)
14,73949933,73963669,14q24.3,14q24.3,614647,"COQ6, CGI10, COQ10D6","Coq6, S. cerevisiae, homolog of",COQ6,51004,ENSG00000119723,NA,"Coenzyme Q10 deficiency, primary, 6, 614650 (3), Autosomal recessive",Coq6 (MGI:1924408)
14,73957915,74019325,14q24,14q24.3,603162,"ENTPD5, CD39L4",Ectonucleoside triphosphate diphosphohydrolase 5,ENTPD5,957,ENSG00000187097,NA,NA,Entpd5 (MGI:1321385)
14,74056846,74084452,14q24.3,14q24.3,603178,"ALDH6A1, MMSDH","Aldehyde dehydrogenase 6 family, member A1 (methylmalonate semialdehyde dehydrogenase)",ALDH6A1,4329,ENSG00000119711,NA,"Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3), Autosomal recessive",Aldh6a1 (MGI:1915077)
14,74239448,74262737,14q24.3,14q24.3,142993,"CHX10, HOX10, MCOP2, MCOPCB3",C. elegans ceh-10 homeo domain-containing homolog,VSX2,338917,ENSG00000119614,NA,"Microphthalmia with coloboma 3, 610092 (3); Microphthalmia, isolated 2, 610093 (3)",Vsx2 (MGI:88401)
14,74285268,74303063,14q24.3,14q24.3,603214,"ABCD4, PXMP1L, P79R, PMP69, MAHCJ","ATP-binding cassette, subfamily D, member 4 (peroxisomal membrane protein 1-like)",ABCD4,5826,ENSG00000119688,NA,"Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3), Autosomal recessive",Abcd4 (MGI:1349217)
14,74405892,74477079,14q24.3,14q24.3,609999,"SYNDIG1L, TMEM90A, CAPUCIN",Synapse differentiation-induced gene 1-like,SYNDIG1L,646658,ENSG00000183379,NA,NA,Syndig1l (MGI:2685107)
14,74479934,74493511,14q24.3,14q24.3,601015,"NPC2, HE1",Epididymal secretory protein HE1,NPC2,10577,ENSG00000119655,NA,"Niemann-pick disease, type C2, 607625 (3), Autosomal recessive",Npc2 (MGI:1915213)
14,74493719,74497105,14q24.3,14q24.3,615317,"ISCA2, MMDS4","Iron-sulfur cluster assembly 2, S. cerevisiae, homolog of",ISCA2,122961,ENSG00000165898,NA,"Multiple mitochondrial dysfunctions syndrome 4, 616370 (3), Autosomal recessive",Isca2 (MGI:1921566)
14,74498182,74612592,14q24,14q24.3,602091,"LTBP2, LTBP3, GLC3D, MSPKA, WMS3",Latent transforming growth factor beta binding protein-2,LTBP2,4053,ENSG00000119681,mutation identified in 1 WMS3 family,"Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3), Autosomal recessive; ?Weill-Marchesani syndrome 3, recessive, 614819 (3), Autosomal recessive",Ltbp2 (MGI:99502)
14,74661255,74713117,14q24.3,14q24.3,615380,"AREL1, KIAA0317",Apoptosis-resistant E3 ubiquitin protein ligase 1,AREL1,9870,ENSG00000119682,NA,NA,Arel1 (MGI:1915747)
14,74853032,74876662,14q24.3,14q24.3,615094,PROX2,Prospero-related homeobox 2,PROX2,283571,ENSG00000119608,NA,NA,Prox2 (MGI:1920672)
14,74881890,74903746,14q24.3,14q24.3,126063,"DLST, PGL7",Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex),DLST,1743,ENSG00000119689,NA,"Paragangliomas 7, 618475 (3), Autosomal dominant",Dlst (MGI:1926170)
14,74941829,74955763,14q24-q31,14q24.3,601121,"PGF, PLGF","Placental growth factor, vascular endothelial growth factor-related protein",PGF,5228,ENSG00000119630,NA,NA,Pgf (MGI:105095)
14,75002920,75012365,14q24,14q24.3,606454,EIF2B2,"Eukaryotic translation initiation factor 2B, subunit 2",EIF2B2,8892,ENSG00000119718,NA,"Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive; Ovarioleukodystrophy, 603896 (3), Autosomal recessive",Eif2b2 (MGI:2145118)
14,75013763,75051531,14q24.3,14q24.3,604395,"MLH3, HNPCC7",Mismatch repair gene MLH3,MLH3,27030,ENSG00000119684,NA,"Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3); Colorectal cancer, somatic, 114500 (3); {Endometrial cancer, susceptibility to}, 608089 (3)",Mlh3 (MGI:1353455)
14,75053220,75069489,14q24.3,14q24.3,600875,"ACYP1, ACYPE","Acylphosphatase, erythrocyte",ACYP1,97,ENSG00000119640,NA,NA,Acyp1 (MGI:1913454)
14,75079352,75127636,14q24.3,14q24.3,609798,"NEK9, NERCC1, LCCS10, APUG, NC",Never in mitosis gene A-related kinase 9,NEK9,91754,ENSG00000119638,mutation identified in 1 APUG family,"?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3), Autosomal recessive; Lethal congenital contracture syndrome 10, 617022 (3), Autosomal recessive; Nevus comedonicus, somatic, 617025 (3)",Nek9 (MGI:2387995)
14,75131468,75176611,14q24.3,14q24.3,605406,"TMED10, TMP21",Transmembrane p24 trafficking protein 10,TMED10,10972,ENSG00000170348,NA,NA,"Tmed10,Tmed10-ps (MGI:3782198,MGI:1915831)"
14,75278827,75282229,14q24.3,14q24.3,164810,FOS,FBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS),FOS,2353,ENSG00000170345,NA,NA,Fos (MGI:95574)
14,75426691,75474106,14q24.3,14q24.3,608657,JDP2,JUN dimerization protein 2,JDP2,122953,ENSG00000140044,NA,NA,Jdp2 (MGI:1932093)
14,75522468,75547003,14q24,14q24.3,612476,"BATF, BATF1, SFA2","Basic leucine zipper transcription factor, ATF-like",BATF,10538,ENSG00000156127,NA,NA,Batf (MGI:1859147)
14,75578619,75648166,14q24.3,14q24.3,610865,"FLVCR2, C14orf58, CCT, PVHH, EPV",Feline leukemia virus subgroup C receptor 2,FLVCR2,55640,ENSG00000119686,NA,"Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3), Autosomal recessive",Flvcr2 (MGI:2384974)
14,75649790,75660875,14q24,14q24.3,604576,"ERG28, C14orf1",Ergosterol biosynthesis 28 homolog,ERG28,11161,ENSG00000133935,NA,NA,Erg28 (MGI:1915571)
14,75661245,75955078,14q24.3,14q24.3,612268,"TTLL5, STAMP, KIAA0998, CORD19","Tubulin tyrosine ligase-like family, member 5",TTLL5,23093,ENSG00000119685,NA,"Cone-rod dystrophy 19, 615860 (3), Autosomal recessive",Ttll5 (MGI:2443657)
14,75958060,75983010,14q24,14q24.3,190230,"TGFB3, ARVD1, RNHF, LDS5","Transforming growth factor, beta-3",TGFB3,7043,ENSG00000119699,NA,"Arrhythmogenic right ventricular dysplasia 1, 107970 (3), Autosomal dominant; Loeys-Dietz syndrome 5, 615582 (3), Autosomal dominant",Tgfb3 (MGI:98727)
14,75985752,76084072,14q24.3,14q24.3,614068,"IFT43, C14orf179, CED3, SRTD18, RP81","Intraflagellar transport 43, Chlamydomonas, homolog of",IFT43,112752,ENSG00000119650,mutation identified in 1 CED3 family and 1 RP81 family,"?Cranioectodermal dysplasia 3, 614099 (3), Autosomal recessive; ?Retinitis pigmentosa 81, 617871 (3), Autosomal recessive; Short-rib thoracic dysplasia 18 with polydactyly, 617866 (3), Autosomal recessive",Ift43 (MGI:1923661)
14,76371346,76501838,14q24.3,14q24.3,602167,"ESRRB, ESRL2, DFNB35",Estrogen-related receptor beta,ESRRB,2103,ENSG00000119715,NA,"Deafness, autosomal recessive 35, 608565 (3), Autosomal recessive",Esrrb (MGI:1346832)
14,77024542,77028707,14q24.3,14q24.3,611720,"IRF2BPL, C14orf4, EAP1, NEDAMSS",Interferon regulatory factor 2-binding protein like,IRF2BPL,64207,ENSG00000119669,NA,"Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3), Autosomal dominant",Irf2bpl (MGI:2442463)
14,77098257,77117286,14q24.3,14q24.3,616995,"CIPC, KIAA1737",Clock-interacting pacemaker,CIPC,85457,ENSG00000198894,NA,NA,Cipc (MGI:1919185)
14,77265490,77271311,14q24,14q24.3,605304,NGB,Neuroglobin,NGB,58157,ENSG00000165553,NA,NA,Ngb (MGI:2151886)
14,77274955,77320884,14q24.3,14q24.3,607439,"POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14",Putative protein O-mannosyltransferase 2,POMT2,29954,ENSG00000009830,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3), Autosomal recessive",Pomt2 (MGI:2444430)
14,77321001,77331596,14q24.3,14q24.3,603758,"GSTZ1, MAAI, MAAID","Glutathione S-transferase, zeta-1 (maleylacetoacetate isomerase)",GSTZ1,2954,ENSG00000100577,NA,"[Maleylacetoacetate isomerase deficiency], 617596 (3), Autosomal recessive",Gstz1 (MGI:1341859)
14,77426674,77457726,14q24.3,14q24.3,613401,"VIPAS39, VIPAR, SPE39, C14orf133","VPS33B-interacting protein, apical-basolateral polarity regulator, spe-39 homolog",VIPAS39,63894,ENSG00000151445,NA,"Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3), Autosomal recessive",Vipas39 (MGI:2144805)
14,77457866,77469471,14q24.3,14q24.3,608466,"AHSA1, AHA1",Activator of heat-shock 90kD protein ATPase 1,AHSA1,10598,ENSG00000100591,NA,NA,Ahsa1 (MGI:2387603)
14,77474393,77498815,14q24.3,14q24.3,612684,"ISM2, THSD3, TAIL1","Isthmin 2, zebrafish, homolog of",ISM2,145501,ENSG00000100593,NA,NA,NA
14,77505996,77616766,14q24.3-q31,14q24.3,605713,"SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C","Serine palmitoyltransferase, long-chain base subunit 2",SPTLC2,9517,ENSG00000100596,NA,"Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3), Autosomal dominant",Sptlc2 (MGI:108074)
14,77672403,77708037,14q24,14q24.3,605345,"ALKBH1, ALKB","AlkB, E. coli, homolog of, 1",ALKBH1,8846,ENSG00000100601,NA,NA,Alkbh1 (MGI:2384034)
14,77708070,77717597,14q24.3,14q24.3,610211,"SLIRP, C14orf156",SRA stem loop-interacting RNA-binding protein,SLIRP,81892,ENSG00000119705,NA,NA,Slirp (MGI:1916394)
14,77717598,77761155,14q24.3,14q24.3,603055,"SKIIP, SKIP, SNW1, BX42",SKI-interacting protein,SNW1,22938,ENSG00000100603,NA,NA,Snw1 (MGI:1913604)
14,77979903,79868290,14q24.3-q31.1,14q24.3-q31.1,600567,NRXN3,Neurexin 3,NRXN3,9369,ENSG00000021645,NA,NA,NA
14,78800000,89300000,14q31,NA,275000,GRD1,"Graves disease, susceptibility to, 1",NA,100312954,NA,associated with rs2268458,"{Graves disease, susceptibility to, 1}, 275000 (2), Autosomal recessive",NA
14,78800000,89300000,14q31,NA,614187,HPPD,"Hypertelorism, preauricular sinus, punctal pits, and deafness",NA,100682260,NA,NA,"Hypertelorism, preauricular sinus, punctal pits, and deafness, 614187 (2), Autosomal dominant",NA
14,80197525,80231056,14q24.3,14q31.1,601413,"DIO2, TXDI2, D2","Deiodinase, iodothyronine, type II",DIO2,1734,ENSG00000211448,NA,NA,Dio2 (MGI:1338833)
14,80954988,81146301,14q31,14q31.1,603372,"TSHR, CHNG1",Thyroid-stimulating hormone receptor,TSHR,7253,ENSG00000165409,NA,"Hyperthyroidism, familial gestational, 603373 (3); Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant; Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive; Thyroid adenoma, hyperfunctioning, somatic (3); Thyroid carcinoma with thyrotoxicosis (3)",Tshr (MGI:98849)
14,81175451,81221389,14q31.1,14q31.1,600520,"GTF2A1, TF2A1","General transcription factor IIA, alpha/beta subunits",GTF2A1,2957,ENSG00000165417,NA,NA,Gtf2a1 (MGI:1933277)
14,81260649,81436464,14q13.1,14q31.1,608467,"STON2, STN2, STNB",Stonin 2,STON2,85439,ENSG00000140022,NA,NA,Ston2 (MGI:1918272)
14,81471546,81533860,14q31,14q31.1,602329,SEL1L,"Suppressor of lin 12 (sel-1), C. elegans, homolog of",SEL1L,6400,ENSG00000071537,NA,NA,Sel1l (MGI:1329016)
14,85527371,85654427,14q24-q32,14q31.3,604807,FLRT2,Fibronectin-like domain-containing leucine-rich transmembrane protein-2,FLRT2,23768,ENSG00000185070,NA,NA,Flrt2 (MGI:3603594)
14,87933013,87993664,14q31,14q31.3,606890,GALC,Galactosylceramidase,GALC,2581,ENSG00000054983,NA,"Krabbe disease, 245200 (3), Autosomal recessive",Galc (MGI:95636)
14,88005134,88014810,14q31-q32.1,14q31.3,604620,"GPR65, TDAG8",G protein-coupled receptor 65,GPR65,8477,ENSG00000140030,NA,NA,Gpr65 (MGI:108031)
14,88180107,88326911,14q31,14q31.3,605873,"KCNK10, TREK2","Potassium channel, subfamily K, member 10",KCNK10,54207,ENSG00000100433,NA,NA,Kcnk10 (MGI:1919508)
14,88385637,88470349,14q31.3,14q31.3,609868,"SPATA7, HSD3, LCA3",Spermatogenesis-associated protein 7,SPATA7,55812,ENSG00000042317,NA,"Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3)",Spata7 (MGI:2144877)
14,88465777,88555006,14q31.3,14q31.3,603271,"PTPN21, PTPD1","Protein-tyrosine phosphatase, nonreceptor-type, 21",PTPN21,11099,ENSG00000070778,NA,NA,Ptpn21 (MGI:1344406)
14,88562908,88627595,14q31.3,14q31.3,613279,"ZC3H14, SUT2, MRT56",Zinc finger CCCH domain-containing protein 14,ZC3H14,79882,ENSG00000100722,NA,"Mental retardation, autosomal recessive 56, 617125 (3), Autosomal recessive",Zc3h14 (MGI:1919824)
14,88612147,88792952,14q31.3,14q31.3,618119,EML5,Echinoderm microtubule-associated protein-like 5,EML5,161436,ENSG00000165521,NA,NA,Eml5 (MGI:2442513)
14,88824152,88881078,14q32.1,14q31.3,608132,"TTC8, BBS8, RP51",Tetratricopeptide repeat domain 8,TTC8,123016,ENSG00000165533,mutation identified in 1 RP51 family,"Bardet-Biedl syndrome 8, 615985 (3), Autosomal recessive; ?Retinitis pigmentosa 51, 613464 (3), Autosomal recessive",Ttc8 (MGI:1923510)
14,89156176,89619164,14q24.3-q31,14q31.3-q32.1,602628,"FOXN3, CHES1",Forkhead box N3,FOXN3,1112,ENSG00000053254,NA,NA,NA
14,89300000,107043718,14q32,NA,608318,CHDS4,"Coronary heart disease, susceptibility to, 4",NA,387585,NA,highest LOD with D14S1426,"{Coronary heart disease, susceptibility to, 4}, 608318 (2)",NA
14,89300000,107043718,14q32,NA,123270,CKBE,"Creatine kinase, ectopic expression",CKBE,1156,NA,"linked to IGH, PI; ?same locus as CKBB","[Creatine kinase, brain type, ectopic expression of], 123270 (2)",NA
14,89300000,107043718,14q32,NA,616604,"DUP14q32, C14DUPq32","Chromosome 14q32 duplication syndrome, 700kB",NA,NA,NA,heterozygous germline duplication of 700kb,"{Myeloproliferative neoplasms, familial, susceptibility to}, 616604 (4), Autosomal dominant",NA
14,89300000,107043718,14q32,NA,608875,GEVQ1,"Gene expression, variation in, quantitative trait locus on chromosome 14",NA,474334,NA,NA,"{Gene expression, variation in, QTL}, 608875 (2)",NA
14,89300000,107043718,14q32,NA,164210,HFM,Hemifacial microsomia,NA,170474,NA,NA,"Hemifacial microsomia, 164210 (2), Autosomal dominant",NA
14,89300000,107043718,14q32,NA,608149,KAOGS,Kagami-Ogata syndrome,NA,NA,NA,uniparental isodisomy of imprinted region of chromosome 14,"Kagami-Ogata syndrome, 608149 (4), Autosomal dominant",NA
14,89300000,107043718,14q32,NA,251600,MCOP1,"Microphthalmia, isolated 1",NA,8113,NA,NA,"Microphthalmia, isolated 1, 251600 (2), Autosomal recessive",NA
14,89300000,95800000,14q32.1,NA,107410,"SERPINA2P, PIL, ATR, ARGS","Serpin peptidase inhibitor, clade A, member 2, pseudogene",SERPINA2,390502,ENSG00000258597,?pseudogene,NA,NA
14,89300000,107043718,14q32,NA,616222,TEMPS,Temple syndrome (maternal uniparental disomy chromosome 14),NA,NA,NA,NA,"Temple syndrome, 616222 (4), Autosomal dominant",NA
14,89954922,90044767,14q31-q32,14q32.11,607198,"TDP1, SCAN1",Tyrosyl-DNA phosphodiesterase 1,TDP1,55775,ENSG00000042088,mutation identified in 1 SCAN1 family,"?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1, 607250 (3), Autosomal recessive",Tdp1 (MGI:1920036)
14,90061993,90185852,14q24.1-q24.3,14q32.11,607367,"KCNK13, THIK1","Potassium channel, subfamily K, member 13",KCNK13,56659,ENSG00000152315,NA,NA,Kcnk13 (MGI:2384976)
14,90256552,90275428,14q32.11,14q32.11,602706,"PSMC1, S4","Proteasome 26S subunit, ATPase, 1",PSMC1,5700,ENSG00000100764,previously assigned to 19p13.3 by FISH,NA,Psmc1 (MGI:106054)
14,90396501,90408274,14q24-q31,14q32.11,114180,"CALM1, PHKD, CPVT4, LQT14","Calmodulin-1 (phosphorylase kinase, delta)",CALM1,801,ENSG00000198668,NA,"Long QT syndrome 14, 616247 (3), Autosomal dominant; Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3), Autosomal dominant",NA
14,90847860,91060648,14q31-q32,14q32.11,603607,"RPS6KA5, MSK1","Ribosomal protein S6 kinase, 90kD, 5",RPS6KA5,9252,ENSG00000100784,NA,NA,Rps6ka5 (MGI:1920336)
14,91232531,91264580,14q31,14q32.11,601404,"GPR68, OGR1, AI2A6",G protein-coupled receptor 68,GPR68,8111,ENSG00000119714,NA,"Amelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3), Autosomal recessive",Gpr68 (MGI:2441763)
14,91271322,91417819,14q32.11,14q32.11-q32.12,611204,"CCDC88C, HKRP2, DAPLE, KIAA1509, HYC1, SCA40",Coiled-coil domain-containing protein 88C,CCDC88C,440193,ENSG00000015133,mutation identified in 1 SCA40 family,"Hydrocephalus, congenital, 1, 236600 (3), Autosomal recessive; ?Spinocerebellar ataxia 40, 616053 (3), Autosomal dominant",Ccdc88c (MGI:1915589)
14,91457136,91510553,14q32.12,14q32.12,610351,"PPP4R3A, SMEK1, PP4R3A, KIAA2010","Protein phosphatase 4, regulatory subunit 3, alpha",PPP4R3A,55671,ENSG00000100796,NA,NA,Ppp4r3a (MGI:1915984)
14,91580697,91732085,14q32.12,14q32.12,611169,"CATSPERB, C14orf161","Cation channel, sperm-associated, beta",CATSPERB,79820,ENSG00000133962,NA,NA,Catsperb (MGI:2443988)
14,91869410,91947701,14q32.1,14q32.12,604580,"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",Fibulin 5,FBLN5,10516,ENSG00000140092,NA,"Cutis laxa, autosomal dominant 2, 614434 (3); Cutis laxa, autosomal recessive, type IA, 219100 (3), Autosomal recessive; Macular degeneration, age-related, 3, 608895 (3), Autosomal dominant; Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3), Autosomal dominant",Fbln5 (MGI:1346091)
14,91965990,92040133,14q31-q32,14q32.12,604505,"TRIP11, TRIP230, CEV14, ACG1A, ODCD",Thyroid hormone receptor interactor 11,TRIP11,9321,ENSG00000100815,NA,"Achondrogenesis, type IA, 200600 (3), Autosomal recessive; Osteochondrodysplasia, 184260 (3), Autosomal recessive",Trip11 (MGI:1924393)
14,92058551,92106620,14q32.12,14q32.12,607047,"ATXN3, MJD, SCA3",Ataxin-3 (josephin),ATXN3,4287,ENSG00000066427,NA,"Machado-Joseph disease, 109150 (3), Autosomal dominant",Atxn3 (MGI:1099442)
14,92116122,92122612,14q32.12,14q32.12,603837,NDUFB1,NADH-ubiquinone oxidoreductase subunit B1,NDUFB1,4707,ENSG00000183648,NA,NA,Ndufb1-ps (MGI:3780865)
14,92322580,92501480,14q32,14q32.12,609840,"SLC24A4, NCKX4, SHEP6, AI2A5","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4",SLC24A4,123041,ENSG00000140090,NA,"Amelogenesis imperfecta, type IIA5, 615887 (3), Autosomal recessive; [Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3), Autosomal recessive; [Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3), Autosomal recessive",Slc24a4 (MGI:2447362)
14,92513772,92688993,17q32.12,14q32.12,610223,"RIN3, FLJ22349",Ras and Rab interactor 3,RIN3,79890,ENSG00000100599,NA,NA,Rin3 (MGI:2385708)
14,92703808,92748626,14q32.1,14q32.12,602620,"LGMN, PRSC1","Legumain (protease, cysteine, 1)",LGMN,5641,ENSG00000100600,NA,NA,Lgmn (MGI:1330838)
14,92794304,92839946,14q,14q32.12,606918,"GOLGA5, RFG5","Golgi autoantigen, golgin subfamily A, 5",GOLGA5,9950,ENSG00000066455,fused with RET to form PTC5,NA,Golga5 (MGI:1351475)
14,92922593,92935292,14q32,14q32.12,118910,CHGA,"Chromogranin A, parathyroid secretory protein-1",CHGA,1113,ENSG00000100604,NA,NA,Chga (MGI:88394)
14,92936913,93115924,14q32.12,14q32.12,601838,"ITPK1, ITRPK1","Inositol 1,3,4-trisphosphate 5/6-kinase",ITPK1,3705,ENSG00000100605,NA,NA,Itpk1 (MGI:2446159)
14,93182198,93184896,14q32.12,14q32.12,609485,"MOAP1, MAP1, PNMA4",Modulator of apoptosis 1,MOAP1,64112,ENSG00000165943,NA,NA,Moap1 (MGI:1915555)
14,93202893,93207064,14q32.12,14q32.12,617436,"GON7, C14orf142","Gon7, S. cerevisiae, homolog of",GON7,84520,ENSG00000170270,NA,NA,Gon7 (MGI:4845848)
14,93207055,93229214,14q32.12,14q32.12,613816,UBR7,Ubiquitin protein ligase E3 component N-recognin 7,UBR7,55148,ENSG00000012963,NA,NA,Ubr7 (MGI:1913872)
14,93237549,93333035,14q32.1,14q32.12,610386,"BTBD7, FUP1",BTB/POX domain-containing protein 7,BTBD7,55727,ENSG00000011114,NA,NA,Btbd7 (MGI:1917858)
14,93333181,93710472,14q32.12,14q32.12,616884,UNC79,"Unc79, C. elegans, homolog of",UNC79,57578,ENSG00000133958,NA,NA,Unc79 (MGI:2684729)
14,93347181,93348355,14q32.12,14q32.12,616855,COX8C,"Cytochrome c oxidase, subunit 8c",COX8C,341947,ENSG00000187581,NA,NA,NA
14,93718297,93789028,14q32.12,14q32.12,613851,"PRIMA1, PRIMA",Proline-rich membrane anchor 1,PRIMA1,145270,ENSG00000175785,NA,NA,Prima1 (MGI:1926097)
14,93934159,93976738,14q32.12,14q32.12,605759,ASB2,Ankyrin repeat-containing SOCS box protein 2,ASB2,51676,ENSG00000100628,NA,NA,Asb2 (MGI:1929743)
14,94026339,94048929,14q32.12,14q32.12,608338,"OTUB2, OTU2, OTB2, C14orf137",OTU domain-containing ubiquitin aldehyde-binding protein 2,OTUB2,78990,ENSG00000089723,NA,NA,Otub2 (MGI:1915399)
14,94048286,94081201,14q32,14q32.12,606181,DDX24,DEAD/H box 24,DDX24,57062,ENSG00000089737,NA,NA,Ddx24 (MGI:1351337)
14,94110735,94116689,14q32,14q32.12,600009,IFI27,"Interferon, alpha-inducible protein-27",IFI27,3429,ENSG00000165949,NA,NA,NA
14,94127780,94129603,14q32.12,14q32.12,611319,"IFI27L2, FAM14A, ISG12B",Interferon alpha inducible protein 27 like 2,IFI27L2,83982,ENSG00000119632,NA,NA,NA
14,94174311,94279734,14q32.13,14q32.12-q32.13,616790,"PPP4R4, PP4R4, KIAA1622","Protein phosphatase 4, regulatory subunit 4",PPP4R4,57718,ENSG00000119698,NA,NA,Ppp4r4 (MGI:1921771)
14,94280459,94293352,14q32.1,14q32.13,605271,"SERPINA10, ZPI","Serine (or cysteine) proteinase inhibitor, clade A, member 10 (protein Z-dependent protease inhibitor precursor)",SERPINA10,51156,ENSG00000140093,NA,NA,Serpina10 (MGI:2667725)
14,94304247,94323335,14q32.1,14q32.13,122500,"CBG, SERPINA6",Corticosteroid-binding globulin,SERPINA6,866,ENSG00000170099,NA,"Corticosteroid-binding globulin deficiency, 611489 (3), Autosomal recessive, Autosomal dominant",Serpina6 (MGI:88278)
14,94376746,94390691,14q32.1,14q32.13,107400,"SERPINA1, PI, AAT","Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)",SERPINA1,5265,ENSG00000197249,NA,"Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive; Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1)","Serpina1e,Serpina1c,Serpina1d,Serpina1a,Serpina1b (MGI:891971,MGI:891970,MGI:891968,MGI:891969,MGI:891967)"
14,94462720,94476332,14q32,14q32.13,615677,"SERPINA9, GCET1, CENTERIN","Serpin peptidase inhibitor, clade A, member 9",SERPINA9,327657,ENSG00000170054,NA,NA,Serpina9 (MGI:1919157)
14,94481650,94517843,14q32.1,14q32.13,617471,"SERPINA12, VASPIN","Serpin peptidase inhibitor, clade A, member 12 (vaspin)",SERPINA12,145264,ENSG00000165953,NA,NA,Serpina12 (MGI:1915304)
14,94561441,94569905,14q31-q32.1,14q32.13,147935,"SERPINA4, KST, PI4","Serpin peptidase inhibitor, clade A, member 4",SERPINA4,5267,ENSG00000100665,"in cluster with related AAT, AACT, CBG, PCI",NA,NA
14,94581425,94593117,14q32.1,14q32.13,601841,"SERPNA5, PCI","Serpin peptidase inhibitor, clade A, member 5 (protein C inhibitor)",SERPINA5,5104,ENSG00000188488,NA,NA,Serpina5 (MGI:107817)
14,94612376,94624052,14q32.1,14q32.13,107280,"SERPINA3, AACT, ACT",Alpha-1-antichymotrypsin,SERPINA3,12,ENSG00000196136,220kb from PI,"Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular disease, occlusive (3)","Serpina3m,Serpina3n,Serpina3k,Serpina3c (MGI:98378,MGI:105045,MGI:102848,MGI:98377)"
14,94768222,94770161,14q32.1,14q32.13,138890,"GSC, SAMS",Goosecoid,GSC,145258,ENSG00000133937,NA,"Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3), Autosomal recessive",Gsc (MGI:95841)
14,95086227,95158262,14q31,14q32.13,606241,"DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW","Dicer, Drosophila, homolog of, 1",DICER1,23405,ENSG00000100697,NA,"GLOW syndrome, somatic mosaic, 618272 (3); Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant; Pleuropulmonary blastoma, 601200 (3), Autosomal dominant; Rhabdomyosarcoma, embryonal, 2, 180295 (3)",Dicer1 (MGI:2177178)
14,95181939,95319907,14q32.13,14q32.13,611121,"CLMN, KIAA1188",Calmin,CLMN,79789,ENSG00000165959,NA,NA,Clmn (MGI:2136957)
14,95407265,95516692,14q32.13,14q32.13,610861,"SYNE3, C14orf49",Spectrin repeat-containing nuclear envelope protein 3 (nesprin 3),SYNE3,161176,ENSG00000176438,NA,NA,Syne3 (MGI:2442408)
14,95535049,95544713,14q32,14q32.13,609588,"GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC",Glutaredoxin 5,GLRX5,51218,ENSG00000182512,NA,"Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3), Autosomal recessive; Spasticity, childhood-onset, with hyperglycinemia, 616859 (3), Autosomal recessive",Glrx5 (MGI:1920296)
14,95652096,95673451,14q32.1,14q32.13,604412,"TCL6, TNG1, TNG2",T-cell leukemia/lymphoma 6,TCL6,27004,NA,NA,NA,NA
14,95686425,95692627,14q32.1,14q32.13,603769,"TCL1B, TML1",T-cell lymphoma/leukemia 1B,TCL1B,9623,ENSG00000213231,NA,"Leukemia/lymphoma, T-cell, 603769 (2)",NA
14,95694159,95714195,14q32.1,14q32.13,186960,"TCL1A, TCL1",T-cell lymphoma/leukemia 1A,TCL1A,8115,ENSG00000100721,NA,"Leukemia/lymphoma, T-cell, 186960 (2)",Tcl1 (MGI:1097166)
14,95876391,95925570,14q32,14q32.2,615719,"TUNAR, TUNA, LINC00617",TCL1 upstream neural differentiation-associated RNA,TUNAR,100507043,ENSG00000250366,NA,NA,NA
14,96204797,96244328,14q32.1-q32.2,14q32.2,113503,BDKRB2,Bradykinin receptor B2,BDKRB2,624,ENSG00000168398,NA,NA,Bdkrb2 (MGI:102845)
14,96256209,96264762,14q32.1-q32.2,14q32.2,600337,BDKRB1,Bradykinin receptor B1,BDKRB1,623,ENSG00000100739,NA,NA,Bdkrb1 (MGI:88144)
14,96279194,96363340,14q32.2,14q32.2,616226,ATG2B,"Autophagy 2, S. cerevisiae, homolog of, B",ATG2B,55102,ENSG00000066739,NA,NA,Atg2b (MGI:1923809)
14,96363451,96387289,14q32.2,14q32.2,616605,"GSKIP, C14orf129",GSK3B-interacting protein,GSKIP,51527,ENSG00000100744,NA,NA,Gskip (MGI:1914037)
14,96392110,96489426,14q32.2,14q32.2,615364,"AK7, SPGF27",Adenylate kinase 7,AK7,122481,ENSG00000140057,mutation identified in 1 SPGF27 family,"?Spermatogenic failure 27, 617965 (3), Autosomal recessive",Ak7 (MGI:1926051)
14,96502375,96567115,14q32.1-q32.2,14q32.2,605553,"PAPOLA, PAP",Poly(A) polymerase,PAPOLA,10914,ENSG00000090060,NA,NA,Papola (MGI:109301)
14,96797381,96881613,14q32,14q32.2,602168,"VRK1, PCH1A",Vaccinia-related kinase-1,VRK1,7443,ENSG00000100749,NA,"Pontocerebellar hypoplasia type 1A, 607596 (3), Autosomal recessive",Vrk1 (MGI:1261847)
14,99169286,99272196,14q32.1,14q32.2,606558,"BCL11B, CTIP2, IMD49, IDDFSTA",C-cell CLL/lymphoma 11B,BCL11B,64919,ENSG00000127152,NA,"Immunodeficiency 49, 617237 (3), Autosomal dominant; Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities, 618092 (3), Autosomal dominant",Bcl11b (MGI:1929913)
14,99397745,99486457,14q32.2,14q32.2,615671,SETD3,SET domain-containing protein 3,SETD3,84193,ENSG00000183576,NA,NA,Setd3 (MGI:1289184)
14,99481408,99512439,14q32,14q32.2,603544,"CCNK, IDDHDF",Cyclin K,CCNK,8812,ENSG00000090061,mutation identified in 1 IDDHDF patient,"?Intellectual developmental disorder with hypertelorism and distinctive facies, 618147 (3), Autosomal dominant",Ccnk (MGI:1276106)
14,99684261,99727320,14q32.1,14q32.2,604087,"CYP46A1, CYP46","Cytochrome P450, family 46, subfamily A, polypeptide 1 (cholesterol 24-hydroxylase)",CYP46A1,10858,ENSG00000036530,NA,NA,Cyp46a1 (MGI:1341877)
14,99737698,99942059,14q32,14q32.2,602033,"EML1, EMAPL, EMAP, BH",Echinoderm microtubule associated protein like 1,EML1,2009,ENSG00000066629,NA,"Band heterotopia, 600348 (3), Autosomal recessive",Eml1 (MGI:1915769)
14,99971421,100144235,14q32.2,14q32.2,616912,EVL,ENAH/VASP-like protein,EVL,51466,ENSG00000196405,NA,NA,Evl (MGI:1194884)
14,100143956,100166885,14q32.2,14q32.2,610862,"DEGS2, DES2","Delta(4)-desaturase, sphingolipid, 2",DEGS2,123099,ENSG00000168350,NA,NA,Degs2 (MGI:1917309)
14,100239143,100282787,14q,14q32.2,600013,"YY1, GADEVS",YY1 transcription factor,YY1,7528,ENSG00000100811,NA,"Gabriele-de Vries syndrome, 617557 (3), Autosomal dominant",Yy1 (MGI:99150)
14,100277985,100306535,14q32,14q32.2,615064,"SLC25A29, CACL, ORNT3","Solute carrier family 25 (carnitine/acylcarnitine translocase), member 29",SLC25A29,123096,ENSG00000197119,NA,NA,Slc25a29 (MGI:2444911)
14,100323338,100330420,14q32.31,14q32.2,609911,"HDMCP, C14orf68",Hepatocellular carcinoma-downregulated mitochondrial carrier protein,SLC25A47,283600,ENSG00000140107,NA,NA,Slc25a47 (MGI:2144766)
14,100333788,100376326,14q32.31,14q32.2,191050,"WARS, HMN9",Tryptophanyl-tRNA synthetase,WARS1,7453,ENSG00000140105,NA,"Neuronopathy, distal hereditary motor, type IX, 617721 (3)",Wars (MGI:104630)
14,100376415,100530302,14q32,14q32.2,618059,WDR25,WD repeat-containing protein 25,WDR25,79446,ENSG00000176473,NA,NA,Wdr25 (MGI:3045255)
14,100726864,100738223,14q32,14q32.2,176290,"DLK1, PREF1, FA1","Delta, Drosophila, homolog-like 1",DLK1,8788,ENSG00000185559,NA,NA,Dlk1 (MGI:94900)
14,100826107,100861025,14q32.3,14q32.2,605636,"MEG3, GTL2",Maternally expressed gene 3,MEG3,55384,ENSG00000214548,100kb from DLK1,NA,NA
14,100880654,100884846,14q32.2,14q32.2,611896,"RTL1, PEG11",Retrotransposon-like gene 1,RTL1,388015,ENSG00000254656,NA,NA,Rtl1 (MGI:2656842)
14,100881006,100881119,14q32.31,14q32.2,611708,"MIR431, MIRN431",Micro RNA 431,MIR431,574038,ENSG00000208001,NA,NA,NA
14,100881885,100881977,14q32.31,14q32.2,611711,"MIR433, MIRN433",Micro RNA 433,MIR433,574034,ENSG00000207569,NA,NA,NA
14,100882978,100883074,14q32.31,14q32.2,611709,"MIR127, MIRN127",Micro RNA 127,MIR127,406914,ENSG00000207608,NA,NA,NA
14,100884701,100884782,14q32.31,14q32.2,611710,"MIR136, MIRN136",Micro RNA 136,MIR136,406927,ENSG00000207942,NA,NA,NA
14,100889648,100999112,14q32,14q32.2-q32.3,613648,MEG8,Maternally expressed gene 8,MEG8,79104,NA,NA,NA,NA
14,100897919,100897995,14q32,14q32.2,613649,SNORD112,"Small nucleolar, C/D box, 112",SNORD112,692215,ENSG00000275662,located in an intron of MEG8,NA,NA
14,100911138,100911212,14q32.31,14q32.31,612553,"MIR370, MIRN370",Micro RNA 370,MIR370,442915,ENSG00000199005,NA,NA,NA
14,100924820,100924889,14q32,14q32.31,613650,SNORD113-1,"Small nucleolar RNA, C/D box, 113-1",SNORD113-1,767561,ENSG00000202191,NA,NA,NA
14,100949832,100949902,14q32,14q32.31,613651,SNORD114-1,"Small nucleolar RNA, C/D box, 114-1",SNORD114-1,767577,ENSG00000199575,NA,NA,NA
14,101022065,101022131,14q32.31,14q32.31,616358,MIR379,Micro RNA 379,MIR379,494328,ENSG00000199088,NA,NA,NA
14,101025016,101025076,14q32,14q32.31,613654,"MIR380, MIRN380",Micro RNA 380,MIR380,494329,ENSG00000198982,NA,NA,NA
14,101029633,101029713,14q32.31,14q32.31,616036,MIR494,Micro RNA 494,MIR494,574452,ENSG00000194717,NA,NA,NA
14,101033754,101033835,14q32.31,14q32.31,615149,MIR551A,Micro RNA 495,MIR495,574453,ENSG00000207743,NA,NA,NA
14,101039689,101039754,14q32.31,14q32.31,610983,"MIR376C, MIR368",Micro RNA 368C,MIR376C,442913,ENSG00000283279,NA,NA,NA
14,101040068,101040147,14q32.31,14q32.31,610960,"MIR376A-2, MIRN376A-2",Micro RNA 376A-2,MIR376A2,664615,ENSG00000283561,NA,NA,NA
14,101040435,101040534,14q32.31,14q32.31,610961,"MIR376B, MIRN376B",Micro RNA 376b,MIR376B,574435,ENSG00000283556,NA,NA,NA
14,101040781,101040848,14q32.31,14q32.31,610959,"MIR376A-1, MIRN376A-1",Micro RNA 376A-1,MIR376A1,494325,ENSG00000283588,NA,NA,NA
14,101046454,101046537,14q32.31,14q32.31,615037,MIR487B,Micro RNA 487B,MIR487B,664616,ENSG00000207754,NA,NA,NA
14,101054686,101054758,14q32.31,14q32.31,610164,MIR134,Micro RNA 134,MIR134,406924,ENSG00000207993,NA,NA,NA
14,101055418,101055490,14q32.31,14q32.31,615385,MIR485,Micro RNA 485,MIR485,574436,ENSG00000208027,NA,NA,NA
14,101065299,101065377,14q32.31,14q32.31,614057,"MIR409, MIRN409",Micro RNA 409,MIR409,574413,ENSG00000199107,NA,NA,NA
14,101065597,101065666,14q32.31,14q32.31,611794,"MIR369, MIR369-3, MIRN369-3",Micro RNA 369,MIR369,442914,ENSG00000199025,NA,NA,NA
14,101065911,101065990,14q32.31,14q32.31,615036,MIR410,Micro RNA 410,MIR410,574434,ENSG00000199092,NA,NA,NA
14,101066723,101066800,14q32.31,14q32.31,616376,MIR656,Micro RNA 656,MIR656,724026,ENSG00000207959,NA,NA,NA
14,101552220,101560421,14q32,14q32.31,608523,DIO3OS,"Deiodinase, iodothyronine, type 3, opposite strand",DIO3OS,64150,ENSG00000258498,NA,NA,NA
14,101561350,101563451,14q32,14q32.31,601038,"DIO3, TXDI3","Deiodinase, iodothyronine, type 3",DIO3,1735,ENSG00000197406,NA,NA,Dio3 (MGI:1306782)
14,101760572,101927991,14q32.31,14q32.31,601645,PPP2R5C,"Protein phosphatase-2, regulatory subunit B (B56), gamma isoform",PPP2R5C,5527,ENSG00000078304,pseudogene on 3p21,NA,NA
14,101964572,102056442,14q32,14q32.31,600112,"DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1","Dynein, cytoplasmic-1, heavy chain-1",DYNC1H1,1778,ENSG00000197102,NA,"Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3), Autosomal dominant; Mental retardation, autosomal dominant 13, 614563 (3), Autosomal dominant; Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3), Autosomal dominant",Dync1h1 (MGI:103147)
14,102080741,102139748,14q32.2,14q32.31,140571,"HSP90AA1, HSPCA, HSPC1, HSP90A, HSP89A, HSPCAL4, LAP2","Heat-shock protein, 90kD, alpha, class A, member 1",HSP90AA1,3320,ENSG00000080824,NA,NA,Hsp90aa1 (MGI:96250)
14,102139422,102224685,14q32.31,14q32.31,617741,WDR20,WD repeat-containing protein 20,WDR20,91833,ENSG00000140153,NA,NA,Wdr20 (MGI:1916891)
14,102224440,102305199,14q32,14q32.31,605762,"RAGE, MOK",Renal tumor antigen,MOK,5891,ENSG00000080823,NA,NA,Mok (MGI:1336881)
14,102348281,102362915,14q32.31,14q32.31,613362,CINP,CDK2-interacting protein,CINP,51550,ENSG00000100865,NA,NA,Cinp (MGI:1914486)
14,102362940,102502476,14q32.31,14q32.31,615000,"TECPR2, KIAA0329, SPG49",Tectonin beta-propeller repeat-containing protein 2,TECPR2,9895,ENSG00000196663,NA,"Spastic paraplegia 49, autosomal recessive, 615031 (3), Autosomal recessive",Tecpr2 (MGI:2144865)
14,102592592,102730571,Chr.14,14q32.31-q32.32,607675,"RCOR, COREST, KIAA0071",REST corepressor,RCOR1,23186,ENSG00000089902,NA,NA,Rcor1 (MGI:106340)
14,102777448,102911499,14q32.32,14q32.32,601896,"TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5",TNF receptor-associated factor 3,TRAF3,7187,ENSG00000131323,mutation identified in 1 IIAE5 patient,"{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, 614849 (3)",Traf3 (MGI:108041)
14,102922429,102933596,14q32,14q32.32,605799,AMN,"Amnionless, mouse, homolog of",AMN,81693,ENSG00000166126,NA,"Megaloblastic anemia-1, Norwegian type, 261100 (3), Autosomal recessive",Amn (MGI:1934943)
14,102932379,103057548,14q32.3,14q32.32,614062,"CDC42BPB, MRCKB","CDC42-binding protein kinase, beta",CDC42BPB,9578,ENSG00000198752,NA,NA,Cdc42bpb (MGI:2136459)
14,103121174,103137438,14q32,14q32.32,603300,TNFAIP2,"Tumor necrosis factor, alpha-induced protein-2",TNFAIP2,7127,ENSG00000185215,NA,NA,Tnfaip2 (MGI:104960)
14,103334236,103345024,14q32.3,14q32.32,601710,EIF5,Eukaryotic translation initiation factor 5,EIF5,1983,ENSG00000100664,NA,NA,Eif5 (MGI:95309)
14,103385363,103503830,14q32.3,14q32.32-q32.33,602678,"MARK3, VIPB",MAP/microtubule affinity-regulating kinase-3,MARK3,4140,ENSG00000075413,mutation identified in 1 VIPB family,"?Visual impairment and progressive phthisis bulbi, 618283 (3), Autosomal recessive",Mark3 (MGI:1341865)
14,103500000,107043718,14q32.33,NA,144120,IGHR,Immunoglobulin heavy chain regulator,NA,NA,NA,NA,"?Hyperimmunoglobulin G1 syndrome, 144120 (2), Autosomal dominant",NA
14,103519666,103522832,14q32,14q32.33,123280,"CKB, CKBB, BCK","Creatine kinase, brain type",CKB,1152,ENSG00000166165,distal to PI and AACT; closely linked to AKT1 and IGH; proximal to IGH,NA,Ckb (MGI:88407)
14,103556543,103562813,14q32.33,14q32.33,603885,BAG5,BCL2-associated athanogene 5,BAG5,9529,ENSG00000166170,NA,NA,Bag5 (MGI:1917619)
14,103562959,103593213,14q32.33,14q32.33,616003,"APOPT1, APOP","Apoptogenic protein 1, mitochondrial",COA8,84334,ENSG00000256053,NA,"Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Apopt1 (MGI:1915270)
14,103629187,103701550,14q32.3,14q32.33,600025,"KLC1, KNS2, KNS2A","Kinesin, light chain 1",KLC1,3831,ENSG00000126214,NA,NA,Klc1 (MGI:107978)
14,103697610,103715485,14q32.3,14q32.33,600675,"XRCC3, CMM6","X-ray-repair, complementing defective, repair in Chinese hamster cells-3",XRCC3,7517,ENSG00000126215,NA,"{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Melanoma, cutaneous malignant, 6}, 613972 (3)",Xrcc3 (MGI:1921585)
14,103715743,103733667,14q32.33,14q32.33,613504,"ZFYVE21, ZF21",Zinc finger FYVE domain-containing protein 21,ZFYVE21,79038,ENSG00000100711,NA,NA,Zfyve21 (MGI:1915770)
14,103733194,103849326,14q32.33,14q32.33,606455,"PPP1R13B, ASPP1, KIAA0771","Protein phosphatase 1, regulatory subunit 13B",PPP1R13B,23368,ENSG00000088808,NA,NA,Ppp1r13b (MGI:1336199)
14,103912287,103921528,14q32.33,14q32.33,604573,"C14orf2, MP68","MP68, rat, homolog of",ATP5MPL,9556,ENSG00000156411,NA,NA,Atp5mpl (MGI:1917507)
14,103928342,104052666,14q32.33,14q32.33,617963,"TDRD9, C14orf75, HLS, SPNE, SPGF30",TUDOR domain-containing protein 9,TDRD9,122402,ENSG00000156414,mutation identified in one SPGF30 family,"?Spermatogenic failure 30, 618110 (3), Autosomal recessive",Tdrd9 (MGI:1921941)
14,104085657,104115581,14q32.33,14q32.33,618472,"ASPG, LYSOLP",Asparaginase,ASPG,374569,ENSG00000166183,NA,NA,Aspg (MGI:2144822)
14,104117404,104117513,14q32.33,14q32.33,611899,"MIR203, MIRN203",Micro RNA 203,MIR203A,406986,ENSG00000207568,NA,NA,NA
14,104138722,104180897,14q32.33,14q32.33,613231,"KIF26A, KIAA1236",Kinesin family member 26A,KIF26A,26153,ENSG00000066735,NA,NA,Kif26a (MGI:2447072)
14,104689605,104722534,14q32.33,14q32.33,610982,"INF2, FSGS5, C14orf173, CMTDIE",Inverted formin 2,INF2,64423,ENSG00000203485,NA,"Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3), Autosomal dominant; Glomerulosclerosis, focal segmental, 5, 613237 (3)",Inf2 (MGI:1917685)
14,104724196,104747324,14q32.33,14q32.33,612498,"ADSSL1, MPD5",Adenylosuccinate synthase-like 1,ADSS1,122622,ENSG00000185100,NA,"Myopathy, distal, 5, 617030 (3), Autosomal recessive",Adssl1 (MGI:87947)
14,104769348,104795747,14q32.3,14q32.33,164730,"AKT1, CWS6",Murine thymoma viral (v-akt) oncogene homolog-1,AKT1,207,ENSG00000142208,proximal to IGH,"Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Cowden syndrome 6, 615109 (3); Ovarian cancer, somatic, 167000 (3); Proteus syndrome, somatic, 176920 (3); {Schizophrenia, susceptibility to}, 181500 (2), Autosomal dominant",Akt1 (MGI:87986)
14,104800553,104804711,14q32.33,14q32.33,613915,"ZBTB42, ZNF925, LCCS6",Zinc finger- and BTB domain-containing protein 42,ZBTB42,100128927,ENSG00000179627,mutation identified in 1 LCCS6 family,"?Lethal congenital contracture syndrome 6, 616248 (3), Autosomal recessive",Zbtb42 (MGI:3644133)
14,105009572,105021082,14q32.33,14q32.33,612270,"CDCA4, HEPP",Cell division cycle-associated protein 4,CDCA4,55038,ENSG00000170779,NA,NA,Cdca4 (MGI:1919213)
14,105049394,105065429,14q32.3,14q32.33,606167,"GPR132, G2A",G protein-coupled receptor-132,GPR132,29933,ENSG00000183484,NA,NA,Gpr132 (MGI:1890220)
14,105140980,105168775,14q32,14q32.33,602570,JAG2,Jagged 2,JAG2,3714,ENSG00000184916,NA,NA,Jag2 (MGI:1098270)
14,105209285,105315576,14q32.33,14q32.33,604902,"BRF1, TAF3C, GTF3B, TF3B90, CFDS","BRF1, S. cerevisiae, homolog of (TATA box-binding protein-associated factor 3C)",BRF1,2972,ENSG00000185024,NA,"Cerebellofaciodental syndrome, 616202 (3), Autosomal recessive",Brf1 (MGI:1919558)
14,105300717,105398146,14q32.33,14q32.33,610423,"PACS2, KIAA0602, EIEE66",Phosphofurin acidic cluster sorting protein 2,PACS2,23241,ENSG00000179364,NA,"Epileptic encephalopathy, early infantile, 66, 618067 (3), Autosomal dominant",Pacs2 (MGI:1924399)
14,105419826,105470728,14q32.3,14q32.33,603526,MTA1,Metastasis-associated gene 1,MTA1,9112,ENSG00000182979,NA,NA,Mta1 (MGI:2150037)
14,105472944,105480169,14q32.3,14q32.33,601183,"CRIP2, CRP2",Cysteine-rich intestinal protein 2,CRIP2,1397,ENSG00000182809,NA,NA,NA
14,105486885,105488946,14q32.33,14q32.33,123875,"CRIP1, CRIP",Cysteine-rich intestinal protein 1,CRIP1,1396,ENSG00000213145,previously assigned to 7q11.23,NA,Crip1 (MGI:88501)
14,105586436,106879843,14q32.33,14q32.33,146910,IGHD@,Immunoglobulin heavy chain diversity gene cluster,IGH,3492,NA,many genes,NA,NA
14,105586436,106879843,14q32.33,14q32.33,147010,IGHJ@,Immunoglobulin heavy chain joining gene cluster,IGH,3492,NA,more than 4 genes,NA,NA
14,105586436,106879843,14q32.33,14q32.33,147070,IGHV@,"Immunoglobin heavy polypeptide, variable gene cluster",IGH,3492,NA,"~250 genes; orientation: cen-PI-D14S1-IGH-IGHV--qter; 3' centromeric, 5' telomeric; IgM telomeric to IgG",NA,NA
14,105586936,105588393,14q32.33,14q32.33,147000,IGHA2,Constant region of heavy chain of IgA2,IGHA2,3494,NA,NA,NA,NA
14,105600065,105601726,14q32.33,14q32.33,147180,IGHE,Constant region of heavy chain of IgE,IGHE,3497,NA,pseudogene IGHEP1 nearby; IGHEP2 on chr.9,NA,NA
14,105624475,105626064,14q32.33,14q32.33,147130,IGHG4,Constant region of heavy chain of IgG4,IGHG4,3503,NA,NA,NA,NA
14,105643202,105644788,14q32.33,14q32.33,147110,IGHG2,Constant region of heavy chain of IgG2,IGHG2,3501,NA,5'-G2-17kb-G4-3'; closeness of IGG3 and IGG1 known from Lepore-like myeloma protein,"IgG2 deficiency, selective (3)",NA
14,105707167,105708663,14q32.33,14q32.33,146900,IGHA1,Constant region of heavy chain of IgA1,IGHA1,3493,NA,Fused with IRTA1 in multiple myeloma,NA,NA
14,105741472,105743069,14q32.33,14q32.33,147100,IGHG1,Constant region of heavy chain of IgG1,IGHG1,3500,NA,NA,NA,NA
14,105765913,105771404,14q32.33,14q32.33,147120,IGHG3,Constant region of heavy chain of IgG3,IGHG3,3502,NA,NA,NA,NA
14,105838400,105845676,14q32.33,14q32.33,147170,IGHD,Constant region of heavy chain of IgD,IGHD,3495,NA,NA,NA,NA
14,105851965,105856216,14q32.33,14q32.33,147020,"IGHM, MU, AGM1",Constant region of heavy chain of IgM,IGHM,3507,NA,NA,"Agammaglobulinemia 1, 601495 (3), Autosomal recessive",NA
14,105914358,105914388,14q32.33,14q32.33,611937,"IGHD3-3, DXP4",Immunoglobulin heavy chain diversity gene 3-3,IGHD3-3,28501,NA,NA,NA,NA
14,105917978,105932641,14q32.33,14q32.33,616623,"KIAA0125, FAM30A, C14orf110","KIAA0125 gene, noncoding",FAM30A,9834,ENSG00000226777,NA,NA,NA
14,106268605,106269060,14q32.33,14q32.33,611939,"IGHV3-23, IGHV323, DP47, VH26",Immunoglobulin heavy chain variable gene 3-23,IGHV3-23,28442,NA,NA,NA,NA
14,0,107043718,Chr.14,NA,151020,LCH,Lentil agglutinin-binding,NA,NA,NA,NA,NA,NA
14,0,107043718,Chr.14,NA,608251,PHOBS,"Phobia, specific",NA,404684,NA,NA,"Phobia, specific, 608251 (2)",NA
14,0,107043718,Chr.14,NA,616606,RC14S,Ring chromosome 14 syndrome,NA,NA,NA,NA,"Ring chromosome 14 syndrome, 616606 (4), Isolated cases",NA
15,4200000,9700000,15p12,NA,180452,RNR3,Ribosomal RNA-3,RNR3,6054,NA,NA,NA,NA
15,19000000,25500000,15q11,NA,608636,AUTS4,"Autism, susceptibility to, 4",NA,NA,NA,NA,"{Autism susceptibility 4}, 608636 (2), Autosomal dominant",NA
15,19000000,33400000,15q11-q13,NA,607202,"CELIAC5, GSES","Celiac disease, susceptibility to, 5",NA,338332,NA,in homogeneous Finnish population,"{Celiac disease, susceptibility to, 5}, 607202 (2)",NA
15,19000000,33400000,15q11-q13,NA,609745,GLC1I,"Glaucoma 1, open angle, I",GLC1I,497188,NA,max lod at GABRB3,"Glaucoma 1, open angle, I, 609745 (2)",NA
15,19000000,101991189,15q11-qter,NA,122460,HCVS,Human coronavirus sensitivity,HCVS,3063,NA,NA,NA,NA
15,19000000,101991189,15q,NA,604329,HYT2,"Hypertension, essential, susceptibility to, 2",NA,50986,NA,NA,"{Hypertension, essential, susceptibility to, 2}, 145500 (2), Multifactorial",NA
15,19000000,27800000,15q11-q12,NA,146990,IGHDY2,Immunoglobulin heavy chain diversity region-2,NA,3496,NA,?functional,NA,NA
15,19000000,101991189,15q,NA,214900,"LCS1, CHLS",Cholestasis-lymphedema syndrome,LCS1,84565,NA,NA,"Cholestasis-lymphedema syndrome, 214900 (2), Autosomal recessive",NA
15,19000000,67200000,15q11-q22,NA,107254,MIC12,Antigen identified by monoclonal antibody 30.2A8,MIC12,4273,NA,"in myoblasts, but not myotubes",NA,NA
15,19000000,27800000,15q11-q12,NA,108990,MIC7,Attached cell antigen 28.3.7,MIC7,4270,NA,NA,NA,NA
15,19000000,33400000,15q11-q13,NA,603857,"MRKN3AS, ZNF127AS",MKRN3 antisense RNA,MKRN3-AS1,10108,NA,NA,NA,NA
15,19000000,49200000,15q11-q21.1,NA,613328,RCHTS,Roifman-Chitayat syndrome,NA,100462676,NA,?1p36.23-p33,"?Roifman-Chitayat syndrome, 613328 (2), Autosomal recessive",NA
15,20500000,25500000,15q11.2,NA,615656,"DEL15q11.2, C15DELq11.2",Chromosome 15q11.2 deletion syndrome,NA,NA,NA,deleted region spans 300-500kb between BP1 and BP2,"Chromosome 15q11.2 deletion syndrome, 615656 (4), Autosomal dominant",NA
15,20500000,27800000,15q11.2-q12,NA,609179,MGR7,"Migraine with aura, susceptibility to, 7",NA,553992,NA,between D15S113 and D15S1019,"{Migraine with aura, susceptibility to, 7}, 609179 (2)",NA
15,20669467,20756150,15q11.2,15q11.2,601889,"NBEAP1, BCL8",Neurobeachin pseudogene 1,NBEAP1,606,NA,NA,NA,NA
15,22786224,22829788,15q11.1,15q11.2,608145,"NIPA1, SPG6",Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 1,NIPA1,123606,ENSG00000170113,NA,"Spastic paraplegia 6, autosomal dominant, 600363 (3), Autosomal dominant",Nipa1 (MGI:2442058)
15,22838640,22868383,15q11.2,15q11.2,608146,NIPA2,Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 2,NIPA2,81614,ENSG00000140157,NA,NA,Nipa2 (MGI:1913918)
15,22867051,22980897,15q11,15q11.2,606322,"CYFIP1, KIAA0068",Cytoplasmic FMRP interacting protein 1,CYFIP1,23191,ENSG00000273749,NA,NA,Cyfip1 (MGI:1338801)
15,22983024,23039672,15q11.2,15q11.2,608147,"TUBGCP5, GCP5, KIAA1899",Tubulin-gamma complex-associated protein 5,TUBGCP5,114791,ENSG00000275835,NA,NA,Tubgcp5 (MGI:2178836)
15,23565673,23568043,15q11-q13,15q11.2,603856,"MKRN3, ZFP127, ZNF127, CPPB2",Makorin 3,MKRN3,7681,ENSG00000179455,expressed only from paternal allele,"Precocious puberty, central, 2, 615346 (3), Autosomal dominant",Mkrn3 (MGI:2181178)
15,23643548,23647866,15q11.2,15q11.2,605283,"MAGEL2, NDNL1, SHFYNG",MAGE-like 2,MAGEL2,54551,ENSG00000254585,NA,"Schaaf-Yang syndrome, 615547 (3), Autosomal dominant",Magel2 (MGI:1351648)
15,23685399,23687304,15q11-q13,15q11.2,602117,NDN,Necdin,NDN,4692,ENSG00000182636,NA,"Prader-Willi syndrome, 176270 (3), Autosomal dominant",Ndn (MGI:97290)
15,24164776,24169947,15q11.2,15q11.2,611217,PWRN2,Prader-Willi region noncoding RNA 2,PWRN2,791115,ENSG00000260551,NA,NA,NA
15,24558156,24587779,15q11.2,15q11.2,611215,PWRN1,Prader-Willi region noncoding RNA 1,PWRN1,791114,ENSG00000259905,NA,NA,NA
15,24675393,24683445,15q11.2,15q11.2,610922,"NPAP1, C15orf2",Nuclear pore associated protein 1,NPAP1,23742,ENSG00000185823,NA,NA,NA
15,24823607,25419461,15q11.2,15q11.2,616259,"SNHG14, LNCAT, UBE3AATS",Small nucleolar RNA host gene 14,SNHG14,104472715,NA,NA,NA,NA
15,24823607,24978722,15q12,15q11.2,182279,SNRPN,Small nuclear ribonucleoprotein polypeptide N,SNRPN,6638,ENSG00000128739,NA,"Prader-Willi syndrome, 176270 (3), Autosomal dominant",Snrpn (MGI:98347)
15,24984859,24988231,15q11-q13,15q11.2,600162,"D15S226E, PAR5",Prader-Willi/Angelman syndrome-5,PWAR5,8123,ENSG00000279192,paternally imprinted,NA,NA
15,25051475,25051571,15q11.2,15q11.2,605436,"SNORD116-1, PWCR1","Small nucleolar RNA, C/D box, 116-1",SNORD116-1,100033413,ENSG00000207063,NA,NA,NA
15,25116544,25122475,15q11-q13,15q11.2,601491,IPW,Imprinted in Prader-Willi syndrome,IPW,3653,NA,NA,NA,NA
15,25135641,25138052,15q11-q13,15q11.2,600161,"D15S227E, PAR1",Prader-Willi/Angelman region-1,PWAR1,145624,ENSG00000279050,paternally imprinted,NA,NA
15,25170722,25170803,15q11.2,15q11.2,609837,"SNORD115-1, RNHBII52","Small nucleolar RNA, C/D box, 115-1",SNORD115-1,338433,ENSG00000201831,NA,NA,NA
15,25333727,25439380,15q11-q13,15q11.2,601623,"UBE3A, ANCR",Ubiquitin protein ligase E3A,UBE3A,7337,ENSG00000114062,same location as PWS,"Angelman syndrome, 105830 (3), Autosomal dominant",Ube3a (MGI:105098)
15,25500000,27800000,15q12,NA,610321,HPC7,"Prostate cancer, hereditary, 7",NA,100188809,NA,NA,"{Prostate cancer, hereditary, 7}, 610321 (2)",NA
15,25500000,44500000,15q12-q15,NA,605738,MCOPCB2,"Microphthalmia, isolated, with coloboma 2",NA,80771,NA,NA,"Microphthalmia with coloboma 2, 605738 (2)",NA
15,25672240,25865143,15q11-q13,15q12,605855,"ATP10A, ATP10C, ATPVC","ATPase, class V, type 10A",ATP10A,57194,ENSG00000206190,NA,NA,Atp10a (MGI:1330809)
15,26543545,26773762,15q11.2-q12,15q12,137192,"GABRB3, ECA5, EIEE43","Gamma-aminobutyric acid (GABA) A receptor, beta-3",GABRB3,2562,ENSG00000166206,NA,"{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3); Epileptic encephalopathy, early infantile, 43, 617113 (3), Autosomal dominant",Gabrb3 (MGI:95621)
15,26867061,26949209,15q11.2-q12,15q12,137142,GABRA5,"Gamma-aminobutyric acid (GABA) A receptor, alpha-5",GABRA5,2558,ENSG00000186297,100kb from GABRB3,NA,Gabra5 (MGI:95617)
15,26971180,27541983,15q11.2-q12,15q12,600233,GABRG3,"Gamma-aminobutyric acid (GABA) A receptor, gamma-3",GABRG3,2567,ENSG00000182256,cen--G3--A5--B3,NA,Gabrg3 (MGI:95624)
15,27719007,28099341,15q11.2-q12,15q12-q13,611409,"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1","Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)",OCA2,4948,ENSG00000104044,?hypopigmentation in PWS and AS,"Albinism, brown oculocutaneous, 203200 (3), Autosomal recessive; Albinism, oculocutaneous, type II, 203200 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive",Oca2 (MGI:97454)
15,27800000,44500000,15q13-q15,NA,109710,B2MR,Beta-2-microglobulin regulator,B2MR,568,NA,NA,NA,NA
15,27800000,42500000,15q13.1-q15.1,NA,608646,CILD4,"Ciliary dyskinesia, primary, 4",NA,408257,NA,between D15S1012 and D15S1048,"Ciliary dyskinesia, primary, 4, 608646 (2)",NA
15,27800000,33400000,15q13,NA,613025,SCZD13,Schizophrenia 13,NA,100329170,NA,associated with deletion at 15q13.3,"{Schizophrenia, susceptibility to, 13}, 613025 (2)",NA
15,27800000,33400000,15q13,NA,208500,"SRTD1, ATD1",Short-rib thoracic dysplasia 1 with or without polydactyly,ATD,465,NA,NA,"Short-rib thoracic dysplasia 1 with or without polydactyly, 208500 (2), Autosomal recessive",NA
15,28111036,28322172,15q13.1,15q13.1,605837,"HERC2, SHEP1, MRT38",HECT domain and RCC1-like domain 2,HERC2,8924,ENSG00000128731,mutations in intron 4,"Mental retardation, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive",Herc2 (MGI:103234)
15,28885478,29118314,15q,15q13.1,602712,APBA2,"Amyloid beta A4 precursor protein-binding, family A, member 2",APBA2,321,ENSG00000034053,NA,NA,Apba2 (MGI:1261791)
15,29264988,29269821,15q13.1,15q13.1,608243,"NSMCE3, NDNL2, MAGEG1, LICS","NSE3 homolog, SMC5-SMC6 complex component",NSMCE3,56160,ENSG00000185115,NA,"Lung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3), Autosomal recessive",Nsmce3 (MGI:1913897)
15,29699366,29969048,15q13,15q13.1,601009,TJP1,Tight junction protein 1 (zona occludens 1),TJP1,7082,ENSG00000104067,NA,NA,Tjp1 (MGI:98759)
15,30626147,30649181,15q13.2,15q13.2,616310,"ARHGAP11B, FAM7B1",RHO GTPase-activating protein 11B,ARHGAP11B,89839,ENSG00000284906,NA,NA,NA
15,30900000,33400000,15q13.3,NA,612001,"DEL15q13.3, MICRODEL15q13.3",Chromosome 15q13.3 microdeletion syndrome,NA,NA,NA,NA,"Chromosome 15q13.3 microdeletion syndrome, 612001 (4)",NA
15,30903851,30943107,15q13.2-q13.3,15q13.3,613534,"FAN1, MTMR15, KIAA1018, KMIN",FANCD2/FANCI-associated nuclease 1,FAN1,22909,ENSG00000198690,NA,"Interstitial nephritis, karyomegalic, 614817 (3), Autosomal recessive",Fan1 (MGI:3045266)
15,31001060,31161272,15q13-q14,15q13.3,603576,"TRPM1, MLSN1, CSNB1C","Transient receptor potential cation channel, subfamily M, member 1 (melastatin)",TRPM1,4308,ENSG00000134160,NA,"Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)",Trpm1 (MGI:1330305)
15,31065031,31065140,15q13.3,15q13.3,613753,"MIR211, MIRN211",Micro RNA 211,MIR211,406993,ENSG00000207702,NA,NA,NA
15,31326834,31435664,15q12,15q13.3,605328,"KLF13, RFLAT1, FKLF2",Kruppel-like factor 13,KLF13,51621,ENSG00000169926,NA,NA,Klf13 (MGI:1354948)
15,31475397,31870672,15q13.3,15q13.3,612024,"OTUD7A, OTUD7, C16orf15, CEZANNE2",OTU domain-containing protein 7A,OTUD7A,161725,ENSG00000169918,NA,NA,Otud7a (MGI:2158505)
15,32030461,32173017,15q14,15q13.3,118511,CHRNA7,"Cholinergic receptor, nicotinic, alpha polypeptide-7",CHRNA7,1139,ENSG00000175344,NA,NA,Chrna7 (MGI:99779)
15,32615143,32639940,15q13.2,15q13.3,610589,"ARHGAP11A, KIAA0013",RHO GTPase-activating protein 11A,ARHGAP11A,9824,ENSG00000198826,NA,NA,Arhgap11a (MGI:2444300)
15,32641612,32697097,15q11-q15,15q13.3,173120,"SCG5, SGNE1",Secretogranin V (7B2 protein ),SCG5,6447,ENSG00000166922,NA,NA,Scg5 (MGI:98289)
15,32718003,32745105,15q13-q15,15q13.3,603054,"GREM1, CKTSF1B1","Gremlin 1 homolog, cystine knot superfamily",GREM1,26585,ENSG00000166923,NA,NA,Grem1 (MGI:1344337)
15,32765543,33194764,15q13-q14,15q13.3,136535,"FMN, LD",Formin (limb deformity),FMN1,342184,ENSG00000248905,NA,NA,Fmn1 (MGI:101815)
15,33310772,33866120,15q14-q15,15q13-q14,180903,RYR3,Ryanodine receptor-3,RYR3,6263,ENSG00000198838,NA,NA,Ryr3 (MGI:99684)
15,33400000,39800000,15q14,NA,616898,"DEL15q14, C15DELq14",Chromosome 15q14 deletion syndrome,NA,NA,NA,NA,"Chromosome 15q14 deletion syndrome, 616898 (4), Autosomal dominant",NA
15,33400000,39800000,15q14,NA,604827,"EIG7, EJM2","Epilepsy, idiopathic generalized, susceptibility to, 7",EJM2,50715,NA,?role of CHRNA7,"{Epilepsy, idiopathic generalized, susceptibility to, 7}, 604827 (2), Autosomal recessive; Epilepsy, juvenile myoclonic, 604827 (2), Autosomal recessive",NA
15,33968496,34067457,15q26,15q14,118496,CHRM5,"Cholinergic receptor, muscarinic, 5",CHRM5,1133,ENSG00000184984,NA,NA,Chrm5 (MGI:109248)
15,33851784,34074876,Chr.15,15q14,605265,AVEN,Cell death regulator AVEN,AVEN,57099,ENSG00000169857,NA,NA,Aven (MGI:1921518)
15,34140673,34210095,15q14,15q14,616235,"KATNBL1, C15orf29","Katanin, p80 subunit, B-like 1",KATNBL1,79768,ENSG00000134152,NA,NA,Katnbl1 (MGI:1919675)
15,34224996,34230164,15q14,15q14,616245,"EMC4, TMEM85, PIG17",ER membrane protein complex subunit 4,EMC4,51234,ENSG00000128463,NA,NA,Emc4 (MGI:1915282)
15,34229783,34338056,15q13-q14,15q14,604878,"SLC12A6, KCC3A, KCC3B, KCC3, ACCPN","Solute carrier family 12 (potassium/chloride transporters), member 6",SLC12A6,9990,ENSG00000140199,NA,"Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3), Autosomal recessive",Slc12a6 (MGI:2135960)
15,34341715,34343160,15q14-q15,15q14,606471,"NOLA3, NOP10, DKCB1","Nucleolar protein family A, member 3",NOP10,55505,ENSG00000182117,NA,"Dyskeratosis congenita, autosomal recessive 1, 224230 (3), Autosomal recessive",Nop10 (MGI:1913431)
15,34358632,34367195,15q14,15q14,612039,"AGPAT7, AYTL3",1-acylglycerol-3-phosphate O-acyltransferase 7,LPCAT4,254531,ENSG00000176454,NA,NA,Lpcat4 (MGI:2138993)
15,34379067,34437465,15q14,15q14,616180,"GOLGA8A, KIAA0855","Golgin A8 family, member A",GOLGA8A,23015,ENSG00000175265,NA,NA,NA
15,34525281,34583569,15q14,15q14,609619,"GOLGA8B, KIAA0855","Golgi autoantigen, golgin subfamily A, 8B",GOLGA8B,440270,ENSG00000215252,NA,NA,NA
15,34751031,34754997,15q14,15q14,607058,"GJD2, GJA9, CX36","Gap junction protein, delta-2 (connexin 36)",GJD2,57369,ENSG00000159248,NA,NA,Gjd2 (MGI:1334209)
15,34790229,34795548,15q14,15q14,102540,"ACTC1, CMD1R, CMH11, ASD5, LVNC4","Actin, alpha, cardiac muscle",ACTC1,70,ENSG00000159251,NA,"Atrial septal defect 5, 612794 (3), Autosomal dominant; Cardiomyopathy, dilated, 1R, 613424 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 11, 612098 (3), Autosomal dominant; Left ventricular noncompaction 4, 613424 (3), Autosomal dominant",Actc1 (MGI:87905)
15,34851781,34969741,15q14,15q14,610548,"AQR, IBP160, KIAA0560","Aquarius, mouse, homolog of",AQR,9716,ENSG00000021776,NA,NA,Aqr (MGI:1276102)
15,35217355,35546192,5q14,15q14,618391,DPH6,Diphthamide biosynthesis protein 6,DPH6,89978,ENSG00000134146,NA,NA,Dph6 (MGI:1913882)
15,36579610,36810247,15q14,15q14,615626,C15orf41,Chromosome 15 open reading fram 41,C15orf41,84529,ENSG00000186073,NA,"Dyserythropoietic anemia, congenital, type Ib, 615631 (3), Autosomal recessive",BC052040 (MGI:3026886)
15,36889203,37101310,15q14-q25,15q14,601740,"MEIS2, MRG1, CPCMR","Meis1, mouse, homolog of, 2",MEIS2,4212,ENSG00000134138,NA,"Cleft palate, cardiac defects, and mental retardation, 600987 (3), Autosomal dominant",Meis2 (MGI:108564)
15,38252086,38357248,15q13.2,15q14,609291,"SPRED1, NFLS, LGSS",Sprouty-related EVH1 domain-containing protein 1,SPRED1,161742,ENSG00000166068,NA,"Legius syndrome, 611431 (3), Autosomal dominant",Spred1 (MGI:2150016)
15,38454126,38487709,15q14,15q14,616142,FAM98B,"Family with sequence similarity 98, member B",FAM98B,283742,ENSG00000171262,NA,NA,Fam98b (MGI:1915465)
15,38488096,38564813,15q15,15q14,603962,RASGRP1,Ras guanyl nucleotide releasing protein-1,RASGRP1,10125,ENSG00000172575,NA,NA,Rasgrp1 (MGI:1314635)
15,39581078,39599465,15q15,15q14,188060,THBS1,Thrombospondin 1,THBS1,7057,ENSG00000137801,NA,NA,Thbs1 (MGI:98737)
15,39597280,39782840,15q14,15q14,615795,"FSIP1, HSD10",Fibrous sheath-interacting protein 1,FSIP1,161835,ENSG00000150667,NA,NA,Fsip1 (MGI:1918563)
15,39795048,39920938,15q14-q15,15q14-q15,612183,GPR176,G protein-coupled receptor 176,GPR176,11245,ENSG00000166073,NA,NA,Gpr176 (MGI:2685858)
15,39800000,44500000,15q15,NA,605419,SCZD10,Schizophrenia 10,SCZD10,63944,NA,between D15S1042 and D15S659,"{Schizophrenia 10}, 605419 (2), Autosomal dominant",NA
15,39934114,40035590,15q15.1,15q15.1,609280,"EIF2AK4, GCN2, KIAA1338, PVOD2",Eukaryotic translation initiation factor 2-alpha kinase 4,EIF2AK4,440275,ENSG00000128829,NA,"Pulmonary venoocclusive disease 2, 234810 (3), Autosomal recessive",Eif2ak4 (MGI:1353427)
15,40035689,40039201,15q22,15q15.1,600708,SRP14,Signal recognition particle 14kD (homologous Alu RNA-binding protein),SRP14,6727,ENSG00000140319,NA,NA,Srp14 (MGI:107169)
15,40087889,40108878,15q14,15q15.1,606266,BMF,BCL2-modifying factor,BMF,90427,ENSG00000104081,NA,NA,Bmf (MGI:2176433)
15,40161008,40221135,15q15,15q15.1,602860,"BUB1B, BUBR1, MVA1","Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of, beta",BUB1B,701,ENSG00000156970,NA,"Colorectal cancer, somatic, 114500 (3); Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive; [Premature chromatid separation trait], 176430 (3), Autosomal dominant",Bub1b (MGI:1333889)
15,40239062,40277486,15q15.1,15q15.1,608110,PAK6,p21-activated kinase 6,PAK6,56924,ENSG00000137843,NA,NA,Pak6 (MGI:2679420)
15,40285495,40307944,15q15,15q15.1,604114,PLCB2,"Phospholipase C, beta-2",PLCB2,5330,ENSG00000137841,NA,Platelet PLC beta-2 deficiency (1),Plcb2 (MGI:107465)
15,40354358,40378620,Chr.15,15q15.1,607503,"DISPB, KIAA1742","Dispatched, Drosophila, homolog of, B",DISP2,85455,ENSG00000140323,NA,NA,Disp2 (MGI:2388733)
15,40382720,40394287,15q15.1,15q15.1,614718,"KNSTRN, C15orf23, SKAP",Kinetochore-localized astrin/SPAG5 binding protein,KNSTRN,90417,ENSG00000128944,NA,NA,Knstrn (MGI:1289298)
15,40405489,40435947,15q14-q15,15q15.1,607036,IVD,Isovaleryl Coenzyme A dehydrogenase,IVD,3712,ENSG00000128928,NA,"Isovaleric acidemia, 243500 (3), Autosomal recessive",Ivd (MGI:1929242)
15,40439756,40468236,15q15.1,15q15.1,613880,"BAHD1, KIAA0945",BROMO-adjacent homology domain-containing protein 1,BAHD1,22893,ENSG00000140320,NA,NA,Bahd1 (MGI:2139371)
15,40470960,40473157,15q14,15q15.1,608429,"CHST14, D4ST1, ATCS, EDSMC1",Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14,CHST14,113189,ENSG00000169105,NA,"Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3), Autosomal recessive",Chst14 (MGI:1919386)
15,40594011,40664341,15q15.1,15q15.1,609173,"KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4",Kinetochore scaffold 1,KNL1,57082,ENSG00000137812,NA,"Microcephaly 4, primary, autosomal recessive, 604321 (3), Autosomal recessive",Knl1 (MGI:1923714)
15,40694773,40732339,15q15.1,15q15.1,179617,"RAD51A, RECA, MRMV2, FANCR","RAD51, S. cerevisiae, homolog of, A (E. coli RecA homolog)",RAD51,5888,ENSG00000051180,mutation identified in 1 FANCR patient,"{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; ?Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant; Mirror movements 2, 614508 (3), Autosomal dominant",Rad51 (MGI:97890)
15,40735883,40755335,15q15.1,15q15.1,611873,"FAM82A2, FAM82C, RMD3, PTPIP51","Family with sequence similarity 82, member A2",RMDN3,55177,ENSG00000137824,NA,NA,Rmdn3 (MGI:1915059)
15,40764067,40767707,15q15.1,15q15.1,602437,"GCHFR, GFRP",GTP cyclohydrolase I feedback regulatory protein,GCHFR,2644,ENSG00000137880,NA,NA,Gchfr (MGI:2443977)
15,40765160,40807476,15q15.1,15q15.1,616844,DNAJC17,"DNAJ/HSP40 homolog, subfamily C, member 17",DNAJC17,55192,ENSG00000104129,NA,NA,Dnajc17 (MGI:1916658)
15,40815450,40828792,15q15.1,15q15.1,613256,"PPP1R14D, GBPI1","Protein phosphatase 1, regulatory subunit 14D",PPP1R14D,54866,ENSG00000166143,NA,NA,Ppp1r14d (MGI:1919362)
15,40894409,40903974,15q15.1,15q15.1,608551,VPS18,"Vacuolar protein sorting 18, yeast, homolog of",VPS18,57617,ENSG00000104142,NA,NA,Vps18 (MGI:2443626)
15,40929339,40939072,15q21.1,15q15.1,605185,"DLL4, AOS6",Delta-like 4,DLL4,54567,ENSG00000128917,NA,"Adams-Oliver syndrome 6, 616589 (3), Autosomal dominant",Dll4 (MGI:1859388)
15,40942136,40956517,15q15.1,15q15.1,614587,CHAC1,"ChaC, E. coli, homolog of, 1",CHAC1,79094,ENSG00000128965,NA,NA,Chac1 (MGI:1916315)
15,40978879,41117777,15q15.1,15q15.1,610169,"INO80, INOC1",INO80 complex subunit,INO80,54617,ENSG00000128908,NA,NA,Ino80 (MGI:1915392)
15,41231155,41281886,15q13.3,15q15.1,606988,"CHP1, SPAX9",Calcineurin like EF-hand protein 1,CHP1,11261,ENSG00000187446,mutation identified in 1 SPAX9 family,"?Spastic ataxia 9, autosomal recessive, 618438 (3), Autosomal recessive",Chp1 (MGI:1927185)
15,41309267,41332620,15q15.1,15q15.1,606020,"OIP5, MIS18B",OPA-interacting protein 5,OIP5,11339,ENSG00000104147,NA,NA,Oip5 (MGI:1917895)
15,41332840,41381049,15q15.1,15q15.1,612818,"NUSAP1, ANKT, NUSAP",Nucleolar and spindle-associated protein 1,NUSAP1,51203,ENSG00000137804,NA,NA,Nusap1 (MGI:2675669)
15,41387348,41402500,15q13.3,15q15.1,606934,"NDUFAF1, CIA30, CGI65, MC1DN11",NADH-ubiquinone oxidoreductase complex assembly factor 1,NDUFAF1,51103,ENSG00000137806,NA,"Mitochondrial complex I deficiency, nuclear type 11, 618234 (3), Autosomal recessive",Ndufaf1 (MGI:1916952)
15,41417103,41483562,15q15.1,15q15.1,611633,"RTF1, KIAA0252","RTF1, S. cerevisiae, homolog of",RTF1,23168,ENSG00000137815,NA,NA,Rtf1 (MGI:1309480)
15,41493873,41503554,15q14-q21,15q15.1,147521,ITPKA,"Inositol 1,4,5-trisphosphate 3-kinase A",ITPKA,3706,ENSG00000137825,NA,NA,Itpka (MGI:1333822)
15,41503636,41513886,15q15.1-q21.1,15q15.1,151520,"LTK, TYK1",Leukocyte tyrosine kinase,LTK,4058,ENSG00000062524,NA,NA,Ltk (MGI:96840)
15,41517175,41544256,15q15.1,15q15.1,611475,"RPAP1, KIAA1403",RNA polymerase II-associated protein 1,RPAP1,26015,ENSG00000103932,NA,NA,Rpap1 (MGI:1916175)
15,41559211,41583588,15q15.1,15q15.1,600341,TYRO3,TYRO3 protein tyrosine kinase,TYRO3,7301,ENSG00000092445,NA,NA,Tyro3 (MGI:104294)
15,41621224,41769942,15q15,15q15.1,616061,"MGA, KIAA0518",MAX dimerization protein MGA,MGA,23269,ENSG00000174197,NA,NA,Mga (MGI:1352483)
15,41774433,41827854,15q13,15q15.1,616786,"MAPKBP1, JNKBP1, NPHP20",Mitogen-activated protein kinase-binding protein 1,MAPKBP1,23005,ENSG00000137802,NA,"Nephronophthisis 20, 617271 (3), Autosomal recessive",Mapkbp1 (MGI:1347004)
15,41848145,41894052,15q21,15q15.1,605916,"SPTBN5, BSPECV","Spectrin, beta, non-erythrocytic 5",SPTBN5,51332,ENSG00000137877,NA,NA,Sptbn5 (MGI:2685200)
15,41838812,41848147,Chr.15,15q15.1,606088,PLA2G4B,"Phospholipase A2, group IVB",PLA2G4B,100137049,ENSG00000243708,NA,NA,Pla2g4b (MGI:2384819)
15,41895932,41972556,15q11.1,15q15.1,605892,EHD4,EH domain-containing 4,EHD4,30844,ENSG00000103966,NA,NA,Ehd4 (MGI:1919619)
15,42067008,42094561,15q15,15q15.1,612864,PLA2G4D,"Phospholipase A2, Group IVD",PLA2G4D,283748,ENSG00000159337,NA,NA,Pla2g4d (MGI:1925640)
15,42158700,42208330,15q15.1,15q15.1,612188,"VPS39, VAM6, TLP, KIAA0770","Vacuolar protein sorting 39, yeast, homolog of",VPS39,23339,ENSG00000166887,NA,NA,Vps39 (MGI:2443189)
15,42273657,42353665,15q15.1-q15.2,15q15.1,104180,GANC,Neutral alpha-glucosidase C,GANC,2595,ENSG00000214013,NA,NA,Ganc (MGI:1923301)
15,42359499,42412316,15q15.1-q21.1,15q15.1,114240,"CAPN3, CANP3, LGMDR1, LGMDD4","Calpain, large polypeptide L3",CAPN3,825,ENSG00000092529,NA,"Muscular dystrophy, limb-girdle, autosomal dominant 4, 618129 (3), Autosomal dominant; Muscular dystrophy, limb-girdle, autosomal recessive 1, 253600 (3), Autosomal recessive",Capn3 (MGI:107437)
15,42491243,42533060,15q21-q22,15q15.1-q15.2,602534,SNAP23,"Synaptosomal-associated protein, 23kD",SNAP23,8773,ENSG00000092531,NA,NA,Snap23 (MGI:109356)
15,42548812,42569993,15q15.2,15q15.2,613429,"HAUS2, CEP27","HAUS augmin-like complex, subunit 2",HAUS2,55142,ENSG00000137814,NA,NA,Haus2 (MGI:1913546)
15,42575605,42720997,15q15,15q15.2,614642,"STARD9, KIAA1300",START domain-containing protein 9,STARD9,57519,ENSG00000159433,NA,NA,Stard9 (MGI:3045258)
15,42723543,42737132,15q15,15q15.2,607465,"CDAN1, CDA1, CDAN1A",Codanin 1,CDAN1,146059,ENSG00000140326,NA,"Dyserythropoietic anemia, congenital, type Ia, 224120 (3), Autosomal recessive",Cdan1 (MGI:1916218)
15,42738729,42920994,15q15.2,15q15.2,611695,"TTBK2, SCA11",Tau tubulin kinase 2,TTBK2,146057,ENSG00000128881,NA,"Spinocerebellar ataxia 11, 604432 (3), Autosomal dominant",Ttbk2 (MGI:2155779)
15,42942896,43106037,15q15-q21.1,15q15.2,605981,"UBR1, JBS",Ubiquitin-protein ligase E3-alpha,UBR1,197131,ENSG00000159459,NA,"Johanson-Blizzard syndrome, 243800 (3), Autosomal recessive",Ubr1 (MGI:1277977)
15,43185117,43197176,Chr.15,15q15.2,607089,"CCNDBP1, GCIP",Cyclin D-type-binding protein 1,CCNDBP1,23582,ENSG00000166946,NA,NA,Ccndbp1 (MGI:109595)
15,43197226,43225855,15q15,15q15.2,177070,"EPB42, SPH5",Erythrocyte surface protein band 4.2,EPB42,2038,ENSG00000166947,NA,"Spherocytosis, type 5, 612690 (3)",Epb42 (MGI:95402)
15,43232589,43266927,15q15.2,15q15.2,603805,"TGM5, TGX, PSS2",Transglutaminase 5,TGM5,9333,ENSG00000104055,NA,"Peeling skin syndrome 2, 609796 (3), Autosomal recessive",Tgm5 (MGI:1921426)
15,43276270,43302254,15q15.2,15q15.2-q15.3,606776,"TGM7, TGMZ",Transglutaminase 7,TGM7,116179,ENSG00000159495,NA,NA,Tgm7 (MGI:2151164)
15,43300000,44500000,15q15.3,NA,611102,"DEL15q15.3, C15DELq15.3",Chromosome 15q15.3 deletion syndrome,NA,NA,NA,NA,"Deafness and male infertility, 611102 (4), Autosomal recessive",NA
15,43300000,44500000,15q15.3,NA,134600,"FRTS1, FRTS, RFS",Fanconi renotubular syndrome,NA,65211,NA,NA,"Fanconi renotubular syndrome 1, 134600 (2), Autosomal dominant",NA
15,43300000,59000000,15q15.3-q22.1,NA,601228,"HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq","Polyposis syndrome, mixed, hereditary 1",NA,NA,NA,duplication of 40kb of 15q resulting in overexpression of GREM1,"{Colorectal cancer, susceptibility to, 4}, 601228 (4), Autosomal dominant; Polyposis syndrome, mixed hereditary 1, 601228 (4), Autosomal dominant",NA
15,43323648,43330572,15q15.3,15q15.3,611246,"LCMT2, TYW4, KIAA0547",Leucine carboxyl methyltransferase 2,LCMT2,9836,ENSG00000168806,NA,NA,Lcmt2 (MGI:1353659)
15,43371072,43409770,15q15,15q15.3,609610,"TUBGCP4, GCP4, MCCRP3",Tubulin-gamma complex-associated protein 4,TUBGCP4,27229,ENSG00000137822,NA,"Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive",Tubgcp4 (MGI:1196293)
15,43403060,43510639,15q15-q21,15q15.3,605230,"TP53BP1, 53BP1",Tumor protein p53-binding protein-1,TP53BP1,7158,ENSG00000067369,NA,NA,Trp53bp1 (MGI:1351320)
15,43517607,43531610,15q13-qter,15q15.3,600178,"MAP1A, MAP1L",Microtubule-associated protein 1A,MAP1A,4130,ENSG00000166963,NA,NA,Map1a (MGI:1306776)
15,43533461,43590271,15q15.3,15q15.3,610979,"PPIP5K1, HISPPD2A, IPS1, KIAA0377",Diphosphoinositol pentakisphosphate kinase 1,PPIP5K1,9677,ENSG00000168781,NA,NA,Ppip5k1 (MGI:2443281)
15,43592856,43599405,15q15,15q15.3,123290,"CKMT1B, CKMT1","Creatine kinase, mitochondrial 1B",CKMT1B,1159,ENSG00000237289,centromeric to CKMT1A,NA,Ckmt1 (MGI:99441)
15,43599562,43618799,15q15,15q15.3,606440,"STRC, DFNB16",Stereocilin,STRC,161497,ENSG00000242866,NA,"Deafness, autosomal recessive 16, 603720 (3), Autosomal recessive",Strc (MGI:2153816)
15,43628502,43648883,15q15.1-q15.3,15q15.3,607249,CATSPER2,"Cation channel, sperm-associated, 2",CATSPER2,117155,ENSG00000166762,in region with tandem duplication containing a CATSPER2 pseudogene,NA,Catsper2 (MGI:2387404)
15,43692643,43699221,15q15,15q15.3,613415,CKMT1A,"Creatine kinase, mitochondrial 1A",CKMT1A,548596,ENSG00000223572,telomeric to CKMT1B,NA,Ckmt1 (MGI:99441)
15,43746437,43773277,15q15,15q15.3,602046,GRP58,"Glucose regulated protein, 58kD",PDIA3,2923,ENSG00000167004,NA,NA,Pdia3 (MGI:95834)
15,43772619,43776965,15q15.3,15q15.3,609885,ELL3,"Elongation factor, RNA polymerase II, 3",ELL3,80237,ENSG00000128886,NA,NA,Ell3 (MGI:2673679)
15,43777085,43796088,15q14.3,15q15.3,605054,"SERF2, H4F5REL",Small EDRK-rich factor 2,SERF2,10169,ENSG00000140264,NA,NA,Serf2 (MGI:1337041)
15,43794173,43800096,15q15.3,15q15.3,614550,SERINC4,Serine incorporator 4,SERINC4,619189,ENSG00000184716,NA,NA,Serinc4 (MGI:2441842)
15,43800420,43802588,15q15.3,15q15.3,612784,HYPK,Huntingtin-interacting protein K,HYPK,25764,ENSG00000242028,NA,NA,Hypk (MGI:1914943)
15,43804491,43824689,15q15-q12,15q15.3,600215,MFAP1,Microfibrillar-associated protein-1,MFAP1,4236,ENSG00000140259,NA,NA,"Mfap1a,Mfap1b (MGI:3694697,MGI:1914782)"
15,43870760,44195293,15q15.3,15q15.3,616309,FRMD5,FERM domain-containing protein 5,FRMD5,84978,ENSG00000171877,NA,NA,Frmd5 (MGI:2442557)
15,44500000,58800000,15q21,NA,105600,"CDAN3, CDA3","Congenital dyserythropoietic anemia, type III",CDAN3,981,NA,NA,"Dyserythropoietic anemia, congenital, type III, 105600 (2), Autosomal dominant",NA
15,44500000,67200000,15q21-q22,NA,605728,"CTRCT25, CCSSO",Cataract 25,NA,80770,NA,NA,"Cataract 25, 605728 (2)",NA
15,44537067,44562802,15q15.3,15q21.1,603910,"EIF3J, EIF3S1","Eukaryotic translation initiation factor 3, subunit J",EIF3J,8669,ENSG00000104131,NA,NA,"Eif3j2,Eif3j1 (MGI:1925905,MGI:3704486)"
15,44562695,44663677,15q21.1,15q21.1,610844,"SPG11, KIAA1840, FLJ21439, ALS5, CMT2X",Spastascin,SPG11,80208,ENSG00000104133,NA,"Amyotrophic lateral sclerosis 5, juvenile, 602099 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3), Autosomal recessive; Spastic paraplegia 11, autosomal recessive, 604360 (3), Autosomal recessive",Spg11 (MGI:2444989)
15,44665731,44711405,15q21.1,15q21.1,614661,"PATL2, PAT1A, OOMD4","Protein associated with topoisomerase II, S. Cerevisiae, homolog of",PATL2,197135,ENSG00000229474,NA,"Oocyte maturation defect 4, 617743 (3), Autosomal recessive",Patl2 (MGI:1914828)
15,44711491,44718876,15q21-q22,15q21.1,109700,"B2M, IMD43",Beta-2-microglobulin,B2M,567,ENSG00000166710,mutation identified in 1 FVA family,"?Amyloidosis, familial visceral, 105200 (3), Autosomal dominant; Immunodeficiency 43, 241600 (3), Autosomal recessive",B2m (MGI:88127)
15,44736527,44767826,15q21.1,15q21.1,616017,"TRIM69, TRIF, RNF36",Tripartite motif-containing protein 69,TRIM69,140691,ENSG00000185880,NA,NA,Trim69 (MGI:1918178)
15,44956673,44979228,15q21.1,15q21.1,617131,"TERB2, C15orf43",Telomere repeat-binding bouquet formation protein 2,TERB2,145645,ENSG00000167014,NA,NA,Terb2 (MGI:1921651)
15,45023103,45077184,15q15.3,15q21.1,182500,"SORD, SORD1",Sorbitol dehydrogenase,SORD,6652,ENSG00000140263,NA,"?Cataract, congenital, 182500 (2)",Sord (MGI:98266)
15,45092649,45114171,15q15.3,15q21.1,606759,"DUOX2, THOX2, TDH6",Dual oxidase 2 (thyroid oxidase 2),DUOX2,50506,ENSG00000140279,NA,"Thyroid dyshormonogenesis 6, 607200 (3), Autosomal recessive",Duox2 (MGI:3036280)
15,45114320,45118420,15q15,15q21.1,612772,"DUOXA2, TDH5",Dual oxidase maturation factor 2,DUOXA2,405753,ENSG00000140274,head-to-head with DUOX2,"Thyroid dyshormonogenesis 5, 274900 (3), Autosomal recessive",Duoxa2 (MGI:1914061)
15,45117365,45129937,15q15,15q21.1,612771,DUOXA1,Dual oxidase maturation factor 1,DUOXA1,90527,ENSG00000140254,tail-to-tail with DUOXA2,NA,Duoxa1 (MGI:2384861)
15,45129993,45165577,15q15.3,15q21.1,606758,"DUOX1, THOX1",Dual oxidase 1 (thyroid oxidase 1),DUOX1,53905,ENSG00000137857,NA,NA,Duox1 (MGI:2139422)
15,45167213,45201115,15q21.1,15q21.1,617313,SHF,SH2 domain-containing adaptor protein F,SHF,90525,ENSG00000138606,NA,NA,Shf (MGI:3613669)
15,45252233,45277845,15q15,15q21.1,606208,"SLC28A2, CNT2, SPNT1","Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2",SLC28A2,9153,ENSG00000137860,NA,NA,Slc28a2 (MGI:1913105)
15,45361123,45402226,15q21.1,15q21.1,602360,"GATM, AGAT, CCDS3",L-arginine:glycine amidinotransferase,GATM,2628,ENSG00000171766,NA,"Cerebral creatine deficiency syndrome 3, 612718 (3), Autosomal recessive",Gatm (MGI:1914342)
15,45430528,45433448,15q21.1,15q21.1,608409,NMES1,Normal mucosa of esophagus-specific gene 1,C15orf48,84419,ENSG00000166920,NA,NA,AA467197 (MGI:3034182)
15,45479605,45523754,15q21.1,15q21.1,602095,"SLC30A4, ZNT4","Solute carrier family 30 (zinc transporter), member 4",SLC30A4,7782,ENSG00000104154,NA,NA,Slc30a4 (MGI:1345282)
15,45511135,45556729,15q21.1,15q21.1,611314,"HMGN2P46, C15orf21",High mobility group nucleosomal binding domain 2 pseudogene 46,HMGN2P46,283651,NA,NA,NA,NA
15,45587122,45609715,15q15,15q21.1,604310,"BLOC1S6, BLOS6, PLDN, PA, HPS9","Biogenesis of lysosome-related organelles complex 1, subunit 6",BLOC1S6,26258,ENSG00000104164,mutation identified in 1 HPS9 patient,"?Hermansky-pudlak syndrome 9, 614171 (3), Autosomal recessive",Bloc1s6 (MGI:1927580)
15,45631147,45691293,15q21.1,15q21.1,617658,"SQOR, SQRDL",Sulfide quinone oxidoreductase,SQOR,58472,ENSG00000137767,NA,NA,Sqor (MGI:1929899)
15,47184088,47774222,15q21.1,15q21.1,609295,"SEMA6D, KIAA1479",Semaphorin 6D,SEMA6D,80031,ENSG00000137872,NA,NA,Sema6d (MGI:2387661)
15,48120989,48142671,15q21.1,15q21.1,609802,"SLC24A5, NCKX5, SHEP4, OCA6","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5",SLC24A5,283652,ENSG00000188467,NA,"Albinism, oculocutaneous, type VI, 113750 (3), Autosomal recessive; [Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3), Autosomal recessive",Slc24a5 (MGI:2677271)
15,48206300,48304077,15q15-q21.1,15q21.1,600839,"SLC12A1, NKCC2","Solute carrier family 12 (sodium/potassium/chloride transporters), member 1",SLC12A1,6557,ENSG00000074803,NA,"Bartter syndrome, type 1, 601678 (3), Autosomal recessive",Slc12a1 (MGI:103150)
15,48329990,48343372,15q15-q21.1,15q21.1,601266,DUT,dUTP pyrophosphatase,DUT,1854,ENSG00000128951,NA,NA,Dut (MGI:1346051)
15,48408305,48645787,15q21.1,15q21.1,134797,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",Fibrillin-1,FBN1,2200,ENSG00000166147,NA,"Acromicric dysplasia, 102370 (3), Autosomal dominant; Ectopia lentis, familial, 129600 (3), Autosomal dominant; Geleophysic dysplasia 2, 614185 (3), Autosomal dominant; MASS syndrome, 604308 (3); Marfan lipodystrophy syndrome, 616914 (3), Autosomal dominant; Marfan syndrome, 154700 (3), Autosomal dominant; Stiff skin syndrome, 184900 (3), Autosomal dominant; Weill-Marchesani syndrome 2, dominant, 608328 (3), Autosomal dominant",Fbn1 (MGI:95489)
15,48662533,48811903,15q21.1,15q21.1,613529,"CEP152, KIAA0912, MCPH9, SCKL5","Centrosomal protein, 152kD",CEP152,22995,ENSG00000103995,NA,"Microcephaly 9, primary, autosomal recessive, 614852 (3), Autosomal recessive; Seckel syndrome 5, 613823 (3), Autosomal recessive",Cep152 (MGI:2139083)
15,48823740,48963918,15q21.1,15q21.1,617372,"SHC4, RALP, SHCD",SHC transforming protein 4,SHC4,399694,ENSG00000185634,NA,NA,Shc4 (MGI:2655364)
15,48878133,48880172,15q21.1-q21.2,15q21.1,605894,"EID1, CRI1, C15orf3",EP300-interacting inhibitor of differentiation 1,EID1,23741,ENSG00000255302,NA,NA,Eid1 (MGI:1889651)
15,48988637,49046445,15q21.1,15q21.1,615756,"SECISBP2L, SBP2L, KIAA0256",Selenocysteine insertion sequence-binding protein 2-like,SECISBP2L,9728,ENSG00000138593,NA,NA,Secisbp2l (MGI:1917604)
15,49122726,49155598,15q21.2,15q21.1,604508,"TRIP15, SGN2, COPS2",Thyroid hormone receptor interactor-15,COPS2,9318,ENSG00000166200,NA,NA,NA
15,49155758,49367882,Chr.15,15q21.1-q21.2,137028,"GALK2, GK2",Galactokinase-2,GALK2,2585,ENSG00000156958,NA,NA,Galk2 (MGI:1917226)
15,49423241,49488774,15q15-q21.1,15q21.2,148180,FGF7,Fibroblast growth factor-7 (keratinocyte growth factor),FGF7,2252,ENSG00000140285,NA,NA,Fgf7 (MGI:95521)
15,50182195,50236391,15q21.2,15q21.2,603247,"SLC27A2, FACVL1, VLACS","Solute carrier family 27 (fatty acid transporter), member 2 (fatty acid CoA ligase, very long-chain 1)",SLC27A2,11001,ENSG00000140284,NA,NA,Slc27a2 (MGI:1347099)
15,50241944,50266048,15q21-q22,15q21.2,142704,HDC,Histidine decarboxylase,HDC,3067,ENSG00000140287,NA,"{Gilles de la Tourette syndrome, susceptibility to}, 137580 (3), Autosomal dominant",Hdc (MGI:96062)
15,50275388,50359305,15q21.2,15q21.2,600610,"GABPB, BABPB2, GABPB1, E4TF1B, NRF2B1","GA-binding protein transcription factor, beta subunit",GABPB1,2553,ENSG00000104064,NA,NA,Gabpb1 (MGI:95611)
15,50424358,50514420,15q21.2,15q21.2,603158,"USP8, HUMORF8, PITA4",Ubiquitin-specific protease 8,USP8,9101,ENSG00000138592,NA,"Pituitary adenoma 4, ACTH-secreting, somatic, 219090 (3)",Usp8 (MGI:1934029)
15,50557157,50686814,15q21,15q21.2,605692,"TRPM7, LTRPC7, CHAK, ALSPDC","Transient receptor potential cation channel, subfamily M, member 7",TRPM7,54822,ENSG00000092439,NA,"{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3), Autosomal dominant",Trpm7 (MGI:1929996)
15,50702265,50765711,15q15.3,15q21.2,608238,"SPPL2A, IMP3",Signal peptide peptidase-like 2A,SPPL2A,84888,ENSG00000138600,NA,NA,Sppl2a (MGI:1913802)
15,50908568,51005899,15q21.2,15q21.2,607244,"AP4E1, SPG51, CPSQ4, STUT1","Adaptor-related protein complex 4, epsilon-1 subunit",AP4E1,23431,ENSG00000081014,NA,"Spastic paraplegia 51, autosomal recessive, 613744 (3), Autosomal recessive; Stuttering, familial persistent, 1, 184450 (3), Autosomal dominant",Ap4e1 (MGI:1336993)
15,51056600,51105275,15q21.2,15q21.2,616438,"TNFAIP8L3, TIPE3",Tumor necrosis factor-alpha-induced protein 8-like 3,TNFAIP8L3,388121,ENSG00000183578,NA,NA,Tnfaip8l3 (MGI:2685363)
15,51208056,51338595,15q21.1,15q21.2,107910,"CYP19A1, CYP19, ARO","Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens)",CYP19A1,1588,ENSG00000137869,close to CYP11 in mouse,"Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300 (3), Autosomal dominant",Cyp19a1 (MGI:88587)
15,51341654,51413364,15q21.2,15q21.2,608603,"GLDN, CRGL2, LCCS11",Gliomedin,GLDN,342035,ENSG00000186417,NA,"Lethal congenital contracture syndrome 11, 617194 (3), Autosomal recessive",Gldn (MGI:2388361)
15,51447721,51622832,15q21.2,15q21.2,612186,"DMXL2, RC3, KIAA0856, PEPNS, DFNA71",DMX-like 2,DMXL2,23312,ENSG00000104093,mutation identified in 1 PEPNS family and 1 DFNA71 family,"?Deafness, autosomal dominant 71, 617605 (3), Autosomal dominant; ?Polyendocrine-polyneuropathy syndrome, 616113 (3), Autosomal recessive",Dmxl2 (MGI:2444630)
15,51681352,51721025,15q21.3,15q21.2,611796,SCG3,Secretogranin III,SCG3,29106,ENSG00000104112,NA,NA,Scg3 (MGI:103032)
15,51751560,51816362,15q21.1-q21.2,15q21.2,602928,TMOD2,"Tropomodulin 2, neuronal",TMOD2,29767,ENSG00000128872,NA,NA,Tmod2 (MGI:1355335)
15,51829652,51915724,15q21.1-q21.2,15q21.2,605112,TMOD3,Tropomodulin 3,TMOD3,29766,ENSG00000138594,NA,NA,Tmod3 (MGI:1355315)
15,51938023,51971800,15q15.3,15q21.2,610507,"LEO1, RDL","LEO1 RNA polymerase II associated factor, S. cerevisiae, homolog of",LEO1,123169,ENSG00000166477,NA,NA,Leo1 (MGI:2685031)
15,52109262,52112774,15q21,15q21.2,606910,BCL2L10,BCL2-like 10,BCL2L10,10017,ENSG00000137875,NA,NA,Bcl2l10 (MGI:1330841)
15,52115099,52191391,15q21.2,15q21.2,604447,"GNB5, GB5, IDDCA, LADCI","Guanine nucleotide-binding protein, beta-5",GNB5,10681,ENSG00000069966,NA,"Intellectual developmental disorder with cardiac arrhythmia, 617173 (3), Autosomal recessive; Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia, 617182 (3), Autosomal recessive",Gnb5 (MGI:101848)
15,52192317,52295803,15q21,15q21.2,610022,MYO5C,Myosin Vc,MYO5C,55930,ENSG00000128833,NA,NA,Myo5c (MGI:2442485)
15,52307282,52529049,15q21,15q21.2,160777,"MYO5A, MYH12, GS1",Myosin Va,MYO5A,4644,ENSG00000197535,NA,"Griscelli syndrome, type 1, 214450 (3), Autosomal recessive",Myo5a (MGI:105976)
15,52547044,52569445,Chr.15,15q21.2,605487,"ARPP19, ARPP16","cAMP-regulated phosphoprotein, 19kD",ARPP19,10776,ENSG00000128989,NA,NA,Arpp19 (MGI:1891691)
15,52755052,52790335,15q21.1-q21.2,15q21.3,604164,"ONECUT1, HNF6A, HNF6","One cut domain, family member 1 (hepatocyte nuclear factor 6-alpha)",ONECUT1,3175,ENSG00000169856,NA,NA,Onecut1 (MGI:1196423)
15,53513740,53762877,15q21.3,15q21.3,613214,"WDR72, AI2A3",WD repeat-containing protein 72,WDR72,256764,ENSG00000166415,NA,"Amelogenesis imperfecta, type IIA3, 613211 (3), Autosomal recessive",Wdr72 (MGI:3583957)
15,53837572,54633439,15q21.3,15q21.3,614568,UNC13C,"Unc13, C. elegans, homolog of, C",UNC13C,440279,ENSG00000137766,NA,NA,Unc13c (MGI:2149021)
15,55180805,55196940,15q21.3,15q21.3,613262,"RSL24D1, RLP24",Ribosomal protein L24 domain-containing protein 1,RSL24D1,51187,ENSG00000137876,NA,NA,Rsl24d1 (MGI:2681840)
15,55202965,55291337,15q21,15q21.3,603868,"RAB27A, RAM, GS2",Ras-associated protein RAB27A,RAB27A,5873,ENSG00000069974,NA,"Griscelli syndrome, type 2, 607624 (3), Autosomal recessive",Rab27a (MGI:1861441)
15,55318938,55355647,15q21-q22,15q21.3,604122,PIGB,"Phosphatidylinositol glycan, class B",PIGB,9488,ENSG00000069943,NA,NA,Pigb (MGI:1891825)
15,55355222,55408509,15q21.3,15q21.3,611326,"CCPG1, KIAA1254, CPR8",Cell cycle progression 1,CCPG1,9236,ENSG00000260916,NA,NA,Ccpg1 (MGI:1196419)
15,55417754,55508233,15q21,15q21.3,608706,"DNAAF4, DYX1C1, DYXC1, DYX1, CILD25","Dynein, axonemal, assembly factor 4",DNAAF4,161582,ENSG00000256061,not confirmed by some studies,"Ciliary dyskinesia, primary, 25, 615482 (3), Autosomal recessive; {Dyslexia, susceptibility to, 1}, 127700 (3), Autosomal dominant",Dnaaf4 (MGI:1914935)
15,55538883,55588970,15q21.3,15q21.3,606902,PYGO1,"Pygopus, Drosophila, homolog of, 1",PYGO1,26108,ENSG00000171016,NA,NA,Pygo1 (MGI:1919385)
15,55611539,55743151,15q21.3,15q21.3,613261,PRTG,"Protogenin, chicken, homolog of",PRTG,283659,ENSG00000166450,NA,NA,Prtg (MGI:2444710)
15,55826916,55993611,15q,15q21.3,602278,NEDD4,"Neural precursor cell expressed, developmentally downregulated-4",NEDD4,4734,ENSG00000069869,NA,NA,NA
15,56087279,56247653,15q21.3,15q21.3,612660,"RFX7, RFXDC2","Regulatory factor X, 7",RFX7,64864,ENSG00000181827,NA,NA,Rfx7 (MGI:2442675)
15,56428723,56465136,15q21.3,15q21.3,610766,"MNS1, FLJ11222",Meiosis-specific nuclear structural protein 1,MNS1,55329,ENSG00000138587,NA,NA,Mns1 (MGI:107933)
15,56918089,57292594,15q21,15q21.3,600480,"TCF12, HTF4, CRS3","Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4)",TCF12,6938,ENSG00000140262,NA,"Craniosynostosis 3, 615314 (3), Autosomal dominant",Tcf12 (MGI:101877)
15,57376457,57550722,15q21.2-q21.3,15q21.3,607856,"CGNL1, FLJ14957, KIAA1749",Cingulin-like 1,CGNL1,84952,ENSG00000128849,NA,NA,Cgnl1 (MGI:1915428)
15,57591903,57685363,15q21.3-q22.1,15q21.3,614071,"GUP, GCOM1, MYOZAP",GRINL1A complex locus upstream gene,MYZAP,100820829,ENSG00000263155,NA,NA,Myzap (MGI:2142908)
15,57706520,57717556,15q22.1,15q21.3,606485,"POLR2M, GDOWN, GRINL1A","Polymerase II, RNA, subunit M",POLR2M,81488,ENSG00000255529,NA,NA,Polr2m (MGI:107282)
15,57953423,58065922,15q21.3,15q21.3,603687,"ALDH1A2, RALDH2","Aldehyde dehydrogenase 1 family, member A2 (retinaldehyde dehydrogenase 2)",ALDH1A2,8854,ENSG00000128918,NA,NA,Aldh1a2 (MGI:107928)
15,58138168,58185910,15q22,15q21.3,602914,AQP9,Aquaporin 9,AQP9,366,ENSG00000103569,NA,NA,Aqp9 (MGI:1891066)
15,58410456,58569843,15q21.3,15q21.3,151670,"LIPC, HL, LIPH, HDLCQ12","Lipase C, hepatic",LIPC,3990,ENSG00000166035,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant; Hepatic lipase deficiency, 614025 (3), Autosomal recessive; [High density lipoprotein cholesterol level QTL 12], 612797 (3)",Lipc (MGI:96216)
15,58588808,58749706,15q21.3,15q21.3,602192,"ADAM10, MADM, RAK, AD18",A disintegrin and metalloprotease domain 10,ADAM10,102,ENSG00000137845,NA,"{Alzheimer disease 18, susceptibility to}, 615590 (3); Reticulate acropigmentation of Kitamura, 615537 (3), Autosomal dominant",Adam10 (MGI:109548)
15,58771257,58861899,15q21.3-q22.1,15q21.3-q22.1,618408,"MINDY2, FAM63B",MINDY lysine-48 deubiquitinase 2,MINDY2,54629,ENSG00000128923,NA,NA,Mindy2 (MGI:2443086)
15,58800000,78000000,15q22-q24,NA,611274,GLC1N,"Glaucoma 1, open angle, N",GLC1N,777645,NA,max lod at D15S125,"Glaucoma 1, open angle, N, 611274 (2)",NA
15,58800000,72400000,15q22-q23,NA,612632,USH1H,"Usher syndrome, type 1H",USH1H,100271837,NA,max lod at D15S980,"Usher syndrome, type 1H, 612632 (2)",NA
15,58987587,59097418,15q22.1-q22.2,15q22.1-q22.2,605840,RNF111,Ring finger protein 111,RNF111,54778,ENSG00000157450,NA,NA,Rnf111 (MGI:1934919)
15,59105145,59125044,15q22.2,15q22.2,602755,CCNB2,Cyclin B2,CCNB2,9133,ENSG00000157456,NA,NA,Ccnb2 (MGI:88311)
15,59132433,59372870,15q21-q22,15q22.2,601479,"MYO1E, MYO1C, FSGS6",Myosin IE,MYO1E,4643,ENSG00000157483,NA,"Glomerulosclerosis, focal segmental, 6, 614131 (3), Autosomal recessive",Myo1e (MGI:106621)
15,59611782,59622722,15q21.3,15q22.2,606836,GCNT3,"Glucosaminyl (N-acetyl) transferase 3, mucin-type",GCNT3,9245,ENSG00000140297,NA,NA,Gcnt3 (MGI:1919327)
15,59638061,59657514,15q22.2,15q22.2,600519,"GTF2A2, TF2A2","General transcription factor IIA, gamma subunit",GTF2A2,2958,ENSG00000140307,"pseudogenes on chr. 1, 8, 9",NA,Gtf2a2 (MGI:1933289)
15,59659145,59689533,15q22.2,15q22.2,603292,"BNIP2, NIP2",BCL2/adenovirus E1B 19kD protein-interacting protein 2,BNIP2,663,ENSG00000140299,NA,NA,Bnip2 (MGI:109327)
15,60347150,60398024,15q21-q22,15q22.2,151740,"ANXA2, ANX2L4, LPC2D, LIP2",Annexin A2 (lipocortin I),ANXA2,302,ENSG00000182718,pseudogenes ANX2P1 on 4q21-q31; ANX2P2 on 9p13; ANX2P3 on 10q24-q22,NA,Anxa2 (MGI:88246)
15,60419608,60479159,15q21.3,15q22.2,610835,NARG2,NMDA receptor-regulated 2,ICE2,79664,ENSG00000128915,pseudogenes on chr.4 and chr.3,NA,Ice2 (MGI:2135947)
15,60488283,61229301,15q21-q22,15q22.2,600825,"RORA, IDDECA",RAR-related orphan receptor A,RORA,6095,ENSG00000069667,NA,"Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, 618060 (3), Autosomal dominant",Rora (MGI:104661)
15,61852388,62060464,15q22.1,15q22.2,608879,"VPS13C, KIAA1421, PARK23","Vacuolar protein sorting 13, yeast, homolog of, C",VPS13C,54832,ENSG00000129003,NA,"Parkinson disease 23, autosomal recessive, early onset, 616840 (3), Autosomal recessive",Vps13c (MGI:2444207)
15,62066976,62070916,15q21.3,15q22.2,610343,"C2CD4A, NLF1",C2 calcium-dependent domain containing 4A,C2CD4A,145741,ENSG00000198535,NA,NA,C2cd4a (MGI:3645763)
15,62163534,62165731,15q21.3,15q22.2,610344,"C2CD4B, NLF2",C2 calcium-dependent domain containing 4B,C2CD4B,388125,ENSG00000205502,NA,NA,C2cd4b (MGI:1922947)
15,62390522,62844630,15q22.2,15q22.2,607349,"TLN2, KIAA0320",Talin 2,TLN2,83660,ENSG00000171914,NA,NA,Tln2 (MGI:1917799)
15,62823956,62824040,15q22.2,15q22.2,615845,MIR190A,Micro RNA 190A,MIR190A,406965,ENSG00000211137,NA,NA,NA
15,63042697,63071914,15q22.1,15q22.2,191010,"TPM1, CMH3, CMD1Y , LVNC9","Tropomyosin 1, alpha",TPM1,7168,ENSG00000140416,NA,"Cardiomyopathy, dilated, 1Y, 611878 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 3, 115196 (3), Autosomal dominant; Left ventricular noncompaction 9, 611878 (3), Autosomal dominant",NA
15,63121805,63142061,15q22.1,15q22.2,608440,LACTB,"Lactamase, beta",LACTB,114294,ENSG00000103642,NA,NA,Lactb (MGI:1933395)
15,63148248,63157476,15q22.2,15q22.2,612055,RPS27L,Ribosomal protein S27-like,RPS27L,51065,ENSG00000185088,NA,NA,Rps27l (MGI:1915191)
15,63189535,63267775,15q22.2,15q22.2,613532,RAB8B,Ras-associated protein RAB8B,RAB8B,51762,ENSG00000166128,NA,NA,Rab8b (MGI:2442982)
15,63277549,63309125,15q22.2,15q22.2,607630,APH1B,"Anterior pharynx defective 1, C. elegans, homolog of, B",APH1B,83464,ENSG00000138613,NA,NA,Aph1b (MGI:3522097)
15,63321377,63382165,15q22,15q22.2,603263,CA12,Carbonic anhydrase XII,CA12,771,ENSG00000074410,NA,"Hyperchlorhidrosis, isolated, 143860 (3), Autosomal recessive",Car12 (MGI:1923709)
15,63504510,63594639,15q22.3,15q22.31,604728,USP3,Ubiquitin-specific protease 3,USP3,9960,ENSG00000140455,NA,NA,Usp3 (MGI:2152450)
15,63597386,63603431,15q22.1,15q22.31,609088,"FBXL22, FBL22",F-box and leucine-rich repeat protein 22,FBXL22,283807,ENSG00000197361,NA,NA,NA
15,63608617,63833947,15q22.31,15q22.31,605109,"HERC1, MDFPMR",HECT domain and RCC1-like domain 1,HERC1,8925,ENSG00000103657,NA,"Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3), Autosomal recessive",Herc1 (MGI:2384589)
15,63907035,64046484,15q22.31,15q22.31,616567,"DAPK2, DRP1",Death-associated protein kinase 2,DAPK2,23604,ENSG00000035664,NA,NA,Dapk2 (MGI:1341297)
15,64072558,64094007,15q22.31,15q22.31,618382,"CIAO2A, CIA2A, FAM96A",Cytosolic iron-sulfur assembly component 2A,CIAO2A,84191,ENSG00000166797,NA,NA,Ciao2a (MGI:1915500)
15,64094065,64144230,15q22.3,15q22.31,601272,"SNX1, SNX1A",Sorting nexin 1,SNX1,6642,ENSG00000028528,NA,NA,Snx1 (MGI:1928395)
15,64155814,64163154,15q21-q22,15q22.31,123841,"PPIB, CYPB, OI9",Peptidyl-prolyl isomerase B,PPIB,5479,ENSG00000166794,NA,"Osteogenesis imperfecta, type IX, 259440 (3), Autosomal recessive",Ppib (MGI:97750)
15,64165524,64356172,15q22.1-q22.31,15q22.31,606274,CSNK1G1,"Casein kinase I, gamma-1",CSNK1G1,53944,ENSG00000169118,NA,NA,Csnk1g1 (MGI:2660884)
15,64364303,64387686,15q22.1,15q22.31,610696,"PAF, OEATC1, KIAA0101","PCNA-associated factor, 15kD",PCLAF,9768,ENSG00000166803,NA,NA,Pclaf (MGI:1915276)
15,64387803,64455302,15q22.31,15q22.31,604501,"TRIP4, ASC1, SMABF1, MDCDC",Thyroid hormone receptor interactor 4,TRIP4,9325,ENSG00000103671,mutation identified in 1 MDCDC family,"?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3), Autosomal recessive; Spinal muscular atrophy with congenital bone fractures 1, 616866 (3), Autosomal recessive",Trip4 (MGI:1928469)
15,64460349,64686067,15q22.31,15q22.31,617474,"ZNF609, KIAA0295",Zinc finger ptoein 609,ZNF609,23060,ENSG00000180357,NA,NA,Zfp609 (MGI:2674092)
15,64687573,64703280,15q22.31,15q22.31,604152,OAZ2,Ornithine decarboxylase antizyme 2,OAZ2,4947,ENSG00000180304,NA,NA,Oaz2 (MGI:109492)
15,64815631,64827172,15q22.31,15q22.31,610953,"PIF1, PIF","Pif1, S. cerevisiae, homolog of",PIF1,80119,ENSG00000140451,NA,NA,Pif1 (MGI:2143057)
15,64963021,64989913,15q21-q22,15q22.31,608181,"ACP33, MAST, SPG21","Acidic cluster protein, 33kD, (maspardin)",SPG21,51324,ENSG00000090487,NA,"Mast syndrome, 248900 (3), Autosomal recessive",Spg21 (MGI:106403)
15,65001511,65029638,15q22.31,15q22.31,611766,"MTFMT, COXPD15, MC1DN27",Mitochondrial methionyl-tRNA formyltransferase,MTFMT,123263,ENSG00000103707,NA,"Combined oxidative phosphorylation deficiency 15, 614947 (3), Autosomal recessive; Mitochondrial complex I deficiency, nuclear type 27, 618248 (3), Autosomal recessive",Mtfmt (MGI:1916856)
15,65045386,65053396,15q21,15q22.31,612085,OSTB,"Organic solute transporter, beta",SLC51B,123264,ENSG00000186198,NA,NA,Slc51b (MGI:3582052)
15,65076815,65079937,15q22.31,15q22.31,613727,"KBTBD13, NEM6",Kelch repeat and BTB/POZ domains-containing protein 13,KBTBD13,390594,ENSG00000234438,NA,"Nemaline myopathy 6, autosomal dominant, 609273 (3), Autosomal dominant",Kbtbd13 (MGI:1921742)
15,65117378,65133807,15q22.31,15q22.31,608138,PDCD7,Programmed cell death 7,PDCD7,10081,ENSG00000090470,NA,NA,Pdcd7 (MGI:1859170)
15,65148218,65185419,15q22.31,15q22.31,615611,"CLPX, EPP2",Caseinolytic mitochondrial matrix peptidase chaperone subunit,CLPX,10845,ENSG00000166855,mutation identified in 1 EPP2 family,"?Protoporphyria, erythropoietic, 2, 618015 (3), Autosomal dominant",Clpx (MGI:1346017)
15,65194759,65213141,15q22,15q22.31,603489,CILP,Cartilage intermediate layer protein,CILP,8483,ENSG00000138615,NA,"{Lumbar disc disease, susceptibility to}, 603932 (3)",Cilp (MGI:2444507)
15,65296050,65296166,15q22.31,15q22.31,180691,"RNU5A, RNU5","RNA, U5A small nuclear",RNU5A-1,26831,ENSG00000199568,NA,NA,NA
15,65327126,65378001,15q22.3-q23,15q22.31,604184,PUNC,Putative neuronal cell adhesion molecule,IGDCC3,9543,ENSG00000174498,NA,NA,Igdcc3 (MGI:1202390)
15,65381483,65422946,15q22.31,15q22.31,616810,"IGDCC4, NOPE, KIAA1628","Immunoglobulin superfamily, DCC subclass, member 4",IGDCC4,57722,ENSG00000103742,NA,NA,Igdcc4 (MGI:1858497)
15,65442462,65517712,15q22,15q22.31,606819,DPP8,Dipeptidyl peptidase 8,DPP8,54878,ENSG00000074603,NA,NA,Dpp8 (MGI:1921638)
15,65530462,65578354,15q22.31,15q22.31,615940,"PTPLAD1, BIND1, HACD3",Protein tyrosine phosphatase-like A domain-containing protein 1,HACD3,51495,ENSG00000074696,NA,NA,Hacd3 (MGI:1889341)
15,65611312,65661001,15q22,15q22.31,603617,"SLC24A1, NCKX1, CSNB1D","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1",SLC24A1,9187,ENSG00000074621,NA,"Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3), Autosomal recessive",Slc24a1 (MGI:2384871)
15,65655233,65792292,15q22.31,15q22.31,600382,DENND4A,DENN/MADD domain containing 4A,DENND4A,10260,ENSG00000174485,NA,NA,Dennd4a (MGI:2142979)
15,65869490,65891988,15q21.3-q22.31,15q22.31,605570,RAB11A,"Ras family, member RAB11A",RAB11A,8766,ENSG00000103769,NA,NA,Rab11a (MGI:1858202)
15,65889716,66253736,15q22.31,15q22.31,612454,"MEGF11, KIAA1781",Multiple epidermal growth factor-like domains 11,MEGF11,84465,ENSG00000157890,NA,NA,Megf11 (MGI:1920951)
15,66293308,66333897,15q22.31,15q22.31,614183,"DIS3L, DIS3L1, KIAA1955","Dis3 mitotic control, S. cerevisiae, homolog-like",DIS3L,115752,ENSG00000166938,NA,NA,Dis3l (MGI:2143272)
15,66334973,66387272,15q22.3,15q22.31,610716,TIPIN,Timeless-interacting protein,TIPIN,54962,ENSG00000075131,NA,NA,Tipin (MGI:1921571)
15,66386872,66491543,15q21,15q22.31,176872,"MAP2K1, PRKMK1, MKK1, MEK1, CFC3",Mitogen-activated protein kinase kinase 1,MAP2K1,5604,ENSG00000169032,pseudogene on 8p21,"Cardiofaciocutaneous syndrome 3, 615279 (3)",Map2k1 (MGI:1346866)
15,66489747,66497814,15q22.31,15q22.31,605979,"SNAPC5, SNAP19","Small nuclear RNA-activating protein complex, polypeptide 5",SNAPC5,10302,ENSG00000174446,NA,NA,Snapc5 (MGI:1914282)
15,66498014,66504854,15q,15q22.31,180479,RPL4,Ribosomal protein L4,RPL4,6124,ENSG00000174444,NA,NA,Rpl4 (MGI:1915141)
15,66505082,66550129,15q22.3,15q22.31,609984,ZWILCH,"Zwilch, Drosophila, homolog of",ZWILCH,55055,ENSG00000174442,NA,NA,Zwilch (MGI:1915264)
15,66547178,66565997,15q22.31,15q22.31,617060,"LCTL, KLG, KLPH",Lactase-like protein,LCTL,197021,ENSG00000188501,NA,NA,Lctl (MGI:2183549)
15,66702109,66782848,15q21-q22,15q22.31,602931,"SMAD6, MADH6, AOVD2","Mothers against decapentaplegic, Drosophila, homolog of, 6",SMAD6,4091,ENSG00000137834,NA,"Aortic valve disease 2, 614823 (3), Autosomal dominant; {Craniosynostosis 7, susceptibility to}, 617439 (3), Autosomal dominant",Smad6 (MGI:1336883)
15,66900000,67000000,15q22.32,NA,612579,STQTL16,Stature quantitative trait locus 16,NA,100270802,NA,associated with rs8038652,"{Stature QTL 16}, 612579 (2)",NA
15,67065601,67195194,15q22.3,15q22.33,603109,"SMAD3, MADH3, LDS3","Mothers against decapentaplegic, Drosophila, homolog of, 3",SMAD3,4088,ENSG00000166949,NA,"Loeys-Dietz syndrome 3, 613795 (3), Autosomal dominant",Smad3 (MGI:1201674)
15,67200000,101991189,15q23-q26.3,NA,607248,GLM4,Glioma susceptibility 4,NA,338030,NA,max lod at D15S130,"{Glioma susceptibility 4}, 607248 (2)",NA
15,67200666,67255197,15q22.33-q23,15q23,614888,"AAGAB, p34, PPKP1A, PPKP1, KPPP1",Alpha- and gamma-adaptin-binding protein,AAGAB,79719,ENSG00000103591,NA,"Keratoderma, palmoplantar, punctate type IA, 148600 (3), Autosomal dominant",Aagab (MGI:1914189)
15,67254785,67501803,15q22.31,15q23,612523,"IQCH, NYDSP5",IQ motif-containing protein H,IQCH,64799,ENSG00000103599,NA,NA,Iqch (MGI:1925500)
15,67542684,67807113,15q23,15q23,602520,"MAP2K5, PRKMK5, MEK5, MAPKK5",Mitogen-activated protein kinase kinase 5,MAP2K5,5607,ENSG00000137764,NA,NA,Map2k5 (MGI:1346345)
15,67825508,67834581,15q23,15q23,611273,"LBXCOR1, CORL1","LBX1 corepressor 1, mouse, homolog of",SKOR1,390598,ENSG00000188779,NA,NA,NA
15,67839939,67840044,15q23,15q23,180692,"RNU6-1, RNU6A, RNU6","RNA, U6 small nuclear 1",RNU6-1,26827,ENSG00000206625,NA,NA,NA
15,68054178,68191463,15q22,15q23,603566,"PIAS1, DDXBP1, GBP","protein inhibitor of activated STAT, 1",PIAS1,8554,ENSG00000033800,NA,NA,Pias1 (MGI:1913125)
15,68206991,68229727,15q21-q23,15q23,606725,"CLN6, CLN4A",CLN6 gene,CLN6,54982,ENSG00000128973,NA,"Ceroid lipofuscinosis, neuronal, 6, 601780 (3), Autosomal recessive; Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3), Autosomal recessive",Cln6 (MGI:2159324)
15,68277744,68295861,15q23,15q23,613539,"FEM1B, KIAA0396","Fem1, C. elegans, homolog of, B",FEM1B,10116,ENSG00000169018,NA,NA,Fem1b (MGI:1335087)
15,68296531,68432311,15q23,15q23,604789,ITGA11,"Integrin, alpha-11",ITGA11,22801,ENSG00000137809,NA,NA,Itga11 (MGI:2442114)
15,68518372,68727805,15q23,15q23,605002,"CORO2B, CLIPINC",Coronin 2B,CORO2B,10391,ENSG00000103647,NA,NA,Coro2b (MGI:2444283)
15,68778534,68820894,15q22.3-q23,15q23,600832,"ANP32A, PHAP1","Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A",ANP32A,8125,ENSG00000140350,NA,NA,NA
15,68930499,69062761,15q23,15q23,606572,NOX5,NADPH oxidase 5,NOX5,79400,ENSG00000255346,NA,NA,NA
15,68930524,68946810,15q22,15q23,609399,SPESP1,Sperm equatorial segment protein 1,SPESP1,246777,ENSG00000258484,NA,NA,Spesp1 (MGI:1913962)
15,69080849,69095823,15q23,15q23,616492,"EWSAT1, LINC00277","Ewing sarcoma-associated transcript 1, noncoding",EWSAT1,283673,ENSG00000212766,NA,NA,NA
15,69160554,69272208,15q23,15q23,612134,"GLCE, HSEPI, KIAA0836",Glucuronic acid epimerase,GLCE,26035,ENSG00000138604,NA,NA,Glce (MGI:2136405)
15,69284133,69407779,15q23,15q23,607781,"PAQR5, MPRG","Progestin and ADIPOQ receptor family, member 5",PAQR5,54852,ENSG00000137819,NA,NA,Paqr5 (MGI:1921340)
15,69414324,69448426,15q23,15q23,605064,"KIF23, KNSL5, MKLP1",Kinesin family member 23,KIF23,9493,ENSG00000137807,NA,NA,Kif23 (MGI:1919069)
15,69452817,69456204,Chr.15,15q23,180520,RPLP1,"Ribosomal phosphoprotein, Large, P1",RPLP1,6176,ENSG00000137818,NA,NA,NA
15,69561719,69571439,15q23,15q23,616387,DRAIC,"Downregulated RNA in androgen-independent cells, noncoding",DRAIC,145837,ENSG00000245750,NA,NA,NA
15,69592199,69695749,15q23,15q23,616273,PCAT29,"Prostate cancer-associated transcript 29, noncoding",PCAT29,104472713,ENSG00000245750,NA,NA,NA
15,70047789,70098170,15q22,15q23,600190,"TLE3, ESG","Transducin-like enhancer of split 3, homolog of Drosophila a E(spl)",TLE3,7090,ENSG00000140332,NA,NA,Tle3 (MGI:104634)
15,70654553,70778822,15q24,15q23,612516,"UACA, NUCLING",Uveal autoantigen with coiled-coil domains and ankyrin repeats,UACA,55075,ENSG00000137831,NA,NA,Uaca (MGI:1919815)
15,70829129,70854156,15q23,15q23,611300,"LARP6, ACHN","La ribonucleoprotein domain family, member 6",LARP6,55323,ENSG00000166173,NA,NA,Larp6 (MGI:1914807)
15,70881341,70892432,15q23,15q23,612538,THAP10,THAP domain-containing protein 10,THAP10,56906,ENSG00000129028,NA,NA,NA
15,71115615,71783382,15q23,15q23,614476,"THSD4, ADAMTSL6",Thrombospondin type-1 domain-containing 4,THSD4,79875,ENSG00000187720,NA,NA,Thsd4 (MGI:2672033)
15,71810553,71818252,15q23,15q23,604485,"NR2E3, PNR, ESCS, RP37","Nuclear receptor subfamily 2, group E, member 3",NR2E3,10002,ENSG00000278570,near BBS4,"Enhanced S-cone syndrome, 268100 (3), Autosomal recessive; Retinitis pigmentosa 37, 611131 (3), Autosomal recessive, Autosomal dominant",Nr2e3 (MGI:1346317)
15,71822290,72118576,15q22-q23,15q23,604875,"MYO9A, CMS24",Myosin IXa,MYO9A,4649,ENSG00000066933,NA,"Myasthenic syndrome, congenital, 24, presynaptic, 618198 (3), Autosomal recessive",Myo9a (MGI:107735)
15,72114257,72143691,15q23,15q23,608659,"SENP8, NEDP1, DEN1","Sentrin-specific protease family, member 8",SENP8,123228,ENSG00000166192,NA,NA,Senp8 (MGI:1918849)
15,72199028,72231623,15q22,15q23,179050,"PKM, PKM2, PK3, THBP1","Pyruvate kinase, muscle",PKM,5315,ENSG00000067225,NA,NA,Pkm (MGI:97591)
15,72284726,72320156,15q24,15q23,612681,"CELF6, BRUNOL6","CUGbp- and ELAV-like family, member 6",CELF6,60677,ENSG00000140488,NA,NA,NA
15,72340923,72376472,15q23-q24,15q23,606869,"HEXA, TSD","Hexosaminidase A, alpha polypeptide",HEXA,3073,ENSG00000213614,on 15q+ in APL,"GM2-gangliosidosis, several forms, 272800 (3), Autosomal recessive; [Hex A pseudodeficiency], 272800 (3), Autosomal recessive; Tay-Sachs disease, 272800 (3), Autosomal recessive",Hexa (MGI:96073)
15,72400000,88500000,15q24-q25,NA,612274,CILD8,"Ciliary dyskinesia, primary, 8",NA,100190786,NA,max lod at D15S154,"Ciliary dyskinesia, primary, 8, 612274 (2)",NA
15,72400000,78000000,15q24,NA,603204,ENFL2,"Epilepsy, nocturnal frontal lobe, type 2",NA,50971,NA,some ENFL not on 20q or 15q,"Epilepsy, nocturnal frontal lobe, type 2, 603204 (2), Autosomal dominant",NA
15,72400000,78000000,15q24,NA,602685,MRST,"Mental retardation, severe, with spasticity and tapetoretinal degeneration",NA,8126,NA,NA,"Mental retardation, severe, with spasticity and tapetoretinal degeneration, 602685 (2)",NA
15,72474329,72602986,15q24,15q24.1,605624,"ARIH1, ARI, UBCH7BP","Ariadne, Drosophila, homolog of, 1",ARIH1,25820,ENSG00000166233,NA,NA,Arih1 (MGI:1344363)
15,72686178,72738475,15q22.3-q23,15q24.1,600374,BBS4,BBS4 gene,BBS4,585,ENSG00000140463,NA,"Bardet-Biedl syndrome 4, 615982 (3), Autosomal recessive",Bbs4 (MGI:2143311)
15,72751293,72783775,15q24.1,15q24.1,611861,ADPGK,ADP-dependent glucokinase,ADPGK,83440,ENSG00000159322,NA,NA,Adpgk (MGI:1919391)
15,73051714,73305205,15q22.3-q23,15q24.1,601907,"NEO1, NGN","Neogenin, chicken, homolog of, 1",NEO1,4756,ENSG00000067141,NA,NA,Neo1 (MGI:1097159)
15,73319858,73368957,15q24-q25,15q24.1,605206,"HCN4, SSS2",Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4,HCN4,10021,ENSG00000138622,NA,"Brugada syndrome 8, 613123 (3); Sick sinus syndrome 2, 163800 (3), Autosomal dominant",Hcn4 (MGI:1298209)
15,73443163,73560012,15q24.1,15q24.1,618421,REC114,Rec114 meiotic recombination protein,REC114,283677,ENSG00000183324,NA,NA,Rec114 (MGI:1920923)
15,73560013,73633388,15q24.1,15q24.1,612820,"NPTN, SDFR1, GP55, NP55, GP65, NP65",Neuroplastin,NPTN,27020,ENSG00000156642,NA,NA,NA
15,73566937,73569542,15q24.1,15q24.1,615176,NPTNIT1,"NPTN intronic transcript 1, noncoding",NPTN-IT1,101241892,ENSG00000281183,NA,NA,NA
15,73683965,73714517,15q23-q24,15q24.1,605715,"CD276, B7H3",CD276 molecule,CD276,80381,ENSG00000103855,NA,NA,Cd276 (MGI:2183926)
15,73735430,73753169,15q24.1,15q24.1,617128,"C15orf59, INSYN1",Chromosome 15 open reading frame 59,INSYN1,388135,ENSG00000205363,NA,NA,Insyn1 (MGI:2442108)
15,73917467,73928247,15q24.1,15q24.1,616800,LOXL1AS1,LOXL1 antisense RNA 1,LOXL1-AS1,100287616,ENSG00000261801,NA,NA,NA
15,73926461,73952136,15q24.1,15q24.1,153456,"LOXL1, LOXL",Lysyl oxidase-like 1,LOXL1,4016,ENSG00000129038,NA,"{Exfoliation syndrome, susceptibility to}, 177650 (3), Autosomal dominant",Loxl1 (MGI:106096)
15,73978925,73994635,15q22,15q24.1,608326,"STOML1, STORP",Stomatin-like protein 1,STOML1,9399,ENSG00000067221,NA,NA,Stoml1 (MGI:1916356)
15,73994672,74047826,15q22,15q24.1,102578,"PML, MYL","Promyelocytic leukemia, inducer of",PML,5371,ENSG00000140464,fused with RARA in APL,"Leukemia, acute promyelocytic, PML/RARA type (3)",Pml (MGI:104662)
15,74069856,74082549,15q22,15q24.1,610288,"GOLGA6, GLP","Golgi autoantigen, golgin subfamily A, 6",GOLGA6A,342096,ENSG00000159289,NA,NA,NA
15,74100313,74141825,15q24.1,15q24.1,614179,"ISLR2, LINX, KIAA1464",Immunoglobulin superfamily containing leucine-rich repeat 2,ISLR2,57611,ENSG00000167178,NA,NA,Islr2 (MGI:2444277)
15,74173709,74176870,15q23-q24,15q24.1,602059,ISLR,Immunoglobulin superfamily containing leucine-rich repeat,ISLR,3671,ENSG00000129009,NA,NA,Islr (MGI:1349645)
15,74179465,74212266,15q24.1,15q24.1,610745,"STRA6, MCOPS9, MCOPCB8","Stimulated by retinoic acid 6, mouse, homolog of",STRA6,64220,ENSG00000137868,NA,"Microphthalmia, isolated, with coloboma 8, 601186 (3), Autosomal recessive; Microphthalmia, syndromic 9, 601186 (3), Autosomal recessive",Stra6 (MGI:107742)
15,74337761,74367645,15q24.1,15q24.1,118485,"CYP11A1, P450SCC","Cytochrome P450, subfamily XIA, polypeptide 1 (cholesterol side chain cleavage enzyme)",CYP11A1,1583,ENSG00000140459,NA,"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)",Cyp11a1 (MGI:88582)
15,74409283,74433957,15q24.1,15q24.1,607961,"SEMA7A, SEMAL, SEMAK1, CDW108, JMH",Semaphorin 7A,SEMA7A,8482,ENSG00000138623,NA,"[Blood group, John-Milton-Hagen system], 614745 (3)",Sema7a (MGI:1306826)
15,74445976,74461828,15q22.3-q23,15q24.1,609748,UBL7,Ubiquitin-like 7,UBL7,84993,ENSG00000138629,NA,NA,Ubl7 (MGI:1916709)
15,74541176,74598130,15q24,15q24.1,612457,"ARID3B, DRIL2, BDP",AT-rich interactive domain-containing protein 3B,ARID3B,10620,ENSG00000179361,NA,NA,Arid3b (MGI:1930768)
15,74608371,74630200,15q24,15q24.1,602990,CLK3,CDC-like kinase 3,CLK3,1198,ENSG00000179335,NA,NA,Clk3 (MGI:1098670)
15,74630557,74696433,15q24.1,15q24.1,609842,"EDC3, YJDC, MRT50","Enhancer of mRNA decapping 3, S. cerevisiae, homolog of",EDC3,80153,ENSG00000179151,mutation identified in 1 MRT50 family,"?Mental retardation, autosomal recessive 50, 616460 (3), Autosomal recessive",Edc3 (MGI:2142951)
15,74719541,74725527,15q24.1,15q24.1,108330,"CYP1A1, CYP1","Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 1",CYP1A1,1543,ENSG00000140465,head-to-head with CYP1A2,NA,Cyp1a1 (MGI:88588)
15,74748844,74756606,15q24.1,15q24.1,124060,CYP1A2,"Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 2",CYP1A2,1544,ENSG00000140505,23.3kb from CYP1A1,NA,Cyp1a2 (MGI:88589)
15,74782079,74803197,15q23-q25,15q24.1,124095,CSK,c-src tyrosine kinase,CSK,1445,ENSG00000103653,NA,NA,Csk (MGI:88537)
15,74836115,74843210,15q24.1,15q24.1,613472,ULK3,UNC51-like kinase 3,ULK3,25989,ENSG00000140474,NA,NA,Ulk3 (MGI:1918992)
15,74843729,74873364,Chr.15,15q24.1,606912,SCAMP2,Secretory carrier membrane protein 2,SCAMP2,10066,ENSG00000140497,NA,NA,Scamp2 (MGI:1346518)
15,74890041,74902218,15q22-qter,15q24.1-q24.2,154550,"MPI, PMI1, CDG1B",Mannosephosphate isomerase (phosphomannose isomerase 1),MPI,4351,ENSG00000178802,NA,"Congenital disorder of glycosylation, type Ib, 602579 (3), Autosomal recessive",Mpi (MGI:97075)
15,74919790,74938072,15q25,15q24.2,603773,COX5A,"Cytochrome C oxidase, subunit Va",COX5A,9377,ENSG00000178741,pseudogene on 14q22,NA,Cox5a (MGI:88474)
15,74995534,75021494,15q23,15q24.2,613766,SCAMP5,Secretory carrier membrane protein 5,SCAMP5,192683,ENSG00000198794,NA,NA,Scamp5 (MGI:1928948)
15,75023543,75060179,15q24.2,15q24.2,609854,PPCDC,Phosphopantothenoylcysteine decarboxylase,PPCDC,60490,ENSG00000138621,NA,NA,Ppcdc (MGI:1914062)
15,75335995,75341926,15q24.2,15q24.2,616701,COMMD4,COMM domain-containing protein 4,COMMD4,54939,ENSG00000140365,NA,NA,Commd4 (MGI:1913449)
15,75346637,75357114,15q24.2,15q24.2,608844,"NEIL1, NEI1, FPG1",Endonuclease VIII-like 1,NEIL1,79661,ENSG00000140398,NA,NA,Neil1 (MGI:1920024)
15,75355791,75368626,15q11-q13,15q24.2,154580,"MAN2C1, MANA","Mannosidase, alpha, class 2C, member 1",MAN2C1,4123,ENSG00000140400,NA,NA,Man2c1 (MGI:1920994)
15,75369378,75455818,15q24,15q24.2,607776,"SIN3A, WITKOS","Sin3, yeast, homolog of, A",SIN3A,25942,ENSG00000169375,NA,"Witteveen-Kolk syndrome, 613406 (3), Autosomal dominant",Sin3a (MGI:107157)
15,75463250,75579314,15q24.2,15q24.2,600768,PTPN9,"Protein-tyrosine phosphatase, nonreceptor-type, 9",PTPN9,5780,ENSG00000169410,NA,NA,Ptpn9 (MGI:1928376)
15,75639084,75640322,15q24,15q24.2,612980,"IMP3, MRPS4, BRMS2","Imp3, S. cerevisiae, homolog of",IMP3,55272,ENSG00000177971,NA,NA,Imp3 (MGI:1916119)
15,75674321,75712847,15q24.2,15q24.2,601172,"CSPG4, MCSPG, MSK16, NG2",Chondroitin sulfate proteoglycan,CSPG4,1464,ENSG00000173546,NA,NA,Cspg4 (MGI:2153093)
15,75843342,75901077,15q23,15q24.2,612501,"UBE2Q2, LOC92912",Ubiquitin-conjugating enzyme E2Q 2,UBE2Q2,92912,ENSG00000140367,NA,NA,Ube2q2 (MGI:2388672)
15,75903858,75942510,15q23,15q24.2,609096,"FBXO22, FBX22",F-box only protein 22,FBXO22,26263,ENSG00000167196,NA,NA,Fbxo22 (MGI:1926014)
15,75933218,76069829,15q24.1,15q24.2,610894,"NRG4, HRG4",Neuregulin 4,NRG4,145957,ENSG00000169752,NA,NA,Nrg4 (MGI:1933833)
15,76215352,76311468,15q23-q25,15q24.2-q24.3,608053,"ETFA, GA2, MADD","Electron transfer flavoprotein, alpha polypeptide",ETFA,2108,ENSG00000140374,NA,"Glutaric acidemia IIA, 231680 (3), Autosomal recessive",Etfa (MGI:106092)
15,76347903,76905456,15q24,15q24.3,611611,"SCAPER, KIAA1454, IDDRP",S-phase cyclin A-associated protein in the endoplasmic reticulum,SCAPER,49855,ENSG00000140386,NA,"Intellectual developmental disorder and retinitis pigmentosa, 618195 (3), Autosomal recessive",Scaper (MGI:1925976)
15,76931748,76954392,15q23,15q24.3,602584,"RCN2, ERC55","Reticulocalbin 2, EF-hand calcium binding domain (endoplasmic reticulum calcium-binding protein, 55kD)",RCN2,5955,ENSG00000117906,NA,NA,Rcn2 (MGI:1349765)
15,76994679,77037474,15q24-q25.1,15q24.3,606347,"PSTPIP1, PSTPIP, CD2BP1, PAPAS",Proline-serine-threonine phosphatase-interacting protein 1,PSTPIP1,9051,ENSG00000140368,NA,"Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3), Autosomal dominant",Pstpip1 (MGI:1321396)
15,77041403,77071108,15q24.3,15q24.3,613134,TSPAN3,Tetraspanin 3,TSPAN3,10099,ENSG00000140391,NA,NA,Tspan3 (MGI:1928098)
15,77100653,77420698,15q24.3,15q24.3,614248,"PEAK1, KIAA2002",Pseudopodium-enriched atypical kinase 1,PEAK1,79834,ENSG00000173517,NA,NA,Peak1 (MGI:2442366)
15,77420650,77519898,15q24,15q24.3,605534,HMG20A,High mobility group protein 20A,HMG20A,10363,ENSG00000140382,NA,NA,Hmg20a (MGI:1914117)
15,77613023,77820899,15q24,15q24.3,609791,"LINGO1, LRRN6A, LERN1, MRT64",Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 1,LINGO1,84894,ENSG00000169783,NA,"Mental retardation, autosomal recessive 64, 618103 (3), Autosomal recessive",Lingo1 (MGI:1915522)
15,78000000,88500000,15q25,NA,614294,"DEL15q25, C15DELq25",Chromosome 15q25 deletion syndrome,NA,NA,NA,"chr15:82,889,423-83,552,890, NCBI36","Chromosome 15q25 deletion syndrome, 614294 (4), Autosomal dominant",NA
15,78000000,101991189,15q25-q26,NA,606451,DFNA30,"Deafness, autosomal dominant 30",DFNA30,23719,NA,NA,"Deafness, autosomal dominant 30, 606451 (2), Autosomal dominant",NA
15,78000000,93800000,15q25.1-q26.1,NA,607728,"POROK4, DSAP2","Porokeratosis 4, disseminated superficial actinic",NA,353147,NA,between D15S1023 and D15S1030,"Porokeratosis 4, disseminated superficial actinic, 607728 (2)",NA
15,78104605,78131975,15q24,15q25.1,605564,"CIB2, KIP2",Calcium- and integrin-binding protein 2,CIB2,10518,ENSG00000136425,NA,"Deafness, autosomal recessive 48, 609439 (3), Autosomal recessive; Usher syndrome, type IJ, 614869 (3), Autosomal recessive",Cib2 (MGI:1929293)
15,78149361,78171944,15q25.1-q25.2,15q25.1,601149,IDH3A,Isocitrate dehydrogenase 3 (NAD+) alpha,IDH3A,3419,ENSG00000166411,NA,NA,Idh3a (MGI:1915084)
15,78167467,78234624,12q23-q24,15q25.1,614362,"ACSBG1, BG, BG1, KIAA0631","Acyl-CoA synthetase, bubble gum family, member 1",ACSBG1,23205,ENSG00000103740,NA,NA,Acsbg1 (MGI:2385656)
15,78340352,78348224,15q24,15q25.1,180230,"CRABP1, RBP5",Cellular retinoic acid-binding protein-1,CRABP1,1381,ENSG00000166426,distal to APL breakpoint,NA,Crabp1 (MGI:88490)
15,78437430,78501455,15q25.1,15q25.1,147582,"IREB2, NDCAMA",Iron-responsive element-binding protein-2,IREB2,3658,ENSG00000136381,mutation identified in 1 NDCAMA patient,"?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia, 618451 (3), Autosomal recessive",Ireb2 (MGI:1928268)
15,78507563,78537372,15q25.1,15q25.1,614681,AGPHD1,Aminoglycoside phosphotransferase domain-containing protein 1,HYKK,123688,ENSG00000188266,NA,NA,Hykk (MGI:2443139)
15,78540404,78552416,15q25.1,15q25.1,176846,"PSMA4, PSC9, HC9","Proteasome subunit, alpha-type, 4",PSMA4,5685,ENSG00000041357,NA,NA,Psma4 (MGI:1347060)
15,78565519,78595268,15q25.1,15q25.1,118505,"CHRNA5, LNCR2","Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5",CHRNA5,1138,ENSG00000169684,NA,"{Lung cancer susceptibility 2}, 612052 (3); {Nicotine dependence, susceptibility to}, 612052 (3)",Chrna5 (MGI:87889)
15,78593051,78621294,15q25.1,15q25.1,118503,"CHRNA3, LNCR2, PAOD2","Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3",CHRNA3,1136,ENSG00000080644,NA,"{Lung cancer susceptibility 2}, 612052 (3)",Chrna3 (MGI:87887)
15,78623281,78655585,15q24,15q25.1,118509,CHRNB4,"Cholinergic receptor, neuronal nicotinic, beta polypeptide-4",CHRNB4,1143,ENSG00000117971,NA,NA,Chrnb4 (MGI:87892)
15,78759202,78811475,15q25.1,15q25.1,605009,ADAMTS7,"A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 7",ADAMTS7,11173,ENSG00000136378,NA,NA,Adamts7 (MGI:1347346)
15,78872780,78898138,15q24,15q25.1,607303,"MORF4L1, MRG15",Mortality factor 4-like 1,MORF4L1,10933,ENSG00000185787,NA,NA,Morf4l1 (MGI:1096551)
15,78921749,78945097,15q24-q25,15q25.1,116820,CTSH,Cathepsin H,CTSH,1512,ENSG00000103811,NA,NA,Ctsh (MGI:107285)
15,78959946,79090779,15q25.1,15q25.1,606600,"RASGRF1, GRF55",Ras protein-specific guanine nucleotide-releasing factor 1,RASGRF1,5923,ENSG00000058335,NA,NA,Rasgrf1 (MGI:99694)
15,79209787,79209870,15q25.1,15q25.1,613146,"MIR184, MIRN184, KTCNCT, EDICT",Micro RNA 184,MIR184,406960,ENSG00000207695,NA,"EDICT syndrome, 614303 (3), Autosomal dominant",NA
15,79411556,79472303,15q25.1,15q25.1,618054,"KIAA1024, MINAR1",Major intrinsically disordered NOTCH2-binding receptor 1,MINAR1,23251,ENSG00000169330,NA,NA,Minar1 (MGI:2667167)
15,79843546,79897284,15q25.1,15q25.1,604197,"MTHFS, NEDMEHM","5,10-methenyltetrahydrofolate synthetase",MTHFS,10588,ENSG00000136371,NA,"Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination, 618367 (3), Autosomal recessive","Mthfsl,Mthfs (MGI:1340032,MGI:3780550)"
15,79960891,79971195,15q24.3,15q25.1,601056,BCL2A1,BCL2-related protein A1,BCL2A1,597,ENSG00000140379,NA,NA,"Bcl2a1d,Bcl2a1b,Bcl2a1a (MGI:102687,MGI:1278325,MGI:1278326)"
15,80059567,80138392,15q25.1,15q25.1,610183,"ZFAND6, ZA20D3, AWP1",Zinc finger AN1 domain-containing protein 6,ZFAND6,54469,ENSG00000086666,NA,NA,Zfand6 (MGI:1929510)
15,80152822,80186948,15q23-q25,15q25.1,613871,FAH,Fumarylacetoacetase,FAH,2184,ENSG00000103876,NA,"Tyrosinemia, type I, 276700 (3), Autosomal recessive",Fah (MGI:95482)
15,80404381,80597932,15q24,15q25.1,606036,"ARNT2, WEDAS",Aryl hydrocarbon receptor nuclear translocator 2,ARNT2,9915,ENSG00000172379,mutation identified in 1 WEDAS family,"?Webb-Dattani syndrome, 615926 (3), Autosomal recessive",Arnt2 (MGI:107188)
15,80695309,80755620,15q25.1,15q25.1,617944,"ABHD17C, FAM108C1",Abhydrolase domain-containing protein 17C,ABHD17C,58489,ENSG00000136379,NA,NA,Abhd17c (MGI:1917428)
15,80779369,80951770,15q24,15q25.1,608366,KIAA1199,KIAA1199 gene,CEMIP,57214,ENSG00000103888,NA,NA,Cemip (MGI:2443629)
15,80947325,80989877,Chr.15,15q25.1,607783,"MESDC2, MESD, BOCA, KIAA0081",Mesoderm development candidate gene 2,MESD,23184,ENSG00000117899,NA,NA,Mesd (MGI:1891421)
15,81000922,81005787,15q25.1,15q25.1,615466,MESDC1,Mesoderm development candidate 1,TLNRD1,59274,ENSG00000140406,NA,NA,Tlnrd1 (MGI:1891420)
15,81196877,81314057,15q26.1,15q25.1,603035,"IL16, LCF",Interleukin 16,IL16,3603,ENSG00000172349,NA,NA,Il16 (MGI:1270855)
15,81309052,81324182,15q26,15q25.1,607050,STARD5,Start domain-containing protein 5,STARD5,80765,ENSG00000172345,NA,NA,Stard5 (MGI:2156765)
15,81331087,81374212,15q25.1,15q25.1,617196,TMC3,Transmembrane channel-like protein 3,TMC3,342125,ENSG00000188869,NA,NA,Tmc3 (MGI:2669033)
15,82041777,82046017,15q25.2,15q25.2,611008,"MEX3B, RKHD3","Mex-3, C. elegans, homolog of, B",MEX3B,84206,ENSG00000183496,NA,NA,Mex3b (MGI:1918252)
15,82130219,82262762,15q25.2,15q25.2,617538,"EFL1, RIA1, EFTUD1, FAM42A, SDS2",Elongation factor-like GTPase 1,EFL1,79631,ENSG00000140598,NA,"Shwachman-Diamond syndrome 2, 617941 (3), Autosomal recessive",Efl1 (MGI:2141969)
15,82536749,82540456,15q,15q25.2,180472,"RPS17, RPS17L1, RPS17L2, DBA4",Ribosomal protein S17,RPS17,6218,ENSG00000182774,previously on chr.11; pseudogenes on 5q33-qter and 17q,"Diamond-Blackfan anemia 4, 612527 (3), Autosomal dominant",Rps17 (MGI:1309526)
15,82543200,82648794,15q25.2,15q25.2,607342,CPEB1,Cytoplasmic polyadenylation element-binding protein 1,CPEB1,64506,ENSG00000214575,NA,NA,Cpeb1 (MGI:108442)
15,82659280,82709907,15q25.2,15q25.2,602166,"AP3B2, NAPTB, EIEE48","Adaptor-related protein complex 3, beta 2 subunit",AP3B2,8120,ENSG00000103723,NA,"Epileptic encephalopathy, early infantile, 48, 617276 (3), Autosomal recessive",Ap3b2 (MGI:1100869)
15,82755944,82756070,15q25.2,15q25.2,612675,"SCARNA15, ACA45",Small cajal body-specific RNA 15,SCARNA15,677778,ENSG00000277864,NA,NA,NA
15,82809627,82836107,15q25.2,15q25.2,612393,"WHAMM, KIAA1971","Was protein homolog associated with actin, golgi membranes, and microtubules",WHAMM,123720,ENSG00000156232,NA,NA,Whamm (MGI:2142282)
15,82836945,82986175,15q24.3,15q25.2,604799,"HOMER2, HOMER2B, HOMER2A, DFNA68","Homer, homolog 2 (Drosophila)",HOMER2,9455,ENSG00000103942,mutation identified in 1 DFNA68 family,"?Deafness, autosomal dominant 68, 616707 (3), Autosomal dominant",Homer2 (MGI:1347354)
15,82986209,82991056,15q25.2,15q25.2,614547,"FAM103A1, RAM","Family with sequence similarity 103, member A1",RAMAC,83640,ENSG00000169612,NA,NA,Ramac (MGI:1914398)
15,83107586,83145402,15q24-q26,15q25.2,606562,TM6SF1,"Transmembrane 6 superfamily, member 1",TM6SF1,53346,ENSG00000136404,NA,NA,Tm6sf1 (MGI:1933209)
15,83112737,83207822,15q25,15q25.2,616643,"HRP3, HDGFRP3",Hepatoma-derived growth factor-related protein 3,HDGFL3,50810,ENSG00000166503,NA,NA,Hdgfl3 (MGI:1352760)
15,83255883,83284663,15q25.1,15q25.2,601930,BNC1,Basonuclin,BNC1,646,ENSG00000169594,NA,NA,Bnc1 (MGI:1097164)
15,83447122,83618742,15q24,15q25.2,603362,SH3GL3,SH3-domain GRB2-like 3,SH3GL3,6457,ENSG00000140600,NA,NA,Sh3gl3 (MGI:700011)
15,83654094,84039841,15q25.2,15q25.2,609199,"ADAMTSL3, KIAA1233",ADAMTS-like protein 3,ADAMTSL3,57188,ENSG00000156218,NA,NA,Adamtsl3 (MGI:3028499)
15,84631459,84642462,15q25.2,15q25.2,610417,SCAND2,SCAN domain-containing 2,SCAND2P,54581,NA,NA,NA,NA
15,84641494,84654342,15q25.2,15q25.2,616144,"WDR73, HSPC264, GAMOS1",WD repeat-containing protein 73,WDR73,84942,ENSG00000177082,NA,"Galloway-Mowat syndrome 1, 251300 (3), Autosomal recessive",Wdr73 (MGI:1919218)
15,84655131,84658610,15q22-qter,15q25.2,162340,NMB,Neuromedin B,NMB,4828,ENSG00000197696,NA,NA,Nmb (MGI:1915289)
15,84669536,84716459,15q25.2-q25.3,15q25.2-q25.3,618258,"SEC11A, SPC18","Sec11, yeast, homolog of, A",SEC11A,23478,ENSG00000140612,NA,NA,Sec11a (MGI:1929464)
15,84700000,93800000,15q25.3-q26.1,NA,609893,"CHNG3, RTSH","Hypothyroidism, congenital, nongoitrous, 3",NA,780915,NA,max lod at D15S655,"Hypothyroidism, congenital, nongoitrous, 3, 609893 (2)",NA
15,84700000,98000000,15q25.3-q26.2,NA,608691,MDD2,Major depressive disorder 2,NA,431709,NA,NA,"Major depressive disorder 2, 608516 (2)",NA
15,84748555,84806444,15q25.3,15q25.3,613624,"ZNF592, KIAA0211",Zinc finger protein 592,ZNF592,9640,ENSG00000166716,NA,NA,Zfp592 (MGI:2443541)
15,84816679,84873481,15q25.2,15q25.3,617608,"ALPK3, MIDORI, KIAA1330, CMH27",Alpha kinase 3,ALPK3,57538,ENSG00000136383,NA,"Cardiomyopathy, familial hypertrophic 27, 618052 (3), Autosomal recessive",Alpk3 (MGI:2151224)
15,84884349,84975648,15q25-q26,15q25.3,606207,"SLC28A1, CNT1, URCTU","Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1",SLC28A1,9154,ENSG00000156222,NA,"[Uridine-cytidineuria], 618477 (3), Autosomal recessive",Slc28a1 (MGI:3605073)
15,84980466,85139141,15q25.3-q26.1,15q25.3,602972,PDE8A,Phosphodiesterase 8A,PDE8A,5151,ENSG00000073417,NA,NA,Pde8a (MGI:1277116)
15,85380602,85749357,15q24-q25,15q25.3,604686,"AKAP13, HT31, LBC, BRX",A-kinase anchor protein 13,AKAP13,11214,ENSG00000170776,NA,NA,Akap13 (MGI:2676556)
15,86079619,87031475,15q25.3,15q25.3,615496,"AGBL1, CCP4, FECD8",ATP/GTP-binding protein-like 1,AGBL1,123624,ENSG00000273540,NA,"Corneal dystrophy, Fuchs endothelial, 8, 615523 (3), Autosomal dominant",Agbl1 (MGI:3646469)
15,87859748,88256795,15q25,15q25.3,191316,"NTRK3, TRKC","Neurotrophic tyrosine kinase, receptor, type 3",NTRK3,4916,ENSG00000140538,NA,NA,Ntrk3 (MGI:97385)
15,88459477,88467387,15q24-q25,15q25.3,611851,MRPL46,Mitochondrial ribosomal protein L46,MRPL46,26589,ENSG00000259494,NA,NA,Mrpl46 (MGI:1914558)
15,88467452,88480775,15q25,15q25.3,611977,MRPS11,Mitochondrial ribosomal protein S11,MRPS11,64963,ENSG00000181991,NA,NA,Mrps11 (MGI:1915244)
15,88500000,101991189,15q26-qter,NA,612626,"DEL15q26qter, C15DELq26qter",Chromosome 15q26-qter deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 15q26-qter deletion syndrome, 612626 (4), Isolated cases",NA
15,88500000,93800000,15q26.1,NA,142340,"DIH1, HCD","Hernia, congenital diaphragmatic 1",DIH1,1732,NA,NA,"Hernia, congenital diaphragmatic 1, 142340 (2), Multifactorial",NA
15,88500000,101991189,15q26,NA,600318,IDDM3,Insulin-dependent diabetes mellitus-3,IDDM3,3402,NA,NA,"{Diabetes mellitus, insulin-dependent, 3}, 600318 (2)",NA
15,88500000,101991189,15q26-qter,NA,614846,LVSKS,Levy-Shanske syndrome (tetrasomy 15q26),NA,NA,NA,NA,"Levy-Shanske syndrome, 614846 (4)",NA
15,88500000,101991189,15q26.1-qter,NA,166800,"OTSC1, OTS",Otosclerosis 1,OTSC1,5012,NA,NA,"Otosclerosis 1, 166800 (2), Autosomal dominant",NA
15,88500000,101991189,15q26,NA,609289,VVS,"Syncope, familial vasovagal",NA,105031671,NA,NA,"Syncope, familial vasovagal, 609289 (2), Autosomal dominant",NA
15,88501923,88546702,15q25.3,15q26.1,608727,DET1,"De-etiolated 1, Arabidopsis, homolog of",DET1,55070,ENSG00000140543,NA,NA,Det1 (MGI:1923625)
15,88604600,88632280,15q26.1,15q26.1,610177,"ISG20L1, AEN",Interferon-stimulated exonuclease gene 20kD-like 1,AEN,64782,ENSG00000181026,NA,NA,Aen (MGI:1915298)
15,88635613,88656482,15q26,15q26.1,604533,"ISG20, HEM45","Interferon-stimulated gene, 20kD",ISG20,3669,ENSG00000172183,NA,NA,Isg20 (MGI:1928895)
15,88803435,88875353,15q26.1,15q26.1,155760,"ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD","Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)",ACAN,176,ENSG00000157766,mutation identified in 1 SEDK family,"Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3), Autosomal dominant; Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3), Autosomal recessive; ?Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3), Autosomal dominant",NA
15,88898682,88913404,15q25,15q26.1,602281,MFGE8,Milk fat globule-EGF factor 8,MFGE8,4240,ENSG00000140545,NA,NA,Mfge8 (MGI:102768)
15,89088421,89202354,15q26.1,15q26.1,612196,"ABHD2, LABH2",Abhydrolase domain-containing 2,ABHD2,11057,ENSG00000140526,NA,NA,Abhd2 (MGI:1914344)
15,89209868,89223178,15q26,15q26.1,180090,RLBP1,"Retinaldehyde-binding protein-1, cellular",RLBP1,6017,ENSG00000140522,NA,"Bothnia retinal dystrophy, 607475 (3), Autosomal recessive; Fundus albipunctatus, 136880 (3), Autosomal recessive, Autosomal dominant; Newfoundland rod-cone dystrophy, 607476 (3); Retinitis punctata albescens, 136880 (3), Autosomal recessive, Autosomal dominant",Rlbp1 (MGI:97930)
15,89243953,89317258,15q25-q26,15q26.1,611360,"FANCI, KIAA1794",FANCI gene,FANCI,55215,ENSG00000140525,NA,"Fanconi anemia, complementation group I, 609053 (3), Autosomal recessive",Fanci (MGI:2384790)
15,89316304,89334823,15q25,15q26.1,174763,"POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS","Polymerase (DNA directed), gamma",POLG,5428,ENSG00000140521,PEO also digenic with C10orf2,"Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive; Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive; Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive; Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant; Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive",Polg (MGI:1196389)
15,89368016,89368105,15q26.1,15q26.1,611188,"MIR9-3, MIRN9-3",Micro RNA 9-3,MIR9-3,407051,ENSG00000284329,NA,NA,NA
15,89471406,89496612,15q25,15q26.1,605381,"RHCG, RHGK",Rhesus blood group-associated kidney homolog,RHCG,51458,ENSG00000140519,NA,NA,Rhcg (MGI:1888517)
15,89575468,89628022,15q26.1,15q26.1,613298,"C15orf42, TRESLIN",Treslin,TICRR,90381,ENSG00000140534,NA,NA,Ticrr (MGI:1924261)
15,89627976,89663085,15q26.1,15q26.1,611254,"KIF7, HLS2, ACLS, JBTS12, AGBK",Kinesin family member 7,KIF7,374654,ENSG00000166813,mutation identified in 1 HLS2 family and 1 AGBK family,"Acrocallosal syndrome, 200990 (3), Autosomal recessive; ?Al-Gazali-Bakalinova syndrome, 607131 (3), Autosomal recessive; ?Hydrolethalus syndrome 2, 614120 (3), Autosomal recessive; Joubert syndrome 12, 200990 (3), Autosomal recessive",Kif7 (MGI:1098239)
15,89664364,89679366,15q26,15q26.1,170290,"PLIN1, PLIN, FPLD4",Perilipin 1,PLIN1,5346,ENSG00000166819,NA,"Lipodystrophy, familial partial, type 4, 613877 (3), Autosomal dominant",Plin1 (MGI:1890505)
15,89681534,89690753,15q26.1,15q26.1,603866,PEX11A,Peroxisome biogenesis factor 11A,PEX11A,8800,ENSG00000166821,NA,NA,Pex11a (MGI:1338788)
15,89734771,89751308,15q26.1,15q26.1,608689,MESP1,Mesoderm posterior bHLH transcription factor 1,MESP1,55897,ENSG00000166823,NA,NA,Mesp1 (MGI:107785)
15,89776331,89778753,15q26.1,15q26.1,605195,"MESP2, SCDO2",Mesoderm posterior bHLH transcription factor 2,MESP2,145873,ENSG00000188095,NA,"Spondylocostal dysostosis 2, autosomal recessive, 608681 (3), Autosomal recessive",Mesp2 (MGI:1096325)
15,89784894,89814851,15q25-q26,15q26.1,151530,"ANPEP, PEPN, CD13","Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150)",ANPEP,290,ENSG00000166825,NA,NA,Anpep (MGI:5000466)
15,89830598,89894384,15q26.1,15q26.1,602416,AP3S2,"Adaptor-related protein complex 3, sigma-2 subunit",AP3S2,10239,ENSG00000157823,NA,NA,Ap3s2 (MGI:1337060)
15,89895005,89912951,15q26.1,15q26.1,615543,"C15orf38, ARPIN",Chromosome 15 open reading frame 38,ARPIN,348110,ENSG00000242498,NA,NA,Arpin (MGI:1917670)
15,90083044,90102553,15q26.1,15q26.1,147650,"IDH2, IDPM, D2HGA2","Isocitrate dehydrogenase, mitochondrial",IDH2,3418,ENSG00000182054,NA,"D-2-hydroxyglutaric aciduria 2, 613657 (3)",Idh2 (MGI:96414)
15,90184919,90229678,15q26.1,15q26.1,617029,SEMA4B,Semaphorin 4B,SEMA4B,10509,ENSG00000185033,NA,NA,Sema4b (MGI:107559)
15,90229974,90265758,15q25.3-q26.1,15q26.1,602293,"CIB1, KIP",Calcium- and integrin-binding protein 1,CIB1,10519,ENSG00000185043,NA,"Epidermodysplasia verruciformis 3, 618267 (3), Autosomal recessive",Cib1 (MGI:1344418)
15,90265662,90272210,15q26.1,15q26.1,616718,NGRN,Neurite outgrowth-associated protein,NGRN,51335,ENSG00000182768,NA,NA,Ngrn (MGI:1933212)
15,90388241,90502238,15q26,15q26.1,603379,"IQGAP1, SAR1","RASGAP-like with IQ motifs (sar1, S. pombe, homolog of)",IQGAP1,8826,ENSG00000140575,amplified in gastric cancer,NA,Iqgap1 (MGI:1352757)
15,90529914,90645344,15q26.1,15q26.1,608986,"CRTC3, TORC3",CREB-regulated transcription coactivator 3,CRTC3,64784,ENSG00000140577,NA,NA,Crtc3 (MGI:1917711)
15,90717345,90816165,15q26.1,15q26.1,604610,"RECQL3, RECQ2, BLM, BS, MGRISCE1","DNA helicase, RecQ-like 3",BLM,641,ENSG00000197299,NA,"Bloom syndrome, 210900 (3), Autosomal recessive",Blm (MGI:1328362)
15,90868587,90883457,15q25-q26,15q26.1,136950,"FURIN, PACE, FUR, PCSK3",Furin (paired basic amino acid cleaving enzyme),FURIN,5045,ENSG00000140564,less than 1.1kb 5' to FES,NA,Furin (MGI:97513)
15,90884420,90895775,15q26.1,15q26.1,190030,FES,"Oncogene FES, feline sarcoma virus",FES,2242,ENSG00000182511,NA,NA,Fes (MGI:95514)
15,90902376,90922584,15q25,15q26.1,600988,"MAN2A2, MANA2X","Mannosidase, alpha-, type II, isozyme X",MAN2A2,4122,ENSG00000196547,NA,NA,Man2a2 (MGI:2150656)
15,90930179,90954092,15q25-q26,15q26.1,611219,"UNC45A, SMAP1, GCUNC45","UNC45, C. elegans, homolog of, A",UNC45A,55898,ENSG00000140553,NA,NA,Unc45a (MGI:2142246)
15,90954863,90964857,15q26.1,15q26.1,617997,RCCD1,RCC1 domain-containing protein 1,RCCD1,91433,ENSG00000166965,NA,NA,Rccd1 (MGI:2444156)
15,90966037,90994575,15q26.1,15q26.1,603484,PRC1,Protein regulating cytokinesis 1,PRC1,9055,ENSG00000198901,NA,NA,Prc1 (MGI:1858961)
15,90998415,91022838,15q26.1,15q26.1,608552,VPS33B,"Vacuolar protein sorting 33, yeast, homolog of, B",VPS33B,26276,ENSG00000184056,NA,"Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3), Autosomal recessive",Vps33b (MGI:2446237)
15,91099587,91302564,15q26.1,15q26.1,185861,"SV2B, KIAA0735",Synaptic vesicle glycoprotein 2B,SV2B,9899,ENSG00000185518,NA,NA,Sv2b (MGI:1927338)
15,91853707,92172434,15q26,15q26.1,612435,"SLCO3A1, OATPD, OATP3A1","Solute carrier organic anion transporter family, member 3A1",SLCO3A1,28232,ENSG00000176463,NA,NA,Slco3a1 (MGI:1351867)
15,92393880,92468727,15q26,15q26.1,602546,STX,Sialyltransferase X,ST8SIA2,8128,ENSG00000140557,NA,NA,St8sia2 (MGI:106020)
15,92900320,93027995,15q26,15q26.1,602119,"CHD2, EEOC",Chromodomain helicase DNA binding protein-2,CHD2,1106,ENSG00000173575,NA,"Epileptic encephalopathy, childhood-onset, 615369 (3), Autosomal dominant",Chd2 (MGI:2448567)
15,93035270,93089210,15q26.1,15q26.1,607362,RGMA,"RGM domain family, member A (repulsive guidance molecule)",RGMA,56963,ENSG00000182175,NA,NA,Rgma (MGI:2679262)
15,94231537,94483951,15q26.2,15q26.2,616297,MCTP2,Multiple C2 domains-containing transmembrane protein 2,MCTP2,55784,ENSG00000140563,NA,NA,Mctp2 (MGI:2685335)
15,96326045,96340262,15q26.1-q26.2,15q26.2,107773,"NR2F2, TFCOUP2, ARP1, CHTD4","Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2)",NR2F2,7026,ENSG00000185551,NA,"Congenital heart defects, multiple types, 4, 615779 (3), Autosomal dominant",Nr2f2 (MGI:1352452)
15,96783434,96785614,15q26.2,15q26.2,613948,"SPATA8, SRG8",Spermatogenesis-associated protein 8,SPATA8,145946,ENSG00000185594,NA,NA,NA
15,98648538,98964529,15q25-q26,15q26.3,147370,IGF1R,Insulin-like growth factor-1 receptor,IGF1R,3480,ENSG00000140443,NA,"Insulin-like growth factor I, resistance to, 270450 (3), Autosomal recessive, Autosomal dominant",Igf1r (MGI:96433)
15,99105068,99136585,15q26.3,15q26.3,606087,"SYNM, DMN",Synemin,SYNM,23336,ENSG00000182253,NA,NA,Synm (MGI:2661187)
15,99565416,99716487,15q26,15q26.3,600660,"MEF2A, ADCAD1","MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)",MEF2A,4205,ENSG00000068305,NA,"{Coronary artery disease, autosomal dominant, 1}, 608320 (3), Autosomal dominant",Mef2a (MGI:99532)
15,99971436,100342923,15q24,15q26.3,607511,"ADAMTS17, WMS4","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 17",ADAMTS17,170691,ENSG00000140470,NA,"Weill-Marchesani 4 syndrome, recessive, 613195 (3), Autosomal recessive",Adamts17 (MGI:3588195)
15,100400394,100544981,15q26.3,15q26.3,615276,"CERS3, LASS3, ARCI9",Ceramide synthase 3,CERS3,204219,ENSG00000154227,NA,"Ichthyosis, congenital, autosomal recessive 9, 615023 (3), Autosomal recessive",Cers3 (MGI:2681008)
15,100566913,100603031,15q26,15q26.3,610350,"LINS1, WINS1, FLJ10583, MRT27","Lines, Drosophila, homolog of, 1",LINS1,55180,ENSG00000140471,NA,"Mental retardation, autosomal recessive 27, 614340 (3), Autosomal recessive",Lins1 (MGI:1919885)
15,100602549,100651700,15q26.3,15q26.3,615052,ASB7,Ankyrin repeat- and SOCS box-containing protein 7,ASB7,140460,ENSG00000183475,NA,NA,Asb7 (MGI:2152835)
15,100879830,100916625,15q26,15q26.3,600463,"ALDH1A3, ALDH6, MCOP8","Aldehyde dehydrogenase 1 family, member A3",ALDH1A3,220,ENSG00000184254,NA,"Microphthalmia, isolated 8, 615113 (3), Autosomal recessive",Aldh1a3 (MGI:1861722)
15,100919016,101078256,15q26.3,15q26.3,610986,LRRK1,Leucine-rich repeat kinase 1,LRRK1,79705,ENSG00000154237,NA,NA,Lrrk1 (MGI:2142227)
15,101175726,101252047,15q26.3,15q26.3,608183,"CHSY1, KIAA0990, TPBS",Carbohydrate synthase 1,CHSY1,22856,ENSG00000131873,NA,"Temtamy preaxial brachydactyly syndrome, 605282 (3), Autosomal recessive",Chsy1 (MGI:2681120)
15,101270808,101277484,15q26.3,15q26.3,607918,"SELENOS, SEPS1, SELS, VIMP, ADO15",Selenoprotein S,SELENOS,55829,ENSG00000131871,NA,NA,Selenos (MGI:95994)
15,101281509,101295281,15q26.3,15q26.3,603521,SNRPA1,Small nuclear ribonucleoprotein polypeptide A',SNRPA1,6627,ENSG00000131876,NA,NA,Snrpa1 (MGI:1916231)
15,101303927,101489983,15q26,15q26.3,167405,"PCSK6, PACE4, SPC4",Proprotein convertase subtilisin/kexin type 6,PCSK6,5046,ENSG00000140479,NA,NA,Pcsk6 (MGI:102897)
15,101632976,101652390,15q26.3,15q26.3,610014,"TM2D3, BLP2",TM2 domain-containing protein 3,TM2D3,80213,ENSG00000184277,NA,NA,Tm2d3 (MGI:1915884)
15,0,101991189,Chr.15,NA,120340,COL1AR,"Collagen I, alpha, receptor",COL1AR,1279,NA,NA,NA,NA
16,0,16700000,16p13,NA,608903,ADHD1,"Attention deficit-hyperactivity disorder, susceptibility to, 1",NA,450087,NA,max lod at D16S3114,"{Attention deficit-hyperactivity disorder}, 143465 (2), Autosomal dominant",NA
16,0,16700000,16p13,NA,608558,BMIQ5,Body mass index quantitative trait locus 5,BMIQ5,449016,NA,near D16S404 and D16S764,"[Body mass index QTL5], 608558 (2)",NA
16,0,16700000,16pter-p13,NA,607339,CHDS1,"Coronary heart disease, susceptibility to, 1",NA,338334,NA,NA,"{Coronary heart disease, susceptibility to}, 607339 (2)",NA
16,0,7800000,16p13.3,NA,610543,"DEL16p13.3, RSTSS",Chromosome 16p13.3 deletion syndrome (Rubinstein-Taybi deletion syndrome),NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 16p13.3 deletion syndrome, 610543 (4)",NA
16,0,7800000,16p13.3,NA,613458,"DUP16p13.3, C16DUPq13.3",Chromosome 16p13.3 duplication syndrome,NA,NA,NA,contiguous gene duplication syndrome,"Chromosome 16p13.3 duplication syndrome, 613458 (4), Autosomal dominant, Isolated cases",NA
16,0,7800000,16pter-p13.3,NA,141750,"HBHR, ATR1","Alpha-thalassemia/mental retardation syndrome, type 1",NA,NA,NA,contiguous gene syndrome involving deletion of HBA1 and HBA2,"Alpha-thalassemia/mental retardation syndrome, type 1, 141750 (4), Autosomal dominant",NA
16,0,36800000,16p,NA,606668,IBD8,Inflammatory bowel disease 8,IBD8,170595,NA,NA,"{Inflammatory bowel disease 8}, 606668 (2)",NA
16,0,28500000,16p13-p12,NA,610260,IHPS2,"Pyloric stenosis, infantile hypertrophic, 2",NA,780923,NA,NA,"Pyloric stenosis, infantile hypertrophic, 2, 610260 (2)",NA
16,0,7800000,16p13.3,NA,156850,MCOPCT1,Microphthalmia with cataract 1,NA,8130,NA,proximal to HBA1,"Microphthalmia with cataract 1, 156850 (2), Autosomal dominant",NA
16,0,7800000,16p13.3,NA,600273,PKDTS,"Polycystic kidney disease, infantile severe, with tuberous sclerosis",NA,NA,NA,contiguous gene syndrome caused by deletion of TSC2 and PKD1,"Polycystic kidney disease, infantile severe, with tuberous sclerosis, 600273 (4), Autosomal dominant",NA
16,46406,53607,16p13.3,16p13.3,606007,"POLR3K, RPC11","Polymerase III, RNA, subunit K",POLR3K,51728,ENSG00000161980,NA,NA,Polr3k (MGI:1914255)
16,58058,76354,16p13.3,16p13.3,614403,"RHBDF1, IRHOM1, DIST1","Rhomboid 5, Drosophila, homolog of, 1",RHBDF1,64285,ENSG00000007384,NA,NA,Rhbdf1 (MGI:104328)
16,77018,85850,16pter-p13.3,16p13.3,156565,"MPG, MDG",N-methylpurine DNA glycosylase,MPG,4350,ENSG00000103152,75kb upstream of HBZ,NA,Mpg (MGI:97073)
16,85385,138697,16p13.3,16p13.3,600928,"NPRL3, CGTHBA, FFEVF3",Nitrogen permease regulator-like 3,NPRL3,8131,ENSG00000103148,NA,"Epilepsy, familial focal, with variable foci 3, 617118 (3), Autosomal dominant",Nprl3 (MGI:109258)
16,152643,154502,16pter-p13.3,16p13.3,142310,HBZ,"Hemoglobin, zeta",HBZ,3050,ENSG00000130656,NA,NA,Hba-x (MGI:96019)
16,165977,166763,16p13.3,16p13.3,609639,HBM,Hemoglobin mu,HBM,3042,ENSG00000206177,?functional,NA,NA
16,172875,173709,16pter-p13.3,16p13.3,141850,"HBA2, HBH, ECYT7",Hemoglobin alpha-2,HBA2,3040,ENSG00000188536,NA,"Erythrocytosis 7, 617981 (3); Heinz body anemia, 140700 (3), Autosomal dominant; Hemoglobin H disease, deletional and nondeletional, 613978 (3); Thalassemia, alpha-, 604131 (3)","Hba-a1,Hba-a2 (MGI:96016,MGI:96015)"
16,176679,177521,16pter-p13.3,16p13.3,141800,"HBA1, HBH, METHBA, ECYT7",Hemoglobin alpha-1,HBA1,3039,ENSG00000206172,"1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'","Erythrocytosis, 7, 617981 (3); Heinz body anemias, alpha-, 140700 (3), Autosomal dominant; Hemoglobin H disease, nondeletional, 613978 (3); Methemoglobinemia, alpha type, 617973 (3); Thalassemias, alpha-, 604131 (3)","Hba-a1,Hba-a2 (MGI:96016,MGI:96015)"
16,180458,181178,16pter-p13.3,16p13.3,142240,HBQ1,Hemoglobin theta-1,HBQ1,3049,ENSG00000086506,NA,NA,Hbq1b (MGI:3613460)
16,188968,229481,16p13.3,16p13.3,607782,LUC7L,"Luc7, S. cerevisiae, homolog of",LUC7L,55692,ENSG00000007392,NA,NA,Luc7l (MGI:1914228)
16,268300,275943,16p13.3,16p13.3,603895,RS11,Regulator of G protein signaling 11,RGS11,8786,ENSG00000076344,NA,NA,Rgs11 (MGI:1354739)
16,283136,287214,16p13.3,16p13.3,608012,"PDIA2, PDIP","Protein disulfide isomerase, family A, member 2",PDIA2,64714,ENSG00000185615,NA,NA,Pdia2 (MGI:1916441)
16,287439,355225,16p13.3,16p13.3,603816,"AXIN1, AXIN",Axis inhibitor 1,AXIN1,8312,ENSG00000103126,hypermethylation of AXIN1 promoter seen in 1 CDUP patient,"?Caudal duplication anomaly, 607864 (3); Hepatocellular carcinoma, somatic, 114550 (3)",Axin1 (MGI:1096327)
16,366968,370537,16p13.3,16p13.3,604853,"MRPL28, MAAT1",Mitochondrial ribosomal protein L28,MRPL28,10573,ENSG00000086504,NA,NA,Mrpl28 (MGI:1915861)
16,396728,400753,16p13.3,16p13.3,601818,NME4,"Non-metastatic cells 4, protein expressed in",NME4,4833,ENSG00000103202,NA,NA,Nme4 (MGI:1931148)
16,401884,412481,16p13.3,16p13.3,615839,"DECR2, PDCR","2,4-dienoyl-CoA reductase 2, peroxisomal",DECR2,26063,ENSG00000242612,NA,NA,Decr2 (MGI:1347059)
16,425620,523010,16p13.3,16p13.3,608738,"RAB11FIP3, EFERIN, KIAA0665",RAB11 family-interacting protein 3,RAB11FIP3,9727,ENSG00000090565,NA,NA,Rab11fip3 (MGI:2444431)
16,527711,554635,16p13.3,16p13.3,603267,SOLH,"Small optic lobes, Drosophila, homolog of",CAPN15,6650,ENSG00000103326,conflicting localization to Xq24,NA,Capn15 (MGI:1355075)
16,569967,584137,16p13.3,16p13.3,605754,PIGQ,Phosphatidylinositol glycan anchor biosynthesis class Q protein,PIGQ,9091,ENSG00000007541,NA,NA,Pigq (MGI:1333114)
16,630984,634116,16p13.3,16p13.3,608021,"WFIKKN1, WFIKKN","WAP, follistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 1",WFIKKN1,117166,ENSG00000127578,NA,NA,Wfikkn1 (MGI:2670967)
16,649362,667832,16p13.3,16p13.3,618290,"WDR90, KIAA1924",WD repeat-containing protein 90,WDR90,197335,ENSG00000161996,NA,NA,Wdr90 (MGI:1921267)
16,668082,674173,16p13.3,16p13.3,613889,"RHOT2, MIRO2, ARHT2","Ras homolog gene family, member T2",RHOT2,89941,ENSG00000140983,NA,NA,Rhot2 (MGI:2384892)
16,675670,678270,16p13.3,16p13.3,603264,"RHBDL, RRP","Rhomboid, Drosophila, homolog of",RHBDL1,9028,ENSG00000103269,NA,NA,Rhbdl1 (MGI:2384891)
16,680409,682800,16p13.3,16p13.3,607207,"STUB1, CHIP, SCAR16, SCA48",STIP1 homologous and U box-containing protein 1,STUB1,10273,ENSG00000103266,mutation identified in 1 SCA48 family,"?Spinocerebellar ataxia 48, 618093 (3), Autosomal dominant; Spinocerebellar ataxia, autosomal recessive 16, 615768 (3), Autosomal recessive",Stub1 (MGI:1891731)
16,692499,707852,16p13.3,16p13.3,609082,"FBXL16, FBL16, C16orf22",F-box and leucine-rich repeat protein 16,FBXL16,146330,ENSG00000127585,NA,NA,Fbxl16 (MGI:2448488)
16,715117,719654,16p13.3,16p13.3,610998,METRN,Meteorin,METRN,79006,ENSG00000103260,NA,NA,Metrn (MGI:1917333)
16,722577,726879,16p13.3,16p13.3,614666,"CCDC78, C16orf25, CNM4",Coiled-coil domain-containing protein 78,CCDC78,124093,ENSG00000162004,mutation identified in 1 CNM4 family,"?Centronuclear myopathy 4, 614807 (3), Autosomal dominant",Ccdc78 (MGI:2685784)
16,729764,740996,16p13.3,16p13.3,611118,"NARFL, IOP1",Nuclear prelamin A recognition factor-like,CIAO3,64428,ENSG00000103245,NA,NA,Ciao3 (MGI:1914813)
16,760733,768864,16p13.3,16p13.3,601051,MSLN,Mesothelin,MSLN,10232,ENSG00000102854,NA,NA,Msln (MGI:1888992)
16,788619,798073,16p13.3,16p13.3,613201,"CHTF18, CHL12, CTF18","Chromosome transmission fidelity factor 18, S. cerevisiae, homolog of",CHTF18,63922,ENSG00000127586,NA,NA,Chtf18 (MGI:2384887)
16,798040,800733,16p13.3,16p13.3,607298,GNG13,"Guanine nucleotide-binding protein, gamma-13",GNG13,51764,ENSG00000127588,NA,NA,Gng13 (MGI:1925616)
16,853631,981612,16p13.3,16p13.3,611761,"LMF1, TMEM112",Lipase maturation factor 1,LMF1,64788,ENSG00000103227,NA,"Lipase deficiency, combined, 246650 (3), Autosomal recessive",Lmf1 (MGI:1923733)
16,981769,986978,16p13.3,16p13.3,605923,SOX8,SRY-box 8,SOX8,30812,ENSG00000005513,NA,NA,Sox8 (MGI:98370)
16,1072755,1081453,16p13.3,16p13.3,182455,SSTR5,Somatostatin receptor-5,SSTR5,6755,ENSG00000162009,NA,"Somatostatin analog, resistance to (3)",Sstr5 (MGI:894282)
16,1088225,1096305,16p13.3,16p13.3,614147,"C1QTNF8, CTRP8",C1q- and tumor necrosis factor-related protein 8,C1QTNF8,390664,ENSG00000184471,NA,NA,NA
16,1153105,1221771,16p13.3,16p13.3,607904,"CACNA1H, EIG6, ECA6, HALD4","Calcium channel, voltage-dependent, T type, alpha-1H subunit",CACNA1H,8912,ENSG00000196557,NA,"{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3); {Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3); Hyperaldosteronism, familial, type IV, 617027 (3), Autosomal dominant",Cacna1h (MGI:1928842)
16,1221650,1226453,16p13.3,16p13.3,609341,"TPSG1, TMT","Tryptase, gamma-1",TPSG1,25823,ENSG00000116176,NA,NA,Tpsg1 (MGI:1349391)
16,1228335,1230183,16p13.3,16p13.3,191081,"TPSB2, TPS2","Tryptase, beta 2",TPSB2,64499,ENSG00000197253,NA,NA,Tpsb2 (MGI:96942)
16,1240704,1242553,16p13.3,16p13.3,191080,"TPSAB1, TPS1","Tryptase, alpha/beta-1",TPSAB1,7177,ENSG00000172236,NA,NA,Tpsb2 (MGI:96942)
16,1256068,1259007,16p13.3,16p13.3,609272,"TPSD1, MCP7L1","Tryptase, delta-1",TPSD1,23430,ENSG00000095917,NA,NA,NA
16,1309151,1327016,16p13.3,16p13.3,601661,UBE2I,Ubiquitin-conjugating enzyme E2I (homologous to yeast UBC9),UBE2I,7329,ENSG00000103275,NA,NA,Ube2i (MGI:107365)
16,1333644,1349440,16p13.3,16p13.3,604009,"BAIAP3, BAP3",BAI1-associated protein 3,BAIAP3,8938,ENSG00000007516,NA,NA,Baiap3 (MGI:2685783)
16,1349239,1351877,16p13.3,16p13.3,617058,TSR3,"TSR3, aminocarboxypropyl transferase ribosome maturation factor",TSR3,115939,ENSG00000007520,NA,NA,Tsr3 (MGI:1915577)
16,1351930,1364112,16p,16p13.3,607838,GNPTAG,"N-acetylglucosamine-1-phosphotransferase, gamma subunit",GNPTG,84572,ENSG00000090581,NA,"Mucolipidosis III gamma, 252605 (3), Autosomal recessive",Gnptg (MGI:2147006)
16,1363204,1414748,16p13.3,16p13.3,617463,"UNKL, ZC3H5L, C16orf28",Unkempt family-like zinc finger,UNKL,64718,ENSG00000059145,NA,NA,Unkl (MGI:1921404)
16,1444932,1475083,16p13,16p13.3,602727,"CLCN7, CLC7, OPTA2, OPTB4",Chloride channel-7,CLCN7,1186,ENSG00000103249,NA,"Osteopetrosis, autosomal dominant 2, 166600 (3), Autosomal dominant; Osteopetrosis, autosomal recessive 4, 611490 (3), Autosomal recessive",Clcn7 (MGI:1347048)
16,1485938,1488908,16p13.3,16p13.3,613442,PTX4,"Pentraxin 4, long",PTX4,390667,ENSG00000251692,NA,NA,Ptx4 (MGI:1915759)
16,1493344,1510458,16p13.3,16p13.3,611140,"TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS","Telomere maintenance 2, S. cerevisiae, homolog of",TELO2,9894,ENSG00000100726,NA,"You-Hoover-Fong syndrome, 616954 (3), Autosomal recessive",Telo2 (MGI:1918968)
16,1510426,1612071,16p13.3,16p13.3,614620,"IFT140, KIAA0590, SRTD9, MZSDS, RP80","Intraflagellar transport 140, Chlamydomonas, homolog of",IFT140,9742,ENSG00000187535,NA,"Retinitis pigmentosa 80, 617781 (3), Autosomal recessive; Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3), Autosomal recessive",Ift140 (MGI:2146906)
16,1528677,1555567,16p13.3,16p13.3,611002,"TMEM204, C16orf30, CLP24",Transmembrane protein 204,TMEM204,79652,ENSG00000131634,NA,NA,Tmem204 (MGI:3039635)
16,1706182,1770316,16p13.3,16p13.3,605431,"MAPK8IP3, SYD2, JSAP1, JIP3, NEDBA",Mitogen-activated protein kinase 8-interacting protein 3,MAPK8IP3,23162,ENSG00000138834,NA,"Neurodevelopmental disorder with or without variable brain abnormalities, 618443 (3), Autosomal dominant",Mapk8ip3 (MGI:1353598)
16,1770319,1771749,16q13,16p13.3,601817,"NME3, NM23H3","Nonmetastatic cells 3, protein expressed in",NME3,4832,ENSG00000103024,NA,NA,Nme3 (MGI:1930182)
16,1771888,1773150,16q13-q21,16p13.3,611994,"MRPS34, MRPS12, COXPD32",Mitochondrial ribosomal protein S34,MRPS34,65993,ENSG00000074071,NA,"Combined oxidative phosphorylation deficiency 32, 617664 (3), Autosomal recessive",Mrps34 (MGI:1930188)
16,1773221,1776713,16p13.3,16p13.3,610886,EME2,"Essential meiotic endonuclease 1, S. pombe, homolog of, 2",EME2,197342,ENSG00000197774,NA,NA,Eme2 (MGI:1919889)
16,1776711,1782570,16p13.3,16p13.3,611659,"SPSB3, SSB3",SPRY domain- and SOCS box-containing 3,SPSB3,90864,ENSG00000162032,NA,NA,Spsb3 (MGI:1891471)
16,1782959,1789185,16p13.3,16p13.3,610779,"NUBP2, CFD1",Nucleotide-binding protein 2,NUBP2,10101,ENSG00000095906,NA,NA,Nubp2 (MGI:1347072)
16,1790412,1794907,16p13.3,16p13.3,601489,"IGFALS, ALS, ACLSD","Insulin-like growth factor-binding protein, acid-labile subunit",IGFALS,3483,ENSG00000099769,NA,"Acid-labile subunit, deficiency of, 615961 (3)",Igfals (MGI:107973)
16,1807628,1827193,16p13,16p13.3,138760,"HAGH, GLO2",Hydroxyacyl glutathione hydrolase; glyoxalase II,HAGH,3029,ENSG00000063854,NA,"[Glyoxalase II deficiency], 614033 (1), Autosomal dominant",Hagh (MGI:95745)
16,1827223,1840206,16p13.3,16p13.3,616320,"FAHD1, FLJ36880",Fumarylacetoacetate hydrolase domain-containing protein 1,FAHD1,81889,ENSG00000180185,NA,NA,Fahd1 (MGI:1915886)
16,1833985,1872163,16p13.3,16p13.3,617670,"MEIOB, SPGF22",Meiosis-specific protein with OB domains,MEIOB,254528,ENSG00000162039,mutation identified in one SPGF22 family,"?Spermatogenic failure 22, 617706 (3), Autosomal recessive",Meiob (MGI:1922428)
16,1938228,1943325,16p13.3,16p13.3,606216,"MSRB1, SEPX1, SELX",Methionine sulfoxide reductase B1,MSRB1,51734,ENSG00000198736,NA,NA,Msrb1 (MGI:1351642)
16,1943973,1955122,16p13.3,16p13.3,617416,RPL3L,Ribosomal protein L3-like,RPL3L,6123,ENSG00000140986,NA,NA,Rpl3l (MGI:1913461)
16,1959537,1961974,16p13.3,16p13.3,603843,NDUFB10,NADH-ubiquinone oxidoreductase subunit B10,NDUFB10,4716,ENSG00000140990,NA,NA,Ndufb10 (MGI:1915592)
16,1962057,1964825,16p13.3,16p13.3,603624,RPS2,Ribosomal protein S2,RPS2,6187,ENSG00000140988,NA,NA,Rps2 (MGI:105110)
16,1972052,1982928,16p13.3,16p13.3,605915,TBL3,Transducin-beta-like 3,TBL3,10607,ENSG00000183751,NA,NA,Tbl3 (MGI:2384863)
16,1978916,1984026,16p13,16p13.3,611256,NOXO1,NADPH oxidase organizer 1,NOXO1,124056,ENSG00000196408,NA,NA,Noxo1 (MGI:1919143)
16,1984192,1987748,16p13.3-p13.12,16p13.3,600924,"GFER, ERV1, ALR","Growth factor, erv1, S. cerevisiae, homolog of (augmenter of liver regeneration)",GFER,2671,ENSG00000127554,NA,"Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)",Gfer (MGI:107757)
16,1989969,1994274,16pter,16p13.3,603927,SYNGR3,Synaptogyrin 3,SYNGR3,9143,ENSG00000127561,NA,NA,Syngr3 (MGI:1341881)
16,1997653,2009820,16p13.3,16p13.3,617508,ZNF598,Zinc finger protein 598,ZNF598,90850,ENSG00000167962,NA,NA,Zfp598 (MGI:2670965)
16,2019784,2020754,16p13.3,16p13.3,607997,"NPW, PPNPW, PPL8",Neuropeptide W,NPW,283869,ENSG00000183971,NA,NA,Npw (MGI:2685781)
16,2026901,2039025,16p13.3,16p13.3,606553,"SLC9A3R2, SIP1, NHERF2","Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 2",SLC9A3R2,9351,ENSG00000065054,NA,NA,Slc9a3r2 (MGI:1890662)
16,2039814,2047871,16p13.3-p13.2,16p13.3,602656,"NTHL1, OCTS3, FAP3","Endonuclease III, E. coli, homolog of",NTHL1,4913,ENSG00000065057,NA,"Familial adenomatous polyposis 3, 616415 (3), Autosomal recessive",Nthl1 (MGI:1313275)
16,2047803,2089490,16p13.3,16p13.3,191092,"TSC2, LAM",Tuberin (tuberous sclerosis 2 gene),TSC2,7249,ENSG00000103197,somatic mutation identified in 1 FCORD2 patient,"?Focal cortical dysplasia, type II, somatic, 607341 (3); Lymphangioleiomyomatosis, somatic, 606690 (3); Tuberous sclerosis-2, 613254 (3), Autosomal dominant",Tsc2 (MGI:102548)
16,2088707,2135897,16p13.3-p13.12,16p13.3,601313,PKD1,Polycystin-1,PKD1,5310,ENSG00000008710,NA,"Polycystic kidney disease 1, 173900 (3), Autosomal dominant",Pkd1 (MGI:97603)
16,2090194,2090283,16p13.3,16p13.3,611621,"MIR1225, MIRN1225",Micro RNA 1225,MIR1225,100188847,ENSG00000221656,NA,NA,NA
16,2148143,2154164,16p13.3,16p13.3,605455,RAB26,RAS-associated protein RAB26,RAB26,25837,ENSG00000167964,NA,NA,Rab26 (MGI:2443284)
16,2155777,2178128,16p13.3,16p13.3,606692,"TRAF7, RFWD1, CAFDADD",TNF receptor-associated factor 7,TRAF7,84231,ENSG00000131653,NA,"Cardiac, facial, and digital anomalies with developmental delay, 618164 (3), Autosomal dominant",Traf7 (MGI:3042141)
16,2177179,2196604,16p13.3,16p13.3,612184,"CASKIN1, KIAA1306",CASK-interacting protein 1,CASKIN1,57524,ENSG00000167971,NA,NA,Caskin1 (MGI:2442952)
16,2204627,2209453,16p13.3,16p13.3,612190,"MLST8, GBL, LST8, WAT1, POP3",MTOR-associated protein LST8,MLST8,64223,ENSG00000167965,NA,NA,Mlst8 (MGI:1929514)
16,2211592,2214839,16p13.3,16p13.3,172280,PGP,Phosphoglycolate phosphatase,PGP,283871,ENSG00000184207,no recombination with PKD1,NA,Pgp (MGI:1914328)
16,2223487,2235741,16p13.3,16p13.3,603022,"E4F1, E4F",E4F transcription factor 1,E4F1,1877,ENSG00000167967,NA,NA,E4f1 (MGI:109530)
16,2239401,2251586,16p13.3,16p13.3,600305,"ECI1, DCI",Enoyl-CoA delta isomerase 1,ECI1,1632,ENSG00000167969,NA,NA,Eci1 (MGI:94871)
16,2253115,2268125,16p13.3,16p13.3,606447,RNPS1,RNA-binding protein S1,RNPS1,10921,ENSG00000205937,NA,NA,Rnps1 (MGI:97960)
16,2275880,2340727,16p13.3,16p13.3,601615,"ABCA3, ABC3, SMDP3",ATP-binding cassette-3,ABCA3,21,ENSG00000167972,NA,"Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3), Autosomal recessive",Abca3 (MGI:1351617)
16,2429446,2458853,16p13.3,16p13.3,600227,"CCNF, FBX1",Cyclin F,CCNF,899,ENSG00000162063,NA,NA,Ccnf (MGI:102551)
16,2471296,2474144,16p13.3,16p13.3,602349,"NTN3, NTN2L",Netrin 3,NTN3,4917,ENSG00000162068,NA,NA,Ntn3 (MGI:1341188)
16,2475103,2509668,16p13.3,16p13.3,613577,"TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65","TBC1 domain family, member 24",TBC1D24,57465,ENSG00000162065,NA,"DOORS syndrome, 220500 (3), Autosomal recessive; Deafness , autosomal recessive 86, 614617 (3), Autosomal recessive; Deafness, autosomal dominant 65, 616044 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 16, 615338 (3), Autosomal recessive; Myoclonic epilepsy, infantile, familial, 605021 (3), Autosomal recessive",Tbc1d24 (MGI:2443456)
16,2513725,2520222,16p13.3,16p13.3,108745,"ATP6V0C, ATP6L, ATP6C","ATPase, H+ transporting, V0 subunit c",ATP6V0C,527,ENSG00000185883,NA,NA,Atp6v0c (MGI:88116)
16,2530034,2531407,16p13.3,16p13.3,611113,"CEMP1, CP23",Cementum protein 1,CEMP1,752014,ENSG00000205923,NA,NA,NA
16,2538013,2603189,16p13.3,16p13.3,605213,"PDPK1, PDK1",3-phosphoinositide-dependent protein kinase 1,PDPK1,5170,ENSG00000140992,NA,NA,Pdpk1 (MGI:1338068)
16,2682522,2709029,16p13.3,16p13.3,611285,KCTD5,Potassium channel tetramerization domain-containing protein 5,KCTD5,54442,ENSG00000167977,NA,NA,Kctd5 (MGI:1916509)
16,2750902,2771411,Chr.16,16p13.3,606032,"SRRM2, SRM300, KIAA0324","Serine/arginine repetitive matrix 2 (ser/arg-rich splicing factor-related nuclear matrix protein, 300kD)",SRRM2,23524,ENSG00000167978,NA,NA,NA
16,2771413,2777279,16p13.3,16p13.3,600787,"TCEB2, ELOB","Transcription elongation factor B, polypeptide 2",ELOB,6923,ENSG00000103363,NA,NA,NA
16,2783952,2787758,16p13.3,16p13.3,613797,"PRSS33, EOS","Protease, serine, 33",PRSS33,260429,ENSG00000103355,NA,NA,Prss33 (MGI:2661234)
16,2817162,2821721,16p13.3,16p13.3,608159,"PRSS21, ESP1","Protease, serine, 21 (testisin)",PRSS21,10942,ENSG00000007038,NA,NA,Prss21 (MGI:1916698)
16,2852728,2858629,16p13.3,16p13.3,609343,PRSS22,"Protease, serine, 22",PRSS22,64063,ENSG00000005001,NA,NA,Prss22 (MGI:1918085)
16,2964274,2968379,16p13.3,16p13.3,609899,"KREMEN2, KRM2",Kringle domain-containing transmembrane protein 2,KREMEN2,79412,ENSG00000131650,NA,NA,Kremen2 (MGI:1920266)
16,2969347,2973483,16p13.3,16p13.3,614578,PAQR4,"Progestin and ADIPOQ receptor family, member 4",PAQR4,124222,ENSG00000162073,NA,NA,Paqr4 (MGI:1923748)
16,2972807,2980493,16p13.3,16p13.3,602474,"PKMYT1, MYT1","Protein kinase, membrane-associated tyrosine/threonine, 1",PKMYT1,9088,ENSG00000127564,NA,NA,Pkmyt1 (MGI:2137630)
16,3012922,3014504,16p13.3,16p13.3,615799,CLDN9,Claudin 9,CLDN9,9080,ENSG00000213937,NA,NA,Cldn9 (MGI:1913100)
16,3014711,3018182,16p13.3,16p13.3,615798,CLDN6,Claudin 6,CLDN6,9074,ENSG00000184697,NA,NA,Cldn6 (MGI:1859284)
16,3020367,3022382,16p13.3,16p13.3,605914,"TNFRSF12A, FN14, TWEAKR","Tumor necrosis factor receptor superfamily, member 12A",TNFRSF12A,51330,ENSG00000006327,NA,NA,Tnfrsf12a (MGI:1351484)
16,3024034,3027749,16p13.3,16p13.3,615403,"THOC6, FSAP35, BBIS",THO complex subunit 6,THOC6,79228,ENSG00000131652,NA,"Beaulieu-Boycott-Innes syndrome, 613680 (3), Autosomal recessive",Thoc6 (MGI:2677480)
16,3027681,3036984,16p13.3,16p13.3,617003,"BICDL2, BICDR2, CCDC64B",BICD family-like cargo adaptor 2,BICDL2,146439,ENSG00000162069,NA,NA,Bicdl2 (MGI:2388267)
16,3045962,3060728,16p13.3,16p13.3,608482,"MMP25, MMP20A",Matrix metalloproteinase 25,MMP25,64386,ENSG00000008516,NA,NA,Mmp25 (MGI:2443938)
16,3065402,3069818,16p13.3,16p13.3,606001,"IL32, NK4",Interleukin 32,IL32,9235,ENSG00000008517,NA,NA,NA
16,3088889,3099293,16p13.3,16p13.3,618365,"ZSCAN10, ZFP206",Zinc finger- and SCAN domain-containing protein 10,ZSCAN10,84891,ENSG00000130182,NA,NA,Zscan10 (MGI:3040700)
16,3112578,3120516,16p13.3,16p13.3,603436,"ZNF205, ZNF210",Zinc finger protein-205,ZNF205,7755,ENSG00000122386,NA,NA,Zfp13 (MGI:99159)
16,3135028,3142803,16p13.3,16p13.3,608387,"ZNF213, CR53",Zinc finger protein 213,ZNF213,7760,ENSG00000085644,NA,NA,Zfp213 (MGI:3053094)
16,3188203,3206505,16p13,16p13.3,603232,"OR1F1, OLFMF","Olfactory receptor, family 1, subfamily F, member 1",OR1F1,4992,ENSG00000168124,NA,NA,NA
16,3222324,3236220,16p13,16p13.3,603231,ZNF200,Zinc finger protein-200,ZNF200,7752,ENSG00000010539,NA,NA,NA
16,3242027,3256775,16p13,16p13.3,608107,"MEFV, MEF, FMF",Pyrin (marenostrin),MEFV,4210,ENSG00000103313,between D16S80 and D16S283,"Familial Mediterranean fever, AD, 134610 (3), Autosomal dominant; Familial Mediterranean fever, AR, 249100 (3), Autosomal recessive",Mefv (MGI:1859396)
16,3283182,3301648,16p13.3,16p13.3,604191,ZNF263,Zinc finger protein 263,ZNF263,10127,ENSG00000006194,NA,NA,Zfp263 (MGI:1921370)
16,3298807,3305429,16p13,16p13.3,612969,"TIGD7, SANCHO",Tigger transposable element-derived gene 7,TIGD7,91151,ENSG00000140993,NA,NA,NA
16,3305405,3322998,16pter-p11,16p13.3,601473,ZNF75A,Zinc finger protein-75A,ZNF75A,7627,ENSG00000162086,NA,NA,NA
16,3401189,3409363,16p13.3,16p13.3,603900,ZNF174,Zinc finger protein-174,ZNF174,7727,ENSG00000103343,NA,NA,Zfp174 (MGI:2686600)
16,3432413,3443503,16p13.3,16p13.3,614685,ZNF597,Zinc finger protein 597,ZNF597,146434,ENSG00000167981,NA,NA,Zfp597 (MGI:1918313)
16,3443610,3486962,16p13.3,16p13.3,614246,"NAA60, NAT15","N-alpha-acetyltransferase 60, NatF catalytic subunit",NAA60,79903,ENSG00000122390,NA,NA,Naa60 (MGI:1922013)
16,3500977,3539047,16p13,16p13.3,616787,"CLUAP1, QILIN, FAP22, KIAA0643",Clusterin-associated protein 1,CLUAP1,23059,ENSG00000103351,NA,NA,Cluap1 (MGI:1924029)
16,3539032,3577781,16p13.3,16p13.3,615648,NLRC3,"NLR family, Caspase recruitment domain-containing 3",NLRC3,197358,ENSG00000167984,NA,NA,Nlrc3 (MGI:2444070)
16,3579652,3611638,16p13.3,16p13.3,613278,"SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP","Slx4, S. cerevisiae, homolog of",SLX4,84464,ENSG00000188827,NA,"Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive",Slx4 (MGI:106299)
16,3611736,3665471,16p13.3,16p13.3,125505,"DNASE1, DNL1",Deoxyribonuclease I,DNASE1,1773,ENSG00000213918,NA,"{Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant",Dnase1 (MGI:103157)
16,3658036,3717523,16p13.3,16p13.3,606219,"TRAP1, HSP75, HSP90L",Tumor necrosis factor receptor-associated protein 1,TRAP1,10131,ENSG00000126602,NA,NA,Trap1 (MGI:1915265)
16,3725053,3880726,16p13.3,16p13.3,600140,"CREBBP, CBP, RSTS1, MKHK1",CREB binding protein,CREBBP,1387,ENSG00000005339,fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML,"Menke-Hennekam syndrome 1, 618332 (3); Rubinstein-Taybi syndrome 1, 180849 (3), Autosomal dominant",Crebbp (MGI:1098280)
16,3953386,4116441,16p13.3,16p13.3,603302,ADCY9,Adenylate cyclase-9,ADCY9,115,ENSG00000162104,NA,NA,Adcy9 (MGI:108450)
16,4189373,4242252,16p13.3,16p13.3,604992,SRL,Sarcalumenin,SRL,6345,ENSG00000185739,NA,NA,Srl (MGI:2146620)
16,4257185,4273022,16p13,16p13.3,600743,TFAP4,Transcription factor AP-4 (activating enhancer-binding protein 4),TFAP4,7023,ENSG00000090447,NA,NA,Tfap4 (MGI:103239)
16,4314760,4339596,16p13.3,16p13.3,608539,"GLIS2, NPHP7",GLIS family zinc finger protein 2,GLIS2,84662,ENSG00000126603,NA,"Nephronophthisis 7, 611498 (3)",Glis2 (MGI:1932535)
16,4340250,4351320,16p13.3,16p13.3,614336,"PAM16, MAGMAS, SMDMDM","Presequence translocase-associated motor 16, S. cerevisiae, homolog of",PAM16,51025,ENSG00000217930,NA,"Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3), Autosomal recessive",Pam16 (MGI:1913699)
16,4354541,4416595,16p13.3,16p13.3,611668,"CORO7, POD1, CRN7",Coronin 7,CORO7,79585,ENSG00000262246,NA,NA,Coro7 (MGI:1926135)
16,4371847,4383537,16p13.3,16p13.3,608843,VASN,Vasorin,VASN,114990,ENSG00000168140,NA,NA,Vasn (MGI:2177651)
16,4425804,4456774,16p13.3,16p13.3,608382,"DNAJA3, TID1","DNAJ, E. coli, homolog of, subfamily A, member 3",DNAJA3,9093,ENSG00000103423,NA,NA,Dnaja3 (MGI:1933786)
16,4474696,4510346,16p13.3,16p13.3,141251,HMOX2,Heme oxygenase 2,HMOX2,3163,ENSG00000103415,NA,NA,Hmox2 (MGI:109373)
16,4510668,4538772,16p13.3,16p13.3,610503,"CDIP1, C16orf5",Cell death-inducing p53 target 1,CDIP1,29965,ENSG00000089486,NA,NA,Cdip1 (MGI:1913876)
16,4624823,4690973,16p13.3,16p13.3,607559,"MGRN1, KIAA0544","Mahogunin, ring finger 1",MGRN1,23295,ENSG00000102858,NA,NA,Mgrn1 (MGI:2447670)
16,4688929,4695858,16p13.3,16p13.3,617338,"NUDT16L1, SDOS",Nudix hydrolase 16-like 1,NUDT16L1,84309,ENSG00000168101,NA,NA,Nudt16l1 (MGI:1914161)
16,4696509,4734376,16p13.3,16p13.3,617310,ANKS3,Ankyrin repeat and sterile alpha motif domains-containing protein 3,ANKS3,124401,ENSG00000168096,NA,NA,Anks3 (MGI:1919865)
16,4777589,4791609,16p13.3,16p13.3,611562,"SEPT12, SPGF10",Septin 12,SEPTIN12,124404,ENSG00000140623,NA,"Spermatogenic failure 10, 614822 (3), Autosomal dominant",Sept12 (MGI:1918339)
16,4796961,4802949,16p13.3,16p13.3,614574,"ROGDI, KTZS","Rogdi, Drosophila, homolog of",ROGDI,79641,ENSG00000067836,NA,"Kohlschutter-Tonz syndrome, 226750 (3), Autosomal recessive",Rogdi (MGI:1913299)
16,4803202,4848031,16p13.3,16p13.3,610660,"GLYR1, NP60",Glyoxylate reductase 1 homolog,GLYR1,84656,ENSG00000140632,NA,NA,Glyr1 (MGI:1921272)
16,4846664,4882400,16p13.3,16p13.3,609771,UBN1,Ubinuclein 1,UBN1,29855,ENSG00000118900,NA,NA,Ubn1 (MGI:1891307)
16,4882506,4937147,16p13,16p13.3,602871,PPL,Periplakin,PPL,5493,ENSG00000118898,NA,NA,Ppl (MGI:1194898)
16,5024843,5033939,16p13.3,16p13.3,607985,"NAGPA, UCE",N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,NAGPA,51172,ENSG00000103174,NA,NA,Nagpa (MGI:1351598)
16,5071808,5087378,16p13.3,16p13.3,605907,"ALG1, HMAT1, HMT1, CDG1K","Alg1, yeast, homolog of (beta-1,4 mannosyltransferase)",ALG1,56052,ENSG00000033011,NA,"Congenital disorder of glycosylation, type Ik, 608540 (3), Autosomal recessive",Alg1 (MGI:2384774)
16,5084283,5097819,16p13.3,16p13.3,615263,"EEF2KMT, FAM86A",Eukaryotic elongation factor 2 lysine methyltransferase,EEF2KMT,196483,ENSG00000118894,NA,NA,Eef2kmt (MGI:1917761)
16,5239751,7713342,16p13,16p13.3,605104,"RBFOX1, 2BP1, FOX1, HRNBP1","RNA-binding protein FOX1, C. elegans, homolog of, 1",RBFOX1,54715,ENSG00000078328,NA,NA,Rbfox1 (MGI:1926224)
16,7800000,10400000,16p13.2,NA,616863,"DEL16p13.2, C16DELp13.2",Chromosome 16p13.2 deletion syndrome,NA,NA,NA,NA,"Chromosome 16p13.2 deletion syndrome, 616863 (4), Autosomal dominant",NA
16,8526548,8590510,16p13.3,16p13.2,611579,TMEM114,Transmembrane protein 114,TMEM114,283953,ENSG00000232258,NA,NA,Tmem114 (MGI:1921970)
16,8621639,8673564,16p13.2,16p13.2,615261,"METTL22, C16orf68",Methyltransferase-like 22,METTL22,79091,ENSG00000067365,NA,NA,Mettl22 (MGI:2384301)
16,8674616,8784574,16p13.3,16p13.2,137150,"ABAT, GABAT",4-aminobutyrate aminotransferase,ABAT,18,ENSG00000183044,NA,"GABA-transaminase deficiency, 613163 (3), Autosomal recessive",Abat (MGI:2443582)
16,8797812,8849325,16p13.3-p13.2,16p13.2,601785,"PMM2, CDG1A",Phosphomannomutase 2,PMM2,5373,ENSG00000140650,NA,"Congenital disorder of glycosylation, type Ia, 212065 (3), Autosomal recessive",Pmm2 (MGI:1859214)
16,8852941,8869011,16p13.2,16p13.2,616885,"CARHSP1, CRHSP24",Calcium-regulated heat-stable protein 1,CARHSP1,23589,ENSG00000153048,NA,NA,Carhsp1 (MGI:1196368)
16,8892093,8963911,16p13.3,16p13.2,602519,"USP7, HAUSP","Ubiquitin-specific protease-7, herpes virus-associated",USP7,7874,ENSG00000187555,previously reported to map to 3p21,NA,Usp7 (MGI:2182061)
16,9753403,10182927,16p13,16p13.2,138253,"GRIN2A, NMDAR2A, FESD, LKS","Glutamate receptor, ionotropic, N-methyl D-aspartate 2A",GRIN2A,2903,ENSG00000183454,NA,"Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3), Autosomal dominant",Grin2a (MGI:95820)
16,10385998,10483642,16p13.13,16p13.2-p13.1,613645,"ATF7IP2, MCAF2",Activating transcription factor 7-interacting protein 2,ATF7IP2,80063,ENSG00000166669,NA,NA,"Gm24392,Atf7ip2 (MGI:5454169,MGI:1922579)"
16,10528421,10580597,16p13.2,16p13.13,602334,"EMP2, NPHS10",Epithelial membrane protein 2,EMP2,2013,ENSG00000213853,NA,"Nephrotic syndrome, type 10, 615861 (3), Autosomal recessive",Emp2 (MGI:1098726)
16,10743163,10769350,16p13.1,16p13.13,600280,"NUBP1, NBP",Nucleotide-binding protein 1,NUBP1,4682,ENSG00000103274,NA,NA,Nubp1 (MGI:1347073)
16,10866207,10941561,16p13,16p13.13,600005,"CIITA, MHC2TA, C2TA",Class II major histocompatibility complex transactivator,CIITA,4261,ENSG00000179583,NA,"Bare lymphocyte syndrome, type II, complementation group A, 209920 (3), Autosomal recessive; {Rheumatoid arthritis, susceptibility to}, 180300 (3)",Ciita (MGI:108445)
16,10928890,10942467,16p13.13,16p13.13,617901,"DEXI, MYLE",Dexamethasone-induced gene,DEXI,28955,ENSG00000182108,NA,NA,Dexi (MGI:1926236)
16,10944487,11193271,16p13.13,16p13.13,611303,"CLEC16A, KIAA0350","C-type lectin domain family 16, member A",CLEC16A,23274,ENSG00000038532,NA,NA,Clec16a (MGI:1921624)
16,11254416,11256181,16p13.2,16p13.13,603597,"SOCS1, SSI1, CIS1, CISH1",Suppressor of cytokine signaling 1,SOCS1,8651,ENSG00000185338,NA,NA,Socs1 (MGI:1354910)
16,11267856,11269324,16p13.3,16p13.13,190232,TNP2,Transition protein-2 (during histone to protamine replacement),TNP2,7142,ENSG00000178279,in 13kb segment with PRM1 and PRM2,NA,NA
16,11275635,11276479,16p13.3,16p13.13,182890,PRM2,Sperm protamine P2,PRM2,5620,ENSG00000122304,in same 4.8kb fragment as PRM2,NA,NA
16,11280840,11281329,16p13.3,16p13.13,182880,PRM1,Sperm protamine P1,PRM1,5619,ENSG00000175646,16q21 = conflicting localization,NA,NA
16,11345437,11351762,16p13.13,16p13.13,612426,"RMI2, C16orf75, BLAP18",RecQ-mediated genome instability 2,RMI2,116028,ENSG00000175643,NA,NA,Rmi2 (MGI:2685383)
16,11547721,11636376,16p13.3-p12,16p13.13,603795,"LITAF, CMT1C",LPS-induced TNFA factor,LITAF,9516,ENSG00000189067,NA,"Charcot-Marie-Tooth disease, type 1C, 601098 (3), Autosomal dominant",Litaf (MGI:1929512)
16,11668454,11679153,16p13,16p13.13,603032,SNN,Stannin,SNN,8303,ENSG00000184602,NA,NA,Snn (MGI:1276549)
16,11679079,11742856,16p13.13,16p13.13,617792,"TXNDC11, EFP1",Thioredoxin domain-containing protein 11,TXNDC11,51061,ENSG00000153066,NA,NA,Txndc11 (MGI:1923620)
16,11819829,11828831,16p13.13,16p13.13,613746,BCAR4,Breast cancer antiestrogen resistance 4,BCAR4,400500,ENSG00000262117,NA,NA,NA
16,11833849,11851541,16p13,16p13.13,615874,"RSL1D1, CSIG, PBK1",Ribosomal L1 domain-containing protein 1,RSL1D1,26156,ENSG00000171490,NA,NA,Rsl1d1 (MGI:1913659)
16,11868127,11916653,16p13.1,16p13.13,139259,GSPT1,G1 to S phase transition-1,GSPT1,2935,ENSG00000103342,NA,NA,Gspt1 (MGI:1316728)
16,11965209,11968067,16p13.1,16p13.13,109545,"TNFRSF17, BCMA","Tumor necrosis factor receptor superfamily, member 17 (B-cell maturation factor)",TNFRSF17,608,ENSG00000048462,NA,NA,Tnfrsf17 (MGI:1343050)
16,12659798,12803886,16p13.12,16p13.12,615603,CPPED1,Calcineurin-like phosphoesterase domain-containing protein 1,CPPED1,55313,ENSG00000103381,NA,NA,Cpped1 (MGI:2443300)
16,12901597,13563426,16p13.12,16p13.12,613346,"SHISA9, CKAMP44","Shisa family, member 9",SHISA9,729993,ENSG00000237515,NA,NA,Shisa9 (MGI:1919805)
16,13920136,13952347,16p13.3-p13.13,16p13.12,133520,"ERCC4, XPF, FANCQ, XFEPS","Excision-repair, complementing defective, in Chinese hamster, number 4",ERCC4,2072,ENSG00000175595,NA,"Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive; XFE progeroid syndrome, 610965 (3), Autosomal recessive; Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive; Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive",Ercc4 (MGI:1354163)
16,14071061,14266778,16p13.1,16p13.12,609463,"MKL2, MRTFB",MKL1/myocardin-like 2,MRTFB,57496,ENSG00000186260,NA,NA,Mrtfb (MGI:3050795)
16,14303966,14304048,16p13.12,16p13.12,614734,MIR193B,Micro RNA 193B,MIR193B,574455,ENSG00000207639,NA,NA,NA
16,14309284,14309370,16p13.12,16p13.12,614735,MIR365A,Micro RNA 365A,MIR365A,100126355,ENSG00000199130,NA,NA,NA
16,14435700,14630285,16p13.12,16p13.12,604212,"PARN, DAN, DKCB6, PFBMFT4",Polyadenylate-specific ribonuclease,PARN,5073,ENSG00000140694,NA,"Dyskeratosis congenita, autosomal recessive 6, 616353 (3), Autosomal recessive; Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3), Autosomal dominant",Parn (MGI:1921358)
16,14672547,14694661,16p13.1-p12,16p13.12,603603,"PLA2G10, SPLA2, GXSPLA2","Phospholipase A2, group X",PLA2G10,8399,ENSG00000069764,NA,NA,Pla2g10 (MGI:1347522)
16,14833720,14896156,16p13.11,16p13.11,609157,NOMO1,Nodal modulator 1,NOMO1,23420,ENSG00000103512,NA,NA,Nomo1 (MGI:2385850)
16,14937442,14952055,16p13.1,16p13.11,606406,NPIP,Nuclear pore complex-interacting protein,NPIPA1,9284,ENSG00000183426,NA,NA,NA
16,14974590,15153342,16p13.11,16p13.11,614244,"PDXDC1, KIAA0251",Pyridoxal-dependent decarboxylase domain-containing protein 1,PDXDC1,23042,ENSG00000179889,NA,NA,Pdxdc1 (MGI:1920909)
16,15037852,15056078,16p13.11,16p13.11,615367,NTAN1,N-terminal asparagine amidase,NTAN1,123803,ENSG00000157045,NA,NA,Ntan1 (MGI:108471)
16,15060021,15094334,16p12,16p13.11,605121,"RRN3, TIFIA","RRN3, S. cerevisiae, homolog of",RRN3,54700,ENSG00000085721,NA,NA,Rrn3 (MGI:1925255)
16,15395568,15413270,16p13.1,16p13.11,618100,MPV17L,MPV17-like protein,MPV17L,255027,ENSG00000156968,NA,NA,Mpv17l (MGI:2135951)
16,15594386,15643165,16p13.13,16p13.11,614593,"MARF1, KIAA0430, LKAP",Meiosis regulator and mRNA stability factor 1,MARF1,9665,ENSG00000166783,NA,NA,Marf1 (MGI:2444505)
16,15643266,15726352,16p13.1,16p13.11,609449,"NDE1, NUDE, LIS4, MHAC",nudE neurodevelopment protein 1,NDE1,54820,ENSG00000072864,mutation identified in 1 MHAC family,"Lissencephaly 4 (with microcephaly), 614019 (3), Autosomal recessive; ?Microhydranencephaly, 605013 (3), Autosomal recessive",Nde1 (MGI:1914453)
16,15703134,15857031,16p13.13-p13.12,16p13.11,160745,"MYH11, AAT4, FAA4","Myosin, heavy polypeptide-11, smooth muscle",MYH11,4629,ENSG00000133392,fused with CBFB by inversion in acute myelomonocytic leukemia,"Aortic aneurysm, familial thoracic 4, 132900 (3), Autosomal dominant",Myh11 (MGI:102643)
16,15865718,15888648,16p13.11,16p13.11,617149,"FOPNL, FOR20, C16orf63",FGFR1OP N-terminal domain-like protein,FOPNL,123811,ENSG00000133393,NA,NA,Fopnl (MGI:1913336)
16,15949615,16143061,16p13.1,16p13.11,158343,"ABCC1, MRP1, MRP","ATP-binding cassette, subfamily C, member 1 (multidrug resistance-associated protein 1)",ABCC1,4363,ENSG00000103222,NA,NA,Abcc1 (MGI:102676)
16,16149564,16223616,16p13.1,16p13.11,603234,"ABCC6, ARA, ABC34, MLP1, PXE, GACI2","ATP-binding cassette, subfamily C, member 6",ABCC6,368,ENSG00000091262,NA,"Arterial calcification, generalized, of infancy, 2, 614473 (3), Autosomal recessive; Pseudoxanthoma elasticum, 264800 (3), Autosomal recessive; Pseudoxanthoma elasticum, forme fruste, 177850 (3), Autosomal dominant",Abcc6 (MGI:1351634)
16,16232527,16294810,16p13.11,16p13.11,609159,NOMO3,Nodal modulator 3,NOMO3,408050,ENSG00000103226,NA,NA,Nomo1 (MGI:2385850)
16,16700000,28500000,16p12,NA,136570,"DEL16p12.1, C16DELp12.1","Chromosome 16p12.1 deletion syndrome, 520kb",NA,NA,NA,between 21.85-22.37 Mb,"Chromosome 16p12.1 deletion syndrome, 520kb, 136570 (4)",NA
16,16700000,35300000,16p12-p11.2,NA,608105,EPRPDC,"Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp",NA,574044,NA,between D16S3133 and D16S3131,"Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp, 608105 (2), Autosomal recessive",NA
16,16700000,28500000,16p12,NA,611247,"MAFD4, BPAD",Major affective disorder 4,NA,100126593,NA,max lod at D16S769,"Major affective disorder 4, 611247 (2)",NA
16,16700000,28500000,16p12.3-p12.1,NA,602594,RP22,Retinitis pigmentosa-22,RP22,6114,NA,NA,"Retinitis pigmentosa 22, 602594 (2)",NA
16,16700000,56000000,16p12.3-q12.2,NA,609939,SLEB6,"Systemic lupus erythematosus, susceptibility to, 6",NA,NA,NA,NA,"{Systemic lupus erythematosus, susceptibility to, 6}, 609939 (2)",NA
16,17101768,17470959,16p13.1,16p12.3,608124,"XYLT1, XT1, DBQD2",Xylosyltransferase 1,XYLT1,64131,ENSG00000103489,NA,"Desbuquois dysplasia 2, 615777 (3), Autosomal recessive; {Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3), Autosomal recessive",Xylt1 (MGI:2451073)
16,18499923,18562142,16p12.3,16p12.3,609158,NOMO2,Nodal modulator 2,NOMO2,283820,ENSG00000185164,NA,NA,Nomo1 (MGI:2385850)
16,18781294,18790333,16p12.3,16p12.3,603674,"RPS15A, DBA20",Ribosomal protein S15a,RPS15A,6210,ENSG00000134419,mutation identified in 1 DBA20 family,"?Diamond-Blackfan anemia 20, 618313 (3), Autosomal dominant",Rps15a (MGI:2389091)
16,18791666,18801548,16p12-p11.2,16p12.3,607669,"ARL6IP1, KIAA0069, SPG61",ADP-ribosylation factor-like 6 interacting protein 1,ARL6IP1,23204,ENSG00000170540,mutation identified in 1 family,"?Spastic paraplegia 61, autosomal recessive, 615685 (3), Autosomal recessive",Arl6ip1 (MGI:1858943)
16,18804852,18926427,16p12,16p12.3,607032,"SMG1, LIP, KIAA0421","SMG1, C. elegans, homolog of",SMG1,23049,ENSG00000157106,NA,NA,Smg1 (MGI:1919742)
16,18983933,19063941,16p12.3,16p12.3,617198,TMC7,Transmembrane channel-like protein 7,TMC7,79905,ENSG00000170537,NA,NA,Tmc7 (MGI:2443317)
16,19067594,19080094,16p13.1-p12,16p12.3,601683,"COQ7, CLK1, COQ10D8","COQ7, S. cerevisiae, homolog of",COQ7,10229,ENSG00000167186,mutation identified in 1 COQ10D8 patient,"?Coenzyme Q10 deficiency, primary, 8, 616733 (3), Autosomal recessive",Coq7 (MGI:107207)
16,19410538,19499112,16p12.3,16p12.3,617197,TMC5,Transmembrane channel-like protein 5,TMC5,79838,ENSG00000103534,NA,NA,Tmc5 (MGI:1921674)
16,19501692,19522144,16p12-p11.2,16p12.3,605943,"GDE1, MIR16",Glycerophosphodiester phosphodiesterase 1,GDE1,51573,ENSG00000006007,NA,NA,Gde1 (MGI:1891827)
16,19523878,19553407,16p12.3,16p12.3,609544,"CCP110, CP110, KIAA0419","Centrosomal coiled-coil protein, 110kD",CCP110,9738,ENSG00000103540,NA,NA,Ccp110 (MGI:2141942)
16,19856690,19886044,16p12.3-p12.1,16p12.3,605948,"GPRC5B, RAIG2","G protein-coupled receptor, family C, group 5, member B",GPRC5B,51704,ENSG00000167191,NA,NA,Gprc5b (MGI:1927596)
16,20031484,20073777,16p12.3,16p12.3,618448,"GPR139, GPRG1",G protein-coupled receptor 139,GPR139,124274,ENSG00000180269,NA,NA,Gpr139 (MGI:2685341)
16,20309573,20327804,16p12.3,16p12.3,602977,GP2,"Glycoprotein 2, zymogen granule membrane",GP2,2813,ENSG00000169347,previously assigned to chr.9,NA,Gp2 (MGI:1914383)
16,20333050,20356300,16p12.3,16p12.3,191845,"UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2","Uromodulin (uromucoid, Tamm-Horsfall glycoprotein)",UMOD,7369,ENSG00000169344,NA,"Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3); Hyperuricemic nephropathy, familial juvenile 1, 162000 (3), Autosomal dominant; Medullary cystic kidney disease 2, 603860 (3)",Umod (MGI:102674)
16,20409533,20441335,16p12.3,16p12.3,614361,ACSM5,"Acyl-CoA synthetase medium-chain family, member 5",ACSM5,54988,ENSG00000183549,NA,NA,Acsm5 (MGI:2444086)
16,20451503,20487668,16p12.3,16p12.3,614358,ACSM2A,"Acyl-CoA synthetase medium-chain family, member 2A",ACSM2A,123876,ENSG00000183747,NA,NA,Acsm2 (MGI:2385289)
16,20536225,20576375,16p12.3,16p12.3,614359,"ACSM2B, HXMA","Acyl-CoA synthetase medium-chain family, member 2B",ACSM2B,348158,ENSG00000066813,NA,NA,NA
16,20623234,20697787,16p12.3,16p12.3,614357,"ACSM1, MACS1","Acyl-CoA synthetase medium-chain family, member 1",ACSM1,116285,ENSG00000166743,NA,NA,Acsm1 (MGI:2152200)
16,20730588,20741829,16p12.3,16p12.3,616662,THUMPD1,THUMP domain-containing protein 1,THUMPD1,55623,ENSG00000066654,NA,NA,Thumpd1 (MGI:2444479)
16,20742439,20797810,16p13.11,16p12.3,145505,"ACSM3, SAH",Acyl-CoA synthetase medium-chain family member 3,ACSM3,6296,ENSG00000005187,NA,"{?Hypertension, essential} (1)",Acsm3 (MGI:99538)
16,20854924,20900357,16p12.3,16p12.3,616167,"DCUN1D3, SCCRO3",DCN1 domain-containing protein 3,DCUN1D3,123879,ENSG00000188215,NA,NA,Dcun1d3 (MGI:2679003)
16,20899625,20925005,16p12.3,16p12.3,614709,LYRM1,LYR motif-containing protein 1,LYRM1,57149,ENSG00000102897,NA,NA,Lyrm1 (MGI:1921169)
16,20933110,21159536,16p12,16p12.3,603334,"DNAH3, DNAHC3B","Dynein, axonemal, heavy chain 3",DNAH3,55567,ENSG00000158486,NA,NA,Dnah3 (MGI:2683040)
16,21158348,21180615,16p12.3,16p12.3,611304,TMEM159,Transmembrane protein 159,TMEM159,57146,ENSG00000011638,NA,NA,Tmem159 (MGI:1925752)
16,21197449,21214509,16p12,16p12.3-p12.2,182888,"ZP2, OOMD6",Zona pellucida glycoprotein 2,ZP2,7783,ENSG00000103310,NA,"Oocyte maturation defect 6, 618353 (3), Autosomal recessive",Zp2 (MGI:99214)
16,21200000,35300000,16p12.2-p11.2,NA,613604,"DEL16p12.1p11.2, C16DELp12.1p11.2",Chromosome 16p12.2-p11.2 deletion syndrome,NA,NA,NA,17.1-8.7 Mb contiguous gene deletion syndrome,"Chromosome 16p12.2-p11.2 deletion syndrome, 613604 (4), Isolated cases",NA
16,21200000,52600000,16p12.2-q12.1,NA,611096,"MRT10, MRT20",611096,MRT10,100101425,NA,"between rs724466 and rs3901517, rs7197568 and rs71972227","Mental retardation, autosomal recessive 10/20, 611096 (2), Autosomal recessive",NA
16,21233698,21253849,16p12.2,16p12.2,609901,"ANKS4B, HARP, FLJ38819",Ankyrin repeat and sterile alpha motif domain-containing protein 4B,ANKS4B,257629,ENSG00000175311,NA,NA,Anks4b (MGI:1919324)
16,21258520,21303061,16p13.11-p12.3,16p12.2,123740,"CRYM, DFNA40","Crystallin, mu",CRYM,1428,ENSG00000103316,NA,"Deafness, autosomal dominant 40, 616357 (3), Autosomal dominant",Crym (MGI:102675)
16,21597220,21657472,16p12.2,16p12.2,609388,"METTL9, DREV",Methyltransferase-like 9,METTL9,51108,ENSG00000197006,NA,NA,Mettl9 (MGI:1914862)
16,21639549,21652607,16p13,16p12.2,606222,"IGSF6, DORA","Immunoglobulin superfamily, member 6",IGSF6,10261,ENSG00000140749,NA,NA,Igsf6 (MGI:1891393)
16,21663967,21762624,16p12.2,16p12.2,607038,"OTOA, DFNB22",Otoancorin,OTOA,146183,ENSG00000155719,NA,"Deafness, autosomal recessive 22, 607039 (3), Autosomal recessive",Otoa (MGI:2149209)
16,21953360,21983659,16p12,16p12.2,191329,"UQCRC2, MC3DN5",Ubiquinol-cytochrome c reductase core protein II,UQCRC2,7385,ENSG00000140740,NA,"Mitochondrial complex III deficiency, nuclear type 5, 615160 (3), Autosomal recessive",Uqcrc2 (MGI:1914253)
16,22206277,22288737,Chr.16,16p12.2,606968,EEF2K,Elongation factor 2 kinase,EEF2K,29904,ENSG00000103319,NA,NA,Eef2k (MGI:1195261)
16,22297374,22335102,16p12.2,16p12.2,617815,"POLR3E, SIN, KIAA1452","Polymerase III, RNA, subunit E",POLR3E,55718,ENSG00000058600,NA,NA,Polr3e (MGI:1349452)
16,22345935,22374618,16p13.1-p12,16p12.2,117340,CDR2,"Cerebellar degeneration-related antigen-2, 62kD",CDR2,1039,ENSG00000140743,NA,NA,Cdr2 (MGI:1100885)
16,22814161,22916337,16p12,16p12.2,604056,"HS3ST2, 30ST2",Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 2,HS3ST2,9956,ENSG00000122254,NA,NA,Hs3st2 (MGI:1333802)
16,23182744,23216882,16p13-p12,16p12.2,600761,"SCNN1G, PHA1, BESC3, LDLS2","Sodium channel, nonvoltage-gated 1, gamma",SCNN1G,6340,ENSG00000166828,same 400kb fragment as SCNN1B,"Bronchiectasis with or without elevated sweat chloride 3, 613071 (3), Autosomal dominant; Liddle syndrome 2, 618114 (3), Autosomal dominant; Pseudohypoaldosteronism, type I, 264350 (3), Autosomal recessive",Scnn1g (MGI:104695)
16,23278230,23381294,16p13-p12,16p12.2,600760,"SCNN1B, BESC1, LIDLS1","Sodium channel, nonvoltage-gated 1, beta",SCNN1B,6338,ENSG00000168447,NA,"Bronchiectasis with or without elevated sweat chloride 1, 211400 (3), Autosomal dominant; Liddle syndrome 1, 177200 (3), Autosomal dominant; Pseudohypoaldosteronism, type I, 264350 (3), Autosomal recessive",Scnn1b (MGI:104696)
16,23388492,23453214,16p,16p12.2,606978,"COG7, CDG2E",Component of oligomeric golgi complex 7,COG7,91949,ENSG00000168434,NA,"Congenital disorder of glycosylation, type IIe, 608779 (3), Autosomal recessive",Cog7 (MGI:2685013)
16,23522012,23557374,16p13.1-p11.2,16p12.2,612799,"EARS2, KIAA1970, COXPD12",Glutamyl-tRNA synthetase 2,EARS2,124454,ENSG00000103356,NA,"Combined oxidative phosphorylation deficiency 12, 614924 (3), Autosomal recessive",Ears2 (MGI:1914667)
16,23581011,23596328,16p12.3-p12.1,16p12.2,603836,NDUFAB1,NADH-ubiquinone oxidoreductase subunit AB1,NDUFAB1,4706,ENSG00000004779,NA,NA,"Ndufab1,Ndufab1-ps (MGI:1917566,MGI:4936891)"
16,23603161,23641356,16p12,16p12.2,610355,"PALB2, FANCN, PNCA3",Partner and localizer of BRCA2,PALB2,79728,ENSG00000083093,NA,"{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; Fanconi anemia, complementation group N, 610832 (3); {Pancreatic cancer, susceptibility to, 3}, 613348 (3)",Palb2 (MGI:3040695)
16,23641365,23677471,16p12.2,16p12.2,612962,"DCTN5, p25",Dynactin 5,DCTN5,84516,ENSG00000166847,NA,NA,Dctn5 (MGI:1891689)
16,23678888,23690366,16p12.2,16p12.2,602098,"PLK1, STPK13",Polo-like kinase 1,PLK1,5347,ENSG00000166851,NA,NA,Plk1 (MGI:97621)
16,23690309,23713247,16p12.2,16p12.2,604034,ERN2,Endoplasmic reticulum-to-nucleus signaling 2,ERN2,10595,ENSG00000134398,NA,NA,Ern2 (MGI:1349436)
16,23835982,24220610,16p11.2,16p12.2-p12.1,176970,"PRKCB1, PKCB","Protein kinase C, beta 1 polypeptide",PRKCB,5579,ENSG00000166501,NA,NA,Prkcb (MGI:97596)
16,24200000,35300000,16p12.1-p11.2,NA,157700,"MMVP1, MVP, PMV","Mitral valve prolapse, myxomatous 1",MMVP1,50951,NA,NA,"Mitral valve prolapse, myxomatous 1, 157700 (2), Autosomal dominant",NA
16,24255552,24362415,16p13.1-p12,16p12.1,606403,CACNG3,"Calcium channel, voltage-dependent, gamma-3 subunit",CACNG3,10368,ENSG00000006116,NA,NA,Cacng3 (MGI:1859165)
16,24539565,24572862,16p12-p11.2,16p12.1,600938,RBBP6,Retinoblastoma-binding protein-6,RBBP6,5930,ENSG00000122257,NA,NA,Rbbp6 (MGI:894835)
16,24610204,24826222,16p12,16p12.1,610739,"TNRC6A, GW182, KIAA1460, FAME6",Trinucleotide repeat-containing gene 6A,TNRC6A,27327,ENSG00000090905,mutation identified in 1 FAME6 family,"?Epilepsy, familial adult myoclonic, 6, 618074 (3)",Tnrc6a (MGI:2385292)
16,24845862,24911627,16p12.1,16p12.1,610238,"SLC5A11, KST1, SGLT6, SMIT2","Solute carrier family 5 (sodium/glucose cotransporter), member 11",SLC5A11,115584,ENSG00000158865,NA,NA,Slc5a11 (MGI:1919316)
16,24919388,25015600,16p12.2,16p12.1,608293,"ARHGAP17, RICH1",RHO GTPase-activating protein 17,ARHGAP17,55114,ENSG00000140750,NA,NA,Arhgap17 (MGI:1917747)
16,25111701,25178230,16p12.3-p12.1,16p12.1,610286,LCMT1,Leucine carboxyl methyltransferase 1,LCMT1,51451,ENSG00000205629,NA,NA,Lcmt1 (MGI:1353593)
16,25216916,25228931,16p12-p11.2,16p12.1,603750,AQP8,Aquaporin 8,AQP8,343,ENSG00000103375,NA,NA,Aqp8 (MGI:1195271)
16,25691958,26137684,16p11.2,16p12.1,604059,"HS3ST4, 30ST4",Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 4,HS3ST4,9951,ENSG00000182601,NA,NA,Hs3st4 (MGI:1333792)
16,27203485,27222304,16p12.1,16p12.1,611917,"KDM8, JMJD5",Lysine demethylase 8,KDM8,79831,ENSG00000155666,NA,NA,Kdm8 (MGI:1924285)
16,27224993,27268771,16p12.1,16p12.1,617263,"NSMCE1, NSE1","Non-SMC element 1, S. cerevisiae, homolog of",NSMCE1,197370,ENSG00000169189,NA,NA,Nsmce1 (MGI:1914961)
16,27313667,27364777,16p12.1-p11.2,16p12.1,147781,"IL4R, IL4RA",Interleukin-4 receptor,IL4R,3566,ENSG00000077238,NA,"{AIDS, slow progression to}, 609423 (3); {Atopy, susceptibility to}, 147050 (3), Autosomal dominant",Il4ra (MGI:105367)
16,27402161,27452042,16p11,16p12.1,605383,"IL21R, IMD56",Interleukin 21 receptor,IL21R,50615,ENSG00000103522,fusion partner with BCL6,"[IgE, elevated level of], 147050 (3), Autosomal dominant; Immunodeficiency 56, 615207 (3), Autosomal recessive",Il21r (MGI:1890475)
16,27460612,27549921,16p12.1,16p12.1,603246,GTF3C1,"General transcription factor 3C, polypeptide 1",GTF3C1,2975,ENSG00000077235,NA,NA,Gtf3c1 (MGI:107887)
16,27550127,27780370,16p12.1,16p12.1,616650,"KATNIP, KIAA0556",Katanin-interacting protein,KIAA0556,23247,ENSG00000047578,NA,"Joubert syndrome 26, 616784 (3), Autosomal recessive",D430042O09Rik (MGI:2442760)
16,27787527,28063713,16p12.1,16p12.1,617161,GSG1L,GSG1-like protein,GSG1L,146395,ENSG00000169181,NA,NA,Gsg1l (MGI:2685483)
16,28097975,28212030,16p12.1,16p12.1,608411,"XPO6, EXP6, KIAA0370",Exportin 6,XPO6,23214,ENSG00000169180,NA,NA,Xpo6 (MGI:2429950)
16,28466652,28492301,16p12.1,16p12.1,607042,"CLN3, BTS",Battenin,CLN3,1201,ENSG00000188603,NA,"Ceroid lipofuscinosis, neuronal, 3, 204200 (3), Autosomal recessive",Cln3 (MGI:107537)
16,28494642,28498963,16p11.2,16p12.1,605220,"APOBR, APOB48R",Apolipoprotein B receptor,APOBR,55911,ENSG00000184730,NA,NA,Apobr (MGI:2176230)
16,28499361,28526729,16p11,16p12.1-p11.2,608273,"IL27, IL30",Interleukin 27,IL27,246778,ENSG00000197272,NA,NA,Il27 (MGI:2384409)
16,28500000,35300000,16p11.2,NA,613444,"BMIQ16, DEL16p.11.2, C16DELp11.2","Chromosome 16p11.2 deletion syndrome, 220kb",NA,NA,NA,NA,"[Body mass index QTL16], 613444 (4); Chromosome 16p11.2 deletion syndrome, 220kb, 613444 (4)",NA
16,28500000,35300000,16p11.2,NA,611913,"DEL16p11.2, C16DELp11.2, AUTS14A","Chromosome 16p11.2 deletion syndrome, 593kb",NA,NA,NA,NA,"{Autism susceptibility 14A}, 611913 (2); Chromosome 16p11.2 deletion syndrome, 593kb, 611913 (4)",NA
16,28500000,35300000,16p11.2,NA,614671,"DUP16p11.2, C16DUPp11.2, AUTS14B",Chromosome 16p11.2 duplication syndrome,NA,NA,NA,NA,"{Autism, susceptibility to, 14B}, 614671 (2); Chromosome 16p11.2 duplication syndrome, 614671 (4)",NA
16,28500000,36800000,16p11,NA,615835,INV16p11,Chromosome 16p11 inversion (0.45Mb),NA,NA,NA,NA,NA,NA
16,28532707,28538973,16p11.2,16p11.2,614812,"NUPR1, COM1, p8","Nuclear protein, transcriptional regulator, 1",NUPR1,26471,ENSG00000176046,NA,NA,Nupr1 (MGI:1891834)
16,28553914,28591789,16p11.2,16p11.2,613374,"CCDC101, STAF36",Coiled-coil domain-containing protein 101,SGF29,112869,ENSG00000176476,NA,NA,Sgf29 (MGI:1922815)
16,28591942,28597069,16p12.1-p11.2,16p11.2,601292,"SULT1A2, STP2","Sulfotransferase family 1A, phenol-preferring, member 2",SULT1A2,6799,ENSG00000197165,45kb from STP1,NA,NA
16,28605586,28623585,16p12.1-p11.2,16p11.2,171150,"SULT1A1, STP1, STP, PST","Sulfotransferase family 1A, phenol-preferring, member 1",SULT1A1,6817,ENSG00000196502,NA,NA,NA
16,28688557,28735729,16p11.2,16p11.2,603916,"EIF3C, EIF3S8","Eukaryotic translation initiation factor 3, subunit C",EIF3C,8663,ENSG00000184110,NA,NA,Eif3c (MGI:1926966)
16,28823047,28837236,16p11,16p11.2,607931,"ATXN2L, A2D",Ataxin 2-like,ATXN2L,11273,ENSG00000168488,pseudogene at 7p21,NA,Atxn2l (MGI:2446242)
16,28842410,28859561,16p11.2,16p11.2,602389,"TUFM, EFTU, COXPD4","Tu translation elongation factor, mitochondrial",TUFM,7284,ENSG00000178952,pseudogene on chr.17,"Combined oxidative phosphorylation deficiency 4, 610678 (3), Autosomal recessive",Tufm (MGI:1923686)
16,28846599,28874212,16p11.2,16p11.2,608937,"SH2B1, SH2B, KIAA1299",SH2B adaptor protein 1,SH2B1,25970,ENSG00000178188,NA,NA,Sh2b1 (MGI:1201407)
16,28878487,28904510,16p12,16p11.2,108730,"ATP2A1, SERCA1","ATPase, Ca++ transporting, fast-twitch, 1",ATP2A1,487,ENSG00000196296,NA,"Brody myopathy, 601003 (3), Autosomal recessive",Atp2a1 (MGI:105058)
16,28904420,28925237,16p11.2,16p11.2,611869,RABEP2,RAB GTPase-binding effector protein 2,RABEP2,79874,ENSG00000177548,NA,NA,Rabep2 (MGI:1917564)
16,28931734,28939346,16p11.2,16p11.2,107265,"CD19, CVID3",CD19 antigen,CD19,930,ENSG00000177455,NA,"Immunodeficiency, common variable, 3, 613493 (3), Autosomal recessive",Cd19 (MGI:88319)
16,28950991,28966464,16p11.2,16p11.2,614525,"NFATC2IP, NIP45",NFATC2-interacting protein,NFATC2IP,84901,ENSG00000176953,NA,NA,Nfatc2ip (MGI:1329015)
16,28973998,28984768,16p11.2,16p11.2,612583,"SPNS1, SPIN1","Spinster, Drosophila, homolog of, 1",SPNS1,83985,ENSG00000169682,NA,NA,Spns1 (MGI:1920908)
16,28984802,28990783,16p11.2,16p11.2,602354,"LAT, IMD52",Linker for activation of T cells,LAT,27040,ENSG00000213658,NA,"Immunodeficiency 52, 617514 (3), Autosomal recessive",Lat (MGI:1342293)
16,29453587,29454963,16p11.2,16p11.2,613182,BOLA2,"BolA, E. coli, homolog of, 2",BOLA2,552900,ENSG00000183336,NA,NA,NA
16,29454500,29458223,16p11.2,16p11.2,615823,"SLX1B, GIYD2","SLX1 structure-specific endonuclease subunit, S. cerevisiae, homolog of, B",SLX1B,79008,ENSG00000181625,NA,NA,Slx1b (MGI:1915220)
16,29459885,29464979,16p11.2,16p11.2,615819,SULT1A4,"Sulfotransferase family 1A, cytosolic, phenol-preferring, member 4",SULT1A4,445329,ENSG00000213648,NA,NA,NA
16,29662949,29670875,16p11.2,16p11.2,182160,"SPN, LSN, CD43",Sialophorin (leukosialin),SPN,6693,ENSG00000197471,NA,NA,Spn (MGI:98384)
16,29670587,29698698,16p11.2,16p11.2,606248,QPRT,Quinolinate phosphoribosyltransferase,QPRT,23475,ENSG00000103485,NA,NA,Qprt (MGI:1914625)
16,29760803,29782972,16p11.2,16p11.2,617311,"ZG16, ZG16A, JCLN1","Zymogen granule protein, 16-kD",ZG16,653808,ENSG00000174992,NA,NA,Zg16 (MGI:1916286)
16,29790712,29805542,16p11.2,16p11.2,603213,"KIF22, KNSL4, KID, OBP, SEMDJL2",Kinesin family member 22,KIF22,3835,ENSG00000079616,NA,"Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3), Autosomal dominant",Kif22 (MGI:109233)
16,29806080,29811182,16p11.2,16p11.2,600999,"MAZ, ZF87, PUR1",MYC-associated zinc finger protein,MAZ,4150,ENSG00000103495,NA,NA,Maz (MGI:1338823)
16,29812192,29815919,16p11.2,16p11.2,614386,"PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA",Proline-rich transmembrane protein 2,PRRT2,112476,ENSG00000167371,NA,"Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3), Autosomal dominant; Episodic kinesigenic dyskinesia 1, 128200 (3), Autosomal dominant; Seizures, benign familial infantile, 2, 605751 (3), Autosomal dominant",Prrt2 (MGI:1916267)
16,29816151,29822488,16p11.2,16p11.2,612033,"PAGR1, C16orf53, PA1",PAXIP1-associated glutamate-rich protein 1,PAGR1,79447,ENSG00000280789,NA,NA,Pagr1a (MGI:1914528)
16,29820393,29848038,16p13.1-p11.2,16p11.2,605088,"MVP, LRP","Major vault protein, rat, homolog of",MVP,9961,ENSG00000013364,NA,NA,Mvp (MGI:1925638)
16,29871158,29899549,16p11.2,16p11.2,616667,"SEZ6L2, BSRPA",SEZ6-like protein 2,SEZ6L2,26470,ENSG00000174938,NA,NA,Sez6l2 (MGI:2385295)
16,29906334,29926231,16p11.2,16p11.2,608947,"KCTD13, POLDIP1, FKSG86",Potassium channel tetramerization domain-containing 13,KCTD13,253980,ENSG00000174943,NA,NA,Kctd13 (MGI:1923739)
16,29973867,29992260,16p13.1-p12,16p11.2,613199,"TAOK2, TAO2, KIAA0881, PSK, PSK1",Tao kinase 2,TAOK2,9344,ENSG00000149930,NA,NA,Taok2 (MGI:1915919)
16,29992320,29996095,16p11.2,16p11.2,603365,HIRIP3,HIRA-interacting protein 3,HIRIP3,8479,ENSG00000149929,NA,NA,Hirip3 (MGI:2142364)
16,30005513,30023279,16p11.2,16p11.2,604567,DOC2A,"Double C2-like domain-containing protein, alpha",DOC2A,8448,ENSG00000149927,NA,NA,Doc2a (MGI:109446)
16,30024422,30053025,16p11.2,16p11.2,615175,FAM57B,"Family with sequence similarity 57, member B",TLCD3B,83723,ENSG00000149926,NA,NA,Fam57b (MGI:1916202)
16,30064278,30072206,16p11.2,16p11.2,103850,"ALDOA, GSD12","Aldolase A, fructose-bisphosphatase",ALDOA,226,ENSG00000149925,pseudogenes on 3 and 10,"Glycogen storage disease XII, 611881 (3), Autosomal recessive",Aldoa (MGI:87994)
16,30075993,30085376,16p12-p11,16p11.2,602035,"PPP4C, PP4, PPX","Protein phosphatase 4, catalytic subunit",PPP4C,5531,ENSG00000149923,NA,NA,Ppp4c (MGI:1891763)
16,30085792,30091926,16p11.2,16p11.2,602427,"TBX6, SCDO5",T-box 6,TBX6,6911,ENSG00000149922,NA,"Spondylocostal dysostosis 5, 122600 (3), Autosomal recessive, Autosomal dominant",Tbx6 (MGI:102539)
16,30092313,30096212,16p11.2,16p11.2,609724,YPEL3,Yippee-like 3,YPEL3,83719,ENSG00000090238,NA,NA,Ypel3 (MGI:1913340)
16,30104809,30113536,16p11.2,16p11.2,616318,"GDPD3, GDE7",Glycerophosphodiester phosphodiesterase domain-containing protein 3,GDPD3,79153,ENSG00000102886,NA,NA,Gdpd3 (MGI:1915866)
16,30114104,30123308,16p11.2,16p11.2,601795,"MAPK3, PRKM3, ERK1",Mitogen-activated protein kinase 3,MAPK3,5595,ENSG00000102882,NA,NA,Mapk3 (MGI:1346859)
16,30183409,30189075,16p11.2,16p11.2,605000,"CORO1A, TACO, CLIPINA, IMD8",Coronin 1A,CORO1A,11151,ENSG00000102879,NA,"Immunodeficiency 8, 615401 (3), Autosomal recessive",Coro1a (MGI:1345961)
16,30193842,30197565,16p11.2,16p11.2,615822,"SLX1A, GIYD1","SLX1 structure-specific endonuclease subunit, S. cerevisiae, homolog of, A",SLX1A,548593,ENSG00000132207,NA,NA,Slx1b (MGI:1915220)
16,30199227,30204328,16p11.2,16p11.2,600641,"SULT1A3, STM","Sulfotransferase family 1A, phenol-preferring, member 3",SULT1A3,6818,ENSG00000261052,NA,NA,NA
16,30350765,30355307,16p11.2,16p11.2,604470,CD2BP2,CD2 antigen-binding protein 2,CD2BP2,10421,ENSG00000169217,NA,NA,Cd2bp2 (MGI:1917483)
16,30357101,30370493,16p11.2,16p11.2,613620,TBC1D10B,"TBC1 domain family, member 10B",TBC1D10B,26000,ENSG00000169221,NA,NA,Tbc1d10b (MGI:1915699)
16,30370933,30377990,16p11.2,16p11.2,617378,"MYLPF, MLC2B, MRLC2, MYL11","Myosin light chain, phosphorylatable, fast skeletal muscle",MYLPF,29895,ENSG00000180209,NA,NA,Mylpf (MGI:97273)
16,30378134,30382829,16p11.2,16p11.2,612897,"SEPT1, DIFF6",Septin 1,SEPTIN1,1731,ENSG00000180096,NA,NA,Sept1 (MGI:1858916)
16,30423614,30430051,16p11.2,16p11.2,615840,DCTPP1,dCTP pyrophosphatase 1,DCTPP1,79077,ENSG00000179958,NA,NA,Dctpp1 (MGI:1913672)
16,30443630,30445873,16p11.2,16p11.2,606218,"SEPHS2, SPS2",Selenophosphate synthetase 2,SEPHS2,22928,ENSG00000179918,NA,NA,Sephs2 (MGI:108388)
16,30472682,30523184,16p11.2,16p11.2,153370,"ITGAL, CD11A, LFA1A","Integrin, alpha-L (antigen CD11A (p180), lymphocyte function-associated antigen-1, alpha polypeptide)",ITGAL,3683,ENSG00000005844,NA,NA,Itgal (MGI:96606)
16,30524003,30532366,16p11.2,16p11.2,618032,ZNF768,Zinc finger protein 768,ZNF768,79724,ENSG00000169957,NA,NA,Zfp768 (MGI:2384582)
16,30602557,30610774,16p11.2,16p11.2,618033,"ZNF689, TIPUH1",Zinc finger protein 689,ZNF689,115509,ENSG00000156853,NA,NA,Zfp689 (MGI:1918381)
16,30650777,30656439,16p11.2,16p11.2,617423,PRR14,Proline-rich protein 14,PRR14,78994,ENSG00000156858,NA,NA,Prr14 (MGI:2384565)
16,30658430,30670809,16p11.2,16p11.2,608601,"FBRS, FBS1",Fibrosin,FBRS,64319,ENSG00000156860,NA,NA,Fbrs (MGI:104648)
16,30699170,30741408,16p11.2,16p11.2,611421,"SRCAP, SWR1, KIAA0309, FLHS",SNF2-related CBP activator protein,SRCAP,10847,ENSG00000080603,NA,"Floating-Harbor syndrome, 136140 (3), Autosomal dominant",Srcap (MGI:2444036)
16,30748298,30761175,16p12.1-p11.2,16p11.2,172471,"PHKG2, GSD9C","Phosphorylase kinase, gamma 2 (testis/liver)",PHKG2,5261,ENSG00000156873,NA,"Cirrhosis due to liver phosphorylase kinase deficiency (3); Glycogen storage disease IXc, 613027 (3), Autosomal recessive",Phkg2 (MGI:1916211)
16,30757225,30762271,16p11.2,16p11.2,618318,"CCDC189, C16orf93",Coiled-coil domain-containing protein 189,CCDC189,90835,ENSG00000196118,NA,NA,Ccdc189 (MGI:2685012)
16,30761611,30800230,16p11.2,16p11.2,607700,"RNF40, BRE1B, RBP95, KIAA0661",Ring finger protein 40,RNF40,9810,ENSG00000103549,NA,NA,Rnf40 (MGI:2142048)
16,30833625,30894715,16p11,16p11.2,605847,BCL7C,B-cell CLL/lymphoma 7C,BCL7C,9274,ENSG00000099385,NA,NA,Bcl7c (MGI:1332237)
16,30895823,30903559,16p11.2-p11.1,16p11.2,600435,"CTF1, CT1",Cardiotrophin 1,CTF1,1489,ENSG00000150281,NA,NA,Ctf1 (MGI:105115)
16,30923054,30948782,16p11.2,16p11.2,609085,"FBXL19, FBL19",F-box and leucine-rich repeat protein 19,FBXL19,54620,ENSG00000099364,NA,NA,Fbxl19 (MGI:3039600)
16,30949067,30954937,16p11.2,16p11.2,610930,"ORAI3, TMEM142C",ORAI calcium release-activated calcium modulator 3,ORAI3,93129,ENSG00000175938,NA,NA,Orai3 (MGI:3039586)
16,30956617,30984663,16p11.2,16p11.2,611052,"SETD1A, SET1A, SET1, KIAA0339",SET domain-containing protein 1A,SETD1A,9739,ENSG00000099381,NA,NA,Setd1a (MGI:2446244)
16,30985188,30989151,16p12-p11.2,16p11.2,607764,"HSD3B7, CBAS1",3-beta-hydroxy-delta-5-C27-steroid oxidoreductase,HSD3B7,80270,ENSG00000099377,NA,"Bile acid synthesis defect, congenital, 1, 607765 (3), Autosomal recessive",Hsd3b7 (MGI:2141879)
16,30989255,31010637,16p11.2,16p11.2,601485,"STX1B, GEFSP9",Syntaxin 1B,STX1B,112755,ENSG00000099365,NA,"Generalized epilepsy with febrile seizures plus, type 9, 616172 (3), Autosomal dominant",Stx1b (MGI:1930705)
16,31033094,31040167,16p11.2,16p11.2,186591,"STX4, STX4A",Syntaxin 4,STX4,6810,ENSG00000103496,NA,NA,Stx4a (MGI:893577)
16,31060842,31074239,16p11.2,16p11.2,617103,ZNF668,Zinc finger protein 668,ZNF668,79759,ENSG00000167394,NA,NA,Zfp668 (MGI:2442943)
16,31083423,31089651,16p11.2,16p11.2,610561,"PRSS53, POL3S","Protease, serine, 53",PRSS53,339105,ENSG00000151006,NA,NA,Prss53 (MGI:2652890)
16,31090841,31094998,16p11.2,16p11.2,608547,"VKORC1, VKOR, VKCFD2, FLJ00289","Vitamin K epoxide reductase complex, subunit 1",VKORC1,79001,ENSG00000167397,NA,"Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3); Warfarin resistance, 122700 (3), Autosomal dominant",Vkorc1 (MGI:106442)
16,31108380,31117650,16p11.2,16p11.2,614901,"BCKDK, BDK, BCKDKD",Branched-chain alpha-keto acid dehydrogenase kinase,BCKDK,10295,ENSG00000103507,NA,"Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)",Bckdk (MGI:1276121)
16,31117663,31131392,16p11.2,16p11.2,609912,"KAT8, MYST1, MOF",K(lysine) acetyltransferase 8,KAT8,84148,ENSG00000103510,NA,NA,Kat8 (MGI:1915023)
16,31131432,31135726,16p11.2,16p11.2,600823,PRSS8,"Protease, serine, 8 (prostasin)",PRSS8,5652,ENSG00000052344,NA,NA,Prss8 (MGI:1923810)
16,31138925,31150082,16p11.2,16p11.2,610560,PRSS36,"Protease, serine, 36",PRSS36,146547,ENSG00000178226,NA,NA,Prss36 (MGI:1924863)
16,31180109,31194870,16p11.2,16p11.2,137070,"FUS, TLS, ALS6, ETM4","Fusion, derived from 12-16 translocation, malignant liposarcoma",FUS,2521,ENSG00000089280,"fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma","Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3); Essential tremor, hereditary, 4, 614782 (3), Autosomal dominant",NA
16,31201485,31202775,16p12-p11.2,16p11.2,606838,"PYCARD, TMS1, ASC",PYD and CARD domain-containing protein (target of methylation-induced silencing 1),PYCARD,29108,ENSG00000103490,NA,NA,Pycard (MGI:1931465)
16,31214118,31231536,16p11.2,16p11.2,613288,"TRIM72, MG53",Tripartite motif-containing protein 72,TRIM72,493829,ENSG00000177238,NA,NA,Trim72 (MGI:3612190)
16,31215961,31217092,16p12.1,16p11.2,615700,"PYDC1, POP1, PYC1, ASC2",Pyrin domain-containing protein 1,PYDC1,260434,ENSG00000169900,NA,NA,NA
16,31259974,31332876,16p11.2,16p11.2,120980,"ITGAM, CR3A, CD11B, MAC1A, SLEB6","Integrin, alpha-M (complement component receptor-3, alpha; antigen CD11B (p170); macrophage antigen, alpha polypeptide)",ITGAM,3684,ENSG00000169896,?in same restriction fragment as LFA1A,NA,Itgam (MGI:96607)
16,31355166,31382998,16p11.2,16p11.2,151510,"ITGAX, CD11C","Integrin, alpha-X (antigen CD11C (p150), alpha polypeptide)",ITGAX,3687,ENSG00000140678,NA,NA,Itgax (MGI:96609)
16,31393222,31426512,16p11.2,16p11.2,602453,"ITGAD, CD11D","Integrin, alpha D",ITGAD,3681,ENSG00000156886,NA,NA,Itgad (MGI:3578624)
16,31427730,31428359,16p11.2,16p11.2,602009,COX6A2,"Cytochrome c oxidase, subunit 6A2",COX6A2,1339,ENSG00000156885,NA,NA,Cox6a2 (MGI:104649)
16,31458272,31467166,16p11.2,16p11.2,615549,"ARMC5, AIMAH2",Armadillo repeat-containing protein 5,ARMC5,79798,ENSG00000140691,NA,"ACTH-independent macronodular adrenal hyperplasia 2, 615954 (3), Autosomal dominant, Somatic mutation",Armc5 (MGI:2384586)
16,31472151,31477959,16p11.2,16p11.2,602353,"TGFB1I1, ARA55, HIC5","Transforming growth factor, beta-1-induced 1",TGFB1I1,7041,ENSG00000140682,NA,NA,Tgfb1i1 (MGI:102784)
16,31482534,31490769,16p11.2,16p11.2,182381,"SLC5A2, SGLT2","Solute carrier family 5 (sodium/glucose cotransporter), member 2",SLC5A2,6524,ENSG00000140675,NA,"Renal glucosuria, 233100 (3), Autosomal recessive, Autosomal dominant",Slc5a2 (MGI:2181411)
16,31527899,31528803,16p11.2,16p11.2,605821,"ERAF, EDRF, AHSP",Erythroid-associated factor (alpha-hemoglobin stabilizing protein),AHSP,51327,ENSG00000169877,NA,NA,NA
16,31873757,31917356,Chr.16,16p11.2,604752,"ZNF267, HZF2",Zinc finger protein-167,ZNF267,10308,ENSG00000185947,NA,NA,Zfp267 (MGI:1098769)
16,32673518,32676128,16p13,16p11.2,617482,TP53TG3,TP53 target gene 3,TP53TG3,24150,ENSG00000183632,NA,NA,NA
16,36800000,74100000,16q11-q22,NA,610753,AA2,Alopecia areata 2,NA,100034703,NA,max lod at D16S415,"Alopecia areata 2, 610753 (2), Autosomal recessive, Autosomal dominant",NA
16,36800000,74100000,16q11.1-q22,NA,126900,DUPC1,Dupuytren contracture 1,NA,780895,NA,max lod at D16S415,"Dupuytren contracture 1, 126900 (2), Autosomal dominant",NA
16,36800000,90338345,16q,NA,610707,PSORS8,Psoriasis susceptibility 8,PSORS8,140454,NA,proximal to D16S3034,"{Psoriasis susceptibility 8}, 610707 (2)",NA
16,36800000,90338345,16q,NA,606711,SLI1,"Specific language impairment QTL, 1",NA,171013,NA,NA,"Specific language impairment QTL, 1, 606711 (2), Multifactorial",NA
16,36800000,90338345,16q,NA,194090,WT3,Wilms tumor-3,NA,8136,NA,loss of heterozygosity,"Wilms tumor, type 3, 194090 (2), Autosomal dominant",NA
16,46578590,46621401,16q11.2,16q11.2,611027,"SHCBP1, PAL",SHC SH2 domain-binding protein 1,SHCBP1,79801,ENSG00000171241,NA,NA,Shcbp1 (MGI:1338802)
16,46656131,46689193,16q11.2,16q11.2,601501,"VPS35, MEM3, PARK17","Vacuolar protein sorting 35, yeast, homolog of",VPS35,55737,ENSG00000069329,NA,"{Parkinson disease 17}, 614203 (3), Autosomal dominant",Vps35 (MGI:1890467)
16,46689645,46698393,16q12,16q11.2,607213,"ORC6, ORC6L","Origin recognition complex, subunit 6, S. cerevisiae, homolog of",ORC6,23594,ENSG00000091651,NA,"Meier-Gorlin syndrome 3, 613803 (3), Autosomal recessive",Orc6 (MGI:1929285)
16,46702281,46763245,16q11.2,16q11.2,612147,"MYLK3, MLCK",Myosin light chain kinase 3,MYLK3,91807,ENSG00000140795,NA,NA,Mylk3 (MGI:2443063)
16,46884361,46931288,16q12.1,16q11.2,138210,"GPT2, ALT2, MRT49",Glutamate pyruvate transaminase 2,GPT2,84706,ENSG00000166123,NA,"Mental retardation, autosomal recessive 49, 616281 (3), Autosomal recessive",Gpt2 (MGI:1915391)
16,46955361,46973673,16q12.1,16q11.2,611322,"DNAJA2, DJ3, CPR3","DNAJ/HSP40 homolog, subfamily A, member 2",DNAJA2,10294,ENSG00000069345,NA,NA,Dnaja2 (MGI:1931882)
16,47000000,52600000,16q12.1,NA,602639,"STHAG2, HYD2","Tooth agenesis, selective, 2",HYD2,8137,NA,NA,"Tooth agenesis, selective, 2, 602639 (2)",NA
16,47000000,79200000,16q12.1-q23.1,NA,614668,STUT4,"Stuttering, familial persistent, 4",NA,100909385,NA,max lod at D16S3043,"Stuttering, familial persistent, 4, 614668 (2)",NA
16,47077702,47144024,16q11,16q12.1,607974,NEOT2,Neuropilin and tolloid like 2,NETO2,81831,ENSG00000171208,NA,NA,Neto2 (MGI:1921763)
16,47154386,47461273,16q12.1,16q12.1,611803,"ITFG1, TIP",Integrin-alpha FG-gap repeat-containing protein 1,ITFG1,81533,ENSG00000129636,NA,NA,Itfg1 (MGI:106419)
16,47461298,47701522,16q12-q13,16q12.1,172490,PHKB,"Phosphorylase kinase, beta polypeptide",PHKB,5257,ENSG00000102893,NA,"Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3), Autosomal recessive",Phkb (MGI:97578)
16,48082972,48146769,16q12.1,16q12.1,607041,"ABCC12, MRP9","ATP-binding cassette, subfamily C, member 12",ABCC12,94160,ENSG00000140798,NA,NA,Abcc12 (MGI:2441679)
16,48164841,48249972,16q12.1,16q12.1,607040,"ABCC11, MRP8, EWWD, WW","ATP-binding cassette, subfamily C, member 11",ABCC11,85320,ENSG00000121270,NA,"[Axillary odor, variation in], 117800 (3), Autosomal dominant; [Colostrum secretion, variation in], 117800 (3), Autosomal dominant; [Earwax, wet/dry], 117800 (3), Autosomal dominant",NA
16,48244299,48363002,16q12.1,16q12.1,617774,"LONP2, PLON, PSLON","LON peptidase 2, peroxisomal",LONP2,83752,ENSG00000102910,NA,NA,Lonp2 (MGI:1914137)
16,48354580,48448434,16q12,16q12.1,602212,SIAH1,"Seven in absentia, Drosophila, homolog of, 1",SIAH1,6477,ENSG00000196470,NA,NA,Siah1a (MGI:108064)
16,49277916,49281837,16q12.1,16q12.1,600432,CLN1,Precerebellin 1,CBLN1,869,ENSG00000102924,NA,NA,Cbln1 (MGI:88281)
16,49487523,49857918,16q12,16q12.1,604557,"ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19",Zinc finger protein 423,ZNF423,23090,ENSG00000102935,NA,"Joubert syndrome 19, 614844 (3), Autosomal recessive, Autosomal dominant; Nephronophthisis 14, 614844 (3), Autosomal recessive, Autosomal dominant",Zfp423 (MGI:1891217)
16,50025205,50037087,16q12.1,16q12.1,616869,"CNEP1R1, NEP1R1, TMEM188",C-terminal domain nuclear envelope phosphatase 1 regulatory subunit 1,CNEP1R1,255919,ENSG00000205423,NA,NA,Cnep1r1 (MGI:1921981)
16,50065940,50107271,16q12.1,16q12.1,614951,"HEATR3, SYO1",HEAT repeat-containing protein 3,HEATR3,55027,ENSG00000155393,NA,NA,Heatr3 (MGI:2444491)
16,50152910,50235309,16q12.1,16q12.1,605540,"TENT4B, PAPD5, TUT3",Terminal nucleotidyltransferase 4B,TENT4B,64282,ENSG00000121274,NA,NA,Tent4b (MGI:1917820)
16,50246137,50318134,16q12-q13,16q12.1,600385,ADCY7,Adenylate cyclase-7,ADCY7,113,ENSG00000121281,NA,NA,Adcy7 (MGI:102891)
16,50548395,50649248,16q12,16q12.1,607851,NKD1,"Naked cuticle, Drosophila, homolog of, 1",NKD1,85407,ENSG00000140807,NA,NA,Nkd1 (MGI:2135954)
16,50666299,50681311,16q12.1,16q12.1,613281,"SNX20, SLIC1",Sorting nexin 20,SNX20,124460,ENSG00000167208,NA,NA,Snx20 (MGI:1918857)
16,50693586,50733076,16q12,16q12.1,605956,"NOD2, CARD15, IBD1, CD, YAOS, BLAUS",Nucleotide-binding oligomerization domain protein 2,NOD2,64127,ENSG00000167207,NA,"Blau syndrome, 186580 (3), Autosomal dominant; {Inflammatory bowel disease 1, Crohn disease}, 266600 (3), Multifactorial; {Psoriatic arthritis, susceptibility to}, 607507 (2); {Yao syndrome}, 617321 (3), Multifactorial",Nod2 (MGI:2429397)
16,50742025,50801934,16q12-q13,16q12.1,605018,"CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS",CYLD gene,CYLD,1540,ENSG00000083799,behaves as tumor suppressor,"Brooke-Spiegler syndrome, 605041 (3), Autosomal dominant; Cylindromatosis, familial, 132700 (3), Autosomal dominant; Trichoepithelioma, multiple familial, 1, 601606 (3), Autosomal dominant",Cyld (MGI:1921506)
16,51135974,51151271,16q12.1,16q12.1,602218,"SALL1, HSAL1, TBS",Sal-like 1,SALL1,6299,ENSG00000103449,NA,"Townes-Brocks branchiootorenal-like syndrome, 107480 (3), Autosomal dominant; Townes-Brocks syndrome 1, 107480 (3), Autosomal dominant",Sall1 (MGI:1889585)
16,53054981,53329149,16q12.2,16q12.2,616936,"CHD9, CREMM, PRIC320, KIAA0308",Chromodomain helicase DNA-binding protein 9,CHD9,80205,ENSG00000177200,NA,NA,Chd9 (MGI:1924001)
16,53434470,53491647,16q12.2,16q12.2,180203,RBL2,Retinoblastoma-like 2,RBL2,5934,ENSG00000103479,NA,NA,Rbl2 (MGI:105085)
16,53491039,53504410,16q12.2,16q12.2,608483,"AKTIP, FTS, FT1",AKT_interacting protein,AKTIP,64400,ENSG00000166971,NA,NA,Aktip (MGI:3693832)
16,53598152,53703937,16q12.2,16q12.2,610937,"RPGRIP1L, KIAA1005, JBTS7, MKS5",RPGRIP1-like,RPGRIP1L,23322,ENSG00000103494,NA,"COACH syndrome, 216360 (3), Autosomal recessive; Joubert syndrome 7, 611560 (3), Autosomal recessive; Meckel syndrome 5, 611561 (3), Autosomal recessive",Rpgrip1l (MGI:1920563)
16,53703962,54121940,16q12.2,16q12.2,610966,"FTO, GDFD, BMIQ14",Fat mass- and obesity-associated gene,FTO,79068,ENSG00000140718,NA,"Growth retardation, developmental delay, facial dysmorphism, 612938 (3), Autosomal recessive; {Obesity, susceptibility to, BMIQ14}, 612460 (3), Autosomal recessive",Fto (MGI:1347093)
16,54283303,54286786,16q12.2,16q12.2,612985,"IRX3, IRXB1",Iroquois homeobox protein 3,IRX3,79191,ENSG00000177508,NA,NA,Irx3 (MGI:1197522)
16,54918862,54929188,16q12.2,16q12.2,615624,CRNDE,"Colorectal neoplasia differentially expressed gene, noncoding",CRNDE,643911,NA,NA,NA,NA
16,54930864,54934484,16q11.2-q13,16q12.2,606195,"IRX5, HMMS",Iroquois homeo box protein 5,IRX5,10265,ENSG00000176842,NA,"Hamamy syndrome, 611174 (3), Autosomal recessive",NA
16,55323759,55330759,16q11.2-q13,16q12.2,606196,"IRX6, IRX7",Iroquois homeo box protein 6,IRX6,79190,ENSG00000159387,NA,NA,Irx6 (MGI:1927642)
16,55478829,55506690,16q13,16q12.2,120360,"MMP2, CLG4A, MONA","Matrix metalloproteinase 2 (gelatinase A, 72kD type IV collagenase)",MMP2,4313,ENSG00000087245,"near MT1,2","Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3), Autosomal recessive",Mmp2 (MGI:97009)
16,55509054,55586665,16q12.2,16q12.2,612040,"LPCAT1, AYTL1",Lysophosphatidylcholine acyltransferase 2,LPCAT2,54947,ENSG00000087253,NA,NA,Lpcat2 (MGI:3606214)
16,55655927,55706191,16q12.2,16q12.2,163970,"SLC6A2, NAT1, NET1","Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, cocaine- and antidepressant-sensitive",SLC6A2,6530,ENSG00000103546,mutation identified in 1 ORSTI family,"?Orthostatic intolerance, 604715 (3)",Slc6a2 (MGI:1270850)
16,55802850,55833126,16q13-q22.1,16q12.2,114835,"CES1, SES1",Carboxylesterase 1 (monocyte/macrophage serine esterase 1),CES1,1066,ENSG00000198848,NA,"Drug metabolism, altered, CES1-related, 618057 (3)",Ces1d (MGI:2148202)
16,56000000,66600000,16q13-q21,NA,605746,ANMA,Anisomastia,NA,80871,NA,NA,"Anisomastia, 605746 (2)",NA
16,56000000,70800000,16q13-q22.1,NA,611031,EKD2,Episodic kinesigenic dyskinesia 2,NA,100124415,NA,max lod at D16S503,"Episodic kinesigenic dyskinesia 2, 611031 (2), Autosomal dominant",NA
16,56191488,56357443,16q13,16q13,139311,"GNAO1, EIEE17, NEDIM","Guanine nucleotide-binding protein (G protein), alpha-activating activity",GNAO1,2775,ENSG00000087258,close to MT1 in mouse,"Epileptic encephalopathy, early infantile, 17, 615473 (3), Autosomal dominant; Neurodevelopmental disorder with involuntary movements, 617493 (3), Autosomal dominant",Gnao1 (MGI:95775)
16,56361451,56425544,16q21,16q13,603243,"AMFR, GP78",Autocrine motility factor receptor,AMFR,267,ENSG00000159461,NA,NA,Amfr (MGI:1345634)
16,56429132,56451331,16q12.2,16q13,604978,"NUDT21, CPSF5, CFIM25",Nudix hydrolase 21,NUDT21,11051,ENSG00000167005,NA,NA,Nudt21 (MGI:1915469)
16,56451523,56479103,16q13,16q13,615857,OGFOD1,2-oxoglutarate- and iron-dependent oxygenase domain-containing protein 1,OGFOD1,55239,ENSG00000087263,NA,NA,Ogfod1 (MGI:2442978)
16,56470402,56520094,16q21,16q13,606151,"BBS2, RP74",Bardet-Biedl syndrome 2,BBS2,583,ENSG00000125124,NA,"Bardet-Biedl syndrome 2, 615981 (3), Autosomal recessive; Retinitis pigmentosa 74, 616562 (3), Autosomal recessive",Bbs2 (MGI:2135267)
16,56565072,56568956,Chr.16,16q13,606206,"MT4, MTIV",Metallothionein 4,MT4,84560,ENSG00000102891,NA,NA,NA
16,56589527,56591084,16q13,16q13,139255,"MT3, GIFB",Metallothionein 3 (growth inhibitory factor (neurotrophic)),MT3,4504,ENSG00000087250,NA,NA,NA
16,56608583,56609496,16q13,16q13,156360,"MT2A, MT2",Metallothionein 2A,MT2A,4502,ENSG00000125148,pseudogene MT2P1 on 4cen-q21,NA,NA
16,56617460,56618817,16q13,16q13,156358,MT1L,Metallothionein 1L,MT1L,4500,ENSG00000260549,NA,NA,NA
16,56625780,56627111,16q13,16q13,156351,MT1E,Metallothionein 1E (functional),MT1E,4493,ENSG00000169715,NA,NA,NA
16,56632658,56633980,16q13,16q13,156357,MT1K,Metallothionein 1K,MT1M,4499,ENSG00000205364,NA,NA,NA
16,56635738,56637085,16q13,16q13,156356,MT1J,Metallothionein 1J,MT1JP,4498,ENSG00000255986,NA,NA,NA
16,56638665,56640086,16q13,16q13,156350,MT1A,Metallothionein 1A (functional),MT1A,4489,ENSG00000205362,proximal to FRA16B,NA,NA
16,56651885,56653203,16q13,16q13,156349,MT1B,Metallothionein 1B (functional),MT1B,4490,ENSG00000169688,NA,NA,NA
16,56657942,56659302,16q13,16q13,156352,MT1F,Metallothionein 1F (functional),MT1F,4494,ENSG00000198417,NA,NA,NA
16,56666729,56668064,16q13,16q13,156353,MT1G,Metallothionein 1G,MT1G,4495,ENSG00000125144,NA,NA,NA
16,56669813,56671128,16q13,16q13,156354,MT1H,Metallothionein 1H,MT1H,4496,ENSG00000205358,NA,NA,NA
16,56676115,56677876,16q13,16q13,156355,MT1I,Metallothionein 1I,MT1IP,644314,NA,NA,NA,NA
16,56682469,56684195,16q13,16q13,156359,MT1X,Metallothionein 1X,MT1X,4501,ENSG00000187193,NA,NA,NA
16,56730128,56850285,16q13,16q13,614351,"NUP93, NIC96, KIAA0095, NPHS12","Nucleoporin, 93kD",NUP93,9688,ENSG00000102900,NA,"Nephrotic syndrome, type 12, 616892 (3), Autosomal recessive",Nup93 (MGI:1919055)
16,56858517,56858600,16q13,16q13,613395,"MIR138-2, MIRN138-2",Micro RNA 138-2,MIR138-2,406930,ENSG00000207649,NA,NA,NA
16,56865206,56915849,16q13,16q13,600968,"SLC12A3, NCCT, TSC","Solute carrier family 12 (sodium/potassium/chloride transporters), member 3",SLC12A3,6559,ENSG00000070915,NA,"Gitelman syndrome, 263800 (3), Autosomal recessive",Slc12a3 (MGI:108114)
16,56932141,56944863,16q12.2-q13,16q13,608070,"HERPUD1, MIF1, HERP, KIAA0025","Homocysteine- and endoplasmic reticulum stress-inducible protein, ubiquitin-like domain-containing, 1",HERPUD1,9709,ENSG00000051108,NA,NA,Herpud1 (MGI:1927406)
16,56961949,56983844,16q21,16q13,118470,"CETP, HDLCQ10","Cholesteryl ester transfer protein, plasma",CETP,1071,ENSG00000087237,NA,"[High density lipoprotein cholesterol level QTL 10], 143470 (3), Autosomal dominant; Hyperalphalipoproteinemia, 143470 (3), Autosomal dominant",NA
16,56989546,57083523,16q13,16q13,613537,NLRC5,"NLR family, caspase recruitment domain-containing 5",NLRC5,84166,ENSG00000140853,NA,NA,Nlrc5 (MGI:3612191)
16,57092582,57148368,16q13,16q13,604206,"CPNE2, CPN2",Copine II,CPNE2,221184,ENSG00000140848,NA,NA,Cpne2 (MGI:2387578)
16,57152465,57186340,16q13,16q13,617766,"FAM192A, NIP30, C16orf94","Family with sequence similarity 192, member A",FAM192A,80011,ENSG00000172775,NA,NA,Fam192a (MGI:1919637)
16,57186136,57240472,16q13,16q13,616585,"RSPRY1, KIAA1972, SEMDFA",RING finger- and SPRY domain-containing protein 11,RSPRY1,89970,ENSG00000159579,NA,"Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3), Autosomal recessive",Rspry1 (MGI:1914860)
16,57245258,57253634,16q13,16q13,615407,"ARL2BP, BART",ADP ribosylation factor-like 2-binding protein,ARL2BP,23568,ENSG00000102931,NA,"Retinitis pigmentosa with or without situs inversus, 615434 (3), Autosomal recessive",Arl2bp (MGI:1349429)
16,57256096,57284671,16q13,16q13,600340,"PLLP, PMLP, TM4SF11",Plasma membrane proteolipid (plasmolipin),PLLP,51090,ENSG00000102934,NA,NA,Pllp (MGI:1915051)
16,57300000,74100000,16q21-q22,NA,616648,OPA8,Optic atrophy 8,OPA8,106783499,NA,max lod at D16S752,"Optic atrophy 8, 616648 (2), Autosomal dominant",NA
16,57358782,57366188,16q13,16q21,602957,"CCL22, SCYA22","Chemokine, C-C motif, ligand 22",CCL22,6367,ENSG00000102962,NA,NA,Ccl22 (MGI:1306779)
16,57372489,57385043,16q,16q21,601880,"CX3CL1, SCYD1, NTT, NTN","Chemokine, C-X3-C motif, ligand 1 (fractalkine; neurotactin)",CX3CL1,6376,ENSG00000006210,NA,NA,Cx3cl1 (MGI:1097153)
16,57396075,57416062,16q13,16q21,601520,"CCL17, SCYA17, TARC","Chemokine, C-C motif, ligand 17",CCL17,6361,ENSG00000102970,NA,NA,Ccl17 (MGI:1329039)
16,57428168,57447527,16q21,16q21,608943,CIAPIN1,Cytokine-induced apoptosis inhibitor 1 (anamorsin),CIAPIN1,57019,ENSG00000005194,NA,NA,Ciapin1 (MGI:1922083)
16,57447478,57461269,16q13,16q21,612837,"COQ9, C16orf49, COQ10D5","Coq9, S. cerevisiae, homolog of",COQ9,57017,ENSG00000088682,NA,"Coenzyme Q10 deficiency, primary, 5, 614654 (3), Autosomal recessive",Coq9 (MGI:1915164)
16,57462678,57472008,16q13-q21,16q21,180663,POLR2C,"Polymerase (RNA) II (DNA directed) polypeptide C, 33kD",POLR2C,5432,ENSG00000102978,NA,NA,Polr2c (MGI:109299)
16,57471921,57487138,16q13,16q21,608333,DOK4,Docking protein 4,DOK4,55715,ENSG00000125170,NA,NA,Dok4 (MGI:2148865)
16,57529338,57578181,16q21,16q21,616965,"ADGRG5, GPR114",Adhesion G protein-coupled receptor G5,ADGRG5,221188,ENSG00000159618,NA,NA,Adgrg5 (MGI:2685955)
16,57619534,57665566,16q13,16q21,604110,"ADGRG1, GPR56, TM7XN1, BFPP, BPPR",Adhesion G protein-coupled receptor G1,ADGRG1,9289,ENSG00000205336,NA,"Polymicrogyria, bilateral frontoparietal, 606854 (3), Autosomal recessive; Polymicrogyria, bilateral perisylvian, 615752 (3)",Adgrg1 (MGI:1340051)
16,57663997,57689377,16q21,16q21,618441,"ADGRG3, GPR97",Adhesion G protein-coupled receptor G3,ADGRG3,222487,ENSG00000182885,NA,NA,Adgrg3 (MGI:1859670)
16,57735769,57757243,16q21,16q21,602703,"KATNB1, LIS6","Katanin, p80 subunit, B1",KATNB1,10300,ENSG00000140854,NA,"Lissencephaly 6, with microcephaly, 616212 (3), Autosomal recessive",Katnb1 (MGI:1921437)
16,57758216,57863052,16q13-q21,16q21,604535,KIFC3,Kinesin family member C3,KIFC3,3801,ENSG00000140859,NA,NA,Kifc3 (MGI:109202)
16,57882339,57971127,16q21,16q21,600724,"CNGB1, CNCG3L, CNCG2, RP45","Cyclic nucleotide gated channel, beta 1",CNGB1,1258,ENSG00000070729,NA,"Retinitis pigmentosa 45, 613767 (3), Autosomal recessive",NA
16,57976434,57988115,16q13,16q21,610264,TEPP,Testis-prostate-placenta-expressed protein,TEPP,374739,ENSG00000159648,NA,NA,Tepp (MGI:1920657)
16,57999602,58021622,16q13,16q21,613276,"USB1, C16orf57, PN",U6 small nuclear RNA biogenesis phosphodiesterase 1,USB1,79650,ENSG00000103005,NA,"Poikiloderma with neutropenia, 604173 (3), Autosomal recessive",Usb1 (MGI:2142454)
16,58025753,58046900,16q13-q21,16q21,602261,MMP15,Matrix metalloproteinase 15,MMP15,4324,ENSG00000102996,NA,NA,Mmp15 (MGI:109320)
16,58113587,58129424,16q21,16q21,617906,"CFAP20, BUG22, C16orf80, FSAP23",Cilia- and flagella-associated protein 20,CFAP20,29105,ENSG00000070761,NA,NA,Cfap20 (MGI:107428)
16,58157906,58198105,16p13.3-p13.2,16q21,115442,CSNK2A2,"Casein kinase-2, alpha-prime polypeptide",CSNK2A2,1459,ENSG00000070770,NA,NA,Csnk2a2 (MGI:88547)
16,58196861,58283835,16q21,16q21,616070,CCDC113,Coiled-coil domain-containing protein 113,CCDC113,29070,ENSG00000103021,NA,NA,Ccdc113 (MGI:3606076)
16,58392470,58406146,16q21,16q21,610610,"GINS3, PSF3",GINS complex subunit 3,GINS3,64785,ENSG00000181938,NA,NA,Gins3 (MGI:1926083)
16,58463644,58515402,16q21-q22.3,16q21,614463,"NDRG4, SMAP8, KIAA1180",NMYC downstream-regulated gene 4,NDRG4,65009,ENSG00000103034,NA,NA,Ndrg4 (MGI:2384590)
16,58515478,58521989,16q21,16q21,616424,SETD6,SET domain-containing protein 6,SETD6,79918,ENSG00000103037,NA,NA,Setd6 (MGI:1913333)
16,58519945,58629885,16q21,16q21,604917,"CNOT1, NOT1, HPE12","CCR4-NOT transcription complex, subunit 1",CNOT1,23019,ENSG00000125107,NA,"Holoprosencephaly 12, with or without pancreatic agenesis, 618500 (3)",Cnot1 (MGI:2442402)
16,58665108,58684769,16q21,16q21,614236,"SLC38A7, SNAT7","Solute carrier family 38 (amino acid transporter), member 7",SLC38A7,55238,ENSG00000103042,NA,NA,Slc38a7 (MGI:2679005)
16,58707130,58734315,16q21,16q21,138150,GOT2,"Glutamic-oxaloacetic transaminase-2, mitochondrial (EC 2.6.1.1)",GOT2,2806,ENSG00000125166,?pseudogenes on 12 and 1,NA,Got2 (MGI:95792)
16,61640397,62036445,16q21-q22.1,16q21,603008,CDH8,Cadherin-8,CDH8,1006,ENSG00000150394,NA,NA,Cdh8 (MGI:107434)
16,64943752,65126111,16q21-q22.1,16q21,600023,"CDH11, CAD11, ESWS","Cadherin-11 (OB-cadherin, osteoblast)",CDH11,1009,ENSG00000140937,NA,"Elsahy-Waters syndrome, 211380 (3), Autosomal recessive",Cdh11 (MGI:99217)
16,66366656,66404783,16q22.1,16q21,601120,CDH5,Cadherin-5,CDH5,1003,ENSG00000179776,NA,NA,Cdh5 (MGI:105057)
16,66427294,66495287,16q21,16q21,612051,"BEAN, SCA31","Brain-expressed, associated with NEDD4",BEAN1,146227,ENSG00000166546,NA,"Spinocerebellar ataxia 31, 117210 (3), Autosomal dominant",Bean1 (MGI:1929597)
16,66508002,66550411,16q22,16q21,188250,"TK2, MTDPS2, PEOB3","Thymidine kinase, mitochondrial",TK2,7084,ENSG00000166548,mutation identified in 1 PEOB3 family,"Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3), Autosomal recessive; ?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3, 617069 (3), Autosomal recessive",Tk2 (MGI:1913266)
16,66552562,66566286,16q23,16q21,616074,"CKLF, HSPC224",Chemokine-like factor,CKLF,51192,ENSG00000217555,NA,NA,Cklf (MGI:1922708)
16,66566438,66579134,16q22,16q21,607884,"CMTM1, CKLFSF1",CKLF-like marvel transmembrane domain-containing 1,CMTM1,113540,ENSG00000089505,NA,NA,NA
16,66579462,66588274,16q22,16q21,607885,"CMTM2, CKLFSF2",CKLF-like marvel transmembrane domain-containing 2,CMTM2,146225,ENSG00000140932,NA,NA,Cmtm2b (MGI:2447311)
16,66598177,66696742,16q22,16q21-q22,607887,"CMTM4, CKLFSF4",CKLF-like marvel transmembrane domain-containing 4,CMTM4,146223,ENSG00000183723,NA,NA,Cmtm4 (MGI:2142888)
16,66600000,74100000,16q22,NA,606179,ANBC,Aneurysmal bone cysts,NA,114293,NA,t(16:17); ?defect at 17p13,"Aneurysmal bone cysts, 606179 (2)",NA
16,66600000,74100000,16q22,NA,613055,ATFB8,"Atrial fibrillation, familial, 8",NA,100306979,NA,associated with rs7193343,"Atrial fibrillation, familial, 8, 613055 (2)",NA
16,66600000,74100000,16q22,NA,614541,"C16DELq22, DEL16q22",Chromosome 16q22 deletion syndrome,NA,NA,NA,NA,"Chromosome 16q22 deletion syndrome, 614541 (4), Isolated cases",NA
16,66600000,70800000,16q22.1,NA,612590,CRCS9,"Colorectal cancer, susceptibility to, 9",NA,100329169,NA,associated with rs9929218,"{Colorectal cancer, susceptibility to, 9}, 612590 (2)",NA
16,66600000,74100000,16q22,NA,604901,NAIC,North American Indian childhood cirrhosis,NA,NA,NA,NA,"North American Indian childhood cirrhosis, 604901 (2)",NA
16,66600000,79200000,16q22.1-q23.1,NA,611571,OTSC4,Otosclerosis 4,OTSC4,286751,NA,between D16S3107 and D16S3097,"{Otosclerosis 4}, 611571 (2), Autosomal dominant",NA
16,66600000,70800000,16q22.1,NA,600223,SCA4,Spinocerebellar ataxia 4,NA,NA,NA,NA,"Spinocerebellar ataxia 4, 600223 (2), Autosomal dominant",NA
16,66603995,66613891,16q22,16q22.1,607886,"CMTM3, CKLFSF3",CKLF-like marvel transmembrane domain-containing 3,CMTM3,123920,ENSG00000140931,NA,NA,Cmtm3 (MGI:2447162)
16,66754409,66801619,16q22.1,16q22.1,617332,"TERB1, CCDC79",Telomere repeat-binding bouquet formation protein 1,TERB1,283847,ENSG00000249961,NA,NA,Terb1 (MGI:2443187)
16,66802877,66830976,16q22,16q22.1,603385,"NAE1, APPBP1",NEDD8 activating enzyme E1 subunit 1,NAE1,8883,ENSG00000159593,NA,NA,Nae1 (MGI:2384561)
16,66844413,66854148,16q21-q23,16q22.1,114770,CA7,Carbonic anhydrase VII,CA7,766,ENSG00000168748,NA,NA,Car7 (MGI:103100)
16,66880514,66891100,16q22.1,16q22.1,615499,"PDP2, KIAA1348",Pyruvate dehydrogenase phosphatase catalytic subunit 2,PDP2,57546,ENSG00000172840,NA,NA,Pdp2 (MGI:1918878)
16,66908121,66918884,16q22.1,16q22.1,603118,CDH16,Cadherin-16,CDH16,1014,ENSG00000166589,NA,NA,Cdh16 (MGI:106671)
16,66921678,66925535,16q22,16q22.1,179503,RRAD,Ras-related associated with diabetes,RRAD,6236,ENSG00000166592,NA,NA,Rrad (MGI:1930943)
16,66932054,66934422,16q22.1,16q22.1,614778,"FAM96B, MIP18","Family with sequence similarity 96, member B",CIAO2B,51647,ENSG00000166595,NA,NA,Ciao2b (MGI:1915773)
16,66934470,66945095,16q22.1,16q22.1,605278,CES2,Carboxylesterase 2,CES2,8824,ENSG00000172831,NA,NA,Ces2h (MGI:3648740)
16,66961265,66975148,16q21,16q22.1,605279,"CES3, ES31",Carboxylesterase 3,CES3,23491,ENSG00000172828,NA,NA,"Ces3a,Ces3b (MGI:102773,MGI:3644960)"
16,67029148,67101057,16q22,16q22.1,121360,"CBFB, PEBP2B","Core-binding factor, beta subunit",CBFB,865,ENSG00000067955,inv(16)(p13;q22); fuses to MYH11,"Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)",Cbfb (MGI:99851)
16,67154184,67159908,16q22,16q22.1,603500,TRADD,TNRF1-associated death domain protein,TRADD,8717,ENSG00000102871,NA,NA,Tradd (MGI:109200)
16,67159956,67164173,16q22.1,16q22.1,609077,"FBXL8, FBL8",F-box and leucine-rich repeat protein 8,FBXL8,55336,ENSG00000135722,NA,NA,Fbxl8 (MGI:1354697)
16,67163760,67169940,16q21-q22.1,16q22.1,602438,"HSF4, CTM, CTRCT5",Heat-shock transcription factor 4,HSF4,3299,ENSG00000102878,NA,"Cataract 5, multiple types, 116800 (3), Autosomal dominant",Hsf4 (MGI:1347058)
16,67170496,67175736,16q21-q23,16q22.1,605235,"NOL3, NOP, MYC, ARC, FCM, MYOCL1",Nucleolar protein 3,NOL3,8996,ENSG00000140939,mutation identified in 1 MYOCL1 family,"?Myoclonus, familial, 1, 614937 (3), Autosomal dominant",Nol3 (MGI:1925938)
16,67184378,67190135,16q22.1,16q22.1,614117,"EXOC3L1, EXOC3L",Exocyst complex component 3-like 1,EXOC3L1,283849,ENSG00000179044,NA,NA,Exoc3l (MGI:3041195)
16,67192154,67198917,16q22.1,16q22.1,600659,E2F4,"E2F transcription factor 4, p107/p130-binding",E2F4,1874,ENSG00000205250,NA,NA,E2f4 (MGI:103012)
16,67202320,67202394,16q22.1,16q22.1,613701,"MIR328, MIRN328",Micro RNA 328,MIR328,442901,ENSG00000207948,NA,NA,NA
16,67199130,67204028,Chr.16,16q22.1,606422,ELMO3,Engulfment and cell motility gene 3,ELMO3,79767,ENSG00000102890,NA,NA,Elmo3 (MGI:2679007)
16,67229388,67247480,16q22,16q22.1,606881,"FHOD1, FHOS",Formin homology 2 domain-containing 1,FHOD1,29109,ENSG00000135723,NA,NA,NA
16,67247548,67272190,16q22.1,16q22.1,600477,"SLC9A5, NHE5","Solute carrier family 9 (sodium/hydrogen exchanger), member 5",SLC9A5,6553,ENSG00000135740,NA,NA,Slc9a5 (MGI:2685542)
16,67277819,67289499,16q22.1,16q22.1,609526,PLEKHG4,Pleckstrin homology domain- and RhoGEF domain-containing protein G4,PLEKHG4,25894,ENSG00000196155,NA,NA,Plekhg4 (MGI:2142544)
16,67389806,67393497,16q22.1,16q22.1,616957,"TPPP3, p20","Tubulin polymerization-promoting protein family, member 3",TPPP3,51673,ENSG00000159713,NA,NA,Tppp3 (MGI:1915221)
16,67431120,67437552,16q22,16q22.1,614232,"HSD11B2, HSD11K, AME",Hydroxysteroid (11-beta) dehydrogenase 2,HSD11B2,3291,ENSG00000176387,NA,"Apparent mineralocorticoid excess, 218030 (3), Autosomal recessive",Hsd11b2 (MGI:104720)
16,67438018,67481156,16q22,16q22.1,607028,ATP6V0D1,"ATPase, H+ transporting, V0 subunit D1",ATP6V0D1,9114,ENSG00000159720,NA,NA,Atp6v0d1 (MGI:1201778)
16,67482570,67483812,16q22,16q22.1,602311,"AGRP, ART, AGRT","Agouti-related transcript, mouse, homolog of",AGRP,181,ENSG00000159723,NA,"{Leanness, inherited} (3); {Obesity, late-onset}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial",Agrp (MGI:892013)
16,67562525,67639184,16q22.1,16q22.1,604167,"CTCF, MRD21",CCCTC-binding factor,CTCF,10664,ENSG00000102974,NA,"Mental retardation, autosomal dominant 21, 615502 (3), Autosomal dominant",Ctcf (MGI:109447)
16,67645003,67657568,16q22.1,16q22.1,610859,"CARMIL2, RLTPR, IMD58",Capping protein regulator and myosin 1 linker 2,CARMIL2,146206,ENSG00000159753,NA,"Immunodeficiency 58, 618131 (3), Autosomal recessive",Carmil2 (MGI:2685431)
16,67657511,67660831,16q22.1,16q22.1,609377,"ACD, PTOP, PIP1, TINT1","Acd, mouse, homolog of",ACD,65057,ENSG00000102977,mutation has been identified in 1 DKCA7 and 1 DKCB7 family,"?Dyskeratosis congenita, autosomal dominant 6, 616553 (3), Autosomal recessive, Autosomal dominant; ?Dyskeratosis congenita, autosomal recessive 7, 616553 (3), Autosomal recessive, Autosomal dominant",Acd (MGI:87873)
16,67723067,67806559,16q22.1,16q22.1,614031,"RANBP10, KIAA1464",Ran-binding protein 10,RANBP10,57610,ENSG00000141084,NA,NA,Ranbp10 (MGI:1921584)
16,67806572,67828067,16q22.1,16q22.1,607720,"TSNAXIP1, TXI1",Translin-associated factor X-interacting protein 1,TSNAXIP1,55815,ENSG00000102904,NA,NA,Tsnaxip1 (MGI:1919486)
16,67828156,67847692,16q22.1,16q22.1,611510,CENPT,Centromere protein T,CENPT,80152,ENSG00000102901,NA,NA,Cenpt (MGI:2443939)
16,67842319,67844194,16q22.1,16q22.1,609119,"THAP11, RONIN",THAP domain-containing protein 11,THAP11,57215,ENSG00000168286,NA,NA,Thap11 (MGI:1930964)
16,67873051,67884498,16q22.1,16q22.1,606030,"EDC4, RCD8, GE1, HEDL5",Enhancer of mRNA decapping 4,EDC4,23644,ENSG00000038358,NA,NA,Edc4 (MGI:2446249)
16,67893253,67929675,16q22.1,16q22.1,177015,PSKH1,Putative serine kinase H1,PSKH1,5681,ENSG00000159792,NA,NA,Pskh1 (MGI:3528383)
16,67929573,67931861,16q22.1,16q22.1,118888,CTRL,Chymotrypsin-like protease,CTRL,1506,ENSG00000141086,NA,NA,Ctrl (MGI:88558)
16,67934505,67936849,16q22.1,16q22.1,176847,"MECL1, LMP10, PSMB10",Proteosome subunit MECL1,PSMB10,5699,ENSG00000205220,3.1kb from LCAT,NA,Psmb10 (MGI:1096380)
16,67939749,67944119,16q22.1,16q22.1,606967,LCAT,Lecithin-cholesterol acyltransferase,LCAT,3931,ENSG00000213398,very close to HP,"Fish-eye disease, 136120 (3), Autosomal recessive; Norum disease, 245900 (3), Autosomal recessive",Lcat (MGI:96755)
16,67943473,67968693,16q22.1,16q22.1,604119,"SLC12A4, KCC1","Solute carrier family 12 (potassium/chloride transporters), member 4",SLC12A4,6560,ENSG00000124067,NA,NA,Slc12a4 (MGI:1309465)
16,67975662,67980498,16q22.1,16q22.1,609926,"DPEP3, MBD3",Dipeptidase 3,DPEP3,64180,ENSG00000141096,NA,NA,Dpep3 (MGI:1919104)
16,67987389,68000643,16q22.1,16q22.1,609925,"DPEP2, MBD2",Dipeptidase 2,DPEP2,64174,ENSG00000167261,NA,NA,Dpep2 (MGI:2442042)
16,68021273,68023866,16q22.1,16q22.1,607618,"DDX28, MDDX28",DEAD/H box 28,DDX28,55794,ENSG00000182810,NA,NA,Ddx28 (MGI:1919236)
16,68023283,68079319,16q22.1,16q22.1,609707,"DUS2L, DUS2",Dihydrouridine synthase 2-like,DUS2,54920,ENSG00000167264,NA,NA,Dus2 (MGI:1913619)
16,68225967,68236174,16q22.1,16q22.1,612960,"ESRP2, RBM35B",Epithelial splicing regulatory protein 2,ESRP2,80004,ENSG00000103067,NA,NA,Esrp2 (MGI:1924661)
16,68085369,68229258,Chr.16,16q22.1,602698,NFATC3,"Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 3",NFATC3,4775,ENSG00000072736,NA,NA,Nfatc3 (MGI:103296)
16,68245370,68261061,16q22.1,16q22.1,609362,"LYPLA3, LLPL, ACS, LPLA2",Lysophospholipase 3,PLA2G15,23659,ENSG00000103066,NA,NA,Pla2g15 (MGI:2178076)
16,68264509,68301818,Chr.16,16q22.1,605641,SLC7A6,"Solute carrier family 7 (y+L-type amino acid transporter), member 6",SLC7A6,9057,ENSG00000103064,NA,NA,Slc7a6 (MGI:2142598)
16,68310950,68360875,16q22.1,16q22.1,610087,"PRMT7, KIAA1933, SBIDDS",Protein arginine N-methyltransferase 7,PRMT7,54496,ENSG00000132600,NA,"Short stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3), Autosomal recessive",Prmt7 (MGI:2384879)
16,68530248,68576071,16q22.1,16q22.1,609451,"ZFP90, NK10, KIAA1954","Zinc finger protein 90, mouse, homolog of",ZFP90,146198,ENSG00000184939,NA,NA,Zfp90 (MGI:104786)
16,68644913,68727572,16q22.1,16q22.1,114021,"CDH3, CDHP, PCAD, HJMD",Cadherin-3 (P-cadherin),CDH3,1001,ENSG00000062038,in mouse tightly linked to ECAD,"Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3), Autosomal recessive; Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3), Autosomal recessive",Cdh3 (MGI:88356)
16,68737291,68835536,16q22.1,16q22.1,192090,"CDH1, UVO, LCAM, ECAD, BCDS1",Cadherin-1 (E-cadherin; uvomorulin),CDH1,999,ENSG00000039068,near LCAT,"Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; {Breast cancer, lobular}, 114480 (3), Autosomal dominant, Somatic mutation; Endometrial carcinoma, somatic, 608089 (3); Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Ovarian cancer, somatic, 167000 (3); {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant, Somatic mutation",Cdh1 (MGI:88354)
16,69105652,69118718,16q22.1,16q22.1,602428,HAS3,Hyaluronan synthase 3,HAS3,3038,ENSG00000103044,NA,NA,Has3 (MGI:109599)
16,69118009,69132587,16q22.1,16q22.1,613202,"CHTF8, CTF8","Chromosome transmission fidelity factor 8, S. cerevisiae, homolog of",CHTF8,54921,ENSG00000168802,NA,NA,Chtf8 (MGI:2443370)
16,69132595,69169033,16q22,16q22.1,607456,"UTP4, CIRH1A, TEX292, KIAA1988","Utp4, S. cerevisiae, homolog of",UTP4,84916,ENSG00000141076,NA,NA,Utp4 (MGI:1096573)
16,69187146,69309051,16q22-q23,16q22.1,600027,"SNTB2, SNT2B2, SNTL","Syntrophin, beta-2",SNTB2,6645,ENSG00000168807,NA,NA,Sntb2 (MGI:101771)
16,69311349,69326938,16q22,16q22.1,609982,"VPS4A, VPS4","Vacuolar protein sorting 4, yeast, homolog of, A",VPS4A,27183,ENSG00000132612,NA,NA,Vps4a (MGI:1890520)
16,69328620,69339622,16q22.1,16q22.1,606979,"COG8, DOR1, CDG2H",Component of oligomeric golgi complex 8,COG8,84342,ENSG00000213380,NA,"Congenital disorder of glycosylation, type IIh, 611182 (3)",Cog8 (MGI:2142885)
16,69355566,69386006,16q22.1,16q22.1,602027,"TERF2, TRF2",Telomeric repeat-binding factor-2,TERF2,7014,ENSG00000132604,NA,NA,Terf2 (MGI:1195972)
16,69424594,69466263,16q22.1,16q22.1,611964,"CYB5B, CYPB5M","Cytochrome b5, type B (outer mitochondrial membrane)",CYB5B,80777,ENSG00000103018,NA,NA,Cyb5b (MGI:1913677)
16,69565951,69704653,16q22.1,16q22.1,604708,"NFAT5, KIAA0827, NFATL1, TONEBP",Nuclear factor of activated T cells 5,NFAT5,10725,ENSG00000102908,NA,NA,Nfat5 (MGI:1859333)
16,69709400,69726559,16q22.1,16q22.1,125860,"NQO1, DIA4, NMOR1","NAD(P)H dehydrogenase, quinone 1 (diaphorase-4)",NQO1,1728,ENSG00000181019,NA,"{Benzene toxicity, susceptibility to} (3); {Breast cancer, poor survival after chemotherapy for} (3); {Leukemia, post-chemotherapy, susceptibility to} (3)",Nqo1 (MGI:103187)
16,69762300,69941740,16q21,16q22.1,602308,WWP2,WW domain-containing protein 2,WWP2,11060,ENSG00000198373,NA,NA,Wwp2 (MGI:1914144)
16,69933080,69933179,16q22.1,16q22.1,611894,"MIR140, MIRN140",Micro RNA 140,MIR140,406932,ENSG00000208017,NA,NA,NA
16,69950231,69968477,16q22.1,16q22.1,616571,CLEC18A,"C-type lecting domain family 18, member A",CLEC18A,348174,ENSG00000157322,NA,NA,NA
16,70113625,70163630,16q22.1,16q22.1,617835,"PDPR, KIAA1990",Pyruvate dehydrogenase phosphatase regulatory subunit,PDPR,55066,ENSG00000090857,NA,NA,Pdpr (MGI:2442188)
16,70173321,70187146,16q22.1,16q22.1,616573,CLEC18C,"C-type lectin domain family 18, member C",CLEC18C,283971,ENSG00000157335,NA,NA,NA
16,70246777,70251939,16q22.1,16q22.1,606490,"EXOSC6, MTR3",Exosome component 6,EXOSC6,118460,ENSG00000223496,NA,NA,Exosc6 (MGI:1919794)
16,70252294,70289508,16q22,16q22.1,601065,"AARS, CMT2N, EIEE29",Alanyl-tRNA synthetase,AARS1,16,ENSG00000090861,NA,"Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 29, 616339 (3), Autosomal recessive",Aars (MGI:2384560)
16,70289766,70335279,Chr.16,16q22.1,605812,"DDX19, DBP5",DEAD/H box 19,DDX19B,11269,ENSG00000157349,NA,NA,Ddx19b (MGI:2148251)
16,70454589,70480273,16q22.1,16q22.1,608675,"FCSK, FUK, CDGF2",Fucose kinase,FCSK,197258,ENSG00000157353,NA,"Congenital disorder of glycosylation with defective fucosylation 2, 618324 (3), Autosomal recessive",Fcsk (MGI:1916071)
16,70480566,70523553,16q22.1,16q22.1,606976,"COG4, COD1, CDG2J, SWILS",Component of oligomeric golgi complex 4,COG4,25839,ENSG00000103051,NA,"Congenital disorder of glycosylation, type IIj, 613489 (3), Autosomal recessive; Saul-Wilson syndrome, 618150 (3), Autosomal dominant",Cog4 (MGI:2142808)
16,70523815,70577667,16q22.1,16q22.1,605592,"SF3B3, SF3B130, SAP130","Splicing factor 3B, subunit 3",SF3B3,23450,ENSG00000189091,NA,NA,Sf3b3 (MGI:1289341)
16,70579894,70660681,16q22.1,16q22.1,612081,"IL34, C16orf77",Interleukin 34,IL34,146433,ENSG00000157368,NA,NA,Il34 (MGI:1923777)
16,70661203,70686052,16q22.1,16q22.1,616951,"MTSS1L, ABBA1",Metastasis suppressor 1-like protein,MTSS2,92154,ENSG00000132613,NA,NA,Mtss2 (MGI:3039591)
16,70687438,70801157,16q22.1,16q22.1-q22.2,604632,"VAC14, TAX1BP2, TRX, SNDC","Vac14, S. cerevisiae, homolog of",VAC14,55697,ENSG00000103043,NA,"Striatonigral degeneration, childhood-onset, 617054 (3), Autosomal recessive",Vac14 (MGI:2157980)
16,70802083,71230721,16q22.2,16q22.2,610812,"HYDIN, HYDIN1, CILD5","Hydin, mouse, homolog of",HYDIN,54768,ENSG00000157423,duplicated copy on 1q21.1,"Ciliary dyskinesia, primary, 5, 608647 (3), Autosomal recessive",Hydin (MGI:2389007)
16,71281391,71290177,16q22.2,16q22.2,616190,"CMTR2, MTR2, FTSJD1",CAP methyltransferase 2,CMTR2,55783,ENSG00000180917,NA,NA,Cmtr2 (MGI:2384580)
16,71358712,71390437,16q22.1,16q22.2,114051,CALB2,"Calbindin 2, 29kD (calretinin)",CALB2,794,ENSG00000172137,NA,NA,Calb2 (MGI:101914)
16,71447596,71462246,16q22,16q22.2,194527,"ZNF23, KOX16",Zinc finger protein-32 (KOX16),ZNF23,7571,ENSG00000167377,NA,NA,Zfp612 (MGI:2443465)
16,71473582,71489323,16q22,16q22.2,194525,"ZNF19, KOX12",Zinc finger protein-19 (KOX12),ZNF19,7567,ENSG00000157429,"?16q23, 19q13",NA,NA
16,71565659,71577091,16q22.1-q22.3,16q22.2,613018,TAT,"Tyrosine aminotransferase, soluble",TAT,6898,ENSG00000198650,NA,"Tyrosinemia, type II, 276600 (3), Autosomal recessive",Tat (MGI:98487)
16,71626179,71641964,16q22.2,16q22.2,614094,MARVELD3,Marvel domain-containing protein 3,MARVELD3,91862,ENSG00000140832,NA,NA,Marveld3 (MGI:1920858)
16,71644923,71724700,16q22.3,16q22.2,611066,"PHLPPL, PHLPP2",PH domain and leucine-rich repeat protein phosphatase-like,PHLPP2,23035,ENSG00000040199,NA,NA,Phlpp2 (MGI:2444928)
16,71728999,71808833,16q23,16q22.2,603533,"AP1G1, ADTG, CLAPG1","Adaptor-related protein complex 1, gamma 1 subunit (adaptin, gamma)",AP1G1,164,ENSG00000166747,NA,NA,Ap1g1 (MGI:101919)
16,71845975,71857327,16q22.2,16q22.2,614301,"ATXN1L, BOAT1",Ataxin 1-like (brother of ataxin 1),ATXN1L,342371,ENSG00000224470,NA,NA,Atxn1l (MGI:3694797)
16,71894407,71931198,16q22.2,16q22.2,616434,"IST1, KIAA0174","Increased sodium tolerance 1, yeast, homolog of",IST1,9798,ENSG00000182149,NA,NA,Ist1 (MGI:1919205)
16,71929537,72000400,16q22,16q22.2,607895,PKD1L3,Polycystin 1-like 3,PKD1L3,342372,ENSG00000277481,NA,NA,Pkd1l3 (MGI:2664670)
16,72008743,72027658,16q22,16q22.2,126064,"DHODH, URA1, POADS",Dihydroorotate dehydrogenase,DHODH,1723,ENSG00000102967,NA,"Miller syndrome, 263750 (3), Autosomal recessive",Dhodh (MGI:1928378)
16,72044260,72094377,16q22.2,16q22.2,617722,"TXNL4B, DLP, DIM2",Thioredoxin-like 4B,TXNL4B,54957,ENSG00000140830,NA,NA,Txnl4b (MGI:2443724)
16,72054504,72061055,16q22.1,16q22.2,140100,HP,Haptoglobin,HP,3240,ENSG00000257017,just distal to fra16q22.1,"[Anhaptoglobinemia], 614081 (3); [Hypohaptoglobinemia], 614081 (3)",Hp (MGI:96211)
16,72063225,72077245,16q22.1,16q22.2,140210,HPR,Haptoglobin-related locus,HPR,3250,ENSG00000261701,2.2kb 3' to HP; multiple tandem genes in blacks,NA,NA
16,72093664,72112911,16q21-q22,16q22.2,605584,"DHX38, DDX38, PRP16, RP84","DEAH (Asp-Glu-Ala-His) box polypeptide 38 (PRP6, S. cerevisiae, homolog of)",DHX38,9785,ENSG00000140829,NA,"Retinitis pigmentosa 84, 618220 (3), Autosomal recessive",Dhx38 (MGI:1927617)
16,72116696,72173907,16q22.2,16q22.2,618085,"PMFBP1, STAP, SPGF31",Polyamine-modulated factor 1-binding protein 1,PMFBP1,83449,ENSG00000118557,NA,"Spermatogenic failure 31, 618112 (3), Autosomal recessive",Pmfbp1 (MGI:1930136)
16,72782884,73059020,16q22.3-q23.1,16q22.2-q22.3,104155,"ZFHX3, ATBF1",Zinc finger homeobox 3,ZFHX3,463,ENSG00000140836,NA,"Prostate cancer, somatic, 176807 (3)",Zfhx3 (MGI:99948)
16,72800000,79200000,16q22.3-q23.1,NA,608932,KTCN2,Keratoconus 2,NA,450092,NA,NA,"Keratoconus 2, 608932 (2)",NA
16,73092348,73093773,16q22.3,16q22.3,615613,"HCCAT5, HTA",Hepatocellular carcinoma-associated transcript 5,HCCAT5,283902,ENSG00000260880,NA,NA,NA
16,74100000,84100000,16q23,NA,612727,BMND13,Bone mineral density quantitative trait locus 13,NA,100294717,NA,associated with rs16945612,"[Bone mineral density QTL 13], 612727 (2)",NA
16,74100000,84100000,16q23,NA,608462,HSCR8,"Hirschsprung disease, susceptibility to, 8",NA,404719,NA,NA,"{Hirschsprung disease, susceptibility to, 8}, 608462 (2)",NA
16,74296813,74306287,16q23-q24,16q23.1,157970,"PSMD7, MOV34","Proteasome 25S subunit, non-ATPase, 7 (Moloney leukemia virus-34 proviral integration homolog)",PSMD7,5713,ENSG00000103035,NA,NA,Psmd7 (MGI:1351511)
16,74408630,74422247,16q22.3,16q23.1,616572,CLEC18B,"C-type lectin domain family 18, member B",CLEC18B,497190,ENSG00000140839,NA,NA,Clec18a (MGI:2672935)
16,74447426,74607143,16q22-q23,16q23.1,600753,GLG1,Golgi apparatus protein 1,GLG1,2734,ENSG00000090863,NA,NA,Glg1 (MGI:104967)
16,74621395,74666891,16q23.1,16q23.1,614151,"RFWD3, FANCW",RING finger and WD repeat domains-containing protein 3,RFWD3,55159,ENSG00000168411,mutation identified in 1 FANCW patient,"?Fanconi anemia, complementation group W, 617784 (3), Autosomal recessive",Rfwd3 (MGI:2384584)
16,74671854,74700888,16q23.1,16q23.1,615153,MLKL,Mixed lineage kinase domain-like protein,MLKL,197259,ENSG00000168404,NA,NA,Mlkl (MGI:1921818)
16,74712954,74774830,16q23,16q23.1,611026,"FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35",Fatty acid 2-hydroxylase,FA2H,79152,ENSG00000103089,NA,"Spastic paraplegia 35, autosomal recessive, 612319 (3), Autosomal recessive",Fa2h (MGI:2443327)
16,74871361,74985145,16q23.1,16q23.1,617418,"WDR59, KIAA1923",WD repeat-containing protein 59,WDR59,79726,ENSG00000103091,NA,NA,Wdr59 (MGI:2442115)
16,74999023,75110993,16q23.1,16q23.1,612060,"ZNRF1, NIN283",Zinc finger and ring finger protein 1,ZNRF1,84937,ENSG00000186187,NA,NA,Znrf1 (MGI:2177308)
16,75111859,75116794,16q23.1,16q23.1,607490,"LDHD, DLACD",D-lactate dehydrogenase,LDHD,197257,ENSG00000166816,NA,"D-lactic aciduria, 245450 (3), Autosomal recessive",Ldhd (MGI:106428)
16,75126284,75172233,16q23.1,16q23.1,617230,"ZFP1, ZNF475","Zinc finger protein 1, mouse, homolog of",ZFP1,162239,ENSG00000184517,NA,NA,Zfp1 (MGI:99154)
16,75218987,75224923,16q23.2-q23.3,16q23.1,118890,CTRB1,Chymotrypsinogen B1,CTRB1,1504,ENSG00000168925,HP-7cM-TAT-9cM-CTRB,NA,NA
16,75228180,75268006,16q23.1,16q23.1,602941,"BCAR1, CRKAS, CAS",Breast cancer antiestrogen resistance 1,BCAR1,9564,ENSG00000050820,NA,NA,Bcar1 (MGI:108091)
16,75293709,75433502,16q22.2-q22.3,16q23.1,608108,"CFDP1, CP27, BCNT",Craniofacial development protein 1,CFDP1,10428,ENSG00000153774,NA,NA,Cfdp1 (MGI:1344403)
16,75472041,75495440,16q22,16q23.1,605294,"CHST6, MCDC1","Carbohydrate sulfotransferase-6 (GlcNAc-6-sulfotransferase, corneal)",CHST6,4166,ENSG00000183196,NA,"Macular corneal dystrophy, 217800 (3), Autosomal recessive",Chst5 (MGI:1931825)
16,75528529,75535169,16q22,16q23.1,604817,CHST5,"Carbohydrate sulfotransferase-5 (GlcNAc-6-O-sulfotransferase, intestinal)",CHST5,23563,ENSG00000135702,NA,NA,NA
16,75536740,75556285,16q23.1,16q23.1,614949,"TMEM231, JBTS20, MKS11",Transmembrane protein 231,TMEM231,79583,ENSG00000205084,NA,"Joubert syndrome 20, 614970 (3), Autosomal recessive; Meckel syndrome 11, 615397 (3), Autosomal recessive",Tmem231 (MGI:2685024)
16,75566378,75577880,16q22.3-q24.1,16q23.1,607452,GABARAPL2,GABA-A receptor-associated protein-like protein 2,GABARAPL2,11345,ENSG00000034713,NA,NA,Gabarapl2 (MGI:1890602)
16,75596867,75623280,16q22.2-q22.3,16q23.1,604230,ADAT1,"Adenosine deaminase, tRNA-specific, 1",ADAT1,23536,ENSG00000065457,NA,NA,Adat1 (MGI:1353631)
16,75627723,75647686,16q22.2-q22.3,16q23.1,601421,"KARS, CMTRIB, DFNB89",Lysyl-tRNA synthetase,KARS1,3735,ENSG00000065427,mutation identified in 1 CMTRIB patient,"?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3), Autosomal recessive; Deafness, autosomal recessive 89, 613916 (3), Autosomal recessive",Kars (MGI:1934754)
16,75647736,75657441,16q23.1,16q23.1,605061,"TERF2IP, RAP1","Telomeric repeat binding factor 2, interacting protein",TERF2IP,54386,ENSG00000166848,NA,NA,Terf2ip (MGI:1929871)
16,76277216,76563609,16q22,16q23.1,610518,"CNTNAP4, CASPR4, KIAA1763",Contactin-associated protein-like 4,CNTNAP4,85445,ENSG00000152910,NA,NA,Cntnap4 (MGI:2183572)
16,77191189,77202397,16q23.1,16q23.1,608954,"MON1B, SRG1, KIAA0872","Mon1, S. cerevisiae, homolog of, B",MON1B,22879,ENSG00000103111,NA,NA,Mon1b (MGI:1923231)
16,77282127,77435033,16q23,16q23.1,607512,"ADAMTS18, MMCAT","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 18",ADAMTS18,170692,ENSG00000140873,NA,"Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3), Autosomal recessive",Adamts18 (MGI:2442600)
16,78022547,78032100,16q23,16q23.1,613588,"CLEC3A, CLECSF1","C-type lectin domain family 3, member A",CLEC3A,10143,ENSG00000166509,NA,NA,Clec3a (MGI:2685642)
16,78099412,79212666,16q23.3-q24.1,16q23.1-q23.2,605131,"WWOX, FOR, SCAR12, EIEE28",WW domain-containing oxidoreductase,WWOX,51741,ENSG00000186153,NA,"Epileptic encephalopathy, early infantile, 28, 616211 (3), Autosomal recessive; Esophageal squamous cell carcinoma, somatic, 133239 (3); Spinocerebellar ataxia, autosomal recessive 12, 614322 (3), Autosomal recessive",Wwox (MGI:1931237)
16,79202623,79601951,16q22-q23,16q23.2,177075,"MAF, CCA4, CTRCT21, AYGRP",v-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog,MAF,4094,ENSG00000178573,NA,"Ayme-Gripp syndrome, 601088 (3), Autosomal dominant; Cataract 21, multiple types, 610202 (3), Autosomal dominant",Maf (MGI:96909)
16,79721311,79770531,16q23.2,16q23.2,616264,"MAFTRR, lincMAF4","MAF transcriptional regulator FNA, noncoding",MAFTRR,102467146,ENSG00000261390,NA,NA,NA
16,80540258,80550810,16q23.3,16q23.2,607168,"DYNLRB2, DNCL2B","Dynein, light chain, roadblock-type 2",DYNLRB2,83657,ENSG00000168589,NA,NA,Dynlrb2 (MGI:1922715)
16,80828734,80892595,16q23.2,16q23.2,618053,"ARLNC1, LINC02170",Androgen receptor-regulated long noncoding RNA 1,ARLNC1,100996425,ENSG00000260896,NA,NA,NA
16,81006497,81033106,16q23.2,16q23.2,611509,CENPN,Centromere protein N,CENPN,55839,ENSG00000166451,NA,NA,Cenpn (MGI:1919405)
16,81035841,81047349,16q23.2,16q23.2,614693,"ATMIN, ASCIZ, KIAA0431",ATM interactor,ATMIN,23300,ENSG00000166454,NA,NA,Atmin (MGI:2682328)
16,81081946,81096374,16q24,16q23.2,238330,"GCSH, NKH",Glycine cleavage system H protein,GCSH,2653,ENSG00000140905,mutation identified in 1 NKH patient,"?Glycine encephalopathy, 605899 (3), Autosomal recessive",Gcsh (MGI:1915383)
16,81100874,81220393,16q23.2,16q23.2,607894,"PKD1L2, PC1L2, KIAA1879",Polycystin 1-like 2,PKD1L2,114780,ENSG00000166473,NA,NA,Pkd1l2 (MGI:2664668)
16,81238447,81291141,16q21-q23,16q23.2,605748,"BCO1, BCMO1, BCDO",Beta-carotene oxygenase 1,BCO1,53630,ENSG00000135697,mutation identified in 1 HCVAD patient,"?Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3), Autosomal dominant",Bco1 (MGI:1926923)
16,81314940,81380197,16q24.1,16q23.2,605379,"GAN, GAN1",Gigaxonin,GAN,8139,ENSG00000261609,NA,"Giant axonal neuropathy-1, 256850 (3), Autosomal recessive",Gan (MGI:1890619)
16,81445169,81711761,16q24,16q23.2-q23.3,610112,"CMIP, KIAA1694, TCMIP",C-MAF-inducing protein,CMIP,80790,ENSG00000153815,NA,NA,Cmip (MGI:1921690)
16,81600000,84100000,16q23.3,NA,613836,ADIPQTL5,"Adiponectin, serum level of, quantitative trait locus 5",NA,100653375,NA,associated with rs3865188,"{Adiponectin, serum level of, QTL5], 613836 (2)",NA
16,81779290,81962684,16q24.1,16q23.3,600220,"PLCG2, FCAS3, APLAID","Phospholipase C, gamma 2",PLCG2,5336,ENSG00000197943,NA,"Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant",Plcg2 (MGI:97616)
16,81988854,82011525,16q23.3,16q23.3,616164,SDR42E1,"Short-chain dehydrogenase/reductase family 42E, member 1",SDR42E1,93517,ENSG00000184860,NA,NA,Sdr42e1 (MGI:1921282)
16,82035252,82098533,16q24.1-q24.2,16q23.3,109685,"HSD17B2, EDH17B2",Hydroxysteroid (17-beta) dehydrogenase 2,HSD17B2,3294,ENSG00000086696,NA,NA,Hsd17b2 (MGI:1096386)
16,82148161,82170223,Chr.16,16q23.3,605500,"MPHOSPH6, MPP",M-phase phosphoprotein 6,MPHOSPH6,10200,ENSG00000135698,NA,NA,Mphosph6 (MGI:1915783)
16,82626822,83800639,16q24.2-q24.3,16q23.3,601364,"CDH13, CDHH","Cadherin-13 (H-cadherin, heart)",CDH13,1012,ENSG00000140945,NA,NA,Cdh13 (MGI:99551)
16,83807977,83819736,16q23.3,16q23.3,604553,HSBP1,Heat-shock factor-binding protein 1,HSBP1,3281,ENSG00000230989,NA,NA,Hsbp1 (MGI:1915446)
16,83899114,83927030,16q24,16q23.3,606761,"MLYCD, MCD",Malonyl-CoA decarboxylase,MLYCD,23417,ENSG00000103150,NA,"Malonyl-CoA decarboxylase deficiency, 248360 (3), Autosomal recessive",Mlycd (MGI:1928485)
16,83953239,83966331,16q23.3,16q23.3,607975,"OSGIN1, OKL38",Oxidative stress-induced growth inhibitor 1,OSGIN1,29948,ENSG00000140961,NA,NA,Osgin1 (MGI:1919089)
16,83968631,84002775,16q23.3,16q23.3,618130,NECAB2,N-terminal EF-hand calcium-binding protein 2,NECAB2,54550,ENSG00000103154,NA,NA,Necab2 (MGI:2152211)
16,84009666,84043371,16q23.3,16q23.3,615585,"SLC38A8, FVH2","Solute carrier family 38 (amino acid transporter), member 8",SLC38A8,146167,ENSG00000166558,NA,"Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3), Autosomal recessive",Slc38a8 (MGI:2685433)
16,84053762,84116941,16q24,16q23.3-q24.1,603355,"MBTPS1, S1P, SEDKF","Membrane-bound transcription factor protease, site 1",MBTPS1,8720,ENSG00000140943,mutation identified in 1 SEDKF patient,"?Spondyloepiphyseal dysplasia, Kondo-Fu type, 618392 (3), Autosomal recessive",Mbtps1 (MGI:1927235)
16,84100000,87000000,16q24.1,NA,607687,HDLC3,"High density lipoprotein cholesterol, low serum, 3",NA,353125,NA,NA,"{High density lipoprotein cholesterol, low serum, 3}, 607687 (2)",NA
16,84100000,90338345,16q24,NA,613547,STQTL22,Stature quantitative trait locus 22,NA,100529227,NA,linked to rs299956 and rs2076962,"{Stature QTL 22}, 613547 (2)",NA
16,84145265,84178760,16q24.1,16q24.1,613190,"DNAAF1, LRRC50, ODA7, CILD13","Dynein, axonemal, assembly factor 1",DNAAF1,123872,ENSG00000154099,NA,"Ciliary dyskinesia, primary, 13, 613193 (3), Autosomal recessive",Dnaaf1 (MGI:1915520)
16,84177846,84187069,16q24,16q24.1,604905,"TAF1C, TAFI110, SL1",TATA box-binding protein-associated factor 1C,TAF1C,9013,ENSG00000103168,NA,NA,Taf1c (MGI:109576)
16,84221134,84239749,16q24.1,16q24.1,607603,"KCNG4, KV6.3, KV6.4","Potassium channel, voltage-gated, subfamily G, member 4",KCNG4,93107,ENSG00000168418,NA,NA,Kcng4 (MGI:1913983)
16,84292232,84329849,16q24.3,16q24.1,605322,"WFDC1, PS20","WAP four-disulfide core domain-1, mouse, homolog of",WFDC1,58189,ENSG00000103175,NA,NA,Wfdc1 (MGI:1915116)
16,84368522,84465776,16q24.1,16q24.1,613082,"ATP2C2, SPCA2, KIAA0703","ATPase, Ca(2+)-transporting, type 2C, member 2",ATP2C2,9914,ENSG00000064270,NA,NA,Atp2c2 (MGI:1916297)
16,84565595,84618077,16q24.1,16q24.1,606748,"COTL1, CLP",Coactosin-like protein 1,COTL1,23406,ENSG00000103187,"pseudogenes on 15, 17, and Y",NA,Cotl1 (MGI:1919292)
16,84699948,84779921,16q24.1,16q24.1,609818,"USP10, KIAA0190",Ubiquitin-specific protein 10,USP10,9100,ENSG00000103194,NA,NA,Usp10 (MGI:894652)
16,84819980,84909509,16q24.1,16q24.1,612434,CRISPLD2,"Cysteine-rich secretory protein, LCCL domain-containing, 2",CRISPLD2,83716,ENSG00000103196,NA,NA,Crispld2 (MGI:1926142)
16,84974174,85011534,16q24.1,16q24.1,614604,"ZDHHC7, DHHC7",Zinc finger DHHC domain-containing protein 7,ZDHHC7,55625,ENSG00000153786,NA,NA,Zdhhc7 (MGI:2142662)
16,85027708,85094229,16q24.1,16q24.1,611675,KIAA0513,KIAA0513 gene,KIAA0513,9764,ENSG00000135709,NA,NA,6430548M08Rik (MGI:2443793)
16,85098357,85112507,16q24.1,16q24.1,617274,FAM92B,"Family with sequence similarity 92, member B",FAM92B,339145,ENSG00000153789,NA,NA,Fam92b (MGI:3588213)
16,85169511,85676199,16q24.1,16q24.1,616886,"GSE1, KIAA0182",GSE1 coiled-coil protein,GSE1,23199,ENSG00000131149,NA,NA,Gse1 (MGI:1098275)
16,85676197,85688953,16q24.1,16q24.1,610609,"GINS2, PSF2",GINS complex subunit 2,GINS2,51659,ENSG00000131153,NA,NA,Gins2 (MGI:1921019)
16,85778623,85799554,16q24.1,16q24.1,604886,"EMC8, NOC4",ER membrane protein complex subunit 8,EMC8,10328,ENSG00000131148,NA,NA,Emc8 (MGI:1343095)
16,85799694,85807053,16q22-qter,16q24.1,123864,"COX4I1, COX4","Cytochrome c oxidase, subunit IV, isoform 1",COX4I1,1327,ENSG00000131143,NA,NA,Cox4i1 (MGI:88473)
16,85899161,85922608,16q24.1,16q24.1,601565,"IRF8, ICSBP1, IMD32A, IMD32B",Interferon regulatory factor 8,IRF8,3394,ENSG00000140968,NA,"Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3), Autosomal dominant; Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 226990 (3), Autosomal recessive",Irf8 (MGI:96395)
16,86196180,86199719,16q24.1,16q24.1,614978,TCONS00024492,Long noncoding RNA TCONS_00024492,LINC01082,100506542,ENSG00000269186,NA,NA,NA
16,86225579,86286246,16q24.1,16q24.1,614977,"LINC01081, TCONS00024764",Long intergenic non-protein coding RNA 1081,LINC01081,101154687,NA,NA,NA,NA
16,86474524,86508859,16q24.1,16q24.1,614975,"FENDRR, FOXF1AS1, TCONS_00024240",FOXF1 adjacent noncoding developmental regulatory RNA,FENDRR,400550,ENSG00000268388,partial overlap with FOXF1 promoter,NA,NA
16,86510526,86515421,16q24,16q24.1,601089,"FOXF1, FKHL5, ACDMPV",Forkhead box F1,FOXF1,2294,ENSG00000103241,NA,"Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3), Autosomal dominant",Foxf1 (MGI:1347470)
16,86530175,86555839,16q24.1,16q24.1,616820,MTHFSD,Methenyltetrahydrofolate synthetase domain-containing protein,MTHFSD,64779,ENSG00000103248,NA,NA,Mthfsd (MGI:2679252)
16,86566828,86569727,16q24.3,16q24.1,602402,"FOXC2, FKHL14, MFH1",Forkhead box C2,FOXC2,2303,ENSG00000176692,NA,"Lymphedema-distichiasis syndrome, 153400 (3), Autosomal dominant; Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3), Autosomal dominant",Foxc2 (MGI:1347481)
16,86578508,86581697,16q24.1,16q24.1,603252,"FOXL1, FKHL11, FREAC7, FKH6",Forkhead box L1,FOXL1,2300,ENSG00000176678,NA,NA,Foxl1 (MGI:1347469)
16,87326986,87392120,16q24.3,16q24.2,609102,"FBXO31, FBX31, FBXO14, FBX14, MRT45",F-box only protein 31,FBXO31,79791,ENSG00000103264,mutation identified in 1 MRT45 family,"?Mental retardation, autosomal recessive 45, 615979 (3), Autosomal recessive",Fbxo31 (MGI:1354708)
16,87392335,87404773,16q24.2,16q24.2,609604,"MAP1LC3B, LC3B","Microtubule-associated protein 1, light chain 3, beta",MAP1LC3B,81631,ENSG00000140941,NA,NA,Map1lc3b (MGI:1914693)
16,87601834,87698155,16q24.3,16q24.2,605268,"JPH3, JP3, HDL2",Junctophilin 3,JPH3,57338,ENSG00000154118,mutation identified in 1 HDL2 family,"Huntington disease-like 2, 606438 (3), Autosomal dominant",Jph3 (MGI:1891497)
16,87830021,87869506,16q24.3,16q24.2,600182,"SLC7A5, D16S469E, MPE16","Solute carrier family 7, member 5",SLC7A5,8140,ENSG00000103257,NA,NA,Slc7a5 (MGI:1298205)
16,87881548,87936574,16q24.3,16q24.2,114761,"CA5A, CA5AD",Carbonic anhydrase VA (mitochondrial),CA5A,763,ENSG00000174990,pseudogene on 16p,"Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3), Autosomal recessive",Car5a (MGI:101946)
16,87949215,88077317,16q24,16q24.2,611564,"BANP, SMAR1",BTG3-associated nuclear protein,BANP,54971,ENSG00000172530,NA,NA,Banp (MGI:1889023)
16,88424804,88440752,16q24,16q24.2,612078,"ZNF469, KIAA1858, BCS1",Zinc finger protein 469,ZNF469,84627,ENSG00000225614,NA,"Brittle cornea syndrome 1, 229200 (3), Autosomal recessive",Zfp469 (MGI:2684868)
16,88451781,88537030,16q24.3,16q24.2,601950,"ZFPM1, FOG, FOG1","Zinc finger protein, multitype 1 (friend of GATA1)",ZFPM1,161882,ENSG00000179588,NA,NA,Zfpm1 (MGI:1095400)
16,88638571,88640467,16q24,16q24.2,604628,IL17C,Interleukin 17C,IL17C,27189,ENSG00000124391,NA,NA,Il17c (MGI:2446486)
16,88643288,88651078,16q24,16q24.2,608508,CYBA,"Cytochrome b-245, alpha polypeptide",CYBA,1535,ENSG00000051523,NA,"Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3), Autosomal recessive",Cyba (MGI:1316658)
16,88651934,88663152,16q24.3,16q24.2,603236,"MVD, MPD, POROK7",Mevalonate pyrophosphate decarboxylase,MVD,4597,ENSG00000167508,NA,"Porokeratosis 7, multiple types, 614714 (3), Autosomal dominant",Mvd (MGI:2179327)
16,88677687,88686506,16q24.3,16q24.2,612741,"SNAI3, SNAIL3, SMUC, ZFP293","SNAIL, Drosophila, homolog of, 3",SNAI3,333929,ENSG00000185669,NA,NA,Snai3 (MGI:1353563)
16,88696498,88706420,16q24.2-q24.3,16q24.2-q24.3,617178,RNF166,RING finger protein 166,RNF166,115992,ENSG00000158717,NA,NA,Rnf166 (MGI:1915968)
16,88700000,90338345,16q24.3,NA,612525,IHPS5,"Pyloric stenosis, infantile hypertrophic, 5",NA,100270639,NA,between rs7197068 and rs750740,"Pyloric stenosis, infantile hypertrophic, 5, 612525 (2)",NA
16,88706480,88715395,16q24.3,16q24.3,617057,"CTU2, C16orf84, NCS2, MFRG","Cytosolic thiouridylase, subunit 2",CTU2,348180,ENSG00000174177,NA,"Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, 618142 (3), Autosomal recessive",Ctu2 (MGI:1914215)
16,88715337,88785219,16q24.3,16q24.3,611184,"PIEZO1, FAM38A, MIB, DHS, LMPHM6",PIEZO1 ion channel,PIEZO1,9780,ENSG00000103335,NA,"Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3), Autosomal dominant; Lymphatic malformation 6, 616843 (3), Autosomal recessive",Piezo1 (MGI:3603204)
16,88803788,88809257,16q24.3,16q24.3,605525,CDT1,Chromatin licensing and DNA replication factor 1,CDT1,81620,ENSG00000167513,NA,"Meier-Gorlin syndrome 4, 613804 (3), Autosomal recessive",Cdt1 (MGI:1914427)
16,88809338,88811927,16q24.3,16q24.3,102600,"APRT, APRTD",Adenine phosphoribosyltransferase,APRT,353,ENSG00000198931,"telomeric to GALNS, transcribed in same cen-tel direction","Adenine phosphoribosyltransferase deficiency, 614723 (3), Autosomal recessive",Aprt (MGI:88061)
16,88813733,88856965,16q24.3,16q24.3,612222,"GALNS, MPS4A",Galactosamine (N-acetyl)-6-sulfate sulfatase,GALNS,2588,ENSG00000141012,centromeric to APRT,"Mucopolysaccharidosis IVA, 253000 (3), Autosomal recessive",Galns (MGI:1355303)
16,88856219,88862685,16q22.1-q22.2,16q24.3,610970,"TRAPPC2L, PERRB",Trafficking protein particle complex 2-like,TRAPPC2L,51693,ENSG00000167515,NA,"Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis, 618331 (3), Autosomal recessive",Trappc2l (MGI:1916295)
16,88874857,88977206,16q24,16q24.3,603870,"CBFA2T3, MTGR2, MTG16","Core-binding factor, alpha subunit 2, translocated to, 3",CBFA2T3,863,ENSG00000129993,NA,NA,Cbfa2t3 (MGI:1338013)
16,89093808,89160555,16q24.3,16q24.3,614245,ACSF3,Acyl-CoA synthetase family member 3,ACSF3,197322,ENSG00000176715,NA,"Combined malonic and methylmalonic aciduria, 614265 (3)",Acsf3 (MGI:2182591)
16,89171747,89195491,16q24.3,16q24.3,114019,"CDH15, CDH14, CDH3, MRD3","Cadherin-15, M-cadherin (myotubule)",CDH15,1013,ENSG00000129910,tightly linked to Aprt in mouse,"Mental retardation, autosomal dominant 3, 612580 (3)",Cdh15 (MGI:106672)
16,89267618,89490560,16q24.3,16q24.3,611192,"ANKRD11, ANCO1, KBGS",Ankyrin repeat domain-containing protein 11,ANKRD11,29123,ENSG00000167522,NA,"KBG syndrome, 148050 (3), Autosomal dominant",Ankrd11 (MGI:1924337)
16,89508378,89557767,16q24.3,16q24.3,602783,"PGN, SPG7, CMAR, CAR",Paraplegin,SPG7,6687,ENSG00000197912,NA,"Spastic paraplegia 7, autosomal recessive, 607259 (3), Autosomal recessive, Autosomal dominant",Spg7 (MGI:2385906)
16,89560656,89566828,16q24.3,16q24.3,113703,"RPL13, BBC1, D16S44E",Ribosomal protein L13,RPL13,6137,ENSG00000167526,NA,NA,"Rpl13-ps6,Rpl13 (MGI:3642685,MGI:105922)"
16,89575757,89597245,16q24.3,16q24.3,605689,CPNE7,Copine VII,CPNE7,27132,ENSG00000178773,NA,NA,Cpne7 (MGI:2142747)
16,89613307,89641539,16q24.3,16q24.3,179780,"DPEP1, RDP, MDP, MBD1",Dipeptidase 1,DPEP1,1800,ENSG00000015413,NA,NA,Dpep1 (MGI:94917)
16,89644430,89657784,16q24.3,16q24.3,164010,"CHMP1A, PCOLN3, PRSM1, PCH8","CHMP family, member 1A",CHMP1A,5119,ENSG00000131165,NA,"Pontocerebellar hypoplasia, type 8, 614961 (3), Autosomal recessive",Chmp1a (MGI:1920159)
16,89657743,89671271,16q24.3,16q24.3,615409,"SPATA33, C16orf55",Spermatogenesis-associated protein 33,SPATA33,124045,ENSG00000167523,NA,NA,Spata33 (MGI:2444920)
16,89686611,89696363,16q24,16q24.3,603464,"CDK10, PISSLRE, ALSAS",Cyclin-dependent kinase 10,CDK10,8558,ENSG00000185324,NA,"Al Kaissi syndrome, 617694 (3), Autosomal recessive",Cdk10 (MGI:2448549)
16,89720367,89740924,16q24.3,16q24.3,608460,ZFP276,Zinc finger protein 276,ZNF276,92822,ENSG00000158805,NA,NA,Zfp276 (MGI:1888495)
16,89737548,89816646,16q24.3,16q24.3,607139,"FANCA, FACA, FA1, FA, FAA","Fanconi anemia, complementation group A",FANCA,2175,ENSG00000187741,linkage heterogeneity,"Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive",Fanca (MGI:1341823)
16,89873591,89911383,16q24.3,16q24.3,612326,"TCF25, NULP1, KIAA1049",Transcription factor 25,TCF25,22980,ENSG00000141002,NA,NA,Tcf25 (MGI:1914105)
16,89917878,89920976,16q24.3,16q24.3,155555,"MC1R, SHEP2, CMM5",Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor),MC1R,4157,ENSG00000258839,NA,"{Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive; [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); {Melanoma, cutaneous malignant, 5}, 613099 (3); [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive; [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive; {UV-induced skin damage}, 266300 (3), Autosomal recessive",Mc1r (MGI:99456)
16,89921924,89936096,16q24.3,16q24.3,602661,"TUBB3, TUBB4, CFEOM3A, CDCBM1","Tubulin, beta-3",TUBB3,10381,ENSG00000258947,NA,"Cortical dysplasia, complex, with other brain malformations 1, 614039 (3), Autosomal dominant; Fibrosis of extraocular muscles, congenital, 3A, 600638 (3), Autosomal dominant",Tubb3 (MGI:107813)
16,89972579,90000786,16q24,16q24.3,603020,"AFG3L1, AFG3","ATPase family gene 3, yeast, homolog of",AFG3L1P,172,ENSG00000223959,NA,NA,NA
16,90019628,90044970,16q24.3,16q24.3,605178,"GAS8, GAS11, CILD33",Growth arrest-specific 8,GAS8,2622,ENSG00000141013,NA,"Ciliary dyskinesia, primary, 33, 616726 (3), Autosomal recessive",Gas8 (MGI:1202386)
16,90028907,90029900,16q24.3,16q24.3,605179,"GAS8-AS1, C16orf3, EID1",GAS8 antisense RNA 1,GAS8-AS1,750,ENSG00000221819,NA,NA,NA
16,90039760,90047782,16q24.3,16q24.3,615805,"URAHP, URAH","Urate (hydroxyiso-) hydrolase, pseudogene",URAHP,100130015,ENSG00000222019,NA,NA,NA
16,0,90338345,Chr.16,NA,133290,ESB3,Esterase-B3,ESB3,2097,NA,NA,NA,NA
16,0,90338345,Chr.16,NA,138060,GRLL1,Glucocorticoid receptor-like 1,NR3C1P1,2910,NA,NA,NA,NA
16,0,90338345,Chr.16,NA,147573,IFNR,Interferon production regulator,IFNR,3466,NA,NA,NA,NA
16,0,90338345,Chr.16,NA,247980,LIPB,"Lipase B, lysosomal acid",LIPB,3989,NA,NA,NA,NA
16,0,90338345,Chr.16,NA,118870,NHCP1,Nonhistone chromosomal protein-1,NHCP1,4805,NA,NA,NA,NA
16,0,90338345,Chr.16,NA,125260,"VDI, DIPI",Vesicular stomatitis virus defective interfering particle repressor,VDI,7420,NA,NA,NA,NA
17,0,10800000,17p13,NA,608631,ASPG2,"Asperger syndrome, susceptibility to, 2",NA,431711,NA,breakpoints between CHRNE and GP1BA,"{Asperger syndrome susceptibility 2}, 608631 (2), Isolated cases, Multifactorial",NA
17,0,3400000,17p13.3,NA,113721,BCPR,Breast cancer-related regulator of TP53,NA,NA,NA,NA,Breast cancer (1),NA
17,0,10800000,17p13,NA,601202,"CTRCT24, CTAA2","Cataract 24, anterior polar",CTAA2,1484,NA,NA,"Cataract 24, anterior polar, 601202 (2), Autosomal dominant",NA
17,0,3400000,17p13.3,NA,615674,DDD3,Dowling-Degos disease 3,NA,102997065,NA,max lod at D17S1529,"Dowling-Degos disease 3, 615674 (2), Autosomal dominant",NA
17,0,3400000,17p13.3,NA,613215,"DUP17p13.3, C17DUPp13.3",Chromosome 17p13.3 duplication syndrome,NA,NA,NA,includes LIS1 and/or YWHAE,"Chromosome 17p13.3 duplication syndrome, 613215 (4)",NA
17,0,3400000,17p13.3,NA,247200,"MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3",Miller-Dieker lissencephaly syndrome (chromosome 17p13.3 deletion syndrome),NA,NA,NA,NA,"Miller-Dieker lissencephaly syndrome, 247200 (4), Autosomal dominant",NA
17,0,16100000,17p13.3-p12,NA,616964,MSPC,"Palmoplantar carcinoma, multiple self-healing",NA,NA,NA,between rs8065368 and rs2322788,"Palmoplantar carcinoma, multiple self-healing, 616964 (2)",NA
17,0,10800000,17p13,NA,605779,NDNC7,"Nail disorder, nonsyndromic congenital, 7 (onychodysplasia, isolated congenital)",NA,81866,NA,NA,"Nail disorder, nonsyndromic congenital, 7, 605779 (2), Autosomal dominant",NA
17,0,10800000,17p13.3-p13.1,NA,612576,"SHFLD3, DUP17p13.3, C17DUPp13.3",Split-hand/foot malformation with long bone deficiency 3,NA,NA,NA,max lod at or near D17S1533; contiguous gene duplication syndrome,"Split-hand/foot malformation with long bone deficiency 3, 612576 (4), Autosomal dominant",NA
17,0,10800000,17p13,NA,613498,SXGQTL1,Sex hormone-binding globulin circulating level quantitative trait locus 1,NA,100528025,NA,associated with rs1799941,"[Sex hormone-binding globulin circulating level QTL 1], 613498 (2)",NA
17,142788,181649,17p13.3,17p13.3,604568,DOC2B,"Double C2-like domain-containing protein, beta",DOC2B,8447,ENSG00000272636,NA,NA,Doc2b (MGI:1100497)
17,212388,352841,17p13.3,17p13.3,604881,"RPH3AL, NOC2",Rabphilin 3A-like,RPH3AL,9501,ENSG00000181031,NA,NA,Rph3al (MGI:1923492)
17,439977,445939,17p13.3,17p13.3,615928,"FAM101B, CFM1","Family with sequence similarity 101, member B",RFLNB,359845,ENSG00000183688,NA,NA,Rflnb (MGI:1923816)
17,508667,714845,17p13.3,17p13.3,615850,"VPS53, HCCS1, PCH2E","Vacuolar protein sorting 53, S. cerevisiae, homolog of",VPS53,55275,ENSG00000141252,NA,"Pontocerebellar hypoplasia, type 2E, 615851 (3), Autosomal recessive",Vps53 (MGI:1915549)
17,732545,742967,17p13.3,17p13.3,611627,"FAM57A, CT120","Family with sequence similarity 57, member A",TLCD3A,79850,ENSG00000167695,NA,NA,Fam57a (MGI:2151840)
17,744420,752867,17p13.3,17p13.3,606969,"GEMIN4, NEDMCR","Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities",GEMIN4,50628,ENSG00000179409,NA,"Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities, 617913 (3), Autosomal recessive",Gemin4 (MGI:2449313)
17,782352,792508,17p13.3,17p13.3,612600,"RNMTL1, HC90",RNA methyltransferase-like 1,MRM3,55178,ENSG00000171861,NA,NA,Mrm3 (MGI:1914640)
17,799309,979775,17p13.3,17p13.3,612895,NXN,Nucleoredoxin,NXN,64359,ENSG00000167693,NA,NA,Nxn (MGI:109331)
17,997128,1003670,17p13.3,17p13.3,607251,"TIMM22, TIM22","Translocase of inner mitochondrial membrane 22, yeast, homolog of",TIMM22,29928,ENSG00000177370,NA,NA,Timm22 (MGI:1929742)
17,1003518,1229721,17p13.3,17p13.3,600365,ABR,Active BCR-related gene,ABR,29,ENSG00000159842,NA,NA,Abr (MGI:107771)
17,1270563,1271270,17p13.3,17p13.3,615416,"BHLHA9, BHLHF42, MSSD, CCSPD","Basic helix-loop-helix family, member A9",BHLHA9,727857,ENSG00000205899,mutation identified in 1 CCSPD family,"?Camptosynpolydactyly, complex, 607539 (3), Autosomal recessive; Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3), Autosomal recessive",Bhlha9 (MGI:2444198)
17,1279661,1300977,17p13.3,17p13.3,612211,"TUSC5, LOST1",Tumor suppressor candidate 5,TRARG1,286753,ENSG00000184811,NA,NA,Trarg1 (MGI:3029307)
17,1344274,1400261,17p13.3,17p13.3,605066,"YWHAE, MDCR, MDS","Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon isoform",YWHAE,7531,ENSG00000108953,NA,NA,Ywhae (MGI:894689)
17,1420692,1456231,17p13.3,17p13.3,164762,CRK,Avian sarcoma virus CT10 (v-crk) oncogene homolog,CRK,1398,ENSG00000167193,NA,NA,Crk (MGI:88508)
17,1464185,1492685,17p13,17p13.3,606538,MYO1C,Myosin IC,MYO1C,4641,ENSG00000197879,NA,NA,Myo1c (MGI:106612)
17,1494574,1516734,17p13.3,17p13.3,607875,"INPP5K, SKIP, MDCCAID",Inositol polyphosphate-5-phosphatase K,INPP5K,51763,ENSG00000132376,NA,"Muscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3), Autosomal recessive",Inpp5k (MGI:1194899)
17,1517717,1562802,17p13.3,17p13.3,600174,"PITPNA, PITPN","Phosphotidylinositol transfer protein, alpha",PITPNA,5306,ENSG00000174238,NA,NA,Pitpna (MGI:99887)
17,1569253,1630013,17p13.3,17p13.3,610791,"SLC43A2, LAT4","Solute carrier family 43 (L-type amino acid transporter, member 2",SLC43A2,124935,ENSG00000167703,NA,NA,Slc43a2 (MGI:2442746)
17,1633857,1645788,17p13.3,17p13.3,607873,"SCARF1, SREC, KIAA0149","Scavenger receptor class F, member 1",SCARF1,8578,ENSG00000074660,NA,NA,Scarf1 (MGI:2449455)
17,1646149,1650076,17p13.3,17p13.3,607848,RILP,RAB-interacting lysosomal protein,RILP,83547,ENSG00000167705,NA,NA,Rilp (MGI:2144271)
17,1650628,1684879,17p13.3,17p13.3,607300,"PRPF8, PRPC8, RP13","Precursor mRNA-processing factor 8, S. cerevisiae, homolog of",PRPF8,10594,ENSG00000174231,NA,"Retinitis pigmentosa 13, 600059 (3), Autosomal dominant",Prpf8 (MGI:2179381)
17,1713902,1713986,17p13.3,17p13.3,612077,"MIR22, MIRN22",Micro RNA 22,MIR22,407004,ENSG00000283824,NA,NA,NA
17,1716522,1738598,17p13.3,17p13.3,614218,"WDR81, CAMRQ2, HYC3",WD repeat-containing protein 81,WDR81,124997,ENSG00000167716,NA,"Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3), Autosomal recessive; Hydrocephalus, congenital, 3, with brain anomalies, 617967 (3), Autosomal recessive",Wdr81 (MGI:2681828)
17,1742807,1755264,17pter-p12,17p13.3,613168,"PLI, SERPINF2",Alpha-2-plasmin inhibitor,SERPINF2,5345,ENSG00000167711,NA,"Alpha-2-plasmin inhibitor deficiency, 262850 (3), Autosomal recessive",Serpinf2 (MGI:107173)
17,1761924,1777573,17p13.3,17p13.3,172860,"SERPINF1, PEDF, OI6","Serpin peptidase inhibitor, clade F, member 1",SERPINF1,5176,ENSG00000132386,same region as RP13,"Osteogenesis imperfecta, type VI, 613982 (3)",Serpinf1 (MGI:108080)
17,1830004,1900081,17p13.3,17p13.3,179835,RPA1,"Replication protein A1, 70kD",RPA1,6117,ENSG00000132383,NA,NA,Rpa1 (MGI:1915525)
17,1934676,2025333,17p13.3,17p13.3,610461,"RTN4RL1, NGRH2, NGR3",Reticulon 4 receptor-like 1,RTN4RL1,146760,ENSG00000185924,NA,NA,Rtn4rl1 (MGI:2661375)
17,2030111,2043430,17p13.3,17p13.3,603527,"DPH1, DPH2L1, OVCA1, DEDSSH",Diphthamide biosynthesis protein 1,DPH1,1801,ENSG00000108963,NA,"Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3), Autosomal recessive",Dph1 (MGI:2151233)
17,2042021,2043424,17p13.3,17p13.3,607896,OVCA2,Ovarian cancer-associated gene 2,OVCA2,124641,ENSG00000262664,NA,NA,Ovca2 (MGI:2179725)
17,2049907,2050007,17p13.3,17p13.3,610016,"MIR132, MIRN132",Micro RNA 132,MIR132,406921,ENSG00000267200,NA,NA,NA
17,2050270,2050379,17p13.3,17p13.3,613487,"MIR212, MIRN212",Micro RNA 212,MIR212,406994,ENSG00000267195,NA,NA,NA
17,2055102,2063240,17p13.3,17p13.3,603825,HIC1,Hypermethylated in cancer,HIC1,3090,ENSG00000177374,NA,NA,Hic1 (MGI:1338010)
17,2059838,2303835,17p13.3,17p13.3,610963,"SMG6, EST1A, KIAA0732","SMG6, C. elegans, homolog of",SMG6,23293,ENSG00000070366,NA,NA,Smg6 (MGI:2144117)
17,2303370,2325266,17p13.3,17p13.3,606477,SRR,Serine racemase,SRR,63826,ENSG00000167720,NA,NA,Srr (MGI:1351636)
17,2322677,2337383,17p13.3,17p13.3,611214,"TSR1, KIAA1401","TSR1, 20S r RNA accumulation, S. cerevisiae, homolog of",TSR1,55720,ENSG00000167721,NA,NA,Tsr1 (MGI:2144566)
17,2336491,2381073,17p13.3,17p13.3,611418,"SGSM2, KIAA0397",Small G protein signaling modulator 2,SGSM2,9905,ENSG00000141258,NA,NA,Sgsm2 (MGI:2144695)
17,2384072,2401059,17p13.3,17p13.3,603039,"MNT, ROX",MAX-binding protein,MNT,4335,ENSG00000070444,NA,NA,Mnt (MGI:109150)
17,2593209,2685616,17p13.3,17p13.3,601545,"PAFAH1B1, LIS1","Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit",PAFAH1B1,5048,ENSG00000007168,NA,"Lissencephaly 1, 607432 (3), Autosomal dominant; Subcortical laminar heterotopia, 607432 (3), Autosomal dominant",Pafah1b1 (MGI:109520)
17,2689386,2712019,17p13.3,17p13.3,616184,"CLUH, CLU1, KIAA0664","Clustered mitochondria, D. discoideum, homolog of",CLUH,23277,ENSG00000132361,NA,NA,Cluh (MGI:1921398)
17,3092057,3092995,17p13.3,17p13.3,164342,"OR1D2, OLFR1","Olfactory receptor, family 1, subfamily D, member 2",OR1D2,4991,ENSG00000184166,cluster of 16 genes in 350kb,NA,Olfr412 (MGI:3030246)
17,3197516,3198447,17p13.3,17p13.3,618047,OR1A2,"Olfactory receptor, family 1, subfamily A, member 2",OR1A2,26189,ENSG00000172150,NA,NA,NA
17,3215620,3216549,17p13.3,17p13.3,618046,OR1A1,"Olfactory receptor, family 1, subfamily A, member 1",OR1A1,8383,ENSG00000172146,NA,NA,"Olfr403,Olfr43 (MGI:3030237,MGI:1333770)"
17,3400000,10800000,17p13.2-p13.1,NA,614341,MRT33,"Mental retardation, autosomal recessive 33",NA,100852394,NA,between rs1367950 and rs1826925,"Mental retardation, autosomal recessive 33, 614341 (2), Autosomal recessive",NA
17,3440010,3513851,17p13.2,17p13.2,617673,SPATA22,Spermatogenesis-associated protein 22,SPATA22,84690,ENSG00000141255,NA,NA,Spata22 (MGI:2685728)
17,3473645,3503404,17pter-p13,17p13.2,608034,ASPA,Aspartoacylase (aminoacylase-2),ASPA,443,ENSG00000108381,NA,"Canavan disease, 271900 (3), Autosomal recessive",Aspa (MGI:87914)
17,3510501,3557811,17p13,17p13.2,607066,"TRPV3, OLMS, FNEPPK2","Transient receptor potential cation channel, subfamily V, member 3",TRPV3,162514,ENSG00000167723,mutation identified in 1 FNEPPK2 family,"Olmsted syndrome, 614594 (3), Autosomal dominant; ?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3), Autosomal dominant",Trpv3 (MGI:2181407)
17,3565445,3609410,17p13,17p13.2,602076,"TRPV1, VR1","Transient receptor potential cation channel, subfamily V, member 1 (vanilloid receptor 1; capsaicin receptor)",TRPV1,7442,ENSG00000196689,NA,NA,Trpv1 (MGI:1341787)
17,3608252,3636249,17p13,17p13.2,605060,"SHPK, CARKL",Sedoheptulokinase,SHPK,23729,ENSG00000197417,NA,"[Sedoheptulokinase deficiency], 617213 (3), Autosomal recessive",Shpk (MGI:1921887)
17,3636467,3663102,17p13,17p13.2,606272,CTNS,Cystinosin,CTNS,1497,ENSG00000040531,?3 allelic forms,"Cystinosis, atypical nephropathic, 219800 (3), Autosomal recessive; Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3), Autosomal recessive; Cystinosis, nephropathic, 219800 (3), Autosomal recessive; Cystinosis, ocular nonnephropathic, 219750 (3), Autosomal recessive",Ctns (MGI:1932872)
17,3662892,3668678,17p13,17p13.2,616484,"TAX1BP3, TIP1",TAX1-binding protein 3,TAX1BP3,30851,ENSG00000213977,NA,NA,Tax1bp3 (MGI:1923531)
17,3714627,3803765,17p13,17p13.2,604682,"ITGAE, CD103","Integrin, alpha-E",ITGAE,3682,ENSG00000083457,NA,NA,Itgae (MGI:1298377)
17,3802157,3846245,17p13.2,17p13.2,616624,"NCBP3, C17orf85",Nuclear cap-binding protein 3,NCBP3,55421,ENSG00000074356,NA,NA,Ncbp3 (MGI:1914124)
17,3896590,3916505,17p13.3,17p13.2,600845,"P2RX1, P2X1","Purinergic receptor P2X, ligand-gated ion channel, 1",P2RX1,5023,ENSG00000108405,NA,NA,P2rx1 (MGI:1098235)
17,3923868,3964463,17p13.3,17p13.2,601929,"ATP2A3, SERCA3","ATPase, Ca(2+)-transporting, ubiquitous",ATP2A3,489,ENSG00000074370,NA,NA,Atp2a3 (MGI:1194503)
17,4163817,4263994,17p13.2,17p13.2,607927,"ANKFY1, ANKHZN, KIAA1255",Ankyrin repeats- and FYVE domain-containing protein 1,ANKFY1,51479,ENSG00000185722,NA,NA,Ankfy1 (MGI:1337008)
17,4269216,4366673,17p13.2,17p13.2,601569,UBE2G,"Ubiquitin-conjugating enzyme E2G (UBC7, C. elegans, homolog of)",UBE2G1,7326,ENSG00000132388,possible pseudogene on 1q42,NA,Ube2g1 (MGI:1914378)
17,4433939,4488203,17p13.2,17p13.2,611701,SPNS3,"Spinster, Drosophila, homolog of, 3",SPNS3,201305,ENSG00000182557,NA,NA,Spns3 (MGI:1924827)
17,4498880,4539034,17p13.2,17p13.2,612584,"SPNS2, DFNB115",Sphingolipid transporter 2,SPNS2,124976,ENSG00000183018,mutation identified in 1 DFNB115 patient,"?Deafness, autosomal recessive 115, 618457 (3), Autosomal recessive",Spns2 (MGI:2384936)
17,4538895,4555385,17p13.3,17p13.2,604885,"MYBBP1A, P160",MYB-binding protein 1A,MYBBP1A,10514,ENSG00000132382,NA,NA,Mybbp1a (MGI:106181)
17,4556926,4560919,17p13.2,17p13.2,612341,GGT6,Gamma-glutamyltransferase 6,GGT6,124975,ENSG00000167741,NA,NA,Ggt6 (MGI:1918772)
17,4630918,4641672,17p13.3,17p13.2,152392,ALOX15,Arachidonate 15-lipoxygenase,ALOX15,246,ENSG00000161905,NA,NA,Alox15 (MGI:87997)
17,4669773,4704136,17p13.3,17p13.2,609455,"PELP1, MNAR","Proline-, glutamic acid-, and leucine-rich protein 1",PELP1,27043,ENSG00000141456,NA,NA,Pelp1 (MGI:1922523)
17,4710493,4721499,17p13,17p13.2,107941,ARRB2,"Arrestin, beta 2",ARRB2,409,ENSG00000141480,NA,NA,Arrb2 (MGI:99474)
17,4731427,4733606,17p13.2,17p13.2,612383,MED11,Mediator complex subunit 11,MED11,400569,ENSG00000161920,NA,NA,Med11 (MGI:1913422)
17,4733532,4739927,17p13,17p13.2,605398,CXCL16,CXC chemokine ligand-16,CXCL16,58191,ENSG00000161921,NA,NA,Cxcl16 (MGI:1932682)
17,4739832,4746118,17p13.2,17p13.2,614312,"ZMYND15, SPGF14",Zinc finger MYND-containing protein 15,ZMYND15,84225,ENSG00000141497,mutation identified in 1 SPGF14 family,"?Spermatogenic failure 14, 615842 (3), Autosomal recessive",Zmynd15 (MGI:3603821)
17,4771885,4783210,17p13.3,17p13.2,604657,TM4SF5,"Transmembrane 4 superfamily, member 5",TM4SF5,9032,ENSG00000142484,NA,NA,Tm4sf5 (MGI:1922854)
17,4796143,4798502,17p13.2,17p13.2,600307,"PSMB6, LMPY","Proteasome subunit, beta-type, 6",PSMB6,5694,ENSG00000142507,NA,NA,Psmb6 (MGI:104880)
17,4807151,4823431,17p13.1,17p13.2,602384,PLD2,Phospholipase D2,PLD2,5338,ENSG00000129219,NA,NA,Pld2 (MGI:892877)
17,4833339,4898060,17p13.1,17p13.2,609426,"MINK1, MINK",Misshapen/nik-related kinase 1,MINK1,50488,ENSG00000141503,NA,NA,Mink1 (MGI:1355329)
17,4897770,4905018,17p13-p12,17p13.2,100725,"CHRNE, SCCMS, CMS4A, CMS4B, CMS4C","Cholinergic receptor, nicotinic, epsilon polypeptide",CHRNE,1145,ENSG00000108556,NA,"Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3), Autosomal recessive, Autosomal dominant; Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3), Autosomal recessive; Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3), Autosomal recessive",Chrne (MGI:87894)
17,4932276,4935022,17pter-p12,17p13.2,606672,"GP1BA, BSS, BDPLT1, VWDP, BDPLT3","Glycoprotein Ib, platelet, alpha polypeptide",GP1BA,2811,ENSG00000185245,NA,"Bernard-Soulier syndrome, type A1 (recessive), 231200 (3), Autosomal recessive; Bernard-Soulier syndrome, type A2 (dominant), 153670 (3), Autosomal dominant; {Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3), Autosomal recessive; von Willebrand disease, platelet-type, 177820 (3), Autosomal dominant",Gp1ba (MGI:1333744)
17,4937129,4940250,17p13.3,17p13.2,604165,"SLC25A11, SLC20A4, OGC, PGL6","Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11",SLC25A11,8402,ENSG00000108528,NA,"Paragangliomas 6, 618464 (3), Autosomal dominant",Slc25a11 (MGI:1915113)
17,4940091,4945221,17p13.2,17p13.2,610431,"RNF167, RING105",RING finger protein 167,RNF167,26001,ENSG00000108523,NA,NA,Rnf167 (MGI:1917760)
17,4945649,4949087,17p13.3,17p13.2,176610,"PFN1, ALS18",Profilin-1,PFN1,5216,ENSG00000108518,NA,"Amyotrophic lateral sclerosis 18, 614808 (3)",Pfn1 (MGI:97549)
17,4949181,4957130,17pter-p12,17p13.2,131370,"ENO3, GSD13","Enolase-3, beta, muscle",ENO3,2027,ENSG00000108515,mutation identified in 1 GSD13 patient,"?Glycogen storage disease XIII, 612932 (3), Autosomal recessive",Eno3 (MGI:95395)
17,4959225,4967816,17p13.2,17p13.2,610056,SPAG7,Sperm-associated antigen 7,SPAG7,9552,ENSG00000091640,NA,NA,Spag7 (MGI:107380)
17,4967992,4988280,17p13.2,17p13.2,611508,"CAMTA2, KIAA0909",Calmodulin-binding transcription activator 2,CAMTA2,23125,ENSG00000108509,NA,NA,Camta2 (MGI:2135957)
17,4988129,5006092,17p13,17p13.2,617374,"INCA1, HSD45","Inhibitor of CDK, cyclin A1-interacting protein 1",INCA1,388324,ENSG00000196388,NA,NA,Inca1 (MGI:2144284)
17,4997949,5028400,17p13.2,17p13.2,603060,"KIF1C, LTXS1, KIAA0706, SPAX2",Kinesin family member 1C,KIF1C,10749,ENSG00000129250,NA,"Spastic ataxia 2, autosomal recessive, 611302 (3), Autosomal recessive",Kif1c (MGI:1098260)
17,5032601,5035431,17p13.2,17p13.2,607883,"SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD","Solute carrier family 52, riboflavin transporter, member 1",SLC52A1,55065,ENSG00000132517,NA,"Riboflavin deficiency, 615026 (3), Autosomal dominant",NA
17,5078466,5096373,17pter-p12,17p13.2,194480,ZFP3,Zinc finger protein-3,ZFP3,124961,ENSG00000180787,probably in cluster with ZNF29 proximal to TP53,NA,Zfp3 (MGI:99177)
17,5105733,5123115,17p13.2,17p13.2,616463,"ZNF232, ZSCAN11",Zinc finger protein 232,ZNF232,7775,ENSG00000167840,NA,NA,NA
17,5116437,5175031,17p13,17p13.2,604334,"USP6, TRE2",Ubiquitin-specific protease 6,USP6,9098,ENSG00000129204,NA,NA,NA
17,5208919,5234859,17p13.2,17p13.2,614406,"SCIMP, C17orf87",SLP adaptor- and CSK-interacting membrane protein,SCIMP,388325,ENSG00000161929,NA,NA,Scimp (MGI:3610314)
17,5282271,5386339,17p13,17p13.2,603616,"RABEP1, RABPT5",RAB GTPase-binding effector protein 1,RABEP1,9135,ENSG00000029725,fused to PDGFRB in CMML,NA,Rabep1 (MGI:1860236)
17,5384832,5419738,17p13,17p13.2,602552,"NUP88, FADS4","Nucleoporin, 88-kD",NUP88,4927,ENSG00000108559,NA,"Fetal akinesia deformation sequence 4, 618393 (3), Autosomal recessive",Nup88 (MGI:104900)
17,5419640,5433019,17p13,17p13.2,617299,"RPAIN, RIP",RPA-interacting protein,RPAIN,84268,ENSG00000129197,NA,NA,Rpain (MGI:1916973)
17,5432776,5439154,17p13.3,17p13.2,601269,"C1QBP, HABP1, COXPD33",Complement component C1q binding protein (hyaluronic acid-binding protein 1),C1QBP,708,ENSG00000108561,NA,"Combined oxidative phosphorylation deficiency 33, 617713 (3), Autosomal recessive",C1qbp (MGI:1194505)
17,5440916,5469054,17p13.2,17p13.2,614405,DHX33,DEAH box polypeptide 33,DHX33,56919,ENSG00000005100,NA,NA,Dhx33 (MGI:2445102)
17,5471250,5486229,17p13.2,17p13.2,610304,DERL2,"DER1-like domain family, member 2",DERL2,51009,ENSG00000072849,NA,NA,Derl2 (MGI:2151483)
17,5486373,5490813,17p13.2,17p13.2,609178,MIS12,"Mis12, S. pombe, homolog of",MIS12,79003,ENSG00000167842,NA,NA,Mis12 (MGI:1914389)
17,5501395,5584508,17p13,17p13.2,606636,"NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK","NLR family, pyrin domain containing 1",NLRP1,22861,ENSG00000091592,NA,"Autoinflammation with arthritis and dyskeratosis, 617388 (3), Autosomal recessive, Autosomal dominant; Palmoplantar carcinoma, multiple self-healing, 615225 (3), Autosomal dominant; {Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)",Nlrp1b (MGI:3582959)
17,6423737,6435120,17p13.1,17p13.2,604392,"AIPL1, LCA4",Arylhydrocarbon-interacting receptor protein-like 1,AIPL1,23746,ENSG00000129221,LCA1 due to GUCY2D mutation also on 17p13.1,"Cone-rod dystrophy, 604393 (3), Autosomal recessive; Leber congenital amaurosis 4, 604393 (3), Autosomal recessive; Retinitis pigmentosa, juvenile, 604393 (3), Autosomal recessive",Aipl1 (MGI:2148800)
17,6444454,6451468,17p13.2,17p13.2,617611,"PIMREG, RCS1, FAM64A",PICALM-interacting mitotic regulator,PIMREG,54478,ENSG00000129195,NA,NA,Pimreg (MGI:1924434)
17,6451262,6556554,17p13.1,17p13.2-p13.1,608921,"PITPNM3, NIR1, CORD5","Phosphatidylinositol transfer protein, membrane-associated, 3",PITPNM3,83394,ENSG00000091622,NA,"Cone-rod dystrophy 5, 600977 (3), Autosomal dominant",Pitpnm3 (MGI:2685726)
17,6500000,10800000,17p13.1,NA,613776,"DEL17p13.1, C17DELp13.1",Chromosome 17p13.1 deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome 17p13.1 deletion syndrome, 613776 (4), Autosomal dominant",NA
17,6578146,6640926,17p13.1,17p13.1,617112,"KIAA0753, OFIP, OFD15",KIAA0753 gene,KIAA0753,9851,ENSG00000198920,mutation identified in 1 OFD15 patient,"?Orofaciodigital syndrome XV, 617127 (3), Autosomal recessive",4933427D14Rik (MGI:1921727)
17,6641059,6644540,17p13.1,17p13.1,616967,"TXNDC17, TRP14, TXNL5",Thioredoxin domain-containing protein 17,TXNDC17,84817,ENSG00000129235,NA,NA,Txndc17 (MGI:1289248)
17,6684712,6713420,17p13-p12,17p13.1,608305,"SLC13A5, NACT, EIEE25","Solute carrier family 13 (sodium-dependent citrate transporter), member 5",SLC13A5,284111,ENSG00000141485,NA,"Epileptic encephalopathy, early infantile, 25, 615905 (3), Autosomal recessive",Slc13a5 (MGI:3037150)
17,6755407,6775646,17p13.2,17p13.1,606717,XAF1,XIAP-associated factor 1,XAF1,54739,ENSG00000132530,NA,NA,Xaf1 (MGI:3772572)
17,6776214,6787645,17p13.2,17p13.1,609106,"FBXO39, FBX39",F-box protein 39,FBXO39,162517,ENSG00000177294,NA,NA,Fbxo39 (MGI:3505735)
17,6797992,6831733,17p13.1,17p13.1,609002,TEKT1,Tektin 1,TEKT1,83659,ENSG00000167858,NA,NA,Tekt1 (MGI:1333819)
17,6993790,7010753,17p13.1,17p13.1,152391,ALOX12,Arachidonate 12-lipoxygenase,ALOX12,239,ENSG00000108839,pseudogene also on chr.17,NA,Alox12 (MGI:87998)
17,7012416,7014532,17p13.1,17p13.1,617098,RNASEK,Ribonuclease K,RNASEK,440400,ENSG00000219200,NA,NA,Rnasek (MGI:106369)
17,7014781,7017519,17p13.1,17p13.1,617215,"C17orf49, BAP18",Chromosome 17 open reading frame 49,C17orf49,124944,ENSG00000258315,NA,NA,0610010K14Rik (MGI:1915609)
17,7017614,7017700,17p13.1,17p13.1,610718,"MIR195, MIRN195",Micro RNA 195,MIR195,406971,ENSG00000284112,NA,NA,NA
17,7017910,7018021,17p13.1,17p13.1,615672,MIR497,Micro RNA 497,MIR497,574456,ENSG00000284027,NA,NA,NA
17,7023049,7029643,17p13.1,17p13.1,608992,"BCL6B, BAZF",B-cell lymphoma 6B,BCL6B,255877,ENSG00000161940,NA,NA,Bcl6b (MGI:1278332)
17,7041620,7044410,17p13.2,17p13.1,615765,"SLC16A11, MCT11","Solute carrier family 16, member 11",SLC16A11,162515,ENSG00000174326,NA,NA,Slc16a11 (MGI:2663709)
17,7074536,7080306,17p13.1,17p13.1,605999,"CLEC10A, CLECSF14, MGL, HML, CD301","C-type lectin domain family 10, member A",CLEC10A,10462,ENSG00000132514,NA,NA,"Clec10a,Mgl2 (MGI:2385729,MGI:96975)"
17,7101321,7115537,17p,17p13.1,108361,ASGR2,Asialoglycoprotein receptor-2,ASGR2,433,ENSG00000161944,NA,NA,Asgr2 (MGI:88082)
17,7173430,7179563,17p13-p11,17p13.1,108360,ASGR1,Asialoglycoprotein receptor-1,ASGR1,432,ENSG00000141505,NA,NA,Asgr1 (MGI:88081)
17,7187179,7220049,17p13.1,17p13.1,602887,"DLG4, PSD95, SAP90","Discs large, Drosophila, homolog of, 4",DLG4,1742,ENSG00000132535,NA,NA,Dlg4 (MGI:1277959)
17,7217124,7225266,17p13,17p13.1,609575,"ACADVL, VLCAD","Acyl-Coenzyme A dehydrogenase, very long chain",ACADVL,37,ENSG00000072778,NA,"VLCAD deficiency, 201475 (3), Autosomal recessive",Acadvl (MGI:895149)
17,7225340,7234543,17p13.1,17p13.1,602151,DVL2,Dishevelled 2,DVL2,1856,ENSG00000004975,NA,NA,Dvl2 (MGI:106613)
17,7235027,7239655,17p13,17p13.1,612910,PHF23,PHD finger protein 23,PHF23,79142,ENSG00000040633,NA,NA,Phf23 (MGI:1925496)
17,7240007,7242448,17p13.1,17p13.1,605125,GABARAP,GABA-A receptor-associated protein,GABARAP,11337,ENSG00000170296,NA,NA,Gabarap (MGI:1861742)
17,7243590,7251977,17p13.1,17p13.1,610684,"CTDNEP1, DULLARD",C-terminal domain nuclear envelope phosphatase 1,CTDNEP1,23399,ENSG00000175826,NA,NA,Ctdnep1 (MGI:1914431)
17,7251736,7259939,17p13.1,17p13.1,615019,"ELP5, DERP6, C17orf81","Elongator acetyltransferase complex, subunit 5",ELP5,23587,ENSG00000170291,NA,NA,Elp5 (MGI:1859017)
17,7281717,7288256,17p13,17p13.1,138190,"SLC2A4, GLUT4","Solute carrier family 2 (facilitated glucose transporter), member 4",SLC2A4,6517,ENSG00000181856,NA,NA,Slc2a4 (MGI:95758)
17,7288253,7294638,17p13.1,17p13.1,611447,"YBX2, MSY2, CSDA3, DBPC",Y box-binding protein 2,YBX2,51087,ENSG00000006047,NA,NA,Ybx2 (MGI:1096372)
17,7306998,7312462,17p13-p12,17p13.1,600187,EIF5A,Eukaryotic translation initiation factor-5A,EIF5A,1984,ENSG00000132507,NA,NA,Eif5a (MGI:106248)
17,7312660,7315359,17p13.1,17p13.1,601935,GPS2,G protein pathway suppressor 2,GPS2,2874,ENSG00000132522,NA,NA,Gps2 (MGI:1891751)
17,7315627,7329334,17p13.1,17p13.1,615865,"NEURL4, KIAA1787",Neuralized E3 ubiquitin protein ligase 4,NEURL4,84461,ENSG00000215041,NA,NA,Neurl4 (MGI:1921092)
17,7351888,7354943,17p13.2,17p13.1,609848,"KCTD11, REn",Potassium channel tetramerization domain-containing protein 11,KCTD11,147040,ENSG00000213859,NA,NA,Kctd11 (MGI:2448712)
17,7336505,7354943,Chr.17,17p13.1,607763,"CENTB1, KIAA0050, ACAP1","Centaurin, beta-1",ACAP1,9744,ENSG00000072818,NA,NA,Acap1 (MGI:2388270)
17,7354967,7357218,17p13.1,17p13.1,617814,TMEM95,Transmembrane protein 95,TMEM95,339168,ENSG00000182896,NA,NA,Tmem95 (MGI:3779488)
17,7380558,7389963,17p13.1,17p13.1,608076,TNK1,"Tyrosine kinase, nonreceptor, 1",TNK1,8711,ENSG00000174292,NA,NA,Tnk1 (MGI:1930958)
17,7389726,7394524,17p13.1,17p13.1,607611,PLSCR3,Phospholipid scramblase 3,PLSCR3,57048,ENSG00000187838,NA,NA,Plscr3 (MGI:1917560)
17,7402974,7404096,17p13.1,17p13.1,617779,"TMEM256, C17orf61",Transmembrane protein 256,TMEM256,254863,ENSG00000205544,NA,NA,Tmem256 (MGI:1916436)
17,7405491,7419859,Chr.17,17p13.1,606479,"NLGN2, KIAA1366",Neuroligin 2,NLGN2,57555,ENSG00000169992,NA,NA,Nlgn2 (MGI:2681835)
17,7420323,7421631,17p13.1,17p13.1,615116,"SPEM1, C17orf83",Spermatid maturation protein 1,SPEM1,374768,ENSG00000181323,NA,NA,Spem1 (MGI:1921538)
17,7435434,7437678,17p13.1,17p13.1,613936,"TMEM102, CBAP",Transmembrane protein 102,TMEM102,284114,ENSG00000181284,NA,NA,Tmem102 (MGI:1921591)
17,7438297,7444936,17q21,17p13.1,601514,"FGF11, FHF3",Fibroblast growth factor-11,FGF11,2256,ENSG00000161958,NA,NA,Fgf11 (MGI:109167)
17,7445060,7457709,17p12-p11,17p13.1,100710,"CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C","Cholinergic receptor, nicotinic, beta polypeptide-1, muscle",CHRNB1,1140,ENSG00000170175,mutation identified in 1 CMS2C family,"Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3), Autosomal dominant; ?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3), Autosomal recessive",Chrnb1 (MGI:87890)
17,7459365,7484248,17p13.1,17p13.1,612308,"ZBTB4, KIAA1538",Zinc finger and BTB domain-containing 4,ZBTB4,57659,ENSG00000174282,NA,NA,Zbtb4 (MGI:1922830)
17,7484365,7514615,17p13.1,17p13.1,180660,"POLR2A, RPOL2","Polymerase (RNA) II (DNA directed) polypeptide A, 220kD",POLR2A,5430,ENSG00000181222,NA,NA,Polr2a (MGI:98086)
17,7549057,7557889,17p13.3,17p13.1,602695,"TNFSF12, TWEAK, APO3L, DR3LG","Tumor necrosis factor ligand superfamily, member 12",TNFSF12,8742,ENSG00000239697,NA,NA,Tnfsf12 (MGI:1196259)
17,7558291,7561607,17p13.1,17p13.1,604472,"TNFSF13, APRIL, TALL2","Tumor necrosis factor ligand superfamily, member 13",TNFSF13,8741,ENSG00000161955,NA,NA,Tnfsf13 (MGI:1916833)
17,7561918,7571968,17p13.1,17p13.1,612844,SENP3,"Sentrin-specific protease family, member 3",SENP3,26168,ENSG00000161956,NA,NA,Senp3 (MGI:2158736)
17,7572824,7579005,17p13,17p13.1,602641,"EIF4A1, DDX2A","Eukaryotic translation initiation factor 4A, isoform 1",EIF4A1,1973,ENSG00000161960,NA,NA,Eif4a1 (MGI:95303)
17,7579637,7582110,17p13,17p13.1,153634,CD68,Macrophage antigen CD68 (macrosialin),CD68,968,ENSG00000129226,NA,NA,Cd68 (MGI:88342)
17,7583646,7588211,17p13.1-p12,17p13.1,604041,"MPDU1, SL15, CDGIF",Mannose-P-dolichol utilization defect 1,MPDU1,9526,ENSG00000129255,NA,"Congenital disorder of glycosylation, type If, 609180 (3), Autosomal recessive",Mpdu1 (MGI:1346040)
17,7588177,7590093,17p13,17p13.1,601297,"SOX15, SOX20",SRY (sex-determining region Y)-box 15,SOX15,6665,ENSG00000129194,NA,NA,Sox15 (MGI:98363)
17,7591229,7614896,17p13.1,17p13.1,605339,FXR2,"Fragile X mental retardation, autosomal homolog-2",FXR2,9513,ENSG00000129245,NA,NA,Fxr2 (MGI:1346074)
17,7614063,7633382,17p13-p12,17p13.1,182205,"SHBG, ABP",Sex hormone-binding globulin (androgen binding protein),SHBG,6462,ENSG00000129214,NA,NA,Shbg (MGI:98295)
17,7626233,7627877,17p13.1,17p13.1,611463,"SAT2, SSAT2",Spermidine/spermine N(1)-acetyltransferase 2,SAT2,112483,ENSG00000141504,NA,NA,Sat2 (MGI:1916465)
17,7646626,7657770,17p,17p13.1,182331,"ATP1B2, AMOG","ATPase, Na+K+ transporting, beta-2 polypeptide",ATP1B2,482,ENSG00000129244,NA,NA,Atp1b2 (MGI:88109)
17,7668401,7687549,17p13.1,17p13.1,191170,"TP53, P53, LFS1 , BCC7, BMFS5",Tumor protein p53,TP53,7157,ENSG00000141510,NA,"{Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; {Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant; Breast cancer, somatic, 114480 (3); {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Autosomal dominant, Somatic mutation; {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation; Hepatocellular carcinoma, somatic, 114550 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; Pancreatic cancer, somatic, 260350 (3)",Trp53 (MGI:98834)
17,7686070,7703501,17p13,17p13.1,612661,"WRAP53, TCAB1, WDR79, DKCB3",WD repeat-containing protein antisense to TP53,WRAP53,55135,ENSG00000141499,NA,"Dyskeratosis congenita, autosomal recessive 3, 613988 (3), Autosomal recessive",Wrap53 (MGI:2384933)
17,7705201,7711371,17p13.1-p11.2,17p13.1,602297,"EFNB3, EPLG8, LERK8, EFL6",Ephrin B3,EFNB3,1949,ENSG00000108947,NA,NA,Efnb3 (MGI:109196)
17,7717743,7833710,17p13,17p13.1,603333,"DNAH2, DNAHC2","Dynein, axonemal, heavy chain-2",DNAH2,146754,ENSG00000183914,NA,NA,Dnah2 (MGI:107731)
17,7834209,7854795,17p13.1,17p13.1,611577,"KDM6B, JMJD3, KIAA0346",Lysine-specific demethylase 6B,KDM6B,23135,ENSG00000132510,NA,NA,Kdm6b (MGI:2448492)
17,7854885,7856098,17p13.1,17p13.1,617813,TMEM88,Transmembrane protein 88,TMEM88,92162,ENSG00000167874,NA,NA,Tmem88 (MGI:1914270)
17,7856680,7885419,17p13.1,17p13.1,617990,"NAA38, LSMD1, MAK31","N-alpha-acetyltransferase 38, NatC auxiliary subunit",NAA38,84316,ENSG00000183011,NA,NA,Naa38 (MGI:1925554)
17,7884763,7912756,17p13,17p13.1,602120,"CHD3, SNIBCPS",Chromodomain helicase DNA binding protein-3,CHD3,1107,ENSG00000170004,NA,"Snijders Blok-Campeau syndrome, 618205 (3), Autosomal dominant",Chd3 (MGI:1344395)
17,7921858,7930345,17p13.1,17p13.1,604111,"KCNAB3, KCNA3B","Potassium voltage-gated channel, shaker-related subfamily, beta member 3",KCNAB3,9196,ENSG00000170049,NA,NA,Kcnab3 (MGI:1336208)
17,7930344,7931998,17p13,17p13.1,610969,"TRAPPC1, MUM2, BET5","Trafficking protein particle complex, subunit 1",TRAPPC1,58485,ENSG00000170043,NA,NA,Trappc1 (MGI:1098727)
17,7932053,7949919,17p13.1,17p13.1,611425,"CNTROB, LIP8",Centrosomal BRCA2-interacting protein,CNTROB,116840,ENSG00000170037,NA,NA,Cntrob (MGI:2443290)
17,8002669,8020339,17p13.1,17p13.1,600179,"GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1","Guanylate cyclase 2D, membrane, retina-specific",GUCY2D,3000,ENSG00000132518,mutation identified in 1 CACD1 family,"?Choroidal dystrophy, central areolar 1, 215500 (3), Autosomal dominant; Cone-rod dystrophy 6, 601777 (3), Autosomal recessive, Autosomal dominant; Leber congenital amaurosis 1, 204000 (3), Autosomal recessive",Gucy2e (MGI:105123)
17,8039039,8049133,17p13.1,17p13.1,603697,ALOX15B,"Arachidonate 15-lipoxygenase, second type",ALOX15B,247,ENSG00000179593,NA,NA,Alox8 (MGI:1098228)
17,8072635,8087715,17p13.1,17p13.1,603741,"ALOX12B, ARCI2","Archidonate 12-lipoxygenase, R type",ALOX12B,242,ENSG00000179477,NA,"Ichthyosis, congenital, autosomal recessive 2, 242100 (3), Autosomal recessive",Alox12b (MGI:1274782)
17,8095899,8118915,17p13.1,17p13.1,607206,"ALOXE3, ARCI3",Arachidonate lipoxygenase 3,ALOXE3,59344,ENSG00000179148,NA,"Ichthyosis, congenital, autosomal recessive 3, 606545 (3), Autosomal recessive",Aloxe3 (MGI:1345140)
17,8119154,8119226,17p13.1,17p13.1,189918,"TRNAK1, TRK1, TRK-TTT3-4",Transfer RNA lysine (TTT) 3-4,TRK-TTT3-5,7206,NA,NA,NA,NA
17,8119751,8119822,17p13.1,17p13.1,189919,"TRNAQ1, TRQ1",tRNA glutamine-1,TRQ-CTG1-5,7228,NA,NA,NA,NA
17,8120313,8120394,17p13.1,17p13.1,189920,"TRNAL2, TRL2",tRNA leucine-2,TRL-TAG1-1,7208,NA,NA,NA,NA
17,8120589,8126031,17p13.2,17p13.1,608059,"HES7, SCDO4","Hairy/enhancer of split, Drosophila, homolog of, 7",HES7,84667,ENSG00000179111,NA,"Spondylocostal dysostosis 4, autosomal recessive, 613686 (3), Autosomal recessive",Hes7 (MGI:2135679)
17,8120924,8121011,17p13.1,17p13.1,610406,"TRNAR1, TRR1",tRNA arginine-1,TRR-TCT2-1,7230,NA,NA,NA,NA
17,8125745,8125815,17p13.1,17p13.1,610407,"TRNAG2, TRG2",tRNA glycine-2,TRG-GCC2-6,7196,NA,at least 8 copies in this region,NA,NA
17,8140469,8156359,17p12,17p13.1,602260,"PER, RIGUI","Period, Drosophila, homolog of",PER1,5187,ENSG00000179094,NA,NA,Per1 (MGI:1098283)
17,8159146,8162947,17p12,17p13.1,185881,"VAMP2, SYB2",Vesicle-associated membrane protein-2 (synaptobrevin-2),VAMP2,6844,ENSG00000220205,NA,NA,Vamp2 (MGI:1313277)
17,8172456,8176379,17p13.1,17p13.1,616183,"TMEM107, MKS13, JBTS29",Transmembrane protein 107,TMEM107,84314,ENSG00000179029,mutation identified in 1 JBTS29,"?Joubert syndrome 29, 617562 (3), Autosomal recessive; Meckel syndrome 13, 617562 (3), Autosomal recessive; Orofaciodigital syndrome XVI, 617563 (3), Autosomal recessive",Tmem107 (MGI:1914160)
17,8173452,8173587,17p13.1,17p13.1,616663,"SNORD118, LCC","Small nucleolar RNA,  C/D box, 118",SNORD118,727676,ENSG00000200463,NA,"Leukoencephalopathy, brain calcifications, and cysts, 614561 (3), Autosomal recessive",NA
17,8188344,8190179,17p13.1,17p13.1,616599,"BORCS6, C17orf59, LYSPERSIN","BLOC1-related complex, subunit 6",BORCS6,54785,ENSG00000196544,NA,NA,Borcs6 (MGI:1919173)
17,8204730,8210766,17p13.1,17p13.1,604970,"STK12, ARK2, AIK2, AIM1",Serine/threonine protein kinase 12,AURKB,9212,ENSG00000178999,NA,NA,Aurkb (MGI:107168)
17,8224814,8248094,17p13.1,17p13.1,613129,"CTC1, CRMCC, C17orf68, AAF132",Conserved telomere maintenance component 1,CTC1,80169,ENSG00000178971,NA,"Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3), Autosomal recessive",Ctc1 (MGI:1916214)
17,8247595,8270490,Chr.17,17p13.1,602133,"PFAS, FGARAT",phosphoribosylformylglycinamidine synthase (FGAR amidotransferase),PFAS,5198,ENSG00000178921,NA,NA,Pfas (MGI:2684864)
17,8287762,8295688,17p13.1,17p13.1,610818,SLC25A35,"Solute carrier family 25, member 35",SLC25A35,399512,ENSG00000125434,NA,NA,Slc25a35 (MGI:1919248)
17,8288669,8290086,17p13.1,17p13.1,607954,"RANGRF, MOG1",RAN guanine nucleotide release factor,RANGRF,29098,ENSG00000108961,NA,NA,Rangrf (MGI:1889073)
17,8310240,8322515,17p13.1,17p13.1,608504,"ARGEF15, KIAA0915",Rho guanine nucleotide exchange factor 15,ARHGEF15,22899,ENSG00000198844,NA,NA,Arhgef15 (MGI:3045246)
17,8339839,8346047,17p13.1,17p13.1,610097,"ODF4, OPPO1",Outer dense fiber of sperm tails 4,ODF4,146852,ENSG00000184650,NA,NA,Odf4 (MGI:2182079)
17,8377515,8383192,17p,17p13.1,603704,"RPL26, DBA11",Ribosomal protein L26,RPL26,6154,ENSG00000161970,mutation identified in 1 family,"?Diamond-Blackfan anemia 11, 614900 (3), Autosomal dominant",Rpl26 (MGI:106022)
17,8435883,8472743,Chr.17,17p13.1,607538,NUDEL,Nude-like protein (endooligopeptidase A),NDEL1,81565,ENSG00000166579,NA,NA,Ndel1 (MGI:1932915)
17,8474204,8631368,17p13,17p13.1,160776,MYH10,"Myosin, heavy polypeptide-10, non-muscle",MYH10,4628,ENSG00000133026,NA,NA,Myh10 (MGI:1930780)
17,8747531,8759427,17p13.1,17p13.1,617628,SPDYE4,"SPEEDY/RINGO cell cycle regulator family, member E4",SPDYE4,388333,ENSG00000183318,NA,NA,NA
17,8802722,8870002,17p13.1,17p13.1,611462,"PIK3R6, C17orf38","Phosphatidylinositol 3-kinase, regulatory subunit 6",PIK3R6,146850,ENSG00000276231,NA,NA,Pik3r6 (MGI:2144613)
17,8878915,8965711,17p13.1,17p13.1,611317,"PIK3R5, p101","Phosphatidylinositol 3-kinase, regulatory subunit 5",PIK3R5,23533,ENSG00000141506,NA,"Ataxia-oculomotor apraxia 3, 615217 (3), Autosomal recessive",Pik3r5 (MGI:2443588)
17,9021509,9243999,17p13.1,17p13.1,601614,"NTN1, NTN1L, MRMV4","Netrin 1, mouse, homolog of",NTN1,9423,ENSG00000065320,NA,"Mirror movements 4, 618264 (3), Autosomal dominant",Ntn1 (MGI:105088)
17,9250470,9575957,17p12,17p13.1,604203,STX8,Syntaxin 8,STX8,9482,ENSG00000170310,NA,NA,Stx8 (MGI:1890156)
17,9576641,9643446,17p13.1,17p13.1,609804,"WDR16, WDRPUH",WD repeat-containing protein 16,CFAP52,146845,ENSG00000166596,NA,NA,Cfap52 (MGI:1919110)
17,9771437,9791591,17p13.1,17p13.1,616161,"DHRS7C, SDR32C2","Short-chain dehydrogenase reductase family, member 7C",DHRS7C,201140,ENSG00000184544,NA,NA,Dhrs7c (MGI:1915710)
17,9825507,9894162,17p13.3,17p13.1,603659,GLP2R,Glucagon-like peptide 2 receptor,GLP2R,9340,ENSG00000065325,NA,NA,Glp2r (MGI:2136733)
17,9896319,9905270,17p13.1,17p13.1,179618,RCV1,Recoverin,RCVRN,5957,ENSG00000109047,NA,NA,Rcvrn (MGI:97883)
17,9910605,10198605,17p,17p13.1,603127,GAS7,Growth arrest-specific 7,GAS7,8522,ENSG00000007237,NA,NA,Gas7 (MGI:1202388)
17,10300864,10373005,17p13.1-p12,17p13.1,603487,MYH13,"Myosin, heavy polypeptide 13, skeletal muscle",MYH13,8735,ENSG00000006788,NA,NA,Myh13 (MGI:1339967)
17,10390321,10421949,17p13.1,17p13.1,160741,"MYH8, DA7","Myosin, heavy polypeptide-8, skeletal muscle, perinatal",MYH8,4626,ENSG00000133020,NA,"Carney complex variant, 608837 (3); Trismus-pseudocamptodactyly syndrome, 158300 (3), Autosomal dominant",Myh8 (MGI:1339712)
17,10443057,10469558,17p13.1,17p13.1,160742,MYH4,"Myosin, heavy polypeptide-4, skeletal muscle",MYH4,4622,ENSG00000264424,NA,NA,Myh4 (MGI:1339713)
17,10492306,10518718,17p13.1,17p13.1,160730,MYH1,"Myosin, heavy polypeptide-1, skeletal muscle, adult",MYH1,4619,ENSG00000109061,cluster = 6 genes in 500kb,NA,Myh1 (MGI:1339711)
17,10521147,10549657,17p13.1,17p13.1,160740,"MYH2, MYPOP","Myosin, heavy polypeptide-2, skeletal muscle, adult",MYH2,4620,ENSG00000125414,NA,"Proximal myopathy and ophthalmoplegia, 605637 (3), Autosomal recessive, Autosomal dominant",Myh2 (MGI:1339710)
17,10628526,10678346,17p13.1,17p13.1,160720,"MYH3, DA2A, DA2B3, DA8, CPSKF1A, CPSKF1B","Myosin, heavy polypeptide-3, skeletal muscle, embryonic",MYH3,4621,ENSG00000109063,NA,"Arthrogryposis, distal, type 2A (Freeman-Sheldon), 193700 (3), Autosomal dominant; Arthrogryposis, distal, type 2B3 (Sheldon-Hall), 618436 (3), Autosomal dominant; Contractures, pterygia, and variable skeletal fusions syndrome 1A, 178110 (3), Autosomal dominant; Contractures, pterygia, and variable skeletal fusions syndrome 1B, 618469 (3), Autosomal recessive",Myh3 (MGI:1339709)
17,10672473,10697532,17p13-p12,17p13.1,603644,"SCO1, SCOD1",SCO1 cytochrome c oxidase assembly protein,SCO1,6341,ENSG00000133028,NA,"Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Sco1 (MGI:106362)
17,10800000,16100000,17p12,NA,605572,AOMS2,Abdominal obesity-metabolic syndrome QTL2,NA,65077,NA,second QTL on 3q27,"Abdominal obesity-metabolic syndrome, 605572 (2), Autosomal dominant",NA
17,10800000,33500000,17p12-q11.2,NA,613392,DFNB85,"Deafness, autosomal recessive 85",DFNB85,100359399,NA,between rs230884 and rs12603885,"Deafness, autosomal recessive 85, 613392 (2), Autosomal recessive",NA
17,10800000,42800000,17p12-q21.2,NA,614928,ECTD6,"Ectodermal dysplasia 6, hair/nail type",NA,101101770,NA,between D17S839 and D17S1299,"Ectodermal dysplasia 6, hair/nail type, 614928 (2), Autosomal recessive",NA
17,10800000,22700000,17p12-p11.2,NA,616652,YUHAL,Yuan-Harel-Lupski syndrome,NA,NA,NA,contiguous gene duplication syndrome,"Yuan-Harel-Lupski syndrome, 616652 (4), Autosomal dominant",NA
17,10822469,10838086,17p13.1,17p12,612068,PIRT,Phosphoinositide-interacting regulator of transient receptor potential channels,PIRT,644139,ENSG00000233670,NA,NA,Pirt (MGI:2443635)
17,11241212,11564062,17p12,17p12,617327,SHISA6,"Shisa family, member 6",SHISA6,388336,ENSG00000188803,NA,NA,Shisa6 (MGI:2685725)
17,11598469,11970167,17p12,17p12,603330,"DNAH9, DNAH17L, DNEL1, CILD40","Dynein, axonemal, heavy chain 9",DNAH9,1770,ENSG00000007174,NA,"Ciliary dyskinesia, primary, 40, 618300 (3), Autosomal recessive",Dnah9 (MGI:1289279)
17,11957432,12021521,17p13-p12,17p12,194524,"ZNF18, KOX11",Zinc finger protein-18 (KOX11),ZNF18,7566,ENSG00000154957,NA,NA,Zkscan6 (MGI:1289293)
17,12020821,12143827,17p11.2,17p12,601335,"SERK1, PRKMK4, MAPKK4, JNKK1",SAPK/ERK kinase-1,MAP2K4,6416,ENSG00000065559,NA,NA,Map2k4 (MGI:1346869)
17,12665889,12768948,17p11.2,17p12,606127,MYOCD,Myocardin,MYOCD,93649,ENSG00000141052,NA,NA,Myocd (MGI:2137495)
17,12789497,12991643,17p12,17p12,617716,"ARHGAP44, RICH2, KIAA0672",RHO GTPase-activating protein 44,ARHGAP44,9912,ENSG00000006740,NA,NA,Arhgap44 (MGI:2144423)
17,12991611,13018063,17p11,17p12,605367,"ELAC2, HPC2, COXPD17","elaC, E. coli, homolog 2",ELAC2,60528,ENSG00000006744,at ~365cR,"Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive; {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3)",Elac2 (MGI:1890496)
17,13494031,13601928,17p12-p11.2,17p12,604057,"HS3ST3A1, 30ST3A1",Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 3A1,HS3ST3A1,9955,ENSG00000153976,NA,NA,Hs3st3a1 (MGI:1333861)
17,14069503,14208676,17p12-p11.2,17p12,602125,COX10,"Cytochrome c oxidase, subunit X",COX10,1352,ENSG00000006695,NA,"Leigh syndrome due to mitochondrial COX4 deficiency, 256000 (3), Autosomal recessive, Mitochondrial; Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Cox10 (MGI:1917633)
17,14301049,14349405,17p12-p11.2,17p12,604058,"HS3ST3B1, 30ST3B1",Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 3B1,HS3ST3B1,9953,ENSG00000125430,NA,NA,Hs3st3b1 (MGI:1333853)
17,15229776,15265325,17p11.2,17p12,601097,"PMP22, CMT1A, CMT1E, DSS, CIDP",Peripheral myelin protein-22,PMP22,5376,ENSG00000109099,mutation identified in 1 CIDP family,"Charcot-Marie-Tooth disease, type 1A, 118220 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 1E, 118300 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; ?Neuropathy, inflammatory demyelinating, 139393 (3), ?Autosomal dominant; Neuropathy, recurrent, with pressure palsies, 162500 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant",Pmp22 (MGI:97631)
17,15303810,15343681,17p12,17p12,612683,TEKT3,Tektin 3,TEKT3,64518,ENSG00000125409,NA,NA,Tekt3 (MGI:1918312)
17,15627965,15684310,17p11.2,17p12,609505,"TRIM16, EBBP",Tripartite motif-containing protein 16,TRIM16,10626,ENSG00000221926,NA,NA,Trim16 (MGI:2137356)
17,15675475,15675642,17p13-p12,17p12,194535,ZNF29,Zinc finger protein-29 (KOX26),ZNF29P,7577,NA,proximal to TP53,NA,NA
17,15927781,15975895,17p12-p11.2,17p12,600446,ADORA2B,Adenosine A2b receptor,ADORA2B,136,ENSG00000170425,incorrectly put on 10,NA,Adora2b (MGI:99403)
17,15976559,15999703,17p12,17p12,614535,"ZSWIM7, SWS1",Zinc finger SWIM domain-containing protein 7,ZSWIM7,125150,ENSG00000214941,NA,NA,Zswim7 (MGI:1916997)
17,15999770,16045427,17p12,17p12,613814,"TTC19, MC3DN2",Tetratricopeptide repeat domain 19,TTC19,54902,ENSG00000011295,NA,"Mitochondrial complex III deficiency, nuclear type 2, 615157 (3), Autosomal recessive",Ttc19 (MGI:1920045)
17,16029156,16216474,11p11.2,17p12-p11,600849,NCOR1,Nuclear receptor corepressor 1,NCOR1,9611,ENSG00000141027,NA,NA,Ncor1 (MGI:1349717)
17,16100000,25100000,17p11,NA,608904,ADHD2,"Attention deficit-hyperactivity disorder, susceptibility to, 2",NA,450088,NA,NA,"{Attention deficit-hyperactivity disorder}, 143465 (2), Autosomal dominant",NA
17,16100000,22700000,17p11.2,NA,607354,"IS2, AIS2","Scoliosis, idiopathic 2",NA,282552,NA,between D17S947 and D17S798,"Scoliosis, idiopathic 2, 607354 (2)",NA
17,16100000,22700000,17p11.2,NA,610883,PTLS,Potocki-Lupski syndrome,NA,NA,NA,contiguous gene syndrome,"Potocki-Lupski syndrome, 610883 (4), Isolated cases",NA
17,16100000,22700000,17p11.2-p11.2,NA,604547,VWSM,Van der Woude syndrome modifier,NA,100917,NA,NA,NA,NA
17,16217208,16351799,17p12-p11.2,17p11.2,605947,"PIGL, CHIME","Phosphatidylinositol glycan, class L",PIGL,9487,ENSG00000108474,NA,"CHIME syndrome, 280000 (3), Autosomal recessive",Pigl (MGI:2681271)
17,16342536,16353468,17p11.2,17p11.2,608139,"CENPV, P30",Centromere protein V,CENPV,201161,ENSG00000166582,NA,NA,Cenpv (MGI:1920389)
17,16380792,16382744,17p12-p11.1,17p11.2,191339,UBB,Ubiquitin B,UBB,7314,ENSG00000170315,NA,NA,NA
17,16415542,16437002,Chr.17,17p11.2,606676,"TRPV2, VRL1","Transient receptor potential cation channel, subfamily V, member 2",TRPV2,51393,ENSG00000187688,NA,NA,Trpv2 (MGI:1341836)
17,16939083,16972087,17p11.2,17p11.2,604907,"TNFRSF13B, TACI, CVID2","Tumor necrosis factor receptor superfamily, member 13B",TNFRSF13B,23495,ENSG00000240505,NA,"Immunodeficiency, common variable, 2, 240500 (3), Autosomal recessive, Autosomal dominant; Immunoglobulin A deficiency 2, 609529 (3)",Tnfrsf13b (MGI:1889411)
17,17042454,17192647,17p11.2,17p11.2,612935,"MPRIP, MRIP, KIAA0864, RIP3, P116RIP",Myosin phosphatase Rho-interacting protein,MPRIP,23164,ENSG00000133030,NA,NA,Mprip (MGI:1349438)
17,17200989,17206904,17p11.2,17p11.2,614960,"PLD6, ZUC","Phospholipase D family, member 6",PLD6,201164,ENSG00000179598,NA,NA,NA
17,17206945,17237187,17p11.2,17p11.2,607273,"FLCN, BHD",Folliculin,FLCN,201163,ENSG00000154803,NA,"Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant; Renal carcinoma, chromophobe, somatic, 144700 (3)",Flcn (MGI:2442184)
17,17246615,17281302,17p11.2,17p11.2,604665,"COPS3, SGN3","COP9 signalosome, subunit 3",COPS3,8533,ENSG00000141030,NA,NA,Cops3 (MGI:1349409)
17,17303372,17347662,17p11.2,17p11.2,605292,"NT5M, DNT2","Deoxyribonucleotidase, mitochondrial (5' nucleotidase, mitochondrial)",NT5M,56953,ENSG00000205309,NA,NA,Nt5m (MGI:1917127)
17,17476999,17493220,17p11.2,17p11.2,609878,"MED9, MED25, FLJ10193","Mediator of RNA polymerase II transcription, subunit 9, S. cerevisiae, homolog of",MED9,55090,ENSG00000141026,NA,NA,Med9 (MGI:2183151)
17,17494436,17496394,17p11.2,17p11.2,605550,"RASD1, DEXRAS1","Ras protein, dexamethasone-induced, 1",RASD1,51655,ENSG00000108551,NA,NA,Rasd1 (MGI:1270848)
17,17505560,17591986,17p11.2,17p11.2,602391,"PEMT, PEMPT",Phosphatidylethanolamine N-methyltransferase,PEMT,10400,ENSG00000133027,NA,NA,Pemt (MGI:104535)
17,17681375,17811452,17p11.2,17p11.2,607642,"RAI1, SMCR, SMS",Retinoic acid-induced gene 1,RAI1,10743,ENSG00000108557,NA,"Smith-Magenis syndrome, 182290 (3), Autosomal dominant, Isolated cases",Rai1 (MGI:103291)
17,17811333,17837016,17p11.2,17p11.2,184756,SREBF1,Sterol regulatory element binding transcription factor 1,SREBF1,6720,ENSG00000072310,NA,NA,Srebf1 (MGI:107606)
17,17813835,17813930,17p11.2,17p11.2,613486,"MIR33B, MIRN33B",Micro RNA 33B,MIR33B,693120,ENSG00000207839,NA,NA,NA
17,17843507,17972405,17p11.2,17p11.2,615519,TOM1L2,TOM1-like 2,TOM1L2,146691,ENSG00000175662,NA,NA,Tom1l2 (MGI:2443306)
17,18015058,18039167,17p11.2,17p11.2,608918,"ATPAF2, ATP12, MC5DN1","ATP synthase, mitochondrial F1 complex, assembly factor 2",ATPAF2,91647,ENSG00000171953,mutation identified in 1 MC5DN1 patient,"?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3), Autosomal recessive",Atpaf2 (MGI:2180561)
17,18039407,18068404,17p11.2,17p11.2,617699,"GID4, VID2, C17orf39","GID complex, subunit 4",GID4,79018,ENSG00000141034,NA,NA,Gid4 (MGI:1914021)
17,18087884,18107969,17p11.2,17p11.2,602986,DRG2,Developmentally regulated GTP-binding protein 2,DRG2,1819,ENSG00000108591,NA,NA,Drg2 (MGI:1342307)
17,18108755,18180243,17p11.2,17p11.2,602666,"MYO15A, DFNB3",Myosin XVA,MYO15A,51168,ENSG00000091536,NA,"Deafness, autosomal recessive 3, 600316 (3), Autosomal recessive",Myo15 (MGI:1261811)
17,18183827,18209953,17p11.2,17p11.2,613303,"ALKBH5, ABH5","AlkB, E. coli, homolog of, 5",ALKBH5,54890,ENSG00000091542,NA,NA,Alkbh5 (MGI:2144489)
17,18225592,18244874,17p12-p11.2,17p11.2,600966,"LLGL1, DLG4",LLGL scribble cell polarity complex component 1,LLGL1,3996,ENSG00000131899,NA,NA,Llgl1 (MGI:102682)
17,18244814,18259021,17p11.2,17p11.2,600362,FLII,"Flightless-I, Drosophila, homolog of",FLII,2314,ENSG00000177731,NA,NA,Flii (MGI:1342286)
17,18260661,18266551,17p11.2,17p11.2,615498,"MEIF2, SMCR7, MID49",Mitochondrial elongation factor 2,MIEF2,125170,ENSG00000177427,NA,NA,Mief2 (MGI:2144199)
17,18269957,18314995,17p12-p11.2,17p11.2,601243,"TOP3A, MGRISCE2, PEOB5","Topoisomerase (DNA) III, alpha",TOP3A,7156,ENSG00000177302,mutation identified in 1 PEOB5 patient,"Microcephaly, growth restriction, and increased sister chromatid exchange 2, 618097 (3), Autosomal recessive; ?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5, 618098 (3), Autosomal recessive",Top3a (MGI:1197527)
17,18315292,18328055,17p11.2,17p11.2,617074,SMCR8,"Smith-Magenis syndrome chromosome region, candidate gene 8",SMCR8,140775,ENSG00000176994,NA,NA,Smcr8 (MGI:2444720)
17,18327859,18363562,17p11.2,17p11.2,182144,SHMT1,Serine hydroxymethyltransferase (soluble),SHMT1,6470,ENSG00000176974,?role in Smith-Magenis syndrome,NA,Shmt1 (MGI:98299)
17,18497089,18503284,17p13.1-q25,17p11.2,600719,NOS2B,Nitric oxide synthase 2B,NOS2P2,201288,NA,NA,NA,NA
17,18744012,18779348,17p12,17p11.2,611679,FBXW10,F-box and WD40 domain protein 10,FBXW10,10517,ENSG00000171931,NA,NA,Fbxw10 (MGI:3052463)
17,18856298,18931286,17p12-p11.2,17p11.2,603762,"PRPSAP2, PAP41",Phosphoribosylpyrophosphate synthetase-associated protein 2,PRPSAP2,5636,ENSG00000141127,NA,NA,Prpsap2 (MGI:2384838)
17,19020655,19047051,17p11.2,17p11.2,604330,"GRAP, DFNB114",GRB2-related adaptor protein,GRAP,10750,ENSG00000154016,NA,"Deafness, autosomal recessive 114, 618456 (3), Autosomal recessive",Grap (MGI:1918770)
17,19188015,19188231,17p11.2,17p11.2,180710,RNU3,"RNA, U3 small nuclear",SNORD3A,780851,ENSG00000263934,deleted in Smith-Magenis syndrome,NA,NA
17,19334694,19377912,17p11.2,17p11.2,614144,"B9D1, MKSR1, MKS9, JBTS27",B9 domain-containing protein 1,B9D1,27077,ENSG00000108641,mutation identified in 1 MKS9 patient,"Joubert syndrome 27, 617120 (3), Autosomal recessive; ?Meckel syndrome 9, 614209 (3), Autosomal recessive",B9d1 (MGI:1351471)
17,19237376,19336714,Chr.17,17p11.2,607263,"EPN2, KIAA1065",Epsin 2,EPN2,22905,ENSG00000072134,NA,NA,Epn2 (MGI:1333766)
17,19377720,19383543,17p11.2,17p11.2,602521,"MAPK7, PRKM7, ERK5",Mitogen-activated protein kinase 7 (extracellular signal-regulated kinase 5),MAPK7,5598,ENSG00000166484,NA,NA,Mapk7 (MGI:1346347)
17,19383444,19387189,17p11.2,17p11.2,600596,MFAP4,Microfibrillar-associated protein-4,MFAP4,4239,ENSG00000166482,NA,NA,Mfap4 (MGI:1342276)
17,19406978,19417275,17p11.2,17p11.2,601237,"RNF112, ZNF179, BFP",RING finger protein 112,RNF112,7732,ENSG00000128482,NA,NA,Rnf112 (MGI:106611)
17,19533853,19579033,17p11.2,17p11.2,609832,"SLC47A1, MATE1, FLJ10847","Solute carrier family 47, member 1",SLC47A1,55244,ENSG00000142494,NA,NA,Slc47a1 (MGI:1914723)
17,19648149,19677595,17p11.2,17p11.2,609523,"ALDH3A2, ALDH10, SLS, FALDH","Aldehyde dehydrogenase 3 family, member A2 (fatty aldehyde dehydrogenase)",ALDH3A2,224,ENSG00000072210,NA,"Sjogren-Larsson syndrome, 270200 (3), Autosomal recessive",Aldh3a2 (MGI:1353452)
17,19678291,19719597,17p11.2,17p11.2,609833,"SLC47A2, MATE2, FLJ31196, MATE2K","Solute carrier family 47, member 2",SLC47A2,146802,ENSG00000180638,NA,NA,NA
17,19737983,19748389,17p11.2,17p11.2,100660,"ALDH3A1, ALDH3","Aldehyde dehydrogenase 3 family, member A1",ALDH3A1,218,ENSG00000108602,NA,NA,Aldh3a1 (MGI:1353451)
17,19770827,19867935,17p11.2,17p11.2,608650,"ULK2, KIAA0623, UNC51.2",UNC51-like kinase 2,ULK2,9706,ENSG00000083290,NA,NA,Ulk2 (MGI:1352758)
17,19904301,19977855,17p11.1,17p11.2,604694,AKAP10,A-kinase anchor protein 10,AKAP10,11216,ENSG00000108599,NA,"{Cardiac conduction defect, susceptibility to}, 115080 (3), Autosomal dominant",Akap10 (MGI:1890218)
17,20009300,20319025,17p11.2,17p11.2,608793,"SPECC1, HCMOGT1, NSP",Sperm antigen with calponin homology and coiled-coil domains 1,SPECC1,92521,ENSG00000128487,NA,NA,Specc1 (MGI:2442356)
17,20999595,21043408,17p11.2,17p11.2,612116,"USP22, KIAA1064",Ubiquitin-specific protease 22,USP22,23326,ENSG00000124422,NA,NA,Usp22 (MGI:2144157)
17,21123367,21192029,17p11.2,17p11.2,616160,"DHRS7B, SDR32C1","Short-chain dehydrogenase reductase family, member 7B",DHRS7B,25979,ENSG00000109016,NA,NA,Dhrs7b (MGI:2384931)
17,21284678,21315239,17q11.2,17p11.2,602315,"PRKMK3, MAPKK3, MEK3","Protein kinase, mitogen-activated, kinase-3",MAP2K3,5606,ENSG00000034152,NA,NA,Map2k3 (MGI:1346868)
17,21376356,21419869,17p11.2-p11.1,17p11.2,602323,"KCNJ12, KCNJN1","Potassium inwardly-rectifying channel, subfamily J, member 12",KCNJ12,3768,ENSG00000184185,NA,NA,Kcnj12 (MGI:108495)
17,21692522,21705699,17p11.2,17p11.2,613236,"KCNJ18, KIR2.6, TTPP2","Potassium channel, inwardly rectifying, subfamily J, member 18",KCNJ18,100134444,ENSG00000260458,NA,"{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3), Autosomal dominant",NA
17,22406018,22413740,17p11.2,17p11.2,605160,"PRG4, FLJ36000",p53-responsive gene 4,NA,284124,ENSG00000276399,NA,NA,NA
17,22523110,22524664,17p11.2,17p11.2,616985,"MTRNR2L1, HN1",MTRNR2-like 1,MTRNR2L1,100462977,ENSG00000256618,NA,NA,NA
17,25100000,33500000,17q11,NA,609378,AUTS6,"Autism, susceptibility to, 6",NA,554314,NA,max lod at D17S1800,"{Autism susceptibility 6}, 609378 (2)",NA
17,25100000,33500000,17q11,NA,606601,"ERVE1, HERVE1","Endogenous retroviral sequence E, 1",ERVE-1,85314,NA,NA,NA,NA
17,25100000,83257441,17q,NA,603918,HYT1,"Hypertension, essential, susceptibility to, 1",NA,117191,NA,~18cM distal to ACE,"{Hypertension, essential, susceptibility to, 1}, 145500 (2), Multifactorial",NA
17,27294079,27315925,17q11.1,17q11.1,610091,"WSB1, SWIP1",WD repeat- and SOCS box-containing protein 1,WSB1,26118,ENSG00000109046,NA,NA,Wsb1 (MGI:1926139)
17,27400000,33500000,17q11.2,NA,601395,"CCL3L1, SCYA3L1, LD78","Chemokine, C-C motif, ligand 3-like 1",CCL3L1,6349,NA,varies in copy number 1-10,"{HIV/AIDS, susceptibility to}, 609423 (3)",NA
17,27400000,33500000,17q11.2,NA,613675,"DEL17q11.2, C17DELq11.2","Chromosome 17q11.2 deletion syndrome, 1.4Mb (NF1 microdeletion syndrome)",NA,NA,NA,NA,"Chromosome 17q11.2 deletion syndrome, 1.4Mb, 613675 (4), Autosomal dominant",NA
17,27400000,72900000,17q11.2-q24,NA,154275,MHS2,Malignant hyperthermia susceptibility 2,MHS2,4264,NA,?due to mutation in SCN4A,"{Malignant hyperthermia susceptibility 2}, 154275 (2), Autosomal dominant",NA
17,27400000,33500000,17q11.2,NA,612575,MPVQTL3,Mean platelet volume quantitative trait locus 3,NA,100271869,NA,associated with rs2138852,"[Mean platelet volume QTL3], 612575 (2)",NA
17,27456440,27626437,17q11.2,17q11.2,601132,"KSR, KSR1",Kinase suppressor of RAS,KSR1,8844,ENSG00000141068,NA,NA,Ksr1 (MGI:105051)
17,27631147,27649559,17q11.2,17q11.2,601879,LGALS9,"Lectin, galactoside-binding, soluble, 9",LGALS9,3965,ENSG00000168961,NA,NA,NA
17,27651442,27664654,17p13.1-q25,17q11.2,600720,NOS2C,Nitric oxide synthase 2C,NOS2P1,645740,NA,NA,NA,NA
17,27756765,27800528,17cen-q11.2,17q11.2,163730,"NOS2A, NOS2","Nitric oxide synthase 2A, inducible, hepatocytes",NOS2,4843,ENSG00000007171,?cluster of 3 NOS2 genes,"{Hypertension, susceptibility to}, 145500 (2), Multifactorial; {Malaria, resistance to}, 611162 (3)",Nos2 (MGI:97361)
17,28226562,28228059,17q11,17q11.2,606637,PYY2,"Peptide YY, 2",PYY2,23615,ENSG00000237575,NA,NA,NA
17,28247443,28248288,17q11,17q11.2,606638,PPY2,Pancreatic polypeptide 2,PPY2P,23614,ENSG00000265060,NA,NA,NA
17,28319040,28328684,17q11.2,17q11.2,612912,"TMEM97, MAC30",Transmembrane protein 97,TMEM97,27346,ENSG00000109084,NA,NA,Tmem97 (MGI:1916321)
17,28328324,28335488,17p11.1,17q11.2,614394,IFT20,"Intraflagellar transport 20, chlamydomonas, homolog of",IFT20,90410,ENSG00000109083,NA,NA,Ift20 (MGI:1915585)
17,28335670,28347008,17q22-q23,17q11.2,191161,TNFAIP1,"Tumor necrosis factor, alpha-induced protein-1 (endothelial)",TNFAIP1,7126,ENSG00000109079,NA,NA,Tnfaip1 (MGI:104961)
17,28346627,28357588,17q11.2,17q11.2,611519,"POLDIP2, PDIP38",Polymerase delta-interacting protein 2,POLDIP2,26073,ENSG00000004142,NA,NA,Poldip2 (MGI:1915061)
17,28357646,28363682,17q11.2,17q11.2,616815,"TMEM199, VMA12, VPH2, C17orf32, CDG2P",Transmembrane protein 199,TMEM199,147007,ENSG00000244045,NA,"Congenital disorder of glycosylation, type IIp, 616829 (3), Autosomal recessive",Tmem199 (MGI:2144113)
17,28364267,28365150,17q11.2,17q11.2,610975,"SEBOX, OG9","Skin-, embryo-, brain-, and oocyte-specific homeobox",SEBOX,645832,ENSG00000274529,NA,NA,Sebox (MGI:108012)
17,28367283,28370306,17q11,17q11.2,193190,"VTN, VNT","Vitronectin (serum spreading factor, somatomedin B, complement S-protein)",VTN,7448,ENSG00000109072,NA,NA,Vtn (MGI:98940)
17,28371693,28404048,17q11,17q11.2,607732,"SARM, KIAA0524",Sterile alpha and heat/armadillo motifs-containing protein,SARM1,23098,ENSG00000004139,NA,NA,Sarm1 (MGI:2136419)
17,28394641,28406629,17q11.1,17q11.2,611672,"SLC46A1, HCP1, PCFT","Solute carrier family 46 (folate transporter), member 1",SLC46A1,113235,ENSG00000076351,NA,"Folate malabsorption, hereditary, 229050 (3), Autosomal recessive",Slc46a1 (MGI:1098733)
17,28473356,28497780,17p11.1-q11.1,17q11.2,604148,"SLC13A2, NADC1","Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2",SLC13A2,9058,ENSG00000007216,NA,NA,Slc13a2 (MGI:1276558)
17,28506210,28538899,17q11-q12,17q11.2,600838,"FOXN1, WHN",Forkhead box N1 (winged helix nude),FOXN1,8456,ENSG00000109101,NA,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3), Autosomal recessive",Foxn1 (MGI:102949)
17,28546706,28552632,17q11.2,17q11.2,604011,"UNC119, HRG4, IMD13","Unc119, C. elegans, homolog of (human retinal gene 4)",UNC119,9094,ENSG00000109103,mutation identified in 1 IMD13 family and CORD family,"?Cone-rod dystrophy (3); ?Immunodeficiency 13, 615518 (3), Autosomal dominant",Unc119 (MGI:1328357)
17,28553386,28571523,17q11.2,17q11.2,610271,"PIGS, GPIBD18","Phosphatidylinositol glycan, class S",PIGS,94005,ENSG00000087111,NA,"Glycosylphosphatidylinositol biosynthesis defect 18, 618143 (3), Autosomal recessive",Pigs (MGI:2687325)
17,28573114,28576962,17cen-q12,17q11.2,103870,ALDOC,"Aldolase C, fructose-bisphosphatase",ALDOC,230,ENSG00000109107,NA,NA,Aldoc (MGI:101863)
17,28577573,28599024,17q11.2,17q11.2,615562,"SPAG5, MAP126, ASTRIN",Sperm-associated antigen 5,SPAG5,10615,ENSG00000076382,NA,NA,Spag5 (MGI:1927470)
17,28648345,28662188,17q11.2,17q11.2,602934,SDF2,Stromal cell-derived factor-2,SDF2,6388,ENSG00000132581,NA,NA,Sdf2 (MGI:108019)
17,28662182,28702678,17q11.2,17q11.2,601333,SUPT6H,"Suppressor of Ty, S.cerevisiae, 6 homolog of",SUPT6H,6830,ENSG00000109111,NA,NA,Supt6 (MGI:107726)
17,28703196,28712064,17q11.2,17q11.2,617376,PROCA1,Proline-rich cyclin A1-interacting protein,PROCA1,147011,ENSG00000167525,NA,NA,Proca1 (MGI:1918274)
17,28714280,28718439,17q11.1,17q11.2,610917,"RAB34, RAH",Ras-associated protein 34,RAB34,83871,ENSG00000109113,NA,NA,Rab34 (MGI:104606)
17,28719984,28724358,17q11,17q11.2,602326,RPL23A,Ribosomal protein L23a,RPL23A,6147,ENSG00000198242,NA,NA,NA
17,28728787,28743454,17q11.1,17q11.2,609799,"NEK8, JCK, NPHP9, RHPD2",Never in mitosis gene A-related kinase 8,NEK8,284086,ENSG00000160602,mutations identified in 1 family with NPHP9,"?Nephronophthisis 9, 613824 (3); Renal-hepatic-pancreatic dysplasia 2, 615415 (3), Autosomal recessive",Nek8 (MGI:1890646)
17,28744003,28750955,17q11.2,17q11.2,602464,"TRAF4, MLN62, CART1",TNF receptor-associated factor 4,TRAF4,9618,ENSG00000076604,NA,NA,Traf4 (MGI:1202880)
17,28854956,28861066,17q11.2,17q11.2,607435,"ERAL1, ERAL1A, ERAL1B, PRLTS6",ERA G-protein-like 1,ERAL1,26284,ENSG00000132591,NA,"Perrault syndrome 6, 617565 (3), Autosomal recessive",Eral1 (MGI:1889295)
17,28861368,28861439,17q11.2,17q11.2,612071,"MIR451, MIRN451",Micro RNA 451,MIR451A,574411,ENSG00000284565,NA,NA,NA
17,28861532,28861617,17q11.2,17q11.2,612070,"MIR144, MIRN144",Micro RNA 144,MIR144,406936,ENSG00000283819,NA,NA,NA
17,28879338,28897732,17q11-q12,17q11.2,131560,"FLOT2, M17S1, ECS1, ESA1",Flotillin 2 (epidermal surface antigen 1),FLOT2,2319,ENSG00000132589,~180kb centromeric to NF1,NA,Flot2 (MGI:103309)
17,28897780,28903078,17q11.2,17q11.2,616157,"DHRS13, SDR7C5","Short-chain dehydrogenase reductase family, member 13",DHRS13,147015,ENSG00000167536,NA,NA,Dhrs13 (MGI:1917701)
17,28954904,29006439,17q11.2,17q11.2,616666,"SEZ6, BSRPC","Seizure-related 6, mouse, homolog of",SEZ6,124925,ENSG00000063015,NA,NA,Sez6 (MGI:104745)
17,29043140,29057226,17q11.2,17q11.2,616713,PIPOX,Pipecolic acid oxidase,PIPOX,51268,ENSG00000179761,NA,NA,Pipox (MGI:1197006)
17,29071121,29180397,17q11.2,17q11.2,610067,"MYO18A, SPR210",Myosin XVIIIA,MYO18A,399687,ENSG00000196535,NA,NA,Myo18a (MGI:2667185)
17,29073520,29075608,17q11.2,17q11.2,609517,"TIAF1, MYO18A, MYSPDZ, MAJN, SPR210, KIAA0216",TGFB1-induced antiapoptotic factor 1,TIAF1,9220,ENSG00000221995,NA,NA,NA
17,29246856,29254493,17q11.1-q12,17q11.2,123610,"CRYBA1, CRYB1, CTRCT10","Crystallin, beta A1",CRYBA1,1411,ENSG00000108255,centromeric to NF1,"Cataract 10, multiple types, 600881 (3), Autosomal dominant",Cryba1 (MGI:88518)
17,29255838,29294147,17q11.2,17q11.2,609356,"NUFIP2, KIAA1321, PIG1",Nuclear fragile X mental retardation protein-interacting protein 2,NUFIP2,57532,ENSG00000108256,NA,NA,Nufip2 (MGI:1915814)
17,29390924,29551903,17q11.2,17q11.2,610266,"TAOK1, PSK2, TAO1, MARKK",TAO kinase 1,TAOK1,57551,ENSG00000160551,NA,NA,Taok1 (MGI:1914490)
17,29573474,29589647,17p11.2,17q11.2,608434,GIT1,G protein-coupled receptor kinase-interacting protein 1,GIT1,28964,ENSG00000108262,NA,NA,Git1 (MGI:1927140)
17,29589768,29615005,17q11.2,17q11.2,615124,ANKRD13B,Ankyrin repeat domain-containing protein 13B,ANKRD13B,124930,ENSG00000198720,NA,NA,Ankrd13b (MGI:2144501)
17,29625937,29930238,17q11.2,17q11.2,606779,"SSH2, KIAA1725","Slingshot, Drosophila, homolog of, 2",SSH2,85464,ENSG00000141298,NA,NA,Ssh2 (MGI:2679255)
17,30116806,30186474,17q11.2,17q11.2,616173,"NSRP1, NSRP70, CCDC55",Nuclear speckle splicing regulatory protein 1,NSRP1,84081,ENSG00000126653,NA,NA,Nsrp1 (MGI:2144305)
17,30194318,30235696,17q11.1-q12,17q11.2,182138,"SLC6A4, HTT, OCD1","Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4",SLC6A4,6532,ENSG00000108576,NA,"{Anxiety-related personality traits}, 607834 (3); {Obsessive-compulsive disorder}, 164230 (3), Autosomal dominant",Slc6a4 (MGI:96285)
17,30248202,30291943,17q11.2,17q11.2,602403,"BLMH, BMH",Bleomycin hydrolase,BLMH,642,ENSG00000108578,NA,NA,Blmh (MGI:1345186)
17,30378926,30469988,17p11.1-q11.1,17q11.2,603102,CPD,Carboxypeptidase D,CPD,1362,ENSG00000108582,NA,NA,Cpd (MGI:107265)
17,30477401,30527591,17q11,17q11.2,604026,"GOSR1, GOS28, GS28",Golgi snap receptor complex member 1,GOSR1,9527,ENSG00000108587,NA,NA,Gosr1 (MGI:1858260)
17,30782683,30824759,17q11.2,17q11.2,614853,"CRLF3, CYTOR4, CRLM9, CREME9",Cytokine receptor-like factor 3,CRLF3,51379,ENSG00000176390,NA,NA,Crlf3 (MGI:1860086)
17,30830829,30895868,17q11.2,17q11.2,609534,"ATAD5, C17orf41, FRAG1, FLJ12735","ATPase family, AAA domain containing 5",ATAD5,79915,ENSG00000176208,NA,NA,Atad5 (MGI:2442925)
17,30898982,30907628,17q11.2,17q11.2,616422,"TEFM, C17orf42","Transcription elongation factor, mitochondrial",TEFM,79736,ENSG00000172171,NA,NA,Tefm (MGI:1915800)
17,30921735,30959397,17q11.2,17q11.2,608635,"ADAP2, CENTA2",ArfGAP with dual PH domains 2,ADAP2,55803,ENSG00000184060,NA,NA,Adap2 (MGI:2663075)
17,30968641,30999910,17q11,17q11.2,611358,RNF135,Ring finger protein 135,RNF135,84282,ENSG00000181481,NA,NA,Rnf135 (MGI:1919206)
17,31094926,31377676,17q11.2,17q11.2,613113,"NF1, VRNF, WSS, NFNS","Neurofibromin (neurofibromatosis, type I)",NF1,4763,ENSG00000196712,NA,"Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant; Watson syndrome, 193520 (3), Autosomal dominant",Nf1 (MGI:97306)
17,31294646,31297238,17q11.2,17q11.2,164345,"OMG, OMGP",Oligodendrocyte-myelin glycoprotein,OMG,4974,ENSG00000126861,within the NF1 gene,NA,Omg (MGI:106586)
17,31303769,31314148,17q11.2,17q11.2,158381,"EVI2B, EVDB",Ecotropic viral integration site 2B,EVI2B,2124,ENSG00000185862,within the NF1 gene,NA,"Evi2,Evi2b (MGI:5439444,MGI:1890682)"
17,31316409,31321621,17q11.2,17q11.2,158380,"EVI2A, EVI2, EVDA",Ecotropic viral integration site 2A,EVI2A,2123,ENSG00000126860,within the NF1 gene,NA,Evi2a (MGI:95458)
17,31391674,31538210,17q11.2,17q11.2,611999,"RAB11FIP4, KIAA1821",RAB11 family-interacting protein 4,RAB11FIP4,84440,ENSG00000131242,NA,NA,Rab11fip4 (MGI:2442920)
17,31559995,31560082,17q11.2,17q11.2,614733,MIR193A,Micro RNA 193A,MIR193A,406968,ENSG00000207614,NA,NA,NA
17,31937006,32001039,17q11.2,17q11.2,606245,"JJAZ1, KIAA0160",JJAZ1 gene,SUZ12,23512,ENSG00000178691,NA,NA,Suz12 (MGI:1261758)
17,32007382,32053499,17q11.2,17q11.2,616558,LRRC37B,Leucine-rich repeat-containing protein 37B,LRRC37B,114659,ENSG00000185158,NA,NA,NA
17,32142453,32253373,17q11.2,17q11.2,613888,"RHOT1, MIRO1, ARHT1","Ras homolog gene family, member T1",RHOT1,55288,ENSG00000126858,NA,NA,Rhot1 (MGI:1926078)
17,32350137,32381884,17q11.2,17q11.2,603428,ZNF207,Zinc finger protein-207,ZNF207,7756,ENSG00000010244,mapped by FISH to 6p21.3,NA,Zfp207 (MGI:1340045)
17,32444509,32483318,17q11.2,17q11.2,604449,"PSMD11, S9","Proteasome 26S subunit, non-ATPase, 11",PSMD11,5717,ENSG00000108671,NA,NA,Psmd11 (MGI:1916327)
17,32485027,32491255,17q11.2,17q11.2,603460,"CDK5R1, p35","Cyclin-dependent kinase 5, regulatory subunit 1",CDK5R1,8851,ENSG00000176749,NA,NA,Cdk5r1 (MGI:101764)
17,32492521,32877171,17q11-q12,17q11.2,606539,"MYO1D, KIAA0727",Myosin ID,MYO1D,4642,ENSG00000176658,NA,NA,Myo1d (MGI:107728)
17,32927909,32944314,17q11.2,17q11.2,615949,"TMEM98, NNO4",Transmembrane protein 98,TMEM98,26022,ENSG00000006042,NA,"Nanophthalmos 4, 615972 (3), Autosomal dominant",Tmem98 (MGI:1923457)
17,32991846,32997876,17q12,17q11.2,612749,"SPACA3, LYZL3, SLLP1, LYC3, ALLP17",Sperm acrosome-associated 3,SPACA3,124912,ENSG00000141316,NA,NA,Spaca3 (MGI:1922872)
17,33013086,34156805,17q11.2-q12,17q11-q12,601784,"ACCN1, BNC1, MDEG","Amiloride-sensitive cation channel 1, neuronal (degenerin)",ASIC2,40,ENSG00000108684,NA,NA,Asic2 (MGI:1100867)
17,33500000,39800000,17q12,NA,603782,"CCL4L, SCYA4L, LAG1","Chemokine, C-C motif, ligand 4-like",CCL4L1,388372,NA,NA,NA,NA
17,33500000,39800000,17q12,NA,614527,"DEL17q12, C17DELq12",Chromosome 17q12 deletion syndrome,NA,NA,NA,NA,"Chromosome 17q12 deletion syndrome, 614527 (4), Autosomal dominant",NA
17,33500000,39800000,17q12,NA,614526,"DUP17q12, C17DUPq12",Chromosome 17q12 duplication syndrome,NA,NA,NA,NA,"Chromosome 17q12 duplication syndrome, 614526 (4), Autosomal dominant",NA
17,33500000,39800000,17q12,NA,611955,HPC11,"Prostate cancer, hereditary, 11",NA,NA,NA,associated with rs4430796 and rs7501939,"{Prostate cancer, hereditary, 11}, 611955 (2)",NA
17,33500000,39800000,17q12,NA,614221,PBC5,"Biliary cirrhosis, primary, 5",NA,100689212,NA,associated with rs9303277,"Biliary cirrhosis, primary, 5, 614221 (2)",NA
17,33500000,52100000,17q12-q21,NA,601363,WT4,Wilms tumor-4,NA,8151,NA,NA,"Wilms tumor, type 4, 601363 (2), Autosomal dominant",NA
17,34255284,34257202,17q11.2-q12,17q12,158105,"CCL2, SCYA2, MCP1, MCAF","Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)",CCL2,6347,ENSG00000108691,NA,"{Coronary artery disease, modifier of} (3); {HIV-1, resistance to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3); {Spina bifida, susceptibility to}, 182940 (3), Autosomal dominant",Ccl12 (MGI:108224)
17,34270220,34272241,17q11.2-q12,17q12,158106,"CCL7, SCYA7, MCP3","Chemokine, C-C motif, ligand 5",CCL7,6354,ENSG00000108688,close to ERBB2,NA,NA
17,34285741,34288333,17q21.1-q21.2,17q12,601156,"CCL11, SCYA11","Chemokine, C-C motif, ligand 11",CCL11,6356,ENSG00000172156,NA,"{Asthma, susceptibility to}, 600807 (3), Autosomal dominant; {HIV1, resistance to}, 609423 (3)",Ccl11 (MGI:103576)
17,34319434,34321401,17q11.2,17q12,602283,"CCL8, SCYA8","Chemokine, C-C motif, ligand 8",CCL8,6355,ENSG00000108700,NA,NA,NA
17,34356479,34358609,17q11.2,17q12,601391,"CCL13, SCYA13, NCC1","Chemokine, C-C motif, ligand 13",CCL13,6357,ENSG00000181374,NA,NA,Ccl2 (MGI:98259)
17,34360327,34363232,Chr.17,17q12,182281,"CCL1, SCYA1","Chemokine, C-C motif, ligand 1",CCL1,6346,ENSG00000108702,NA,NA,Ccl1 (MGI:98258)
17,34580748,34639317,17q12,17q12,616178,"TMEM132E, DFNB99",Transmembrane protein 132E,TMEM132E,124842,ENSG00000181291,mutation identified in 1 DFNB99 family,"?Deafness, autosomal recessive 99, 618481 (3)",Tmem132e (MGI:2685490)
17,34927860,34981221,17q12,17q12,610730,"CCT6B, CCTZ2","Chaperonin containing T-complex polypeptide 1, subunit 6B",CCT6B,10693,ENSG00000132141,NA,NA,Cct6b (MGI:1329013)
17,34980497,35009742,17q11.2-q12,17q12,600940,LIG3,"Ligase III, DNA, ATP-dependent",LIG3,3980,ENSG00000005156,NA,NA,Lig3 (MGI:109152)
17,35005989,35089225,17q12,17q12,609735,RFFL,Ring finger and FYVE-like domain containing 1 (rififylin),RFFL,117584,ENSG00000092871,NA,NA,Rffl (MGI:1914588)
17,35092220,35119868,17q11,17q12,602954,"RAD51D, RAD51L3, BROVCA4","RAD51, S. cerevisiae, homolog of, D",RAD51D,5892,ENSG00000185379,NA,"{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)",Rad51d (MGI:1261809)
17,35147792,35189344,17q11,17q12,611220,"UNC45B, SMUNC45, CTRCT43","UNC45, C. elegans, homolog of, B",UNC45B,146862,ENSG00000141161,mutation identified in 1 CTRCT43 family,"?Cataract 43, 616279 (3), Autosomal dominant",Unc45b (MGI:2443377)
17,35243071,35273654,17q12,17q12,614952,SLFN5,"Schlafen family, member 5",SLFN5,162394,ENSG00000166750,NA,NA,Slfn5 (MGI:1329004)
17,35350304,35373913,17q12,17q12,614953,SLFN11,"Schlafen family, member 11",SLFN11,91607,ENSG00000172716,NA,NA,NA
17,35407170,35433309,17q12,17q12,614955,SLFN12,"Schlafen family, member 12",SLFN12,55106,ENSG00000172123,NA,NA,NA
17,35435095,35451102,17q12,17q12,614957,SLFN13,"Schlafen family, member 13",SLFN13,146857,ENSG00000154760,NA,NA,"Slfn8,Slfn9 (MGI:2672859,MGI:2445121)"
17,35474919,35537860,17q12,17q12,614956,SLFN12L,"Schlafen family, member 12-like",SLFN12L,100506736,ENSG00000205045,NA,NA,"Slfn3,Slfn4 (MGI:1329005,MGI:1329010)"
17,35545731,35560840,17q12,17q12,614958,"SLFN14, BDPLT20","Schlafen family, member 14",SLFN14,342618,ENSG00000236320,NA,"Bleeding disorder, platelet-type, 20, 616913 (3), Autosomal dominant",Slfn14 (MGI:2684866)
17,35574794,35578570,17q12,17q12,601758,"PEX12, PBD3A",Peroxisome biogenesis factor 12,PEX12,5193,ENSG00000108733,NA,"Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3), Autosomal recessive; Peroxisome biogenesis disorder 3B, 266510 (3), Autosomal recessive",Pex12 (MGI:2144177)
17,35587264,35726412,17q11.2-q12,17q12,601025,"AP2B1, CLAPB1, ADTB2","Adaptor-related protein complex 2, beta 1 subunit",AP2B1,163,ENSG00000006125,NA,NA,NA
17,35731638,35743520,17q12,17q12,612128,"RASL10B, RRP17","Ras-like, family 10, member B",RASL10B,91608,ENSG00000270885,NA,NA,Rasl10b (MGI:2685575)
17,35744510,35752877,17q12,17q12,611398,"GAS2L2, GAR17, CILD41",Growth arrest-specific 2-like 2,GAS2L2,246176,ENSG00000270765,mutation identified in 1 CILD41 patient,"?Ciliary dyskinesia, primary, 41, 618449 (3), Autosomal recessive",Gas2l2 (MGI:3652048)
17,35756248,35795706,17q11.2,17q12,608417,MMP28,Matrix metalloproteinase 28,MMP28,79148,ENSG00000271447,NA,NA,Mmp28 (MGI:2153062)
17,35809483,35847241,17q11.1-q11.2,17q12,601574,"TAF15, TAF2N, RBP56","TAF15 RNA polymerase II, TATA box-binding protein-associated factor, 68kD",TAF15,8148,ENSG00000270647,fusion gene with CSMF,"Chondrosarcoma, extraskeletal myxoid, 612237 (1)",Taf15 (MGI:1917689)
17,35871490,35880359,17q11.2-q12,17q12,187011,"CCL5, SCYA5, D17S136E, TCP228","Chemokine, C-C motif, ligand 5",CCL5,6352,ENSG00000271503,NA,"{HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid progression of} (3)",Ccl5 (MGI:98262)
17,35918079,35931820,17q11.2,17q12,612896,RDM1,RAD52 motif-containing protein 1,RDM1,201299,ENSG00000278023,NA,NA,Rdm1 (MGI:1913849)
17,35934517,35943712,17q11.2,17q12,612751,LYZL6,Lysozyme-like 6,LYZL6,57151,ENSG00000275722,NA,NA,Lyzl6 (MGI:1916694)
17,35976492,35983619,17q11.2,17q12,601394,"CCL16, SCYA16, NCC4","Chemokine, C-C motif, ligand 16",CCL16,6360,ENSG00000275152,NA,NA,NA
17,35983287,35986728,17q11.2,17q12,601392,"CCL14, SCYA14, NCC2","Chemokine, C-C motif, ligand 14",CCL14,6358,ENSG00000276409,NA,NA,NA
17,35997581,36001552,17q11.2,17q12,601393,"CCL15, SCYA15, NCC3, LKN1","Chemokine, C-C motif, ligand 15",CCL15,6359,ENSG00000275718,NA,NA,NA
17,36013055,36018178,17q12,17q12,602494,"CCL23, SCYA23","Chemokine, C-C motif, ligand 23",CCL23,6368,ENSG00000274736,NA,NA,NA
17,36064271,36072031,17q11.2,17q12,603757,"CCL18, SCYA18, PARC, AMAC1, DCCK1","Chemokine, C-C motif, ligand 18",CCL18,6362,ENSG00000275385,"in 47kb, CCL18-CCL3-CCL4",NA,NA
17,36088255,36090142,17q12,17q12,182283,"CCL3, SCYA3, MIP1A","Chemokine, C-C motif, ligand 3",CCL3,6348,ENSG00000277632,"in 47kb, CCL18-CCL3-CCL4","{HIV infection, resistance to}, 609423 (2)",NA
17,36103826,36105613,17q12,17q12,182284,"CCL4, SCYA4, ACT2, MIP1B, AT744.1","Chemokine, C-C motif, ligand 4",CCL4,6351,ENSG00000275302,NA,NA,Ccl4 (MGI:98261)
17,36165680,36176623,17q12,17q12,610144,"TBC1D3B, PRC17","TBC1 domain family, member 3B",TBC1D3B,414059,ENSG00000274808,NA,NA,NA
17,36211062,36212877,17q12,17q12,610757,CCL4L2,"Chemokine, CC motif, ligand 4-like 2",CCL4L2,9560,ENSG00000276070,NA,NA,NA
17,36322241,36334758,17q12,17q12,610810,TBC1D3G,"TBC1 domain family, member 3G",TBC1D3G,101060321,ENSG00000260287,NA,NA,NA
17,36377474,36388451,17q12,17q12,610811,TBC1D3H,"TBC1 domain family, member 3H",TBC1D3H,729877,ENSG00000274226,NA,NA,NA
17,36428611,36439520,17q12,17q12,610809,TBC1D3F,"TBC1 domain family, member 3F",TBC1D3F,84218,ENSG00000275954,NA,NA,NA
17,36486626,36499311,17q12,17q12,604500,"ZNHIT3, TRIP3, PEHO",Zinc finger HIT domain-containing protein 3,ZNHIT3,9326,ENSG00000273611,NA,"PEHO syndrome, 260565 (3), Autosomal recessive",Znhit3 (MGI:3051596)
17,36495635,36535456,17q12,17q12,617379,"MYO19, MYOHD1",Myosin XIX,MYO19,80179,ENSG00000278259,NA,NA,Myo19 (MGI:1913446)
17,36534761,36539302,17q12,17q12,610275,"PIGW, HPMRS5","Phosphatidylinositol glycan, class W",PIGW,284098,ENSG00000277161,NA,"Glycosylphosphatidylinositol biosynthesis defect 11, 616025 (3), Autosomal recessive",Pigw (MGI:1917575)
17,36544912,36589847,17q12-q21.1,17q12,612275,"GGNBP2, DIF3, LCRG1, LZK1",Gametogenetin-binding protein 2,GGNBP2,79893,ENSG00000278311,NA,NA,Ggnbp2 (MGI:2387356)
17,36591845,36600803,17q12,17q12,616159,"DHRS11, SDR24C1","Short-chain dehydrogenase reductase family, member 11",DHRS11,79154,ENSG00000278535,NA,NA,Dhrs11 (MGI:2652816)
17,36601582,36634697,17q12,17q12,618099,MRM1,Mitochondrial ribosomal RNA methyltransferase 1,MRM1,79922,ENSG00000278619,NA,NA,Mrm1 (MGI:2443470)
17,36937474,36944611,17q12,17q12,601999,"LHX1, LIM1",LIM/homeodomain protein LHX1,LHX1,3975,ENSG00000273706,previously mapped to 11p13-p12 by FISH,NA,Lhx1 (MGI:99783)
17,36948953,37056870,17q11.2-q12,17q12,608463,"AATF, CHE1",Apoptosis-antagonizing transcription factor,AATF,26574,ENSG00000275700,NA,NA,Aatf (MGI:1929608)
17,37084991,37406835,17q21,17q12,200350,"ACACA, ACAC, ACC1, ACACAD","Acetyl-Coenzyme A carboxylase, alpha",ACACA,31,ENSG00000278540,proximal to q21.33; others put at 17q12,"Acetyl-CoA carboxylase deficiency, 613933 (1), Autosomal recessive",Acaca (MGI:108451)
17,37406876,37479724,17q12-q21,17q12,602276,"TADA2L, TADA2A, ADA2A",Transcriptional adaptor 2A,TADA2A,6871,ENSG00000276234,NA,NA,Tada2a (MGI:2144471)
17,37488560,37513500,Chr.17,17q12,606618,"DUSP14, MKP6",Dual-specificity phosphatase 14,DUSP14,11072,ENSG00000276023,NA,NA,Dusp14 (MGI:1927168)
17,37514806,37609495,Chr.17,17q12,607291,"AP1GBP1, SYNG",Adaptor-related protein complex 1 gamma subunit-binding protein 1,SYNRG,11276,ENSG00000275066,NA,NA,Synrg (MGI:1354742)
17,37609738,37643447,17q21.1,17q12,612500,"DDX52, ROK1, HUSSY19",DEAD box polypeptide 52,DDX52,11056,ENSG00000278053,NA,NA,Ddx52 (MGI:1925644)
17,37686430,37745058,17q12,17q12,189907,"HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11",HNF1 homeobox B (transcription factor 2),HNF1B,6928,ENSG00000275410,NA,"Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant; {Renal cell carcinoma}, 144700 (3); Renal cysts and diabetes syndrome, 137920 (3), Autosomal dominant",Hnf1b (MGI:98505)
17,38004032,38014907,17q12,17q12,610807,TBC1D3D,"TBC1 domain family, member 3D",TBC1D3D,101060389,ENSG00000274419,NA,NA,NA
17,38057692,38068633,17q12,17q12,610806,TBC1D3C,"TBC1 domain family, member 3C",TBC1D3C,414060,ENSG00000278299,NA,NA,NA
17,38118407,38138867,17q12,17q12,610808,TBC1D3E,"TBC1 domain family, member 3E",TBC1D3E,102723859,ENSG00000278599,NA,NA,NA
17,38181475,38192554,17q12,17q12,607741,"TBC1D3, PRC17, TBC1D3A",TBC1D3 gene,TBC1D3,729873,ENSG00000274611,NA,NA,NA
17,38297022,38323217,17q21.31,17q12,611850,MRPL45,Mitochondrial ribosomal protein L45,MRPL45,84311,ENSG00000278845,pseudogenes on 2 and 17,NA,Mrpl45 (MGI:1914286)
17,38325609,38343809,17q12,17q12,614515,"GPR179, GPR158L, GPR158L1, CSNB1E",G protein-coupled receptor 179,GPR179,440435,ENSG00000277399,NA,"Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3), Autosomal recessive",Gpr179 (MGI:2443409)
17,38419285,38512388,17q12,17q12,610590,"ARHGAP23, KIAA1501",RHO GTPase-activating protein 23,ARHGAP23,57636,ENSG00000275832,NA,NA,Arhgap23 (MGI:3697726)
17,38530014,38607165,17q12,17q12,610786,"SRCIN1, SNIP, KIAA1684",Src kinase signaling inhibitor 1,SRCIN1,80725,ENSG00000277363,NA,NA,Srcin1 (MGI:1933179)
17,38671702,38674956,17q12,17q12,617795,"EPOP, C17orf96",Elongin BC- and polycomb repressive complex 2-associated protein,EPOP,100170841,ENSG00000273604,NA,NA,Epop (MGI:2143991)
17,38705272,38729794,17q21,17q12,600328,"MLLT6, AF17","Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 6",MLLT6,4302,ENSG00000275023,NA,NA,Mllt6 (MGI:1935145)
17,38730340,38735604,17q12,17q12,611933,"CISD3, MINER2",CDGSH iron sulfur domain protein 3,CISD3,284106,ENSG00000277972,NA,NA,"Cisd3b,Cisd3 (MGI:5012452,MGI:101788)"
17,38733897,38749816,17q12,17q12,600346,"RNF110, ZNF144, MEL18, TPFS",Ring finger protein 110 (zinc finger protein-144),PCGF2,7703,ENSG00000277258,NA,"Turnpenny-Fry syndrome, 618371 (3), Autosomal dominant",Pcgf2 (MGI:99161)
17,38752712,38764230,17q12,17q12,602176,PSMB3,"Proteasome subunit, beta type, 3",PSMB3,5691,ENSG00000277791,previously assigned to 2q35,NA,Psmb3 (MGI:1347014)
17,38765690,38799904,17q12,17q12,603261,"PIP4K2B, PIP5P4KB, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase, type II, beta",PIP4K2B,8396,ENSG00000276293,NA,NA,Pip4k2b (MGI:1934234)
17,38847859,38853720,17q,17q12,603662,RPL23,Ribosomal protein L23,RPL23,9349,ENSG00000125691,NA,NA,Rpl23 (MGI:1929455)
17,38869858,38921769,17q21,17q12,602920,"LASP1, MLN50",LIM and SH3 protein 1,LASP1,3927,ENSG00000002834,fused to MLL in AML,NA,Lasp1 (MGI:109656)
17,38925167,38929383,17q12,17q12,617544,LINC00672,Long intergenic noncoding RNA 672,LINC00672,100505576,ENSG00000263874,NA,NA,NA
17,38936277,38967475,17q12,17q12,609498,FBXO47,F-box only protein 47,FBXO47,494188,ENSG00000204952,NA,NA,Fbxo47 (MGI:1920223)
17,39063312,39151636,17q21.1,17q12,606826,"PLXDC1, TEM7",Plexin domain containing 1,PLXDC1,57125,ENSG00000161381,NA,NA,Plxdc1 (MGI:1919574)
17,39173452,39197668,17q21-q22,17q12,114207,"CACNB1, CACNLB1, CCHLB1","Calcium channel, voltage-dependent, beta 1 subunit",CACNB1,782,ENSG00000067191,NA,NA,Cacnb1 (MGI:102522)
17,39200282,39204731,17q11,17q12,180466,RPL19,Ribosomal protein L19,RPL19,6143,ENSG00000108298,NA,NA,Rpl19 (MGI:98020)
17,39252662,39402555,17q21.2,17q12,609086,"FBXL20, FBL20, FBL2, SCR",F-box and leucine-rich repeat protein 20,FBXL20,84961,ENSG00000108306,NA,NA,Fbxl20 (MGI:1919444)
17,39404284,39451280,17q12,17q12,604311,"MED1, PPARBP, PBP, TRAP220",Mediator complex subunit 1 (peroxisome proliferator-activated receptor-binding protein),MED1,5469,ENSG00000125686,NA,NA,Med1 (MGI:1100846)
17,39461485,39567559,17q21,17q12,615514,"CDK12, CRKRS, CRK7, KIAA0904",Cyclin-dependent kinase 12,CDK12,51755,ENSG00000167258,NA,NA,Cdk12 (MGI:1098802)
17,39603767,39607919,17q12,17q12,601725,"NEUROD2, EIEE72",Neurogenic differentiation 2,NEUROD2,4761,ENSG00000171532,NA,"Epileptic encephalopathy, early infantile, 72, 618374 (3), Autosomal dominant",Neurod2 (MGI:107755)
17,39637079,39664200,17q11-q21,17q12,607048,"STARD3, MLN64",Start domain-containing protein 3,STARD3,10948,ENSG00000131748,NA,NA,Stard3 (MGI:1929618)
17,39665345,39666553,17q12,17q12,604488,"TCAP, LGMDR7, CMH25",Telethonin,TCAP,8557,ENSG00000173991,NA,"Cardiomyopathy, hypertrophic, 25, 607487 (3), Autosomal dominant; Muscular dystrophy, limb-girdle, autosomal recessive 7, 601954 (3), Autosomal recessive",Tcap (MGI:1330233)
17,39668018,39670474,17q12,17q12,171190,"PNMT, PENT",Phenylethanolamine N-methyltransferase,PNMT,5409,ENSG00000141744,NA,NA,Pnmt (MGI:97724)
17,39671121,39688069,17q12,17q12,611801,"PGAP3, PERLD1, CAB2, MGC9753, HPMRS4",Post-GPI attachment to proteins 3,PGAP3,93210,ENSG00000161395,NA,"Hyperphosphatasia with mental retardation syndrome 4, 615716 (3), Autosomal recessive",Pgap3 (MGI:2444461)
17,39688083,39728661,17q21.1,17q12,164870,"ERBB2, NGL, NEU, HER2",Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog),ERBB2,2064,ENSG00000141736,NA,"Adenocarcinoma of lung, somatic, 211980 (3); Gastric cancer, somatic, 613659 (3); Glioblastoma, somatic, 137800 (3); Ovarian cancer, somatic (3)",Erbb2 (MGI:95410)
17,39728499,39730562,17q12,17q12,611802,"MIEN1, C17orf37, RDX12",Migration and invasion enhancer 1,MIEN1,84299,ENSG00000141741,NA,NA,Mien1 (MGI:1913678)
17,39737937,39747284,17q21-q22,17q12,601522,GRB7,Growth factor receptor-bound protein 7,GRB7,2886,ENSG00000141738,NA,NA,Grb7 (MGI:102683)
17,39757714,39864311,17q21,17q12-q21,606221,"IKZF3, ZNFN1A3, AIOLOS",Ikaros family zinc finger 3,IKZF3,22806,ENSG00000161405,NA,NA,Ikzf3 (MGI:1342542)
17,39800000,52100000,17q21,NA,611403,ASRT6,"Asthma-related traits, susceptibility to, 6",NA,100188840,NA,strongly associated with rs7216389,"{Asthma-related traits, susceptibility to, 6}, 611403 (2)",NA
17,39800000,52100000,17q21,NA,610676,AUTS7,"Autism, susceptibility to, 7",NA,100188816,NA,max lod at D17S2180,"{Autism susceptibility 7}, 610676 (2)",NA
17,39800000,59500000,17q21-q22,NA,610997,HPC9,"Prostate cancer, hereditary, 9",NA,NA,NA,max LOD at D17S1820,"{Prostate cancer, hereditary, 9}, 610997 (2)",NA
17,39800000,59500000,17q21-q22,NA,608474,MYP5,Myopia 5,MYP5,404682,NA,between D17S787 and D17S1811,"Myopia 5, 608474 (2), Autosomal dominant",NA
17,39800000,59500000,17q21-q22,NA,168860,"PTLAH, FPAH",Patella aplasia or hypoplasia,PTLAH,8830,NA,NA,"Patella aplasia or hypoplasia, 168860 (2), Autosomal dominant",NA
17,39868163,39877895,17q12-q21,17q21.1,608499,"ZPBP2, ZPBPL",Zona pellucida-binding protein 2,ZPBP2,124626,ENSG00000186075,NA,NA,Zpbp2 (MGI:1916626)
17,39904594,39918649,17q21,17q21.1,611221,"GSDMB, GSDML",Gasdermin B,GSDMB,55876,ENSG00000073605,NA,NA,NA
17,39921040,39927600,17q21.1,17q21.1,610075,ORMDL3,ORM1-like protein 3,ORMDL3,94103,ENSG00000172057,NA,NA,Ormdl3 (MGI:1913862)
17,39962972,39977767,17q12,17q21.1,611218,"GSDMA, GSDM1, GSDM",Gasdermin A,GSDMA,284110,ENSG00000167914,NA,NA,Gsdma (MGI:1889509)
17,39980806,39997958,17q21.1,17q21.1,617676,"PSMD3, RPN3","Proteasome 26S subunit, non-ATPase, 3",PSMD3,5709,ENSG00000108344,NA,NA,Psmd3 (MGI:98858)
17,40015360,40017812,17q11.2-q12,17q21.1,138970,"CSF3, GCSF",Colony-stimulating factor-3 (granulocyte),CSF3,1440,ENSG00000108342,NA,NA,Csf3 (MGI:1339751)
17,40019096,40054635,17q21.1,17q21.1,607000,"MED24, TRAP100, KIAA0130",Mediator complex subunit 24,MED24,9862,ENSG00000008838,NA,NA,Med24 (MGI:1344385)
17,40062192,40093866,17q11.2,17q21.1,190120,"THRA, ERBA1, THRA1, CHNG6","Thyroid hormone receptor, alpha (oncogene ERBA1)",THRA,7067,ENSG00000126351,NA,"Hypothyroidism, congenital, nongoitrous, 6, 614450 (3), Autosomal dominant",Thra (MGI:98742)
17,40092792,40100588,17q11.2,17q21.1,602408,"NR1D1, THRAL, EAR1","Nuclear receptor 1, subfamily D, member 1 (thyroid hormone receptor, alpha-1-like)",NR1D1,9572,ENSG00000126368,NA,NA,Nr1d1 (MGI:2444210)
17,40121970,40136916,17q21.1,17q21.1,614801,MSL1,"Male-specific lethal 1, Drosophila, homolog of",MSL1,339287,ENSG00000188895,NA,NA,Msl1 (MGI:1921276)
17,40140505,40172171,17q12-q21.3,17q21.1,606504,"MLN51, CASC3",MLN51 gene,CASC3,22794,ENSG00000108349,NA,NA,Casc3 (MGI:2179723)
17,40200000,42800000,17q21.2,NA,612380,IBD22,Inflammatory bowel disease 22,NA,100240732,NA,associated with rs744166,"{Inflammatory bowel disease 22}, 612380 (2)",NA
17,40219303,40284135,17q21.2,17q21.2,609692,"WIRE, WICH",WASP-interacting protein-related protein,WIPF2,147179,ENSG00000171475,NA,NA,Wipf2 (MGI:1924462)
17,40287877,40304656,17q21.2,17q21.2,602627,"CDC6, CDC18L, MGORS5","Cell division cycle 6, S. cerevisiae, homolog of",CDC6,990,ENSG00000094804,mutation identified in 1 MGORS5 patient,"?Meier-Gorlin syndrome 5, 613805 (3), Autosomal recessive",Cdc6 (MGI:1345150)
17,40309179,40357642,17q21.1,17q21.2,180240,RARA,"Retinoic acid receptor, alpha polypeptide",RARA,5914,ENSG00000131759,fused with MYL in APL,"Leukemia, acute promyelocytic, 612376 (1)",Rara (MGI:97856)
17,40360651,40364736,17q21.1,17q21.2,607425,"GJD3, GJC1, CX31.9","Gap junction protein, delta-3 (31.9kD)",GJD3,125111,ENSG00000183153,NA,NA,Gjd3 (MGI:2384150)
17,40388524,40417901,17q21-q22,17q21.2,126430,"TOP2A, TOP2","Topoisomerase (DNA) II, alpha, 170kD",TOP2A,7153,ENSG00000131747,NA,"DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)",Top2a (MGI:98790)
17,40443449,40457724,17q12-q21,17q21.2,146733,IGFBP4,Insulin-like growth factor-binding protein-4,IGFBP4,3487,ENSG00000141753,NA,NA,Igfbp4 (MGI:96439)
17,40475827,40501680,17q12-q21,17q21.2,608385,"TNS4, CTEN",Tensin 4,TNS4,84951,ENSG00000131746,NA,NA,Tns4 (MGI:2144377)
17,40553768,40565471,17q12-q21.2,17q21.2,600242,"CCR7, CMKBR7, EBI1",Chemokine (C-C) receptor 7 (Epstein-Barr virus induced gene 1),CCR7,1236,ENSG00000126353,NA,NA,Ccr7 (MGI:103011)
17,40624961,40647817,17q21.2,17q21.2,603111,"SMARCE1, BAF57, CSS5","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1",SMARCE1,6605,ENSG00000073584,NA,"Coffin-Siris syndrome 5, 616938 (3), Autosomal dominant; {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant",Smarce1 (MGI:1927347)
17,40694245,40703751,17q11.2,17q21.2,607742,"KRT24, FLJ20261",Keratin 24,KRT24,192666,ENSG00000167916,NA,NA,Krt24 (MGI:1922956)
17,40748020,40755541,17q21.2,17q21.2,616646,"KRT25, K25, KRT24IRS1, ARWH3","Keratin 25, type I",KRT25,147183,ENSG00000204897,NA,"Woolly hair, autosomal recessive 3, 616760 (3), Autosomal recessive",Krt25 (MGI:1918060)
17,40766237,40772158,17q21.2,17q21.2,616675,"KRT26, K25, K25B, K25IRS2","Keratin 26, type I",KRT26,353288,ENSG00000186393,NA,NA,Krt26 (MGI:2444913)
17,40776807,40782549,17q21.2,17q21.2,616676,"KRT27, KRT25C, K25IRS3","Keratin 27, type I",KRT27,342574,ENSG00000171446,NA,NA,Krt27 (MGI:1339999)
17,40792195,40799958,17q21.2,17q21.2,616677,"KRT28, K25D, K25IRS4","Keratin 28, type I",KRT28,162605,ENSG00000173908,NA,NA,Krt28 (MGI:1918093)
17,40818116,40822620,17q21-q22,17q21.2,148080,"KRT10, EHK, BCIE, BIE",Keratin 10,KRT10,3858,ENSG00000186395,in cluster of class I keratins,"Epidermolytic hyperkeratosis, 113800 (3), Autosomal recessive, Autosomal dominant; Ichthyosis with confetti, 609165 (3), Autosomal dominant; Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3), Autosomal dominant",NA
17,40861302,40867222,17q12,17q21.2,601687,KRT12,Keratin 12,KRT12,3859,ENSG00000187242,NA,"Meesmann corneal dystrophy, 122100 (3), Autosomal dominant",Krt12 (MGI:96687)
17,40875888,40885241,17q12-q21,17q21.2,608218,"KRT20, CD20, KRT21",Keratin 20,KRT20,54474,ENSG00000171431,NA,NA,Krt20 (MGI:1914059)
17,40922695,40937642,17q21.2,17q21.2,606194,KRT23,Keratin 23,KRT23,25984,ENSG00000108244,NA,NA,Krt23 (MGI:2148866)
17,40958416,40966947,17q21.2,17q21.2,616678,KRT39,"Keratin 38, type I",KRT39,390792,ENSG00000196859,NA,NA,Krt39 (MGI:3588208)
17,40977714,40987134,17q21.2,17q21.2,616679,"KRT40, KA36","Keratin 40, type I",KRT40,125115,ENSG00000204889,NA,NA,Krt40 (MGI:3629968)
17,41026025,41027207,17q12-q21,17q21.2,608822,"KRTAP-15, KAP1.5",Keratin-associated protein 1-5,KRTAP1-5,83895,ENSG00000221852,NA,NA,Krtap1-4 (MGI:3651229)
17,41029676,41030124,17q12-q21,17q21.2,608821,"KRTAP1-4, KAP1.4",Keratin-associated protein 1-4,KRTAP1-4,728255,ENSG00000204887,NA,NA,NA
17,41033883,41034873,17q12-q21,17q21.2,608820,"KRTAP1-3, KAP1.3, KAP1.2, KAP1.9",Keratin-associated protein 1-3,KRTAP1-3,81850,ENSG00000221880,NA,NA,Krtap9-3 (MGI:1922836)
17,41040540,41041449,17q12-q21,17q21.2,608819,"KRTAP1-1, KAP1.1, KAP1.7, KAP1.6",Keratin-associated protein 1-1,KRTAP1-1,81851,ENSG00000188581,NA,NA,Krtap1-3 (MGI:3650443)
17,41345703,41350827,17q12-q21,17q21.2,602761,"KRT33A, KRTHA3A, HA3I",Keratin 33A,KRT33A,3883,ENSG00000006059,NA,NA,NA
17,41363497,41369812,17q12-q21,17q21.2,602762,"KRT33B, KRTHA3A, HA3II",Keratin 33B,KRT33B,3884,ENSG00000131738,NA,NA,NA
17,41377664,41383815,17q12-q21,17q21.2,602763,"KRT34, KRTHA4, HA4",Keratin 34,KRT34,3885,ENSG00000131737,NA,NA,Krt34 (MGI:1309994)
17,41393720,41397607,17q12-q21,17q21.2,601077,"KRT31, KRTHA1, HA1",Keratin 31,KRT31,3881,ENSG00000094796,NA,NA,"Krt33b,Krt33a,Krt31 (MGI:1919138,MGI:1309993,MGI:1309991)"
17,41420546,41424584,17q12-q21,17q21.2,604541,"KRT37, KRTHA7, HA7",Keratin 37,KRT37,8688,ENSG00000108417,NA,NA,NA
17,41436368,41441343,17q12-q21,17q21.2,604542,"KRT38,  KRTHA8, HA8",Keratin 38,KRT38,8687,ENSG00000171360,NA,NA,NA
17,41459512,41469251,17q12-q21,17q21.2,602760,"KRT32, KRTHA2, HA2",Keratin 32,KRT32,3882,ENSG00000108759,NA,NA,Krt32 (MGI:1309995)
17,41476688,41482742,17q12-q21,17q21.2,602764,"KRT35, KRTHA5",Keratin 35,KRT35,3886,ENSG00000197079,NA,NA,Krt35 (MGI:1858899)
17,41486135,41489863,17q12-q21,17q21.2,604540,"KRT36, KRTHA6, HA6",Keratin 36,KRT36,8689,ENSG00000126337,NA,NA,Krt36 (MGI:109364)
17,41500980,41505611,17q21.2,17q21.2,148065,"KRT13, WSN2",Keratin 13,KRT13,3860,ENSG00000171401,"in same PFGE fragment as KRT10, KRT15","White sponge nevus 2, 615785 (3), Autosomal dominant",Krt13 (MGI:101925)
17,41513744,41521923,17q21-q22,17q21.2,148030,KRT15,Keratin 15,KRT15,3866,ENSG00000171346,tightly linked to Hox-2 in mouse,NA,Krt15 (MGI:96689)
17,41523616,41528307,17q21-q22,17q21.2,148020,KRT19,Keratin 19,KRT19,3880,ENSG00000171345,probably 17q21-q22,NA,Krt19 (MGI:96693)
17,41565835,41572058,17q12-q21,17q21.2,607606,"KRT9, EPPK",Keratin 9,KRT9,3857,ENSG00000171403,NA,"Palmoplantar keratoderma, epidermolytic, 144200 (3), Autosomal dominant",NA
17,41582278,41586894,17q12-q21,17q21.2,148066,KRT14,Keratin 14,KRT14,3861,ENSG00000186847,NA,"Dermatopathia pigmentosa reticularis, 125595 (3), Autosomal dominant; Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3), Autosomal dominant; Epidermolysis bullosa simplex, Koebner type, 131900 (3), Autosomal dominant; Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3), Autosomal dominant; Epidermolysis bullosa simplex, recessive 1, 601001 (3), Autosomal recessive; Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3), Autosomal dominant",Krt14 (MGI:96688)
17,41609777,41612766,17q12-q21,17q21.2,148067,"KRT16, FNEPPK, PC1",Keratin 16,KRT16,3868,ENSG00000186832,probably 17q21-q22,"Pachyonychia congenita 1, 167200 (3), Autosomal dominant; Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3), Autosomal dominant",Krt16 (MGI:96690)
17,41619441,41624574,17q12-q21,17q21.2,148069,"KRT17, PC2, PCHC1",Keratin 17,KRT17,3872,ENSG00000128422,~5' to KRT16; probably 17q21-q22,"Pachyonychia congenita 2, 167210 (3), Autosomal dominant; Steatocystoma multiplex, 184500 (3), Autosomal dominant",Krt17 (MGI:96691)
17,41712330,41715968,17q21,17q21.2,137250,"GAS, GAST",Gastrin,GAST,2520,ENSG00000184502,NA,NA,Gast (MGI:104768)
17,41717738,41734645,17q21.2-q21.3,17q21.2,600947,"HAP1, HLP, HAP2",Huntingtin-associated protein 1 (neuroan 1),HAP1,9001,ENSG00000173805,NA,NA,Hap1 (MGI:1261831)
17,41754606,41786767,17q21,17q21.2,173325,"JUP, DP3, PDGB, ARVD12",Junction plakoglobin,JUP,3728,ENSG00000173801,incorrectly mapped to 7; close to BRCA1,"Arrhythmogenic right ventricular dysplasia 12, 611528 (3), Autosomal dominant; Naxos disease, 601214 (3), Autosomal recessive",Jup (MGI:96650)
17,41801951,41812709,17q21.2,17q21.2,617419,"P3H4, SC65, LEPREL4",Proyly 3-hydroxylase 4,P3H4,10609,ENSG00000141696,NA,NA,P3h4 (MGI:1913430)
17,41812709,41823216,17q21.2,17q21.2,607063,"FKBP10, FKBP65, OI11, BRKS1",FK506-binding protein 10,FKBP10,60681,ENSG00000141756,NA,"Bruck syndrome 1, 259450 (3), Autosomal recessive; Osteogenesis imperfecta, type XI, 610968 (3), Autosomal recessive",Fkbp10 (MGI:104769)
17,41835684,41848383,17q21.2,17q21.2,608778,"KLHL10, SPGF11",Kelch-like 10,KLHL10,317719,ENSG00000161594,NA,"Spermatogenic failure 11, 615081 (3), Autosomal dominant",Klhl10 (MGI:2181067)
17,41866915,41930541,17q21.1,17q21.2,108728,ACLY,ATP citrate lyase,ACLY,47,ENSG00000131473,NA,NA,Acly (MGI:103251)
17,41930593,41966516,17q21.2,17q21.2,617095,"TTC25, CILD35",Tetratricopeptide repeat domain-containing protein 25,TTC25,83538,ENSG00000204815,NA,"Ciliary dyskinesia, primary, 35, 617092 (3), Autosomal recessive",Ttc25 (MGI:1921657)
17,41966794,41977739,17q21,17q21.2,123830,"CNP, CNP1","2', 3' cyclic nucleotide 3' phosphohydrolase",CNP,1267,ENSG00000173786,flanked by THRA1 and NGFR,NA,Cnp (MGI:88437)
17,41976420,42021370,17q11-q23,17q21.2,601964,"DANJC7, TTC2, TPR2","DnaJ, E. coli, homolog of, subfamily C, member 7 (tetratricopeptide repeat domain 2)",DNAJC7,7266,ENSG00000168259,NA,NA,Dnajc7 (MGI:1928373)
17,42017575,42025640,17q21.1,17q21.2,604497,"NKIRAS2, KBRAS2",NFKB inhibitor-interacting Ras-like protein 2,NKIRAS2,28511,ENSG00000168256,NA,NA,Nkiras2 (MGI:1919216)
17,42101403,42112720,17q21.2,17q21.2,608588,"DHX58, LGP2, D11LGP2",DEAH (Asp-Glu-Ala-His) box polypeptide 58,DHX58,79132,ENSG00000108771,NA,NA,Dhx58 (MGI:1931560)
17,42113110,42121408,17q21,17q21.2,602301,"KAT2A, GCN5L2, GCN5",K(lysine) acetyltransferase 2A,KAT2A,2648,ENSG00000108773,NA,NA,Kat2a (MGI:1343101)
17,42122803,42123351,17q21.3,17q21.2,608344,HSPB9,Heat-shock 27kD protein 9,HSPB9,94086,ENSG00000260325,NA,NA,Hspb9 (MGI:1922732)
17,42124978,42154988,17q21.2,17q21.2,604037,"RAB5C, RABL",Ras-associated protein RAB5c,RAB5C,5878,ENSG00000108774,NA,NA,Rab5c (MGI:105306)
17,42184059,42185451,17q21,17q21.2,602358,"HCRT, OX, NRCLP1",Hypocretin,HCRT,3060,ENSG00000161610,mutation identified in 1 NRCLP1 patient,"?Narcolepsy 1, 161400 (3), Autosomal dominant",Hcrt (MGI:1202306)
17,42199176,42288436,17q11.2,17q21.2,604260,STAT5B,Signal transducer and activator of transcription 5B,STAT5B,6777,ENSG00000173757,fused with RARA in PML,"Growth hormone insensitivity with immunodeficiency, 245590 (3); Leukemia, acute promyelocytic, somatic, 102578 (3)",Stat5b (MGI:103035)
17,42287546,42311942,17q21.2,17q21.2,601511,"STAT5A, STAT5, MGF",Signal transducer and activator of transcription 5a,STAT5A,6776,ENSG00000126561,NA,NA,Stat5a (MGI:103036)
17,42313323,42388501,17q21,17q21.2,102582,"STAT3, APRF, HIES, ADMIO1",Signal transducer and activator of transcription-3 (acute-phase response factor),STAT3,6774,ENSG00000168610,NA,"Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3), Autosomal dominant; Hyper-IgE recurrent infection syndrome, 147060 (3), Autosomal dominant",Stat3 (MGI:103038)
17,42402448,42423268,17q21,17q21.2,603198,"CAVIN1, PTRF",Caveolae-associated protein 1,CAVIN1,284119,ENSG00000177469,NA,"Lipodystrophy, congenital generalized, type 4, 613327 (3), Autosomal recessive",Cavin1 (MGI:1277968)
17,42458873,42522610,17q21,17q21.2,192130,"ATP6V0A1, ATP6N1A, VPP1","ATPase, H+ transporting, V0 subunit A1",ATP6V0A1,535,ENSG00000033627,NA,NA,Atp6v0a1 (MGI:103286)
17,42534237,42544448,17q21,17q21.2,609701,"NAGLU, MPS3B, CMT2V","N-acetylglucosaminidase, alpha-",NAGLU,4669,ENSG00000108784,mutation identified in 1 CMT2V family,"?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3), Autosomal dominant; Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3), Autosomal recessive",Naglu (MGI:1351641)
17,42552922,42555213,17q21.2,17q21.2,109684,"HSD17B1, EDH17B2",Estradiol 17-beta-dehydrogenase-1,HSD17B1,3292,ENSG00000108786,NA,NA,Hsd17b1 (MGI:105077)
17,42562147,42566276,17q12-q21,17q21.2,609855,"COASY, NBIA6, PCH12",Coenzyme A synthase,COASY,80347,ENSG00000068120,NA,"Neurodegeneration with brain iron accumulation 6, 615643 (3), Autosomal recessive; Pontocerebellar hypoplasia, type 12, 618266 (3), Autosomal recessive",Coasy (MGI:1918993)
17,42567059,42573202,17q21.1,17q21.2,602976,"MLX, TCFL4",MAX-like protein X,MLX,6945,ENSG00000108788,NA,NA,Mlx (MGI:108398)
17,42572309,42577830,17q21.2,17q21.2,608665,"PSMC3IP, TBPIP, GT198, HOP2, ODG3",PSMC3-interacting protein,PSMC3IP,29893,ENSG00000131470,NA,"Ovarian dysgenesis 3, 614324 (3), Autosomal recessive",Psmc3ip (MGI:1098610)
17,42579507,42609426,17q21.2,17q21.2,616498,FAM134C,"Family with sequence similarity 134, member C",RETREG3,162427,ENSG00000141699,NA,NA,Retreg3 (MGI:1915248)
17,42609389,42615237,17q21,17q21.2,191135,"TUBG1, CDCBM4","Tubulin, gamma 1",TUBG1,7283,ENSG00000131462,NA,"Cortical dysplasia, complex, with other brain malformations 4, 615412 (3), Autosomal dominant",Tubg1 (MGI:101834)
17,42659283,42667005,17q21,17q21.2,605785,TUBG2,"Tubulin, gamma 2",TUBG2,27175,ENSG00000037042,pseudogene on chr. 7,NA,Tubg2 (MGI:2144208)
17,42678888,42681842,17q21.2,17q21.2,600240,"CCR10, GPR2",Chemokine (C-C) receptor 10,CCR10,2826,ENSG00000184451,NA,NA,Ccr10 (MGI:1096320)
17,42679766,42699992,17q21,17q21.2,602346,"CNTNAP1, CASPR, P190, CHN3",Contactin-associated protein 1,CNTNAP1,8506,ENSG00000108797,NA,"Hypomyelinating neuropathy, congenital, 3, 618186 (3), Autosomal recessive; Lethal congenital contracture syndrome 7, 616286 (3), Autosomal recessive",Cntnap1 (MGI:1858201)
17,42700274,42745077,17q21.1-q21.3,17q21.2,601674,EZH1,"Enhancer of zeste, Drosophila, homolog of, 1",EZH1,2145,ENSG00000108799,NA,NA,Ezh1 (MGI:1097695)
17,42761226,42763040,17q12-q21.1,17q21.2,605154,RAMP2,Receptor activity-modifying protein 2,RAMP2,10266,ENSG00000131477,NA,NA,Ramp2 (MGI:1859650)
17,42773448,42779598,17q21.3,17q21.2,610907,"VPS25, FAP20","Vacuolar protein sorting 25, S. cerevisiae, homolog of",VPS25,84313,ENSG00000131475,NA,NA,Vps25 (MGI:106354)
17,42779700,42797065,17q21-q22,17q21.2,601844,"WNK4, PRKWNK4, PHA2B",WNK lysine deficient protein kinase 4,WNK4,65266,ENSG00000126562,NA,"Pseudohypoaldosteronism, type IIB, 614491 (3), Autosomal dominant",Wnk4 (MGI:1917097)
17,42797624,42798703,17q21.31,17q21.2,614775,"COA3, CCDC56",Cytochrome c oxidase assembly factor 3,COA3,28958,ENSG00000183978,NA,NA,Coa3 (MGI:1098757)
17,42798748,42811586,17q21.2-q21.31,17q21.2-q21.3,618166,"CNTD1, COSA1",Cyclin N-terminal domain-containing protein 1,CNTD1,124817,ENSG00000176563,NA,NA,Cntd1 (MGI:1923965)
17,42800000,46800000,17q21.31,NA,613533,"DUP17q21.31, C17DUPq21.31",Chromosome 17q21.31 duplication syndrome,NA,NA,NA,contiguous gene duplication syndrome,"Chromosome 17q21.31 duplication syndrome, 613533 (4)",NA
17,42800000,52100000,17q21.3,NA,603279,ERDA1,"Expanded repeat domain, CAG/CTG, 1",ERDA1,9030,NA,no apparent pathology,NA,NA
17,42800000,59500000,17q21.31-q22,NA,615162,MRT35,"Mental retardation, autosomal recessive 35",NA,101409266,NA,between rs4792947 and rs11079258,"Mental retardation, autosomal recessive 35, 615162 (2), Autosomal recessive",NA
17,42810131,42824315,17q21,17q21.31,604378,BECN1,Beclin 1,BECN1,8678,ENSG00000126581,NA,NA,Becn1 (MGI:1891828)
17,42833141,42843759,17q12-q21,17q21.31,605129,"PSME3, PA28G",Proteasome activator subunit 3,PSME3,10197,ENSG00000131467,NA,NA,Psme3 (MGI:1096366)
17,42844579,42850706,17q21,17q21.31,602268,"AOC2, RAO","Amine oxidase, copper-containing, 2",AOC2,314,ENSG00000131480,NA,NA,Aoc2 (MGI:2668431)
17,42851181,42858129,17q21,17q21.31,603735,"AOC3, HPAO, VAP1","Amine oxidase, copper-containing 3",AOC3,8639,ENSG00000131471,NA,NA,Aoc3 (MGI:1306797)
17,42900798,42914437,17q21,17q21.31,613742,"G6PC, G6PT","Glucose-6-phosphatase, catalytic",G6PC,2538,ENSG00000131482,NA,"Glycogen storage disease Ia, 232200 (3), Autosomal recessive",G6pc (MGI:95607)
17,42950525,42964453,17q21.31,17q21.31,613212,AARSD1,Alanyl-tRNA synthetase domain-containing 1,AARSD1,80755,ENSG00000266967,NA,NA,Aarsd1 (MGI:1916934)
17,42998272,43002958,17q21.1-q21.2,17q21.31,607526,"RPL27, DBA16",Ribosomal protein L27,RPL27,6155,ENSG00000131469,mutation identified in 1 DBA16 patient,"?Diamond-Blackfan anemia 16, 617408 (3), Autosomal dominant",Rpl27 (MGI:98036)
17,43006783,43014458,17q21,17q21.31,600735,IFI35,Interferon-induced protein-35,IFI35,3430,ENSG00000068079,NA,NA,Ifi35 (MGI:1917360)
17,43014606,43022384,17q21,17q21.31,604631,VAT1,Vesicle amine transport protein 1,VAT1,10493,ENSG00000108828,NA,NA,Vat1 (MGI:1349450)
17,43025230,43032040,17q21,17q21.31,601555,"RND2, ARHN, RHO7","Ras homolog gene family, member N (GTP-binding protein Rho7)",RND2,8153,ENSG00000108830,NA,NA,Rnd2 (MGI:1338755)
17,43044294,43125482,17q21,17q21.31,113705,"BRCA1, PSCP, BROVCA1, PNCA4, FANCS",Breast cancer-1 gene,BRCA1,672,ENSG00000012048,NA,"{Breast-ovarian cancer, familial, 1}, 604370 (3), Autosomal dominant, Multifactorial; Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)",Brca1 (MGI:104537)
17,43170309,43211687,17q21.1,17q21.31,166945,"NBR1, M17S2","Neighbor of BRCA1 gene 1 (membrane component, chromosome 17, surface marker 2)",NBR1,4077,ENSG00000188554,NA,NA,Nbr1 (MGI:108498)
17,43233789,43233976,17q21-q22,17q21.31,180690,"RNU2-1, RNU2","RNA, U2 small nuclear, 1",RNU2-1,6066,ENSG00000274585,NA,NA,NA
17,43398992,43401136,17q12-q21,17q21.31,600732,"ARL4D, ARF4L",ADP-ribosylation factor-like 4D,ARL4D,379,ENSG00000175906,NA,NA,Arl4d (MGI:1933155)
17,43483864,43544798,17q21.31,17q21.31,600396,"DHX8, DDX8, HRH1",DEAH (Asp-Glu-Ala-His) box polypeptide 8,DHX8,1659,ENSG00000067596,NA,NA,Dhx8 (MGI:1306823)
17,43527842,43546339,17q21,17q21.31,600711,ETV4,"ETS variant gene-4 (E1A enhancer-binding protein, E1AF)",ETV4,2118,ENSG00000175832,NA,NA,Etv4 (MGI:99423)
17,43640388,43661976,17q21,17q21.31,600147,"MEOX1, MOX1, KFS2","Mesenchyme homeo box 1 (Mox1, mouse, homolog of)",MEOX1,4222,ENSG00000005102,NA,"Klippel-Feil syndrome 2, 214300 (3), Autosomal recessive",Meox1 (MGI:103220)
17,43753737,43758790,17q12-q21,17q21.31,605740,"SOST, VBCH, CDD, SOST1",Sclerostin,SOST,50964,ENSG00000167941,NA,"Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3), Autosomal dominant; Sclerosteosis 1, 269500 (3), Autosomal recessive; Van Buchem disease, 239100 (3), Autosomal recessive",Sost (MGI:1921749)
17,43766124,43778976,17q21,17q21.31,600183,"DUSP3, VHR",Dual specificity phosphatase-3 (vaccinia virus phosphatase VH1-related),DUSP3,1845,ENSG00000108861,NA,NA,Dusp3 (MGI:1919599)
17,43800798,43833193,17q12-q21,17q21.31,601114,"MPP3, DLG3","Membrane protein, palmitoylated-3 (MAGUK p55 subfamily member 3)",MPP3,4356,ENSG00000161647,NA,NA,Mpp3 (MGI:1328354)
17,43847096,43863638,17q21.31,17q21.31,610520,"CD300LG, TREM4, CLM9","CD300 antigen-like family, member G",CD300LG,146894,ENSG00000161649,NA,NA,Cd300lg (MGI:1289168)
17,43875356,43909710,17q12-q21,17q21.31,600723,"MPP2, DLG2","Membrane protein, palmitoylated-2 (MAGUK p55 subfamily member 2)",MPP2,4355,ENSG00000108852,NA,NA,Mpp2 (MGI:1858257)
17,43940801,43944211,17q12-q21,17q21.31,167780,PPY,Pancreatic polypeptide,PPY,5539,ENSG00000108849,"in rat, close to GH",NA,Ppy (MGI:97753)
17,43952732,44004468,17q21,17q21.31,600781,PYY,Peptide YY,PYY,5697,ENSG00000131096,10kb from PPY,NA,Pyy (MGI:99924)
17,44004545,44009067,17q21.31,17q21.31,608300,NAGS,N-acetylglutamate synthase,NAGS,162417,ENSG00000161653,NA,"N-acetylglutamate synthase deficiency, 237310 (3), Autosomal recessive",Nags (MGI:2387600)
17,44034634,44067586,17q21.31,17q21.31,611793,LSM12,"LSM12, S. cerevisiae, homolog of",LSM12,124801,ENSG00000161654,NA,NA,Lsm12 (MGI:1919592)
17,44070699,44076343,17q21,17q21.31,611045,"G6PC3, UGRP, SCN4","Glucose-6-phosphatase, catalytic, 3",G6PC3,92579,ENSG00000141349,NA,"Dursun syndrome, 612541 (3), Autosomal recessive; Neutropenia, severe congenital 4, autosomal recessive, 612541 (3), Autosomal recessive",G6pc3 (MGI:1915651)
17,44076752,44123650,17q21,17q21.31,605315,HDAC5,Histone deacetylase 5,HDAC5,10014,ENSG00000108840,NA,NA,Hdac5 (MGI:1333784)
17,44170703,44179083,17q21.31,17q21.31,615056,ASB16,Ankyrin repeat- and SOCS box-containing protein 16,ASB16,92591,ENSG00000161664,NA,NA,Asb16 (MGI:2654437)
17,44205035,44221303,17q21.3,17q21.31,600673,"UBTF, UBF, CONDBA","Upstream binding transcription factor, RNA polymerase I",UBTF,7343,ENSG00000108312,NA,"Neurodegeneration, childhood-onset, with brain atrophy, 617672 (3), Autosomal dominant",Ubtf (MGI:98512)
17,44226962,44230071,17q21-q22,17q21.31,600739,SHCL1,SHC (Src homology 2 domain-containing) transforming protein-like 1,SHC1P2,6466,NA,NA,NA,NA
17,44248389,44268160,17q21-q22,17q21.31,109270,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC","Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)",SLC4A1,6521,ENSG00000004939,NA,"[Blood group, Diego], 110500 (3); [Blood group, Froese], 601551 (3); [Blood group, Swann], 601550 (3); [Blood group, Waldner], 112010 (3); [Blood group, Wright], 112050 (3); Cryohydrocytosis, 185020 (3), Autosomal dominant; [Malaria, resistance to], 611162 (3); Ovalocytosis, SA type, 166900 (3), Autosomal dominant; Renal tubular acidosis, distal, AD, 179800 (3), Autosomal dominant; Renal tubular acidosis, distal, AR, 611590 (3), Autosomal recessive; Spherocytosis, type 4, 612653 (3), Autosomal dominant",Slc4a1 (MGI:109393)
17,44308558,44318669,17q21.3,17q21.31,605448,"RUNDC3A, RPIP8",RUN domain contain 3A,RUNDC3A,10900,ENSG00000108309,NA,NA,Rundc3a (MGI:1858752)
17,44319624,44324869,17q21.31,17q21.31,610820,"SLC25A39, CGI69","Solute carrier family 25, member 39",SLC25A39,51629,ENSG00000013306,NA,NA,Slc25a39 (MGI:1196386)
17,44345085,44353105,17q21.32,17q21.31,138945,"GRN, CLN11",Granulin,GRN,2896,ENSG00000030582,NA,"Aphasia, primary progressive, 607485 (3), Autosomal dominant; Ceroid lipofuscinosis, neuronal, 11, 614706 (3), Autosomal recessive; Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3), Autosomal dominant",Grn (MGI:95832)
17,44372180,44389648,17q21.32,17q21.31,607759,"ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16","Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)",ITGA2B,3674,ENSG00000005961,3' to GP3A; BAK platelet antigen,"Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3), Autosomal dominant; Glanzmann thrombasthenia, 273800 (3), Autosomal recessive; Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)",Itga2b (MGI:96601)
17,44395276,44503588,17q21.31,17q21.31,614396,"GPATCH8, KIAA0553",G-patch domain-containing protein 8,GPATCH8,23131,ENSG00000186566,NA,NA,Gpatch8 (MGI:1918667)
17,44557483,44561261,17q21.1,17q21.31,600667,"FZD2, OMOD2","Frizzled, Drosophila, homolog of, 2",FZD2,2535,ENSG00000180340,NA,"Omodysplasia 2, 164745 (3), Autosomal dominant",Fzd2 (MGI:1888513)
17,44656416,44677085,17q21.31,17q21.31,616934,"MEIOC, C17orf104",Meiosis-specific protein with coiled-coil domain,MEIOC,284071,ENSG00000180336,NA,NA,Meioc (MGI:2686410)
17,44708580,44752731,17q21,17q21.31,611661,"DBF4B, DRF1, ASKL1","DBF4, S. cerevisiae, homolog of, B",DBF4B,80174,ENSG00000161692,NA,NA,NA
17,44758987,44781845,17q21.3,17q21.31,155120,"ADAM11, MDC",A disintegrin and metalloproteinase domain 11,ADAM11,4185,ENSG00000073670,NA,NA,Adam11 (MGI:1098667)
17,44794987,44831363,17q21.31,17q21.31,608655,"GJC1, GJA7, CX45","Gap junction protein, gamma-1",GJC1,10052,ENSG00000182963,NA,NA,Gjc1 (MGI:95718)
17,44849947,44899624,17q21.31,17q21.31,603892,"EFTUD2, KIAA0031, MFDGA",Elongation factor Tu GTP-binding domain-containing 2,EFTUD2,9343,ENSG00000108883,NA,"Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3), Autosomal dominant",Eftud2 (MGI:1336880)
17,44899711,44905389,17q21.31,17q21.31,614677,"CCDC103, SMH, PR46B, CILD17",Coiled-coil domain-containing protein 103,CCDC103,388389,ENSG00000167131,NA,"Ciliary dyskinesia, primary, 17, 614679 (3), Autosomal recessive",Ccdc103 (MGI:1920543)
17,44903158,44915551,17q21,17q21.31,137780,"GFAP, ALXDRD",Glial fibrillary acidic protein,GFAP,2670,ENSG00000131095,NA,"Alexander disease, 203450 (3), Autosomal dominant",Gfap (MGI:95697)
17,44924710,44947772,17q21.31,17q21.31,614570,KIF18B,Kinesin family member 18B,KIF18B,146909,ENSG00000186185,NA,NA,Kif18b (MGI:2446979)
17,44959692,44968302,17q21,17q21.31,611586,"C1QL1, CRF, C1QRF","Complement component 1, q subcomponent-like 1",C1QL1,10882,ENSG00000131094,NA,NA,C1ql1 (MGI:1344400)
17,45061316,45109015,17q21.31,17q21.31,160993,"NMT1, NMT",N-myristoyltransferase 1,NMT1,4836,ENSG00000136448,NA,NA,Nmt1 (MGI:102579)
17,45147316,45152100,Chr.17,17q21.31,607328,"CLP1, HIS1",Cardiac lineage protein 1,HEXIM1,10614,ENSG00000186834,NA,NA,Hexim1 (MGI:2385923)
17,45159947,45170039,17q21.32,17q21.31,615695,HEXIM2,Hexamethylene bis acetamide-inducible protein 2,HEXIM2,124790,ENSG00000168517,NA,NA,Hexim2 (MGI:1918309)
17,45220267,45247321,17q21,17q21.31,604656,"FMNL, C17orf1B",Formin-like,FMNL1,752,ENSG00000184922,NA,NA,NA
17,45263118,45317047,17q21,17q21.31,604655,"MAP3K14, NIK, HSNIK",Mitogen-activated protein kinase kinase kinase-14,MAP3K14,9020,ENSG00000006062,NA,NA,Map3k14 (MGI:1858204)
17,45393901,45432915,17q21,17q21.31,610591,"ARHGAP27, CAMGAP1",RHO GTPase-activating protein 27,ARHGAP27,201176,ENSG00000159314,NA,NA,Arhgap27 (MGI:1916903)
17,45434261,45490779,17q21.3,17q21.31,611466,"PLEKHM1, AP162, KIAA0356, OPTB6, OPTA3","Pleckstrin homology domain-containing protein, family M, member 1",PLEKHM1,9842,ENSG00000225190,mutation identified in 1 OPTB6 family,"Osteopetrosis, autosomal dominant 3, 618107 (3), Autosomal dominant; ?Osteopetrosis, autosomal recessive 6, 611497 (3), Autosomal recessive",Plekhm1 (MGI:2443207)
17,45784279,45835827,17q12-q22,17q21.31,122561,"CRHR1, CRHR",Corticotropin releasing hormone receptor 1,CRHR1,1394,ENSG00000120088,NA,NA,Crhr1 (MGI:88498)
17,45844880,45847066,17q21.31,17q21.31,608284,IMP5,Intramembrane protease 5,SPPL2C,162540,ENSG00000185294,NA,NA,Sppl2c (MGI:3045264)
17,45894381,46028333,17q21.1,17q21.31,157140,"MAPT, MTBT1, DDPAC, MSTD",Microtubule-associated protein tau,MAPT,4137,ENSG00000186868,see 6p21,"Dementia, frontotemporal, with or without parkinsonism, 600274 (3), Autosomal dominant; {Parkinson disease, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial; Pick disease, 172700 (3), Autosomal dominant; Supranuclear palsy, progressive, 601104 (3), Autosomal dominant; Supranuclear palsy, progressive atypical, 260540 (3), Autosomal recessive",Mapt (MGI:97180)
17,45999249,45999693,17q21.1,17q21.31,607067,STH,Saitohin,STH,246744,ENSG00000256762,in intron 9 of TAU,NA,NA
17,46027334,46225373,17q21.31,17q21.31,612452,"KANSL1, KIAA1267, MSL1V1, KDVS",KAT8 regulatory NSL complex subunit 1,KANSL1,284058,ENSG00000120071,NA,"Koolen-De Vries syndrome, 610443 (3), Autosomal dominant",Kansl1 (MGI:1923969)
17,46295130,46337793,17q21.31-q21.32,17q21.31,616555,LRRC37A,Leucine-rich repeat-containing protein 37A,LRRC37A,9884,ENSG00000176681,NA,NA,NA
17,46512709,47049127,17q21.31-q21.32,17q21.31-q21.32,616556,LRRC37A2,Leucine-rich repeat-containing protein 37A2,LRRC37A2,474170,ENSG00000238083,NA,NA,NA
17,46590668,46757463,17q21-q22,17q21.31,601633,NSF,N-ethylmaleimide-sensitive factor,NSF,4905,ENSG00000073969,NA,NA,Nsf (MGI:104560)
17,46762505,46818691,17q21,17q21.31-q21.32,165330,"WNT3, INT4, TETAMS","Wingless-type MMTV integration site family, member 3",WNT3,7473,ENSG00000108379,mutation identified in 1 TETAMS1 family,"?Tetra-amelia syndrome 1, 273395 (3), Autosomal recessive",Wnt3 (MGI:98955)
17,46833200,46886737,17q21,17q21.32,602864,WNT15,"Wingless-type MMTV integration site family, member 15",WNT9B,7484,ENSG00000158955,NA,NA,Wnt9b (MGI:1197020)
17,46923107,46975518,17q21,17q21.32,604027,"GOSR2, GS27, EPM6",Golgi snap receptor complex member 2,GOSR2,9570,ENSG00000108433,NA,"Epilepsy, progressive myoclonic 6, 614018 (3), Autosomal recessive",Gosr2 (MGI:1927204)
17,47117696,47189338,17q12-q23.2,17q21.32,116946,CDC27,Cell division cycle 27,CDC27,996,ENSG00000004897,between ERBB2 and PRKCA,NA,Cdc27 (MGI:102685)
17,47209016,47227649,17q21.32,17q21.32,160770,MYL4,"Myosin, light polypeptide-4, alkali, atrial, embryonic",MYL4,4635,ENSG00000198336,mutation identified in 1 ATFB18 family,"?Atrial fibrillation, familial, 18, 617280 (3), Autosomal dominant",Myl4 (MGI:97267)
17,47253841,47312710,17q21.32,17q21.32,173470,"ITGB3, GP3A, GT, BDPLT2, BDPLT16","Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)",ITGB3,3690,ENSG00000259207,in same 260kb fragment as GP2B; PL(A) platelet antigen,"Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3), Autosomal dominant; Glanzmann thrombasthenia, 273800 (3), Autosomal recessive; {Myocardial infarction, susceptibility to}, 608446 (3); Purpura, posttransfusion (3); Thrombocytopenia, neonatal alloimmune (3)",Itgb3 (MGI:96612)
17,47522932,47623275,17q21,17q21.32,606793,"NPEPPS, PSA, MP100","Aminopeptidase, puromycin-sensitive",NPEPPS,9520,ENSG00000141279,NA,NA,Npepps (MGI:1101358)
17,47649918,47685504,17q21,17q21.32,602738,KPNB1,Karyopherin beta-1,KPNB1,3837,ENSG00000108424,NA,NA,Kpnb1 (MGI:107532)
17,47694064,47712062,17q21.32,17q21.32,608476,"TBKBP1, PROSAPIP2, KIAA0775",TBK1-binding protein 1,TBKBP1,9755,ENSG00000198933,NA,NA,Tbkbp1 (MGI:1920424)
17,47733235,47746121,17q21.3,17q21.32,604895,"TBX21, TBET",T-box 21,TBX21,30009,ENSG00000073861,NA,"Asthma and nasal polyps, 208550 (3), Autosomal recessive; {Asthma, aspirin-induced, susceptibility to}, 208550 (3), Autosomal recessive",Tbx21 (MGI:1888984)
17,47807366,47821821,17q21.2,17q21.32,606735,"OSBPL7, ORP7",Oxysterol-binding protein-like protein 7,OSBPL7,114881,ENSG00000006025,NA,NA,Osbpl7 (MGI:1918490)
17,47823271,47831540,17q21.3,17q21.32,611825,"MRPL10, MRPL8",Mitochondrial ribosomal protein L10,MRPL10,124995,ENSG00000159111,NA,NA,Mrpl10 (MGI:1333801)
17,47837690,47841291,17q21.3,17q21.32,614966,"SCRN2, SES2",Secernin 2,SCRN2,90507,ENSG00000141295,NA,NA,Scrn2 (MGI:1343092)
17,47896031,47932270,17q21.32,17q21.32,601801,SP2,Transcription factor Sp2,SP2,6668,ENSG00000167182,NA,NA,Sp2 (MGI:1926162)
17,47941523,47949307,17q21.32,17q21.32,603287,PNPO,Pyridoxamine 5'-phosphate oxidase,PNPO,55163,ENSG00000108439,NA,"Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3), Autosomal recessive",Pnpo (MGI:2144151)
17,47967903,47981785,17q21.31,17q21.32,608202,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,CDK5RAP3,80279,ENSG00000108465,NA,NA,Cdk5rap3 (MGI:1933126)
17,48026166,48048085,17q21.32,17q21.32,615526,COPZ2,"Coatomer protein complex, subunit zeta-2",COPZ2,51226,ENSG00000005243,NA,NA,Copz2 (MGI:1929008)
17,48037160,48037246,17q21.32,17q21.32,613788,"MIR152, MIRN152",Micro RNA 152,MIR152,406943,ENSG00000207947,NA,NA,NA
17,48048358,48061544,17q21.3,17q21.32,163260,"NFE2L1, NRF1","Nuclear factor, erythroid-derived 2-like 1",NFE2L1,4779,ENSG00000082641,NA,NA,Nfe2l1 (MGI:99421)
17,48107532,48123600,17q21.32,17q21.32,614906,SNX11,Sorting nexin 11,SNX11,29916,ENSG00000002919,NA,NA,Snx11 (MGI:1921729)
17,48133437,48430249,17q21.32,17q21.32,604969,"SKAP1, SCAP1, SKAP55","SRC kinase-associated phosphoprotein 1, 55kD",SKAP1,8631,ENSG00000141293,NA,NA,Skap1 (MGI:1925723)
17,48528525,48531010,17q21-q22,17q21.32,142968,"HOXB1, HOX2I, HCFP3",Homeo box-B1,HOXB1,3211,ENSG00000120094,NA,"Facial paresis, hereditary congenital, 3, 614744 (3), Autosomal recessive",Hoxb1 (MGI:96182)
17,48542654,48545030,17q21-q22,17q21.32,142967,"HOXB2, HOX2H",Homeo box-B2,HOXB2,3212,ENSG00000173917,NA,NA,Hoxb2 (MGI:96183)
17,48544350,48551240,17q21.32,17q21.32,618066,"HOXBAS1, HOXB3OS","Homeobox B cluster antisense RNA 1, noncoding",HOXB-AS1,100874362,ENSG00000230148,NA,NA,NA
17,48548869,48590271,17q21-q22,17q21.32,142966,"HOXB3, HOX2G",Homeo box-B3,HOXB3,3213,ENSG00000120093,NA,NA,Hoxb3 (MGI:96184)
17,48575506,48578349,17q21-q22,17q21.32,142965,"HOXB4, HOX2F",Homeo box-B4,HOXB4,3214,ENSG00000182742,NA,NA,Hoxb4 (MGI:96185)
17,48579837,48579946,17q21,17q21.32,610173,MIR10A,Micro RNA 10A,MIR10A,406902,ENSG00000284038,NA,NA,NA
17,48591256,48593740,17q21-q22,17q21.32,142960,"HOXB5, HOX2A",Homeo box-B5,HOXB5,3215,ENSG00000120075,NA,NA,Hoxb5 (MGI:96186)
17,48595735,48604985,17q21-q22,17q21.32,142961,"HOXB6, HOX2B",Homeo box-B6,HOXB6,3216,ENSG00000108511,NA,NA,Hoxb6 (MGI:96187)
17,48607231,48611016,17q21-q22,17q21.32,142962,"HOXB7, HOX2C",Homeo box-B7,HOXB7,3217,ENSG00000260027,NA,NA,Hoxb7 (MGI:96188)
17,48612345,48619530,17q21-q22,17q21.32,142963,"HOXB8, HOX2D",Homeo box-B8,HOXB8,3218,ENSG00000120068,NA,NA,Hoxb8 (MGI:96189)
17,48621155,48626357,17q21-q22,17q21.32,142964,"HOXB9, HOX2E",Homeo box-B9,HOXB9,3219,ENSG00000170689,NA,NA,Hoxb9 (MGI:96190)
17,48632489,48632558,17q21-q22,17q21.32,608632,"MIR196A1, MIRN196A1",Micro RNA 196A1,MIR196A1,406972,ENSG00000210741,NA,NA,NA
17,48720801,48724757,17q21.3,17q21.32,610787,"PRAC2, HOXBAS5",PRAC2 small nuclear protein,PRAC2,360205,ENSG00000229637,NA,NA,NA
17,48721718,48722517,17q21.3,17q21.32,609819,PRAC1,"Prostate, rectum, and colon gene",PRAC1,84366,ENSG00000159182,NA,NA,NA
17,48724762,48728748,17q21.2,17q21.32,604607,"HOXB13, HPC9",Homeo box B13,HOXB13,10481,ENSG00000159184,NA,"{Prostate cancer, hereditary, 9}, 610997 (3)",Hoxb13 (MGI:107730)
17,48762230,48817246,17q21.32,17q21.32,610849,TTLL6,"Tubulin tyrosine ligase-like family, member 6",TTLL6,284076,ENSG00000170703,NA,NA,Ttll6 (MGI:2683461)
17,48892786,48895870,Chr.17,17q21.32,603192,ATP5G1,"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 1",ATP5MC1,516,ENSG00000159199,NA,NA,Atp5g1 (MGI:107653)
17,48908406,48929055,17q21.32,17q21.32,611362,"UBE2Z, USE1",Ubiquitin-conjugating enzyme E2Z,UBE2Z,65264,ENSG00000159202,NA,NA,Ube2z (MGI:1343160)
17,48929315,48944841,17q21.32,17q21.32,610904,"SNF8, VPS22, EAP30","SNF8, S. cerevisiae, homolog of",SNF8,11267,ENSG00000159210,NA,NA,Snf8 (MGI:1343161)
17,48958553,48968595,17q21.3-q22,17q21.32,137240,GIP,Gastric inhibitory polypeptide,GIP,2695,ENSG00000159224,NA,NA,Gip (MGI:107504)
17,48997384,49056144,17q21.3,17q21.32,608288,"IGF2BP1, IMP1, CRDBP, ZBP1",Insulin-like growth factor 2 mRNA-binding protein 1,IGF2BP1,10642,ENSG00000159217,NA,NA,Igf2bp1 (MGI:1890357)
17,49120346,49176839,17q21.2,17q21.32,111730,"B4GALGT2, GALGT2, SD","Beta-1,4-N-acetyl-galactosaminyl transferase 2",B4GALNT2,124872,ENSG00000167080,NA,NA,B4galnt2 (MGI:1342058)
17,49206233,49210573,17q21,17q21.32,139391,GNGT2,"Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 2",GNGT2,2793,ENSG00000167083,NA,NA,Gngt2 (MGI:893584)
17,49210226,49223224,17q21.3,17q21.32,606363,NESH,NESH protein,ABI3,51225,ENSG00000108798,NA,NA,Abi3 (MGI:1913860)
17,49289205,49362472,17q21.32,17q21.32-q21.33,613907,"ZNF652, KIAA0924",Zinc finger protein 652,ZNF652,22834,ENSG00000198740,NA,NA,Zfp652 (MGI:2442221)
17,49404047,49414904,17q21,17q21.33,176705,PHB,Prohibitin,PHB,5245,ENSG00000167085,NA,"{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation",Phb (MGI:97572)
17,49495292,49515007,17q21-q22,17q21.33,162010,"NGFR, TNFRSF16",Nerve growth factor receptor,NGFR,4804,ENSG00000064300,"distal to APL breakpoint, q21; < 0.5mb from HOX2",NA,Ngfr (MGI:97323)
17,49575870,49583809,17q21.33,17q21.33,604636,"NXPH3, NPH3",Neuroexophilin 3,NXPH3,11248,ENSG00000182575,NA,NA,Nxph3 (MGI:1336188)
17,49598883,49678162,17q21.33,17q21.33,602650,SPOP,Speckle-type POZ protein,SPOP,8405,ENSG00000121067,NA,NA,Spop (MGI:1343085)
17,49700942,49708172,17q21.33,17q21.33,610790,"SLC35B1, UGTREL1","Solute carrier family 35, member B1",SLC35B1,10237,ENSG00000121073,NA,NA,Slc35b1 (MGI:1343133)
17,49788680,49835025,17q21.32,17q21.33,609880,"KAT7, MYST2, HBO1",K(lysine) acetyltransferase 7,KAT7,11143,ENSG00000136504,NA,NA,Kat7 (MGI:2182799)
17,49838308,49848016,17q21.3,17q21.33,607833,"RAC4, PPTC, HK1",Tachykinin 4,TAC4,255061,ENSG00000176358,NA,NA,NA
17,49968969,49974958,17q21.3-q22,17q21.33,601911,"DLX4, DLX7, DLX8, OFC15",Distal-less homeo box-4,DLX4,1748,ENSG00000108813,mutation identified in 1 OFC15 family,"?Orofacial cleft 15, 616788 (3), Autosomal dominant",Dlx4 (MGI:94904)
17,49990004,49995223,17q21.3-q22,17q21.33,600525,"DLX3, TDO, AI4",Distal-less homeo box-3,DLX3,1747,ENSG00000064195,NA,"Amelogenesis imperfecta, type IV, 104510 (3), Autosomal dominant; Trichodontoosseous syndrome, 190320 (3), Autosomal dominant",Dlx3 (MGI:94903)
17,50056064,50090480,17q21.33,17q21.33,605025,"ITGA3, CD49C, GAPB3, ILNEB","Integrin, alpha-3",ITGA3,3675,ENSG00000005884,NA,"Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3), Autosomal recessive",Itga3 (MGI:96602)
17,50094736,50112151,17q21.33,17q21.33,602525,PDK2,"Pyruvate dehydrogenase kinase, isoenzyme 2",PDK2,5164,ENSG00000005882,NA,NA,Pdk2 (MGI:1343087)
17,50133736,50150676,17q21.33,17q21.33,603325,"PPP1R9B, SPINO","Protein phosphatase 1, regulatory subunit 9B",PPP1R9B,84687,ENSG00000108819,NA,NA,Ppp1r9b (MGI:2387581)
17,50165516,50175931,17q12-q21.33,17q21.33,600119,"SGCA, ADL, DAG2, LGMDR3","Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein; adhalin)",SGCA,6442,ENSG00000108823,NA,"Muscular dystrophy, limb-girdle, autosomal recessive 3, 608099 (3), Autosomal recessive",Sgca (MGI:894698)
17,50171427,50172475,17q21.33,17q21.33,608101,HILS1,Spermatid-specific linker histone H1-like protein,HILS1,373861,NA,NA,NA,NA
17,50184095,50201648,17q21.31-q22,17q21.33,120150,"COL1A1, OI1, OI2, OI3, OI4, EDSARTH1","Collagen I, alpha-1 polypeptide",COL1A1,1277,ENSG00000108821,fused with PDGFB in DFPB,"{Bone mineral density variation QTL, osteoporosis}, 166710 (3), Autosomal dominant; Caffey disease, 114000 (3), Autosomal dominant; Ehlers-Danlos syndrome, arthrochalasia type, 1, 130060 (3), Autosomal dominant; Osteogenesis imperfecta, type I, 166200 (3), Autosomal dominant; Osteogenesis imperfecta, type II, 166210 (3), Autosomal dominant; Osteogenesis imperfecta, type III, 259420 (3), Autosomal dominant; Osteogenesis imperfecta, type IV, 166220 (3), Autosomal dominant",Col1a1 (MGI:88467)
17,50346031,50361184,17q21.3-q22,17q21.33,608125,"XYLT2, XT2, SOS",Xylosyltransferase 2,XYLT2,64132,ENSG00000015532,NA,"{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3), Autosomal recessive; Spondyloocular syndrome, 605822 (3), Autosomal recessive",Xylt2 (MGI:2444797)
17,50367866,50373183,17q21.3-q22,17q21.33,611837,MRPL27,Mitochondrial ribosomal protein L27,MRPL27,51264,ENSG00000108826,NA,NA,Mrpl27 (MGI:2137224)
17,50373219,50381478,17q21.3,17q21.33,610885,EME1,"Essential meiotic endonuclease 1, S. pombe, homolog of, 1",EME1,146956,ENSG00000154920,NA,NA,Eme1 (MGI:3576783)
17,50381237,50397522,17q21.33,17q21.33,614854,"LRRC59, p34",Leucine-rich repeat-containing protein 59,LRRC59,55379,ENSG00000108829,NA,NA,Lrrc59 (MGI:2138133)
17,50426157,50474844,17q21.33,17q21.33,610465,"ACSF2, FLJ20920",Acyl-CoA synthetase family member 2,ACSF2,80221,ENSG00000167107,NA,NA,Acsf2 (MGI:2388287)
17,50464491,50469880,17q21.33,17q21.33,602178,CHAD,Chondroadherin,CHAD,1101,ENSG00000136457,NA,NA,Chad (MGI:1096866)
17,50507777,50531501,17q21,17q21.33,609835,"MYCBPAP, AMAP1",MYCBP-associated protein,MYCBPAP,84073,ENSG00000136449,NA,NA,Mycbpap (MGI:2388726)
17,50532734,50543749,Chr.17,17q21.33,607264,EPN3,Epsin 3,EPN3,55040,ENSG00000049283,NA,NA,Epn3 (MGI:1919139)
17,50547088,50555851,17q21.33,17q21.33,613939,"SPATA20, SSP411",Spermatogenesis-associated protein 20,SPATA20,64847,ENSG00000006282,NA,NA,Spata20 (MGI:2183449)
17,50560714,50629624,17q22,17q21.33,604065,"CACNA1G, SCA42, SCA42ND","Calcium channel, voltage-dependent, T type, alpha-1G subunit",CACNA1G,8913,ENSG00000006283,NA,"Spinocerebellar ataxia 42, 616795 (3), Autosomal dominant; Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits, 618087 (3), Autosomal dominant",Cacna1g (MGI:1201678)
17,50634880,50692252,17q22,17q21.33,604323,"ABCC3, CMOAT2, MRP3, MLP2","ATP-binding cassette, sub-family C, member 3",ABCC3,8714,ENSG00000108846,NA,NA,Abcc3 (MGI:1923658)
17,50719564,50756218,17q21.3,17q21.33,609434,"LUC7L3, CROP, LUC7A","Luc7, S. cerevisiae, homolog of, 3",LUC7L3,51747,ENSG00000108848,NA,NA,Luc7l3 (MGI:1914934)
17,50834583,50842352,17q21.3,17q21.33,610895,"WFIKKN2, WFIKKNRP","WAP, fillistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 2",WFIKKN2,124857,ENSG00000173714,NA,NA,Wfikkn2 (MGI:2669209)
17,50862222,50867977,17q21,17q21.33,605523,"TOB1, TOB","Transducer of ERBB2, 1",TOB1,10140,ENSG00000141232,NA,NA,Tob1 (MGI:1349721)
17,50962173,51120867,17q21.33,17q21.33,605430,"SPAG9, SYD1, KIAA0516",Sperm-associated antigen 9,SPAG9,9043,ENSG00000008294,NA,NA,Spag9 (MGI:1918084)
17,51153558,51162088,17q21.3,17q21.33,156490,"NME1, NM23","Non-metastatic cells 1, protein (NM23A) expressed in",NME1,4830,ENSG00000239672,NA,"Neuroblastoma, 256700 (3), Autosomal dominant, Somatic mutation",Nme1 (MGI:97355)
17,51165535,51171743,17q21.3,17q21.33,156491,NME2,"Non-metastatic cells 2, protein (NM23) expressed in",NME2,4831,ENSG00000243678,NA,NA,Nme2 (MGI:97356)
17,51260545,51297932,17q21.33,17q21.33,612816,UTP18,"UTP18, S. cerevisiae, homolog of",UTP18,51096,ENSG00000011260,NA,NA,Utp18 (MGI:1923402)
17,51630312,52160016,17q21.33-q22,17q21-q22,604642,"CA10, CARPX",Carbonic anhydrase X,CA10,56934,ENSG00000154975,NA,NA,Car10 (MGI:1919855)
17,52100000,59500000,17q22,NA,151441,BCL5,B-cell CLL/lymphoma-5,BCL5,603,NA,NA,NA,NA
17,53822926,53825192,17q22,17q22,615142,KIF2B,Kinesin family member 2B,KIF2B,84643,ENSG00000141200,NA,NA,Kif2b (MGI:1920720)
17,54900690,54961966,17q22,17q22,604701,TOM1L1,TOM1-like 1,TOM1L1,10040,ENSG00000141198,NA,NA,Tom1l1 (MGI:1919193)
17,54951897,54968784,17q22,17q22,603648,COX11,"Cytochrome c oxidase, subunit 11",COX11,1353,ENSG00000166260,pseudogene on 6p23-p22,NA,Cox11 (MGI:1917052)
17,54968727,55173631,17q22,17q22,610415,"STXBP4, SYNIP",Syntaxin-binding protein 4,STXBP4,252983,ENSG00000166263,NA,NA,Stxbp4 (MGI:1342296)
17,55264959,55325186,17q22,17q22,142385,HLF,Hepatic leukemia factor,HLF,3131,ENSG00000108924,NA,NA,Hlf (MGI:96108)
17,55392616,55421885,17q22,17q22,604467,"MMD, MMD1, PAQR11",Monocyte-to-macrophage differentiation-associated protein,MMD,23531,ENSG00000108960,NA,NA,Mmd (MGI:1914718)
17,55719626,55732080,17q22,17q22,616334,TMEM100,Transmembrane protein 100,TMEM100,55273,ENSG00000166292,NA,NA,Tmem100 (MGI:1915138)
17,55750978,55845000,17q21-q22,17q22,606055,PCTP,Phosphatidylcholine transfer protein,PCTP,58488,ENSG00000141179,NA,NA,Pctp (MGI:107375)
17,56593698,56595597,17q22,17q22,602991,"NOG, SYM1, SYNS1A","Noggin, mouse, homolog of",NOG,9241,ENSG00000183691,NA,"Brachydactyly, type B2, 611377 (3), Autosomal dominant; Multiple synostoses syndrome 1, 186500 (3), Autosomal dominant; Stapes ankylosis with broad thumbs and toes, 184460 (3), Autosomal dominant; Symphalangism, proximal, 1A, 185800 (3), Autosomal dominant; Tarsal-carpal coalition syndrome, 186570 (3), Autosomal dominant",Nog (MGI:104327)
17,56834130,56869566,17q22,17q22,601440,"DGKE, NPHS7, AHUS7","Diacylglycerol kinase, epsilon, 64-kD",DGKE,8526,ENSG00000153933,NA,"{Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3), Autosomal recessive; Nephrotic syndrome, type 7, 615008 (3), Autosomal recessive",Dgke (MGI:1889276)
17,56887908,56914048,17q23.1,17q22,600453,"TRIM25, ZNF147, EFP",Tripartite motif-containing 25,TRIM25,7706,ENSG00000121060,300kb from MPO,NA,Trim25 (MGI:102749)
17,56938198,56961049,17q22-q23,17q22,600272,"COIL, CLN80",Coilin p80,COIL,8161,ENSG00000121058,NA,NA,Coil (MGI:104842)
17,57085245,57121343,Chr.17,17q22,602449,"AKAP1, AKAP149, SAKAP84","A-kinase anchor protein 1, 149kD",AKAP1,8165,ENSG00000121057,NA,NA,Akap1 (MGI:104729)
17,57255850,57684688,17q22,17q22,607897,MSI2,"Musashi, Drosophila, homolog of, 2",MSI2,124540,ENSG00000153944,NA,NA,Msi2 (MGI:1923876)
17,57834780,57850043,17q22-q23,17q22,611985,MRPS23,Mitochondrial ribosomal protein S23,MRPS23,51649,ENSG00000181610,NA,NA,Mrps23 (MGI:1928138)
17,57971546,57988253,17q22,17q22,606747,"VEZF1, ZNF161",Vascular endothelial zinc finger 1,VEZF1,7716,ENSG00000136451,NA,NA,Vezf1 (MGI:1313291)
17,58000918,58007345,17q21.3-q22,17q22,600812,"SRSF1, SFRS1, ASF, SF2, SRp30a","Splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)",SRSF1,6426,ENSG00000136450,NA,NA,Srsf1 (MGI:98283)
17,58083418,58095541,17q23.2,17q22,608942,"DYNLL2, DLC2","Dynein, light chain, LC8-type 2",DYNLL2,140735,ENSG00000264364,NA,NA,Dynll2 (MGI:1915347)
17,58192725,58205173,17q23.1,17q22,131399,"EPX, EPXD",Eosinophil peroxidase,EPX,8288,ENSG00000121053,NA,"[Eosinophil peroxidase deficiency], 261500 (3), Autosomal recessive",Epx (MGI:107569)
17,58205435,58219604,17q23,17q22,609883,"MKS1, MKS, BBS13, JBTS28",MKS1 gene,MKS1,54903,ENSG00000011143,frequent in Finland,"Bardet-Biedl syndrome 13, 615990 (3), Autosomal recessive; Joubert syndrome 28, 617121 (3), Autosomal recessive; Meckel syndrome 1, 249000 (3), Autosomal recessive",Mks1 (MGI:3584243)
17,58238425,58268517,17q23.1,17q22,150205,LPO,Lactoperoxidase,LPO,4025,ENSG00000167419,NA,NA,Lpo (MGI:1923363)
17,58269854,58280934,17q23.1,17q22,606989,MPO,Myeloperoxidase,MPO,4353,ENSG00000005381,translocated in t(15;17)(q22;q11.2),"{Alzheimer disease, susceptibility to}, 104300 (3), Autosomal dominant; {Lung cancer, protection against, in smokers} (3); Myeloperoxidase deficiency, 254600 (3), Autosomal recessive",Mpo (MGI:97137)
17,58301230,58328794,17q23.2,17q22,610764,"BZRAP1, PRAX1, RIMBP1, KIAA0612",Benzodiazapine receptor (peripheral)-associated protein 1,TSPOAP1,9256,ENSG00000005379,NA,NA,Tspoap1 (MGI:2450877)
17,58331231,58331317,17q22,17q22,615657,MIR142,Micro RNA 142,MIR142,406934,ENSG00000284353,NA,NA,NA
17,58345174,58352237,17q22,17q22,603555,SUPT4H1,"Suppressor of Ty, S. cerevisiae, homolog of, 1",SUPT4H1,6827,ENSG00000213246,NA,NA,Supt4a (MGI:107416)
17,58352499,58418893,17q23.2,17q22,612482,"RNF43, RNF124, SSPCS",Ring finger protein 43,RNF43,54894,ENSG00000108375,NA,"Sessile serrated polyposis cancer syndrome, 617108 (3), Autosomal dominant",Rnf43 (MGI:2442609)
17,58489532,58518108,Chr.17,17q22,603559,MTMR4,Myotubularin-related protein 4,MTMR4,9110,ENSG00000108389,NA,NA,Mtmr4 (MGI:2180699)
17,58520249,58544371,17q23,17q22,603696,"SEPT4, PNUTL2",Septin 4,SEPTIN4,5414,ENSG00000108387,NA,NA,Sept4 (MGI:1270156)
17,58556676,58692054,17q22,17q22,605792,"TEX14, SPGF23",Testis-expressed gene 14,TEX14,56155,ENSG00000121101,mutation identified in 1 SPGF23 family,"?Spermatogenic failure 23, 617707 (3), Autosomal recessive",Tex14 (MGI:1933227)
17,58692139,58735610,17q22,17q22,602774,"RAD51C, FANCO, BROVCA3","RAD51, S. cerevisiae, homolog of, C",RAD51C,5889,ENSG00000108384,NA,"{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive",Rad51c (MGI:2150020)
17,58968009,59106963,17q22-q23,17q22,605073,"TRIM37, MUL, KIAA0898",Tripartite motif-containing 37,TRIM37,4591,ENSG00000108395,NA,"Mulibrey nanism, 253250 (3), Autosomal recessive",Trim37 (MGI:2153072)
17,59109856,59155185,17q22,17q22,616674,"SKA2, FAM33A","Spindle- and kinetochore-associated complex, subunit 2",SKA2,348235,ENSG00000182628,NA,NA,Ska2 (MGI:1913390)
17,59151135,59151220,17q22,17q22,615675,"MIR301A, MIR301",Micro RNA 301A,MIR301A,407027,ENSG00000207996,NA,NA,NA
17,59155354,59206708,17q22,17q22,615920,PRR11,Proline-rich protein 11,PRR11,55771,ENSG00000068489,NA,NA,Prr11 (MGI:2444496)
17,59210009,59215249,17q22,17q22,613175,"C17orf71, SMG8",Chromosome 17 open reading frame 71,SMG8,55181,ENSG00000167447,NA,NA,Smg8 (MGI:1921383)
17,59220469,59275969,17q23.2,17q22,616317,"GDPD1, GDE4",Glycerophosphodiester phosphodiesterase domain-containing protein 1,GDPD1,284161,ENSG00000153982,NA,NA,Gdpd1 (MGI:1913819)
17,59331654,59401731,17q23.2,17q22,609723,YPEL2,Yippee-like 2,YPEL2,388403,ENSG00000175155,NA,NA,Ypel2 (MGI:1925114)
17,59500000,64600000,17q23,NA,609656,BSZQTL,Bone size quantitative trait locus 1,NA,100188793,NA,NA,"{Bone size QTL}, 609656 (2)",NA
17,59500000,63100000,17q23.1-q23.2,NA,613355,"DEL17q23.1q23.2, C17DELq23.1q23.2",Chromosome 17q23.1-q23.2 deletion syndrome,NA,NA,NA,NA,"Chromosome 17q23.1-q23.2 deletion syndrome, 613355 (4), Isolated cases",NA
17,59500000,63100000,17q23.1-q23.2,NA,613618,"DUP17q23.1q23.2, C17DUPq23.1q23.2",Chromosome 17q23.1-q23.2 duplication syndrome,NA,NA,NA,2.2 Mb contiguous gene duplication syndrome,"Chromosome 17q23.1-q23.2 duplication syndrome, 613618 (4), Autosomal dominant",NA
17,59500000,83257441,17q23-qter,NA,170200,PEPE,Peptidase E,PEPE,5185,NA,NA,NA,NA
17,59565562,59608344,17q23.3,17q23.1,607570,"DHX40, DDX40",DEAH (Asp-Glu-Ala-His) box polypeptide 40,DHX40,79665,ENSG00000108406,NA,NA,Dhx40 (MGI:1914737)
17,59619688,59696955,17q23,17q23.1,118955,"CLTC, MRD56","Clathrin, heavy polypeptide (Hc)",CLTC,1213,ENSG00000141367,fusion gene with TFE3 in renal adenocarcinoma,"Mental retardation, autosomal dominant 56, 617854 (3), Autosomal dominant",Cltc (MGI:2388633)
17,59697305,59707625,17q23.1,17q23.1,608625,"PTRH2, BIT1, IMNEPD",Peptidyl-tRNA hydrolase 2,PTRH2,51651,ENSG00000141378,NA,"Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3), Autosomal recessive",Ptrh2 (MGI:2444848)
17,59707653,59842254,17q23.1,17q23.1,611753,"VMP1, TMEM49, EPG3",Vacuole membrane protein 1,VMP1,81671,ENSG00000062716,NA,NA,Vmp1 (MGI:1923159)
17,59841265,59841336,17q23.1,17q23.1,611020,"MIR21, MIRN21",Micro RNA 21,MIR21,406991,ENSG00000284190,NA,NA,NA
17,59859466,59892947,Chr.17,17q23.1,607344,"TUBD1, TUBD","Tubulin, delta-1",TUBD1,51174,ENSG00000108423,NA,NA,Tubd1 (MGI:1891826)
17,59893045,59950573,17q23.1,17q23.1,608938,"RPS6KB1, S6K1","Ribosomal protein S6 kinase, 70kD",RPS6KB1,6198,ENSG00000108443,NA,NA,Rps6kb1 (MGI:1270849)
17,59952239,59964739,17q23.1,17q23.1,615172,RNFT1,"RING finger protein, transmembrane 1",RNFT1,51136,ENSG00000189050,NA,NA,Rnft1 (MGI:1924142)
17,60083565,60088466,17q23,17q23.1,615772,"LNCDC, LOC615638","Long noncoding RNA, dendritic cell",WFDC21P,645638,ENSG00000261040,NA,NA,NA
17,60149935,60179020,17q23,17q23.1,114760,"CA4, RP17",Carbonic anhydrase IV,CA4,762,ENSG00000167434,NA,"Retinitis pigmentosa 17, 600852 (3), Autosomal dominant",Car4 (MGI:1096574)
17,60177230,60422469,17q22,17q23.1-q23.2,607740,"USP32, USP10",Ubiquitin-specific protease 32,USP32,84669,ENSG00000170832,NA,NA,Usp32 (MGI:2144475)
17,60200000,76800000,17q23.2-q25.1,NA,612967,BMIQ15,Body mass index quantitative trait locus 15,NA,100302719,NA,associated with rs228883 and rs1005651,"[Body mass index QTL 15], 612967 (2)",NA
17,60443148,60526241,17q22-q23,17q23.2,605324,"APPBP2, PAT1",Amyloid beta precursor protein-binding protein 2,APPBP2,10513,ENSG00000062725,NA,NA,Appbp2 (MGI:1914134)
17,60600182,60666279,17q22-q23,17q23.2,605100,"PPM1D, WIP1, JDVS","Protein phosphatase, magnesium-dependent, 1, delta isoform",PPM1D,8493,ENSG00000170836,amplified in breast cancer,"Breast cancer, somatic, 114480 (3); Jansen de Vries syndrome, 617450 (3), Autosomal dominant",Ppm1d (MGI:1858214)
17,61399842,61409465,17q23,17q23.2,600747,"TBX2, VETD",T-box 2,TBX2,6909,ENSG00000121068,NA,"Vertebral anomalies and variable endocrine and T-cell dysfunction, 618223 (3), Autosomal dominant",Tbx2 (MGI:98494)
17,61452421,61485109,17q21-q22,17q23.2,601719,"TBX4, ICPPS",T-box 4,TBX4,9496,ENSG00000121075,NA,"Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension, 147891 (3), Autosomal dominant",Tbx4 (MGI:102556)
17,61679185,61864119,17q22,17q23.2,605882,"BRIP1, BACH1, FANCJ",BRCA1-associated C-terminal helicase 1,BRIP1,83990,ENSG00000136492,?or 17q23,"{Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; Fanconi anemia, complementation group J, 609054 (3)",Brip1 (MGI:2442836)
17,61865366,61927981,17q23.2,17q23.2,611346,"INTS2, INT2, KIAA1287",Integrator complex subunit 2,INTS2,57508,ENSG00000108506,NA,NA,Ints2 (MGI:1917672)
17,61942604,62065982,17q22-q23,17q23.2,603808,"MED13, THRAP1, TRAP240",Mediator complex subunit 13,MED13,9969,ENSG00000108510,NA,NA,Med13 (MGI:3029632)
17,62470907,62615480,17q23.2,17q23.2,608439,"TLK2, MRD57",Tousled-like kinase 2,TLK2,11011,ENSG00000146872,NA,"Mental retardation, autosomal dominant 57, 618050 (3), Autosomal dominant",Tlk2 (MGI:1346023)
17,62627669,62693596,17q23.2,17q23.2,612264,"MRC2, ENDO180, UPARAP, CD280","Mannose receptor, C-type, 2",MRC2,9902,ENSG00000011028,NA,NA,Mrc2 (MGI:107818)
17,62701313,62808345,17q23.2,17q23.2,613337,MARCH10,Membrane-associated RING-CH finger protein 10,MARCHF10,162333,ENSG00000173838,NA,NA,March10 (MGI:2443469)
17,62966234,63427705,17q23.3,17q23.2-q23.3,615047,"TANC2, KIAA1636","Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 2",TANC2,26115,ENSG00000170921,NA,NA,Tanc2 (MGI:2444121)
17,63432303,63446305,17q11-qter,17q23.3,600019,"CYB561, ORTHYP2",Cytochrome b-561,CYB561,1534,ENSG00000008283,NA,"Orthostatic hypotension 2, 618182 (3), Autosomal recessive",Cyb561 (MGI:103253)
17,63477060,63498372,17q23,17q23.3,106180,"ACE, DCP1, ACE1, MVCD3, ICH",Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1),ACE,1636,ENSG00000159640,NA,"[Angiotensin I-converting enzyme, benign serum increase] (3); {Microvascular complications of diabetes 3}, 612624 (3); {Myocardial infarction, susceptibility to} (3); Renal tubular dysgenesis, 267430 (3), Autosomal recessive; {SARS, progression of} (3); {Stroke, hemorrhagic}, 614519 (3)",Ace (MGI:87874)
17,63523333,63548986,17q23.3,17q23.3,608168,"KCNH6, HERG2","Potassium channel, voltage-gated, subfamily H, member 6",KCNH6,81033,ENSG00000173826,NA,NA,Kcnh6 (MGI:2684139)
17,63600894,63608364,17q22-q24.2,17q23.3,612958,"TACO1, CCDC44",Translational activator of mitochondrially encoded cytochrome c oxidase subunit I,TACO1,51204,ENSG00000136463,NA,"Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Taco1 (MGI:1917457)
17,63622208,63696304,17q23.3,17q23.3,602539,"MAP3K3, MEKK3, MAPKKK3",Mitogen-activated kinase kinase kinase 3,MAP3K3,4215,ENSG00000198909,NA,NA,Map3k3 (MGI:1346874)
17,63702831,63741985,17q23.3,17q23.3,608626,"STRADA, STRAD, LYK5",STE20-related kinase adaptor alpha,STRADA,92335,ENSG00000266173,NA,"Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3), Autosomal recessive",Strada (MGI:1919399)
17,63745254,63773596,17q23.3,17q23.3,618260,"CCDC47, THNS",Coiled-coil domain-containing protein 47,CCDC47,57003,ENSG00000108588,NA,"Trichohepatoneurodevelopmental syndrome, 618268 (3), Autosomal recessive",Ccdc47 (MGI:1914413)
17,63773855,63819316,17q23.3,17q23.3,613369,"DDX42, RHELP",DEAD (Asp-Glu-Ala-Asp) box polypeptide 42,DDX42,11325,ENSG00000198231,NA,NA,Ddx42 (MGI:1919297)
17,63819432,63827662,17q23.3,17q23.3,618411,FTSJ3,FTSJ RNA 2-prime-O-methyltransferase 3,FTSJ3,117246,ENSG00000108592,NA,NA,Ftsj3 (MGI:1860295)
17,63827430,63832026,17q24-q25,17q23.3,601681,"PSMC5, TRIP1","Proteasome (prosome, macropain) 26S subunit, ATPase, 5",PSMC5,5705,ENSG00000087191,NA,NA,Psmc5 (MGI:105047)
17,63832080,63842684,17q23-q24,17q23.3,601736,"SMARCD2, BAF60B, SGD2","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2",SMARCD2,6603,ENSG00000108604,NA,"Specific granule deficiency 2, 617475 (3), Autosomal recessive",Smarcd2 (MGI:1933621)
17,63857015,63864378,17q23.3,17q23.3,612756,TCAM1,Testicular cell adhesion molecule 1,TCAM1P,146771,ENSG00000240280,NA,NA,NA
17,63872011,63873728,17q22-q24,17q23.3,118820,"CSH2, CSB",Chorionic somatomammotropin B,CSH2,1443,ENSG00000213218,NA,NA,NA
17,63880214,63881943,17q22-q24,17q23.3,139240,"GH2, GHV",Growth hormone-2,GH2,2689,ENSG00000136487,NA,NA,NA
17,63894917,63896573,17q22-q24,17q23.3,150200,"CSH1, CSA, PL",Chorionic somatomammotropin hormone-1,CSH1,1442,ENSG00000136488,NA,[Placental lactogen deficiency] (1),NA
17,63909601,63911279,17q22-q24,17q23.3,603515,"CSHL1, CSL",Chorionic somatomammotropin hormone-like 1,CSHL1,1444,ENSG00000204414,NA,NA,Gh (MGI:95707)
17,63917202,63918838,17q22-q24,17q23.3,139250,"GH1, GHN, IGHD1A, IGHD1B, IGHD2",Growth hormone-1,GH1,2688,ENSG00000259384,5'-GH1-CSHP1-CSH1-GH2-CSH2-3',"Growth hormone deficiency, isolated, type IA, 262400 (3), Autosomal recessive; Growth hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type II, 173100 (3), Autosomal dominant; Kowarski syndrome, 262650 (3), Autosomal recessive",NA
17,63928739,63932330,17q23,17q23.3,147245,"CD79B, IGB, B29, AGM6",CD79B antigen,CD79B,974,ENSG00000007312,NA,"Agammaglobulinemia 6, 612692 (3), Autosomal recessive",Cd79b (MGI:96431)
17,63938553,63972917,17q23.1-q25.3,17q23.3,603967,"SCN4A, HYPP, NAC1A, HOKPP2, CMS16","Sodium channel, voltage-gated, type IV, alpha polypeptide",SCN4A,6329,ENSG00000007314,21.5kb from GH1,"Hyperkalemic periodic paralysis, type 2, 170500 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 2, 613345 (3), Autosomal dominant; Myasthenic syndrome, congenital, 16, 614198 (3), Autosomal recessive; Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3), Autosomal dominant; Paramyotonia congenita, 168300 (3), Autosomal dominant",Scn4a (MGI:98250)
17,64002594,64020633,17q23-q25,17q23.3,146630,ICAM2,Intercellular adhesion molecule-2,ICAM2,3384,ENSG00000108622,NA,NA,Icam2 (MGI:96394)
17,64039141,64132468,17q23.3,17q23.3,604033,"ERN1, IRE1, IRE1A",Endoplasmic reticulum-to-nucleus signaling 1,ERN1,2081,ENSG00000178607,NA,NA,Ern1 (MGI:1930134)
17,64319414,64413843,17q23,17q23.3,173445,PECAM1,Platelet/endothelial cell adhesion molecule (CD31 antigen),PECAM1,5175,ENSG00000261371,NA,NA,Pecam1 (MGI:97537)
17,64477784,64497053,17q23-q24,17q23.3,604983,"POLG2, POLGB, PEOA4","Polymerase, DNA, gamma-2",POLG2,11232,ENSG00000256525,NA,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3), Autosomal dominant",Polg2 (MGI:1354947)
17,64498253,64506865,17q23-q25,17q23.3,180630,"DDX5, HLR1, G17P1","DEAD/H box-5 (RNA helicase, 68kD)",DDX5,1655,ENSG00000108654,near BRCA1,NA,Ddx5 (MGI:105037)
17,64542281,64662306,17q23.3-q24.1,17q23.3-q24.1,605532,SMURF2,SMAD-specific E3 ubiquitin protein ligase 2,SMURF2,64750,ENSG00000108854,NA,NA,Smurf2 (MGI:1913563)
17,64600000,72900000,17q24,NA,115660,"CTRCT7, CCA1",Cataract 7,CCA1,878,NA,NA,"Cataract 7, 115660 (2), Autosomal dominant",NA
17,64600000,72900000,17q24,NA,616425,SRXY10,"46,XY sex reversal 10",NA,NA,NA,deletion of 32.5kb XYSR regulatory region upstream of SOX9,"46XY sex reversal 10, 616425 (4), Autosomal dominant",NA
17,64854133,64919490,17q24.1,17q24.1,616557,LRRC37A3,Leucine-rich repeat-containing protein 37A3,LRRC37A3,374819,ENSG00000176809,NA,NA,NA
17,65009288,65056739,17q24.3,17q24.1,604406,GNA13,"Guanine nucleotide-binding protein, alpha-13",GNA13,10672,ENSG00000120063,NA,NA,Gna13 (MGI:95768)
17,65137337,65227702,17q23-q24,17q24.1,604067,"RGS9, PERRS",Regulator of G protein signaling 9,RGS9,8787,ENSG00000108370,NA,"Bradyopsia, 608415 (3)",Rgs9 (MGI:1338824)
17,65528562,65561647,17q24,17q24.1,604025,"AXIN2, ODCRCS","Axis inhibitor 2 (conductin, mouse, homolog of)",AXIN2,8313,ENSG00000168646,NA,"Colorectal cancer, somatic, 114500 (3); Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant",Axin2 (MGI:1270862)
17,66200000,72900000,17q24.2-q24.3,NA,135400,"HTGH, DEL17q24","Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (chromosome 17q24 microdeletion syndrome)",NA,NA,NA,NA,"Hypertrichosis terminalis, generalized, with or without gingival hyperplasia, 135400 (4), Autosomal recessive",NA
17,66212032,66229414,17q23-qter,17q24.2,138700,APOH,Apolipoprotein H (beta-2-glycoprotein I),APOH,350,ENSG00000091583,NA,NA,Apoh (MGI:88058)
17,66302612,66810742,17q22-q23.2,17q24.2,176960,"PRKCA, PKCA","Protein kinase C, alpha polypeptide",PRKCA,5578,ENSG00000154229,cen-COL1A1-PKCA-GH1,"Pituitary tumor, invasive (3)",Prkca (MGI:97595)
17,66877272,66885277,17q24,17q24.2,606405,CACNG5,"Calcium channel, voltage-dependent, gamma-5 subunit",CACNG5,27091,ENSG00000075429,NA,NA,Cacng5 (MGI:2157946)
17,66964706,67033397,17q24.2,17q24.2,606404,CACNG4,"Calcium channel, voltage-dependent, gamma-4 subunit",CACNG4,27092,ENSG00000075461,NA,NA,Cacng4 (MGI:1859167)
17,67044553,67056796,17q24,17q24.2,114209,"CACNG1, CACNLG","Calcium channel, voltage-dependent, gamma-1 subunit",CACNG1,786,ENSG00000108878,NA,NA,Cacng1 (MGI:1206582)
17,67070443,67245988,17q24.2,17q24.2,606699,"HELZ, KIAA0054, HUMORF5",Helicase with zinc finger domain,HELZ,9931,ENSG00000198265,NA,NA,Helz (MGI:1925705)
17,67337915,67366597,17q24.2,17q24.2,604450,"PSMD12, P55, STISS","Proteasome 26S subunit, non-ATPase, 12",PSMD12,5718,ENSG00000197170,NA,"Stankiewicz-Isidor syndrome, 617516 (3), Autosomal dominant",Psmd12 (MGI:1914247)
17,67377280,67697255,17q24.2,17q24.2,605134,"PITPNC1, RDGBB","Phosphatidylinositol transfer protein, cytoplasmic, 1",PITPNC1,26207,ENSG00000154217,NA,NA,NA
17,67717832,67744530,17q24.2,17q24.2,615366,NOL11,Nucleolar protein 11,NOL11,25926,ENSG00000130935,NA,NA,Nol11 (MGI:1916229)
17,67825502,67984377,17q24,17q24.2,601819,"BPTF, FALZ, FAC1, NURF301, NEDDFL",Bromodomain PHD finger transcription factor,BPTF,2186,ENSG00000171634,NA,"Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3), Autosomal dominant",Bptf (MGI:2444008)
17,68035734,68046858,17q23-q24,17q24.2,600685,"KPNA2, RCH1, QIP2",Karyopherin alpha-2,KPNA2,3838,ENSG00000182481,NA,NA,Kpna2 (MGI:103561)
17,68205485,68257163,17q24.2,17q24.2,615169,AMZ2,Archaelysin family metallopeptidase 2,AMZ2,51321,ENSG00000196704,NA,NA,NA
17,68259169,68452018,17q24.2,17q24.2,610008,"ARSG, KIAA1001, USH4",Arylsulfatase G,ARSG,22901,ENSG00000141337,NA,"Usher syndrome, type IV, 618144 (3), Autosomal recessive",Arsg (MGI:1921258)
17,68267025,68291438,17q24.2,17q24.2,603880,"SLC16A6, MCT7",Solute carrier family 16 (monocarboxylic acid transporter) member 6,SLC16A6,9120,ENSG00000108932,NA,NA,Slc16a6 (MGI:2144585)
17,68413622,68551315,17q23-q24,17q24.2,188830,"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1","Protein kinase, cAMP-dependent, regulatory, type I, alpha",PRKAR1A,5573,ENSG00000108946,fused with RET to form PTC2,"Acrodysostosis 1, with or without hormone resistance, 101800 (3), Autosomal dominant; Adrenocortical tumor, somatic (3); Carney complex, type 1, 160980 (3), Autosomal dominant; Myxoma, intracardiac, 255960 (3), Autosomal dominant; Pigmented nodular adrenocortical disease, primary, 1, 610489 (3), Autosomal dominant",Prkar1a (MGI:104878)
17,68530275,68601366,17q24.2,17q24.2,611062,"FAM20A, AIGFS, AI1G","Family with sequence similarity 20, member A",FAM20A,54757,ENSG00000108950,NA,"Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3), Autosomal recessive",Fam20a (MGI:2388266)
17,68867284,68955425,17q24.2,17q24.2,612505,"ABCA8, KIAA0822","ATP-binding cassette, subfamily A, member 8",ABCA8,10351,ENSG00000141338,NA,NA,Abca8b (MGI:1351668)
17,68974487,69078977,17q24.2,17q24.2,612507,ABCA9,"ATP-binding cassette, subfamily A, member 9",ABCA9,10350,ENSG00000154258,NA,NA,Abca9 (MGI:2386796)
17,69062043,69141926,17q24.2,17q24.2-q24.3,612504,ABCA6,"ATP-binding cassette, subfamily A, member 6",ABCA6,23460,ENSG00000154262,NA,NA,Abca6 (MGI:1923434)
17,69100000,76800000,17q24.3-q25.1,NA,261800,PRBNS,Pierre Robin syndrome,NA,100301572,NA,between D17S795 and D17S929,"Pierre Robin syndrome, 261800 (2), Autosomal recessive",NA
17,69100000,76800000,17q24.3-q25.1,NA,278850,"SRXX2, DUP17q24.3",46XX sex reversal 2,NA,NA,NA,duplication or triplication of 68kb XXSR regulatory region upstream of SOX9,"46XX sex reversal 2, 278850 (4), Autosomal dominant",NA
17,69100000,72900000,17q24.3,NA,614834,TTPP3,"Thyrotoxic periodic paralysis, susceptibility to, 3",NA,112272595,NA,associated with rs312691,"{Thyrotoxic periodic paralysis, susceptibility to, 3}, 614834 (2)",NA
17,69148006,69244814,17q24.2,17q24.3,612508,ABCA10,"ATP-binding cassette, subfamily A, member 10",ABCA10,10349,ENSG00000154263,NA,NA,NA
17,69244310,69327132,17q24.2,17q24.3,612503,"ABCA5, KIAA1888, HTC3","ATP-binding cassette, subfamily A, member 5",ABCA5,23461,ENSG00000154265,mutation identified in 1 HTC3 patient,"?Hypertrichosis, congenital generalized, with gingival hyperplasia, 135400 (3), Autosomal recessive",Abca5 (MGI:2386607)
17,69414696,69553864,17q24.3,17q24.3,601254,"MAP2K6, PRKMK6, MKK6, MEK6, MAPKK6",Mitogen-activated protein kinase kinase 6,MAP2K6,5608,ENSG00000108984,NA,NA,Map2k6 (MGI:1346870)
17,70075224,70135607,17q25,17q24.3,605722,"KCNJ16, KIR5.1","Potassium channel, inwardly rectifying, subfamily J, member 16",KCNJ16,3773,ENSG00000153822,NA,NA,Kcnj16 (MGI:1314842)
17,70169534,70180043,17q23.1-q24.2,17q24.3,600681,"KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9","Potassium channel, inwardly rectifying, subfamily J, member 2",KCNJ2,3759,ENSG00000123700,NA,"Andersen syndrome, 170390 (3), Autosomal dominant; Atrial fibrillation, familial, 9, 613980 (3), Autosomal dominant; Short QT syndrome 3, 609622 (3)",Kcnj2 (MGI:104744)
17,72121019,72126415,17q24.3-q25.1,17q24.3,608160,"SOX9, CMD1, SRA1",SRY (sex-determining region Y)-box 9,SOX9,6662,ENSG00000125398,NA,"Acampomelic campomelic dysplasia, 114290 (3), Autosomal dominant; Campomelic dysplasia, 114290 (3), Autosomal dominant; Campomelic dysplasia with autosomal sex reversal, 114290 (3), Autosomal dominant",Sox9 (MGI:98371)
17,72403321,72592803,17q24.3,17q24.3,617079,"LINC00673, HILNC75, SLNCR, LUCAIR1",Long intergenic noncoding RNA 673,LINC00673,100499467,ENSG00000227036,NA,NA,NA
17,72645948,73092713,17q24.3-q25.1,17q24.3-q25.1,616508,"SLC39A11, ZIP11, C17orf26","Solute carrier family 39 (zinc transporter), member 11",SLC39A11,201266,ENSG00000133195,NA,NA,Slc39a11 (MGI:1917056)
17,72900000,83257441,17q25,NA,602197,CDR3,Cerebellar degeneration-related autoantigen-3,NA,8163,NA,NA,NA,NA
17,72900000,83257441,17q25,NA,614163,DSPS,"Delayed sleep phase syndrome, susceptibility to",NA,NA,NA,associated with rs28936679 in AANAT,"{Delayed sleep phase syndrome, susceptibility to}, 614163 (2), Autosomal dominant",NA
17,72900000,83257441,17q25,NA,603411,EPR1,Effector cell protease receptor 1,NA,NA,NA,NA,NA,NA
17,72900000,83257441,17q25.1-q25.3,NA,614149,NDNC9,"Nail disorder, nonsyndromic congenital, 9 (anonychia-onycholysis)",NA,100682325,NA,max lod at D17S1301,"Nail disorder, nonsyndromic congenital, 9, 614149 (2), Autosomal recessive",NA
17,73165009,73176632,17q24,17q25.1,182452,SSTR2,Somatostatin receptor-2,SSTR2,6752,ENSG00000180616,NA,NA,Sstr2 (MGI:98328)
17,73193054,73208506,17q25.1,17q25.1,606973,"COG1, LDLB, KIAA1381, CDG2G",Component of oligomeric golgi complex 1,COG1,9382,ENSG00000166685,NA,"Congenital disorder of glycosylation, type IIg, 611209 (3), Autosomal recessive",Cog1 (MGI:1333873)
17,73283623,73312000,17q24-q25,17q25.1,605468,"CDC42EP4, BORG4",CDC42 effector protein 4 (binder of Rho GTPases 4),CDC42EP4,23580,ENSG00000179604,NA,NA,Cdc42ep4 (MGI:1929760)
17,73334383,73644480,17q25.1,17q25.1,607217,"SDK2, KIAA1514","Sidekick, Drosophila, homolog of, 2",SDK2,54549,ENSG00000069188,NA,NA,Sdk2 (MGI:2443847)
17,74203677,74210654,17q,17q25.1,604182,RPL38,Ribosomal protein L38,RPL38,6169,ENSG00000172809,NA,NA,Rpl38 (MGI:1914921)
17,74213570,74262019,17q25.1,17q25.1,608855,TTYH2,"Tweety, Drosophila, homolog of, 2",TTYH2,94015,ENSG00000141540,NA,NA,Ttyh2 (MGI:2157091)
17,74274209,74314883,17q25,17q25.1,605483,"DNAI2, CILD9","Dynein, axonemal, intermediate chain 2",DNAI2,64446,ENSG00000171595,NA,"Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)",Dnaic2 (MGI:2685574)
17,74367505,74372599,17q25.1,17q25.1,609046,"GPR142, PGR2",G protein-coupled receptor 142,GPR142,350383,ENSG00000257008,NA,NA,Gpr142 (MGI:2668437)
17,74431349,74451657,17q25.1-q25.3,17q25.1,605949,"GPRC5C, RAIG3","G protein-coupled receptor, family C, group 5, member C",GPRC5C,55890,ENSG00000170412,NA,NA,Gprc5c (MGI:1917605)
17,74466372,74484797,17q24,17q25.1,606790,"CMRF35H, CMRF35H9",CMRF35H antigen,CD300A,11314,ENSG00000167851,NA,NA,Cd300a (MGI:2443411)
17,74521173,74531474,17q25.1,17q25.1,610705,"CD300LB, TREM5, IREM3","CD300 antigen-like family, member B",CD300LB,124599,ENSG00000178789,NA,NA,Cd300lb (MGI:2685099)
17,74534358,74546114,17q22-q24,17q25.1,606786,"CMRF35, CMRF35A",CMRF35 antigen,CD300C,10871,ENSG00000167850,NA,NA,"Cd300c2,Cd300c (MGI:2153249,MGI:3032626)"
17,74557228,74567511,17q25.1,17q25.1,616560,CD300H,CD300H antigen,CD300H,100130520,ENSG00000284690,NA,NA,NA
17,74579364,74592282,17q25.1,17q25.1,616301,"CD300LD, CD300D","CD300 antigen-like family, member D",CD300LD,100131439,ENSG00000204345,NA,NA,"Cd300ld,Cd300ld3,Cd300ld4,Cd300ld5 (MGI:3702661,MGI:2687214,MGI:2442358,MGI:3702658)"
17,74609884,74623957,17q25.1,17q25.1,609801,"CD300E, CD300LE, IREM2, CLM2",CD300E antigen,CD300E,342510,ENSG00000186407,NA,NA,Cd300e (MGI:2387602)
17,74671130,74747334,17q25.1,17q25.1,609956,RAB37,Pas-associated protein RAB37,RAB37,326624,ENSG00000172794,NA,NA,Rab37 (MGI:1929945)
17,74694307,74712999,17q25.1,17q25.1,609807,"CD300LF, IGSF13, IREM1, CLM1","CD300 antigen-like family, member F",CD300LF,146722,ENSG00000186074,NA,NA,Cd300lf (MGI:2442359)
17,74748627,74769352,17q25.1,17q25.1,604990,"SLC9A3R1, EBP50, NHERF1, NPHLOP2","Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 1",SLC9A3R1,9368,ENSG00000109062,NA,"Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3), Autosomal dominant",Slc9a3r1 (MGI:1349482)
17,74842020,74860842,17q25,17q25.1,138254,"GRIN2C, NMDAR2C","Glutamate receptor, ionotropic, N-methyl D-aspartate 2C",GRIN2C,2905,ENSG00000161509,NA,NA,Grin2c (MGI:95822)
17,74862496,74873030,17q24-q25,17q25.1,103270,"FDXR, ADXR, ANOA",Ferredoxin reductase (adrenodoxin reductase),FDXR,2232,ENSG00000161513,NA,"Auditory neuropathy and optic atrophy, 617717 (3), Autosomal recessive",Fdxr (MGI:104724)
17,74916082,74923254,17q24-q25,17q25.1,607696,"SANS, USH1G",Scaffold protein containing ankyrin repeats and SAM domain,USH1G,124590,ENSG00000182040,?allelic to DFNA20,"Usher syndrome, type 1G, 606943 (3), Autosomal recessive",Ush1g (MGI:2450757)
17,74922954,74933912,17q25.3,17q25.1,607827,OTOP2,Otopetrin 2,OTOP2,92736,ENSG00000183034,NA,NA,Otop2 (MGI:2388365)
17,74935801,74949992,17q25.3,17q25.1,607828,OTOP3,Otopetrin 3,OTOP3,347741,ENSG00000182938,NA,NA,Otop3 (MGI:1916852)
17,74950741,74972762,17q25.1,17q25.1,605752,"HID1, 17orf28, DMC1",HID1 domain-containing protein 1,HID1,283987,ENSG00000167861,NA,NA,Hid1 (MGI:2445087)
17,75012669,75021260,17q25.1,17q25.1,603000,"ICT1, DS1",Immature colon carcinoma transcript 1,MRPL58,3396,ENSG00000167862,NA,NA,Mrpl58 (MGI:1915822)
17,75032566,75065888,17q25.1,17q25.1,613422,"KCTD2, KIAA0176",Potassium channel tetramerization domain-containing 2,KCTD2,23510,ENSG00000180901,NA,NA,Kctd2 (MGI:1917632)
17,75038862,75046968,17q25.1,17q25.1,618121,"ATP5PD, APT5H","ATP synthase, peripheral stalk, subunit D",ATP5PD,10476,ENSG00000167863,NA,NA,Atp5h (MGI:1918929)
17,75087764,75106161,17q25.1,17q25.1,603879,"SLC16A5, MCT6",Solute carrier family 16 (monocarboxylic acid transporter) member 5,SLC16A5,9121,ENSG00000170190,NA,NA,Slc16a5 (MGI:2443515)
17,75130224,75131964,17q23-q25,17q25.1,191720,"NT5C, UMPH2, DNT1","5', 3' nucleotidase, cytosolic",NT5C,30833,ENSG00000125458,NA,NA,Nt5c (MGI:1354954)
17,75205435,75235758,17q25,17q25.1,170285,"NUP85, PCNT1, PCNT, NPHS17",Nucleoporin 85kD,NUP85,79902,ENSG00000125450,NA,"Nephrotic syndrome, type 17, 618176 (3), Autosomal recessive",Nup85 (MGI:3046173)
17,75261878,75266375,17q23-q25,17q25.1,611974,"MRPS7, COXPD34",Mitochondrial ribosomal protein S7,MRPS7,51081,ENSG00000125445,mutation identified in 1 COXPD34 family,"?Combined oxidative phosphorylation deficiency 34, 617872 (3), Autosomal recessive",Mrps7 (MGI:1354367)
17,75225463,75262362,Chr.17,17q25.1,606006,"GGA3, KIAA0154","Golgi associated, gamma adaptin ear containing, ARF binding protein 3",GGA3,23163,ENSG00000125447,NA,NA,Gga3 (MGI:2384159)
17,75266227,75271291,17q25.1,17q25.1,612072,"MIF4GD, SLIP1",MIF4G domain-containing protein,MIF4GD,57409,ENSG00000125457,NA,NA,Mif4gd (MGI:1916924)
17,75272979,75289957,17q25.3,17q25.1,606521,"SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4","Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19",SLC25A19,60386,ENSG00000125454,NA,"Microcephaly, Amish type, 607196 (3), Autosomal recessive; Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3), Autosomal recessive",Slc25a19 (MGI:1914533)
17,75318075,75405708,17q24-q25,17q25.1,108355,GRB2,Growth factor receptor-bound protein 2,GRB2,2885,ENSG00000177885,NA,NA,Grb2 (MGI:95805)
17,75441158,75500451,17q25.1,17q25.1,618163,"TMEM94, KIAA0195, IDDCDF",Transmembrane protein 94,TMEM94,9772,ENSG00000177728,NA,"Intellectual developmental disorder with cardiac defects and dysmorphic facies, 618316 (3), Autosomal recessive",Tmem94 (MGI:1919197)
17,75500260,75515536,17q25.1,17q25.1,612185,"CASKIN2, KIAA1139",CASK-interacting protein 2,CASKIN2,57513,ENSG00000177303,NA,NA,Caskin2 (MGI:2157062)
17,75516527,75524734,17q25.1,17q25.1,608755,"TSEN54, SEN54, PCH2A, PCH4, PCH5","tRNA splicing endonuclease 54, S. cerevisiae, homolog of",TSEN54,283989,ENSG00000182173,mutation identified in 1 PCH5 patient,"Pontocerebellar hypoplasia type 2A, 277470 (3), Autosomal recessive; Pontocerebellar hypoplasia type 4, 225753 (3), Autosomal recessive; ?Pontocerebellar hypoplasia type 5, 610204 (3), Autosomal recessive",Tsen54 (MGI:1923515)
17,75525079,75575208,17q25.1,17q25.1,618483,LLGL2,LLGL scribble cell polarity complex component 2,LLGL2,3993,ENSG00000073350,NA,NA,NA
17,75626844,75667201,17q25,17q25.1,603781,"RECQL5, RECQ5","DNA helicase, RecQ-like 5",RECQL5,9400,ENSG00000108469,NA,NA,Recql5 (MGI:2156841)
17,75667115,75708061,17q25.1,17q25.1,610218,"SAP30BP, HTRP, HCNGP, HTRG",SAP30-binding protein,SAP30BP,29115,ENSG00000161526,NA,NA,Sap30bp (MGI:1927479)
17,75721338,75757818,17q11-qter,17q25.1,147557,ITGB4,"Integrin, beta-4",ITGB4,3691,ENSG00000132470,NA,"Epidermolysis bullosa of hands and feet, 131800 (3), Autosomal dominant; Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3), Autosomal recessive",Itgb4 (MGI:96613)
17,75757893,75765191,17q24,17q25.1,604313,GALK1,Galactokinase-1,GALK1,2584,ENSG00000108479,NA,"Galactokinase deficiency with cataracts, 230200 (3), Autosomal recessive",Galk1 (MGI:95730)
17,75776433,75779778,17q25,17q25.1,601058,H3F3B,"H3 histone, family 3B (H3.3B)",H3F3B,3021,ENSG00000132475,NA,NA,"H3f3b,H3f3a (MGI:1101768,MGI:1097686)"
17,75784770,75825798,17q25.1,17q25.1,616375,"UNK, UNKEMPT, ZC3H5, KIAA1753",Unkempt family zinc finger protein,UNK,85451,ENSG00000132478,NA,NA,Unk (MGI:2442456)
17,75827224,75844716,17q25.1,17q25.1,608897,"UNC13D, MUNC13-4, HPLH3, HLH3, FHL3","UNC13, C. elegans, homolog of, D",UNC13D,201294,ENSG00000092929,NA,"Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)",Unc13d (MGI:1917700)
17,75845698,75856435,17q25,17q25.1,606962,"WBP2, DFNB107",WW domain-binding protein 2,WBP2,23558,ENSG00000132471,NA,"Deafness, autosomal recessive 107, 617639 (3), Autosomal recessive",Wbp2 (MGI:104709)
17,75874163,75878598,17q24-q25,17q25.1,611041,"TRIM47, GOA",Tripartite motif-containing protein 47,TRIM47,91107,ENSG00000132481,NA,NA,Trim47 (MGI:1917374)
17,75898642,75905099,17q23-q25,17q25.1,611844,MRPL38,Mitochondrial ribosomal protein L38,MRPL38,64978,ENSG00000204316,NA,NA,Mrpl38 (MGI:1926269)
17,75909573,75938231,17q25.1,17q25.1,616807,"FGF1, ALB",FAS-binding factor 1,FBF1,85302,ENSG00000188878,NA,NA,Fbf1 (MGI:1922033)
17,75941506,75979198,17q25.1,17q25.1,609751,"ACOX1, ACOX, SCOX","Acyl-Coenzyme A oxidase 1, palmitoyl",ACOX1,51,ENSG00000161533,NA,"Peroxisomal acyl-CoA oxidase deficiency, 264470 (3), Autosomal recessive",Acox1 (MGI:1330812)
17,75979239,76000585,17q25.1,17q25.1,613130,"TEN1, C17orf106","TEN1, CST complex subunit",TEN1,100134934,ENSG00000257949,NA,NA,Ten1 (MGI:1916785)
17,76000905,76005998,17q22-qter,17q25.1,123828,CDK3,Cyclin-dependent kinase 3,CDK3,1018,ENSG00000250506,distal to BRCA1,NA,NA
17,76006844,76027305,17q25,17q25.1,601590,EVPL,Envoplakin,EVPL,2125,ENSG00000167880,NA,NA,Evpl (MGI:107507)
17,76038774,76072525,17q25.1,17q25.1,604858,SRP68,"Signal recognition particle, 68kD",SRP68,6730,ENSG00000167881,NA,NA,Srp68 (MGI:1917447)
17,76070823,76077536,17q25.3,17q25.1,603691,"GALR2, GALNR2",Galanin receptor 2,GALR2,8811,ENSG00000182687,NA,NA,Galr2 (MGI:1337018)
17,76079181,76082805,17q25.3,17q25.1,610935,"LGICZ1, ZAC, L2","Ligand-gated ion channel, zinc-activated, 1",ZACN,353174,ENSG00000186919,NA,NA,NA
17,76080992,76103786,17q25.1,17q25.1,608163,"EXOC1, EX070, KIAA1067",Exocyst complex component 7,EXOC7,23265,ENSG00000182473,NA,NA,Exoc7 (MGI:1859270)
17,76136332,76141244,17q22-q25,17q25.1,602291,"FOXJ1, FKHL13, HFH4",Forkhead box J1,FOXJ1,2302,ENSG00000129654,NA,NA,Foxj1 (MGI:1347474)
17,76271295,76308810,17q25.1,17q25.1,618304,"QRICH2, SPGF35",Glutamine-rich protein 2,QRICH2,84074,ENSG00000129646,NA,"Spermatogenic failure 35, 618341 (3), Autosomal recessive",Qrich2 (MGI:2684912)
17,76309477,76354197,17q24-q25,17q25.1,601249,PRPSAP1,Phosphoribosyl pyrophosphate synthetase-associated protein-1,PRPSAP1,5635,ENSG00000161542,NA,NA,Prpsap1 (MGI:1915013)
17,76383203,76387854,17q25.2,17q25.1,603730,SPHK1,Sphingosine kinase,SPHK1,8877,ENSG00000176170,NA,NA,Sphk1 (MGI:1316649)
17,76389455,76453233,17q25.1,17q25.1,617649,"UBE2O, KIAA1734",Ubiquitin-conjugating enzyme E2O,UBE2O,63893,ENSG00000175931,NA,NA,Ube2o (MGI:2444266)
17,76453350,76470796,17q25,17q25.1,600950,"AANAT, SNAT",Arylalkylamine N-acetyltransferase,AANAT,15,ENSG00000129673,NA,NA,Aanat (MGI:1328365)
17,76470892,76501439,17q25.1,17q25.1,614404,"RHBDF2, IRHOM2, TOC","Rhomboid 5, Drosophila, homolog of, 2",RHBDF2,79651,ENSG00000129667,NA,"Tylosis with esophageal cancer, 148500 (3), Autosomal dominant",Rhbdf2 (MGI:2442473)
17,76527355,76557691,17q25,17q25.1,608759,"CYGB, HGB, STAP",Cytoglobin,CYGB,114757,ENSG00000161544,NA,NA,Cygb (MGI:2149481)
17,76527585,76555338,17q22,17q25.1,610598,"PRCD, RP36","PRCD, Dog, homolog of",PRCD,768206,ENSG00000214140,NA,"Retinitis pigmentosa 36, 610599 (3)",NA
17,76565376,76586127,17q25.1,17q25.1,610137,"ST6GALNAC2, SIAT7B, SAITL1","ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2",ST6GALNAC2,10610,ENSG00000070731,NA,NA,St6galnac2 (MGI:107553)
17,76617768,76643837,17q25.1,17q25.1,610138,"ST6GALNAC1, SIAT7A, STYI","ST6 alpha-N-aetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1",ST6GALNAC1,55808,ENSG00000070526,NA,NA,St6galnac1 (MGI:1341826)
17,76712829,76726798,17q25,17q25.1,604914,"JMJD6, PSR",Jumonji domain containing 6 (phosphatidylserine receptor),JMJD6,23210,ENSG00000070495,NA,NA,Jmjd6 (MGI:1858910)
17,76725875,76733880,17q25.1,17q25.1,615262,"METTL23, C17orf95, MRT44",Methyltransferase-like 23,METTL23,124512,ENSG00000181038,NA,"Mental retardation, autosomal recessive 44, 615942 (3), Autosomal recessive",Mettl23 (MGI:1921569)
17,76734114,76737410,17q25,17q25.1,600813,"SRSF2, SFRS2, SC35",Serine/arginine-rich splicing factor 2,SRSF2,6427,ENSG00000161547,NA,NA,Srsf2 (MGI:98284)
17,76868403,76950392,17q25.3,17q25.2,612441,MGAT5B,"Alpha-1,6-mannosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase isozyme B",MGAT5B,146664,ENSG00000167889,NA,NA,Mgat5b (MGI:3606200)
17,77088684,77217100,17q25.1-q25.2,17q25.2-q25.3,601504,SEC14L,"SEC14, S. cerevisiae, like",SEC14L1,6397,ENSG00000129657,NA,NA,Sec14l1 (MGI:1921386)
17,77200000,83257441,17q25.3,NA,605805,ATOD4,"Dermatitis, atopic, 4",NA,NA,NA,maximum lod at D17S1290,"{Dermatitis, atopic, susceptibility to, 4}, 605805 (2)",NA
17,77200000,83257441,17q25.3,NA,612239,IS5,"Scoliosis, idiopathic, susceptibility to, 5",NA,100190985,NA,between D17S1806 and 17qter,"{Scoliosis, idiopathic, susceptibility to, 5}, 612239 (2)",NA
17,77281498,77500595,17q25,17q25.3,604061,"SEPT9, MSF, MSF1, NAPB",Septin 9,SEPTIN9,10801,ENSG00000184640,NA,"Amyotrophy, hereditary neuralgic, 162100 (3), Autosomal dominant; Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1)",Sept9 (MGI:1858222)
17,77958852,78108834,17q25.3,17q25.3,610741,"TNRC6C, KIAA1582",Trinucleotide repeat-containing gene 6C,TNRC6C,57690,ENSG00000078687,NA,NA,Tnrc6c (MGI:2443265)
17,78108774,78132426,17q25,17q25.3,605828,"TMC6, EVER1, EV1",Transmembrane channel-like 6,TMC6,11322,ENSG00000141524,NA,"Epidermodysplasia verruciformis, 226400 (3), Autosomal recessive",Tmc6 (MGI:1098686)
17,78129297,78142967,17q25,17q25.3,605829,"TMC8, EVER2, EV2",Transmembrane channel-like 8,TMC8,147138,ENSG00000167895,previously mapped to 2p24-p21,"Epidermodysplasia verruciformis 2, 618231 (3)",Tmc8 (MGI:2669037)
17,78168544,78172963,17q25,17q25.3,603926,SYNGR2,Synaptogyrin 2,SYNGR2,9144,ENSG00000108639,"pseudogene on 15q11; near EV1, EV2, TK1",NA,Syngr2 (MGI:1328324)
17,78174078,78187203,17q25.2-q25.3,17q25.3,188300,TK1,Thymidine kinase-1,TK1,7083,ENSG00000167900,NA,NA,Tk1 (MGI:98763)
17,78214252,78225634,17q25,17q25.3,603352,API4,Apoptosis inhibitor 4,BIRC5,332,ENSG00000089685,NA,NA,Birc5 (MGI:1203517)
17,78356776,78360078,17q25.3,17q25.3,604176,"SOCS3, SSI3, CIS3",Suppressor of cytokine signaling 3,SOCS3,9021,ENSG00000184557,NA,NA,Socs3 (MGI:1201791)
17,78378617,78424658,17q25.3,17q25.3,614942,PGS1,Phosphatidylglycerophosphate synthase 1,PGS1,9489,ENSG00000087157,NA,NA,Pgs1 (MGI:1921701)
17,78423696,78577435,17q25,17q25.3,610063,"DNAH17, DNEL2","Dynein, axonemal, heavy chain 17",DNAH17,8632,ENSG00000187775,NA,NA,Dnah17 (MGI:1917176)
17,78674046,78782341,17q25,17q25.3,182115,"CYTH1, D17S811E, SEC7",Cytohesin 1,CYTH1,9267,ENSG00000108669,NA,NA,Cyth1 (MGI:1334257)
17,78787380,78840839,17q25.3,17q25.3,612543,"USP36, KIAA1453",Ubiquitin-specific protease 36,USP36,57602,ENSG00000055483,NA,NA,Usp36 (MGI:1919594)
17,78852976,78925386,17q25,17q25.3,188825,TIMP2,Tissue inhibitor of metalloproteinase-2,TIMP2,7077,ENSG00000035862,NA,NA,Timp2 (MGI:98753)
17,78971254,78979922,17q25,17q25.3,600626,LGALS3BP,"Lectin, galactoside-binding, soluble, 3 binding protein (galectin 6 binding protein)",LGALS3BP,3959,ENSG00000108679,NA,NA,Lgals3bp (MGI:99554)
17,78991715,79009792,17q25.3,17q25.3,613165,"CANT1, SCAN1, DBQD1, EDM7",Calcium-activated nucleotidase 1,CANT1,124583,ENSG00000171302,NA,"Desbuquois dysplasia 1, 251450 (3), Autosomal recessive; Epiphyseal dysplasia, multiple, 7, 617719 (3), Autosomal recessive",Cant1 (MGI:1923275)
17,79022933,79049787,17q25,17q25.3,610365,"C1QTNF1, GIP",C1q- and tumor necrosis factor-related protein 1,C1QTNF1,114897,ENSG00000173918,NA,NA,C1qtnf1 (MGI:1919254)
17,79074811,79088602,17q25.3,17q25.3,611898,"NAGLUEB, FLJ21865","N-acetylglucosaminidase, endo-beta",ENGASE,64772,ENSG00000167280,NA,NA,Engase (MGI:2443788)
17,79089344,79665599,17q25.3,17q25.3,616999,"RBFOX3, FOX3, NEUN, HRNBP3","RNA-binding protein FOX1, C. Elegans, homolog of, 3",RBFOX3,146713,ENSG00000167281,NA,NA,NA
17,79730918,79742925,17q25.3,17q25.3,616997,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase 7,ENPP7,339221,ENSG00000182156,NA,NA,Enpp7 (MGI:3027917)
17,79776253,79787982,17q25,17q25.3,602770,"CBX2, M33, SRXY5","Chromobox homolog 2, Drosophila polycomb class",CBX2,84733,ENSG00000173894,mutation identified in 1 SRXY5 patient,"?46XY sex reversal 5, 613080 (3), Autosomal recessive",Cbx2 (MGI:88289)
17,79792131,79797076,17q25.3,17q25.3,617354,"CBX8, PC3",Chromobox homolog 8,CBX8,57332,ENSG00000141570,NA,NA,Cbx8 (MGI:1353589)
17,79833155,79839439,17q25.3,17q25.3,603079,"CBX4, PC2","Chromobox homolog 4, Drosophila polycomb class",CBX4,8535,ENSG00000141582,NA,NA,Cbx4 (MGI:1195985)
17,79932342,80035874,17q25.3,17q25.3,616637,TBC1D16,"TBC1 domain family, member 16",TBC1D16,125058,ENSG00000167291,NA,NA,Tbc1d16 (MGI:2652878)
17,80036631,80100612,17q25.3,17q25.3,613799,"CCDC40, KIAA1640",Coiled-coil domain-containing protein 40,CCDC40,55036,ENSG00000141519,NA,"Ciliary dyskinesia, primary, 15, 613808 (3)",Ccdc40 (MGI:2443893)
17,80101534,80119880,17q25.2-q25.3,17q25.3,606800,GAA,"Glucosidase, acid alpha-",GAA,2548,ENSG00000171298,distal to TK1,"Glycogen storage disease II, 232300 (3), Autosomal recessive",Gaa (MGI:95609)
17,80134368,80147127,17q25.3,17q25.3,608546,"DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS",DEAD/H Box 48,EIF4A3,9775,ENSG00000141543,NA,"Robin sequence with cleft mandible and limb anomalies, 268305 (3), Autosomal recessive",Eif4a3 (MGI:1923731)
17,80169991,80209330,17q25.3,17q25.3,607211,"CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP",Caspase recruitment domain-containing protein 14,CARD14,79092,ENSG00000141527,NA,"Pityriasis rubra pilaris, 173200 (3), Autosomal dominant; Psoriasis 2, 602723 (3), Autosomal dominant",Card14 (MGI:2386258)
17,80200667,80220399,17q25.3,17q25.3,605270,"SGSH, MPS3A, SFMD",N-sulfoglucosamine sulfohydrolase (sulfamidase),SGSH,6448,ENSG00000181523,NA,"Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3), Autosomal recessive",Sgsh (MGI:1350341)
17,80220286,80253501,17q25,17q25.3,610117,SLC26A11,"Solute carrier family 26 (sulfate transporter), member 11",SLC26A11,284129,ENSG00000181045,NA,NA,Slc26a11 (MGI:2444589)
17,80260819,80398793,17q25,17q25.3,613768,"RNF213, ALO17, KIAA1618, MYMY2",Ring finger protein 213,RNF213,57674,ENSG00000173821,NA,"{Moyamoya disease 2, susceptibility to}, 607151 (3)",Rnf213 (MGI:1289196)
17,80466833,80476606,17q25.1-q25.2,17q25.3,602367,"NPTX1, NP1","Pentraxin I, neuronal",NPTX1,4884,ENSG00000171246,NA,NA,Nptx1 (MGI:107811)
17,80544837,80966367,17q25.3,17q25.3,607130,"RPTOR, RAPTOR, KIAA1303",Regulatory-associated protein of MTOR,RPTOR,57521,ENSG00000141564,NA,NA,Rptor (MGI:1921620)
17,80991840,81000132,17q25.3,17q25.3,610901,CHMP6,"CHMP family, member 6",CHMP6,79643,ENSG00000176108,NA,NA,Chmp6 (MGI:3583942)
17,81035130,81117433,17q25,17q25.3,605475,"BAIAP2, IRSP53",BAI1-associated protein 2,BAIAP2,10458,ENSG00000175866,NA,NA,Baiap2 (MGI:2137336)
17,81117294,81166220,17q25.3,17q25.3,605276,"AATK, AATYK",Apoptosis-associated tyrosine kinase,AATK,9625,ENSG00000181409,NA,NA,Aatk (MGI:1197518)
17,81125882,81125948,17q25.3,17q25.3,614059,"MIR338, MIRN338",Micro RNA 338,MIR338,442906,ENSG00000283604,NA,NA,NA
17,81189594,81222988,17q25.3,17q25.3,613479,"AZI1, ZA1, KIAA1118","5-azacytidine-induced gene 1, mouse, homolog of",CEP131,22994,ENSG00000141577,NA,NA,Cep131 (MGI:107440)
17,81239310,81241309,17q25.3,17q25.3,618461,"NDUFAF8, C17orf89","NADH dehydrogenase (ubiquinone) complex I, assembly factor 8",NDUFAF8,284184,ENSG00000224877,NA,NA,Ndufaf8 (MGI:1913676)
17,81244810,81295432,17q25.3,17q25.3,616525,SLC38A10,"Solute carrier family 38 (amino acid transporter), member 10",SLC38A10,124565,ENSG00000157637,NA,NA,Slc38a10 (MGI:1919305)
17,81395430,81466330,17q25.3,17q25.3,617646,"BAHCC1, BAHD2, KIAA1447",BAH domain- and coiled-coil domain-containing protein 1,BAHCC1,57597,ENSG00000266074,NA,NA,Bahcc1 (MGI:2679272)
17,81509970,81512798,17q25.3,17q25.3,102560,"ACTG1, DFNA20, DFNA26, BRWS2","Actin, gamma-1",ACTG1,71,ENSG00000184009,NA,"Baraitser-Winter syndrome 2, 614583 (3), Autosomal dominant; Deafness, autosomal dominant 20/26, 604717 (3), Autosomal dominant",Actg1 (MGI:87906)
17,81513018,81537129,17q25,17q25.3,607643,"FSCN2, RFSN, RP30","Fascin, sea urchin, homolog of, 2",FSCN2,25794,ENSG00000186765,within 200kb of ACTG1,"Retinitis pigmentosa 30, 607921 (3)",Fscn2 (MGI:2443337)
17,81539884,81552402,17q25.3,17q25.3,611301,"C17orf70, FAAP100",Chromosome 17 open reading frame 70,FAAP100,80233,ENSG00000185504,NA,NA,Faap100 (MGI:1919135)
17,81556884,81637147,17qter,17q25.3,606590,"NPL4, KIAA1499","Npl4, S. cerevisiae, homolog of",NPLOC4,55666,ENSG00000182446,NA,NA,Nploc4 (MGI:2679787)
17,81650458,81663417,17q25,17q25.3,180073,"PDE6G, PDEG, RP57","Phosphodiesterase-6G, cGMP-specific, rod, gamma",PDE6G,5148,ENSG00000185527,NA,"Retinitis pigmentosa 57, 613582 (3), Autosomal recessive",Pde6g (MGI:97526)
17,81666696,81673906,17q25.3,17q25.3,614271,CCDC137,Coiled-coil domain-containing protein 137,CCDC137,339230,ENSG00000185298,NA,NA,Ccdc137 (MGI:1914541)
17,81684010,81702120,17q25,17q25.3,604375,"HGS, HRS",Human growth factor-regulated tyrosine kinase substrate,HGS,9146,ENSG00000185359,NA,NA,Hgs (MGI:104681)
17,81703366,81707516,17q25-qter,17q25.3,602375,"MRPL12, RPML12","Ribosomal protein, mitochondrial, L12",MRPL12,6182,ENSG00000262814,NA,NA,Mrpl12 (MGI:1926273)
17,81712235,81721015,17q25.3,17q25.3,606794,"SLC25A10, DIC","Solute carrier family 25 (mitochondrial carrier), member 10 (dicarboxylate ion carrier)",SLC25A10,1468,ENSG00000183048,NA,NA,Slc25a10 (MGI:1353497)
17,81804077,81814007,17q25,17q25.3,138033,GCGR,Glucagon receptor,GCGR,2642,ENSG00000215644,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant",Gcgr (MGI:99572)
17,81822360,81833290,17q25.3,17q25.3,616514,"FAM195B, MCRIP1","Family with sequence similarity 194, member B",MCRIP1,348262,ENSG00000225663,NA,NA,Mcrip1 (MGI:2384752)
17,81843158,81860534,17q25,17q25.3,176790,"P4HB, PROHB, CLCRP1","Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide",P4HB,5034,ENSG00000185624,NA,"Cole-Carpenter syndrome 1, 112240 (3), Autosomal dominant",P4hb (MGI:97464)
17,81867718,81871405,17q25.3,17q25.3,601925,"ARHGDIA, GDIA1, NPHS8",Rho GDP dissociation inhibitor (GDI) alpha,ARHGDIA,396,ENSG00000141522,NA,"Nephrotic syndrome, type 8, 615244 (3), Autosomal recessive",Arhgdia (MGI:2178103)
17,81887834,81891586,17q25.3,17q25.3,604171,"ALYREF, THOC4, ALY, BEF",ALY/REF export factor,ALYREF,10189,ENSG00000183684,NA,NA,NA
17,81890789,81900532,17q25.3,17q25.3,614534,"ANAPC11, APC11",Anaphase-promoting complex subunit 11,ANAPC11,51529,ENSG00000141552,NA,NA,Anapc11 (MGI:1913406)
17,81902237,81902904,17q25.3,17q25.3,607996,"NPB, PPL7",Neuropeptide B,NPB,256933,ENSG00000183979,NA,NA,Npb (MGI:2387153)
17,81911938,81918175,17q25.3,17q25.3,606212,"SIRT7, SIR2L7","Sirtuin 7 (Sir2, S. cerevisiae, homolog of, 7)",SIRT7,51547,ENSG00000187531,NA,NA,Sirt7 (MGI:2385849)
17,81918269,81927734,17q25,17q25.3,602020,MAFG,"v-maf avian musculoaponeurotic fibrosarcoma oncogene family, protein G",MAFG,4097,ENSG00000197063,NA,NA,Mafg (MGI:96911)
17,81932383,81937327,17q25.3,17q25.3,179035,"PYCR1, PRO3, ARCL2B, ARCL3B",Pyrroline-5-carboxylate reductase-1,PYCR1,5831,ENSG00000183010,NA,"Cutis laxa, autosomal recessive, type IIB, 612940 (3), Autosomal recessive; Cutis laxa, autosomal recessive, type IIIB, 614438 (3)",Pycr1 (MGI:2384795)
17,81952506,81961186,17q25.3,17q25.3,609847,NOTUM,"Notum, Drosophila, homolog of",NOTUM,147111,ENSG00000185269,NA,NA,Notum (MGI:1924833)
17,81977549,82017668,17q25,17q25.3,606236,"ASPSCR1, RCC17, ASPL, ASPS","Alveolar soft-part sarcoma chromosome region, candidate 1",ASPSCR1,79058,ENSG00000169696,t(X;17)(p11.2;q25),"Alveolar soft-part sarcoma, 606243 (3)",Aspscr1 (MGI:1916188)
17,82018702,82022929,17q25.3,17q25.3,615128,"STRA13, CENPX, FAAP10, MHF2, D9",Stimulated by retinoic acid 13,CENPX,201254,ENSG00000169689,NA,NA,Cenpx (MGI:894324)
17,82031677,82034203,17q25.3,17q25.3,602050,RAC3,"Ras-related C3 botulinum toxin substrate-3 (rho family, small GTP-binding protein Rac3)",RAC3,5881,ENSG00000169750,NA,NA,Rac3 (MGI:2180784)
17,82035857,82037696,17q25.3,17q25.3,608347,"DCXR, P34H, PNTSU",Dicarbonyl/L-xylulose reductase,DCXR,51181,ENSG00000169738,NA,"[Pentosuria], 260800 (3), Autosomal recessive",Dcxr (MGI:1915130)
17,82047901,82051810,17q25,17q25.3,602578,RFNG,Radical fringe,RFNG,5986,ENSG00000169733,NA,NA,Rfng (MGI:894275)
17,82051464,82058063,17q25.3,17q25.3,601934,GPS1,G protein pathway suppressor 1,GPS1,2873,ENSG00000169727,NA,NA,Gps1 (MGI:2384801)
17,82078337,82098302,17q25,17q25.3,600212,FASN,Fatty acid synthase,FASN,2194,ENSG00000169710,NA,NA,Fasn (MGI:95485)
17,82217950,82239498,17q25.3,17q25.3,603877,"SLC16A3, MCT4",Solute carrier family 16 (monocarboxylic acid transporter) member 3,SLC16A3,9123,ENSG00000141526,NA,NA,Slc16a3 (MGI:1933438)
17,82239018,82273749,17q25,17q25.3,600864,"CSNK1D, ASPS, FASPS2","Casein kinase-1, delta",CSNK1D,1453,ENSG00000141551,NA,"Advanced sleep-phase syndrome, familial, 2, 615224 (3), Autosomal dominant",Csnk1d (MGI:1355272)
17,82314864,82320828,17q25.2-q25.3,17q25.3,186820,CD7,CD7 antigen (p41),CD7,924,ENSG00000173762,NA,NA,Cd7 (MGI:88344)
17,82321023,82333950,17q25.2-q25.3,17q25.3,602602,"SECTM1, K12",Secreted and transmembrane 1,SECTM1,6398,ENSG00000141574,NA,NA,Sectm1a (MGI:2384805)
17,82359246,82363775,17q25.3,17q25.3,615647,TEX19,Testis-expressed gene 19,TEX19,400629,ENSG00000182459,NA,NA,Tex19.2 (MGI:1918206)
17,82374276,82375585,17q25.3,17q25.3,600896,"GPR14, UTR2, UTR",G protein-coupled receptor-14 (urotensin II receptor),UTS2R,2837,ENSG00000181408,NA,NA,Uts2r (MGI:2183450)
17,82519731,82604601,17q25,17q25.3,147685,"FOXK2, ILF1",Forkhead box K2 (interleukin enhancer-binding factor 1),FOXK2,3607,ENSG00000141568,NA,NA,Foxk2 (MGI:1916087)
17,82614561,82648529,17q25.3,17q25.3,609226,"WDR45B, WIPI3, WDR45L, NEDSBAS",WD repeat domain 45B,WDR45B,56270,ENSG00000141580,NA,"Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3), Autosomal recessive",Wdr45b (MGI:1914090)
17,82716705,82728016,17q25,17q25.3,611683,FN3KRP,Fructosamine 3-kinase-related protein,FN3KRP,79672,ENSG00000141560,NA,NA,Fn3krp (MGI:2679256)
17,82735614,82751195,17q25.3,17q25.3,608425,FN3K,Fructosamine 3-kinase,FN3K,64122,ENSG00000167363,NA,NA,Fn3k (MGI:1926834)
17,82752047,82945913,17q25,17q25.3,604649,"TBCD, PEBAT",Tubulin-specific chaperone D,TBCD,6904,ENSG00000141556,NA,"Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3), Autosomal recessive",Tbcd (MGI:1919686)
17,82829433,82840021,17q25.3,17q25.3,610226,"ZNF750, FLJ13841",Zinc finger protein 750,ZNF750,79755,ENSG00000141579,NA,"Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)",Zfp750 (MGI:2442210)
17,82942148,83051844,17q25.3,17q25.3,615337,B3GNTL1,"Beat-1,3-N-acetylglucosaminyltransferase-like 1",B3GNTL1,146712,ENSG00000175711,NA,NA,B3gntl1 (MGI:2441705)
17,83079608,83095125,17q25.3,17q25.3,616241,METRNL,Meteorin-like protein,METRNL,284207,ENSG00000176845,NA,NA,Metrnl (MGI:2384806)
17,0,83257441,Chr.17,NA,138110,G6PDL,Glucose-6-phosphate dehydrogenase-like,NA,NA,NA,NA,NA,NA
17,0,83257441,Chr.17,NA,610064,ODS1,"Opioid dependence, susceptibility to, 1",NA,100188802,NA,NA,"{Opioid dependence, susceptibility to, 1}, 610064 (2)",NA
18,0,15400000,18p11.3-p11.2,NA,104000,AA1,Alopecia areata 1,NA,100034700,NA,max lod at D18S967,"Alopecia areata 1, 104000 (2), Multifactorial",NA
18,0,18500000,18p,NA,146390,"DEL18p, C18DELp",Chromosome 18p deletion syndrome,NA,NA,NA,NA,"Chromosome 18p deletion syndrome, 146390 (4), Autosomal dominant",NA
18,0,7200000,18p11.32-p11.31,NA,609647,DFNB46,"Deafness, neurosensory, autosomal recessive 46",DFNB46,449488,NA,between D18S59 and D18S391,"Deafness, autosomal recessive 46, 609647 (2), Autosomal recessive",NA
18,0,18500000,18p11,NA,607488,DYT15,"Dystonia-15, myoclonic",DYT15,317714,NA,NA,"Dystonia-15, myoclonic, 607488 (2), Autosomal dominant",NA
18,0,18500000,18p,NA,602124,DYT7,"Dystonia-7 (torsion dystonia, adult-onset, focal)",DYT7,1866,NA,NA,"Dystonia-7, torsion, 602124 (2), Autosomal dominant",NA
18,0,15400000,18pter-p11.21,NA,131150,ERV1,Oncogene ERV1; endogenous retrovirus-1,NA,NA,NA,NA,NA,NA
18,0,18500000,18p11,NA,612354,IBD21,Inflammatory bowel disease 21,NA,100192312,NA,associated with rs2542151,"{Inflammatory bowel disease 21}, 612354 (2), Autosomal dominant",NA
18,0,18500000,18p,NA,125480,"MAFD1, BPAD, MD1",Major affective disorder 1,MAFD1,4095,NA,?also 18q,"{Major affective disorder 1}, 125480 (2), Autosomal dominant",NA
18,0,7200000,18p11.3,NA,614343,MRT19,"Mental retardation, autosomal recessive 19",MRT19,100852395,NA,between rs4606805 and rs1787846,"Mental retardation, autosomal recessive 19, 614343 (2), Autosomal recessive",NA
18,0,7200000,18p11.3,NA,612353,"POROK6, DSAP4",Porokeratosis 6,NA,100196911,NA,between telomere and D18S391,"Porokeratosis 6, multiple types, 612353 (2), Autosomal dominant",NA
18,0,18500000,18p,NA,603206,SCZD8,"Schizophrenia susceptibility locus, chromosome 18-related",SCZD8,8806,NA,NA,"{Schizophrenia}, 181500 (2), Autosomal dominant",NA
18,0,18500000,18p,NA,614290,TET18P,Tetrasomy 18p,NA,NA,NA,NA,"Tetrasomy 18p, 614290 (4)",NA
18,158556,214628,18p,18p11.32,607274,"USP14, TGT",Ubiquitin-specific protease 14,USP14,9097,ENSG00000101557,NA,NA,Usp14 (MGI:1928898)
18,214347,268046,18p11.32,18p11.32,606930,"THOC1, HPR1",THO complex 1 (nuclear matrix protein p84),THOC1,9984,ENSG00000079134,NA,NA,Thoc1 (MGI:1919668)
18,316736,500700,18p11.32,18p11.32,607621,"COLEC12, SRCL, CLP1",Collectin 12,COLEC12,81035,ENSG00000158270,NA,NA,Colec12 (MGI:2152907)
18,580379,582113,18p11.32,18p11.32,603187,"CETN1, CEN1",Centrin-1,CETN1,1068,ENSG00000177143,NA,NA,Cetn1 (MGI:1347086)
18,596997,650297,18p11.3,18p11.32,616990,CLUL1,Clusterin-like protein 1,CLUL1,27098,ENSG00000079101,NA,NA,NA
18,657652,673577,18p11.32,18p11.32,188350,"TYMS, TS, TMS",Thymidylate synthase,TYMS,7298,ENSG00000176890,<50 kb from YES1,NA,Tyms (MGI:98878)
18,670317,712663,18p11.32,18p11.32,607427,"ENOSF1, RTS",Enolase superfamily member 1,ENOSF1,55556,ENSG00000132199,NA,NA,NA
18,721587,812845,18p11.3,18p11.32,164880,YES1,Oncogene YES-1,YES1,7525,ENSG00000176105,<50 kb from TYMS,NA,Yes1 (MGI:99147)
18,904383,912171,18p11,18p11.32,102980,ADCYAP1,Adenylate cyclase activating polypeptide-1 (pituitary),ADCYAP1,116,ENSG00000141433,NA,NA,Adcyap1 (MGI:105094)
18,2655886,2805016,18p11.32,18p11.32,614982,"SMCHD1, KIAA0650, BAMS",Structural maintenance of chromosomes flexible hinge domain-containing protein 1,SMCHD1,23347,ENSG00000101596,NA,"Bosma arhinia microphthalmia syndrome, 603457 (3), Autosomal dominant; Fascioscapulohumeral muscular dystrophy 2, digenic, 158901 (3)",Smchd1 (MGI:1921605)
18,2900000,7200000,18p11.31,NA,160700,MYP2,"Myopia, high grade, autosomal dominant 1",MYP2,4658,NA,NA,"Myopia-2, 160700 (2), Autosomal dominant",NA
18,2916993,3013314,18p,18p11.31,605519,LPIN2,Lipin 2,LPIN2,9663,ENSG00000101577,NA,"Majeed syndrome, 609628 (3)",Lpin2 (MGI:1891341)
18,3066806,3220107,18p11.31,18p11.31,603508,"MYOM1, SKELEMIN",Myomesin 1,MYOM1,8736,ENSG00000101605,NA,NA,Myom1 (MGI:1341430)
18,3262112,3278283,18p11.31,18p11.31,609211,"MYL12B, MRLC2","Myosin, light chain 12B, regulatory",MYL12B,103910,ENSG00000118680,NA,NA,Myl12a (MGI:1914518)
18,3411926,3459979,18p11.3,18p11.31,602630,"TGIF1, HPE4",TG-interacting factor 1,TGIF1,7050,ENSG00000177426,NA,"Holoprosencephaly 4, 142946 (3), Autosomal dominant",Tgif1 (MGI:1194497)
18,3496031,4455440,18p11.31,18p11.31,605445,"DLGAP1, DAP1, DLGAP1A, DLGAP1B",Discs large-associated protein 1,DLGAP1,9229,ENSG00000170579,NA,NA,Dlgap1 (MGI:1346065)
18,5142910,5197751,18p11.31,18p11.31,616427,C18orf42,Chromosome 18 open reading frame 42,AKAIN1,642597,ENSG00000231824,NA,NA,Akain1 (MGI:2444600)
18,5289018,5297052,18p11.21,18p11.31,602126,"ZFP161, ZF5",Zinc finger protein-161,ZBTB14,7541,ENSG00000198081,NA,NA,Zbtb14 (MGI:1195345)
18,5392275,5630662,18p11.3,18p11.31,605331,"EPB41L3, DAL1",Erythrocyte membrane protein band 4.1-like 3,EPB41L3,23136,ENSG00000082397,NA,NA,Epb41l3 (MGI:103008)
18,5954702,6415258,18p11.31,18p11.31,617135,L3MBTL4,L3MBT-like 4,L3MBTL4,91133,ENSG00000154655,NA,NA,L3mbtl4 (MGI:2444889)
18,6729715,6915715,18p11.31,18p11.31,610592,"ARHGAP28, KIAA1314",RHO GTPase-activating protein 28,ARHGAP28,79822,ENSG00000088756,NA,NA,Arhgap28 (MGI:2147003)
18,6941741,7117796,18p11.31,18p11.31,150320,"LAMA1, PTBHS","Laminin, alpha-1",LAMA1,284217,ENSG00000101680,NA,"Poretti-Boltshauser syndrome, 615960 (3), Autosomal recessive",Lama1 (MGI:99892)
18,7200000,39500000,18p11.23-q12.2,NA,107200,ANIC,"Anosmia, isolated congenital",NA,550625,NA,max lod at D18S1108,"Anosmia, isolated congenital, 107200 (2), Autosomal dominant",NA
18,7200000,15400000,18p11.2,NA,606616,"DYX6, DYXQTL18","Dyslexia, susceptibility to, 6",DYX6,266691,NA,NA,"{Dyslexia, susceptibility to, 6}, 606616 (2)",NA
18,7200000,15400000,18p11.2,NA,609253,FEB6,"Febrile seizures, familial, 6",FEB6,619397,NA,max lod at D18S1158,"Febrile seizures, familial, 6, 609253 (2), Autosomal dominant",NA
18,7200000,8500000,18p11.23,NA,612410,PSORS10,Psoriasis susceptibility 10,PSORS10,503613,NA,between D18S63 and D18S967,"{Psoriasis susceptibility 10}, 612410 (2)",NA
18,7567315,8406860,18p11.2,18p11.23,176888,"PTPRM, PTPRL1, RPTPM","Protein tyrosine phosphatase, receptor type, mu polypeptide",PTPRM,5797,ENSG00000173482,NA,NA,Ptprm (MGI:102694)
18,8609427,8639382,18p11.22,18p11.22,616448,RAB12,Ras-associated protein RAB12,RAB12,201475,ENSG00000206418,NA,NA,Rab12 (MGI:894284)
18,8695855,8707620,18p11.22,18p11.22,616131,"GACAT2, MTCL1AS1","Gastric cancer-associated transcript 2, noncoding",GACAT2,100287082,ENSG00000265962,NA,NA,NA
18,8706053,8832777,18p11.22,18p11.22,615766,"MTCL1, KIAA0802",Microtubule crosslinking factor 1,MTCL1,23255,ENSG00000168502,NA,NA,Mtcl1 (MGI:1915867)
18,9102641,9134340,18p11.31-p11.2,18p11.22,600532,"NDUFV2, MC1DN7",NADH-ubiquinone oxidoreductase core subunit V2,NDUFV2,4729,ENSG00000178127,pseudogene on 19q13.3-qter,"Mitochondrial complex I deficiency, nuclear type 7, 618229 (3), Autosomal recessive",Ndufv2 (MGI:1920150)
18,9136766,9285984,18p11.22,18p11.22,610616,"ANKRD12, ANCO1, KIAA0874",Ankyrin repeat domain-containing protein 12,ANKRD12,23253,ENSG00000101745,NA,NA,Ankrd12 (MGI:1914357)
18,9334772,9402419,18p11.3-p11.2,18p11.22,605049,"TWSG1, TSG","Twisted gastrulation, Drosophila, homolog of",TWSG1,57045,ENSG00000128791,NA,NA,Twsg1 (MGI:2137520)
18,9475512,9538113,18p11,18p11.22,605801,"RALBP1, RLIP76",RALA-binding protein 1,RALBP1,10928,ENSG00000017797,NA,NA,Ralbp1 (MGI:108466)
18,9546790,9615272,18p11.22,18p11.22,604908,"PPP4R1, PP4R1","Protein phosphatase 4, regulatory subunit 1",PPP4R1,9989,ENSG00000154845,NA,NA,Ppp4r1 (MGI:1917601)
18,9708186,9862550,18p11.3,18p11.22,605694,RAB31,Ras-associated protein RAB31,RAB31,11031,ENSG00000168461,NA,NA,Rab31 (MGI:1914603)
18,9885972,9889274,18p11.22,18p11.22,617790,"TXNDC2, SPTRX1",Thioredoxin domain-containing protein 2,TXNDC2,84203,ENSG00000168454,NA,NA,Txndc2 (MGI:2389312)
18,9914015,9960020,18p11.22,18p11.22,605703,"VAPA, VAP33",Vesicle-associated membrane protein-associated protein A,VAPA,9218,ENSG00000101558,NA,NA,Vapa (MGI:1353561)
18,10454634,10489948,18p11,18p11.22,607479,"APCDD1, HHS, HYPT1, HTS",Adenomatosis polyposis coli down-regulated 1,APCDD1,147495,ENSG00000154856,NA,"Hypotrichosis 1, 605389 (3), Autosomal dominant",Apcdd1 (MGI:3513977)
18,10526026,10552768,18p11.22,18p11.22,603216,NAPG,"N-ethylmaleimide-sensitive factor attachment protein, gamma",NAPG,8774,ENSG00000134265,NA,NA,Napg (MGI:104561)
18,10670236,11149584,18p11.22,18p11.22-p11.21,613629,"PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT",PIEZO-type mechanosensitive ion channel component 2,PIEZO2,63895,ENSG00000154864,mutation identified in 1 MWKS patient,"Arthrogryposis, distal, type 3, 114300 (3), Autosomal dominant; Arthrogryposis, distal, type 5, 108145 (3), Autosomal dominant; Arthrogryposis, distal, with impaired proprioception and touch, 617146 (3), Autosomal recessive; ?Marden-Walker syndrome, 248700 (3), Autosomal dominant",Piezo2 (MGI:1918781)
18,11689014,11885684,18p11.21,18p11.21,139312,"GNAL, DYT25","Guanine nucleotide-binding protein, alpha-subunit, olfactory type",GNAL,2774,ENSG00000141404,NA,"Dystonia 25, 615073 (3), Autosomal dominant",Gnal (MGI:95774)
18,11851412,11854443,18p11,18p11.21,606486,"CHMP1B, C10orf2","CHMP family, member 1B",CHMP1B,57132,ENSG00000255112,NA,NA,Chmp1b (MGI:1914314)
18,11882621,11908796,18p11.2,18p11.21,611900,MPPE1,Metallophosphoesterase 1,MPPE1,65258,ENSG00000154889,NA,NA,Mppe1 (MGI:2661311)
18,11981464,12030877,18p11.2,18p11.21,605922,IMPA2,Myo-inositol monophosphatase 2,IMPA2,3613,ENSG00000141401,NA,NA,Impa2 (MGI:2149728)
18,12254360,12277594,18p11.21,18p11.21,604440,CIDEA,Cell death-inducing DFFA-like effector A,CIDEA,1149,ENSG00000176194,NA,NA,Cidea (MGI:1270845)
18,12307668,12329825,18p11.21,18p11.21,615103,"TUBB6, FPVEPD","Tubulin, beta-6",TUBB6,84617,ENSG00000176014,mutation identified in 1 FPVEPD family,"?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction, 617732 (3), Autosomal dominant",Tubb6 (MGI:1915201)
18,12328943,12377308,18p11,18p11.21,604581,"AFG3L2, SCA28, SPAX5",ATPase family gene 3-like 2,AFG3L2,10939,ENSG00000141385,NA,"Spastic ataxia 5, autosomal recessive, 614487 (3), Autosomal recessive; Spinocerebellar ataxia 28, 610246 (3), Autosomal dominant",Afg3l2 (MGI:1916847)
18,12407928,12432237,18p11.21,18p11.21,616545,"PRELID3A, SLMO1, C18orf43",PRELI domain-containing protein 3A,PRELID3A,10650,ENSG00000141391,NA,NA,Prelid3a (MGI:2442865)
18,12658738,12725739,18p11.21,18p11.21,609702,"PSMG2, TNFSF5IP1, HCCA3, CLAST3, PAC2","Proteasome (prosome, macropain) assembly chaperone 1",PSMG2,56984,ENSG00000128789,NA,NA,Psmg2 (MGI:1922901)
18,12785477,12884350,18p11.3-p11.2,18p11.21,176887,"PTPN2, PTPT","Protein tyrosine phosphatase, nonreceptor-type, 2",PTPN2,5771,ENSG00000175354,NA,NA,Ptpn2 (MGI:97806)
18,12947983,12987664,18p11.21,18p11.21,609263,"SEH1L, SEH1, SEC13L",Seh1-like protein,SEH1L,81929,ENSG00000085415,NA,NA,Seh1l (MGI:1919374)
18,12991300,13125052,18p11.21,18p11.21,616426,"CEP192, PPP1R62, KIAA1569","Centrosomal protein, 192kD",CEP192,55125,ENSG00000101639,NA,NA,Cep192 (MGI:1918049)
18,13217603,13652753,18p11.2,18p11.21,606571,C18orf1,Chromosome 18 open reading frame 1,LDLRAD4,753,ENSG00000168675,NA,NA,Ldlrad4 (MGI:1277150)
18,13663346,13726557,18p11.21,18p11.21,617975,"FAM210A, C18orf19","Family with sequence similarity 210, member A",FAM210A,125228,ENSG00000177150,NA,NA,Fam210a (MGI:1914000)
18,13726644,13764555,18p11.23-p11.22,18p11.21,603514,"RNMT, MET",RNA guanine-7-methyltransferase,RNMT,8731,ENSG00000101654,NA,NA,Rnmt (MGI:1915147)
18,13824148,13827322,18p11.2,18p11.21,600042,MC5R,Melanocortin-5 receptor,MC5R,4161,ENSG00000176136,NA,NA,Mc5r (MGI:99420)
18,13882041,13915706,18p11.2,18p11.21,607397,MC2R,Melanocortin-2 receptor (ACTH receptor),MC2R,4158,ENSG00000185231,NA,"Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3), Autosomal recessive",Mc2r (MGI:96928)
18,14748171,14855464,18p11.21,18p11.21,616565,ANKRD30B,Ankyrin repeat domain-containing protein 30B,ANKRD30B,374860,ENSG00000180777,NA,NA,NA
18,18500000,80373285,18q,NA,601808,DEL18q,Chromosome 18q deletion syndrome,NA,NA,NA,NA,"Chromosome 18q deletion syndrome, 601808 (4), Autosomal dominant",NA
18,18500000,80373285,18q,NA,143850,OHDS,Orthostatic hypotensive disorder of Streeten,NA,50948,NA,NA,"Orthostatic hypotensive disorder of Streeten, 143850 (2), Autosomal dominant",NA
18,20946905,21111812,18q11.1,18q11.1,601702,ROCK1,RHO-associated coiled-coil-containing protein kinase 1,ROCK1,6093,ENSG00000067900,NA,NA,Rock1 (MGI:107927)
18,21242224,21528502,18q11.1,18q11.1-q11.2,617782,"GREB1L, C18orf6, KIAA1772, RHDA3",GREB1-like protein,GREB1L,80000,ENSG00000141449,NA,"Renal hypodysplasia/aplasia 3, 617805 (3), Autosomal dominant",Greb1l (MGI:3576497)
18,21500000,39500000,18q11.2-q12.2,NA,613930,APMR3,Alopecia-mental retardation syndrome 3,NA,100653369,NA,between D18S866 and D18S811,"Alopecia-mental retardation syndrome 3, 613930 (2), Autosomal recessive",NA
18,21529280,21600735,18q11.2,18q11.2,609674,"ESCO1, ECO1, CTF, ESO1, EFO1, KIAA1911","Establishment of cohesion 1, S. cerevisiae, homolog of, 1",ESCO1,114799,ENSG00000141446,NA,NA,Esco1 (MGI:1925055)
18,21612313,21633519,18q11.2,18q11.2,601063,SNRPD1,Small nuclear ribonucleoprotein polypeptide D1,SNRPD1,6632,ENSG00000167088,NA,NA,Snrpd1 (MGI:98344)
18,21650896,21704792,18q11.1,18q11.2,612197,"ABHD3, LABH3",Abhydrolase domain-containing 3,ABHD3,171586,ENSG00000158201,NA,NA,Abhd3 (MGI:2147183)
18,21740792,21870956,18q11.2,18q11.2,608677,"MIB1, MIB, DIP1, KIAA1323, LVNC7","Mindbomb, Drosophila, homolog of, 1",MIB1,57534,ENSG00000101752,NA,"Left ventricular noncompaction 7, 615092 (3), Autosomal dominant",Mib1 (MGI:2443157)
18,21825697,21825784,18q11.2,18q11.2,610254,MIR133A1,Micro RNA 133A1,MIR133A1,406922,ENSG00000283927,NA,NA,NA
18,21829003,21829087,18q11.2,18q11.2,610252,MIR1-2,Micro RNA 1-2,MIR1-2,406905,ENSG00000284453,NA,NA,NA
18,22169436,22202527,18q11.1-q11.2,18q11.2,601656,"GATA6, AVSD5, ASD9, PACHD",GATA-binding protein-6,GATA6,2627,ENSG00000141448,NA,"Atrial septal defect 9, 614475 (3), Autosomal dominant; Atrioventricular septal defect 5, 614474 (3), Autosomal dominant; Pancreatic agenesis and congenital heart defects, 600001 (3), Autosomal dominant; Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3), Autosomal dominant",Gata6 (MGI:107516)
18,22914120,23026485,18q11.2,18q11.2,604124,"RBBP8, RIM, SCKL2, JWDS",Retinoblastoma-binding protein 8,RBBP8,5932,ENSG00000101773,NA,"Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3), Autosomal recessive",Rbbp8 (MGI:2442995)
18,23237251,23437968,18q11.2,18q11.2,615430,"TMEM241, C18orf45",Transmembrane protein 241,TMEM241,85019,ENSG00000134490,NA,NA,Tmem241 (MGI:2442435)
18,23452822,23483139,18q11.2,18q11.2,603579,"RIOK3, SUDD",RIO kinase 3,RIOK3,8780,ENSG00000101782,NA,NA,Riok3 (MGI:1914128)
18,23506183,23586505,18q11-q12,18q11.2,607623,"NPC1, NPC",NPC1 gene,NPC1,4864,ENSG00000141458,some families not linked to 18; type D prob. allelic,"Niemann-Pick disease, type C1, 257220 (3), Autosomal recessive; Niemann-Pick disease, type D, 257220 (3), Autosomal recessive",Npc1 (MGI:1097712)
18,23689442,23956221,18q11.2,18q11.2,600805,"LAMA3, LOCS","Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)",LAMA3,3909,ENSG00000053747,NA,"Epidermolysis bullosa, generalized atrophic benign, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Laryngoonychocutaneous syndrome, 245660 (3), Autosomal recessive",Lama3 (MGI:99909)
18,24138955,24161599,18q12.2,18q11.2,612135,"CABYR, FSP2",Calcium-binding tyrosine phosphorylation-regulated protein,CABYR,26256,ENSG00000154040,NA,NA,Cabyr (MGI:1918382)
18,24162044,24397881,18q11-q12,18q11.2,606730,"OSBPL1A, ORP1",Oxysterol-binding protein-like protein 1A,OSBPL1A,114876,ENSG00000141447,NA,NA,Osbpl1a (MGI:1927551)
18,24426669,24453530,18q11.2-q12.1,18q11.2,615319,IMPACT,Impact RWD domain protein,IMPACT,55364,ENSG00000154059,NA,NA,Impact (MGI:1098233)
18,24460636,24479973,18q11.2,18q11.2,606792,"HRH4, HH4R",Histamine receptor H4,HRH4,59340,ENSG00000134489,NA,NA,Hrh4 (MGI:2429635)
18,25061923,25352193,18q11.2,18q11.2,610974,"ZNF521, EHZF, EVI3",Zinc finger protein 521,ZNF521,25925,ENSG00000198795,NA,NA,Zfp521 (MGI:95459)
18,26016252,26091216,18q11.2,18q11.2,600192,"SS18, SSXT, SYT","Synovial sarcoma translocation, chromosome 18",SS18,6760,ENSG00000141380,5' SYST/3' SSRC in t(X;18),"Sarcoma, synovial (1)",Ss18 (MGI:107708)
18,26133868,26193354,18q11.2,18q11.2,617841,"PSMA8, PSMA7L","Proteasome subunit, alpha-type, 8",PSMA8,143471,ENSG00000154611,NA,NA,Psma8 (MGI:1920927)
18,26226444,26391684,18q11.2,18q11.2,601689,"TAF4B, TAF2C2, TAFII105, SPGF13","TAF4b RNA polymerase II, TATA box-binding protein-associated factor, 105kD",TAF4B,6875,ENSG00000141384,mutation identified in 1 SPGF13 family,"?Spermatogenic failure 13, 615841 (3), Autosomal recessive",Taf4b (MGI:2152345)
18,26454909,26657472,18q11.2,18q11.2,613420,"KCTD1, SENS",Potassium channel tetramerization domain-containing 1,KCTD1,284252,ENSG00000134504,NA,"Scalp-ear-nipple syndrome, 181270 (3), Autosomal dominant",Kctd1 (MGI:1918269)
18,26687620,26703637,18q11.2,18q11.2,617647,"PCAT18, LINC01092","Prostate cancer-associated transcript 18, noncoding",PCAT18,728606,ENSG00000265369,NA,NA,NA
18,26852037,26865802,18q11.2-q12.1,18q11.2,600308,"AQP4, MIWC",Aquaporin-4,AQP4,361,ENSG00000171885,NA,NA,Aqp4 (MGI:107387)
18,26906480,27185363,18q11.2,18q11.2,610191,"CHST9, GalNAc4ST2",Carbohydrate sulfotransferase 9,CHST9,83539,ENSG00000154080,NA,NA,Chst9 (MGI:1918617)
18,27932877,28177129,18q11.2,18q12.1,114020,"CDH2, NCAD","Cadherin 2 (cadherin, neuronal type; N-cadherin)",CDH2,1000,ENSG00000170558,NA,NA,Cdh2 (MGI:88355)
18,30989364,31042814,18q12.1,18q12.1,600271,"DSC3, DSC4",Desmocollin-3,DSC3,1825,ENSG00000134762,mutation identified in 1 HYPTSV family,"?Hypotrichosis and recurrent skin vesicles, 613102 (3), Autosomal recessive",Dsc3 (MGI:1194993)
18,31058839,31102420,18q12.1,18q12.1,125645,"DSC2, DSC3, ARVD11",Desmocollin-2,DSC2,1824,ENSG00000134755,NA,"Arrhythmogenic right ventricular dysplasia 11, 610476 (3), Autosomal recessive, Autosomal dominant; Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3), Autosomal recessive, Autosomal dominant",Dsc2 (MGI:103221)
18,31129235,31162855,18q12.1,18q12.1,125643,DSC1,Desmocollin-1,DSC1,1823,ENSG00000134765,NA,NA,Dsc1 (MGI:109173)
18,31318159,31359245,18q12.1-q12.2,18q12.1,125670,"DSG1, PPKS1, SPPK1, EPKHE",Desmoglein-1,DSG1,1828,ENSG00000134760,pemphigus foliaceous antigen,"Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3), Autosomal recessive; Keratosis palmoplantaris striata I, AD, 148700 (3), Autosomal dominant","Dsg1a,Dsg1b (MGI:94930,MGI:2664357)"
18,31376776,31415790,18q12,18q12.1,607892,"DSG4, LAH, HYPT6",Desmoglein 4,DSG4,147409,ENSG00000175065,NA,"Hypotrichosis 6, 607903 (3), Autosomal recessive",Dsg4 (MGI:2661061)
18,31447740,31478711,18q12.1-q12.2,18q12.1,169615,DSG3,Desmoglein-3 (pemphigus vulgaris antigen),DSG3,1830,ENSG00000134757,NA,NA,Dsg3 (MGI:99499)
18,31498176,31549007,18q12.1-q12.2,18q12.1,125671,"DSG2, ARVD10, ARVC10, CMD1BB",Desmoglein-2,DSG2,1829,ENSG00000046604,NA,"Arrhythmogenic right ventricular dysplasia 10, 610193 (3), Autosomal dominant; Cardiomyopathy, dilated, 1BB, 612877 (3)",Dsg2 (MGI:1196466)
18,31591766,31599023,18q11.2-q12.1,18q12.1,176300,"TTR, PALB",Transthyretin (prealbumin),TTR,7276,ENSG00000118271,NA,"Amyloidosis, hereditary, transthyretin-related, 105210 (3), Autosomal dominant; Carpal tunnel syndrome, familial, 115430 (3), Autosomal dominant; [Dystransthyretinemic hyperthyroxinemia], 145680 (3), Autosomal dominant",Ttr (MGI:98865)
18,31621035,31724669,18q11,18q12.1,604017,B4GALT6,"Beta-1,4-galactosyltransferase 6",B4GALT6,9331,ENSG00000118276,NA,NA,B4galt6 (MGI:1928380)
18,31759561,31760879,18q12.1,18q12.1,616153,"SLC25A52, MCART2","Solute carrier family 25, member 52",SLC25A52,147407,ENSG00000141437,NA,NA,NA
18,31829179,31943127,18q12.1,18q12.1,614136,"TRAPPC8, KIAA1012","Trafficking protein particle complex, subunit 8",TRAPPC8,22878,ENSG00000153339,NA,NA,Trappc8 (MGI:2443008)
18,32018584,32090755,18q12.1,18q12.1,610432,"RNF125, TRAC1, TNORS",RING finger protein 125,RNF125,54941,ENSG00000101695,NA,"Tenorio syndrome, 616260 (3), Autosomal dominant",NA
18,32091857,32131560,18q12.1,18q12.1,616319,"RNF138, NARF",RING finger protein 138,RNF138,51444,ENSG00000134758,NA,NA,Rnf138 (MGI:1929211)
18,32190038,32222606,18q12.2-q12.3,18q12.1,600389,MEP1B,"Meprin A, beta",MEP1B,4225,ENSG00000141434,NA,NA,Mep1b (MGI:96964)
18,32263520,32470881,18q12.1,18q12.1,617998,GAREM1,"GRB2-associated regulator of MAPK1, subtype 1",GAREM1,64762,ENSG00000141441,NA,NA,Garem1 (MGI:2685790)
18,32672672,32773022,18q12.1,18q12.1,613772,"KLHL14, PRINTOR, KIAA1384",Kelch-like 14,KLHL14,57565,ENSG00000197705,NA,NA,Klhl14 (MGI:1921249)
18,33578218,33751194,18q12.1,18q12.1,615115,"ASXL3, KIAA1713, BRPS",Additional sex combs-like 3,ASXL3,80816,ENSG00000141431,NA,"Bainbridge-Ropers syndrome, 615485 (3), Autosomal dominant",Asxl3 (MGI:2685175)
18,33851099,34224956,18q12.1,18q12.1,603577,"NOL4, NOLP",Nucleolar protein 4,NOL4,8715,ENSG00000101746,NA,NA,Nol4 (MGI:2441684)
18,34493289,34891843,18q12.1-q12.2,18q12.1,601239,"DTNA, D18S892E, DRP3, LVNC1","Dystobrevin, alpha (dystrophin-related protein 3)",DTNA,1837,ENSG00000134769,NA,"Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3), Autosomal dominant",Dtna (MGI:106039)
18,34976927,35143469,18q12,18q12.1-q12.2,605789,"MAPRE2, EB2, RP1, CSCSC2","Microtubule-associated protein, RP/EB family, member 2",MAPRE2,10982,ENSG00000166974,NA,"Symmetric circumferential skin creases, congenital, 2, 616734 (3), Autosomal dominant",NA
18,35100000,45900000,18q12.2-q12.3,NA,605293,OPA4,Optic atrophy 4,OPA4,58156,NA,NA,"Optic atrophy 4, 605293 (2)",NA
18,35240703,35259226,18q12,18q12.2,609601,ZNF397,Zinc finger protein-397,ZNF397,84307,ENSG00000186812,NA,NA,Zfp397 (MGI:1916506)
18,35290271,35310765,18q12,18q12.2,604754,"ZNFEB, ZNF271",Epstein-Barr virus-induced zinc finger protein,ZNF271P,10778,ENSG00000257267,NA,NA,NA
18,35332226,35344455,18q12,18q12.2,194534,ZNF24,Zinc finger protein-24 (KOX17),ZNF24,7572,ENSG00000172466,NA,NA,Zfp24 (MGI:1929704)
18,35366693,35377336,18q12,18q12.2,609600,ZNF396,Zinc finger protein-396,ZNF396,252884,ENSG00000186496,NA,NA,NA
18,35654568,35711833,18q12.1,18q12.2,602273,GALNT1,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1,GALNT1,2589,ENSG00000141429,NA,NA,Galnt1 (MGI:894693)
18,35904817,35904925,18q12.2,18q12.2,612698,"MIR187, MIRN187",Micro RNA 187,MIR187,406963,ENSG00000207797,NA,NA,NA
18,35982384,36067593,18q12,18q12.2,610347,"RPRD1A, P15RS, FLJ10656",Regulation of nuclear pre-mRNA domain-containing protein 1A,RPRD1A,55197,ENSG00000141425,NA,NA,Rprd1a (MGI:2385066)
18,36129873,36180556,18q12.2,18q12.2,616054,"ELP2, STATIP1, MRT58","Elongator acetyltransferase complex, subunit 2",ELP2,55250,ENSG00000134759,NA,"Mental retardation, autosomal recessive 58, 617270 (3), Autosomal recessive",Elp2 (MGI:1889642)
18,36187496,36272156,18q12.2,18q12.2,613274,"MOCOS, MCS, XAN2",Molybdenum cofactor sulfurase,MOCOS,55034,ENSG00000075643,NA,"Xanthinuria, type II, 603592 (3), Autosomal recessive",Mocos (MGI:1915841)
18,36297712,36780219,18q12.2,18q12.2,609691,"FHOD3, FHOS2, KIAA1695",Formin homology-2 domain-containing protein 3,FHOD3,80206,ENSG00000134775,NA,NA,Fhod3 (MGI:1925847)
18,36828816,37232139,18q12.2,18q12.2,616480,"KIAA1328, HINDERIN",Hinderin,KIAA1328,57536,ENSG00000150477,NA,NA,AW554918 (MGI:2147376)
18,37243039,37565797,18q12,18q12.2,612679,"CELF4, BRUNOL4","CUGbp- and ELAV-like family, member 4",CELF4,56853,ENSG00000101489,NA,NA,Celf4 (MGI:1932407)
18,39500000,45900000,18q12.3,NA,614319,VUR6,Vesicoureteral reflux 6,NA,100820763,NA,closest marker rs1054986,"Vesicoureteral reflux 6, 614319 (2)",NA
18,41955225,42087829,18q12.3,18q12.3,602609,PIK3C3,"Phosphatidylinositol 3-kinase, class 3",PIK3C3,5289,ENSG00000078142,NA,NA,Pik3c3 (MGI:2445019)
18,42743217,43115691,18q12.3,18q12.3,609592,"RIT2, RIN, ROC2",Ric-like protein without CAAX motif 2,RIT2,6014,ENSG00000152214,NA,NA,Rit2 (MGI:108054)
18,43267891,43277489,18q12.3,18q12.3,600103,SYT4,Synaptotagmin-4,SYT4,6860,ENSG00000132872,NA,NA,Syt4 (MGI:101759)
18,44680071,45068509,18q12.31,18q12.3,611060,"SETBP1, KIAA0437, SEB, MRD29",SET-binding protein 1,SETBP1,26040,ENSG00000152217,fused with NUP98 in ALL,"Mental retardation, autosomal dominant 29, 616078 (3), Autosomal dominant; Schinzel-Giedion midface retraction syndrome, 269150 (3), Autosomal dominant",Setbp1 (MGI:1933199)
18,45202957,45683685,18q12.1-q21.1,18q12.3,601611,"SLC14A2, UT2, UTR","Solute carrier family 14 (urea transporter), member 2",SLC14A2,8170,ENSG00000132874,NA,NA,Slc14a2 (MGI:1351653)
18,45724126,45752519,18q11-q12,18q12.3,613868,"SLC14A1, JK, UTE, UT1","Solute carrier family 14 (urea transporter), member 1 (Kidd blood group)",SLC14A1,6563,ENSG00000141469,previous suggestion of chr.7 or chr.2,"[Blood group, Kidd], 111000 (3)",Slc14a1 (MGI:1351654)
18,45800585,45967338,18q12.3-q21.1,18q12.3-q21.1,615068,"EPG5, KIAA1632, HEEW1, VICIS","Ectopic P-granules autophagy protein 5, C. elegans, homolog of",EPG5,57724,ENSG00000152223,NA,"Vici syndrome, 242840 (3), Autosomal recessive",Epg5 (MGI:1918673)
18,45825674,45844093,18q12.3,18q12.3,618105,SIGLEC15,Sialic acid-binding immunoglobulin-like lectin 15,SIGLEC15,284266,ENSG00000197046,NA,NA,Siglec15 (MGI:3646642)
18,45900000,63900000,18q21,NA,606640,ALS3,Amyotrophic lateral sclerosis 3,ALS3,253,NA,NA,"Amyotrophic lateral sclerosis 3, 606640 (2), Autosomal dominant",NA
18,45900000,63900000,18q21.1-q21.3,NA,600624,"CORD1, CRD1","Cone rod dystrophy 1, autosomal dominant",CORD1,1319,NA,NA,"Cone-rod retinal dystrophy-1, 600624 (2), Autosomal dominant",NA
18,45900000,63900000,18q21,NA,601941,IDDM6,Insulin-dependent diabetes mellitus-6,IDDM6,3405,NA,NA,"{Diabetes mellitus, insulin-dependent, 6}, 601941 (2)",NA
18,45900000,63900000,18q21,NA,182090,SSAV1,Simian sarcoma-associated virus-1/Gibbon ape leukemia virus,NA,6739,NA,NA,NA,NA
18,45983535,46072326,18q21.1,18q21.1,616046,"PSTPIP2, MAYP",Proline/serine/threonine phosphatase-interacting protein 2,PSTPIP2,9050,ENSG00000152229,NA,NA,Pstpip2 (MGI:1335088)
18,46080247,46104232,18q12-q21,18q21.1,164360,"ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22","ATP synthase, H+ transporting (ATPase, mitochondrial)",ATP5F1A,498,ENSG00000152234,"pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family","?Combined oxidative phosphorylation deficiency 22, 616045 (3), Autosomal recessive; ?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4, 615228 (3), Autosomal recessive",Atp5a1 (MGI:88115)
18,46104331,46128332,18q21.1,18q21.1,608775,"HAUS1, CCDC5, HEIC","HAUS augmin-like complex, subunit 1",HAUS1,115106,ENSG00000152240,"pseudogenes on 5, 8, and X",NA,Haus1 (MGI:2385076)
18,46476960,46657114,18q12-q21,18q21.1,613072,"LOXHD1, DFNB77",Lipoxygenase homology domains-containing 1,LOXHD1,125336,ENSG00000167210,NA,"Deafness, autosomal recessive 77, 613079 (3), Autosomal recessive",NA
18,46667820,46757052,18q21.1,18q21.1,607162,SIAT8E,Sialyltransferase 8E,ST8SIA5,29906,ENSG00000101638,NA,NA,St8sia5 (MGI:109243)
18,46803217,46920166,18q21.1,18q21.1,603567,"PIAS2, PIASX",Protein inhibitor of activated STAT2,PIAS2,9063,ENSG00000078043,NA,NA,Pias2 (MGI:1096566)
18,46917549,47104794,18q21.1,18q21.1,614697,KATNAL2,"Katanin, p60 subunit, A-like protein 2",KATNAL2,83473,ENSG00000167216,NA,NA,Katnal2 (MGI:1924234)
18,47152833,47176363,18q21.1,18q21.1,609382,"IER3IP1, MEDS",Immediate-early response 3-interacting protein 1,IER3IP1,51124,ENSG00000134049,NA,"Microcephaly, epilepsy, and diabetes syndrome, 614231 (3), Autosomal recessive",Ier3ip1 (MGI:1913441)
18,47206168,47249182,18q21.1,18q21.1,617138,"SKOR2, FUSSEL18, CORL2",SKI family transcriptional corepressor 2,SKOR2,652991,ENSG00000215474,NA,NA,Skor2 (MGI:3645984)
18,47808956,47931187,18q21,18q21.1,601366,"MADH2, JV18, SMAD2","Mothers against decapentaplegic, Drosophila, homolog of, 2",SMAD2,4087,ENSG00000175387,NA,NA,Smad2 (MGI:108051)
18,48026671,48412638,18q21,18q21.1,616591,"ZBTB7C, APM1",Zinc finger- and BTB domain-containing protein 7C,ZBTB7C,201501,ENSG00000184828,NA,NA,Zbtb7c (MGI:2443302)
18,48539030,48863216,18q21.1,18q21.1,613178,"KIAA0427, CTIF",KIAA0427 gene,CTIF,9811,ENSG00000134030,NA,NA,Ctif (MGI:2685518)
18,48919852,48950710,18q21.1,18q21.1,602932,"SMAD7, MADH7, CRCS3","Mothers against decapentaplegic, Drosophila, homolog of, 7",SMAD7,4092,ENSG00000101665,NA,"{Colorectal cancer, susceptibility to, 3}, 612229 (3)",Smad7 (MGI:1100518)
18,49041473,49460708,18q12-q21.1,18q21.1,607461,"DYM, FLJ90130, DMC, SMC",Dymeclin,DYM,54808,ENSG00000141627,NA,"Dyggve-Melchior-Clausen disease, 223800 (3), Autosomal recessive; Smith-McCort dysplasia, 607326 (3), Autosomal recessive",Dym (MGI:1918480)
18,49488480,49492464,18q,18q21.1,603661,RPL17,Ribosomal protein L17,RPL17,6139,ENSG00000265681,NA,NA,"Rpl17-ps8,Rpl17 (MGI:2448270,MGI:3802129)"
18,49560698,49599184,18q21.1,18q21.1,603684,"LIPG, EL, EDL","Lipase G, endothelial",LIPG,9388,ENSG00000101670,NA,NA,Lipg (MGI:1341803)
18,49782163,49813532,18q21.1,18q21.1,604770,ACAA2,Acetyl-CoA acyltransferase 2,ACAA2,10449,ENSG00000167315,NA,NA,Acaa2 (MGI:1098623)
18,49814022,49814442,18q21.1,18q21.1,615645,SCARNA17,Small Cajal body-specific RNA 17,SCARNA17,677769,ENSG00000267322,NA,NA,NA
18,49822788,50195146,18q21,18q21.1,606540,"MYO5B, KIAA1119",Myosin VB,MYO5B,4645,ENSG00000167306,NA,"Microvillus inclusion disease, 251850 (3), Autosomal recessive",Myo5b (MGI:106598)
18,50227192,50266494,18q21.1,18q21.1,614759,"CCDC11, HTX6",Coiled-coil domain-containing protein 11,CFAP53,220136,ENSG00000172361,NA,"Heterotaxy, visceral, 6, autosomal recessive, 614779 (3), Autosomal recessive",Cfap53 (MGI:1921703)
18,50266881,50281773,18q21.1,18q21.1,156535,"MBD1, PCM1",Methyl=CpG binding domain protein 1 (protein containing methyl-CpG binding domain 1),MBD1,4152,ENSG00000141644,NA,NA,Mbd1 (MGI:1333811)
18,50375045,50394167,18q21.1,18q21.1,616673,"SKA1, C18orf24","Spindle- and kinetochore-associated complex, subunit 1",SKA1,220134,ENSG00000154839,NA,NA,Ska1 (MGI:1913718)
18,50559771,50731825,18q12-q21,18q21.1-q21.2,176949,"MAPK4, PRKM4, ERK3",Mitogen-activated protein kinase 4,MAPK4,5596,ENSG00000141639,NA,NA,Mapk4 (MGI:2444559)
18,50700000,56200000,18q21.2,NA,611014,HYT8,"Hypertension, essential, susceptibility to, 8",NA,100188321,NA,associated with rs1941958 and rs1893379,"{Hypertension, essential, susceptibility to, 8}, 611014 (2)",NA
18,50795129,50825412,18q21,18q21.2,608080,"MRO, B29",Maestro,MRO,83876,ENSG00000134042,NA,NA,Mro (MGI:2152817)
18,50878701,50954256,18q21,18q21.2,154270,ME2,"Malic enzyme, mitochondrial",ME2,4200,ENSG00000082212,10cM distal to F13A; previously mapped to chr.6,NA,Me2 (MGI:2147351)
18,50968039,50988120,18q21,18q21.2,608079,"ELAC1, D29","Elac, E. coli, homolog of, 1",ELAC1,55520,ENSG00000141642,NA,NA,Elac1 (MGI:1890495)
18,51030212,51085041,18q21.1,18q21.2,600993,"SMAD4, MADH4, DPC4, JIP, MYHRS","Mothers against decapentaplegic, Drosophila, homolog of, 4",SMAD4,4089,ENSG00000141646,NA,"Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant; Myhre syndrome, 139210 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant",Smad4 (MGI:894293)
18,51174549,51197680,18q21.2,18q21.2,611005,"MEX3C, RKHD2","Mex-3, C. elegans, homolog of, C",MEX3C,51320,ENSG00000176624,NA,NA,Mex3c (MGI:2652843)
18,52340171,53535898,18q21.3,18q21.2,120470,"DCC, MRMV1, HGPPS2",Deleted in colorectal carcinoma,DCC,1630,ENSG00000187323,NA,"Colorectal cancer, somatic, 114500 (3); Esophageal carcinoma, somatic, 133239 (3); Gaze palsy, familial horizontal, with progressive scoliosis, 2, 617542 (3), Autosomal recessive; Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3), Autosomal dominant",Dcc (MGI:94869)
18,54151605,54224668,18q21,18q21.2,603547,MBD2,Methyl-CpG-binding domain protein 2,MBD2,8932,ENSG00000134046,NA,NA,Mbd2 (MGI:1333813)
18,54269478,54321265,18q21.1,18q21.2,605252,"POLI, RAD30B","Polymerase, DNA, iota",POLI,11201,ENSG00000101751,NA,NA,Poli (MGI:1347081)
18,54324591,54358461,18q21,18q21.2,607051,STARD6,Start domain-containing protein 6,STARD6,147323,ENSG00000174448,NA,NA,Stard6 (MGI:2156774)
18,54357905,54382034,18q21,18q21.2,613258,"C18orf54, LAS2",Chromosome 18 open reading frame 54,C18orf54,162681,ENSG00000166845,NA,NA,4930503L19Rik (MGI:1922045)
18,54717841,54895515,18q21.2,18q21.2,603869,RAB27B,RAS-associated protein RAB27B,RAB27B,5874,ENSG00000041353,NA,NA,Rab27b (MGI:1931295)
18,54901508,54959538,18q21.2,18q21.2,616909,CCDC68,Coiled-coil domain-containing protein 68,CCDC68,80323,ENSG00000166510,NA,NA,Ccdc68 (MGI:3612676)
18,55222184,55635956,18q21.2,18q21.2,602272,"TCF4, SEF2, ITF2, PTHS, FECD3",Transcription factor-4 (immunoglobulin transcription factor-2),TCF4,6925,ENSG00000196628,NA,"Corneal dystrophy, Fuchs endothelial, 3, 613267 (3), Autosomal dominant; Pitt-Hopkins syndrome, 610954 (3), Autosomal dominant",Tcf4 (MGI:98506)
18,56200000,63900000,18q21.3,NA,212200,CNSN,Carnosinemia (carnosinase),NA,8173,NA,NA,"Carnosinemia, 212200 (2), Autosomal recessive",NA
18,56597208,56638688,18q21.31,18q21.31,603049,"TXNL1, TXNL",Thioredoxin-like 1,TXNL1,9352,ENSG00000091164,NA,NA,Txnl1 (MGI:1860078)
18,56651358,57029804,18q21.3,18q21.31,613473,"WDR7, TRAG, KIAA0541",WD repeat-containing protein 7,WDR7,23335,ENSG00000091157,NA,NA,Wdr7 (MGI:1860197)
18,57054558,57072118,18q21.2,18q21.31,615173,LINC-ROR,"Long intergenic noncoding RNA, regulator of reprogramming",LINC-ROR,100885779,ENSG00000258609,NA,NA,NA
18,57435373,57491297,18q21.1-q21.2,18q21.31,604894,"ONECUT2, OC2","One cut domain, family member 2",ONECUT2,9480,ENSG00000119547,NA,NA,Onecut2 (MGI:1891408)
18,57544388,57586707,18q21.3,18q21.31,612386,"FECH, FCE, EPP1",Ferrochelatase,FECH,2235,ENSG00000066926,NA,"Protoporphyria, erythropoietic, 1, 177000 (3), Autosomal recessive",Fech (MGI:95513)
18,57600655,57621835,18q21.1-q21.3,18q21.31,108410,"NARS, ASNRS",Asparaginyl-tRNA synthetase,NARS1,4677,ENSG00000134440,NA,NA,Nars (MGI:1917473)
18,57646425,57803821,18q21,18q21.31,602397,"ATP8B1, FIC1, BRIC, PFIC1, ICP1","ATPase, class I, type 8B, member 1",ATP8B1,5205,ENSG00000081923,NA,"Cholestasis, benign recurrent intrahepatic, 243300 (3), Autosomal recessive; Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3), Autosomal dominant; Cholestasis, progressive familial intrahepatic 1, 211600 (3), Autosomal recessive",Atp8b1 (MGI:1859665)
18,58044225,58401539,18q21,18q21.31,606384,"NEDD4L, KIAA0439, RSP5, PVNH7",Ubiquitin protein ligase NEDD4-like,NEDD4L,23327,ENSG00000049759,NA,"Periventricular nodular heterotopia 7, 617201 (3), Autosomal dominant",Nedd4l (MGI:1933754)
18,58451073,58451157,18q21,18q21.31,609582,"MIR122A, MIRN122A",Micro RNA 122A,MIR122,406906,ENSG00000284440,NA,NA,NA
18,58671419,58754476,18q21,18q21.32,604860,"MALT1, MLT, IMD12",Mucosa-associated lymphoid tissue lymphoma translocation gene 1,MALT1,10892,ENSG00000172175,fused with API2 in MALT lymphoma,"Immunodeficiency 12, 615468 (3), Autosomal recessive",Malt1 (MGI:2445027)
18,59219187,59230770,18q21,18q21.32,137260,GRP,Gastrin-releasing peptide,GRP,2922,ENSG00000134443,mammalian equivalent of bombesin,NA,Grp (MGI:95833)
18,59267037,59273453,18q21.3,18q21.32,601881,"RAX, RX, MCOP3",Retina and anterior neural fold homeobox gene,RAX,30062,ENSG00000134438,NA,"Microphthalmia, isolated 3, 611038 (3), Autosomal recessive",Rax (MGI:109632)
18,59327822,59359264,18q21.3-q22,18q21.32,601567,"LMAN1, ERGIC53, F5F8D, MCFD1","Lectin, mannose-binding, 1",LMAN1,3998,ENSG00000074695,NA,"Combined factor V and VIII deficiency, 227300 (3), Autosomal recessive",Lman1 (MGI:1917611)
18,59430938,59698180,18q21.32,18q21.32,612753,"CCBE1, KIAA1983, HKLLS1",Collagen and calcium-binding EGF domain-containing protein 1,CCBE1,147372,ENSG00000183287,NA,"Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3), Autosomal recessive",Ccbe1 (MGI:2445053)
18,59899995,59904304,18q21.32,18q21.32,604959,"PMAIP1, APR, NOXA",Phorbol-12-myristate-13-acetate-induced protein 1,PMAIP1,5366,ENSG00000141682,NA,NA,NA
18,60371061,60372774,18q22,18q21.32,155541,"MC4R, BMIQ20",Melanocortin-4 receptor,MC4R,4160,ENSG00000166603,NA,"Obesity (BMIQ20), 618406 (3); {Obesity, resistence to (BMIQ20)}, 618306 (3)",Mc4r (MGI:99457)
18,61333429,61555778,18q22-q23,18q21.33,605807,CDH20,Cadherin 20,CDH20,28316,ENSG00000101542,NA,NA,Cdh20 (MGI:1346069)
18,61808066,61894419,18q21.33,18q21.33,616512,RNF152,Ring finger protein 152,RNF152,220441,ENSG00000176641,NA,NA,Rnf152 (MGI:2443787)
18,62041163,62187117,18q21.33,18q21.33,606097,"PIGN, MCAHS1","Phosphatidylinositol glycan, class N",PIGN,23556,ENSG00000197563,NA,"Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3), Autosomal recessive",Pign (MGI:1351629)
18,62187254,62310248,18q21.33,18q21.33,618001,"RELCH, KIAA1468","RAB11 effector containing LIS1 homology domain, coiled-coil domains, and HEAT repeats",RELCH,57614,ENSG00000134444,NA,NA,Relch (MGI:1922832)
18,62325286,62391287,18q22.1,18q21.33,603499,"TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2","Tumor necrosis factor receptor superfamily, member 11A",TNFRSF11A,8792,ENSG00000141655,NA,"Osteolysis, familial expansile, 174810 (3), Autosomal dominant; Osteopetrosis, autosomal recessive 7, 612301 (3), Autosomal recessive; {Paget disease of bone 2, early-onset}, 602080 (3), Autosomal dominant",Tnfrsf11a (MGI:1314891)
18,62715444,62980432,18q21.33,18q21.33,609396,"PHLPP1, SCOP, KIAA0606",PH domain and leucine-rich repeat protein phosphatase,PHLPP1,23239,ENSG00000081913,NA,NA,Phlpp1 (MGI:2138327)
18,63123345,63320279,18q21.3,18q21.33,151430,BCL2,B-cell CLL/lymphoma-2,BCL2,596,ENSG00000171791,most frequent hematologic malignancy t(14;18)(q32;q21),"Leukemia/lymphoma, B-cell, 2 (3)",Bcl2 (MGI:88138)
18,63327725,63367233,18q21.3,18q21.33,136440,"KDSR, FVT1, EKVP4",3-ketodihydrosphingosine reductase,KDSR,2531,ENSG00000119537,~10kb 5' to BCL2,"Erythrokeratodermia variabilis et progressiva 4, 617526 (3), Autosomal recessive",Kdsr (MGI:1918000)
18,63389189,63422494,18q21.3,18q21.33,609983,"VPS4B, SKD1","Vacuolar protein sorting 4, yeast, homolog of, B",VPS4B,9525,ENSG00000119541,NA,NA,Vps4b (MGI:1100499)
18,63476957,63505084,18q21.3,18q21.33,154790,"PI5, SERPINB5",Protease inhibitor 5 (maspin),SERPINB5,5268,ENSG00000206075,in cluster of serpins,NA,Serpinb5 (MGI:109579)
18,63519163,63569328,18q21.3,18q21.33,615662,SERPINB12,"Serpin peptidase inhibitor, clade (ovalbumin), member 12",SERPINB12,89777,ENSG00000166634,NA,NA,Serpinb12 (MGI:1919119)
18,63586653,63599198,18q21.3,18q21.33,604445,"SERPINB13, PI13, HURPIN",Protease inhibitor 13,SERPINB13,5275,ENSG00000197641,NA,NA,Serpinb13 (MGI:3042250)
18,63637258,63644309,18q21.3,18q21.33,600518,"SERPINB4, SCCA2","Serpin peptidase inhibitor, clade B (ovalbumin), member 4 (squamous cell carcinoma antigen 2)",SERPINB4,6318,ENSG00000206073,NA,NA,Serpinb3a (MGI:3573933)
18,63655196,63661892,18q21.3,18q21.33,600517,"SERPINB3, SCCA1","Serpin peptidase inhibitor, clade B (ovalbumin), member 3 (squamous cell carcinoma antigen 1)",SERPINB3,6317,ENSG00000057149,NA,NA,Serpinb3d (MGI:2683295)
18,63702306,63723892,18q21.3,18q21.33,615682,SERPINB11,"Serpin peptidase inhibitor, clade B (ovalbumin), member 11",SERPINB11,89778,ENSG00000206072,NA,NA,Serpinb11 (MGI:1914207)
18,63753046,63805375,18q21.3,18q21.33,603357,"SERPINB7, MEGSIN, PPKN","Serpin peptidase inhibitor, clade B (ovalbumin), member 7",SERPINB7,8710,ENSG00000166396,NA,"Palmoplantar keratoderma, Nagashima type, 615598 (3), Autosomal recessive",Serpinb7 (MGI:2151053)
18,63887704,63903889,18q21.3,18q21.3-q22.1,173390,"SERPINB2, PAI2, PLANH2","Serpin peptidase inhibitor, clade B (ovalbumin), member 2 (Plasminogen activator inhibitor, type II (arginine-serpin))",SERPINB2,5055,ENSG00000197632,600kb telomeric to BCL2,NA,Serpinb2 (MGI:97609)
18,63900000,75400000,18q22,NA,609334,"DUP18pDEL18q, DUP18qDEL18p",Chromosome 18 pericentric inversion,NA,NA,NA,NA,"Chromosome 18 pericentric inversion, 609334 (4)",NA
18,63900000,75400000,18q22.1-q22.3,NA,602401,ECTD8,"Ectodermal dysplasia 8, hair/tooth/nail type",NA,101101768,NA,between D18S857 and D18S815,"Ectodermal dysplasia 8, hair/tooth/nail type, 602401 (2), Autosomal recessive",NA
18,63907957,63936110,18q21.3,18q22.1,602058,"SERPINB10, PI10","Protease inhibitor 10, ovalbumin type (bomapin)",SERPINB10,5273,ENSG00000242550,NA,NA,Serpinb10 (MGI:2138648)
18,63949258,63969328,18q21.3,18q22.1,612086,HMSD,"Minor histocompatibility antigen, serpin domain-containing",HMSD,284293,ENSG00000221887,NA,NA,NA
18,63970028,64019778,18q21.3,18q22.1,601697,"SERPINB8, PI8, CAP2, PSS5","Serpin family B, member 8",SERPINB8,5271,ENSG00000166401,NA,"Peeling skin syndrome 5, 617115 (3), Autosomal recessive",Serpinb8 (MGI:894657)
18,64080008,64149025,18q22.1,18q22.1,617489,LINC00305,Long intergenic noncoding RNA 305,LINC00305,221241,ENSG00000179676,NA,NA,NA
18,65750251,65890336,18q22-q23,18q22.1,605806,CDH7,Cadherin-7,CDH7,1005,ENSG00000081138,NA,NA,Cdh7 (MGI:2442792)
18,66501082,66604240,18q22-q23,18q22.1,603016,"CDH19, CDH7",Cadherin 19,CDH19,28513,ENSG00000071991,NA,NA,Cdh19 (MGI:3588198)
18,67506586,67516719,18q21-q22,18q22.1,611125,"DSEL, C18orf4, NCAG1",Dermatan sulfate epimerase-like,DSEL,92126,ENSG00000171451,NA,NA,Dsel (MGI:2442948)
18,68673687,68715172,18q22.1,18q22.1,616102,"TMX3, TXNDC10, KIAA1830",Thioredoxin-related transmembrane protein 3,TMX3,54495,ENSG00000166479,NA,NA,Tmx3 (MGI:2442418)
18,69853273,69962085,18q22.3,18q22.2,605397,"DNAM1, CD226",DNAX accessory molecule 1,CD226,10666,ENSG00000150637,NA,NA,Cd226 (MGI:3039602)
18,70003030,70205725,18q22.2,18q22.2,610436,"RTTN, MSSP",Rotatin,RTTN,25914,ENSG00000176225,NA,"Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3), Autosomal recessive",Rttn (MGI:2179288)
18,70289044,70330198,18q21.1,18q22.2,605118,"SOCS6, SSI4, STAT4, CIS4",Suppressor of cytokine signaling 6,SOCS6,9306,ENSG00000170677,NA,NA,Socs6 (MGI:1924885)
18,72533719,72638484,18q22.3,18q22.3,600433,CBLN2,Cerebellin 2 precursor,CBLN2,147381,ENSG00000141668,NA,NA,Cbln2 (MGI:88282)
18,72742313,72867986,18q22-q23,18q22.3,607973,"NETO1, BCTL1",Neuropilin and tolloid like 1,NETO1,81832,ENSG00000166342,NA,NA,Neto1 (MGI:2180216)
18,74073342,74147833,18q22.3,18q22.3,609093,"FBXO15, FBX15",F-box only protein 15,FBXO15,201456,ENSG00000141665,NA,NA,Fbxo15 (MGI:1354755)
18,74148516,74160530,18q22.3,18q22.3,615180,"TIMM21, TIM21","Translocase of inner mitochondrial membrane 21, yeast, homolog of",TIMM21,29090,ENSG00000075336,NA,NA,Timm21 (MGI:1920595)
18,74250845,74291979,18q23,18q22.3,613218,"CYB5A, MCB5, METAG",Cytochrome b5,CYB5A,1528,ENSG00000166347,"pseudogenes on X, 14q, 20p; mutation identified in 1 MET5 patient","Methemoglobinemia and ambiguous genitalia, 250790 (3), Autosomal recessive",Cyb5a (MGI:1926952)
18,74435727,74464645,18q22.3,18q22.3,614544,FAM69C,"Family with sequence similarity 69, member C",DIPK1C,125704,ENSG00000187773,NA,NA,Dipk1c (MGI:3041188)
18,74496362,74523453,18q23,18q22.3,169800,PEPA,Peptidase A,CNDP2,55748,ENSG00000133313,NA,NA,Cndp2 (MGI:1913304)
18,74534499,74587211,18q22.3,18q22.3,609064,"CNDP1, CN1",Carnosine dipeptidase 1,CNDP1,84735,ENSG00000150656,NA,NA,Cndp1 (MGI:2451097)
18,74590474,75065671,18q22.3,18q22.3,615894,ZNF407,Zinc finger protein 407,ZNF407,55628,ENSG00000215421,NA,NA,Zfp407 (MGI:2685179)
18,75210796,75289949,18q22.3,18q22.3,614427,"TSHZ1, TSH1, CAA",Teashirt zinc finger homeobox 1,TSHZ1,10194,ENSG00000179981,NA,"Aural atresia, congenital, 607842 (3), Autosomal dominant",Tshz1 (MGI:1346031)
18,76357681,76495254,18q23,18q23,615114,"ZNF516, KIAA0222",Zinc finger protein 516,ZNF516,9658,ENSG00000101493,NA,NA,Zfp516 (MGI:2443957)
18,76822549,76970731,18q22-q23,18q23,604760,ZNF236,Zinc finger protein-236,ZNF236,7776,ENSG00000130856,NA,NA,Zfp236 (MGI:1926950)
18,76978832,77133707,18q22-qter,18q23,159430,MBP,Myelin basic protein,MBP,4155,ENSG00000197971,"defective in ""shiverer,"" neurologic mutant in mouse",NA,Mbp (MGI:96925)
18,77250051,77270141,18q23,18q23,600377,"GALR1, GALNR1, GALNR",Galanin receptor 1,GALR1,2587,ENSG00000166573,NA,NA,Galr1 (MGI:1096364)
18,78980274,78998968,18q23,18q23,605079,SALL3,Sal-like 3,SALL3,27164,ENSG00000256463,NA,NA,Sall3 (MGI:109295)
18,79069274,79378390,18q22.3-qter,18q23,614446,ATP9B,"ATPase, class II, type 9B",ATP9B,374868,ENSG00000166377,NA,NA,Atp9b (MGI:1354757)
18,79395929,79529322,18q23,18q23,600489,NFATC1,"Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1",NFATC1,4772,ENSG00000131196,NA,NA,Nfatc1 (MGI:102469)
18,79679800,79756624,18q23,18q23,604927,"CTDP1, FCP1, CCFDN","C-terminal domain of RNA polymerase II subunit A, phosphatase of, subunit 1",CTDP1,9150,ENSG00000060069,NA,"Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3), Autosomal recessive",Ctdp1 (MGI:1926953)
18,79970812,80033935,18q23,18q23,611595,"TXNL4A, DIM1, BMKS",Thioredoxin-like 4A,TXNL4A,10907,ENSG00000141759,NA,"Burn-McKeown syndrome, 608572 (3), Autosomal recessive",Txnl4a (MGI:1351613)
18,80109250,80140345,18q23,18q23,617422,"ADNP2, KIAA0863",Activity-dependent neuroprotector homeobox 2,ADNP2,22850,ENSG00000101544,NA,NA,Adnp2 (MGI:2448562)
18,80157231,80247513,18q23,18q23,608976,PARD6G,"partitioning-defective protein 6, C. elegans, homolog of",PARD6G,84552,ENSG00000178184,NA,NA,Pard6g (MGI:2135606)
19,0,12600000,19p13.3-p13.2,NA,108725,"ATHS, ALP",Atherosclerosis susceptibility (lipoprotein associated),ATHS,470,NA,closely linked to LDLR; may be LDLR,"{Atherosclerosis, susceptibility to}, 108725 (2), Autosomal dominant",NA
19,0,58617616,19pter-q13,NA,120050,CXB3S,Coxsackie virus B3 sensitivity,CXB3S,1526,NA,NA,NA,NA
19,0,26200000,19p,NA,600209,EXT3,"Exostoses, multiple, 3",EXT3,2133,NA,NA,"Exostoses, multiple, type 3, 600209 (2), Autosomal dominant",NA
19,0,6900000,19p13.3,NA,602477,FEB2,"Febrile seizures, familial, 2",FEB2,2234,NA,NA,"Febrile seizures, familial, 2, 602477 (2), Autosomal dominant",NA
19,0,19900000,19pter-p13.1,NA,614233,"FPH1, MUH, HPP","Hyperpigmentation, familial progressive, 1",NA,NA,NA,NA,"Hyperpigmentation, familial progressive, 1, 614233 (2)",NA
19,0,19900000,19p13,NA,606674,IBD6,Inflammatory bowel disease 6,IBD6,50942,NA,NA,"{Inflammatory bowel disease 6}, 606674 (2)",NA
19,0,6900000,19p13.3,NA,181800,"IS1, AIS",Adolescent idiopathic scoliosis,NA,260402,NA,NA,"Scoliosis, idiopathic 1, 181800 (2), Autosomal dominant",NA
19,0,6900000,19p13.3,NA,605305,"KIR2DL5A, KIR2DL5","Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A",KIR2DL5A,57292,NA,NA,NA,NA
19,0,6900000,19p13.3,NA,601846,MDRV,Muscular dystrophy with rimmed vacuoles,MDRV,4195,NA,NA,"Muscular dystrophy with rimmed vacuoles, 601846 (2), Autosomal dominant",NA
19,0,19900000,19p13,NA,607508,MGR5,"Migraine with or without aura, susceptibility to, 5",NA,387576,NA,NA,"{Migraine with or without aura, susceptibility to, 5}, 607508 (2), Autosomal dominant",NA
19,0,19900000,19p13,NA,615830,PPNAD4,"Pigmented nodular adrenocortical disease, primary, 4",NA,NA,NA,duplication of 294kb to 2.7Mb on 19p13,"Pigmented nodular adrenocortical disease, primary, 4, 615830 (4), Autosomal dominant",NA
19,0,19900000,19p13,NA,605364,PSORS6,Psoriasis susceptibility 6,PSORS6,63869,NA,NA,"{Psoriasis susceptibility 6}, 605364 (2)",NA
19,281042,291412,19p13.3,19p13.3,607126,"PLPP2, PPAP2C",Phospholipid phosphatase 2,PLPP2,8612,ENSG00000141934,NA,NA,Plpp2 (MGI:1354945)
19,361746,376692,19p13.3,19p13.3,609503,THEG,"Testicular haploid expressed gene, mouse, homolog of",THEG,51298,ENSG00000105549,NA,NA,Theg (MGI:1338756)
19,405434,409146,19p13.3,19p13.3,610336,"C2CD4C, NLF3, KIAA1957",C2 calcium-dependent domain containing 4C,C2CD4C,126567,ENSG00000183186,NA,NA,C2cd4c (MGI:2685084)
19,416582,461010,19p13.3,19p13.3,605217,"SHC2, SHCB, SCK",SHC transforming protein 2,SHC2,25759,ENSG00000129946,NA,NA,Shc2 (MGI:106180)
19,496485,505342,19p13.3,19p13.3,102670,MACAM1,Mucosal addressin cell adhesion molecule-1,MADCAM1,8174,ENSG00000099866,NA,NA,NA
19,531719,542087,19p13.3,19p13.3,116948,CDC34,Cell division cycle 34,CDC34,997,ENSG00000099804,NA,NA,Cdc34 (MGI:102657)
19,544052,549921,19p13.3,19p13.3,600311,GZMM,Granzyme M (lymphocyte met-ase 1),GZMM,3004,ENSG00000197540,NA,NA,Gzmm (MGI:99549)
19,571282,583492,19p13.3,19p13.3,109480,BSG,Basigin (blood group OK),BSG,682,ENSG00000172270,NA,"[Blood group, OK], 111380 (3)",Bsg (MGI:88208)
19,589880,617158,19p13.3,19p13.3,602781,"HCN2, BCNG2",Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2,HCN2,610,ENSG00000099822,NA,NA,Hcn2 (MGI:1298210)
19,617220,633556,19p13.3,19p13.3,601778,"POLRMT, APOLMT",Polymerase (RNA) mitochondrial (DNA directed),POLRMT,5442,ENSG00000099821,NA,NA,Polrmt (MGI:1915843)
19,639894,644372,19p13.3,19p13.3,605831,FGF22,Fibroblast growth factor 22,FGF22,27006,ENSG00000070388,NA,NA,Fgf22 (MGI:1914362)
19,647525,663213,19p13.3,19p13.3,615177,RNF126,RING finger protein 126,RNF126,55658,ENSG00000070423,NA,NA,Rnf126 (MGI:1917544)
19,676391,683384,19p13,19p13.3,605343,"FSTL3, FLRG",Follistatin-like 3,FSTL3,10272,ENSG00000070404,NA,NA,Fstl3 (MGI:1890391)
19,708934,748328,19p13.3,19p13.3,608134,"PALM, KIAA0270",Paralemmin,PALM,5064,ENSG00000099864,NA,NA,Palm (MGI:1261814)
19,748412,764317,19p13.3,19p13.3,615289,"MISP, C19orf21",Mitotic spindle-positioning protein,MISP,126353,ENSG00000099812,NA,NA,Misp (MGI:1926156)
19,797451,812315,19p13.3,19p13.3,600693,"PTBP1, PTB, HNRNPI",Polypyrimidine tract-binding protein 1,PTBP1,5725,ENSG00000011304,pseudogene on chr. 14,NA,Ptbp1 (MGI:97791)
19,810965,824243,19p13.3,19p13.3,610391,"PLPPR3, LPPR3, LPR3, PRG2",Phospholipid phosphatase-related protein 3,PLPPR3,79948,ENSG00000129951,NA,NA,Plppr3 (MGI:2388640)
19,827836,832017,19p13.3,19p13.3,162815,"AZU1, CAP37",Azurocidin-1 (cationic antimicrobial protein-37),AZU1,566,ENSG00000172232,5\(rm-AZU1-8kb-PR3-3kb-ELAN-3',NA,NA
19,840964,848174,19p13.3,19p13.3,177020,"PRTN3, AGP7",Proteinase 3,PRTN3,5657,ENSG00000196415,NA,NA,Prtn3 (MGI:893580)
19,850996,856249,19p13.3,19p13.3,130130,"ELANE, ELA2, SCN1","Elastase, neutrophil-expressed",ELANE,1991,ENSG00000197561,NA,"Neutropenia, cyclic, 162800 (3), Autosomal dominant; Neutropenia, severe congenital 1, autosomal dominant, 202700 (3), Autosomal dominant",Elane (MGI:2679229)
19,859663,863640,19p13.3,19p13.3,134350,"CFD, ADN",Complement factor D,CFD,1675,ENSG00000197766,NA,"Complement factor D deficiency, 613912 (3), Autosomal recessive",Cfd (MGI:87931)
19,867960,893227,19p13.3,19p13.3,604062,"MED16, THRAP5, DRIP92, TRAP95",Mediator complex subunit 16,MED16,10025,ENSG00000175221,NA,NA,Med16 (MGI:2158394)
19,916692,921004,19p13.3,19p13.3,604161,"KISS1R, GPR54, HH8, CPPB1",KISS1 receptor,KISS1R,84634,ENSG00000116014,mutation identified in 1 CPPB1 patient,"Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3), Autosomal recessive; ?Precocious puberty, central, 1, 176400 (3), Autosomal dominant",Kiss1r (MGI:2148793)
19,925732,975938,19p13.3,19p13.3,603265,DRIL1,"Dead ringer, Drosophila, homolog-like 1",ARID3A,1820,ENSG00000116017,NA,NA,Arid3a (MGI:1328360)
19,1000418,1009747,19p13.3,19p13.3,606651,GRIN3B,"Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B",GRIN3B,116444,ENSG00000116032,NA,NA,Grin3b (MGI:2150393)
19,1009650,1021141,19p13.3,19p13.3,611011,"TMEM259, C19orf6",Transmembrane protein 259 (membralin),TMEM259,91304,ENSG00000182087,NA,NA,Tmem259 (MGI:2177957)
19,1026607,1039064,19p13.3,19p13.3,602373,CNN2,Calonin 2,CNN2,1265,ENSG00000064666,previously assigned to 21q11.1,NA,Cnn2 (MGI:105093)
19,1040102,1065571,19p13.3,19p13.3,605414,"ABCA7, ABCX, AD9","ATP-binding cassette, subfamily A, member 7",ABCA7,10347,ENSG00000064687,NA,"{Alzheimer disease 9, susceptibility to}, 608907 (3), Autosomal dominant",Abca7 (MGI:1351646)
19,1065958,1087830,19p13.3,19p13.3,601155,"HMHA1, HLA-HA1, KIAA0223",Minor histocompatibility antigen HA-1,ARHGAP45,23526,ENSG00000180448,NA,NA,Arhgap45 (MGI:1917969)
19,1086573,1095391,19p13.3,19p13.3,180664,POLR2E,"Polymerase (RNA) II (DNA directed) polypeptide E, 25kD",POLR2E,5434,ENSG00000099817,NA,NA,Polr2e (MGI:1913670)
19,1103993,1106778,19p13.3,19p13.3,138322,"GPX4, SMDS",Glutathione peroxidase-4 (phospholipid hydroperoxidase),GPX4,2879,ENSG00000167468,NA,"Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3), Autosomal recessive",Gpx4 (MGI:104767)
19,1107636,1174267,19p13.3,19p13.3,615729,"SBNO2, KIAA0963","Strawberry notch, Drosophila, homolog of, 2",SBNO2,22904,ENSG00000064932,NA,NA,Sbno2 (MGI:2448490)
19,1205798,1228434,19p13.3,19p13.3,602216,"STK11, PJS, LKB1",Serine/threonine protein kinase-11,STK11,6794,ENSG00000118046,NA,"Melanoma, malignant, somatic (3); Pancreatic cancer, somatic, 260350 (3); Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant; Testicular tumor, somatic, 273300 (3)",Stk11 (MGI:1341870)
19,1241750,1244824,19p13.3,19p13.3,603150,"ATP5F1D, ATP5D, MC5DN5",ATP synthase F1 subunit delta,ATP5F1D,513,ENSG00000099624,NA,"Mitochondrial complex V (ATP synthase) deficiency, 618120 (3), Autosomal recessive",Atp5d (MGI:1913293)
19,1248551,1259142,19p13.3,19p13.3,606700,MIDN,"Midnolin, mouse, homolog of",MIDN,90007,ENSG00000167470,NA,NA,Midn (MGI:1890222)
19,1269267,1274809,19p13.3,19p13.3,602649,CIRBP,Cold-inducible RNA-binding protein,CIRBP,1153,ENSG00000099622,NA,NA,Cirbp (MGI:893588)
19,1282816,1301430,19p13.3,19p13.3,602756,"EFNA2, EPLG6, LERK6",Ephrin A2,EFNA2,1943,ENSG00000099617,NA,NA,Efna2 (MGI:102707)
19,1383903,1395583,19p13,19p13.3,601825,"NDUFS7, PSST, MC1DN3",NADH-ubiquinone oxidoreductase core subunit S7,NDUFS7,374291,ENSG00000115286,NA,"Mitochondrial complex I deficiency, nuclear type 3, 618224 (3), Autosomal recessive",Ndufs7 (MGI:1922656)
19,1397025,1401541,19p13.3,19p13.3,601240,"GAMT, CCDS2",Guanidinoacetate methyltransferase,GAMT,2593,ENSG00000130005,NA,"Cerebral creatine deficiency syndrome 2, 612736 (3), Autosomal recessive",Gamt (MGI:1098221)
19,1438363,1440496,19p,19p13.3,180535,"RPS15, RIG",Ribosomal protein S15,RPS15,6209,ENSG00000115268,NA,NA,Rps15 (MGI:98117)
19,1446267,1473243,19p13.3,19p13.3,612034,"APC2, APCL, SOTOS3",APC2 gene,APC2,10297,ENSG00000115266,mutation identified in 1 SOTOS3 family,"?Sotos syndrome 3, 617169 (3), Autosomal recessive",Apc2 (MGI:1346052)
19,1481427,1490873,19p13.3,19p13.3,600487,PCSK4,Proprotein convertase subtilisin/kexin type 4,PCSK4,54760,ENSG00000115257,NA,NA,Pcsk4 (MGI:97514)
19,1491180,1497926,19p13.3,19p13.3,609346,"REEP6, DP1L1, TB2L1, C19orf32, RP77",Receptor expression-enhancing protein 6,REEP6,92840,ENSG00000115255,NA,"Retinitis pigmentosa 77, 617304 (3), Autosomal recessive",Reep6 (MGI:1917585)
19,1554668,1568324,19p13.3,19p13.3,611009,"MEX3D, RKHD1, TINO, KIAA2031","Mex-3, C. elegans, homolog of, D",MEX3D,399664,ENSG00000181588,NA,NA,Mex3d (MGI:2681847)
19,1573595,1592864,19p13.3,19p13.3,603573,MBD3,Methyl-CpG-binding domain protein 3,MBD3,53615,ENSG00000071655,NA,NA,Mbd3 (MGI:1333812)
19,1597168,1605461,19p13.3,19p13.3,609711,UQCR,"Ubiquinol-cytochrome c reductase, 6.4kD subunit",UQCR11,10975,ENSG00000127540,NA,NA,Uqcr11 (MGI:1913844)
19,1609291,1652614,19p13.3,19p13.3,147141,"TCF3, E2A, AGM8",Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47),TCF3,6929,ENSG00000071564,NA,"Agammaglobulinemia 8, autosomal dominant, 616941 (3), Autosomal dominant",Tcf3 (MGI:98510)
19,1753505,1780987,19p13.3,19p13.3,611294,"ONECUT3, OC3",One cut homeobox 3,ONECUT3,390874,ENSG00000205922,NA,NA,NA
19,1782067,1812275,19p13.3,19p13.3,605866,"ATP8B3, ATPIK","ATPase, class I, type 8B, member 3",ATP8B3,148229,ENSG00000130270,NA,NA,Atp8b3 (MGI:1914581)
19,1815247,1848682,19p13.3,19p13.3,609614,"REXO1, REX1, ELOABP1, TCEB3BP1","RNA exonuclease 1, S. cerevisiae, homolog of",REXO1,57455,ENSG00000079313,NA,NA,Rexo1 (MGI:1914182)
19,1816158,1816237,19p13.3,19p13.3,615201,MIR1909,Micro RNA 1909,MIR1909,100302210,ENSG00000284216,NA,NA,NA
19,1852398,1863578,19p13.3,19p13.3,606139,"KLF16, BTEB4, DRRF",Kruppel-like factor 16,KLF16,83855,ENSG00000129911,NA,NA,NA
19,1876809,1885518,19p13.3,19p13.3,617942,"ABHD17A, FAM108A1",Abhydrolase domain-containing protein 17A,ABHD17A,81926,ENSG00000129968,NA,NA,Abhd17a (MGI:106388)
19,1905398,1913446,19p13.3,19p13.3,615302,"ADAT3, TAD3, MRT36","Adenosine deaminase, tRNA-specific, 3",ADAT3,113179,ENSG00000213638,NA,"Mental retardation, autosomal recessive 36, 615286 (3), Autosomal recessive",Adat3 (MGI:1924344)
19,1905398,1926012,19p13.3,19p13.3,613764,SCAMP4,Secretory carrier membrane protein 4,SCAMP4,113178,ENSG00000227500,NA,NA,Scamp4 (MGI:1928947)
19,1941148,1981337,19p13.3,19p13.3,602214,CSNK1G2,"Casein kinase 1, gamma-2",CSNK1G2,1455,ENSG00000133275,NA,NA,Csnk1g2 (MGI:1920014)
19,2037470,2051277,19p13.3,19p13.3,605069,"MKNK2, MNK2, GPRK7",Mitogen-activated protein kinase-interacting serine/threonine kinase-2,MKNK2,2872,ENSG00000099875,NA,NA,Mknk2 (MGI:894279)
19,2100987,2151619,19p13.3,19p13.3,607246,"AP3D1, HPS10","Adaptor-related protein complex 3, delta-1 subunit",AP3D1,8943,ENSG00000065000,mutation identified in 1 HPS10 patient,"?Hermansky-Pudlak syndrome 10, 617050 (3), Autosomal recessive",Ap3d1 (MGI:107734)
19,2163932,2232577,19p13.3,19p13.3,607375,"DOT1L, DOT1, KIAA1814","Dot1, yeast, homolog of",DOT1L,84444,ENSG00000104885,NA,NA,Dot1l (MGI:2143886)
19,2229951,2236723,19p13.3,19p13.3,617834,"PLEKHJ1, GNRPX","Pleckstrin homology domain-containing protein, family J, member 1",PLEKHJ1,55111,ENSG00000104886,NA,NA,Plekhj1 (MGI:1925920)
19,2236823,2248654,19p13.3-p13.2,19p13.3,600796,"SF3A2, SAP62, PRP11","Splicing factor 3a, subunit 2, 66kD",SF3A2,8175,ENSG00000104897,NA,NA,NA
19,2249322,2252072,19p13.3-p13.2,19p13.3,600957,"AMH, MIF",Anti-Mullerian hormone,AMH,268,ENSG00000104899,NA,"Persistent Mullerian duct syndrome, type I, 261550 (3), Autosomal recessive",Amh (MGI:88006)
19,2252251,2260812,19p13.3,19p13.3,608743,"JSRP1, JP45",Junctional sarcoplasmic reticulum protein 1,JSRP1,126306,ENSG00000167476,NA,NA,Jsrp1 (MGI:1916700)
19,2269485,2273487,19p13.3,19p13.3,601579,OAZ1,Ornithine decarboxylase antizyme 1,OAZ1,4946,ENSG00000104904,NA,NA,Oaz1 (MGI:109433)
19,2289783,2308153,19p13.3,19p13.3,609792,"LRRN6B, LINGO3, LERN2","Leucine-rich repeat protein, neuronal, 6B",LINGO3,645191,ENSG00000220008,NA,NA,Lingo3 (MGI:3609246)
19,2321520,2328629,19p13.3,19p13.3,607287,LSM7,LSM7 protein,LSM7,51690,ENSG00000130332,NA,NA,Lsm7 (MGI:1913344)
19,2328570,2355094,19p13.3,19p13.3,608239,"SNPPL2B, IMP4, KIAA1532",Signal peptide peptidase-like 2B,SPPL2B,56928,ENSG00000005206,NA,NA,Sppl2b (MGI:1920468)
19,2385253,2426260,19p13.3,19p13.3,610477,TMPRSS9,"Transmembrane protease, serine 9",TMPRSS9,360200,ENSG00000178297,NA,NA,Tmprss9 (MGI:3612246)
19,2425624,2427585,19p13.3,19p13.3,607383,TIMM13,"Translocase of inner mitochondrial membrane 13, yeast, homolog of",TIMM13,26517,ENSG00000099800,NA,NA,Timm13 (MGI:1353432)
19,2428165,2456958,19p13.3,19p13.3,150341,"LMNB2, LMN2, EPM9",Lamin B2,LMNB2,84823,ENSG00000176619,mutation identified in 1 EPM9 family,"?Epilepsy, progressive myoclonic, 9, 616540 (3), Autosomal recessive; {Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3), Autosomal dominant",Lmnb2 (MGI:96796)
19,2476126,2478258,19p13.3,19p13.3,604948,"GADD45B, MYD118","Growth arrest- and DNA damage-inducible gene 45, beta",GADD45B,4616,ENSG00000099860,NA,NA,Gadd45b (MGI:107776)
19,2714566,2721371,19p13.3,19p13.3,607862,"DIRAS1, RIG","DIRAS family, GTP-binding Ras-like protein 1",DIRAS1,148252,ENSG00000176490,NA,NA,Diras1 (MGI:2183442)
19,2732523,2740075,19p13.3,19p13.3,612168,"SLC39A3, ZIP3","Solute carrier family 39, zinc transporter, member 3",SLC39A3,29985,ENSG00000141873,NA,NA,Slc39a3 (MGI:2147269)
19,2754713,2783316,19p13,19p13.3,603419,"SGTA, SGT","Small glutamine-rich tetratricopeptide repeat-containing protein, alpha",SGTA,6449,ENSG00000104969,NA,NA,Sgta (MGI:1098703)
19,2785465,2815806,19p13.3,19p13.3,601117,THOP1,Thimet oligopeptidase-1,THOP1,7064,ENSG00000172009,NA,NA,Thop1 (MGI:1354165)
19,2933217,2944970,19p,19p13.3,194551,ZNF77,Zinc finger protein-77 (pT1),ZNF77,58492,ENSG00000175691,NA,NA,NA
19,2977409,2995183,19p13.3,19p13.3,612399,"TLE6, GRG6, PREMBL",Transducin-like enhancer of split 6,TLE6,79816,ENSG00000104953,NA,"Preimplantation embryonic lethality, 616814 (3), Autosomal recessive",Tle6 (MGI:2149593)
19,2997637,3047634,19p13.3,19p13.3,601041,"TLE2, ESG2",Transducin-like enhancer of split 2 (homolog of Drosophila E(spl)),TLE2,7089,ENSG00000065717,NA,NA,Tle2 (MGI:104635)
19,3052909,3063106,19p13.3,19p13.3,600188,AES,Amino-terminal enhancer of split,TLE5,166,ENSG00000104964,NA,NA,Tle5 (MGI:95806)
19,3094361,3123998,19p13,19p13.3,139313,"GNA11, HHC2, HYPOC2","Guanine nucleotide-binding protein, Gq class, GNA11",GNA11,2767,ENSG00000088256,NA,"Hypocalcemia, autosomal dominant 2, 615361 (3), Autosomal dominant; Hypocalciuric hypercalcemia, type II, 145981 (3), Autosomal dominant",Gna11 (MGI:95766)
19,3136032,3163748,19p13,19p13.3,139314,"GNA15, GNA16",Guanine nucleotide-binding protein (G protein) alpha 15 (Gq class),GNA15,2769,ENSG00000060558,NA,NA,Gna15 (MGI:95770)
19,3178768,3180331,19p13.3,19p13.3,603751,"S1PR4, EDG6, S1P4",Sphingosine-1-phosphate receptor 4,S1PR4,8698,ENSG00000125910,NA,NA,S1pr4 (MGI:1333809)
19,3224660,3297075,19p13,19p13.3,612680,"CELF5, BRUNOL5","CUGbp- and ELAV-like family, member 5",CELF5,60680,ENSG00000161082,NA,NA,Celf5 (MGI:2442333)
19,3359629,3469216,19p13.3,19p13.3,600729,NFIC,Nuclear factor I/C (CCAAT-binding transcription factor),NFIC,4782,ENSG00000141905,order: cen-NFIX-NFIC-tel,NA,Nfic (MGI:109591)
19,3490820,3500939,19p13.3,19p13.3,611262,"DOHH, HLRC1",Deoxyhypusine hydroxylase,DOHH,83475,ENSG00000129932,NA,NA,Dohh (MGI:1915964)
19,3506262,3538333,19p13.3,19p13.3,603619,"HCDH, FZR","CDH1/HCT1, S. cerevisiae, homolog of",FZR1,51343,ENSG00000105325,NA,NA,Fzr1 (MGI:1926790)
19,3538269,3557591,19p13.3,19p13.3,617745,"MFSD12, PP3501",Major facilitator superfamily domain-containing protein 12,MFSD12,126321,ENSG00000161091,NA,NA,Mfsd12 (MGI:3604804)
19,3572915,3579082,19p13.3,19p13.3,605535,"HMG20B, BRAF35",High mobility group protein 20B,HMG20B,10362,ENSG00000064961,NA,NA,Hmg20b (MGI:1341190)
19,3585477,3593540,19p13.3,19p13.3,608792,"GIPC3, DFNB15, DFNB72, DFNB95",GAIP C-terminus-interacting protein 3,GIPC3,126326,ENSG00000179855,NA,"Deafness, autosomal recessive 15, 601869 (3), Autosomal recessive",Gipc3 (MGI:2387006)
19,3594505,3608748,19p13.3,19p13.3,188070,"TBXA2R, BDPLT13",Thromboxane A2 receptor,TBXA2R,6915,ENSG00000006638,NA,"{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3), Autosomal dominant",Tbxa2r (MGI:98496)
19,3630180,3700485,19p13.3,19p13.3,606102,"PIP5K1C, LCCS3","Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma",PIP5K1C,23396,ENSG00000186111,NA,"Lethal congenital contractural syndrome 3, 611369 (3), Autosomal recessive",Pip5k1c (MGI:1298224)
19,3708383,3750812,19p13.3,19p13.3,612689,"TJP3, ZO3",Tight junction protein 3,TJP3,27134,ENSG00000105289,NA,NA,Tjp3 (MGI:1351650)
19,3750771,3761695,19p13.3,19p13.3,604262,"APBA3, X11L2, MINT3","Amyloid beta A4 precursor protein-binding, family A, member 3",APBA3,9546,ENSG00000011132,NA,NA,Apba3 (MGI:1888527)
19,3762681,3767564,19p13.3,19p13.3,611858,MRPL54,Mitochondrial ribosomal protein L54,MRPL54,116541,ENSG00000183617,NA,NA,Mrpl54 (MGI:1913297)
19,3769088,3772227,19p13.3,19p13.3,610362,"RAX2, RAXL1, QRX, CORD11, ARMD6",Retina and anterior neural fold homeobox 2,RAX2,84839,ENSG00000173976,mutation identified in 1 ARMD6 patient,"Cone-rod dystrophy 11, 610381 (3), Autosomal dominant; ?Macular degeneration, age-related, 6, 613757 (3)",NA
19,3777972,3801798,19p13.3,19p13.3,600038,"MATK, HYL, CTK",Megakaryocyte-associated tyrosine kinase,MATK,4145,ENSG00000007264,NA,NA,Matk (MGI:99259)
19,3880684,3928081,19p13.3,19p13.3,608179,"ATCAY, CLAC, KIAA1872",Caytaxin,ATCAY,85300,ENSG00000167654,NA,"Ataxia, cerebellar, Cayman type, 601238 (3), Autosomal recessive",Atcay (MGI:2448730)
19,3933102,3942415,19p13.3,19p13.3,608705,"ITGB1BP3, MIBP","Integrin, beta-1, binding protein of, 3",NMRK2,27231,ENSG00000077009,NA,NA,Nmrk2 (MGI:1916814)
19,3958452,3971098,19q13.3,19p13.3,603289,ZIPK,ZIP kinase,DAPK3,1613,ENSG00000167657,NA,NA,Dapk3 (MGI:1203520)
19,3976055,3985462,19pter-q12,19p13.3,130610,"EEF2, EF2, SCA26",Eukaryotic translation elongation factor-2,EEF2,1938,ENSG00000167658,mutation identified in 1 family,"?Spinocerebellar ataxia 26, 609306 (3), Autosomal dominant",Eef2 (MGI:95288)
19,4007735,4039385,19p13.3,19p13.3,605989,"PIAS4, PIASY",Protein inhibitor of activated STAT4,PIAS4,51588,ENSG00000105229,NA,NA,Pias4 (MGI:2136940)
19,4043302,4066898,19p13.3,19p13.3,605878,"ZBTB7A, FBI1, LRF",Zinc finger and BTB domain containing 7A,ZBTB7A,51341,ENSG00000178951,NA,NA,Zbtb7a (MGI:1335091)
19,4090320,4124183,19p13.3,19p13.3,601263,"MAP2K2, PRKMK2, MEK2, MKK2, CFC4",Mitogen-activated protein kinase kinase 2,MAP2K2,5605,ENSG00000126934,previously assigned to 7q32,"Cardiofaciocutaneous syndrome 4, 615280 (3)",Map2k2 (MGI:1346867)
19,4153630,4173053,19p13.3,19p13.3,611998,"CREB3L3, CREBH",cAMP responsive element-binding protein 3-like 3,CREB3L3,84699,ENSG00000060566,NA,NA,Creb3l3 (MGI:2384786)
19,4174108,4182562,19p13.3,19p13.3,606211,"SIRT6, SIR2L6","Sirtuin 6 (Sir2, S. cerevisiae, homolog of, 6)",SIRT6,51548,ENSG00000077463,NA,NA,Sirt6 (MGI:1354161)
19,4229195,4237538,19p13.3,19p13.3,605816,EBI3,Epstein-Barr virus-induced gene 3,EBI3,10148,ENSG00000105246,NA,NA,Ebi3 (MGI:1354171)
19,4278600,4290722,19p13.3,19p13.3,610481,SHD,SH2 domain-containing protein D,SHD,56961,ENSG00000105251,NA,NA,Shd (MGI:1099461)
19,4292226,4302438,19p13.3,19p13.3,614715,"TMIGD2, IGPR1",Transmembrane and immunoglobulin domains-containing protein 2 `,TMIGD2,126259,ENSG00000167664,NA,NA,NA
19,4304593,4323845,19p13.3,19p13.3,609828,"FSD1, GLFND",Fibronectin type 3 and SPRY domains-containing protein 1,FSD1,79187,ENSG00000105255,NA,NA,Fsd1 (MGI:1934858)
19,4324042,4338876,19p13.3,19p13.3,607881,"STAP2, BKS",Signal-transducing adaptor protein 2,STAP2,55620,ENSG00000178078,NA,NA,Stap2 (MGI:2147039)
19,4360368,4400546,19p13.3,19p13.3,601768,"SH3GL1, EEN",SH3 domain GRB2-like 1 (Extra 11-19 leukemia fusion gene),SH3GL1,6455,ENSG00000141985,NA,"Leukemia, acute myeloid, 601626 (1), Autosomal dominant, Somatic mutation",Sh3gl1 (MGI:700010)
19,4402595,4448321,19p13.3,19p13.3,601246,"CHAF1A, CAF1B, CAF1P150","Chromatin assembly factor I, subunit A",CHAF1A,10036,ENSG00000167670,NA,NA,Chaf1a (MGI:1351331)
19,4445005,4458758,19p13,19p13.3,611946,"UBXN6, UBXD1",UBX domain protein 6,UBXN6,80700,ENSG00000167671,NA,NA,Ubxn6 (MGI:1913780)
19,4472296,4502219,19p13.3,19p13.3,617884,"HDGFL2, HDGFRP2",Hepatoma-derived growth factor-like protein 2,HDGFL2,84717,ENSG00000167674,NA,NA,Hdgfl2 (MGI:1194492)
19,4502191,4520284,19p13.3,19p13.3,613247,"PLIN4, KIAA1881",Perilipin 4,PLIN4,729359,ENSG00000167676,NA,NA,Plin4 (MGI:1929709)
19,4522530,4535223,19p13.3,19p13.3,613248,"PLIN5, LSDP5",Perilipin 5,PLIN5,440503,ENSG00000214456,NA,NA,Plin5 (MGI:1914218)
19,4536401,4540035,19p13.3,19p13.3,611289,"LRG1, LRG",Leucine-rich alpha-2-glycoprotein 1,LRG1,116844,ENSG00000171236,NA,NA,Lrg1 (MGI:1924155)
19,4542587,4581483,19p13.3,19p13.3,608873,SEMA6B,Semaphorin 6B,SEMA6B,10501,ENSG00000167680,NA,NA,Sema6b (MGI:1202889)
19,4657544,4670402,19p13.3,19p13.3,606746,"C19orf10, SF20, IL25",Stroma-derived growth factor 20,MYDGF,56005,NA,NA,NA,Mydgf (MGI:2156020)
19,4724069,4724140,19p13.3,19p13.3,615303,TRNAG3,Transfer RNA glycine 3,TRG-TCC1-1,7197,NA,NA,NA,NA
19,4724634,4724706,19p13.3,19p13.3,615304,TRNAV32,Transfer RNA valine 32,TRV-CAC3-1,100189416,NA,NA,NA,NA
19,4791733,4801272,19p13.3,19p13.3,613538,FEM1A,"Fem1, C. elegans, homolog of, A",FEM1A,55527,ENSG00000141965,NA,NA,Fem1a (MGI:1335089)
19,4815923,4831741,19p13.3,19p13.3,607601,"TICAM1, TRIF, IIAE6",TIR domain-containing adaptor molecule 1,TICAM1,148022,ENSG00000127666,NA,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, 614850 (3), Autosomal recessive, Autosomal dominant",Ticam1 (MGI:2147032)
19,4838340,4867666,19p13.3,19p13.3,602702,"PLIN3, M6PRBP1, TIP47",Perilipin 3,PLIN3,10226,ENSG00000105355,NA,NA,Plin3 (MGI:1914155)
19,4903079,4962153,19p13.3,19p13.3,607990,"UHRF1, ICBP90, NP95",Ubiquitin-like protein containing PHD and RING finger domains 1,UHRF1,29128,ENSG00000276043,NA,NA,Uhrf1 (MGI:1338889)
19,4969086,5153602,19p13.3,19p13.3,609765,"KDM4B, JMJD2B, KIAA0876",Lysine-specific demethylase 4B,KDM4B,23030,ENSG00000127663,NA,NA,Kdm4b (MGI:2442355)
19,5205502,5340811,19p13.3,19p13.3,601576,PTPRS,"Protein tyrosine phosphatase, receptor type, sigma",PTPRS,5802,ENSG00000105426,NA,NA,Ptprs (MGI:97815)
19,5455416,5456855,19p13.3,19p13.3,612063,"ZNRF4, SPERIZIN",Zinc finger and ring finger protein 4,ZNRF4,148066,ENSG00000105428,NA,NA,Znrf4 (MGI:1341258)
19,5558166,5568033,19p13.3,19p13.3,615241,TINCR,Terminal differentiation-induced noncoding RNA,TINCR,257000,ENSG00000223573,NA,NA,NA
19,5586992,5622845,19p13.3,19p13.3,608066,"SAFB2, KIAA0138",Scaffold attachment factor B2,SAFB2,9667,ENSG00000130254,NA,NA,Safb2 (MGI:2146808)
19,5623080,5668477,19p13.3-p13.2,19p13.3,602895,"SAFB, HET",Scaffold attachment factor B,SAFB,6294,ENSG00000160633,NA,NA,Safb (MGI:2146974)
19,5678413,5680895,19p13.3,19p13.3,616658,"MICOS13, C19orf70, MIC13, QIL1",Mitochondrial contact site and cristae organizing system subunit 13,MICOS13,125988,ENSG00000174917,NA,"Combined oxidative phosphorylation deficiency 37, 618329 (3), Autosomal recessive",Micos13 (MGI:2442174)
19,5690294,5691874,19p13.3,19p13.3,617893,RPL36,Ribosomal protein L36,RPL36,25873,ENSG00000130255,NA,NA,Rpl36-ps12 (MGI:3782787)
19,5691833,5720451,19p13.2,19p13.3,605490,"LONP1, PRSS15, LON, CODASS","lon peptidase 1, mitochondrial",LONP1,9361,ENSG00000196365,NA,"CODAS syndrome, 600373 (3), Autosomal recessive",Lonp1 (MGI:1921392)
19,5720155,5778733,19p13.3,19p13.3,617490,"CATSPERD, TMEM146","Cation channel, sperm-associated, auxiliary subunit delta",CATSPERD,257062,ENSG00000174898,NA,NA,Catsperd (MGI:2147030)
19,5805386,5828323,19p13.3,19p13.3,602018,"NRTN, NTN",Neurturin,NRTN,4902,ENSG00000171119,NA,NA,Nrtn (MGI:108417)
19,5830407,5840018,19p13.3,19p13.3,136836,FUT6,"Fucosyltransferase 6 (alpha (1,3) fucosyltransferase)",FUT6,2528,ENSG00000156413,"in cluster with FUT3, FUT5","Fucosyltransferase 6 deficiency, 613852 (3)",NA
19,5842887,5851473,19p13.3,19p13.3,111100,"FUT3, LE",Fucosyltransferase 3,FUT3,2525,ENSG00000171124,cen-FUT5-23kb-FUT3-14kb-FUT6-ter,"[Blood group, Lewis] (3)",NA
19,5865825,5870539,19p13.3,19p13.3,136835,FUT5,"Fucosyltransferase 5 (alpha (1,3) fucosyltransferase)",FUT5,2527,ENSG00000130383,cen-FUT5-FUT3-FUT6-ter,NA,NA
19,5891275,5904012,19p13.3,19p13.3,612638,"NDUFA11, MC1DN14",NADH-ubiquinone oxidoreductase subunit A11,NDUFA11,126328,ENSG00000174886,NA,"Mitochondrial complex I deficiency, nuclear type 14, 618236 (3), Autosomal recessive","Ndufa11,Ndufa11b (MGI:3645174,MGI:1917125)"
19,5904871,5910852,19p13.3,19p13.3,617204,VMAC,Vimentin-type intermediate filament-associated coiled-coil protein,VMAC,400673,ENSG00000187650,NA,NA,Vmac (MGI:2146912)
19,5913647,5916210,19p13.3,19p13.3,114212,CAPS,Calcyphosine,CAPS,828,ENSG00000105519,NA,NA,NA
19,5916138,5978139,19p13.3,19p13.3,603327,RANBP3,RAN-binding protein-3,RANBP3,8498,ENSG00000031823,NA,NA,Ranbp3 (MGI:1919060)
19,5993163,6110600,19p13.3-p13.2,19p13.3,142765,RFX2,Regulatory factor (trans-acting) 2 (influences HLA class II expression),RFX2,5990,ENSG00000087903,NA,NA,Rfx2 (MGI:106583)
19,6135632,6193102,19p13.3,19p13.3,614363,"ACSBG2, BGR","Acyl-CoA synthetase, bubblegum family, member 2",ACSBG2,81616,ENSG00000130377,NA,NA,Acsbg2 (MGI:3587728)
19,6210380,6279974,19p13.3,19p13.3,159556,"MLLT1, ENL","Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 1",MLLT1,4298,ENSG00000130382,fuses with ALL1,NA,Mllt1 (MGI:1927238)
19,6306141,6360367,19p13.3,19p13.3,613491,ACER1,Alkaline ceraminidase 1,ACER1,125981,ENSG00000167769,NA,NA,Acer1 (MGI:2181962)
19,6361530,6370241,19p13.3,19p13.3,601119,"CLPP, PRLTS3, DFNB81","ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of",CLPP,8192,ENSG00000125656,NA,"Perrault syndrome 3, 614129 (3), Autosomal recessive",Clpp (MGI:1858213)
19,6372793,6375249,19p13.3,19p13.3,613305,"ALKBH7, ABH7","AlkB, E. coli, homolog of, 7",ALKBH7,84266,ENSG00000125652,NA,NA,Alkbh7 (MGI:1913650)
19,6375147,6375915,19p13.3,19p13.3,602921,PSPN,Persephin,PSPN,5623,ENSG00000125650,NA,NA,Pspn (MGI:1201684)
19,6379568,6393185,19p13.3,19p13.3,189968,"GTF2F1, RAP74","General transcription factor IIF, polypeptide 1 (74kD subunit)",GTF2F1,2962,ENSG00000125651,NA,NA,Gtf2f1 (MGI:1923848)
19,6413101,6424810,19p13.3,19p13.3,603445,"KHSRP, KSRP, FUBP2, FBP2",KH-type splicing regulatory protein,KHSRP,8570,ENSG00000088247,NA,NA,Khsrp (MGI:1336214)
19,6426036,6436266,19p13.3,19p13.3,610822,SLC25A41,"Solute carrier family 25, member 41",SLC25A41,284427,ENSG00000181240,NA,NA,Slc25a41 (MGI:2144215)
19,6463776,6467220,19p13.3,19p13.3,609737,CRB3,"Crumbs, Drosophila, homolog of, 3",CRB3,92359,ENSG00000130545,NA,NA,NA
19,6467203,6481797,19p13.3,19p13.3,613634,DENND1C,DENN/MADD domain-containing protein 1C,DENND1C,79958,ENSG00000205744,NA,NA,Dennd1c (MGI:1918035)
19,6494318,6502847,19p13.3,19p13.3,602662,"TUBB4A, DYT4, HLD6","Tubulin, beta-4A",TUBB4A,10382,ENSG00000104833,NA,"Dystonia 4, torsion, autosomal dominant, 128101 (3), Autosomal dominant; Leukodystrophy, hypomyelinating, 6, 612438 (3), Autosomal dominant",Tubb4a (MGI:107848)
19,6531025,6535923,19p13.3,19p13.3,606182,TNFSF9,"Tumor necrosis factor ligand superfamily, member 9",TNFSF9,8744,ENSG00000125657,NA,NA,NA
19,6581647,6591149,19p13,19p13.3,602840,"TNFSF7, CD70, CD27L, LPFS3","Tumor necrosis factor ligand superfamily, member 7 (CD70 antigen)",CD70,970,ENSG00000125726,NA,"Lymphoproliferative syndrome 3, 618261 (3), Autosomal recessive",Cd70 (MGI:1195273)
19,6658125,6670594,19p13.3,19p13.3,604520,"TNFSF14, HVEML","Tumor necrosis factor ligand superfamily, member 14",TNFSF14,8740,ENSG00000125735,NA,NA,Tnfsf14 (MGI:1355317)
19,6677703,6720649,19p13.3-p13.2,19p13.3,120700,"C3, ARMD9, AHUS5",Complement component-3,C3,718,ENSG00000125730,LE ~7cM in males vs. C3 RFLP,"C3 deficiency, 613779 (3), Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3), Autosomal dominant; {Macular degeneration, age-related, 9}, 611378 (3)",C3 (MGI:88227)
19,6739679,6751529,19p13.3,19p13.3,604504,"TRIP10, CIP4",Thyroid hormone receptor interactor 10,TRIP10,9322,ENSG00000125733,NA,NA,Trip10 (MGI:2146901)
19,6772707,6857365,19p13.3-p13.2,19p13.3,164875,"VAV1, VAV",Oncogene VAV1,VAV1,7409,ENSG00000141968,close to INSR,NA,Vav1 (MGI:98923)
19,6887548,6940449,19p13.3,19p13.3-p13.2,600493,"ADGRE1, EMR1",Adhesion G protein-coupled receptor E1,ADGRE1,2015,ENSG00000174837,NA,NA,Adgre1 (MGI:106912)
19,6900000,50900000,19p13.2-q13.3,NA,164953,"LPSA, D19S381E","Oncogene liposarcoma (DNA segment, single copy, expressed, probes MC15, MC6)",NA,8177,NA,NA,Liposarcoma (1),NA
19,6900000,12600000,19p13.2,NA,614223,NRCLP6,Narcolepsy 6,NA,100689216,NA,associated with rs2305795,"Narcolepsy 6, 614223 (2)",NA
19,6900000,19900000,19p13.2-p13.1,NA,607324,PAPA3,"Polydactyly, postaxial, type A3",NA,338333,NA,between D19S1165 and D19S929,"Polydactyly, postaxial, type A3, 607324 (2)",NA
19,6900000,12600000,19p13.2,NA,184700,"PCOS1, PCO1, PCO",Polycystic ovary syndrome 1,PCOS1,5120,NA,max lod at D19S884,"Polycystic ovary syndrome 1, 184700 (2), Autosomal dominant",NA
19,6900000,12600000,19p13.2,NA,603386,TCO,"Thyroid carcinoma, nonmedullary, with cell oxyphilia",NA,50975,NA,NA,"Thyroid carcinoma, nonmedullary, with cell oxyphilia, 603386 (2)",NA
19,6952499,6990845,19p13.3,19p13.2,612305,"ADGRE4P, EMR4, GPR127, EMR4P, FIRE","Adhesion G protein-coupled receptor E4, pseudogene",ADGRE4P,326342,ENSG00000268758,NA,NA,NA
19,7049339,7051734,19p13.2,19p13.2,607964,MBD3L2,Methyl-CpG binding domain protein 3-like 2,MBD3L2,125997,ENSG00000230522,NA,NA,Mbd3l2 (MGI:2158460)
19,7112256,7294413,19p13.2,19p13.2,147670,"INSR, HHF5",Insulin receptor,INSR,3643,ENSG00000171105,1 gene for alpha and beta subunits,"Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3); Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3), Autosomal dominant; Leprechaunism, 246200 (3), Autosomal recessive; Rabson-Mendenhall syndrome, 262190 (3), Autosomal recessive",Insr (MGI:96575)
19,7348900,7476989,19p13.2,19p13.2,616432,"ARHGEF18, KIAA0521, RP78",Rho guanine nucleotide exchange factor 18,ARHGEF18,23370,ENSG00000104880,NA,"Retinitis pigmentosa 78, 617433 (3), Autosomal recessive",Arhgef18 (MGI:2142567)
19,7476874,7494976,19p13.3,19p13.2,607583,PEX11G,Peroxisome biogenesis factor 11G,PEX11G,92960,ENSG00000104883,NA,NA,Pex11g (MGI:1920905)
19,7522623,7534008,19p13.3-p13.2,19p13.2,605248,"MCOLN1, ML4",Mucolipin 1,MCOLN1,57192,ENSG00000090674,NA,"Mucolipidosis IV, 252650 (3), Autosomal recessive",Mcoln1 (MGI:1890498)
19,7534163,7561766,19p13.3,19p13.2,603197,"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",Patatin-like phospholipase domain-containing protein 6,PNPLA6,10908,ENSG00000032444,mutation identified in 1 LMNS family,"Boucher-Neuhauser syndrome, 215470 (3), Autosomal recessive; ?Laurence-Moon syndrome, 245800 (3), Autosomal recessive; Oliver-McFarlane syndrome, 275400 (3), Autosomal recessive; Spastic paraplegia 39, autosomal recessive, 612020 (3), Autosomal recessive",Pnpla6 (MGI:1354723)
19,7595862,7618303,19p13.2,19p13.2,612685,"CAMSAP3, NEZHA, KIAA1543",Calmodulin-regulated spectrin-associated protein 3,CAMSAP3,57662,ENSG00000076826,NA,NA,Camsap3 (MGI:1916947)
19,7619524,7629544,19p13.2,19p13.2,610850,XAB2,XPA-binding protein 2,XAB2,56949,ENSG00000076924,NA,NA,Xab2 (MGI:1914689)
19,7629784,7631955,19p13.2,19p13.2,614770,"PET100, C19orf79","PET100, S. cerevisiae, homolog of",PET100,100131801,ENSG00000229833,NA,"Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Pet100 (MGI:3615306)
19,7637100,7647873,19p13.3-p13.2,19p13.2,601717,"STXBP2, UNC18B, FHL5",Syntaxin binding protein 2,STXBP2,6813,ENSG00000076944,NA,"Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)",Stxbp2 (MGI:107370)
19,7669048,7670454,19p13.2,19p13.2,605565,"RETN, RSTN, FIZZ3",Resistin,RETN,56729,ENSG00000104918,NA,"{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant; {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3), Autosomal dominant",Retn (MGI:1888506)
19,7677056,7679832,19p13.3,19p13.2,609565,MCEMP1,Mast cell-expressed membrane protein 1,MCEMP1,199675,ENSG00000183019,NA,NA,Mcemp1 (MGI:1916439)
19,7688756,7702754,19p13.3,19p13.2,151445,"FCER2, FCE2, CD23, CLEC4J","Fc fragment of IgE, low affinity II, receptor for (CD23A)",FCER2,2208,ENSG00000104921,NA,NA,Fcer2a (MGI:95497)
19,7728956,7732180,19p13.3,19p13.2,616256,"CLEC4G, LSECTIN","C-type lectin domain family 4, member G",CLEC4G,339390,ENSG00000182566,NA,NA,Clec4g (MGI:1923113)
19,7739992,7747608,19p13.3,19p13.2,604672,"CD209, CDSIGN",CD209 antigen,CD209,30835,ENSG00000090659,NA,"{Dengue fever, protection against}, 614371 (3); {HIV type 1, susceptibility to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)",Cd209e (MGI:2157948)
19,7763051,7770558,19p13.3,19p13.2,605872,"CLEC4M, CD209L, LSIGN, DCSIGNR","C-type lectin domain family 4, member M",CLEC4M,10332,ENSG00000104938,NA,"SARS infection, protection against, 605872 (2)",Cd209a (MGI:2157942)
19,7888504,7902022,19p13.2,19p13.2,612891,LRRC8E,Leucine-rich repeat-containing protein 8E,LRRC8E,80131,ENSG00000171017,NA,NA,Lrrc8e (MGI:1919517)
19,7903784,7914477,19p13.2,19p13.2,603014,"MAP2K7, PRKMK7, MKK7, JNKK2, MAPKK7",Mitogen-activated protein kinase kinase 7,MAP2K7,5609,ENSG00000076984,NA,NA,Map2k7 (MGI:1346871)
19,7920337,7923250,19p13.2,19p13.2,605076,"SNAPC2, SNAP45","Small nuclear RNA-activating protein complex, polypeptide 2",SNAPC2,6618,ENSG00000104976,NA,NA,Snapc2 (MGI:1914861)
19,7924490,7926134,19p13.2,19p13.2,600135,"CTXN1, CTXN",Cortexin 1,CTXN1,404217,ENSG00000178531,NA,NA,Ctxn1 (MGI:88566)
19,7926717,7943665,19p13.3-p13.2,19p13.2,605058,TIMM44,"Translocase of inner mitochondrial membrane 44, yeast, homolog of",TIMM44,10469,ENSG00000104980,NA,NA,Timm44 (MGI:1343262)
19,7958572,8005640,19p13.2,19p13.2,603466,"ELAVL1, HUR","Embryonic lethal, abnormal vision, Drosophila, homolog-like 1",ELAVL1,1994,ENSG00000066044,NA,NA,Elavl1 (MGI:1100851)
19,8052317,8062662,19p13.2,19p13.2,602565,"CCL25, SCYA25, TECK","Chemokine, C-C motif, ligand 25",CCL25,6370,ENSG00000131142,NA,NA,Ccl25 (MGI:1099448)
19,8209328,8262432,19p13.2,19p13.2,615334,"CERS4, LASS4, TRH1",Ceramide synthase 4,CERS4,79603,ENSG00000090661,NA,NA,Cers4 (MGI:1914510)
19,8302126,8308357,19p13.2,19p13.2,606475,"CD320, 8D6, 8D6A, TCBLR",CD320 molecule,CD320,51293,ENSG00000167775,NA,"Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3)",Cd320 (MGI:1860083)
19,8308602,8321412,19p13.2,19p13.2,602139,NDUFA7,NADH-ubiquinone oxidoreductase subunit A7,NDUFA7,4701,ENSG00000267855,previously assigned to 20p13,NA,Ndufa7 (MGI:1913666)
19,8321495,8323339,19p13.2,19p13.2,603685,"RPS28, DBA15",Ribosomal protein S28,RPS28,6234,ENSG00000233927,NA,"Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3), Autosomal dominant",Rps28 (MGI:1859516)
19,8322583,8343261,19p13.2,19p13.2,614611,KANK3,KN motif- and ankyrin repeat domain-containing protein 3,KANK3,256949,ENSG00000186994,NA,NA,Kank3 (MGI:1098615)
19,8364128,8374372,19p13.3,19p13.2,605910,"ANGPTL4, PGAR, HFARP, FIAF, TGQTL",Angiopoietin-like 4,ANGPTL4,51129,ENSG00000167772,NA,"Plasma triglyceride level QTL, low, 615881 (3), Autosomal dominant",Angptl4 (MGI:1888999)
19,8390359,8404433,19p13.2,19p13.2,604198,"RAB11B, NDAGSCW",Ras-associated protein RAB11B,RAB11B,9230,ENSG00000185236,NA,"Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3), Autosomal dominant",Rab11b (MGI:99425)
19,8413302,8439016,19p13.2,19p13.2,613332,MARCH2,Membrane-associated RING-CH finger protein 2,MARCHF2,51257,ENSG00000099785,NA,NA,March2 (MGI:1925915)
19,8444574,8489113,19p13.3-p13.2,19p13.2,160994,"HNRPM, HNRPM4, NAGR1",Heterogeneous nuclear ribonucleoprotein M,HNRNPM,4670,ENSG00000099783,NA,NA,Hnrnpm (MGI:1926465)
19,8490054,8502639,19p13.2,19p13.2,606466,PRAM1,PML-RARA target gene encoding an adaptor molecule 1,PRAM1,84106,ENSG00000133246,NA,NA,Pram1 (MGI:3576625)
19,8520777,8577441,19p13.3-p13.2,19p13.2,601480,MYO1F,Myosin IF,MYO1F,4542,ENSG00000142347,NA,NA,Myo1f (MGI:107711)
19,8580239,8610714,19p13.3-p13.2,19p13.2,608990,"ADAMTS10, WMS1","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 10",ADAMTS10,81794,ENSG00000142303,NA,"Weill-Marchesani syndrome 1, recessive, 277600 (3), Autosomal recessive",Adamts10 (MGI:2449112)
19,8842592,8843339,19p13.2,19p13.2,607963,MBD3L1,Methyl-CpG binding domain protein 3-like 1,MBD3L1,85509,ENSG00000170948,NA,NA,Mbd3l1 (MGI:1920753)
19,8848839,9010389,19p13.2,19p13.2,606154,"MUC16, CA125",Mucin 16,MUC16,94025,ENSG00000181143,NA,NA,NA
19,9140379,9163418,19p13,19p13.2,613864,"ZNF317, KIAA1588",Zinc finger protein 317,ZNF317,57693,ENSG00000130803,NA,NA,Zfp317 (MGI:107775)
19,9213849,9214870,19p13.2,19p13.2,611538,"OR7D4, OR19B","Olfactory receptor, family 7, subfamily D, member 4",OR7D4,125958,ENSG00000174667,NA,NA,Olfr39 (MGI:1313142)
19,9291139,9309837,19p13.2,19p13.2,609571,"ZNF699, FLJ38144",Zinc finger protein 699,ZNF699,374879,ENSG00000196110,NA,NA,NA
19,9363012,9382616,19p13,19p13.2,601276,ZNF177,Zinc finger protein 177,ZNF177,7730,ENSG00000188629,NA,NA,NA
19,9412425,9435577,19p13.2,19p13.2,604751,"ZNF266, HZF1",Zinc finger protein-266,ZNF266,10781,ENSG00000174652,NA,NA,Zfp266 (MGI:1924769)
19,9560336,9584543,19p,19p13.2,194628,"ZNF121, D19S204",Zinc finger protein-121 (clone ZHC32),ZNF121,7675,ENSG00000197961,NA,NA,NA
19,9810266,9820527,19p13.2,19p13.2,609079,"FBXL12, FBL12",F-box and leucine-rich repeat protein 12,FBXL12,54850,ENSG00000127452,NA,NA,Fbxl12 (MGI:1354738)
19,9827917,9830114,19p13.2,19p13.2,606849,"UBL5, HUB1",Ubiquitin-like 5,UBL5,59286,ENSG00000198258,pseudogene on 17p11.2,NA,Ubl5 (MGI:1913427)
19,9835206,9849688,19p13,19p13.2,601052,"PIN1, DOD","Peptidyl-prolyl cis/trans isomerase, NIMA-interacting",PIN1,5300,ENSG00000127445,NA,NA,Pin1 (MGI:1346036)
19,9853717,9936514,19p13.2,19p13.2,617492,"OLFM2, NOE2",Olfactomedin 2,OLFM2,93145,ENSG00000105088,NA,NA,Olfm2 (MGI:3045350)
19,9959560,10010531,19p13.2,19p13.2,120216,COL5A3,"Collagen, type V, alpha-3 polypeptide",COL5A3,50509,ENSG00000080573,NA,NA,Col5a3 (MGI:1858212)
19,10013482,10022278,19p13,19p13.2,608575,"RDH8, PRRDH",Retinol dehydrogenase 8,RDH8,50700,ENSG00000080511,NA,NA,Rdh8 (MGI:2685028)
19,10086118,10093248,19p13.2,19p13.2,616808,"C19orf66, RYDEN",Chromosome 19 open reading frame 66,SHFL,55337,ENSG00000130813,NA,NA,Shfl (MGI:2441788)
19,10092336,10106406,19p13.2,19p13.2,609336,"ANGPTL6, AGF",Angiopoietin-like 6,ANGPTL6,83854,ENSG00000130812,NA,NA,Angptl6 (MGI:1917976)
19,10106222,10112011,19p13,19p13.2,607793,"PPAN, SSF1","Peter pan, Drosophila, homolog of",PPAN,56342,ENSG00000130810,fuses with P2RY11,NA,Ppan (MGI:2178445)
19,10111692,10115371,19p13,19p13.2,602697,P2RY11,"Purinergic receptor P2Y, G protein-coupled, 11",P2RY11,5032,ENSG00000244165,fuses with PPAN,NA,NA
19,10115013,10119898,19p13.2,19p13.2,603913,"EIF3G, EIF3S4","Eukaryotic translation initiation factor 3, subunit G",EIF3G,8666,ENSG00000130811,NA,NA,Eif3g (MGI:1858258)
19,10133345,10194952,19p13.3-p13.2,19p13.2,126375,"DNMT1, MCMT, HSN1E, ADCADN",DNA methyltransferase 1,DNMT1,1786,ENSG00000130816,NA,"Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3), Autosomal dominant; Neuropathy, hereditary sensory, type IE, 614116 (3), Autosomal dominant",Dnmt1 (MGI:94912)
19,10221432,10231330,19p13.2,19p13.2,605111,"S1PR2, EDG5, DFNB68",Sphingosine-1-phosphate receptor 2,S1PR2,9294,ENSG00000267534,NA,"Deafness, autosomal recessive 68, 610419 (3), Autosomal recessive",S1pr2 (MGI:99569)
19,10251961,10260054,19p13.2,19p13.2,611823,MRPL4,Mitochondrial ribosomal protein L4,MRPL4,51073,ENSG00000105364,NA,NA,Mrpl4 (MGI:2137210)
19,10271119,10286614,19p13.3-p13.2,19p13.2,147840,ICAM1,Intercellular adhesion molecule-1,ICAM1,3383,ENSG00000090339,close to Ldlr in mouse,"{Malaria, cerebral, susceptibility to}, 611162 (3)",Icam1 (MGI:96392)
19,10286954,10288519,19p13.3,19p13.2,614088,"ICAM4, CD242, LW",Intracellular adhesion molecule 4,ICAM4,3386,ENSG00000105371,"close to C3, LU","[Blood group, Landsteiner-Wiener], 111250 (3)",Icam4 (MGI:1925619)
19,10289350,10296777,19p13.2,19p13.2,601852,"ICAM5, TLCN, TLN",Intercellular adhesion molecule 5 (telencephalin),ICAM5,7087,ENSG00000105376,NA,NA,Icam5 (MGI:109430)
19,10304802,10309556,19p13.2,19p13.2,611639,"ZGLP1, GLP1",Zinc finger GATA-like protein 1,ZGLP1,100125288,ENSG00000220201,NA,NA,Zglp1 (MGI:3696042)
19,10310044,10316014,19p13.2,19p13.2,614585,"FDX2, FDX1L, MEOAL",Ferredoxin 2,FDX2,112812,ENSG00000267673,NA,"Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy, 251900 (3), Autosomal recessive",Fdx2 (MGI:1915415)
19,10316211,10333528,19p13.2,19p13.2,609950,"RAVER1, KIAA1978","Raver1, mouse, homolog of",RAVER1,125950,ENSG00000161847,NA,NA,Raver1 (MGI:1919016)
19,10333775,10339623,19p13.3-p13.2,19p13.2,146631,"ICAM3, CDW50",Intercellular adhesion molecule-3,ICAM3,3385,ENSG00000076662,NA,NA,NA
19,10350527,10380571,19p13.2,19p13.2,176941,"TYK2, IMD35",Tyrosine kinase 2,TYK2,7297,ENSG00000105397,NA,"Immunodeficiency 35, 611521 (3), Autosomal recessive",Tyk2 (MGI:1929470)
19,10391127,10403567,19p13.2,19p13.2,605065,CDC37,"Cell division cycle 37, S. cerevisiae, homolog of",CDC37,11140,ENSG00000105401,NA,NA,Cdc37 (MGI:109531)
19,10416772,10469630,19p13.2,19p13.2,600126,"PDE4A, DPDE2","Phosphodiesterase-4A, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E2)",PDE4A,5141,ENSG00000065989,NA,NA,Pde4a (MGI:99558)
19,10486124,10503355,19p13.2,19p13.2,606016,"KEAP1, KIAA0132",Kelch-like ECH-associated protein 1,KEAP1,9817,ENSG00000079999,NA,NA,Keap1 (MGI:1858732)
19,10512741,10517964,19p13.2,19p13.2,605146,"S1PR5, EDG8",Sphingosine-1-phosphate receptor 5,S1PR5,53637,ENSG00000180739,NA,NA,S1pr5 (MGI:2150641)
19,10543896,10553417,19p13.2,19p13.2,611340,"ATG4D, APG4D, AUTL4","Autophagy 4, S. cerevisiae, homolog of, D",ATG4D,84971,ENSG00000130734,NA,NA,Atg4d (MGI:2444308)
19,10566459,10568978,19p13,19p13.2,600927,CDKN2D,"Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)",CDKN2D,1032,ENSG00000129355,possible tumor suppressor,NA,Cdkn2d (MGI:105387)
19,10572670,10587314,19p13.2,19p13.2,607309,"AP1M2, MU1B","Adaptor-related protein complex 1, mu-2 subunit",AP1M2,10053,ENSG00000129354,NA,NA,Ap1m2 (MGI:1336974)
19,10602454,10644556,19p13.1,19p13.2,606106,"SLC44A2, CTL2","Solute carrier family 44, member 2",SLC44A2,57153,ENSG00000129353,NA,NA,Slc44a2 (MGI:1915932)
19,10654260,10692418,19p13,19p13.2,603182,"ILF3, NF90, DRBP76, MPHOSPH4, NFAR",Interleukin enhancer-binding factor 3,ILF3,3609,ENSG00000129351,NA,NA,Ilf3 (MGI:1339973)
19,10701438,10713364,19p13.2,19p13.2,609615,"QTRT1, TGT",Queuine tRNA-ribosyltransferase 1,QTRT1,81890,ENSG00000213339,NA,NA,Qtrt1 (MGI:1931441)
19,10718052,10831909,19p13.2,19p13.2,602378,"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",Dynamin-2,DNM2,1785,ENSG00000079805,1 LCCS5 family identified with mutation,"Centronuclear myopathy 1, 160150 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal type 2M, 606482 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3), Autosomal dominant; Lethal congenital contracture syndrome 5, 615368 (3), Autosomal recessive",Dnm2 (MGI:109547)
19,10817425,10817495,19p13.2,19p13.2,610719,"MIR199A1, MIRN199A1",Micro RNA 199A1,MIR199A1,406976,ENSG00000207752,NA,NA,NA
19,10832066,10836211,19p13.2,19p13.2,605395,"TMED1, IL1RL1LG",Transmembrane p24 trafficking protein 1 (interleukin-1 receptor-like 1 ligand),TMED1,11018,ENSG00000099203,NA,NA,Tmed1 (MGI:106201)
19,10871552,10923077,19p13.2,19p13.2,603934,"CARM1, PRMT4",Coactivator-associated arginine methyltransferase 1,CARM1,10498,ENSG00000142453,NA,NA,Carm1 (MGI:1913208)
19,10922184,10928687,19p13.2,19p13.2,617522,YIPF2,"YIP1 domain family, member 2",YIPF2,78992,ENSG00000130733,NA,NA,Yipf2 (MGI:1922016)
19,10928810,10930253,19p13.2,19p13.2,617380,"TIMM29, C19orf52",Translocase of inner mitochondrial membrane 29,TIMM29,90580,ENSG00000142444,NA,NA,Timm29 (MGI:1917023)
19,10960996,11062467,19p13.2,19p13.2,603254,"SMARCA4, BRG1, RTPS2, MRD16, CSS4","SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4",SMARCA4,6597,ENSG00000127616,NA,"Coffin-Siris syndrome 4, 614609 (3), Autosomal dominant; {Rhabdoid tumor predisposition syndrome 2}, 613325 (3), Autosomal dominant",Smarca4 (MGI:88192)
19,11089361,11133829,19p13.2,19p13.2,606945,"LDLR, FHCL1, FHC, FH, LDLCQ2",Low density lipoprotein receptor,LDLR,3949,ENSG00000130164,~20cM distal to C3,"Hypercholesterolemia, familial, 1, 143890 (3), Autosomal dominant; LDL cholesterol level QTL2, 143890 (3), Autosomal dominant",Ldlr (MGI:96765)
19,11145492,11155996,19p13.2,19p13.2,609394,"SPC24, SPBC24","SPC24, NDC80 kinetochore complex component",SPC24,147841,ENSG00000161888,NA,NA,Spc24 (MGI:1914879)
19,11164266,11197544,19p13.2,19p13.2,614610,"KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16",KN motif- and ankyrin repeat domain-containing protein 2,KANK2,25959,ENSG00000197256,NA,"Nephrotic syndrome, type 16, 617783 (3), Autosomal recessive; Palmoplantar keratoderma and woolly hair, 616099 (3), Autosomal recessive",Kank2 (MGI:2384568)
19,11199294,11262523,19p13.2,19p13.2,614194,"DOCK6, KIAA1395, AOS2",Dedicator of cytokinesis 6,DOCK6,57572,ENSG00000130158,NA,"Adams-Oliver syndrome 2, 614219 (3), Autosomal recessive",Dock6 (MGI:1914789)
19,11239618,11241942,19p13.2,19p13.2,616223,"ANGPTL8, C19orf80, LIPASIN",Angiopoietin-like protein 8,ANGPTL8,55908,ENSG00000130173,within intron of DOCK6,NA,Angptl8 (MGI:3643534)
19,11296138,11326995,9q34,19p13.2,617580,"TSPAN16, TM4SF16",Tetraspanin 16,TSPAN16,26526,ENSG00000130167,NA,NA,NA
19,11322067,11339656,19p13.2,19p13.2,604350,"RAD3D, GOV","Ras family, member RAB3D",RAB3D,9545,ENSG00000105514,NA,NA,Rab3d (MGI:97844)
19,11342511,11346458,19p13.2,19p13.2,613771,TMEM205,Transmembrane protein 205,TMEM205,374882,ENSG00000105518,NA,NA,Tmem205 (MGI:3045495)
19,11374706,11376950,19p13.2,19p13.2,614536,"SWSAP1, ZSWIM7AP1, C19orf39",SWIM-type zinc finger domain-containing protein 7-associated protein 1,SWSAP1,126074,ENSG00000173928,NA,NA,Swsap1 (MGI:1914212)
19,11377204,11384341,19p13.3-p13.2,19p13.2,133171,EPOR,Erythropoietin receptor,EPOR,2057,ENSG00000187266,NA,"[Erythrocytosis, familial, 1], 133100 (3), Autosomal dominant",Epor (MGI:95408)
19,11394059,11419313,19p13.2,19p13.2,616743,RGL3,Ral guanine nucleotide dissociation stimulator-like 3,RGL3,57139,ENSG00000205517,NA,NA,Rgl3 (MGI:1918996)
19,11420604,11435781,19p13.2,19p13.2,615956,"CCDC151, CILD30",Coiled-coil domain-containing protein 151,CCDC151,115948,ENSG00000198003,NA,"Ciliary dyskinesia, primary, 30, 616037 (3), Autosomal recessive",Ccdc151 (MGI:1924859)
19,11435256,11450967,19p13.2-p13.1,19p13.2,177060,"PRKCSH, G19P1, PCLD1",Protein kinase C substrate 80K-H,PRKCSH,5589,ENSG00000130175,NA,"Polycystic liver disease 1, 174050 (3), Autosomal dominant",Prkcsh (MGI:107877)
19,11451325,11481045,19p13.2,19p13.2,603458,"ELAVL3, HUC, PLE21","Embryonic lethal, abnormal vision, Drosophila, homolog-like 3",ELAVL3,1995,ENSG00000196361,centromeric to ELAVL1,NA,Elavl3 (MGI:109157)
19,11483428,11505838,19p13.2,19p13.2,611371,"ZNF653, ZIP67",Zinc finger protein 653,ZNF653,115950,ENSG00000161914,NA,NA,Zfp653 (MGI:2442362)
19,11505915,11529133,19p13.2,19p13.2,608388,"SITPEC, ECSIT","Signaling intermediate in toll pathway, evolutionarily conserved",ECSIT,51295,ENSG00000130159,NA,NA,Ecsit (MGI:1349469)
19,11538774,11550322,19p13.2,19p13.2,600806,"CNN1, SMCC",Calponin 1,CNN1,1264,ENSG00000130176,NA,NA,Cnn1 (MGI:104979)
19,11574659,11578982,19p13.3-p13.1,19p13.2,171640,"ACP5, SPENCDI","Acid phosphatase 5, tartrate resistant",ACP5,54,ENSG00000102575,incorrectly assigned to 15 by A,"Spondyloenchondrodysplasia with immune dysregulation, 607944 (3), Autosomal recessive",NA
19,11575254,11619160,19p13.2,19p13.2,612248,ZNF627,Zinc finger protein 627,ZNF627,199692,ENSG00000198551,NA,NA,Zfp867 (MGI:2681848)
19,11887772,11980221,19p13.2,19p13.2,194543,ZNF69,Zinc finger protein-69 (Cos5),ZNF69,7620,ENSG00000198429,previously assigned to 22q11.2,NA,NA
19,12131349,12140349,19p13.3-p13.2,19p13.2,194557,"ZNF20, KOX13",Zinc finger protein-14 (KOX 6),ZNF20,7568,ENSG00000132010,NA,NA,NA
19,12163046,12189880,19p13.2-p13.12,19p13.2,604078,ZNF136,Zinc finger protein-136,ZNF136,7695,ENSG00000196646,NA,NA,NA
19,12224685,12294898,19p13.2,19p13.2,194542,"ZNF44, KOX7",Zinc finger protein-44 (KOX7),ZNF44,51710,ENSG00000197857,previously assigned to 16p11,NA,NA
19,12429705,12441020,19p13.2,19p13.2,606697,ZK1,Zinc finger protein ZK1,ZNF443,10224,ENSG00000180855,NA,NA,Zfp709 (MGI:2384299)
19,12600000,13800000,19p13.13,NA,613638,"DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13",Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome),NA,NA,NA,contiguous gene syndrome,"Chromosome 19p13.13 deletion syndrome, 613638 (4); Chromosome 19p13.13 duplication syndrome, 613638 (4)",NA
19,12600000,24200000,19p13.1-p12,NA,603985,ZNF103,Zinc finger protein-103,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603987,ZNF105,Zinc finger protein-105,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603988,ZNF106,Zinc finger protein-106,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603991,ZNF109,Zinc finger protein-109,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603992,ZNF110,Zinc finger protein-110,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603993,ZNF111,Zinc finger protein-111,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603995,ZNF113,Zinc finger protein-113,NA,NA,NA,?13q21,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603997,ZNF118,Zinc finger protein-118,NA,NA,NA,?13q21,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603998,ZNF119,Zinc finger protein-119,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603999,ZNF120,Zinc finger protein-120,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,604000,ZNF122,Zinc finger protein-122,NA,NA,NA,NA,NA,NA
19,12600000,24200000,19p13.1-p12,NA,603976,ZNF94,Zinc finger protein-94,NA,NA,NA,NA,NA,NA
19,12646507,12666776,19cen-q12,19p13.13,609458,"MAN2B1, MANB","Mannosidase, alpha, class 2B, member 1",MAN2B1,4125,ENSG00000104774,NA,"Mannosidosis, alpha-, types I and II, 248500 (3), Autosomal recessive",Man2b1 (MGI:107286)
19,12666803,12675831,19p13.13,19p13.13,616850,"WDR83, MORG1",WD repeat-containing protein 83,WDR83,84292,ENSG00000123154,NA,NA,Wdr83 (MGI:1915086)
19,12668070,12671022,19p13.3,19p13.13,618474,"WDR83OS, C19orf56, ASTERIX",WDR83 opposite strand,WDR83OS,51398,ENSG00000105583,NA,NA,Wdr83os (MGI:3041257)
19,12672469,12681886,19p13.12-p13.11,19p13.13,600944,"DHPS, NEDSSWI",Deoxyhypusine synthase,DHPS,1725,ENSG00000095059,NA,"Neurodevelopmental disorder with seizures and speech and walking impairment, 618480 (3)",Dhps (MGI:2683592)
19,12688915,12696899,19p13.2,19p13.13,609074,"FBXW9, FBW9",F-box and WD40 domain protein 9,FBXW9,84261,ENSG00000132004,NA,NA,Fbxw9 (MGI:1915878)
19,12699200,12723931,19p13.13,19p13.13,603002,"TNPO2, TRN2, KPNB2B",Transportin 2,TNPO2,30000,ENSG00000105576,NA,NA,Tnpo2 (MGI:2384849)
19,12737458,12748323,19q13.3,19p13.13,601913,"ASNA1, ARSA1","arsA arsenite transporter, ATP-binding, E. coli, homolog of, 1",GET3,439,ENSG00000198356,NA,NA,Asna1 (MGI:1928379)
19,12751790,12758457,19p13.2-p13.12,19p13.13,607335,"BEST2, VMD2L1",Bestrophin 2,BEST2,54831,ENSG00000039987,NA,NA,Best2 (MGI:2387588)
19,12763001,12778483,19p13.13,19p13.13,607824,"HOOK2, HK2","Hook, Drosophila, homolog of, 2",HOOK2,29911,ENSG00000095066,NA,NA,Hook2 (MGI:2181664)
19,12791485,12793314,19p13.2,19p13.13,165161,JUNB,jun B proto-oncogene,JUNB,3726,ENSG00000171223,NA,NA,Junb (MGI:96647)
19,12796822,12801799,19p13.2,19p13.13,600538,"PRDX2, PRX2, TDPX1, PTX1, NKEFB",Peroxiredoxin 2,PRDX2,7001,ENSG00000167815,prev. mapped to chr.13,NA,Prdx2 (MGI:109486)
19,12802053,12813647,19p13.13,19p13.13,606034,"RNASEH2A, RNHIA, AGS4","Ribonuclease H2, large subunit",RNASEH2A,10535,ENSG00000104889,NA,"Aicardi-Goutieres syndrome 4, 610333 (3), Autosomal recessive",Rnaseh2a (MGI:1916974)
19,12825476,12835427,19p13,19p13.13,609553,RTBDN,Retbindin,RTBDN,83546,ENSG00000132026,NA,NA,Rtbdn (MGI:2443686)
19,12838514,12874951,19p13.2,19p13.13,612256,"MAST1, SAST, KIAA0973, MCCCHCM",Microtubule-associated serine/threonine kinase 1,MAST1,22983,ENSG00000105613,NA,"Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, 618273 (3), Autosomal dominant",Mast1 (MGI:1861901)
19,12875208,12881448,19p13.2-q13.4,19p13.13,126350,"DNASE2, DNL","Deoxyribonuclease II, lysosomal",DNASE2,1777,ENSG00000105612,NA,NA,Dnase2a (MGI:1329019)
19,12884421,12887202,19p13.13-p13.12,19p13.13,600599,"KLF1, EKLF, INLU, HBFQTL6, CDAN4","Kruppel-like factor 1, erythroid",KLF1,10661,ENSG00000105610,NA,"Blood group--Lutheran inhibitor, 111150 (3); Dyserythropoietic anemia, congenital, type IV, 613673 (3), Autosomal dominant; [Hereditary persistence of fetal hemoglobin], 613566 (3)",Klf1 (MGI:1342771)
19,12891128,12915344,19p13.2,19p13.13,608801,GCDH,Glutaryl-Coenzyme A dehydrogenase,GCDH,2639,ENSG00000105607,NA,"Glutaricaciduria, type I, 231670 (3), Autosomal recessive",Gcdh (MGI:104541)
19,12898228,12919673,19p13.13,19p13.13,611487,"SYCE2, CESC1",Synaptonemal complex central element protein 2,SYCE2,256126,ENSG00000161860,NA,NA,Syce2 (MGI:1919096)
19,12938599,12944489,19p13.2,19p13.13,109091,"CALR, SSA",Sicca syndrome antigen A (autoantigen Ro; calreticulin),CALR,811,ENSG00000179218,"distal to C3, near LDLR","Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3)",Calr (MGI:88252)
19,12945813,12953642,19p13.2,19p13.13,600061,"RAD23A, HHR23A","RAD23, S. cerevisiae, homolog of, A",RAD23A,5886,ENSG00000179262,NA,NA,Rad23a (MGI:105126)
19,12953118,12957222,19p13.13,19p13.13,605162,"GADD45GIP1, PRG6, CRIF1",Growth arrest- and DNA damage-inducible DABB45G-interacting protein,GADD45GIP1,90480,ENSG00000179271,NA,NA,Gadd45gip1 (MGI:1914947)
19,12969617,12974752,19p13.2-p13.13,19p13.13,609068,"DAND5, CER2, CERL2, DANTE, COCO","DAN domain family, member 5",DAND5,199699,ENSG00000179284,NA,NA,Dand5 (MGI:1344365)
19,12995474,13098795,19p13.3,19p13.13,164005,"NFIX, NF1A, SOTOS2, MRSHSS",Nuclear factor I/X (CCAAT-binding transcription factor),NFIX,4784,ENSG00000008441,NA,"Marshall-Smith syndrome, 602535 (3), Autosomal dominant; Sotos syndrome 2, 614753 (3), Autosomal dominant",Nfix (MGI:97311)
19,13097165,13103750,19p13.2-p13.1,19p13.13,151440,LYL1,Lymphoblastic leukemia derived sequence-1,LYL1,4066,ENSG00000104903,NA,"Leukemia, T-cell acute lymphoblastoid, 151440 (2)",Lyl1 (MGI:96891)
19,13104899,13117566,19p13.3,19p13.13,611669,"TRMT1, TRM1, MRT68","tRNA methyltransferase 1, S. cerevisiae, homolog of",TRMT1,55621,ENSG00000104907,NA,"Mental retardation, autosomal recessive 68, 618302 (3), Autosomal recessive",Trmt1 (MGI:1289155)
19,13116847,13141146,19p13.13,19p13.13,610672,"NACC1, BTBD14B, NECFM","Nucleus accumbens-associated protein 1, BEN and BTB/POZ domains-containing",NACC1,112939,ENSG00000160877,NA,"Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3), Autosomal dominant",Nacc1 (MGI:1914080)
19,13144057,13150374,19p13.2,19p13.13,603765,"STX10, SYN10",Syntaxin 10,STX10,8677,ENSG00000104915,NA,NA,NA
19,13206441,13506478,19p13,19p13.13,601011,"CACNA1A, CACNL1A4, SCA6, EIEE42","Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",CACNA1A,773,ENSG00000141837,NA,"Epileptic encephalopathy, early infantile, 42, 617106 (3), Autosomal dominant; Episodic ataxia, type 2, 108500 (3), Autosomal dominant; Migraine, familial hemiplegic, 1, 141500 (3), Autosomal dominant; Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3), Autosomal dominant; Spinocerebellar ataxia 6, 183086 (3), Autosomal dominant",Cacna1a (MGI:109482)
19,13764491,13774281,19p13.2,19p13.13,615105,"MRI1, MRDI","Methylthioribose-1-phosphate isomerase, S. cerevisiae, homolog of",MRI1,84245,ENSG00000037757,NA,NA,Mri1 (MGI:1915123)
19,13836286,13836358,19p13.12,19p13.12,610724,"MIR24-2, MIRN24-2",Micro RNA 24-2,MIR24-2,407013,ENSG00000284387,NA,NA,NA
19,13836439,13836516,19p13.12,19p13.12,612153,"MIR27, MIRN27A",Micro RNA 27A,MIR27A,407018,ENSG00000207808,NA,NA,NA
19,13836586,13836658,19p13.13,19p13.12,607962,"MIR23A, MIRN23A",Micro RNA 23a,MIR23A,407010,ENSG00000207980,NA,NA,NA
19,13862035,13880756,19p13.13,19p13.12,608229,"NANOS3, NOS3","Nanos, Drosophila, homolog of, 3",NANOS3,342977,ENSG00000187556,NA,NA,Nanos3 (MGI:2675387)
19,13874698,13874807,19p13.3,19p13.12,612746,"MIR181C, MIRN181C",Micro RNA 181C,MIR181C,406957,ENSG00000207613,NA,NA,NA
19,13906148,13930878,19p13.12,19p13.12,610055,"CC2D1A, MRT3",Coiled-coil and C2 domain-containing 1A,CC2D1A,54862,ENSG00000132024,NA,"Mental retardation, autosomal recessive 3, 608443 (3), Autosomal recessive",Cc2d1a (MGI:2384831)
19,13961529,14007513,19p13.1,19p13.12,600006,RFX1,Regulatory factor (trans-acting) 1 (influences HLA class II expression),RFX1,5989,ENSG00000132005,NA,NA,Rfx1 (MGI:105982)
19,14028147,14031557,19p13.3,19p13.12,606855,"RLN3, H3, RXN3",Relaxin 3,RLN3,117579,ENSG00000171136,NA,NA,Rln3 (MGI:2158015)
19,14031761,14053217,19p13.11,19p13.12,605350,"TCCR, WSX1",T-cell cytokine receptor,IL27RA,9466,ENSG00000104998,NA,NA,Il27ra (MGI:1355318)
19,14091687,14117761,19p13.1,19p13.12,601639,PRKACA,"Protein kinase, cAMP-dependent, catalytic, alpha",PRKACA,5566,ENSG00000072062,NA,"Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3)",Prkaca (MGI:97592)
19,14119511,14136588,19p13.13,19p13.12,609190,ASF1B,"Anti-silencing function 1, S. cerevisiae, homolog of, B",ASF1B,55723,ENSG00000105011,NA,NA,Asf1b (MGI:1914179)
19,14147736,14206244,19p13.3,19p13.12,616416,"ADGRL1, LPHN1, CIRL1, CL1, LEC2, KIAA0821",Adhesion G protein-coupled receptor L1,ADGRL1,22859,ENSG00000072071,NA,NA,Adgrl1 (MGI:1929461)
19,14381143,14408724,19p13.1,19p13.12,601211,"ADGRE5, CD97",Adhesion G protein-coupled receptor E5,ADGRE5,976,ENSG00000123146,NA,NA,Adgre5 (MGI:1347095)
19,14433305,14471858,19p12,19p13.12,601032,"PKN1, PRKCL1, PRK1, PAK1",Protein kinase N1,PKN1,5585,ENSG00000123143,NA,NA,Pkn1 (MGI:108022)
19,14472465,14475353,19p13.1,19p13.12,176802,PTGER1,"Prostaglandin E receptor 1, EP1 subtype, 42kD",PTGER1,5731,ENSG00000160951,NA,NA,Ptger1 (MGI:97793)
19,14477758,14496148,19p13.1,19p13.12,605072,"RGS19IP1, C19orf3, GIPC",Regulator of G-protein signaling 19 interacting protein 1,GIPC1,10755,ENSG00000123159,NA,NA,Gipc1 (MGI:1926252)
19,14514763,14530596,19p13.2,19p13.12,604572,"DNAJB1, HSPF1","DnaJ, E. coli, homolog of, subfamily B, member 1 (heat-shock 40kD protein 1)",DNAJB1,3337,ENSG00000132002,NA,NA,Dnajb1 (MGI:1931874)
19,14527751,14565979,19p13.12,19p13.12,610057,"TECR, GPSN2, TER, SC2, MRT14","Trans-2,3-enoyl-CoA reductase",TECR,9524,ENSG00000099797,NA,"Mental retardation, autosomal recessive 14, 614020 (3), Autosomal recessive",Tecr (MGI:1915408)
19,14566077,14572065,19p13.12-p13.11,19p13.12,603842,NDUFB7,NADH-ubiquinone oxidoreductase subunit B7,NDUFB7,4713,ENSG00000099795,NA,NA,Ndufb7 (MGI:1914166)
19,14580776,14612026,19p13.12,19p13.12,616838,CLEC17A,"C-type lectin domain family 17, member A",CLEC17A,388512,ENSG00000187912,NA,NA,NA
19,14600174,14674917,19p13.1,19p13.12,606101,EMR3,"EGF-like module-containing, mucin-like hormone receptor 3",ADGRE3,84658,ENSG00000131355,NA,NA,NA
19,14689786,14733741,19p13.1,19p13.12,611811,"ZNF333, KIAA1806",Zinc finger protein 333,ZNF333,84449,ENSG00000160961,NA,NA,NA
19,14732391,14778559,19p13.1,19p13.12,606100,"ADGRE2, EMR2, VBU",Adhesion G protein-coupled receptor E2,ADGRE2,30817,ENSG00000127507,NA,"Vibratory urticaria, 125630 (3), Autosomal dominant",NA
19,14950032,15010642,19p13.12,19p13.12,600637,"SLC1A6, EAAT4","Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6",SLC1A6,6511,ENSG00000105143,NA,NA,Slc1a6 (MGI:1096331)
19,15049479,15058292,19p13.1,19p13.12,605848,"CASP14, ARCI12","Caspase 14, apoptosis-related cysteine protease",CASP14,23581,ENSG00000105141,NA,"Ichthyosis, congenital, autosomal recessive 12, 617320 (3), Autosomal recessive",Casp14 (MGI:1335092)
19,15107400,15114984,19p13.12,19p13.12,617377,SYDE1,"Synapse defective Rho GTPase, C. elegans, homolog of, 1",SYDE1,85360,ENSG00000105137,NA,NA,Syde1 (MGI:1918959)
19,15114981,15125785,19p13.1,19p13.12,605770,"ILVBL, AHAS","IlvB-like (acetolactate synthase, bacterial, homolog of)",ILVBL,10994,ENSG00000105135,NA,NA,Ilvbl (MGI:1351911)
19,15159037,15200994,19p13.2-p13.1,19p13.12,600276,"NOTCH3, CADASIL1, CASIL, IMF2, LMNS","Notch, Drosophila, homolog of, 3",NOTCH3,4854,ENSG00000074181,mutation identified in 1 IMF2 family,"Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3), Autosomal dominant; Lateral meningocele syndrome, 130720 (3), Autosomal dominant; ?Myofibromatosis, infantile 2, 615293 (3), Autosomal dominant",Notch3 (MGI:99460)
19,15226918,15233452,19p13.12,19p13.12,617400,"EPHX3, ABHD9",Epoxide hydrolase 3,EPHX3,79852,ENSG00000105131,NA,NA,Ephx3 (MGI:1919182)
19,15236835,15332538,19p13.1,19p13.12,608749,"BRD4, CAP, HUNK1",Bromodomain-containing protein 4,BRD4,23476,ENSG00000141867,fused with NUT,NA,NA
19,15353384,15379786,19p13.12,19p13.12,604692,"AKAP8, AKAP95",A-kinase anchor protein 8,AKAP8,10270,ENSG00000105127,NA,NA,Akap8 (MGI:1928488)
19,15380047,15419120,19p13.12-p13.11,19p13.12,609475,"AKAP8L, HA95, NAKAP, HAP95",A-kinase anchor protein 8-like protein,AKAP8L,26993,ENSG00000011243,NA,NA,Akap8l (MGI:1860606)
19,15451623,15464570,19p13.12,19p13.12,616561,RASAL3,Ras protein activator-like 3,RASAL3,64926,ENSG00000105122,NA,NA,Rasal3 (MGI:2444128)
19,15468644,15479500,19p13.12,19p13.12,608199,PGRPL,"Peptidoglycan recognition protein, long",PGLYRP2,114770,ENSG00000161031,NA,NA,Pglyrp2 (MGI:1928099)
19,15508486,15552316,19p13.12,19p13.12,611495,"CYP4F22, ARCI5, LI3","Cytochrome P450, family 4, subfamily F, polypeptide 22",CYP4F22,126410,ENSG00000171954,NA,"Ichthyosis, congenital, autosomal recessive 5, 604777 (3), Autosomal recessive",Cyp4f39 (MGI:2445210)
19,15615206,15630638,19p13.1,19p13.12,611545,CYP4F8,"Cytochrome P450, family 4, subfamily F, polypeptide 8",CYP4F8,11283,ENSG00000186526,NA,NA,Cyp4f15 (MGI:2146921)
19,15640896,15662824,19p13.2,19p13.12,601270,"CYP4F3, LTB4H","Cytochrome P450, subfamily IVF, polypeptide 3",CYP4F3,4051,ENSG00000186529,NA,NA,Cyp4f13 (MGI:2158641)
19,15673017,15698818,19p13.1,19p13.12,611485,CYP4F12,"Cytochrome P450, family 4, subfamily F, polypeptide 12",CYP4F12,66002,ENSG00000186204,NA,NA,Cyp4f14 (MGI:1927669)
19,15828946,15836320,19p13.12,19p13.12,617500,"UCA1, LINC00178, CUDR",Urothelial cancer-associated gene 1,UCA1,652995,ENSG00000214049,NA,NA,NA
19,15878022,15898073,19p13.12,19p13.12,604426,CYP4F2,"Cytochrome P450, family 4, subfamily F, polypeptide 2",CYP4F2,8529,ENSG00000186115,NA,NA,Cyp4f18 (MGI:1919304)
19,15912369,15934865,19p13.1,19p13.12,611517,CYP4F11,"Cytochrome P450, family 4, subfamily F, polypeptide 11",CYP4F11,57834,ENSG00000171903,NA,NA,Cyp4f40 (MGI:3645508)
19,16067506,16103004,19p13.1,19p13.12-p13.11,600317,TPM4,Tropomyosin 4,TPM4,7171,ENSG00000167460,NA,NA,NA
19,16111888,16134233,19p13.2-cen,19p13.11,165040,"RAB8A, MEL",Ras-associated protein RAB8A (oncogene MEL),RAB8A,4218,ENSG00000167461,NA,NA,Rab8a (MGI:96960)
19,16134027,16158574,19q13.2,19p13.11,608349,"HSH2D, ALX",Hemotopoietic SH2 domain-containing protein,HSH2D,84941,ENSG00000196684,NA,NA,Hsh2d (MGI:2676364)
19,16185183,16192045,19p13.12,19p13.11,614554,"FAM32A, OTAG12","Family with sequence similarity 32, member A",FAM32A,26017,ENSG00000105058,NA,NA,Fam32a (MGI:1915172)
19,16197910,16245905,19p13.12,19p13.11,603535,"AP1M1, AP47, CLAPM2","Adaptor-related protein complex 1, mu 1 subunit",AP1M1,8907,ENSG00000072958,NA,NA,Ap1m1 (MGI:102776)
19,16324825,16328661,19p13.1,19p13.11,602016,"KLF2, LKLF",Kruppel-like factor 2,KLF2,10365,ENSG00000127528,NA,NA,Klf2 (MGI:1342772)
19,16355243,16472011,19p13.11,19p13.11,616826,"EPS15L1, EPS15R",EPS15-like protein 1,EPS15L1,58513,ENSG00000127527,NA,NA,Eps15l1 (MGI:104582)
19,16479056,16496191,19p13.12,19p13.11,611414,"CALR3, CRT2",Calreticulin 3,CALR3,125972,ENSG00000269058,NA,NA,Calr3 (MGI:1920566)
19,16574921,16628203,19p13.11,19p13.11,605043,"MED26, CRSP7, CRSP70",Mediator complex subunit 26,MED26,9441,ENSG00000105085,NA,NA,Med26 (MGI:1917875)
19,16661138,16690022,19p13.11,19p13.11,611235,"TMEM38A, TRICA",Transmembrane protein 38A,TMEM38A,79041,ENSG00000072954,NA,NA,Tmem38a (MGI:1921416)
19,16719525,16817962,19p13.11,19p13.11,616250,NWD1,NACHT domain- and WD repeat-containing protein 1,NWD1,284434,ENSG00000188039,NA,NA,Nwd1 (MGI:2442268)
19,16829397,16880354,19p13.11,19p13.11,607777,"SIN3B, KIAA0700","Sin3, yeast, homolog of, B",SIN3B,23309,ENSG00000127511,NA,NA,Sin3b (MGI:107158)
19,16888998,16892605,19p12,19p13.11,602779,"F2RL3, PAR4","Coagulation factor II, thrombin, receptor-like 3 (protease-activated receptor-4)",F2RL3,9002,ENSG00000127533,NA,NA,F2rl3 (MGI:1298207)
19,16892950,17026817,19p13.11,19p13.11,608841,"CPAMD8, KIAA1283, ASGD8",Complement component 3- and pregnancy zone protein-like alpha-2-macroglobin domain-containing protein 8,CPAMD8,27151,ENSG00000160111,NA,"Anterior segment dysgenesis 8, 617319 (3), Autosomal recessive",NA
19,17049728,17075605,19p13.11,19p13.11,613434,"HAUS8, DGT4, HICE1","HAUS augmin-like complex, subunit 8",HAUS8,93323,ENSG00000131351,NA,NA,Haus8 (MGI:1923728)
19,17075776,17213285,19p13.1,19p13.11,602129,"MYO9B, MYR5, CELIAC4",Myosin IXB,MYO9B,4650,ENSG00000099331,NA,"{Celiac disease, susceptibility to, 4}, 609753 (3)",Myo9b (MGI:106624)
19,17231884,17245341,19p13.1,19p13.11,132880,"NR2F6, ERBAL2, EAR2","Nuclear receptor subfamily 2, group F, member 6",NR2F6,2063,ENSG00000160113,NA,NA,Nr2f6 (MGI:1352453)
19,17249170,17264795,19p13.1,19p13.11,611810,"USHBP1, MCC2",USH1C-binding protein 1,USHBP1,83878,ENSG00000130307,NA,NA,Ushbp1 (MGI:1922920)
19,17267375,17279352,19p13.11,19p13.11,612766,"C10orf62, MERIT40, NBA1",Chromosome 19 open reading frame 62,BABAM1,29086,ENSG00000105393,NA,NA,Babam1 (MGI:1915501)
19,17302806,17306842,19p13.1,19p13.11,611840,MRPL34,Mitochondrial ribosomal protein L34,MRPL34,64981,ENSG00000130312,NA,NA,Mrpl34 (MGI:2137227)
19,17323222,17334854,19p13.11,19p13.11,610216,"TMEM16H, KIAA1623",Transmembrane protein 16H,ANO8,57719,ENSG00000074855,NA,NA,Ano8 (MGI:2687327)
19,17334981,17342730,19p13.11,19p13.11,608536,"GTPBP3, MSS1, COXPD23",GTP-binding protein 3,GTPBP3,84705,ENSG00000130299,NA,"Combined oxidative phosphorylation deficiency 23, 616198 (3), Autosomal recessive",Gtpbp3 (MGI:1917609)
19,17351454,17377341,19p13.2,19p13.11,607647,"PLVAP, PV1, DIAR10",Plasmalemma vesicle-associated protein,PLVAP,83483,ENSG00000130300,NA,"Diarrhea 10, protein-losing enteropathy type, 618183 (3), Autosomal recessive",Plvap (MGI:1890497)
19,17402938,17405629,19p13.2,19p13.11,600534,BST2,Bone marrow stromal cell antigen,BST2,684,ENSG00000130303,NA,NA,NA
19,17455424,17460925,19p13.11,19p13.11,608791,"NXNL1, RDCVF, TXNL6, LOC115861",Nucleoredoxin-like protein 1,NXNL1,115861,ENSG00000171773,NA,NA,Nxnl1 (MGI:1924446)
19,17468744,17506168,19p13.1,19p13.11,600691,"SLC27A1, FATP, FATP1","Solute carrier family 27, member 1",SLC27A1,376497,ENSG00000130304,NA,NA,Slc27a1 (MGI:1347098)
19,17511648,17521290,19p13.2,19p13.11,604951,PGLS,6-phosphogluconolactonase,PGLS,25796,ENSG00000130313,NA,NA,Pgls (MGI:1913421)
19,17523300,17556754,19p13.11,19p13.11,609967,BCNP1,B-cell novel protein 1,NIBAN3,199786,ENSG00000167483,NA,NA,Fam129c (MGI:3686743)
19,17555648,17583158,19p13.11,19p13.11,617531,"COLGALT1, GLT25D1, BSVD3",Collagen beta(1-0)galactosyltransferase 1,COLGALT1,79709,ENSG00000130309,NA,"Brain small vessel disease 3, 618360 (3), Autosomal recessive",Colgalt1 (MGI:1924348)
19,17601327,17688343,19p13.3,19p13.11,609894,"UNC13A, KIAA1032","UNC13, C. elegans, homolog of, A",UNC13A,23025,ENSG00000130477,NA,NA,Unc13a (MGI:3051532)
19,17719479,17734514,19p13.11,19p13.11,607573,"MAP1S, BPY2IP1, VCY2IP1, C19orf5",Microtubule-associated protein 1S,MAP1S,55201,ENSG00000130479,NA,NA,Map1s (MGI:2443304)
19,17747717,17788561,19p13.11,19p13.11,613437,FCHO1,FCH domain-only protein 1,FCHO1,23149,ENSG00000130475,NA,NA,Fcho1 (MGI:1921265)
19,17794827,17813575,19p,19p13.11,605863,"TMEM3, B3GNT3","Transmembrane protein 3 (beta-1,3-N-acetylglucosaminyltransferase 3)",B3GNT3,10331,ENSG00000179913,NA,NA,B3gnt3 (MGI:2152535)
19,17816511,17821518,19p13.2,19p13.11,146738,INSL3,"Insulin-like 3, Leydig cell",INSL3,3640,ENSG00000248099,NA,"Cryptorchidism, 219050 (3), Autosomal dominant",Insl3 (MGI:108427)
19,17824781,17848070,19p13.1,19p13.11,600173,"JAK3, JAKL","Janus kinase 3 (Janus kinase, leukocyte)",JAK3,3718,ENSG00000105639,NA,"SCID, autosomal recessive, T-negative/B-positive type, 600802 (3), Autosomal recessive",Jak3 (MGI:99928)
19,17859909,17863318,19p,19p13.11,604178,RPL18A,Ribosomal protein L18a,RPL18A,6142,ENSG00000105640,NA,NA,Rpl18a (MGI:1924058)
19,17871393,17895174,19p13.2-p12,19p13.11,601843,"SLC5A5, NIS, TDH1","Solute carrier family 5 (sodium iodide symporter), member-5",SLC5A5,6528,ENSG00000105641,NA,"Thyroid dyshormonogenesis 1, 274400 (3), Autosomal recessive",Slc5a5 (MGI:2149330)
19,18058993,18099026,19p13.1,19p13.11,601604,"IL12RB1, IMD30","Interleukin-12 receptor, beta-1",IL12RB1,3594,ENSG00000096996,NA,"Immunodeficiency 30, 614891 (3), Autosomal recessive",Il12rb1 (MGI:104579)
19,18097763,18151691,19p13.11,19p13.11,612258,"MAST3, KIAA0561",Microtubule-associated serine/threonine kinase 3,MAST3,23031,ENSG00000099308,NA,NA,Mast3 (MGI:2683541)
19,18153162,18170531,19q13.2-q13.4,19p13.11,603157,"PIK3R2, MPPH1","Phosphatidylinositol 3-kinase, regulatory subunit 2",PIK3R2,5296,ENSG00000105647,NA,"Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3), Autosomal dominant",Pik3r2 (MGI:1098772)
19,18173812,18178116,19p13.11,19p13.11,604664,"IFI30, GILT",Interferon-gamma-inducible protein 30,IFI30,10437,ENSG00000216490,NA,NA,Ifi30 (MGI:2137648)
19,18193217,18196947,19p13.11,19p13.11,616133,MPV17L2,MPV17-like protein 2,MPV17L2,84769,ENSG00000254858,NA,NA,Mpv17l2 (MGI:2681846)
19,18196783,18204041,19p13.1-p12,19p13.11,179490,RAB3A,RAS-associated protein RAB3A,RAB3A,5864,ENSG00000105649,NA,NA,Rab3a (MGI:97843)
19,18207960,18248199,19p13.1,19p13.11,600128,"PDE4C, DPDE1","Phosphodiesterase-4C, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E1)",PDE4C,5143,ENSG00000105650,between JUND (proximal) and RAB3A (distal),NA,Pde4c (MGI:99556)
19,18279693,18281621,19p13.1-p12,19p13.11,165162,JUND,jun D proto-oncogene,JUND,3727,ENSG00000130522,NA,NA,Jund (MGI:96648)
19,18306235,18323075,19p13.11,19p13.11,607284,LSM4,LSM4 protein,LSM4,25804,ENSG00000130520,NA,NA,Lsm4 (MGI:1354692)
19,18340586,18369951,19p13.11,19p13.11,610694,"PGPEP1, PCP, PGP",Pyroglutamyl peptidase I,PGPEP1,54858,ENSG00000130517,NA,NA,Pgpep1 (MGI:1913772)
19,18382169,18389175,19p13.2-p13.1,19p13.11,605312,"GDF15, PLAB, PDF, MIC1","Growth/differentiation factor-15 (bone morphogenetic protein, placental)",GDF15,9518,ENSG00000130513,NA,NA,Gdf15 (MGI:1346047)
19,18391136,18397644,19p13.2-p12,19p13.11,607518,"LRRC25, MAPA",Leucine rich repeat containing 25,LRRC25,126364,ENSG00000175489,NA,NA,Lrrc25 (MGI:2445284)
19,18418718,18434561,19p13.1,19p13.11,607391,SSBP4,Single-stranded DNA-binding protein 4,SSBP4,170463,ENSG00000130511,NA,NA,Ssbp4 (MGI:1924150)
19,18434387,18438648,19p13.1,19p13.11,611670,"ISYNA1, IPS",Myoinositol 1-phosphate synthase A1,ISYNA1,51477,ENSG00000105655,pseudogene on 4p15,NA,Isyna1 (MGI:1919030)
19,18442662,18522069,19p13.1,19p13.11,600284,ELL,ELL gene (11-19 lysine-rich leukemia gene),ELL,8178,ENSG00000105656,NA,NA,Ell (MGI:109377)
19,18531762,18543572,19p12,19p13.11,604840,"FKBP8, FKBP38",FK506-binding protein 8,FKBP8,23770,ENSG00000105701,pseudogene on 1q32,NA,Fkbp8 (MGI:1341070)
19,18557761,18569386,19p13.11,19p13.11,615178,"KXD1, C10orf50",KXDL motif-containing protein 1,KXD1,79036,ENSG00000105700,NA,NA,Kxd1 (MGI:1922870)
19,18563765,18577549,19p13.1-p12,19p13.11,191321,UBA52,Ubiquitin A-52 residue ribosomal protein fusion product 1,UBA52,7311,ENSG00000221983,NA,NA,Uba52-ps (MGI:3644625)
19,18593236,18606798,19p12,19p13.11,604237,"CRLF1, CISS1",Cytokine-like factor 1,CRLF1,9244,ENSG00000006016,NA,"Cold-induced sweating syndrome 1, 272430 (3), Autosomal recessive",Crlf1 (MGI:1340030)
19,18612869,18621039,19p12,19p13.11,617096,"TMEM59L, BSMAP",Transmembrane protein 59-like,TMEM59L,25789,ENSG00000105696,NA,NA,Tmem59l (MGI:1915187)
19,18683620,18782332,19p13,19p13.11,607536,"CRTC1, MECT1, KIAA0616, FLJ14027",CREB-regulated transcription coactivator 1,CRTC1,23373,ENSG00000105662,t(11;19),Mucoepidermoid salivary gland carcinoma (3),Crtc1 (MGI:2142523)
19,18782772,18791304,19p13.1,19p13.11,600310,"COMP, EDM1, MED, PSACH",Cartilage oligomeric matrix protein,COMP,1311,ENSG00000105664,NA,"Epiphyseal dysplasia, multiple, 1, 132400 (3), Autosomal dominant; Pseudoachondroplasia, 177170 (3), Autosomal dominant",Comp (MGI:88469)
19,18831404,18868229,19p13.2-p13.11,19p13.11,601430,"UPF1, RENT1, HUPF1","Upf1, yeast, homolog of",UPF1,5976,ENSG00000005007,NA,NA,Upf1 (MGI:107995)
19,18868544,18896726,19p12,19p13.11,606919,"CERS1, LASS1, UOG1, EPM8",Ceramide synthase 1,CERS1,10715,ENSG00000223802,mutation identified in 1 EPM8 family,"?Epilepsy, progressive myoclonic, 8, 616230 (3), Autosomal recessive",Cers1 (MGI:2136690)
19,18868544,18896157,19p12,19p13.11,602880,"GDF1, DTGA3, DORV, RAI, CHTD6",Growth/differentiation factor 1,GDF1,2657,ENSG00000130283,NA,"Congenital heart defects, multiple types, 6, 613854 (3), Autosomal dominant; Right atrial isomerism (Ivemark), 208530 (3), Autosomal recessive",Gdf1 (MGI:95683)
19,18899513,18919386,19p13.11,19p13.11,606942,COPE,"Cotamer protein complex, subunit epsilon",COPE,11316,ENSG00000105669,NA,NA,Cope (MGI:1891702)
19,18929200,18941257,19p13.11,19p13.11,604800,HOMER3,"Homer, homolog 3 (Drosophila)",HOMER3,9454,ENSG00000051128,NA,NA,Homer3 (MGI:1347359)
19,18990886,19034051,19p13.11,19p13.11,607993,"SUGP2, SRFS14, KIAA0365",SURP and G-patch domains-containing protein 2,SUGP2,10147,ENSG00000064607,NA,NA,Sugp2 (MGI:2678085)
19,19063993,19113029,19p13.11,19p13.11,610823,"SLC25A42, MECREN","Solute carrier family 25, member 42",SLC25A42,284439,ENSG00000181035,NA,"Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, 618416 (3), Autosomal recessive",Slc25a42 (MGI:1920345)
19,19145566,19170262,19p12,19p13.11,600661,MEF2B,"MADS box transcription enhancer factor 2, polypeptide B (myocyte enhancer factor 2B)",MEF2B,100271849,ENSG00000213999,NA,NA,Mef2b (MGI:104526)
19,19176905,19192151,19p13.11,19p13.11,616601,"BORCS8, MEF2BNB","BLOC1-related complex, subunit 8",BORCS8,729991,ENSG00000254901,NA,NA,Borcs8 (MGI:1919618)
19,19192198,19201868,19p12,19p13.11,603200,RFXANK,"Regulatory factor X, ankyrin repeat-containing",RFXANK,8625,ENSG00000064490,NA,"MHC class II deficiency, complementation group B, 209920 (3), Autosomal recessive",Rfxank (MGI:1333865)
19,19201408,19203413,19p13.11,19p13.11,608719,"NR2C2AP, TRA16",Nuclear receptor 2C2 associated protein,NR2C2AP,126382,ENSG00000184162,NA,NA,Nr2c2ap (MGI:1922942)
19,19211957,19252232,19p12,19p13.11,600826,"CSPG3, NCAN",Chondroitin sulfate proteoglycan 3 (neurocan),NCAN,1463,ENSG00000130287,NA,NA,Ncan (MGI:104694)
19,19264365,19273300,19p12,19p13.11,606563,"TM6SF2, KIAA1926","Transmembrane 6 superfamily, member 2",TM6SF2,53345,ENSG00000213996,NA,NA,Tm6sf2 (MGI:1933210)
19,19276032,19320508,19p13.11,19p13.11,607992,"SUGP1, SF4",SURP and G-patch domains-containing protein 1,SUGP1,57794,ENSG00000105705,NA,NA,Sugp1 (MGI:1917866)
19,19320606,19358753,19p13.11,19p13.11,614560,"MAU2, SCC4, KIAA0892","MAU2 chromatid cohesion factor, C. elegans, homolog of",MAU2,23383,ENSG00000129933,NA,NA,Mau2 (MGI:1921799)
19,19385802,19508931,19q13.11,19p13.11,614997,GATAD2A,GATA zinc finger domain-containing protein 2A,GATAD2A,54815,ENSG00000167491,NA,NA,Gatad2a (MGI:2384585)
19,19514218,19515547,19p13.11,19p13.11,610712,"TSSK6, SSTK, TSSK4",Testis-specific serine/threonine kinase 6,TSSK6,83983,ENSG00000178093,NA,NA,Tssk6 (MGI:2148775)
19,19516224,19528197,19p13.2-p13.1,19p13.11,609435,"NDUFA13, GRIM19, MC1DN28",NADH-ubiquinone oxidoreductase subunit A13,NDUFA13,51079,ENSG00000186010,mutation identified in 1 MC1DN28 family,"?Mitochondrial complex I deficiency, nuclear type 28, 618249 (3), Autosomal recessive; {Thyroid carcinoma, Hurthle cell}, 607464 (3)",Ndufa13 (MGI:1914434)
19,19538264,19546658,19p13.11,19p13.11,612419,CILP2,Cartilage intermediate layer protein 2,CILP2,148113,ENSG00000160161,NA,NA,Cilp2 (MGI:1915959)
19,19561706,19618915,19p13.11,19p13.11,608127,PBX4,Pre-B-cell leukemia transcription factor 4,PBX4,80714,ENSG00000105717,NA,NA,Pbx4 (MGI:1931321)
19,19623654,19628394,19p12,19p13.11,605110,"LPAR2, EDG4",Lysophosphatidic acid receptor 2,LPAR2,9170,ENSG00000064547,NA,NA,Lpar2 (MGI:1858422)
19,19629475,19643656,19p12-p11,19p13.11,609694,GMIP,GEM-interacting protein,GMIP,51291,ENSG00000089639,NA,NA,Gmip (MGI:1926066)
19,19668069,19683505,19p13.1-p12,19p13.11,603983,ZNF101,Zinc finger protein-101,ZNF101,94039,ENSG00000181896,NA,NA,NA
19,19710471,19733111,19p13.3-p13.2,19p13.11,194556,"ZNF14, KOX6",Zinc finger protein-14 (KOX 6),ZNF14,7561,ENSG00000105708,NA,NA,"Zfp976,Zfp975 (MGI:3648690,MGI:3036263)"
19,19756370,19776412,19p13.11,19p13.11,617117,LINC00663,Long intergenic noncoding RNA 663,LINC00663,284440,NA,NA,NA,NA
19,19865829,19894673,19p13,19p13.11,606954,ZNF253,Zinc finger protein 253,ZNF253,56242,ENSG00000256771,NA,NA,Zfp65 (MGI:107769)
19,19900945,19935574,19p13.1-p12,19p12,603975,ZNF93,Zinc finger protein-93,ZNF93,81931,ENSG00000184635,NA,NA,Zfp457 (MGI:2664334)
19,20077999,20127089,19p13.1-p12,19p12,603973,ZNF90,Zinc finger protein-90,ZNF90,7643,ENSG00000213988,NA,NA,NA
19,20531229,20565820,19p13.1-p12,19p12,603984,"ZNF737, ZNF102",Zinc finger protein-737,ZNF737,100129842,ENSG00000237440,NA,NA,NA
19,20923226,20950696,19p13.1-p12,19p12,603899,ZNF85,Zinc finger protein-85,ZNF85,7639,ENSG00000105750,NA,NA,NA
19,21722770,21767578,19p13.1-p12,19p12,603982,ZNF100,Zinc finger protein-100,ZNF100,163227,ENSG00000197020,NA,NA,NA
19,21804945,21852094,19p13.1-p12,19p12,603972,ZNF43,Zinc finger protein-43,ZNF43,7594,ENSG00000198521,NA,NA,Zfp458 (MGI:3040691)
19,21939765,22010942,19p13.1-p12,19p12,603977,"ZNF208, ZNF95",Zinc finger protein-208,ZNF208,7757,ENSG00000160321,NA,NA,Zfp619 (MGI:1917477)
19,22052483,22091479,19p12,19p12,606957,ZNF257,Zinc finger protein 257,ZNF257,113835,ENSG00000197134,NA,NA,NA
19,22391018,22422345,19p12,19p12,603980,ZNF98,Zinc finger protein-98,ZNF98,148198,ENSG00000197360,NA,NA,NA
19,22752182,22784150,19p12,19p12,603981,ZNF99,Zinc finger protein-99,ZNF99,7652,ENSG00000213973,NA,NA,NA
19,23305003,23395526,19p13.1-p12,19p12,603971,ZNF91,Zinc finger protein-91,ZNF91,7644,ENSG00000167232,NA,NA,Zfp869 (MGI:1914119)
19,24033404,24129967,19p13.12-p13.11,19p12,604768,"ZNF254, ZNF91L",Zinc finger protein-254,ZNF254,9534,ENSG00000213096,NA,NA,NA
19,26200000,58617616,19q,NA,601764,"BFIS1, BFIC1",Benign familial infantile seizures,NA,8181,NA,NA,"Seizures, benign familial infantile, 1, 601764 (2), Autosomal dominant",NA
19,26200000,58617616,19q,NA,607592,HPCQTL19,Prostate cancer aggressiveness quantitative trait locus on chromosome 19,NA,347747,NA,D19S902,"{Prostate cancer aggressiveness QTL}, 607592 (2)",NA
19,26200000,58617616,19q,NA,606712,SLI2,"Specific language impairment QTL, 2",NA,171014,NA,NA,"Specific language impairment QTL, 2, 606712 (2), Multifactorial",NA
19,28100000,31900000,19q12,NA,606875,HSCR7,"Hirschsprung disease, susceptibility to, 7",NA,246322,NA,NA,"{Hirschsprung disease, susceptibility to, 7}, 606875 (2)",NA
19,29205319,29213150,19q12,19q12,191327,UQCRFS1,"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1",UQCRFS1,7386,ENSG00000169021,NA,NA,Uqcrfs1 (MGI:1913944)
19,29606262,29617254,19q12,19q12,606114,"RPP29, POP4","Ribonuclease P, 29kD subunit",POP4,10775,ENSG00000105171,NA,NA,Pop4 (MGI:1913411)
19,29665421,29675476,19q11,19q12,615200,"PLEKHF1, LAPF, PHAFIN1","Pleckstrin homolog domain-containing protein, family F, member 1",PLEKHF1,79156,ENSG00000166289,NA,NA,Plekhf1 (MGI:1919537)
19,29698885,29715788,19q12,19q12,614297,"C19orf12, NBIA4, SPG43",Chromosome 19 open reading frame 12,C19orf12,83636,ENSG00000131943,mutation identified in 1 SPG43 family,"Neurodegeneration with brain iron accumulation 4, 614298 (3), Autosomal recessive; ?Spastic paraplegia 43, autosomal recessive, 615043 (3), Autosomal recessive",1600014C10Rik (MGI:1919494)
19,29811990,29824311,19q13.1,19q12,123837,CCNE1,Cyclin E1,CCNE1,898,ENSG00000105173,NA,NA,Ccne1 (MGI:88316)
19,29923649,30016611,19q12,19q12,603494,"URI1, NNX3, RMP",Prefoldin-like chaperone URI1,URI1,8725,ENSG00000105176,NA,NA,Uri1 (MGI:1342294)
19,30224235,30713585,19q12,19q12,618037,"ZNF536, KIAA0390",Zinc finger protein 536,ZNF536,9745,ENSG00000198597,NA,NA,Zfp536 (MGI:1926102)
19,31149869,31349524,19q13.11,19q12,614119,"TSHZ3, KIAA1474",Teashirt zinc finger homeobox 3,TSHZ3,57616,ENSG00000121297,NA,NA,Tshz3 (MGI:2442819)
19,31900000,58617616,19q13,NA,100070,"AAA1, AAA","Aortic aneurysm, familial abdominal 1",NA,100329167,NA,near D19S416,"Aortic aneurysm, familial abdominal 1, 100070 (2), Autosomal dominant",NA
19,31900000,58617616,19q13,NA,608542,ANIB2,"Aneurysm, intracranial berry, 2",ANIB2,449013,NA,between D19S245 and D19S246,"Aneurysm, intracranial berry, 2, 608542 (2)",NA
19,31900000,58617616,19q13,NA,609376,"CTRCT35, CATCN1",Cataract 35,NA,619404,NA,max lod at D19S416,"Cataract 35, congenital nuclear, 609376 (2), Autosomal recessive",NA
19,31900000,35100000,19q13.11,NA,613026,"DEL19q13.11d, C19DELq13.11d","Chromosome 19q13.11 deletion syndrome, distal",NA,NA,NA,contiguous gene syndrome,"Chromosome 19q13.11 deletion syndrome, distal, 613026 (4), Autosomal dominant",NA
19,31900000,35100000,19q13.11,NA,617219,"DEL19q13.11p, C19DELq13.11p","Chromosome 19q13.11 deletion syndrome, proximal",NA,NA,NA,NA,"Chromosome 19q13.11 deletion syndrome, proximal, 617219 (4), Autosomal dominant",NA
19,31900000,58617616,19q13.1-qter,NA,129150,E11S,Echo 11 sensitivity,E11S,1878,NA,NA,NA,NA
19,31900000,58617616,19q13,NA,611907,EA7,"Episodic ataxia, type 7",NA,100188859,NA,between rs1366444 and rs952108,"Episodic ataxia, type 7, 611907 (2), Autosomal dominant",NA
19,31900000,58617616,19q13,NA,600757,OFC3,Orofacial cleft 3,OFC3,4965,NA,?role of BCL3,"Orofacial cleft 3, 600757 (2), ?Autosomal dominant",NA
19,31900000,58617616,19q13,NA,614746,UAQTL5,"Uric acid concentration, serum, quantitative trait locus 5",NA,100996934,NA,associated with rs150414818,"[Uric acid concentration, serum, QTL5], 614746 (2)",NA
19,32405764,32485889,19q13.11,19q13.11,613894,DPY19L3,DPY19-like 3,DPY19L3,147991,ENSG00000178904,NA,NA,Dpy19l3 (MGI:2443952)
19,32581189,32587452,19q13.11,19q13.11,604583,"PDCD5, TFAR19",Programmed cell death 5,PDCD5,9141,ENSG00000105185,NA,NA,"Pdcd5,Pdcd5-ps (MGI:3782009,MGI:1913538)"
19,32675847,32678299,19q13.11,19q13.11,607814,"RGS9BP, R9AP, RGS9, PERRS",Regulator of G protein signaling 9-binding protein,RGS9BP,388531,ENSG00000186326,NA,"Bradyopsia, 608415 (3)",Rgs9bp (MGI:2384418)
19,32830510,32870956,19q13.1,19q13.11,604144,"SLC7A9, CSNU3","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9",SLC7A9,11136,ENSG00000021488,NA,"Cystinuria, 220100 (3), Autosomal recessive, Autosomal dominant",Slc7a9 (MGI:1353656)
19,32875924,32972023,19q13.11,19q13.11,615470,"CEP89, CCDC123, CEP123, FLJ14640","Centrosomal protein, 89kD",CEP89,84902,ENSG00000121289,NA,NA,Cep89 (MGI:1919390)
19,32972211,32978228,19q13.11,19q13.11,610884,"C19orf40, FAAP24","Chromosome 19 open reading frame 40 (Fanconi anemia-associated protein, 24kD",FAAP24,91442,ENSG00000131944,NA,NA,Faap24 (MGI:2142208)
19,32978591,33064887,19q13.11,19q13.11,617932,RHPN2,Rhophilin 2,RHPN2,85415,ENSG00000131941,NA,NA,Rhpn2 (MGI:1289234)
19,33194329,33208863,19q12-q13.2,19q13.11,603159,LRP3,Low density lipoprotein receptor related protein 3,LRP3,4037,ENSG00000130881,NA,NA,Lrp3 (MGI:3584516)
19,33208663,33225849,19q13.11,19q13.11,607959,"SLC7A10, ASC1","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 10",SLC7A10,56301,ENSG00000130876,NA,NA,Slc7a10 (MGI:1858261)
19,33299933,33302563,19q13.1,19q13.11,116897,"CEBPA, CEBP","CCAAT/enhancer-binding protein (C/EBP), alpha",CEBPA,1050,ENSG00000245848,germline mutation identified in 1 AML family,"?Leukemia, acute myeloid, 601626 (3), Autosomal dominant, Somatic mutation; Leukemia, acute myeloid, somatic, 601626 (3)",Cebpa (MGI:99480)
19,33373708,33382685,19q13.11,19q13.11,138972,"CEBPG, GPE1BP","CCAAT/enhancer-binding protein, gamma",CEBPG,1054,ENSG00000153879,NA,NA,Cebpg (MGI:104982)
19,33386949,33521790,19cen-q13.11,19q13.11,613230,PEPD,Peptidase D (prolidase),PEPD,5184,ENSG00000124299,closely linked to APOC2,"Prolidase deficiency, 170100 (3), Autosomal recessive",Pepd (MGI:97542)
19,33621952,33773508,19q13.1,19q13.11,610190,"CHST8, GALNAC4ST1, PSS3",Carbohydrate sulfotransferase 8,CHST8,64377,ENSG00000124302,mutation has been identified in 1 PSS3 family,"?Peeling skin syndrome 3, 616265 (3), Autosomal recessive",Chst8 (MGI:1916197)
19,33795539,33815760,19q13.11,19q13.11,615240,KCTD15,Potassium channel tetramerization domain-containing protein 15,KCTD15,79047,ENSG00000153885,NA,NA,Kctd15 (MGI:2385276)
19,34172498,34229514,19q13.11,19q13.11,610677,"LSM14A, RAP55",LSM14A protein,LSM14A,26065,ENSG00000257103,NA,NA,Lsm14a (MGI:1914320)
19,34353329,34402412,19q13.1,19q13.11,172400,GPI,Glucose phosphate isomerase; neuroleukin,GPI,2821,ENSG00000105220,NA,"Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3), Autosomal recessive",Gpi1 (MGI:95797)
19,34404397,34426167,19q13.11,19q13.11,615661,"PDCD2L, MGC13096",Programmed cell death 2-like protein,PDCD2L,84306,ENSG00000126249,NA,NA,Pdcd2l (MGI:1915329)
19,34428175,34471250,19q12,19q13.11,613295,"UBA2, SAE2",Ubiquitin-like modifier-activating enzyme 2,UBA2,10054,ENSG00000126261,NA,NA,Uba2 (MGI:1858313)
19,34481757,34512303,19q13.12,19q13.11,614790,WTIP,WT1-interacting protein,WTIP,126374,ENSG00000142279,NA,NA,Wtip (MGI:2141920)
19,34590624,34594584,19q13.11,19q13.11,615063,SCGB2B2,"Secretoglobin, family 2B, member 2",SCGB2B2,284402,ENSG00000205209,NA,NA,NA
19,34734193,34746482,19q13.2,19q13.11,606741,ZNF181,Zinc finger protein-181,ZNF181,339318,ENSG00000197841,NA,NA,NA
19,35030469,35040448,19q13.1,19q13.11,600235,"SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52","Sodium channel, voltage-gated, type I, beta polypeptide",SCN1B,6324,ENSG00000105711,NA,"Atrial fibrillation, familial, 13, 615377 (3), Autosomal dominant; Brugada syndrome 5, 612838 (3); Cardiac conduction defect, nonspecific, 612838 (3); Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 52, 617350 (3), Autosomal recessive",Scn1b (MGI:98247)
19,35040505,35066572,19q11-q13.2,19q13.11,142440,HPN,Hepsin,HPN,3249,ENSG00000105707,NA,NA,Hpn (MGI:1196620)
19,35115817,35124323,19q13.12,19q13.12,604996,"FXYD3, PLML, MAT8",FXYD domain-containing ion transport regulator 3,FXYD3,5349,ENSG00000089356,NA,NA,Fxyd3 (MGI:107497)
19,35124512,35135058,19q13.11,19q13.12,608303,"LGI4, AMCNMY","Leucine-rich gene, glioma-inactivated, 4",LGI4,163175,ENSG00000153902,NA,"Arthrogryposis multiplex congenita, neurogenic, with myelin defect, 617468 (3), Autosomal recessive",Lgi4 (MGI:2180197)
19,35137205,35143108,19q13.1,19q13.12,602359,"FXYD1, PLM",FXYD domain-containing ion transport regulator 1 (phospholemman),FXYD1,5348,ENSG00000266964,NA,NA,Fxyd1 (MGI:1889273)
19,35143254,35154301,19q13.12,19q13.12,606684,FXYD7,FXYD domain-containing ion transport regulator 7,FXYD7,53822,ENSG00000221946,NA,NA,Fxyd7 (MGI:1889006)
19,35154734,35169884,19q13.12,19q13.12,606669,FXYD5,FXYD domain-containing ion transport regulator 5,FXYD5,53827,ENSG00000089327,NA,NA,Fxyd5 (MGI:1201785)
19,35248655,35267963,19q13.12,19q13.12,616582,LSR,Lipolysis-stimulated lipoprotein receptor,LSR,51599,ENSG00000105699,NA,NA,Lsr (MGI:1927471)
19,35268961,35279820,19q13.1,19q13.12,600390,"USF2, FIP","Upstream transcription factor 2, c-fos interacting",USF2,7392,ENSG00000105698,NA,NA,Usf2 (MGI:99961)
19,35282527,35285142,19q13,19q13.12,606464,"HAMP, LEAP1, HEPC, HFE2B",Hepcidin antimicrobial peptide,HAMP,57817,ENSG00000105697,digenic form with HAMP and HFE mutations,"Hemochromatosis, type 2B, 613313 (3), Autosomal recessive",NA
19,35292085,35313806,19q13.1,19q13.12,159460,"MAG, GMA, SPG75",Myelin-associated glycoprotein,MAG,4099,ENSG00000105695,NA,"Spastic paraplegia 75, autosomal recessive, 616680 (3), Autosomal recessive",Mag (MGI:96912)
19,35329168,35347360,19q13.1,19q13.12,107266,CD22,CD22 antigen,CD22,933,ENSG00000012124,NA,NA,Cd22 (MGI:88322)
19,35351541,35352463,19q13.1,19q13.12,603820,"FFAR1, GPR40",Free fatty acid receptor 1,FFAR1,2864,ENSG00000126266,NA,NA,Ffar1 (MGI:2684079)
19,35358105,35360490,19q13.1,19q13.12,603821,"FFAR3, GPR41",Free fatty acid receptor 3,FFAR3,2865,ENSG00000185897,NA,NA,Ffar3 (MGI:2685324)
19,35371094,35372452,19q13.1,19q13.12,603822,GPR42,G protein-coupled receptor-42,GPR42,2866,ENSG00000126251,NA,NA,NA
19,35448256,35451766,19q13.1,19q13.12,603823,"FFAR2, GPR43",Free fatty acid receptor 2,FFAR2,2867,ENSG00000126262,NA,NA,Ffar2 (MGI:2441731)
19,35487323,35490463,19q13.1,19q13.12,617212,KDAP,Keratinocyte differentiation-associated protein,KRTDAP,388533,ENSG00000188508,NA,NA,Krtdap (MGI:1928282)
19,35497216,35513677,19q13.1,19q13.12,617211,DMKN,Dermokine,DMKN,93099,ENSG00000161249,NA,NA,Dmkn (MGI:1920962)
19,35523366,35528370,19q13.1,19q13.12,609969,SBSN,Suprabasin,SBSN,374897,ENSG00000189001,NA,NA,Sbsn (MGI:2446326)
19,35533455,35545318,19q13.1,19q13.12,609169,"GAPDHS, GAPD2","Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic",GAPDHS,26330,ENSG00000105679,9.5 Mbp prox. to APOE,NA,Gapdhs (MGI:95653)
19,35550030,35563657,19q13.1,19q13.12,137216,"ATP4A, ATP6A","ATPase, H+, K+ transporting, alpha",ATP4A,495,ENSG00000105675,NA,NA,Atp4a (MGI:88113)
19,35612734,35625354,19q13.12,19q13.12,613432,"HAUS5, DGT5, KIAA0841","HAUS augmin-like complex, subunit 5",HAUS5,23354,ENSG00000249115,NA,NA,Haus5 (MGI:1919159)
19,35629015,35637685,19q13.12,19q13.12,613232,RBM42,RNA-binding motif protein 42,RBM42,79171,ENSG00000126254,NA,NA,Rbm42 (MGI:1915285)
19,35641174,35644870,19q13.1,19q13.12,609358,"ETV2, ETSRP71",ETS variant gene 2,ETV2,2116,ENSG00000105672,NA,NA,Etv2 (MGI:99253)
19,35648322,35658781,19q13.1,19q13.12,124089,COX6B1,"Cytochrome c oxidase, subunit VIb polypeptide 1 (ubiquitous)",COX6B1,1340,ENSG00000126267,NA,"Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial",Cox6b1 (MGI:107460)
19,35666515,35678484,19q13.1,19q13.12,611557,"UPK1A, UPIA",Uroplakin 1A,UPK1A,11045,ENSG00000105668,NA,NA,Upk1a (MGI:98911)
19,35704480,35717047,19q13.1,19q13.12,605859,"ZBTB32, FAXF, TZFP, ROG",Zinc finger- and BTB domain-containing protein 32,ZBTB32,27033,ENSG00000011590,NA,NA,Zbtb32 (MGI:1891838)
19,35717817,35738879,19q13.1,19q13.12,606834,"KMT2B, MLL4, KIAA0304, DYT28",Lysine (K)-specific methyltransferase 2B,KMT2B,9757,ENSG00000272333,NA,"Dystonia 28, childhood-onset, 617284 (3), Autosomal dominant",Kmt2b (MGI:109565)
19,35738800,35742451,19q13.12,19q13.12,614143,"IGFLR1, TMEM149",IGF-like family receptor 1,IGFLR1,79713,ENSG00000126246,NA,NA,Igflr1 (MGI:3655979)
19,35742463,35745441,19q13.2,19q13.12,601080,"U2AF1L4, U2AF1RS3",U2 small nuclear RNA auxillary factor 1-like 4,U2AF1L4,199746,ENSG00000161265,NA,NA,NA
19,35745650,35747518,19q13.1,19q13.12,607632,"PSENEN, PEN2, ACNINV2","Presenilin enhancer 2, C. elegans, homolog of",PSENEN,55851,ENSG00000205155,NA,"Acne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3), Autosomal dominant",Psenen (MGI:1913590)
19,35754565,35757028,19q13.13,19q13.12,610695,"HSPB6, HSP20",Heat-shock 27kD protein 6,HSPB6,126393,ENSG00000004776,NA,NA,Hspb6 (MGI:2685325)
19,35775514,35788821,19q13.12,19q13.12,614902,"ARHGAP33, TCGAP",Rho GTPase-activating protein 33,ARHGAP33,115703,ENSG00000004777,NA,NA,Arhgap33 (MGI:2673998)
19,35799986,35813298,19q13.12,19q13.12,616377,"PRODH2, HYPDH",Proline dehydrogenase (oxidase) 2,PRODH2,58510,ENSG00000250799,NA,NA,Prodh2 (MGI:1929093)
19,35825371,35851992,19q13.1,19q13.12,602716,"NPHS1, NPHN",Nephrin,NPHS1,4868,ENSG00000161270,NA,"Nephrotic syndrome, type 1, 256300 (3), Autosomal recessive",Nphs1 (MGI:1859637)
19,35851634,35867145,19q13.1,19q13.12,607762,"KIRREL2, NEPH3, NLG1, FILTRIN",Kin or IRRE-like 2 (nephrin-like 3),KIRREL2,84063,ENSG00000126259,NA,NA,Kirrel2 (MGI:2442334)
19,35868444,35879796,19q13.2,19q13.12,104775,"APLP1, APLP",Amyloid beta (A4) precursor-like protein-1,APLP1,333,ENSG00000105290,NA,NA,Aplp1 (MGI:88046)
19,35902364,35904376,19q13.1,19q13.12,604089,DAP10,DNAX-activation protein 10,HCST,10870,ENSG00000126264,NA,NA,Hcst (MGI:1344360)
19,35904400,35908308,19q13.1,19q13.12,604142,"TYROBP, DAP12, PLOSL1",TYRO protein tyrosine kinase-binding protein,TYROBP,7305,ENSG00000011600,NA,"Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, 221770 (3), Autosomal recessive",Tyrobp (MGI:1277211)
19,35937119,35945194,19q13.2,19q13.12,612809,"LRFN3, SALM4",Leucine-rich repeat and fibronectin type III domain-containing protein 3,LRFN3,79414,ENSG00000126243,NA,NA,Lrfn3 (MGI:2442512)
19,35995187,35996317,19q12-q13.2,19q13.12,612848,SDHAF1,Succinate dehydrogenase complex assembly factor 1,SDHAF1,644096,ENSG00000205138,NA,"Mitochondrial complex II deficiency, 252011 (3), Autosomal recessive",Sdhaf1 (MGI:1915582)
19,36003306,36008812,19q13.12,19q13.12,615535,"SYNE4, NESP4, C19orf46, DFNB76",Spectrin repeat-containing nuclear envelope protein 4,SYNE4,163183,ENSG00000181392,NA,"Deafness, autosomal recessive 76, 615540 (3), Autosomal recessive",Syne4 (MGI:2141950)
19,36009119,36014238,19q13.12,19q13.12,613304,"ALKBH6, ABH6","AlkB, E. coli, homolog of, 6",ALKBH6,84964,ENSG00000239382,NA,NA,Alkbh6 (MGI:2142037)
19,36014659,36032872,19q13,19q13.12,607382,"CLIP3, CLIPR59","CAP-GLY domain-containing linker protein 3, 607382 (3)",CLIP3,25999,ENSG00000105270,NA,NA,Clip3 (MGI:1923936)
19,36034983,36054761,19q13.12,19q13.12,612536,THAP8,THAP domain-containing protein 8,THAP8,199745,ENSG00000161277,NA,NA,NA
19,36054880,36111144,19q13.12,19q13.12,613583,"WDR62, C19orf14, MCPH2",WD repeat-containing protein 62,WDR62,284403,ENSG00000075702,NA,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3), Autosomal recessive",Wdr62 (MGI:1923696)
19,36111179,36113710,19q13.1,19q13.12,616442,OVOL3,ovo-like 3,OVOL3,728361,ENSG00000105261,NA,NA,Ovol3 (MGI:2388075)
19,36113708,36114874,19q12,19q13.12,180662,POLR2I,"Polymerase (RNA) II (DNA directed) polypeptide I, 14.5kD",POLR2I,5438,ENSG00000105258,NA,NA,Polr2i (MGI:1917170)
19,36114985,36125947,19q13.11-q13.12,19q13.12,601303,CKAP1,Cytoskeleton-associated protein 1,TBCB,1155,ENSG00000105254,NA,NA,Tbcb (MGI:1913661)
19,36140065,36150352,19q13.12,19q13.12,114170,"CAPNS1, CAPN4","Calpain, small polypeptide",CAPNS1,826,ENSG00000126247,NA,NA,Capns1 (MGI:88266)
19,36150921,36152446,19q13.12,19q13.12,123995,"COX7A1, COX7AM","Cytochrome c oxidase, subunit VIIa, polypeptide-1, muscle",COX7A1,1346,ENSG00000161281,NA,NA,Cox7a1 (MGI:1316714)
19,36182059,36245927,19q13.12,19q13.12,614275,ZNF565,Zinc finger protein 565,ZNF565,147929,ENSG00000196357,NA,NA,Zfp84 (MGI:107780)
19,36214601,36238773,19q13.1,19q13.12,601505,"ZNF146, OZF",Zinc finger protein-146,ZNF146,7705,ENSG00000167635,NA,NA,Zfp146 (MGI:1347092)
19,36510686,36528487,19q13.12,19q13.12,613749,"ZNF260, PEX1",Zinc finger protein 260,ZNF260,339324,ENSG00000254004,NA,NA,Zfp260 (MGI:1347071)
19,36605312,36634113,19q13.13,19q13.12,609516,"ZNF382, KS1",Zinc finger protein 382,ZNF382,84911,ENSG00000161298,NA,NA,Zfp382 (MGI:3588204)
19,36636617,36666836,19q13.4,19q13.12,608640,"ZNF461, GIOT1",Zinc finger protein-461,ZNF461,92283,ENSG00000197808,NA,NA,NA
19,36916328,36997931,19q13.12,19q13.12,617566,"ZNF568, ZFP568",Zinc finger protein 568,ZNF568,374900,ENSG00000198453,NA,NA,NA
19,37007814,37130367,19q13.12,19q13.12,617216,"ZNF420, APAK",Zinc finger protein 420,ZNF420,147923,ENSG00000197050,NA,NA,Zfp420 (MGI:2444666)
19,37312836,37364454,19q13.12,19q13.12,165250,HKR1,GLI-Kruppel family member HKR1 (oncogene HKR1),ZNF875,284459,ENSG00000181666,NA,NA,NA
19,37411145,37469262,19q13.12,19q13.12,613904,ZNF569,Zinc finger protein 569,ZNF569,148266,ENSG00000196437,NA,NA,Zfp74 (MGI:107784)
19,37551373,37614178,19q13.13,19q13.12,613903,ZNF540,Zinc finger protein 540,ZNF540,163255,ENSG00000171817,NA,NA,NA
19,37631005,37656260,19q13.12,19q13.12,617317,"ZFP30, ZNF745, KIAA0961","Zinc finger protein 30, mouse, homolog of",ZFP30,22835,ENSG00000120784,NA,NA,Zfp30 (MGI:99178)
19,37906821,38208368,19q13.1,19q13.1-q13.2,616655,"SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45",SIPA1-like protein 3,SIPA1L3,23094,ENSG00000105738,mutation identified in 1 CTRCT45 family,"?Cataract 45, 616851 (3), Autosomal recessive",Sipa1l3 (MGI:1921456)
19,38200000,58617616,19q13.2-q13.4,NA,603855,CFM1,Cystic fibrosis modifier-1,CFM1,10167,NA,NA,"{Meconium ileus in cystic fibrosis, susceptibility to}, 603855 (2)",NA
19,38200000,50900000,19q13.2-q13.3,NA,611097,MRT11,"Mental retardation, autosomal recessive, 11",MRT11,100101426,NA,between rs2109075 and rs8101149,"Mental retardation, autosomal recessive, 11, 611097 (2), Autosomal recessive",NA
19,38200000,42900000,19q13.2,NA,227050,TEC,Transient erythroblastopenia of childhood,NA,100124696,NA,NA,"Transient erythroblastopenia of childhood, 227050 (2), Autosomal recessive",NA
19,38200000,50900000,19q13.2-q13.3,NA,165060,"TRNAU1, TRSP",Transfer RNA selenocysteine 1 (anticodon UCA),TRU-TCA1-1,7234,NA,pseudogene on 22,NA,NA
19,38211005,38229713,19q13.13-q13.2,19q13.2,601670,"DPF1, NEUD4","D4, zinc, and double PHD fingers family, member 1",DPF1,8193,ENSG00000011332,NA,NA,Dpf1 (MGI:1352748)
19,38251236,38256373,19q13.1,19q13.2,608153,"PPP1R14A, CPI17","Protein phosphatase 1, regulatory subunit 14A",PPP1R14A,94274,ENSG00000167641,NA,NA,Ppp1r14a (MGI:1931139)
19,38264572,38292614,19q13.1,19q13.2,605124,"SPINT2, HAI2, DIAR3","Serine protease inhibitor, Kunitz-type, 2 (hepatocyte growth factor activator inhibitor 2; bikunin, placental)",SPINT2,10653,ENSG00000167642,NA,"Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3), Autosomal recessive",Spint2 (MGI:1338031)
19,38319844,38332075,19q13.1,19q13.2,603939,"KCNK6, TWIK2, TOSS","Potassium channel, subfamily K, member 6",KCNK6,9424,ENSG00000099337,NA,NA,Kcnk6 (MGI:1891291)
19,38335829,38370942,19q13.1,19q13.2,613452,CATSPERG,"Cation channel, sperm-associated, gamma",CATSPERG,57828,ENSG00000099338,NA,NA,"Catsperg2,Catsperg1 (MGI:2443617,MGI:1923968)"
19,38374549,38383823,19q13.2,19q13.2,617844,PSMD8,"Proteasome 26S subunit, non-ATPase, 8",PSMD8,5714,ENSG00000099341,NA,NA,Psmd8 (MGI:1888669)
19,38384266,38388602,19q13.2,19q13.2,609966,GGN,"Gametogenetin, mouse, homolog of",GGN,199720,ENSG00000179168,NA,NA,Ggn (MGI:2181461)
19,38390060,38399883,19q13.13,19q13.2,609293,SPRED3,Sprouty-related EVH1 domain-containing protein 3,SPRED3,399473,ENSG00000188766,NA,NA,Spred3 (MGI:2142186)
19,38409054,38426304,19q13.1,19q13.2,607320,RASGRP4,Ras guanyl nucleotide-releasing protein 4,RASGRP4,115727,ENSG00000171777,NA,NA,Rasgrp4 (MGI:2386851)
19,38433690,38587563,19q13.1,19q13.2,180901,"RYR1, MHS, CCO","Ryanodine receptor-1, skeletal",RYR1,6261,ENSG00000196218,NA,"Central core disease, 117000 (3), Autosomal recessive, Autosomal dominant; King-Denborough syndrome, 145600 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 1}, 145600 (3), Autosomal dominant; Minicore myopathy with external ophthalmoplegia, 255320 (3), Autosomal recessive; Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3), Autosomal recessive, Autosomal dominant",Ryr1 (MGI:99659)
19,38587640,38617952,19q13.1-q13.4,19q13.2,601983,"MAP4K1, HPK1",Mitogen-activated protein kinase kinase kinase kinase 1,MAP4K1,11184,ENSG00000104814,NA,NA,Map4k1 (MGI:1346882)
19,38619187,38636953,19q13.2,19q13.2,609596,"EIF3K, PLAC24, EIF3S12","Eukaryotic translation initiation factor 3, subunit K",EIF3K,27335,ENSG00000178982,NA,NA,Eif3k (MGI:1921080)
19,38647648,38731588,19q13,19q13.2,604638,"ACTN4, FSGS1, FSGS","Actinin, alpha-4",ACTN4,81,ENSG00000130402,NA,"Glomerulosclerosis, focal segmental, 1, 603278 (3), Autosomal dominant",Actn4 (MGI:1890773)
19,38730047,38744473,19q13,19q13.2,608839,CAPN12,Calpain 12,CAPN12,147968,ENSG00000182472,NA,NA,Capn12 (MGI:1891369)
19,38770967,38773516,19q13.2,19q13.2,600615,LGALS7,"Lectin, galactoside-binding, soluble, 7 (galectin 7)",LGALS7,3963,ENSG00000205076,NA,NA,Lgals7 (MGI:1316742)
19,38789199,38791753,19q13.2,19q13.2,617139,LGALS7B,"Lectin, galactoside-binding, soluble, 7B",LGALS7B,653499,ENSG00000178934,NA,NA,Lgals7 (MGI:1316742)
19,38801670,38813613,19q13.2,19q13.2,602518,LGALS4,"Lectin, galactoside-binding, soluble, 4",LGALS4,3960,ENSG00000171747,NA,NA,Lgals4 (MGI:107536)
19,38815421,38831793,19q13,19q13.2,600696,ECH1,"Enoyl Coenzyme A hydratase 1, peroxisomal",ECH1,1891,ENSG00000104823,NA,NA,Ech1 (MGI:1858208)
19,38836369,38852346,19q13.2,19q13.2,603083,"HNRNPL, HNRPL",Heterogeneous nuclear riboprotein 1,HNRNPL,3191,ENSG00000104824,NA,NA,Hnrnpl (MGI:104816)
19,38878554,38899861,19q,19q13.2,604480,"SIRT2, SIR2L, SIR2L2","Sirtuin, S. cerevisiae, homolog 2",SIRT2,22933,ENSG00000068903,NA,NA,Sirt2 (MGI:1927664)
19,38899502,38908893,19q13.1,19q13.2,604495,"NFKBIB, IKBB, TRIP9","Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, beta",NFKBIB,4793,ENSG00000104825,NA,NA,Nfkbib (MGI:104752)
19,38908170,38914370,19q13.2,19q13.2,617634,CCER2,Coiled-coil glutamate-rich protein 2,CCER2,643669,ENSG00000262484,NA,NA,Ccer2 (MGI:3645242)
19,38915265,38930762,19q13.2,19q13.2,612804,SARS2,Seryl-tRNA synthetase 2,SARS2,54938,ENSG00000104835,NA,"Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3), Autosomal recessive",Sars2 (MGI:1919234)
19,38930707,38933019,19q13.1,19q13.2,603021,"MRPS12, RPSM12","Ribosomal protein, mitochondrial, S12",MRPS12,6183,ENSG00000128626,NA,NA,Mrps12 (MGI:1346333)
19,38941400,38975812,19q13.2,19q13.2,609094,"FBXO17, FBX17, FBX26, FBG4",F-box only protein 17,FBXO17,115290,ENSG00000269190,NA,NA,Fbxo17 (MGI:1354707)
19,39007063,39032554,19q13.2,19q13.2,609099,"FBXO27, FBX27, FBG5",F-box only protein 27,FBXO27,126433,ENSG00000161243,NA,NA,Fbxo27 (MGI:2685007)
19,39083010,39112073,19q13.2,19q13.2,610490,"PAPL, FLJ16165","Purple acid phosphatase, long form",ACP7,390928,ENSG00000183760,NA,NA,Acp7 (MGI:2142121)
19,39125785,39182815,19q13.2,19q13.2,605451,PAK4,p21-activated kinase 4,PAK4,10298,ENSG00000130669,NA,NA,Pak4 (MGI:1917834)
19,39196963,39201883,19q13.2,19q13.2,615901,"NCCRP1, FBXO50","Nonspecific cytotoxic cell receptor protein 1, zebrafish, homolog of",NCCRP1,342897,ENSG00000188505,NA,NA,Nccrp1 (MGI:2685009)
19,39243552,39245076,19q13.13,19q13.2,607402,"IFNL3, IL28B","Interferon, lambda 3",IFNL3,282617,ENSG00000197110,NA,"{Hepatitis C virus infection, response to therapy of}, 609532 (3)","Ifnl2,Ifnl3 (MGI:3647279,MGI:2450574)"
19,39246313,39248855,19q13.13,19q13.2,615090,IFNL4,"Interferon, lambda-4",IFNL4,101180976,ENSG00000272395,NA,NA,NA
19,39268516,39270091,19q13.13,19q13.2,607401,"IFNL2, IL28A","Interferon, lambda 2",IFNL2,282616,ENSG00000183709,NA,NA,NA
19,39296406,39298672,19q13.13,19q13.2,607403,"IFNL1, IL29","Interferon, lambda 1",IFNL1,282618,ENSG00000182393,NA,NA,NA
19,39306816,39320866,19q13.2,19q13.2,612807,"LRFN1, SALM2, KIAA1484",Leucine-rich repeat and fibronectin type III domain-containing protein 1,LRFN1,57622,ENSG00000128011,NA,NA,Lrfn1 (MGI:2136810)
19,39328358,39336042,19q13.2,19q13.2,604104,GMFG,"Glia maturation factor, gamma",GMFG,9535,ENSG00000130755,NA,NA,"Gmfg,Gmfg-ps (MGI:1927135,MGI:3704264)"
19,39385628,39391194,19q13.2,19q13.2,610506,"PAF1, PD2","PAF1 RNA polymerase II-associated factor, S. cerevisiae, homolog of",PAF1,54623,ENSG00000006712,NA,NA,Paf1 (MGI:1923988)
19,39391377,39400640,19q13.2,19q13.2,612914,"MED29, IXL",Mediator complex subunit 29,MED29,55588,ENSG00000063322,NA,NA,Med29 (MGI:1914474)
19,39406846,39409406,19q13.1,19q13.2,190700,"ZFP36, TTP","Zfp36, mouse, homolog of",ZFP36,7538,ENSG00000128016,NA,NA,Zfp36 (MGI:99180)
19,39412581,39428414,19q13.1,19q13.2,611893,"PLEKHG2, CLG, LDAMD",Pleckstrin homology domain- and RhoGEF domain-containing protein G2,PLEKHG2,64857,ENSG00000090924,NA,"Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3), Autosomal recessive",Plekhg2 (MGI:2141874)
19,39433136,39435948,19q,19q13.2,603675,RPS16,Ribosomal protein S16,RPS16,6217,ENSG00000105193,NA,NA,Rps16 (MGI:98118)
19,39445545,39476669,19q13.1-q13.2,19q13.2,602102,"SUPT5H, SPT5","Suppressor of Ty 5, S. cerevisiae, homolog of",SUPT5H,6829,ENSG00000196235,NA,NA,Supt5 (MGI:1202400)
19,39480837,39493778,19q13.2,19q13.2,607381,"TIMM50, TIM50, MGCA9","Translocase of inner mitochondrial membrane 50, yeast, homolog of",TIMM50,92609,ENSG00000105197,NA,"3-methylglutaconic aciduria, type IX, 617698 (3), Autosomal recessive",Timm50 (MGI:1913775)
19,39498946,39508468,19q13,19q13.2,602768,"DLL3, SCDO1","Delta, Drosophila, homolog of",DLL3,10683,ENSG00000090932,NA,"Spondylocostal dysostosis 1, autosomal recessive, 277300 (3), Autosomal recessive",Dll3 (MGI:1096877)
19,39515112,39520685,19q13.13,19q13.2,607919,"SELENOV, SELV",Selenoprotein V,SELENOV,348303,ENSG00000186838,NA,NA,Selenov (MGI:3608324)
19,39538706,39540160,19q13.2,19q13.2,609773,"EID2, CRI2",EP300-interacting inhibitor of differentiation 2,EID2,163126,ENSG00000176396,NA,NA,Eid2 (MGI:2681174)
19,39602410,39607473,19q13.1,19q13.2,608717,"LGALS13, GAL13, PP13","Lectin, galactoside-binding, soluble, 13",LGALS13,29124,ENSG00000105198,NA,NA,NA
19,39704480,39709443,19q13.2,19q13.2,607260,PPL13,Placental protein 13-like protein,LGALS14,56891,ENSG00000006659,NA,NA,NA
19,39731254,39738028,19q13.1,19q13.2,153310,CLC,Charcot-Leyden crystal protein,CLC,1178,ENSG00000105205,NA,NA,NA
19,39825346,39834232,19q12-q13.11,19q13.2,604556,"DYRK1B, MIRK, AOMS3",Dual-specificity tyrosine phosphorylation-regulated kinase 1B,DYRK1B,9149,ENSG00000105204,NA,"Abdominal obesity-metabolic syndrome 3, 615812 (3), Autosomal dominant",Dyrk1b (MGI:1330302)
19,39834457,39846394,19q13.2,19q13.2,134795,FBL,Fibrillarin,FBL,2091,ENSG00000105202,NA,NA,Fbl (MGI:95486)
19,39863322,39934625,19q13.2,19q13.2,617553,FCGBP,Fc fragment of IgG-binding protein,FCGBP,8857,ENSG00000275395,NA,NA,Fcgbp (MGI:2444336)
19,39971004,39981763,19q13.11-q13.13,19q13.2,602707,"PSMC4, TBP7, S6","Proteasome 26S subunit, ATPase, 4",PSMC4,5704,ENSG00000013275,NA,NA,Psmc4 (MGI:1346093)
19,40191425,40215574,19q13.1-q13.2,19q13.2,600137,"MAP3K10, MLK2, MST",Mitogen-activated protein kinase kinase kinase 10,MAP3K10,4294,ENSG00000130758,NA,NA,Map3k10 (MGI:1346879)
19,40230316,40285530,19q13.1-q13.2,19q13.2,164731,"AKT2, HIHGHH",Murine thymoma viral (v-akt) homolog-2,AKT2,208,ENSG00000105221,NA,"Diabetes mellitus, type II, 125853 (3), Autosomal dominant; Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3), Autosomal dominant",Akt2 (MGI:104874)
19,40348394,40378489,19q13.2,19q13.2,615698,"PLD3, HUK4, SCA46","Phospholipase D family, member 3",PLD3,23646,ENSG00000105223,mutation identified in 1 SCA46 family,"?Spinocerebellar ataxia 46, 617770 (3), Autosomal dominant",Pld3 (MGI:1333782)
19,40379270,40390864,19q13.2,19q13.2,611712,HIPK4,Homeodomain-interacting protein kinase 4,HIPK4,147746,ENSG00000160396,NA,NA,Hipk4 (MGI:2685008)
19,40393761,40414717,19q13.1-q13.2,19q13.2,605725,"PRX, CMT4F",Periaxin,PRX,57716,ENSG00000105227,NA,"Charcot-Marie-Tooth disease, type 4F, 614895 (3), Autosomal recessive; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant",Prx (MGI:108176)
19,40421588,40425991,19q13.2,19q13.2,617850,"SERTAD1, TRIPBR1",SERTA domain-containing protein 1,SERTAD1,29950,ENSG00000197019,NA,NA,Sertad1 (MGI:1913438)
19,40440840,40444334,19q13.1,19q13.2,612125,"SERTAD3, RBT1",SERTA domain-containing 3,SERTAD3,29946,ENSG00000167565,NA,NA,Sertad3 (MGI:2180697)
19,40447767,40465744,19q13.13-q13.2,19q13.2,600941,"BLVRB, BVRB, FLR",Biliverdin reductase B,BLVRB,645,ENSG00000090013,NA,NA,Blvrb (MGI:2385271)
19,40467000,40576463,19q13.13,19q13.2,606214,"SPTBN4, QV, NEDHND, CMND","Spectrin, beta, nonerythrocytic, 4 (quivering, mouse, homolog of)",SPTBN4,57731,ENSG00000160460,NA,"Neurodevelopmental disorder with hypotonia, neuropathy, and deafness, 617519 (3), Autosomal recessive",Sptbn4 (MGI:1890574)
19,40576863,40591398,19q13.2,19q13.2,617322,"SHKBP1, SB1",SH3KBP1-binding protein 1,SHKBP1,92799,ENSG00000160410,NA,NA,Shkbp1 (MGI:2385803)
19,40593165,40629819,19q13.1-q13.2,19q13.2,604710,"LTBP4, LTBP4S, LTBP4L, ARCL1C",Latent transforming growth factor-beta-binding protein 4,LTBP4,8425,ENSG00000090006,NA,"Cutis laxa, autosomal recessive, type IC, 613177 (3), Autosomal recessive",Ltbp4 (MGI:1321395)
19,40665904,40690650,19q13.13-q13.2,19q13.2,604018,"NUMBL, NUMBR, NBL","Numb, Drosophila, homolog-like",NUMBL,9253,ENSG00000105245,NA,NA,Numbl (MGI:894702)
19,40691529,40716885,19q13.1,19q13.2,615567,"COQ8B, ADCK4, NPHS9",Coenzyme Q8B,COQ8B,79934,ENSG00000123815,NA,"Nephrotic syndrome, type 9, 615573 (3), Autosomal recessive",Coq8b (MGI:1924139)
19,40717111,40740859,19q13.2,19q13.2,606476,ITPKC,"Inositol 1,4,5-trisphosphate 3-kinase C",ITPKC,80271,ENSG00000086544,NA,"{Kawasaki disease, susceptibility to}, 611775 (3)",Itpkc (MGI:2442554)
19,40751202,40765388,19q13.1,19q13.2,182285,SNRPA,Small nuclear ribonucleoprotein polypeptide A,SNRPA,6626,ENSG00000077312,NA,NA,NA
19,40775159,40777489,19q13.32-q13.33,19q13.2,601340,MIA,Melanoma inhibitory activity,MIA,8190,ENSG00000261857,NA,NA,Mia (MGI:109615)
19,40778246,40796941,19q13.2-q13.3,19q13.2,612945,RAB4B,Ras-associated protein RAB4B,RAB4B,53916,ENSG00000167578,NA,NA,Rab4b (MGI:105071)
19,40799190,40808433,19q13.2,19q13.2,606424,"EGLN2, PHD1, HIFPH1","Egl9, C. elegans, homolog of, 2",EGLN2,112398,ENSG00000269858,NA,NA,Egln2 (MGI:1932287)
19,40843540,40850446,19q13.2,19q13.2,122720,"CYP2A6, CYP2A3, CYP2A, P450C2A","Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6",CYP2A6,1548,ENSG00000255974,NA,"Coumarin resistance, 122700 (3), Autosomal dominant; {Lung cancer, resistance to}, 211980 (3), Autosomal dominant, Somatic mutation; {Nicotine addiction, protection from}, 188890 (3)","Cyp2a4,Cyp2a5 (MGI:88597,MGI:88596)"
19,40875438,40885950,19q13.2,19q13.2,608054,CYP2A7,"Cytochrome P450, subfamily IIA, polypeptide 7",CYP2A7,1549,ENSG00000198077,NA,NA,"Cyp2a4,Cyp2a5 (MGI:88597,MGI:88596)"
19,40890825,40900507,19q13.2,19q13.2,601133,CYP2G1,"Cytochrome P450, subfamily IIG, polypeptide 1",CYP2G1P,22952,ENSG00000130612,NA,NA,NA
19,40991281,41018397,19q13.2,19q13.2,123930,"CYP2B6, CYP2B, EFVM","Cytochrome P450, family 2, subfamily B, polypeptide 6",CYP2B6,1555,ENSG00000197408,same NotI fragment as CYP2A,"{Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3); Efavirenz, poor metabolism of, 614546 (3)",Cyp2b10 (MGI:88598)
19,41088450,41096194,19q13.2,19q13.2,608055,CYP2A13,"Cytochrome P450, subfamily IIA, polypeptide 13",CYP2A13,1553,ENSG00000197838,NA,NA,"Cyp2a4,Cyp2a5 (MGI:88597,MGI:88596)"
19,41114291,41128380,19q13.2,19q13.2,124070,CYP2F1,"Cytochrome P450, subfamily IIF, polypeptide 1",CYP2F1,1572,ENSG00000197446,"CYP2A, CYP2B, CYP2F1 in 240kb",NA,Cyp2f2 (MGI:88608)
19,41193218,41207538,19q13.2,19q13.2,611529,CYP2S1,"Cytochrome P450, family 2, subfamily S, polypeptide 1",CYP2S1,29785,ENSG00000167600,NA,NA,Cyp2s1 (MGI:1921384)
19,41219222,41261766,19q13.1-q13.2,19q13.2,109135,AXL,AXL transforming sequence (a receptor tyrosine kinase),AXL,558,ENSG00000167601,NA,NA,Axl (MGI:1347244)
19,41262518,41307786,19q13.2,19q13.2,605800,"HNRNPUL1, HNRPUL1, E1BAP5",Heterogeneous nuclear ribonucleoprotein U-like 1,HNRNPUL1,11100,ENSG00000105323,NA,NA,Hnrnpul1 (MGI:2443517)
19,41330322,41353921,19q13.1,19q13.2,190180,"TGFB1, DPD1, CED, IBDIMDE","Transforming growth factor, beta-1",TGFB1,7040,ENSG00000105329,NA,"Camurati-Engelmann disease, 131300 (3), Autosomal dominant; {Cystic fibrosis lung disease, modifier of}, 219700 (3), Autosomal recessive; Inflammatory bowel disease, immunodeficiency, and encephalopathy, 618213 (3), Autosomal recessive",Tgfb1 (MGI:98725)
19,41354416,41364533,19q13.2,19q13.2,611951,"B9D2, MKS10, JBTS34",B9 domain-containing protein 2,B9D2,80776,ENSG00000123810,mutation identified in 1 MKS10 family,"Joubert syndrome 34, 614175 (3), Autosomal recessive; ?Meckel syndrome 10, 614175 (3), Autosomal recessive",B9d2 (MGI:2387643)
19,41363946,41384082,19q13.2,19q13.2,618294,"TMEM91, DSPC3",Transmembrane protein 91,TMEM91,641649,ENSG00000142046,NA,NA,Tmem91 (MGI:2443589)
19,41386373,41397358,19q13.2,19q13.2,606492,"EXOSC5, RRP46",Exosome component 5,EXOSC5,56915,ENSG00000077348,NA,NA,Exosc5 (MGI:107889)
19,41397817,41425001,19q13.1-q13.2,19q13.2,608348,"BCKDHA, MSUD1","Branched chain keto acid dehydrogenase E1, alpha polypeptide",BCKDHA,593,ENSG00000248098,NA,"Maple syrup urine disease, type Ia, 248600 (3), Autosomal recessive",Bckdha (MGI:107701)
19,41425358,41429023,19q13.2,19q13.2,615357,"B3GNT8, BGALT15, B3GALT7","Beta-1,3-galactosyltransferase 8",B3GNT8,374907,ENSG00000177191,NA,NA,B3gnt8 (MGI:2385269)
19,41431317,41447821,19q13.2,19q13.2,617262,ATP5SL,ATP5S-like protein,DMAC2,55101,ENSG00000105341,NA,NA,Dmac2 (MGI:1913599)
19,41454168,41500648,19q13,19q13.2,618192,"PCAT19, LINC01190","Prostate cancer-associated transcript 19, noncoding",PCAT19,100505495,ENSG00000267107,NA,NA,NA
19,41549235,41586843,19q13,19q13.2,618191,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,CEACAM21,90273,ENSG00000007129,NA,NA,NA
19,41708625,41730432,19q13.2,19q13.2,114890,"CEACAM5, CEA",Carcinoembryonic antigen-related cell adhesion molecule 5,CEACAM5,1048,ENSG00000105388,proximal to PSG cluster in 1.1-1.2Mb segment,NA,NA
19,41755528,41772210,19q13.2,19q13.2,163980,"CEACAM6, NCA",Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific crossreacting antigen),CEACAM6,4680,ENSG00000086548,in CEA cluster,NA,NA
19,41844742,41852332,19q13.2,19q13.2,614806,DMRTC2,Doublesex- and MAB3-related transcription factor C2,DMRTC2,63946,ENSG00000142025,NA,NA,Dmrtc2 (MGI:1918491)
19,41860254,41872924,19q13.2,19q13.2,603474,"RPS19, DBA, DBA1",Ribosomal protein S19,RPS19,6223,ENSG00000105372,NA,"Diamond-Blackfan anemia 1, 105650 (3), Autosomal dominant",Rps19 (MGI:1333780)
19,41877119,41881371,19q13.2,19q13.2,112205,"CD79A, IGA",CD79A antigen (immunoglobulin-associated alpha),CD79A,973,ENSG00000105369,NA,"Agammaglobulinemia 3, 613501 (3), Autosomal recessive",Cd79a (MGI:101774)
19,41883183,41907451,19q13.13,19q13.2,601855,"ARHGEF1, LBCL2, IMD62","Rho guanine nucleotide exchange factor, 115-kD",ARHGEF1,9138,ENSG00000076928,mutation identified in 1 IMD62 family,"?Immunodeficiency 62, 618459 (3), Autosomal recessive",Arhgef1 (MGI:1353510)
19,41956682,41959320,19q13.2,19q13.2,604925,PRA1,Prenylated RAB acceptor 1,RABAC1,10567,ENSG00000105404,NA,NA,Rabac1 (MGI:1201692)
19,41966581,41994229,19q12-q13.2,19q13.2,182350,"ATP1A3, DYT12, RDP, AHC2, CAPOS","ATPase, Na+K+ transporting, alpha-3 polypeptide",ATP1A3,478,ENSG00000105409,NA,"Alternating hemiplegia of childhood 2, 614820 (3), Autosomal dominant; CAPOS syndrome, 601338 (3), Autosomal dominant; Dystonia-12, 128235 (3), Autosomal dominant",Atp1a3 (MGI:88107)
19,41998315,42071803,19q13.2,19q13.2,600283,GRIK5,"Glutamate receptor, ionotropic, kainate 5",GRIK5,2901,ENSG00000105737,NA,NA,Grik5 (MGI:95818)
19,42086112,42197930,19q13.2,19q13.2,164176,"POU2F2, OTF2, OCT2","POU domain, class 2, transcription factor 2",POU2F2,5452,ENSG00000028277,NA,NA,Pou2f2 (MGI:101897)
19,42198597,42220151,19q13.2,19q13.2,617078,"DEDD2, FLAME3",Death effector domain-containing protein 2,DEDD2,162989,ENSG00000160570,NA,NA,Dedd2 (MGI:1914629)
19,42220311,42228200,19q13.2,19q13.2,614387,"ZNF526, KIAA1951",Zinc finger protein 526,ZNF526,116115,ENSG00000167625,NA,NA,Zfp526 (MGI:2445181)
19,42230185,42243329,19q13.2,19q13.2,606784,GSK3A,Glycogen synthase kinase 3-alpha,GSK3A,2931,ENSG00000105723,NA,NA,Gsk3a (MGI:2152453)
19,42247560,42255127,19q13.1,19q13.2,611888,"ERF, PE2, CRS4, CHYTS",ETS2 repressor factor,ERF,2077,ENSG00000105722,NA,"Chitayat syndrome, 617180 (3), Autosomal dominant; Craniosynostosis 4, 600775 (3), Autosomal dominant",Erf (MGI:109637)
19,42268536,42295795,19q13.2,19q13.2,612082,"CIC, KIAA0306, MRD45","Capicua, Drosophila, homolog of",CIC,23152,ENSG00000079432,NA,"Mental retardation, autosomal dominant 45, 617600 (3), Autosomal dominant",Cic (MGI:1918972)
19,42297032,42302799,19q13.1,19q13.2,603074,PAFAH1B3,"Platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit",PAFAH1B3,5050,ENSG00000079462,NA,NA,Pafah1b3 (MGI:108414)
19,42325634,42378764,19q12,19q13.2,604267,"MEGF8, EGFL4, CRPT2",Multiple epidermal growth factor-like domains 8,MEGF8,1954,ENSG00000105429,NA,"Carpenter syndrome 2, 614976 (3), Autosomal recessive",Megf8 (MGI:2446294)
19,42387018,42390317,19q13,19q13.2,611764,CNFN,Cornifelin,CNFN,84518,ENSG00000105427,NA,NA,Cnfn (MGI:1919633)
19,42401511,42427420,19q13.1-q13.2,19q13.2,151750,"LIPE, LHS, FPLD6","Lipase E, hormone-sensitive",LIPE,3991,ENSG00000079435,NA,"Lipodystrophy, familial partial, type 6, 615980 (3), Autosomal recessive",Lipe (MGI:96790)
19,42428277,42443047,19q11,19q13.2,611387,"CXCL17, VCC1, DMC",Chemokine (C-X-C motif) ligand 17,CXCL17,284340,ENSG00000189377,NA,NA,Cxcl17 (MGI:2387642)
19,42507305,42528481,19q13.2,19q13.2,109770,"CEACAM1, BGP",Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein),CEACAM1,634,ENSG00000079385,in CEA cluster,NA,"Ceacam1,Ceacam2 (MGI:1347246,MGI:1347245)"
19,42580242,42595156,19q13.2,19q13.2,615747,"CEACAM8, CD66B, CGM6",Carcinoembryonic antigen-related cell adhesion molecule 8,CEACAM8,1088,ENSG00000124469,NA,NA,NA
19,42721641,42740485,19q13.2,19q13.2,176392,PSG3,Pregnancy-specific beta-1-glycoprotein-3,PSG3,5671,ENSG00000221826,NA,NA,NA
19,42752685,42765691,19q13.2,19q13.2,176397,PSG8,Pregnancy-specific beta-1-glycoprotein-8,PSG8,440533,ENSG00000124467,NA,NA,NA
19,42836996,42855717,19q13.2,19q13.2,176399,"PSG10, PSG12",Pregnancy-specific beta-1-glycoprotein-10,PSG10P,653492,NA,NA,NA,NA
19,42866463,42879712,19q13.2,19q13.2,176390,"PSG1, PSBG1, B1G1, SP1",Pregnancy-specific beta-1-glycoprotein-1,PSG1,5669,ENSG00000231924,distal to CEA,NA,NA
19,42902085,42917893,19q13.2,19q13.31,176395,PSG6,Pregnancy-specific beta-1-glycoprotein-6,PSG6,5675,ENSG00000170848,NA,NA,NA
19,42924131,42937206,19q13.2,19q13.31,176396,PSG7,Pregnancy-specific beta-1-glycoprotein-7,PSG7,5676,ENSG00000221878,NA,NA,NA
19,43007655,43026468,19q13.2,19q13.31,176401,"PSG11, PSG13, PSG14",Pregnancy-specific beta-1-glycoprotein-11,PSG11,5680,ENSG00000243130,NA,NA,NA
19,43064208,43082700,19q13.2,19q13.31,176391,"PSG2, PSBG2",Pregnancy-specific beta-1-glycoprotein-2,PSG2,5670,ENSG00000242221,NA,NA,NA
19,43167742,43186535,19q13.2,19q13.31,176394,PSG5,Pregnancy-specific beta-1-glycoprotein-5,PSG5,5673,ENSG00000204941,NA,NA,NA
19,43192701,43205773,19q13.2,19q13.31,176393,PSG4,Pregnancy-specific beta-1-glycoprotein-4,PSG4,5672,ENSG00000243137,NA,NA,NA
19,43253281,43269529,19q13.2,19q13.31,176398,"PSG9, PSG11",Pregnancy-specific beta-1-glycoprotein-9,PSG9,5678,ENSG00000183668,NA,NA,NA
19,43349055,43349547,19q13.2,19q13.31,605157,PRG1,p53-responsive gene 1,NA,23574,NA,NA,NA,NA
19,43353685,43366062,19q13.2,19q13.31,162860,"NB1, PRV1, CD177, HNA2A",Neutrophil-specific antigen 1,CD177,57126,ENSG00000204936,NA,NA,Cd177 (MGI:1916141)
19,43388610,43418614,19q13.31,19q13.31,612665,"TEX101, SGRG, TES101RP",Testis-expressed gene 101,TEX101,83639,ENSG00000131126,NA,NA,Tex101 (MGI:1930791)
19,43460786,43465607,19q13.1-q13.2,19q13.31,609484,LYPD3,LY6/PLAUR domain-containing protein 3,LYPD3,27076,ENSG00000124466,NA,NA,Lypd3 (MGI:1919684)
19,43506718,43527200,19q13.32,19q13.31,608451,"ETHE1, HSCO, D83198",ETHE1 gene,ETHE1,23474,ENSG00000105755,NA,"Ethylmalonic encephalopathy, 602473 (3), Autosomal recessive",Ethe1 (MGI:1913321)
19,43543311,43575577,19q13.2,19q13.31,194360,"XRCC1, SCAR26","X-ray-repair, complementing defective, repair in Chinese hamster cells-1",XRCC1,7515,ENSG00000073050,mutation identified in 1 SCAR26 patient,"?Spinocerebellar ataxia, autosomal recessive 26, 617633 (3), Autosomal recessive",Xrcc1 (MGI:99137)
19,43622367,43641983,19q13.2,19q13.31,609744,"CADM4, IGSF4C, TSLL2, NECL4, SYNCAM4",Cell adhesion molecule 4,CADM4,199731,ENSG00000105767,NA,NA,Cadm4 (MGI:2449088)
19,43646094,43670345,19q13,19q13.31,173391,"PLAUR, URKR","Plasminogen activator, urokinase, receptor",PLAUR,5329,ENSG00000011422,NA,NA,Plaur (MGI:97612)
19,43727982,43754961,19q13.31,19q13.31,613176,"C19orf61, SMG9, HBMS",Chromosome 19 open reading frame 61,SMG9,56006,ENSG00000105771,NA,"Heart and brain malformation syndrome, 616920 (3), Autosomal recessive",Smg9 (MGI:1919247)
19,43766532,43782138,19q13.2,19q13.31,602754,"KCNN4, KCA4, SK4, DHS2","Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4",KCNN4,3783,ENSG00000104783,NA,"Dehydrated hereditary stomatocytosis 2, 616689 (3), Autosomal dominant",Kcnn4 (MGI:1277957)
19,43912623,43935314,19q13.2,19q13.31,194554,"ZNF45, ZNF13, KOX5",Zinc finger protein-45,ZNF45,7596,ENSG00000124459,NA,NA,NA
19,43967005,43998325,19q13.2-q13.32,19q13.31,604086,ZNF155,Zinc finger protein-155,ZNF155,7711,ENSG00000204920,NA,NA,NA
19,44025323,44033109,19q13.2,19q13.31,617357,ZNF222,Zinc finger protein 222,ZNF222,7673,ENSG00000159885,NA,NA,NA
19,44094349,44109885,19q13.2-qter,19q13.31,194555,"ZNF224, ZNF255, BMZF2, KOX22, ZNF27",Zinc finger protein-224,ZNF224,7767,ENSG00000267680,NA,NA,NA
19,44141529,44160312,19q13.31,19q13.31,604750,"ZNF234, ZNF269, HZF4",Zinc finger protein 234,ZNF234,10780,ENSG00000263002,NA,NA,NA
19,44286347,44305706,19q13.2,19q13.31,604749,"ZFP93, ANF270, HZF6","Zinc finger protein 93, mouse, homolog of",ZNF235,9310,ENSG00000159917,NA,NA,Zfp235 (MGI:1929117)
19,44326552,44367214,19p13.1-p12,19q13.31,603994,ZNF112,Zinc finger protein-112,ZNF112,7771,ENSG00000062370,NA,NA,Zfp112 (MGI:1929115)
19,44474442,44500521,19q13.2,19q13.31,606740,ZNF180,Zinc finger protein-180,ZNF180,7733,ENSG00000167384,NA,NA,Zfp180 (MGI:1923701)
19,44643797,44666161,19q13.2-q13.3,19q13.31,173850,"PVR, PVS",Polio virus receptor,PVR,5817,ENSG00000073008,NA,NA,NA
19,44671451,44684354,19q13.31,19q13.31,606691,"CEACAM19, CEAL1",Carcinoembryonic antigen related cell adhesion molecule 19,CEACAM19,56971,ENSG00000186567,NA,NA,Ceacam19 (MGI:2443001)
19,44699150,44710717,19q13.31,19q13.31-q13.32,614591,"CEACAM16, CEAL2, DFNA4B, DFNB113",Carcinoembryonic antigen-related cell adhesion molecule 16,CEACAM16,388551,ENSG00000213892,NA,"Deafness, autosomal dominant 4B, 614614 (3), Autosomal dominant; Deafness, autosomal recessive 113, 618410 (3), Autosomal recessive",Ceacam16 (MGI:2685615)
19,44742619,44760043,19q13,19q13.32,109560,BCL3,B-cell CLL/lymphoma-3,BCL3,602,ENSG00000069399,NA,"Leukemia/lymphoma, B-cell, 3, 109560 (2)",Bcl3 (MGI:88140)
19,44777854,44800651,19q13.2,19q13.32,608453,CBLC,CAS-BR-M murine ecotropic retroviral transforming sequence C,CBLC,23624,ENSG00000142273,NA,NA,Cblc (MGI:1931457)
19,44809058,44821420,19q13.2,19q13.32,612773,"LU, AU, BCAM",B-cell adhesion molecule,BCAM,4059,ENSG00000187244,linked to SE,"[Blood group, Auberger system], 111200 (3); [Blood group, Lutheran null], 247420 (3), Autosomal recessive; [Blood group, Lutheran system], 111200 (3)",Bcam (MGI:1929940)
19,44846296,44889222,19q13.2,19q13.32,600798,"NECTIN2, PVRL2, HVEB, PVRR2, PRR2",Nectin 2,NECTIN2,5819,ENSG00000130202,NA,NA,Nectin2 (MGI:97822)
19,44891219,44903688,19q13.2,19q13.32,608061,"TOMM40, TOM40, PEREC1","Translocase of outer mitochondrial membrane 40, yeast, homolog of",TOMM40,10452,ENSG00000130204,NA,NA,Tomm40 (MGI:1858259)
19,44905795,44909394,19q13.2,19q13.32,107741,"APOE, AD2, LPG, LDLCQ5",Apolipoprotein E,APOE,348,ENSG00000130203,possible 2nd locus for AD2 on chr.19,"Alzheimer disease-2, 104310 (3), Autosomal dominant; {Coronary artery disease, severe, susceptibility to}, 617347 (3); Hyperlipoproteinemia, type III, 617347 (3); Lipoprotein glomerulopathy, 611771 (3); {?Macular degeneration, age-related}, 603075 (3), Autosomal dominant; Sea-blue histiocyte disease, 269600 (3), Autosomal recessive",Apoe (MGI:88057)
19,44914324,44919345,19q13.2,19q13.32,107710,APOC1,Apolipoprotein C-I,APOC1,341,ENSG00000130208,NA,NA,NA
19,44942236,44945495,19q13.2,19q13.32,600745,APOC4,Apolipoprotein C-IV,APOC4,346,ENSG00000267467,555bp upstream of APOC2,NA,Apoc4 (MGI:87878)
19,44946050,44949564,19q13.2,19q13.32,608083,APOC2,Apolipoprotein C-II,APOC2,344,ENSG00000234906,NA,"Hyperlipoproteinemia, type Ib, 207750 (3), Autosomal recessive",Apoc2 (MGI:88054)
19,44954584,44993345,19q13.3,19q13.32,604783,CLPTM1,Cleft lip and palate-associated transmembrane protein 1,CLPTM1,1209,ENSG00000104853,NA,NA,Clptm1 (MGI:1927155)
19,45001448,45038193,19q13.32,19q13.32,604758,"RELB, IREL, IMD53",v-rel avian reticuloendotheliosis viral oncogene homolog B,RELB,5971,ENSG00000104856,mutation identified in 1 IMD53 family,"?Immunodeficiency 53, 617585 (3), Autosomal recessive",Relb (MGI:103289)
19,45071499,45076477,19q13.32,19q13.32,613226,"ZNF296, ZFP296, ZNF342",Zinc finger protein 296,ZNF296,162979,ENSG00000170684,NA,NA,Zfp296 (MGI:1926956)
19,45075626,45091517,19q13.32,19q13.32,607419,GEMIN7,GEM-associated protein 7,GEMIN7,79760,ENSG00000142252,NA,NA,Gemin7 (MGI:1916981)
19,45162932,45179265,19q13.32,19q13.32,610396,TRAPPC6A,"Trafficking protein particle complex, subunit 6A",TRAPPC6A,79090,ENSG00000007255,NA,NA,Trappc6a (MGI:1914341)
19,45178744,45202714,19q13,19q13.32,609762,"BLOC1S3, BLOS3, HPS8","Biogenesis of lysosome-related organelles complex 1, subunit 3",BLOC1S3,388552,ENSG00000189114,NA,"Hermansky-Pudlak syndrome 8, 614077 (3), Autosomal recessive",Bloc1s3 (MGI:2678952)
19,45212376,45234210,19q13.32,19q13.32,616927,"EXOC3L2, XTP7",Exocyst complex component 3-like 2,EXOC3L2,90332,ENSG00000283632,NA,NA,Exoc3l2 (MGI:1921713)
19,45251270,45305283,19q13.2,19q13.32,606495,"MARK4, KIAA1860, MARKL1",Map/microtubule affinity-regulating kinase-4,MARK4,57787,ENSG00000007047,NA,NA,Mark4 (MGI:1920955)
19,45306412,45322874,19q13,19q13.32,123310,"CKM, CKMM","Creatine kinase, muscle type",CKM,1158,ENSG00000104879,NA,NA,Ckm (MGI:88413)
19,45340749,45351547,19q13.2-q13.3,19q13.32,601334,"KLC3, KLC2L","Kinesin, light chain, 3",KLC3,147700,ENSG00000104892,NA,NA,Klc3 (MGI:1277971)
19,45349836,45370646,19q13.2-q13.3,19q13.32,126340,"ERCC2, EM9, XPD, COFS2, TTD1","Excision repair cross complementing rodent repair deficiency, complementation group-2",ERCC2,2068,ENSG00000104884,< 250kb from ERCC1; mutation identified in 1 COFS2 patient,"?Cerebrooculofacioskeletal syndrome 2, 610756 (3), Autosomal recessive; Trichothiodystrophy 1, photosensitive, 601675 (3), Autosomal recessive; Xeroderma pigmentosum, group D, 278730 (3), Autosomal recessive",Ercc2 (MGI:95413)
19,45379633,45406360,19q13.32,19q13.32,607463,"PPP1R13L, RAI, IASPP, NKIP1","Protein phosphatase 1, regulatory subunit 13-like",PPP1R13L,10848,ENSG00000104881,NA,NA,Ppp1r13l (MGI:3525053)
19,45406643,45410765,19q13.2-q13.3,19q13.32,107325,"CD3EAP, ASE1, PAF49",CD3-epsilon-associated protein,CD3EAP,10849,ENSG00000117877,NA,NA,Cd3eap (MGI:1917583)
19,45407333,45451546,19q13.2-q13.3,19q13.32,126380,"ERCC1, UV20, COFS4","Excision repair cross complementing rodent repair deficiency, complementation group-1",ERCC1,2067,ENSG00000012061,distal to CKM,"Cerebrooculofacioskeletal syndrome 4, 610758 (3), Autosomal recessive",Ercc1 (MGI:95412)
19,45467995,45475178,19q13.3,19q13.32,164772,FOSB,Oncogene FOS-B,FOSB,2354,ENSG00000125740,NA,NA,Fosb (MGI:95575)
19,45485293,45497046,19q13.3,19q13.32,603183,"RTN2, NSPL1, SPG12",Reticulon-2,RTN2,6253,ENSG00000125744,NA,"Spastic paraplegia 12, autosomal dominant, 604805 (3), Autosomal dominant",Rtn2 (MGI:107612)
19,45507458,45526988,19q13.2-q13.3,19q13.32,601703,VASP,Vasodilator-stimulated phosphoprotein,VASP,7408,ENSG00000125753,NA,NA,Vasp (MGI:109268)
19,45527426,45584801,19q13.2-q13.3,19q13.32,606580,"OPA3, MGA3",OPA3 gene,OPA3,80207,ENSG00000125741,NA,"3-methylglutaconic aciduria, type III, 258501 (3), Autosomal recessive; Optic atrophy 3 with cataract, 165300 (3), Autosomal dominant",Opa3 (MGI:2686271)
19,45589763,45602211,19q13.2-q13.3,19q13.32,600551,GPR4,G protein-coupled receptor-4,GPR4,2828,ENSG00000177464,NA,NA,Gpr4 (MGI:2441992)
19,45609395,45645628,19q13.32,19q13.32,617494,"EML2, EMAP2, ELP70",Echinoderm microtubule-associated protein-like 2,EML2,24139,ENSG00000125746,NA,NA,Eml2 (MGI:1919455)
19,45668186,45683721,19q13.3,19q13.32,137241,"GIPR, PGQTL2",Gastric inhibitory polypeptide receptor,GIPR,2696,ENSG00000010310,NA,"[Plasma glucose, 2-hour, QTL 2], 137241 (2)",Gipr (MGI:1352753)
19,45687453,45692315,19q13.32,19q13.32,601061,SNRPD2,Small nuclear ribonucleoprotein polypeptide D2,SNRPD2,6633,ENSG00000125743,NA,NA,Snrpd2 (MGI:98345)
19,45710628,45733176,19q13.3,19q13.32,609117,"FBXO46, FBX46",F-box only protein 46,FBXO46,23403,ENSG00000177051,NA,NA,Fbxo46 (MGI:2444918)
19,45764784,45769251,19q13.3,19q13.32,600963,"SIX5, DMAHP, BOR2","Sine oculis homeo box, Drosophila, homolog of, 5",SIX5,147912,ENSG00000177045,NA,"Branchiootorenal syndrome 2, 610896 (3)",Six5 (MGI:106220)
19,45769708,45782489,19q13.2-q13.3,19q13.32,605377,"DMPK, DM, DMK",Dystrophia myotonica-protein kinase,DMPK,1760,ENSG00000104936,distal to APOLP2; distal to CKM,"Myotonic dystrophy 1, 160900 (3), Autosomal dominant",Dmpk (MGI:94906)
19,45782946,45792844,19q13.3,19q13.32,609857,"DMWD, DMRN9",Dystrophia myotonica WD repeat-containing protein,DMWD,1762,ENSG00000185800,NA,NA,Dmwd (MGI:94907)
19,45795712,45815341,19q13.3,19q13.32,607548,RSHL1,Radial spokehead-like 1,RSPH6A,81492,ENSG00000104941,NA,NA,Rsph6a (MGI:1927643)
19,45815409,45863166,19q13.3,19q13.32,602388,SPK,Symplekin,SYMPK,8189,ENSG00000125755,NA,NA,Sympk (MGI:1915438)
19,45864325,45873796,19q13.2-q13.4,19q13.32,602295,"FOXA3, HNF3G","Forkhead box A3 (hepatocyte nuclear factor-3, gamma)",FOXA3,3171,ENSG00000170608,NA,NA,Foxa3 (MGI:1347477)
19,45883607,45886140,19q13.32,19q13.32,615331,IRF2BP1,Interferon regulatory factor 2-binding protein 1,IRF2BP1,26145,ENSG00000170604,NA,NA,Irf2bp1 (MGI:2442159)
19,45890019,45902618,19q13.32,19q13.32,617861,MYPOP,"MYB-related transcription factor, partner of profilin",MYPOP,339344,ENSG00000176182,NA,NA,Mypop (MGI:2446472)
19,45913213,45914777,19q13.32,19q13.32,608228,"NANOS2, NOS2","Nanos, Drosophila, homolog of, 2",NANOS2,339345,ENSG00000188425,NA,NA,Nanos2 (MGI:2676627)
19,45933733,45973864,19q13.3,19q13.32,601991,"NOVA2, ANOVA",NOVA alternative splicing regulator 2,NOVA2,4858,ENSG00000104967,NA,NA,Nova2 (MGI:104296)
19,46019152,46023052,19q13,19q13.32,604963,"PGRP, PGRPS",Peptidoglycan recognition protein,PGLYRP1,8993,ENSG00000008438,NA,NA,Pglyrp1 (MGI:1345092)
19,46039181,46077717,19p13.3,19q13.32,610547,IGFL4,IGF-like family member 4,IGFL4,444882,ENSG00000204869,NA,NA,NA
19,46078512,46215361,19p13.3,19q13.32,610545,IGFL2,IGF-like family member 2,IGFL2,147920,ENSG00000204866,NA,NA,NA
19,46119777,46127100,19p13.3,19q13.32,610546,IGFL3,IGF-like family member 3,IGFL3,388555,ENSG00000188624,NA,NA,Igfl3 (MGI:2685426)
19,46229741,46231242,19p13.3,19q13.32,610544,IGFL1,IGF-like family member 1,IGFL1,374918,ENSG00000188293,NA,NA,NA
19,46297041,46343432,19q13.2,19q13.32,609976,"HIF3A, IPAS","Hypoxia-inducible factor 3, alpha subunit",HIF3A,64344,ENSG00000124440,NA,NA,Hif3a (MGI:1859778)
19,46347068,46390974,19q13.3,19q13.32,600658,"PPP5C, PP5","Protein phosphatase-5, catalytic subunit",PPP5C,5536,ENSG00000011485,NA,NA,Ppp5c (MGI:102666)
19,46410328,46413563,19q13.2-q13.32,19q13.32,614145,"CCDC8, 3M3",Coiled-coil domain-containing protein 8,CCDC8,83987,ENSG00000169515,NA,"3-M syndrome 3, 614205 (3), Autosomal recessive",Ccdc8 (MGI:3612184)
19,46601073,46610781,19q13.2-q13.3,19q13.32,114183,CALM3,Calmodulin-3,CALM3,808,ENSG00000160014,NA,NA,NA
19,46610039,46625096,19q13.3,19q13.32,600022,PTGIR,Prostaglandin I2 (prostacyclin) receptor (IP),PTGIR,5739,ENSG00000160013,NA,NA,Ptgir (MGI:99535)
19,46647550,46661181,19q13.3,19q13.32,611112,DACT3,"Dapper, antagonist of beta-catenin, 3",DACT3,147906,ENSG00000197380,NA,NA,Dact3 (MGI:3654828)
19,46674315,46717126,19q13.3,19q13.32,607074,"PRKD2, PKD2",Protein kinase D2,PRKD2,25865,ENSG00000105287,NA,NA,Prkd2 (MGI:2141917)
19,46719508,46746474,19q13.32,19q13.32,614767,"STRN4, ZIN","Striatin, calmodulin-binding protein 4",STRN4,29888,ENSG00000090372,NA,NA,Strn4 (MGI:2142346)
19,46746014,46758574,19q13.3,19q13.32,606596,"FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5",Fukutin-related protein,FKRP,79147,ENSG00000181027,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3), Autosomal recessive",Fkrp (MGI:2447586)
19,46774882,46788593,19q13.3,19q13.32,109190,"SLC1A5, RDRC, M7V1, M7VS1","Solute carrier family 1 (neutral amino acid transporter), member 5 (receptor for RD114/simian type D retroviruses)",SLC1A5,6510,ENSG00000105281,NA,NA,Slc1a5 (MGI:105305)
19,46838135,46850845,19q13.2-q13.3,19q13.32,602242,"AP2S1, CLAPS2, AP17, HHC3","Adaptor-related protein complex 2, sigma 1 subunit",AP2S1,1175,ENSG00000042753,NA,"Hypocalciuric hypercalcemia, type III, 600740 (3), Autosomal dominant",Ap2s1 (MGI:2141861)
19,46860996,47005076,19q13.2-q13.4,19q13.32,605277,"GRLF1, P190A",Glucocorticoid receptor DNA-binding factor 1,ARHGAP35,2909,ENSG00000160007,NA,NA,Arhgap35 (MGI:1929494)
19,47019836,47045774,19q13.2-q13.3,19q13.32,603346,"NPAS1, MOP5",Neuronal PAS domain protein 1,NPAS1,4861,ENSG00000130751,NA,NA,Npas1 (MGI:109205)
19,47130834,47210635,19q13.32,19q13.32,613294,"SAE1, SUA1, AOS1","SUMO1-activating enzyme, subunit 1",SAE1,10055,ENSG00000142230,NA,NA,Sae1 (MGI:1929264)
19,47220821,47232997,19q,19q13.32,605854,PUMA,p53-upregulated modulator of apoptosis,BBC3,27113,ENSG00000105327,NA,NA,Bbc3 (MGI:2181667)
19,47309860,47322065,19q13.3-q13.4,19q13.32,113995,"C5AR1, C5R1, C5AR",Complement component 5a receptor 1,C5AR1,728,ENSG00000197405,NA,NA,C5ar1 (MGI:88232)
19,47331613,47347328,19q13.4,19q13.32,609949,"C5AR2, GPF77, C5L2",Complement component 5a receptor 2,C5AR2,27202,ENSG00000134830,NA,NA,C5ar2 (MGI:2442013)
19,47349314,47382703,19q13.32,19q13.32,615475,"DHX34, KIAA0134",DEAH box polypeptide 34,DHX34,9704,ENSG00000134815,NA,NA,Dhx34 (MGI:1918973)
19,47428016,47471892,19q13.32,19q13.32,601901,"SLC8A2, NCX2","Solute carrier family 8, member 2 (sodium-calcium exchanger 2)",SLC8A2,6543,ENSG00000118160,NA,NA,Slc8a2 (MGI:107996)
19,47475140,47486791,19q13.4,19q13.32,615620,"KPTN, 2E4, MRT41",Kaptin,KPTN,11133,ENSG00000118162,NA,"Mental retardation, autosomal recessive 41, 615637 (3), Autosomal recessive",Kptn (MGI:1890380)
19,47487633,47515257,19q13.3,19q13.32-q13.33,603215,"NAPA, SNAPA","N-ethylmaleimide-sensitive factor attachment protein, alpha",NAPA,8775,ENSG00000105402,NA,NA,Napa (MGI:104563)
19,47608195,47703276,19q13.3,19q13.33,605690,"BICRA, GLTSCR1",BRD4-interacting chromatin remodeling complex-associated protein,BICRA,29998,ENSG00000063169,NA,NA,Bicra (MGI:2154263)
19,47713421,47743133,19q13.3,19q13.33,605890,EHD2,EH domain-containing 2,EHD2,30846,ENSG00000024422,NA,NA,Ehd2 (MGI:2154274)
19,47745545,47757057,19q13.3,19q13.33,605691,"NOP53, GLTSCR2",NOP53 ribosome biogenesis factor,NOP53,29997,ENSG00000105373,NA,NA,Nop53 (MGI:2154441)
19,47778702,47784681,19q13.3,19q13.33,603235,"SELENOW, SEPW1",Selenoprotein W,SELENOW,6415,ENSG00000178980,NA,NA,Selenow (MGI:1100878)
19,47801242,47803603,19q13.32,19q13.33,611166,TPRX1,Tetrapeptide repeat homeobox 1,TPRX1,284355,ENSG00000178928,NA,NA,NA
19,47821936,47843323,19q13.3,19q13.33,602225,"CRX, CORD2, CRD, LCA7",Cone-rod homeo box-containing gene,CRX,1406,ENSG00000105392,NA,"Cone-rod retinal dystrophy-2, 120970 (3), Autosomal dominant; Leber congenital amaurosis 7, 613829 (3)",Crx (MGI:1194883)
19,47870466,47886314,19q13.3,19q13.33,125263,"SULT2A1, STD","Sulfotransferase family 2A, dehydroepiandrosterone-preferring, member 1 (DHEA sulfotransferase)",SULT2A1,6822,ENSG00000105398,NA,NA,"Sult2a4,Sult2a3,Sult2a1,Sult2a6,Sult2a5 (MGI:98430,MGI:3645854,MGI:3648915,MGI:3648378,MGI:3645873)"
19,47967257,47992169,19q13.32,19q13.33,612213,BSPH1,Bovine seminal plasma protein-like 1,BSPH1,100131137,ENSG00000188334,NA,NA,Bsph1 (MGI:2685613)
19,47994631,48025153,19q13.33,19q13.33,607443,ELSPBP1,Epididymal sperm binding protein 1,ELSPBP1,64100,ENSG00000169393,NA,NA,NA
19,48029382,48048341,19q13.33,19q13.33,607315,"CABP5, CABP3",Calcium-binding protein 5,CABP5,56344,ENSG00000105507,NA,NA,Cabp5 (MGI:1352746)
19,48047842,48111382,19q13.3,19q13.33,603602,PLA2G4C,"Phospholipase A2, group IVC",PLA2G4C,8605,ENSG00000105499,NA,NA,Pla2g4c (MGI:1196403)
19,48115444,48170602,19q13.2-q13.3,19q13.33,126391,LIG1,"Ligase I, DNA, ATP-dependent",LIG1,3978,ENSG00000105486,NA,NA,Lig1 (MGI:101789)
19,48203147,48256263,19q13.3,19q13.33,609051,"CARD8, TUCAN, KIAA0955, NDPP1",Caspase recruitment domain-containing protein 8,CARD8,22900,ENSG00000105483,NA,NA,NA
19,48270080,48287607,19q13.33,19q13.33,603996,ZNF114,Zinc finger protein-114,ZNF114,163071,ENSG00000178150,NA,NA,NA
19,48296451,48321970,19q13.3,19q13.33,615038,"CCDC114, CILD20",Coiled-coil domain-containing protein 114,CCDC114,93233,ENSG00000105479,NA,"Ciliary dyskinesia, primary, 20, 615067 (3), Autosomal recessive",Ccdc114 (MGI:2446120)
19,48325503,48330553,19q13.3,19q13.33,602335,EMP3,Epithelial membrane protein 3,EMP3,2014,ENSG00000142227,NA,NA,Emp3 (MGI:1098729)
19,48364266,48376376,19q13.3,19q13.33,608373,SYNGR4,Synaptogyrin 4,SYNGR4,23546,ENSG00000105467,NA,NA,Syngr4 (MGI:1928903)
19,48382574,48391550,19q13.33,19q13.33,131235,"KDELR1, ERD2, HDEL",KDEL endoplasmic reticulum protein retention receptor 1,KDELR1,10945,ENSG00000105438,NA,NA,Kdelr1 (MGI:1915387)
19,48394874,48444936,19q13.1-qter,19q13.33,602717,"GRIN2D, NMDAR2D, EIEE46","Glutamate receptor, ionotropic, N-methyl-D-aspartate 2D",GRIN2D,2906,ENSG00000105464,NA,"Epileptic encephalopathy, early infantile, 46, 617162 (3), Autosomal dominant",Grin2d (MGI:95823)
19,48445982,48457021,19q13.3,19q13.33,610597,"GRWD1, GRWD, KIAA1942",Glutamate-rich WD repeat-containing protein 1,GRWD1,83743,ENSG00000105447,NA,NA,Grwd1 (MGI:2141989)
19,48455706,48466109,19q13.33,19q13.33,603953,KCNJ14,"Potassium inwardly-rectifying channel, subfamily J, member 14",KCNJ14,3770,ENSG00000182324,NA,NA,Kcnj14 (MGI:2384820)
19,48469207,48482313,19q13,19q13.33,602488,"CYTH2, PSCD2, ARNO, PSCD2L",Cytohesin 2,CYTH2,9266,ENSG00000105443,NA,NA,Cyth2 (MGI:1334255)
19,48552171,48599426,19q13.3,19q13.33,604125,"SULT2B1, ARCI14","Sulfotransferase family 2B, member 1",SULT2B1,6820,ENSG00000088002,NA,"Ichthyosis, congenital, autosomal recessive 14, 617571 (3), Autosomal recessive",Sult2b1 (MGI:1926342)
19,48606741,48607713,19q13.33,19q13.33,609932,"SPACA4, SAMP14",Sperm acrosome-associated protein 4,SPACA4,171169,ENSG00000177202,NA,NA,Spaca4 (MGI:1916613)
19,48615326,48619417,19q,19q13.33,604179,"RPL18, DBA18",Ribosomal protein L18,RPL18,6141,ENSG00000063177,mutation identified in 1 DBA18 family,"?Diamond-Blackfan anemia 18, 618310 (3), Autosomal dominant",Rpl18 (MGI:98003)
19,48619290,48630406,19q13.2,19q13.33,607092,SPHK2,Sphingosine kinase 2,SPHK2,56848,ENSG00000063176,NA,NA,Sphk2 (MGI:1861380)
19,48630029,48637378,19q13.3,19q13.33,124097,DBP,D site of albumin promoter binding protein,DBP,1628,ENSG00000105516,NA,NA,Dbp (MGI:94866)
19,48637941,48646311,19q13.2-q13.3,19q13.33,604644,"CA11, CARP2",Carbonic anhydrase XI,CA11,770,ENSG00000063180,NA,NA,Car11 (MGI:1336193)
19,48695970,48705950,19q13.3,19q13.33,182100,"FUT2, SE, B12QTL1",Fucosyltransferase-2 (secretor),FUT2,2524,ENSG00000176920,"H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1","[Bombay phenotype, digenic], 616754 (3), Autosomal recessive; {Norwalk virus infection, resistance to} (3); {Vitamin B12 plasma level QTL1}, 612542 (3)",Fut2 (MGI:109374)
19,48712440,48719897,19q13.33,19q13.33,610349,"MAMSTR, MASTR",MEF2-activating SAP transcriptional regulator,MAMSTR,284358,ENSG00000176909,NA,NA,Mamstr (MGI:1921740)
19,48720584,48740832,19q13.33,19q13.33,609623,"RASIP1, RAIN",Ras-interacting protein 1,RASIP1,54922,ENSG00000105538,NA,NA,Rasip1 (MGI:1917153)
19,48740851,48746908,19q13.33,19q13.33,609278,"IZUMO1, MGC34799",Izumo sperm-egg fusion protein 1,IZUMO1,284359,ENSG00000182264,NA,NA,Izumo1 (MGI:1920706)
19,48748010,48755389,19q13.3,19q13.33,211100,"FUT1, H, HH",Fucosyltransferase-1 (Bombay phenotype),FUT1,2523,ENSG00000174951,SE tightly linked,"[Bombay phenotype], 616754 (3), Autosomal recessive",Fut1 (MGI:109375)
19,48755523,48758329,19q13,19q13.33,609436,FGF21,Fibroblast growth factor 21,FGF21,26291,ENSG00000105550,NA,NA,Fgf21 (MGI:1861377)
19,48795063,48811028,19q13,19q13.33,113530,"BCAT2, BCT2","Branched chain aminotransferase-2, mitochondrial",BCAT2,587,ENSG00000105552,NA,?Hypervalinemia or hyperleucine-isoleucinemia (1),Bcat2 (MGI:1276534)
19,48813013,48836687,19q13.33,19q13.33,612832,"HSD17B14, DHRS10, RETSDR3",17-beta-hydroxysteroid dehydrogenase XIV,HSD17B14,51171,ENSG00000087076,NA,NA,Hsd17b14 (MGI:1913315)
19,48837091,48868621,19q13.33,19q13.33,607769,"PLEKHA4, PEPP1","Pleckstrin homology domain-containing protein, family A, member 4",PLEKHA4,57664,ENSG00000105559,NA,NA,Plekha4 (MGI:1916467)
19,48872391,48876061,19q13.2,19q13.33,611048,"PPP1R15A, GADD34","Protein phosphatase 1, regulatory subunit 15A",PPP1R15A,23645,ENSG00000087074,NA,NA,Ppp1r15a (MGI:1927072)
19,48880816,48900220,19q13.1,19q13.33,602309,TULP2,Tubby-like protein-2,TULP2,7288,ENSG00000104804,NA,NA,Tulp2 (MGI:1861600)
19,48900311,48923371,19q13.2-q13.4,19q13.33,601323,NUCB1,Nucleobindin 1,NUCB1,4924,ENSG00000104805,NA,NA,Nucb1 (MGI:97388)
19,48932789,48944968,19q13.33,19q13.33,606377,"DHDH, HUM2DD",Dimeric dihydrodiol dehydrogenase,DHDH,27294,ENSG00000104808,NA,NA,Dhdh (MGI:1919005)
19,48954824,48961797,19q13.3-q13.4,19q13.33,600040,BAX,BCL2-associated X protein,BAX,581,ENSG00000087088,NA,"Colorectal cancer, somatic, 114500 (3); T-cell acute lymphoblastic leukemia, somatic, 613065 (3)",Bax (MGI:99702)
19,48963940,48966878,19q13.3-q13.4,19q13.33,134790,"FTL, NBIA3, LFTD","Ferritin, light chain",FTL,2512,ENSG00000087086,NA,"Hyperferritinemia-cataract syndrome, 600886 (3), Autosomal dominant; L-ferritin deficiency, dominant and recessive, 615604 (3), Autosomal recessive, Autosomal dominant; Neurodegeneration with brain iron accumulation 3, 606159 (3), Autosomal dominant","Ftl1,Ftl1-ps2 (MGI:5434102,MGI:95589)"
19,48968124,48993352,19q13.3,19q13.33,138570,"GYS1, GYS",Glycogen synthase,GYS1,2997,ENSG00000104812,NA,"Glycogen storage disease 0, muscle, 611556 (3), Autosomal recessive",Gys1 (MGI:101805)
19,48993447,49015994,19q13.3,19q13.33,604788,"RUVBL2, TIP48, ECP51","RUVB, E. coli, homolog-like 2 (TATA box-binding protein-interacting protein)",RUVBL2,10856,ENSG00000183207,NA,NA,Ruvbl2 (MGI:1342299)
19,49015979,49017089,19q13.32,19q13.33,152780,"LHB, HH23","Luteinizing hormone, beta polypeptide",LHB,3972,ENSG00000104826,"beta chains of FSH, TSH on 11p, 1p, respectively","Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3), Autosomal recessive",Lhb (MGI:96782)
19,49022868,49024374,19q13.32,19q13.33,118860,CGB,"Chorionic gonadotropin, beta polypeptide",CGB3,1082,ENSG00000104827,at least 5 genes,NA,NA
19,49035568,49036933,19q13.33,19q13.33,608823,CGB1,"Chorionic gonadotropin, beta polypeptide 1",CGB1,114335,ENSG00000267631,NA,NA,NA
19,49054273,49057247,19q13.33,19q13.33,608826,"CGB7, CGB6","Chorionic gonadotropin, beta polypeptide 7",CGB7,94027,ENSG00000196337,NA,NA,NA
19,49058283,49065075,19q13.3,19q13.33,162662,"NTF4 , NTF5, NT5, NT4, GLC1O",Neurotrophin-4 (neurotrophin-4/5),NTF4,4909,ENSG00000225950,"3 genes, ? functional, also on 19","Glaucoma 1, open angle, 1O, 613100 (3)",Ntf5 (MGI:97381)
19,49067417,49072940,19q13.3,19q13.33,176268,KCNA7,"Potassium voltage-gated channel, shaker-related subfamily, member 7",KCNA7,3743,ENSG00000104848,NA,NA,Kcna7 (MGI:96664)
19,49085450,49108605,19q13.3,19q13.33,180740,"SNRP70, U1RNP, RNPU1Z, RPU1","Small nuclear ribonucleoprotein, U1 subunit, 70kD",SNRNP70,6625,ENSG00000104852,NA,NA,Snrnp70 (MGI:98341)
19,49114338,49118463,19q13.33,19q13.33,612331,"LIN7B, VELI2, MALS2","Lin7, C. elegans, homolog of, B",LIN7B,64130,ENSG00000104863,NA,NA,Lin7b (MGI:1330858)
19,49119388,49151029,19q13.33,19q13.33,603144,"PPFIA3, LPNA3","Protein tyrosine phosphatase, receptor type, f polypeptide (liprin-alpha-3)",PPFIA3,8541,ENSG00000177380,NA,NA,Ppfia3 (MGI:1924037)
19,49151197,49155463,19q13.3,19q13.33,142705,HRC,Histidine-rich calcium-binding protein,HRC,3270,ENSG00000130528,NA,NA,NA
19,49157791,49211840,19q13.32,19q13.33,606936,"TRPM4, PFHB1B","Transient receptor potential cation channel, subfamily M, member 4",TRPM4,54795,ENSG00000130529,NA,"Progressive familial heart block, type IB, 604559 (3), Autosomal dominant",Trpm4 (MGI:1915917)
19,49289631,49332319,19q13.33,19q13.33,607972,"SLC6A16, NT5","Solute carrier family 6 (neurotransmitter transporter), member 16",SLC6A16,28968,ENSG00000063127,NA,NA,Slc6a16 (MGI:2685930)
19,49334960,49340607,19p13-q13.4,19q13.33,151523,CD37,Leukocyte surface antigen CD37,CD37,951,ENSG00000104894,NA,NA,Cd37 (MGI:88330)
19,49340594,49362451,19q13.3,19q13.33,601729,"TEAD2, TEF4",TEA domain family member 2,TEAD2,8463,ENSG00000074219,NA,NA,Tead2 (MGI:104904)
19,49360519,49375131,19q13.33,19q13.33,605418,"DKKL1, SGY1, SGY",Dickkopf-like 1,DKKL1,27120,ENSG00000104901,NA,NA,Dkkl1 (MGI:1354963)
19,49388217,49418001,19q13.33,19q13.33,618125,"CCDC155, KASH5",Coiled-coil domain-containing protein 155,CCDC155,147872,ENSG00000161609,NA,NA,Ccdc155 (MGI:2687329)
19,49422418,49423440,19q13.33,19q13.33,608386,"PTH2, TIP39",Parathyroid hormone 2,PTH2,113091,ENSG00000142538,NA,NA,Pth2 (MGI:2152297)
19,49429400,49441526,19q13,19q13.33,605208,"SLC17A7, BNPI, VGLUT1","Solute carrier family 17, (sodium-dependent inorganic phosphate cotransporter), member 7",SLC17A7,57030,ENSG00000104888,NA,NA,Slc17a7 (MGI:1920211)
19,49446297,49452391,19q13.33,19q13.33,611480,"PIH1D1, NOP17",PIH1 domain-containing protein 1,PIH1D1,55011,ENSG00000104872,NA,NA,Pih1d1 (MGI:1916095)
19,49453224,49471049,19q13.33,19q13.33,613358,ALDH16A1,"Aldehyde dehydrogenase 16 family, member A1",ALDH16A1,126133,ENSG00000161618,NA,NA,Aldh16a1 (MGI:1916998)
19,49474171,49487036,19q13.33,19q13.33,600007,"FLT3LG, FLG3L",FMS-related tyrosine kinase 3 ligand,FLT3LG,2323,ENSG00000090554,NA,NA,Flt3l (MGI:95560)
19,49496433,49499707,19q,19q13.33,180471,RPS11,Ribosomal protein S11,RPS11,6205,ENSG00000142534,NA,NA,Rps11 (MGI:1351329)
19,49500784,49500867,19q13.33,19q13.33,611114,"MIR150, MIRN150",Micro RNA 150,MIR150,406942,ENSG00000207782,NA,NA,NA
19,49512660,49526427,19q13.3,19q13.33,601437,FCGRT,"Fc fragment of IgG, receptor, transporter, alpha",FCGRT,2217,ENSG00000104870,NA,NA,Fcgrt (MGI:103017)
19,49555467,49580571,19q13.33,19q13.33,616759,NOSIP,Nitric oxide synthase-interacting protein,NOSIP,51070,ENSG00000142546,NA,NA,Nosip (MGI:1913644)
19,49580616,49591007,19q13.33,19q13.33,604429,"PRRG2, PRGP2",Proline-rich gamma-carboxyglutamic acid protein 2,PRRG2,5639,ENSG00000126460,NA,NA,Prrg2 (MGI:1929596)
19,49591176,49626438,19q13.33,19q13.33,616633,"PRR12, KIAA1205",Proline-rich protein 12,PRR12,57479,ENSG00000126464,NA,NA,Prr12 (MGI:2679002)
19,49635291,49640142,19q13.3-qter,19q13.33,165090,RRAS,Oncogene RRAS,RRAS,6237,ENSG00000126458,NA,NA,Rras (MGI:98179)
19,49640480,49658641,19q13.3,19q13.33,617264,SCAF1,SR-related C-terminal domain-associated factor 1,SCAF1,58506,ENSG00000126461,NA,NA,NA
19,49659568,49665874,19q13.3-q13.4,19q13.33,603734,"IRF3, IIAE7",Interferon regulatory factor 3,IRF3,3661,ENSG00000126456,NA,"{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}, 616532 (3), Autosomal dominant",Irf3 (MGI:1859179)
19,49664833,49673915,19q13.3,19q13.33,610837,BCL2L12,BCL2-like 12,BCL2L12,83596,ENSG00000126453,NA,NA,Bcl2l12 (MGI:1922986)
19,49676165,49688449,19q13,19q13.33,602950,"PRMT1, HRMT1L2, IR1B4",Protein arginine methyltransferase 1,PRMT1,3276,ENSG00000126457,NA,NA,Prmt1 (MGI:107846)
19,49690671,49713730,19q13.33,19q13.33,608846,"CPT1C, SPG73",Carnitine palmitoyltransferase IC,CPT1C,126129,ENSG00000169169,mutation identified in 1 SPG73 family,"?Spastic paraplegia 73, autosomal dominant, 616282 (3), Autosomal dominant",Cpt1c (MGI:2446526)
19,49767000,49807113,19q13.3,19q13.33,601026,"AP2A1, CLAPA1, ADTAA","Adaptor-related protein complex 2, alpha 1 subunit",AP2A1,160,ENSG00000196961,match to PAC AC006942,NA,Ap2a1 (MGI:101921)
19,49806865,49817375,19q13,19q13.33,610622,"FUZ, NTD","Fuzzy, Drosophila, homolog of",FUZ,80199,ENSG00000010361,NA,"{Neural tube defects, susceptibility to}, 182940 (3), Autosomal dominant",Fuz (MGI:1917550)
19,49818278,49840383,19q13.3,19q13.33,610197,"MED25, PTOV2, ARC92, CMT2B2, BVSYS","Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of",MED25,81857,ENSG00000104973,mutation identified in 1 CMT2B2 family,"Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3), Autosomal recessive; ?Charcot-Marie-Tooth disease, type 2B2, 605589 (3), Autosomal recessive",Med25 (MGI:1922863)
19,49848553,49860743,19q13.3-q13.4,19q13.33,610195,"PTOV1, ACID2",Prostate tumor overexpressed gene 1,PTOV1,53635,ENSG00000104960,NA,NA,Ptov1 (MGI:1933946)
19,49861203,49867575,19q13.4,19q13.33,605610,"PNKP, PNK, MCSZ, EIEE10, AOA4",Polynucleotide kinase 3' phosphatase,PNKP,11284,ENSG00000039650,NA,"Ataxia-oculomotor apraxia 4, 616267 (3), Autosomal recessive; Microcephaly, seizures, and developmental delay, 613402 (3), Autosomal recessive",Pnkp (MGI:1891698)
19,49869032,49878355,19q13.33,19q13.33,610221,"AKT1S1, PRAS40","AKT1 substrate 1, proline-rich",AKT1S1,84335,ENSG00000204673,NA,NA,Akt1s1 (MGI:1914855)
19,49877530,49888749,19q13.33,19q13.33,616659,TBC1D17,"TBC1 domain family, member 17",TBC1D17,79735,ENSG00000104946,NA,NA,Tbc1d17 (MGI:2449973)
19,49889653,49929538,19q13.3-q13.4,19q13.33,609742,"IL4I1, FIG1",Interleukin 4-induced gene 1,IL4I1,259307,ENSG00000104951,NA,NA,"Il4i1b,Il4i1 (MGI:5439399,MGI:109552)"
19,49906824,49929503,19q13.33,19q13.33,605815,"NUP62, SNDI, IBSN","Nucleoporin, 62-kD",NUP62,23636,ENSG00000213024,NA,"Striatonigral degeneration, infantile, 271930 (3), Autosomal recessive",Nup62 (MGI:1351500)
19,49928701,49933935,19q13.3,19q13.33,606398,"ATF5, ATFX",Activating transcription factor 5,ATF5,22809,ENSG00000169136,NA,NA,Atf5 (MGI:2141857)
19,49948824,49961171,19q13.3-q13.4,19q13.33,607157,SIGLEC11,Sialic acid-binding immunoglobulin-like lectin 11,SIGLEC11,114132,ENSG00000161640,pseudogene 8kb upstream,NA,NA
19,50026004,50048775,19q13.33,19q13.33,617908,"ZNF473, ZFP100, KIAA1141",Zinc finger protein 473,ZNF473,25888,ENSG00000142528,NA,NA,Zfp473 (MGI:2442697)
19,50188185,50310543,19q13.33,19q13.33,608568,"MYH14, KIAA2034, DFNA4A, PNMHH","Myosin, heavy chain 14, nonmuscle",MYH14,79784,ENSG00000105357,mutation identified in 1 PNMHH family,"Deafness, autosomal dominant 4A, 600652 (3), Autosomal dominant; ?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3), Autosomal dominant",Myh14 (MGI:1919210)
19,50311936,50333535,19q13.3-q13.4,19q13.33,176264,"KCNC3, SCA13","Potassium voltage-gated channel, Shaw-related subfamily, member 3",KCNC3,3748,ENSG00000131398,NA,"Spinocerebellar ataxia 13, 605259 (3), Autosomal dominant",Kcnc3 (MGI:96669)
19,50358471,50369330,19q13.33,19q13.33,605631,"NAPA, NAP1, SNAPA",Napsin A,NAPSA,9476,ENSG00000131400,NA,NA,Napsa (MGI:109365)
19,50376456,50383387,19q13.3,19q13.33,600380,"NR1H2, UNR","Nuclear receptor subfamily 1, group H, member 2 (ubiquitously-expressed nuclear receptor)",NR1H2,7376,ENSG00000131408,NA,NA,Nr1h2 (MGI:1352463)
19,50384290,50418017,19q13.3-q13.4,19q13.33,174761,"POLD1, CRCS10, MDPL","Polymerase (DNA directed), delta 1, catalytic subunit",POLD1,5424,ENSG00000062822,NA,"{Colorectal cancer, susceptibility to, 10}, 612591 (3), Autosomal dominant; Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3), Autosomal dominant",Pold1 (MGI:97741)
19,50418937,50431313,19q13.3-q13.4,19q13.33,606802,SPIB,SPIB transcription factor,SPIB,6689,ENSG00000269404,NA,NA,Spib (MGI:892986)
19,50432891,50466320,19q13.33,19q13.33,160793,"MYBPC2, MYBPCF","Myosin-binding protein C, fast type",MYBPC2,4606,ENSG00000086967,NA,NA,Mybpc2 (MGI:1336170)
19,50476482,50505904,19q13.33,19q13.33,614545,"EMC10, C19orf63, HSS1, HSM1",ER membrane protein complex subunit 10,EMC10,284361,ENSG00000161671,NA,NA,Emc10 (MGI:1916933)
19,50505996,50511354,19q13.33,19q13.33,615324,JOSD2,Josephin domain-containing protein 2,JOSD2,126119,ENSG00000161677,NA,NA,Josd2 (MGI:1913374)
19,50621976,50639880,19q,19q13.33,600327,SYT3,Synaptotagmin-3,SYT3,84258,ENSG00000213023,NA,NA,Syt3 (MGI:99665)
19,50659254,50719801,19q13.33,19q13.33,604999,"SHANK1, SSTRIP",SH3 and multiple ankyrin repeat domains 1,SHANK1,50944,ENSG00000161681,NA,NA,Shank1 (MGI:3613677)
19,50723363,50725707,19q13.3,19q13.33,604713,"CLEC11A, SCGF, LSLCL","C-type lectin domain family 11, member A",CLEC11A,6320,ENSG00000105472,NA,NA,Clec11a (MGI:1298219)
19,50770463,50771731,19q13.3,19q13.33,603195,GPR32,G protein-coupled receptor-32,GPR32,2854,ENSG00000142511,NA,NA,NA
19,50790414,50795218,19q13,19q13.33,606362,"ACPT, AI1J","Acid phosphatase, testicular",ACP4,93650,ENSG00000142513,NA,"Amelogenesis imperfecta, type IJ, 617297 (3), Autosomal recessive",Acp4 (MGI:3644563)
19,50819145,50823786,19q13.4,19q13.33,147910,"KLK1, KLKR",Kallikrein 1,KLK1,3816,ENSG00000167748,~10cM distal to APOC2,"[Kallikrein, decreased urinary activity of], 615953 (3)",NA
19,50825288,50834336,19q13.4,19q13.33,610601,KLK15,Kallikrein-related peptidase 15,KLK15,55554,ENSG00000174562,NA,NA,Klk15 (MGI:2447533)
19,50854914,50860763,19q13.4,19q13.33,176820,"KLK3, APS, PSA",Kallikrein-related peptidase 3,KLK3,354,ENSG00000142515,"probably with cluster KLK1, KLK2",NA,"Klk1b21,Klk1b9,Klk1b11,Klk1b22,Klk1b8,Klk1,Klk1b5,Klk1b26,Klk1b3,Klk1b24,Klk1b4,Klk1b1,Klk1b16,Klk1b27 (MGI:102850,MGI:95293,MGI:95291,MGI:892019,MGI:892018,MGI:97320,MGI:97322,MGI:892023,MGI:892022,MGI:892021,MGI:892020,MGI:891982,MGI:891980,MGI:891981)"
19,50873432,50880566,19q13.4,19q13.33,147960,KLK2,Kallikrein-related peptidase 2,KLK2,3817,ENSG00000167751,12kb from APS,NA,NA
19,50900000,58617616,19q13.4-qter,NA,102699,AAVS1,Adeno-associated virus integration site-1,AAVS1,17,NA,NA,NA,NA
19,50900000,58617616,19q13.4,NA,611959,HPC15,"Prostate cancer, hereditary, 15",NA,100188868,NA,associated with rs2735839,"{Prostate cancer, hereditary, 15}, 611959 (2)",NA
19,50900000,58617616,19q13.4,NA,604937,"KIR2DL2, NKAT6","Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2",KIR2DL2,3803,NA,NA,NA,NA
19,50900000,58617616,19q13.4,NA,615727,KIR2DL5B,"Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B",KIR2DL5B,553128,NA,NA,NA,NA
19,50900000,58617616,19q13.4,NA,604952,KIR2DS1,"Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1",KIR2DS1,3806,NA,NA,NA,NA
19,50900000,58617616,19q13.4,NA,604953,"KIR2DS2, NKAT5","Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2",KIR2DS2,100132285,NA,NA,NA,NA
19,50900000,58617616,19q13.4,NA,604954,"KIR2DS3, NKAT7","Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3",KIR2DS3,3808,NA,NA,NA,NA
19,50900000,58617616,19q13.4,NA,604956,"KIR2DS5, NKAT9, CD158G","Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5",KIR2DS5,3810,NA,NA,NA,NA
19,50900000,58617616,19q13.4,NA,604818,"LILRA3, LIR4, ILT6, HM43","Leukocyte immunoglobulin-like receptor, subfamily A, member 3",LILRA3,11026,NA,NA,NA,NA
19,50900000,58617616,19q13.4,NA,612884,MENOQ2,"Menopause, natural, age at, QTL2",NA,100302517,NA,"associated with rs1172822, rs2384687, rs1551562, rs897798","{Menopause, natural, age at, QTL2}, 612884 (2)",NA
19,50906351,50910744,19q13.4,19q13.41,603767,"KLK4, EMSP1, PRSS17, AI2A1",Kallikrein-related peptidase 4,KLK4,9622,ENSG00000167749,NA,"Amelogenesis imperfecta, type IIA1, 204700 (3), Autosomal recessive",Klk4 (MGI:1861379)
19,50943298,50953037,19q13.4,19q13.41,605643,"KLK5, SCTE, KLKL2",Kallikrein-related peptidase 5,KLK5,25818,ENSG00000167754,NA,NA,Klk5 (MGI:1915918)
19,50958630,50969597,19q13.4,19q13.41,602652,"KLK6, PRSS9, ZYME",Kallikrein-related peptidase 6,KLK6,5653,ENSG00000167755,NA,NA,Klk6 (MGI:1343166)
19,50976467,50984063,19q13.41,19q13.41,604438,"LKL7, PRSS6, SCCE",Kallikrein-related peptidase 7,KLK7,5650,ENSG00000169035,NA,NA,Klk7 (MGI:1346336)
19,50996007,51001701,19q13.4,19q13.41,605644,"KLK8, TADG14, PRSS19",Kallikrein-related peptidase 8,KLK8,11202,ENSG00000129455,NA,NA,Klk8 (MGI:1343327)
19,51002507,51009591,19q13.4,19q13.41,605504,"KLK9, KLKL3",Kallikrein-related peptidase 9,KLK9,284366,ENSG00000213022,NA,NA,Klk9 (MGI:1921082)
19,51012738,51020174,19q13.4,19q13.41,602673,"KLK10, PRSSL1, NES1",Kallikrein-related peptidase 10,KLK10,5655,ENSG00000129451,NA,NA,Klk10 (MGI:1916790)
19,51022230,51027990,19q13.4,19q13.41,604434,"KLK11, PRSS20, TLSP",Kallikrein-related peptidase 11,KLK11,11012,ENSG00000167757,NA,NA,Klk11 (MGI:1929977)
19,51028953,51035648,19q13.4,19q13.41,605539,"KLK12, KLKL5",Kallikrein-related peptidase 12,KLK12,43849,ENSG00000186474,NA,NA,Klk12 (MGI:1916761)
19,51055625,51065109,19q13.4,19q13.41,605505,"KLK13, KLKL4",Kallikrein-related peptidase 13,KLK13,26085,ENSG00000167759,NA,NA,Klk13 (MGI:3615275)
19,51077493,51084209,19q13.4,19q13.41,606135,KLK14,Kallikrein-related peptidase 14,KLK14,43847,ENSG00000129437,NA,NA,Klk14 (MGI:2447564)
19,51097605,51108408,19q13.33,19q13.41,612694,"CTU1, ATPBD3",Cytothiouridylase subunit 1,CTU1,90353,ENSG00000142544,NA,NA,Ctu1 (MGI:2385277)
19,51124879,51140479,19q13.4,19q13.41,605640,SIGLEC9,Sialic acid-binding immunoglobulin-like lectin 9,SIGLEC9,27180,ENSG00000129450,NA,NA,Siglece (MGI:1932475)
19,51142259,51153525,19q13.3,19q13.41,604410,"SIGLEC7, AIRM1",Sialic acid-binding immunoglobulin-like lectin 7,SIGLEC7,27036,ENSG00000168995,NA,NA,NA
19,51211053,51240015,19q13.3-q13.4,19q13.41,159590,CD33,CD33 antigen (gp67),CD33,945,ENSG00000105383,NA,NA,NA
19,51331535,51342123,19q13.41,19q13.41,617740,VSIG10L,V-set and immunoglobulin domains-containing protein 10-like,VSIG10L,147645,ENSG00000186806,NA,NA,Vsig10l (MGI:1922940)
19,51345154,51366387,19q13.3,19q13.41,130410,"ETFB, MADD","Electron transfer flavoprotein, beta polypeptide",ETFB,2109,ENSG00000105379,NA,"Glutaric acidemia IIB, 231680 (3), Autosomal recessive",Etfb (MGI:106098)
19,51379908,51387973,19q13.4,19q13.41,154045,"LIM2, MP19, CTRCT19","Lens intrinsic protein 2, 19kD",LIM2,3982,ENSG00000105370,same cosmid as ETFB,"Cataract 19, multiple types, 615277 (3), Autosomal recessive",Lim2 (MGI:104698)
19,51410019,51417641,19q13.4,19q13.41,606091,SIGLEC10,Sialic acid-binding immunoglobulin-like lectin 10,SIGLEC10,89790,ENSG00000142512,NA,NA,Siglecg (MGI:2443630)
19,51450996,51458453,19q13.33-q13.41,19q13.41,605639,"SIGLEC8, SAF2, SIGLEC8L",Sialic acid-binding immunoglobulin-like lectin 8,SIGLEC8,27181,ENSG00000105366,NA,NA,Siglecf (MGI:2681107)
19,51491226,51501799,19q13.4,19q13.41,606094,"SIGLEC12, SIGLECL1, S2V, SLG",Sialic acid-binding immunoglobulin-like lectin 12,SIGLEC12,89858,ENSG00000254521,NA,NA,NA
19,51517818,51531802,19q13.3,19q13.41,604405,"SIGLEC6, CD33L, CD33L1, OBBP1",Sialic acid-binding immunoglobulin-like lectin 6,SIGLEC6,946,ENSG00000105492,NA,NA,NA
19,51571282,51592509,19q13.4,19q13.41,601139,"ZNF175, OTK18",Zinc finger protein-175,ZNF175,7728,ENSG00000105497,NA,NA,Zfp715 (MGI:1917180)
19,51610966,51630473,19q13.3,19q13.41,604200,"SIGLEC5, CD33L2, OBBP2",Sialic acid-binding Ig-like lectin 5,SIGLEC5,8778,ENSG00000105501,NA,NA,NA
19,51639477,51646878,19q13.14,19q13.41,618132,SIGLEC14,Sialic acid-binding immunoglobulin-like lectin 14,SIGLEC14,100049587,ENSG00000254415,NA,NA,NA
19,51692611,51692680,19q13.41,19q13.41,614510,MIR99B,Micro RNA 99B,MIR99B,407056,ENSG00000207550,NA,NA,NA
19,51692785,51692863,19q13.41,19q13.41,611250,"MIRLET7E, LET7E",Micro RNA Let7e,MIRLET7E,406887,ENSG00000198972,NA,NA,NA
19,51693253,51693338,19q13.33,19q13.41,611191,"MIR125A, MIRN125A",Micro RNA 125A,MIR125A,406910,ENSG00000208008,NA,NA,NA
19,51713111,51723990,19q13.3-q13.4,19q13.41,601463,HAS1,Hyaluronan synthase 1,HAS1,3036,ENSG00000105509,NA,NA,Has1 (MGI:106590)
19,51745171,51751896,19q13.4,19q13.41,136537,FPR1,Formyl peptide receptor-1,FPR1,2357,ENSG00000171051,NA,NA,Fpr1 (MGI:107443)
19,51752025,51770530,19q13.3-q13.4,19q13.41,136538,"FPR2, FPRL1, FPRH1, LXA4R, HM63",Formyl peptide receptor 2,FPR2,2358,ENSG00000171049,NA,NA,Fpr2 (MGI:1278319)
19,51795156,51826206,19q13.3-q13.4,19q13.41,136539,"FPR3, FPRL2, FPRH2",Formyl peptide receptor 3,FPR3,2359,ENSG00000187474,NA,NA,NA
19,51889234,51905016,19q13.41,19q13.41,611903,ZNF649,Zinc finger protein 649,ZNF649,65251,ENSG00000198093,NA,NA,NA
19,51964339,51986855,19q13.41,19q13.41,605422,"ZNF350, ZBRK1",Zinc finger protein 350,ZNF350,59348,ENSG00000256683,NA,NA,NA
19,52189801,52229517,19q13.4,19q13.41,605983,"PPP2R1A, MRD36","Protein phosphatase 2, structural/regulatory subunit A, alpha",PPP2R1A,5518,ENSG00000105568,NA,"Mental retardation, autosomal dominant 36, 616362 (3), Autosomal dominant",Ppp2r1a (MGI:1926334)
19,52297168,52325926,19q13.41,19q13.41,613910,ZNF480,Zinc finger protein 480,ZNF480,147657,ENSG00000198464,NA,NA,NA
19,52392751,52418407,19q13.41,19q13.41,615580,"ZNF528, KIAA1827",Zinc finger protein 528,ZNF528,84436,ENSG00000167555,NA,NA,NA
19,52596683,52600151,19q13.3-q13.4,19q13.41,604079,ZNF137,Zinc finger protein-137,ZNF137P,7696,NA,NA,NA,NA
19,52612363,52690580,19q13.3-q13.4,19q13.41,194558,ZNF83,Zinc finger protein-83,ZNF83,55769,ENSG00000167766,NA,NA,NA
19,52838009,52857648,19q13.4,19q13.41,616841,ZNF468,Zinc finger protein 468,ZNF468,90333,ENSG00000204604,NA,NA,NA
19,52859490,52897726,19q13.3-q13.4,19q13.41,606427,ZNF320,Zinc finger protein 320,ZNF320,162967,ENSG00000182986,NA,NA,NA
19,53066613,53103433,19q13.3-q13.4,19q13.41-q13.42,600398,ZNF160,Zinc finger protein-160,ZNF160,90338,ENSG00000170949,NA,NA,NA
19,53503818,53580268,19q13.3-q13.4,19q13.42,606043,"ZNF331, ZNF463",Zinc finger protein-331,ZNF331,55422,ENSG00000130844,NA,NA,NA
19,53601113,53637056,19q13.42,19q13.42,611165,DPRX,Divergent-paired related homeobox,DPRX,503834,ENSG00000204595,many pseudogenes,NA,NA
19,53707452,53707538,19q13.42,19q13.42,615908,MIR520C,Micro RNA 520C,MIR520C,574476,ENSG00000207738,NA,NA,NA
19,53713346,53713433,19q13.42,19q13.42,614247,"MIR519D, MIRN519D",Micro RNA 519D,MIR519D,574480,ENSG00000207981,NA,NA,NA
19,53722165,53722254,19q13.42,19q13.42,616272,MIR520G,Micro RNA 520G,MIR520G,574484,ENSG00000207799,NA,NA,NA
19,53742511,53742598,19q13.42,19q13.42,614755,MIR520H,Micro RNA 520H,MIR520H,574493,ENSG00000207861,NA,NA,NA
19,53787674,53787740,19q13.41,19q13.42,612043,MIR371A,Micro RNA 371A,MIR371A,442916,ENSG00000199031,NA,NA,NA
19,53787889,53787955,19q13.41,19q13.42,612044,"MIR372, MIRN372",Micro RNA 372,MIR372,442917,ENSG00000199095,NA,NA,NA
19,53788704,53788772,19q13.41,19q13.42,611954,"MIR373, MIRN373",Micro RNA 373,MIR373,442918,ENSG00000199143,NA,NA,NA
19,53793583,53824402,19q13.4,19q13.42,609648,"NLRP12, NALP12, PYPAF7, RNO, FCAS2","NLR family, pyrin domain containing 12",NLRP12,91662,ENSG00000142405,NA,"Familial cold autoinflammatory syndrome 2, 611762 (3), Autosomal dominant",Nlrp12 (MGI:2676630)
19,53865627,53876434,19q13.33-q13.4,19q13.42,609959,MYADM,Myeloid-associated differentiation marker,MYADM,91663,ENSG00000179820,NA,NA,Myadm (MGI:1355332)
19,53882196,53907651,19q13.4,19q13.42,176980,"PRKCG, PKCC, PKCG, SCA14","Protein kinase C, gamma polypeptide",PRKCG,5582,ENSG00000126583,NA,"Spinocerebellar ataxia 14, 605361 (3), Autosomal dominant",Prkcg (MGI:97597)
19,53909424,53943943,19q13.4,19q13.42,606899,CACNG7,"Calcium channel, voltage-dependent, gamma-7 subunit",CACNG7,59284,ENSG00000105605,NA,NA,Cacng7 (MGI:1932374)
19,53962936,53990214,19q13.4,19q13.42,606900,CACNG8,"Calcium channel, voltage-dependent, gamma-8 subunit",CACNG8,59283,ENSG00000142408,NA,NA,Cacng8 (MGI:1932376)
19,53991148,54012665,19q13.4,19q13.42,606898,CACNG6,"Calcium channel, voltage-dependent, gamma-6 subunit",CACNG6,59285,ENSG00000130433,NA,NA,Cacng6 (MGI:1859168)
19,54040824,54063965,19q13.4,19q13.42,616804,"VSTM1, SIRL1",V-SET and transmembrane domains-containing protein 1,VSTM1,284415,ENSG00000189068,NA,NA,NA
19,54069894,54081364,19q13.4,19q13.42,616802,TARM1,T cell-interacting activating receptor on myeloid cells 1,TARM1,441864,ENSG00000248385,NA,NA,Tarm1 (MGI:2442280)
19,54094667,54102685,19q13.4,19q13.42,606862,OSCAR,Osteoclast-associated receptor,OSCAR,126014,ENSG00000170909,NA,NA,Oscar (MGI:2179720)
19,54102337,54107567,19q13.42,19q13.42,603832,NDUFA3,NADH-ubiquinone oxidoreductase subunit A3,NDUFA3,4696,ENSG00000170906,NA,NA,Ndufa3 (MGI:1913341)
19,54115705,54131718,19q13.4,19q13.42,606419,"PRPF31, PRP31, RP11","Precursor RNA-processing factor 31, S. cerevisiae, homolog of",PRPF31,26121,ENSG00000105618,NA,"Retinitis pigmentosa 11, 600138 (3), Autosomal dominant",Prpf31 (MGI:1916238)
19,54137688,54155689,19q13.4,19q13.42,604910,"CNOT3, NOT3","CCR4-NOT transcription complex, subunit 3",CNOT3,4849,ENSG00000088038,NA,NA,Cnot3 (MGI:2385261)
19,54160094,54173217,19q13.42,19q13.42,617181,TMC4,Transmembrane channel-like protein 4,TMC4,147798,ENSG00000167608,NA,NA,Tmc4 (MGI:2669035)
19,54173411,54189881,19q13.4,19q13.42,606048,"MBOAT7, BB1, LENG4, MRT57",Membrane bound O-acyltransferase domain containing 7,MBOAT7,79143,ENSG00000125505,NA,"Mental retardation, autosomal recessive 57, 617188 (3), Autosomal recessive",Mboat7 (MGI:1924832)
19,54189969,54194535,19q13.4,19q13.42,608754,"TSEN34, PCH2C, LENG5, SEN34","tRNA splicing endonuclease 34, S. cerevisiae, homolog of",TSEN34,79042,ENSG00000170892,mutation identified in 1 PCH2C patient,"?Pontocerebellar hypoplasia type 2C, 612390 (3)",Tsen34 (MGI:1913328)
19,54200556,54207646,19q13.4,19q13.42,603631,RPS9,Ribosomal protein S9,RPS9,6203,ENSG00000170889,NA,NA,Rps9 (MGI:1924096)
19,54216277,54223086,19q13.4,19q13.42,604820,"LILRB3, LIR3, ILT5, HL9","Leukocyte immunoglobulin-like receptor, subfamily B, member 3",LILRB3,11025,ENSG00000204577,NA,NA,"Pira1,Lilra6,Pira2,Gm14548,Pira6,Gm15448,Pirb (MGI:1195970,MGI:1195974,MGI:3705216,MGI:1195971,MGI:894311,MGI:3709645,MGI:1195969)"
19,54249420,54257291,19q13.2,19q13.42,604814,"LILRB5, LIR8","Leukocyte immunoglobulin-like receptor, subfamily B, member 5",LILRB5,10990,ENSG00000105609,NA,NA,NA
19,54273811,54281177,19q13.4,19q13.42,604815,"LILRB2, LIR2, ILT4, MIR10","Leukocyte immunoglobulin-like receptor, subfamily B, member 2",LILRB2,10288,ENSG00000131042,NA,NA,NA
19,54307069,54313165,19q13.4,19q13.42,606047,"LILRA9, ILT11, CD85F, LIR9","Leukocyte immunoglobulin-like receptor, subfamily A, member 5",LILRA5,353514,ENSG00000187116,NA,NA,Lilra5 (MGI:3647196)
19,54333184,54339161,19q13.42,19q13.42,607517,"LILRA4, ILT7","Leukocyte immunoglobulin-like receptor, subfamily A, member 4",LILRA4,23547,ENSG00000239961,NA,NA,NA
19,54351383,54370555,19q13.4,19q13.42,602992,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,LAIR1,3903,ENSG00000167613,NA,NA,Lair1 (MGI:105492)
19,54415463,54436903,19q13.4,19q13.42,605784,TTYH1,"Tweety, Drosophila, homolog of, 1",TTYH1,57348,ENSG00000167614,NA,NA,Ttyh1 (MGI:1889007)
19,54447620,54462021,19q13.42,19q13.42,616575,"LENG8, KIAA1932",Leukocyte receptor cluster gene 8,LENG8,114823,ENSG00000167615,NA,NA,Leng8 (MGI:2142195)
19,54465025,54473295,19q13.42,19q13.42,609171,"CDC42EP5, CEP5, BORG3",CDC42 effector protein 5,CDC42EP5,148170,ENSG00000167617,NA,NA,Cdc42ep5 (MGI:1929745)
19,54502809,54510692,19q13.42,19q13.42,602993,"LIAR2, CD306",Leukocyte-associated immunoglobulin-like receptor 2,LAIR2,3904,ENSG00000167618,NA,NA,NA
19,54572987,54590286,19q13.4,19q13.42,604812,"LILRA2, LIR7, ILT1","Leukocyte immunoglobulin-like receptor, subfamily A, member 2",LILRA2,11027,ENSG00000239998,NA,NA,NA
19,54593575,54602380,19q13.2,19q13.42,604810,"LILRA1, LIR6","Leukocyte immunoglobulin-like receptor, subfamily A, member 1",LILRA1,11024,ENSG00000104974,NA,NA,NA
19,54616929,54637924,19q13.4,19q13.42,604811,"LILRB1, LIR1, ILT2, MIR7, CD85","Leukocyte immunoglobulin-like receptor, subfamily B, member 1",LILRB1,10859,ENSG00000104972,NA,NA,NA
19,54662523,54670358,19q13.4,19q13.42,604821,"LILRB4, LIR5, ILT3, HM18","Leukocyte immunoglobulin-like receptor, subfamily B, member 4",LILRB4,11006,ENSG00000186818,NA,NA,"Lilrb4a,Lilr4b (MGI:102701,MGI:102702)"
19,54724446,54736535,19q13.4,19q13.42,610095,"KIR3KL3, KIRC1, KIR3DL7, KIR44","Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3",KIR3DL3,115653,ENSG00000242019,NA,NA,"Kir3dl2,Kir3dl1 (MGI:2652397,MGI:3612791)"
19,54738512,54753051,19q13.4,19q13.42,604938,"KIR2DL3, NKAT2","Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3",KIR2DL3,3804,ENSG00000243772,NA,NA,NA
19,54769207,54784325,19q13.4,19q13.42,604936,"KIR2DL1, NKAT1","Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1",KIR2DL1,3802,ENSG00000125498,NA,NA,NA
19,54786361,54790417,19q13.4,19q13.42,610604,"KIR3DP1, CD158C, KIRX, KIR48, KIR2DS6","Killer cell immunoglobulin-like receptor, three domains, pseudogene",KIR3DP1,548594,NA,functional in some individuals,NA,NA
19,54803609,54814516,19q13.4,19q13.42,604945,"KIR2DL4, KIR103AS","Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4",KIR2DL4,3805,ENSG00000189013,NA,NA,NA
19,54816437,54830777,19q13.4,19q13.42,604946,"KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1","Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1",KIR3DL1,3811,ENSG00000167633,NA,"{AIDS, delayed/rapid progression to}, 609423 (3)",NA
19,54832706,54848574,19q13.4,19q13.42,604955,"KIR2DS4, NKAT8","Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4",KIR2DS4,3809,ENSG00000221957,NA,NA,NA
19,54850319,54867208,19q13.4,19q13.42,604947,"KIR3DL2, NKAT4","Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2",KIR3DL2,3812,ENSG00000240403,NA,NA,NA
19,54874230,54891419,19q13.4,19q13.42,147045,FCAR,"Fc fragment of IgA, receptor for",FCAR,2204,ENSG00000186431,NA,NA,NA
19,54906062,54938210,19q13.42,19q13.42,604530,"NCR1, LY94, NKP46","Natural cytotoxicity triggering receptor 1 (lymphocyte antigen 94, mouse, homolog of)",NCR1,9437,ENSG00000189430,NA,NA,Ncr1 (MGI:1336212)
19,54923508,54965183,19q13.4,19q13.42,609661,"NALP7, NOD12, PYPAF3, HYDM","NACHT domain-, leucine-rich repeat-, and PYD-containing protein 7",NLRP7,199713,ENSG00000167634,NA,"Hydatidiform mole, recurrent, 1, 231090 (3), Autosomal recessive",NA
19,54965283,55001141,19q13.4,19q13.42,609364,"NALP2, PAN1, PYPAF2","NACHT-, leucine-rich repeat-, and PYD-containing 2",NLRP2,55655,ENSG00000022556,NA,NA,Nlrp2 (MGI:3041206)
19,55013704,55038263,19q13.4,19q13.42,605546,"GP6, GPIV, BDPLT11","Glycoprotein VI, platelet",GP6,51206,ENSG00000088053,NA,"Bleeding disorder, platelet-type, 11, 614201 (3), Autosomal recessive",Gp6 (MGI:1889810)
19,55075868,55087922,19q13.4,19q13.42,614987,"EPS8L1, EPS8R1",EPS8-like protein 1,EPS8L1,54869,ENSG00000131037,NA,NA,Eps8l1 (MGI:1914675)
19,55090912,55117636,19q13.3-q13.4,19q13.42,613245,"PPP1R12C, MBS85","Protein phosphatase 1, regulatory subunit 12C",PPP1R12C,54776,ENSG00000125503,NA,NA,Ppp1r12c (MGI:1924258)
19,55132697,55149331,19q13.4,19q13.42,191041,"TNNT1, ANM, NEM5","Troponin-T1, skeletal, slow",TNNT1,7138,ENSG00000105048,NA,"Nemaline myopathy 5, Amish type, 605355 (3), Autosomal recessive",Tnnt1 (MGI:1333868)
19,55151766,55157731,19q13.4,19q13.42,191044,"TNNI3, CMH7, CMD2A, RCM1, CMD1FF","Troponin-I, cardiac",TNNI3,7137,ENSG00000129991,mutation identified in 1 CMD2A family,"Cardiomyopathy, dilated, 1FF, 613286 (3); ?Cardiomyopathy, dilated, 2A, 611880 (3), Autosomal recessive; Cardiomyopathy, familial restrictive, 1, 115210 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 7, 613690 (3), Autosomal dominant",Tnni3 (MGI:98783)
19,55158660,55166721,19q13.4,19q13.42,614566,"DNAAF3, PF22, DAB1, CILD2","Dynein, axonemal, assembly factor 3",DNAAF3,352909,ENSG00000167646,NA,"Ciliary dyskinesia, primary, 2, 606763 (3), Autosomal recessive",Dnaaf3 (MGI:3588207)
19,55171195,55180440,19q13.42,19q13.42,600782,SYT5,Synaptotagmin-5,SYT5,6861,ENSG00000129990,NA,NA,Syt5 (MGI:1926368)
19,55181246,55209505,19q13.4,19q13.42,602510,PTPRH,"Protein tyrosine phosphatase, receptor type, H",PTPRH,5794,ENSG00000080031,NA,NA,Ptprh (MGI:3026877)
19,55226633,55229263,19q13.42,19q13.42,617806,TMEM86B,Transmembrane protein 86B,TMEM86B,255043,ENSG00000180089,NA,NA,Tmem86b (MGI:1915505)
19,55229778,55259016,19q13.42,19q13.42,610875,"SAPS1, PP6R1, KIAA1115","SAPS domain family, member 1",PPP6R1,22870,ENSG00000105063,NA,NA,Ppp6r1 (MGI:2442163)
19,55262222,55280422,19q13.42,19q13.42,612939,HSPBP1,Heat-shock 70kD protein-binding protein 1,HSPBP1,23640,ENSG00000133265,NA,NA,Hspbp1 (MGI:1913495)
19,55283996,55312561,19q13.4,19q13.42,609235,"BRSK1, KIAA1811",BR serine/threonine kinase 1,BRSK1,84446,ENSG00000160469,NA,NA,Brsk1 (MGI:2685946)
19,55308868,55334042,19q13.42,19q13.42,617291,"TMEM150B, DRAM3, TTN2, TMEM224",Transmembrane protein 150B,TMEM150B,284417,ENSG00000180061,NA,NA,Tmem150b (MGI:2679718)
19,55339875,55348120,19q13.42,19q13.42,613198,SUV420H2,"Suppressor of variegation 4-20, Drosophila, homolog of, 2",KMT5C,84787,ENSG00000133247,NA,NA,Kmt5c (MGI:2385262)
19,55349703,55354718,19q13.4,19q13.42,618127,"COX6B2, CT59","Cytochrome c oxidase, subunit 6B2",COX6B2,125965,ENSG00000160471,NA,NA,Cox6b2 (MGI:3044182)
19,55364381,55370462,19q13.3-q13.4,19q13.42,147681,IL11,Interleukin-11,IL11,3589,ENSG00000095752,NA,NA,Il11 (MGI:107613)
19,55385931,55403341,19q13.4,19q13.42,603638,RPL28,Ribosomal protein L28,RPL28,6158,ENSG00000108107,NA,NA,Rpl28 (MGI:101839)
19,55399744,55408438,19q13.42,19q13.42,610309,"UBE2S, EPF5, E2EPF",Ubiquitin-conjugating enzyme E2S,UBE2S,27338,ENSG00000108106,NA,NA,Ube2s (MGI:1925141)
19,55428737,55442862,19q13.42,19q13.42,617328,SHISA7,"Shisa family, member 7",SHISA7,729956,ENSG00000187902,NA,NA,Shisa7 (MGI:3605641)
19,55452984,55461641,19q13.42,19q13.42,612928,ISOC2,Isochorismatase domain-containing 2,ISOC2,79763,ENSG00000063241,NA,NA,Isoc2a (MGI:3609243)
19,55476602,55484486,19q13.4,19q13.42,610671,"ZNF628, ZEC",Zinc finger protein 628,ZNF628,89887,ENSG00000197483,NA,NA,Zfp628 (MGI:2665174)
19,55488435,55519098,19q13.4,19q13.42,618194,SSC5D,Scavenger receptor cysteine-rich family member with 5 domains,SSC5D,284297,ENSG00000179954,NA,NA,Ssc5d (MGI:3606211)
19,55591375,55599702,19q13.42,19q13.42,609133,"FIZ1, FLJ14768",FLT3-interacting zinc finger protein 1,FIZ1,84922,ENSG00000179943,NA,NA,Fiz1 (MGI:1344336)
19,55641001,55643469,19q13.42,19q13.42,617888,ZNF580,Zinc finger protein 580,ZNF580,51157,ENSG00000213015,NA,NA,Zfp580 (MGI:1916242)
19,55647399,55653160,19q13.42,19q13.42,613478,CCDC106,Coiled-coil domain-containing protein 106,CCDC106,29903,ENSG00000173581,NA,NA,Ccdc106 (MGI:2385900)
19,55654049,55674715,19q13.42,19q13.42,191318,"U2AF2, U2AF65",U2 small nuclear RNA auxiliary factor 2,U2AF2,11338,ENSG00000063244,NA,NA,U2af2 (MGI:98886)
19,55675194,55695766,19q13,19q13.42,607262,EPN1,Epsin 1,EPN1,29924,ENSG00000063245,NA,NA,Epn1 (MGI:1333763)
19,55708437,55738401,19q13.4,19q13.42,609663,"NALP9, NOD6","NACHT domain-, leucine-rich repeat-, and PYD-containing protein 9",NLRP9,338321,ENSG00000185792,NA,NA,Nlrp9b (MGI:2675377)
19,55757297,55763420,19q13.4,19q13.42,612601,"RFPL4A, RNF210",Ret finger protein-like 4A,RFPL4A,342931,ENSG00000223638,NA,NA,NA
19,55785396,55836761,19q13.4,19q13.42-q13.43,609664,"NALP11, PYPAF7, NOD17","NACHT domain-, leucine-rich repeat-, and PYD-containing protein 11",NLRP11,204801,ENSG00000179873,NA,NA,NA
19,55836539,55881854,19q13.4,19q13.43,609645,"NALP4, PAN2, PYPAF4","NACHT domain-, leucine-rich repeat-c and PYD-containing protein 4",NLRP4,147945,ENSG00000160505,NA,NA,"Nlrp4c,Nlrp4e (MGI:3056600,MGI:1890518)"
19,55891691,55932335,19q13.4,19q13.43,609660,"NALP13, NOD14","NACHT domain-, leucine-rich repeat-, and PYD-containing protein 13",NLRP13,126204,ENSG00000173572,NA,NA,NA
19,55947831,55988628,19q13.4,19q13.43,609659,"NALP8, NOD16, PAN4","NACHT domain-, leucine-rich repeat-, and PYD-containing protein 8",NLRP8,126205,ENSG00000179709,NA,NA,NA
19,55999725,56061809,19q13,19q13.43,609658,"NALP5, MATER","NACHT domain-, leucine-rich repeat-, and PYD-containing protein 5",NLRP5,126206,ENSG00000171487,NA,NA,Nlrp5 (MGI:1345193)
19,56132508,56160892,19q13.43,19q13.43,607874,"ZNF444, EZF2",Zinc finger protein 444,ZNF444,55311,ENSG00000167685,NA,NA,Zfp444 (MGI:1923365)
19,56176007,56185774,19q13.4,19q13.43,611178,"GALP, ALARIN",Galanin-like peptide (GALP precursor protein),GALP,85569,ENSG00000197487,NA,NA,Galp (MGI:2663979)
19,56382750,56393584,19q13.43,19q13.43,615600,ZNF582,Zinc finger protein 582,ZNF582,147948,ENSG00000018869,NA,NA,NA
19,56438511,56478064,19q13.4,19q13.43,611024,"ZNF667, MIPU1",Zinc finger protein 667,ZNF667,63934,ENSG00000198046,NA,NA,Zfp667 (MGI:2442757)
19,56536789,56559191,19q13.4,19q13.43,616798,ZFP28,Zinc finger protein 28,ZFP28,140612,ENSG00000196867,NA,NA,Zfp28 (MGI:99175)
19,56595295,56624485,19q13.4,19q13.43,194545,ZNF71,Zinc finger protein-71 (Cos26),ZNF71,58491,ENSG00000197951,previously assigned to 22q11.2,NA,NA
19,56810081,56840725,19q13.4,19q13.43,601483,PEG3,Paternally expressed gene 3,PEG3,5178,ENSG00000198300,NA,NA,Peg3 (MGI:104748)
19,57151725,57167487,19q13.43,19q13.43,611168,DUXA,Double homeobox A,DUXA,503835,ENSG00000258873,many pseudogenes,NA,NA
19,57191499,57222845,19q13.4,19q13.43,604668,ZNF264,Zinc finger protein-264,ZNF264,9422,ENSG00000083844,NA,NA,NA
19,57230316,57235549,19q13.43,19q13.43,603495,"AURKC, STK13, AIE2, SPGF5",Aurora kinase C,AURKC,6795,ENSG00000105146,NA,"Spermatogenic failure 5, 243060 (3), Autosomal recessive",Aurkc (MGI:1321119)
19,57279966,57294068,19q13.4,19q13.43,604755,"ZNF272, HZF8, ZNF460",Zinc finger protein-272,ZNF460,10794,ENSG00000197714,NA,NA,NA
19,57320471,57330769,19q13.43,19q13.43,616847,ZNF543,Zinc finger protein 543,ZNF543,125919,ENSG00000178229,NA,NA,NA
19,57351252,57359897,19q13.43,19q13.43,613840,ZNF304,Zinc finger protein 304,ZNF304,57343,ENSG00000131845,NA,NA,NA
19,57455173,57456738,19q13.4,19q13.43,605234,"VN1R1, V1RL1",Vomeronasal 1 receptor 1,VN1R1,57191,ENSG00000178201,NA,NA,NA
19,57487719,57496097,19q13.43,19q13.43,617410,ZNF419,Zinc finger protein 419,ZNF419,79744,ENSG00000105136,NA,NA,NA
19,57614241,57624723,19q13.4,19q13.43,604076,ZNF134,Zinc finger protein-134,ZNF134,7693,ENSG00000213762,NA,NA,NA
19,57633166,57644045,19q13.4,19q13.43,601856,ZNFC25,Zinc finger protein-C2H2-25,ZNF211,10520,ENSG00000121417,NA,NA,NA
19,57651496,57679151,19q13.43,19q13.43,613419,"ZSCAN4, ZNF494",Zinc finger- and SCAN domain-containing protein 4,ZSCAN4,201516,ENSG00000180532,NA,NA,NA
19,57696274,57709210,19q13.4,19q13.43,604085,ZNF154,Zinc finger protein-154,ZNF154,7710,ENSG00000179909,NA,NA,NA
19,57940832,57947705,19q13,19q13.43,606956,ZNF256,Zinc finger protein 256,ZNF256,10172,ENSG00000152454,NA,NA,NA
19,57977047,58003345,19q13.4,19q13.43,613905,"ZNF606, ZNF328, KIAA1852",Zinc finger protein 606,ZNF606,80095,ENSG00000166704,NA,NA,Zfp606 (MGI:1914620)
19,58059226,58069754,19q13.4,19q13.43,604077,ZNF135,Zinc finger protein-135,ZNF135,7694,ENSG00000176293,NA,NA,NA
19,58182988,58213561,19q13.4,19q13.43,605467,ZNF274,Zinc finger protein-274,ZNF274,10782,ENSG00000171606,NA,NA,"Zfp369,Zfp110 (MGI:1890378,MGI:2176229)"
19,58278954,58302790,19q13.43,19q13.43,194532,ZNF8,Zinc finger protein-8,ZNF8,7554,ENSG00000278129,previously assigned to 20q13,NA,Zfp128 (MGI:2389445)
19,58326993,58342335,19q13.43,19q13.43,165260,"ZSCAN22, HKR2",Zinc finger- and SCAN domain-containing protein 22,ZSCAN22,342945,ENSG00000182318,NA,NA,Zscan22 (MGI:2443312)
19,58345182,58353491,19cen-q13.2,19q13.43,138670,A1BG,"Glycoprotein, alpha-1B",A1BG,1,ENSG00000121410,order:  C3-SE-LU-A1BG,NA,A1bg (MGI:2152878)
19,58387268,58394803,19q13.4,19q13.43,603630,RPS5,Ribosomal protein S5,RPS5,6193,ENSG00000083845,NA,NA,Rps5 (MGI:1097682)
19,58432813,58440152,19q13.4,19q13.43,604074,ZNF132,Zinc finger protein-132,ZNF132,7691,ENSG00000131849,NA,NA,NA
19,58467079,58475435,19q13.43,19q13.43,617477,"ZNF324, ZF5128",Zinc finger protein 324,ZNF324,25799,ENSG00000083812,NA,NA,Zfp324 (MGI:2444641)
19,58498332,58512064,19q13.43,19q13.43,603314,"SLC27A5, FATP5, VLACSR, VLCSH2","Solute carrier family 27 (fatty acid transporter), member 5",SLC27A5,10998,ENSG00000083807,NA,NA,Slc27a5 (MGI:1347100)
19,58544063,58550721,19q13.4,19q13.43,601742,"TRIM28, KAP1, TIF1B",Tripartite motif-containing protein 28,TRIM28,10155,ENSG00000130726,NA,NA,Trim28 (MGI:109274)
19,58551565,58555623,19q,19q13.43,610893,"CHMP2A, VPS2A, VPS2, BC2","CHMP family, member 2A",CHMP2A,27243,ENSG00000130724,NA,NA,Chmp2a (MGI:1916203)
19,58555711,58558610,19q13.43,19q13.43,603173,"UBE2M, UBC12",Ubiquitin-conjugating enzyme E2M,UBE2M,9040,ENSG00000130725,NA,NA,Ube2m (MGI:108278)
19,58561916,58574477,19q13.2-q13.4,19q13.43,194550,"ZNF42, MZF1",Zinc finger protein-42 (myeloid-specific retinoic acid responsive),MZF1,7593,ENSG00000099326,NA,NA,Mzf1 (MGI:107457)
19,0,58617616,Chr.19,NA,603979,ZNF97,Zinc finger protein-97,NA,NA,NA,NA,NA,NA
20,0,28100000,20p,NA,607116,AD8,Alzheimer disease 8,NA,353128,NA,?related to CST3,"Alzheimer disease 8, 607116 (2)",NA
20,0,5100000,20p13,NA,608031,ALS7,Amyotrophic lateral sclerosis 7,ALS7,406238,NA,max lod at D20S103,"Amyotrophic lateral sclerosis 7, 608031 (2)",NA
20,0,28100000,20p,NA,605804,ATOD3,"Dermatitis, atopic, 3",NA,117187,NA,max lod at D20S115,"{Dermatitis, atopic, susceptibility to, 3}, 605804 (2)",NA
20,0,25700000,20pter-p11.2,NA,608559,BMIQ6,Body mass index quantitative trait locus 6,BMIQ6,449017,NA,near D20S482 and D20S851,"[Body mass index QTL6], 608559 (2)",NA
20,0,5100000,20p13,NA,611242,RLS5,"Restless legs syndrome, susceptibility to, 5",NA,100188839,NA,max lod at D20S849,"{Restless legs syndrome 5}, 611242 (2)",NA
20,297569,300320,20p13,20p13,618326,ZCCHC3,Zinc finger CCHC domain-containing protein 3,ZCCHC3,85364,ENSG00000247315,NA,NA,Zcchc3 (MGI:1915167)
20,325570,330227,20p13,20p13,601947,"SOX12, SOX22",SRY (sex-determining region Y)-box 12,SOX12,6666,ENSG00000177732,NA,NA,Sox12 (MGI:98360)
20,346725,359704,20p13,20p13,610666,NRSN2,Neurensin 2,NRSN2,80023,ENSG00000125841,NA,NA,Nrsn2 (MGI:2684969)
20,380628,397558,20p13,20p13,607898,"TRIB3, NIPK, SINK, C20orf97, SKIP3","Tribbles, Drosophila, homolog of, 3",TRIB3,57761,ENSG00000101255,NA,NA,Trib3 (MGI:1345675)
20,408049,432138,20p13,20p13,610924,"RBCK1, HOIL1, PGBM1, PBMEI",RANBP-type and C3HC4-type zinc finger-containing 1,RBCK1,10616,ENSG00000125826,NA,"Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3), Autosomal recessive",Rbck1 (MGI:1344372)
20,435476,462552,20p13,20p13,611663,"TBC1D20, C20orf140, WARBM4","TBC1 domain family, member 20",TBC1D20,128637,ENSG00000125875,NA,"Warburg micro syndrome 4, 615663 (3), Autosomal recessive",Tbc1d20 (MGI:1914481)
20,472497,543789,20p13,20p13,115440,"CSNK2A1, CK2A1, OCNDS","Casein kinase-2, alpha-1 polypeptide",CSNK2A1,1457,ENSG00000101266,pseudogene on 11p15,"Okur-Chung neurodevelopmental syndrome, 617062 (3), Autosomal dominant",Csnk2a1 (MGI:88543)
20,603992,610265,20p13,20p13,601010,TCF15,Transcription factor-15 (basic helix-loop-helix),TCF15,6939,ENSG00000125878,NA,NA,Tcf15 (MGI:104664)
20,646614,653199,20p13,20p13,617583,"SRXN1, SRX",Sulfiredoxin 1,SRXN1,140809,ENSG00000271303,NA,NA,Srxn1 (MGI:104971)
20,760079,775984,20p13,20p13,613350,"SLC52A3, C20orf54, RFT2, BVVLS1","Solute carrier family 52, riboflavin transporter, member 3",SLC52A3,113278,ENSG00000101276,mutation identified in 1 FZLD family,"Brown-Vialetto-Van Laere syndrome 1, 211530 (3), Autosomal recessive; ?Fazio-Londe disease, 211500 (3), Autosomal recessive",Slc52a3 (MGI:1916948)
20,833714,846278,20p13,20p13,611393,"FAM110A, C20orf55","Family with sequence similarity 110, member A",FAM110A,83541,ENSG00000125898,NA,NA,Fam110a (MGI:1921097)
20,869899,916367,20p13,20p13,603705,"ANGPT4, ANG4",Angiopoietin 4,ANGPT4,51378,ENSG00000101280,no ANGT3 in human,NA,Angpt4 (MGI:1336887)
20,958451,1002310,20p13,20p13,610573,"RSPO4, CRISTIN4","R-spondin family, member 4",RSPO4,343637,ENSG00000101282,NA,"Anonychia congenita, 206800 (3), Autosomal recessive",Rspo4 (MGI:1924467)
20,1113228,1172245,20p13,20p13,617858,"PSMF1, PI31",Proteasome inhibitor subunit 1,PSMF1,9491,ENSG00000125818,NA,NA,Psmf1 (MGI:1346072)
20,1266291,1309326,20p13,20p13,604942,SNPH,Syntaphilin,SNPH,9751,ENSG00000101298,NA,NA,Snph (MGI:2139270)
20,1309908,1329138,20p13,20p13,617358,"SDCBP2, SITAC, ST2, SITAC18",Syndecan-binding protein 2,SDCBP2,27111,ENSG00000125775,NA,NA,Sdcbp2 (MGI:2385156)
20,1368976,1393171,20p13,20p13,186945,"FKBP1A, FKBP12","FK506-binding protein-1A, 12kD",FKBP1A,2280,ENSG00000088832,NA,NA,Fkbp1a (MGI:95541)
20,1442161,1467792,20p,20p13,606610,P47,"p47, rat, homolog of",NSFL1C,55968,ENSG00000088833,NA,NA,Nsfl1c (MGI:3042273)
20,1564192,1620446,20p13,20p13,603889,SIRPB1,"Signal regulatory protein, beta-1",SIRPB1,10326,ENSG00000101307,NA,NA,"Sirpb1a,Sirpb1b,Sirpb1c (MGI:2444824,MGI:3807521,MGI:3779828)"
20,1629151,1686515,20p13,20p13,605466,"SIRPG, SIRPB2","Signal regulatory protein, gamma",SIRPG,55423,ENSG00000089012,NA,NA,NA
20,1894166,1940591,20p13,20p13,602461,SHPS1,SHP substrate-1,SIRPA,140885,ENSG00000198053,NA,NA,Sirpa (MGI:108563)
20,1978755,1994284,20p13,20p13,131340,"PDYN, SCA23",Prodynorphin,PDYN,5173,ENSG00000101327,NA,"Spinocerebellar ataxia 23, 610245 (3), Autosomal dominant",Pdyn (MGI:97535)
20,2098020,2148554,20p13,20p13,609370,"STK35, CLIK1",Serine/threonine kinase 35,STK35,140901,ENSG00000125834,NA,NA,Stk35 (MGI:1914583)
20,2296000,2341078,20q12,20p13,600238,"TGM3, UHS2","Transglutaminase-3 (E polypeptide, protein-glutamine-gamma-glutamyl transferase)",TGM3,7053,ENSG00000125780,mutation identified in 1 UHS2 patient,"?Uncombable hair syndrome 2, 617251 (3), Autosomal recessive",Tgm3 (MGI:98732)
20,2380900,2432752,20p13-p12.2,20p13,613900,"TGM6, TG6, TGY, SCA35",Transglutaminase 6,TGM6,343641,ENSG00000166948,NA,"Spinocerebellar ataxia 35, 613908 (3), Autosomal dominant",Tgm6 (MGI:3044321)
20,2461641,2470788,20p13,20p13,182282,"SNRPB, CCMS",Small nuclear ribonucleoprotein polypeptides B and B1,SNRPB,6628,ENSG00000125835,NA,"Cerebrocostomandibular syndrome, 117650 (3), Autosomal dominant",Snrpb (MGI:98342)
20,2536606,2641783,20p13,20p13,606707,TMC2,Transmembrane channel-like protein 2,TMC2,117532,ENSG00000149488,NA,NA,Tmc2 (MGI:2151017)
20,2652531,2658392,20p13,20p13,614154,"NOP56, SCA36","Nop56, S. cerevisiae, homolog of",NOP56,10528,ENSG00000101361,NA,"Spinocerebellar ataxia 36, 614153 (3), Autosomal dominant",Nop56 (MGI:1914384)
20,2652776,2652841,20p13,20p13,614155,"MIR1292, MIRN1292",Micro RNA 1292,MIR1292,100302138,ENSG00000284481,NA,NA,NA
20,2658389,2664222,20p13,20p13,604526,"IDH3B, RP46","Isocitrate dehydrogenase 3, beta subunit",IDH3B,3420,ENSG00000101365,NA,"Retinitis pigmentosa 46, 612572 (3)",Idh3b (MGI:2158650)
20,2692877,2760107,20p13,20p13,609935,"EBF4, KIAA1442",Early B-cell factor 4,EBF4,57593,ENSG00000088881,NA,NA,Ebf4 (MGI:2385972)
20,2840696,2866731,20p13,20p13,608550,VPS16,"Vacuolar protein sorting 18, yeast, homolog of",VPS16,64601,ENSG00000215305,NA,NA,Vps16 (MGI:2136772)
20,2864194,3038668,20p13,20p13,176884,"PTPRA, PTPA, PTPRL2, LRP","Protein tyrosine phosphatase, receptor type, alpha polypeptide",PTPRA,5786,ENSG00000132670,NA,NA,Ptpra (MGI:97808)
20,3039060,3045895,20p13,20p13,602352,GNRH2,Gonadotropin-releasing hormone-2,GNRH2,2797,ENSG00000125787,NA,NA,NA
20,3046051,3048249,20p13,20p13,611988,"MRPS26, MRPS13",Mitochondrial ribosomal protein S26,MRPS26,64949,ENSG00000125901,NA,NA,Mrps26 (MGI:1333830)
20,3068870,3072516,20p13,20p13,167050,OXT,Oxytocin-neurophysin I,OXT,5020,ENSG00000101405,12kb from ARVP,NA,Oxt (MGI:97453)
20,3082555,3093520,20p13,20p13,192340,"AVP, AVRP, VP","Arginine vasopressin (neurophysin II, antidiuretic hormone)",AVP,551,ENSG00000101200,distal 20p,"Diabetes insipidus, neurohypophyseal, 125700 (3), Autosomal dominant",Avp (MGI:88121)
20,3146518,3159864,20p13,20p13,614272,FASTKD5,Fast kinase domain-containing protein 5,FASTKD5,60493,ENSG00000215251,NA,NA,Fastkd5 (MGI:2139469)
20,3162616,3173596,20p13,20p13,610484,"PROSAPIP1, KIAA0552",Proline-rich synapse-associated protein-interacting protein 1,LZTS3,9762,ENSG00000088899,NA,NA,Lzts3 (MGI:2656976)
20,3190349,3204681,20p13,20p13,616177,"DDRGK1, UFBP1, C20orf116, SEMDSH",DDRGK domain-containing protein 1,DDRGK1,65992,ENSG00000198171,NA,"Spondyloepimetaphyseal dysplasia, Shohat type, 602557 (3), Autosomal recessive",Ddrgk1 (MGI:1924256)
20,3208675,3227448,20p,20p13,147520,"ITPA, EIEE35",Inosine triphosphatase-A,ITPA,3704,ENSG00000125877,NA,"Epileptic encephalopathy, early infantile, 35, 616647 (3), Autosomal recessive; [Inosine triphosphatase deficiency], 613850 (3)",Itpa (MGI:96622)
20,3227416,3241483,20p13-p12,20p13,610206,"SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4","Solute carrier family 4 (sodium borate cotransporter), member 11",SLC4A11,83959,ENSG00000088836,NA,"Corneal dystrophy, Fuchs endothelial, 4, 613268 (3); Corneal endothelial dystrophy and perceptive deafness, 217400 (3), Autosomal recessive; Corneal endothelial dystrophy, autosomal recessive, 217700 (3), Autosomal recessive",Slc4a11 (MGI:2138987)
20,3249301,3407661,20p13,20p13,614146,C20orf194,Chromosome 20 open reading frame 194,C20orf194,25943,ENSG00000088854,NA,NA,4930402H24Rik (MGI:1923029)
20,3471017,3651117,20p13,20p13,603130,"ATRN, MGCA","Attractin (mahogany, mouse, homolog of)",ATRN,8455,ENSG00000088812,NA,NA,Atrn (MGI:1341628)
20,3667964,3682689,20p13,20p13,607114,ADAM33,A disintegrin and metalloproteinase domain 33,ADAM33,80332,ENSG00000149451,NA,NA,Adam33 (MGI:1341813)
20,3686969,3712599,20p13,20p13,600751,"SIGLEC1, SN, CD169",Sialic acid-binding immunoglobulin-like lectin 1 (sialoadhesin),SIGLEC1,6614,ENSG00000088827,NA,NA,Siglec1 (MGI:99668)
20,3732684,3753110,20p13,20p13,610702,HSPA12B,Heat-shock 70kD protein 12B,HSPA12B,116835,ENSG00000132622,NA,NA,Hspa12b (MGI:1919880)
20,3777503,3781447,20p13,20p13,610674,"C20orf28, CLAMP, SPEF1",Sperm flagellar protein 1,SPEF1,25876,ENSG00000101222,NA,NA,Spef1 (MGI:3513546)
20,3783850,3786739,20p13,20p13,117140,CENPB,Centromeric protein B,CENPB,1059,ENSG00000125817,NA,NA,Cenpb (MGI:88376)
20,3786771,3806120,20p13,20p13,116949,CDC25B,Cell division cycle 25B,CDC25B,994,ENSG00000101224,NA,NA,Cdc25b (MGI:99701)
20,3820523,3828837,20p13,20p13,614824,"AP5S1, C20orf29","Adaptor-related protein complex 5, sigma-1 subunit",AP5S1,55317,ENSG00000125843,NA,NA,Ap5s1 (MGI:1916846)
20,3846798,3876122,20p13,20p13,609676,"MAVS, VISA, IPS1, CARDIF, KIAA1271",Mitochondrial antiviral signaling protein,MAVS,57506,ENSG00000088888,NA,NA,Mavs (MGI:2444773)
20,3888780,3933086,20p13-p12.3,20p13,606157,"PANK2, NBIA1, PKAN, HARP",Pantothenate kinase 2,PANK2,80025,ENSG00000125779,NA,"HARP syndrome, 607236 (3), Autosomal recessive; Neurodegeneration with brain iron accumulation 1, 234200 (3), Autosomal recessive",Pank2 (MGI:1921700)
20,3917493,3917570,20p13,20p13,613188,"MIR103-2, MIRN103-2",Micro RNA 103-2,MIR103A2,406896,ENSG00000199024,NA,NA,NA
20,3927310,4015587,20p13-p12.1,20p13,612489,"RNF24, G1L",Ring finger protein 24,RNF24,11237,ENSG00000101236,NA,NA,Rnf24 (MGI:1261771)
20,4148778,4187746,20p13,20p13,615854,"SMOX, SMO, PAO1, C20orf16, PAOH",Spermine oxidase,SMOX,54498,ENSG00000088826,NA,NA,Smox (MGI:2445356)
20,4220629,4249286,20p13,20p13,104219,"ADRA1D, ADRA1A","Adrenergic, alpha-1D-, receptor",ADRA1D,146,ENSG00000171873,incorrectly assigned to 5q,NA,Adra1d (MGI:106673)
20,4686455,4701587,20pter-p12,20p13,176640,"PRNP, PRIP, KURU, CJD",Prion protein (p27-30),PRNP,5621,ENSG00000171867,pter-PRNP-SCG1-BMP2A-PAX1-cen,"Cerebral amyloid angiopathy, PRNP-related, 137440 (3), Autosomal dominant; Creutzfeldt-Jakob disease, 123400 (3), Autosomal dominant; Gerstmann-Straussler disease, 137440 (3), Autosomal dominant; Huntington disease-like 1, 603218 (3), Autosomal dominant; Insomnia, fatal familial, 600072 (3), Autosomal dominant; {Kuru, susceptibility to}, 245300 (3); Prion disease with protracted course, 606688 (3), Autosomal dominant",Prnp (MGI:97769)
20,4721908,4728459,20pter-p12,20p13,604263,"PRND, DPL","Prion gene complex, downstream (doppel)",PRND,23627,ENSG00000171864,NA,NA,"Prn,Prnd (MGI:1346999,MGI:97767)"
20,4852357,5010312,20p13-p12,20p13,603791,"SLC23A2, SVCT2","Solute carrier family 23 (nucleobase transporters), member 2 (sodium-dependent vitamin C transporter 2)",SLC23A2,9962,ENSG00000089057,NA,NA,Slc23a2 (MGI:1859682)
20,5064876,5113090,20p13,20p13-p12,617019,"TMEM230, C20orf30",Transmembrane protein 230,TMEM230,29058,ENSG00000089063,NA,NA,Tmem230 (MGI:1917862)
20,5100000,9200000,20p12.3,NA,611738,BMND7,Bone mineral density QTL 7,NA,100188853,NA,most significant association with haplotype C,"{Osteoporosis}, 166710 (2), Autosomal dominant",NA
20,5100000,9200000,20p12.3,NA,612592,CRCS11,"Colorectal cancer, susceptibility to, 11",NA,100271692,NA,associated with rs961253,"{Colorectal cancer, susceptibility to, 11}, 612592 (2)",NA
20,5100000,17900000,20p12,NA,608696,"GLC1K, JOAG3","Glaucoma 1K, primary open angle, juvenile-onset",GLC1K,574077,NA,between D20S189 and D20S104,"Glaucoma 1K, primary open angle, juvenile-onset, 608696 (2)",NA
20,5100000,17900000,20p12,NA,610065,SLEB7,"Systemic lupus erythematosus, susceptibility to, 7",NA,100188803,NA,NA,"{Systemic lupus erythematosus, susceptibility to, 7}, 610065 (2)",NA
20,5114952,5126621,20p12,20p12.3,176740,"PCNA, ATLD2",Proliferating cell nuclear antigen,PCNA,5111,ENSG00000132646,pseudogenes on X and 6; mutation identified in one ATLD2 family,"?Ataxia-telangiectasia-like disorder 2, 615919 (3), Autosomal recessive",Pcna (MGI:97503)
20,5126843,5197886,20p13,20p12.3,603549,CDS2,CDP-diacylglycerol synthase 2,CDS2,8760,ENSG00000101290,NA,NA,Cds2 (MGI:1332236)
20,5298851,5316731,20p13,20p12.3,607123,"PROKR2, PKR2, GPR73L1, HH3",Prokineticin receptor 2,PROKR2,128674,ENSG00000101292,NA,"Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3), Autosomal dominant",Prokr2 (MGI:2181363)
20,5544398,5611045,20p12.3,20p12.3,614124,"GPCPD1, GDE5, KIAA1434","Glycerophosphocholine phosphodiesterase GDE1, S. cerevisiae, homolog of",GPCPD1,56261,ENSG00000125772,NA,NA,Gpcpd1 (MGI:104898)
20,5750285,5864406,20p12.3,20p12.3,618028,"SHLD1, RINN3, C20orf196","Shield complex, subunit 1",SHLD1,149840,ENSG00000171984,NA,NA,Shld1 (MGI:1920997)
20,5911509,5925352,20pter-p12,20p12.3,118920,"CHGB, SCG1",Chromogranin B (secretogranin B),CHGB,1114,ENSG00000089199,NA,NA,Chgb (MGI:88395)
20,5950651,6000940,20p13-p12.3,20p12.3,608187,"MCM8, POF10",Minichromosome maintenance complement component 8,MCM8,84515,ENSG00000125885,mutation identified in 1 POF10 family,"?Premature ovarian failure 10, 612885 (3), Autosomal recessive",Mcm8 (MGI:1913884)
20,6005937,6040052,20p13-p12.3,20p12.3,608188,"CRLS1, GCD10, C20orf155",Cardiolipin synthase 1,CRLS1,54675,ENSG00000088766,NA,NA,Crls1 (MGI:1913836)
20,6074844,6123608,20p13,20p12.3,607900,"FERMT1, KIND1, URP1, C20orf42","Fermitin family, member 1",FERMT1,55612,ENSG00000101311,NA,"Kindler syndrome, 173650 (3), Autosomal recessive",Fermt1 (MGI:2443583)
20,6767685,6780245,20p12,20p12.3,112261,"BMP2, BMP2A, BDA2, SSFSC",Bone morphogenetic protein-2,BMP2,650,ENSG00000125845,NA,"Brachydactyly, type A2, 112600 (3), Autosomal dominant; {HFE hemochromatosis, modifier of}, 235200 (3), Autosomal recessive; Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, 617877 (3), Autosomal dominant",Bmp2 (MGI:88177)
20,7882984,7940457,20p12,20p12.3,605023,"HAO1, GOX1",Hydroxyacid oxidase 1,HAO1,54363,ENSG00000101323,NA,NA,Hao1 (MGI:96011)
20,7977345,8019760,20p12.3,20p12.3,616766,TMX4,Thioredoxin-related transmembrane protein 4,TMX4,56255,ENSG00000125827,NA,NA,Tmx4 (MGI:106558)
20,8132265,8884899,20p12,20p12.3,607120,"PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12","Phospholipase C, beta-1",PLCB1,23236,ENSG00000182621,NA,"Epileptic encephalopathy, early infantile, 12, 613722 (3), Autosomal recessive",Plcb1 (MGI:97613)
20,9068709,9480815,20p12,20p12.3-p12.2,600810,"PLCB4, ARCND2","Phospholipase C, beta 4",PLCB4,5332,ENSG00000101333,NA,"Auriculocondylar syndrome 2, 614669 (3), Autosomal recessive, Autosomal dominant",Plcb4 (MGI:107464)
20,9514357,9530523,20p12.2,20p12.2,614641,"LAMP5, BADLAMP",Lysosome-associated membrane protein 5,LAMP5,24141,ENSG00000125869,NA,NA,Lamp5 (MGI:1923411)
20,10218797,10307419,20p11.2,20p12.2,600322,"SNAP25, CMS18","Synaptosomal-associated protein, 25kD",SNAP25,6616,ENSG00000132639,mutation identified in 1 CMS18 patient,"?Myasthenic syndrome, congenital, 18, 616330 (3), Autosomal dominant",Snap25 (MGI:98331)
20,10401008,10434238,20p12,20p12.2,604896,"MKKS, HMCS, KMS, MKS, BBS6",McKusick-Kaufman syndrome gene,MKKS,8195,ENSG00000125863,NA,"Bardet-Biedl syndrome 6, 605231 (3), Autosomal recessive; McKusick-Kaufman syndrome, 236700 (3), Autosomal recessive",Mkks (MGI:1891836)
20,10435135,10628137,20p12.2,20p12.2,615958,"SLX4IP, C20orf94",SLX4-interacting protein,SLX4IP,128710,ENSG00000149346,NA,NA,Slx4ip (MGI:1921493)
20,10637683,10673998,20p12,20p12.2,601920,"JAG1, AGS1, AHD, DCHE",Jagged 1,JAG1,182,ENSG00000101384,mutation identified in 1 DCHE family,"Alagille syndrome 1, 118450 (3), Autosomal dominant; ?Deafness, congenital heart defects, and posterior embryotoxon, 617992 (3); Tetralogy of Fallot, 187500 (3), Autosomal dominant",Jag1 (MGI:1095416)
20,11890722,11926594,20p12.2,20p12.2,615566,"BTBD3, KIAA0952",BTB/POZ domain-containing protein 3,BTBD3,22903,ENSG00000132640,NA,NA,NA
20,13008971,13169102,20p12.3-p12.1,20p12.1,611120,"SPTLC3, SPTLC2L","Serine palmitoyltransferase, long-chain base subunit 3",SPTLC3,55304,ENSG00000172296,NA,NA,Sptlc3 (MGI:2444678)
20,13104759,13638935,20p12.1,20p12.1,608270,"TASP1, C20orf13",Threonine aspartase 1,TASP1,55617,ENSG00000089123,NA,NA,Tasp1 (MGI:1923062)
20,13221273,13326733,20p12.1,20p12.1,615793,"ISM1, ISM","Isthmin 1, angiogenesis inhibitor",ISM1,140862,ENSG00000101230,NA,NA,Ism1 (MGI:2442963)
20,13785025,13821579,20p12.1,20p12.1,612360,"NDUFAF5, C20orf7, MC1DN16",NADH-ubiquinone oxidoreductase complex assembly factor 5,NDUFAF5,79133,ENSG00000101247,NA,"Mitochondrial complex I deficiency, nuclear type 16, 618238 (3), Autosomal recessive",Ndufaf5 (MGI:1916737)
20,13848585,13995332,20p12.1,20p12.1,614289,SEL1L2,Suppressor of Lin12-like 2,SEL1L2,80343,ENSG00000101251,NA,NA,NA
20,13995515,16053196,20p12,20p12.1,611567,"MACROD2, C2orf133",Macro domain-containing 2,MACROD2,140733,ENSG00000172264,NA,NA,Macrod2 (MGI:1920149)
20,14322984,14337846,20p11,20p12.1,604808,"FLRT3, HH21",Fibronectin-like domain-containing leucine-rich transmembrane protein-3,FLRT3,23767,ENSG00000125848,NA,"Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3), Autosomal dominant",Flrt3 (MGI:1918686)
20,16272103,16573456,20p12.1,20p12.1,618171,KIF16B,Kinesin family member 16B,KIF16B,55614,ENSG00000089177,NA,NA,Kif16b (MGI:1098240)
20,16730025,16742563,20p12.1,20p12.1,603520,SNRPB2,Small nuclear ribonucleoprotein polypeptide B-double prime,SNRPB2,6629,ENSG00000125870,NA,NA,Snrpb2 (MGI:104805)
20,16748352,16752163,20p11,20p12.1,606067,OTOR,Otoraplin,OTOR,56914,ENSG00000125879,NA,NA,Otor (MGI:1888678)
20,17226106,17484577,20p11.2,20p12.1,162151,"PCSK2, NEC2, PC2",Proprotein convertase subtilisin/kexin type 2,PCSK2,5126,ENSG00000125851,NA,NA,Pcsk2 (MGI:97512)
20,17493904,17569219,20p12.1-p11.23,20p12.1,603307,"BFSP1, CP115, CTRCT33",Beaded filament structural protein-1 (filensin),BFSP1,631,ENSG00000125864,NA,"Cataract 33, multiple types, 611391 (3), Autosomal recessive, Autosomal dominant",Bfsp1 (MGI:101770)
20,17569172,17609918,20p12.1,20p12.1,609114,"DSTN, ADF",Destrin,DSTN,11034,ENSG00000125868,NA,NA,Dstn (MGI:1929270)
20,17613677,17682282,20p12-p11.2,20p12.1,601418,"RRBP1, ES130",Ribosome binding protein-1,RRBP1,6238,ENSG00000125844,NA,NA,NA
20,17900000,47800000,20p11.2-q13.12,NA,612406,DYT17,"Dystonia-17, primary torsion",DYT17,100216344,NA,between D20S472 and D20S911,"Dystonia-17, primary torsion, 612406 (2), Autosomal recessive",NA
20,17941599,17968793,20p11,20p11.23,605937,SNX5,Sorting nexin 5,SNX5,27131,ENSG00000089006,NA,NA,Snx5 (MGI:1916428)
20,17968593,17991121,20p11.23,20p11.23,615076,"MGME1, C20orf72, MTDPS11",Mitochondrial genome maintenance exonuclease 1,MGME1,92667,ENSG00000125871,NA,"Mitochondrial DNA depletion syndrome 11, 615084 (3), Autosomal recessive",Mgme1 (MGI:1921778)
20,18024151,18059187,20p11.23,20p11.23,616441,"OVOL2, ZNF339, PPCD1",ovo-like 2,OVOL2,58495,ENSG00000125850,NA,"Corneal dystrophy, posterior polymorphous, 1, 122000 (3), Autosomal dominant",Ovol2 (MGI:1338039)
20,18137862,18143168,20p11.23,20p11.23,614771,PET117,"PET117, S. cerevisiae, homolog of",PET117,100303755,ENSG00000232838,NA,NA,Pet117 (MGI:5295678)
20,18142223,18188386,20p11.23,20p11.23,617501,"KAT14, CRP2BP, CSRP2BP, ATAC2",Lysine acetyltransferase 14,KAT14,57325,ENSG00000149474,NA,NA,Kat14 (MGI:1917264)
20,18288227,18316995,20p11.2,20p11.23,604075,ZNF133,Zinc finger protein-133,ZNF133,7692,ENSG00000125846,NA,NA,NA
20,18467388,18484647,20p11.23,20p11.23,617455,"POLR3F, RPC39, RPC6","Polymerase III, RNA, subunit F",POLR3F,10621,ENSG00000132664,NA,NA,Polr3f (MGI:1924086)
20,18486539,18497249,20p11.2,20p11.23,602908,"RBBP9, BOG",Retinoma-binding protein 9,RBBP9,10741,ENSG00000089050,NA,NA,Rbbp9 (MGI:1347074)
20,18507481,18561414,20p11.2,20p11.23,610512,"SEC23B, CDAN2, HEMPAS, CWS7","Sec23, S. cerevisiae, homolog of, B",SEC23B,10483,ENSG00000101310,mutation identified in 1 CWS7 family,"?Cowden syndrome 7, 616858 (3), Autosomal dominant; Dyserythropoietic anemia, congenital, type II, 224100 (3), Autosomal recessive",Sec23b (MGI:1350925)
20,18588053,18766643,20p11,20p11.23,610996,"DTD1, C20orf88","D-tyrosyl-tRNA deacylase 1, S. cerevisiae, homolog of",DTD1,92675,ENSG00000125821,NA,NA,Dtd1 (MGI:1913294)
20,19212641,19722925,20p13,20p11.23,609839,"SLC24A3, NCKX3","Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3",SLC24A3,57419,ENSG00000185052,NA,NA,Slc24a3 (MGI:2137513)
20,19757609,20002458,20p11.22,20p11.23,610222,"RIN2, MACS",RAS and RAB interactor 2,RIN2,54453,ENSG00000132669,NA,"Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3), Autosomal recessive",Rin2 (MGI:1921280)
20,20017289,20033654,20p11.2,20p11.23,610833,"NAT5, NAT3",N-acetyltransferase 5,NAA20,51126,ENSG00000173418,NA,NA,Naa20 (MGI:1915127)
20,20034360,20056045,20p11.2,20p11.23,610952,"CRNKL1, CRN",Crooked neck pre-mRNA splicing factor-like 1,CRNKL1,51340,ENSG00000101343,NA,NA,Crnkl1 (MGI:1914127)
20,20368103,20370948,20p11.2,20p11.23,600010,"INSM1, IA1",Insulinoma-associated 1,INSM1,3642,ENSG00000173404,NA,NA,Insm1 (MGI:1859980)
20,21087603,21106357,20p11.23,20p11.23,614992,LINC00237,Long intergenic noncoding RNA 237,LINC00237,105372556,ENSG00000225127,NA,NA,NA
20,21125974,21246621,20p11.23,20p11.23,615757,"KIZ, KIZUNA, C20orf19, RP69",Kizuna centrosomal protein,KIZ,55857,ENSG00000088970,NA,"Retinitis pigmentosa 69, 615780 (3), Autosomal recessive",Kiz (MGI:2684960)
20,21300000,22300000,20p11.22,NA,612421,AGA3,"Alopecia, androgenetic, 3",NA,100217387,NA,associated with rs1160312,"Alopecia, androgenetic, 3, 612421 (2)",NA
20,21303312,21389824,20p11.2-p11.1,20p11.22,608851,XRN2,Exoribonuclease 2,XRN2,22803,ENSG00000088930,NA,NA,Xrn2 (MGI:894687)
20,21395364,21397525,20p11,20p11.22,607808,"NKX2-4, NKX2D",NK2 homeobox 4,NKX2-4,644524,ENSG00000125816,NA,NA,Nkx2-4 (MGI:97349)
20,21511009,21514063,20p11,20p11.22,604612,"NKX2-2, NKX2B","NK2, homeobox 2",NKX2-2,4821,ENSG00000125820,NA,NA,Nkx2-2 (MGI:97347)
20,21705658,21718485,20p11.2,20p11.22,167411,"PAX1, OFC2",Paired box homeotic gene-1,PAX1,5075,ENSG00000125813,mutation identified in 1 family,"?Otofaciocervical syndrome 2, 615560 (3), Autosomal recessive",Pax1 (MGI:97485)
20,22580997,22585489,20p11,20p11.21,600288,"FOXA2, HNF3B","Forkhead box A2 (hepatic nuclear factor-3, beta)",FOXA2,3170,ENSG00000125798,NA,NA,Foxa2 (MGI:1347476)
20,23035419,23036676,20p11.2,20p11.21,182454,SSTR4,Somatostatin receptor-4,SSTR4,6754,ENSG00000132671,NA,NA,Sstr4 (MGI:105372)
20,23045632,23049663,20p11.2,20p11.21,188040,"THBD, THRM, AHUS6, THPH12",Thrombomodulin,THBD,7056,ENSG00000178726,NA,"{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3), Autosomal dominant; Thrombophilia due to thrombomodulin defect, 614486 (3)",Thbd (MGI:98736)
20,23076553,23086829,20p11.21,20p11.21,120577,"C1QR1, CD93, C1QR","Complement component 1, q subcomponent, receptor 1",CD93,22918,ENSG00000125810,NA,NA,Cd93 (MGI:106664)
20,23350790,23354770,20p12-p11.2,20p11.21,605811,"NXT1, MTR2",NTF2-related export protein 1,NXT1,29107,ENSG00000132661,NA,NA,Nxt1 (MGI:1929619)
20,23361584,23375398,20p11.21,20p11.21,613842,"GZF1, ZNF336, JLSM",GDNF-inducible zinc finger protein 1,GZF1,64412,ENSG00000125812,NA,"Joint laxity, short stature, and myopia, 617662 (3), Autosomal recessive",Gzf1 (MGI:1921783)
20,23374518,23421518,20p11.21,20p11.21,611270,"NAPB, SNAPB","N-ethylmaleimide-sensitive factor attachment protein, beta",NAPB,63908,ENSG00000125814,NA,NA,Napb (MGI:104562)
20,23450411,23452875,20p11.21,20p11.21,609731,"CST11, CST8L",Cystatin 11,CST11,140880,ENSG00000125831,NA,NA,Cst11 (MGI:1925490)
20,23564731,23568483,20p11.2,20p11.21,616536,CST9L,Cystatin 9-like,CST9L,128821,ENSG00000101435,NA,NA,Cst9 (MGI:1340053)
20,23602409,23605972,20p11.2,20p11.21,616543,"CST9, CLM",Cystatin 9,CST9,128822,ENSG00000173335,NA,NA,NA
20,23626705,23637954,20p11.2,20p11.21,604312,"CST3, ARMD11",Cystatin C,CST3,1471,ENSG00000101439,proximal to 20p11.2,"Cerebral amyloid angiopathy, 105150 (3), Autosomal dominant; {Macular degeneration, age-related, 11}, 611953 (3)",Cst3 (MGI:102519)
20,23685639,23689024,20p11.2,20p11.21,123857,CST4,Cystatin S,CST4,1472,ENSG00000101441,NA,NA,NA
20,23747552,23750936,20p11.2,20p11.21,123855,CST1,Cystatin SN,CST1,1469,ENSG00000170373,NA,NA,NA
20,23823768,23826728,20p11.2,20p11.21,123856,CST2,Cystatin SA,CST2,1470,ENSG00000170369,NA,NA,NA
20,23875933,23879747,20p11.21,20p11.21,123858,CST5,Cystatin D,CST5,1473,ENSG00000170367,NA,NA,Cst10 (MGI:1930004)
20,23985052,23989133,20p11.1,20p11.21,612338,"GGTLC1, GGTL6, GGTLA4","Gamma-glutamyltransferase, light chain 1",GGTLC1,92086,ENSG00000149435,NA,NA,NA
20,24091534,24112233,20p11.21,20p11.21,618507,WAKMAR1,Wound- and keratinocyte migration-associated long noncoding RNA 1,NA,105372576,NA,NA,NA,NA
20,24469198,24666616,20p11.21,20p11.21,614311,"SYNDIG1, TMEM90B",Synapse differentiation-induced gene 1,SYNDIG1,79953,ENSG00000101463,NA,NA,Syndig1 (MGI:3702158)
20,24949268,24959927,20p11.2,20p11.21,603253,"CST7, CMAP",Cystatin 7,CST7,8530,ENSG00000077984,NA,NA,Cst7 (MGI:1298217)
20,24962924,24992929,20p11.2,20p11.21,615884,"APMAP, C20orf3, BSCV",Adipocyte plasma membrane-associated protein,APMAP,57136,ENSG00000101474,NA,NA,Apmap (MGI:1919131)
20,25006229,25058181,20p11.23-p11.21,20p11.21,614355,"ACSS1, ACECS1","Acyl-CoA synthetase short-chain family, member 1",ACSS1,84532,ENSG00000154930,NA,NA,Acss1 (MGI:1915988)
20,25069939,25082378,20p11.2,20p11.21,605020,"VSX1, RINX, KTCN1, CAASDS","Visual system homeo box gene 1, zebrafish, homolog of",VSX1,30813,ENSG00000100987,mutation identified in 1 CAASDS family,"?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3); Keratoconus 1, 148300 (3), Autosomal dominant",Vsx1 (MGI:1890816)
20,25195669,25228074,20q11.2,20p11.21,603160,"ENTPD6, CD39L2",Ectonucleoside triphosphate diphosphohydrolase 6,ENTPD6,955,ENSG00000197586,NA,NA,Entpd6 (MGI:1202295)
20,25248038,25298011,20p11.2-p11.1,20p11.21,138550,PYGB,"Phosphorylase, glycogen, brain",PYGB,5834,ENSG00000100994,NA,NA,Pygb (MGI:97828)
20,25294742,25390834,20p11.21,20p11.21,613599,"ABHD12, PHARC",Abhydrolase domain-containing protein 12,ABHD12,26090,ENSG00000100997,NA,"Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3), Autosomal recessive",Abhd12 (MGI:1923442)
20,25407469,25448567,20p11.21,20p11.21,610608,"GINS1, PSF1, KIAA0186, IMD55",GINS complex subunit 1,GINS1,9837,ENSG00000101003,NA,"Immunodeficiency 55, 617827 (3), Autosomal recessive",Gins1 (MGI:1916520)
20,25612934,25624013,20p11,20p11.21,610763,"NANP, HDHD4",N-acetylneuraminic acid phosphatase,NANP,140838,ENSG00000170191,NA,NA,Nanp (MGI:1914561)
20,28100000,64444167,20q11-q13,NA,610261,HYT5,"Hypertension, essential, susceptibility to, 5",NA,100188807,NA,NA,"{Hypertension, essential, susceptibility to, 5}, 145500 (2), Multifactorial",NA
20,28100000,64444167,20q11-q13,NA,617352,MBCS,Mulchandani-Bhoj-Conlin syndrome,NA,NA,NA,maternal uniparental disomy of imprinted region,"Mulchandani-Bhoj-Conlin syndrome, 617352 (3)",NA
20,28100000,64444167,20q11-q13,NA,608029,"SCAR6, CLA3","Spinocerebellar ataxia, autosomal recessive 6",CLA3,1167,NA,between D20S471 and D20S119,"Spinocerebellar ataxia, autosomal recessive 6, 608029 (2), Autosomal recessive",NA
20,30400000,39000000,20q11.2,NA,612263,CMM7,"Melanoma, cutaneous malignant, susceptibility to, 7",NA,100190932,NA,between rs910873 and rs1885120,"{Melanoma, cutaneous malignant, 7}, 612263 (2)",NA
20,30400000,43100000,20q11.2-q12,NA,601308,"MLRL, MTS",Myeloid leukemia-related locus (myeloid tumor suppressor),NA,8201,NA,NA,NA,NA
20,31368600,31373922,20q11,20q11.21,607650,"DEFB118, C20orf63, ESC42","Defensin, beta, 118",DEFB118,117285,ENSG00000131068,NA,NA,NA
20,31377162,31390648,20q11.1,20q11.21,615997,"DEFB119, DEFB120, DEFB20","Defensin, beta, 119",DEFB119,245932,ENSG00000180483,NA,NA,Defb19 (MGI:2385955)
20,31404844,31418521,20q11.1,20q11.21,616075,"DEFB121, DEFB21","Defensin, beta, 121",DEFB121,245934,ENSG00000204548,NA,NA,NA
20,31421438,31429179,20q11.1,20q11.21,616077,"DEFB122, DEFB22","Defensin, beta, 122, pseudogene",DEFB122,245935,ENSG00000204547,NA,NA,NA
20,31440631,31450256,20q11.1,20q11.21,616076,"DEFB123, DEFB23","Defensin, beta, 123",DEFB123,245936,ENSG00000180424,NA,NA,NA
20,31475272,31484894,20q11.21,20q11.21,610388,"REM1, GES",RRAD- and GEM-like GTPase 1,REM1,28954,ENSG00000088320,NA,NA,Rem1 (MGI:1097696)
20,31514409,31569566,20q11.21,20q11.21,607106,"HM13, SPP",Minor histocompatibility 13 (signal peptide peptidase),HM13,81502,ENSG00000101294,NA,NA,H13 (MGI:95886)
20,31605288,31606509,20q11,20q11.21,600349,ID1,"Inhibitor of DNA binding 1, dominant negative",ID1,3397,ENSG00000125968,NA,NA,Id1 (MGI:96396)
20,31637855,31645008,20q11.21,20q11.21,607976,COX4I2,"Cytochrome c oxidase, subunit IV, isoform 2",COX4I2,84701,ENSG00000131055,NA,"Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3), Autosomal recessive",Cox4i2 (MGI:2135755)
20,31664451,31723962,20q11.21,20q11.21,600039,"BCL2L1, BCLX, BCLXL, BCLXS",BCL2-like 1,BCL2L1,598,ENSG00000171552,NA,NA,Bcl2l1 (MGI:88139)
20,31739247,31801801,20q11.2,20q11.21,605917,"C20orf1, P100","Proliferation-associated nuclear protein, 100kD",TPX2,22974,ENSG00000088325,NA,NA,Tpx2 (MGI:1919369)
20,31819374,31834696,20q13.3,20q11.21,606566,"MYLK2, MLCK",Myosin light chain kinase 2,MYLK2,85366,ENSG00000101306,NA,"Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3), Autosomal dominant",Mylk2 (MGI:2139434)
20,31844302,31845603,20q11.1-q11.2,20q11.21,602939,"FOXS1, FKHL18, FREAC10",Forkhead box S1,FOXS1,2307,ENSG00000179772,NA,NA,Foxs1 (MGI:95546)
20,31845577,31870743,20q11.21,20q11.21,616776,"DUSP15, VHY",Dual-specificity phosphatase 15,DUSP15,128853,ENSG00000149599,NA,NA,Dusp15 (MGI:1934928)
20,31944336,31952045,20q11,20q11.21,610789,"PDRG1, PDRG, C20orf126",P53 and DNA damage-regulated 1,PDRG1,81572,ENSG00000088356,NA,NA,Pdrg1 (MGI:1915809)
20,32052241,32101842,20q11-q12,20q11.21,142370,HCK,Hemopoietic cell kinase,HCK,3055,ENSG00000101336,NA,NA,Hck (MGI:96052)
20,32109713,32167257,20q11.21,20q11.21,617727,"TM9SF4, KIAA0255","Transmembrane 9 superfamily, member 4",TM9SF4,9777,ENSG00000101337,NA,NA,Tm9sf4 (MGI:2139220)
20,32192503,32207742,20q11.21,20q11.21,604866,PLAGL2,Pleomorphic adenoma gene-like 2,PLAGL2,5326,ENSG00000126003,NA,NA,Plagl2 (MGI:1933165)
20,32207879,32238657,20q11.21,20q11.21,607491,"POFUT1, OFUCT1, KIAA0180, DDD2",Protein O-fucosyltransferase 1,POFUT1,23509,ENSG00000101346,NA,"Dowling-Degos disease 2, 615327 (3), Autosomal dominant",Pofut1 (MGI:2153207)
20,32277650,32335010,20q11.21,20q11.21,603754,"KIF3B, KIAA0359",Kinesin family member 3B,KIF3B,9371,ENSG00000101350,NA,NA,Kif3b (MGI:107688)
20,32358061,32439318,20q11.21,20q11.21,612990,"ASXL1, KIAA0978, BOPS, MDS",Additional sex combs-like 1,ASXL1,171023,ENSG00000171456,NA,"Bohring-Opitz syndrome, 605039 (3), Autosomal dominant; Myelodysplastic syndrome, somatic, 614286 (3)",Asxl1 (MGI:2684063)
20,32702690,32744007,20q11.21,20q11.21,616703,COMMD7,COMM domain-containing protein 7,COMMD7,149951,ENSG00000149600,NA,NA,Commd7 (MGI:1914197)
20,32762384,32809355,20q11.2,20q11.21,602900,"DNMT3B, ICF1",DNA methyltransferase 3B,DNMT3B,1789,ENSG00000088305,NA,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3), Autosomal recessive",Dnmt3b (MGI:1261819)
20,32819779,32850404,20q11.1-q11.23,20q11.21,603108,"MAPRE1, EB1","Microtubule-associated protein, RP/EB family, member 1",MAPRE1,22919,ENSG00000101367,NA,NA,Mapre1 (MGI:891995)
20,32983772,33004448,20q11.2,20q11.21,613942,"SUN5, TSARG4, SPAG4L, SPGF16",Sad1 and Unc84 domain-containing protein 5,SUN5,140732,ENSG00000167098,NA,"Spermatogenic failure 16, 617187 (3), Autosomal recessive",Sun5 (MGI:1923657)
20,33007703,33023702,20q11,20q11.21,614108,"BPIFB2, BPIL1","BPI fold-containing protein, family B, member 2",BPIFB2,80341,ENSG00000078898,NA,NA,Bpifb2 (MGI:1913807)
20,33031647,33044107,20q11,20q11.21,614110,"BPIFB6, BPIL3","BPI fold-containing protein, family B, member 6",BPIFB6,128859,ENSG00000167104,NA,NA,Bpifb6 (MGI:2684965)
20,33055330,33073636,20q11.21,20q11.21,615717,"BPIFBP3, RYA3","BPI fold-containing protein, family B, member 3",BPIFB3,359710,ENSG00000186190,NA,NA,Bpifb3 (MGI:2675077)
20,33081511,33111750,20q11.21,20q11.21,615718,"BPIFB4, RY2G5","BPI fold-containing protein, family B, member 4",BPIFB4,149954,ENSG00000186191,NA,NA,Bpifb4 (MGI:2685852)
20,33193604,33210461,20q11.21,20q11.21,607627,BASE,Breast cancer- and salivary gland-expressed gene,BPIFA4P,317716,ENSG00000183566,NA,NA,NA
20,33235995,33243305,20q11,20q11.21,607412,"BPIFA1, PLUNC, SPLUNC1","BPI fold-containing protein, family A, member 1",BPIFA1,51297,ENSG00000198183,NA,NA,Bpifa1 (MGI:1338036)
20,33358838,33403029,20q11.2,20q11.21,608200,CDK5RAP1,CDK5 regulatory subunit-associated protein 1,CDK5RAP1,51654,ENSG00000101391,NA,NA,Cdk5rap1 (MGI:1914221)
20,33407956,33443891,20q11.2,20q11.21,601017,"SNTA1, SNT1, TACIP1, LQT12","Syntrophin, alpha-1",SNTA1,6640,ENSG00000101400,NA,"Long QT syndrome 12, 612955 (3), Autosomal dominant",Snta1 (MGI:101772)
20,33490069,33650030,20q11.2,20q11.21-q11.22,603672,"CBFA2T2, MTGR1, EHT","Core-binding factor, runt domain, alpha subunit 2, translocated to, 2 (ETO homolog on chromosome 20)",CBFA2T2,9139,ENSG00000078699,NA,NA,Cbfa2t2 (MGI:1333833)
20,33500000,35800000,20q11.22,NA,612228,STQTL14,Stature quantitative trait locus 14,NA,100270797,NA,associated with rs6060373,"{Stature QTL 14}, 612228 (2)",NA
20,33657086,33674427,20q11.22,20q11.22,612478,"NECAB3, EFCBP3, NIP1, APBA2BP, XB51, STIP3",N-terminal EF-hand calcium-binding protein 3,NECAB3,63941,ENSG00000125967,NA,NA,Necab3 (MGI:1861721)
20,33675476,33686384,20q11.2,20q11.22,189971,E2F1,E2F transcription factor-1,E2F1,1869,ENSG00000101412,NA,NA,E2f1 (MGI:101941)
20,33702757,33720309,20q11.22,20q11.22,616397,"PXMP4, PMP24",Peroxisomal membrane protein 4,PXMP4,11264,ENSG00000101417,NA,NA,Pxmp4 (MGI:1891701)
20,33731656,33792268,20q11.22,20q11.22,618269,"ZNF341, HIES3",Zinc finger protein 341,ZNF341,84905,ENSG00000131061,NA,"Hyper-IgE recurrent infection syndrome 3, autosomal recessive, 618282 (3), Autosomal recessive",Zfp341 (MGI:2682937)
20,33811347,33854365,20q11.21,20q11.22,610897,"CHMP4B, SNF7, CTPP3, CTRCT31","CHMP family, member 4B",CHMP4B,128866,ENSG00000101421,NA,"Cataract 31, multiple types, 605387 (3), Autosomal dominant",Chmp4b (MGI:1922858)
20,34088308,34112242,20q11.22,20q11.22,603908,EIF2S2,"Eukaryotic translation initiation factor 2, subunit 2",EIF2S2,8894,ENSG00000125977,NA,NA,Eif2s2 (MGI:1914454)
20,34186492,34269343,20q11.2,20q11.22,600201,"ASIP, AGTIL, SHEP9","Agouti, mouse, signaling protein",ASIP,434,ENSG00000101440,NA,"[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3); [Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3)",a (MGI:87853)
20,34235011,34311975,20cen-q13.1,20q11.22,180960,"AHCY, SAHH",S-adenosylhomocysteine hydrolase,AHCY,191,ENSG00000101444,~13cM from ADA,"Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3), Autosomal recessive",Ahcy (MGI:87968)
20,34363272,34511772,20q11.22-q11.23,20q11.22,606409,"ITCH, AIP4, NAPP1, ADMFD","Itchy, mouse, homolog of",ITCH,83737,ENSG00000078747,NA,"Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3), Autosomal recessive",Itch (MGI:1202301)
20,34516383,34540957,20q12-q13.11,20q11.22,607167,"DYNLRB1, DNCL2A, DNLC2A","Dynein, light chain, roadblock type, 1",DYNLRB1,83658,ENSG00000125971,NA,NA,Dynlrb1 (MGI:1914318)
20,34546822,34560344,20cen-q13,20q11.22,601242,"MAP1ALC3, MAP1BLC3","Microtubule-associated proteins 1A and 1B, light chain 3",MAP1LC3A,84557,ENSG00000101460,NA,NA,Map1lc3a (MGI:1915661)
20,34560541,34677284,20q11.22,20q11.22,608528,"PIGU, CDC91L1",Phosphatidylinositol glycan anchor biosynthesis class U protein,PIGU,128869,ENSG00000101464,NA,NA,Pigu (MGI:3039607)
20,34704343,34713438,20q11.2,20q11.22,617549,"TP53INP2, PIGU, DOR, C20orf110",Tumor protein p53-inducible nuclear protein 2,TP53INP2,58476,ENSG00000078804,NA,NA,Trp53inp2 (MGI:1915978)
20,34714773,34825650,20q11,20q11.22,605299,"NCOA6, ASC2, RAP250, NRC, PRIP",Nuclear receptor coactivator 6,NCOA6,23054,ENSG00000198646,NA,NA,NA
20,34844719,34872857,20q11.2,20q11.22,612342,"GGT7, GGTL3, GGTL5, GGT4",Gamma-glutamyltransferase 7,GGT7,2686,ENSG00000131067,NA,NA,Ggt7 (MGI:1913385)
20,34874941,34927965,20q11.22,20q11.22,605832,"ACSS2, ACS",Acetyl-CoA synthetase short-chain family member 2,ACSS2,55902,ENSG00000131069,NA,NA,Acss2 (MGI:1890410)
20,34928431,34956026,20q11.2,20q11.22,601002,"GSS, GSHS",Glutathione synthetase,GSS,2937,ENSG00000100983,NA,"Glutathione synthetase deficiency, 266130 (3), Autosomal recessive; Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3), Autosomal recessive",Gss (MGI:95852)
20,34955867,35002436,20q11.22,20q11.22,609928,"MYH7B, MYH14, KIAA1512","Myosin, heavy chain 7B, cardiac muscle, beta",MYH7B,57644,ENSG00000078814,NA,NA,Myh7b (MGI:3710243)
20,34990375,34990496,20q11.22,20q11.22,613614,"MIR499, MIRN499",Micro RNA 499,MIR499A,574501,ENSG00000207635,NA,NA,NA
20,35002403,35092834,20q11.23,20q11.22,608430,"TRPC4AP, TRUSS",TRPC4-associated protein,TRPC4AP,26133,ENSG00000100991,NA,NA,Trpc4ap (MGI:1930751)
20,35115356,35147357,20q11.22,20q11.22,610302,EDEM2,Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2,EDEM2,55741,ENSG00000088298,NA,NA,Edem2 (MGI:1915540)
20,35172071,35215988,20q11.2,20q11.22,600646,"PROCR, EPCR, CCCA, CCD41",Protein C receptor,PROCR,10544,ENSG00000101000,NA,NA,Procr (MGI:104596)
20,35226689,35276997,20q11.2,20q11.22,604871,MMP25,Matrix metalloproteinase 24,MMP24,10893,ENSG00000125966,NA,NA,Mmp24 (MGI:1341867)
20,35278905,35284815,20q11.2,20q11.22,602912,"EIF6, EIF3A, ITGB4BP",Eukaryotic translation initiation factor 6,EIF6,3692,ENSG00000242372,NA,NA,Eif6 (MGI:1196288)
20,35302565,35412141,20q11.22,20q11.22,611797,"UQCC, CBP3, BFZB, C20orf44",Ubiquinol-cytochrome C reductase complex chaperone,UQCC1,55245,ENSG00000101019,NA,NA,Uqcc1 (MGI:1929472)
20,35433346,35454748,20q11.2,20q11.22,601146,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1),GDF5,8200,ENSG00000125965,mutation identified in 1 AMDHT family,"?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3), Autosomal recessive; Brachydactyly, type A1, C, 615072 (3), Autosomal recessive, Autosomal dominant; Brachydactyly, type A2, 112600 (3), Autosomal dominant; Brachydactyly, type C, 113100 (3), Autosomal dominant; Chondrodysplasia, Grebe type, 200700 (3), Autosomal recessive; Du Pan syndrome, 228900 (3), Autosomal recessive; Multiple synostoses syndrome 2, 610017 (3), Autosomal dominant; {Osteoarthritis-5}, 612400 (3); Symphalangism, proximal, 1B, 615298 (3)",Gdf5 (MGI:95688)
20,35455136,35519279,20q11.2,20q11.22,609689,"CEP250, CEP2, CNAP1, CRDHL2","Centrosomal protein, 250kD",CEP250,11190,ENSG00000126001,NA,"Cone-rod dystrophy and hearing loss 2, 618358 (3), Autosomal recessive",Cep250 (MGI:108084)
20,35542077,35557633,20q11.22,20q11.22,616971,"ERGIC3, C2orf47",Endoplasmic reticulum-golgi intermediate compartment protein 3,ERGIC3,51614,ENSG00000125991,NA,NA,Ergic3 (MGI:1913616)
20,35615828,35621093,20q11.2,20q11.22,603038,SPAG4,Sperm-associated antigen-4,SPAG4,6676,ENSG00000061656,NA,NA,Spag4 (MGI:2444120)
20,35626030,35664936,20q11.22,20q11.22,604205,"CPNE1, CPN1",Copine I,CPNE1,8904,ENSG00000214078,NA,NA,Cpne1 (MGI:2386621)
20,35648924,35664899,20q11.2,20q11.22,607179,"RBM12, KIAA0765, SCZD19",RNA-binding motif protein 12,RBM12,10137,ENSG00000244462,NA,"{Schizophrenia 19, susceptibility to}, 617629 (3), Autosomal dominant",Rbm12 (MGI:1922960)
20,35668051,35699364,20q11.22,20q11.22,603485,"NFS1, NIFS",Nitrogen fixation gene 1,NFS1,9054,ENSG00000244005,NA,NA,Nfs1 (MGI:1316706)
20,35701346,35742335,20q11.22,20q11.22,604739,"RBM39, CAPER, RNPC2",RNA binding motif protein 39,RBM39,9584,ENSG00000131051,NA,NA,Rbm39 (MGI:2157953)
20,35772002,35950371,20q11.1-q11.23,20q11.22-q11.23,610335,"PHF20, GLEA2, HCA58",PHD finger protein 20,PHF20,51230,ENSG00000025293,NA,NA,Phf20 (MGI:2444148)
20,35953616,35955358,20q11.23,20q11.23,610416,"SCAND1, RAZ1, SDP1",SCAN domain-containing 1,SCAND1,51282,ENSG00000171222,NA,NA,Scand1 (MGI:1343132)
20,36045617,36050959,20q11.23,20q11.23,617037,"NORAD, LINC00657",Noncoding RNA activated by DNA damage,NORAD,647979,ENSG00000260032,NA,NA,NA
20,36064890,36232798,20q11.2-q12,20q11.23,602879,"EPB41L1, MRD11",Erythrocyte membrane protein band 4.1-like 1,EPB41L1,2036,ENSG00000088367,mutation identified in 1 patient,"?Mental retardation, autosomal dominant 11, 614257 (3), Autosomal dominant",Epb41l1 (MGI:103010)
20,36236135,36256940,20q11.23,20q11.23,617365,"AAR2, C20orf4","Aar2 splicing factor, S. cerevisiae, homolog of",AAR2,25980,ENSG00000131043,NA,NA,Aar2 (MGI:1915545)
20,36306338,36528634,20q11.23,20q11.23,616191,"DLGAP4, SAPAP4, KIAA0964",Discs LARGE-associated protein 4,DLGAP4,22839,ENSG00000080845,noncoding RNAs transcribed from intron 1 are expressed in all tissues,NA,Dlgap4 (MGI:2138865)
20,36541518,36551446,20q11.23,20q11.23,609905,"MYL9, MLC2","Myosin light chain 9, regulatory",MYL9,10398,ENSG00000101335,NA,NA,Myl9 (MGI:2138915)
20,36573472,36593951,20q11.2-q12,20q11.23,607294,TGIF2,Transforming growth factor-beta-induced factor 2,TGIF2,60436,ENSG00000118707,NA,NA,Tgif2 (MGI:1915299)
20,36612317,36646206,20q11.23,20q11.23,606577,"SLA2, SLAP2",SRC-like adaptor 2,SLA2,84174,ENSG00000101082,NA,NA,Sla2 (MGI:1925049)
20,36651765,36746137,20q11.21-q11.23,20q11.23,605273,NDRG3,N-myc downstream-regulated gene 3,NDRG3,57446,ENSG00000101079,NA,NA,Ndrg3 (MGI:1352499)
20,36751790,36773814,20q11.23,20q11.23,609175,"DSN1, C20orf172","DSN1 homolog, MIS12 kinetochore complex component",DSN1,79980,ENSG00000149636,NA,NA,Dsn1 (MGI:1914184)
20,36889772,36951842,20q11.2,20q11.23,606754,"SAMHD1, AGS5, DCIP, CHBL2",SAM domain- and HD domain-containing protein 1,SAMHD1,25939,ENSG00000101347,mutation identified in 1 CHBL2 family,"Aicardi-Goutieres syndrome 5, 612952 (3), Autosomal recessive; ?Chilblain lupus 2, 614415 (3), Autosomal dominant",Samhd1 (MGI:1927468)
20,36996348,37096028,20q11.2,20q11.23,116957,"RBL1, CP107",Retinoblastoma-like 1 (p107),RBL1,5933,ENSG00000080839,NA,NA,Rbl1 (MGI:103300)
20,37179045,37241622,20q12-q13.1,20q11.23,180490,RPN2,Ribophorin II,RPN2,6185,ENSG00000118705,NA,NA,Rpn2 (MGI:98085)
20,37251085,37261816,20q11.2,20q11.23,139190,"GHRH, GHRF",Growth hormone releasing hormone (somatocrinin),GHRH,2691,ENSG00000118702,NA,Gigantism due to GHRF hypersecretion (1); ?Isolated growth hormone deficiency due to defect in GHRF (1),Ghrh (MGI:95709)
20,37344684,37405431,20q12-q13,20q11.23,190090,"SRC, ASV, SRC1, THC6","Protooncogene SRC, Rous sarcoma",SRC,6714,ENSG00000197122,mutation identified in 1 THC6 family,"Colon cancer, advanced, somatic, 114500 (3); ?Thrombocytopenia 6, 616937 (3), Autosomal dominant",Src (MGI:98397)
20,37517416,37527930,20q11.2-q12,20q11.23,613110,"BLCAP, BC10",Bladder cancer-associated protein,BLCAP,10904,ENSG00000166619,NA,NA,Blcap (MGI:1858907)
20,37521249,37523689,20q11.2-q12,20q11.23,603106,NNAT,Neuronatin,NNAT,4826,ENSG00000053438,NA,NA,Nnat (MGI:104716)
20,37693954,37872128,20q11.2-q12,20q11.23,611537,"CTNNBL1, NAP","Catenin, beta-like, 1",CTNNBL1,56259,ENSG00000132792,NA,NA,Ctnnbl1 (MGI:1913892)
20,37903103,37945349,20q11.23,20q11.23,616537,"VSTM2L, C20orf102",V-SET and transmembrane domains-containing protein 2-like,VSTM2L,128434,ENSG00000132821,NA,NA,Vstm2l (MGI:2685537)
20,37983013,38033460,20q11.23,20q11.23,614425,"TTI1, KIAA0406",TELO2-interacting protein 1,TTI1,9675,ENSG00000101407,NA,NA,Tti1 (MGI:1922675)
20,38033461,38092365,20q11.23,20q11.23,614694,"RPRD1B, CREPT",Regulation of nuclear pre-mRNA domain-containing protein 1B,RPRD1B,58490,ENSG00000101413,NA,NA,Rprd1b (MGI:1917720)
20,38127384,38166507,20q11.2-q12,20q11.23,190196,TGM2,"Transglutaminase-2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)",TGM2,7052,ENSG00000198959,NA,NA,Tgm2 (MGI:98731)
20,38304149,38337504,20q11.23-q12,20q11.23,109195,BPI,Bactericidal/permeability-increasing protein,BPI,671,ENSG00000101425,NA,NA,Bpi (MGI:3045315)
20,38346481,38377012,20q11.23-q12,20q11.23,151990,LBP,Lipopolysaccharide-binding protein,LBP,3929,ENSG00000129988,NA,NA,Lbp (MGI:1098776)
20,38581196,38588462,20q11.23,20q11.23,611396,"ADIG, SMAF1",Adipogenin,ADIG,149685,ENSG00000182035,NA,NA,NA
20,38724485,38729371,20q11.23,20q11.23,616440,"SLC32A1, VGAT, VIAAT","Solute carrier family 32 (GABA vesicular transporter), member 1",SLC32A1,140679,ENSG00000101438,NA,NA,Slc32a1 (MGI:1194488)
20,38805693,38923023,20q11.22-q12,20q11.23,613275,"PPP1R16B, TIMAP, KIAA0823","Protein phosphatase 1, regulatory subunit 16B",PPP1R16B,26051,ENSG00000101445,NA,NA,Ppp1r16b (MGI:2151841)
20,38926416,38953105,20q11.23,20q11.23,618380,"FAM83D, CHICA","Family with sequence similarity 83, member D",FAM83D,81610,ENSG00000101447,NA,NA,Fam83d (MGI:1919128)
20,39000000,51200000,20q12-q13.1,NA,603694,NIDDM3,Noninsulin-dependent diabetes mellitus 3,NA,50982,NA,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (2), Autosomal dominant",NA
20,39000000,47800000,20q12-q13.12,NA,613938,PSMNSW,"Parasomnia, sleepwalking type",NA,100653383,NA,between 55.6 and 61.4 cM,"Parasomnia, sleepwalking type, 613938 (2), Autosomal dominant, Multifactorial",NA
20,40004460,40008528,20q11.23,20q12,617038,"LINC01370, HILNC25",Long intergenic noncoding RNA 1370,LINC01370,100505663,NA,NA,NA,NA
20,40685847,40689235,20q11.2-q13.1,20q12,608968,"MAFB, KRML, MCTO, DURS3","v-MAF musculoaponeurotic fibrosarcoma oncogene family, protein B",MAFB,9935,ENSG00000204103,NA,"Duane retraction syndrome 3, 617041 (3), Autosomal dominant; Multicentric carpotarsal osteolysis syndrome, 166300 (3), Autosomal dominant",Mafb (MGI:104555)
20,41028821,41124486,20q12-q13.1,20q12,126420,TOP1,Topoisomerase (DNA) I,TOP1,7150,ENSG00000198900,pseudogenes on chr.1 and 22,"DNA topoisomerase I, camptothecin-resistant (3)",Top1 (MGI:98788)
20,41137518,41177625,20q12-q13.1,20q12,172420,"PLCG1, PLC1","Phospholipase C, gamma 1 (formerly subtype 148)",PLCG1,5335,ENSG00000124181,NA,NA,Plcg1 (MGI:97615)
20,41178449,41317639,20q12,20q12,609598,"ZHX3, KIAA0395",Zinc finger and homeodomain protein-3,ZHX3,23051,ENSG00000174306,NA,NA,Zhx3 (MGI:2444772)
20,41340778,41360584,20q,20q12,605520,LPIN3,Lipin 3,LPIN3,64900,ENSG00000132793,NA,NA,Lpin3 (MGI:1891342)
20,41402082,41618376,20q11.23-q12,20q12,616114,"CHD6, CHD5, RIGB",Chromodomain helicase DNA-binding protein 6,CHD6,84181,ENSG00000124177,NA,NA,Chd6 (MGI:1918639)
20,42029958,43189905,20q12-q13.1,20q12-q13,608712,"PTPRT, KIAA0283","Protein-tyrosine phosphatase, receptor-type, T",PTPRT,11122,ENSG00000196090,NA,NA,Ptprt (MGI:1321152)
20,43100000,64444167,20q13,NA,608878,GEVQ2,"Gene expression, variation in, quantitative trait locus on chromosome 20",NA,474333,NA,NA,"{Gene expression, variation in, QTL}, 608878 (2)",NA
20,43100000,43500000,20q13.11,NA,603388,GRD2,"Graves disease, susceptibility to, 2",NA,50976,NA,NA,"{Graves disease, susceptibility to, 2}, 603388 (2)",NA
20,43100000,64444167,20q13,NA,608656,HPC3,"Prostate cancer, hereditary, 3",NA,408259,NA,NA,"{Prostate cancer, susceptibility to, 3}, 608656 (2)",NA
20,43100000,64444167,20q13,NA,612566,IBD24,Inflammatory bowel disease 24,NA,100270798,NA,associated with rs2315008 and rs4809330,"{Inflammatory bowel disease 24}, 612566 (2)",NA
20,43100000,64444167,20q13,NA,612950,PSORS12,Psoriasis susceptibility 12,NA,NA,NA,associated with rs495337,"{Psoriasis susceptibility 12}, 612950 (2)",NA
20,43100000,64444167,20q13,NA,610066,SLEB8,"Systemic lupus erythematosus, susceptibility to, 8",NA,100188804,NA,NA,"{Systemic lupus erythematosus, susceptibility to, 8}, 610066 (2)",NA
20,43457863,43464242,20q13.11,20q13.11,601944,"SRSF6, SFRS6, SRp55","Splicing factor, serine/arginine-rich, 6",SRSF6,6431,ENSG00000124193,NA,NA,Srsf6 (MGI:1915246)
20,43507696,43541894,20q12,20q13.12,608802,"L3MBTL, L3MBTL1, KIAA0681",L3MBT-like,L3MBTL1,26013,ENSG00000185513,NA,NA,L3mbtl1 (MGI:2676663)
20,43559026,43585632,20q13.2,20q13.12,607589,SGK2,Serum/glucocorticoid-regulated kinase 2,SGK2,10110,ENSG00000101049,NA,NA,Sgk2 (MGI:1351318)
20,43590936,43647298,20q13.12,20q13.12,617094,IFT52,"Intraflagellar transport 52, Chlamydomonas, homolog of",IFT52,51098,ENSG00000101052,NA,"Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3), Autosomal recessive",Ift52 (MGI:2387217)
20,43667018,43716495,20q13.1,20q13.12,601415,"MYBL2, BMYB",v-myb avian myeloblastosis viral oncogene homolog-like 2,MYBL2,4605,ENSG00000101057,NA,NA,Mybl2 (MGI:101785)
20,43914851,44069615,20q13.12,20q13.12,611163,"TOX2, GCX1, C20orf100",TOX high mobility group box family member 2,TOX2,84969,ENSG00000124191,NA,NA,Tox2 (MGI:3611233)
20,44111696,44187945,20q12,20q13.12,605267,"JPH2, JP2, CMH17",Junctophilin 2,JPH2,57158,ENSG00000149596,NA,"Cardiomyopathy, hypertrophic, 17, 613873 (3), Autosomal dominant",Jph2 (MGI:1891496)
20,44302839,44311201,20q13.12,20q13.12,612029,"FIT2, C20orf142",Fat-inducing transcript 2,FITM2,128486,ENSG00000197296,NA,NA,Fitm2 (MGI:2444508)
20,44355698,44434595,20q12-q13.1,20q13.12,600281,"HNF4A, TCF14, MODY1, FRTS4","Hepatocyte nuclear factor 4, alpha (transcription factor-14)",HNF4A,3172,ENSG00000101076,NA,"{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant; Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3), Autosomal dominant; MODY, type I, 125850 (3), Autosomal dominant",Hnf4a (MGI:109128)
20,44496220,44522115,20q13.1-q13.3,20q13.12,607165,"SERINC3, TDE1",Serine incorporator 3,SERINC3,10955,ENSG00000132824,NA,NA,Serinc3 (MGI:1349457)
20,44531780,44619036,20q,20q13.12,604932,PKIG,"Protein kinase, cAMP-dependent catalytic, inhibitor gamma",PKIG,11142,ENSG00000168734,NA,NA,Pkig (MGI:1343086)
20,44619518,44651757,20q13.11,20q13.12,608958,ADA,Adenosine deaminase,ADA,100,ENSG00000196839,NA,"Adenosine deaminase deficiency, partial, 102700 (3), Autosomal recessive, Somatic mosaicism; Severe combined immunodeficiency due to ADA deficiency, 102700 (3), Autosomal recessive, Somatic mosaicism",Ada (MGI:87916)
20,44714203,44728040,20q12-q13,20q13.12,603399,WISP2,Wnt-1 inducible signaling pathway protein 2,CCN5,8839,ENSG00000064205,NA,NA,Ccn5 (MGI:1328326)
20,44745604,44752312,20q12-q13,20q13.12,607368,"KCNK15, TASK5","Potassium channel, subfamily K, member 15",KCNK15,60598,ENSG00000124249,NA,NA,Kcnk15 (MGI:2675209)
20,44751807,44810545,20q13.3,20q13.12,611601,RIMS4,Protein regulating synaptic membrane exocytosis 4,RIMS4,140730,ENSG00000101098,NA,NA,Rims4 (MGI:2674366)
20,44885704,44908531,20q13.1,20q13.12,601289,YWHAB,"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide",YWHAB,7529,ENSG00000166913,NA,NA,Ywhab (MGI:1891917)
20,44942129,44960424,20q13.12,20q13.12,616049,"TOMM34, TOM34","Translocase of outer mitochondrial membrane 34, yeast, homolog of",TOMM34,10953,ENSG00000025772,NA,NA,Tomm34 (MGI:1914395)
20,44966469,45080020,20q13.2,20q13.12,604965,"STK4, MST1, KRS2, TIIAC",Serine/threonine protein kinase 4,STK4,6789,ENSG00000101109,NA,"T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)",Stk4 (MGI:1929004)
20,45091213,45101126,20q13.12,20q13.12,602905,"KCNS1, KV9.1","Potassium channel, voltage-gated, delayed-rectifier, subfamily S, member 1",KCNS1,3787,ENSG00000124134,NA,NA,Kcns1 (MGI:1197019)
20,45109458,45116320,20q12-q13.2,20q13.12,605161,"WFDC5, PRG5, WAP1",WAP 4-disulfide core domain 5,WFDC5,149708,ENSG00000175121,NA,NA,Wfdc5 (MGI:2384800)
20,45123424,45124464,20q12-q13.1,20q13.12,609872,"WFDC12, WAP2, SWAM2",Wap 4-disulfide core domain 12,WFDC12,128488,ENSG00000168703,NA,NA,NA
20,45174901,45176543,20q12-q13,20q13.12,182257,PI3,"Protease inhibitor 3, skin derived (SKALP)",PI3,5266,ENSG00000124102,NA,NA,NA
20,45207032,45209767,20q12-q13.1,20q13.12,182140,"SEMG1, SEMG",Semenogelin,SEMG1,6406,ENSG00000124233,NA,NA,NA
20,45221372,45224457,20q12-q13.1,20q13.12,182141,SEMG2,Semenogelin II,SEMG2,6407,ENSG00000124157,NA,NA,NA
20,45252238,45254563,20q13.12,20q13.12,107285,"SLPI, HUSI",Secretory leukocyte protease inhibitor,SLPI,6590,ENSG00000124107,NA,NA,Slpi (MGI:109297)
20,45293445,45308565,20q13.1-q13.2,20q13.12,603897,MATN4,Matrilin 4,MATN4,8785,ENSG00000124159,NA,NA,Matn4 (MGI:1328314)
20,45306835,45319676,20q13.12,20q13.12,616104,"RBPJL, RBPL, SUHL",RBPJ-like protein,RBPJL,11317,ENSG00000124232,NA,NA,Rbpjl (MGI:1196616)
20,45325287,45348423,20q12-q13,20q13.12,600017,SDC4,"Syndecan 4 (amphiglycan, ryudocan)",SDC4,6385,ENSG00000124145,NA,NA,Sdc4 (MGI:1349164)
20,45361948,45376797,20q13.12,20q13.12,612979,SYS1,"Sys1 golgi-localized integral membrane protein, S. cerevisiae, homolog of",SYS1,90196,ENSG00000204070,NA,NA,Sys1 (MGI:1913710)
20,45372556,45378549,20q13.12,20q13.12,617316,TP53TG5,TP53 target gene 5,TP53TG5,27296,ENSG00000124251,NA,NA,Trp53tg5 (MGI:1920853)
20,45405992,45410609,20q12,20q13.12,611453,"DBNDD2, HSMNP1",Dysbindin domain-containing 2,DBNDD2,55861,ENSG00000244274,NA,NA,Dbndd2 (MGI:106562)
20,45416066,45426244,20q13.12,20q13.12,610272,"PIGT, NDAP, PNH2, MCAHS3","Phosphatidylinositol glycan, class T",PIGT,51604,ENSG00000124155,mutation identified in 1 PNH2 family,"Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3), Autosomal recessive; ?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3), Autosomal dominant, Somatic mutation",Pigt (MGI:1926178)
20,45469752,45481531,20q13.12,20q13.12,617548,"WFDC2, HE4, WAP5",WAP 4-disulfide core domain 2,WFDC2,10406,ENSG00000101443,NA,NA,Wfdc2 (MGI:1914951)
20,45512460,45515621,20q12-q13.1,20q13.12,613941,SPINT3,"Serin protease inhibitor, Kunitz-type, 3",SPINT3,10816,ENSG00000101446,NA,NA,NA
20,45540625,45547400,20q13.2,20q13.12,609031,"SPINLW1, EPPIN, WAP7",Serine protease inhibitor-like protein with Kunitz and WAP domains 1,EPPIN,57119,ENSG00000101448,NA,NA,Wfdc6a (MGI:2684968)
20,45791953,45811418,20q13.12,20q13.12,611388,"DNTTIP1, TDIF1, C20orf167","Deoxynucleotidyltransferase, terminal, interacting protein 1",DNTTIP1,116092,ENSG00000101457,NA,NA,Dnttip1 (MGI:1923483)
20,45812575,45816956,20q13.12,20q13.12,605574,"UBE2C, UBCH10",Ubiquitin-conjugating enzyme E2C,UBE2C,11065,ENSG00000175063,NA,NA,Ube2c (MGI:1915862)
20,45823213,45833328,20q12-q13.11,20q13.12,191039,TNNC2,"Troponin C2, fast",TNNC2,7125,ENSG00000101470,NA,NA,Tnnc2 (MGI:98780)
20,45841720,45857404,20q13.1,20q13.12,608123,"ACOT8, PTE1",Acyl-CoA thioesterase 8,ACOT8,10005,ENSG00000101473,NA,NA,Acot8 (MGI:2158201)
20,45890143,45898819,20q13.1,20q13.12,613111,"CTSA, PPGB, GSL, NGBE, GLB2",Cathepsin A (protective protein for beta-galactosidase),CTSA,5476,ENSG00000064601,NA,"Galactosialidosis, 256540 (3), Autosomal recessive",Ctsa (MGI:97748)
20,45898619,45912363,20q12-q13.1,20q13.12,172425,"PLTP, HDLCQ9",Phospholipid transfer protein,PLTP,5360,ENSG00000100979,NA,[High density lipoprotein cholesterol level QTL 9] (3),Pltp (MGI:103151)
20,45948652,45972909,20q11.2-q13.1,20q13.12,610827,"ZNF335, NIF1, NIF2, MCPH10",Zinc finger protein 335,ZNF335,63925,ENSG00000198026,NA,"Microcephaly 10, primary, autosomal recessive, 615095 (3), Autosomal recessive",Zfp335 (MGI:2682313)
20,46008907,46016560,20q11.2-q13.1,20q13.12,120361,"MMP9, CLG4B, MANDP2","Matrix metalloproteinase 9 (gelatinase B, 92kD type IV collagenase)",MMP9,4318,ENSG00000100985,NA,"Metaphyseal anadysplasia 2, 613073 (3)",Mmp9 (MGI:97011)
20,46021685,46060149,20q12-q13.1,20q13.12,606726,"SLC12A5, KCC2, KIAA1176, EIEE34, EIG14","Solute carrier family 12, (potassium-chloride transporter) member 5",SLC12A5,57468,ENSG00000124140,NA,"{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3), Autosomal dominant; Epileptic encephalopathy, early infantile, 34, 616645 (3), Autosomal recessive",Slc12a5 (MGI:1862037)
20,46060990,46089961,20q13.1,20q13.12,616825,"NCOA5, CIA",Nuclear receptor coactivator 5,NCOA5,57727,ENSG00000124160,NA,NA,Ncoa5 (MGI:2385165)
20,46118241,46129857,20q12-q13.2,20q13.12,109535,"CD40, TNFRSF5",CD40 antigen,CD40,958,ENSG00000101017,NA,"Immunodeficiency with hyper-IgM, type 3, 606843 (3), Autosomal recessive",Cd40 (MGI:88336)
20,46173732,46308497,20q13.1,20q13.12,609920,CDH22,Cadherin 22,CDH22,64405,ENSG00000149654,NA,NA,Cdh22 (MGI:1341843)
20,46366044,46407050,20q13,20q13.12,606421,"ELMO2, CED12, VMPI",Engulfment and cell motility gene 2,ELMO2,63916,ENSG00000062598,NA,"Vascular malformation, primary intraosseous, 606893 (3), Autosomal recessive",Elmo2 (MGI:2153045)
20,46557827,46684484,20q12-q13.1,20q13.12,606411,"SLC13A3, NADC3, ARLIAK","Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3",SLC13A3,64849,ENSG00000158296,NA,"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, 618384 (3), Autosomal recessive",Slc13a3 (MGI:2149635)
20,46684364,46689443,20q13.12,20q13.12,608679,"TP53RK, PRPK, GAMOS4",TP53-regulating kinase,TP53RK,112858,ENSG00000172315,NA,"Galloway-Mowat syndrome 4, 617730 (3), Autosomal recessive","Trp53rkb,Trp53rka (MGI:1918294,MGI:1914050)"
20,46708357,46736346,20q13.1,20q13.12,606145,"SLC2A10, GLUT10, ATORS","Solute carrier family 2 (facilitated glucose transporter), member 10",SLC2A10,81031,ENSG00000197496,NA,"Arterial tortuosity syndrome, 208050 (3), Autosomal recessive",Slc2a10 (MGI:2156687)
20,46894623,47188843,20q13.1,20q13.12,601654,EYA2,"Eyes absent, Drosophila, homolog of, 2",EYA2,2139,ENSG00000064655,NA,NA,Eya2 (MGI:109341)
20,47209213,47356888,20q13.12,20q13.12,615713,"ZMYND8, PRKCBP1",Zinc finger MYND domain-containing protein 8,ZMYND8,23613,ENSG00000101040,NA,NA,Zmynd8 (MGI:1918025)
20,47501886,47656871,20q12,20q13.12,601937,"NCOA3, AIB1, TNRC14",Nuclear receptor coactivator 3 (amplified in breast cancer-1),NCOA3,8202,ENSG00000124151,NA,NA,Ncoa3 (MGI:1276535)
20,47654568,47786615,20q13.12,20q13.12,610013,"SULF2, KIAA1247",Sulfatase 2,SULF2,55959,ENSG00000196562,NA,NA,Sulf2 (MGI:1919293)
20,48624251,48827998,20q13.13,20q13.13,606905,"PREX1, KIAA1415","Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1",PREX1,57580,ENSG00000124126,NA,NA,Prex1 (MGI:3040696)
20,48921710,49036692,20q13.13,20q13.13,605371,"ARFGEF2, BIG2, PVNH2","ADP-ribosylation factor guanine nucleotide-exchange factor 2, brefeldin A-inhibited",ARFGEF2,10564,ENSG00000124198,NA,"Periventricular heterotopia with microcephaly, 608097 (3), Autosomal recessive",Arfgef2 (MGI:2139354)
20,49046245,49096959,20q13,20q13.13,601342,"CSE1L, CAS","Chromosome segregation-1, yeast, homolog of, like",CSE1L,1434,ENSG00000124207,NA,NA,Cse1l (MGI:1339951)
20,49113338,49219294,20q13.1,20q13.13,601716,"STAU1, STAU","Staufen, Drosophila, homolog of, 1",STAU1,6780,ENSG00000124214,NA,NA,Stau1 (MGI:1338864)
20,49219294,49244076,20q13.13,20q13.13,616621,"DDX27, RHLP",DEAD box polypeptide 27,DDX27,55661,ENSG00000124228,NA,NA,Ddx27 (MGI:2385884)
20,49363876,49484032,20q13.2,20q13.13,600397,"KCNB1, EIEE26","Potassium voltage-gated channel, Shab-related subfamily, member 1",KCNB1,3745,ENSG00000158445,NA,"Epileptic encephalopathy, early infantile, 26, 616056 (3), Autosomal dominant",Kcnb1 (MGI:96666)
20,49503873,49568136,20q13.11-q13.13,20q13.13,601699,"PTGIS, CYP8A1, PGIS, CYP8",Prostaglandin I2 synthase,PTGIS,5740,ENSG00000124212,NA,"Hypertension, essential, 145500 (3), Multifactorial",Ptgis (MGI:1097156)
20,49632944,49713877,20q13.1-q13.2,20q13.13,604016,B4GALT5,"Beta-1,4-galactosyltransferase 5",B4GALT5,9334,ENSG00000158470,previously mapped to chr.11,NA,B4galt5 (MGI:1927169)
20,49812712,49892241,20q13.13,20q13.13,612730,"SLC9A8, NHE8, KIAA0939","Solute carrier family 9 (sodium/hydrogen exchanger), member 8",SLC9A8,23315,ENSG00000197818,NA,NA,Slc9a8 (MGI:1924281)
20,49903390,49915528,20q13.1-q13.2,20q13.13,607662,"SPATA2, KIAA0757",Spermatogenesis-associated protein 2,SPATA2,9825,ENSG00000158480,NA,NA,Spata2 (MGI:2146885)
20,49936396,49953884,20q13,20q13.13,612451,"RNF114, ZNF313",Ring finger protein 114,RNF114,55905,ENSG00000124226,NA,NA,Rnf114 (MGI:1933159)
20,49982979,49988885,20q13.1,20q13.13,604238,SNAI1,"Snail 1, Drosophila, homolog of",SNAI1,6615,ENSG00000124216,pseudogene on 2q34,NA,Snai1 (MGI:98330)
20,50081123,50115956,20q13.2,20q13.13,602995,"UBE2V1, UEV1",Ubiquitin-conjugating enzyme E2 variant 1,UBE2V1,7335,ENSG00000244687,NA,NA,Ube2v1 (MGI:1913839)
20,50118253,50153797,20q13.2,20q13.13,610994,"TMEM189, KUA",Transmembrane protein 189,TMEM189,387521,ENSG00000240849,NA,NA,Tmem189 (MGI:2142624)
20,50190582,50192689,20q13.1,20q13.13,189965,"CEBPB, TCF5","CCAAT/enhancer-binding protein (C/EBP), beta (transcription factor-5)",CEBPB,1051,ENSG00000172216,NA,NA,Cebpb (MGI:88373)
20,50510320,50585240,20q13.1-q13.2,20q13.13,176885,"PTPN1, PTP1B","Protein tyrosine phosphatase, nonreceptor-type, 1",PTPN1,5770,ENSG00000196396,20pter-q12 by REa,"{Insulin resistance, susceptibility to}, 125853 (3), Autosomal dominant",Ptpn1 (MGI:97805)
20,50731579,50753740,20q13.13,20q13.13,608975,PARD6B,"Partitioning-defective protein 6, C. elegans, homolog of, beta",PARD6B,84612,ENSG00000124171,NA,NA,Pard6b (MGI:2135605)
20,50794893,50877735,20q13.13,20q13.13,607471,BCAS4,Breast carcinoma amplified sequence 4,BCAS4,55653,ENSG00000124243,NA,NA,NA
20,50888917,50931436,20q13.13,20q13.13,611386,"ADNP, ADNP1, KIAA0784, HVDAS, MRD28",Activity-dependent neuroprotector homeobox,ADNP,23394,ENSG00000101126,NA,"Helsmoortel-van der Aa syndrome, 615873 (3), Autosomal dominant",Adnp (MGI:1338758)
20,50934854,50958563,20q13.13,20q13.13,603503,"DPM1, MPDS, CDGIE","Dolichyl-phosphate mannosyltransferase 1, catalytic subunit",DPM1,8813,ENSG00000000419,NA,"Congenital disorder of glycosylation, type Ie, 608799 (3), Autosomal recessive",Dpm1 (MGI:1330239)
20,51003655,51023175,20q13,20q13.13,603788,"KCNG1, KH2","Potassium voltage-gated channel, subfamily G, member 1",KCNG1,3755,ENSG00000026559,NA,NA,Kcng1 (MGI:3616086)
20,51200000,64444167,20q13.2-q13.3,NA,610248,DFNB65,"Deafness, autosomal recessive 65",DFNB65,692219,NA,max lod at D20S840,"Deafness, autosomal recessive 65, 610248 (2), Autosomal recessive",NA
20,51200000,64444167,20q13.2-q13.3,NA,130180,"EEGV1, EEGL",Electroencephalographic variant pattern 1,EEGV1,1940,NA,NA,NA,NA
20,51386962,51562856,20q13.2-q13.3,20q13.2,600490,"NFATC2, NFATP","Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 2",NFATC2,4773,ENSG00000101096,NA,NA,Nfatc2 (MGI:102463)
20,51782330,51802520,20q13.13-q13.2,20q13.2,607343,"SALL4, HSAL4",sal-like 4,SALL4,57167,ENSG00000101115,NA,"Duane-radial ray syndrome, 607323 (3), Autosomal dominant; IVIC syndrome, 147750 (3), Autosomal dominant",Sall4 (MGI:2139360)
20,52084010,52191984,20q13.2,20q13.2,618111,"ZFP64, ZNF338",Zinc finger protein 64,ZFP64,55734,ENSG00000020256,NA,NA,Zfp64 (MGI:107342)
20,52972308,53495329,20q13.2,20q13.2,614118,TSHZ2,Teashirt zinc finger homeobox 2,TSHZ2,128553,ENSG00000182463,NA,NA,Tshz2 (MGI:2153084)
20,53567064,53608968,20q13.2,20q13.2,602967,ZNF217,Zinc finger protein-217,ZNF217,7764,ENSG00000171940,NA,NA,Zfp217 (MGI:2685408)
20,53943537,54070764,20q13.2,20q13.2,602968,"BCAS1, NABC1",Breast carcinoma amplified sequence,BCAS1,8537,ENSG00000064787,NA,NA,Bcas1 (MGI:1924210)
20,54145730,54174031,20q13.2-q13.3,20q13.2,126065,"CYP24A1, CYP24, HCINF1","Cytochrome P450, family 24, subfamily A, polypeptide 1 (vitamin D 24-hydroxylase)",CYP24A1,1591,ENSG00000019186,NA,"Hypercalcemia, infantile, 1, 143880 (3), Autosomal recessive",Cyp24a1 (MGI:88593)
20,54208086,54219960,20q13.2,20q13.2,604898,"PFDN4, C1",Prefoldin 4,PFDN4,5203,ENSG00000101132,NA,NA,Pfdn4 (MGI:1923512)
20,54475592,54651170,20q13.2,20q13.2,608334,DOK5,Docking protein 5,DOK5,55816,ENSG00000101134,NA,NA,Dok5 (MGI:1924079)
20,55997356,56005518,20q13.2,20q13.2,615029,CBLN4,Precerebellin 4,CBLN4,140689,ENSG00000054803,NA,NA,Cbln4 (MGI:2154433)
20,56248731,56249814,20q13.2,20q13.2,155540,"MC3R, BMIQ9",Melanocortin-3 receptor,MC3R,4159,ENSG00000124089,NA,"{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3)",Mc3r (MGI:96929)
20,56369388,56392336,20q13.2-q13.3,20q13.2,603072,"AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK",Aurora kinase A,AURKA,6790,ENSG00000087586,NA,"{Colon cancer, susceptibility to}, 114500 (3), Autosomal dominant, Somatic mutation",Aurka (MGI:894678)
20,56392370,56406361,20q13.2,20q13.2-q13.3,600369,CSTF1,"Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kD",CSTF1,1477,ENSG00000101138,NA,NA,Cstf1 (MGI:1914587)
20,56400000,64444167,20q13.31-q13.33,NA,612929,MTBS3,"Mycobacterium tuberculosis, susceptibility to, 3",NA,100302686,NA,associated with rs3827103,"{Mycobacterium tuberculosis, susceptibility to, 3}, 612929 (2)",NA
20,56629305,56639282,20q13.2,20q13.31,601602,TFAP2C,Transcription factor AP-2 gamma (activating enhancer-binding protein 2 gamma),TFAP2C,7022,ENSG00000087510,NA,NA,Tfap2c (MGI:106032)
20,57168752,57266640,20q13.1-q13.3,20q13.31,112267,BMP7,Bone morphogenetic protein-7 (osteogenic protein-1),BMP7,655,ENSG00000101144,NA,NA,Bmp7 (MGI:103302)
20,57329756,57343992,20q13.2-q13.3,20q13.31,605114,SPO11,"Spo11, S. cerevisiae, homolog of",SPO11,23626,ENSG00000054796,NA,NA,Spo11 (MGI:1349669)
20,57351238,57379201,20q13.31,20q13.31,603343,"RAE1, MRNP41","RNA export 1, S. pombe, homolog of",RAE1,8480,ENSG00000101146,NA,NA,Rae1 (MGI:1913929)
20,57391395,57409332,20q13.31,20q13.31,612428,"RBM38, RNPC1",RNA-binding motif protein 38,RBM38,55544,ENSG00000132819,NA,NA,Rbm38 (MGI:1889294)
20,57495964,57525651,20q13.2,20q13.31,607022,"CTCFL, BORIS",CCCTC-binding factor-like protein,CTCFL,140690,ENSG00000124092,NA,NA,Ctcfl (MGI:3652571)
20,57561109,57568120,20q13.31,20q13.31,614168,"PCK1, PCKDC",Phosphoenolpyruvate carboxykinase-1 (soluble),PCK1,5105,ENSG00000124253,mutation identified in 1 PCKDC family,"?Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3), Autosomal recessive",Pck1 (MGI:97501)
20,57603845,57620575,20q13.31,20q13.31,606750,"ZBP1, C20orf183, DLM1",Z-DNA binding protein 1 (tumor stroma and activated macrophage protein DLM1),ZBP1,81030,ENSG00000124256,NA,NA,Zbp1 (MGI:1927449)
20,57648391,57711535,20q13,20q13.31,606564,"PMEPA1, TMEPAI","Prostate transmembrane protein, androgen-induced",PMEPA1,56937,ENSG00000124225,NA,NA,Pmepa1 (MGI:1929600)
20,58309714,58367506,20q13.3,20q13.32,612966,RAB22A,Ras-associated protein RAB22A,RAB22A,57403,ENSG00000124209,NA,NA,Rab22a (MGI:105072)
20,58389118,58451100,20q13.3,20q13.32,605704,"VAPB, VAPC, ALS8",Vesicle-associated membrane protein-associated protein B,VAPB,9217,ENSG00000124164,NA,"Amyotrophic lateral sclerosis 8, 608627 (3), Autosomal dominant; Spinal muscular atrophy, late-onset, Finkel type, 182980 (3), Autosomal dominant",Vapb (MGI:1928744)
20,58651252,58679525,20q13.32,20q13.32,603666,"STX16, SYN16",Syntaxin 16,STX16,8675,ENSG00000124222,NA,"Pseudohypoparathyroidism, type IB, 603233 (3), Autosomal dominant",Stx16 (MGI:1923396)
20,58817614,58817693,20q13.3,20q13.32,610945,"MIR296, MIRN296",Micro RNA 296,MIR296,407022,ENSG00000284040,NA,NA,NA
20,58818225,58818312,20q13.32,20q13.32,614914,MIR298,Micro RNA 298,MIR298,100126296,ENSG00000216031,NA,NA,NA
20,58818917,58850902,20q13.2,20q13.32,610540,"GNASAS1, GNASAS, SANG, NESPAS",GNAS antisense RNA 1,GNAS-AS1,149775,ENSG00000235590,NA,"Pseudohypoparathyroidism, type IB, 603233 (3), Autosomal dominant",NA
20,58839680,58911195,20q13.2,20q13.32,139320,"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3","GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)",GNAS,2778,ENSG00000087460,NA,"ACTH-independent macronodular adrenal hyperplasia, 219080 (3), Somatic mutation; McCune-Albright syndrome, somatic, mosaic, 174800 (3); Osseous heteroplasia, progressive, 166350 (3), Autosomal dominant; Pituitary adenoma 3, multiple types, somatic, 617686 (3); Pseudohypoparathyroidism Ia, 103580 (3), Autosomal dominant; Pseudohypoparathyroidism Ib, 603233 (3), Autosomal dominant; Pseudohypoparathyroidism Ic, 612462 (3), Autosomal dominant; Pseudopseudohypoparathyroidism, 612463 (3), Autosomal dominant",Gnas (MGI:95777)
20,58981251,58995132,20q13,20q13.32,605297,"TH1L, TH1","TH1, Drosophila, homolog of",NELFCD,51497,ENSG00000101158,NA,NA,Nelfcd (MGI:1926424)
20,58995184,59007253,20q13,20q13.32,603169,CTSZ,Cathepsin Z,CTSZ,1522,ENSG00000101160,NA,NA,Ctsz (MGI:1891190)
20,59016025,59026653,20q13.3,20q13.32,612901,TUBB1,"Tubulin, beta-1",TUBB1,81027,ENSG00000101162,NA,"Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3), Autosomal dominant",Tubb1 (MGI:107814)
20,59025474,59032334,20q13.3,20q13.32,606153,"ATP5E, MC5DN3","ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit",ATP5F1E,514,ENSG00000124172,pseudogene on 4q25; mutation identified in 1 MC5DN3 patient,"?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)",NA
20,59300414,59325991,20q13.2-q13.3,20q13.32,131242,"EDN3, WS4B, HSCR4",Endothelin-3,EDN3,1908,ENSG00000124205,NA,"Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant; {Hirschsprung disease, susceptibility to, 4}, 613712 (3), Autosomal dominant; Waardenburg syndrome, type 4B, 613265 (3), Autosomal recessive, Autosomal dominant",Edn3 (MGI:95285)
20,59577496,59849828,20q13.32,20q13.32-q13.33,608725,"PHACTR3, SCAPININ",Phosphatase and actin regulator 3,PHACTR3,116154,ENSG00000087495,NA,NA,Phactr3 (MGI:1921439)
20,59700000,64444167,20q13.33,NA,613031,GLM6,Glioma susceptibility 6,NA,100415895,NA,associated with rs6010620,"{Glioma susceptibility 6}, 613031 (2)",NA
20,59863276,59933699,20q13.33,20q13.33,604105,"SYCP2, SCP2",Synaptonemal complex protein 2,SYCP2,10388,ENSG00000196074,NA,NA,Sycp2 (MGI:1933281)
20,59936662,59940304,20q13.3,20q13.33,603326,"PPP1R3D, PPP1R6","Protein phosphatase 1, regulatory subunit 3D",PPP1R3D,5509,ENSG00000132825,NA,NA,Ppp1r3d (MGI:1917664)
20,59957763,60037970,20q13.33,20q13.33,617685,CDH26,Cadherin 26,CDH26,60437,ENSG00000124215,NA,NA,Cdh26 (MGI:2685856)
20,61252260,61940616,20q13.3,20q13.33,603006,CDH4,Cadherin 4,CDH4,1002,ENSG00000179242,NA,NA,Cdh4 (MGI:99218)
20,61974797,62065809,20q13.33,20q13.33,601796,"TAF4, TAF2C1, TAFII130, TAF2C","TAF4 RNA polymerase II, TATA box-binding protein-associated factor, 135kD",TAF4,6874,ENSG00000130699,NA,NA,Taf4 (MGI:2152346)
20,62136732,62143393,20q13.33,20q13.33,606607,PSMA7,"Proteasome subunit, alpha-type, 7",PSMA7,5688,ENSG00000101182,NA,NA,Psma7 (MGI:1347070)
20,62143719,62182513,20q13.3,20q13.33,606472,"SS18L1, KIAA0693, CREST",SS18-like gene 1,SS18L1,26039,ENSG00000184402,NA,NA,Ss18l1 (MGI:2444061)
20,62182745,62203567,20q13.33,20q13.33,610919,"GTPBP5, OBGH1",GTP-binding protein 5,MTG2,26164,ENSG00000101181,NA,NA,Mtg2 (MGI:106565)
20,62213844,62220277,20q13.33,20q13.33,604525,"HRH3, GPCR97",Histamine receptor H3,HRH3,11255,ENSG00000101180,NA,NA,Hrh3 (MGI:2139279)
20,62238520,62296212,20q,20q13.33,606731,"OSBPL2, ORP2, KIAA0772, DNFA67",Oxysterol-binding protein-like protein 2,OSBPL2,9885,ENSG00000130703,NA,"Deafness, autosomal dominant 67, 616340 (3), Autosomal dominant",Osbpl2 (MGI:2442832)
20,62302060,62308861,20q13.33,20q13.33,610650,"ADRM1, ARM1, RPN13",Adhesion-regulating molecule 1,ADRM1,11047,ENSG00000130706,NA,NA,Adrm1 (MGI:1929289)
20,62309059,62367317,20q13.2-q13.3,20q13.33,601033,LAMA5,"Laminin, alpha-5",LAMA5,3911,ENSG00000130702,NA,NA,Lama5 (MGI:105382)
20,62386274,62388519,20q13.3,20q13.33,180477,RPS21,Ribosomal protein S21,RPS21,6227,ENSG00000171858,NA,NA,Rps21 (MGI:1913731)
20,62463496,62475994,20q13.2-q13.3,20q13.33,611496,"GATA5, CHTD5",GATA-binding protein 5,GATA5,140628,ENSG00000130700,NA,"Congenital heart defects, multiple types, 5, 617912 (3), Autosomal recessive, Autosomal dominant",Gata5 (MGI:109497)
20,62554305,62554375,20q13.33,20q13.33,609326,MIR1-1,Micro RNA 1-1,MIR1-1,406904,ENSG00000199017,NA,NA,NA
20,62564911,62565012,20q13.33,20q13.33,610255,MIR133A2,Micro RNA 133A2,MIR133A2,406923,ENSG00000284508,NA,NA,NA
20,62642057,62690721,20q13.33,20q13.33,612436,"SLCO4A1, OATPE, OATP4A1","Solute carrier organic anion transporter family, member 4A1",SLCO4A1,28231,ENSG00000101187,NA,NA,Slco4a1 (MGI:1351866)
20,62708769,62762770,20q13,20q13.33,162651,NTSR1,Neurotensin receptor,NTSR1,4923,ENSG00000101188,NA,NA,Ntsr1 (MGI:97386)
20,62796404,62801737,20q13.33,20q13.33,611157,"MRGBP, C20orf20",MRG/MORF4L-binding protein,MRGBP,55257,ENSG00000101189,NA,NA,Mrgbp (MGI:1920497)
20,62804834,62813999,20q13.33,20q13.33,606459,OGFR,Opioid growth factor receptor,OGFR,11054,ENSG00000060491,NA,NA,Ogfr (MGI:1919325)
20,62817049,62841158,20q13.3,20q13.33,120270,"COL9A3, EDM3, IDD","Collagen IX, alpha-3 polypeptide",COL9A3,1299,ENSG00000092758,NA,"Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3), Autosomal dominant; {Intervertebral disc disease, susceptibility to}, 603932 (3)",Col9a3 (MGI:894686)
20,62877737,62937951,20q13.33,20q13.33,604140,"DATF1, DIO1",Death-associated transcription factor 1,DIDO1,11083,ENSG00000101191,NA,NA,Dido1 (MGI:1344352)
20,62938146,62948474,20q13.33,20q13.33,611625,"GID8, C20orf11, TWA1","GID complex, subunit 8",GID8,54994,ENSG00000101193,NA,NA,Gid8 (MGI:1923675)
20,62952689,62969584,20q13.3,20q13.33,612107,"SLC17A9, C20orf59, POROK8","Solute carrier family 17, member 9",SLC17A9,63910,ENSG00000101194,NA,"Porokeratosis 8, disseminated superficial actinic type, 616063 (3), Autosomal dominant",Slc17a9 (MGI:1919107)
20,63005926,63006963,20q13,20q13.33,609331,"BHLHE23, BHLHB4","Basic helix-loop-helix family, member E23",BHLHE23,128408,ENSG00000125533,NA,NA,Bhlhe23 (MGI:2153710)
20,63095492,63102318,20q13.33,20q13.33,610557,"HAR1B, HAR1R",Highly accelerated region gene 1B,HAR1B,768097,ENSG00000231133,NA,NA,NA
20,63101291,63104385,20q13.33,20q13.33,610556,"HAR1A, HAR1F",Highly accelerated region gene 1A,HAR1A,768096,NA,NA,NA,NA
20,63195428,63216130,20q13.33,20q13.33,616529,YTHDF1,YTH N6-methyladenosine RNA-binding protein 1,YTHDF1,54915,ENSG00000149658,NA,NA,Ythdf1 (MGI:1917431)
20,63235904,63240494,20q13.3,20q13.33,605737,"BIRC7, MLIAP, KIAP, LIVIN",Baculoviral IAP repeat-containing protein 7,BIRC7,79444,ENSG00000101197,NA,NA,Birc7 (MGI:2676458)
20,63240779,63256405,20q13.33,20q13.33,612873,NKAIN4,Na+/K+ transporting ATPase-interacting 4,NKAIN4,128414,ENSG00000101198,NA,NA,Nkain4 (MGI:1915372)
20,63272784,63289789,20q13.33,20q13.33,608377,ARFGAP1,ADP-ribosylation factor GTPase-activating protein 1,ARFGAP1,55738,ENSG00000101199,NA,NA,Arfgap1 (MGI:2183559)
20,63343222,63375470,20q13.2-q13.3,20q13.33,118504,"CHRNA4, ENFL1","Cholinergic receptor, nicotinic, alpha polypeptide-4",CHRNA4,1137,ENSG00000101204,NA,"Epilepsy, nocturnal frontal lobe, 1, 600513 (3), Autosomal dominant; {Nicotine addiction, susceptibility to}, 188890 (3)",Chrna4 (MGI:87888)
20,63400207,63472654,20q13.3,20q13.33,602235,"KCNQ2, EBN1, EIEE7, BFNS1","Potassium voltage-gated channel, KQT-like subfamily, member 2",KCNQ2,3785,ENSG00000075043,NA,"Epileptic encephalopathy, early infantile, 7, 613720 (3), Autosomal dominant; Myokymia, 121200 (3), Autosomal dominant; Seizures, benign neonatal, 1, 121200 (3), Autosomal dominant",Kcnq2 (MGI:1309503)
20,63488013,63499082,20q13,20q13.33,602959,"EEF1A2, EIEE33, MRD38","Eukaryotic translation elongation factor-1, alpha-2",EEF1A2,1917,ENSG00000101210,NA,"Epileptic encephalopathy, early infantile, 33, 616409 (3), Autosomal dominant; Mental retardation, autosomal dominant 38, 616393 (3), Autosomal dominant",Eef1a2 (MGI:1096317)
20,63528000,63537375,20q13.3,20q13.33,602004,"PTK6, BRK",Protein-tyrosine kinase 6,PTK6,5753,ENSG00000101213,NA,NA,Ptk6 (MGI:99683)
20,63539923,63547503,20q13.33,20q13.33,617797,"SRMS, C20orf148",Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,SRMS,6725,ENSG00000125508,NA,NA,Srms (MGI:101865)
20,63558085,63574238,20q13.3,20q13.33,611265,"PRIC285, PDIP1, KIAA1769","Peroxisomal proliferator-activated receptor alpha-interacting cofactor complex, 285kD subunit",HELZ2,85441,ENSG00000130589,NA,NA,Helz2 (MGI:2385169)
20,63587601,63627100,20q13.33,20q13.33,607451,"GMEB2, KIAA1269",Glucocorticoid modulatory element-binding protein 2,GMEB2,26205,ENSG00000101216,NA,NA,Gmeb2 (MGI:2652836)
20,63639704,63653609,20q13.3,20q13.33,608362,"STMN3, SCLIP",Stathmin-like 3,STMN3,50861,ENSG00000197457,NA,NA,Stmn3 (MGI:1277137)
20,63657809,63696252,20q13.3,20q13.33,608833,"RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3",Regulator of telomere elongation helicase 1,RTEL1,51750,ENSG00000258366,NA,"Dyskeratosis congenita, autosomal dominant 4, 615190 (3), Autosomal recessive, Autosomal dominant; Dyskeratosis congenita, autosomal recessive 5, 615190 (3), Autosomal recessive, Autosomal dominant; Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3), Autosomal dominant",Rtel1 (MGI:2139369)
20,63696651,63698683,20q13,20q13.33,603361,"TNFRSF6B, DCR3","Tumor necrosis factor receptor superfamily, member 6b (decoy receptor 3)",TNFRSF6B,8771,ENSG00000243509,NA,NA,NA
20,63698641,63708012,20q13.33,20q13.33,604699,"ARFRP1, ARP",ADP-ribosylation factor-related protein 1,ARFRP1,10139,ENSG00000101246,NA,NA,Arfrp1 (MGI:1923938)
20,63735700,63739106,20q13.3,20q13.33,609809,"LIME1, LIME",LCK-interacting transmembrane adaptor 1,LIME1,54923,ENSG00000203896,NA,NA,Lime1 (MGI:1919949)
20,63743669,63832331,20q13.33,20q13.33,614639,"ZBTB46, BZEL",Zinc finger- and BTB domain-containing protein 46,ZBTB46,140685,ENSG00000130584,NA,NA,Zbtb46 (MGI:1919397)
20,63865227,63891544,20q13.2-q13.3,20q13.33,603747,TPD52L2,Tumor protein D52-like 2,TPD52L2,7165,ENSG00000101150,NA,NA,Tpd52l2 (MGI:1913564)
20,63895125,63936025,20q13.33,20q13.33,611203,"DNAJC5, DNAJC5A, CSP, CLN4B","DNAJ/HSP40 homolog, subfamily C, member 5",DNAJC5,80331,ENSG00000101152,NA,"Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3), Autosomal dominant",Dnajc5 (MGI:892995)
20,63939828,63956446,20q13.33,20q13.33,610866,"UCKL1, UCK1L, URKL1",Uridine/cytidine kinase-like 1,UCKL1,54963,ENSG00000198276,NA,NA,Uckl1 (MGI:1915806)
20,63956702,63969929,20q13.33,20q13.33,617886,"ZNF512B, KIAA1196",Zinc finger protein 512B,ZNF512B,57473,ENSG00000196700,NA,NA,Zfp512b (MGI:2685478)
20,63981131,64033099,20q13.33,20q13.33,613979,"PRPF6, PRP6, ANT1, TOM, C20orf14","Precursor mRNA-processing factor 6, S. cerevisiae, homolog of",PRPF6,24148,ENSG00000101161,NA,"Retinitis pigmentosa 60, 613983 (3), Autosomal dominant",Prpf6 (MGI:1922946)
20,64047581,64049638,20q13.33,20q13.33,601618,"SOX18, HLTS, HLTRS","SOX18, mouse, homolog of",SOX18,54345,ENSG00000203883,NA,"Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3), Autosomal recessive; Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3), Autosomal dominant",Sox18 (MGI:103559)
20,64073180,64080003,20q13.3,20q13.33,605071,"RGS19, GAIP",Regulator of G protein signaling 19,RGS19,10287,ENSG00000171700,NA,NA,Rgs19 (MGI:1915153)
20,64080081,64100642,20q13.33,20q13.33,602548,"OPRL1, NOP",Opioid receptor-like 1,OPRL1,4987,ENSG00000125510,NA,NA,Oprl1 (MGI:97440)
20,64105829,64106830,20q13.3,20q13.33,600731,GPR8,G protein-coupled receptor-8,NPBWR2,2832,ENSG00000125522,related sequence on 14,NA,NA
20,64164451,64242252,20q13.3,20q13.33,600379,"MYT1, PLPB1",Myelin transcription factor 1,MYT1,4661,ENSG00000196132,NA,NA,Myt1 (MGI:1100535)
20,0,64444167,Chr.20,NA,151310,"HTL, LEUT, HLT","Leucine transport, high",HTL,3343,NA,NA,NA,NA
21,0,15000000,21p13-q11,NA,610838,AUTS12,"Autism, susceptibility to, 12",NA,100188314,NA,max lod at D21S1437,"{Autism susceptibility 12}, 610838 (2)",NA
21,3100000,7000000,21p12,NA,180453,RNR4,Ribosomal RNA-4,RNR4,6055,NA,NA,NA,NA
21,7000000,10900000,21p11.2,NA,605167,"BAGE1, BAGE","BAGE family, member 1",BAGE,574,NA,previously assigned to chr.13,NA,NA
21,7000000,10900000,21p11.2,NA,617777,BAGE3,"BAGE family, member 3",BAGE3,85318,NA,NA,NA,NA
21,10413531,10491614,21p11.2,21p11.2,617776,BAGE2,"BAGE family, member 2",BAGE2,85319,NA,NA,NA,NA
21,10521513,10606269,21p,21p11.2,604336,TPTE,Transmembrane phosphatase with tensin homology,TPTE,7179,ENSG00000274391,NA,NA,NA
21,13000000,15000000,21q11.2,NA,609039,NRCLP3,Narcolepsy 3,NA,494446,NA,max lod at D21S1245,"Narcolepsy 3, 609039 (2), Autosomal dominant",NA
21,13000000,15000000,21q11.2,NA,159595,"TAM, MST","Myeloproliferative syndrome, transient (transient abnormal myelopoiesis)",NA,8205,NA,NA,"Leukemia, transient, of Down syndrome, 159595 (2)",NA
21,13610080,13641584,21q11.2,21q11.2,607549,"POTED, ANKRD21, POTE","POTE ankyrin domain family, member D",POTED,317754,ENSG00000166351,NA,NA,NA
21,14108812,14210952,21q11.2,21q11.2,609252,"LIPI, LPDL, PRED5",Lipase I,LIPI,149998,ENSG00000188992,NA,NA,Lipi (MGI:2443868)
21,14216106,14228371,21q11.2,21q11.2,617937,RBM11,RNA-binding motif protein 11,RBM11,54033,ENSG00000185272,NA,NA,Rbm11 (MGI:2447622)
21,14273798,14301385,21q11.2,21q11.2,608835,ABCC13,"ATP-binding cassette, subfamily C, member 13",ABCC13,150000,ENSG00000243064,NA,NA,NA
21,14371114,14383145,21q11.1,21q11.2,601100,STCH,"Stress 70 protein chaperone, microsome-associated, p60",HSPA13,6782,ENSG00000155304,NA,NA,Hspa13 (MGI:1309463)
21,14485227,14583401,21q11.2,21q11.2,607978,"SAMSN1, HACS1","SAM domain, SH3 domain, and nuclear localization signals 1",SAMSN1,64092,ENSG00000155307,NA,NA,Samsn1 (MGI:1914992)
21,14961234,15065902,21q11,21q11.2-q21.1,602490,"NRIP1, RIP140, CAKUT3",Nuclear receptor interacting protein 1 (receptor interacting protein 140),NRIP1,8204,ENSG00000180530,mutation identified in 1 CAKUT3 family,"?Congenital anomalies of kidney and urinary tract 3, 618270 (3), Autosomal dominant",Nrip1 (MGI:1315213)
21,15000000,30200000,21q21,NA,602097,USH1E,"Usher syndrome-1E, autosomal recessive, severe",USH1E,7396,NA,NA,"Usher syndrome, type 1E, 602097 (2), Autosomal recessive",NA
21,16070487,16631726,21q21.1,21q21.1,615964,"MIR99AHG, MONC, LINC00478","MIR99A-LET7C cluster host gene, noncoding",MIR99AHG,388815,ENSG00000215386,NA,NA,NA
21,16539088,16539168,21q21.1,21q21.1,614509,MIR99A,Micro RNA 99A,MIR99A,407055,ENSG00000207638,NA,NA,NA
21,16539827,16539910,21q21.1,21q21.1,612144,"MIRLET7C, MIRNLET7C, LET7C",Micro RNA Let7c,MIRLET7C,406885,ENSG00000199030,NA,NA,NA
21,16590236,16590324,21q21.1,21q21.1,610105,"MIR125B2, MIRN125B2",Micro RNA 125B-2,MIR125B2,406912,ENSG00000207863,NA,NA,NA
21,17512905,17636212,21q11.2,21q21.1,602621,"CXADR, CAR",Coxsackie virus and adenovirus receptor,CXADR,1525,ENSG00000154639,pseudogenes on chr.15 and chr.18,NA,Cxadr (MGI:1201679)
21,17593652,17612939,21q11.2-q21.1,21q21.1,605674,"BTG3, ANA, TOB5",B-cell translocation gene 3,BTG3,10950,ENSG00000154640,NA,NA,Btg3 (MGI:109532)
21,17819328,18267370,21q21,21q21.1,607247,CHODL,Chondrolectin,CHODL,140578,ENSG00000154645,NA,NA,Chodl (MGI:2179069)
21,18269106,18403805,21q21,21q21.1,606635,"TMPRSS15, PRSS7, ENTK","Transmembrane protease, serine 15",TMPRSS15,5651,ENSG00000154646,NA,"Enterokinase deficiency, 226200 (3), Autosomal recessive",Tmprss15 (MGI:1197523)
21,20998338,21543328,21q21,21q21.1,602040,NCAM2,"Cell adhesion molecule, neural, 2",NCAM2,4685,ENSG00000154654,NA,NA,Ncam2 (MGI:97282)
21,25573979,25574043,21q21.3,21q21.3,609337,"MIR155, BIC, MIRN155",Micro RNA 155,MIR155,406947,ENSG00000283904,NA,NA,NA
21,25585655,25607857,21q11.2-q21,21q21.3,611845,"MRPL39, MRPL5",Mitochondrial ribosomal protein L39,MRPL39,54148,ENSG00000154719,NA,NA,Mrpl39 (MGI:1351620)
21,25607549,25717561,21q21.2,21q21.3,606870,"JAM2, VEJAM",Junctional adhesion molecule 2,JAM2,58494,ENSG00000154721,NA,NA,Jam2 (MGI:1933820)
21,25724479,25735653,21q21.3,21q21.3,603152,"ATP5J, ATP5","ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6",ATP5PF,522,ENSG00000154723,NA,NA,Atp5j (MGI:107777)
21,25734971,25772459,21q21-q22.1,21q21.3,600609,"GABPA, E4TF1A","GA-binding protein transcription factor, alpha subunit, 60kD",GABPA,2551,ENSG00000154727,NA,NA,Gabpa (MGI:95610)
21,25880549,26171127,21q21,21q21.3,104760,"APP, AAA, CVAP, AD1",Amyloid beta (A4) precursor protein,APP,351,ENSG00000142192,proximal to SOD; very distal q21 or boundary with q22,"Alzheimer disease 1, familial, 104300 (3), Autosomal dominant; Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3), Autosomal dominant",App (MGI:88059)
21,26393634,26569251,21q21.3,21q21.3,616021,"CYYR1AS1, CYYR1-AS1",CYRR1 antisense RNA 1,CYYR1-AS1,100996571,ENSG00000197934,NA,NA,NA
21,26466208,26573403,21q21.3,21q21.3,616020,CYYR1,Cysteine/tyrosine-rich protein 1,CYYR1,116159,ENSG00000166265,NA,NA,Cyyr1 (MGI:2152187)
21,26835754,26845408,21q21.2,21q21.3,605174,"ADAMTS1, METH1","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 1",ADAMTS1,9510,ENSG00000154734,NA,NA,Adamts1 (MGI:109249)
21,26917921,26967757,21q21-q22,21q21.3,605007,"ADAMTS5, ADAMTS11","A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 5 (aggrecanase 2)",ADAMTS5,11096,ENSG00000154736,NA,NA,Adamts5 (MGI:1346321)
21,28439660,28885372,21q21.3,21q21.3,614553,N6AMT1,"N6 adenine-specific DNA methyltransferase 1, putative",N6AMT1,29104,ENSG00000156239,NA,NA,N6amt1 (MGI:1915018)
21,28928143,28992987,21q22.11,21q21.3,613083,"LTN1, RNF160, KIAA0714",Listerin E3 ubiquitin protein ligase 1,LTN1,26046,ENSG00000198862,NA,NA,Ltn1 (MGI:1926163)
21,29004383,29019370,21q22.1,21q21.3,617843,"RWDD2B, C21orf6",RWD domain-containing protein 2B,RWDD2B,10069,ENSG00000156253,NA,NA,Rwdd2b (MGI:1858215)
21,29024616,29054487,21q21.3,21q21.3,604735,"USP16, UBPM",Ubiquitin-specific protease 16,USP16,10600,ENSG00000156256,NA,NA,Usp16 (MGI:1921362)
21,29056321,29073796,21q21.3,21q21.3,617786,"CCT8, KIAA0002","Chaperonin containing T-complex polypeptide 1, subunit 8",CCT8,10694,ENSG00000156261,NA,NA,Cct8 (MGI:107183)
21,29077113,29175888,21q21,21q21.3,611110,"TAK1L, C21orf7",TAK1-like,MAP3K7CL,56911,ENSG00000156265,NA,NA,NA
21,29298921,29361895,21q22.1,21q21.3,602751,BACH1,BTB and CNC homology 1,BACH1,571,ENSG00000156273,NA,NA,Bach1 (MGI:894680)
21,29536932,29940051,21q22,21q21.3,138245,"GRIK1, GLUR5","Glutamate receptor, ionotropic, kainate 1",GRIK1,2897,ENSG00000171189,NA,NA,Grik1 (MGI:95814)
21,30165564,30166804,21q21.3,21q21.3,617005,CLDN17,Claudin 17,CLDN17,26285,ENSG00000156282,NA,NA,Cldn17 (MGI:2652030)
21,30200000,46709983,21q22,NA,611515,FEB7,"Febrile seizures, familial, 7",FEB7,100049160,NA,max lod at D21S1910,"Febrile seizures, familial, 7, 611515 (2)",NA
21,30200000,46709983,21q22,NA,609428,TUKLS,Tukel syndrome,NA,574049,NA,max lod at D21S1259,"Tukel syndrome, 609428 (2), Autosomal recessive",NA
21,30214005,30216096,21q22.11,21q22.11,611231,CLDN8,Claudin 8,CLDN8,9073,ENSG00000156284,NA,NA,Cldn8 (MGI:1859286)
21,30396030,30396821,21q22.11,21q22.11,608718,KRTAP13-1,Keratin-associated protein 13-1,KRTAP13-1,140258,ENSG00000198390,NA,NA,Krtap13-1 (MGI:2146359)
21,30880643,30881579,21q22.11,21q22.11,600064,"KRTAP11-1, HACL1",Keratin-associated protein 11-1,KRTAP11-1,337880,ENSG00000182591,NA,NA,Krtap11-1 (MGI:99447)
21,31118417,31559976,21q22.1,21q22.11,600687,TIAM1,T-cell lymphoma invasion and metastasis 1,TIAM1,7074,ENSG00000156299,NA,NA,Tiam1 (MGI:103306)
21,31659621,31668930,21q22.1,21q22.11,147450,"SOD1, ALS1","Superoxide dismutase-1, soluble",SOD1,6647,ENSG00000142168,mid q22.1,"Amyotrophic lateral sclerosis 1, 105400 (3), Autosomal recessive, Autosomal dominant",Sod1 (MGI:98351)
21,31668986,31732117,21q22.11,21q22.11,616023,"SCAF4, KIAA1172",SR-related C-terminal domain-associated factor 4,SCAF4,57466,ENSG00000156304,NA,NA,Scaf4 (MGI:2146350)
21,31873019,32004063,21q22,21q22.11,606532,HUNK,Hormonally upregulated NEU-associated kinase,HUNK,30811,ENSG00000142149,NA,NA,Hunk (MGI:1347352)
21,32154681,32283953,21q22.11,21q22.11,618137,MIS18A,Mis18 kinetochore protein A,MIS18A,54069,ENSG00000159055,NA,NA,Mis18a (MGI:1913828)
21,32291812,32314783,21q22.1,21q22.11,609196,"MRAP, FALP, C21orf61, GCCD2, FGD2",Melanocortin 2 receptor accessory protein,MRAP,56246,ENSG00000170262,NA,"Glucocorticoid deficiency 2, 607398 (3), Autosomal recessive",Mrap (MGI:1924287)
21,32311017,32393011,21q22.1,21q22.11,608865,"URB1, NPA1, C21orf108, KIAA0539",URB1 ribosome biogenesis 1 homolog (S. cerevisiae),URB1,9875,ENSG00000142207,NA,NA,Urb1 (MGI:2146468)
21,32573720,32585522,21q22.1,21q22.11,608365,TCP10L,T-complex protein 10-like,TCP10L,140290,ENSG00000242220,NA,NA,NA
21,32599353,32612870,21q22.11,21q22.11,615494,"C21orf59, CILD26",Chromosome 21 open reading frame 59,CFAP298,56683,ENSG00000159079,NA,"Ciliary dyskinesia, primary, 26, 615500 (3), Autosomal recessive",Cfap298 (MGI:1915251)
21,32628758,32731246,21q22.2,21q22.11,604297,"SYNJ1, PARK20, EIEE53",Synaptojanin 1,SYNJ1,8867,ENSG00000159082,NA,"Epileptic encephalopathy, early infantile, 53, 617389 (3), Autosomal recessive; Parkinson disease 20, early-onset, 615530 (3), Autosomal recessive",Synj1 (MGI:1354961)
21,32733898,32771857,21q22.11,21q22.11,617621,"PAXBP1, GCFC1, C21orf66",PAX3- and PAX7-binding protein 1,PAXBP1,94104,ENSG00000159086,NA,NA,Paxbp1 (MGI:1914617)
21,33025934,33029195,21q22.11,21q22.11,606386,"OLIG2, PRKCBP2",Oligodendrocyte lineage transcription factor 2,OLIG2,10215,ENSG00000205927,NA,NA,Olig2 (MGI:1355331)
21,33070140,33072412,21q22.11,21q22.11,606385,OLIG1,Oligodendrocyte lineage transcription factor 1,OLIG1,116448,ENSG00000184221,NA,NA,Olig1 (MGI:1355334)
21,33229894,33265663,21q22.1,21q22.11,602376,"IFNAR2, IMD45","Interferon, alpha, beta, and omega, receptor 2",IFNAR2,3455,ENSG00000159110,mutation identified in 1 IMD45 family,"{Hepatitis B virus, susceptibility to}, 610424 (3); ?Immunodeficiency 45, 616669 (3), Autosomal recessive",Ifnar2 (MGI:1098243)
21,33266366,33297220,21q22.1,21q22.11,123889,"CRFB4, IBD25","Cytokine receptor, family II, member 4",IL10RB,3588,ENSG00000243646,35kb distal to IFNAR; D21S58,"{Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3), Autosomal recessive",Il10rb (MGI:109380)
21,33324442,33360360,21q22.1,21q22.11,107450,IFNAR1,"Interferon, alpha, beta and omega, receptor 1",IFNAR1,3454,ENSG00000142166,NA,NA,Ifnar1 (MGI:107658)
21,33402895,33437520,21q22.1-q22.2,21q22.11,147569,"IFNGR2, IFNGT1, IFGR2, IMD28",Interferon gamma receptor-2 (interferon gamma transducer 1),IFNGR2,3460,ENSG00000159128,NA,"Immunodeficiency 28, mycobacteriosis, 614889 (3), Autosomal recessive",Ifngr2 (MGI:107654)
21,33432485,33480008,21q22.11,21q22.11,617894,"TMEM50B, C21orf4",Transmembrane protein 50B,TMEM50B,757,ENSG00000142188,NA,NA,Tmem50b (MGI:1925225)
21,33503930,33542891,21q22.1,21q22.11,138440,"GART, PRGS, PGFT",Phosphoribosylglycinamide formyltransferase (phosphoribosylglycinamide synthetase; phosphoribosylaminoimidazole synthetase),GART,2618,ENSG00000159131,"multifunctional protein: Ade(-)C, Ade(-)G, GART",NA,Gart (MGI:95654)
21,33543037,33577513,21q22.1-q22.2,21q22.11,182465,"SON, TOKIMS",SON DNA-binding protein,SON,6651,ENSG00000159140,NA,"ZTTK syndrome, 617140 (3), Autosomal dominant",Son (MGI:98353)
21,33577550,33588683,21q22.1,21q22.11,611428,"DONSON, C21orf60, MISSLA, MIMIS",Downstream neighbor of SON,DONSON,29980,ENSG00000159147,NA,"Microcephaly, short stature, and limb abnormalities, 617604 (3), Autosomal recessive; Microcephaly-micromelia syndrome, 251230 (3), Autosomal recessive",Donson (MGI:1890621)
21,33589340,33641740,21q22.1,21q22.11,603920,CRYZL1,"Crystallin, zeta-like 1",CRYZL1,9946,ENSG00000205758,NA,NA,Cryzl1 (MGI:1913859)
21,33642451,33899860,21q22.1-q22.2,21q22.11,602442,"ITSN1, SH3D1A, SH3P17",Intersectin 1 (SH3 domain protein-1A),ITSN1,6453,ENSG00000205726,NA,NA,Itsn1 (MGI:1338069)
21,33903452,33915803,21q22.1-q22.2,21q22.11,600828,ATP5O,"ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein)",ATP5PO,539,ENSG00000241837,NA,NA,Atp5o (MGI:106341)
21,34073577,34143029,21q21.3-q22.1,21q22.11,611973,MRPS6,Mitochondrial ribosomal protein S6,MRPS6,64968,ENSG00000243927,NA,NA,Mrps6 (MGI:2153111)
21,34073577,34106259,21q22,21q22.11,600444,SLC5A3,"Solute carrier family 5 (inositol transporter), member 3",SLC5A3,6526,ENSG00000198743,?role in Down syndrome,NA,Slc5a3 (MGI:1858226)
21,34364023,34371140,21q22.1,21q22.11,603796,"KCNE2, MIRP1, LQT6, ATFB4","Potassium voltage-gated channel, Isk-related family, member 2",KCNE2,9992,ENSG00000159197,NA,"Atrial fibrillation, familial, 4, 611493 (3); Long QT syndrome 6, 613693 (3), Autosomal dominant",Kcne2 (MGI:1891123)
21,34446687,34512209,21q22.1-q22.2,21q22.12,176261,"KCNE1, JLNS, LQT5, JLNS2","Potassium voltage-gated channel, Isk-related subfamily, member 1",KCNE1,3753,ENSG00000180509,NA,"Jervell and Lange-Nielsen syndrome 2, 612347 (3), Autosomal recessive; Long QT syndrome 5, 613695 (3), Autosomal dominant",NA
21,34516441,34615122,21q22.1-q22.2,21q22.12,602917,"RCAN1, DSCR1, MCIP1, CSP1",Regulator of calcineurin 1,RCAN1,1827,ENSG00000159200,NA,NA,Rcan1 (MGI:1890564)
21,34668952,34718222,21q22.12,21q22.12,615321,"CLIC6, CLIC1L",Chloride intracellular channel 6,CLIC6,54102,ENSG00000159212,NA,NA,Clic6 (MGI:2146607)
21,34787800,35049333,21q22.3,21q22.12,151385,"RUNX1, CBFA2, AML1",Runt-related transcription factor 1 (aml1 oncogene),RUNX1,861,ENSG00000159216,NA,"Leukemia, acute myeloid, 601626 (3), Autosomal dominant, Somatic mutation; Platelet disorder, familial, with associated myeloid malignancy, 601399 (3), Autosomal dominant",Runx1 (MGI:99852)
21,35720714,35720807,21q22.12,21q22.12,616090,MIR802,Micro RNA 802,MIR802,768219,ENSG00000211590,NA,NA,NA
21,36070023,36073163,21q22.12,21q22.12,114830,CBR1,Carbonyl reductase 1,CBR1,873,ENSG00000159228,NA,NA,Cbr1 (MGI:88284)
21,36134900,36146561,21q22.2,21q22.12,603608,CBR3,Carbonyl reductase 3,CBR3,874,ENSG00000159231,NA,NA,Cbr3 (MGI:1309992)
21,36156780,36294273,21q22.2,21q22.12,604803,"DOPEY2, 21orf5, KIAA0933",Dopey family member 2,DOP1B,9980,ENSG00000142197,NA,NA,Dop1b (MGI:1917278)
21,36320188,36376645,21q22.12,21q22.12,610078,"MORC3, NXP2",MORC family CW-type zinc finger 3,MORC3,23515,ENSG00000159256,NA,NA,Morc3 (MGI:2136841)
21,36380144,36419014,21q22.2,21q22.12-q22.13,601245,CAF1A,"Chromatin assembly factor I, p60 subunit",CHAF1B,8208,ENSG00000159259,NA,NA,Chaf1b (MGI:1314881)
21,36400000,46709983,21q22.13-qter,NA,609876,BMND6,Bone mineral density QTL 6,NA,100188797,NA,max lod at D21S1446,"[Bone mineral density QTL 6], 609876 (2)",NA
21,36400000,38300000,21q22.13,NA,609633,"MAFD3, BPEO",Major affective disorder 3,NA,100188792,NA,max lod at D21S1252,"{Major affective disorder 3, early onset}, 609633 (2)",NA
21,36460620,36576568,21q22.3,21q22.13,605608,"CLDN14, DFNB29",Claudin 14,CLDN14,23562,ENSG00000159261,NA,"Deafness, autosomal recessive 29, 614035 (3), Autosomal recessive",Cldn14 (MGI:1860425)
21,36699114,36750218,21q22.2,21q22.13,600892,SIM2,"Single-minded, Drosophila, homolog of, 2",SIM2,6493,ENSG00000159263,NA,NA,Sim2 (MGI:98307)
21,36748624,36990393,21q22.1,21q22.13,609018,"HLCS, HCS",Holocarboxylase synthetase,HLCS,3141,ENSG00000159267,NA,"Holocarboxylase synthetase deficiency, 253270 (3), Autosomal recessive",Hlcs (MGI:894646)
21,37006149,37019661,21q22.2,21q22.13,609892,"DSCR6, RIPPLY3",Down syndrome critical region gene 6,RIPPLY3,53820,ENSG00000183145,NA,NA,Ripply3 (MGI:2181192)
21,37065363,37073157,21q22.1-q22.2,21q22.13,605938,"PIGP, DSCR5, EIEE55","Phosphatidylinositol glycan, class P",PIGP,51227,ENSG00000185808,mutation identified one EIEE55 family,"?Epileptic encephalopathy, early infantile, 55, 617599 (3), Autosomal recessive",Pigp (MGI:1860433)
21,37073183,37203117,21q22.2,21q22.13,602259,"TTC3, TPRD",Tetratricopeptide repeat domain 3,TTC3,7267,ENSG00000182670,NA,NA,Ttc3 (MGI:1276539)
21,37223419,37268107,21q22.2,21q22.13,605298,"DSCR3, DSCRA",Down syndrome critical region gene 3,VPS26C,10311,ENSG00000157538,NA,NA,Vps26c (MGI:1206040)
21,37365572,37526357,21q22.1,21q22.13,600855,"DYRK1A, MNBH, MNB, MRD7","Dual specificity tyrosine-(Y)-phosphorylation regulated kinase-1A (\'minibrain\', Drosophila, homolog of)",DYRK1A,1859,ENSG00000157540,?triplicate state responsible for mental defect in Down syndrome,"Mental retardation, autosomal dominant 7, 614104 (3), Autosomal dominant",Dyrk1a (MGI:1330299)
21,37607372,37916456,21q22.1,21q22.13,600877,"KCNJ6, GIRK2, KCNJ7, KPLBS","Potassium inwardly-rectifying channel, subfamily J, member 6",KCNJ6,3763,ENSG00000157542,NA,"Keppen-Lubinsky syndrome, 614098 (3), Autosomal dominant",Kcnj6 (MGI:104781)
21,38054010,38121359,21q22.2,21q22.13,604829,"DSCR4, DSCRB",Down syndrome critical region gene 4,DSCR4,10281,ENSG00000184029,NA,NA,NA
21,38121450,38156510,21q22.2,21q22.13,613396,"DSCR8, MMA1",Down syndrome critical region gene 8,DSCR8,84677,ENSG00000198054,NA,NA,NA
21,38229925,38307356,21q22.2,21q22.1-q22.2,602106,KCNJ15,"Potassium inwardly-rectifying channel, subfamily J, member 15",KCNJ15,3772,ENSG00000157551,NA,NA,Kcnj15 (MGI:1310000)
21,38367260,38661782,21q22.3,21q22.2,165080,ERG,"Erythroblastosis virus E26, avian, (v-ets) oncogene related",ERG,2078,ENSG00000157554,"fused with EWS in Ewing sarcoma, with FUS in leukemia",NA,Erg (MGI:95415)
21,38739020,38773476,21q22.2-q22.3,21q22.2,611723,C21orf24,Chromosome 21 open reading frame 24,LINC00114,400866,ENSG00000223806,NA,NA,NA
21,38805182,38824954,21q22.3,21q22.2,164740,ETS2,Oncogene ETS-2,ETS2,2114,ENSG00000157557,proximal q22.3,NA,Ets2 (MGI:95456)
21,39174768,39183513,21q22.3,21q22.2,605296,"PSMG1, DSCR2, C21LRP","Proteasome (prosome, macropain) assembly chaperone 1",PSMG1,8624,ENSG00000183527,NA,NA,Psmg1 (MGI:1860263)
21,39184175,39321594,21q22.2-q22.3,21q22.2,617824,"BRWD1, WRD9, C21orf107",Bromodomain and WD repeat domain-containing protein 1,BRWD1,54014,ENSG00000185658,NA,NA,Brwd1 (MGI:1890651)
21,39342314,39349087,21q22.3,21q22.2,163920,"HMGN1, HMG14",High-mobility group nucleosomal binding protein 1,HMGN1,3150,ENSG00000205581,NA,NA,Hmgn1 (MGI:96120)
21,39380243,39428527,21q22.3,21q22.2,602915,"WRB, CHD5",Tryptophan-rich basic protein,GET1,7485,ENSG00000182093,NA,NA,Wrb (MGI:2136882)
21,39445864,39515505,21q22.3,21q22.2,602230,SH3GBR,SH3 domain binding glutamic acid-rich protein,SH3BGR,6450,ENSG00000185437,NA,NA,NA
21,39612939,39673136,21q22.3,21q22.2,604066,"B3GALT5, GLCT5","UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5",B3GALT5,10317,ENSG00000183778,NA,NA,B3galt5 (MGI:2136878)
21,39632464,39802095,21q22.2,21q22.2,610638,"IGSF5, JAM4","Immunoglobulin superfamily, member 5",IGSF5,150084,ENSG00000183067,NA,NA,Igsf5 (MGI:1919308)
21,39867437,39929391,21q22.3,21q22.2,601629,PCP4,Purkinje cell protein 4,PCP4,5121,ENSG00000183036,NA,NA,Pcp4 (MGI:97509)
21,40010998,40847157,21q22.2-q22.3,21q22.2,602523,DSCAM,Down syndrome cell adhesion molecule,DSCAM,1826,ENSG00000171587,NA,NA,Dscam (MGI:1196281)
21,41168159,41282529,21q22.3,21q22.2-q22.3,605668,"BACE2, ALP56, DRAP",Beta-site amyloid beta A4 precursor protein-cleaving enzyme 2 (Down syndrome region aspartic protease),BACE2,25825,ENSG00000182240,NA,NA,Bace2 (MGI:1860440)
21,41175230,41185238,21q22.3,21q22.2,613770,PLAC4,Placenta-specific gene 4,PLAC4,191585,ENSG00000280109,NA,NA,NA
21,41200000,46709983,21q22.3,NA,190685,"DCR, DSCR",Down syndrome chromosome region,NA,NA,NA,many genes are involved in this phenotype,"Down syndrome, 190685 (4), Isolated cases",NA
21,41200000,46709983,21q22.3,NA,236100,HPE1,"Holoprosencephaly-1, alobar",HPE1,3244,NA,NA,"Holoprosencephaly 1, 236100 (2), Autosomal dominant, Isolated cases",NA
21,41304228,41357726,21q22,21q22.3,608617,FAM3B,"Family with sequence similarity 3, member B",FAM3B,54097,ENSG00000183844,NA,NA,Fam3b (MGI:1270150)
21,41361943,41409392,21q22.3,21q22.3,147890,MX2,Myxovirus (influenza) resistance-2,MX2,4600,ENSG00000183486,NA,NA,NA
21,41420328,41459213,21q22.3,21q22.3,147150,"MX1, MX, IFI78",Myxovirus (influenza) resistance-1 (interferon induced protein p78),MX1,4599,ENSG00000157601,NA,NA,NA
21,41464304,41508157,21q22.3,21q22.3,602060,TMPRSS2,"Transmembrane protease, serine 2",TMPRSS2,7113,ENSG00000184012,NA,NA,Tmprss2 (MGI:1354381)
21,41739372,41767051,21q22.3,21q22.3,605706,"RIPK4, NKRD3, DIK, PPS2, CHANDS",Receptor-interacting serine-threonine kinase 4,RIPK4,54101,ENSG00000183421,NA,"CHAND syndrome, 214350 (3), Autosomal recessive; Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3), Autosomal recessive",Ripk4 (MGI:1919638)
21,41798224,41879481,21q22.3,21q22.3,617692,"PRDM15, ZNF298",PR domain-containing protein 15,PRDM15,63977,ENSG00000141956,NA,NA,Prdm15 (MGI:1930121)
21,41885109,41954017,21q22.3,21q22.3,617581,"C2CD2, TMEM24L, C21orf25",C2 calcium-dependent domain-containing protein 2,C2CD2,25966,ENSG00000157617,NA,NA,C2cd2 (MGI:1891883)
21,41986830,42010417,21q22.3,21q22.3,616485,"ZBTB21, ZNF295, KIAA1227",Zinc finger- and BTB domain-containing protein 21,ZBTB21,49854,ENSG00000173276,NA,NA,Zbtb21 (MGI:1927240)
21,42062876,42143453,21q22.3,21q22.3,613859,UMODL1,Uromodulin-like 1,UMODL1,89766,ENSG00000177398,NA,NA,Umodl1 (MGI:1929785)
21,42199688,42304386,21q22.3,21q22.3,603076,"ABCG1, ABC8, WHITE1","ATP-binding cassette, subfamily G, member 1 (white, Drosophila, homolog of)",ABCG1,9619,ENSG00000160179,NA,NA,Abcg1 (MGI:107704)
21,42311666,42315595,21q22.3,21q22.3,600633,"TFF3, ITF",Trefoil factor 3 (intestinal),TFF3,7033,ENSG00000160180,NA,NA,Tff3 (MGI:104638)
21,42346356,42350993,21q22.3,21q22.3,182590,"TFF2, SML1",Trefoil factor 2 (spasmolytic protein-1),TFF2,7032,ENSG00000160181,within 230kb of BCEI,NA,Tff2 (MGI:1306805)
21,42362281,42366534,21q22.3,21q22.3,113710,"TFF1, BCEI","Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in)",TFF1,7031,ENSG00000160182,NA,NA,Tff1 (MGI:88135)
21,42371836,42396051,21q22.3,21q22.3,605511,"TMPRSS3, ECHOS1, DFNB8, DFNB10","Transmembrane protease, serine 3",TMPRSS3,64699,ENSG00000160183,NA,"Deafness, autosomal recessive 8/10, 601072 (3), Autosomal recessive",Tmprss3 (MGI:2155445)
21,42403879,42447683,21q22.3,21q22.3,605736,UBASH3A,Ubiquitin-associated and SH3 domain-containing protein A,UBASH3A,53347,ENSG00000160185,NA,NA,Ubash3a (MGI:1926074)
21,42472485,42496245,21q22.3,21q22.3,609314,"RSPH1, TSGA2, TSA2, CILD24","Radial spoke head 1, Chlamydomonas, homolog of",RSPH1,89765,ENSG00000160188,NA,"Ciliary dyskinesia, primary, 24, 615481 (3), Autosomal recessive",Rsph1 (MGI:1194909)
21,42499621,42581435,21q22.3,21q22.3,608094,"SLC37A1, G3PP","Solute carrier family 37 (glycerol-3-phosphate transporter), member 1",SLC37A1,54020,ENSG00000160190,NA,NA,Slc37a1 (MGI:2446181)
21,42653620,42775508,21q22.3,21q22.3,602973,"PDE9A, HSPDE9A2",Phosphodiesterase 9A,PDE9A,5152,ENSG00000160191,NA,NA,Pde9a (MGI:1277179)
21,42843074,42891694,21q22.3,21q22.3,605924,"WDR4, MIGSB, GAMOS6",WD repeat-containing protein 4,WDR4,10785,ENSG00000160193,NA,"Galloway-Mowat syndrome 6, 618347 (3), Autosomal recessive; Microcephaly, growth deficiency, seizures, and brain malformations, 618346 (3), Autosomal recessive",Wdr4 (MGI:1889002)
21,42893270,42913298,21q22.3,21q22.3,602184,NDUFV3,NADH-ubiquinone oxidoreductase subunit V3,NDUFV3,4731,ENSG00000160194,NA,NA,Ndufv3 (MGI:1890894)
21,42974509,43033930,21q22.3,21q22.3,602100,PKNOX1,PBX/knotted 1 homeo box 1,PKNOX1,5316,ENSG00000160199,NA,NA,Pknox1 (MGI:1201409)
21,43053189,43076860,21q22.3,21q22.3,613381,CBS,Cystathionine beta-synthase,CBS,875,ENSG00000160200,subtelomeric,"Homocystinuria, B6-responsive and nonresponsive types, 236200 (3), Autosomal recessive; Thrombosis, hyperhomocysteinemic, 236200 (3), Autosomal recessive",Cbs (MGI:88285)
21,43092955,43108290,21q22.3,21q22.3,191317,U2AF1,U2(RNU2) small nuclear RNA auxillary factor 1,U2AF1,7307,ENSG00000160201,NA,NA,NA
21,43169007,43172809,21q22.3,21q22.3,123580,"CRYAA, CRYA1, CTRCT9","Crystallin, alpha A",CRYAA,1409,ENSG00000160202,NA,"Cataract 9, multiple types, 604219 (3), Autosomal recessive, Autosomal dominant",Cryaa (MGI:88515)
21,43414482,43427130,21q22.3,21q22.3,605705,"SIK1, SNF1LK, MSK, EIEE30",Salt-inducible kinase 1,SIK1,150094,ENSG00000142178,NA,"Epileptic encephalopathy, early infantile, 30, 616341 (3), Autosomal dominant",NA
21,43453986,43659498,21q22.3,21q22.3,604554,HSF2BP,Heat-shock transcription factor 2-binding protein,HSF2BP,11077,ENSG00000160207,NA,NA,Hsf2bp (MGI:1921627)
21,43659559,43696078,21q22,21q22.3,610654,"RRP1B, KIAA0179, NNP1L","Ribosomal RNA-processing protein 1, S. cerevisiae, homolog of, B",RRP1B,23076,ENSG00000160208,NA,NA,Rrp1b (MGI:1919712)
21,43719128,43762298,21q22.3,21q22.3,179020,"PDXK, PNK, PKH",Pyridoxal kinase,PDXK,8566,ENSG00000160209,NA,NA,Pdxk (MGI:1351869)
21,43773664,43776374,21q22.3,21q22.3,601145,"CSTB, STFB, EPM1, PME, EPM1A, ULD",Cystatin B (stefin B),CSTB,1476,ENSG00000160213,NA,"Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3), Autosomal recessive",Cstb (MGI:109514)
21,43865159,43987591,21q22.3,21q22.3,614794,"AGPAT3, LPAAT3",1-acylglycerol-3-phosphate O-acyltransferase 3,AGPAT3,56894,ENSG00000160216,NA,NA,Agpat3 (MGI:1336186)
21,44012308,44106551,21q22.3,21q22.3,602103,"TRAPPC10, TMEM1, EHOC1","Trafficking protein particle complex, subunit 10",TRAPPC10,7109,ENSG00000160218,near PWP2H,NA,Trappc10 (MGI:1336209)
21,44107322,44131180,21q22.3,21q22.3,601475,"PWP2H, PWP2","PWP2 periodic tryptophan protein, yeast, homolog of",PWP2,5822,ENSG00000241945,NA,NA,NA
21,44133611,44145722,21q22.3,21q22.3,601659,"GATD3A, ES1, HES1, GT335, C21orf33",Glutamine amidotransferase-like class 1 domain-containing protein 3A,GATD3A,8209,ENSG00000160221,NA,NA,Gatd3a (MGI:1351861)
21,44216978,44240942,21q22.3,21q22.3,605717,"ICOSLG, B7H2, GL50, B7RP1",Inducible T-cell co-stimulator ligand,ICOSLG,23308,ENSG00000160223,NA,NA,Icosl (MGI:1354701)
21,44246338,44262215,21q22.3,21q22.3,606588,DNMT3L,DNA methyltransferase 3-like protein,DNMT3L,29947,ENSG00000142182,NA,NA,Dnmt3l (MGI:1859287)
21,44285875,44298647,21q22.3,21q22.3,607358,"AIRE, APECED, APS1",Autoimmune regulator,AIRE,326,ENSG00000160224,NA,"Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3), Autosomal recessive, Autosomal dominant",Aire (MGI:1338803)
21,44300039,44327372,21q22.3,21q22.3,171860,PFKL,"Phosphofructokinase, liver type",PFKL,5211,ENSG00000141959,NA,Hemolytic anemia due to phosphofructokinase deficiency (1),Pfkl (MGI:97547)
21,44328943,44339416,21q22.3,21q22.3,603191,"CFAP410, C21orf2, SMDAX, RDMS",Cilia and flagella-associated protein 410,CFAP410,755,ENSG00000160226,NA,"Retinal dystrophy with macular staphyloma, 617547 (3), Autosomal recessive; Spondylometaphyseal dysplasia, axial, 602271 (3), Autosomal recessive",Cfap410 (MGI:1915134)
21,44350111,44443080,21q22.3,21q22.3,603749,"TRPM2, TRPC7, KNP3","Transient receptor potential cation channel, subfamily M, member 2",TRPM2,7226,ENSG00000142185,NA,NA,Trpm2 (MGI:1351901)
21,44455509,44462195,21q22.3,21q22.3,617620,"LRRC3, C21orf102, C21orf30",Leucine-rich repeat-containing protein 3,LRRC3,81543,ENSG00000160233,NA,NA,Lrrc3 (MGI:2447899)
21,44497892,44711571,21q22.3,21q22.3,612920,"TSPEAR, C21orf29, DFNB98, ECTD14",Thrombospondin-type laminin G domain and EAR repeats,TSPEAR,54084,ENSG00000175894,mutation identified in 1 DFNB98 family,"?Deafness, autosomal recessive 98, 614861 (3), Autosomal recessive; Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis, 618180 (3), Autosomal recessive",Tspear (MGI:2671932)
21,44768579,44801819,21q22.3,21q22.3,603124,"UBE2G2, UBC7",Ubiquitin-conjugating enzyme E2G 2,UBE2G2,7327,ENSG00000184787,NA,NA,Ube2g2 (MGI:1343188)
21,44805616,44818128,21q22.3,21q22.3,602231,"SUMO3, SMT3H1",Small ubiquitin-like modifier 3,SUMO3,6612,ENSG00000184900,NA,NA,Sumo3 (MGI:1336201)
21,44849584,44873902,21q22.3,21q22.3,603784,"PTTG1IP, C21orf1, C21orf3, PBF",Pituitary tumor-transforming gene 1 protein-interacting protein,PTTG1IP,754,ENSG00000183255,NA,NA,Pttg1ip (MGI:2652132)
21,44885948,44928814,21q22.3,21q22.3,600065,"ITGB2, CD18, LCAMB, LAD","Integrin, beta-2 (antigen CD18 (p95), lymphocyte function-associated antigen-1; macrophage antigen, beta polypeptide)",ITGB2,3689,ENSG00000160255,"common subunit for CR3, LFA1, and P150,95","Leukocyte adhesion deficiency, 116920 (3), Autosomal recessive",Itgb2 (MGI:96611)
21,44989863,44994085,21q22.3,21q22.3,610259,"LINC00163, NCRNA00163, NLC1A",Long intergenic nonprotein coding RNA 163,LINC00163,727699,ENSG00000234880,NA,NA,NA
21,44999207,45004726,21q22.3,21q22.3,617191,"PICSAR, LINC00162, NLC1C",p38-inhibited cutaneous squamous cell carcinoma-associated long intergenic noncoding RNA,PICSAR,378825,ENSG00000275874,NA,NA,NA
21,45074577,45226562,21q22.3,21q22.3,601218,"ADARB1, RED1","Adenosine deaminase, RNA-specific, B1 (RED1, rat, homolog of)",ADARB1,104,ENSG00000197381,NA,NA,Adarb1 (MGI:891999)
21,45263927,45287913,21q22.3,21q22.3,610249,"POFUT2, C21Orf80, KIAA0958",Protein O-fucosyltransferase 2,POFUT2,23275,ENSG00000186866,NA,NA,Pofut2 (MGI:1916863)
21,45405164,45513719,21q22.3,21q22.3,120328,"COL18A1, KNO1","Collagen XVIII, alpha-1 polypeptide",COL18A1,80781,ENSG00000182871,NA,"Knobloch syndrome, type 1, 267750 (3), Autosomal recessive",Col18a1 (MGI:88451)
21,45502516,45563139,21q22.3,21q22.3,600424,"SLC19A1, FOLT","Solute carrier family 19 (folate transporter), member 1",SLC19A1,6573,ENSG00000173638,NA,NA,Slc19a1 (MGI:103182)
21,45643724,45942453,21q22.3,21q22.3,608502,PCBP3,Poly(rC)-binding protein 3,PCBP3,54039,ENSG00000183570,NA,NA,Pcbp3 (MGI:1890470)
21,45981748,46005048,21q22.3,21q22.3,120220,"COL6A1, BTHLM1, UCHMD1","Collagen VI, alpha-1 polypeptide",COL6A1,1291,ENSG00000142156,NA,"Bethlem myopathy 1, 158810 (3), Autosomal recessive, Autosomal dominant; Ullrich congenital muscular dystrophy 1, 254090 (3), Autosomal recessive, Autosomal dominant",Col6a1 (MGI:88459)
21,46098070,46132848,21q22.3,21q22.3,120240,"COL6A2, BTHLM1, UCMD1","Collagen VI, alpha-2 polypeptide",COL6A2,1292,ENSG00000142173,mutation identified in 1 MYSCL family,"Bethlem myopathy 1, 158810 (3), Autosomal recessive, Autosomal dominant; ?Myosclerosis, congenital, 255600 (3), Autosomal recessive; Ullrich congenital muscular dystrophy 1, 254090 (3), Autosomal recessive, Autosomal dominant",Col6a2 (MGI:88460)
21,46135980,46156481,21q22.3,21q22.3,606806,FTCD,Formiminotransferase cyclodeminase,FTCD,10841,ENSG00000160282,NA,"Glutamate formiminotransferase deficiency, 229100 (3), Autosomal recessive",Ftcd (MGI:1339962)
21,46161147,46185162,21q22.3,21q22.3,612412,C21orf56,Chromosome 21 open reading frame 56,SPATC1L,84221,ENSG00000160284,NA,NA,Spatc1l (MGI:1923823)
21,46188445,46228823,21q22.3,21q22.3,600909,"LSS, OSC, CTRCT44, HYPT14",Lanosterol synthase,LSS,4047,ENSG00000160285,NA,"Cataract 44, 616509 (3), Autosomal recessive; Hypotrichosis 14, 618275 (3), Autosomal recessive",Lss (MGI:1336155)
21,46235129,46286296,21q22.3,21q22.3,603294,"MCM3AP, MAP80, GANP, PNRIID","Minichromosome maintenance 3-associated protein, 80-kD",MCM3AP,8888,ENSG00000160294,NA,"Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3), Autosomal recessive",Mcm3ap (MGI:1930089)
21,46286055,46314187,21q22.3,21q22.3,617461,"YBEY, C21orf57",YBEY metallopeptidase,YBEY,54059,ENSG00000182362,NA,NA,Ybey (MGI:2656825)
21,46324121,46445768,21q22.3,21q22.3,605925,"PCNT, PCNT2, KEN, SCKL4, MOPD2",Pericentrin,PCNT,5116,ENSG00000160299,NA,"Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3), Autosomal recessive",NA
21,46458890,46571225,21q22.3,21q22.3,607711,"DIP2, KIAA0184","Disco-interacting protein 2, Drosophila, homolog of",DIP2A,23181,ENSG00000160305,previously mapped to Chr.2,NA,Dip2a (MGI:2385920)
21,46598603,46605242,21q22.2-q22.3,21q22.3,176990,S100B,"S100 calcium-binding protein, beta (neural)",S100B,6285,ENSG00000160307,NA,NA,S100b (MGI:98217)
21,46635155,46665684,21q22.3,21q22.3,601961,"HRMT1L1, PRMT2","HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 1",PRMT2,3275,ENSG00000160310,NA,NA,Prmt2 (MGI:1316652)
21,0,46709983,Chr.21,NA,109670,BAS,"Beta-adrenergic stimulation, response to",NA,8213,NA,NA,NA,NA
21,0,46709983,Chr.21,NA,143460,HTOR,5-hydroxytryptamine oxygenase regulator,HTOR,3349,NA,NA,NA,NA
22,4300000,9400000,22p12,NA,180454,RNR5,Ribosomal RNA-5,RNR5,6056,NA,NA,NA,NA
22,11474776,11479842,22p,22p11.2,194547,ZNF73,Zinc finger protein-73 (Cos12),ZNF73P,105379427,NA,NA,NA,NA
22,15000000,25500000,22q11,NA,125520,ACF,Asymmetric crying facies (Cayler cardiofacial syndrome),NA,387569,NA,NA,"Cayler cardiofacial syndrome, 125520 (2), Autosomal dominant",NA
22,15000000,25500000,22q11,NA,115470,"CECR, CES",Cat eye syndrome,NA,NA,NA,partial tetrasomy of 22q11,"Cat eye syndrome, 115470 (4), Autosomal dominant",NA
22,15000000,37200000,22q11-q12,NA,151626,"LRE1, L1.2",Line-1.2 retrotransposable element,NA,NA,NA,NA,NA,NA
22,15690025,15721630,22q11.1,22q11.1,608913,"POTEH, POTE22, ACTBL1","POTE ankyrin domain family, member H",POTEH,23784,ENSG00000198062,NA,NA,NA
22,16195708,16198039,22p,22q11.1,194546,ZNF72,Zinc finger protein-72 (Cos8),ZNF72P,100287084,NA,NA,NA,NA
22,16783411,16825411,22q11.1,22q11.1,611674,"XKR3, XTES, XRG3","X Kell blood group precursor-related family, member 3",XKR3,150165,ENSG00000172967,NA,NA,NA
22,17084958,17115693,22q11.22-q11.23,22q11.1,605461,"IL17RA, IL17R, IMD51",Interleukin 17 receptor A,IL17RA,23765,ENSG00000177663,NA,"Immunodeficiency 51, 613953 (3), Autosomal recessive",Il17ra (MGI:107399)
22,17178789,17221853,22q11.2,22q11.1,607575,"ADA2, CECR1, VAIHS, SNEDS",Adenosine deaminase 2,ADA2,51816,ENSG00000093072,mutation identified in 1 SNEDS family,"?Sneddon syndrome, 182410 (3), Autosomal recessive; Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome, 615688 (3), Autosomal recessive",NA
22,17359948,17558154,22q11.2,22q11.1-q11.2,607576,"CECR2, KIAA1740","Cat eye syndrome chromosome region, candidate 2",CECR2,27443,ENSG00000099954,NA,NA,Cecr2 (MGI:1923799)
22,17400000,25500000,22q11.2,NA,611867,"DEL22q11.2, C22DELq11.2","Chromosome 22q11.2 deletion syndrome, distal",NA,NA,NA,NA,"Chromosome 22q11.2 deletion syndrome, distal, 611867 (4)",NA
22,17400000,25500000,22q11.2,NA,609029,DER22t11-22,Emanuel syndrome (supernumerary der(22)t(11;22) syndrome),NA,NA,NA,NA,"Emanuel syndrome, 609029 (4), Inherited chromosomal imbalance",NA
22,17400000,25500000,22q11.2,NA,613700,DER22t8-22,Supernumerary der(22)t(8;22) syndrome,NA,NA,NA,NA,"Supernumerary der(22)t(8-22) syndrome, 613700 (4)",NA
22,17400000,29200000,22q11.21-q12.1,NA,608264,DFNB40,"Deafness, autosomal recessive 40",DFNB40,379003,NA,NA,"Deafness, autosomal recessive 40, 608264 (2), Autosomal recessive",NA
22,17400000,25500000,22q11.2,NA,608363,DUP22q11.2,Chromosome 22q11.2 microduplication syndrome,NA,NA,NA,contiguous gene microduplication syndrome,"Chromosome 22q11.2 microduplication syndrome, 608363 (4), Autosomal dominant, Isolated cases",NA
22,17400000,25500000,22q11.2,NA,600436,GSTT1,"Glutathione S-transferase, theta-1",GSTT1,2952,NA,NA,NA,NA
22,17400000,25500000,22q11.2,NA,147230,IGLJ@,Immunoglobulin lambda light chain joining gene cluster,NA,8217,NA,nine J-C duplexes,NA,NA
22,17400000,25500000,22q11.2,NA,147240,IGLV@,Immunoglobulin lambda light chain variable gene cluster,NA,3546,NA,many genes,NA,NA
22,17562469,17592255,22q11.2,22q11.21,609303,"SLC25A18, GC2","Solute carrier family 25 (mitochondrial carrier, glutamate), member 18",SLC25A18,83733,ENSG00000182902,NA,NA,Slc25a18 (MGI:1919053)
22,17592135,17628821,22q11.2,22q11.21,108746,"ATP6V1E1, ATP6E, ARCL2C","ATPase, H+ transporting, V1 subunit E1",ATP6V1E1,529,ENSG00000131100,NA,"Cutis laxa, autosomal recessive, type IIC, 617402 (3), Autosomal recessive",Atp6v1e1 (MGI:894326)
22,17734139,17774664,22q11.2,22q11.21,601997,BID,BH3-interacting domain death agonist,BID,637,ENSG00000015475,NA,NA,Bid (MGI:108093)
22,17787648,18024560,22q11.21,22q11.21,608882,"MICAL3, KIAA1364","Microtubule-associated monooxygenase, calponin and LIM domains-containing 3",MICAL3,57553,ENSG00000243156,NA,NA,Mical3 (MGI:2442733)
22,17980867,17980960,22q11.21,22q11.21,616205,MIR648,Micro RNA 648,MIR648,693233,ENSG00000207780,in intron 1 of MICAL3,NA,NA
22,18077919,18105395,22q11.21,22q11.21,608666,"PEX26, PBD7A, PBD7B",Peroxisome biogenesis factor 26,PEX26,55670,ENSG00000215193,NA,"Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3), Autosomal recessive; Peroxisome biogenesis disorder 7B, 614873 (3), Autosomal recessive",Pex26 (MGI:1921293)
22,18110808,18131731,22q11,22q11.21,605742,"TUBA8, TUBAL2, CDCBM8","Tubulin, alpha 8",TUBA8,51807,ENSG00000183785,NA,"Cortical dysplasia, complex, with other brain malformations 8, 613180 (3), Autosomal recessive",Tuba8 (MGI:1858225)
22,18149854,18177396,22q11.2,22q11.21,607057,"USP18, UBP43, ISG43, PTORCH2",Ubiquitin-specific protease 18,USP18,11274,ENSG00000184979,NA,"Pseudo-TORCH syndrome 2, 617397 (3), Autosomal recessive",Usp18 (MGI:1344364)
22,18516334,18518164,22q11.2,22q11.21,612340,GGTLC3,"Gamma-glutamyltransferase, light chain 3",GGTLC3,728226,ENSG00000274252,NA,NA,NA
22,18605814,18611918,22q11.21,22q11.21,612699,"RIMBP3, RIMBP3A, KIAA1666",RIMS-binding protein 3,RIMBP3,85376,ENSG00000275793,NA,NA,Rimbp3 (MGI:2685449)
22,18906319,18914237,22q11,22q11.21,601279,DGCR6,DiGeorge syndrome critical region 6,DGCR6,8214,ENSG00000183628,NA,NA,NA
22,18912780,18936552,22q11.2,22q11.21,606810,"PRODH, PRODH2, SCZD4",Proline dehydrogenase (proline oxidase),PRODH,5625,ENSG00000100033,NA,"Hyperprolinemia, type I, 239500 (3), Autosomal recessive; {Schizophrenia, susceptibility to, 4}, 600850 (3), Autosomal dominant",Prodh (MGI:97770)
22,18970497,19031241,22q11.2,22q11.21,618040,"DGCR5, LINC00037",Digeorge syndrome critical region gene 5,DGCR5,26220,ENSG00000273032,NA,NA,NA
22,19036281,19122453,22q11.2,22q11.21,600594,"DGCR2, IDD",DiGeorge critical region gene 2 (integral membrane protein deleted in DiGeorge syndrome),DGCR2,9993,ENSG00000070413,NA,NA,Dgcr2 (MGI:892866)
22,19130278,19144725,22q11.2,22q11.21,601755,"ESS2, DGSI, DGCR14","Ess2 splicing factor, Xenopus, homolog of",ESS2,8220,ENSG00000100056,NA,NA,Ess2 (MGI:107854)
22,19131307,19132621,22q11.21,22q11.21,610710,"TSSK2, STK22B",Testis-specific serine/threonine kinase 2,TSSK2,23617,ENSG00000206203,NA,NA,Tssk2 (MGI:1347559)
22,19148990,19150282,22q11.21,22q11.21,601845,"GSC2, GSCL",Goosecoid homeobox 2,GSC2,2928,ENSG00000063515,NA,NA,Gsc2 (MGI:892006)
22,19175574,19178862,22q11,22q11.21,190315,"SLC25A1, SLC20A3, CTP, D2L2AD, CMS23","Solute carrier family 25 (mitochondrial citrate transporter), member 1",SLC25A1,6576,ENSG00000100075,mutation identified in 1 CMS23 family,"Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3), Autosomal recessive; ?Myasthenic syndrome, congenital, 23, presynaptic, 618197 (3), Autosomal recessive",NA
22,19179472,19291718,22q11.2,22q11.21,601273,"CLTCL1, CLTD","Clathrin, heavy polypeptide-like 1",CLTCL1,8218,ENSG00000070371,NA,NA,NA
22,19253130,19253468,22q11,22q11.21,601225,"DVL, DVL1","Dishevelled, Drosophila, homolog-like",DVL1P1,8215,NA,NA,NA,NA
22,19330697,19431732,22q11,22q11.21,600237,"HIRA, TUPLE1","Histone cell cycle regulation defective, S. cerevisiae, homolog of, A (Tup-like enhancer of split 1)",HIRA,7290,ENSG00000100084,?role in CATCH22,NA,Hira (MGI:99430)
22,19431901,19436077,22q11.21,22q11.21,605089,"MRPL40, NLVCF, MRPL22",Mitochondrial ribosomal protein L40,MRPL40,64976,ENSG00000185608,NA,NA,Mrpl40 (MGI:1332635)
22,19449910,19479192,22q11.2,22q11.21,601754,UFD1L,Ubiquitin fusion degradation 1-like,UFD1,7353,ENSG00000070010,?role in CATCH22,NA,Ufd1 (MGI:109353)
22,19479293,19520611,22q11.2,22q11.21,603465,"CDC45L, CDC45L2, MGORS7","Cell division cycle 45, S. Cerevisiae, homolog-like",CDC45,8318,ENSG00000093009,NA,"Meier-Gorlin syndrome 7, 617063 (3), Autosomal recessive",Cdc45 (MGI:1338073)
22,19523023,19525336,22q11.2,22q11.21,602101,"CLDN5, TMVCF, AWAL",Claudin-5 (transmembrane protein deleted in velocardiofacial syndrome),CLDN5,7122,ENSG00000184113,NA,NA,Cldn5 (MGI:1276112)
22,19714502,19723318,22q11.2,22q11.21,602724,"SEPT5, PNUTL1, CDCREL",Septin 5,SEPTIN5,5413,ENSG00000184702,just 5' of GP1BB,NA,Sept5 (MGI:1195461)
22,19723542,19724773,22q11.2,22q11.21,138720,"GP1BB, BS, BDPLT1","Glycoprotein Ib, platelet, beta polypeptide",GP1BB,2812,ENSG00000203618,NA,"Bernard-Soulier syndrome, type B, 231200 (3), Autosomal recessive; Giant platelet disorder, isolated, 231200 (3), Autosomal recessive",Gp1bb (MGI:107852)
22,19756702,19783592,22q11.2,22q11.21,602054,"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",T-box 1,TBX1,6899,ENSG00000184058,NA,"Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome, 188400 (3), Autosomal dominant; Tetralogy of Fallot, 187500 (3), Autosomal dominant; Velocardiofacial syndrome, 192430 (3), Autosomal dominant",Tbx1 (MGI:98493)
22,19783222,19854873,22q11.2,22q11.21,610778,"GNB1L, WDR14","Guanine nucleotide-binding protein, beta-1-like",GNB1L,54584,ENSG00000185838,NA,NA,Gnb1l (MGI:1338057)
22,19875517,19941991,22q11.2,22q11.21,606448,"TXNRD2, TRXR2, SELZ, GCCD5",Thioredoxin reductase 2,TXNRD2,10587,ENSG00000184470,mutation identified in 1 GCCD5 family,"?Glucocorticoid deficiency 5, 617825 (3), Autosomal recessive",Txnrd2 (MGI:1347023)
22,19941739,19969974,22q11.2,22q11.21,116790,COMT,Catechol-O-methyltransferase,COMT,1312,ENSG00000093010,NA,"{Panic disorder, susceptibility to}, 167870 (3), ?Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant",Comt (MGI:88470)
22,19966726,20016822,22q11,22q11.21,602269,ARVCF,Armadillo repeat gene deleted in VCFS,ARVCF,421,ENSG00000099889,?role in VCFS,NA,Arvcf (MGI:109620)
22,20016999,20067163,22q11.2,22q11.21,616830,"TANGO2, C22orf25, MECRCN","Transport and golgi organization 2, Drosophila, homolog of",TANGO2,128989,ENSG00000183597,NA,"Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3), Autosomal recessive",Tango2 (MGI:101825)
22,20033138,20033219,22q11.21,22q11.21,615576,MIR185,Micro RNA 185,MIR185,406961,ENSG00000208023,within first intron of C22orf25,NA,NA
22,20080231,20111876,22q11.2,22q11.21,609030,DGCR8,DiGeorge syndrome critical region gene 8,DGCR8,54487,ENSG00000128191,NA,NA,Dgcr8 (MGI:2151114)
22,20111871,20117253,22q11.21,22q11.21,611151,"TRMT2A, HTF9C","tRNA methyltransferase 2, S. cerevisiae, homolog of, A",TRMT2A,27037,ENSG00000099899,NA,NA,Trmt2a (MGI:96270)
22,20116103,20127354,22q11.21,22q11.21,601180,"RANBP1, HTF9A",RAN-binding protein 1,RANBP1,5902,ENSG00000099901,NA,NA,Ranbp1 (MGI:96269)
22,20131803,20148006,22q11.21,22q11.21,608784,"ZDHHC8, ZNF378, KIAA1292",Zinc finger DHHC domain-containing protein 8,ZDHHC8,29801,ENSG00000099904,NA,NA,Zdhhc8 (MGI:1338012)
22,20241414,20268317,22q11,22q11.21,605566,"RTN4R, NOGOR",NOGO receptor (reticulon 4 receptor),RTN4R,65078,ENSG00000040608,NA,"{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant",Rtn4r (MGI:2136886)
22,20314237,20320059,22q11,22q11.21,609459,DGCR6L,DiGeorge syndrome critical region gene 6-like,DGCR6L,85359,ENSG00000128185,NA,NA,NA
22,20394114,20408462,22q11.2,22q11.21,194548,ZNF74,Zinc finger protein-74 (Cos52),ZNF74,7625,ENSG00000185252,NA,NA,NA
22,20424583,20437824,22q11,22q11.21,613619,"SCARF2, SREC2, VDEGS","Scavenger receptor class F, member 2",SCARF2,91179,ENSG00000244486,NA,"Van den Ende-Gupta syndrome, 600920 (3), Autosomal recessive",Scarf2 (MGI:1858430)
22,20441518,20497304,22q11.21,22q11.21,618020,KLHL22,Kelch-like 22,KLHL22,84861,ENSG00000099910,NA,NA,Klhl22 (MGI:1337995)
22,20507581,20587620,22q11.2,22q11.21,607372,"MED15, PCQAP, TIG1, ARC105",Mediator complex subunit 15,MED15,51586,ENSG00000099917,NA,NA,NA
22,20707690,20858811,22q11.21,22q11.21,600286,"PI4KA, PIK4CA, PMGYCHA","Phosphatidylinositol 4-kinase, catalytic, alpha",PI4KA,5297,ENSG00000241973,NA,"Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3), Autosomal recessive",Pi4ka (MGI:2448506)
22,20774112,20787719,22q11,22q11.21,142360,"HCF2, HC2, SERPIND1, THPH10",Heparin cofactor II,SERPIND1,3053,ENSG00000099937,proximal to BCR,"Thrombophilia due to heparin cofactor II deficiency, 612356 (3), Autosomal dominant",Serpind1 (MGI:96051)
22,20859006,20891213,22q11.2,22q11.21,604202,"SNAP29, CEDNIK","Synaptosomal-associated protein, 29kD",SNAP29,9342,ENSG00000099940,NA,"Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3), Autosomal recessive",Snap29 (MGI:1914724)
22,20917406,20953748,22q11,22q11.21,602007,CRKL,v-crk avian sarcoma virus CT10 oncogene homolog-like,CRKL,1399,ENSG00000099942,NA,NA,Crkl (MGI:104686)
22,20965171,20981359,22q11.21,22q11.21,617298,"AIFM3, AIFL","Apoptosis-inducing factor, mitochondria-associated, 3",AIFM3,150209,ENSG00000183773,NA,NA,Aifm3 (MGI:1919418)
22,20982296,20999031,22q11.1-q11.2,22q11.21,600574,"LZTR1, SWNTS2, NS10, NS2",Leucine-zipper-like regulator-1,LZTR1,8216,ENSG00000099949,NA,"Noonan syndrome 10, 616564 (3), Autosomal dominant; Noonan syndrome 2, 605275 (3), Autosomal recessive; {Schwannomatosis-2, susceptibility to}, 615670 (3), Autosomal dominant",Lztr1 (MGI:1914113)
22,21009698,21028012,22q11,22q11.21,608077,"P2RXL1, P2XM, P2X6",Purinergic receptor P2X-like 1,P2RX6,9127,ENSG00000099957,NA,NA,P2rx6 (MGI:1337113)
22,21028717,21032560,22q11.2,22q11.21,603752,"SLC7A4, CAT4","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 4",SLC7A4,6545,ENSG00000099960,NA,NA,Slc7a4 (MGI:2146512)
22,21207971,21283022,22q11.1,22q11.21,137181,GGT2,Gamma-glutamyltransferase-2,GGT2,728441,ENSG00000133475,NA,"[Gamma-glutamyltransferase, familial high serum], 137181 (2)",NA
22,21383750,21389168,22q11.21,22q11.21,612700,RIMBP3B,RIMS-binding protein 3B,RIMBP3B,440804,ENSG00000274600,NA,NA,Rimbp3 (MGI:2685449)
22,21417370,21451462,22q11.2,22q11.21,607712,"HIC2, HRG22, KIAA1020",Hypermethylated in cancer 2,HIC2,23119,ENSG00000169635,NA,NA,Hic2 (MGI:1929869)
22,21545665,21551460,22q11.21,22q11.21,612701,RIMBP3C,RIMS-binding protein 3C,RIMBP3C,150221,ENSG00000183246,NA,NA,Rimbp3 (MGI:2685449)
22,21549446,21624033,22q11.2-q13.1,22q11.21,603721,"UBE2L3, UBCH7",Ubiquitin-conjugating enzyme E2L 3,UBE2L3,7332,ENSG00000185651,pseudogenes on 12q12 and 19q13.1-q13.2,NA,Ube2l3 (MGI:109240)
22,21642301,21644298,22q11.2,22q11.21,607551,SDF2L1,Stromal cell-derived factor 2-like 1,SDF2L1,23753,ENSG00000128228,NA,NA,Sdf2l1 (MGI:2149842)
22,21653303,21653384,22q11.21-q11.22,22q11.21,613682,"MIR130B, MIRN130B",Micro RNA 130B,MIR130B,406920,ENSG00000283871,NA,NA,NA
22,21665983,21700014,22q11.21,22q11.21-q11.22,607588,"PPIL2, CYP60",Peptidyl-prolyl isomerase-like 2,PPIL2,23759,ENSG00000100023,NA,NA,Ppil2 (MGI:2447857)
22,21697535,21735833,22q11.2,22q11.21-q11.22,608082,YPEL1,Yippee-like 1,YPEL1,29799,ENSG00000100027,pseudogene on 9p24.3,NA,Ypel1 (MGI:1913303)
22,21759656,21867679,22q11.2,22q11.22,176948,"MAPK1, PRKM1, ERK2",Mitogen-activated protein kinase 1,MAPK1,5594,ENSG00000100030,NA,NA,Mapk1 (MGI:1346858)
22,21957024,21982842,22q11,22q11.22,603582,TOP3B,"Topoisomerase, DNA, III, beta",TOP3B,8940,ENSG00000100038,NA,NA,Top3b (MGI:1333803)
22,22244785,22245514,22q11.2,22q11.22,605141,"VPREB1, IGI, VPREB",Pre-B lymphocyte gene 1,VPREB1,7441,ENSG00000169575,NA,NA,"Vpreb1,Vpreb2 (MGI:98936,MGI:98937)"
22,22547695,22559360,22q11.22,22q11.22,606021,"PRAME, MAPE, OIP4",Preferentially expressed antigen in melanoma,PRAME,23532,ENSG00000185686,NA,NA,NA
22,22644619,22647897,22q11.2,22q11.22,612339,"GGTLC2, GGTL4","Gamma-glutamyltransferase, light chain 2",GGTLC2,91227,ENSG00000100121,NA,NA,NA
22,22822775,22822870,22q11.22,22q11.22,615379,MIR650,Micro RNA 650,MIR650,723778,ENSG00000284049,NA,NA,NA
22,22895374,22895693,22q11.2,22q11.22,147220,"IGLC1, IGLC",Constant region of lambda light chains,IGLC1,3537,NA,several genes,NA,NA
22,23059407,23180047,22q11.2,22q11.22-q11.23,605663,"RSPH14, RTDR1","Radial spoke head 14, Chlamydomonas, homolog of",RSPH14,27156,ENSG00000100218,NA,NA,Rsph14 (MGI:1918486)
22,23070518,23125036,22q11.2,22q11.22-q11.23,139160,GNAZ,"Guanine nucleotide-binding protein (G protein), alpha z polypeptide",GNAZ,2781,ENSG00000128266,NA,NA,Gnaz (MGI:95780)
22,23145297,23169284,22q11.2,22q11.23,605662,RAB36,"Ras family, member 36",RAB36,9609,ENSG00000100228,NA,NA,Rab36 (MGI:1924127)
22,23180508,23318036,22q11.21,22q11.23,151410,"BCR, CML, PHL, ALL",Breakpoint cluster region,BCR,613,ENSG00000186716,Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML,"Leukemia, acute lymphocytic, somatic, 613065 (3); Leukemia, chronic myeloid, somatic, 608232 (3)",Bcr (MGI:88141)
22,23573124,23580289,22q11.21,22q11.23,146770,"IGLL1, IGO, IGL5, VPREB2, AGM2",Immunoglobulin lambda-like polypeptide 1 (immunoglobulin omega peptide),IGLL1,3543,ENSG00000128322,between BCR2 and BCR4; distal to IGLC,"Agammaglobulinemia 2, 613500 (3), Autosomal recessive",Igll1 (MGI:96529)
22,23690860,23699175,22q11.2,22q11.23,612214,"RGL4, RGR",Ral guanine nucleotide dissociation stimulator-like 4,RGL4,266747,ENSG00000159496,NA,NA,NA
22,23738681,23751111,22q11.2,22q11.23,194544,ZNF70,Zinc finger protein-70 (Cos17),ZNF70,7621,ENSG00000187792,NA,NA,NA
22,23752742,23754424,22q11,22q11.23,605017,VPREB3,Pre-B-lymphocyte gene 3,VPREB3,29802,ENSG00000128218,NA,NA,Vpreb3 (MGI:98938)
22,23765833,23767971,22q11.23,22q11.23,615903,"CHCHD10, FTDALS2, SMAJ, IMMD",Coiled-coil-helix-coiled-coil-helix domain-containing protein 10,CHCHD10,400916,ENSG00000250479,mutation identified in 1 IMMD family,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3), Autosomal dominant; ?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3), Autosomal dominant; Spinal muscular atrophy, Jokela type, 615048 (3), Autosomal dominant",Chchd10 (MGI:2143558)
22,23772818,23784315,22q11.2,22q11.23,185261,"MMP11, STMY3",Matrix metalloproteinase 11 (stromelysin 3),MMP11,4320,ENSG00000099953,NA,NA,Mmp11 (MGI:97008)
22,23786965,23838008,22q11,22q11.23,601607,"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",SMARCB1,6598,ENSG00000099956,NA,"Coffin-Siris syndrome 3, 614608 (3), Autosomal dominant; {Rhabdoid tumor predisposition syndrome 1}, 609322 (3), Autosomal dominant; Rhabdoid tumors, somatic, 609322 (3); {Schwannomatosis-1, susceptibility to}, 162091 (3), Autosomal dominant",Smarcb1 (MGI:1328366)
22,23834497,23839347,22q11.23,22q11.23,610305,DERL3,"DER1-like domain family, member 3",DERL3,91319,ENSG00000099958,NA,NA,Derl3 (MGI:1917627)
22,23856702,23886311,22q11.2,22q11.23,610367,"SLC2A11, GLUT11","Solute carrier family 2 (facilitated glucose transporter), member 11",SLC2A11,66035,ENSG00000133460,NA,NA,NA
22,23894382,23895222,22q11.2,22q11.23,153620,MIF,Macrophage migration inhibitory factor,MIF,4282,ENSG00000240972,previously assigned to chr.19,"{Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)",Mif (MGI:96982)
22,23971364,23979827,22q11.2,22q11.23,602750,DDT,D-dopachrome tautomerase,DDT,1652,ENSG00000099977,NA,NA,Ddt (MGI:1298381)
22,23980133,23983914,22q11.2,22q11.23,600437,GSTT2,Glutathione S-transferase theta-2,GSTT2,2953,ENSG00000099984,NA,NA,Gstt2 (MGI:106188)
22,24011191,24178627,22q11.2,22q11.23,604251,"CABIN1, CAIN",Calcineurin-binding protein 1,CABIN1,23523,ENSG00000099991,NA,NA,Cabin1 (MGI:1298375)
22,24181486,24189105,22q11.23,22q11.23,615825,SUSD2,Sushi domain-containing protein 2,SUSD2,56241,ENSG00000099994,NA,NA,Susd2 (MGI:1918983)
22,24219653,24245141,22q11.2,22q11.23,137168,GGT5,Gamma-glutamyltransferase 5,GGT5,2687,ENSG00000099998,NA,NA,Ggt5 (MGI:1346063)
22,24270816,24417739,22q11.23,22q11.23,614140,"SPECC1L, KIAA0376, OBLFC1, GBBB2, TBHS",Sperm antigen with calponin homology and coiled-coil domains 1-like,SPECC1L,23384,ENSG00000100014,mutation identified in 1 OBLFC1 patient,"?Facial clefting, oblique, 1, 600251 (3), Autosomal dominant; Hypertelorism, Teebi type, 145420 (3), Autosomal dominant; Opitz GBBB syndrome, type II, 145410 (3), Autosomal dominant",Specc1l (MGI:1921642)
22,24423596,24442359,22q11.2,22q11.23,102776,ADORA2A,Adenosine A2a receptor,ADORA2A,135,ENSG00000128271,incorrectly assigned to 11q,NA,Adora2a (MGI:99402)
22,24495059,24528680,22q11.2,22q11.23,606673,"UPB1, BUP1",Beta-ureidopropionase,UPB1,51733,ENSG00000100024,NA,"Beta-ureidopropionase deficiency, 613161 (3), Autosomal recessive",Upb1 (MGI:2143535)
22,24555649,24574970,22q11.23,22q11.23,601062,SNRPD3,Small nuclear ribonucleoprotein polypeptide D3,SNRPD3,6634,ENSG00000100028,NA,NA,Snrpd3 (MGI:1914582)
22,24583749,24629004,22q11.2,22q11.23,612346,"GGT1, GGT, GGTD",Gamma-glutamyltransferase 1,GGT1,2678,ENSG00000100031,mutation identified in 1 GGTD family,"?Glutathioninuria, 231950 (3), Autosomal recessive",Ggt1 (MGI:95706)
22,24719033,24774719,22q11.2,22q11.23,610314,PIWIL3,PIWI-like 3,PIWIL3,440822,ENSG00000184571,NA,NA,NA
22,25194243,25207616,22q11.2-q12.2,22q11.23,123630,"CRYBB3, CRYB3, CATCN2, CTRCT22","Crystallin, beta-B3",CRYBB3,1417,ENSG00000100053,NA,"Cataract 22, 609741 (3), Autosomal recessive, Autosomal dominant",Crybb3 (MGI:102717)
22,25211659,25231868,22q11.2-q12.2,22q11.23,123620,"CRYBB2, CRYB2, CTRCT3, CCA2","Crystallin, beta-B2",CRYBB2,1415,ENSG00000244752,2nd CRYB2 gene in same region,"Cataract 3, multiple types, 601547 (3), Autosomal dominant",Crybb2 (MGI:88519)
22,25500000,37200000,22q12,NA,613106,BRV2,"Vertigo, benign recurrent, 2",NA,100313948,NA,NA,"Vertigo, benign recurrent, 2, 613106 (2)",NA
22,25500000,50818468,22q12-q13,NA,603116,CDAGS,"Craniosynostosis, anal anomalies, and porokeratosis syndrome",NA,574043,NA,NA,"CDAGS syndrome, 603116 (2), Autosomal recessive",NA
22,25500000,50818468,22q12-q13,NA,613284,HCHGQ3,Hematocrit/hemoglobin quantitative trait locus 3,NA,100381206,NA,associated with rs855791,"[Hematocrit/hemoglobin quantitative trait locus 3], 613284 (2)",NA
22,25500000,31800000,22q12.1-q12.2,NA,606960,ITS,Insulinoma tumor suppressor gene locus,NA,282551,NA,NA,Insulinoma (1),NA
22,25500000,37200000,22q12,NA,608207,KAZA1,"Kala-azar (visceral leishmaniasis), susceptibility to, 1",NA,387582,NA,NA,"{Kala-azar, susceptibility to, 1}, 608207 (2)",NA
22,25500000,37200000,22q12,NA,611004,SQTL2,Smoking as a quantitative trait locus 2,NA,100188828,NA,max lod at D22S315,"{Smoking as a quantitative trait locus 2}, 611004 (2)",NA
22,25564674,25729293,22q11,22q12.1,109636,"ADRBK2, BARK2, GRK3","Adrenergic, beta, receptor kinase-2",GRK3,157,ENSG00000100077,NA,NA,Grk3 (MGI:87941)
22,25742132,26063846,22q12.1,22q12.1,607295,"MYO18B, KFS4",Myosin XVIIIB,MYO18B,84700,ENSG00000133454,NA,"Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3), Autosomal recessive",Myo18b (MGI:1921626)
22,26169461,26383596,22q12.1,22q12.1,607021,SEZ6L,Seizure-related 6-like,SEZ6L,23544,ENSG00000100095,NA,NA,Sez6l (MGI:1935121)
22,26443108,26483862,22q11.2-q12.2,22q12.1,606682,HPS4,HPS gene 4,HPS4,89781,ENSG00000100099,NA,"Hermansky-Pudlak syndrome 4, 614073 (3), Autosomal recessive",Hps4 (MGI:2177742)
22,26483866,26494657,22q12.1,22q12.1,602254,SRRD,SRR1 domain-containing protein,SRRD,402055,ENSG00000100104,NA,NA,Srrd (MGI:1917368)
22,26491239,26513590,22q12.1,22q12.1,612747,"TFIP11, TIP39, NTR1",Tuftelin-interacting protein 11,TFIP11,24144,ENSG00000100109,NA,NA,Tfip11 (MGI:1930075)
22,26521995,26590131,22q12.1,22q12.1,603126,TPST2,Tyrosylprotein phosphotransferase 2,TPST2,8459,ENSG00000128294,NA,NA,Tpst2 (MGI:1309516)
22,26599277,26618103,22q11.2-q12.1,22q12.1,600929,"CRYBB1, CATCN3, CTRCT17","Crystallin, beta B1",CRYBB1,1414,ENSG00000100122,NA,"Cataract 17, multiple types, 611544 (3), Autosomal recessive, Autosomal dominant",Crybb1 (MGI:104992)
22,26607981,26630671,22q11.2-q13.1,22q12.1,123631,"CRYBA4, CTRCT23","Crystallin, beta polypeptide A4",CRYBA4,1413,ENSG00000196431,NA,"Cataract 23, 610425 (3)",Cryba4 (MGI:102716)
22,26657481,26676477,22q12.1,22q12.1,611082,"MIAT, C22orf35",MIAT gene,MIAT,440823,ENSG00000225783,NA,"{Myocardial infarction, susceptibility to}, 608446 (3)",NA
22,27748276,27801755,22q12.3-qter,22q12.1,156100,"MN1, MGCR",Meningioma chromosome region,MN1,4330,ENSG00000169184,fused with TEL in AML,"Meningioma, 607174 (3), Autosomal dominant",Mn1 (MGI:1261813)
22,27851668,27919305,22q12.1,22q12.1,606876,PITPNB,"Phosphatidylinositol transfer protein, beta",PITPNB,23760,ENSG00000180957,NA,NA,Pitpnb (MGI:1927542)
22,27978013,28679864,22q12.1,22q12.1,615098,"TTC28, TPRBK, KIAA1043",Tetratricopeptide repeat domain-containing protein 28,TTC28,23331,ENSG00000100154,NA,NA,Ttc28 (MGI:2140873)
22,28687742,28741865,22q12.1,22q12.1,604373,"CHEK2, RAD53, CHK2, CDS1, LFS2","Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of)",CHEK2,11200,ENSG00000183765,NA,"{Breast and colorectal cancer, susceptibility to} (3); {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3), Autosomal dominant, Somatic mutation",Chek2 (MGI:1355321)
22,28741991,28757517,22q11-q12,22q12.1,608142,"HSC20, HSCB, JAC1","HSC20, E. coli, homolog of",HSCB,150274,ENSG00000100209,NA,NA,Hscb (MGI:2141135)
22,28794559,28800571,22q12,22q12.1,194355,"XBP1, XBP2",X-box-binding protein-1,XBP1,7494,ENSG00000100219,pseudogene on chr.5,"{Major affective disorder-7, susceptibility to}, 612371 (3)",Xbp1 (MGI:98970)
22,28800656,29057487,22q12.1,22q12.1,612062,"ZNRF3, KIAA1133",Zinc finger and ring finger protein 3,ZNRF3,84133,ENSG00000183579,NA,NA,Znrf3 (MGI:3039616)
22,29073034,29168332,22q12.1,22q12.1,609898,"KREMEN1, KRM1, ECTD13",Kringle domain-containing transmembrane protein 1,KREMEN1,83999,ENSG00000183762,NA,"Ectodermal dysplasia 13, hair/tooth type, 617392 (3), Autosomal recessive",Kremen1 (MGI:1933988)
22,29268253,29300522,22q12,22q12.2,133450,"EWSR1, EWS",Ewing sarcoma breakpoint region-1,EWSR1,2130,ENSG00000182944,t(11;22)(q24;q12); t(21;22)(q22;q12),"Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3)",NA
22,29306649,29312786,22q12,22q12.2,602128,"GAS2L1, GAR22",Growth arrest-specific 2 like 1,GAS2L1,10634,ENSG00000185340,NA,NA,Gas2l1 (MGI:1926176)
22,29312932,29319617,22q12,22q12.2,602220,"RASL10A, RRP22","Ras-like, family 10, member A",RASL10A,10633,ENSG00000100276,NA,NA,Rasl10a (MGI:1922918)
22,29327679,29388582,22q12,22q12.2,600157,"AP1B1, ADTB1, BAM22, CLAPB2","Adaptor-related protein complex 1, beta 1 subunit (adaptin, beta)",AP1B1,162,ENSG00000100280,NA,NA,Ap1b1 (MGI:1096368)
22,29403030,29442489,22q12-q13,22q12.2,605968,RFPL1,RET finger protein-like 1,RFPL1,5988,ENSG00000128250,NA,NA,NA
22,29437014,29442128,22q12-q13,22q12.2,605972,RFPL1S,"Ret finger protein-like 1, antisense",RFPL1S,10740,NA,NA,NA,NA
22,29480217,29491389,22q12.2,22q12.2,162230,"NEFH, CMT2CC","Neurofilament, heavy polypeptide",NEFH,4744,ENSG00000100285,mutation identified in 1 family with ALS susceptibility,"?{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3), Autosomal dominant",Nefh (MGI:97309)
22,29505878,29553759,22q12,22q12.2,612733,"THOC5, FMIP",THO complex 5,THOC5,8563,ENSG00000100296,NA,NA,Thoc5 (MGI:1351333)
22,29554807,29581112,22q12,22q12.2,603249,NIPSNAP1,4-nitrophenylphosphatase domain and nonneuronal SNAP25-like 1,NIPSNAP1,8508,ENSG00000184117,NA,NA,Nipsnap1 (MGI:1278344)
22,29603555,29698599,22q12.2,22q12.2,607379,NF2,Merlin,NF2,4771,ENSG00000186575,loss of heterozygosity,"Meningioma, NF2-related, somatic, 607174 (3); Neurofibromatosis, type 2, 101000 (3), Autosomal dominant; Schwannomatosis, somatic, 162091 (3)",Nf2 (MGI:97307)
22,29767368,29770412,22cen-q12,22q12.2,610843,UCRC,"Ubiquinol-cytochrome C reductase complex, 7.2kD subunit",UQCR10,29796,ENSG00000184076,NA,NA,Uqcr10 (MGI:1913402)
22,29788607,29838281,22q12.2,22q12.2,614216,"ASCC2, p100","Activating signal cointegrator 1 complex, subunit 2",ASCC2,84164,ENSG00000100325,NA,NA,Ascc2 (MGI:1922702)
22,29883168,30030867,22q12,22q12.2,603558,MTMR3,Myotubularin-related protein 3,MTMR3,8897,ENSG00000100330,NA,NA,Mtmr3 (MGI:1921552)
22,30240452,30257486,22q12.1-q12.2,22q12.2,159540,"LIF, HILDA",Leukemia inhibitory factor (cholinergic differentiation factor),LIF,3976,ENSG00000128342,distal to ES,NA,Lif (MGI:96787)
22,30262828,30266850,22q12.1-q12.2,22q12.2,165095,OSM,Oncostatin M,OSM,5008,ENSG00000099985,10kb from LIF,NA,Osm (MGI:104749)
22,30285117,30289626,22q12.2,22q12.2,617034,"GATSL3, CASTOR1",GATS protein-like 3,CASTOR1,652968,ENSG00000239282,NA,NA,Castor1 (MGI:1919212)
22,30291989,30326940,22q12.1-qter,22q12.2,610020,"TBC1D10A, EPI64","TBC1 domain family, member 10A",TBC1D10A,83874,ENSG00000099992,NA,NA,Tbc1d10a (MGI:2144164)
22,30331987,30356893,22q12.2,22q12.2,605595,"SF3A1, SF3A120, SAP114, PRP21","Splicing factor 3A, subunit 1",SF3A1,10291,ENSG00000099995,NA,NA,Sf3a1 (MGI:1914715)
22,30396940,30425302,22q12.1-qter,22q12.2,607558,"SEC14L2, TAP, KIAA1186",Sec14-like 2,SEC14L2,23541,ENSG00000100003,NA,NA,Sec14l2 (MGI:1915065)
22,30425767,30429053,22q12.2,22q12.2,610235,MTFP1,Mitochondrial fission process 1,MTFP1,51537,ENSG00000242114,NA,NA,Mtfp1 (MGI:1916686)
22,30447958,30472046,22q12,22q12.2,612824,"SEC14L3, TAP2",Sec14-like 3,SEC14L3,266629,ENSG00000100012,NA,NA,Sec14l3 (MGI:3617848)
22,30488149,30505710,22q12,22q12.2,612825,"SEC14L4, TAP3",Sec14-like 4,SEC14L4,284904,ENSG00000133488,NA,NA,Sec14l4 (MGI:2144095)
22,30554634,30574664,22q12.2,22q12.2,602300,"GAL3ST1, CST",Galactose-3-O-sulfotransferase 1,GAL3ST1,9514,ENSG00000128242,NA,NA,Gal3st1 (MGI:1858277)
22,30576624,30607012,22q12.1,22q12.2,605819,"PES1, PES","Pescadillo, zebrafish, homolog of, 1",PES1,23481,ENSG00000100029,NA,NA,Pes1 (MGI:1890613)
22,30607082,30627270,22q11.2-qter,22q12.2,613441,"TCN2, TC2",Transcobalamin II,TCN2,6948,ENSG00000185339,linked to P1,"Transcobalamin II deficiency, 275350 (3), Autosomal recessive",Tcn2 (MGI:98534)
22,30693781,30907823,22q12,22q12.2,606729,"OSBP2, ORP4, KIAA1664",Oxysterol-binding protein 2,OSBP2,23762,ENSG00000184792,NA,NA,Osbp2 (MGI:1921559)
22,30925129,30968773,22q12.2,22q12.2,616661,"MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z",MORC family CW-type zinc finger protein 2,MORC2,22880,ENSG00000133422,NA,"Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3), Autosomal dominant",Morc2a (MGI:1921772)
22,30969210,30979394,22q12.2,22q12.2,614971,TUG1,"Taurine-upregulated gene 1, noncoding",TUG1,55000,ENSG00000253352,NA,NA,NA
22,31081298,31104623,22q12.3,22q12.2,602127,SMTN,Smoothelin,SMTN,6525,ENSG00000183963,NA,NA,Smtn (MGI:1354727)
22,31104776,31107567,22q12.2,22q12.2,610918,"SELENOM, SELM, SEPM",Selenoprotein M,SELENOM,140606,ENSG00000198832,NA,NA,Selenom (MGI:2149786)
22,31107735,31134696,22q11.2-q13.2,22q12.2,606481,"INPP5J, PIB5PA, PIPP",Inositol polyphosphate-5-phosphatase J,INPP5J,27124,ENSG00000185133,NA,NA,Inpp5j (MGI:2158663)
22,31134806,31140507,22q11.2-q13.2,22q12.2,611651,"PLA2G3, SPLA2III","Phospholipase A2, group III",PLA2G3,50487,ENSG00000100078,NA,NA,Pla2g3 (MGI:2444945)
22,31212297,31280079,22q12.2,22q12.2,601988,LIMK2,LIM domain kinase 2,LIMK2,3985,ENSG00000182541,NA,NA,Limk2 (MGI:1197517)
22,31325803,31346345,22q12,22q12.2,605165,"ZNF278, PATZ, MAZR",Zinc finger protein-278,PATZ1,23598,ENSG00000100105,NA,NA,Patz1 (MGI:1891832)
22,31399603,31434451,22q12.2,22q12.2,603952,"DRG1, NEDD3",Developmentally regulated GTP-binding protein 1,DRG1,4733,ENSG00000185721,NA,NA,Drg1 (MGI:1343297)
22,31434647,31489949,22q11.2,22q12.2,607445,EIF4ENIF1,Eukaryotic translation initiation factor 4E nuclear import factor 1,EIF4ENIF1,56478,ENSG00000184708,NA,NA,Eif4enif1 (MGI:1921453)
22,31496138,31618587,22q12.2,22q12.2,612765,"SFI1, KIAA0542","SFI1, yeast, homolog of",SFI1,9814,ENSG00000198089,NA,NA,Sfi1 (MGI:1926137)
22,31618490,31662563,22q12,22q12.2,612770,"PISD, PSD, PSSC",Phosphatidylserine decarboxylase,PISD,23761,ENSG00000241878,NA,NA,Pisd (MGI:2445114)
22,31753967,31907014,22q12.2-q12.3,22q12.2-q12.3,614191,"DEPDC5, KIAA0645, FFEVF1",DEP domain-containing protein 5,DEPDC5,9681,ENSG00000100150,NA,"Epilepsy, familial focal, with variable foci 1, 604364 (3), Autosomal dominant",Depdc5 (MGI:2141101)
22,31800000,37200000,22q12.3,NA,609558,HPC6,"Prostate cancer, hereditary, 6",NA,100188789,NA,between D22S1265 and D22S277,"{Prostate cancer, susceptibility to}, 609558 (2)",NA
22,31800000,40600000,22q12.3-q13.1,NA,613689,MDNS,Mammary-digital-nail syndrome,NA,100529148,NA,"max lod at D22S277, D22S1142, D22S683, D22S283","Mammary-digital-nail syndrome, 613689 (2), Autosomal dominant",NA
22,31944534,31957602,22q12,22q12.3,113508,"YWHAH, YWHA1","Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide 22",YWHAH,7533,ENSG00000128245,NA,NA,Ywhah (MGI:109194)
22,32043049,32113028,22q13.1,22q12.3,182380,"SLC5A1, SGLT1","Solute carrier family 5 (sodium/glucose transporter), member 1",SLC5A1,6523,ENSG00000100170,NA,"Glucose/galactose malabsorption, 606824 (3), Autosomal recessive",Slc5a1 (MGI:107678)
22,32190434,32204848,22q12-q13,22q12.3,605969,RFPL2,RET finger protein-like 2,RFPL2,10739,ENSG00000128253,NA,NA,NA
22,32354884,32361160,22q12-q13,22q12.3,605970,RFPL3,RET finger protein-like 3,RFPL3,10738,ENSG00000128276,NA,NA,NA
22,32359905,32371263,22q12-q13,22q12.3,605971,RFPL3S,"Ret finger protein-like 3, antisense",RFPL3S,10737,ENSG00000205853,NA,NA,NA
22,32387581,32412246,22q12.3,22q12.3,613901,"RTCB, C22orf28, HSPC117","RNA 2-prime, 3-prime cyclic phosphate and 5-prime-OH ligase",RTCB,51493,ENSG00000100220,NA,NA,Rtcb (MGI:106379)
22,32413844,32464464,22q13,22q12.3,614109,"BPIFC, BPIL2","BPI fold-containing protein, family C",BPIFC,254240,ENSG00000184459,NA,NA,Bpifc (MGI:3026884)
22,32474681,32498830,22q12-q13,22q12.3,605648,"FBXO7, FBX7, FBX, PKPS, PARK15",F-box only protein 7,FBXO7,25793,ENSG00000100225,NA,"Parkinson disease 15, autosomal recessive, 260300 (3), Autosomal recessive",Fbxo7 (MGI:1917004)
22,32507819,33058380,22q12.3,22q12.3,602705,SYN3,Synapsin III,SYN3,8224,ENSG00000185666,?relation to schizophrenia,NA,Syn3 (MGI:1351334)
22,32800815,32863040,22q12.1-q13.2,22q12.3,188826,"TIMP3, SFD",Tissue inhibitor of metalloproteinase-3,TIMP3,7078,ENSG00000100234,NA,"Sorsby fundus dystrophy, 136900 (3), Autosomal dominant",Timp3 (MGI:98754)
22,33162236,33922887,22q12.3-q13.1,22q12.3,603590,"LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6",Acetylglucosaminyltransferase-like protein,LARGE1,9215,ENSG00000133424,NA,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3), Autosomal recessive",Large1 (MGI:1342270)
22,35066157,35087386,22q12.3,22q12.3,612019,"ISX, RAXLX",Intestine-specific homeobox,ISX,91464,ENSG00000175329,NA,NA,Isx (MGI:1918847)
22,35256696,35295806,22q13.1,22q12.3,604702,"HMGXB4, HMG2L1",HMG box domain-containing 4,HMGXB4,10042,ENSG00000100281,NA,NA,Hmgxb4 (MGI:1918073)
22,35299274,35347993,22q13.1,22q12.3,604700,TOM1,"Target of MYB1, chicken, homolog of",TOM1,10043,ENSG00000100284,NA,NA,Tom1 (MGI:1338026)
22,35381095,35394206,22q12,22q12.3,141250,"HMOX1, HMOX1D",Heme oxygenase 1,HMOX1,3162,ENSG00000100292,NA,"Heme oxygenase-1 deficiency, 614034 (3); {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)",Hmox1 (MGI:96163)
22,35400132,35454941,22q13.1,22q12.3,602696,"MCM5, CDC46, MGORS8","Minichromosome maintenance, S. cerevisiae, homolog of, 5",MCM5,4174,ENSG00000100297,mutation identified in 1 MGORS8 patient,"?Meier-Gorlin syndrome 8, 617564 (3), Autosomal recessive",Mcm5 (MGI:103197)
22,35540493,35554002,22q12.3,22q12.3,612842,"RASD2, RHES, TEM2","RASD family, member 2",RASD2,23551,ENSG00000100302,NA,NA,Rasd2 (MGI:1922391)
22,35606763,35623353,22q11.2-q13,22q12.3,160000,MB,Myoglobin,MB,4151,ENSG00000198125,NA,NA,Mb (MGI:96922)
22,35648315,35668405,22q12.3,22q12.3,607256,APOL6,Apolipoprotein L6,APOL6,80830,ENSG00000221963,NA,NA,Apol6 (MGI:1919189)
22,35708423,35730324,22q12.3,22q12.3,607255,APOL5,Apolipoprotein L5,APOL5,80831,ENSG00000128313,NA,NA,NA
22,35738733,36028891,22q13.1,22q12.3,612149,"RBFOX2, RBM9, FOX2, RTA","RNA binding protein, fox-1 homolog 2",RBFOX2,23543,ENSG00000100320,NA,NA,Rbfox2 (MGI:1933973)
22,36140322,36166176,22q12.3,22q12.3,607253,APOL3,Apolipoprotein L3,APOL3,80833,ENSG00000128284,NA,NA,NA
22,36189127,36204832,22q12.3,22q12.3,607254,APOL4,Apolipoprotein L4,APOL4,80832,ENSG00000100336,NA,"{Schizophrenia}, 181500 (1), Autosomal dominant",NA
22,36226208,36239953,22q12.3,22q12.3,607252,APOL2,Apolipoprotein L2,APOL2,23780,ENSG00000128335,NA,"{Schizophrenia}, 181500 (1), Autosomal dominant",Apol8 (MGI:2444921)
22,36253070,36267530,22q12.3,22q12.3,603743,"APOL1, FSGS4",Apolipoprotein L1,APOL1,8542,ENSG00000100342,NA,"{End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3); {Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3)",NA
22,36281276,36388066,22q11.2,22q12.3,160775,"MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS","Myosin, heavy polypeptide-9, nonmuscle",MYH9,4627,ENSG00000100345,NA,"Deafness, autosomal dominant 17, 603622 (3), Autosomal dominant; Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, 155100 (3), Autosomal dominant",Myh9 (MGI:107717)
22,36467035,36482024,22q12.3,22q12.3,609063,"TXN2, TRX2, MTRX, COXPD29",Thioredoxin 2,TXN2,25828,ENSG00000100348,mutation identified in 1 COXPD29 patient,"?Combined oxidative phosphorylation deficiency 29, 616811 (3), Autosomal recessive",Txn2 (MGI:1929468)
22,36487189,36507039,22q12.3,22q12.3,613777,"FOXRED2, ERFAD",FAD-dependent oxidoreductase domain-containing protein 2,FOXRED2,80020,ENSG00000100350,NA,NA,Foxred2 (MGI:106315)
22,36510849,36529229,22q13.1,22q12.3,603915,"EIF3D, EIF3S7","Eukaryotic translation initiation factor 3, subunit D",EIF3D,8664,ENSG00000100353,NA,NA,Eif3d (MGI:1933181)
22,36560868,36702857,22q13.1,22q12.3,602911,"CACNG2, MRD10","Calcium channel, voltage-dependent, gamma-2 subunit (stargazin)",CACNG2,10369,ENSG00000166862,mutation identified one MRD10 patient,"?Mental retardation, autosomal dominant 10, 614256 (3), Autosomal dominant",Cacng2 (MGI:1316660)
22,36758207,36776118,22q12.3,22q12.3,615870,"IFT27, RABL4, BBS19","Intraflagellar transport 27, Chlamydomonas, homolog of",IFT27,11020,ENSG00000100360,mutation identified in 1 BBS19 family,"?Bardet-Biedl syndrome 19, 615996 (3), Autosomal recessive",Ift27 (MGI:1914292)
22,36800702,36819498,22q12-q13.1,22q12.3,168890,PVALB,Parvalbumin,PVALB,5816,ENSG00000100362,?role in DiGeorge syndrome,NA,Pvalb (MGI:97821)
22,36860987,36878016,22q13.1,22q12.3,601488,"NCF4, P40PHOX, CGD3",Neutrophil cytosolic factor-4,NCF4,4689,ENSG00000100365,mutation identified in 1 CGD3 patient,"?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3), Autosomal recessive",Ncf4 (MGI:109186)
22,36913573,36940448,22q12.2-q13.1,22q12.3,138981,"CSF2RB, SMDP5","Colony-stimulating factor-2 receptor, beta, low-affinity",CSF2RB,1439,ENSG00000100368,NA,"Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3), Autosomal recessive","Csf2rb2,Csf2rb (MGI:1339759,MGI:1339760)"
22,37010858,37020182,22q11.2-qter,22q12.3,180370,"TST, RDS",Thiosulfate sulfurtransferase (Rhodanese),TST,7263,ENSG00000128311,NA,NA,Tst (MGI:98852)
22,37019640,37029821,22q11.2-qter,22q12.3,602496,MPST,Mercaptopyruvate sulfurtransferase,MPST,4357,ENSG00000128309,NA,NA,Mpst (MGI:2179733)
22,37051724,37063389,22q12.3,22q12.3,616386,KCTD17,Potassium channel tetramerization domain-containing protein 17,KCTD17,79734,ENSG00000100379,NA,"Dystonia 26, myoclonic, 616398 (3), Autosomal dominant",Kctd17 (MGI:1920094)
22,37065435,37110624,22q12-q13,22q12.3,609862,"TMPRSS6, IRIDA","Transmembrane protease, serine 6 (matriptase 2)",TMPRSS6,164656,ENSG00000187045,NA,"Iron-refractory iron deficiency anemia, 206200 (3), Autosomal recessive",Tmprss6 (MGI:1919003)
22,37125837,37175117,22q11.2-q13,22q12.3,146710,"IL2RB, IMD63","Interleukin-2 receptor, beta polypeptide",IL2RB,3560,ENSG00000100385,NA,"Immunodeficiency 63 with lymphoproliferation and autoimmunity, 618495 (3)",Il2rb (MGI:96550)
22,37180165,37199422,22q12.3,22q12.3,614910,"C1QTNF6, CTFP6",C1q- and tumor necrosis factor-related protein 6,C1QTNF6,114904,ENSG00000133466,NA,NA,C1qtnf6 (MGI:1919959)
22,37200000,50818468,22q13,NA,615538,"DUP22q13, C22DUPq13",Chromosome 22q13 duplication syndrome,NA,NA,NA,NA,"Chromosome 22q13 duplication syndrome, 615538 (4), Isolated cases",NA
22,37200000,50818468,22q13,NA,610873,MENAQ1,"Menarche, age at, QTL 1",NA,100188822,NA,max lod at UT7136,"{Menarche, age at, QTL}, 610873 (2)",NA
22,37200000,50818468,22q13,NA,613282,NAFLD1,"Fatty liver disease, nonalcoholic, susceptibility to, 1",NA,100380876,NA,associated with rs738409,"{Fatty liver disease, nonalcoholic, susceptibility to, 1}, 613282 (2), Multifactorial",NA
22,37200000,50818468,22q13,NA,612417,NRCLP4,Narcolepsy 4,NA,100216484,NA,associated with rs5770917,"{Narcolepsy 4}, 612417 (2)",NA
22,37204236,37220450,22q13.1,22q13.1,182453,SSTR3,Somatostatin receptor-3,SSTR3,6753,ENSG00000278195,NA,NA,Sstr3 (MGI:98329)
22,37225269,37244268,22q12.3-q13.2,22q13.1,602049,RAC2,"Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP-binding protein Rac2)",RAC2,5880,ENSG00000128340,NA,"Neutrophil immunodeficiency syndrome, 608203 (3)",Rac2 (MGI:97846)
22,37282507,37315340,22q12.3-q13.1,22q13.1,606514,"CYTH4, PSCD4, CYT4",Cytohesin 4,CYTH4,27128,ENSG00000100055,NA,NA,Cyth4 (MGI:2441702)
22,37469062,37486439,22q12,22q13.1,602577,MFNG,Manic fringe,MFNG,4242,ENSG00000100060,NA,NA,Mfng (MGI:1095404)
22,37490361,37519414,22q13.1,22q13.1,607209,"CARD10, CARMA3, BIMP1",Caspase recruitment domain-containing protein 10,CARD10,29775,ENSG00000100065,NA,NA,Card10 (MGI:2146012)
22,37560479,37569404,22q13.1,22q13.1,606084,"CDC42EP1, MSE55, BORG5, CEP1",CDC42 effector protein 1,CDC42EP1,11135,ENSG00000128283,NA,NA,Cdc42ep1 (MGI:1929763)
22,37570247,37580086,22q13.1,22q13.1,150571,LGALS2,"Lectin, galactoside-binding, soluble, 2",LGALS2,3957,ENSG00000100079,NA,"{Myocardial infarction, susceptibility to}, 608446 (3)",Lgals2 (MGI:895068)
22,37608473,37633563,22q13.31,22q13.1,606004,GGA1,"Golgi associated, gamma adaptin ear containing, ARF binding protein 1",GGA1,26088,ENSG00000100083,NA,NA,Gga1 (MGI:2146207)
22,37639668,37656118,22q13.1,22q13.1,617368,"SH3BP1, ARHGAP43, BGIN",SH3 domain-binding protein 1,SH3BP1,23616,ENSG00000100092,NA,NA,Sh3bp1 (MGI:104603)
22,37675635,37679801,22q12-q13.1,22q13.1,150570,LGALS1,"Lectin, galactose-binding, soluble, 1",LGALS1,3956,ENSG00000100097,NA,NA,Lgals1 (MGI:96777)
22,37697047,37776555,22q13.1,22q13.1,609761,"TRIOBP, KIAA1662",Trio- and F-actin-binding protein,TRIOBP,11078,ENSG00000100106,NA,"Deafness, autosomal recessive 28, 609823 (3), Autosomal recessive",Triobp (MGI:1349410)
22,37805106,37807435,22q13.1,22q13.1,142708,"H1F0, H1FV","H1 histone family, member 0",H1F0,3005,ENSG00000189060,NA,NA,H1f0 (MGI:95893)
22,37807893,37817176,22q12-q13,22q13.1,607422,"GCAT, KBL",Glycine C-acetyltransferase,GCAT,23464,ENSG00000100116,NA,NA,Gcat (MGI:1349389)
22,37823381,37825484,22q12.2-q13.1,22q13.1,603692,GALR3,Galanin receptor 3,GALR3,8484,ENSG00000128310,NA,NA,Galr3 (MGI:1329003)
22,37830852,37849317,22q13.1,22q13.1,613383,"ANKRD54, LIAR",Ankyrin repeat domain-containing protein 54,ANKRD54,129138,ENSG00000100124,NA,NA,Ankrd54 (MGI:2444209)
22,37847677,37847773,22q13.1,22q13.1,613556,MIR659,Micro RNA 659,MIR659,724029,ENSG00000207696,NA,NA,NA
22,37953662,38041914,22q13.1,22q13.1,604414,POLR2F,"Polymerase II, RNA, subunit F",POLR2F,5435,ENSG00000100142,NA,NA,Polr2f (MGI:1349393)
22,37972311,37984531,22q13,22q13.1,602229,"SOX10, WS4, WS4C, PCWH",SRY (sex-determining region Y)-box-10,SOX10,6663,ENSG00000100146,megacolon and spotting in mice,"PCWH syndrome, 609136 (3), Autosomal dominant; Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3), Autosomal dominant; Waardenburg syndrome, type 4C, 613266 (3), Autosomal dominant",Sox10 (MGI:98358)
22,38056310,38075703,22q12.3-q13.2,22q13.1,605926,"PICK1, PRKCABP",Protein interacting with C kinase 1,PICK1,9463,ENSG00000100151,NA,NA,Pick1 (MGI:894645)
22,38078136,38083162,22q12.3-q13.2,22q13.1,610409,"SLC16A8, MCT3","Solute carrier family 16 (monocarboxylic acid transporter), member 8",SLC16A8,23539,ENSG00000100156,NA,NA,Slc16a8 (MGI:1929519)
22,38084888,38110943,22q13.1,22q13.1,617536,"BAIAP2L2, PINKBAR",Bai1-associated protein 2-like 2,BAIAP2L2,80115,ENSG00000128298,NA,NA,Baiap2l2 (MGI:2652819)
22,38111494,38181829,22q13.1,22q13.1,603604,"PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14","Phospholipase A2, group VI",PLA2G6,8398,ENSG00000184381,NA,"Infantile neuroaxonal dystrophy 1, 256600 (3), Autosomal recessive; Neurodegeneration with brain iron accumulation 2B, 610217 (3), Autosomal recessive; Parkinson disease 14, autosomal recessive, 612953 (3), Autosomal recessive",Pla2g6 (MGI:1859152)
22,38201931,38216510,22q12.2-q13.2,22q13.1,604877,MAFF,"v-MAF avian musculoaponeurotic fibrosarcoma oncogene family, protein F",MAFF,23764,ENSG00000185022,NA,NA,Maff (MGI:96910)
22,38290690,38318083,22q12-q13,22q13.1,600863,CSNK1E,"Casein kinase-1, epsilon",CSNK1E,1454,ENSG00000213923,NA,NA,Csnk1e (MGI:1351660)
22,38426326,38455198,22q13.1,22q13.1,600504,"KCNJ4, HIR","Potassium inwardly-rectifying channel, subfamily J, member 4",KCNJ4,3761,ENSG00000168135,NA,NA,Kcnj4 (MGI:104743)
22,38483437,38506310,22q13.1,22q13.1,608469,"DDX17, RH70, P72",DEAD/H box-17,DDX17,10521,ENSG00000100201,NA,NA,Ddx17 (MGI:1914290)
22,38509153,38570285,22q13.1,22q13.1,602721,"DMC1, LIM15","Disrupted meiotic cDNA 1, yeast, homolog of",DMC1,11144,ENSG00000100206,NA,NA,Dmc1 (MGI:105393)
22,38656652,38673849,22q12-q13,22q13.1,607757,"CBY, C22orf2, HS508I15A",Chibby,CBY1,25776,ENSG00000100211,NA,NA,Cby1 (MGI:1920989)
22,38681956,38685420,22q12-q13,22q13.1,607046,"TOMM22, TOM22","Translocase of outer mitochondrial membrane 22, yeast, homolog of",TOMM22,56993,ENSG00000100216,NA,NA,Tomm22 (MGI:2450248)
22,38683915,38701402,22q13.1,22q13.1,615323,"JOSD1, KIAA0063",Josephin domain-containing protein 1,JOSD1,9929,ENSG00000100221,NA,NA,NA
22,38704560,38738264,22q12-q13.1,22q13.1,602245,"GTPBP1, GP1",GTP-binding protein 1,GTPBP1,9567,ENSG00000100226,NA,NA,Gtpbp1 (MGI:109443)
22,38734726,38756013,22q12-q13,22q13.1,613569,"SUN2, UNC84B, KIAA0668",SAD1 and UNC84 domain-containing protein 2,SUN2,25777,ENSG00000100242,NA,NA,Sun2 (MGI:2443011)
22,38778507,38794142,22q13.1,22q13.1,610565,"DNAL4, MRMV3","Dynein, axonemal, light chain 4",DNAL4,10126,ENSG00000100246,mutation identified in 1 MRMV3 family,"?Mirror movements 3, 616059 (3), Autosomal recessive",Dnal4 (MGI:1859217)
22,38861421,38872215,22q13.1,22q13.1,617438,CBX6,Chromobox homolog 6,CBX6,23466,ENSG00000183741,NA,NA,Cbx6 (MGI:3512628)
22,38957608,38963183,22q13,22q13.1,607109,"APOBEC3A, PHRBN","Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (phorbolin 1)",APOBEC3A,200315,ENSG00000128383,NA,NA,NA
22,38982346,38992778,22q13,22q13.1,607110,"APOBEC3B, PHRBNL","Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",APOBEC3B,9582,ENSG00000179750,NA,NA,Apobec3 (MGI:1933111)
22,39014235,39020351,22q13,22q13.1,607750,APOBEC3C,"Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3C",APOBEC3C,27350,ENSG00000244509,NA,NA,NA
22,39019080,39055971,22q12-q13.2,22q13.1,608993,APOBEC3F,"Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3F",APOBEC3F,200316,ENSG00000128394,NA,NA,NA
22,39077004,39087742,22q12-q13.2,22q13.1,607113,"APOBEC3G, MDS019, CEM15, FLJ12740","Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G",APOBEC3G,60489,ENSG00000239713,NA,NA,NA
22,39097202,39104066,22q13.1,22q13.1,610976,"APOBEC3H, ARP10","Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H",APOBEC3H,164668,ENSG00000100298,NA,NA,NA
22,39130771,39152679,22q13.1,22q13.1,608457,CBX7,Chromobox homolog 7,CBX7,23492,ENSG00000100307,NA,NA,Cbx7 (MGI:1196439)
22,39223358,39244981,22q12.3-q13.1,22q13.1,190040,"PDGFB, SIS, IBGC5","Platelet-derived growth factor, beta polypeptide (oncogene SIS)",PDGFB,5155,ENSG00000100311,fused with COL1A1 in DFSP,"Basal ganglia calcification, idiopathic, 5, 615483 (3), Autosomal dominant; Dermatofibrosarcoma protuberans, 607907 (3); Meningioma, SIS-related, 607174 (3), Autosomal dominant",Pdgfb (MGI:97528)
22,39312881,39319622,22q,22q13.1,604163,RPL3,Ribosomal protein L3,RPL3,6122,ENSG00000100316,NA,NA,Rpl3 (MGI:1351605)
22,39313818,39313910,22q13,22q13.1,611071,"SNORD83B, RNU83B","Small nucleolar RNA, C/D box, 83B",SNORD83B,116938,ENSG00000209480,NA,NA,NA
22,39315212,39315306,22q13,22q13.1,611070,"SNORD83A, RNU83A","Small nucleolar RNA, C/D box, 83A",SNORD83A,116937,ENSG00000209482,NA,NA,NA
22,39316841,39316895,22q13,22q13.1,611069,RNU86,"RNA, U86 small nucleolar",SNORD139,116936,NA,NA,NA,NA
22,39319051,39319112,22q13,22q13.1,611068,"SNORD43, RNU43","Small nucleolar RNA, C/D box, 43",SNORD43,26807,ENSG00000263764,NA,NA,NA
22,39349948,39385574,22q13,22q13.1,603925,SYNGR1,Synaptogyrin 1,SYNGR1,9145,ENSG00000100321,NA,NA,Syngr1 (MGI:1328323)
22,39399779,39437131,22q13.1,22q13.1,602615,"TAB1, MAP3K7IP1",Tak1 (MAP3K7) binding protein 1,TAB1,10454,ENSG00000100324,NA,NA,Tab1 (MGI:1913763)
22,39457011,39492193,22q13.1,22q13.1,604621,"MGAT3, GNT3","Beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase",MGAT3,4248,ENSG00000128268,NA,NA,Mgat3 (MGI:104532)
22,39500099,39518133,22q13.1,22q13.1,615497,"MEIF1, SMCR7L, MID51",Mitochondrial elongation factor 1,MIEF1,54471,ENSG00000100335,NA,NA,Mief1 (MGI:2146020)
22,39514493,39522685,22q13.1,22q13.1,604064,"ATF4, CREB2, TAXREB67",Activating transcription factor 4,ATF4,468,ENSG00000128272,NA,NA,Atf4 (MGI:88096)
22,39529092,39532854,22q13.1,22q13.1,610225,"RPS19BP1, S19BP, MGC52010",Ribosomal protein S19 binding protein 1,RPS19BP1,91582,ENSG00000187051,NA,NA,Rps19bp1 (MGI:1913788)
22,39570752,39689736,22q13.1,22q13.1,608230,"CACNA1I, KIAA1120","Calcium channel, voltage-dependent, T type, alpha-1I subunit",CACNA1I,8911,ENSG00000100346,NA,NA,Cacna1i (MGI:2178051)
22,39901072,39973720,22q12-qter,22q13.1,604518,"GRAP2, GRID",GRB2-related adaptor protein 2,GRAP2,9402,ENSG00000100351,NA,NA,Grap2 (MGI:1333842)
22,40044816,40335807,22q13.1,22q13.1,610740,"TNRC6B, KIAA1093",Trinucleotide repeat-containing gene 6B,TNRC6B,23112,ENSG00000100354,NA,NA,Tnrc6b (MGI:2443730)
22,40346499,40387488,22q13.1,22q13.1,608222,ADSL,Adenylosuccinate lyase,ADSL,158,ENSG00000239900,ade(-)I; bifunctional,"Adenylosuccinase deficiency, 103050 (3), Autosomal recessive",Adsl (MGI:103202)
22,40370561,40410288,22q13.1,22q13.1,610440,"SGSM3, RUTBC3, MAP, RUSC3",Small G protein signaling modulator 3,SGSM3,27352,ENSG00000100359,NA,NA,Sgsm3 (MGI:1916329)
22,40410288,40636718,22q13,22q13.1-q13.2,606078,"MKL1, AMKL, MAL",Megakaryoblastic leukemia 1 gene,MRTFA,57591,ENSG00000196588,fusion with RBM15,"Megakaryoblastic leukemia, acute (3)",Mrtfa (MGI:2384495)
22,40679177,40682813,22q13.3,22q13.2,601751,"MCHR1, GPR24, SLC1",Melanin-concentrating hormone receptor 1,MCHR1,2847,ENSG00000128285,NA,NA,Mchr1 (MGI:2180756)
22,40769629,40819398,22q13,22q13.2,606795,"SLC25A17, PMP34","Solute carrier family 25 (mitochondrial carrier), member 17 (peroxisomal membrane protein, 34kD)",SLC25A17,10478,ENSG00000100372,NA,NA,Slc25a17 (MGI:1342248)
22,40824534,40857007,22q13,22q13.2,606796,"ST13, P48, HOP",Suppression of tumorigenicity 13,ST13,6767,ENSG00000100380,NA,NA,St13 (MGI:1917606)
22,40857080,40932814,22q13.31-q13.33,22q13.2,613553,"XPNPEP3, APP3, NPHPL1",X-prolyl aminopeptidase 3,XPNPEP3,63929,ENSG00000196236,NA,"Nephronophthisis-like nephropathy 1, 613159 (3), Autosomal recessive",NA
22,40859548,40862112,22q13.2,22q13.2,611336,"DNAJB7, DJ5, HSC3","DNAJ/HSP40 homolog, subfamily B, member 7",DNAJB7,150353,ENSG00000172404,NA,NA,Dnajb7 (MGI:1914012)
22,40951377,40973308,22q13.2,22q13.2,603814,"RBX1, ROC1",RING-box 1,RBX1,9978,ENSG00000100387,NA,NA,Rbx1-ps (MGI:3710517)
22,41092591,41180076,22q13,22q13.2,602700,"EP300, RSTS2, MKHK2","E1A-binding protein, 300kD",EP300,2033,ENSG00000100393,NA,"Colorectal cancer, somatic, 114500 (3); Menke-Hennekam syndrome 2, 618333 (3); Rubinstein-Taybi syndrome 2, 613684 (3), Autosomal dominant",Ep300 (MGI:1276116)
22,41205191,41231270,22q13.3,22q13.2,611865,"L3MBTL2, L3MBT",L3MBT-like 2,L3MBTL2,83746,ENSG00000100395,NA,NA,L3mbtl2 (MGI:2443584)
22,41229509,41241770,22q13.2,22q13.2,616236,CHADL,Chondroadherin-like,CHADL,150356,ENSG00000100399,NA,NA,Chadl (MGI:3036284)
22,41244778,41302368,22q13.2,22q13.2,602362,RANGAP1,"GTPase-activating protein, RAN, 1",RANGAP1,5905,ENSG00000100401,NA,NA,Rangap1 (MGI:103071)
22,41301524,41360146,22q13.2,22q13.2,618206,"ZC3H7B, ROXAN1, KIAA1031",Zinc finger CCCH domain-containing protein 7B,ZC3H7B,23264,ENSG00000100403,NA,NA,Zc3h7b (MGI:1328310)
22,41367332,41399327,22q13,22q13.2,188595,TEF,Thyrotroph embryonic factor,TEF,7008,ENSG00000167074,NA,NA,Tef (MGI:98663)
22,41433491,41448229,22q13.1-q13.31,22q13.2,607396,"TOB2, KIAA1663","Transducer of erbb2, 2",TOB2,10766,ENSG00000183864,NA,NA,Tob2 (MGI:1888525)
22,41459716,41468691,22q13.2,22q13.2,617846,"PHF5A, SF3B7, SF3B14B",PHD finger protein 5A,PHF5A,84844,ENSG00000100410,NA,NA,Phf5a (MGI:2156864)
22,41468755,41528978,22q13.2,22q13.2,100850,"ACO2, ICRD, OPA9","Aconitase, mitochondrial",ACO2,50,ENSG00000100412,distal to Ph1 break; mutation identified in 1 OPA9 family,"Infantile cerebellar-retinal degeneration, 614559 (3), Autosomal recessive; ?Optic atrophy 9, 616289 (3), Autosomal recessive",Aco2 (MGI:87880)
22,41561009,41576665,22q13.2,22q13.2,617689,"CSDC2, PIPPIN",Cold-shock domain-containing protein C2,CSDC2,27254,ENSG00000172346,NA,NA,Csdc2 (MGI:2146027)
22,41576894,41589865,22q13.1,22q13.2,601786,PMM1,Phosphomannomutase 1,PMM1,5372,ENSG00000100417,NA,NA,Pmm1 (MGI:1353418)
22,41598027,41621076,22q13.2,22q13.2,614637,"DESI1, PPPDE2",Desumoylating isopeptidase 1,DESI1,27351,ENSG00000100418,NA,NA,Desi1 (MGI:106313)
22,41621162,41664047,22q11-q13,22q13.2,152690,"XRCC6, G22P1, TLAA, Ku70","X-ray repair, complementing defecting, in chinese hamster, 6",XRCC6,2547,ENSG00000196419,tight linkage to CYP2D,NA,Xrcc6 (MGI:95606)
22,41673932,41690491,22q13.2,22q13.2,601304,NHP2L1,"Non-histone chromosome protein 2, S. cerevisiae, like 1",SNU13,4809,ENSG00000100138,previously assigned to 12q24.3 by FISH,NA,Snu13 (MGI:893586)
22,41699502,41799476,22q13,22q13.2,608797,"MEI1, SPATA38, HYDM3","Mei1, mouse, homolog of",MEI1,150365,ENSG00000167077,NA,"Hydatidiform mole, recurrent, 3, 618431 (3)",Mei1 (MGI:3028590)
22,41833078,41907307,22q13,22q13.2,600481,SREBF2,Sterol regulatory element binding transcription factor 2,SREBF2,6721,ENSG00000198911,NA,NA,Srebf2 (MGI:107585)
22,41900943,41901011,22q13.2,22q13.2,612156,"MIR33A, MIRN33A",Micro RNA 33A,MIR33A,407039,ENSG00000207932,NA,NA,NA
22,41906048,41915094,22q13.2,22q13.2,617329,SHISA8,"Shisa family, member 8",SHISA8,440829,ENSG00000234965,NA,NA,Shisa8 (MGI:2146080)
22,41925031,41926816,22q13.1-q13.31,22q13.2,606269,"TNFRSF13C, BAFFR, CVID4","Tumor necrosis factor receptor superfamily, member 13C",TNFRSF13C,115650,ENSG00000159958,NA,"Immunodeficiency, common variable, 4, 613494 (3), Autosomal recessive",Tnfrsf13c (MGI:1919299)
22,41927746,41947163,22q13.31,22q13.2,610152,"PANE1, C22orf18",Proliferation-associated nuclear element 1,CENPM,79019,ENSG00000100162,NA,NA,Cenpm (MGI:1913820)
22,41969437,41998220,22q13.2,22q13.2,608314,"SEPT3, SEP3",Septin 3,SEPTIN3,55964,ENSG00000100167,NA,NA,Sept3 (MGI:1345148)
22,41995102,42059401,22q13.2,22q13.2,610981,"WBP2NL, PAWP",WWBP2 N-terminal-like protein,WBP2NL,164684,ENSG00000183066,NA,NA,Wbp2nl (MGI:1921966)
22,42058333,42070841,22q11,22q13.2,104170,NAGA,"Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)",NAGA,4668,ENSG00000198951,proximal to Ph1 break,"Kanzaki disease, 609242 (3), Autosomal recessive; Schindler disease, type I, 609241 (3), Autosomal recessive; Schindler disease, type III, 609241 (3), Autosomal recessive",Naga (MGI:1261422)
22,42074243,42079437,22q13.2,22q13.2,614240,"FAM109B, SES2, IPIP27B","Family with sequence similarity 109, member B",PHETA2,150368,ENSG00000177096,NA,NA,Pheta2 (MGI:2443609)
22,42079690,42084283,22q13.2,22q13.2,615588,"SMDT1, EMRE, C22orf32",Single-pass membrane protein with aspartate-rich tail 1,SMDT1,91689,ENSG00000183172,NA,NA,Smdt1 (MGI:1916279)
22,42085525,42090771,22q13.1,22q13.2,602138,"NDUFA6, MC1DN33",NADH-ubiquinone oxidoreductase subunit A6,NDUFA6,4700,ENSG00000184983,NA,"Mitochondrial complex I deficiency, nuclear type 33, 618253 (3), Autosomal recessive",Ndufa6 (MGI:1914380)
22,42126498,42130809,22q13.1,22q13.2,124030,"CYP2D6, CPD6, P450DB1","Cytochrome P450, subfamily IID, polypeptide 6",CYP2D6,1565,ENSG00000100197,NA,"{Codeine sensitivity}, 608902 (3), Autosomal recessive; {Debrisoquine sensitivity}, 608902 (3), Autosomal recessive",NA
22,42160012,42283926,22q13.3,22q13.2,603107,"TCF20, SPBP, AR1, DDVIBA",Transcription factor 20,TCF20,6942,ENSG00000100207,NA,"Developmental delay with variable intellectual impairment and behavioral abnormalities, 618430 (3), Autosomal dominant",Tcf20 (MGI:108399)
22,42380406,42438154,22q13.2,22q13.2,608740,"NFAM1, CNAIP",NFAT activating protein with ITAM motif 1,NFAM1,150372,ENSG00000235568,NA,NA,Nfam1 (MGI:1921289)
22,42500578,42512559,22q13.2,22q13.2,607979,SERHL,Serine hydrolase-like,SERHL,94009,ENSG00000172250,NA,NA,NA
22,42583720,42614961,22q13.2,22q13.2,611520,"POLDIP3, SKAR, PDIP46",Polymerase delta-interacting protein 3,POLDIP3,84271,ENSG00000100227,NA,NA,Poldip3 (MGI:1921076)
22,42617839,42649391,22q13.31-qter,22q13.2,613213,"CYB5R3, DIA1, B5R",Cytochrome b5 reductase 3,CYB5R3,1727,ENSG00000100243,NA,"Methemoglobinemia, type I, 250800 (3), Autosomal recessive; Methemoglobinemia, type II, 250800 (3), Autosomal recessive",NA
22,42692111,42721300,22q13.2,22q13.2,607922,"A4GALT, P1PK","Alpha 1,4-galactosyltransferase",A4GALT,53947,ENSG00000128274,NA,"[Blood group, P1Pk system, P(2) phenotype], 111400 (3); [Blood group, P1Pk system, p phenotype], 111400 (3); NOR polyagglutination syndrome, 111400 (3)",A4galt (MGI:3512453)
22,42796501,42857293,22q13.2,22q13.2,612439,ARFGAP3,ADP-ribosylation factor GTPase-activating protein 3,ARFGAP3,26286,ENSG00000242247,NA,NA,Arfgap3 (MGI:1913501)
22,42869765,43015175,22q13.2,22q13.2,604960,PACSIN2,Protein kinase C and casein kinase substrate in neurons 2,PACSIN2,11252,ENSG00000100266,NA,NA,Pacsin2 (MGI:1345153)
22,43039515,43089427,22q13.1,22q13.2,608955,"TTLL1, KIAA0173",tubulin tyrosine ligase-like protein 1,TTLL1,25809,ENSG00000100271,NA,NA,Ttll1 (MGI:2443047)
22,43110749,43129711,22q13.3,22q13.2,603392,"BIK, NBK",Bcl2-interacting killer,BIK,638,ENSG00000100290,NA,NA,Bik (MGI:1206591)
22,43132205,43143397,22q13.31,22q13.2,614479,MCAT,"Malonyl CoA:ACP acyltransferase, mitochondrial",MCAT,27349,ENSG00000100294,NA,NA,Mcat (MGI:2388651)
22,43151558,43163241,22q13.31,22q13.2,109610,"TSPO, BZRP, PBR, PBS, BPBS","Translocator protein, 18kD (benzodiazepine receptor, peripheral type)",TSPO,706,ENSG00000100300,NA,NA,Tspo (MGI:88222)
22,43197279,43343371,22q13,22q13.2,611746,SCUBE1,"Signal peptide-, CUB domain-, and EGF-like domains-containing protein 1",SCUBE1,80274,ENSG00000159307,NA,NA,Scube1 (MGI:1890616)
22,43412013,43507847,22q13.31,22q13.2,602112,"MPPED1, C22orf1, 239AB",Metallophosphoesterase domain-containing protein 1,MPPED1,758,ENSG00000186732,NA,NA,Mpped1 (MGI:106316)
22,43824508,43862512,22q13.31,22q13.31,608359,"SULT4A1, BRSTL1","Sulfotransferase family 4A, member 1",SULT4A1,25830,ENSG00000130540,NA,NA,Sult4a1 (MGI:1888971)
22,43879677,43892012,22q13.31,22q13.31,611589,"PNPLA5, GS2L",Patatin-like phospholipase domain-containing 5,PNPLA5,150379,ENSG00000100341,NA,NA,Pnpla5 (MGI:1923022)
22,43923804,43947581,22q13,22q13.31,609567,"PNPLA3, ADPN",Patatin-like phospholipase domain-containing protein 3,PNPLA3,80339,ENSG00000100344,NA,NA,Pnpla3 (MGI:2151796)
22,43955441,43996528,22q13.31,22q13.31,612058,"SAMM50, SAM50","Sorting and assembly machinery component 50, S. cerevisiae, homolog of",SAMM50,25813,ENSG00000100347,NA,NA,Samm50 (MGI:1915903)
22,43999163,44169232,22q13.31,22q13.31,608121,PARVB,"Parvin, beta",PARVB,29780,ENSG00000188677,NA,NA,Parvb (MGI:2153063)
22,44170227,44208468,22q13.31,22q13.31,608122,PARVG,"Parvin, gamma",PARVG,64098,ENSG00000138964,NA,NA,Parvg (MGI:2158329)
22,44668546,44737680,22q13.31,22q13.31,609406,"PRR5, PP610",Proline-rich protein 5,PRR5,55615,ENSG00000186654,NA,NA,Prr5 (MGI:1924714)
22,44752557,44862783,22q13.31,22q13.31,609405,"ARHGAP8, BPGAP1","GTPase-activating protein, RHO, 8",ARHGAP8,23779,ENSG00000241484,NA,NA,Arhgap8 (MGI:1920417)
22,44881161,45010004,22q13.31,22q13.31,616727,"PHF21B, PHF4, BHC80L",PHD finger protein 21B,PHF21B,112885,ENSG00000056487,NA,NA,Phf21b (MGI:2443812)
22,45163924,45188016,22q13.3,22q13.31,604646,"NUP50, NPAP60L, NPAP60","Nucleoporin, 50 kD",NUP50,10762,ENSG00000093000,NA,NA,Nup50 (MGI:1351502)
22,45284948,45295873,22q13.31,22q13.31,611559,"UPK3A, UPK3, UPIII",Uroplakin 3A,UPK3A,7380,ENSG00000100373,NA,NA,Upk3a (MGI:98914)
22,45502882,45601134,22q13.3,22q13.31,135820,FBLN1,Fibulin 1,FBLN1,2192,ENSG00000077942,NA,"Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4), Autosomal dominant",Fbln1 (MGI:95487)
22,45671797,45845306,22q13,22q13.31,611150,"ATXN10, SCA10",Ataxin 10,ATXN10,25814,ENSG00000130638,ATTCTn repeat in intron 9,"Spinocerebellar ataxia 10, 603516 (3), Autosomal dominant",Atxn10 (MGI:1859293)
22,45920361,45977161,22q13,22q13.31,601967,WNT7B,"Wingless-type MMTV integration site family, member-7B",WNT7B,7477,ENSG00000188064,NA,NA,Wnt7b (MGI:98962)
22,46085996,46113927,22q13.31,22q13.31,618216,"MIRLET7BHG, LINC-PPARA","MIRLET7B host gene, noncoding",MIRLET7BHG,400931,ENSG00000197182,NA,NA,NA
22,46112748,46112821,22q13.31,22q13.31,612143,"MIRLET7A3, LET7A3, MIRNLET7A3",Micro RNA let7a3,MIRLET7A3,406883,ENSG00000283990,NA,NA,NA
22,46113685,46113767,22q13,22q13.31,611249,"MIRLET7B, LET7B, MIRNLET7B",Micro RNA Let7B,MIRLET7B,406884,ENSG00000284520,NA,NA,NA
22,46150525,46243755,22q12-q13.1,22q13.31,170998,"PPARA, PPAR",Peroxisome proliferator-activated receptor-alpha,PPARA,5465,ENSG00000186951,NA,"{Hyperapobetalipoproteinemia, susceptibility to} (3)",Ppara (MGI:104740)
22,46255662,46263342,22q13.3,22q13.31,604670,PKDREJ,Polycystic kidney disease and sea urchin REJ homolog-like,PKDREJ,10343,ENSG00000130943,NA,NA,Pkdrej (MGI:1338786)
22,46335400,46357339,22q13,22q13.31,610230,"TRMU, MTO2",tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase,TRMU,55687,ENSG00000100416,NA,"{Deafness, mitochondrial, modifier of}, 580000 (3), Mitochondrial; Liver failure, transient infantile, 613070 (3), Autosomal recessive",Trmu (MGI:1919276)
22,46360833,46537619,22q13.3,22q13.31,604523,CELSR1,Cadherin EGF LAG seven-pass G-type receptor 1,CELSR1,9620,ENSG00000075275,NA,NA,Celsr1 (MGI:1100883)
22,46576016,46682755,22q13.31,22q13.31,613691,"GRAMD4, KIAA0767, DIP",Gram domain-containing protein 4,GRAMD4,23151,ENSG00000075240,NA,NA,Gramd4 (MGI:2676308)
22,46684409,46738251,22q13,22q13.31,610307,"CERK, KIAA1646",Ceramide kinase,CERK,64781,ENSG00000100422,NA,NA,Cerk (MGI:2386052)
22,46762616,47224974,22q13.31,22q13.31,616879,"TBC1D22A, C22orf4","TBC1 domain family, member 22A",TBC1D22A,25771,ENSG00000054611,NA,NA,Tbc1d22a (MGI:1289265)
22,48489552,48751931,22q13.32,22q13.32,617499,"FAM19A5, TAFA5","Family with sequence similarity 19, member A5, CC motif chemokine-like",TAFA5,25817,ENSG00000219438,NA,NA,Tafa5 (MGI:2146182)
22,49773277,49827872,22q13,22q13.33,604589,BRL,BR140-like gene,BRD1,23774,ENSG00000100425,NA,NA,Brd1 (MGI:1924161)
22,49853843,49890079,22q13.33,22q13.33,612552,"ZBED4, KIAA0637",Zinc finger BED domain-containing protein 4,ZBED4,9889,ENSG00000100426,NA,NA,NA
22,49860162,49918468,22q13.33,22q13.33,607144,"ALG12, CDG1G",Dolichyl-P-mannose:Man-7-GlcNAc-2-PP-dolichyl-alpha-6- mannosyltransferase,ALG12,79087,ENSG00000182858,NA,"Congenital disorder of glycosylation, type Ig, 607143 (3), Autosomal recessive",Alg12 (MGI:2385025)
22,49960771,49964071,22q13.33,22q13.33,610580,PIM3,Oncogene PIM3,PIM3,415116,ENSG00000198355,NA,NA,Pim3 (MGI:1355297)
22,49993577,50013826,22q13,22q13.33,613414,IL17REL,Interleukin 17 receptor E-like,IL17REL,400935,ENSG00000188263,NA,NA,NA
22,50059390,50085928,22q13.33,22q13.33,605908,"MLC1, LVM, VL",MLC1 gene,MLC1,23209,ENSG00000100427,NA,"Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3), Autosomal recessive",Mlc1 (MGI:2157910)
22,50090005,50161704,22q13.33,22q13.33,605794,MOV10L1,Mov10-like 1,MOV10L1,54456,ENSG00000073146,NA,NA,Mov10l1 (MGI:1891384)
22,50170730,50180294,22q13,22q13.33,608421,"PANX2, PX2",Pannexin 2,PANX2,56666,ENSG00000073150,NA,NA,Panx2 (MGI:1890615)
22,50201010,50217615,22q13.33,22q13.33,607917,"SELENOO, SELO",Selenoprotein O,SELENOO,83642,ENSG00000073169,NA,NA,Selenoo (MGI:1919007)
22,50217693,50245027,22q13.33,22q13.33,610053,"TUBGCP6, GCP6, KIAA1669, MCCRP1",Tubulin-gamma complex-associated protein 6,TUBGCP6,85378,ENSG00000128159,NA,"Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3), Autosomal recessive",Tubgcp6 (MGI:2146071)
22,50252900,50261809,22q13.3,22q13.33,602399,"MAPK12, SAPK3, ERK3",Mitogen-activated protein kinase 12 (Stress-activated protein kinase-3),MAPK12,6300,ENSG00000188130,NA,NA,Mapk12 (MGI:1353438)
22,50274978,50307645,22q13.31-q13.33,22q13.33,604293,"PLXNB2, MM1",Plexin B2,PLXNB2,23654,ENSG00000196576,NA,NA,Plxnb2 (MGI:2154239)
22,50343326,50445089,22q13.33,22q13.33,610877,"SAPS2, PP6R2, KIAA0685","SAPS domain family, member 2",PPP6R2,9701,ENSG00000100239,NA,NA,Ppp6r2 (MGI:1918724)
22,50444999,50475034,22q13.33,22q13.33,603560,"SBF1, MTMR5, CMT4B3",SET-binding factor 1 (myotubularin-related protein 5),SBF1,6305,ENSG00000100241,NA,"Charcot-Marie-Tooth disease, type 4B3, 615284 (3), Autosomal recessive",Sbf1 (MGI:1925230)
22,50483987,50490647,22q13.33,22q13.33,606774,"MIOX, ALDRL6",Myoinositol oxygenase,MIOX,55586,ENSG00000100253,NA,NA,Miox (MGI:1891725)
22,50508215,50524779,22q13.33,22q13.33,611230,"NCAPH2, CAPH2",Non-SMC condensin II complex subunit H2,NCAPH2,29781,ENSG00000025770,NA,NA,Ncaph2 (MGI:1289164)
22,50523567,50526438,22q13,22q13.33,604272,"SCO2, CEMCOX1, MYP6",SCO2 cytochrome c oxidase assembly protein,SCO2,9997,ENSG00000284194,NA,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 (3), Autosomal recessive; Myopia 6, 608908 (3), Autosomal dominant",Sco2 (MGI:3818630)
22,50525751,50530084,22q13.32-qter,22q13.33,131222,"TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1",Thymidine phosphorylase,TYMP,1890,ENSG00000025708,NA,"Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3), Autosomal recessive",Tymp (MGI:1920212)
22,50551111,50562918,22q13.33,22q13.33,615775,SYCE3,Synaptonemal complex central element protein 3,SYCE3,644186,ENSG00000217442,NA,NA,Syce3 (MGI:1922709)
22,50568860,50578611,22q13,22q13.33,601987,CPT1B,"Carnitine palmitoyltransferase I, muscle",CPT1B,1375,ENSG00000205560,NA,NA,Cpt1b (MGI:1098297)
22,50578957,50582998,22q13,22q13.33,612395,"CHKB, CHKL, CKEKB, EKB, MDCMC","Choline kinase, beta",CHKB,1120,ENSG00000100288,NA,"Muscular dystrophy, congenital, megaconial type, 602541 (3), Autosomal recessive",Chkb (MGI:1328313)
22,50600792,50613977,22q13,22q13.33,607755,"MAPK8IP2, JIP2, IB2",Mitogen-activated protein kinase 8-interacting protein 2,MAPK8IP2,23542,ENSG00000008735,NA,NA,Mapk8ip2 (MGI:1926555)
22,50622753,50628151,22q13.31-qter,22q13.33,607574,ARSA,Arylsulfatase A,ARSA,410,ENSG00000100299,NA,"Metachromatic leukodystrophy, 250100 (3), Autosomal recessive",Arsa (MGI:88077)
22,50674641,50733211,22q13.3,22q13.33,606230,"SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15",SH3 and multiple ankyrin repeat domains 3,SHANK3,85358,ENSG00000251322,NA,"Phelan-McDermid syndrome, 606232 (3), Autosomal dominant; {Schizophrenia 15}, 613950 (3), Autosomal dominant",Shank3 (MGI:1930016)
22,50738203,50745338,22q13.33,22q13.33,102480,ACR,Acrosin,ACR,49,ENSG00000100312,NA,"?Male infertility due to acrosin deficiency, 102480 (2)",Acr (MGI:87884)
22,50767499,50783704,22q13.3,22q13.33,605413,RABL2B,RAB-like 2B,RABL2B,11158,ENSG00000079974,NA,NA,NA
22,0,50818468,Chr.22,NA,107260,MSK41,Antigen MSK41 identified by monoclonal antibody E3,NA,NA,NA,NA,NA,NA
X,0,24900000,Xp22,NA,304050,AIC,Aicardi syndrome,AIC,192,NA,?in p22.31 with FDH as contiguous gene syndrome,"Aicardi syndrome, 304050 (2), X-linked dominant",NA
X,0,24900000,Xp22,NA,300870,ANIB5,"Aneurysm, intracranial berry, 5",NA,NA,NA,NA,"Aneurysm, intracranial berry, 5, 300870 (2)",NA
X,0,6100000,Xpter-p22.32,NA,301780,ARSC2,"Arylsulfatase C, f form",ARSC2,413,NA,"probably close to STS = ARSC1, or s form",NA,NA
X,0,9600000,Xp22.3,NA,300211,EMWX,"Episodic muscle weakness, X-linked",EMWX,10118,NA,NA,"Episodic muscle weakness, X-linked, 300211 (2)",NA
X,0,9600000,Xp22.3,NA,300406,FGS3,FG syndrome 3,FGS3,93985,NA,NA,"FG syndrome 3, 300406 (2)",NA
X,0,6100000,Xpter-p22.32,NA,300221,HDPA,"Hodgkin disease, susceptibility, pseudoautosomal",NA,50829,NA,NA,"{Hodgkin disease susceptibility, pseudoautosomal}, 300221 (2)",NA
X,0,9600000,Xp22.3,NA,300778,LECD,"Corneal dystrophy, Lisch epithelial",NA,100302509,NA,max lod between DXYS233 and DXYS228X,"Corneal dystrophy, Lisch epithelial, 300778 (2), X-linked dominant",NA
X,0,24900000,Xp22,NA,300273,MNG2,Multinodular goiter-2,NA,59081,NA,NA,"Goiter, multinodular, 2, 300273 (2), X-linked dominant",NA
X,0,9600000,Xp22.3,NA,300428,MRX2,"Mental retardation, X-linked, 2",NA,NA,NA,NA,"Mental retardation, X-linked 2, 300428 (2), X-linked",NA
X,0,9600000,Xp22.3,NA,300650,OASD,Ocular albinism and sensorineural deafness,OASD,4941,NA,?allelic to OA1,"Ocular albinism with sensorineural deafness, 300650 (2), X-linked",NA
X,0,4400000,Xp22.33,NA,313000,VSPA,Visuospatial/perceptual abilities,NA,59332,NA,NA,"Turner syndrome-associated neurocognitive phenotype, 313000 (2), ?X-linked recessive; [Visuospatial/perceptual abilities], 313000 (2), ?X-linked recessive",NA
X,0,6100000,Xpter-p22.32,NA,314700,XG,Xg blood group,NA,NA,NA,nonlyonizing; spans pseudoautosomal boundary; XGPY on Yq11.21,"[Blood group, XG system] (3)",NA
X,276355,303355,Xp22.33,Xp22.33,300974,PLCXD1,"Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 1",PLCXD1,55344,ENSG00000182378,in pseudoautosomal region,NA,NA
X,303351,318818,Xp22.33,Xp22.33,300124,"GTPBP6, PGPL",GTP-binding protein 6,GTPBP6,8225,ENSG00000178605,NA,NA,Gtpbp6 (MGI:1306825)
X,333932,387326,Xp22.33,Xp22.33,300339,"PPP2R3B, PR48","Protein phosphatase 2, regulatory subunit B-double prime, beta",PPP2R3B,28227,ENSG00000167393,NA,NA,NA
X,624343,659410,Xpter-p22.32,Xp22.33,312865,"SHOX, GCFX, SS, PHOG",Short stature homeo box,SHOX,6473,ENSG00000185960,pseudoautosomal; ?gene causing short stature in Turner syndrome,"Langer mesomelic dysplasia, 249700 (3); Leri-Weill dyschondrosteosis, 127300 (3); Short stature, idiopathic familial, 300582 (3)",NA
X,1190436,1212761,Xp22.3,Xp22.33,300357,"CRLF2, CRL2",Cytokine receptor-like factor 2,CRLF2,64109,ENSG00000205755,pseudoautosomal,NA,Crlf2 (MGI:1889506)
X,1268799,1325096,Xp22.32,Xp22.33,306250,"CSF2RA, SMDP4","Colony-stimulating factor-2 receptor, alpha, low-affinity, granulocyte-macrophage",CSF2RA,1438,ENSG00000198223,order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen,"Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)",NA
X,1336573,1382688,Xp22.3,Xp22.33,308385,IL3RA,"Interleukin-3 receptor, alpha subunit",IL3RA,3563,ENSG00000185291,same 190kb segment as CSF2RA,NA,Il3ra (MGI:96553)
X,1386151,1392112,Xp22.32,Xp22.33,300151,"SLC25A6, ANT3","Solute carrier family 25 (mitochondrial carrier), member 6 (adenine nucleotide translocator-3, liver)",SLC25A6,293,ENSG00000169100,1st intron ~1.3Mb from Xqter; nonlyonized,NA,NA
X,1403138,1453793,Xpter-p22.32,Xp22.33,300162,"ASMTLX, ASTML",Acetylserotonin methyltransferase-like,ASMTL,8623,ENSG00000169093,NA,NA,NA
X,1462575,1537487,Xp22.3,Xp22.33,300525,"P2RY8, P2Y8","Pyrimidinergic receptor P2Y, G protein-coupled, 8",P2RY8,286530,ENSG00000182162,NA,NA,NA
X,1591592,1602519,Xp22.32,Xp22.33,312095,"AKAP17A, SFRS17A, DXYS155E, XE7",A kinase (PRKA) anchor protein 17A,AKAP17A,8227,ENSG00000197976,nonlyonizing,NA,NA
X,1595454,1643080,Xpter-p22.32,Xp22.33,300015,"ASMT, HIOMT",Acetylserotonin methyltransferase,ASMT,438,ENSG00000196433,pseudoautosomal,NA,NA
X,2486413,2500975,Xp22.33,Xp22.33,300178,"ZBED1, ALTE, KIAA0785, TRAMP",Zinc finger BED domain-containing protein 1,ZBED1,9189,ENSG00000214717,NA,NA,NA
X,2691132,2741308,Xpter-p22.32,Xp22.33,313470,"CD99, MIC2, MIC2X",CD99 antigen (MIC2 (monoclonal antibody 12E7)),CD99,4267,ENSG00000002586,distal to STS,NA,NA
X,2751103,2816499,Xp22.33,Xp22.33,300879,"XG, PBDX",XG glycoprotein,XG,7499,ENSG00000124343,NA,NA,NA
X,2828711,2882819,Xp22.3,Xp22.33,300198,"GYG2, GN2",Glycogenin 2,GYG2,8908,ENSG00000056998,NA,NA,NA
X,2903971,2929344,Xp22.3,Xp22.33,300002,ARSD,Arylsulfatase D,ARSD,414,ENSG00000006756,NA,NA,NA
X,2934631,2968311,Xp22.3,Xp22.33,300180,"ARSE, CDPX1, CDPXR",Arylsulfatase E,ARSE,415,ENSG00000157399,CDPX1 in contiguous gene syndrome with STS,"Chondrodysplasia punctata, X-linked recessive, 302950 (3), X-linked recessive",NA
X,3006612,3033384,Xp22.3,Xp22.33,300586,ARSH,Arylsulfatase H,ARSH,347527,ENSG00000205667,NA,NA,NA
X,3040233,3112728,Xp22.3,Xp22.33,300003,ARSF,Arylsulfatase F,ARSF,416,ENSG00000062096,NA,NA,NA
X,3308564,3346651,Xp22.33,Xp22.33,300938,MXRA5,Matrix remodeling-associated protein 5,MXRA5,25878,ENSG00000101825,NA,NA,NA
X,3604339,3713648,Xp22.3,Xp22.33,300083,PRKX,"Protein kinase, X-linked",PRKX,5613,ENSG00000183943,NA,NA,Prkx (MGI:1309999)
X,4400000,6100000,Xp22.32,NA,314705,XGR,XG/MIC2 regulator,XGR,7501,NA,?between XG and MIC2,NA,NA
X,5890025,6228877,Xp22.33,Xp22.32-p22.31,300427,"NLGN4, KIAA1260, AUTSX2, ASPGX2",Neuroligin 4,NLGN4X,57502,ENSG00000146938,NA,"{Asperger syndrome susceptibility, X-linked 2}, 300497 (3), X-linked; {Autism susceptibility, X-linked 2}, 300495 (3), Isolated cases, X-linked, Multifactorial; Mental retardation, X-linked, 300495 (3), Isolated cases, X-linked, Multifactorial",NA
X,6533617,6535117,Xp22.3,Xp22.31,300533,"VCX3A, VCX8R, VCXA","Variably charged, X chromosome, 3A",VCX3A,51481,ENSG00000169059,NA,NA,NA
X,6768839,7148152,Xp22.32,Xp22.31,306480,"HDHD1A, DXF68S1E, GS1",Haloacid dehalogenase-like hydrolase domain-containing 1A,PUDP,8226,ENSG00000130021,escapes X-inactivation; 100kb telomeric to STS,NA,Pudp (MGI:1914615)
X,7147289,7354809,Xp22.32,Xp22.31,300747,"STS, ARSC1, ARSC, SSDD, XLI","Steroid sulfatase, microsomal (arylsulfatase C, isozyme S)",STS,412,ENSG00000101846,nonlyonizing,"Ichthyosis, X-linked, 308100 (3), X-linked recessive",NA
X,7842261,7844142,Xp22.3,Xp22.31,300229,"VCX, VCXB1, VCX10R","Variably charged, X chromosome",VCX,26609,ENSG00000182583,NA,NA,NA
X,7898246,7928586,Xp22.3,Xp22.31,300102,DXS1283E,GS2 gene,PNPLA4,8228,ENSG00000006757,NA,NA,NA
X,8169943,8171266,Xp22.3,Xp22.31,300532,"VCX2, VCX2R, VCXB","Variably charged, X chromosome, 2",VCX2,51480,ENSG00000177504,NA,NA,NA
X,8464829,8466509,Xp22.31,Xp22.31,300981,"VCS3B, VCXC","Variably charged, X chromosome, 3B",VCX3B,425054,ENSG00000205642,NA,NA,NA
X,8528873,8732136,Xp22.3,Xp22.31,300836,"KAL1, KMS, ADMLX, HH1",Kallmann syndrome-1 sequence (anosmin-1),ANOS1,3730,ENSG00000011201,with ichthyosis in probable microdeletion syndrome,"Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3), X-linked recessive",NA
X,8790794,8801382,Xp22.33-p22.32,Xp22.31,300477,FAM9A,"Family with sequence similarity 9, member A",FAM9A,171482,ENSG00000183304,"pseudogene on Xq28, Yp11.31, 1p36.12, 8p11.1",NA,NA
X,9024231,9034126,Xp22.32,Xp22.31,300478,FAM9B,"Family with sequence similarity 9, member B",FAM9B,171483,ENSG00000177138,NA,NA,NA
X,9463294,9719739,Xp22.3,Xp22.3-p22.2,300196,"TBL1X, TBL1","Transducin-beta-like 1, X-linked",TBL1X,6907,ENSG00000101849,NA,NA,Tbl1x (MGI:1336172)
X,9600000,17400000,Xp22.2,NA,302801,CMTX2,"Charcot-Marie-Tooth disease, X-linked recessive, 2",CMTX2,1253,NA,NA,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 2, 302801 (2), X-linked recessive",NA
X,9600000,17400000,Xp22.2,NA,305435,"HBFQTL3, FCP1, FCPX, FCP",Fetal hemoglobin quantitative trait locus 3,FCP1,2221,NA,NA,"Fetal hemoglobin quantitative trait locus 3, 305435 (2), X-linked",NA
X,9600000,17400000,Xp22.2,NA,300355,MRX73,"Mental retardation, X-linked 73",MRX73,23694,NA,between DXS8019 and DXS365,"Mental retardation, X-linked 73, 300355 (2), X-linked recessive",NA
X,9725345,9786259,Xp22.3,Xp22.2,300808,"GPR143, OA1, NYS6",G protein-coupled receptor 143,GPR143,4935,ENSG00000101850,linked to XG,"Nystagmus 6, congenital, X-linked, 300814 (3); Ocular albinism, type I, Nettleship-Falls type, 300500 (3), X-linked",Gpr143 (MGI:107193)
X,9786405,9949442,Xp22.3,Xp22.2,300103,"SHROOM2, APXL",Shroom family member 2,SHROOM2,357,ENSG00000146950,NA,NA,Shroom2 (MGI:107194)
X,10156944,10237659,Xp22.3,Xp22.2,302910,"CLCN4, MRX49, MRX15, MRXSRC",Chloride channel-4,CLCN4,1183,ENSG00000073464,NA,"Raynaud-Claes syndrome, 300114 (3), X-linked dominant",Clcn4 (MGI:104571)
X,10445309,10833682,Xp22,Xp22.2,300552,"MID1, OGS1, BBBG1, FXY, OSX",Midline-1,MID1,4281,ENSG00000101871,type II defect on chr.22,"Opitz GBBB syndrome, type I, 300000 (3), X-linked recessive",Mid1 (MGI:1100537)
X,11111331,11123085,Xp22,Xp22.2,300056,"HCCS, MCOPS7, LSDMCA1",Holocytochrome c synthase (cytochrome c heme-lyase),HCCS,3052,ENSG00000004961,NA,"Linear skin defects with multiple congenital anomalies 1, 309801 (3), X-linked dominant",Hccs (MGI:106911)
X,11137542,11665919,Xp22.3,Xp22.2,300118,ARHGAP6,Rho GTPase-activating protein-6,ARHGAP6,395,ENSG00000047648,NA,NA,Arhgap6 (MGI:1196332)
X,11293412,11304148,Xp22.3-p22.1,Xp22.2,300391,"AMELX, AMG, AIH1, AMGX, AI1E",Amelogenin,AMELX,265,ENSG00000125363,also Y,"Amelogenesis imperfecta, type 1E, 301200 (3), X-linked dominant",NA
X,11758158,11775771,Xp22.3,Xp22.2,300609,MSL3L1,Male-specific lethal 3-like 1,MSL3,10943,ENSG00000005302,NA,NA,Msl3 (MGI:1341851)
X,11822438,12724522,Xp22.2,Xp22.2,300838,"FRMPD4, PRESO, KIAA0316, MRX104",FERM and PDZ domains-containing protein 4,FRMPD4,9758,ENSG00000169933,NA,"Mental retardation, X-linked 104, 300983 (3), X-linked",Frmpd4 (MGI:3042378)
X,12791354,12824226,Xp22.3-p22.2,Xp22.2,311860,PRPS2,Phosphoribosyl pyrophosphate synthetase-2,PRPS2,5634,ENSG00000101911,between STS and ZFX,NA,Prps2 (MGI:97776)
X,12867071,12890360,Xp22.3-p22.2,Xp22.2,300365,TLR7,Toll-like receptor 7,TLR7,51284,ENSG00000196664,centromeric to TLR8,NA,Tlr7 (MGI:2176882)
X,12906619,12923168,Xp22.3-p22.2,Xp22.2,300366,TLR8,Toll-like receptor 8,TLR8,51311,ENSG00000101916,16kb telomeric to TLR7,NA,Tlr8 (MGI:2176887)
X,12975109,12977222,Xq21.3-q22,Xp22.2,300159,"TMSB4X, TMSB4, TB4X, PTMB4","Thymosin, beta-4, X chromosome",TMSB4X,7114,ENSG00000205542,NA,NA,NA
X,13035616,13044792,Xp22.31,Xp22.2,300479,FAM9C,"Family with sequence similarity 9, member C",FAM9C,171484,ENSG00000187268,NA,NA,NA
X,13318646,13320398,Xp22.2,Xp22.2,300920,ATXN3L,Ataxin 3-like,ATXN3L,92552,ENSG00000123594,NA,NA,NA
X,13569600,13633574,Xp22,Xp22.2,300239,EGFL6,Epidermal growth factor-like 6,EGFL6,25975,ENSG00000198759,NA,NA,Egfl6 (MGI:1858599)
X,13689120,13710503,Xp22.2,Xp22.2,300284,RAB9,RAS-associated protein RAB9,RAB9A,9367,ENSG00000123595,NA,NA,Rab9 (MGI:1890695)
X,13712241,13734634,Xp22.2-p22.1,Xp22.2,300202,"TRAPPC2, SEDL, SEDT",Trafficking protein particle complex 2 (sedlin),TRAPPC2,6399,ENSG00000196459,NA,"Spondyloepiphyseal dysplasia tarda, 313400 (3), X-linked recessive",Trappc2 (MGI:1913476)
X,13734712,13773977,Xp22.3-p22.2,Xp22.2,300170,"OFD1, CXorf5, SGBS2, JBTS10, RP23",OFD1 protein,OFD1,8481,ENSG00000046651,mutation identified in 1 RP23 family,"Joubert syndrome 10, 300804 (3), X-linked recessive; Orofaciodigital syndrome I, 311200 (3), X-linked dominant; ?Retinitis pigmentosa 23, 300424 (3), X-linked recessive; Simpson-Golabi-Behmel syndrome, type 2, 300209 (3), X-linked recessive",Ofd1 (MGI:1350328)
X,13770921,13938823,Xp22.2,Xp22.2,300051,"GPM6B, M6B",Glycoprotein M6B,GPM6B,2824,ENSG00000046653,NA,NA,Gpm6b (MGI:107672)
X,14002493,14029917,Xp22.2,Xp22.2,300962,"GEMIN8, FAM51A1",GEM-associated protein 8,GEMIN8,54960,ENSG00000046647,NA,NA,Gemin8 (MGI:2384300)
X,14529297,14731811,Xp22.1-p21.2,Xp22.2,305990,GLRA2,"Glycine receptor, alpha-2 polypeptide",GLRA2,2742,ENSG00000101958,NA,NA,Glra2 (MGI:95748)
X,14690862,14873254,Xp22.31,Xp22.2,300515,"FANCB, FAAP95, FAAP90, FLJ34064","Fanconi anemia, complementation group B gene",FANCB,2187,ENSG00000181544,NA,"Fanconi anemia, complementation group B, 300514 (3), X-linked recessive",Fancb (MGI:2448558)
X,15243986,15270475,Xp22.2,Xp22.2,300890,ASB9,Ankyrin repeat- and SOCS box-containing protein 9,ASB9,140462,ENSG00000102048,NA,NA,Asb9 (MGI:1916549)
X,15281696,15315639,Xp22.31,Xp22.2,300626,ASB11,Ankyrin repeat- and SOCS box-containing protein 11,ASB11,140456,ENSG00000165192,NA,NA,Asb11 (MGI:1916104)
X,15319450,15335553,Xp22.1,Xp22.2,311770,"PIGA, PNH1, MCAHS2","Phosphatidylinositol glycan, class A",PIGA,5277,ENSG00000165195,pseudogene on chr.12,"Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3), X-linked recessive; Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3)",Piga (MGI:99461)
X,15345595,15384412,Xp22.31,Xp22.2,300091,"FIGF, VEGFD",c-fos induced growth factor (vascular endothelial growth factor D),VEGFD,2277,ENSG00000165197,NA,NA,Vegfd (MGI:108037)
X,15384798,15493587,Xp22.2,Xp22.2,300931,PIR,Pirin,PIR,8544,ENSG00000087842,NA,NA,Pir (MGI:1916906)
X,15494519,15602068,Xp22,Xp22.2,300335,"ACE2, ACEH",Angiotensin I converting enzyme 2,ACE2,59272,ENSG00000130234,NA,NA,Ace2 (MGI:1917258)
X,15500776,15556518,Xp22.2,Xp22.2,300101,BMX,BMX non-receptor tyrosine kinase,BMX,660,ENSG00000102010,NA,NA,Bmx (MGI:1101778)
X,15627317,15675623,Xp22,Xp22.2,300631,"TMEM27, NX17",Transmembrane protein 27 (collectrin),CLTRN,57393,ENSG00000147003,NA,NA,Cltrn (MGI:1926234)
X,15738269,15788410,Xp22.1,Xp22.2,300230,CA5B,"Carbonic anhydrase VB, mitochondrial",CA5B,11238,ENSG00000169239,NA,NA,Car5b (MGI:1926249)
X,15785715,15787588,Xp22.2,Xp22.2,300165,INE2,Inactivation escape 2,INE2,8551,ENSG00000281371,NA,NA,NA
X,15790450,15826806,Xp22.1,Xp22.2,300028,"ZRSR2, U2AF1RS2","Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 2",ZRSR2,8233,ENSG00000169249,NA,NA,Zrsr2 (MGI:103287)
X,15825805,15854965,Xp22,Xp22.2,300629,"AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS","Adaptor-related protein complex 1, sigma-2 subunit",AP1S2,8905,ENSG00000182287,NA,"Mental retardation, X-linked syndromic 5, 304340 (3), X-linked recessive",Ap1s2 (MGI:1889383)
X,16123564,16153517,Xp22.3-p21.2,Xp22.2,305670,GRPR,Gastrin-releasing peptide receptor,GRPR,2925,ENSG00000126010,NA,NA,Grpr (MGI:95836)
X,16167480,16172393,Xp21.3,Xp22.2,300763,MAGEB17,"Melanoma antigen, family B, 17",MAGEB17,645864,ENSG00000182798,NA,NA,"Gm5071,Gm5072 (MGI:3645128,MGI:3643982)"
X,16587998,16712916,Xp22,Xp22.2,300380,CTPS2,Cytidine 5-prime triphosphate synthetase 2,CTPS2,56474,ENSG00000047230,NA,NA,Ctps2 (MGI:1933185)
X,16649786,16654673,Xp,Xp22.2,302020,"CALB3, CABP9K",Calbindin 3 (vitamin D-dependent calcium-binding protein),S100G,795,ENSG00000169906,NA,NA,S100g (MGI:104528)
X,16786431,16844518,Xp22.1,Xp22.2,300677,"CXorf15, FIAT",Chromosome X open reading frame 15,TXLNG,55787,ENSG00000086712,NA,NA,Txlng (MGI:3590652)
X,16844340,16870361,Xp22.2,Xp22.2,300825,RBBP7,Retinoblastoma-binding protein 7,RBBP7,5931,ENSG00000102054,NA,NA,Rbbp7 (MGI:1194910)
X,16946657,17220723,Chr.X,Xp22.2,300317,"REPS2, POB1",RALBP1-associated EPS domain-containing protein 2,REPS2,9185,ENSG00000169891,NA,NA,Reps2 (MGI:2663511)
X,17375199,17735993,Xp22.13,Xp22.2-p22.1,300457,"NHS, CXN, CTRCT40",NHS gene,NHS,4810,ENSG00000188158,NA,"Cataract 40, X-linked, 302200 (3), X-linked; Nance-Horan syndrome, 302350 (3), X-linked dominant",Nhs (MGI:2684894)
X,17737448,17754987,Xp22.2-p22.1,Xp22.13,300227,SCML1,"Sex comb on midleg, Drosophila, homolog-like 1",SCML1,6322,ENSG00000047634,NA,NA,NA
X,17800048,17861345,Xp22,Xp22.13,300217,RAI2,Retinoic acid-induced 2,RAI2,10742,ENSG00000131831,NA,NA,Rai2 (MGI:1344378)
X,18239312,18355088,Xp22,Xp22.13,300208,SCML2,"Sex comb on midleg, Drosophila, homolog-like 2",SCML2,10389,ENSG00000102098,NA,NA,NA
X,18425604,18653628,Xp22,Xp22.13,300203,"CDKL5, STK9, ISSX, EIEE2",Cyclin-dependent kinase-like 5 (serine/threonine protein kinase 9),CDKL5,6792,ENSG00000008086,NA,"Epileptic encephalopathy, early infantile, 2, 300672 (3), X-linked dominant",Cdkl5 (MGI:1278336)
X,18639687,18672102,Xp22.2-p22.1,Xp22.13,300839,"RS1, XLRS1",Retinoschisin,RS1,6247,ENSG00000102104,25cM from XG,"Retinoschisis, 312700 (3), X-linked recessive",Rs1 (MGI:1336189)
X,18675908,18827920,Xp22.2-p22.1,Xp22.13,300109,PPEF1,"Protein phosphatase, EF hand calcium-binding domain 1",PPEF1,5475,ENSG00000086717,NA,NA,Ppef1 (MGI:1097157)
X,18892297,18984113,Xp22.2-p22.1,Xp22.13,300798,"PHKA2, PHK, XLG, PYKL, GSD9A","Phosphorylase kinase, liver, alpha-2 subunit",PHKA2,5256,ENSG00000044446,NA,"Glycogen storage disease, type IXa1, 306000 (3), X-linked recessive; Glycogen storage disease, type IXa2, 306000 (3), X-linked recessive",Phka2 (MGI:97577)
X,18989306,19122955,Xp21.3,Xp22.13,300572,"ADGRG2, GPR64, HE6, CBAVDX",Adhesion G protein-coupled receptor G2,ADGRG2,10149,ENSG00000173698,NA,"Congenital bilateral absence of vas deferens, X-linked, 300985 (3), X-linked",Adgrg2 (MGI:2446854)
X,19343892,19361717,Xp22.2-p22.1,Xp22.12,300502,"PDHA1, PHE1A, PDHAD","Pyruvate dehydrogenase, E1-alpha polypeptide-1",PDHA1,5160,ENSG00000131828,NA,"Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3), X-linked dominant",Pdha1 (MGI:97532)
X,19360057,19515260,Xp22.12,Xp22.12,300820,"MAP3K15, ASK3",Mitogen-activated protein kinase kinase kinase 15,MAP3K15,389840,ENSG00000180815,NA,NA,Map3k15 (MGI:2448588)
X,19533964,19887599,Xp22.1-p21.3,Xp22.12,300374,"SH3KBP1, CIN85, IMD61, AGMX2",SH3-domain kinase-binding protein 1,SH3KBP1,30011,ENSG00000147010,mutation identified in 1 IMD61 family,"?Immunodeficiency 61, 300310 (3), X-linked recessive",Sh3kbp1 (MGI:1889583)
X,20124524,20141837,Chr.X,Xp22.12,300186,"EIF1A, EIF4C, EIF1AX",Eukaryotic translation initiation factor 1A,EIF1AX,1964,ENSG00000173674,NA,NA,Eif1a (MGI:95298)
X,20149910,20267513,Xp22.2-p22.1,Xp22.12,300075,"RPS6KA3, RSK2, MRX19","Ribosomal protein S6 kinase, 90kD, polypeptide 3",RPS6KA3,6197,ENSG00000177189,NA,"Coffin-Lowry syndrome, 303600 (3), X-linked dominant; Mental retardation, X-linked 19, 300844 (3), X-linked dominant",Rps6ka3 (MGI:104557)
X,21374417,21654688,Xp22.12,Xp22.12,300724,"CNKSR2, CNK2, KIAA0902, MRXSHG",connector enhancer of KSR 2,CNKSR2,22866,ENSG00000149970,conflicting assignment to chr.1,"Mental retardation, X-linked, syndromic, Houge type, 301008 (3), X-linked",Cnksr2 (MGI:2661175)
X,21705971,21758159,Xp22.1,Xp22.12,300226,"SMPX, DFNX4","Small muscle protein, X-linked",SMPX,23676,ENSG00000091482,NA,"Deafness, X-linked 4, 300066 (3), X-linked dominant",NA
X,21839616,21885422,Xp22.12-p22.11,Xp22.12,300294,"MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19","Membrane-bound transcription factor protease, site 2",MBTPS2,51360,ENSG00000012174,mutation identified in 1 OLMSX family,"IFAP syndrome with or without BRESHECK syndrome, 308205 (3), X-linked recessive; Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3), X-linked recessive; ?Olmsted syndrome, X-linked, 300918 (3), X-linked recessive; Osteogenesis imperfecta, type XIX, 301014 (3), X-linked recessive",Mbtps2 (MGI:2444506)
X,21855986,21858739,Xp22.2-p22.1,Xp22.12,300570,"YY2, ZNF631",Transcription factor YY2,YY2,404281,ENSG00000230797,NA,NA,Yy2 (MGI:3837947)
X,21940572,21994836,Xp22.1,Xp22.11,300105,"SMS, SRS, MRSR",Spermine synthase,SMS,6611,ENSG00000102172,NA,"Mental retardation, X-linked, Snyder-Robinson type, 309583 (3), X-linked recessive","Sms-ps,Sms (MGI:109490,MGI:3705601)"
X,22032324,22251309,Xp22.2-p22.1,Xp22.11,300550,"PHEX, HYP, HPDR1, LXHR","Phosphate regulating endopeptidase homolog, X-linked",PHEX,5251,ENSG00000102174,NA,"Hypophosphatemic rickets, X-linked dominant, 307800 (3), X-linked dominant",Phex (MGI:107489)
X,23334368,23404373,Xp22.11,Xp22.11,300828,"PTCHD1, AUTSX4",Patched domain-containing protein 1,PTCHD1,139411,ENSG00000165186,NA,"{Autism, susceptibility to, X-linked 4}, 300830 (3), X-linked recessive",Ptchd1 (MGI:2685233)
X,23667492,23686396,Xp22.11,Xp22.11,300927,"PRDX4, AOE372",Peroxiredoxin 4,PRDX4,10549,ENSG00000123131,NA,NA,Prdx4 (MGI:1859815)
X,23701054,23743275,Xp22.11,Xp22.11,300862,"ACOT9, MTACT48",Acyl-CoA thioesterase 9,ACOT9,23597,ENSG00000123130,NA,NA,"Acot9,Acot10 (MGI:1928939,MGI:1928940)"
X,23783157,23786222,Xp22.1,Xp22.11,313020,"SAT1, SSAT",Spermidine/spermine N1-acetyltransferase 1,SAT1,6303,ENSG00000130066,NA,NA,Sat1 (MGI:98233)
X,23833347,23907939,Xp22.1,Xp22.11,300753,"APOO, MYO25, FAM121B",Apolipoprotein O,APOO,79135,ENSG00000184831,NA,NA,Apoo (MGI:1915566)
X,23983715,24027185,Xp22.1,Xp22.11,300980,"KLHL15, KIAA1677",Kelch-like 15,KLHL15,80311,ENSG00000174010,NA,"Mental retardation, X-linked 103, 300982 (3), X-linked recessive",Klhl15 (MGI:1923400)
X,24054955,24078809,Xp22.2-p22.1,Xp22.11,300161,"EIF2S3, EIF2G, MEHMO, MRXSBRK","Eukaryotic translation initiation factor 2, subunit 3",EIF2S3,1968,ENSG00000130741,NA,"MEHMO syndrome, 300148 (3), X-linked recessive",Eif2s3x (MGI:1349431)
X,24148981,24216254,Xp22.2-p21.3,Xp22.11,314980,ZFX,"Zinc finger protein, X-linked",ZFX,7543,ENSG00000005889,nonlyonizing,NA,Zfx (MGI:99211)
X,24465226,24550465,Xp22.11,Xp22.11,300906,"PDK3, CMTX6","Pyruvate dehydrogenase kinase, isoenzyme 3",PDK3,5165,ENSG00000067992,1 family identified with mutation,"?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3), X-linked dominant",Pdk3 (MGI:2384308)
X,24558086,24672886,Xp22.11,Xp22.11,300948,PCYT1B,"Phosphate cytidylyltransferase 1, choline, beta isoform",PCYT1B,9468,ENSG00000102230,NA,NA,Pcyt1b (MGI:2147987)
X,24693876,24996985,Xp22.3-p21.1,Xp22.1-p21.3,312040,POLA1,"Polymerase, DNA, alpha-1",POLA1,5422,ENSG00000101868,NA,"Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3), X-linked recessive",Pola1 (MGI:99660)
X,24900000,37800000,Xp21,NA,300679,"DELXp21, CXDELp21",Chromosome Xp21 deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Chromosome Xp21 deletion syndrome, 300679 (4)",NA
X,24900000,29300000,Xp21.3,NA,300488,MENOQ1,"Menopause, natural, age at, QTL 1",NA,494029,NA,NA,"{Menopause, natural, age at, QTL1}, 300488 (2), X-linked dominant",NA
X,24900000,31500000,Xp21.3-p21.2,NA,312612,RP6,"Retinitis pigmentosa-6, X-linked recessive",RP6,6104,NA,NA,"?Retinitis pigmentosa, X-linked recessive, 6, 312612 (2), X-linked",NA
X,25003693,25015964,Xp22.13,Xp21.3,300382,"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32","Aristaless-related homeobox, X-linked",ARX,170302,ENSG00000004848,NA,"Epileptic encephalopathy, early infantile, 1, 308350 (3), X-linked recessive; Hydranencephaly with abnormal genitalia, 300215 (3), X-linked; Lissencephaly, X-linked 2, 300215 (3), X-linked; Mental retardation, X-linked 29 and others, 300419 (3), X-linked recessive; Partington syndrome, 309510 (3), X-linked recessive; Proud syndrome, 300004 (3), X-linked",Arx (MGI:1097716)
X,26192439,26195645,Xp22,Xp21.3,300467,MAGEB6,"Melanoma antigen, family B, 6",MAGEB6,158809,ENSG00000176746,NA,NA,NA
X,26216168,26218269,Xp22,Xp21.3,300466,MAGEB5,"Melanoma antigen, family B, 5",MAGEB5,347541,ENSG00000188408,NA,NA,"Gm14781,Mageb5 (MGI:2148169,MGI:3712084)"
X,27807989,27823013,Xp21.3,Xp21.3,300761,MAGEB10,"Melanoma antigen, family B, 10",MAGEB10,139422,ENSG00000177689,NA,NA,NA
X,28587445,29956717,Xp22.1-p21.3,Xp21.3-p21.2,300206,"IL1RAPL1, IL1R8, MRX21, MRX34",Il-1 receptor accessory protein-like 1,IL1RAPL1,11141,ENSG00000169306,NA,"Mental retardation, X-linked 21/34, 300143 (3), X-linked recessive",Il1rapl1 (MGI:2687319)
X,29300000,31500000,Xp21.2,NA,300030,"DFNX3, DFN4","Deafness, X-linked 3",DFNX3,1680,NA,?same as DMD,"Deafness, X-linked 3, 300030 (2), X-linked",NA
X,29300000,85400000,Xp21.2-q21.1,NA,309050,"XS, LUXS","Lutheran suppressor, X-linked",XS,7523,NA,NA,NA,NA
X,30215562,30220088,Xp21.3,Xp21.2,300098,"MAGEB2, DAM6","Melanoma antigen, family B, 2",MAGEB2,4113,ENSG00000099399,NA,NA,Mageb4 (MGI:2148568)
X,30230435,30237492,Xp21.3,Xp21.2,300152,MAGEB3,"Melanoma antigen, family B, 3",MAGEB3,4114,ENSG00000198798,NA,NA,NA
X,30241999,30244186,Xp21.3,Xp21.2,300153,MAGEB4,"Melanoma antigen, family B, 4",MAGEB4,4115,ENSG00000120289,NA,NA,NA
X,30243730,30252039,Xp21.3,Xp21.2,300097,"MAGEB1, MAGEL1, DAM10","Melanoma antigen, family B, 1",MAGEB1,4112,ENSG00000214107,NA,NA,"Mageb1,Mageb2,Mageb3 (MGI:105109,MGI:105118,MGI:105117)"
X,30304205,30309389,Xp21.3-p21.2,Xp21.2,300473,"NR0B1, DAX1, AHC, AHX, SRXY2","Nuclear receptor subfamily 0, group B, member 1",NR0B1,190,ENSG00000169297,distal to GK,"Adrenal hypoplasia, congenital, 300200 (3), X-linked recessive; 46XY sex reversal 2, dosage-sensitive, 300018 (3), X-linked",Nr0b1 (MGI:1352460)
X,30653347,30731461,Xp21.3-p21.2,Xp21.2,300474,GK,Glycerol kinase,GK,2710,ENSG00000198814,2Mb distal to DMD; pseudogene on 4q32,"Glycerol kinase deficiency, 307030 (3), X-linked recessive",Gykl1 (MGI:891990)
X,30827441,30889390,Xp21.2,Xp21.2,300480,TAB3,Tak1 (MAP3K7) binding protein 3,TAB3,257397,ENSG00000157625,NA,NA,Tab3 (MGI:1913974)
X,31071232,31072040,Xp21.2,Xp21.2,300308,FTHL17,Ferritin heavy polypeptide-like 17,FTHL17,53940,ENSG00000132446,NA,NA,NA
X,31119218,33339459,Xp21.2,Xp21.2-p21.1,300377,"DMD, BMD, CMD3B",Dystrophin,DMD,1756,ENSG00000198947,dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13,"Becker muscular dystrophy, 300376 (3), X-linked recessive; Cardiomyopathy, dilated, 3B, 302045 (3), X-linked; Duchenne muscular dystrophy, 310200 (3), X-linked recessive",Dmd (MGI:94909)
X,31500000,50100000,Xp21.1-p11.23,NA,300858,MRXS17,"Mental retardation, X-linked, syndromic 17",NA,100739996,NA,between rs2748314 and rs5906782,"Mental retardation, X-linked, syndromic 17, 300858 (2), X-linked recessive",NA
X,34627074,34657284,Xp11.4,Xp21.1,300698,"TMEM47, BCMP1",Transmembrane protein 47,TMEM47,83604,ENSG00000147027,NA,NA,Tmem47 (MGI:2177570)
X,35798341,35803771,Xp21.3,Xp21.1,300762,MAGEB16,"Melanoma antigen, family B, 16",MAGEB16,139604,ENSG00000189023,NA,NA,Mageb16 (MGI:1919217)
X,37349329,37457294,Xp21.1,Xp21.1,300935,"PRRG1, PRGP1",Proline-rich gamma-carboxyglutamic acid protein 1,PRRG1,5638,ENSG00000130962,NA,NA,Prrg1 (MGI:1917364)
X,37685685,37732129,Xp21.2-p21.1,Xp21.1,314850,"XK, MCLDS",Kell blood group precursor,XK,7504,ENSG00000047597,~500kb distal to CGD,"McLeod syndrome with or without chronic granulomatous disease, 300842 (3), X-linked",Xk (MGI:103569)
X,37780016,37813460,Xp21.1,Xp21.1-p11.4,300481,"CYBB, CGD, AMCBX2, IMD34","Cytochrome b-245, beta polypeptide",CYBB,1536,ENSG00000165168,proximal to DMD,"Chronic granulomatous disease, X-linked, 306400 (3), X-linked recessive; Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3), X-linked recessive",Cybb (MGI:88574)
X,37800000,58100000,Xp11.4-p11.2,NA,300638,GAGE8,G antigen 8,GAGE8,100101629,NA,NA,NA,NA
X,37800000,61000000,Xp11,NA,300351,"GRDX, GD3","Graves disease, susceptibility to, X-linked",NA,117189,NA,NA,"{Graves disease, susceptibility to, X-linked}, 300351 (2)",NA
X,37800000,61000000,Xp11,NA,300136,IDDMX,"Diabetes mellitus, insulin-dependent, X-linked, susceptibility to",NA,8245,NA,only with DR3,"{Diabetes mellitus, insulin-dependent, X-linked}, 300136 (2)",NA
X,37800000,61000000,Xp11,NA,308905,LOAS,"Leber optic atrophy, susceptibility to",NA,100188775,NA,NA,"{Leber optic atrophy, susceptibility to}, 308905 (2), X-linked",NA
X,37800000,99100000,Xp11-q21,NA,300047,MRX20,"Mental retardation, X-linked-20",MRX20,4384,NA,NA,"Mental retardation, X-linked 20, 300047 (2), X-linked",NA
X,37800000,61000000,Xp11,NA,309545,MRXS12,"Mental retardation, X-linked, syndromic 12",NA,8246,NA,NA,"?Mental retardation, X-linked, syndromic 12, 309545 (2), X-linked",NA
X,37800000,42500000,Xp11.4,NA,300589,NYS5,"Nystagmus 5, congenital, X-linked",NA,780901,NA,max lod at DXS993,"Nystagmus 5, congenital, X-linked, 300589 (2), X-linked dominant",NA
X,37800000,58100000,Xp11.4-p11.21,NA,311050,OPA2,"Optic atrophy, X-linked",OPA2,4977,NA,NA,"Optic atrophy 2, X-linked, 311050 (2), X-linked",NA
X,37800000,99100000,Xp11-q21,NA,309610,"PRS, MRXS2","Prieto syndrome (mental retardation, X-linked, syndromic 2, with dysmorphism and cerebral atrophy)",PRS,5640,NA,NA,"Prieto syndrome, 309610 (2), X-linked recessive",NA
X,37838835,37847570,Xp21,Xp11.4,300302,TCTE1L,T complex-associated testis-expressed 1-like,DYNLT3,6990,ENSG00000165169,NA,NA,Dynlt3 (MGI:1914367)
X,38149334,38220923,Xp21.1,Xp11.4,300187,"SRPX, ETX1","Sushi-repeat-containing protein, X chromosome",SRPX,8406,ENSG00000101955,probably between OTC and CGD,NA,Srpx (MGI:1858306)
X,38269162,38327508,Xp11.4,Xp11.4,312610,"RPGR, RP3, CRD, RP15, COD1, CORDX1",Retinitis pigmentosa GTPase regulator,RPGR,6103,ENSG00000156313,NA,"Cone-rod dystrophy, X-linked, 1, 304020 (3), X-linked; Macular degeneration, X-linked atrophic, 300834 (3), X-linked recessive; Retinitis pigmentosa 3, 300029 (3); Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)",Rpgr (MGI:1344037)
X,38352527,38421445,Xp21.1,Xp11.4,300461,OTC,Ornithine transcarbamylase,OTC,5009,ENSG00000036473,"proximal to DMD, CGD","Ornithine transcarbamylase deficiency, 311250 (3), X-linked recessive",Otc (MGI:97448)
X,38561477,38688917,Xq11,Xp11.4,300096,"TSPAN7, TM4SF2, MXS1, A15, MRX58",Tetraspanin 7,TSPAN7,7102,ENSG00000156298,NA,"Mental retardation, X-linked 58, 300210 (3), X-linked recessive",Tspan7 (MGI:1298407)
X,38801431,38806531,Xp11.4,Xp11.4,300961,"MID1IP1, MIG12",MID1-interacting protein 1,MID1IP1,58526,ENSG00000165175,NA,NA,Mid1ip1 (MGI:1915291)
X,40051245,40177389,Xp11.4,Xp11.4,300485,"BCOR, KIAA1575, MCOPS2, MAA2, ANOP2",BCL6 corepressor,BCOR,54880,ENSG00000183337,NA,"Microphthalmia, syndromic 2, 300166 (3), X-linked dominant",Bcor (MGI:1918708)
X,40580969,40606847,Xp11.4,Xp11.4,300556,"ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS","ATPase, H+ transporting, lysosomal, accessory protein 2",ATP6AP2,10159,ENSG00000182220,mutation identified in 1 XPDS family,"Mental retardation, X-linked, syndromic, Hedera type, 300423 (3), X-linked recessive; ?Parkinsonism with spasticity, X-linked, 300911 (3), X-linked recessive",Atp6ap2 (MGI:1917745)
X,40648304,40736121,Xp11.4-p11.2,Xp11.4,300182,"MED14, CRSP2, CXorf4, TRAP170, EXLM1",Mediator complex subunit 14,MED14,9282,ENSG00000180182,NA,NA,Med14 (MGI:1349442)
X,41085419,41236578,Xp11.4,Xp11.4,300072,"USP9X, DFFRX, MRX99, MRXS99F","Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked)",USP9X,8239,ENSG00000124486,NA,"Mental retardation, X-linked 99, 300919 (3), X-linked recessive; Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3), X-linked dominant",Usp9x (MGI:894681)
X,41333307,41364471,Xp11.3-p11.23,Xp11.4,300160,"DDX3X, DDX3, DBX, MRX102","DEAD/H box-3, X-linked",DDX3X,1654,ENSG00000215301,NA,"Mental retardation, X-linked 102, 300958 (3), X-linked recessive, X-linked dominant",Ddx3x (MGI:103064)
X,41447459,41476413,Xp11.4,Xp11.4,300278,"NYX, CSNB1A, NBM1",Nyctalopin,NYX,60506,ENSG00000188937,NA,"Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3), X-linked recessive",Nyx (MGI:2448607)
X,41514933,41923553,Xp11.4,Xp11.4,300172,"CASK, MICPCH, FGS4, CMG, MRXSNA",Calcium/calmodulin-dependent serine protein kinase,CASK,8573,ENSG00000147044,NA,"FG syndrome 4, 300422 (3); Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3), X-linked dominant; Mental retardation, with or without nystagmus, 300422 (3)",Cask (MGI:1309489)
X,41686396,41697274,Xp11.4,Xp11.4,300241,GPR34,G protein-coupled receptor 34,GPR34,2857,ENSG00000171659,NA,NA,Gpr34 (MGI:1346334)
X,41724180,41730129,Xp11.4,Xp11.4,300748,GPR82,G protein-coupled receptor 82,GPR82,27197,ENSG00000171657,NA,NA,Gpr82 (MGI:2441734)
X,42500000,68500000,Xp11.3-q12,NA,300652,AGSPX,"Angioma serptiginosum, X-linked",NA,100188767,NA,between DXS8026 and DXS106,"Angio serpiginosum, 300652 (2), X-linked dominant",NA
X,42500000,47600000,Xp11.3,NA,300578,"DELXp11.3, CXDELp11.3",Chromosome Xp11.3 deletion syndrome (X-linked mental retardation with retinitis pigmentosa),NA,NA,NA,NA,"Chromosome Xp11.3 deletion syndrome, 300578 (4), X-linked recessive",NA
X,42500000,76800000,Xp11.3-q13.3,NA,300062,MRX14,"Mental retardation, X-linked-14",MRX14,4378,NA,NA,"Mental retardation, X-linked 14, 300062 (2), X-linked",NA
X,42500000,58100000,Xp11.3-p11.21,NA,300498,MRX45,"Mental retardation, X-linked 45",NA,NA,NA,NA,"Mental retardation,X-linked 45, 300498 (2), X-linked",NA
X,42500000,58100000,Xp11.3-p11.21,NA,300115,MRX50,"Mental retardation, X-linked nonspecific, type 50",MRX50,4413,NA,NA,"Mental retardation, X-linked 50, 300115 (2), X-linked",NA
X,42500000,109400000,Xp11.3-q22.3,NA,300505,MRX84,"Mental retardation, X-linked 84",MRX84,378882,NA,29 other MRX loci in same region,"Mental retardation, X-linked 84, 300505 (2), X-linked recessive",NA
X,42500000,47600000,Xp11.3,NA,300848,MRX89,"Mental retardation, X-linked 89",NA,NA,NA,t(X;7)(p11.3;q11.21),"Mental retardation, X-linked 89, 300848 (2), X-linked dominant",NA
X,42500000,47600000,Xp11.3,NA,300851,MRX92,"Mental retardation, X-linked 92",NA,102775565,NA,previously associated with ZNF674,"Mental retardation, X-linked 92, 300851 (2), X-linked recessive",NA
X,42500000,109400000,Xp11.3-q22,NA,300218,MRXS7,"Mental retardation, X-linked, syndromic 7",MRXS7,4429,NA,NA,"Mental retardation, X-linked syndromic 7, 300218 (2)",NA
X,42777365,42778162,Xp11.3,Xp11.3,301017,PPP1R2C,"Protein phosphatase 1, regulatory subunit 2C",PPP1R2C,80316,ENSG00000102055,NA,NA,NA
X,43654906,43746823,Xp11.23,Xp11.3,309850,"MAOA, BRNRS",Monoamine oxidase A,MAOA,4128,ENSG00000189221,"NDP, MAOA, MAOB closely linked","{Antisocial behavior}, 300615 (3), X-linked recessive; Brunner syndrome, 300615 (3), X-linked recessive",Maoa (MGI:96915)
X,43766609,43882449,Xp11.23,Xp11.3,309860,MAOB,Monoamine oxidase B,MAOB,4129,ENSG00000069535,NA,NA,Maob (MGI:96916)
X,43948775,43973389,Xp11.4,Xp11.3,300658,"NDP, ND, EVR2",Norrin,NDP,4693,ENSG00000124479,NA,"Exudative vitreoretinopathy 2, X-linked, 305390 (3); Norrie disease, 310600 (3), X-linked recessive",Ndp (MGI:102570)
X,44146253,44343671,Xp11.3,Xp11.3,300817,EFHC2,EF-hand domain (C-terminal)-containing protein 2,EFHC2,80258,ENSG00000183690,NA,NA,Efhc2 (MGI:1921655)
X,44523638,44542858,Xp11.3,Xp11.3,300871,FUNDC1,FUN14 domain-containing protein 1,FUNDC1,139341,ENSG00000069509,NA,NA,Fundc1 (MGI:1919268)
X,44844020,44844887,Xp11.3,Xp11.3,300678,"DUSP21, LMWDSP21",Dual-specificity phosphatase 21,DUSP21,63904,ENSG00000189037,NA,NA,NA
X,44873174,45112611,Xp11.2,Xp11.3,300128,"KDM6A, UTX, KABUK2",Lysine (K)-specific demethylase 6A,KDM6A,7403,ENSG00000147050,UTY also in mouse and man; escapes inactivation,"Kabuki syndrome 2, 300867 (3), X-linked dominant",Kdm6a (MGI:1095419)
X,45148372,45200875,Xp11.3,Xp11.3,300959,"CXorf36, DIA1R",Chromosome X open reading frame 36,DIPK2B,79742,ENSG00000147113,NA,NA,Dipk2b (MGI:1923155)
X,45746156,45746265,Xp11.3,Xp11.3,300568,"MIR221, MIRN221",Micro RNA 221,MIR221,407006,ENSG00000207870,near MIRN222,NA,NA
X,45747014,45747123,Xp11.3,Xp11.3,300569,"MIR222, MIRN222",Micro RNA 222,MIR222,407007,ENSG00000207725,near MIRN221,NA,NA
X,46447188,46474638,Xp11.3,Xp11.3,300585,"ZNF673, FLJ20344",Zinc finger protein 673,KRBOX4,55634,ENSG00000147121,NA,NA,NA
X,46497724,46545465,Xp11,Xp11.3,300573,ZNF674,Zinc finger protein 674,ZNF674,641339,ENSG00000251192,NA,NA,NA
X,46573764,46598495,Xp11.3,Xp11.3,300375,"CHST7, C6ST2",Carbohydrate sulfotransferase 7,CHST7,56548,ENSG00000147119,NA,NA,Chst7 (MGI:1891767)
X,46599250,46759162,Xp11.3,Xp11.3,300368,"SLC9A7, NHE7, MRX108","Solute carrier family 9 (sodium/hydrogen exchanger), member 7",SLC9A7,84679,ENSG00000065923,NA,"Intellectual developmental disorder, X-linked 108, 301024 (3), X-linked recessive",Slc9a7 (MGI:2444530)
X,46837042,46882357,Xp11.23,Xp11.3,300757,RP2,"Retinitis pigmentosa-2, X-linked recessive",RP2,6102,ENSG00000102218,NA,"Retinitis pigmentosa 2, 312600 (3), X-linked",Rp2 (MGI:1277953)
X,46912275,47061241,Xp11.23,Xp11.3,300618,"PHF16, JADE3, KIAA0215",PHD finger protein 16,JADE3,9767,ENSG00000102221,NA,NA,Jade3 (MGI:2148019)
X,47078354,47093313,Xp11.2-q11.2,Xp11.3,300212,"RGN, SMP30",Regucalcin,RGN,9104,ENSG00000130988,NA,NA,Rgn (MGI:108024)
X,47142215,47145209,Xp11.3,Xp11.3,300403,"NDUFB11, LSDMCA3, MC1DN30",NADH-ubiquinone oxidoreductase subunit B11,NDUFB11,54539,ENSG00000147123,mutation identified in 1 MC1DN30 patient,"Linear skin defects with multiple congenital anomalies 3, 300952 (3), X-linked dominant; ?Mitochondrial complex I deficiency, nuclear type 30, 301021 (3), X-linked",Ndufb11 (MGI:1349919)
X,47145195,47186814,Xp11.23,Xp11.3,300080,"RBM10, DXS8237E, KIAA0122, TARPS",RNA-binding motif protein 10,RBM10,8241,ENSG00000182872,NA,"TARP syndrome, 311900 (3), X-linked recessive",Rbm10 (MGI:2384310)
X,47190846,47215127,Xp11.23,Xp11.3,314370,"UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1",Ubiquitin-like modifier-activating enzyme 1,UBA1,7317,ENSG00000130985,escapes inactivation,"Spinal muscular atrophy, X-linked 2, infantile, 301830 (3), X-linked recessive",Uba1 (MGI:98890)
X,47204847,47205860,Xp11.23,Xp11.3,300164,INE1,Inactivation escape 1,INE1,8552,ENSG00000224975,NA,NA,NA
X,47217880,47229996,Xp11.3-p11.23,Xp11.3,311550,"CDK16, PCTK1, PCTAIRE1",Cyclin-dependent kinase 16,CDK16,5127,ENSG00000102225,NA,NA,Cdk16 (MGI:97516)
X,47232914,47248327,Xp21.2-p11.2,Xp11.3,300050,"USP11, UHX1",Ubiquitin-specific protease-11 (ubiquitin carboxyl-terminal hydrolase),USP11,8237,NA,NA,NA,Usp11 (MGI:2384312)
X,47370599,47413698,Xp11.2,Xp11.3,300024,ZNF157,Zinc finger protein-157 (HZF22),ZNF157,7712,ENSG00000147117,NA,NA,NA
X,47444690,47485933,Xp22.1-cen,Xp11.3,314995,ZNF41,Zinc finger protein-41,ZNF41,7592,ENSG00000147124,NA,NA,NA
X,47561099,47571920,Xp11.4-p11.2,Xp11.3,311010,"ARAF1, RAFA1, PKS2",Oncogene ARAF1,ARAF,369,ENSG00000078061,NA,NA,Araf (MGI:88065)
X,47571900,47619856,Xp11.4-p11.2,Xp11.3-p11.2,313440,SYN1,Synapsin I,SYN1,6853,ENSG00000008056,5kb from PFC,"Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3), X-linked recessive, X-linked dominant",Syn1 (MGI:98460)
X,47582407,47586788,Xp11.3-p11.23,Xp11.3,305370,"TIMP1, TIMP, EPA",Erythroid-potentiating activity (tissue inhibitor of metalloproteinases),TIMP1,7076,ENSG00000102265,in intron of SYN1,NA,Timp1 (MGI:98752)
X,47600000,54800000,Xp11.23-p11.22,NA,300801,"DUPXp11.23p11.22, CXDUPp11.23p11.22",Chromosome Xp11.23-p11.22 duplication syndrome,NA,NA,NA,NA,"Chromosome Xp11.23-p11.22 duplication syndrome, 300801 (4), X-linked dominant",NA
X,47600000,50100000,Xp11.23,NA,300726,GAGE2B,G antigen 2B,GAGE2B,645037,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300595,"GAGE2C, GAGE2",G antigen 2C,GAGE2C,2574,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300735,GAGE2D,G antigen 2D,GAGE2D,729408,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300736,GAGE2E,G antigen 2E,GAGE2E,26749,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300596,GAGE3,G antigen 3,NA,NA,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300597,GAGE4,G antigen 4,GAGE4,2576,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300598,GAGE5,G antigen 5,GAGE5,2577,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300599,GAGE6,G antigen 6,GAGE6,2578,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300601,GAGE7,G antigen 7,GAGE7,2579,NA,NA,NA,NA
X,47600000,50100000,Xp11.23,NA,300637,GAGE7B,G antigen 7B,GAGE12I,26748,NA,NA,NA,NA
X,47600000,68500000,Xp11.2-q12,NA,300433,MRX81,"Mental retardation, X-linked 81",MRX81,266678,NA,between DXS1039 and DXS1216,"Mental retardation, X-linked 81, 300433 (2), X-linked recessive",NA
X,47623163,47630304,Xp11.4-p11.23,Xp11.23,300383,"PFC, PFD","Properdin P factor, complement",CFP,5199,ENSG00000126759,NA,"Properdin deficiency, X-linked, 312060 (3), X-linked recessive",Cfp (MGI:97545)
X,47635519,47650603,Xp11.2,Xp11.23,311040,ELK1,"ELK1, member of ETS oncogene family",ELK1,2002,ENSG00000126767,distal to OATL1,NA,Elk1 (MGI:101833)
X,47651791,47659179,Xp11.23,Xp11.23,300234,UXT,Ubiquitously expressed transcript,UXT,8409,ENSG00000126756,NA,NA,Uxt (MGI:1277988)
X,47836863,47925625,Xp22.1-p11,Xp11.23,314998,ZNF81,Zinc finger protein-81 (HFZ20),ZNF81,347344,ENSG00000197779,NA,NA,NA
X,47974850,48003988,Xp11.3,Xp11.23,314993,ZNF21,Zinc finger protein-12,ZNF182,7569,ENSG00000147118,NA,NA,Zfp182 (MGI:2442220)
X,48004335,48009735,Xp11.23,Xp11.23,300593,"SPACA5, LOC389852",Sperm acrosome associated 5,SPACA5,389852,ENSG00000171489,NA,NA,Spaca5 (MGI:2685564)
X,48058177,48071657,Xp11.23,Xp11.23,300819,ZNF630,Zinc finger protein 630,ZNF630,57232,ENSG00000221994,NA,NA,NA
X,48107981,48120685,Xp11.23,Xp11.23,300541,SSX6,"Synovial sarcoma, X breakpoint 6",SSX6P,280657,NA,NA,NA,NA
X,48177981,48196797,Xp11.23,Xp11.23,300327,SSX5,"Synovial sarcoma, X breakpoint 5",SSX5,6758,ENSG00000165583,NA,NA,NA
X,48255391,48267443,Xp11.23,Xp11.23,312820,"SSX1, SSRC","Synovial sarcoma, X breakpoint 1",SSX1,6756,ENSG00000126752,fused with SYT in synovial sarcoma,"?Sarcoma, synovial, 300813 (3)",NA
X,48301549,48306178,Xp11.23,Xp11.23,300544,SSX9,"Sarcoma, synovial, X breakpoint 9",SSX9P,280660,ENSG00000204648,NA,NA,NA
X,48346426,48356705,Xp11.23,Xp11.23,300325,SSX3,"Synovial sarcoma, X breakpoint 3",SSX3,10214,ENSG00000165584,NA,NA,NA
X,48383526,48393346,Xp11.23,Xp11.23,300326,SSX4,"Synovial sarcoma, X breakpoint 4",SSX4,6759,ENSG00000268009,NA,NA,Ssxb2 (MGI:2446771)
X,48458543,48470259,Xp11.23,Xp11.23,300649,"SLC38A5, SN2","Solute carrier family 38 (amino acid transporter), member 5",SLC38A5,92745,ENSG00000017483,NA,NA,Slc38a5 (MGI:2148066)
X,48476020,48486363,Xp11.23,Xp11.23,300499,"FTSJ1, JM23, SPB1, MRX44, MRX9",FTSJ RNA 2-prime-O-methyltransferase 1,FTSJ1,24140,ENSG00000068438,NA,"Mental retardation, X-linked 9/44, 309549 (3), X-linked recessive",Ftsj1 (MGI:1859648)
X,48508991,48520813,Xp11.23,Xp11.23,300651,"PORCN, PORC, DHOF, FODH","Porcupine, Drosophila, homolog of",PORCN,64840,ENSG00000102312,NA,"Focal dermal hypoplasia, 305600 (3), X-linked dominant",Porcn (MGI:1890212)
X,48521807,48528715,Xp11.23-p11.22,Xp11.23,300205,"EBP, CDPX2, CPXD, CPX, MEND",Emopamil-binding protein,EBP,10682,ENSG00000147155,NA,"Chondrodysplasia punctata, X-linked dominant, 302960 (3), X-linked dominant; MEND syndrome, 300960 (3), X-linked recessive",Ebp (MGI:107822)
X,48539618,48562608,Xp11.3-p11.23,Xp11.23,311240,"TBC1D25, OATL1","TBC1 domain family, member 25",TBC1D25,4943,ENSG00000068354,NA,NA,Tbc1d25 (MGI:2444862)
X,48574478,48581161,Xp11.23,Xp11.23,300027,RBM3,RNA binding motif protein 3,RBM3,5935,ENSG00000102317,NA,NA,"Rbm3,Rbm3-ps (MGI:1099460,MGI:3642874)"
X,48590052,48608868,Xp11.23,Xp11.23,300512,WDR13,WD repeat-containing protein 13,WDR13,64743,ENSG00000101940,NA,NA,Wdr13 (MGI:1914661)
X,48683752,48691426,Xp11.23-p11.22,Xp11.23,300392,"WAS, IMD2, THC1, SCNX",Wiskott-Aldrich syndrome gene,WAS,7454,ENSG00000015285,t(18;X)(q11.2;p11.2); distal to TIMP,"Neutropenia, severe congenital, X-linked, 300299 (3), X-linked recessive; Thrombocytopenia, X-linked, 313900 (3), X-linked recessive; Thrombocytopenia, X-linked, intermittent, 313900 (3), X-linked recessive; Wiskott-Aldrich syndrome, 301000 (3), X-linked recessive",Was (MGI:105059)
X,48695553,48709015,Xp11.23,Xp11.23,300254,SUV39H1,"Suppressor of variegation 3-9, Drosophila, homolog of, 1",SUV39H1,6839,ENSG00000101945,NA,NA,Suv39h1 (MGI:1099440)
X,48786539,48794310,Xp11.23,Xp11.23,305371,"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",GATA-binding protein-1 (globin transcription factor-1),GATA1,2623,ENSG00000102145,NA,"Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3), X-linked recessive; Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3), X-linked recessive; Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3), X-linked recessive",Gata1 (MGI:95661)
X,48801397,48824981,Xp11.23,Xp11.23,300272,"HDAC6, CPBHM",Histone deacetylase 6,HDAC6,10013,ENSG00000094631,mutation identified in 1 CPBHM family,"?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3), X-linked dominant",Hdac6 (MGI:1333752)
X,48826512,48829868,Xp11.2,Xp11.23,300437,"HRAS2, HRASP",v-Ha-ras harvey rat sarcoma viral oncogene homolog 2,ERAS,3266,ENSG00000187682,NA,NA,Eras (MGI:2665023)
X,48831095,48835609,Xp11.3,Xp11.23,300399,"PCSK1N, PROSAAS","Proprotein convertase, subtilisin/kexin-type, 1, inhibitor of",PCSK1N,27344,ENSG00000102109,NA,NA,Pcsk1n (MGI:1353431)
X,48893446,48898142,Xp11.2,Xp11.23,300249,"TIMM17B, TIM17B","Translocase of inner mitochondrial membrane 17, yeast, homolog of, B",TIMM17B,10245,ENSG00000126768,NA,NA,Timm17b (MGI:1343176)
X,48897861,48903144,Xp11.23,Xp11.23,300463,"PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8",Polyglutamine-binding protein 1,PQBP1,10084,ENSG00000102103,NA,"Renpenning syndrome, 309500 (3), X-linked recessive",Pqbp1 (MGI:1859638)
X,48903182,48911957,Xp11.23-p11.22,Xp11.23,314375,"SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M","Solute carrier family 35 (UDP-galactose transporter), member 2",SLC35A2,7355,ENSG00000102100,NA,"Congenital disorder of glycosylation, type IIm, 300896 (3), X-linked dominant, Somatic mosaicism",NA
X,48913181,48919023,Chr.X,Xp11.23,300295,PIM2,Oncogene PIM2,PIM2,11040,ENSG00000102096,NA,NA,Pim2 (MGI:97587)
X,48922023,48960782,Xp11.23,Xp11.23,300713,"OTUD5, DUBA",OTU domain-containing protein 5,OTUD5,55593,ENSG00000068308,NA,NA,NA
X,48960982,48972102,Xp11.23,Xp11.23,300281,KCND1,"Potassium voltage-gated channel, SHAL-related subfamily, member 1",KCND1,3750,ENSG00000102057,NA,NA,Kcnd1 (MGI:96671)
X,48973722,49002263,Xp11.23,Xp11.23,300408,"GRIPAP1, GRASP1, KIAA1167",GRIP1-associated protein 1,GRIPAP1,56850,ENSG00000068400,NA,NA,Gripap1 (MGI:1859616)
X,49028725,49043356,Xp11.22,Xp11.23,314310,"TFE3, RCCX1",Transcription factor for IgH enhancer,TFE3,7030,ENSG00000068323,fuses with PRCC in RCCP,"Renal cell carcinoma, papillary, 1, 300854 (3)",Tfe3 (MGI:98511)
X,49053571,49069857,Xp11.23,Xp11.23,300947,CCDC120,Coiled-coil domain-containing protein 120,CCDC120,90060,ENSG00000147144,NA,NA,Ccdc120 (MGI:1859619)
X,49071160,49074001,Xp11.23,Xp11.23,300840,"PRAF2, JM4","PRA1 domain family, member 2",PRAF2,11230,ENSG00000243279,NA,NA,Praf2 (MGI:1859607)
X,49074432,49101120,Xp11.23,Xp11.23,300526,"WDR45, WIPI4, NBIA5",WD repeat-containing protein 45,WDR45,11152,ENSG00000196998,?pseudogene on 4q31.3,"Neurodegeneration with brain iron accumulation 5, 300894 (3), X-linked dominant",Wdr45 (MGI:1859606)
X,49113395,49124546,Xp11.23,Xp11.23,301003,"GPKOW, GPATCH5",G-patch domain and KO@ motifs,GPKOW,27238,ENSG00000068394,NA,NA,Gpkow (MGI:1859610)
X,49171897,49175234,Xp11.23-p11.22,Xp11.23,300112,PLP2,Proteolipid protein 2,PLP2,5355,ENSG00000102007,NA,NA,Plp2 (MGI:1298382)
X,49174801,49186372,Xp11.23,Xp11.23,300111,"PRICKLE3, LMO6","Prickle, Drosophila, homolog of, 3",PRICKLE3,4007,ENSG00000012211,NA,NA,Prickle3 (MGI:1859635)
X,49187811,49200201,Xp11.23-p11.22,Xp11.23,313475,"SYP, MRXSYP",Synaptophysin,SYP,6855,ENSG00000102003,NA,"Mental retardation, X-linked 96, 300802 (3), X-linked recessive",Syp (MGI:98467)
X,49205062,49233403,Xp11.23,Xp11.23,300110,"CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2","Calcium channel, voltage-dependent, alpha-1F subunit",CACNA1F,778,ENSG00000102001,NA,"Aland Island eye disease, 300600 (3), X-linked; Cone-rod dystrophy, X-linked, 3, 300476 (3), X-linked recessive; Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3), X-linked",Cacna1f (MGI:1859639)
X,49235469,49250525,Xp11.23,Xp11.23,300859,"CCDC22, RTSC2",Coiled-coil domain-containing protein 22,CCDC22,28952,ENSG00000101997,NA,"Ritscher-Schinzel syndrome 2, 300963 (3), X-linked recessive",Ccdc22 (MGI:1859608)
X,49250435,49264931,Xp11.23-q13.3,Xp11.23,300292,"FOXP3, IPEX, AIID, XPID, PIDX",Forkhead box P3 (scurfin),FOXP3,50943,ENSG00000049768,NA,"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3), X-linked recessive",Foxp3 (MGI:1891436)
X,49303645,49319843,Xp11.23,Xp11.23,300737,GAGE10,G antigen 10,GAGE10,102724473,ENSG00000215274,NA,NA,NA
X,49322029,49329386,Xp11.23,Xp11.23,300733,GAGE12J,G antigen 12J,GAGE12J,729396,ENSG00000224659,NA,NA,NA
X,49331602,49338951,Xp11.23,Xp11.23,300734,GAGE13,G antigen 13,GAGE13,645051,ENSG00000274274,NA,NA,NA
X,49532176,49539540,Xp11.23,Xp11.23,300727,GAGE12C,G antigen 12C,GAGE12C,729422,ENSG00000237671,NA,NA,NA
X,49541721,49549106,Xp11.23,Xp11.23,300728,GAGE12D,G antigen 12D,GAGE12D,100132399,ENSG00000227488,NA,NA,NA
X,49551288,49558648,Xp11.23,Xp11.23,300729,GAGE12E,G antigen 12E,GAGE12E,729431,ENSG00000216649,NA,NA,NA
X,49560807,49568207,Xp11.23,Xp11.23,300730,GAGE12F,G antigen 12F,GAGE12F,100008586,ENSG00000236362,NA,NA,NA
X,49570396,49577756,Xp11.23,Xp11.23,300731,GAGE12G,G antigen 12G,GAGE12G,645073,ENSG00000215269,NA,NA,NA
X,49579948,49587303,Xp11.23,Xp11.23,300732,GAGE12H,G antigen 12H,GAGE12H,729442,ENSG00000224902,NA,NA,NA
X,49589514,49596826,Xp11.23,Xp11.23,300720,GAGE2A,G antigen 2A,GAGE2A,729447,ENSG00000189064,NA,NA,NA
X,49598991,49608535,Xp11.23,Xp11.23,300594,GAGE1,G antigen 1,GAGE1,2543,ENSG00000205777,NA,NA,NA
X,49687446,49696018,Xp11.23,Xp11.23,300288,"GAGEB1, PAGE1","P antigen family, member 1",PAGE1,8712,ENSG00000068985,NA,NA,NA
X,49829259,49834263,Xp11.23,Xp11.23,300287,"PAGE4, GAGEC1","P antigen family, member 4",PAGE4,9506,ENSG00000101951,NA,NA,NA
X,49879483,49882557,Xp11.2,Xp11.23,300975,"USP27X, USP22L, MRX105","Ubiquitin-specific protease 27, X-linked",USP27X,389856,ENSG00000273820,NA,"Mental retardation, X-linked 105, 300984 (3), X-linked recessive",Usp27x (MGI:1859645)
X,49922595,50099234,Xp11.22,Xp11.23,300008,"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",Chloride channel-5,CLCN5,1184,ENSG00000171365,NA,"Dent disease, 300009 (3), X-linked recessive; Hypophosphatemic rickets, 300554 (3), X-linked recessive; Nephrolithiasis, type I, 310468 (3), X-linked recessive; Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3), X-linked recessive",Clcn5 (MGI:99486)
X,50003147,50003237,Xp11.23,Xp11.23,301023,MIR532,Micro RNA 532,MIR532,693124,ENSG00000207758,NA,NA,NA
X,50014597,50014682,Xp11.23,Xp11.23,300893,MIR502,Micro RNA 502,MIR502,574504,ENSG00000272080,NA,NA,NA
X,50100000,54800000,Xp11.22,NA,300705,"DUPXp11.22, MRX17, MRX31",Xp11.22 microduplication syndrome,NA,NA,NA,minimal duplicated region 228 kb overlapping HUWE1 and HSD17B10,"Xp11.22 microduplication syndrome, 300705 (4)",NA
X,50100000,54800000,Xp11.22,NA,300704,HPCX2,"Prostate cancer, hereditary, X-linked 2",NA,100188769,NA,associated with rs5945572,"{Prostate cancer, hereditary, X-linked 2}, 300704 (2)",NA
X,50100000,54800000,Xp11.22,NA,300856,HYSP4,"Hypospadias 4, X-linked, susceptibility to",NA,100689214,NA,associated with rs1934179 and rs7063116,"{Hypospadias 4, X-linked, susceptibility to}, 300856 (2)",NA
X,50190776,50201006,Xp11.2,Xp11.22,300185,"AKAP4, AKAP82, HI, FSC1","A-kinase anchor protein 4, 82kD",AKAP4,8852,ENSG00000147081,NA,NA,Akap4 (MGI:102794)
X,50202712,50351913,Xp11.22,Xp11.22,300456,CCNB3,Cyclin B3,CCNB3,85417,ENSG00000147082,NA,NA,Ccnb3 (MGI:2183443)
X,50365408,50470850,Xp11.22,Xp11.22,300837,DGKK,"Diacylglycerol kinase, kappa, 142kD",DGKK,139189,ENSG00000274588,NA,NA,Dgkk (MGI:3580254)
X,50575533,50814163,Xp11.2,Xp11.22,300579,"SHROOM4, KIAA1202, SDSX",Shroom family member 4,SHROOM4,57477,ENSG00000158352,NA,"Stocco dos Santos X-linked mental retardation syndrome, 300434 (3), X-linked",Shroom4 (MGI:2685570)
X,50910734,50916640,Xp11.2,Xp11.22,300247,"BMP15, GDF9B, ODG2, POF4",Bone morphogenetic protein 15,BMP15,9210,ENSG00000130385,NA,"Ovarian dysgenesis 2, 300510 (3), X-linked; Premature ovarian failure 4, 300510 (3), X-linked",Bmp15 (MGI:1316745)
X,51332230,51337524,Xp11.23,Xp11.22,300527,"NUDT10, DIPP3A, APS2",Nucleoside diphosphate-linked moiety X motif 10,NUDT10,170685,ENSG00000122824,NA,NA,NA
X,51490010,51496591,Xp11.23,Xp11.22,300528,"NUDT11, DIPP3B, APS1",Nucleoside diphosphate-linked moiety X motif 11,NUDT11,55190,ENSG00000196368,NA,NA,"Nudt11,Nudt10 (MGI:2147931,MGI:1930957)"
X,51743441,51746231,Xp11.23-p11.21,Xp11.22,300418,"GSPT2, GST2, ERF3B",G1- to S-phase transition 2,GSPT2,23708,ENSG00000189369,NA,NA,Gspt2 (MGI:1316727)
X,51802997,51902353,Xp11.23,Xp11.22,300224,MAGED1,"Melanoma antigen, family D, 1",MAGED1,9500,ENSG00000179222,NA,NA,Maged1 (MGI:1930187)
X,52061826,52069271,Xp11,Xp11.22,300765,MAGED4B,"Melanoma antigen, family D, 4B",MAGED4B,81557,ENSG00000187243,NA,NA,NA
X,52184822,52192267,Xp11,Xp11.22,300702,"MAGED4, MAGEE1, KIAA1859","Melanoma antigen, family D, 4",MAGED4,728239,ENSG00000154545,NA,NA,NA
X,52368995,52375682,Xp11.22,Xp11.22,300416,"XAGE2, GAGED3","X antigen family, member 2",XAGE2,9502,ENSG00000155622,NA,NA,NA
X,52495667,52500814,Xp11.22,Xp11.22,300742,XAGE1A,"X antigen family, member 1A",XAGE1A,653220,ENSG00000204379,NA,NA,NA
X,52495667,52500814,Xp11.22,Xp11.22,300743,XAGE1B,"X antigen family, member 1B",XAGE1A,653220,ENSG00000204379,NA,NA,NA
X,52512073,52517220,Xp11.22,Xp11.22,300744,XAGE1C,"X antigen family, member 1C",XAGE1B,653067,ENSG00000204382,NA,NA,NA
X,52512073,52517220,Xp11.22,Xp11.22,300745,XAGE1E,"X antigen family, member 1E",XAGE1B,653067,ENSG00000204382,NA,NA,NA
X,52512073,52517220,Chr.X,Xp11.22,300289,"GAGED2, XAGE1","G antigen, family D, 2",XAGE1B,653067,ENSG00000204382,NA,NA,NA
X,52622934,52633947,Xp11.22,Xp11.22,300543,SSX8,"Sarcoma, synovial, X breakpoint 8",SSX8P,280659,NA,NA,NA,NA
X,52644060,52654899,Xp11.22,Xp11.22,300542,SSX7,"Sarcoma, synovial, X breakpoint 7",SSX7,280658,ENSG00000187754,NA,NA,NA
X,52696895,52707226,Xp11.22,Xp11.22,300192,SSX2,"Sarcoma, synovial, X breakpoint 2",SSX2,6757,ENSG00000241476,NA,"?Sarcoma, synovial, 300813 (3)",NA
X,52796143,52797426,Xp11,Xp11.22,300668,SPANXN5,"SPANX family, member N5",SPANXN5,494197,ENSG00000204363,NA,NA,NA
X,52862527,52868139,Xp11.22,Xp11.22,300740,"XAGE3, PLAC6","X antigen family, member 3",XAGE3,170626,ENSG00000171402,NA,NA,NA
X,53049323,53080614,Xp11.22,Xp11.22,300253,"GPR173, SREB3",G protein-coupled receptor 173,GPR173,54328,ENSG00000184194,NA,NA,Gpr173 (MGI:1918021)
X,53082366,53088539,Xp11.2,Xp11.22,300564,"TSPYL2, CDA1, DENTT, CINAP",TSPY-like 2,TSPYL2,64061,ENSG00000184205,NA,NA,Tspyl2 (MGI:106244)
X,53094156,53148007,Xp11.22,Xp11.22,301019,"KANTR, LINC01155","KDM5C adjacent transcript, noncoding",KANTR,102723508,NA,NA,NA,NA
X,53176276,53225421,Xp11.22-p11.21,Xp11.22,314690,"KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ","Lysine-specific demethylase 5C (Jumonji, AT-rich interactive domain 1C)",KDM5C,8242,ENSG00000126012,escapes inactivation,"Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3), X-linked recessive",Kdm5c (MGI:99781)
X,53225783,53321355,Xp11.22,Xp11.22,300522,"IQSEC2, KIAA0522, MRX1, MRX78",IQ motif- and Sec7 domain-containing protein 2,IQSEC2,23096,ENSG00000124313,NA,"Mental retardation, X-linked 1/78, 309530 (3), X-linked dominant",Iqsec2 (MGI:3528396)
X,53374148,53422727,Xp11.22-p11.21,Xp11.22,300040,"SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2","Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; DXS423E; SB1.8)",SMC1A,8243,ENSG00000072501,escapes lyonization,"Cornelia de Lange syndrome 2, 300590 (3), X-linked dominant",Smc1a (MGI:1344345)
X,53431257,53434375,Xp11.2,Xp11.22,300256,"HSD17B10, HADH2, ERAB, MRXS10, HSD10MD",17-beta-hydroxysteroid dehydrogenase X,HSD17B10,3028,ENSG00000072506,NA,"HSD10 mitochondrial disease, 300438 (3), X-linked dominant",Hsd17b10 (MGI:1333871)
X,53532095,53686722,Xp11.2,Xp11.22,300697,"HUWE1, UREB1, KIAA0312, LASU1, MRXST","HECT, UBA, and WWE domains-containing protein 1",HUWE1,10075,ENSG00000086758,NA,"Mental retardation, X-linked syndromic, Turner type, 309590 (3), X-linked",Huwe1 (MGI:1926884)
X,53556222,53556340,Xp11.22,Xp11.22,300810,"MIR98, MIRN98",Micro RNA 98,MIR98,407054,ENSG00000271886,NA,NA,NA
X,53557191,53557273,Xp11.22,Xp11.22,300721,"MIRLET7F2, LET7F2, MIRNLET7F2",Micro RNA Let7f2,MIRLET7F2,406889,ENSG00000208012,NA,NA,NA
X,53936679,54048934,Xp11.2,Xp11.22,300560,"PHF8, ZNF422, KIAA1111, MRXSSD",PHD finger protein 8,PHF8,23133,ENSG00000172943,NA,"Mental retardation syndrome, X-linked, Siderius type, 300263 (3), X-linked recessive",Phf8 (MGI:2444341)
X,54068323,54183283,Xp11.2,Xp11.22,300741,"FAM120C, CXorf17","Family with sequence similarity 120, member C",FAM120C,54954,ENSG00000184083,NA,NA,Fam120c (MGI:2387687)
X,54192822,54358694,Xp11.2,Xp11.22,300358,"WNK3, PRKWNK3, KIAA1566",WNK lysine deficient protein kinase 3,WNK3,65267,ENSG00000196632,NA,NA,Wnk3 (MGI:2652875)
X,54440374,54448031,Xp11.22,Xp11.22,300945,"TSR2, WGG1, DBA14","TSR2, 20S rRNA accumulation, S. cerevisiae, homolog of",TSR2,90121,ENSG00000158526,mutation identified in 1 DBA14 family,"?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3), X-linked recessive",Tsr2 (MGI:1916749)
X,54445453,54496233,Xp11.21,Xp11.22,300546,"FGD1, FGDY, AAS, MRXS16","FYVE, RhoGEF, and PH domain-containing protein 1",FGD1,2245,ENSG00000102302,NA,"Aarskog-Scott syndrome, 305400 (3), X-linked recessive; Mental retardation, X-linked syndromic 16, 305400 (3), X-linked recessive",Fgd1 (MGI:104566)
X,54530218,54567288,Xp11.22,Xp11.22,300873,GNL3L,Guanine nucleotide binding protein-like 3-like protein,GNL3L,54552,ENSG00000130119,NA,NA,Gnl3l (MGI:2448557)
X,54807744,54816014,Xp11.2,Xp11.21,300470,"MAGED2, MAGED, BARTS5","Melanoma antigen, family D, 2",MAGED2,10916,ENSG00000102316,NA,"Bartter syndrome, type 5, antenatal, transient, 300971 (3), X-linked recessive",Maged2 (MGI:1933391)
X,54814369,54814499,Xp11.21,Xp11.21,300662,SNORA11,"Small nucleolar RNA, H/ACA box, 11",SNORA11,677799,ENSG00000221716,in intron 1 of MAGED2,NA,NA
X,54920562,54931435,Xp11.22-p11.21,Xp11.21,300132,TRO,Trophinin,TRO,7216,ENSG00000067445,NA,NA,Tro (MGI:1928994)
X,54932960,55000051,Xp11.21,Xp11.21,311790,"PFKFB1, PFRX","Fructose-2,6-bisphosphatase",PFKFB1,5207,ENSG00000158571,?Xq27-q25; ?Xcen-q13,NA,Pfkfb1 (MGI:107816)
X,55000362,55009056,Xp11.21,Xp11.21,300773,"APEX2, APE2, XTH2, APEXL2",APEX nuclease (apurinic/apyrimidinic endonuclease) 2,APEX2,27301,ENSG00000169188,NA,NA,Apex2 (MGI:1924872)
X,55009054,55030976,Xp11.21,Xp11.21,301300,"ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1","Aminolevulinate, delta-, synthase-2",ALAS2,212,ENSG00000158578,NA,"Anemia, sideroblastic, 1, 300751 (3), X-linked recessive; Protoporphyria, erythropoietic, X-linked, 300752 (3), X-linked",Alas2 (MGI:87990)
X,55089017,55092841,Xp11.21,Xp11.21,300738,"PAGE2, GAGEC2","P antigen family, member 2",PAGE2,203569,ENSG00000234068,NA,NA,NA
X,55220345,55224107,Xp11.21,Xp11.21,301009,"PAGE5, CT16, GAGEE1","P antigen family, member 5",PAGE5,90737,ENSG00000158639,NA,NA,NA
X,55257600,55264915,Xp11.21,Xp11.21,300739,"PAGE3, GAGEC1","P antigen family, member 3",PAGE3,139793,ENSG00000204279,NA,NA,NA
X,55452126,55453565,Xp11.21,Xp11.21,300548,"MAGEH1, MAGEH","Melanoma antigen, family H, 1",MAGEH1,28986,ENSG00000187601,NA,NA,Mageh1 (MGI:1922875)
X,55623399,55626191,Xp11.21,Xp11.21,300949,"FOXR2, FOXN6",Forkhead box R2,FOXR2,139628,ENSG00000189299,NA,NA,Foxr2 (MGI:3511682)
X,55717676,55760208,Xp11.21,Xp11.21,300725,"RRAGB, RAGB",Ras-related GTP-binding protein B,RRAGB,10325,ENSG00000083750,NA,NA,Rragb (MGI:3038613)
X,55908122,56291530,Chr.X,Xp11.21,300286,"KLF8, ZNF741, BKLF3",Kruppel-like factor 8,KLF8,11279,ENSG00000102349,NA,NA,Klf8 (MGI:2442430)
X,56563592,56567009,Xp11.23-p11.1,Xp11.21,300264,"UBQLN2, PLIC2, CHAP1, ALS15",Ubiquilin 2,UBQLN2,29978,ENSG00000188021,NA,"Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3), X-linked dominant",Ubqln2 (MGI:1860283)
X,56729241,56819178,Xp11.1,Xp11.21,300992,"NBDY, LINC01420, NOBODY",Negative regulator of P-body association,NBDY,550643,ENSG00000204272,NA,NA,NA
X,57112141,57121904,Xp11.21,Xp11.21,300517,SPIN2,"Spindlin family, member 2",SPIN2B,474343,ENSG00000186787,NA,NA,"Gm21637,Spin2e,Spin2d,Gm5923,Gm3757,Gm5926,Gm2854,Spin2-ps4,Gm2892,Spin2-ps1,Gm21466,Spin2-ps3,Spin2-ps2 (MGI:1922101,MGI:3781932,MGI:3645924,MGI:3650966,MGI:3645574,MGI:5434847,MGI:5434821,MGI:3781070,MGI:3647272,MGI:3781026,MGI:3805546,MGI:5434992,MGI:3705652)"
X,57121860,57489195,Xp11,Xp11.21,300654,FAAH2,Fatty acid amide hydrolase 2,FAAH2,158584,ENSG00000165591,NA,NA,NA
X,57133042,57138687,Xp11.21,Xp11.21,300621,DSF34,DXF34 gene,SPIN2A,54466,ENSG00000147059,NA,NA,"Gm21637,Spin2e,Spin2d,Gm5923,Gm3757,Gm5926,Gm2854,Spin2-ps4,Gm2892,Spin2-ps1,Gm21466,Spin2-ps3,Spin2-ps2 (MGI:1922101,MGI:3781932,MGI:3645924,MGI:3650966,MGI:3645574,MGI:5434847,MGI:5434821,MGI:3781070,MGI:3647272,MGI:3781026,MGI:3805546,MGI:5434992,MGI:3705652)"
X,57591835,57597476,Xp11.21,Xp11.21,300236,ZXDB,"Zinc finger-encoding gene, X-linked, duplicated, B",ZXDB,158586,ENSG00000198455,NA,NA,Zxdb (MGI:3694898)
X,57905429,57910632,Xp11.21,Xp11.21,300235,ZXDA,"Zinc finger-encoding gene, X-linked, duplicated, A",ZXDA,7789,ENSG00000198205,NA,NA,NA
X,61000000,68500000,Xq11-q12,NA,300710,AGA2,"Alopecia, androgenetic, 2",NA,100188771,NA,associated with rs6152,"Alopecia, androgenetic, 2, 300710 (2)",NA
X,61000000,156040895,Xq,NA,300082,CGF1,"Cognitive function-1, social",CGF1,1083,NA,imprinted locus,"[Social cognition], 300082 (2), X-linked",NA
X,61000000,156040895,Xq,NA,300010,"DXS435E, A11",A-11 gene,NA,NA,NA,NA,NA,NA
X,61000000,156040895,Xq,NA,300125,MGR2,"Migraine, familial typical, susceptibility to, 2",NA,8249,NA,NA,"{Migraine, familial typical, susceptibility to, 2}, 300125 (2), X-linked",NA
X,61000000,156040895,Xq,NA,300259,MTBSX,"Mycobacterium tuberculosis, susceptibility to, X-linked",NA,57789,NA,NA,"{Mycobacterium tuberculosis, susceptibility, X-linked}, 300259 (2)",NA
X,63634966,63785545,Xq22.1,Xq11.1,300429,"ARHGEF9, PEM2, KIAA0424, EIEE8",Rho guanine nucleotide exchange factor 9,ARHGEF9,23229,ENSG00000131089,NA,"Epileptic encephalopathy, early infantile, 8, 300607 (3), X-linked recessive",Arhgef9 (MGI:2442233)
X,63800000,65400000,Xq11.2,NA,300266,SPG16,"Spastic paraplegia 16, X-linked, complicated",SPG16,57760,NA,NA,"Spastic paraplegia 16, X-linked, complicated, 300266 (2), X-linked recessive",NA
X,64185116,64205707,Xq11.1,Xq11.2,300647,"AMER1, FAM123B, WTX, OSCS",APC membrane recruitment protein 1,AMER1,139285,ENSG00000184675,NA,"Osteopathia striata with cranial sclerosis, 300373 (3), X-linked dominant",Amer1 (MGI:1919595)
X,64224193,64230606,Xq11.2,Xq11.2,300891,ASB12,Ankyrin repeat- and SOCS box-containing protein 12,ASB12,142689,ENSG00000198881,NA,NA,Asb12 (MGI:1917642)
X,64915801,65034740,Xq11.2,Xq11.2,300897,"ZC4H2, KIAA1166, WRWF, MRXS4",Zinc finger C4H2 domain-containing protein,ZC4H2,55906,ENSG00000126970,NA,"Wieacker-Wolff syndrome, 314580 (3), X-linked recessive",Zc4h2 (MGI:2679294)
X,65034814,65507886,Xq12,Xq11-q12,300889,"ZC3H12B, MCPIP2",Zinc finger CCCH domain-containing protein 12B,ZC3H12B,340554,ENSG00000102053,NA,NA,Zc3h12b (MGI:2442133)
X,65400000,99100000,Xq12-q21.3,NA,300454,MRX77,"Mental retardation, X-linked 77",MRX77,93991,NA,NA,"Mental retardation, X-linked 77, 300454 (2), X-linked recessive",NA
X,65400000,92700000,Xq12-q21.31,NA,300709,MRXS9,"Mental retardation, X-linked, syndromic 9",NA,NA,NA,between DXS1111 and DXS1197,"Mental retardation, X-linked, syndromic 9, 300709 (2)",NA
X,65512581,65534805,Xq12,Xq12,300964,"LAS1L, WTS",Las1-like ribosome biogenesis factor,LAS1L,81887,ENSG00000001497,NA,"Wilson-Turner syndrome, 309585 (3), X-linked recessive",Las1l (MGI:1923380)
X,65588381,65741930,Xq11.2-q12,Xq12,309845,"MSN, IMD50",Moesin,MSN,4478,ENSG00000147065,NA,"Immunodeficiency 50, 300988 (3), X-linked recessive",Msn (MGI:97167)
X,66018869,66018978,Xq12,Xq12,300694,"MIR223, MIRN223",Micro RNA 223,MIR223,407008,ENSG00000284567,NA,NA,NA
X,66021737,66040124,Xq12,Xq12,300353,Z39IG,Immunoglobulin superfamily protein Z39IG,VSIG4,11326,ENSG00000155659,NA,NA,Vsig4 (MGI:2679720)
X,66162525,66268862,Xq11-q12,Xq12,300167,HEPH,Hephaestin,HEPH,9843,ENSG00000089472,NA,NA,Heph (MGI:1332240)
X,66594383,66639302,Xq12,Xq12,300276,"EDAR2, XEDAR, EDAA2R",Ectodysplasin A2 receptor,EDA2R,60401,ENSG00000131080,NA,NA,Eda2r (MGI:2442860)
X,67544020,67730618,Xq11-q12,Xq12,313700,"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",Androgen receptor (dihydrotestosterone receptor),AR,367,ENSG00000169083,NA,"Androgen insensitivity, 300068 (3), X-linked recessive; Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive; Hypospadias 1, X-linked, 300633 (3), X-linked recessive; {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant, Somatic mutation; Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive",Ar (MGI:88064)
X,68042343,68433840,Xq12,Xq12,300127,"OPHN1, MRX60",Oligophrenin-1,OPHN1,4983,ENSG00000079482,NA,"Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3), X-linked recessive",Ophn1 (MGI:2151070)
X,68498361,68572458,Xq12-q13.1,Xq12-q13,300996,YIPF6,"YIP1 domain family, member 6",YIPF6,286451,ENSG00000181704,NA,NA,Yipf6 (MGI:1925179)
X,68500000,103300000,Xq13.1-q22.1,NA,300580,CFTDX,"Myopathy, congenital, with fiber-type disproportion, X-linked",NA,100188765,NA,between DXS8019 and DXS99,"Myopathy, congenital, with fiber-type disproportion, X-linked, 300580 (2), X-linked dominant",NA
X,68647668,68725841,Xq13.1,Xq13.1,300689,"STARD8, DLC3, STARTGAP3, KIAA0189",START domain-containing protein 8,STARD8,9754,ENSG00000130052,NA,NA,Stard8 (MGI:2448556)
X,68828996,68842163,Xq12,Xq13.1,300035,"EFNB1, EPLG2, CFNS, CFND",eph-related receptor tyrosine kinase ligand 2 (ephrin B1),EFNB1,1947,ENSG00000090776,?CFNS also on Xp22,"Craniofrontonasal dysplasia, 304110 (3), X-linked dominant",Efnb1 (MGI:102708)
X,69160745,69165515,Xq13.1,Xq13.1,300420,PJA1,Praja 1,PJA1,64219,ENSG00000181191,NA,NA,Pja1 (MGI:1101765)
X,69616085,70039471,Xq12-q13.1,Xq13.1,300451,"EDA, ED1, ECTD1, HED1, STHAGX1",Ectodysplasin A,EDA,1896,ENSG00000158813,NA,"Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3), X-linked recessive; Tooth agenesis, selective, X-linked 1, 313500 (3), X-linked dominant",NA
X,70040541,70049969,Xq13.1,Xq13.1,300925,"AWAT2, DC4, MFAT",Acyl-CoA wax alcohol acyltransferase 2,AWAT2,158835,ENSG00000147160,NA,NA,Awat2 (MGI:3045345)
X,70062456,70064178,Xq13.1,Xq13.1,300714,"OTUD6A, DUBA2",OTU domain-containing protein 6A,OTUD6A,139562,ENSG00000189401,NA,NA,Otud6a (MGI:3644685)
X,70133446,70166323,Xq13.1-q13.3,Xq13.1,300139,IGBP1,Immunoglobulin-binding protein 1,IGBP1,3476,ENSG00000089289,NA,"Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3), X-linked recessive",Igbp1 (MGI:1346500)
X,70177482,70205703,Xq13.1,Xq13.1,300926,"DGAT2L6, DC3",Diacylglycerol O-acyltransferase 2-like 6,DGAT2L6,347516,ENSG00000184210,NA,NA,Dgat2l6 (MGI:3045268)
X,70233488,70240660,Xq13.1,Xq13.1,300924,"AWAT1, DGA2",Acyl-CoA wax alcohol acyltransferase 1,AWAT1,158833,ENSG00000204195,NA,NA,Awat1 (MGI:3588200)
X,70258165,70259803,Xq13,Xq13.1,300038,"P2RY4, NRU, P2Y4","Pyrimidinergic receptor P2Y, G-protein coupled, 4",P2RY4,5030,ENSG00000186912,NA,NA,P2ry4 (MGI:1926594)
X,70268333,70281839,Xcen-q21,Xq13.1,301770,"ARR3, MYP26","Arrestin 3, retinal",ARR3,407,ENSG00000120500,NA,"Myopia 26, X-linked, female-limited, 301010 (3), X-linked",Arr3 (MGI:2159617)
X,70286594,70289957,Xq13.1,Xq13.1,300632,"PDZD11, AIPP1, PISP",PDZ domain-containing 11,PDZD11,51248,ENSG00000120509,NA,NA,Pdzd11 (MGI:1919871)
X,70290103,70420885,Xq13.1,Xq13.1,300521,"KIF4A, KIF4, MRX100",Kinesin family member 4A,KIF4A,24137,ENSG00000090889,mutation identified in 1 MRX100 family,"?Mental retardation, X-linked 100, 300923 (3), X-linked recessive",Kif4 (MGI:108389)
X,70423030,70433390,Xq13.1,Xq13.1,300940,"GDPD2, GDE3",Glycerophosphodiester phosphodiesterase domain-containing protein 2,GDPD2,54857,ENSG00000130055,NA,NA,Gdpd2 (MGI:1918834)
X,70444834,70505489,Xq13.1,Xq13.1,300189,"DLG3, NEDLG, SAP102, MRX90","Discs large, Drosophila, homolog of, 3",DLG3,1741,ENSG00000082458,NA,"Mental retardation, X-linked 90, 300850 (3), X-linked recessive",Dlg3 (MGI:1888986)
X,70511226,70908710,Xq13.1,Xq13.1,300311,"TEX11, SPGFX2",Testis-expressed gene 11,TEX11,56159,ENSG00000120498,NA,"Spermatogenic failure, X-linked, 2, 309120 (3), X-linked recessive",Tex11 (MGI:1933237)
X,70925578,70931095,Xq13.1,Xq13.1,300443,"SLC7A3, CAT3","Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3",SLC7A3,84889,ENSG00000165349,NA,NA,Slc7a3 (MGI:1100521)
X,71059246,71073425,Xq13.1,Xq13.1,300883,SNX12,Sorting nexin 12,SNX12,29934,ENSG00000147164,NA,NA,Snx12 (MGI:1919331)
X,71095850,71103533,Xq13.1,Xq13.1,300033,"FOXO4, MLLT7, AFX1",Forkhead box O4,FOXO4,4303,ENSG00000184481,NA,NA,Foxo4 (MGI:1891915)
X,71107403,71111630,Xq13,Xq13.1,308380,"IL2RG, SCIDX1, SCIDX, IMD4","Interleukin-2 receptor, gamma",IL2RG,3561,ENSG00000147168,linked to DXS159,"Combined immunodeficiency, X-linked, moderate, 312863 (3), X-linked recessive; Severe combined immunodeficiency, X-linked, 300400 (3), X-linked recessive",Il2rg (MGI:96551)
X,71118595,71142449,Xq13,Xq13.1,300188,"MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX","Mediator of RNA polymerase II transcription, subunit 12, S. cerevisiae, homolog of",MED12,9968,ENSG00000184634,NA,"Lujan-Fryns syndrome, 309520 (3), X-linked recessive; Ohdo syndrome, X-linked, 300895 (3), X-linked recessive; Opitz-Kaveggia syndrome, 305450 (3), X-linked recessive",Med12 (MGI:1926212)
X,71144388,71175306,Xq13,Xq13.1,300336,"NLGN3, ASPGX1, AUTSX1",Neuroligin 3,NLGN3,54413,ENSG00000196338,NA,"{Asperger syndrome susceptibility, X-linked 1}, 300494 (3), Isolated cases, X-linked, Multifactorial; {Autism susceptibility, X-linked 1}, 300425 (3), X-linked",Nlgn3 (MGI:2444609)
X,71215211,71225515,Xq13.1,Xq13.1,304040,"GJB1, CX32, CMTX1","Gap junction protein, beta-1, 32kD (connexin 32)",GJB1,2705,ENSG00000169562,NA,"Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3), X-linked dominant",Gjb1 (MGI:95719)
X,71239623,71255196,Xq13.1,Xq13.1,300061,"ZMYM3, ZNF261, DXS6673E","Zinc finger, MYM-type 3",ZMYM3,9203,ENSG00000147130,NA,NA,Zmym3 (MGI:1927231)
X,71283191,71301167,Xq13.1,Xq13.1,300084,"NONO, NRB54, MRXS34","Non-Pou domain-containing octamer (ATGCAAAT) binding protein (nuclear RNA-binding protein, 54-kD)",NONO,4841,ENSG00000147140,2Mb proximal to PHKA1,"Mental retardation, X-linked, syndromic 34, 300967 (3), X-linked",Nono (MGI:1855692)
X,71301749,71305370,Xq12-q13,Xq13.1,300332,ITGB1BP2,"Integrin, beta-1, binding protein of, 2",ITGB1BP2,26548,ENSG00000147166,NA,NA,Itgb1bp2 (MGI:1353420)
X,71366219,71530524,Xq13,Xq13.1,313650,"TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33","TAF1 RNA polymerase II, TATA box-binding protein-associated factor, 250kD",TAF1,6872,ENSG00000147133,SVA retrotransposon insertion,"Dystonia-Parkinsonism, X-linked, 314250 (3), X-linked recessive; Mental retardation, X-linked, syndromic 33, 300966 (3), X-linked recessive",Taf1 (MGI:1336878)
X,71491680,71492448,Xq12,Xq13.1,300452,"INGX, ING2","Inhibitor of growth, X-linked",INGX,27160,ENSG00000243468,NA,NA,NA
X,71533103,71575891,Xq13,Xq13.1,300255,"OGT, MRX106",O-linked N-acetylglucosamine transferase,OGT,8473,ENSG00000147162,NA,"Mental retardation, X-linked 106, 300997 (3), X-linked recessive",Ogt (MGI:1339639)
X,71578023,71613582,Xq13.1,Xq13.1,300369,ACRC,Acidic repeat-containing gene,GCNA,93953,ENSG00000147174,NA,NA,NA
X,71615912,71618514,Xq13,Xq13.1,300574,"CXCR3, GPR9, CD182","Chemokine, C-X-C motif, receptor 3 (G protein-coupled receptor-9)",CXCR3,2833,ENSG00000186810,previously assigned to chr.8,NA,Cxcr3 (MGI:1277207)
X,72181675,72263963,Xq13,Xq13.1,300252,"PIN4, PAR14, EPVH","Peptidyl-prolyl cis/trans isomerase, nima-interacting, 4",PIN4,5303,ENSG00000102309,NA,NA,Pin4 (MGI:1916963)
X,72204664,72239026,Xq13.1,Xq13.1,300687,"ERCC6L, PICH",ERCC6-like,ERCC6L,54821,ENSG00000186871,NA,NA,Ercc6l (MGI:2654144)
X,72272041,72277247,Xq13.1,Xq13.1,312760,"RPS4X, CCG2, SCAR","Ribosomal protein S4, X-linked",RPS4X,6191,ENSG00000198034,cen-RPS4X-PHKA1-XIST-qter in 2.6Mb,NA,NA
X,72301637,72307156,Xq13.1,Xq13.1,300149,MSG1,Melanocyte-specific gene 1,CITED1,4435,ENSG00000125931,NA,NA,Cited1 (MGI:108023)
X,72329515,72573102,Xq13,Xq13.1,300269,"HDAC8, MRXS6, CDLS5",Histone deacetylase 8,HDAC8,55869,ENSG00000147099,NA,"Cornelia de Lange syndrome 5, 300882 (3), X-linked dominant",Hdac8 (MGI:1917565)
X,72578813,72714305,Xq13,Xq13.1,311870,PHKA1,"Phosphorylase kinase, muscle, alpha polypeptide",PHKA1,5255,ENSG00000067177,?proximal and close to PGKA;,"Muscle glycogenosis, 300559 (3), X-linked recessive",Phka1 (MGI:97576)
X,72872024,72943930,Xq13,Xq13.1,300878,DMRTC1,Doublesex- and MAB3-related transcription factor C1,DMRTC1,63947,ENSG00000269502,NA,NA,NA
X,73000000,74700000,Xq13.2,NA,300262,MRXSAB,Abidi X-linked mental retardation syndrome,NA,57792,NA,NA,"Mental retardation, X-linked syndromic, Abidi type, 300262 (2)",NA
X,73212298,73214850,Xq13.2,Xq13.2,300026,"NAP1L2, BPX",Nucleosome assembly protein 1-like 2,NAP1L2,4674,ENSG00000186462,NA,NA,Nap1l2 (MGI:106654)
X,73447253,73454584,Xq13.2,Xq13.2,300025,CDX4,Caudal type homeo box transcription factor 4,CDX4,1046,ENSG00000131264,NA,NA,Cdx4 (MGI:88362)
X,73563044,73687108,Xq13.2,Xq13.2,300922,"CHIC1, BRX",Cystein-rich hydrophobic domain protein 1,CHIC1,53344,ENSG00000204116,NA,NA,Chic1 (MGI:1344694)
X,73792204,73829230,Xq13.2,Xq13.2,300181,TSIX,X-inactivation-specific transcript-antisense,TSIX,9383,ENSG00000270641,NA,NA,NA
X,73820650,73852752,Xq13.2,Xq13.2,314670,"XIC, XCE, XIST, SXI1",X chromosome controlling element (X-inactivation center),XIST,7503,ENSG00000229807,"q13-q21; metaphase bend, or fold, at q13.3-q21.1","X-inactivation, familial skewed, 300087 (3)",NA
X,73944323,74070383,Xq13.2,Xq13.2,300832,"NCRNA00183, JPX, ENOX",Noncoding RNA 183,JPX,554203,ENSG00000225470,NA,NA,NA
X,74028135,74293573,Xq13.2,Xq13.2,300936,"FTX, LINC00182","FTX transcript, XIST regulator, noncoding",FTX,100302692,ENSG00000230590,NA,NA,NA
X,74421492,74533915,Xq13.2,Xq13.2,300095,"SLC16A2, DXS128, XPCT","Solute carrier family 16 (monocarboxylic acid transporters), member 2",SLC16A2,6567,ENSG00000147100,NA,"Allan-Herndon-Dudley syndrome, 300523 (3), X-linked",Slc16a2 (MGI:1203732)
X,74582975,74614623,Xq13-q21,Xq13.2,300379,"RLIM, RNF12, TOKAS","RING finger protein, LIM domain-interacting",RLIM,51132,ENSG00000131263,NA,"Tonne-Kalscheuer syndrome, 300978 (3), X-linked",Rlim (MGI:1342291)
X,74732855,74925451,Xq13.2,Xq13.3,300524,"NEXMIF, KIAA2022, MRX98",Neurite extension and migration factor,NEXMIF,340533,ENSG00000050030,inv(X)(q13;p22),"Mental retardation, X-linked 98, 300912 (3), X-linked dominant",Nexmif (MGI:2148050)
X,75051047,75156282,Xq13.1-q13.3,Xq13.3,300135,"ABCB7, ABC7, ASAT",ATP-binding cassette-7,ABCB7,22,ENSG00000131269,NA,"Anemia, sideroblastic, with ataxia, 301310 (3), X-linked recessive",Abcb7 (MGI:109533)
X,75156368,75304896,Xq13.3,Xq13.3,300656,UPRT,"Uracil phosphoribosyltransferase, S. cerevisiae, homolog of",UPRT,139596,ENSG00000094841,NA,NA,Uprt (MGI:2685620)
X,75368426,75523501,Xq13.3,Xq13.3,300576,"ZDHHC15, MRX91",Zinc finger DHHC domain-containing protein 15,ZDHHC15,158866,ENSG00000102383,disruption of ZDHHC15 identified in 1 patient,"?Mental retardation, X-linked 91, 300577 (3), X-linked dominant",Zdhhc15 (MGI:1915336)
X,75582653,75585916,Xq13.3,Xq13.3,300956,BRAFP1,BRAF pseudogene 1,BRAFP1,286494,NA,NA,NA,NA
X,75782986,75785253,Xq13.1,Xq13.3,300760,MAGEE2,"Melanoma antigen, family E, 2",MAGEE2,139599,ENSG00000186675,NA,NA,Magee2 (MGI:2148316)
X,76427709,76431341,Xq13.1,Xq13.3,300759,"MAGEE1, DAMAGE, KIAA1587","Melanoma antigen, family E, 1",MAGEE1,57692,ENSG00000198934,NA,NA,Magee1 (MGI:2148149)
X,76800000,99100000,Xq21,NA,303110,"DELXq21, CXDELq21",Chromosome Xq21 deletion syndrome,NA,NA,NA,at least CHM and POU3F4 deleted,"Choroideremia, deafness, and mental retardation, 303110 (4), X-linked recessive",NA
X,76800000,129500000,Xq21-q25,NA,300557,PARK12,Parkinson disease-12,PARK12,677662,NA,"max lod with DXS1106, DXS8055, DXS1001","{Parkinson disease 12}, 300557 (2)",NA
X,77447388,77457277,Xq21.1,Xq21.1,300827,"FGF16, MF4",Fibroblast growth factor 16,FGF16,8823,ENSG00000196468,previously mapped to 8q21.3,"Metacarpal 4-5 fusion, 309630 (3), X-linked recessive",Fgf16 (MGI:1931627)
X,77504877,77786234,Xq13,Xq21.1,300032,"ATRX, XH2, XNP, SHS, SFM1, MRXHF1",ATR-X gene (helicase 2; X-linked nuclear protein),ATRX,546,ENSG00000085224,NA,"Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Alpha-thalassemia/mental retardation syndrome, 301040 (3), X-linked dominant; Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3), X-linked recessive",Atrx (MGI:103067)
X,77825746,77895567,Xq13.1-q13.2,Xq21.1,300715,"MAGT1, IAP, XMEN",Magnesium transporter 1,MAGT1,84061,ENSG00000102158,NA,"Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)",Magt1 (MGI:1914325)
X,77899467,77907375,Xq21.1,Xq21.1,300885,"COX7B, LSDMCA2","Cytochrome c oxidase, subunit VIIb",COX7B,1349,ENSG00000131174,NA,"Linear skin defects with multiple congenital anomalies 2, 300887 (3), X-linked dominant",Cox7b (MGI:1913392)
X,77910655,78050394,Xq12-q13,Xq21.1,300011,"ATP7A, MNK, MK, OHS, SMAX3","ATPase, Cu++ transporting, alpha polypeptide",ATP7A,538,ENSG00000165240,"probably Xq13.2-q13.3, ~150kb prox. to PGK1","Menkes disease, 309400 (3), X-linked recessive; Occipital horn syndrome, 304150 (3), X-linked recessive; Spinal muscular atrophy, distal, X-linked 3, 300489 (3), X-linked recessive",Atp7a (MGI:99400)
X,77967948,77969637,Xq13.3,Xq21.1,300567,"PGAM4, PGAM3",Phosphoglycerate mutase family member 4,PGAM4,441531,ENSG00000226784,NA,NA,NA
X,78104247,78129294,Xq13,Xq21.1,311800,"PGK1, PGKA",Phosphoglycerate kinase-1,PGK1,5230,ENSG00000102144,"?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6","Phosphoglycerate kinase 1 deficiency, 300653 (3), X-linked recessive",Pgk1 (MGI:97555)
X,78129747,78139649,Xq13.1-q22.1,Xq21.1,300754,"TAF9B, TAF9L, TAFII31L","TAF9B RNA polymerase II, TATA box-binding protein-associated factor, 31kD",TAF9B,51616,ENSG00000187325,NA,NA,Taf9b (MGI:3039562)
X,78271467,78327690,Xq13-q21,Xq21.1,300201,"CYSLTR1, CYSLT1",Cysteinyl leukotriene receptor 1,CYSLTR1,10800,ENSG00000173198,NA,NA,Cysltr1 (MGI:1926218)
X,78747657,78758713,Xq13-q21.1,Xq21.1,300086,"LPAR4, LPA4, P2RY9, P2Y9, GPR23",Lysophosphatidic acid receptor 4,LPAR4,2846,ENSG00000147145,NA,NA,Lpar4 (MGI:1925384)
X,78945331,78963726,Xq21.1,Xq21.1,300529,"P2RY10, P2Y10","Purinergic receptor P2Y, G protein-coupled, 10",P2RY10,27334,ENSG00000078589,NA,NA,P2ry10 (MGI:1926076)
X,79170971,79175317,Xq21.1,Xq21.1,300903,"GPR174, GPCR17",G protein-coupled receptor 174,GPR174,84636,ENSG00000147138,NA,NA,Gpr174 (MGI:2685222)
X,79360383,79367551,Xq13.3-q21.2,Xq21.1,300222,"ITM2A, E25A",Integral membrane protein 2A,ITM2A,9452,ENSG00000078596,NA,NA,Itm2a (MGI:107706)
X,80014752,80031773,Xq12-q21,Xq21.1,300307,"TBX22, CPX, ABERS",T-box 22,TBX22,50945,ENSG00000122145,1 ABERS family identified with mutation,"?Abruzzo-Erickson syndrome, 302905 (3), X-linked; Cleft palate with ankyloglossia, 303400 (3), X-linked",Tbx22 (MGI:2389465)
X,80335438,80446884,Xq21.1,Xq21.1,300976,FAM46D,"Family with sequence similarity 46, member D",TENT5D,169966,ENSG00000174016,NA,NA,Tent5d (MGI:2685223)
X,80669502,80809876,Xq13,Xq21.1,300553,"BRWD3, MRX93",Bromodomain-and WD repeat-containing protein 3,BRWD3,254065,ENSG00000165288,NA,"Mental retardation, X-linked 93, 300659 (3), X-linked recessive",Brwd3 (MGI:3029414)
X,81113698,81201912,Xq13,Xq21.1,300385,NSBP1,Nucleosomal binding protein 1,HMGN5,79366,ENSG00000198157,NA,NA,NA
X,81201983,81298546,Xq13.3,Xq21.1,300190,SH3BGR,SH3-binding domain glutamic acid-rich protein-like,SH3BGRL,6451,ENSG00000131171,NA,NA,Sh3bgrl (MGI:1930849)
X,83508289,83512126,Xq21.1,Xq21.1,300039,"POU3F4, DFN3, DFNX2","POU domain, class 3, transcription factor 4",POU3F4,5456,ENSG00000196767,NA,"Deafness, X-linked 2, 304400 (3), X-linked recessive",Pou3f4 (MGI:101894)
X,83861125,83886699,Xq21.1,Xq21.1,300768,CYLC1,Cylicin 1,CYLC1,1538,ENSG00000183035,NA,NA,NA
X,84058345,84188198,Xq21,Xq21.1,300303,"RPS6KA6, RSK4","Ribosomal protein S6 kinase, 90kD, 6",RPS6KA6,27330,ENSG00000072133,NA,NA,Rps6ka6 (MGI:1914321)
X,84317877,84502577,Xq21.1,Xq21.1,300994,"HDX, CXorf43",Highly divergent homeobox,HDX,139324,ENSG00000165259,NA,NA,Hdx (MGI:2685226)
X,85003851,85093314,Xq21.2,Xq21.1,300955,"APOOL, FAM121A, Cxorf33",Apolipoprotein O-like,APOOL,139322,ENSG00000155008,NA,NA,Apool (MGI:1915367)
X,85243819,85273361,Xq21.1-q21.3,Xq21.1,314990,"ZNF711, ZNF6, CMPX1, MRX97",Zinc finger protein-711,ZNF711,7552,ENSG00000147180,NA,"Mental retardation, X-linked 97, 300803 (3), X-linked",Zfp711 (MGI:3045342)
X,85277395,85379708,Xq21,Xq21.1,300603,"FLJ22792, POF1B, POF2B",FLJ22792 gene,POF1B,79983,ENSG00000124429,mutation identified in 1 POF2B family,"?Premature ovarian failure 2B, 300604 (3), X-linked recessive",Pof1b (MGI:1916943)
X,85861179,86047557,Xq21.2,Xq21.2,300390,"CHM, TCD",Rab escort protein 1,CHM,1121,ENSG00000188419,NA,"Choroideremia, 303100 (3), X-linked dominant",Chm (MGI:892979)
X,86148450,86832601,Xq21.3,Xq21.2,300608,DACH2,"Dachshund, Drosophila, homolog of, 2",DACH2,117154,ENSG00000126733,NA,NA,Dach2 (MGI:1890446)
X,87000000,99100000,Xq21.3,NA,300756,AD16,Alzheimer disease 16,NA,100271718,NA,associated with rs5984894,"{Alzheimer disease 16}, 300756 (2)",NA
X,87517729,87670049,Xq21.3,Xq21.31,300348,KLHL4,Kelch-like 4,KLHL4,56062,ENSG00000102271,NA,NA,Klhl4 (MGI:2442829)
X,89921907,89922882,Xp21.3,Xq21.31,300411,"TGIF2LX, TGIFLX","Transforming growth factor-beta-induced factor 2-like, X-linked",TGIF2LX,90316,ENSG00000153779,NA,NA,"Tgif2lx2,Tgif2lx1 (MGI:3800824,MGI:2387796)"
X,91434838,91438583,Xq21.3,Xq21.31,300407,"PABPC5, PABP5","Polyadenylate-binding protein, cytoplasmic, 5",PABPC5,140886,ENSG00000174740,NA,NA,Pabpc5 (MGI:2136401)
X,91779309,92623229,Xq21.3,Xq21.31,300246,"PCDH11X, PCDH11, PCDHX","Protocadherin 11, X-linked",PCDH11X,27328,ENSG00000102290,NA,NA,Pcdh11x (MGI:2442849)
X,93670929,93673577,Xq21.3-q22,Xq21.32,300117,NAP1L3,Nucleosome assembly protein 1-like 3,NAP1L3,4675,ENSG00000186310,NA,NA,Nap1l3 (MGI:1859565)
X,94300000,117400000,Xq21.33-q23,NA,300861,MRXSCS,"Mental retardation, X-linked, syndromic, Chudley-Schwartz type",NA,100820761,NA,max lod at DXS1120,"Mental retardation, X-linked, syndromic, Chudley-Schwartz type, 300861 (2), X-linked recessive",NA
X,96684662,97604996,Xq22,Xq21.33,300108,"DIAPH2, DIA, POF2A","Diaphanous, Drosophila, homolog of, 2",DIAPH2,1730,ENSG00000147202,mutation identified in 1 POF2A family,"?Premature ovarian failure 2A, 300511 (3), X-linked dominant",NA
X,96883907,96885466,Xq21.33,Xq21.33,300767,RPA4,Replication protein A4,RPA4,29935,ENSG00000204086,NA,NA,NA
X,97528363,97564534,Xq21-q22,Xq21.33,300347,EPAG,Early lymphoid activation gene,DIAPH2-AS1,10824,ENSG00000236256,NA,NA,NA
X,99100000,156040895,Xq22-q28,NA,301201,"AI1E2, AIH3","Amelogenesis imperfecta, hypomaturation or hypoplastic type, X-linked 2",AIH3,201,NA,NA,"?Amelogenesis imperfecta, type IE, X-linked 2, 301201 (2), X-linked",NA
X,100291643,100410272,Xq22,Xq22.1,300460,"PCDH19, KIAA1313, EFMR, EIEE9",Protocadherin 19,PCDH19,57526,ENSG00000165194,NA,"Epileptic encephalopathy, early infantile, 9, 300088 (3), X-linked",Pcdh19 (MGI:2685563)
X,100584935,100599884,Xq22,Xq22.1,300459,"TNMD, TEM, CHM1L",Tenomodulin,TNMD,64102,ENSG00000000005,NA,NA,Tnmd (MGI:1929885)
X,100627107,100637103,Xq22,Xq22.1,300191,"TSPAN6, TM4SF6",Tetraspanin 6,TSPAN6,7105,ENSG00000000003,NA,NA,Tspan6 (MGI:1926264)
X,100644198,100675787,Xq21.33-q23,Xq22.1,300642,"SRPX2, SRPUL, RESDX","SUSHI repeat-containing protein, X-linked, 2",SRPX2,27286,ENSG00000102359,mutation identified in 1 RESDX family,"?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)",Srpx2 (MGI:1916042)
X,100671963,100732136,Xq21.33,Xq22.1,300723,SYTL4,Synaptotagmin-like 4,SYTL4,94121,ENSG00000102362,NA,NA,Sytl4 (MGI:1351606)
X,100820358,100843533,Xq22.1,Xq22.1,300907,CSTF64,"Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD",CSTF2,1478,ENSG00000101811,NA,NA,Cstf2 (MGI:1343054)
X,100843323,100874358,Xq22,Xq22.1,300225,"NOX1, MOX1, NOH1",NADPH oxidase 1,NOX1,27035,ENSG00000007952,NA,NA,Nox1 (MGI:2450016)
X,100886918,100957400,Xq22.1,Xq22.1,300684,"XKRX, XPLAC, XKR2, XRG2","X Kell blood group precursor-related, X-linked",XKRX,402415,ENSG00000182489,NA,NA,Xkrx (MGI:3584011)
X,101098158,101181846,Xq22,Xq22.1,300065,"FSHPRH1, LRPR1","FSH primary response, rat, homolog of, 1",CENPI,2491,ENSG00000102384,NA,NA,Cenpi (MGI:2147897)
X,101219785,101264496,Xq22,Xq22.1,300052,DRP2,Dystrophin-related protein 2,DRP2,1821,ENSG00000102385,NA,NA,Drp2 (MGI:107432)
X,101268256,101293082,Chr.X,Xq22.1,300314,"TAF7L, TAF2Q","TAF7-like RNA polymerase II, TATA box-binding protein-associated factor, 50kD",TAF7L,54457,ENSG00000102387,NA,NA,Taf7l (MGI:1921719)
X,101345660,101348741,Xq22,Xq22.1,300356,"TIMM8A, DFN1, DDP, MTS, DDP1","Translocase of inner mitochondrial membrane 8, yeast, homolog of, A",TIMM8A,1678,ENSG00000126953,NA,"Mohr-Tranebjaerg syndrome, 304700 (3), X-linked recessive",Timm8a1 (MGI:1353433)
X,101349446,101390795,Xq21.3-q22,Xq22.1,300300,"BTK, AGMX1, IMD1, XLA, AT, IGHD3",Bruton agammaglobulinemia tyrosine kinase,BTK,695,ENSG00000010671,NA,"Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive; Isolated growth hormone deficiency, type III, with agammaglobulinemia, 307200 (3), X-linked recessive",Btk (MGI:88216)
X,101391010,101396154,Xq22.1,Xq22.1,300902,"RPL36A, RPL44",Ribosomal protein L36A,RPL36A,6173,ENSG00000241343,NA,NA,NA
X,101397790,101408012,Xq22,Xq22.1,300644,GLA,"Galactosidase, alpha",GLA,2717,ENSG00000102393,NA,"Fabry disease, 301500 (3), X-linked; Fabry disease, cardiac variant, 301500 (3), X-linked",Gla (MGI:1347344)
X,101408132,101414139,Xq22,Xq22.1,300610,"HNRNPH2, NRPH2, MRXSB",Heterogeneous nuclear ribonucleoprotein H2,HNRNPH2,3188,ENSG00000126945,"second signal at 6q25.3-q26, pseudogene?","Mental retardation, X-linked, syndromic, Bain type, 300986 (3), X-linked dominant",Hnrnph2 (MGI:1201779)
X,101550546,101554699,Xq21.33-q22.2,Xq22.1,300362,"ARMCX1, ALEX1","Armadillo repeat containing, X-linked 1",ARMCX1,51309,ENSG00000126947,NA,NA,Armcx1 (MGI:1925498)
X,101623129,101631909,Xq21.33-q22.2,Xq22.1,300364,"ARMCX3, ALEX3","Armadillo repeat containing, X-linked 3",ARMCX3,51566,ENSG00000102401,NA,NA,Armcx3 (MGI:1918953)
X,101655280,101659877,Xq21.33-q22.2,Xq22.1,300363,"ARMCX2, ALEX2, KIAA0512","Armadillo repeat containing, X-linked 2",ARMCX2,9823,ENSG00000184867,NA,NA,Armcx2 (MGI:1914666)
X,101832111,101857576,Xq22.1,Xq22.1,300319,NXF5,Nuclear RNA export factor 5,NXF5,55998,ENSG00000126952,NA,NA,NA
X,101882287,101932134,Xq22.1,Xq22.1,301007,"ZMAT1, KIAA1789","Zinc finger, matrin-type 1",ZMAT1,84460,ENSG00000166432,NA,NA,Zmat1 (MGI:2442284)
X,102153706,102155976,Xq22.1,Xq22.1,300693,"BEX5, NGFRAP1L1",BEX family member 5,BEX5,340542,ENSG00000184515,NA,NA,NA
X,102247099,102326719,Chr.X,Xq22.1,300315,NXF2,Nuclear RNA export factor 2,NXF2,56001,ENSG00000269405,NA,NA,Nxf2 (MGI:1933192)
X,102513681,102516738,Xq22.1,Xq22.1,300939,"TMSB15A, TMSB15, TMSNB","Thymosin, beta-15A",TMSB15A,11013,ENSG00000158164,NA,NA,NA
X,102549964,102571692,Xq22.1-q22.3,Xq22.1,300318,NXF4,Nuclear RNA export factor 4,NXF4,55999,ENSG00000196970,NA,NA,NA
X,102651365,102659082,Xq22,Xq22.1,300417,"GPRASP1, GASP, KIAA0443",G protein-coupled receptor-associated sorting protein 1,GPRASP1,9737,ENSG00000198932,conflicting assignment to chr.9,NA,Gprasp1 (MGI:1917418)
X,102712175,102717732,Xq22.1,Xq22.1,300969,"GPRASP2, GASP2, DFNX7",G protein-coupled receptor-associated sorting protein 2,GPRASP2,114928,ENSG00000158301,mutation identified in 1 DFNX7 family,"?Deafness, X-linked 7, 301018 (3), X-linked recessive",NA
X,102720742,102753539,Xq22.1,Xq22.1,300921,"BHLHB9, P60TRP, KIAA1701","Basic helix-loop-helix domain-containing protein, class B, 9",BHLHB9,80823,ENSG00000198908,NA,NA,Bhlhb9 (MGI:1917487)
X,102937271,102938299,Xq22.2,Xq22.1,300405,"RAB40AL, RLGP, MRXSMP","Ras-associated protein, RAB40A-like",RAB40AL,282808,ENSG00000102128,NA,NA,NA
X,103062650,103064170,Xq22.1-q22.2,Xq22.1,300690,BEX1,Brain-expressed X-linked gene 1,BEX1,55859,ENSG00000133169,NA,NA,Bex2 (MGI:1338017)
X,103075809,103093142,Xq21.3-q22.3,Xq22.1,300316,NXF3,Nuclear RNA export factor 3,NXF3,56000,ENSG00000147206,NA,NA,Nxf3 (MGI:2685230)
X,103215091,103217245,Xq22.2,Xq22.1,300692,BEX4,BEX family member 4,BEX4,56271,ENSG00000102409,NA,NA,Bex4 (MGI:3606746)
X,103300000,138900000,Xq22.2-q26,NA,300324,MRX53,"Mental retardation, X-linked-53",MRX53,4416,NA,NA,"Mental retardation, X-linked 53, 300324 (2), X-linked recessive",NA
X,103309345,103310989,Xq22,Xq22.2,300691,BEX2,Brain-expressed X-linked gene 2,BEX2,84707,ENSG00000133134,NA,NA,NA
X,103330185,103332325,Xq22.1-q22.3,Xq22.2,300771,TCEAL7,Transcription elongation factor A-like 7,TCEAL7,56849,ENSG00000182916,NA,NA,Tceal7 (MGI:1915746)
X,103376322,103378163,Xq22.1-q23,Xq22.2,300361,"NGFRAP1, BEX3, NADE, DXS6984E",Nerve growth factor receptor (TNFRSF16) associated protein 1,BEX3,27018,ENSG00000166681,NA,NA,Bex3 (MGI:1338016)
X,103628715,103630952,Xq22.1,Xq22.2,300237,"TCEAL1, P21, SIIR",Transcription elongation factor A-like 1,TCEAL1,9338,ENSG00000172465,NA,NA,Tceal1 (MGI:2385317)
X,103675497,103688157,Xq22,Xq22.2,300409,"MORFL2, MRGX, KIAA0026",Mortality factor 4-like 2,MORF4L2,9643,ENSG00000123562,NA,NA,Morf4l2 (MGI:1927167)
X,103776323,103832281,Xq22.1-q22.3,Xq22.2,300285,"RAB9B, RAB9L",RAS-associated protein RAB9B,RAB9B,51209,ENSG00000123570,NA,NA,Rab9b (MGI:2442454)
X,103776505,103792618,Xq22,Xq22.2,300401,"PLP1, PMD, HLD1, SPG2",Proteolipid protein 1,PLP1,5354,ENSG00000123560,NA,"Pelizaeus-Merzbacher disease, 312080 (3), X-linked recessive; Spastic paraplegia 2, X-linked, 312920 (3), X-linked recessive",Plp1 (MGI:97623)
X,103918895,103974425,Xq22.2,Xq22.2,301011,TMSB15B,"Thymosin, beta-15B",TMSB15B,286527,ENSG00000158427,opposite strand relative to TMSB15A,NA,NA
X,104011146,104013686,Xq22.2,Xq22.2,300507,H2BFWT,"H2B histone family, member W, testis-specific",H2BFWT,158983,ENSG00000123569,NA,NA,NA
X,104099213,104157008,Xq22.2,Xq22.2,300941,SLC25A53,"Solute carrier family 25, member 53",SLC25A53,401612,ENSG00000269743,NA,NA,Slc25a53 (MGI:1914312)
X,104250037,104254932,Xq22.1-q22.3,Xq22.2,300154,"ESX1L, ESXR1",ESX1-like protein,ESX1,80712,ENSG00000123576,NA,NA,NA
X,104500000,109400000,Xq22.3,NA,300194,"AMMEC, DELXq22.3, CXDELq22.3","Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (AMME complex)",NA,NA,NA,contiguous gene deletion syndrome,"Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis, 300194 (4)",NA
X,104500000,109400000,Xq22.3,NA,300581,FGS5,FG syndrome 5,FGS5,780900,NA,NA,"FG syndrome 5, 300581 (2)",NA
X,104566198,105769728,Xq22,Xq22.3,300277,IL1RAPL2,Interleukin 1 receptor accessory protein-like 2,IL1RAPL2,26280,ENSG00000189108,NA,NA,Il1rapl2 (MGI:1913106)
X,105218928,105220692,Chr.X,Xq22.3,300312,TEX13A,Testis-expressed gene 13A,TEX13A,56157,ENSG00000268629,NA,NA,Tex13a (MGI:1915194)
X,105821941,105958609,Xq22.3,Xq22.3,300791,"NRK, NESK",NIK-related kinase,NRK,203447,ENSG00000123572,NA,NA,Nrk (MGI:1351326)
X,106032434,106038726,Xq22.2,Xq22.3,314200,"TBG, TBGQTL",Thyroxine-binding globulin,SERPINA7,6906,ENSG00000123561,NA,"[Thyroxine-binding globulin QTL], 300932 (3), X-linked",Serpina7 (MGI:3041197)
X,106693837,106797015,Xq22.3,Xq22.3,300439,"RNF128, GRAIL",Ring finger protein 128,RNF128,79589,ENSG00000133135,NA,NA,Rnf128 (MGI:1914139)
X,106802672,106876149,Xq22.3,Xq22.3,301027,"TBC1D8B, NPHS20","TBC1 domain family, member 8B",TBC1D8B,54885,ENSG00000133138,NA,"Nephrotic syndrome, type 20, 301028 (3)",Tbc1d8b (MGI:1918101)
X,106900062,106903340,Xq22.3,Xq22.3,300575,RIPPLY1,"Ripply1, zebrafish, homolog of",RIPPLY1,92129,ENSG00000147223,NA,NA,NA
X,106900163,106930860,Xq22.3-q23,Xq22.3,300520,CLDN2,Claudin 2,CLDN2,9075,ENSG00000165376,NA,NA,Cldn2 (MGI:1276110)
X,106940299,107000243,Xq22.3,Xq22.3,300970,"MORC4, ZCW4, ZCWCC2",MORC family CW-type zinc finger protein 4,MORC4,79710,ENSG00000133131,NA,NA,Morc4 (MGI:1922996)
X,107206610,107244246,Xq22.3,Xq22.3,300933,"PIH1D3, CILD36",PIH1 domain-containing protein 3,PIH1D3,139212,ENSG00000080572,NA,"Ciliary dyskinesia, primary, 36, X-linked, 300991 (3), X-linked recessive","Pih1h3b,Pih1d3 (MGI:3607720,MGI:1921958)"
X,107272463,107276555,Xq22-q23,Xq22.3,310310,MYCL2,MYCL-related processed gene,MYCLP1,4611,NA,pseudogene on Xq27.3,NA,NA
X,107522449,107605263,Xq22.3,Xq22.3,301005,"FRMPD3, KIAA1817",FERM- and PDZ domain-containing protein 3,FRMPD3,84443,ENSG00000147234,NA,NA,NA
X,107628423,107651025,Xq22-q24,Xq22.3,311850,"PRPS1, CMTX5, DFNX1, DFN2",Phosphoribosyl pyrophosphate synthetase-1,PRPS1,5631,ENSG00000147224,NA,"Arts syndrome, 301835 (3), X-linked recessive; Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3), X-linked recessive; Deafness, X-linked 1, 304500 (3), X-linked; Gout, PRPS-related, 300661 (3), X-linked recessive; Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3), X-linked recessive",Prps1 (MGI:97775)
X,107713220,107777328,Xq22.2,Xq22.3,300506,"TSC22D3, DSIPI, GILZ","TSC22 domain family, member 3",TSC22D3,1831,ENSG00000157514,NA,NA,Tsc22d3 (MGI:1196284)
X,107820452,107931636,Xq22,Xq22.3,300204,"MID2, MRX101",Midline 2,MID2,11043,ENSG00000080561,mutation identified in 1 MRX101 family,"?Mental retardation, X-linked 101, 300928 (3), X-linked recessive",Mid2 (MGI:1344333)
X,107980863,107982369,Chr.X,Xq22.3,300313,TEX13B,Testis-expressed gene 13B,TEX13B,56156,ENSG00000170925,NA,NA,Tex13b (MGI:1890544)
X,108018885,108079183,Xq22.1-q22.3,Xq22.3,300620,"VSIG1, GPA34",V-set and immunoglobulin domains-containing protein 1,VSIG1,340547,ENSG00000101842,NA,NA,Vsig1 (MGI:1926039)
X,108084204,108091643,Xq22.3,Xq22.3,300880,"PSMD10, p28","Proteasome 26S subunit, non-ATPase, 10",PSMD10,5716,ENSG00000101843,NA,NA,Psmd10 (MGI:1858898)
X,108091666,108154670,Xq22,Xq22.3,300663,"ATG4A, APG4A, AUTL2","Autophagy 4, S. cerevisiae, homolog of, A",ATG4A,115201,ENSG00000101844,NA,NA,Atg4a (MGI:2147903)
X,108155606,108439492,Xq22.3,Xq22.3,303631,"COL4A6, DELXq22.3, CXDELq22.3, DFNX6","Collagen IV, alpha-6 polypeptide",COL4A6,1288,ENSG00000197565,mutation identified in 1 DFNX6 family,"?Deafness, X-linked 6, 300914 (3), X-linked recessive",Col4a6 (MGI:2152695)
X,108439837,108697544,Xq22.3,Xq22.3,303630,"COL4A5, ATS1","Collagen IV, alpha-5 polypeptide",COL4A5,1287,ENSG00000188153,diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6,"Alport syndrome 1, X-linked, 301050 (3), X-linked dominant",Col4a5 (MGI:88456)
X,108719948,108736583,Xq22.3,Xq22.3,300904,IRS4,Insulin receptor substrate 4,IRS4,8471,ENSG00000133124,NA,NA,NA
X,109372060,109482085,Xq22,Xq22-q23,300041,"GUCY2F, GUC2F",Guanylate cyclase 2F,GUCY2F,2986,ENSG00000101890,NA,NA,Gucy2f (MGI:105119)
X,109400000,138900000,Xq23-q26,NA,300464,CHDS3,"Coronary heart disease, susceptibility to, 3",NA,387573,NA,NA,"{Coronary heart disease, susceptibility to, 3}, 300464 (2)",NA
X,109400000,117400000,Xq23,NA,300711,IHPS4,"Pyloric stenosis, infantile hypertrophic, 4",NA,100188772,NA,max lod at rs3027802,"Pyloric stenosis, infantile hypertrophic, 4, 300711 (2)",NA
X,109400000,121800000,Xq23-q24,NA,300046,MRX23,"Mental retardation, X-linked-23",MRX23,4387,NA,"other MRX in same region MRX27, MRX30, MRX35, MRX47, MRX80","Mental retardation, X-linked 23, 300046 (2), X-linked",NA
X,109400000,143000000,Xq23-q27.2,NA,300613,MYP13,Myopia 13,MYP13,677764,NA,between DXS1210 and DXS1227,"Myopia 13, 300613 (2)",NA
X,109535823,109544697,Xq23,Xq23,300320,NXT2,NTF2-related export protein 2,NXT2,55916,ENSG00000101888,NA,NA,Nxt2 (MGI:2147914)
X,109623699,109625171,Xq22.3,Xq23,300328,KCNE1L,"Potassium voltage-gated channel, Isk-related family, member 1-like",KCNE5,23630,ENSG00000176076,NA,NA,Kcne1l (MGI:1913490)
X,109641334,109733391,Xq22.3,Xq23,300157,"ACSL4, FACL4, ACS4, MRX63",Acyl-CoA synthetase long-chain family member 4,ACSL4,2182,ENSG00000068366,NA,"Mental retardation, X-linked 63, 300387 (3), X-linked dominant",Acsl4 (MGI:1354713)
X,110194185,110440232,Xq22.3,Xq23,300195,"AMMECR1, MFHIEN","Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis chromosomal region gene 1",AMMECR1,9949,ENSG00000101935,NA,"Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3), X-linked recessive",Ammecr1 (MGI:1860206)
X,110358100,110456333,Xq23,Xq23,300965,"RGAG1, MAR9, KIAA1318",Retrotransposon GAG domain-containing protein 1,RTL9,57529,ENSG00000243978,NA,NA,Rtl9 (MGI:2685231)
X,110673855,110795816,Xq22.1-q23,Xq23,300350,"CHRDL1, VOPT, MGC1",Chordin-like 1,CHRDL1,91851,ENSG00000101938,NA,"Megalocornea 1, X-linked, 309300 (3), X-linked recessive",Chrdl1 (MGI:1933172)
X,110944240,111227360,Xq23,Xq23,300142,"PAK3, MRX30, MRX47",p21-activated kinase-3,PAK3,5063,ENSG00000077264,NA,"Mental retardation, X-linked 30/47, 300558 (3), X-linked recessive",Pak3 (MGI:1339656)
X,111245098,111270482,Xq23,Xq23,300146,CAPN6,Calpain 6,CAPN6,827,ENSG00000077274,NA,NA,Capn6 (MGI:1100850)
X,111293778,111412204,Xq22.3-q23,Xq23,300121,"DCX, DBCN, LISX",Doublecortin,DCX,1641,ENSG00000077279,NA,"Lissencephaly, X-linked, 300067 (3), X-linked; Subcortical laminal heterotopia, X-linked, 300067 (3), X-linked",Dcx (MGI:1277171)
X,111680740,111764163,Xq23,Xq23,300776,"ALG13, GLT28D1, CDG1S, EIEE36","Alg13, S. cerevisiae, homolog of",ALG13,79868,ENSG00000101901,mutation identified in 1 CDG1S male patient,"?Congenital disorder of glycosylation, type Is, 300884 (3), X-linked dominant; Epileptic encephalopathy, early infantile, 36, 300884 (3), X-linked dominant",NA
X,111774313,112082942,Xq23,Xq23,300334,"TRPC5, TRP5",Transient receptor potential channel 5,TRPC5,7224,ENSG00000072315,NA,NA,Trpc5 (MGI:109524)
X,112630647,112680177,Xq23,Xq23,300566,LHFPL1,LHFP-like protein 1,LHFPL1,340596,ENSG00000182508,NA,NA,Lhfpl1 (MGI:1891214)
X,112774502,112840945,Chr.X,Xq23,300410,"AMOT, KIAA1071",Angiomotin,AMOT,154796,ENSG00000126016,NA,NA,Amot (MGI:108440)
X,113616299,113618152,Xq23,Xq23,300901,XACT,"Active X chromosome-coating transcript, noncoding",XACT,105463123,NA,NA,NA,NA
X,114584077,114910060,Xq24,Xq23,312861,HTR2C,5-hydroxytryptamine (serotonin) receptor-2C,HTR2C,3358,ENSG00000147246,formerly HTR1C,NA,Htr2c (MGI:96281)
X,114823453,114823563,Xq23,Xq23,300686,"MIR448, MIRN448",Micro RNA 448,MIR448,554212,ENSG00000199001,NA,NA,NA
X,115003981,115017615,Xq24,Xq23,300130,IL13RA2,"Interleukin-13 receptor, alpha-2",IL13RA2,3598,ENSG00000123496,NA,NA,Il13ra2 (MGI:1277954)
X,115289714,115307562,Xq23,Xq23,300616,LUZP4,Leucine zipper protein 4,LUZP4,51213,ENSG00000102021,NA,NA,NA
X,115561173,115650860,Xq23,Xq23,300131,"PLS3, BMND18",Plastin 3,PLS3,5358,ENSG00000102024,NA,"Bone mineral density QTL18, osteoporosis, 300910 (3), X-linked dominant",Pls3 (MGI:104807)
X,115840395,115969110,Xq23,Xq23,301004,DANT2,"DXZ4-associated noncoding transcript 2, distal",DANT2,642776,ENSG00000235244,NA,NA,NA
X,115840963,115905526,Xq23,Xq23,301001,DANT1,"DXZ4-associated noncoding transcript 1, proximal",DANT1,106029310,NA,NA,NA,NA
X,116170743,116174973,Xq23,Xq23,300034,AGTR2,Angiotensin receptor 2,AGTR2,186,ENSG00000180772,NA,NA,Agtr2 (MGI:87966)
X,116436605,116461457,Xq23-q24,Xq23,300444,SLC6A14,"Solute carrier family 6 (neurotransmitter transporter), member 14",SLC6A14,11254,ENSG00000268104,NA,NA,Slc6a14 (MGI:1890216)
X,116461685,116462975,Xq22,Xq23,300625,"KKLC1, CXorf61",Kita-Kyushu lung cancer antigen 1,CT83,203413,ENSG00000204019,NA,NA,NA
X,117400000,138900000,Xq24-q26,NA,300700,"ADFN, ALDS",Albinism-deafness syndrome,ADFN,122,NA,~8cM proximal to F9,"Albinism-deafness syndrome, 300700 (2), X-linked",NA
X,117400000,121800000,Xq24,NA,300306,BMIQ11,Body Mass Index quantitative trait locus 11,NA,NA,NA,NA,"{Obesity, susceptibility to, BMIQ11}, 300306 (2)",NA
X,117400000,148000000,Xq24-q27,NA,301845,BZX,Bazex syndrome,NA,8255,NA,NA,"Bazex syndrome, 301845 (2), X-linked dominant",NA
X,117400000,156040895,Xq24-qter,NA,304730,CND,Corneal dermoids,NA,8231,NA,NA,"Dermoids of cornea, 304730 (2), X-linked",NA
X,117400000,121800000,Xq24,NA,300360,MRSS,"Mental retardation, X-linked, with short stature",NA,NA,NA,NA,"Mental retardation, X-linked, with short stature, 300360 (2)",NA
X,117400000,129500000,Xq24-q25,NA,300518,MRX82,"Mental retardation, X-linked 82",MRX82,378484,NA,between DXS6805 and DXS7346,"Mental retardation, X-linked 82, 300518 (2), X-linked recessive",NA
X,117400000,121800000,Xq24,NA,300852,MRX88,"Mental retardation, X-linked 88",NA,105463129,NA,NA,"Mental retardation, X-linked 88, 300852 (2), X-linked",NA
X,117400000,141200000,Xq24-q27.1,NA,300245,"PTOS2, PTOSX","Ptosis, hereditary congenital 2",NA,54115,NA,NA,"Ptosis, hereditary congenital 2, 300245 (2), X-linked dominant",NA
X,117400000,129500000,Xq24-q25,NA,300378,RRDX,Radial ray deficiency,NA,266719,NA,NA,"Radial ray deficiency, 300378 (2)",NA
X,117400000,129500000,Xq24-q25,NA,300750,SPG34,"Spastic paraplegia 34, X-linked",SPG34,724110,NA,max lod at DXS8057,"Spastic paraplegia 34, X-linked, 300750 (2), X-linked recessive",NA
X,117400000,129500000,Xq24-q25,NA,300591,STQTL6,Stature quantitative trait locus 6,NA,100037264,NA,max lod at DXS8067,"{Stature QTL 6}, 300591 (2)",NA
X,117897812,118117339,Xq24,Xq24,300655,"KLHL13, KIAA1309",Kelch-like 13,KLHL13,90293,ENSG00000003096,NA,NA,Klhl13 (MGI:1914705)
X,118495663,118686159,Xq24,Xq24,300681,"DOCK11, ACG, ZIZ2",Dedicator of cytokinesis 11,DOCK11,139818,ENSG00000147251,NA,NA,Dock11 (MGI:1923224)
X,118726953,118794532,Chr.X,Xq24,300119,IL13RA1,"Interleukin-13 receptor, alpha-1",IL13RA1,3597,ENSG00000131724,NA,NA,Il13ra1 (MGI:105052)
X,118823823,118826967,Xq24,Xq24,300701,"ZCCHC12, SIZN1",Zinc finger CCHC domain-containing protein 12,ZCCHC12,170261,ENSG00000174460,NA,NA,Zcchc12 (MGI:1919943)
X,119078634,119151082,Xq24,Xq24,300995,KIAA1210,Kiaa1210 gene,KIAA1210,57481,ENSG00000250423,NA,NA,NA
X,119236244,119244465,Xq22-q24,Xq24,300435,PGRMC1,Progesterone receptor membrane component 1,PGRMC1,10857,ENSG00000101856,NA,NA,Pgrmc1 (MGI:1858305)
X,119399325,119454477,Xq24,Xq24,300641,SLC25A43,"Solute carrier family 25, member 43",SLC25A43,203427,ENSG00000077713,NA,NA,Slc25a43 (MGI:2684854)
X,119468443,119471395,Xq24-q26,Xq24,300150,"SLC25A5, ANT2, T3","Solute carrier family 25 (mitochondrial carrier), member 5 (adenine nucleotide translocator-2, fibroblast)",SLC25A5,292,ENSG00000005022,NA,NA,Slc25a5 (MGI:1353496)
X,119538148,119565408,Xq24,Xq24,301012,"CXorf56, MRX107",Chromosome X open reading frame 56,CXorf56,63932,ENSG00000018610,mutation identified in 1 MRX107 family,"?Mental retardation, X-linked 107, 301013 (3), X-linked",C330007P06Rik (MGI:1924894)
X,119574562,119584422,Xq24,Xq24,312180,"UBE2A, RAD6A, MRXSN, MRXS30",Ubiquitin-conjugating enzyme E2A (RAD6 homolog),UBE2A,7319,ENSG00000077721,NA,"Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3), X-linked recessive",Ube2a (MGI:102959)
X,119588336,119606463,Xq24,Xq24,300440,"NKRF, NRF",NFKB-repressing factor,NKRF,55922,ENSG00000186416,NA,NA,Nkrf (MGI:1924536)
X,119615723,119693195,Xq24,Xq24,300683,"SEPT6, SEP2, KIAA0128",Septin 6,SEPTIN6,23157,ENSG00000125354,NA,NA,Sept6 (MGI:1888939)
X,119786503,119791629,Xq24,Xq24,300899,RPL39,Ribosomal protein L39,RPL39,6170,ENSG00000198918,NA,NA,Rpl39 (MGI:1914498)
X,119805310,119853027,Xq25-q26,Xq24,300298,"UPF3B, RENT3B, MRXS14","UPF3 regulator of nonsense transcripts, yeast, homolog of, B",UPF3B,65109,ENSG00000125351,NA,"Mental retardation, X-linked, syndromic 14, 300676 (3), X-linked recessive",Upf3b (MGI:1915384)
X,119870474,119871732,Xq24,Xq24,300951,"RNF113A, ZNF183, TTD5",RING finger protein 113A,RNF113A,7737,ENSG00000125352,mutation identified in 1 TTD5 family,"?Trichothiodystrophy 5, nonphotosensitive, 300953 (3), X-linked dominant",Rnf113a2 (MGI:1913631)
X,119871831,119876661,Xq24,Xq24,300078,"NDUFA1, MWFE, MC1DN12",NADH-ubiquinone oxidoreductase subunit A1,NDUFA1,4694,ENSG00000125356,NA,"Mitochondrial complex I deficiency, nuclear type 12, 301020 (3), X-linked recessive",Ndufa1 (MGI:1929511)
X,119895892,119920715,Xq24,Xq24,300462,"AKAP14, AKAP28",A-kinase anchor protein 14,AKAP14,158798,ENSG00000186471,NA,NA,Akap14 (MGI:3618288)
X,119920671,119943750,Xq24,Xq24,300766,NKAP,NFKB-activating protein,NKAP,79576,ENSG00000101882,NA,NA,Nkap (MGI:1914300)
X,120010716,120015550,Xq24,Xq24,300973,RHOXF1P1,"RHOX homeobox family member 1, pseudogene 1",RHOXF1P1,101928941,ENSG00000234493,NA,NA,NA
X,120109048,120117650,Xq24,Xq24,300446,"RHOXF1, OTEX, PEPP1","RHOX homeobox family, member 1",RHOXF1,158800,ENSG00000101883,NA,NA,NA
X,120158534,120165629,Xq24,Xq24,300447,"RHOXF2, PEPP2","RHOX homeobox family, member 2",RHOXF2,84528,ENSG00000131721,NA,NA,NA
X,120250811,120258397,Xq23,Xq24,300329,"ZBTB33, KAISO",Zinc finger- and BTB domain-containing protein 33,ZBTB33,10009,ENSG00000177485,NA,NA,Zbtb33 (MGI:1927290)
X,120426147,120469348,Xq24,Xq24,309060,"LAMP2, LAMPB, LGP110",Lysosome-associated membrane protein-2,LAMP2,3920,ENSG00000005893,NA,"Danon disease, 300257 (3), X-linked dominant",Lamp2 (MGI:96748)
X,120524588,120575828,Xq23,Xq24,300304,"CUL4B, MRXSC, MRXHF2, SFM2, MRXS15",Cullin-4B,CUL4B,8450,ENSG00000158290,NA,"Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3), X-linked recessive",Cul4b (MGI:1919834)
X,120604100,120621158,Xq22-q24,Xq24,300587,"MCTS1, MCT1",Malignant T-cell amplified sequence 1,MCTS1,28985,ENSG00000232119,NA,NA,Mcts1 (MGI:1916245)
X,120625673,120630149,Xq23,Xq24,300611,"C1GALT1C1, COSMC, C1GALT2, TNPS",C1GALT1-specific chaperone 1,C1GALT1C1,29071,ENSG00000171155,NA,"Tn polyagglutination syndrome, somatic, 300622 (3)",C1galt1c1 (MGI:1913493)
X,120872551,120875924,Xq24,Xq24,300790,"CT47B1, CT47A13","Cancer/testis antigen family 47, member B1",CT47B1,643311,ENSG00000236446,NA,NA,NA
X,120933839,120937259,Xq24,Xq24,300592,"CT47A11, LOC255313","Cancer/testis antigen family 47, member A11",CT47A11,255313,ENSG00000226929,NA,NA,NA
X,120938700,120942120,Xq24,Xq24,300789,CT47A10,"Cancer/testis antigen family 47, member A10",CT47A10,728036,ENSG00000224089,NA,NA,NA
X,120943560,120946980,Xq24,Xq24,300788,CT47A9,"Cancer/testis antigen family 47, member A9",CT47A9,728042,ENSG00000226600,NA,NA,NA
X,120948421,120951841,Xq24,Xq24,300787,CT47A8,"Cancer/testis antigen family 47, member A8",CT47A8,728049,ENSG00000230347,NA,NA,NA
X,120953281,120956599,Xq24,Xq24,300786,CT47A7,"Cancer/testis antigen family 47, member A7",CT47A7,653282,ENSG00000228517,NA,NA,NA
X,120958164,120961587,Xq24,Xq24,300785,CT47A6,"Cancer/testis antigen family 47, member A6",CT47A6,728062,ENSG00000226023,NA,NA,NA
X,120963025,120966445,Xq24,Xq24,300784,CT47A5,"Cancer/testis antigen family 47, member A5",CT47A5,728072,ENSG00000237957,NA,NA,NA
X,120967885,120971305,Xq24,Xq24,300783,CT47A4,"Cancer/testis antigen family 47, member A4",CT47A4,728075,ENSG00000230594,NA,NA,NA
X,120972745,120976165,Xq24,Xq24,300782,CT47A3,"Cancer/testis antigen family 47, member A3",CT47A3,728082,ENSG00000236126,NA,NA,NA
X,120977605,120981025,Xq24,Xq24,300781,CT47A2,"Cancer/testis antigen family 47, member A2",CT47A2,728090,ENSG00000242362,NA,NA,NA
X,120982465,120985885,Xq24,Xq24,300780,CT47A1,"Cancer/testis antigen family 45, member A1",CT47A1,728096,ENSG00000236371,NA,NA,NA
X,121047609,121050093,Xq25,Xq24,300144,GLUD2,Glutamate dehydrogenase-2,GLUD2,2747,ENSG00000182890,NA,"{Parkinson disease, age of onset, modifier}, 168600 (3), Autosomal dominant, Multifactorial",NA
X,121800000,129500000,Xq25,NA,300979,DUPXq25,Xq25 duplication syndrome,NA,NA,NA,NA,"Xq25 duplication syndrome, 300979 (4), X-linked",NA
X,121800000,148000000,Xq25-q27,NA,300660,LKMCD,Leukoencephalopathy with metaphyseal chondrodysplasia,NA,100302058,NA,between DXS8093 and DXS1232,"Leukoencephalopathy with metaphyseal chondrodysplasia, 300660 (2), X-linked recessive",NA
X,121800000,138900000,Xq25-q26,NA,300436,MRX46,"Mental retardation, X-linked 46",NA,NA,NA,between DXS8072 and DXS294,"Mental retardation, X-linked 46, 300436 (2), X-linked recessive",NA
X,121800000,141200000,Xq25-q27.1,NA,300703,SCAX5,"Spinocerebellar ataxia, X-linked 5",NA,100188768,NA,between DXS1047 and DXS1227,"Spinocerebellar ataxia, X-linked 5, 300703 (2), X-linked recessive",NA
X,121800000,138900000,Xq25-q26,NA,300179,SXI2,"X inactivation, familial skewed, 2",NA,117237,NA,NA,"X inactivation, familial skewed, 2, 300179 (2)",NA
X,121800000,131300000,Xq25-q26.1,NA,313850,"THAS, TAS",Thoracoabdominal syndrome,THAS,7055,NA,NA,"Thoracoabdominal syndrome, 313850 (2), X-linked",NA
X,121800000,129500000,Xq25,NA,300779,XECD,"Corneal dystrophy, endothelial, X-linked",NA,100302510,NA,between DXS8057 and DXS1047,"Corneal dystrophy, endothelial, X-linked, 300779 (2), X-linked dominant",NA
X,123184242,123490914,Xq25-q26,Xq25,305915,"GRIA3, GLUR3, MRX94","Glutamate receptor, ionotropic, AMPA 3",GRIA3,2892,ENSG00000125675,NA,"Mental retardation, X-linked 94, 300699 (3), X-linked recessive",Gria3 (MGI:95810)
X,123600562,123733053,Xq25,Xq25,300395,"THOC2, THO2, MRX12, MRX35","THO complex 2 (Tho2, yeast, homolog of)",THOC2,57187,ENSG00000125676,NA,"Mental retardation, X-linked 12/35, 300957 (3), X-linked recessive",Thoc2 (MGI:2442413)
X,123859811,123913978,Xq25,Xq25,300079,"XIAP, BIRC4, API3, XLP2","Inhibitor of apoptosis, X-linked",XIAP,331,ENSG00000101966,NA,"Lymphoproliferative syndrome, X-linked, 2, 300635 (3), X-linked recessive",Xiap (MGI:107572)
X,123960559,124102655,Xq25,Xq25,300826,"STAG2, SA2, NEDXCF",Stromal antigen 2,STAG2,10735,ENSG00000101972,NA,"Neurodevelopmental disorder, X-linked, with craniofacial abnormalities, 301022 (3), X-linked",Stag2 (MGI:1098583)
X,124346281,124373159,Xq25,Xq25,300490,"SH2D1A, LYP, IMD5, XLP, XLPD1",SH2 domain protein 1A,SH2D1A,4068,ENSG00000183918,1cM from DXS42; no recombination with DXS37,"Lymphoproliferative syndrome, X-linked, 1, 308240 (3), X-linked recessive",Sh2d1a (MGI:1328352)
X,124375902,125204380,Xq25,Xq25,300588,"TENM1, ODZ1, TNM1",Teneurin transmembrane protein 1,TENM1,10178,ENSG00000009694,NA,NA,Tenm1 (MGI:1345185)
X,128050961,128052402,Xq25,Xq25,300487,"ACTRT1, ARPT1",Actin-related protein T1,ACTRT1,139741,ENSG00000123165,NA,NA,Actrt1 (MGI:1920610)
X,129446500,129523563,Xq26.1,Xq25-q26,300012,"SMARCA1, SNF2L1","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1",SMARCA1,6594,ENSG00000102038,NA,NA,Smarca1 (MGI:1935127)
X,129500000,148000000,Xq26-q27,NA,300712,CFSS,Craniofacioskeletal syndrome,NA,100188773,NA,NA,"?Craniofacioskeletal syndrome, 300712 (2), X-linked recessive, X-linked dominant",NA
X,129500000,138900000,Xq26,NA,302802,CMTX3,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 3",NA,NA,NA,genomic rearrangement between 8q24.3 and Xq27.1,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 3, 302802 (4), X-linked recessive",NA
X,129500000,138900000,Xq26,NA,309555,GUST,"Gustavson mental retardation syndrome (with microcephaly, optic atrophy, deafness)",NA,8258,NA,NA,"Gustavson syndrome, 309555 (2), X-linked",NA
X,129500000,156040895,Xq26-qter,NA,300076,INDX,"Immunoneurologic syndrome X-linked, of Woods, Black, and Norbury",NA,8259,NA,NA,"Woods-Black-Norbury syndrome, 300076 (2), X-linked dominant",NA
X,129500000,138900000,Xq26,NA,300372,MRX42,"Mental retardation, X-linked nonspecific, 42",MRX42,4406,NA,?pericentromeric region,"Mental retardation, X-linked 42, 300372 (2)",NA
X,129500000,148000000,Xq26-q27,NA,300155,RP24,Retinitis pigmentosa-24,RP24,6116,NA,NA,"Retinitis pigmentosa 24, 300155 (2)",NA
X,129500000,138900000,Xq26,NA,313350,"SHFM2, SHFD2","Split hand/foot malformation, type (ectrodactyly) 2",SHFM2,6463,NA,NA,"Split hand/foot malformation 2, 313350 (2), X-linked",NA
X,129540258,129592555,Xq26.1,Xq26.1,300535,"OCRL, LOCR, OCRL1, NPHL2",Phosphatidylinositol polyphosphate 5-phosphatase (OCRL gene),OCRL,4952,ENSG00000122126,NA,"Dent disease 2, 300555 (3), X-linked recessive; Lowe syndrome, 309000 (3), X-linked recessive",Ocrl (MGI:109589)
X,129645258,129654955,Xq25-q26.3,Xq26.1,300297,APLN,Apelin,APLN,8862,ENSG00000171388,NA,NA,Apln (MGI:1353624)
X,129738978,129769535,Xq25,Xq26.1,300145,"XPNPEP2, AEACEI",X-prolyl aminopeptidase 2 (aminopeptidase P),XPNPEP2,7512,ENSG00000122121,NA,"{Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3)",Xpnpep2 (MGI:2180001)
X,129779948,129795200,Xq26.1,Xq26.1,300441,"SASH3, HACS2, CXorf9, SLY",SAM and SH3 domain containing 3,SASH3,54440,ENSG00000122122,NA,NA,Sash3 (MGI:1921381)
X,129803287,129843885,Xq26.1,Xq26.1,300646,"ZDHHC9, DHHC9, MRXSZ",Zinc finger DHHC domain-containing protein 9,ZDHHC9,51114,ENSG00000188706,NA,"Mental retardation, X-linked syndromic, Raymond type, 300799 (3)",Zdhhc9 (MGI:2444393)
X,129906120,129929761,Xq26.1,Xq26.1,300508,UTP14A,"Utp14, S. cerevisiae, homolog of, A",UTP14A,10813,ENSG00000156697,NA,NA,Utp14a (MGI:1919804)
X,129980284,130058082,Xq25-q26.1,Xq26.1,300688,BCORL1,BCL6 corepressor-like 1,BCORL1,63035,ENSG00000085185,NA,NA,Bcorl1 (MGI:2443910)
X,130064873,130110890,Xq26,Xq26.1,300775,"ELF4, MEF",E74-like factor 4,ELF4,2000,ENSG00000102034,NA,NA,Elf4 (MGI:1928377)
X,130129361,130165886,Xq26.1,Xq26.1,300169,"AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5","Apoptosis-inducing factor, mitochondrion-associated, 1",AIFM1,9131,ENSG00000156709,NA,"Combined oxidative phosphorylation deficiency 6, 300816 (3), X-linked recessive; Cowchock syndrome, 310490 (3), X-linked recessive; Deafness, X-linked 5, 300614 (3), X-linked recessive",Aifm1 (MGI:1349419)
X,130110632,130184872,Chr.X,Xq26.1,300333,RAB33A,Ras-associated protein RAB33A,RAB33A,9363,ENSG00000134594,NA,NA,Rab33a (MGI:109493)
X,130339887,130373360,Xq24,Xq26.1,300242,"SLC25A14, BMCP1","Solute carrier family 25 (mitochondrial carrier), member 14",SLC25A14,9016,ENSG00000102078,NA,NA,Slc25a14 (MGI:1330823)
X,130384344,130385536,Xq26.1,Xq26.1,300513,"GPR119, GPCR2",G protein-coupled receptor 119,GPR119,139760,ENSG00000147262,NA,NA,Gpr119 (MGI:2668412)
X,130622329,130903316,Xq25-q26.2,Xq26.1,300282,ENOX2,ECTO-NOX disulfide-thiol exchanger 2,ENOX2,10495,ENSG00000165675,NA,NA,Enox2 (MGI:2384799)
X,131058345,131089884,Xq26.1,Xq26.1,300937,ARHGAP36,Rho GTPase-activating protein 36,ARHGAP36,158763,ENSG00000147256,NA,NA,Arhgap36 (MGI:1922654)
X,131273505,131289456,Xq25,Xq26.1,300137,"IGSF1, IGDC1, CHTE","Immunoglobulin superfamily, member 1",IGSF1,3547,ENSG00000147255,NA,"Hypothyroidism, central, and testicular enlargement, 300888 (3), X-linked recessive",Igsf1 (MGI:2147913)
X,131691524,131830642,Xq26.1,Xq26.2,300999,"FIRRE, LINC01200",Functional intergenic repeating RNA element,FIRRE,286467,ENSG00000213468,NA,NA,NA
X,132023301,132075942,Xq26,Xq26.2,300547,"MASK, MST4",MST3- and SOK1-related kinase,STK26,51765,ENSG00000134602,NA,NA,Stk26 (MGI:1917665)
X,132074925,132128021,Xq26.2,Xq26.2,300628,"FRMD7, NYS1, XIPAN",FERM domain-containing 7,FRMD7,90167,ENSG00000165694,NA,"Nystagmus 1, congenital, X-linked, 310700 (3), X-linked; Nystagmus, infantile periodic alternating, X-linked, 310700 (3), X-linked",Frmd7 (MGI:2686379)
X,132203023,132219479,Xq26.2,Xq26.2,301016,RAP2C,Ras-related protein 2C,RAP2C,57826,ENSG00000123728,NA,NA,Rap2c (MGI:1919315)
X,132369313,132490034,Xq26,Xq26.2,300413,"MBNL3, MBXL",Muscleblind-like protein 3,MBNL3,55796,ENSG00000076770,NA,NA,Mbnl3 (MGI:2444912)
X,132626011,132961369,Xq26.2,Xq26.2,300545,"HS6ST2, MRXSPM",Heparan sulfate 6-O-sulfotransferase 2,HS6ST2,90161,ENSG00000171004,mutation identified in 1 MRXSPM family,"?Paganini-Miozzo syndrome, 301025 (3), X-linked recessive",Hs6st2 (MGI:1354959)
X,133024630,133083767,Xq26.2,Xq26.2,300309,USP26,Ubiquitin-specific protease 26,USP26,83844,ENSG00000134588,NA,NA,Usp26 (MGI:1933247)
X,133216661,133218353,Xq26.2,Xq26.2,300772,"TFDP3, HCA661, CT30, DP4","Transcription factor DP family, member 3",TFDP3,51270,ENSG00000183434,NA,NA,NA
X,133300102,133415488,Xq26,Xq26.2,300168,"GPC4, KPTS",Glypican 4,GPC4,2239,ENSG00000076716,centromeric to GPC3,"Keipert syndrome, 301026 (3), X-linked recessive",Gpc4 (MGI:104902)
X,133535744,133985645,Xq26,Xq26.2,300037,"GPC3, SDYS, SGBS1",Glypican 3,GPC3,2719,ENSG00000147257,NA,"Simpson-Golabi-Behmel syndrome, type 1, 312870 (3), X-linked recessive; Wilms tumor, somatic, 194070 (3)",Gpc3 (MGI:104903)
X,134169670,134169765,Xq26.2,Xq26.2,300722,"MIR19B2, MIRN19B2",Micro RNA 19B2,MIR19B2,406981,ENSG00000284107,NA,NA,NA
X,134169808,134169876,Xq26.2,Xq26.2,300950,MIR20B,Micro RNA 20B,MIR20B,574032,ENSG00000284043,NA,NA,NA
X,134170197,134170277,Xq26.2,Xq26.2,300792,"MIR106A, MIRN106A",Micro RNA 106A,MIR106A,406899,ENSG00000284157,NA,NA,NA
X,134373311,134428789,Xq26.3,Xq26.2,300414,"PHF6, BFLS",PHD finger protein 6,PHF6,84295,ENSG00000156531,NA,"Borjeson-Forssman-Lehmann syndrome, 301900 (3), X-linked recessive",Phf6 (MGI:1918248)
X,134460164,134500667,Xq26.2,Xq26.2-q26.3,308000,"HPRT1, HPRT",Hypoxanthine phosphoribosyltransferase 1,HPRT1,3251,ENSG00000165704,NA,"HPRT-related gout, 300323 (3), X-linked recessive; Lesch-Nyhan syndrome, 300322 (3), X-linked recessive",Hprt (MGI:96217)
X,134500000,138900000,Xq26.3,NA,300795,"CT45A4, CT45.4","Cancer/testis antigen family 45, member A4",NA,NA,NA,NA,NA,NA
X,134500000,138900000,Xq26.3,NA,300942,"CXDUPq26.3, DUPXq26.3, XLAG",Chromosome Xq26.3 duplication syndrome,NA,NA,NA,NA,"Chromosome Xq26.3 duplication syndrome, 300942 (4), X-linked dominant",NA
X,134500000,138900000,Xq26.3,NA,300833,SRXX3,46XX sex reversal 3,NA,NA,NA,due to deletion/duplication/rearrangement upstream of SOX3,"46XX sex reversal 3, 300833 (4), X-linked dominant",NA
X,134546327,134546397,Xq26.3,Xq26.3,300865,MIR503,Micro RNA 503,MIR503,574506,ENSG00000208005,NA,NA,NA
X,134546613,134546710,Xq26.3,Xq26.3,300682,"MIR424, MIRN424, MIR322",Micro RNA 424,MIR424,494336,ENSG00000284231,NA,NA,NA
X,134565837,134764321,Xq26,Xq26.3,300296,PLAC1,Placenta-specific gene 1,PLAC1,10761,ENSG00000170965,NA,NA,Plac1 (MGI:1926287)
X,134887625,134915313,Xq26.3,Xq26.3,300674,MOSPD1,Motile sperm domain-containing protein 1,MOSPD1,56180,ENSG00000101928,NA,NA,Mospd1 (MGI:1917630)
X,135032354,135033545,Xq26,Xq26.3,300213,CXX1,CAAX box protein 1,RTL8C,8933,ENSG00000134590,NA,NA,Rtl8c (MGI:1920115)
X,135248588,135344628,Xq26,Xq26.3,314997,"ZNF75D, ZNF75",Zinc finger protein-75D,ZNF75D,7626,ENSG00000186376,1Mb distal to HPRT,NA,NA
X,135344769,135363412,Xq26.3,Xq26.3,300627,"ZNF449, ZSCAN19",Zinc finger protein 449,ZNF449,203523,ENSG00000173275,NA,NA,Zfp449 (MGI:1925869)
X,135708397,135723317,Xq26.3,Xq26.3,300648,"CT45A1, CT45","Cancer/testis antigen family 45, member A1",CT45A1,541466,ENSG00000268940,NA,NA,NA
X,135760138,135768190,Xq26.3,Xq26.3,300794,"CT45A3, CT45.3","Cancer/testis antigen family 45, member A3",CT45A3,441519,ENSG00000269096,NA,NA,NA
X,135777129,135785513,Xq26.3,Xq26.3,300796,"CT45A5, CT45.5","Cancer/testis antigen family 45, member A5",CT45A5,441521,ENSG00000228836,NA,NA,NA
X,135794686,135802760,Xq26.3,Xq26.3,300797,"CT45A6, CT45.6","Cancer/testis antigen family 45, member A6",CT45A6,541465,ENSG00000278289,NA,NA,NA
X,135811667,135820061,Xq26.3,Xq26.3,300793,"CT45A2, CT45.2","Cancer/testis antigen family 45, member A2",CT45A2,728911,ENSG00000271449,NA,NA,NA
X,135893606,135913061,Xq28,Xq26.3,300359,SAGE,Sarcoma antigen,SAGE1,55511,ENSG00000181433,NA,NA,NA
X,135974595,136047268,Xq26.3,Xq26.3,300231,"SLC9A6, NHE6","Solute carrier family 9 (sodium/hydrogen exchanger), member 6",SLC9A6,10479,ENSG00000198689,NA,"Mental retardation, X-linked syndromic, Christianson type, 300243 (3), X-linked dominant",Slc9a6 (MGI:2443511)
X,136146701,136211358,Xq27.2,Xq26.3,300163,"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU",Four-and-a-half LIM domains 1,FHL1,2273,ENSG00000022267,mutation identified in 1 FCMSU family,"Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3), X-linked recessive; Myopathy, X-linked, with postural muscle atrophy, 300696 (3), X-linked recessive; Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3), X-linked dominant; Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3), X-linked; Scapuloperoneal myopathy, X-linked dominant, 300695 (3), X-linked dominant; ?Uruguay faciocardiomusculoskeletal syndrome, 300280 (3), X-linked recessive",Fhl1 (MGI:1298387)
X,136213219,136256481,Xq26.3,Xq26.3,300930,"MAP7D3, MDP3",MAP7 domain-containing protein 3,MAP7D3,79649,ENSG00000129680,NA,NA,Map7d3 (MGI:2445051)
X,136487946,136493779,Xq26-q28,Xq26.3,300107,BRS3,Bombesin-like receptor 3,BRS3,680,ENSG00000102239,NA,NA,Brs3 (MGI:1100501)
X,136497078,136512345,Xq26.3,Xq26.3,300346,"HTATSF1, TATSF1",HIV-1 TAT stimulatory factor 1,HTATSF1,27336,ENSG00000102241,NA,NA,Htatsf1 (MGI:1919709)
X,136532214,136556798,Xq26.1-q27.2,Xq26.3,300583,"VGLL1, VGL1, TDU",Vestigial-like 1,VGLL1,51442,ENSG00000102243,NA,NA,Vgll1 (MGI:2655768)
X,136648176,136660389,Xq26,Xq26.3,300386,"TNFSF5, CD40LG, HIGM1, IGM","Tumor necrosis factor ligand superfamily, member 5",CD40LG,959,ENSG00000102245,Between DSX144E and DSX300,"Immunodeficiency, X-linked, with hyper-IgM, 308230 (3), X-linked recessive",Cd40lg (MGI:88337)
X,136665546,136780944,Xq26,Xq26.3,300267,"ARHGEF6, COOL2",Rho guanine nucleotide exchange factor-6,ARHGEF6,9459,ENSG00000129675,NA,NA,Arhgef6 (MGI:1920591)
X,136869191,136880779,Xq26,Xq26.3,300199,"RBMX, MRXS11","RNA-binding motif protein, X chromosome",RBMX,27316,ENSG00000147274,mutation identified in 1 MRXS11 family,"?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3), X-linked recessive",Rbmx (MGI:1343044)
X,137030147,137031673,Xq26.3,Xq26.3,300393,"GPR101, PAGH2, PITA2",G protein-coupled receptor 101,GPR101,83550,ENSG00000165370,NA,"Pituitary adenoma 2, GH-secreting, 300943 (3), X-linked",Gpr101 (MGI:2685211)
X,137566126,137577690,Xq26.2,Xq26.3,300265,"ZIC3, HTX1, HTX, VACTERLX","Zic family, member 3",ZIC3,7547,ENSG00000156925,NA,"Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3), X-linked recessive; Heterotaxy, visceral, 1, X-linked, 306955 (3), X-linked recessive; VACTERL association, X-linked, 314390 (3), X-linked recessive",Zic3 (MGI:106676)
X,138614726,139222888,Xq26.3,Xq26.3-q27.1,300070,"FGF13, FGF2",Fibroblast growth factor-13,FGF13,2258,ENSG00000129682,NA,NA,Fgf13 (MGI:109178)
X,138900000,148000000,Xq27,NA,300536,BMND4,Bone mineral density QTL 4,NA,554316,NA,NA,"[Bone mineral density QTL 4], 300536 (2)",NA
X,138900000,141200000,Xq27.1,NA,300898,"CIRS7, CDR1AS",Circular RNA sponge for MIR7,NA,NA,NA,NA,NA,NA
X,138900000,148000000,Xq27,NA,300085,COD2,"Cone dystrophy-2, X-linked",COD2,1275,NA,NA,"Cone dystrophy, progressive X-linked, 2, 300085 (2), X-linked",NA
X,138900000,156040895,Xq27-q28,NA,300147,HPCX1,"Prostate cancer, hereditary, X-linked 1",HPCX,9566,NA,between D3S2390 and bG82i1.0,"{Prostate cancer, hereditary, X-linked 1}, 300147 (2)",NA
X,138900000,141200000,Xq27.1,NA,307700,"HPT, HPTX, HYPX",Hypoparathyroidism,NA,NA,NA,interstitial deletion/insertion on Xq27.1,"Hypoparathyroidism, X-linked, 307700 (4), X-linked",NA
X,138900000,141200000,Xq27.1,NA,307150,"HTC2, HCG, CGH, CXINSq27.1","Hypertrichosis, congenital generalized",NA,NA,NA,palindrome-mediated interchromosomal insertion at Xq27.1,"Hypertrichosis, congenital generalized, 307150 (4), X-linked dominant",NA
X,138900000,156040895,Xq27-q28,NA,301590,"MCOPS4, ANOP1","Microphthalmia, syndromic 4",ANOP1,289,NA,NA,"?Microphthalmia, syndromic 4, 301590 (2), X-linked recessive",NA
X,138900000,148000000,Xq27,NA,300228,TGCT1,Testicular germ cell tumor 1,TGCT1,50830,NA,NA,"Testicular germ cell tumor, 300228 (2)",NA
X,139530719,139563458,Xq27.1-q27.2,Xq27.1,300746,"F9, HEMB, THPH8",Coagulation factor IX (plasma thromboplastic component),F9,2158,ENSG00000101981,distal to HPRT; proximal part of Xq27,"{Deep venous thrombosis, protection against}, 300807 (3); Hemophilia B, 306900 (3), X-linked recessive; Thrombophilia, X-linked, due to factor IX defect, 300807 (3); {Warfarin sensitivity}, 122700 (3), Autosomal dominant",F9 (MGI:88384)
X,139581767,139708278,Xq27,Xq27.1,311030,"MCF2, DBL",Oncogene MCF2 (oncogene DBL),MCF2,4168,ENSG00000101977,~60kb telomeric to F9; 5' replacement by chr.15 segment,NA,Mcf2 (MGI:96932)
X,139726345,139933082,Xq27,Xq27.1,300516,"ATP11C, ATPIQ, ATPIG, HACXL","ATPase, class VI, type 11C",ATP11C,286410,ENSG00000101974,mutation identified in 1 HACXL patient,"?Hemolytic anemia, congenital, X-linked, 301015 (3), X-linked recessive",Atp11c (MGI:1859661)
X,140502986,140505059,Xq26.3,Xq27.1,313430,"SOX3, MRGH",SRY (sex determining region Y)-box 3,SOX3,6658,ENSG00000134595,P mutant in BFLS,"Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3); Panhypopituitarism, X-linked, 312000 (3), X-linked",Sox3 (MGI:98365)
X,140783259,140784557,Xq27.1-q27.2,Xq27.1,302650,"CDR1, CDR62A","Cerebellar degeneration-related protein-1, 34kD",CDR1,1038,ENSG00000184258,between HPRT and F9,NA,NA
X,141002593,141003705,Xq27.1-q27.3,Xq27.1,300669,"SPANXB1, SPANXB","SPANX family, member B1",SPANXB1,728695,ENSG00000227234,NA,NA,NA
X,141173234,141177128,Xq27,Xq27.1,300402,LDOC1,Leucine zipper downregulated in cancer 1,LDOC1,23641,ENSG00000182195,NA,NA,Ldoc1 (MGI:2685212)
X,141200000,156040895,Xq27.2-q28,NA,300388,"BPP, PMGX, CBPS","Polymicrogyria, bilateral perisylvian",NA,NA,NA,possible genetic heterogeneity,"Polymicrogyria, bilateral perisylvian, 300388 (2), X-linked dominant",NA
X,141241462,141242516,Xq26.3-q27.1,Xq27.2,300330,"SPANXC, CTP11","Sperm protein associated with the nucleus, X chromosome, family member C",SPANXC,64663,ENSG00000198573,NA,NA,NA
X,141583673,141584737,Xq27.1,Xq27.2,300305,"SPANXA1, SPANX","Sperm protein associated with the nucleus, X chromosome, family member A1",SPANXA1,30014,ENSG00000198021,NA,NA,NA
X,141589707,141590761,Xq27.2,Xq27.2,300493,SPANXA2,"Sperm protein associated with the nucleus, X chromosome, family member A2",SPANXA2,728712,ENSG00000203926,NA,NA,NA
X,141697410,141698738,Xq27.1,Xq27.2,300670,SPANXD,"SPANX family, member D",SPANXD,64648,ENSG00000196406,NA,NA,NA
X,141697410,141698738,Xq27.1,Xq27.2,300671,SPANXE,"SPANX family, member E",SPANXD,64648,ENSG00000196406,NA,NA,NA
X,141838315,141898141,Xq27,Xq27.2,300469,MAGEC3,"Melanoma antigen, family C, 3",MAGEC3,139081,ENSG00000165509,NA,NA,NA
X,141903876,141909400,Xq26,Xq27.2,300223,MAGEC1,"Melanoma antigen, family C, 1",MAGEC1,9947,ENSG00000155495,NA,NA,NA
X,142202341,142205289,Xq27,Xq27.2,300468,"MAGEC2, MAGEE1, CT10, HCA587","Melanoma antigen, family C, 2",MAGEC2,51438,ENSG00000046774,NA,NA,NA
X,143000000,156040895,Xq27.3-q28,NA,300869,"DUPXq27.3q28, CXDUPq27.3q28",Chromosome Xq27.3-q28 duplication syndrome,NA,NA,NA,NA,"Chromosome Xq27.3-q28 duplication syndrome, 300869 (4), X-linked recessive",NA
X,143000000,148000000,Xq27.3,NA,300509,DYX9,"Dyslexia, susceptibility to, 9",DYX9,474159,NA,max lod at DXS8043,"{Dyslexia, susceptibility to, 9}, 300509 (2)",NA
X,143000000,156040895,Xq27.3-qter,NA,302000,EBM,"Epidermolysis bullosa, macular type",EBM,1881,NA,NA,NA,NA
X,143025927,143038636,Xq27,Xq27.3,300667,SPANXN4,"SPANX family, member N4",SPANXN4,441525,ENSG00000189326,NA,NA,NA
X,143508734,143517474,Xq27,Xq27.3,300666,SPANXN3,"SPANX family, member N3",SPANXN3,139067,ENSG00000189252,NA,NA,NA
X,143622789,143636100,Xq27,Xq27.3,300562,SLITRK4,"SLIT- and NTRK-like family, member 4",SLITRK4,139065,ENSG00000179542,NA,NA,Slitrk4 (MGI:2442509)
X,143712034,143720667,Xq27,Xq27.3,300665,SPANXN2,"SPANX family, member N2",SPANXN2,494119,ENSG00000268988,NA,NA,NA
X,145247502,145256207,Xq27,Xq27.3,300664,SPANXN1,"SPANX family, member N1",SPANXN1,494118,ENSG00000203923,NA,NA,NA
X,145817828,145829855,Xq27,Xq27.3,300561,"SLITRK2, KIAA1854, CXorf1, CXorf2","SLIT- and NTRK-like family, member 2",SLITRK2,84631,ENSG00000185985,NA,NA,Slitrk2 (MGI:2679449)
X,147230719,147230842,Xq27.3,Xq27.3,300877,MIR506,Micro RNA 506,MIR506,574511,ENSG00000207731,NA,NA,NA
X,147236912,147237026,Xq27.3,Xq27.3,300874,MIR508,Micro RNA 508,MIR508,574513,ENSG00000207589,NA,NA,NA
X,147259651,147259725,Xq27.3,Xq27.3,300876,MIR509-3,Micro RNA 509-3,MIR509-3,100126337,ENSG00000212014,NA,NA,NA
X,147260531,147260624,Xq27.3,Xq27.3,300875,MIR509-1,Micro RNA 509-2,MIR509-1,574514,ENSG00000208000,NA,NA,NA
X,147272334,147272407,Xq27.3,Xq27.3,300866,MIR510,Micro RNA 510,MIR510,574515,ENSG00000207641,NA,NA,NA
X,147909430,147911816,Xq27,Xq27.3,300805,"FMR1AS1, ASFMR1",FMR1 antisense RNA 1,FMR1-AS1,100126270,ENSG00000268066,NA,NA,NA
X,147911918,147951126,Xq27.3,Xq27.3,309550,"FMR1, FRAXA, POF1",FMR1 gene,FMR1,2332,ENSG00000102081,8-8.7Mb from telomere,"Fragile X syndrome, 300624 (3), X-linked dominant; Fragile X tremor/ataxia syndrome, 300623 (3), X-linked dominant; Premature ovarian failure 1, 311360 (3), X-linked",Fmr1 (MGI:95564)
X,148000000,156040895,Xq28,NA,300843,BED,Bornholm eye disease,NA,100653365,NA,linked to F8,"Bornholm eye disease, 300843 (2), X-linked recessive",NA
X,148000000,156040895,Xq28,NA,300815,"DUPXq28, CXq28",Chromosome Xq28 duplication syndrome,NA,NA,NA,NA,"Chromosome Xq28 duplication syndrome, 300815 (4)",NA
X,148000000,156040895,Xq28,NA,305424,"DXS522E, F8B","DNA segment, single copy, expressed probes, intron 22 probe, F8B",NA,NA,NA,NA,NA,NA
X,148000000,156040895,Xq28,NA,306995,"HMS1, GAY1","Homosexuality, male",NA,NA,NA,NA,"[?Homosexuality, male], 306995 (2), X-linked",NA
X,148000000,156040895,Xq28,NA,309200,"MAFD2, MDX",Major affective disorder 2,MAFD2,4096,NA,"linkage to G6PD,CB in non-Ashkenazi Jews","{?Major affective disorder 2}, 309200 (2), X-linked dominant",NA
X,148000000,156040895,Xq28,NA,309620,"MRSD, CHRS",Mental retardation-skeletal dysplasia,MRSD,4364,NA,NA,"Mental retardation-skeletal dysplasia, 309620 (2), X-linked",NA
X,148000000,156040895,Xq28,NA,300261,MRXSA,Armfield X-linked mental retardation syndrome,NA,57791,NA,NA,"Mental retardation syndrome, X-linked, Armfield type, 300261 (2), X-linked recessive",NA
X,148000000,156040895,Xq28,NA,300845,"MYMY4, CXDELq38","Moyamoya disease 4 with short stature, hypergonadotropic hypogonadism and facial dysmorphism",NA,NA,NA,contiguous gene deletion syndrome (3.4kb),"Moyamoya disease 4, 300845 (4), X-linked recessive",NA
X,148000000,156040895,Xq28,NA,310460,MYP1,"Myopia 1, X-linked",MYP1,4657,NA,NA,"Myopia-1, 310460 (2), X-linked recessive",NA
X,148000000,156040895,Xq28,NA,300605,RP34,Retinitis pigmentosa 34,RP34,777642,NA,NA,"Retinitis pigmentosa 34, 300605 (2)",NA
X,148000000,156040895,Xq28,NA,300809,SLEB15,"Systemic lupus erythematosus, susceptibility to, 15",NA,100379200,NA,associated with rs17435,"{Systemic lupus erythematosus, susceptibility to, 15}, 300809 (2)",NA
X,148000000,156040895,Xq28,NA,314300,"TKCR, TKC","Torticollis, keloids, cryptorchidism and renal dysplasia",TKCR,7085,NA,distal to G6PD,"Goeminne TKCR syndrome, 314300 (2), X-linked",NA
X,148000000,156040895,Xq28,NA,314900,XM,Xm,XM,7506,NA,"linked to DCB, PCB",NA,NA
X,148500616,149000662,Xq28,Xq28,300806,"AFF2, FMR2, FRAXE, MRX2","AF4/FMR2 family, member 2 (fragile site, X-linked, E)",AFF2,2334,ENSG00000155966,NA,"Mental retardation, X-linked, FRAXE type, 309548 (3), X-linked recessive",NA
X,149476987,149505353,Xq28,Xq28,300823,"IDS, MPS2, SIDS",Iduronate 2-sulfatase (Hunter syndrome),IDS,3423,ENSG00000010404,telomeric IDS2 source of inversion in IDS,"Mucopolysaccharidosis II, 309900 (3), X-linked recessive",Ids (MGI:96417)
X,149540600,149555344,Xq27,Xq28,300954,"CXorf40A, EOLA1",Chromosome X open reading frame 40A,CXorf40A,91966,ENSG00000197620,NA,NA,1110012L19Rik (MGI:1915868)
X,149581652,149587467,Xq28,Xq28,300764,MAGEA9B,"Melanoma antigen, family A, 9B",MAGEA9B,728269,ENSG00000267978,NA,NA,NA
X,149596555,149631911,Xq28,Xq28,300031,"FAM11A, FRAXF","Family with sequence similarity 11, member A",TMEM185A,84548,ENSG00000269556,NA,NA,Tmem185a (MGI:2448555)
X,149688192,149717267,Xq28,Xq28,300344,"MAGEA11, MAGE11","Melanoma antigen, family A, 11",MAGEA11,4110,ENSG00000185247,NA,NA,Magea4 (MGI:1333839)
X,149781875,149787736,Xq28,Xq28,300342,"MAGEA9, MAGE9","Melanoma antigen, family A, 9",MAGEA9,4108,ENSG00000123584,NA,NA,NA
X,149825707,149879798,Xq28,Xq28,300892,"LINC00850, KUCG1",Long intergenic noncoding RNA 850,LINC00850,101241891,ENSG00000280752,NA,NA,NA
X,149881140,149885834,Xq28,Xq28,300341,"MAGEA8, MAGE8","Melanoma antigen, family A, 8",MAGEA8,4107,ENSG00000156009,NA,NA,NA
X,150361563,150514177,Xq28,Xq28,300120,"MAMLD1, CXorf6, F18, HYSP2",Mastermind-like domain containing 1,MAMLD1,10046,ENSG00000013619,near MTM1 in microdeletion,"Hypospadias 2, X-linked, 300758 (3), X-linked recessive",NA
X,150562657,150673142,Xq28,Xq28,300415,"MTM1, MTMX",Myotubularin,MTM1,4534,ENSG00000171100,close to F8,"Myotubular myopathy, X-linked, 310400 (3), X-linked recessive",Mtm1 (MGI:1099452)
X,150692961,150765107,Xq28,Xq28,300171,MTMR1,Myotubularin-related protein-1,MTMR1,8776,ENSG00000063601,NA,NA,Mtmr1 (MGI:1858271)
X,150766335,150898815,Xq28,Xq28,300846,"CD99L2, CD99B",CD99 antigen-like 2,CD99L2,83692,ENSG00000102181,NA,NA,Cd99l2 (MGI:2177151)
X,150980506,150990774,Xq28,Xq28,300193,"HMGB3, HMG4, HMG2A, MCOPS13",High-mobility group box 3 (high mobility group protein 4),HMGB3,3149,ENSG00000029993,mutation identified in 1 MCOPS13 family,"?Microphthalmia, syndromic 13, 300915 (3), X-linked",NA
X,151176583,151182854,Xq28,Xq28,300207,GPR50,G protein-coupled receptor 50,GPR50,9248,ENSG00000102195,NA,NA,Gpr50 (MGI:1333877)
X,151396594,151409363,Xq28,Xq28,300913,"VMA21, XMEA","Vma21, S. cerevisiae, homolog of",VMA21,203547,ENSG00000160131,NA,"Myopathy, X-linked, with excessive autophagy, 310440 (3), X-linked recessive",NA
X,151563183,151676738,Xq28,Xq28,300993,"PASD1, CT64, OXTES1",PAS domain-containing repressor 1,PASD1,139135,ENSG00000166049,NA,NA,NA
X,151694605,151701590,Xq28,Xq28,300685,"PRRG3, PRGP3, TMG3",Proline-rich gamma-carboxyglutamic acid protein 3,PRRG3,79057,ENSG00000130032,NA,NA,Prrg3 (MGI:2685214)
X,151716034,151723193,Xq28,Xq28,300450,FATE1,Fetal and adult testis-expressed gene 1,FATE1,89885,ENSG00000147378,NA,NA,NA
X,151734745,151745563,Xq27,Xq28,300338,"CNGA2, CNG2, OCNC1","Cyclic nucleotide-gated channel, alpha-2",CNGA2,1260,ENSG00000183862,NA,NA,Cnga2 (MGI:108040)
X,151912888,151925169,Xq28,Xq28,300175,"MAGEA4, MAGE4A, MAGE4B","Melanoma antigen, family A, 4",MAGEA4,4103,ENSG00000147381,NA,NA,NA
X,151953123,151974691,Xq28,Xq28,300093,GABRE,"Gamma-aminobutyric acid (GABA) A receptor, epsilon",GABRE,2564,ENSG00000102287,NA,NA,NA
X,151958577,151958657,Xq28,Xq28,300769,"MIR224, MIRN224",Micro RNA 224,MIR224,407009,ENSG00000284363,NA,NA,NA
X,152114048,152117938,Xq28,Xq28,300340,"MAGEA5, MAGE5","Melanoma antigen, family A, 5",MAGEA5,4104,NA,NA,NA,NA
X,152133309,152138577,Xq28,Xq28,300343,"MAGEA10, MAGE10","Melanoma antigen, family A, 10",MAGEA10,4109,ENSG00000124260,NA,NA,Magea10 (MGI:3588211)
X,152166233,152451340,Xq28,Xq28,305660,GABRA3,"Gamma-aminobutyric acid (GABA) A receptor, alpha-3",GABRA3,2556,ENSG00000011677,4Mb from telomere,NA,Gabra3 (MGI:95615)
X,152392218,152392298,Xq28,Xq28,300811,"MIR105-1, MIRN105-1",Micro RNA 105-1,MIR105-1,406897,ENSG00000207957,NA,NA,NA
X,152394411,152394491,Xq28,Xq28,300812,"MIR105-2, MIRN105-2",Micro RNA 105-2,MIR105-2,406898,ENSG00000207818,NA,NA,NA
X,152637894,152659827,Xq28,Xq28,300349,GABRQ,"Gamma-aminobutyric acid receptor, theta",GABRQ,55879,ENSG00000268089,NA,NA,Gabrq (MGI:1888498)
X,152698741,152702346,Xq28,Xq28,300174,"MAGEA3, MAGE3","Melanoma antigen, family A, 3",MAGEA3,4102,ENSG00000221867,NA,NA,NA
X,152714527,152718606,Xq28,Xq28,300549,MAGEA2B,"Melanoma antigen, family A, 2B",MAGEA2B,266740,ENSG00000183305,NA,NA,NA
X,152727483,152733720,Xq28,Xq28,300944,"CSAG1, CSAGE","CSAG family, member 1 `",CSAG1,158511,ENSG00000198930,NA,NA,NA
X,152733756,152737668,Xq28,Xq28,300177,"MAGEA12, MAGE12","Melanoma antigen, family A, 12",MAGEA12,4111,ENSG00000213401,NA,NA,NA
X,152749862,152753941,Xq28,Xq28,300173,"MAGEA2, MAGE2","Melanoma antigen, family A, 2",MAGEA2,4101,ENSG00000268606,NA,NA,NA
X,152766135,152769728,Xq28,Xq28,300176,"MAGEA6, MAGE6","Melanoma antigen, family A, 6",MAGEA6,4105,ENSG00000197172,NA,NA,NA
X,152826978,152830756,Xq28,Xq28,300006,"CETN2, CALT","Centrin, EF-hand protein, 2 (caltractin)",CETN2,1069,ENSG00000147400,NA,NA,Cetn2 (MGI:1347085)
X,152830966,152869728,Xq28,Xq28,300275,NSDHL,NAD(P)H steroid dehydrogenase-like protein,NSDHL,50814,ENSG00000147383,NA,"CHILD syndrome, 308050 (3), X-linked dominant; CK syndrome, 300831 (3), X-linked recessive",Nsdhl (MGI:1099438)
X,152898131,152973480,Xq28,Xq28,300381,ZNF185,Zinc finger protein 185,ZNF185,7739,ENSG00000147394,NA,NA,NA
X,152988823,152994457,Xq28,Xq28,300916,"PNMA5, KIAA1934","Paraneoplastic MA antigen family, member 5",PNMA5,114824,ENSG00000198883,NA,NA,Pnma5 (MGI:2180566)
X,153056469,153060461,Xq28,Xq28,300675,"PNMA3, MA3",Paraneoplastic MA antigen 3,PNMA3,29944,ENSG00000183837,NA,NA,Pnma3 (MGI:2180565)
X,153072413,153075018,Xq28,Xq28,300917,"PNMA6A, PNMA6","Paraneoplastic MA antigen family, member 6A",PNMA6A,84968,ENSG00000235961,NA,NA,NA
X,153179283,153183879,Xq28,Xq28,300016,MAGE1,Melanoma antigen 1 (directs expression of antigen MZ2-E),MAGEA1,4100,ENSG00000198681,cluster of 12 genes,NA,NA
X,153444719,153446486,Xq28,Xq28,300370,TREX2,3-prime repair exonuclease 2,TREX2,11219,ENSG00000183479,NA,NA,Trex2 (MGI:1346343)
X,153447664,153495524,Xq28,Xq28,300540,"HAUS7, UCHL5IP, UIP1","HAUS augmin-like complex, subunit 7",HAUS7,55559,ENSG00000213397,NA,NA,Haus7 (MGI:1920988)
X,153494979,153509545,Xq28,Xq28,301870,"BGN, SEMDX, MRLS",Biglycan,BGN,633,ENSG00000182492,proximal Xq28,"Meester-Loeys syndrome, 300989 (3), X-linked; Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3), X-linked recessive",Bgn (MGI:88158)
X,153517676,153582928,Xq28,Xq28,300014,"ATP2B3, PMCA3, SCAX1","ATPase, Ca++ transporting, plasma membrane, 3",ATP2B3,492,ENSG00000067842,mutation identified in 1 family,"?Spinocerebellar ataxia, X-linked 1, 302500 (3), X-linked recessive",Atp2b3 (MGI:1347353)
X,153587924,153599164,Xq28,Xq28,300708,"FAM58A, STAR","Family with sequence similarity 58, member A",CCNQ,92002,ENSG00000262919,NA,"STAR syndrome, 300707 (3), X-linked dominant",Ccnq (MGI:1916359)
X,153642440,153651325,Xq28,Xq28,300134,"DUSP9, MKP4",Dual-specificity phosphatase 9,DUSP9,1852,ENSG00000130829,NA,NA,Dusp9 (MGI:2387107)
X,153669722,153687770,Xq28,Xq28,300680,"PNCK, CAMK1B, BSTK3","Pregnancy-upregulated, nonubiquitous, CAM kinase",PNCK,139728,ENSG00000130822,NA,NA,Pnck (MGI:1347357)
X,153687925,153696592,Xq28,Xq28,300036,"SLC6A8, CRTR, CCDS1","Solute carrier family 6 (neurotransmitter transporter, creatine), member 8",SLC6A8,6535,ENSG00000130821,distal to G6PD,"Cerebral creatine deficiency syndrome 1, 300352 (3), X-linked recessive",Slc6a8 (MGI:2147834)
X,153700491,153724745,Xq28,Xq28,300398,"BCAP31, BAP31, DXS1357E, DDCH",B-cell receptor-associated protein 31,BCAP31,10134,ENSG00000185825,NA,"Deafness, dystonia, and cerebral hypomyelination, 300475 (3), X-linked recessive",Bcap31 (MGI:1350933)
X,153724850,153744754,Xq28,Xq28,300371,"ABCD1, ALD, AMN","ATP-binding cassette, subfamily D, member 1",ABCD1,215,ENSG00000101986,about 650kb from GCP/RCP,"Adrenoleukodystrophy, 300100 (3), X-linked recessive; Adrenomyeloneuropathy, adult, 300100 (3), X-linked recessive",Abcd1 (MGI:1349215)
X,153764195,153779345,Xq28,Xq28,300214,"PLXNB3, PLXN6",Plexin B3,PLXNB3,5365,ENSG00000198753,NA,NA,Plxnb3 (MGI:2154240)
X,153781000,153785731,Xq28,Xq28,301002,"SRPK3, STK23, MSSK1","Protein kinase, serine/arginine-specific, 3",SRPK3,26576,ENSG00000184343,NA,NA,Srpk3 (MGI:1891338)
X,153785767,153794374,Xq28,Xq28,300089,IDH3G,"Isocitrate dehydrogenase 3 (NAD+), gamma",IDH3G,3421,ENSG00000067829,NA,NA,Idh3g (MGI:1099463)
X,153794158,153798511,Xq28,Xq28,300090,"SSR4, TRAPD, CDG1Y","Signal sequence receptor, delta",SSR4,6748,ENSG00000180879,NA,"Congenital disorder of glycosylation, type Iy, 300934 (3), X-linked recessive",Ssr4 (MGI:1099464)
X,153802165,153830886,Xq28,Xq28,300634,"PDZD4, PDZK4, PDZRN4L, KIAA1444, LU1",PDZ domain-containing 4,PDZD4,57595,ENSG00000067840,NA,NA,Pdzd4 (MGI:2443483)
X,153861513,153886172,Xq28,Xq28,308840,"L1CAM, CAML1, HSAS1, MASA, SPG1",L1 cell adhesion molecule,L1CAM,3897,ENSG00000198910,between RCP/GCP cluster and G6PD,"CRASH syndrome, 303350 (3), X-linked recessive; Corpus callosum, partial agenesis of, 304100 (3), X-linked recessive; Hydrocephalus due to aqueductal stenosis, 307000 (3), X-linked recessive; Hydrocephalus with Hirschsprung disease, 307000 (3), X-linked recessive; Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3), X-linked recessive; MASA syndrome, 303350 (3), X-linked recessive",L1cam (MGI:96721)
X,153902624,153907165,Xq28,Xq28,300538,"AVPR2, DIR, DI1, ADHR",Arginine vasopressin receptor-2,AVPR2,554,ENSG00000126895,NA,"Diabetes insipidus, nephrogenic, 304800 (3), X-linked recessive; Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3), X-linked recessive",Avpr2 (MGI:88123)
X,153907377,153926263,Xq28,Xq28,300023,RGC1,Rho-GAP hematopoietic protein C1,ARHGAP4,393,ENSG00000089820,NA,NA,Arhgap4 (MGI:2159577)
X,153929224,153935036,Xq28,Xq28,300013,"NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1","N-alpha-acetyltransferase 10, NatA catalytic subunit",NAA10,8260,ENSG00000102030,mutation identified in 1 MCOPS1 family,"?Microphthalmia, syndromic 1, 309800 (3), X-linked; Ogden syndrome, 300855 (3), X-linked recessive, X-linked dominant",Naa10 (MGI:1915255)
X,153935262,153944642,Xq28,Xq28,312420,RENBP,Renin-binding protein,RENBP,5973,ENSG00000102032,NA,NA,Renbp (MGI:105940)
X,153947555,153972359,Xq28,Xq28,300019,"HCFC1, HCF1, MRX3",Host cell factor C1 (VP16-accessory protein),HCFC1,3054,ENSG00000172534,50kb distal to V2R,"Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3), X-linked recessive",Hcfc1 (MGI:105942)
X,153972753,153983193,Xq28,Xq28,300059,"TMEM187, CXorf12, DXS9878E, ITBA1 gene",Transmembrane protein 187,TMEM187,8269,ENSG00000177854,NA,NA,NA
X,154010506,154019983,Xq28,Xq28,300283,IRAK1,Interleukin 1 receptor-associated kinase 1,IRAK1,3654,ENSG00000184216,NA,NA,Irak1 (MGI:107420)
X,154019919,154019988,Xq28,Xq28,300929,MIR718,Micro RNA 718,MIR718,100313781,ENSG00000284286,NA,NA,NA
X,154021572,154097730,Xq28,Xq28,300005,"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13",Methyl-CpG-binding protein-2,MECP2,4204,ENSG00000169057,70kb centromeric of RCP/GCP,"{Autism susceptibility, X-linked 3}, 300496 (3), X-linked; Encephalopathy, neonatal severe, 300673 (3), X-linked recessive; Mental retardation, X-linked syndromic, Lubs type, 300260 (3), X-linked recessive; Mental retardation, X-linked, syndromic 13, 300055 (3), X-linked recessive; Rett syndrome, 312750 (3), X-linked dominant; Rett syndrome, atypical, 312750 (3), X-linked dominant; Rett syndrome, preserved speech variant, 312750 (3), X-linked dominant",Mecp2 (MGI:99918)
X,154137726,154144285,Xq28,Xq28,300824,OPN1C,"OPN1LW and OPN1MW genes, controller of",NA,107604627,NA,NA,NA,NA
X,154144242,154159031,Xq28,Xq28,300822,"OPN1LW, RCP, CBP, CBBM","Red cone pigment (opsin 1, long-wave-sensitive)",OPN1LW,5956,ENSG00000102076,5' to CBD,"Blue cone monochromacy, 303700 (3), X-linked recessive; Colorblindness, protan, 303900 (3), X-linked",Opn1mw (MGI:1097692)
X,154182595,154196860,Xq28,Xq28,300821,"OPN1MW, GCP, CBD, CBBM","Green cone pigment (opsin 1, medium-wave-sensitive)",OPN1MW,2652,ENSG00000268221,linked to G6PD; multiple genes,"Blue cone monochromacy, 303700 (3), X-linked recessive; Colorblindness, deutan, 303800 (3), X-linked",NA
X,154271264,154295355,Xq28,Xq28,300092,TEX28,Testis-expressed gene on Xq28,TEX28,1527,ENSG00000278057,NA,NA,Tex28 (MGI:2686384)
X,154295794,154330362,Xq28,Xq28,300044,"TKTL1, TKT2, TKR",Transketolase-like 1,TKTL1,8277,ENSG00000007350,between GCP and FLN1,NA,Tktl1 (MGI:1933244)
X,154348530,154374637,Xq28,Xq28,300017,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2","Filamin A, alpha (actin-binding protein-280)",FLNA,2316,ENSG00000196924,mutation identified in 1 FGS2 patient,"Cardiac valvular dysplasia, X-linked, 314400 (3), X-linked recessive; Congenital short bowel syndrome, 300048 (3), X-linked recessive; ?FG syndrome 2, 300321 (3), X-linked; Frontometaphyseal dysplasia 1, 305620 (3), X-linked recessive; Heterotopia, periventricular, 1, 300049 (3), X-linked dominant; Intestinal pseudoobstruction, neuronal, 300048 (3), X-linked recessive; Melnick-Needles syndrome, 309350 (3), X-linked dominant; Otopalatodigital syndrome, type I, 311300 (3), X-linked dominant; Otopalatodigital syndrome, type II, 304120 (3), X-linked dominant; Terminal osseous dysplasia, 300244 (3), X-linked dominant",Flna (MGI:95556)
X,154379235,154381522,Xq28,Xq28,300384,"EMD, EDMD, STA",Emerin,EMD,2010,ENSG00000102119,in distal Xq28,"Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3), X-linked recessive",Emd (MGI:108117)
X,154398064,154402338,Xq28,Xq28,312173,"RPL10, DXS648, QM, AUTSX5, MRXS35",Ribosomal protein L10,RPL10,6134,ENSG00000147403,NA,"{Autism, susceptibility to, X-linked 5}, 300847 (3); Mental retardation, X-linked, syndromic, 35, 300998 (3), X-linked recessive",Rpl10 (MGI:105943)
X,154401235,154412100,Xq28,Xq28,300081,"DNASE1L1, DNL1L",Deoxyribonuclease I-like 1,DNASE1L1,1774,ENSG00000013563,between QM and DXS1010E,NA,Dnase1l1 (MGI:109628)
X,154411517,154421725,Xq28,Xq28,300394,"TAZ, EFE2, BTHS, CMD3A, LVNCX",Tafazzin,TAZ,6901,ENSG00000102125,NA,"Barth syndrome, 302060 (3), X-linked recessive",Taz (MGI:109626)
X,154428668,154436515,Xq28,Xq28,300197,"ATP6AP1, ATP6IP1, ATP6S1, VATPS1","ATPase, H+ transporting, lysosomal, accessory protein 1",ATP6AP1,537,ENSG00000071553,NA,"Immunodeficiency 47, 300972 (3), X-linked recessive",Atp6ap1 (MGI:109629)
X,154437153,154443466,Xq28,Xq28,300104,"GDI1, RABGD1A, MRX41, MRX48",GDP dissociation inhibitor 1,GDI1,2664,ENSG00000203879,NA,"Mental retardation, X-linked 41, 300849 (3), X-linked dominant",Gdi1 (MGI:99846)
X,154444140,154450653,Xq28,Xq28,300453,"FAM50A, DXS9928E, HXC26","Family with sequence similarity 50, member A",FAM50A,9130,ENSG00000071859,NA,NA,Fam50a (MGI:1351626)
X,154458280,154477778,Xq28,Xq28,300022,SEX,Sex chromosome X transmembrane protein of HGF receptor family 3,PLXNA3,55558,ENSG00000130827,NA,NA,Plxna3 (MGI:107683)
X,154477768,154479256,Xq28,Xq28,300060,"LAGE3, ITBA2, GAMOS2",L antigen family member 3,LAGE3,8270,ENSG00000196976,NA,"Galloway-Mowat syndrome 2, X-linked, 301006 (3), X-linked recessive",NA
X,154483716,154486614,Xq28,Xq28,312070,"UBL4A, GDX, UBL4, DX254E",Ubiquitin-like 4A,UBL4A,8266,ENSG00000102178,40kb 3' to G6PD,NA,"Ubl4a,Gm44504 (MGI:95049,MGI:5621304)"
X,154487309,154490655,Xq28,Xq28,312090,"SLC10A3, P3",Solute carrier family 10 (sodium/bile acid cotransporter family) member 3 (protein p3),SLC10A3,8273,ENSG00000126903,order: G6PD-3'-(7kb)-5'-P3-3'-(0.5kb)-5'-GDX,NA,Slc10a3 (MGI:95048)
X,154506158,154516256,Xq28,Xq28,300492,FAM3A,"Family with sequence similarity 3, member A",FAM3A,60343,ENSG00000071889,NA,NA,Fam3a (MGI:1913544)
X,154531389,154547568,Xq28,Xq28,305900,"G6PD, G6PD1",Glucose-6-phosphate dehydrogenase,G6PD,2539,ENSG00000160211,NA,"Hemolytic anemia, G6PD deficient (favism), 300908 (3), X-linked dominant; {Resistance to malaria due to G6PD deficiency}, 611162 (3)",G6pdx (MGI:105979)
X,154542211,154565045,Xq28,Xq28,300248,"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33, EDAID1","Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)",IKBKG,8517,ENSG00000269335,NA,"Ectodermal dysplasia and immunodeficiency 1, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency 33, 300636 (3), X-linked recessive; Immunodeficiency, isolated, 300584 (3); Incontinentia pigmenti, 308300 (3), X-linked dominant; Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)",Ikbkg (MGI:1338074)
X,154585132,154586815,Xq28,Xq28,300657,"CTAG1A, LAGE2A",Cancer/testis antigen 1A,CTAG1A,246100,ENSG00000268651,NA,NA,NA
X,154617608,154619270,Xq28,Xq28,300156,"CTAG1B, CTAG1",Cancer/testis antigen 1B,CTAG1B,1485,ENSG00000184033,NA,NA,NA
X,154651971,154653578,Xq28,Xq28,300396,"CTAG2, LAGE1, CAMEL",Cancer/testis antigen 2,CTAG2,30848,ENSG00000126890,NA,NA,NA
X,154675248,154751582,Xq28,Xq28,300482,GAB3,GRB2-associated binding protein 3,GAB3,139716,ENSG00000160219,NA,NA,Gab3 (MGI:2387324)
X,154762741,154777688,Xq28,Xq28,300126,"DKC1, DKCX",Dyskerin,DKC1,1736,ENSG00000130826,NA,"Dyskeratosis congenita, X-linked, 305000 (3), X-linked recessive",Dkc1 (MGI:1861727)
X,154778683,154805526,Xq28,Xq28,305360,"MPP1, PEMP, EMP55","Membrane protein, palmitoylated-1, 55kD",MPP1,4354,ENSG00000130830,~30kb 3' and centromeric to F8,NA,Mpp1 (MGI:105941)
X,154835787,155022722,Xq28,Xq28,300841,"F8, F8C, HEMA","Coagulation factor VIII, procoagulant component",F8,2157,ENSG00000185010,cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere,"Hemophilia A, 306700 (3), X-linked recessive",F8 (MGI:88383)
X,154886359,154888060,Xq28,Xq28,305423,"F8A, DXS522E, HAP40",Factor VIII associated gene 1,F8A1,8263,ENSG00000277203,"3 copies, 1 in intron 22 of F8C",NA,F8a (MGI:95474)
X,155064033,155071135,Xq28,Xq28,300116,MTCP1,Mature T-cell proliferation 1,MTCP1,4515,ENSG00000214827,NA,NA,NA
X,155071402,155126765,Xq28,Xq28,300617,"BRCC3, BRCC36","BRCA1/BRCA2-containing complex, subunit 3",BRCC3,79184,ENSG00000185515,NA,NA,Brcc3 (MGI:2389572)
X,155197006,155239840,Xq28,Xq28,300133,VBP1,Von Hippel-Lindau binding protein-1,VBP1,7411,ENSG00000155959,NA,NA,Vbp1 (MGI:1333804)
X,155258234,155264490,Xq28,Xq28,300774,"RAB39B, MRX72, WSMN",Ras-associated protein RAB39B,RAB39B,116442,ENSG00000155961,mutation identified in 1 WSMN family,"Mental retardation, X-linked 72, 300271 (3), X-linked recessive; ?Waisman syndrome, 311510 (3), X-linked recessive",Rab39b (MGI:1915040)
X,155276210,155334613,Xq28,Xq28,300138,"CLIC2, XAP121, MRXS32",Chloride intracellular channel 2,CLIC2,1193,ENSG00000155962,mutation identified in 1 MRXS32 family,"?Mental retardation, X-linked, syndromic 32, 300886 (3), X-linked recessive",NA
X,155459418,155459934,Xq28,Xq28,300445,"H2AFB, H2ABBD","H2A histone family, member B",H2AFB3,83740,ENSG00000277745,NA,NA,"H2afb2,H2afb1,H2afb3 (MGI:3644875,MGI:3644980,MGI:3642445)"
X,155489010,155612951,Xq28,Xq28,300777,"TMLHE, BBOX2, TMLH, TMLHED, AUTSX6",Epsilon-trimethyllysine hydroxylase,TMLHE,55217,ENSG00000185973,NA,"{Autism, susceptibility to, X-linked 6}, 300872 (3), X-linked recessive",Tmlhe (MGI:2180203)
X,155612564,155782458,Xq28,Xq28,300531,SPRY3,"Sprouty, Drosophila, homolog of, 3",SPRY3,10251,ENSG00000168939,in pseudoautosomal region PAR2,NA,Spry3 (MGI:1345188)
X,155881279,155943768,Xq28,Xq28,300053,"VAMP7, SYBL1, TIVAMP",Vesicle-associated membrane protein 7,VAMP7,6845,ENSG00000124333,NA,NA,Vamp7 (MGI:1096399)
X,155997630,156013016,Xq28,Xq28,300007,IL9R,Interleukin-9 receptor,IL9R,3581,ENSG00000124334,in PAR2 pseudoautosomal region,NA,Il9r (MGI:96564)
X,0,156040895,Chr.X,NA,300864,CCCSX,"Cerebral-cerebellar-coloboma syndrome, X-linked",NA,100820758,NA,NA,"Cerebral-cerebellar-coloboma syndrome, X-linked, 300864 (2), X-linked recessive",NA
X,0,156040895,Chr.X,NA,300471,CVMRF,Cubitus valgus with mental retardation and unusual facies,NA,494028,NA,NA,"Cubitus valgus with mental retardation and unusual facies, 300471 (2), X-linked recessive",NA
X,0,156040895,Chr.X,NA,300719,DFCTRPS,"Deafness, cataract, retinitis pigmentosa, and sperm abnormalities",NA,100188774,NA,NA,"Deafness, cataract, retinitis pigmentosa, and sperm abnormalities, 300719 (2), X-linked recessive",NA
X,0,156040895,Chr.X,NA,300345,MCOPCB1,"Microphthalmia, isolated, with coloboma 1",NA,85503,NA,NA,"Microphthalmia with coloboma 1, 300345 (2)",NA
X,0,156040895,Chr.X,NA,300716,MRX95,"Mental retardation, X-linked 95",NA,102775568,NA,NA,"Mental retardation, X-linked 95, 300716 (2), X-linked dominant",NA
X,0,156040895,Chr.X,NA,300519,MRXSMP,"Mental retardation, X-linked, syndromic, Martin-Probst type",NA,574047,NA,NA,"Mental retardation, X-linked, syndromic, Martin-Probst type, 300519 (2), X-linked recessive",NA
X,0,156040895,Chr.X,NA,300484,OFD8,Orofaciodigital syndrome VIII,NA,NA,NA,NA,"Orofaciodigital syndrome VIII, 300484 (2), X-linked recessive",NA
X,0,156040895,Chr.X,NA,300331,THCYTX,"Thrombocythemia, X-linked",NA,84434,NA,NA,"Thrombocythemia, X-linked, 300331 (2), X-linked recessive",NA
Y,0,300000,Yp11.32,NA,400046,PLCXD1Y,"Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 1",NA,NA,NA,in pseudoautosomal region,NA,NA
Y,0,10400000,Yp11,NA,489500,XGR,XG regulator,XGR,7501,NA,in pseudoautosomal region,NA,NA
Y,624343,659410,Ypter-p11.2,Yp11.2,400020,SHOXY,"Short stature homeo box, Y-linked",SHOX,6473,ENSG00000185960,pseudoautosomal,"Langer mesomelic dysplasia, 249700 (3); Leri-Weill dyschondrosteosis, 127300 (3); Short stature, idiopathic familial, 300582 (3)",NA
Y,1190436,1212761,Yp11.3,Yp11.2,400023,CRLF2Y,"Cytokine receptor-like factor 2, Y-linked",CRLF2,64109,ENSG00000205755,pseudoautosomal,NA,NA
Y,1268799,1325096,Yp11,Yp11.2,425000,CSF2RY,"Granulocyte-macrophage colony-stimulating factor receptor, alpha subunit (Y chromosome)",CSF2RA,1438,ENSG00000198223,306250 = X homolog; distal to MIC2Y,NA,Csf2ra (MGI:1339754)
Y,1336573,1382688,Yp11.3,Yp11.2,430000,"IL3RA, IL3RY, IL3RAY",Interleukin-3 receptor (Y chromosome),IL3RA,3563,ENSG00000185291,308385 = X homolog; pseudoautosomal,NA,NA
Y,1386151,1392112,Yp,Yp11.2,403000,ANT3Y,Adenine nucleotide translocator-3 (Y chromosome),SLC25A6,293,ENSG00000169100,300151 = X homolog; proximal to CSF2RY,NA,NA
Y,1403138,1453793,Ypter-p11.2,Yp11.2,400011,ASMTLY,"Acetylserotonin methyltransferase-like, Y-linked",ASMTL,8623,ENSG00000169093,NA,NA,NA
Y,1591592,1602519,Ypter-p11.2,Yp11.2,465000,"AKAP17A, SFRS17A, XE7Y",A kinase (PRKA) anchor protein 17A,AKAP17A,8227,ENSG00000197976,see 300015 locus,NA,NA
Y,1595454,1643080,Ypter-p11.2,Yp11.2,402500,ASMTY,Acetylserotonin methyltransferase (Y chromosome),ASMT,438,ENSG00000196433,pseudoautosomal,NA,NA
Y,2691132,2741308,Ypter-p11.2,Yp11.2,450000,MIC2Y,"Antigen identified by monoclonal 12E7, Y homolog",CD99,4267,ENSG00000002586,pseudoautosomal,NA,NA
Y,2786854,2787681,Yp11.3,Yp11.2,480000,"SRY, TDF, TDY, SRXX1, SRXY1",Sex-determining region Y (testis determining factor),SRY,6736,ENSG00000184895,NA,"46XX sex reversal 1, 400045 (4), X-linked dominant; 46XY sex reversal 1, 400044 (3), Y-linked",NA
Y,2841601,2867267,Yp11.3,Yp11.2,470000,RPS4Y1,"Ribosomal protein S4, Y-linked, 1",RPS4Y1,6192,ENSG00000129824,NA,NA,Rps4x (MGI:98158)
Y,2935380,2982507,Yp11.3,Yp11.2,490000,ZFY,"Zinc finger protein, Y-linked",ZFY,7544,ENSG00000067646,NA,NA,NA
Y,3579084,3580040,Yp11.2,Yp11.2,400025,"TGIF2LY, TGIFLY","Transforming growth factor-beta-induced factor 2-like, Y-linked",TGIF2LY,90655,ENSG00000176679,NA,NA,NA
Y,5000043,5742227,Yp11.2,Yp11.2,400022,"PCDH11Y, PCDH22, PCDHY",Protocadherin 22,PCDH11Y,83259,ENSG00000099715,NA,NA,NA
Y,6865917,6874026,Yp11,Yp11.2,410000,"AMELY, AMGL",Amelogenin (Y chromosome),AMELY,266,ENSG00000099721,301200 = X homolog,NA,Amelx (MGI:88005)
Y,6908593,7107153,Yp11.2,Yp11.2,400033,"TBL1Y, DFNY2","Transducin-beta-like 1, Y-linked",TBL1Y,90665,ENSG00000092377,mutation identified in 1 DFNY2 family,"?Deafness, Y-linked 2, 400047 (3), Y-linked",NA
Y,7273971,7381546,Yp11.2,Yp11.2,400008,PRKY,"Protein kinase, Y-linked",PRKY,5616,ENSG00000099725,NA,NA,NA
Y,9466954,9469755,Ypter-p11.2,Yp11.2,480100,"TSPY1, TSPY","Testis-specific protein, Y-linked, 1",TSPY1,7258,ENSG00000258992,NA,NA,NA
Y,10400000,26600000,Yq11,NA,400042,"DELYq11, CYDELq11, SPGFY1",Chromosome Yq11 interstitial deletion syndrome,NA,NA,NA,contiguous gene deletion syndrome,"Spermatogenic failure, Y-linked, 1, 400042 (4)",NA
Y,10400000,57227415,Yq,NA,425500,HEY,"Hairy ears, Y-linked",NA,100188776,NA,NA,"?Hairy ears, Y-linked, 425500 (2), Y-linked",NA
Y,10600000,26600000,Yq11.2,NA,400032,CYorf15B,Chromosome Y open reading frame 15B,NA,NA,NA,NA,NA,NA
Y,12701230,12860838,Yq11.2,Yq11.221,400005,"USP9Y, DFFRY, SPGFY2","Ubiquitin-specific protease-9, Y chromosome (Drosophila fat facets related, Y-linked)",USP9Y,8287,ENSG00000114374,NA,"Spermatogenic failure, Y-linked, 2, 415000 (3), Y-linked",Usp9y (MGI:1313274)
Y,12903998,12920477,Yq11,Yq11.221,400010,"DDX3Y, DBY","DEAD/H box-3, Y-linked",DDX3Y,8653,ENSG00000067048,NA,NA,Ddx3y (MGI:1349406)
Y,13231826,13480669,Yq11,Yq11.221,400009,UTY,Ubiquitously transcribed TPR gene on Y chromosome,UTY,7404,ENSG00000183878,NA,NA,NA
Y,13703898,13706023,Yq11.221,Yq11.221,400017,TMSB4Y,"Thymosin, beta-4, Y chromosome",TMSB4Y,9087,ENSG00000154620,NA,NA,NA
Y,13985771,13986511,Yq11.221,Yq11.221,400012,"VCY, BPY1","Variably charged, Y chromosome",VCY,9084,ENSG00000129864,NA,NA,NA
Y,14522615,14845653,Yq11.2,Yq11.221,400028,"NLGN4Y, KIAA0951","Neuroligin 4, Y-linked",NLGN4Y,22829,ENSG00000165246,NA,NA,NA
Y,17768979,17770559,Yq11.222,Yq11.222,400015,XKRY,XK-related protein on Y chromosome,XKRY,9082,NA,NA,NA,NA
Y,18025786,18027745,Yq11.221,Yq11.222,400018,CDY2,"Chromodomain protein, Y chromosome, 2",CDY2A,9426,ENSG00000182415,NA,NA,NA
Y,18529677,18588962,Yq11.2,Yq11.222,400029,HSFY,"Heat shock transcription factor, Y-linked",HSFY1,86614,ENSG00000172468,NA,NA,Hsfy2 (MGI:1918316)
Y,19567357,19607169,Yq11.2,Yq11.222-q11.223,400031,CYorf15A,Chromosome Y open reading frame 15A,TXLNGY,246126,ENSG00000131002,NA,NA,NA
Y,19703864,19745340,Yq11,Yq11.223,426000,"KDM5D, JARID1D, SMCY, HYA",Lysine-specific demethylase 5D,KDM5D,8284,ENSG00000012817,encodes H-Y epitope in mouse,NA,Kdm5d (MGI:99780)
Y,20575710,20593153,Yq11.223,Yq11.223,400014,EIF1AY,"Eukaryotic translation initiation factor 1A, Y isoform",EIF1AY,9086,ENSG00000198692,NA,NA,Eif1ax (MGI:1913485)
Y,20756107,20781031,Yq11.2,Yq11.223,400030,RPS4Y2,"Ribosomal protein S4, Y-linked",RPS4Y2,140032,ENSG00000280969,NA,NA,NA
Y,21534878,21559682,Yq11,Yq11.223,400006,"RBMY1A1, RBM1, YRRM1, RBM2","RNA binding motif protein, Y chromosome, family 1, member A1",RBMY1A1,5940,ENSG00000234414,NA,NA,NA
Y,22071755,22096006,Yq11.2,Yq11.223,400041,PRY2,"PTPBL-related gene on Y, 2",PRY2,442862,ENSG00000169807,NA,NA,NA
Y,22296797,22298875,Yq11.223,Yq11.223,400038,TTTY5,"Testis-specific transcript, Y-linked, 5",TTTY5,83863,ENSG00000215560,NA,NA,NA
Y,22439592,22441458,Yq11.223,Yq11.223,400039,TTTY6,"Testis-specific transcript, Y-linked, 6",TTTY6,84672,ENSG00000131538,NA,NA,NA
Y,22490290,22516302,Yq11.223,Yq11.223,400019,PRY,"PTPN13-like, Y-linked",PRY,9081,ENSG00000169789,NA,NA,NA
Y,22851583,22852714,Yq11.223,Yq11.223,400040,TTY17,"Testis-specific transcript, Y-linked, 17",TTTY17A,252949,ENSG00000228240,NA,NA,NA
Y,22936454,22973283,Yq11.223,Yq11.223,400037,TTTY4,"Testis-specific transcript, Y-linked, 4",TTTY4,114761,ENSG00000226906,NA,NA,NA
Y,22984262,23005464,Yq,Yq11.223,400013,BPY2,"Basic protein on Y chromosome, 2",BPY2,9083,ENSG00000183753,NA,NA,NA
Y,23129354,23199116,Yq11,Yq11.223,400003,DAZ,Deleted in azoospermia,DAZ1,1617,ENSG00000188120,?same as AZF,?Sertoli-cell-only syndrome (1),NA
Y,23219456,23291355,Yq11.2,Yq11.223,400026,DAZ2,Deleted in azoospermia 2,DAZ2,57055,ENSG00000205944,NA,NA,Dazl (MGI:1342328)
Y,24209966,24214830,Yq11.23,Yq11.23,400035,GOLGA2LY,"Golgi autoantigen, golgin subfamily A, 2-like, Y-linked",GOLGA2P2Y,84559,ENSG00000239533,NA,NA,NA
Y,24763068,24813491,Yq11.2,Yq11.23,400027,DAZ3,Deleted in azoospermia 3,DAZ3,57054,ENSG00000187191,NA,NA,NA
Y,25482907,25486704,Yq11.23,Yq11.23,400034,"CSPG4P1Y, CSPG4LY","Chondroitin sulfate proteoglycan 4 pseudogene 1, Y-linked",CSPG4P1Y,114758,ENSG00000240450,NA,NA,NA
Y,25622094,25625510,Yq11.23,Yq11.23,400016,"CDY1, CDY","Chromodomain protein, Y chromosome",CDY1,9085,ENSG00000172288,NA,NA,NA
Y,25728489,25733387,Yq11.23,Yq11.23,400036,TTTY3,"Testis-specific transcript, Y-linked, 3",TTTY3,114760,ENSG00000231141,NA,NA,NA
Y,26600000,57227415,Yq12,NA,475000,"GCY, TSY, STA","Growth control, Y-chromosome influenced",GCY,2656,NA,NA,NA,NA
Y,0,57227415,Chr.Y,NA,400043,DFNY1,"Deafness, Y-linked 1",DFNY1,724074,NA,NA,"Deafness, Y-linked 1, 400043 (2), Y-linked",NA
Y,0,57227415,Chr.Y,NA,400004,RPY,"Retinitis pigmentosa, Y-linked",NA,79051,NA,NA,"Retinitis pigmentosa, Y-linked, 400004 (2), Y-linked",NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Source of data in fields are as follows:,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# -------------------------------,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Chromosome (NCBI),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Genomic position start * (NCBI),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Genomic position end (NCBI),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Cyto location (OMIM),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Computed cyto location (UCSC),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# MIM Number for Gene/Locus (OMIM),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Gene symbols (OMIM),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Gene name (OMIM),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Approved gene symbol (HGNC),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Entrez gene ID (NCBI),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Ensembl gene ID (Ensembl),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Comments (OMIM),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Phenotype(s) (OMIM),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Mouse gene symbol & ID (MGI),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# * for phenotypes with mapping key of (2) or genes not found in NCBI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"# data, genomic coordinates are derived from OMIM's cyto location mapped",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# to genomic using UCSC table.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# OMIM Phenotype field is nested:,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# -------------------------------,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"# Each Phenotype is followed by its MIM number, if different from",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"# that of the locus, preceded by a comma",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Phenotype mapping key in parentheses follows the phenotype MIM,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# number (explanation below).,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Allelic disorders are separated by a semi-colon following the,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# phenotype mapping key.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Inheritance for the phenotype follows the phenotype mapping key,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"# preceded by a ,<space>",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Explanation of the symbols and question marks (?) in the Phenotype,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# field is given in OMIM FAQ 1.6),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Phenotype Mapping Method - Appears in parentheses after a disorder :,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# --------------------------------------------------------------------,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# 1 - the disorder is placed on the map based on its association with,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"# a gene, but the underlying defect is not known.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# 2 - the disorder has been placed on the map by linkage; no mutation has,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# been found.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# 3 - the molecular basis for the disorder is known; a mutation has been,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# found in the gene.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"# 4 - a contiguous gene deletion or duplication syndrome, multiple genes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# are deleted or duplicated causing the phenotype.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# Genomic Coordinates - GRCh38 :,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# ------------------------------,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"# The genomic coordinates for the genes are for GRCh38, if you need",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"# coordinates for for GRCh37, you can get them from this file and use",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
# the MIM number or the Entrez gene ID to map them:,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#   ftp://ftp.ncbi.nlm.nih.gov//genomes/H_sapiens/ARCHIVE/ANNOTATION_RELEASE.105/GFF/ref_GRCh37.p13_top_level.gff3.gz,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
#,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
